Gene	"Gene synonym"	Ensembl	"Gene description"	Uniprot	Chromosome	Position	"Protein class"	"Biological process"	"Molecular function"	"Disease involvement"	Evidence	"HPA evidence"	"UniProt evidence"	"NeXtProt evidence"	"MS evidence"	"RNA tissue specificity"	"RNA tissue distribution"	"RNA tissue specificity score"	"RNA tissue specific NX"	"RNA single cell type specificity"	"RNA single cell type distribution"	"RNA single cell type specificity score"	"RNA single cell type specific NX"	"RNA cancer specificity"	"RNA cancer distribution"	"RNA cancer specificity score"	"RNA cancer specific FPKM"	"RNA brain regional specificity"	"RNA brain regional distribution"	"RNA brain regional specificity score"	"RNA brain regional specific NX"	"RNA blood cell specificity"	"RNA blood cell distribution"	"RNA blood cell specificity score"	"RNA blood cell specific NX"	"RNA blood lineage specificity"	"RNA blood lineage distribution"	"RNA blood lineage specificity score"	"RNA blood lineage specific NX"	"RNA cell line specificity"	"RNA cell line distribution"	"RNA cell line specificity score"	"RNA cell line specific NX"	"RNA mouse brain regional specificity"	"RNA mouse brain regional distribution"	"RNA mouse brain regional specificity score"	"RNA mouse brain regional specific pTPM"	"RNA pig brain regional specificity"	"RNA pig brain regional distribution"	"RNA pig brain regional specificity score"	"RNA pig brain regional specific pTPM"	Antibody	"Reliability (IH)"	"Reliability (Mouse Brain)"	"Reliability (IF)"	"Subcellular location"	"Secretome location"	"CCD Protein"	"CCD Transcript"	"Blood concentration - Conc. blood IM [pg/L]"	"Blood concentration - Conc. blood MS [pg/L]"	"Subcellular main location"	"Subcellular additional location"	"Antibody RRID"	"Pathology prognostics - Breast cancer"	"Pathology prognostics - Cervical cancer"	"Pathology prognostics - Colorectal cancer"	"Pathology prognostics - Endometrial cancer"	"Pathology prognostics - Glioma"	"Pathology prognostics - Head and neck cancer"	"Pathology prognostics - Liver cancer"	"Pathology prognostics - Lung cancer"	"Pathology prognostics - Melanoma"	"Pathology prognostics - Ovarian cancer"	"Pathology prognostics - Pancreatic cancer"	"Pathology prognostics - Prostate cancer"	"Pathology prognostics - Renal cancer"	"Pathology prognostics - Stomach cancer"	"Pathology prognostics - Testis cancer"	"Pathology prognostics - Thyroid cancer"	"Pathology prognostics - Urothelial cancer"	"Tissue RNA - adipose tissue [NX]"	"Tissue RNA - adrenal gland [NX]"	"Tissue RNA - amygdala [NX]"	"Tissue RNA - appendix [NX]"	"Tissue RNA - basal ganglia [NX]"	"Tissue RNA - bone marrow [NX]"	"Tissue RNA - breast [NX]"	"Tissue RNA - cerebellum [NX]"	"Tissue RNA - cerebral cortex [NX]"	"Tissue RNA - cervix, uterine [NX]"	"Tissue RNA - colon [NX]"	"Tissue RNA - corpus callosum [NX]"	"Tissue RNA - ductus deferens [NX]"	"Tissue RNA - duodenum [NX]"	"Tissue RNA - endometrium 1 [NX]"	"Tissue RNA - epididymis [NX]"	"Tissue RNA - esophagus [NX]"	"Tissue RNA - fallopian tube [NX]"	"Tissue RNA - gallbladder [NX]"	"Tissue RNA - heart muscle [NX]"	"Tissue RNA - hippocampal formation [NX]"	"Tissue RNA - hypothalamus [NX]"	"Tissue RNA - kidney [NX]"	"Tissue RNA - liver [NX]"	"Tissue RNA - lung [NX]"	"Tissue RNA - lymph node [NX]"	"Tissue RNA - midbrain [NX]"	"Tissue RNA - olfactory region [NX]"	"Tissue RNA - ovary [NX]"	"Tissue RNA - pancreas [NX]"	"Tissue RNA - parathyroid gland [NX]"	"Tissue RNA - pituitary gland [NX]"	"Tissue RNA - placenta [NX]"	"Tissue RNA - pons and medulla [NX]"	"Tissue RNA - prostate [NX]"	"Tissue RNA - rectum [NX]"	"Tissue RNA - retina [NX]"	"Tissue RNA - salivary gland [NX]"	"Tissue RNA - seminal vesicle [NX]"	"Tissue RNA - skeletal muscle [NX]"	"Tissue RNA - skin 1 [NX]"	"Tissue RNA - small intestine [NX]"	"Tissue RNA - smooth muscle [NX]"	"Tissue RNA - spinal cord [NX]"	"Tissue RNA - spleen [NX]"	"Tissue RNA - stomach 1 [NX]"	"Tissue RNA - testis [NX]"	"Tissue RNA - thalamus [NX]"	"Tissue RNA - thymus [NX]"	"Tissue RNA - thyroid gland [NX]"	"Tissue RNA - tongue [NX]"	"Tissue RNA - tonsil [NX]"	"Tissue RNA - urinary bladder [NX]"	"Tissue RNA - vagina [NX]"	"Tissue RNA - B-cells [NX]"	"Tissue RNA - dendritic cells [NX]"	"Tissue RNA - granulocytes [NX]"	"Tissue RNA - monocytes [NX]"	"Tissue RNA - NK-cells [NX]"	"Tissue RNA - T-cells [NX]"	"Tissue RNA - total PBMC [NX]"	"Cell RNA - A-431 [NX]"	"Cell RNA - A549 [NX]"	"Cell RNA - AF22 [NX]"	"Cell RNA - AN3-CA [NX]"	"Cell RNA - ASC diff [NX]"	"Cell RNA - ASC TERT1 [NX]"	"Cell RNA - BEWO [NX]"	"Cell RNA - BJ [NX]"	"Cell RNA - BJ hTERT+ [NX]"	"Cell RNA - BJ hTERT+ SV40 Large T+ [NX]"	"Cell RNA - BJ hTERT+ SV40 Large T+ RasG12V [NX]"	"Cell RNA - CACO-2 [NX]"	"Cell RNA - CAPAN-2 [NX]"	"Cell RNA - Daudi [NX]"	"Cell RNA - EFO-21 [NX]"	"Cell RNA - fHDF/TERT166 [NX]"	"Cell RNA - GAMG [NX]"	"Cell RNA - HaCaT [NX]"	"Cell RNA - HAP1 [NX]"	"Cell RNA - HBEC3-KT [NX]"	"Cell RNA - HBF TERT88 [NX]"	"Cell RNA - HDLM-2 [NX]"	"Cell RNA - HEK 293 [NX]"	"Cell RNA - HEL [NX]"	"Cell RNA - HeLa [NX]"	"Cell RNA - Hep G2 [NX]"	"Cell RNA - HHSteC [NX]"	"Cell RNA - HL-60 [NX]"	"Cell RNA - HMC-1 [NX]"	"Cell RNA - HSkMC [NX]"	"Cell RNA - hTCEpi [NX]"	"Cell RNA - hTEC/SVTERT24-B [NX]"	"Cell RNA - hTERT-HME1 [NX]"	"Cell RNA - hTERT-RPE1 [NX]"	"Cell RNA - HUVEC TERT2 [NX]"	"Cell RNA - JURKAT [NX]"	"Cell RNA - K-562 [NX]"	"Cell RNA - Karpas-707 [NX]"	"Cell RNA - LHCN-M2 [NX]"	"Cell RNA - MCF7 [NX]"	"Cell RNA - MOLT-4 [NX]"	"Cell RNA - NB-4 [NX]"	"Cell RNA - NTERA-2 [NX]"	"Cell RNA - OE19 [NX]"	"Cell RNA - PC-3 [NX]"	"Cell RNA - REH [NX]"	"Cell RNA - RH-30 [NX]"	"Cell RNA - RPMI-8226 [NX]"	"Cell RNA - RPTEC TERT1 [NX]"	"Cell RNA - RT4 [NX]"	"Cell RNA - SCLC-21H [NX]"	"Cell RNA - SH-SY5Y [NX]"	"Cell RNA - SiHa [NX]"	"Cell RNA - SK-BR-3 [NX]"	"Cell RNA - SK-MEL-30 [NX]"	"Cell RNA - SuSa [NX]"	"Cell RNA - T-47d [NX]"	"Cell RNA - THP-1 [NX]"	"Cell RNA - TIME [NX]"	"Cell RNA - U-138 MG [NX]"	"Cell RNA - U-2 OS [NX]"	"Cell RNA - U-2197 [NX]"	"Cell RNA - U-251 MG [NX]"	"Cell RNA - U-266/70 [NX]"	"Cell RNA - U-266/84 [NX]"	"Cell RNA - U-698 [NX]"	"Cell RNA - U-87 MG [NX]"	"Cell RNA - U-937 [NX]"	"Cell RNA - WM-115 [NX]"	"Blood RNA - basophil [NX]"	"Blood RNA - classical monocyte [NX]"	"Blood RNA - eosinophil [NX]"	"Blood RNA - gdT-cell [NX]"	"Blood RNA - intermediate monocyte [NX]"	"Blood RNA - MAIT T-cell [NX]"	"Blood RNA - memory B-cell [NX]"	"Blood RNA - memory CD4 T-cell [NX]"	"Blood RNA - memory CD8 T-cell [NX]"	"Blood RNA - myeloid DC [NX]"	"Blood RNA - naive B-cell [NX]"	"Blood RNA - naive CD4 T-cell [NX]"	"Blood RNA - naive CD8 T-cell [NX]"	"Blood RNA - neutrophil [NX]"	"Blood RNA - NK-cell [NX]"	"Blood RNA - non-classical monocyte [NX]"	"Blood RNA - plasmacytoid DC [NX]"	"Blood RNA - T-reg [NX]"	"Blood RNA - total PBMC [NX]"	"Brain RNA - amygdala [NX]"	"Brain RNA - basal ganglia [NX]"	"Brain RNA - cerebellum [NX]"	"Brain RNA - cerebral cortex [NX]"	"Brain RNA - hippocampal formation [NX]"	"Brain RNA - hypothalamus [NX]"	"Brain RNA - midbrain [NX]"	"Brain RNA - olfactory region [NX]"	"Brain RNA - pons and medulla [NX]"	"Brain RNA - thalamus [NX]"	"Single Cell Type RNA - Alveolar cells type 1 [NX]"	"Single Cell Type RNA - Alveolar cells type 2 [NX]"	"Single Cell Type RNA - B-cells [NX]"	"Single Cell Type RNA - Basal glandular cells [NX]"	"Single Cell Type RNA - Basal keratinocytes [NX]"	"Single Cell Type RNA - Bipolar cells [NX]"	"Single Cell Type RNA - Cardiomyocytes [NX]"	"Single Cell Type RNA - Cholangiocytes [NX]"	"Single Cell Type RNA - Ciliated cells [NX]"	"Single Cell Type RNA - Club cells [NX]"	"Single Cell Type RNA - Collecting duct cells [NX]"	"Single Cell Type RNA - Cone photoreceptor cells [NX]"	"Single Cell Type RNA - Cytotrophoblasts [NX]"	"Single Cell Type RNA - Distal tubular cells [NX]"	"Single Cell Type RNA - Ductal cells [NX]"	"Single Cell Type RNA - Early spermatids [NX]"	"Single Cell Type RNA - Endothelial cells [NX]"	"Single Cell Type RNA - Enterocytes [NX]"	"Single Cell Type RNA - Erythroid cells [NX]"	"Single Cell Type RNA - Exocrine glandular cells [NX]"	"Single Cell Type RNA - Extravillous trophoblasts [NX]"	"Single Cell Type RNA - Fibroblasts [NX]"	"Single Cell Type RNA - Glandular cells [NX]"	"Single Cell Type RNA - granulocytes [NX]"	"Single Cell Type RNA - Hepatocytes [NX]"	"Single Cell Type RNA - Hofbauer cells [NX]"	"Single Cell Type RNA - Horizontal cells [NX]"	"Single Cell Type RNA - Intestinal endocrine cells [NX]"	"Single Cell Type RNA - Ito cells [NX]"	"Single Cell Type RNA - Kupffer cells [NX]"	"Single Cell Type RNA - Late spermatids [NX]"	"Single Cell Type RNA - Leydig cells [NX]"	"Single Cell Type RNA - Macrophages [NX]"	"Single Cell Type RNA - Melanocytes [NX]"	"Single Cell Type RNA - monocytes [NX]"	"Single Cell Type RNA - Mucus-secreting cells [NX]"	"Single Cell Type RNA - Muller glia cells [NX]"	"Single Cell Type RNA - Pancreatic endocrine cells [NX]"	"Single Cell Type RNA - Paneth cells [NX]"	"Single Cell Type RNA - Peritubular cells [NX]"	"Single Cell Type RNA - Proximal tubular cells [NX]"	"Single Cell Type RNA - Rod photoreceptor cells [NX]"	"Single Cell Type RNA - Sertoli cells [NX]"	"Single Cell Type RNA - Smooth muscle cells [NX]"	"Single Cell Type RNA - Spermatocytes [NX]"	"Single Cell Type RNA - Spermatogonia [NX]"	"Single Cell Type RNA - Suprabasal keratinocytes [NX]"	"Single Cell Type RNA - Syncytiotrophoblasts [NX]"	"Single Cell Type RNA - T-cells [NX]"	"Single Cell Type RNA - Undifferentiated cells [NX]"	"Single Cell Type RNA - Urothelial cells [NX]"
A3GALT2	"A3GALT2P, IGB3S, IGBS3S"	ENSG00000184389	"Alpha 1,3-galactosyltransferase 2"	U3KPV4	1	33306766-33321098	"Enzymes, Predicted membrane proteins"		"Glycosyltransferase, Transferase"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Low tissue specificity"	"Detected in some"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Cell type enriched"	"Detected in single"	15	"neutrophil: 2.1"	"Lineage enriched"	"Detected in single"	15	"granulocytes: 2.1"	"Group enriched"	"Detected in some"	4	"HeLa: 5.2;SiHa: 3.3"	"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"									NA	NA						"unprognostic (1.86e-2)"	"unprognostic (2.36e-2)"		"unprognostic (2.39e-1)"	"unprognostic (1.18e-1)"	"unprognostic (2.61e-3)"		"unprognostic (4.96e-2)"	"unprognostic (6.83e-2)"	"unprognostic (5.81e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.89e-1)"	"unprognostic (4.90e-8)"	"unprognostic (1.17e-1)"		"unprognostic (1.12e-2)"	"unprognostic (7.87e-2)"	0.7	0.1	0.1	1.2	0.2	1.3	0.4	1.3	0.9	0.4	0.2			0.0	0.5	0.0	0.2	0.2	1.4	0.1	0.2	0.1	0.4	0.1	0.5	0.1	0.0		0.4	0.1	0.0	0.4	0.1		0.6	0.0		0.2	0.4	0.2	0.1	0.1	0.2	0.2	0.8	0.3	2.1			0.4		0.0	0.2	0.1	0.0	0.0	2.1	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.5	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.3	0.3	5.2	0.0	0.2	0.0	0.0	0.7	0.2	0.2	0.6	0.4	0.0	0.1	0.0	0.0	0.2	0.0	0.3	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.2	3.3	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	2.1	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
A4GALT	"A14GALT, Gb3S, P(k), P1"	ENSG00000128274	"Alpha 1,4-galactosyltransferase (P blood group)"	Q9NPC4	22	42692112-42721298	"Enzymes, Predicted membrane proteins"	"Lipid biosynthesis, Lipid metabolism"	"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Urothelial cells: 69.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	13	"NK-cell: 1.4;plasmacytoid DC: 3.4"	"Group enriched"	"Detected in many"	13	"dendritic cells: 3.4;NK-cells: 1.4"	"Cell line enhanced"	"Detected in many"		"ASC diff: 21.9;ASC TERT1: 17.9;RPTEC TERT1: 14.8;TIME: 15.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA001141			Uncertain	Mitochondria		NA	NA			Mitochondria		"HPA001141: AB_1078139"	"unprognostic (2.59e-2)"	"prognostic favorable (2.48e-4)"	"unprognostic (2.24e-2)"	"unprognostic (4.54e-3)"	"unprognostic (7.41e-2)"	"unprognostic (1.53e-1)"	"unprognostic (8.20e-2)"	"unprognostic (2.10e-1)"	"unprognostic (2.30e-1)"	"unprognostic (1.28e-1)"	"unprognostic (4.82e-3)"	"unprognostic (4.16e-2)"	"unprognostic (1.80e-2)"	"unprognostic (1.96e-1)"	"unprognostic (8.72e-2)"	"unprognostic (3.46e-2)"	"unprognostic (2.74e-1)"	22.7	5.9	3.5	8.2	3.7	3.8	15.3	1.4	3.8	21.2	12.0	2.3	32.6	4.8	13.0	16.9	15.0	11.7	11.0	26.8	2.3	1.3	30.0	4.4	14.0	6.4	2.9	3.0	11.8	3.4	1.4	7.7	12.6	2.9	15.4	2.1	9.9	15.4	39.8	12.5	8.7	7.0	18.6	5.3	11.4	11.3	6.7	2.4	1.3	10.7	13.0	10.1	16.1	25.6	0.1	3.4	0.0	0.0	1.4	0.0	0.0	0.6	7.4	0.0	0.0	21.9	17.9	11.2	2.9	3.2	0.6	1.1	2.3	1.2	7.2	5.2	5.2	3.8	0.7	7.1	3.5	0.1	0.0	1.4	0.1	11.8	0.2	6.6	0.0	0.5	10.5	1.0	3.1	0.5	1.0	2.6	0.0	0.0	0.0	2.8	10.1	0.0	0.0	0.9	0.5	1.8	0.0	1.7	0.7	14.8	12.7	0.1	0.0	9.1	0.2	0.0	1.4	5.8	0.8	15.7	0.0	1.4	13.4	3.8	1.5	6.8	0.0	3.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	3.4	0.0	0.0	3.5	3.7	1.4	3.8	2.3	1.3	2.9	3.0	2.9	2.4	0.0	0.3	1.4	28.5	8.1	0.0	14.6	2.5	2.7	9.1	17.4	0.0	36.7	11.6	18.0	0.4	40.9	0.0	23.3	1.0	26.1	24.9	31.4	1.1	0.2	4.8	0.0	0.0	22.1	1.8	1.5	42.8	5.4	6.8	52.3	0.0	0.5	3.7	0.0	28.3	45.6	0.4	38.8	39.6	0.4	0.4	7.8	7.9	1.0	0.0	69.8
AACS	"ACSF1, FLJ12389, SUR-5"	ENSG00000081760	"Acetoacetyl-CoA synthetase"	Q86V21	12	125065379-125143333	"Enzymes, Predicted membrane proteins"	"Fatty acid metabolism, Lipid metabolism"	Ligase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Early spermatids: 54.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA058815	Approved		Approved	Vesicles		NA	NA			Vesicles		"HPA058815: AB_2683826"	"unprognostic (1.28e-1)"	"unprognostic (9.78e-2)"	"unprognostic (1.86e-1)"	"unprognostic (1.06e-1)"	"unprognostic (1.98e-3)"	"unprognostic (9.46e-3)"	"unprognostic (6.60e-6)"	"unprognostic (3.03e-2)"	"unprognostic (3.32e-2)"	"unprognostic (2.45e-2)"	"unprognostic (2.38e-2)"	"unprognostic (3.04e-1)"	"unprognostic (2.69e-2)"	"unprognostic (1.69e-1)"	"unprognostic (3.73e-2)"	"unprognostic (7.71e-2)"	"unprognostic (6.80e-2)"	21.1	6.5	9.0	10.5	13.0	2.5	33.7	6.6	22.0	11.7	9.3	5.3	7.4	12.9	5.2	7.7	22.3	6.6	12.9	5.8	8.1	5.6	6.8	3.3	4.9	4.9	5.1	13.1	4.9	9.7	5.8	6.7	4.8	10.0	6.7	8.6	5.1	33.7	12.9	3.7	26.9	8.7	4.5	4.2	4.3	12.7	9.7	3.6	6.8	7.6	12.2	8.7	5.0	9.9	3.0	11.8	6.9	2.3	5.8	5.7	3.8	14.5	14.5	6.3	8.6	23.4	15.3	10.6	11.8	11.3	14.0	12.6	18.7	9.7	9.0	12.2	14.2	6.1	15.9	11.8	12.7	7.6	9.7	10.8	7.2	9.7	14.2	19.5	5.1	7.3	16.9	10.4	11.9	12.1	17.6	10.2	5.3	5.0	5.6	8.9	26.6	5.9	6.8	8.0	15.3	17.2	1.1	16.1	12.4	14.3	22.2	17.0	4.9	12.5	19.8	9.1	6.5	14.8	11.3	9.7	6.8	10.8	7.6	9.0	12.7	7.2	9.8	8.5	8.4	7.4	6.9	2.3	6.7	4.2	0.7	5.4	3.0	3.9	3.2	2.8	1.7	5.7	3.8	0.3	5.8	0.8	11.8	2.4	3.8	9.0	13.0	6.6	22.0	8.1	5.6	5.1	13.1	10.0	3.6	6.0	12.9	0.8	4.9	14.7	16.4	7.3	12.7	0.0	5.7	5.2	25.5	1.8	6.6	9.5	54.0	5.8	9.9	0.0	9.5	7.4	11.4	9.4	2.3	2.5	4.1	6.4	24.2	0.6	3.2	14.6	8.6	2.8	5.0	5.4	20.1	5.4	8.7	5.8	4.9	6.2	20.1	0.0	7.6	12.7	5.4	24.6	2.1	9.2	15.1	4.9
AADAC	"CES5A1, DAC"	ENSG00000114771	"Arylacetamide deacetylase"	P22760	3	151814037-151828488	"Enzymes, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adrenal gland: 66.2;intestine: 81.7;liver: 123.1"	"Cell type enriched"	"Detected in some"	10	"Hepatocytes: 610.4"	"Cancer enriched"	"Detected in many"	22	"liver cancer: 153.4"	"Region enriched"	"Detected in single"	7	"basal ganglia: 1.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A549: 11.9;ASC diff: 4.5;EFO-21: 6.4;HBEC3-KT: 5.7"	"Not detected"	"Not detected"							HPA002911	Approved					NA	NA					"HPA002911: AB_1078074"	"unprognostic (1.26e-1)"	"unprognostic (1.82e-2)"	"unprognostic (8.11e-2)"	"unprognostic (4.41e-2)"		"unprognostic (9.23e-2)"	"unprognostic (7.82e-2)"	"unprognostic (2.15e-1)"	"unprognostic (9.89e-2)"	"prognostic favorable (5.58e-6)"	"prognostic unfavorable (5.02e-4)"			"prognostic unfavorable (2.19e-4)"	"unprognostic (1.22e-1)"		"unprognostic (1.27e-1)"	3.9	66.2	0.1	0.1	1.6	0.0	2.1	0.1	0.1	0.1	26.1	0.5	0.4	29.6	0.1	0.3	0.3	0.2	4.3	0.2	0.1	0.0	0.1	123.1	1.7	0.1	0.1	0.1	0.1	22.7	0.0	0.1	1.7	0.2	0.3	0.0	0.1	0.3	0.1	0.2	1.7	81.7	0.1	0.1	0.1	7.3	0.3	0.1	0.1	0.2	4.8	1.3	0.6	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	11.9	0.0	0.0	4.5	0.2	0.3	0.0	0.0	0.1	0.0	1.1	0.1	0.2	6.4	0.0	0.1	0.4	0.0	5.7	0.0	0.0	0.0	0.0	0.0	0.5	0.4	0.7	0.1	0.1	0.1	0.6	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.2	1.3	0.2	1.4	0.3	0.2	0.4	2.1	0.0	2.3	0.2	1.9	0.3	0.1	0.0	0.0	0.0	0.0	2.5	0.0	2.4	1.4	0.0	0.4	0.0	0.5	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	1.6	0.1	0.1	0.1	0.0	0.1	0.1	0.2	0.1	0.0	11.0	0.0	0.0	0.2	0.0	1.1	58.6	4.0	12.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	44.0	0.0	0.2	0.0	0.0	610.4	0.2	0.0	0.0	3.7	10.8	0.0	0.0	0.0	3.3	0.0	0.0	0.0	3.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	3.0	0.2	0.0	0.0	0.1
AADAT	"KAT2, KATII, KYAT2"	ENSG00000109576	"Aminoadipate aminotransferase"	Q8N5Z0	4	170060222-170091699	"Enzymes, Predicted intracellular proteins"		"Aminotransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"liver: 56.5"	"Cell type enhanced"	"Detected in many"	16	"Extravillous trophoblasts: 60.6;Hepatocytes: 22.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			HPA037502	Enhanced		Approved	"Vesicles,Plasma membrane"		NA	NA			"Plasma membrane"	Vesicles	"HPA037502: AB_10671759"	"unprognostic (1.90e-1)"	"unprognostic (1.82e-2)"	"prognostic favorable (5.59e-4)"	"unprognostic (4.21e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.06e-1)"	"unprognostic (7.41e-2)"	"unprognostic (1.03e-2)"	"unprognostic (2.97e-2)"	"unprognostic (3.38e-2)"	"unprognostic (1.23e-2)"	"unprognostic (3.55e-1)"	"unprognostic (1.35e-1)"	"unprognostic (1.23e-2)"	"unprognostic (1.39e-1)"	"unprognostic (7.28e-3)"	"unprognostic (1.17e-2)"	3.0	3.1	9.2	2.2	9.0	0.9	4.7	0.8	10.8	8.3	4.7	10.3	2.9	1.9	9.7	5.8	2.8	5.7	3.9	2.8	7.2	6.4	6.3	56.5	4.7	1.1	8.2	8.0	4.7	4.6	7.6	8.9	2.2	6.0	13.3	5.0	6.6	1.7	5.4	3.6	1.8	2.0	7.0	7.0	2.0	3.2	7.2	9.2	0.9	7.0	1.2	1.3	5.5	4.9	0.4	0.4	0.0	0.7	0.0	0.7	0.0	2.2	5.5	16.7	0.0	3.3	13.0	6.0	5.7	2.8	3.3	3.3	5.3	0.6	0.0	0.9	6.3	4.3	1.9	7.4	2.7	2.3	0.0	6.4	0.0	6.2	8.9	2.7	0.0	2.4	5.3	1.6	2.7	3.5	9.1	3.1	7.5	0.9	0.1	12.6	5.6	2.7	0.1	12.6	6.2	5.0	0.0	5.2	0.0	2.9	10.0	13.5	15.7	4.5	1.1	5.4	5.6	0.0	1.1	2.1	8.4	9.0	9.5	8.8	0.0	0.0	0.0	8.4	0.0	9.8	0.0	0.7	0.0	0.0	0.1	0.2	0.0	0.3	0.3	0.4	0.4	0.3	0.0	0.0	0.0	0.2	0.0	0.7	0.0	9.2	9.0	0.8	10.8	7.2	6.4	8.2	8.0	6.0	9.2	0.0	5.1	0.0	2.6	0.8	5.1	1.1	2.5	14.7	3.4	0.0	2.0	1.4	0.0	1.3	0.4	0.5	0.0	0.0	1.9	60.6	2.4	3.6	0.0	22.9	1.4	0.0	6.4	0.0	0.3	0.6	1.1	0.6	1.7	0.0	1.3	3.2	0.9	0.0	2.1	6.5	8.2	6.5	2.2	2.4	12.5	0.4	4.7	0.0	2.3	1.4
AAK1	"DKFZp686K16132, KIAA1048"	ENSG00000115977	"AP2 associated kinase 1"	Q2M2I8	2	69457997-69674349	"Enzymes, Predicted intracellular proteins"	Endocytosis	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	4	"parathyroid gland: 109.7"	"Cell type enhanced"	"Detected in all"	9	"Cone photoreceptor cells: 732.4;Rod photoreceptor cells: 621.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA017931, HPA020289"	Enhanced		Approved	"Vesicles,Plasma membrane,Cytosol"		NA	No			"Vesicles, Plasma membrane"	Cytosol	"HPA017931: AB_1844406, HPA020289: AB_1844407"	"unprognostic (2.11e-3)"	"unprognostic (3.18e-2)"	"unprognostic (3.67e-1)"	"unprognostic (1.01e-3)"	"unprognostic (5.06e-2)"	"unprognostic (4.04e-2)"	"unprognostic (4.23e-2)"	"unprognostic (1.14e-1)"	"unprognostic (3.52e-1)"	"prognostic unfavorable (3.19e-4)"	"unprognostic (1.24e-1)"	"unprognostic (7.65e-2)"	"unprognostic (4.18e-2)"	"unprognostic (1.30e-1)"	"unprognostic (5.40e-2)"	"unprognostic (6.76e-3)"	"unprognostic (1.18e-1)"	5.1	5.9	11.0	5.7	11.9	7.8	6.9	25.2	26.5	4.8	4.2	3.9	6.3	3.8	4.7	7.1	3.8	4.9	4.3	7.9	14.4	12.8	7.2	3.1	7.5	6.8	9.4	11.6	3.3	6.7	109.7	10.3	6.9	10.2	5.0	4.6	4.7	3.6	12.3	6.8	3.7	3.7	5.4	9.3	5.5	5.4	4.1	6.9	4.7	16.0	2.1	5.3	4.9	5.8	1.0	0.8	4.1	3.9	2.8	5.6	1.3	16.8	10.1	9.3	9.0	8.9	9.9	29.9	13.7	10.9	8.3	7.4	10.2	6.7	0.6	3.4	17.9	11.4	7.9	7.1	7.1	17.0	12.5	3.0	9.1	6.1	6.9	8.1	6.4	21.7	8.5	6.3	15.6	20.3	6.8	17.6	8.6	1.9	9.5	14.4	2.8	5.9	3.4	4.4	3.1	5.6	3.9	10.0	1.4	6.6	35.3	3.1	4.9	7.9	6.1	7.1	6.4	3.6	9.1	17.5	18.7	12.5	13.4	13.5	9.3	2.4	1.0	15.6	10.9	12.7	2.5	1.4	0.6	4.5	0.6	4.2	0.4	4.0	3.0	0.8	1.0	5.6	4.5	4.1	2.8	3.9	0.7	3.1	1.3	11.0	11.9	25.2	26.5	14.4	12.8	9.4	11.6	10.2	6.9	32.8	38.8	3.0	17.4	14.2	235.7	71.2	99.3	10.7	23.9	136.1	732.4	65.1	36.5	37.7	19.2	43.8	67.4	23.3	57.5	45.9	24.0	51.4	20.7	30.1	51.9	289.2	69.3	93.9	98.0	23.3	35.4	45.1	10.1	50.5	26.9	42.5	48.8	26.4	43.9	53.7	621.3	19.4	29.2	45.9	51.3	8.7	178.4	135.1	14.6	50.6
AANAT	SNAT	ENSG00000129673	"Aralkylamine N-acetyltransferase"	Q16613	17	76453351-76470117	"Enzymes, Predicted intracellular proteins"	"Biological rhythms, Melatonin biosynthesis"	"Acyltransferase, Transferase"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in some"	5	"retina: 27.7;testis: 8.2"	"Cell type enriched"	"Detected in some"	9	"Bipolar cells: 269.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"A549: 4.6;Daudi: 3.8;SCLC-21H: 5.7;U-266/70: 4.6;U-266/84: 4.8;U-698: 6.8"	"Not detected"	"Not detected"							HPA054321			Supported	Cytosol	"Intracellular and membrane"	NA	NA			Cytosol		"HPA054321: AB_2682449"	"unprognostic (7.89e-2)"	"unprognostic (2.62e-1)"	"unprognostic (1.41e-1)"	"unprognostic (2.44e-1)"	"unprognostic (1.83e-2)"	"unprognostic (2.03e-2)"	"unprognostic (1.05e-2)"	"unprognostic (3.09e-1)"	"unprognostic (1.01e-2)"	"unprognostic (3.61e-1)"	"unprognostic (9.30e-2)"	"unprognostic (4.19e-1)"	"unprognostic (2.81e-7)"	"unprognostic (1.04e-1)"	"unprognostic (6.00e-2)"	"unprognostic (4.47e-2)"	"unprognostic (1.34e-2)"	0.3	0.2	1.2	3.8	0.8	2.7	0.3	1.3	1.6	0.3	0.3	0.3	0.3	0.3	0.3	0.3	0.8	0.4	1.8	0.3	1.2	1.5	0.3	0.3	0.3	3.3	1.7	0.7	0.4	0.3	0.0	0.9	0.3	1.9	0.3	0.0	27.7	0.3	0.3	1.8	3.3	0.7	0.3	1.2	2.2	0.2	8.2	0.3	0.3	0.8	0.3	0.3	0.9	0.3	1.3	1.3	2.2	0.1	1.8	0.2	0.0	0.9	4.6	0.7	0.5	0.0	0.1	0.5	0.0	0.4	0.3	0.1	0.1	3.3	3.8	0.5	0.0	0.7	1.2	0.0	0.0	0.3	0.0	1.2	0.1	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	1.2	0.4	0.0	2.0	0.4	0.6	0.1	0.1	1.2	1.5	0.4	0.2	0.2	2.0	0.0	0.1	5.7	0.4	0.1	0.2	1.6	0.6	2.8	0.7	0.0	0.0	1.8	0.2	0.1	4.6	4.8	6.8	1.2	0.4	0.8	2.0	0.1	2.2	0.2	0.0	0.0	0.6	0.1	0.0	0.0	1.3	0.0	0.2	0.6	1.8	0.0	1.3	0.1	0.0	1.2	0.8	1.3	0.9	1.2	1.5	1.7	0.7	1.9	0.3	0.0	0.0	0.0	0.0	0.0	269.2	0.3	0.0	0.0	0.0	0.0	11.8	0.1	0.0	0.0	5.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	6.4	1.2	0.0	0.0	12.3	0.3	0.0	0.0	0.0	0.0	6.6	0.2	0.0	0.0	0.3	29.7	0.0	0.0	1.7	1.0	0.0	0.1	0.0	0.0	0.0
AARS	"AlaRS, CMT2N"	ENSG00000090861	"Alanyl-tRNA synthetase"	P49588	16	70252295-70289543	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Protein biosynthesis"	"Aminoacyl-tRNA synthetase, Ligase, RNA-binding, tRNA-binding"	"Charcot-Marie-Tooth disease, Disease mutation, Epilepsy, Neurodegeneration, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"CAB034261, HPA040870"	Supported		Supported	Cytosol		NA	NA		700000	Cytosol		"CAB034261: AB_1562673, HPA040870: AB_10794995"	"unprognostic (1.98e-2)"	"unprognostic (6.87e-2)"	"unprognostic (8.02e-2)"	"unprognostic (5.72e-2)"	"unprognostic (3.58e-1)"	"unprognostic (2.50e-2)"	"unprognostic (7.99e-2)"	"unprognostic (2.36e-1)"	"unprognostic (1.99e-1)"	"unprognostic (1.76e-1)"	"unprognostic (8.33e-2)"	"unprognostic (2.92e-1)"	"unprognostic (3.42e-2)"	"unprognostic (3.75e-2)"	"unprognostic (2.05e-3)"	"unprognostic (8.22e-2)"	"unprognostic (3.83e-3)"	22.8	25.3	28.0	19.6	34.8	5.9	22.6	36.4	54.0	22.3	18.4	30.6	21.4	16.8	22.0	33.9	14.5	20.4	14.1	20.9	29.5	31.7	25.5	36.4	19.5	17.9	40.3	40.5	18.7	45.4	61.2	23.1	21.0	37.5	23.2	17.5	17.3	30.1	30.0	25.2	14.1	14.4	28.4	33.2	16.7	21.1	12.2	32.7	10.3	42.1	10.6	20.9	17.7	26.9	13.4	11.6	3.9	13.3	21.3	13.4	11.6	23.3	39.3	10.8	40.3	25.4	23.1	26.2	18.5	25.7	23.4	29.6	32.2	31.5	26.5	24.9	18.6	17.9	27.3	31.3	25.2	32.9	12.0	11.3	26.1	16.7	28.5	67.3	15.6	15.7	27.3	38.1	44.9	100.6	18.6	23.1	41.9	33.2	35.0	17.4	52.8	16.8	18.3	20.4	30.1	22.7	32.1	6.9	57.9	15.9	12.0	13.5	11.6	51.4	12.1	45.5	16.1	37.9	34.5	15.3	17.3	16.8	17.1	15.4	49.4	32.4	48.9	29.5	24.5	33.8	3.9	8.6	3.9	12.6	12.7	12.8	13.4	10.9	12.1	11.6	11.4	13.1	13.4	1.3	21.3	13.3	7.9	8.4	11.6	28.0	34.8	36.4	54.0	29.5	31.7	40.3	40.5	37.5	32.7	8.9	17.3	8.2	15.7	7.3	35.7	22.2	17.8	14.7	11.4	8.7	17.7	53.2	29.9	24.7	8.6	14.3	9.8	46.7	25.3	24.1	12.2	18.2	20.7	43.2	23.5	52.4	22.4	19.0	9.4	5.2	29.1	9.8	11.8	34.3	13.3	35.9	23.6	8.6	38.2	27.4	38.4	0.0	13.9	17.5	29.0	7.4	43.5	10.5	12.1	13.3
AARS2	"AARSL, bA444E17.1, KIAA1270"	ENSG00000124608	"Alanyl-tRNA synthetase 2, mitochondrial"	Q5JTZ9	6	44299654-44313326	"Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Protein biosynthesis"	"Aminoacyl-tRNA synthetase, Ligase, RNA-binding, tRNA-binding"	"Cancer-related genes, Cardiomyopathy, Disease mutation, Neurodegeneration, Premature ovarian failure, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Cone photoreceptor cells: 11.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035636, HPA061396"	Approved		Enhanced	Mitochondria		NA	NA			Mitochondria		"HPA035636: AB_10670837, HPA061396: AB_2684502"	"unprognostic (1.56e-1)"	"unprognostic (3.24e-2)"	"unprognostic (2.58e-2)"	"unprognostic (2.04e-3)"	"unprognostic (2.83e-1)"	"unprognostic (1.69e-1)"	"unprognostic (8.83e-3)"	"unprognostic (5.12e-2)"	"unprognostic (3.64e-2)"	"unprognostic (1.38e-1)"	"unprognostic (2.19e-2)"	"unprognostic (1.37e-2)"	"unprognostic (1.74e-1)"	"unprognostic (1.84e-1)"	"unprognostic (1.48e-1)"	"unprognostic (1.08e-1)"	"unprognostic (2.02e-1)"	8.6	10.7	15.9	16.2	11.8	11.4	9.9	23.5	19.8	11.4	14.5	11.4	13.0	15.3	14.1	10.4	17.2	13.4	15.9	10.4	13.2	8.9	10.3	12.6	10.9	13.4	12.4	14.3	17.1	13.8	16.2	14.2	10.1	11.1	13.2	9.8	11.2	14.4	14.6	10.2	16.8	18.3	12.1	8.8	14.1	12.3	12.9	14.1	14.7	12.3	10.4	13.4	10.2	13.9	7.1	3.2	3.7	3.4	3.7	5.5	2.8	9.7	7.3	9.6	17.6	5.7	5.2	12.7	8.0	4.1	8.5	8.2	7.9	5.3	10.7	12.8	3.5	9.0	7.3	10.6	11.5	3.3	7.5	16.9	12.4	7.1	9.3	3.7	11.5	11.1	4.4	7.3	6.8	7.3	5.2	7.2	15.0	14.6	10.5	4.5	10.9	9.6	9.9	7.1	28.1	7.1	11.5	5.8	7.3	4.4	8.8	22.8	8.2	6.9	7.8	10.7	6.7	7.2	15.0	6.1	9.2	9.3	5.7	10.0	6.2	5.7	11.0	5.2	10.2	15.9	3.7	2.4	0.0	3.4	3.3	5.5	3.6	4.8	4.4	2.6	7.1	4.7	4.3	0.7	3.7	3.4	3.2	3.0	2.8	15.9	11.8	23.5	19.8	13.2	8.9	12.4	14.3	11.1	14.1	6.0	3.5	2.4	1.9	0.6	6.3	2.8	7.6	4.0	3.4	0.0	11.8	4.4	0.0	2.1	2.2	2.9	4.4	0.0	0.3	4.4	1.4	1.2	0.0	2.4	2.7	0.0	0.0	3.7	2.8	0.4	4.4	1.6	0.0	5.4	1.4	1.5	1.1	0.0	4.2	0.8	6.7	0.0	1.4	3.3	7.0	0.4	4.5	2.2	3.3	1.4
AASS	"LKRSDH, LORSDH"	ENSG00000008311	"Aminoadipate-semialdehyde synthase"	Q9UDR5	7	122075647-122144280	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		"Multifunctional enzyme, Oxidoreductase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	11	"Hepatocytes: 98.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"basophil: 3.5"	"Group enriched"	"Detected in many"	4	"B-cells: 1.0;granulocytes: 3.5;T-cells: 1.2"	"Cell line enhanced"	"Detected in many"		"AN3-CA: 25.6;NTERA-2: 25.0;SuSa: 21.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA020637, HPA020728, HPA020734"	Enhanced		Enhanced	Vesicles,Mitochondria		Yes	No		17000	Mitochondria	Vesicles	"HPA020637: AB_1844415, HPA020728: AB_1844416, HPA020734: AB_1844417"	"unprognostic (4.84e-2)"	"unprognostic (2.29e-1)"	"unprognostic (7.91e-4)"	"unprognostic (6.08e-2)"	"unprognostic (1.49e-2)"	"unprognostic (8.00e-2)"	"prognostic favorable (9.81e-4)"	"unprognostic (4.48e-3)"	"unprognostic (2.38e-1)"	"unprognostic (1.47e-1)"	"unprognostic (1.98e-1)"	"unprognostic (1.99e-1)"	"unprognostic (7.76e-3)"	"unprognostic (8.56e-3)"	"unprognostic (1.55e-1)"	"unprognostic (6.50e-2)"	"unprognostic (2.67e-1)"	13.9	9.5	7.4	4.8	11.8	1.6	11.2	2.7	9.8	16.0	8.1	12.5	8.2	2.2	16.8	11.6	6.4	14.9	6.7	12.6	8.8	3.7	14.4	35.8	9.1	3.3	15.2	5.0	36.7	10.7	14.9	10.4	7.1	9.9	9.2	3.8	9.2	5.4	10.4	11.3	4.4	5.5	9.3	12.1	5.2	9.0	5.1	13.2	0.8	7.8	8.3	3.1	11.0	9.0	1.0	0.4	3.5	0.1	0.3	1.2	0.1	0.1	0.0	15.8	25.6	13.3	8.5	6.2	4.3	4.6	4.5	6.5	7.3	0.2	0.0	0.2	3.0	5.1	2.7	18.3	8.2	6.2	0.0	6.7	5.5	3.5	4.7	10.8	0.0	1.8	7.5	0.2	5.4	5.7	12.6	10.8	7.3	1.4	10.1	3.1	0.0	0.5	0.0	25.0	0.0	1.0	8.3	8.4	0.3	2.1	1.7	1.6	0.5	1.4	0.0	2.6	21.7	0.4	0.0	4.9	8.8	2.7	4.1	4.1	2.2	1.6	0.0	3.2	0.5	3.4	3.5	0.1	0.0	0.7	0.0	0.1	0.5	0.8	0.0	0.4	1.0	1.2	0.5	0.0	0.3	0.0	0.0	0.7	0.1	7.4	11.8	2.7	7.3	8.8	3.7	15.2	5.0	9.9	13.2	8.9	28.6	1.5	8.9	5.6	6.3	8.1	7.6	0.0	7.9	14.0	15.7	9.1	0.0	1.8	9.2	9.2	1.0	0.0	1.5	2.5	9.3	5.2	3.5	98.3	1.2	11.1	2.9	19.6	1.8	5.4	17.5	1.5	11.8	0.0	2.4	8.7	2.6	2.9	23.0	7.8	2.2	19.4	21.6	6.4	1.5	4.1	4.2	2.2	1.5	3.7
AATK	"AATYK, AATYK1, KIAA0641, LMR1, LMTK1, PPP1R77"	ENSG00000181409	"Apoptosis associated tyrosine kinase"	Q6ZMQ8	17	81117295-81166077	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 35.3;intestine: 28.7"	"Cell type enhanced"	"Detected in many"	11	"Alveolar cells type 1: 29.8;Alveolar cells type 2: 23.6;Bipolar cells: 43.5;Horizontal cells: 20.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	21	"neutrophil: 3.6"	"Lineage enriched"	"Detected in single"	21	"granulocytes: 3.6"	"Group enriched"	"Detected in some"	6	"CACO-2: 30.3;SH-SY5Y: 10.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA009073	Enhanced		Uncertain	Mitochondria		NA	NA			Mitochondria		"HPA009073: AB_1078076"	"unprognostic (3.47e-3)"	"unprognostic (3.01e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.95e-4)"	"unprognostic (1.96e-1)"	"unprognostic (1.94e-1)"	"unprognostic (7.29e-2)"	"unprognostic (9.85e-2)"	"unprognostic (6.09e-2)"	"unprognostic (4.27e-2)"	"unprognostic (2.88e-3)"	"unprognostic (2.48e-1)"	"unprognostic (4.28e-6)"	"unprognostic (1.58e-3)"	"unprognostic (1.21e-1)"	"unprognostic (1.39e-1)"	"unprognostic (4.57e-2)"	2.8	4.7	14.3	3.2	16.6	3.7	0.9	19.0	29.0	1.2	3.3	16.5	0.0	28.7	1.0	1.1	1.7	1.2	2.7	2.3	23.6	13.9	1.2	1.2	9.7	1.5	20.1	13.6	1.0	17.9	3.6	6.4	2.6	11.0	2.4	1.1	4.1	5.6	3.6	1.1	1.9	20.3	1.3	35.3	5.9	4.5	1.3	9.8	0.0	1.3	0.0	1.0	1.3	1.1	0.0	0.0	3.6	0.1	0.0	0.0	0.0	0.0	0.2	0.3	2.5	0.0	0.0	0.6	0.0	0.0	0.0	0.0	30.3	0.0	0.0	0.2	0.0	0.0	0.0	0.4	0.0	0.0	0.0	1.6	1.2	1.4	1.8	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	3.2	0.0	0.1	0.5	0.3	0.1	1.3	2.5	0.2	0.0	0.0	2.9	10.4	0.2	0.0	1.5	0.1	0.3	0.8	1.1	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.6	0.0	0.0	0.0	0.0	0.0	14.3	16.6	19.0	22.3	23.6	13.9	20.1	13.6	11.0	9.8	29.8	23.6	0.0	0.8	0.2	43.5	2.2	2.5	0.0	0.0	0.0	3.9	0.0	0.0	0.6	0.0	1.1	6.9	0.0	1.6	0.1	0.4	1.0	5.8	0.0	2.0	20.6	1.7	0.6	4.1	0.0	1.4	0.6	5.0	0.0	4.5	8.3	1.3	4.5	2.5	0.8	4.1	0.0	0.8	0.5	0.2	0.3	1.9	0.7	7.2	0.1
ABAT	GABAT	ENSG00000183044	"4-aminobutyrate aminotransferase"	P80404	16	8674565-8784575	"Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"	"Neurotransmitter degradation"	"Aminotransferase, Transferase"	"Disease mutation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 53.3;liver: 136.5;pancreas: 54.2"	"Cell type enhanced"	"Detected in many"	19	"Hepatocytes: 234.8;Proximal tubular cells: 72.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Hep G2: 45.3;MCF7: 29.1;RH-30: 25.6;T-47d: 15.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041528, HPA041690"	Enhanced	Supported	Supported	Mitochondria		No	No		1500000	Mitochondria		"HPA041528: AB_10795690, HPA041690: AB_10794674"	"unprognostic (1.77e-2)"	"unprognostic (3.27e-1)"	"unprognostic (1.00e-1)"	"unprognostic (2.71e-1)"	"unprognostic (2.90e-1)"	"unprognostic (2.05e-1)"	"prognostic favorable (5.36e-5)"	"prognostic favorable (5.93e-4)"	"unprognostic (1.71e-1)"	"unprognostic (1.30e-1)"	"unprognostic (1.56e-2)"	"unprognostic (1.04e-1)"	"prognostic favorable (5.44e-8)"	"unprognostic (2.10e-1)"	"unprognostic (2.48e-2)"	"unprognostic (3.80e-1)"	"unprognostic (1.50e-2)"	2.1	12.6	26.1	2.7	39.3	1.7	3.2	19.9	43.3	2.2	5.2	10.9	0.1	17.5	2.1	5.0	3.0	2.8	2.7	6.2	20.4	30.9	53.3	136.5	2.8	2.8	24.5	26.1	5.3	54.2	4.0	22.1	2.3	14.3	9.9	4.2	2.6	2.6	2.5	1.4	2.1	8.4	2.1	14.1	2.5	3.9	6.3	11.8	1.0	12.7	0.4	3.3	6.4	1.1	2.2	1.9	8.8	5.8	1.6	2.5	1.8	0.2	0.0	12.1	6.9	1.9	0.7	0.5	1.4	0.8	0.7	0.2	4.5	0.3	1.4	0.5	0.8	0.4	3.1	0.8	2.8	0.9	0.8	0.6	2.0	0.0	45.3	3.1	0.4	3.1	2.5	1.3	1.2	0.5	0.3	0.2	3.9	0.3	1.0	0.2	29.1	0.7	0.2	1.0	8.5	0.1	3.5	25.6	0.6	0.4	7.2	1.9	5.8	0.7	0.4	0.0	2.5	15.9	1.2	0.2	0.2	2.0	0.9	0.0	1.1	0.1	0.3	0.3	2.1	1.4	1.1	3.1	4.1	2.5	3.6	1.1	0.8	1.7	1.7	1.9	2.2	1.1	1.8	8.8	1.6	5.8	0.3	1.6	1.8	26.1	39.3	19.9	35.1	20.4	30.9	24.5	26.1	14.3	11.8	0.0	5.8	12.2	3.3	1.3	16.6	8.9	15.3	2.7	7.9	1.8	3.9	1.2	19.9	1.2	8.3	1.4	10.3	0.0	5.5	1.2	2.1	9.6	1.1	234.8	4.3	33.4	15.0	5.5	9.1	6.0	3.4	5.4	1.7	0.0	4.9	48.7	6.3	6.5	4.2	72.0	6.0	0.0	2.5	1.5	0.9	0.5	1.1	7.2	6.8	4.2
ABCB1	"ABC20, CD243, CLCS, GP170, MDR1, P-gp, PGY1"	ENSG00000085563	"ATP binding cassette subfamily B member 1"	P08183	7	87503633-87713323	"Cancer-related genes, CD markers, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	Transport	Translocase	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adrenal gland: 57.8;intestine: 49.6"	"Cell type enhanced"	"Detected in many"	13	"Cholangiocytes: 104.4;Enterocytes: 174.5;Paneth cells: 77.2"	"Cancer enhanced"	"Detected in many"		"renal cancer: 14.2"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"MAIT T-cell: 19.2"	"Group enriched"	"Detected in many"	8	"NK-cells: 11.4;T-cells: 19.2"	"Cell line enhanced"	"Detected in some"		"CACO-2: 30.1;HEK 293: 9.3;HEL: 16.7;Hep G2: 8.2;RPTEC TERT1: 11.5;SH-SY5Y: 36.8"									"CAB001716, HPA002199, HPA074614"	Enhanced		Approved	"Nucleoplasm,Plasma membrane,Focal adhesion sites"		NA	NA			"Nucleoplasm, Plasma membrane"	"Focal adhesion sites"	"CAB001716: , HPA002199: AB_1844428, HPA074614: "	"unprognostic (5.38e-3)"	"unprognostic (2.45e-2)"	"unprognostic (1.42e-1)"	"unprognostic (1.06e-1)"	"unprognostic (2.25e-2)"	"unprognostic (9.99e-5)"	"unprognostic (2.23e-3)"	"unprognostic (5.65e-3)"	"unprognostic (1.14e-1)"	"unprognostic (5.17e-2)"	"prognostic favorable (3.33e-4)"	"unprognostic (5.19e-1)"	"prognostic favorable (2.95e-4)"	"unprognostic (2.06e-1)"	"unprognostic (1.50e-1)"	"unprognostic (3.83e-1)"	"unprognostic (6.12e-2)"	2.6	57.8	9.4	3.2	11.5	1.2	3.4	5.1	10.5	5.5	22.7	3.8	2.0	14.4	9.4	3.5	2.0	3.2	9.0	1.8	9.2	6.6	19.1	15.6	3.8	2.2	9.4	5.7	2.2	1.5	1.7	1.3	3.1	11.1	2.7	10.7	7.6	1.5	2.1	1.1	1.3	49.6	5.7	9.0	2.4	1.7	1.3	8.6	0.1	2.4	1.4	2.2	2.6	5.9	1.9	0.0	0.1	0.0	11.4	19.2	1.5	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	30.1	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	9.3	16.7	1.9	8.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	11.5	0.1	0.4	36.8	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	1.9	0.0	0.4	3.2	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	7.8	0.0	19.2	0.4	2.0	4.7	0.0	1.9	1.2	4.8	0.1	11.4	0.0	0.0	0.0	1.5	9.4	11.5	5.1	10.5	9.2	6.6	9.4	5.7	11.1	8.6	0.0	4.8	5.9	0.1	0.7	0.6	2.8	104.4	1.4	1.2	47.1	0.0	5.0	5.0	10.2	21.6	23.1	174.5	23.3	1.6	0.1	0.5	0.1	3.5	32.6	0.4	0.0	0.0	3.7	1.2	2.5	0.9	0.8	0.0	0.0	8.9	0.0	11.4	77.2	0.0	44.0	0.9	0.0	0.8	0.5	0.4	0.5	8.2	27.3	1.7	0.1
ABCB4	"GBD1, MDR2, MDR3, PFIC-3, PGY3"	ENSG00000005471	"ATP binding cassette subfamily B member 4"	P21439	7	87401697-87480435	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Lipid transport, Transport"	Translocase	"Disease mutation, Intrahepatic cholestasis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	8	"liver: 93.2"	"Cell type enriched"	"Detected in some"	6	"Hepatocytes: 235.3"	"Cancer enriched"	"Detected in some"	11	"liver cancer: 16.3"	"Low region specificity"	"Detected in single"			"Group enriched"	"Detected in some"	6	"memory B-cell: 4.9;naive B-cell: 11.4"	"Lineage enriched"	"Detected in many"	8	"B-cells: 11.4"	"Group enriched"	"Detected in some"	5	"SH-SY5Y: 12.0;WM-115: 22.9"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"HPA049395, HPA053288"	Enhanced		Approved	"Nucleoplasm,Plasma membrane,Actin filaments,Focal adhesion sites"		NA	NA			"Nucleoplasm, Plasma membrane, Actin filaments"	"Focal adhesion sites"	"HPA049395: AB_2680745, HPA053288: AB_2682102"	"unprognostic (7.92e-2)"	"unprognostic (8.87e-2)"	"unprognostic (1.97e-1)"	"unprognostic (1.90e-1)"	"unprognostic (8.95e-2)"	"unprognostic (1.06e-2)"	"unprognostic (2.35e-3)"	"unprognostic (9.91e-2)"	"unprognostic (3.53e-1)"	"unprognostic (1.19e-1)"	"unprognostic (2.44e-3)"	"unprognostic (8.43e-2)"	"unprognostic (2.83e-2)"	"unprognostic (8.01e-3)"	"unprognostic (7.12e-2)"	"unprognostic (2.11e-2)"	"unprognostic (2.47e-1)"	0.5	4.1	0.2	4.3	0.2	0.2	0.3	0.1	1.1	0.2	0.6	0.4	0.0	0.0	0.1	0.2	0.6	0.1	0.3	4.0	0.3	0.2	0.4	93.2	0.1	4.1	0.3	0.2	0.3	0.1	0.0	0.5	0.0	0.3	0.3	0.4	0.8	0.4	0.1	2.9	0.6	1.2	1.6	0.5	5.2	0.2	0.5	0.4	0.1	0.4	4.2	3.2	0.6	0.5	11.4	1.4	0.0	0.0	0.0	0.1	0.2	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.1	2.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.5	0.3	0.0	3.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	12.0	0.0	0.6	2.2	0.5	0.2	0.5	0.0	0.2	1.6	0.1	0.0	0.0	0.0	2.8	0.2	0.0	22.9	0.0	0.0	0.0	0.0	0.0	0.1	4.9	0.0	0.1	1.4	11.4	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.2	0.2	0.2	0.1	1.1	0.3	0.2	0.3	0.2	0.3	0.4	0.0	0.3	23.1	0.0	0.9	0.0	9.3	0.0	0.0	0.0	1.8	0.0	0.9	0.0	0.1	0.6	0.8	0.1	0.0	0.0	0.2	1.5	0.0	0.0	235.3	0.5	36.5	0.0	5.5	5.4	0.2	0.0	0.0	10.1	0.0	0.0	0.0	0.1	0.0	0.4	0.5	0.0	0.0	0.9	0.5	0.1	0.4	0.1	0.0	0.0	0.0
ABHD10	FLJ11342	ENSG00000144827	"Abhydrolase domain containing 10"	Q9NUJ1	3	111979010-111993363	"Enzymes, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036991, HPA036992, HPA066081"	Supported		Approved	Mitochondria	"Intracellular and membrane"	No	No		85000	Mitochondria		"HPA036991: AB_2675420, HPA036992: AB_10672345, HPA066081: AB_2685610"	"unprognostic (1.65e-1)"	"prognostic favorable (7.57e-4)"	"unprognostic (1.61e-1)"	"unprognostic (1.63e-1)"	"unprognostic (1.05e-1)"	"unprognostic (1.30e-2)"	"unprognostic (8.95e-2)"	"unprognostic (1.14e-1)"	"unprognostic (8.50e-2)"	"unprognostic (1.69e-2)"	"unprognostic (1.70e-1)"	"unprognostic (3.91e-2)"	"prognostic favorable (4.72e-9)"	"unprognostic (1.59e-2)"	"unprognostic (1.72e-1)"	"unprognostic (4.18e-3)"	"unprognostic (2.76e-2)"	8.5	18.3	17.5	8.1	27.5	7.6	12.4	23.2	23.2	9.9	11.3	13.7	8.6	9.4	9.4	42.4	7.0	12.5	8.4	19.8	18.6	19.6	39.1	26.6	9.7	14.0	17.0	21.6	16.8	12.1	8.8	26.1	8.8	19.1	17.1	12.3	12.6	19.8	12.0	10.4	8.2	8.6	8.9	14.8	12.4	11.6	12.6	15.1	16.6	25.3	6.7	12.6	8.7	7.9	18.3	19.7	17.7	14.8	7.8	12.7	10.8	18.7	16.3	18.0	5.9	10.4	14.0	9.7	19.9	10.5	16.4	15.8	16.8	10.9	17.0	11.2	8.3	11.2	10.4	7.9	11.0	22.5	5.7	10.0	14.0	8.0	14.5	8.3	28.0	15.1	8.5	8.3	8.4	21.2	11.3	17.5	20.4	6.4	7.3	17.9	6.3	26.4	13.1	11.7	20.9	25.9	23.9	11.5	7.8	17.0	8.2	12.1	8.9	15.9	11.6	18.5	7.4	13.0	10.3	9.8	9.8	12.6	7.0	10.3	11.7	4.1	29.0	9.9	15.4	10.4	17.7	11.8	17.5	7.4	14.8	12.7	18.3	9.3	8.4	19.7	15.9	12.0	10.5	1.8	7.8	11.6	12.5	8.8	10.8	17.5	27.5	23.2	23.2	18.6	19.6	17.0	21.6	19.1	15.1	0.0	4.5	17.1	8.5	6.3	20.8	20.0	7.6	18.7	9.1	10.4	7.9	15.2	29.9	4.3	0.7	7.5	5.3	0.0	6.9	12.2	9.4	5.4	9.2	22.5	12.6	39.7	11.6	11.6	20.8	1.9	9.8	11.2	10.1	2.8	10.9	18.9	4.7	2.9	7.1	27.8	12.6	0.0	10.7	29.6	34.3	7.2	4.6	10.9	10.5	4.2
ABHD12	"ABHD12A, BEM46L2, C20orf22, dJ965G21.2, DKFZP434P106"	ENSG00000100997	"Abhydrolase domain containing 12"	Q8N2K0	20	25294743-25390983	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Lipid metabolism"	Hydrolase	"Cataract, Deafness, Disease mutation, Neuropathy, Retinitis pigmentosa"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"Karpas-707: 71.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA026866	Uncertain					NA	NA					"HPA026866: AB_1844446"	"prognostic unfavorable (3.81e-5)"	"prognostic favorable (1.30e-5)"	"unprognostic (1.32e-1)"	"unprognostic (8.74e-2)"	"unprognostic (3.67e-2)"	"unprognostic (6.56e-2)"	"prognostic unfavorable (7.18e-4)"	"unprognostic (8.51e-2)"	"unprognostic (7.91e-3)"	"unprognostic (2.08e-1)"	"unprognostic (4.08e-2)"	"unprognostic (8.46e-2)"	"unprognostic (1.36e-3)"	"unprognostic (2.45e-1)"	"unprognostic (4.65e-2)"	"unprognostic (1.55e-1)"	"unprognostic (8.11e-3)"	11.3	13.4	27.4	10.0	32.1	9.8	10.4	22.3	39.8	11.1	15.6	30.8	14.1	20.7	9.1	58.9	20.4	11.3	14.0	12.2	41.5	25.9	18.9	13.1	14.0	10.3	31.5	21.0	13.8	65.6	16.0	14.4	25.6	26.9	15.6	15.2	11.5	13.8	17.4	4.0	16.2	21.1	9.9	43.3	7.8	22.1	7.6	19.0	10.2	36.8	7.9	16.0	15.7	10.9	3.9	14.6	12.6	14.2	11.1	11.5	6.0	14.9	34.2	8.8	11.1	18.1	10.8	21.8	21.5	18.0	16.9	19.5	20.0	22.9	4.7	12.2	16.9	40.3	24.3	11.2	12.8	14.4	4.9	9.0	7.6	9.4	27.7	14.4	7.3	16.2	13.5	8.4	20.8	9.9	20.6	7.7	8.8	5.5	71.7	16.0	30.9	11.0	7.7	6.8	18.5	21.7	8.5	22.7	44.7	11.4	31.1	11.3	9.5	18.1	44.7	31.8	16.4	15.1	12.5	9.6	21.4	14.5	13.0	12.4	8.4	7.8	7.5	14.9	8.7	13.7	9.8	14.2	12.6	8.0	12.2	6.4	3.1	8.8	11.5	14.6	3.9	7.5	7.4	1.8	11.1	13.1	13.1	7.9	6.0	27.4	32.1	22.3	39.8	41.5	25.9	31.5	21.0	26.9	19.0	6.0	6.2	9.7	26.7	15.8	33.4	14.0	38.2	10.7	9.1	26.2	9.8	77.6	23.2	30.2	42.1	13.8	92.3	0.0	29.7	81.1	22.7	35.8	10.3	16.1	103.4	39.7	32.6	11.6	27.2	80.7	15.0	39.8	32.1	91.0	27.6	27.0	20.7	45.6	19.4	19.5	20.6	25.8	14.6	18.2	32.5	15.9	109.4	13.8	31.4	31.0
ABHD17A	"C19orf27, FAM108A1, MGC5244"	ENSG00000129968	"Abhydrolase domain containing 17A"	Q96GS6	19	1876810-1885547	"Enzymes, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"U-266/70: 37.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043270, HPA047226, HPA069225"	Uncertain		Approved	"Nuclear speckles,Vesicles"		NA	NA			Vesicles	"Nuclear speckles"	"HPA043270: AB_2678401, HPA047226: AB_2679991, HPA069225: "	"unprognostic (3.77e-2)"	"unprognostic (1.85e-1)"	"unprognostic (3.57e-2)"	"prognostic favorable (1.73e-4)"	"unprognostic (3.70e-2)"	"prognostic favorable (6.46e-4)"	"unprognostic (1.69e-2)"	"unprognostic (1.92e-2)"	"unprognostic (5.09e-1)"	"unprognostic (1.44e-1)"	"prognostic favorable (1.76e-5)"	"unprognostic (1.29e-2)"	"unprognostic (1.85e-3)"	"unprognostic (1.17e-1)"	"unprognostic (2.71e-1)"	"unprognostic (3.17e-1)"	"unprognostic (1.60e-2)"	28.1	11.9	26.6	8.9	23.9	10.0	6.8	16.4	29.4	9.0	14.1	15.3	10.3	16.5	8.8	7.0	9.9	7.1	11.7	12.9	30.9	14.4	11.9	8.2	13.0	9.1	19.0	16.7	9.4	16.6	3.8	7.7	13.4	13.2	13.9	2.1	8.4	21.0	11.2	47.4	20.7	15.8	5.2	25.5	25.7	23.3	12.1	7.9	10.9	11.4	9.6	7.1	6.3	7.3	4.5	1.5	5.9	1.5	4.7	8.5	1.0	16.7	5.8	1.7	6.6	3.1	3.8	13.2	11.3	3.5	3.1	3.1	2.7	2.9	8.2	4.6	2.4	0.7	10.5	1.1	4.4	0.1	19.0	25.0	6.1	2.2	7.4	4.5	6.0	20.8	4.1	3.5	1.7	1.2	2.0	6.5	8.3	10.4	9.3	2.2	9.4	10.9	12.0	12.8	3.2	13.1	12.8	5.8	12.3	2.2	3.4	7.8	18.0	5.9	6.4	10.7	0.4	6.6	11.1	12.4	3.7	8.7	15.2	11.0	37.4	22.4	6.9	8.5	8.1	6.1	2.5	1.5	5.9	8.5	0.9	6.2	4.5	3.9	5.5	1.5	2.4	4.1	4.4	1.7	4.7	1.0	1.5	3.5	1.0	26.6	23.9	16.4	29.4	30.9	14.4	19.0	16.7	13.2	7.9	3.0	7.2	31.2	18.9	28.6	40.6	3.0	28.1	1.4	7.9	14.0	37.3	59.5	8.3	27.9	4.8	47.9	44.2	23.3	32.7	33.7	26.8	25.1	10.3	18.7	55.3	52.4	29.3	55.9	28.5	4.0	27.9	25.8	25.3	26.2	27.8	45.9	34.1	27.9	34.3	15.9	29.8	12.9	16.4	12.3	22.9	40.1	54.9	96.5	25.1	26.6
ABHD17B	"C9orf77, CGI-67, FAM108B1"	ENSG00000107362	"Abhydrolase domain containing 17B"	Q5VST6	9	71862452-71910931	"Enzymes, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 46.2"	"Cell type enhanced"	"Detected in many"	4	"Rod photoreceptor cells: 54.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"REH: 36.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA047862	Uncertain					NA	NA					"HPA047862: AB_10959595"	"unprognostic (7.47e-2)"	"unprognostic (4.41e-2)"	"unprognostic (4.03e-3)"	"unprognostic (5.59e-2)"	"unprognostic (5.57e-2)"	"unprognostic (8.53e-3)"	"unprognostic (9.44e-2)"	"unprognostic (6.84e-2)"	"unprognostic (5.46e-2)"	"unprognostic (3.44e-2)"	"unprognostic (3.49e-2)"	"unprognostic (1.74e-1)"	"prognostic favorable (2.59e-4)"	"unprognostic (4.33e-2)"	"unprognostic (2.12e-1)"	"unprognostic (3.06e-3)"	"unprognostic (1.34e-2)"	7.7	6.6	16.5	6.9	25.0	18.0	8.2	14.4	21.6	9.0	12.0	43.3	2.3	18.1	9.5	4.6	13.5	9.6	9.1	5.8	23.6	13.8	13.4	13.6	7.5	10.8	44.0	13.6	7.6	6.4	12.7	5.8	7.8	24.3	11.0	11.2	9.0	9.4	5.1	13.6	11.2	14.9	9.4	30.4	8.9	8.9	11.1	38.2	46.2	8.8	3.6	10.7	11.8	8.8	7.2	5.7	8.1	3.8	6.6	4.9	1.7	6.3	6.1	14.0	8.1	7.3	4.5	12.3	7.0	7.6	6.1	5.2	1.8	4.0	15.4	6.5	4.7	5.1	12.6	13.6	4.6	7.1	7.9	8.1	9.0	10.3	5.9	5.1	10.6	14.6	5.6	6.5	5.5	4.9	5.5	7.9	26.0	7.3	7.0	5.2	2.9	27.4	8.4	21.2	8.0	8.7	36.8	10.7	0.1	7.0	12.8	9.3	10.8	7.4	8.0	6.0	10.5	2.6	7.7	6.3	5.9	7.7	10.9	5.6	6.9	8.1	12.2	4.7	7.6	2.9	8.1	3.8	4.1	3.1	1.4	3.0	4.2	3.8	4.3	4.8	7.2	3.2	4.5	2.9	6.6	1.3	5.7	4.9	1.7	16.5	25.0	14.4	20.8	23.6	13.8	44.0	13.6	24.3	38.2	6.0	4.6	13.2	28.4	15.1	13.8	7.0	5.1	17.4	10.3	5.2	11.8	9.1	10.0	7.3	15.6	8.2	22.1	0.0	5.0	6.9	9.6	21.5	17.3	8.2	5.1	4.8	8.5	10.4	4.7	6.0	10.6	7.0	5.0	6.4	22.8	24.7	3.9	14.2	9.9	9.9	54.4	0.0	16.1	33.6	20.2	8.5	6.1	25.4	10.6	41.0
ABHD17C	FAM108C1	ENSG00000136379	"Abhydrolase domain containing 17C"	Q6PCB6	15	80679684-80755621	"Enzymes, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"Enterocytes: 88.3;Mucus-secreting cells: 89.7;Paneth cells: 62.2;Urothelial cells: 77.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"OE19: 40.7;RT4: 33.2;SK-MEL-30: 36.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA048890	Uncertain					NA	NA					"HPA048890: AB_2680546"	"unprognostic (3.60e-1)"	"unprognostic (5.07e-2)"	"unprognostic (1.58e-1)"	"unprognostic (2.19e-2)"	"unprognostic (7.51e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.59e-2)"	"unprognostic (2.32e-1)"	"unprognostic (1.40e-1)"	"unprognostic (2.59e-2)"	"unprognostic (5.08e-3)"	"unprognostic (2.87e-1)"	"unprognostic (1.23e-3)"	"unprognostic (5.75e-2)"	"unprognostic (2.91e-1)"	"unprognostic (1.35e-1)"	"unprognostic (1.89e-3)"	2.1	3.8	14.6	16.8	16.0	3.7	8.0	6.6	13.0	13.8	42.0	5.4	4.6	15.5	4.5	1.8	31.7	7.7	12.2	3.1	10.7	8.5	10.4	5.4	27.2	11.6	8.2	8.2	2.0	8.3	5.1	6.0	19.7	5.7	12.6	38.1	3.9	16.2	6.0	1.6	12.6	25.9	6.8	6.2	5.7	23.5	3.6	5.6	2.7	7.8	13.9	23.2	13.8	13.0	1.2	1.1	0.0	0.5	0.0	2.8	0.3	8.3	8.0	5.2	6.5	1.9	3.9	8.9	8.1	30.5	6.9	6.7	6.6	18.8	2.8	3.3	8.5	4.9	17.2	14.4	7.4	6.2	19.7	8.2	0.0	6.1	7.0	3.3	2.5	4.1	8.4	9.0	4.9	2.4	6.0	7.4	2.9	0.0	3.6	3.9	23.3	0.2	0.2	7.6	40.7	3.0	5.5	4.4	7.8	5.6	33.2	4.6	1.9	6.4	11.1	36.7	2.3	5.5	4.3	2.5	4.2	3.5	4.6	7.1	0.2	0.1	2.7	2.7	23.0	4.6	0.0	0.1	0.0	2.7	0.3	2.0	1.2	2.1	2.8	0.4	0.1	0.3	0.6	0.0	0.0	0.5	1.1	0.1	0.3	14.6	16.0	6.6	13.0	10.7	8.5	8.2	8.2	5.7	5.6	11.9	8.4	1.3	6.6	6.4	4.3	3.9	17.8	6.7	6.8	7.0	7.9	1.6	38.1	5.6	0.1	2.3	88.3	0.0	7.7	4.9	2.1	23.3	0.0	4.2	1.0	9.5	13.9	4.3	1.8	0.2	1.1	1.8	8.5	1.0	89.7	3.8	18.3	62.2	0.0	4.7	20.1	0.0	1.5	0.7	5.6	19.8	0.8	2.2	41.7	77.1
ABHD2	LABH2	ENSG00000140526	"Abhydrolase domain containing 2"	P08910	15	89087459-89202360	"Enzymes, Predicted membrane proteins"	"Lipid degradation, Lipid metabolism"	"Hydrolase, Serine esterase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	6	"Early spermatids: 303.3;Hepatocytes: 272.0;Late spermatids: 360.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"eosinophil: 29.0;neutrophil: 22.7"	"Lineage enriched"	"Detected in all"	4	"granulocytes: 29.0"	"Cell line enriched"	"Detected in all"	4	"HEL: 85.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA005999	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			Cytosol	Nucleoplasm	"HPA005999: AB_1078080"	"unprognostic (6.60e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.08e-1)"	"unprognostic (3.00e-2)"	"unprognostic (2.16e-1)"	"unprognostic (1.56e-1)"	"unprognostic (2.26e-1)"	"unprognostic (1.67e-1)"	"unprognostic (3.34e-1)"	"unprognostic (3.67e-3)"	"unprognostic (3.41e-3)"	"unprognostic (1.80e-1)"	"prognostic favorable (2.18e-7)"	"unprognostic (4.17e-1)"	"unprognostic (3.07e-2)"	"unprognostic (1.34e-2)"	"unprognostic (1.60e-1)"	13.2	24.8	14.8	9.5	19.3	15.6	11.7	25.2	23.4	10.7	16.1	12.0	6.5	23.4	18.2	34.7	9.0	12.1	32.2	24.5	12.2	11.3	11.8	76.4	22.2	11.2	11.1	14.8	13.1	28.3	11.2	18.1	5.6	19.8	22.9	9.6	22.6	11.8	10.0	19.3	7.5	18.5	11.4	8.3	14.2	35.8	42.9	7.6	7.7	8.6	8.1	12.1	13.5	10.4	1.1	3.0	29.0	7.0	4.7	3.5	2.5	8.1	15.8	3.9	4.2	7.7	10.4	2.1	5.5	16.5	5.3	5.0	3.9	14.2	2.3	6.4	6.9	14.6	10.9	8.6	6.7	7.5	12.2	3.8	85.1	3.7	3.0	3.9	5.8	20.0	5.3	4.8	18.8	12.1	8.7	6.4	5.3	7.5	7.3	14.5	3.4	3.6	1.4	1.7	19.2	4.7	5.2	8.2	17.7	7.1	12.9	6.7	10.1	10.5	4.9	8.8	3.7	5.5	4.6	9.8	18.6	6.3	6.7	13.8	6.0	11.9	2.8	15.2	5.4	14.4	3.1	5.6	29.0	1.6	4.8	0.9	1.1	1.5	1.5	3.0	1.1	1.4	1.5	22.7	4.7	7.0	2.4	3.5	2.5	14.8	19.3	25.2	23.4	12.2	11.3	11.1	14.8	19.8	7.6	89.3	113.5	3.0	42.1	16.6	23.6	42.1	163.1	95.0	100.1	40.1	17.7	3.6	1.7	43.2	303.3	25.9	52.7	23.3	74.0	6.2	25.7	185.3	57.9	272.0	39.6	19.1	46.9	22.7	53.9	360.0	30.5	37.9	55.6	12.6	45.6	51.3	79.4	31.3	56.3	11.3	14.4	77.6	50.5	77.4	9.8	15.3	2.2	22.5	31.7	70.1
ABHD3	LABH3	ENSG00000158201	"Abhydrolase domain containing 3"	Q8WU67	18	21650897-21704805	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Lipid metabolism, Phospholipid metabolism"	"Hydrolase, Serine esterase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"REH: 54.7;RPMI-8226: 60.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA010729	Approved		Approved	"Nucleoplasm,Vesicles,Plasma membrane"		NA	NA			"Nucleoplasm, Plasma membrane"	Vesicles	"HPA010729: AB_1844449"	"unprognostic (1.46e-1)"	"unprognostic (4.61e-2)"	"unprognostic (2.37e-2)"	"unprognostic (3.52e-1)"	"unprognostic (8.46e-2)"	"unprognostic (3.14e-3)"	"unprognostic (3.54e-3)"	"unprognostic (1.52e-1)"	"prognostic unfavorable (8.52e-4)"	"unprognostic (6.21e-2)"	"unprognostic (1.98e-1)"	"unprognostic (6.37e-2)"	"unprognostic (1.73e-1)"	"unprognostic (2.15e-2)"	"unprognostic (1.00e-1)"	"unprognostic (3.98e-2)"	"unprognostic (4.58e-2)"	9.2	5.4	12.0	14.2	10.7	8.6	20.7	19.5	11.1	6.4	34.2	4.8	5.1	23.8	6.0	5.4	12.7	7.8	13.5	7.1	8.8	8.5	8.7	21.7	12.8	21.3	11.5	5.0	9.4	8.8	10.7	11.8	10.8	16.6	6.9	37.1	14.7	10.3	4.1	10.1	3.8	45.3	5.5	12.3	17.9	19.0	4.4	10.8	20.9	12.9	6.7	13.7	9.2	25.5	7.1	6.1	33.0	23.3	7.1	17.6	9.1	7.5	5.5	5.4	3.4	3.4	2.3	0.0	5.0	2.0	3.5	4.8	5.7	7.8	21.7	9.1	1.6	16.0	25.1	8.7	4.1	5.0	13.6	6.0	2.3	9.3	9.8	5.2	10.2	7.9	2.0	4.8	5.2	2.4	1.8	2.3	7.5	6.0	12.9	3.1	3.0	9.9	11.4	2.6	24.2	12.9	54.7	4.1	60.9	9.8	7.3	4.5	2.0	11.3	10.1	2.8	6.1	3.1	18.1	1.8	3.5	5.0	6.1	7.6	14.6	9.4	22.3	4.4	13.4	7.9	29.1	10.2	11.4	11.1	17.9	8.5	7.1	10.0	10.6	6.1	5.1	8.2	10.3	33.0	7.1	23.3	4.2	17.6	9.1	12.0	10.7	19.5	11.1	8.8	8.5	11.5	5.0	16.6	10.8	8.9	9.4	22.4	33.1	29.8	13.4	3.6	45.9	16.0	7.9	3.5	45.2	23.7	1.7	47.1	3.1	9.6	90.1	0.0	24.3	19.9	15.1	42.5	11.5	26.1	56.1	0.0	34.9	12.3	24.7	1.1	6.9	28.6	30.4	17.2	46.9	9.4	35.8	46.5	6.0	7.7	13.6	12.9	15.9	3.5	8.5	13.2	78.8	38.3	23.5	28.7
ABHD4	FLJ12816	ENSG00000100439	"Abhydrolase domain containing 4"	Q8TB40	14	22598237-22613215	"Enzymes, Predicted intracellular proteins"	"Lipid degradation, Lipid metabolism"	Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"ASC diff: 44.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA000600	Uncertain		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA000600: AB_1078081"	"unprognostic (5.04e-2)"	"unprognostic (5.15e-2)"	"unprognostic (2.68e-3)"	"unprognostic (8.17e-2)"	"unprognostic (1.17e-1)"	"unprognostic (5.24e-2)"	"unprognostic (1.19e-3)"	"unprognostic (3.69e-2)"	"unprognostic (1.28e-1)"	"unprognostic (5.72e-2)"	"unprognostic (1.32e-3)"	"unprognostic (3.73e-1)"	"unprognostic (1.56e-2)"	"unprognostic (5.18e-2)"	"unprognostic (1.37e-1)"	"unprognostic (4.51e-2)"	"unprognostic (1.03e-2)"	17.2	24.9	12.8	6.4	14.5	10.0	20.5	12.3	13.9	19.4	14.7	21.4	37.5	13.4	26.0	26.2	28.6	14.4	22.4	16.4	14.1	10.4	23.9	17.0	13.6	8.7	18.9	12.9	15.4	11.4	14.8	12.2	15.9	15.5	19.3	12.8	22.2	13.9	35.5	17.9	14.2	26.3	22.8	18.5	11.9	18.5	45.0	16.4	5.1	25.1	11.1	14.7	23.2	20.7	3.8	2.8	18.6	4.2	4.4	6.0	3.4	7.8	13.2	5.4	4.9	44.0	16.0	5.2	3.5	18.2	8.9	16.7	8.0	12.6	0.7	9.4	15.5	9.6	15.4	3.4	9.2	7.3	5.8	1.2	2.9	9.2	26.3	20.1	0.4	10.7	20.3	7.2	11.7	10.0	18.7	9.2	5.5	2.1	14.4	8.2	4.3	0.2	0.4	6.6	32.1	9.7	2.1	4.8	3.2	10.4	8.4	0.3	1.1	23.9	8.5	9.1	11.3	3.3	0.8	6.5	3.9	5.4	6.3	1.4	15.6	8.1	0.2	2.9	0.6	3.1	18.6	4.2	6.6	6.0	3.2	5.0	3.8	3.9	3.9	2.8	2.4	1.3	2.6	17.4	4.4	2.9	0.4	2.3	3.4	12.8	14.5	12.3	13.0	14.1	10.4	18.9	12.9	15.5	16.4	11.9	3.5	3.2	5.8	2.9	3.0	5.2	15.3	0.0	2.3	3.5	3.9	5.0	8.3	10.7	3.2	5.9	9.8	0.0	10.3	1.5	5.0	6.9	4.7	7.3	6.4	7.9	5.8	8.6	4.7	3.2	5.2	3.8	1.7	13.6	6.1	7.5	8.8	10.5	7.8	4.2	3.1	6.5	6.2	0.7	0.5	2.4	22.4	5.3	2.8	9.3
ABHD5	"CGI-58, NCIE2"	ENSG00000011198	"Abhydrolase domain containing 5"	Q8WTS1	3	43690108-43734371	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Differentiation, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism"	"Acyltransferase, Transferase"	"Cataract, Deafness, Disease mutation, Ichthyosis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"breast: 70.3"	"Cell type enhanced"	"Detected in many"	7	"Syncytiotrophoblasts: 171.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"basophil: 26.1;classical monocyte: 7.6;neutrophil: 21.0"	"Group enriched"	"Detected in many"	5	"granulocytes: 26.1;monocytes: 7.6"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB020685, HPA035851, HPA035852"	Approved		Supported	Nucleoplasm,Vesicles,Cytosol		NA	NA			"Vesicles, Cytosol"	Nucleoplasm	"CAB020685: , HPA035851: AB_10671942, HPA035852: AB_10672073"	"unprognostic (2.58e-1)"	"unprognostic (2.73e-1)"	"prognostic favorable (8.89e-4)"	"unprognostic (1.07e-1)"	"unprognostic (1.75e-2)"	"unprognostic (2.26e-1)"	"unprognostic (6.13e-2)"	"unprognostic (2.40e-2)"	"unprognostic (5.33e-2)"	"unprognostic (3.50e-3)"	"unprognostic (2.56e-2)"	"unprognostic (4.13e-3)"	"prognostic favorable (9.17e-5)"	"unprognostic (2.48e-1)"	"unprognostic (8.87e-2)"	"unprognostic (4.18e-2)"	"unprognostic (4.18e-2)"	26.5	10.5	5.2	7.4	12.2	32.2	70.3	8.5	10.3	7.6	10.2	10.5	5.9	7.4	4.6	4.0	22.7	3.7	10.4	9.8	7.4	4.5	10.1	18.4	14.1	8.7	18.5	4.6	4.2	12.8	9.1	8.6	20.2	14.9	5.8	6.7	4.4	21.1	7.4	10.4	24.8	15.1	8.1	19.0	7.0	8.9	8.1	12.5	3.3	13.2	9.9	6.7	11.2	16.0	1.7	3.6	26.1	7.6	0.9	2.4	2.5	8.5	3.0	3.6	3.8	15.2	5.8	7.5	34.9	13.9	9.6	7.2	4.7	3.0	7.1	4.8	10.9	8.5	2.8	5.7	8.5	9.8	25.8	5.5	18.2	11.6	3.2	7.6	4.1	5.9	6.4	29.5	16.1	13.8	8.4	16.0	4.8	10.8	5.4	21.3	4.6	2.9	2.9	9.7	6.8	9.8	1.3	10.4	4.1	12.4	17.0	4.4	6.0	15.3	8.3	3.6	4.0	8.9	3.5	8.8	8.5	6.7	15.7	15.1	4.9	13.6	3.4	9.0	7.5	6.6	26.1	7.6	4.4	1.2	3.7	1.0	1.7	0.9	1.4	3.6	1.2	0.8	1.3	21.0	0.9	2.7	0.9	2.4	2.5	5.2	12.2	8.5	10.3	7.4	4.5	18.5	4.6	14.9	12.5	23.8	43.8	8.5	23.5	35.4	11.3	9.7	15.3	17.4	25.0	26.2	25.5	13.3	28.2	49.4	13.5	16.9	64.4	23.3	53.5	21.2	16.2	21.6	16.1	11.3	16.6	3.2	34.9	14.7	26.6	12.9	4.9	30.4	6.8	16.2	17.1	12.4	61.4	24.6	5.3	31.4	14.7	0.0	26.8	35.6	43.9	35.8	171.7	15.8	18.2	41.1
ABHD6		ENSG00000163686	"Abhydrolase domain containing 6"	Q9BV23	3	58237506-58295693	"Enzymes, Predicted membrane proteins"	"Lipid metabolism"	Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 43.4"	"Cell type enhanced"	"Detected in many"	8	"Hepatocytes: 53.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA017283, HPA073225"	Uncertain		Approved	Nucleoplasm,Vesicles		NA	NA			Vesicles	Nucleoplasm	"HPA017283: AB_1844452, HPA073225: AB_2686583"	"unprognostic (4.20e-2)"	"unprognostic (7.92e-2)"	"prognostic favorable (1.13e-4)"	"unprognostic (2.35e-2)"	"unprognostic (1.16e-2)"	"unprognostic (3.00e-1)"	"unprognostic (5.45e-2)"	"unprognostic (1.15e-2)"	"unprognostic (9.54e-2)"	"unprognostic (1.11e-3)"	"unprognostic (1.34e-2)"	"unprognostic (1.94e-1)"	"prognostic favorable (1.11e-11)"	"unprognostic (1.94e-1)"	"unprognostic (2.41e-1)"	"unprognostic (2.72e-1)"	"unprognostic (6.31e-2)"	8.3	10.0	11.6	4.6	14.0	1.0	5.8	17.7	22.5	3.7	8.1	30.0	10.3	26.3	4.7	10.8	4.8	6.9	4.4	4.1	19.0	9.2	24.3	43.4	6.3	5.2	18.6	12.2	4.1	2.4	4.8	15.2	4.8	19.0	4.4	8.1	10.5	3.0	12.9	3.1	17.2	33.5	6.8	24.0	22.8	9.0	3.1	14.3	2.0	6.6	2.1	5.4	4.6	4.1	3.9	7.0	2.1	9.3	0.7	2.6	1.1	2.0	7.7	1.1	5.0	14.5	2.6	13.4	5.4	4.8	5.7	7.7	4.0	2.8	3.9	0.5	2.9	17.6	6.0	5.2	2.4	5.1	6.6	2.6	3.3	5.2	5.5	4.9	1.0	17.6	2.5	11.1	5.2	2.5	6.7	3.2	6.5	3.9	9.0	4.6	1.5	6.7	0.4	3.7	16.7	17.0	2.5	2.3	8.7	8.7	2.8	6.7	2.7	5.9	3.3	11.1	2.3	2.2	2.7	3.4	4.1	4.5	10.1	6.4	2.6	7.6	0.1	10.5	9.9	5.6	0.0	2.8	2.1	2.1	9.3	2.0	3.9	1.2	2.6	4.6	3.0	1.2	1.5	0.0	0.7	6.2	7.0	1.4	1.1	11.6	14.0	17.7	22.5	19.0	9.2	18.6	12.2	19.0	14.3	0.0	2.6	8.8	2.6	7.7	13.8	4.8	0.0	17.4	5.7	3.5	3.9	2.2	1.7	2.9	0.8	7.8	13.6	0.0	1.6	0.4	2.1	1.3	10.5	53.3	8.1	14.3	0.0	26.4	14.6	0.4	6.4	9.6	3.3	14.4	2.2	10.8	1.6	0.0	7.8	15.4	3.0	0.0	3.5	0.5	2.3	21.5	0.5	3.2	4.5	2.0
ABL1	"ABL, c-ABL, JTK7, p150"	ENSG00000097007	"ABL proto-oncogene 1, non-receptor tyrosine kinase"	P00519	9	130713946-130887675	"Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins, RAS pathway related proteins"	"Apoptosis, Autophagy, Cell adhesion, DNA damage, DNA repair, Endocytosis"	"DNA-binding, Kinase, Transferase, Tyrosine-protein kinase"	"Cancer-related genes, Disease mutation, FDA approved drug targets, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002686, HPA027251, HPA027280, HPA028409"	Supported		Enhanced	"Nucleoplasm,Nuclear bodies"		Yes	No			Nucleoplasm	"Nuclear bodies"	"CAB002686: , HPA027251: AB_1844453, HPA027280: AB_1844454, HPA028409: AB_10601011"	"unprognostic (4.82e-2)"	"unprognostic (3.99e-2)"	"unprognostic (5.55e-2)"	"unprognostic (4.72e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.46e-1)"	"unprognostic (3.75e-3)"	"unprognostic (1.89e-3)"	"unprognostic (2.34e-1)"	"unprognostic (2.54e-2)"	"unprognostic (1.09e-2)"	"unprognostic (1.48e-1)"	"unprognostic (3.96e-3)"	"unprognostic (1.10e-2)"	"unprognostic (1.47e-1)"	"unprognostic (1.22e-1)"	"unprognostic (1.06e-1)"	20.1	11.6	12.4	15.0	18.1	10.7	22.0	6.7	16.0	28.9	34.3	29.1	12.1	11.9	26.6	16.9	21.4	20.8	30.9	14.2	10.3	8.4	9.9	6.7	13.8	8.7	24.1	9.4	24.2	12.2	27.7	14.5	13.6	17.1	27.3	15.8	19.4	14.6	18.0	10.8	14.2	17.0	66.6	14.3	10.8	21.9	9.8	21.2	5.8	19.5	11.4	9.1	35.8	31.9	3.1	3.1	1.1	5.0	2.4	2.6	1.6	7.2	16.1	17.2	20.8	25.3	30.9	6.3	12.7	19.9	14.9	12.6	12.6	9.4	11.9	7.3	16.8	15.3	14.0	8.7	11.7	11.0	7.4	5.4	7.8	27.4	10.7	17.3	11.9	10.9	22.5	12.9	26.6	16.5	20.8	20.6	15.4	43.5	9.5	18.1	13.7	15.1	9.8	19.1	11.3	11.9	17.5	22.3	12.8	15.1	8.5	16.1	20.1	21.3	8.3	10.2	10.5	16.2	11.0	23.6	57.2	14.8	21.8	19.9	2.9	6.8	15.9	23.5	9.9	18.1	0.2	2.1	1.1	2.0	1.2	2.6	3.1	2.0	1.9	2.0	1.4	1.9	1.7	0.2	2.4	5.0	3.1	0.9	1.6	12.4	18.1	6.7	16.0	10.3	8.4	24.1	9.4	17.1	21.2	8.9	9.9	4.2	6.4	8.1	6.2	5.8	12.7	5.3	5.7	14.0	11.8	11.3	1.7	12.6	3.1	14.3	15.4	0.0	9.5	3.5	27.8	8.1	2.3	13.4	13.7	9.5	21.2	20.3	13.7	7.4	25.9	6.5	5.0	3.6	15.7	15.7	14.3	20.3	24.1	8.4	9.7	19.4	21.0	11.9	13.6	5.9	12.7	7.9	19.1	6.4
ABL2	"ABLL, ARG"	ENSG00000143322	"ABL proto-oncogene 2, non-receptor tyrosine kinase"	P42684	1	179099327-179229684	"Cancer-related genes, Enzymes, Predicted intracellular proteins, RAS pathway related proteins"	"Cell adhesion"	"Kinase, Transferase, Tyrosine-protein kinase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"Cone photoreceptor cells: 157.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"hTERT-HME1: 32.3;TIME: 30.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001866, CAB017106, HPA072754"	Uncertain		Approved	Nucleoplasm,Vesicles		NA	NA			Nucleoplasm	Vesicles	"CAB017106: , HPA001866: AB_1078082, HPA072754: AB_2732212"	"unprognostic (3.05e-1)"	"prognostic unfavorable (3.50e-4)"	"unprognostic (1.07e-1)"	"unprognostic (4.71e-2)"	"unprognostic (9.45e-2)"	"unprognostic (8.23e-3)"	"unprognostic (1.91e-2)"	"unprognostic (4.81e-3)"	"unprognostic (1.26e-1)"	"unprognostic (6.98e-2)"	"unprognostic (1.12e-1)"	"unprognostic (3.73e-1)"	"prognostic unfavorable (1.78e-7)"	"unprognostic (4.76e-2)"	"unprognostic (4.14e-2)"	"unprognostic (6.08e-2)"	"prognostic unfavorable (8.40e-4)"	14.3	5.2	8.6	7.4	13.7	3.7	8.3	14.9	10.6	9.2	6.6	5.8	4.5	4.0	5.4	4.7	3.9	4.3	18.8	6.8	9.7	3.9	4.9	4.3	11.5	3.7	6.5	6.1	5.6	8.4	9.2	8.4	6.1	8.1	5.1	5.2	5.8	4.5	4.4	5.2	6.6	3.7	6.9	6.2	3.9	4.7	9.2	8.6	3.6	5.8	3.1	3.6	6.7	11.2	2.8	2.0	3.8	1.2	1.8	2.2	0.6	10.1	5.6	3.7	2.5	3.2	7.4	2.3	11.3	9.3	13.9	10.1	4.1	3.1	5.9	8.4	8.0	9.6	5.1	5.4	3.8	19.8	3.7	4.9	2.8	5.1	2.0	5.9	3.1	0.9	6.8	5.0	19.8	32.3	6.0	15.4	3.0	6.7	1.7	18.1	2.7	2.5	1.7	3.6	2.0	1.8	3.7	6.3	2.9	4.7	1.6	2.3	5.2	9.4	3.0	23.2	5.9	2.7	2.6	30.1	14.5	10.8	6.9	18.1	3.1	3.9	6.1	6.8	1.8	13.9	3.8	1.2	0.4	2.2	0.4	1.0	1.8	1.4	1.4	0.9	2.8	1.9	2.0	2.6	1.8	0.5	2.0	0.8	0.6	8.6	13.7	14.9	10.6	9.7	3.9	6.5	6.1	8.1	8.6	20.8	26.6	12.4	33.8	41.7	36.0	7.0	17.8	6.7	10.3	10.4	157.1	7.7	10.0	12.7	14.0	46.7	9.7	0.0	11.9	6.7	36.0	32.7	16.2	14.5	21.0	23.8	25.9	33.7	32.7	21.4	14.1	36.5	65.8	12.6	9.6	9.8	30.1	14.4	12.7	8.4	34.1	6.5	29.3	18.2	26.3	33.5	8.7	10.1	13.9	20.7
AC008397.2		ENSG00000285188	"CAMP-specific 3',5'-cyclic phosphodiesterase 4C "	Q08493	19	18207961-18255419	"Enzymes, FDA approved drug targets, Predicted intracellular proteins"		Hydrolase	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"gallbladder: 22.4;intestine: 15.6;pancreas: 14.2"	"Group enriched"	"Detected in some"	8	"Alveolar cells type 1: 8.9;Alveolar cells type 2: 8.8"									"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 3.7;U-2197: 1.6;U-87 MG: 4.8"									"HPA048975, HPA054218"	Uncertain		Approved	"Midbody ring,Centrosome,Cytosol"		NA	NA			"Centrosome, Cytosol"	"Midbody ring"	"HPA048975: AB_2680581, HPA054218: "																		0.0	0.0	0.0	3.7	0.0	0.0	0.0	0.0	1.2	1.9	15.6	0.0	0.0	1.3	1.1	3.6	4.0	1.0	22.4	0.6	0.0		0.6	0.0	2.0	0.0	0.0	0.0	0.0	14.2	0.0	0.0	0.8	0.0	0.0	1.7	0.0	2.1	1.1	3.7	0.0	8.0	0.6	0.0	0.4	7.1	0.2	0.0	0.0	0.4	0.8	4.1	0.7	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	3.7	0.1	0.0	0.0	0.2	0.0	0.3	0.3	0.4	0.0	0.1	0.5	0.0	0.0	0.2	0.1	0.0	0.1	0.2	0.9	0.0	0.0	0.3	0.4	0.0	0.8	0.0	0.3	0.0	0.0	0.3	0.7	0.0	0.0	0.0	0.0	0.3	0.5	0.0	0.0	0.4	0.1	0.0	0.1	0.3	0.1	0.0	0.0	0.2	0.7	0.1	0.2	0.0	0.0	0.2	1.6	0.0	0.3	0.2	0.1	4.8	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											8.9	8.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
ACAA1		ENSG00000060971	"Acetyl-CoA acyltransferase 1"	P09110	3	38103129-38137242	"Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"	"Fatty acid metabolism, Lipid metabolism"	"Acyltransferase, Transferase"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 152.1"	"Cell type enhanced"	"Detected in all"	9	"Hepatocytes: 651.0;Proximal tubular cells: 601.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"OE19: 51.9;SK-BR-3: 82.5"					"Low region specificity"	"Detected in all"			"HPA006764, HPA007244"	Enhanced		Supported	Peroxisomes		NA	NA		4300000	Peroxisomes		"HPA006764: AB_1078085, HPA007244: AB_1078084"	"prognostic favorable (3.00e-4)"	"unprognostic (5.57e-2)"	"unprognostic (4.54e-2)"	"prognostic favorable (7.53e-4)"	"unprognostic (2.63e-1)"	"prognostic favorable (1.23e-4)"	"unprognostic (9.35e-3)"	"unprognostic (2.91e-2)"	"unprognostic (8.11e-2)"	"unprognostic (2.22e-1)"	"unprognostic (2.24e-1)"	"unprognostic (4.90e-1)"	"prognostic favorable (6.99e-9)"	"unprognostic (1.72e-1)"	"unprognostic (1.99e-1)"	"unprognostic (2.50e-2)"	"unprognostic (1.65e-2)"	9.5	12.7	11.0	5.6	11.9	9.6	10.2	8.1	14.3	6.7	16.1	12.5	10.6	23.4	4.9	13.3	12.1	4.6	16.0	17.7	10.2	8.9	48.7	152.1	8.2	5.9	14.0	9.4	5.0	19.2	7.4	5.9	6.8	11.0	13.4	12.4	7.3	11.5	9.4	9.8	6.2	23.8	4.8	12.7	10.0	8.5	4.4	10.9	5.7	9.3	10.1	10.2	9.4	7.0	9.2	47.0	32.8	45.2	17.8	19.3	18.8	8.1	8.9	3.0	9.5	13.1	7.7	10.6	7.5	10.9	8.6	8.2	11.9	9.2	4.8	5.4	12.0	4.2	5.4	8.2	12.7	4.7	7.0	8.5	6.2	7.9	33.7	8.5	14.3	14.0	14.2	9.1	7.4	5.3	5.4	11.6	11.8	5.8	5.7	9.5	10.6	13.8	10.2	3.2	51.9	10.8	3.1	5.8	8.1	24.2	24.2	2.6	4.1	7.3	82.5	5.2	4.4	8.5	11.5	8.4	5.2	5.0	10.4	10.3	7.6	4.8	3.8	8.5	12.5	8.3	15.3	29.9	32.8	13.6	40.7	11.4	9.2	13.1	13.3	47.0	8.7	13.0	12.1	20.4	17.8	45.2	27.7	19.3	18.8	11.0	11.9	8.1	14.3	10.2	8.9	14.0	9.4	11.0	10.9	38.7	31.4	45.5	55.9	29.7	37.5	2.4	109.5	17.4	19.4	62.8	13.7	77.1	140.9	89.4	3.0	25.4	292.3	23.3	69.3	52.5	32.7	64.1	18.5	651.0	74.1	7.9	52.9	34.4	86.5	6.4	33.1	68.8	55.6	86.6	63.2	33.0	78.8	122.8	31.1	601.4	14.2	32.3	25.8	17.5	11.7	31.0	83.1	42.0	60.0	69.8
ACAA2	DSAEC	ENSG00000167315	"Acetyl-CoA acyltransferase 2"	P42765	18	49782167-49813960	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Fatty acid metabolism, Lipid metabolism"	"Acyltransferase, Hydrolase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	4	"liver: 245.7"	"Cell type enhanced"	"Detected in many"	9	"Hepatocytes: 686.3;Proximal tubular cells: 536.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042303	Approved		Supported	Mitochondria		NA	NA		3200000	Mitochondria		"HPA042303: AB_10794046"	"unprognostic (7.94e-2)"	"unprognostic (3.14e-2)"	"unprognostic (2.20e-3)"	"prognostic unfavorable (8.53e-4)"	"unprognostic (2.92e-2)"	"unprognostic (2.28e-2)"	"unprognostic (7.63e-2)"	"unprognostic (1.70e-1)"	"unprognostic (7.97e-2)"	"unprognostic (8.03e-3)"	"unprognostic (1.72e-1)"	"unprognostic (3.84e-1)"	"prognostic favorable (1.36e-10)"	"unprognostic (1.39e-1)"	"unprognostic (2.24e-1)"	"unprognostic (8.26e-3)"	"unprognostic (3.41e-1)"	22.7	12.9	9.4	6.9	10.7	4.4	13.0	3.6	7.0	4.1	27.2	8.0	7.8	25.9	5.1	5.1	7.1	4.1	9.2	38.9	6.8	7.0	60.3	245.7	7.9	7.5	10.7	6.1	6.4	13.6	6.3	7.1	7.5	6.7	7.9	18.4	9.5	3.3	6.2	22.9	4.2	37.0	11.3	9.7	6.9	6.0	6.5	7.5	8.4	15.7	8.8	5.0	8.1	4.9	13.0	31.8	27.5	33.0	35.5	40.9	28.6	0.8	14.1	23.6	21.6	31.3	16.6	12.0	7.2	11.8	12.2	9.5	30.0	12.3	12.6	15.5	26.6	12.6	0.9	39.3	4.6	12.1	38.6	9.2	8.9	18.5	35.6	14.8	0.1	16.9	21.9	1.5	19.7	6.2	9.9	20.0	18.3	7.7	11.9	33.9	16.3	0.5	19.5	21.4	5.3	5.7	31.0	50.5	46.2	41.3	0.6	33.9	26.9	0.5	16.6	1.1	19.5	9.4	13.1	9.5	10.4	13.1	15.7	7.9	24.2	27.9	32.2	7.4	18.2	9.5	13.1	25.9	27.5	32.1	33.0	40.9	13.0	19.2	28.6	31.8	9.7	16.4	24.3	2.5	35.5	31.1	14.9	22.6	28.6	9.4	10.7	3.6	7.0	6.8	7.0	10.7	6.1	6.7	7.5	35.7	38.9	45.7	10.9	3.2	5.9	161.7	229.3	29.4	30.7	52.4	3.9	30.0	250.4	111.1	56.2	32.3	191.9	0.0	40.7	49.6	32.6	10.2	44.9	686.3	101.9	1.6	38.5	46.6	63.1	122.0	44.5	46.6	18.6	61.3	59.2	53.2	84.8	76.3	35.0	536.1	27.2	19.4	17.6	27.7	39.6	4.3	22.5	68.2	98.9	4.5
ACACA	"ACAC, ACC, ACC1"	ENSG00000278540	"Acetyl-CoA carboxylase alpha"	Q13085	17	37084988-37406818	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism"	"Allosteric enzyme, Ligase, Multifunctional enzyme"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB013715, HPA036650, HPA063018"	Approved		Supported	"Nucleoli fibrillar center,Actin filaments,Cytosol"		NA	NA			Cytosol	"Nucleoli fibrillar center, Actin filaments"	"CAB013715: , HPA036650: AB_2675228, HPA063018: AB_2684922"	"unprognostic (1.96e-2)"	"unprognostic (1.07e-2)"	"unprognostic (3.04e-2)"	"unprognostic (1.10e-1)"	"unprognostic (4.86e-2)"	"unprognostic (1.19e-1)"	"prognostic unfavorable (1.24e-5)"	"unprognostic (8.81e-2)"	"unprognostic (6.56e-2)"	"unprognostic (2.38e-3)"	"unprognostic (3.38e-1)"	"unprognostic (2.24e-1)"	"unprognostic (6.72e-2)"	"unprognostic (1.18e-1)"	"unprognostic (4.89e-1)"	"unprognostic (4.49e-2)"	"unprognostic (2.03e-2)"	10.7	4.8	5.6	2.5	7.7	3.0	18.5	6.0	11.5	5.3	4.2	6.9	12.7	3.8	4.5	11.7	9.2	3.8	3.6	2.3	4.9		3.0	5.8	7.3	3.5	6.3	4.6	4.3	2.3	13.6	7.9	2.6	6.1	12.2	5.1	4.8	4.6	14.4	11.3	5.4	2.5	7.8	4.2	2.3	3.9	5.5	5.7	2.0	4.2	4.5	5.0	4.3	4.6	4.4	3.2	1.3	4.1	2.0	3.9	2.0	14.9	3.1	18.2	19.1	25.4	25.1	6.3	6.6	9.4	6.9	12.6	12.1	2.6	2.0	5.4	10.7	18.3	15.4	3.3	22.6	10.9	5.9	9.9	11.9	7.9	12.3	4.0	6.4	2.4	20.2	13.2	18.4	13.7	8.7	12.2	10.7	28.3	1.4	1.0	12.6	6.8	9.8	13.8	9.4	9.9	10.5	11.4	2.7	16.4	16.9	20.6	8.1	11.9	5.6	5.3	16.5	11.2	7.4	10.8	5.9	9.4	8.2	1.6	4.0	4.7	18.6	5.4	5.4	8.1	1.1	2.8	0.3	2.3	4.1	2.1	2.7	2.5	2.7	3.2	4.4	3.9	2.7	1.3	2.0	2.7	2.4	3.2	2.0											29.8	40.1	3.7	15.6	10.3	15.4	6.5	2.5	8.1	12.5	10.4	25.5	14.2	8.3	5.9	46.0	7.5	4.8	23.3	7.2	5.4	7.5	20.3	6.9	8.1	5.0	22.3	8.6	4.3	2.1	39.8	9.2	4.2	10.1	3.6	7.2	19.9	6.5	5.8	14.9	5.0	10.7	6.5	4.8	7.9	17.9	13.9	13.6	4.3	8.7	18.2
ACACB	"ACC2, ACCB, HACC275"	ENSG00000076555	"Acetyl-CoA carboxylase beta"	O00763	12	109116595-109268226	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism"	"Allosteric enzyme, Ligase, Multifunctional enzyme"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	5	"adipose tissue: 104.5;breast: 67.4;liver: 42.0;skeletal muscle: 154.2"	"Cell type enhanced"	"Detected in many"	14	"Hepatocytes: 159.9;Peritubular cells: 47.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"eosinophil: 15.5"	"Lineage enriched"	"Detected in many"	6	"granulocytes: 15.5"	"Cell line enriched"	"Detected in many"	18	"ASC diff: 73.2"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			HPA006554	Enhanced				"Intracellular and membrane"	NA	NA					"HPA006554: AB_1844495"	"unprognostic (2.24e-1)"	"unprognostic (4.66e-1)"	"unprognostic (3.97e-2)"	"unprognostic (4.54e-6)"	"unprognostic (2.82e-1)"	"unprognostic (1.59e-2)"	"unprognostic (8.62e-3)"	"unprognostic (5.81e-2)"	"unprognostic (2.86e-1)"	"unprognostic (1.63e-2)"	"prognostic favorable (1.93e-4)"	"unprognostic (6.63e-2)"	"prognostic favorable (1.15e-5)"	"unprognostic (2.36e-1)"	"unprognostic (2.01e-1)"	"unprognostic (1.21e-3)"	"unprognostic (2.58e-2)"	104.5	8.2	4.3	10.6	4.0	1.6	67.4	3.3	3.5	3.5	19.3	3.2	6.2	3.8	4.6	4.3	4.9	3.9	10.5	12.1	4.5	2.0	5.4	42.0	3.1	4.0	6.4	2.7	6.8	8.5	8.9	7.1	1.3	3.7	3.6	3.9	4.0	5.8	9.0	154.2	2.8	4.8	7.5	6.5	2.5	5.6	1.6	4.9	0.4	6.2	12.5	1.7	7.3	6.3	2.5	0.2	15.5	0.4	0.1	1.7	0.1	0.2	1.8	1.1	2.2	73.2	0.5	0.8	0.3	0.4	0.3	0.2	1.2	0.3	0.9	0.5	0.3	0.8	1.5	0.9	0.5	0.2	1.1	1.7	2.0	1.8	1.3	0.3	1.7	0.5	0.8	0.4	0.7	0.2	0.5	0.1	1.5	0.2	0.1	0.2	0.5	1.2	1.6	1.2	0.1	3.9	0.6	1.5	0.4	0.6	0.6	0.7	1.7	1.8	0.9	1.1	0.5	0.8	1.8	0.1	0.7	0.4	0.8	0.6	2.8	1.5	1.2	1.7	1.4	0.5	4.1	0.4	15.5	1.1	0.1	0.6	1.7	1.0	0.3	0.2	2.5	1.7	0.9	0.6	0.1	0.2	0.2	0.6	0.1	4.3	4.0	3.3	3.5	4.5	2.0	6.4	2.7	3.7	4.9	6.0	0.6	0.0	2.5	2.1	1.3	29.0	28.1	1.4	2.3	22.7	0.0	0.4	1.7	1.0	27.5	7.1	12.9	0.0	3.6	0.4	5.4	1.4	1.1	159.9	1.6	22.3	9.8	31.3	8.6	31.3	27.0	2.2	5.0	1.0	8.8	7.5	3.5	7.0	47.4	6.5	4.7	6.5	7.6	2.7	2.5	1.4	0.1	0.0	9.7	0.7
ACADL	"ACAD4, LCAD"	ENSG00000115361	"Acyl-CoA dehydrogenase long chain"	P28330	2	210187939-210225491	"Enzymes, Predicted intracellular proteins"	"Fatty acid metabolism, Lipid metabolism"	Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lung: 29.5;thyroid gland: 29.7"	"Cell type enhanced"	"Detected in many"	7	"Alveolar cells type 2: 49.8;Early spermatids: 59.0;Late spermatids: 54.8;Leydig cells: 43.4;Peritubular cells: 43.9"	"Group enriched"	"Detected in many"	8	"liver cancer: 2.2;prostate cancer: 6.8;renal cancer: 8.8;thyroid cancer: 4.6"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HAP1: 3.0;HeLa: 7.0;RPTEC TERT1: 6.3;RT4: 2.4;SuSa: 6.5;U-2 OS: 3.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA011990	Enhanced	Supported				NA	NA					"HPA011990: AB_1844465"	"unprognostic (6.29e-3)"	"unprognostic (7.61e-2)"		"unprognostic (1.40e-1)"	"unprognostic (1.53e-1)"	"unprognostic (1.33e-2)"	"unprognostic (7.66e-3)"	"unprognostic (3.24e-1)"	"unprognostic (1.55e-1)"	"unprognostic (1.75e-1)"	"unprognostic (1.66e-1)"	"unprognostic (1.99e-1)"	"prognostic favorable (1.58e-11)"	"unprognostic (4.22e-3)"	"unprognostic (1.18e-4)"	"unprognostic (8.81e-3)"	"unprognostic (1.06e-1)"	9.6	1.1	2.0	1.0	1.8	0.0	10.7	1.4	1.8	3.2	0.8	1.5	4.5	0.1	0.7	6.8	1.3	2.3	2.1	2.2	2.4	1.0	17.3	23.0	29.5	0.0	1.6	2.3	12.2	19.3	11.6	5.8	1.2	3.4	14.5	0.2	3.2	9.9	4.8	7.0	2.2	0.3	1.5	3.1	0.0	3.3	4.2	0.9	0.7	29.7	3.7	0.0	0.7	4.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.6	0.3	0.2	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.0	0.4	0.0	0.0	2.3	0.0	7.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.9	0.0	0.6	0.0	0.0	0.0	6.3	2.4	0.1	0.9	0.0	0.1	0.0	6.5	0.0	0.0	0.0	0.0	3.5	0.1	0.8	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	1.8	1.4	1.8	2.4	1.0	1.6	2.3	3.4	0.9	26.8	49.8	0.0	1.1	0.6	0.2	0.8	10.2	1.4	12.5	21.0	2.0	5.8	13.3	3.4	59.0	0.0	0.0	0.0	10.5	0.4	1.3	4.7	2.3	20.7	0.5	0.0	0.0	1.3	0.3	54.8	43.4	0.8	0.0	0.0	0.0	0.0	5.3	0.0	43.9	25.4	0.1	0.0	1.0	0.6	0.5	0.9	5.3	0.0	0.0	0.6
ACADM	"ACAD1, MCAD, MCADH"	ENSG00000117054	"Acyl-CoA dehydrogenase medium chain"	P11310	1	75724347-75787575	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Fatty acid metabolism, Lipid metabolism"	Oxidoreductase	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 89.7;skeletal muscle: 82.8"	"Group enriched"	"Detected in many"	4	"Cardiomyocytes: 330.8;Ciliated cells: 152.6;Distal tubular cells: 291.8;Hepatocytes: 232.4;Proximal tubular cells: 350.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"Daudi: 77.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006198, HPA026542"	Enhanced		Enhanced	Mitochondria		NA	NA		1200000	Mitochondria		"HPA006198: AB_1078087, HPA026542: AB_1844469"	"unprognostic (9.04e-3)"	"unprognostic (2.36e-1)"	"prognostic favorable (7.30e-4)"	"unprognostic (5.09e-3)"	"unprognostic (1.61e-3)"	"unprognostic (5.68e-2)"	"unprognostic (6.75e-2)"	"unprognostic (1.11e-1)"	"unprognostic (8.02e-2)"	"unprognostic (4.95e-2)"	"unprognostic (9.40e-3)"	"unprognostic (3.35e-1)"	"prognostic favorable (3.83e-8)"	"unprognostic (1.27e-1)"	"unprognostic (4.09e-2)"	"unprognostic (3.56e-2)"	"unprognostic (1.24e-1)"	18.1	25.0	12.3	11.3	13.0	3.9	18.0	12.0	10.8	8.4	21.6	8.3	10.1	25.1	6.7	8.6	21.9	7.6	6.7	49.7	10.5	11.2	71.1	89.7	6.3	9.4	13.0	9.2	10.5	10.3	8.1	12.0	4.2	14.3	9.2	12.1	8.0	9.0	11.7	82.8	5.6	25.1	9.8	10.7	12.3	12.0	8.5	11.0	11.0	12.2	42.1	10.0	9.5	8.1	29.7	16.7	14.1	13.8	16.8	20.0	13.2	7.0	5.6	17.7	7.8	15.3	12.6	5.0	13.3	10.9	13.0	11.0	10.5	11.3	77.6	11.8	9.5	11.2	6.6	15.1	11.3	16.3	30.0	7.4	25.4	17.3	16.2	10.7	21.7	7.1	14.5	6.5	11.4	6.8	10.1	10.2	16.9	25.9	17.5	14.0	2.6	25.4	10.2	14.3	21.5	13.6	33.2	23.4	8.1	21.6	18.7	9.6	12.1	10.8	32.1	27.7	12.8	9.5	27.5	5.5	8.9	8.8	7.6	21.7	11.4	16.3	34.5	7.5	17.7	10.1	10.7	9.6	14.1	13.2	13.8	20.0	29.7	13.8	15.9	14.3	18.0	15.8	17.6	0.8	16.8	12.7	16.7	13.8	13.2	12.3	13.0	12.0	10.8	10.5	11.2	13.0	9.2	14.3	11.0	53.6	43.4	62.8	34.2	24.3	36.0	330.8	53.5	152.6	51.2	55.8	23.6	30.2	291.8	28.7	45.7	27.1	38.4	23.3	23.5	17.3	29.9	27.0	42.8	232.4	67.1	28.6	39.0	43.6	39.4	18.0	43.4	40.9	49.0	30.7	34.0	51.0	23.3	33.6	42.8	350.1	27.0	0.0	32.5	64.2	67.3	23.6	12.8	30.5	42.5	35.5
ACADS	"ACAD3, SCAD"	ENSG00000122971	"Acyl-CoA dehydrogenase short chain"	P16219	12	120725735-120740008	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Fatty acid metabolism, Lipid metabolism"	Oxidoreductase	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 58.4;skeletal muscle: 50.7"	"Cell type enhanced"	"Detected in many"	9	"Enterocytes: 312.7;Hepatocytes: 154.5;Paneth cells: 154.3;Undifferentiated cells: 144.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HMC-1: 23.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004799, CAB019284, HPA022271"	Enhanced		Enhanced	Nucleoplasm,Centrosome,Mitochondria		NA	NA		15000	Mitochondria	"Nucleoplasm, Centrosome"	"CAB019284: , HPA004799: AB_1844471, HPA022271: AB_1844472"	"unprognostic (7.14e-2)"	"unprognostic (3.03e-3)"	"unprognostic (8.15e-2)"	"prognostic favorable (5.05e-4)"	"unprognostic (1.11e-3)"	"unprognostic (5.75e-2)"	"prognostic favorable (2.43e-4)"	"unprognostic (5.65e-2)"	"unprognostic (1.22e-1)"	"unprognostic (2.14e-1)"	"unprognostic (2.69e-2)"	"unprognostic (4.04e-2)"	"prognostic favorable (3.33e-6)"	"unprognostic (1.23e-2)"	"unprognostic (1.81e-1)"	"unprognostic (1.21e-1)"	"prognostic favorable (6.34e-5)"	19.5	14.5	5.7	10.0	5.2	5.3	18.0	2.3	4.6	2.9	26.2	4.7	4.5	35.8	2.8	5.3	5.0	2.9	9.1	32.6	3.7	3.3	13.2	58.4	5.6	7.8	5.0	4.1	2.3	14.4	3.0	2.4	4.3	3.8	4.1	9.0	5.6	8.9	4.6	50.7	3.4	35.3	6.5	3.8	8.6	9.5	10.7	5.4	4.0	8.1	16.8	4.3	5.0	3.2	6.8	11.4	7.2	14.0	15.3	14.7	10.0	2.0	7.2	0.4	6.3	8.6	3.4	7.2	3.0	3.0	3.9	2.9	5.6	5.1	0.2	7.8	2.5	1.8	3.3	4.2	1.3	0.5	10.5	5.3	5.2	2.2	11.9	6.2	0.4	23.6	10.3	2.0	1.7	0.1	1.2	3.9	13.3	4.2	0.0	1.7	4.2	7.2	12.0	1.3	6.6	3.0	5.3	2.7	1.4	7.3	11.5	0.7	4.0	6.2	0.0	9.8	0.6	5.0	8.2	4.4	0.1	3.1	3.0	0.5	10.0	5.6	2.5	6.7	4.4	2.6	7.2	13.0	6.4	12.4	14.0	8.8	5.9	11.3	13.0	11.4	6.8	14.7	13.2	1.3	15.3	8.7	9.5	11.9	10.0	5.7	5.2	2.3	4.6	3.7	3.3	5.0	4.1	3.8	5.4	11.9	10.7	10.2	10.2	6.0	1.1	32.5	30.6	2.7	5.7	17.4	0.0	60.7	43.1	26.8	15.8	14.2	312.7	23.3	28.4	26.2	16.9	7.1	19.5	154.5	47.4	1.6	43.8	12.9	27.2	26.3	19.8	11.1	16.9	32.5	94.5	13.0	25.9	154.3	17.0	74.9	0.7	6.5	13.0	29.1	8.3	4.0	63.2	20.3	144.6	9.0
ACADSB	"ACAD7, SBCAD"	ENSG00000196177	"Acyl-CoA dehydrogenase short/branched chain"	P45954	10	123008979-123058311	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Fatty acid metabolism, Lipid metabolism"	Oxidoreductase	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	4	"kidney: 28.9;liver: 114.2"	"Cell type enriched"	"Detected in many"	4	"Hepatocytes: 481.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"Hep G2: 35.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041458, HPA063555"	Enhanced		Supported	Mitochondria		NA	NA		63000	Mitochondria		"HPA041458: AB_2677491, HPA063555: "	"unprognostic (1.53e-2)"	"unprognostic (1.31e-1)"	"unprognostic (3.91e-3)"	"unprognostic (2.02e-1)"	"unprognostic (1.25e-1)"	"unprognostic (4.87e-2)"	"unprognostic (4.15e-2)"	"unprognostic (1.32e-3)"	"unprognostic (1.30e-1)"	"unprognostic (3.67e-1)"	"prognostic favorable (3.40e-4)"	"unprognostic (9.37e-3)"	"prognostic favorable (6.37e-12)"	"unprognostic (2.69e-1)"	"unprognostic (7.20e-2)"	"unprognostic (1.60e-3)"	"unprognostic (7.14e-2)"	4.6	9.4	6.7	2.4	9.0	1.4	8.3	10.3	8.3	3.9	5.3	5.5	6.4	16.8	4.1	3.3	4.4	4.1	3.1	13.7	8.5	4.8	28.9	114.2	4.3	2.7	5.1	8.2	5.0	5.3	8.0	4.9	1.9	7.5	7.9	5.8	4.9	5.6	6.0	12.7	4.7	5.5	5.2	4.8	2.7	4.8	2.9	5.4	3.6	4.3	7.9	3.9	5.0	4.1	6.3	6.8	13.5	5.0	9.0	11.7	6.0	9.7	7.0	5.2	9.5	7.1	8.9	4.6	6.0	12.2	6.1	6.1	6.1	3.2	10.2	4.2	5.1	3.7	4.1	8.1	4.2	10.1	6.6	8.4	5.3	2.1	35.3	5.0	7.5	5.1	6.5	4.3	3.8	3.5	9.0	5.8	8.6	5.1	7.5	7.5	4.5	7.1	6.2	3.2	5.4	4.4	8.5	10.9	3.2	8.6	10.8	1.0	6.0	9.2	2.8	9.5	5.2	8.4	3.7	6.1	3.3	3.0	7.5	7.3	8.5	9.6	5.4	5.1	7.1	2.5	13.5	5.0	12.3	10.0	5.0	11.7	5.9	9.4	8.6	6.8	6.3	8.9	9.9	3.2	9.0	3.0	4.1	7.6	6.0	6.7	9.0	10.3	8.3	8.5	4.8	5.1	8.2	7.5	5.4	26.8	40.3	7.3	7.2	8.2	17.2	64.9	43.3	17.4	29.6	10.4	9.8	17.9	39.7	6.4	6.0	7.4	6.8	0.0	4.2	2.5	7.5	26.5	3.5	481.6	6.3	20.6	11.6	15.4	11.8	7.8	12.4	7.6	6.8	8.2	13.3	12.2	4.3	5.8	10.3	116.2	7.3	19.4	11.3	9.7	2.5	12.0	25.2	13.8	15.7	10.7
ACADVL	"ACAD6, LCACD, VLCAD"	ENSG00000072778	"Acyl-CoA dehydrogenase very long chain"	P49748	17	7217125-7225273	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Fatty acid metabolism, Lipid metabolism"	Oxidoreductase	"Cardiomyopathy, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019006, HPA020595"	Enhanced		Supported	Nucleoplasm,Nucleoli,Mitochondria		NA	NA		19000000	Mitochondria	"Nucleoplasm, Nucleoli"	"HPA019006: AB_1844478, HPA020595: AB_1844479"	"unprognostic (4.81e-2)"	"unprognostic (2.86e-1)"	"unprognostic (2.21e-2)"	"unprognostic (1.09e-2)"	"unprognostic (6.63e-3)"	"unprognostic (1.51e-1)"	"unprognostic (1.89e-2)"	"unprognostic (1.39e-1)"	"unprognostic (1.07e-1)"	"unprognostic (3.21e-1)"	"prognostic favorable (6.87e-4)"	"unprognostic (3.55e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.34e-1)"	"unprognostic (1.58e-1)"	"unprognostic (4.01e-1)"	"unprognostic (2.84e-3)"	32.7	69.2	22.8	18.2	21.1	15.1	24.1	19.8	18.4	21.1	44.0	16.5	26.7	51.7	17.4	19.7	31.5	14.2	24.4	118.2	20.2	12.2	35.2	90.0	17.3	9.8	18.5	16.8	15.5	67.8	31.5	32.3	40.2	20.9	22.1	24.2	20.0	27.4	29.0	132.3	20.3	51.2	25.0	15.7	21.9	28.7	11.5	18.6	14.6	29.6	36.9	21.2	22.4	31.8	8.3	32.0	37.9	29.0	11.6	14.9	20.0	33.5	32.1	13.2	18.1	57.0	21.0	25.0	24.7	34.4	28.1	17.5	12.9	30.3	18.0	20.6	51.7	10.1	25.9	8.8	27.0	24.9	56.9	9.1	9.6	22.8	19.7	27.4	9.1	25.0	23.3	24.7	23.5	37.1	43.6	25.3	22.1	12.3	21.9	45.1	12.7	9.4	11.0	6.2	35.2	12.7	13.2	14.6	42.6	62.6	30.6	3.5	8.7	34.8	44.3	20.2	12.9	20.3	14.0	25.1	24.9	18.7	12.6	24.1	20.6	9.6	0.9	45.9	16.1	18.1	6.8	29.0	37.9	13.5	18.0	12.4	8.3	10.9	14.9	32.0	7.6	8.3	10.2	6.3	11.6	12.0	26.0	9.7	20.0	22.8	21.1	19.8	18.4	20.2	12.2	18.5	16.8	20.9	18.6	56.6	73.4	64.0	249.7	77.5	39.6	397.7	150.3	17.4	43.3	191.9	58.9	369.3	157.5	241.9	107.0	71.4	453.8	23.3	66.5	164.5	100.7	311.9	89.7	297.9	171.6	31.8	172.2	51.5	68.0	184.1	115.3	93.1	77.6	423.8	144.6	37.1	129.2	196.4	124.8	276.8	38.8	103.5	102.3	100.5	34.7	76.5	554.7	68.2	215.2	275.4
ACAT1	"ACAT, THIL"	ENSG00000075239	"Acetyl-CoA acetyltransferase 1"	P24752	11	108121516-108147776	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Fatty acid metabolism, Lipid metabolism"	"Acyltransferase, Transferase"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 267.1"	"Cell type enhanced"	"Detected in all"	10	"Distal tubular cells: 591.9;Hepatocytes: 643.6;Proximal tubular cells: 1104.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"RPMI-8226: 86.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004428, HPA007569"	Enhanced		Enhanced	Mitochondria		NA	NA		870000	Mitochondria		"HPA004428: AB_1078088, HPA007569: AB_1844482"	"unprognostic (3.70e-3)"	"unprognostic (2.23e-2)"	"unprognostic (7.84e-3)"	"unprognostic (4.65e-2)"	"unprognostic (3.05e-2)"	"unprognostic (1.12e-1)"	"prognostic favorable (1.43e-5)"	"unprognostic (3.59e-3)"	"unprognostic (1.26e-1)"	"unprognostic (5.20e-2)"	"unprognostic (2.64e-2)"	"unprognostic (1.13e-2)"	"prognostic favorable (0.00e+0)"	"unprognostic (1.96e-1)"	"unprognostic (1.68e-1)"	"unprognostic (8.06e-2)"	"unprognostic (6.62e-3)"	18.8	28.5	8.9	6.9	9.5	5.4	16.9	5.6	11.6	8.5	16.8	8.5	9.4	15.5	8.8	8.9	8.8	7.6	5.1	53.8	7.4	7.4	88.8	267.1	7.3	6.0	9.9	9.9	10.3	27.3	14.3	6.3	3.8	22.4	7.6	13.1	10.6	27.1	15.9	65.0	8.2	10.9	16.4	8.1	7.7	13.9	14.2	7.2	1.7	10.1	32.1	5.2	12.3	6.9	18.8	20.2	2.3	14.7	7.7	20.7	11.6	16.1	13.3	10.5	30.2	34.0	30.1	5.9	15.5	16.7	16.9	19.7	36.5	16.8	8.9	26.7	17.3	26.5	17.1	30.4	14.7	18.4	17.9	24.9	25.8	15.1	33.1	23.5	24.3	15.3	27.2	16.3	14.7	27.6	19.4	17.9	20.5	35.8	13.3	26.8	9.3	14.4	22.8	10.3	21.0	29.7	20.1	20.7	86.8	23.1	10.6	16.8	20.0	25.3	32.9	17.0	9.2	28.0	20.0	19.9	18.1	10.6	16.5	18.6	4.5	13.2	16.8	8.1	48.9	12.8	0.8	9.8	2.3	15.6	14.7	17.7	18.8	17.6	17.5	20.2	10.2	15.5	14.3	1.0	7.7	14.4	7.0	20.7	11.6	8.9	9.5	5.6	11.6	7.4	7.4	9.9	9.9	22.4	7.2	50.6	77.4	72.9	45.6	38.2	28.8	404.6	79.0	85.6	26.1	99.5	25.5	38.2	591.9	37.4	319.5	68.1	61.5	93.5	53.3	35.3	44.8	27.3	26.6	643.6	86.3	36.5	28.8	95.8	65.2	38.7	61.5	42.1	55.6	58.7	33.3	35.0	46.6	90.8	77.4	1104.9	23.8	64.7	64.3	159.1	28.1	42.3	21.1	42.4	83.1	20.7
ACAT2		ENSG00000120437	"Acetyl-CoA acetyltransferase 2"	Q9BWD1	6	159760328-159779055	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 20.4;liver: 31.0"	"Cell type enhanced"	"Detected in many"	5	"Early spermatids: 168.5;Exocrine glandular cells: 155.7"	"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"GAMG: 48.1"					"Low region specificity"	"Detected in all"			"CAB021106, HPA025736, HPA025765, HPA025811"	Enhanced		Approved	Nucleoplasm,Cytosol		NA	NA		16000000	Cytosol	Nucleoplasm	"CAB021106: AB_10058215, HPA025736: AB_1844487, HPA025765: AB_1844485, HPA025811: AB_1844488"	"unprognostic (3.31e-1)"	"unprognostic (2.44e-2)"	"prognostic favorable (1.12e-4)"	"prognostic unfavorable (7.25e-4)"	"unprognostic (1.38e-1)"	"unprognostic (2.03e-1)"	"unprognostic (9.25e-2)"	"unprognostic (4.76e-2)"	"unprognostic (1.43e-1)"	"unprognostic (2.58e-1)"	"unprognostic (1.21e-1)"	"unprognostic (1.59e-1)"	"prognostic unfavorable (7.38e-4)"	"unprognostic (1.39e-1)"	"unprognostic (1.50e-2)"	"unprognostic (8.56e-2)"	"unprognostic (2.54e-2)"	1.6	2.6	2.7	1.5	1.7	1.6	2.2	2.2	6.3	2.1	4.3			3.2	1.4	4.8	5.7	1.0	0.7	0.7	2.9	3.6	3.0	31.0	1.8	2.5	2.9		2.1	0.7	1.3	1.2	0.9		4.2	3.9		2.3	0.5	0.1	2.4	1.6	1.4	5.1	1.1	1.7	6.6			0.9		4.2	1.1	2.6	13.3	9.5	12.3	8.4	10.0	20.4	12.2	6.7	6.3	42.7	16.3	6.1	11.3	1.4	5.9	7.1	14.1	24.4	24.5	8.6	5.6	3.0	4.7	48.1	6.5	17.7	46.2	16.7	3.3	18.1	13.1	10.2	40.6	6.1	7.6	3.5	6.1	3.4	23.3	10.0	2.1	6.9	16.0	14.1	9.6	8.5	11.9	13.0	12.1	14.3	6.7	4.6	8.1	9.6	17.4	32.9	8.7	11.4	6.5	6.9	4.5	2.4	2.0	8.5	15.1	4.3	5.2	4.5	7.3	15.2	4.6	8.4	13.8	1.5	14.9	7.8	6.1	7.1	12.3	13.9	8.4	13.7	13.3	15.9	13.8	9.5	13.3	16.0	12.3	3.2	10.0	5.6	8.7	20.4	12.2											11.9	35.5	24.6	29.0	23.2	14.0	1.2	40.8	20.1	21.6	19.2	2.0	44.4	59.7	47.3	168.5	10.9	23.5	0.0	155.7	84.2	22.6	31.4	12.7	55.7	46.8	12.7	16.4	12.9	10.5	110.0	12.7	23.1	28.7	92.8	21.4	21.8	47.0	17.5	18.0	33.8	19.6	0.0	34.0	14.7	48.7	18.3	29.4	26.6	23.3	27.6
ACE	"ACE1, CD143, DCP1"	ENSG00000159640	"Angiotensin I converting enzyme"	P12821	17	63477061-63498380	"Candidate cardiovascular disease genes, CD markers, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"		"Carboxypeptidase, Hydrolase, Metalloprotease, Protease"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"intestine: 205.6"	"Group enriched"	"Detected in many"	25	"Early spermatids: 470.5;Late spermatids: 1015.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Cell type enhanced"	"Detected in some"		"memory B-cell: 3.7"	"Group enriched"	"Detected in many"	23	"B-cells: 3.7;monocytes: 2.0;T-cells: 1.9"	"Group enriched"	"Detected in some"	4	"ASC TERT1: 36.7;HUVEC TERT2: 18.7"									"CAB002426, CAB002921, HPA029298, HPA069790"	Enhanced		Approved	Vesicles	"Secreted to blood"	NA	NA	104000000	92000000	Vesicles		"CAB002426: AB_442052, CAB002921: , HPA029298: AB_10960255, HPA069790: AB_2686197"	"unprognostic (4.72e-2)"	"unprognostic (4.16e-1)"	"unprognostic (1.93e-3)"	"unprognostic (6.06e-2)"	"unprognostic (2.78e-1)"	"unprognostic (1.35e-2)"	"unprognostic (4.37e-1)"	"unprognostic (1.54e-1)"	"unprognostic (1.56e-1)"	"unprognostic (1.25e-2)"	"unprognostic (3.13e-2)"	"unprognostic (2.38e-1)"	"unprognostic (7.66e-2)"	"unprognostic (9.07e-2)"	"unprognostic (1.66e-1)"	"unprognostic (1.08e-1)"	"unprognostic (2.76e-2)"	6.8	2.0	0.5	2.4	4.2	0.0	2.9	0.5	1.1	5.3	83.2	0.7	37.7	46.4	4.5	5.1	1.7	1.5	4.4	4.7	0.6	0.7	2.6	1.4	16.3	2.2	0.4	0.7	1.4	3.0	3.6	3.6	3.6	0.8	3.4	1.4	1.7	2.5	20.1	3.6	1.3	205.6	2.4	0.6	1.4	1.9	32.6	1.3	0.5	6.9	3.1	2.2	1.7	1.6	3.7	0.1	0.0	2.0	0.0	1.9	0.4	0.0	0.0	0.0	0.0	1.5	36.7	0.4	1.3	2.7	0.0	0.0	0.5	3.2	0.7	1.1	6.2	0.0	0.0	1.7	0.0	0.0	0.0	0.7	3.5	0.0	0.0	0.8	0.0	0.0	2.4	0.0	0.0	0.0	0.6	18.7	0.0	3.1	0.0	0.0	0.6	0.0	0.8	0.3	6.3	0.4	0.1	0.2	0.5	0.0	0.0	4.6	3.2	0.0	0.0	0.0	0.7	1.6	0.2	0.0	0.1	0.1	0.3	0.0	0.0	0.0	0.0	0.5	0.0	0.2	0.0	0.0	0.0	0.4	0.6	0.9	3.7	1.9	1.4	0.1	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.4	0.5	4.2	0.5	1.1	0.6	0.7	0.4	0.7	0.8	1.3	0.0	3.5	0.0	1.5	1.3	3.1	1.4	0.0	0.0	1.2	0.0	0.0	0.1	0.0	3.4	470.5	13.5	29.6	0.0	0.4	0.1	1.0	6.0	6.9	0.0	4.4	0.0	17.3	2.5	18.5	1015.1	4.0	5.1	3.3	0.0	8.7	1.9	0.7	10.2	2.5	10.7	1.0	0.0	0.9	8.1	3.4	0.1	0.1	0.9	8.6	2.1
ACE2		ENSG00000130234	"Angiotensin I converting enzyme 2"	Q9BYF1	X	15561033-15602148	"Enzymes, FDA approved drug targets, Predicted membrane proteins, Predicted secreted proteins"	"Host-virus interaction"	"Carboxypeptidase, Host cell receptor for virus entry, Hydrolase, Metalloprotease, Protease, Receptor"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"intestine: 122.0"	"Cell type enhanced"	"Detected in many"	13	"Cholangiocytes: 61.1;Enterocytes: 38.8;Proximal tubular cells: 45.6;Sertoli cells: 19.4"	"Cancer enhanced"	"Detected in many"		"renal cancer: 26.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 2.4;HaCaT: 4.1;Hep G2: 2.5;NB-4: 2.2;RPMI-8226: 2.1;RT4: 2.5;SH-SY5Y: 2.8;SuSa: 1.9"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"HPA000288, CAB026174, CAB026213, CAB080024, CAB080025, CAB080027, CAB080028"	Enhanced				"Secreted to blood"	NA	NA		85000			"CAB026174: , CAB026213: , CAB080024: AB_10864415, CAB080025: AB_2809589, CAB080027: AB_2665870, CAB080028: AB_2665871, HPA000288: AB_1078160"	"unprognostic (1.40e-1)"	"unprognostic (7.26e-2)"	"unprognostic (2.76e-2)"	"unprognostic (5.71e-2)"	"unprognostic (2.51e-1)"	"unprognostic (5.26e-2)"	"prognostic favorable (4.21e-4)"	"unprognostic (2.34e-2)"	"unprognostic (6.74e-3)"	"unprognostic (2.54e-3)"	"unprognostic (1.00e-1)"	"unprognostic (1.74e-1)"	"prognostic favorable (2.12e-5)"	"unprognostic (1.94e-1)"	"unprognostic (9.62e-2)"	"unprognostic (2.11e-1)"	"unprognostic (7.10e-2)"	4.5	0.4	0.2	0.8	0.2	0.0	2.3	0.2	0.2	0.4	49.1	0.2	2.3	46.0	0.4	2.7	1.2	0.6	16.4	10.5	0.2	0.1	23.2	1.2	0.8	0.6	0.2	0.2	1.3	1.6	0.0	0.2	1.0	0.2	0.5	1.3	0.2	1.1	1.2	0.7	0.2	122.0	0.3	0.2	0.2	0.5	17.9	0.2	0.2	4.5	0.5	0.2	0.4	0.9	0.0	0.0	0.2	0.0	0.0	0.3	0.0	0.2	0.0	0.4	0.0	0.7	0.0	2.4	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.7	0.0	0.4	4.1	0.2	0.1	0.0	0.1	0.1	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.3	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.1	0.2	0.2	0.0	0.0	2.1	0.4	2.5	0.6	2.8	0.1	0.3	0.2	1.9	0.2	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.2	0.2	0.2	0.1	0.2	0.2	0.2	0.2	0.0	0.3	2.2	0.5	0.1	0.0	9.8	61.1	0.0	0.0	0.0	0.0	2.9	3.3	0.5	0.4	0.0	38.8	0.0	0.7	0.2	0.0	0.4	0.0	0.8	0.7	0.0	6.9	0.0	0.0	1.1	7.8	0.0	0.0	0.0	1.2	0.0	0.9	4.2	5.6	45.6	0.0	19.4	0.0	1.1	0.7	0.1	10.6	0.0	3.3	1.6
ACER1	ASAH3	ENSG00000167769	"Alkaline ceramidase 1"	Q8TDN7	19	6306142-6333629	"Enzymes, Predicted membrane proteins"	"Lipid metabolism, Sphingolipid metabolism"	Hydrolase		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Group enriched"	"Detected in some"	6	"esophagus: 14.3;skin 1: 38.2;tongue: 17.3"	"Cell type enhanced"	"Detected in some"	23	"Melanocytes: 1.7;Spermatocytes: 1.8;Suprabasal keratinocytes: 5.1"	"Group enriched"	"Detected in some"	7	"head and neck cancer: 1.0;melanoma: 2.2;prostate cancer: 0.6"	"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in some"	5	"MCF7: 2.2;T-47d: 8.1"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"									NA	NA						"unprognostic (1.13e-2)"	"unprognostic (2.87e-4)"		"unprognostic (5.04e-2)"	"unprognostic (6.18e-2)"	"unprognostic (8.16e-4)"	"unprognostic (7.27e-4)"	"unprognostic (2.17e-2)"	"unprognostic (1.61e-1)"	"unprognostic (1.99e-1)"	"unprognostic (1.02e-4)"	"unprognostic (1.02e-1)"	"unprognostic (1.30e-5)"	"unprognostic (2.11e-1)"	"unprognostic (4.44e-2)"	"unprognostic (4.22e-1)"	"unprognostic (2.24e-1)"	0.1	0.0	0.1	0.1	0.1	0.0	2.2	0.1	0.1	3.8	0.1	0.1	0.1	0.0	0.4	0.1	14.3	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.2	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	1.1	0.0	0.1	1.4	0.1	0.2	38.2	0.1	0.1	0.1	0.1	0.0	0.4	0.1	0.1	0.1	17.3	3.5	0.1	2.2	0.6	0.4	0.4	0.2	1.0	3.6	0.7	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.7	0.1	0.1	0.3	0.0	0.0	0.1	0.0	0.0	1.0	0.0	0.1	0.0	2.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.3	0.0	0.1	8.1	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.2	0.0	0.2	0.1	0.1	0.2	0.0	3.6	0.1	3.5	1.6	0.0	0.6	2.3	2.3	0.4	1.0	0.2	0.4	2.0	0.7	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	1.7	0.0	0.0	0.0	0.1	0.0	0.7	0.0	0.0	0.0	0.0	1.8	0.5	5.1	0.0	0.0	0.0	0.1
ACER2	"ALKCDase2, ASAH3L, FLJ41587"	ENSG00000177076	"Alkaline ceramidase 2"	Q5QJU3	9	19409059-19452020	"Enzymes, Predicted membrane proteins"	"Lipid metabolism, Sphingolipid metabolism"	Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"stomach 1: 41.0;urinary bladder: 31.3;vagina: 40.6"	"Cell type enhanced"	"Detected in some"	11	"Cone photoreceptor cells: 2.0;Early spermatids: 2.1;Ito cells: 1.8;Late spermatids: 1.8;Syncytiotrophoblasts: 3.3"	"Cancer enhanced"	"Detected in many"		"urothelial cancer: 15.6"	"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"intermediate monocyte: 3.1"	"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"BEWO: 16.7;RT4: 41.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA						"unprognostic (1.94e-1)"	"unprognostic (2.29e-1)"	"unprognostic (2.06e-1)"	"unprognostic (2.30e-1)"	"unprognostic (1.57e-1)"	"unprognostic (1.69e-1)"	"unprognostic (1.19e-1)"	"unprognostic (3.95e-2)"	"unprognostic (2.03e-1)"	"unprognostic (3.90e-1)"	"unprognostic (1.34e-1)"	"unprognostic (1.73e-1)"	"unprognostic (2.13e-2)"	"unprognostic (1.52e-1)"	"unprognostic (1.09e-1)"	"unprognostic (7.42e-2)"	"unprognostic (8.46e-3)"	17.4	1.7	3.1	0.7	5.9	0.4	20.7	2.3	6.8	1.4	3.5	0.9	5.3	3.0	1.3	3.0	1.8	2.8	1.3	3.2	3.0	1.9	1.6	2.6	1.5	0.6	4.4	0.3	1.3	4.7	2.7	1.6	20.0	4.5	9.4	3.1	1.4	1.8	6.8	2.1	4.0	1.7	2.1	2.9	1.2	41.0	1.3	4.7	0.4	1.8	1.0	0.8	31.3	40.6	1.0	1.2	0.0	3.1	0.0	1.0	0.5	0.6	1.3	2.1	1.1	3.5	0.2	16.7	1.1	0.8	0.5	0.5	0.3	1.0	0.7	0.4	0.1	0.2	2.5	0.5	3.3	0.9	1.4	0.6	1.1	1.0	1.5	0.7	0.2	1.1	1.1	3.1	1.3	1.4	0.3	3.5	1.2	1.7	2.1	1.2	1.0	1.9	0.9	1.6	6.0	0.5	1.7	0.6	0.4	0.3	41.0	3.9	0.9	0.2	1.1	0.2	5.6	1.4	1.4	1.7	0.3	0.8	0.3	0.5	0.7	0.9	0.8	0.3	0.8	0.7	0.0	0.1	0.0	0.8	3.1	0.2	1.0	0.3	0.3	0.3	0.4	1.0	0.2	0.0	0.0	0.0	1.2	0.3	0.5	3.1	5.9	2.3	6.8	3.0	1.9	4.4	0.3	4.5	4.7	0.0	0.0	0.0	0.2	0.2	0.6	0.1	0.0	0.0	0.0	0.0	2.0	0.4	0.0	0.1	2.1	0.3	0.0	0.0	0.0	0.4	0.0	0.1	0.0	0.0	0.1	0.0	0.0	1.8	0.0	1.8	0.3	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.5	0.0	0.0	0.4	0.5	0.0	3.3	0.0	0.0	0.5
ACHE	YT	ENSG00000087085	"Acetylcholinesterase (Cartwright blood group)"	P22303	7	100889994-100896974	"Blood group antigen proteins, Enzymes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Neurotransmitter degradation"	"Blood group antigen, Hydrolase, Serine esterase"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"brain: 43.8;skeletal muscle: 98.2"	"Cell type enhanced"	"Detected in many"	7	"Enterocytes: 45.5;Erythroid cells: 46.7;Exocrine glandular cells: 34.7;Horizontal cells: 52.4;Paneth cells: 52.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 8.2;CACO-2: 12.9;K-562: 15.2;Karpas-707: 25.2;U-2 OS: 6.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA027098			Approved	"Golgi apparatus,Vesicles"	"Intracellular and membrane"	NA	NA		650000	"Golgi apparatus"	Vesicles	"HPA027098: AB_2672111"	"unprognostic (2.23e-1)"	"unprognostic (9.44e-2)"	"unprognostic (2.71e-2)"	"unprognostic (5.80e-3)"	"prognostic unfavorable (5.27e-4)"	"unprognostic (2.49e-1)"	"unprognostic (2.54e-1)"	"unprognostic (1.36e-2)"	"unprognostic (2.48e-2)"	"unprognostic (8.92e-2)"	"unprognostic (2.65e-2)"	"unprognostic (1.78e-1)"	"prognostic unfavorable (3.88e-5)"	"unprognostic (2.95e-1)"	"unprognostic (2.59e-2)"	"unprognostic (9.28e-2)"	"unprognostic (8.38e-2)"	1.4	4.8	5.8	3.5	16.1	10.3	1.4	22.8	11.8	1.4	4.2	2.7	1.4	5.7	1.9	2.6	2.8	1.8	3.1	4.5	5.5	43.8	1.4	1.8	1.8	5.9	22.2	4.8	1.7	1.6	7.0	3.2	2.0	37.9	3.3	3.4	4.6	6.5	3.3	98.2	1.4	7.9	1.9	8.7	2.3	2.1	1.9	2.6	3.5	1.6	15.9	3.2	2.1	1.2	0.0	0.3	0.0	0.0	0.0	0.7	0.0	0.0	0.2	0.3	0.2	0.5	0.0	8.2	0.3	0.0	0.1	0.2	12.9	0.3	0.0	0.5	0.0	1.2	0.4	2.2	0.1	0.0	4.4	0.5	0.2	0.0	0.1	0.0	0.0	0.4	0.4	0.0	0.1	0.0	0.0	0.0	0.1	15.2	25.2	0.1	3.6	0.0	0.1	1.2	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.7	1.4	0.0	1.0	0.0	3.7	0.0	0.0	0.1	0.7	6.0	0.1	0.1	0.0	0.1	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.8	16.1	22.8	11.8	5.5	43.8	22.2	4.8	37.9	2.6	0.0	0.0	0.0	21.7	0.7	7.2	4.5	0.0	0.0	0.0	0.0	0.0	5.4	0.0	6.2	0.0	2.3	45.5	46.7	34.7	1.9	4.2	17.2	0.0	0.0	0.7	52.4	3.4	1.3	0.0	0.0	0.6	0.0	1.7	8.2	7.6	11.9	30.0	52.6	0.7	1.0	4.3	0.0	3.3	3.9	4.5	0.9	5.9	0.0	3.3	11.2
ACLY	"ACL, ATPCL, CLATP"	ENSG00000131473	"ATP citrate lyase"	P53396	17	41866908-41930542	"Cancer-related genes, Citric acid cycle related proteins, Enzymes, Plasma proteins, Predicted intracellular proteins"	"Lipid biosynthesis, Lipid metabolism"	Transferase	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB007783, HPA022434, HPA022953, HPA022959, HPA028758"	Enhanced		Supported	"Nucleoplasm,Plasma membrane,Cytosol"		No	No		2100000	"Plasma membrane, Cytosol"	Nucleoplasm	"CAB007783: AB_562242, HPA022434: AB_1844513, HPA022953: AB_1844514, HPA022959: AB_1844515, HPA028758: AB_10603575"	"unprognostic (2.21e-2)"	"prognostic unfavorable (1.79e-4)"	"unprognostic (1.41e-1)"	"unprognostic (1.21e-2)"	"unprognostic (2.83e-1)"	"unprognostic (8.94e-3)"	"prognostic unfavorable (3.66e-4)"	"unprognostic (3.38e-3)"	"unprognostic (4.11e-2)"	"unprognostic (5.94e-3)"	"unprognostic (2.13e-2)"	"unprognostic (3.01e-2)"	"unprognostic (3.88e-3)"	"unprognostic (1.66e-1)"	"unprognostic (9.36e-2)"	"unprognostic (3.90e-2)"	"unprognostic (4.67e-3)"	38.3	24.0	16.7	26.2	22.9	19.1	35.7	21.5	29.1	22.9	22.2	25.1	18.0	30.7	27.0	24.9	23.2	23.7	28.2	18.4	18.3	33.7	37.8	22.2	23.3	27.4	23.1	17.9	19.0	30.6	27.1	19.5	26.7	49.0	41.3	23.2	15.6	25.4	19.6	10.9	19.6	29.6	27.2	26.2	24.5	24.6	20.7	21.4	32.0	21.3	18.2	24.6	20.3	21.3	16.1	23.9	25.2	26.3	16.0	23.9	21.4	23.4	80.1	37.8	32.6	58.5	54.9	34.8	33.1	36.2	41.7	52.4	40.6	27.1	38.2	21.3	46.4	39.2	37.4	48.7	56.7	34.9	34.4	46.6	21.8	46.1	42.2	27.2	35.3	28.6	43.6	17.1	73.2	14.8	27.4	43.9	29.6	26.9	30.5	34.5	23.9	58.1	19.8	24.6	15.8	14.5	38.1	45.7	49.0	42.7	41.9	71.2	39.1	23.6	73.9	25.3	34.1	44.1	33.8	47.2	32.6	26.8	32.7	54.3	17.9	22.7	36.3	55.0	27.4	26.4	18.9	20.7	25.2	23.8	22.1	22.5	16.1	19.0	21.3	23.9	13.8	14.6	16.1	10.7	16.0	26.3	13.9	23.9	21.4	16.7	22.9	21.5	27.7	18.3	33.7	23.1	17.9	49.0	21.4	26.8	22.1	18.5	8.0	22.1	9.0	9.6	40.8	18.7	15.9	22.7	3.9	19.9	10.0	29.9	66.2	28.7	23.4	0.0	29.7	39.3	29.9	33.0	14.0	24.6	27.1	17.5	63.4	40.5	40.5	11.4	57.2	21.6	30.4	31.5	46.6	7.0	34.4	17.3	48.1	71.1	6.5	12.9	16.5	21.4	33.8	28.9	18.5	21.3	19.8	12.0
ACMSD		ENSG00000153086	"Aminocarboxymuconate semialdehyde decarboxylase"	Q8TDX5	2	134838547-134902034	"Enzymes, Predicted intracellular proteins"		"Decarboxylase, Lyase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	21	"kidney: 44.8;liver: 64.1"	"Cell type enhanced"	"Detected in some"	29	"Cholangiocytes: 58.6;Distal tubular cells: 46.4;Hepatocytes: 104.7;Proximal tubular cells: 312.9"	"Group enriched"	"Detected in some"	23	"liver cancer: 21.2;renal cancer: 19.8"	"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enriched"	"Detected in some"	22	"RPTEC TERT1: 24.8"	"Not detected"	"Not detected"							"HPA010533, HPA011179"	Enhanced					NA	NA		11000			"HPA010533: AB_1844517, HPA011179: AB_1844516"	"unprognostic (1.06e-2)"	"unprognostic (5.30e-2)"	"unprognostic (1.40e-1)"	"unprognostic (7.50e-2)"	"unprognostic (3.79e-2)"	"unprognostic (1.36e-2)"	"unprognostic (4.40e-3)"	"unprognostic (1.15e-1)"	"unprognostic (5.35e-4)"	"unprognostic (7.60e-2)"	"unprognostic (5.17e-2)"	"unprognostic (2.44e-3)"	"prognostic favorable (2.39e-4)"	"unprognostic (1.26e-1)"	"unprognostic (1.70e-1)"	"unprognostic (2.93e-2)"	"unprognostic (2.65e-5)"	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.2	0.0	0.0	2.5	0.0	0.0	0.0	44.8	64.1	0.1	0.0	0.0	0.0	0.1	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.5	1.4	0.9	0.6	0.2	1.7	0.5	0.3	0.1	0.4	0.3	0.0	0.0	0.2	0.5	0.0	0.0	0.0	0.3	0.0	0.9	0.1	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.7	0.3	0.2	0.7	0.0	0.3	0.2	0.0	0.0	0.0	0.0	0.7	0.0	0.4	0.4	0.0	0.0	0.3	0.6	0.2	1.1	0.1	0.5	0.1	0.5	0.2	24.8	0.3	1.0	0.3	0.1	0.2	0.4	0.7	0.2	0.6	0.8	0.0	0.3	0.2	0.7	0.2	0.1	0.4	0.2	0.3	0.6	0.0	0.6	0.9	0.9	0.5	0.4	1.5	0.9	1.3	0.9	1.1	1.7	0.9	0.4	0.2	0.5	1.4	0.8	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.4	0.0	0.0	0.0	0.1	58.6	0.0	0.0	8.7	0.0	0.0	46.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	104.7	0.0	0.0	0.0	2.5	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	312.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
ACO1	"IREB1, IREBP, IRP1"	ENSG00000122729	"Aconitase 1"	P21399	9	32384603-32454769	"Cancer-related genes, Citric acid cycle related proteins, Enzymes, Plasma proteins, Predicted intracellular proteins"	"Tricarboxylic acid cycle"	"Lyase, RNA-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 80.9"	"Cell type enhanced"	"Detected in many"	8	"Hepatocytes: 174.5;Proximal tubular cells: 160.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"ASC diff: 53.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019371, HPA024157"	Enhanced		Supported	Mitochondria,Cytosol		NA	NA		8000000	"Mitochondria, Cytosol"		"HPA019371: AB_1844519, HPA024157: AB_1844520"	"unprognostic (2.11e-1)"	"unprognostic (5.61e-2)"	"unprognostic (8.38e-2)"	"unprognostic (9.12e-2)"	"unprognostic (2.63e-1)"	"unprognostic (3.12e-2)"	"unprognostic (4.25e-3)"	"unprognostic (2.61e-2)"	"unprognostic (1.37e-1)"	"unprognostic (1.19e-1)"	"unprognostic (2.55e-1)"	"unprognostic (3.08e-1)"	"prognostic favorable (5.73e-5)"	"unprognostic (2.54e-1)"	"unprognostic (6.58e-2)"	"unprognostic (1.65e-1)"	"unprognostic (3.23e-2)"	41.4	27.2	9.6	7.1	9.4	1.5	30.1	8.9	8.1	9.3	19.7	6.2	6.4	21.9	12.8	14.6	12.8	7.2	8.9	15.1	6.5	7.6	40.5	80.9	9.2	9.4	6.1	6.2	14.1	27.9	8.9	8.7	11.3	7.7	10.7	9.8	11.7	11.7	9.5	11.2	5.5	28.4	14.5	6.0	6.4	13.5	11.4	5.9	6.0	18.4	7.2	5.1	13.9	11.7	4.7	7.1	21.4	8.8	4.7	7.4	6.2	9.5	8.7	6.8	10.7	53.1	28.8	3.1	18.1	44.5	8.3	6.6	9.2	3.0	1.9	5.8	18.9	22.8	1.3	13.5	17.3	16.8	6.0	3.6	14.0	9.5	10.0	26.7	1.3	5.6	25.0	5.3	21.4	15.1	25.7	21.5	7.4	5.0	4.1	23.7	2.5	7.4	6.7	7.1	6.0	9.4	5.8	10.1	1.9	31.7	8.8	0.9	2.8	18.8	0.7	1.9	7.6	4.4	3.4	23.2	30.4	10.3	10.1	4.7	2.1	3.9	3.8	21.2	4.7	2.6	21.4	8.7	2.4	7.4	8.8	6.4	4.7	5.2	5.7	7.1	4.2	6.8	7.0	1.0	4.7	7.2	3.4	2.8	6.2	9.6	9.4	8.9	8.1	6.5	7.6	6.1	6.2	7.7	5.9	3.0	25.5	7.5	6.9	3.9	18.8	39.8	45.9	8.1	9.1	22.7	21.6	39.8	16.6	14.3	6.3	18.2	29.7	0.0	35.8	17.8	21.6	11.2	2.3	174.5	13.3	31.8	4.7	14.1	12.7	5.1	21.9	7.2	6.8	2.8	32.4	30.7	23.2	21.0	21.9	160.8	13.9	19.4	22.3	6.1	16.2	4.6	44.7	8.7	26.9	7.1
ACO2	ACONM	ENSG00000100412	"Aconitase 2"	Q99798	22	41469125-41528989	"Citric acid cycle related proteins, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Tricarboxylic acid cycle"	Lyase	"Disease mutation, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 121.0;skeletal muscle: 157.9"	"Cell type enhanced"	"Detected in all"	5	"Proximal tubular cells: 244.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA001097	Enhanced	Approved	Approved	Mitochondria		NA	NA		4000000	Mitochondria		"HPA001097: AB_1078092"	"unprognostic (1.95e-1)"	"unprognostic (2.50e-2)"	"unprognostic (2.35e-2)"	"unprognostic (3.06e-2)"	"unprognostic (6.51e-2)"	"unprognostic (1.26e-1)"	"unprognostic (3.99e-2)"	"unprognostic (6.54e-2)"	"unprognostic (1.20e-2)"	"unprognostic (7.32e-2)"	"unprognostic (1.64e-2)"	"unprognostic (6.07e-2)"	"prognostic favorable (0.00e+0)"	"unprognostic (1.46e-2)"	"unprognostic (9.60e-2)"	"unprognostic (6.45e-2)"	"unprognostic (1.12e-2)"	22.8	18.5	41.4	11.1	38.2	9.8	12.2	21.0	43.5	12.2	25.4	27.7	12.3	45.1	9.5	9.9	17.5	15.7	11.1	121.0	33.8	24.2	37.9	22.2	10.0	11.1	27.6	32.7	8.6	17.2	48.5	7.6	9.1	24.9	12.5	20.0	14.7	20.1	15.2	157.9	9.8	46.6	12.5	28.6	10.0	21.0	9.6	23.1	9.5	16.0	42.7	12.0	12.3	8.8	22.9	28.1	7.3	36.6	15.8	16.4	19.4	13.9	16.2	16.3	33.7	28.2	18.4	22.9	12.8	16.3	21.6	20.2	23.9	18.2	32.0	21.0	19.1	18.1	32.1	30.3	23.5	11.4	21.2	21.6	15.5	22.7	25.4	24.6	41.3	23.8	32.6	18.9	22.4	23.9	16.7	21.4	17.1	20.0	35.0	17.0	26.1	21.1	14.0	11.1	79.8	32.6	28.6	11.2	44.4	27.9	27.7	11.7	10.0	31.6	37.3	23.8	14.0	21.7	22.1	15.2	18.5	20.7	16.8	14.0	20.8	25.8	22.4	29.9	18.1	19.9	4.5	21.1	7.3	14.7	31.3	14.0	22.9	12.5	15.8	28.1	20.2	14.2	14.6	5.3	15.8	36.6	11.2	16.4	19.4	41.4	38.2	21.0	43.5	33.8	24.2	27.6	32.7	24.9	23.1	23.8	35.1	48.4	42.0	16.7	52.7	8.1	53.5	38.8	18.2	57.6	76.6	84.6	111.0	47.3	10.7	21.1	193.9	23.3	37.3	50.2	22.9	31.1	40.3	50.4	81.0	50.9	51.1	16.5	27.5	6.8	22.5	35.7	33.7	87.4	92.9	56.0	39.9	87.7	26.2	244.6	62.4	58.2	31.1	23.6	36.4	14.1	161.6	34.6	88.8	55.9
ACOD1	"CAD, IRG1"	ENSG00000102794	"Aconitate decarboxylase 1"	A6NK06	13	76948497-76958642	"Enzymes, Predicted intracellular proteins"	"Immunity, Inflammatory response, Innate immunity"	"Antimicrobial, Lyase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"liver: 3.0;lymphoid tissue: 5.8"	"Cell type enriched"	"Detected in single"	9	"Distal tubular cells: 1.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"PC-3: 1.1;U-87 MG: 3.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA040143	Uncertain					NA	NA					"HPA040143: AB_10793916"	"unprognostic (2.39e-1)"	"unprognostic (6.42e-2)"	"unprognostic (2.37e-1)"			"unprognostic (3.54e-2)"		"unprognostic (3.09e-1)"	"unprognostic (8.30e-2)"	"unprognostic (4.30e-2)"			"unprognostic (1.64e-5)"	"unprognostic (7.70e-2)"	"unprognostic (3.68e-2)"		"unprognostic (6.51e-3)"	1.4	0.1	0.0	5.8	0.0	0.6	0.0	0.1	0.0	0.0	1.2	0.0	0.0	0.0	0.0	1.4	0.0	0.1	0.1	0.1	0.0	0.0	0.3	3.0	1.1	4.3	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.8	0.8	0.3	0.0	0.6	0.0	0.0	0.1	0.5	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.3	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.0	0.0	3.4	0.0	0.0	0.0	0.7	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
ACOT1	"ACH2, CTE-1, LACH2"	ENSG00000184227	"Acyl-CoA thioesterase 1"	Q86TX2	14	73537114-73543794	"Enzymes, Predicted intracellular proteins"	"Fatty acid metabolism, Lipid metabolism"	"Hydrolase, Serine esterase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 27.6"	"Cell type enriched"	"Detected in some"	6	"Cardiomyocytes: 44.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Hep G2: 18.2;T-47d: 25.1"									HPA043705	Approved		Approved	Mitochondria		NA	NA			Mitochondria		"HPA043705: AB_2678626"	"unprognostic (4.74e-3)"	"unprognostic (3.81e-3)"	"unprognostic (7.65e-2)"	"unprognostic (8.66e-2)"	"unprognostic (1.22e-1)"	"unprognostic (1.29e-1)"	"unprognostic (4.54e-2)"	"unprognostic (1.29e-2)"	"unprognostic (1.53e-1)"	"unprognostic (1.73e-2)"	"unprognostic (1.84e-1)"	"unprognostic (4.16e-1)"	"prognostic favorable (5.09e-8)"	"unprognostic (1.35e-3)"	"unprognostic (4.60e-2)"	"unprognostic (1.75e-1)"	"unprognostic (1.43e-1)"	8.5	7.2	5.1	3.7	3.9	1.0	13.7	2.0	7.7	3.0	5.8	4.1	0.9	5.3	6.8	8.8	2.7	3.4	1.8	11.3	4.3	3.6	16.4	27.6	9.0	0.9	3.2	6.0	4.5	1.4	2.9	0.9	4.1	5.6	5.5	3.4	2.4	2.7	6.1	10.7	3.8	12.9	13.0	1.9	1.0	3.4	2.7	2.4	0.9	1.8	5.0	1.9	5.6	1.7	3.8	5.7	1.0	1.7	4.2	6.3	3.1	4.2	5.0	1.9	0.1	9.9	6.1	0.1	1.3	5.4	4.5	8.2	1.9	2.1	0.0	0.0	3.6	0.0	2.5	0.0	0.9	2.2	2.3	1.6	2.7	1.2	18.2	9.6	0.1	3.0	7.9	0.4	3.6	0.0	0.1	2.0	0.0	0.0	0.0	3.5	1.6	0.3	0.5	1.9	0.6	1.9	5.1	3.9	0.1	4.4	4.7	2.3	3.8	4.2	12.4	6.8	0.4	25.1	6.2	2.2	2.5	3.2	2.3	0.0	0.0	0.0	1.3	3.6	0.0	4.0	0.1	1.3	1.0	6.0	1.7	4.9	3.8	5.5	4.7	5.7	2.6	4.8	5.3	0.2	4.2	1.5	3.2	6.3	3.1	5.1	3.9	2.0	7.7	4.3	3.6	3.2	6.0	5.6	2.4	0.0	2.7	0.0	0.0	0.0	0.0	44.7	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.5	0.4	0.0	0.0	0.0	7.2	0.2	0.3	0.0	0.0	0.6	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	1.7	0.0	0.4	0.8	0.0	0.0	0.5	0.0	0.2	0.0	0.7	0.0	0.0	0.0
ACOT12	"Cach, STARD15, THEAL"	ENSG00000172497	"Acyl-CoA thioesterase 12"	Q8WYK0	5	81330005-81394179	"Enzymes, Predicted intracellular proteins, Transporters"	"Fatty acid metabolism, Lipid metabolism"	"Hydrolase, Serine esterase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	38	"liver: 49.6"	"Cell type enriched"	"Detected in some"	7	"Hepatocytes: 37.1"	"Cancer enriched"	"Detected in single"	76	"liver cancer: 13.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AN3-CA: 1.0;CACO-2: 2.5;Karpas-707: 1.8;SK-MEL-30: 4.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"HPA037723, HPA037724"			Approved	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA037723: AB_10672606, HPA037724: AB_2675631"	"unprognostic (6.06e-2)"				"unprognostic (1.39e-1)"		"prognostic favorable (5.30e-4)"		"unprognostic (7.68e-2)"	"unprognostic (8.22e-2)"	"unprognostic (5.68e-3)"	"unprognostic (2.46e-1)"	"unprognostic (6.86e-2)"	"unprognostic (1.46e-2)"	"unprognostic (3.07e-1)"	"unprognostic (1.06e-1)"		0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.1	1.2	49.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.7	0.0	0.5	0.1	0.0	0.1	2.5	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.9	0.0	0.1	0.0	0.0	0.3	0.0	0.4	0.0	1.8	0.0	0.0	0.0	0.1	0.5	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	4.2	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.2	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.3	5.1	0.0	0.0	1.8	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	37.1	0.4	0.0	0.0	0.6	1.2	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	2.2	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0
ACOT2	"Mte1, ZAP128"	ENSG00000119673	"Acyl-CoA thioesterase 2"	P49753	14	73567620-73575658	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Fatty acid metabolism, Lipid metabolism"	"Hydrolase, Serine esterase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 60.5"	"Cell type enhanced"	"Detected in many"	5	"Cardiomyocytes: 43.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"											"HPA043705, HPA060170"	Enhanced		Approved	Mitochondria		NA	NA			Mitochondria		"HPA043705: AB_2678626, HPA060170: AB_2732642"	"unprognostic (4.44e-3)"	"unprognostic (1.68e-2)"	"unprognostic (3.17e-1)"	"unprognostic (8.66e-2)"	"unprognostic (1.78e-1)"	"unprognostic (1.55e-1)"	"unprognostic (2.78e-2)"	"unprognostic (6.61e-2)"	"unprognostic (4.10e-2)"	"unprognostic (9.21e-2)"	"unprognostic (6.42e-2)"	"unprognostic (1.64e-1)"	"prognostic favorable (2.28e-6)"	"unprognostic (1.66e-3)"	"unprognostic (1.04e-1)"	"unprognostic (1.52e-1)"	"unprognostic (4.35e-1)"	41.4	16.5	5.9	6.4	5.3	2.7	13.4	3.3	8.7	7.8	11.9	4.6	4.0	12.8	13.9	10.6	9.4	8.3	8.8	35.1	4.5	4.0	25.0	60.5	6.2	4.4	4.3	5.4	6.2	8.1	6.4	2.7	7.9	4.3	8.5	6.2	6.9	7.3	6.8	50.7	3.9	12.0	16.3	3.2	4.3	7.4	5.7	3.7	5.3	7.4	11.6	3.9	11.3	4.6	9.7	13.8	1.8	4.4	9.0	19.0	8.1	11.2	11.0	2.3	9.7	10.3	4.0	0.4	6.0	14.0	9.8	13.0	7.8	7.5	0.0	4.4	3.2	5.1	6.2	0.0	0.6	5.2	14.2	13.9	6.8	4.5	26.8	6.7	0.0	19.3	9.1	0.0	3.7	0.0	9.6	4.2	0.0	0.0	0.0	8.4	4.7	1.0	7.7	3.3	1.3	16.7	16.1	9.8	0.1	3.6	4.7	10.1	12.2	14.8	11.5	12.0	1.1	27.6	5.4	7.6	8.6	21.6	5.5	5.7	0.0	0.0	4.0	7.2	0.0	8.1	1.5	3.7	1.8	14.6	4.4	10.7	9.7	13.7	11.1	13.8	7.9	12.4	13.5	0.1	9.0	3.9	8.5	19.0	8.1	5.9	5.3	3.3	8.7	4.5	4.0	4.3	5.4	4.3	3.7	0.0	5.4	1.7	1.0	1.4	0.9	43.0	7.6	4.0	1.2	7.0	9.8	4.6	11.6	18.3	1.0	3.6	16.2	0.0	29.2	2.3	3.9	0.3	13.8	25.8	13.9	1.6	15.1	3.7	4.0	0.4	5.5	2.0	5.0	30.7	15.1	3.3	19.0	5.8	7.8	16.5	4.5	6.5	4.2	0.4	4.3	0.4	6.9	5.7	19.7	0.4
ACOT4	"FLJ31235, PTE-Ib, PTE2B"	ENSG00000177465	"Acyl-CoA thioesterase 4"	Q8N9L9	14	73591706-73596496	"Enzymes, Predicted intracellular proteins"	"Fatty acid metabolism, Lipid metabolism"	"Hydrolase, Serine esterase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 15.6"	"Cell type enhanced"	"Detected in many"	11	"Hepatocytes: 22.2;Proximal tubular cells: 51.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"CAPAN-2: 7.3;MCF7: 5.6;SK-BR-3: 11.7;T-47d: 29.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA000779	Enhanced					NA	NA					"HPA000779: AB_1078093"	"unprognostic (2.29e-3)"	"unprognostic (2.53e-3)"	"unprognostic (2.30e-1)"	"unprognostic (2.29e-3)"	"unprognostic (1.16e-1)"	"unprognostic (2.11e-1)"	"unprognostic (2.25e-2)"	"unprognostic (3.10e-2)"	"unprognostic (1.72e-2)"	"unprognostic (9.56e-2)"	"prognostic unfavorable (1.77e-4)"	"unprognostic (3.95e-1)"	"prognostic favorable (8.43e-5)"	"unprognostic (2.47e-1)"	"unprognostic (1.92e-1)"	"unprognostic (7.31e-2)"	"unprognostic (1.73e-1)"	6.3	2.2	2.9	1.4	3.6	0.6	4.4	1.6	5.7	3.6	2.6	1.0	1.5	3.9	1.0	2.4	2.0	0.9	3.3	2.9	2.1	2.0	13.0	15.6	3.9	1.1	1.6	2.8	0.9	2.2	1.1	0.7	4.9	2.7	1.4	3.1	1.8	3.1	3.4	0.7	0.9	7.4	2.5	0.8	1.4	1.9	2.8	0.9	0.3	1.2	0.8	1.2	1.1	1.3	1.7	0.6	5.0	0.4	4.6	10.6	3.2	4.3	1.2	0.1	0.0	0.5	0.2	0.0	0.3	0.0	0.3	0.5	0.1	7.3	0.0	0.2	0.4	0.0	0.4	0.0	0.0	0.0	2.3	0.0	0.0	1.6	0.0	0.8	0.0	4.1	0.3	0.5	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.2	5.6	0.1	0.8	0.4	1.5	1.2	0.0	0.0	0.0	0.1	2.1	0.6	0.2	2.8	11.7	0.8	0.0	29.2	4.4	0.1	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	5.0	0.0	1.0	10.6	0.4	5.5	1.6	5.2	6.0	0.2	1.7	3.2	6.5	0.3	4.6	0.2	0.6	4.8	3.2	2.9	3.6	1.6	5.7	2.1	2.0	1.6	2.8	2.7	0.9	0.0	2.4	2.2	1.0	0.2	0.2	1.2	2.5	2.7	1.2	10.4	0.0	11.8	13.3	3.6	1.6	0.3	10.3	0.0	8.3	11.5	1.1	0.5	5.7	22.2	10.2	1.6	0.0	0.0	2.7	3.8	0.3	1.7	0.0	1.8	2.7	0.5	4.8	2.9	0.4	51.8	0.5	0.0	0.9	2.7	14.3	0.3	3.8	4.4	2.8	1.1
ACOT7	"ACH1, ACT, BACH, CTE-II, hBACH, LACH1, MGC1126"	ENSG00000097021	"Acyl-CoA thioesterase 7"	O00154	1	6264269-6394391	"Enzymes, Predicted intracellular proteins"	"Fatty acid metabolism, Lipid metabolism"	"Hydrolase, Serine esterase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 50.0"	"Cell type enhanced"	"Detected in many"	8	"granulocytes: 137.0;Late spermatids: 118.5;Proximal tubular cells: 214.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"NK-cell: 20.5;plasmacytoid DC: 19.4"	"Group enriched"	"Detected in many"	4	"dendritic cells: 19.4;NK-cells: 20.5"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA025735, HPA025762"	Enhanced		Supported	Nucleoplasm,Cytosol		No	No		29000	Cytosol	Nucleoplasm	"HPA025735: AB_1844523, HPA025762: AB_1844524"	"unprognostic (3.94e-2)"	"unprognostic (1.74e-1)"	"unprognostic (7.09e-2)"	"unprognostic (4.33e-2)"	"unprognostic (4.10e-2)"	"unprognostic (5.06e-2)"	"prognostic unfavorable (2.31e-5)"	"prognostic unfavorable (1.29e-4)"	"unprognostic (2.35e-2)"	"unprognostic (4.05e-2)"	"unprognostic (1.15e-1)"	"unprognostic (1.73e-1)"	"prognostic unfavorable (2.55e-6)"	"unprognostic (2.68e-2)"	"unprognostic (1.45e-1)"	"unprognostic (9.06e-2)"	"unprognostic (3.72e-2)"	4.7	13.3	25.8	10.8	29.8	7.7	3.9	23.9	50.0	4.4	18.3	11.3	0.5	33.2	5.1	3.8	14.3	4.4	5.3	6.3	27.8	43.9	29.4	9.1	8.6	12.3	36.0	20.7	5.3	4.0	1.9	18.5	7.4	49.9	5.6	13.5	6.6	4.1	4.9	1.5	9.4	33.2	14.3	14.2	8.9	6.2	13.1	6.9	9.0	2.3	6.5	11.6	9.1	6.6	1.0	19.4	0.4	0.6	20.5	4.4	2.8	23.7	20.7	20.4	22.0	4.7	7.8	7.7	20.5	10.6	30.4	18.2	71.4	7.7	29.1	15.1	16.6	23.5	23.5	32.9	54.7	11.4	25.5	28.7	15.3	16.4	25.3	19.3	17.9	12.7	6.9	10.5	25.1	29.8	8.1	17.0	36.5	12.4	6.3	16.0	27.7	37.3	19.0	10.2	23.9	48.0	44.6	23.5	19.7	17.1	9.1	11.2	31.7	18.4	28.3	65.2	10.5	10.1	8.4	27.5	27.7	16.2	27.4	32.3	5.3	21.6	40.9	17.5	31.3	16.8	0.0	0.1	0.1	4.1	0.6	1.0	1.0	3.4	3.6	2.9	0.4	1.2	2.3	0.4	20.5	0.5	19.4	4.4	2.8	25.8	29.8	23.9	50.0	27.8	43.9	36.0	20.7	49.9	6.9	6.0	25.5	13.7	13.3	28.2	33.6	8.1	12.7	1.4	7.9	8.7	9.8	15.1	13.3	19.1	73.6	15.6	70.9	0.0	6.2	23.1	14.2	7.0	137.0	13.4	26.8	44.5	4.6	5.5	4.0	118.5	3.4	16.9	37.1	25.2	88.8	10.6	16.5	29.1	6.7	214.2	15.6	0.0	6.2	38.2	26.7	25.7	14.4	21.4	48.7	19.5
ACOT8	"hACTE-III, hTE, NAP1, PTE-2, PTE1"	ENSG00000101473	"Acyl-CoA thioesterase 8"	O14734	20	45841721-45857406	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Fatty acid metabolism, Host-virus interaction, Lipid metabolism, Peroxisome biogenesis"	"Hydrolase, Serine esterase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB010261	Approved		Supported	Vesicles,Mitochondria		NA	NA			Vesicles	Mitochondria	"CAB010261: AB_2221664"	"unprognostic (2.36e-2)"	"unprognostic (6.95e-2)"	"unprognostic (2.12e-1)"	"unprognostic (1.28e-2)"	"unprognostic (2.13e-1)"	"unprognostic (4.27e-1)"	"unprognostic (1.03e-3)"	"unprognostic (2.92e-2)"	"unprognostic (4.70e-1)"	"unprognostic (1.72e-1)"	"unprognostic (2.28e-2)"	"unprognostic (2.03e-2)"	"prognostic favorable (3.18e-4)"	"unprognostic (2.79e-1)"	"unprognostic (1.23e-1)"	"unprognostic (4.61e-2)"	"unprognostic (2.98e-1)"	7.0	22.6	23.5	10.9	24.3	16.5	8.7	14.4	32.6	6.8	17.1	13.5	9.9	23.3	6.5	13.1	15.8	12.2	10.1	27.0	22.8	19.3	15.3	19.0	9.7	12.1	22.1	19.0	8.3	17.4	5.9	11.4	8.1	19.5	9.6	14.3	10.4	14.4	7.3	21.7	16.7	22.2	7.3	14.6	9.1	16.7	12.8	11.1	17.1	12.4	8.6	12.2	10.9	7.2	20.5	27.0	31.0	26.2	11.2	22.5	18.8	7.7	9.3	3.2	6.4	9.0	5.5	5.6	5.3	4.3	7.4	6.9	13.6	10.8	9.7	23.9	7.2	17.1	15.2	6.1	13.1	2.5	7.2	10.7	9.7	12.5	13.0	8.1	9.3	9.1	6.4	10.1	7.1	5.1	11.0	4.5	11.4	8.6	12.1	5.2	21.8	13.2	12.1	5.6	15.2	24.9	6.4	5.9	17.4	7.8	8.8	11.0	5.2	11.6	29.8	18.1	5.2	16.4	22.8	5.2	18.3	4.1	9.4	8.7	10.3	15.2	6.1	22.7	9.8	9.7	20.0	26.2	31.0	18.8	25.0	17.1	20.5	18.1	17.0	27.0	19.3	16.1	17.3	18.7	11.2	23.4	17.0	22.5	18.8	23.5	24.3	14.4	32.6	22.8	19.3	22.1	19.0	19.5	11.1	32.8	13.1	13.4	10.4	5.5	17.5	9.4	10.2	17.4	9.1	12.2	15.7	27.1	54.7	19.6	30.4	8.2	74.4	0.0	18.1	16.7	7.2	11.9	13.9	22.2	24.7	7.9	18.5	11.6	16.5	58.7	9.2	13.0	10.1	26.2	34.3	15.2	19.9	59.6	8.1	57.5	19.5	12.9	8.5	25.9	8.7	6.9	16.2	14.6	27.0	11.6
ACOX1	PALMCOX	ENSG00000161533	"Acyl-CoA oxidase 1"	Q15067	17	75941507-75979363	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Fatty acid metabolism, Lipid metabolism"	Oxidoreductase	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 95.6"	"Cell type enhanced"	"Detected in many"	7	"Enterocytes: 185.5;Hepatocytes: 244.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	5	"basophil: 22.9;neutrophil: 38.6"	"Lineage enriched"	"Detected in all"	7	"granulocytes: 38.6"	"Cell line enhanced"	"Detected in all"		"BEWO: 35.3;RT4: 47.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB021094, HPA021192, HPA021195, HPA028759"	Approved		Approved	Nucleoli,Peroxisomes		NA	NA		160000	Peroxisomes	Nucleoli	"CAB021094: AB_10261667, HPA021192: AB_1844527, HPA021195: AB_1844528, HPA028759: AB_10601352"	"unprognostic (7.47e-2)"	"unprognostic (3.69e-1)"	"unprognostic (1.25e-3)"	"unprognostic (1.36e-1)"	"unprognostic (7.49e-2)"	"unprognostic (8.14e-2)"	"unprognostic (3.75e-2)"	"unprognostic (4.95e-2)"	"unprognostic (1.61e-1)"	"unprognostic (5.33e-2)"	"unprognostic (1.25e-1)"	"unprognostic (3.38e-2)"	"prognostic favorable (5.25e-7)"	"unprognostic (3.39e-1)"	"unprognostic (2.41e-2)"	"unprognostic (1.72e-1)"	"unprognostic (4.46e-2)"	21.8	12.9	8.8	8.3	10.2	4.2	13.6	6.4	9.8	6.4	26.5	8.2	9.6	31.0	6.6	6.7	19.5	6.0	12.3	16.0	8.3	7.9	20.8	95.6	9.2	7.5	8.2	8.3	7.6	28.7	9.8	8.9	13.6	7.8	9.5	14.3	11.3	9.5	9.1	18.3	13.4	53.1	7.9	6.7	7.2	13.6	6.2	6.3	7.1	9.1	11.4	10.6	10.6	7.9	1.6	3.3	38.6	5.8	2.1	2.7	2.2	5.4	7.7	2.5	3.8	13.3	5.6	35.3	4.0	4.0	4.8	5.5	5.4	9.0	3.1	4.3	6.8	4.5	3.3	10.7	4.2	7.6	2.8	3.2	4.0	4.4	17.7	7.2	3.4	2.6	9.3	3.3	5.4	3.6	5.1	12.0	4.3	4.1	3.1	5.3	16.1	7.6	2.5	1.9	13.5	6.7	4.2	7.7	3.6	8.1	47.5	3.1	4.6	11.4	17.8	3.8	8.7	10.9	3.9	7.9	6.7	4.9	5.4	3.8	5.1	3.5	1.2	3.9	3.2	3.9	22.9	5.8	1.6	2.1	4.5	2.7	1.6	2.0	2.7	3.3	1.6	2.4	2.3	38.6	2.1	2.8	2.9	2.6	2.2	8.8	10.2	6.4	9.8	8.3	7.9	8.2	8.3	7.8	6.3	26.8	20.6	3.0	13.1	11.9	23.8	38.6	48.4	14.7	18.2	22.7	21.6	32.5	18.3	19.8	8.4	14.6	185.5	23.3	35.6	39.3	17.0	27.2	16.2	244.8	23.1	17.5	33.1	22.1	31.8	6.5	27.6	19.9	13.5	25.2	35.0	64.2	31.5	87.7	44.2	74.6	28.4	0.0	16.4	5.6	10.7	26.5	36.2	10.2	32.4	22.6
ACOX2	"BRCACOX, BRCOX, THCCox"	ENSG00000168306	"Acyl-CoA oxidase 2"	Q99424	3	58505136-58537319	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Fatty acid metabolism, Lipid metabolism"	Oxidoreductase	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"liver: 70.5"	"Cell type enhanced"	"Detected in many"	16	"Hepatocytes: 75.4;Proximal tubular cells: 33.8"	"Cancer enhanced"	"Detected in many"		"liver cancer: 25.0"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC diff: 12.5;ASC TERT1: 20.7;fHDF/TERT166: 6.7;Hep G2: 8.0;HSkMC: 13.5"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"HPA038280, HPA064845"	Enhanced		Approved	Vesicles,Cytosol		No	No		190000	Vesicles	Cytosol	"HPA038280: AB_10672623, HPA064845: AB_2685368"	"unprognostic (6.62e-2)"	"unprognostic (2.10e-1)"	"unprognostic (1.08e-1)"	"unprognostic (2.51e-2)"	"unprognostic (8.34e-2)"	"unprognostic (1.48e-2)"	"unprognostic (8.67e-3)"	"unprognostic (6.45e-2)"	"unprognostic (1.00e-1)"	"unprognostic (1.85e-1)"	"unprognostic (1.70e-3)"	"unprognostic (1.26e-2)"	"unprognostic (1.68e-3)"	"unprognostic (4.00e-3)"	"unprognostic (2.34e-1)"	"unprognostic (1.26e-1)"	"unprognostic (5.63e-3)"	4.0	5.3	1.9	3.8	2.5	0.1	3.4	1.6	2.1	4.4	10.2	2.7	9.5	10.0	9.0	6.2	3.8	4.4	4.8	8.8	2.4	1.4	17.1	70.5	2.8	0.7	2.0	1.7	5.1	2.9	3.8	3.0	1.4	4.0	7.2	3.4	11.4	3.0	5.9	4.2	1.7	13.7	10.6	2.5	0.9	2.6	4.0	2.0	1.0	7.7	2.7	1.6	5.4	5.2	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	12.5	20.7	3.6	2.3	0.2	0.0	0.3	0.6	0.0	0.0	0.0	6.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.0	1.8	0.0	0.0	13.5	0.0	0.0	0.0	1.6	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.2	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	2.5	1.6	2.1	2.4	1.4	2.0	1.7	4.0	2.0	3.0	4.3	0.5	7.2	0.6	0.2	14.4	0.0	0.0	1.2	3.5	0.0	0.6	13.3	0.3	0.1	1.1	5.4	0.0	1.7	0.2	5.0	0.8	1.1	75.4	5.3	1.6	2.9	4.3	2.2	1.4	10.0	0.8	0.0	0.0	4.7	10.0	0.5	0.0	8.1	33.8	0.8	6.5	3.4	0.2	0.5	0.3	0.7	0.0	3.6	0.8
ACOX3		ENSG00000087008	"Acyl-CoA oxidase 3, pristanoyl"	O15254	4	8366282-8440723	"Enzymes, Predicted intracellular proteins"	"Fatty acid metabolism, Lipid metabolism"	Oxidoreductase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	8	"Syncytiotrophoblasts: 62.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035840, HPA035841"	Uncertain		Approved	Peroxisomes		NA	NA			Peroxisomes		"HPA035840: AB_10696514, HPA035841: AB_10671940"	"unprognostic (3.07e-2)"	"unprognostic (5.51e-2)"	"unprognostic (1.12e-1)"	"prognostic favorable (2.16e-4)"	"unprognostic (5.52e-2)"	"unprognostic (1.81e-3)"	"unprognostic (2.21e-1)"	"unprognostic (3.37e-2)"	"unprognostic (2.27e-1)"	"unprognostic (4.43e-2)"	"unprognostic (4.81e-1)"	"unprognostic (1.39e-1)"	"unprognostic (1.46e-2)"	"unprognostic (3.58e-2)"	"unprognostic (2.84e-1)"	"unprognostic (1.69e-1)"	"unprognostic (2.65e-1)"	9.6	12.0	9.9	7.4	10.9	5.0	15.5	11.7	12.8	12.2	9.9	11.5	11.2	10.8	10.7	12.3	32.0	9.2	7.4	20.6	9.0	6.7	8.3	18.0	8.9	7.4	10.3	8.4	9.8	15.4	10.0	14.8	28.9	10.2	13.4	8.0	12.0	19.1	11.2	8.2	14.8	10.5	18.6	7.2	7.6	12.7	5.0	11.6	9.0	11.5	7.4	14.2	14.8	16.0	4.6	16.8	2.6	12.0	7.3	8.0	6.9	6.3	6.9	7.8	10.3	8.4	14.3	12.7	8.0	11.1	13.8	12.0	3.4	8.5	8.5	8.7	16.4	18.6	3.9	3.3	10.4	10.7	2.9	3.3	3.7	5.8	10.5	13.9	7.4	7.0	14.3	9.0	12.3	4.8	9.9	16.2	9.5	4.9	7.8	11.8	5.8	7.9	11.0	4.3	8.1	12.0	8.4	12.8	10.1	8.4	8.9	3.8	8.7	10.3	5.3	5.3	6.7	5.3	10.7	15.6	13.6	4.4	5.5	8.4	5.9	3.9	3.8	17.3	9.4	8.6	0.0	10.6	2.6	5.2	12.0	5.4	4.6	6.1	6.6	14.0	4.5	5.6	5.8	2.5	7.3	10.6	16.8	8.0	6.9	9.9	10.9	11.7	12.8	9.0	6.7	10.3	8.4	10.2	11.6	6.0	5.1	6.4	6.8	3.9	8.6	8.5	7.6	4.0	4.5	10.4	31.4	19.8	3.3	13.9	2.2	3.9	11.8	0.0	11.9	8.2	5.8	7.8	0.0	9.9	8.9	1.6	1.7	5.5	3.2	2.1	6.4	4.2	5.0	8.2	4.9	4.1	15.1	9.9	10.6	5.1	15.8	0.0	6.2	1.2	1.9	5.1	62.4	5.0	6.7	10.0
ACP1	"HAAP, LMW-PTP, LMWPTP"	ENSG00000143727	"Acid phosphatase 1"	P24666	2	264140-278283	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in all"	5	"Early spermatids: 913.9;Late spermatids: 1666.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA016754	Approved		Approved	Nucleoplasm,Cytosol		NA	NA		3700000	Nucleoplasm	Cytosol	"HPA016754: AB_1844505"	"unprognostic (1.15e-1)"	"unprognostic (1.36e-1)"	"unprognostic (1.37e-2)"	"unprognostic (6.25e-3)"	"unprognostic (1.06e-2)"	"unprognostic (1.43e-1)"	"prognostic unfavorable (6.67e-6)"	"unprognostic (2.45e-1)"	"prognostic unfavorable (3.04e-4)"	"unprognostic (9.72e-3)"	"unprognostic (4.89e-2)"	"unprognostic (2.71e-2)"	"unprognostic (7.10e-2)"	"unprognostic (2.88e-2)"	"unprognostic (3.39e-2)"	"unprognostic (1.92e-1)"	"unprognostic (2.44e-2)"	22.3	59.7	38.0	20.8	40.3	38.0	33.0	27.9	43.7	23.1	29.7	27.4	24.4	31.1	25.2	36.2	24.8	29.5	26.9	27.4	34.6	33.7	42.1	54.8	24.7	29.4	31.5	34.6	33.7	53.0	28.4	43.9	39.7	39.7	27.0	32.8	28.5	46.0	23.8	35.4	21.6	34.5	24.2	28.6	28.1	34.2	38.3	21.2	33.0	32.5	32.8	29.8	22.7	20.3	33.9	20.3	17.3	23.0	35.3	41.0	33.1	17.8	26.6	41.5	22.8	18.8	18.8	33.7	21.7	23.1	21.7	19.2	36.5	18.0	11.2	16.9	20.3	28.5	17.5	40.3	23.6	19.6	27.3	41.0	32.8	24.1	79.8	26.1	37.2	18.9	19.2	21.5	20.3	25.2	23.0	24.6	42.0	33.1	21.9	25.6	24.2	40.0	36.0	50.1	47.2	30.0	26.6	42.1	25.6	33.9	25.5	45.3	44.8	13.5	32.0	43.4	28.3	18.9	19.9	20.3	23.9	15.9	19.7	32.7	29.8	59.1	34.9	28.3	32.2	28.1	17.3	19.8	17.1	30.1	22.7	39.7	33.9	34.3	34.4	17.7	31.1	41.0	39.7	3.5	35.3	23.0	20.3	35.6	33.1	38.0	40.3	27.9	43.7	34.6	33.7	31.5	34.6	39.7	21.2	41.7	88.5	101.3	80.3	70.3	51.3	74.2	109.5	129.8	67.1	64.6	7.9	179.7	228.8	194.3	913.9	64.7	84.9	163.5	146.5	234.8	71.9	111.0	68.2	112.0	123.7	27.0	79.2	50.3	57.7	1666.6	87.5	74.7	77.6	116.4	107.9	64.8	155.5	108.7	86.7	241.7	43.6	90.5	79.3	111.8	121.7	79.7	157.0	93.8	114.3	108.3
ACP2	LAP	ENSG00000134575	"Acid phosphatase 2, lysosomal"	P11117	11	47239302-47248906	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"		Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Hofbauer cells: 103.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"intermediate monocyte: 30.3"	"Lineage enriched"	"Detected in all"	5	"monocytes: 30.3"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"								"Intracellular and membrane"	NA	NA		8100				"unprognostic (5.27e-3)"	"unprognostic (1.56e-1)"	"unprognostic (3.86e-2)"	"prognostic favorable (1.04e-4)"	"unprognostic (7.90e-3)"	"unprognostic (2.93e-1)"	"unprognostic (6.16e-3)"	"unprognostic (1.09e-1)"	"unprognostic (2.63e-1)"	"unprognostic (3.28e-3)"	"unprognostic (2.64e-3)"	"unprognostic (5.42e-2)"	"unprognostic (1.07e-2)"	"unprognostic (1.79e-1)"	"unprognostic (1.20e-1)"	"unprognostic (8.68e-3)"	"unprognostic (1.57e-1)"	15.7	23.6	13.1	13.9	13.6	3.6	13.0	12.5	19.5	11.3	15.4	11.7	15.4	26.9	10.5	20.0	8.9	9.3	12.4	18.1	14.4	18.2	18.7	65.4	13.3	40.7	11.8	12.7	8.1	36.2	13.6	13.8	31.3	12.2	15.3	11.7	16.4	32.3	18.5	10.1	7.0	24.4	10.8	11.0	18.9	14.2	14.6	7.1	10.0	12.4	9.6	9.7	14.3	8.0	1.0	6.6	4.6	30.3	3.8	5.6	4.2	6.8	14.2	13.8	12.2	12.4	6.2	10.7	11.3	20.2	20.7	21.6	9.8	11.2	1.8	9.3	14.4	6.2	10.1	7.2	10.4	10.0	35.2	12.4	4.6	20.9	10.2	17.2	6.8	11.8	15.1	6.6	10.7	6.3	12.5	14.9	6.2	8.3	14.8	13.5	11.1	5.6	6.1	9.5	10.4	8.6	4.4	18.7	14.9	15.5	16.0	7.3	11.4	15.6	34.8	8.0	7.5	21.2	6.0	8.8	10.5	8.8	13.7	16.1	12.4	16.0	1.5	15.5	3.4	16.1	4.6	7.2	3.0	5.6	30.3	4.4	1.0	3.5	5.0	6.6	0.7	3.1	2.7	1.2	3.8	19.5	0.2	3.6	4.2	13.1	13.6	12.5	19.5	14.4	18.2	11.8	12.7	12.2	7.1	17.9	18.1	4.5	10.0	3.7	13.1	7.3	20.4	10.7	7.9	17.4	5.9	36.5	8.3	47.8	1.4	13.9	43.0	0.0	52.7	28.2	10.4	9.4	11.5	74.2	103.8	11.1	14.5	48.5	51.1	1.7	4.6	17.1	23.6	43.3	23.6	21.3	29.5	28.1	9.9	23.4	11.5	19.4	7.5	9.7	17.0	2.0	24.5	7.5	10.9	5.1
ACP4	ACPT	ENSG00000142513	"Acid phosphatase 4"	Q9BZG2	19	50790415-50795224	"Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins"		Hydrolase	"Amelogenesis imperfecta, Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"skin 1: 4.2;testis: 4.0"	"Not detected"	"Not detected"			"Low cancer specificity"	"Detected in single"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HEK 293: 4.4;Karpas-707: 2.9;U-266/84: 5.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"									NA	NA						"unprognostic (9.41e-2)"	"unprognostic (1.86e-1)"	"unprognostic (4.00e-3)"	"unprognostic (3.70e-3)"	"unprognostic (7.62e-2)"	"unprognostic (3.18e-2)"	"unprognostic (3.89e-3)"	"unprognostic (5.46e-2)"	"unprognostic (2.47e-1)"	"unprognostic (5.59e-2)"	"unprognostic (3.96e-1)"	"unprognostic (1.45e-1)"	"unprognostic (2.37e-3)"	"unprognostic (2.36e-1)"	"unprognostic (4.40e-1)"	"unprognostic (1.02e-1)"	"unprognostic (1.32e-1)"	0.0	0.0	0.0	0.0	0.2	1.5	0.0	0.0	0.1	0.0	0.0			0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.5	0.2	0.0	0.1	0.0	0.0	0.1		0.2	0.7	1.1	0.0	0.0		0.0	0.0		0.0	0.0	0.0	4.2	0.1	0.0	0.0	0.0	0.0	4.0			0.0		0.0	0.0	0.0	0.9	0.3	0.0	0.5	0.3	0.8	0.0	0.5	0.2	0.9	1.6	0.0	0.0	1.0	0.5	0.0	0.0	0.0	2.2	0.2	0.8	0.1	0.0	0.1	0.6	0.0	0.0	0.0	1.6	4.4	0.1	1.3	0.7	0.0	0.6	0.6	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.5	2.9	0.0	0.9	0.7	1.4	0.5	0.8	1.5	1.0	0.4	0.6	0.0	1.6	0.4	0.6	0.3	0.3	0.7	0.1	0.1	1.0	0.0	0.7	0.6	0.8	0.4	0.7	5.4	0.6	0.7	0.9	0.3	0.0	0.1	0.0	0.2	0.5	0.8	0.8	0.6	0.5	0.0	0.9	0.8	0.5	0.0	0.3	0.2	0.3	0.1	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0
ACP5	"HPAP, TRAP"	ENSG00000102575	"Acid phosphatase 5, tartrate resistant"	P13686	19	11574660-11579008	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		Hydrolase	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 117.9;lung: 151.9"	"Cell type enhanced"	"Detected in many"	12	"Hofbauer cells: 439.8;Ito cells: 434.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"memory B-cell: 51.4"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"BEWO: 14.6;BJ hTERT+: 9.8;K-562: 10.3;RPMI-8226: 13.9;SK-MEL-30: 41.4;U-138 MG: 38.9"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"CAB002584, HPA057655, HPA059463"	Enhanced		Uncertain	Cytosol	"Intracellular and membrane"	NA	NA		3700000	Cytosol		"CAB002584: AB_564039, HPA057655: AB_2683490, HPA059463: AB_2684028"	"unprognostic (4.27e-2)"	"unprognostic (2.05e-2)"	"unprognostic (2.93e-1)"	"unprognostic (8.60e-3)"	"unprognostic (2.96e-1)"	"unprognostic (1.95e-2)"	"unprognostic (5.21e-2)"	"unprognostic (5.17e-3)"	"unprognostic (5.13e-2)"	"unprognostic (3.80e-1)"	"unprognostic (3.66e-3)"	"unprognostic (9.09e-2)"	"unprognostic (1.39e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.17e-1)"	"unprognostic (1.05e-1)"	"unprognostic (1.19e-1)"	117.9	2.8	0.9	21.1	1.1	1.4	7.7	0.7	1.0	11.9	10.2	1.2	2.1	7.7	7.7	6.5	12.1	3.5	9.1	6.8	0.9	0.4	28.0	16.3	151.9	30.8	1.0	1.0	13.2	8.7	0.2	1.6	9.2	1.2	6.4	8.7	19.1	8.6	2.8	3.0	10.4	15.6	3.3	1.9	20.7	15.0	3.5	0.7	9.2	2.2	8.2	18.4	11.4	10.1	51.4	13.9	16.8	9.4	2.6	16.0	8.1	3.3	0.4	0.0	0.0	0.2	0.0	14.6	0.4	9.8	0.0	0.0	0.0	0.1	0.5	0.6	2.9	2.4	0.1	0.0	1.5	0.0	3.7	0.3	0.1	0.0	1.8	0.6	0.0	0.2	0.0	1.1	0.1	0.0	0.0	0.0	0.0	10.3	0.0	0.0	0.7	0.3	0.5	0.3	0.1	0.3	0.1	0.7	13.9	0.0	0.1	0.2	0.3	0.0	0.0	41.4	0.4	0.0	0.1	0.3	38.9	0.4	0.7	0.1	0.2	1.8	0.2	8.0	0.0	1.2	0.0	9.4	16.8	4.1	9.1	2.1	51.4	6.4	4.7	1.7	23.5	8.3	4.7	2.6	2.6	8.7	13.9	16.0	8.1	0.9	1.1	0.7	1.0	0.9	0.4	1.0	1.0	1.2	0.7	8.9	8.5	68.7	8.2	9.2	6.0	1.1	22.9	2.7	2.3	7.0	17.7	29.7	8.3	1.6	0.1	2.9	5.9	0.0	9.9	23.7	12.1	16.2	65.4	6.4	439.8	1.6	2.9	434.6	101.6	0.0	1.7	100.7	13.5	131.7	4.5	43.7	4.7	21.0	11.3	91.3	31.7	0.0	3.2	0.0	0.1	9.7	21.9	25.4	8.3	4.3
ACP6	"ACPL1, LPAP"	ENSG00000162836	"Acid phosphatase 6, lysophosphatidic"	Q9NPH0	1	147629652-147670496	"Enzymes, Predicted intracellular proteins"	"Lipid metabolism, Phospholipid metabolism"	Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"OE19: 38.9;RPTEC TERT1: 44.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA028560	Uncertain				"Intracellular and membrane"	NA	NA		64000			"HPA028560: AB_10602427"	"unprognostic (3.17e-2)"	"unprognostic (3.01e-2)"	"unprognostic (3.50e-1)"	"unprognostic (1.87e-2)"	"unprognostic (3.85e-1)"	"unprognostic (8.50e-3)"	"unprognostic (3.36e-3)"	"unprognostic (1.00e-1)"	"unprognostic (6.32e-2)"	"unprognostic (1.30e-2)"	"unprognostic (3.09e-1)"	"unprognostic (1.06e-1)"	"unprognostic (4.52e-2)"	"unprognostic (3.94e-1)"	"unprognostic (8.07e-2)"	"unprognostic (1.26e-1)"	"prognostic favorable (6.44e-4)"	6.0	14.5	8.8	6.6	10.7	4.7	19.3	10.5	9.1	12.6	10.5	7.6	13.1	7.7	10.0	17.6	8.1	13.9	13.6	8.5	13.0	6.0	17.0	13.3	7.6	3.8	10.2	8.0	11.6	18.5	18.1	22.5	4.4	11.6	13.6	10.2	12.7	12.3	19.2	7.6	9.2	8.9	9.7	11.2	6.6	12.8	8.2	12.7	10.8	20.7	5.8	9.7	16.8	6.9	2.9	4.8	11.5	2.2	0.3	12.4	2.6	7.4	3.1	2.6	4.6	1.7	1.6	7.5	1.7	5.4	5.5	6.5	3.6	11.6	2.1	6.5	3.7	4.2	13.0	3.5	11.6	5.7	2.9	5.8	7.8	4.4	6.8	5.0	1.4	0.3	2.4	8.6	2.8	5.8	6.6	5.5	11.0	3.6	1.2	6.2	5.5	5.7	3.6	6.2	38.9	23.0	4.1	2.2	25.2	44.4	14.9	2.2	2.6	6.3	4.6	12.8	6.2	7.4	2.1	3.8	1.7	3.3	0.3	5.4	4.9	7.3	0.9	3.2	0.1	9.4	0.0	2.2	11.5	4.3	0.7	7.5	2.5	7.2	5.8	4.8	2.9	8.0	6.9	3.3	0.3	0.3	3.0	12.4	2.6	8.8	10.7	10.5	9.1	13.0	6.0	10.2	8.0	11.6	12.7	17.9	11.5	0.0	4.7	1.0	1.9	5.6	15.3	14.7	4.5	15.7	0.0	17.2	14.9	6.8	4.7	2.2	3.8	0.0	13.3	5.8	2.0	5.7	1.1	9.6	4.0	0.0	8.7	5.5	3.7	0.9	5.5	3.9	3.3	3.6	8.1	11.8	14.6	5.8	3.9	12.4	1.0	12.9	3.1	3.9	4.4	1.1	6.8	5.7	8.4	5.1
ACP7	"FLJ16165, PAPL, PAPL1"	ENSG00000183760	"Acid phosphatase 7, tartrate resistant (putative)"	Q6ZNF0	19	39083913-39111493	"Enzymes, Predicted intracellular proteins, Predicted secreted proteins"		Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	7	"brain: 15.2;lymphoid tissue: 6.1;skin 1: 14.1;tongue: 5.5"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"cervical cancer: 0.8;head and neck cancer: 2.6;lung cancer: 1.4;melanoma: 1.0;urothelial cancer: 1.0"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"GAMG: 21.5;U-87 MG: 28.9"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			HPA042613	Uncertain				"Secreted - unknown location"	NA	NA					"HPA042613: AB_10963214"	"unprognostic (6.35e-2)"	"unprognostic (1.97e-1)"	"unprognostic (1.48e-1)"	"unprognostic (6.74e-3)"	"unprognostic (1.92e-3)"	"unprognostic (1.41e-1)"	"unprognostic (3.41e-1)"	"unprognostic (4.94e-3)"	"unprognostic (2.66e-1)"	"unprognostic (2.15e-1)"	"unprognostic (1.50e-1)"	"unprognostic (9.81e-2)"	"unprognostic (1.51e-5)"	"unprognostic (4.36e-3)"	"unprognostic (5.08e-2)"	"unprognostic (2.31e-2)"	"unprognostic (2.42e-1)"	0.3	0.3	1.6	0.3	5.5	0.3	1.0	15.2	5.4	0.9	0.3	4.2	0.3	0.4	0.4	1.4	1.1	0.3	0.9	0.3	2.5	1.2	0.3	0.3	0.4	0.3	6.5	0.7	0.3	0.3	0.3	0.0	0.3	5.2	1.2	0.3	0.0	0.6	0.3	0.3	14.1	0.3	0.3	4.1	0.3	0.6	0.4	5.3	0.0	0.3	5.5	6.1	0.5	0.7	0.0	0.0	0.0	0.0	0.0	0.8	0.0	3.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.7	0.4	0.5	0.3	3.2	0.0	0.0	0.0	21.5	0.2	0.0	0.6	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	6.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	1.2	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	3.9	0.7	0.0	0.0	0.0	0.0	0.0	28.9	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	5.5	15.2	5.4	2.5	1.2	6.5	0.7	5.2	5.3	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
ACPP	"ACP-3, ACP3, PAP"	ENSG00000014257	"Acid phosphatase, prostate"	P15309	3	132317367-132368298	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"		Hydrolase	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	8	"prostate: 345.2"	"Cell type enriched"	"Detected in many"	135	"Glandular cells: 2098.0"	"Cancer enriched"	"Detected in many"	275	"prostate cancer: 1227.2"	"Low region specificity"	"Detected in single"			"Cell type enhanced"	"Detected in many"		"eosinophil: 43.1"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"BJ hTERT+: 10.2;OE19: 12.7;RPMI-8226: 32.4;U-698: 9.4;U-87 MG: 9.0"	"Low region specificity"	"Detected in some"							"CAB000071, HPA004335, HPA063916"	Enhanced				"Secreted to blood"	NA	NA	460000	9200			"CAB000071: , HPA004335: AB_1079684, HPA063916: AB_2685152"	"unprognostic (6.67e-2)"	"unprognostic (4.70e-2)"	"unprognostic (1.76e-1)"	"unprognostic (7.77e-2)"	"unprognostic (1.74e-1)"	"unprognostic (2.58e-2)"	"unprognostic (2.46e-1)"	"unprognostic (7.41e-2)"	"unprognostic (1.81e-1)"	"unprognostic (3.78e-3)"	"unprognostic (2.14e-1)"	"unprognostic (5.95e-2)"	"unprognostic (9.38e-2)"	"unprognostic (1.35e-1)"	"unprognostic (1.18e-1)"	"unprognostic (3.91e-2)"	"unprognostic (1.71e-1)"	0.4	0.6	0.4	0.7	1.6	1.4	0.8	0.3	0.7	3.9	0.4	0.2	0.0	0.4	0.3	2.5	14.7	0.6	0.2	0.9	0.3	0.3	6.2	0.3	2.0	2.7	0.6	0.8	0.4	0.8	0.5	0.3	5.3	0.7	345.2	0.7	0.8	9.1	0.2	0.3	2.5	0.4	0.4	2.2	1.0	0.5	1.0	0.6	0.2	1.3	6.6	6.8	0.5	1.5	0.2	11.2	43.1	9.7	0.9	0.0	2.9	0.2	0.0	0.0	0.0	0.1	0.6	7.0	0.1	10.2	0.0	0.0	0.2	0.2	5.7	0.4	0.0	0.0	2.9	0.0	0.0	0.0	0.0	0.3	1.2	0.2	0.1	0.1	4.1	0.1	0.6	0.8	0.0	0.0	0.1	0.0	0.0	0.1	1.6	0.1	0.1	0.0	7.8	0.4	12.7	1.2	0.0	0.0	32.4	3.1	3.8	0.0	2.5	0.0	1.2	0.3	1.1	0.2	3.7	0.0	0.0	0.1	1.5	0.0	0.4	0.2	9.4	9.0	7.3	0.1	0.0	9.7	43.1	0.0	8.6	0.0	0.2	0.0	0.0	11.2	0.0	0.0	0.0	8.5	0.9	7.7	0.8	0.0	2.9	0.4	1.6	0.3	0.7	0.3	0.3	0.6	0.8	0.7	0.6	0.0	10.7	0.0	13.0	0.8	0.0	0.5	0.0	0.0	4.5	7.0	0.0	9.6	0.0	1.1	0.0	0.0	1.0	0.0	1.6	1.0	0.8	2098.0	0.0	0.0	4.1	0.0	15.5	0.0	9.2	0.0	0.0	2.8	0.0	0.0	2.4	0.3	1.2	5.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	3.0	7.4	0.0	1.0	11.5
ACR		ENSG00000100312	Acrosin	P10323	22	50738196-50745334	"Enzymes, Predicted secreted proteins"		"Hydrolase, Protease, Serine protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	87	"testis: 106.3"	"Cell type enriched"	"Detected in some"	4	"Early spermatids: 388.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"CAPAN-2: 1.0;Hep G2: 1.8;HUVEC TERT2: 1.1;NTERA-2: 1.7;TIME: 1.5"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			HPA048687	Enhanced				"Secreted in male reproductive system"	NA	NA					"HPA048687: AB_2680494"	"unprognostic (1.71e-1)"	"unprognostic (1.26e-1)"	"unprognostic (1.04e-1)"	"unprognostic (6.27e-3)"	"unprognostic (3.58e-2)"	"unprognostic (8.04e-2)"	"unprognostic (3.30e-3)"	"unprognostic (5.41e-2)"	"unprognostic (1.51e-1)"	"unprognostic (2.28e-1)"	"unprognostic (1.34e-2)"	"unprognostic (2.12e-1)"	"unprognostic (1.48e-1)"	"unprognostic (1.23e-2)"	"unprognostic (1.71e-1)"	"unprognostic (2.27e-1)"	"unprognostic (1.25e-1)"	0.9	0.0	0.2	0.2	0.3	0.0	0.6	0.2	0.3	0.2	0.2	0.2	0.2	0.1	0.3	0.7	0.2	0.4	0.2	0.2	0.2	0.0	0.2	0.3	0.6	0.2	0.2	0.2	0.2	0.2	0.0	0.2	0.2	0.2	0.2	0.0	0.2	0.4	0.2	0.2	0.2	0.2	0.2	0.2	1.2	0.0	106.3	0.2	0.2	0.2	0.3	0.2	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.5	0.0	0.6	0.2	0.0	0.0	0.0	0.3	0.0	1.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	1.8	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	1.1	0.7	0.0	0.0	0.0	0.4	0.0	0.0	1.7	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.2	0.1	0.0	0.1	0.2	0.0	0.0	1.5	0.0	0.7	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.2	0.3	0.2	0.0	0.2	0.2	0.2	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	388.8	1.3	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	2.9	8.6	0.0	86.9	3.1	0.0	0.0	0.0	1.3	0.0	0.0	0.0	2.5	0.0	0.0	6.5	0.0	28.8	1.7	0.0	0.0	0.0	1.5	0.1
ACSBG1	"BG1, BGM, FLJ30320, hBG1, hsBG, KIAA0631, MGC14352"	ENSG00000103740	"Acyl-CoA synthetase bubblegum family member 1"	Q96GR2	15	78167468-78245688	"Enzymes, Predicted intracellular proteins"	"Fatty acid metabolism, Lipid metabolism"	Ligase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"adrenal gland: 11.4;brain: 40.5;skin 1: 19.9"	"Cell type enhanced"	"Detected in some"	22	"Ciliated cells: 26.8;Spermatogonia: 7.7"	"Cancer enhanced"	"Detected in some"		"glioma: 3.8"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"plasmacytoid DC: 3.9"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"NTERA-2: 8.1;SK-MEL-30: 3.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041642, CAB045955, HPA058869"	Approved		Approved	Vesicles		NA	NA			Vesicles		"CAB045955: AB_11124196, HPA041642: AB_2677593, HPA058869: AB_2683840"	"unprognostic (1.28e-1)"	"unprognostic (1.63e-2)"	"unprognostic (1.29e-2)"	"unprognostic (2.28e-1)"	"unprognostic (2.29e-2)"	"unprognostic (4.18e-2)"	"unprognostic (1.32e-2)"	"unprognostic (1.58e-2)"	"unprognostic (1.86e-1)"	"unprognostic (5.64e-2)"	"unprognostic (2.02e-1)"	"unprognostic (4.13e-1)"	"unprognostic (1.05e-1)"	"unprognostic (1.40e-1)"	"unprognostic (2.96e-1)"	"unprognostic (4.19e-2)"	"unprognostic (1.42e-2)"	1.1	11.4	16.9	1.5	26.9	4.5	3.8	6.6	27.0	1.1	1.2	10.5	0.0	1.6	1.2	2.3	1.3	5.9	1.3	1.1	16.4	8.5	1.0	1.0	1.7	1.6	21.1	13.9	1.2	1.0	0.9	0.3	1.1	32.9	2.0	1.1	0.0	1.5	1.4	1.2	19.9	1.5	1.2	40.5	1.3	1.2	5.4	19.0	0.0	1.2	0.0	1.1	1.5	0.2	0.4	3.9	1.2	0.2	0.6	0.2	1.5	0.8	0.1	1.6	2.4	0.0	0.0	0.6	0.5	0.0	0.5	0.1	0.5	0.6	0.8	0.2	0.1	0.6	0.9	0.1	0.3	0.2	0.4	1.4	0.7	1.4	0.7	0.0	0.7	1.6	0.6	0.0	0.4	0.2	0.5	0.2	1.0	0.5	1.1	0.1	0.4	0.6	1.4	8.1	0.7	0.3	0.3	1.0	0.5	0.0	1.0	0.6	0.9	0.4	1.0	3.8	1.0	0.5	0.5	1.0	0.6	0.6	0.5	0.3	0.9	0.3	0.9	0.3	0.6	1.6	0.4	0.2	0.1	0.2	0.1	0.1	0.3	0.1	0.0	0.1	0.4	0.2	0.1	1.2	0.6	0.2	3.9	0.0	1.5	16.9	26.9	6.6	17.9	16.4	8.5	21.1	13.9	32.9	19.0	0.0	1.3	0.0	0.3	1.0	2.1	2.0	0.0	26.8	4.5	0.0	3.9	0.2	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.1	0.3	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.0	0.3	0.0	1.7	0.0	0.0	0.0	0.2	0.0	0.0	0.0	2.9	0.0	0.9	0.9	7.7	0.5	0.3	0.0	0.0	0.3
ACSBG2	"BGR, DKFZp434K1635, PRTD-NY3"	ENSG00000130377	"Acyl-CoA synthetase bubblegum family member 2"	Q5FVE4	19	6135247-6193094	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Differentiation, Fatty acid metabolism, Lipid metabolism, Spermatogenesis"	"Developmental protein, Ligase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	39	"testis: 71.3"	"Group enriched"	"Detected in some"	68	"Early spermatids: 443.1;Late spermatids: 1482.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 1.5;HEL: 3.4;Karpas-707: 2.6;MCF7: 1.0"	"Not detected"	"Not detected"							"HPA043421, HPA051013"	Enhanced		Supported	Cytosol		NA	NA			Cytosol		"HPA043421: AB_10794182, HPA051013: AB_2681311"	"unprognostic (4.13e-2)"	"unprognostic (1.28e-1)"	"unprognostic (2.47e-1)"	"unprognostic (3.27e-2)"	"unprognostic (4.33e-2)"	"unprognostic (1.92e-4)"	"unprognostic (1.96e-2)"	"unprognostic (4.17e-2)"	"unprognostic (2.07e-1)"	"unprognostic (2.62e-1)"	"unprognostic (6.88e-3)"	"unprognostic (3.13e-2)"	"unprognostic (3.91e-3)"	"unprognostic (2.20e-1)"	"unprognostic (9.23e-2)"	"unprognostic (8.78e-2)"	"unprognostic (4.70e-4)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.3	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	71.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.5	0.0	0.4	0.0	0.1	0.0	0.6	0.4	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.1	0.1	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	3.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.7	0.0	2.6	0.0	1.0	0.2	0.7	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.4	0.5	0.0	0.3	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	443.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1482.1	10.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.7	1.0	0.0	6.5	0.0	14.2	5.7	0.0	1.1	0.0	0.0	0.0
ACSL1	"ACS1, FACL1, FACL2, LACS, LACS1, LACS2"	ENSG00000151726	"Acyl-CoA synthetase long chain family member 1"	P33121	4	184755595-184826818	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Fatty acid metabolism, Lipid metabolism"	Ligase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adipose tissue: 105.0;liver: 190.9"	"Group enriched"	"Detected in many"	4	"Early spermatids: 359.4;Hepatocytes: 1018.8;Late spermatids: 335.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	9	"neutrophil: 80.2"	"Lineage enriched"	"Detected in many"	9	"granulocytes: 80.2"	"Cell line enhanced"	"Detected in many"		"ASC diff: 151.2;ASC TERT1: 36.7;HSkMC: 80.3;RPTEC TERT1: 47.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA011316, HPA011964"	Enhanced		Uncertain	Nucleoplasm,Mitochondria,Cytosol		NA	NA			Nucleoplasm	"Mitochondria, Cytosol"	"HPA011316: AB_1844536, HPA011964: AB_1844537"	"unprognostic (1.10e-2)"	"unprognostic (3.19e-1)"	"unprognostic (1.04e-1)"	"unprognostic (1.64e-3)"	"unprognostic (2.93e-2)"	"unprognostic (1.21e-2)"	"unprognostic (1.82e-3)"	"unprognostic (2.75e-2)"	"unprognostic (1.79e-1)"	"unprognostic (5.89e-2)"	"unprognostic (9.83e-2)"	"unprognostic (3.15e-1)"	"prognostic favorable (1.25e-5)"	"unprognostic (2.77e-1)"	"unprognostic (4.38e-2)"	"unprognostic (6.25e-3)"	"unprognostic (3.13e-2)"	105.0	6.7	4.2	14.1	13.5	46.0	54.4	3.2	9.6	7.2	12.2	16.4	5.5	4.9	5.7	12.7	8.8	6.4	5.7	24.3	6.4	4.1	32.8	190.9	20.7	18.9	24.0	3.8	4.2	7.3	5.9	8.7	4.4	11.6	14.2	2.6	9.1	17.9	4.8	89.1	20.4	4.5	6.4	18.2	16.9	6.5	6.4	15.9	2.1	8.3	10.1	5.8	7.6	11.0	0.5	2.2	80.2	8.9	0.7	0.7	2.9	6.1	1.9	1.2	3.1	151.2	36.7	1.0	3.4	1.7	2.0	1.4	0.4	1.7	2.5	0.3	4.0	4.9	3.8	5.4	2.2	1.7	12.4	1.9	1.8	1.7	5.0	24.3	4.9	4.6	80.3	18.6	1.7	8.7	3.6	2.6	0.4	0.8	7.8	9.8	3.2	0.3	6.8	0.2	4.1	2.7	0.9	1.0	3.2	47.8	17.5	4.6	4.3	3.1	9.4	10.5	0.5	3.4	5.0	2.8	1.8	2.1	4.3	1.0	3.0	1.5	1.1	5.8	6.9	2.8	2.3	8.9	2.8	0.5	5.2	0.5	0.5	0.4	0.2	2.2	0.5	0.4	0.3	80.2	0.7	3.6	0.4	0.7	2.9	4.2	13.5	3.2	9.6	6.4	4.1	24.0	3.8	11.6	15.9	23.8	107.2	14.5	16.5	18.7	5.8	89.7	28.1	13.4	21.6	29.6	17.7	8.6	79.6	3.9	359.4	5.6	2.6	0.0	11.0	1.9	9.1	56.1	23.1	1018.8	39.4	3.2	0.0	19.0	136.2	335.5	17.8	64.1	30.4	24.4	4.2	3.3	9.0	0.9	15.6	75.0	10.3	12.9	12.0	8.1	16.7	35.9	2.9	10.0	1.7	21.4
ACSL3	"ACS3, FACL3, PRO2194"	ENSG00000123983	"Acyl-CoA synthetase long chain family member 3"	O95573	2	222860934-222944639	"Cancer-related genes, Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Fatty acid metabolism, Lipid metabolism"	Ligase	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	4	"parathyroid gland: 206.1"	"Cell type enhanced"	"Detected in all"	9	"Horizontal cells: 494.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"SK-MEL-30: 94.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA011315, HPA071021"	Approved		Approved	"Nucleoli,Nucleoli rim,Lipid droplets"		NA	NA			"Nucleoli, Nucleoli rim"	"Lipid droplets"	"HPA011315: AB_1848344, HPA071021: AB_2686335"	"unprognostic (1.87e-1)"	"unprognostic (5.64e-2)"	"unprognostic (2.36e-1)"	"unprognostic (9.35e-3)"	"unprognostic (7.53e-2)"	"unprognostic (2.07e-2)"	"prognostic unfavorable (2.75e-4)"	"prognostic unfavorable (8.78e-4)"	"unprognostic (3.90e-2)"	"unprognostic (2.50e-1)"	"unprognostic (2.64e-1)"	"unprognostic (4.26e-2)"	"unprognostic (1.17e-3)"	"unprognostic (1.36e-1)"	"unprognostic (2.72e-1)"	"unprognostic (2.65e-1)"	"unprognostic (1.60e-1)"	14.7	17.0	22.8	9.9	26.0	16.3	51.5	19.4	45.9	15.3	16.5	16.1	11.6	12.7	10.9	18.4	28.3	9.0	11.8	22.7	20.9	22.8	17.9	22.3	15.6	10.5	19.6	21.2	11.7	10.3	206.1	8.8	19.1	24.4	44.4	16.7	14.4	34.2	15.5	19.1	11.4	12.7	12.2	22.2	9.7	28.3	13.7	14.2	13.5	17.3	11.2	8.7	14.6	15.4	15.0	22.5	21.8	16.8	16.6	20.1	16.5	10.1	17.9	27.4	29.8	12.0	29.8	7.6	12.9	33.6	15.5	32.7	16.1	26.1	4.8	7.5	12.3	33.5	29.9	5.9	28.7	20.1	8.7	11.2	11.4	14.5	17.9	26.5	7.5	5.6	15.3	40.8	25.6	44.7	11.9	16.8	8.5	21.5	18.6	21.8	21.5	14.6	8.8	13.9	23.0	9.3	8.0	23.2	8.2	22.3	41.6	14.5	10.7	7.6	20.6	94.2	22.1	10.3	18.4	11.6	10.4	16.6	8.9	9.4	6.6	3.2	16.8	11.1	7.1	31.4	16.6	14.6	21.8	20.1	16.8	19.3	11.6	12.8	14.6	15.7	15.0	18.7	16.7	21.8	16.6	15.9	22.5	9.5	16.5	22.8	26.0	19.4	45.9	20.9	22.8	19.6	21.2	24.4	14.2	32.8	58.5	16.4	65.8	41.3	91.7	51.2	40.8	37.5	44.3	34.9	72.6	32.9	6.6	28.6	31.0	38.3	33.1	23.3	27.3	8.4	36.3	113.5	26.5	47.9	33.5	494.2	20.1	36.2	50.2	18.9	24.2	42.9	45.5	32.5	32.3	205.8	32.5	38.6	33.6	12.5	51.8	45.3	51.8	50.2	49.9	42.7	50.7	27.7	46.5	102.1
ACSL4	"ACS4, FACL4, LACS4, MRX63, MRX68"	ENSG00000068366	"Acyl-CoA synthetase long chain family member 4"	O60488	X	109624244-109733403	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Fatty acid metabolism, Lipid metabolism"	Ligase	"Alport syndrome, Deafness, Disease mutation, Elliptocytosis, Hereditary hemolytic anemia, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	6	"Alveolar cells type 2: 210.9;granulocytes: 598.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HMC-1: 81.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000286, HPA005552"	Supported		Approved	"Golgi apparatus,Mitochondria"		NA	NA		100000	"Golgi apparatus"	Mitochondria	"HPA000286: AB_2665966, HPA005552: AB_1078774"	"unprognostic (9.13e-2)"	"unprognostic (3.38e-1)"	"unprognostic (1.39e-1)"	"unprognostic (2.61e-1)"	"unprognostic (2.55e-1)"	"unprognostic (2.94e-2)"	"unprognostic (5.32e-2)"	"unprognostic (4.14e-3)"	"unprognostic (1.92e-1)"	"unprognostic (9.45e-2)"	"unprognostic (1.92e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.64e-2)"	"unprognostic (1.81e-1)"	"unprognostic (4.78e-1)"	"unprognostic (3.29e-2)"	"prognostic favorable (5.73e-4)"	29.5	31.1	16.3	25.5	18.0	9.2	30.0	13.9	22.8	34.7	10.5	8.8	4.6	10.0	13.7	11.7	11.2	10.7	20.1	20.3	27.6	20.3	31.2	9.6	27.8	29.6	15.2	19.0	13.1	8.8	16.7	12.9	33.9	21.1	9.7	9.7	8.0	10.7	11.0	42.5	9.1	9.0	15.8	24.6	17.0	12.9	17.7	9.7	9.5	12.8	8.5	11.9	19.5	21.0	2.2	6.5	20.3	10.9	2.2	4.0	3.8	13.9	4.5	5.6	6.0	21.1	13.2	4.4	20.5	22.7	20.0	20.9	4.4	9.7	10.0	8.0	14.8	24.6	4.0	4.8	19.7	31.6	3.5	5.0	39.4	6.4	46.6	9.7	9.3	81.7	11.4	7.7	22.8	16.7	11.6	15.0	6.4	1.1	12.3	22.9	0.9	8.1	12.3	7.0	3.1	8.2	5.9	10.3	8.2	28.7	4.5	3.7	2.8	24.5	0.0	12.6	11.5	0.3	10.0	27.7	18.3	5.2	28.9	18.8	6.1	7.0	9.4	32.3	20.9	11.6	15.5	7.0	20.3	2.8	9.8	2.0	2.2	2.5	2.2	6.5	2.2	2.0	2.4	19.8	2.2	10.9	2.6	4.0	3.8	16.3	18.0	13.9	22.6	27.6	20.3	15.2	19.0	21.1	9.7	71.5	210.9	20.6	16.2	19.8	34.7	32.3	10.2	17.4	64.8	69.8	2.0	5.7	43.1	24.1	1.2	28.6	0.7	23.3	22.2	29.6	17.9	10.6	598.2	1.7	22.2	6.4	7.5	17.8	68.3	2.0	5.2	45.1	15.1	64.9	2.9	11.7	26.4	1.4	9.6	10.0	14.5	0.0	22.3	3.9	3.8	7.0	26.4	13.8	1.7	12.4
ACSL5	"ACS2, ACS5, FACL5"	ENSG00000197142	"Acyl-CoA synthetase long chain family member 5"	Q9ULC5	10	112374018-112428380	"Enzymes, Plasma proteins, Predicted membrane proteins"	"Fatty acid metabolism, Lipid metabolism"	Ligase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"intestine: 278.7"	"Cell type enhanced"	"Detected in many"	12	"Enterocytes: 266.6;Paneth cells: 93.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"CAPAN-2: 43.3;RT4: 44.2;U-937: 21.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007162, CAB035986, CAB062546"	Enhanced		Supported	Nucleoplasm,Mitochondria		NA	NA		22000	Mitochondria	Nucleoplasm	"CAB035986: AB_941506, CAB062546: AB_2665614, HPA007162: AB_2667761"	"unprognostic (5.75e-3)"	"unprognostic (2.06e-1)"	"unprognostic (3.08e-2)"	"prognostic favorable (1.13e-4)"	"unprognostic (2.45e-1)"	"unprognostic (2.13e-2)"	"unprognostic (4.92e-2)"	"unprognostic (5.90e-2)"	"unprognostic (1.67e-1)"	"unprognostic (4.06e-2)"	"unprognostic (4.18e-3)"	"unprognostic (7.40e-2)"	"unprognostic (5.25e-3)"	"unprognostic (2.11e-1)"	"unprognostic (1.10e-1)"	"unprognostic (5.92e-3)"	"unprognostic (1.08e-3)"	10.0	1.4	3.1	12.7	3.5	2.2	6.4	1.2	3.1	9.3	84.6	1.6	3.8	64.5	8.7	41.8	4.2	8.0	11.2	3.1	3.3	3.1	3.2	56.5	10.8	7.1	4.0	1.2	5.0	1.6	0.1	1.2	2.1	3.9	7.0	21.5	8.4	2.4	4.0	2.6	1.3	278.7	2.6	3.8	12.4	7.7	2.3	2.5	6.3	3.1	2.7	7.2	17.4	6.7	10.8	19.4	16.3	17.0	16.2	25.1	11.7	11.6	0.3	0.2	0.0	0.8	0.1	1.0	0.3	2.3	0.0	0.2	10.6	43.3	14.2	2.6	0.6	2.1	0.1	0.0	0.0	0.2	11.9	0.0	11.1	0.4	18.5	2.8	17.2	18.8	1.9	0.0	0.2	0.0	0.8	0.8	0.0	0.0	6.5	0.0	0.0	0.0	7.9	0.0	9.8	0.4	3.9	0.0	8.7	1.2	44.2	0.0	0.3	17.3	6.6	0.0	0.0	0.0	9.7	12.5	0.1	0.1	0.7	0.7	4.7	0.0	6.9	0.4	21.6	0.0	14.5	9.3	16.3	16.7	17.0	16.6	10.8	13.7	18.4	19.4	8.2	9.5	14.5	2.5	16.2	15.9	6.2	25.1	11.7	3.1	3.5	1.2	3.1	3.3	3.1	4.0	1.2	3.9	2.5	11.9	43.5	21.6	7.4	3.4	0.0	1.4	12.7	5.3	33.0	0.0	3.9	1.6	0.0	12.0	65.8	24.5	266.6	0.0	5.6	1.9	1.7	5.7	17.3	79.9	16.7	0.0	39.2	16.0	19.2	29.7	14.7	23.5	3.3	4.6	84.3	0.0	29.0	93.1	11.3	0.0	1.2	0.0	1.4	1.7	1.4	1.5	0.6	14.9	90.6	41.4
ACSL6	"ACS2, FACL6, KIAA0837, LACS2, LACS5"	ENSG00000164398	"Acyl-CoA synthetase long chain family member 6"	Q9UKU0	5	131949973-132012243	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Fatty acid metabolism, Lipid metabolism"	Ligase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 34.0;ductus deferens: 30.1;seminal vesicle: 35.8;testis: 23.0"	"Cell type enhanced"	"Detected in many"	14	"Cone photoreceptor cells: 216.0;Erythroid cells: 116.8;Rod photoreceptor cells: 126.2"	"Group enriched"	"Detected in some"	6	"colorectal cancer: 1.8;glioma: 1.9;liver cancer: 0.9"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in some"	5	"SCLC-21H: 14.9;U-937: 8.7"									HPA040470	Enhanced					NA	NA					"HPA040470: AB_10794033"	"unprognostic (1.99e-2)"	"unprognostic (1.94e-1)"	"unprognostic (3.55e-3)"	"unprognostic (5.89e-2)"	"unprognostic (6.97e-2)"	"unprognostic (1.92e-2)"	"unprognostic (8.38e-3)"	"unprognostic (5.84e-2)"	"unprognostic (8.69e-2)"	"unprognostic (7.57e-2)"	"unprognostic (9.28e-4)"	"unprognostic (8.69e-2)"	"unprognostic (3.22e-2)"	"unprognostic (6.24e-3)"	"unprognostic (1.79e-1)"	"unprognostic (6.44e-3)"	"unprognostic (1.70e-1)"	0.6	4.8	16.5	1.5	15.7	21.3	0.7	22.8	34.0	0.5	0.7	5.3	30.1	5.4	0.5	1.0	0.9	0.7	0.9	2.0	12.4	9.7	2.3	2.6	0.8	2.5	9.6	12.1	0.5	1.9	13.0	2.7	1.1	12.1	0.8	0.8	3.3	0.8	35.8	3.6	0.6	3.3	0.5	4.2	1.2	1.2	23.0	4.7	0.0	0.9	0.0	1.5	0.7	0.3	0.1	0.0	0.6	0.1	1.2	4.2	1.1	0.0	0.0	0.3	0.1	0.6	0.0	0.5	0.0	0.0	0.0	0.1	0.8	0.0	0.1	0.0	0.0	0.5	0.1	1.6	0.2	0.0	0.0	0.9	0.1	0.0	2.2	0.0	0.2	2.1	0.0	0.1	0.0	0.1	0.0	0.0	2.1	1.0	0.2	0.0	0.0	0.0	1.5	0.9	0.0	0.1	0.1	0.0	0.1	0.0	0.0	14.9	0.7	0.2	0.2	1.2	0.5	0.1	0.0	0.0	0.0	0.1	0.2	0.2	0.1	0.5	0.0	0.3	8.7	0.5	0.6	0.1	0.1	1.5	0.0	3.5	0.1	2.1	4.2	0.0	0.1	3.9	1.8	0.2	1.2	0.0	0.0	0.1	1.1	16.5	15.7	22.8	18.8	12.4	9.7	9.6	12.1	12.1	4.7	23.8	33.5	0.5	1.0	1.6	55.8	0.0	2.5	14.7	29.6	1.8	216.0	0.3	6.6	0.4	22.7	0.4	0.7	116.8	0.2	0.2	1.1	1.0	9.3	5.7	0.1	20.6	2.4	2.5	1.2	3.6	0.3	7.9	0.0	0.0	0.6	20.4	0.2	0.9	1.8	0.3	126.2	0.0	0.8	16.1	1.3	1.1	0.2	10.7	0.2	0.9
ACSM1	"BUCS1, MACS1"	ENSG00000166743	"Acyl-CoA synthetase medium chain family member 1"	Q08AH1	16	20623237-20698890	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Fatty acid metabolism, Lipid metabolism"	Ligase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	19	"breast: 83.4"	"Cell type enhanced"	"Detected in many"	10	"Cholangiocytes: 7.6;Early spermatids: 11.5;Late spermatids: 18.5"	"Group enriched"	"Detected in many"	8	"liver cancer: 14.7;prostate cancer: 36.7"					"Cell type enhanced"	"Detected in some"		"eosinophil: 3.5;memory B-cell: 3.4"	"Low lineage specificity"	"Detected in many"			"Cell line enriched"	"Detected in some"	5	"NTERA-2: 18.8"	"Not detected"	"Not detected"							HPA046291	Uncertain					NA	NA					"HPA046291: AB_10960704"	"unprognostic (1.08e-2)"	"unprognostic (3.07e-2)"	"unprognostic (1.41e-1)"	"unprognostic (1.86e-2)"	"unprognostic (5.49e-4)"	"unprognostic (1.66e-1)"	"unprognostic (3.50e-2)"	"unprognostic (9.46e-2)"	"unprognostic (3.10e-1)"	"unprognostic (8.44e-3)"	"unprognostic (2.10e-1)"	"unprognostic (2.64e-1)"	"unprognostic (8.24e-2)"	"unprognostic (3.79e-2)"	"unprognostic (3.01e-1)"	"unprognostic (9.58e-2)"	"unprognostic (2.33e-3)"	0.0	0.1	0.0	0.0	0.0	1.1	83.4	0.1	0.1	1.7	0.4			0.2	2.3	0.2	0.1	2.4	0.2	0.1	0.0	0.0	1.2	3.8	0.2	0.1	0.0		2.8	1.4	0.5	0.0	0.0		3.4	0.2		1.2	0.2	0.1	2.2	0.4	0.3	0.0	0.2	2.1	4.5			0.2		0.1	1.1	1.5	3.4	0.0	3.5	0.9	1.3	0.6	0.1	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.1	0.3	0.0	0.1	0.2	0.0	0.7	0.0	0.0	0.0	0.1	0.0	1.4	0.0	0.9	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	4.1	0.0	0.0	0.1	0.0	0.1	18.8	0.0	0.0	0.0	0.0	0.0	0.7	0.1	0.0	0.0	0.0	0.6	0.0	0.5	1.1	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.9	3.5	0.1	0.2	0.1	3.4	0.6	0.0	0.0	2.9	0.5	0.2	0.0	1.3	0.0	0.0	0.0	0.1											0.0	0.0	0.0	2.3	0.6	0.0	0.3	7.6	4.0	1.2	0.0	0.0	0.1	1.7	3.0	11.5	0.7	0.4	0.0	2.0	0.1	0.0	3.1	0.0	0.8	0.2	0.0	1.2	0.6	0.0	18.5	4.0	1.8	0.0	2.8	3.7	0.0	1.5	3.5	6.7	1.2	0.0	0.0	0.0	0.5	0.0	1.4	0.1	0.0	2.2	1.2
ACSM2A	"A-923A4.1, ACSM2, MGC150530"	ENSG00000183747	"Acyl-CoA synthetase medium chain family member 2A"	Q08AH3	16	20451461-20487667	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Fatty acid metabolism, Lipid metabolism"	Ligase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	90	"kidney: 63.5;liver: 82.6"	"Group enriched"	"Detected in some"	13	"Hepatocytes: 567.1;Proximal tubular cells: 367.9"	"Group enriched"	"Detected in some"	479	"liver cancer: 22.7;renal cancer: 25.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	5	"Hep G2: 6.6"									HPA057699	Supported					NA	NA					"HPA057699: AB_2683506"	"unprognostic (1.17e-4)"						"prognostic favorable (1.41e-5)"				"unprognostic (5.25e-1)"	"unprognostic (2.42e-1)"	"unprognostic (9.28e-3)"	"unprognostic (1.52e-1)"	"unprognostic (5.10e-1)"	"unprognostic (2.09e-1)"		0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.6	0.1	0.0	0.1	0.1	0.1	0.0	63.5	82.6	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.8	0.0	0.0	0.1	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	6.6	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.7	0.0	0.1	0.6	0.2	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.0	25.5	0.0	0.2	0.0	0.3	35.7	0.0	0.0	7.0	0.0	0.0	26.6	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	567.1	0.0	0.0	0.0	21.5	17.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	367.9	0.0	0.0	0.0	0.2	0.0	0.1	0.2	0.5	0.0	0.0
ACSM2B	"ACSM2, HXMA, HYST1046"	ENSG00000066813	"Acyl-CoA synthetase medium chain family member 2B"	Q68CK6	16	20536226-20576427	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Fatty acid metabolism, Lipid metabolism"	Ligase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	69	"kidney: 76.1;liver: 93.4"	"Group enriched"	"Detected in some"	13	"Hepatocytes: 830.9;Proximal tubular cells: 347.6"	"Group enriched"	"Detected in some"	450	"liver cancer: 30.9;renal cancer: 17.5"	"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"AF22: 5.5;Hep G2: 10.1"									HPA057699	Supported					NA	NA					"HPA057699: AB_2683506"	"unprognostic (1.34e-2)"						"prognostic favorable (3.31e-4)"				"unprognostic (7.13e-2)"	"unprognostic (2.29e-1)"	"unprognostic (6.67e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.15e-1)"	"unprognostic (2.22e-2)"		0.2	0.0	0.2	0.2	0.2	0.0	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.0	0.2	0.2	0.2	0.0	0.2	0.2	0.2	0.0	76.1	93.4	0.2	0.2	0.2	0.2	0.2	0.2	0.0	0.2	0.2	0.2	0.2	0.0	0.2	0.2	0.2	0.2	0.0	0.2	0.2	0.2	0.2	0.0	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.6	0.9	1.0	0.5	0.2	1.2	0.0	1.0	0.0	5.5	1.5	0.0	0.0	1.4	0.9	0.2	0.0	0.0	1.2	0.9	0.1	2.8	0.0	0.9	0.8	0.0	0.0	0.0	1.0	0.7	0.3	1.3	10.1	0.0	1.3	1.4	0.0	0.0	0.0	0.4	0.8	0.6	0.3	0.9	1.2	0.0	0.7	0.6	1.3	1.2	1.7	0.0	0.1	1.2	0.2	0.4	0.2	1.9	1.0	2.7	0.0	1.0	0.2	2.0	0.4	0.0	0.0	1.0	0.0	0.8	0.8	0.5	0.7	0.7	3.5	1.9	0.5	0.5	0.2	0.6	0.0	0.6	0.1	0.8	0.2	0.1	0.6	0.7	1.2	1.0	0.2	0.1	0.9	0.2	0.0	0.2	0.2	0.2	0.2	0.2	0.0	0.2	0.2	0.2	0.2	0.0	0.0	41.9	0.0	0.2	0.0	0.3	28.1	0.0	0.0	7.0	0.0	0.0	29.9	0.1	0.7	0.5	0.0	46.7	0.0	0.0	0.0	0.0	0.0	830.9	0.1	0.0	1.7	23.9	21.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	347.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0
ACSM3	"SA, SAH"	ENSG00000005187	"Acyl-CoA synthetase medium chain family member 3"	Q53FZ2	16	20610243-20797581	"Enzymes, Predicted intracellular proteins"	"Fatty acid metabolism, Lipid metabolism"	Ligase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 58.6;ovary: 47.7;pancreas: 46.6"	"Cell type enhanced"	"Detected in many"	8	"Distal tubular cells: 71.3;Ito cells: 98.8;Proximal tubular cells: 77.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Cell type enhanced"	"Detected in many"		"eosinophil: 18.3"	"Group enriched"	"Detected in all"	4	"granulocytes: 18.3;T-cells: 7.4"	"Cell line enhanced"	"Detected in some"		"HEL: 20.3;HMC-1: 85.9;K-562: 60.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA041013	Uncertain					NA	NA					"HPA041013: AB_10671693"	"unprognostic (1.62e-4)"	"unprognostic (1.30e-2)"	"unprognostic (2.12e-2)"	"unprognostic (9.50e-2)"	"unprognostic (1.48e-1)"	"unprognostic (2.32e-2)"	"unprognostic (1.42e-2)"	"unprognostic (2.20e-1)"	"unprognostic (8.14e-3)"	"prognostic favorable (1.97e-4)"	"unprognostic (3.56e-2)"	"unprognostic (1.95e-3)"	"prognostic favorable (9.88e-6)"	"unprognostic (1.27e-1)"	"unprognostic (6.96e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.84e-2)"	2.1	1.8	0.3	3.7	1.0	3.4	18.6	0.4	0.4	10.9	7.0	0.5	4.3	1.7	10.4	5.3	2.9	11.2	5.0	4.0	0.3	0.3	33.1	58.6	6.4	3.7	0.4	0.3	47.7	46.6	5.1	1.0	1.8	0.7	9.6	7.2	1.4	3.6	6.5	1.0	2.0	3.1	3.2	0.5	1.3	10.9	14.7	0.3	1.5	1.5	1.6	1.8	3.9	6.6	2.2	1.9	18.3	2.9	1.9	7.4	2.3	0.2	2.8	0.5	0.1	0.8	0.5	0.3	0.0	0.3	0.0	0.2	0.2	4.0	0.3	4.5	0.1	0.1	0.3	0.0	0.4	0.3	0.9	1.4	20.3	0.0	1.5	0.3	2.2	85.9	0.8	0.4	0.1	0.4	0.4	0.0	0.1	60.5	3.4	0.0	0.3	0.1	0.7	0.1	3.0	0.7	0.6	0.0	4.3	4.1	0.2	0.1	0.1	0.0	1.2	0.0	0.1	1.3	0.1	0.3	0.2	0.2	0.2	0.1	4.9	3.8	0.2	0.3	1.6	0.1	2.3	1.6	18.3	3.3	1.0	3.8	1.4	4.1	3.0	0.2	2.2	6.5	7.4	0.5	1.9	2.9	1.9	4.6	2.3	0.3	1.0	0.4	0.4	0.3	0.3	0.4	0.3	0.7	0.3	3.0	25.3	23.1	29.1	2.5	0.0	3.2	17.8	2.7	2.3	12.2	0.0	14.9	71.3	44.7	11.7	0.5	3.9	0.0	11.1	1.0	1.5	14.6	0.0	34.1	3.2	0.0	2.4	98.8	6.9	9.1	25.6	1.5	0.0	1.0	9.1	0.0	14.1	11.5	12.0	77.8	0.0	0.0	3.1	2.7	1.0	1.6	16.0	5.7	22.5	4.3
ACSM4		ENSG00000215009	"Acyl-CoA synthetase medium chain family member 4"	P0C7M7	12	7304284-7328724	"Enzymes, Predicted membrane proteins"	"Fatty acid metabolism, Lipid metabolism"	Ligase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"lymphoid tissue: 2.0;testis: 3.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"GAMG: 2.1;HDLM-2: 3.8;Karpas-707: 2.6;NB-4: 4.0;SH-SY5Y: 4.7;U-87 MG: 6.7"	"Region enhanced"	"Detected in single"		"olfactory region: 0.6"	"Not detected"	"Not detected"			HPA049895	Uncertain					NA	NA					"HPA049895: AB_2680940"	"unprognostic (9.50e-5)"	"unprognostic (5.45e-2)"	"unprognostic (4.84e-2)"	"unprognostic (6.06e-4)"	"unprognostic (1.77e-2)"	"unprognostic (1.76e-2)"	"unprognostic (2.24e-3)"	"unprognostic (3.31e-3)"	"unprognostic (3.85e-2)"	"unprognostic (8.78e-2)"	"unprognostic (3.27e-1)"	"unprognostic (3.60e-1)"	"unprognostic (2.45e-9)"	"unprognostic (1.82e-2)"	"unprognostic (1.97e-1)"	"unprognostic (1.27e-1)"	"unprognostic (1.73e-1)"	0.2	0.5	0.1	0.7	0.1	0.0	0.1	0.1	0.6	0.1	0.1			0.9	0.1	0.0	0.1	0.1	0.9	0.1	0.1	0.1	0.1	0.1	0.1	0.4	0.1		0.1	0.1	0.0	0.1	0.0		0.1	0.0		0.1	0.0	0.1	0.1	1.3	0.0	0.1	2.0	0.1	3.6			0.1		0.0	0.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.4	0.0	0.1	0.0	2.1	0.0	0.0	0.0	0.0	3.8	0.0	0.0	0.3	1.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0	4.0	0.0	0.0	0.0	0.5	0.4	0.3	0.0	0.0	0.7	4.7	0.7	1.1	0.0	0.0	0.0	1.5	1.0	0.5	0.4	0.1	0.0	0.1	0.1	0.0	6.7	0.1	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0
ACSM5	FLJ20581	ENSG00000183549	"Acyl-CoA synthetase medium chain family member 5"	Q6NUN0	16	20409534-20441336	"Enzymes, Predicted intracellular proteins"	"Fatty acid metabolism, Lipid metabolism"	Ligase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	9	"liver: 94.6"	"Cell type enriched"	"Detected in some"	6	"Hepatocytes: 179.6"	"Group enriched"	"Detected in some"	7	"liver cancer: 20.5;renal cancer: 9.6"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	6	"classical monocyte: 2.8;intermediate monocyte: 1.9;myeloid DC: 3.2;non-classical monocyte: 1.3"	"Group enriched"	"Detected in many"	8	"dendritic cells: 3.2;monocytes: 2.8"	"Group enriched"	"Detected in some"	5	"ASC diff: 5.8;ASC TERT1: 12.6;HSkMC: 15.0;U-87 MG: 9.2"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			HPA041435	Uncertain		Uncertain	Vesicles		NA	NA			Vesicles		"HPA041435: AB_10961121"	"unprognostic (1.01e-1)"	"unprognostic (1.61e-3)"	"unprognostic (3.73e-2)"	"unprognostic (1.98e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.59e-2)"	"unprognostic (1.84e-2)"	"unprognostic (4.64e-3)"	"unprognostic (1.64e-1)"	"unprognostic (2.01e-2)"	"unprognostic (2.15e-2)"	"unprognostic (2.33e-1)"	"unprognostic (5.11e-3)"	"unprognostic (2.09e-2)"	"unprognostic (3.85e-2)"	"unprognostic (2.78e-2)"	"unprognostic (1.57e-1)"	11.1	1.1	1.9	0.7	2.1	0.4	3.2	1.3	1.6	1.0	1.0	2.9	0.0	0.5	0.3	2.8	0.5	0.6	1.0	0.9	3.0	1.9	8.9	94.6	0.9	1.6	2.9	2.1	0.4	1.4	0.4	0.1	0.7	2.0	0.4	0.6	0.5	0.5	0.5	4.4	0.6	0.6	0.5	2.9	1.7	0.9	1.0	3.0	0.1	1.7	0.6	0.4	0.5	0.7	0.3	3.2	0.3	2.8	0.0	0.3	0.5	0.0	0.0	0.1	0.1	5.8	12.6	0.0	0.1	1.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.2	0.0	0.2	0.0	15.0	0.0	0.8	0.1	0.3	0.0	0.0	0.1	0.6	1.7	0.0	0.0	0.3	0.2	0.0	0.0	0.0	0.1	2.2	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.4	0.0	0.3	0.1	0.0	0.0	0.1	0.0	0.0	9.2	0.1	0.0	0.3	2.8	0.1	0.1	1.9	0.1	0.1	0.3	0.2	3.2	0.3	0.2	0.3	0.1	0.0	1.3	0.1	0.0	0.5	1.9	2.1	1.3	1.6	3.0	1.9	2.9	2.1	2.0	3.0	0.0	0.0	0.0	0.1	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	6.6	0.3	0.4	0.6	0.0	0.0	0.0	0.0	0.7	0.3	0.0	179.6	3.3	0.0	0.0	6.7	8.8	0.2	8.6	1.2	0.0	1.8	0.0	1.1	0.0	0.0	5.6	31.5	0.0	0.0	0.1	0.0	0.2	0.5	0.0	0.0	0.0	0.1
ACSM6	"bA310E22.3, C10orf129"	ENSG00000173124	"Acyl-CoA synthetase medium chain family member 6"	Q6P461	10	95194200-95228928	"Enzymes, Predicted membrane proteins"	"Fatty acid metabolism, Lipid metabolism"	Ligase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"lymphoid tissue: 16.3;pancreas: 7.3;stomach 1: 6.2"	"Group enriched"	"Detected in some"	16	"Cone photoreceptor cells: 2.0;Early spermatids: 1.9;Rod photoreceptor cells: 4.6"	"Cancer enriched"	"Detected in single"	7	"urothelial cancer: 1.2"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"eosinophil: 1.0"	"Low lineage specificity"	"Detected in single"			"Cell line enriched"	"Detected in single"	30	"RT4: 9.2"									HPA044593	Uncertain					NA	NA					"HPA044593: AB_10960261"	"unprognostic (2.91e-2)"				"unprognostic (2.87e-1)"	"unprognostic (3.64e-2)"	"unprognostic (5.73e-2)"	"unprognostic (2.48e-2)"		"unprognostic (6.34e-2)"	"unprognostic (1.41e-2)"	"unprognostic (1.91e-1)"	"unprognostic (3.75e-3)"	"unprognostic (2.25e-1)"	"unprognostic (2.37e-1)"	"unprognostic (1.11e-1)"	"prognostic favorable (7.71e-4)"	0.1	0.0	0.0	0.0	0.0	0.1	0.7	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	7.3	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.1	0.0	3.4	0.0	0.8	0.4	0.0	6.2	0.3	0.0	16.3	0.8	0.0	0.0	2.5	1.9	0.1	0.0	1.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	4.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
ACSS1	"ACAS2L, AceCS2L, dJ568C11.3, MGC33843"	ENSG00000154930	"Acyl-CoA synthetase short chain family member 1"	Q9NUB1	20	25006230-25058980	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"		Ligase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"placenta: 66.4"	"Cell type enhanced"	"Detected in many"	14	"Cytotrophoblasts: 211.3;Syncytiotrophoblasts: 350.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Hep G2: 19.6;JURKAT: 20.6;OE19: 25.4;RPMI-8226: 29.2;U-937: 20.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041014, HPA043228"	Enhanced					NA	NA					"HPA041014: AB_2677251, HPA043228: AB_2678372"	"unprognostic (6.87e-2)"	"prognostic favorable (9.37e-4)"	"unprognostic (5.32e-2)"	"unprognostic (1.54e-1)"	"unprognostic (2.78e-1)"	"unprognostic (3.03e-2)"	"unprognostic (3.20e-3)"	"prognostic favorable (8.33e-5)"	"unprognostic (2.44e-1)"	"unprognostic (2.17e-2)"	"unprognostic (2.43e-1)"	"unprognostic (7.72e-2)"	"unprognostic (4.58e-3)"	"unprognostic (5.85e-2)"	"unprognostic (2.68e-1)"	"unprognostic (3.69e-1)"	"unprognostic (1.60e-1)"	6.1	4.8	22.8	8.6	26.6	16.3	9.1	17.1	19.6	9.0	14.0	21.8	9.7	28.1	8.5	12.3	7.5	10.8	12.4	32.4	26.3	9.2	19.5	5.5	10.8	13.4	15.1	20.4	12.3	28.8	9.3	5.7	66.4	21.3	14.8	12.5	9.9	21.8	10.2	19.5	9.3	25.9	8.0	11.1	16.1	26.9	21.6	22.9	11.9	14.9	4.8	12.2	8.7	7.1	7.2	4.4	8.7	6.3	12.6	5.5	2.7	0.0	4.7	1.4	0.0	4.5	1.7	0.1	0.5	2.0	2.0	1.4	4.7	0.6	8.2	0.8	1.9	8.8	2.4	6.9	1.0	0.4	0.0	0.6	14.1	0.1	19.6	4.6	3.3	0.1	2.9	3.5	0.2	0.0	0.0	4.4	20.6	0.7	15.8	0.1	0.5	19.0	5.6	0.1	25.4	7.6	14.9	0.4	29.2	3.0	3.7	3.4	0.1	0.9	1.9	13.1	0.1	9.1	7.5	0.6	0.0	0.0	0.0	0.2	11.0	0.7	0.0	0.2	20.3	5.2	6.3	3.7	8.7	5.5	6.3	4.5	5.2	3.7	4.8	4.4	7.2	3.2	4.9	0.8	12.6	4.1	2.8	3.2	2.7	22.8	26.6	17.1	19.6	26.3	9.2	15.1	20.4	21.3	22.9	11.9	13.7	25.6	6.7	4.6	2.4	60.2	45.9	9.4	9.1	10.4	0.0	211.3	64.6	3.4	72.5	7.1	29.0	23.3	6.7	6.5	11.6	9.5	5.7	5.0	43.5	0.0	0.0	9.2	7.5	14.5	31.9	8.1	6.8	2.8	28.5	14.3	3.0	14.0	30.4	14.0	0.7	19.4	14.4	0.9	1.1	3.8	350.8	23.5	21.3	3.0
ACSS2	"ACAS2, AceCS, ACS, ACSA, dJ1161H23.1"	ENSG00000131069	"Acyl-CoA synthetase short chain family member 2"	Q9NR19	20	34872146-34927962	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"		Ligase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 63.4"	"Cell type enhanced"	"Detected in all"	5	"Enterocytes: 98.3;Mucus-secreting cells: 80.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"basophil: 17.0"	"Group enriched"	"Detected in many"	5	"dendritic cells: 12.6;granulocytes: 17.0;monocytes: 11.6"	"Cell line enhanced"	"Detected in many"		"RPMI-8226: 26.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA004141	Approved		Approved	Nucleoplasm,Vesicles,Cytosol		NA	NA			"Nucleoplasm, Cytosol"	Vesicles	"HPA004141: AB_1078094"	"unprognostic (1.97e-2)"	"unprognostic (1.33e-1)"	"unprognostic (1.70e-1)"	"unprognostic (2.25e-2)"	"unprognostic (1.84e-2)"	"unprognostic (1.86e-1)"	"unprognostic (1.42e-1)"	"unprognostic (5.45e-2)"	"unprognostic (1.13e-1)"	"unprognostic (3.92e-2)"	"unprognostic (1.66e-1)"	"unprognostic (1.42e-2)"	"prognostic favorable (2.04e-4)"	"unprognostic (2.72e-1)"	"unprognostic (2.32e-1)"	"unprognostic (3.08e-1)"	"unprognostic (2.54e-1)"	30.3	12.6	2.8	9.2	7.0	1.9	12.4	5.6	7.0	6.8	21.0	10.6	8.3	21.4	6.6	7.0	8.1	4.5	7.7	24.8	2.9	2.5	11.2	15.7	11.7	3.2	6.8	3.2	5.1	3.2	4.7	2.5	4.6	5.5	3.4	10.4	3.5	9.8	6.8	63.4	6.8	24.1	3.0	6.1	2.7	13.4	3.1	7.1	1.1	3.9	7.3	3.0	6.5	6.1	0.7	12.6	17.0	11.6	0.3	3.0	4.7	11.9	1.6	1.2	1.6	8.5	9.0	12.4	7.1	5.5	2.0	3.5	4.3	6.6	0.0	8.1	3.1	7.7	9.0	2.9	17.9	1.5	0.1	2.8	16.6	0.8	2.0	6.2	1.6	9.1	6.1	3.9	2.9	2.8	2.9	3.1	1.2	10.5	1.3	2.7	1.4	0.5	7.3	0.8	3.6	20.3	4.4	7.8	26.2	6.8	1.2	1.1	5.4	8.7	6.4	6.9	3.4	3.1	3.6	11.7	2.4	3.3	4.3	2.3	11.3	8.2	3.8	6.7	2.6	1.9	17.0	11.6	3.0	0.6	7.2	0.5	0.4	1.6	0.7	12.6	0.7	3.0	1.5	6.5	0.3	3.4	2.1	1.1	4.7	2.8	7.0	5.6	7.0	2.9	2.5	6.8	3.2	5.5	7.1	11.9	40.9	3.0	8.5	6.9	6.0	70.4	25.5	5.3	13.6	10.4	5.9	13.6	10.0	16.5	7.2	13.2	98.3	23.3	29.5	8.5	8.9	8.8	9.2	44.8	14.7	7.9	7.5	10.4	17.2	6.0	10.6	13.8	13.5	19.8	80.6	8.8	18.1	60.0	4.2	51.2	3.4	12.9	9.9	11.6	7.3	9.5	17.5	5.0	60.0	8.9
ACSS3	FLJ21963	ENSG00000111058	"Acyl-CoA synthetase short chain family member 3"	Q9H6R3	12	80936414-81261205	"Enzymes, Predicted membrane proteins"		Ligase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Alveolar cells type 2: 42.8;Hepatocytes: 47.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	18	"basophil: 8.3;neutrophil: 6.0"	"Lineage enriched"	"Detected in single"	71	"granulocytes: 8.3"	"Cell line enhanced"	"Detected in many"		"ASC diff: 9.4;ASC TERT1: 10.7;Hep G2: 26.5;hTERT-RPE1: 9.1;RH-30: 12.3;SK-BR-3: 11.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA039353, HPA047956, HPA061517"	Approved		Supported	Mitochondria		NA	NA			Mitochondria		"HPA039353: AB_2676460, HPA047956: AB_2680223, HPA061517: AB_2684549"	"unprognostic (8.59e-2)"	"unprognostic (9.29e-4)"	"unprognostic (1.47e-1)"	"unprognostic (9.37e-3)"	"unprognostic (2.46e-2)"	"unprognostic (2.21e-1)"	"unprognostic (9.25e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.34e-1)"	"unprognostic (7.18e-3)"	"unprognostic (1.68e-1)"	"unprognostic (7.79e-2)"	"prognostic favorable (0.00e+0)"	"unprognostic (6.16e-4)"	"unprognostic (1.63e-1)"	"unprognostic (2.00e-1)"	"unprognostic (2.00e-4)"	19.6	18.3	7.4	1.9	8.3	1.0	8.1	2.7	7.7	13.2	2.6	5.5	10.8	1.2	18.2	14.4	2.0	8.3	8.1	10.9	6.4	3.9	24.4	37.1	8.8	1.7	7.4	6.5	16.7	2.6	21.3	11.0	4.1	6.5	7.1	1.6	10.3	20.4	11.4	9.8	2.1	1.9	6.6	5.5	2.8	1.9	4.0	4.1	0.0	9.2	2.9	1.6	3.5	6.3	0.0	0.0	8.3	0.0	0.0	0.1	0.0	0.0	0.1	2.2	0.0	9.4	10.7	0.0	1.5	7.0	1.1	1.2	0.3	0.0	0.1	0.0	3.1	3.3	0.1	0.0	0.0	0.7	0.0	1.7	0.0	0.1	26.5	3.2	0.3	0.0	7.2	0.0	0.3	0.0	9.1	0.2	0.0	0.0	0.0	5.0	0.6	0.0	0.1	3.2	0.0	0.0	0.0	12.3	1.7	0.0	0.0	2.1	0.0	0.0	11.6	0.0	4.8	5.2	0.3	0.0	1.9	1.8	0.2	0.7	0.1	0.1	0.0	2.3	0.0	2.1	8.3	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.0	0.0	0.0	0.0	0.1	0.0	7.4	8.3	2.7	7.7	6.4	3.9	7.4	6.5	6.5	4.1	20.8	42.8	0.0	7.0	0.8	31.6	19.3	15.3	6.7	5.7	12.2	3.9	1.3	5.0	4.0	33.3	1.0	0.0	0.0	2.6	0.6	4.3	4.4	0.0	47.4	0.6	27.0	0.0	3.1	2.4	6.4	22.2	0.4	0.0	0.0	0.0	19.7	0.2	0.0	22.3	26.7	4.5	6.5	5.7	4.2	0.5	0.1	0.5	0.0	0.0	2.0
ACVR1	"ACVR1A, ACVRLK2, ALK2, SKR1"	ENSG00000115170	"Activin A receptor type 1"	Q04771	2	157736444-157875862	"Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"		"Kinase, Receptor, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes, Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007505, HPA046514"	Approved		Uncertain	Nucleoli,Cytosol		NA	NA			Nucleoli	Cytosol	"HPA007505: AB_1844752, HPA046514: AB_2732526"	"unprognostic (6.99e-2)"	"unprognostic (3.32e-2)"	"unprognostic (3.02e-1)"	"unprognostic (1.19e-2)"	"unprognostic (2.73e-1)"	"unprognostic (6.09e-2)"	"unprognostic (3.66e-3)"	"unprognostic (1.08e-1)"	"unprognostic (3.99e-1)"	"unprognostic (3.20e-1)"	"unprognostic (2.65e-2)"	"unprognostic (4.29e-2)"	"unprognostic (2.42e-1)"	"unprognostic (3.43e-3)"	"unprognostic (3.17e-1)"	"unprognostic (1.76e-2)"	"prognostic unfavorable (5.17e-4)"	18.9	9.2	18.0	10.0	12.7	1.6	38.7	15.3	12.2	25.2	14.4	7.4	8.4	8.9	24.8	26.8	11.0	16.6	20.5	18.8	18.7	8.6	21.7	18.9	22.5	15.1	10.4	7.9	18.5	12.3	11.3	17.0	14.2	12.3	16.8	10.5	14.3	18.1	13.6	15.6	12.8	11.5	29.2	12.3	9.2	11.8	8.8	10.9	7.5	34.0	14.6	6.9	16.1	32.5	1.4	2.4	3.8	2.6	1.9	10.0	1.6	2.1	4.3	5.0	6.5	25.4	26.5	7.0	15.4	25.6	12.4	13.2	3.4	4.8	0.0	7.1	16.6	12.0	6.0	3.6	8.3	13.3	14.7	3.1	8.7	2.5	4.9	20.1	0.6	10.4	33.2	15.8	25.3	32.3	16.2	13.4	2.4	3.2	2.4	15.5	3.8	0.1	0.2	7.5	3.0	7.8	1.4	6.7	1.8	16.0	8.1	4.4	5.5	5.9	3.4	21.1	8.2	1.8	2.3	19.3	18.8	6.2	9.2	5.8	1.6	1.2	0.1	19.3	0.5	20.2	3.8	2.6	0.2	1.1	1.7	1.2	1.4	7.8	2.5	1.8	0.8	3.1	1.5	0.8	1.9	2.3	2.4	10.0	1.6	18.0	12.7	15.3	12.2	18.7	8.6	10.4	7.9	12.3	10.9	8.9	7.0	0.8	6.8	8.8	7.5	9.2	12.7	6.7	9.1	7.0	0.0	7.0	5.0	8.4	0.5	13.5	3.1	0.0	15.5	4.4	11.6	8.9	4.7	12.1	6.5	3.2	4.1	17.2	11.6	1.1	18.7	7.7	3.3	3.6	5.2	6.1	14.7	3.5	14.9	15.3	1.5	12.9	15.5	0.5	2.5	6.6	8.8	1.0	3.5	7.6
ACVR1B	"ActRIB, ACVRLK4, ALK4, SKR2"	ENSG00000135503	"Activin A receptor type 1B"	P36896	12	51951667-51997078	"Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"		"Kinase, Receptor, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB026126, HPA063761"	Approved		Approved	Cytosol		NA	NA			Cytosol		"CAB026126: , HPA063761: AB_2685115"	"unprognostic (8.66e-2)"	"unprognostic (5.72e-2)"	"unprognostic (1.16e-1)"	"unprognostic (3.23e-3)"	"unprognostic (2.34e-1)"	"unprognostic (2.54e-1)"	"unprognostic (1.21e-3)"	"unprognostic (1.00e-1)"	"unprognostic (7.68e-2)"	"unprognostic (5.29e-2)"	"unprognostic (2.56e-1)"	"unprognostic (2.37e-1)"	"unprognostic (4.52e-2)"	"unprognostic (9.02e-2)"	"unprognostic (6.60e-2)"	"unprognostic (8.96e-2)"	"unprognostic (4.79e-2)"	11.1	7.4	12.0	6.4	14.6	7.9	14.3	14.2	24.4	8.6	16.7	5.1	28.0	19.2	6.7	13.1	14.4	10.9	11.1	7.6	11.2	10.5	24.6	21.0	10.3	7.1	8.1	14.7	7.1	35.1	24.9	10.9	7.5	7.3	10.0	17.1	8.7	21.7	34.3	11.7	30.6	19.8	8.2	5.8	6.7	17.2	10.6	4.8	3.9	9.9	5.8	8.4	10.1	12.1	0.5	1.3	6.8	4.0	0.1	1.6	0.6	6.4	14.1	11.0	6.0	12.6	9.9	6.2	7.3	8.3	7.8	5.9	28.4	10.0	2.8	10.2	7.9	8.6	11.4	10.4	8.8	8.1	4.1	12.3	6.9	3.5	8.8	14.4	11.2	26.0	19.3	11.5	8.8	11.1	8.3	10.9	10.3	7.4	8.8	6.9	13.1	10.6	9.7	10.6	13.6	4.9	5.7	8.5	3.6	21.9	9.8	14.0	11.6	7.8	11.2	5.1	8.1	12.4	7.3	6.9	5.4	8.2	6.0	3.5	5.4	3.7	3.9	5.8	5.4	6.9	4.5	2.2	6.8	0.7	3.3	1.0	0.1	0.6	0.7	1.3	0.5	1.6	0.9	1.9	0.1	4.0	0.7	1.0	0.6	12.0	14.6	14.2	24.4	11.2	10.5	8.1	14.7	7.3	4.8	3.0	12.0	3.4	9.2	16.6	41.6	5.4	22.9	13.4	14.8	24.4	27.5	0.5	3.3	12.7	2.3	9.8	23.9	0.0	12.5	0.6	5.7	12.2	10.5	19.5	3.7	35.0	23.6	14.7	16.7	6.3	9.2	7.7	6.8	2.8	32.6	10.6	12.7	24.6	8.9	16.5	23.8	6.5	15.9	3.9	16.5	22.1	0.5	2.5	22.6	11.2
ACVR1C	"ACVRLK7, ALK7"	ENSG00000123612	"Activin A receptor type 1C"	Q8NER5	2	157526767-157629005	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	Apoptosis	"Kinase, Receptor, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"adipose tissue: 36.2;breast: 15.3"	"Cell type enhanced"	"Detected in many"	12	"Enterocytes: 11.4;Leydig cells: 29.4;Paneth cells: 10.4;Undifferentiated cells: 12.1"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"naive CD4 T-cell: 2.8"	"Lineage enriched"	"Detected in single"	4	"T-cells: 2.8"	"Group enriched"	"Detected in some"	4	"ASC diff: 15.4;HDLM-2: 6.8"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"basal ganglia: 29.2;cerebral cortex: 8.1;hippocampal formation: 21.6"	"HPA007982, HPA011933"	Approved				"Intracellular and membrane"	NA	NA					"HPA007982: AB_1078134, HPA011933: AB_1844754"	"unprognostic (1.03e-1)"	"unprognostic (4.55e-2)"	"unprognostic (9.65e-2)"	"unprognostic (1.22e-1)"	"unprognostic (2.92e-1)"	"unprognostic (7.64e-2)"	"unprognostic (1.00e-1)"	"unprognostic (3.48e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.35e-1)"	"unprognostic (7.12e-3)"	"unprognostic (3.62e-1)"	"unprognostic (9.31e-6)"	"unprognostic (7.28e-2)"	"unprognostic (1.95e-1)"	"unprognostic (9.74e-2)"	"unprognostic (1.30e-1)"	36.2	3.7	3.9	2.7	10.3	0.7	15.3	1.6	4.4	0.9	9.4	2.7	0.0	5.5	0.7	1.0	0.8	0.8	1.8	1.0	9.2	3.1	1.1	3.3	0.8	1.2	3.7	3.1	5.1	2.4	0.5	12.0	0.7	3.5	0.9	4.4	0.0	1.5	1.0	1.3	0.7	4.4	0.8	2.8	0.8	3.4	1.1	4.0	0.0	0.9	0.5	1.0	0.6	2.9	0.6	0.0	0.0	0.0	0.0	2.8	0.4	2.0	0.0	0.0	0.2	15.4	0.5	0.3	0.4	0.4	0.1	0.5	2.3	0.2	0.0	0.2	1.2	1.0	0.0	0.1	0.0	0.3	6.8	1.0	0.0	0.0	0.5	0.0	0.0	1.2	0.2	0.1	0.4	0.0	0.4	0.0	0.0	0.0	0.4	0.4	0.3	0.0	0.0	1.4	0.1	0.7	0.0	0.8	0.1	0.0	0.0	0.4	0.0	0.0	0.0	2.3	0.3	0.0	0.3	0.0	0.8	0.2	0.0	0.2	0.8	2.4	0.0	0.6	0.0	0.3	0.0	0.0	0.0	0.5	0.0	1.0	0.6	1.8	1.2	0.0	0.5	2.8	1.1	0.0	0.0	0.0	0.0	0.0	0.4	3.9	10.3	1.6	4.4	9.2	3.1	3.7	3.1	3.5	4.0	0.0	0.6	0.0	0.9	0.6	0.0	1.2	0.0	0.0	1.2	0.0	0.0	0.2	0.0	0.2	1.1	1.0	11.4	0.0	0.2	0.3	1.2	0.8	0.0	4.7	0.1	0.0	7.5	0.0	0.0	0.4	29.4	0.0	3.3	7.2	8.4	1.0	0.4	10.4	8.5	0.7	0.0	0.0	1.0	0.0	2.0	1.3	0.2	0.0	12.1	0.4
ACVR2A	"ACTRII, ACVR2"	ENSG00000121989	"Activin A receptor type 2A"	P27037	2	147844517-147930826	"Cancer-related genes, Enzymes, Predicted membrane proteins"		"Kinase, Receptor, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HHSteC: 21.0;RH-30: 17.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA046997	Approved		Approved	Cytosol		NA	NA			Cytosol		"HPA046997: AB_10970077"	"unprognostic (4.55e-2)"	"unprognostic (2.26e-2)"	"unprognostic (2.09e-1)"	"unprognostic (7.34e-3)"	"unprognostic (2.75e-1)"	"unprognostic (1.17e-1)"	"unprognostic (4.41e-3)"	"unprognostic (8.73e-3)"	"unprognostic (1.30e-2)"	"unprognostic (3.61e-1)"	"unprognostic (1.34e-2)"	"unprognostic (1.52e-1)"	"prognostic favorable (1.62e-4)"	"unprognostic (1.16e-1)"	"unprognostic (1.40e-1)"	"unprognostic (3.95e-1)"	"unprognostic (3.99e-2)"	12.0	6.0	13.6	8.2	9.9	3.8	10.7	14.5	14.2	10.2	14.1	4.7	9.7	10.4	9.3	9.9	13.6	7.6	17.7	5.6	10.0	9.0	9.0	10.3	7.5	4.7	5.9	10.6	7.6	9.8	8.6	15.9	10.6	7.3	12.2	9.1	7.6	12.2	12.0	19.6	29.5	17.8	13.8	5.4	6.5	9.3	11.0	6.4	1.5	9.5	6.9	6.8	13.5	11.8	0.7	3.0	0.5	3.6	7.7	4.6	1.4	1.3	1.6	10.0	3.7	5.9	3.8	4.1	3.1	3.7	5.3	9.3	4.3	6.0	0.0	2.8	4.9	1.9	4.7	9.1	4.5	6.8	1.0	5.5	0.6	2.8	7.4	21.0	0.6	0.7	6.3	5.7	3.4	6.8	4.1	4.0	1.2	1.4	2.6	3.6	3.5	0.3	0.5	11.3	4.0	2.6	0.1	17.5	0.9	4.2	8.5	9.9	5.6	2.6	3.1	3.8	4.5	1.9	1.0	3.1	4.9	5.8	4.6	2.1	0.7	0.2	1.8	3.0	0.3	3.9	0.4	3.0	0.5	1.2	3.6	0.5	0.3	4.6	2.1	2.3	0.7	3.0	0.7	0.1	7.7	3.1	3.0	0.4	1.4	13.6	9.9	14.5	14.2	10.0	9.0	5.9	10.6	7.3	6.4	6.0	6.5	0.5	6.7	26.4	15.8	7.8	10.2	8.1	11.4	7.0	13.7	3.9	1.7	5.0	4.1	9.8	13.2	0.0	5.6	2.1	13.5	6.7	0.0	8.6	4.7	11.1	8.6	12.9	9.4	0.8	9.2	7.6	10.1	8.2	13.8	3.7	6.3	8.6	10.6	5.0	8.5	32.3	14.4	13.8	12.8	26.1	4.5	5.1	8.5	7.1
ACVR2B	ActR-IIB	ENSG00000114739	"Activin A receptor type 2B"	Q13705	3	38453851-38493142	"Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins"		"Kinase, Receptor, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes, Disease mutation, Heterotaxy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Rod photoreceptor cells: 25.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"AF22: 16.4;NTERA-2: 20.3;SuSa: 12.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA007398, CAB025115, HPA040384"	Approved		Uncertain	"Nucleoplasm,Nuclear bodies,Cytosol"		No	No			Cytosol	"Nucleoplasm, Nuclear bodies"	"CAB025115: , HPA007398: AB_2667822, HPA040384: AB_2732484"	"unprognostic (5.11e-2)"	"unprognostic (1.54e-1)"	"unprognostic (3.47e-1)"	"unprognostic (8.73e-2)"	"unprognostic (9.24e-2)"	"unprognostic (2.21e-1)"	"unprognostic (1.32e-2)"	"unprognostic (1.25e-2)"	"unprognostic (1.88e-1)"	"unprognostic (1.53e-2)"	"unprognostic (5.14e-2)"	"unprognostic (1.30e-1)"	"unprognostic (4.08e-3)"	"unprognostic (1.64e-1)"	"unprognostic (1.98e-1)"	"unprognostic (1.83e-1)"	"unprognostic (4.75e-1)"	2.8	7.4	5.5	4.6	7.9	1.1	5.5	13.2	7.5	5.2	3.4	7.2	4.5	2.8	4.7	5.1	2.5	5.6	3.3	3.9	5.9	5.4	5.3	5.4	6.9	2.2	5.9	5.4	8.3	6.1	11.3	5.1	16.0	6.5	3.9	3.6	5.0	4.6	4.2	15.9	2.4	2.8	4.6	4.7	3.1	4.0	9.1	9.1	12.8	4.8	1.7	2.2	4.2	10.3	0.3	0.3	0.5	0.2	0.5	1.6	0.3	0.8	1.4	16.4	1.4	0.6	0.4	8.8	0.3	0.5	0.3	0.7	2.3	1.1	0.1	1.2	0.3	0.5	1.0	6.3	1.0	0.9	2.4	4.1	4.2	2.5	3.5	0.8	2.9	1.6	0.7	0.9	0.5	1.8	1.0	1.1	6.2	6.9	1.4	0.3	1.3	5.1	1.9	20.3	0.8	0.7	1.7	5.5	1.0	1.0	1.9	3.8	6.7	0.4	2.5	2.2	12.2	1.3	3.9	0.9	0.5	2.7	0.4	1.4	3.9	5.4	0.9	0.6	2.5	1.1	0.5	0.1	0.1	0.4	0.2	0.6	0.2	1.0	0.5	0.0	0.3	1.6	1.5	0.3	0.5	0.2	0.3	0.7	0.3	5.5	7.9	13.2	7.0	5.9	5.4	5.9	5.4	6.5	9.1	6.0	6.7	0.5	3.6	3.5	20.7	11.6	5.1	6.7	4.5	0.0	21.6	6.7	0.0	3.2	9.1	6.1	2.9	0.0	3.3	5.8	3.1	3.2	1.1	7.5	2.2	20.6	6.9	4.9	2.1	12.6	10.9	3.2	6.8	0.0	3.2	9.6	3.8	2.5	7.4	2.8	25.5	0.0	5.6	8.1	19.0	3.4	5.1	2.5	4.7	3.3
ACVRL1	"ACVRLK1, ALK1, HHT, HHT2, ORW2"	ENSG00000139567	"Activin A receptor like type 1"	P37023	12	51906908-51923361	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	Angiogenesis	"Kinase, Receptor, Serine/threonine-protein kinase, Transferase"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lung: 55.0"	"Cell type enhanced"	"Detected in many"	8	"Endothelial cells: 53.3;Enterocytes: 82.1;Ito cells: 40.5;Paneth cells: 50.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	12	"classical monocyte: 3.6;myeloid DC: 5.0"	"Group enriched"	"Detected in many"	12	"dendritic cells: 5.0;monocytes: 3.6"	"Cell line enhanced"	"Detected in some"		"ASC diff: 18.5;ASC TERT1: 12.6;EFO-21: 16.4;HUVEC TERT2: 59.9;TIME: 46.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA007041	Approved				"Intracellular and membrane"	NA	NA					"HPA007041: AB_1078097"	"unprognostic (2.50e-1)"	"unprognostic (4.83e-1)"	"unprognostic (3.79e-2)"	"unprognostic (3.61e-2)"	"unprognostic (4.98e-1)"	"unprognostic (4.06e-3)"	"unprognostic (2.79e-1)"	"unprognostic (1.35e-1)"	"unprognostic (5.80e-2)"	"unprognostic (5.10e-2)"	"unprognostic (4.60e-2)"	"unprognostic (4.64e-2)"	"unprognostic (1.12e-3)"	"unprognostic (1.39e-1)"	"unprognostic (7.98e-3)"	"unprognostic (2.79e-1)"	"unprognostic (1.10e-1)"	25.5	5.1	3.2	9.3	4.3	0.2	15.6	1.6	3.6	15.1	20.1	3.7	13.1	4.9	12.7	11.0	12.1	13.9	11.0	15.4	3.7	3.2	13.6	3.4	55.0	19.1	4.9	3.6	5.9	6.1	21.6	2.7	44.1	5.3	12.3	14.7	12.3	6.9	10.6	14.2	8.0	11.1	8.2	3.7	14.8	8.1	3.5	3.6	1.7	12.9	6.8	5.4	9.3	11.2	0.1	5.0	0.3	3.6	0.0	0.1	0.7	0.0	0.2	0.1	0.0	18.5	12.6	0.0	0.8	1.6	0.0	0.0	0.1	0.1	0.0	16.4	6.9	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.4	0.0	0.0	2.7	0.0	0.4	5.2	0.0	0.1	0.0	0.0	59.9	0.0	0.0	0.0	0.4	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	1.1	46.3	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.1	3.6	0.1	0.0	0.1	0.0	0.0	0.0	0.0	5.0	0.1	0.0	0.1	0.3	0.0	0.0	0.1	0.0	0.7	3.2	4.3	1.6	3.6	3.7	3.2	4.9	3.6	5.3	3.6	3.0	12.2	0.0	0.2	4.6	0.0	3.9	0.0	4.0	2.3	0.0	0.0	0.5	0.0	2.5	0.0	53.3	82.1	0.0	1.2	36.2	20.2	0.5	0.0	0.0	10.2	0.0	5.2	40.5	25.4	0.7	10.9	5.6	5.0	15.4	26.0	2.3	0.0	50.9	3.2	0.0	0.2	38.8	15.3	0.1	0.7	4.6	2.2	0.0	26.4	0.4
ACY1		ENSG00000243989	"Aminoacylase 1"	Q03154	3	51983278-51989202	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		Hydrolase	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	6	"intestine: 53.3;kidney: 91.6;liver: 77.8"	"Cell type enhanced"	"Detected in many"	12	"Enterocytes: 70.2;Erythroid cells: 23.3;Proximal tubular cells: 35.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"											"CAB003695, HPA036174, HPA036175"	Enhanced					NA	NA		28000000			"CAB003695: AB_425286, HPA036174: AB_2674988, HPA036175: AB_2674989"	"unprognostic (4.28e-2)"	"unprognostic (1.89e-1)"	"unprognostic (2.10e-1)"	"unprognostic (2.48e-3)"	"unprognostic (3.15e-1)"	"unprognostic (6.51e-2)"	"unprognostic (2.82e-2)"	"unprognostic (1.47e-1)"	"unprognostic (1.05e-2)"	"unprognostic (6.08e-2)"	"unprognostic (2.36e-2)"	"unprognostic (2.70e-2)"	"prognostic favorable (2.93e-4)"	"unprognostic (3.57e-1)"	"unprognostic (3.75e-1)"	"unprognostic (7.88e-2)"	"prognostic favorable (6.77e-4)"	4.4	8.5	2.5	3.9	3.0	1.5	4.4	1.5	3.3	3.2	24.9	4.1	9.8	34.5	1.9	7.9	3.8	3.0	8.4	4.1	2.3	1.8	91.6	77.8	3.5	6.3	2.8	2.9	2.1	9.0	6.2	1.9	4.3	2.9	3.7	6.2	6.6	9.4	9.2	7.6	2.6	53.3	2.1	3.5	3.4	4.9	1.5	1.7	0.6	5.9	6.7	4.1	3.3	2.5	5.0	12.1	3.8	10.0	12.1	6.4	4.5	3.9	8.0	3.9	10.8	9.0	12.1	12.8	4.2	7.9	9.3	5.1	12.4	20.8	2.5	3.5	7.3	3.4	4.9	4.0	25.6	3.7	6.9	5.1	8.9	4.6	38.3	16.6	6.0	5.8	14.0	21.2	8.2	22.1	7.6	3.5	4.4	13.4	7.9	9.1	11.1	0.0	11.0	5.7	25.3	13.6	3.1	3.3	22.5	24.3	15.0	5.5	5.0	5.3	17.5	9.2	1.6	14.1	7.9	1.7	6.7	6.4	8.3	4.9	20.9	4.9	3.8	7.8	12.5	8.0	3.8	10.0	0.2	6.4	9.0	3.6	5.0	2.0	2.8	12.1	4.0	3.3	4.0	0.0	12.1	3.4	1.9	2.7	4.5	2.5	3.0	1.5	3.3	2.3	1.8	2.8	2.9	2.9	1.7	3.0	2.7	0.8	0.8	0.6	0.0	0.1	2.5	2.7	3.4	5.2	0.0	3.3	8.3	12.2	0.2	0.5	70.2	23.3	7.4	3.7	0.8	0.5	6.9	10.9	1.7	0.0	2.4	1.8	2.1	0.4	0.6	2.4	0.0	16.2	9.3	0.8	12.6	21.0	0.0	35.6	0.9	0.0	0.5	0.0	0.2	0.4	3.4	1.5	12.1	0.3
ACY3	"ACY-3, HCBP1, MGC9740"	ENSG00000132744	"Aminoacylase 3"	Q96HD9	11	67642555-67650659	"Enzymes, Predicted intracellular proteins"	"Host-virus interaction"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"intestine: 72.2;kidney: 28.9"	"Cell type enriched"	"Detected in many"	6	"Proximal tubular cells: 163.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"non-classical monocyte: 21.1"	"Group enriched"	"Detected in many"	6	"dendritic cells: 5.9;monocytes: 21.1"	"Cell line enhanced"	"Detected in some"		"CACO-2: 6.1;CAPAN-2: 9.5;Daudi: 34.5;OE19: 9.6;RPMI-8226: 6.0"	"Low region specificity"	"Detected in all"							"HPA039219, HPA048187"	Enhanced					NA	NA					"HPA039219: AB_10671872, HPA048187: AB_2680306"	"unprognostic (8.37e-3)"	"unprognostic (1.29e-1)"	"unprognostic (1.04e-1)"	"prognostic favorable (4.80e-4)"	"unprognostic (1.07e-1)"	"unprognostic (1.99e-2)"	"unprognostic (1.38e-2)"	"unprognostic (1.43e-1)"	"unprognostic (7.37e-4)"	"unprognostic (2.44e-3)"	"unprognostic (1.15e-1)"	"unprognostic (3.21e-1)"	"unprognostic (2.63e-3)"	"unprognostic (1.07e-1)"	"unprognostic (8.24e-2)"	"unprognostic (2.68e-2)"	"unprognostic (1.48e-3)"	0.1	0.1	3.4	1.8	5.5	0.6	0.5	0.8	7.8	5.5	13.0	15.3	0.2	38.2	0.3	2.1	0.7	0.4	6.1	0.1	3.1	2.9	28.9	18.3	0.2	3.1	4.6	5.1	0.1	11.2	0.0	0.3	0.1	7.1	0.4	2.2	0.3	1.2	0.2	0.1	0.1	72.2	0.1	5.2	0.9	5.9	0.1	2.8	0.7	0.2	0.0	4.2	0.2	0.2	1.1	5.9	0.0	21.1	2.3	0.9	1.2	0.1	0.8	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	6.1	9.5	34.5	0.4	0.0	0.9	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	3.3	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.3	0.0	0.0	1.2	1.5	0.0	9.6	0.0	1.1	0.0	6.0	0.0	0.0	0.0	0.1	0.2	0.8	0.0	0.0	0.0	1.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	3.8	0.3	0.0	0.5	0.0	0.1	4.9	0.5	1.0	0.2	0.1	2.6	1.1	0.9	0.6	0.0	2.3	21.1	5.9	0.0	1.2	3.4	5.5	0.8	7.8	3.1	2.9	4.6	5.1	7.1	2.8	0.0	1.7	6.3	0.1	0.0	0.0	0.4	10.2	0.0	1.2	21.0	0.0	0.2	26.6	3.5	0.0	0.0	11.8	0.0	9.0	0.2	0.0	0.6	0.0	17.9	1.7	0.0	1.2	0.0	0.3	0.0	0.0	0.9	5.0	0.0	25.1	0.0	6.8	5.9	0.0	163.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.9	6.6	0.8
ACYP1		ENSG00000119640	"Acylphosphatase 1"	P07311	14	75053221-75069483	"Enzymes, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA034944	Approved		Approved	Nucleoplasm,Cytosol		NA	NA		92000	Cytosol	Nucleoplasm	"HPA034944: AB_10669898"	"prognostic favorable (1.17e-4)"	"unprognostic (3.83e-3)"	"unprognostic (1.92e-1)"	"unprognostic (5.90e-2)"	"unprognostic (1.26e-1)"	"unprognostic (1.85e-1)"	"prognostic unfavorable (6.14e-7)"	"unprognostic (5.48e-2)"	"unprognostic (4.40e-1)"	"unprognostic (1.64e-2)"	"unprognostic (1.37e-3)"	"unprognostic (3.56e-2)"	"unprognostic (4.74e-2)"	"unprognostic (6.69e-3)"	"unprognostic (9.39e-2)"	"unprognostic (1.07e-1)"	"unprognostic (5.32e-3)"	8.7	27.4	23.0	13.9	20.4	12.7	16.2	24.0	25.2	10.6	14.9	14.8	14.3	11.3	10.2	26.9	11.6	21.4	7.1	10.8	19.9	30.2	12.2	5.2	10.9	17.6	28.7	19.3	9.1	7.0	8.9	38.2	10.4	24.4	10.0	19.8	9.4	9.7	12.9	22.3	24.4	11.3	11.4	27.5	10.9	14.0	16.7	22.9	8.3	20.2	10.3	19.0	7.5	12.0	10.6	7.6	12.3	6.6	10.0	17.8	5.1	24.8	13.7	19.8	12.1	8.0	9.4	11.0	14.3	5.6	14.6	20.8	13.8	28.1	27.5	8.8	5.9	8.7	22.4	13.0	6.3	23.9	39.9	16.0	17.8	36.1	9.7	4.8	11.2	18.7	5.2	9.1	20.1	10.4	9.4	19.1	26.1	14.0	33.2	19.1	17.0	25.1	20.9	6.0	21.8	13.8	20.2	26.1	12.8	20.5	13.2	36.3	14.7	9.8	6.7	22.2	9.8	14.8	11.1	9.0	10.0	18.5	20.1	15.3	7.9	16.0	28.8	15.3	13.2	10.7	3.9	2.2	12.3	8.6	4.3	9.7	10.0	14.5	9.9	3.8	10.6	12.2	11.3	0.9	10.0	6.6	7.6	17.8	5.1	23.0	20.4	24.0	25.2	19.9	30.2	28.7	19.3	24.4	22.9	6.0	7.8	18.2	36.9	25.4	31.8	17.9	35.7	80.3	19.4	62.8	11.8	19.4	33.2	16.7	18.7	25.1	15.8	70.0	16.2	27.5	20.2	16.2	11.5	4.3	19.1	41.3	28.9	6.7	3.8	7.0	15.5	11.7	37.1	10.0	22.3	16.1	18.0	20.1	15.6	17.3	29.9	25.8	25.8	90.7	15.8	21.0	11.4	22.3	32.3	31.1
ACYP2		ENSG00000170634	"Acylphosphatase 2"	P14621	2	53970838-54305300	"Enzymes, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 116.4"	"Cell type enhanced"	"Detected in all"	6	"Cardiomyocytes: 159.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			HPA035301	Uncertain		Approved	Nucleoplasm	"Intracellular and membrane"	NA	NA			Nucleoplasm		"HPA035301: AB_10670291"	"unprognostic (1.19e-1)"	"unprognostic (2.84e-2)"	"unprognostic (3.40e-1)"	"unprognostic (2.16e-1)"	"unprognostic (6.90e-3)"	"unprognostic (6.21e-2)"	"unprognostic (2.03e-3)"	"unprognostic (3.17e-1)"	"unprognostic (5.22e-2)"	"unprognostic (7.83e-3)"	"unprognostic (3.64e-3)"	"unprognostic (1.16e-1)"	"unprognostic (6.66e-2)"	"unprognostic (2.13e-1)"	"unprognostic (1.97e-1)"	"unprognostic (3.24e-1)"	"unprognostic (2.24e-2)"	12.9	24.0	31.0	4.6	33.9	5.6	10.1	15.5	29.3	6.7	6.2	19.4	4.4	6.2	6.7	10.5	6.6	7.1	7.3	39.6	29.1	28.4	8.8	18.7	7.2	7.5	35.7	18.2	5.7	10.3	9.1	9.7	5.9	28.1	10.4	4.8	6.3	11.5	8.4	116.4	6.6	5.6	6.9	35.7	7.8	7.5	6.5	22.7	3.5	8.2	22.9	6.4	8.2	4.1	20.9	23.7	24.1	10.2	12.6	15.9	8.9	7.7	4.3	4.6	3.8	16.8	13.3	4.2	9.3	7.0	5.8	5.1	1.0	5.6	15.1	24.7	9.2	5.8	6.6	2.5	7.8	5.4	13.0	10.3	11.6	4.7	11.5	6.9	9.7	5.6	9.6	14.6	4.1	6.9	11.8	2.6	7.8	4.8	8.1	12.2	4.9	6.0	12.0	5.2	6.1	5.4	4.8	4.4	8.5	13.6	7.1	13.3	8.8	11.3	7.1	4.2	1.8	2.6	8.9	9.3	8.2	7.9	3.6	8.6	17.1	9.4	8.4	11.9	16.6	9.0	24.1	10.2	19.8	13.4	9.0	11.9	20.9	13.4	12.7	14.7	19.7	15.9	13.4	8.5	12.6	8.8	23.7	11.6	8.9	31.0	33.9	15.5	29.3	29.1	28.4	35.7	18.2	28.1	22.7	14.9	13.2	27.4	34.8	18.2	14.8	159.9	25.5	25.4	21.6	17.4	9.8	12.0	53.0	19.2	60.2	23.2	19.1	23.3	33.4	5.0	14.9	30.3	19.6	58.0	27.9	27.0	29.4	26.4	35.8	48.4	12.4	30.9	21.9	21.6	25.3	53.2	29.4	17.5	29.0	36.5	28.8	51.8	26.4	19.2	9.7	18.6	8.6	17.0	18.0	35.7
ADA		ENSG00000196839	"Adenosine deaminase"	P00813	20	44619522-44652233	"Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"	"Cell adhesion, Nucleotide metabolism"	Hydrolase	"Disease mutation, FDA approved drug targets, Hereditary hemolytic anemia, SCID"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"blood: 64.0;intestine: 142.2;lymphoid tissue: 99.0"	"Cell type enhanced"	"Detected in many"	10	"Extravillous trophoblasts: 90.2;Leydig cells: 39.1;monocytes: 49.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"non-classical monocyte: 64.0"	"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"JURKAT: 61.5;MOLT-4: 198.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA001399, CAB004307, HPA023884"	Enhanced		Supported	"Plasma membrane,Cytosol"		No	No		650000	"Plasma membrane"	Cytosol	"CAB004307: AB_626634, HPA001399: AB_1078099, HPA023884: AB_1844573"	"unprognostic (4.30e-2)"	"unprognostic (6.89e-2)"	"unprognostic (3.96e-2)"	"prognostic unfavorable (1.23e-7)"	"unprognostic (9.33e-2)"	"unprognostic (9.07e-3)"	"prognostic unfavorable (6.77e-5)"	"prognostic unfavorable (2.20e-4)"	"unprognostic (1.59e-1)"	"unprognostic (2.16e-1)"	"unprognostic (3.66e-2)"	"unprognostic (3.48e-1)"	"prognostic unfavorable (2.94e-14)"	"unprognostic (2.29e-1)"	"unprognostic (1.04e-2)"	"unprognostic (1.53e-1)"	"unprognostic (1.82e-1)"	8.1	3.2	2.5	5.4	6.5	5.3	5.1	0.9	5.0	2.8	7.4	5.0	1.8	142.2	1.7	3.4	4.6	2.4	3.0	9.2	2.7	0.8	1.3	2.1	2.8	8.9	3.6	2.3	1.2	2.4	0.8	0.3	1.8	3.9	1.8	1.5	0.7	2.6	1.3	2.0	2.8	5.0	2.1	1.3	9.5	19.7	1.6	6.1	99.0	2.8	2.1	7.6	3.6	2.6	1.3	41.6	0.5	64.0	16.9	10.3	9.6	1.4	4.0	2.0	1.4	3.9	5.5	3.3	1.4	0.8	1.4	1.0	1.8	1.5	4.0	1.7	1.9	2.7	0.2	1.4	5.9	0.8	0.3	1.8	0.8	0.7	1.4	1.6	0.6	2.2	26.2	2.5	0.5	0.9	1.3	5.4	61.5	2.0	3.3	0.6	3.4	198.0	2.9	0.5	1.8	1.4	10.7	2.8	9.9	0.2	0.0	0.0	0.9	2.1	0.4	2.5	2.7	0.4	1.9	1.7	1.0	2.0	2.2	0.2	4.3	2.7	8.3	0.3	3.3	0.9	0.0	1.8	0.2	8.7	30.7	5.7	1.3	7.3	10.3	6.8	1.0	5.7	8.1	0.5	16.9	64.0	41.6	5.3	9.6	2.5	6.5	0.9	5.0	2.7	0.8	3.6	2.3	3.9	6.1	0.0	3.4	12.7	3.0	11.4	0.0	1.9	0.0	2.7	0.0	1.8	0.0	2.3	0.0	3.7	0.1	16.2	0.5	0.0	17.9	90.2	16.7	0.9	0.0	2.9	27.6	0.0	0.0	6.7	13.4	1.5	39.1	14.4	8.5	49.5	1.4	2.9	8.2	0.0	2.5	2.1	0.0	12.9	16.1	0.4	1.3	12.2	3.1	30.5	3.3	2.4
ADA2	"ADGF, CECR1, IDGFL"	ENSG00000093072	"Adenosine deaminase 2"	Q9NZK5	22	17178790-17221989	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins"		"Heparin-binding, Hydrolase"	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 63.0"	"Group enriched"	"Detected in some"	5	"Alveolar cells type 2: 22.1;Ciliated cells: 28.1;Club cells: 20.5;Hofbauer cells: 58.5;Macrophages: 37.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"CAPAN-2: 13.2;EFO-21: 11.6;HUVEC TERT2: 12.5;Karpas-707: 22.3;MOLT-4: 20.7;U-266/70: 12.8;U-937: 21.0"					"Low region specificity"	"Detected in all"			HPA007888	Uncertain				"Secreted to blood"	NA	NA		50000000			"HPA007888: AB_1078495"	"unprognostic (1.03e-3)"	"unprognostic (2.00e-3)"	"unprognostic (6.59e-2)"	"unprognostic (2.50e-1)"	"unprognostic (1.48e-2)"	"unprognostic (7.01e-3)"	"unprognostic (4.48e-2)"	"unprognostic (3.09e-3)"	"unprognostic (3.80e-2)"	"prognostic favorable (9.26e-4)"	"prognostic favorable (8.91e-4)"	"unprognostic (1.41e-1)"	"unprognostic (1.49e-1)"	"unprognostic (4.86e-3)"	"unprognostic (1.96e-2)"	"unprognostic (4.83e-2)"	"unprognostic (2.51e-1)"	24.7	6.6	6.9	15.3	7.5	8.7	6.3	9.7	9.2	7.8	9.8	17.3	3.9	7.0	9.6	7.0	6.9	18.2	12.4	15.9	6.4	8.8	15.2	8.5	28.6	24.3	9.2	5.8	8.9	6.7	0.6	13.7	8.4	14.5	7.4	12.3	15.3	6.9	6.3	2.5	2.5	12.6	7.9	18.2	45.0	7.2	9.7	5.3	63.0	7.5	2.9	22.6	18.0	4.1	6.1	29.8	2.6	46.4	9.5	7.9	28.3	0.0	0.0	3.4	0.0	0.0	0.6	0.1	1.2	0.2	0.0	0.0	0.0	13.2	3.0	11.6	3.6	0.0	0.3	0.2	0.1	0.0	0.0	0.0	0.1	0.0	0.0	2.2	0.2	0.1	6.3	0.0	0.1	0.0	0.0	12.5	4.4	0.1	22.3	0.5	0.0	20.7	1.5	10.3	0.0	0.0	0.4	0.0	3.2	0.0	3.9	5.9	0.1	0.0	0.1	0.0	10.6	0.0	5.9	1.4	0.0	0.1	0.1	0.0	12.8	1.1	0.7	0.1	21.0	0.1	2.6	44.1	2.4	7.9	46.4	6.3	6.1	6.4	7.9	29.8	5.0	7.6	7.8	2.1	9.5	35.2	14.7	3.6	28.3	6.9	7.5	9.7	9.2	6.4	8.8	9.2	5.8	14.5	5.3	0.0	22.1	0.0	0.0	0.0	0.0	0.0	0.0	28.1	20.5	5.2	0.0	0.4	6.6	2.3	0.0	0.0	0.0	0.0	4.6	0.6	0.0	0.0	4.7	0.0	58.5	0.0	0.0	0.0	0.0	0.0	0.0	37.4	0.0	1.8	0.0	0.0	1.3	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0
ADAM10	"CD156c, HsT18717, kuz, MADM"	ENSG00000137845	"ADAM metallopeptidase domain 10"	O14672	15	58588807-58749978	"Cancer-related genes, CD markers, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Notch signaling pathway"	"Hydrolase, Metalloprotease, Protease"	"Alzheimer disease, Amyloidosis, Cancer-related genes, Disease mutation, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"U-2197: 77.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB001709, HPA050670"	Approved		Supported	"Nucleoplasm,Vesicles,Plasma membrane"	"Intracellular and membrane"	NA	NA		8200000	"Plasma membrane"	"Nucleoplasm, Vesicles"	"CAB001709: , HPA050670: "	"unprognostic (1.43e-1)"	"unprognostic (1.38e-1)"	"unprognostic (2.77e-1)"	"unprognostic (5.04e-2)"	"unprognostic (3.09e-1)"	"unprognostic (2.70e-3)"	"unprognostic (7.48e-2)"	"prognostic unfavorable (8.46e-5)"	"unprognostic (3.99e-2)"	"unprognostic (1.19e-1)"	"prognostic unfavorable (1.90e-4)"	"unprognostic (6.69e-2)"	"unprognostic (2.57e-2)"	"unprognostic (2.57e-3)"	"unprognostic (9.14e-2)"	"unprognostic (2.09e-2)"	"unprognostic (1.60e-2)"	25.9	11.1	15.5	17.1	17.7	15.6	20.0	25.2	17.6	18.6	20.1	15.7	12.7	13.9	19.9	11.8	17.1	13.8	18.0	18.8	17.6	13.7	20.8	14.8	25.0	26.1	23.1	12.4	13.9	13.1	10.9	11.6	36.1	14.5	23.6	16.7	14.6	12.4	19.1	8.9	15.4	15.6	12.8	30.4	40.4	18.4	8.5	18.9	38.5	27.3	9.2	14.9	30.0	19.1	6.2	12.7	26.9	23.7	9.8	12.2	12.8	12.1	27.4	7.5	8.1	9.6	13.9	18.9	10.4	31.0	7.7	10.7	12.6	16.1	5.6	32.2	9.3	13.5	24.8	4.5	11.0	10.2	8.4	5.8	9.6	10.0	11.7	10.7	6.8	27.7	12.1	8.1	5.4	7.9	11.2	14.9	12.2	6.0	15.3	13.5	4.5	22.4	7.7	10.2	4.0	3.9	9.3	24.5	14.4	17.9	32.7	8.1	5.3	11.3	13.2	18.0	17.1	7.8	13.6	10.5	10.1	11.3	77.5	10.0	8.6	18.5	6.1	14.1	13.1	17.6	12.9	18.8	10.4	8.1	21.5	12.2	5.3	8.0	7.1	12.7	6.2	8.4	7.0	26.9	9.8	23.7	5.8	10.3	12.8	15.5	17.7	25.2	16.9	17.6	13.7	23.1	12.4	14.5	18.9	77.4	49.8	30.6	25.8	23.7	20.2	29.7	30.6	30.8	35.2	76.8	25.5	27.4	1.7	45.7	21.6	61.6	39.3	0.0	27.7	46.7	28.8	75.5	27.9	30.4	56.9	42.9	34.7	76.1	87.0	16.2	16.7	64.0	43.9	13.6	45.8	27.0	37.3	43.2	15.9	20.3	32.7	12.9	28.3	13.6	16.2	19.4	22.2	43.6	33.7	59.6
ADAM17	"CD156B, cSVP, TACE"	ENSG00000151694	"ADAM metallopeptidase domain 17"	P78536	2	9488486-9555792	"CD markers, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Notch signaling pathway"	"Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA010738, HPA051575"	Approved		Supported	Cytosol	"Intracellular and membrane"	NA	NA		27000	Cytosol		"HPA010738: AB_1078100, HPA051575: AB_2681539"	"unprognostic (2.28e-1)"	"unprognostic (1.29e-3)"	"unprognostic (1.28e-1)"	"unprognostic (3.51e-3)"	"unprognostic (1.57e-1)"	"unprognostic (5.15e-2)"	"unprognostic (2.12e-3)"	"unprognostic (1.55e-1)"	"unprognostic (4.09e-2)"	"unprognostic (3.69e-1)"	"unprognostic (3.53e-3)"	"unprognostic (3.13e-1)"	"unprognostic (3.82e-3)"	"unprognostic (8.63e-2)"	"unprognostic (2.61e-1)"	"unprognostic (4.48e-2)"	"prognostic unfavorable (4.23e-5)"	18.6	11.0	13.6	15.4	13.8	21.9	14.7	20.4	15.5	14.0	11.7	13.8	8.3	8.7	14.2	15.8	18.7	10.7	17.4	13.4	11.2	12.4	12.4	7.8	24.7	15.0	11.6	11.7	18.1	9.6	10.9	11.9	29.0	11.2	8.2	9.4	10.6	12.5	9.8	12.3	16.7	11.1	13.9	14.3	21.4	8.9	17.4	12.3	14.7	12.5	13.9	20.3	12.3	14.4	7.0	7.7	16.0	10.2	6.0	7.9	6.0	7.7	12.7	13.4	13.9	26.4	19.7	24.1	8.1	13.8	9.3	13.9	11.2	18.6	22.0	11.7	10.1	27.3	14.1	9.8	17.2	12.8	8.8	9.8	11.2	9.6	9.9	37.3	11.0	12.6	22.0	17.3	14.9	29.0	20.8	23.4	8.4	15.3	8.5	10.0	7.3	8.2	11.0	11.0	10.8	5.1	9.6	13.1	10.4	12.4	12.8	7.9	19.7	9.0	11.0	19.2	15.1	5.7	14.2	18.7	16.6	8.7	11.6	15.4	11.1	9.9	19.2	13.8	7.1	19.7	16.0	9.8	7.6	6.1	10.2	7.9	7.0	5.0	5.1	7.7	5.1	4.5	4.6	11.8	6.0	9.5	4.3	5.7	6.0	13.6	13.8	20.4	13.1	11.2	12.4	11.6	11.7	11.2	12.3	44.7	76.6	33.0	41.9	115.4	24.9	2.8	12.7	25.4	40.9	29.6	51.1	25.3	5.0	20.9	64.8	44.9	15.5	23.3	16.8	39.0	58.0	41.4	29.0	11.0	32.9	9.5	18.9	42.4	70.5	10.4	17.5	74.4	38.8	26.2	13.4	12.3	18.2	17.3	15.2	7.5	38.2	38.8	26.7	25.4	37.8	135.3	46.8	26.2	12.5	92.9
ADAMTS13	"C9orf8, DKFZp434C2322, FLJ42993, MGC118899, MGC118900, TTP, vWF-CP, VWFCP"	ENSG00000160323	"ADAM metallopeptidase with thrombospondin type 1 motif 13"	Q76LX8	9	133414358-133459402	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins"	"Blood coagulation, Hemostasis"	"Hydrolase, Metalloprotease, Protease"	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	8	"liver: 53.7"	"Cell type enhanced"	"Detected in many"	12	"Cholangiocytes: 7.6;Early spermatids: 20.6;Ito cells: 8.0;Late spermatids: 10.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	4	"basophil: 2.3"	"Lineage enriched"	"Detected in single"	4	"granulocytes: 2.3"	"Cell line enhanced"	"Detected in many"		"SuSa: 7.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"HPA042014, HPA042844, HPA052077"	Approved		Approved	Vesicles	"Secreted to blood"	NA	NA	1300000000	38000000	Vesicles		"HPA042014: AB_2677798, HPA042844: AB_2678200, HPA052077: "	"unprognostic (1.09e-1)"	"unprognostic (1.45e-1)"	"unprognostic (8.75e-4)"	"unprognostic (1.49e-2)"	"unprognostic (1.83e-1)"	"unprognostic (3.02e-1)"	"unprognostic (4.76e-2)"	"unprognostic (2.54e-1)"	"unprognostic (2.33e-2)"	"unprognostic (1.88e-1)"	"unprognostic (4.52e-5)"	"unprognostic (1.11e-1)"	"unprognostic (9.91e-2)"	"unprognostic (4.78e-2)"	"unprognostic (3.57e-1)"	"unprognostic (1.82e-2)"	"unprognostic (2.30e-3)"	1.4	1.0	3.1	1.4	3.7	0.5	1.4	6.6	4.2	1.4	1.4	1.4	1.4	4.1	1.6	4.0	1.4	2.1	1.5	1.7	3.4	2.2	1.8	53.7	4.8	1.4	2.1	1.4	2.3	1.8	2.2	4.2	1.7	1.6	1.6	1.1	1.6	2.5	2.0	2.6	2.9	4.4	1.4	2.0	1.4	5.5	3.8	1.4	1.4	1.7	1.4	1.4	1.7	1.4	0.3	0.0	2.3	0.0	0.0	0.5	0.1	0.0	1.3	3.3	4.6	2.7	2.4	1.2	1.1	0.9	0.4	0.6	0.5	3.6	0.4	1.5	0.8	1.1	0.6	0.3	0.6	0.1	1.9	3.0	0.4	1.3	0.7	1.9	0.1	1.1	6.4	1.6	0.5	1.2	2.2	0.3	2.3	0.1	1.4	0.5	5.5	0.1	1.5	3.5	1.9	2.0	0.4	0.4	1.6	1.5	1.4	2.1	6.8	2.3	1.3	1.8	7.1	5.8	0.6	0.8	2.4	1.4	1.6	0.0	2.5	0.6	0.5	2.0	0.4	2.8	2.3	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.5	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	3.1	3.7	6.6	4.2	3.4	2.2	2.1	1.4	1.6	1.4	0.0	1.3	0.0	0.1	0.2	1.4	3.6	7.6	0.0	3.4	0.0	0.0	0.1	1.7	0.6	20.6	0.3	1.0	0.0	0.3	0.2	0.8	0.4	0.0	1.5	0.2	3.2	1.2	8.0	0.0	10.2	0.9	0.0	0.0	0.0	1.3	1.9	0.3	1.4	1.4	0.7	1.7	0.0	0.4	4.7	3.8	0.4	0.1	0.0	0.6	0.3
ADAMTS2	"ADAM-TS2, ADAMTS-3, hPCPNI, NPI, PCINP"	ENSG00000087116	"ADAM metallopeptidase with thrombospondin type 1 motif 2"	O95450	5	179110851-179345430	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins"	"Collagen degradation"	"Hydrolase, Metalloprotease, Protease"	"Ehlers-Danlos syndrome"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	16	"Ito cells: 28.8;Kupffer cells: 58.6;Sertoli cells: 25.8;Smooth muscle cells: 16.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"ASC diff: 14.0;ASC TERT1: 14.0;BJ: 12.3;fHDF/TERT166: 14.5;HHSteC: 45.5;HSkMC: 36.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"HPA028363, HPA028444"	Uncertain		Approved	"Vesicles,Plasma membrane"	"Secreted to extracellular matrix"	NA	NA			"Plasma membrane"	Vesicles	"HPA028363: , HPA028444: AB_10601964"	"unprognostic (6.78e-2)"	"unprognostic (7.83e-2)"	"unprognostic (1.13e-1)"	"unprognostic (5.50e-2)"	"unprognostic (8.85e-3)"	"unprognostic (4.80e-2)"	"unprognostic (1.09e-1)"	"unprognostic (2.22e-2)"	"unprognostic (1.58e-1)"	"unprognostic (1.91e-2)"	"unprognostic (2.08e-1)"	"unprognostic (2.45e-1)"	"prognostic unfavorable (1.71e-8)"	"unprognostic (1.32e-3)"	"unprognostic (1.03e-2)"	"unprognostic (7.16e-3)"	"unprognostic (1.48e-2)"	24.2	4.3	0.9	5.8	0.7	0.7	29.1	0.9	2.3	16.3	10.1	0.4	3.9	2.7	12.0	9.5	6.0	7.2	9.5	10.1	0.7	1.2	4.2	7.4	13.1	25.9	1.0	1.3	6.3	2.7	1.0	8.7	15.1	2.4	6.0	2.6	3.8	2.5	3.8	3.8	4.6	4.6	13.8	0.7	16.5	4.2	4.3	0.5	0.8	3.2	5.9	1.2	8.8	14.7	1.4	1.3	2.1	0.3	0.8	0.6	0.1	0.0	0.0	0.0	0.3	14.0	14.0	0.0	12.3	2.1	4.7	5.0	0.0	0.0	0.0	0.1	14.5	0.3	0.0	0.7	0.0	2.0	0.0	0.7	0.0	0.0	0.9	45.5	0.0	0.0	36.3	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	3.3	0.0	0.0	0.4	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	2.9	0.5	0.0	0.0	0.1	0.8	0.0	4.0	0.0	7.9	1.2	10.3	0.0	0.1	0.0	0.0	0.3	0.1	0.0	1.5	0.3	0.4	0.6	0.2	0.3	0.6	0.5	0.4	1.3	1.4	0.5	0.5	2.1	0.8	0.1	0.8	0.5	0.1	0.9	0.7	0.9	2.3	0.7	1.2	1.0	1.3	2.4	0.5	0.0	0.6	0.0	0.3	1.9	0.0	1.2	2.5	0.0	0.0	0.0	0.0	0.2	0.0	0.0	1.0	1.4	0.0	0.0	0.0	0.1	13.5	0.2	1.1	0.5	3.9	0.0	0.0	28.8	58.6	2.1	4.6	2.9	0.0	0.0	0.0	0.0	0.8	0.0	12.0	0.0	0.0	25.8	16.1	0.5	2.6	2.4	0.0	0.0	0.0	0.1
ADAMTS4	"ADAMTS-2, ADMP-1, KIAA0688"	ENSG00000158859	"ADAM metallopeptidase with thrombospondin type 1 motif 4"	O75173	1	161184308-161199056	"Cancer-related genes, Enzymes, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins, Transporters"		"Hydrolase, Metalloprotease, Protease"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 58.0"	"Cell type enriched"	"Detected in many"	7	"Smooth muscle cells: 356.4"	"Low cancer specificity"	"Detected in all"			"Group enriched"	"Detected in all"	5	"basal ganglia: 20.7;cerebral cortex: 10.0;midbrain: 28.6;pons and medulla: 20.5;thalamus: 15.7"	"Cell type enriched"	"Detected in some"	8	"plasmacytoid DC: 8.0"	"Lineage enriched"	"Detected in many"	8	"dendritic cells: 8.0"	"Cell line enhanced"	"Detected in some"		"hTEC/SVTERT24-B: 10.9;HUVEC TERT2: 13.2;SH-SY5Y: 7.4;TIME: 11.1;U-138 MG: 6.9;U-251 MG: 9.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"CAB025876, HPA051296, HPA068374"	Uncertain		Supported	"Nuclear speckles"	"Secreted to extracellular matrix"	NA	NA			"Nuclear speckles"		"CAB025876: , HPA051296: AB_2681426, HPA068374: AB_2685978"	"unprognostic (2.70e-2)"	"unprognostic (8.10e-3)"	"unprognostic (3.00e-3)"	"unprognostic (2.75e-1)"	"unprognostic (9.95e-3)"	"unprognostic (1.19e-1)"	"unprognostic (1.07e-1)"	"prognostic unfavorable (5.00e-4)"	"unprognostic (1.20e-2)"	"unprognostic (9.59e-3)"	"unprognostic (2.48e-2)"	"unprognostic (1.59e-1)"	"prognostic unfavorable (7.27e-7)"	"unprognostic (1.10e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.44e-3)"	"unprognostic (3.13e-2)"	58.0	9.7	2.6	18.1	20.7	1.8	14.6	1.5	10.7	7.8	6.3	33.4	0.0	1.9	5.8	2.0	7.7	14.2	16.4	19.5	3.4	2.3	3.1	11.0	15.7	2.7	28.6	3.5	35.7	10.6	4.7	4.9	4.4	20.5	5.8	3.4	0.0	1.7	1.7	7.7	1.7	3.0	12.0	15.5	1.9	8.1	1.7	15.7	0.0	7.5	1.2	1.4	8.7	4.0	0.5	8.0	1.0	0.2	0.4	0.6	0.2	0.0	0.0	0.2	0.1	6.1	3.9	0.6	4.9	0.2	0.4	2.8	0.2	0.1	0.2	4.1	1.5	0.0	0.1	0.0	0.0	1.7	0.1	0.3	0.1	0.4	1.2	0.6	0.0	0.1	4.3	0.0	10.9	0.1	0.0	13.2	0.1	0.1	0.3	0.3	0.1	0.0	0.2	4.9	0.0	0.0	0.1	4.8	0.1	0.0	0.1	0.1	7.4	0.0	0.1	0.1	0.3	0.2	0.5	11.1	6.9	0.1	0.3	9.8	0.2	0.1	0.1	2.1	0.1	0.1	0.7	0.2	0.2	0.6	0.1	0.3	0.3	0.3	0.3	0.1	0.5	0.4	0.4	1.0	0.4	0.1	8.0	0.3	0.2	2.6	20.7	1.5	10.0	3.4	2.3	28.6	3.5	20.5	15.7	0.0	5.5	0.0	2.3	27.7	2.2	2.8	0.0	0.0	1.2	0.0	0.0	0.2	0.0	0.3	0.0	43.0	0.0	0.0	0.0	0.2	33.3	8.7	0.0	0.8	0.8	3.2	0.0	48.5	1.5	0.0	0.3	6.0	33.7	1.8	0.0	0.3	0.0	0.0	1.1	0.0	1.0	51.8	356.4	2.3	0.6	16.7	0.3	1.5	0.0	4.4
ADAR	"ADAR1, G1P1, IFI4"	ENSG00000160710	"Adenosine deaminase, RNA specific"	P55265	1	154582062-154627999	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Antiviral defense, Immunity, Innate immunity, mRNA processing, RNA-mediated gene silencing"	"DNA-binding, Hydrolase, RNA-binding"	"Aicardi-Goutieres syndrome, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003890, HPA051519, CAB056157"	Enhanced		Enhanced	Nucleoplasm,Nucleoli		No	No			Nucleoli	Nucleoplasm	"CAB056157: AB_2665578, HPA003890: AB_1078103, HPA051519: AB_2681520"	"unprognostic (3.46e-1)"	"unprognostic (8.11e-2)"	"unprognostic (1.42e-1)"	"unprognostic (1.83e-2)"	"unprognostic (2.38e-1)"	"unprognostic (9.37e-2)"	"unprognostic (2.07e-2)"	"unprognostic (6.97e-2)"	"unprognostic (2.03e-1)"	"unprognostic (2.90e-1)"	"unprognostic (4.13e-2)"	"unprognostic (7.16e-2)"	"prognostic unfavorable (7.30e-5)"	"unprognostic (3.44e-1)"	"unprognostic (1.49e-1)"	"unprognostic (9.00e-2)"	"unprognostic (3.94e-2)"	36.1	33.1	30.3	36.6	44.4	43.1	29.7	41.4	50.8	30.7	28.2	33.3	19.9	31.4	38.0	26.5	27.7	32.9	28.9	24.0	25.7	38.1	31.5	36.0	34.7	41.3	27.3	32.6	39.2	29.5	46.2	38.4	33.9	39.8	28.8	31.1	32.2	36.7	30.2	14.0	27.0	40.6	36.3	24.4	47.7	29.1	21.9	26.9	57.6	32.8	16.7	41.9	29.7	27.6	7.8	6.1	25.1	8.6	6.4	9.7	5.6	26.6	30.9	26.5	32.6	26.8	27.8	31.5	18.4	36.9	61.6	53.5	26.6	26.2	48.0	29.7	29.3	34.2	25.9	33.8	34.9	31.4	46.6	16.9	25.0	21.9	15.0	29.2	35.3	27.8	27.0	25.5	31.5	32.3	25.2	31.5	34.7	23.6	37.0	21.5	32.5	42.6	18.2	43.7	35.7	23.3	40.8	21.8	38.6	21.1	29.7	26.4	31.5	31.7	51.3	37.6	41.3	34.5	43.5	28.7	22.1	21.8	18.2	21.2	43.8	48.0	51.6	21.5	23.3	24.9	6.9	6.6	12.0	9.4	8.3	8.8	7.8	9.4	9.7	6.1	6.2	8.8	8.6	25.1	6.4	8.6	5.5	7.1	5.6	30.3	44.4	41.4	50.8	25.7	38.1	27.3	32.6	39.8	26.9	77.4	46.4	72.2	33.2	29.7	90.3	15.5	33.1	41.5	43.3	45.4	90.3	33.7	8.3	43.8	3.6	83.1	68.1	23.3	58.0	42.0	39.5	47.9	61.1	78.8	46.9	158.9	60.6	78.0	80.2	9.5	68.1	57.4	18.6	68.5	54.5	46.8	58.0	53.7	55.5	36.0	81.7	51.8	36.9	11.7	23.2	35.3	26.3	58.3	48.2	41.3
ADARB1	"ADAR2, ADAR2a, ADAR2a-L1, ADAR2a-L2, ADAR2a-L3, ADAR2b, ADAR2c, ADAR2d, ADAR2g, DRABA2, DRADA2, hRED1, RED1"	ENSG00000197381	"Adenosine deaminase, RNA specific B1"	P78563	21	45073853-45226560	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Antiviral defense, Immunity, Innate immunity, mRNA processing"	"Hydrolase, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"smooth muscle: 59.9"	"Cell type enhanced"	"Detected in many"	9	"Bipolar cells: 52.9;Horizontal cells: 65.2;Muller glia cells: 34.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HeLa: 27.9;HHSteC: 32.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA029645			Supported	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA029645: AB_10602106"	"unprognostic (2.69e-1)"	"unprognostic (7.65e-2)"	"prognostic unfavorable (8.16e-5)"	"unprognostic (1.82e-2)"	"unprognostic (1.07e-2)"	"unprognostic (9.07e-2)"	"unprognostic (3.29e-2)"	"unprognostic (6.97e-2)"	"unprognostic (3.82e-2)"	"unprognostic (1.23e-2)"	"unprognostic (1.28e-1)"	"unprognostic (3.44e-1)"	"prognostic unfavorable (3.56e-4)"	"unprognostic (4.57e-2)"	"unprognostic (3.06e-1)"	"unprognostic (2.73e-2)"	"unprognostic (2.38e-2)"	12.2	5.3	7.1	10.4	8.4	4.5	8.9	33.1	11.6	11.7	17.2	2.5	5.6	2.9	13.4	6.6	14.0	8.8	11.1	6.7	7.3	8.1	4.6	4.0	19.9	11.8	7.4	8.1	5.3	4.7	19.0	3.7	12.0	13.6	14.7	5.0	11.0	4.6	8.7	11.8	10.8	5.9	59.9	3.5	10.5	11.7	3.8	4.0	3.9	3.8	4.5	8.4	34.6	20.3	6.1	2.1	4.8	0.6	0.5	2.6	0.5	3.1	0.4	2.5	2.9	3.1	2.1	3.4	2.1	3.5	6.9	4.4	5.0	0.5	1.0	5.8	10.5	3.8	0.3	3.7	8.9	7.6	0.7	3.3	6.9	27.9	3.3	32.3	4.7	3.4	11.6	3.9	2.4	7.2	2.6	7.2	9.6	1.6	0.4	20.0	2.3	3.1	4.5	4.0	1.6	4.8	0.9	2.4	3.2	1.5	1.0	14.7	3.9	17.1	0.7	5.4	4.3	1.6	3.8	7.6	2.3	2.8	9.2	8.0	3.1	1.4	0.8	2.0	11.1	12.1	1.3	0.2	4.8	1.1	0.6	1.8	2.4	2.6	1.6	0.0	6.1	1.8	1.4	0.2	0.5	0.3	2.1	1.6	0.5	7.1	8.4	33.1	11.6	7.3	8.1	7.4	8.1	13.6	4.0	0.0	0.6	3.2	2.5	9.8	52.9	17.1	0.0	0.0	2.3	0.0	11.8	0.4	0.0	1.3	2.0	13.5	0.4	0.0	0.4	0.9	11.0	4.9	8.1	5.9	6.1	65.2	0.0	14.7	3.4	1.9	3.4	2.9	5.0	7.2	0.7	34.4	1.0	0.0	5.3	2.2	15.5	0.0	18.6	4.1	11.5	6.4	0.8	6.9	1.2	2.0
ADAT1		ENSG00000065457	"Adenosine deaminase, tRNA specific 1"	Q9BUB4	16	75596981-75623300	"Enzymes, Predicted intracellular proteins"	"tRNA processing"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in all"	5	"Early spermatids: 80.3;Late spermatids: 160.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040713, HPA040903"	Approved		Supported	Nucleoplasm		NA	NA			Nucleoplasm		"HPA040713: AB_10795371, HPA040903: AB_10794071"	"unprognostic (7.71e-3)"	"unprognostic (5.35e-2)"	"unprognostic (7.62e-2)"	"unprognostic (9.00e-2)"	"unprognostic (9.99e-2)"	"unprognostic (4.69e-2)"	"unprognostic (4.54e-2)"	"unprognostic (6.65e-3)"	"unprognostic (3.38e-1)"	"unprognostic (1.14e-2)"	"unprognostic (9.75e-2)"	"unprognostic (2.97e-1)"	"unprognostic (4.60e-3)"	"unprognostic (7.21e-2)"	"unprognostic (4.92e-1)"	"unprognostic (5.58e-3)"	"unprognostic (8.27e-2)"	14.8	17.1	12.5	12.6	18.2	13.0	15.1	11.0	23.3	13.5	12.4	21.4	11.8	10.1	15.1	24.4	12.0	12.6	15.8	10.4	17.2	15.1	17.2	17.8	12.8	21.2	16.7	20.5	11.1	15.3	33.5	16.7	14.0	22.3	15.3	15.1	11.8	12.2	14.2	9.0	21.2	13.6	12.6	16.0	21.3	11.7	51.8	16.8	19.4	20.6	9.2	16.7	17.1	11.3	12.5	8.6	15.0	13.0	12.1	20.5	8.3	14.1	23.2	14.0	14.5	21.1	17.3	13.1	15.7	18.0	21.4	17.1	19.2	21.7	16.8	16.7	14.2	12.1	16.1	12.9	20.2	21.3	11.0	7.6	7.4	16.1	13.5	15.5	14.3	16.7	19.1	15.9	31.8	26.0	6.7	17.9	20.7	12.4	7.6	18.8	53.0	16.6	13.5	11.5	14.5	10.0	19.7	12.0	20.8	20.9	21.8	19.8	20.5	35.5	11.1	9.7	12.9	23.0	9.5	13.0	34.4	14.2	13.8	15.0	16.1	22.6	46.9	14.9	15.3	28.4	9.6	7.2	15.0	14.7	8.4	20.5	12.5	13.8	20.0	8.0	11.8	8.5	12.0	9.5	12.1	13.0	8.6	14.0	8.3	12.5	18.2	11.0	23.3	17.2	15.1	16.7	20.5	22.3	16.8	8.9	4.3	7.6	4.6	4.0	13.4	4.8	5.1	9.4	4.5	7.0	25.5	11.0	14.9	7.4	80.3	8.5	5.9	23.3	6.7	7.7	5.4	7.1	8.1	8.7	8.8	12.7	13.8	6.7	10.4	160.0	9.2	10.2	3.3	10.8	5.3	7.2	8.0	3.5	7.4	8.6	18.9	6.5	5.7	14.0	11.7	4.6	8.1	9.6	8.0	6.5
ADAT2	"DEADC1, dJ20N2.1, TAD2"	ENSG00000189007	"Adenosine deaminase, tRNA specific 2"	Q7Z6V5	6	143422832-143450673	"Enzymes, Predicted intracellular proteins"	"tRNA processing"	Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Erythroid cells: 23.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA035479	Approved		Approved	"Nucleoplasm,Golgi apparatus,Cytosol"		NA	NA			"Golgi apparatus"	"Nucleoplasm, Cytosol"	"HPA035479: AB_10611672"	"unprognostic (2.24e-1)"	"unprognostic (3.07e-3)"	"unprognostic (1.55e-1)"	"unprognostic (8.20e-2)"	"unprognostic (3.05e-2)"	"unprognostic (8.58e-2)"	"unprognostic (1.07e-3)"	"unprognostic (3.31e-2)"	"unprognostic (1.34e-1)"	"unprognostic (7.30e-2)"	"unprognostic (1.27e-1)"	"unprognostic (1.25e-2)"	"unprognostic (9.28e-5)"	"unprognostic (4.88e-2)"	"unprognostic (6.96e-2)"	"unprognostic (7.29e-2)"	"unprognostic (4.08e-2)"	7.3	9.5	6.6	15.1	9.4	17.1	8.6	7.7	8.8	6.6	9.5	4.9	4.7	9.9	8.3	5.3	12.0	7.9	7.6	4.2	5.2	3.8	7.5	13.2	11.3	17.6	4.9	8.0	7.5	13.3	7.1	9.6	4.0	7.3	8.6	13.3	6.0	10.1	6.2	13.3	17.1	10.0	6.5	6.7	13.1	10.8	4.1	5.3	8.6	10.8	10.1	13.5	6.6	8.7	2.8	3.2	0.4	1.4	1.9	6.6	2.3	2.9	2.5	3.1	10.6	2.6	8.5	4.7	4.2	1.9	2.9	4.1	6.7	7.5	10.5	4.6	2.8	3.3	8.6	5.8	5.9	5.7	5.5	13.0	14.8	10.5	13.5	3.3	20.8	7.4	2.9	8.7	5.7	9.1	2.5	6.2	9.7	16.1	9.1	4.4	4.2	8.0	11.7	4.0	4.0	4.8	9.8	9.2	8.5	4.5	3.3	6.9	4.7	3.5	9.5	2.8	1.7	4.0	7.6	4.8	4.3	3.6	8.8	8.0	9.4	6.6	7.9	4.0	17.5	4.9	0.0	0.9	0.0	3.2	1.4	4.7	2.8	3.0	2.9	3.2	2.0	3.4	5.1	0.4	1.9	0.2	3.0	6.6	2.3	6.6	9.4	7.7	8.8	5.2	3.8	4.9	8.0	7.3	5.3	6.0	11.7	0.8	3.4	6.0	3.6	2.7	0.0	2.7	4.5	1.8	0.0	2.0	3.3	3.4	1.0	4.7	1.8	23.3	3.4	2.1	4.4	2.9	7.0	4.0	4.1	1.6	4.1	4.3	5.1	1.1	6.4	2.8	5.0	0.0	5.6	2.0	4.8	0.0	3.2	0.7	3.1	0.0	4.9	1.8	5.4	8.2	0.7	6.9	7.8	3.8
ADCK1	FLJ39600	ENSG00000063761	"AarF domain containing kinase 1"	Q86TW2	14	77800083-77935012	"Enzymes, Predicted secreted proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Cone photoreceptor cells: 19.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA051012, HPA055014"	Uncertain		Uncertain	Nucleoplasm	"Secreted - unknown location"	NA	NA			Nucleoplasm		"HPA051012: AB_2681310, HPA055014: AB_2682672"	"unprognostic (6.36e-2)"	"unprognostic (7.09e-2)"	"unprognostic (6.00e-2)"	"unprognostic (1.76e-1)"	"unprognostic (2.24e-1)"	"unprognostic (1.46e-1)"	"prognostic unfavorable (1.70e-4)"	"prognostic favorable (4.11e-5)"	"unprognostic (2.33e-1)"	"unprognostic (1.64e-1)"	"unprognostic (4.57e-3)"	"unprognostic (1.38e-1)"	"prognostic favorable (5.82e-6)"	"unprognostic (6.30e-3)"	"unprognostic (2.06e-1)"	"unprognostic (9.57e-2)"	"unprognostic (4.06e-1)"	7.2	11.0	11.0	7.0	15.2	7.4	6.9	6.8	20.5	5.6	10.3	19.0	7.7	11.2	7.7	10.3	7.7	7.1	9.1	11.1	12.4	10.4	8.8	10.5	6.2	6.0	13.5	9.4	6.6	9.8	11.3	11.3	7.8	15.0	8.2	10.3	13.8	10.6	8.9	13.7	8.5	8.5	10.5	10.6	9.7	7.5	5.5	11.5	10.8	9.1	7.8	7.5	6.9	5.0	4.0	8.9	1.4	7.2	3.4	5.3	3.1	3.3	5.4	3.3	10.8	8.1	4.6	4.3	3.4	5.7	3.1	3.8	3.0	8.0	7.3	5.5	6.0	5.7	6.4	17.8	5.4	2.0	4.2	5.6	1.9	3.4	4.9	8.3	2.8	4.1	5.8	10.1	1.2	3.9	3.2	4.4	6.4	7.0	4.5	4.0	16.8	3.4	5.6	6.4	12.3	6.4	5.6	0.5	5.8	4.4	8.5	7.2	4.0	6.6	9.3	4.0	5.1	13.3	6.2	3.9	2.9	2.3	5.9	3.1	4.6	5.0	4.2	4.4	4.9	3.8	1.4	4.7	1.3	5.3	7.2	3.5	1.7	2.2	3.1	8.9	4.0	2.5	4.6	0.4	3.4	2.8	7.0	3.7	3.1	11.0	15.2	6.8	20.5	12.4	10.4	13.5	9.4	15.0	11.5	0.0	3.0	0.8	1.8	0.8	5.0	4.8	0.0	1.4	1.2	0.0	19.6	6.8	3.3	3.6	1.2	1.2	2.1	0.0	4.3	3.6	2.0	1.3	1.1	5.8	8.2	7.9	1.7	1.8	5.1	0.4	1.4	5.4	0.0	1.0	3.6	3.2	3.0	0.0	1.8	3.3	8.8	0.0	1.9	1.7	9.7	1.3	4.5	1.8	4.9	0.9
ADCK2	MGC20727	ENSG00000133597	"AarF domain containing kinase 2"	Q7Z695	7	140673153-140696261	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"							"Low region specificity"	"Detected in all"			HPA036036	Approved		Uncertain	Centrosome,Cytosol		NA	NA			"Centrosome, Cytosol"		"HPA036036: AB_10672078"	"unprognostic (2.76e-1)"	"unprognostic (1.79e-1)"	"unprognostic (5.72e-2)"	"unprognostic (5.30e-2)"	"unprognostic (4.03e-3)"	"unprognostic (1.52e-1)"	"unprognostic (3.05e-2)"	"unprognostic (7.48e-2)"	"unprognostic (2.61e-1)"	"unprognostic (7.10e-3)"	"unprognostic (6.81e-3)"	"unprognostic (9.36e-3)"	"prognostic favorable (9.75e-5)"	"unprognostic (1.89e-2)"	"unprognostic (2.00e-1)"	"unprognostic (4.13e-1)"	"unprognostic (2.13e-1)"	12.3	10.6	15.3	11.3	16.6	8.8	13.4	15.4	27.0	12.3	15.1	26.3	13.2	8.8	10.3	11.4	18.0	20.0	10.3	10.2	16.6	18.2	12.3	12.5	12.8	15.6	19.5	13.1	14.5	22.8	21.4	12.7	19.9	18.2	14.4	13.2	10.7	16.8	14.0	12.5	25.8	13.0	10.9	24.0	13.6	13.0	7.6	13.3	20.6	25.1	9.9	16.2	13.4	18.9	8.2	12.0	3.2	5.0	5.1	7.3	2.2	16.0	11.6	2.7	12.7	10.0	11.4	16.5	8.3	10.2	8.7	5.8	10.5	11.4	21.6	12.6	5.8	20.4	13.3	13.9	9.5	2.6	15.9	14.2	4.5	4.5	5.1	13.9	3.0	11.3	9.5	29.1	5.0	6.9	9.0	7.5	15.4	7.9	10.6	3.1	20.0	22.5	7.5	4.0	12.8	12.6	17.8	0.1	10.4	4.7	16.1	10.8	7.6	11.4	16.7	11.4	5.5	14.8	6.1	7.9	10.9	3.8	18.1	16.0	7.4	11.2	15.8	16.1	12.1	12.9	0.0	3.7	3.2	5.4	5.0	4.9	8.2	4.8	5.3	5.7	4.2	7.3	4.7	0.1	5.1	3.0	12.0	6.0	2.2	15.3	16.6	15.4	27.0	16.6	18.2	19.5	13.1	18.2	13.3	8.9	5.1	8.2	18.5	11.0	11.4	5.8	5.1	2.7	1.2	8.7	0.0	25.4	5.0	5.3	16.9	9.0	8.5	0.0	6.4	18.4	7.1	15.5	11.5	8.6	27.9	11.1	16.1	6.7	7.9	12.5	3.1	11.8	3.3	7.2	13.8	11.6	5.9	14.4	12.7	4.8	4.8	0.0	6.9	5.9	3.1	12.2	28.3	7.7	11.3	16.1
ADCK5	FLJ35454	ENSG00000173137	"AarF domain containing kinase 5"	Q3MIX3	8	144373101-144393242	"Enzymes, Predicted membrane proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Enterocytes: 43.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA025692, HPA028679"	Approved		Approved	"Plasma membrane,Cytosol"		NA	NA			"Plasma membrane, Cytosol"		"HPA025692: AB_10599486, HPA028679: AB_10600226"	"unprognostic (6.76e-2)"	"unprognostic (1.66e-1)"	"unprognostic (1.68e-2)"	"unprognostic (8.96e-2)"	"unprognostic (1.68e-2)"	"unprognostic (1.00e-1)"	"unprognostic (2.31e-3)"	"unprognostic (6.45e-2)"	"unprognostic (2.70e-1)"	"unprognostic (4.25e-2)"	"unprognostic (6.60e-2)"	"unprognostic (2.03e-2)"	"unprognostic (1.33e-3)"	"unprognostic (1.39e-2)"	"unprognostic (1.20e-1)"	"unprognostic (3.47e-1)"	"unprognostic (2.90e-2)"	4.1	10.0	4.8	8.9	4.5	4.5	4.3	11.5	9.1	4.6	18.3	2.8	7.6	19.1	5.8	4.2	7.2	4.2	6.3	3.8	3.9	4.1	4.8	6.9	3.7	5.0	3.4	8.4	5.5	5.6	4.7	4.1	3.7	4.5	4.7	4.0	4.6	7.4	4.7	5.6	8.3	17.0	2.7	2.4	6.7	5.6	7.7	3.8	6.8	4.1	4.9	6.1	5.1	5.0	4.7	6.3	2.5	5.4	1.8	4.1	2.8	3.9	4.9	1.1	3.4	0.9	0.8	5.7	3.3	1.9	2.7	0.9	5.3	4.2	1.7	2.4	0.7	0.9	5.2	0.2	3.6	0.2	4.4	1.6	4.5	3.6	5.9	2.7	1.0	3.5	1.4	2.1	0.9	0.8	1.5	1.8	3.1	2.9	3.1	1.5	10.3	3.2	4.4	0.7	3.4	3.7	4.3	1.7	3.1	1.8	3.7	0.7	1.8	4.9	3.9	2.8	0.9	3.4	3.0	1.3	1.4	5.2	3.5	2.2	1.4	0.4	1.6	3.2	3.9	2.0	1.8	4.2	2.5	2.3	5.4	3.0	1.8	2.8	1.8	6.3	4.7	2.9	1.5	0.7	1.8	5.0	4.0	4.1	2.8	4.8	4.5	11.5	9.1	3.9	4.1	3.4	8.4	4.5	3.8	3.0	1.7	2.2	3.4	3.7	9.2	2.0	7.6	6.7	1.2	5.2	15.7	3.5	3.3	7.7	6.5	4.1	43.3	0.0	6.3	9.4	3.9	2.3	9.2	6.7	7.0	3.2	8.1	3.7	3.8	8.6	5.5	5.2	3.3	11.8	26.0	5.8	9.0	14.0	6.7	5.1	15.2	12.9	3.3	13.4	10.4	4.4	2.1	5.7	20.0	2.2
ADCY1	"AC1, DFNB44"	ENSG00000164742	"Adenylate cyclase 1"	Q08828	7	45574140-45723116	"Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Biological rhythms, cAMP biosynthesis"	"Calmodulin-binding, Lyase"	"Cancer-related genes, Deafness, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 29.0"	"Group enriched"	"Detected in many"	8	"Cone photoreceptor cells: 490.9;Rod photoreceptor cells: 145.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"hTERT-HME1: 15.3;SH-SY5Y: 17.6;SK-MEL-30: 20.3;WM-115: 11.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB018364, HPA068274"	Uncertain		Approved	Mitochondria		NA	NA			Mitochondria		"CAB018364: AB_2223098, HPA068274: "	"unprognostic (9.41e-3)"	"unprognostic (7.30e-4)"	"unprognostic (9.31e-2)"	"unprognostic (2.98e-1)"	"unprognostic (4.18e-2)"	"unprognostic (3.07e-3)"	"unprognostic (1.32e-1)"	"unprognostic (7.31e-2)"	"unprognostic (1.64e-3)"	"unprognostic (2.89e-1)"	"unprognostic (7.73e-3)"	"unprognostic (1.54e-1)"	"unprognostic (4.74e-6)"	"unprognostic (2.49e-1)"	"unprognostic (7.65e-3)"	"unprognostic (2.87e-1)"	"unprognostic (2.23e-1)"	2.8	2.8	11.5	0.7	11.7	0.4	6.8	22.7	29.0	7.8	0.9	2.0	0.0	0.7	2.7	1.1	1.2	2.4	1.2	4.0	11.6	4.0	1.8	9.6	1.0	0.8	5.8	13.4	1.2	3.6	1.0	1.5	0.9	6.2	4.1	1.0	5.0	0.8	2.1	9.2	0.6	0.7	1.6	2.2	1.0	1.8	3.9	1.2	0.0	3.0	0.2	0.8	1.0	1.5	0.5	0.4	0.6	0.1	0.0	0.2	0.0	0.5	3.9	1.5	2.2	2.9	0.0	2.7	0.1	0.0	0.5	0.2	0.4	0.0	0.0	0.2	0.1	4.0	1.2	2.5	0.2	0.0	7.0	1.8	0.0	0.0	0.3	0.0	0.1	0.0	3.4	1.9	0.3	15.3	0.0	0.1	5.8	0.2	4.7	0.2	4.6	0.0	0.0	5.7	3.3	0.0	0.0	0.0	7.6	0.0	3.8	9.2	17.6	1.4	0.0	20.3	2.2	1.3	2.3	0.0	0.4	2.9	0.3	2.3	0.0	0.0	0.0	0.0	0.0	11.6	0.4	0.1	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.4	0.2	0.2	0.0	0.6	0.0	0.0	0.0	0.0	0.0	11.5	11.7	22.7	29.0	11.6	4.0	5.8	13.4	6.2	1.2	0.0	0.0	0.0	0.4	0.2	35.8	9.0	0.0	0.0	0.0	0.0	490.9	0.1	1.7	0.0	2.3	1.0	0.0	0.0	0.8	0.1	1.9	2.6	0.0	34.7	0.3	39.7	30.0	18.4	3.2	0.4	1.7	0.0	3.3	0.0	0.2	11.9	0.9	0.0	7.1	0.2	145.7	0.0	5.0	0.7	6.8	0.1	0.0	0.0	0.5	0.3
ADCY10	"HCA2, RP1-313L4.2, SAC, SACI, Sacy"	ENSG00000143199	"Adenylate cyclase 10"	Q96PN6	1	167809388-167914215	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"cAMP biosynthesis"	Lyase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	16	"liver: 14.9;testis: 38.6"	"Group enriched"	"Detected in some"	11	"Early spermatids: 64.6;Late spermatids: 64.3"	"Cancer enhanced"	"Detected in single"		"liver cancer: 0.7"	"Region enriched"	"Detected in single"	5	"cerebellum: 1.6"	"Cell type enhanced"	"Detected in single"		"neutrophil: 1.4"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"BEWO: 2.7;T-47d: 5.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"HPA015243, HPA017749"	Approved					NA	NA					"HPA015243: AB_1856540, HPA017749: AB_1856541"	"unprognostic (1.20e-1)"	"unprognostic (2.53e-1)"	"unprognostic (1.95e-2)"	"unprognostic (1.17e-2)"	"unprognostic (2.05e-1)"	"unprognostic (1.65e-1)"	"unprognostic (5.35e-2)"	"unprognostic (1.56e-1)"	"unprognostic (1.63e-1)"	"unprognostic (3.65e-1)"	"unprognostic (4.43e-2)"	"unprognostic (7.83e-5)"	"unprognostic (5.86e-7)"	"unprognostic (4.73e-2)"	"unprognostic (1.33e-1)"	"unprognostic (7.83e-2)"	"unprognostic (2.59e-1)"	0.1	0.1	0.2	0.1	0.3	0.0	1.3	1.6	0.3	0.1	0.1	0.1	0.1	0.3	0.1	0.1	0.1	0.0	0.1	0.1	0.3	0.2	0.3	14.9	0.1	0.1	0.2	0.3	0.1	0.4	0.0	0.1	0.1	0.1	0.2	0.2	0.1	0.7	0.1	0.1	0.1	0.2	0.1	0.1	0.1	0.1	38.6	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	1.4	0.6	0.0	0.3	0.4	0.3	0.1	0.2	0.2	0.6	0.5	2.7	0.1	1.0	0.3	1.1	1.6	0.1	0.2	0.3	0.0	0.0	0.0	1.1	0.1	0.2	0.4	1.6	0.5	0.3	0.7	0.1	0.0	0.0	0.1	1.9	0.8	0.6	0.3	0.0	0.7	1.2	0.1	0.1	0.0	0.5	0.8	1.0	0.8	0.0	0.1	0.0	0.3	1.2	0.0	0.4	0.0	0.0	0.0	0.5	1.6	5.0	0.8	0.1	0.2	0.0	0.3	0.1	1.2	0.6	0.8	0.7	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.6	0.0	0.0	0.4	0.2	0.3	1.6	0.3	0.3	0.2	0.2	0.3	0.1	0.1	0.0	0.0	0.0	0.1	0.5	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	64.6	0.0	0.5	0.0	0.0	0.4	0.0	0.2	0.0	5.9	0.1	0.0	0.0	1.3	0.0	64.3	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.3	4.1	0.7	0.4	1.5	0.0	0.0	0.1
ADCY2	"AC2, HBAC2, KIAA1060"	ENSG00000078295	"Adenylate cyclase 2"	Q08462	5	7396208-7830081	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"cAMP biosynthesis"	Lyase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	7	"brain: 35.9;skeletal muscle: 58.6"	"Cell type enhanced"	"Detected in many"	24	"Cone photoreceptor cells: 64.8;Horizontal cells: 190.7;Melanocytes: 38.8"	"Cancer enhanced"	"Detected in some"		"glioma: 4.9"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Group enriched"	"Detected in some"	7	"AF22: 9.0;NTERA-2: 6.9;SK-MEL-30: 7.5;SuSa: 6.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB031482, HPA038015, HPA038483"	Approved					NA	NA					"CAB031482: AB_630838, HPA038015: AB_10673653, HPA038483: AB_10675799"	"unprognostic (6.48e-2)"	"unprognostic (2.60e-2)"	"unprognostic (1.49e-1)"	"unprognostic (5.65e-2)"	"unprognostic (3.77e-1)"	"unprognostic (4.03e-4)"	"unprognostic (1.94e-2)"	"unprognostic (1.60e-2)"	"unprognostic (2.20e-1)"	"unprognostic (1.48e-1)"	"unprognostic (2.67e-2)"	"unprognostic (7.68e-2)"	"unprognostic (1.09e-5)"	"unprognostic (1.05e-1)"	"unprognostic (7.33e-3)"	"unprognostic (4.90e-2)"	"unprognostic (3.92e-3)"	1.8	3.3	16.8	1.3	14.5	1.2	2.8	6.6	35.9	4.9	1.9	6.7	0.7	1.9	3.9	1.7	4.0	4.1	2.1	1.2	14.5	9.4	1.2	1.1	1.3	1.1	12.8	10.0	5.1	1.9	1.0	5.1	1.8	11.3	6.2	1.6	2.0	1.5	5.1	58.6	6.3	1.8	4.3	12.5	1.2	2.6	3.6	5.4	0.0	1.1	5.1	1.2	1.9	2.1	0.9	0.4	1.5	0.4	0.3	0.6	0.0	0.0	0.0	9.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	6.9	0.0	0.0	0.1	1.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	7.5	6.4	0.3	0.0	0.0	0.2	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.9	0.4	0.1	0.4	0.2	0.4	0.5	0.3	0.3	0.1	0.9	0.4	0.6	1.5	0.3	0.3	0.4	0.2	0.0	16.8	14.5	6.6	22.5	14.5	9.4	12.8	10.0	11.3	5.4	3.0	2.4	0.0	0.6	5.3	28.6	1.6	0.0	9.4	4.5	0.0	64.8	0.6	0.0	0.5	2.5	1.4	0.0	0.0	0.4	0.2	2.8	7.3	1.1	0.0	0.2	190.7	12.1	0.6	0.0	2.1	4.0	2.6	38.8	0.0	0.1	1.9	2.0	0.3	1.8	0.2	4.0	0.0	1.0	1.2	0.7	4.1	0.7	0.0	0.2	0.8
ADCY3	AC3	ENSG00000138031	"Adenylate cyclase 3"	O60266	2	24819169-24919839	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"cAMP biosynthesis, Olfaction, Sensory transduction"	"Calmodulin-binding, Lyase"	Obesity	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	14	"Leydig cells: 54.1;Sertoli cells: 109.9;Smooth muscle cells: 59.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB010223	Approved					NA	NA					"CAB010223: AB_630839"	"unprognostic (3.05e-1)"	"unprognostic (1.10e-1)"	"unprognostic (4.91e-2)"	"unprognostic (1.39e-3)"	"unprognostic (5.01e-2)"	"unprognostic (7.66e-2)"	"unprognostic (1.28e-1)"	"unprognostic (6.06e-2)"	"unprognostic (8.43e-2)"	"unprognostic (6.89e-2)"	"unprognostic (8.22e-3)"	"unprognostic (2.52e-1)"	"prognostic unfavorable (1.32e-9)"	"unprognostic (3.74e-2)"	"unprognostic (5.56e-2)"	"unprognostic (1.11e-1)"	"unprognostic (8.55e-3)"	35.8	8.2	14.4	11.7	26.0	13.2	41.2	15.0	21.7	22.5	15.1	16.5	6.5	7.6	23.3	15.6	17.4	21.4	18.2	18.2	13.7	13.1	9.5	4.6	15.3	13.7	29.6	14.1	29.5	7.7	15.4	16.2	58.6	16.3	15.1	11.7	11.3	8.7	24.9	7.9	14.8	12.3	25.1	12.4	11.7	9.8	11.3	18.2	4.3	14.4	13.9	12.8	13.5	24.2	7.2	11.0	3.2	1.8	1.1	3.1	1.2	28.4	19.6	6.3	10.7	32.4	25.8	12.4	14.3	21.0	12.5	11.5	15.8	9.8	9.9	3.2	20.9	15.6	20.8	15.6	19.5	8.7	22.6	20.7	16.2	21.5	2.0	24.6	9.2	10.2	21.6	16.5	12.4	18.9	8.0	11.4	8.7	8.1	17.4	7.2	20.4	8.9	2.2	6.9	13.8	8.6	15.8	33.3	20.6	5.4	17.0	10.4	7.6	17.9	21.3	12.3	5.4	5.4	7.7	10.9	21.8	15.7	12.6	21.5	18.1	42.2	38.8	7.1	14.6	13.6	3.2	1.8	0.0	0.6	1.8	0.3	6.4	1.4	0.5	11.0	7.2	0.7	0.6	0.0	1.1	0.4	10.1	3.1	1.2	14.4	26.0	15.0	21.7	13.7	13.1	29.6	14.1	16.3	18.2	0.0	2.6	2.9	3.6	9.7	1.3	1.4	0.0	0.0	1.2	1.8	0.0	0.7	0.0	0.9	0.2	5.0	4.0	0.0	0.0	1.6	17.7	2.9	18.4	0.2	12.4	0.0	1.2	6.7	3.2	1.9	54.1	5.1	6.8	5.4	3.5	1.5	0.7	3.5	27.6	0.1	1.7	109.9	59.0	0.3	2.2	10.3	1.0	6.1	8.8	3.1
ADCY4	AC4	ENSG00000129467	"Adenylate cyclase 4"	Q8NFM4	14	24318349-24335093	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"cAMP biosynthesis"	Lyase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	6	"Endothelial cells: 57.3;Ito cells: 40.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	4	"basophil: 5.0"	"Lineage enriched"	"Detected in many"	4	"granulocytes: 5.0"	"Group enriched"	"Detected in some"	6	"HUVEC TERT2: 9.9;TIME: 4.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB005070, HPA048344"	Approved					NA	NA					"CAB005070: AB_2273639, HPA048344: AB_2680366"	"unprognostic (5.59e-2)"	"unprognostic (1.34e-1)"	"unprognostic (3.47e-4)"	"prognostic favorable (8.20e-4)"	"unprognostic (4.06e-1)"	"unprognostic (2.82e-3)"	"unprognostic (1.75e-4)"	"unprognostic (8.58e-2)"	"unprognostic (2.51e-2)"	"unprognostic (7.88e-2)"	"unprognostic (6.77e-2)"	"unprognostic (7.87e-2)"	"prognostic unfavorable (7.01e-4)"	"unprognostic (8.02e-2)"	"unprognostic (3.88e-2)"	"unprognostic (1.57e-1)"	"unprognostic (3.47e-2)"	15.8	2.7	2.3	4.6	2.0	1.5	14.2	1.1	2.4	13.3	4.4	1.6	6.3	1.7	16.8	10.0	6.0	7.7	10.9	10.3	1.6	1.4	6.3	2.0	14.7	8.4	2.3	1.5	3.2	2.1	4.7	1.8	17.8	2.7	4.8	2.3	5.8	3.6	8.0	6.2	4.4	3.9	7.0	1.9	9.3	3.4	2.6	1.6	0.0	7.4	7.3	3.3	5.9	12.6	0.0	1.1	5.0	0.2	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.9	0.0	0.9	0.4	1.0	0.1	0.0	0.6	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.3	0.5	0.0	0.0	0.0	0.0	0.7	0.1	0.0	0.8	0.0	0.2	0.0	0.0	9.9	0.0	0.0	0.4	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	1.2	4.1	0.3	0.1	1.0	0.0	0.2	0.0	0.0	0.0	0.4	0.1	5.0	0.2	0.2	0.0	0.0	0.1	0.0	0.1	0.0	1.1	0.0	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.0	2.3	2.0	1.1	2.4	1.6	1.4	2.3	1.5	2.7	1.6	0.0	2.6	0.0	0.2	3.2	0.0	8.1	0.0	1.4	1.2	1.8	0.0	0.1	0.0	0.8	1.0	57.3	1.7	0.0	2.8	0.1	1.7	0.2	1.1	0.0	1.3	1.6	1.2	40.5	7.2	5.9	0.0	2.3	6.8	3.6	5.0	0.8	1.4	1.5	0.0	0.0	0.3	6.5	2.3	0.3	0.5	2.5	0.0	2.6	1.6	0.3
ADCY5	AC5	ENSG00000173175	"Adenylate cyclase 5"	O95622	3	123282296-123449758	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"cAMP biosynthesis"	Lyase	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 69.9"	"Cell type enhanced"	"Detected in many"	10	"Cardiomyocytes: 56.0;Paneth cells: 59.6;Peritubular cells: 69.3;Sertoli cells: 64.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"MCF7: 18.0;RPMI-8226: 3.1;RPTEC TERT1: 6.5"	"Region enriched"	"Detected in many"	5	"basal ganglia: 347.3"	"Region enriched"	"Detected in all"	6	"basal ganglia: 205.1"	"HPA017730, HPA077682"	Uncertain		Enhanced	"Intermediate filaments"		NA	NA			"Intermediate filaments"		"HPA017730: AB_1844595, HPA077682: AB_2686851"	"unprognostic (3.55e-2)"	"unprognostic (1.01e-3)"	"unprognostic (7.61e-3)"	"unprognostic (2.05e-2)"	"unprognostic (1.25e-1)"	"unprognostic (1.26e-2)"	"unprognostic (1.48e-1)"	"unprognostic (7.61e-2)"	"unprognostic (2.49e-2)"	"unprognostic (2.34e-1)"	"unprognostic (7.27e-3)"	"unprognostic (2.64e-2)"	"prognostic favorable (7.46e-6)"	"unprognostic (1.81e-2)"	"unprognostic (5.65e-2)"	"unprognostic (3.19e-2)"	"unprognostic (5.97e-4)"	13.3	3.0	12.5	3.7	32.0	0.6	9.3	2.6	14.4	4.5	11.7	10.4	3.1	4.2	6.2	4.4	13.8	5.3	7.3	69.9	10.4	8.3	5.3	2.4	2.6	2.0	15.0	8.6	10.1	5.7	1.1	7.7	4.8	9.7	13.8	4.6	4.6	3.1	16.3	2.2	1.1	4.8	13.5	8.8	4.7	9.6	5.9	16.0	0.0	1.0	0.2	2.6	9.5	8.5	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.7	1.6	0.1	0.1	0.1	0.4	0.0	0.0	0.4	0.1	0.1	0.1	0.0	0.4	0.2	2.7	0.5	0.8	0.0	0.0	0.1	1.0	0.0	0.2	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.1	18.0	0.0	0.0	1.0	0.0	0.1	0.0	0.4	3.1	6.5	0.6	2.2	2.0	0.0	0.6	0.1	2.2	0.0	0.1	0.0	0.1	1.5	0.1	0.3	0.2	0.7	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.5	0.1	12.5	32.0	2.6	14.4	10.4	8.3	15.0	8.6	9.7	16.0	0.0	0.0	0.0	0.1	0.2	16.5	56.0	2.5	0.0	0.0	7.0	0.0	1.1	0.0	11.5	0.7	0.4	0.5	0.0	6.3	3.1	2.3	0.1	0.0	0.0	0.2	0.0	0.0	2.5	0.0	1.1	19.0	0.0	0.0	1.8	0.3	0.8	0.6	59.6	69.3	0.7	1.5	64.7	12.2	0.7	5.6	0.6	10.4	0.0	1.2	0.0
ADCY6	AC6	ENSG00000174233	"Adenylate cyclase 6"	O43306	12	48766194-48789037	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"cAMP biosynthesis"	Lyase	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	5	"Paneth cells: 31.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"SK-BR-3: 30.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB018365	Approved		Approved	"Golgi apparatus"		NA	NA			"Golgi apparatus"		"CAB018365: AB_2257941"	"unprognostic (1.18e-2)"	"unprognostic (2.20e-2)"	"unprognostic (6.89e-2)"	"unprognostic (1.31e-1)"	"unprognostic (3.84e-2)"	"unprognostic (3.68e-2)"	"prognostic unfavorable (8.23e-4)"	"unprognostic (1.55e-1)"	"unprognostic (1.07e-1)"	"unprognostic (1.29e-1)"	"unprognostic (2.59e-1)"	"unprognostic (1.64e-2)"	"unprognostic (5.06e-3)"	"unprognostic (5.10e-3)"	"unprognostic (1.09e-1)"	"unprognostic (3.09e-1)"	"unprognostic (2.48e-2)"	25.9	9.6	14.1	12.4	7.5	0.8	19.7	15.0	17.0	9.8	15.2	5.5	16.2	12.3	13.2	12.8	6.2	9.5	17.6	37.5	9.9	8.3	11.3	5.6	8.5	4.7	5.6	11.0	14.6	17.4	15.8	9.1	9.5	8.9	11.1	12.6	11.8	19.9	12.0	7.3	10.2	13.9	9.1	4.7	2.9	13.5	4.0	5.5	0.6	11.1	6.8	3.8	7.8	14.9	1.8	0.4	1.4	0.4	0.5	0.4	0.5	5.9	11.6	13.4	8.4	14.1	7.1	14.5	7.4	7.4	9.0	6.3	20.6	20.2	0.0	16.9	6.4	3.6	4.8	3.9	4.9	3.2	0.0	6.0	5.5	15.8	3.7	8.1	0.0	4.5	9.0	6.1	7.5	2.8	16.5	8.1	0.3	0.7	2.0	6.6	10.3	0.0	0.2	4.6	9.1	5.5	1.9	5.1	3.3	10.1	18.7	2.0	8.3	7.6	30.4	6.6	5.9	23.7	1.5	9.3	8.4	6.1	4.4	3.2	3.1	1.6	0.2	7.6	0.0	3.8	1.4	0.4	0.4	0.3	0.2	0.2	1.1	0.3	0.2	0.3	1.8	0.4	0.3	0.9	0.5	0.4	0.4	0.2	0.5	14.1	7.5	15.0	17.0	9.9	8.3	5.6	11.0	8.9	5.5	0.0	5.4	0.8	2.8	2.4	7.4	6.7	10.2	1.4	5.7	17.4	19.6	5.4	0.0	5.6	0.4	6.0	26.4	0.0	3.5	2.2	5.7	6.2	1.1	6.0	1.9	9.5	8.1	4.9	0.3	0.5	10.6	1.1	6.8	1.0	24.4	5.6	8.0	31.6	8.9	2.9	8.6	19.4	16.7	1.2	1.3	1.8	4.2	0.0	19.7	5.8
ADCY7	"AC7, KIAA0037"	ENSG00000121281	"Adenylate cyclase 7"	P51828	16	50246137-50318135	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"cAMP biosynthesis"	Lyase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	9	"Alveolar cells type 2: 34.7;granulocytes: 48.6;Hofbauer cells: 30.2;Kupffer cells: 61.4;Macrophages: 41.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HEL: 23.3;HMC-1: 65.3;RPMI-8226: 32.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA041218, HPA048241"	Uncertain		Approved	Cytosol		NA	NA			Cytosol		"HPA041218: AB_2677365, HPA048241: AB_2680326"	"unprognostic (1.98e-1)"	"prognostic unfavorable (5.31e-4)"	"unprognostic (1.24e-1)"	"unprognostic (1.78e-1)"	"unprognostic (3.77e-1)"	"unprognostic (2.80e-1)"	"unprognostic (3.90e-2)"	"unprognostic (7.75e-2)"	"unprognostic (1.21e-1)"	"unprognostic (2.56e-2)"	"unprognostic (1.65e-1)"	"unprognostic (1.18e-1)"	"unprognostic (5.59e-3)"	"unprognostic (7.34e-2)"	"unprognostic (2.15e-3)"	"unprognostic (2.18e-1)"	"unprognostic (9.52e-4)"	6.3	4.3	7.0	17.4	9.7	14.9	3.9	1.2	5.2	3.7	5.0	9.8	0.8	2.8	3.7	4.8	13.2	5.3	6.9	7.3	5.3	4.2	3.3	3.6	16.4	16.5	8.8	4.4	17.1	3.7	1.0	3.4	9.7	8.6	3.5	5.9	6.2	6.5	1.6	1.8	7.9	10.4	5.0	12.3	26.9	4.9	2.1	9.2	21.8	3.7	3.1	26.0	6.6	6.1	3.6	12.5	6.5	16.7	8.4	7.0	5.0	4.0	5.5	0.2	0.8	0.6	7.1	0.5	2.8	1.3	2.2	2.0	5.2	8.4	1.6	7.6	11.4	0.1	14.7	5.8	2.4	2.7	15.4	2.0	23.3	4.2	1.5	6.5	4.4	65.3	3.8	2.4	1.6	2.6	1.2	0.6	5.3	8.5	3.2	3.1	2.3	1.7	10.4	1.0	1.9	7.9	1.6	2.1	32.4	1.5	0.4	1.0	2.7	1.5	0.6	1.3	1.4	0.1	13.0	5.2	0.3	7.6	0.8	0.8	0.3	0.1	3.5	2.4	9.5	1.0	6.5	7.8	2.9	7.0	11.7	5.1	3.2	2.8	5.0	12.5	3.6	2.6	3.7	4.4	8.4	16.7	6.5	3.9	5.0	7.0	9.7	1.2	5.2	5.3	4.2	8.8	4.4	8.6	9.2	17.9	34.7	6.9	0.3	3.3	1.0	0.6	0.0	0.0	12.5	0.0	5.9	9.3	0.0	1.6	1.3	1.0	1.7	0.0	0.2	0.9	11.4	0.3	48.6	0.2	30.2	0.0	0.0	1.8	61.4	0.5	0.6	41.8	5.0	3.6	0.5	0.9	3.1	7.0	1.1	0.0	0.4	6.5	1.4	0.0	0.7	3.4	3.3	18.5	2.1	1.0
ADCY8	"AC8, ADCY3, HBAC1"	ENSG00000155897	"Adenylate cyclase 8"	P40145	8	130780301-131042426	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"cAMP biosynthesis"	Lyase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 9.6;epididymis: 27.8"	"Cell type enhanced"	"Detected in some"	22	"Cardiomyocytes: 1.0;Early spermatids: 2.5"	"Group enriched"	"Detected in some"	5	"glioma: 6.0;ovarian cancer: 1.8;thyroid cancer: 1.7"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC TERT1: 3.9;GAMG: 6.3;U-138 MG: 13.7;U-87 MG: 26.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB018652, HPA024291"	Supported					NA	NA					"CAB018652: AB_633654, HPA024291: AB_1844597"	"unprognostic (5.59e-3)"				"unprognostic (3.10e-1)"	"unprognostic (1.82e-1)"	"unprognostic (1.09e-1)"	"unprognostic (2.78e-2)"	"unprognostic (1.74e-1)"	"unprognostic (1.05e-1)"	"unprognostic (8.22e-3)"	"unprognostic (4.91e-2)"	"unprognostic (7.39e-3)"	"unprognostic (1.92e-1)"	"unprognostic (2.44e-2)"	"unprognostic (6.67e-2)"		0.2	0.2	8.2	0.2	5.1	0.2	0.9	5.3	9.6	0.8	0.2	1.2	1.4	0.2	0.3	27.8	0.2	4.8	0.2	0.3	6.4	6.2	0.5	0.2	1.6	0.2	7.8	0.6	0.3	0.2	0.2	0.0	0.2	5.7	0.2	0.2	0.0	2.8	2.0	0.2	1.5	0.2	0.9	5.0	0.2	0.3	0.7	1.1	0.0	0.2	0.0	0.2	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.0	3.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	13.7	0.3	0.0	0.0	0.0	0.0	0.0	26.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.2	5.1	5.3	5.0	6.4	6.2	7.8	0.6	5.7	1.1	0.0	1.0	0.0	0.0	0.0	0.6	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0
ADCY9	AC9	ENSG00000162104	"Adenylate cyclase 9"	O60503	16	3953387-4116185	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"cAMP biosynthesis"	Lyase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skeletal muscle: 36.4"	"Cell type enhanced"	"Detected in many"	5	"Cholangiocytes: 28.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"fHDF/TERT166: 24.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041328, HPA044225"	Approved		Approved	Cytosol		NA	NA			Cytosol		"HPA041328: AB_2677414, HPA044225: AB_2678863"	"unprognostic (1.78e-1)"	"unprognostic (5.54e-2)"	"unprognostic (2.57e-1)"	"prognostic unfavorable (2.55e-5)"	"unprognostic (6.62e-2)"	"unprognostic (1.30e-2)"	"unprognostic (2.52e-1)"	"unprognostic (3.61e-2)"	"unprognostic (6.93e-2)"	"unprognostic (4.76e-3)"	"unprognostic (5.40e-2)"	"unprognostic (1.37e-1)"	"prognostic favorable (5.24e-8)"	"unprognostic (1.19e-1)"	"unprognostic (1.66e-1)"	"unprognostic (1.44e-1)"	"unprognostic (1.55e-2)"	5.2	4.8	7.1	3.2	10.9	0.9	5.4	8.5	9.6	7.0	6.4	4.1	4.4	6.5	6.5	4.4	6.8	7.7	6.5	13.3	6.2	3.0	8.0	9.6	11.1	2.5	3.0	6.2	9.4	12.5	12.3	5.8	7.8	7.7	3.6	5.5	9.0	10.1	5.0	36.4	4.4	10.9	6.3	2.2	3.2	5.5	4.4	3.4	0.7	21.8	7.7	3.0	7.9	4.8	0.1	1.0	3.2	1.5	1.0	1.9	0.9	4.9	7.6	2.3	4.3	8.3	10.2	3.5	8.8	9.2	4.9	4.0	6.3	4.4	0.0	13.5	24.0	3.0	4.8	9.1	5.4	3.4	6.1	8.8	0.2	17.4	12.1	9.1	0.6	4.0	10.8	8.5	5.7	3.0	4.1	3.3	1.6	2.7	0.0	5.0	9.1	0.0	2.6	4.2	2.1	4.1	7.8	11.1	0.2	1.8	1.3	5.3	2.3	6.8	8.1	5.9	2.7	20.5	8.9	3.0	9.8	2.7	9.5	3.8	1.9	1.1	1.0	2.1	2.7	3.8	3.2	1.5	1.0	1.9	1.5	1.7	0.0	0.6	0.6	0.1	0.1	0.1	1.1	0.3	1.0	0.0	1.0	0.0	0.9	7.1	10.9	8.5	9.6	6.2	3.0	3.0	6.2	7.7	3.4	11.9	10.9	0.5	1.0	5.7	9.3	15.1	28.1	6.7	7.9	12.2	11.8	1.4	0.0	3.8	0.6	5.2	13.6	0.0	4.6	1.7	6.9	0.6	0.0	17.4	1.4	1.6	1.2	8.0	5.9	1.5	7.8	2.6	6.8	1.0	8.4	7.5	2.8	0.0	7.1	4.7	12.8	0.0	13.8	1.1	5.2	3.3	0.8	4.3	5.2	0.9
ADGB	"C6orf103, CAPN16, dJ408K24.1, FLJ23121"	ENSG00000118492	Androglobin	Q8N7X0	6	146598965-146815462	"Enzymes, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 20.9;epididymis: 13.1;testis: 30.6"	"Cell type enhanced"	"Detected in some"	26	"Ciliated cells: 121.8;Early spermatids: 236.9;Late spermatids: 53.2"	"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	5	"basal ganglia: 6.6;pons and medulla: 20.9"	"Cell type enriched"	"Detected in single"	10	"myeloid DC: 2.6"	"Lineage enriched"	"Detected in single"	10	"dendritic cells: 2.6"	"Cell line enriched"	"Detected in single"	25	"HDLM-2: 17.9"					"Low region specificity"	"Detected in all"			"HPA036340, HPA036341"	Enhanced		Uncertain	Nucleoplasm,Mitochondria		No	NA			Mitochondria	Nucleoplasm	"HPA036340: AB_2675071, HPA036341: AB_10672241"	"unprognostic (4.15e-3)"		"unprognostic (1.23e-2)"	"unprognostic (9.30e-3)"	"unprognostic (1.09e-1)"	"unprognostic (2.07e-2)"		"unprognostic (3.11e-2)"	"unprognostic (5.05e-1)"	"unprognostic (2.34e-1)"	"unprognostic (4.83e-3)"	"unprognostic (1.05e-1)"	"unprognostic (1.93e-1)"	"unprognostic (1.77e-2)"	"unprognostic (3.66e-2)"	"unprognostic (2.68e-1)"		0.1	0.1	1.6	0.1	6.6	0.1	0.2	0.0	0.2	1.0	0.5	5.1	0.0	0.1	0.4	13.1	0.2	9.8	0.1	0.1	2.2	2.7	0.2	0.2	4.8	0.2	0.0	0.0	4.3	0.1	0.3	0.8	0.2	20.9	0.2	0.4	0.0	0.1	0.3	0.1	0.3	0.1	0.1	0.4	0.1	0.2	30.6	1.2	0.0	0.2	0.1	0.2	0.1	0.0	0.0	2.6	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	17.9	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.6	6.6	0.0	0.1	2.2	2.7	0.0	0.0	20.9	1.2	3.0	1.0	0.0	0.0	0.0	0.0	0.8	0.0	121.8	14.8	0.0	3.9	0.0	0.0	0.0	236.9	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	53.2	2.6	1.2	0.0	0.0	0.0	0.2	0.0	0.0	2.5	0.0	0.0	0.0	0.0	19.2	3.0	0.0	0.0	0.0	0.0	0.0
ADH1A	ADH1	ENSG00000187758	"Alcohol dehydrogenase 1A (class I), alpha polypeptide"	P07327	4	99276367-99291028	"Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"		Oxidoreductase	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	322	"liver: 250.3"	"Cell type enriched"	"Detected in some"	10	"Hepatocytes: 212.0"	"Cancer enriched"	"Detected in some"	251	"liver cancer: 165.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	5	"ASC diff: 11.2"									"CAB009562, HPA047814, HPA060902"	Enhanced		Approved	"Plasma membrane,Cytosol"		NA	NA		12000000	"Plasma membrane, Cytosol"		"CAB009562: AB_2257984, HPA047814: AB_2680163, HPA060902: AB_2684384"	"unprognostic (5.89e-2)"	"unprognostic (6.16e-2)"		"unprognostic (1.20e-1)"	"unprognostic (2.07e-1)"	"unprognostic (4.40e-1)"	"prognostic favorable (2.38e-4)"	"unprognostic (2.78e-3)"		"unprognostic (4.25e-1)"	"unprognostic (4.79e-3)"	"unprognostic (6.21e-2)"	"unprognostic (9.36e-2)"	"unprognostic (3.25e-2)"	"unprognostic (1.40e-1)"		"unprognostic (2.86e-2)"	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.7	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	250.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	11.2	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.1	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.1	0.0	1.3	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	1.0	0.0	0.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.2	20.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	212.0	0.0	0.0	0.0	7.4	6.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.0	0.0	0.0	0.0	0.0
ADH1B	ADH2	ENSG00000196616	"Alcohol dehydrogenase 1B (class I), beta polypeptide"	P00325	4	99304964-99352760	"Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"		Oxidoreductase	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"adipose tissue: 253.5;liver: 466.3"	"Cell type enriched"	"Detected in many"	38	"Hepatocytes: 3603.2"	"Cancer enriched"	"Detected in many"	31	"liver cancer: 223.1"	"Group enriched"	"Detected in some"	5	"midbrain: 2.3;pons and medulla: 1.6"	"Low cell type specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Cell line enriched"	"Detected in some"	7	"ASC diff: 394.3"									"HPA047814, HPA060902"	Supported		Approved	"Plasma membrane,Cytosol"		NA	NA		16000000	"Plasma membrane, Cytosol"		"HPA047814: AB_2680163, HPA060902: AB_2684384"	"unprognostic (5.13e-2)"	"unprognostic (9.80e-3)"	"unprognostic (6.59e-2)"	"unprognostic (5.56e-2)"	"unprognostic (9.49e-2)"	"unprognostic (5.53e-2)"	"unprognostic (1.54e-3)"	"unprognostic (1.04e-2)"	"unprognostic (6.51e-2)"	"unprognostic (2.73e-2)"	"unprognostic (7.47e-3)"	"unprognostic (7.79e-2)"	"prognostic unfavorable (7.87e-4)"	"unprognostic (4.60e-3)"	"unprognostic (2.33e-1)"	"unprognostic (2.58e-1)"	"unprognostic (1.60e-2)"	253.5	12.3	0.2	21.8	0.0	0.4	78.7	0.2	0.4	18.3	60.0	0.4	5.7	3.5	12.8	14.4	33.5	22.3	31.9	24.2	0.3	0.0	9.2	466.3	43.8	17.5	2.3	0.1	18.0	8.7	0.8	5.3	0.9	1.6	30.7	10.1	2.3	11.2	3.9	20.5	11.9	25.4	30.8	2.4	5.9	10.9	18.0	0.2	0.2	16.1	9.7	2.0	42.3	76.0	0.6	0.2	1.2	0.3	0.8	0.4	0.0	0.0	0.0	0.0	0.0	394.3	57.8	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.1	0.0	12.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.3	0.3	0.2	0.1	0.1	0.2	0.4	0.1	0.0	0.6	0.3	0.4	1.2	0.8	0.1	0.2	0.1	0.0	0.2	0.0	0.2	0.0	0.3	0.0	2.3	0.1	1.6	0.2	0.0	4.3	14.0	0.4	19.8	0.0	8.9	66.2	0.0	3.4	0.0	0.0	0.0	0.0	0.0	0.4	9.2	0.0	46.7	0.0	0.0	81.0	0.3	1.1	3603.2	0.1	0.0	0.0	93.9	77.5	0.0	51.2	1.0	27.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	6.5	43.7	0.0	0.0	11.4	0.1	12.5	0.0	0.1
ADH1C	ADH3	ENSG00000248144	"Alcohol dehydrogenase 1C (class I), gamma polypeptide"	P00326	4	99336492-99353027	"Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"		Oxidoreductase	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"intestine: 47.1;liver: 149.4;stomach 1: 43.1"	"Cell type enhanced"	"Detected in many"	15	"Exocrine glandular cells: 606.8;Hepatocytes: 378.8;Undifferentiated cells: 355.3"	"Cancer enriched"	"Detected in many"	7	"liver cancer: 238.2"					"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"ASC TERT1: 5.2;HSkMC: 15.4"									"HPA047814, HPA060902"	Supported		Supported	"Plasma membrane,Cytosol"		NA	NA		9700000	"Plasma membrane, Cytosol"		"HPA047814: AB_2680163, HPA060902: AB_2684384"	"unprognostic (3.98e-2)"	"unprognostic (9.88e-3)"	"unprognostic (7.04e-2)"	"unprognostic (1.90e-1)"	"unprognostic (5.14e-1)"	"unprognostic (1.57e-1)"	"prognostic favorable (4.55e-4)"	"prognostic favorable (2.99e-4)"	"unprognostic (8.25e-2)"	"unprognostic (8.89e-3)"	"unprognostic (7.95e-2)"	"unprognostic (2.04e-1)"	"unprognostic (1.12e-1)"	"unprognostic (1.21e-1)"	"unprognostic (1.53e-1)"	"unprognostic (1.70e-1)"	"unprognostic (9.37e-2)"	4.7	0.0	0.0	18.5	0.0	0.0	1.1	0.0	0.0	1.1	37.9	0.0	1.1	43.4	0.3	1.2	1.7	0.0	12.0	2.0	0.0		8.3	149.4	1.1	0.0	0.2	0.0	1.1	11.4	0.0	0.0	0.0	0.0	2.5	13.6	0.0	1.1	0.8	6.0	0.0	47.1	0.9	0.5	0.0	43.1	1.6	0.0	0.0	0.5	2.0	0.2	1.3	0.7	0.2	0.2	0.3	0.1	0.1	0.3	0.1	0.0	2.3	0.0	0.1	1.8	5.2	1.1	0.0	0.7	0.1	0.0	0.0	0.0	0.2	0.2	0.2	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.6	0.3	0.1	0.5	1.4	0.3	15.4	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.2	0.0	0.0	0.4	1.0	0.4	0.0	0.1	0.1	0.9	2.2	0.9	0.0	0.4	1.6	0.7	0.8	0.0	0.0	0.2	0.0	0.1	0.0	0.6	0.3	0.2	0.1	0.0	0.3	0.0	0.8	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.3	0.0	0.2	0.0	0.1	0.3	0.1	0.0	0.2	0.0	0.1											3.0	5.3	1.5	3.6	0.0	0.0	0.8	50.9	80.3	45.5	27.9	0.0	0.0	0.0	141.2	2.4	0.0	51.2	23.3	606.8	0.0	0.0	1.2	0.0	378.8	0.0	0.0	20.7	12.9	12.9	0.6	9.8	0.0	0.0	3.6	36.7	0.0	99.5	63.1	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	355.3	2.0
ADH4	ADH-2	ENSG00000198099	"Alcohol dehydrogenase 4 (class II), pi polypeptide"	P08319	4	99123657-99157792	"Enzymes, Plasma proteins, Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	31	"liver: 345.2"	"Cell type enriched"	"Detected in some"	34	"Hepatocytes: 802.6"	"Cancer enriched"	"Detected in some"	60	"liver cancer: 230.7"	"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enriched"	"Detected in some"	11	"Hep G2: 22.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA020525	Enhanced		Uncertain	Nucleoplasm,Cytosol		NA	NA		5300000	"Nucleoplasm, Cytosol"		"HPA020525: AB_1844609"	"unprognostic (2.75e-1)"	"unprognostic (1.69e-2)"	"unprognostic (1.85e-2)"	"unprognostic (5.54e-3)"	"unprognostic (2.14e-2)"	"unprognostic (1.33e-2)"	"prognostic favorable (7.08e-6)"	"unprognostic (1.49e-1)"		"unprognostic (1.39e-2)"	"unprognostic (6.91e-2)"	"unprognostic (1.88e-1)"	"unprognostic (2.34e-2)"	"unprognostic (7.16e-3)"	"unprognostic (2.20e-1)"		"unprognostic (5.89e-3)"	0.3	0.1	0.0	0.1	0.0	0.0	0.6	0.0	0.1	0.2	3.6	0.0	0.1	11.0	0.0	0.1	0.7	0.0	0.0	0.1	0.0	0.0	0.2	345.2	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.4	0.1	0.4	0.1	4.5	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.2	0.8	0.1	0.1	0.5	1.2	0.7	2.8	0.5	0.4	0.9	0.1	0.3	0.3	0.2	0.3	0.5	0.1	0.2	0.2	0.0	0.0	0.0	0.2	0.2	0.5	0.3	0.0	0.2	0.3	0.0	0.2	0.4	0.3	0.1	0.6	0.8	22.4	0.1	1.8	0.5	0.3	0.0	0.2	0.2	0.2	0.1	0.2	0.4	1.0	0.1	0.3	0.3	0.6	0.4	0.0	0.2	0.2	1.8	0.5	0.2	0.4	0.2	0.3	2.0	0.3	0.0	0.3	0.5	0.0	0.4	0.5	0.2	0.5	0.1	0.6	0.4	0.7	0.1	0.7	0.1	2.8	0.4	0.5	0.9	0.5	0.8	0.4	0.5	0.5	0.1	1.2	0.8	0.8	1.0	0.4	0.5	0.7	0.3	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.2	15.3	0.0	0.0	1.8	0.0	0.0	0.0	0.0	21.9	0.0	0.0	23.3	0.5	0.0	0.0	0.0	0.0	802.6	0.0	0.0	0.0	13.5	20.9	2.6	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.6	0.0
ADH5	"ADH-3, ADHX, FDH, GSNOR"	ENSG00000197894	"Alcohol dehydrogenase 5 (class III), chi polypeptide"	P11766	4	99070978-99088801	"Enzymes, Plasma proteins, Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA044578, HPA061919"	Approved					NA	NA		6800000			"HPA044578: AB_2679002, HPA061919: AB_2684638"	"unprognostic (1.05e-1)"	"unprognostic (1.63e-2)"	"unprognostic (1.14e-3)"	"prognostic favorable (9.90e-5)"	"unprognostic (2.63e-1)"	"unprognostic (1.58e-2)"	"unprognostic (1.11e-1)"	"unprognostic (9.48e-2)"	"prognostic unfavorable (3.54e-4)"	"unprognostic (1.47e-1)"	"unprognostic (1.02e-2)"	"unprognostic (1.22e-1)"	"prognostic favorable (4.58e-10)"	"unprognostic (1.79e-3)"	"unprognostic (9.05e-2)"	"unprognostic (1.15e-2)"	"unprognostic (1.13e-1)"	35.6	19.8	17.3	18.5	18.5	6.3	28.6	11.2	22.3	34.1	39.4	19.8	17.0	24.9	53.8	40.3	43.5	28.6	20.8	31.9	13.7	16.6	46.6	69.7	19.9	15.3	15.7	16.1	39.1	12.8	10.5	15.1	19.9	18.6	45.0	27.7	28.7	17.3	35.9	20.7	13.8	28.5	43.6	13.5	20.5	27.0	27.2	10.0	35.2	30.4	18.4	18.6	60.0	22.0	13.9	12.5	18.2	11.1	26.2	25.3	17.0	15.9	13.0	38.6	21.7	70.2	65.3	23.2	26.6	46.9	28.9	25.3	14.9	19.0	18.5	15.5	38.4	18.6	13.6	26.5	36.9	27.9	13.3	11.1	12.8	17.7	58.6	68.0	22.3	10.4	58.7	28.7	21.6	17.1	30.2	22.2	19.5	23.6	10.6	38.0	18.1	30.0	20.1	31.0	3.9	15.7	22.0	21.6	9.7	45.6	18.7	14.8	19.4	16.0	19.0	29.0	29.6	15.4	15.7	16.6	26.4	16.7	17.2	18.2	11.1	13.8	25.6	27.0	14.8	26.7	9.8	11.1	18.2	18.4	9.8	16.7	13.9	20.3	17.1	12.5	13.1	19.9	18.3	1.6	26.2	7.1	10.8	25.3	17.0	17.3	18.5	11.2	22.3	13.7	16.6	15.7	16.1	18.6	10.0	98.3	64.6	43.8	63.4	35.1	30.0	106.4	73.9	30.8	44.3	52.4	9.8	240.9	167.5	86.8	17.9	51.9	76.6	0.0	73.3	214.7	80.7	31.1	25.5	170.8	104.3	36.5	76.5	49.1	42.8	12.1	173.4	41.1	50.6	74.9	93.0	139.4	66.9	77.2	239.7	228.9	45.0	109.9	78.7	24.1	44.7	20.1	69.5	40.6	88.1	46.7
ADH6	ADH-5	ENSG00000172955	"Alcohol dehydrogenase 6 (class V)"	P28332	4	99202638-99219537	"Enzymes, Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"liver: 123.3"	"Group enriched"	"Detected in some"	10	"Hepatocytes: 299.7;Proximal tubular cells: 76.3"	"Cancer enriched"	"Detected in many"	18	"liver cancer: 46.9"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"neutrophil: 1.3"	"Low lineage specificity"	"Detected in single"			"Cell line enriched"	"Detected in some"	5	"Hep G2: 31.3"					"Not detected"	"Not detected"			"HPA067946, HPA069081"	Enhanced					NA	NA		480000			"HPA067946: AB_2732776, HPA069081: AB_2732127"	"unprognostic (1.38e-2)"	"unprognostic (1.83e-2)"	"unprognostic (5.82e-2)"	"unprognostic (1.49e-3)"	"unprognostic (8.49e-2)"	"unprognostic (1.08e-1)"	"unprognostic (5.11e-3)"	"unprognostic (2.40e-1)"	"unprognostic (3.60e-2)"	"unprognostic (1.35e-1)"	"unprognostic (9.72e-3)"	"unprognostic (1.67e-1)"	"unprognostic (3.66e-3)"	"unprognostic (1.35e-1)"	"unprognostic (2.43e-1)"	"unprognostic (8.74e-3)"	"unprognostic (3.86e-3)"	0.1	0.1	0.1	1.1	0.1	0.0	0.1	0.1	0.1	0.1	6.0	0.0	0.0	7.2	0.1	0.2	0.2	1.5	5.6	0.1	0.1	0.1	10.6	123.3	0.1	0.0	0.1	0.0	0.1	0.2	0.0	0.1	0.0	0.1	0.1	1.4	0.0	0.1	0.0	0.1	0.6	23.7	0.2	0.1	0.1	0.1	0.1	0.0	0.0	0.1	0.1	0.0	0.1	0.1	0.5	0.0	1.3	0.1	0.2	0.2	0.3	0.0	0.4	0.1	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	31.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.1	6.6	0.1	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.1	0.5	0.2	0.0	0.0	0.3	0.1	0.2	1.3	0.2	0.1	0.0	0.1	0.3	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.0	0.0	0.3	1.4	0.0	0.5	0.0	0.3	15.3	18.7	1.2	5.2	0.0	0.0	6.6	0.0	0.0	0.0	12.6	0.0	0.2	0.0	0.0	0.0	0.0	299.7	0.0	0.0	11.6	5.5	2.7	0.0	0.0	0.0	0.0	0.0	4.7	0.0	0.0	2.6	0.0	76.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	6.9	0.1
ADH7	ADH-4	ENSG00000196344	"Alcohol dehydrogenase 7 (class IV), mu or sigma polypeptide"	P40394	4	99412261-99435737	"Enzymes, Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"esophagus: 75.0;lymphoid tissue: 30.7;tongue: 68.7"	"Group enriched"	"Detected in some"	15	"Ciliated cells: 8.1;Club cells: 10.3"	"Group enriched"	"Detected in some"	17	"cervical cancer: 18.4;head and neck cancer: 18.9;lung cancer: 22.4;urothelial cancer: 5.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	7	"ASC TERT1: 4.0;HaCaT: 4.5"	"Not detected"	"Not detected"							HPA039695	Enhanced		Supported	"Plasma membrane,Cytosol"		NA	NA			"Plasma membrane, Cytosol"		"HPA039695: AB_10795681"		"unprognostic (1.02e-2)"			"unprognostic (8.64e-2)"	"unprognostic (4.86e-2)"	"unprognostic (5.66e-3)"	"unprognostic (4.50e-2)"	"unprognostic (1.66e-1)"					"unprognostic (2.02e-1)"			"unprognostic (1.88e-2)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	75.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.7	0.0	0.0	0.2	0.0	0.1	0.0	0.0	9.4	0.0	0.0	0.1	0.0	68.7	30.7	0.1	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	4.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	4.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.2	0.0	8.1	10.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6
ADHFE1	"ADHFe1, FLJ32430"	ENSG00000147576	"Alcohol dehydrogenase, iron containing 1"	Q8IWW8	8	66430185-66471601	"Enzymes, Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 44.5"	"Cell type enhanced"	"Detected in many"	12	"Cardiomyocytes: 32.1;Syncytiotrophoblasts: 97.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"ASC diff: 4.6;HHSteC: 3.0;HSkMC: 2.7;hTERT-RPE1: 2.9;RPTEC TERT1: 4.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA023062	Enhanced		Approved	Vesicles		NA	NA			Vesicles		"HPA023062: AB_1844611"	"prognostic favorable (5.76e-5)"	"unprognostic (8.69e-2)"	"unprognostic (6.71e-2)"	"unprognostic (2.70e-1)"	"unprognostic (1.14e-1)"	"unprognostic (1.22e-1)"	"prognostic favorable (9.90e-5)"	"unprognostic (7.76e-3)"	"unprognostic (2.88e-1)"	"unprognostic (1.32e-1)"	"unprognostic (1.59e-1)"	"unprognostic (9.43e-2)"	"prognostic favorable (4.55e-5)"	"unprognostic (1.37e-2)"	"unprognostic (2.06e-1)"	"unprognostic (4.66e-2)"	"unprognostic (5.94e-3)"	12.5	3.2	10.3	2.2	9.7	1.8	4.3	2.2	10.7	5.9	3.8	10.9	4.8	2.7	4.2	8.6	3.1	5.9	5.0	34.6	6.9	5.4	11.8	44.5	3.6	2.3	8.6	7.5	5.2	8.3	11.6	9.8	3.7	6.9	7.3	3.1	10.7	6.6	10.5	35.7	2.4	2.4	6.9	4.8	2.8	8.6	3.2	7.3	0.0	4.5	12.9	2.5	6.2	1.9	1.3	0.4	3.4	1.1	2.2	2.6	0.6	0.0	0.0	0.0	0.0	4.6	0.0	0.0	0.5	0.4	0.3	0.0	0.0	1.7	0.0	0.0	0.7	0.3	0.3	0.0	0.0	0.0	1.7	0.0	0.0	0.6	0.0	3.0	0.0	0.2	2.7	0.0	0.0	1.3	2.9	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	4.5	0.0	0.2	0.9	0.0	0.5	1.2	1.4	2.0	0.0	0.0	0.3	0.2	0.0	0.0	1.2	0.1	0.1	0.8	0.0	0.3	3.4	1.1	0.0	2.6	0.0	2.4	1.3	0.5	2.2	0.4	0.8	0.7	2.2	0.1	2.2	0.0	0.3	0.0	0.6	10.3	9.7	2.2	7.8	6.9	5.4	8.6	7.5	6.9	7.3	8.9	12.4	2.7	3.8	0.9	1.4	32.1	15.3	20.1	13.6	8.7	9.8	7.1	10.0	1.1	0.3	1.6	2.0	0.0	0.6	0.8	2.7	4.3	8.1	23.7	2.1	0.0	3.5	7.4	1.0	1.0	22.2	1.4	0.0	0.0	1.5	6.7	0.8	5.8	25.5	10.9	7.6	0.0	3.3	0.2	0.2	0.9	97.4	8.7	1.8	2.0
ADI1	"APL1, ARD, FLJ10913, HMFT1638, MTCBP-1, mtnD, SIPL"	ENSG00000182551	"Acireductone dioxygenase 1"	Q9BV57	2	3497361-3519736	"Enzymes, Predicted intracellular proteins"	"Amino-acid biosynthesis, Methionine biosynthesis"	"Dioxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 127.7"	"Cell type enhanced"	"Detected in all"	7	"Distal tubular cells: 752.7;Hepatocytes: 1079.9;Proximal tubular cells: 1041.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035403, HPA035404"	Approved		Supported	"Nucleoplasm,Golgi apparatus"		NA	NA			Nucleoplasm	"Golgi apparatus"	"HPA035403: AB_10603576, HPA035404: AB_2674611"	"unprognostic (2.19e-2)"	"unprognostic (1.68e-2)"	"unprognostic (2.60e-2)"	"unprognostic (1.75e-1)"	"unprognostic (3.65e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.16e-3)"	"unprognostic (4.23e-3)"	"unprognostic (2.36e-3)"	"unprognostic (4.00e-3)"	"unprognostic (2.97e-2)"	"unprognostic (1.50e-1)"	"unprognostic (1.90e-2)"	"unprognostic (1.56e-1)"	"unprognostic (9.94e-2)"	"unprognostic (6.76e-2)"	"unprognostic (8.74e-2)"	13.5	19.1	10.8	9.0	11.5	6.4	15.1	5.2	9.2	12.5	60.6	9.3	29.9	27.3	11.7	17.8	16.3	11.4	35.5	49.5	9.0	7.9	42.6	127.7	10.8	12.4	11.3	9.4	12.8	14.7	9.2	8.4	18.7	9.6	24.5	11.8	10.7	22.7	27.0	43.1	7.9	38.9	17.3	11.7	16.6	18.3	8.0	7.9	4.9	12.9	18.9	10.4	14.7	17.9	14.2	37.8	64.7	26.5	10.1	17.7	32.2	12.0	14.7	13.3	10.6	46.7	22.8	24.9	25.2	32.6	27.4	19.9	20.9	13.8	5.7	39.9	26.7	4.6	11.0	15.7	11.8	14.1	10.2	35.1	17.6	9.5	33.8	39.1	18.2	39.5	25.2	15.7	12.8	16.0	9.7	17.2	8.4	13.1	10.0	21.5	27.1	6.1	32.1	11.6	27.4	23.0	6.5	8.5	32.4	19.0	18.0	14.9	15.0	13.9	14.7	9.6	8.2	15.6	19.3	14.3	18.9	7.7	9.2	14.1	9.9	23.9	23.4	13.9	28.3	9.9	14.2	26.5	64.7	6.3	25.2	6.8	14.2	14.9	5.9	25.6	11.2	17.7	5.9	12.3	10.1	22.0	37.8	13.8	32.2	10.8	11.5	5.2	9.2	9.0	7.9	11.3	9.4	9.6	7.9	62.5	87.9	109.0	118.8	67.5	8.0	255.0	285.3	33.5	56.9	144.8	13.7	343.4	752.7	121.5	6.7	56.4	182.2	46.7	76.6	194.2	104.6	159.8	40.5	1079.9	211.6	7.9	54.8	164.5	143.1	16.8	126.8	60.1	194.0	117.2	123.2	123.6	76.7	181.4	197.7	1041.1	13.1	161.7	119.7	4.6	8.9	67.1	319.0	55.1	135.6	117.6
ADK	AK	ENSG00000156110	"Adenosine kinase"	P55263	10	74151185-74709303	"Disease related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins"	"Purine salvage"	"Kinase, Transferase"	"Disease mutation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 71.9"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB032876, HPA038391, HPA038409, HPA075222"	Approved		Supported	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA		320000	"Nucleoplasm, Cytosol"	"Plasma membrane"	"CAB032876: AB_2242229, HPA038391: AB_2675990, HPA038409: AB_10675798, HPA075222: "	"unprognostic (1.55e-3)"	"unprognostic (1.09e-1)"	"unprognostic (1.88e-1)"	"unprognostic (2.62e-2)"	"unprognostic (2.52e-2)"	"prognostic unfavorable (1.93e-4)"	"prognostic favorable (9.91e-4)"	"unprognostic (2.64e-1)"	"unprognostic (2.88e-1)"	"unprognostic (1.55e-1)"	"unprognostic (8.15e-3)"	"unprognostic (2.51e-1)"	"unprognostic (1.89e-3)"	"unprognostic (2.03e-1)"	"unprognostic (2.88e-2)"	"unprognostic (4.97e-3)"	"unprognostic (2.95e-2)"	13.8	10.7	11.8	13.6	25.4	12.1	14.5	11.2	11.8	9.5	9.3	9.0	9.6	8.8	6.6	10.6	29.4	8.9	6.3	15.7	9.8	11.1	19.0	71.9	15.1	17.9	12.3	9.3	5.2	12.6	15.1	23.5	43.2	11.6	8.7	10.8	8.5	13.1	11.4	18.1	20.8	6.4	8.3	13.2	11.3	7.4	11.9	10.3	13.4	20.8	24.1	21.9	12.6	14.7	49.3	23.0	5.4	21.6	6.5	15.7	9.8	38.1	8.6	9.1	12.2	9.2	14.2	21.0	33.2	26.3	25.7	28.9	24.1	39.8	20.0	8.3	13.3	12.1	34.9	10.7	35.3	41.2	13.4	12.3	12.7	14.1	25.9	10.5	20.3	5.2	13.0	23.3	18.7	46.6	19.0	22.3	9.3	10.1	6.5	19.3	21.3	23.9	27.5	2.6	17.8	60.9	23.1	15.8	17.2	28.1	21.0	7.2	8.5	14.6	56.7	11.0	8.5	37.7	15.4	19.1	8.5	15.7	22.7	27.3	9.4	10.6	22.6	16.1	29.3	5.2	1.3	10.1	1.4	4.5	18.0	10.0	29.7	9.5	8.2	23.0	49.3	7.9	6.5	5.4	6.5	21.6	16.7	15.7	9.8	11.8	25.4	11.2	11.8	9.8	11.1	12.3	9.3	11.6	10.3	77.4	57.2	37.1	62.9	83.7	14.5	53.3	35.7	34.8	76.2	29.6	53.0	120.6	77.9	60.0	55.9	14.7	5.9	0.0	58.9	113.1	27.2	33.9	19.8	112.8	36.3	11.1	10.4	14.7	21.4	22.9	15.5	40.6	45.5	31.5	11.5	10.0	45.7	14.0	11.3	48.3	27.9	6.5	32.8	13.3	12.2	84.8	89.7	20.3	19.9	57.0
ADO	"C10orf22, FLJ14547"	ENSG00000181915	"2-aminoethanethiol dioxygenase"	Q96SZ5	10	62804857-62808483	"Enzymes, Predicted intracellular proteins"		"Dioxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	6	"Early spermatids: 143.0;Late spermatids: 211.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"PC-3: 48.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039194, HPA040437"	Approved					NA	NA					"HPA039194: AB_10794994, HPA040437: AB_10795633"	"unprognostic (4.41e-2)"	"unprognostic (1.44e-1)"	"unprognostic (9.25e-2)"	"unprognostic (1.73e-2)"	"unprognostic (1.54e-2)"	"unprognostic (1.57e-1)"	"prognostic unfavorable (8.01e-5)"	"unprognostic (4.48e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.29e-1)"	"unprognostic (4.24e-2)"	"unprognostic (8.64e-2)"	"unprognostic (8.68e-2)"	"unprognostic (4.11e-2)"	"unprognostic (7.46e-2)"	"unprognostic (2.64e-1)"	"unprognostic (4.59e-2)"	8.9	9.2	12.1	7.5	14.4	4.4	9.8	15.9	22.9	9.5	7.4	18.4	4.1	7.2	10.1	14.3	7.2	7.7	8.7	14.5	14.6	9.7	11.9	7.6	7.9	9.3	20.2	11.0	11.6	8.2	13.0	5.0	7.5	15.6	10.6	6.9	7.4	6.4	9.9	11.6	6.3	6.9	9.8	37.7	8.8	7.4	36.1	12.4	10.0	12.7	6.1	10.0	8.0	10.2	4.0	3.0	2.7	4.3	2.4	2.8	1.4	6.6	5.0	10.0	16.3	11.0	8.4	5.8	8.4	10.0	9.1	9.9	7.8	5.4	6.3	4.4	8.6	7.2	10.3	10.3	6.4	9.7	8.4	7.7	4.3	5.2	6.5	11.4	14.7	11.2	7.1	12.6	9.5	15.5	13.9	6.8	8.4	7.8	6.1	12.0	6.4	9.5	14.4	9.2	6.5	48.7	11.3	7.9	3.8	8.7	4.3	10.4	17.1	8.4	11.7	16.7	8.4	7.6	10.2	5.9	9.2	9.3	7.3	13.8	11.2	20.7	10.2	11.1	15.7	5.8	2.7	2.7	0.8	1.4	4.3	2.8	4.0	1.9	2.1	3.0	3.0	1.7	2.8	0.0	2.4	3.0	2.0	1.0	1.4	12.1	14.4	15.9	22.9	14.6	9.7	20.2	11.0	15.6	12.4	8.9	5.3	3.2	9.6	14.2	21.9	26.0	7.6	5.3	3.4	14.0	5.9	6.9	16.6	5.8	143.0	7.5	3.9	0.0	4.6	6.4	11.4	8.9	2.3	3.2	11.0	30.2	4.7	8.0	13.0	211.6	9.8	11.5	11.8	12.6	7.8	12.8	6.2	0.0	25.1	11.5	14.8	12.9	12.3	31.9	8.3	19.1	3.2	12.1	8.4	9.2
ADPGK	"ADP-GK, DKFZp434B195"	ENSG00000159322	"ADP dependent glucokinase"	Q9BRR6	15	72751369-72785846	"Enzymes, Predicted intracellular proteins"	Glycolysis	"Kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"monocytes: 143.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA045194, HPA058525"	Approved		Approved	Centrosome	"Intracellular and membrane"	NA	NA		35000	Centrosome		"HPA045194: AB_10964638, HPA058525: AB_2683742"	"unprognostic (5.96e-3)"	"unprognostic (1.19e-1)"	"unprognostic (2.22e-1)"	"unprognostic (1.82e-1)"	"unprognostic (1.29e-1)"	"unprognostic (1.98e-1)"	"unprognostic (1.45e-1)"	"unprognostic (8.50e-2)"	"unprognostic (2.27e-1)"	"unprognostic (1.09e-1)"	"unprognostic (1.21e-1)"	"prognostic unfavorable (2.22e-4)"	"prognostic unfavorable (4.52e-7)"	"unprognostic (1.92e-1)"	"unprognostic (6.05e-2)"	"unprognostic (1.60e-1)"	"unprognostic (2.07e-2)"	15.3	13.5	6.7	16.4	10.7	23.1	13.2	7.8	11.7	10.2	11.3	14.9	11.2	8.9	9.5	14.3	11.1	11.0	12.0	9.3	7.0	9.0	13.3	12.8	18.7	19.8	11.7	6.3	10.7	15.2	4.9	9.1	18.2	13.4	14.2	13.7	20.4	15.8	9.8	7.5	10.9	13.1	8.9	9.8	21.4	10.5	10.7	8.8	19.6	12.0	7.8	21.2	12.3	9.6	14.2	32.0	22.2	30.3	13.8	13.0	22.6	6.8	14.3	7.6	9.0	17.3	13.2	10.3	19.9	19.5	20.9	29.1	8.0	18.0	12.9	14.9	12.4	20.8	18.6	21.6	10.4	15.7	12.7	14.7	9.6	4.2	7.5	11.1	22.1	14.4	14.3	6.1	11.0	10.3	10.3	12.1	10.1	10.1	22.1	12.6	4.3	6.8	9.9	11.4	13.6	6.7	8.1	12.4	17.8	10.8	8.0	5.5	5.7	18.2	7.5	9.6	12.5	7.2	26.8	9.9	10.5	8.8	39.7	18.0	22.4	42.7	12.8	18.4	21.8	17.4	22.2	30.3	21.9	10.6	21.0	13.0	14.2	9.7	10.7	32.0	12.5	8.5	9.8	12.0	13.8	17.1	24.4	7.6	22.6	6.7	10.7	7.8	11.7	7.0	9.0	11.7	6.3	13.4	8.8	17.9	33.0	73.1	17.0	13.6	17.9	2.6	2.5	14.7	19.4	19.2	13.7	33.6	6.6	23.4	12.1	17.9	13.2	0.0	15.4	50.9	22.6	31.3	48.4	22.2	72.8	14.3	7.5	17.8	79.5	4.2	20.1	63.6	25.3	143.3	15.2	12.9	19.0	19.8	14.5	10.3	26.6	19.4	12.2	16.8	25.8	15.8	34.9	34.6	19.3	21.9
ADPRH	ARH1	ENSG00000144843	"ADP-ribosylarginine hydrolase"	P54922	3	119579268-119589945	"Enzymes, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 16.0;HEL: 11.5;HMC-1: 13.0;Karpas-707: 17.6;U-266/70: 17.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB001701, HPA036961"	Approved		Approved	"Nucleoplasm,Nuclear membrane"		NA	NA			"Nuclear membrane"	Nucleoplasm	"CAB001701: , HPA036961: AB_2675405"	"prognostic favorable (2.42e-4)"	"unprognostic (2.29e-1)"	"unprognostic (4.77e-1)"	"unprognostic (2.39e-2)"	"unprognostic (3.38e-2)"	"unprognostic (2.65e-1)"	"unprognostic (3.06e-2)"	"unprognostic (2.63e-1)"	"unprognostic (4.24e-2)"	"unprognostic (3.31e-3)"	"unprognostic (1.88e-1)"	"unprognostic (1.71e-1)"	"unprognostic (6.04e-2)"	"unprognostic (2.60e-3)"	"unprognostic (8.87e-2)"	"unprognostic (2.03e-1)"	"unprognostic (4.35e-2)"	14.3	8.5	2.3	10.9	4.6	2.5	14.8	1.2	2.4	7.1	6.2	4.7	14.6	1.9	7.9	6.2	5.0	5.4	6.6	8.4	2.3	2.4	5.1	5.5	17.4	18.9	3.7	2.7	3.6	11.9	8.1	2.8	23.0	4.0	6.3	3.9	6.8	6.5	14.5	19.7	3.1	6.4	8.8	4.7	13.6	5.1	4.1	3.6	5.3	7.4	5.8	12.0	7.1	6.9	8.2	8.0	13.3	13.0	3.4	9.6	4.9	1.6	2.0	0.5	0.0	1.7	1.9	0.0	1.4	0.3	1.2	1.6	0.6	1.3	0.4	0.6	2.1	0.0	0.1	1.4	0.0	1.2	16.0	0.1	11.5	0.2	0.0	2.8	0.0	13.0	2.8	0.0	0.6	0.0	0.5	5.0	0.0	1.0	17.6	7.6	0.5	0.0	2.7	4.8	0.1	4.0	0.0	5.7	0.7	0.7	0.6	0.3	0.0	0.0	0.1	4.3	0.7	3.1	7.2	4.1	0.0	0.8	3.2	0.3	17.2	3.8	0.0	2.1	0.0	3.1	7.8	13.0	13.3	0.6	12.0	0.6	8.2	1.4	1.3	8.0	4.9	0.2	0.6	0.4	3.4	9.2	7.0	9.6	4.9	2.3	4.6	1.2	2.4	2.3	2.4	3.7	2.7	4.0	3.6	8.9	7.5	4.5	0.7	0.7	0.6	4.1	2.5	2.7	4.5	3.5	3.9	4.8	1.7	2.2	0.8	8.4	0.0	0.0	2.9	3.2	1.1	0.9	10.4	1.3	8.4	0.0	0.0	5.5	9.4	0.4	0.3	10.6	1.7	7.2	0.1	0.8	2.4	0.0	2.8	0.8	4.6	0.0	2.9	0.5	0.2	0.6	9.8	1.3	0.0	0.1
ADPRHL2	"ARH3, FLJ20446"	ENSG00000116863	"ADP-ribosylhydrolase like 2"	Q9NX46	1	36088875-36093932	"Enzymes, Predicted intracellular proteins"	"DNA damage, DNA repair"	Hydrolase	"Disease mutation, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA026641, HPA027104, HPA027141"	Approved		Enhanced	Nucleoplasm	"Intracellular and membrane"	NA	NA			Nucleoplasm		"HPA026641: , HPA027104: AB_10601330, HPA027141: AB_1844619"	"unprognostic (3.22e-3)"	"unprognostic (5.10e-2)"	"unprognostic (2.95e-2)"	"unprognostic (1.61e-2)"	"unprognostic (5.98e-2)"	"unprognostic (2.09e-1)"	"prognostic unfavorable (2.10e-7)"	"unprognostic (3.71e-2)"	"unprognostic (2.63e-1)"	"unprognostic (5.34e-2)"	"unprognostic (3.17e-2)"	"unprognostic (7.80e-2)"	"prognostic unfavorable (3.71e-4)"	"unprognostic (4.37e-2)"	"unprognostic (9.31e-2)"	"unprognostic (3.65e-2)"	"unprognostic (4.74e-2)"	15.5	27.6	17.4	15.2	17.4	16.9	20.0	16.5	22.7	15.9	17.3	30.3	17.7	15.6	14.3	17.8	26.3	28.4	13.5	15.1	19.1	18.9	19.8	16.5	20.7	19.1	25.8	18.5	19.7	27.6	15.1	14.0	20.9	19.7	16.6	12.9	12.2	21.9	20.2	26.4	24.4	17.7	22.2	23.5	18.0	14.1	25.1	20.0	21.2	21.2	22.3	19.7	16.1	15.9	27.7	38.9	34.1	38.8	23.5	29.3	29.2	25.7	10.9	13.0	18.3	12.0	8.8	18.6	19.2	16.2	31.1	30.7	12.9	23.4	18.4	18.8	19.1	16.1	16.1	16.4	29.5	18.7	13.1	20.6	16.7	13.2	17.3	22.7	19.0	9.9	10.3	22.6	28.1	12.3	23.7	19.6	17.8	14.4	15.3	14.5	12.4	19.2	28.8	28.0	15.3	22.7	15.7	13.7	18.5	27.8	21.2	16.0	25.4	14.1	14.8	31.3	18.0	15.2	16.5	13.4	18.0	18.6	24.9	25.4	19.9	19.0	16.3	26.0	18.9	11.0	18.2	32.4	34.1	25.5	38.7	24.0	23.6	27.9	29.3	38.9	27.7	28.3	24.0	31.4	23.5	38.8	24.6	22.8	29.2	17.4	17.4	16.5	22.7	19.1	18.9	25.8	18.5	19.7	20.0	29.8	10.0	22.9	24.4	34.9	17.7	7.3	15.3	30.8	14.8	21.0	5.9	67.9	29.9	47.4	6.6	17.1	20.1	0.0	30.7	33.5	19.7	18.0	14.9	6.0	46.0	9.5	16.7	11.1	11.2	7.9	15.3	22.0	25.3	45.1	12.5	24.3	38.3	15.0	17.0	36.1	15.8	25.8	17.9	24.4	46.2	35.8	59.0	19.2	19.8	22.7
ADPRM	"C17orf48, MDS006"	ENSG00000170222	"ADP-ribose/CDP-alcohol diphosphatase, manganese dependent"	Q3LIE5	17	10697594-10711233	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"		Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Rod photoreceptor cells: 33.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023265, HPA023820"	Approved					NA	NA					"HPA023265: AB_1845590, HPA023820: AB_1845591"	"unprognostic (7.58e-3)"	"prognostic favorable (1.69e-4)"	"unprognostic (1.42e-1)"	"prognostic favorable (2.38e-5)"	"unprognostic (2.49e-1)"	"unprognostic (1.30e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.35e-1)"	"unprognostic (1.43e-2)"	"unprognostic (1.43e-1)"	"unprognostic (6.26e-3)"	"unprognostic (2.97e-1)"	"unprognostic (6.53e-3)"	"unprognostic (2.65e-2)"	"unprognostic (1.83e-1)"	"unprognostic (4.77e-2)"	"unprognostic (5.97e-2)"	11.1	8.2	6.4	9.3	13.1	12.9	13.0	9.8	12.2	10.3	8.1	10.1	16.1	6.6	11.3	9.1	7.8	9.0	7.9	6.4	9.6	6.1	7.8	15.2	6.9	23.2	8.1	5.6	14.2	12.4	4.2	11.9	4.9	9.3	16.7	7.5	8.3	8.8	13.4	14.8	9.2	9.9	6.5	7.3	10.5	12.2	9.5	8.2	18.8	14.6	10.4	11.1	8.8	9.0	10.5	4.2	6.1	3.5	4.0	18.7	5.9	4.1	2.2	4.5	5.3	10.5	13.6	2.3	7.9	8.8	5.8	8.7	1.4	2.0	8.1	4.3	8.3	3.0	3.4	1.9	5.7	6.9	5.1	5.3	5.9	3.7	4.5	18.8	3.0	5.5	15.6	10.4	6.1	9.0	10.7	10.1	8.3	4.0	1.5	8.3	1.1	3.9	5.4	3.7	3.0	2.1	3.4	5.3	2.4	10.1	3.1	1.0	6.4	4.2	1.6	9.8	4.9	3.8	6.0	10.3	4.0	2.4	4.5	5.2	2.0	1.4	2.4	7.9	4.5	6.7	3.4	3.5	6.1	3.2	3.0	5.4	8.2	8.8	5.8	4.2	10.5	18.7	12.0	2.5	4.0	3.1	2.4	7.7	5.9	6.4	13.1	9.8	12.2	9.6	6.1	8.1	5.6	9.3	8.2	3.0	1.3	31.2	12.3	4.6	10.4	2.2	2.5	2.7	5.7	1.8	17.7	6.0	3.3	7.7	6.0	6.0	5.1	0.0	7.3	5.7	5.4	10.1	13.9	7.8	5.8	3.2	4.6	4.3	5.1	4.1	14.7	7.9	10.1	10.8	7.4	13.2	7.7	3.5	7.8	6.1	33.4	6.5	10.3	9.2	9.2	4.1	6.9	10.0	4.7	8.9
ADSL		ENSG00000239900	"Adenylosuccinate lyase"	P30566	22	40346500-40390463	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Purine biosynthesis"	Lyase	"Disease mutation, Epilepsy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 79.0"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000525, CAB019285"	Enhanced		Enhanced	Cytosol		NA	NA		180000	Cytosol		"CAB019285: , HPA000525: AB_1078106"	"unprognostic (2.80e-1)"	"unprognostic (2.12e-1)"	"prognostic favorable (2.38e-4)"	"unprognostic (2.64e-1)"	"unprognostic (1.02e-1)"	"unprognostic (6.87e-3)"	"prognostic unfavorable (5.81e-8)"	"unprognostic (1.35e-1)"	"unprognostic (1.25e-1)"	"unprognostic (3.99e-1)"	"unprognostic (6.28e-2)"	"unprognostic (1.85e-1)"	"unprognostic (2.99e-2)"	"unprognostic (8.43e-2)"	"unprognostic (2.70e-1)"	"unprognostic (4.06e-1)"	"unprognostic (1.44e-2)"	9.3	11.6	5.0	13.7	8.5	11.2	9.0	6.8	10.1	7.9	9.5	7.3	4.4	6.0	10.8	9.4	9.7	9.0	6.9	14.6	4.5	4.7	12.0	17.3	6.8	17.6	4.9	4.9	10.5	21.8	5.4	9.1	9.5	5.1	7.1	9.7	9.2	14.7	6.4	79.0	6.2	9.4	10.7	4.9	14.5	9.6	10.9	4.4	18.8	8.4	23.6	15.5	9.5	7.4	15.3	28.8	11.0	22.7	19.8	34.0	24.6	21.4	25.3	21.8	31.1	14.7	20.8	25.3	19.6	19.4	42.6	32.5	41.8	12.6	62.4	16.7	22.7	19.4	16.2	48.6	31.6	43.8	16.6	45.7	28.3	28.6	38.5	30.9	92.1	23.8	22.3	17.9	37.4	39.7	21.1	31.4	28.2	33.4	27.4	31.8	24.0	28.4	32.9	35.5	25.9	27.0	43.3	45.8	44.3	27.4	17.0	14.1	13.9	23.4	13.0	37.2	20.0	17.9	29.1	20.8	22.8	42.2	20.1	37.5	26.0	45.4	47.8	19.0	34.2	22.2	11.0	19.3	7.8	16.2	22.7	22.8	15.3	34.0	21.7	28.8	14.9	27.0	20.8	1.9	19.8	20.2	14.9	34.0	24.6	5.0	8.5	6.8	10.1	4.5	4.7	4.9	4.9	5.1	4.4	11.9	9.6	11.9	15.4	16.1	15.9	25.7	20.4	5.3	7.9	3.5	35.3	78.9	6.6	48.2	34.1	17.1	14.2	0.0	38.1	60.7	23.3	13.9	36.8	21.3	54.2	6.4	13.3	33.2	40.2	16.1	23.0	24.7	11.8	41.5	20.7	43.1	33.8	7.0	13.4	13.5	17.0	25.8	17.6	39.7	73.9	13.2	27.7	27.4	37.6	9.3
ADSS		ENSG00000035687	"Adenylosuccinate synthase"	P30520	1	244408494-244452134	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Purine biosynthesis"	Ligase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA024400	Supported		Supported	"Plasma membrane,Cytosol"		NA	NA		620000	Cytosol	"Plasma membrane"	"HPA024400: AB_1844623"	"unprognostic (4.24e-3)"	"unprognostic (2.63e-1)"	"unprognostic (3.95e-2)"	"unprognostic (8.68e-2)"	"unprognostic (6.91e-2)"	"unprognostic (2.04e-1)"	"unprognostic (1.62e-2)"	"unprognostic (2.58e-1)"	"unprognostic (1.12e-1)"	"unprognostic (1.01e-2)"	"unprognostic (1.44e-2)"	"unprognostic (3.10e-1)"	"unprognostic (1.35e-1)"	"unprognostic (7.62e-2)"	"unprognostic (1.86e-1)"	"unprognostic (2.04e-1)"	"unprognostic (1.18e-2)"	19.4	17.8	23.2	23.8	31.2	29.2	26.3	18.3	26.3	20.9	20.9	35.9	27.1	21.1	18.9	23.3	27.7	18.3	15.8	9.8	24.9	23.4	25.1	19.3	19.2	21.2	42.5	16.6	20.9	21.2	26.6	17.7	21.0	34.9	19.8	22.7	13.1	25.0	21.7	11.0	26.5	23.2	22.9	29.3	24.9	24.7	48.9	36.7	26.7	26.3	17.9	24.8	26.5	21.8	10.9	13.6	24.6	21.3	15.5	16.0	11.9	25.7	14.2	12.4	10.9	14.6	20.9	22.9	26.0	21.9	18.7	14.2	18.7	24.9	23.0	17.3	20.0	8.0	19.5	13.5	17.0	21.0	17.0	24.0	15.3	14.2	14.1	17.5	36.2	19.8	14.3	20.6	17.4	17.6	21.8	66.6	12.7	26.5	17.1	18.5	6.1	23.2	24.3	33.0	24.6	15.7	21.5	11.8	24.8	31.0	16.0	16.9	14.8	22.1	20.6	26.0	13.8	14.3	19.3	29.1	17.3	9.5	20.0	27.0	20.8	27.2	17.4	14.3	42.5	25.5	24.6	15.8	13.0	15.0	20.5	16.0	10.9	13.7	12.8	13.6	8.6	11.8	13.3	11.9	15.5	21.3	5.5	14.7	11.9	23.2	31.2	18.3	26.3	24.9	23.4	42.5	16.6	34.9	36.7	44.7	30.5	40.0	44.7	90.9	12.4	5.8	35.7	127.2	85.3	57.6	5.9	47.0	74.6	41.2	102.9	33.7	30.0	0.0	44.0	83.0	35.8	40.9	28.9	29.6	33.8	9.5	17.3	37.4	38.1	103.8	17.5	51.2	40.5	37.9	29.4	34.0	38.5	21.0	15.9	57.5	7.2	12.9	34.0	104.8	68.7	86.1	45.2	60.6	38.1	62.8
ADSSL1	FLJ38602	ENSG00000185100	"Adenylosuccinate synthase like 1"	Q8N142	14	104724186-104747325	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Purine biosynthesis"	Ligase	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"skeletal muscle: 200.5;tongue: 53.2"	"Cell type enhanced"	"Detected in many"	21	"Cardiomyocytes: 119.6;Early spermatids: 397.7;Late spermatids: 83.9;Muller glia cells: 76.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"intermediate monocyte: 2.1"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"EFO-21: 12.0;MCF7: 10.6;OE19: 17.0;SiHa: 17.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA		220000				"unprognostic (2.23e-2)"	"unprognostic (3.15e-1)"	"unprognostic (1.72e-3)"	"unprognostic (5.14e-2)"	"unprognostic (2.81e-3)"	"unprognostic (3.46e-1)"	"unprognostic (1.70e-2)"	"unprognostic (1.15e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.58e-2)"	"unprognostic (2.26e-1)"	"unprognostic (3.35e-1)"	"prognostic unfavorable (4.99e-4)"	"unprognostic (2.33e-1)"	"unprognostic (2.35e-1)"	"unprognostic (2.18e-2)"	"unprognostic (2.78e-2)"	2.5	1.1	0.8	0.5	1.8	0.4	0.9	0.3	1.2	0.8	0.7	3.4	0.3	0.8	0.9	3.5	3.9	1.5	2.2	27.8	1.2	1.5	2.9	7.2	0.7	0.5	3.3	0.4	0.8	1.7	1.9	2.2	1.6	2.0	1.9	0.6	4.6	3.2	1.1	200.5	1.3	0.8	1.0	2.1	0.5	1.2	3.4	2.0	0.0	1.7	53.2	2.8	6.1	3.8	0.0	0.4	1.2	2.1	0.0	0.5	0.0	0.1	2.5	1.8	5.5	1.3	0.8	0.6	0.7	1.0	0.2	0.5	0.2	1.9	0.0	12.0	0.6	0.4	1.0	0.1	0.4	0.4	0.8	0.4	0.0	5.9	0.8	1.4	0.0	4.7	2.6	1.8	0.0	2.0	2.1	0.3	0.2	2.1	0.0	0.9	10.6	0.0	0.5	1.6	17.0	1.1	0.1	0.2	0.6	0.4	1.3	1.6	3.3	17.8	0.8	2.4	1.5	5.6	1.5	0.6	0.1	0.5	1.2	0.0	3.5	2.5	0.0	1.7	0.8	1.2	0.0	0.1	1.2	0.5	2.1	0.0	0.0	0.1	0.4	0.4	0.0	0.4	0.5	0.8	0.0	0.1	0.0	0.0	0.0	0.8	1.8	0.3	1.2	1.2	1.5	3.3	0.4	2.0	2.0	3.0	0.3	0.0	5.2	4.6	3.5	119.6	2.5	14.7	2.3	3.5	0.0	2.8	6.6	2.1	397.7	3.1	3.2	0.0	4.3	1.4	4.7	3.6	0.0	12.8	3.0	4.8	9.2	7.4	2.2	83.9	8.1	2.6	10.1	1.8	2.5	76.5	2.0	3.5	17.3	14.6	2.6	12.9	3.1	35.8	21.6	5.3	1.3	1.7	1.7	7.1
AEBP1	ACLP	ENSG00000106624	"AE binding protein 1"	Q8IUX7	7	44104361-44114562	"Enzymes, Predicted intracellular proteins, Predicted secreted proteins"	"Transcription, Transcription regulation"	"Calmodulin-binding, DNA-binding, Repressor"	"Disease mutation, Ehlers-Danlos syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"vagina: 177.1"	"Cell type enhanced"	"Detected in many"	19	"Fibroblasts: 159.0;Leydig cells: 140.4;Peritubular cells: 478.4;Smooth muscle cells: 174.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	5	"plasmacytoid DC: 10.5"	"Lineage enriched"	"Detected in many"	5	"dendritic cells: 10.5"	"Cell line enhanced"	"Detected in many"		"ASC diff: 34.9;BJ: 45.9;BJ hTERT+: 30.3;fHDF/TERT166: 49.3;JURKAT: 34.8;WM-115: 28.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"CAB009966, HPA047724, HPA063595, HPA064970"	Supported		Supported	Nucleoplasm,Vesicles,Cytosol	"Secreted - unknown location"	NA	NA		2300000	Vesicles	"Nucleoplasm, Cytosol"	"CAB009966: AB_2225690, HPA047724: AB_2680132, HPA063595: AB_2685052, HPA064970: AB_2685394"	"unprognostic (1.70e-2)"	"unprognostic (5.42e-2)"	"unprognostic (1.66e-2)"	"unprognostic (1.45e-1)"	"prognostic unfavorable (1.60e-4)"	"unprognostic (1.13e-1)"	"unprognostic (7.00e-2)"	"unprognostic (8.79e-2)"	"unprognostic (2.52e-1)"	"unprognostic (3.27e-2)"	"unprognostic (1.26e-1)"	"unprognostic (1.94e-1)"	"prognostic unfavorable (9.31e-9)"	"unprognostic (2.88e-3)"	"unprognostic (9.58e-2)"	"unprognostic (1.17e-2)"	"unprognostic (6.28e-3)"	46.5	19.0	8.9	23.9	9.5	3.1	90.9	1.7	5.4	78.1	20.5	17.9	15.8	5.8	73.7	39.4	20.7	43.7	47.9	35.4	12.7	6.4	19.6	6.3	35.5	13.0	12.5	10.8	84.8	8.8	2.7	10.9	26.7	17.2	46.1	7.9	33.3	11.9	70.2	11.4	19.7	16.9	42.6	43.7	16.6	17.6	30.6	9.6	48.0	19.6	12.3	7.5	58.2	177.1	2.3	10.5	0.0	0.0	0.2	1.4	0.4	0.1	0.0	10.8	0.0	34.9	12.4	0.2	45.9	30.3	5.2	1.1	0.0	0.0	1.2	5.1	49.3	0.0	0.0	0.5	0.8	2.2	0.1	0.0	3.1	0.0	0.0	9.8	0.0	0.0	18.8	0.0	17.7	0.0	0.2	2.3	34.8	1.9	0.0	0.0	0.0	19.9	3.7	4.6	0.0	0.0	16.5	0.4	0.3	1.2	0.0	1.1	6.1	0.0	0.0	20.1	10.6	0.1	3.3	8.0	0.0	21.3	0.1	0.0	0.2	0.2	24.2	0.1	0.0	28.2	0.0	0.0	0.0	0.4	0.0	0.3	2.1	0.4	0.0	0.0	2.3	1.4	0.8	0.0	0.2	0.0	10.5	0.0	0.4	8.9	9.5	1.7	5.4	12.7	6.4	12.5	10.8	17.2	9.6	0.0	4.5	6.7	5.4	30.7	0.2	15.5	0.0	4.0	2.3	7.0	0.0	1.7	0.0	0.8	2.0	14.4	0.0	0.0	0.0	2.6	159.0	2.4	2.3	0.0	3.1	0.0	0.0	38.6	1.9	9.5	140.4	3.8	81.0	1.0	0.0	0.1	0.7	0.0	478.4	0.6	0.6	38.8	174.1	2.4	4.5	24.0	2.9	0.7	0.0	2.0
AFG3L2	"SCA28, SPAX5"	ENSG00000141385	"AFG3 like matrix AAA peptidase subunit 2"	Q9Y4W6	18	12328944-12377314	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted membrane proteins"		"Hydrolase, Metalloprotease, Protease"	"Disease mutation, Neurodegeneration, Spinocerebellar ataxia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004479, HPA004480"	Enhanced		Supported	Mitochondria		NA	NA			Mitochondria		"HPA004479: AB_1078109, HPA004480: AB_1078108"	"unprognostic (1.11e-1)"	"unprognostic (7.49e-2)"	"unprognostic (1.67e-1)"	"prognostic unfavorable (8.68e-4)"	"unprognostic (1.31e-1)"	"unprognostic (5.06e-3)"	"unprognostic (1.61e-1)"	"unprognostic (2.33e-1)"	"unprognostic (5.35e-2)"	"unprognostic (1.54e-2)"	"unprognostic (4.05e-2)"	"unprognostic (3.00e-2)"	"prognostic favorable (6.05e-14)"	"unprognostic (5.90e-2)"	"unprognostic (9.41e-2)"	"unprognostic (5.74e-3)"	"unprognostic (2.22e-1)"	11.5	15.8	11.8	14.3	14.0	11.7	19.9	17.2	30.3	11.2	25.7	9.5	12.7	33.1	11.4	10.1	18.3	10.4	11.2	77.4	13.2	13.1	27.2	22.9	16.3	23.7	12.0	13.2	12.0	23.1	34.3	12.6	9.9	16.9	10.8	23.5	12.2	14.9	14.8	61.0	17.5	35.0	15.1	14.0	9.9	16.0	8.9	7.1	10.7	16.9	22.4	13.2	14.0	11.6	10.1	15.8	8.5	12.3	19.9	15.2	8.4	15.0	15.4	11.0	12.4	12.7	14.0	14.7	16.9	16.8	24.2	17.8	23.8	9.3	43.4	18.6	15.3	21.5	15.2	27.8	19.4	19.8	10.1	11.9	13.0	16.9	22.3	17.4	48.9	19.5	15.4	21.3	22.9	30.3	13.4	17.6	15.6	29.2	25.7	11.8	23.9	17.5	15.0	15.3	74.6	11.4	19.7	34.8	36.2	20.8	33.5	20.6	14.4	26.5	28.8	23.7	14.8	13.2	22.1	13.3	28.9	24.8	27.4	22.0	18.1	20.8	27.8	15.8	19.3	13.2	2.6	11.5	8.5	8.7	12.3	10.7	10.1	10.4	13.7	15.8	7.7	13.3	15.2	0.8	19.9	10.8	8.1	6.4	8.4	11.8	14.0	17.2	30.3	13.2	13.1	12.0	13.2	16.9	7.1	38.7	35.6	27.6	31.2	19.7	46.8	69.2	40.8	28.1	33.0	33.2	47.1	50.2	61.3	33.0	4.2	23.3	78.3	46.7	32.4	29.6	23.8	24.6	13.9	71.5	32.6	28.6	37.6	18.4	22.3	2.7	30.5	25.6	21.9	20.8	71.9	29.1	36.4	31.7	28.3	54.2	55.2	25.8	20.6	47.7	72.0	27.4	77.6	17.5	75.2	29.8
AFMID	"DKFZp686F03259, KF"	ENSG00000183077	Arylformamidase	Q63HM1	17	78187317-78207701	"Enzymes, Predicted intracellular proteins"	"Tryptophan catabolism"	Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 78.7"	"Cell type enhanced"	"Detected in many"	6	"Cholangiocytes: 68.8;Hepatocytes: 100.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"intermediate monocyte: 14.5"	"Group enriched"	"Detected in all"	5	"B-cells: 5.1;dendritic cells: 6.7;monocytes: 14.5"	"Cell line enhanced"	"Detected in all"		"Hep G2: 62.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA023861, HPA026536"	Uncertain		Approved	Mitochondria		NA	NA			Mitochondria		"HPA023861: AB_1844636, HPA026536: AB_1844637"	"unprognostic (3.55e-2)"	"unprognostic (1.54e-2)"	"unprognostic (1.53e-1)"	"unprognostic (2.65e-3)"	"unprognostic (2.06e-1)"	"unprognostic (4.73e-2)"	"unprognostic (2.78e-1)"	"unprognostic (1.83e-1)"	"unprognostic (1.49e-3)"	"unprognostic (1.53e-2)"	"unprognostic (5.78e-2)"	"unprognostic (9.59e-3)"	"unprognostic (9.12e-2)"	"unprognostic (1.80e-2)"	"unprognostic (1.43e-1)"	"unprognostic (1.94e-1)"	"unprognostic (7.79e-2)"	5.9	3.5	12.1	5.4	17.1	4.6	33.0	27.1	18.3	6.1	7.5	44.8	11.7	8.5	7.5	7.0	7.7	11.3	11.4	9.4	17.3	12.0	39.4	78.7	10.6	5.2	29.7	13.3	15.9	27.7	6.9	4.1	12.4	18.1	10.7	9.2	5.8	24.7	11.8	7.9	15.5	7.1	6.6	27.0	6.2	10.2	6.2	23.9	3.9	6.5	5.6	6.2	6.7	7.4	5.1	6.7	1.7	14.5	1.6	1.1	1.5	7.0	10.0	8.8	8.0	10.0	11.7	4.8	10.1	5.8	7.2	8.6	10.6	5.9	22.1	6.7	7.7	4.2	6.1	14.9	8.9	10.1	14.0	11.9	17.8	11.8	62.3	8.7	14.7	9.2	15.6	9.4	8.3	10.9	11.8	13.4	6.7	18.0	7.8	5.5	7.0	11.2	22.4	7.2	17.2	17.3	12.8	9.0	26.5	9.7	6.5	19.7	14.6	8.7	26.3	8.2	9.2	7.9	14.3	6.6	11.0	7.2	6.9	7.1	11.9	7.8	22.7	9.1	7.2	2.8	1.1	6.1	0.7	0.7	14.5	1.1	5.1	1.0	1.1	6.7	2.0	0.6	0.6	1.7	1.6	9.3	4.4	0.9	1.5	12.1	17.1	27.1	18.3	17.3	12.0	29.7	13.3	18.1	23.9	14.9	13.6	10.0	19.1	23.5	1.4	11.5	68.8	17.4	12.5	61.1	3.9	10.9	14.9	10.4	0.3	14.7	12.9	0.0	7.4	9.5	15.0	15.8	2.3	100.2	9.5	1.6	12.6	21.5	21.9	1.5	20.8	18.3	28.7	10.8	20.6	1.7	8.6	24.9	20.5	39.6	1.5	0.0	7.5	1.2	11.8	35.9	9.6	4.4	25.0	12.2
AGA	ASRG	ENSG00000038002	Aspartylglucosaminidase	P20933	4	177430770-177442503	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		"Hydrolase, Protease"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"BJ hTERT+: 32.2;Karpas-707: 45.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031415, HPA031417"	Enhanced				"Intracellular and membrane"	NA	NA		28000000			"HPA031415: AB_10603578, HPA031417: AB_10670967"	"unprognostic (8.76e-2)"	"unprognostic (1.56e-1)"	"unprognostic (2.22e-3)"	"unprognostic (2.11e-3)"	"unprognostic (2.70e-2)"	"prognostic unfavorable (8.61e-4)"	"prognostic unfavorable (1.99e-4)"	"unprognostic (3.79e-1)"	"unprognostic (6.44e-2)"	"unprognostic (4.23e-2)"	"unprognostic (4.28e-2)"	"unprognostic (1.09e-1)"	"unprognostic (7.49e-2)"	"unprognostic (2.07e-1)"	"unprognostic (3.49e-1)"	"unprognostic (7.42e-2)"	"unprognostic (1.47e-2)"	12.8	15.1	11.2	11.2	11.9	10.9	18.5	4.4	13.7	13.5	12.1	24.2	8.0	8.0	9.8	26.4	18.8	7.1	15.1	8.4	13.0	9.4	20.5	26.5	12.4	12.3	14.0	11.0	10.2	14.7	19.2	9.0	9.3	15.0	10.1	11.1	24.0	27.1	10.8	6.7	16.9	14.4	8.1	22.3	14.9	13.0	13.3	10.0	13.4	14.0	14.3	18.3	9.0	10.2	10.0	11.1	16.3	23.8	8.9	16.3	10.3	2.1	4.7	5.4	7.7	6.4	5.7	3.7	15.8	32.2	8.2	10.4	2.5	10.6	10.5	2.9	12.2	4.0	2.6	4.6	5.2	16.7	6.8	3.0	4.4	5.2	6.9	4.2	7.6	3.0	4.0	9.1	6.0	2.7	7.4	7.7	4.7	3.9	45.6	3.3	5.8	6.1	4.8	2.1	4.2	4.9	1.9	2.2	1.6	8.7	5.3	3.0	6.9	4.7	4.1	12.5	4.3	9.3	15.7	2.4	5.7	5.1	2.7	6.1	8.8	6.7	5.6	9.2	8.7	6.4	15.0	10.7	16.3	11.7	18.9	13.4	10.0	12.8	14.0	10.5	8.1	11.4	16.3	2.4	8.9	23.8	11.1	12.0	10.3	11.2	11.9	4.4	13.7	13.0	9.4	14.0	11.0	15.0	10.0	11.9	9.1	12.3	14.9	21.3	3.3	5.7	17.8	5.3	11.4	14.0	2.0	21.6	5.0	21.9	11.4	11.1	9.1	0.0	27.5	25.3	15.5	15.7	13.9	15.1	21.7	6.4	5.2	6.2	9.1	6.8	10.3	22.8	37.1	25.2	16.6	17.6	20.6	5.8	9.2	16.3	3.7	0.0	12.4	34.8	31.5	23.8	19.0	22.3	13.4	15.2
AGBL1	"CCP4, FLJ32310"	ENSG00000273540	"ATP/GTP binding protein like 1"	Q96MI9	15	86079973-87029052	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		"Carboxypeptidase, Hydrolase, Metalloprotease, Protease"	"Corneal dystrophy"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"skeletal muscle: 16.7;tongue: 35.5"	"Cell type enhanced"	"Detected in some"	28	"Alveolar cells type 1: 3.0;Alveolar cells type 2: 11.8;Early spermatids: 2.1;Late spermatids: 1.7"	"Not detected"	"Not detected"							"Cell type enhanced"	"Detected in single"		"neutrophil: 1.3"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"AF22: 2.5;RH-30: 1.8;SCLC-21H: 2.8"	"Low region specificity"	"Detected in single"													NA	NA										"unprognostic (3.70e-2)"	"unprognostic (4.46e-2)"		"unprognostic (1.06e-1)"										0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.8	0.0	0.0	0.4	0.0	0.0	0.0	5.8	1.3	0.0	0.0	0.0	0.1		0.0	0.0	2.9	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.6	0.6	0.0	0.0	1.3	0.0	16.7	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.5	35.5	1.0	0.0	0.0	0.5	0.3	1.3	0.3	0.3	0.2	0.0	0.0	0.1	2.5	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.8	0.3	0.0	0.1	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.2	0.0	0.1	0.1	0.2	0.0	0.0	0.2	0.1	1.8	0.1	0.0	0.2	2.8	0.2	0.3	0.0	0.0	0.1	0.1	0.0	0.0	0.2	0.4	0.2	0.0	0.2	0.0	0.2	0.1	0.1	0.0	0.7	0.3	0.2	0.1	0.1	0.1	0.2	0.2	0.2	0.0	0.5	0.1	0.1	1.3	0.3	0.0	0.3	0.1	0.0											3.0	11.8	0.0	0.0	0.0	1.6	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0
AGBL2	"CCP2, FLJ23598"	ENSG00000165923	"ATP/GTP binding protein like 2"	Q5U5Z8	11	47659591-47715389	"Enzymes, Predicted intracellular proteins"		"Carboxypeptidase, Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"testis: 34.0"	"Cell type enriched"	"Detected in some"	5	"Ciliated cells: 107.1"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"CAPAN-2: 6.1;T-47d: 3.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA007718	Uncertain					NA	NA					"HPA007718: AB_1078110"	"unprognostic (3.44e-5)"	"unprognostic (1.16e-1)"	"unprognostic (5.84e-2)"	"unprognostic (5.33e-4)"	"unprognostic (1.13e-1)"	"unprognostic (3.00e-1)"	"unprognostic (2.05e-1)"	"unprognostic (1.38e-2)"	"unprognostic (9.83e-3)"	"unprognostic (4.11e-2)"	"unprognostic (5.56e-2)"	"unprognostic (1.79e-1)"	"unprognostic (8.24e-6)"	"unprognostic (1.01e-2)"	"unprognostic (1.28e-1)"	"unprognostic (9.62e-2)"	"unprognostic (1.17e-3)"	0.4	1.7	0.8	6.6	2.7	0.7	1.1	3.6	1.1	1.9	2.0	2.8	1.5	1.1	1.6	11.2	0.5	12.2	2.4	0.4	1.3	1.4	1.8	3.0	6.4	1.4	0.3	0.3	2.1	4.7	1.2	3.8	0.7	3.4	1.6	0.8	0.7	1.1	1.7	0.4	0.6	3.3	0.6	0.7	1.7	0.8	34.0	0.7	4.4	1.9	0.5	2.6	2.1	1.4	2.6	1.5	0.4	0.2	1.4	2.2	0.6	1.2	0.0	0.0	0.0	0.3	1.7	0.1	0.4	0.8	0.5	1.7	0.6	6.1	0.1	0.4	0.4	0.8	1.6	0.0	0.1	0.8	1.8	0.4	0.3	2.9	2.2	0.9	0.0	1.0	1.8	0.7	0.9	0.5	0.6	0.1	2.1	0.4	1.3	0.9	2.4	1.2	0.6	0.0	0.3	0.1	1.7	0.1	0.5	0.9	2.7	2.2	0.5	0.7	0.0	0.7	0.0	3.5	0.0	0.2	0.2	0.5	0.3	0.0	0.0	0.1	0.1	0.3	0.3	0.3	0.0	0.1	0.0	1.5	0.0	1.3	1.0	1.6	1.2	0.1	2.6	1.9	1.7	0.4	1.4	0.2	1.5	2.2	0.6	0.8	2.7	3.6	1.1	1.3	1.4	0.3	0.3	3.4	0.7	0.0	2.4	0.0	1.2	0.1	0.0	0.4	0.0	107.1	10.3	7.0	0.0	0.4	0.0	0.2	23.4	0.0	1.0	0.0	0.0	0.2	0.6	0.3	0.0	0.6	0.1	0.0	1.2	0.6	0.3	6.6	0.3	0.3	0.0	1.8	0.6	0.5	0.2	0.0	1.4	0.0	0.4	0.0	0.1	19.6	1.0	0.0	0.3	0.7	0.8	0.3
AGBL3	"CCP3, MGC32955"	ENSG00000146856	"ATP/GTP binding protein like 3"	Q8NEM8	7	134986508-135147963	"Enzymes, Predicted intracellular proteins"		"Carboxypeptidase, Hydrolase, Metalloprotease, Protease"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	11	"Early spermatids: 40.4;Spermatocytes: 19.5"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HEK 293: 8.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA020397, HPA024150"	Uncertain		Approved	Cytosol		NA	No			Cytosol		"HPA020397: AB_2242453, HPA024150: AB_1844639"	"unprognostic (8.84e-2)"	"unprognostic (1.49e-2)"	"unprognostic (4.72e-2)"	"unprognostic (2.18e-1)"	"unprognostic (1.47e-1)"	"unprognostic (3.39e-3)"	"unprognostic (3.32e-3)"	"unprognostic (4.18e-2)"	"unprognostic (7.15e-4)"	"unprognostic (5.00e-3)"	"unprognostic (6.10e-4)"	"unprognostic (3.16e-2)"	"prognostic unfavorable (4.02e-4)"	"unprognostic (2.18e-2)"	"unprognostic (2.14e-1)"	"unprognostic (8.13e-2)"	"unprognostic (1.11e-3)"	3.2	2.7	4.2	4.1	8.4	3.8	4.6	8.7	4.5	4.3	2.4	4.4	4.5	1.6	5.5	15.4	2.2	3.6	3.1	2.4	5.0	3.4	5.3	2.6	3.6	4.0	2.7	4.5	6.8	4.5	0.6	9.2	1.9	3.3	3.8	3.0	3.1	4.9	4.3	4.2	4.7	3.7	3.3	2.9	6.5	4.4	18.7	3.7	2.7	5.4	0.8	2.8	3.3	2.5	2.2	1.7	0.5	0.2	2.2	5.0	1.7	2.6	1.4	3.6	0.8	1.0	1.4	2.2	0.7	0.0	0.5	0.8	4.7	3.0	4.3	1.3	0.0	1.4	2.8	1.3	0.5	0.0	3.4	8.8	3.6	5.3	4.6	0.0	1.6	0.0	0.2	0.0	2.1	0.0	0.0	1.6	4.7	2.6	2.5	0.6	2.5	0.9	1.5	3.1	0.4	0.3	2.5	0.2	1.2	2.6	0.5	2.1	2.4	0.5	0.0	0.3	0.1	1.9	3.5	0.0	0.4	0.9	0.5	1.6	5.3	1.6	1.9	1.8	4.3	4.4	0.0	0.2	0.4	2.4	0.0	1.8	2.1	1.2	2.5	0.5	2.2	2.0	5.0	0.5	2.2	0.1	1.7	1.7	1.7	4.2	8.4	8.7	4.5	5.0	3.4	2.7	4.5	3.3	3.7	3.0	1.1	1.3	1.0	1.1	4.9	1.6	5.1	5.3	2.3	8.7	2.0	0.2	6.6	3.1	40.4	3.8	0.3	0.0	2.5	0.3	1.4	1.5	1.1	1.6	0.4	3.2	2.9	5.5	1.6	8.5	3.1	0.3	5.0	11.8	0.3	2.7	1.6	0.0	2.1	5.1	2.9	0.0	2.3	19.5	3.6	0.3	0.1	1.0	0.0	0.8
AGBL4	"CCP6, FLJ14442"	ENSG00000186094	"ATP/GTP binding protein like 4"	Q5VU57	1	48532855-50023913	"Enzymes, Predicted intracellular proteins"		"Carboxypeptidase, Hydrolase, Metalloprotease, Protease"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"brain: 20.4;pituitary gland: 31.5"	"Cell type enhanced"	"Detected in some"	23	"Cone photoreceptor cells: 80.5;Rod photoreceptor cells: 22.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"NTERA-2: 3.7;SCLC-21H: 5.3;SH-SY5Y: 2.0;SuSa: 1.8;U-937: 2.2"	"Low region specificity"	"Detected in many"							HPA037994	Approved					NA	NA					"HPA037994: AB_10673036"	"unprognostic (3.06e-2)"	"unprognostic (2.76e-1)"	"unprognostic (2.58e-2)"	"unprognostic (3.31e-4)"	"unprognostic (3.42e-4)"	"unprognostic (1.72e-1)"	"unprognostic (3.86e-3)"	"unprognostic (2.31e-2)"	"unprognostic (1.50e-1)"	"unprognostic (1.14e-1)"	"unprognostic (5.85e-3)"	"unprognostic (3.91e-2)"	"unprognostic (1.51e-4)"	"unprognostic (5.95e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.18e-2)"	"unprognostic (2.85e-1)"	1.4	4.5	7.8	0.8	13.6	1.1	1.5	1.3	20.4	1.0	0.8	3.0	0.1	0.7	1.0	4.5	0.9	7.8	1.0	3.7	7.1	7.2	10.2	4.6	1.6	0.8	3.2	11.6	1.3	2.7	3.6	31.5	2.7	6.7	1.0	0.7	4.6	0.8	1.5	0.9	1.5	0.8	0.7	1.5	1.3	1.1	10.7	1.9	0.0	3.4	0.0	0.8	0.7	0.7	0.8	0.5	2.2	0.3	0.6	1.8	0.2	0.0	0.5	0.8	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.5	0.1	0.0	0.0	0.0	0.9	0.1	0.2	0.2	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.3	0.2	0.0	0.3	0.1	0.4	3.7	0.0	0.4	0.1	0.1	0.1	0.1	0.3	5.3	2.0	0.0	0.2	0.0	1.8	0.0	0.3	0.0	0.0	1.4	0.2	0.0	0.2	0.0	0.1	0.1	2.2	0.5	2.2	0.3	0.4	0.3	0.3	1.8	0.5	0.2	0.1	0.2	0.8	0.4	0.2	1.0	0.6	0.2	0.5	0.3	0.2	7.8	13.6	1.3	20.4	7.1	7.2	3.2	11.6	6.7	1.9	0.0	0.0	0.0	0.6	0.2	2.3	1.0	0.0	9.4	1.2	3.5	80.5	0.1	1.7	0.1	9.7	0.1	0.0	0.0	0.2	0.0	0.2	0.3	0.0	0.0	0.1	4.8	5.8	0.6	0.0	6.5	0.3	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.7	3.8	22.3	0.0	0.0	13.6	3.6	0.0	0.1	0.0	0.0	0.1
AGBL5	"CCP5, FLJ21839"	ENSG00000084693	"ATP/GTP binding protein like 5"	Q8NDL9	2	27042364-27070622	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		"Carboxypeptidase, Hydrolase, Metalloprotease, Protease"	"Disease mutation, Retinitis pigmentosa"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	8	"testis: 91.6"	"Group enriched"	"Detected in many"	7	"Early spermatids: 249.1;Late spermatids: 264.5;Spermatocytes: 150.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA030981	Uncertain		Supported	"Microtubules,Cytokinetic bridge,Cytosol"		Yes	No			"Cytokinetic bridge"	"Microtubules, Cytosol"	"HPA030981: AB_10611673"	"unprognostic (1.29e-2)"	"unprognostic (8.70e-2)"	"unprognostic (2.26e-1)"	"unprognostic (3.13e-3)"	"unprognostic (1.95e-1)"	"unprognostic (1.07e-1)"	"prognostic unfavorable (6.87e-5)"	"unprognostic (1.86e-1)"	"unprognostic (4.34e-1)"	"unprognostic (6.20e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.20e-1)"	"unprognostic (3.41e-2)"	"unprognostic (5.56e-2)"	"unprognostic (2.05e-1)"	"unprognostic (1.69e-2)"	"unprognostic (4.50e-2)"	3.8	8.1	3.9	3.5	4.8	3.8	4.2	3.1	6.6	5.0	6.8	6.6	11.7	2.8	5.4	9.3	6.3	7.2	6.6	4.1	3.4	3.9	8.2	3.0	3.6	3.2	3.5	3.4	5.9	5.9	11.2	6.2	6.3	5.4	6.8	3.8	7.7	8.2	5.9	2.6	6.8	3.9	8.6	3.4	4.6	5.4	91.6	3.5	8.4	9.9	4.9	4.4	7.8	3.5	5.7	5.4	7.1	2.3	11.2	6.3	4.6	23.0	15.0	24.5	16.3	5.2	10.5	27.4	4.7	10.3	13.7	14.2	12.9	17.7	12.8	14.9	8.1	19.3	10.6	19.6	21.4	15.2	10.7	29.0	18.7	18.7	27.8	10.6	9.0	6.3	11.0	16.2	12.0	9.9	21.0	14.3	18.7	16.0	10.4	13.2	9.1	26.2	13.6	17.3	16.8	10.3	27.1	27.7	20.0	14.1	5.9	16.4	23.5	9.3	7.3	15.2	25.1	11.0	7.0	6.8	12.8	17.6	6.1	10.1	20.8	10.9	26.2	14.2	10.4	11.4	7.1	2.3	5.7	4.5	1.3	3.4	5.7	5.7	6.3	5.4	3.0	5.1	2.8	1.4	11.2	0.9	3.0	3.6	4.6	3.9	4.8	3.1	6.6	3.4	3.9	3.5	3.4	5.4	3.5	0.0	8.5	1.9	5.9	3.0	4.9	5.0	12.7	1.4	5.7	8.7	0.0	12.8	16.6	7.0	249.1	3.6	4.6	0.0	5.2	6.0	4.1	6.6	1.1	3.4	4.4	0.0	2.4	6.2	2.7	264.5	9.8	5.3	6.8	6.4	8.7	4.4	4.8	7.0	10.6	18.1	8.7	0.0	5.8	150.8	30.0	2.4	7.0	4.1	8.4	6.8
AGK	"FLJ10842, MULK"	ENSG00000006530	"Acylglycerol kinase"	Q53H12	7	141551189-141655244	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		"Kinase, Transferase"	"Cardiomyopathy, Cataract, Disease mutation, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"NK-cell: 37.9"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA020959, HPA053471"	Supported		Supported	Vesicles,Mitochondria	"Intracellular and membrane"	NA	NA			Mitochondria	Vesicles	"HPA020959: AB_1854206, HPA053471: AB_2682164"	"unprognostic (1.11e-1)"	"unprognostic (1.43e-1)"	"unprognostic (2.79e-1)"	"unprognostic (1.28e-2)"	"unprognostic (9.47e-3)"	"unprognostic (5.43e-2)"	"unprognostic (2.15e-2)"	"unprognostic (3.68e-2)"	"unprognostic (2.03e-1)"	"unprognostic (3.43e-2)"	"unprognostic (1.14e-1)"	"unprognostic (6.24e-3)"	"unprognostic (7.90e-2)"	"unprognostic (9.29e-2)"	"unprognostic (9.65e-2)"	"unprognostic (3.30e-1)"	"unprognostic (1.18e-1)"	8.7	12.0	11.9	8.0	19.0	5.9	10.6	21.3	23.7	8.8	8.9	10.2	8.8	6.4	16.8	17.1	9.5	11.9	6.8	24.5	16.1	12.3	16.0	10.5	8.4	10.0	11.8	18.8	10.8	8.0	15.7	13.3	9.9	14.2	10.1	13.4	10.6	13.5	10.7	8.4	6.8	8.8	15.0	13.9	12.2	9.0	12.9	9.0	7.8	9.8	8.4	15.6	8.4	8.5	4.6	6.4	0.4	5.5	37.9	10.3	5.7	12.4	13.5	13.4	11.0	10.6	13.2	9.1	13.2	12.9	21.2	21.2	10.5	9.6	14.0	11.8	12.6	20.0	9.3	18.7	15.4	22.9	16.5	16.6	13.0	6.4	10.4	15.8	9.0	7.0	14.7	13.6	18.6	18.2	9.9	16.2	16.1	19.3	20.0	10.2	12.5	24.3	4.1	14.2	9.6	15.2	15.7	2.3	41.9	13.6	10.6	11.7	16.1	13.7	16.6	13.6	14.1	8.9	9.9	9.1	9.8	7.7	13.1	19.0	15.2	15.0	6.7	16.2	4.2	27.0	0.0	2.6	0.4	9.1	5.5	6.5	4.6	7.4	10.3	6.4	2.5	5.5	9.6	0.2	37.9	3.2	2.5	7.2	5.7	11.9	19.0	21.3	23.7	16.1	12.3	11.8	18.8	14.2	9.0	0.0	5.9	3.7	5.1	2.7	10.7	16.8	5.1	6.7	5.7	12.2	7.9	13.4	8.3	6.3	10.0	5.8	2.0	0.0	6.1	6.7	5.4	2.6	8.1	4.5	6.1	14.3	0.0	3.1	4.7	8.5	6.4	4.7	6.8	18.0	2.9	9.8	4.6	0.0	9.9	6.1	16.4	0.0	6.2	4.6	4.9	2.4	7.7	11.4	5.6	2.7
AGL		ENSG00000162688	"Amylo-alpha-1, 6-glucosidase, 4-alpha-glucanotransferase"	P35573	1	99850084-99924023	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted membrane proteins"	"Glycogen biosynthesis"	"Glycosidase, Glycosyltransferase, Hydrolase, Multifunctional enzyme, Transferase"	"Disease mutation, Glycogen storage disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	5	"liver: 23.1;skeletal muscle: 85.6;tongue: 34.4"	"Cell type enhanced"	"Detected in all"	6	"Muller glia cells: 151.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028498, HPA054340"	Approved		Supported	"Nucleoplasm,Nuclear bodies,Cytosol"		NA	NA		16000	Nucleoplasm	"Nuclear bodies, Cytosol"	"HPA028498: AB_10600975, HPA054340: AB_2682455"	"unprognostic (2.90e-1)"	"unprognostic (5.34e-2)"	"unprognostic (3.99e-3)"	"unprognostic (2.18e-2)"	"unprognostic (6.46e-3)"	"unprognostic (5.13e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.92e-2)"	"unprognostic (9.37e-3)"	"unprognostic (1.11e-1)"	"unprognostic (8.10e-3)"	"unprognostic (7.61e-2)"	"prognostic favorable (1.73e-10)"	"unprognostic (6.38e-2)"	"unprognostic (2.89e-1)"	"unprognostic (1.15e-1)"	"unprognostic (7.13e-2)"	5.0	4.5	2.5	4.7	3.6	2.0	4.2	5.4	6.1	3.4	4.5	2.1	5.4	3.3	4.8	4.2	9.1	4.1	2.6	8.2	2.2	2.3	5.8	23.1	4.2	5.3	2.4	4.2	3.8	3.6	8.7	4.7	4.8	2.9	5.5	4.2	3.9	5.1	8.7	85.6	3.7	4.0	5.4	2.8	4.8	4.4	2.9	1.2	7.1	4.3	34.4	3.4	6.7	3.6	3.0	2.3	3.5	1.6	6.1	4.3	2.1	12.1	3.6	4.3	7.0	7.1	6.8	14.5	3.8	5.7	3.4	6.0	13.5	4.1	15.9	7.4	6.5	3.0	6.9	25.1	7.5	6.4	8.4	7.9	9.2	12.4	7.5	4.7	8.2	5.6	8.2	4.9	4.7	3.9	4.8	5.3	5.6	15.2	1.1	3.5	3.8	9.6	2.6	6.8	5.4	4.6	0.0	1.4	0.8	10.3	16.4	10.7	7.4	11.1	10.7	6.0	8.4	7.7	5.5	5.4	4.1	5.9	5.5	3.7	4.5	3.6	18.4	7.2	2.2	2.1	0.1	1.3	3.5	4.3	1.6	4.1	3.0	3.2	2.9	2.3	2.9	3.2	3.2	1.5	6.1	0.9	2.1	3.3	2.1	2.5	3.6	5.4	6.1	2.2	2.3	2.4	4.2	2.9	1.2	20.8	23.2	15.3	15.5	9.4	36.9	94.9	20.4	29.4	29.6	15.7	51.1	77.6	19.9	11.9	1.1	10.8	15.8	23.3	11.2	17.2	13.6	9.9	10.4	84.7	15.8	49.3	16.1	16.0	16.2	1.1	9.5	9.2	15.1	10.8	18.2	151.6	14.2	10.5	20.1	16.3	47.8	6.5	14.2	8.1	11.7	8.2	24.4	15.0	17.4	16.6
AGMAT	FLJ23384	ENSG00000116771	Agmatinase	Q9BSE5	1	15572353-15585110	"Enzymes, Predicted intracellular proteins"	"Putrescine biosynthesis, Spermidine biosynthesis"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 21.3;kidney: 54.7;liver: 66.1"	"Cell type enriched"	"Detected in many"	7	"Proximal tubular cells: 278.6"	"Group enriched"	"Detected in all"	5	"colorectal cancer: 18.5;liver cancer: 25.3;renal cancer: 11.2;stomach cancer: 11.1"	"Low region specificity"	"Detected in single"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"B-cells: 4.6;T-cells: 10.5"	"Cell line enhanced"	"Detected in many"		"CACO-2: 19.0;Hep G2: 46.0;RPMI-8226: 11.4"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"HPA026443, HPA028321"	Enhanced					NA	NA		250000			"HPA026443: AB_1844644, HPA028321: AB_10600779"	"unprognostic (2.27e-2)"	"unprognostic (3.45e-1)"	"unprognostic (1.79e-3)"	"unprognostic (3.60e-2)"	"unprognostic (8.72e-2)"	"unprognostic (6.66e-3)"	"unprognostic (9.48e-2)"	"unprognostic (1.19e-2)"	"unprognostic (2.06e-2)"	"unprognostic (2.37e-2)"	"unprognostic (1.13e-2)"	"unprognostic (2.35e-1)"	"prognostic favorable (5.13e-4)"	"unprognostic (4.43e-3)"	"unprognostic (2.44e-1)"	"unprognostic (1.33e-1)"	"unprognostic (2.45e-2)"	0.7	0.8	0.7	2.8	0.5	0.1	0.4	0.2	1.0	0.2	14.9	0.3	0.0	7.1	0.3	1.2	0.5	0.2	3.6	0.3	0.6	0.8	54.7	66.1	0.2	1.3	0.7	0.3	0.2	1.1	1.3	0.4	0.2	0.6	0.3	2.8	0.1	9.6	0.0	12.3	0.2	21.3	0.1	0.3	1.0	0.5	0.5	0.1	1.0	0.3	1.7	1.5	0.4	0.2	4.6	0.4	1.4	0.3	0.4	10.5	2.8	4.0	3.2	0.2	0.1	0.0	0.4	0.1	0.7	0.7	0.4	0.2	19.0	2.6	0.0	0.1	0.5	0.0	0.0	0.0	0.0	0.5	3.9	0.0	2.5	2.7	46.0	0.5	2.0	0.0	0.5	0.2	1.3	0.0	0.3	0.4	0.0	0.0	5.4	1.0	4.3	0.0	1.9	4.3	3.2	1.8	0.0	0.0	11.4	0.1	1.0	0.7	0.6	5.5	0.2	0.6	0.2	0.7	3.8	0.5	0.1	0.1	1.0	0.0	0.1	3.0	2.6	0.2	0.0	0.0	0.9	0.3	0.2	2.4	0.3	3.1	4.6	5.7	3.0	0.2	3.2	10.5	5.9	1.4	0.4	0.2	0.4	7.1	2.8	0.7	0.5	0.2	1.0	0.6	0.8	0.7	0.3	0.6	0.1	0.0	0.0	3.2	1.5	0.2	1.2	0.4	5.1	1.4	0.0	3.5	0.0	0.7	26.6	0.8	6.9	0.1	12.9	0.0	0.8	0.7	0.7	0.9	0.0	38.9	0.9	3.2	1.2	1.8	2.2	3.6	0.3	0.4	1.7	1.0	6.7	0.8	2.0	3.5	0.0	278.6	1.7	0.0	0.4	1.6	2.9	0.5	0.7	5.0	13.8	2.6
AGMO	"FLJ16237, TMEM195"	ENSG00000187546	"Alkylglycerol monooxygenase"	Q6ZNB7	7	15200318-15562015	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	7	"intestine: 41.9;liver: 57.9"	"Cell type enriched"	"Detected in some"	5	"Hepatocytes: 79.7"	"Cancer enriched"	"Detected in many"	5	"liver cancer: 15.7"	"Low region specificity"	"Detected in some"			"Group enriched"	"Detected in some"	5	"basophil: 3.6;neutrophil: 3.1"	"Lineage enriched"	"Detected in single"	5	"granulocytes: 3.6"	"Cell line enhanced"	"Detected in some"		"HSkMC: 4.1;Karpas-707: 8.7;NTERA-2: 3.9;SCLC-21H: 3.7;TIME: 4.4;WM-115: 17.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA057900			Uncertain	Vesicles		NA	NA			Vesicles		"HPA057900: "	"unprognostic (2.82e-1)"	"unprognostic (9.28e-2)"	"unprognostic (5.60e-3)"	"unprognostic (1.44e-4)"	"unprognostic (7.52e-2)"	"unprognostic (1.07e-2)"	"unprognostic (3.61e-2)"	"unprognostic (6.56e-2)"	"unprognostic (3.31e-1)"	"unprognostic (3.35e-1)"	"unprognostic (4.18e-3)"	"unprognostic (3.24e-1)"	"unprognostic (1.64e-1)"	"unprognostic (2.04e-2)"	"unprognostic (3.45e-1)"	"unprognostic (1.00e-1)"	"unprognostic (1.93e-1)"	6.8	0.2	0.8	1.0	1.2	0.1	3.7	0.3	0.5	0.3	16.5	1.1	0.1	4.6	0.3	7.3	0.3	0.3	4.7	0.9	0.7	0.6	5.3	57.9	0.4	0.5	1.1	0.8	0.3	0.3	0.0	0.7	0.4	0.7	0.4	0.3	0.0	0.4	0.1	0.5	0.5	41.9	0.1	1.1	0.3	0.3	1.8	2.0	0.0	0.7	0.1	0.1	1.0	0.4	0.2	0.1	3.6	0.1	0.6	0.1	0.0	0.0	2.5	0.1	2.2	0.2	3.2	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.3	0.0	0.0	4.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.7	0.0	0.0	0.0	0.1	3.9	0.0	0.0	0.0	0.0	1.3	0.0	0.7	3.7	0.0	0.0	0.0	0.0	2.9	0.0	0.0	4.4	1.5	0.3	0.2	0.0	0.7	0.0	0.0	0.0	0.0	17.2	3.6	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.0	0.0	0.2	0.1	0.1	3.1	0.6	0.0	0.1	0.0	0.0	0.8	1.2	0.3	0.4	0.7	0.6	1.1	0.8	0.7	2.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	15.3	0.0	0.0	3.5	0.0	0.1	0.0	0.0	0.7	0.1	2.6	0.0	0.0	0.1	0.7	0.0	0.0	79.7	0.1	0.0	1.7	1.3	1.3	0.9	0.0	0.1	3.3	0.0	0.1	0.0	0.6	0.0	0.0	15.2	0.0	6.5	0.2	0.4	2.5	0.0	0.1	0.0	0.6	0.0
AGO2	"CASC7, EIF2C2, hAGO2, LINC00980, Q10"	ENSG00000123908	"Argonaute 2, RISC catalytic component"	Q9UKV8	8	140520156-140635619	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"RNA-mediated gene silencing, Transcription, Transcription regulation, Translation regulation"	"Endonuclease, Hydrolase, Nuclease, Repressor, Ribonucleoprotein, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB019309, HPA067849"	Approved		Supported	"Cytosol,Cytoplasmic bodies"		NA	NA		35000000	"Cytoplasmic bodies"	Cytosol	"CAB019309: , HPA067849: "	"unprognostic (2.75e-2)"	"unprognostic (1.79e-3)"	"unprognostic (1.27e-1)"	"prognostic unfavorable (1.21e-4)"	"unprognostic (2.46e-1)"	"unprognostic (2.15e-1)"	"unprognostic (1.49e-3)"	"unprognostic (8.86e-2)"	"unprognostic (2.21e-1)"	"unprognostic (8.50e-2)"	"unprognostic (3.47e-2)"	"unprognostic (2.73e-1)"	"prognostic unfavorable (1.82e-5)"	"unprognostic (1.32e-1)"	"unprognostic (2.77e-1)"	"unprognostic (1.32e-1)"	"unprognostic (3.02e-1)"	11.2	6.6	7.7	9.9	13.1	16.2	25.0	9.9	11.4	7.5	9.2	12.1	12.8	5.3	10.2	10.4	10.6	8.6	8.8	12.4	8.8	5.3	6.9	7.4	13.2	12.5	13.4	5.0	11.8	8.4	13.2	8.8	9.9	10.7	7.5	6.9	5.6	8.1	12.6	37.1	14.1	7.5	15.0	11.7	6.9	10.0	5.9	12.7	11.1	8.6	8.2	8.9	10.4	18.4	2.5	2.1	6.4	2.6	2.4	3.0	1.5	12.8	10.6	10.9	12.4	7.1	8.4	9.2	8.1	5.9	3.6	4.5	11.7	3.9	14.7	10.2	7.8	3.9	8.7	18.4	8.7	8.1	8.3	9.6	17.2	18.2	7.4	6.5	7.1	5.9	5.7	7.9	10.0	10.5	5.0	8.4	9.3	18.0	9.3	11.8	19.4	12.2	5.6	8.0	8.8	18.5	12.6	9.2	6.6	4.6	13.3	12.8	9.3	12.6	4.3	9.0	11.7	11.1	10.3	11.7	6.3	17.6	9.9	12.9	8.2	2.7	10.4	4.7	12.9	9.3	1.8	2.6	0.7	2.7	2.3	3.0	1.3	2.6	2.3	2.1	2.5	2.7	2.7	6.4	2.4	2.3	1.5	2.1	1.5	7.7	13.1	9.9	11.4	8.8	5.3	13.4	5.0	10.7	12.7	20.8	21.4	18.4	57.8	19.5	24.7	19.4	10.2	24.1	36.4	14.0	41.2	36.5	6.6	23.4	15.7	24.8	9.7	70.0	15.6	17.2	23.7	85.4	16.2	12.4	13.3	39.7	23.3	25.8	23.8	10.0	34.5	19.0	5.0	22.6	22.7	30.6	29.0	17.5	43.5	7.4	29.6	32.3	13.1	3.2	1.4	20.8	66.1	25.4	19.6	78.7
AGPAT1	LPAAT-alpha	ENSG00000204310	"1-acylglycerol-3-phosphate O-acyltransferase 1"	Q99943	6	32168212-32178096	"Enzymes, Predicted membrane proteins"	"Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism"	"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"ASC diff: 35.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA048478, HPA073355"	Approved		Supported	"Endoplasmic reticulum,Rods & Rings"		NA	NA			"Endoplasmic reticulum"	"Rods & Rings"	"HPA048478: AB_2680411, HPA073355: AB_2686596"	"prognostic unfavorable (1.93e-4)"	"unprognostic (9.35e-3)"	"unprognostic (1.87e-3)"	"prognostic unfavorable (5.21e-4)"	"unprognostic (4.79e-2)"	"unprognostic (7.05e-2)"	"unprognostic (7.16e-3)"	"unprognostic (1.55e-1)"	"unprognostic (3.79e-1)"	"unprognostic (4.24e-3)"	"unprognostic (1.84e-3)"	"unprognostic (1.77e-1)"	"unprognostic (6.58e-2)"	"unprognostic (1.97e-2)"	"unprognostic (2.16e-1)"	"unprognostic (9.92e-3)"	"unprognostic (7.00e-2)"	11.7	32.3	21.5	8.3	33.1	7.4	12.1	18.7	32.4	26.9	22.1	19.6	19.6	32.0	25.1	53.3	13.8	26.9	22.3	19.4	22.8	21.1	26.4	20.3	24.3	10.7	20.3	23.6	33.1	18.5	1.3	16.6	18.5	22.4	18.5	24.8	17.5	17.4	19.5	25.5	9.1	46.9	17.9	18.6	11.7	27.8	27.7	17.4	12.1	33.4	9.0	14.6	19.3	12.7	6.7	13.8	13.2	9.6	8.9	10.1	5.7	0.0	0.1	13.5	0.0	35.3	23.8	12.5	0.0	0.0	0.0	0.0	27.5	0.0	0.0	11.6	33.7	9.5	3.3	29.1	9.6	0.0	0.0	22.5	0.0	0.0	29.0	0.0	0.0	27.3	13.3	12.4	0.0	12.6	29.0	8.2	23.0	17.3	17.7	29.2	7.3	0.0	6.3	0.0	0.0	4.2	0.1	0.0	0.1	8.8	0.0	0.0	0.0	13.4	4.3	15.1	14.6	16.9	0.0	5.8	0.0	5.0	0.0	0.0	10.6	10.1	4.4	17.4	0.0	0.0	2.7	5.7	13.2	9.2	9.6	8.7	6.7	5.8	10.1	10.3	5.9	5.0	7.3	11.0	8.9	6.6	13.8	7.8	5.7	21.5	33.1	18.7	32.4	22.8	21.1	20.3	23.6	22.4	17.4	14.9	18.1	19.4	9.5	8.0	26.4	3.1	12.7	12.0	7.9	34.9	11.8	28.8	5.0	16.4	52.8	13.5	30.7	0.0	12.4	25.8	14.4	11.5	12.7	27.1	22.0	30.2	28.3	18.4	17.4	64.8	12.4	17.4	8.5	5.4	24.1	34.1	13.6	21.0	20.1	22.3	17.0	0.0	20.8	45.5	20.6	3.1	12.8	12.1	20.4	10.5
AGPAT2	"BSCL, LPAAT-beta"	ENSG00000169692	"1-acylglycerol-3-phosphate O-acyltransferase 2"	O15120	9	136673143-136687423	"Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins"	"Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism"	"Acyltransferase, Transferase"	"Congenital generalized lipodystrophy, Diabetes mellitus, Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adipose tissue: 71.5;liver: 63.1"	"Cell type enhanced"	"Detected in many"	11	"Enterocytes: 930.5;Paneth cells: 350.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 50.5"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			HPA019544	Uncertain		Approved	Centrosome		NA	NA			Centrosome		"HPA019544: AB_1844646"	"unprognostic (3.20e-2)"	"unprognostic (1.27e-1)"	"unprognostic (5.01e-3)"	"unprognostic (9.26e-2)"	"unprognostic (1.50e-1)"	"unprognostic (9.30e-3)"	"unprognostic (5.06e-3)"	"unprognostic (8.98e-2)"	"unprognostic (1.42e-1)"	"unprognostic (1.27e-1)"	"unprognostic (2.17e-1)"	"unprognostic (5.61e-2)"	"unprognostic (2.60e-1)"	"unprognostic (2.19e-2)"	"unprognostic (1.92e-1)"	"unprognostic (4.58e-2)"	"unprognostic (2.93e-1)"	71.5	5.3	2.3	8.1	2.2	8.4	35.2	2.0	3.0	7.4	20.2	2.2	5.9	31.3	4.7	7.1	11.7	4.1	15.8	12.4	2.8	2.4	10.9	63.1	12.1	11.1	2.5	2.8	5.3	47.7	2.5	6.2	4.9	2.6	5.5	3.3	8.9	12.9	6.2	9.5	7.0	33.6	4.0	1.9	6.8	11.0	5.2	1.9	5.1	13.4	7.0	8.8	6.6	4.9	7.0	20.3	33.2	28.4	2.1	2.5	9.8	14.7	20.8	2.4	11.5	17.9	5.6	10.5	9.8	7.8	6.7	5.1	23.6	29.2	4.9	22.1	5.6	10.9	40.1	3.5	6.1	0.7	50.5	15.9	7.2	8.6	5.1	12.3	7.5	17.6	5.3	8.5	5.7	3.0	5.8	3.5	6.6	8.7	0.8	2.8	26.6	0.5	23.5	6.3	27.2	37.8	11.1	8.9	26.9	7.9	9.3	5.5	8.9	12.7	13.4	16.1	2.0	8.5	29.8	6.8	8.9	9.2	2.9	6.2	1.2	0.1	3.1	0.1	16.3	8.9	6.0	28.4	33.2	2.2	25.3	2.1	4.1	1.9	2.5	14.9	7.0	1.6	1.8	19.1	2.1	22.2	20.3	2.3	9.8	2.3	2.2	2.0	3.0	2.8	2.4	2.5	2.8	2.6	1.9	14.9	59.7	17.6	50.1	40.2	2.1	34.7	68.8	10.7	18.2	69.8	0.0	6.7	46.4	135.1	138.9	26.4	930.5	0.0	193.7	28.9	36.3	80.5	13.8	203.0	114.8	38.1	34.3	22.1	50.6	271.0	24.7	62.8	129.9	36.9	126.5	13.3	140.9	350.7	19.1	33.5	3.6	45.3	29.6	1.1	36.6	71.0	5.7	20.3	115.8	138.0
AGPAT3	LPAAT-gamma	ENSG00000160216	"1-acylglycerol-3-phosphate O-acyltransferase 3"	Q9NRZ7	21	43865186-43986536	"Enzymes, Predicted membrane proteins"	"Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism"	"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 59.1"	"Cell type enhanced"	"Detected in many"	7	"Cone photoreceptor cells: 172.8;Early spermatids: 230.1;Late spermatids: 164.7;Rod photoreceptor cells: 181.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA						"unprognostic (2.36e-2)"	"prognostic unfavorable (8.31e-4)"	"unprognostic (5.50e-2)"	"unprognostic (4.56e-3)"	"unprognostic (4.70e-2)"	"unprognostic (8.55e-2)"	"unprognostic (4.88e-2)"	"unprognostic (9.72e-3)"	"unprognostic (2.14e-1)"	"unprognostic (3.54e-2)"	"unprognostic (1.65e-1)"	"unprognostic (2.84e-1)"	"prognostic favorable (2.29e-4)"	"unprognostic (1.50e-2)"	"unprognostic (8.91e-2)"	"unprognostic (1.80e-1)"	"unprognostic (4.60e-2)"	12.0	10.2	21.5	11.1	23.0	5.8	12.7	14.6	22.7	6.4	20.1	18.9	8.5	27.4	5.1	10.4	13.4	8.1	8.6	11.6	19.9	15.1	33.8	30.2	9.9	9.0	21.7	11.4	5.4	12.7	17.1	7.3	7.6	13.6	7.9	7.6	10.6	24.0	8.0	59.1	10.2	34.6	5.8	25.2	10.2	11.1	11.7	11.4	7.2	14.1	15.0	7.0	9.8	6.6	1.3	4.5	2.4	10.6	0.7	3.5	2.0	26.9	15.4	3.8	10.5	7.8	8.6	3.0	12.5	15.7	15.9	9.8	15.1	19.7	9.1	9.5	14.8	14.9	10.5	6.6	13.8	4.6	43.5	17.6	4.0	9.5	20.2	13.6	14.7	9.1	10.2	11.9	14.0	5.9	14.9	11.9	3.1	22.5	15.1	5.7	11.6	0.1	9.1	1.8	10.7	10.9	15.1	4.4	24.6	12.6	26.6	13.3	9.7	15.2	17.4	11.6	1.6	12.0	16.0	17.6	10.1	0.1	15.1	12.7	12.1	18.0	5.7	13.1	29.4	9.1	0.0	4.1	2.4	1.5	8.9	1.5	1.3	2.1	2.2	4.5	1.2	1.7	1.9	1.0	0.7	10.6	1.1	3.5	2.0	21.5	23.0	14.6	22.7	19.9	15.1	21.7	11.4	13.6	11.4	11.9	23.1	7.5	7.5	7.1	36.1	31.3	20.4	32.1	22.7	24.4	172.8	13.2	8.3	23.9	230.1	11.7	47.3	0.0	25.5	0.7	8.9	14.4	4.7	59.5	16.9	62.0	13.3	15.4	24.3	164.7	7.2	22.0	1.7	27.9	21.9	27.1	23.5	20.1	5.3	42.8	181.7	6.5	7.8	9.0	2.1	9.7	10.1	9.2	19.3	12.2
AGPAT4	"dJ473J16.2, LPAAT-delta"	ENSG00000026652	"1-acylglycerol-3-phosphate O-acyltransferase 4"	Q9NRZ5	6	161129979-161274061	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism"	"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 49.0"	"Cell type enhanced"	"Detected in many"	7	"Early spermatids: 51.8;Late spermatids: 44.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"AF22: 19.8;HEL: 14.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA053287, HPA060525"	Approved		Approved	"Nucleoli,Golgi apparatus,Vesicles"		NA	NA			"Golgi apparatus"	"Nucleoli, Vesicles"	"HPA053287: AB_2682101, HPA060525: AB_2684306"	"unprognostic (5.69e-2)"	"prognostic unfavorable (1.45e-4)"	"unprognostic (1.73e-1)"	"unprognostic (3.43e-2)"	"unprognostic (4.14e-2)"	"unprognostic (6.67e-3)"	"unprognostic (1.94e-4)"	"unprognostic (1.05e-1)"	"unprognostic (3.42e-2)"	"unprognostic (2.77e-2)"	"unprognostic (1.76e-3)"	"unprognostic (1.67e-1)"	"prognostic unfavorable (4.08e-4)"	"unprognostic (1.82e-2)"	"unprognostic (8.87e-2)"	"unprognostic (3.63e-4)"	"unprognostic (5.51e-2)"	5.6	4.2	10.5	3.5	19.1	8.0	4.5	9.6	26.6	5.3	4.2	35.6	1.0	2.6	10.7	4.5	5.2	7.2	8.0	2.9	14.2	11.8	5.2	2.0	6.1	2.0	25.8	12.4	10.0	2.3	1.3	9.8	14.6	27.4	3.7	4.4	0.7	2.7	4.9	2.1	1.9	2.5	8.5	49.0	5.2	3.0	4.2	19.8	0.6	4.8	2.0	2.2	4.0	3.8	1.1	1.9	0.6	3.5	5.8	7.0	2.1	0.3	0.8	19.8	3.9	3.7	7.6	0.8	0.7	0.2	1.5	2.5	1.1	3.5	0.5	1.4	3.1	9.2	0.3	3.6	3.0	1.4	2.2	6.2	14.8	3.5	0.0	2.9	0.1	2.1	9.1	1.5	4.0	2.1	7.1	4.6	2.3	7.3	6.8	1.8	0.0	1.0	1.6	4.7	0.0	7.5	0.0	0.9	0.4	4.3	0.3	11.5	4.4	3.0	1.6	0.8	8.1	0.8	1.0	5.1	2.1	2.6	1.4	3.3	0.5	0.7	0.0	7.8	0.8	1.3	0.0	3.5	0.0	7.0	2.8	2.3	0.4	3.3	4.1	1.9	1.1	1.7	2.7	0.6	5.8	2.5	1.5	2.9	2.1	10.5	19.1	9.6	15.8	14.2	11.8	25.8	12.4	27.4	19.8	3.0	5.6	5.2	4.6	2.9	1.0	4.0	2.5	10.7	5.7	5.2	0.0	16.0	0.0	4.3	51.8	12.2	0.0	0.0	7.0	10.7	11.3	0.8	10.5	0.4	16.7	0.0	1.7	9.8	7.6	44.8	5.5	15.4	3.3	11.8	0.0	4.0	5.9	0.0	8.1	0.3	0.9	19.4	6.2	3.6	2.9	2.3	18.5	7.4	0.0	3.2
AGPAT5	"FLJ11210, LPAAT-e, LPAAT-epsilon"	ENSG00000155189	"1-acylglycerol-3-phosphate O-acyltransferase 5"	Q9NUQ2	8	6708357-6759666	"Enzymes, Predicted membrane proteins"	"Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism"	"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA010644, HPA010950, HPA011646"	Approved		Supported	Mitochondria		NA	NA			Mitochondria		"HPA010644: AB_1844647, HPA010950: AB_1844648, HPA011646: "	"unprognostic (1.05e-3)"	"unprognostic (4.69e-1)"	"prognostic favorable (8.82e-4)"	"unprognostic (2.05e-2)"	"unprognostic (2.99e-1)"	"unprognostic (1.44e-2)"	"prognostic unfavorable (4.57e-4)"	"unprognostic (4.92e-1)"	"unprognostic (1.82e-1)"	"unprognostic (2.98e-2)"	"unprognostic (6.33e-2)"	"unprognostic (2.91e-1)"	"unprognostic (6.62e-2)"	"unprognostic (2.83e-1)"	"unprognostic (3.60e-1)"	"unprognostic (1.53e-2)"	"unprognostic (5.09e-3)"	5.9	12.5	20.0	8.5	20.7	5.1	9.8	10.0	21.2	6.0	12.2	16.5	6.8	9.3	9.3	19.1	8.4	9.7	5.9	4.0	19.3	16.9	14.2	14.3	5.1	16.8	18.7	9.5	6.4	16.2	11.4	18.5	16.3	14.2	11.0	12.3	3.3	5.4	16.0	10.2	5.1	8.4	8.6	30.6	8.6	11.0	30.8	12.7	14.3	7.3	6.8	10.4	7.3	5.7	11.0	8.4	3.0	4.8	5.3	3.9	2.9	9.4	7.6	11.9	7.0	3.1	5.1	10.6	5.0	5.2	7.5	7.3	4.7	7.5	20.7	3.3	3.3	10.5	11.2	9.1	10.1	13.2	4.5	6.2	25.4	5.9	10.6	7.9	10.6	11.1	6.8	8.6	7.3	9.8	6.9	13.1	8.7	18.7	11.1	12.3	6.1	19.2	13.1	20.8	12.7	5.9	13.9	14.3	8.1	6.8	13.3	24.4	12.8	4.8	8.8	9.5	7.3	4.0	14.0	5.4	12.3	5.8	4.7	13.9	4.2	12.8	11.3	7.2	12.8	14.6	3.0	4.1	2.6	1.9	4.8	3.9	8.7	3.0	3.3	2.7	11.0	2.3	2.7	0.4	5.3	4.2	8.4	2.7	2.9	20.0	20.7	10.0	14.6	19.3	16.9	18.7	9.5	14.2	12.7	3.0	4.1	16.6	10.5	8.0	7.7	5.3	12.7	10.7	7.9	7.0	2.0	7.7	3.3	8.4	29.8	15.8	11.4	0.0	8.5	10.7	5.7	13.4	17.4	29.2	11.0	6.4	21.2	8.6	14.0	22.9	14.7	6.4	6.8	1.0	7.9	37.9	8.0	8.6	14.5	17.4	8.8	6.5	13.2	20.9	8.6	9.2	15.4	4.4	20.0	10.6
AGPS	"ADAP-S, ADAS, ADHAPS, ADPS, ALDHPSY"	ENSG00000018510	"Alkylglycerone phosphate synthase"	O00116	2	177392644-177559299	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Lipid biosynthesis, Lipid metabolism"	Transferase	"Cataract, Disease mutation, Dwarfism, Rhizomelic chondrodysplasia punctata"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	10	"Early spermatids: 201.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030209, HPA030210, HPA030211"	Supported		Supported	Peroxisomes	"Intracellular and membrane"	NA	NA		9300	Peroxisomes		"HPA030209: AB_10600634, HPA030210: AB_10600202, HPA030211: AB_10602195"	"unprognostic (7.10e-2)"	"unprognostic (1.20e-2)"	"unprognostic (1.76e-3)"	"unprognostic (3.79e-2)"	"unprognostic (8.34e-2)"	"unprognostic (3.78e-2)"	"prognostic unfavorable (8.62e-6)"	"unprognostic (1.23e-2)"	"unprognostic (7.23e-2)"	"unprognostic (5.41e-2)"	"prognostic unfavorable (8.35e-4)"	"unprognostic (7.74e-2)"	"prognostic favorable (9.45e-4)"	"unprognostic (7.18e-2)"	"unprognostic (3.46e-1)"	"unprognostic (4.94e-3)"	"unprognostic (1.92e-2)"	22.9	17.7	13.5	21.2	14.9	28.3	17.1	14.9	13.4	16.0	23.5	17.2	14.1	14.1	22.4	10.5	18.4	12.5	16.0	23.9	14.2	13.5	20.8	21.2	15.2	14.7	17.4	11.8	16.4	21.2	37.0	11.7	14.7	15.0	14.7	24.0	8.0	18.2	10.8	23.2	9.6	17.6	21.3	31.8	17.1	14.5	19.1	13.7	29.5	14.2	14.4	14.5	16.9	20.7	3.4	7.6	11.2	6.8	5.6	6.4	3.0	18.1	11.6	8.2	8.5	10.6	11.6	19.7	14.2	7.1	12.2	12.1	21.7	12.6	20.4	31.0	14.7	19.8	19.8	22.2	14.4	15.9	26.9	7.5	28.3	20.2	25.4	10.8	30.7	30.2	10.1	9.1	19.5	15.6	11.2	24.3	15.5	19.4	12.8	14.6	0.0	24.8	10.4	14.0	13.4	19.3	19.9	24.7	12.3	20.7	21.7	10.2	12.3	26.9	2.3	16.7	20.4	0.1	12.8	24.9	10.9	37.4	11.2	24.8	16.5	28.6	10.2	10.0	13.8	4.2	3.8	6.1	11.2	4.3	6.7	6.4	3.4	5.5	5.3	7.6	2.1	5.3	3.1	1.3	5.6	6.8	0.7	6.2	3.0	13.5	14.9	14.9	13.4	14.2	13.5	17.4	11.8	15.0	13.7	14.9	16.2	8.2	5.5	9.6	11.1	17.3	12.7	17.4	7.9	14.0	2.0	12.4	11.6	18.7	201.7	9.3	16.8	23.3	20.1	17.2	15.1	3.1	63.4	25.2	28.4	14.3	19.0	13.5	27.2	24.3	13.6	24.2	13.5	31.5	25.9	11.6	19.9	10.5	13.1	41.6	6.9	6.5	16.2	38.6	25.3	8.5	5.8	17.0	19.4	5.5
AGTPBP1	"CCP1, KIAA1035, Nna1"	ENSG00000135049	"ATP/GTP binding protein 1"	Q9UPW5	9	85546539-85742029	"Enzymes, Predicted intracellular proteins"		"Carboxypeptidase, Hydrolase, Metalloprotease, Protease"	"Disease mutation, Neurodegeneration"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 48.2"	"Cell type enhanced"	"Detected in many"	6	"Cone photoreceptor cells: 96.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA057208, HPA071094"	Approved		Approved	Nucleoli,Vesicles		NA	NA			"Nucleoli, Vesicles"		"HPA057208: AB_2683370, HPA071094: "	"unprognostic (2.15e-1)"	"unprognostic (3.78e-2)"	"unprognostic (4.93e-3)"	"unprognostic (6.12e-2)"	"unprognostic (1.42e-1)"	"unprognostic (8.95e-3)"	"unprognostic (1.86e-2)"	"unprognostic (1.65e-1)"	"unprognostic (1.71e-1)"	"unprognostic (8.26e-3)"	"unprognostic (5.69e-3)"	"unprognostic (6.31e-2)"	"unprognostic (3.07e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.39e-1)"	"unprognostic (9.60e-3)"	"unprognostic (1.25e-1)"	7.9	5.7	13.1	8.6	14.6	48.2	6.0	14.2	21.4	5.1	5.0	21.6	1.8	3.8	5.0	4.2	5.4	4.2	5.3	11.2	17.3	13.5	6.8	4.5	11.9	16.0	18.8	14.5	3.5	6.4	8.0	4.8	6.0	23.5	4.9	5.9	7.4	3.9	3.4	13.6	6.0	4.3	6.4	24.1	12.8	5.3	12.5	14.4	8.8	5.8	4.3	7.8	5.7	3.8	1.6	10.7	20.3	9.5	4.5	6.6	5.7	2.9	5.7	16.9	6.7	3.5	3.8	6.4	4.4	3.8	4.5	5.2	3.0	5.1	18.4	3.8	4.6	8.0	1.7	7.8	5.6	4.3	19.5	6.9	3.1	6.9	5.4	7.3	14.1	3.7	3.6	6.6	4.2	14.5	2.9	7.2	9.5	3.9	14.8	2.0	4.6	11.0	8.4	11.7	10.6	4.0	10.1	6.2	5.6	7.9	3.2	20.4	14.5	5.0	5.5	9.1	16.8	2.1	4.6	7.1	2.9	5.2	18.5	5.2	10.1	8.4	8.4	6.2	13.9	5.9	20.3	9.5	8.3	6.6	5.7	6.4	1.6	3.3	5.1	10.7	1.2	2.7	5.2	14.0	4.5	4.3	1.7	3.4	5.7	13.1	14.6	14.2	21.4	17.3	13.5	18.8	14.5	23.5	14.4	59.6	13.8	5.4	2.3	7.0	29.1	39.1	0.0	18.7	21.6	3.5	96.2	3.7	6.6	4.8	44.2	7.5	2.7	0.0	3.5	3.5	4.5	3.7	25.5	3.6	7.2	33.4	7.5	10.4	38.6	49.1	1.7	22.6	3.3	9.0	4.9	16.0	4.6	0.0	2.5	6.1	56.8	12.9	7.2	25.0	27.2	9.4	2.4	20.8	3.8	1.6
AGXT	"AGT, AGT1, AGXT1, PH1, SPAT, SPT"	ENSG00000172482	"Alanine-glyoxylate aminotransferase"	P21549	2	240868479-240880502	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		"Aminotransferase, Transferase"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	172	"liver: 247.3"	"Cell type enriched"	"Detected in many"	17	"Hepatocytes: 1878.6"	"Cancer enriched"	"Detected in some"	425	"liver cancer: 253.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	5	"Hep G2: 13.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA035370, HPA035371"	Enhanced		Supported	Vesicles		NA	NA		5200000	Vesicles		"HPA035370: AB_10673218, HPA035371: AB_2674593"	"unprognostic (3.14e-2)"	"unprognostic (2.58e-1)"	"unprognostic (3.37e-4)"	"unprognostic (1.04e-1)"	"unprognostic (1.23e-2)"	"unprognostic (9.56e-2)"	"prognostic favorable (5.92e-5)"	"unprognostic (8.28e-2)"	"unprognostic (2.77e-1)"	"unprognostic (5.39e-2)"	"unprognostic (1.55e-1)"	"unprognostic (7.57e-3)"	"unprognostic (2.54e-1)"	"unprognostic (9.22e-2)"	"unprognostic (1.37e-1)"		"unprognostic (3.26e-2)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	247.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.5	0.0	13.4	0.0	1.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.2	1.3	0.0	0.0	0.0	0.1	0.0	0.8	2.6	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.2	0.0	0.4	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	11.5	0.0	0.0	0.0	0.8	28.1	0.0	0.0	7.0	0.0	0.5	19.9	0.0	0.0	0.0	2.6	46.7	1.6	22.7	0.0	0.5	0.0	1878.6	0.2	0.0	8.6	45.4	38.8	0.0	0.9	0.0	0.0	0.0	3.9	0.0	0.2	7.0	0.4	108.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	8.2	1.2	0.0
AGXT2	AGT2	ENSG00000113492	"Alanine--glyoxylate aminotransferase 2"	Q9BYV1	5	34998101-35048135	"Enzymes, Predicted intracellular proteins"		"Aminotransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	23	"kidney: 63.2;liver: 63.3"	"Group enriched"	"Detected in some"	5	"Hepatocytes: 87.7;Proximal tubular cells: 319.5"	"Group enriched"	"Detected in some"	112	"liver cancer: 9.2;renal cancer: 12.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	11	"T-47d: 3.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA037382	Enhanced					NA	NA		7300			"HPA037382: AB_10670851"	"unprognostic (2.61e-1)"						"unprognostic (1.40e-2)"						"prognostic favorable (7.47e-4)"	"unprognostic (8.24e-2)"	"unprognostic (1.28e-1)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.9	0.0	0.0	0.0	63.2	63.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	3.5	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.2	0.0	0.0	0.0	8.7	0.0	0.0	38.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	87.7	0.0	0.0	0.0	1.8	1.3	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	319.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
AHCY	SAHH	ENSG00000101444	Adenosylhomocysteinase	P23526	20	34280268-34311802	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"One-carbon metabolism"	Hydrolase	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Proximal tubular cells: 192.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA041225, HPA044675"	Approved		Supported	Cytosol		NA	NA		3900000	Cytosol		"HPA041225: AB_2677371, HPA044675: AB_2679041"	"unprognostic (3.35e-1)"	"unprognostic (2.17e-1)"	"unprognostic (2.41e-2)"	"unprognostic (1.32e-2)"	"unprognostic (7.74e-2)"	"unprognostic (3.15e-2)"	"unprognostic (7.34e-3)"	"unprognostic (1.10e-1)"	"unprognostic (8.88e-2)"	"unprognostic (2.61e-1)"	"unprognostic (4.21e-2)"	"unprognostic (1.24e-1)"	"unprognostic (5.27e-2)"	"unprognostic (2.06e-1)"	"unprognostic (1.20e-1)"	"unprognostic (1.88e-1)"	"unprognostic (2.93e-3)"	15.3	18.6	11.7	15.4	15.0	17.0	24.3	6.3	16.4	25.1	30.0	14.7	18.4	24.6	20.2	23.9	43.4	26.6	22.4	26.0	12.0	12.8	52.2	99.8	19.1	18.1	16.0	10.6	39.1	72.0	15.7	15.0	44.5	13.2	26.9	20.2	14.4	32.4	18.3	48.2	14.8	20.4	18.8	15.7	17.9	22.2	33.3	13.4	25.0	52.8	31.0	29.2	18.2	20.5	9.1	24.1	2.3	26.0	4.6	7.4	11.4	37.4	49.1	20.8	36.7	24.3	26.2	23.9	15.4	22.1	34.3	27.3	132.5	32.4	58.3	27.5	19.7	22.2	43.0	48.9	86.4	22.1	7.7	29.7	70.3	24.4	85.2	26.2	32.8	23.1	54.2	39.4	21.3	34.3	18.4	23.4	21.7	34.2	14.8	18.2	39.6	42.8	31.0	26.7	48.0	47.9	32.2	53.0	41.0	30.7	26.6	36.1	24.0	30.7	36.5	51.0	17.2	54.8	30.6	14.8	29.9	31.9	15.1	29.0	22.1	32.3	35.1	22.0	20.3	15.9	2.3	13.7	0.4	4.1	26.0	6.7	9.1	6.0	5.3	21.1	7.8	6.6	7.4	1.1	4.6	16.5	24.1	6.7	11.4	11.7	15.0	6.3	16.4	12.0	12.8	16.0	10.6	13.2	13.4	38.7	21.0	33.5	72.2	32.5	11.9	44.7	25.5	17.4	29.6	26.2	0.0	93.3	49.7	60.3	58.3	23.6	33.8	0.0	70.9	130.4	41.1	68.4	20.7	56.7	103.0	11.1	20.2	16.5	33.2	135.4	39.4	28.0	25.3	26.2	64.7	41.2	59.2	24.6	38.2	192.2	10.2	12.9	38.1	20.7	47.5	34.5	76.9	18.5	111.0	66.8
AHCYL2	KIAA0828	ENSG00000158467	"Adenosylhomocysteinase like 2"	Q96HN2	7	129225023-129430211	"Enzymes, Predicted intracellular proteins"	"One-carbon metabolism"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"intestine: 72.4"	"Cell type enhanced"	"Detected in many"	7	"Alveolar cells type 2: 75.8;Enterocytes: 114.1;Muller glia cells: 87.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enriched"	"Detected in all"	8	"HDLM-2: 73.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA053128	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			Cytosol	Nucleoplasm	"HPA053128: AB_2682050"	"unprognostic (1.57e-1)"	"unprognostic (2.91e-1)"	"unprognostic (8.52e-3)"	"unprognostic (1.71e-3)"	"unprognostic (7.44e-3)"	"prognostic favorable (4.17e-4)"	"unprognostic (8.85e-2)"	"unprognostic (1.43e-1)"	"unprognostic (3.35e-1)"	"unprognostic (2.74e-1)"	"unprognostic (1.63e-1)"	"unprognostic (6.79e-3)"	"prognostic favorable (1.08e-7)"	"unprognostic (4.70e-3)"	"unprognostic (2.46e-1)"	"unprognostic (7.21e-2)"	"unprognostic (2.62e-1)"	4.3	6.6	12.8	5.9	20.3	1.5	4.3	7.2	16.9	7.1	61.8	13.3	5.1	23.1	6.1	3.3	5.7	4.4	22.7	3.4	16.5	9.6	11.9	3.4	26.1	4.2	10.7	14.9	5.7	5.8	9.1	12.8	5.1	19.8	5.0	72.4	24.3	15.0	3.3	20.7	9.8	15.0	5.3	11.4	2.9	16.5	8.1	9.6	4.6	24.1	4.0	4.0	5.4	4.7	0.9	1.3	2.0	2.5	3.3	5.0	0.5	2.7	4.3	8.3	4.9	2.2	3.3	1.7	2.1	3.0	2.4	2.2	2.5	1.8	1.6	2.2	2.3	5.2	1.9	4.1	3.4	2.7	73.5	5.1	3.9	4.8	2.0	1.3	2.8	5.0	3.0	4.4	1.9	3.0	4.1	4.8	3.2	1.7	9.3	3.1	2.5	4.2	3.7	4.1	2.7	3.0	2.8	2.2	4.4	4.9	3.6	3.8	2.4	4.9	2.1	2.9	7.2	2.0	2.1	2.7	2.1	1.2	5.5	2.2	3.9	4.4	2.2	5.4	3.1	3.2	0.1	1.2	2.0	0.9	2.5	1.2	0.9	1.5	0.7	1.3	0.5	1.3	0.5	0.4	3.3	1.2	0.4	5.0	0.5	12.8	20.3	7.2	16.9	16.5	9.6	10.7	14.9	19.8	9.6	56.6	75.8	3.4	4.5	13.9	9.4	4.5	17.8	5.3	19.4	5.2	5.9	8.4	10.0	3.6	61.0	3.9	114.1	0.0	4.9	2.2	3.1	6.2	5.7	4.9	3.9	4.8	8.7	4.3	8.3	20.3	3.7	5.1	23.6	7.2	29.7	87.7	4.5	30.8	6.3	15.7	5.0	6.5	1.2	4.6	2.4	8.5	12.7	3.2	32.7	13.9
AICDA	"AID, ARP2, CDA2, HIGM2"	ENSG00000111732	"Activation induced cytidine deaminase"	Q9GZX7	12	8602166-8612871	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"mRNA processing"	Hydrolase	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"blood: 6.6;lymphoid tissue: 22.3"	"Cell type enhanced"	"Detected in single"	10	"Alveolar cells type 2: 1.1"	"Cancer enhanced"	"Detected in single"		"testis cancer: 0.8"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"naive B-cell: 6.6"	"Group enriched"	"Detected in many"	6	"B-cells: 6.6;granulocytes: 1.6"	"Group enriched"	"Detected in some"	6	"Daudi: 49.6;U-698: 41.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"									NA	NA						"unprognostic (2.71e-2)"	"unprognostic (1.39e-2)"		"unprognostic (7.76e-2)"	"unprognostic (1.68e-1)"	"unprognostic (8.73e-3)"		"unprognostic (1.11e-1)"	"unprognostic (4.05e-2)"	"unprognostic (9.69e-2)"	"unprognostic (1.96e-2)"		"unprognostic (4.04e-6)"	"unprognostic (8.82e-2)"	"unprognostic (1.28e-1)"	"unprognostic (4.21e-1)"	"unprognostic (4.65e-1)"	1.3	0.1	0.1	22.3	0.1	0.4	0.4	0.1	0.1	0.2	0.3	0.1	0.1	0.0	0.9	0.1	0.1	0.2	0.3	0.4	0.1	0.0	0.2	0.1	0.5	15.5	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.3	0.0	0.1	1.8	0.1	1.1	0.5	3.9	0.1	0.1	1.7	0.2	0.2	0.1	0.6	0.3	0.1	12.2	0.1	0.7	6.6	0.7	1.6	0.7	0.5	0.4	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	49.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.7	7.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.2	0.0	0.1	0.2	0.0	0.0	0.0	41.4	0.0	0.1	0.0	1.0	0.7	0.4	0.4	0.3	0.2	4.3	0.4	0.2	0.4	6.6	0.4	0.4	1.6	0.5	0.4	0.7	0.3	0.4	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	1.1	0.0	0.3	0.2	0.4	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.2	0.4	0.2	0.0	0.0	0.1	0.0	0.0	0.6	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2
AK1		ENSG00000106992	"Adenylate kinase 1"	P00568	9	127866480-127877743	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		"Kinase, Transferase"	"Disease mutation, Hereditary hemolytic anemia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"fallopian tube: 84.5;skeletal muscle: 279.0"	"Cell type enhanced"	"Detected in all"	11	"Late spermatids: 823.7;Peritubular cells: 363.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"U-2197: 46.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006456, CAB009893"	Enhanced		Supported	Cytosol		NA	NA		32000000	Cytosol		"CAB009893: AB_2225151, HPA006456: AB_1078116"	"unprognostic (6.07e-3)"	"unprognostic (1.44e-2)"	"unprognostic (2.36e-2)"	"unprognostic (1.03e-1)"	"unprognostic (3.44e-1)"	"unprognostic (3.09e-1)"	"unprognostic (1.52e-2)"	"unprognostic (3.12e-2)"	"unprognostic (2.19e-1)"	"unprognostic (5.74e-2)"	"unprognostic (6.65e-3)"	"unprognostic (2.07e-1)"	"unprognostic (1.81e-2)"	"prognostic favorable (7.31e-4)"	"unprognostic (2.62e-1)"	"unprognostic (8.40e-3)"	"unprognostic (6.99e-3)"	7.7	9.2	19.6	3.7	18.8	6.5	3.9	9.8	17.3	10.5	8.6	18.1	12.2	5.2	3.4	17.3	9.0	84.5	12.0	60.4	17.6	18.5	6.3	10.7	18.7	2.2	16.4	15.3	12.3	4.6	5.6	7.1	2.9	17.5	5.2	10.8	7.0	13.4	15.7	279.0	3.4	2.6	6.3	11.5	5.6	5.8	9.8	11.1	0.0	10.5	61.5	4.0	4.4	4.4	1.2	3.4	2.8	0.4	1.4	1.5	1.2	15.0	6.5	8.3	11.4	20.3	41.3	7.6	10.5	10.6	18.7	11.4	4.8	9.6	0.4	11.5	21.6	12.4	21.7	0.0	11.7	7.5	2.4	7.2	2.2	18.7	8.4	11.4	0.0	0.2	31.4	22.8	13.9	10.1	10.3	25.0	0.2	8.9	0.6	21.2	14.4	0.0	0.3	3.0	37.8	20.2	0.4	8.4	3.3	12.5	1.1	13.6	8.4	27.7	16.0	8.0	4.5	12.8	9.0	20.6	13.1	5.3	46.1	10.0	1.0	0.1	0.0	16.4	0.0	9.1	0.9	0.4	0.4	1.5	0.3	1.1	0.3	0.6	1.1	0.1	1.2	0.3	1.1	2.8	1.4	0.4	3.4	0.3	1.2	19.6	18.8	9.8	17.3	17.6	18.5	16.4	15.3	17.5	11.1	38.7	148.9	3.7	16.6	23.5	48.5	42.8	30.6	46.8	19.4	7.0	15.7	6.3	14.9	97.5	229.8	49.4	94.1	93.5	54.8	37.4	51.2	15.5	1.1	69.2	46.3	46.1	102.2	47.9	3.2	823.7	209.7	11.0	79.2	2.8	66.4	290.8	46.6	58.8	363.1	6.3	55.1	25.8	50.9	14.4	15.6	24.8	11.3	7.5	73.1	20.9
AK2		ENSG00000004455	"Adenylate kinase 2"	P54819	1	33007940-33080996	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		"Kinase, Transferase"	"Disease mutation, SCID"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Proximal tubular cells: 362.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA018479, CAB079913"	Approved		Approved	Mitochondria		NA	NA		5500000	Mitochondria		"CAB079913: AB_2546087, HPA018479: AB_1844676"	"prognostic favorable (4.37e-4)"	"unprognostic (3.25e-2)"	"unprognostic (2.80e-2)"	"prognostic unfavorable (8.65e-4)"	"unprognostic (3.16e-2)"	"unprognostic (8.21e-2)"	"prognostic unfavorable (9.32e-4)"	"unprognostic (7.86e-3)"	"unprognostic (1.85e-2)"	"unprognostic (1.28e-1)"	"prognostic unfavorable (6.40e-4)"	"unprognostic (4.95e-2)"	"unprognostic (8.33e-3)"	"unprognostic (9.56e-3)"	"unprognostic (2.71e-1)"	"unprognostic (1.40e-1)"	"unprognostic (5.40e-3)"	24.9	27.1	16.0	27.6	20.3	18.3	24.2	19.1	17.6	21.4	31.3	24.6	22.4	36.6	20.6	22.8	31.6	17.6	25.0	33.9	15.1	14.5	51.2	46.5	17.9	18.2	23.1	9.9	24.3	23.2	27.2	16.2	18.6	19.7	22.4	31.8	20.4	31.4	21.5	73.8	20.6	37.1	18.7	25.9	24.7	24.0	29.3	25.0	40.2	37.4	34.4	28.7	26.7	23.3	31.7	51.9	50.9	41.2	27.4	24.4	43.1	45.7	20.3	19.2	22.3	13.3	16.7	19.5	25.8	20.0	38.9	40.9	39.0	41.5	85.2	30.7	19.1	27.9	33.2	44.6	43.9	41.9	37.2	32.6	56.4	39.1	29.7	31.2	100.3	32.0	16.5	33.2	33.3	67.3	21.7	26.5	36.0	59.9	32.1	23.1	23.0	37.9	55.5	26.8	44.1	31.2	44.3	32.7	56.1	38.3	27.6	28.3	16.6	29.5	32.8	82.3	23.8	26.6	71.4	19.4	23.6	28.5	36.3	48.3	33.5	43.8	79.4	32.0	95.0	27.2	11.0	41.2	50.9	22.0	37.4	23.0	31.7	20.6	20.6	51.9	27.7	21.2	19.8	11.3	27.4	31.5	39.1	24.4	43.1	16.0	20.3	19.1	17.6	15.1	14.5	23.1	9.9	19.7	25.0	47.6	66.5	38.7	80.7	111.2	21.1	86.7	71.4	46.8	83.0	106.4	78.5	137.4	217.2	94.6	81.6	64.2	135.8	0.0	107.9	138.4	58.1	76.3	39.3	127.8	84.9	7.9	48.5	31.9	41.6	29.1	43.4	51.1	82.7	58.7	70.5	20.1	99.6	51.8	41.4	362.4	38.8	51.8	59.5	97.9	21.1	107.3	181.1	37.4	94.5	113.8
AK3	"AK3L1, AK6, AKL3L1"	ENSG00000147853	"Adenylate kinase 3"	Q9UIJ7	9	4709559-4742043	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 86.8;HEL: 55.6"	"Low region specificity"	"Detected in all"							HPA063324	Enhanced		Supported	Mitochondria		NA	NA		68000	Mitochondria		"HPA063324: AB_2684985"	"unprognostic (1.30e-2)"	"unprognostic (2.25e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.06e-1)"	"unprognostic (6.55e-2)"	"unprognostic (1.02e-1)"	"unprognostic (2.21e-3)"	"unprognostic (6.44e-2)"	"unprognostic (2.81e-2)"	"unprognostic (9.81e-3)"	"unprognostic (1.90e-1)"	"unprognostic (2.76e-2)"	"prognostic favorable (6.07e-9)"	"unprognostic (1.24e-1)"	"unprognostic (1.40e-1)"	"unprognostic (1.39e-1)"	"unprognostic (1.55e-3)"	24.6	25.1	20.9	9.8	22.4	6.8	24.0	14.6	17.5	17.7	23.7	15.3	16.0	24.4	18.9	17.5	28.3	14.0	16.1	90.0	22.4	16.4	37.7	75.1	16.4	13.1	25.2	15.2	22.4	15.7	16.9	14.1	13.0	22.9	19.0	23.0	17.4	14.5	19.1	72.0	18.1	22.0	21.2	24.1	12.1	22.5	9.3	24.9	15.2	20.8	32.8	14.9	20.1	17.1	7.0	14.4	17.0	5.6	14.7	17.1	10.2	8.8	7.5	12.8	5.2	17.9	13.2	0.9	11.3	26.5	7.1	10.6	1.3	9.9	8.3	3.8	14.3	3.9	5.8	9.3	10.8	12.0	86.8	7.0	55.6	13.3	22.5	14.1	5.8	2.9	20.8	9.7	6.0	8.4	16.5	20.8	8.5	4.2	11.3	21.1	5.3	5.6	16.9	11.4	17.4	2.8	7.6	4.6	4.1	20.6	12.5	21.1	13.3	13.2	4.3	7.5	13.0	6.0	11.7	12.8	5.9	6.0	15.5	8.8	2.9	1.8	10.2	10.9	4.4	4.2	6.8	5.6	17.0	16.2	4.4	14.7	7.0	12.5	14.8	10.5	6.9	16.6	17.1	1.9	14.7	3.4	14.4	16.7	10.2	20.9	22.4	14.6	17.5	22.4	16.4	25.2	15.2	22.9	24.9	53.6	88.6	32.0	59.7	65.9	11.9	155.8	66.2	45.5	68.2	62.8	21.6	83.2	218.8	74.1	2.6	56.6	104.3	0.0	61.0	10.9	79.1	116.1	44.0	282.7	40.3	14.3	105.2	74.3	36.8	1.9	100.7	36.7	70.9	53.3	103.3	22.3	61.2	57.5	140.7	148.4	8.8	103.5	59.8	6.6	15.3	91.2	179.0	38.5	135.0	92.5
AK4	"AK3, AK3L1"	ENSG00000162433	"Adenylate kinase 4"	P27144	1	65147549-65232145	"Enzymes, Predicted intracellular proteins"		"Kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"kidney: 89.7;liver: 50.7"	"Cell type enhanced"	"Detected in many"	15	"Hepatocytes: 223.0;Proximal tubular cells: 422.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"classical monocyte: 6.1;myeloid DC: 5.3"	"Group enriched"	"Detected in many"	7	"dendritic cells: 5.3;granulocytes: 1.6;monocytes: 6.1"	"Cell line enhanced"	"Detected in many"		"Hep G2: 59.4"	"Low region specificity"	"Detected in all"							"HPA042753, HPA049461"	Enhanced		Supported	Mitochondria	"Intracellular and membrane"	NA	NA		18000	Mitochondria		"HPA042753: AB_2678146, HPA049461: AB_2680776"	"unprognostic (3.73e-2)"	"prognostic unfavorable (4.17e-4)"	"unprognostic (2.25e-1)"	"unprognostic (3.05e-3)"	"unprognostic (1.48e-2)"	"prognostic unfavorable (8.83e-4)"	"unprognostic (1.16e-3)"	"unprognostic (3.89e-2)"	"unprognostic (4.03e-1)"	"unprognostic (5.39e-2)"	"prognostic unfavorable (4.34e-5)"	"unprognostic (6.71e-2)"	"prognostic unfavorable (4.36e-4)"	"prognostic unfavorable (4.87e-4)"	"unprognostic (2.69e-1)"	"unprognostic (7.07e-2)"	"unprognostic (7.57e-2)"	12.4	1.6	11.7	3.7	11.2	2.7	13.4	12.0	9.9	4.0	9.5	4.0	4.7	2.7	3.9	4.4	12.3	4.2	8.6	26.0	9.3	7.1	89.7	50.7	1.6	1.4	6.3	9.1	5.8	1.8	8.2	2.6	4.5	7.2	8.9	7.7	4.4	9.4	7.3	2.2	14.0	3.5	13.6	8.1	1.2	7.8	6.0	5.0	0.4	1.9	5.7	3.2	12.4	7.4	0.5	5.3	1.6	6.1	0.6	0.5	1.4	20.6	1.4	1.6	7.0	15.6	14.9	3.5	3.5	4.4	7.6	21.2	31.0	2.5	11.1	9.2	5.4	9.5	13.4	5.5	26.1	30.6	9.3	6.3	10.8	7.0	59.4	0.7	8.3	1.3	8.2	14.7	7.4	21.9	12.6	0.2	3.5	13.4	0.2	11.6	8.8	0.3	0.3	7.2	0.3	12.4	0.0	12.1	2.0	11.2	0.9	6.1	4.5	6.2	0.4	4.9	8.0	8.7	3.7	1.2	12.7	10.9	0.9	5.9	11.7	5.2	0.6	20.5	3.1	0.7	1.6	6.1	0.0	0.2	1.4	0.4	0.5	0.2	0.5	5.3	0.4	0.2	0.2	1.0	0.6	0.2	0.8	0.1	1.4	11.7	11.2	12.0	9.9	9.3	7.1	6.3	9.1	7.2	5.0	0.0	0.3	4.9	19.8	44.2	14.7	91.5	61.1	5.3	6.8	29.6	2.0	1.2	48.0	16.1	1.6	17.5	13.5	0.0	11.0	13.9	10.3	33.2	0.0	223.0	3.3	15.9	5.2	5.5	5.6	4.2	3.7	2.7	23.6	7.2	6.7	27.4	22.8	3.5	8.9	422.4	6.2	6.5	27.4	2.1	5.1	65.0	4.1	1.0	22.9	16.6
AK5		ENSG00000154027	"Adenylate kinase 5"	Q9Y6K8	1	77282051-77559969	"Enzymes, Predicted intracellular proteins"		"Kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	7	"brain: 95.5"	"Cell type enhanced"	"Detected in many"	22	"Early spermatids: 137.0;Extravillous trophoblasts: 30.0;Spermatogonia: 72.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"myeloid DC: 10.9;naive CD4 T-cell: 14.2"	"Group enriched"	"Detected in many"	15	"dendritic cells: 10.9;T-cells: 14.2"	"Cell line enhanced"	"Detected in many"		"ASC TERT1: 30.3;BJ: 20.7;fHDF/TERT166: 23.6;LHCN-M2: 59.3;U-2 OS: 18.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA019128, HPA057255"	Enhanced		Supported	"Centriolar satellite,Cytosol"		NA	NA			Cytosol	"Centriolar satellite"	"HPA019128: AB_1844682, HPA057255: AB_2683383"	"unprognostic (4.07e-2)"	"unprognostic (4.23e-1)"	"unprognostic (1.13e-1)"	"unprognostic (2.85e-2)"	"unprognostic (1.03e-1)"	"unprognostic (6.04e-2)"	"unprognostic (2.20e-1)"	"unprognostic (2.01e-2)"	"unprognostic (1.84e-1)"	"unprognostic (1.51e-1)"	"unprognostic (1.91e-2)"	"prognostic favorable (3.88e-4)"	"unprognostic (3.56e-3)"	"unprognostic (6.17e-4)"	"unprognostic (1.18e-1)"	"unprognostic (5.96e-2)"	"unprognostic (6.76e-2)"	1.8	2.1	43.8	1.9	35.7	3.7	14.1	1.3	95.5	2.0	1.8	20.4	0.0	1.8	1.6	1.5	1.8	1.8	1.7	1.5	35.8	11.8	2.0	1.2	1.4	2.5	13.0	41.1	1.5	2.1	2.4	1.4	1.8	11.4	2.7	1.8	0.0	3.1	2.7	1.3	2.4	1.7	1.7	14.2	2.4	2.9	7.3	13.9	0.0	1.7	0.0	2.1	1.5	0.4	0.8	10.9	0.7	0.7	0.1	14.2	1.9	0.0	1.1	0.9	0.0	11.2	30.3	0.4	20.7	4.4	3.4	1.4	0.1	0.5	0.1	0.1	23.6	1.3	0.1	0.0	0.0	1.7	0.7	0.2	0.1	0.1	0.0	0.5	0.1	0.0	3.7	0.1	0.6	1.3	12.0	9.7	0.1	0.2	0.2	59.3	0.2	0.0	0.1	1.2	5.5	7.5	0.5	2.2	0.3	9.2	0.3	4.6	1.1	0.0	0.0	1.3	0.1	0.1	0.1	2.4	8.2	18.6	0.4	0.6	4.8	4.3	0.0	1.6	1.0	3.0	0.7	0.7	0.0	3.4	0.1	0.5	0.8	3.2	1.6	10.9	0.8	14.2	7.8	0.5	0.1	0.2	1.2	1.4	1.9	43.8	35.7	1.3	47.1	35.8	11.8	13.0	41.1	11.4	13.9	0.0	0.0	0.0	0.5	0.2	0.5	1.2	0.0	0.0	0.0	1.8	0.0	0.9	6.6	0.2	137.0	1.1	0.0	0.0	0.6	30.0	1.2	2.2	0.0	0.0	2.2	12.7	11.5	0.6	0.0	16.1	1.1	0.4	3.3	0.0	0.0	0.0	0.1	0.0	0.7	4.5	0.2	0.0	3.1	6.5	72.5	0.3	2.4	1.5	0.0	0.1
AK6	CINAP	ENSG00000085231	"Adenylate kinase 6"	Q9Y3D8	5	69350984-69370013	"Enzymes, Predicted intracellular proteins"		"Kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Late spermatids: 216.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"CAB005361, HPA070217"	Supported		Supported	"Nuclear speckles,Centrosome,Cytosol"		No	No			"Nuclear speckles"	"Centrosome, Cytosol"	"CAB005361: AB_2302969, HPA070217: "	"unprognostic (5.47e-2)"	"unprognostic (1.54e-2)"	"unprognostic (1.48e-1)"	"unprognostic (8.58e-2)"	"unprognostic (8.73e-2)"	"unprognostic (4.09e-2)"	"prognostic unfavorable (9.54e-4)"	"unprognostic (1.79e-1)"	"unprognostic (3.41e-2)"	"unprognostic (6.21e-2)"	"unprognostic (2.55e-2)"	"unprognostic (2.25e-2)"	"unprognostic (1.14e-2)"	"unprognostic (1.31e-1)"	"unprognostic (1.84e-1)"	"unprognostic (2.22e-1)"	"unprognostic (2.55e-2)"	27.6	27.7	25.1	16.9	25.4	14.8	23.3	21.5	23.6	17.6	22.7	11.3	16.4	18.3	18.3	30.4	26.7	15.4	15.1	17.9	23.2	22.2	30.2	42.3	17.0	18.7	20.9	16.2	18.8	17.2	15.8	26.3	21.5	23.3	18.2	20.6	12.3	14.5	14.6	41.4	11.9	24.0	16.7	19.6	21.8	17.0	46.1	17.5	25.2	24.3	24.2	18.8	19.7	13.7	22.2	22.0	14.3	15.9	16.6	21.2	10.0	17.1	9.6	12.6	16.8	20.6	13.7	23.6	25.9	9.7	12.8	15.9	26.7	14.9	36.9	24.6	11.7	30.5	5.8	19.7	12.4	19.5	15.1	9.4	18.1	20.4	20.4	16.9	21.5	7.9	8.0	16.4	12.7	18.2	12.2	8.2	21.2	16.9	12.2	16.4	20.0	19.8	14.6	10.4	8.6	6.4	23.3	15.6	20.4	20.0	14.0	6.5	6.4	13.4	10.8	18.6	10.7	11.5	24.3	10.8	9.6	15.4	17.8	21.4	14.7	30.5	32.7	12.4	31.7	12.4	13.7	13.0	14.3	15.5	15.9	16.1	22.2	18.4	19.3	18.0	18.1	20.1	21.2	2.1	16.6	14.2	22.0	18.1	10.0	25.1	25.4	21.5	23.6	23.2	22.2	20.9	16.2	23.3	17.5	20.8	35.4	37.1	87.7	0.0	18.7	49.5	17.8	33.5	30.7	22.7	9.8	72.3	157.5	66.4	145.7	28.1	24.8	0.0	67.7	77.3	45.1	82.1	19.8	41.0	62.2	19.1	9.4	27.6	25.3	216.1	31.1	35.2	0.0	50.5	24.5	36.8	52.7	29.1	30.1	110.2	20.0	51.8	65.6	42.4	42.4	0.0	55.4	25.9	41.3	76.3
AK7	FLJ32864	ENSG00000140057	"Adenylate kinase 7"	Q96M32	14	96392111-96489427	"Enzymes, Predicted intracellular proteins"	"Cilium biogenesis/degradation"	"Kinase, Transferase"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"fallopian tube: 29.0"	"Cell type enriched"	"Detected in many"	7	"Ciliated cells: 175.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in single"	17	"basophil: 10.6"	"Lineage enriched"	"Detected in single"	22	"granulocytes: 10.6"	"Cell line enhanced"	"Detected in some"		"BEWO: 10.6;CAPAN-2: 9.2;MCF7: 29.4;REH: 20.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA003543	Enhanced					NA	NA					"HPA003543: AB_1078117"	"unprognostic (4.18e-3)"	"unprognostic (1.14e-1)"	"unprognostic (9.40e-3)"	"prognostic favorable (3.18e-4)"	"unprognostic (4.98e-5)"	"unprognostic (8.41e-2)"	"unprognostic (9.81e-3)"	"unprognostic (1.29e-1)"	"unprognostic (9.02e-2)"	"unprognostic (3.65e-4)"	"unprognostic (8.64e-2)"	"unprognostic (1.89e-1)"	"prognostic favorable (1.14e-4)"	"unprognostic (2.00e-2)"	"unprognostic (1.23e-2)"	"unprognostic (4.01e-2)"	"unprognostic (2.25e-3)"	1.5	3.4	4.0	0.9	12.6	2.0	2.1	0.7	3.1	2.7	2.8	8.4	5.1	2.5	2.8	13.1	2.4	29.0	5.0	1.2	6.7	9.2	7.6	3.0	9.2	1.4	2.3	2.6	4.9	2.9	11.7	17.5	0.9	16.7	1.4	2.2	1.5	1.6	2.9	0.5	7.5	3.1	1.6	2.7	4.3	3.5	17.6	4.2	1.1	4.8	1.3	0.8	1.1	1.5	0.4	0.1	10.6	0.3	0.3	0.4	0.2	0.1	2.9	1.2	1.0	0.5	1.8	10.6	0.2	0.3	0.2	0.1	0.3	9.2	0.2	0.2	0.1	0.2	1.1	2.9	0.1	0.1	1.3	0.2	0.2	1.4	0.1	0.5	0.1	0.2	0.1	0.4	1.5	0.0	0.5	0.1	0.9	0.1	0.2	0.2	29.4	0.2	0.2	0.5	1.3	0.6	20.9	0.3	0.3	4.6	0.2	2.0	4.2	1.1	0.4	0.0	1.2	2.5	0.1	0.0	0.3	0.1	0.3	0.1	0.4	1.3	0.1	0.1	0.0	0.4	10.6	0.2	0.1	0.2	0.0	0.1	0.1	0.1	0.4	0.1	0.4	0.2	0.2	0.6	0.3	0.3	0.1	0.1	0.2	4.0	12.6	0.7	3.1	6.7	9.2	2.3	2.6	16.7	4.2	6.0	2.6	0.5	0.7	1.5	0.0	0.3	2.5	175.3	18.2	7.0	2.0	0.7	3.3	2.4	14.5	0.9	1.1	0.0	1.0	1.5	0.4	0.4	0.0	0.6	0.2	0.0	1.2	0.6	0.3	2.2	0.0	0.6	1.7	0.0	0.4	0.9	0.3	0.0	0.0	3.0	1.5	0.0	0.2	24.1	9.4	2.6	2.4	0.0	1.3	0.4
AK8	"C9orf98, FLJ32704"	ENSG00000165695	"Adenylate kinase 8"	Q96MA6	9	132725578-132878777	"Enzymes, Predicted intracellular proteins"		"Kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"epididymis: 12.8;fallopian tube: 17.7;testis: 15.6"	"Group enriched"	"Detected in many"	7	"Early spermatids: 81.9;Late spermatids: 93.2;monocytes: 85.6;Spermatocytes: 23.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in single"	8	"NK-cell: 3.9"	"Lineage enriched"	"Detected in single"	8	"NK-cells: 3.9"	"Cell line enhanced"	"Detected in some"		"AN3-CA: 3.1;MCF7: 5.3;RPTEC TERT1: 6.2;T-47d: 4.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA021443, HPA023894"	Enhanced					NA	NA					"HPA021443: AB_1845852, HPA023894: AB_1845854"	"unprognostic (4.14e-2)"	"unprognostic (1.20e-4)"	"unprognostic (1.31e-2)"	"unprognostic (1.70e-3)"	"unprognostic (2.16e-1)"	"unprognostic (2.38e-2)"	"unprognostic (1.14e-1)"	"unprognostic (3.18e-1)"	"unprognostic (3.43e-1)"	"unprognostic (1.71e-1)"	"unprognostic (7.51e-2)"	"unprognostic (1.42e-1)"	"prognostic favorable (1.61e-4)"	"unprognostic (9.89e-2)"	"unprognostic (3.22e-2)"	"unprognostic (2.03e-1)"	"unprognostic (1.43e-1)"	0.5	0.7	1.3	0.5	2.2	0.0	0.5	1.6	1.3	1.6	0.5	0.5	0.5	0.0	1.1	12.8	0.5	17.7	0.7	0.5	1.3	2.0	1.4	0.5	1.1	0.5	1.2	0.5	0.9	0.5	2.5	1.7	1.5	2.3	0.5	0.0	0.9	1.0	1.8	0.5	1.1	0.5	0.5	1.7	0.5	0.3	15.6	0.5	0.5	3.1	0.5	0.5	0.5	0.5	0.1	0.0	0.0	0.0	3.9	0.5	0.0	2.0	1.0	0.6	3.1	0.4	0.8	0.6	0.3	0.2	0.2	0.0	0.4	2.2	0.0	0.7	0.3	0.8	0.5	0.3	0.0	0.1	0.1	0.7	0.0	0.2	0.0	1.3	0.0	0.0	1.9	0.9	0.3	0.6	0.6	0.2	1.8	0.1	0.0	0.5	5.3	1.5	0.4	0.2	0.9	0.6	0.0	0.0	0.0	6.2	0.0	1.1	1.2	2.6	0.0	0.4	0.6	4.1	0.0	0.0	0.8	0.2	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.5	0.0	0.0	3.9	0.0	0.0	0.0	0.0	1.3	2.2	1.6	1.0	1.3	2.0	1.2	0.5	2.3	0.5	3.0	1.7	0.0	0.5	0.5	0.2	0.8	0.0	10.7	2.3	3.5	0.0	0.4	0.0	1.9	81.9	0.5	0.0	0.0	0.5	0.4	0.7	0.5	0.0	0.0	1.5	0.0	0.0	0.0	0.3	93.2	5.8	0.8	1.7	85.6	0.7	0.6	1.0	0.0	3.9	4.4	1.7	0.0	0.5	23.3	5.7	1.4	0.3	0.0	0.6	0.5
AK9	"AKD1, AKD2, C6orf199, C6orf224, dJ70A9.1, FLJ25791, FLJ42177, MGC26954"	ENSG00000155085	"Adenylate kinase 9"	Q5TCS8	6	109492856-109691217	"Cancer-related genes, Enzymes, Predicted intracellular proteins"	"Nucleotide metabolism"	"Kinase, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	10	"Ciliated cells: 165.9;Spermatocytes: 116.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in single"							"HPA030804, HPA030805, HPA031779, HPA031781, HPA036324, HPA036711"	Enhanced		Enhanced	"Nucleoplasm,Nuclear membrane"		NA	NA			"Nucleoplasm, Nuclear membrane"		"HPA030804: AB_2673617, HPA030805: AB_2673618, HPA031779: AB_10603674, HPA031781: AB_2674044, HPA036324: AB_2675060, HPA036711: AB_2675265"	"unprognostic (9.68e-3)"	"unprognostic (2.15e-1)"	"unprognostic (1.66e-2)"	"unprognostic (2.36e-2)"	"unprognostic (3.42e-1)"	"unprognostic (7.28e-2)"	"unprognostic (1.41e-3)"	"unprognostic (6.76e-3)"	"unprognostic (1.89e-1)"	"unprognostic (3.50e-2)"	"unprognostic (1.67e-4)"	"unprognostic (2.58e-1)"	"unprognostic (2.98e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.30e-1)"	"unprognostic (8.39e-2)"	"unprognostic (5.56e-2)"	4.6	4.7	7.7	5.6	8.4	4.7	8.3	13.5	8.7	5.0	6.5	8.5	4.1	5.0	6.3	11.1	6.2	11.3	5.2	6.9	9.1	10.3	7.6	4.5	6.7	5.5	9.4	4.9	6.7	4.6	15.4	33.3	4.4	11.5	5.9	6.7	3.7	7.0	6.3	6.1	5.5	6.2	5.7	11.7	6.5	6.1	22.0	7.7	20.5	11.4	4.1	5.0	5.9	4.4	11.2	2.9	15.1	4.1	4.9	6.4	1.6	2.5	1.8	7.6	13.5	7.1	4.5	5.7	4.0	5.0	4.2	5.7	2.9	5.3	5.5	2.1	3.7	9.2	4.5	2.2	4.3	8.9	11.7	4.7	4.2	4.4	2.9	5.8	5.3	2.6	3.6	8.4	7.7	10.1	10.3	5.5	8.4	3.9	4.6	3.1	5.2	4.6	3.5	1.7	5.8	2.9	6.1	4.2	5.1	6.1	5.0	9.2	7.9	4.8	4.6	6.6	4.5	6.0	6.4	5.8	4.0	2.7	5.8	2.6	2.4	2.1	3.2	8.1	6.7	2.2	15.1	2.8	6.5	5.1	1.5	4.4	10.5	5.1	6.1	2.0	11.2	6.4	5.5	5.4	4.9	4.1	2.9	3.6	1.6	7.7	8.4	13.5	8.7	9.1	10.3	9.4	4.9	11.5	7.7	26.8	18.8	6.6	7.7	2.4	14.6	16.1	2.5	165.9	18.2	8.7	13.7	3.3	0.0	7.0	55.8	11.3	10.5	0.0	3.9	1.2	3.5	4.8	20.9	1.8	3.0	19.1	19.0	5.5	4.6	32.1	6.9	5.3	5.0	1.8	14.3	15.2	6.1	7.8	6.0	5.6	48.9	25.8	5.2	116.9	28.5	2.3	4.7	12.8	9.9	7.5
AKR1A1	"ALR, DD3"	ENSG00000117448	"Aldo-keto reductase family 1 member A1"	P14550	1	45550543-45570049	"Enzymes, Plasma proteins, Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	10	"Proximal tubular cells: 1001.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB006246, HPA017919, HPA019649, HPA027734"	Approved		Supported	Nucleoplasm,Cytosol		NA	NA		8100000	Cytosol	Nucleoplasm	"CAB006246: AB_425840, HPA017919: AB_1844695, HPA019649: AB_1844696, HPA027734: AB_10600976"	"unprognostic (1.73e-1)"	"prognostic favorable (2.66e-6)"	"unprognostic (4.03e-1)"	"prognostic favorable (2.92e-4)"	"unprognostic (1.17e-1)"	"unprognostic (1.77e-2)"	"unprognostic (6.54e-3)"	"unprognostic (1.31e-3)"	"unprognostic (2.52e-1)"	"unprognostic (1.24e-1)"	"unprognostic (1.83e-1)"	"unprognostic (8.43e-2)"	"unprognostic (4.51e-2)"	"unprognostic (1.56e-2)"	"unprognostic (2.46e-1)"	"unprognostic (2.89e-2)"	"unprognostic (4.57e-2)"	20.0	20.4	12.0	27.9	13.9	9.7	31.8	11.5	23.6	21.7	39.6	18.7	20.0	43.6	18.5	31.7	39.0	21.8	31.7	18.5	11.2	12.0	79.6	80.4	26.0	33.8	15.0	13.9	18.3	44.2	11.3	27.5	20.2	13.1	19.4	28.9	16.7	59.8	24.1	13.4	18.2	69.7	19.4	16.3	25.6	27.7	10.5	13.1	24.8	24.6	31.3	33.2	17.4	18.6	23.3	46.8	26.8	56.3	13.8	18.7	38.4	16.4	23.8	21.8	16.8	47.4	34.4	15.4	19.5	45.7	17.1	34.5	9.9	12.7	40.6	15.7	22.3	17.9	21.1	22.9	28.5	16.1	16.3	20.6	23.5	20.2	43.3	39.6	30.3	26.4	38.0	25.8	21.6	40.2	32.3	39.4	29.6	12.0	32.5	20.0	11.9	32.4	13.2	23.7	53.3	16.3	37.4	26.1	47.1	48.6	22.5	26.0	15.0	16.9	67.5	24.7	31.3	18.9	17.4	24.0	7.9	17.6	27.4	11.6	22.4	29.9	19.1	15.5	39.5	6.7	26.8	56.3	10.5	16.3	51.8	17.8	23.3	15.3	16.0	46.8	22.7	13.1	13.5	2.6	13.8	38.1	40.8	18.7	38.4	12.0	13.9	11.5	23.6	11.2	12.0	15.0	13.9	13.1	13.1	44.7	49.4	132.5	80.9	43.7	20.8	32.3	96.8	60.2	53.4	75.0	35.3	93.6	154.2	163.4	4.1	51.7	130.2	0.0	136.9	121.2	79.9	92.3	108.6	269.4	347.1	15.9	113.6	74.9	110.8	5.9	63.3	159.5	77.6	161.5	133.1	26.5	118.5	151.9	52.6	1001.5	34.9	6.5	49.5	3.2	27.2	41.0	56.8	53.3	166.2	98.2
AKR1B1	"ALDR1, AR"	ENSG00000085662	"Aldo-keto reductase family 1 member B"	P15121	7	134442350-134459284	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins"		Oxidoreductase	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	4	"adrenal gland: 302.2;seminal vesicle: 109.3"	"Cell type enhanced"	"Detected in many"	13	"Collecting duct cells: 615.9;Cytotrophoblasts: 969.9;Extravillous trophoblasts: 1080.2;Syncytiotrophoblasts: 1691.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"A549: 122.4;BJ hTERT+: 224.5;RPTEC TERT1: 106.2;U-87 MG: 101.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA026425, CAB027391, CAB047353, HPA052751"	Enhanced		Supported	Nucleoplasm,Cytosol		No	No		1700000	Cytosol	Nucleoplasm	"CAB027391: , CAB047353: , HPA026425: AB_10601563, HPA052751: AB_2681935"	"unprognostic (2.76e-2)"	"unprognostic (2.84e-2)"	"unprognostic (2.02e-2)"	"unprognostic (1.37e-2)"	"unprognostic (6.81e-2)"	"unprognostic (2.26e-1)"	"unprognostic (4.18e-2)"	"unprognostic (5.09e-2)"	"unprognostic (2.51e-3)"	"unprognostic (2.47e-1)"	"unprognostic (2.98e-2)"	"unprognostic (8.78e-2)"	"unprognostic (2.81e-2)"	"prognostic unfavorable (2.44e-5)"	"unprognostic (2.03e-1)"	"unprognostic (1.39e-1)"	"prognostic unfavorable (7.00e-4)"	5.9	302.2	7.5	4.7	13.7	2.5	9.5	6.9	10.9	4.4	3.9	8.2	50.4	2.7	4.6	6.1	4.2	4.6	5.2	24.2	7.3	8.4	17.7	2.5	6.9	10.0	9.5	9.0	8.2	7.2	9.4	8.0	24.8	11.9	5.5	4.1	5.8	4.4	109.3	37.6	2.8	4.8	5.6	7.9	6.7	5.0	5.2	5.9	7.3	6.0	10.3	7.6	7.1	3.7	31.4	34.8	22.5	26.0	26.3	42.7	47.2	13.5	122.4	13.8	19.5	59.5	16.2	36.8	13.1	224.5	19.3	25.0	5.6	12.4	0.0	6.1	21.9	85.2	5.7	15.0	13.1	15.4	4.8	13.7	6.9	18.4	16.6	85.3	0.0	0.0	15.1	9.8	27.6	7.3	18.9	27.2	13.6	0.0	4.6	21.3	0.2	20.3	9.3	22.9	0.9	0.1	21.2	8.8	10.2	106.2	66.2	10.3	22.9	91.9	0.1	9.6	9.4	0.0	10.3	21.4	19.1	8.9	1.7	14.2	12.6	13.9	34.2	101.0	0.0	11.4	22.5	26.0	1.2	37.9	17.0	34.0	31.4	32.4	36.7	34.8	28.5	42.7	41.1	2.1	26.3	8.9	4.9	22.0	47.2	7.5	13.7	6.9	10.9	7.3	8.4	9.5	9.0	11.9	5.9	11.9	23.7	50.6	46.4	18.3	34.0	127.0	30.6	24.1	23.9	615.9	7.9	969.9	139.3	102.5	3.0	53.2	0.7	0.0	35.6	1080.2	76.5	15.6	52.0	1.3	331.4	68.3	29.7	89.6	135.4	11.5	73.4	69.6	28.7	93.8	13.6	46.3	62.2	5.8	72.9	43.7	20.2	58.2	30.9	20.7	70.9	10.2	1691.2	45.4	5.0	37.4
AKR1B15		ENSG00000227471	"Aldo-keto reductase family 1 member B15"	C9JRZ8	7	134549136-134579875	"Enzymes, Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"breast: 61.7;placenta: 31.8"	"Cell type enhanced"	"Detected in some"	27	"Early spermatids: 2.3;Late spermatids: 2.7;Syncytiotrophoblasts: 8.7"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"basophil: 1.8"	"Lineage enhanced"	"Detected in single"		"granulocytes: 1.8"	"Cell line enhanced"	"Detected in some"		"A549: 15.5;HDLM-2: 12.3;Hep G2: 10.8;SK-BR-3: 5.2;U-87 MG: 6.6"									"HPA020280, HPA073633"	Uncertain		Supported	"Plasma membrane,Cytosol"		NA	NA			Cytosol	"Plasma membrane"	"HPA020280: AB_10602228, HPA073633: AB_2686620"	"unprognostic (2.35e-1)"	"unprognostic (3.85e-2)"	"unprognostic (9.74e-3)"	"unprognostic (2.74e-2)"	"unprognostic (2.08e-1)"	"prognostic favorable (8.36e-4)"	"prognostic unfavorable (1.80e-5)"	"unprognostic (5.04e-2)"	"unprognostic (2.39e-1)"	"unprognostic (2.75e-1)"	"unprognostic (2.14e-3)"	"unprognostic (1.24e-1)"	"unprognostic (1.22e-7)"	"unprognostic (6.88e-2)"	"unprognostic (4.29e-1)"	"unprognostic (2.99e-3)"	"prognostic unfavorable (1.90e-5)"	2.7	0.1	0.1	0.1	0.1	0.0	61.7	0.1	0.2	1.6	0.6	0.2	0.1	5.6	0.1	1.5	3.8	0.0	2.2	0.1	0.1	0.0	0.1	0.8	0.1	0.1	0.1	0.1	0.2	0.1	0.0	0.1	31.8	0.2	0.8	0.2	0.5	2.9	0.1	11.6	1.9	1.7	0.8	0.4	0.1	5.0	0.6	0.1	0.3	0.4	16.1	1.8	1.5	3.0	0.1	0.0	1.8	0.1	0.4	0.0	0.3	0.0	15.5	0.2	0.0	0.6	0.5	1.0	0.0	0.4	0.0	0.0	0.1	0.2	0.1	0.0	0.0	0.7	0.1	0.0	0.1	0.0	12.3	0.1	0.1	0.2	10.8	0.0	0.2	0.5	0.0	0.2	0.1	0.1	0.1	0.0	0.1	0.1	0.6	0.0	0.0	0.2	0.2	3.2	0.3	0.0	0.1	0.2	0.3	0.1	0.1	0.1	0.1	0.6	5.2	0.0	0.1	0.1	0.3	0.0	0.1	0.7	0.4	0.0	0.2	0.2	0.2	6.6	0.2	0.2	1.8	0.0	0.7	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.0	0.0	0.0	0.3	0.1	0.1	0.1	0.2	0.1	0.0	0.1	0.1	0.2	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.4	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	8.7	0.0	0.0	0.1
AKR1C1	"DD1, DDH, DDH1, HAKRC, MBAB"	ENSG00000187134	"Aldo-keto reductase family 1 member C1"	Q04828	10	4963253-4983283	"Enzymes, Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 145.9;tongue: 74.5"	"Cell type enhanced"	"Detected in many"	10	"Cholangiocytes: 239.5;Exocrine glandular cells: 290.3;Hepatocytes: 511.8"	"Cancer enhanced"	"Detected in many"		"liver cancer: 64.2"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"basophil: 4.2"	"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in many"	8	"ASC diff: 185.8;Hep G2: 315.1;OE19: 134.5"									"CAB047303, HPA068265"	Enhanced		Enhanced	"Endoplasmic reticulum,Cytosol"		NA	NA			"Endoplasmic reticulum, Cytosol"		"CAB047303: , HPA068265: AB_2685966"	"unprognostic (1.54e-2)"	"prognostic favorable (3.05e-4)"	"unprognostic (4.04e-2)"	"unprognostic (8.38e-2)"	"unprognostic (3.18e-2)"	"unprognostic (7.05e-2)"	"prognostic unfavorable (1.56e-4)"	"unprognostic (1.70e-1)"	"unprognostic (1.63e-1)"	"unprognostic (8.38e-2)"	"unprognostic (4.65e-1)"	"unprognostic (1.82e-2)"	"prognostic favorable (8.03e-9)"	"unprognostic (1.19e-1)"	"unprognostic (1.22e-1)"	"unprognostic (5.72e-2)"	"unprognostic (6.30e-2)"	52.0	3.8	2.1	3.4	4.1	1.4	36.0	2.6	2.7	2.2	3.2	2.6	1.2	6.2	1.4	4.0	19.2	1.7	16.1	22.1	2.6	2.6	32.0	145.9	11.2	2.5	5.4	1.4	3.8	4.9	0.6	4.1	0.7	6.6	5.1	3.2	3.8	13.1	3.4	17.1	4.7	4.6	4.8	6.8	0.9	21.9	5.2	3.2	0.0	11.5	74.5	5.0	17.4	10.8	0.0	0.9	4.2	0.1	0.3	1.7	0.8	0.0	25.5	0.1	25.7	185.8	22.4	0.0	0.8	5.7	0.3	0.2	0.4	0.0	0.0	0.3	5.7	4.4	0.2	0.0	1.3	0.1	0.0	0.0	0.7	4.1	315.1	1.8	0.1	0.0	11.4	1.6	2.6	1.6	0.0	0.6	0.1	5.4	0.0	4.4	0.1	0.0	0.0	0.0	134.5	0.0	0.0	0.0	0.2	1.4	4.8	0.0	0.1	1.4	0.0	0.0	0.0	0.0	0.4	5.0	2.2	0.1	5.9	0.2	0.1	0.0	0.0	7.9	0.7	0.0	4.2	0.1	1.1	1.7	0.0	0.1	0.0	0.7	0.4	0.2	0.0	0.3	1.5	0.9	0.3	0.0	0.9	0.4	0.8	2.1	4.1	2.6	2.7	2.6	2.6	5.4	1.4	6.6	3.2	62.5	27.2	1.5	11.8	18.8	2.5	2.4	239.5	96.4	128.5	59.3	0.0	0.0	11.6	33.9	14.9	17.8	9.3	70.0	290.3	0.0	13.4	11.4	4.6	511.8	0.3	0.0	1.7	26.4	14.5	8.0	140.4	3.8	101.3	8.2	1.7	47.9	184.6	0.9	138.6	40.8	4.3	0.0	14.4	1.7	0.7	17.9	0.1	0.9	2.6	140.8
AKR1C2	"BABP, DD, DD2, DDH2, HAKRD, MCDR2, TDD"	ENSG00000151632	"Aldo-keto reductase family 1 member C2"	P52895	10	4987400-5018031	"Disease related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins"	"Lipid metabolism, Steroid metabolism"	Oxidoreductase	"Disease mutation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"breast: 71.9;liver: 122.7;tongue: 111.8"	"Cell type enhanced"	"Detected in many"	14	"Cholangiocytes: 135.0;Hepatocytes: 341.7;Pancreatic endocrine cells: 140.7"	"Group enriched"	"Detected in many"	6	"cervical cancer: 21.7;head and neck cancer: 31.5;liver cancer: 50.2;lung cancer: 69.0;urothelial cancer: 35.7"	"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in single"	5	"plasmacytoid DC: 1.4"	"Lineage enriched"	"Detected in single"	5	"dendritic cells: 1.4"	"Group enriched"	"Detected in some"	4	"A549: 130.6;ASC diff: 162.1;Hep G2: 243.7;OE19: 168.2;RT4: 74.6"									"CAB047304, HPA068265"	Enhanced		Approved	"Nucleoplasm,Nucleoli fibrillar center,Endoplasmic reticulum,Cytosol"		NA	NA			"Nucleoplasm, Cytosol"	"Nucleoli fibrillar center, Endoplasmic reticulum"	"CAB047304: , HPA068265: AB_2685966"	"unprognostic (6.77e-2)"	"unprognostic (8.88e-3)"	"unprognostic (3.02e-2)"	"unprognostic (2.24e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.72e-2)"	"unprognostic (2.86e-2)"	"unprognostic (8.65e-2)"	"unprognostic (5.03e-2)"	"unprognostic (2.58e-1)"	"unprognostic (1.02e-1)"	"unprognostic (6.25e-3)"	"unprognostic (8.58e-2)"	"unprognostic (1.09e-2)"	"unprognostic (8.60e-3)"	"unprognostic (1.46e-2)"	"unprognostic (8.30e-2)"	60.4	4.0	1.8	2.0	3.3	0.0	71.9	2.5	2.1	1.3	2.9	1.0	1.2	5.5	1.0	3.0	17.4	1.5	19.4	9.3	1.7	2.3	4.8	122.7	5.9	1.1	4.7	0.9	1.9	2.4	0.0	1.8	0.1	4.2	8.1	2.4	2.0	12.0	2.4	19.8	4.2	2.4	4.4	3.9	0.6	26.2	2.3	2.6	0.1	4.2	111.8	5.5	25.3	11.9	0.0	1.4	0.3	0.0	0.0	0.0	0.0	0.0	130.6	0.1	13.8	162.1	5.6	0.0	0.0	0.5	0.0	0.1	0.5	0.0	0.0	0.7	0.9	0.6	3.6	0.0	0.6	0.0	0.0	0.0	0.0	36.8	243.7	0.3	0.0	0.0	14.5	8.2	0.6	0.6	0.0	0.0	0.0	5.0	0.0	1.3	0.2	0.0	0.0	0.0	168.2	0.0	0.0	0.0	2.1	1.2	74.6	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.2	0.5	0.3	0.1	4.8	0.0	0.0	0.0	0.0	1.7	1.9	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	1.8	3.3	2.5	2.1	1.7	2.3	4.7	0.9	4.2	2.6	11.9	3.2	0.0	3.2	10.5	1.8	3.7	135.0	18.7	19.4	0.0	0.0	0.0	0.0	12.3	18.3	8.7	9.3	0.0	93.5	0.1	15.0	4.5	0.0	341.7	0.1	3.2	1.7	12.3	13.7	5.6	73.4	1.1	8.5	1.0	2.8	33.8	140.7	7.0	73.9	2.6	2.6	0.0	7.6	0.3	0.3	11.8	0.0	1.3	7.4	79.1
AKR1C3	"DDX, HAKRB, HSD17B5, KIAA0119, PGFS"	ENSG00000196139	"Aldo-keto reductase family 1 member C3"	P42330	10	5035354-5107686	"Enzymes, Plasma proteins, Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 50.1;intestine: 52.3"	"Cell type enhanced"	"Detected in many"	12	"Enterocytes: 261.7;Exocrine glandular cells: 644.1;Pancreatic endocrine cells: 362.8;Proximal tubular cells: 434.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"basophil: 50.1;gdT-cell: 26.7"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"A549: 115.0;ASC diff: 66.2;Hep G2: 48.3;OE19: 226.4;RT4: 45.4"									"CAB010874, HPA068265"	Enhanced		Approved	"Nucleoplasm,Nucleoli fibrillar center,Endoplasmic reticulum,Cytosol"		NA	NA		11000000	"Nucleoplasm, Cytosol"	"Nucleoli fibrillar center, Endoplasmic reticulum"	"CAB010874: AB_476751, HPA068265: AB_2685966"	"unprognostic (4.20e-3)"	"unprognostic (2.70e-2)"	"unprognostic (8.92e-2)"	"unprognostic (1.53e-1)"	"unprognostic (1.05e-1)"	"unprognostic (1.81e-3)"	"prognostic unfavorable (1.96e-4)"	"unprognostic (1.41e-1)"	"unprognostic (6.74e-2)"	"unprognostic (5.08e-2)"	"unprognostic (1.31e-1)"	"unprognostic (4.33e-2)"	"prognostic unfavorable (1.22e-4)"	"unprognostic (4.45e-1)"	"unprognostic (3.70e-2)"	"unprognostic (1.79e-3)"	"unprognostic (4.24e-3)"	16.6	6.6	3.2	3.2	3.9	3.5	12.8	3.2	3.9	3.2	17.3	3.2	3.2	52.3	3.2	3.2	6.0	4.5	32.2	4.8	4.4	1.0	20.1	34.4	5.5	3.2	3.2	3.2	3.2	4.2	1.8	3.2	3.2	4.2	3.2	11.4	3.2	4.4	3.2	13.0	2.6	31.1	4.2	3.2	3.2	28.6	3.2	3.2	3.2	3.2	3.2	3.2	12.3	3.2	0.1	9.6	50.1	0.7	4.6	26.7	9.7	0.0	115.0	0.0	33.6	66.2	23.8	0.0	0.0	1.6	0.0	0.1	3.4	1.9	0.0	6.2	1.5	3.4	0.9	0.1	2.3	0.0	0.2	0.0	0.2	35.6	48.3	0.3	0.0	0.0	13.2	4.7	1.5	0.0	1.9	2.2	0.2	0.7	0.0	3.0	0.2	0.7	0.1	0.0	226.4	0.3	0.2	0.7	3.4	11.3	45.4	0.0	0.2	16.5	0.0	0.0	0.0	0.0	0.0	16.0	0.3	0.3	6.9	0.2	0.0	0.0	0.0	3.8	4.5	0.3	50.1	0.7	1.1	26.7	0.2	1.7	0.0	5.0	4.8	0.5	0.1	3.2	2.4	1.9	4.6	0.3	9.6	4.9	9.7	3.2	3.9	3.2	3.9	4.4	1.0	3.2	3.2	4.2	3.2	41.7	4.0	1.5	1.1	10.6	1.7	3.6	0.0	88.3	61.4	34.9	0.0	0.1	36.5	85.3	2.9	61.2	261.7	0.0	644.1	0.0	13.8	0.7	5.7	0.0	1.6	1.6	18.4	0.0	0.0	2.1	72.5	19.0	20.3	5.4	31.0	121.7	362.8	121.1	100.4	434.1	3.6	25.8	8.0	0.3	0.7	9.4	0.0	0.0	103.0	27.3
AKR1C4	"3-alpha-HSD, C11, CDR, CHDR, DD4, HAKRA, MGC22581"	ENSG00000198610	"Aldo-keto reductase family 1 member C4"	P17516	10	5195462-5218949	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	17	"liver: 127.0"	"Cell type enriched"	"Detected in some"	10	"Hepatocytes: 437.4"	"Cancer enriched"	"Detected in some"	86	"liver cancer: 108.4"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"basophil: 1.2;gdT-cell: 1.1"	"Group enriched"	"Detected in many"	6	"granulocytes: 1.2;T-cells: 1.1"	"Group enriched"	"Detected in some"	4	"HDLM-2: 11.6;OE19: 5.1"									"HPA044720, HPA068265"	Uncertain		Approved	"Nucleoplasm,Nucleoli fibrillar center,Endoplasmic reticulum,Cytosol"		NA	NA		1800000	"Nucleoplasm, Cytosol"	"Nucleoli fibrillar center, Endoplasmic reticulum"	"HPA044720: AB_2679058, HPA068265: AB_2685966"	"unprognostic (2.21e-1)"	"unprognostic (3.04e-1)"	"unprognostic (5.15e-2)"	"unprognostic (1.25e-1)"		"unprognostic (5.99e-2)"	"unprognostic (9.40e-2)"	"unprognostic (2.32e-1)"		"unprognostic (1.26e-1)"	"unprognostic (1.52e-2)"		"unprognostic (1.29e-1)"	"unprognostic (3.31e-1)"	"unprognostic (7.34e-2)"		"unprognostic (1.45e-2)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.3	0.0	0.0	0.0	0.0	7.4	0.0	0.0	0.0	0.0	127.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	1.2	0.0	0.0	1.1	0.1	0.0	1.5	0.1	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	11.6	0.0	0.5	0.3	1.9	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	5.1	0.0	0.0	0.7	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.1	0.4	0.0	0.0	0.0	0.1	0.1	0.1	0.0	1.2	0.0	0.0	1.1	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.2	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	3.9	0.0	0.0	0.0	0.2	45.9	2.7	1.2	0.0	0.0	0.0	0.0	0.0	5.8	0.0	0.0	23.3	0.6	0.0	0.0	0.0	0.0	437.4	0.0	0.0	0.0	14.1	11.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.4	0.6	0.0	0.0	0.0	0.5	0.2	0.0	0.0	0.0	0.0	0.1
AKR1D1	SRD5B1	ENSG00000122787	"Aldo-keto reductase family 1 member D1"	P51857	7	138002324-138117986	"Disease related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins"	"Bile acid catabolism, Lipid degradation, Lipid metabolism, Steroid metabolism"	Oxidoreductase	"Disease mutation, FDA approved drug targets, Intrahepatic cholestasis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	38	"liver: 103.2"	"Group enriched"	"Detected in some"	41	"Early spermatids: 50.2;Hepatocytes: 96.2;Late spermatids: 85.4"	"Cancer enriched"	"Detected in single"	77	"liver cancer: 20.1"	"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enriched"	"Detected in single"	20	"Hep G2: 16.9"	"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			HPA057002	Enhanced		Approved	Nucleoplasm,Cytosol		No	NA			Nucleoplasm	Cytosol	"HPA057002: AB_2683308"	"unprognostic (2.38e-1)"	"unprognostic (1.65e-2)"			"unprognostic (1.02e-2)"	"unprognostic (1.52e-2)"	"prognostic favorable (9.91e-5)"	"unprognostic (6.11e-2)"	"unprognostic (2.31e-1)"	"unprognostic (1.30e-1)"	"unprognostic (6.87e-2)"	"unprognostic (2.94e-1)"	"unprognostic (9.68e-3)"	"unprognostic (2.90e-1)"	"unprognostic (5.80e-2)"	"unprognostic (3.11e-1)"	"unprognostic (1.67e-2)"	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	103.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.5	2.7	0.5	0.7	0.7	0.2	0.2	0.0	0.2	0.2	0.0	0.0	0.5	0.1	0.0	0.1	0.0	0.8	0.3	0.2	0.1	0.0	0.6	0.3	0.0	0.0	0.2	0.3	0.1	0.4	0.3	16.9	0.0	0.5	0.7	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.3	0.0	0.0	0.3	0.2	0.1	0.0	0.2	0.1	0.4	0.0	0.3	0.0	0.2	0.2	0.2	0.1	0.1	0.1	0.2	0.4	0.3	0.2	0.1	0.3	0.2	0.3	0.3	0.2	0.2	0.3	0.3	2.7	0.5	0.6	0.4	0.4	0.3	0.6	0.4	0.4	0.3	1.1	0.5	0.7	1.8	0.7	0.5	0.5	0.5	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	50.2	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.0	96.2	0.4	0.0	0.0	1.3	1.9	85.4	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.5	0.2	0.0	0.2	0.0	0.0	0.1
AKR1E2	"AKR1CL2, AKRDC1, MGC10612"	ENSG00000165568	"Aldo-keto reductase family 1 member E2"	Q96JD6	10	4786629-4848062	"Enzymes, Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	7	"testis: 35.0"	"Group enriched"	"Detected in some"	5	"Early spermatids: 126.7;Late spermatids: 125.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	4	"basophil: 3.2;myeloid DC: 1.6;naive CD4 T-cell: 1.4;plasmacytoid DC: 1.8"	"Group enriched"	"Detected in many"	5	"dendritic cells: 1.8;granulocytes: 3.2;T-cells: 1.4"	"Cell line enhanced"	"Detected in many"		"JURKAT: 11.3;RT4: 9.4;U-2197: 17.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"HPA037821, HPA037822"	Enhanced		Supported	"Nucleoplasm,Golgi apparatus"		NA	NA			"Nucleoplasm, Golgi apparatus"		"HPA037821: AB_2675687, HPA037822: AB_10671722"	"unprognostic (2.33e-2)"	"unprognostic (2.59e-2)"	"unprognostic (1.68e-2)"	"unprognostic (8.27e-2)"	"unprognostic (7.33e-2)"	"unprognostic (1.99e-1)"	"unprognostic (1.44e-1)"	"unprognostic (7.42e-3)"	"unprognostic (7.47e-2)"	"unprognostic (2.77e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.53e-1)"	"unprognostic (3.06e-2)"	"unprognostic (2.74e-1)"	"unprognostic (2.04e-2)"	"unprognostic (1.62e-4)"	"unprognostic (5.62e-2)"	3.3	1.6	1.8	3.2	2.6	2.4	4.2	1.4	2.5	2.6	2.3	0.7	3.4	1.8	5.0	1.7	1.9	1.4	5.0	2.7	1.5	1.5	1.8	1.1	4.4	2.8	1.4	2.1	1.5	2.7	3.7	1.2	2.6	1.9	1.7	1.7	5.0	1.9	2.6	2.3	2.0	1.7	2.9	2.1	1.5	2.1	35.0	0.9	0.8	4.5	2.0	0.6	1.7	2.9	0.1	1.8	3.2	0.4	0.0	1.4	0.3	0.4	5.1	2.0	0.9	0.0	0.0	0.1	2.0	0.1	0.1	0.0	8.0	0.8	0.0	0.0	5.2	0.0	0.6	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	2.5	0.0	0.0	1.0	5.5	1.0	0.0	0.0	5.9	11.3	4.5	0.0	0.0	4.8	0.6	0.0	2.1	7.2	3.8	0.0	0.0	0.0	1.4	9.4	0.0	4.4	7.5	2.1	4.0	2.2	4.0	2.2	3.5	0.0	1.8	17.8	0.0	2.4	0.0	0.0	0.1	0.0	1.4	3.2	0.4	0.3	0.1	0.2	0.0	0.1	0.4	0.2	1.6	0.0	1.4	0.4	0.1	0.0	0.0	1.8	0.0	0.3	1.8	2.6	1.4	2.5	1.5	1.5	1.4	2.1	1.9	0.9	0.0	0.0	0.0	0.1	0.0	0.0	0.8	0.0	0.0	0.0	1.8	0.0	0.1	0.0	0.1	126.7	1.4	0.0	0.0	0.0	0.0	1.1	0.1	0.0	0.0	1.1	1.6	0.0	1.8	0.6	125.1	2.6	0.5	3.3	1.0	0.0	0.3	0.1	0.0	1.4	0.3	1.1	0.0	0.9	23.0	4.7	0.1	0.0	0.0	0.0	0.1
AKR7A2	AFAR	ENSG00000053371	"Aldo-keto reductase family 7 member A2"	O43488	1	19303965-19312146	"Enzymes, Plasma proteins, Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	8	"Proximal tubular cells: 516.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"CAB032587, CAB032841, HPA064638"	Enhanced		Supported	Cytosol		NA	NA		2700000	Cytosol		"CAB032587: AB_673379, CAB032841: AB_2224545, HPA064638: AB_2685307"	"unprognostic (1.06e-1)"	"unprognostic (3.48e-2)"	"unprognostic (7.23e-2)"	"unprognostic (5.76e-2)"	"unprognostic (9.92e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.14e-2)"	"unprognostic (3.14e-3)"	"unprognostic (1.99e-1)"	"unprognostic (2.50e-2)"	"unprognostic (5.11e-2)"	"unprognostic (7.11e-2)"	"prognostic favorable (2.67e-4)"	"unprognostic (3.72e-2)"	"unprognostic (8.53e-2)"	"unprognostic (1.01e-1)"	"prognostic unfavorable (8.59e-4)"	21.2	39.0	25.2	14.0	26.9	15.2	22.0	19.8	26.2	32.9	38.5	28.1	28.7	56.0	20.2	23.0	25.7	35.1	31.9	31.2	22.0	19.4	49.3	32.4	14.4	21.9	24.9	26.2	31.6	60.8	14.8	19.0	17.2	23.6	19.9	19.5	25.8	21.4	24.9	33.8	18.8	43.1	20.8	20.0	16.3	22.3	21.6	21.4	24.7	22.9	20.2	18.3	16.7	21.6	23.0	40.1	13.7	29.0	22.2	27.1	23.5	24.1	15.3	16.8	15.5	26.6	25.9	11.2	18.1	22.2	25.4	22.9	19.4	20.5	17.5	19.4	24.3	14.3	19.3	18.7	27.2	12.1	13.9	29.7	11.0	14.8	31.0	20.7	12.1	8.9	25.8	21.5	19.5	12.0	24.1	21.5	23.1	16.0	16.5	26.0	24.1	23.5	11.8	4.8	34.0	19.3	24.8	21.0	30.9	24.7	10.7	31.6	11.8	19.7	17.9	30.4	10.0	35.5	42.3	16.8	15.9	16.9	17.1	13.5	20.1	12.6	21.4	34.4	27.9	22.4	0.1	29.0	13.7	23.0	23.7	26.8	23.0	20.7	20.3	40.1	21.4	23.9	20.6	3.4	22.2	17.8	35.0	27.1	23.5	25.2	26.9	19.8	26.2	22.0	19.4	24.9	26.2	23.6	21.4	14.9	21.1	39.8	56.3	21.6	32.8	23.2	94.3	28.1	11.4	73.3	5.9	113.3	215.5	57.4	69.6	30.0	128.4	23.3	32.2	83.3	55.7	48.3	10.3	81.5	89.0	20.6	95.6	38.1	55.4	39.4	71.7	32.8	50.6	63.1	87.2	111.7	40.7	123.6	63.6	516.4	22.5	45.3	39.1	63.0	23.2	29.7	85.8	48.1	129.1	48.9
AKT1	"AKT, PKB, PRKBA, RAC"	ENSG00000142208	"AKT serine/threonine kinase 1"	P31749	14	104769349-104795751	"Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, RAS pathway related proteins"	"Apoptosis, Carbohydrate metabolism, Glucose metabolism, Glycogen biosynthesis, Glycogen metabolism, Neurogenesis, Sugar transport, Translation regulation, Transport"	"Developmental protein, Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes, Disease mutation, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"eosinophil: 30.7"	"Lineage enriched"	"Detected in all"	5	"granulocytes: 30.7"	"Cell line enhanced"	"Detected in all"		"MCF7: 115.3"	"Low region specificity"	"Detected in all"							"HPA002891, CAB003765"	Supported		Supported	Nucleoplasm,Microtubules		NA	NA			Nucleoplasm	Microtubules	"CAB003765: AB_562035, HPA002891: AB_1078123"	"unprognostic (3.30e-2)"	"unprognostic (4.27e-2)"	"unprognostic (1.98e-1)"	"unprognostic (1.84e-1)"	"unprognostic (3.70e-1)"	"unprognostic (9.17e-3)"	"unprognostic (1.55e-3)"	"unprognostic (1.21e-1)"	"unprognostic (1.47e-1)"	"prognostic favorable (4.83e-4)"	"unprognostic (3.58e-2)"	"unprognostic (1.90e-2)"	"prognostic favorable (2.12e-4)"	"unprognostic (7.14e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.06e-1)"	"unprognostic (2.41e-1)"	31.7	45.4	22.9	24.2	23.6	20.3	40.0	20.9	29.5	24.7	32.6	20.0	30.8	22.5	27.0	21.5	33.0	25.5	30.3	47.7	22.9	19.1	26.3	49.2	31.3	21.0	22.1	14.7	25.9	43.0	20.3	16.7	28.4	21.5	31.1	18.2	25.3	30.4	36.1	23.8	20.4	24.0	40.5	17.5	35.4	32.6	16.2	18.8	26.3	32.7	22.4	29.3	36.7	35.9	3.2	5.2	30.7	5.8	5.7	6.2	3.0	15.4	30.8	25.5	37.9	19.7	20.5	28.5	28.4	34.6	42.0	33.7	20.2	18.7	18.7	21.9	38.9	21.4	20.1	18.0	26.4	18.3	42.6	7.3	14.1	18.4	21.7	21.9	23.0	36.9	29.3	22.3	21.0	14.0	20.2	31.4	18.4	12.3	20.8	26.9	115.3	28.9	29.4	6.6	30.3	22.1	27.3	23.6	12.7	19.4	38.4	29.3	24.3	23.7	31.0	17.8	11.9	40.6	34.3	25.0	28.2	13.5	40.1	28.5	22.6	10.9	16.1	23.8	19.5	33.9	3.3	5.3	30.7	5.4	5.2	4.0	2.9	4.8	6.2	3.6	3.2	2.5	5.7	11.8	5.7	5.8	5.2	4.7	3.0	22.9	23.6	20.9	29.5	22.9	19.1	22.1	14.7	21.5	18.8	14.9	24.3	13.4	13.8	11.0	24.3	13.8	40.8	5.3	11.4	21.0	11.8	15.1	11.6	21.0	1.2	19.6	22.2	0.0	30.3	25.7	18.8	34.2	2.3	38.4	20.2	39.7	28.8	24.5	23.7	3.1	26.4	18.1	10.1	17.2	36.1	35.8	43.4	17.3	29.0	13.9	24.0	25.8	11.8	0.9	5.1	12.2	19.6	18.1	26.9	30.8
AKT2		ENSG00000105221	"AKT serine/threonine kinase 2"	P31751	19	40230317-40285536	"Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, RAS pathway related proteins"	"Apoptosis, Carbohydrate metabolism, Glucose metabolism, Glycogen biosynthesis, Glycogen metabolism, Sugar transport, Translation regulation, Transport"	"Developmental protein, Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes, Diabetes mellitus, Disease mutation, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Rod photoreceptor cells: 109.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004204, HPA064521"	Uncertain		Supported	Nucleoplasm,Vesicles,Cytosol		NA	NA			"Nucleoplasm, Vesicles, Cytosol"		"CAB004204: AB_626659, HPA064521: AB_2685278"	"unprognostic (6.13e-2)"	"unprognostic (2.21e-1)"	"unprognostic (1.56e-1)"	"prognostic unfavorable (1.05e-6)"	"unprognostic (2.85e-1)"	"unprognostic (6.40e-3)"	"unprognostic (9.59e-2)"	"unprognostic (1.22e-2)"	"unprognostic (2.98e-2)"	"unprognostic (2.49e-2)"	"unprognostic (3.02e-1)"	"prognostic unfavorable (4.74e-4)"	"unprognostic (1.30e-2)"	"unprognostic (1.89e-1)"	"unprognostic (3.28e-1)"	"unprognostic (6.16e-2)"	"unprognostic (2.00e-1)"	31.1	20.3	15.4	17.6	15.2	21.3	18.2	46.3	18.2	23.3	18.2	23.4	21.2	12.3	22.8	28.0	22.1	22.7	14.0	23.1	15.4	10.0	23.0	62.5	14.6	17.8	17.9	13.3	27.8	24.5	21.1	24.0	17.5	14.7	19.7	12.3	26.8	18.5	24.3	48.5	18.3	17.1	20.0	16.8	18.7	15.5	21.3	15.7	26.6	52.6	29.5	23.6	19.6	19.9	6.3	8.8	7.7	4.4	3.2	4.9	2.4	22.8	56.3	21.5	22.1	26.8	32.8	11.9	15.3	22.6	31.7	28.3	24.8	21.3	23.3	13.6	33.6	13.3	10.0	23.8	31.8	20.4	22.3	27.1	15.3	35.7	15.5	16.8	17.5	18.4	30.2	19.1	21.5	20.4	25.1	6.9	25.7	19.6	24.5	17.6	19.0	27.8	8.5	11.6	25.4	15.1	18.5	11.7	16.8	24.7	37.4	29.6	18.1	15.7	26.8	12.7	23.0	21.2	22.6	6.8	19.4	19.2	17.3	23.9	22.8	19.5	19.1	18.9	20.8	15.8	7.6	4.4	3.6	4.5	2.0	4.5	3.9	3.6	3.0	3.0	6.3	3.5	4.9	7.7	3.2	2.6	8.8	2.7	2.4	15.4	15.2	46.3	18.2	15.4	10.0	17.9	13.3	14.7	15.7	14.9	12.8	36.4	20.9	21.2	67.1	26.8	28.1	12.0	10.3	57.6	39.3	25.4	18.3	18.1	2.9	17.0	18.8	0.0	26.0	20.6	22.1	24.5	13.9	74.6	19.3	57.2	18.5	12.9	19.7	7.4	39.7	13.5	21.9	19.8	19.0	52.5	20.4	19.2	25.1	18.3	109.8	19.4	23.3	11.6	16.2	24.0	32.4	17.1	20.1	24.4
AKT3	"PKBG, PRKBG, RAC-gamma"	ENSG00000117020	"AKT serine/threonine kinase 3"	Q9Y243	1	243488233-243851079	"Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, RAS pathway related proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Early spermatids: 71.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB013090, HPA026441"	Approved		Supported	Cytosol		NA	NA			Cytosol		"CAB013090: AB_2533692, HPA026441: AB_1844711"	"unprognostic (1.33e-1)"	"unprognostic (1.27e-1)"	"unprognostic (2.40e-2)"	"unprognostic (8.45e-2)"	"unprognostic (1.89e-1)"	"unprognostic (1.75e-1)"	"unprognostic (1.96e-1)"	"unprognostic (3.77e-1)"	"unprognostic (2.32e-1)"	"unprognostic (2.28e-1)"	"unprognostic (5.47e-3)"	"unprognostic (1.37e-1)"	"unprognostic (6.71e-2)"	"unprognostic (3.64e-3)"	"unprognostic (1.29e-1)"	"unprognostic (8.14e-2)"	"prognostic unfavorable (9.27e-4)"	15.4	17.0	16.0	7.8	15.2	2.2	11.0	39.9	33.4	16.9	16.1	12.4	17.4	4.1	19.7	12.3	10.0	11.8	12.1	9.8	15.5	13.6	12.8	4.0	11.3	7.9	14.2	15.8	29.8	4.4	15.1	14.6	17.0	18.4	19.4	6.6	8.9	4.1	23.9	4.8	4.7	8.1	20.4	12.1	9.9	8.7	10.4	14.8	2.9	17.7	5.0	6.2	17.2	18.6	1.9	0.8	1.2	0.9	3.8	3.6	0.6	23.6	2.4	15.0	0.0	11.1	12.7	8.0	13.3	12.3	8.7	7.7	0.1	9.7	0.0	0.0	17.0	7.5	0.3	8.3	5.3	11.5	6.0	6.5	0.3	0.0	0.0	5.8	0.1	2.6	6.6	0.0	10.8	9.8	18.9	17.7	3.9	0.0	0.1	3.9	0.0	5.1	1.1	6.4	0.0	3.7	2.7	9.1	0.1	2.9	0.9	19.3	25.4	0.1	0.0	24.0	9.1	0.0	8.1	13.9	15.5	11.9	0.1	11.1	1.3	0.4	2.8	11.3	1.3	12.9	1.2	0.9	0.5	2.3	0.3	3.6	1.0	2.2	2.5	0.8	1.9	1.9	1.7	0.2	3.8	0.7	0.6	0.7	0.6	16.0	15.2	39.9	22.9	15.5	13.6	14.2	15.8	18.4	14.8	3.0	2.1	8.6	11.6	2.2	41.5	5.5	5.1	0.0	4.5	26.2	31.4	9.5	0.0	10.4	71.8	31.5	0.0	0.0	1.5	6.5	7.3	18.3	4.7	0.2	2.7	39.7	0.0	44.8	8.8	51.9	25.3	9.5	6.8	10.0	0.0	20.1	1.0	0.0	33.2	4.4	33.7	19.4	22.9	12.2	11.5	1.5	10.4	13.8	0.0	7.2
ALAD	"ALADH, PBGS"	ENSG00000148218	"Aminolevulinate dehydratase"	P13716	9	113386317-113401333	"Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"	"Heme biosynthesis, Porphyrin biosynthesis"	"Allosteric enzyme, Lyase"	"Disease mutation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 84.2"	"Cell type enhanced"	"Detected in all"	4	"Erythroid cells: 70.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021023, HPA022124"	Enhanced					NA	NA		44000000			"HPA021023: AB_1844716, HPA022124: AB_1844717"	"unprognostic (2.75e-1)"	"unprognostic (6.26e-2)"	"prognostic unfavorable (7.33e-5)"	"prognostic favorable (5.64e-4)"	"unprognostic (4.16e-2)"	"unprognostic (9.49e-2)"	"prognostic favorable (8.80e-5)"	"unprognostic (2.87e-3)"	"unprognostic (3.49e-1)"	"unprognostic (2.95e-1)"	"unprognostic (1.62e-1)"	"unprognostic (3.31e-2)"	"prognostic favorable (1.65e-4)"	"unprognostic (1.75e-1)"	"unprognostic (1.22e-1)"	"unprognostic (3.40e-1)"	"unprognostic (1.31e-2)"	19.9	70.3	24.1	6.4	26.3	27.3	13.7	14.0	24.8	8.3	10.5	28.3	8.8	11.6	7.5	11.5	14.6	6.8	13.0	23.3	24.6	20.8	29.9	84.2	8.4	5.9	37.5	20.6	12.3	18.8	24.1	7.2	10.2	27.9	14.5	10.2	9.8	37.2	15.1	10.6	15.6	10.7	8.9	40.1	5.9	18.1	5.4	28.6	4.7	10.9	6.6	7.5	9.0	8.0	7.6	12.1	19.1	13.1	5.5	9.7	7.6	3.3	5.8	4.6	6.4	32.2	22.1	29.3	9.1	15.3	6.0	7.7	8.1	7.0	4.7	5.6	12.9	4.6	12.4	3.3	6.3	3.5	11.7	4.2	9.3	7.3	10.6	7.3	8.5	8.0	18.7	4.7	5.5	2.4	23.9	11.8	7.9	3.5	7.0	9.9	24.5	9.8	8.4	2.3	24.4	11.6	7.7	8.0	8.1	9.4	7.1	4.2	4.0	11.6	14.1	8.3	8.7	14.8	9.8	12.8	5.4	4.1	10.6	5.1	10.5	9.8	3.7	15.1	7.9	5.8	7.2	11.5	19.1	9.7	13.1	5.4	5.9	8.4	5.4	12.1	7.6	8.1	8.9	5.6	5.5	12.7	4.9	8.5	7.6	24.1	26.3	14.0	24.8	24.6	20.8	37.5	20.6	27.9	28.6	14.9	14.1	10.2	9.3	6.3	12.5	50.8	17.8	10.7	9.1	14.0	25.5	36.1	11.6	14.5	4.7	12.8	25.6	70.0	23.3	18.1	9.4	7.0	13.9	55.7	15.4	4.8	8.7	12.9	16.7	6.9	10.9	10.2	11.8	5.4	13.8	5.8	15.3	28.8	13.8	42.7	14.9	6.5	9.9	6.2	7.5	8.0	9.5	6.9	16.9	6.8
ALAS1	"ALAS, ALAS3"	ENSG00000023330	"5'-aminolevulinate synthase 1"	P13196	3	52198086-52214327	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Heme biosynthesis"	"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adrenal gland: 167.6;liver: 136.4"	"Cell type enhanced"	"Detected in many"	8	"Hepatocytes: 210.5;Syncytiotrophoblasts: 258.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"basophil: 55.0"	"Lineage enriched"	"Detected in all"	5	"granulocytes: 55.0"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB017498, HPA035860"	Enhanced		Supported	Nucleoplasm,Mitochondria		NA	NA			Mitochondria	Nucleoplasm	"CAB017498: AB_2225629, HPA035860: AB_10672992"	"unprognostic (1.17e-1)"	"unprognostic (1.65e-1)"	"unprognostic (1.50e-1)"	"unprognostic (7.09e-2)"	"unprognostic (2.33e-1)"	"unprognostic (6.21e-2)"	"prognostic favorable (1.82e-5)"	"unprognostic (3.98e-2)"	"unprognostic (1.26e-1)"	"unprognostic (2.31e-2)"	"unprognostic (9.86e-2)"	"unprognostic (5.64e-2)"	"prognostic favorable (6.06e-7)"	"unprognostic (8.45e-2)"	"unprognostic (3.91e-2)"	"unprognostic (1.07e-1)"	"unprognostic (1.75e-2)"	9.2	167.6	7.8	6.7	10.6	39.1	8.9	17.0	15.4	6.0	11.0	12.0	15.3	11.4	6.3	11.8	10.5	4.7	8.7	24.8	8.8	7.0	14.1	136.4	13.5	10.0	7.6	9.9	5.8	6.1	8.5	5.8	13.4	12.2	7.3	11.1	8.3	15.7	16.9	24.6	6.8	17.4	6.5	7.3	6.3	12.2	9.7	5.0	7.5	7.4	11.4	9.6	12.1	7.6	6.8	8.4	55.0	12.2	8.8	11.3	6.3	10.3	16.1	11.4	10.5	17.8	13.3	31.0	15.2	14.1	20.4	19.8	21.4	19.6	9.7	3.8	10.6	41.4	6.1	16.3	12.5	16.7	18.8	6.4	12.4	12.7	16.2	25.2	20.1	25.0	16.5	11.7	32.4	10.8	7.5	18.6	17.0	7.3	8.0	18.5	8.4	9.5	30.7	9.8	11.9	27.9	5.7	7.1	15.3	17.9	62.7	6.0	4.0	24.6	12.1	13.7	9.6	6.9	28.7	13.3	11.4	11.3	23.5	21.9	11.9	20.5	14.6	12.7	21.9	18.1	55.0	9.2	27.8	6.9	12.2	11.3	6.8	7.2	7.7	8.4	6.0	6.5	7.0	14.2	8.8	10.2	4.8	9.7	6.3	7.8	10.6	17.0	15.4	8.8	7.0	7.6	9.9	12.2	5.0	32.8	47.6	4.5	16.4	15.3	15.1	88.4	35.7	38.8	27.3	22.7	3.9	67.2	48.0	28.5	9.7	25.9	35.4	0.0	27.6	21.7	19.9	18.1	89.4	210.5	62.6	11.1	33.3	25.2	14.6	3.1	12.4	23.3	5.0	73.9	18.6	9.1	33.4	18.7	15.6	25.9	6.8	12.9	27.3	23.7	19.0	14.2	258.6	17.3	16.1	24.3
ALAS2	ASB	ENSG00000158578	"5'-aminolevulinate synthase 2"	P22557	X	55009055-55031064	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Heme biosynthesis"	"Acyltransferase, Transferase"	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"bone marrow: 130.9;placenta: 53.5"	"Cell type enriched"	"Detected in some"	86	"Erythroid cells: 1168.1"	"Low cancer specificity"	"Detected in single"			"Low region specificity"	"Detected in some"			"Cell type enriched"	"Detected in single"	6	"plasmacytoid DC: 2.0"	"Lineage enriched"	"Detected in single"	6	"dendritic cells: 2.0"	"Group enriched"	"Detected in some"	87	"HEL: 32.8;K-562: 36.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in some"								"Intracellular and membrane"	NA	NA						"unprognostic (7.82e-2)"	"unprognostic (2.01e-1)"	"unprognostic (6.41e-2)"	"unprognostic (1.14e-2)"	"unprognostic (2.98e-3)"	"unprognostic (5.59e-2)"	"unprognostic (1.37e-1)"	"unprognostic (1.47e-1)"	"unprognostic (8.68e-2)"	"unprognostic (4.07e-2)"	"unprognostic (2.72e-1)"	"unprognostic (3.45e-1)"	"unprognostic (2.32e-2)"	"unprognostic (6.63e-3)"	"unprognostic (4.39e-1)"	"unprognostic (1.23e-1)"	"unprognostic (1.89e-1)"	1.7	0.4	0.8	0.4	0.8	130.9	0.5	0.2	0.5	0.3	0.4	0.5	0.0	0.4	0.3	0.3	2.3	1.0	0.5	2.9	0.7	0.7	1.6	2.4	17.3	0.3	1.3	0.7	6.1	2.3	0.3	1.0	53.5	2.3	2.6	0.3	1.0	0.5	0.3	3.7	0.4	0.4	1.1	0.9	22.3	0.3	0.5	0.0	0.4	3.2	0.0	0.3	7.0	6.5	0.3	2.0	0.3	0.1	0.0	0.3	10.7	0.0	0.0	0.0	0.3	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	32.8	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	36.8	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.2	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.3	0.3	0.0	0.0	0.1	0.1	0.0	0.2	0.3	0.0	0.0	2.0	0.0	10.7	0.8	0.8	0.2	0.5	0.7	0.7	1.3	0.7	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	5.8	0.0	0.0	0.0	1168.1	0.2	0.6	0.2	0.0	0.0	0.8	1.9	0.0	1.7	0.0	1.3	0.0	0.0	0.0	13.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0
ALDH18A1	"GSAS, P5CS, PYCS, SPG9"	ENSG00000059573	"Aldehyde dehydrogenase 18 family member A1"	P54886	10	95605929-95656706	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Amino-acid biosynthesis, Proline biosynthesis"	"Kinase, Multifunctional enzyme, Oxidoreductase, Transferase"	"Disease mutation, Hereditary spastic paraplegia, Mental retardation, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"salivary gland: 68.8"	"Cell type enhanced"	"Detected in many"	5	"Enterocytes: 58.2;Paneth cells: 54.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008333, HPA012604"	Approved		Enhanced	Mitochondria		NA	NA		23000	Mitochondria		"HPA008333: AB_1078125, HPA012604: AB_1844721"	"unprognostic (5.97e-3)"	"unprognostic (2.08e-2)"	"unprognostic (5.75e-2)"	"prognostic favorable (4.20e-4)"	"unprognostic (1.60e-2)"	"unprognostic (1.06e-1)"	"unprognostic (8.30e-3)"	"unprognostic (7.08e-2)"	"unprognostic (4.06e-2)"	"unprognostic (8.04e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.81e-1)"	"prognostic unfavorable (3.60e-9)"	"unprognostic (1.02e-3)"	"unprognostic (6.57e-2)"	"unprognostic (1.29e-3)"	"unprognostic (6.43e-2)"	6.3	10.4	7.1	10.4	7.9	5.2	7.7	7.3	9.3	13.7	20.1	7.2	20.5	33.8	9.3	12.3	12.8	8.5	15.2	7.2	6.2	7.1	13.0	28.9	6.6	7.4	6.7	5.3	14.5	40.7	12.7	17.4	14.3	7.7	9.6	19.4	7.9	68.8	20.5	3.5	9.6	45.4	10.0	5.4	8.6	15.2	8.4	5.4	12.7	25.9	9.7	15.9	8.6	8.2	13.1	5.2	0.3	4.0	13.0	16.3	8.0	18.3	17.4	16.8	44.0	22.6	21.8	18.1	21.5	32.3	21.9	27.6	34.9	14.7	62.6	20.1	33.8	10.6	24.4	33.6	22.1	24.9	17.7	26.4	19.8	12.4	49.5	14.8	34.6	22.2	22.9	13.6	17.8	34.9	36.4	22.9	23.6	18.5	13.2	16.3	26.4	31.2	22.3	19.8	30.5	17.4	29.4	19.2	21.4	25.5	14.0	16.8	16.6	17.1	13.6	15.8	20.1	20.3	16.2	18.9	9.1	14.5	23.4	24.6	15.3	11.3	38.3	17.7	40.1	11.6	0.0	1.4	0.1	15.5	2.7	16.3	13.1	14.2	16.0	5.2	9.0	12.1	13.4	0.3	13.0	4.0	3.1	13.3	8.0	7.1	7.9	7.3	9.3	6.2	7.1	6.7	5.3	7.7	5.4	6.0	8.6	11.5	6.6	10.0	5.7	4.3	10.2	16.0	14.8	19.2	0.0	36.1	1.7	12.5	0.7	5.4	58.2	0.0	18.4	25.8	17.5	15.6	8.1	23.1	10.1	9.5	19.0	4.9	3.2	0.4	8.6	3.1	15.1	2.8	37.5	5.2	12.4	54.7	11.3	7.9	2.8	0.0	5.6	5.1	9.0	7.0	25.3	8.7	30.7	8.1
ALDH1A1	"ALDH1, PUMB1, RALDH1"	ENSG00000165092	"Aldehyde dehydrogenase 1 family member A1"	P00352	9	72900662-73080442	"Enzymes, Plasma proteins, Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 207.2"	"Cell type enhanced"	"Detected in many"	7	"Ciliated cells: 583.5;Hepatocytes: 620.8;Leydig cells: 376.3"	"Cancer enhanced"	"Detected in all"		"liver cancer: 399.1"	"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	6	"classical monocyte: 34.2"	"Lineage enriched"	"Detected in many"	30	"monocytes: 34.2"	"Cell line enhanced"	"Detected in some"		"A549: 294.7;Hep G2: 90.7;RPTEC TERT1: 52.5"					"Region enriched"	"Detected in all"	6	"midbrain: 171.1"	"HPA002123, CAB020690"	Enhanced	Approved	Enhanced	Cytosol		NA	NA		62000000	Cytosol		"CAB020690: , HPA002123: AB_1844722"	"unprognostic (8.46e-3)"	"prognostic favorable (7.77e-5)"	"unprognostic (5.59e-2)"	"unprognostic (1.69e-1)"	"unprognostic (1.49e-2)"	"unprognostic (8.71e-2)"	"unprognostic (3.64e-2)"	"unprognostic (3.98e-2)"	"unprognostic (4.53e-2)"	"unprognostic (6.83e-2)"	"unprognostic (4.45e-2)"	"unprognostic (3.73e-1)"	"unprognostic (3.24e-3)"	"unprognostic (2.20e-1)"	"unprognostic (2.36e-1)"	"unprognostic (2.96e-2)"	"unprognostic (1.90e-3)"	20.0	26.9	8.8	12.3	21.4	3.9	10.8	44.8	11.7	33.6	53.6	14.5	65.3	77.1	25.5	87.1	14.5	27.8	38.3	8.9	12.5	5.9	86.7	207.2	31.4	9.4	56.4	3.6	35.8	69.7	0.7	57.5	7.9	14.0	20.0	13.1	30.2	31.8	40.3	12.1	2.7	76.5	17.1	29.1	16.3	75.5	43.0	14.9	2.0	45.8	21.0	16.8	14.1	16.0	0.3	0.5	1.1	34.2	0.0	0.1	10.5	0.0	294.7	0.0	0.0	1.7	0.0	0.1	10.2	0.0	0.0	0.0	9.9	0.0	0.0	3.8	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	16.7	0.0	90.7	1.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	10.5	0.0	1.1	0.0	11.3	0.5	0.0	0.1	0.0	0.5	0.0	0.0	3.3	0.1	52.5	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	34.2	0.5	0.0	5.8	0.0	0.0	0.1	0.0	0.5	0.3	0.0	0.0	1.1	0.0	0.4	0.3	0.0	10.5	8.8	21.4	44.8	11.7	12.5	5.9	56.4	3.6	14.0	14.9	89.3	82.8	17.6	12.3	2.4	0.0	2.8	211.5	583.5	271.8	109.9	0.0	1.1	330.0	52.4	8.7	10.5	29.0	23.3	296.8	1.1	30.2	1.8	152.7	620.8	115.7	0.0	52.7	105.0	82.2	16.5	376.3	13.6	6.8	5.4	141.2	0.0	193.4	16.9	194.8	295.4	0.3	25.8	9.2	3.6	3.8	2.8	2.1	20.0	42.1	18.3
ALDH1A2	RALDH2	ENSG00000128918	"Aldehyde dehydrogenase 1 family member A2"	O94788	15	57953424-58497866	"Enzymes, Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	14	"Early spermatids: 87.7;Late spermatids: 37.6;Spermatocytes: 44.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in some"	22	"neutrophil: 22.6"	"Lineage enriched"	"Detected in single"	56	"granulocytes: 22.6"	"Group enriched"	"Detected in some"	5	"AN3-CA: 67.9;HEK 293: 22.7;JURKAT: 65.7;K-562: 58.1;MOLT-4: 70.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA010022	Approved					NA	NA					"HPA010022: AB_1844723"	"unprognostic (1.11e-2)"	"unprognostic (2.52e-2)"	"unprognostic (2.00e-1)"	"unprognostic (3.09e-1)"	"unprognostic (1.44e-2)"	"unprognostic (1.16e-2)"	"unprognostic (1.04e-4)"	"unprognostic (1.08e-1)"	"unprognostic (9.03e-3)"	"unprognostic (6.92e-3)"	"unprognostic (5.48e-2)"	"unprognostic (6.19e-2)"	"unprognostic (2.57e-3)"	"unprognostic (3.18e-2)"	"unprognostic (4.95e-2)"	"unprognostic (1.99e-2)"	"unprognostic (1.80e-3)"	11.4	2.3	0.6	1.9	1.0	1.3	6.5	0.9	0.9	23.1	1.9	0.7	32.7	0.1	43.1	14.7	2.3	29.1	16.8	17.3	1.8	0.4	8.4	1.3	7.0	0.9	0.7	1.1	12.7	1.2	19.1	18.1	12.8	2.5	13.3	0.0	24.4	2.4	29.5	3.1	1.0	0.9	11.3	2.1	1.6	0.6	39.9	0.4	2.3	1.0	2.6	0.4	2.8	12.3	0.0	0.0	22.6	0.4	0.0	0.0	0.0	0.2	0.0	0.0	67.9	0.0	0.0	0.0	0.0	0.9	0.1	0.2	0.0	0.0	0.0	0.6	0.0	0.0	0.1	2.1	0.0	0.1	0.0	22.7	0.0	0.6	0.1	0.0	0.0	0.3	0.3	0.0	0.0	0.0	0.0	4.0	65.7	58.1	0.0	0.0	0.0	70.2	0.0	0.1	1.8	3.3	0.0	0.1	0.0	11.5	0.3	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.1	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	22.6	0.0	0.2	0.0	0.0	0.0	0.6	1.0	0.9	0.9	1.8	0.4	0.7	1.1	2.5	0.4	6.0	11.5	0.0	1.5	0.6	0.4	2.2	12.7	1.4	5.7	7.0	0.0	0.2	11.6	10.1	87.7	1.5	0.0	0.0	0.3	0.4	2.0	1.3	1.1	12.9	2.1	0.0	0.0	2.5	1.8	37.6	4.9	1.9	1.7	1.0	0.0	8.4	0.5	0.0	4.9	0.3	0.0	0.0	2.5	44.7	14.8	0.4	0.5	0.0	0.1	1.2
ALDH1A3	"ALDH6, RALDH3"	ENSG00000184254	"Aldehyde dehydrogenase 1 family member A3"	P47895	15	100877714-100916626	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		Oxidoreductase	"Disease mutation, Microphthalmia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	14	"Glandular cells: 329.1;Leydig cells: 180.1;Peritubular cells: 127.3;Urothelial cells: 421.1"	"Group enriched"	"Detected in many"	7	"melanoma: 16.8;prostate cancer: 80.5"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	4	"basophil: 1.0;eosinophil: 2.1;plasmacytoid DC: 1.5"	"Group enriched"	"Detected in many"	5	"dendritic cells: 1.5;granulocytes: 2.1"	"Cell line enhanced"	"Detected in many"		"A-431: 42.6;HaCaT: 53.0;HBEC3-KT: 131.3;hTERT-RPE1: 43.5;U-2197: 75.5;U-87 MG: 60.0;WM-115: 62.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"HPA046271, HPA064749"	Enhanced		Supported	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA046271: AB_10965992, HPA064749: AB_2685344"	"unprognostic (6.87e-2)"	"unprognostic (2.23e-1)"	"unprognostic (6.20e-3)"	"unprognostic (1.21e-3)"	"unprognostic (1.76e-2)"	"unprognostic (1.14e-1)"	"unprognostic (6.28e-2)"	"unprognostic (5.46e-2)"	"unprognostic (9.62e-2)"	"unprognostic (4.53e-2)"	"unprognostic (3.64e-2)"	"unprognostic (2.56e-1)"	"unprognostic (1.25e-2)"	"unprognostic (2.61e-2)"	"unprognostic (2.12e-1)"	"unprognostic (7.34e-2)"	"unprognostic (6.07e-3)"	30.3	5.7	2.3	14.9	1.6	0.0	11.1	4.1	2.6	14.2	11.5	1.6	10.5	5.2	5.9	37.9	10.5	11.5	15.0	6.1	2.1	2.0	3.7	1.7	4.2	5.5	2.6	1.7	9.0	7.4	3.2	13.2	5.1	3.9	51.9	3.2	49.9	41.5	19.2	6.1	1.7	15.6	14.2	6.4	1.5	5.3	15.9	0.7	0.6	0.9	15.2	18.9	18.0	9.8	0.3	1.5	2.1	0.2	0.0	0.0	0.1	42.6	5.7	0.0	0.0	9.4	4.2	0.1	0.3	0.3	0.2	0.1	0.1	34.1	0.3	0.5	11.5	6.8	53.0	1.0	131.3	0.8	0.0	0.2	0.2	2.3	0.0	3.2	0.1	0.2	3.0	3.6	2.9	0.5	43.5	0.4	0.0	0.0	0.3	0.2	0.4	0.0	0.2	1.1	1.1	34.7	0.0	0.5	0.2	0.0	35.8	0.0	3.0	13.2	11.7	4.0	0.4	1.1	0.3	6.7	0.0	0.1	75.5	1.6	0.0	0.4	0.2	60.0	0.0	62.0	1.0	0.2	2.1	0.0	0.0	0.0	0.3	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	1.5	0.0	0.1	2.3	1.6	4.1	2.6	2.1	2.0	2.6	1.7	3.9	0.7	14.9	7.5	0.0	119.5	0.6	0.0	1.2	0.0	38.8	62.6	97.7	0.0	7.4	3.3	68.6	0.8	5.6	0.2	0.0	1.2	0.3	4.7	329.1	5.7	0.0	1.0	0.0	3.4	1.3	0.0	2.5	180.1	1.3	0.0	1.0	1.5	0.0	18.3	0.0	127.3	0.5	0.0	12.9	0.9	0.5	0.7	1.4	4.1	0.0	0.2	421.1
ALDH1B1	"ALDH5, ALDHX"	ENSG00000137124	"Aldehyde dehydrogenase 1 family member B1"	P30837	9	38392664-38398661	"Enzymes, Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"smooth muscle: 113.9"	"Group enriched"	"Detected in many"	5	"Cholangiocytes: 117.2;Ductal cells: 60.1;Extravillous trophoblasts: 40.0;Hepatocytes: 113.4;Proximal tubular cells: 118.8;Undifferentiated cells: 68.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"OE19: 55.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA021037, HPA077080"	Enhanced		Supported	Nucleoplasm,Vesicles,Mitochondria,Cytosol		NA	NA		210000	Mitochondria	"Nucleoplasm, Vesicles, Cytosol"	"HPA021037: AB_1844724, HPA077080: "	"unprognostic (4.16e-1)"	"unprognostic (1.98e-2)"	"unprognostic (5.84e-2)"	"unprognostic (1.55e-3)"	"unprognostic (2.47e-2)"	"unprognostic (4.48e-3)"	"unprognostic (2.84e-3)"	"unprognostic (2.70e-2)"	"unprognostic (1.91e-1)"	"unprognostic (1.35e-1)"	"unprognostic (2.09e-1)"	"unprognostic (1.00e-1)"	"prognostic favorable (2.05e-4)"	"unprognostic (1.04e-1)"	"unprognostic (1.63e-1)"	"prognostic unfavorable (1.17e-5)"	"unprognostic (2.89e-2)"	7.4	4.9	2.1	16.8	2.1	0.6	5.4	1.1	5.4	5.8	25.4	1.7	6.1	7.0	27.3	10.7	21.6	16.7	30.8	11.6	3.1	2.0	18.0	55.2	3.5	5.9	2.4	2.0	12.2	14.6	1.4	1.4	1.6	3.0	22.7	11.5	5.2	5.9	18.2	19.4	3.0	11.2	113.9	2.7	2.8	15.8	7.8	1.7	1.6	6.3	7.0	2.0	54.5	8.3	5.9	9.4	1.2	10.5	7.5	10.2	5.1	21.5	20.1	6.2	9.9	8.8	10.5	5.0	10.3	5.2	8.7	9.0	13.4	4.2	13.6	6.2	14.5	13.2	3.0	20.4	21.9	8.7	15.2	8.8	6.7	14.8	39.8	6.4	10.7	7.6	12.5	4.8	7.1	6.2	17.9	8.3	3.3	19.4	13.4	13.2	8.2	0.0	4.3	18.4	55.5	9.0	4.4	37.6	10.4	7.8	9.7	13.6	6.3	7.9	5.2	6.0	6.8	4.9	8.4	5.6	10.1	16.7	8.4	12.9	2.0	3.9	5.4	5.2	11.0	6.8	0.2	4.2	0.2	7.3	9.1	10.2	5.9	7.0	6.6	9.4	3.1	5.8	6.8	1.2	7.5	10.5	1.3	4.8	5.1	2.1	2.1	1.1	5.4	3.1	2.0	2.4	2.0	3.0	1.7	8.9	1.7	3.6	3.8	0.9	1.3	5.6	117.2	0.0	3.4	15.7	2.0	1.3	14.9	60.1	0.5	3.8	7.0	0.0	5.9	40.0	6.2	2.9	9.2	113.4	6.5	0.0	15.0	9.8	3.8	1.3	6.1	4.0	0.0	7.2	16.9	1.3	14.2	3.5	6.3	118.8	0.3	0.0	9.5	0.3	0.6	0.9	1.5	2.9	68.9	2.6
ALDH1L1	"10-fTHF, FTHFD"	ENSG00000144908	"Aldehyde dehydrogenase 1 family member L1"	O75891	3	126103562-126197994	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"One-carbon metabolism"	Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 48.1;liver: 148.7"	"Group enriched"	"Detected in many"	6	"Hepatocytes: 554.3;Proximal tubular cells: 175.8"	"Cancer enhanced"	"Detected in many"		"liver cancer: 40.4"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC diff: 10.9;Hep G2: 23.9;Karpas-707: 24.7;RPMI-8226: 12.9;RT4: 66.0;U-266/70: 13.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036900, HPA050139"	Enhanced	Supported	Supported	Cytosol		No	No		640000	Cytosol		"HPA036900: AB_10672273, HPA050139: AB_2681031"	"unprognostic (5.93e-2)"	"unprognostic (1.22e-1)"	"unprognostic (9.12e-2)"	"unprognostic (2.68e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.10e-1)"	"unprognostic (7.12e-2)"	"unprognostic (1.29e-1)"	"unprognostic (3.05e-2)"	"unprognostic (4.73e-2)"	"unprognostic (3.05e-3)"	"unprognostic (8.40e-2)"	"prognostic favorable (2.42e-8)"	"unprognostic (3.60e-1)"	"unprognostic (1.47e-1)"	"unprognostic (7.03e-3)"	"unprognostic (7.93e-2)"	28.9	12.1	13.7	1.8	17.1	1.2	6.0	8.6	10.9	7.8	4.9	5.7	2.3	1.1	1.9	2.2	3.6	3.4	1.9	8.1	8.9	5.3	48.1	148.7	1.3	1.2	9.2	10.1	11.3	10.2	1.4	0.9	1.1	10.8	3.3	3.3	5.1	34.1	4.1	30.7	1.5	1.3	2.4	7.7	1.1	1.9	4.9	6.2	0.0	1.7	6.2	2.8	11.0	3.1	0.1	0.8	0.8	0.2	0.2	0.4	0.0	0.4	0.0	0.0	0.0	10.9	0.0	0.1	0.1	0.4	0.1	0.2	0.0	0.9	0.7	3.2	0.0	0.6	0.1	0.2	0.4	0.2	0.0	0.0	0.0	0.1	23.9	3.2	3.1	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	24.7	0.4	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	12.9	0.3	66.0	0.1	0.1	0.3	3.2	0.0	0.2	0.0	0.0	0.1	0.4	1.9	0.0	0.0	13.6	4.2	0.1	0.0	0.0	0.0	0.8	0.2	0.0	0.1	0.2	0.0	0.0	0.2	0.0	0.2	0.1	0.4	0.2	0.2	0.2	0.0	0.8	0.1	0.0	13.7	17.1	8.6	10.9	8.9	5.3	9.2	10.1	10.8	6.2	0.0	5.9	4.5	44.7	0.1	0.2	14.9	22.9	10.7	64.8	12.2	0.0	0.0	61.3	2.2	18.0	2.7	2.3	0.0	4.8	0.1	0.8	8.1	25.6	554.3	0.1	0.0	1.2	12.3	15.3	25.4	24.5	2.6	3.3	0.0	9.1	35.7	1.9	0.0	21.2	175.8	1.0	6.5	1.0	1.1	1.2	0.0	0.1	7.0	2.2	48.0
ALDH1L2	"FLJ38508, mtFDH"	ENSG00000136010	"Aldehyde dehydrogenase 1 family member L2"	Q3SY69	12	105019784-105084577	"Enzymes, Predicted intracellular proteins"	"One-carbon metabolism"	Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	7	"pancreas: 48.9;salivary gland: 31.6"	"Cell type enhanced"	"Detected in many"	6	"Exocrine glandular cells: 8.3;monocytes: 6.4;Pancreatic endocrine cells: 5.6;Peritubular cells: 6.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	5	"plasmacytoid DC: 1.3"	"Lineage enriched"	"Detected in single"	6	"dendritic cells: 1.3"	"Cell line enhanced"	"Detected in many"		"ASC diff: 23.0;ASC TERT1: 31.5;fHDF/TERT166: 35.7;HHSteC: 20.3;HSkMC: 25.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039481, HPA059282"	Approved		Enhanced	Mitochondria		No	No			Mitochondria		"HPA039481: AB_10795465, HPA059282: AB_2732633"	"unprognostic (5.99e-2)"	"unprognostic (1.42e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.36e-3)"	"unprognostic (1.76e-1)"	"unprognostic (8.86e-2)"	"unprognostic (1.75e-1)"	"unprognostic (2.92e-1)"	"unprognostic (5.74e-2)"	"unprognostic (1.51e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.61e-1)"	"unprognostic (8.19e-8)"	"unprognostic (3.21e-3)"	"unprognostic (1.33e-1)"	"unprognostic (2.53e-3)"	"unprognostic (2.52e-5)"	4.2	1.2	3.2	2.7	1.9	0.7	2.7	5.3	2.7	5.5	2.2	0.9	3.3	2.4	2.9	3.2	1.5	2.6	2.7	2.9	1.6	2.0	0.7	0.4	2.7	2.0	2.0	2.1	1.0	48.9	0.7	2.8	1.1	2.5	3.6	2.3	4.8	31.6	4.5	1.0	1.5	1.3	5.4	5.3	1.2	3.7	0.8	1.3	0.0	2.2	1.4	3.0	3.9	2.2	0.2	1.3	0.0	0.1	0.0	0.1	0.1	4.4	0.4	0.2	9.6	23.0	31.5	0.5	14.2	9.2	1.8	4.9	0.5	0.0	0.0	0.6	35.7	0.0	0.0	0.0	0.3	2.3	0.0	0.1	0.2	0.0	1.1	20.3	1.8	0.0	25.5	1.1	4.8	9.1	0.0	1.0	0.0	0.7	12.9	3.7	0.0	0.0	0.1	0.6	0.0	0.1	0.0	0.0	1.3	0.0	0.0	3.3	1.6	0.0	2.9	7.2	0.1	2.1	15.2	0.1	1.4	1.4	0.0	0.7	16.0	4.2	0.0	5.8	6.6	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	1.3	0.0	0.1	3.2	1.9	5.3	2.4	1.6	2.0	2.0	2.1	2.5	1.3	0.0	1.1	0.0	0.1	0.5	1.5	1.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	3.7	0.1	0.0	0.0	8.3	0.3	4.3	0.3	0.0	0.0	0.4	4.8	0.0	1.8	0.3	4.5	3.4	1.1	5.0	6.4	0.0	1.2	5.6	0.0	6.3	0.0	0.5	0.0	3.1	0.4	0.0	0.5	0.2	0.0	0.0	0.1
ALDH2		ENSG00000111275	"Aldehyde dehydrogenase 2 family (mitochondrial)"	P05091	12	111766887-111817529	"Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"		Oxidoreductase	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 279.7"	"Cell type enhanced"	"Detected in all"	9	"Hepatocytes: 770.8;monocytes: 1397.7;Proximal tubular cells: 645.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"classical monocyte: 45.8;myeloid DC: 46.6"	"Group enriched"	"Detected in many"	4	"dendritic cells: 46.6;monocytes: 45.8"	"Cell line enhanced"	"Detected in many"		"ASC diff: 25.4;HHSteC: 28.4;OE19: 41.9;SK-BR-3: 57.1;THP-1: 25.4"									HPA051065	Approved					NA	NA		1400000			"HPA051065: AB_2681332"	"unprognostic (9.22e-3)"	"unprognostic (1.20e-2)"	"unprognostic (4.14e-3)"	"prognostic favorable (2.63e-4)"	"unprognostic (1.16e-1)"	"unprognostic (1.32e-3)"	"prognostic favorable (3.95e-7)"	"unprognostic (5.62e-3)"	"unprognostic (3.00e-1)"	"unprognostic (1.16e-1)"	"unprognostic (8.22e-2)"	"unprognostic (1.51e-1)"	"prognostic favorable (5.24e-6)"	"unprognostic (9.70e-2)"	"unprognostic (3.40e-1)"	"unprognostic (1.50e-2)"	"prognostic unfavorable (7.71e-4)"	88.9	34.0	42.1	17.0	44.6	9.9	39.6	14.3	30.9	10.4	25.3	17.5	16.8	25.6	9.0	11.6	26.4	10.3	28.5	45.0	30.9	24.2	59.0	279.7	38.1	13.3	34.1	32.6	16.1	14.0	2.2	7.6	4.0	30.6	13.5	26.2	13.1	17.9	30.7	40.1	43.5	25.5	29.4	26.6	8.0	34.9	9.5	23.8	3.3	12.0	28.1	18.2	17.0	22.9	1.4	46.6	10.8	45.8	0.7	0.2	21.7	2.4	3.6	5.3	9.1	25.4	3.8	17.4	2.6	4.7	1.2	0.9	6.5	3.4	0.1	13.0	5.7	3.4	4.5	0.0	1.3	0.7	0.1	1.7	0.2	2.3	17.6	28.4	0.2	0.2	6.9	6.5	4.2	0.1	5.1	7.6	0.2	4.8	0.8	1.1	0.1	0.2	6.3	7.0	41.9	0.6	0.1	0.1	0.5	8.8	0.1	2.1	6.6	6.4	57.1	0.0	10.1	5.7	25.4	0.3	0.1	4.8	0.1	0.1	1.5	0.8	6.9	6.3	0.2	0.1	0.9	45.8	10.8	0.1	20.1	0.2	1.4	0.0	0.1	46.6	1.2	0.1	0.1	2.3	0.7	5.0	15.5	0.1	21.7	42.1	44.6	14.3	30.9	30.9	24.2	34.1	32.6	30.6	23.8	137.0	197.2	37.4	126.5	53.2	67.9	333.7	140.1	95.0	178.6	62.8	17.7	50.7	338.2	110.9	3.4	72.6	272.6	70.0	195.0	101.4	59.3	72.9	29.0	770.8	132.7	33.4	53.0	106.2	211.9	7.0	73.9	169.3	33.7	1397.7	184.2	107.6	110.7	325.4	140.0	645.3	34.9	45.3	77.3	2.7	3.2	109.0	35.2	13.8	218.4	82.3
ALDH3A1	ALDH3	ENSG00000108602	"Aldehyde dehydrogenase 3 family member A1"	P30838	17	19737984-19748943	"Enzymes, Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 88.2;lymphoid tissue: 70.3;stomach 1: 49.9;tongue: 106.6"	"Cell type enhanced"	"Detected in many"	15	"Basal keratinocytes: 39.2;Ciliated cells: 100.4;Club cells: 55.7;Suprabasal keratinocytes: 28.0;Urothelial cells: 32.1"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in single"		"pons and medulla: 1.8"	"Cell type enhanced"	"Detected in some"		"NK-cell: 2.4"	"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in some"	22	"A549: 261.5;OE19: 326.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"CAB045957, HPA051150, HPA063783"	Enhanced		Supported	"Nucleoplasm,Vesicles,Plasma membrane,Cytosol"		No	No			"Plasma membrane, Cytosol"	"Nucleoplasm, Vesicles"	"CAB045957: AB_11127164, HPA051150: AB_2681364, HPA063783: AB_2685122"	"unprognostic (3.11e-5)"	"unprognostic (1.20e-2)"	"unprognostic (1.08e-1)"	"unprognostic (7.04e-3)"	"unprognostic (4.36e-3)"	"prognostic favorable (7.55e-5)"	"unprognostic (3.12e-1)"	"unprognostic (3.84e-1)"	"unprognostic (2.10e-1)"	"unprognostic (1.67e-1)"	"unprognostic (2.69e-3)"	"unprognostic (5.54e-2)"	"unprognostic (1.72e-1)"	"unprognostic (3.84e-2)"	"unprognostic (1.83e-1)"	"unprognostic (2.88e-2)"	"unprognostic (7.23e-2)"	0.7	0.1	0.2	0.8	0.4	0.0	0.5	0.2	0.3	1.3	0.9	0.8	0.3	1.3	0.2	0.4	88.2	1.2	3.8	0.2	0.4	0.0	0.4	0.4	26.0	0.2	0.2	0.3	0.6	0.2	0.0	0.3	0.2	1.8	0.5	0.6	0.5	26.7	0.3	0.4	16.2	0.6	0.3	0.3	0.3	49.9	0.3	0.2	0.2	0.2	106.6	70.3	1.6	3.9	1.1	0.3	0.0	0.0	2.4	0.7	0.1	0.0	261.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	13.1	0.0	0.1	0.0	0.1	1.5	0.0	0.6	0.0	0.0	0.0	0.0	6.6	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	326.9	1.0	0.0	0.0	0.0	0.0	4.6	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.1	0.0	0.0	0.3	1.1	0.0	0.7	0.0	2.4	0.0	0.0	0.0	0.1	0.2	0.4	0.2	0.3	0.4	0.0	0.2	0.3	1.8	0.2	3.0	5.6	0.0	23.3	39.2	0.0	0.4	2.5	100.4	55.7	0.0	0.0	0.0	0.0	0.8	1.3	0.4	3.3	0.0	0.4	0.0	0.6	2.6	2.3	0.0	0.2	0.0	1.7	0.6	0.8	1.9	0.9	1.1	0.0	0.0	4.2	1.9	5.8	5.9	1.8	4.4	0.1	0.0	0.3	0.7	7.3	28.0	0.0	0.0	7.5	32.1
ALDH3A2	"ALDH10, FALDH, SLS"	ENSG00000072210	"Aldehyde dehydrogenase 3 family member A2"	P51648	17	19648136-19677598	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Fatty acid metabolism, Lipid metabolism"	Oxidoreductase	"Disease mutation, Ichthyosis, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"A549: 35.6;OE19: 66.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA014769, CAB020692"	Approved					NA	NA					"CAB020692: , HPA014769: AB_1844728"	"unprognostic (1.42e-1)"	"unprognostic (7.62e-2)"	"unprognostic (7.77e-2)"	"unprognostic (2.49e-2)"	"unprognostic (4.59e-1)"	"unprognostic (1.64e-1)"	"unprognostic (1.59e-1)"	"unprognostic (1.31e-2)"	"unprognostic (2.23e-1)"	"unprognostic (3.93e-3)"	"unprognostic (2.40e-1)"	"unprognostic (2.63e-1)"	"prognostic favorable (3.85e-8)"	"unprognostic (4.12e-2)"	"unprognostic (1.55e-1)"	"unprognostic (1.42e-2)"	"unprognostic (1.26e-1)"	22.3	66.4	8.5	9.0	24.6	2.8	10.0	8.8	12.8	13.7	15.9	17.5	7.5	15.6	13.5	19.2	39.6	10.7	26.4	12.5	9.5	6.5	52.5	88.6	17.7	4.3	11.1	10.3	13.5	24.4	10.1	14.9	3.1	14.4	20.7	11.1	16.2	26.0	10.0	18.5	57.1	26.6	10.5	10.2	8.0	18.3	9.8	15.4	4.5	27.3	27.9	22.5	9.8	17.0	3.9	14.3	11.6	14.2	8.6	6.4	5.7	5.7	35.6	3.6	8.9	17.0	14.3	2.5	1.7	4.3	3.4	3.8	11.1	9.2	1.8	4.1	7.0	5.9	12.7	14.0	17.1	2.4	7.9	6.1	0.9	18.7	27.2	3.2	4.2	0.4	7.9	24.3	3.1	1.9	8.9	6.7	4.8	0.2	0.0	8.5	7.7	0.1	5.2	8.5	66.4	19.5	4.1	10.2	5.4	3.9	18.0	6.9	4.9	15.5	6.0	4.9	22.9	10.4	3.9	7.9	2.2	4.0	5.7	5.3	2.4	6.0	2.5	10.5	0.0	7.0	0.0	14.2	11.6	4.2	12.6	6.4	3.9	4.3	3.7	14.3	3.0	4.9	3.4	0.7	8.6	13.7	0.2	5.8	5.7	8.5	24.6	8.8	12.8	9.5	6.5	11.1	10.3	14.4	15.4	163.8	69.7	11.9	106.4	50.7	13.8	39.2	104.4	69.6	113.7	31.4	11.8	10.6	36.5	84.4	78.7	15.8	49.7	0.0	45.0	3.4	27.7	87.9	27.8	102.6	23.4	6.4	15.5	14.1	16.7	14.7	51.8	24.2	6.8	21.6	25.0	98.7	45.1	28.1	75.7	88.8	20.1	12.9	14.6	10.4	22.6	78.9	1.1	13.8	36.8	28.6
ALDH3B1	ALDH7	ENSG00000006534	"Aldehyde dehydrogenase 3 family member B1"	P43353	11	68008578-68029282	"Enzymes, Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 39.8"	"Cell type enhanced"	"Detected in many"	16	"Alveolar cells type 1: 107.2;Ciliated cells: 265.0;Club cells: 76.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"eosinophil: 39.8"	"Group enriched"	"Detected in many"	10	"dendritic cells: 17.6;granulocytes: 39.8;monocytes: 32.9"	"Cell line enhanced"	"Detected in many"		"A549: 45.0;CAPAN-2: 46.3;U-87 MG: 27.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA038525	Uncertain					NA	NA					"HPA038525: AB_2676062"	"unprognostic (3.50e-1)"	"unprognostic (4.22e-1)"	"prognostic unfavorable (1.18e-4)"	"unprognostic (1.56e-2)"	"unprognostic (9.66e-3)"	"unprognostic (9.73e-2)"	"unprognostic (7.93e-3)"	"unprognostic (2.62e-1)"	"unprognostic (2.01e-1)"	"unprognostic (1.06e-1)"	"prognostic unfavorable (6.07e-4)"	"unprognostic (8.27e-2)"	"unprognostic (6.49e-3)"	"unprognostic (1.00e-1)"	"unprognostic (2.75e-2)"	"unprognostic (6.69e-3)"	"unprognostic (1.06e-1)"	9.1	9.8	1.8	5.0	2.5	21.4	2.4	1.3	2.3	6.2	7.8	4.2	1.1	11.8	4.0	7.0	4.0	21.0	13.7	3.1	2.6	2.4	9.3	5.1	28.5	14.3	4.3	1.4	6.6	12.9	0.0	3.8	13.4	3.8	4.6	3.1	7.8	5.7	2.0	2.0	1.8	21.4	4.2	5.6	11.7	10.4	2.9	1.9	0.7	1.7	1.5	3.3	7.6	3.8	0.1	17.6	39.8	32.9	2.9	0.1	9.8	3.3	45.0	0.3	0.9	3.0	9.6	8.1	4.6	7.6	3.3	1.6	1.6	46.3	0.2	8.2	10.6	4.7	3.8	0.1	0.6	0.8	0.1	0.3	0.4	18.1	3.9	19.1	2.6	0.1	7.0	2.0	1.6	4.5	7.5	0.1	0.2	0.1	8.2	5.3	2.7	0.2	2.5	0.3	22.4	2.7	1.0	1.8	24.7	5.4	0.4	0.5	0.2	10.6	8.9	4.4	0.2	10.3	5.8	5.1	4.8	6.7	23.1	1.5	0.1	0.8	0.0	27.3	7.3	2.2	11.8	23.0	39.8	0.0	32.9	0.1	0.1	0.0	0.0	17.6	0.1	0.0	0.0	6.9	2.9	29.1	1.8	0.0	9.8	1.8	2.5	1.3	2.3	2.6	2.4	4.3	1.4	3.8	1.9	107.2	53.7	0.9	2.6	1.9	0.5	2.4	17.8	265.0	76.2	5.2	0.0	0.7	0.0	4.9	18.4	1.9	11.7	0.0	2.2	6.7	8.2	2.5	23.3	2.0	31.5	3.2	2.4	1.3	54.8	7.6	1.7	31.3	3.3	8.2	10.0	2.0	11.4	7.0	1.4	20.0	0.4	0.0	4.2	0.2	0.2	0.9	0.6	0.0	10.0	4.4
ALDH3B2	ALDH8	ENSG00000132746	"Aldehyde dehydrogenase 3 family member B2"	P48448	11	67662162-67681200	"Enzymes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins"		Oxidoreductase	"FDA approved drug targets"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"breast: 28.1;esophagus: 48.2;lymphoid tissue: 34.2;skin 1: 38.7"	"Cell type enhanced"	"Detected in some"	10	"Collecting duct cells: 5.2;Cytotrophoblasts: 8.5;Extravillous trophoblasts: 8.0;Suprabasal keratinocytes: 12.9;Syncytiotrophoblasts: 12.2;Urothelial cells: 6.2"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"naive B-cell: 1.0"	"Low lineage specificity"	"Detected in single"			"Group enriched"	"Detected in some"	5	"MCF7: 31.6;SK-BR-3: 32.7"					"Not detected"	"Not detected"			HPA045132	Approved					NA	NA					"HPA045132: AB_10795993"	"unprognostic (2.25e-1)"	"unprognostic (2.41e-1)"	"unprognostic (1.65e-1)"	"unprognostic (8.65e-2)"		"unprognostic (2.13e-1)"	"unprognostic (6.09e-2)"	"unprognostic (3.12e-2)"	"unprognostic (6.32e-2)"	"unprognostic (1.48e-1)"	"unprognostic (5.56e-2)"	"unprognostic (1.24e-2)"	"unprognostic (1.40e-2)"	"unprognostic (2.59e-2)"	"unprognostic (1.61e-1)"	"unprognostic (1.15e-2)"	"unprognostic (5.92e-2)"	0.1	0.0	0.1	0.1	0.1	0.0	28.1	0.1	0.1	6.7	0.1	0.1	5.0	0.0	1.5	2.4	48.2	1.5	0.1	0.1	0.1	0.0	0.6	0.1	0.6	0.1	0.1	0.1	0.4	0.1	0.6	0.3	11.2	0.1	1.8	0.0	0.1	17.1	4.6	0.1	38.7	0.1	0.1	0.1	0.1	0.1	0.3	0.1	0.8	0.1	25.7	34.2	4.6	11.6	1.0	0.1	0.6	0.2	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	3.5	0.0	0.0	0.0	0.0	0.5	1.8	1.6	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.6	0.0	3.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	31.6	2.6	0.0	0.0	4.3	0.0	0.0	0.0	0.1	0.0	4.7	0.0	0.0	0.0	32.7	0.0	0.2	6.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.2	0.6	0.0	0.2	0.0	0.0	0.0	0.0	0.1	1.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	2.9	0.0	1.5	1.4	0.0	0.3	0.0	0.0	0.0	5.2	0.0	8.5	1.7	0.3	0.0	0.0	0.0	0.0	0.2	8.0	0.4	1.5	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.9	12.2	0.0	0.0	6.2
ALDH4A1	"ALDH4, P5CDh"	ENSG00000159423	"Aldehyde dehydrogenase 4 family member A1"	P30038	1	18871430-18902781	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Proline metabolism"	Oxidoreductase	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"kidney: 73.7;liver: 92.6"	"Cell type enhanced"	"Detected in many"	16	"Hepatocytes: 313.9;Proximal tubular cells: 167.5"	"Cancer enhanced"	"Detected in all"		"liver cancer: 72.0"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in all"		"Hep G2: 34.6;SK-BR-3: 35.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004645, HPA006401, HPA072759"	Enhanced		Supported	Mitochondria		NA	NA		40000	Mitochondria		"CAB004645: AB_425775, HPA006401: AB_1844731, HPA072759: "	"unprognostic (1.17e-1)"	"prognostic favorable (5.06e-4)"	"unprognostic (1.38e-2)"	"unprognostic (4.16e-2)"	"unprognostic (3.15e-1)"	"unprognostic (7.67e-2)"	"unprognostic (1.28e-1)"	"unprognostic (6.18e-2)"	"unprognostic (1.92e-1)"	"unprognostic (1.09e-2)"	"unprognostic (1.02e-1)"	"unprognostic (2.06e-1)"	"unprognostic (4.27e-3)"	"unprognostic (9.41e-3)"	"unprognostic (3.83e-1)"	"unprognostic (2.69e-3)"	"unprognostic (9.34e-2)"	22.9	4.1	14.4	2.0	18.0	4.6	6.6	3.1	16.8	3.8	2.4	8.6	18.9	1.3	2.5	5.2	11.4	2.7	3.0	12.6	8.6	7.1	73.7	92.6	2.4	1.7	15.9	11.2	2.9	2.2	9.4	2.4	8.3	8.5	12.1	1.6	9.7	2.4	12.1	25.6	8.0	1.3	3.3	2.7	2.1	3.4	1.4	6.6	2.8	3.0	8.9	2.9	8.3	3.6	1.5	7.2	2.6	5.6	0.3	1.4	2.2	5.1	8.0	4.1	12.1	17.4	2.6	10.0	4.9	3.0	5.1	4.1	5.8	3.8	3.4	6.6	6.4	2.4	13.8	6.9	14.7	1.9	1.9	6.1	1.9	1.9	34.6	5.5	1.7	6.2	6.7	8.2	2.8	2.8	3.8	5.7	5.8	7.7	2.5	3.4	13.2	1.7	8.3	2.0	10.6	4.1	10.7	3.4	4.0	5.3	13.0	8.1	3.1	8.7	35.8	6.4	6.5	16.3	2.6	4.7	4.4	5.8	5.3	1.7	2.8	6.6	1.0	1.6	13.5	5.8	0.0	4.1	2.6	1.1	5.6	0.9	1.5	0.7	1.4	7.2	1.1	0.3	0.9	0.6	0.3	3.1	2.4	1.0	2.2	14.4	18.0	3.1	16.8	8.6	7.1	15.9	11.2	8.5	6.6	0.0	3.2	7.2	14.0	6.6	3.1	18.5	38.2	1.4	0.0	43.6	9.8	61.1	39.7	5.6	0.4	2.7	0.4	0.0	0.8	7.2	2.3	9.5	4.6	313.9	11.9	19.1	2.4	16.5	14.0	0.4	1.1	1.4	3.3	17.2	2.9	10.8	2.9	1.5	2.5	167.5	4.2	6.5	4.3	2.1	3.6	4.6	72.4	2.2	3.3	9.7
ALDH5A1	"SSADH, SSDH"	ENSG00000112294	"Aldehyde dehydrogenase 5 family member A1"	P51649	6	24494852-24537207	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		Oxidoreductase	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 62.6"	"Cell type enhanced"	"Detected in many"	10	"Hepatocytes: 85.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"Daudi: 41.1;U-698: 51.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029715, HPA029716"	Enhanced		Supported	Mitochondria		NA	NA		44000	Mitochondria		"HPA029715: AB_10599994, HPA029716: AB_10601876"	"unprognostic (7.43e-2)"	"unprognostic (1.12e-3)"	"unprognostic (1.80e-1)"	"unprognostic (1.22e-1)"	"unprognostic (2.23e-1)"	"unprognostic (3.27e-1)"	"prognostic favorable (7.61e-6)"	"unprognostic (2.38e-2)"	"unprognostic (2.17e-2)"	"prognostic favorable (6.20e-4)"	"unprognostic (1.43e-2)"	"unprognostic (1.21e-1)"	"prognostic favorable (3.68e-4)"	"unprognostic (1.04e-2)"	"unprognostic (1.16e-1)"	"unprognostic (2.00e-2)"	"unprognostic (1.08e-2)"	5.8	4.8	23.7	8.3	27.4	3.1	4.1	13.5	21.5	4.1	6.0	9.5	1.2	7.7	3.9	3.1	5.6	13.5	4.4	9.8	17.3	21.0	18.4	62.6	5.0	8.9	16.0	14.7	5.8	6.6	11.4	4.5	2.2	13.0	6.2	5.7	4.1	3.9	4.3	31.1	6.9	5.4	2.8	10.9	4.8	5.2	3.7	8.8	21.4	12.1	4.9	8.8	6.3	5.5	3.9	3.8	0.4	0.2	1.6	6.8	1.2	3.2	3.0	2.1	3.2	0.0	0.0	3.5	0.3	0.6	0.8	0.5	11.7	0.8	41.1	6.2	0.3	0.7	0.0	3.4	0.4	0.5	4.2	5.7	6.4	1.9	13.4	0.5	9.9	0.8	0.3	1.6	0.1	0.0	2.3	0.0	11.3	3.2	0.0	0.6	7.6	12.0	5.9	0.8	5.8	1.5	13.9	0.6	0.4	2.5	6.6	3.7	3.3	3.8	0.4	4.0	0.9	5.9	5.4	0.0	0.4	2.1	0.1	2.1	5.8	8.6	51.4	0.0	3.1	0.4	0.4	0.1	0.2	1.7	0.0	3.3	3.7	2.4	2.8	0.2	3.9	6.8	5.7	0.4	1.6	0.2	3.8	1.6	1.2	23.7	27.4	13.5	21.5	17.3	21.0	16.0	14.7	13.0	8.8	14.9	22.3	8.8	4.6	1.4	10.6	29.9	5.1	13.4	9.1	7.0	15.7	5.0	1.7	1.8	0.5	3.1	8.4	23.3	0.8	4.3	2.1	5.1	6.9	85.5	3.2	15.9	8.1	6.7	3.8	0.0	3.1	2.0	1.7	0.0	10.5	10.4	1.3	3.5	4.2	24.0	6.5	0.0	1.6	1.4	6.1	2.6	1.6	5.4	16.7	11.5
ALDH6A1	MMSDH	ENSG00000119711	"Aldehyde dehydrogenase 6 family member A1"	Q02252	14	74056850-74084493	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"		Oxidoreductase	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	4	"kidney: 140.0;liver: 134.5"	"Cell type enhanced"	"Detected in many"	15	"Hepatocytes: 453.8;Proximal tubular cells: 730.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"eosinophil: 25.5"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"T-47d: 29.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029072, HPA029073, HPA029074, HPA029075"	Enhanced		Enhanced	Mitochondria		No	No		9100	Mitochondria		"HPA029072: AB_10599176, HPA029073: AB_10601877, HPA029074: AB_10601000, HPA029075: AB_10602005"	"unprognostic (1.45e-1)"	"unprognostic (5.38e-2)"	"unprognostic (6.89e-2)"	"unprognostic (6.95e-3)"	"unprognostic (1.46e-1)"	"unprognostic (7.93e-2)"	"unprognostic (1.11e-3)"	"prognostic favorable (4.22e-4)"	"unprognostic (1.58e-1)"	"unprognostic (9.10e-2)"	"unprognostic (3.11e-2)"	"unprognostic (2.13e-1)"	"prognostic favorable (2.00e-15)"	"unprognostic (4.59e-1)"	"unprognostic (1.92e-1)"	"unprognostic (6.05e-3)"	"unprognostic (1.12e-1)"	14.1	6.9	31.3	2.8	30.9	2.3	6.7	11.6	26.4	8.0	11.0	20.1	4.6	11.0	5.5	5.5	5.0	6.2	4.8	15.6	21.1	14.2	140.0	134.5	4.7	3.0	19.4	18.5	12.3	11.8	16.4	3.2	4.0	14.8	11.0	7.2	7.1	7.8	7.8	10.5	3.4	9.3	5.6	13.1	3.1	9.6	7.4	18.7	2.0	12.1	4.0	3.1	6.3	3.3	4.5	5.6	25.5	3.8	5.5	6.7	2.8	4.6	4.0	5.7	12.1	20.9	10.2	9.2	3.2	6.1	3.5	6.0	9.1	5.2	5.4	7.2	6.9	2.9	2.7	13.0	3.6	7.7	4.8	1.8	2.5	4.2	9.9	23.8	1.3	1.2	15.0	6.6	4.5	11.4	9.2	6.2	12.2	4.0	7.5	2.4	17.8	3.7	2.0	4.5	17.2	2.7	7.6	5.9	7.1	5.6	3.5	2.3	3.6	10.7	11.6	2.8	10.1	29.7	4.8	1.9	4.0	4.9	6.2	1.2	5.1	9.2	5.5	5.2	1.6	3.8	13.3	3.8	25.5	4.5	2.9	6.7	4.5	5.1	5.3	5.6	3.6	6.5	4.6	1.5	5.5	2.4	3.2	3.6	2.8	31.3	30.9	11.6	26.4	21.1	14.2	19.4	18.5	14.8	18.7	35.7	48.4	23.6	21.0	8.1	17.6	73.0	48.4	25.4	29.6	62.8	3.9	22.5	170.8	8.1	19.8	13.5	22.3	0.0	2.7	12.8	13.1	38.6	7.0	453.8	14.9	11.1	16.3	58.3	22.2	15.8	26.7	9.0	23.6	20.8	37.9	90.4	5.6	10.5	45.3	730.1	15.1	12.9	21.7	10.5	3.9	6.5	25.6	6.9	37.0	15.2
ALDH7A1	"ATQ1, EPD, PDE"	ENSG00000164904	"Aldehyde dehydrogenase 7 family member A1"	P49419	5	126531200-126595418	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		Oxidoreductase	"Disease mutation, Epilepsy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 64.4"	"Cell type enhanced"	"Detected in many"	9	"Cytotrophoblasts: 364.8;Proximal tubular cells: 241.4;Syncytiotrophoblasts: 185.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"plasmacytoid DC: 9.7"	"Lineage enriched"	"Detected in many"	5	"dendritic cells: 9.7"	"Cell line enhanced"	"Detected in many"		"HBEC3-KT: 61.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023296, HPA053675"	Enhanced		Supported	Mitochondria,Cytosol		Yes	No		140000	Mitochondria	Cytosol	"HPA023296: AB_1844738, HPA053675: "	"unprognostic (1.37e-1)"	"unprognostic (9.67e-2)"	"unprognostic (2.07e-2)"	"unprognostic (2.20e-2)"	"unprognostic (4.15e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.58e-3)"	"unprognostic (9.49e-3)"	"unprognostic (7.61e-2)"	"unprognostic (7.08e-2)"	"unprognostic (2.10e-1)"	"unprognostic (1.33e-1)"	"prognostic favorable (3.08e-4)"	"unprognostic (1.51e-1)"	"unprognostic (3.70e-1)"	"unprognostic (3.10e-3)"	"unprognostic (4.93e-2)"	9.0	14.2	46.0	3.4	39.1	0.8	18.8	11.0	22.5	14.0	11.5	23.1	7.2	9.5	10.5	7.5	13.5	11.9	7.8	10.8	35.0	17.3	46.5	64.4	6.4	3.1	28.7	18.5	27.6	10.8	17.7	5.9	17.7	16.9	17.6	11.2	13.7	15.0	12.2	4.5	11.9	8.1	9.8	20.2	2.8	9.0	4.9	28.4	4.0	19.4	10.1	7.4	7.2	7.1	1.3	9.7	0.7	0.3	0.1	1.8	0.6	15.0	10.0	28.3	46.8	23.5	14.0	36.1	18.1	22.4	21.1	27.2	28.0	14.5	0.0	18.5	14.1	8.8	11.3	8.8	61.1	19.4	0.0	10.6	2.9	14.9	23.8	11.5	0.0	0.0	17.1	14.4	16.4	11.8	15.6	16.8	0.0	0.0	0.0	18.5	9.9	0.6	0.0	19.1	11.1	8.5	9.0	32.1	0.0	20.0	11.5	9.6	11.5	0.0	10.0	10.5	22.7	18.0	0.6	20.4	6.1	18.9	7.0	12.4	0.0	0.0	0.0	3.3	0.0	9.8	0.7	0.3	0.1	0.2	0.0	0.3	1.3	0.3	0.2	2.7	1.1	1.8	1.0	0.3	0.1	0.0	9.7	0.1	0.6	46.0	39.1	11.0	22.5	35.0	17.3	28.7	18.5	16.9	28.4	14.9	24.0	11.8	48.6	23.0	22.4	35.5	25.5	20.1	33.0	40.1	21.6	364.8	64.6	31.9	24.9	14.7	17.8	0.0	12.1	88.6	30.8	28.6	6.9	69.5	42.5	23.8	20.8	20.9	9.4	29.5	23.6	7.4	52.3	12.6	22.1	96.8	15.1	8.6	35.0	241.4	12.2	19.4	17.3	1.0	3.1	14.1	185.9	2.5	43.7	34.8
ALDH9A1	"ALDH4, ALDH7, ALDH9, E3"	ENSG00000143149	"Aldehyde dehydrogenase 9 family member A1"	P49189	1	165662216-165698863	"Enzymes, Plasma proteins, Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	6	"Muller glia cells: 289.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006077, HPA010873"	Approved		Approved	Cytosol	"Intracellular and membrane"	NA	NA		1100000	Cytosol		"HPA006077: , HPA010873: AB_1078126"	"unprognostic (2.24e-1)"	"unprognostic (3.16e-2)"	"unprognostic (4.17e-2)"	"unprognostic (1.25e-1)"	"unprognostic (3.21e-2)"	"unprognostic (1.25e-1)"	"unprognostic (4.14e-2)"	"unprognostic (4.87e-2)"	"unprognostic (2.30e-1)"	"unprognostic (1.83e-1)"	"prognostic favorable (4.56e-4)"	"unprognostic (5.51e-2)"	"unprognostic (9.05e-2)"	"unprognostic (1.67e-1)"	"unprognostic (1.49e-1)"	"unprognostic (1.43e-1)"	"unprognostic (2.15e-1)"	39.1	52.7	30.8	17.4	25.4	7.7	39.6	16.2	26.6	20.3	18.0	22.7	17.1	19.5	15.5	35.5	47.0	18.8	22.2	22.2	24.8	21.1	50.5	73.5	20.7	20.4	23.7	18.4	20.6	17.8	31.2	19.2	14.1	22.8	24.6	18.7	27.2	52.2	23.2	29.9	22.6	23.9	19.2	21.9	18.8	14.7	37.3	21.5	12.4	45.1	24.2	27.9	18.5	19.1	29.6	20.2	29.4	24.5	23.1	39.0	24.4	17.0	16.7	15.6	14.0	49.9	44.0	13.1	22.6	32.1	22.8	19.8	10.3	12.8	0.0	21.7	20.2	11.2	13.5	12.6	22.1	27.0	7.9	16.0	10.9	12.0	11.2	25.7	17.0	11.6	28.2	11.2	24.1	20.2	31.6	19.7	14.5	17.2	15.4	35.4	10.2	11.3	17.6	22.7	44.9	20.5	9.7	19.8	22.8	29.6	16.2	18.6	12.8	16.1	18.2	20.7	22.1	34.6	25.9	19.4	13.8	13.5	16.7	11.4	14.4	18.7	17.0	15.5	16.3	13.2	26.8	20.3	28.1	28.3	21.5	30.1	29.6	27.7	30.6	20.2	26.0	28.1	32.0	29.4	23.1	24.5	12.6	39.0	24.4	30.8	25.4	16.2	26.6	24.8	21.1	23.7	18.4	22.8	21.5	14.9	37.5	27.9	34.1	29.0	24.6	38.9	48.4	69.6	30.7	48.8	21.6	42.9	82.9	36.4	32.5	37.9	44.4	23.3	32.5	64.2	46.7	49.5	36.9	114.6	53.7	12.7	53.6	52.8	58.2	28.9	88.3	37.5	54.0	19.8	52.5	289.8	28.8	31.6	108.5	141.7	26.8	25.8	36.0	33.8	46.2	45.4	31.9	38.9	58.1	23.5
ALDOA		ENSG00000149925	"Aldolase, fructose-bisphosphate A"	P04075	16	30064164-30070457	"Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	Glycolysis	Lyase	"Cancer-related genes, Disease mutation, Glycogen storage disease, Hereditary hemolytic anemia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	6	"skeletal muscle: 1296.2"	"Group enriched"	"Detected in some"	13284	"Cardiomyocytes: 1628.0;Cytotrophoblasts: 1088.2;Extravillous trophoblasts: 1710.3;Hofbauer cells: 1077.0;Syncytiotrophoblasts: 1138.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA004177, CAB006252"	Enhanced		Approved	Cytosol		NA	NA		1200000000	Cytosol		"CAB006252: AB_437007, HPA004177: AB_1078128"	"unprognostic (2.63e-2)"	"unprognostic (3.22e-2)"	"unprognostic (6.80e-2)"	"unprognostic (1.33e-1)"	"unprognostic (6.74e-3)"	"unprognostic (4.28e-3)"	"prognostic unfavorable (5.79e-5)"	"prognostic unfavorable (7.32e-5)"	"unprognostic (1.68e-1)"	"unprognostic (1.81e-1)"	"unprognostic (2.30e-2)"	"unprognostic (1.57e-1)"	"unprognostic (1.81e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.22e-1)"	"unprognostic (2.19e-3)"	"unprognostic (4.48e-2)"	27.9	30.9	34.7	24.2	42.3	36.0	25.3	31.2	59.7	21.0	32.8	16.3	25.9	29.4	21.9	33.9	73.5	22.1	24.4	109.3	31.6	33.4	28.2	11.1	17.9	34.0	35.0	49.6	23.4	19.4	51.0	25.2	19.9	38.0	23.6	23.5	24.6	37.9	36.9	1296.2	28.4	21.5	30.1	22.7	17.4	24.4	9.2	18.9	18.5	26.6	189.8	29.0	36.8	27.7	61.1	142.9	165.7	166.3	50.5	93.2	217.0	138.8	104.7	31.5	101.2	48.3	55.1	100.7	84.1	87.6	85.8	107.3	74.0	107.1	94.7	137.9	84.8	47.1	106.1	63.2	183.3	63.0	41.6	83.1	77.5	84.0	163.3	75.5	112.6	83.2	75.5	64.7	96.3	64.7	141.5	63.1	44.7	66.6	62.5	90.9	198.0	68.4	93.0	78.4	54.0	88.3	102.2	50.6	211.6	106.8	79.1	63.1	44.4	52.4	221.3	78.4	41.1	94.1	76.4	75.0	126.7	50.6	69.1	90.9	123.6	84.3	86.6	235.7	109.4	100.0	106.7	164.0	130.3	70.2	156.8	79.1	61.1	76.8	72.5	142.9	55.5	73.8	70.3	165.7	50.5	166.3	53.8	93.2	217.0	34.7	42.3	31.2	59.7	31.6	33.4	35.0	49.6	38.0	18.9	0.0	0.0	0.0	0.0	0.0	0.0	1628.0	0.0	0.0	0.0	0.0	0.0	1088.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1710.3	0.0	0.0	0.0	0.0	1077.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1138.4	0.0	0.0	0.0
ALDOA		ENSG00000285043	"Aldolase, fructose-bisphosphate A"	P04075	16	30053090-30070420	"Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	Glycolysis	Lyase	"Cancer-related genes, Disease mutation, Glycogen storage disease, Hereditary hemolytic anemia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	5	"Enterocytes: 1558.3"									"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"											HPA004177	Uncertain		Approved	Cytosol		NA	NA		1200000000	Cytosol		"HPA004177: AB_1078128"																		1.8	0.9	2.7	1.1	5.0	2.1	7.2	0.7	7.7	4.9	1.5	2.0	2.4	0.0	2.5	3.9	0.9	3.6	1.6	5.3	2.3		1.3	0.0	2.3	2.0	0.8	4.4	2.2	0.8	0.8	3.0	1.4	4.0	2.4	0.5	2.8	1.6	7.5	10.6	0.6	0.1	1.9	0.4	1.7	1.3	11.6	0.8	1.2	4.7	0.2	2.7	1.2	1.0	7.0	6.6	0.9	6.2	4.2	8.5	12.5	3.8	8.9	1.9	6.2	1.5	5.2	1.5	4.1	7.0	5.5	21.8	3.6	5.1	24.7	6.0	6.8	1.8	6.4	14.1	11.1	3.8	4.4	8.0	6.0	8.3	6.0	11.6	10.6	2.3	5.1	0.5	10.8	12.4	4.5	7.8	4.0	1.2	7.2	13.5	3.9	5.0	8.1	2.1	1.7	5.6	7.7	4.0	22.7	15.3	0.7	6.2	5.1	1.0	1.7	1.5	0.6	5.2	4.0	1.7	8.1	2.5	3.7	5.4	7.4	5.5	8.1	7.7	11.5	3.5	0.1	6.2	0.1	5.3	2.6	7.4	7.0	7.0	5.7	6.6	6.2	8.5	6.6	0.9	4.2	2.3	5.6	5.4	12.5											11.9	25.9	269.9	530.0	703.6	362.0	0.0	315.9	36.1	40.9	40.1	111.9	0.0	94.5	100.6	190.1	242.7	1558.3	46.7	66.6	0.0	38.0	448.8	200.0	94.7	0.0	692.8	311.1	289.1	683.7	930.6	352.7	289.5	877.3	70.3	597.6	553.3	106.3	971.1	380.8	45.3	219.0	478.6	664.3	23.8	81.3	598.3	0.0	258.9	731.1	912.8
ALDOB		ENSG00000136872	"Aldolase, fructose-bisphosphate B"	P05062	9	101420578-101435823	"Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	Glycolysis	Lyase	"Cancer-related genes, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	30	"intestine: 804.1;kidney: 253.1;liver: 598.8"	"Group enriched"	"Detected in many"	9	"Hepatocytes: 2651.5;Proximal tubular cells: 6429.5"	"Cancer enriched"	"Detected in many"	31	"liver cancer: 1414.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 14.4;NB-4: 13.5;RPMI-8226: 15.6;SH-SY5Y: 13.5;U-2197: 5.4"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"HPA002198, CAB020827"	Enhanced					NA	NA		930000000			"CAB020827: , HPA002198: AB_1078129"	"unprognostic (6.58e-3)"	"unprognostic (2.83e-1)"	"unprognostic (1.43e-3)"	"unprognostic (1.03e-1)"	"unprognostic (8.10e-2)"	"unprognostic (1.96e-2)"	"unprognostic (1.44e-3)"	"unprognostic (4.34e-2)"	"unprognostic (4.57e-2)"	"unprognostic (2.66e-1)"	"unprognostic (5.79e-2)"	"unprognostic (7.48e-2)"	"unprognostic (1.66e-2)"	"unprognostic (2.02e-1)"	"unprognostic (2.58e-1)"	"unprognostic (5.19e-2)"	"unprognostic (1.96e-2)"	0.1	0.1	0.1	0.6	0.1	0.0	0.1	0.1	0.2	0.1	334.5	0.2	0.2	145.9	0.2	0.6	0.1	0.1	5.7	0.1	0.1	0.1	253.1	598.8	0.1	0.1	0.1	0.1	0.1	18.3	0.0	0.4	0.1	0.4	0.1	0.0	0.2	0.2	0.1	0.1	0.1	804.1	0.1	0.1	0.2	1.5	0.3	0.1	0.2	0.2	0.2	0.1	0.1	0.1	0.0	0.0	0.0	0.1	0.2	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	14.4	0.0	0.0	0.0	0.0	0.4	0.0	3.0	1.4	0.0	0.0	0.4	0.0	0.0	0.0	0.3	0.0	1.3	0.0	0.4	0.0	3.6	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.1	0.0	0.0	0.2	13.5	0.2	0.4	0.0	0.2	3.1	15.6	0.0	0.0	2.6	13.5	1.6	0.0	0.0	0.0	0.0	0.1	0.7	0.0	0.7	5.4	0.2	0.4	0.2	1.6	0.0	1.1	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.2	0.1	0.1	0.1	0.1	0.4	0.1	0.0	0.0	48.6	0.0	0.0	1.0	0.9	448.4	0.0	0.0	143.1	0.0	0.0	525.6	3.8	0.0	0.0	62.6	46.7	221.2	0.0	0.0	0.0	0.0	2651.5	0.2	3.2	0.0	50.3	57.0	0.0	0.0	0.0	0.0	6.4	2.6	0.4	297.3	28.8	0.0	6429.5	0.6	0.0	0.0	0.0	0.0	0.0	0.2	5.0	1.5	0.0
ALDOC		ENSG00000109107	"Aldolase, fructose-bisphosphate C"	P09972	17	28573115-28577264	"Cancer-related genes, Candidate cardiovascular disease genes, Enzymes, Plasma proteins, Predicted intracellular proteins"	Glycolysis	Lyase	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"brain: 166.7;heart muscle: 56.9"	"Cell type enhanced"	"Detected in many"	11	"Cone photoreceptor cells: 100.1;Horizontal cells: 259.0;Rod photoreceptor cells: 259.1"	"Cancer enriched"	"Detected in all"	6	"glioma: 128.9"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"RPMI-8226: 63.4;U-266/70: 43.8;U-87 MG: 28.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003282, CAB020828, HPA067442"	Enhanced	Supported	Approved	"Nucleoplasm,Nucleoli fibrillar center,Vesicles,Cytosol"		Yes	No		280000000	"Nucleoplasm, Nucleoli fibrillar center"	"Vesicles, Cytosol"	"CAB020828: , HPA003282: AB_1078130, HPA067442: "	"unprognostic (2.90e-1)"	"unprognostic (4.45e-3)"	"unprognostic (5.69e-3)"	"unprognostic (1.43e-1)"	"unprognostic (3.56e-1)"	"prognostic unfavorable (9.80e-4)"	"unprognostic (1.03e-1)"	"unprognostic (1.70e-1)"	"unprognostic (1.30e-1)"	"unprognostic (6.03e-3)"	"unprognostic (3.90e-1)"	"unprognostic (3.24e-2)"	"prognostic unfavorable (1.29e-7)"	"unprognostic (1.28e-1)"	"unprognostic (2.00e-1)"	"unprognostic (2.74e-2)"	"unprognostic (1.23e-1)"	26.0	9.4	86.7	4.8	78.9	7.5	9.8	100.1	166.7	3.8	5.3	17.4	0.3	7.0	4.4	4.6	7.1	3.9	4.4	56.9	64.6	54.3	3.3	26.2	4.6	6.5	69.9	51.4	12.8	1.6	4.7	2.3	2.1	98.1	6.0	5.6	16.5	4.2	6.1	1.7	12.5	15.0	4.6	34.4	6.7	8.7	4.6	23.4	0.0	2.1	0.5	10.0	3.4	3.5	12.2	4.6	8.8	4.1	13.7	20.5	8.8	7.5	0.5	3.5	14.7	7.4	7.6	0.7	3.9	8.8	3.0	18.5	4.4	0.7	3.5	4.6	3.4	0.8	9.9	2.4	24.1	5.6	3.1	2.3	6.8	2.8	7.5	6.9	2.5	8.0	7.0	3.4	0.3	6.0	0.4	1.3	7.3	4.6	19.1	2.6	3.6	2.9	8.3	5.5	1.6	3.9	2.4	0.4	63.4	0.4	1.0	9.4	16.7	2.2	18.1	0.1	5.8	9.8	5.6	0.9	0.3	1.4	0.5	0.6	43.8	12.5	2.6	28.6	7.1	0.5	0.1	3.5	1.4	11.4	4.1	16.2	12.2	15.6	9.2	4.6	11.5	20.5	15.1	8.8	13.7	2.3	2.2	19.5	8.8	86.7	78.9	100.1	78.5	64.6	54.3	69.9	51.4	98.1	23.4	0.0	12.0	9.3	17.7	6.6	72.2	19.0	5.1	0.0	7.9	7.0	100.1	1.2	3.3	14.2	0.8	8.4	22.7	0.0	8.9	3.9	7.1	4.4	12.7	50.8	4.4	259.0	20.7	16.5	4.7	0.8	8.6	3.7	23.6	58.7	8.7	81.4	11.6	14.0	9.6	1.6	259.1	12.9	17.6	0.4	3.2	9.5	1.3	17.0	3.3	8.0
ALG1	"CDG1K, HMAT1, HMT-1, Mat-1"	ENSG00000033011	"ALG1, chitobiosyldiphosphodolichol beta-mannosyltransferase"	Q9BT22	16	5033960-5087379	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"		"Glycosyltransferase, Transferase"	"Congenital disorder of glycosylation, Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											HPA060392	Approved		Approved	"Nucleoli fibrillar center,Endoplasmic reticulum"	"Intracellular and membrane"	NA	NA			"Endoplasmic reticulum"	"Nucleoli fibrillar center"	"HPA060392: AB_2684273"	"unprognostic (1.66e-2)"	"unprognostic (5.18e-1)"	"prognostic favorable (5.79e-4)"	"unprognostic (1.55e-2)"	"unprognostic (2.10e-2)"	"unprognostic (3.22e-2)"	"unprognostic (2.84e-2)"	"unprognostic (2.52e-1)"	"unprognostic (1.18e-2)"	"unprognostic (1.17e-1)"	"unprognostic (2.15e-1)"	"unprognostic (2.87e-1)"	"unprognostic (5.27e-2)"	"unprognostic (1.02e-2)"	"prognostic unfavorable (6.93e-4)"	"unprognostic (2.58e-3)"	"unprognostic (3.86e-2)"	11.0	22.2	8.7	10.8	12.8	6.6	12.8	9.3	18.8	13.7	16.4	14.9	10.1	14.7	12.1	17.0	11.7	12.4	14.3	8.1	8.8	10.4	18.9	31.6	9.9	12.7	10.5	6.5	10.1	27.9	21.5	13.6	10.7	14.6	10.8	17.2	15.5	20.6	12.0	7.3	9.1	12.8	12.1	9.4	16.2	16.5	19.4	11.4	16.0	15.0	8.7	14.5	12.1	8.7	20.7	24.3	7.8	23.3	20.9	26.5	31.7	6.5	17.8	4.5	8.4	17.2	10.3	8.3	14.7	20.7	19.2	19.3	14.7	24.2	13.9	12.7	18.7	8.0	17.6	12.3	14.5	13.1	11.4	13.9	7.8	14.8	30.3	14.1	13.6	13.7	12.4	11.0	15.1	9.6	7.6	11.4	11.3	9.7	18.2	14.2	17.7	8.7	16.7	17.0	11.9	10.2	16.2	6.2	38.7	12.0	7.1	7.6	7.7	15.7	24.6	8.4	6.3	16.0	11.1	10.9	9.0	8.3	45.5	12.3	13.3	16.0	9.4	7.4	14.6	12.7	3.3	23.3	7.8	26.5	21.6	23.1	19.8	22.9	25.4	24.3	20.7	21.0	23.7	1.5	20.9	21.2	21.2	21.6	31.7	8.7	12.8	9.3	18.8	8.8	10.4	10.5	6.5	14.6	11.4	14.9	6.7	14.0	2.8	2.2	7.1	0.6	12.7	12.0	7.9	7.0	11.8	13.9	3.3	15.9	8.2	4.5	8.4	0.0	24.6	16.8	7.2	3.4	1.1	15.5	19.6	3.2	12.9	9.2	8.2	23.0	8.9	5.9	10.1	6.4	17.7	7.2	18.4	10.5	6.3	8.7	5.0	6.5	1.4	25.9	17.2	1.4	7.1	8.7	18.0	3.5
ALG10	"ALG10A, DIE2, FLJ14751"	ENSG00000139133	"ALG10, alpha-1,2-glucosyltransferase"	Q5BKT4	12	34022281-34029694	"Enzymes, Predicted membrane proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA043329, HPA063387"	Approved		Approved	"Endoplasmic reticulum"		NA	NA			"Endoplasmic reticulum"		"HPA043329: AB_2678432, HPA063387: AB_2685000"	"unprognostic (1.71e-1)"	"unprognostic (4.98e-2)"	"unprognostic (3.16e-3)"	"unprognostic (2.80e-2)"	"unprognostic (9.23e-2)"	"unprognostic (3.49e-2)"	"unprognostic (5.88e-4)"	"unprognostic (2.13e-1)"	"unprognostic (1.73e-2)"	"unprognostic (8.01e-2)"	"unprognostic (5.41e-2)"	"unprognostic (1.16e-1)"	"unprognostic (9.29e-2)"	"unprognostic (8.99e-2)"	"unprognostic (1.53e-1)"	"unprognostic (2.43e-1)"	"unprognostic (6.45e-2)"	6.2	7.0	2.7	5.4	5.9	6.9	6.9	4.0	5.5	5.3	4.6	3.8	3.6	3.4	10.3	5.5	6.0	6.2	3.7	4.6	2.6	2.9	4.6	5.7	5.4	6.7	4.1	1.7	7.1	7.8	7.5	6.1	7.2	3.5	5.8	4.1	8.7	9.0	4.4	4.6	5.1	5.0	4.0	3.5	6.1	5.1	8.0	3.6	17.2	6.2	3.0	9.8	5.8	4.8	2.7	1.8	4.5	2.7	2.1	3.8	1.6	4.5	5.4	3.5	5.8	4.2	3.3	12.4	4.4	4.1	4.8	8.6	7.9	11.0	6.9	6.5	2.2	7.1	6.9	6.6	5.6	6.5	11.0	6.3	6.4	5.7	3.1	1.7	9.2	6.7	3.6	3.3	10.1	7.7	2.3	3.2	6.2	9.6	11.7	3.9	6.2	5.9	5.1	13.1	2.7	6.8	5.3	12.7	7.0	2.6	6.8	3.1	2.5	7.7	3.3	5.5	10.5	7.9	2.5	6.8	6.6	9.8	8.8	5.5	6.4	11.5	13.3	4.6	3.7	5.2	0.0	2.7	4.5	1.9	1.2	3.0	2.5	2.6	1.1	1.8	2.7	3.1	3.8	0.4	2.1	1.2	1.8	3.0	1.6	2.7	5.9	4.0	5.5	2.6	2.9	4.1	1.7	3.5	3.6	6.0	0.3	3.0	2.5	1.3	3.5	0.8	2.5	4.0	3.4	5.2	3.9	6.4	1.7	1.9	0.6	2.1	1.0	0.0	3.3	4.7	2.1	0.6	1.1	2.4	2.9	1.6	1.2	0.6	2.7	0.0	1.4	2.1	0.0	4.6	1.9	3.7	2.6	0.0	1.1	1.1	4.1	0.0	1.0	7.5	3.0	2.4	2.6	4.3	1.7	1.4
ALG10B	KCR1	ENSG00000175548	"ALG10B, alpha-1,2-glucosyltransferase"	Q5I7T1	12	38316578-38329728	"Enzymes, Predicted membrane proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Cone photoreceptor cells: 31.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"											"HPA043329, HPA063387"	Approved		Approved	"Endoplasmic reticulum"		NA	NA			"Endoplasmic reticulum"		"HPA043329: AB_2678432, HPA063387: AB_2685000"	"unprognostic (4.55e-2)"	"unprognostic (1.01e-1)"	"unprognostic (2.32e-1)"	"unprognostic (1.25e-1)"	"unprognostic (1.79e-1)"	"unprognostic (3.01e-1)"	"unprognostic (4.43e-2)"	"unprognostic (8.58e-2)"	"unprognostic (7.40e-2)"	"unprognostic (8.40e-2)"	"unprognostic (1.17e-1)"	"unprognostic (2.05e-2)"	"unprognostic (1.91e-1)"	"unprognostic (3.30e-3)"	"unprognostic (2.63e-1)"	"unprognostic (1.93e-1)"	"unprognostic (2.28e-1)"	8.2	8.5	4.3	4.9	7.0	6.6	9.1	5.3	7.2	6.1	4.4	5.4	9.5	4.2	8.5	6.7	6.9	6.4	6.0	5.8	5.0	2.7	5.9	6.6	6.5	7.3	6.6	4.8	8.7	9.6	8.7	7.8	11.6	4.3	6.1	4.5	10.5	9.3	9.7	5.8	7.7	6.5	4.6	4.5	7.5	6.4	8.9	5.0	10.5	7.4	5.6	6.6	7.7	6.8	3.6	2.6	2.0	2.0	1.4	4.1	1.2	5.0	4.7	6.2	6.2	3.1	5.8	6.4	4.0	2.1	5.4	4.8	1.7	15.3	7.7	7.0	2.0	4.0	5.3	5.4	4.4	7.8	5.1	6.9	8.1	8.1	3.4	3.4	10.8	5.7	3.2	5.8	7.6	5.6	4.8	3.9	9.8	9.1	4.7	4.5	3.8	7.2	8.6	7.8	0.5	4.7	2.4	13.3	6.1	4.6	6.3	1.8	6.4	7.0	2.4	4.8	6.9	10.7	4.4	3.3	5.7	6.6	5.0	5.0	3.7	9.5	12.3	4.8	7.6	7.1	1.2	1.5	2.0	1.1	2.0	2.2	1.8	1.1	1.8	1.1	3.6	2.2	2.7	0.6	1.4	1.4	2.6	4.1	1.2	4.3	7.0	5.3	7.2	5.0	2.7	6.6	4.8	4.3	5.0	6.0	11.5	0.5	3.5	1.8	12.9	3.0	0.0	6.7	9.1	3.5	31.4	15.2	6.6	3.6	0.2	4.9	1.2	0.0	5.0	8.2	3.5	2.4	1.1	5.9	4.2	9.5	0.0	6.2	1.5	1.5	3.7	1.9	1.7	0.0	2.5	8.9	3.5	2.0	5.3	2.2	12.4	6.5	1.4	8.3	3.4	1.6	6.8	1.3	2.5	2.3
ALG11	"CDG1P, KIAA0266"	ENSG00000253710	"ALG11, alpha-1,2-mannosyltransferase"	Q2TAA5	13	52012398-52029664	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"		"Glycosyltransferase, Transferase"	"Congenital disorder of glycosylation, Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Alveolar cells type 1: 17.9;Ciliated cells: 17.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA047214	Approved					NA	NA					"HPA047214: AB_10961640"	"unprognostic (9.21e-2)"	"unprognostic (1.31e-3)"	"unprognostic (2.02e-1)"	"unprognostic (4.18e-2)"	"unprognostic (2.21e-2)"	"unprognostic (3.04e-2)"	"unprognostic (9.15e-3)"	"unprognostic (1.69e-1)"	"unprognostic (2.28e-1)"	"unprognostic (8.97e-3)"	"unprognostic (8.89e-3)"	"unprognostic (7.47e-2)"	"unprognostic (2.30e-4)"	"unprognostic (1.87e-2)"	"unprognostic (1.60e-1)"	"unprognostic (6.03e-2)"	"unprognostic (9.71e-3)"	14.7	16.9	11.9	9.6	16.2	14.2	13.8	11.8	17.7	13.9	11.9	12.6	15.9	9.8	15.2	13.0	12.6	12.9	11.3	12.2	13.4	9.5	17.3	20.9	11.5	9.3	13.5	11.5	13.1	15.6	18.4	18.4	19.5	15.7	13.5	13.9	11.4	17.6	13.7	13.0	13.7	15.6	14.2	16.6	11.6	13.1	12.2	12.3	13.8	19.6	7.0	10.3	14.7	11.2	10.4	14.4	14.6	14.1	8.7	13.3	6.4	5.0	7.1	12.3	12.2	11.1	10.9	10.8	13.5	11.4	10.4	9.0	9.5	12.3	10.0	3.7	11.6	10.8	10.7	12.7	8.9	14.2	11.8	9.6	23.9	7.6	8.6	10.7	20.0	24.0	10.0	13.4	9.6	11.4	8.6	9.3	11.5	13.6	9.8	12.6	4.5	9.7	7.4	12.7	15.7	5.9	12.6	8.9	6.1	10.3	9.9	5.2	9.6	10.3	9.6	8.4	10.3	11.7	11.7	13.2	9.6	7.8	9.8	9.8	5.5	7.7	13.2	6.3	7.6	15.8	14.6	7.4	9.8	11.3	6.0	11.2	8.0	10.2	10.5	8.3	10.4	13.1	13.3	4.1	8.7	14.1	14.4	9.8	6.4	11.9	16.2	11.8	17.7	13.4	9.5	13.5	11.5	15.7	12.3	17.9	5.1	1.5	2.3	2.2	5.8	5.5	5.1	17.4	10.3	3.5	5.9	3.0	1.7	2.4	0.7	3.5	2.5	0.0	2.0	2.6	2.2	2.1	3.5	3.0	2.2	4.8	2.9	7.4	2.1	0.2	3.1	3.3	1.7	1.0	1.8	3.6	2.2	1.7	1.1	1.1	6.7	0.0	1.4	4.2	3.3	2.0	4.0	3.1	1.7	3.3
ALG12	"CDG1G, ECM39"	ENSG00000182858	"ALG12, alpha-1,6-mannosyltransferase"	Q9BV10	22	49900229-49918458	"Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins"		"Glycosyltransferase, Transferase"	"Congenital disorder of glycosylation, Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003076, HPA051665"	Approved		Approved	"Endoplasmic reticulum"		NA	NA			"Endoplasmic reticulum"		"HPA003076: AB_2666777, HPA051665: AB_2681566"	"unprognostic (1.66e-1)"	"unprognostic (1.26e-1)"	"unprognostic (4.39e-3)"	"prognostic favorable (6.09e-4)"	"unprognostic (2.29e-1)"	"unprognostic (3.32e-2)"	"unprognostic (4.27e-3)"	"unprognostic (3.33e-2)"	"unprognostic (1.46e-1)"	"unprognostic (3.32e-2)"	"unprognostic (1.42e-1)"	"unprognostic (2.21e-1)"	"prognostic favorable (3.60e-5)"	"unprognostic (1.62e-2)"	"unprognostic (3.00e-2)"	"unprognostic (9.89e-3)"	"unprognostic (6.32e-2)"	9.8	13.3	9.6	11.3	11.2	8.5	9.9	16.0	12.7	10.9	11.7	16.2	15.7	18.0	13.2	11.5	12.1	11.4	11.0	12.0	10.0	5.8	14.1	22.8	10.8	9.2	11.6	7.9	11.8	17.5	14.7	10.6	11.3	10.9	13.5	7.1	12.2	19.4	10.2	8.7	11.5	14.8	7.7	8.9	11.5	14.5	6.5	14.9	12.6	24.5	10.5	12.8	12.1	10.3	7.6	7.8	17.7	9.4	16.1	12.7	7.9	7.0	7.1	7.5	12.5	14.5	6.8	8.4	7.4	6.7	8.8	7.1	11.6	10.2	3.8	6.8	6.6	9.6	12.9	9.2	8.8	4.4	6.0	13.5	3.5	11.9	11.7	16.4	8.7	7.7	10.2	9.1	8.6	12.4	9.7	8.4	8.7	4.3	9.6	4.6	16.1	8.4	7.1	7.2	9.4	6.6	14.2	9.5	10.0	9.2	8.1	5.1	8.4	11.8	22.5	9.2	10.6	9.2	7.8	6.5	9.8	7.5	6.8	5.6	8.5	3.9	5.0	10.9	6.7	9.3	17.7	8.8	7.4	12.4	8.2	12.7	5.3	9.8	12.2	7.7	7.6	8.3	9.3	6.9	16.1	9.4	7.8	12.3	7.9	9.6	11.2	16.0	12.7	10.0	5.8	11.6	7.9	10.9	14.9	8.9	1.9	8.1	9.0	3.7	5.4	1.2	2.5	5.3	7.9	17.4	2.0	17.2	3.3	14.4	4.7	6.9	15.5	0.0	11.7	19.0	7.8	8.8	8.1	11.9	15.8	3.2	6.4	7.4	8.6	3.0	8.1	6.1	10.1	10.8	11.2	3.4	10.1	7.0	7.8	5.5	5.1	0.0	3.3	8.6	9.4	5.3	22.0	12.9	13.7	8.1
ALG13	"CDG1S, CXorf45, FLJ23018, GLT28D1, MDS031, TDRD13, YGL047W"	ENSG00000101901	"ALG13, UDP-N-acetylglucosaminyltransferase subunit"	Q9NP73	X	111665811-111760649	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Ubl conjugation pathway"	"Glycosyltransferase, Hydrolase, Multifunctional enzyme, Protease, Thiol protease, Transferase"	"Congenital disorder of glycosylation, Disease mutation, Epilepsy"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"HPA002853, HPA005498"	Approved		Approved	Vesicles,Cytosol		NA	NA			Vesicles	Cytosol	"HPA002853: AB_1078131, HPA005498: "	"unprognostic (4.13e-1)"	"unprognostic (1.80e-1)"	"unprognostic (2.45e-2)"	"unprognostic (1.51e-1)"	"unprognostic (6.97e-2)"	"unprognostic (6.14e-2)"	"unprognostic (2.74e-1)"	"unprognostic (6.55e-3)"	"unprognostic (2.26e-2)"	"unprognostic (3.39e-3)"	"unprognostic (1.73e-2)"	"unprognostic (4.62e-3)"	"prognostic unfavorable (1.10e-6)"	"unprognostic (1.19e-1)"	"unprognostic (1.29e-2)"	"unprognostic (9.70e-2)"	"unprognostic (2.45e-2)"	20.6	23.0	18.4	23.2	23.2	19.3	24.8	20.9	25.5	21.1	23.3	21.6	22.0	18.0	26.3	28.5	18.3	22.5	22.2	16.8	16.6	16.2	23.5	31.1	19.7	28.4	22.4	16.1	24.2	18.8	13.0	41.7	18.7	19.5	26.7	26.5	16.3	19.5	25.6	11.2	25.2	25.7	23.5	21.6	31.4	20.1	19.0	20.3	23.6	24.5	14.6	25.8	18.3	20.9	10.2	14.4	21.7	12.5	3.4	11.1	7.1	10.9	12.4	11.1	7.0	7.2	10.4	6.3	8.9	9.2	11.5	14.3	12.4	11.5	9.5	17.1	12.3	23.8	6.3	13.2	6.3	12.1	6.8	8.8	5.2	14.0	14.1	10.7	9.5	21.0	12.3	11.8	9.2	20.0	12.0	12.5	10.9	11.6	27.4	11.4	27.8	8.0	8.6	10.2	32.8	17.0	6.2	7.1	13.2	18.3	16.9	6.7	9.8	12.7	7.7	7.7	11.6	6.9	9.2	8.4	9.9	4.9	12.8	17.0	13.2	21.9	15.3	10.6	12.6	7.5	21.7	12.4	12.2	7.8	12.5	7.6	8.4	8.9	7.6	14.4	10.2	11.1	9.1	2.5	3.4	9.4	7.5	10.7	7.1	18.4	23.2	20.9	25.5	16.6	16.2	22.4	16.1	19.5	20.3	14.9	31.5	32.3	54.9	31.3	12.7	15.1	20.4	34.8	25.0	17.4	9.8	22.8	38.1	27.8	14.0	38.3	32.8	0.0	45.1	32.1	22.1	46.9	109.4	26.7	37.3	11.1	25.4	23.4	36.4	6.8	19.8	44.5	27.0	35.1	42.8	12.8	44.6	41.2	15.2	44.0	14.8	25.8	39.0	9.9	16.3	30.9	40.7	34.5	28.5	55.9
ALG2	"CDG1I, CDGIi, FLJ14511, hALPG2, NET38"	ENSG00000119523	"ALG2, alpha-1,3/1,6-mannosyltransferase"	Q9H553	9	99216426-99221956	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"		"Glycosyltransferase, Transferase"	"Congenital disorder of glycosylation, Congenital myasthenic syndrome, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"monocytes: 93.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041512, HPA041601"	Approved		Enhanced	"Actin filaments,Cytosol"		No	No			"Actin filaments, Cytosol"		"HPA041512: AB_10794380, HPA041601: AB_10794302"	"unprognostic (8.86e-3)"	"unprognostic (4.39e-1)"	"unprognostic (2.37e-1)"	"prognostic favorable (8.44e-5)"	"unprognostic (9.21e-3)"	"prognostic unfavorable (1.56e-4)"	"unprognostic (1.06e-2)"	"unprognostic (5.94e-2)"	"unprognostic (3.31e-1)"	"unprognostic (3.66e-1)"	"unprognostic (2.99e-2)"	"unprognostic (1.08e-1)"	"prognostic favorable (2.28e-7)"	"unprognostic (4.16e-2)"	"unprognostic (1.73e-1)"	"unprognostic (3.10e-2)"	"unprognostic (4.81e-1)"	12.5	28.0	9.2	9.4	9.7	10.5	16.4	13.1	12.5	18.8	12.9	11.6	31.1	11.0	15.2	39.2	12.3	15.8	13.9	12.1	8.3	9.5	24.8	45.5	16.0	12.8	10.8	6.5	18.4	43.4	14.7	22.4	22.5	12.0	16.7	14.9	14.7	24.1	32.6	13.3	8.7	15.5	12.6	11.3	15.9	15.0	12.6	9.7	14.8	26.0	9.9	15.8	12.9	11.8	16.8	41.0	18.2	18.5	17.5	26.4	17.8	8.1	11.0	8.1	11.6	30.1	19.6	16.7	16.7	26.6	17.1	14.9	13.1	11.8	8.8	7.8	19.2	23.2	32.3	13.7	17.9	17.2	13.3	6.3	5.2	8.7	19.4	36.2	9.1	9.9	21.4	23.4	14.5	26.4	16.5	19.1	5.7	9.1	19.9	15.8	17.1	4.6	10.9	10.5	26.9	15.5	5.3	16.5	13.7	22.9	10.4	8.7	7.1	12.3	22.7	21.5	12.9	9.2	7.8	13.5	11.7	11.6	14.9	10.4	18.7	10.1	3.8	22.0	7.3	5.7	18.2	18.5	11.2	18.6	14.6	26.4	16.8	17.7	18.4	23.0	13.3	15.4	15.0	5.0	17.5	12.9	41.0	18.8	17.8	9.2	9.7	13.1	12.5	8.3	9.5	10.8	6.5	12.0	9.7	11.9	22.2	18.6	17.3	20.7	11.4	6.0	20.4	14.7	14.8	22.7	2.0	44.0	18.3	32.0	22.1	17.7	16.9	0.0	30.7	28.2	25.8	31.0	7.0	52.1	25.7	9.5	12.0	24.5	25.6	16.5	24.7	22.6	20.3	93.8	19.7	13.4	30.1	14.0	23.7	31.7	7.0	6.5	18.9	20.2	23.7	20.7	74.6	15.9	16.8	28.9
ALG3	"CDGS4, D16Ertd36e, Not56, NOT56L"	ENSG00000214160	"ALG3, alpha-1,3- mannosyltransferase"	Q92685	3	184242301-184249548	"Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins"		"Glycosyltransferase, Transferase"	"Congenital disorder of glycosylation, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 74.4"	"Cell type enhanced"	"Detected in all"	6	"Late spermatids: 169.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA045103	Enhanced					NA	NA					"HPA045103: AB_10960547"	"unprognostic (3.63e-2)"	"unprognostic (2.60e-1)"	"unprognostic (2.36e-2)"	"unprognostic (1.80e-3)"	"unprognostic (3.63e-1)"	"unprognostic (7.93e-3)"	"prognostic unfavorable (1.58e-5)"	"prognostic unfavorable (8.67e-5)"	"unprognostic (6.18e-2)"	"unprognostic (1.24e-1)"	"unprognostic (4.19e-3)"	"unprognostic (6.15e-2)"	"prognostic unfavorable (1.25e-4)"	"unprognostic (9.35e-2)"	"unprognostic (1.03e-1)"	"unprognostic (2.64e-1)"	"unprognostic (5.02e-2)"	14.2	24.1	7.7	12.2	10.3	11.6	15.4	7.2	12.9	11.5	15.5	13.7	15.2	14.3	12.8	11.2	20.5	11.5	15.4	13.0	7.3	6.5	19.7	74.4	12.9	16.8	11.5	7.3	12.7	37.7	18.4	11.7	26.6	10.2	14.0	16.0	12.4	20.9	13.7	18.9	18.4	16.3	14.0	7.9	14.9	15.0	20.8	10.1	13.9	15.9	14.9	18.8	17.4	15.8	14.2	30.1	6.0	25.4	18.7	18.0	15.5	20.1	17.6	4.8	16.1	19.4	11.1	16.4	10.9	12.4	14.9	12.8	26.9	13.6	17.8	29.7	13.4	30.2	24.3	17.3	23.6	9.3	12.8	20.1	15.9	13.4	21.6	17.8	25.8	14.4	13.1	19.8	17.6	24.9	7.8	8.1	12.2	15.7	36.0	9.6	24.8	12.5	20.9	15.1	40.2	23.0	13.0	7.5	70.6	16.8	6.7	12.1	10.2	10.1	40.0	17.3	6.1	37.9	14.7	6.5	15.8	10.0	13.8	23.1	19.7	34.6	18.8	14.1	33.9	14.1	0.2	25.4	6.0	16.0	25.0	18.0	14.2	17.3	16.2	30.1	12.3	15.6	15.1	0.9	18.7	19.7	27.4	18.0	15.5	7.7	10.3	7.2	12.9	7.3	6.5	11.5	7.3	10.2	10.1	6.0	14.9	23.1	21.9	22.1	9.4	8.4	22.9	10.7	19.4	19.2	9.8	63.5	6.6	48.3	89.2	15.7	30.3	46.7	54.5	79.0	18.5	26.2	12.7	43.7	62.9	7.9	13.9	14.7	21.8	169.9	11.5	18.6	20.3	15.4	27.2	14.3	42.1	21.0	14.2	23.8	9.9	19.4	19.1	28.7	33.6	23.6	55.0	19.3	41.5	24.2
ALG5	bA421P11.2	ENSG00000120697	"ALG5, dolichyl-phosphate beta-glucosyltransferase"	Q9Y673	13	36949775-37000261	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA007989	Approved		Approved	Cytosol		No	No			Cytosol		"HPA007989: AB_1078132"	"unprognostic (1.87e-1)"	"unprognostic (1.73e-2)"	"unprognostic (6.07e-2)"	"unprognostic (1.05e-3)"	"unprognostic (3.01e-1)"	"prognostic unfavorable (2.11e-4)"	"unprognostic (1.57e-2)"	"unprognostic (5.82e-2)"	"unprognostic (5.21e-2)"	"unprognostic (7.46e-2)"	"unprognostic (3.51e-2)"	"unprognostic (3.30e-1)"	"prognostic favorable (1.40e-5)"	"unprognostic (7.44e-2)"	"unprognostic (1.66e-1)"	"unprognostic (7.14e-3)"	"unprognostic (1.86e-1)"	14.7	18.2	11.8	14.0	14.2	11.3	19.9	10.9	13.7	16.7	16.5	10.3	34.2	13.0	13.5	34.8	11.7	12.4	12.9	13.1	10.0	10.5	18.1	36.7	19.1	28.0	16.1	12.8	11.8	60.4	11.8	11.6	17.0	12.1	12.9	20.8	7.3	30.2	37.0	9.0	11.0	12.6	10.9	15.1	12.9	17.6	7.2	14.2	15.4	25.5	12.1	12.4	12.4	11.1	19.1	45.5	17.7	24.8	22.1	25.2	26.9	9.6	13.0	12.0	12.3	33.1	22.2	8.8	26.8	28.5	22.7	18.6	25.4	33.7	13.9	11.1	16.2	19.3	23.9	14.8	20.4	21.2	14.8	29.0	31.9	10.8	15.9	32.4	27.0	16.7	23.3	30.1	18.1	24.3	14.9	17.3	15.6	14.6	17.3	20.5	17.3	18.2	21.6	12.3	60.8	10.6	22.2	14.8	34.0	24.1	18.3	9.6	18.7	11.3	21.0	15.5	9.5	12.7	26.9	13.2	12.7	7.2	14.0	17.0	14.8	11.4	18.2	19.6	17.2	21.0	17.7	24.1	10.0	24.4	24.8	24.6	19.1	23.0	24.4	23.6	17.0	21.2	23.2	2.7	22.1	20.2	45.5	25.2	26.9	11.8	14.2	10.9	13.7	10.0	10.5	16.1	12.8	12.1	14.2	47.6	44.6	33.5	34.8	30.8	16.4	9.7	81.5	22.7	31.8	50.6	9.8	71.9	19.9	78.2	27.2	40.9	34.9	0.0	121.6	63.8	57.3	47.1	28.8	63.8	63.1	11.1	34.7	32.5	37.8	17.9	37.2	44.2	75.9	39.7	51.8	33.6	80.6	45.6	36.0	43.5	23.5	45.3	44.3	47.0	21.3	26.5	68.0	41.5	66.2	37.2
ALG6		ENSG00000088035	"ALG6, alpha-1,3-glucosyltransferase"	Q9Y672	1	63367590-63438562	"Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins"		"Glycosyltransferase, Transferase"	"Congenital disorder of glycosylation, Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Cytotrophoblasts: 39.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA062536, HPA076130"	Approved		Approved	"Endoplasmic reticulum"		NA	NA			"Endoplasmic reticulum"		"HPA062536: AB_2684792, HPA076130: "	"unprognostic (1.21e-1)"	"unprognostic (5.60e-3)"	"prognostic favorable (4.86e-4)"	"unprognostic (1.59e-1)"	"unprognostic (3.45e-1)"	"unprognostic (2.45e-2)"	"prognostic unfavorable (9.46e-4)"	"unprognostic (2.07e-1)"	"unprognostic (9.81e-3)"	"unprognostic (4.65e-2)"	"unprognostic (2.00e-2)"	"unprognostic (3.90e-2)"	"prognostic unfavorable (2.63e-6)"	"unprognostic (1.84e-3)"	"unprognostic (1.07e-1)"	"unprognostic (4.61e-2)"	"unprognostic (3.41e-1)"	9.7	13.7	9.3	13.5	13.5	8.8	11.6	12.2	12.6	9.9	11.8	10.1	9.0	12.1	11.0	14.3	16.7	9.6	9.1	9.9	11.2	7.1	10.3	14.6	10.0	13.4	8.2	11.1	10.8	11.5	10.6	10.0	14.1	11.6	8.9	14.0	10.2	12.9	11.9	8.0	13.7	13.5	7.5	10.5	14.5	10.0	6.9	8.7	25.9	9.7	8.5	21.7	10.0	11.6	7.5	7.9	24.2	7.4	7.4	10.6	5.6	5.3	4.8	8.5	7.7	10.2	8.8	11.2	6.3	2.2	3.3	3.8	5.6	5.4	13.9	15.2	5.2	14.6	10.3	12.4	10.1	6.0	15.6	9.8	10.7	5.5	4.6	5.0	12.7	9.3	7.3	6.1	8.1	3.0	6.1	12.5	14.2	11.3	11.2	7.7	7.0	12.2	10.7	26.0	14.6	7.2	12.5	12.0	16.4	9.5	7.4	7.9	4.3	16.8	17.5	16.5	16.3	9.7	7.2	6.8	5.5	5.5	11.6	8.1	9.5	13.3	11.5	5.3	12.7	18.4	24.2	7.4	13.6	8.8	6.6	10.6	7.5	7.2	8.5	7.9	5.6	8.7	9.1	4.3	7.4	6.4	6.5	9.4	5.6	9.3	13.5	12.2	12.6	11.2	7.1	8.2	11.1	11.6	8.7	8.9	3.7	7.5	8.0	9.7	5.6	2.8	10.2	4.0	7.9	3.5	3.9	39.5	1.7	10.5	1.9	5.8	5.8	0.0	7.8	23.6	8.2	5.4	9.2	9.2	13.7	6.4	4.1	8.0	5.9	1.7	6.4	7.5	15.1	0.0	7.8	4.9	6.5	0.0	4.6	5.9	5.1	6.5	5.1	12.1	15.9	9.7	22.4	13.8	9.3	6.4
ALG8	MGC2840	ENSG00000159063	"ALG8, alpha-1,3-glucosyltransferase"	Q9BVK2	11	78100936-78139660	"Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins"		"Glycosyltransferase, Transferase"	"Congenital disorder of glycosylation, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Spermatocytes: 115.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA051898	Approved		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA051898: AB_2681656"	"unprognostic (1.37e-1)"	"unprognostic (9.24e-2)"	"unprognostic (4.60e-2)"	"unprognostic (2.69e-2)"	"unprognostic (2.65e-1)"	"unprognostic (6.49e-2)"	"unprognostic (5.38e-3)"	"unprognostic (5.91e-2)"	"unprognostic (1.39e-1)"	"unprognostic (1.10e-3)"	"unprognostic (5.29e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.35e-2)"	"unprognostic (1.19e-1)"	"unprognostic (2.34e-1)"	"unprognostic (3.78e-2)"	"unprognostic (6.37e-2)"	20.2	24.5	18.0	11.2	22.3	9.7	23.7	13.8	17.9	16.5	15.0	20.7	23.9	10.3	14.5	30.9	13.3	18.4	12.3	13.0	15.9	16.0	24.9	40.8	12.8	15.7	16.0	11.6	22.9	23.4	24.2	23.6	21.7	17.1	15.5	19.0	17.6	23.2	19.5	8.2	13.3	13.3	14.8	17.6	13.8	13.1	38.9	16.5	18.2	29.7	13.1	17.4	13.2	11.2	21.9	19.4	3.0	20.3	18.2	19.0	14.9	8.9	24.6	23.6	20.2	20.5	14.4	12.7	13.1	19.7	22.5	21.8	46.6	32.7	20.9	24.3	15.7	29.5	25.7	27.5	18.9	36.4	15.0	16.5	25.2	21.7	20.9	13.3	24.0	16.8	11.5	12.2	26.3	13.1	12.9	16.3	19.0	31.2	21.6	30.1	13.0	20.0	27.1	26.3	60.1	12.9	21.4	10.9	49.8	22.6	13.8	6.9	17.4	18.9	30.7	9.5	22.5	34.3	19.0	10.0	15.3	17.8	34.4	11.3	15.5	30.1	30.9	8.5	23.6	26.4	0.3	17.5	3.0	15.7	19.5	17.5	21.9	16.0	16.1	19.4	16.6	19.0	17.2	1.1	18.2	20.3	18.7	13.0	14.9	18.0	22.3	13.8	17.9	15.9	16.0	16.0	11.6	17.1	16.5	11.9	12.3	25.2	20.6	9.3	13.9	6.3	25.5	10.7	13.6	19.2	17.7	44.1	5.0	18.7	10.7	14.3	6.0	0.0	22.1	52.0	15.3	15.6	11.5	36.4	27.9	15.9	7.5	11.1	14.0	9.8	16.7	17.3	25.3	4.6	15.5	8.2	16.4	5.8	14.9	14.6	12.9	0.0	15.2	115.0	39.1	7.9	27.3	14.9	14.0	15.7
ALG9	DIBD1	ENSG00000086848	"ALG9, alpha-1,2-mannosyltransferase"	Q9H6U8	11	111782195-111871581	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"		"Glycosyltransferase, Transferase"	"Congenital disorder of glycosylation, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											HPA038575	Approved		Approved	"Endoplasmic reticulum"		NA	NA			"Endoplasmic reticulum"		"HPA038575: AB_10672718"	"unprognostic (1.48e-1)"	"unprognostic (5.39e-2)"	"unprognostic (6.22e-2)"	"unprognostic (5.34e-3)"	"unprognostic (8.72e-2)"	"unprognostic (2.90e-1)"	"unprognostic (2.43e-2)"	"unprognostic (1.04e-2)"	"unprognostic (7.07e-3)"	"unprognostic (5.11e-2)"	"unprognostic (8.75e-3)"	"unprognostic (1.52e-2)"	"prognostic unfavorable (7.29e-5)"	"unprognostic (9.15e-2)"	"unprognostic (7.76e-2)"	"unprognostic (4.20e-2)"	"unprognostic (1.10e-2)"	19.9	13.5	11.8	11.4	17.9	9.0	16.8	19.3	19.3	16.9	13.7	15.6	15.7	16.2	19.1	15.7	13.8	12.5	14.0	14.3	11.6	13.7	13.7	17.7	12.3	13.5	12.2	11.2	19.2	29.9	21.0	16.5	20.3	14.6	14.7	14.9	17.5	34.3	20.1	11.7	17.3	13.2	15.8	13.2	13.0	14.1	25.0	9.8	15.3	17.4	10.9	15.2	13.8	14.2	7.8	9.5	7.0	7.9	7.1	12.2	6.5	9.9	10.1	19.8	19.4	12.3	11.8	15.0	13.0	10.6	10.8	11.7	17.2	17.0	16.1	18.5	14.6	13.6	18.7	10.3	15.7	15.2	12.4	8.1	12.2	5.9	12.6	14.3	13.7	8.5	10.2	10.6	11.2	11.1	15.5	10.3	12.5	12.2	25.2	17.6	7.3	13.7	12.2	6.5	13.9	11.2	12.6	17.6	31.3	11.8	8.9	9.7	16.7	11.4	17.5	7.0	14.4	18.9	5.6	10.2	22.7	16.0	11.0	14.0	8.2	6.1	15.1	9.4	17.1	15.3	6.7	5.8	7.0	8.5	7.9	9.4	7.8	8.0	8.8	9.5	6.6	12.2	7.3	2.3	7.1	6.9	9.4	7.7	6.5	11.8	17.9	19.3	19.3	11.6	13.7	12.2	11.2	14.6	9.8	0.0	4.1	2.9	1.2	1.8	9.4	5.0	2.5	1.4	4.5	7.0	7.9	3.0	3.3	6.3	4.3	2.1	3.2	0.0	6.1	11.4	2.8	1.2	0.0	5.8	2.7	14.3	4.1	2.5	1.2	3.5	4.4	2.3	0.0	3.6	3.4	5.4	5.9	3.5	3.5	2.2	10.3	6.5	4.1	3.7	5.5	1.4	7.6	2.5	3.9	0.6
ALK	CD246	ENSG00000171094	"ALK receptor tyrosine kinase"	Q9UM73	2	29192774-29921566	"Cancer-related genes, CD markers, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"		"Kinase, Receptor, Transferase, Tyrosine-protein kinase"	"Cancer-related genes, Disease mutation, FDA approved drug targets, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 8.1;pituitary gland: 17.9"	"Group enriched"	"Detected in some"	12	"Early spermatids: 36.6;Late spermatids: 30.9"	"Group enriched"	"Detected in some"	5	"glioma: 1.0;melanoma: 1.5;ovarian cancer: 0.7;thyroid cancer: 1.3"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	6	"SH-SY5Y: 27.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA010694	Approved		Supported	"Plasma membrane"		NA	NA			"Plasma membrane"		"HPA010694: AB_1078133"	"unprognostic (4.96e-2)"	"unprognostic (1.11e-2)"	"unprognostic (1.45e-1)"	"unprognostic (4.56e-7)"	"unprognostic (7.17e-2)"	"unprognostic (1.71e-1)"	"unprognostic (9.07e-3)"	"unprognostic (6.29e-3)"	"unprognostic (1.18e-1)"	"unprognostic (1.01e-1)"	"unprognostic (2.67e-4)"	"unprognostic (3.70e-2)"	"unprognostic (2.06e-2)"	"unprognostic (7.15e-2)"	"unprognostic (1.98e-1)"	"unprognostic (1.38e-1)"	"unprognostic (3.61e-2)"	1.8	3.1	3.6	1.2	4.4	0.3	1.1	0.5	8.1	0.7	2.1	2.0	0.0	0.7	0.5	0.5	0.6	0.5	1.2	0.4	3.4	4.9	0.4	0.5	1.1	0.5	2.7	4.2	0.6	0.4	0.4	17.9	0.5	5.5	0.5	1.2	2.4	0.9	0.8	0.3	0.9	1.5	0.9	2.1	0.5	0.8	4.9	0.9	0.0	1.6	0.0	0.3	0.6	1.2	0.0	0.0	0.0	0.2	0.0	0.7	0.0	0.0	0.0	0.4	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.5	0.0	3.6	0.0	0.0	0.1	0.3	27.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	3.2	0.0	4.1	0.0	0.1	0.0	0.7	0.0	0.2	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	3.6	4.4	0.5	5.9	3.4	4.9	2.7	4.2	5.5	0.9	0.0	0.0	0.0	0.0	0.0	1.5	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	36.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.0	30.9	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.9	0.2	0.0	0.0	0.0	0.0	0.0
ALKBH1	"ABH, alkB, ALKBH, hABH"	ENSG00000100601	"AlkB homolog 1, histone H2A dioxygenase"	Q13686	14	77672404-77708020	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"DNA damage, DNA repair, RNA repair, Translation regulation"	"Dioxygenase, Lyase, Multifunctional enzyme, Oxidoreductase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA044087, HPA060061"	Approved		Supported	"Nucleoplasm,Endoplasmic reticulum"	"Intracellular and membrane"	NA	NA			Nucleoplasm	"Endoplasmic reticulum"	"HPA044087: AB_2678803, HPA060061: "	"unprognostic (1.92e-2)"	"unprognostic (8.38e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.37e-3)"	"unprognostic (3.41e-2)"	"unprognostic (5.03e-2)"	"unprognostic (3.74e-3)"	"unprognostic (7.45e-3)"	"unprognostic (2.68e-2)"	"unprognostic (3.95e-2)"	"unprognostic (5.05e-3)"	"unprognostic (2.16e-2)"	"prognostic favorable (1.80e-4)"	"unprognostic (1.65e-3)"	"unprognostic (1.46e-1)"	"unprognostic (2.63e-1)"	"unprognostic (2.44e-2)"	8.2	8.5	6.2	6.7	8.6	2.7	9.7	9.6	8.8	9.7	9.1	8.2	4.5	6.5	7.0	5.9	7.1	8.0	5.8	11.1	5.4	5.7	7.9	9.4	5.9	8.3	6.5	3.7	8.3	7.9	8.4	11.2	10.2	6.4	9.3	9.1	9.9	7.2	8.7	16.5	8.2	6.7	7.8	5.5	8.3	7.8	9.9	6.6	12.7	8.8	6.5	10.3	8.5	9.4	5.4	4.9	11.4	5.7	5.2	5.3	3.2	5.3	8.0	6.5	4.4	7.0	7.7	8.2	5.6	7.3	12.4	14.0	8.1	3.3	8.3	3.2	5.1	5.8	4.9	14.2	6.1	14.7	5.6	5.6	4.4	4.7	6.8	9.9	4.6	2.9	6.5	10.1	7.3	11.6	5.5	10.1	6.5	6.8	4.8	6.6	8.5	6.2	6.0	7.2	8.1	10.3	6.2	6.6	5.5	7.1	4.8	8.4	6.3	4.6	4.8	6.1	5.6	11.8	4.8	4.6	5.2	5.3	5.7	4.5	6.0	9.5	8.1	3.5	6.7	5.1	11.4	5.0	2.2	5.0	5.7	4.3	5.4	4.7	5.0	4.9	4.9	5.0	3.9	1.4	5.2	3.8	2.6	5.3	3.2	6.2	8.6	9.6	8.8	5.4	5.7	6.5	3.7	6.4	6.6	0.0	4.6	3.7	4.9	7.4	4.0	6.5	0.0	5.3	3.4	1.8	2.0	8.9	8.3	5.3	3.3	4.1	4.2	0.0	6.1	6.7	6.0	3.8	9.2	3.0	6.5	0.0	2.4	3.1	4.6	3.1	6.1	5.6	5.0	5.4	4.6	7.3	5.7	0.0	4.9	5.1	4.9	6.5	5.2	15.8	14.9	4.6	10.2	4.4	4.2	3.0
ALKBH2	"ABH2, MGC90512"	ENSG00000189046	"AlkB homolog 2, alpha-ketoglutarate dependent dioxygenase"	Q6NS38	12	109088188-109093631	"Enzymes, Predicted intracellular proteins"	"DNA damage, DNA repair"	"Dioxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB011198, HPA045392, HPA051976"	Approved		Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"CAB011198: AB_261971, HPA045392: AB_2679309, HPA051976: AB_2681680"	"prognostic favorable (6.67e-5)"	"unprognostic (3.66e-3)"	"unprognostic (1.08e-1)"	"unprognostic (4.64e-2)"	"unprognostic (4.55e-2)"	"unprognostic (4.71e-2)"	"unprognostic (1.69e-1)"	"unprognostic (9.60e-2)"	"unprognostic (3.63e-1)"	"unprognostic (1.85e-1)"	"unprognostic (6.39e-2)"	"unprognostic (6.43e-3)"	"prognostic unfavorable (1.41e-5)"	"unprognostic (1.01e-2)"	"unprognostic (7.88e-2)"	"unprognostic (6.24e-2)"	"prognostic favorable (8.67e-4)"	16.1	12.3	13.6	16.9	13.4	8.2	22.3	12.7	20.5	12.9	11.7	15.2	14.6	9.0	18.0	14.2	14.1	18.3	12.2	12.3	13.5	12.3	12.0	25.6	9.8	17.0	14.3	8.9	23.1	18.5	7.1	7.8	8.1	15.7	15.0	10.7	10.8	18.9	18.5	20.0	25.0	10.7	15.9	15.4	12.3	12.6	14.3	13.5	11.3	13.9	19.7	16.5	15.5	13.8	16.9	13.1	1.1	6.7	9.0	18.2	6.9	13.0	22.4	12.8	28.6	9.0	12.3	20.4	8.7	5.8	9.2	10.3	23.5	9.4	20.1	8.7	5.0	4.3	9.5	21.5	8.7	5.4	17.9	19.2	10.0	12.7	21.4	12.0	13.8	9.4	12.6	19.0	8.7	22.4	11.4	3.5	19.4	14.8	12.0	6.1	23.0	12.7	27.8	17.7	13.8	22.8	11.3	12.5	21.6	12.2	18.2	13.2	22.8	9.2	30.0	18.2	5.0	18.4	8.5	3.6	10.3	11.2	9.7	12.8	16.9	19.6	43.8	8.8	12.0	16.4	1.1	5.1	0.7	8.0	6.7	14.1	16.2	12.1	11.2	5.1	16.9	18.2	10.7	0.9	9.0	4.3	13.1	9.0	6.9	13.6	13.4	12.7	20.5	13.5	12.3	14.3	8.9	15.7	13.5	8.9	4.6	11.9	40.0	45.2	4.3	5.9	10.2	13.4	18.2	8.7	2.0	14.2	13.3	16.1	10.1	14.7	2.6	0.0	20.7	22.0	18.8	11.8	5.8	19.2	9.1	4.8	8.1	4.9	7.1	4.9	24.7	7.4	25.3	3.6	10.2	10.0	18.9	2.9	16.3	14.6	6.4	0.0	27.8	8.8	28.1	52.4	4.2	11.5	14.5	23.5
ALKBH3	DEPC-1	ENSG00000166199	"AlkB homolog 3, alpha-ketoglutaratedependent dioxygenase"	Q96Q83	11	43880811-43920266	"Enzymes, Predicted intracellular proteins"	"DNA damage, DNA repair"	"Dioxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Early spermatids: 78.8;Late spermatids: 69.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"							"Low region specificity"	"Detected in all"			"HPA009674, HPA046489"	Approved		Supported	Nucleoplasm,Mitochondria		NA	NA			Nucleoplasm	Mitochondria	"HPA009674: AB_1850460, HPA046489: AB_2679671"	"unprognostic (3.53e-1)"	"unprognostic (2.41e-1)"	"unprognostic (7.43e-3)"	"unprognostic (4.70e-2)"	"unprognostic (6.94e-3)"	"unprognostic (1.89e-1)"	"unprognostic (7.71e-2)"	"unprognostic (5.42e-2)"	"unprognostic (8.56e-2)"	"unprognostic (4.62e-1)"	"unprognostic (5.87e-2)"	"unprognostic (7.02e-2)"	"unprognostic (2.09e-2)"	"unprognostic (1.22e-1)"	"unprognostic (2.31e-1)"	"unprognostic (2.76e-1)"	"unprognostic (1.35e-2)"	17.6	14.2	14.3	13.2	16.7	8.6	26.5	21.2	22.7	19.1	15.7	19.5	12.8	13.2	22.6	31.2	16.2	20.0	16.4	12.5	14.3	13.4	15.6	25.8	15.1	17.3	15.0	14.4	21.8	23.5	22.1	16.6	9.1	15.6	19.1	16.6	19.5	25.5	19.1	29.1	20.2	15.0	18.3	14.8	17.8	17.0	17.3	12.1	14.5	16.4	21.4	22.2	15.2	17.4	14.9	18.5	21.2	21.0	17.1	21.3	13.8	7.4	13.0	5.2	0.0	10.1	13.0	0.0	9.1	20.2	18.3	18.0	6.1	5.8	1.1	5.8	13.7	9.9	10.2	7.1	15.7	17.0	0.0	24.9	10.9	8.8	12.8	25.1	20.0	14.6	13.7	27.3	8.1	39.4	7.6	13.1	21.5	15.4	11.9	9.0	8.9	17.9	10.3	9.5	7.9	19.1	5.2	11.2	14.0	11.0	11.7	9.7	7.8	7.0	11.1	16.7	4.8	16.1	12.3	9.2	10.4	5.8	17.0	13.0	10.8	11.3	12.1	15.5	8.5	8.5	21.2	12.9	7.1	17.0	14.1	16.2	14.4	17.4	15.1	18.5	14.9	21.3	18.9	2.3	17.1	21.0	16.3	16.2	13.8	14.3	16.7	21.2	22.7	14.3	13.4	15.0	14.4	15.6	12.1	14.9	10.4	11.1	9.1	9.2	10.0	5.6	12.7	16.0	10.3	15.7	3.9	3.1	26.6	17.0	78.8	13.7	9.2	0.0	28.4	4.0	9.7	6.6	7.0	11.3	16.7	9.5	9.1	14.7	10.7	69.5	15.0	13.1	16.9	15.4	12.7	17.2	23.0	7.0	9.9	14.1	10.5	6.5	19.6	18.7	9.5	6.1	1.8	14.9	13.1	5.0
ALKBH8	"MGC10235, TRM9, TRMT9A"	ENSG00000137760	"AlkB homolog 8, tRNA methyltransferase"	Q96BT7	11	107502726-107565746	"Enzymes, Predicted intracellular proteins"		"Methyltransferase, Multifunctional enzyme, Oxidoreductase, RNA-binding, Transferase"	"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038724, HPA038725, HPA061514"	Approved		Supported	"Nucleoplasm,Nuclear bodies"		NA	NA			"Nuclear bodies"	Nucleoplasm	"HPA038724: AB_2676176, HPA038725: AB_10674838, HPA061514: AB_2684547"	"unprognostic (2.66e-2)"	"unprognostic (3.82e-1)"	"unprognostic (8.19e-2)"	"unprognostic (3.76e-1)"	"unprognostic (4.04e-2)"	"unprognostic (2.97e-1)"	"unprognostic (1.22e-2)"	"unprognostic (1.95e-1)"	"unprognostic (4.45e-2)"	"unprognostic (7.67e-2)"	"unprognostic (1.89e-2)"	"unprognostic (7.95e-2)"	"unprognostic (2.81e-1)"	"unprognostic (2.03e-1)"	"unprognostic (2.04e-1)"	"unprognostic (2.34e-3)"	"unprognostic (1.01e-1)"	9.7	6.7	7.2	14.1	12.6	6.1	11.3	9.9	11.7	8.6	7.4	7.6	9.4	6.7	9.5	7.1	9.8	7.4	6.0	12.4	7.4	7.6	9.2	9.5	7.5	11.5	7.2	5.5	9.9	7.0	13.4	10.0	6.9	7.9	8.9	7.9	8.1	7.7	7.5	12.6	9.7	7.8	9.0	7.0	10.8	6.8	5.8	5.8	9.2	11.1	5.7	12.0	8.9	8.1	3.7	3.3	0.5	4.1	4.8	6.2	2.2	4.9	6.0	6.3	6.8	3.5	7.8	5.2	9.6	7.1	7.1	7.7	11.1	9.1	11.6	5.5	9.1	9.7	8.9	9.3	7.7	9.2	10.3	6.2	9.7	2.4	5.1	5.2	12.3	12.0	4.8	8.8	9.1	11.6	3.6	8.7	9.1	13.7	3.9	5.6	4.4	11.1	6.2	8.3	9.6	10.0	10.2	9.7	8.0	5.6	5.4	5.7	6.4	5.5	4.1	4.0	3.9	6.8	3.7	8.2	15.4	9.2	5.0	11.8	3.6	3.9	9.1	4.3	8.3	15.1	0.0	2.0	0.5	4.5	4.1	4.3	1.9	3.3	3.9	3.3	3.7	6.2	5.2	0.0	4.8	2.7	2.0	3.5	2.2	7.2	12.6	9.9	11.7	7.4	7.6	7.2	5.5	7.9	5.8	0.0	4.0	2.9	1.7	1.8	5.9	10.0	7.6	0.0	4.5	1.8	5.9	1.8	0.0	1.8	0.2	2.2	1.1	0.0	2.9	2.3	3.4	1.1	9.3	6.4	2.4	1.6	1.2	4.3	2.5	0.0	2.6	2.2	3.3	3.6	3.0	2.5	1.9	4.0	3.9	2.6	3.5	0.0	2.3	1.7	2.9	3.6	0.7	5.0	3.8	0.6
ALOX12	12S-LOX	ENSG00000108839	"Arachidonate 12-lipoxygenase, 12S type"	P18054	17	6996065-7010736	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Fatty acid metabolism, Lipid metabolism"	"Dioxygenase, Hydrolase, Oxidoreductase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"cervix, uterine: 28.6;esophagus: 28.4;tongue: 22.7;vagina: 42.7"	"Group enriched"	"Detected in some"	6	"Cardiomyocytes: 1.8;Suprabasal keratinocytes: 1.0;Urothelial cells: 1.7"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"neutrophil: 4.8"	"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"A-431: 17.5;HEL: 28.0"	"Region enriched"	"Detected in single"	5	"olfactory region: 5.4"					"HPA010691, CAB019287, HPA064819"	Enhanced		Supported	"Nuclear speckles,Vesicles,Cytosol"		NA	NA		5800000	Cytosol	"Nuclear speckles, Vesicles"	"CAB019287: , HPA010691: AB_1844756, HPA064819: "	"unprognostic (3.61e-3)"	"unprognostic (6.93e-2)"	"unprognostic (7.17e-5)"	"unprognostic (9.43e-2)"	"unprognostic (6.06e-2)"	"unprognostic (2.25e-3)"	"unprognostic (2.45e-1)"	"unprognostic (3.16e-1)"	"unprognostic (3.02e-2)"	"unprognostic (1.59e-2)"	"unprognostic (3.96e-5)"	"unprognostic (4.01e-3)"	"unprognostic (2.25e-2)"	"unprognostic (1.56e-1)"	"unprognostic (2.87e-1)"	"unprognostic (5.90e-2)"	"unprognostic (3.47e-2)"	0.3	0.6	0.3	1.5	0.4	2.0	0.3	0.3	1.0	28.6	0.4	0.3	0.3	0.7	3.4	0.5	28.4	0.4	1.6	0.8	0.3	0.1	0.3	0.3	0.5	1.9	0.5	0.3	0.4	0.8	0.0	0.3	0.7	0.4	0.3	0.0	0.4	8.1	0.3	0.5	12.8	0.8	0.3	0.3	1.5	0.3	0.6	0.3	0.3	0.8	22.7	9.5	1.2	42.7	1.1	1.3	4.8	0.9	0.7	0.8	14.3	17.5	2.9	1.3	1.0	0.0	0.0	1.2	1.1	0.0	0.0	0.0	2.6	0.6	0.9	0.6	0.0	1.0	2.2	0.0	0.1	0.0	1.9	2.3	28.0	3.9	1.9	0.1	0.2	4.6	0.0	0.0	0.0	0.0	1.7	0.0	1.9	1.8	1.0	0.0	0.2	0.3	0.6	0.9	0.1	0.6	1.0	0.6	0.4	0.0	2.2	0.1	0.6	0.5	0.6	0.2	1.8	1.0	0.7	3.2	1.5	0.9	1.5	0.7	0.5	0.2	0.5	0.9	2.1	0.7	1.8	0.9	1.7	0.7	0.5	0.5	1.1	0.5	0.8	0.7	0.7	0.2	0.4	4.8	0.7	0.4	1.3	0.3	14.3	0.3	0.4	0.3	0.6	0.3	0.1	0.5	0.3	0.4	0.3	0.0	0.0	0.0	0.0	0.1	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	1.0	0.0	0.0	0.0	1.7
ALOX15	15-LOX-1	ENSG00000161905	"Arachidonate 15-lipoxygenase"	P16050	17	4630902-4642294	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Fatty acid metabolism, Lipid metabolism"	"Dioxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 27.9;blood: 89.8;lung: 24.4"	"Cell type enriched"	"Detected in some"	15	"Ciliated cells: 210.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Cell type enriched"	"Detected in single"	183	"eosinophil: 89.8"	"Lineage enriched"	"Detected in single"	183	"granulocytes: 89.8"	"Group enriched"	"Detected in some"	7	"HMC-1: 16.5;MCF7: 14.3;T-47d: 4.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"CAB004962, CAB004963, HPA013859"	Approved					NA	NA					"CAB004962: , CAB004963: , HPA013859: AB_1844758"	"unprognostic (5.31e-4)"	"unprognostic (1.43e-2)"	"unprognostic (2.81e-2)"	"unprognostic (8.36e-3)"	"unprognostic (2.22e-1)"	"unprognostic (8.60e-2)"	"unprognostic (2.36e-1)"	"unprognostic (2.66e-2)"	"unprognostic (1.70e-2)"	"unprognostic (1.84e-2)"	"unprognostic (2.51e-2)"	"unprognostic (3.77e-1)"	"unprognostic (1.31e-3)"	"unprognostic (1.88e-2)"	"unprognostic (1.30e-1)"	"unprognostic (2.78e-1)"	"unprognostic (1.59e-1)"	27.9	0.1	0.2	4.5	1.1	0.2	4.2	0.2	0.3	0.5	2.8	0.2	0.2	1.9	0.2	8.1	0.4	14.4	1.5	2.7	0.3	0.4	0.2	1.7	24.4	1.7	0.5	0.2	3.0	0.2	0.0	6.3	1.5	0.4	0.3	0.9	0.2	1.0	0.2	0.2	2.2	3.7	0.5	0.7	1.1	1.0	1.4	0.4	2.0	0.2	0.2	0.4	1.9	0.2	0.0	0.4	89.8	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.4	0.0	0.6	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.2	0.1	0.0	16.5	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.2	0.0	14.3	0.0	0.3	1.2	1.4	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	4.4	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.5	0.0	0.1	0.0	0.0	0.0	89.8	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.2	1.1	0.2	0.3	0.3	0.4	0.5	0.2	0.4	0.4	0.0	0.6	0.0	0.0	1.3	0.0	0.4	0.0	210.1	5.7	0.0	0.0	1.6	0.0	0.0	13.6	0.0	0.0	0.0	0.0	0.1	0.2	0.1	1.1	0.0	0.4	0.0	0.0	0.0	0.0	1.3	0.0	0.6	0.0	6.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	1.1	0.6	6.2	0.0	0.0	0.2
ALOX15B	15-LOX-2	ENSG00000179593	"Arachidonate 15-lipoxygenase, type B"	O15296	17	8039017-8049134	"Enzymes, Predicted intracellular proteins"	"Lipid metabolism"	"Dioxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"breast: 57.4;esophagus: 30.6;lung: 44.0;prostate: 35.9"	"Cell type enhanced"	"Detected in many"	26	"Alveolar cells type 2: 58.0;Kupffer cells: 33.3;monocytes: 149.7"	"Cancer enhanced"	"Detected in all"		"prostate cancer: 91.2"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	9	"classical monocyte: 6.1;myeloid DC: 6.8"	"Group enriched"	"Detected in many"	9	"dendritic cells: 6.8;monocytes: 6.1"	"Cell line enhanced"	"Detected in some"		"HHSteC: 6.1;HSkMC: 13.0;hTCEpi: 26.8"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			HPA010562	Enhanced		Supported	"Plasma membrane,Cytosol"		NA	NA			"Plasma membrane, Cytosol"		"HPA010562: AB_2668305"	"unprognostic (1.76e-2)"	"unprognostic (6.47e-2)"	"unprognostic (2.56e-1)"	"unprognostic (2.28e-3)"	"unprognostic (1.67e-2)"	"unprognostic (1.52e-1)"	"unprognostic (1.34e-1)"	"unprognostic (1.52e-1)"	"unprognostic (2.28e-1)"	"unprognostic (1.85e-1)"	"unprognostic (1.44e-2)"	"unprognostic (4.59e-1)"	"unprognostic (1.59e-2)"	"unprognostic (9.37e-2)"	"unprognostic (1.48e-1)"	"unprognostic (2.32e-2)"	"unprognostic (9.49e-2)"	8.9	0.6	0.4	0.7	0.6	0.3	57.4	0.1	0.4	7.6	4.6	0.1	0.0	0.2	0.3	0.7	30.6	0.8	0.5	0.2	1.3	0.0	2.9	0.7	44.0	7.1	1.8	0.3	0.8	0.8	0.2	0.9	0.7	1.3	35.9	0.3	0.1	3.6	0.2	0.3	15.4	1.9	0.2	4.1	3.1	1.6	1.0	2.0	0.5	0.8	6.6	4.1	1.1	12.9	0.0	6.8	0.2	6.1	0.7	0.0	1.7	0.0	0.0	0.0	0.0	0.4	0.6	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.8	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	6.1	0.0	0.0	13.0	26.8	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.8	0.0	0.0	0.0	0.2	0.7	0.0	0.2	0.0	1.7	0.4	0.6	0.1	0.4	1.3	0.0	1.8	0.3	1.3	2.0	0.0	58.0	0.0	0.5	2.7	0.0	0.3	2.5	2.7	2.3	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.3	0.0	0.1	16.8	1.1	0.0	4.1	0.0	0.0	1.3	33.3	0.0	0.0	1.9	5.0	149.7	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.7	0.7	1.0	0.7	0.0	0.0	1.8
ALOX5	5-LOX	ENSG00000012779	"Arachidonate 5-lipoxygenase"	P09917	10	45374176-45446119	"Enzymes, FDA approved drug targets, Predicted intracellular proteins"	"Leukotriene biosynthesis"	"Dioxygenase, Hydrolase, Oxidoreductase"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 45.2;bone marrow: 39.9;lymphoid tissue: 41.8"	"Cell type enhanced"	"Detected in many"	13	"granulocytes: 194.3;Hofbauer cells: 78.7;Kupffer cells: 81.6;Macrophages: 81.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"BEWO: 7.9;CAPAN-2: 6.1;Daudi: 22.3;HMC-1: 16.0;Karpas-707: 7.0;RT4: 10.5;U-266/70: 10.5;U-698: 7.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA071285	Enhanced		Supported	Nucleoplasm		NA	NA			Nucleoplasm		"HPA071285: AB_2686379"	"unprognostic (2.57e-2)"	"unprognostic (2.81e-1)"	"unprognostic (4.82e-2)"	"unprognostic (1.75e-2)"	"unprognostic (7.98e-3)"	"unprognostic (1.26e-1)"	"unprognostic (5.32e-2)"	"unprognostic (8.69e-2)"	"unprognostic (1.86e-2)"	"unprognostic (6.91e-2)"	"unprognostic (5.04e-2)"	"unprognostic (3.42e-1)"	"prognostic unfavorable (1.80e-5)"	"unprognostic (5.59e-3)"	"unprognostic (4.22e-2)"	"unprognostic (1.53e-1)"	"prognostic favorable (7.18e-4)"	7.4	3.9	2.9	18.3	7.4	39.9	5.8	13.2	3.2	3.4	6.5	6.4	1.0	4.5	3.2	4.7	4.9	5.4	8.0	6.1	3.9	2.6	4.8	2.6	34.7	36.9	9.0	1.7	2.6	10.0	1.3	1.7	11.2	6.1	7.8	3.4	3.2	6.6	3.4	1.1	2.9	14.4	7.8	8.4	41.8	4.5	2.0	6.2	2.4	3.0	1.4	16.7	27.2	10.5	14.8	11.1	45.2	21.3	0.0	0.5	9.5	0.0	0.0	0.0	0.0	0.0	0.0	7.9	0.0	0.0	0.0	0.0	0.0	6.1	22.3	0.8	0.0	0.0	0.3	0.2	0.0	0.0	0.4	0.2	4.3	0.0	0.0	0.0	0.0	16.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	7.0	0.0	0.0	0.0	0.3	0.0	1.0	0.0	0.1	0.0	0.8	0.3	10.5	0.5	0.0	0.0	0.2	0.0	0.1	0.1	0.5	0.0	0.0	1.2	0.0	0.0	10.5	1.9	7.4	0.0	0.1	0.0	36.7	21.3	27.0	0.0	20.0	0.1	14.8	0.5	0.2	11.1	10.4	0.0	0.0	45.2	0.0	19.6	0.3	0.1	9.5	2.9	7.4	13.2	3.2	3.9	2.6	9.0	1.7	6.1	6.2	14.9	58.3	34.9	5.4	1.0	0.8	2.0	15.3	4.0	12.5	8.7	2.0	0.5	0.0	19.2	0.4	0.7	2.1	0.0	18.9	1.4	0.6	3.3	194.3	0.6	78.7	0.0	6.8	2.5	81.6	1.1	0.3	81.2	0.0	18.0	0.7	0.3	17.8	0.0	0.0	0.0	0.2	12.9	0.7	0.4	0.8	1.3	3.4	1.3	0.4	35.5
ALOXE3	"E-LOX, eLOX3"	ENSG00000179148	"Arachidonate lipoxygenase 3"	Q9BYJ1	17	8095900-8119047	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Fatty acid metabolism, Lipid metabolism"	"Dioxygenase, Isomerase, Lyase, Oxidoreductase"	"Disease mutation, Ichthyosis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	11	"skin 1: 30.2"	"Cell type enhanced"	"Detected in some"	12	"Basal glandular cells: 1.6;Glandular cells: 2.0;Pancreatic endocrine cells: 3.6;Spermatogonia: 1.5;Suprabasal keratinocytes: 1.6"	"Cancer enhanced"	"Detected in some"		"head and neck cancer: 3.9"	"Group enriched"	"Detected in many"	8	"basal ganglia: 1.1;cerebellum: 1.4;cerebral cortex: 2.3;pons and medulla: 1.1"	"Group enriched"	"Detected in some"	5	"gdT-cell: 1.0;naive CD4 T-cell: 2.7"	"Lineage enriched"	"Detected in single"	28	"T-cells: 2.7"	"Cell line enhanced"	"Detected in some"		"A-431: 6.6;HBEC3-KT: 10.8;hTCEpi: 8.0;hTERT-HME1: 15.1;T-47d: 4.8"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"HPA023120, HPA078597"	Enhanced		Approved	"Plasma membrane,Cytosol"		NA	NA			"Plasma membrane, Cytosol"		"HPA023120: AB_10959300, HPA078597: AB_2732385"	"unprognostic (2.40e-1)"	"unprognostic (3.01e-2)"	"unprognostic (1.87e-3)"	"unprognostic (2.09e-4)"	"unprognostic (1.07e-2)"	"unprognostic (4.06e-2)"		"unprognostic (3.56e-4)"	"unprognostic (3.60e-1)"	"unprognostic (4.65e-2)"	"unprognostic (3.82e-2)"	"unprognostic (3.72e-1)"	"unprognostic (3.66e-5)"	"unprognostic (9.81e-2)"	"unprognostic (2.55e-1)"	"unprognostic (1.08e-2)"	"unprognostic (2.88e-2)"	0.1	0.0	0.1	0.1	1.1	0.0	1.6	1.4	2.3	1.2	0.1	0.1	0.1	0.0	0.1	0.1	0.3	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	1.1	0.1	0.0	0.1	0.1	0.1	0.1	30.2	0.1	0.1	0.1	0.1	0.0	0.4	0.1	0.1	0.1	0.1	1.0	0.1	0.8	0.0	0.0	0.0	0.0	0.0	2.7	0.2	6.6	0.8	0.0	0.0	0.0	0.0	0.0	0.5	0.5	0.1	0.4	0.1	0.5	0.2	0.2	0.1	3.2	0.5	0.9	10.8	0.1	0.0	0.4	0.0	0.2	0.0	0.0	0.0	0.0	0.0	8.0	0.2	15.1	0.0	0.0	1.0	0.0	0.1	0.0	2.4	0.0	0.0	0.0	0.2	2.2	0.0	0.0	0.0	0.1	0.3	0.0	0.1	0.0	0.7	0.0	0.0	4.8	0.0	0.1	0.0	2.3	0.0	0.3	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	2.7	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.1	1.1	1.4	2.3	0.1	0.1	0.1	0.1	1.1	0.1	0.0	0.0	0.0	1.6	0.2	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.0	0.0	0.0	0.8	0.9	0.0	2.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	3.6	0.0	0.0	0.0	0.0	0.0	0.1	0.5	1.5	1.6	0.9	0.0	0.0	0.7
ALPI		ENSG00000163295	"Alkaline phosphatase, intestinal"	P09923	2	232456123-232460032	"Enzymes, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	406	"intestine: 133.2"	"Group enriched"	"Detected in some"	6	"Enterocytes: 45.5;Paneth cells: 17.5"	"Cancer enhanced"	"Detected in many"		"liver cancer: 4.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	12	"CACO-2: 12.7"									"HPA038764, HPA038765, HPA051699"	Supported		Approved	"Plasma membrane"	"Intracellular and membrane"	NA	NA			"Plasma membrane"		"HPA038764: AB_2676194, HPA038765: AB_2676195, HPA051699: AB_2681577"			"unprognostic (1.01e-1)"	"unprognostic (7.71e-2)"			"unprognostic (4.14e-2)"			"unprognostic (1.47e-1)"	"unprognostic (9.57e-4)"		"unprognostic (8.07e-2)"	"unprognostic (1.71e-1)"	"unprognostic (9.99e-2)"			0.1	0.1	0.1	0.2	0.1	0.0	0.1	0.1	0.1	0.1	63.0	0.0	0.0	57.3	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.3	0.1	0.1	0.0	0.1	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.1	1.3	0.0	0.1	0.0	0.1	0.1	133.2	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	12.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.2	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	45.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.9	0.0	0.0	17.5	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.1	0.0
ALPK1	"FLJ22670, KIAA1527, Lak"	ENSG00000073331	"Alpha kinase 1"	Q96QP1	4	112285509-112442620	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Immunity, Innate immunity"	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"neutrophil: 16.3"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in many"							"HPA027435, HPA027443"	Approved		Approved	Centrosome		NA	NA			Centrosome		"HPA027435: AB_10599614, HPA027443: AB_10599421"	"unprognostic (6.24e-2)"	"unprognostic (1.92e-1)"	"unprognostic (9.30e-2)"	"unprognostic (1.69e-2)"	"unprognostic (7.40e-2)"	"unprognostic (5.45e-2)"	"unprognostic (2.55e-2)"	"unprognostic (7.47e-2)"	"unprognostic (2.34e-1)"	"unprognostic (1.38e-1)"	"unprognostic (7.14e-2)"	"unprognostic (2.78e-1)"	"prognostic unfavorable (5.82e-7)"	"unprognostic (1.60e-1)"	"unprognostic (4.17e-2)"	"unprognostic (2.81e-1)"	"prognostic favorable (1.17e-4)"	15.1	10.6	5.3	8.3	7.7	17.3	9.3	1.3	5.9	10.8	9.5	5.8	3.0	4.5	9.8	9.2	8.8	9.2	7.5	6.1	6.1	2.3	10.8	13.4	13.2	11.4	9.7	1.0	17.4	9.7	11.0	14.0	11.5	6.6	14.0	7.8	9.6	10.4	6.8	5.0	11.8	12.1	11.3	16.6	16.2	7.4	4.2	8.5	13.7	12.4	4.7	13.7	13.6	11.6	0.9	3.2	16.3	4.3	0.4	0.8	1.2	1.6	5.0	1.6	0.3	6.6	10.6	2.0	1.9	3.5	2.6	3.3	0.5	7.7	5.1	3.3	3.3	5.3	1.1	1.7	3.0	3.9	6.5	1.7	3.6	2.0	0.4	10.6	2.2	2.2	13.1	8.6	3.8	7.9	5.9	1.0	2.7	0.9	8.9	5.0	3.1	1.3	2.0	0.4	3.7	1.3	0.6	1.1	1.6	3.9	1.9	0.5	0.8	1.8	6.6	2.9	0.3	3.0	4.1	1.9	2.4	2.1	3.7	1.3	2.3	0.7	4.4	5.7	4.6	2.1	1.3	3.2	1.4	0.2	4.3	0.6	0.8	0.6	0.1	3.2	0.9	0.8	0.6	16.3	0.4	1.9	0.5	0.0	1.2	5.3	7.7	1.3	5.9	6.1	2.3	9.7	1.0	6.6	8.5	11.9	20.3	0.9	9.4	2.6	0.2	3.1	0.0	20.1	13.6	5.2	0.0	4.0	0.0	5.6	7.5	5.5	7.0	0.0	5.8	2.6	4.1	7.1	5.8	5.8	8.7	0.0	1.2	5.5	14.8	1.6	3.4	14.0	6.8	10.0	8.5	11.3	6.3	8.6	7.1	4.0	0.2	6.5	5.1	0.7	0.5	4.0	6.1	2.2	5.7	10.3
ALPK2	HAK	ENSG00000198796	"Alpha kinase 2"	Q86TB3	18	58481247-58628957	"Cancer-related genes, Enzymes, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"heart muscle: 35.3;skeletal muscle: 35.3;tongue: 12.4"	"Cell type enhanced"	"Detected in some"	19	"Cardiomyocytes: 79.2;Cone photoreceptor cells: 45.2;monocytes: 31.5"	"Cancer enriched"	"Detected in some"	6	"renal cancer: 7.3"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"non-classical monocyte: 1.8"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"BJ: 26.6;BJ hTERT+: 16.2;fHDF/TERT166: 24.0;U-138 MG: 13.5"	"Region enhanced"	"Detected in single"		"cerebellum: 1.1"	"Not detected"	"Not detected"			"HPA027377, HPA027976, HPA028084, HPA029801"	Uncertain		Approved	Cytosol		NA	NA			Cytosol		"HPA027377: AB_10600635, HPA027976: AB_10611246, HPA028084: AB_10601996, HPA029801: AB_10602006"	"unprognostic (7.35e-2)"	"unprognostic (4.91e-2)"	"unprognostic (1.64e-1)"	"unprognostic (4.60e-3)"	"unprognostic (2.64e-1)"	"unprognostic (8.27e-2)"	"unprognostic (1.22e-1)"	"unprognostic (1.41e-1)"	"unprognostic (3.44e-1)"	"unprognostic (1.06e-1)"	"unprognostic (5.13e-2)"	"unprognostic (1.33e-2)"	"prognostic unfavorable (8.20e-5)"	"unprognostic (5.27e-3)"	"unprognostic (2.50e-1)"	"unprognostic (4.73e-2)"	"unprognostic (3.20e-2)"	0.8	0.0	0.1	2.8	0.1	0.0	0.1	0.1	0.2	0.1	0.1	0.1	0.1	0.0	0.1	0.9	0.8	0.0	0.4	35.3	0.1	0.0	5.2	2.8	0.1	3.3	0.1	0.1	0.1	0.1	0.0	0.1	0.5	0.1	0.1	0.0	0.2	0.4	0.1	35.3	0.3	0.6	0.1	0.1	0.2	1.2	0.6	0.1	5.5	0.3	12.4	7.9	0.5	0.1	0.0	0.5	0.0	1.8	0.0	0.3	0.0	0.0	7.0	0.5	0.0	0.2	1.8	0.1	26.6	16.2	11.2	9.7	1.7	0.0	0.0	2.8	24.0	1.5	0.0	0.0	0.0	11.5	5.8	0.0	0.0	2.2	0.9	1.5	0.0	0.0	1.6	0.0	3.4	0.1	0.3	0.0	0.0	0.0	0.2	7.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	5.9	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.0	4.5	0.0	0.0	0.0	13.5	6.0	1.8	4.5	10.9	9.4	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.1	0.0	0.0	1.8	0.5	0.1	0.0	0.1	0.1	0.1	0.2	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.0	79.2	0.0	0.0	0.0	0.0	45.2	0.0	1.7	0.4	14.2	0.0	0.0	0.0	0.6	0.0	0.7	0.1	0.0	2.4	0.5	1.6	0.0	0.6	0.0	15.3	0.3	0.9	0.0	31.5	0.0	2.9	0.3	0.2	0.0	9.8	0.5	0.0	0.0	0.2	0.1	0.6	0.1	0.0	0.0	0.0
ALPK3	"KIAA1330, MAK, Midori"	ENSG00000136383	"Alpha kinase 3"	Q96L96	15	84816680-84873482	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		"Developmental protein, Kinase, Serine/threonine-protein kinase, Transferase"	"Cardiomyopathy, Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 18.4;skeletal muscle: 47.6"	"Cell type enhanced"	"Detected in many"	13	"Cardiomyocytes: 52.4;Cholangiocytes: 20.4;Exocrine glandular cells: 17.3"	"Low cancer specificity"	"Detected in many"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 9.5;HDLM-2: 7.1;HUVEC TERT2: 10.2;LHCN-M2: 13.9;NTERA-2: 8.5;RH-30: 25.0;THP-1: 6.1"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			HPA026558	Uncertain		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA026558: AB_1844774"	"unprognostic (2.69e-2)"	"unprognostic (1.42e-1)"	"unprognostic (2.71e-2)"	"unprognostic (4.61e-2)"	"unprognostic (2.08e-1)"	"unprognostic (6.53e-2)"	"unprognostic (1.44e-3)"	"unprognostic (1.42e-1)"	"unprognostic (1.68e-2)"	"unprognostic (1.82e-1)"	"unprognostic (1.74e-3)"	"unprognostic (1.23e-1)"	"prognostic favorable (3.95e-7)"	"unprognostic (1.76e-2)"	"unprognostic (1.77e-1)"	"unprognostic (2.96e-2)"	"unprognostic (4.87e-2)"	3.7	1.8	0.0	0.0	0.0	0.0	0.7	0.0	0.1	0.5	1.4			0.0	0.1	1.7	0.8	0.2	0.3	18.4	0.0	0.6	1.6	1.3	1.0	0.0	0.1		0.0	2.1	8.8	6.9	0.6		0.4	0.0		0.4	0.2	47.6	0.0	0.2	0.8	0.0	0.0	1.2	0.0			0.6		0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	1.1	0.1	0.1	0.1	0.2	0.0	9.5	0.0	0.0	0.0	0.0	0.0	4.1	0.0	0.3	0.0	0.1	0.7	0.0	0.0	0.0	7.1	1.1	1.1	0.2	0.0	0.1	0.0	0.0	0.9	0.1	0.0	0.0	0.1	10.2	0.0	0.0	0.0	13.9	0.5	0.0	0.1	8.5	0.2	0.0	0.0	25.0	0.1	0.0	2.6	0.0	0.1	0.0	1.3	0.0	1.3	0.0	6.1	0.2	0.0	0.0	0.0	0.0	0.2	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0											6.0	2.4	0.5	0.0	0.8	3.1	52.4	20.4	0.0	1.2	8.7	15.7	0.2	0.0	3.1	0.1	4.5	0.0	0.0	17.3	0.6	1.5	0.5	1.1	1.5	7.9	0.0	8.7	2.5	0.3	0.0	0.0	1.9	3.3	8.2	0.3	0.9	13.6	0.2	0.0	1.7	3.0	0.0	8.3	0.2	3.1	0.1	0.6	0.0	0.3	0.8
ALPL	"HOPS, TNSALP"	ENSG00000162551	"Alkaline phosphatase, liver/bone/kidney"	P05186	1	21509372-21578412	"Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	Biomineralization	Hydrolase	"Cancer-related genes, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 73.3;liver: 52.7;lung: 45.1"	"Cell type enhanced"	"Detected in many"	15	"Alveolar cells type 2: 88.5;Hepatocytes: 25.3;Ito cells: 25.8;Proximal tubular cells: 44.8;Rod photoreceptor cells: 28.1"	"Cancer enhanced"	"Detected in all"		"testis cancer: 199.6"	"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	91	"neutrophil: 73.3"	"Lineage enriched"	"Detected in single"	127	"granulocytes: 73.3"	"Cell line enhanced"	"Detected in some"		"HSkMC: 53.1;hTEC/SVTERT24-B: 41.5;LHCN-M2: 30.2;SCLC-21H: 26.4;SuSa: 14.8"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA007105, HPA008765, CAB020829"	Enhanced		Approved	Cytosol	"Intracellular and membrane"	NA	NA		7300000	Cytosol		"CAB020829: , HPA007105: AB_1078137, HPA008765: AB_1078138"	"unprognostic (3.89e-2)"	"unprognostic (1.27e-1)"	"unprognostic (5.57e-2)"	"unprognostic (1.19e-1)"	"prognostic unfavorable (7.57e-4)"	"unprognostic (3.05e-3)"	"unprognostic (6.50e-3)"	"unprognostic (1.01e-1)"	"prognostic unfavorable (7.08e-4)"	"unprognostic (1.17e-2)"	"unprognostic (2.48e-3)"	"unprognostic (1.74e-1)"	"unprognostic (7.28e-2)"	"unprognostic (1.73e-2)"	"unprognostic (2.27e-1)"	"unprognostic (9.70e-3)"	"unprognostic (2.58e-1)"	15.9	22.7	4.5	17.6	6.0	2.6	10.6	2.2	7.8	2.2	2.1	4.1	0.7	1.9	3.7	1.1	2.0	5.7	2.8	10.9	5.7	4.2	29.7	52.7	45.1	28.1	5.3	4.8	1.2	4.3	2.4	4.1	2.2	7.7	2.6	1.3	18.3	3.1	6.6	0.9	1.8	2.7	2.5	3.8	19.6	1.8	2.9	2.7	0.5	3.7	1.7	3.9	7.1	8.4	0.5	0.0	73.3	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.2	2.0	3.3	0.1	0.7	0.2	0.4	0.2	0.0	0.7	2.3	0.0	0.0	0.0	9.1	0.0	0.1	0.0	0.6	0.0	1.1	1.1	0.5	0.0	0.2	53.1	0.0	41.5	0.1	0.0	0.0	0.0	0.0	0.0	30.2	0.0	0.0	0.0	12.1	0.0	0.0	0.0	1.1	0.0	0.0	0.0	26.4	0.3	0.0	0.0	0.1	14.8	0.0	0.0	0.0	1.5	1.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.8	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.1	0.0	0.0	73.3	0.0	0.0	0.0	0.0	0.0	4.5	6.0	2.2	7.8	5.7	4.2	5.3	4.8	7.7	2.7	3.0	88.5	0.5	0.5	0.1	2.6	2.0	0.0	1.4	10.3	0.0	0.0	0.0	6.6	0.0	1.2	7.1	0.0	23.3	0.0	0.3	0.3	1.5	7.0	25.3	0.1	1.6	0.0	25.8	1.0	4.4	0.3	0.1	0.0	0.0	0.0	2.6	0.0	0.0	0.0	44.8	28.1	0.0	1.0	0.3	13.6	0.4	1.3	0.0	0.0	0.3
ALPP		ENSG00000163283	"Alkaline phosphatase, placental"	P05187	2	232378534-232382889	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins"		Hydrolase	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	17	"placenta: 240.2"	"Group enriched"	"Detected in some"	19	"Alveolar cells type 1: 11.9;Club cells: 3.4;Syncytiotrophoblasts: 5.6"	"Cancer enhanced"	"Detected in many"		"endometrial cancer: 15.3"	"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in some"	6	"HaCaT: 88.1;SiHa: 24.3"									"CAB026327, HPA038764, HPA038765, HPA051699"	Enhanced		Approved	"Plasma membrane"	"Intracellular and membrane"	NA	NA			"Plasma membrane"		"CAB026327: , HPA038764: AB_2676194, HPA038765: AB_2676195, HPA051699: AB_2681577"		"unprognostic (4.86e-2)"	"unprognostic (5.19e-3)"	"unprognostic (6.67e-3)"		"unprognostic (2.60e-1)"		"unprognostic (2.44e-3)"		"unprognostic (1.26e-2)"	"prognostic unfavorable (4.33e-4)"	"unprognostic (1.44e-1)"		"unprognostic (4.09e-1)"	"unprognostic (2.12e-1)"		"unprognostic (1.27e-2)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	14.5	0.1	0.0	0.0	0.0	0.1	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	9.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	240.2	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	1.0	0.5	1.6	0.5	1.1	0.5	0.3	0.4	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.1	9.9	0.0	0.0	0.0	0.0	88.1	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	24.3	8.6	0.0	0.8	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.4	0.7	0.5	0.2	0.5	0.3	0.3	0.3	0.1	1.0	0.4	0.4	1.6	1.1	0.5	0.5	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.9	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	3.4	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	5.6	0.0	0.0	0.0
ALPPL2		ENSG00000163286	"Alkaline phosphatase, placental like 2"	P10696	2	232406843-232410714	"Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"		Hydrolase	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"fallopian tube: 4.2;lung: 9.4"	"Cell type enhanced"	"Detected in some"	28	"Alveolar cells type 1: 6.0;Ciliated cells: 1.4;Club cells: 2.3"	"Cancer enhanced"	"Detected in many"		"endometrial cancer: 49.1;testis cancer: 64.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"CAPAN-2: 21.4;HaCaT: 15.7;SuSa: 25.7"									"CAB020698, HPA038764, HPA038765, HPA051699"	Approved		Approved	"Plasma membrane"	"Intracellular and membrane"	NA	NA			"Plasma membrane"		"CAB020698: , HPA038764: AB_2676194, HPA038765: AB_2676195, HPA051699: AB_2681577"		"unprognostic (1.39e-1)"	"unprognostic (6.63e-3)"	"unprognostic (1.27e-2)"		"unprognostic (2.89e-1)"		"unprognostic (1.46e-1)"		"unprognostic (1.26e-1)"	"unprognostic (1.69e-3)"			"unprognostic (1.65e-1)"	"unprognostic (2.67e-1)"		"unprognostic (6.72e-3)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	1.0	0.0	0.0	0.2	1.5	0.0	0.0	4.2	0.0	0.0	0.0	0.0	0.0	0.0	9.4	0.0	0.0	0.0	1.5	0.0	0.0	0.0	1.9	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	1.6	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.3	0.0	0.0	0.0	0.0	0.4	21.4	0.0	0.0	0.0	0.0	15.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	2.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.2	0.0	25.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	1.4	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.1	0.0	0.0	0.0
AMACR	"P504S, RACE"	ENSG00000242110	"Alpha-methylacyl-CoA racemase"	Q9UHK6	5	33986178-34008108	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		Isomerase	"Disease mutation, Intrahepatic cholestasis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 68.0;liver: 63.6"	"Cell type enhanced"	"Detected in many"	10	"Hepatocytes: 17.8;Late spermatids: 18.9;Proximal tubular cells: 33.2"	"Cancer enhanced"	"Detected in all"		"prostate cancer: 34.5"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"U-266/70: 59.8;U-266/84: 31.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB001809, HPA019527, HPA020912"	Enhanced		Supported	"Vesicles,Plasma membrane"		NA	NA		65000	"Vesicles, Plasma membrane"		"CAB001809: AB_2305454, HPA019527: AB_10669651, HPA020912: AB_10670034"	"unprognostic (8.96e-2)"	"unprognostic (5.20e-3)"	"prognostic favorable (7.11e-4)"	"unprognostic (9.55e-2)"	"unprognostic (1.39e-1)"	"unprognostic (9.12e-3)"	"unprognostic (1.68e-1)"	"unprognostic (5.41e-2)"	"unprognostic (1.50e-1)"	"unprognostic (1.60e-1)"	"unprognostic (5.59e-5)"	"unprognostic (1.95e-2)"	"unprognostic (5.52e-3)"	"unprognostic (6.32e-2)"	"unprognostic (3.41e-1)"	"unprognostic (2.18e-1)"	"unprognostic (1.50e-1)"	2.8	8.3	5.2	2.7	8.2	0.9	2.8	4.7	7.8	4.4	14.1	4.3	6.5	6.2	4.0	3.6	8.2	2.3	11.0	3.5	4.5	6.8	68.0	63.6	3.3	2.0	4.5	4.5	2.9	5.1	5.4	4.3	3.2	7.0	13.9	15.5	5.5	25.4	5.4	6.0	2.6	7.4	3.7	3.8	2.9	15.9	2.1	2.1	3.8	3.3	3.4	3.3	5.7	4.5	7.8	10.2	11.2	14.2	9.9	10.0	6.8	4.1	6.6	3.7	4.8	2.6	4.1	6.4	5.5	4.1	2.5	1.9	21.6	5.0	1.3	2.9	7.8	9.7	1.9	0.9	4.0	2.6	4.1	3.5	3.1	4.8	6.2	1.8	1.9	1.0	6.2	2.0	3.3	1.2	3.6	2.8	2.7	1.2	4.9	7.5	3.0	1.6	2.4	3.3	3.0	10.8	1.9	6.3	2.1	11.3	20.7	2.1	2.9	9.1	6.5	5.5	3.2	5.0	1.9	5.2	8.4	1.9	2.1	4.4	59.8	31.1	2.4	2.4	3.9	6.2	0.3	7.1	10.2	10.0	8.8	8.4	7.8	8.7	7.8	10.2	7.0	8.1	6.1	11.2	9.9	14.2	5.3	8.9	6.8	5.2	8.2	4.7	7.8	4.5	6.8	4.5	4.5	7.0	2.1	3.0	2.6	0.0	0.4	0.3	3.3	0.9	7.6	4.0	5.7	1.8	0.0	0.9	5.0	0.7	8.1	0.8	5.0	0.0	3.3	0.9	1.1	0.6	0.0	17.8	0.9	4.8	4.1	1.3	1.2	18.9	0.6	0.8	0.0	1.8	4.5	10.6	2.4	3.5	2.1	33.2	0.8	0.0	0.5	0.7	0.7	0.5	0.2	0.8	4.0	0.3
AMD1	SAMDC	ENSG00000123505	"Adenosylmethionine decarboxylase 1"	P17707	6	110874770-110895713	"Enzymes, Predicted intracellular proteins"	"Polyamine biosynthesis, Spermidine biosynthesis"	"Decarboxylase, Lyase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"prostate: 104.7"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"HPA029281, HPA029282"	Approved		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA029281: AB_10600101, HPA029282: AB_10599965"	"prognostic unfavorable (3.87e-4)"	"unprognostic (4.68e-2)"	"unprognostic (1.85e-3)"	"unprognostic (1.01e-1)"	"unprognostic (2.01e-1)"	"unprognostic (1.05e-1)"	"prognostic unfavorable (1.91e-6)"	"unprognostic (1.18e-1)"	"unprognostic (2.03e-2)"	"unprognostic (6.50e-2)"	"unprognostic (2.25e-1)"	"unprognostic (4.20e-1)"	"prognostic favorable (4.28e-4)"	"unprognostic (8.62e-3)"	"unprognostic (1.55e-1)"	"unprognostic (4.41e-2)"	"unprognostic (7.71e-2)"	16.7	15.2	29.7	16.9	35.6	38.1	17.8	27.3	34.2	18.6	18.6	45.7	12.5	14.9	18.9	14.2	28.9	14.7	17.5	18.5	32.5	21.5	25.2	16.9	16.9	18.5	39.0	22.0	16.9	20.2	21.8	26.2	33.8	32.7	104.7	19.4	12.8	17.5	19.2	15.3	14.5	13.5	18.4	38.3	16.7	18.4	15.8	46.0	19.4	25.5	20.1	24.6	12.6	16.8	6.6	12.9	42.0	14.0	6.1	9.2	6.5	20.8	14.3	17.5	33.1	26.5	16.9	22.9	30.1	33.4	23.5	27.7	22.7	13.2	36.9	14.6	19.0	25.0	14.4	41.3	27.2	32.4	21.6	23.9	38.2	13.0	23.8	15.8	32.9	22.9	11.3	25.2	16.2	32.8	8.2	20.4	19.0	28.5	32.2	39.5	12.6	43.7	25.3	21.5	20.8	13.1	24.1	17.6	21.9	26.6	28.0	22.5	16.0	18.3	23.3	26.5	14.9	15.0	28.2	13.4	15.6	11.8	83.0	32.4	8.8	14.3	37.7	18.0	26.4	20.0	15.0	9.8	14.7	7.6	11.6	8.9	6.3	7.6	8.7	12.9	6.6	9.2	9.0	42.0	6.1	14.0	5.8	8.8	6.5	29.7	35.6	27.3	34.2	32.5	21.5	39.0	22.0	32.7	46.0	35.7	72.7	96.8	225.1	280.1	92.0	87.2	86.6	30.8	108.1	52.4	56.9	32.2	124.3	65.9	25.2	75.1	78.4	70.0	59.9	125.5	124.4	304.0	93.3	52.5	68.2	73.1	119.2	47.9	101.7	37.7	40.6	70.6	124.9	74.9	52.0	241.3	72.3	49.3	47.0	70.8	99.1	19.4	119.5	83.5	72.8	251.9	45.7	59.8	63.1	119.5
AMDHD1	MGC35366	ENSG00000139344	"Amidohydrolase domain containing 1"	Q96NU7	12	95943293-95968716	"Enzymes, Predicted intracellular proteins"	"Histidine metabolism"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	9	"liver: 99.0"	"Cell type enriched"	"Detected in many"	5	"Hepatocytes: 125.2"	"Cancer enriched"	"Detected in many"	14	"liver cancer: 23.4"	"Low region specificity"	"Detected in single"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"A-431: 19.5;HMC-1: 21.5;Karpas-707: 26.6;SiHa: 17.8;SK-BR-3: 20.0;U-266/70: 21.5;U-266/84: 25.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA039720, HPA040149"	Uncertain		Approved	"Nucleoplasm,Plasma membrane,Cytosol"		No	NA		410000	Cytosol	"Nucleoplasm, Plasma membrane"	"HPA039720: AB_10672967, HPA040149: "	"unprognostic (4.81e-2)"	"unprognostic (2.91e-1)"	"unprognostic (1.53e-1)"	"unprognostic (2.09e-2)"	"unprognostic (1.80e-2)"	"unprognostic (2.88e-2)"	"unprognostic (2.33e-2)"	"unprognostic (6.62e-3)"	"unprognostic (1.06e-1)"	"unprognostic (7.01e-2)"	"unprognostic (3.35e-3)"	"unprognostic (1.17e-1)"	"unprognostic (4.63e-3)"	"unprognostic (3.98e-2)"	"unprognostic (1.70e-1)"	"unprognostic (4.08e-3)"	"unprognostic (2.61e-1)"	1.1	5.7	0.5	2.4	0.8	2.0	0.9	0.5	1.3	0.7	0.7	0.6	0.4	1.9	0.9	0.5	0.8	0.5	0.7	1.1	0.6	0.5	4.4	99.0	1.3	1.4	0.5	0.4	0.7	1.1	0.0	1.2	0.6	1.0	0.7	0.0	0.8	1.3	0.7	11.3	2.2	1.9	0.6	0.6	2.9	1.9	6.2	0.5	0.7	0.6	0.7	0.7	0.8	0.9	1.5	1.2	3.7	3.8	5.7	1.6	1.4	19.5	4.3	0.3	2.8	0.1	0.0	4.4	0.6	0.2	0.3	0.6	1.9	2.5	1.7	1.9	0.0	1.1	3.7	0.1	0.0	0.1	6.8	0.7	1.9	3.0	3.8	0.0	2.5	21.5	0.0	0.1	0.3	0.0	0.1	0.1	1.7	1.3	26.6	0.0	3.0	1.6	4.8	2.0	0.7	1.0	3.5	0.1	2.2	0.0	1.8	2.2	3.2	17.8	20.0	2.3	0.0	2.1	3.6	0.0	2.8	9.7	3.5	2.4	21.5	25.2	2.7	1.9	5.2	3.1	0.3	1.6	3.7	1.2	1.4	1.1	1.5	0.6	1.6	1.2	1.0	1.0	1.1	1.2	5.7	3.8	0.6	0.3	1.4	0.5	0.8	0.5	0.6	0.6	0.5	0.5	0.4	1.0	0.5	0.0	0.3	2.2	0.2	0.3	0.0	0.4	0.0	0.0	1.2	3.5	0.0	0.5	3.3	0.1	0.6	0.3	0.0	0.0	1.0	0.1	0.3	0.0	0.0	125.2	4.1	1.6	1.7	11.1	3.7	0.0	0.3	1.1	3.3	0.0	0.0	1.9	0.3	0.0	0.0	23.2	0.0	0.0	0.0	1.2	1.9	0.3	0.2	2.9	0.0	0.1
AMDHD2	CGI-14	ENSG00000162066	"Amidohydrolase domain containing 2"	Q9Y303	16	2520357-2531422	"Enzymes, Predicted intracellular proteins"	"Carbohydrate metabolism"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"Hofbauer cells: 104.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"											"HPA041184, HPA041321"	Enhanced		Approved	Nucleoli,Cytosol		No	No		69000	"Nucleoli, Cytosol"		"HPA041184: AB_10803998, HPA041321: AB_10795588"	"unprognostic (1.20e-1)"	"prognostic favorable (5.19e-4)"	"unprognostic (7.86e-3)"	"unprognostic (2.39e-1)"	"unprognostic (1.70e-2)"	"unprognostic (1.37e-1)"	"unprognostic (1.48e-2)"	"unprognostic (2.14e-1)"	"unprognostic (3.28e-1)"	"unprognostic (1.66e-1)"	"unprognostic (1.88e-2)"	"unprognostic (8.68e-2)"	"unprognostic (1.30e-1)"	"unprognostic (8.37e-2)"	"unprognostic (4.71e-2)"	"unprognostic (1.66e-1)"	"unprognostic (1.20e-1)"	12.8	16.9	8.6	11.4	10.1	12.7	10.9	7.3	16.0	9.4	8.8	11.1	11.3	19.5	10.4	11.9	8.4	9.0	14.6	11.8	7.1	4.8	15.3	10.5	20.0	15.8	9.8	11.3	8.1	10.1	6.5	7.5	10.7	8.9	8.6	2.4	10.9	16.1	9.6	10.2	15.0	19.1	7.2	8.3	22.2	11.5	25.7	7.9	7.3	9.9	11.0	8.9	9.3	8.0	9.8	17.1	16.6	15.8	4.9	8.1	4.8	6.5	8.8	1.9	4.0	2.1	1.7	14.3	5.9	2.5	4.7	5.9	6.3	11.6	3.0	4.2	1.1	10.1	6.0	1.1	1.6	0.1	3.8	5.3	4.3	7.9	8.2	8.0	3.1	14.1	4.0	1.7	3.4	0.5	1.2	2.9	8.5	9.8	7.2	1.9	15.6	5.1	8.6	4.1	0.5	6.8	19.7	3.0	11.0	1.3	3.6	7.3	7.2	3.8	9.2	15.5	0.3	9.5	0.8	4.0	5.3	8.1	10.5	3.0	15.2	9.7	5.9	5.9	5.9	6.6	9.9	6.1	16.5	7.4	15.8	5.5	9.8	5.9	5.3	2.3	7.4	5.0	4.2	16.6	4.9	15.2	17.1	8.1	4.8	8.6	10.1	7.3	16.0	7.1	4.8	9.8	11.3	8.9	7.9	3.0	12.3	13.1	4.6	7.9	9.0	2.0	7.6	5.3	2.3	5.2	5.9	14.1	5.0	24.6	45.6	7.1	18.1	0.0	14.7	23.4	8.0	6.0	6.9	10.4	104.3	22.3	12.1	18.4	33.6	16.0	9.8	15.9	18.6	34.3	9.0	10.8	16.8	14.4	6.0	38.1	12.0	0.0	4.4	7.7	17.2	7.9	23.3	15.3	7.0	3.8
AMFR	"gp78, RNF45"	ENSG00000159461	"Autocrine motility factor receptor"	Q9UKV5	16	56361452-56425538	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Ubl conjugation pathway, Wnt signaling pathway"	"Receptor, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Early spermatids: 124.0;Hepatocytes: 146.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB026381, HPA029018, HPA077835"	Approved		Supported	"Endoplasmic reticulum,Golgi apparatus"		NA	NA			"Endoplasmic reticulum, Golgi apparatus"		"CAB026381: , HPA029018: AB_2672869, HPA077835: AB_2686856"	"unprognostic (1.72e-2)"	"unprognostic (1.62e-1)"	"unprognostic (1.62e-2)"	"unprognostic (2.43e-2)"	"unprognostic (3.60e-3)"	"unprognostic (6.06e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.26e-3)"	"unprognostic (1.28e-1)"	"unprognostic (1.43e-1)"	"unprognostic (2.97e-1)"	"unprognostic (4.16e-2)"	"unprognostic (5.52e-3)"	"unprognostic (1.45e-1)"	"unprognostic (1.68e-1)"	"unprognostic (1.91e-1)"	"unprognostic (2.28e-1)"	13.9	25.9	21.3	10.6	23.8	14.1	28.7	12.6	25.0	17.2	21.0	24.5	18.5	21.6	16.6	25.2	20.8	15.3	13.7	17.6	20.6	20.2	35.2	50.0	13.3	19.3	22.3	14.3	20.5	14.0	33.3	13.0	41.6	18.9	14.9	11.8	23.8	12.6	18.6	71.6	11.9	18.8	16.0	25.0	14.3	12.2	36.8	17.5	14.6	18.6	10.1	19.3	15.5	16.9	18.3	10.6	21.4	13.1	11.7	9.7	4.0	17.7	24.8	10.8	19.9	33.9	19.1	9.5	19.2	23.8	26.1	20.5	22.0	16.9	46.3	22.2	25.9	15.4	16.6	16.6	14.9	24.9	10.3	17.0	14.0	10.2	23.6	29.7	10.8	16.2	22.1	21.7	20.8	24.9	18.5	15.2	13.6	14.5	6.4	18.9	11.2	16.2	11.6	5.1	9.2	17.0	18.4	21.9	17.4	16.1	18.6	10.9	8.3	45.1	15.8	14.5	11.1	47.6	11.4	19.6	24.6	13.5	12.4	12.9	13.8	12.1	24.6	17.9	7.9	11.2	21.4	8.5	10.9	6.9	9.9	9.7	18.3	8.7	7.1	7.8	15.6	9.1	9.5	10.5	11.7	13.1	10.6	9.0	4.0	21.3	23.8	12.6	25.0	20.6	20.2	22.3	14.3	18.9	17.5	8.9	7.0	28.6	15.3	22.9	17.3	18.2	30.6	1.4	9.1	94.2	37.3	20.9	21.6	18.1	124.0	20.4	37.5	0.0	37.1	5.8	28.2	27.6	8.1	146.0	15.4	30.2	23.8	39.3	62.3	81.3	38.0	22.3	28.7	15.4	25.9	45.2	27.4	21.0	32.2	42.8	41.0	12.9	26.9	32.0	10.8	18.2	20.4	15.2	19.8	17.2
AMHR2	"MISR2, MISRII"	ENSG00000135409	"Anti-Mullerian hormone receptor type 2"	Q16671	12	53423855-53431534	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"		"Kinase, Receptor, Serine/threonine-protein kinase, Transferase"	"Disease mutation, Pseudohermaphroditism"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"adrenal gland: 27.1;ovary: 38.2;testis: 15.2"	"Group enriched"	"Detected in some"	4	"granulocytes: 25.4;Ito cells: 12.3"	"Cancer enhanced"	"Detected in single"		"testis cancer: 0.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	18	"HEL: 28.3;K-562: 15.3"	"Low region specificity"	"Detected in many"			"Region enriched"	"Detected in single"	10	"hippocampal formation: 14.3"	"HPA060228, HPA069636"			Approved	Nucleoplasm,Vesicles,Cytosol		NA	NA			Vesicles	"Nucleoplasm, Cytosol"	"HPA060228: AB_2684227, HPA069636: AB_2686163"	"unprognostic (5.79e-2)"	"unprognostic (3.65e-1)"	"unprognostic (3.98e-1)"	"unprognostic (1.71e-1)"	"unprognostic (1.14e-1)"	"unprognostic (4.61e-3)"	"unprognostic (2.33e-1)"	"unprognostic (1.44e-2)"	"unprognostic (2.91e-1)"	"unprognostic (4.98e-2)"	"unprognostic (1.35e-1)"	"unprognostic (2.32e-1)"	"unprognostic (2.15e-2)"	"unprognostic (3.34e-2)"	"unprognostic (1.42e-1)"	"unprognostic (2.04e-1)"	"unprognostic (1.97e-1)"	0.3	27.1	0.2	0.2	0.4	0.0	0.2	0.2	0.2	0.2	0.3	0.3	0.2	0.0	0.3	0.6	0.4	0.2	0.4	0.8	0.2	0.0	0.2	1.1	0.3	0.2	0.2	0.2	38.2	8.8	0.1	0.2	0.2	0.3	0.4	0.0	0.2	0.2	0.2	2.5	0.0	0.4	0.5	0.2	3.7	0.3	15.2	0.2	0.2	0.2	0.5	0.3	0.3	0.2	0.0	0.0	0.7	0.0	0.0	0.0	0.3	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.1	28.3	0.0	0.5	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.3	0.2	0.4	0.2	0.2	0.2	0.0	0.2	0.2	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	1.7	1.8	2.4	0.0	0.0	0.0	1.8	0.0	0.0	0.1	25.4	0.0	0.1	0.0	0.0	12.3	2.2	1.3	4.6	0.0	0.0	0.0	0.0	0.0	4.6	0.0	3.9	0.0	0.0	0.0	0.0	0.5	0.3	0.0	0.2	0.0	0.0	0.0
AMPD1	"MAD, MADA"	ENSG00000116748	"Adenosine monophosphate deaminase 1"	P23109	1	114673090-114695618	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Nucleotide metabolism"	Hydrolase	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	8	"skeletal muscle: 212.4"	"Cell type enhanced"	"Detected in some"	19	"Late spermatids: 1.5;Melanocytes: 1.7"	"Low cancer specificity"	"Detected in single"			"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	31	"memory B-cell: 3.0"	"Lineage enriched"	"Detected in single"	31	"B-cells: 3.0"	"Cell line enriched"	"Detected in single"	32	"U-266/70: 14.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA026478, HPA028080"	Enhanced				"Intracellular and membrane"	NA	NA					"HPA026478: AB_10599969, HPA028080: AB_10600776"	"unprognostic (1.98e-3)"	"unprognostic (1.43e-3)"	"unprognostic (8.75e-3)"	"unprognostic (8.03e-2)"		"unprognostic (1.95e-2)"		"unprognostic (5.61e-3)"	"unprognostic (8.21e-2)"	"unprognostic (4.29e-3)"	"unprognostic (2.48e-1)"	"unprognostic (2.26e-1)"	"unprognostic (1.36e-5)"	"unprognostic (1.68e-1)"	"unprognostic (3.70e-1)"	"unprognostic (3.36e-1)"	"unprognostic (4.02e-1)"	2.9	0.1	0.1	0.1	0.1	0.0	0.5	0.1	0.1	0.2	3.3	0.0	0.0	3.5	0.1	3.3	1.4	0.2	0.2	0.1	0.1	0.1	0.1	0.1	0.2	0.4	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.6	1.2	0.0	2.1	1.5	212.4	0.1	1.4	0.0	0.1	0.5	0.7	0.1	0.0	0.0	0.2	25.3	2.8	0.2	0.1	3.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.3	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	1.5	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
AMPD2	SPG63	ENSG00000116337	"Adenosine monophosphate deaminase 2"	Q01433	1	109616104-109632051	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Nucleotide metabolism"	Hydrolase	"Disease mutation, Hereditary spastic paraplegia, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 64.4"	"Cell type enhanced"	"Detected in many"	6	"Cone photoreceptor cells: 58.9;Horizontal cells: 49.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in all"	5	"dendritic cells: 8.8;granulocytes: 29.7;monocytes: 24.5"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027137, HPA045760, HPA050590"	Approved		Enhanced	Cytosol		NA	NA		380000	Cytosol		"HPA027137: AB_2672129, HPA045760: AB_2679443, HPA050590: AB_2681184"	"unprognostic (2.78e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.50e-1)"	"unprognostic (1.43e-3)"	"unprognostic (9.01e-2)"	"unprognostic (5.25e-2)"	"unprognostic (3.91e-3)"	"unprognostic (1.71e-1)"	"unprognostic (4.02e-1)"	"unprognostic (1.23e-1)"	"unprognostic (8.10e-3)"	"unprognostic (1.50e-1)"	"prognostic unfavorable (3.78e-10)"	"unprognostic (9.16e-2)"	"unprognostic (2.03e-1)"	"unprognostic (1.35e-2)"	"unprognostic (1.60e-1)"	8.1	22.7	20.2	21.7	41.3	64.4	4.9	16.3	26.8	9.5	10.1	9.5	6.3	17.1	9.0	6.0	5.9	11.8	13.2	5.2	21.7	19.4	7.8	13.0	8.2	10.7	14.2	14.2	16.3	9.4	13.0	37.1	10.8	18.3	9.7	5.7	15.7	9.1	12.2	2.1	10.0	11.6	9.1	8.5	15.9	8.3	5.3	12.2	10.3	6.4	3.0	7.5	8.2	8.1	2.8	8.8	29.7	24.5	3.0	4.3	5.4	10.9	12.7	18.7	15.8	16.3	16.3	7.1	15.6	31.9	16.0	15.8	9.7	4.7	5.4	12.0	29.2	10.5	8.6	9.8	14.5	9.9	8.7	13.2	28.5	16.7	10.8	15.3	12.1	30.7	18.3	7.7	21.1	16.4	28.9	13.8	11.9	8.8	14.7	11.4	16.9	17.9	29.0	12.1	10.2	13.6	12.7	7.2	8.4	14.7	6.7	14.5	15.3	10.6	13.0	12.6	7.0	7.3	11.3	13.1	19.8	23.0	24.1	16.0	29.5	14.3	7.8	29.5	18.8	20.6	0.5	9.2	11.2	3.4	19.6	4.3	2.8	3.3	3.4	8.8	1.7	3.8	2.8	29.7	3.0	24.5	1.4	2.6	5.4	20.2	41.3	16.3	26.8	21.7	19.4	14.2	14.2	18.3	12.2	3.0	8.5	8.3	4.7	7.9	35.7	2.5	17.8	4.0	5.7	0.0	58.9	4.0	6.6	9.7	2.9	6.2	3.9	0.0	9.6	7.4	11.8	4.5	3.5	17.8	10.5	49.3	16.8	6.2	37.8	1.3	12.0	28.6	5.0	1.0	8.6	9.1	8.3	0.0	20.1	3.9	5.8	12.9	11.7	4.5	2.6	7.0	2.2	10.1	9.7	3.4
AMPD3		ENSG00000133805	"Adenosine monophosphate deaminase 3"	Q01432	11	10308313-10507579	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Nucleotide metabolism"	Hydrolase	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 39.2;skeletal muscle: 61.0"	"Cell type enhanced"	"Detected in many"	7	"Erythroid cells: 46.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 24.7;CAPAN-2: 19.3;HMC-1: 20.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038662, HPA047408"	Uncertain		Approved	"Nuclear membrane"		NA	NA			"Nuclear membrane"		"HPA038662: AB_2676136, HPA047408: AB_2680034"	"unprognostic (2.24e-1)"	"unprognostic (3.88e-3)"	"unprognostic (1.44e-2)"	"prognostic favorable (2.37e-4)"	"unprognostic (1.89e-2)"	"unprognostic (1.71e-3)"	"unprognostic (2.91e-3)"	"unprognostic (1.25e-1)"	"unprognostic (7.83e-2)"	"unprognostic (2.26e-1)"	"unprognostic (1.84e-2)"	"unprognostic (4.68e-1)"	"unprognostic (3.06e-2)"	"unprognostic (7.07e-2)"	"unprognostic (4.42e-2)"	"unprognostic (2.98e-1)"	"unprognostic (2.12e-2)"	2.9	13.7	5.3	13.8	14.0	39.2	2.3	2.3	7.8	3.3	3.4	19.6	0.7	4.7	3.1	4.2	5.2	8.0	4.6	2.1	7.4	7.1	4.2	1.5	4.5	12.7	15.2	5.7	2.3	2.5	24.9	14.5	3.7	11.2	5.5	4.9	4.3	4.7	2.8	61.0	10.8	5.0	3.1	12.8	8.3	4.6	1.4	12.6	14.8	2.7	7.6	14.2	6.1	5.1	7.6	3.9	17.0	6.0	3.3	5.3	2.3	7.6	1.1	0.3	0.1	4.1	2.9	0.4	6.9	24.7	1.7	1.8	3.8	19.3	2.8	0.7	3.1	6.8	4.8	0.1	6.5	5.1	6.9	0.2	6.8	1.0	0.5	1.4	9.2	20.5	10.8	10.2	3.4	4.4	4.3	0.7	4.6	10.3	3.0	5.6	0.2	5.4	12.1	0.9	0.6	6.8	2.0	9.0	9.9	0.3	6.5	2.9	1.5	1.5	0.2	0.4	0.6	0.2	3.1	1.9	7.9	0.1	5.4	0.2	2.7	1.5	3.0	9.0	9.2	0.2	6.6	6.0	17.0	2.3	3.8	5.3	7.6	3.3	2.5	3.9	5.8	3.7	2.5	8.3	3.3	1.6	2.5	1.9	2.3	5.3	14.0	2.3	7.8	7.4	7.1	15.2	5.7	11.2	12.6	0.0	4.6	5.2	8.9	11.1	20.7	5.6	7.6	12.0	7.9	14.0	2.0	0.7	14.9	2.4	7.0	1.0	1.7	46.7	1.4	1.1	1.4	17.1	11.5	0.6	13.4	0.0	9.8	1.8	14.3	14.2	0.9	9.1	3.3	13.6	3.2	6.8	3.9	2.9	0.0	1.0	1.3	0.0	1.7	0.2	0.5	10.9	1.0	2.9	2.2	16.1
AMT	"GCST, NKH"	ENSG00000145020	Aminomethyltransferase	P48728	3	49416775-49422753	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		"Aminotransferase, Transferase"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	4	"Hepatocytes: 37.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"NK-cell: 8.9"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"BEWO: 10.4;Hep G2: 29.9;NTERA-2: 5.4;SH-SY5Y: 7.9;SuSa: 7.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA005566	Supported		Supported	Nucleoplasm,Mitochondria		NA	NA			Mitochondria	Nucleoplasm	"HPA005566: AB_1844811"	"unprognostic (2.10e-2)"	"unprognostic (1.65e-2)"	"unprognostic (1.82e-1)"	"unprognostic (9.14e-3)"	"unprognostic (4.04e-1)"	"unprognostic (1.11e-2)"	"unprognostic (2.81e-1)"	"unprognostic (2.17e-3)"	"unprognostic (1.94e-1)"	"unprognostic (3.29e-1)"	"unprognostic (7.17e-3)"	"unprognostic (1.88e-1)"	"prognostic favorable (3.90e-8)"	"unprognostic (4.40e-1)"	"unprognostic (1.91e-1)"	"unprognostic (3.60e-1)"	"unprognostic (1.98e-3)"	4.7	10.9	6.6	8.0	8.8	6.0	6.6	16.7	10.4	8.4	10.0	7.4	21.3	10.9	9.2	11.1	3.4	9.7	13.0	16.6	7.4	2.0	21.4	41.2	5.6	2.3	7.6	8.3	14.5	18.5	16.3	10.4	2.5	10.7	9.1	10.1	12.2	9.8	20.0	3.8	5.4	11.0	7.1	5.8	7.9	8.1	2.6	7.4	1.7	8.7	0.4	1.8	6.2	8.1	0.7	5.4	4.7	3.2	8.9	1.6	2.3	0.1	0.5	0.7	0.1	0.4	0.0	10.4	0.0	0.2	0.1	0.2	0.3	0.2	0.0	0.1	0.2	0.0	0.2	0.1	0.4	0.1	0.2	0.2	0.0	0.3	29.9	1.1	0.0	0.1	0.3	0.7	0.0	0.4	1.1	0.1	0.2	0.0	0.0	0.1	0.3	0.2	0.2	5.4	0.0	0.1	0.0	0.1	0.2	0.7	0.2	0.0	7.9	0.1	0.0	0.6	7.3	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.6	0.1	0.0	0.0	0.1	0.0	0.0	3.2	4.7	0.0	1.9	0.1	0.6	0.0	0.0	5.4	0.7	1.6	1.5	0.3	8.9	0.7	0.5	0.0	2.3	6.6	8.8	16.7	10.4	7.4	2.0	7.6	8.3	10.7	7.4	3.0	11.6	3.7	11.4	2.5	17.2	18.3	17.8	6.7	7.9	0.0	19.6	22.7	0.0	0.7	1.7	2.7	19.7	0.0	0.6	6.5	4.7	10.1	7.0	37.3	4.4	7.9	12.2	3.1	2.7	1.6	9.8	3.5	5.0	0.0	16.2	21.5	0.5	14.0	6.0	0.7	17.7	6.5	4.3	1.4	0.4	2.4	8.6	5.7	31.1	8.6
AMY1A	AMY1	ENSG00000237763	"Amylase, alpha 1A (salivary)"	P04745	1	103655290-103664554	"Enzymes, Predicted secreted proteins"	"Carbohydrate metabolism"	"Glycosidase, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	100	"salivary gland: 654.0"	"Cell type enriched"	"Detected in some"	11	"Ciliated cells: 38.8"	"Not detected"	"Not detected"							"Low cell type specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"NTERA-2: 1.4;SH-SY5Y: 2.4"									"CAB004310, HPA045394, HPA045399, HPA046980"	Enhanced				"Secreted to digestive system"	NA	NA		68000000			"CAB004310: AB_626668, HPA045394: AB_2679311, HPA045399: AB_2679313, HPA046980: AB_2679889"																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.5	0.0			0.0	0.0	0.0	0.1	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0		0.0	3.7	0.0	0.0	0.0		0.0	0.0		654.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.2		0.0	0.0	0.1	0.1	0.3	0.3	0.6	0.0	1.1	0.7	0.1	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.2	0.0	0.0	0.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	1.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.2	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.3	0.1	0.6	0.0	0.1	1.1	0.1	0.3	0.1	0.0	0.7	0.2	0.0	0.5	0.0	0.1	0.7											3.0	2.1	0.0	0.8	0.6	0.0	2.4	0.0	38.8	3.4	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3
AMY1B	AMY1	ENSG00000174876	"Amylase, alpha 1B (salivary)"	P04745	1	103687415-103696680	"Enzymes, Predicted secreted proteins"	"Carbohydrate metabolism"	"Glycosidase, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	13	"salivary gland: 302.4"	"Cell type enriched"	"Detected in some"	10	"Ciliated cells: 34.8"	"Cancer enhanced"	"Detected in single"		"ovarian cancer: 0.5"	"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"NTERA-2: 1.2;SH-SY5Y: 2.1;U-266/70: 1.8"									"HPA045394, HPA045399, HPA046980"	Supported				"Secreted to digestive system"	NA	NA		68000000			"HPA045394: AB_2679311, HPA045399: AB_2679313, HPA046980: AB_2679889"					"unprognostic (7.34e-2)"			"unprognostic (2.59e-1)"		"unprognostic (6.05e-2)"				"unprognostic (6.08e-2)"		"unprognostic (1.96e-1)"		0.2	0.0	0.2	0.2	0.2	0.0	0.2	0.2	0.2	6.5	0.2	0.2	0.2	0.0	0.2	0.2	0.2	4.0	0.2	0.2	0.2	0.0	0.2	0.2	0.7	0.2	0.2	0.2	0.2	23.0	0.0	0.2	0.2	0.2	0.2	0.0	0.2	302.4	0.2	0.2	0.0	0.2	0.2	0.2	0.2	0.0	0.4	0.2	0.2	1.1	0.2	0.2	0.2	0.2	0.1	0.3	0.3	0.6	0.0	1.1	0.7	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.7	0.0	0.0	0.0	0.2	0.0	0.0	0.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.3	0.5	1.2	0.0	0.0	0.7	0.1	0.4	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.2	0.0	1.8	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.3	0.2	0.6	0.0	0.1	1.1	0.1	0.3	0.1	0.0	0.7	0.2	0.0	0.5	0.0	0.1	0.7	0.2	0.2	0.2	0.2	0.2	0.0	0.2	0.2	0.2	0.2	3.0	3.2	0.0	0.1	0.2	0.0	0.7	0.0	34.8	3.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0
AMY1C	AMY1	ENSG00000187733	"Amylase, alpha 1C (salivary)"	P04745	1	103750406-103758690	"Enzymes, Predicted secreted proteins"	"Carbohydrate metabolism"	"Glycosidase, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"pancreas: 34.3;salivary gland: 62.5"	"Group enriched"	"Detected in some"	6	"Alveolar cells type 2: 33.4;Ciliated cells: 95.0"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	4	"THP-1: 3.7"									"HPA045394, HPA045399, HPA046980"	Supported				"Secreted to digestive system"	NA	NA		68000000			"HPA045394: AB_2679311, HPA045399: AB_2679313, HPA046980: AB_2679889"																		0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	6.2	0.0			0.0	0.0	0.0	0.0	16.4	0.0	0.0	0.0	0.0	0.0	0.0	5.7	0.0	0.0		0.0	34.3	0.0	0.0	0.0		0.0	0.0		62.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.5			9.6		4.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	3.7	0.0	0.0	0.0	0.2	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0											3.0	33.4	0.0	0.0	0.0	0.0	0.4	0.0	95.0	11.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
AMY2A	AMY2	ENSG00000243480	"Amylase, alpha 2A (pancreatic)"	P04746	1	103616811-103625780	"Enzymes, FDA approved drug targets, Predicted secreted proteins"	"Carbohydrate metabolism"	"Glycosidase, Hydrolase"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	31	"pancreas: 1849.4"	"Cell type enriched"	"Detected in some"	68	"Exocrine glandular cells: 849.6"	"Cancer enriched"	"Detected in single"	2010	"pancreatic cancer: 200.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"THP-1: 1.0;U-2 OS: 1.3"									"HPA045394, HPA045399, CAB045960, HPA046980"	Enhanced				"Secreted to digestive system"	NA	NA		77000000			"CAB045960: AB_2226891, HPA045394: AB_2679311, HPA045399: AB_2679313, HPA046980: AB_2679889"					"unprognostic (3.27e-1)"					"unprognostic (1.78e-3)"	"unprognostic (3.24e-2)"			"unprognostic (1.29e-1)"		"unprognostic (2.13e-2)"		0.2	0.0	0.2	0.2	0.2	0.0	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.1	0.2	0.2	0.2	0.0	0.2	0.2	0.2	0.0	0.2	0.2	0.2	0.2	0.2	0.2	0.9	1849.4	0.0	0.2	0.2	0.2	0.2	0.0	0.2	59.9	0.2	0.2	0.0	0.2	0.2	0.2	0.2	0.0	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.0	0.2	0.2	0.3	0.0	0.1	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.2	0.3	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.2	0.0	0.0	0.2	0.0	0.2	0.2	0.2	0.2	0.2	0.2	0.0	0.2	0.2	0.2	0.2	0.0	0.0	0.0	0.7	0.0	0.0	0.8	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.9	1.5	0.0	0.0	0.0	849.6	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.2	0.0	0.0	12.4	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.4
AMY2B	AMY2	ENSG00000240038	"Amylase, alpha 2B (pancreatic)"	P19961	1	103553815-103579534	"Enzymes, Plasma proteins, Predicted secreted proteins"	"Carbohydrate metabolism"	"Glycosidase, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"pancreas: 939.9"	"Group enriched"	"Detected in many"	4	"Cone photoreceptor cells: 31.4;Exocrine glandular cells: 124.1"	"Cancer enriched"	"Detected in many"	15	"pancreatic cancer: 25.1"	"Low region specificity"	"Detected in some"			"Cell type enhanced"	"Detected in many"		"classical monocyte: 8.5"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"ASC TERT1: 11.5;EFO-21: 11.8;HSkMC: 7.8"									"HPA045394, HPA045399, HPA046980"	Supported				"Secreted to digestive system"	NA	NA		75000000			"HPA045394: AB_2679311, HPA045399: AB_2679313, HPA046980: AB_2679889"	"unprognostic (8.69e-4)"	"unprognostic (3.71e-3)"	"unprognostic (6.41e-2)"	"unprognostic (9.75e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.51e-4)"	"unprognostic (1.21e-2)"	"unprognostic (1.63e-2)"	"unprognostic (2.13e-1)"	"unprognostic (1.98e-1)"	"unprognostic (1.07e-1)"	"unprognostic (2.49e-2)"	"unprognostic (7.41e-3)"	"unprognostic (1.55e-2)"	"unprognostic (5.74e-2)"	"unprognostic (4.22e-1)"	"unprognostic (3.12e-4)"	1.7	0.5	0.8	0.8	1.5	0.4	1.0	2.6	0.8	0.9	0.9	0.8	0.8	0.5	0.8	1.0	0.8	1.5	0.9	1.1	0.8	0.5	1.5	1.1	1.0	1.1	1.0	0.9	1.2	939.9	0.8	1.1	0.8	0.8	0.9	0.4	0.9	145.7	1.0	1.7	1.3	0.9	0.8	0.8	1.0	0.4	0.8	0.8	0.8	2.4	1.1	0.8	0.8	0.8	1.8	2.6	1.9	8.5	0.1	1.1	1.9	0.0	0.6	1.3	0.0	6.4	11.5	1.2	0.9	0.9	0.7	1.7	0.0	0.2	1.1	11.8	0.3	0.0	1.4	0.1	1.4	1.6	1.4	1.8	2.1	4.4	0.9	1.0	2.6	2.8	7.8	7.7	0.8	1.3	2.0	0.2	3.3	0.0	3.5	0.9	0.0	2.1	0.5	0.1	0.1	1.6	0.6	0.0	5.1	6.6	2.1	3.2	0.6	2.7	1.3	0.8	2.1	0.1	1.5	0.9	0.4	1.0	0.5	0.7	4.0	0.1	0.3	2.2	2.0	0.2	0.0	8.5	1.7	0.8	3.9	0.6	1.7	0.3	0.4	2.6	1.8	1.1	0.4	1.9	0.1	3.6	0.8	0.3	1.9	0.8	1.5	2.6	0.8	0.8	0.5	1.0	0.9	0.8	0.8	11.9	16.1	3.2	2.8	4.1	10.0	6.9	5.1	17.4	18.2	1.8	31.4	0.3	0.0	0.7	4.8	1.5	3.6	0.0	124.1	0.2	1.4	1.2	3.5	5.9	1.5	9.5	4.7	1.8	7.0	2.3	2.3	3.1	5.0	1.8	2.5	2.4	1.3	1.4	1.8	0.4	16.2	0.0	2.2	1.7	0.6	2.6	0.2	0.8	2.5	0.9
AMZ1	KIAA1950	ENSG00000174945	"Archaelysin family metallopeptidase 1"	Q400G9	7	2679522-2775500	"Enzymes, Predicted intracellular proteins"		"Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"brain: 10.0"	"Cell type enhanced"	"Detected in some"	20	"Cone photoreceptor cells: 3.9;Early spermatids: 18.8;Extravillous trophoblasts: 7.0;Late spermatids: 6.0"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	6	"memory B-cell: 4.2;naive B-cell: 2.4;T-reg: 1.0"	"Group enriched"	"Detected in many"	6	"B-cells: 4.2;T-cells: 1.0"	"Cell line enhanced"	"Detected in some"		"BEWO: 6.2;MCF7: 6.4;SK-BR-3: 4.6;T-47d: 24.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA020233	Uncertain					NA	NA					"HPA020233: AB_1844818"	"unprognostic (9.08e-3)"	"unprognostic (1.66e-1)"	"unprognostic (3.23e-3)"	"unprognostic (1.81e-1)"	"unprognostic (5.72e-2)"	"unprognostic (7.79e-2)"	"unprognostic (2.02e-2)"	"unprognostic (3.42e-1)"	"unprognostic (1.98e-1)"	"unprognostic (7.16e-3)"	"unprognostic (1.08e-1)"	"unprognostic (1.21e-1)"	"unprognostic (3.64e-9)"	"unprognostic (1.60e-3)"	"unprognostic (1.60e-1)"	"unprognostic (1.44e-1)"	"unprognostic (1.13e-1)"	0.7	0.7	8.4	1.2	7.1	2.0	0.9	1.4	10.0	3.2	0.6	6.5	0.0	0.8	4.0	0.6	0.7	1.4	1.0	0.9	5.9	4.9	0.5	1.2	2.8	1.2	6.0	4.8	1.4	0.8	0.7	1.1	3.6	4.2	0.8	0.7	0.2	0.6	0.6	0.6	0.8	0.6	3.3	3.8	2.0	0.7	1.4	4.4	0.0	0.7	0.0	1.8	0.7	0.7	4.2	0.1	0.4	0.1	0.1	1.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	6.2	2.0	3.0	1.4	2.0	0.0	0.8	0.5	0.2	1.9	0.2	0.0	0.0	0.0	1.4	0.3	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	1.4	0.0	6.4	0.0	0.6	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	4.6	0.0	0.1	24.4	0.0	0.0	0.1	0.1	0.1	0.0	0.9	0.2	0.0	0.5	0.0	0.1	0.4	0.0	0.2	0.1	0.0	0.0	4.2	0.1	0.0	0.0	2.4	0.1	0.0	0.1	0.1	0.1	0.1	1.0	0.1	8.4	7.1	1.4	8.7	5.9	4.9	6.0	4.8	4.2	4.4	0.0	0.3	0.0	0.1	0.0	0.6	3.2	0.0	0.0	0.0	0.0	3.9	0.3	0.0	0.0	18.8	0.3	0.0	0.0	0.0	7.0	0.4	0.1	0.0	0.0	1.8	0.0	0.0	0.0	0.0	6.0	0.0	1.5	1.7	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.7	0.0	0.5	0.0	0.2	0.1	0.1	0.0	0.0	0.0
AMZ2		ENSG00000196704	"Archaelysin family metallopeptidase 2"	Q86W34	17	68247574-68257164	"Enzymes, Predicted intracellular proteins"		"Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"Early spermatids: 585.3;Late spermatids: 1307.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023299, HPA052406"	Enhanced		Supported	"Nucleoplasm,Nuclear bodies,Cytosol"		NA	NA			Nucleoplasm	"Nuclear bodies, Cytosol"	"HPA023299: AB_2226909, HPA052406: AB_2681818"	"unprognostic (3.04e-1)"	"unprognostic (3.68e-2)"	"unprognostic (3.93e-2)"	"unprognostic (3.27e-3)"	"unprognostic (3.32e-1)"	"unprognostic (1.79e-2)"	"prognostic unfavorable (1.32e-5)"	"unprognostic (2.43e-1)"	"unprognostic (3.92e-2)"	"unprognostic (2.83e-3)"	"unprognostic (3.59e-3)"	"unprognostic (3.37e-1)"	"prognostic unfavorable (3.14e-4)"	"unprognostic (2.37e-1)"	"unprognostic (2.95e-1)"	"unprognostic (3.28e-1)"	"unprognostic (7.62e-2)"	22.3	21.3	29.3	13.7	43.3	14.2	20.8	29.2	35.8	19.8	19.8	20.3	19.6	11.9	19.0	25.3	22.3	24.6	17.7	33.6	26.8	23.7	26.8	16.6	14.1	22.4	26.0	27.0	23.4	20.4	29.4	25.4	18.9	28.3	21.1	15.0	19.0	17.9	25.1	39.9	15.5	13.5	19.3	27.8	16.6	15.7	77.2	20.5	15.5	28.4	20.6	22.4	20.2	14.9	20.9	17.2	31.4	21.1	34.8	31.2	19.7	23.4	26.1	22.1	18.7	17.0	29.6	34.8	17.0	23.0	29.6	24.9	10.7	15.1	35.1	19.2	26.3	27.9	11.6	18.0	50.1	38.9	12.4	17.0	12.9	11.6	20.8	32.2	11.7	22.3	25.2	56.3	27.5	51.3	29.3	29.9	30.2	13.2	22.5	37.4	17.4	26.4	10.9	10.4	12.5	24.4	10.1	60.2	26.3	17.8	12.4	22.3	17.5	15.8	32.6	31.7	47.6	25.7	8.1	15.5	39.9	19.0	14.3	18.4	31.6	29.0	60.6	28.1	16.7	20.1	31.4	14.4	19.6	22.1	16.6	28.6	17.4	27.3	29.0	17.2	20.9	24.4	26.3	25.2	34.8	21.1	15.7	31.2	19.7	29.3	43.3	29.2	35.8	26.8	23.7	26.0	27.0	28.3	20.5	11.9	14.1	28.3	32.0	16.6	13.3	73.2	22.9	57.6	21.6	22.7	7.9	54.0	92.9	25.1	585.3	25.4	8.9	0.0	22.9	56.9	31.5	18.0	32.4	13.7	37.1	17.5	20.3	22.7	19.9	1307.8	33.4	36.7	54.0	56.9	16.8	56.2	24.4	12.9	30.8	48.5	11.6	19.4	27.2	187.0	54.0	19.7	28.6	51.1	15.8	15.9
ANKIB1	"DKFZP434A0225, KIAA1386"	ENSG00000001629	"Ankyrin repeat and IBR domain containing 1"	Q9P2G1	7	92246234-92401384	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019358, HPA021780"	Uncertain		Supported	"Plasma membrane,Cytosol"		NA	NA			"Plasma membrane, Cytosol"		"HPA019358: AB_1844831, HPA021780: AB_2670819"	"unprognostic (1.77e-1)"	"unprognostic (5.96e-3)"	"unprognostic (1.23e-1)"	"unprognostic (4.97e-3)"	"unprognostic (2.75e-1)"	"unprognostic (7.67e-2)"	"unprognostic (4.88e-3)"	"unprognostic (2.14e-1)"	"unprognostic (4.24e-2)"	"unprognostic (1.87e-2)"	"unprognostic (1.52e-3)"	"unprognostic (1.48e-1)"	"unprognostic (1.06e-3)"	"unprognostic (4.05e-2)"	"unprognostic (3.00e-1)"	"unprognostic (3.00e-2)"	"unprognostic (3.20e-1)"	11.9	11.8	21.4	9.2	29.2	5.8	12.3	15.0	25.5	13.6	12.1	34.9	16.0	10.7	12.6	16.4	11.8	10.0	14.7	9.7	22.7	20.0	25.3	10.1	10.6	11.5	31.1	18.4	13.1	12.7	28.5	10.9	12.2	23.4	10.2	12.6	8.4	12.7	18.4	8.6	14.0	11.3	13.4	23.8	11.4	10.9	19.4	35.0	11.5	17.1	4.5	11.1	13.1	13.3	4.8	4.5	3.1	2.0	3.2	4.9	1.1	16.8	10.3	9.1	13.8	16.9	18.0	9.7	13.2	15.1	12.8	16.8	7.5	26.1	9.7	11.6	19.5	33.1	8.1	8.4	13.8	19.6	16.4	6.9	6.1	11.9	6.0	11.5	8.7	13.6	12.2	11.7	15.1	20.0	18.0	14.5	8.8	7.8	21.0	15.1	13.6	18.5	8.2	9.9	11.8	11.6	7.0	11.2	10.4	13.6	14.6	12.7	14.9	18.9	21.3	11.1	18.9	8.8	5.0	12.9	24.8	20.1	28.0	13.4	13.2	23.5	12.2	14.4	10.6	28.3	2.8	1.3	3.1	2.7	2.0	2.2	3.9	2.6	3.8	1.1	4.8	2.2	2.8	0.8	3.2	1.6	4.5	4.9	1.1	21.4	29.2	15.0	25.5	22.7	20.0	31.1	18.4	23.4	35.0	23.8	25.4	15.9	15.3	16.6	20.1	32.3	17.8	14.7	23.9	26.2	17.7	11.3	1.7	18.0	40.4	15.7	15.3	0.0	16.6	22.9	19.1	16.9	26.5	12.9	11.8	28.6	40.3	28.3	21.1	45.0	30.8	16.4	16.9	6.4	23.5	26.9	26.0	7.0	38.2	30.1	15.7	19.4	18.1	58.5	57.5	19.8	11.7	17.5	19.2	21.8
ANKK1	X-kinase	ENSG00000170209	"Ankyrin repeat and kinase domain containing 1"	Q8NFD2	11	113387791-113400418	"Enzymes, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"skin 1: 9.7;tongue: 6.3"	"Cell type enhanced"	"Detected in some"	10	"Ciliated cells: 1.4;Horizontal cells: 1.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Cell type enhanced"	"Detected in some"		"basophil: 1.4;naive B-cell: 1.3"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"HaCaT: 2.0;hTCEpi: 6.7;RT4: 3.2;U-266/70: 1.3"	"Not detected"	"Not detected"							HPA012813	Uncertain					NA	NA					"HPA012813: AB_1844832"	"unprognostic (5.63e-3)"	"unprognostic (6.67e-3)"	"unprognostic (5.09e-3)"	"unprognostic (6.27e-3)"	"unprognostic (5.56e-4)"	"unprognostic (7.02e-2)"	"unprognostic (2.07e-1)"	"unprognostic (1.75e-1)"	"unprognostic (4.50e-1)"	"unprognostic (3.15e-1)"	"unprognostic (3.36e-2)"	"unprognostic (2.18e-1)"	"unprognostic (5.39e-6)"	"unprognostic (3.17e-2)"	"unprognostic (3.83e-2)"	"unprognostic (2.79e-1)"	"unprognostic (4.65e-2)"	0.6	0.5	0.6	0.6	2.0	0.4	1.2	0.6	1.4	1.5	0.6	0.6	0.6	0.4	0.7	0.9	0.6	3.3	0.6	0.6	0.6	1.2	0.6	0.6	0.6	1.1	0.6	0.6	1.0	0.6	0.4	4.7	0.6	0.6	1.9	0.1	0.6	1.8	1.0	0.7	9.7	0.6	0.6	2.3	0.9	0.2	1.0	0.6	0.6	1.2	6.3	1.5	0.6	1.2	1.3	0.2	1.4	0.1	0.1	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	2.0	0.1	0.1	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	6.7	0.0	0.4	0.2	0.0	0.0	0.0	0.4	0.0	0.3	0.0	0.1	0.9	0.0	0.0	0.0	0.1	0.1	0.3	3.2	0.2	0.1	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.3	0.2	0.0	1.3	0.6	0.0	0.0	0.2	0.0	1.4	0.1	0.2	0.4	0.1	0.1	0.0	0.1	0.0	0.0	1.3	0.2	0.1	0.7	0.1	0.0	0.2	0.0	0.1	0.6	2.0	0.6	1.4	0.6	1.2	0.6	0.6	0.6	0.6	0.0	0.3	0.0	0.6	0.6	0.9	0.4	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.6
ANPEP	"CD13, gp150, LAP1, p150, PEPN"	ENSG00000166825	"Alanyl aminopeptidase, membrane"	P15144	15	89784889-89815401	"CD markers, Enzymes, Plasma proteins, Predicted membrane proteins"	"Angiogenesis, Differentiation, Host-virus interaction"	"Aminopeptidase, Developmental protein, Host cell receptor for virus entry, Hydrolase, Metalloprotease, Protease, Receptor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 195.3;kidney: 78.7;pancreas: 93.9"	"Cell type enhanced"	"Detected in many"	16	"Cholangiocytes: 372.0;Enterocytes: 993.7;Exocrine glandular cells: 328.5;Proximal tubular cells: 388.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Cell type enriched"	"Detected in many"	5	"neutrophil: 59.4"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 59.4"	"Cell line enhanced"	"Detected in many"		"ASC TERT1: 78.5;BJ: 78.2;BJ hTERT+: 111.8;fHDF/TERT166: 67.0;HMC-1: 71.1;HSkMC: 68.7;HUVEC TERT2: 87.5;TIME: 87.4;U-2197: 95.3"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"CAB002417, HPA004625"	Enhanced		Supported	"Plasma membrane"		NA	NA		1500000000	"Plasma membrane"		"CAB002417: AB_563491, HPA004625: AB_2667199"	"unprognostic (6.31e-2)"	"unprognostic (7.94e-3)"	"unprognostic (6.91e-2)"	"unprognostic (2.16e-1)"	"unprognostic (2.50e-1)"	"unprognostic (1.13e-1)"	"unprognostic (2.23e-2)"	"unprognostic (1.89e-1)"	"unprognostic (2.50e-1)"	"unprognostic (7.73e-2)"	"unprognostic (5.28e-3)"	"unprognostic (3.96e-1)"	"unprognostic (4.04e-3)"	"unprognostic (3.20e-2)"	"unprognostic (2.01e-2)"	"unprognostic (4.61e-3)"	"unprognostic (1.99e-2)"	21.3	1.1	0.6	2.9	0.8	9.5	17.0	1.0	1.3	8.2	21.2	0.8	0.5	195.3	1.4	8.4	3.6	1.4	27.7	3.7	0.4	0.3	78.7	37.7	9.7	9.3	0.9	0.9	1.8	93.9	0.0	0.7	14.7	1.3	8.6	4.7	4.0	6.6	1.8	1.6	4.9	155.8	4.3	1.2	7.2	0.8	4.7	0.2	5.6	1.5	4.2	3.8	4.7	3.0	0.0	6.9	59.4	12.8	0.0	0.0	5.5	0.0	5.0	0.0	0.0	61.3	78.5	0.5	78.2	111.8	9.6	8.5	0.5	0.0	0.0	0.9	67.0	0.0	0.0	0.6	0.0	3.8	0.0	0.0	14.7	0.4	11.7	36.1	1.0	71.1	68.7	0.1	30.2	0.0	0.4	87.5	0.0	0.4	0.1	3.7	0.0	0.0	34.7	0.2	0.0	5.3	0.0	0.0	0.8	43.7	0.0	0.1	0.7	0.0	0.1	0.0	0.1	0.0	6.8	87.4	42.2	0.0	95.3	0.0	0.0	0.0	0.0	0.1	0.0	2.2	5.7	12.8	10.4	0.0	7.0	0.0	0.0	0.0	0.0	6.9	0.0	0.0	0.0	59.4	0.0	12.0	0.1	0.0	5.5	0.6	0.8	1.0	1.3	0.4	0.3	0.9	0.9	1.3	0.2	0.0	4.8	8.2	3.1	8.9	0.0	0.8	372.0	2.7	20.5	19.2	0.0	9.7	36.5	10.6	0.1	1.8	993.7	0.0	328.5	12.0	36.3	18.0	24.2	144.7	39.4	0.0	2.9	101.9	51.7	0.0	2.6	46.4	3.3	39.7	10.5	0.0	120.5	201.5	1.4	388.5	0.0	25.8	5.0	0.4	0.1	5.1	5.4	1.0	18.3	1.3
AOAH		ENSG00000136250	"Acyloxyacyl hydrolase"	P28039	7	36512949-36724549	"Enzymes, Predicted secreted proteins"	"Lipid metabolism"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 54.6;lymphoid tissue: 57.4"	"Cell type enhanced"	"Detected in many"	17	"Hofbauer cells: 31.1;Kupffer cells: 110.3;Macrophages: 54.2;T-cells: 51.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"classical monocyte: 54.6"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"GAMG: 4.1;NB-4: 21.3;THP-1: 16.3;U-937: 7.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"HPA021666, HPA026716"	Approved		Uncertain	Vesicles	"Secreted to blood"	NA	NA			Vesicles		"HPA021666: AB_2670799, HPA026716: AB_2671960"	"unprognostic (3.55e-2)"	"unprognostic (4.03e-3)"	"unprognostic (4.45e-2)"	"unprognostic (3.58e-1)"	"unprognostic (6.06e-2)"	"unprognostic (4.78e-2)"	"unprognostic (2.40e-1)"	"unprognostic (3.14e-3)"	"unprognostic (5.42e-2)"	"unprognostic (6.02e-2)"	"unprognostic (3.36e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.46e-3)"	"unprognostic (1.75e-1)"	"unprognostic (1.92e-3)"	"unprognostic (2.38e-1)"	"unprognostic (1.35e-1)"	8.4	3.4	5.2	17.2	4.9	19.3	2.8	1.9	3.6	3.1	5.3	7.4	0.2	4.9	3.9	7.2	2.5	3.1	8.4	3.4	4.8	3.8	3.1	6.8	9.4	23.2	6.9	2.0	2.1	2.3	0.6	2.4	5.7	5.8	3.8	7.3	3.8	4.5	1.4	1.5	1.6	7.6	4.7	12.6	57.4	3.3	1.4	6.8	14.0	2.9	0.4	10.9	7.2	2.8	0.3	34.8	18.7	54.6	19.2	8.8	31.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.1	0.5	0.0	0.0	0.0	2.9	0.0	0.3	0.1	0.0	0.0	1.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.5	21.3	0.1	0.0	0.0	0.4	0.0	0.2	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	16.3	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	7.1	0.0	0.3	54.6	17.6	8.8	47.9	1.8	0.3	0.4	6.1	34.8	0.0	1.0	7.8	18.7	19.2	20.2	0.5	0.1	31.0	5.2	4.9	1.9	3.6	4.8	3.8	6.9	2.0	5.8	6.8	0.0	14.0	8.8	0.0	0.7	0.0	0.4	0.0	1.4	4.5	0.0	0.0	0.2	1.7	0.2	0.4	0.5	5.8	0.0	0.0	0.2	0.5	0.1	4.7	0.6	31.1	0.0	14.9	3.1	110.3	0.4	0.0	54.2	0.0	19.0	0.4	3.2	0.0	1.5	0.4	0.3	0.2	0.0	0.9	0.0	0.0	0.3	0.1	51.7	0.5	0.1
AOC1	"ABP1, DAO"	ENSG00000002726	"Amine oxidase, copper containing 1"	P19801	7	150824627-150861504	"Enzymes, Predicted secreted proteins"		"Heparin-binding, Oxidoreductase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"intestine: 108.6;placenta: 240.4"	"Cell type enhanced"	"Detected in many"	19	"Collecting duct cells: 258.2;Enterocytes: 648.3;Paneth cells: 375.2"	"Group enriched"	"Detected in many"	5	"colorectal cancer: 61.3;endometrial cancer: 39.1;pancreatic cancer: 26.9;renal cancer: 69.4;stomach cancer: 43.2"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in some"	10	"eosinophil: 20.3"	"Lineage enriched"	"Detected in many"	20	"granulocytes: 20.3"	"Cell line enhanced"	"Detected in some"		"CAPAN-2: 16.4;HaCaT: 5.0;NB-4: 5.0;RPMI-8226: 6.0;THP-1: 21.4"					"Not detected"	"Not detected"			"HPA031032, HPA031033"	Approved				"Secreted in other tissues"	NA	NA		800000			"HPA031032: AB_10670150, HPA031033: AB_10669670"	"unprognostic (1.73e-2)"	"unprognostic (2.53e-1)"	"unprognostic (1.58e-2)"	"unprognostic (2.84e-2)"	"unprognostic (6.31e-3)"	"unprognostic (8.31e-3)"	"unprognostic (9.07e-3)"	"unprognostic (6.42e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.96e-1)"	"unprognostic (3.11e-1)"	"prognostic favorable (1.71e-4)"	"unprognostic (5.32e-3)"	"unprognostic (3.62e-2)"	"unprognostic (1.49e-2)"	"unprognostic (1.69e-1)"	"unprognostic (1.64e-1)"	0.3	0.3	0.3	6.7	0.3	0.0	0.3	0.3	0.3	0.9	68.3	0.2	1.2	30.2	0.3	3.9	1.7	0.3	4.4	0.3	0.3	0.3	37.9	1.5	0.3	0.6	0.3	0.1	0.3	0.6	0.0	0.3	240.4	0.1	1.3	15.5	0.1	0.4	0.2	0.3	0.8	108.6	0.2	0.3	0.4	2.7	1.8	0.1	0.7	0.3	0.1	1.0	0.4	0.4	0.0	1.0	20.3	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.4	0.0	0.0	0.8	0.1	0.0	0.0	0.0	2.5	16.4	0.0	2.2	0.0	1.4	5.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.4	0.0	0.3	0.1	5.0	0.2	1.5	0.0	0.0	0.0	6.0	0.2	0.1	1.8	2.1	0.0	0.7	0.0	0.3	0.6	21.4	0.5	0.2	0.1	0.5	0.0	0.2	0.1	0.1	0.1	0.8	0.0	0.1	0.1	20.3	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.3	0.3	0.3	0.3	0.3	0.1	0.1	0.1	0.0	0.0	2.2	0.0	0.0	0.0	0.3	0.0	0.0	1.2	258.2	0.0	1.1	13.3	0.0	5.7	0.0	648.3	0.0	3.0	3.0	0.2	0.9	5.7	0.0	2.8	0.0	41.6	0.0	0.0	8.4	0.0	1.3	0.0	115.4	108.6	0.0	2.2	375.2	0.0	73.1	0.0	0.0	0.1	2.8	0.7	0.1	2.9	0.0	80.4	0.3
AOC2	"DAO2, RAO"	ENSG00000131480	"Amine oxidase, copper containing 2"	O75106	17	42844600-42850707	"Enzymes, Predicted intracellular proteins"	"Catecholamine metabolism"	Oxidoreductase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	11	"retina: 133.5"	"Cell type enriched"	"Detected in some"	9	"Early spermatids: 28.8"	"Cancer enhanced"	"Detected in some"		"testis cancer: 3.8"	"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in single"	4	"neutrophil: 4.0"	"Lineage enriched"	"Detected in single"	6	"granulocytes: 4.0"	"Cell line enhanced"	"Detected in many"		"ASC diff: 14.3"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			HPA057779	Uncertain				"Intracellular and membrane"	NA	NA					"HPA057779: "	"unprognostic (3.79e-2)"	"unprognostic (2.33e-1)"	"unprognostic (5.10e-4)"	"unprognostic (1.90e-2)"	"unprognostic (1.48e-2)"	"unprognostic (2.42e-1)"	"unprognostic (4.63e-2)"	"unprognostic (2.63e-2)"	"unprognostic (1.39e-1)"	"unprognostic (3.64e-2)"	"unprognostic (2.16e-2)"	"unprognostic (8.27e-3)"	"unprognostic (4.55e-5)"	"unprognostic (3.55e-2)"	"unprognostic (2.73e-1)"	"unprognostic (1.63e-2)"	"prognostic favorable (2.47e-4)"	11.6	1.2	0.9	1.3	3.2	1.8	3.1	3.2	1.6	1.5	1.1	0.9	0.9	0.6	1.5	1.2	1.0	1.5	1.5	1.3	1.2	1.8	0.9	3.6	2.2	1.0	0.9	0.9	1.0	1.2	0.8	2.1	0.9	0.9	1.3	0.5	133.5	1.2	1.2	1.4	1.2	1.0	1.3	1.0	1.7	0.7	6.5	0.9	1.0	1.0	0.9	1.2	1.6	0.9	0.1	0.0	4.0	0.0	0.0	0.6	0.0	0.2	2.8	0.6	3.1	14.3	1.4	7.4	0.9	0.9	2.0	2.8	2.2	0.3	1.1	1.4	0.3	0.9	1.2	2.7	0.7	4.1	2.3	7.3	0.4	1.3	2.2	0.9	0.4	2.8	2.2	2.5	1.9	2.9	0.4	0.5	3.8	0.7	2.6	0.6	0.3	0.6	1.1	1.1	0.3	0.9	1.4	2.9	2.3	0.4	4.4	1.0	0.6	0.1	1.0	4.0	6.0	0.5	0.2	0.5	1.9	4.1	2.5	1.2	5.7	5.6	1.1	0.5	2.6	1.0	0.0	0.0	0.8	0.0	0.0	0.6	0.1	0.0	0.0	0.0	0.0	0.2	0.0	4.0	0.0	0.0	0.0	0.0	0.0	0.9	3.2	3.2	1.6	1.2	1.8	0.9	0.9	0.9	0.9	0.0	0.3	0.0	0.5	0.9	0.2	0.3	0.0	0.0	1.2	0.0	2.0	0.1	0.0	0.4	28.8	0.7	0.0	0.0	0.3	0.1	0.2	0.7	0.0	0.8	0.1	0.0	0.0	0.6	0.8	3.3	0.3	0.0	0.0	0.0	0.1	0.3	0.2	0.0	0.0	0.2	0.6	0.0	0.9	2.1	2.7	1.4	0.0	0.0	0.0	0.5
AOC3	"HPAO, VAP-1, VAP1"	ENSG00000131471	"Amine oxidase, copper containing 3"	Q16853	17	42851184-42858130	"Cancer-related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Cell adhesion"	Oxidoreductase	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	19	"Peritubular cells: 70.4;Sertoli cells: 116.4;Smooth muscle cells: 56.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in single"	13	"neutrophil: 1.2"	"Lineage enriched"	"Detected in single"	13	"granulocytes: 1.2"	"Cell line enriched"	"Detected in some"	18	"ASC diff: 85.5"	"Low region specificity"	"Detected in many"							"HPA000980, CAB025797"	Enhanced		Approved	"Golgi apparatus,Cytosol"	"Secreted - unknown location"	NA	NA		240000000	Cytosol	"Golgi apparatus"	"CAB025797: , HPA000980: AB_1078170"	"unprognostic (2.20e-1)"	"unprognostic (4.49e-2)"	"prognostic unfavorable (3.68e-4)"	"unprognostic (2.97e-2)"	"unprognostic (1.17e-1)"	"unprognostic (2.64e-1)"	"unprognostic (2.22e-1)"	"unprognostic (2.15e-2)"	"unprognostic (1.48e-1)"	"unprognostic (4.00e-2)"	"unprognostic (2.95e-1)"	"unprognostic (9.02e-2)"	"prognostic unfavorable (1.79e-5)"	"unprognostic (5.61e-2)"	"unprognostic (1.67e-1)"	"unprognostic (8.39e-2)"	"prognostic unfavorable (6.98e-4)"	97.0	11.5	0.4	18.7	1.0	0.0	67.7	0.5	1.3	26.9	44.3	1.0	16.3	3.6	44.7	34.8	36.1	18.5	50.9	12.1	0.4	0.4	5.8	8.3	48.0	7.9	0.5	1.2	23.8	2.4	2.2	1.3	10.8	2.0	36.5	9.4	32.1	8.0	24.7	7.7	5.5	15.0	79.2	0.6	7.5	17.7	16.2	0.3	1.0	6.6	11.6	2.6	75.9	20.9	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.2	85.5	0.1	1.3	0.0	0.0	0.0	0.2	0.2	0.0	0.1	0.2	0.0	0.0	0.1	0.2	0.0	0.2	0.3	1.5	0.1	0.1	4.7	0.2	0.0	0.2	0.9	0.2	0.1	0.2	0.0	0.0	0.5	0.0	0.4	0.1	0.0	0.0	0.3	0.1	0.0	0.1	0.2	0.2	0.7	0.0	0.5	0.0	0.1	0.0	0.0	0.5	0.6	0.0	0.0	0.0	0.0	0.7	0.3	0.1	1.2	1.4	0.1	0.1	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.4	1.0	0.5	1.3	0.4	0.4	0.5	1.2	2.0	0.3	3.0	8.9	0.8	0.0	2.6	0.0	3.2	0.0	1.4	3.4	0.0	0.0	0.1	0.0	0.1	3.8	4.7	0.0	0.0	0.2	0.1	2.6	0.2	1.1	0.0	1.1	0.0	0.0	22.7	3.0	2.1	3.1	0.5	3.3	0.0	0.0	0.4	0.1	0.0	70.4	0.7	0.5	116.4	56.5	0.9	0.7	1.6	0.2	0.0	0.0	0.3
AOX1	"AO, AOH1"	ENSG00000138356	"Aldehyde oxidase 1"	Q06278	2	200585868-200677064	"Enzymes, Plasma proteins, Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"liver: 228.8"	"Cell type enriched"	"Detected in many"	6	"Hepatocytes: 649.9"	"Cancer enriched"	"Detected in many"	9	"liver cancer: 122.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC diff: 85.8;ASC TERT1: 44.1;HSkMC: 17.7;hTERT-HME1: 17.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA040199, HPA040215"	Enhanced					NA	NA		410000			"HPA040199: AB_10795273, HPA040215: AB_10795360"	"unprognostic (4.39e-2)"	"unprognostic (1.03e-3)"	"unprognostic (1.96e-1)"	"unprognostic (3.15e-2)"	"unprognostic (1.17e-4)"	"unprognostic (1.92e-2)"	"unprognostic (2.34e-2)"	"unprognostic (3.54e-1)"	"unprognostic (1.15e-1)"	"unprognostic (4.93e-2)"	"unprognostic (5.48e-2)"	"unprognostic (2.00e-2)"	"prognostic favorable (6.05e-5)"	"unprognostic (1.33e-2)"	"unprognostic (8.16e-3)"	"unprognostic (3.38e-2)"	"unprognostic (4.99e-3)"	12.8	55.6	0.1	1.8	0.4	0.2	10.5	0.3	0.2	2.9	3.2	1.3	18.6	0.3	2.0	11.1	3.9	8.1	4.0	3.5	0.3	0.0	20.8	228.8	3.6	7.5	0.2	0.2	12.2	28.5	0.2	0.8	1.9	0.6	4.4	1.0	1.6	2.7	20.1	2.5	3.2	1.7	6.9	0.4	1.7	2.4	10.8	0.2	0.1	4.8	2.7	0.6	7.1	10.6	0.0	0.0	0.0	0.5	0.0	0.2	0.1	0.1	0.0	0.0	0.0	85.8	44.1	0.0	1.4	2.6	1.1	2.1	0.0	0.0	0.0	0.1	1.7	0.5	0.0	0.0	3.9	4.8	0.0	0.1	0.0	1.0	4.3	5.7	0.2	0.0	17.7	1.0	5.6	17.7	1.1	0.0	0.0	0.0	0.0	3.9	0.1	0.0	0.0	1.7	0.0	1.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.1	0.0	0.0	6.8	3.0	2.4	0.0	0.5	0.0	0.0	0.6	2.3	0.1	0.3	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.4	0.3	0.2	0.3	0.0	0.2	0.2	0.6	0.2	3.0	0.6	13.7	0.5	1.5	0.0	0.7	12.7	0.0	0.0	3.5	0.0	0.0	10.0	0.6	0.5	1.3	0.0	0.0	22.4	0.1	10.2	8.3	0.0	649.9	0.4	0.0	2.9	15.4	20.2	0.9	68.4	1.6	3.3	0.0	0.0	0.4	18.4	0.0	77.1	111.5	0.0	0.0	2.8	0.7	0.6	1.4	0.0	0.0	0.0	0.3
APEH	"D3F15S2, D3S48E, DNF15S2"	ENSG00000164062	"Acylaminoacyl-peptide hydrolase"	P13798	3	49674002-49683963	"Enzymes, Plasma proteins, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029700, HPA029701, HPA029702, HPA029703"	Enhanced		Enhanced	Cytosol		No	No		1600000	Cytosol		"HPA029700: AB_10599278, HPA029701: AB_10600333, HPA029702: AB_10602411, HPA029703: AB_10601348"	"unprognostic (4.93e-2)"	"unprognostic (5.42e-2)"	"unprognostic (6.04e-3)"	"unprognostic (2.71e-1)"	"unprognostic (9.32e-2)"	"unprognostic (8.20e-2)"	"unprognostic (3.65e-2)"	"unprognostic (2.48e-1)"	"unprognostic (5.89e-2)"	"unprognostic (8.03e-2)"	"unprognostic (3.21e-1)"	"unprognostic (4.30e-2)"	"prognostic favorable (3.32e-10)"	"unprognostic (2.11e-2)"	"unprognostic (1.12e-1)"	"unprognostic (4.34e-2)"	"unprognostic (7.67e-2)"	12.3	31.4	14.3	16.9	18.4	17.3	13.5	14.2	28.2	13.4	23.5	14.4	25.3	24.2	14.1	19.0	23.8	17.2	19.1	23.1	14.2	14.2	33.6	36.9	15.0	23.9	13.9	20.0	13.9	22.7	33.5	26.6	18.6	16.3	16.1	26.6	19.5	19.8	19.8	55.1	16.9	21.7	14.1	9.8	19.2	21.9	22.3	11.7	22.6	26.6	26.6	20.7	19.9	13.7	20.5	26.2	30.4	27.9	21.8	29.5	28.1	25.8	21.1	23.2	30.0	20.3	13.6	30.7	16.9	21.7	23.8	25.5	34.0	28.1	33.1	19.0	19.2	21.7	24.0	25.9	39.2	18.1	15.7	10.7	35.7	35.3	27.8	20.1	38.2	55.6	15.4	29.6	13.6	28.3	23.8	21.5	23.3	22.1	16.5	23.6	23.9	26.9	19.4	13.7	37.3	19.3	10.2	19.9	43.0	47.1	61.4	11.1	19.3	19.1	46.4	21.0	17.9	30.6	20.4	9.7	14.7	25.8	23.0	22.8	18.9	13.5	19.7	25.4	27.1	21.2	30.2	25.5	30.4	28.5	27.9	22.5	20.5	23.5	26.7	26.2	17.4	24.9	24.2	8.0	21.8	26.7	21.0	29.5	28.1	14.3	18.4	14.2	28.2	14.2	14.2	13.9	20.0	16.3	11.7	38.7	22.3	16.0	19.8	7.7	7.8	42.0	33.1	9.4	20.5	26.2	11.8	72.6	36.5	39.0	4.6	8.3	73.8	23.3	30.4	54.6	12.8	15.2	23.1	65.2	45.5	7.9	25.4	14.1	36.8	8.1	14.1	18.1	20.3	22.6	44.7	21.8	35.8	28.8	12.7	64.9	9.9	12.9	14.2	30.5	28.4	8.2	51.9	25.3	51.1	21.0
APEX1	"APE, APE-1, APEN, APEX, APX, HAP1, REF-1, REF1"	ENSG00000100823	"Apurinic/apyrimidinic endodeoxyribonuclease 1"	P27695	14	20455191-20457772	"Cancer-related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"	"DNA damage, DNA recombination, DNA repair, Transcription, Transcription regulation"	"Activator, DNA-binding, Endonuclease, Exonuclease, Hydrolase, Nuclease, Repressor, RNA-binding"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA000956, HPA002564, CAB004294, CAB047307"	Supported		Supported	Nucleoplasm		Yes	No		98000	Nucleoplasm		"CAB004294: AB_626685, CAB047307: , HPA000956: AB_2666158, HPA002564: AB_1078174"	"unprognostic (2.80e-3)"	"unprognostic (1.39e-1)"	"unprognostic (1.55e-2)"	"unprognostic (4.74e-3)"	"unprognostic (1.97e-2)"	"unprognostic (5.88e-2)"	"prognostic unfavorable (7.82e-5)"	"unprognostic (4.21e-2)"	"unprognostic (3.14e-2)"	"unprognostic (2.46e-2)"	"unprognostic (2.42e-2)"	"unprognostic (1.68e-1)"	"unprognostic (1.38e-1)"	"unprognostic (1.22e-1)"	"unprognostic (1.83e-2)"	"unprognostic (2.54e-1)"	"unprognostic (7.08e-2)"	43.9	52.8	30.6	33.2	32.5	55.6	43.6	24.1	44.9	38.5	41.9	37.3	28.4	44.1	53.2	30.1	40.7	42.9	46.4	34.4	28.0	27.4	44.4	61.3	31.8	44.5	30.2	31.1	64.7	48.4	31.8	21.7	29.4	34.4	36.1	39.8	36.0	35.5	38.9	53.2	41.2	37.6	40.9	30.1	51.0	41.7	20.9	28.3	73.2	51.2	38.5	48.4	41.8	32.7	35.0	53.0	1.5	23.7	20.6	32.5	38.4	44.6	54.9	49.3	45.4	34.7	50.1	42.5	42.0	45.2	62.6	54.3	40.0	44.4	86.3	37.5	32.0	33.5	47.9	58.6	44.4	58.2	38.5	25.0	34.9	32.5	66.7	36.5	110.9	36.3	51.7	49.0	40.7	40.4	50.2	52.2	35.7	40.5	28.4	50.1	43.5	71.0	46.7	48.5	50.7	49.7	79.0	55.4	36.2	52.5	60.3	59.5	37.8	45.5	56.8	45.1	36.3	34.5	50.2	33.7	33.0	55.4	33.2	39.1	38.2	66.1	58.2	14.8	70.5	41.7	0.1	23.7	1.5	19.0	20.5	25.9	35.0	23.8	22.6	46.8	31.4	32.5	28.3	1.5	20.6	12.4	53.0	14.1	38.4	30.6	32.5	24.1	44.9	28.0	27.4	30.2	31.1	34.4	28.3	59.6	45.2	101.2	74.7	94.4	52.3	42.8	86.6	72.3	79.6	64.6	39.3	161.9	127.6	119.2	16.8	57.5	33.9	0.0	91.3	165.4	86.9	49.2	78.7	65.2	158.8	27.0	115.1	39.3	80.7	4.0	74.5	109.4	60.8	100.0	78.8	68.5	83.2	73.7	60.5	126.7	45.4	51.8	136.6	6.3	43.7	84.8	84.9	76.1	136.8	42.5
APEX2	"APE2, APEXL2, XTH2, ZGRF2"	ENSG00000169188	"Apurinic/apyrimidinic endodeoxyribonuclease 2"	Q9UBZ4	X	55000357-55009057	"Enzymes, Predicted intracellular proteins"	"Cell cycle, DNA damage, DNA recombination, DNA repair"	"DNA-binding, Endonuclease, Exonuclease, Hydrolase, Nuclease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Erythroid cells: 70.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA048577			Supported	"Nucleoplasm,Nucleoli fibrillar center,Vesicles"		NA	Yes			"Nucleoplasm, Nucleoli fibrillar center"	Vesicles	"HPA048577: AB_2680448"	"unprognostic (2.90e-2)"	"prognostic favorable (6.17e-4)"	"unprognostic (4.32e-2)"	"unprognostic (2.39e-1)"	"unprognostic (1.62e-1)"	"unprognostic (5.62e-2)"	"prognostic unfavorable (6.13e-7)"	"unprognostic (5.89e-2)"	"unprognostic (4.87e-2)"	"prognostic favorable (5.21e-4)"	"unprognostic (7.46e-2)"	"unprognostic (3.16e-1)"	"unprognostic (6.86e-2)"	"unprognostic (1.03e-2)"	"unprognostic (3.17e-2)"	"unprognostic (1.40e-1)"	"prognostic favorable (6.63e-4)"	11.1	12.8	8.6	12.0	12.3	11.9	10.2	8.7	11.8	10.0	12.3	13.7	8.2	12.3	11.5	12.6	20.8	10.7	13.9	10.6	8.7	7.2	15.4	18.5	10.3	14.2	9.7	6.0	14.4	10.7	10.7	12.7	17.8	8.8	11.0	15.1	9.1	10.4	10.0	10.3	16.7	18.7	10.0	9.9	18.0	10.8	7.7	8.9	21.9	10.6	10.2	27.4	11.6	12.7	6.7	9.4	9.2	9.9	26.6	7.5	6.3	22.0	19.9	7.9	11.4	11.5	7.7	13.4	9.1	12.3	17.7	17.3	10.8	18.6	14.6	14.3	8.6	20.9	16.6	18.0	17.3	13.4	11.8	13.7	17.8	19.8	11.0	7.4	10.9	16.8	7.6	14.2	24.9	9.0	8.4	14.0	15.6	9.1	9.9	13.1	21.5	14.7	14.3	15.6	10.5	24.0	13.1	13.1	15.9	9.5	11.1	7.3	8.0	17.2	20.9	8.8	18.8	16.5	8.5	8.1	10.5	15.3	21.1	11.8	10.4	13.3	12.1	11.2	18.7	12.4	9.2	7.8	8.5	7.5	9.9	6.2	6.1	7.1	7.4	9.4	6.7	6.4	6.2	2.9	26.6	8.3	5.1	7.5	6.3	8.6	12.3	8.7	11.8	8.7	7.2	9.7	6.0	8.8	8.9	3.0	16.9	15.2	10.8	11.4	3.2	4.7	10.2	12.0	9.1	10.4	0.0	43.2	13.3	21.7	0.2	7.7	13.7	70.0	13.2	28.4	7.0	7.8	8.1	10.2	21.2	6.4	5.8	8.6	8.6	0.8	5.5	13.5	0.0	29.7	11.1	5.8	15.0	14.8	8.1	15.8	2.1	19.4	4.4	1.0	10.8	11.0	39.8	15.8	11.3	10.0
APIP	"APIP2, CGI-29, Mmrp19"	ENSG00000149089	"APAF1 interacting protein"	Q96GX9	11	34853094-34916499	"Enzymes, Predicted intracellular proteins"	"Amino-acid biosynthesis, Apoptosis, Methionine biosynthesis"	Lyase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	5	"Distal tubular cells: 159.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021188, HPA024131"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA		77000	Nucleoplasm	Cytosol	"HPA021188: AB_10610977, HPA024131: AB_10602171"	"unprognostic (2.80e-1)"	"unprognostic (7.68e-2)"	"unprognostic (5.30e-2)"	"unprognostic (3.68e-3)"	"unprognostic (4.22e-2)"	"unprognostic (1.76e-1)"	"prognostic unfavorable (1.99e-4)"	"unprognostic (2.74e-2)"	"unprognostic (3.84e-2)"	"unprognostic (9.16e-2)"	"unprognostic (2.45e-2)"	"unprognostic (1.68e-1)"	"unprognostic (1.51e-1)"	"unprognostic (3.23e-1)"	"unprognostic (5.48e-2)"	"unprognostic (7.44e-2)"	"unprognostic (1.58e-2)"	23.2	29.8	12.0	13.7	18.7	9.6	15.8	7.6	12.6	12.7	13.8	17.9	16.8	10.5	15.3	10.8	12.2	13.9	12.1	15.4	14.5	11.7	24.8	21.8	16.2	14.4	21.5	11.7	13.2	19.7	13.4	10.3	12.5	21.1	14.1	12.6	10.4	18.5	20.4	48.7	6.8	13.9	16.0	27.8	13.9	19.1	9.7	21.1	23.9	19.0	12.9	11.5	19.0	16.1	14.2	25.6	14.9	19.8	17.5	15.8	10.6	8.6	9.3	11.0	2.6	9.0	9.0	4.9	12.8	12.3	12.6	14.4	5.5	7.6	26.6	7.8	4.7	13.0	10.4	20.1	8.6	16.3	16.3	19.1	13.7	9.9	13.9	13.9	38.0	10.5	8.8	6.4	8.0	13.2	5.6	10.3	15.5	32.2	16.4	8.7	8.3	18.1	17.5	8.8	11.8	22.0	11.7	32.3	9.1	13.0	12.5	9.3	4.5	16.1	12.9	15.7	5.5	13.5	11.8	8.6	9.5	9.6	24.3	3.1	16.1	12.0	30.0	11.8	8.1	12.1	4.7	16.9	14.9	11.0	17.5	13.6	14.2	13.4	11.9	25.6	13.4	13.8	11.7	4.1	17.5	19.8	16.5	15.8	10.6	12.0	18.7	7.6	12.6	14.5	11.7	21.5	11.7	21.1	21.1	32.8	26.7	21.4	29.7	22.1	22.7	19.8	40.8	48.2	28.4	17.4	3.9	31.1	159.2	23.6	5.4	20.4	30.7	23.3	28.4	20.1	20.0	35.6	19.7	21.2	67.0	17.5	34.1	22.1	46.7	7.4	22.2	39.5	20.3	66.7	30.2	16.6	21.6	24.6	23.3	70.8	21.9	38.8	25.8	22.8	24.0	23.1	22.1	24.1	38.3	41.1
APLF	"C2orf13, MGC47799, Xip1, ZCCHH1"	ENSG00000169621	"Aprataxin and PNKP like factor"	Q8IW19	2	68467561-68655862	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"DNA damage, DNA repair"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	19	"Early spermatids: 110.5;Late spermatids: 132.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"basophil: 9.3"	"Lineage enriched"	"Detected in all"	4	"granulocytes: 9.3"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029396, HPA034642, HPA034643"	Uncertain		Supported	Nucleoplasm		NA	NA			Nucleoplasm		"HPA029396: AB_10610285, HPA034642: AB_2674259, HPA034643: AB_10602431"	"unprognostic (9.37e-2)"	"unprognostic (1.04e-1)"	"unprognostic (2.14e-1)"	"unprognostic (4.29e-3)"	"unprognostic (5.18e-3)"	"unprognostic (2.39e-3)"	"unprognostic (3.24e-1)"	"unprognostic (1.46e-1)"	"unprognostic (4.00e-2)"	"unprognostic (2.78e-1)"	"unprognostic (1.25e-3)"	"unprognostic (3.28e-1)"	"unprognostic (5.02e-3)"	"unprognostic (8.44e-2)"	"unprognostic (5.95e-2)"	"unprognostic (1.35e-2)"	"unprognostic (1.85e-3)"	5.2	4.4	3.8	7.3	6.5	2.8	8.2	1.1	5.0	8.0	5.7	3.1	3.8	2.6	8.8	4.0	10.6	3.3	4.1	3.8	4.7	2.0	3.7	5.1	3.4	5.8	3.6	2.1	4.3	3.8	4.1	5.1	6.2	3.2	8.5	2.7	2.3	6.4	4.8	5.4	9.2	3.3	9.2	5.6	5.7	3.6	4.1	6.1	5.1	4.4	7.5	5.8	6.9	6.9	1.1	1.4	9.3	1.2	1.5	2.2	0.9	3.6	0.9	4.1	4.1	5.5	7.4	2.1	3.2	5.8	1.9	2.4	2.3	3.0	6.7	2.6	2.6	4.5	1.2	0.5	4.4	4.6	6.2	0.8	5.5	0.8	1.4	2.6	1.9	4.9	4.1	3.7	2.7	4.1	4.9	1.4	4.2	1.1	4.8	1.9	0.6	2.7	5.0	2.3	3.6	1.6	3.6	1.4	3.0	3.8	2.0	1.2	2.7	3.2	0.4	3.8	6.0	0.3	1.1	3.6	6.7	1.5	3.4	2.5	4.4	2.4	5.2	2.9	2.7	4.4	9.3	0.9	3.1	0.9	1.2	1.0	1.1	1.4	1.3	1.3	1.0	1.5	0.8	0.0	1.5	0.9	1.4	2.2	0.9	3.8	6.5	1.1	5.0	4.7	2.0	3.6	2.1	3.2	6.1	3.0	1.6	0.9	2.2	2.2	0.1	2.6	0.0	1.4	3.4	0.0	2.0	5.3	0.0	2.7	110.5	2.5	0.0	0.0	1.7	2.0	2.3	1.5	0.0	0.8	1.9	3.2	3.4	2.5	0.3	132.8	4.0	1.7	0.0	6.4	0.5	0.5	0.9	0.0	1.8	1.9	0.3	0.0	2.7	5.0	3.9	2.9	4.1	0.0	0.7	1.3
APOBEC1	"APOBEC-1, BEDP, CDAR1, HEPR"	ENSG00000111701	"Apolipoprotein B mRNA editing enzyme catalytic subunit 1"	P41238	12	7649400-7665903	"Enzymes, Predicted intracellular proteins"	"mRNA processing"	Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in some"	51	"intestine: 56.1"	"Cell type enhanced"	"Detected in some"	23	"Cholangiocytes: 7.6;Enterocytes: 23.9;Paneth cells: 31.7"	"Group enriched"	"Detected in some"	9	"colorectal cancer: 6.2;pancreatic cancer: 6.1;stomach cancer: 3.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	23	"CAPAN-2: 6.2;OE19: 8.0"	"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"									NA	NA								"unprognostic (2.35e-1)"					"unprognostic (3.80e-4)"			"unprognostic (7.96e-3)"			"unprognostic (1.79e-1)"	"unprognostic (4.38e-1)"			0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	16.8	0.0	0.0	23.7	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	56.1	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	23.9	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	2.5	31.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0
APOBEC2	"ARCD1, ARP1"	ENSG00000124701	"Apolipoprotein B mRNA editing enzyme catalytic subunit 2"	Q9Y235	6	41053304-41064511	"Enzymes, Predicted intracellular proteins"	"mRNA processing"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	13	"heart muscle: 58.4;skeletal muscle: 163.0;tongue: 53.9"	"Cell type enriched"	"Detected in many"	5	"Cardiomyocytes: 89.6"	"Cancer enhanced"	"Detected in some"		"pancreatic cancer: 4.9"	"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"BEWO: 2.2;CACO-2: 9.0;HSkMC: 3.1;SuSa: 2.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA014252, HPA017957"	Enhanced					NA	NA					"HPA014252: AB_1844932, HPA017957: AB_1844933"	"unprognostic (5.05e-2)"	"unprognostic (5.55e-2)"	"unprognostic (1.87e-1)"	"unprognostic (2.77e-1)"	"unprognostic (2.51e-2)"	"unprognostic (8.16e-3)"	"unprognostic (1.43e-1)"	"unprognostic (7.22e-2)"	"unprognostic (1.24e-1)"	"unprognostic (2.50e-2)"	"unprognostic (1.21e-1)"	"unprognostic (3.87e-1)"	"unprognostic (2.01e-2)"	"unprognostic (7.02e-2)"	"unprognostic (3.69e-1)"	"unprognostic (1.31e-3)"	"unprognostic (2.19e-2)"	1.1	0.2	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	6.1	2.8	0.0	0.0	58.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	6.8	0.0	0.0	0.1	0.0	1.6	0.0	0.1	3.2	0.0	163.0	0.2	0.2	0.4	0.0	0.0	2.2	0.5	0.0	1.3	0.5	53.9	4.2	0.1	0.0	5.5	5.5	3.6	2.4	1.5	4.8	0.4	0.1	0.0	0.5	0.3	0.0	0.0	2.2	0.0	0.0	0.0	0.0	9.0	0.0	0.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.8	0.1	0.0	0.6	0.0	1.0	0.1	3.1	0.0	0.0	0.0	0.1	0.0	1.4	0.5	0.4	0.0	0.0	0.2	1.0	0.1	1.3	0.1	0.5	0.5	0.1	0.1	0.0	1.2	0.3	0.0	0.0	0.1	2.4	0.2	0.1	0.0	0.0	0.3	0.4	0.1	1.7	0.3	0.8	0.2	0.5	0.0	1.3	2.0	3.6	4.4	1.3	3.5	4.3	4.0	4.8	1.1	5.5	4.2	4.6	1.6	1.5	2.4	5.5	3.3	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.2	2.3	89.6	0.0	0.0	0.0	0.0	2.0	1.4	0.0	2.5	9.7	0.0	0.0	0.0	18.9	5.0	0.0	0.0	0.0	0.0	0.3	1.6	0.0	0.0	0.0	19.0	0.3	0.0	1.7	0.0	0.0	1.0	3.5	0.0	0.0	1.1	2.6	0.0	0.1	0.2	0.2	0.0	1.1	0.0	0.0	0.0
APRT		ENSG00000198931	"Adenine phosphoribosyltransferase"	P07741	16	88809339-88811944	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Purine salvage"	"Glycosyltransferase, Transferase"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA026681	Approved		Approved	Nucleoplasm,Cytosol		NA	NA		1200000	"Nucleoplasm, Cytosol"		"HPA026681: AB_1844964"	"unprognostic (5.87e-2)"	"unprognostic (5.10e-2)"	"unprognostic (1.98e-1)"	"unprognostic (3.67e-2)"	"unprognostic (1.78e-1)"	"unprognostic (2.50e-3)"	"unprognostic (1.72e-3)"	"unprognostic (6.90e-2)"	"unprognostic (1.71e-1)"	"unprognostic (1.82e-1)"	"unprognostic (6.78e-2)"	"unprognostic (8.74e-2)"	"unprognostic (9.58e-3)"	"unprognostic (1.14e-1)"	"unprognostic (2.51e-1)"	"unprognostic (4.75e-2)"	"unprognostic (1.48e-2)"	22.9	37.1	10.9	33.6	13.2	32.9	31.6	10.1	15.3	22.7	31.1	10.7	33.6	27.1	19.9	28.3	50.7	21.0	30.4	22.5	9.1	8.2	27.7	60.4	30.6	94.2	14.8	10.7	17.9	58.2	19.4	15.6	19.3	11.0	25.1	15.1	13.9	48.2	37.4	26.2	49.8	24.3	18.4	12.1	30.4	27.5	16.0	12.2	37.9	29.5	49.7	35.8	18.5	32.8	65.4	92.1	24.2	70.2	58.2	83.7	104.7	25.6	37.7	7.4	33.3	9.1	18.1	39.4	19.4	17.3	22.9	8.9	38.8	31.2	23.9	38.1	11.0	10.9	27.5	12.1	31.9	4.6	16.8	72.1	20.3	17.8	40.5	28.8	13.9	16.7	19.3	34.6	18.3	23.2	10.6	28.6	40.7	42.7	17.9	11.6	94.5	39.2	41.1	28.5	26.7	49.4	42.3	11.5	56.5	25.3	17.5	36.8	22.6	37.0	21.7	20.9	7.2	71.5	27.7	18.5	20.7	18.1	16.7	19.1	35.2	29.5	65.7	30.5	37.0	18.3	8.5	70.2	24.2	63.0	57.7	83.7	63.2	81.9	67.5	71.6	65.4	75.9	64.3	4.3	58.2	37.1	92.1	66.1	104.7	10.9	13.2	10.1	15.3	9.1	8.2	14.8	10.7	11.0	12.2	107.2	125.0	285.8	232.8	283.3	20.2	39.3	252.3	87.0	112.6	87.2	5.9	238.4	344.8	378.2	9.5	147.6	262.7	70.0	383.2	347.1	184.5	203.2	130.3	282.7	315.2	14.3	202.5	130.8	259.2	24.9	222.1	260.5	281.7	449.1	262.5	57.6	343.1	185.9	127.3	427.1	16.1	38.8	137.7	8.1	99.7	432.5	144.4	269.7	340.7	292.1
APTX	"AOA, AOA1, AXA1, EAOH, EOAHA, FLJ20157"	ENSG00000137074	Aprataxin	Q7Z2E3	9	32972606-33025168	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"DNA damage, DNA repair"	"DNA-binding, Hydrolase"	"Disease mutation, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA064930	Supported		Supported	Nucleoplasm,Nucleoli		No	No			"Nucleoplasm, Nucleoli"		"HPA064930: AB_2685386"	"unprognostic (9.18e-2)"	"unprognostic (2.65e-2)"	"unprognostic (3.61e-2)"	"unprognostic (1.73e-2)"	"unprognostic (4.04e-1)"	"unprognostic (8.16e-2)"	"unprognostic (2.26e-2)"	"unprognostic (1.00e-1)"	"unprognostic (1.32e-2)"	"unprognostic (2.78e-3)"	"unprognostic (3.48e-3)"	"unprognostic (3.49e-2)"	"prognostic favorable (6.01e-5)"	"unprognostic (7.87e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.13e-1)"	"unprognostic (6.50e-2)"	12.9	20.3	17.5	11.2	18.4	19.9	16.5	15.1	21.7	12.0	15.2	19.3	9.3	11.7	14.7	12.9	19.1	14.7	8.0	11.9	13.3	13.9	17.9	23.4	12.6	11.8	16.4	16.5	11.8	14.3	15.8	14.3	12.1	20.2	12.1	18.1	14.6	12.5	11.9	14.1	20.6	13.8	14.6	15.7	11.7	12.5	18.2	14.5	8.8	10.5	12.6	16.1	13.4	12.1	17.1	18.4	16.1	20.8	26.4	19.4	15.0	21.6	16.4	12.5	10.8	12.8	11.2	16.6	14.5	15.1	17.7	19.6	21.8	7.7	16.9	8.7	12.1	11.0	11.5	20.3	19.4	22.0	22.8	8.3	10.0	23.5	22.2	14.8	16.1	9.6	15.0	23.8	20.3	26.4	11.3	16.9	13.1	15.1	16.9	16.5	9.3	14.4	23.7	19.1	14.2	17.7	13.1	8.7	12.0	14.5	13.2	8.7	7.3	13.3	11.9	9.7	12.1	13.5	6.6	10.4	9.9	13.2	17.1	14.9	7.3	12.0	16.9	14.7	13.2	7.9	9.1	17.7	14.9	13.4	16.3	17.6	17.0	15.2	15.5	18.4	17.1	18.0	14.6	16.1	26.4	20.8	17.9	19.4	15.0	17.5	18.4	15.1	21.7	13.3	13.9	16.4	16.5	20.2	14.5	17.9	31.9	15.7	18.7	14.8	13.6	12.9	28.1	25.4	19.4	8.7	9.8	23.7	24.9	20.4	49.1	11.9	11.6	0.0	24.6	22.8	12.6	16.4	16.1	17.4	16.5	12.7	16.1	6.7	15.2	35.4	12.4	14.5	13.5	20.8	12.6	17.8	24.5	3.5	9.9	24.1	16.2	12.9	12.2	35.9	27.0	18.4	23.3	14.1	15.1	20.4
AQR	"fSAP164, IBP160, KIAA0560"	ENSG00000021776	"Aquarius intron-binding spliceosomal factor"	O60306	15	34851782-34969839	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"mRNA processing, mRNA splicing"	"Helicase, Hydrolase, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Cone photoreceptor cells: 108.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040624, HPA055647"			Enhanced	Nucleoplasm		No	No			Nucleoplasm		"HPA040624: AB_2677050, HPA055647: AB_2682874"	"unprognostic (1.73e-1)"	"unprognostic (3.71e-2)"	"unprognostic (2.97e-1)"	"unprognostic (1.32e-2)"	"unprognostic (1.03e-1)"	"unprognostic (9.04e-2)"	"unprognostic (4.25e-2)"	"unprognostic (1.90e-1)"	"unprognostic (5.95e-2)"	"unprognostic (2.65e-1)"	"unprognostic (1.14e-2)"	"unprognostic (1.48e-1)"	"prognostic favorable (4.83e-4)"	"unprognostic (2.97e-1)"	"unprognostic (2.47e-1)"	"unprognostic (3.84e-1)"	"unprognostic (3.13e-2)"	15.5	15.8	8.0	14.0	12.4	9.7	16.1	11.2	14.3	16.6	11.2	11.8	8.7	9.2	18.5	11.8	18.3	12.3	8.7	9.9	8.4	7.5	14.4	11.2	10.7	12.6	8.7	6.9	15.5	13.6	16.8	13.2	15.3	13.2	12.0	11.8	12.4	15.1	11.3	8.7	14.2	13.0	14.3	8.3	16.8	12.9	15.8	9.2	27.9	14.8	8.5	16.5	15.7	14.9	5.9	5.5	7.1	5.1	4.5	6.5	2.9	5.0	13.1	8.7	9.1	11.8	11.0	4.5	6.2	7.9	8.3	7.5	5.9	3.1	4.1	4.0	10.5	5.5	8.0	14.6	8.9	9.2	5.8	5.9	13.2	11.6	5.4	6.7	10.7	6.2	8.5	5.9	6.5	6.9	7.8	7.0	3.3	9.3	4.1	8.2	3.4	6.2	7.2	8.6	11.7	5.4	8.5	15.0	4.1	8.4	8.9	9.5	7.4	10.1	9.7	2.2	8.0	6.8	8.4	9.1	6.2	3.4	4.2	5.5	5.0	6.1	8.4	7.7	9.3	6.2	7.1	4.7	2.7	6.5	5.1	5.7	4.0	5.7	6.2	3.8	5.9	5.8	6.4	2.3	4.5	3.0	5.5	4.6	2.9	8.0	12.4	11.2	13.4	8.4	7.5	8.7	6.9	13.2	9.2	11.9	27.0	11.9	11.9	8.5	25.3	14.6	20.4	29.4	36.4	14.0	108.0	13.3	3.3	11.5	36.0	17.9	15.5	0.0	12.3	12.0	10.6	12.5	23.1	17.1	13.1	23.8	12.7	31.9	17.0	6.9	19.2	12.7	15.1	13.6	17.7	17.4	15.9	14.0	17.3	10.3	38.7	6.5	9.8	19.3	20.1	8.4	11.1	20.8	19.1	11.2
ARAF	ARAF1	ENSG00000078061	"A-Raf proto-oncogene, serine/threonine kinase"	P10398	X	47561100-47571920	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"	Proto-oncogene	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA046188, HPA066326"	Approved		Approved	"Nucleoplasm,Nucleoli fibrillar center"		NA	NA			"Nucleoli fibrillar center"	Nucleoplasm	"HPA046188: AB_2679578, HPA066326: AB_2685659"	"unprognostic (1.21e-1)"	"unprognostic (5.69e-3)"	"unprognostic (2.47e-2)"	"unprognostic (2.10e-2)"	"unprognostic (7.63e-2)"	"unprognostic (9.35e-2)"	"unprognostic (1.79e-2)"	"unprognostic (1.07e-1)"	"unprognostic (3.76e-2)"	"unprognostic (1.61e-1)"	"unprognostic (6.75e-2)"	"unprognostic (8.65e-2)"	"prognostic favorable (1.45e-6)"	"unprognostic (1.97e-1)"	"unprognostic (2.01e-1)"	"unprognostic (6.37e-2)"	"unprognostic (4.71e-2)"	22.2	24.2	10.9	16.5	15.5	41.9	19.5	16.0	13.7	18.0	23.2	21.1	24.1	17.8	21.3	18.4	19.4	18.7	21.0	28.6	12.8	7.3	28.0	49.6	21.8	20.2	16.4	9.5	23.4	35.1	28.1	16.9	25.3	13.5	23.5	15.8	25.4	22.1	18.5	60.8	18.9	23.8	18.6	11.2	27.4	24.2	10.2	16.3	27.7	23.1	23.9	27.3	20.2	16.9	23.9	34.3	36.1	38.4	22.4	29.1	27.5	20.3	29.3	12.6	20.2	19.2	15.3	17.0	17.2	18.2	25.7	23.7	23.9	25.0	12.1	14.1	23.0	21.6	28.7	22.2	23.7	14.8	22.3	26.1	12.1	31.1	12.3	27.0	24.0	37.2	20.1	24.2	24.5	21.5	17.0	19.7	15.4	22.5	23.9	17.4	34.4	17.4	25.9	18.1	17.2	32.8	16.2	16.4	27.3	14.7	19.5	14.3	11.0	18.5	17.1	10.1	20.8	32.2	18.2	18.7	16.7	18.8	33.3	17.3	31.0	19.8	9.4	22.2	27.2	13.3	23.9	29.0	36.1	29.1	35.4	26.9	21.4	25.5	26.7	34.3	23.9	22.7	26.7	23.6	22.4	38.4	24.7	25.1	27.5	10.9	15.5	16.0	13.7	12.8	7.3	16.4	9.5	13.5	16.3	14.9	36.4	18.8	19.6	14.0	4.0	23.6	30.6	8.1	10.3	17.4	9.8	27.3	19.9	24.2	1.1	17.9	37.6	0.0	29.9	25.3	15.5	19.0	16.1	35.8	24.8	12.7	30.5	22.7	22.7	3.0	16.1	21.7	32.1	55.1	36.8	13.3	23.6	40.2	16.6	22.1	8.2	19.4	18.6	5.6	10.2	14.2	37.3	27.4	26.6	21.6
AREL1	"FIEL1, KIAA0317"	ENSG00000119682	"Apoptosis resistant E3 ubiquitin protein ligase 1"	O15033	14	74653437-74713115	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Apoptosis, Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA051306	Uncertain					NA	NA					"HPA051306: AB_2681433"	"unprognostic (1.92e-1)"	"unprognostic (1.34e-1)"	"unprognostic (1.76e-1)"	"unprognostic (1.92e-3)"	"unprognostic (1.29e-1)"	"unprognostic (2.49e-2)"	"unprognostic (1.58e-3)"	"unprognostic (9.32e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.32e-1)"	"unprognostic (2.24e-1)"	"unprognostic (2.12e-1)"	"prognostic favorable (4.67e-6)"	"unprognostic (6.73e-2)"	"unprognostic (3.14e-1)"	"unprognostic (1.52e-1)"	"unprognostic (7.18e-2)"	8.5	13.7	11.8	12.2	22.2	17.6	8.8	14.4	25.7	9.3	11.9	16.5	9.8	13.8	12.8	11.4	14.5	12.6	8.4	12.3	11.3	9.7	17.5	9.8	12.1	12.0	8.6	8.4	11.9	15.7	19.4	9.5	11.9	13.3	10.0	15.0	18.3	14.9	9.8	17.9	10.7	16.0	10.1	11.1	12.3	12.0	20.0	7.2	17.1	18.6	11.2	14.9	11.2	10.8	3.2	7.0	9.7	7.6	4.6	7.3	4.5	12.3	15.5	15.4	15.6	13.5	9.7	13.3	13.1	15.6	16.8	16.2	13.0	15.0	10.6	7.1	18.7	15.0	16.0	17.8	14.3	22.1	18.8	8.7	16.2	10.4	8.1	8.8	11.5	16.1	12.5	10.5	12.1	13.2	20.3	15.8	15.9	12.5	11.8	21.6	15.4	12.1	5.0	10.3	15.4	16.1	12.9	17.9	6.6	12.9	28.3	16.8	22.2	12.0	16.1	8.5	10.8	14.0	12.2	22.1	16.4	19.3	9.7	16.1	14.3	21.0	21.7	19.4	8.7	12.4	2.1	4.8	9.7	7.3	7.6	5.4	3.2	4.2	6.0	7.0	2.1	4.6	3.8	9.7	4.6	4.1	2.3	3.8	4.5	11.8	22.2	14.4	25.7	11.3	9.7	8.6	8.4	13.3	7.2	11.9	2.9	2.2	2.9	3.2	11.2	9.3	2.5	2.7	5.7	10.4	25.5	3.4	1.7	5.9	2.3	3.8	12.3	23.3	8.0	2.7	3.5	5.7	1.1	10.5	6.9	15.9	14.3	6.2	13.9	2.7	8.1	5.5	5.0	6.4	12.0	4.8	8.6	7.0	6.3	3.7	11.3	0.0	3.4	6.6	9.8	2.9	4.9	5.7	8.8	5.1
ARG1		ENSG00000118520	"Arginase 1"	P05089	6	131573144-131584332	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Adaptive immunity, Arginine metabolism, Immunity, Innate immunity, Urea cycle"	Hydrolase	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	8	"liver: 284.1"	"Cell type enriched"	"Detected in some"	19	"Hepatocytes: 867.5"	"Cancer enriched"	"Detected in some"	45	"liver cancer: 167.7"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in some"	5	"neutrophil: 24.4"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 24.4"	"Cell line enhanced"	"Detected in some"		"Daudi: 1.5;Hep G2: 1.7;HL-60: 4.0;RH-30: 1.6;SiHa: 1.8;U-698: 2.2"	"Region enhanced"	"Detected in single"		"cerebellum: 2.7"	"Not detected"	"Not detected"			"HPA003595, CAB009434, HPA024006, CAB056159"	Enhanced					NA	NA		15000000			"CAB009434: AB_2058955, CAB056159: AB_2665582, HPA003595: AB_1078190, HPA024006: AB_1844987"	"unprognostic (2.00e-1)"	"unprognostic (2.09e-1)"	"unprognostic (2.49e-1)"	"unprognostic (1.74e-1)"	"unprognostic (9.95e-2)"	"unprognostic (7.96e-2)"	"unprognostic (7.73e-2)"	"unprognostic (1.68e-1)"	"unprognostic (1.22e-1)"	"unprognostic (1.56e-2)"	"unprognostic (7.55e-3)"	"unprognostic (8.35e-2)"	"unprognostic (1.25e-2)"	"unprognostic (2.90e-2)"	"unprognostic (2.75e-1)"	"unprognostic (1.11e-2)"	"unprognostic (1.79e-2)"	1.0	0.0	0.1	0.1	0.1	34.3	0.6	0.1	0.2	0.1	0.1	0.1	0.1	0.0	0.1	0.2	0.2	0.3	0.1	3.0	0.2	0.0	0.1	284.1	5.1	0.8	0.2	0.1	0.4	0.2	0.0	0.1	1.0	0.1	0.1	0.0	0.1	0.1	0.1	0.3	14.6	0.1	0.1	0.1	3.5	0.0	0.3	0.1	0.5	0.3	1.7	0.3	0.3	0.7	0.1	0.1	24.4	0.4	0.0	4.7	0.1	0.0	0.0	0.1	0.4	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.3	0.1	1.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.3	0.2	1.7	0.0	4.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.5	0.6	0.0	0.5	0.1	0.4	0.1	0.0	0.0	0.0	1.6	0.4	0.0	0.3	0.2	0.1	1.8	0.4	0.3	0.2	0.1	0.5	0.0	0.0	0.2	0.3	0.1	1.0	0.2	2.2	0.1	0.5	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.1	0.4	0.1	24.4	0.0	0.4	0.1	4.7	0.1	0.1	0.1	0.1	0.2	0.2	0.0	0.2	0.1	0.1	0.1	0.0	0.0	13.9	0.0	0.0	0.0	0.0	17.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	46.7	0.0	0.0	0.0	0.0	0.0	867.5	0.0	0.0	0.0	25.2	17.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0
ARG2		ENSG00000081181	"Arginase 2"	P78540	14	67619798-67651720	"Cancer-related genes, Enzymes, Predicted intracellular proteins"	"Adaptive immunity, Arginine metabolism, Immunity, Innate immunity, Urea cycle"	Hydrolase	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"prostate: 53.7;thyroid gland: 75.4"	"Cell type enhanced"	"Detected in many"	17	"Basal glandular cells: 140.3;Collecting duct cells: 157.1;Syncytiotrophoblasts: 502.9;Urothelial cells: 134.9"	"Cancer enhanced"	"Detected in all"		"prostate cancer: 49.9"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HAP1: 24.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA000663, CAB009435"	Enhanced		Supported	Mitochondria		NA	NA			Mitochondria		"CAB009435: AB_2059089, HPA000663: AB_1078192"	"unprognostic (8.74e-3)"	"unprognostic (3.06e-2)"	"unprognostic (1.35e-2)"	"unprognostic (2.29e-1)"	"unprognostic (2.30e-1)"	"unprognostic (9.13e-2)"	"unprognostic (1.10e-2)"	"unprognostic (3.43e-3)"	"unprognostic (4.62e-3)"	"unprognostic (5.37e-2)"	"unprognostic (4.66e-3)"	"unprognostic (1.72e-1)"	"unprognostic (9.39e-2)"	"unprognostic (4.26e-1)"	"unprognostic (2.31e-1)"	"unprognostic (4.34e-1)"	"unprognostic (1.26e-1)"	1.5	3.9	2.4	1.7	6.4	0.6	2.7	8.3	5.3	9.3	5.4	0.5	2.0	2.1	3.7	2.3	7.3	0.8	4.9	2.1	3.3	5.5	41.4	2.0	1.7	0.6	3.2	1.7	8.8	2.6	32.1	22.5	4.4	4.6	53.7	1.1	3.4	26.6	3.8	17.2	0.8	10.4	2.2	3.9	0.7	1.4	1.9	2.1	0.1	75.4	13.6	2.2	5.3	4.1	2.5	1.7	2.0	1.4	0.3	2.9	3.4	3.5	0.5	6.2	4.0	0.9	0.0	8.4	2.7	7.5	9.0	15.3	15.3	1.8	6.0	0.7	1.8	4.1	0.8	24.9	11.3	11.0	0.2	6.2	2.7	1.1	17.4	2.7	0.6	16.3	0.4	14.7	4.4	21.5	0.7	15.3	16.1	7.9	0.0	0.6	1.7	0.9	0.6	11.8	1.5	0.2	0.2	0.8	6.8	7.3	5.9	13.8	5.2	1.7	1.7	2.6	15.0	6.4	0.2	3.1	2.7	6.9	0.2	2.0	0.5	0.9	2.0	5.5	3.1	4.6	0.3	1.4	2.0	1.1	0.5	0.5	0.7	0.3	0.9	1.7	2.5	0.6	0.6	1.7	0.3	1.2	0.1	2.9	3.4	2.4	6.4	8.3	5.3	3.3	5.5	3.2	1.7	4.6	2.1	0.0	4.3	3.7	140.3	7.8	5.0	5.0	2.5	2.7	27.3	157.1	9.8	82.0	31.5	9.2	12.3	3.0	14.8	23.3	2.8	5.2	3.7	84.0	6.9	1.5	12.3	9.5	35.3	1.8	0.3	1.0	0.3	3.9	10.1	1.0	4.3	40.7	4.5	3.5	0.4	75.6	16.0	6.5	4.1	7.2	2.6	4.6	502.9	5.0	3.3	134.9
ARIH1	"ARI, HARI, HHARI, UBCH7BP"	ENSG00000166233	"Ariadne RBR E3 ubiquitin protein ligase 1"	Q9Y4X5	15	72474326-72602985	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003295, HPA073245"	Approved		Approved	"Nucleoplasm,Golgi apparatus"		NA	NA			"Golgi apparatus"	Nucleoplasm	"HPA003295: AB_1845017, HPA073245: AB_2686587"	"unprognostic (3.31e-2)"	"unprognostic (1.92e-1)"	"unprognostic (2.25e-1)"	"unprognostic (3.18e-2)"	"unprognostic (8.21e-2)"	"unprognostic (5.45e-2)"	"unprognostic (1.73e-1)"	"unprognostic (9.43e-2)"	"unprognostic (7.92e-2)"	"unprognostic (1.37e-1)"	"unprognostic (4.96e-2)"	"unprognostic (9.19e-2)"	"unprognostic (1.78e-1)"	"unprognostic (2.93e-1)"	"unprognostic (3.19e-1)"	"unprognostic (1.04e-1)"	"unprognostic (5.70e-2)"	15.3	15.6	11.4	17.4	15.5	24.6	13.3	20.4	21.5	15.8	14.5	10.4	14.0	17.0	21.1	11.2	14.2	12.3	14.4	19.7	10.5	10.5	10.9	10.5	13.7	9.3	10.1	15.0	17.3	13.5	12.9	14.0	15.4	12.6	14.0	7.6	13.0	13.2	13.1	68.3	16.3	13.5	15.8	10.7	11.4	12.5	55.2	10.0	16.9	11.7	13.0	12.7	18.4	20.4	1.9	1.1	4.6	1.5	2.1	2.5	0.3	9.4	9.9	9.8	5.7	5.1	3.6	11.5	10.6	3.9	4.8	3.3	10.0	8.1	9.2	16.0	4.5	17.0	13.5	10.0	5.5	2.7	16.4	6.9	7.0	12.2	6.6	3.6	10.4	8.1	4.2	1.9	5.3	6.9	4.6	3.5	6.8	7.3	11.0	4.7	6.1	10.0	4.0	10.6	3.4	3.6	11.4	11.9	5.2	2.7	15.8	9.2	10.5	13.8	6.2	16.3	13.5	5.0	12.0	9.1	8.0	11.1	30.7	14.8	11.6	23.2	10.8	5.3	9.5	8.4	4.6	1.0	2.2	1.7	1.5	1.5	0.7	1.3	1.1	0.7	1.9	1.6	1.5	3.4	2.1	0.7	1.1	2.5	0.3	11.4	15.5	20.4	14.0	10.5	10.5	10.1	15.0	12.6	10.0	17.9	30.7	20.4	42.7	58.8	62.5	41.5	20.4	29.4	30.7	17.4	86.4	15.9	3.3	17.2	84.9	33.4	23.6	0.0	16.2	16.9	29.1	45.9	43.7	24.7	16.7	58.8	44.6	41.1	23.7	41.4	26.4	21.3	15.1	10.0	22.7	24.7	20.6	20.1	25.8	12.2	60.6	19.4	46.1	40.7	29.7	52.2	34.1	30.5	20.9	52.0
ARIH2	TRIAD1	ENSG00000177479	"Ariadne RBR E3 ubiquitin protein ligase 2"	O95376	3	48918821-48986382	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA067381, HPA069715, HPA070963"			Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"HPA067381: AB_2685827, HPA069715: AB_2686182, HPA070963: AB_2686329"	"unprognostic (7.24e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.26e-1)"	"unprognostic (2.74e-1)"	"unprognostic (2.55e-1)"	"unprognostic (4.79e-3)"	"prognostic unfavorable (1.70e-4)"	"unprognostic (1.90e-2)"	"unprognostic (4.01e-2)"	"unprognostic (5.01e-2)"	"prognostic favorable (7.31e-4)"	"unprognostic (5.01e-3)"	"prognostic favorable (6.60e-4)"	"unprognostic (1.15e-1)"	"unprognostic (7.04e-2)"	"unprognostic (1.27e-2)"	"unprognostic (1.39e-2)"	15.0	16.2	14.1	12.8	20.6	16.0	19.2	22.7	22.5	14.1	18.6	25.4	13.9	10.0	18.7	29.2	14.9	16.2	12.8	38.5	15.8	14.9	14.3	17.2	14.5	17.8	24.7	18.3	18.3	20.5	23.1	19.8	15.3	19.7	16.5	15.5	19.2	13.2	19.5	71.3	11.4	14.4	23.0	18.8	17.5	15.7	27.5	21.4	17.7	18.7	15.2	17.2	16.4	14.1	20.6	21.7	27.6	24.5	15.8	32.6	25.3	14.3	14.5	14.0	19.8	20.7	11.4	19.0	16.9	19.8	21.2	23.5	15.2	12.8	29.3	7.9	18.1	30.8	8.6	28.8	17.3	26.0	19.7	17.5	30.2	19.1	12.4	18.8	22.3	14.6	12.2	26.2	26.4	35.9	12.1	15.9	14.1	23.8	20.1	18.7	9.9	22.5	9.2	23.8	15.5	22.0	8.4	16.0	24.4	12.4	19.4	6.1	16.6	16.6	20.9	16.2	17.3	10.6	15.9	15.1	12.9	18.7	19.2	26.5	26.3	50.8	37.1	14.1	18.7	16.1	27.6	24.5	26.2	32.6	21.6	22.1	19.5	20.9	26.7	21.7	20.6	21.6	27.8	17.2	15.8	13.5	18.7	22.9	25.3	14.1	20.6	22.7	22.5	15.8	14.9	24.7	18.3	19.7	21.4	32.8	22.3	31.1	35.9	45.2	56.4	60.0	30.6	37.5	58.0	27.9	82.5	31.2	24.9	23.6	8.2	33.8	20.3	23.3	37.3	30.6	28.0	46.9	42.9	36.5	23.8	54.0	16.0	35.0	26.4	4.7	38.6	33.2	28.7	41.5	22.9	39.7	33.1	22.9	40.7	25.6	73.6	25.8	35.4	140.0	77.3	47.2	44.6	50.1	26.5	58.6
ARSA		ENSG00000100299	"Arylsulfatase A"	P15289	22	50622754-50628173	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		Hydrolase	"Disease mutation, Ichthyosis, Leukodystrophy, Metachromatic leukodystrophy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Enterocytes: 87.0;Late spermatids: 100.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Karpas-707: 39.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA005554, CAB025183"	Enhanced		Uncertain	"Golgi apparatus,Cytosol"	"Intracellular and membrane"	NA	NA		4500000	"Golgi apparatus"	Cytosol	"CAB025183: , HPA005554: AB_1078220"	"unprognostic (1.55e-1)"	"unprognostic (1.97e-1)"	"unprognostic (4.07e-2)"	"prognostic favorable (2.96e-5)"	"unprognostic (4.66e-2)"	"unprognostic (4.40e-1)"	"unprognostic (1.43e-2)"	"unprognostic (1.15e-1)"	"unprognostic (3.61e-2)"	"unprognostic (2.16e-1)"	"unprognostic (4.47e-2)"	"unprognostic (2.76e-1)"	"unprognostic (9.90e-2)"	"unprognostic (1.41e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.87e-1)"	"unprognostic (7.73e-3)"	19.0	15.2	14.0	15.2	15.7	16.6	15.2	11.9	17.9	12.0	20.3	21.4	26.4	30.2	13.3	21.4	15.6	18.5	23.3	18.8	13.4	8.8	17.5	24.1	15.7	16.8	19.1	10.3	9.3	45.4	13.1	20.4	18.5	17.3	15.8	8.8	14.0	36.8	21.9	6.3	11.1	23.4	8.7	13.2	25.6	23.6	27.2	17.9	10.6	18.7	7.5	16.5	14.8	13.3	5.6	15.7	30.1	19.8	3.9	8.9	7.7	4.1	5.8	2.8	5.4	20.9	11.4	7.0	6.7	8.2	2.9	5.0	1.6	6.4	2.8	4.1	11.0	5.4	6.4	0.6	6.2	0.4	1.2	4.4	1.6	6.5	5.8	14.5	2.4	17.1	13.5	12.1	4.8	3.1	9.9	6.6	5.8	1.7	39.3	5.9	4.7	2.2	2.8	0.8	4.3	5.8	2.0	0.2	12.9	4.9	6.4	1.3	4.3	9.5	8.5	4.8	2.6	3.8	3.0	11.6	2.1	8.0	7.5	1.9	9.3	0.8	2.1	6.1	2.2	6.9	4.3	13.7	17.1	8.9	16.0	7.9	5.6	6.5	7.3	11.2	5.6	3.9	5.3	30.1	3.9	19.8	15.7	8.5	7.7	14.0	15.7	11.9	17.9	13.4	8.8	19.1	10.3	17.3	17.9	6.0	11.7	17.5	11.1	4.1	4.9	6.5	30.6	13.4	4.5	12.2	3.9	10.2	1.7	28.6	51.1	7.9	87.0	23.3	18.7	18.1	13.0	12.6	5.8	27.6	33.4	6.4	35.3	9.2	28.5	100.4	10.0	17.4	16.9	37.9	23.2	9.3	25.7	35.9	5.6	20.6	6.2	0.0	4.7	43.1	3.1	4.8	11.1	10.5	19.0	14.9
ARSB		ENSG00000113273	"Arylsulfatase B"	P15848	5	78777209-78986087	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		Hydrolase	"Disease mutation, Ichthyosis, Leukodystrophy, Metachromatic leukodystrophy, Mucopolysaccharidosis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Kupffer cells: 23.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"eosinophil: 17.2"	"Group enriched"	"Detected in many"	7	"dendritic cells: 5.5;granulocytes: 17.2;monocytes: 5.7"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037770, HPA037771"	Approved		Approved	"Golgi apparatus"	"Intracellular and membrane"	NA	NA			"Golgi apparatus"		"HPA037770: AB_10671719, HPA037771: AB_10671720"	"unprognostic (1.61e-1)"	"unprognostic (1.02e-1)"	"unprognostic (1.97e-2)"	"unprognostic (1.09e-2)"	"unprognostic (7.34e-2)"	"unprognostic (2.65e-1)"	"unprognostic (8.69e-3)"	"unprognostic (3.77e-2)"	"unprognostic (1.22e-1)"	"unprognostic (7.20e-2)"	"unprognostic (1.74e-1)"	"unprognostic (3.59e-2)"	"unprognostic (2.48e-2)"	"unprognostic (9.57e-3)"	"unprognostic (9.88e-2)"	"unprognostic (6.54e-3)"	"prognostic unfavorable (3.42e-4)"	15.2	8.4	7.7	9.9	8.9	9.4	11.4	6.2	10.4	7.8	8.7	10.8	2.6	4.0	14.1	6.7	8.6	6.7	12.0	13.0	7.7	5.8	23.2	9.3	10.8	17.2	7.1	6.1	6.1	9.6	10.7	6.1	14.7	7.1	7.5	10.5	12.1	5.2	9.3	5.3	3.4	6.0	18.0	8.3	10.9	7.9	4.1	5.6	7.2	6.4	4.0	6.2	10.3	5.6	1.2	5.5	17.2	5.7	0.1	0.6	1.6	2.3	5.6	9.0	2.9	22.0	8.7	8.3	13.1	11.5	9.7	12.0	4.9	4.3	2.7	14.1	12.7	14.8	1.9	3.4	3.7	9.6	23.3	2.6	4.4	5.9	18.7	5.0	4.9	5.3	10.1	1.2	10.2	3.4	8.1	11.4	1.7	0.9	6.4	9.8	4.5	2.3	9.2	2.7	0.5	2.9	3.4	5.4	2.9	6.1	3.0	3.2	7.4	9.8	3.1	5.7	6.6	3.4	12.8	7.5	8.7	5.0	3.9	11.6	5.5	9.9	3.6	10.6	10.6	19.8	10.5	5.7	17.2	0.6	4.6	0.4	1.2	0.3	0.3	5.5	1.1	0.2	0.4	3.3	0.1	3.7	4.0	0.5	1.6	7.7	8.9	6.2	10.4	7.7	5.8	7.1	6.1	7.1	5.6	0.0	1.3	3.0	1.3	0.7	3.0	5.8	2.5	4.0	0.0	3.5	5.9	1.8	3.3	3.1	0.4	4.3	0.6	0.0	7.9	4.0	9.3	1.9	0.0	3.4	15.4	6.4	1.2	13.5	23.4	0.2	4.0	12.6	13.5	15.4	5.6	3.0	4.4	3.5	3.5	17.2	2.7	6.5	3.1	1.1	1.9	1.1	2.2	2.9	1.9	0.9
ART1	"ART2, CD296"	ENSG00000129744	"ADP-ribosyltransferase 1"	P52961	11	3645128-3664416	"CD markers, Enzymes, Predicted membrane proteins"		"Glycosyltransferase, Transferase"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Group enriched"	"Detected in some"	20	"skeletal muscle: 50.9;tongue: 13.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA051148	Uncertain					NA	NA					"HPA051148: AB_2681363"	"unprognostic (3.73e-1)"							"unprognostic (4.58e-2)"		"unprognostic (3.12e-2)"	"unprognostic (1.35e-1)"	"unprognostic (3.01e-1)"	"unprognostic (1.19e-1)"	"unprognostic (1.06e-1)"		"unprognostic (1.73e-1)"		1.5	0.1	0.1	0.0	0.1	0.0	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.5	0.6	0.1	0.0	0.2	0.1	0.1	0.4	0.0	0.3	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.4	0.2	0.0	0.3	0.2	0.1	50.9	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.1	13.7	0.5	0.0	0.0	0.5	0.0	0.6	0.0	0.0	0.3	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.3	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.2	0.3	0.0	0.5	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.4	0.1	0.1	0.1	0.2	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
ART3		ENSG00000156219	"ADP-ribosyltransferase 3"	Q13508	4	76011184-76112802	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	12	"brain: 29.1;heart muscle: 55.1;skeletal muscle: 85.2;testis: 42.6;tongue: 27.2"	"Group enriched"	"Detected in some"	7	"Cardiomyocytes: 65.9;Spermatocytes: 192.9"	"Cancer enhanced"	"Detected in some"		"breast cancer: 2.3"	"Region enhanced"	"Detected in many"		"cerebellum: 29.1"	"Cell type enriched"	"Detected in single"	5	"gdT-cell: 1.9"	"Lineage enriched"	"Detected in single"	18	"T-cells: 1.9"	"Group enriched"	"Detected in some"	8	"NB-4: 6.2;NTERA-2: 16.9;SK-MEL-30: 7.5"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			HPA011268	Enhanced				"Intracellular and membrane"	NA	NA		45000000			"HPA011268: AB_1845059"	"unprognostic (2.45e-1)"	"unprognostic (2.84e-2)"	"unprognostic (3.12e-2)"	"unprognostic (2.77e-3)"	"unprognostic (4.53e-2)"	"unprognostic (1.34e-1)"	"unprognostic (3.34e-1)"	"unprognostic (9.85e-4)"	"unprognostic (2.35e-1)"	"unprognostic (5.10e-2)"	"unprognostic (1.64e-2)"	"unprognostic (2.95e-1)"	"unprognostic (1.73e-2)"	"unprognostic (2.53e-1)"	"unprognostic (1.48e-1)"	"unprognostic (2.58e-2)"	"unprognostic (6.61e-3)"	3.5	0.6	4.9	0.9	1.9	0.4	0.7	29.1	9.0	1.0	1.3	6.0	0.0	0.6	0.5	1.1	2.5	0.5	0.5	55.1	3.0	0.9	0.5	0.5	0.6	0.5	3.9	2.0	0.5	3.8	0.4	1.1	0.5	2.7	1.0	1.4	0.4	1.3	1.0	85.2	0.5	0.8	0.6	3.0	1.5	0.9	42.6	7.2	0.0	0.5	27.2	0.5	0.6	0.7	0.0	0.0	0.1	0.0	0.0	1.9	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.6	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.4	0.0	1.2	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	6.2	16.9	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.5	0.4	0.0	0.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	1.2	0.0	0.0	0.1	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.2	4.9	1.9	29.1	9.0	3.0	0.9	3.9	2.0	2.7	7.2	0.0	0.0	0.0	0.4	0.5	0.4	65.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.7	0.4	0.0	0.0	0.0	0.1	0.4	0.7	0.0	0.0	0.1	0.0	0.0	0.0	0.0	9.0	1.7	0.0	1.7	0.0	0.0	0.1	0.0	0.0	1.1	0.0	0.3	0.0	3.1	192.9	19.4	0.3	0.0	0.0	0.0	0.4
ART4	"CD297, DO, DOK1"	ENSG00000111339	"ADP-ribosyltransferase 4 (Dombrock blood group)"	Q93070	12	14825569-14843533	"Blood group antigen proteins, CD markers, Enzymes, Predicted membrane proteins, Predicted secreted proteins"		"Blood group antigen, Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 33.7;lymphoid tissue: 17.8;placenta: 17.8"	"Cell type enhanced"	"Detected in many"	20	"Erythroid cells: 93.5;Hepatocytes: 21.3;Ito cells: 55.3"	"Cancer enhanced"	"Detected in some"		"liver cancer: 3.8"	"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"AN3-CA: 5.2;HEL: 10.3;Hep G2: 6.1;HUVEC TERT2: 23.4"	"Region enhanced"	"Detected in single"		"olfactory region: 2.2"	"Low region specificity"	"Detected in single"			HPA075664			Approved	"Rods & Rings"	"Secreted to blood"	NA	NA		11000000	"Rods & Rings"		"HPA075664: "	"unprognostic (2.50e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.57e-1)"	"unprognostic (1.18e-2)"	"unprognostic (1.55e-1)"	"unprognostic (1.37e-2)"	"unprognostic (1.92e-1)"	"unprognostic (1.90e-2)"	"unprognostic (1.10e-1)"	"unprognostic (2.64e-1)"	"unprognostic (1.37e-1)"	"unprognostic (1.90e-2)"	"unprognostic (2.62e-3)"	"unprognostic (4.33e-3)"	"unprognostic (1.25e-3)"	"unprognostic (1.05e-1)"	"unprognostic (1.71e-1)"	2.7	2.0	0.2	1.7	0.2	2.4	2.1	0.2	0.2	1.4	1.3	0.1	1.9	0.0	1.1	3.7	3.1	1.9	6.1	10.1	0.2	0.2	6.6	33.7	2.1	17.0	0.2	0.0	1.3	1.9	0.0	0.4	17.8	0.3	0.8	0.2	0.0	0.7	0.4	1.9	0.5	0.8	1.5	0.2	17.8	0.5	1.4	0.0	0.1	4.6	1.3	1.3	1.3	1.2	0.6	0.6	1.4	0.4	0.6	1.3	0.3	0.0	0.0	0.2	5.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.3	0.0	6.1	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	23.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.6	0.1	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.4	0.4	0.5	0.3	0.4	0.5	0.3	0.3	0.2	0.6	0.5	1.3	1.4	0.6	0.2	0.6	0.2	0.3	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.0	0.3	0.0	0.0	0.6	0.0	0.8	0.2	1.8	1.4	12.7	0.0	0.0	1.8	11.8	0.1	0.0	0.7	0.4	2.8	0.0	93.5	1.8	1.4	1.9	0.1	0.0	21.3	0.1	0.0	0.0	55.3	7.5	0.0	1.7	0.6	1.7	0.0	0.0	0.2	0.3	0.0	0.0	0.0	12.6	6.5	0.8	0.0	0.0	0.1	0.2	0.0	0.0	0.3
ART5		ENSG00000167311	"ADP-ribosyltransferase 5"	Q96L15	11	3638503-3642316	"Enzymes, Predicted intracellular proteins, Predicted secreted proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skeletal muscle: 12.1;testis: 33.3"	"Group enriched"	"Detected in some"	4	"Early spermatids: 12.7;Late spermatids: 14.5;Spermatocytes: 15.9"	"Cancer enhanced"	"Detected in some"		"testis cancer: 4.5"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	11	"memory CD4 T-cell: 1.0"	"Lineage enriched"	"Detected in single"	11	"T-cells: 1.0"	"Cell line enriched"	"Detected in some"	5	"SuSa: 17.9"	"Region enriched"	"Detected in single"	5	"olfactory region: 0.5"	"Not detected"	"Not detected"			"HPA041637, HPA044099"	Uncertain				"Secreted in other tissues"	NA	NA					"HPA041637: AB_2677589, HPA044099: AB_2678808"	"unprognostic (6.32e-2)"	"unprognostic (3.26e-5)"	"unprognostic (4.09e-3)"	"unprognostic (2.06e-4)"	"unprognostic (1.53e-2)"	"unprognostic (1.47e-2)"	"unprognostic (2.22e-2)"	"unprognostic (1.21e-2)"	"unprognostic (5.65e-2)"	"unprognostic (2.59e-2)"	"unprognostic (1.17e-1)"	"unprognostic (1.67e-1)"	"prognostic favorable (1.85e-4)"	"unprognostic (3.10e-3)"	"unprognostic (3.46e-2)"	"unprognostic (1.96e-1)"	"unprognostic (3.18e-1)"	0.8	0.1	0.3	0.3	0.5	0.0	0.8	0.3	0.6	3.3	0.3	0.3	1.0	0.0	3.3	0.9	0.4	1.5	1.2	2.9	0.3	0.2	0.7	0.6	0.9	0.3	0.3	0.3	9.3	0.3	1.7	0.6	1.7	0.5	1.1	0.0	5.3	1.2	0.8	12.1	0.3	0.4	1.0	0.3	0.5	0.3	33.3	0.5	0.3	3.5	5.2	0.5	0.5	1.9	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.1	2.0	2.2	0.0	0.0	3.7	0.2	1.8	0.9	2.1	0.1	0.0	0.0	0.9	0.2	0.0	0.0	1.8	0.0	0.5	0.0	2.6	0.0	0.4	0.2	0.0	0.0	1.7	0.6	0.0	0.0	0.0	0.3	0.0	0.1	0.6	0.0	0.2	0.4	0.0	0.0	1.8	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.7	0.0	1.8	0.1	17.9	0.6	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.5	0.3	0.6	0.3	0.2	0.3	0.3	0.5	0.5	0.0	2.6	0.0	1.8	0.2	0.4	1.6	0.0	0.0	1.2	0.0	0.0	0.4	0.0	0.4	12.7	0.3	0.0	0.0	0.2	0.4	0.7	0.6	0.0	1.7	0.1	0.0	0.0	0.0	0.3	14.5	3.1	0.0	0.0	0.0	0.0	3.3	0.2	0.0	1.1	0.3	0.7	0.0	0.2	15.9	1.7	0.3	2.4	0.0	0.0	0.1
AS3MT	CYT19	ENSG00000214435	"Arsenite methyltransferase"	Q9HBK9	10	102869516-102901899	"Enzymes, Predicted intracellular proteins"		"Methyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adrenal gland: 92.8;parathyroid gland: 30.0"	"Cell type enhanced"	"Detected in single"	20	"Club cells: 1.2"	"Cancer enhanced"	"Detected in single"		"liver cancer: 1.0"	"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	6	"NK-cell: 1.4"	"Lineage enriched"	"Detected in single"	6	"NK-cells: 1.4"	"Cell line enhanced"	"Detected in many"		"AF22: 14.3;REH: 27.2;SH-SY5Y: 14.6;T-47d: 22.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA017856	Enhanced		Approved	Mitochondria		NA	NA			Mitochondria		"HPA017856: AB_1847420"	"unprognostic (1.11e-1)"	"unprognostic (2.02e-4)"	"unprognostic (2.45e-1)"	"unprognostic (2.25e-1)"	"unprognostic (3.39e-1)"	"unprognostic (1.66e-1)"	"unprognostic (7.02e-4)"	"unprognostic (3.22e-1)"	"unprognostic (1.42e-1)"	"unprognostic (3.90e-2)"	"unprognostic (2.03e-1)"	"unprognostic (1.83e-1)"	"unprognostic (3.83e-10)"	"unprognostic (1.04e-2)"	"unprognostic (4.17e-2)"	"unprognostic (1.59e-1)"	"unprognostic (2.16e-2)"	2.0	92.8	3.7	0.7	8.6	0.5	2.6	4.5	6.4	4.0	2.0	2.2	0.4	1.3	3.8	3.2	2.1	2.1	5.2	10.0	5.7	3.1	7.4	22.4	1.7	0.9	2.8	4.4	3.9	8.7	30.0	2.4	0.5	4.6	4.2	0.8	8.9	2.2	3.4	6.0	1.8	1.3	3.9	2.7	5.6	1.7	3.5	1.6	0.3	3.2	1.0	0.7	1.8	1.8	0.0	0.0	0.0	0.0	1.4	0.2	0.0	0.0	3.9	14.3	8.9	0.3	0.3	2.6	4.1	3.5	6.2	7.6	10.6	0.6	0.2	1.2	5.4	0.3	0.2	12.1	0.7	6.4	0.0	3.5	0.0	1.7	10.4	4.1	0.2	0.1	1.9	1.6	0.8	0.0	11.2	0.2	13.2	0.0	0.2	5.5	0.1	2.4	0.3	6.8	0.0	0.6	27.2	0.0	0.1	1.3	0.1	0.4	14.6	0.0	0.2	1.9	4.9	22.7	0.3	0.1	1.3	0.0	2.0	0.0	0.3	0.2	0.0	4.5	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	3.7	8.6	4.5	6.4	5.7	3.1	2.8	4.4	4.6	1.6	0.0	0.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
ASAH1	"AC, ACDase, ASAH, FLJ21558, PHP32"	ENSG00000104763	"N-acylsphingosine amidohydrolase 1"	Q13510	8	18055992-18084998	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Lipid metabolism, Sphingolipid metabolism"	Hydrolase	"Disease mutation, Epilepsy, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	5	"Hofbauer cells: 805.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	5	"basophil: 27.0;classical monocyte: 53.6;eosinophil: 36.5;intermediate monocyte: 77.9;myeloid DC: 20.8;neutrophil: 73.8;non-classical monocyte: 80.5"	"Group enriched"	"Detected in all"	6	"dendritic cells: 20.8;granulocytes: 73.8;monocytes: 80.5"	"Cell line enhanced"	"Detected in all"		"ASC diff: 72.7;SK-MEL-30: 103.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA005468	Supported				"Intracellular and membrane"	NA	NA		410000			"HPA005468: AB_1845062"	"unprognostic (1.99e-1)"	"unprognostic (1.86e-1)"	"unprognostic (4.15e-3)"	"unprognostic (9.23e-2)"	"unprognostic (4.69e-2)"	"unprognostic (4.63e-2)"	"unprognostic (2.25e-2)"	"unprognostic (4.29e-3)"	"unprognostic (2.44e-1)"	"unprognostic (4.85e-2)"	"unprognostic (1.89e-1)"	"unprognostic (3.03e-2)"	"prognostic favorable (3.08e-8)"	"unprognostic (1.95e-1)"	"unprognostic (3.91e-2)"	"unprognostic (6.54e-3)"	"unprognostic (7.36e-3)"	41.9	16.8	18.5	11.2	20.7	20.7	44.2	17.6	19.1	23.9	18.5	15.4	31.5	11.9	17.6	30.6	19.8	16.2	22.3	120.4	17.5	19.2	45.0	13.2	57.2	40.2	27.0	16.7	13.0	16.5	18.0	28.2	36.5	29.8	19.5	19.7	33.3	20.4	39.4	18.2	16.4	16.4	19.5	40.9	25.9	12.9	8.2	15.9	4.5	73.4	15.1	12.3	31.4	16.0	9.8	20.8	73.8	80.5	6.7	6.0	38.7	8.4	11.7	4.6	11.4	72.7	8.6	7.1	8.6	12.3	4.2	7.5	6.2	11.7	5.2	11.0	9.5	28.9	11.1	2.8	4.5	5.2	4.0	6.8	23.3	8.8	16.8	19.9	4.7	26.1	18.5	15.6	6.1	4.2	9.7	1.1	9.0	4.1	11.1	12.1	8.5	2.6	8.4	5.4	18.3	7.2	3.3	4.6	7.0	20.1	48.1	7.6	10.1	8.0	26.4	103.3	6.7	8.6	5.4	7.5	5.5	7.9	10.0	4.1	13.7	30.8	3.8	16.3	10.7	4.4	27.0	53.6	36.5	6.0	77.9	5.4	9.8	4.5	4.5	20.8	7.7	5.3	4.8	73.8	6.7	80.5	3.9	4.9	38.7	18.5	20.7	17.6	19.1	17.5	19.2	27.0	16.7	29.8	15.9	294.8	337.4	90.6	70.3	52.1	87.7	644.7	119.8	140.5	197.9	427.5	43.2	150.6	51.4	112.4	1.9	67.4	63.2	140.2	91.9	53.3	103.9	123.4	247.5	40.0	805.1	73.1	94.1	132.6	474.5	1.9	82.0	445.8	301.9	103.6	90.2	564.6	58.0	94.7	99.3	242.2	72.1	174.6	116.2	11.2	53.7	56.1	123.9	47.3	78.2	113.1
ASAH2		ENSG00000188611	"N-acylsphingosine amidohydrolase 2"	Q9NR71	10	50182778-50248610	"Enzymes, Predicted intracellular proteins"	"Apoptosis, Lipid metabolism, Sphingolipid metabolism"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	17	"intestine: 43.9"	"Cell type enhanced"	"Detected in many"	9	"Late spermatids: 6.0;Muller glia cells: 10.2;Sertoli cells: 6.5"	"Low cancer specificity"	"Detected in single"							"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in many"											HPA061171	Supported		Approved	"Focal adhesion sites"	"Intracellular and membrane"	NA	NA		1200000	"Focal adhesion sites"		"HPA061171: AB_2684442"	"unprognostic (3.59e-2)"	"unprognostic (3.63e-2)"	"unprognostic (1.66e-1)"	"unprognostic (3.84e-2)"	"unprognostic (3.66e-1)"	"unprognostic (4.48e-2)"	"unprognostic (2.25e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.65e-2)"	"unprognostic (4.33e-2)"	"unprognostic (2.17e-1)"	"unprognostic (1.14e-1)"	"unprognostic (8.29e-2)"	"unprognostic (1.86e-2)"	"unprognostic (5.64e-2)"	"unprognostic (3.22e-1)"	"unprognostic (1.02e-3)"	0.3	1.1	0.6	0.2	0.9	0.0	0.5	0.5	1.3	1.7	0.5			43.9	0.7	0.3	0.7	0.5	0.2	0.9	0.5	1.4	0.6	1.6	0.4	0.2	1.2		1.4	1.5	0.3	1.0	0.4		0.5	0.3		0.9	0.2	0.8	0.7	33.4	0.7	0.6	0.2	2.5	1.1			0.6		0.1	1.0	0.5	0.9	0.9	0.0	0.0	0.0	2.2	0.1	1.8	1.4	1.6	2.2	2.9	1.1	2.0	2.0	1.3	3.8	3.5	1.0	4.6	0.0	2.2	2.7	3.1	1.7	2.1	0.7	4.7	2.3	3.8	1.3	3.8	2.9	1.8	0.4	0.2	0.4	2.6	6.6	7.5	0.5	0.8	0.0	2.5	1.2	2.5	1.5	1.4	0.1	4.8	0.0	4.1	0.0	6.4	1.6	2.1	0.3	2.7	7.3	2.5	1.8	3.3	3.9	1.5	1.0	2.0	1.9	4.4	4.7	6.1	1.9	0.2	0.0	5.5	0.0	1.7	0.0	0.0	0.0	0.7	0.0	2.2	0.9	0.4	1.7	0.0	0.1	1.4	2.1	0.0	0.0	0.0	0.9	0.6	0.1											0.0	0.0	0.0	0.2	0.3	1.8	3.0	0.0	0.0	1.2	0.0	2.0	0.3	0.0	1.1	4.1	0.1	1.3	0.0	1.3	0.2	0.4	0.2	0.0	1.8	0.2	1.6	0.0	0.6	0.0	6.0	1.1	0.0	0.0	0.0	1.2	10.2	1.4	0.0	1.4	0.6	1.8	6.5	0.9	0.9	0.8	0.1	0.2	0.0	0.6	0.1
ASCC3	"ASC1p200, dJ121G13.4, dJ467N11.1, HELIC1, RNAH"	ENSG00000112249	"Activating signal cointegrator 1 complex subunit 3"	Q8N3C0	6	100508194-100881372	"Enzymes, Predicted intracellular proteins"	"DNA damage, DNA repair, Transcription, Transcription regulation"	"Helicase, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031608, HPA031609, HPA031610"	Enhanced		Supported	"Golgi apparatus,Cytosol"		NA	NA			Cytosol	"Golgi apparatus"	"HPA031608: AB_10599970, HPA031609: AB_10600777, HPA031610: AB_10611526"	"unprognostic (6.79e-2)"	"unprognostic (1.46e-2)"	"unprognostic (2.96e-3)"	"unprognostic (1.12e-1)"	"unprognostic (9.70e-3)"	"unprognostic (4.56e-2)"	"unprognostic (1.50e-1)"	"unprognostic (5.14e-2)"	"unprognostic (4.02e-1)"	"unprognostic (3.34e-1)"	"unprognostic (5.08e-3)"	"unprognostic (1.16e-1)"	"unprognostic (9.91e-2)"	"unprognostic (1.90e-1)"	"unprognostic (1.56e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.55e-2)"	15.9	15.4	10.9	15.5	14.5	13.6	13.4	16.1	11.7	16.7	13.2	7.7	10.1	11.4	16.4	12.9	18.4	11.3	11.1	14.9	9.7	8.4	10.4	28.3	12.6	13.1	13.1	7.6	13.8	15.1	25.0	38.6	26.1	10.4	16.4	17.1	6.4	15.4	14.0	13.6	15.3	16.1	12.2	15.5	17.7	11.5	11.7	12.4	25.0	10.6	11.6	15.2	16.0	17.9	8.5	9.4	5.9	6.4	6.0	7.8	1.8	7.1	8.9	13.4	8.2	15.0	19.2	20.8	31.2	20.1	10.8	12.5	18.1	5.7	21.9	6.1	20.9	8.6	16.0	11.5	27.7	17.5	13.8	9.8	16.6	16.6	11.8	13.8	17.5	12.8	17.4	14.2	15.7	20.0	10.2	19.8	9.1	19.5	10.0	29.7	6.9	8.7	5.3	7.0	13.7	6.8	10.5	10.2	8.1	10.6	20.2	8.8	6.6	12.9	11.8	5.4	24.9	6.5	10.0	27.1	12.0	9.1	10.4	13.1	4.3	4.0	19.5	8.7	13.2	12.5	5.9	3.9	2.4	6.7	6.4	7.8	5.8	5.6	6.0	4.1	8.5	6.5	6.2	0.3	6.0	5.2	9.4	4.3	1.8	10.9	14.5	16.1	11.7	9.7	8.4	13.1	7.6	10.4	12.4	29.8	19.8	36.0	39.8	22.7	25.2	28.6	20.4	33.5	39.8	3.5	21.6	20.4	10.0	20.1	6.1	18.0	14.6	23.3	21.5	57.6	23.6	58.3	20.9	28.8	15.8	27.0	13.3	8.6	19.6	1.5	21.3	20.7	5.0	15.4	16.4	16.4	22.7	11.0	16.3	9.7	30.3	6.5	26.4	47.4	20.0	24.0	31.8	23.5	17.1	49.7
ASH1L	"ASH1, ASH1L1, huASH1, KMT2H"	ENSG00000116539	"ASH1 like histone lysine methyltransferase"	Q9NR48	1	155335268-155562807	"Enzymes, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Activator, Chromatin regulator, Methyltransferase, Transferase"	"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA004806	Approved		Supported	"Nucleoplasm,Golgi apparatus"		NA	NA			"Nucleoplasm, Golgi apparatus"		"HPA004806: AB_1845087"	"unprognostic (2.98e-1)"	"unprognostic (3.15e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.70e-2)"	"unprognostic (2.05e-2)"	"unprognostic (4.75e-2)"	"unprognostic (1.42e-1)"	"unprognostic (1.87e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.59e-1)"	"unprognostic (1.07e-1)"	"unprognostic (6.84e-2)"	"prognostic favorable (3.80e-4)"	"unprognostic (2.95e-1)"	"unprognostic (1.62e-1)"	"unprognostic (2.45e-2)"	"unprognostic (1.94e-1)"	20.1	10.1	12.1	17.7	14.5	12.3	14.5	23.6	15.5	15.4	17.7	15.5	20.4	8.2	18.7	12.5	12.5	12.2	10.0	11.0	11.8	10.6	13.0	8.9	10.6	9.4	16.6	11.5	23.5	10.0	24.4	22.6	12.9	13.2	18.9	10.7	10.7	11.8	22.2	21.8	12.8	12.8	17.4	14.5	8.6	10.4	7.8	14.3	15.6	16.8	7.1	10.6	17.8	19.9	11.0	5.7	16.5	5.3	8.6	10.7	1.7	13.6	11.7	7.7	6.6	17.4	18.7	8.7	11.1	11.6	7.6	6.4	8.7	9.1	6.1	11.2	14.5	5.8	14.2	12.1	9.7	12.0	6.0	7.8	7.5	11.6	4.7	8.4	8.3	5.9	11.5	10.8	12.7	12.5	11.5	9.0	6.0	10.7	9.2	12.6	10.7	5.6	4.5	7.3	17.0	11.4	5.2	15.9	7.0	8.4	15.1	7.9	11.7	17.5	15.8	8.6	8.4	12.7	18.2	13.8	11.7	12.6	11.1	13.6	8.6	4.9	9.7	9.1	6.3	10.1	16.5	5.3	11.0	8.3	3.2	7.9	10.0	7.8	6.3	2.5	11.0	10.7	5.5	12.8	8.6	3.5	5.7	8.6	1.7	12.1	14.5	23.6	15.2	11.8	10.6	16.6	11.5	13.2	14.3	56.6	88.1	42.2	92.1	92.3	138.8	87.3	43.3	45.5	96.7	48.8	190.5	40.3	14.9	37.0	14.5	82.3	61.6	23.3	34.5	22.1	98.4	94.0	78.6	28.8	21.6	108.1	64.8	59.5	40.8	12.1	94.6	55.1	50.6	62.3	49.5	77.4	31.8	59.1	111.7	23.9	119.9	97.0	97.6	85.7	46.2	97.9	63.7	68.9	46.6	109.1
ASL		ENSG00000126522	"Argininosuccinate lyase"	P04424	7	66075798-66093558	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Amino-acid biosynthesis, Arginine biosynthesis, Urea cycle"	Lyase	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 99.5"	"Cell type enhanced"	"Detected in many"	9	"Enterocytes: 226.8;Hepatocytes: 477.5;Paneth cells: 217.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"CAB003696, HPA016646"	Enhanced		Approved	Cytosol		NA	NA		10000000	Cytosol		"CAB003696: AB_425316, HPA016646: AB_1845096"	"unprognostic (2.95e-2)"	"prognostic unfavorable (4.05e-6)"	"unprognostic (4.83e-1)"	"unprognostic (4.18e-3)"	"unprognostic (3.52e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.98e-1)"	"unprognostic (2.07e-1)"	"unprognostic (7.28e-2)"	"unprognostic (2.49e-2)"	"unprognostic (7.25e-2)"	"unprognostic (4.95e-2)"	"unprognostic (2.07e-2)"	"unprognostic (3.69e-1)"	"unprognostic (1.45e-1)"	"unprognostic (2.19e-1)"	"unprognostic (8.40e-3)"	5.6	4.8	4.0	8.0	4.3	7.3	5.9	7.2	7.4	5.5	17.2	3.7	7.8	20.8	5.0	7.1	7.7	4.9	19.5	4.3	3.7	4.3	16.0	99.5	8.1	4.5	4.4	6.2	5.9	10.4	3.3	5.8	3.3	7.2	5.4	12.4	5.8	7.1	5.7	2.4	4.1	16.6	3.4	3.2	8.6	12.6	2.1	3.5	1.2	7.1	7.9	5.9	5.2	5.9	8.6	19.3	20.7	18.4	30.4	9.2	10.7	18.2	7.5	4.1	14.8	9.5	7.3	9.0	12.8	11.2	18.3	16.7	16.9	22.6	5.6	20.5	16.8	13.3	5.0	2.6	21.7	5.3	4.6	3.4	7.4	7.3	26.1	17.7	8.4	21.7	13.7	7.9	12.8	20.5	4.6	18.0	4.0	13.1	10.7	10.1	13.0	1.7	11.6	6.2	22.8	9.7	4.5	4.3	19.3	13.3	11.0	7.1	9.7	11.7	40.8	4.4	4.4	17.8	7.6	20.4	23.2	12.0	9.2	16.5	11.7	6.1	7.3	21.9	16.0	18.7	12.1	18.1	20.7	7.7	18.4	6.5	8.6	5.2	6.1	19.3	5.6	3.7	4.0	4.0	30.4	13.8	1.2	9.2	10.7	4.0	4.3	7.2	7.4	3.7	4.3	4.4	6.2	7.2	3.5	17.9	52.0	20.8	16.7	4.8	12.5	7.1	132.5	38.8	15.9	29.6	21.6	19.3	44.7	51.9	3.5	25.6	226.8	0.0	192.3	35.3	14.5	13.1	44.9	477.5	40.4	14.3	51.9	35.6	39.6	4.9	8.6	16.1	8.5	61.3	87.3	6.5	99.6	217.5	7.8	174.9	12.2	12.9	13.9	3.0	5.8	3.8	18.7	27.5	126.5	20.6
ASMT	"ASMTY, HIOMT, HIOMTY"	ENSG00000196433	"Acetylserotonin O-methyltransferase"	P46597	X	1615001-1643081	"Enzymes, Predicted intracellular proteins"	"Melatonin biosynthesis"	"Methyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"brain: 8.8;epididymis: 7.0"	"Cell type enhanced"	"Detected in single"	28	"Alveolar cells type 2: 2.6"	"Not detected"	"Not detected"			"Region enriched"	"Detected in some"	5	"pons and medulla: 8.8"	"Group enriched"	"Detected in some"	4	"memory B-cell: 2.2;memory CD8 T-cell: 2.0;naive B-cell: 3.8;NK-cell: 1.0"	"Group enriched"	"Detected in many"	4	"B-cells: 3.8;NK-cells: 1.0;T-cells: 2.0"	"Cell line enhanced"	"Detected in some"		"BEWO: 2.9;NTERA-2: 1.5;U-266/70: 2.2;U-266/84: 3.7"															NA	NA						"unprognostic (1.84e-2)"	"unprognostic (1.63e-3)"	"unprognostic (1.89e-1)"	"unprognostic (1.40e-1)"	"unprognostic (3.02e-1)"	"unprognostic (8.55e-4)"	"unprognostic (1.54e-1)"	"unprognostic (2.27e-2)"	"unprognostic (4.30e-3)"	"unprognostic (1.56e-1)"	"unprognostic (1.43e-3)"	"unprognostic (2.64e-1)"	"unprognostic (4.04e-3)"	"unprognostic (1.49e-1)"	"unprognostic (3.27e-2)"	"unprognostic (2.23e-1)"	"unprognostic (2.79e-3)"	0.6	2.3	0.6	1.2	0.7	2.4	0.8	1.2	0.6	1.3	0.8	0.6	0.6	0.3	1.4	7.0	0.6	0.9	0.7	0.6	0.8	0.7	0.6	0.6	0.8	0.8	1.8	0.6	0.7	1.3	0.7	3.8	0.6	8.8	1.0	0.2	0.6	1.2	1.0	0.8	1.6	0.7	0.9	4.1	1.4	0.6	0.6	0.6	0.6	1.1	0.6	0.6	0.6	0.9	3.8	0.0	0.5	0.0	1.0	2.0	0.1	0.1	0.0	0.1	0.1	0.3	0.0	2.9	0.2	0.0	0.6	0.0	0.0	0.1	0.4	0.1	0.0	0.4	0.3	0.0	0.0	0.2	0.0	0.5	0.0	0.0	0.6	0.0	0.0	0.1	0.0	0.0	0.2	0.3	0.0	0.0	0.3	0.1	0.1	0.0	0.0	0.1	0.1	1.5	0.0	0.0	0.8	0.1	0.2	0.8	0.1	0.1	0.0	0.0	0.4	0.1	0.2	0.1	0.4	0.0	0.0	0.0	1.3	0.0	2.2	3.7	1.3	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	2.2	0.5	2.0	0.0	3.8	0.2	0.1	0.5	1.0	0.0	0.0	0.0	0.1	0.6	0.7	1.2	0.6	0.8	0.7	1.8	0.6	8.8	0.6	0.0	2.6	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.5	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0
ASNS		ENSG00000070669	"Asparagine synthetase (glutamine-hydrolyzing)"	P08243	7	97852118-97872542	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Amino-acid biosynthesis, Asparagine biosynthesis"	Ligase	"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"pancreas: 68.0"	"Cell type enhanced"	"Detected in many"	10	"Early spermatids: 197.3;Erythroid cells: 93.5;Late spermatids: 147.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in all"	5	"B-cells: 8.6;T-cells: 13.2"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004924, HPA029318, HPA064737"	Approved		Enhanced	Cytosol		No	No			Cytosol		"HPA004924: AB_2667295, HPA029318: AB_10602389, HPA064737: AB_2685341"	"unprognostic (3.93e-2)"	"unprognostic (2.51e-1)"	"unprognostic (6.70e-2)"	"prognostic unfavorable (4.24e-4)"	"unprognostic (3.64e-1)"	"prognostic unfavorable (8.79e-5)"	"prognostic unfavorable (9.42e-6)"	"unprognostic (2.28e-2)"	"unprognostic (9.08e-2)"	"unprognostic (1.89e-1)"	"unprognostic (8.10e-3)"	"unprognostic (2.53e-3)"	"prognostic unfavorable (6.21e-7)"	"unprognostic (5.33e-1)"	"unprognostic (2.15e-1)"	"unprognostic (6.21e-2)"	"unprognostic (1.33e-1)"	6.5	7.5	15.9	10.9	21.4	7.6	9.9	31.7	32.3	5.7	10.1	9.4	5.6	6.5	10.0	19.9	10.2	6.9	6.8	9.2	24.5	20.4	6.5	5.9	9.6	16.0	16.3	13.4	19.2	68.0	16.7	16.7	3.2	35.9	9.2	12.7	4.4	49.9	9.3	3.5	13.6	7.8	11.3	20.6	11.0	20.8	16.9	9.2	3.6	16.7	8.2	15.0	9.6	6.6	8.6	1.4	1.5	1.2	2.2	13.2	3.2	19.0	7.3	7.4	60.1	5.9	8.3	18.1	14.1	9.0	6.7	20.2	9.4	7.6	15.0	7.1	28.7	14.0	8.7	19.1	22.3	16.1	18.7	14.1	4.8	3.7	7.0	54.3	30.6	13.5	16.3	75.0	8.8	54.5	3.6	5.5	14.1	26.8	53.3	10.6	40.3	0.9	8.1	10.1	45.6	20.0	2.3	1.4	39.3	4.3	3.7	32.3	24.3	3.6	19.6	76.0	9.9	8.3	21.5	1.4	3.3	22.1	8.8	6.6	63.1	31.5	57.1	41.8	13.9	32.1	1.5	0.3	0.5	3.8	1.2	4.9	8.6	7.4	3.4	1.4	6.2	10.2	5.5	1.5	2.2	0.8	0.1	13.2	3.2	15.9	21.4	31.7	32.3	24.5	20.4	16.3	13.4	35.9	9.2	8.9	4.5	3.7	18.8	11.0	20.1	5.9	12.7	1.4	3.4	8.7	23.6	2.0	6.6	34.4	197.3	3.1	1.7	93.5	52.9	7.7	6.6	17.6	8.1	1.6	1.0	23.8	23.4	2.5	0.6	147.0	8.9	1.8	8.5	11.8	12.9	8.5	38.4	11.9	8.9	3.1	25.4	6.5	12.3	2.3	7.0	9.5	4.7	13.3	7.9	15.2
ASPA	"ACY2, ASP"	ENSG00000108381	Aspartoacylase	P45381	17	3472374-3503419	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		Hydrolase	"Disease mutation, Leukodystrophy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 51.3;kidney: 33.2"	"Group enriched"	"Detected in many"	4	"Collecting duct cells: 24.4;Leydig cells: 46.1;Melanocytes: 43.9;Peritubular cells: 45.3;Proximal tubular cells: 65.3"	"Cancer enhanced"	"Detected in some"		"renal cancer: 7.7"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"ASC diff: 8.3;ASC TERT1: 6.5;CACO-2: 5.5;HSkMC: 11.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA022142, HPA022145"	Enhanced		Approved	Cytosol		NA	NA			Cytosol		"HPA022142: AB_1845102, HPA022145: AB_1845103"	"unprognostic (4.42e-2)"	"unprognostic (4.79e-2)"	"unprognostic (2.02e-2)"	"unprognostic (2.79e-3)"	"unprognostic (4.36e-2)"	"unprognostic (5.01e-1)"	"unprognostic (1.08e-3)"	"unprognostic (3.57e-1)"	"unprognostic (4.17e-1)"	"unprognostic (3.43e-1)"	"unprognostic (5.27e-2)"	"unprognostic (6.27e-2)"	"unprognostic (1.25e-1)"	"unprognostic (7.07e-4)"	"unprognostic (2.77e-1)"	"unprognostic (4.68e-1)"	"unprognostic (1.49e-1)"	10.9	4.1	14.5	1.8	37.6	1.7	3.3	3.0	19.4	6.2	3.6	35.2	3.1	9.7	4.1	5.5	4.5	5.0	3.3	2.2	21.9	11.0	33.2	12.6	3.2	1.3	50.2	11.3	2.9	1.0	0.9	0.9	3.1	18.9	4.0	4.6	2.6	1.9	4.8	9.3	4.6	13.3	2.9	22.4	4.6	3.9	5.6	51.3	0.0	1.8	1.1	0.8	4.5	3.5	1.7	1.2	3.6	0.7	1.6	1.3	0.2	0.4	0.2	0.9	0.7	8.3	6.5	0.5	0.4	0.3	0.3	0.3	5.5	0.3	1.1	0.3	1.0	0.5	0.5	0.5	0.3	0.4	2.9	0.3	0.5	0.9	0.4	0.9	0.7	0.8	11.7	0.6	0.7	0.2	0.4	0.1	0.7	0.6	2.0	0.4	0.4	0.4	1.0	0.8	0.4	0.5	0.4	0.5	0.9	0.4	1.7	0.7	0.5	1.6	0.6	1.3	0.8	0.6	0.3	0.6	1.0	0.7	0.7	0.4	1.2	0.6	0.7	0.4	0.6	0.8	3.4	0.7	0.8	1.2	0.6	1.0	1.1	1.0	0.9	0.5	1.7	1.2	1.3	3.6	1.6	0.7	1.2	0.5	0.2	14.5	37.6	3.0	19.4	21.9	11.0	50.2	11.3	18.9	51.3	8.9	1.0	0.0	1.2	4.6	0.4	0.8	5.1	0.0	1.2	24.4	0.0	0.0	6.6	0.0	2.8	0.5	1.0	0.0	0.2	0.1	7.4	0.3	0.0	10.2	0.2	7.9	2.4	4.9	1.5	0.5	46.1	0.8	43.9	0.0	0.1	3.4	0.0	0.0	45.3	65.3	0.5	0.0	4.2	4.8	0.6	1.5	0.1	0.0	1.2	1.7
ASPDH		ENSG00000204653	"Aspartate dehydrogenase domain containing"	A6ND91	19	50511600-50514690	"Enzymes, Predicted intracellular proteins"	"Pyridine nucleotide biosynthesis"	Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"brain: 26.9;kidney: 24.7;liver: 59.8"	"Group enriched"	"Detected in some"	8	"Hepatocytes: 137.5;Proximal tubular cells: 442.0"	"Cancer enriched"	"Detected in some"	13	"liver cancer: 24.2"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HEK 293: 13.6;MOLT-4: 15.9;SH-SY5Y: 9.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA042631, HPA042654"	Approved		Approved	Nucleoplasm,Cytosol		Yes	NA		51000	Nucleoplasm	Cytosol	"HPA042631: AB_10794530, HPA042654: AB_10794383"	"unprognostic (5.79e-2)"	"unprognostic (9.47e-2)"	"unprognostic (8.97e-3)"	"unprognostic (6.13e-3)"	"unprognostic (5.13e-1)"	"unprognostic (3.64e-2)"	"unprognostic (3.15e-3)"	"unprognostic (3.32e-2)"	"unprognostic (2.87e-2)"	"unprognostic (2.09e-2)"	"unprognostic (2.87e-3)"	"unprognostic (6.70e-3)"	"unprognostic (9.65e-3)"	"unprognostic (3.36e-2)"	"unprognostic (1.07e-1)"	"unprognostic (5.31e-4)"	"unprognostic (1.99e-3)"	1.3	3.2	11.7	1.6	16.2	1.3	0.9	7.4	26.9	0.9	1.0	8.9	0.0	6.9	1.1	0.9	1.2	0.9	2.3	1.2	12.9	8.3	24.7	59.8	1.1	1.6	9.2	9.8	0.9	1.5	0.9	7.7	0.9	4.1	1.2	0.9	1.0	2.3	0.9	1.1	1.8	2.9	0.9	5.1	1.4	1.1	1.1	6.6	1.3	1.7	0.0	0.9	1.1	0.0	0.0	0.4	0.0	0.5	0.0	0.2	0.0	0.1	2.3	0.0	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.2	0.7	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	13.6	0.0	0.6	3.8	0.0	1.1	1.3	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.3	1.6	0.0	1.6	15.9	0.1	0.0	0.5	0.3	0.3	0.3	1.1	0.0	0.2	1.8	9.5	0.0	0.0	0.8	0.0	0.0	0.0	0.3	0.0	0.7	0.0	0.0	3.7	0.7	2.0	0.2	2.4	0.0	0.0	0.5	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.0	11.7	16.2	7.4	26.9	12.9	8.3	9.2	9.8	4.1	6.6	0.0	0.0	0.9	0.0	0.0	22.8	0.3	2.5	0.0	0.0	8.7	3.9	0.0	38.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	137.5	0.0	0.0	6.8	0.0	0.6	1.2	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	442.0	3.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
ASPG	C14orf76	ENSG00000166183	Asparaginase	Q86U10	14	104085679-104115581	"Enzymes, Predicted intracellular proteins"	"Lipid degradation, Lipid metabolism"	"Acyltransferase, Hydrolase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"heart muscle: 29.7;liver: 88.7"	"Cell type enhanced"	"Detected in many"	20	"Cardiomyocytes: 19.5;Hepatocytes: 83.1;Proximal tubular cells: 39.3"	"Cancer enhanced"	"Detected in many"		"liver cancer: 4.4"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"neutrophil: 1.0"	"Lineage enriched"	"Detected in single"	5	"granulocytes: 1.0"	"Cell line enhanced"	"Detected in some"		"EFO-21: 2.6;HDLM-2: 3.0;HeLa: 2.5;HMC-1: 3.2;RPTEC TERT1: 1.9"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			HPA069761	Enhanced					NA	NA					"HPA069761: AB_2686191"	"unprognostic (1.45e-2)"	"unprognostic (7.43e-3)"	"unprognostic (2.38e-3)"	"unprognostic (1.30e-1)"	"unprognostic (7.23e-2)"	"unprognostic (1.74e-2)"	"unprognostic (1.72e-2)"	"unprognostic (3.47e-2)"	"unprognostic (1.98e-1)"	"unprognostic (2.20e-1)"	"unprognostic (2.50e-1)"	"unprognostic (1.10e-1)"	"unprognostic (8.75e-2)"	"unprognostic (7.98e-2)"	"unprognostic (3.85e-1)"	"unprognostic (1.52e-2)"	"unprognostic (2.32e-2)"	0.7	0.5	0.4	0.4	0.5	0.0	2.1	0.4	0.5	1.5	2.3	0.5	0.4	0.5	1.6	1.0	10.2	2.0	0.8	29.7	0.4	0.0	9.8	88.7	1.3	0.9	0.4	0.4	4.9	0.4	0.7	0.4	0.8	0.7	0.4	0.8	1.2	0.8	0.4	0.4	5.2	0.8	1.1	0.4	0.4	1.6	0.9	0.4	0.4	1.3	0.6	1.7	0.5	2.8	0.2	0.0	1.0	0.1	0.2	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	1.2	1.8	0.8	2.6	0.0	0.0	0.2	0.0	0.0	0.0	3.0	0.0	0.0	2.5	0.0	0.0	0.0	3.2	0.0	0.3	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	1.7	0.0	0.1	0.7	1.0	0.0	0.7	0.6	1.9	1.9	1.5	1.2	0.0	0.1	0.8	0.2	1.2	0.5	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	1.0	0.2	0.0	0.0	0.0	0.0	0.4	0.5	0.4	0.5	0.4	0.0	0.4	0.4	0.7	0.4	6.0	1.7	0.0	0.1	1.5	1.0	19.5	2.5	2.7	0.0	0.0	0.0	0.1	3.3	0.0	0.4	0.3	8.4	0.0	0.2	0.1	0.6	0.2	0.0	83.1	0.2	4.8	1.7	3.7	0.6	0.0	0.0	0.0	0.0	0.0	10.8	0.2	0.3	5.9	1.1	39.3	0.2	0.0	0.0	0.4	0.7	8.0	0.5	0.0	3.0	2.5
ASPH	"BAH, CASQ2BP1, HAAH, JCTN"	ENSG00000198363	"Aspartate beta-hydroxylase"	Q12797	8	61500556-61714640	"Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"		"Dioxygenase, Oxidoreductase"	"Cancer-related genes, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Muller glia cells: 462.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"plasmacytoid DC: 21.0"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"U-87 MG: 102.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA055161, HPA059303"	Uncertain		Enhanced	"Endoplasmic reticulum"		NA	NA		900000	"Endoplasmic reticulum"		"HPA055161: AB_2682721, HPA059303: AB_2683973"	"unprognostic (8.07e-2)"	"prognostic unfavorable (8.07e-5)"	"unprognostic (1.73e-2)"	"unprognostic (4.48e-2)"	"unprognostic (2.32e-1)"	"unprognostic (1.85e-2)"	"unprognostic (2.82e-2)"	"prognostic unfavorable (3.61e-4)"	"unprognostic (6.39e-2)"	"unprognostic (3.64e-1)"	"prognostic unfavorable (1.75e-4)"	"unprognostic (9.50e-2)"	"prognostic unfavorable (1.57e-5)"	"unprognostic (8.96e-2)"	"unprognostic (1.65e-1)"	"prognostic unfavorable (4.24e-4)"	"unprognostic (2.74e-2)"	104.6	60.4	27.3	15.0	29.5	4.8	84.3	35.2	31.3	22.3	23.8	10.6	18.3	14.0	16.8	17.8	22.4	16.5	19.1	33.9	26.1	22.4	19.0	23.0	22.5	10.9	21.1	22.2	20.5	13.8	12.5	15.7	14.7	20.5	17.3	26.8	23.6	28.8	23.4	103.1	12.0	13.9	26.1	16.7	12.8	30.5	6.4	19.6	2.9	31.7	36.0	13.7	30.0	25.4	3.3	21.0	15.9	5.2	4.9	3.4	2.3	49.9	72.6	10.2	6.2	45.7	43.5	3.5	89.7	83.3	38.4	40.3	12.4	66.6	3.8	6.2	52.5	30.9	18.7	6.3	31.3	65.7	1.4	6.4	8.9	44.1	33.9	29.3	1.3	1.4	35.7	7.0	21.3	27.3	75.4	16.2	2.0	2.4	3.6	33.8	10.6	0.3	1.8	5.8	48.4	42.8	2.4	11.0	0.8	23.4	41.4	10.6	3.6	27.8	13.1	11.1	5.8	5.3	2.4	50.8	38.9	20.0	35.5	31.6	2.3	2.9	0.1	102.4	0.8	26.0	1.1	5.2	0.1	1.6	1.9	3.1	3.3	2.3	1.6	6.1	3.3	3.4	1.6	15.9	4.9	1.0	21.0	2.3	2.3	27.3	29.5	35.2	31.3	26.1	22.4	21.1	22.2	20.5	19.6	181.7	183.4	8.3	108.3	41.8	126.7	192.2	22.9	57.6	137.6	82.0	276.9	97.4	13.3	97.2	1.6	71.6	39.8	0.0	158.3	85.9	64.5	113.1	8.1	51.6	62.4	120.8	111.8	38.6	25.4	0.5	65.6	43.4	40.5	13.6	178.8	462.0	186.9	24.6	54.1	31.9	150.0	45.3	73.9	2.6	16.8	44.0	40.2	10.0	58.7	212.3
ASRGL1	"ALP, ALP1, FLJ22316"	ENSG00000162174	"Asparaginase like 1"	Q7L266	11	62337448-62393412	"Enzymes, Predicted intracellular proteins"		"Hydrolase, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 52.4;cervix, uterine: 68.7;testis: 57.6"	"Cell type enhanced"	"Detected in many"	10	"Early spermatids: 275.4;Late spermatids: 421.8;Spermatocytes: 320.2"	"Cancer enhanced"	"Detected in all"		"endometrial cancer: 53.4"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"basophil: 51.4;eosinophil: 52.4"	"Group enriched"	"Detected in many"	4	"granulocytes: 52.4;monocytes: 14.2"	"Cell line enhanced"	"Detected in many"		"EFO-21: 30.5;HAP1: 29.4;RPTEC TERT1: 26.0;SCLC-21H: 40.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029725, HPA055572, CAB070192"	Enhanced		Approved	"Nucleoplasm,Microtubules,Cytokinetic bridge"		NA	NA			Microtubules	"Nucleoplasm, Cytokinetic bridge"	"CAB070192: AB_2665720, HPA029725: AB_10602328, HPA055572: AB_2682854"	"unprognostic (1.14e-1)"	"unprognostic (8.38e-3)"	"prognostic favorable (6.14e-4)"	"prognostic favorable (1.56e-5)"	"unprognostic (5.35e-2)"	"unprognostic (8.19e-2)"	"prognostic unfavorable (9.46e-4)"	"unprognostic (8.67e-2)"	"unprognostic (1.85e-1)"	"unprognostic (3.54e-2)"	"unprognostic (2.71e-1)"	"unprognostic (4.44e-1)"	"prognostic favorable (4.32e-7)"	"unprognostic (2.28e-2)"	"unprognostic (1.53e-1)"	"unprognostic (5.43e-3)"	"unprognostic (1.40e-1)"	3.6	2.6	27.8	3.8	37.0	7.1	4.6	12.3	22.3	68.7	7.9	9.9	2.0	4.1	15.3	7.9	1.4	36.8	9.5	1.7	19.5	19.0	23.8	2.4	6.6	3.3	30.8	11.8	1.6	5.1	1.5	5.7	2.3	16.4	8.6	9.9	4.9	6.4	4.8	2.3	1.2	3.1	3.0	9.6	2.4	5.6	57.6	11.3	2.8	3.7	0.0	3.0	2.9	1.0	0.5	8.2	52.4	14.2	2.5	0.7	4.9	0.8	6.7	7.4	9.6	0.0	0.0	5.8	0.8	0.3	1.3	1.2	11.0	3.0	0.7	30.5	0.1	3.3	0.6	29.4	0.3	1.5	1.1	12.1	0.4	9.1	8.0	0.2	8.1	11.0	0.3	0.1	0.6	0.1	0.4	13.8	16.7	8.2	7.6	0.3	12.8	21.8	5.4	10.1	4.6	5.3	8.9	4.4	4.1	26.0	2.1	40.1	5.7	5.7	9.9	4.9	8.0	5.3	4.1	0.7	0.1	5.6	0.4	3.3	11.7	11.1	1.0	0.3	4.2	3.4	51.4	14.2	52.4	0.6	10.3	0.4	0.5	0.2	0.7	8.2	0.4	0.5	0.7	3.3	2.5	7.2	1.4	0.1	4.9	27.8	37.0	12.3	22.3	19.5	19.0	30.8	11.8	16.4	11.3	6.0	26.7	10.4	1.9	3.1	21.7	1.6	53.5	1.4	3.4	21.0	31.4	1.4	112.7	25.5	275.4	23.3	4.1	0.0	19.3	1.8	3.8	54.4	76.5	2.6	22.5	15.9	45.3	31.9	9.1	421.8	8.1	27.7	1.7	0.0	35.8	78.6	8.8	5.8	6.7	99.6	37.4	12.9	2.3	320.2	48.6	1.1	0.7	6.9	26.0	5.3
ASS1	"ASS, CTLN1"	ENSG00000130707	"Argininosuccinate synthase 1"	P00966	9	130444929-130501274	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Amino-acid biosynthesis, Arginine biosynthesis, Urea cycle"	Ligase	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"kidney: 121.5;liver: 309.9"	"Cell type enhanced"	"Detected in many"	10	"Enterocytes: 457.5;Hepatocytes: 809.9;Proximal tubular cells: 889.6;Urothelial cells: 385.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	15	"plasmacytoid DC: 4.6"	"Lineage enriched"	"Detected in single"	46	"dendritic cells: 4.6"	"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 87.4;HaCaT: 82.8;hTCEpi: 80.5;RPMI-8226: 134.1;THP-1: 100.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA020896, HPA020934"	Enhanced		Approved	Nucleoplasm,Cytosol		No	No		4500000	Cytosol	Nucleoplasm	"HPA020896: AB_1845117, HPA020934: AB_1845118"	"unprognostic (3.73e-2)"	"unprognostic (1.77e-2)"	"unprognostic (2.78e-1)"	"prognostic unfavorable (8.14e-9)"	"unprognostic (3.06e-1)"	"unprognostic (1.05e-2)"	"unprognostic (2.93e-2)"	"unprognostic (3.71e-2)"	"unprognostic (3.27e-2)"	"unprognostic (1.22e-1)"	"unprognostic (4.02e-2)"	"unprognostic (4.24e-2)"	"unprognostic (2.92e-3)"	"unprognostic (1.41e-2)"	"unprognostic (1.05e-1)"	"unprognostic (3.14e-1)"	"unprognostic (4.72e-3)"	20.6	15.4	4.6	7.1	4.1	0.0	15.7	2.3	5.4	8.3	18.5	3.5	33.9	11.9	12.0	12.6	9.4	16.6	14.0	11.4	3.8	5.7	121.5	309.9	8.0	2.2	3.2	4.3	11.4	7.9	0.5	4.6	8.7	4.5	12.1	16.8	10.7	26.3	40.6	7.4	12.5	26.8	5.9	3.4	2.7	5.2	8.7	2.2	0.8	17.5	7.0	4.5	17.7	8.6	0.0	4.6	0.0	0.0	0.0	0.0	0.0	11.7	1.1	1.3	2.2	8.9	22.7	4.3	14.0	87.4	2.8	8.5	5.0	3.3	0.0	9.5	28.9	0.8	82.8	5.8	0.5	1.9	2.0	2.6	0.0	1.8	12.8	31.0	1.7	0.1	15.0	80.5	4.5	8.1	0.0	0.1	37.6	0.4	52.2	2.8	58.1	0.6	24.5	1.8	60.2	2.6	0.1	1.5	134.1	7.6	5.8	33.8	0.5	50.0	52.7	3.9	5.4	36.2	100.4	0.0	1.1	7.0	0.2	1.2	8.7	8.3	2.9	22.0	13.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	4.6	0.0	0.0	4.6	4.1	2.3	5.4	3.8	5.7	3.2	4.3	4.5	2.2	23.8	25.8	33.7	45.3	62.6	0.0	5.0	94.3	20.1	50.0	45.4	0.0	159.6	112.7	79.7	0.8	23.2	457.5	0.0	98.3	5.0	15.7	85.0	5.7	809.9	12.7	0.0	11.5	35.0	18.0	2.7	28.7	2.6	3.3	2.8	129.1	4.8	73.5	143.8	117.4	889.6	0.3	0.0	10.8	1.1	2.0	15.3	120.5	12.5	77.1	385.2
ASTL	"ovastacin, SAS1B"	ENSG00000188886	"Astacin like metalloendopeptidase"	Q6HA08	2	96123850-96138436	"Enzymes, Predicted secreted proteins"	Fertilization	"Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"bone marrow: 8.5"	"Not detected"	"Not detected"			"Low cancer specificity"	"Detected in single"							"Low cell type specificity"	"Detected in some"			"Group enriched"	"Detected in many"	5	"NK-cells: 1.9;T-cells: 1.8"	"Cell line enhanced"	"Detected in some"		"BEWO: 3.0;fHDF/TERT166: 2.1;JURKAT: 2.3;RT4: 3.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA015620	Uncertain				"Secreted in female reproductive system"	NA	NA					"HPA015620: AB_1845121"	"unprognostic (3.21e-2)"	"unprognostic (1.45e-2)"	"unprognostic (3.87e-2)"	"unprognostic (3.45e-4)"	"unprognostic (1.00e-2)"	"unprognostic (3.03e-2)"		"unprognostic (3.53e-2)"	"unprognostic (5.12e-2)"	"unprognostic (3.62e-1)"	"unprognostic (3.40e-1)"	"unprognostic (1.95e-1)"	"unprognostic (2.61e-5)"	"unprognostic (3.41e-3)"	"unprognostic (1.08e-1)"	"unprognostic (1.67e-1)"	"unprognostic (9.93e-3)"	0.2	0.1	0.2	0.6	0.4	8.5	0.1	1.3	0.8	0.0	0.5			0.1	0.3	0.4	0.5	0.0	0.4	0.0	0.8	0.0	0.1	0.0	0.5	1.1	0.0		0.2	0.0	0.0	0.8	0.0		0.9	0.2		0.6	2.7	0.0	2.3	1.1	0.0	0.0	2.3	0.2	0.7			0.0		0.7	3.2	0.0	0.3	0.0	0.0	0.0	1.9	1.8	0.3	0.0	0.0	0.0	0.1	0.0	0.4	3.0	0.0	0.0	0.0	0.1	1.2	0.1	0.1	1.2	2.1	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.8	0.0	0.5	1.1	0.9	0.7	0.1	0.0	0.0	0.0	0.4	0.0	3.8	0.8	0.0	0.0	0.3	0.3	0.0	1.4	0.5	0.0	0.0	0.4	0.0	0.0	0.2	0.0	0.5	0.0	0.2	0.2	0.0	0.0	0.0	0.5	0.0	1.2	0.3	1.8	1.8	0.0	0.0	0.3	0.6	0.0	1.9	0.0	0.0	0.0	0.3											0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
ATAD1	FLJ14600	ENSG00000138138	"ATPase family, AAA domain containing 1"	Q8NBU5	10	87751512-87841343	"Enzymes, Predicted membrane proteins"		Hydrolase	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	14	"Early spermatids: 802.3;Late spermatids: 1314.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA037569	Uncertain		Approved	"Nucleoli rim,Mitochondria"		NA	NA			"Nucleoli rim"	Mitochondria	"HPA037569: AB_10672496"	"unprognostic (9.92e-2)"	"unprognostic (2.90e-1)"	"unprognostic (4.05e-2)"	"unprognostic (2.68e-1)"	"unprognostic (3.24e-2)"	"unprognostic (6.60e-3)"	"unprognostic (3.38e-1)"	"unprognostic (1.40e-1)"	"unprognostic (2.35e-1)"	"unprognostic (8.45e-2)"	"unprognostic (1.35e-3)"	"unprognostic (1.67e-2)"	"prognostic favorable (3.98e-6)"	"unprognostic (2.35e-1)"	"unprognostic (3.29e-1)"	"unprognostic (3.45e-2)"	"unprognostic (4.22e-2)"	16.2	21.3	20.4	15.1	26.2	8.0	19.4	22.4	29.8	19.2	15.9	14.4	16.0	13.5	19.6	17.0	17.3	14.8	13.3	39.9	20.4	22.2	20.6	22.1	14.1	14.2	20.4	17.1	19.1	12.6	25.6	24.9	30.2	31.2	24.3	18.4	19.8	15.8	20.4	32.1	14.4	14.1	18.4	18.2	12.5	14.0	19.8	14.7	18.0	20.1	18.5	15.7	18.9	15.2	9.0	7.3	6.7	7.6	9.8	13.5	7.4	9.9	9.4	12.0	11.4	14.5	12.8	9.1	10.1	16.7	10.4	11.7	8.4	28.8	9.6	7.7	8.4	6.1	16.5	10.0	8.6	12.1	8.5	13.5	7.9	13.1	10.4	17.2	21.4	5.4	12.7	23.9	11.0	27.3	19.0	6.9	9.7	7.6	12.5	11.5	6.0	13.7	14.5	8.9	7.7	6.6	9.4	7.6	10.5	15.9	7.6	7.6	16.7	8.9	6.3	20.2	12.7	16.6	10.1	8.4	9.5	8.4	6.4	13.1	16.8	15.4	12.3	10.5	14.9	7.3	6.7	3.8	5.7	9.2	5.9	13.5	9.0	10.3	11.4	7.3	7.6	11.8	11.6	2.2	9.8	7.6	5.5	9.3	7.4	20.4	26.2	22.4	29.8	20.4	22.2	20.4	17.1	31.2	14.7	50.6	28.3	26.2	34.8	23.8	46.9	66.0	25.5	40.2	25.0	21.0	33.4	32.0	19.9	34.6	802.3	18.5	22.5	0.0	24.4	24.9	28.9	35.7	28.8	24.5	24.0	66.7	21.9	12.9	14.8	1314.1	33.1	25.4	30.4	15.4	23.3	53.3	31.9	26.4	44.2	23.7	46.8	58.2	38.7	58.1	20.9	26.3	73.9	29.9	22.1	44.1
ATAD2	"ANCCA, CT137, DKFZp667N1320, MGC29843, MGC5254, PRO2000"	ENSG00000156802	"ATPase family, AAA domain containing 2"	Q6PL18	8	123319850-123416350	"Enzymes, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Activator, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 53.8"	"Cell type enhanced"	"Detected in many"	7	"Spermatocytes: 74.6;Spermatogonia: 90.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"SK-BR-3: 75.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA029424, CAB056158"	Enhanced		Enhanced	Nucleoplasm		Yes	Yes			Nucleoplasm		"CAB056158: AB_2665580, HPA029424: AB_10611680"	"unprognostic (1.56e-1)"	"unprognostic (4.55e-2)"	"unprognostic (2.07e-1)"	"prognostic unfavorable (2.04e-4)"	"unprognostic (2.08e-1)"	"unprognostic (4.44e-2)"	"unprognostic (2.98e-2)"	"unprognostic (2.74e-3)"	"unprognostic (2.02e-3)"	"unprognostic (5.62e-2)"	"unprognostic (1.19e-2)"	"unprognostic (4.98e-2)"	"prognostic unfavorable (8.33e-15)"	"unprognostic (1.15e-2)"	"unprognostic (1.82e-1)"	"unprognostic (4.84e-2)"	"unprognostic (6.17e-2)"	4.1	4.9	4.6	12.6	9.2	22.8	7.2	5.6	6.9	14.0	8.6	1.5	13.4	5.3	4.7	5.0	10.7	4.7	3.5	13.7	4.2	6.3	2.2	10.1	9.8	13.7	4.0	4.3	9.9	3.9	3.5	18.7	5.2	4.0	11.4	7.5	2.4	6.8	15.4	13.8	7.2	6.6	5.5	4.1	8.8	6.9	20.2	3.4	53.8	4.8	6.3	12.7	9.9	5.9	4.3	2.3	7.2	2.8	4.0	7.4	1.8	25.5	9.9	14.2	4.8	2.5	3.2	6.2	20.0	6.9	17.3	19.3	7.5	11.1	16.7	6.1	6.3	6.8	12.2	18.9	6.4	27.8	23.2	10.1	30.0	10.7	15.2	1.0	10.9	14.9	1.0	1.0	16.4	5.4	3.7	5.2	9.8	14.0	17.0	12.8	26.4	31.4	8.2	2.5	19.3	9.9	16.4	16.9	9.0	6.1	11.7	18.2	7.9	29.0	75.6	5.1	6.0	15.4	10.4	3.2	13.1	18.1	10.3	24.0	5.5	9.8	15.5	8.6	18.4	10.2	7.2	1.5	5.4	2.9	1.3	4.0	4.3	4.2	4.8	2.3	2.8	2.8	3.0	0.4	4.0	2.8	0.3	7.4	1.8	4.6	9.2	5.6	6.9	4.2	6.3	4.0	4.3	4.0	3.4	6.0	8.3	14.2	19.9	14.1	2.5	22.9	2.5	5.3	11.4	3.5	3.9	8.2	1.7	2.4	46.2	6.7	2.2	23.3	1.9	21.2	7.3	19.9	13.9	14.0	9.7	1.6	1.2	9.2	11.1	17.9	6.9	6.6	1.7	5.4	4.4	5.2	2.7	3.5	13.1	0.9	2.1	0.0	8.6	74.6	90.7	10.7	11.3	15.3	12.8	24.8
ATAT1	"C6orf134, Em:AB023049.7, FLJ13158, MEC17"	ENSG00000137343	"Alpha tubulin acetyltransferase 1"	Q5SQI0	6	30626842-30646823	"Enzymes, Predicted intracellular proteins"		"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	8	"Early spermatids: 67.3;Late spermatids: 33.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"AF22: 10.9;AN3-CA: 8.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA046816, HPA050999"	Approved		Approved	"Golgi apparatus,Cytosol"	"Intracellular and membrane"	No	No			"Golgi apparatus, Cytosol"		"HPA046816: AB_2679822, HPA050999: AB_2681303"	"unprognostic (3.98e-1)"	"unprognostic (3.18e-1)"	"unprognostic (4.30e-2)"	"unprognostic (2.67e-2)"	"unprognostic (8.86e-2)"	"unprognostic (8.18e-3)"	"prognostic unfavorable (1.03e-5)"	"unprognostic (1.49e-2)"	"unprognostic (5.39e-2)"	"unprognostic (2.37e-2)"	"unprognostic (1.29e-3)"	"unprognostic (1.25e-2)"	"prognostic unfavorable (7.78e-5)"	"unprognostic (2.62e-2)"	"unprognostic (1.51e-1)"	"unprognostic (2.02e-1)"	"prognostic favorable (1.35e-4)"	4.8	3.8	16.8	5.4	16.8	4.4	4.1	12.5	20.7	5.5	4.9	16.3	3.0	4.6	10.2	21.0	3.2	8.3	5.4	3.9	15.7	15.9	4.4	3.8	3.9	4.8	14.0	12.2	10.1	4.4	4.4	10.6	4.3	13.0	9.8	5.3	4.1	5.4	4.0	4.5	6.9	6.1	4.9	13.5	4.3	7.9	7.0	12.8	3.3	4.3	1.7	5.6	4.0	3.8	1.7	2.6	2.6	1.7	0.7	2.1	0.8	2.0	1.1	10.9	8.1	1.5	1.1	0.4	0.3	0.1	0.4	0.8	2.9	2.1	0.3	1.7	1.7	3.4	2.4	4.0	1.4	0.1	1.5	4.7	0.1	0.4	2.7	0.7	0.2	1.3	2.2	0.9	0.7	0.0	1.3	0.9	5.6	1.6	0.2	2.0	1.8	1.6	0.7	0.7	3.3	0.2	0.9	0.3	0.6	2.0	3.0	0.6	4.3	0.7	1.0	0.7	0.3	4.4	0.5	0.8	3.1	2.2	0.1	0.8	1.6	2.1	1.0	2.5	4.8	3.2	2.6	1.7	1.3	0.8	1.5	1.0	1.7	1.0	0.8	1.6	1.2	2.1	1.6	0.3	0.7	1.1	2.6	0.9	0.8	16.8	16.8	12.5	20.7	15.7	15.9	14.0	12.2	13.0	12.8	0.0	1.0	0.0	12.1	4.9	9.3	1.3	5.1	5.3	1.2	14.0	9.8	9.9	6.6	9.5	67.3	4.9	7.3	0.0	3.9	5.7	6.2	9.0	1.1	1.6	5.3	1.6	17.2	3.7	1.8	33.6	3.7	3.7	0.0	12.6	9.3	11.5	7.5	10.5	8.1	3.7	9.6	6.5	4.2	9.9	9.3	4.6	7.4	5.0	10.2	12.3
ATE1		ENSG00000107669	"Arginyltransferase 1"	O95260	10	121740421-121928801	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Cardiomyocytes: 62.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038444, HPA057549"	Approved		Supported	Nucleoplasm		NA	NA			Nucleoplasm		"HPA038444: AB_10672745, HPA057549: AB_2683463"	"unprognostic (1.37e-1)"	"unprognostic (5.19e-2)"	"unprognostic (2.75e-3)"	"unprognostic (2.40e-1)"	"unprognostic (4.67e-2)"	"unprognostic (6.65e-3)"	"unprognostic (1.85e-1)"	"unprognostic (1.42e-1)"	"unprognostic (1.71e-1)"	"unprognostic (1.00e-1)"	"unprognostic (2.52e-1)"	"unprognostic (5.69e-2)"	"prognostic favorable (2.67e-4)"	"unprognostic (3.20e-1)"	"unprognostic (8.08e-2)"	"unprognostic (2.16e-1)"	"unprognostic (1.02e-1)"	15.4	16.9	14.6	16.8	18.8	14.7	16.9	23.1	20.8	17.4	18.8	17.6	12.6	13.5	14.4	14.3	15.7	13.6	14.4	27.5	15.0	18.4	23.1	23.0	14.0	11.7	17.6	14.0	14.4	13.4	23.6	22.5	15.0	15.4	16.5	20.0	19.0	14.1	16.6	33.6	12.0	16.2	25.8	15.6	12.9	12.0	18.1	14.6	21.4	22.0	11.2	14.3	22.8	15.2	14.0	14.4	17.1	11.5	9.9	16.0	8.5	10.0	17.1	13.3	11.2	9.2	11.0	9.1	8.8	15.9	10.6	11.2	22.2	12.5	12.4	7.3	10.1	7.1	10.3	12.3	8.8	10.3	20.4	10.9	4.4	7.5	17.9	9.4	18.9	10.4	8.0	8.2	11.0	23.3	12.5	11.5	8.2	6.8	25.7	8.4	6.3	10.2	7.8	6.8	10.9	8.2	10.0	14.0	7.2	13.4	8.6	3.8	12.4	12.0	8.5	18.2	8.9	6.2	4.8	14.1	6.1	6.0	9.1	15.7	22.4	30.8	15.1	9.5	13.2	5.1	17.1	11.1	14.7	16.0	11.1	15.5	13.0	13.9	13.7	9.4	14.0	15.7	14.3	8.1	9.9	11.5	14.4	13.6	8.5	14.6	18.8	23.1	20.8	15.0	18.4	17.6	14.0	15.4	14.6	8.9	15.8	7.4	11.5	7.4	21.9	62.1	7.6	12.0	14.8	19.2	11.8	6.1	14.9	9.2	5.3	13.6	18.8	0.0	11.6	8.0	10.8	18.1	11.6	23.8	8.5	22.3	21.2	26.4	14.8	5.8	19.0	10.5	13.5	6.4	14.8	18.4	12.5	14.4	24.4	29.3	31.4	0.0	11.7	23.5	33.8	15.3	7.2	10.4	15.0	14.6
ATF2	"CRE-BP1, CREB2, HB16, TREB7"	ENSG00000115966	"Activating transcription factor 2"	P15336	2	175072250-175168382	"Enzymes, Predicted intracellular proteins, Transcription factors"	"DNA damage, Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Early spermatids: 100.8;Late spermatids: 111.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB003769, HPA022134"	Supported	Supported	Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"CAB003769: AB_562241, HPA022134: AB_1845138"	"unprognostic (1.11e-1)"	"unprognostic (2.01e-1)"	"unprognostic (9.81e-2)"	"unprognostic (1.93e-1)"	"unprognostic (9.29e-3)"	"unprognostic (2.56e-1)"	"prognostic unfavorable (7.08e-5)"	"unprognostic (2.28e-2)"	"unprognostic (3.70e-2)"	"unprognostic (6.47e-2)"	"unprognostic (7.17e-2)"	"unprognostic (4.02e-2)"	"unprognostic (4.40e-3)"	"unprognostic (1.15e-2)"	"unprognostic (1.50e-1)"	"unprognostic (7.21e-3)"	"unprognostic (6.70e-2)"	25.3	21.0	25.3	14.3	29.3	14.3	19.7	39.6	33.4	27.5	15.9	18.0	15.7	12.8	22.4	22.6	16.0	19.5	17.9	14.1	25.1	28.0	23.0	26.8	15.2	17.6	23.2	18.4	27.3	19.0	24.0	33.0	19.9	29.6	19.0	16.0	14.9	16.8	19.1	13.9	10.1	13.2	18.3	22.9	17.5	13.8	19.9	18.9	34.6	32.6	10.2	20.1	21.7	16.7	15.0	18.7	24.2	14.8	15.3	22.0	14.3	7.3	6.5	19.4	12.5	17.3	18.5	8.9	12.1	20.8	14.7	21.4	14.0	13.8	11.1	13.3	14.2	17.4	7.2	14.7	7.4	23.1	13.8	8.5	15.7	11.9	30.5	19.4	14.5	16.5	13.8	16.5	18.9	22.6	19.5	20.2	10.5	12.7	17.4	16.4	5.6	23.4	18.1	18.0	12.6	14.8	20.4	8.9	17.2	21.5	6.5	16.1	13.3	15.2	4.7	17.8	16.3	10.5	16.2	12.7	17.2	9.0	9.1	7.2	16.6	25.0	14.2	13.5	13.9	11.6	24.2	14.4	16.8	18.2	12.8	22.0	15.0	15.7	18.8	18.7	12.7	18.3	19.9	9.3	15.3	14.8	10.5	19.8	14.3	25.3	29.3	39.6	33.4	25.1	28.0	23.2	18.4	29.6	18.9	14.9	10.4	18.4	14.2	29.3	20.8	18.7	20.4	21.4	14.8	22.7	9.8	11.7	11.6	12.1	100.8	23.3	13.2	0.0	6.1	9.9	28.8	16.7	28.9	24.6	16.4	38.1	15.6	18.4	26.8	111.2	30.2	20.4	28.7	10.0	14.8	24.9	12.5	8.6	26.9	14.9	24.6	12.9	38.1	32.4	11.7	22.1	5.3	24.5	13.6	9.5
ATG4A	"APG4A, AUTL2"	ENSG00000101844	"Autophagy related 4A cysteine peptidase"	Q8WYN0	X	108091668-108154671	"Enzymes, Predicted intracellular proteins"	"Autophagy, Protein transport, Transport, Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HUVEC TERT2: 40.9"					"Low region specificity"	"Detected in all"			"HPA036374, HPA064759"	Uncertain		Approved	"Actin filaments,Microtubules"		NA	NA			Microtubules	"Actin filaments"	"HPA036374: AB_10672354, HPA064759: AB_2685346"	"prognostic unfavorable (1.36e-5)"	"unprognostic (1.41e-2)"	"unprognostic (3.65e-1)"	"unprognostic (2.52e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.79e-1)"	"unprognostic (1.18e-1)"	"unprognostic (2.83e-3)"	"unprognostic (2.23e-1)"	"unprognostic (3.14e-1)"	"unprognostic (2.62e-2)"	"unprognostic (4.09e-1)"	"unprognostic (1.03e-3)"	"unprognostic (7.53e-2)"	"unprognostic (2.98e-1)"	"unprognostic (5.02e-3)"	"unprognostic (1.20e-2)"	8.2	11.8	6.4	6.1	8.0	6.1	7.4	9.7	6.2	6.8	10.0	5.5	8.6	10.3	6.9	10.4	10.6	5.4	6.5	10.9	4.3	3.2	15.3	23.4	10.8	8.2	6.9	5.7	4.7	22.3	8.2	13.1	7.9	7.2	6.6	11.3	6.7	17.2	6.2	18.8	6.3	18.7	7.2	6.7	10.5	12.9	3.1	8.2	12.0	12.0	7.4	10.5	7.4	7.8	8.7	9.8	18.7	9.9	10.0	11.9	7.4	5.9	2.9	1.9	3.6	18.8	6.4	2.4	8.4	5.2	4.3	5.1	2.4	3.3	6.6	7.6	6.6	7.0	2.9	5.7	6.1	6.5	11.0	6.2	2.7	5.2	1.5	4.1	5.9	9.1	6.7	6.5	5.3	2.1	4.1	40.9	9.2	8.5	20.9	7.9	5.4	5.5	5.4	3.6	11.0	8.6	3.8	3.3	9.4	6.3	5.3	2.7	2.1	5.3	6.6	3.5	6.2	3.2	5.4	11.3	2.5	1.2	9.1	4.5	9.7	11.0	7.1	5.3	6.7	3.8	18.7	7.0	13.1	11.6	9.9	8.3	8.7	8.9	10.9	9.8	7.6	7.0	11.9	2.2	10.0	6.7	4.6	9.2	7.4	6.4	8.0	9.7	6.2	4.3	3.2	6.9	5.7	7.2	8.2	3.0	10.1	5.2	4.1	4.5	2.5	17.0	7.6	17.4	6.8	5.2	3.9	5.3	23.2	8.3	5.6	8.5	13.5	0.0	15.5	6.4	5.2	6.9	3.5	12.1	8.0	1.6	6.4	8.6	4.3	7.0	2.6	6.1	13.5	2.8	7.2	7.8	13.0	5.8	7.1	18.8	4.8	0.0	8.0	2.3	3.8	4.5	8.7	9.5	3.5	6.3
ATG4B	"Apg4B, AUTL1, DKFZp586D1822, KIAA0943"	ENSG00000168397	"Autophagy related 4B cysteine peptidase"	Q9Y4P1	2	241637213-241673857	"Enzymes, Predicted intracellular proteins, Transporters"	"Autophagy, Protein transport, Transport, Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB037195, HPA069803"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"CAB037195: AB_1078237, HPA069803: AB_2686200"	"unprognostic (1.51e-1)"	"unprognostic (8.80e-2)"	"prognostic unfavorable (6.85e-4)"	"unprognostic (1.51e-1)"	"unprognostic (2.43e-2)"	"unprognostic (2.67e-3)"	"unprognostic (1.07e-3)"	"unprognostic (1.06e-1)"	"unprognostic (1.61e-1)"	"unprognostic (1.58e-1)"	"unprognostic (1.15e-3)"	"unprognostic (3.02e-2)"	"prognostic unfavorable (2.79e-4)"	"unprognostic (2.60e-1)"	"unprognostic (6.63e-2)"	"unprognostic (1.66e-1)"	"prognostic favorable (9.64e-4)"	10.9	16.5	19.6	16.6	21.3	31.3	15.1	34.8	25.7	13.5	18.7	21.7	23.2	14.6	33.5	24.0	26.7	17.7	18.8	19.5	20.5	21.5	17.2	15.5	15.8	19.4	29.2	19.7	17.3	19.2	18.7	27.4	15.4	20.3	20.5	18.9	20.8	22.8	14.2	17.2	26.6	21.1	18.9	23.1	18.7	15.5	28.0	21.4	21.2	18.2	7.3	21.9	15.3	14.4	16.5	20.3	18.9	18.6	11.4	19.6	16.8	8.7	13.6	19.5	15.0	19.5	14.2	19.3	12.8	14.0	16.6	13.8	14.9	15.5	6.7	5.8	23.0	13.4	12.9	18.5	24.4	16.1	14.3	18.8	19.8	22.0	32.2	25.4	11.4	11.1	14.1	17.0	18.6	18.0	17.7	17.1	26.1	16.8	10.3	18.8	21.4	20.4	20.1	22.7	15.7	14.5	35.2	17.9	10.1	13.0	28.3	19.5	13.5	10.9	14.5	15.3	16.6	16.0	16.8	18.6	15.8	10.8	10.5	13.8	11.6	12.1	25.7	19.2	14.2	14.8	4.6	18.6	18.9	18.7	15.5	15.5	15.7	15.2	16.5	20.3	16.5	19.6	14.7	14.8	11.4	16.2	16.3	19.3	16.8	19.6	21.3	34.8	25.7	20.5	21.5	29.2	19.7	20.3	21.4	29.8	35.6	22.7	23.7	21.6	21.6	14.1	33.1	10.7	13.6	26.2	31.4	31.0	16.6	32.4	12.9	23.6	57.6	23.3	34.9	23.5	23.5	30.3	18.5	24.9	29.3	39.7	34.4	24.5	27.8	19.8	20.4	31.5	27.0	64.1	34.3	30.2	33.1	28.1	23.3	18.2	25.2	19.4	23.4	44.0	53.5	22.2	45.1	33.0	27.0	27.5
ATG4C	"APG4C, AUTL1, AUTL3, FLJ14867"	ENSG00000125703	"Autophagy related 4C cysteine peptidase"	Q96DT6	1	62784135-62865513	"Enzymes, Predicted intracellular proteins"	"Autophagy, Protein transport, Transport, Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA007049	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"HPA007049: AB_1845159"	"unprognostic (1.28e-1)"	"unprognostic (2.69e-1)"	"prognostic favorable (9.83e-4)"	"unprognostic (7.43e-2)"	"unprognostic (1.17e-1)"	"unprognostic (1.70e-1)"	"unprognostic (3.76e-2)"	"unprognostic (8.36e-2)"	"unprognostic (1.83e-2)"	"unprognostic (1.30e-1)"	"unprognostic (3.77e-1)"	"unprognostic (1.93e-1)"	"unprognostic (5.66e-2)"	"unprognostic (1.81e-1)"	"unprognostic (4.17e-2)"	"unprognostic (3.26e-2)"	"unprognostic (1.19e-1)"	8.8	9.8	19.4	11.3	32.8	6.0	9.2	16.7	23.4	10.6	9.5	29.8	7.2	7.7	9.6	7.2	8.6	8.0	10.4	7.2	23.7	15.5	13.5	12.6	9.2	13.7	42.6	16.5	10.3	11.2	15.5	11.3	15.0	22.4	8.0	10.6	4.9	10.8	8.0	6.4	6.3	7.8	11.2	26.5	13.3	8.6	8.9	40.4	11.0	12.0	3.7	12.4	13.4	6.8	20.6	19.4	16.0	10.9	7.0	9.4	6.7	7.6	6.1	9.5	8.3	12.5	13.5	9.5	11.5	7.8	11.1	12.5	4.5	6.1	16.3	8.9	5.8	13.0	5.9	11.3	8.7	16.1	12.2	10.4	18.3	6.5	5.8	8.9	14.8	12.3	11.1	6.2	11.8	5.6	10.8	13.3	18.0	15.5	13.3	9.3	3.6	14.9	5.7	13.9	11.0	10.1	17.9	22.8	11.5	8.0	5.6	12.9	6.5	7.6	14.4	14.8	17.2	7.0	7.0	5.2	8.9	8.7	15.0	12.6	11.6	15.6	13.3	10.2	14.7	10.7	16.0	10.9	8.5	4.8	8.8	6.6	20.6	6.6	5.6	19.4	19.1	9.4	7.7	1.6	7.0	5.0	11.6	5.7	6.7	19.4	32.8	16.7	23.4	23.7	15.5	42.6	16.5	22.4	40.4	6.0	8.8	28.4	6.2	4.4	5.1	8.1	10.2	1.4	9.1	7.0	2.0	33.2	16.6	6.4	1.3	11.6	3.6	0.0	7.3	24.5	8.4	4.1	11.5	8.9	31.5	4.8	5.8	13.5	18.6	1.4	8.1	20.5	8.5	30.7	4.4	9.7	4.5	4.5	9.2	19.9	5.1	6.5	7.6	30.5	13.3	3.4	24.3	9.6	6.6	2.7
ATG4D	"APG4-D, APG4D, AUTL4"	ENSG00000130734	"Autophagy related 4D cysteine peptidase"	Q86TL0	19	10543895-10553418	"Enzymes, Predicted intracellular proteins, Transporters"	"Apoptosis, Autophagy, Protein transport, Transport, Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Enterocytes: 90.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA067683	Approved		Supported	Nucleoplasm,Mitochondria		NA	NA			"Nucleoplasm, Mitochondria"		"HPA067683: AB_2685886"	"unprognostic (2.85e-1)"	"prognostic favorable (3.18e-5)"	"unprognostic (2.73e-1)"	"unprognostic (3.67e-1)"	"unprognostic (2.18e-1)"	"unprognostic (1.15e-2)"	"unprognostic (3.52e-2)"	"unprognostic (1.23e-1)"	"unprognostic (4.28e-2)"	"unprognostic (7.30e-2)"	"prognostic favorable (9.95e-4)"	"unprognostic (1.52e-1)"	"prognostic favorable (2.39e-7)"	"prognostic favorable (5.03e-4)"	"unprognostic (3.78e-2)"	"unprognostic (2.29e-1)"	"unprognostic (3.18e-3)"	6.4	10.8	5.1	9.2	7.8	35.0	6.3	15.6	14.9	6.2	18.4	9.8	8.1	26.0	6.1	7.2	18.4	5.5	7.6	15.4	4.6	4.9	14.5	8.8	7.3	9.8	9.6	6.4	7.0	16.1	8.2	12.1	6.9	7.3	9.7	7.3	7.8	11.5	8.5	31.5	17.7	27.3	4.0	4.5	12.0	10.5	29.0	8.8	19.9	9.8	16.4	10.5	7.5	9.6	2.0	7.6	5.7	1.6	2.2	3.6	1.4	7.0	4.7	6.6	8.9	1.2	1.0	5.1	4.3	4.3	6.2	6.8	7.9	2.3	4.5	8.2	0.5	4.7	11.1	4.1	3.7	0.8	4.4	10.7	12.0	11.5	4.4	4.1	4.8	12.3	1.0	7.7	5.3	1.9	1.6	1.8	9.9	8.9	11.0	1.9	11.3	14.1	29.3	10.0	3.2	12.9	10.4	4.1	8.0	3.5	9.5	24.8	9.6	6.4	12.5	4.9	1.2	7.7	11.8	3.4	9.5	6.0	19.0	9.6	9.8	6.6	5.3	8.1	9.3	10.7	3.0	1.6	5.7	2.1	1.5	3.1	2.0	2.5	2.3	1.1	1.0	2.5	3.4	0.5	2.2	0.7	7.6	3.6	1.4	5.1	7.8	15.6	14.9	4.6	4.9	9.6	6.4	7.3	8.8	8.9	10.0	8.8	18.9	27.1	15.0	0.4	17.8	2.7	1.2	1.8	13.7	23.7	11.6	14.3	51.1	4.1	90.5	23.3	14.4	5.4	10.1	17.3	6.9	9.7	11.7	27.0	21.4	5.5	12.0	6.8	8.1	8.7	11.8	19.0	28.4	10.6	16.6	38.2	4.2	16.8	17.6	12.9	16.0	63.1	19.6	27.4	30.6	21.3	23.3	29.3
ATIC	"AICARFT, IMPCHASE, PURH"	ENSG00000138363	"5-aminoimidazole-4-carboxamide ribonucleotide formyltransferase/IMP cyclohydrolase"	P31939	2	215311817-215349773	"Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"	"Purine biosynthesis"	"Hydrolase, Multifunctional enzyme, Transferase"	"Cancer-related genes, Disease mutation, Epilepsy, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Cytotrophoblasts: 144.4;Extravillous trophoblasts: 132.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB013462, HPA021012"	Supported		Approved	"Plasma membrane,Cytosol"		NA	NA		3400000	Cytosol	"Plasma membrane"	"CAB013462: , HPA021012: AB_1845169"	"unprognostic (1.41e-2)"	"unprognostic (2.18e-1)"	"unprognostic (1.13e-2)"	"unprognostic (8.46e-2)"	"unprognostic (2.90e-1)"	"unprognostic (3.81e-2)"	"prognostic unfavorable (1.99e-7)"	"unprognostic (1.86e-2)"	"unprognostic (5.07e-2)"	"unprognostic (1.83e-1)"	"unprognostic (6.31e-3)"	"unprognostic (9.21e-2)"	"prognostic unfavorable (8.77e-4)"	"unprognostic (1.00e-1)"	"unprognostic (1.30e-1)"	"unprognostic (4.18e-2)"	"unprognostic (4.39e-3)"	19.4	27.4	21.1	23.0	28.4	16.9	24.8	12.1	32.3	20.6	26.7	29.1	18.1	23.4	27.9	15.6	19.1	21.9	19.1	18.2	20.3	21.1	23.1	35.6	17.3	36.1	29.7	19.9	23.4	32.9	25.1	21.1	31.1	24.4	21.9	35.9	19.5	14.4	29.4	35.5	17.0	20.6	26.7	21.7	29.0	20.4	15.0	28.0	46.3	16.1	13.5	35.3	27.6	18.0	21.7	13.4	2.9	8.9	19.6	22.8	10.0	20.5	31.1	17.4	29.5	23.4	23.7	8.7	21.0	18.3	24.0	27.6	60.0	32.2	29.9	26.0	21.9	33.8	21.6	38.2	31.7	34.5	22.3	36.9	36.4	26.7	53.7	30.3	45.6	18.7	20.0	24.3	32.1	38.8	16.6	16.0	29.0	47.0	25.0	33.0	30.3	39.7	22.2	66.8	32.9	17.5	36.9	25.0	26.8	25.5	33.2	27.3	18.9	16.9	20.8	23.7	40.4	34.1	16.2	14.1	20.4	21.1	26.3	13.2	31.6	41.2	62.1	17.7	25.4	29.4	2.9	6.0	0.1	13.2	8.9	22.8	21.7	18.6	20.0	13.4	13.2	18.9	17.5	0.7	19.6	7.4	11.7	17.7	10.0	21.1	28.4	12.1	32.3	20.3	21.1	29.7	19.9	24.4	28.0	11.9	17.1	19.3	23.5	13.4	9.6	18.5	25.5	26.8	19.4	22.7	3.9	144.4	23.2	32.2	0.8	6.3	13.5	0.0	42.8	132.7	23.3	16.1	24.3	18.7	46.4	9.5	18.5	4.3	15.0	0.0	22.2	18.7	28.7	32.5	29.9	20.6	30.0	21.0	32.2	44.0	12.8	25.8	19.8	3.2	40.3	7.4	79.8	21.5	52.7	17.4
ATM	"ATA, ATC, ATD, ATDC, TEL1, TELO1"	ENSG00000149311	"ATM serine/threonine kinase"	Q13315	11	108222484-108369102	"Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Cell cycle, DNA damage"	"DNA-binding, Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes, Disease mutation, Neurodegeneration, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Cone photoreceptor cells: 198.3;Rod photoreceptor cells: 196.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"U-698: 48.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB000102, HPA067142"	Supported		Enhanced	Nucleoplasm,Vesicles		NA	NA			Nucleoplasm	Vesicles	"CAB000102: , HPA067142: AB_2685789"	"unprognostic (9.77e-2)"	"unprognostic (1.47e-1)"	"unprognostic (3.04e-1)"	"unprognostic (2.36e-1)"	"unprognostic (5.70e-2)"	"unprognostic (2.86e-2)"	"unprognostic (6.32e-3)"	"unprognostic (1.05e-1)"	"unprognostic (8.19e-2)"	"unprognostic (1.63e-1)"	"unprognostic (7.68e-2)"	"unprognostic (6.16e-2)"	"unprognostic (2.17e-3)"	"unprognostic (3.10e-1)"	"unprognostic (7.87e-2)"	"unprognostic (1.21e-1)"	"unprognostic (2.81e-1)"	8.3	10.9	12.7	26.5	19.3	16.8	9.4	17.7	14.4	10.9	8.5	10.9	8.8	6.0	11.2	11.4	6.9	9.5	9.2	9.6	12.4	8.5	7.7	9.5	10.1	33.4	19.6	6.7	20.5	20.7	15.7	29.2	8.8	14.5	9.1	7.9	7.2	15.1	9.8	6.2	8.4	16.5	10.6	23.4	22.6	8.9	6.1	17.9	19.5	10.7	5.1	26.9	10.7	10.7	13.7	6.1	13.5	12.5	7.6	18.5	4.4	2.7	3.9	7.7	4.1	10.0	14.6	2.0	6.1	6.8	3.5	5.9	4.8	6.5	9.6	9.1	4.9	5.6	4.1	5.8	5.1	5.5	7.7	3.4	8.7	4.8	4.8	5.3	10.5	9.4	9.4	3.2	5.4	10.4	7.7	7.4	8.2	8.4	6.6	6.9	2.0	7.1	9.7	6.3	4.1	3.9	5.6	5.3	15.1	4.0	5.5	5.2	6.4	7.1	3.3	10.5	7.1	5.0	5.9	11.5	8.8	4.9	5.0	5.7	4.4	4.6	48.5	5.8	11.5	9.8	13.5	5.7	3.8	14.9	5.3	10.4	11.1	10.5	11.3	2.7	13.7	18.5	17.9	10.8	7.6	12.5	6.1	5.3	4.4	12.7	19.3	17.7	14.4	12.4	8.5	19.6	6.7	14.5	17.9	35.7	21.0	122.7	17.4	11.2	101.7	35.4	10.2	13.4	19.4	21.0	198.3	14.8	5.0	7.7	12.8	18.8	4.9	0.0	10.6	10.5	26.4	9.5	12.7	21.2	26.0	57.2	19.5	36.8	82.2	2.7	36.5	48.1	25.3	9.0	15.9	35.9	7.6	10.5	26.2	10.3	196.6	25.8	17.3	18.7	33.6	10.8	3.5	111.7	11.7	9.9
ATP10A	"ATP10C, ATPVA, ATPVC, KIAA0566"	ENSG00000206190	"ATPase phospholipid transporting 10A (putative)"	O60312	15	25677273-25865172	"Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins"	"Lipid transport, Transport"	Translocase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	9	"Alveolar cells type 1: 29.8;Early spermatids: 17.6;granulocytes: 15.0;Late spermatids: 14.7;Melanocytes: 16.9;Peritubular cells: 16.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	12	"dendritic cells: 3.0;NK-cells: 4.7;T-cells: 4.0"	"Cell line enhanced"	"Detected in some"		"BJ: 13.0;fHDF/TERT166: 19.1;HMC-1: 12.7;RPTEC TERT1: 10.2;SK-MEL-30: 17.3"	"Low region specificity"	"Detected in all"							"HPA041496, HPA042509"	Uncertain					NA	NA					"HPA041496: AB_2677513, HPA042509: AB_2678032"	"unprognostic (3.70e-1)"	"unprognostic (2.83e-2)"	"unprognostic (2.30e-4)"	"unprognostic (1.18e-1)"	"unprognostic (9.46e-2)"	"unprognostic (2.91e-2)"	"unprognostic (2.67e-1)"	"unprognostic (4.95e-1)"	"unprognostic (1.12e-1)"	"unprognostic (2.78e-1)"	"unprognostic (1.26e-1)"	"unprognostic (1.33e-1)"	"prognostic unfavorable (6.60e-5)"	"unprognostic (1.30e-1)"	"unprognostic (1.38e-2)"	"unprognostic (4.89e-2)"	"unprognostic (9.42e-2)"	7.4	14.1	5.3	5.4	9.8	4.7	5.7	3.4	11.0	5.3	3.3	6.2	1.4	1.5	1.9	2.1	3.7	3.1	7.1	2.9	8.0	5.8	6.0	1.0	12.2	14.8	9.3	9.0	1.6	1.9	1.9	2.5	3.6	11.3	3.6	2.3	4.0	14.4	1.5	0.7	3.3	3.6	5.3	6.4	3.5	4.0	6.0	6.2	1.5	3.0	1.6	3.3	4.2	3.3	0.0	3.0	0.0	0.3	4.7	4.0	1.7	0.0	3.4	0.7	0.0	2.7	2.6	0.0	13.0	6.3	4.0	7.1	0.0	0.0	0.0	0.7	19.1	0.0	0.0	6.6	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.7	0.6	0.0	0.5	0.0	1.6	0.0	0.4	0.0	0.0	2.5	0.0	0.5	0.0	0.9	0.0	0.8	2.4	2.4	0.8	10.2	0.0	0.0	0.0	0.0	0.0	17.3	0.0	5.2	0.5	0.0	5.3	0.2	7.6	0.1	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.3	0.0	1.9	0.2	1.9	0.0	2.2	2.1	0.4	0.0	4.0	3.7	0.0	4.7	0.1	3.0	0.7	1.7	5.3	9.8	3.4	11.0	8.0	5.8	9.3	9.0	11.3	6.2	29.8	7.5	0.0	0.0	0.9	0.0	1.4	2.5	6.7	7.9	0.0	0.0	0.0	0.0	0.2	17.6	0.8	0.0	0.0	0.0	0.1	2.8	0.9	15.0	0.0	2.2	0.0	0.0	0.6	2.1	14.7	3.7	4.4	16.9	0.0	0.0	0.0	0.6	0.0	16.6	0.0	0.0	0.0	8.1	0.4	0.7	0.4	0.0	4.4	0.0	0.0
ATP10B	"ATPVB, FLJ21477, KIAA0715"	ENSG00000118322	"ATPase phospholipid transporting 10B (putative)"	O94823	5	160563120-160852214	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Lipid transport, Transport"	Translocase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 27.8;intestine: 35.4"	"Cell type enhanced"	"Detected in some"	11	"Enterocytes: 80.4;Mucus-secreting cells: 52.8;Paneth cells: 67.1;Undifferentiated cells: 77.9"	"Group enriched"	"Detected in many"	7	"colorectal cancer: 19.0;pancreatic cancer: 4.2;stomach cancer: 8.6"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	11	"WM-115: 17.8"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA034574	Uncertain					NA	NA					"HPA034574: AB_10669992"	"unprognostic (1.47e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.28e-2)"	"unprognostic (4.47e-4)"	"unprognostic (3.99e-2)"	"unprognostic (6.10e-3)"	"unprognostic (4.69e-2)"	"unprognostic (4.86e-2)"	"unprognostic (2.54e-1)"	"unprognostic (1.20e-2)"	"unprognostic (3.42e-2)"	"unprognostic (5.12e-2)"	"unprognostic (2.38e-3)"	"unprognostic (5.13e-2)"	"unprognostic (2.56e-1)"	"unprognostic (3.38e-1)"	"unprognostic (2.14e-1)"	0.5	0.4	4.3	4.1	9.4	0.4	0.7	5.1	10.0	1.7	33.8	27.8	1.5	18.9	0.4	11.4	8.2	0.7	12.8	0.5	5.5	2.8	0.5	0.4	0.5	0.4	13.8	6.8	0.4	4.2	0.4	0.4	0.4	13.1	0.5	35.4	0.0	2.8	1.0	0.4	8.4	21.1	1.6	20.2	0.4	4.1	0.7	14.0	0.0	0.5	0.0	2.5	1.8	3.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.6	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.7	0.2	0.7	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	17.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.3	9.4	5.1	10.0	5.5	2.8	13.8	6.8	13.1	14.0	0.0	0.0	0.0	0.0	0.3	0.0	1.0	25.5	0.0	0.0	1.8	0.0	0.0	0.0	11.1	0.1	0.0	80.4	0.0	17.2	0.1	0.0	0.2	0.0	0.0	0.1	0.0	12.7	0.0	0.0	0.0	0.0	0.0	1.7	2.8	52.8	0.0	25.1	67.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.5	0.0	77.9	1.0
ATP10D	"ATPVD, KIAA1487"	ENSG00000145246	"ATPase phospholipid transporting 10D (putative)"	Q9P241	4	47485288-47593486	"Enzymes, Predicted membrane proteins"	"Lipid transport, Transport"	Translocase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"placenta: 55.7"	"Cell type enhanced"	"Detected in many"	11	"Leydig cells: 57.5;Syncytiotrophoblasts: 147.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	9	"basophil: 31.5"	"Lineage enriched"	"Detected in many"	9	"granulocytes: 31.5"	"Cell line enhanced"	"Detected in many"		"HAP1: 24.4"									HPA050808	Approved		Supported	"Nucleoplasm,Plasma membrane"		NA	NA			"Nucleoplasm, Plasma membrane"		"HPA050808: AB_2681242"	"unprognostic (1.62e-1)"	"unprognostic (2.97e-1)"	"unprognostic (4.93e-2)"	"unprognostic (1.47e-2)"	"unprognostic (1.16e-1)"	"unprognostic (4.23e-2)"	"unprognostic (1.65e-2)"	"unprognostic (8.05e-2)"	"unprognostic (3.48e-2)"	"unprognostic (3.54e-2)"	"unprognostic (3.04e-1)"	"unprognostic (2.43e-1)"	"prognostic favorable (5.00e-8)"	"unprognostic (3.97e-2)"	"unprognostic (4.47e-3)"	"unprognostic (1.11e-2)"	"unprognostic (3.37e-2)"	8.1	9.7	7.6	6.8	8.0	1.4	6.9	3.9	7.5	10.2	7.4	5.2	10.4	4.5	12.9	10.1	15.2	6.7	8.6	7.4	7.3	4.0	14.5	5.8	9.4	6.7	7.0	4.8	10.0	6.2	16.9	18.6	55.7	8.1	8.1	4.5	7.7	7.5	11.5	2.8	14.8	6.0	11.4	8.9	12.7	7.6	3.9	7.3	3.6	10.7	5.4	9.2	9.9	13.1	3.6	1.8	31.5	2.9	1.0	0.9	0.6	1.4	1.0	2.3	1.6	6.7	7.3	0.4	10.4	12.6	5.0	9.0	5.4	9.0	4.6	3.9	16.8	8.5	2.7	24.4	8.7	7.7	1.8	1.9	3.7	1.7	0.3	6.0	1.1	2.3	6.3	6.7	9.8	6.5	16.5	8.4	2.3	0.0	2.5	13.6	0.5	2.4	0.7	0.8	0.0	1.3	2.8	5.3	0.0	9.1	1.8	1.5	2.9	4.8	1.2	3.1	5.4	2.2	1.2	12.7	12.4	2.5	1.1	4.5	1.1	0.8	0.0	6.1	6.9	3.9	31.5	1.4	0.1	0.6	2.3	0.9	1.3	0.2	0.3	1.8	3.6	0.0	0.4	0.7	1.0	2.9	1.1	0.3	0.6	7.6	8.0	3.9	7.5	7.3	4.0	7.0	4.8	8.1	7.3	8.9	6.9	15.0	7.9	17.1	10.9	3.6	0.0	2.7	2.3	15.7	29.5	27.1	1.7	4.3	1.6	14.0	1.6	0.0	4.1	7.4	11.8	5.8	2.3	4.9	11.7	12.7	9.2	17.8	16.1	0.6	57.5	9.1	6.8	7.2	4.3	28.8	2.7	2.5	23.7	9.1	8.9	25.8	9.8	0.4	2.7	23.6	147.8	11.5	3.7	6.5
ATP11A	"ATPIH, ATPIS, KIAA1021"	ENSG00000068650	"ATPase phospholipid transporting 11A"	P98196	13	112690329-112887168	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Lipid transport, Transport"	Translocase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"Alveolar cells type 1: 202.5;Alveolar cells type 2: 171.3;Cone photoreceptor cells: 221.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035583, HPA035584"	Approved		Enhanced	Vesicles		NA	NA			Vesicles		"HPA035583: AB_10671106, HPA035584: AB_10672096"	"unprognostic (1.67e-1)"	"unprognostic (5.06e-3)"	"unprognostic (1.58e-1)"	"unprognostic (5.27e-2)"	"unprognostic (6.58e-2)"	"unprognostic (8.84e-2)"	"unprognostic (5.87e-3)"	"unprognostic (1.80e-2)"	"unprognostic (6.97e-2)"	"unprognostic (1.54e-3)"	"unprognostic (3.93e-2)"	"unprognostic (4.23e-1)"	"prognostic favorable (7.44e-4)"	"unprognostic (3.85e-2)"	"unprognostic (3.69e-1)"	"unprognostic (3.26e-2)"	"unprognostic (7.40e-3)"	11.1	11.5	7.2	8.3	16.4	15.7	7.9	5.0	12.5	13.6	5.8	24.4	8.7	9.5	13.7	9.2	8.5	10.8	14.6	19.6	7.2	5.4	12.9	12.3	36.9	7.5	17.7	6.9	8.6	13.2	36.1	17.8	11.2	12.8	5.0	3.6	10.0	12.0	9.0	11.2	11.4	8.7	9.1	12.5	10.2	6.1	9.7	16.2	2.1	16.4	6.4	6.0	5.7	11.3	4.2	1.1	6.4	3.1	0.0	1.0	0.6	14.0	7.2	9.1	10.7	4.6	6.3	16.2	6.7	3.9	5.7	4.7	22.6	16.3	7.1	8.2	5.6	7.4	12.0	8.2	5.5	5.6	7.1	7.7	8.2	6.0	11.7	7.3	15.3	13.4	4.2	4.3	6.9	4.2	4.6	15.0	6.5	5.6	1.2	4.0	5.3	6.9	9.7	3.9	16.1	5.1	6.1	3.7	4.0	31.3	3.3	14.6	4.0	6.5	8.5	5.6	12.4	3.2	20.5	9.8	0.0	12.5	7.4	5.0	3.9	7.5	3.0	2.5	14.5	6.3	0.0	2.3	3.1	1.0	3.1	0.6	1.3	0.6	0.5	1.1	4.2	0.7	0.4	6.4	0.0	2.7	1.1	0.1	0.6	7.2	16.4	5.0	12.5	7.2	5.4	17.7	6.9	12.8	16.2	202.5	171.3	5.6	2.8	9.6	29.4	38.0	35.7	16.0	45.5	15.7	221.9	0.6	5.0	31.2	0.7	19.8	4.2	0.0	10.0	26.5	10.6	5.3	11.5	13.2	17.6	12.7	11.5	24.5	33.5	1.4	10.3	21.3	10.1	7.2	3.3	10.4	18.9	5.8	4.6	15.8	44.2	0.0	5.1	3.9	9.0	8.4	7.2	5.7	5.2	3.7
ATP11B	"ATPIF, ATPIR, KIAA0956"	ENSG00000058063	"ATPase phospholipid transporting 11B (putative)"	Q9Y2G3	3	182793500-182921635	"Enzymes, Predicted membrane proteins, Transporters"	"Lipid transport, Transport"	Translocase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA036237, HPA036238"	Uncertain		Approved	"Centriolar satellite,Cytosol"		NA	NA			"Centriolar satellite, Cytosol"		"HPA036237: AB_10673123, HPA036238: AB_10670792"	"unprognostic (4.52e-2)"	"unprognostic (1.81e-1)"	"unprognostic (3.37e-2)"	"prognostic unfavorable (3.44e-4)"	"unprognostic (1.50e-1)"	"unprognostic (1.50e-1)"	"unprognostic (6.73e-2)"	"unprognostic (2.03e-3)"	"unprognostic (7.28e-2)"	"unprognostic (1.18e-1)"	"prognostic unfavorable (1.09e-4)"	"unprognostic (2.02e-1)"	"unprognostic (1.71e-1)"	"unprognostic (1.62e-1)"	"unprognostic (3.22e-1)"	"unprognostic (8.66e-2)"	"unprognostic (1.35e-1)"	16.8	7.9	7.7	19.7	9.8	35.4	17.0	18.4	9.4	20.5	21.6	8.9	14.3	13.6	15.0	11.7	37.3	11.8	12.7	21.1	6.9	5.9	13.7	14.3	19.4	20.3	10.3	5.7	15.2	14.6	21.0	26.0	8.0	8.3	16.8	16.9	9.8	19.7	13.8	13.1	21.8	22.8	16.5	11.3	23.4	27.6	22.8	8.9	49.0	10.8	20.4	21.9	22.7	25.5	3.6	4.2	7.5	1.8	3.0	3.4	1.3	22.7	3.3	7.2	10.0	15.3	16.8	6.6	10.5	14.5	8.2	9.6	8.1	11.8	10.6	18.0	15.1	17.1	13.8	8.5	10.8	14.3	23.4	6.8	25.4	4.4	1.7	8.9	20.0	16.3	11.3	12.3	9.2	13.3	12.1	12.8	16.9	9.0	32.9	13.2	7.7	16.6	6.4	5.1	12.9	6.4	6.9	21.0	12.7	9.9	19.1	4.3	7.7	29.3	3.7	12.8	6.8	4.1	14.9	12.6	12.5	13.5	10.7	18.2	45.0	40.2	19.8	8.6	8.6	7.3	7.5	1.7	7.2	3.1	1.8	3.0	3.6	2.7	3.1	1.9	2.4	2.3	3.4	6.8	3.0	1.7	4.2	2.0	1.3	7.7	9.8	18.4	9.4	6.9	5.9	10.3	5.7	8.3	8.9	14.9	10.4	9.7	20.0	30.5	11.4	15.9	17.8	6.7	11.4	19.2	13.7	9.6	0.0	10.9	27.7	14.5	26.1	46.7	14.4	3.2	14.9	34.3	10.5	13.6	9.2	36.5	6.4	14.1	17.8	19.9	17.8	17.7	13.5	5.4	27.5	8.1	20.8	27.1	19.8	6.2	28.3	19.4	16.5	15.4	10.7	39.0	8.0	24.9	20.4	44.2
ATP11C	"ATPIG, ATPIQ"	ENSG00000101974	"ATPase phospholipid transporting 11C"	Q8NB49	X	139726346-139945276	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Lipid transport, Transport"	Translocase	"Disease mutation, Hereditary hemolytic anemia"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"monocytes: 47.7;Spermatogonia: 49.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA030830	Approved					NA	NA					"HPA030830: AB_10601336"	"unprognostic (8.94e-2)"	"unprognostic (1.00e-2)"	"unprognostic (3.06e-2)"	"unprognostic (3.42e-3)"	"unprognostic (3.08e-1)"	"unprognostic (3.46e-1)"	"unprognostic (1.41e-1)"	"unprognostic (3.41e-1)"	"unprognostic (1.20e-1)"	"unprognostic (1.37e-1)"	"unprognostic (4.80e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.57e-1)"	"unprognostic (3.65e-2)"	"unprognostic (9.75e-2)"	"unprognostic (2.73e-1)"	"unprognostic (5.18e-2)"	12.8	7.0	4.8	7.6	10.6	4.6	9.6	8.0	5.8	13.1	8.8	5.3	30.2	4.8	12.0	9.5	7.3	9.1	7.4	5.2	6.7	4.5	10.8	41.4	6.7	11.2	9.6	3.2	13.1	4.6	6.8	4.2	4.6	9.5	11.5	6.4	10.7	5.8	21.4	6.6	5.6	7.8	11.3	6.3	14.4	7.1	7.9	9.7	14.9	6.1	4.0	7.4	12.7	12.2	2.8	2.1	5.1	1.7	3.5	2.5	0.5	9.4	4.0	8.4	13.6	12.5	17.0	10.6	11.4	15.3	9.2	12.8	3.6	7.7	13.6	25.7	16.1	6.1	8.0	20.1	5.2	14.5	12.4	11.8	6.9	8.9	7.0	13.9	11.9	4.4	11.2	3.5	10.0	8.6	10.3	15.9	10.6	7.7	10.5	12.1	5.1	10.9	8.1	14.1	0.0	7.7	11.0	9.0	11.3	7.8	15.8	6.5	10.8	4.5	0.5	5.9	8.2	3.4	6.6	17.8	12.6	4.2	15.2	15.4	3.0	2.9	10.8	5.8	15.0	6.3	5.1	1.5	0.4	1.2	1.0	2.5	2.8	1.4	1.1	1.2	2.7	1.4	2.2	2.8	3.5	1.7	2.1	1.0	0.5	4.8	10.6	8.0	5.8	6.7	4.5	9.6	3.2	9.5	9.7	14.9	9.6	13.0	14.5	12.9	1.6	3.9	2.5	5.3	11.4	10.4	0.0	1.7	1.7	4.8	9.9	20.3	4.5	0.0	8.5	10.5	16.6	10.9	9.2	43.9	7.9	0.0	8.7	28.8	29.5	8.5	13.3	8.6	10.1	47.7	6.0	2.8	6.4	5.8	14.5	8.2	3.4	0.0	20.6	23.2	49.4	11.8	5.6	8.7	4.5	13.6
ATP12A	"#945, 2, ATP1AL1, HK"	ENSG00000075673	"ATPase H+/K+ transporting non-gastric alpha2 subunit"	P54707	13	24680411-24712493	"Enzymes, Plasma proteins, Predicted membrane proteins, Transporters"	"Hydrogen ion transport, Ion transport, Potassium transport, Transport"	Translocase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"esophagus: 12.3;lymphoid tissue: 38.4"	"Group enriched"	"Detected in some"	7	"Ciliated cells: 5.3;Club cells: 18.2"	"Cancer enhanced"	"Detected in many"		"testis cancer: 12.3"	"Region enhanced"	"Detected in single"		"cerebral cortex: 1.3"	"Cell type enriched"	"Detected in single"	5	"T-reg: 1.7"	"Lineage enriched"	"Detected in single"	18	"T-cells: 1.7"	"Cell line enriched"	"Detected in some"	8	"SuSa: 11.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA039526	Approved		Approved	"Plasma membrane,Actin filaments,Cytosol"		NA	NA			"Plasma membrane, Cytosol"	"Actin filaments"	"HPA039526: AB_10673534"	"unprognostic (8.33e-3)"	"unprognostic (3.58e-2)"	"unprognostic (2.93e-1)"	"unprognostic (5.21e-3)"	"unprognostic (2.58e-1)"	"unprognostic (1.21e-2)"		"unprognostic (8.03e-3)"	"unprognostic (2.64e-1)"	"unprognostic (1.50e-1)"	"unprognostic (1.18e-1)"	"unprognostic (3.39e-1)"	"unprognostic (2.24e-1)"	"unprognostic (1.78e-1)"	"unprognostic (1.67e-1)"	"unprognostic (6.80e-2)"	"unprognostic (8.22e-3)"	0.1	0.1	0.1	0.0	0.1	0.0	0.8	0.2	1.3	0.4	0.1	0.0	0.0	0.0	0.2	0.2	12.3	0.1	0.0	0.1	0.3	0.2	8.8	0.1	6.1	0.0	0.1	0.0	0.1	1.0	0.0	0.2	5.8	0.4	0.3	2.2	0.0	0.4	0.0	0.1	9.8	0.1	0.0	0.1	0.1	0.1	1.0	0.0	1.2	0.2	2.9	38.4	0.1	0.6	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.2	0.5	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	11.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.2	0.0	0.0	0.7	0.3	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.0	0.0	0.0	0.0	1.7	0.0	0.1	0.1	0.2	1.3	0.3	0.2	0.1	0.0	0.4	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.3	0.0	5.3	18.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.7	0.8	0.0	0.0	0.0	0.0	0.2
ATP1A1		ENSG00000163399	"ATPase Na+/K+ transporting subunit alpha 1"	P05023	1	116372668-116410261	"Cancer-related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted membrane proteins, Transporters"	"Ion transport, Potassium transport, Sodium transport, Sodium/potassium transport, Transport"	Translocase	"Cancer-related genes, Charcot-Marie-Tooth disease, Epilepsy, FDA approved drug targets, Mental retardation, Neurodegeneration, Neuropathy, Primary hypomagnesemia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"intestine: 195.4;parathyroid gland: 194.4"	"Cell type enhanced"	"Detected in all"	5	"Enterocytes: 917.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"SK-MEL-30: 254.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB018702, CAB069993"	Enhanced					NA	NA		380000			"CAB018702: AB_626713, CAB069993: AB_2060979"	"unprognostic (6.18e-2)"	"unprognostic (2.18e-1)"	"unprognostic (6.91e-2)"	"unprognostic (1.42e-2)"	"unprognostic (6.80e-2)"	"unprognostic (2.15e-1)"	"prognostic unfavorable (1.42e-4)"	"unprognostic (1.80e-1)"	"unprognostic (1.21e-2)"	"unprognostic (6.32e-2)"	"unprognostic (1.61e-2)"	"unprognostic (1.65e-1)"	"prognostic favorable (8.98e-8)"	"unprognostic (4.75e-2)"	"unprognostic (1.17e-1)"	"unprognostic (3.11e-2)"	"prognostic unfavorable (4.01e-4)"	17.4	25.6	22.4	16.2	40.3	10.5	26.9	74.2	67.4	17.8	121.9	14.2	56.1	92.3	13.1	38.3	34.9	17.7	65.8	41.1	26.1	18.7	162.7	34.6	35.1	9.6	19.2	27.6	17.4	78.6	194.4	25.0	19.2	34.1	22.1	65.7	24.1	84.4	53.7	19.0	40.5	195.4	17.7	20.7	13.7	25.0	17.0	13.9	9.1	101.2	13.7	16.2	14.2	23.1	10.3	22.0	6.4	29.7	10.4	30.2	17.2	33.7	12.4	12.9	6.5	26.0	25.3	66.6	20.2	40.3	24.9	35.4	49.8	24.2	26.7	28.6	23.9	25.3	44.1	25.5	42.6	36.3	9.8	28.3	15.5	23.5	42.0	19.9	38.9	21.9	28.1	71.5	29.0	38.3	35.2	30.5	16.3	25.6	25.8	22.0	67.0	15.7	14.1	30.4	53.6	25.0	15.2	30.3	23.6	90.1	34.8	12.7	11.2	31.4	59.6	254.2	33.2	15.7	22.6	26.9	14.2	19.9	36.7	40.9	12.5	9.7	20.5	43.6	22.5	83.4	6.4	13.3	6.1	23.2	20.9	24.8	10.3	26.4	24.9	22.0	5.3	30.2	22.0	1.6	10.4	29.7	11.1	20.3	17.2	22.4	40.3	74.2	67.4	26.1	18.7	19.2	27.6	34.1	13.9	256.1	246.7	58.7	265.3	245.9	76.0	62.7	540.1	113.8	203.6	731.0	375.0	70.1	316.7	432.8	25.0	117.9	917.6	93.5	278.3	130.8	110.9	297.5	43.8	66.4	114.8	96.9	169.4	90.9	77.6	11.5	109.0	130.5	197.4	47.7	304.0	513.0	192.4	264.8	94.7	289.6	141.6	32.3	179.2	17.9	27.5	235.0	56.5	95.6	365.5	236.0
ATP1A2	"FHM2, MHP2"	ENSG00000018625	"ATPase Na+/K+ transporting subunit alpha 2"	P50993	1	160115759-160143591	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters"	"Ion transport, Potassium transport, Sodium transport, Sodium/potassium transport, Transport"	Translocase	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	6	"brain: 109.8;skeletal muscle: 305.8"	"Cell type enhanced"	"Detected in some"	18	"Cardiomyocytes: 142.4;Muller glia cells: 63.9;Peritubular cells: 37.1;Sertoli cells: 84.1;Smooth muscle cells: 32.5"	"Cancer enriched"	"Detected in many"	18	"glioma: 91.9"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"AF22: 32.9;HHSteC: 9.6;RH-30: 10.7;U-87 MG: 6.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB022230	Enhanced					NA	NA					"CAB022230: "	"unprognostic (1.08e-2)"	"unprognostic (4.42e-2)"	"unprognostic (3.41e-2)"	"unprognostic (2.83e-1)"	"unprognostic (2.83e-1)"	"unprognostic (7.98e-2)"	"unprognostic (2.16e-2)"	"unprognostic (1.31e-1)"	"unprognostic (1.50e-1)"	"unprognostic (8.85e-2)"	"unprognostic (8.63e-4)"	"unprognostic (1.70e-2)"	"unprognostic (9.40e-3)"	"unprognostic (1.49e-2)"	"unprognostic (2.40e-1)"	"unprognostic (7.16e-2)"	"unprognostic (5.32e-3)"	12.6	3.9	61.4	2.8	80.1	2.3	6.5	30.4	109.8	4.7	6.6	27.4	2.4	3.7	4.2	7.4	15.3	6.0	5.3	35.4	42.2	27.0	3.3	2.5	3.8	2.4	45.6	37.9	9.9	2.6	2.4	4.6	3.6	58.0	13.8	5.6	12.5	3.1	14.2	305.8	2.8	4.4	5.4	51.5	2.7	2.8	3.9	28.3	0.0	2.6	17.7	2.5	5.5	1.3	0.6	1.4	1.7	0.4	0.6	0.5	0.3	0.0	0.0	32.9	0.0	3.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.6	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.0	0.0	0.1	2.9	0.0	0.0	0.0	10.7	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.3	0.0	2.6	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	6.7	0.0	0.0	1.3	0.4	0.3	0.3	0.3	0.2	0.4	0.3	0.2	0.7	0.6	0.3	0.5	1.7	0.6	0.2	1.4	0.2	0.3	61.4	80.1	30.4	52.0	42.2	27.0	45.6	37.9	58.0	28.3	0.0	0.0	0.0	0.8	0.5	0.7	142.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	1.6	0.0	0.0	0.0	0.0	1.8	0.6	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.4	26.7	0.0	0.0	0.0	0.0	63.9	0.0	0.0	37.1	0.0	1.9	84.1	32.5	0.3	0.2	0.5	0.1	0.0	0.0	0.5
ATP1A3	DYT12	ENSG00000105409	"ATPase Na+/K+ transporting subunit alpha 3"	P13637	19	41966582-41997497	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Ion transport, Potassium transport, Sodium transport, Sodium/potassium transport, Transport"	Translocase	"Deafness, Disease mutation, Dystonia, Parkinsonism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"brain: 146.4;heart muscle: 78.3"	"Cell type enhanced"	"Detected in some"	17	"Bipolar cells: 387.3;Cone photoreceptor cells: 161.0;Horizontal cells: 201.8;Late spermatids: 93.3;Rod photoreceptor cells: 178.0"	"Group enriched"	"Detected in many"	6	"glioma: 21.6;testis cancer: 4.4"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"gdT-cell: 2.2;memory CD8 T-cell: 1.7"	"Lineage enriched"	"Detected in single"	6	"T-cells: 2.2"	"Cell line enhanced"	"Detected in many"		"Daudi: 20.7;JURKAT: 13.5;Karpas-707: 13.2;REH: 13.0;SCLC-21H: 49.1;SH-SY5Y: 21.1"									"CAB033630, HPA045367, HPA056446"	Enhanced	Approved				NA	NA					"CAB033630: AB_781528, HPA045367: AB_2679297, HPA056446: AB_2683136"	"unprognostic (1.90e-1)"	"unprognostic (8.65e-2)"	"unprognostic (4.57e-2)"	"unprognostic (8.20e-3)"	"unprognostic (8.94e-2)"	"unprognostic (2.52e-1)"	"unprognostic (3.16e-2)"	"unprognostic (7.66e-2)"	"unprognostic (8.02e-2)"	"prognostic unfavorable (3.44e-4)"	"prognostic favorable (6.15e-5)"	"unprognostic (4.02e-3)"	"prognostic unfavorable (3.02e-6)"	"unprognostic (6.84e-2)"	"unprognostic (6.48e-2)"	"unprognostic (3.45e-1)"	"unprognostic (1.27e-1)"	1.9	12.8	34.0	2.5	30.8	2.1	1.8	42.8	146.4	1.8	2.4	4.8	0.0	2.4	1.8	1.8	2.0	1.8	1.9	78.3	48.3	54.6	1.8	1.8	1.9	2.3	39.9	42.6	1.8	2.3	1.8	3.0	1.8	94.4	1.8	2.3	17.3	2.2	1.8	1.8	2.0	2.7	2.2	18.5	2.1	2.0	18.6	6.9	0.0	1.8	0.0	2.1	1.9	0.1	0.3	0.1	0.0	0.0	0.1	2.2	0.3	0.0	0.8	0.3	8.7	0.0	0.0	0.0	0.1	0.0	0.6	0.6	0.3	1.6	20.7	0.9	0.1	2.0	0.2	6.1	0.0	0.2	3.9	1.1	1.8	0.0	0.1	0.0	0.0	6.8	0.0	0.0	0.0	0.1	0.1	0.0	13.5	0.0	13.2	0.1	0.3	3.7	0.0	1.1	2.9	5.3	13.0	7.1	0.6	0.0	0.2	49.1	21.1	0.1	1.6	0.0	0.0	1.3	0.9	0.0	1.1	1.1	0.0	0.4	1.3	0.9	4.7	1.9	7.2	0.2	0.0	0.0	0.0	2.2	0.0	0.2	0.3	0.6	1.7	0.0	0.0	0.2	1.0	0.0	0.1	0.0	0.1	0.7	0.3	34.0	30.8	42.8	66.6	48.3	54.6	39.9	42.6	94.4	6.9	0.0	7.9	0.5	0.3	0.2	387.3	15.7	0.0	0.0	0.0	0.0	161.0	0.0	0.0	0.0	33.6	0.3	0.0	0.0	0.0	0.1	0.6	0.2	1.1	0.0	0.2	201.8	0.0	0.0	0.0	93.3	1.7	0.2	0.0	0.0	0.0	25.9	0.0	0.0	0.4	0.0	178.0	0.0	0.0	21.3	3.2	0.3	0.2	1.9	0.0	0.4
ATP1A4	ATP1AL2	ENSG00000132681	"ATPase Na+/K+ transporting subunit alpha 4"	Q13733	1	160151570-160186977	"Enzymes, Predicted membrane proteins"	"Ion transport, Potassium transport, Sodium transport, Sodium/potassium transport, Transport"	Translocase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"placenta: 13.1;seminal vesicle: 19.0;testis: 35.8"	"Cell type enhanced"	"Detected in some"	20	"Cytotrophoblasts: 20.6;Early spermatids: 67.0;Syncytiotrophoblasts: 31.9"	"Group enriched"	"Detected in some"	8	"breast cancer: 0.8;urothelial cancer: 1.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	11	"BEWO: 10.8;HDLM-2: 26.8;RT4: 32.4"	"Not detected"	"Not detected"													NA	NA						"unprognostic (1.33e-1)"	"unprognostic (4.01e-3)"	"unprognostic (2.20e-1)"	"unprognostic (1.94e-1)"	"unprognostic (2.09e-1)"	"unprognostic (8.55e-2)"	"unprognostic (1.22e-1)"	"unprognostic (7.48e-3)"	"unprognostic (2.45e-1)"	"unprognostic (8.77e-3)"	"unprognostic (1.98e-2)"	"unprognostic (3.17e-2)"	"unprognostic (2.43e-3)"	"unprognostic (1.07e-1)"	"unprognostic (1.30e-1)"	"unprognostic (4.09e-2)"	"prognostic favorable (2.20e-4)"	0.4	0.3	0.4	0.8	0.3	0.0	2.2	0.4	0.3	0.3	0.3	0.0	11.2	0.0	0.2	0.3	0.3	0.3	0.8	0.3	0.3	0.3	0.2	0.2	0.3	3.8	0.3	0.0	0.2	0.2	0.0	0.3	13.1	0.0	0.6	0.0	0.4	1.2	19.0	3.2	0.3	0.5	1.6	0.3	1.1	0.3	35.8	0.0	0.9	0.2	0.2	1.6	8.9	5.9	0.0	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	26.8	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	32.4	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.3	0.4	0.3	0.3	0.3	0.3	0.0	0.0	0.0	0.0	1.1	0.0	5.5	0.2	0.0	0.8	0.0	0.0	0.0	1.8	0.0	20.6	0.0	0.0	67.0	0.0	0.0	0.0	0.0	11.9	0.4	0.7	1.1	0.0	2.4	0.0	0.0	0.0	0.0	4.2	0.0	0.0	0.0	10.8	0.0	0.0	0.0	0.0	0.4	0.0	2.1	0.0	0.0	0.2	0.2	0.0	31.9	0.0	0.0	11.2
ATP23	"KUB3, XRCC6BP1"	ENSG00000166896	"ATP23 metallopeptidase and ATP synthase assembly factor homolog"	Q9Y6H3	12	57941541-57957269	"Enzymes, Predicted intracellular proteins"		"Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 39.5"	"Cell type enhanced"	"Detected in many"	8	"Cytotrophoblasts: 11.7;Distal tubular cells: 14.9;Extravillous trophoblasts: 11.6;granulocytes: 10.5;Hofbauer cells: 9.7;Proximal tubular cells: 18.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"NB-4: 15.2;RH-30: 49.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035804, HPA043204"	Uncertain		Enhanced	"Vesicles,Plasma membrane,Cell Junctions,Cytosol"		NA	NA			"Vesicles, Plasma membrane"	"Cell Junctions, Cytosol"	"HPA035804: AB_10601026, HPA043204: AB_2678361"	"unprognostic (2.56e-1)"	"unprognostic (1.31e-2)"	"unprognostic (8.82e-2)"	"unprognostic (2.92e-2)"	"unprognostic (2.30e-2)"	"unprognostic (6.16e-2)"	"unprognostic (1.20e-1)"	"unprognostic (5.28e-2)"	"unprognostic (5.41e-3)"	"unprognostic (1.03e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.06e-1)"	"prognostic unfavorable (1.44e-5)"	"unprognostic (4.36e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.80e-1)"	"unprognostic (2.27e-1)"	6.7	4.9	4.3	5.2	5.3	11.3	4.8	6.1	4.8	5.6	8.2	1.3	2.5	3.9	3.2	4.2	7.3	3.1	2.4	6.4	4.2	3.6	5.4	6.2	2.7	6.8	2.7	3.8	4.2	5.8	3.2	3.0	3.5	2.9	5.1	8.2	2.3	3.4	3.3	11.7	5.6	4.3	6.5	3.4	3.7	3.8	39.5	2.0	20.8	4.7	5.9	4.7	6.3	6.2	3.0	4.5	12.0	4.5	2.6	5.6	3.0	2.0	1.5	1.9	2.2	2.8	2.7	1.0	1.9	2.0	2.2	2.1	1.2	2.5	6.9	2.5	1.5	2.2	1.9	1.8	2.0	3.8	3.5	1.8	4.5	1.3	2.0	1.2	9.1	3.1	1.4	1.5	1.3	0.6	2.2	1.5	5.0	4.7	5.0	1.8	3.1	4.9	15.2	1.7	3.4	3.7	3.2	49.9	2.9	1.8	2.6	1.2	1.8	3.1	2.9	1.6	0.9	5.0	8.6	0.8	1.7	2.9	2.2	1.9	4.1	2.1	3.6	1.8	9.8	2.7	7.6	4.5	12.0	3.5	2.4	2.6	3.0	4.0	3.3	4.5	3.0	4.3	4.0	1.9	2.6	4.2	2.1	5.6	3.0	4.3	5.3	6.1	4.8	4.2	3.6	2.7	3.8	2.9	2.0	0.0	8.6	0.0	0.0	0.0	0.0	0.0	0.0	1.4	3.4	3.5	0.0	11.7	14.9	5.1	0.0	0.0	0.0	0.0	9.4	11.6	0.0	0.0	10.5	0.0	9.7	0.0	0.0	0.0	0.0	0.0	0.0	3.4	0.0	1.8	0.0	0.0	4.0	0.0	0.0	18.5	0.0	0.0	0.0	0.0	0.0	0.0	2.9	0.0	0.0	0.0
ATP2A1	"ATP2A, SERCA1"	ENSG00000196296	"ATPase sarcoplasmic/endoplasmic reticulum Ca2+ transporting 1"	O14983	16	28878405-28904509	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Calcium transport, Ion transport, Transport"	Translocase	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	26	"skeletal muscle: 456.3;tongue: 209.0"	"Cell type enhanced"	"Detected in some"	20	"Cone photoreceptor cells: 13.7;Late spermatids: 2.9;Rod photoreceptor cells: 4.6;Spermatogonia: 3.0"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 4.7"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in many"		"NK-cell: 4.7"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HEK 293: 19.8"	"Region enriched"	"Detected in single"	8	"thalamus: 14.3"	"Not detected"	"Not detected"			"CAB002310, CAB032706"	Enhanced		Approved	"Endoplasmic reticulum"		NA	NA			"Endoplasmic reticulum"		"CAB002310: AB_564139, CAB032706: AB_2061286"	"unprognostic (2.37e-1)"	"unprognostic (6.81e-2)"	"unprognostic (2.23e-5)"	"unprognostic (5.35e-2)"	"unprognostic (2.27e-1)"	"unprognostic (2.04e-1)"	"unprognostic (1.89e-1)"	"unprognostic (1.19e-1)"	"unprognostic (5.24e-2)"	"unprognostic (1.87e-1)"	"unprognostic (5.22e-2)"	"unprognostic (4.94e-2)"	"unprognostic (2.72e-4)"	"unprognostic (1.70e-2)"	"unprognostic (1.91e-1)"	"unprognostic (1.49e-1)"	"unprognostic (2.51e-2)"	7.6	0.1	0.1	0.2	0.1	0.2	0.2	0.2	0.1	0.1	0.1	0.0	0.0	0.2	0.1	1.1	5.2	0.1	0.1	0.1	0.1	0.1	0.1	0.3	0.1	0.2	0.1	0.0	0.1	0.1	0.1	0.3	0.1	0.0	0.6	0.1	12.6	7.0	0.3	456.3	0.2	0.2	0.1	0.1	0.1	0.1	0.9	0.0	0.0	4.2	209.0	6.5	0.2	0.1	1.6	3.1	0.7	0.2	4.7	1.5	0.6	4.8	5.2	9.6	5.8	0.4	1.6	8.9	2.3	1.3	0.4	0.4	2.9	4.4	7.6	2.7	0.4	3.2	5.1	2.4	0.1	0.7	3.8	19.8	2.7	11.8	9.0	0.2	1.1	2.6	4.1	1.1	0.6	0.5	4.9	0.2	14.3	5.2	6.5	0.3	9.7	10.9	6.1	9.7	1.8	7.4	16.9	6.8	5.7	0.0	0.6	6.2	4.9	3.3	4.5	3.4	3.7	3.4	2.7	2.0	3.0	6.3	5.6	2.8	9.5	5.8	7.4	5.9	15.0	2.9	0.0	0.1	0.7	1.0	0.0	1.3	1.6	1.1	1.0	0.0	0.8	1.4	1.3	0.0	4.7	0.2	3.1	1.5	0.6	0.1	0.1	0.2	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	2.3	0.3	0.0	0.0	0.0	0.0	13.7	0.3	0.0	0.1	1.0	0.0	0.5	0.0	0.2	0.1	0.2	0.1	0.0	0.8	0.1	0.0	0.0	0.0	0.3	2.9	0.3	0.0	0.0	0.0	0.1	0.5	0.2	0.3	0.0	0.0	4.6	0.0	0.0	1.8	3.0	0.1	0.6	0.0	0.6	0.0
ATP2A2	"ATP2B, DAR, SERCA2"	ENSG00000174437	"ATPase sarcoplasmic/endoplasmic reticulum Ca2+ transporting 2"	P16615	12	110280756-110351093	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Calcium transport, Ion transport, Transport"	Translocase	"Disease mutation, Epilepsy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	5	"heart muscle: 188.3;skeletal muscle: 319.7"	"Cell type enriched"	"Detected in all"	12	"Cardiomyocytes: 1592.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA062605	Enhanced					NA	NA		38000000			"HPA062605: AB_2684805"	"unprognostic (4.81e-2)"	"unprognostic (2.16e-2)"	"unprognostic (1.87e-1)"	"unprognostic (3.41e-3)"	"unprognostic (2.50e-1)"	"unprognostic (3.98e-3)"	"unprognostic (1.91e-2)"	"unprognostic (6.20e-2)"	"unprognostic (4.69e-2)"	"unprognostic (2.42e-1)"	"unprognostic (1.20e-2)"	"unprognostic (1.00e-1)"	"unprognostic (3.47e-2)"	"unprognostic (1.36e-3)"	"unprognostic (2.26e-1)"	"unprognostic (5.62e-2)"	"unprognostic (9.93e-2)"	8.4	8.8	7.3	8.5	14.5	5.7	7.5	7.4	20.8	8.2	9.6	8.0	8.3	7.3	9.4	10.3	24.1	9.4	9.3	188.3	10.1	5.0	6.7	11.8	8.9	5.6	5.6	13.1	8.5	7.6	8.7	6.1	8.1	10.2	13.0	11.2	22.3	18.3	9.6	319.7	9.3	9.3	14.3	7.4	5.4	7.9	11.9	7.1	3.1	12.6	51.3	12.7	13.4	11.4	0.8	2.2	0.2	4.4	1.7	1.7	0.7	35.5	70.9	35.9	28.8	23.9	30.6	51.8	44.3	55.8	45.0	30.3	51.2	37.9	43.9	37.5	42.1	34.0	52.0	59.4	70.0	51.2	36.3	29.7	38.3	28.4	29.9	40.6	43.7	37.1	32.1	49.4	57.1	55.4	43.3	34.7	23.0	44.6	21.5	36.6	34.1	23.6	27.1	40.9	36.5	35.9	24.9	32.3	36.2	22.2	73.4	38.0	28.5	55.8	45.8	25.9	34.2	61.6	23.6	37.2	41.7	22.4	27.7	33.8	44.2	53.8	49.2	38.0	18.9	47.2	0.0	1.9	0.0	1.7	4.4	0.9	0.7	1.3	1.1	1.9	0.8	1.3	1.2	0.2	1.7	2.3	2.2	1.2	0.7	7.3	14.5	7.4	20.8	10.1	5.0	5.6	13.1	10.2	7.1	41.7	53.9	23.1	78.3	101.7	60.4	1592.4	45.9	96.4	83.0	48.8	60.9	28.0	1.7	40.8	10.7	37.6	123.8	23.3	60.6	31.5	51.2	89.3	43.9	110.5	56.0	79.4	131.8	41.1	50.1	9.0	28.1	40.7	64.1	19.0	80.6	24.0	82.4	70.2	78.1	23.9	39.0	51.8	126.0	61.6	55.1	95.2	25.6	17.0	66.5	93.6
ATP2A3	SERCA3	ENSG00000074370	"ATPase sarcoplasmic/endoplasmic reticulum Ca2+ transporting 3"	Q93084	17	3923870-3964464	"Enzymes, Plasma proteins, Predicted membrane proteins"	"Calcium transport, Ion transport, Transport"	Translocase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 82.4;salivary gland: 88.1"	"Cell type enhanced"	"Detected in many"	10	"Enterocytes: 61.6;Intestinal endocrine cells: 94.0;Mucus-secreting cells: 112.7;Paneth cells: 46.0"	"Low cancer specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"cerebellum: 10.9;midbrain: 4.1"	"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Daudi: 39.3;HMC-1: 58.2;JURKAT: 32.7;MOLT-4: 52.0;SK-BR-3: 42.3"	"Region enriched"	"Detected in some"	15	"cerebellum: 75.4"	"Low region specificity"	"Detected in many"			"HPA007180, CAB010882"	Approved					NA	NA		100000000			"CAB010882: AB_258368, HPA007180: AB_1845177"	"unprognostic (4.14e-2)"	"prognostic favorable (4.69e-5)"	"unprognostic (1.21e-2)"	"unprognostic (3.68e-2)"	"unprognostic (1.02e-2)"	"prognostic favorable (2.51e-4)"	"unprognostic (8.83e-3)"	"unprognostic (2.30e-1)"	"unprognostic (8.29e-2)"	"unprognostic (3.67e-3)"	"unprognostic (3.95e-3)"	"unprognostic (1.73e-1)"	"unprognostic (1.45e-3)"	"unprognostic (1.60e-1)"	"unprognostic (3.25e-2)"	"unprognostic (1.54e-1)"	"unprognostic (1.97e-3)"	2.1	4.9	0.9	36.9	1.6	24.3	2.7	10.9	1.7	2.3	15.4	1.8	48.8	8.1	3.4	2.8	4.5	2.2	16.0	2.6	0.9	0.7	3.4	1.6	7.8	25.6	4.1	1.4	2.1	20.2	0.0	0.8	1.7	1.4	7.4	9.0	8.7	88.1	47.3	0.9	9.4	26.1	3.0	1.0	36.4	25.5	1.6	1.2	82.4	4.2	6.0	47.5	5.4	2.6	8.3	10.8	21.1	1.0	2.5	7.8	3.9	0.0	1.6	0.0	1.4	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.5	0.3	39.3	2.4	0.1	0.0	0.1	0.6	0.0	0.0	4.8	0.4	20.5	1.2	0.0	0.3	22.3	58.2	0.0	0.0	0.1	0.0	0.0	0.0	32.7	4.1	25.4	0.0	24.4	52.0	24.0	0.2	11.1	0.3	5.7	0.0	9.0	0.0	0.7	2.5	0.7	0.3	42.3	0.0	0.2	2.6	5.5	0.1	0.0	0.4	0.1	0.0	9.4	2.8	13.8	0.5	15.9	0.0	9.1	1.0	21.1	7.8	0.6	6.1	6.9	4.8	7.2	1.0	8.3	3.6	4.4	9.0	2.5	0.3	10.8	4.2	3.9	0.9	1.6	10.9	1.7	0.9	0.7	4.1	1.4	1.4	1.2	0.0	3.4	44.0	0.4	0.8	0.0	2.2	5.1	1.4	2.3	22.7	0.0	0.2	0.0	1.7	0.1	3.6	61.6	0.0	10.8	0.2	2.0	6.5	33.4	0.8	2.8	0.0	94.0	7.4	3.5	0.0	0.0	2.6	11.8	0.0	112.7	0.2	17.0	46.0	0.7	0.2	0.1	0.0	3.1	0.0	0.7	0.3	0.0	20.8	41.2	2.5
ATP2B1	PMCA1	ENSG00000070961	"ATPase plasma membrane Ca2+ transporting 1"	P20020	12	89588049-89709300	"Enzymes, Plasma proteins, Predicted membrane proteins"	"Calcium transport, Ion transport, Transport"	"Calmodulin-binding, Translocase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 53.8"	"Cell type enhanced"	"Detected in many"	4	"Bipolar cells: 311.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"hTERT-HME1: 59.7;LHCN-M2: 92.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB005605, HPA011166, HPA012945"	Enhanced	Supported	Supported	"Plasma membrane"		NA	NA			"Plasma membrane"		"CAB005605: AB_2061563, HPA011166: AB_1855484, HPA012945: AB_1855483"	"unprognostic (6.78e-2)"	"unprognostic (5.27e-2)"	"unprognostic (1.57e-2)"	"unprognostic (8.23e-2)"	"unprognostic (1.72e-1)"	"unprognostic (6.44e-2)"	"prognostic unfavorable (7.74e-4)"	"unprognostic (2.77e-2)"	"unprognostic (2.46e-2)"	"unprognostic (7.82e-2)"	"unprognostic (5.98e-2)"	"unprognostic (2.68e-1)"	"unprognostic (4.60e-2)"	"unprognostic (1.92e-2)"	"unprognostic (2.31e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.13e-2)"	8.7	5.1	23.4	12.5	53.8	40.5	8.8	30.9	44.1	9.0	14.0	4.1	4.0	17.8	8.2	5.8	6.5	8.4	11.3	5.2	29.0	11.8	7.4	10.0	9.2	11.8	7.8	31.5	7.6	7.4	13.7	8.7	11.7	9.2	6.4	14.8	2.9	5.6	6.9	10.9	11.3	12.8	8.7	6.1	12.7	12.4	9.8	16.4	5.7	6.3	6.0	12.3	9.9	7.4	27.1	16.2	41.5	25.6	8.4	16.3	6.2	4.2	21.5	8.5	4.1	12.4	19.7	3.9	13.0	42.9	12.6	20.2	8.6	3.9	8.4	0.9	18.1	14.6	3.8	7.4	3.6	35.5	2.9	8.7	3.0	7.6	7.5	40.3	12.5	5.0	16.3	6.9	39.5	59.7	14.9	3.2	3.2	4.9	3.1	92.7	6.7	3.9	5.4	6.6	5.9	10.3	5.6	27.4	3.5	12.0	19.8	8.0	4.4	15.1	4.3	3.6	18.0	6.3	1.4	2.2	34.5	5.6	12.6	14.2	2.3	3.6	9.0	15.6	3.5	7.6	2.7	13.0	6.7	7.1	13.6	9.0	27.1	12.4	9.0	16.2	27.0	4.6	5.7	41.5	8.4	25.6	2.9	16.3	6.2	23.4	53.8	30.9	44.1	29.0	11.8	7.8	31.5	9.2	16.4	41.7	42.4	79.2	52.7	179.2	311.6	18.9	45.9	29.4	36.4	50.6	145.3	117.8	1.7	21.2	1.8	49.1	113.3	0.0	24.6	36.9	79.9	37.8	30.1	35.8	157.7	286.0	87.9	47.3	100.2	6.0	27.0	213.2	52.3	116.4	24.1	78.6	21.7	48.2	30.1	23.1	99.9	32.3	51.5	12.9	122.1	178.9	191.3	55.4	45.3	59.3
ATP2B2	PMCA2	ENSG00000157087	"ATPase plasma membrane Ca2+ transporting 2"	Q01814	3	10324023-10708007	"Enzymes, Plasma proteins, Predicted membrane proteins, Transporters"	"Calcium transport, Ion transport, Transport"	"Calmodulin-binding, Translocase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	7	"brain: 55.1;liver: 15.2;salivary gland: 28.6;skeletal muscle: 30.3"	"Group enriched"	"Detected in some"	5	"Bipolar cells: 85.3;Hepatocytes: 27.0;Horizontal cells: 98.5"	"Cancer enhanced"	"Detected in some"		"liver cancer: 7.7"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"EFO-21: 5.4;RPMI-8226: 15.3;SCLC-21H: 5.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB005606	Enhanced					NA	NA					"CAB005606: AB_2243199"	"unprognostic (2.04e-1)"	"unprognostic (1.26e-2)"	"unprognostic (6.84e-2)"	"unprognostic (1.59e-2)"	"unprognostic (3.59e-1)"	"unprognostic (3.62e-1)"	"unprognostic (4.09e-2)"	"unprognostic (4.65e-1)"	"unprognostic (5.61e-2)"	"unprognostic (1.93e-1)"	"unprognostic (2.32e-4)"	"unprognostic (2.70e-1)"	"unprognostic (1.46e-3)"	"unprognostic (1.08e-3)"	"unprognostic (1.33e-2)"	"unprognostic (8.34e-2)"	"unprognostic (7.95e-3)"	1.0	1.5	7.6	1.0	23.0	0.9	1.0	39.9	55.1	3.0	1.0	2.4	0.0	1.0	3.2	1.1	1.1	4.3	1.0	1.0	10.0	6.2	1.1	15.2	1.0	1.0	7.9	14.7	1.0	1.1	0.9	1.7	0.9	15.5	1.0	1.0	0.7	28.6	0.9	30.3	1.3	1.0	2.3	2.5	1.0	1.0	1.5	4.2	0.0	0.9	0.0	1.0	0.9	0.2	0.0	0.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.4	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	1.3	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	15.3	0.0	0.0	5.8	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.3	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.1	7.6	23.0	39.9	55.1	10.0	6.2	7.9	14.7	15.5	4.2	0.0	0.0	0.0	0.0	0.5	85.3	7.6	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	27.0	0.0	98.5	0.0	0.6	1.0	5.7	0.0	0.0	3.3	0.0	0.0	14.5	0.0	0.0	0.0	0.0	7.4	0.0	0.0	0.1	0.1	0.3	0.0	0.0	0.0	0.0
ATP2B3	"CFAP39, CLA2, PMCA3, SCAX1"	ENSG00000067842	"ATPase plasma membrane Ca2+ transporting 3"	Q16720	X	153517676-153582939	"Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted membrane proteins"	"Calcium transport, Ion transport, Transport"	"Calmodulin-binding, Translocase"	"Cancer-related genes, Disease mutation, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	7	"adrenal gland: 18.6;brain: 23.2"	"Group enriched"	"Detected in some"	4	"Bipolar cells: 5.0;Extravillous trophoblasts: 8.3;Rod photoreceptor cells: 2.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"SCLC-21H: 14.6;SH-SY5Y: 4.3;THP-1: 3.5;U-937: 3.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA001583	Enhanced	Supported				NA	NA					"HPA001583: AB_1079641"	"unprognostic (1.35e-1)"	"unprognostic (3.07e-2)"	"unprognostic (3.28e-1)"	"unprognostic (6.82e-2)"	"unprognostic (1.30e-1)"	"unprognostic (4.32e-2)"	"unprognostic (2.67e-1)"	"unprognostic (6.34e-2)"	"unprognostic (2.68e-2)"	"unprognostic (8.58e-2)"	"unprognostic (1.38e-3)"	"unprognostic (3.44e-1)"	"unprognostic (2.71e-12)"	"unprognostic (1.44e-3)"	"unprognostic (2.04e-1)"		"unprognostic (2.42e-2)"	0.8	18.6	5.4	0.9	11.3	0.8	0.8	16.1	23.2	0.8	0.9	3.9	0.0	0.9	0.9	2.6	0.8	3.1	0.8	0.8	7.8	5.5	1.0	0.8	0.8	0.8	4.3	11.5	0.8	0.9	0.8	1.2	1.7	13.6	0.8	0.8	1.4	1.3	1.3	0.8	0.9	0.9	0.9	1.4	0.8	0.8	1.1	0.9	0.0	0.8	0.0	0.8	0.8	0.1	0.0	0.5	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.6	4.3	0.0	0.0	0.0	0.1	0.0	3.5	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	3.4	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	5.4	11.3	16.1	20.7	7.8	5.5	4.3	11.5	13.6	0.9	0.0	0.0	0.0	0.0	0.0	5.0	1.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.3	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.4	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0
ATP2B4	"ATP2B2, MXRA1, PMCA4"	ENSG00000058668	"ATPase plasma membrane Ca2+ transporting 4"	P23634	1	203626561-203744081	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Calcium transport, Ion transport, Transport"	"Calmodulin-binding, Translocase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Muller glia cells: 153.7;Suprabasal keratinocytes: 132.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 59.5;fHDF/TERT166: 45.1;SuSa: 49.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB016118, HPA040431"	Enhanced		Supported	"Plasma membrane"		NA	NA		21000	"Plasma membrane"		"CAB016118: AB_2061729, HPA040431: AB_2676980"	"unprognostic (7.43e-2)"	"unprognostic (1.58e-1)"	"unprognostic (1.60e-2)"	"unprognostic (8.17e-2)"	"unprognostic (2.53e-2)"	"unprognostic (9.23e-3)"	"unprognostic (8.68e-2)"	"unprognostic (3.81e-2)"	"unprognostic (9.74e-2)"	"unprognostic (1.70e-1)"	"unprognostic (1.64e-2)"	"unprognostic (1.12e-1)"	"prognostic unfavorable (1.21e-4)"	"unprognostic (3.52e-3)"	"unprognostic (2.61e-2)"	"unprognostic (1.30e-1)"	"unprognostic (2.56e-3)"	23.0	14.0	24.8	10.8	14.2	5.9	11.6	9.4	23.6	32.6	44.2	7.5	12.9	5.3	69.6	13.1	20.4	27.0	13.9	24.0	13.1	8.7	5.0	14.2	16.1	5.3	6.4	19.2	21.9	6.4	8.0	4.8	16.2	9.3	17.0	13.4	11.6	7.5	31.5	5.4	22.0	13.2	74.2	5.7	4.8	16.4	13.1	7.5	9.0	8.3	8.4	7.7	32.8	14.2	1.0	4.2	4.5	2.2	4.2	10.4	2.6	9.2	1.7	3.4	3.2	26.0	38.8	18.0	41.8	59.5	7.1	6.1	0.8	4.7	2.1	6.1	45.1	9.5	9.0	4.9	5.8	7.5	26.5	1.7	6.2	8.3	0.5	9.3	8.8	11.0	28.1	5.7	22.8	3.5	17.3	13.5	12.3	2.7	4.2	5.2	0.5	8.9	2.9	2.0	1.7	5.2	4.7	2.5	3.3	2.4	0.8	1.0	1.4	14.7	2.2	6.6	49.6	1.9	4.3	11.8	17.3	2.5	29.0	10.0	2.8	4.2	1.1	17.3	6.4	5.1	3.0	2.2	0.0	10.4	1.5	7.9	1.0	6.6	8.3	2.4	0.3	1.6	4.2	4.5	4.2	2.2	4.2	6.3	2.6	24.8	14.2	9.4	23.6	13.1	8.7	6.4	19.2	9.3	7.5	83.4	62.7	10.4	15.6	86.3	2.8	64.1	7.6	34.8	40.9	17.4	2.0	22.3	0.0	31.1	4.3	39.1	3.9	23.3	13.2	13.3	48.3	9.5	9.3	15.7	31.0	111.2	23.0	54.6	14.6	1.3	40.6	13.2	25.3	7.2	1.9	153.7	25.2	11.9	35.7	5.0	6.9	19.4	82.4	22.3	2.1	132.0	21.7	45.7	2.6	43.3
ATP2C1	"ATP2C1A, BCPM, KIAA1347, PMR1, SPCA1"	ENSG00000017260	"ATPase secretory pathway Ca2+ transporting 1"	P98194	3	130850595-131016712	"Disease related genes, Enzymes, FDA approved drug targets, Predicted membrane proteins, Transporters"	"Calcium transport, Ion transport, Transport"	Translocase	"Disease mutation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB010207, HPA035116, HPA069684"	Supported		Supported	"Golgi apparatus"		NA	NA		28000	"Golgi apparatus"		"CAB010207: AB_2061744, HPA035116: AB_10673106, HPA069684: AB_2686169"	"unprognostic (1.52e-1)"	"unprognostic (1.37e-1)"	"unprognostic (2.74e-2)"	"unprognostic (1.08e-1)"	"unprognostic (2.99e-1)"	"unprognostic (1.32e-2)"	"prognostic unfavorable (5.06e-6)"	"unprognostic (7.66e-2)"	"unprognostic (6.52e-2)"	"unprognostic (2.45e-1)"	"prognostic unfavorable (1.52e-4)"	"unprognostic (8.44e-2)"	"prognostic favorable (1.55e-4)"	"unprognostic (2.19e-1)"	"unprognostic (1.95e-1)"	"unprognostic (3.73e-2)"	"unprognostic (3.06e-1)"	18.6	22.9	29.6	14.5	29.4	20.4	36.8	24.5	34.6	22.2	21.6	23.0	14.3	14.4	19.3	18.0	16.9	23.4	16.8	19.2	31.6	32.3	28.0	17.1	30.7	16.0	31.8	25.4	18.5	14.6	47.6	31.0	19.6	26.7	54.0	22.4	18.1	20.3	16.6	16.1	21.3	16.0	19.2	44.6	11.1	18.7	16.0	25.6	20.5	21.7	15.5	15.4	19.3	29.6	4.7	7.6	21.6	7.0	8.7	7.2	4.9	36.6	14.4	14.5	13.9	40.6	32.9	15.6	40.1	53.5	20.2	25.5	23.4	30.3	13.3	27.9	37.9	28.1	43.7	27.2	22.1	29.6	28.7	9.8	35.4	15.3	10.8	25.9	14.1	43.2	25.8	22.3	21.2	24.1	36.9	21.3	16.9	10.2	24.3	24.8	16.3	13.8	11.3	16.4	20.0	15.7	10.0	14.4	20.9	37.2	24.7	22.4	13.4	34.5	10.8	20.2	21.6	16.0	11.6	29.1	21.5	12.0	27.6	18.4	15.7	19.0	19.7	22.2	10.6	17.9	21.6	7.0	12.1	6.3	6.0	5.9	4.7	6.2	5.6	7.6	2.9	4.3	4.3	3.5	8.7	7.0	6.6	7.2	4.9	29.6	29.4	24.5	34.6	31.6	32.3	31.8	25.4	26.7	25.6	35.7	45.2	11.3	32.9	34.9	26.4	27.0	40.8	24.1	23.9	43.6	19.6	13.5	5.0	32.7	12.6	25.1	15.9	0.0	33.1	24.1	29.4	68.4	27.7	24.6	26.6	77.9	34.2	22.7	18.3	14.0	15.0	28.6	20.3	19.8	31.3	22.6	44.4	25.9	13.8	18.6	33.2	6.5	24.2	15.2	14.9	46.2	14.8	13.8	29.3	33.5
ATP2C2	"KIAA0703, SPCA2"	ENSG00000064270	"ATPase secretory pathway Ca2+ transporting 2"	O75185	16	84368527-84464187	"Enzymes, Predicted membrane proteins, Transporters"	"Calcium transport, Ion transport, Transport"	Translocase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 23.0;salivary gland: 35.8"	"Cell type enhanced"	"Detected in many"	8	"Alveolar cells type 2: 42.2;Ciliated cells: 72.3;Mucus-secreting cells: 62.9;Undifferentiated cells: 69.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in single"	24	"neutrophil: 2.7"	"Lineage enriched"	"Detected in single"	24	"granulocytes: 2.7"	"Cell line enhanced"	"Detected in some"		"MCF7: 14.5;OE19: 26.0;RT4: 11.4;SK-BR-3: 20.2;T-47d: 6.7"	"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			"HPA052262, HPA075812"	Approved		Approved	"Plasma membrane,Focal adhesion sites"		NA	NA			"Plasma membrane, Focal adhesion sites"		"HPA052262: AB_2681776, HPA075812: AB_2686765"	"unprognostic (2.28e-2)"	"unprognostic (6.13e-2)"	"unprognostic (3.34e-2)"	"prognostic favorable (6.20e-6)"	"unprognostic (2.04e-1)"	"unprognostic (2.41e-2)"	"unprognostic (8.36e-2)"	"unprognostic (1.72e-1)"	"unprognostic (9.92e-2)"	"unprognostic (1.89e-2)"	"unprognostic (5.08e-2)"	"unprognostic (2.16e-1)"	"unprognostic (8.37e-3)"	"unprognostic (1.17e-1)"	"unprognostic (1.02e-1)"	"unprognostic (4.32e-4)"	"unprognostic (1.39e-1)"	0.3	0.0	2.1	8.0	1.5	6.1	2.5	0.2	2.0	3.5	23.0	0.5	1.9	16.3	1.8	1.9	2.7	4.0	18.8	0.4	1.8	1.9	2.6	0.2	21.9	0.2	1.3	0.7	1.3	0.5	0.0	2.9	4.8	0.7	7.9	21.9	1.0	35.8	0.2	0.9	15.2	14.5	0.5	0.6	0.2	3.4	0.4	0.4	0.3	8.2	2.2	8.1	4.8	7.8	0.0	0.0	2.7	0.0	0.0	0.1	0.0	3.6	0.2	0.4	0.0	0.0	0.0	3.9	0.1	0.0	0.0	0.0	3.4	3.2	0.0	0.0	0.0	0.0	5.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.5	0.0	0.0	0.0	26.0	0.1	0.0	0.0	0.1	0.0	11.4	2.9	0.0	0.0	20.2	0.1	0.5	6.7	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.0	2.1	1.5	0.2	2.0	1.8	1.9	1.3	0.7	0.7	0.4	29.8	42.2	0.0	12.3	0.6	1.4	0.6	2.5	72.3	29.6	0.0	0.0	1.9	0.0	7.2	3.0	0.6	15.4	0.0	2.3	2.2	0.3	21.6	9.2	0.0	0.2	0.0	32.8	0.0	0.0	1.1	0.0	0.7	1.7	0.0	62.9	1.3	3.1	17.3	0.0	1.9	5.6	0.0	0.5	0.7	0.6	1.0	20.1	0.0	69.5	9.5
ATP4A	ATP6A	ENSG00000105675	"ATPase H+/K+ transporting alpha subunit"	P20648	19	35550043-35563658	"Enzymes, FDA approved drug targets, Plasma proteins, Predicted membrane proteins, Transporters"	"Hydrogen ion transport, Ion transport, Potassium transport, Transport"	Translocase	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	24	"stomach 1: 120.1"	"Group enriched"	"Detected in some"	4	"Early spermatids: 7.3;Late spermatids: 15.2"	"Cancer enriched"	"Detected in single"	21	"stomach cancer: 5.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"THP-1: 1.2;U-138 MG: 1.5"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in some"			"HPA039154, HPA076684"	Enhanced					NA	NA		790000			"HPA039154: AB_10672772, HPA076684: "	"unprognostic (3.54e-2)"	"unprognostic (6.98e-3)"		"unprognostic (2.77e-2)"	"unprognostic (1.43e-1)"	"unprognostic (5.84e-3)"		"unprognostic (4.96e-2)"	"unprognostic (1.02e-1)"	"unprognostic (1.50e-1)"	"unprognostic (9.68e-2)"	"unprognostic (1.47e-3)"	"unprognostic (3.90e-3)"	"unprognostic (3.92e-2)"	"unprognostic (4.86e-2)"	"unprognostic (1.23e-1)"	"unprognostic (2.18e-1)"	0.1	0.2	0.1	0.1	0.6	0.0	0.1	0.1	0.6	0.1	0.1	3.4	0.1	0.0	0.1	0.1	4.9	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	2.0	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.1	2.1	0.1	0.1	120.1	0.1	0.1	0.7	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.3	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	1.2	0.0	1.5	0.3	0.0	0.0	0.4	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.6	0.1	0.6	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.3	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.2	0.6	0.0	0.0	1.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.9	2.6	0.0	0.0	0.0	0.0	0.0
ATP5F1B	"ATP5B, ATPSB"	ENSG00000110955	"ATP synthase F1 subunit beta"	P06576	12	56638175-56646068	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"ATP synthesis, Hydrogen ion transport, Ion transport, Transport"	Translocase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	8	"Cytotrophoblasts: 693.2;Distal tubular cells: 1049.5;Proximal tubular cells: 698.1;Syncytiotrophoblasts: 952.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA001520, HPA001528, CAB017527"	Enhanced		Enhanced	Mitochondria		NA	NA		100000000	Mitochondria		"CAB017527: AB_1121153, HPA001520: AB_1078243, HPA001528: AB_1078242"	"prognostic unfavorable (7.17e-6)"	"unprognostic (5.69e-2)"	"unprognostic (1.08e-2)"	"unprognostic (7.24e-2)"	"unprognostic (8.39e-2)"	"unprognostic (1.84e-2)"	"unprognostic (2.12e-3)"	"unprognostic (1.92e-2)"	"unprognostic (8.19e-3)"	"unprognostic (2.38e-2)"	"unprognostic (1.44e-2)"	"unprognostic (2.11e-2)"	"prognostic favorable (1.43e-9)"	"unprognostic (2.79e-1)"	"unprognostic (3.22e-1)"	"unprognostic (1.33e-1)"	"unprognostic (3.30e-2)"	41.3	66.2	32.4	34.1	53.4	39.3	33.1	55.4	92.6	26.1	73.0	34.4	36.1	68.1	27.9	28.5	58.6	28.5	36.9	225.0	33.2	34.9	95.2	85.7	28.3	39.2	40.5	35.5	25.1	42.7	85.2	30.1	31.3	69.6	29.0	78.5	42.8	64.7	38.1	236.2	42.3	74.6	35.5	24.9	33.5	51.0	31.4	18.3	47.5	38.4	123.6	45.8	36.6	32.8	41.2	91.7	40.2	90.1	36.3	46.6	105.6	66.5	81.0	64.4	99.3	58.1	62.1	113.8	67.7	63.2	117.1	66.8	131.5	74.3	118.4	73.4	83.4	49.0	89.2	135.6	82.1	106.1	55.5	93.9	129.9	75.6	80.6	72.0	145.2	92.0	76.1	82.9	91.5	118.2	89.2	96.2	88.4	116.9	136.5	98.2	61.7	107.5	85.4	108.4	88.2	156.0	103.7	72.1	150.9	127.5	118.6	73.7	65.5	103.5	148.2	115.1	70.7	139.1	109.8	65.2	46.1	51.4	67.3	73.1	65.9	81.9	122.5	69.4	97.2	70.6	40.2	64.6	34.6	40.2	80.6	44.9	41.2	38.0	42.7	91.7	31.7	31.1	36.7	17.8	36.3	90.1	46.3	46.6	105.6	32.4	53.4	55.4	92.6	33.2	34.9	40.5	35.5	69.6	18.3	125.0	160.8	0.0	0.0	0.0	0.0	0.0	0.0	188.7	149.0	263.5	0.0	693.2	1049.5	441.8	0.0	0.0	0.0	0.0	323.3	482.8	0.0	0.0	133.7	0.0	535.7	0.0	0.0	0.0	0.0	0.0	0.0	117.6	0.0	490.5	0.0	0.0	298.7	0.0	0.0	698.1	0.0	0.0	0.0	0.0	0.0	0.0	952.2	0.0	0.0	0.0
ATP6V1A	"ATP6A1, ATP6V1A1, VA68, Vma1, VPP2"	ENSG00000114573	"ATPase H+ transporting V1 subunit A"	P38606	3	113747019-113812056	"Disease related genes, Enzymes, Plasma proteins, Predicted intracellular proteins, Transporters"	"Hydrogen ion transport, Ion transport, Transport"	Translocase	"Disease mutation, Epilepsy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"Early spermatids: 467.9;Late spermatids: 569.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"neutrophil: 33.6"	"Group enriched"	"Detected in all"	6	"dendritic cells: 16.4;granulocytes: 33.6;monocytes: 15.4"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB006910, HPA035084"	Approved		Supported	Nucleoplasm,Vesicles,Cytosol		NA	NA		2700000	"Vesicles, Cytosol"	Nucleoplasm	"CAB006910: , HPA035084: AB_2674454"	"unprognostic (1.32e-1)"	"unprognostic (8.68e-2)"	"unprognostic (5.87e-2)"	"unprognostic (4.70e-2)"	"unprognostic (1.36e-1)"	"unprognostic (2.00e-1)"	"unprognostic (3.43e-2)"	"unprognostic (2.90e-2)"	"unprognostic (1.42e-1)"	"unprognostic (2.25e-1)"	"unprognostic (1.36e-2)"	"unprognostic (5.19e-3)"	"prognostic favorable (3.82e-12)"	"unprognostic (8.82e-2)"	"unprognostic (2.46e-3)"	"unprognostic (2.43e-1)"	"unprognostic (1.52e-2)"	12.8	19.8	24.1	10.4	33.2	7.4	12.7	34.8	52.8	14.0	11.1	10.3	5.6	9.3	7.5	8.2	13.2	10.0	10.8	4.7	26.2	38.2	47.9	18.2	12.3	11.4	25.4	25.0	6.2	10.5	39.3	13.5	12.3	52.0	11.2	11.8	14.7	18.0	8.4	4.5	12.6	7.9	8.2	13.6	13.7	10.9	8.9	8.3	9.6	21.0	5.7	13.6	10.2	8.2	3.8	16.4	33.6	15.4	3.8	3.4	6.0	25.4	11.6	14.6	12.7	30.9	13.8	15.6	13.8	21.1	14.5	20.1	21.8	20.5	20.9	32.9	20.1	16.1	16.6	33.0	18.2	19.1	9.5	9.1	18.5	18.0	16.8	25.5	13.6	21.7	18.6	12.6	18.8	13.2	22.6	23.6	10.6	21.1	15.8	21.5	16.7	9.9	6.1	18.3	17.8	14.6	8.6	10.6	23.7	39.8	24.3	28.3	10.4	24.2	16.5	18.1	21.0	25.0	11.0	21.7	13.6	10.1	9.3	8.2	16.6	17.8	19.3	26.6	17.2	15.0	9.2	15.4	5.2	2.8	11.7	2.6	3.8	2.6	2.7	16.4	2.9	2.5	2.9	33.6	3.8	9.5	4.6	3.4	6.0	24.1	33.2	34.8	52.8	26.2	38.2	25.4	25.0	52.0	8.3	26.8	28.3	28.9	13.2	27.0	92.7	7.9	33.1	14.7	19.4	94.2	39.3	18.1	69.6	25.2	467.9	26.0	24.0	0.0	23.9	18.8	17.8	28.2	10.4	64.4	67.8	95.3	53.6	36.2	95.4	569.6	16.7	67.0	43.9	49.5	25.8	42.1	22.3	24.6	21.5	62.8	37.3	6.5	14.6	25.3	14.3	41.9	36.7	17.1	21.3	21.1
ATP7A	MNK	ENSG00000165240	"ATPase copper transporting alpha"	Q04656	X	77910656-78050395	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Copper transport, Ion transport, Transport"	Translocase	"Disease mutation, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Sertoli cells: 32.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA012887, HPA048107"	Approved		Supported	"Golgi apparatus"		NA	NA			"Golgi apparatus"		"HPA012887: AB_1845205, HPA048107: AB_2680266"	"unprognostic (3.14e-2)"	"unprognostic (3.48e-1)"	"unprognostic (4.90e-2)"	"unprognostic (1.49e-2)"	"unprognostic (1.26e-1)"	"unprognostic (1.03e-1)"	"unprognostic (7.17e-3)"	"unprognostic (2.59e-2)"	"unprognostic (3.17e-2)"	"unprognostic (2.47e-1)"	"unprognostic (2.30e-2)"	"unprognostic (1.14e-1)"	"prognostic favorable (8.38e-4)"	"unprognostic (1.06e-1)"	"unprognostic (2.16e-1)"	"unprognostic (3.69e-1)"	"unprognostic (2.52e-1)"	9.8	7.4	2.6	8.6	4.6	6.4	8.5	2.3	2.9	8.2	7.7	5.9	9.6	4.8	9.5	7.6	10.0	5.7	4.5	5.1	2.9	2.8	9.0	3.3	9.3	9.3	4.1	1.7	7.3	6.3	13.2	15.9	5.0	4.3	8.2	4.4	5.2	12.3	10.3	6.1	15.9	8.5	7.8	6.3	10.8	7.0	2.7	6.0	15.6	6.0	7.1	11.7	11.8	7.0	2.3	1.4	10.7	2.4	1.7	3.0	1.2	2.6	6.8	4.5	4.6	4.3	4.6	0.8	4.0	5.5	2.3	4.8	0.9	3.0	3.8	5.9	3.9	2.9	3.2	5.9	3.2	4.4	5.6	4.0	1.9	6.6	0.7	5.5	3.3	3.6	4.8	1.3	5.0	1.5	5.5	6.2	3.9	15.5	14.7	4.3	2.2	3.6	1.1	1.3	9.1	1.5	3.0	7.6	12.8	3.9	7.3	1.4	17.4	9.8	2.4	5.0	3.0	1.8	1.1	7.8	3.1	3.2	4.4	1.5	4.8	8.4	4.4	5.2	2.0	4.8	8.3	2.0	5.5	2.4	1.9	1.2	2.0	1.7	1.7	1.3	2.3	2.1	3.0	10.7	1.7	2.4	1.4	0.6	1.2	2.6	4.6	2.3	2.9	2.9	2.8	4.1	1.7	4.3	6.0	0.0	5.9	2.0	4.6	6.5	6.1	4.5	0.0	9.4	3.4	8.7	3.9	1.8	1.7	4.3	0.4	7.1	2.8	0.0	12.0	1.9	5.4	5.7	9.2	2.4	12.0	1.6	4.6	9.2	9.9	1.1	6.6	5.4	18.6	1.8	6.2	3.8	6.0	2.9	9.2	5.4	3.6	32.3	4.2	0.9	5.4	14.4	1.8	5.0	4.1	5.5
ATP7B	WND	ENSG00000123191	"ATPase copper transporting beta"	P35670	13	51930436-52012125	"Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins, Transporters"	"Copper transport, Ion transport, Transport"	Translocase	"Cancer-related genes, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"gallbladder: 18.5;liver: 13.5"	"Cell type enhanced"	"Detected in many"	13	"Cone photoreceptor cells: 21.6;Early spermatids: 29.4;Late spermatids: 57.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"neutrophil: 1.0"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"BEWO: 19.3;CACO-2: 11.1;HEL: 29.3;Hep G2: 10.1;RPTEC TERT1: 17.1"	"Low region specificity"	"Detected in many"							"HPA009137, HPA013187"	Supported		Supported	"Golgi apparatus"		NA	NA			"Golgi apparatus"		"HPA009137: AB_2668214, HPA013187: AB_1845206"	"unprognostic (1.13e-2)"	"unprognostic (1.61e-1)"	"unprognostic (2.15e-1)"	"prognostic unfavorable (5.01e-4)"	"unprognostic (3.49e-1)"	"unprognostic (5.51e-2)"	"unprognostic (1.55e-2)"	"unprognostic (1.18e-1)"	"unprognostic (2.24e-1)"	"unprognostic (5.77e-2)"	"unprognostic (8.29e-2)"	"unprognostic (1.17e-1)"	"unprognostic (3.26e-3)"	"unprognostic (4.66e-2)"	"unprognostic (3.54e-1)"	"unprognostic (6.21e-3)"	"unprognostic (1.40e-1)"	3.4	0.7	1.8	2.4	2.9	1.8	1.6	7.0	2.8	1.4	6.8	1.1	1.1	10.5	1.6	1.9	1.1	1.9	18.5	1.8	2.1	2.1	2.1	13.5	1.2	1.1	1.6	1.1	2.0	1.7	7.7	1.2	7.1	3.5	1.9	2.6	1.4	3.0	1.1	1.1	0.7	9.6	1.5	1.1	1.6	4.5	7.1	1.6	1.1	1.1	1.1	1.1	2.1	1.1	0.0	0.0	1.0	0.3	0.0	0.5	0.1	0.4	1.6	3.0	2.7	0.6	0.5	19.3	0.8	0.2	0.9	0.7	11.1	0.1	0.0	0.3	1.4	2.1	0.2	2.1	2.4	0.6	0.2	4.1	29.3	0.3	10.1	0.9	0.3	6.9	1.2	2.9	0.1	1.1	1.3	2.1	2.1	7.8	0.0	0.9	0.5	0.1	0.7	1.0	3.7	1.0	1.1	0.8	0.0	17.1	1.9	2.2	1.3	1.1	1.6	1.1	3.4	4.6	0.2	1.1	0.1	1.0	1.6	0.3	0.3	0.4	0.1	0.0	0.1	0.4	0.0	0.3	0.0	0.0	0.0	0.5	0.0	0.3	0.1	0.0	0.0	0.1	0.0	1.0	0.0	0.0	0.0	0.0	0.1	1.8	2.9	7.0	2.8	2.1	2.1	1.6	1.1	3.5	1.6	6.0	0.0	1.7	0.7	0.3	3.0	1.8	0.0	5.3	3.4	1.8	21.6	10.2	0.0	1.5	29.4	1.1	6.1	0.0	0.8	4.4	0.6	1.3	0.0	16.3	2.0	0.0	2.4	3.7	1.0	57.4	2.0	0.0	1.7	0.0	4.0	0.5	1.7	2.9	0.7	1.3	6.7	6.5	0.9	1.1	1.9	0.4	3.8	0.0	4.7	1.1
ATP8A1	ATPIA	ENSG00000124406	"ATPase phospholipid transporting 8A1"	Q9Y2Q0	4	42408373-42657105	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Lipid transport, Transport"	Translocase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"parathyroid gland: 38.9"	"Cell type enhanced"	"Detected in many"	7	"Alveolar cells type 2: 61.4;Cone photoreceptor cells: 76.6;Horizontal cells: 58.8;Intestinal endocrine cells: 81.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"AN3-CA: 17.2;Daudi: 28.1;HEL: 9.9;REH: 9.7;SH-SY5Y: 9.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA052935	Enhanced		Supported	Vesicles		NA	NA		20000	Vesicles		"HPA052935: AB_2681992"	"unprognostic (8.63e-2)"	"unprognostic (3.43e-2)"	"unprognostic (1.16e-2)"	"unprognostic (7.61e-2)"	"unprognostic (6.59e-2)"	"unprognostic (6.82e-3)"	"unprognostic (7.69e-2)"	"unprognostic (2.02e-3)"	"unprognostic (3.99e-1)"	"unprognostic (2.99e-3)"	"unprognostic (4.39e-2)"	"unprognostic (9.71e-2)"	"prognostic favorable (5.54e-10)"	"unprognostic (2.43e-1)"	"unprognostic (3.25e-1)"	"unprognostic (8.21e-2)"	"unprognostic (2.25e-1)"	5.3	8.6	14.2	8.0	29.6	18.5	4.8	7.2	32.0	3.1	11.3	27.3	8.4	4.2	3.4	11.6	2.9	3.5	2.8	8.0	13.7	8.8	4.0	2.1	10.6	12.5	18.0	17.4	15.1	10.0	38.9	6.9	2.6	15.3	7.9	10.7	3.9	4.4	15.2	16.9	3.2	8.1	3.1	23.1	7.8	10.5	2.8	24.9	8.9	34.9	1.9	10.3	4.5	4.0	4.4	3.8	0.9	3.3	3.2	7.3	0.9	0.0	0.1	0.3	17.2	0.1	0.0	0.1	0.0	0.0	0.0	0.0	1.8	0.2	28.1	8.0	0.1	0.0	1.4	4.0	0.0	0.0	4.4	2.8	9.9	1.0	0.4	0.0	2.4	0.2	0.3	0.0	0.0	0.0	0.3	0.1	6.3	0.0	3.2	0.0	1.2	3.5	0.8	1.3	1.1	0.3	9.7	0.0	3.1	6.1	0.3	3.1	9.3	0.2	5.9	0.0	0.7	1.9	0.0	0.2	0.0	1.3	0.3	0.0	1.1	0.0	5.7	0.4	3.4	0.1	0.0	1.0	0.9	6.0	0.4	3.2	2.6	1.9	6.5	0.9	4.4	2.9	7.3	0.9	3.2	3.3	3.8	1.4	0.9	14.2	29.6	7.2	22.1	13.7	8.8	18.0	17.4	15.3	24.9	26.8	61.4	5.1	1.7	1.3	17.7	12.8	0.0	0.0	9.1	5.2	76.6	0.0	3.3	0.0	3.0	9.3	46.1	0.0	2.2	0.1	2.2	16.2	8.1	1.1	1.5	58.8	81.2	17.8	7.5	2.3	3.1	3.8	3.3	1.8	23.3	1.0	0.8	7.0	1.8	1.4	41.3	0.0	0.3	1.1	4.1	1.3	0.0	21.8	23.1	2.4
ATP8A2	"ATPIB, ML-1"	ENSG00000132932	"ATPase phospholipid transporting 8A2"	Q9NTI2	13	25372071-26025851	"Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins"	"Lipid transport, Transport"	Translocase	"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"brain: 34.9;pituitary gland: 37.0;testis: 10.4"	"Cell type enhanced"	"Detected in many"	13	"Cone photoreceptor cells: 90.3;Early spermatids: 29.4;Rod photoreceptor cells: 86.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"naive CD4 T-cell: 2.3;naive CD8 T-cell: 3.3"	"Lineage enriched"	"Detected in single"	12	"T-cells: 3.3"	"Group enriched"	"Detected in some"	4	"HMC-1: 21.6;JURKAT: 9.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039926, HPA040033"	Enhanced		Supported	"Nucleoplasm,Plasma membrane"		NA	NA			"Plasma membrane"	Nucleoplasm	"HPA039926: AB_10794205, HPA040033: AB_2676809"	"unprognostic (3.79e-2)"	"unprognostic (4.28e-2)"	"unprognostic (3.32e-2)"	"unprognostic (1.95e-4)"	"unprognostic (3.57e-2)"	"unprognostic (1.89e-1)"	"unprognostic (1.31e-2)"	"unprognostic (2.97e-3)"	"unprognostic (2.77e-1)"	"unprognostic (3.66e-1)"	"unprognostic (4.96e-4)"	"unprognostic (1.24e-1)"	"unprognostic (1.18e-2)"	"unprognostic (4.20e-5)"	"unprognostic (9.10e-2)"	"unprognostic (2.95e-1)"	"unprognostic (7.22e-2)"	1.1	4.9	11.2	1.4	11.4	0.8	2.2	34.9	30.2	1.1	1.3	1.3	0.0	1.4	2.1	4.8	0.9	0.9	1.0	1.0	9.4	11.8	1.3	0.8	2.3	1.9	6.7	10.4	1.2	1.9	0.9	37.0	1.2	19.8	1.1	1.3	3.1	1.0	1.0	1.3	0.9	1.5	1.0	3.5	1.3	1.8	10.4	1.4	0.0	1.0	0.0	1.2	1.2	0.3	0.0	0.0	0.2	0.0	0.2	3.3	0.6	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.7	1.0	0.0	0.0	0.6	1.4	0.0	0.0	0.0	0.2	0.9	0.0	0.0	0.0	0.0	21.6	0.2	0.0	0.0	0.0	0.6	0.5	9.6	0.0	0.0	1.7	0.3	3.7	0.0	2.0	0.0	0.7	0.0	2.7	1.0	0.2	0.1	3.3	0.0	0.1	0.3	0.1	0.4	0.0	0.4	0.2	0.1	1.1	0.3	0.4	0.2	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	1.0	0.0	0.2	0.0	0.8	0.6	0.0	0.0	2.3	3.3	0.2	0.2	0.0	0.0	0.7	0.6	11.2	11.4	34.9	18.4	9.4	11.8	6.7	10.4	19.8	1.4	0.0	9.8	0.9	0.1	0.9	20.0	2.2	2.5	0.0	0.0	0.0	90.3	1.2	0.0	0.3	29.4	1.5	0.0	0.0	0.0	0.3	0.4	0.2	4.7	0.0	2.4	20.6	0.0	0.0	0.0	24.5	0.9	0.0	0.0	0.0	0.0	4.5	0.0	0.0	1.1	0.6	86.2	12.9	0.0	12.9	9.9	0.4	0.9	0.5	0.0	0.0
ATP8B1	"ATPIC, BRIC, FIC1, PFIC, PFIC1"	ENSG00000081923	"ATPase phospholipid transporting 8B1"	O43520	18	57646426-57803101	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Hearing, Lipid transport, Transport"	Translocase	"Disease mutation, Intrahepatic cholestasis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 21.3"	"Cell type enhanced"	"Detected in many"	7	"Enterocytes: 198.4;Mucus-secreting cells: 179.9;Undifferentiated cells: 138.5"	"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"fHDF/TERT166: 27.5;HBF TERT88: 24.7;RT4: 58.5"	"Low region specificity"	"Detected in many"							"HPA018673, HPA018674"	Enhanced		Supported	"Nucleoplasm,Nuclear bodies,Plasma membrane,Cytosol"		NA	NA			"Plasma membrane, Cytosol"	"Nucleoplasm, Nuclear bodies"	"HPA018673: AB_1845207, HPA018674: AB_1845208"	"unprognostic (1.83e-1)"	"unprognostic (1.32e-1)"	"prognostic favorable (2.60e-4)"	"unprognostic (8.81e-2)"	"unprognostic (1.32e-3)"	"unprognostic (2.06e-1)"	"unprognostic (1.39e-1)"	"unprognostic (1.02e-1)"	"unprognostic (9.62e-3)"	"unprognostic (1.97e-1)"	"unprognostic (3.30e-3)"	"unprognostic (4.55e-3)"	"prognostic favorable (6.35e-4)"	"unprognostic (1.88e-1)"	"unprognostic (2.22e-1)"	"unprognostic (3.25e-1)"	"unprognostic (8.60e-3)"	3.8	2.3	0.0	1.8	0.0	0.0	3.4	0.0	0.3	4.5	21.3			8.9	2.4	0.8	6.7	2.6	4.8	1.8	0.2	0.0	2.1	3.0	3.6	0.0	0.1		0.7	10.7	2.7	1.1	1.3		6.0	19.3		5.8	2.8	0.4	3.6	11.1	2.0	0.2	1.2	13.3	0.0			5.7		0.2	12.8	5.4	6.0	2.0	4.7	2.1	0.7	1.3	0.3	10.2	3.5	0.1	0.1	3.6	6.6	5.0	19.9	19.4	21.0	13.1	2.6	8.9	0.7	6.0	27.5	8.3	15.2	0.1	4.2	24.7	0.2	0.4	0.1	0.9	0.9	1.1	0.2	0.1	1.0	3.8	6.3	11.1	15.5	11.0	0.2	0.1	0.4	12.1	4.9	0.2	0.2	0.2	11.0	1.0	0.1	0.1	0.2	2.9	58.5	0.4	0.3	0.4	12.3	0.1	0.5	3.8	0.6	12.6	17.1	0.6	2.7	4.6	0.2	0.1	0.2	0.4	0.2	0.9	0.8	2.1	0.5	1.3	0.9	1.0	2.7	1.0	0.7	0.5	6.0	0.9	1.0	4.7	0.7	1.2	2.0	0.4	0.3											17.9	18.2	4.5	44.8	6.9	0.7	4.0	33.1	40.2	48.9	38.4	0.0	17.1	0.0	20.8	2.0	26.8	198.4	0.0	45.9	1.9	5.1	74.4	4.6	16.8	2.3	6.4	65.7	30.1	3.8	0.0	0.3	1.3	6.8	1.0	179.9	0.2	33.7	74.8	0.0	0.1	1.1	12.9	17.6	0.3	1.2	14.3	9.2	1.5	138.5	100.6
ATP8B2	"ATPID, KIAA1137"	ENSG00000143515	"ATPase phospholipid transporting 8B2"	P98198	1	154325553-154351307	"Enzymes, Predicted membrane proteins"	"Lipid transport, Transport"	Translocase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Ito cells: 12.3;Peritubular cells: 13.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"granulocytes: 3.1;T-cells: 6.5"	"Cell line enhanced"	"Detected in many"		"ASC diff: 41.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA046680	Approved					NA	NA					"HPA046680: AB_2679749"	"unprognostic (1.68e-1)"	"unprognostic (3.68e-1)"	"unprognostic (8.40e-2)"	"unprognostic (5.16e-2)"	"unprognostic (4.52e-1)"	"unprognostic (8.17e-2)"	"unprognostic (2.27e-2)"	"unprognostic (6.93e-3)"	"unprognostic (2.57e-1)"	"unprognostic (1.69e-1)"	"prognostic favorable (1.60e-4)"	"unprognostic (2.82e-1)"	"unprognostic (1.89e-3)"	"unprognostic (7.77e-3)"	"unprognostic (6.58e-2)"	"unprognostic (3.19e-2)"	"prognostic unfavorable (5.29e-5)"	13.6	7.0	5.5	15.0	7.1	3.4	11.9	26.8	8.9	29.1	11.2	7.4	11.5	8.6	28.9	15.2	14.4	21.5	18.4	11.7	7.0	6.8	6.6	2.6	12.2	16.1	6.2	5.8	27.5	5.3	5.1	13.9	10.9	6.1	15.3	6.8	12.5	5.4	16.4	4.3	6.1	11.8	29.4	5.1	14.7	11.4	12.7	5.1	18.9	11.2	8.1	13.6	20.5	24.9	0.6	0.7	3.1	0.0	0.9	6.5	1.0	0.7	5.1	6.5	6.7	41.8	28.3	0.1	15.7	26.2	9.1	10.9	0.1	0.2	0.6	8.3	37.9	6.0	3.2	7.8	1.8	6.4	17.2	6.3	6.5	6.3	5.9	12.7	0.0	5.1	18.2	0.4	13.8	13.2	12.0	14.0	8.3	12.9	15.8	7.7	6.7	12.2	0.8	15.5	0.1	6.5	13.6	4.5	23.4	1.7	0.1	5.8	8.0	4.1	0.9	9.8	9.7	4.8	4.9	12.2	13.8	7.0	17.3	4.7	21.9	26.8	3.9	4.8	0.7	8.4	3.1	0.0	3.0	2.2	0.0	1.5	0.6	3.5	3.7	0.0	0.4	2.9	2.5	0.1	0.9	0.0	0.7	6.5	1.0	5.5	7.1	26.8	8.9	7.0	6.8	6.2	5.8	6.1	5.1	3.0	5.0	2.2	1.5	2.3	0.7	5.1	0.0	6.7	3.4	0.0	2.0	0.1	0.0	1.2	0.4	8.4	0.0	0.0	0.2	0.4	8.1	4.3	7.0	0.9	0.4	7.9	0.0	12.3	1.0	0.4	10.6	0.0	6.8	0.0	0.0	2.6	1.4	0.0	13.8	0.1	0.4	0.0	6.2	2.6	3.6	1.4	0.2	8.2	0.0	0.4
ATP8B3	ATPIK	ENSG00000130270	"ATPase phospholipid transporting 8B3"	O60423	19	1782075-1812276	"Enzymes, Predicted membrane proteins"	"Lipid transport, Transport"	Translocase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	8	"testis: 55.8"	"Cell type enhanced"	"Detected in many"	17	"Late spermatids: 8.9;Spermatocytes: 26.5"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in many"		"intermediate monocyte: 6.9"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HMC-1: 10.6;Karpas-707: 18.7;U-266/70: 15.6"					"Not detected"	"Not detected"									NA	NA						"unprognostic (6.50e-2)"	"unprognostic (1.81e-2)"	"unprognostic (1.02e-1)"	"unprognostic (6.05e-5)"	"unprognostic (6.66e-2)"	"unprognostic (7.91e-2)"	"unprognostic (1.86e-2)"	"unprognostic (2.66e-2)"	"unprognostic (2.42e-1)"	"unprognostic (2.55e-3)"	"unprognostic (1.28e-2)"	"unprognostic (6.15e-3)"	"prognostic unfavorable (4.80e-9)"	"unprognostic (8.05e-2)"	"unprognostic (3.20e-1)"	"unprognostic (3.19e-2)"	"unprognostic (1.19e-1)"	0.6	3.1	0.2	3.1	0.2	7.1	0.6	0.2	0.7	1.5	0.7	0.2	0.2	0.4	1.8	4.3	0.6	0.6	1.0	2.2	0.3	0.2	0.4	1.0	1.9	1.1	0.2	0.5	1.9	0.3	0.3	0.6	0.5	0.4	0.5	0.4	1.1	0.5	1.6	0.2	0.8	0.7	1.0	0.7	4.8	0.4	55.8	0.0	5.5	0.7	1.2	1.5	0.8	1.0	0.1	1.2	1.7	6.9	2.2	2.8	1.2	0.6	5.1	0.6	0.8	0.7	0.5	0.0	2.0	3.1	2.0	1.9	0.0	2.1	2.2	2.3	1.6	0.2	0.1	0.4	0.0	0.9	2.1	0.1	0.7	2.5	1.0	0.2	1.3	10.6	0.2	0.2	0.0	2.2	3.0	0.5	6.5	1.6	18.7	3.3	0.0	1.4	3.9	0.1	0.3	2.4	2.2	0.4	0.3	2.7	0.1	0.0	0.7	0.5	0.0	0.3	0.6	0.6	6.5	4.9	0.1	4.1	0.8	2.1	15.6	7.6	0.6	4.0	6.5	2.6	0.0	2.2	1.7	1.9	6.9	0.8	0.0	1.4	1.1	1.2	0.1	0.6	1.9	0.6	2.2	1.8	0.5	2.8	1.2	0.2	0.2	0.2	0.7	0.3	0.2	0.2	0.5	0.4	0.0	0.0	1.1	0.0	0.6	0.7	1.9	1.4	2.5	0.0	0.0	0.0	2.0	0.1	0.0	0.8	6.2	1.0	0.0	0.0	0.2	0.9	1.4	0.3	1.1	0.8	1.3	0.0	0.0	5.5	3.3	8.9	0.3	0.5	1.7	0.0	0.0	0.8	0.2	0.0	0.4	0.0	0.6	0.0	0.9	26.5	3.2	1.3	0.3	2.5	0.0	0.1
ATP8B4	"ATPIM, KIAA1939"	ENSG00000104043	"ATPase phospholipid transporting 8B4 (putative)"	Q8TF62	15	49858238-50182817	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Lipid transport, Transport"	Translocase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 28.1;cervix, uterine: 26.0;endometrium 1: 18.2"	"Group enriched"	"Detected in many"	4	"Early spermatids: 23.4;granulocytes: 19.6;Hofbauer cells: 12.9;Kupffer cells: 29.9;Late spermatids: 19.9;Macrophages: 17.3;T-cells: 8.6"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"basophil: 6.9;NK-cell: 10.6"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"HMC-1: 19.1;NB-4: 7.3;THP-1: 12.3;U-937: 38.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA040254	Approved		Uncertain	Nucleoplasm,Vesicles,Cytosol		NA	NA			"Nucleoplasm, Vesicles"	Cytosol	"HPA040254: AB_10673028"	"unprognostic (6.45e-3)"	"unprognostic (3.83e-2)"	"unprognostic (5.39e-2)"	"unprognostic (2.96e-3)"	"unprognostic (3.25e-1)"	"unprognostic (6.51e-3)"	"unprognostic (1.03e-1)"	"unprognostic (4.87e-3)"	"unprognostic (1.64e-2)"	"unprognostic (5.11e-2)"	"unprognostic (1.20e-1)"	"unprognostic (3.74e-2)"	"unprognostic (5.99e-2)"	"unprognostic (5.12e-2)"	"unprognostic (1.20e-2)"	"unprognostic (1.53e-1)"	"unprognostic (2.08e-1)"	2.3	1.2	1.6	1.5	2.1	28.1	1.0	0.6	0.9	26.0	1.5	1.7	1.6	0.4	18.2	3.5	0.6	9.5	3.1	0.8	2.5	0.9	1.0	1.2	3.2	0.7	2.7	0.1	3.9	0.4	0.2	1.1	2.9	2.1	0.7	1.2	0.8	0.9	0.6	0.4	0.5	1.1	2.7	3.1	2.3	0.6	0.9	4.6	0.8	0.5	0.8	2.1	1.3	1.5	0.0	2.2	6.9	1.7	10.6	0.5	0.8	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.1	0.1	0.0	0.0	5.2	0.0	3.0	0.6	0.0	0.0	5.3	19.1	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	7.3	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.6	0.0	0.0	0.0	0.0	12.3	0.0	0.0	0.1	0.5	0.0	0.0	0.0	0.0	0.4	38.5	0.0	6.9	1.7	2.4	0.5	0.8	0.0	0.0	0.0	0.1	2.2	0.0	0.0	0.0	0.8	10.6	0.3	0.0	0.0	0.8	1.6	2.1	0.6	0.9	2.5	0.9	2.7	0.1	2.1	4.6	0.0	3.4	1.3	0.1	1.3	0.2	1.2	0.0	0.0	0.0	0.0	0.0	2.9	0.0	0.0	23.4	0.5	0.4	0.0	0.0	1.6	3.3	0.5	19.6	2.8	12.9	0.0	0.0	1.8	29.9	19.9	1.7	17.3	1.7	1.0	0.3	0.5	0.0	0.0	0.7	0.8	0.0	0.0	4.3	0.4	0.6	0.3	2.4	8.6	0.0	0.1
ATP9A	"ATPIIA, KIAA0611"	ENSG00000054793	"ATPase phospholipid transporting 9A (putative)"	O75110	20	51596514-51768634	"Enzymes, Predicted membrane proteins, Transporters"		Translocase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 64.7"	"Cell type enhanced"	"Detected in many"	5	"Intestinal endocrine cells: 53.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	5	"basophil: 6.3;NK-cell: 2.2"	"Group enriched"	"Detected in many"	5	"granulocytes: 6.3;NK-cells: 2.2"	"Cell line enhanced"	"Detected in many"		"EFO-21: 29.3;SK-BR-3: 28.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB020699, HPA035630"	Enhanced					NA	NA					"CAB020699: , HPA035630: AB_10669526"	"unprognostic (5.19e-2)"	"unprognostic (5.28e-2)"	"unprognostic (3.46e-1)"	"unprognostic (1.05e-1)"	"unprognostic (3.76e-1)"	"unprognostic (1.37e-1)"	"unprognostic (3.76e-2)"	"unprognostic (4.79e-2)"	"unprognostic (7.45e-2)"	"unprognostic (1.58e-1)"	"unprognostic (1.26e-2)"	"unprognostic (1.79e-1)"	"prognostic favorable (5.67e-5)"	"unprognostic (5.82e-2)"	"unprognostic (5.81e-1)"	"unprognostic (8.74e-2)"	"unprognostic (2.82e-1)"	18.5	8.2	23.7	3.9	31.8	2.0	11.2	29.8	64.7	5.6	12.2	19.9	8.2	9.1	8.6	13.1	8.8	16.9	8.2	7.7	24.3	26.8	6.8	5.4	6.7	2.6	21.1	23.9	13.2	10.0	22.7	8.3	3.6	22.5	14.3	11.3	4.1	14.9	11.3	9.2	4.1	11.5	8.7	18.9	2.2	14.0	12.4	15.8	0.8	18.7	2.9	2.4	7.4	5.6	0.0	0.0	6.3	0.2	2.2	0.8	1.8	9.7	8.3	6.9	15.4	20.3	15.1	0.1	3.5	6.7	2.3	0.7	19.1	20.3	0.0	29.3	14.5	11.7	7.8	9.0	5.1	2.3	7.5	2.7	0.0	9.2	7.7	2.8	0.0	0.0	5.0	10.4	0.5	1.4	5.4	12.5	1.8	0.0	0.0	2.6	13.6	0.7	0.0	1.2	9.9	10.6	1.5	0.0	0.0	4.7	13.7	13.0	9.3	14.0	28.1	5.1	2.5	5.3	0.2	8.1	19.3	5.2	7.5	1.5	0.0	0.1	0.3	5.1	0.0	1.7	6.3	0.0	0.0	0.8	0.2	0.0	0.0	0.2	0.7	0.0	0.0	0.0	0.1	0.4	2.2	0.1	0.0	0.0	1.8	23.7	31.8	29.8	34.9	24.3	26.8	21.1	23.9	22.5	15.8	14.9	12.8	0.0	10.2	2.6	32.1	11.5	30.6	17.4	14.8	17.4	3.9	0.3	1.7	18.0	0.6	5.4	32.5	0.0	14.8	0.2	7.1	27.0	1.1	10.0	4.5	41.3	53.0	11.1	2.7	1.7	12.4	1.6	3.3	0.0	36.1	4.5	21.7	24.6	21.9	1.2	6.4	6.5	7.1	0.9	1.5	3.6	0.2	0.5	19.7	25.5
ATP9B	ATPIIB	ENSG00000166377	"ATPase phospholipid transporting 9B (putative)"	O43861	18	79069285-79378287	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"		Translocase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	8	"Alveolar cells type 1: 119.1;Alveolar cells type 2: 156.1;Ciliated cells: 168.6;Club cells: 95.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA029364	Approved					NA	NA					"HPA029364: AB_10602595"	"unprognostic (2.84e-3)"	"unprognostic (1.66e-1)"	"unprognostic (1.88e-1)"	"unprognostic (6.51e-3)"	"unprognostic (7.32e-2)"	"unprognostic (7.66e-4)"	"unprognostic (2.45e-2)"	"unprognostic (7.43e-2)"	"unprognostic (2.55e-2)"	"unprognostic (8.21e-2)"	"unprognostic (1.61e-1)"	"unprognostic (2.93e-1)"	"unprognostic (1.92e-3)"	"unprognostic (1.40e-1)"	"unprognostic (1.84e-1)"	"unprognostic (2.05e-2)"	"unprognostic (1.09e-2)"	14.5	11.0	11.7	16.8	11.6	30.1	11.7	16.8	15.2	14.3	10.7	17.5	15.2	7.1	21.8	17.6	11.3	11.9	14.5	10.7	11.4	8.2	13.1	16.7	13.9	13.2	10.8	9.7	18.2	14.3	25.8	15.5	10.9	11.3	12.8	11.4	12.3	14.2	17.3	18.8	13.3	9.1	14.8	17.1	9.7	11.5	22.1	12.4	19.3	14.6	9.6	16.4	14.6	13.3	9.8	8.4	14.2	16.3	8.6	12.2	6.9	15.2	8.0	11.2	12.4	5.8	9.8	8.7	8.2	5.6	4.9	4.2	8.6	10.9	8.5	13.7	5.9	4.7	6.9	9.2	4.6	8.0	13.1	3.9	10.0	9.2	6.1	7.7	18.2	10.7	7.8	5.8	8.0	4.9	7.3	6.8	10.5	9.6	21.5	6.9	13.3	11.9	7.1	15.9	9.7	10.0	11.4	9.3	11.4	7.0	13.2	8.3	8.7	9.2	9.7	5.6	20.2	11.4	10.8	12.0	10.4	16.9	4.7	5.4	10.8	17.6	19.1	6.0	12.1	10.7	14.2	12.0	9.1	8.4	10.1	9.8	9.0	9.6	8.1	8.4	9.8	12.2	9.5	13.0	8.6	16.3	8.0	7.4	6.9	11.7	11.6	16.8	15.2	11.4	8.2	10.8	9.7	11.3	12.4	119.1	156.1	11.9	6.2	5.0	34.8	10.3	15.3	168.6	95.5	8.7	39.3	5.6	1.7	5.4	19.8	9.8	5.4	0.0	4.9	3.3	7.8	5.5	40.6	6.4	12.9	39.7	11.5	9.2	11.3	34.5	14.7	12.2	6.8	5.4	7.8	17.8	6.6	9.0	10.6	3.1	39.0	6.5	7.3	26.1	16.4	6.4	6.4	16.0	8.1	7.0
ATR	"FRP1, MEC1, SCKL, SCKL1"	ENSG00000175054	"ATR serine/threonine kinase"	Q13535	3	142449235-142578826	"Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"DNA damage, DNA repair"	"DNA-binding, Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes, Disease mutation, Dwarfism, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Cone photoreceptor cells: 35.3;Spermatocytes: 42.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA054320			Supported	"Nucleoplasm,Golgi apparatus"		No	No			Nucleoplasm	"Golgi apparatus"	"HPA054320: AB_2682448"	"unprognostic (1.47e-1)"	"unprognostic (8.90e-2)"	"unprognostic (2.90e-1)"	"unprognostic (4.23e-2)"	"unprognostic (2.25e-2)"	"unprognostic (6.42e-2)"	"prognostic unfavorable (8.39e-5)"	"unprognostic (3.44e-1)"	"unprognostic (1.67e-1)"	"unprognostic (3.02e-1)"	"prognostic unfavorable (1.23e-5)"	"unprognostic (1.94e-1)"	"unprognostic (5.61e-2)"	"unprognostic (1.06e-1)"	"unprognostic (3.55e-1)"	"unprognostic (1.69e-2)"	"unprognostic (1.43e-1)"	10.5	24.3	7.7	11.4	15.9	10.1	14.8	11.3	14.6	10.1	8.5	10.0	10.4	6.0	14.7	16.8	9.4	12.1	9.3	8.8	9.8	7.1	9.6	12.0	10.3	16.0	10.0	8.1	12.3	13.6	18.0	22.5	8.8	12.5	11.0	11.2	9.5	12.5	10.8	7.7	11.2	10.9	9.8	8.8	14.2	9.0	15.3	9.7	19.0	13.8	7.7	15.1	10.9	10.6	5.8	2.8	2.2	4.0	6.7	6.0	0.8	22.7	11.2	7.5	8.5	10.7	11.8	8.9	12.6	7.1	9.4	9.7	5.2	7.3	18.6	13.0	8.9	12.3	14.8	11.0	11.6	14.2	5.9	7.2	10.2	8.5	5.1	4.7	17.1	5.7	9.2	6.4	8.9	10.6	6.4	9.7	9.7	7.1	8.4	9.6	10.0	12.9	7.1	7.2	14.9	8.0	10.7	10.9	13.5	9.5	10.6	5.3	5.4	23.2	8.4	8.2	7.1	12.2	6.9	12.5	9.6	4.8	12.4	13.5	11.0	6.5	17.3	12.5	6.7	7.6	0.7	2.7	2.2	4.4	4.0	6.0	3.1	3.2	4.2	2.8	5.8	4.1	4.0	1.7	6.7	2.5	2.5	2.4	0.8	7.7	15.9	11.3	14.6	9.8	7.1	10.0	8.1	12.5	9.7	6.0	8.8	13.4	6.5	3.5	14.7	7.1	7.6	18.7	6.8	3.5	35.3	6.6	0.0	5.3	12.0	7.1	2.1	0.0	4.3	3.3	4.8	6.7	1.1	6.0	5.7	7.9	7.5	8.6	9.1	6.9	6.1	6.9	10.1	4.6	5.4	4.8	6.2	0.0	6.7	4.1	23.4	0.0	6.4	42.3	15.8	4.0	4.2	5.1	7.0	5.2
ATRX	"JMS, MRX52, RAD54, XH2, XNP"	ENSG00000085224	"ATRX, chromatin remodeler"	P46100	X	77504878-77786269	"Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Transcription factors"	"DNA damage, DNA repair, Transcription, Transcription regulation"	"Chromatin regulator, DNA-binding, Helicase, Hydrolase"	"Cancer-related genes, Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001906, CAB009372, HPA064684, CAB068176"	Supported		Supported	"Nuclear bodies"		NA	NA			"Nuclear bodies"		"CAB009372: AB_2061023, CAB068176: AB_2665665, HPA001906: AB_1078249, HPA064684: AB_2685321"	"unprognostic (1.77e-2)"	"unprognostic (1.55e-1)"	"unprognostic (6.65e-2)"	"unprognostic (4.37e-2)"	"unprognostic (1.67e-1)"	"unprognostic (9.69e-2)"	"unprognostic (8.11e-2)"	"unprognostic (1.15e-2)"	"unprognostic (6.04e-2)"	"unprognostic (2.35e-2)"	"unprognostic (1.09e-1)"	"unprognostic (5.80e-2)"	"unprognostic (5.14e-3)"	"unprognostic (1.50e-1)"	"unprognostic (6.19e-2)"	"unprognostic (1.76e-2)"	"unprognostic (2.24e-1)"	16.4	16.6	24.5	18.9	29.3	24.3	16.3	48.2	26.4	20.6	15.4	7.1	18.9	10.2	20.2	17.1	13.5	13.8	13.4	15.1	22.9	15.8	16.6	12.2	15.9	18.6	21.1	21.3	25.4	18.3	35.7	28.1	15.9	20.2	18.4	12.6	7.1	15.8	16.5	20.1	14.1	13.5	22.3	15.3	20.1	15.6	6.5	22.4	23.7	19.8	12.7	16.5	19.9	21.1	21.9	12.8	21.5	11.5	14.6	17.7	5.7	15.3	24.7	25.4	17.1	12.7	17.1	9.0	13.3	12.3	9.9	11.7	8.4	13.5	21.4	13.7	14.1	18.6	13.7	20.4	7.9	16.8	12.0	13.3	12.9	29.4	6.2	6.9	16.7	4.4	11.2	7.8	14.5	13.9	12.3	17.4	13.5	15.1	24.6	12.3	12.1	12.9	8.7	18.4	7.1	19.2	21.0	35.2	10.9	9.6	20.6	14.5	25.1	26.8	10.5	8.8	17.2	8.5	8.6	24.0	14.0	21.6	15.6	9.3	7.3	22.7	19.2	10.2	13.3	12.3	21.3	6.9	13.8	17.7	8.7	17.1	19.2	16.3	13.7	5.1	21.9	16.8	13.5	21.5	14.6	11.5	12.8	12.8	5.7	24.5	29.3	48.2	26.4	22.9	15.8	21.1	21.3	20.2	22.4	148.9	213.6	88.0	96.7	82.1	217.2	263.3	58.6	120.5	117.2	68.0	200.3	58.0	19.9	72.8	3.1	123.5	43.3	23.3	72.0	39.7	90.3	99.7	106.6	45.6	60.7	149.4	121.7	91.4	84.5	4.9	150.4	86.3	59.1	120.0	68.3	114.7	80.3	40.3	195.6	28.6	231.4	90.5	113.3	13.6	49.5	73.8	50.0	94.4	62.6	104.6
ATXN3	"ATX3, JOS, MJD, SCA3"	ENSG00000066427	"Ataxin 3"	P54252	14	92044496-92106625	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Transcription, Transcription regulation, Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"	"Neurodegeneration, Spinocerebellar ataxia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"CAB021976, HPA024123, HPA069338"	Uncertain		Approved	"Nucleoplasm,Nucleoli,Plasma membrane"		NA	NA			"Nucleoplasm, Nucleoli"	"Plasma membrane"	"CAB021976: , HPA024123: AB_1845133, HPA069338: AB_2686124"	"unprognostic (1.06e-2)"	"unprognostic (2.93e-1)"	"unprognostic (1.22e-1)"	"unprognostic (3.67e-2)"	"unprognostic (5.76e-2)"	"unprognostic (1.57e-1)"	"unprognostic (1.42e-1)"	"unprognostic (9.85e-3)"	"unprognostic (1.69e-1)"	"unprognostic (6.75e-2)"	"unprognostic (1.04e-2)"	"unprognostic (3.06e-2)"	"unprognostic (2.03e-2)"	"unprognostic (8.94e-3)"	"unprognostic (4.22e-1)"	"unprognostic (1.64e-1)"	"unprognostic (1.11e-1)"	17.8	10.3	10.2	9.1	11.6	14.3	12.8	18.7	12.1	16.0	11.8	12.2	11.9	6.4	17.9	12.4	17.7	9.5	11.2	10.4	9.0	9.9	9.9	16.0	12.3	11.6	16.3	9.5	14.0	10.3	11.9	17.2	11.7	13.8	15.8	11.7	8.6	11.4	10.2	6.1	21.0	8.7	20.6	16.5	12.6	9.0	14.8	14.3	16.2	11.5	12.0	15.6	15.4	13.6	9.8	14.5	11.4	18.8	7.0	8.5	5.3	5.6	11.1	10.1	9.3	14.7	14.4	19.7	6.4	10.5	8.2	11.5	8.1	15.7	11.5	12.8	10.5	9.7	9.9	7.7	14.1	18.2	13.1	2.3	4.9	5.4	11.8	12.1	8.6	8.8	11.6	12.6	14.3	15.0	11.0	12.6	12.9	6.5	8.6	12.4	22.0	9.0	7.8	7.1	18.8	9.2	7.2	18.5	6.5	10.5	12.8	3.4	6.0	15.6	6.6	8.8	14.1	12.3	6.1	6.7	8.1	11.9	5.2	3.4	7.5	12.5	10.6	6.0	8.5	4.7	11.4	13.4	9.4	5.9	14.5	7.0	7.1	6.9	6.5	14.5	9.8	7.6	8.5	11.3	7.0	18.8	8.4	6.8	5.3	10.2	11.6	18.7	12.1	9.0	9.9	16.3	9.5	13.8	14.3	14.9	14.3	18.1	26.1	22.6	32.4	17.3	17.8	12.0	12.5	40.1	47.1	17.4	13.3	17.7	18.3	43.4	11.7	0.0	15.0	23.8	25.4	29.1	23.2	19.1	20.8	25.4	15.4	39.3	27.2	18.5	62.7	31.8	21.9	30.7	16.0	20.6	17.6	17.5	61.2	14.6	45.6	45.3	35.8	30.5	60.9	26.5	21.2	23.0	19.4	25.1
ATXN3L	MJDL	ENSG00000123594	"Ataxin 3 like"	Q9H3M9	X	13318236-13320399	"Enzymes, Predicted intracellular proteins"	"Transcription, Transcription regulation, Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	30	"testis: 8.0"	"Group enriched"	"Detected in some"	58	"Early spermatids: 59.4;Late spermatids: 131.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"AN3-CA: 1.0"									"HPA024123, HPA027539"	Uncertain					NA	NA					"HPA024123: AB_1845133, HPA027539: AB_10602435"																		0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	8.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	59.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	131.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	1.7	0.5	0.0	0.0	0.0	0.0	0.0
AUH		ENSG00000148090	"AU RNA binding methylglutaconyl-CoA hydratase"	Q13825	9	91213815-91361913	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Branched-chain amino acid catabolism"	"Lyase, RNA-binding"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	8	"Distal tubular cells: 162.5;Proximal tubular cells: 92.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HDLM-2: 41.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA004171	Enhanced				"Intracellular and membrane"	NA	NA					"HPA004171: AB_1845215"	"unprognostic (4.10e-2)"	"unprognostic (8.95e-2)"	"unprognostic (5.56e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.54e-1)"	"unprognostic (1.49e-1)"	"unprognostic (3.24e-2)"	"unprognostic (3.05e-2)"	"unprognostic (3.57e-1)"	"unprognostic (1.11e-3)"	"unprognostic (1.41e-1)"	"unprognostic (1.76e-1)"	"prognostic favorable (0.00e+0)"	"unprognostic (8.23e-3)"	"unprognostic (2.84e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.23e-1)"	13.0	39.6	14.3	15.6	20.1	3.8	15.2	22.5	20.7	14.1	19.8	10.5	25.3	19.2	11.1	16.0	8.9	10.7	11.4	30.4	15.4	19.7	50.4	21.3	9.7	6.7	19.1	9.0	11.8	20.7	27.0	10.1	13.1	16.3	23.8	14.4	10.6	20.1	35.4	31.0	6.7	16.0	10.4	15.2	7.7	17.7	6.1	12.1	9.1	17.5	11.8	8.9	10.2	10.5	8.7	5.8	16.1	4.6	9.9	10.0	5.3	4.6	4.5	6.3	3.2	7.9	8.5	9.8	4.1	5.2	3.2	3.7	2.5	5.9	5.4	4.3	4.4	9.7	6.8	9.4	5.2	4.6	41.8	8.0	3.7	4.9	15.0	6.0	5.3	3.9	7.0	6.6	2.6	9.0	7.6	3.9	5.6	5.1	8.2	3.8	4.4	7.3	12.0	7.9	11.3	6.5	4.3	5.1	9.3	14.1	2.5	6.5	4.7	6.2	14.9	7.8	15.1	2.7	3.5	4.0	3.2	4.1	4.7	4.0	9.4	7.9	1.8	5.1	4.3	2.2	15.2	4.6	16.1	6.9	3.2	7.9	7.8	7.6	10.0	4.2	8.7	9.6	8.8	7.1	9.9	2.1	5.8	9.3	5.3	14.3	20.1	22.5	20.7	15.4	19.7	19.1	9.0	16.3	12.1	0.0	7.7	5.2	22.9	4.6	17.8	32.7	28.1	13.4	4.5	26.2	23.6	37.5	162.5	21.0	2.6	11.2	33.1	23.3	14.0	23.8	11.3	45.7	1.1	16.0	11.6	12.7	22.0	11.1	9.4	1.0	13.3	7.6	11.8	44.1	16.4	8.5	13.9	23.7	10.6	92.2	32.2	12.9	7.5	9.4	11.7	3.6	30.4	13.1	23.0	22.0
AURKA	"AIK, ARK1, AurA, BTAK, PPP1R47, STK15, STK6, STK7"	ENSG00000087586	"Aurora kinase A"	O14965	20	56369389-56392337	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Cilium biogenesis/degradation, Mitosis"	"Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"lymphoid tissue: 32.3;testis: 41.1"	"Cell type enhanced"	"Detected in many"	8	"Erythroid cells: 70.0;Extravillous trophoblasts: 59.5;granulocytes: 55.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in many"							"CAB001454, HPA002636"	Enhanced		Approved	Nucleoplasm,Centrosome,Cytosol		Yes	Yes			"Nucleoplasm, Centrosome, Cytosol"		"CAB001454: AB_563420, HPA002636: AB_1845217"	"unprognostic (7.73e-2)"	"unprognostic (2.46e-2)"	"unprognostic (2.76e-2)"	"prognostic unfavorable (9.40e-5)"	"unprognostic (1.92e-1)"	"unprognostic (2.11e-2)"	"prognostic unfavorable (1.49e-4)"	"unprognostic (4.69e-3)"	"unprognostic (2.42e-1)"	"unprognostic (6.88e-2)"	"prognostic unfavorable (6.13e-4)"	"unprognostic (1.40e-1)"	"prognostic unfavorable (1.47e-8)"	"unprognostic (1.67e-1)"	"unprognostic (6.83e-2)"	"unprognostic (9.00e-2)"	"unprognostic (5.14e-2)"	3.7	2.3	1.5	12.7	1.3	8.3	3.0	1.3	1.8	1.4	6.7	1.3	0.8	7.3	1.8	1.2	7.7	1.1	3.7	4.1	1.1	1.1	2.4	5.1	2.9	12.3	1.6	0.9	8.3	1.4	0.3	0.7	6.1	1.5	1.0	8.3	1.5	2.7	0.5	6.9	2.1	7.2	2.7	1.3	7.4	4.3	41.1	1.1	32.3	1.2	5.9	13.3	2.4	2.4	3.9	5.2	6.0	8.7	2.0	6.6	2.6	33.0	24.4	16.3	11.5	0.9	2.1	20.7	27.1	12.7	65.7	27.7	68.2	23.2	10.8	18.7	11.1	34.1	26.7	29.0	18.2	70.0	9.8	11.1	19.3	25.0	42.5	0.5	25.8	27.2	1.0	1.9	22.7	20.4	5.2	15.3	17.7	21.9	8.6	27.9	33.7	15.4	20.0	14.9	27.1	25.1	11.7	31.5	12.0	10.5	8.7	14.1	7.6	37.9	43.6	18.2	15.6	25.8	16.1	8.8	28.6	28.3	15.8	38.2	12.1	14.0	18.8	15.4	15.0	23.6	0.2	5.3	6.0	1.9	8.7	2.9	3.9	3.3	1.9	5.2	1.4	1.5	1.5	3.7	2.0	4.8	1.2	6.6	2.6	1.5	1.3	1.3	1.8	1.1	1.1	1.6	0.9	1.5	1.1	0.0	3.2	4.5	1.1	1.0	1.0	3.4	2.5	1.4	2.3	3.5	2.0	9.8	1.7	3.9	16.9	1.6	5.3	70.0	4.2	59.5	3.8	0.7	55.2	2.4	14.8	1.6	5.8	3.1	2.4	9.5	1.4	5.5	0.0	18.0	5.7	3.5	3.6	3.5	0.4	1.9	2.5	6.5	2.1	16.2	31.6	1.0	6.9	4.9	9.8	1.4
AURKB	"Aik2, AIM-1, ARK2, AurB, IPL1, PPP1R48, STK12, STK5"	ENSG00000178999	"Aurora kinase B"	Q96GD4	17	8204733-8210600	"Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"	"Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 19.7;lymphoid tissue: 59.9"	"Group enriched"	"Detected in many"	6	"Erythroid cells: 46.7;Extravillous trophoblasts: 76.2;Hofbauer cells: 23.9"	"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in many"		"T-reg: 10.9"	"Lineage enriched"	"Detected in many"	5	"T-cells: 10.9"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"CAB005862, HPA037708"	Enhanced		Enhanced	Nucleoplasm,Midbody		Yes	Yes			Nucleoplasm	Midbody	"CAB005862: AB_449204, HPA037708: AB_2675623"	"unprognostic (4.76e-2)"	"unprognostic (3.61e-3)"	"unprognostic (2.25e-1)"	"unprognostic (3.14e-2)"	"unprognostic (2.27e-1)"	"unprognostic (6.05e-2)"	"prognostic unfavorable (1.24e-4)"	"unprognostic (1.99e-3)"	"unprognostic (9.41e-3)"	"unprognostic (3.47e-2)"	"unprognostic (4.61e-3)"	"unprognostic (1.01e-2)"	"prognostic unfavorable (0.00e+0)"	"unprognostic (7.77e-2)"	"unprognostic (2.93e-1)"	"unprognostic (6.76e-2)"	"unprognostic (3.77e-1)"	1.2	1.3	0.4	22.1	0.6	19.7	2.0	0.6	0.6	2.6	5.8	0.5	0.9	5.9	0.9	1.3	17.1	0.3	2.2	1.0	0.4	0.2	1.4	1.8	2.4	17.8	0.4	0.4	0.8	0.6	0.0	0.4	3.8	0.8	0.9	5.5	0.7	2.7	0.4	2.1	5.0	8.1	1.3	0.7	11.2	4.2	1.2	0.4	59.9	0.5	8.0	19.1	2.1	5.0	2.3	0.8	1.2	0.6	0.5	10.9	1.4	41.6	28.6	42.7	20.5	0.9	1.4	16.4	20.0	10.8	41.5	38.3	37.0	12.6	41.6	10.4	7.9	17.3	30.7	30.9	13.7	34.3	18.2	50.8	24.8	16.4	31.2	0.1	13.0	24.4	0.7	0.6	24.3	15.2	4.1	19.0	27.4	15.4	16.1	18.1	19.8	47.5	18.6	26.5	13.7	12.7	32.2	39.3	17.2	9.0	8.2	9.3	13.2	17.8	8.0	13.6	13.3	14.0	8.8	7.4	16.6	17.1	14.9	52.0	11.8	7.8	31.3	8.0	19.9	33.6	0.0	0.6	0.9	0.6	0.4	0.2	1.6	1.9	3.1	0.8	2.3	0.2	1.0	1.2	0.5	0.3	0.2	10.9	1.4	0.4	0.6	0.6	0.6	0.4	0.2	0.4	0.4	0.8	0.4	0.0	0.3	2.2	0.3	3.9	0.0	1.1	0.0	0.0	3.4	0.0	0.0	5.1	0.0	0.2	0.0	0.0	1.4	46.7	0.0	76.2	4.7	0.4	4.6	0.6	23.9	0.0	0.0	4.9	6.3	0.0	0.6	4.4	1.7	0.0	4.2	0.0	0.2	2.9	0.0	0.0	0.0	0.0	0.3	0.7	2.0	2.0	7.6	2.5	6.3	1.4
AURKC	"ARK3, AurC, STK13"	ENSG00000105146	"Aurora kinase C"	Q9UQB9	19	57230802-57235548	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Cell cycle, Cell division, Meiosis, Mitosis"	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	21	"testis: 72.0"	"Group enriched"	"Detected in many"	4	"Early spermatids: 101.7;Spermatocytes: 69.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enriched"	"Detected in some"	7	"NTERA-2: 30.0"					"Low region specificity"	"Detected in all"			HPA034859	Uncertain					NA	NA					"HPA034859: AB_10670298"	"unprognostic (7.27e-2)"	"unprognostic (1.76e-1)"	"unprognostic (6.45e-2)"	"unprognostic (8.07e-3)"	"unprognostic (3.29e-1)"	"unprognostic (5.99e-2)"	"unprognostic (1.11e-2)"	"unprognostic (7.02e-2)"	"unprognostic (1.13e-1)"	"unprognostic (2.09e-1)"	"unprognostic (1.47e-2)"	"unprognostic (2.51e-1)"	"unprognostic (1.20e-5)"	"unprognostic (4.26e-2)"	"unprognostic (1.61e-1)"	"unprognostic (1.55e-1)"	"unprognostic (6.46e-4)"	0.6	0.5	0.9	0.9	1.2	0.7	1.5	0.7	2.0	0.4	0.6	0.6	0.2	0.0	0.8	1.3	0.5	0.6	2.6	0.9	0.9	1.1	0.8	1.8	1.3	2.2	1.2	0.2	0.4	0.5	0.1	1.3	1.2	1.7	0.5	0.8	1.1	0.5	0.9	2.3	0.6	0.4	1.1	2.1	3.4	0.4	72.0	0.6	0.7	0.8	1.0	1.3	0.5	0.4	2.1	1.0	1.7	1.0	1.0	0.6	0.2	0.2	0.1	0.7	0.3	0.2	0.7	0.3	1.3	0.6	0.9	3.5	0.9	0.1	0.0	0.1	0.5	0.8	0.0	0.0	0.7	0.6	0.0	3.8	0.1	0.3	0.0	1.1	0.0	0.2	0.9	0.7	0.7	0.5	1.1	0.6	0.4	0.1	0.0	1.2	0.0	1.1	0.6	30.0	0.1	0.8	0.1	0.2	0.6	0.7	1.2	1.4	0.4	0.0	0.2	0.1	0.1	0.1	1.3	0.3	0.2	4.2	0.3	0.7	1.4	1.9	0.6	0.8	0.0	0.0	0.0	0.1	1.7	0.6	1.0	0.0	1.9	0.0	0.0	0.9	2.1	0.0	0.0	0.1	1.0	0.3	1.0	0.0	0.2	0.9	1.2	0.7	1.6	0.9	1.1	1.2	0.2	1.7	0.6	0.0	0.3	0.0	0.6	1.0	2.5	1.2	0.0	1.4	3.4	1.8	0.0	0.4	1.7	1.5	101.7	0.6	0.0	0.0	0.9	0.7	0.4	1.1	0.0	0.0	3.2	0.0	1.7	1.8	1.3	11.5	1.4	1.0	5.0	1.8	0.0	1.7	0.9	0.3	0.4	0.3	0.8	6.5	0.5	69.6	19.2	1.0	0.2	0.0	0.4	1.4
AWAT1	DGAT2L3	ENSG00000204195	"Acyl-CoA wax alcohol acyltransferase 1"	Q58HT5	X	70234655-70240627	"Enzymes, Predicted membrane proteins"	"Lipid biosynthesis, Lipid metabolism"	"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in some"	11	"breast: 3.8;skin 1: 6.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"HEK 293: 1.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA063412	Enhanced					NA	NA					"HPA063412: AB_2685009"	"unprognostic (1.12e-1)"			"unprognostic (1.78e-1)"						"unprognostic (1.96e-2)"				"unprognostic (4.90e-2)"	"unprognostic (2.08e-1)"	"unprognostic (6.78e-2)"		0.0	0.0	0.0	0.0	0.0	0.0	3.8	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.4	0.0	0.0	0.0		0.0	0.0		0.2	0.0	0.0	6.1	0.0	0.0	0.0	0.0	0.0	0.0			0.0		0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
AWAT2	"DGAT2L4, MFAT"	ENSG00000147160	"Acyl-CoA wax alcohol acyltransferase 2"	Q6E213	X	70040542-70049938	"Enzymes, Predicted membrane proteins"	"Lipid biosynthesis, Lipid metabolism"	"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in some"	10	"breast: 5.7;skin 1: 14.0"	"Cell type enhanced"	"Detected in single"	30	"Spermatocytes: 1.2"	"Cancer enriched"	"Detected in single"	7	"testis cancer: 0.6"					"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	7	"HUVEC TERT2: 2.4;PC-3: 2.6;SK-BR-3: 1.1"	"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			HPA062748	Approved					NA	NA					"HPA062748: AB_2684862"	"unprognostic (3.41e-2)"			"unprognostic (1.06e-1)"	"unprognostic (2.99e-2)"			"unprognostic (4.11e-2)"		"unprognostic (1.11e-1)"					"unprognostic (8.60e-2)"	"unprognostic (4.55e-2)"		0.0	0.0	0.0	0.0	0.0	0.0	5.7	0.0	0.0	0.0	0.0			0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.6	0.0	0.0	14.0	0.0	0.0	0.0	0.0	0.0	0.9			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0
AXL	"ARK, JTK11, Tyro7, UFO"	ENSG00000167601	"AXL receptor tyrosine kinase"	P30530	19	41219203-41261766	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted membrane proteins"	"Differentiation, Host-virus interaction, Immunity, Innate immunity"	"Host cell receptor for virus entry, Kinase, Receptor, Transferase, Tyrosine-protein kinase"	"Oncogene, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	13	"Kupffer cells: 104.4;Sertoli cells: 207.0;Smooth muscle cells: 341.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"NK-cell: 8.8;plasmacytoid DC: 18.3"	"Group enriched"	"Detected in many"	14	"dendritic cells: 18.3;NK-cells: 8.8"	"Cell line enhanced"	"Detected in many"		"fHDF/TERT166: 67.0;U-251 MG: 71.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB032501, HPA037422, HPA037423, HPA075217"	Uncertain		Supported	"Vesicles,Plasma membrane,Actin filaments"		NA	Yes	12100000	61000000	"Plasma membrane"	"Vesicles, Actin filaments"	"CAB032501: AB_2062572, HPA037422: AB_10672347, HPA037423: AB_2675470, HPA075217: "	"unprognostic (2.20e-1)"	"unprognostic (2.02e-1)"	"unprognostic (6.79e-3)"	"unprognostic (1.01e-1)"	"unprognostic (1.40e-1)"	"unprognostic (8.49e-3)"	"unprognostic (2.42e-1)"	"unprognostic (1.74e-1)"	"unprognostic (3.15e-2)"	"unprognostic (2.82e-2)"	"unprognostic (9.57e-3)"	"unprognostic (1.98e-1)"	"prognostic unfavorable (2.53e-7)"	"unprognostic (1.16e-3)"	"unprognostic (1.52e-2)"	"unprognostic (5.56e-2)"	"unprognostic (4.83e-3)"	38.0	15.4	10.6	11.7	12.7	1.3	27.1	6.3	12.1	26.2	26.8	13.4	8.1	9.1	28.0	19.4	21.8	17.4	17.8	18.5	11.5	6.1	7.8	13.0	20.0	7.6	10.6	9.3	20.9	5.1	9.6	5.6	26.6	10.1	19.5	10.2	16.8	7.8	20.4	14.1	13.8	12.8	29.4	10.7	27.3	16.2	22.4	10.4	3.4	12.0	8.4	5.8	35.6	18.3	0.1	18.3	0.9	0.2	8.8	0.3	0.2	53.3	21.4	1.3	0.1	4.8	4.9	0.0	42.3	38.1	62.2	38.6	1.1	25.1	0.0	17.2	67.0	32.5	4.5	0.0	28.5	53.6	0.0	0.0	0.0	14.2	0.8	17.6	0.0	0.0	3.7	0.5	36.6	56.9	35.3	23.0	0.0	2.0	0.0	38.5	0.0	0.0	0.0	0.5	0.1	10.3	0.0	22.7	0.0	27.8	0.0	0.0	0.0	10.9	0.0	0.2	8.2	0.1	0.9	47.2	44.1	30.1	42.1	71.7	0.0	0.1	0.1	29.4	0.0	32.8	0.9	0.2	0.1	0.1	0.2	0.2	0.1	0.3	0.1	4.2	0.1	0.2	0.2	0.3	8.8	0.1	18.3	0.2	0.2	10.6	12.7	6.3	12.1	11.5	6.1	10.6	9.3	10.1	10.4	8.9	2.2	0.5	72.4	37.1	0.0	4.2	0.0	4.0	5.7	5.2	0.0	2.3	0.0	4.0	8.6	2.9	0.0	0.0	0.2	1.7	91.1	28.0	0.0	0.0	26.7	1.6	0.0	13.5	104.4	2.7	57.0	49.8	25.3	4.6	0.0	28.7	8.9	0.0	75.0	0.0	1.1	207.0	341.9	0.5	2.1	25.5	9.6	2.5	0.0	26.4
AZU1	"AZAMP, AZU, CAP37, HBP, HUMAZUR, NAZC"	ENSG00000172232	"Azurocidin 1"	P20160	19	825097-832018	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	Chemotaxis	"Antibiotic, Antimicrobial, Heparin-binding, Serine protease homolog"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	7	"bone marrow: 238.2"	"Group enriched"	"Detected in some"	5	"Hofbauer cells: 3.3;Kupffer cells: 4.6"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"classical monocyte: 3.3;neutrophil: 7.6"	"Group enriched"	"Detected in many"	6	"granulocytes: 7.6;monocytes: 3.3"	"Cell line enriched"	"Detected in some"	7	"THP-1: 154.5"					"Not detected"	"Not detected"			"HPA055851, HPA075964"	Enhanced		Enhanced	Vesicles	"Secreted to blood"	NA	NA		290000	Vesicles		"HPA055851: AB_2682943, HPA075964: "	"unprognostic (1.12e-2)"	"unprognostic (3.71e-2)"	"unprognostic (4.44e-2)"	"unprognostic (8.85e-3)"	"unprognostic (1.62e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.39e-1)"	"unprognostic (8.12e-2)"	"unprognostic (3.32e-1)"	"unprognostic (4.22e-3)"	"unprognostic (2.58e-1)"	"unprognostic (1.50e-1)"	"unprognostic (1.01e-6)"	"unprognostic (1.11e-2)"	"unprognostic (1.10e-1)"	"unprognostic (2.46e-2)"	"unprognostic (3.04e-2)"	0.3	0.2	0.4	0.2	0.5	238.2	0.6	0.0	0.6	0.2	0.2	1.0	0.0	0.2	0.2	0.2	0.2	0.8	0.2	34.6	0.4	0.5	0.2	1.5	15.3	0.2	0.2	0.0	0.5	0.1	0.1	0.9	3.8	0.2	0.2	0.2	0.2	0.6	0.2	1.0	0.4	0.2	0.2	0.1	18.6	0.2	1.2	0.0	20.6	1.3	0.0	0.2	0.1	0.4	0.0	0.8	7.6	3.3	0.0	0.3	4.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	17.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	154.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	21.5	0.0	0.0	3.3	0.2	0.3	0.8	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	7.6	0.0	0.5	0.0	0.0	4.1	0.4	0.5	0.0	0.6	0.4	0.5	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.2	0.0	0.2	3.3	0.0	0.0	0.0	4.6	0.4	0.0	0.2	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.1	0.0	0.0	0.8	0.0
B3GALNT1	"B3GALT3, beta3Gal-T3, galT3, GLOB, P1"	ENSG00000169255	"Beta-1,3-N-acetylgalactosaminyltransferase 1 (globoside blood group)"	O75752	3	161083883-161105384	"Blood group antigen proteins, Enzymes, Plasma proteins, Predicted intracellular proteins"		"Blood group antigen, Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 36.8"	"Cell type enhanced"	"Detected in many"	7	"Bipolar cells: 52.9;Cardiomyocytes: 51.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	7	"basophil: 4.9;NK-cell: 16.7"	"Group enriched"	"Detected in many"	7	"granulocytes: 4.9;NK-cells: 16.7"	"Cell line enhanced"	"Detected in many"		"PC-3: 17.2;RT4: 52.6"	"Low region specificity"	"Detected in all"							HPA041204			Approved	Vesicles		NA	NA		290000	Vesicles		"HPA041204: AB_10795585"	"unprognostic (3.85e-2)"	"unprognostic (5.11e-3)"	"unprognostic (3.02e-1)"	"unprognostic (1.06e-2)"	"unprognostic (7.83e-2)"	"unprognostic (4.07e-2)"	"unprognostic (9.26e-5)"	"unprognostic (1.49e-2)"	"unprognostic (1.12e-2)"	"unprognostic (1.88e-2)"	"unprognostic (3.44e-2)"	"unprognostic (3.24e-1)"	"unprognostic (2.09e-3)"	"unprognostic (1.32e-1)"	"unprognostic (4.90e-2)"	"unprognostic (3.66e-2)"	"unprognostic (3.19e-3)"	3.8	5.4	14.0	3.0	24.5	3.1	7.4	17.2	24.7	15.5	2.3	5.5	2.6	1.5	8.3	6.9	5.4	10.4	7.1	36.8	15.4	21.6	14.3	1.0	10.8	3.5	11.3	16.2	13.8	7.8	6.5	8.5	10.0	17.7	8.9	2.0	7.5	14.8	6.7	1.1	2.2	1.9	7.2	7.6	4.2	7.5	6.2	5.0	1.1	19.5	2.3	3.9	10.5	4.7	1.4	1.4	4.9	0.2	16.7	0.7	0.5	6.7	0.2	3.1	0.1	0.3	1.0	0.1	3.7	3.3	8.2	2.8	4.4	5.1	0.0	15.1	3.1	4.9	1.5	0.0	6.6	2.7	0.1	0.0	3.7	2.8	0.0	4.8	0.1	0.1	10.1	2.0	2.2	0.5	6.4	12.1	0.0	0.0	0.0	3.3	10.9	0.0	0.0	7.5	0.1	17.2	0.1	0.0	0.1	3.9	52.6	6.3	0.0	9.5	3.5	2.7	1.4	14.5	5.5	0.0	0.1	6.6	0.2	0.1	1.5	0.0	0.0	5.8	0.0	0.0	4.9	0.2	0.0	0.4	0.1	0.4	1.4	0.2	0.4	1.4	0.3	0.5	0.7	0.4	16.7	0.0	1.0	0.0	0.5	14.0	24.5	17.2	24.7	15.4	21.6	11.3	16.2	17.7	5.0	17.9	2.1	3.4	4.2	4.4	52.9	51.9	0.0	2.7	10.3	14.0	11.8	18.5	10.0	3.0	0.6	6.8	0.0	0.0	7.4	10.2	16.9	4.9	10.3	0.0	8.4	6.4	1.7	6.7	1.3	1.7	6.6	4.6	10.1	7.2	0.0	10.8	7.2	0.0	4.9	13.6	7.2	0.0	13.3	3.7	16.8	2.3	4.2	1.8	0.4	4.1
B3GALNT2	MGC39558	ENSG00000162885	"Beta-1,3-N-acetylgalactosaminyltransferase 2"	Q8NCR0	1	235449923-235504481	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		"Glycosyltransferase, Transferase"	"Congenital muscular dystrophy, Disease mutation, Dystroglycanopathy, Lissencephaly"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"pancreas: 35.7"	"Cell type enriched"	"Detected in many"	7	"Cone photoreceptor cells: 237.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA012502, HPA050662"	Approved		Approved	"Nucleoplasm,Golgi apparatus"	"Intracellular and membrane"	NA	NA			Nucleoplasm	"Golgi apparatus"	"HPA012502: AB_1845228, HPA050662: AB_2681209"	"unprognostic (5.50e-2)"	"unprognostic (3.16e-3)"	"unprognostic (6.60e-2)"	"unprognostic (1.63e-1)"	"unprognostic (1.36e-2)"	"unprognostic (1.28e-1)"	"unprognostic (7.59e-3)"	"unprognostic (1.96e-2)"	"unprognostic (3.39e-2)"	"unprognostic (3.38e-1)"	"unprognostic (7.19e-3)"	"unprognostic (2.89e-1)"	"unprognostic (1.99e-1)"	"unprognostic (5.52e-2)"	"unprognostic (3.40e-1)"	"unprognostic (3.53e-3)"	"unprognostic (8.34e-3)"	5.0	6.3	3.9	4.3	5.1	1.3	8.4	4.7	4.5	5.4	7.6	3.5	5.1	3.3	8.0	8.7	10.3	6.1	9.7	7.9	2.8	2.9	3.7	4.6	3.7	3.1	3.0	3.2	5.9	35.7	9.8	8.9	4.5	4.7	8.3	5.8	8.5	8.7	7.3	21.6	6.1	6.9	16.9	2.5	3.3	9.2	5.8	3.9	4.7	7.1	7.0	5.0	9.7	5.9	1.5	5.7	2.4	2.7	1.9	1.9	1.3	9.9	6.5	7.2	10.7	11.7	9.9	17.4	8.7	7.9	6.6	6.1	5.0	8.9	5.2	11.5	9.9	4.3	12.6	14.0	10.2	8.2	10.2	9.7	3.3	8.3	5.7	7.4	10.7	3.7	7.1	6.6	6.8	16.5	5.0	10.1	14.1	8.0	7.0	6.2	4.7	6.7	3.9	10.3	6.3	3.7	7.4	12.0	13.2	4.2	11.8	9.3	11.9	15.1	5.7	7.5	3.1	11.0	10.9	9.9	5.8	9.6	9.8	11.6	10.2	8.4	3.2	3.8	7.7	13.4	2.4	2.3	1.1	1.1	2.7	1.7	1.5	0.8	1.9	5.7	1.1	1.0	1.3	0.2	1.9	2.5	3.1	0.5	1.3	3.9	5.1	4.7	4.5	2.8	2.9	3.0	3.2	4.7	3.9	8.9	5.3	6.4	25.1	27.7	18.9	5.4	2.5	5.3	4.5	5.2	237.6	17.0	0.0	5.8	13.0	6.7	7.3	0.0	6.1	5.6	8.1	23.5	5.7	4.4	3.5	27.0	8.6	4.3	3.1	4.5	9.8	7.9	1.7	9.0	4.6	7.8	7.6	4.3	15.2	0.8	17.3	0.0	14.4	16.6	34.1	26.0	18.8	5.3	5.2	31.0
B3GALT1	beta3Gal-T1	ENSG00000172318	"Beta-1,3-galactosyltransferase 1"	Q9Y5Z6	2	167868948-167874041	"Enzymes, Predicted intracellular proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"blood: 2.4;brain: 5.1;intestine: 5.8;skeletal muscle: 7.1"	"Cell type enhanced"	"Detected in some"	9	"Enterocytes: 3.1;Mucus-secreting cells: 4.2;Undifferentiated cells: 5.2"	"Cancer enhanced"	"Detected in some"		"glioma: 2.2"					"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enriched"	"Detected in some"	8	"AN3-CA: 28.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA						"unprognostic (1.98e-2)"	"unprognostic (4.34e-2)"	"unprognostic (1.12e-2)"	"unprognostic (7.22e-2)"	"unprognostic (1.67e-1)"	"unprognostic (4.23e-3)"	"unprognostic (2.49e-1)"	"unprognostic (2.84e-2)"	"unprognostic (1.30e-1)"	"unprognostic (3.94e-2)"	"unprognostic (8.72e-2)"	"unprognostic (6.44e-2)"	"unprognostic (2.30e-3)"	"unprognostic (8.34e-2)"	"unprognostic (1.98e-2)"	"unprognostic (1.44e-1)"	"unprognostic (3.79e-1)"	0.1	0.6	0.5	0.0	1.6	0.0	0.3	0.9	5.1	0.2	5.6			0.0	0.2	0.3	0.0	0.8	0.0	0.0	0.4	0.6	0.0	0.0	0.0	0.0	0.3		0.1	0.2	0.0	0.8	0.0		0.1	5.8		0.1	0.9	7.1	0.0	0.1	0.0	0.1	0.0	0.0	0.5			0.1		0.0	0.0	0.1	1.4	0.8	2.0	0.5	1.0	2.4	0.4	0.0	0.0	2.2	28.6	0.2	0.0	0.0	0.4	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.1	0.0	1.1	0.1	0.0	0.0	0.0	0.0	3.7	0.0	1.0	0.0	0.1	0.0	0.4	0.0	1.9	0.3	0.0	0.0	0.5	1.4	0.0	0.0	0.0	0.2	0.1	0.3	0.3	0.0	0.6	0.0	0.5	0.0	2.6	2.0	0.5	0.3	0.6	0.3	0.7	1.1	0.7	0.7	0.2	1.4	2.4	1.3	1.5	1.0	0.3	0.8	0.6	0.4											0.0	2.2	0.0	0.0	0.1	2.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.2	3.1	0.0	0.2	0.0	0.2	0.1	1.1	0.0	0.1	1.6	0.0	0.0	0.0	0.0	0.6	0.0	1.7	0.0	4.2	1.9	0.0	0.0	1.4	0.2	1.4	0.0	0.0	0.0	2.0	0.0	0.0	0.0	5.2	0.0
B3GALT2	beta3Gal-T2	ENSG00000162630	"Beta-1,3-galactosyltransferase 2"	O43825	1	193179045-193186654	"Enzymes, Predicted membrane proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"brain: 32.9;gallbladder: 19.0;heart muscle: 25.1"	"Cell type enhanced"	"Detected in some"	13	"Bipolar cells: 47.7;Cardiomyocytes: 27.8;Cholangiocytes: 15.3;Leydig cells: 29.4;Peritubular cells: 19.8"	"Cancer enhanced"	"Detected in some"		"glioma: 2.4"	"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	4	"MAIT T-cell: 11.9"	"Lineage enriched"	"Detected in single"	57	"T-cells: 11.9"	"Group enriched"	"Detected in some"	4	"AF22: 16.4;ASC TERT1: 7.5;LHCN-M2: 11.1;WM-115: 19.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA078659			Approved	"Plasma membrane"		NA	NA			"Plasma membrane"		"HPA078659: AB_2686887"	"unprognostic (1.83e-2)"	"unprognostic (3.81e-2)"	"unprognostic (1.91e-2)"	"unprognostic (1.17e-1)"	"unprognostic (3.67e-1)"	"unprognostic (1.58e-3)"	"unprognostic (2.34e-3)"	"unprognostic (2.43e-3)"	"unprognostic (1.63e-1)"	"unprognostic (2.44e-1)"	"unprognostic (6.14e-4)"	"unprognostic (4.41e-2)"	"unprognostic (8.10e-3)"	"unprognostic (2.72e-1)"	"unprognostic (1.36e-1)"	"unprognostic (1.89e-1)"	"unprognostic (4.56e-3)"	0.7	2.0	11.3	1.3	8.9	0.7	0.9	1.4	32.9	0.8	1.7	1.2	0.9	1.6	0.6	1.8	1.2	0.7	19.0	25.1	10.1	7.9	1.7	0.8	2.6	0.7	5.7	19.1	13.8	0.8	0.4	0.9	0.9	5.0	6.5	2.0	0.3	0.5	7.1	0.6	0.7	4.1	0.8	6.5	1.4	2.1	1.4	4.7	0.0	1.8	0.0	1.6	2.0	0.7	0.0	0.2	0.1	0.0	0.0	11.9	0.3	0.0	0.0	16.4	0.0	0.4	7.5	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	3.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	11.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0	1.4	1.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	19.4	0.0	0.0	0.0	0.2	0.0	11.9	0.0	2.7	1.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	2.3	0.3	11.3	8.9	1.4	32.9	10.1	7.9	5.7	19.1	5.0	4.7	0.0	0.3	0.0	0.0	0.2	47.7	27.8	15.3	4.0	0.0	1.8	3.9	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.8	0.3	2.3	0.0	0.2	7.9	2.9	1.3	0.3	0.0	29.4	0.1	0.0	0.0	0.3	1.7	0.4	0.0	19.8	0.0	5.8	0.0	0.4	0.0	0.0	0.3	0.0	5.1	0.4	0.0
B3GALT4	"beta3Gal-T4, GalT4"	ENSG00000235863	"Beta-1,3-galactosyltransferase 4"	O96024	6	33277132-33284832	"Enzymes, Predicted intracellular proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Late spermatids: 54.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"CAPAN-2: 5.1;SCLC-21H: 3.2;SK-BR-3: 5.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA043001	Approved					NA	NA					"HPA043001: AB_2678265"	"unprognostic (3.71e-2)"	"unprognostic (1.33e-2)"	"unprognostic (6.02e-2)"	"unprognostic (1.00e-1)"	"unprognostic (6.10e-3)"	"unprognostic (1.66e-2)"	"unprognostic (6.00e-2)"	"unprognostic (2.17e-1)"	"unprognostic (1.39e-1)"	"unprognostic (1.84e-1)"	"unprognostic (1.98e-2)"	"unprognostic (1.96e-1)"	"unprognostic (1.17e-3)"	"unprognostic (6.83e-2)"	"unprognostic (1.94e-1)"	"unprognostic (1.22e-2)"	"unprognostic (3.75e-2)"	7.0	6.9	3.0	9.8	4.0	3.0	6.7	5.3	6.3	7.6	9.0	6.2	13.1	8.0	6.2	7.0	14.0	6.1	9.4	5.7	3.6	3.4	7.1	1.7	6.7	11.9	3.7	3.0	3.1	3.1	5.3	4.4	7.4	4.0	6.5	4.9	6.7	9.1	15.9	2.7	10.9	12.5	4.3	4.6	11.1	7.7	19.0	2.5	14.7	5.6	5.3	9.8	8.6	7.9	7.3	4.1	12.4	8.4	6.3	9.5	5.2	0.0	0.3	0.6	0.2	0.9	1.6	0.8	0.3	0.4	0.0	0.1	0.0	5.1	0.0	0.0	0.7	1.2	2.6	0.0	0.2	0.0	2.8	0.3	0.9	0.4	0.0	1.0	0.0	2.7	2.1	1.3	0.1	0.1	0.0	0.7	2.4	0.0	0.3	0.0	0.1	1.3	1.2	0.2	1.9	0.3	0.2	0.0	0.0	0.0	0.8	3.2	0.4	0.1	5.2	0.4	0.6	0.0	1.4	1.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.7	0.0	0.7	12.4	6.9	10.0	9.5	6.7	7.4	6.0	5.9	8.0	4.1	7.3	5.7	5.1	7.3	6.3	8.4	3.3	6.3	5.2	3.0	4.0	5.3	6.3	3.6	3.4	3.7	3.0	4.0	2.5	11.9	4.5	10.4	5.9	2.9	13.7	3.3	17.8	14.7	7.9	14.0	3.9	15.4	5.0	12.9	25.9	9.8	29.5	0.0	16.5	9.9	5.2	9.6	10.3	0.5	18.3	11.1	12.1	11.1	23.0	54.2	7.2	12.7	8.5	30.7	15.3	11.8	14.7	25.9	5.6	5.3	13.9	6.5	3.8	28.9	3.0	4.3	26.8	14.9	10.1	14.6
B3GALT6	beta3GalT6	ENSG00000176022	"Beta-1,3-galactosyltransferase 6"	Q96L58	1	1232265-1235041	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		"Glycosyltransferase, Transferase"	"Disease mutation, Dwarfism, Ehlers-Danlos syndrome"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"SCLC-21H: 38.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA						"unprognostic (9.76e-2)"	"unprognostic (6.97e-2)"	"unprognostic (4.70e-2)"	"unprognostic (1.44e-1)"	"unprognostic (1.39e-1)"	"unprognostic (4.62e-2)"	"unprognostic (2.65e-3)"	"unprognostic (1.86e-1)"	"unprognostic (1.37e-1)"	"unprognostic (2.66e-1)"	"unprognostic (3.08e-2)"	"unprognostic (2.40e-2)"	"unprognostic (1.85e-1)"	"unprognostic (1.54e-1)"	"unprognostic (1.48e-1)"	"unprognostic (3.28e-1)"	"unprognostic (9.89e-2)"	12.2	9.4	13.4	9.9	11.7	3.0	10.2	10.3	17.2	10.0	7.5	11.1	9.5	7.2	11.9	9.3	7.7	11.9	7.1	12.6	13.7	12.9	9.8	19.5	10.1	12.3	9.4	7.9	11.4	14.7	14.1	10.4	12.3	10.4	9.6	6.0	11.4	9.9	8.7	9.6	13.4	7.0	9.3	8.4	12.9	9.2	8.4	10.8	14.7	10.1	7.0	7.7	8.2	9.0	5.2	5.1	2.9	4.1	6.0	6.6	2.2	10.6	5.4	9.3	9.7	9.4	6.4	7.2	11.4	9.7	9.6	7.8	4.8	10.9	8.0	6.8	6.7	8.3	9.6	4.0	6.1	5.9	14.0	15.2	14.8	5.4	4.5	9.7	9.1	9.4	5.9	4.5	6.3	6.2	5.8	7.2	9.3	10.3	7.2	9.7	6.1	12.4	16.5	12.0	11.2	20.5	11.9	3.7	6.5	9.4	3.3	38.3	15.7	8.4	10.0	5.7	5.7	8.4	13.2	7.7	9.9	4.4	6.2	16.3	4.5	3.8	7.3	7.8	20.6	11.2	2.9	2.8	0.9	3.8	3.5	6.6	3.1	3.9	4.5	3.8	5.2	3.4	4.1	1.4	6.0	4.1	5.1	1.6	2.2	13.4	11.7	10.3	17.2	13.7	12.9	9.4	7.9	10.4	10.8	11.9	6.9	8.3	19.2	7.4	12.1	6.4	7.6	2.7	3.4	12.2	3.9	1.4	6.6	7.4	0.4	9.6	1.6	0.0	10.7	3.0	6.2	12.4	0.0	10.5	6.3	19.1	5.8	7.4	7.5	0.9	2.6	7.2	1.7	1.0	3.9	8.2	9.0	0.0	3.9	9.9	8.3	0.0	6.2	1.4	2.7	11.0	1.1	6.9	4.4	9.5
B3GAT1	"CD57, GlcAT-P, HNK-1, LEU7, NK-1"	ENSG00000109956	"Beta-1,3-glucuronyltransferase 1"	Q9P2W7	11	134378504-134411918	"Enzymes, Predicted intracellular proteins, Predicted secreted proteins"		Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	10	"brain: 76.0"	"Cell type enhanced"	"Detected in some"	30	"Bipolar cells: 34.2;Horizontal cells: 22.3;Muller glia cells: 119.7"	"Group enriched"	"Detected in some"	11	"glioma: 10.8;prostate cancer: 3.5;thyroid cancer: 4.1"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"gdT-cell: 3.8;naive CD8 T-cell: 2.4"	"Lineage enriched"	"Detected in single"	39	"T-cells: 3.8"	"Cell line enhanced"	"Detected in some"		"AF22: 17.4;HMC-1: 19.3;NTERA-2: 16.7;SH-SY5Y: 6.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002500, CAB010893, HPA069468, HPA074314"	Enhanced		Enhanced	Vesicles	"Secreted in brain"	NA	NA			Vesicles		"CAB002500: AB_563601, CAB010893: AB_1078474, HPA069468: AB_2686138, HPA074314: "	"unprognostic (6.72e-2)"	"unprognostic (3.97e-4)"	"unprognostic (2.13e-2)"	"unprognostic (1.40e-3)"	"unprognostic (5.52e-2)"	"unprognostic (2.60e-3)"	"unprognostic (6.30e-2)"	"unprognostic (1.96e-2)"	"unprognostic (8.74e-2)"	"unprognostic (2.72e-1)"	"unprognostic (1.57e-3)"	"unprognostic (1.58e-1)"	"unprognostic (9.34e-3)"	"unprognostic (3.87e-3)"	"unprognostic (2.42e-1)"	"unprognostic (4.07e-2)"	"unprognostic (2.26e-2)"	1.5	5.8	38.9	1.7	23.7	2.1	5.6	9.2	76.0	1.7	1.5	25.8	0.0	1.8	1.6	1.7	1.4	1.6	1.7	1.5	43.4	14.9	2.1	6.0	1.8	3.3	30.3	19.5	1.5	1.7	1.4	0.9	1.4	19.7	4.2	1.5	2.1	2.2	1.8	1.4	1.8	1.6	1.5	45.1	2.1	6.0	1.8	25.2	0.0	7.7	0.0	1.7	2.5	0.0	0.0	0.0	0.0	0.0	0.0	3.8	0.4	0.0	0.0	17.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.5	3.0	0.0	0.7	0.9	1.1	0.0	0.0	0.0	0.5	0.0	0.1	0.0	0.1	0.0	19.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.1	0.0	0.1	16.7	0.8	0.0	0.3	0.0	1.2	0.0	0.1	2.3	6.4	0.0	0.0	0.0	1.1	0.1	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.1	0.0	4.3	0.0	0.0	0.0	3.8	0.0	0.0	0.0	0.8	1.9	0.0	0.0	0.2	2.4	0.0	0.0	0.0	0.0	0.0	0.4	38.9	23.7	9.2	33.7	43.4	14.9	30.3	19.5	19.7	25.2	0.0	0.0	0.0	0.0	0.0	34.2	1.0	2.5	0.0	0.0	0.0	3.9	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	1.9	0.1	22.3	1.7	0.0	0.3	2.5	0.0	0.0	0.0	0.0	0.0	119.7	0.0	0.0	0.4	2.3	6.3	0.0	0.0	0.2	0.1	0.0	0.1	3.2	0.0	0.1
B3GAT2	GlcAT-S	ENSG00000112309	"Beta-1,3-glucuronyltransferase 2"	Q9NPZ5	6	70856679-70957038	"Enzymes, Predicted membrane proteins"		Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in many"	9	"brain: 27.2"	"Cell type enriched"	"Detected in many"	9	"Horizontal cells: 301.9"	"Group enriched"	"Detected in some"	20	"glioma: 4.7;testis cancer: 1.3"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enriched"	"Detected in some"	20	"SCLC-21H: 22.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA012059	Uncertain					NA	NA					"HPA012059: AB_2061050"	"unprognostic (7.10e-3)"	"unprognostic (7.81e-2)"	"unprognostic (1.63e-1)"	"unprognostic (1.10e-3)"	"unprognostic (2.21e-1)"	"unprognostic (1.22e-2)"	"unprognostic (1.96e-2)"	"unprognostic (4.88e-2)"	"unprognostic (4.22e-2)"	"unprognostic (9.16e-4)"	"unprognostic (8.09e-2)"	"unprognostic (7.43e-3)"	"unprognostic (6.88e-7)"	"unprognostic (2.72e-2)"	"unprognostic (3.35e-2)"	"unprognostic (2.53e-2)"	"unprognostic (3.45e-3)"	1.8	1.5	9.5	1.9	7.8	1.6	1.1	3.2	27.2	0.8	1.1	26.2	0.0	2.3	1.4	1.1	1.4	1.1	1.4	1.5	19.2	11.5	1.0	1.3	1.2	2.0	9.7	13.6	1.1	2.2	0.8	0.5	1.2	21.0	1.3	0.9	0.4	1.5	0.9	1.5	1.9	2.4	1.1	17.3	2.0	1.5	2.9	16.3	0.0	1.5	0.0	0.9	1.3	0.9	1.2	1.0	2.0	1.2	1.1	2.2	0.2	0.3	0.0	0.6	0.4	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.1	0.2	0.1	0.0	0.1	0.2	0.1	0.0	0.0	0.2	1.1	0.1	0.3	0.2	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.2	0.0	0.6	0.1	0.5	0.0	0.2	0.0	0.5	0.7	0.1	0.1	0.2	0.3	0.2	0.0	0.2	22.7	0.2	0.0	0.1	0.0	0.4	0.1	0.0	0.1	0.1	0.2	0.1	0.3	0.5	0.0	0.1	0.1	0.1	0.1	1.3	1.2	1.2	1.0	1.0	0.9	1.0	1.5	2.1	0.4	1.2	1.7	1.8	2.0	1.1	1.1	1.0	2.2	0.2	9.5	7.8	3.2	11.2	19.2	11.5	9.7	13.6	21.0	16.3	0.0	2.1	16.6	7.9	22.7	12.4	0.8	7.6	0.0	0.0	15.7	21.6	5.1	0.0	5.0	6.6	7.5	11.0	0.0	3.3	2.8	10.3	14.9	0.0	7.7	7.0	301.9	0.0	3.7	5.3	4.0	18.4	11.1	13.5	11.8	4.1	17.1	7.1	7.0	12.7	0.5	21.5	12.9	8.2	17.4	32.2	17.3	5.9	13.1	3.8	9.9
B3GAT3	GlcAT-I	ENSG00000149541	"Beta-1,3-glucuronyltransferase 3"	O94766	11	62615296-62622175	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		Transferase	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA051328	Approved				"Intracellular and membrane"	NA	NA		1600000			"HPA051328: AB_2681444"	"unprognostic (1.55e-1)"	"unprognostic (3.93e-2)"	"unprognostic (8.45e-3)"	"unprognostic (2.31e-1)"	"prognostic unfavorable (4.69e-4)"	"unprognostic (3.80e-2)"	"prognostic unfavorable (5.11e-6)"	"unprognostic (4.94e-2)"	"unprognostic (2.42e-1)"	"unprognostic (3.66e-2)"	"unprognostic (1.08e-3)"	"unprognostic (1.40e-1)"	"unprognostic (1.58e-3)"	"unprognostic (1.46e-3)"	"unprognostic (6.00e-2)"	"unprognostic (4.48e-2)"	"unprognostic (2.58e-2)"	14.4	21.6	24.8	15.9	29.2	15.0	19.7	28.9	29.1	15.4	12.9	24.2	8.1	17.6	14.9	18.8	10.6	21.1	15.3	13.1	25.8	25.6	17.4	21.5	12.8	22.9	30.0	16.8	17.0	22.4	18.5	25.6	19.9	25.7	18.2	6.8	19.0	24.9	20.9	6.4	23.1	16.5	14.2	24.4	17.5	15.5	12.0	24.8	17.5	14.5	5.4	12.9	14.4	17.4	11.2	15.7	15.7	18.9	24.5	14.1	9.4	9.8	16.3	8.9	15.4	12.2	12.1	6.5	8.2	11.6	7.8	8.8	7.2	14.7	8.7	28.4	8.2	21.7	6.4	9.0	8.2	1.7	19.4	17.4	4.1	7.5	9.1	29.6	5.9	9.8	21.4	14.0	10.2	4.2	12.8	6.9	11.3	13.8	22.0	9.2	25.1	10.0	21.0	13.8	5.6	15.3	10.2	6.4	47.9	16.2	1.9	9.4	15.4	9.4	11.1	37.5	3.1	14.9	11.6	5.3	7.9	6.2	21.1	15.7	22.9	7.6	10.1	24.2	10.7	16.6	15.7	18.4	15.5	14.1	18.3	9.3	11.2	9.8	11.4	15.7	9.1	9.8	11.4	5.4	24.5	18.9	9.3	11.7	9.4	24.8	29.2	28.9	27.7	25.8	25.6	30.0	16.8	25.7	24.8	6.0	10.4	30.4	32.3	17.5	51.2	3.2	25.5	6.7	18.2	38.4	31.4	64.6	13.3	30.5	0.4	21.0	25.1	0.0	40.4	49.5	29.4	29.0	1.1	24.6	59.6	46.1	24.2	26.4	39.3	1.9	33.4	30.8	42.2	55.1	20.6	46.3	31.6	28.1	21.2	15.3	38.8	25.8	20.2	6.3	23.5	16.9	36.4	44.6	24.7	17.3
B3GNT2	"B3GN-T1, B3GN-T2, B3GNT-2, B3GNT1, BETA3GNT"	ENSG00000170340	"UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 2"	Q9NY97	2	62196113-62224731	"Enzymes, Plasma proteins, Predicted membrane proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"REH: 43.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA005997	Approved		Approved	Vesicles		NA	NA		43000000	Vesicles		"HPA005997: AB_1845234"	"unprognostic (1.38e-1)"	"unprognostic (1.13e-1)"	"unprognostic (1.28e-1)"	"unprognostic (2.64e-2)"	"unprognostic (1.23e-2)"	"unprognostic (1.67e-1)"	"unprognostic (1.51e-1)"	"unprognostic (1.55e-2)"	"unprognostic (2.13e-2)"	"unprognostic (3.76e-1)"	"prognostic unfavorable (1.62e-4)"	"unprognostic (3.63e-1)"	"unprognostic (1.11e-2)"	"unprognostic (9.55e-2)"	"unprognostic (3.05e-2)"	"unprognostic (3.18e-1)"	"unprognostic (1.25e-1)"	18.9	14.3	8.6	10.8	23.0	41.6	17.5	3.1	14.1	18.4	17.9	7.4	5.6	17.9	19.8	8.0	24.5	8.7	18.1	20.9	7.6	11.5	24.4	14.2	23.9	13.9	9.7	7.1	9.0	43.2	5.4	25.9	22.8	9.5	7.5	16.3	14.4	17.2	6.0	5.2	13.0	21.7	16.3	7.6	14.6	12.0	7.0	10.6	27.0	15.6	8.5	18.5	11.8	14.7	8.4	6.8	28.3	5.6	20.3	19.3	8.2	7.8	5.4	8.2	3.6	9.0	4.1	23.7	7.6	8.5	6.1	8.2	11.1	12.6	8.5	7.0	7.1	8.6	7.5	5.2	6.4	10.6	17.6	4.2	20.8	2.6	6.5	6.8	12.4	9.4	4.9	12.1	11.7	4.2	4.3	9.1	5.9	11.3	5.3	7.3	5.9	23.6	18.6	7.8	14.2	2.2	43.4	5.7	4.6	11.6	7.7	8.0	5.9	5.4	11.7	8.7	13.8	3.3	14.7	10.3	7.4	6.5	12.5	7.5	15.1	5.3	36.5	5.8	21.6	7.1	7.2	4.5	28.3	11.0	4.4	15.6	7.6	8.2	19.3	5.5	8.4	9.9	14.4	11.3	20.3	5.6	6.8	13.2	8.2	8.6	23.0	3.1	14.1	7.6	11.5	9.7	7.1	9.5	10.6	59.6	9.8	25.1	27.0	63.4	16.0	8.7	17.8	5.3	3.4	17.4	0.0	31.1	19.9	20.8	0.1	21.0	17.3	46.7	50.7	30.1	35.3	23.6	3.5	15.5	51.9	0.0	9.1	37.4	22.7	0.2	2.3	20.4	33.7	24.4	19.1	8.1	37.8	21.8	2.1	18.9	2.4	64.7	52.3	0.2	1.5	56.7	54.6	17.5	11.9	34.6
B3GNT3	"B3GN-T3, B3GNT-3, beta3Gn-T3, HP10328, TMEM3"	ENSG00000179913	"UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 3"	Q9Y2A9	19	17794828-17813082	"Enzymes, Predicted intracellular proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"gallbladder: 69.9;intestine: 61.6;placenta: 56.0"	"Cell type enhanced"	"Detected in many"	6	"Cholangiocytes: 53.5;Cytotrophoblasts: 51.9;Enterocytes: 58.5;Mucus-secreting cells: 40.2;Paneth cells: 42.5;Syncytiotrophoblasts: 57.1;Urothelial cells: 43.1"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	12	"memory CD4 T-cell: 2.7;memory CD8 T-cell: 1.1;naive CD4 T-cell: 3.2"	"Lineage enriched"	"Detected in single"	32	"T-cells: 3.2"	"Cell line enhanced"	"Detected in some"		"A-431: 16.5;BEWO: 16.3;CAPAN-2: 44.2;OE19: 40.5;RT4: 15.8;SK-BR-3: 15.0"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			HPA024298	Enhanced				"Intracellular and membrane"	NA	NA					"HPA024298: AB_1845236"	"unprognostic (1.10e-1)"	"unprognostic (5.19e-2)"	"unprognostic (1.84e-1)"	"unprognostic (4.84e-3)"		"unprognostic (1.10e-1)"	"unprognostic (1.18e-1)"	"prognostic unfavorable (4.25e-5)"	"unprognostic (3.26e-1)"	"unprognostic (4.64e-2)"	"prognostic unfavorable (2.16e-4)"	"unprognostic (1.91e-1)"	"unprognostic (1.44e-2)"	"unprognostic (7.38e-2)"	"unprognostic (1.26e-1)"	"unprognostic (7.10e-2)"	"unprognostic (2.57e-2)"	0.4	0.2	0.2	8.7	0.3	0.0	1.8	0.2	0.3	3.5	25.3	0.0	12.0	16.6	0.4	1.2	15.1	0.6	69.9	0.5	0.2	0.3	11.4	2.5	1.0	1.2	0.2	0.0	0.3	9.1	0.0	0.3	56.0	0.0	4.4	22.4	0.3	24.4	12.8	0.3	2.0	61.6	1.9	0.2	0.3	21.8	0.3	0.0	0.3	0.4	2.6	18.3	10.2	5.4	0.0	0.0	0.0	0.0	0.0	3.2	0.6	16.5	4.4	0.0	0.0	0.0	0.0	16.3	0.0	0.0	0.0	0.0	0.2	44.2	0.0	11.3	0.0	0.0	1.6	0.0	5.3	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.6	0.0	0.0	0.1	40.5	7.1	0.0	0.0	0.4	9.8	15.8	0.0	0.0	0.0	15.0	0.0	0.0	0.7	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	1.1	0.0	0.0	3.2	0.1	0.0	0.0	0.0	0.0	0.0	0.6	0.2	0.3	0.2	0.3	0.2	0.3	0.2	0.0	0.0	0.0	0.0	2.9	0.5	1.3	0.1	0.0	0.4	53.5	0.0	6.8	15.7	0.0	51.9	1.7	15.2	0.0	0.5	58.5	0.0	24.8	5.9	0.7	7.2	5.7	0.0	5.1	0.0	15.6	0.6	0.0	0.0	0.0	0.0	0.0	1.0	40.2	0.0	23.5	42.5	0.0	1.8	0.0	0.0	0.0	0.0	0.4	0.0	57.1	0.0	20.6	43.1
B3GNT4	"B3GN-T4, beta3Gn-T4"	ENSG00000176383	"UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 4"	Q9C0J1	12	122203543-122208952	"Enzymes, Predicted intracellular proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"brain: 16.3;skin 1: 8.5"	"Cell type enhanced"	"Detected in some"	11	"Alveolar cells type 2: 2.6;Proximal tubular cells: 6.1;Spermatogonia: 2.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 8.2;hTCEpi: 9.9;T-47d: 7.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA055261	Uncertain		Approved	Nucleoli,Mitochondria		NA	NA			Mitochondria	Nucleoli	"HPA055261: AB_2682765"	"unprognostic (1.67e-1)"	"unprognostic (1.66e-1)"	"unprognostic (1.27e-1)"	"unprognostic (2.36e-1)"	"unprognostic (1.10e-2)"	"unprognostic (2.60e-2)"	"unprognostic (1.32e-3)"	"unprognostic (1.98e-1)"	"unprognostic (3.44e-2)"	"unprognostic (1.21e-1)"	"unprognostic (3.82e-2)"	"unprognostic (3.69e-1)"	"prognostic unfavorable (3.52e-6)"	"unprognostic (1.24e-1)"	"unprognostic (2.79e-1)"	"unprognostic (8.97e-2)"	"unprognostic (9.47e-2)"	0.7	3.2	7.3	0.8	6.8	4.6	0.8	16.3	9.1	0.5	0.7	0.5	0.0	1.0	0.6	0.7	1.8	1.1	1.1	0.8	4.9	4.0	6.1	0.6	1.1	0.9	1.5	7.3	0.8	0.8	0.8	1.9	0.8	4.0	0.7	0.6	1.0	1.7	0.7	1.1	8.5	1.0	0.6	0.6	1.0	0.7	2.0	0.3	0.0	0.8	0.3	0.8	0.6	0.5	0.8	1.0	0.8	1.7	0.4	1.9	0.4	5.5	1.0	0.4	2.2	0.2	0.1	1.0	0.1	0.0	0.3	0.7	3.5	0.5	0.5	1.0	0.0	0.4	2.0	2.7	2.2	0.2	8.2	2.8	0.2	1.5	0.3	0.6	0.7	1.1	0.7	9.9	0.1	0.5	0.8	0.0	2.0	1.6	0.7	0.2	4.9	0.0	0.7	0.6	0.2	2.0	0.4	0.6	1.0	1.4	0.6	1.4	1.8	1.6	1.0	0.5	0.9	7.6	0.1	0.1	0.5	2.8	0.5	0.3	0.6	5.0	1.2	0.5	0.8	0.3	0.8	0.4	0.2	0.8	0.1	0.4	0.8	1.3	0.2	0.2	0.5	1.9	0.2	0.5	0.4	1.7	1.0	0.6	0.4	7.3	6.8	16.3	8.1	4.9	4.0	1.5	7.3	4.0	0.3	0.0	2.6	0.0	0.7	1.1	0.1	0.4	0.0	1.4	1.2	0.0	0.0	0.4	1.7	1.0	0.2	0.0	0.0	0.0	0.2	0.4	0.2	0.3	0.0	0.0	0.2	0.0	0.0	0.6	0.6	0.0	0.3	0.2	0.0	0.0	0.0	0.3	0.4	0.6	0.0	6.1	0.1	0.0	0.2	0.5	2.6	1.3	0.5	0.5	0.3	0.4
B3GNT5	"B3GN-T5, beta3Gn-T5"	ENSG00000176597	"UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 5"	Q9BYG0	3	183253244-183298504	"Enzymes, Predicted intracellular proteins"		"Developmental protein, Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"intestine: 80.2"	"Cell type enhanced"	"Detected in many"	5	"Ciliated cells: 101.7;Syncytiotrophoblasts: 132.0;Urothelial cells: 125.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in some"	6	"neutrophil: 9.0"	"Lineage enriched"	"Detected in many"	6	"granulocytes: 9.0"	"Cell line enhanced"	"Detected in many"		"GAMG: 30.4;HBEC3-KT: 25.2;hTCEpi: 30.7"	"Region enriched"	"Detected in single"	12	"cerebellum: 16.5"	"Low region specificity"	"Detected in all"			HPA017292	Uncertain		Approved	Nucleoli		NA	NA			Nucleoli		"HPA017292: AB_1845237"	"unprognostic (2.17e-1)"	"unprognostic (5.73e-2)"	"unprognostic (1.07e-2)"	"unprognostic (4.83e-3)"	"unprognostic (1.89e-1)"	"unprognostic (3.08e-2)"	"prognostic unfavorable (5.09e-4)"	"unprognostic (7.10e-3)"	"unprognostic (7.78e-2)"	"unprognostic (8.48e-2)"	"prognostic unfavorable (7.23e-6)"	"unprognostic (4.20e-1)"	"prognostic unfavorable (1.30e-7)"	"unprognostic (1.18e-2)"	"unprognostic (2.71e-1)"	"unprognostic (3.53e-2)"	"unprognostic (8.10e-3)"	8.6	1.4	2.2	6.1	2.3	31.6	4.3	1.2	2.5	6.4	29.8	5.4	2.1	17.5	3.2	5.4	23.5	5.4	10.1	3.3	3.0	2.9	3.5	3.0	11.2	5.1	4.0	0.7	4.2	3.5	1.8	5.1	19.8	4.5	3.9	9.2	3.2	8.7	2.5	6.6	8.0	80.2	2.9	6.3	2.3	5.1	2.9	2.3	1.0	4.6	18.9	8.9	5.0	10.6	0.1	1.1	9.0	1.5	0.0	0.3	0.4	16.1	1.5	8.7	5.3	7.3	21.6	7.9	0.2	0.4	1.7	1.4	3.2	8.5	0.0	1.0	0.0	30.4	7.4	8.9	25.2	1.4	0.0	5.5	0.8	0.7	0.0	9.3	8.1	4.0	10.1	30.7	1.3	23.0	2.3	15.7	0.0	9.2	0.0	13.8	0.0	0.0	2.6	3.6	9.5	14.0	2.5	4.4	0.0	5.3	4.5	0.4	8.3	4.5	0.0	1.9	4.1	0.0	9.9	23.1	0.4	3.4	0.5	3.9	0.0	0.0	0.0	3.3	19.2	8.6	0.0	1.5	1.5	0.0	0.3	0.0	0.1	0.1	0.0	1.1	0.0	0.0	0.0	9.0	0.0	0.0	0.0	0.3	0.4	2.2	2.3	1.2	2.5	3.0	2.9	4.0	0.7	4.5	2.3	6.0	17.4	0.0	55.5	57.9	7.1	2.0	12.7	101.7	27.3	5.2	21.6	24.4	1.7	15.7	9.9	10.0	77.7	0.0	10.5	9.4	7.4	42.6	13.9	0.4	25.3	3.2	36.7	3.1	9.7	19.2	1.4	50.1	11.8	11.8	73.1	3.2	25.3	42.1	0.4	4.3	12.7	0.0	3.4	0.9	0.4	74.2	132.0	0.7	26.9	125.2
B3GNT6	B3Gn-T6	ENSG00000198488	"UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 6"	Q6ZMB0	11	77034398-77041973	"Enzymes, Predicted intracellular proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"intestine: 15.8;lymphoid tissue: 17.5;stomach 1: 17.9"	"Cell type enriched"	"Detected in some"	38	"Mucus-secreting cells: 60.5"	"Group enriched"	"Detected in some"	14	"colorectal cancer: 6.3;lung cancer: 3.9;pancreatic cancer: 5.1;prostate cancer: 5.0;stomach cancer: 4.7"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"basophil: 2.3;neutrophil: 2.2"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"MCF7: 2.0;RPMI-8226: 1.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA039805	Enhanced				"Intracellular and membrane"	NA	NA					"HPA039805: AB_2676690"		"unprognostic (1.71e-1)"	"prognostic favorable (2.31e-4)"	"unprognostic (4.79e-2)"	"unprognostic (5.42e-2)"	"unprognostic (7.64e-2)"		"unprognostic (1.95e-1)"		"unprognostic (2.72e-1)"	"unprognostic (1.23e-2)"	"unprognostic (7.77e-2)"		"unprognostic (2.19e-1)"		"unprognostic (9.30e-2)"	"unprognostic (1.71e-1)"	0.2	0.2	0.3	6.6	0.4	0.0	0.2	0.3	0.4	0.5	15.8	0.0	0.0	3.7	0.2	0.0	2.5	0.2	0.9	0.2	0.3	0.3	0.2	0.2	1.4	0.0	0.3	0.0	0.2	0.2	0.0	0.2	0.0	0.0	0.3	12.4	0.0	1.6	0.0	0.2	0.2	9.4	0.0	0.2	0.2	17.9	0.6	0.0	0.0	0.2	3.4	17.5	0.2	0.3	0.4	0.3	2.3	0.2	0.8	0.5	0.2	0.1	0.0	0.5	0.5	0.0	0.2	0.2	0.1	0.2	0.5	0.1	1.2	0.2	0.7	0.3	0.0	0.5	0.0	0.1	0.6	0.1	0.4	0.2	0.2	0.1	0.2	0.0	0.6	0.2	0.5	0.5	0.0	0.0	0.0	0.0	0.0	0.2	0.7	0.0	2.0	0.2	0.5	0.7	0.0	0.0	0.0	0.1	1.5	0.0	0.3	0.3	0.4	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.1	0.2	0.1	0.3	0.4	0.5	0.3	0.1	0.2	0.2	2.3	0.2	0.3	0.4	0.2	0.5	0.2	0.2	0.2	0.0	0.4	0.3	0.3	2.2	0.8	0.0	0.3	0.1	0.2	0.3	0.4	0.3	0.4	0.3	0.3	0.3	0.0	0.0	0.0	0.0	0.3	0.0	0.5	0.0	0.0	0.4	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	60.5	0.0	0.9	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.8	0.1
B4GALNT1	"beta1-4GalNAc-T, GALGT, SPG26"	ENSG00000135454	"Beta-1,4-N-acetyl-galactosaminyltransferase 1"	Q00973	12	57623410-57633355	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Lipid metabolism, Sphingolipid metabolism"	"Glycosyltransferase, Transferase"	"Disease mutation, Hereditary spastic paraplegia, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 32.4"	"Cell type enhanced"	"Detected in some"	16	"Bipolar cells: 8.1;Horizontal cells: 20.6;Sertoli cells: 6.5;Smooth muscle cells: 6.6"	"Cancer enriched"	"Detected in many"	6	"glioma: 10.8"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"gdT-cell: 1.9"	"Lineage enhanced"	"Detected in single"		"T-cells: 1.9"	"Cell line enhanced"	"Detected in many"		"EFO-21: 22.0;HDLM-2: 18.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA008968	Enhanced				"Intracellular and membrane"	NA	NA		9500			"HPA008968: AB_1078253"	"unprognostic (3.18e-1)"	"unprognostic (8.34e-2)"	"unprognostic (2.05e-2)"	"unprognostic (3.33e-3)"	"unprognostic (2.54e-1)"	"unprognostic (2.70e-3)"	"unprognostic (3.73e-5)"	"unprognostic (1.26e-2)"	"unprognostic (1.72e-1)"	"unprognostic (2.66e-1)"	"unprognostic (2.00e-1)"	"unprognostic (1.67e-1)"	"prognostic unfavorable (3.18e-14)"	"unprognostic (2.52e-2)"	"unprognostic (1.81e-1)"	"unprognostic (1.44e-2)"	"unprognostic (4.92e-4)"	3.0	2.1	12.9	2.3	16.4	1.0	1.5	26.5	32.4	1.9	2.4	1.0	0.0	1.4	2.2	3.8	1.3	1.4	1.5	3.9	15.3	11.2	1.3	1.3	1.7	1.6	6.5	14.3	1.0	1.2	1.1	1.0	1.3	11.6	4.2	2.2	1.6	3.2	6.8	8.1	1.6	1.9	3.2	2.3	1.3	1.4	1.6	2.3	0.0	1.3	0.6	1.8	1.5	0.9	0.0	0.0	0.0	0.0	0.8	1.9	0.0	2.8	14.7	3.2	5.7	0.2	0.0	0.0	1.4	3.0	6.0	6.4	0.9	7.7	0.8	22.0	4.1	13.6	1.4	2.5	1.1	2.0	18.7	0.9	0.2	3.7	4.8	0.2	0.7	1.4	0.0	0.4	3.6	0.2	2.4	0.1	3.3	2.3	4.6	1.0	3.8	0.6	0.0	3.8	0.3	2.9	0.0	4.4	2.3	0.0	0.0	12.3	3.1	0.8	0.4	0.1	0.2	2.7	1.0	0.0	3.6	8.3	6.9	9.1	11.5	8.6	0.8	8.1	0.9	9.6	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.8	0.0	0.0	0.0	0.0	12.9	16.4	26.5	25.9	15.3	11.2	6.5	14.3	11.6	2.3	0.0	0.0	0.0	0.0	0.3	8.1	4.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.4	0.1	0.0	0.0	0.2	0.2	1.1	0.1	0.0	0.0	0.1	20.6	0.0	0.0	0.0	0.4	2.6	0.0	3.3	4.6	0.0	0.8	0.6	0.0	2.8	0.0	1.9	6.5	6.6	0.3	0.9	0.0	0.0	0.0	0.0	0.1
B4GALNT3	"B4GalNac-T3, FLJ16224, FLJ40362"	ENSG00000139044	"Beta-1,4-N-acetyl-galactosaminyltransferase 3"	Q6L9W6	12	460364-563509	"Enzymes, Predicted intracellular proteins"		Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"stomach 1: 43.1"	"Cell type enhanced"	"Detected in many"	9	"Enterocytes: 46.6;Late spermatids: 64.3;Paneth cells: 36.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in single"		"MAIT T-cell: 1.4"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"BEWO: 26.2;HDLM-2: 9.2;HEK 293: 9.2;NTERA-2: 11.6;U-937: 11.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA011404	Enhanced		Supported	"Golgi apparatus,Vesicles"	"Intracellular and membrane"	NA	NA			"Golgi apparatus"	Vesicles	"HPA011404: AB_1845242"	"unprognostic (2.38e-2)"	"unprognostic (9.59e-3)"	"unprognostic (1.38e-1)"	"prognostic favorable (1.69e-10)"	"unprognostic (4.22e-2)"	"unprognostic (4.63e-2)"	"unprognostic (1.46e-2)"	"unprognostic (9.53e-3)"	"unprognostic (3.29e-1)"	"unprognostic (1.61e-1)"	"unprognostic (1.23e-1)"	"unprognostic (1.02e-1)"	"unprognostic (5.46e-2)"	"unprognostic (9.99e-3)"	"unprognostic (2.82e-1)"	"unprognostic (2.48e-2)"	"unprognostic (2.98e-1)"	0.3	5.7	1.4	2.1	3.8	1.5	1.1	0.3	8.2	6.1	12.8	0.6	0.4	0.8	8.5	2.9	6.0	3.4	9.6	16.8	5.6	0.9	4.1	0.3	6.2	0.2	0.9	1.7	2.1	7.9	2.5	14.7	0.1	2.0	1.6	9.8	1.5	3.8	1.1	2.7	11.0	1.7	1.9	0.5	0.4	43.1	8.0	0.1	1.0	2.1	9.1	4.1	1.8	4.0	0.0	0.0	0.7	0.1	0.0	1.4	0.0	0.0	0.0	0.2	0.9	0.0	0.0	26.2	0.0	0.0	0.0	0.0	6.5	5.0	0.0	0.7	0.0	0.5	2.9	6.5	0.7	0.0	9.2	9.2	0.0	0.0	1.3	0.0	0.1	3.9	0.0	4.6	0.0	0.0	0.1	0.0	1.0	0.0	0.0	0.0	0.3	0.0	0.0	11.6	7.9	0.5	0.4	3.6	0.0	6.3	5.5	3.1	2.0	0.6	0.2	0.7	4.2	0.6	2.0	0.0	0.0	2.0	0.2	0.6	0.0	0.1	0.1	0.0	11.3	4.4	0.0	0.1	0.0	0.0	0.0	1.4	0.0	0.1	0.5	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	1.4	3.8	0.3	8.2	5.6	0.9	0.9	1.7	2.0	0.1	0.0	6.5	0.0	4.8	6.6	0.0	11.8	2.5	6.7	5.7	8.7	0.0	0.0	0.0	8.9	25.7	0.0	46.6	0.0	4.2	0.1	0.6	8.9	0.0	0.0	0.6	0.0	9.9	0.0	0.0	64.3	0.0	0.0	0.0	1.0	18.8	0.0	12.7	36.2	0.0	0.0	0.0	0.0	0.9	1.9	1.4	15.2	0.0	1.7	20.2	13.6
B4GALNT4	"FLJ25045, NGalNAc-T1"	ENSG00000182272	"Beta-1,4-N-acetyl-galactosaminyltransferase 4"	Q76KP1	11	369796-382116	"Enzymes, Predicted intracellular proteins"		Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 35.1;ovary: 18.6"	"Cell type enhanced"	"Detected in some"	16	"Bipolar cells: 17.5;Cardiomyocytes: 11.2;Horizontal cells: 31.8;Muller glia cells: 40.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AF22: 20.2;NTERA-2: 18.0;SCLC-21H: 22.4;SH-SY5Y: 27.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043276, HPA053126"	Uncertain		Uncertain	Nucleoplasm,Vesicles,Cytosol	"Intracellular and membrane"	NA	No			"Nucleoplasm, Cytosol"	Vesicles	"HPA043276: , HPA053126: AB_2682049"	"unprognostic (6.11e-2)"	"unprognostic (7.82e-2)"	"unprognostic (1.79e-1)"	"unprognostic (6.92e-3)"	"unprognostic (5.36e-2)"	"unprognostic (1.57e-1)"	"unprognostic (1.45e-1)"	"unprognostic (2.72e-2)"	"unprognostic (1.33e-1)"	"unprognostic (1.53e-1)"	"unprognostic (1.69e-3)"	"unprognostic (4.99e-3)"	"unprognostic (1.52e-10)"	"unprognostic (9.01e-2)"	"unprognostic (2.56e-1)"	"unprognostic (2.92e-4)"	"unprognostic (1.25e-1)"	1.6	2.5	20.6	2.8	16.7	1.2	3.5	26.5	35.1	5.9	2.0	8.6	0.8	2.4	8.6	2.4	1.8	8.7	2.1	1.4	17.6	16.8	1.2	1.1	1.3	1.6	11.5	14.9	18.6	1.8	6.3	6.1	1.1	13.0	3.8	1.6	2.3	4.0	3.7	1.1	3.8	2.9	3.1	8.3	1.5	1.5	1.8	11.0	0.0	1.1	0.0	1.7	1.3	1.9	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	2.6	20.2	11.5	0.0	0.0	4.7	3.6	0.9	1.6	0.5	2.0	0.0	0.0	2.7	0.4	3.2	0.7	2.7	4.8	0.5	0.0	6.8	0.0	6.4	6.2	0.2	0.0	4.9	0.4	2.9	0.1	2.2	7.3	0.2	1.0	6.1	0.0	0.0	5.9	0.2	0.0	18.0	0.3	7.9	0.0	0.0	2.6	0.2	0.0	22.4	27.3	1.3	1.0	0.2	2.2	7.9	0.0	4.9	1.1	6.4	1.9	0.2	0.0	0.9	0.0	0.0	0.0	3.3	0.0	0.0	0.0	0.4	0.0	0.3	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	20.6	16.7	26.5	21.2	17.6	16.8	11.5	14.9	13.0	11.0	0.0	0.0	0.0	1.3	0.7	17.5	11.2	0.0	0.0	0.0	1.8	3.9	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.7	0.0	0.0	0.2	31.8	1.7	0.0	0.0	0.0	2.8	0.0	3.3	0.0	0.0	40.9	0.3	0.0	1.1	0.0	8.1	0.0	0.2	0.0	0.2	0.3	0.2	0.0	0.0	0.4
B4GALT1	"beta4Gal-T1, GGTB2"	ENSG00000086062	"Beta-1,4-galactosyltransferase 1"	P15291	9	33104082-33167356	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted membrane proteins"		"Glycosyltransferase, Transferase"	"Congenital disorder of glycosylation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"plasmacytoid DC: 56.4"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HDLM-2: 56.9;SiHa: 107.2"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"HPA010806, HPA010807"	Enhanced		Enhanced	"Golgi apparatus"	"Intracellular and membrane"	NA	NA		98000000	"Golgi apparatus"		"HPA010806: AB_1078255, HPA010807: AB_1078254"	"unprognostic (7.57e-2)"	"unprognostic (1.24e-2)"	"unprognostic (2.09e-1)"	"prognostic favorable (6.85e-7)"	"unprognostic (1.83e-2)"	"unprognostic (9.94e-2)"	"unprognostic (3.08e-2)"	"prognostic unfavorable (1.25e-4)"	"unprognostic (1.07e-1)"	"unprognostic (5.45e-2)"	"unprognostic (1.68e-3)"	"unprognostic (2.78e-1)"	"unprognostic (7.93e-3)"	"unprognostic (4.98e-2)"	"unprognostic (3.91e-2)"	"unprognostic (7.07e-2)"	"unprognostic (3.46e-2)"	32.0	19.5	4.5	22.5	4.5	22.1	35.1	5.9	3.5	25.4	20.4	6.4	29.1	6.5	19.5	34.1	24.7	26.3	24.2	33.1	3.2	2.5	31.7	91.2	34.9	44.9	5.8	2.2	56.8	20.1	30.2	11.9	79.0	5.9	22.6	11.1	32.1	39.1	42.7	15.0	17.6	18.9	17.7	6.4	38.5	19.9	37.6	3.6	23.1	39.3	16.9	41.0	26.4	21.6	24.8	56.4	24.9	9.1	18.2	16.5	5.4	16.2	12.0	2.2	3.1	11.4	20.2	40.7	17.0	21.3	10.3	10.2	7.3	19.0	6.2	10.8	24.7	13.3	8.8	2.3	21.0	10.3	56.9	2.3	3.5	50.2	5.6	22.5	2.9	6.0	22.5	37.7	11.7	14.3	22.2	10.9	1.9	4.0	7.8	9.7	14.2	2.6	5.8	1.3	9.0	3.7	3.4	2.1	4.1	30.7	14.2	1.7	2.1	107.2	20.9	4.2	7.3	26.4	5.3	10.0	7.3	8.7	23.5	6.6	1.3	2.8	3.9	22.8	4.0	2.7	6.2	9.1	5.0	13.0	7.8	16.5	24.8	8.7	11.4	6.1	20.7	5.3	6.7	24.9	18.2	6.0	56.4	5.7	5.4	4.5	4.5	5.9	3.5	3.2	2.5	5.8	2.2	5.9	3.6	80.4	65.7	101.3	48.3	125.9	1.4	29.7	86.6	26.8	59.1	158.7	19.6	74.7	13.3	63.1	9.2	49.6	45.8	23.3	110.1	134.4	71.0	89.2	36.8	170.8	48.5	0.0	8.1	90.9	71.6	5.1	46.9	58.9	91.1	22.6	42.2	7.2	120.8	32.3	41.8	46.1	39.5	51.8	65.3	4.8	13.4	94.7	145.4	44.5	21.7	74.5
B4GALT2	beta4Gal-T2	ENSG00000117411	"Beta-1,4-galactosyltransferase 2"	O60909	1	43978943-43991170	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007620, HPA047739"	Supported		Supported	"Golgi apparatus,Vesicles"		NA	NA		12000	"Golgi apparatus, Vesicles"		"HPA007620: AB_2667879, HPA047739: AB_2680141"	"unprognostic (1.11e-1)"	"unprognostic (1.82e-1)"	"unprognostic (1.15e-1)"	"unprognostic (7.59e-2)"	"unprognostic (1.19e-1)"	"unprognostic (2.35e-1)"	"prognostic unfavorable (2.96e-5)"	"unprognostic (1.12e-2)"	"unprognostic (1.45e-1)"	"unprognostic (2.08e-2)"	"unprognostic (4.23e-3)"	"unprognostic (7.58e-2)"	"prognostic unfavorable (3.62e-5)"	"unprognostic (6.54e-2)"	"unprognostic (1.52e-1)"	"unprognostic (7.66e-2)"	"unprognostic (3.12e-3)"	18.6	8.6	34.5	10.1	22.4	4.6	15.6	8.1	35.7	18.4	16.1	16.1	10.7	9.4	13.3	8.5	20.2	11.4	11.9	23.3	25.3	18.9	8.4	24.2	7.7	4.4	18.9	15.6	15.3	39.5	9.9	10.6	9.9	12.7	13.5	10.4	8.7	21.4	21.5	41.0	19.5	9.4	21.3	16.1	5.2	11.2	11.4	11.3	1.9	9.0	12.1	10.1	16.5	11.7	1.7	0.4	0.1	0.6	0.2	2.6	0.7	20.1	14.7	15.3	26.1	20.9	18.7	15.4	22.8	18.8	18.2	16.7	9.7	17.7	13.2	11.7	36.4	16.7	14.0	13.7	23.3	8.5	13.3	26.0	8.8	10.2	22.1	16.9	8.4	0.3	16.3	27.3	13.0	26.7	19.2	21.0	5.3	16.6	8.6	14.2	14.5	4.4	8.4	21.4	14.4	18.4	15.7	20.6	20.7	12.9	9.4	27.9	23.2	10.0	31.6	15.3	8.0	13.7	10.0	16.5	31.7	40.6	21.9	25.4	3.1	6.0	5.6	14.2	6.4	21.1	0.0	0.2	0.0	2.6	0.6	2.4	1.7	1.2	2.2	0.4	0.5	0.0	2.0	0.1	0.2	0.1	0.2	1.1	0.7	34.5	22.4	8.1	35.7	25.3	18.9	18.9	15.6	12.7	11.3	0.0	12.0	0.8	8.4	6.9	13.5	12.2	7.6	2.7	4.5	14.0	3.9	1.6	1.7	12.6	14.0	7.4	5.8	0.0	17.4	6.6	10.6	10.5	0.0	17.8	2.1	17.5	15.6	4.3	0.6	5.4	15.3	1.8	3.3	2.8	19.7	7.5	21.8	7.0	11.7	8.6	12.0	6.5	6.1	3.5	13.0	11.0	0.5	1.3	13.3	14.9
B4GALT3	beta4Gal-T3	ENSG00000158850	"Beta-1,4-galactosyltransferase 3"	O60512	1	161171310-161177968	"Enzymes, Predicted intracellular proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Syncytiotrophoblasts: 95.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"U-266/70: 74.9"	"Low region specificity"	"Detected in all"							HPA010793	Approved		Supported	"Golgi apparatus,Cytosol"		NA	NA		74000	"Golgi apparatus"	Cytosol	"HPA010793: AB_1078256"	"unprognostic (5.67e-3)"	"unprognostic (7.68e-3)"	"unprognostic (1.20e-2)"	"unprognostic (8.15e-3)"	"unprognostic (3.91e-1)"	"unprognostic (1.10e-2)"	"prognostic unfavorable (5.87e-5)"	"unprognostic (3.11e-2)"	"unprognostic (3.13e-1)"	"unprognostic (4.64e-2)"	"unprognostic (1.41e-1)"	"unprognostic (3.69e-1)"	"prognostic unfavorable (7.12e-7)"	"unprognostic (1.86e-1)"	"unprognostic (1.56e-1)"	"unprognostic (1.66e-1)"	"unprognostic (1.38e-1)"	20.7	18.7	16.5	17.2	22.1	17.3	33.4	20.1	23.2	15.0	19.0	12.4	22.2	18.4	13.6	21.0	20.4	17.2	17.5	17.2	13.4	14.7	22.5	21.7	20.8	21.6	16.4	13.4	25.4	37.5	15.8	29.1	41.0	16.6	18.5	19.3	14.8	33.0	27.8	19.5	20.2	15.1	11.7	14.1	26.6	21.5	28.4	16.4	14.8	28.2	10.7	21.4	20.6	22.9	16.7	22.6	7.1	12.6	15.1	25.5	11.9	9.9	6.6	9.8	12.9	14.6	7.5	15.7	5.7	10.2	11.8	10.9	13.0	20.4	9.2	16.3	6.4	11.3	10.2	10.3	6.3	7.0	9.6	12.6	5.3	4.4	10.4	10.5	10.3	14.8	10.4	9.4	10.9	11.9	14.2	13.4	12.1	17.0	20.8	9.6	10.3	6.7	9.9	12.3	20.1	14.1	8.2	5.5	22.7	10.1	6.2	14.0	16.6	5.7	15.1	11.9	13.9	15.1	18.9	5.6	5.9	10.7	6.7	16.6	74.9	40.4	12.3	8.8	8.9	9.4	5.1	8.9	7.1	17.6	10.1	15.7	16.7	16.7	16.8	10.8	13.5	16.4	15.4	5.9	15.1	12.6	22.6	25.5	11.9	16.5	22.1	20.1	23.2	13.4	14.7	16.4	13.4	16.6	16.4	17.9	18.3	36.5	26.3	34.2	12.6	9.5	7.6	10.7	6.8	24.4	2.0	38.4	5.0	25.4	7.0	20.2	14.7	0.0	19.9	75.2	19.5	33.5	9.2	11.6	25.2	25.4	27.6	26.4	16.8	4.0	8.9	13.8	21.9	6.4	22.4	7.4	28.1	14.4	6.7	17.3	6.3	25.8	34.6	9.8	42.9	36.6	95.5	34.6	21.7	45.5
B4GALT4	beta4Gal-T4	ENSG00000121578	"Beta-1,4-galactosyltransferase 4"	O60513	3	119211732-119241103	"Enzymes, Predicted intracellular proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Extravillous trophoblasts: 111.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"BJ: 38.8"	"Low region specificity"	"Detected in all"							"HPA046819, HPA063546"	Approved		Supported	"Golgi apparatus"	"Intracellular and membrane"	NA	NA			"Golgi apparatus"		"HPA046819: AB_2679824, HPA063546: AB_2685036"	"unprognostic (4.07e-2)"	"unprognostic (1.78e-2)"	"unprognostic (3.27e-2)"	"unprognostic (1.14e-3)"	"unprognostic (4.59e-2)"	"unprognostic (1.20e-1)"	"prognostic unfavorable (4.04e-4)"	"unprognostic (6.30e-2)"	"unprognostic (1.20e-1)"	"unprognostic (3.58e-1)"	"unprognostic (6.10e-3)"	"unprognostic (2.26e-2)"	"unprognostic (2.76e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.18e-1)"	"unprognostic (2.37e-1)"	"unprognostic (1.11e-1)"	9.6	7.7	7.0	8.6	8.5	11.6	8.8	5.3	6.6	10.1	20.8	8.2	12.6	14.6	15.1	43.4	13.2	12.6	21.3	11.1	6.0	6.2	15.0	11.8	8.9	8.0	7.7	7.3	13.5	20.8	8.5	16.2	23.7	9.1	9.4	17.9	10.2	10.1	16.1	4.8	10.9	40.4	11.3	9.3	8.2	16.8	5.8	6.5	8.5	10.8	6.5	11.4	13.0	8.7	3.7	4.7	11.2	4.6	11.7	12.2	4.8	17.6	34.3	4.0	2.8	12.5	10.4	20.4	38.8	17.2	18.1	18.2	20.2	5.7	3.8	8.1	20.3	10.9	24.3	6.8	5.2	18.3	7.5	2.3	5.2	5.8	10.7	8.6	3.1	4.7	7.5	7.3	7.7	6.2	6.9	1.7	2.8	3.6	4.0	7.4	6.7	1.4	2.7	5.2	10.2	9.3	1.4	3.7	1.5	9.9	19.4	3.5	8.2	9.3	4.1	8.4	9.0	8.9	1.4	1.2	8.6	7.9	4.3	4.3	8.9	7.0	5.0	7.2	2.9	7.1	11.2	3.7	6.8	12.2	4.6	6.9	3.7	6.0	6.4	4.7	2.9	11.3	6.8	2.2	11.7	4.0	3.1	2.3	4.8	7.0	8.5	5.3	6.6	6.0	6.2	7.7	7.3	9.1	6.5	0.0	6.5	17.8	18.3	9.5	10.5	7.7	40.8	30.8	18.2	7.0	3.9	30.1	1.7	26.8	0.9	8.3	39.8	0.0	29.7	111.2	24.4	21.4	12.7	9.0	12.7	17.5	13.3	4.3	7.5	1.7	13.8	10.8	13.5	13.6	76.6	21.5	28.0	42.1	26.5	21.6	9.4	19.4	12.7	1.6	10.5	9.3	43.7	14.6	21.7	68.6
B4GALT6	beta4GalT-VI	ENSG00000118276	"Beta-1,4-galactosyltransferase 6"	Q9UBX8	18	31622247-31685836	"Enzymes, Predicted intracellular proteins"	"Lipid biosynthesis, Lipid metabolism, Sphingolipid metabolism"	"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 22.3"	"Group enriched"	"Detected in many"	4	"Bipolar cells: 67.0;Cone photoreceptor cells: 37.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"NK-cell: 3.8"	"Group enriched"	"Detected in many"	5	"NK-cells: 3.8;T-cells: 1.1"	"Cell line enhanced"	"Detected in many"		"WM-115: 51.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB020701, HPA058284"	Approved				"Intracellular and membrane"	NA	NA					"CAB020701: , HPA058284: AB_2683668"	"unprognostic (3.79e-1)"	"unprognostic (4.52e-1)"	"unprognostic (6.54e-3)"	"unprognostic (2.23e-4)"	"unprognostic (1.05e-1)"	"unprognostic (1.42e-1)"	"unprognostic (1.31e-2)"	"unprognostic (4.50e-2)"	"unprognostic (5.18e-1)"	"unprognostic (1.13e-1)"	"prognostic favorable (5.65e-4)"	"unprognostic (2.77e-1)"	"prognostic favorable (6.40e-5)"	"unprognostic (5.37e-1)"	"unprognostic (1.52e-1)"	"unprognostic (1.10e-2)"	"unprognostic (4.00e-1)"	3.6	13.8	7.8	2.8	16.0	4.4	2.1	20.6	22.3	2.2	3.5	2.6	0.0	7.7	2.5	2.2	4.8	2.5	7.2	3.8	10.7	7.9	3.7	2.7	1.8	1.2	6.1	10.0	4.3	2.1	7.3	14.8	2.7	16.3	5.8	3.6	13.2	4.6	4.4	3.3	2.2	9.7	1.7	3.1	1.5	3.4	5.4	2.3	5.0	2.1	1.5	1.0	3.6	2.1	0.0	0.5	0.0	0.4	3.8	1.1	0.3	2.3	5.4	9.7	5.4	0.1	0.2	3.6	0.7	0.0	0.1	0.0	10.0	2.0	3.7	4.5	0.9	11.7	0.9	5.1	4.3	0.6	14.5	4.5	4.8	0.5	0.2	1.1	8.8	0.8	1.0	0.9	1.4	3.1	4.9	5.3	8.8	0.7	0.0	0.0	1.4	9.8	0.6	4.2	2.8	2.9	18.4	1.7	0.0	1.1	4.9	5.1	8.1	3.5	0.6	6.3	8.2	0.6	2.7	5.3	11.0	2.3	0.0	5.9	3.6	0.2	7.6	4.5	8.0	51.0	0.0	0.1	0.0	0.9	0.1	0.0	0.0	0.1	0.9	0.5	0.0	0.0	1.1	0.0	3.8	0.4	0.0	0.0	0.3	7.8	16.0	20.6	22.3	10.7	7.9	6.1	10.0	16.3	2.3	0.0	0.3	0.0	0.7	4.8	67.0	6.7	0.0	0.0	1.2	1.8	37.3	0.4	3.3	1.3	3.6	2.3	3.1	0.0	1.0	0.2	1.7	1.5	0.0	1.7	0.6	12.7	2.9	3.7	0.8	3.3	1.1	0.0	0.0	0.0	2.6	3.3	1.7	2.5	2.5	1.1	4.7	0.0	0.9	0.5	10.2	1.5	0.2	0.5	2.9	0.6
B4GALT7	"beta4Gal-T7, XGALT-1"	ENSG00000027847	"Beta-1,4-galactosyltransferase 7"	Q9UBV7	5	177600100-177610347	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		"Glycosyltransferase, Transferase"	"Disease mutation, Dwarfism, Ehlers-Danlos syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"Extravillous trophoblasts: 110.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042330	Supported					NA	NA					"HPA042330: AB_10796576"	"unprognostic (1.19e-1)"	"unprognostic (1.82e-1)"	"unprognostic (3.12e-1)"	"unprognostic (5.97e-2)"	"prognostic unfavorable (2.29e-4)"	"unprognostic (9.53e-2)"	"unprognostic (4.19e-3)"	"unprognostic (3.86e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.21e-1)"	"unprognostic (1.82e-3)"	"unprognostic (2.00e-2)"	"unprognostic (4.81e-2)"	"unprognostic (2.39e-1)"	"unprognostic (4.44e-2)"	"unprognostic (2.90e-1)"	"unprognostic (4.00e-2)"	13.8	33.0	16.0	20.4	14.3	20.7	19.1	10.6	19.6	13.3	12.4	14.9	20.4	16.1	15.5	15.9	11.7	13.3	20.3	17.3	13.7	18.0	16.2	21.3	12.0	21.5	15.1	17.9	16.9	37.0	15.5	23.9	15.3	14.3	16.4	11.7	14.7	22.4	20.9	14.4	12.9	13.7	12.2	10.8	16.3	16.2	16.1	11.7	10.4	16.7	9.8	18.6	13.0	10.2	15.8	16.3	11.2	16.1	8.5	12.5	9.0	8.5	15.2	6.4	16.0	12.8	9.6	28.9	13.4	14.2	12.2	14.0	14.3	13.7	11.1	24.7	13.6	21.4	10.2	4.4	28.6	5.3	36.9	11.6	5.8	11.9	10.0	18.6	6.0	10.2	14.7	10.2	13.1	10.7	11.2	13.5	7.5	5.0	10.7	12.3	20.0	5.1	7.4	6.2	7.7	22.4	10.4	4.6	12.1	9.2	13.1	5.7	6.5	6.6	13.5	11.7	5.3	8.7	7.1	10.4	15.6	9.0	10.2	13.2	13.4	6.2	7.8	13.2	14.5	14.1	11.2	14.6	7.8	12.5	16.1	11.3	12.8	11.6	11.0	16.3	15.8	10.5	10.3	1.0	8.5	15.3	12.8	7.5	9.0	16.0	14.3	10.6	19.6	13.7	18.0	15.1	17.9	14.3	11.7	3.0	6.4	14.9	14.1	6.0	11.8	5.9	10.2	5.3	10.3	15.7	3.9	37.3	6.6	28.8	12.3	11.3	13.7	0.0	34.1	110.0	18.1	23.5	10.3	13.9	28.4	11.1	13.9	10.4	8.8	7.8	13.0	10.6	20.3	33.3	19.6	12.2	26.0	10.5	17.3	15.8	15.1	0.0	11.4	13.0	12.4	7.8	36.7	10.1	20.9	13.9
BAAT	BAT	ENSG00000136881	"Bile acid-CoA:amino acid N-acyltransferase"	Q14032	9	101360417-101383519	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Fatty acid metabolism, Lipid metabolism"	"Acyltransferase, Hydrolase, Serine esterase, Transferase"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	6	"liver: 128.4"	"Cell type enriched"	"Detected in some"	8	"Hepatocytes: 745.7"	"Cancer enriched"	"Detected in many"	42	"liver cancer: 181.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A549: 6.1;CACO-2: 3.4;Hep G2: 2.4;OE19: 2.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA021251, HPA021330"	Enhanced		Uncertain	Vesicles		NA	NA		470000	Vesicles		"HPA021251: AB_1845247, HPA021330: AB_2670674"	"unprognostic (2.53e-2)"	"unprognostic (1.81e-1)"	"unprognostic (9.97e-2)"	"unprognostic (9.33e-2)"	"unprognostic (7.75e-3)"	"unprognostic (4.68e-2)"	"prognostic favorable (4.97e-4)"	"unprognostic (2.14e-2)"	"unprognostic (6.19e-2)"	"unprognostic (4.43e-4)"	"unprognostic (3.65e-1)"	"unprognostic (2.15e-1)"	"prognostic unfavorable (4.24e-7)"	"unprognostic (1.74e-1)"	"unprognostic (2.12e-1)"	"unprognostic (2.17e-2)"	"unprognostic (1.75e-1)"	0.0	0.0	0.1	0.0	0.2	0.1	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	22.8	0.0	0.1	0.1	0.2	128.4	0.2	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.3	0.2	0.0	0.7	0.1	0.1	6.1	0.4	0.3	0.0	0.0	0.0	0.3	0.1	0.1	0.3	3.4	0.1	0.6	0.2	0.0	0.3	0.3	0.1	0.2	0.5	0.3	0.1	0.5	0.2	2.4	0.0	0.9	0.3	0.0	1.0	0.1	0.0	0.1	0.0	0.8	0.7	0.4	0.5	0.1	0.2	0.3	1.0	2.6	0.7	0.2	1.1	0.2	0.6	0.2	0.3	0.4	0.4	0.2	0.5	0.2	0.0	0.2	0.1	0.6	0.6	0.2	0.4	0.4	0.6	0.5	0.5	0.2	0.6	0.3	0.2	0.0	0.7	0.1	0.1	0.5	0.1	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.2	0.1	0.2	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	11.5	0.0	0.0	0.8	0.4	89.2	0.0	0.0	0.0	0.0	0.0	0.0	8.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	745.7	0.0	0.0	0.0	11.1	12.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0
BACE1	BACE	ENSG00000186318	"Beta-secretase 1"	P56817	11	117285207-117316259	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins, Transporters"		"Aspartyl protease, Hydrolase, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	8	"brain: 53.0;pancreas: 161.1"	"Cell type enhanced"	"Detected in many"	12	"Cone photoreceptor cells: 111.9;Early spermatids: 89.1;Late spermatids: 222.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"fHDF/TERT166: 38.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB016358	Approved		Supported	"Plasma membrane"		NA	NA			"Plasma membrane"		"CAB016358: AB_626716"	"unprognostic (7.96e-3)"	"unprognostic (8.05e-2)"	"unprognostic (3.55e-2)"	"unprognostic (3.05e-3)"	"unprognostic (8.94e-2)"	"unprognostic (3.39e-1)"	"unprognostic (1.03e-1)"	"unprognostic (2.60e-1)"	"unprognostic (4.54e-2)"	"unprognostic (8.04e-2)"	"unprognostic (8.09e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.12e-1)"	"unprognostic (1.35e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.27e-1)"	"prognostic unfavorable (6.76e-4)"	6.5	7.1	12.1	3.8	18.8	2.2	5.5	9.6	22.4	9.8	4.6	42.5	2.7	3.4	9.3	5.6	7.6	8.6	9.1	5.9	16.9	12.4	6.8	12.1	7.3	2.8	28.8	15.0	11.4	161.1	12.8	4.2	6.3	26.4	6.5	4.7	6.9	5.3	9.9	6.2	7.2	3.6	11.7	53.0	5.7	4.9	4.1	21.4	0.0	6.3	2.3	2.8	6.7	5.5	4.0	2.2	0.7	3.2	2.2	6.7	1.1	3.9	4.7	9.7	14.8	32.2	34.7	0.4	21.3	18.6	10.4	8.5	3.6	6.3	0.8	5.2	38.6	7.8	6.9	10.3	6.1	8.5	2.3	5.5	2.4	7.9	4.3	15.9	0.8	0.5	30.0	9.6	13.2	12.9	25.7	8.9	1.4	0.8	0.4	19.0	14.3	0.6	1.9	6.3	4.1	10.4	1.8	4.4	0.8	4.4	2.2	12.6	14.1	7.9	1.0	2.3	8.9	10.2	2.7	12.2	18.7	2.0	19.5	6.8	0.3	0.3	0.4	8.8	1.2	13.0	0.6	2.0	0.7	2.0	3.2	5.2	4.0	6.7	5.3	2.2	1.8	3.1	2.7	0.0	2.2	1.3	1.3	6.3	1.1	12.1	18.8	9.6	21.7	16.9	12.4	28.8	15.0	26.4	21.4	17.9	8.5	0.0	3.8	4.1	53.4	8.1	17.8	4.0	20.5	5.2	111.9	0.8	5.0	4.7	89.1	5.2	1.5	0.0	17.3	0.9	11.5	2.8	2.3	31.6	7.9	54.0	20.8	6.7	12.6	222.6	17.8	5.8	3.3	1.8	2.4	16.6	5.8	4.0	20.8	5.4	48.1	6.5	6.6	3.2	1.7	3.0	0.7	1.0	2.7	2.5
BACE2	"AEPLC, ALP56, CEAP1, DRAP"	ENSG00000182240	"Beta-site APP-cleaving enzyme 2"	Q9Y5Z0	21	41167801-41282518	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins, Transporters"		"Aspartyl protease, Hydrolase, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	9	"Glandular cells: 265.1;Syncytiotrophoblasts: 430.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	6	"basophil: 4.8;eosinophil: 8.4"	"Lineage enriched"	"Detected in many"	8	"granulocytes: 8.4"	"Cell line enhanced"	"Detected in many"		"OE19: 42.8;SK-BR-3: 24.4;SK-MEL-30: 18.9;WM-115: 17.3"	"Low region specificity"	"Detected in all"							HPA035416	Approved				"Intracellular and membrane"	NA	NA					"HPA035416: AB_2732467"	"unprognostic (1.71e-2)"	"prognostic unfavorable (1.11e-4)"	"unprognostic (5.23e-2)"	"unprognostic (8.12e-3)"	"prognostic unfavorable (5.86e-4)"	"unprognostic (1.52e-2)"	"unprognostic (2.58e-2)"	"unprognostic (2.64e-3)"	"unprognostic (7.24e-2)"	"unprognostic (2.49e-1)"	"unprognostic (3.46e-2)"	"unprognostic (8.50e-2)"	"unprognostic (1.22e-1)"	"unprognostic (4.04e-1)"	"unprognostic (2.10e-1)"	"unprognostic (2.76e-2)"	"unprognostic (5.83e-2)"	16.1	2.5	1.4	5.9	1.6	0.9	13.8	0.9	2.0	9.0	11.0	3.4	5.6	5.1	10.3	10.7	13.0	6.8	38.9	7.2	1.7	1.6	11.4	4.4	4.9	21.6	2.7	0.5	8.4	29.0	3.3	2.2	17.2	4.4	22.7	7.4	8.7	28.3	4.4	10.6	5.5	5.4	7.8	5.9	7.0	31.6	5.1	1.4	1.3	9.9	7.6	14.3	11.8	33.6	1.0	0.0	8.4	0.0	0.3	0.0	0.0	14.4	1.3	4.8	0.0	1.3	1.3	0.0	3.6	0.0	2.5	2.1	0.0	5.6	0.0	6.8	4.5	3.9	4.5	0.0	8.5	0.8	0.0	7.2	2.8	1.6	0.0	0.6	0.0	6.8	3.5	1.6	0.3	1.8	11.1	7.2	3.3	0.0	0.0	3.4	2.7	1.6	0.0	3.8	42.8	7.4	0.5	0.0	5.4	4.4	0.9	0.2	0.0	0.2	24.4	18.9	0.6	6.8	0.0	7.1	4.0	2.9	3.3	5.1	0.0	0.0	0.0	8.3	0.0	17.3	4.8	0.0	8.4	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	1.4	1.6	0.9	2.0	1.7	1.6	2.7	0.5	4.4	1.4	11.9	15.7	28.2	70.7	16.5	0.3	6.1	124.9	96.4	81.9	19.2	2.0	98.7	79.6	150.6	17.8	58.1	13.6	0.0	91.4	48.8	34.0	265.1	88.9	0.5	22.6	0.0	17.7	36.8	13.4	7.9	13.3	4.8	170.4	4.6	61.8	2.5	75.6	17.3	17.7	1.1	0.2	0.0	30.1	0.5	0.4	10.3	430.4	2.2	37.1	109.5
BAP1	"hucep-6, KIAA0272, UCHL2"	ENSG00000163930	"BRCA1 associated protein 1"	Q92560	3	52401013-52410350	"Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Ubl conjugation pathway"	"Chromatin regulator, Hydrolase, Protease, Thiol protease"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Early spermatids: 81.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004322, HPA028814, HPA028815, HPA055560"	Approved		Enhanced	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"CAB004322: AB_626723, HPA028814: AB_10602393, HPA028815: AB_2672785, HPA055560: AB_2682850"	"unprognostic (1.52e-1)"	"unprognostic (7.96e-2)"	"unprognostic (1.96e-2)"	"unprognostic (6.04e-2)"	"unprognostic (1.74e-1)"	"unprognostic (2.55e-2)"	"unprognostic (9.41e-3)"	"unprognostic (8.53e-3)"	"unprognostic (1.33e-1)"	"unprognostic (3.15e-1)"	"unprognostic (4.64e-3)"	"unprognostic (3.30e-3)"	"prognostic favorable (3.29e-7)"	"unprognostic (6.37e-2)"	"unprognostic (1.91e-1)"	"unprognostic (5.54e-2)"	"unprognostic (2.92e-1)"	13.8	17.6	35.6	14.7	33.3	37.3	13.5	21.8	50.4	12.5	17.0	16.3	11.5	12.4	14.7	14.6	21.2	12.1	15.7	16.4	41.5	15.5	16.6	19.0	14.9	15.2	19.4	27.6	16.9	16.3	30.0	11.1	14.8	19.6	14.4	14.9	15.6	17.9	14.6	24.8	40.5	13.9	14.5	10.0	16.1	13.3	37.3	14.7	18.6	15.3	12.9	16.0	14.1	11.7	5.5	8.4	11.3	5.0	3.0	8.5	3.9	14.8	16.9	20.6	17.4	19.9	12.8	23.2	14.7	19.1	24.0	18.6	20.5	13.9	21.4	7.4	20.5	27.1	12.1	21.6	23.8	15.3	21.1	20.5	26.4	35.8	21.2	18.5	24.8	23.5	19.1	31.9	26.5	14.2	13.2	19.1	41.2	22.6	18.9	18.0	12.9	29.4	34.0	23.2	11.8	20.6	12.7	16.7	21.1	14.8	24.1	7.8	25.3	18.1	5.3	21.5	12.1	14.8	34.3	20.4	21.7	20.0	26.0	27.3	28.7	37.7	30.6	23.7	26.2	25.6	3.4	5.0	7.4	8.5	3.9	4.0	5.0	6.8	6.9	3.3	5.5	4.9	6.4	11.3	3.0	3.1	8.4	6.0	3.9	35.6	33.3	21.8	50.4	41.5	15.5	19.4	27.6	19.6	14.7	0.0	13.6	15.0	8.8	28.0	15.3	19.3	10.2	5.3	9.1	24.4	0.0	12.2	10.0	12.0	81.1	12.4	17.6	0.0	14.3	13.1	11.8	9.7	20.7	25.8	11.0	9.5	10.4	15.4	19.3	32.6	9.5	10.2	11.8	11.8	12.9	9.9	12.6	15.3	11.0	14.6	11.3	19.4	13.2	30.9	12.4	20.6	10.1	11.3	16.4	8.5
BARD1		ENSG00000138376	"BRCA1 associated RING domain 1"	Q99728	2	214725646-214809711	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins"	"DNA damage, DNA repair, Ubl conjugation pathway"	Transferase	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Basal glandular cells: 54.9;Basal keratinocytes: 60.9;Spermatogonia: 54.9;Suprabasal keratinocytes: 65.1;Urothelial cells: 57.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"CAB034106, HPA035354, HPA044864"	Enhanced		Supported	"Nuclear speckles,Cytoplasmic bodies"		No	No			"Nuclear speckles"	"Cytoplasmic bodies"	"CAB034106: AB_2061237, HPA035354: AB_2674585, HPA044864: AB_2679119"	"unprognostic (4.85e-2)"	"unprognostic (1.87e-2)"	"unprognostic (1.74e-2)"	"unprognostic (8.37e-3)"	"unprognostic (2.57e-2)"	"unprognostic (1.03e-2)"	"unprognostic (6.25e-4)"	"unprognostic (1.99e-1)"	"unprognostic (2.16e-2)"	"unprognostic (3.92e-3)"	"unprognostic (2.80e-2)"	"unprognostic (7.41e-2)"	"unprognostic (1.94e-8)"	"unprognostic (3.94e-2)"	"unprognostic (2.28e-1)"	"unprognostic (1.57e-1)"	"unprognostic (1.08e-1)"	4.4	1.9	3.2	11.8	4.8	16.1	4.9	1.2	5.8	7.3	5.4	5.4	3.6	3.7	6.8	5.0	10.0	4.1	3.9	3.6	3.4	2.8	2.2	2.1	5.3	8.2	5.1	1.9	5.8	3.7	3.6	6.3	3.8	4.5	5.7	6.1	1.9	4.7	6.5	12.4	16.3	4.5	7.5	5.3	4.7	3.8	9.5	3.9	25.8	4.0	8.0	9.9	8.3	7.8	9.7	6.6	6.0	3.4	6.1	16.0	2.0	7.8	4.3	11.9	6.1	1.6	2.0	8.2	9.6	5.6	9.4	10.9	5.5	7.8	8.5	4.6	3.9	5.8	8.6	8.5	5.6	13.5	6.7	4.4	8.4	8.0	5.8	0.6	9.4	8.5	2.7	0.8	8.3	4.6	3.2	3.2	9.4	4.7	23.9	9.1	6.5	16.8	9.8	9.4	4.9	2.2	14.5	12.0	7.7	2.8	6.6	3.7	6.0	8.8	10.1	3.5	7.1	10.3	9.4	2.7	12.2	8.6	7.1	8.6	7.2	8.0	17.2	4.9	7.2	8.1	2.9	1.7	6.0	4.8	3.4	3.1	8.9	5.3	5.2	3.0	9.7	2.5	3.6	0.5	6.1	2.9	6.6	16.0	2.0	3.2	4.8	1.2	5.8	3.4	2.8	5.1	1.9	4.5	3.9	6.0	2.1	9.5	54.9	60.9	3.3	12.5	15.3	12.0	9.1	8.7	0.0	9.4	3.3	6.8	8.1	7.5	3.4	23.3	6.0	13.6	7.7	21.0	15.0	3.6	10.6	1.6	1.2	12.3	8.8	3.6	5.8	8.8	3.3	17.2	11.3	3.3	5.6	5.8	9.6	0.6	6.8	19.4	15.5	19.7	54.9	65.1	4.2	8.6	11.0	57.3
BAZ1B	"WBSCR10, WBSCR9, WSTF"	ENSG00000009954	"Bromodomain adjacent to zinc finger domain 1B"	Q9UIG0	7	73440398-73522278	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"DNA damage, Transcription, Transcription regulation"	"Kinase, Transferase, Tyrosine-protein kinase"	"Williams-Beuren syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB037081, CAB037158, HPA067010"	Supported		Supported	"Nuclear bodies"		NA	NA			"Nuclear bodies"		"CAB037081: AB_477637, CAB037158: AB_477636, HPA067010: AB_2685763"	"unprognostic (1.17e-1)"	"unprognostic (1.09e-1)"	"unprognostic (1.07e-1)"	"unprognostic (2.06e-2)"	"unprognostic (1.37e-1)"	"unprognostic (5.72e-2)"	"unprognostic (1.10e-3)"	"unprognostic (1.89e-1)"	"unprognostic (1.09e-1)"	"unprognostic (2.50e-2)"	"unprognostic (1.53e-1)"	"unprognostic (2.12e-1)"	"unprognostic (7.13e-2)"	"unprognostic (1.03e-1)"	"unprognostic (4.41e-2)"	"unprognostic (1.09e-1)"	"unprognostic (3.16e-1)"	23.3	22.3	21.4	26.4	23.9	20.7	24.6	32.4	23.4	24.6	24.2	21.1	34.1	15.3	26.3	19.8	18.1	20.6	16.5	19.8	22.4	21.4	17.1	23.4	19.4	24.7	29.3	19.4	31.8	20.2	34.9	27.0	23.1	22.3	23.1	20.5	16.4	18.0	30.8	28.9	14.6	19.2	28.7	22.9	22.2	18.8	16.2	27.3	46.5	23.5	17.9	27.7	24.7	24.4	5.3	6.2	6.1	3.1	5.6	6.3	1.7	21.0	21.7	29.9	33.4	15.5	16.6	10.0	20.5	15.7	19.7	20.8	17.6	16.0	39.8	4.8	18.2	30.1	14.8	36.3	13.6	29.8	22.4	18.4	23.7	25.8	15.2	17.3	35.7	20.1	11.8	13.3	24.3	30.0	14.8	15.7	21.8	41.2	25.1	22.1	20.0	36.5	16.4	19.4	16.2	16.2	37.2	26.2	26.5	11.2	16.5	30.0	25.6	29.2	32.6	17.0	26.7	20.0	17.9	18.3	34.3	19.8	20.5	34.8	14.5	23.1	68.2	19.4	33.8	31.0	6.1	3.1	1.9	6.3	2.2	5.5	2.5	4.8	4.6	2.1	5.3	3.8	4.1	2.2	5.6	1.7	6.2	4.7	1.7	21.4	23.9	32.4	23.4	22.4	21.4	29.3	19.4	22.3	27.3	71.5	120.0	59.6	29.7	26.6	70.4	68.2	28.1	69.6	93.3	19.2	41.2	44.5	6.6	33.2	6.4	50.4	22.5	0.0	19.8	50.2	34.4	24.5	48.7	47.1	29.2	57.2	33.4	30.7	35.9	5.9	56.7	29.8	11.8	39.7	25.8	48.9	24.9	5.8	71.8	11.3	51.0	32.3	46.7	59.6	105.4	22.1	28.9	43.6	35.7	33.8
BBOX1	"BBH, BBOX, G-BBH, gamma-BBH"	ENSG00000129151	"Gamma-butyrobetaine hydroxylase 1"	O75936	11	27040725-27127809	"Enzymes, Predicted intracellular proteins"	"Carnitine biosynthesis"	"Dioxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"kidney: 139.4;liver: 39.3"	"Cell type enriched"	"Detected in many"	5	"Proximal tubular cells: 1023.7"	"Group enriched"	"Detected in many"	6	"glioma: 23.7;renal cancer: 59.4"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"hTCEpi: 16.2;RPTEC TERT1: 10.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA007600, HPA027823"	Enhanced	Approved	Uncertain	"Vesicles,Actin filaments"		NA	NA		25000	Vesicles	"Actin filaments"	"HPA007600: AB_1845284, HPA027823: AB_10602394"	"unprognostic (9.96e-3)"	"unprognostic (1.80e-2)"	"unprognostic (8.17e-2)"	"prognostic unfavorable (6.65e-4)"	"unprognostic (7.03e-2)"	"unprognostic (6.66e-2)"	"unprognostic (7.05e-3)"	"unprognostic (1.13e-2)"	"unprognostic (3.03e-1)"	"unprognostic (6.89e-2)"	"unprognostic (2.03e-2)"	"unprognostic (1.60e-1)"	"prognostic favorable (1.45e-5)"	"unprognostic (1.71e-2)"	"unprognostic (2.70e-1)"	"unprognostic (3.22e-1)"	"unprognostic (1.73e-3)"	0.9	0.5	9.2	0.5	7.1	0.5	8.2	3.9	7.5	1.5	0.6	4.9	0.1	0.5	0.6	3.6	5.7	3.8	3.6	0.5	7.9	6.3	139.4	39.3	0.6	0.6	10.9	4.3	0.5	0.8	0.5	8.3	1.3	9.2	0.7	0.5	0.0	2.2	2.0	0.6	16.4	0.5	0.5	7.1	0.5	0.6	0.6	5.8	0.0	8.9	1.6	0.7	0.6	3.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	1.0	16.2	0.0	0.0	3.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	10.0	0.0	0.0	0.0	0.5	2.5	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.2	7.1	3.9	7.5	7.9	6.3	10.9	4.3	9.2	5.8	0.0	1.1	0.0	5.5	7.2	0.0	0.0	17.8	6.7	2.3	43.6	0.0	0.1	189.0	0.3	0.7	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	25.4	0.0	0.0	0.0	0.6	1.2	1.1	0.0	0.0	1.7	0.0	0.0	11.3	0.1	0.0	0.4	1023.7	0.3	0.0	0.4	0.0	0.1	31.2	0.2	0.0	0.0	2.2
BCAT1	BCT1	ENSG00000060982	"Branched chain amino acid transaminase 1"	P54687	12	24810022-24949459	"Enzymes, Predicted intracellular proteins"	"Amino-acid biosynthesis, Branched-chain amino acid biosynthesis"	"Aminotransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"pancreas: 52.7"	"Cell type enhanced"	"Detected in many"	10	"Bipolar cells: 113.0;Early spermatids: 140.5;Exocrine glandular cells: 118.7;Late spermatids: 235.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"non-classical monocyte: 14.7"	"Group enriched"	"Detected in many"	9	"dendritic cells: 5.4;monocytes: 14.7"	"Cell line enhanced"	"Detected in many"		"HDLM-2: 51.9;NTERA-2: 59.6;RH-30: 65.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA048592	Uncertain					NA	NA		85000			"HPA048592: AB_2680454"	"unprognostic (1.90e-2)"	"unprognostic (1.87e-3)"	"unprognostic (1.37e-2)"	"unprognostic (1.72e-1)"	"unprognostic (1.27e-1)"	"prognostic unfavorable (3.55e-4)"	"unprognostic (3.05e-5)"	"unprognostic (9.49e-3)"	"unprognostic (4.22e-2)"	"unprognostic (4.77e-3)"	"unprognostic (1.97e-3)"	"unprognostic (4.06e-1)"	"prognostic unfavorable (1.38e-4)"	"prognostic unfavorable (4.95e-4)"	"unprognostic (5.44e-2)"	"unprognostic (7.55e-2)"	"prognostic unfavorable (8.54e-4)"	12.5	6.1	5.2	6.9	5.7	2.6	6.3	1.3	7.8	4.3	3.0	2.6	0.0	1.4	8.6	3.9	2.9	7.8	4.7	2.4	4.7	7.9	1.8	1.8	13.8	7.4	11.3	2.9	8.3	52.7	1.1	19.1	14.0	18.5	2.0	3.1	12.3	4.4	1.4	1.3	1.2	3.8	5.9	6.3	2.4	2.4	7.3	2.0	7.1	1.7	0.7	5.3	4.3	6.3	1.1	5.4	1.0	14.7	0.0	0.2	0.8	6.0	2.4	22.5	0.0	6.5	12.7	11.6	12.4	8.3	7.0	11.8	13.6	17.1	22.5	0.0	20.6	1.3	2.4	16.0	0.1	18.8	51.9	3.1	18.3	0.4	7.3	23.5	20.7	6.7	16.4	0.4	17.8	3.7	15.2	23.7	11.7	17.6	0.2	5.9	0.1	13.0	5.8	59.6	0.0	1.6	0.0	65.0	0.3	0.0	2.1	0.0	12.3	0.0	0.0	0.1	25.2	0.0	8.9	31.0	4.2	15.7	16.7	11.6	2.7	2.7	31.4	14.8	12.5	0.0	0.0	2.1	0.0	0.0	3.4	0.1	1.1	0.0	0.1	5.4	0.0	0.0	0.0	1.0	0.0	14.7	3.3	0.2	0.8	5.2	5.7	1.3	7.4	4.7	7.9	11.3	2.9	18.5	2.0	14.9	21.3	0.8	0.1	7.7	113.0	1.9	2.5	0.0	1.2	0.0	2.0	45.4	1.7	1.4	140.5	9.0	0.0	0.0	118.7	16.8	13.4	0.3	11.5	0.0	64.2	39.7	0.0	9.8	81.1	235.6	6.6	40.9	6.8	26.2	0.0	5.2	79.2	0.0	3.9	0.0	9.2	6.5	1.4	1.7	1.1	6.4	18.8	0.7	0.0	0.1
BCAT2	"BCAM, BCT2"	ENSG00000105552	"Branched chain amino acid transaminase 2"	O15382	19	48795062-48811029	"Enzymes, Predicted intracellular proteins"	"Amino-acid biosynthesis, Branched-chain amino acid biosynthesis"	"Aminotransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"RT4: 72.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA054091	Enhanced		Supported	Mitochondria		NA	NA		3400000	Mitochondria		"HPA054091: AB_2682374"	"unprognostic (2.58e-2)"	"unprognostic (1.23e-2)"	"unprognostic (2.16e-1)"	"unprognostic (2.51e-3)"	"unprognostic (1.54e-1)"	"unprognostic (2.97e-2)"	"unprognostic (1.69e-1)"	"unprognostic (1.17e-2)"	"unprognostic (2.98e-2)"	"unprognostic (1.03e-1)"	"unprognostic (8.32e-3)"	"unprognostic (1.06e-1)"	"prognostic favorable (3.68e-5)"	"unprognostic (1.87e-3)"	"unprognostic (1.35e-1)"	"unprognostic (2.42e-1)"	"unprognostic (7.50e-3)"	11.8	34.1	6.7	10.9	7.7	3.8	15.0	15.0	10.7	11.9	16.7	11.3	15.8	10.2	12.9	9.8	24.6	11.9	15.2	25.1	6.8	6.9	22.6	8.0	19.9	16.3	9.8	7.8	22.3	42.6	9.0	12.3	27.5	22.0	16.8	12.1	6.3	24.7	17.2	23.3	9.8	10.3	17.5	7.6	10.9	22.8	15.9	10.7	12.5	19.1	23.3	16.7	29.2	12.2	15.0	18.2	1.8	9.8	8.8	15.4	7.1	17.5	21.1	5.6	11.9	23.4	7.9	10.0	7.8	4.0	9.6	9.4	21.2	10.8	20.7	8.9	6.9	3.0	8.3	8.6	13.6	4.8	12.8	21.9	7.6	9.5	1.4	22.7	10.2	7.1	11.5	8.7	7.1	10.3	9.4	13.3	16.0	9.6	12.7	3.5	21.0	13.9	10.8	4.9	27.9	10.3	21.2	9.7	22.8	9.1	72.7	30.3	8.6	11.8	19.5	5.7	4.1	12.4	5.0	7.4	9.4	9.0	11.0	9.7	12.0	15.9	9.9	5.1	16.0	6.1	0.0	8.7	1.8	9.7	9.8	13.6	15.0	11.7	12.4	16.1	12.8	10.8	9.6	0.4	8.8	3.7	18.2	15.4	7.1	6.7	7.7	15.0	10.7	6.8	6.9	9.8	7.8	22.0	10.7	26.8	34.4	9.0	26.7	5.4	8.2	22.1	20.4	6.7	13.6	12.2	19.6	54.6	61.3	34.2	5.8	13.5	15.6	0.0	18.6	15.8	11.7	16.4	23.1	8.3	23.4	1.6	19.1	12.3	4.7	6.2	16.1	8.6	23.6	33.3	25.8	5.6	19.8	14.0	28.3	28.2	11.2	19.4	16.1	7.0	17.1	6.1	38.3	7.0	30.3	40.4
BCHE	"CHE1, CHE2, E1"	ENSG00000114200	Butyrylcholinesterase	P06276	3	165772904-165837472	"Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"		"Hydrolase, Serine esterase"	"Disease mutation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"liver: 145.4"	"Cell type enriched"	"Detected in many"	10	"Hepatocytes: 360.7"	"Group enriched"	"Detected in many"	6	"glioma: 24.0;liver cancer: 13.7;melanoma: 18.9"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	9	"Karpas-707: 131.7"	"Low region specificity"	"Detected in all"							HPA001560	Approved				"Secreted to blood"	NA	NA		13000000000			"HPA001560: AB_1078271"	"unprognostic (4.74e-2)"	"unprognostic (2.00e-1)"	"unprognostic (9.21e-4)"	"unprognostic (8.19e-8)"	"unprognostic (2.66e-2)"	"prognostic unfavorable (1.06e-4)"	"unprognostic (1.44e-1)"	"unprognostic (5.04e-2)"	"unprognostic (6.15e-2)"	"unprognostic (9.59e-2)"	"unprognostic (5.15e-2)"	"unprognostic (3.65e-2)"	"unprognostic (3.18e-3)"	"unprognostic (4.46e-5)"	"unprognostic (2.17e-2)"	"unprognostic (5.92e-2)"	"unprognostic (4.26e-4)"	14.0	3.9	6.7	6.2	4.3	0.4	1.9	3.6	9.1	24.4	15.5	4.7	8.3	1.8	20.2	13.4	20.0	18.0	2.2	7.8	6.1	4.4	2.8	145.4	3.7	0.7	5.5	2.7	10.3	1.1	0.4	1.2	0.5	4.7	4.7	5.3	0.7	1.0	10.5	1.1	2.8	6.4	13.9	3.4	3.7	1.9	1.8	6.1	1.0	0.8	0.4	0.5	9.7	2.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	14.3	0.0	0.0	0.0	0.0	0.0	0.2	0.1	1.2	0.0	0.0	0.0	5.4	0.0	0.0	0.1	0.9	0.0	1.0	0.0	0.1	0.0	0.0	0.0	1.1	0.0	0.0	4.2	0.2	0.0	1.4	4.4	0.6	5.2	0.0	131.7	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	4.8	10.9	0.1	0.0	0.0	0.1	0.0	0.0	7.5	0.0	5.8	0.0	0.0	3.2	0.0	0.0	1.3	0.5	0.0	0.2	1.3	0.0	14.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.7	4.3	3.6	4.3	6.1	4.4	5.5	2.7	4.7	6.1	0.0	0.0	0.0	0.3	4.8	0.9	4.3	12.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	22.1	1.5	0.0	0.0	0.0	0.0	2.2	0.2	0.0	360.7	0.1	1.6	0.0	6.2	5.3	5.5	2.0	0.0	18.6	0.0	0.0	34.4	0.0	0.0	0.0	2.9	1.0	0.0	4.6	0.3	0.1	3.0	0.0	0.0	0.0	0.1
BCKDHA	"MSU, OVD1A"	ENSG00000248098	"Branched chain keto acid dehydrogenase E1, alpha polypeptide"	P12694	19	41397460-41425005	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		Oxidoreductase	"Disease mutation, Maple syrup urine disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Alveolar cells type 2: 13.3;Ductal cells: 12.3;monocytes: 15.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"U-266/70: 49.4"	"Low region specificity"	"Detected in all"							HPA036640	Supported					NA	NA					"HPA036640: AB_10671964"	"unprognostic (4.50e-2)"	"unprognostic (6.85e-2)"	"unprognostic (1.14e-1)"	"unprognostic (8.58e-3)"	"unprognostic (1.26e-2)"	"prognostic favorable (9.37e-4)"	"unprognostic (2.41e-2)"	"unprognostic (8.55e-2)"	"unprognostic (1.82e-1)"	"unprognostic (1.48e-2)"	"unprognostic (1.12e-2)"	"unprognostic (1.53e-1)"	"prognostic favorable (5.33e-10)"	"unprognostic (1.73e-1)"	"unprognostic (1.37e-1)"	"prognostic unfavorable (3.27e-5)"	"unprognostic (9.66e-2)"	18.4	36.1	11.5	9.2	14.9	11.4	12.9	9.3	19.3	12.5	11.2	16.6	25.0	11.2	11.0	11.2	31.0	15.0	12.4	41.1	10.8	9.5	23.4	47.6	12.3	17.0	16.0	17.6	13.8	28.2	15.7	12.6	13.4	12.7	12.6	8.8	15.0	23.1	31.1	61.7	15.6	10.4	10.8	11.2	13.2	22.0	21.2	13.5	15.8	21.8	25.3	15.9	14.0	15.1	16.5	45.9	17.6	38.0	25.9	19.7	27.1	14.4	26.5	2.3	14.2	6.6	4.1	6.1	3.5	6.8	7.0	8.9	6.0	10.0	11.7	8.0	3.8	2.8	5.8	4.4	7.2	3.7	12.2	12.7	8.1	13.8	5.7	14.3	8.5	6.0	7.3	10.4	4.7	10.3	7.8	13.4	15.6	8.1	22.0	6.3	13.0	7.3	5.1	4.0	17.4	6.6	8.8	7.9	27.7	9.8	6.8	10.3	12.4	12.5	28.6	8.7	3.3	14.6	22.9	10.1	7.5	7.7	4.3	7.6	49.4	19.9	11.4	27.1	15.9	8.7	13.5	36.9	17.6	15.8	38.0	18.2	16.5	15.9	16.1	45.9	16.4	13.4	15.3	10.9	25.9	26.1	17.6	19.7	27.1	11.5	14.9	9.3	19.3	10.8	9.5	16.0	17.6	12.7	13.5	0.0	13.3	0.5	0.0	0.2	0.0	0.0	0.0	1.4	6.8	5.2	0.0	1.6	3.3	12.3	0.6	0.6	3.4	0.0	10.3	1.6	0.8	0.0	4.7	2.1	2.5	0.0	5.8	3.1	4.1	0.4	0.6	1.2	3.3	15.4	5.3	0.4	9.4	2.9	0.4	1.6	1.2	0.0	0.4	1.7	0.9	0.6	1.7	0.0	6.4	0.0
BCKDHB		ENSG00000083123	"Branched chain keto acid dehydrogenase E1 subunit beta"	P21953	6	80106647-80346270	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		Oxidoreductase	"Disease mutation, Maple syrup urine disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 58.6"	"Cell type enhanced"	"Detected in many"	5	"Early spermatids: 56.4;Hepatocytes: 55.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031580, HPA031956"	Approved		Supported	Nucleoli,Mitochondria	"Intracellular and membrane"	Yes	No			Mitochondria	Nucleoli	"HPA031580: AB_10696054, HPA031956: "	"unprognostic (4.23e-1)"	"unprognostic (1.61e-1)"	"unprognostic (9.50e-3)"	"unprognostic (9.37e-3)"	"unprognostic (1.66e-1)"	"unprognostic (6.03e-2)"	"unprognostic (6.84e-3)"	"unprognostic (2.30e-2)"	"unprognostic (1.94e-1)"	"unprognostic (7.32e-3)"	"unprognostic (2.67e-1)"	"unprognostic (4.65e-2)"	"prognostic favorable (5.54e-9)"	"unprognostic (2.67e-1)"	"unprognostic (1.12e-1)"	"unprognostic (8.02e-2)"	"unprognostic (1.49e-2)"	13.9	12.0	9.9	9.0	12.2	5.8	18.1	9.5	14.3	10.2	17.3	22.7	9.4	9.1	11.6	7.7	10.2	10.9	7.4	14.7	11.9	7.6	24.7	58.6	6.4	8.1	11.3	11.2	13.9	12.1	13.7	15.5	5.5	14.1	13.1	16.5	11.7	30.5	10.3	8.2	8.6	11.8	11.5	16.7	5.3	15.0	10.0	12.4	11.2	12.5	7.9	7.7	14.0	8.2	9.1	10.3	2.6	4.3	13.4	15.7	5.2	7.0	2.6	10.0	13.4	10.2	8.9	8.0	5.0	10.4	8.3	11.4	4.3	9.7	20.0	5.4	12.0	9.7	7.1	5.5	6.6	11.6	24.8	8.2	9.9	6.9	5.8	11.3	14.0	4.5	8.5	6.8	5.7	7.1	7.4	9.8	15.6	8.3	17.9	18.5	3.9	5.1	8.2	7.4	15.4	3.4	13.0	31.1	17.1	22.9	10.8	6.7	9.5	8.5	7.1	5.0	11.5	9.1	10.8	4.2	5.0	3.4	4.5	6.7	12.8	12.5	6.6	6.1	10.5	7.4	2.6	3.4	0.8	8.5	4.0	11.1	9.1	7.2	7.2	6.6	9.1	9.6	10.0	0.7	13.4	4.3	10.3	15.7	5.2	9.9	12.2	9.5	14.3	11.9	7.6	11.3	11.2	14.1	12.4	8.9	15.2	6.7	10.1	7.6	7.0	26.0	10.2	16.0	14.8	5.2	2.0	15.7	23.2	6.8	56.4	9.0	12.4	0.0	9.0	6.6	13.0	8.6	16.1	55.0	10.2	3.2	11.5	11.1	9.8	4.1	8.1	6.1	15.1	10.0	28.8	14.6	4.5	11.5	8.1	25.2	8.2	6.5	8.9	7.7	4.8	10.8	8.7	8.9	15.3	9.8
BCKDK		ENSG00000103507	"Branched chain ketoacid dehydrogenase kinase"	O14874	16	31106107-31112791	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		"Kinase, Transferase"	"Autism, Autism spectrum disorder, Disease mutation, Epilepsy, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"dendritic cells: 26.8;granulocytes: 26.6;monocytes: 33.0"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA017995, HPA056067"	Supported		Supported	Mitochondria		NA	NA			Mitochondria		"HPA017995: AB_1845309, HPA056067: AB_2683024"	"unprognostic (1.37e-1)"	"unprognostic (2.57e-1)"	"unprognostic (6.94e-2)"	"unprognostic (5.20e-2)"	"unprognostic (5.39e-2)"	"unprognostic (3.61e-2)"	"unprognostic (1.01e-1)"	"unprognostic (5.47e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.90e-1)"	"unprognostic (1.35e-1)"	"unprognostic (3.24e-2)"	"unprognostic (2.66e-3)"	"unprognostic (4.85e-2)"	"unprognostic (3.93e-2)"	"unprognostic (1.00e-1)"	"unprognostic (4.97e-2)"	15.4	29.7	11.9	13.1	15.0	9.4	18.3	18.8	21.3	11.7	14.1	9.6	19.9	11.2	14.8	14.9	14.9	13.8	15.1	39.2	14.2	10.3	21.3	46.5	18.2	32.5	10.7	17.3	15.1	52.4	17.4	8.9	11.4	13.2	14.9	9.9	10.4	33.9	25.7	67.7	21.5	12.2	19.9	15.6	16.0	19.9	11.2	9.3	8.0	11.7	25.9	10.6	15.3	12.0	6.9	26.8	26.6	33.0	6.3	6.8	13.6	18.2	20.5	11.6	17.4	14.3	14.4	12.6	15.9	19.6	24.8	24.3	13.4	12.2	17.1	23.1	19.8	12.1	12.7	8.2	27.7	16.0	13.8	25.4	18.5	13.9	24.3	25.2	9.6	17.0	21.1	11.2	21.2	17.7	22.8	26.4	13.1	9.3	16.2	37.1	31.1	8.8	12.7	9.8	8.5	16.6	17.9	16.9	31.5	18.9	12.6	17.9	16.4	12.3	30.5	9.9	10.4	18.4	9.2	16.9	18.9	10.9	19.4	13.2	16.9	6.0	6.1	21.5	13.9	17.7	12.2	33.0	23.1	5.7	27.4	5.6	6.9	5.2	4.2	26.8	5.4	4.4	5.0	26.6	6.3	19.3	5.8	6.8	13.6	11.9	15.0	18.8	21.3	14.2	10.3	10.7	17.3	13.2	9.3	17.9	17.8	27.4	21.2	16.5	11.0	32.1	25.5	13.4	9.1	19.2	0.0	47.3	68.0	57.7	2.2	20.9	39.3	0.0	68.3	54.7	20.7	26.1	33.4	34.7	83.9	11.1	19.1	27.0	41.9	3.6	19.2	56.7	11.8	95.6	20.5	22.1	49.3	40.3	24.1	65.3	7.2	45.3	28.9	16.7	15.2	24.0	58.0	14.4	26.7	19.3
BCO1	"BCDO, BCDO1, BCMO, BCMO1, FLJ10730"	ENSG00000135697	"Beta-carotene oxygenase 1"	Q9HAY6	16	81238448-81291142	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		"Dioxygenase, Oxidoreductase"	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	8	"intestine: 28.1;retina: 62.0"	"Cell type enhanced"	"Detected in some"	13	"Mucus-secreting cells: 7.2;Paneth cells: 2.5;Proximal tubular cells: 5.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A549: 12.8;EFO-21: 9.7;HAP1: 3.7;NTERA-2: 5.2;RPTEC TERT1: 9.8"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			HPA043811			Uncertain	"Actin filaments,Centriolar satellite"		NA	NA			"Actin filaments, Centriolar satellite"		"HPA043811: AB_10962487"	"unprognostic (2.78e-1)"	"unprognostic (3.88e-3)"	"unprognostic (2.61e-1)"	"unprognostic (3.32e-1)"	"unprognostic (4.05e-2)"	"unprognostic (8.01e-4)"	"unprognostic (1.65e-1)"	"unprognostic (2.99e-2)"	"unprognostic (1.58e-3)"	"unprognostic (7.26e-2)"	"unprognostic (2.97e-2)"	"unprognostic (1.08e-3)"	"unprognostic (1.46e-1)"	"unprognostic (1.90e-2)"	"unprognostic (2.48e-1)"	"unprognostic (5.07e-2)"	"unprognostic (1.09e-1)"	0.1	0.0	1.3	0.2	1.4	0.0	0.2	0.2	1.6	0.3	28.1	0.3	1.4	11.0	0.7	0.5	0.7	0.6	1.4	0.1	1.7	1.9	4.2	2.5	0.3	0.1	0.8	0.1	2.0	0.4	0.0	1.9	0.1	5.9	1.3	3.6	62.0	1.3	2.8	0.6	0.3	16.9	0.4	0.4	0.1	2.3	0.2	0.3	0.3	0.2	0.5	0.1	0.6	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.8	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.3	0.4	2.6	0.0	9.7	0.0	0.4	0.1	3.7	0.0	0.0	0.1	0.4	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	5.2	0.8	0.0	0.0	0.0	0.0	9.8	0.3	0.4	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	1.4	0.2	1.6	1.7	1.9	0.8	0.1	5.9	0.3	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.0	1.8	0.0	0.5	0.0	0.5	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	1.2	0.6	0.0	0.0	1.4	0.0	0.0	0.0	7.2	0.0	0.4	2.5	1.1	5.5	0.0	0.0	0.0	0.5	0.0	0.0	0.2	0.0	1.7	0.6
BCO2	"B-DIOX-II, BCDO2, FLJ34464"	ENSG00000197580	"Beta-carotene oxygenase 2"	Q9BYV7	11	112175467-112224699	"Enzymes, Predicted intracellular proteins"		"Dioxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 28.9;liver: 44.0"	"Cell type enhanced"	"Detected in many"	17	"Cone photoreceptor cells: 386.8;Horizontal cells: 127.1;Rod photoreceptor cells: 238.0"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	5	"NK-cell: 2.8"	"Lineage enriched"	"Detected in single"	5	"NK-cells: 2.8"	"Cell line enhanced"	"Detected in some"		"CAPAN-2: 7.6;HHSteC: 16.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			HPA061542	Supported					NA	NA					"HPA061542: "	"unprognostic (2.92e-1)"	"unprognostic (1.89e-1)"	"unprognostic (3.76e-2)"	"unprognostic (1.40e-1)"	"unprognostic (1.91e-1)"	"unprognostic (1.50e-2)"	"unprognostic (7.60e-3)"	"unprognostic (1.88e-1)"	"unprognostic (3.18e-2)"	"unprognostic (6.40e-2)"	"unprognostic (2.39e-2)"	"unprognostic (6.91e-2)"	"unprognostic (1.36e-4)"	"unprognostic (2.31e-2)"	"unprognostic (9.86e-2)"	"unprognostic (1.07e-2)"	"unprognostic (1.34e-1)"	2.3	14.7	4.0	0.9	6.8	0.8	1.3	1.9	4.6	1.2	1.5	5.9	0.3	1.1	2.0	2.8	2.1	9.5	6.0	28.9	3.5	3.9	1.6	44.0	1.8	0.9	10.5	2.6	1.5	1.3	0.8	16.3	3.9	9.5	1.3	1.1	12.4	1.1	1.5	17.3	1.5	1.6	4.4	11.0	1.0	1.1	2.4	9.8	0.0	1.9	1.0	1.3	1.3	2.7	0.3	0.5	0.3	0.6	2.8	0.2	0.0	0.1	1.3	0.6	0.8	0.5	0.6	0.0	0.4	0.3	0.1	0.7	0.0	7.6	0.5	0.6	0.9	0.7	1.6	0.0	0.3	0.5	0.1	0.2	1.0	0.7	0.5	16.4	0.5	0.3	0.1	3.1	0.2	0.5	1.5	0.1	0.1	0.2	0.4	0.1	0.1	0.6	1.6	0.1	0.8	0.2	0.4	0.2	0.2	0.3	0.3	0.6	0.3	0.6	0.3	0.0	0.2	0.4	0.3	0.0	0.2	0.2	0.2	0.1	0.1	0.1	0.3	0.0	3.4	0.4	0.1	0.6	0.0	0.1	0.0	0.0	0.3	0.2	0.1	0.5	0.2	0.0	0.0	0.3	2.8	0.2	0.2	0.0	0.0	4.0	6.8	1.9	4.6	3.5	3.9	10.5	2.6	9.5	9.8	3.0	1.9	3.7	15.0	3.0	12.6	42.5	38.2	53.5	9.1	5.2	386.8	0.2	0.0	2.8	2.2	4.0	7.0	0.0	1.8	0.3	5.6	7.3	5.7	78.4	0.9	127.1	7.9	15.4	3.0	1.7	3.7	2.6	1.7	4.6	0.7	13.3	1.2	3.5	3.5	1.0	238.0	0.0	4.6	5.4	2.4	2.8	0.6	3.9	2.9	8.9
BCR	"ALL, BCR1, CML, D22S11, D22S662, PHL"	ENSG00000186716	"BCR, RhoGEF and GTPase activating protein"	P11274	22	23179704-23318037	"Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins"		"GTPase activation, Guanine-nucleotide releasing factor, Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes, FDA approved drug targets, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Ito cells: 62.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"K-562: 44.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB010421, CAB018545, HPA038337"	Approved		Approved	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Plasma membrane, Cytosol"	Nucleoplasm	"CAB010421: AB_2274682, CAB018545: AB_2063918, HPA038337: AB_10675795"	"unprognostic (7.46e-3)"	"unprognostic (2.43e-2)"	"unprognostic (2.15e-3)"	"unprognostic (1.16e-1)"	"unprognostic (5.35e-2)"	"unprognostic (1.45e-1)"	"unprognostic (5.08e-2)"	"unprognostic (1.44e-1)"	"unprognostic (7.55e-2)"	"unprognostic (1.81e-1)"	"unprognostic (9.46e-2)"	"unprognostic (2.39e-2)"	"prognostic favorable (9.15e-10)"	"unprognostic (1.47e-1)"	"unprognostic (7.10e-2)"	"unprognostic (4.10e-2)"	"unprognostic (7.43e-2)"	14.5	8.4	24.0	9.1	41.2	26.7	10.5	14.2	26.5	13.6	9.7	10.3	10.6	8.7	9.2	13.9	19.3	10.8	8.3	7.8	20.9	13.0	16.3	8.3	11.3	10.9	16.0	15.6	8.8	12.9	14.5	14.9	15.7	14.2	7.0	6.8	8.3	15.5	9.7	3.4	12.8	8.7	9.0	9.5	9.1	14.0	9.6	15.4	11.8	16.6	5.5	9.2	9.2	8.8	1.5	0.8	1.2	1.0	2.8	6.6	2.5	19.0	8.2	12.7	13.0	7.6	5.2	19.2	6.9	6.5	6.4	5.2	14.4	7.7	13.3	12.9	5.9	6.2	19.6	1.3	19.2	1.8	25.4	13.2	11.6	11.3	11.4	9.9	10.7	6.1	4.4	13.0	9.5	8.4	11.4	22.3	9.6	44.4	6.3	2.9	12.5	10.0	8.4	10.7	15.1	8.1	13.2	5.1	8.7	9.9	12.1	11.7	11.1	12.6	10.9	5.2	8.5	6.9	8.8	25.1	3.8	0.4	6.2	5.7	1.4	5.8	4.7	9.9	8.1	5.9	0.0	1.0	0.0	6.6	0.4	2.3	1.4	3.3	3.3	0.8	1.5	2.6	3.6	1.2	2.8	1.0	0.8	1.6	2.5	24.0	41.2	14.2	24.9	20.9	13.0	16.0	15.6	14.2	15.4	8.9	11.5	3.0	9.5	13.7	24.0	7.3	20.4	2.7	19.4	17.4	21.6	10.5	8.3	12.4	3.9	22.4	11.1	0.0	14.1	5.9	7.3	10.2	10.4	18.4	6.0	22.3	19.1	62.0	10.8	7.7	8.1	5.4	5.0	6.4	12.0	13.4	21.8	5.8	5.3	14.3	8.0	0.0	8.6	1.6	6.8	13.8	9.0	9.2	11.2	11.5
BDH1	"BDH, SDR9C1"	ENSG00000161267	"3-hydroxybutyrate dehydrogenase 1"	Q02338	3	197509783-197573323	"Candidate cardiovascular disease genes, Enzymes, Predicted intracellular proteins"		"Allosteric enzyme, Oxidoreductase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	8	"liver: 156.0"	"Cell type enhanced"	"Detected in many"	6	"Hepatocytes: 92.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"OE19: 20.3;U-937: 35.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030947, HPA058709"	Enhanced		Approved	Mitochondria		NA	NA			Mitochondria		"HPA030947: AB_10669548, HPA058709: AB_2683797"	"unprognostic (2.72e-2)"	"prognostic favorable (1.09e-4)"	"unprognostic (1.13e-1)"	"unprognostic (3.93e-1)"	"unprognostic (3.35e-2)"	"unprognostic (1.07e-1)"	"prognostic favorable (9.86e-7)"	"unprognostic (2.08e-1)"	"unprognostic (3.85e-2)"	"unprognostic (4.53e-2)"	"unprognostic (5.17e-3)"	"unprognostic (5.85e-3)"	"prognostic favorable (7.12e-8)"	"unprognostic (5.62e-2)"	"unprognostic (1.74e-1)"	"unprognostic (6.22e-2)"	"unprognostic (1.02e-1)"	3.5	2.8	6.6	5.2	11.2	4.7	4.6	18.1	13.8	4.0	13.9	4.6	6.3	9.6	2.1	3.6	12.9	5.5	6.1	19.6	6.3	5.8	6.0	156.0	2.0	4.2	5.9	9.1	3.0	2.8	5.8	3.6	1.4	7.7	4.5	11.1	6.2	8.6	4.4	7.3	8.0	13.7	2.4	3.5	2.3	4.7	1.8	3.6	5.4	5.2	11.3	7.4	3.6	3.6	6.1	4.6	2.9	1.6	4.7	9.9	4.0	10.4	1.4	0.6	5.4	0.9	0.0	0.0	1.2	1.0	5.4	3.1	9.4	3.5	0.0	15.6	0.3	0.4	4.9	4.7	2.5	2.1	0.1	0.0	5.5	3.6	3.2	4.0	12.3	5.8	1.6	2.9	2.1	4.6	0.5	1.3	6.3	0.0	4.2	0.1	18.6	9.5	8.3	4.1	20.3	1.9	9.0	2.0	14.3	5.8	4.8	9.9	4.3	3.8	0.5	2.0	0.2	12.5	10.3	0.1	0.3	1.8	0.0	9.8	4.8	9.1	0.1	0.3	35.0	0.6	2.9	1.6	0.6	5.9	0.2	8.2	6.1	6.5	5.3	4.2	5.5	9.9	5.9	0.0	4.7	0.3	4.6	4.2	4.0	6.6	11.2	18.1	13.8	6.3	5.8	5.9	9.1	7.7	3.6	3.0	6.5	8.0	8.1	8.2	20.4	35.0	17.8	49.5	10.3	12.2	19.6	1.6	44.7	4.7	7.8	1.5	56.7	0.0	4.9	3.6	5.1	6.8	1.1	92.8	7.2	17.5	26.2	4.9	3.3	10.3	5.2	5.5	15.1	0.0	38.7	16.2	2.2	31.6	3.9	12.1	32.8	0.0	5.4	14.1	4.7	9.5	1.6	9.6	56.2	11.9
BDH2	"DHRS6, FLJ13261, PRO20933, SDR15C1, UCPA-OR, UNQ6308"	ENSG00000164039	"3-hydroxybutyrate dehydrogenase 2"	Q9BUT1	4	103079435-103099883	"Enzymes, Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"kidney: 139.1"	"Cell type enhanced"	"Detected in many"	16	"Distal tubular cells: 179.1;Proximal tubular cells: 617.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"RPTEC TERT1: 41.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA036028, HPA036029"	Enhanced		Supported	Cytosol		NA	NA			Cytosol		"HPA036028: AB_10670674, HPA036029: AB_2674909"	"unprognostic (2.12e-2)"	"unprognostic (1.91e-1)"	"unprognostic (1.64e-1)"	"prognostic favorable (5.21e-4)"	"unprognostic (3.92e-1)"	"unprognostic (2.28e-1)"	"unprognostic (3.82e-2)"	"prognostic favorable (1.20e-4)"	"unprognostic (1.71e-1)"	"unprognostic (2.04e-1)"	"unprognostic (4.37e-1)"	"unprognostic (1.95e-1)"	"prognostic favorable (4.45e-13)"	"unprognostic (2.54e-2)"	"unprognostic (1.60e-1)"	"prognostic favorable (7.75e-4)"	"unprognostic (9.69e-3)"	12.4	33.1	22.6	7.7	26.0	2.8	17.6	9.6	18.5	15.7	18.9	14.8	12.3	36.7	11.6	18.8	10.4	16.6	13.5	14.9	26.6	15.4	139.1	39.3	13.8	6.0	38.2	15.6	26.2	8.3	23.5	14.8	8.1	29.0	13.0	11.2	27.0	10.2	15.2	6.9	7.9	34.8	10.2	29.7	6.7	11.8	7.2	32.4	10.4	25.1	12.0	7.6	11.0	11.8	9.5	7.5	1.4	4.1	11.6	18.5	7.5	2.6	4.5	25.9	7.8	27.1	30.1	3.7	6.2	16.0	5.9	10.0	3.6	10.3	10.7	10.9	9.5	2.4	1.2	13.4	10.0	6.8	6.3	8.1	2.0	6.6	11.8	17.4	6.2	3.1	24.0	9.4	10.1	2.3	27.0	19.9	17.7	6.5	3.4	22.7	1.4	27.8	6.1	7.8	2.4	2.1	20.1	25.0	6.3	41.3	5.0	3.5	12.5	11.0	5.8	7.0	11.4	5.2	5.1	12.2	7.0	3.7	4.4	2.4	6.5	6.5	11.0	9.3	7.5	5.8	1.4	4.1	0.2	11.9	1.8	12.8	9.5	12.1	11.3	5.8	9.0	14.2	15.3	0.3	11.6	0.3	7.5	18.5	7.5	22.6	26.0	9.6	18.5	26.6	15.4	38.2	15.6	29.0	32.4	29.8	52.6	3.4	39.4	27.0	1.3	8.5	38.2	22.7	33.0	102.9	0.0	6.7	179.1	38.9	1.1	24.3	37.4	0.0	19.3	13.9	51.4	21.0	18.5	63.8	17.7	3.2	22.0	28.3	13.2	2.1	64.7	10.3	21.9	19.8	19.9	45.8	21.4	14.1	73.2	617.5	2.2	12.9	24.2	0.7	1.7	23.3	2.9	17.3	23.0	33.1
BHMT	BHMT1	ENSG00000145692	"Betaine--homocysteine S-methyltransferase"	Q93088	5	79111779-79132290	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Methyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	39	"kidney: 105.9;liver: 216.2"	"Group enriched"	"Detected in some"	8	"Hepatocytes: 455.1;Proximal tubular cells: 647.0"	"Cancer enhanced"	"Detected in some"		"liver cancer: 90.6;renal cancer: 50.4"	"Region enhanced"	"Detected in single"		"hippocampal formation: 1.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"Hep G2: 8.4;NTERA-2: 3.6;SCLC-21H: 2.3"					"Not detected"	"Not detected"			"HPA038285, HPA058310"	Enhanced		Supported	Cytosol		No	NA		9200000	Cytosol		"HPA038285: AB_10675791, HPA058310: AB_2683675"	"unprognostic (2.61e-2)"	"unprognostic (4.12e-1)"	"unprognostic (4.45e-1)"	"unprognostic (4.14e-3)"	"unprognostic (5.62e-2)"	"unprognostic (4.14e-1)"	"prognostic favorable (7.32e-4)"	"unprognostic (5.33e-2)"	"unprognostic (1.51e-1)"	"unprognostic (1.13e-1)"	"unprognostic (9.66e-4)"	"unprognostic (6.42e-2)"	"unprognostic (8.26e-3)"	"unprognostic (1.77e-1)"	"unprognostic (3.22e-1)"	"unprognostic (3.60e-2)"	"unprognostic (2.30e-3)"	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.1	0.0	2.8	0.0	0.0	0.0	0.1	1.5	0.0	105.9	216.2	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.1	2.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.7	0.5	0.0	0.3	0.2	0.0	0.0	0.1	0.0	0.0	4.1	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.4	0.0	0.1	0.2	0.0	0.0	0.0	0.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	8.4	0.0	1.2	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	3.6	0.0	0.0	0.0	1.2	0.0	0.0	0.0	2.3	0.0	0.6	0.2	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	1.5	0.0	0.0	0.6	0.1	0.0	0.0	0.0	7.2	0.0	0.0	0.0	0.2	2.5	0.0	0.0	15.7	0.0	0.0	66.3	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	455.1	0.0	0.0	0.0	3.7	9.2	0.4	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	647.0	0.1	0.0	0.1	0.0	0.9	0.0	0.1	0.0	0.0	0.3
BHMT2		ENSG00000132840	"Betaine--homocysteine S-methyltransferase 2"	Q9H2M3	5	79069717-79089466	"Cancer-related genes, Enzymes, Predicted intracellular proteins"		"Methyltransferase, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	10	"kidney: 87.9;liver: 122.9"	"Cell type enhanced"	"Detected in many"	25	"Distal tubular cells: 81.2;Hepatocytes: 181.0;Proximal tubular cells: 412.5"	"Group enriched"	"Detected in many"	14	"liver cancer: 79.6;renal cancer: 52.9"	"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"BJ hTERT+: 9.1;Hep G2: 38.1;hTEC/SVTERT24-B: 23.4;U-87 MG: 9.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA044573	Enhanced					NA	NA		1400000			"HPA044573: AB_10795044"	"unprognostic (5.03e-2)"	"unprognostic (4.42e-2)"	"unprognostic (2.60e-2)"	"unprognostic (3.76e-2)"	"unprognostic (4.40e-2)"	"unprognostic (2.90e-3)"	"unprognostic (1.56e-2)"	"unprognostic (1.95e-1)"	"unprognostic (1.87e-2)"	"unprognostic (2.45e-3)"	"unprognostic (1.41e-2)"	"unprognostic (1.02e-1)"	"unprognostic (1.76e-2)"	"unprognostic (5.05e-2)"	"unprognostic (1.49e-1)"	"unprognostic (1.60e-1)"	"unprognostic (1.06e-3)"	9.3	4.4	1.7	0.9	2.0	0.2	8.2	1.1	1.0	1.7	3.4	1.1	2.9	0.6	3.2	10.5	3.5	1.4	2.9	3.3	1.5	1.5	87.9	122.9	0.6	0.4	1.6	1.0	1.9	0.5	0.5	3.2	0.3	3.5	3.0	0.8	8.2	0.8	4.0	2.2	0.4	1.3	10.5	2.2	0.3	2.4	1.4	0.9	0.0	4.6	1.9	0.4	6.4	4.4	0.9	0.5	3.2	0.4	2.4	0.7	0.3	0.0	0.0	0.0	0.0	4.4	3.2	1.5	3.8	9.1	2.1	4.2	0.0	0.0	0.0	0.0	4.9	0.0	0.0	0.0	0.0	3.1	0.0	0.0	0.1	0.1	38.1	3.5	0.2	0.0	3.9	0.0	23.4	0.0	4.1	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	1.2	0.0	0.2	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	9.8	0.2	0.0	2.5	0.4	0.7	0.4	0.3	0.5	0.5	0.6	0.4	0.2	0.9	0.6	0.7	3.2	2.4	0.2	0.5	0.4	0.3	1.7	2.0	1.1	1.0	1.5	1.5	1.6	1.0	3.5	0.9	6.0	0.3	0.5	0.4	0.7	1.5	3.5	0.0	0.0	0.0	43.6	2.0	0.2	81.2	0.1	0.3	1.6	0.0	0.0	0.0	0.3	7.3	0.4	0.0	181.0	0.3	0.0	1.2	3.1	3.3	0.0	25.3	1.1	0.0	0.0	0.0	4.8	0.0	0.0	35.0	412.5	1.1	6.5	1.7	0.5	0.4	0.9	0.2	0.0	0.0	0.9
BIRC2	"API1, c-IAP1, cIAP1, hiap-2, MIHB, RNF48"	ENSG00000110330	"Baculoviral IAP repeat containing 2"	Q13490	11	102347211-102378670	"Cancer-related genes, Enzymes, Predicted intracellular proteins"	"Apoptosis, Transcription, Transcription regulation, Ubl conjugation pathway"	"Activator, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"							"HPA005513, CAB020661"	Supported		Supported	"Nucleoplasm,Nucleoli fibrillar center,Cytosol"		NA	NA			"Nucleoli fibrillar center, Cytosol"	Nucleoplasm	"CAB020661: , HPA005513: AB_1846746"	"unprognostic (1.36e-1)"	"unprognostic (3.29e-1)"	"unprognostic (9.52e-3)"	"unprognostic (1.62e-1)"	"unprognostic (1.37e-1)"	"unprognostic (7.02e-2)"	"unprognostic (2.72e-2)"	"unprognostic (1.04e-2)"	"unprognostic (1.17e-2)"	"unprognostic (9.59e-2)"	"unprognostic (1.05e-2)"	"unprognostic (3.02e-2)"	"unprognostic (1.84e-2)"	"unprognostic (1.07e-1)"	"unprognostic (9.20e-2)"	"unprognostic (5.00e-2)"	"unprognostic (1.64e-2)"	20.9	25.8	19.1	23.3	24.1	25.9	57.0	20.5	28.5	25.1	22.2	18.4	18.7	19.3	24.6	31.1	18.6	17.0	21.1	39.2	19.1	18.3	24.3	36.8	34.0	47.2	23.3	15.8	21.5	40.8	22.0	27.3	24.3	22.3	19.6	22.2	14.3	21.9	22.1	38.8	17.3	24.4	23.8	26.3	27.6	19.0	19.7	15.5	51.2	18.9	17.3	21.9	22.2	20.2	5.8	12.6	37.5	16.6	12.2	12.0	9.8	9.8	7.3	11.3	8.8	14.3	19.9	7.2	38.3	14.6	22.0	13.4	9.1	24.6	10.9	37.9	17.5	12.3	10.9	7.3	10.1	26.4	14.5	3.7	10.9	5.4	11.0	14.6	6.6	7.0	12.7	19.7	12.5	16.1	20.3	15.0	6.6	9.8	0.0	39.5	3.1	6.9	5.8	5.4	11.8	7.1	3.5	14.7	7.2	17.0	11.4	4.7	6.2	13.3	8.1	11.4	18.1	12.8	8.0	24.6	46.5	10.5	14.0	24.6	4.5	6.1	7.4	10.0	8.3	33.8	31.7	16.6	37.5	9.1	15.2	7.5	5.8	8.7	8.4	12.6	5.6	11.3	11.3	25.5	12.2	16.3	7.6	12.0	9.8	19.1	24.1	20.5	28.5	19.1	18.3	23.3	15.8	22.3	15.5	38.7	40.9	33.3	88.5	59.6	24.1	51.6	63.7	60.2	44.3	61.1	27.5	32.6	36.5	42.3	11.1	49.4	69.1	23.3	63.8	22.6	51.4	66.2	61.2	138.2	36.5	19.1	46.6	67.5	96.7	7.4	33.6	60.1	49.0	85.6	48.7	27.5	44.2	49.9	27.3	66.5	29.1	25.8	53.9	31.1	41.3	54.8	29.4	45.8	37.3	65.0
BIRC3	"API2, c-IAP2, cIAP2, hiap-1, MALT2, MIHC, RNF49"	ENSG00000023445	"Baculoviral IAP repeat containing 3"	Q13489	11	102317450-102339403	"Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Apoptosis, Ubl conjugation pathway"	Transferase	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 46.0;lymphoid tissue: 46.3"	"Cell type enhanced"	"Detected in many"	16	"granulocytes: 530.1;monocytes: 1925.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"memory B-cell: 32.9;naive B-cell: 32.9"	"Group enriched"	"Detected in many"	10	"B-cells: 32.9;T-cells: 17.1"	"Cell line enhanced"	"Detected in many"		"CAPAN-2: 38.4;Daudi: 33.7;HDLM-2: 31.9;hTERT-HME1: 33.6;U-266/70: 22.5;U-266/84: 19.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA002317	Enhanced	Approved	Supported	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"HPA002317: AB_1846748"	"prognostic favorable (3.60e-4)"	"unprognostic (2.89e-1)"	"prognostic favorable (9.35e-4)"	"unprognostic (3.28e-2)"	"prognostic unfavorable (7.28e-4)"	"unprognostic (5.83e-3)"	"unprognostic (2.23e-1)"	"unprognostic (3.88e-3)"	"unprognostic (9.62e-2)"	"unprognostic (1.29e-1)"	"prognostic unfavorable (3.03e-4)"	"unprognostic (3.21e-1)"	"prognostic unfavorable (6.66e-6)"	"unprognostic (6.42e-2)"	"unprognostic (6.23e-3)"	"unprognostic (1.00e-1)"	"unprognostic (3.85e-2)"	6.9	3.3	1.4	43.9	2.3	5.1	5.4	0.5	2.0	5.3	13.1	0.5	2.8	6.8	2.9	3.7	8.4	3.9	13.9	6.0	2.2	1.3	10.8	12.5	21.8	46.3	2.8	1.2	3.4	7.0	1.1	14.5	0.9	2.2	8.7	6.2	1.1	9.2	4.7	2.2	5.5	46.0	7.3	3.0	34.9	15.9	3.2	2.7	34.2	3.0	4.1	34.0	12.6	6.2	32.9	0.8	2.0	2.6	2.5	17.1	2.8	6.5	5.3	0.0	0.1	0.1	0.7	0.6	0.5	4.4	0.6	0.7	0.9	38.4	33.7	17.4	0.3	5.5	3.6	0.0	0.9	2.1	31.9	0.1	0.1	1.6	0.2	6.6	0.5	0.7	0.7	4.7	2.1	33.6	1.2	0.1	2.7	0.1	0.0	0.8	0.0	2.3	0.3	0.1	3.1	0.2	0.0	0.3	1.7	8.7	3.4	0.0	0.1	0.5	0.6	0.3	0.2	1.7	0.3	1.7	7.3	0.8	0.4	6.7	22.5	19.2	11.9	1.3	1.9	0.9	2.0	0.9	0.4	1.4	2.2	2.5	32.9	10.7	3.5	0.8	32.9	7.5	2.2	0.5	2.5	2.6	0.3	17.1	2.8	1.4	2.3	0.5	2.0	2.2	1.3	2.8	1.2	2.2	2.7	134.0	68.1	285.1	318.0	89.9	0.3	12.0	76.5	30.8	73.9	38.4	0.0	1.7	6.6	193.4	1.3	50.1	284.0	46.7	153.8	0.5	71.9	371.3	530.1	3.4	11.1	0.0	14.5	7.4	18.1	1.3	4.6	71.9	182.2	1925.2	27.1	0.1	190.8	361.2	2.1	8.8	0.0	0.0	133.5	0.5	0.4	73.9	0.5	89.3	29.9	164.7
BIRC6	BRUCE	ENSG00000115760	"Baculoviral IAP repeat containing 6"	Q9NR09	2	32357028-32618899	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins"	"Apoptosis, Cell cycle, Cell division, Mitosis, Ubl conjugation pathway"	"Protease inhibitor, Thiol protease inhibitor, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Cone photoreceptor cells: 180.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA074409, HPA074738"	Approved		Supported	"Golgi apparatus,Vesicles,Mitotic spindle"		Yes	No			"Golgi apparatus, Vesicles"	"Mitotic spindle"	"HPA074409: , HPA074738: AB_2686710"	"unprognostic (3.38e-2)"	"unprognostic (8.13e-3)"	"unprognostic (8.88e-2)"	"unprognostic (7.06e-3)"	"unprognostic (6.69e-3)"	"unprognostic (9.01e-2)"	"unprognostic (4.51e-2)"	"unprognostic (2.07e-1)"	"unprognostic (1.32e-1)"	"unprognostic (1.86e-1)"	"unprognostic (4.49e-2)"	"unprognostic (4.00e-2)"	"unprognostic (2.07e-2)"	"unprognostic (1.30e-1)"	"unprognostic (4.61e-1)"	"unprognostic (7.32e-2)"	"unprognostic (3.37e-1)"	15.0	16.7	10.3	20.7	14.4	18.4	16.1	21.9	13.7	16.2	13.0	15.3	15.6	8.7	17.2	13.9	13.2	13.1	11.7	11.4	9.8	7.3	14.1	14.8	12.5	16.1	13.9	11.8	23.6	24.8	32.5	17.4	14.1	14.8	11.3	13.6	11.5	14.7	17.1	20.9	14.9	16.0	12.5	13.3	16.1	13.9	13.0	14.4	23.1	21.5	9.2	17.2	16.2	12.0	3.8	2.8	10.6	2.4	2.3	3.4	0.7	15.3	12.8	11.9	5.1	9.4	13.4	7.2	6.8	9.6	8.4	8.0	8.8	3.6	16.4	5.4	12.7	9.6	7.1	16.7	10.1	10.4	13.2	7.6	22.3	8.1	7.3	5.2	20.6	7.9	8.9	4.9	13.1	11.7	6.8	12.4	3.7	18.1	7.1	7.7	5.9	10.3	4.8	8.0	5.8	7.6	10.5	19.3	5.6	6.1	15.8	8.9	13.6	13.4	7.0	6.2	9.5	4.6	7.4	19.4	8.8	9.9	5.9	10.4	9.5	13.3	22.0	6.4	10.2	5.7	10.6	1.6	0.9	2.7	1.2	3.4	1.7	2.1	2.3	1.3	3.8	2.3	2.6	2.7	2.3	2.4	2.8	1.6	0.7	10.3	14.4	21.9	13.7	9.8	7.3	13.9	11.8	14.8	14.4	29.8	26.2	37.9	25.6	40.9	59.4	42.2	30.6	10.7	35.2	34.9	180.6	28.6	1.7	22.3	35.8	45.7	44.5	0.0	26.8	18.3	30.5	38.3	29.9	44.3	26.3	65.2	31.2	46.1	58.6	13.7	42.0	32.8	21.9	31.5	36.3	39.9	28.2	25.9	55.5	19.2	89.9	38.8	42.4	52.0	44.5	47.9	31.8	56.8	37.0	38.9
BIRC7	"KIAP, ML-IAP, mliap, RNF50"	ENSG00000101197	"Baculoviral IAP repeat containing 7"	Q96CA5	20	63235883-63240507	"Enzymes, Predicted intracellular proteins"	"Apoptosis, Ubl conjugation pathway"	"Protease inhibitor, Thiol protease inhibitor, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"epididymis: 14.4;placenta: 13.6;retina: 21.1"	"Group enriched"	"Detected in some"	5	"Hofbauer cells: 56.9;Melanocytes: 25.3;Muller glia cells: 46.0"	"Cancer enriched"	"Detected in many"	10	"melanoma: 73.7"	"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in single"		"naive CD8 T-cell: 2.0"	"Lineage enriched"	"Detected in single"	9	"T-cells: 2.0"	"Cell line enriched"	"Detected in some"	4	"SK-MEL-30: 63.7"	"Not detected"	"Not detected"							"HPA047850, HPA061283"			Enhanced	Nucleoplasm,Centrosome,Cytosol		NA	NA			Nucleoplasm	"Centrosome, Cytosol"	"HPA047850: AB_2680181, HPA061283: "	"unprognostic (3.60e-1)"	"unprognostic (7.94e-2)"	"unprognostic (2.70e-2)"	"unprognostic (1.78e-3)"	"unprognostic (1.15e-1)"	"unprognostic (8.11e-2)"	"unprognostic (1.69e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.62e-3)"	"unprognostic (1.24e-2)"	"unprognostic (6.90e-2)"	"unprognostic (2.27e-1)"	"unprognostic (8.82e-3)"	"unprognostic (1.22e-2)"	"unprognostic (4.77e-2)"	"unprognostic (2.55e-2)"	"unprognostic (4.84e-2)"	1.6	1.3	1.0	0.7	1.0	0.3	0.7	0.1	2.2	3.0	1.3	0.5	0.1	0.4	0.8	14.4	0.3	0.3	0.5	2.8	0.9	1.1	2.6	0.8	2.3	2.2	4.9	1.0	0.2	0.1	0.1	0.6	13.6	1.5	0.4	0.3	21.1	0.8	0.1	0.1	4.9	0.3	0.2	4.3	1.6	0.3	0.4	0.3	0.3	0.3	1.0	0.5	0.4	1.8	0.0	0.0	0.0	0.2	0.0	2.0	0.1	0.1	1.4	0.0	0.0	0.0	0.0	2.9	0.0	0.0	0.0	0.0	2.2	0.4	0.0	6.2	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	7.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	12.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	63.7	1.6	0.4	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	14.3	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.9	2.0	0.0	0.0	0.0	0.0	0.0	0.1	1.0	1.0	0.1	2.2	0.9	1.1	4.9	1.0	1.5	0.3	0.0	0.6	0.0	0.0	1.1	0.0	0.6	0.0	0.0	0.0	1.8	0.0	1.4	0.0	0.6	0.1	0.0	0.0	0.0	0.6	8.2	0.5	0.0	2.3	0.0	56.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	25.3	0.0	0.0	46.0	2.3	0.0	0.0	1.1	0.8	0.0	0.0	0.0	0.0	0.0	7.1	0.0	0.0	0.0
BLK	MGC10442	ENSG00000136573	"BLK proto-oncogene, Src family tyrosine kinase"	P51451	8	11486894-11564604	"Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		"Kinase, Transferase, Tyrosine-protein kinase"	"Cancer-related genes, Diabetes mellitus"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	15	"blood: 47.8;intestine: 23.5;lymphoid tissue: 39.8"	"Cell type enriched"	"Detected in some"	52	"B-cells: 93.8"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"memory B-cell: 47.8;naive B-cell: 33.9"	"Lineage enriched"	"Detected in many"	5	"B-cells: 47.8"	"Cell line enhanced"	"Detected in some"		"Daudi: 44.0;REH: 11.9;RPMI-8226: 14.5;U-698: 21.5;U-87 MG: 9.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"CAB005093, HPA069571"	Approved		Uncertain	Nucleoplasm		NA	NA			Nucleoplasm		"CAB005093: AB_2274756, HPA069571: AB_2732137"	"unprognostic (6.50e-5)"	"unprognostic (4.22e-3)"	"unprognostic (5.64e-2)"	"unprognostic (1.42e-1)"	"unprognostic (3.45e-1)"	"unprognostic (5.98e-6)"	"unprognostic (1.59e-2)"	"unprognostic (8.94e-4)"	"unprognostic (1.02e-3)"	"unprognostic (9.83e-3)"	"unprognostic (1.22e-2)"	"unprognostic (4.66e-2)"	"unprognostic (9.05e-6)"	"unprognostic (5.62e-2)"	"unprognostic (5.43e-2)"	"unprognostic (2.19e-1)"	"unprognostic (1.16e-1)"	0.5	0.2	0.1	32.3	0.1	1.7	0.2	0.1	0.1	0.1	1.2	0.0	0.0	0.3	0.1	0.0	1.9	0.2	0.4	0.3	0.1	0.1	1.3	0.5	0.6	27.6	0.1	0.1	0.1	0.1	0.0	0.1	0.0	0.0	0.4	0.4	0.3	2.4	0.0	0.1	0.1	23.5	0.0	0.1	31.9	1.4	0.2	0.0	3.9	0.7	0.4	39.8	2.5	0.4	47.8	4.3	0.1	0.0	0.0	9.8	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	44.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	11.9	0.0	14.5	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	2.3	3.8	21.5	9.1	0.0	0.0	0.0	0.0	0.0	0.5	0.0	9.8	47.8	0.3	1.1	0.0	33.9	0.2	0.1	0.1	0.0	0.0	4.3	0.4	1.9	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	93.8	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
BLM	"BS, RECQ2, RECQL3"	ENSG00000197299	"Bloom syndrome RecQ like helicase"	P54132	15	90717327-90816165	"Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"DNA damage, DNA repair, DNA replication"	"DNA-binding, Helicase, Hydrolase"	"Cancer-related genes, Disease mutation, Dwarfism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"lymphoid tissue: 36.7"	"Cell type enhanced"	"Detected in many"	6	"B-cells: 18.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA005689	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA005689: AB_1845372"	"unprognostic (2.77e-1)"	"unprognostic (3.82e-3)"	"unprognostic (4.03e-2)"	"unprognostic (2.98e-2)"	"unprognostic (4.75e-2)"	"unprognostic (9.89e-2)"	"unprognostic (6.12e-5)"	"unprognostic (2.82e-2)"	"unprognostic (4.55e-3)"	"unprognostic (5.24e-3)"	"unprognostic (1.80e-3)"	"unprognostic (9.12e-2)"	"unprognostic (1.55e-15)"	"unprognostic (6.53e-3)"	"unprognostic (6.55e-2)"	"unprognostic (2.43e-1)"	"unprognostic (1.83e-2)"	1.8	0.4	3.1	11.4	1.5	5.5	0.6	4.7	2.6	0.7	1.9	0.9	0.5	1.4	1.2	1.1	2.9	0.4	1.3	1.0	2.3	2.4	0.9	0.5	2.0	7.7	2.8	0.2	0.9	0.4	0.0	1.2	3.6	0.5	0.7	2.5	0.7	7.8	0.0	1.7	0.6	2.8	0.5	1.9	6.7	1.4	4.9	0.5	36.7	0.6	3.1	9.3	1.4	0.7	7.4	1.2	4.3	1.6	4.6	5.0	1.6	5.5	7.8	8.8	5.1	0.0	0.4	5.5	4.1	1.2	4.7	5.1	6.9	3.9	14.2	2.6	1.1	5.9	9.2	13.5	3.7	6.1	8.6	10.0	14.9	8.5	2.2	0.0	14.3	7.4	0.0	0.0	4.7	2.4	0.6	3.3	7.7	12.8	4.4	4.9	3.4	10.7	7.8	9.3	12.1	1.7	10.9	16.5	5.5	1.1	9.9	6.5	6.1	3.3	4.5	2.6	8.6	3.1	11.7	1.8	3.4	6.3	3.5	8.8	3.3	13.2	14.8	1.9	10.1	5.9	2.5	1.0	4.3	3.1	1.2	4.8	7.4	2.8	3.8	1.2	4.3	2.0	2.2	0.8	4.6	1.6	1.2	5.0	1.6	3.1	1.5	4.7	1.7	2.3	2.4	2.8	0.2	0.5	0.5	3.0	12.8	18.6	0.5	0.2	2.9	8.4	0.0	9.4	6.8	0.0	2.0	1.8	1.7	0.9	2.0	0.7	0.0	0.0	0.6	6.5	1.5	0.6	12.7	0.5	4.8	0.0	0.0	2.5	9.7	1.6	0.0	3.8	0.0	1.0	1.2	1.2	0.8	0.0	0.4	0.0	6.5	0.0	0.4	12.0	11.8	0.5	0.8	8.7	2.3	0.3
BLMH	BH	ENSG00000108578	"Bleomycin hydrolase"	Q13867	17	30248195-30292056	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins"		"Hydrolase, Protease, Thiol protease"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skin 1: 67.5"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"							"HPA039548, HPA064307"	Enhanced		Supported	"Nucleoplasm,Nuclear bodies,Cytosol"		No	No		59000000	"Nucleoplasm, Nuclear bodies, Cytosol"		"HPA039548: AB_10805479, HPA064307: AB_2685241"	"unprognostic (6.85e-2)"	"unprognostic (2.79e-1)"	"unprognostic (1.48e-1)"	"unprognostic (2.46e-1)"	"unprognostic (1.76e-1)"	"unprognostic (2.54e-2)"	"unprognostic (3.91e-3)"	"unprognostic (2.07e-1)"	"unprognostic (2.05e-3)"	"unprognostic (6.69e-3)"	"unprognostic (1.95e-3)"	"unprognostic (2.14e-2)"	"unprognostic (2.14e-2)"	"unprognostic (1.22e-3)"	"unprognostic (1.05e-1)"	"unprognostic (1.34e-1)"	"unprognostic (1.44e-1)"	11.2	8.3	9.0	17.1	10.2	8.5	14.2	12.1	14.5	10.5	9.8	8.5	9.6	6.7	13.1	12.2	15.7	8.4	10.1	9.7	7.5	7.2	13.6	7.5	13.6	20.3	9.5	8.5	8.8	15.3	15.0	8.3	14.6	9.2	8.4	8.5	7.3	12.8	9.5	15.0	67.5	10.0	15.7	11.1	13.2	9.2	12.4	8.6	24.7	9.3	15.5	13.6	10.8	11.7	4.6	6.6	0.9	5.7	9.8	17.3	6.3	10.2	16.2	15.6	10.8	10.7	11.5	7.6	9.5	5.9	15.1	13.0	23.7	3.0	30.4	17.0	7.7	6.8	7.1	33.8	13.0	12.8	8.0	26.6	18.6	14.5	20.1	15.7	33.9	11.5	13.6	0.9	11.8	6.8	12.4	22.1	25.5	39.7	12.4	6.2	7.7	42.0	24.8	15.0	0.0	7.6	36.4	40.6	20.1	12.0	9.1	36.1	12.9	8.4	16.5	10.4	28.2	11.2	17.5	14.0	9.3	18.8	4.1	16.8	15.0	30.9	41.1	7.1	0.0	12.4	0.0	5.7	0.9	10.5	3.9	17.3	4.6	12.6	13.7	6.5	4.2	11.6	12.3	0.7	9.8	1.9	6.6	12.4	6.3	9.0	10.2	12.1	14.5	7.5	7.2	9.5	8.5	9.2	8.6	3.0	13.0	12.3	14.0	14.2	18.2	16.5	12.7	6.7	2.3	10.4	11.8	41.1	6.6	14.9	8.2	17.9	8.9	0.0	12.2	31.7	13.3	8.5	43.8	6.6	22.1	12.7	17.2	28.3	21.8	5.2	15.0	10.4	10.1	10.0	7.6	10.9	8.9	8.6	23.3	17.0	16.0	6.5	15.3	9.7	16.7	11.0	23.0	18.7	10.7	5.9
BLVRA	BLVR	ENSG00000106605	"Biliverdin reductase A"	P53004	7	43758680-43807342	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Hofbauer cells: 210.4;monocytes: 171.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019709, HPA042865, HPA054322"	Approved		Supported	Cytosol		NA	NA		1600000	Cytosol		"HPA019709: AB_2670239, HPA042865: AB_10797024, HPA054322: AB_2682450"	"unprognostic (2.47e-2)"	"unprognostic (8.38e-3)"	"unprognostic (1.79e-2)"	"unprognostic (2.16e-3)"	"unprognostic (6.45e-3)"	"unprognostic (5.01e-2)"	"unprognostic (1.63e-2)"	"prognostic favorable (8.65e-4)"	"unprognostic (1.42e-1)"	"unprognostic (1.75e-2)"	"unprognostic (2.93e-1)"	"unprognostic (9.27e-2)"	"unprognostic (1.15e-2)"	"unprognostic (5.63e-3)"	"unprognostic (3.18e-1)"	"unprognostic (2.13e-3)"	"unprognostic (4.56e-2)"	31.7	13.1	14.5	16.2	14.7	23.8	22.5	13.3	21.9	22.7	25.9	9.1	12.6	5.2	19.3	58.7	35.8	18.7	17.5	21.7	11.9	16.2	26.8	6.0	27.7	25.1	15.8	15.4	26.4	14.8	19.3	13.1	12.2	20.5	21.8	8.8	17.2	17.9	21.1	23.0	15.1	12.2	26.4	10.6	40.9	17.7	9.3	6.7	12.1	19.0	21.3	21.5	28.5	18.9	4.9	23.2	27.5	61.6	3.4	14.0	30.7	11.3	22.0	6.4	26.7	13.7	18.3	0.3	7.7	23.9	13.2	16.2	5.2	6.8	0.0	14.9	12.2	46.9	14.9	19.6	19.5	11.3	53.1	13.7	24.4	20.3	32.2	35.0	2.7	9.2	12.4	33.1	13.9	9.3	26.7	22.4	12.3	16.1	13.5	10.0	12.2	8.4	1.4	8.7	2.5	25.4	18.8	11.1	61.4	29.3	6.3	8.3	25.6	15.8	15.8	12.8	11.8	35.5	18.3	13.6	12.2	13.5	5.3	13.1	18.3	14.4	0.0	19.9	11.0	18.9	7.8	50.5	27.5	7.0	61.6	6.6	4.9	14.0	11.7	23.2	2.4	7.5	5.8	4.5	3.4	57.7	3.4	13.6	30.7	14.5	14.7	13.3	21.9	11.9	16.2	15.8	15.4	20.5	6.7	56.6	76.2	9.0	49.2	25.8	17.0	52.9	12.7	76.3	62.6	33.2	2.0	8.3	48.0	45.9	0.6	26.4	1.3	46.7	30.3	8.7	33.7	33.1	108.6	0.9	210.4	7.9	0.0	24.5	107.5	1.3	34.2	72.6	43.9	171.3	0.0	19.3	29.9	0.0	27.3	86.5	11.5	45.3	49.2	2.6	3.8	30.1	4.3	25.0	0.4	35.9
BLVRB	"FLR, SDR43U1"	ENSG00000090013	"Biliverdin reductase B"	P30043	19	40447765-40465840	"Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"		Oxidoreductase	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 137.6"	"Cell type enhanced"	"Detected in all"	13	"Erythroid cells: 2523.0;Hofbauer cells: 895.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"classical monocyte: 73.4"	"Group enriched"	"Detected in all"	7	"dendritic cells: 54.8;monocytes: 73.4"	"Cell line enhanced"	"Detected in many"		"A549: 81.2;K-562: 73.7;OE19: 64.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041698, HPA041937"	Enhanced		Supported	"Nucleoplasm,Vesicles,Plasma membrane,Cytosol"		No	No		440000000	Cytosol	"Nucleoplasm, Vesicles, Plasma membrane"	"HPA041698: AB_10796781, HPA041937: AB_10794308"	"unprognostic (1.86e-1)"	"unprognostic (1.14e-2)"	"unprognostic (4.23e-1)"	"unprognostic (1.50e-1)"	"unprognostic (2.08e-1)"	"unprognostic (2.46e-1)"	"unprognostic (9.92e-2)"	"unprognostic (1.20e-2)"	"unprognostic (8.56e-2)"	"unprognostic (1.35e-1)"	"prognostic unfavorable (3.90e-4)"	"unprognostic (2.30e-1)"	"unprognostic (2.70e-1)"	"unprognostic (2.02e-1)"	"unprognostic (5.11e-2)"	"unprognostic (1.25e-1)"	"unprognostic (3.92e-2)"	36.9	17.9	10.9	12.8	12.2	137.6	28.9	3.5	10.9	17.0	26.7	7.7	18.5	20.9	14.1	19.6	45.3	14.6	19.0	31.0	8.2	8.6	31.8	72.4	37.3	30.0	11.7	9.6	21.3	19.4	5.7	5.6	32.2	13.8	22.9	7.7	17.5	27.1	22.1	43.4	16.7	26.4	22.1	9.7	47.1	31.1	7.6	7.9	6.6	24.3	42.9	24.4	29.9	22.1	8.6	54.8	9.1	73.4	4.0	5.3	34.4	34.2	81.2	1.1	12.1	11.3	10.9	9.6	4.3	12.7	5.9	11.5	15.9	31.1	11.5	33.5	7.7	19.2	11.0	4.1	9.4	1.2	19.5	3.5	17.5	12.2	9.6	26.1	0.2	5.1	10.6	17.9	7.9	4.4	6.0	6.2	4.3	73.7	20.9	6.9	53.2	0.9	1.0	0.3	64.3	22.7	8.1	3.8	18.6	7.4	23.1	0.0	1.8	13.1	34.7	13.2	1.6	33.7	2.6	6.7	15.8	16.9	24.2	2.3	11.4	13.4	4.3	41.1	6.9	6.1	5.0	73.4	2.6	4.6	33.7	4.4	8.6	4.0	4.0	54.8	5.4	4.2	3.3	9.1	4.0	16.9	11.5	5.3	34.4	10.9	12.2	3.5	10.9	8.2	8.6	11.7	9.6	13.8	7.9	205.4	126.9	50.2	283.1	114.9	10.9	116.8	180.9	95.0	73.9	92.5	5.9	76.7	225.5	197.9	7.2	54.2	483.6	2523.0	231.2	82.2	103.0	212.9	41.6	520.7	895.0	9.5	43.0	55.9	549.4	16.6	115.1	152.9	136.7	94.6	130.3	62.8	228.4	480.5	88.4	302.1	11.3	32.3	73.1	2.1	3.6	114.0	62.5	43.7	144.8	253.2
BMP1	PCOLC	ENSG00000168487	"Bone morphogenetic protein 1"	P13497	8	22164736-22212326	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted secreted proteins"	"Chondrogenesis, Differentiation, Osteogenesis"	"Cytokine, Developmental protein, Growth factor, Hydrolase, Metalloprotease, Protease"	"Disease mutation, Osteogenesis imperfecta"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	8	"lung: 72.2;placenta: 106.2"	"Cell type enhanced"	"Detected in many"	8	"Alveolar cells type 2: 61.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA014572	Enhanced				"Secreted to extracellular matrix"	NA	NA		2100000			"HPA014572: AB_1845390"	"unprognostic (1.24e-1)"	"unprognostic (8.01e-2)"	"unprognostic (3.75e-2)"	"unprognostic (5.89e-2)"	"unprognostic (1.34e-2)"	"unprognostic (6.76e-2)"	"unprognostic (9.53e-2)"	"unprognostic (2.64e-3)"	"unprognostic (1.66e-1)"	"unprognostic (9.75e-3)"	"unprognostic (7.05e-3)"	"unprognostic (3.14e-2)"	"prognostic unfavorable (3.37e-9)"	"unprognostic (2.11e-2)"	"unprognostic (6.57e-2)"	"unprognostic (1.50e-3)"	"unprognostic (3.34e-2)"	6.9	11.7	2.7	3.6	4.6	1.1	5.9	7.8	4.2	8.1	5.8	3.1	3.7	4.4	9.4	5.2	4.8	7.7	5.4	3.4	2.6	1.3	4.9	9.2	72.2	3.2	3.4	1.5	5.2	3.7	2.8	2.2	106.2	3.5	6.5	4.7	4.6	2.4	4.6	2.4	6.8	5.7	11.0	3.6	3.2	2.9	2.2	3.6	1.0	7.1	2.4	2.9	9.9	9.5	0.0	0.9	0.1	1.4	0.8	2.2	0.4	4.6	4.8	1.3	6.2	15.2	11.3	6.8	20.2	16.8	10.3	9.6	2.5	3.0	1.1	12.7	18.5	6.4	10.1	1.5	5.3	2.0	1.0	2.1	1.7	7.3	2.8	12.4	0.7	3.4	12.8	8.5	8.0	2.6	18.3	10.0	0.6	2.1	2.0	5.6	1.7	0.4	1.0	0.8	6.9	2.6	1.1	3.3	4.9	8.9	0.7	0.8	3.3	14.6	0.8	3.3	5.6	0.9	2.0	12.6	2.7	5.9	6.5	5.9	1.0	0.6	0.2	5.3	2.7	7.4	0.0	1.4	0.0	2.2	0.7	1.4	0.0	0.4	1.0	0.0	0.0	0.3	1.7	0.1	0.8	0.5	0.9	0.0	0.4	2.7	4.6	7.8	4.2	2.6	1.3	3.4	1.5	3.5	3.6	6.0	61.3	0.5	5.3	5.6	1.5	3.0	2.5	1.4	2.3	5.2	0.0	2.4	0.0	21.2	0.5	10.5	18.6	0.0	7.1	8.6	24.4	2.5	15.0	15.8	4.1	1.6	2.9	14.1	4.0	0.5	9.5	3.5	10.1	0.0	5.5	3.2	11.4	11.0	10.3	3.1	1.0	25.8	18.4	0.9	3.6	4.5	20.4	1.9	9.7	6.4
BMP2K	"BIKe, DKFZp434K0614"	ENSG00000138756	"BMP2 inducible kinase"	Q9NSY1	4	78776342-78916372	"Enzymes, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"granulocytes: 124.9;Hofbauer cells: 112.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in all"		"HEL: 38.8;HMC-1: 42.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA026436, HPA026451, HPA026501"	Approved		Supported	"Nuclear speckles"		NA	NA			"Nuclear speckles"		"HPA026436: AB_10600102, HPA026451: AB_10600228, HPA026501: AB_10601341"	"unprognostic (7.96e-2)"	"unprognostic (3.68e-1)"	"prognostic favorable (1.74e-4)"	"unprognostic (9.08e-2)"	"unprognostic (1.97e-1)"	"unprognostic (9.73e-3)"	"unprognostic (1.51e-2)"	"unprognostic (1.47e-1)"	"unprognostic (2.98e-1)"	"unprognostic (7.60e-2)"	"unprognostic (1.39e-1)"	"unprognostic (9.60e-2)"	"unprognostic (9.90e-2)"	"unprognostic (9.45e-2)"	"unprognostic (1.59e-1)"	"unprognostic (1.55e-2)"	"unprognostic (3.18e-2)"	11.4	11.1	15.6	18.6	15.0	15.3	12.0	8.2	12.7	11.1	13.9	20.3	2.1	8.0	11.3	9.6	15.7	10.0	12.3	17.0	18.0	9.5	8.3	10.2	14.1	22.9	20.9	12.0	6.5	6.4	7.7	7.8	14.4	14.5	8.4	18.9	11.4	10.2	6.0	7.5	14.5	15.9	10.4	28.3	19.2	7.4	19.6	16.5	19.9	12.5	5.9	24.4	9.7	12.8	2.7	1.7	3.8	2.6	0.4	0.4	0.5	5.5	2.0	3.0	4.0	6.0	5.8	2.4	5.4	8.3	6.0	7.9	3.8	2.9	6.7	2.7	25.8	5.2	1.3	3.6	4.3	11.0	1.9	1.3	38.8	2.4	1.7	6.7	8.1	42.0	8.4	5.6	9.4	8.7	3.2	8.1	4.9	10.4	19.5	7.1	1.2	4.8	3.4	1.4	3.7	1.4	7.0	5.5	1.6	7.3	3.0	4.8	2.6	7.8	4.0	4.7	3.8	1.4	4.2	7.9	5.9	2.3	9.8	5.7	3.6	1.4	2.6	5.2	10.2	4.1	0.4	2.2	1.2	0.1	0.9	0.1	2.7	0.1	0.0	1.7	2.7	0.4	0.2	3.8	0.4	2.6	1.3	0.0	0.5	15.6	15.0	8.2	12.7	18.0	9.5	20.9	12.0	14.5	16.5	26.8	18.1	10.4	3.8	22.1	9.6	5.7	2.5	6.7	6.8	7.0	3.9	4.0	0.0	7.0	11.1	12.4	19.7	46.7	7.6	11.6	12.4	6.3	124.9	16.3	112.6	9.5	6.4	30.7	61.7	7.6	7.5	31.6	27.0	22.6	41.6	46.4	10.6	48.2	6.3	18.1	8.4	6.5	7.4	24.1	9.6	27.5	2.9	3.9	21.8	2.3
BMPR1A	"ACVRLK3, ALK3, CD292"	ENSG00000107779	"Bone morphogenetic protein receptor type 1A"	P36894	10	86756601-86932838	"Cancer-related genes, CD markers, Disease related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins"		"Kinase, Receptor, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes, Disease mutation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB019398	Approved		Approved	Cytosol		NA	NA			Cytosol		"CAB019398: "	"unprognostic (1.36e-1)"	"unprognostic (2.46e-1)"	"unprognostic (3.34e-1)"	"unprognostic (9.61e-2)"	"unprognostic (1.05e-3)"	"unprognostic (9.34e-2)"	"prognostic unfavorable (8.93e-4)"	"unprognostic (3.64e-1)"	"unprognostic (2.38e-2)"	"unprognostic (1.53e-1)"	"unprognostic (9.24e-2)"	"unprognostic (9.42e-2)"	"unprognostic (4.32e-2)"	"unprognostic (1.80e-1)"	"unprognostic (1.47e-1)"	"unprognostic (1.01e-2)"	"unprognostic (1.07e-1)"	8.9	7.0	9.4	7.9	12.4	0.9	10.7	14.1	9.2	19.4	20.6	10.9	7.7	6.2	16.3	12.3	8.4	10.9	10.8	11.0	7.7	6.1	8.2	4.6	7.4	2.9	7.3	7.6	16.1	10.6	10.0	14.0	7.4	8.5	12.8	9.3	10.9	12.6	14.2	8.4	11.3	9.8	16.5	12.2	3.4	12.1	7.8	9.2	0.3	19.4	7.8	5.7	16.0	11.4	1.8	1.1	3.6	0.8	0.9	1.4	0.3	7.3	3.7	14.3	12.1	7.5	4.8	2.5	7.4	7.7	4.3	5.1	6.2	6.4	2.2	3.4	9.4	3.1	7.8	6.3	8.0	6.4	2.4	3.6	2.8	3.5	10.3	4.0	3.8	19.7	4.2	3.4	5.8	4.3	6.4	0.0	4.1	4.4	1.5	5.0	3.1	2.6	3.1	7.7	2.6	1.7	0.0	5.6	0.0	8.9	6.9	1.4	4.6	8.2	4.2	4.9	18.2	7.1	1.9	3.7	3.1	5.0	6.4	6.8	0.4	6.8	2.8	2.7	2.6	2.5	2.0	0.8	0.6	1.4	0.5	0.9	1.8	1.4	1.2	0.3	1.5	1.0	1.1	3.6	0.9	0.6	1.1	0.7	0.3	9.4	12.4	14.1	9.2	7.7	6.1	7.3	7.6	8.5	9.2	32.8	24.8	0.0	6.7	10.8	6.0	19.0	10.2	13.4	9.1	10.4	19.6	10.0	1.7	9.8	0.6	2.1	9.0	0.0	8.1	0.7	13.3	12.9	15.0	7.2	2.7	11.1	17.3	8.0	4.0	1.7	31.1	3.5	8.5	1.0	13.6	12.9	7.7	3.5	29.4	4.7	19.0	6.5	14.1	2.3	3.6	8.5	4.2	0.0	10.0	4.2
BMPR1B	"ALK6, CDw293"	ENSG00000138696	"Bone morphogenetic protein receptor type 1B"	O00238	4	94757968-95158448	"CD markers, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	Chondrogenesis	"Kinase, Receptor, Serine/threonine-protein kinase, Transferase"	"Disease mutation, Dwarfism"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"cervix, uterine: 28.0;ductus deferens: 25.1;prostate: 25.3;seminal vesicle: 32.0"	"Group enriched"	"Detected in many"	5	"Ciliated cells: 14.7;Club cells: 22.7;Collecting duct cells: 57.6;Glandular cells: 28.8;Intestinal endocrine cells: 17.6;Melanocytes: 27.0;Muller glia cells: 44.8"	"Cancer enhanced"	"Detected in many"		"breast cancer: 32.4;prostate cancer: 24.7"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"A549: 18.7;MCF7: 9.4;SH-SY5Y: 15.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA						"unprognostic (2.25e-1)"	"unprognostic (1.80e-2)"	"unprognostic (1.40e-3)"	"prognostic favorable (2.84e-4)"	"unprognostic (1.57e-1)"	"unprognostic (4.22e-2)"	"unprognostic (1.92e-1)"	"unprognostic (2.86e-2)"	"unprognostic (2.95e-2)"	"unprognostic (1.01e-1)"	"unprognostic (3.97e-2)"	"unprognostic (3.93e-1)"	"unprognostic (1.62e-3)"	"unprognostic (7.89e-4)"	"unprognostic (6.22e-2)"	"unprognostic (3.81e-3)"	"unprognostic (2.63e-2)"	1.1	5.6	12.7	0.8	15.0	0.7	1.7	11.6	12.7	28.0	1.2	5.5	25.1	0.7	5.3	3.2	1.1	14.3	3.4	1.3	13.4	5.9	9.3	1.4	2.4	0.5	5.4	8.6	7.6	1.7	0.6	2.4	1.2	12.1	25.3	0.8	0.7	1.4	32.0	3.3	1.4	0.6	1.2	7.5	1.4	2.8	4.3	11.2	10.8	0.8	0.1	0.6	0.7	0.7	0.4	0.5	1.9	0.9	0.8	1.6	0.3	0.0	18.7	5.0	0.0	2.0	4.6	0.1	0.1	0.0	0.1	0.4	0.0	0.1	0.0	0.2	0.8	0.0	1.0	2.9	6.9	0.0	0.0	4.6	0.0	1.1	0.0	0.5	0.4	0.0	2.8	7.6	2.8	5.7	0.3	0.0	0.0	0.0	0.0	7.2	9.4	0.6	0.1	1.8	0.1	3.2	0.1	2.8	0.1	3.6	0.1	0.2	15.6	0.2	2.5	2.5	0.7	1.9	0.0	0.0	4.0	3.2	0.1	3.4	0.0	0.0	0.0	1.5	0.0	0.4	1.9	0.3	0.5	0.4	0.5	0.7	0.4	0.6	0.3	0.3	0.3	0.5	0.5	0.8	0.8	0.9	0.5	1.6	0.3	12.7	15.0	11.6	11.8	13.4	5.9	5.4	8.6	12.1	11.2	6.0	0.0	0.0	1.3	2.4	0.2	3.6	5.1	14.7	22.7	57.6	0.0	0.0	1.7	2.9	1.1	0.3	0.0	0.0	0.3	0.2	1.4	28.8	0.0	0.0	0.1	0.0	17.6	4.9	0.0	1.6	2.8	0.3	27.0	0.0	0.0	44.8	0.7	0.0	3.5	0.0	1.2	0.0	1.4	1.6	1.3	1.9	0.0	0.0	0.0	1.0
BMPR2	"BMPR-II, BMPR3, BRK-3, PPH1, T-ALK"	ENSG00000204217	"Bone morphogenetic protein receptor type 2"	Q13873	2	202376936-202567751	"Disease related genes, Enzymes, FDA approved drug targets, Predicted membrane proteins"		"Kinase, Receptor, Serine/threonine-protein kinase, Transferase"	"Disease mutation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA017385, HPA049014"	Approved		Supported	"Nucleoplasm,Plasma membrane"		NA	NA			"Plasma membrane"	Nucleoplasm	"HPA017385: AB_1845397, HPA049014: AB_2680599"	"unprognostic (2.17e-1)"	"unprognostic (9.00e-2)"	"unprognostic (2.35e-1)"	"unprognostic (2.73e-1)"	"unprognostic (1.67e-1)"	"unprognostic (2.55e-1)"	"unprognostic (4.30e-2)"	"unprognostic (1.11e-1)"	"unprognostic (3.18e-2)"	"unprognostic (1.10e-2)"	"unprognostic (2.13e-2)"	"unprognostic (1.97e-1)"	"unprognostic (1.29e-2)"	"unprognostic (1.21e-3)"	"unprognostic (9.20e-2)"	"unprognostic (1.18e-1)"	"unprognostic (3.40e-1)"	18.1	15.0	12.1	9.8	14.2	1.1	10.2	9.5	17.1	15.7	11.7	8.2	6.5	5.5	12.9	10.2	10.6	10.3	13.2	14.6	10.8	13.5	10.7	11.5	24.9	4.4	10.4	14.5	12.0	7.0	15.5	6.1	21.7	10.8	11.0	7.7	11.4	7.1	9.1	10.6	7.2	8.1	15.3	7.5	8.9	7.2	12.9	3.8	3.9	11.6	5.2	5.4	11.1	8.9	1.6	2.6	0.9	2.7	1.1	3.6	0.9	5.7	5.4	5.6	8.8	14.0	13.6	10.8	12.0	12.1	10.5	10.5	4.7	8.7	2.0	14.0	24.2	9.0	10.9	7.3	9.3	16.5	6.0	5.0	6.1	5.8	7.3	9.7	1.7	4.8	9.9	8.8	7.7	10.3	16.2	30.2	2.5	3.9	10.0	12.9	10.8	1.4	1.6	3.1	2.8	5.0	3.9	11.0	3.0	8.9	12.3	5.7	5.7	12.8	7.6	14.1	14.3	5.9	4.0	33.3	21.4	11.4	7.3	7.2	1.4	1.7	0.6	5.1	3.9	6.2	0.5	2.0	0.9	3.4	1.8	2.5	1.5	1.3	2.2	2.3	1.6	2.7	1.4	0.6	1.1	2.7	2.6	3.6	0.9	12.1	14.2	9.5	17.1	10.8	13.5	10.4	14.5	10.8	3.8	98.3	38.9	17.1	16.1	29.8	51.7	46.4	12.7	21.4	39.8	19.2	76.6	14.0	1.7	27.3	2.4	119.4	12.7	0.0	24.7	19.4	40.9	19.9	23.1	15.5	16.2	33.4	24.1	109.2	20.0	2.3	31.4	17.4	40.5	15.4	16.3	38.7	36.3	20.9	40.3	10.7	29.9	64.7	45.7	17.7	11.1	31.5	16.7	13.8	13.4	22.7
BMX	"ETK, PSCTK3"	ENSG00000102010	"BMX non-receptor tyrosine kinase"	P51813	X	15464246-15556529	"Enzymes, Predicted intracellular proteins"	"Apoptosis, Cell adhesion, Stress response"	"Kinase, Transferase, Tyrosine-protein kinase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"epididymis: 57.1"	"Group enriched"	"Detected in some"	9	"Endothelial cells: 18.5;Ito cells: 51.5"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	17	"neutrophil: 10.5"	"Lineage enriched"	"Detected in single"	105	"granulocytes: 10.5"	"Cell line enriched"	"Detected in single"	121	"HUVEC TERT2: 90.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001048, CAB032495"	Enhanced		Supported	"Nucleoplasm,Plasma membrane"		NA	NA			"Plasma membrane"	Nucleoplasm	"CAB032495: AB_2290760, HPA001048: AB_1078289"	"unprognostic (7.80e-2)"	"unprognostic (4.92e-3)"	"unprognostic (1.16e-2)"	"unprognostic (4.07e-3)"	"unprognostic (2.69e-1)"	"unprognostic (2.14e-1)"	"unprognostic (1.06e-3)"	"unprognostic (2.36e-1)"	"unprognostic (1.87e-1)"	"unprognostic (1.21e-1)"	"unprognostic (1.78e-1)"	"unprognostic (1.06e-1)"	"unprognostic (1.26e-2)"	"unprognostic (1.84e-2)"	"unprognostic (3.64e-2)"	"unprognostic (1.26e-1)"	"unprognostic (2.81e-2)"	8.2	0.3	0.1	1.0	0.7	3.6	5.4	0.1	0.3	2.2	5.5	0.1	4.6	2.4	2.6	57.1	1.5	2.5	2.6	10.5	0.5	0.0	0.2	0.9	3.7	6.5	0.4	0.0	1.4	0.9	0.2	0.6	2.6	0.7	2.2	1.4	0.5	1.5	0.6	4.2	1.6	5.5	2.2	0.4	2.4	1.5	1.9	0.1	0.2	2.2	1.1	0.8	2.8	2.4	0.0	0.0	10.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	90.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.5	0.0	0.0	0.0	0.0	0.0	0.1	0.7	0.1	0.3	0.5	0.0	0.4	0.0	0.7	0.1	0.0	1.4	0.0	0.5	0.3	0.0	1.2	0.0	1.4	0.0	1.8	0.0	0.0	0.0	0.0	0.0	18.5	0.0	0.0	0.2	0.0	0.5	0.4	0.0	0.2	0.1	0.0	4.1	51.5	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.1
BPGM		ENSG00000172331	"Bisphosphoglycerate mutase"	P07738	7	134646808-134679813	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	Glycolysis	"Hydrolase, Isomerase"	"Congenital erythrocytosis, Disease mutation, Hereditary hemolytic anemia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	5	"placenta: 184.7"	"Group enriched"	"Detected in all"	5	"Distal tubular cells: 109.5;Erythroid cells: 303.7;Syncytiotrophoblasts: 308.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HDLM-2: 38.0;RT4: 61.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA016493, HPA028735"	Enhanced		Approved	"Nucleoplasm,Nucleoli,Nucleoli rim"		NA	NA		69000000	"Nucleoli, Nucleoli rim"	Nucleoplasm	"HPA016493: AB_1845414, HPA028735: AB_10600791"	"unprognostic (2.56e-1)"	"prognostic favorable (7.95e-4)"	"unprognostic (3.19e-1)"	"unprognostic (3.94e-1)"	"unprognostic (1.78e-1)"	"unprognostic (5.22e-2)"	"unprognostic (3.81e-3)"	"unprognostic (1.96e-1)"	"unprognostic (7.74e-2)"	"unprognostic (4.67e-3)"	"unprognostic (7.42e-2)"	"unprognostic (5.69e-2)"	"prognostic favorable (1.54e-8)"	"unprognostic (2.18e-1)"	"unprognostic (1.35e-1)"	"unprognostic (2.73e-1)"	"unprognostic (3.78e-2)"	6.1	7.3	13.6	4.5	11.1	37.7	6.9	11.7	11.6	7.1	6.9	9.1	6.1	4.3	5.4	10.2	14.6	4.7	6.9	7.3	12.5	14.2	19.1	8.1	8.0	5.2	13.9	7.8	5.7	5.4	16.5	14.4	184.7	12.4	7.5	5.4	6.7	10.6	10.3	17.7	5.5	6.0	6.6	15.9	8.6	6.8	7.4	8.8	8.5	7.5	22.2	13.3	24.9	9.5	11.6	10.2	28.2	12.8	9.8	14.5	12.8	4.5	5.5	7.4	9.9	8.5	5.0	7.4	13.7	16.6	5.3	8.0	2.2	6.1	5.5	4.1	7.6	10.6	3.7	7.8	7.5	9.4	38.0	6.8	3.2	5.1	2.5	5.8	6.0	4.2	4.9	6.9	10.0	5.5	8.2	19.3	7.0	9.2	7.0	12.6	2.2	9.8	8.4	7.6	9.3	5.3	7.5	5.3	4.0	12.1	61.1	6.3	10.7	6.3	7.7	6.8	8.2	5.1	3.9	14.7	8.5	2.0	11.4	11.1	11.5	13.2	6.9	14.7	5.8	14.5	28.2	9.8	27.6	14.5	12.8	10.4	11.6	9.5	12.7	10.2	10.5	13.2	13.4	18.0	9.8	12.5	6.7	12.0	12.8	13.6	11.1	11.7	11.6	12.5	14.2	13.9	7.8	12.4	8.8	8.9	26.7	14.4	18.4	34.7	20.3	20.5	15.3	29.4	14.8	26.2	2.0	35.3	109.5	38.4	2.2	11.9	5.1	303.7	15.9	28.0	17.1	21.1	24.3	4.3	13.3	19.1	12.6	8.0	7.3	5.1	9.5	11.3	21.9	19.8	3.8	18.6	36.1	3.5	11.3	47.1	11.6	6.5	24.7	27.9	22.5	11.5	308.5	21.5	4.5	13.7
BPNT1		ENSG00000162813	"3'(2'), 5'-bisphosphate nucleotidase 1"	O95861	1	220057482-220090462	"Enzymes, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Enterocytes: 50.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"Daudi: 60.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA048461	Approved		Approved	"Nuclear speckles"		NA	NA		170000	"Nuclear speckles"		"HPA048461: AB_2680404"	"unprognostic (6.42e-2)"	"unprognostic (4.69e-2)"	"unprognostic (2.78e-2)"	"unprognostic (1.02e-1)"	"unprognostic (5.19e-3)"	"unprognostic (7.65e-2)"	"unprognostic (2.07e-2)"	"unprognostic (3.00e-1)"	"unprognostic (2.44e-1)"	"unprognostic (1.66e-1)"	"unprognostic (6.69e-2)"	"unprognostic (2.87e-1)"	"prognostic favorable (6.38e-4)"	"unprognostic (1.82e-2)"	"unprognostic (6.58e-2)"	"unprognostic (2.91e-1)"	"unprognostic (1.35e-1)"	11.1	24.1	12.7	22.2	17.2	2.9	13.4	13.7	16.5	12.9	27.9	15.9	14.4	30.5	10.6	8.0	14.9	11.5	16.1	11.6	11.3	10.8	31.0	17.0	11.5	21.5	14.0	10.6	13.5	8.6	14.1	20.2	12.7	11.9	9.6	22.5	11.8	22.2	12.2	7.6	10.6	49.0	12.3	17.6	12.0	12.9	10.4	13.3	15.6	13.8	12.6	28.8	13.5	10.4	18.9	10.9	11.6	8.5	12.1	13.8	7.6	11.8	9.8	7.4	5.9	13.2	10.6	11.0	16.0	7.8	13.8	12.8	12.9	24.1	60.2	21.1	10.4	6.4	8.6	14.9	13.4	11.2	21.6	17.3	10.8	12.7	15.9	7.7	28.8	10.2	9.9	6.4	20.4	7.6	8.6	10.8	17.4	18.8	6.0	13.1	6.7	16.5	7.9	6.3	9.6	12.1	11.9	21.3	17.0	17.1	16.3	13.7	11.3	20.2	24.3	13.2	7.5	19.1	10.0	18.0	8.6	6.7	11.9	19.8	10.6	25.5	28.5	7.7	10.8	19.4	11.6	7.8	5.0	11.0	8.5	8.7	18.9	11.3	11.0	9.0	14.1	13.8	10.2	1.1	12.1	7.8	10.9	11.5	7.6	12.7	17.2	13.7	16.5	11.3	10.8	14.0	10.6	11.9	13.3	26.8	19.2	20.8	9.9	3.0	12.5	11.1	15.3	10.7	17.0	14.0	9.8	11.9	11.6	15.3	1.9	4.2	50.6	0.0	13.9	11.4	7.2	5.8	3.5	11.3	8.6	6.4	18.5	4.9	5.7	2.4	8.9	8.3	10.1	7.2	12.6	10.1	15.8	24.6	12.7	21.7	11.2	12.9	6.6	12.5	12.6	4.4	21.1	7.0	15.5	10.7
BRAF	BRAF1	ENSG00000157764	"B-Raf proto-oncogene, serine/threonine kinase"	P15056	7	140719327-140924928	"Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins"		"Allosteric enzyme, Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes, Cardiomyopathy, Deafness, Disease mutation, Ectodermal dysplasia, FDA approved drug targets, Mental retardation, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001328, CAB004552, HPA071048"	Approved		Approved	Vesicles,Cytosol		No	No			Vesicles	Cytosol	"CAB004552: AB_626760, HPA001328: AB_1078296, HPA071048: AB_2686336"	"unprognostic (2.98e-3)"	"unprognostic (5.66e-2)"	"unprognostic (2.20e-2)"	"unprognostic (2.66e-3)"	"unprognostic (2.44e-1)"	"unprognostic (1.48e-2)"	"unprognostic (2.07e-2)"	"unprognostic (4.23e-2)"	"unprognostic (4.07e-2)"	"unprognostic (1.58e-2)"	"unprognostic (6.53e-2)"	"unprognostic (1.91e-2)"	"unprognostic (3.79e-3)"	"unprognostic (2.08e-1)"	"unprognostic (1.76e-1)"	"unprognostic (8.01e-2)"	"unprognostic (5.46e-2)"	13.1	12.1	20.1	16.5	20.4	27.8	14.2	29.9	21.5	12.4	12.3	9.5	12.5	9.3	15.3	17.0	11.8	11.5	12.0	13.6	13.2	12.2	13.7	12.8	15.9	13.3	9.9	17.8	16.8	13.2	28.9	24.8	13.7	15.3	14.5	11.0	10.7	11.6	16.6	12.9	15.6	10.5	13.0	10.9	12.3	12.0	24.9	12.2	13.5	16.6	7.5	12.1	18.6	18.1	2.6	1.9	7.5	2.4	7.0	5.6	1.1	5.5	4.7	6.9	8.3	8.4	11.0	11.1	6.2	6.6	5.0	7.2	5.1	6.0	9.5	4.8	6.4	8.0	3.1	6.1	4.9	9.3	8.8	5.0	6.2	4.6	4.7	7.2	10.0	6.2	7.3	5.6	5.3	11.1	7.4	5.8	7.1	9.7	17.1	8.8	2.9	13.3	10.5	6.4	5.4	3.0	8.7	5.9	7.7	4.9	10.7	8.1	6.8	7.2	4.4	6.5	7.1	4.1	6.8	8.6	5.5	4.2	11.7	5.0	19.8	11.2	15.2	8.9	10.1	5.9	3.3	2.0	7.5	3.1	1.7	2.1	2.6	3.0	2.4	1.6	2.6	5.6	2.8	4.1	7.0	2.4	1.9	2.7	1.1	20.1	20.4	29.9	21.5	13.2	12.2	9.9	17.8	15.3	12.2	20.8	34.2	19.5	20.3	19.2	29.1	12.7	5.1	24.1	25.0	24.4	33.4	12.4	6.6	10.9	55.6	17.1	7.5	0.0	8.6	10.3	13.1	23.9	24.3	8.7	7.9	23.8	18.4	8.6	14.8	30.8	15.3	17.2	15.1	10.0	8.1	11.8	12.5	6.6	9.6	9.6	32.5	6.5	17.3	33.7	23.0	21.0	63.2	17.5	8.1	23.8
BRAP	"BRAP2, IMP, RNF52"	ENSG00000089234	"BRCA1 associated protein"	Q7Z569	12	111642146-111685986	"Enzymes, Predicted intracellular proteins, RAS pathway related proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 55.9"	"Group enriched"	"Detected in many"	5	"Early spermatids: 224.1;Late spermatids: 273.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040357, HPA058820"	Approved		Supported	"Nuclear membrane,Cytosol"		NA	NA			Cytosol	"Nuclear membrane"	"HPA040357: AB_10967924, HPA058820: AB_2683827"	"unprognostic (7.02e-2)"	"unprognostic (2.37e-3)"	"unprognostic (5.33e-2)"	"unprognostic (1.73e-1)"	"unprognostic (1.70e-1)"	"unprognostic (1.69e-1)"	"prognostic unfavorable (7.65e-6)"	"unprognostic (2.14e-1)"	"unprognostic (9.24e-3)"	"unprognostic (2.80e-1)"	"unprognostic (1.81e-2)"	"unprognostic (1.67e-1)"	"unprognostic (1.19e-1)"	"unprognostic (3.66e-2)"	"unprognostic (1.58e-1)"	"unprognostic (3.57e-2)"	"unprognostic (8.08e-2)"	9.8	9.9	9.8	7.2	11.6	26.5	9.6	10.0	12.8	8.3	9.3	10.0	8.0	8.6	10.1	7.0	9.4	8.4	7.3	8.8	8.6	8.7	8.4	9.3	7.9	9.7	9.2	8.5	9.7	7.8	9.4	10.4	9.8	12.0	8.3	9.0	6.7	8.9	9.7	19.1	12.7	9.3	9.1	11.1	9.6	7.9	55.9	10.1	12.4	9.5	5.6	10.4	10.2	11.8	12.7	11.7	25.7	13.5	16.6	18.5	11.6	9.9	14.6	12.0	13.7	12.8	10.8	20.0	13.9	11.7	16.2	12.5	19.6	6.9	19.1	8.4	13.1	9.2	12.2	16.7	11.4	17.4	12.2	10.8	23.6	9.1	13.1	16.2	20.7	16.0	12.2	16.2	14.0	22.8	14.0	14.0	13.3	24.5	6.3	13.3	12.5	17.2	20.0	16.1	10.5	15.4	16.0	13.0	17.0	10.7	20.9	14.9	11.0	16.3	13.9	13.6	14.4	15.3	13.2	12.9	10.4	9.7	9.4	9.8	16.1	20.3	21.1	9.9	11.5	11.4	16.1	13.0	24.0	14.7	13.5	14.3	12.7	15.4	14.7	11.7	12.5	14.6	14.8	25.7	16.6	10.6	8.4	18.5	11.6	9.8	11.6	10.0	12.8	8.6	8.7	9.2	8.5	12.0	10.1	20.8	9.1	7.5	8.2	10.0	8.1	10.6	17.8	13.4	10.3	10.4	27.5	11.4	5.0	11.0	224.1	9.3	12.8	0.0	6.6	12.6	8.5	9.9	8.1	7.9	9.3	3.2	9.2	8.6	6.4	273.6	12.4	11.3	3.3	20.8	10.6	7.8	11.8	10.5	12.7	11.9	11.5	6.5	10.7	49.2	33.7	11.0	18.8	10.1	9.3	11.2
BRCA1	"BRCC1, FANCS, PPP1R53, RNF53"	ENSG00000012048	"BRCA1, DNA repair associated"	P38398	17	43044295-43170245	"Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Cell cycle, DNA damage, DNA recombination, DNA repair, Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism, Transcription, Transcription regulation, Ubl conjugation pathway"	"Activator, DNA-binding, Transferase"	"Cancer-related genes, Disease mutation, Fanconi anemia, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	9	"Spermatocytes: 64.7;Spermatogonia: 61.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in all"	5	"dendritic cells: 9.1;granulocytes: 9.7;monocytes: 12.7"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB001946, HPA004840, HPA034966, HPA057371"	Approved		Supported	"Nucleoplasm,Nuclear bodies"		NA	Yes			"Nucleoplasm, Nuclear bodies"		"CAB001946: , HPA004840: , HPA034966: AB_10795287, HPA057371: AB_2732611"	"unprognostic (7.87e-3)"	"unprognostic (6.97e-2)"	"unprognostic (3.53e-3)"	"unprognostic (2.39e-1)"	"unprognostic (5.42e-2)"	"unprognostic (7.07e-3)"	"unprognostic (1.56e-3)"	"unprognostic (4.14e-3)"	"unprognostic (9.62e-3)"	"unprognostic (2.47e-1)"	"unprognostic (5.53e-3)"	"unprognostic (1.28e-1)"	"unprognostic (1.08e-4)"	"unprognostic (1.08e-3)"	"unprognostic (1.48e-1)"	"unprognostic (2.12e-1)"	"unprognostic (8.31e-2)"	4.8	4.3	6.0	9.6	11.3	15.3	5.1	12.9	10.6	5.4	9.2	3.4	6.8	4.3	5.4	5.5	9.1	5.5	3.3	6.5	6.6	5.3	4.2	7.7	4.9	13.0	7.5	5.9	5.1	4.7	4.2	11.0	5.3	10.5	4.1	10.4	3.7	5.4	7.4	7.3	8.3	6.7	5.5	9.2	5.9	5.1	17.6	7.0	10.9	15.6	7.3	14.6	5.5	5.6	2.0	9.1	9.7	12.7	1.4	1.3	10.7	15.7	25.6	14.1	11.2	2.3	5.2	13.8	18.6	8.0	15.6	14.9	15.5	12.3	36.4	3.4	7.1	18.5	18.3	19.1	10.4	26.2	16.6	14.0	17.1	20.1	13.4	0.5	30.5	14.9	1.4	1.7	23.5	7.5	4.0	8.1	17.0	25.8	15.6	14.7	10.5	25.5	10.1	7.7	10.6	6.8	17.6	29.7	14.9	5.8	15.3	9.7	10.4	14.3	4.7	7.0	10.0	12.6	14.1	5.2	14.0	11.4	18.1	19.3	7.3	17.8	28.0	11.3	18.1	14.6	4.6	12.7	1.8	1.3	4.0	1.3	1.1	1.3	1.0	9.1	2.0	1.2	1.3	9.7	1.4	1.5	1.4	0.4	10.7	6.0	11.3	12.9	10.6	6.6	5.3	7.5	5.9	10.5	7.0	0.0	3.2	5.2	3.8	2.6	8.3	10.4	7.6	13.4	5.7	1.8	21.6	7.0	0.0	2.6	11.1	2.9	1.0	0.0	1.0	17.5	2.9	2.4	8.1	16.1	8.6	11.1	0.0	5.5	4.0	5.2	2.3	5.3	0.0	3.6	3.7	2.8	1.6	3.1	1.4	0.8	21.1	6.5	1.4	64.7	61.1	1.9	3.3	2.5	3.5	2.5
BRCC3	"BRCC36, C6.1A, CXorf53"	ENSG00000185515	"BRCA1/BRCA2-containing complex subunit 3"	P46736	X	155071420-155123074	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Cell cycle, Cell division, DNA damage, DNA repair, Mitosis, Ubl conjugation pathway"	"Chromatin regulator, Hydrolase, Metalloprotease, Protease"	Proto-oncogene	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			HPA048737			Supported	Nucleoplasm		NA	NA			Nucleoplasm		"HPA048737: AB_2680504"	"unprognostic (1.16e-2)"	"unprognostic (2.40e-2)"	"unprognostic (5.99e-2)"	"unprognostic (1.53e-1)"	"unprognostic (1.43e-1)"	"unprognostic (2.88e-2)"	"unprognostic (4.48e-2)"	"unprognostic (6.47e-3)"	"unprognostic (1.33e-1)"	"unprognostic (9.68e-2)"	"unprognostic (1.35e-3)"	"unprognostic (3.72e-2)"	"unprognostic (3.71e-3)"	"unprognostic (7.14e-3)"	"unprognostic (1.57e-1)"	"unprognostic (1.17e-1)"	"unprognostic (1.90e-1)"	12.9	14.8	11.3	11.2	16.5	14.0	12.9	20.0	18.6	11.8	19.5	9.1	15.2	16.7	9.4	11.8	20.4	12.1	8.3	10.3	10.3	12.1	18.3	12.3	9.4	12.5	10.4	10.5	10.7	12.2	14.3	11.8	14.2	15.3	12.2	19.5	8.7	15.5	12.6	21.3	10.0	19.2	13.1	8.9	11.1	13.7	3.9	12.9	10.2	13.9	13.7	12.7	11.4	11.6	13.4	16.2	25.0	17.8	21.0	19.0	12.3	31.2	19.3	8.2	6.4	6.1	5.1	13.5	12.8	8.1	7.9	17.3	17.5	13.7	30.0	23.4	8.1	12.1	12.2	21.0	11.4	11.4	17.4	16.7	6.0	30.5	14.4	5.4	21.3	9.4	6.2	5.2	12.8	10.9	7.8	10.8	12.0	9.8	8.9	6.3	13.2	8.1	7.6	7.2	32.2	13.8	12.8	14.0	12.5	9.4	14.8	13.4	5.7	8.4	13.5	7.6	10.2	9.4	7.2	12.0	7.0	10.8	10.3	19.2	11.4	18.6	39.0	10.2	19.9	8.2	22.6	14.7	25.0	16.2	17.8	19.0	13.4	16.0	14.8	16.2	11.8	12.5	14.0	8.0	21.0	16.9	10.4	18.6	12.3	11.3	16.5	20.0	18.6	10.3	12.1	10.4	10.5	15.3	12.9	29.8	15.1	9.3	5.8	4.8	12.7	24.6	10.2	38.8	42.1	7.0	13.7	22.3	16.6	19.5	0.4	7.8	14.7	0.0	17.5	21.1	9.1	7.6	25.5	7.6	15.5	7.9	9.2	6.2	8.3	0.8	5.5	10.9	5.0	19.8	21.3	12.9	11.9	17.3	11.3	13.5	13.5	19.4	7.1	0.6	1.3	5.6	11.3	11.8	26.0	7.5
BRIP1	"BACH1, FANCJ, OF"	ENSG00000136492	"BRCA1 interacting protein C-terminal helicase 1"	Q9BX63	17	61681266-61863521	"Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"DNA damage, DNA repair"	"Helicase, Hydrolase"	"Cancer-related genes, Disease mutation, Fanconi anemia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 30.1"	"Group enriched"	"Detected in many"	11	"Early spermatids: 136.2;Late spermatids: 148.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"B-cells: 2.2;granulocytes: 2.1;T-cells: 3.7"	"Cell line enhanced"	"Detected in many"		"MCF7: 42.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA005474	Approved		Supported	"Nucleoplasm,Nuclear membrane"		NA	Yes			"Nucleoplasm, Nuclear membrane"		"HPA005474: AB_2667333"	"unprognostic (1.88e-1)"	"unprognostic (1.55e-2)"	"prognostic favorable (3.45e-5)"	"unprognostic (6.85e-4)"	"unprognostic (3.09e-1)"	"prognostic favorable (3.62e-4)"	"unprognostic (2.60e-3)"	"unprognostic (5.60e-2)"	"unprognostic (5.66e-3)"	"unprognostic (6.71e-2)"	"unprognostic (1.50e-3)"	"unprognostic (2.75e-2)"	"unprognostic (3.41e-12)"	"unprognostic (1.19e-2)"	"unprognostic (2.25e-1)"	"unprognostic (3.96e-2)"	"unprognostic (3.62e-3)"	1.0	0.9	0.7	6.3	3.5	9.1	1.1	0.6	1.4	1.4	2.6	0.2	0.6	2.8	1.5	1.2	3.7	0.8	1.8	0.4	0.5	0.5	0.6	2.3	1.3	4.0	0.5	0.9	2.1	1.3	0.1	0.4	1.7	0.7	1.0	2.8	0.4	1.4	0.0	0.4	2.7	5.5	1.0	0.5	2.3	1.3	10.8	0.4	30.1	0.4	2.0	6.6	1.3	1.7	2.2	0.5	2.1	0.3	0.6	3.7	0.5	12.5	4.3	12.4	7.1	0.4	1.1	2.7	11.6	6.8	12.4	16.1	4.4	4.0	7.5	2.7	2.4	3.6	4.5	6.4	2.4	16.8	1.9	7.8	7.6	6.8	5.4	0.1	9.8	4.5	0.2	0.1	9.9	2.6	1.7	2.7	7.4	5.3	5.1	7.8	42.2	15.5	3.4	2.7	3.0	3.7	9.7	23.9	3.6	1.7	5.7	5.0	12.9	4.5	1.6	1.8	4.9	4.2	3.8	2.3	18.3	13.4	6.7	13.3	3.2	6.1	8.0	3.7	4.7	4.5	2.1	0.3	1.5	0.5	0.2	0.6	2.2	1.2	0.6	0.4	1.8	1.8	0.9	1.0	0.6	0.2	0.5	3.7	0.5	0.7	3.5	0.6	1.4	0.5	0.5	0.5	0.9	0.7	0.4	0.0	0.3	1.5	1.3	2.1	0.1	0.5	0.0	1.4	6.8	0.0	0.0	0.7	0.0	0.3	136.2	0.3	0.9	0.0	0.2	2.5	0.6	0.1	0.0	3.0	1.4	0.0	0.0	0.6	0.3	148.4	1.1	0.4	3.3	1.0	1.5	0.3	0.5	0.0	1.1	0.0	0.2	0.0	0.9	13.3	4.5	0.4	0.2	0.8	2.5	0.3
BRSK1	KIAA1811	ENSG00000160469	"BR serine/threonine kinase 1"	Q8TDC3	19	55282072-55312533	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Cell cycle, DNA damage, Neurogenesis"	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"brain: 65.0"	"Cell type enhanced"	"Detected in many"	13	"Bipolar cells: 30.8;Enterocytes: 12.3;Horizontal cells: 36.5"	"Cancer enhanced"	"Detected in all"		"glioma: 12.5"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"SCLC-21H: 26.2;SH-SY5Y: 23.6;WM-115: 21.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021212, HPA061719"	Enhanced		Supported	"Nucleoplasm,Cell Junctions"		NA	NA			Nucleoplasm	"Cell Junctions"	"HPA021212: AB_1845455, HPA061719: AB_2684593"	"unprognostic (1.42e-3)"	"unprognostic (2.92e-2)"	"unprognostic (1.20e-1)"	"unprognostic (6.69e-3)"	"unprognostic (2.71e-1)"	"unprognostic (4.21e-2)"	"unprognostic (3.06e-6)"	"unprognostic (4.24e-1)"	"unprognostic (2.06e-2)"	"unprognostic (3.04e-1)"	"prognostic favorable (1.02e-4)"	"unprognostic (3.00e-1)"	"prognostic unfavorable (7.98e-6)"	"unprognostic (1.16e-1)"	"unprognostic (6.61e-3)"	"unprognostic (1.34e-1)"	"unprognostic (2.09e-1)"	1.4	9.8	28.6	3.2	23.6	1.0	1.6	26.7	65.0	1.8	2.2	7.9	0.1	3.3	5.4	3.7	3.0	2.3	3.9	6.5	33.4	20.0	1.4	0.8	1.7	2.4	20.4	14.8	2.4	2.6	12.4	11.0	1.5	13.3	3.8	1.9	2.8	2.5	4.6	1.0	1.1	2.6	4.9	9.2	1.5	1.9	4.4	7.2	0.0	3.0	0.0	1.6	3.2	0.7	0.0	0.3	0.0	0.9	0.1	0.8	0.2	0.3	1.3	15.5	8.2	0.0	0.6	0.1	2.4	3.4	3.3	4.9	5.9	2.7	3.1	1.7	2.8	3.1	0.1	3.2	0.1	3.1	14.6	12.8	2.0	1.6	0.6	3.3	0.6	6.0	2.2	0.3	3.4	0.0	12.9	0.1	8.2	2.8	19.1	3.0	0.8	3.7	0.7	11.2	0.3	1.0	8.5	3.9	0.5	0.2	0.0	26.2	23.6	0.0	0.4	5.7	4.6	1.3	1.7	0.0	6.4	6.8	3.5	4.6	15.8	11.6	7.1	6.5	1.4	21.4	0.0	0.9	0.0	0.1	0.4	0.8	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.1	0.0	0.3	0.0	0.2	28.6	23.6	26.7	40.2	33.4	20.0	20.4	14.8	13.3	7.2	0.0	2.2	0.0	1.0	0.1	30.8	0.8	0.0	0.0	1.2	1.8	2.0	0.0	0.0	0.3	0.8	0.3	12.3	0.0	0.0	0.0	0.5	0.8	0.0	0.0	1.4	36.5	3.4	0.0	7.8	0.0	0.6	0.4	0.0	0.0	1.0	3.2	0.2	0.0	4.6	0.8	10.2	0.0	1.0	3.9	6.5	0.0	0.0	0.8	1.2	0.1
BRSK2	"C11orf7, PEN11B, STK29"	ENSG00000174672	"BR serine/threonine kinase 2"	Q8IWQ3	11	1389899-1462689	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Apoptosis, Cell cycle, Cell division, Exocytosis, Mitosis, Neurogenesis"	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	10	"brain: 34.9;pancreas: 78.8"	"Group enriched"	"Detected in some"	6	"Bipolar cells: 79.7;Cone photoreceptor cells: 33.4;Horizontal cells: 65.2;Muller glia cells: 24.5;Rod photoreceptor cells: 27.0"	"Cancer enhanced"	"Detected in many"		"glioma: 3.7"	"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	13	"NK-cell: 1.3"	"Lineage enriched"	"Detected in single"	13	"NK-cells: 1.3"	"Cell line enhanced"	"Detected in some"		"AF22: 9.1;AN3-CA: 9.9;CACO-2: 7.9;HAP1: 7.4;NTERA-2: 15.3;SCLC-21H: 35.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA073690			Approved	"Golgi apparatus"		NA	NA			"Golgi apparatus"		"HPA073690: "	"unprognostic (5.47e-2)"	"unprognostic (4.11e-2)"	"unprognostic (1.26e-1)"	"unprognostic (2.85e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.40e-2)"	"unprognostic (1.05e-2)"	"unprognostic (3.63e-1)"	"unprognostic (6.42e-2)"	"unprognostic (3.86e-2)"	"unprognostic (2.22e-2)"	"unprognostic (2.31e-1)"	"unprognostic (3.17e-7)"	"unprognostic (3.24e-2)"	"unprognostic (1.57e-1)"	"unprognostic (1.49e-3)"	"unprognostic (1.86e-1)"	1.5	3.5	13.6	1.5	12.8	1.3	1.3	30.8	34.9	1.3	1.5	10.0	0.0	1.7	1.4	1.3	1.3	1.4	1.9	1.5	15.6	10.6	1.4	1.3	1.4	1.3	8.3	17.2	1.4	78.8	1.6	4.6	1.8	9.5	1.6	1.4	2.2	1.6	1.4	1.5	1.5	1.9	1.4	6.5	1.3	1.9	5.5	9.2	0.0	1.9	0.0	1.3	1.3	0.2	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	4.0	9.1	9.9	0.1	0.3	0.0	0.1	0.1	0.7	0.3	7.9	0.5	0.0	1.4	0.1	0.1	0.0	7.4	0.0	0.6	0.9	3.9	0.0	0.0	0.1	0.4	0.0	0.3	0.1	0.0	0.0	0.9	0.2	0.0	0.3	0.1	0.0	0.1	0.9	0.0	0.0	15.3	2.7	1.2	0.0	0.0	0.0	0.1	0.1	35.8	5.3	1.8	0.1	2.5	0.2	0.2	0.4	0.2	0.8	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	13.6	12.8	30.8	23.3	15.6	10.6	8.3	17.2	9.5	9.2	0.0	0.0	0.0	0.1	0.2	79.7	2.2	0.0	0.0	0.0	0.0	33.4	0.0	0.0	0.1	0.3	0.3	0.0	0.0	0.9	0.0	0.2	0.2	0.0	0.0	0.2	65.2	0.0	0.0	0.0	0.4	0.9	0.0	0.0	0.0	0.0	24.5	0.5	0.0	1.1	0.0	27.0	6.5	8.0	0.7	1.5	0.0	0.0	0.0	0.0	0.0
BST1	CD157	ENSG00000109743	"Bone marrow stromal cell antigen 1"	Q10588	4	15702950-15738313	"CD markers, Enzymes, Plasma proteins, Predicted intracellular proteins"		"Hydrolase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 59.5;bone marrow: 54.9;intestine: 61.3"	"Cell type enhanced"	"Detected in many"	6	"Hofbauer cells: 39.0;Kupffer cells: 36.4;Macrophages: 29.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"classical monocyte: 52.7;neutrophil: 59.5"	"Group enriched"	"Detected in many"	105	"dendritic cells: 16.6;granulocytes: 59.5;monocytes: 52.7"	"Cell line enhanced"	"Detected in many"		"THP-1: 37.1;TIME: 20.4;U-937: 24.2;WM-115: 22.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA050121	Uncertain				"Intracellular and membrane"	NA	NA		170000000			"HPA050121: AB_2681025"	"unprognostic (2.95e-1)"	"unprognostic (3.61e-1)"	"unprognostic (1.27e-1)"	"unprognostic (4.00e-2)"	"unprognostic (7.49e-2)"	"unprognostic (2.89e-1)"	"unprognostic (4.55e-2)"	"unprognostic (2.70e-1)"	"unprognostic (1.75e-1)"	"unprognostic (1.84e-1)"	"unprognostic (1.08e-1)"	"unprognostic (4.06e-2)"	"unprognostic (4.83e-3)"	"unprognostic (1.94e-3)"	"unprognostic (3.11e-1)"	"unprognostic (1.57e-2)"	"unprognostic (1.95e-1)"	14.3	2.0	1.1	5.6	2.0	54.9	6.6	0.8	1.5	7.2	33.8	1.5	2.1	20.4	6.4	7.0	4.6	5.6	10.3	14.5	1.8	0.8	6.6	3.7	9.4	9.6	1.3	1.9	5.5	1.0	0.4	1.3	8.0	1.3	7.5	4.0	5.4	2.8	2.2	3.4	3.5	61.3	7.9	1.5	13.6	2.4	2.4	1.2	2.8	3.5	2.9	1.8	7.5	16.1	0.4	16.6	59.5	52.7	0.1	0.3	19.6	0.2	5.5	0.5	0.4	13.5	3.2	0.7	10.5	1.0	9.6	10.8	0.1	5.7	0.3	0.9	5.3	0.2	0.1	1.5	0.2	8.2	0.3	0.2	2.5	0.3	0.2	3.4	3.3	7.3	2.7	0.7	6.1	0.5	0.4	1.5	2.3	0.3	0.2	5.6	0.1	1.0	1.9	1.2	0.4	1.1	0.3	0.7	0.2	0.3	0.3	0.7	2.1	0.2	0.3	7.0	0.5	0.2	37.1	20.4	0.3	0.5	3.7	0.4	0.2	0.0	0.3	1.3	24.2	22.1	7.6	52.7	3.9	0.2	19.8	0.3	0.4	0.1	0.1	16.6	0.2	0.2	0.1	59.5	0.1	13.6	5.5	0.2	19.6	1.1	2.0	0.8	1.5	1.8	0.8	1.3	1.9	1.3	1.2	3.0	3.0	0.0	0.8	4.0	0.2	0.8	5.1	2.7	1.2	1.8	0.0	14.0	1.7	4.1	2.7	2.1	3.2	0.0	2.3	18.7	18.6	0.5	16.1	1.8	39.0	0.0	1.2	3.7	36.4	0.7	2.8	29.9	13.5	0.0	7.0	0.3	0.8	7.0	2.1	6.7	0.0	6.5	10.8	2.3	1.2	2.6	5.9	0.0	16.6	2.7
BTD		ENSG00000169814	Biotinidase	P43251	3	15601341-15647640	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins"		Hydrolase	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA052275	Uncertain				"Secreted to blood"	NA	NA		2900000000			"HPA052275: AB_2681782"	"unprognostic (6.04e-2)"	"unprognostic (2.42e-1)"	"unprognostic (9.37e-3)"	"unprognostic (5.84e-2)"	"unprognostic (2.13e-1)"	"unprognostic (1.95e-2)"	"unprognostic (6.37e-3)"	"unprognostic (4.26e-2)"	"unprognostic (3.29e-2)"	"unprognostic (1.23e-2)"	"unprognostic (1.05e-2)"	"unprognostic (1.29e-1)"	"prognostic favorable (2.60e-9)"	"unprognostic (2.44e-2)"	"unprognostic (4.90e-2)"	"unprognostic (1.67e-3)"	"unprognostic (3.73e-2)"	18.5	17.9	7.5	3.9	10.2	4.4	13.5	17.0	11.8	11.2	28.1	19.6	12.2	25.3	12.3	34.1	7.1	10.3	10.4	6.9	8.0	6.8	20.0	50.7	8.2	5.2	12.3	9.5	17.2	26.6	19.6	11.1	10.7	9.3	10.7	9.4	20.0	11.6	12.1	6.9	6.5	40.5	7.9	8.8	7.6	12.9	15.0	12.6	5.9	14.8	3.8	6.2	11.7	9.1	8.4	13.7	31.0	11.9	7.5	15.6	8.7	3.8	10.8	3.3	3.2	28.3	7.8	19.6	7.0	9.4	8.3	15.0	3.8	10.3	1.0	8.4	16.2	3.4	4.3	2.6	8.3	9.7	3.3	5.5	5.9	14.5	11.6	6.8	2.9	6.9	9.5	8.6	21.9	2.2	19.6	15.9	2.4	3.8	13.8	23.3	4.6	1.6	3.4	3.6	8.2	6.0	2.1	8.3	13.0	8.0	7.8	2.3	5.7	8.3	2.0	11.0	7.7	10.2	5.6	10.8	9.0	6.9	8.4	4.4	3.2	4.9	1.2	10.5	3.5	6.5	31.0	11.9	25.2	13.2	11.1	12.3	8.4	14.1	11.3	12.1	7.8	12.2	9.2	10.8	7.5	8.4	13.7	15.6	8.7	7.5	10.2	17.0	11.8	8.0	6.8	12.3	9.5	9.3	12.6	6.0	8.3	10.4	10.9	5.3	12.4	5.3	45.9	17.4	3.4	17.4	17.7	22.1	5.0	15.4	24.9	7.1	10.6	23.3	24.6	16.7	10.3	6.2	4.7	58.9	13.6	4.8	6.9	23.4	8.9	12.5	30.0	8.2	10.1	10.8	7.5	18.0	12.6	17.3	17.0	23.2	43.4	12.9	5.2	20.4	6.8	4.8	19.3	13.8	7.6	9.1
BTK	"AGMX1, ATK, IMD1, PSCTK1, XLA"	ENSG00000010671	"Bruton tyrosine kinase"	Q06187	X	101349447-101390796	"Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"	"Adaptive immunity, Apoptosis, Immunity, Innate immunity, Transcription, Transcription regulation"	"Kinase, Transferase, Tyrosine-protein kinase"	"Cancer-related genes, Disease mutation, Dwarfism, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"blood: 77.5;lymphoid tissue: 37.0"	"Cell type enhanced"	"Detected in some"	19	"B-cells: 86.8;granulocytes: 203.6;Hofbauer cells: 50.3;Kupffer cells: 53.4;Macrophages: 53.0;monocytes: 52.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"basophil: 77.5"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"Daudi: 29.5;HEL: 40.9;HMC-1: 147.5;U-937: 21.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA001198, HPA002028, CAB016689"	Enhanced		Supported	"Plasma membrane,Cytosol"		NA	NA		610000	"Plasma membrane, Cytosol"		"CAB016689: AB_1611894, HPA001198: AB_1078305, HPA002028: AB_1078306"	"unprognostic (3.19e-2)"	"unprognostic (2.51e-3)"	"unprognostic (1.06e-2)"	"unprognostic (3.66e-2)"	"unprognostic (5.69e-2)"	"unprognostic (3.76e-3)"	"unprognostic (6.55e-2)"	"unprognostic (3.58e-3)"	"unprognostic (6.02e-2)"	"unprognostic (3.12e-1)"	"unprognostic (1.02e-1)"	"unprognostic (1.41e-1)"	"unprognostic (2.08e-3)"	"unprognostic (7.80e-2)"	"unprognostic (1.29e-2)"	"unprognostic (1.56e-2)"	"unprognostic (8.14e-2)"	7.3	2.4	3.3	23.5	5.6	14.0	2.6	0.8	3.6	2.3	3.0	4.7	0.3	2.2	1.9	2.6	2.4	2.0	3.7	3.3	3.3	2.5	2.2	2.5	10.7	25.1	5.4	1.2	1.2	1.5	0.2	1.4	3.2	4.1	2.5	4.5	1.5	3.2	1.0	1.0	2.5	12.9	3.3	10.8	37.0	3.1	1.3	6.3	4.0	1.7	1.8	36.7	5.8	2.0	13.7	13.2	77.5	20.7	0.0	0.0	6.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	29.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	40.9	0.0	0.0	0.0	16.4	147.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.6	0.3	0.0	0.0	0.0	11.5	0.2	0.0	0.0	12.3	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	9.8	0.0	0.0	0.0	0.0	0.0	0.3	0.2	14.0	0.0	21.4	0.0	77.5	11.3	19.3	0.0	18.1	0.0	13.7	0.0	0.0	13.2	13.7	0.0	0.0	4.5	0.0	20.7	6.0	0.0	6.1	3.3	5.6	0.8	3.6	3.3	2.5	5.4	1.2	4.1	6.3	3.0	12.8	86.8	0.1	0.9	0.0	0.4	0.0	0.0	1.2	0.0	0.0	1.1	0.0	0.0	0.2	0.6	0.0	23.3	0.0	0.4	0.5	0.0	203.6	0.0	50.3	0.0	0.0	1.3	53.4	0.0	0.3	53.0	3.3	52.3	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.3	0.4	1.6	0.3	1.6	0.8	0.0	0.1
BUB1	"BUB1A, BUB1L, hBUB1"	ENSG00000169679	"BUB1 mitotic checkpoint serine/threonine kinase"	O43683	2	110637698-110678114	"Enzymes, Predicted intracellular proteins"	"Apoptosis, Cell cycle, Cell division, Chromosome partition, Host-virus interaction, Mitosis"	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"lymphoid tissue: 56.5;testis: 30.9"	"Cell type enriched"	"Detected in many"	5	"Spermatocytes: 68.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Cell type enhanced"	"Detected in many"		"T-reg: 6.1"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HEL: 68.1"	"Not detected"	"Not detected"							HPA006123			Supported	Nucleoplasm,Cytosol		NA	Yes			Nucleoplasm	Cytosol	"HPA006123: AB_1845498"	"unprognostic (7.74e-2)"	"unprognostic (3.45e-2)"	"unprognostic (9.72e-3)"	"prognostic unfavorable (3.65e-4)"	"unprognostic (1.61e-1)"	"unprognostic (5.62e-3)"	"prognostic unfavorable (1.03e-5)"	"prognostic unfavorable (3.94e-4)"	"unprognostic (1.26e-3)"	"unprognostic (1.15e-1)"	"prognostic unfavorable (2.37e-5)"	"unprognostic (1.76e-1)"	"unprognostic (0.00e+0)"	"unprognostic (2.45e-2)"	"unprognostic (3.64e-1)"	"unprognostic (5.01e-2)"	"unprognostic (1.28e-1)"	1.1	0.9	0.5	15.8	1.0	8.9	0.6	0.3	1.0	1.2	2.8	0.4	0.0	2.4	0.7	2.3	5.8	0.5	1.0	1.1	0.5	0.5	0.9	0.8	2.1	11.6	0.6	0.2	1.0	0.7	0.0	0.4	2.4	0.5	0.7	4.3	0.4	1.4	0.0	0.5	1.8	3.1	1.4	1.3	7.9	1.8	30.9	0.1	56.5	0.6	5.7	12.1	2.5	2.0	1.8	2.4	3.0	0.2	1.4	6.1	1.1	30.3	8.9	23.4	14.7	1.0	1.7	12.4	15.8	10.4	27.5	20.8	18.7	17.5	20.6	9.8	9.1	25.8	13.3	29.9	11.5	34.2	16.3	14.6	68.1	9.5	14.9	0.2	19.6	19.3	0.4	0.7	21.2	10.5	3.9	16.1	23.1	29.8	43.0	22.5	10.0	32.8	16.4	22.6	10.8	16.9	21.8	20.0	31.4	5.6	9.6	15.7	6.8	11.2	9.6	8.5	14.9	7.5	16.6	6.6	12.5	20.5	9.4	21.9	22.5	21.1	25.3	8.5	15.2	22.0	3.0	0.0	0.7	0.6	0.2	0.9	1.8	2.5	1.0	0.8	1.4	1.6	1.5	0.0	1.4	0.1	2.4	6.1	1.1	0.5	1.0	0.3	1.0	0.5	0.5	0.6	0.2	0.5	0.1	0.0	1.0	7.8	0.2	0.5	0.0	0.8	0.0	1.4	2.3	0.0	0.0	1.3	0.0	0.2	8.3	0.0	0.0	0.0	0.0	8.1	0.3	0.2	0.0	0.2	6.6	0.0	0.0	1.3	1.3	4.7	0.3	1.7	0.0	1.0	0.9	0.0	0.1	0.0	0.4	0.0	0.0	6.5	0.0	68.0	14.1	0.4	0.6	2.5	2.0	0.9
BUB1B	"Bub1A, BUBR1, MAD3L, SSK1"	ENSG00000156970	"BUB1 mitotic checkpoint serine/threonine kinase B"	O60566	15	40161023-40221136	"Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Apoptosis, Cell cycle, Cell division, Mitosis"	"Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes, Disease mutation, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 49.5;testis: 25.6"	"Group enriched"	"Detected in many"	7	"Spermatocytes: 66.9;Spermatogonia: 28.8"	"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"naive B-cell: 2.8;plasmacytoid DC: 2.8"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA008419			Supported	Cytosol		Yes	Yes			Cytosol		"HPA008419: AB_1078308"	"unprognostic (4.40e-2)"	"unprognostic (2.23e-1)"	"unprognostic (4.65e-2)"	"unprognostic (2.44e-3)"	"unprognostic (9.66e-2)"	"unprognostic (3.52e-2)"	"prognostic unfavorable (7.43e-6)"	"prognostic unfavorable (3.56e-4)"	"unprognostic (3.69e-3)"	"unprognostic (2.32e-1)"	"prognostic unfavorable (1.79e-4)"	"unprognostic (1.76e-2)"	"unprognostic (0.00e+0)"	"unprognostic (3.75e-2)"	"unprognostic (4.66e-2)"	"unprognostic (2.20e-1)"	"unprognostic (3.94e-2)"	1.0	0.9	0.3	18.4	0.6	11.4	1.5	0.4	0.5	1.3	4.0	0.4	0.1	3.3	1.1	0.8	6.5	0.5	1.1	0.6	0.4	0.4	0.8	0.7	1.8	8.7	0.4	0.3	0.6	0.5	0.0	0.4	3.4	0.5	0.6	4.4	0.3	1.6	0.1	0.7	2.3	2.9	1.2	0.6	5.4	1.7	25.6	0.1	49.5	0.5	3.1	10.6	1.1	2.0	2.8	2.8	0.0	0.2	0.7	0.7	0.5	21.8	11.1	35.5	14.1	0.9	2.5	11.5	20.8	11.7	22.3	19.4	16.2	8.4	19.8	11.7	7.5	20.5	24.7	33.5	11.3	24.3	17.0	18.0	28.9	28.7	15.0	0.0	26.1	15.9	0.5	0.6	13.6	12.8	4.4	16.1	22.9	24.9	21.1	22.2	7.4	20.4	15.9	24.0	18.4	12.7	21.9	29.2	15.0	6.8	11.1	23.2	14.3	12.8	12.3	4.5	16.2	14.3	13.5	9.3	17.1	18.1	17.0	18.4	11.1	18.8	32.4	9.1	29.3	22.2	0.0	0.0	0.0	0.2	0.2	0.3	2.4	0.7	0.6	0.7	2.8	0.1	0.4	0.0	0.7	0.1	2.8	0.0	0.5	0.3	0.6	0.4	0.5	0.4	0.4	0.4	0.3	0.5	0.1	3.0	1.4	0.8	0.3	0.7	0.4	0.4	0.0	0.0	3.4	0.0	0.0	1.3	0.0	0.3	2.5	0.0	0.3	0.0	0.0	5.1	0.4	0.2	0.0	0.2	4.3	0.0	0.0	1.3	0.6	2.4	1.4	1.5	0.0	0.0	1.4	0.0	0.8	0.8	0.4	0.0	0.1	6.5	0.0	66.9	28.8	0.3	0.7	0.8	1.7	0.4
C1GALT1	"C1GALT, T-synthase"	ENSG00000106392	"Core 1 synthase, glycoprotein-N-acetylgalactosamine 3-beta-galactosyltransferase 1"	Q9NS00	7	7156934-7248651	"Enzymes, Predicted intracellular proteins"	"Angiogenesis, Differentiation"	"Developmental protein, Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"Syncytiotrophoblasts: 171.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"LHCN-M2: 81.9"	"Low region specificity"	"Detected in all"							"HPA011294, HPA012819"	Enhanced		Approved	"Nuclear bodies,Cytosol"		NA	NA		10000	"Nuclear bodies, Cytosol"		"HPA011294: AB_1845623, HPA012819: AB_1845624"	"unprognostic (1.52e-1)"	"prognostic unfavorable (1.04e-4)"	"unprognostic (7.38e-2)"	"unprognostic (8.78e-2)"	"unprognostic (2.97e-2)"	"unprognostic (1.04e-2)"	"prognostic unfavorable (1.42e-5)"	"unprognostic (2.03e-2)"	"unprognostic (2.26e-1)"	"unprognostic (1.17e-1)"	"unprognostic (1.43e-1)"	"unprognostic (1.40e-1)"	"unprognostic (2.83e-1)"	"unprognostic (3.28e-1)"	"unprognostic (8.28e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.33e-1)"	11.4	7.7	10.1	12.4	14.1	23.1	11.0	10.6	14.9	13.9	10.7	21.5	4.0	19.3	5.4	7.1	24.7	12.7	16.1	11.6	12.8	10.8	21.5	14.7	10.9	11.7	23.7	8.9	6.2	6.2	42.3	11.0	30.2	19.2	5.7	12.2	8.1	17.6	5.7	8.1	8.6	15.8	5.3	31.0	13.8	15.3	5.4	21.4	12.9	10.6	6.2	11.6	10.3	8.4	15.9	13.5	33.2	26.0	16.6	17.4	12.2	18.9	8.2	2.5	4.3	7.5	15.8	8.8	21.8	16.3	10.2	15.1	5.6	19.7	8.9	5.6	8.6	27.4	6.1	3.7	8.2	16.1	5.3	3.0	8.4	4.9	15.5	8.2	8.8	3.7	12.9	5.8	25.0	19.3	12.8	8.3	8.9	18.0	5.6	81.9	3.2	2.4	4.3	15.9	12.6	8.9	8.0	14.9	5.4	11.5	8.4	3.1	8.2	13.8	15.6	14.8	16.2	4.9	4.5	8.7	16.3	25.3	23.2	8.8	10.7	9.1	10.1	10.8	11.9	18.1	33.2	11.1	31.2	16.1	16.5	16.9	15.9	15.0	17.4	12.2	13.7	15.7	17.0	24.3	16.6	26.0	13.5	13.0	12.2	10.1	14.1	10.6	14.9	12.8	10.8	23.7	8.9	19.2	21.4	38.7	50.4	35.6	14.0	23.4	22.1	22.0	30.6	18.7	21.6	17.4	31.4	79.2	5.0	23.7	13.7	11.7	21.0	0.0	22.7	66.8	16.9	13.7	11.5	19.5	32.6	44.5	15.0	11.6	19.3	12.2	6.1	21.9	21.9	10.0	20.0	23.0	35.5	17.5	6.0	37.2	32.9	6.5	8.9	15.0	29.3	16.9	171.3	29.2	26.5	17.1
C1R		ENSG00000159403	"Complement C1r"	P00736	12	7080209-7092607	"Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Complement pathway, Immunity, Innate immunity"	"Hydrolase, Protease, Serine protease"	"Disease mutation, Ehlers-Danlos syndrome, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 370.2"	"Group enriched"	"Detected in many"	5	"Fibroblasts: 462.9;Hepatocytes: 1385.8;Leydig cells: 1057.9;Peritubular cells: 364.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"eosinophil: 2.0;gdT-cell: 1.6;MAIT T-cell: 2.0;memory CD4 T-cell: 1.4;memory CD8 T-cell: 3.4;naive CD4 T-cell: 2.8;naive CD8 T-cell: 2.9;neutrophil: 2.5;NK-cell: 3.2;T-reg: 1.4"	"Group enriched"	"Detected in many"	6	"granulocytes: 2.5;NK-cells: 3.2;T-cells: 3.4"	"Cell line enhanced"	"Detected in many"		"ASC diff: 181.7;ASC TERT1: 92.7;BJ hTERT+: 80.0;BJ hTERT+ SV40 Large T+ RasG12V: 49.3;HSkMC: 107.4"					"Low region specificity"	"Detected in all"			"HPA001251, HPA001551"	Uncertain		Uncertain	Nucleoplasm,Cytosol	"Secreted to blood"	NA	NA		14000000000	"Nucleoplasm, Cytosol"		"HPA001251: AB_2666252, HPA001551: AB_10754818"	"unprognostic (1.55e-2)"	"unprognostic (8.97e-2)"	"unprognostic (3.46e-2)"	"unprognostic (1.92e-1)"	"unprognostic (1.47e-2)"	"unprognostic (2.66e-2)"	"unprognostic (1.94e-2)"	"unprognostic (2.05e-1)"	"unprognostic (2.50e-1)"	"unprognostic (1.72e-1)"	"unprognostic (1.21e-1)"	"unprognostic (4.16e-2)"	"prognostic unfavorable (1.94e-14)"	"unprognostic (3.54e-2)"	"unprognostic (2.25e-2)"	"unprognostic (6.13e-2)"	"unprognostic (2.59e-2)"	45.8	17.4	2.6	18.1	3.8	0.0	82.0	1.4	2.8	36.7	24.5	2.4	11.2	5.0	27.2	66.8	38.1	33.3	46.7	49.5	1.9	1.8	27.5	370.2	25.3	46.8	3.5	2.0	103.5	11.4	1.4	6.3	10.3	4.6	47.8	15.3	17.7	12.8	13.2	16.0	10.7	14.4	53.2	6.2	35.1	19.8	39.3	1.9	2.3	30.6	20.7	15.1	46.8	83.8	0.4	0.0	2.5	0.4	3.2	3.4	0.8	0.1	1.5	0.1	1.3	181.7	92.7	0.1	20.4	80.0	24.2	49.3	0.2	0.3	0.0	0.6	15.9	1.6	0.3	1.7	0.8	3.4	1.9	0.1	0.0	0.6	0.6	34.9	0.1	0.2	107.4	0.5	11.0	0.8	18.4	0.4	0.1	0.0	2.5	3.1	0.0	0.9	0.1	0.8	0.0	0.1	1.1	0.5	0.1	0.1	0.9	0.0	0.3	14.7	0.4	0.4	0.2	0.0	0.0	0.0	5.8	0.9	26.7	0.1	0.1	0.4	0.0	8.3	0.1	0.8	0.0	0.4	2.0	1.6	0.1	2.0	0.0	1.4	3.4	0.0	0.4	2.8	2.9	2.5	3.2	0.0	0.0	1.4	0.8	2.6	3.8	1.4	2.8	1.9	1.8	3.5	2.0	4.6	1.9	20.8	84.7	28.4	53.6	48.5	0.2	14.6	168.2	6.7	34.2	17.4	2.0	2.9	3.3	164.2	3.5	51.3	0.3	23.3	39.1	4.8	462.9	14.1	9.3	1385.8	10.3	0.0	0.0	128.9	25.4	9.4	1057.9	10.1	50.6	2.8	0.6	15.1	74.1	0.6	364.9	5.0	0.9	168.1	97.8	5.7	4.1	35.0	4.3	13.1	0.7	9.8
C1RL	"C1r-LP, C1RL1"	ENSG00000139178	"Complement C1r subcomponent like"	Q9NZP8	12	7089587-7109273	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Complement pathway, Immunity, Innate immunity"	"Hydrolase, Protease, Serine protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 96.1"	"Cell type enhanced"	"Detected in many"	11	"Hepatocytes: 133.0;Leydig cells: 51.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"neutrophil: 11.7"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 11.7"	"Cell line enhanced"	"Detected in many"		"ASC TERT1: 31.8;HSkMC: 35.2"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"HPA011338, CAB026172"	Supported				"Secreted to blood"	NA	NA	5500000000	20000000000			"CAB026172: , HPA011338: AB_1847111"	"prognostic favorable (7.92e-4)"	"unprognostic (7.76e-2)"	"unprognostic (3.91e-3)"	"unprognostic (5.25e-3)"	"unprognostic (2.92e-3)"	"unprognostic (9.60e-2)"	"unprognostic (2.75e-3)"	"unprognostic (7.76e-2)"	"unprognostic (1.22e-1)"	"unprognostic (4.34e-1)"	"unprognostic (9.58e-3)"	"unprognostic (1.57e-1)"	"prognostic unfavorable (1.52e-7)"	"unprognostic (1.75e-1)"	"unprognostic (5.74e-2)"	"unprognostic (2.52e-1)"	"unprognostic (2.26e-3)"	16.5	31.2	3.8	10.0	5.5	6.1	14.2	1.2	4.9	12.1	13.5	3.2	10.5	6.0	12.4	14.9	13.3	14.5	14.7	10.0	2.5	1.6	21.4	96.1	14.2	13.1	4.5	2.7	21.3	23.8	5.2	15.7	4.2	6.4	16.5	7.2	11.3	16.9	11.5	11.1	7.8	9.5	15.4	9.3	12.7	11.1	7.2	4.7	2.8	14.4	8.1	7.0	15.5	16.4	2.2	1.7	11.7	2.5	0.6	1.4	0.9	2.2	6.0	0.6	6.0	18.5	31.8	4.2	3.7	17.3	3.7	11.3	3.8	10.4	0.9	3.2	3.0	3.8	5.0	1.6	6.4	1.5	9.3	0.3	3.5	5.9	8.8	15.0	0.7	17.3	35.2	12.1	2.4	7.4	18.1	3.9	1.9	2.8	2.3	2.3	0.1	0.5	0.7	1.1	0.5	0.2	2.0	0.0	0.7	10.5	10.1	0.4	1.3	12.7	1.6	2.3	1.1	1.5	3.1	3.3	3.4	6.3	3.9	0.7	1.7	0.7	0.1	6.4	2.5	1.5	7.2	1.5	8.0	1.4	2.3	0.6	2.2	1.4	1.0	1.7	1.1	0.9	0.8	11.7	0.6	2.5	0.9	0.8	0.9	3.8	5.5	1.2	4.9	2.5	1.6	4.5	2.7	6.4	4.7	14.9	30.5	9.5	12.8	3.4	0.4	2.1	20.4	14.7	28.4	5.2	2.0	0.1	1.7	24.9	0.1	10.8	7.8	0.0	46.6	0.2	11.9	10.2	3.5	133.0	3.0	0.0	4.1	23.4	9.8	0.9	51.5	10.7	3.3	10.0	8.1	3.4	26.2	7.0	19.1	7.6	1.0	0.0	5.1	0.5	0.7	2.8	0.1	13.1	8.4	7.3
C1S		ENSG00000182326	"Complement C1s"	P09871	12	6988259-7071032	"Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Complement pathway, Immunity, Innate immunity"	"Hydrolase, Protease, Serine protease"	"Disease mutation, Ehlers-Danlos syndrome, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 351.6"	"Cell type enhanced"	"Detected in many"	21	"Hepatocytes: 2464.3;Leydig cells: 1104.9;Peritubular cells: 601.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	10	"neutrophil: 6.2"	"Lineage enriched"	"Detected in single"	17	"granulocytes: 6.2"	"Cell line enhanced"	"Detected in many"		"ASC diff: 99.3;ASC TERT1: 132.1;BJ hTERT+: 42.1;HSkMC: 70.1"					"Low region specificity"	"Detected in all"			"CAB016722, HPA018852"	Supported		Approved	Nucleoplasm,Cytosol	"Secreted to blood"	NA	NA	93000000000	13000000000	Nucleoplasm	Cytosol	"CAB016722: , HPA018852: AB_1847112"	"unprognostic (2.72e-3)"	"unprognostic (7.31e-2)"	"unprognostic (9.37e-2)"	"unprognostic (1.39e-2)"	"unprognostic (1.05e-2)"	"unprognostic (9.63e-2)"	"prognostic favorable (7.73e-4)"	"unprognostic (6.38e-2)"	"unprognostic (1.16e-1)"	"unprognostic (6.14e-2)"	"unprognostic (1.57e-1)"	"unprognostic (1.85e-2)"	"prognostic unfavorable (7.44e-15)"	"unprognostic (2.02e-2)"	"unprognostic (5.68e-3)"	"unprognostic (1.19e-2)"	"unprognostic (5.39e-2)"	48.7	16.6	3.3	18.7	4.1	0.0	55.7	1.9	3.1	35.3	31.1	2.9	12.7	6.8	32.2	50.0	38.3	46.4	47.2	34.4	2.5	1.1	18.0	351.6	31.4	21.1	6.3	3.2	98.8	15.5	1.9	6.0	8.5	6.5	52.1	18.6	26.1	14.6	12.4	18.2	14.7	19.2	47.6	8.8	32.5	24.6	37.2	2.3	3.2	30.5	22.7	18.8	48.6	73.0	0.2	0.1	6.2	0.3	0.2	0.1	0.0	0.0	2.2	0.1	1.3	99.3	132.1	0.4	17.9	42.1	9.5	17.4	0.0	0.2	0.0	2.4	22.2	2.5	0.1	0.0	0.2	0.8	0.0	0.0	0.0	0.6	4.7	29.9	0.2	0.1	70.1	0.3	7.7	0.5	11.9	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.1	1.2	0.0	0.0	0.0	0.1	0.1	0.3	0.3	0.0	0.1	10.9	0.2	0.2	2.1	0.0	0.0	0.0	4.4	0.3	16.9	0.0	0.0	0.0	0.1	9.5	0.1	0.2	0.6	0.3	0.2	0.0	0.1	0.0	0.2	0.0	0.1	0.0	0.2	0.1	0.1	6.2	0.2	0.1	0.1	0.0	0.0	3.3	4.1	1.9	3.1	2.5	1.1	6.3	3.2	6.5	2.3	14.9	34.2	18.3	17.5	67.8	0.6	21.4	152.8	6.7	20.5	3.5	0.0	2.9	1.7	170.0	5.7	37.8	0.0	46.7	37.9	3.5	388.0	7.4	4.7	2464.3	7.1	4.8	0.0	105.6	49.3	8.8	1104.9	9.4	84.4	1.8	0.0	15.1	43.6	0.0	601.8	4.1	0.9	135.8	123.7	5.0	4.1	47.0	2.2	4.3	0.0	3.0
C2		ENSG00000166278	"Complement C2"	P06681	6	31897785-31945672	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins"	"Complement pathway, Immunity, Innate immunity"	"Hydrolase, Protease, Serine protease"	"Age-related macular degeneration, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	7	"liver: 132.7"	"Cell type enhanced"	"Detected in many"	17	"Alveolar cells type 2: 116.0;Hepatocytes: 339.0;Hofbauer cells: 221.2"	"Cancer enriched"	"Detected in all"	9	"liver cancer: 100.2"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	7	"classical monocyte: 2.9;intermediate monocyte: 6.4;non-classical monocyte: 6.5"	"Lineage enriched"	"Detected in single"	8	"monocytes: 6.5"	"Group enriched"	"Detected in some"	5	"Hep G2: 17.3;Karpas-707: 54.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			CAB016775	Supported				"Secreted to blood"	NA	NA		52000000000			"CAB016775: "	"unprognostic (2.05e-1)"	"unprognostic (1.22e-1)"	"unprognostic (7.68e-2)"	"unprognostic (1.49e-3)"	"unprognostic (7.40e-2)"	"unprognostic (3.34e-2)"	"unprognostic (1.36e-2)"	"unprognostic (8.88e-3)"	"unprognostic (3.02e-1)"	"unprognostic (2.59e-3)"	"unprognostic (3.27e-2)"	"unprognostic (3.15e-3)"	"prognostic unfavorable (2.64e-7)"	"unprognostic (2.05e-1)"	"unprognostic (4.42e-2)"	"unprognostic (7.37e-2)"	"unprognostic (2.55e-2)"	9.2	3.2	0.9	4.8	1.5	0.8	5.0	1.2	1.3	2.0	5.3	1.8	1.6	2.5	2.0	4.8	1.9	3.3	3.2	5.4	0.8	0.8	13.1	132.7	19.4	13.1	1.2	0.3	2.7	2.1	0.8	2.8	7.6	1.7	1.8	4.3	2.9	2.4	1.5	0.7	1.6	6.6	3.5	1.8	12.1	1.9	2.0	1.0	1.8	1.2	0.8	3.4	2.7	1.5	0.2	0.5	0.8	6.5	0.1	0.3	1.2	0.1	0.0	0.0	0.2	0.0	0.0	0.7	0.2	0.1	0.2	0.1	0.1	0.1	0.2	0.6	0.3	0.1	0.2	0.0	0.0	0.1	0.1	0.1	0.1	0.1	17.3	0.3	0.0	0.2	0.9	0.1	0.2	0.0	0.2	0.0	0.3	0.1	54.0	0.0	0.0	0.1	0.2	0.1	0.0	0.0	0.0	1.4	0.6	0.0	0.0	0.1	0.1	1.0	0.1	0.0	0.1	0.1	2.4	0.1	0.1	0.2	0.2	0.0	0.2	6.7	1.0	0.2	0.3	0.0	0.1	2.9	0.0	0.1	6.4	0.1	0.1	0.1	0.1	0.5	0.2	0.3	0.2	0.8	0.1	6.5	0.0	0.1	1.2	0.9	1.5	1.2	1.2	0.8	0.8	1.2	0.3	1.7	1.0	23.8	116.0	3.0	1.0	3.0	1.4	0.4	10.2	9.4	6.8	1.8	0.0	1.6	0.0	0.4	0.1	0.7	2.8	23.3	2.4	1.8	15.8	5.9	3.5	339.0	221.2	1.6	2.4	25.2	60.2	0.8	6.4	8.4	3.3	10.0	4.1	0.0	7.1	15.3	1.1	30.0	0.8	0.0	2.3	0.6	0.9	2.5	3.3	3.2	3.9	2.5
C9orf3	"AOPEP, AP-O, APO, C90RF3, FLJ14675"	ENSG00000148120	"Chromosome 9 open reading frame 3"	Q8N6M6	9	94726701-95087218	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Aminopeptidase, Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Melanocytes: 187.3;Smooth muscle cells: 202.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"A549: 20.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004633, HPA072729"	Approved		Approved	"Cell Junctions"		NA	NA			"Cell Junctions"		"HPA004633: AB_1078362, HPA072729: AB_2686553"	"unprognostic (4.25e-2)"	"unprognostic (1.07e-3)"	"unprognostic (6.29e-2)"	"unprognostic (1.71e-1)"	"unprognostic (1.12e-1)"	"unprognostic (2.75e-2)"	"unprognostic (9.59e-2)"	"unprognostic (4.24e-2)"	"unprognostic (2.99e-2)"	"unprognostic (1.34e-1)"	"unprognostic (2.60e-2)"	"unprognostic (2.80e-1)"	"prognostic favorable (6.33e-5)"	"unprognostic (2.31e-1)"	"unprognostic (2.56e-1)"	"unprognostic (3.29e-2)"	"unprognostic (3.37e-2)"	6.2	8.5	6.8	9.1	12.7	2.4	11.3	10.5	10.3	14.0	17.8	24.6	24.1	5.1	28.8	15.0	20.2	16.0	17.9	29.9	8.9	5.9	12.7	28.1	10.9	3.1	11.3	6.1	11.7	24.7	25.0	11.1	24.4	11.3	22.1	6.8	11.4	13.1	17.6	29.8	39.1	8.1	32.2	11.6	6.8	10.8	6.4	11.4	3.3	11.6	23.7	7.8	12.9	25.1	5.4	5.8	2.1	3.6	3.4	3.6	1.8	4.6	20.6	2.2	3.9	2.3	3.0	8.8	4.4	2.0	4.7	2.8	4.4	6.0	1.4	3.8	7.4	6.6	18.2	4.1	4.2	2.3	9.6	3.2	1.3	18.7	3.9	4.8	1.2	1.0	3.1	17.6	4.1	2.7	12.6	2.6	2.2	2.1	1.9	8.5	6.7	1.7	1.5	2.9	5.5	8.6	2.7	7.2	1.7	8.1	4.1	4.6	6.9	7.5	7.0	1.6	6.3	7.7	0.9	2.0	2.0	2.0	8.3	2.3	1.7	2.2	0.7	7.0	1.1	3.6	0.3	3.6	2.1	3.6	2.5	2.3	2.4	3.0	3.3	5.8	5.4	2.3	2.7	1.3	3.4	1.7	5.2	1.9	1.8	6.8	12.7	10.5	10.3	8.9	5.9	11.3	6.1	11.3	11.4	20.8	26.6	2.0	151.6	128.8	21.9	142.0	61.1	30.8	31.8	12.2	17.7	55.1	38.1	34.9	33.0	58.5	10.1	0.0	83.2	34.0	56.4	54.9	3.5	70.1	8.0	11.1	10.9	21.5	6.2	19.5	17.5	5.9	187.3	1.8	8.5	71.9	51.7	14.4	100.0	32.7	12.4	12.9	202.8	14.3	20.0	131.6	73.8	3.5	9.5	61.6
CA1	Car1	ENSG00000133742	"Carbonic anhydrase 1"	P00915	8	85327608-85379014	"Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"		Lyase	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"bone marrow: 156.0;intestine: 203.6"	"Cell type enriched"	"Detected in some"	19	"Erythroid cells: 11890.7"	"Group enriched"	"Detected in some"	10	"colorectal cancer: 3.4;stomach cancer: 0.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	1207	"HEL: 169.2"	"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			"HPA006558, CAB025790"	Enhanced					NA	NA		7800000000			"CAB025790: , HPA006558: AB_1845989"	"unprognostic (1.44e-1)"	"unprognostic (7.56e-2)"	"unprognostic (1.70e-1)"	"unprognostic (3.57e-3)"	"unprognostic (2.08e-2)"	"unprognostic (1.66e-1)"	"unprognostic (2.84e-2)"	"unprognostic (2.03e-2)"		"unprognostic (1.73e-2)"	"unprognostic (6.12e-2)"	"unprognostic (1.63e-1)"	"unprognostic (1.04e-1)"	"unprognostic (5.61e-2)"	"unprognostic (3.01e-2)"	"unprognostic (2.38e-1)"	"unprognostic (3.95e-2)"	1.8	0.4	0.5	11.5	0.5	156.0	0.4	0.3	0.4	0.3	95.4	1.5	0.0	0.0	0.3	0.0	0.6	0.7	0.0	17.6	0.5	0.4	0.8	2.9	32.2	0.2	0.9	0.0	0.8	0.5	0.0	1.0	24.0	0.6	1.1	203.6	2.6	0.3	0.1	3.1	0.2	0.4	3.2	0.5	14.3	0.3	0.3	0.0	0.2	7.5	0.0	0.2	4.5	16.0	0.7	0.7	0.0	0.3	0.0	0.1	7.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	169.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.7	0.0	0.0	0.3	0.3	0.0	0.0	0.0	0.0	0.0	0.7	0.0	7.5	0.5	0.5	0.3	0.4	0.5	0.4	0.9	0.0	0.6	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	624.8	11890.7	0.0	0.0	0.0	0.1	23.0	0.6	0.0	0.0	44.0	1.3	1.6	0.0	0.0	0.0	0.0	0.0	89.9	0.0	0.0	422.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	79.4	0.0
CA12	HsT18816	ENSG00000074410	"Carbonic anhydrase 12"	O43570	15	63321378-63382161	"Disease related genes, Enzymes, FDA approved drug targets, Predicted membrane proteins"		Lyase	"Disease mutation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 103.5"	"Cell type enhanced"	"Detected in many"	9	"Basal keratinocytes: 155.1;Enterocytes: 240.0;Paneth cells: 157.9;Suprabasal keratinocytes: 220.4"	"Cancer enhanced"	"Detected in all"		"renal cancer: 109.3"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"A549: 39.0;ASC TERT1: 41.1;RT4: 41.3;SK-BR-3: 33.1;T-47d: 53.4;U-138 MG: 57.0;U-87 MG: 68.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA008773, CAB025181, CAB062549, CAB068179"	Enhanced					NA	NA		29000			"CAB025181: , CAB062549: AB_2665617, CAB068179: AB_2665616, HPA008773: AB_1078394"	"unprognostic (2.01e-1)"	"unprognostic (8.38e-3)"	"unprognostic (3.47e-1)"	"unprognostic (3.25e-3)"	"unprognostic (2.73e-2)"	"unprognostic (2.47e-2)"	"unprognostic (7.48e-2)"	"unprognostic (3.43e-3)"	"unprognostic (2.29e-1)"	"unprognostic (4.67e-2)"	"prognostic unfavorable (3.80e-6)"	"unprognostic (2.59e-1)"	"unprognostic (1.51e-1)"	"unprognostic (2.38e-1)"	"unprognostic (6.56e-2)"	"unprognostic (7.26e-2)"	"unprognostic (1.21e-1)"	3.7	0.3	4.7	15.0	27.4	0.3	14.5	3.7	2.3	15.7	32.0	2.6	5.0	0.4	9.8	12.3	42.8	8.5	2.6	1.6	4.9	1.4	103.5	0.3	1.2	0.3	1.8	0.2	2.1	43.8	0.3	3.9	5.9	16.9	3.8	30.3	8.5	8.2	17.9	0.5	44.1	2.4	18.1	0.1	0.4	2.2	1.3	6.7	0.0	1.7	18.4	25.9	10.6	14.5	0.3	0.2	0.6	0.7	0.3	0.2	0.0	0.0	39.0	0.6	0.1	5.2	41.1	2.1	2.8	2.5	0.4	0.7	0.2	0.1	0.0	9.6	2.3	15.4	0.2	0.0	1.9	1.1	0.0	1.4	0.0	2.6	0.0	0.1	0.0	0.0	15.5	2.1	11.9	3.8	0.0	0.5	0.0	0.0	0.0	0.5	22.4	0.0	0.0	0.6	0.0	6.1	0.0	0.0	0.0	0.0	41.3	0.3	0.0	0.1	33.1	0.0	0.4	53.4	0.0	0.0	57.0	3.0	1.8	0.0	0.0	0.0	0.0	68.4	0.0	0.1	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.3	0.1	0.2	0.6	0.3	0.7	0.2	0.1	0.0	4.7	27.4	3.7	1.3	4.9	1.4	1.8	0.2	16.9	6.7	0.0	5.8	1.5	18.6	155.1	0.0	0.6	0.0	2.7	3.4	38.4	0.0	0.4	46.4	14.9	12.0	0.0	240.0	0.0	48.3	1.7	5.1	14.8	1.1	0.0	0.6	0.0	8.1	0.0	0.0	3.0	0.0	2.2	21.9	0.0	92.2	2.5	15.0	157.9	0.0	59.0	0.2	0.0	3.9	0.0	0.0	220.4	1.5	0.0	95.7	16.3
CA13	"CAXIII, FLJ37995, MGC59868"	ENSG00000185015	"Carbonic anhydrase 13"	Q8N1Q1	8	85220587-85284073	"Enzymes, Predicted intracellular proteins"		Lyase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 56.7"	"Cell type enhanced"	"Detected in many"	7	"Cone photoreceptor cells: 31.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HEL: 12.5;OE19: 24.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA024689, CAB025567"	Enhanced		Approved	Nucleoplasm,Nucleoli,Vesicles		NA	NA		100000	Nucleoli	"Nucleoplasm, Vesicles"	"CAB025567: , HPA024689: AB_1846004"	"unprognostic (1.12e-2)"	"unprognostic (2.20e-1)"	"unprognostic (1.75e-1)"	"unprognostic (9.16e-5)"	"unprognostic (2.21e-2)"	"unprognostic (2.08e-1)"	"unprognostic (9.39e-2)"	"unprognostic (7.90e-3)"	"unprognostic (1.97e-1)"	"unprognostic (1.34e-2)"	"unprognostic (3.58e-2)"	"unprognostic (3.13e-1)"	"prognostic favorable (9.40e-4)"	"unprognostic (7.59e-2)"	"unprognostic (1.59e-1)"	"unprognostic (1.55e-2)"	"unprognostic (3.00e-1)"	2.6	2.6	2.0	1.9	3.1	0.5	2.9	2.4	2.4	3.2	18.2	0.8	0.0	14.2	1.8	1.7	6.7	1.4	25.6	5.8	1.6	1.9	10.4	17.1	9.5	2.4	2.0	0.1	2.2	1.6	9.3	6.5	1.0	5.7	2.6	3.7	1.9	7.0	1.0	1.9	7.1	56.7	1.9	5.2	2.2	7.0	0.9	0.9	0.4	10.3	3.9	5.6	2.9	5.2	0.8	2.1	3.2	2.5	0.5	0.5	1.0	0.2	0.3	0.7	0.1	0.5	0.5	0.3	0.8	0.9	0.1	2.4	5.8	4.5	0.3	0.4	1.0	5.1	1.9	1.8	2.3	0.1	1.3	0.8	12.5	1.6	5.3	1.2	0.2	0.5	1.9	0.4	0.2	1.0	1.5	1.3	0.5	3.1	2.4	2.1	0.0	0.2	0.2	0.3	24.6	0.3	0.2	1.8	0.1	6.7	0.2	0.2	0.0	0.4	0.0	1.3	0.9	0.4	0.6	1.2	2.3	3.3	0.1	1.3	1.0	0.4	1.5	4.8	1.8	2.2	3.2	2.5	1.3	0.4	0.7	0.2	0.2	0.2	0.1	2.1	0.8	0.3	0.5	0.9	0.5	0.8	0.9	0.1	1.0	2.0	3.1	2.4	2.4	1.6	1.9	2.0	0.1	5.7	0.9	3.0	7.7	1.4	2.1	1.5	1.5	5.2	5.1	10.7	12.5	12.2	31.4	0.2	8.3	3.2	9.1	2.1	16.9	0.0	1.4	0.2	3.1	2.1	0.0	4.7	0.9	0.0	4.6	9.8	3.0	10.4	0.0	2.2	5.0	0.0	3.2	2.0	3.1	4.9	0.0	16.1	5.1	0.0	1.0	1.2	2.3	2.8	0.2	1.0	3.4	1.8
CA14		ENSG00000118298	"Carbonic anhydrase 14"	Q9ULX7	1	150257159-150265078	"Enzymes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins"		Lyase	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 20.9;retina: 29.4;seminal vesicle: 16.5;skeletal muscle: 24.1"	"Group enriched"	"Detected in some"	16	"Cardiomyocytes: 44.5;Melanocytes: 50.6;Muller glia cells: 123.0"	"Group enriched"	"Detected in many"	7	"glioma: 4.9;melanoma: 23.2"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in some"	7	"AF22: 28.7;AN3-CA: 17.0;NTERA-2: 22.3;SK-MEL-30: 57.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA008482	Approved		Approved	"Plasma membrane"		NA	NA			"Plasma membrane"		"HPA008482: AB_1078395"	"unprognostic (3.06e-2)"	"unprognostic (1.67e-1)"	"unprognostic (2.10e-2)"	"unprognostic (3.25e-2)"	"prognostic favorable (8.47e-4)"	"unprognostic (7.28e-2)"	"unprognostic (4.48e-2)"	"unprognostic (1.49e-1)"	"unprognostic (2.10e-1)"	"unprognostic (2.47e-1)"	"unprognostic (5.46e-2)"	"unprognostic (1.73e-1)"	"unprognostic (5.89e-3)"	"unprognostic (1.91e-1)"	"unprognostic (1.49e-1)"	"unprognostic (1.22e-1)"	"unprognostic (5.80e-2)"	0.1	0.3	4.6	0.2	5.2	0.9	0.3	1.4	6.8	0.1	1.7	10.8	0.1	0.3	0.1	0.5	1.6	1.3	0.7	4.4	6.4	4.1	0.3	6.3	0.2	0.2	11.3	3.2	1.4	0.3	0.8	0.1	0.3	4.4	3.2	0.7	29.4	0.6	16.5	24.1	3.7	0.6	0.5	20.9	0.3	0.8	0.5	2.7	0.1	0.9	0.1	0.1	0.2	0.1	2.8	2.2	2.1	2.0	0.2	1.6	0.2	0.2	0.0	28.7	17.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.1	0.1	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.2	0.0	0.2	0.0	0.1	22.3	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.8	0.4	0.0	0.1	57.1	4.1	0.2	0.1	0.0	0.0	0.0	0.0	0.1	0.2	1.3	0.1	0.1	0.1	0.0	0.0	0.9	1.3	1.6	2.0	0.6	2.0	1.0	1.2	0.2	2.8	1.2	1.3	2.1	0.2	0.5	2.2	0.0	0.2	4.6	5.2	1.4	4.7	6.4	4.1	11.3	3.2	4.4	2.7	3.0	0.3	0.0	0.2	1.9	1.4	44.5	0.0	0.0	1.2	0.0	0.0	0.4	0.0	0.4	0.0	0.1	0.0	0.0	0.6	0.0	0.4	0.1	0.0	3.8	0.1	0.0	0.0	0.0	0.3	0.0	0.9	0.0	50.6	0.0	0.0	123.0	1.2	0.0	3.2	0.0	4.5	0.0	0.0	0.0	0.0	0.4	0.2	0.0	0.1	0.4
CA2	"CA-II, CAII, Car2"	ENSG00000104267	"Carbonic anhydrase 2"	P00918	8	85463852-85481493	"Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"		Lyase	"Disease mutation, FDA approved drug targets, Osteopetrosis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 108.1;stomach 1: 171.5"	"Cell type enhanced"	"Detected in many"	14	"Enterocytes: 870.3;Erythroid cells: 2055.8;Muller glia cells: 1176.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"basophil: 20.3"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"HaCaT: 33.8;HEK 293: 142.4;THP-1: 59.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA001550, CAB010102"	Enhanced					NA	Yes		790000000			"CAB010102: AB_626796, HPA001550: AB_1078393"	"unprognostic (6.78e-2)"	"unprognostic (3.06e-2)"	"unprognostic (1.05e-2)"	"unprognostic (1.63e-1)"	"unprognostic (2.59e-1)"	"unprognostic (9.24e-2)"	"unprognostic (1.74e-1)"	"unprognostic (1.72e-2)"	"unprognostic (1.07e-1)"	"unprognostic (5.23e-2)"	"unprognostic (1.57e-1)"	"unprognostic (9.89e-2)"	"prognostic favorable (5.57e-6)"	"unprognostic (2.45e-1)"	"unprognostic (2.03e-1)"	"unprognostic (1.32e-1)"	"unprognostic (6.49e-3)"	1.6	2.2	24.4	21.5	32.6	32.4	6.9	4.3	23.2	1.3	108.1	28.9	42.0	46.9	0.9	2.2	5.6	0.9	33.0	4.3	29.1	14.5	53.5	43.0	10.2	1.3	49.0	14.2	0.5	9.1	3.1	2.0	3.5	65.0	0.8	105.6	7.0	14.0	54.2	9.2	13.3	7.6	6.0	27.5	2.5	171.5	5.1	58.3	0.0	3.8	2.4	1.1	1.0	1.4	1.9	8.0	20.3	8.2	0.0	4.4	17.5	0.5	0.3	1.6	0.0	0.0	0.0	4.4	0.0	0.0	0.0	0.0	2.0	0.1	0.0	1.2	0.0	0.0	33.8	4.9	1.7	0.0	0.0	142.4	4.4	2.5	0.0	0.0	3.1	0.6	0.0	8.6	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.4	0.4	11.2	0.0	2.7	0.1	0.0	0.5	1.1	0.0	0.0	0.7	0.0	0.0	1.3	0.0	59.7	0.0	0.0	0.9	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	20.3	3.1	4.4	0.1	8.2	4.4	0.6	0.0	0.4	8.0	1.9	0.0	0.0	6.8	0.0	7.1	0.8	0.0	17.5	24.4	32.6	4.3	23.2	29.1	14.5	49.0	14.2	65.0	58.3	14.9	56.8	27.3	1.0	80.5	23.5	18.5	400.0	0.0	1.2	153.5	60.9	10.7	295.1	50.5	65.5	14.6	870.3	2055.8	9.9	311.4	6.4	1.1	16.1	101.2	34.8	12.7	29.2	1.8	8.2	179.8	3.1	46.0	70.9	1.0	94.2	1176.2	10.3	374.2	2.1	304.9	61.5	0.0	7.3	1.7	2.3	97.6	14.3	5.7	229.3	0.3
CA3	"CAIII, Car3"	ENSG00000164879	"Carbonic anhydrase 3"	P07451	8	85373436-85449040	"Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"		Lyase	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	12	"skeletal muscle: 347.5"	"Cell type enriched"	"Detected in some"	14	"Erythroid cells: 280.4"	"Group enriched"	"Detected in many"	7	"glioma: 23.1;prostate cancer: 9.4"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"plasmacytoid DC: 1.8"	"Low lineage specificity"	"Detected in single"			"Group enriched"	"Detected in some"	9	"HEL: 23.8;RH-30: 40.1"	"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			"CAB004967, HPA021775, HPA026700"	Enhanced					NA	NA		31000000			"CAB004967: AB_437014, HPA021775: AB_1845990, HPA026700: AB_1845991"	"prognostic favorable (4.24e-6)"	"unprognostic (1.40e-1)"	"unprognostic (1.50e-2)"	"unprognostic (2.22e-3)"	"unprognostic (4.71e-2)"	"unprognostic (8.43e-3)"	"unprognostic (3.56e-2)"	"unprognostic (4.04e-2)"	"unprognostic (1.11e-1)"	"unprognostic (3.68e-1)"	"unprognostic (4.71e-2)"	"unprognostic (3.54e-1)"	"unprognostic (3.19e-2)"	"unprognostic (1.18e-1)"	"unprognostic (9.96e-2)"	"unprognostic (1.39e-1)"	"unprognostic (2.19e-1)"	18.0	0.4	0.2	0.1	0.2	0.5	0.6	0.2	0.1	0.5	0.3	0.0	0.1	0.1	0.6	29.0	9.5	1.0	0.2	1.3	0.2	0.1	0.2	0.2	4.1	0.0	0.1	0.0	0.1	0.1	0.0	0.3	0.0	0.0	6.6	0.0	0.0	5.5	0.2	347.5	0.3	0.4	1.4	0.1	0.1	0.3	0.5	0.0	0.0	0.3	14.1	3.4	0.7	0.5	0.5	1.8	0.0	0.0	0.0	0.8	0.2	0.9	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.5	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.2	0.1	23.8	0.0	0.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	3.7	0.0	0.0	40.1	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.9	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.3	0.0	0.8	0.0	0.0	0.0	1.8	0.0	0.2	0.2	0.2	0.2	0.1	0.2	0.1	0.1	0.0	0.0	0.0	3.0	3.4	0.0	0.9	0.5	0.0	0.8	7.6	0.0	0.0	0.0	5.9	0.6	0.0	0.7	20.2	0.0	0.7	280.4	0.2	0.0	0.6	0.5	0.0	0.0	0.4	0.0	0.0	1.8	0.3	4.7	0.3	0.0	0.0	0.0	0.3	16.0	0.2	1.7	0.0	0.5	1.4	0.0	0.1	0.5	0.9	0.9	1.4	0.0	0.6	0.3
CA4	"CAIV, Car4, RP17"	ENSG00000167434	"Carbonic anhydrase 4"	P22748	17	60149936-60170899	"Disease related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins"		Lyase	"Disease mutation, FDA approved drug targets, Retinitis pigmentosa"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 81.7"	"Cell type enriched"	"Detected in many"	43	"Paneth cells: 2128.8"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in many"	4	"cerebellum: 50.1"	"Cell type enriched"	"Detected in some"	7	"neutrophil: 37.0"	"Lineage enriched"	"Detected in single"	370	"granulocytes: 37.0"	"Cell line enhanced"	"Detected in some"		"HUVEC TERT2: 1.5;NTERA-2: 3.4;OE19: 3.9;RPTEC TERT1: 1.9;SuSa: 2.6"	"Region enriched"	"Detected in all"	5	"cerebellum: 336.9"	"Low region specificity"	"Detected in many"			"HPA011089, HPA017258"	Enhanced					NA	NA		190000			"HPA011089: AB_1845996, HPA017258: AB_1845997"	"unprognostic (2.07e-2)"	"unprognostic (7.85e-2)"	"unprognostic (1.55e-2)"	"unprognostic (7.78e-3)"	"unprognostic (8.42e-2)"	"unprognostic (1.19e-1)"	"unprognostic (3.19e-2)"	"unprognostic (5.84e-2)"	"unprognostic (7.76e-2)"	"unprognostic (9.74e-2)"	"unprognostic (1.54e-1)"	"unprognostic (1.71e-2)"	"unprognostic (2.68e-3)"	"unprognostic (8.59e-2)"	"unprognostic (1.43e-1)"	"unprognostic (2.45e-1)"	"unprognostic (4.57e-2)"	32.2	0.9	3.4	9.8	4.4	5.7	46.4	50.1	11.8	2.3	81.7	2.0	31.5	1.4	2.3	17.4	0.9	1.7	12.2	8.8	4.7	2.6	12.0	0.3	33.3	2.4	3.5	5.2	1.9	9.5	3.3	5.1	3.2	3.0	2.4	54.9	20.3	4.8	24.0	10.0	1.0	3.2	1.1	2.1	4.9	2.5	1.2	0.3	0.2	23.1	5.0	0.2	1.7	7.9	0.0	0.0	37.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.6	0.1	0.3	0.0	0.0	0.0	0.5	0.8	0.1	0.0	0.3	0.0	0.0	0.3	1.3	0.0	0.0	0.7	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.3	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.3	3.4	3.9	0.0	0.0	0.2	1.3	1.9	0.0	0.7	0.3	0.2	0.0	0.0	2.6	0.0	0.6	0.0	0.2	0.7	0.4	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	5.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	37.0	0.0	0.0	0.0	0.0	0.0	3.4	4.4	50.1	11.8	4.7	2.6	3.5	5.2	3.0	0.3	0.0	3.7	0.0	0.2	1.3	0.0	9.2	0.0	1.4	1.2	14.0	0.0	0.0	28.2	3.1	0.2	15.8	49.7	0.0	0.2	0.0	1.5	0.1	11.5	0.0	0.5	0.0	18.6	1.8	0.0	0.0	0.6	0.8	0.0	0.0	27.9	0.0	0.1	2128.8	0.0	18.6	0.0	6.5	17.9	0.0	0.0	1.0	0.0	0.0	32.8	0.3
CA5A	"CA5, CAV, CAVA"	ENSG00000174990	"Carbonic anhydrase 5A"	P35218	16	87881546-87936529	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		Lyase	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	6	"liver: 26.4"	"Cell type enriched"	"Detected in many"	6	"Hepatocytes: 35.0"	"Cancer enriched"	"Detected in single"	26	"liver cancer: 2.0"					"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"Hep G2: 6.8"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"									NA	NA						"unprognostic (1.91e-1)"	"unprognostic (8.64e-3)"	"unprognostic (3.36e-2)"	"unprognostic (6.11e-2)"	"unprognostic (2.49e-2)"	"unprognostic (2.96e-1)"	"unprognostic (8.39e-3)"	"unprognostic (3.50e-3)"	"unprognostic (1.42e-2)"	"unprognostic (1.12e-1)"	"unprognostic (6.55e-2)"	"unprognostic (4.23e-2)"	"unprognostic (7.99e-3)"	"unprognostic (1.77e-1)"	"unprognostic (5.03e-3)"	"unprognostic (3.37e-2)"	"unprognostic (2.76e-2)"	0.0	0.0	0.3	0.8	0.4	2.7	0.0	0.1	0.7	0.0	0.0			0.1	0.1	0.6	0.0	0.0	0.0	0.0	0.4	0.3	0.0	26.4	0.2	0.3	0.4		0.0	0.0	0.0	0.0	0.1		0.0	0.1		0.0	0.0	0.3	0.7	0.1	0.0	0.3	0.8	0.0	0.3			0.1		0.0	0.0	0.0	1.9	1.6	4.7	1.1	1.9	1.1	0.4	0.2	0.3	0.3	0.7	0.1	0.0	0.5	0.4	0.1	0.0	0.1	0.5	0.6	0.6	0.2	0.2	0.3	0.6	0.2	0.3	0.1	0.4	0.3	0.4	1.1	6.8	0.0	0.4	1.7	0.8	0.0	0.2	0.4	0.5	0.3	0.5	0.4	1.6	0.1	0.5	0.2	1.0	0.5	0.3	0.6	0.4	0.4	0.2	0.2	0.6	0.4	0.2	0.2	0.3	0.1	0.5	0.6	0.3	0.4	0.8	0.2	0.5	0.3	0.7	0.4	0.4	0.6	0.9	0.4	4.1	1.1	1.0	0.8	0.7	0.8	0.9	0.8	0.6	0.3	1.9	1.1	1.1	4.7	1.9	0.7	1.6	0.5	0.4											0.0	4.3	0.0	2.5	0.3	1.7	1.4	0.0	2.7	2.3	1.8	3.9	0.3	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.4	1.4	5.8	35.0	0.1	3.2	0.0	1.3	0.6	0.8	0.3	1.9	0.0	0.0	0.0	0.9	0.0	0.0	1.1	0.0	2.6	0.0	0.0	0.3	0.6	0.3	0.2	0.0	0.0	1.3
CA5B		ENSG00000169239	"Carbonic anhydrase 5B"	Q9Y2D0	X	15688830-15788409	"Enzymes, Predicted intracellular proteins"		Lyase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Muller glia cells: 37.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"ASC TERT1: 15.7;fHDF/TERT166: 17.9;hTERT-HME1: 23.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA012618	Uncertain		Supported	Mitochondria		NA	NA			Mitochondria		"HPA012618: AB_1846000"	"unprognostic (1.62e-2)"	"unprognostic (2.10e-3)"	"unprognostic (2.86e-1)"	"unprognostic (1.55e-3)"	"unprognostic (1.16e-2)"	"unprognostic (4.59e-5)"	"unprognostic (2.50e-1)"	"unprognostic (6.89e-4)"	"unprognostic (4.11e-1)"	"unprognostic (3.89e-3)"	"unprognostic (1.54e-1)"	"unprognostic (1.17e-1)"	"prognostic favorable (6.66e-6)"	"unprognostic (2.43e-1)"	"unprognostic (1.38e-1)"	"unprognostic (8.94e-2)"	"unprognostic (3.08e-1)"	9.3	4.6	10.6	4.9	11.1	4.1	10.2	3.1	7.8	28.7	3.6	11.5	1.4	2.2	9.8	3.7	8.1	9.5	9.1	6.5	9.9	8.2	10.3	7.8	7.3	8.8	12.2	6.7	15.2	4.4	16.8	4.4	3.9	13.1	6.2	4.7	29.5	8.3	6.2	2.0	7.5	4.1	9.4	7.1	5.3	5.4	23.0	8.1	2.3	8.9	10.9	11.6	6.3	9.4	4.3	3.5	2.7	3.6	7.9	13.3	7.0	2.7	1.7	2.0	3.2	5.9	15.7	1.1	2.9	3.7	2.2	3.2	0.8	1.9	0.8	3.1	17.9	4.2	3.0	6.9	3.3	3.9	0.7	3.3	1.5	2.1	0.7	5.8	1.9	3.4	3.6	3.6	2.9	23.5	3.9	3.2	2.3	0.8	2.1	10.3	1.5	1.6	1.5	0.8	0.5	12.5	0.9	1.4	1.4	3.3	2.0	1.7	3.7	4.1	1.5	2.6	2.4	2.1	1.9	4.3	2.6	1.7	13.9	1.6	1.5	1.5	0.9	2.9	3.9	4.8	2.7	3.0	0.3	13.1	3.6	11.4	3.6	13.3	12.3	3.5	4.3	9.8	8.3	1.7	7.9	2.3	0.5	10.0	7.0	10.6	11.1	3.1	7.8	9.9	8.2	12.2	6.7	13.1	8.1	0.0	9.3	7.2	5.3	3.8	8.9	1.6	0.0	17.4	10.3	1.8	15.7	1.4	1.7	3.6	0.9	10.7	0.5	23.3	3.5	1.2	7.2	9.7	2.3	2.4	1.7	1.6	2.9	3.7	7.8	1.3	7.2	9.6	3.3	1.0	2.4	37.2	3.8	0.9	4.9	2.2	8.0	6.5	7.2	3.3	5.9	4.0	1.6	15.9	1.7	6.3
CA6		ENSG00000131686	"Carbonic anhydrase 6"	P23280	1	8945867-8975092	"Enzymes, Predicted secreted proteins"		Lyase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	50	"salivary gland: 1237.9"	"Cell type enriched"	"Detected in single"	404	"Melanocytes: 170.4"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"naive CD8 T-cell: 15.4"	"Lineage enriched"	"Detected in many"	10	"T-cells: 15.4"	"Cell line enhanced"	"Detected in many"		"Daudi: 5.5;U-2197: 4.8"					"Not detected"	"Not detected"			"HPA028550, HPA028692"	Enhanced				"Secreted to digestive system"	NA	NA		34000000			"HPA028550: AB_10600105, HPA028692: AB_10601883"	"unprognostic (2.54e-5)"	"unprognostic (1.09e-1)"	"unprognostic (1.10e-1)"	"unprognostic (2.37e-1)"	"unprognostic (2.90e-1)"	"unprognostic (9.28e-2)"		"unprognostic (2.70e-3)"	"unprognostic (1.24e-1)"	"unprognostic (1.73e-1)"	"unprognostic (5.93e-2)"	"unprognostic (4.41e-2)"	"unprognostic (4.29e-5)"	"unprognostic (1.14e-1)"	"unprognostic (1.31e-1)"	"unprognostic (2.35e-1)"		0.3	0.0	0.1	0.0	0.1	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1237.9	0.0	0.1	24.9	0.0	0.0	0.1	0.2	0.0	0.1	0.0	0.0	0.0	0.8	0.2	0.0	0.1	0.6	0.4	1.5	0.3	0.4	15.4	1.6	1.2	0.5	0.9	1.8	0.3	0.3	1.4	0.9	0.1	0.2	0.6	1.0	1.6	5.5	0.6	0.5	1.3	1.6	0.4	0.1	0.8	0.6	0.6	0.8	2.0	1.1	0.4	2.0	2.0	0.0	1.0	0.9	0.1	1.2	0.7	1.4	0.7	3.4	0.1	0.8	1.0	1.5	1.1	1.0	0.8	1.5	0.6	0.3	0.2	1.0	1.0	0.9	0.2	0.9	0.3	0.9	1.5	0.8	0.3	2.8	1.5	4.8	1.2	1.5	0.5	1.7	0.6	1.8	1.4	1.1	0.3	0.2	0.4	0.2	0.4	0.3	0.8	2.8	0.0	0.6	5.6	15.4	1.5	0.4	0.2	0.4	0.3	1.6	0.1	0.1	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	170.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0
CA7		ENSG00000168748	"Carbonic anhydrase 7"	P43166	16	66844379-66854153	"Enzymes, FDA approved drug targets, Predicted intracellular proteins"		Lyase	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in some"	5	"intestine: 37.2"	"Cell type enriched"	"Detected in some"	58	"Paneth cells: 2512.0"	"Cancer enhanced"	"Detected in some"		"colorectal cancer: 0.9"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"CACO-2: 1.3;HAP1: 1.8;NTERA-2: 1.6;REH: 3.4;SCLC-21H: 2.7;THP-1: 5.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA047237	Uncertain					NA	NA					"HPA047237: AB_2679994"	"unprognostic (8.77e-4)"	"unprognostic (5.23e-4)"	"unprognostic (1.57e-1)"	"unprognostic (1.96e-2)"	"unprognostic (2.19e-1)"	"unprognostic (2.16e-2)"		"unprognostic (7.90e-2)"	"unprognostic (1.59e-1)"	"unprognostic (1.84e-2)"	"unprognostic (9.62e-2)"	"unprognostic (1.69e-2)"	"unprognostic (7.12e-3)"	"unprognostic (8.47e-2)"	"unprognostic (5.20e-1)"	"unprognostic (1.90e-2)"	"unprognostic (6.46e-2)"	0.2	0.2	3.2	0.4	7.5	0.2	0.2	3.9	7.7	0.2	37.2	0.3	0.0	4.8	0.3	0.9	0.3	0.2	0.2	0.2	6.3	0.5	0.2	0.2	0.2	0.2	0.7	2.9	0.2	0.2	0.2	0.0	0.2	1.8	0.2	32.0	0.0	1.1	0.4	0.2	0.2	22.8	1.0	0.1	0.2	0.2	0.5	1.3	0.1	0.2	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.2	0.0	0.4	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.9	3.4	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	5.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.2	7.5	3.9	7.7	6.3	0.5	0.7	2.9	1.8	1.3	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	43.2	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	15.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	19.1	0.0	0.0	2512.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	25.5	0.0
CA9	"CAIX, MN"	ENSG00000107159	"Carbonic anhydrase 9"	Q16790	9	35673856-35681159	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"		Lyase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	8	"gallbladder: 70.4;pancreas: 47.4;stomach 1: 70.8"	"Cell type enhanced"	"Detected in some"	25	"Cholangiocytes: 53.5;Early spermatids: 178.0;Exocrine glandular cells: 46.4;Pancreatic endocrine cells: 33.9"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in single"	10	"cerebellum: 7.3"	"Cell type enhanced"	"Detected in single"		"plasmacytoid DC: 1.1"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"A-431: 40.0;HDLM-2: 20.8;hTERT-RPE1: 25.5;U-87 MG: 83.9"	"Region enriched"	"Detected in some"	4	"cerebellum: 13.8"	"Low region specificity"	"Detected in some"			"CAB005100, CAB017107, HPA055207"	Enhanced		Supported	"Plasma membrane"	"Intracellular and membrane"	NA	NA			"Plasma membrane"		"CAB005100: AB_2066539, CAB017107: , HPA055207: AB_2682738"	"unprognostic (8.01e-3)"	"unprognostic (1.34e-2)"	"unprognostic (2.28e-1)"	"unprognostic (2.00e-2)"	"unprognostic (1.59e-2)"	"unprognostic (1.15e-1)"	"prognostic unfavorable (1.71e-5)"	"unprognostic (1.47e-2)"	"unprognostic (3.90e-2)"	"unprognostic (1.29e-1)"	"unprognostic (6.24e-3)"	"unprognostic (1.13e-1)"	"prognostic unfavorable (2.22e-7)"	"unprognostic (7.29e-2)"	"prognostic favorable (9.50e-4)"	"unprognostic (2.97e-3)"	"unprognostic (8.67e-2)"	1.0	0.1	0.0	0.1	0.3	0.0	0.0	7.3	0.7	0.5	7.2	0.1	0.2	6.7	0.1	1.5	0.3	0.1	70.4	0.7	0.0	0.0	0.1	0.7	0.1	0.0	0.0	0.0	0.7	47.4	0.0	0.2	0.7	0.4	0.2	0.0	0.1	0.0	0.0	0.0	2.6	8.0	0.0	0.4	0.0	70.8	1.4	0.0	0.0	0.0	0.0	0.0	1.3	0.2	0.0	1.1	0.0	0.0	0.4	0.1	0.0	40.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.1	1.2	0.0	0.2	0.3	20.8	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	25.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	2.1	0.0	0.1	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	4.2	0.0	0.0	1.0	0.0	0.0	0.0	83.9	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	1.1	0.0	0.0	0.0	0.3	7.3	0.7	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.6	3.9	0.0	0.3	53.5	0.0	0.0	0.0	0.0	0.0	0.0	27.8	178.0	0.0	0.0	0.0	46.4	0.1	0.2	0.2	0.0	0.0	0.1	0.0	0.0	0.6	0.0	12.2	1.4	0.0	0.0	1.0	0.1	1.5	33.9	0.0	0.7	0.0	0.0	0.0	0.4	0.9	2.7	2.8	0.2	0.0	0.2	0.3
CAD	GATD4	ENSG00000084774	"Carbamoyl-phosphate synthetase 2, aspartate transcarbamylase, and dihydroorotase"	P27708	2	27217390-27243943	"Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Pyrimidine biosynthesis"	"Allosteric enzyme, Hydrolase, Ligase, Multifunctional enzyme, Transferase"	"Cancer-related genes, Congenital disorder of glycosylation, Disease mutation, Epilepsy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB007781, HPA057266, HPA069341"	Supported		Supported	Nucleoplasm		No	No		26000	Nucleoplasm		"CAB007781: AB_562057, HPA057266: AB_2683387, HPA069341: AB_2686125"	"unprognostic (1.69e-1)"	"unprognostic (7.34e-2)"	"unprognostic (1.49e-1)"	"unprognostic (4.71e-3)"	"unprognostic (2.55e-1)"	"unprognostic (1.92e-1)"	"prognostic unfavorable (1.72e-11)"	"unprognostic (1.25e-1)"	"unprognostic (2.22e-1)"	"unprognostic (2.37e-1)"	"unprognostic (1.01e-1)"	"unprognostic (6.11e-2)"	"prognostic unfavorable (1.82e-4)"	"unprognostic (6.94e-2)"	"unprognostic (1.75e-1)"	"unprognostic (1.14e-1)"	"unprognostic (5.93e-3)"	12.0	11.9	10.1	23.1	12.4	11.1	18.9	13.3	13.1	14.6	12.4	10.9	9.7	12.1	21.0	18.0	16.3	16.6	15.8	9.8	8.6	8.8	13.1	22.9	13.0	27.9	11.8	9.5	24.4	18.1	10.7	16.4	10.6	10.1	12.5	11.6	12.9	11.7	18.3	12.3	26.0	13.2	17.3	12.5	18.7	11.4	21.3	10.8	35.2	13.8	14.1	18.5	12.7	13.1	5.1	4.9	0.8	2.3	3.7	7.9	2.6	25.3	23.0	10.2	20.5	16.7	13.7	8.1	10.8	7.5	13.6	9.7	26.0	10.1	22.7	9.8	9.8	10.5	14.4	30.1	14.3	10.3	14.8	24.3	32.4	17.5	13.5	8.3	25.5	16.4	10.4	11.8	19.8	22.6	6.3	14.6	21.1	22.8	12.7	12.0	25.5	16.2	38.0	24.6	10.7	17.5	28.5	30.7	23.6	10.1	13.0	20.6	10.3	15.0	10.7	12.6	7.9	8.4	10.7	13.1	20.7	17.1	16.1	21.6	26.4	16.9	46.4	8.3	24.6	17.8	0.0	1.2	0.5	4.7	2.3	4.0	5.1	6.5	7.7	2.7	5.0	4.3	4.3	0.8	3.7	1.2	4.9	7.9	2.6	10.1	12.4	13.3	13.1	8.6	8.8	11.8	9.5	10.1	10.8	3.0	3.8	2.2	3.7	3.3	8.9	4.8	15.3	2.7	5.7	1.8	15.7	4.7	0.0	6.1	1.1	3.8	2.5	0.0	3.0	4.7	5.0	2.4	4.6	4.9	6.9	6.4	6.3	4.3	2.4	1.4	5.8	2.2	3.3	5.4	5.2	4.1	5.3	0.0	9.2	1.3	6.2	0.0	5.1	4.9	10.0	3.0	1.8	4.5	6.8	2.0
CAMK1	CaMKI	ENSG00000134072	"Calcium/calmodulin dependent protein kinase I"	Q14012	3	9757342-9769992	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Cell cycle, Differentiation, Neurogenesis"	"Allosteric enzyme, Calmodulin-binding, Developmental protein, Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adrenal gland: 60.5;blood: 59.4"	"Cell type enhanced"	"Detected in many"	6	"Hofbauer cells: 76.7;Sertoli cells: 58.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	6	"eosinophil: 59.4"	"Lineage enriched"	"Detected in many"	6	"granulocytes: 59.4"	"Cell line enriched"	"Detected in many"	4	"HMC-1: 94.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB031904, HPA051409"	Approved		Approved	Cytosol		NA	NA		550000	Cytosol		"CAB031904: AB_630964, HPA051409: AB_2681473"	"unprognostic (4.43e-2)"	"unprognostic (3.05e-1)"	"unprognostic (1.68e-1)"	"unprognostic (1.29e-1)"	"unprognostic (1.11e-1)"	"unprognostic (3.06e-2)"	"prognostic unfavorable (7.52e-4)"	"unprognostic (5.53e-2)"	"unprognostic (3.32e-1)"	"unprognostic (9.74e-2)"	"unprognostic (1.37e-3)"	"unprognostic (2.17e-1)"	"unprognostic (1.14e-3)"	"unprognostic (7.76e-2)"	"unprognostic (1.72e-1)"	"unprognostic (3.67e-2)"	"unprognostic (3.01e-1)"	27.1	60.5	28.0	11.7	26.0	3.5	34.1	12.4	31.2	9.5	10.7	4.4	5.8	6.8	12.6	10.5	7.1	12.6	8.9	10.2	21.4	14.0	13.1	20.7	9.2	10.4	10.3	19.9	21.5	4.5	7.4	7.9	5.1	10.1	18.6	8.1	6.8	5.1	15.1	4.7	3.3	8.3	18.4	7.2	7.1	8.1	13.4	5.6	0.6	7.0	3.7	10.4	9.5	10.3	0.0	3.2	59.4	9.2	0.7	0.4	0.9	0.1	3.7	3.0	0.0	15.4	5.7	7.5	8.8	4.9	10.1	9.6	5.4	0.6	0.2	2.0	5.9	1.5	0.6	0.0	1.1	6.3	0.1	21.6	11.9	7.0	7.5	8.6	1.0	94.0	6.0	0.9	14.2	1.5	8.3	8.4	0.2	1.5	0.2	3.7	2.2	0.0	8.7	2.1	0.1	5.8	0.0	0.1	0.2	6.0	0.6	1.0	3.8	1.5	0.1	0.8	1.3	0.9	15.2	4.4	4.6	5.7	6.5	11.0	0.1	0.0	0.2	9.8	3.3	0.6	3.3	4.8	59.4	0.0	9.2	0.0	0.0	0.1	0.0	3.2	0.0	0.0	0.0	0.2	0.7	9.2	0.1	0.4	0.9	28.0	26.0	12.4	31.2	21.4	14.0	10.3	19.9	10.1	5.6	0.0	1.9	6.4	17.8	4.4	8.1	0.0	10.2	1.4	2.3	10.4	2.0	0.4	8.3	13.1	1.5	22.7	2.0	0.0	3.6	1.0	11.6	14.9	31.0	21.2	76.7	0.0	5.8	17.8	40.5	3.9	33.4	50.8	5.0	19.0	1.3	30.9	6.0	3.5	42.5	35.3	8.0	58.2	35.0	1.1	1.1	3.3	0.7	7.5	5.5	10.8
CAMK1D	CKLiK	ENSG00000183049	"Calcium/calmodulin dependent protein kinase ID"	Q8IU85	10	12349482-12835545	"Enzymes, Plasma proteins, Predicted membrane proteins"	"Inflammatory response, Neurogenesis"	"Allosteric enzyme, Calmodulin-binding, Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"Bipolar cells: 148.3;Cone photoreceptor cells: 369.1;Rod photoreceptor cells: 206.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"eosinophil: 31.8"	"Lineage enriched"	"Detected in all"	4	"granulocytes: 31.8"	"Cell line enhanced"	"Detected in many"		"HDLM-2: 47.7;U-266/70: 22.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA007266	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"HPA007266: AB_1078389"	"unprognostic (1.06e-1)"	"unprognostic (2.19e-2)"	"unprognostic (2.77e-1)"	"unprognostic (3.65e-3)"	"unprognostic (4.23e-1)"	"unprognostic (2.32e-2)"	"unprognostic (6.90e-3)"	"prognostic favorable (1.67e-4)"	"unprognostic (1.06e-1)"	"unprognostic (1.49e-2)"	"unprognostic (2.95e-1)"	"unprognostic (7.40e-2)"	"unprognostic (1.35e-2)"	"unprognostic (6.55e-2)"	"unprognostic (1.65e-1)"	"unprognostic (4.66e-2)"	"unprognostic (2.56e-3)"	5.1	5.3	20.9	10.5	22.1	6.6	4.0	23.4	33.5	8.3	11.5	4.6	10.0	3.8	3.3	3.3	8.7	4.3	6.8	13.8	18.6	7.2	2.2	11.5	7.6	9.3	5.8	17.8	2.6	17.0	1.3	2.5	3.2	5.0	4.9	12.9	11.9	4.5	15.4	1.7	18.5	5.5	5.6	4.9	10.5	3.4	6.2	6.8	20.8	13.6	2.9	12.5	8.1	7.0	7.1	4.2	31.8	3.7	1.4	2.3	1.3	0.1	2.6	3.0	0.2	1.8	0.6	0.2	0.4	0.9	0.6	0.9	3.6	2.0	1.4	0.3	0.2	1.5	1.4	3.6	0.5	0.5	47.7	1.8	5.7	8.5	0.2	0.5	0.1	5.2	0.1	2.3	1.2	0.1	6.4	0.3	3.1	0.1	0.2	0.7	3.0	11.1	2.3	2.0	0.0	1.2	8.5	1.6	2.6	0.1	2.8	4.6	2.1	5.7	2.1	0.0	0.4	1.5	1.4	0.1	2.5	3.7	7.9	1.7	22.0	6.9	4.8	3.7	3.7	0.0	8.3	2.2	31.8	1.8	3.1	1.9	5.6	1.6	2.3	4.2	7.1	1.9	1.3	13.9	1.4	3.7	1.4	0.5	1.3	20.9	22.1	23.4	33.5	18.6	7.2	5.8	17.8	5.0	6.8	3.0	28.0	44.7	7.2	20.4	148.3	10.3	15.3	20.1	29.6	1.8	369.1	0.2	0.0	7.8	7.2	8.3	8.8	0.0	19.1	0.7	22.0	3.5	22.0	11.0	15.1	42.9	15.4	11.1	39.3	7.4	21.9	37.1	3.3	24.4	26.1	18.0	9.6	35.1	57.3	0.5	206.3	25.8	9.2	3.9	9.6	36.0	0.2	10.2	29.3	16.3
CAMK1G	"CLICKIII, dJ272L16.1, VWS1"	ENSG00000008118	"Calcium/calmodulin dependent protein kinase IG"	Q96NX5	1	209583717-209613938	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"		"Allosteric enzyme, Calmodulin-binding, Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"brain: 34.4;ovary: 29.2"	"Group enriched"	"Detected in some"	6	"Peritubular cells: 6.3;Sertoli cells: 6.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"hTEC/SVTERT24-B: 11.6;hTERT-RPE1: 6.9;SK-MEL-30: 3.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA						"unprognostic (5.17e-2)"	"unprognostic (9.64e-2)"	"unprognostic (1.73e-1)"	"unprognostic (1.49e-3)"	"unprognostic (2.56e-2)"	"unprognostic (1.93e-1)"	"unprognostic (6.79e-2)"	"unprognostic (3.98e-1)"	"unprognostic (3.59e-3)"	"unprognostic (8.55e-3)"	"unprognostic (3.17e-2)"	"unprognostic (1.14e-2)"	"unprognostic (4.25e-2)"	"unprognostic (1.75e-1)"	"unprognostic (2.27e-1)"	"unprognostic (9.10e-2)"	"unprognostic (3.43e-2)"	0.7	3.5	7.5	0.9	34.4	1.0	0.7	1.3	27.8	1.1	0.8	0.7	1.2	0.8	1.8	6.1	0.6	0.9	1.5	0.6	10.9	9.2	6.9	0.9	1.2	0.8	3.6	17.7	29.2	1.3	0.6	2.0	2.8	3.9	4.6	0.8	0.6	0.6	7.4	0.6	0.6	0.8	2.3	0.9	6.1	0.7	1.4	2.7	0.0	0.7	0.0	0.8	1.1	0.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.2	0.0	0.0	1.9	0.3	0.8	0.2	0.0	0.1	0.0	0.0	0.7	0.1	0.2	0.0	0.0	1.2	0.6	0.0	0.0	0.1	0.0	0.7	0.0	0.0	0.0	0.1	11.6	0.0	6.9	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.8	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	3.4	1.6	0.0	0.0	0.2	2.0	0.2	0.0	0.1	0.0	0.2	0.0	0.7	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.5	34.4	1.3	27.8	10.9	9.2	3.6	17.7	3.9	2.7	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.2	0.1	0.0	6.3	0.3	0.0	6.5	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.1
CAMK2A	"CAMKA, CaMKIINalpha, KIAA0968"	ENSG00000070808	"Calcium/calmodulin dependent protein kinase II alpha"	Q9UQM7	5	150219491-150290291	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"		"Calmodulin-binding, Kinase, Serine/threonine-protein kinase, Transferase"	"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	21	"brain: 105.7;skeletal muscle: 50.1"	"Cell type enhanced"	"Detected in some"	20	"Basal keratinocytes: 3.1;Cardiomyocytes: 11.0;Fibroblasts: 2.8;Melanocytes: 3.3"	"Cancer enriched"	"Detected in single"	13	"glioma: 6.0"	"Group enriched"	"Detected in all"	6	"amygdala: 60.7;basal ganglia: 50.6;cerebral cortex: 99.6;hippocampal formation: 74.6;olfactory region: 39.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HaCaT: 2.7;SCLC-21H: 9.6;SuSa: 2.6;U-87 MG: 8.1"	"Group enriched"	"Detected in all"	4	"amygdala: 1311.6;basal ganglia: 698.1;cerebral cortex: 1576.4;hippocampal formation: 1569.1"	"Low region specificity"	"Detected in all"			"CAB004330, HPA051783, HPA051785, HPA053973"	Supported		Approved	"Plasma membrane,Cell Junctions,Cytosol"		NA	NA		21000	"Plasma membrane"	"Cell Junctions, Cytosol"	"CAB004330: AB_626788, HPA051783: AB_2681608, HPA051785: AB_2681609, HPA053973: AB_2682328"	"unprognostic (7.20e-3)"	"unprognostic (6.47e-3)"	"unprognostic (6.16e-3)"	"unprognostic (4.85e-2)"	"unprognostic (4.25e-2)"	"unprognostic (1.06e-3)"	"unprognostic (1.13e-1)"	"unprognostic (6.19e-3)"	"unprognostic (3.07e-1)"	"unprognostic (1.05e-1)"	"unprognostic (4.49e-2)"	"unprognostic (1.41e-2)"	"unprognostic (2.00e-8)"	"unprognostic (2.71e-4)"	"unprognostic (1.68e-1)"	"unprognostic (1.70e-2)"	"unprognostic (1.36e-3)"	1.3	1.7	60.7	1.3	50.6	1.3	1.1	1.4	105.7	1.8	1.3	3.7	0.0	1.2	2.1	1.4	1.9	1.7	1.3	3.7	74.6	10.5	1.6	1.2	1.5	1.2	5.1	39.8	1.3	1.1	1.1	0.4	1.3	2.4	1.6	1.3	0.0	1.2	1.4	50.1	1.6	1.3	2.5	1.7	1.2	1.3	1.2	2.3	0.0	1.2	0.0	1.1	1.4	0.1	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.6	0.5	0.0	0.0	0.6	0.0	0.5	1.3	0.8	0.7	0.0	0.1	0.0	0.2	0.6	0.1	2.7	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.4	0.1	0.0	0.2	0.5	0.2	1.7	0.0	1.1	0.0	0.0	0.0	0.7	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.5	0.2	0.0	0.0	9.6	0.0	0.1	0.2	0.3	2.6	0.0	0.1	0.0	0.0	0.3	0.0	0.1	0.2	0.1	0.0	8.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	60.7	50.6	1.4	99.6	74.6	10.5	5.1	39.8	2.4	2.3	0.0	0.0	0.0	0.0	3.1	0.1	11.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.3	0.0	0.0	0.3	0.0	0.0	0.4	0.8	0.0	0.0	1.1	0.0	0.2	1.3	0.2	0.0	0.0	0.0
CAMK2B	"CAM2, CAMK2, CAMKB"	ENSG00000058404	"Calcium/calmodulin dependent protein kinase II beta"	Q13554	7	44217150-44334577	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Differentiation, Neurogenesis"	"Actin-binding, Calmodulin-binding, Developmental protein, Kinase, Serine/threonine-protein kinase, Transferase"	"Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 81.9;heart muscle: 39.2;skeletal muscle: 70.7"	"Cell type enriched"	"Detected in many"	11	"Bipolar cells: 838.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enriched"	"Detected in some"	8	"SCLC-21H: 42.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB006849, HPA026307, HPA051783, HPA051785, HPA053973"	Enhanced	Supported	Supported	"Plasma membrane,Cell Junctions,Cytosol"		NA	NA		680000	"Plasma membrane"	"Cell Junctions, Cytosol"	"CAB006849: , HPA026307: AB_1845941, HPA051783: AB_2681608, HPA051785: AB_2681609, HPA053973: AB_2682328"	"unprognostic (1.88e-3)"	"unprognostic (4.49e-2)"	"unprognostic (3.55e-3)"	"unprognostic (1.36e-2)"	"unprognostic (5.25e-2)"	"unprognostic (2.90e-2)"	"unprognostic (8.78e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.44e-1)"	"unprognostic (2.71e-1)"	"unprognostic (1.17e-2)"	"unprognostic (1.60e-2)"	"unprognostic (5.23e-7)"	"unprognostic (7.04e-2)"	"unprognostic (2.34e-1)"	"unprognostic (3.15e-2)"	"unprognostic (3.95e-2)"	1.4	8.1	20.6	1.4	46.7	1.2	2.0	60.1	81.9	1.2	1.4	4.0	0.7	1.7	1.3	18.8	2.0	1.8	1.2	39.2	36.5	18.0	1.7	3.5	1.2	1.8	10.3	21.3	1.1	3.3	5.6	9.9	1.1	13.4	3.0	1.4	2.7	1.8	2.2	70.7	1.8	1.6	1.2	4.1	1.3	2.4	2.3	4.8	0.0	7.7	2.4	2.0	1.1	0.0	1.3	1.0	3.2	1.2	3.2	1.2	0.8	0.0	0.3	0.2	0.3	0.0	0.2	0.2	0.1	0.0	0.1	0.0	0.1	0.1	0.1	0.9	0.2	0.1	0.1	0.2	0.8	0.0	1.1	2.4	0.0	0.1	0.1	0.0	0.0	0.5	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.4	0.0	5.3	0.0	0.2	0.1	0.0	2.4	0.1	0.9	0.1	0.0	0.0	42.0	2.2	0.2	0.0	0.0	0.1	1.9	0.2	0.2	0.2	0.4	0.2	0.0	0.5	0.4	0.1	0.2	0.0	0.2	3.2	0.7	1.0	0.8	0.9	1.2	1.1	1.0	0.5	0.5	1.3	1.2	1.1	2.0	3.2	1.2	1.0	0.9	0.8	20.6	46.7	60.1	42.4	36.5	18.0	10.3	21.3	13.4	4.8	0.0	0.0	0.0	27.8	1.0	838.1	74.9	2.5	0.0	0.0	0.0	43.2	0.0	8.3	0.0	0.8	0.6	0.0	0.0	0.0	0.1	0.4	2.6	4.6	4.4	0.2	57.2	39.0	0.0	1.2	2.1	1.7	0.0	1.7	0.0	0.0	14.1	0.1	0.0	0.0	0.8	46.7	0.0	0.9	0.0	1.7	0.4	0.2	0.0	0.0	0.7
CAMK2D	CAMKD	ENSG00000145349	"Calcium/calmodulin dependent protein kinase II delta"	Q13557	4	113451032-113761927	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"		"Calmodulin-binding, Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	8	"Cardiomyocytes: 243.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"ASC TERT1: 67.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA026281, HPA051783, HPA051785, HPA053973"	Approved		Approved	"Plasma membrane,Cell Junctions,Cytosol"		NA	NA		140000	"Plasma membrane"	"Cell Junctions, Cytosol"	"HPA026281: AB_1845944, HPA051783: AB_2681608, HPA051785: AB_2681609, HPA053973: AB_2682328"	"unprognostic (2.14e-2)"	"unprognostic (3.17e-1)"	"unprognostic (2.13e-1)"	"unprognostic (7.49e-2)"	"unprognostic (2.19e-1)"	"unprognostic (5.09e-1)"	"unprognostic (4.26e-2)"	"unprognostic (1.17e-1)"	"unprognostic (2.26e-1)"	"unprognostic (2.62e-1)"	"unprognostic (7.81e-2)"	"unprognostic (7.91e-3)"	"unprognostic (2.62e-2)"	"unprognostic (1.46e-1)"	"unprognostic (9.68e-2)"	"unprognostic (1.87e-1)"	"unprognostic (1.90e-2)"	22.8	12.9	47.7	18.3	13.0	2.8	23.5	50.2	30.6	11.0	18.2	7.4	28.6	13.6	11.6	9.4	15.6	9.6	14.8	77.1	17.9	21.4	9.6	17.6	14.7	17.5	14.0	23.8	12.9	7.4	33.7	7.0	9.3	12.5	16.3	19.0	9.9	9.4	48.3	48.5	10.8	19.2	26.2	16.0	8.4	17.6	9.4	8.5	11.2	11.6	9.8	14.5	21.5	22.6	18.5	11.2	0.6	8.8	6.4	9.7	5.2	1.0	14.5	16.1	5.4	35.2	67.4	5.7	34.1	22.8	13.4	11.6	9.8	4.1	20.9	5.0	23.7	17.0	0.5	10.0	5.3	13.7	8.0	2.5	0.0	5.3	11.2	17.9	0.0	0.0	43.0	7.3	10.4	25.8	21.3	11.9	2.6	0.8	9.3	25.3	3.9	2.1	0.8	2.3	13.9	5.4	4.0	18.9	0.1	13.7	9.9	4.3	4.4	4.6	6.9	4.6	14.0	0.1	5.6	7.1	35.5	8.4	15.1	6.7	7.3	3.6	17.9	18.3	1.3	16.7	0.0	8.8	0.0	5.1	5.1	9.7	8.0	5.0	5.6	11.2	18.5	5.8	4.9	0.6	6.4	1.7	0.0	9.3	5.2	47.7	13.0	50.2	25.6	17.9	21.4	14.0	23.8	12.5	8.5	38.7	29.9	22.6	16.0	16.4	72.0	243.3	58.6	20.1	28.4	27.9	82.5	0.4	5.0	6.4	2.9	29.8	57.0	0.0	17.5	0.4	34.7	31.3	9.3	49.4	15.8	68.3	99.5	19.6	16.8	4.5	18.7	21.0	5.0	2.8	82.1	41.3	11.4	45.6	18.7	17.7	71.5	6.5	33.3	2.9	4.4	27.9	0.9	17.5	41.1	16.3
CAMK2G	CAMKG	ENSG00000148660	"Calcium/calmodulin dependent protein kinase II gamma"	Q13555	10	73812501-73874591	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Differentiation, Neurogenesis"	"Calmodulin-binding, Developmental protein, Kinase, Serine/threonine-protein kinase, Transferase"	"Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 73.0"	"Cell type enhanced"	"Detected in many"	6	"Cone photoreceptor cells: 94.2;Cytotrophoblasts: 130.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Lineage enriched"	"Detected in all"	4	"granulocytes: 39.8"	"Cell line enhanced"	"Detected in all"		"PC-3: 46.3;SK-BR-3: 58.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040656, HPA051783, HPA051785, HPA053973"	Approved		Approved	"Plasma membrane,Cell Junctions,Cytosol"		NA	NA		170000	"Plasma membrane"	"Cell Junctions, Cytosol"	"HPA040656: AB_2677065, HPA051783: AB_2681608, HPA051785: AB_2681609, HPA053973: AB_2682328"	"unprognostic (8.63e-3)"	"unprognostic (2.01e-1)"	"unprognostic (1.05e-1)"	"unprognostic (3.46e-3)"	"unprognostic (4.27e-2)"	"unprognostic (1.82e-2)"	"unprognostic (2.19e-2)"	"unprognostic (2.36e-1)"	"unprognostic (2.48e-1)"	"unprognostic (6.25e-2)"	"unprognostic (2.92e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.73e-2)"	"unprognostic (2.48e-1)"	"unprognostic (8.28e-2)"	"unprognostic (9.64e-2)"	"unprognostic (4.62e-2)"	9.1	8.8	27.4	9.4	20.7	17.4	6.8	22.2	53.8	9.0	37.3	13.3	9.7	19.7	20.1	9.1	20.6	13.2	10.6	6.7	22.8	24.4	11.6	5.9	10.7	8.9	26.8	31.2	6.4	5.7	8.0	6.0	15.8	38.6	18.5	15.5	8.5	12.4	29.8	73.0	9.1	18.1	29.6	29.8	11.0	14.2	3.8	13.4	4.4	6.4	7.6	8.7	26.5	10.8	4.2	7.1	39.8	5.6	9.8	9.2	5.0	11.1	8.0	7.3	13.9	5.3	8.7	8.6	7.6	13.2	10.6	8.7	12.5	12.0	8.2	8.1	9.8	4.1	17.4	5.7	6.5	8.4	7.5	6.8	5.6	6.2	5.6	2.6	7.6	9.5	4.6	5.9	10.5	7.3	16.3	9.0	10.6	6.1	12.4	5.8	7.8	12.7	11.4	5.3	6.8	46.3	11.6	7.6	4.3	5.5	16.2	3.8	8.8	4.4	58.3	3.7	5.6	10.9	4.8	11.0	7.9	12.7	4.2	10.3	3.8	4.5	7.7	8.4	21.9	2.8	8.5	5.6	39.8	7.5	2.3	9.2	4.2	8.4	8.0	7.1	3.9	8.1	7.9	36.4	9.8	4.0	2.4	8.1	5.0	27.4	20.7	22.2	53.8	22.8	24.4	26.8	31.2	38.6	13.4	14.9	9.4	11.5	7.6	8.4	55.8	6.1	15.3	6.7	9.1	7.0	94.2	130.5	11.6	10.6	1.9	18.0	50.5	0.0	17.2	36.6	11.5	7.3	16.1	7.8	22.8	25.4	23.0	12.3	13.6	2.3	11.8	10.5	11.8	5.4	20.0	16.3	16.9	51.8	17.7	27.0	74.1	45.3	50.6	0.5	10.6	11.0	67.9	22.4	26.2	10.7
CAMK4	CaMK-GR	ENSG00000152495	"Calcium/calmodulin dependent protein kinase IV"	Q16566	5	111223653-111494886	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Adaptive immunity, Immunity, Inflammatory response"	"Calmodulin-binding, Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 48.9;lymphoid tissue: 71.7"	"Cell type enhanced"	"Detected in many"	27	"Bipolar cells: 47.8;Early spermatids: 236.0;Late spermatids: 80.4"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"MAIT T-cell: 14.1;memory CD4 T-cell: 10.3;memory CD8 T-cell: 7.8;naive CD4 T-cell: 19.8;naive CD8 T-cell: 10.9;T-reg: 11.3"	"Lineage enriched"	"Detected in single"	26	"T-cells: 19.8"	"Cell line enhanced"	"Detected in many"		"HDLM-2: 39.4;JURKAT: 27.3;MOLT-4: 12.0;SH-SY5Y: 15.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004347, HPA011753, HPA017206"	Approved		Supported	"Nucleoplasm,Nucleoli fibrillar center"		NA	NA			"Nucleoplasm, Nucleoli fibrillar center"		"CAB004347: AB_626793, HPA011753: AB_1845950, HPA017206: AB_1845949"	"unprognostic (2.99e-5)"	"unprognostic (7.19e-2)"	"unprognostic (3.43e-3)"	"unprognostic (5.11e-2)"	"unprognostic (4.75e-3)"	"unprognostic (3.48e-2)"	"unprognostic (7.66e-4)"	"unprognostic (7.22e-3)"	"unprognostic (2.49e-1)"	"unprognostic (2.92e-1)"	"unprognostic (1.09e-1)"	"unprognostic (1.46e-1)"	"unprognostic (2.23e-5)"	"unprognostic (2.42e-2)"	"unprognostic (3.01e-2)"	"unprognostic (1.66e-1)"	"unprognostic (9.99e-3)"	1.1	6.5	9.5	6.4	34.2	4.6	1.0	48.9	16.5	1.8	2.3	1.0	0.0	2.4	1.3	0.8	1.4	0.9	2.7	0.9	5.9	3.2	1.4	2.5	1.9	12.0	2.3	6.8	1.4	0.9	0.3	1.3	0.6	3.4	5.8	2.5	0.1	1.7	2.6	0.8	0.9	3.8	1.5	2.0	4.2	2.6	13.8	6.6	71.7	1.0	0.0	8.1	2.8	1.1	0.7	0.0	0.4	0.0	0.6	19.8	3.4	0.0	0.0	1.4	0.9	0.3	1.1	0.0	0.3	3.0	3.6	3.6	0.0	0.0	0.0	1.9	0.1	2.4	0.1	3.0	0.3	2.6	39.4	2.4	0.5	1.3	0.0	0.1	0.2	0.1	0.1	0.0	7.6	0.8	2.2	0.6	27.3	0.0	1.4	0.2	0.0	12.0	0.0	1.8	0.0	0.1	1.8	2.3	0.1	1.3	0.0	8.6	15.4	0.5	0.0	2.6	0.1	0.0	0.2	0.0	7.5	4.4	0.0	6.6	1.2	0.1	0.0	3.6	0.0	2.8	0.0	0.0	0.0	2.8	0.0	14.1	0.7	10.3	7.8	0.0	0.2	19.8	10.9	0.4	0.6	0.0	0.0	11.3	3.4	9.5	34.2	48.9	15.1	5.9	3.2	2.3	6.8	3.4	6.6	0.0	0.6	4.2	0.2	1.0	47.8	2.8	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	236.0	0.7	0.0	0.0	0.0	0.1	1.6	0.4	4.6	0.2	0.2	0.0	0.0	0.6	1.0	80.4	3.7	1.1	0.0	0.0	0.1	2.1	0.8	0.0	1.4	0.0	4.1	0.0	4.5	3.2	6.1	0.9	0.0	29.9	0.0	0.3
CAMKK1	"CAMKKA, DKFZp761M0423, MGC34095"	ENSG00000004660	"Calcium/calmodulin dependent protein kinase kinase 1"	Q8N5S9	17	3860315-3894891	"Enzymes, Predicted intracellular proteins"		"Calmodulin-binding, Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 38.9;salivary gland: 27.1"	"Cell type enhanced"	"Detected in many"	9	"Bipolar cells: 36.4;Rod photoreceptor cells: 24.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HeLa: 18.2;U-87 MG: 20.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009111, HPA028062"	Approved		Supported	Cytosol		No	No			Cytosol		"CAB009111: AB_2068406, HPA028062: AB_1845954"	"unprognostic (1.39e-2)"	"unprognostic (2.13e-1)"	"unprognostic (8.66e-3)"	"unprognostic (4.40e-3)"	"unprognostic (2.94e-3)"	"unprognostic (4.79e-2)"	"unprognostic (1.98e-1)"	"unprognostic (4.47e-3)"	"unprognostic (8.23e-2)"	"unprognostic (1.03e-2)"	"prognostic favorable (2.65e-4)"	"unprognostic (1.98e-1)"	"unprognostic (1.59e-1)"	"unprognostic (7.19e-2)"	"unprognostic (8.70e-2)"	"unprognostic (8.36e-2)"	"unprognostic (3.10e-1)"	4.3	10.2	15.3	5.1	21.4	3.7	4.7	23.2	38.9	4.1	3.2	2.2	4.0	3.1	7.5	5.2	4.2	3.7	3.8	5.7	13.8	6.8	1.5	1.0	4.0	2.5	5.5	16.0	6.0	7.5	5.0	10.1	2.3	11.2	3.3	3.1	2.5	27.1	11.2	2.2	7.8	3.7	6.2	2.2	4.3	2.9	6.1	5.0	1.7	7.2	2.3	2.5	5.6	4.9	0.1	1.6	5.6	4.1	0.0	1.0	1.1	4.9	8.5	0.9	4.3	3.1	5.5	0.3	3.4	3.7	3.3	1.5	3.1	1.5	3.0	3.7	6.6	3.4	14.7	2.3	4.2	2.0	0.1	7.8	3.4	18.2	1.1	3.1	0.5	2.7	4.2	3.6	6.2	2.1	2.9	1.5	4.4	2.6	0.1	1.6	1.3	4.1	1.9	1.0	7.2	8.1	2.1	3.7	3.4	3.5	3.1	5.0	2.8	1.3	10.2	2.2	0.5	3.9	1.1	2.0	5.7	7.7	7.3	2.8	0.4	0.2	0.1	20.8	2.9	0.7	0.0	1.8	3.6	0.6	3.9	1.0	0.0	0.6	0.5	1.6	0.1	0.6	0.3	5.6	0.0	4.1	0.8	0.0	1.1	15.3	21.4	23.2	38.9	13.8	6.8	5.5	16.0	11.2	5.0	6.0	15.1	8.5	1.9	3.3	36.4	5.7	0.0	1.4	5.7	1.8	15.7	0.2	0.0	0.4	0.0	4.4	0.5	0.0	1.4	0.1	4.5	1.4	16.2	0.2	3.8	7.9	4.1	3.1	1.9	0.4	1.1	3.6	8.5	0.0	1.4	3.8	0.8	0.0	1.1	0.0	24.1	0.0	2.0	0.1	1.4	4.6	0.2	0.7	2.3	0.8
CAMKK2	"CAMKK, CAMKKB, KIAA0787, MGC15254"	ENSG00000110931	"Calcium/calmodulin dependent protein kinase kinase 2"	Q96RR4	12	121237691-121298308	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"		"Calmodulin-binding, Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	5	"brain: 125.5"	"Cell type enhanced"	"Detected in many"	5	"Horizontal cells: 58.8;Late spermatids: 64.8"	"Low cancer specificity"	"Detected in all"			"Region enhanced"	"Detected in all"		"cerebellum: 125.5"	"Group enriched"	"Detected in many"	5	"classical monocyte: 14.2;eosinophil: 26.1;intermediate monocyte: 19.4;myeloid DC: 7.2;neutrophil: 17.2;non-classical monocyte: 16.5"	"Group enriched"	"Detected in all"	5	"dendritic cells: 7.2;granulocytes: 26.1;monocytes: 19.4"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA017389, HPA063713"	Approved	Supported	Supported	Cytosol		NA	NA			Cytosol		"HPA017389: AB_1845956, HPA063713: "	"unprognostic (5.08e-2)"	"unprognostic (1.81e-1)"	"unprognostic (1.38e-1)"	"unprognostic (3.08e-1)"	"unprognostic (1.88e-1)"	"unprognostic (1.12e-1)"	"unprognostic (2.62e-3)"	"unprognostic (2.80e-2)"	"unprognostic (1.93e-1)"	"unprognostic (7.76e-2)"	"unprognostic (5.01e-2)"	"unprognostic (1.70e-1)"	"unprognostic (1.75e-1)"	"unprognostic (4.13e-1)"	"unprognostic (3.34e-2)"	"unprognostic (1.67e-1)"	"unprognostic (1.38e-1)"	11.7	6.5	19.7	7.8	30.2	13.8	8.8	125.5	45.5	9.0	9.5	7.1	2.6	12.8	8.6	5.3	8.3	11.8	6.3	6.9	11.2	5.1	7.1	8.9	9.6	6.9	6.2	17.3	10.5	5.8	6.4	4.1	7.5	9.1	12.2	9.7	6.2	7.5	13.2	5.1	9.1	13.2	10.3	6.2	14.1	7.6	3.6	5.8	5.2	6.1	4.5	7.2	7.2	7.4	2.2	7.2	26.1	19.4	3.6	2.2	6.3	12.5	9.4	7.0	13.5	21.1	19.7	10.7	10.4	11.0	8.5	7.8	9.8	5.4	19.4	8.7	21.0	6.0	10.4	8.6	11.2	6.7	13.3	16.9	9.6	6.3	9.6	14.3	21.9	9.2	12.7	16.6	8.0	18.2	11.5	19.9	14.8	11.1	10.5	8.2	12.1	24.3	18.0	5.1	10.5	10.7	15.8	8.2	17.2	8.2	14.0	26.9	10.8	13.6	7.3	8.6	5.9	18.2	26.8	14.5	7.0	5.7	5.9	5.7	40.3	23.9	14.7	13.1	15.4	6.9	0.7	14.2	26.1	2.1	19.4	2.2	2.2	1.7	1.9	7.2	1.2	1.5	1.7	17.2	3.6	16.5	1.6	1.3	6.3	19.7	30.2	125.5	45.5	11.2	5.1	6.2	17.3	9.1	5.8	8.9	3.5	4.1	5.1	7.0	21.6	7.0	20.4	8.1	6.8	8.7	2.0	7.4	3.3	8.7	15.7	17.5	18.2	0.0	9.0	6.7	12.5	10.8	5.8	18.3	7.1	58.8	33.0	12.9	13.9	64.8	19.0	13.7	8.5	15.4	15.9	5.1	7.5	11.5	29.7	8.4	6.4	19.4	21.3	0.7	2.4	5.3	2.9	7.1	15.6	5.8
CAMKMT	"C2orf34, CLNMT"	ENSG00000143919	"Calmodulin-lysine N-methyltransferase"	Q7Z624	2	44361950-44772592	"Enzymes, Predicted intracellular proteins"		"Methyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"Early spermatids: 52.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA067912			Supported	Nucleoplasm		NA	NA			Nucleoplasm		"HPA067912: AB_2685922"	"unprognostic (2.28e-1)"	"unprognostic (6.15e-2)"	"unprognostic (1.96e-1)"	"unprognostic (2.39e-2)"	"prognostic favorable (9.10e-4)"	"unprognostic (1.03e-1)"	"unprognostic (9.58e-3)"	"unprognostic (1.46e-3)"	"unprognostic (1.85e-1)"	"unprognostic (7.42e-2)"	"unprognostic (8.76e-2)"	"unprognostic (1.37e-1)"	"unprognostic (3.33e-1)"	"unprognostic (4.82e-2)"	"unprognostic (4.66e-2)"	"unprognostic (1.70e-1)"	"unprognostic (8.57e-2)"	7.1	8.0	13.9	10.8	21.7	13.9	8.2	15.4	13.1	9.8	10.8	8.2	8.7	8.7	11.0	10.5	8.8	8.1	14.8	7.3	11.8	14.8	11.4	7.0	8.2	8.1	14.1	4.3	6.7	17.6	15.7	17.6	5.2	13.7	5.8	10.9	8.4	12.0	6.4	10.9	9.7	10.8	8.2	10.5	8.4	7.8	19.0	12.6	13.7	12.1	8.1	10.7	7.9	10.0	17.7	9.9	9.3	8.5	7.7	17.2	6.9	7.0	4.4	5.4	4.8	5.7	5.8	11.5	5.9	4.1	3.0	3.9	8.1	6.4	6.8	6.6	3.8	3.9	5.9	7.3	9.1	5.3	25.4	10.5	10.0	9.3	15.2	2.2	6.5	7.1	2.4	5.6	4.1	7.8	4.5	4.4	7.3	7.9	12.1	4.9	7.3	11.8	13.2	9.9	16.7	4.7	7.0	6.4	13.6	14.5	7.9	10.5	9.6	5.6	16.8	6.1	5.3	6.1	5.5	6.0	4.1	4.8	4.9	4.3	9.6	8.0	12.3	4.5	11.5	3.1	9.3	8.5	5.9	11.7	6.7	11.7	17.7	11.2	9.7	9.5	13.4	17.2	13.5	5.1	7.7	7.1	9.9	16.0	6.9	13.9	21.7	15.4	13.1	11.8	14.8	14.1	4.3	13.7	12.6	6.0	1.9	6.5	6.4	4.6	4.2	1.5	7.6	0.0	0.0	8.7	0.0	3.2	19.9	10.2	52.0	3.5	4.7	0.0	13.8	4.1	5.1	4.8	5.7	5.1	5.2	1.6	0.0	1.3	1.8	25.7	7.5	4.0	10.1	7.2	4.8	15.5	7.3	6.5	5.3	11.2	2.3	0.0	5.1	18.0	5.4	6.5	2.2	8.7	7.4	5.2
CAMKV	"MGC8407, VACAMKL"	ENSG00000164076	"CaM kinase like vesicle associated"	Q8NCB2	3	49857988-49870222	"Enzymes, Predicted intracellular proteins"		Calmodulin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	36	"brain: 77.2"	"Cell type enhanced"	"Detected in some"	14	"Bipolar cells: 2.3;Cone photoreceptor cells: 2.0;Early spermatids: 4.6;Horizontal cells: 3.2;Late spermatids: 6.5"	"Group enriched"	"Detected in some"	11	"glioma: 4.0;testis cancer: 5.2"	"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in single"	12	"neutrophil: 1.2"	"Lineage enriched"	"Detected in single"	12	"granulocytes: 1.2"	"Cell line enhanced"	"Detected in some"		"AF22: 5.3;HAP1: 7.0;NTERA-2: 25.2;RPMI-8226: 4.8;SCLC-21H: 8.6;SH-SY5Y: 5.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA007656, CAB034931"	Enhanced	Supported	Approved	"Nucleoplasm,Cytokinetic bridge"		NA	NA			Nucleoplasm	"Cytokinetic bridge"	"CAB034931: AB_2068550, HPA007656: AB_1078391"	"unprognostic (9.47e-4)"	"unprognostic (5.65e-3)"	"unprognostic (1.42e-1)"	"unprognostic (2.70e-7)"	"unprognostic (2.76e-1)"	"unprognostic (7.95e-4)"		"unprognostic (3.09e-2)"	"unprognostic (2.61e-1)"	"unprognostic (1.48e-1)"	"unprognostic (4.30e-3)"	"unprognostic (1.72e-1)"	"unprognostic (8.11e-2)"	"unprognostic (1.00e-3)"	"unprognostic (7.61e-2)"	"unprognostic (9.51e-2)"	"unprognostic (1.67e-3)"	1.2	2.1	20.7	1.2	77.2	1.2	1.2	0.5	62.8	1.2	1.2	1.7	0.0	1.2	1.2	1.2	1.2	1.2	1.2	1.2	33.4	11.7	1.2	1.2	1.2	1.2	3.3	23.5	1.2	1.2	1.2	1.8	1.2	2.1	1.2	1.2	0.0	1.2	1.2	1.2	1.3	1.2	1.2	1.9	1.2	1.3	2.1	6.0	0.0	1.2	0.0	1.2	1.2	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.2	5.3	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.0	7.0	0.0	0.0	0.1	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.6	0.0	0.0	0.1	0.7	0.1	25.2	0.0	0.1	0.8	0.0	4.8	0.0	0.0	8.6	5.5	0.0	0.0	0.0	1.0	0.0	1.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	20.7	77.2	0.5	34.0	33.4	11.7	3.3	23.5	2.1	6.0	0.0	0.0	0.0	0.0	0.2	2.3	0.5	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	4.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	3.2	1.2	0.0	0.0	6.5	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	1.4	0.0	0.0	0.3	0.7	0.1	0.2	0.0	0.1	0.0
CANT1	"SCAN-1, SHAPY"	ENSG00000171302	"Calcium activated nucleotidase 1"	Q8WVQ1	17	78991717-79009867	"Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"		Hydrolase	"Cancer-related genes, Disease mutation, Dwarfism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	6	"Mucus-secreting cells: 134.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"OE19: 92.2;T-47d: 60.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019627, HPA019639, HPA022818"	Enhanced		Supported	"Golgi apparatus"		NA	NA		2300000	"Golgi apparatus"		"HPA019627: AB_1845969, HPA019639: AB_1845970, HPA022818: AB_1845971"	"unprognostic (1.98e-2)"	"unprognostic (2.49e-2)"	"unprognostic (1.50e-2)"	"unprognostic (5.36e-2)"	"unprognostic (2.13e-2)"	"unprognostic (2.21e-2)"	"prognostic unfavorable (1.41e-4)"	"prognostic unfavorable (2.90e-4)"	"unprognostic (1.76e-1)"	"unprognostic (9.00e-2)"	"unprognostic (3.30e-1)"	"unprognostic (2.49e-1)"	"prognostic unfavorable (6.21e-4)"	"unprognostic (7.04e-2)"	"unprognostic (5.06e-2)"	"unprognostic (1.16e-1)"	"unprognostic (7.23e-2)"	13.8	15.3	9.6	13.1	10.2	8.1	13.0	12.2	10.8	17.7	43.8	12.3	25.4	25.5	12.0	14.3	27.5	10.0	19.5	10.8	9.0	6.9	10.3	17.7	11.1	11.5	12.5	7.7	10.4	14.7	13.1	11.8	33.0	12.0	36.7	41.5	7.9	30.3	41.4	9.0	8.9	27.2	8.0	12.4	18.1	25.8	19.0	10.3	14.1	12.4	8.9	14.4	10.3	13.7	4.1	3.8	17.5	4.4	3.1	6.2	4.4	22.2	24.4	6.8	9.9	6.5	7.8	8.8	13.8	12.1	14.8	12.6	11.6	21.1	5.4	8.1	9.6	18.1	11.3	5.8	10.8	14.9	9.0	10.6	7.0	7.4	9.6	5.6	6.7	11.1	8.0	7.0	13.7	7.5	8.8	25.6	9.1	8.8	9.2	9.8	12.1	10.1	4.0	4.7	92.2	26.0	5.7	11.2	6.1	6.5	11.2	9.9	9.9	7.3	48.8	10.4	11.4	60.2	8.0	12.7	22.2	20.1	9.9	17.2	10.9	9.0	5.3	14.2	5.2	13.9	6.1	3.8	8.1	6.2	4.4	6.1	4.1	4.6	5.2	3.8	2.9	4.5	4.4	17.5	3.1	2.9	2.7	3.8	4.4	9.6	10.2	12.2	10.8	9.0	6.9	12.5	7.7	12.0	10.3	26.8	19.4	13.7	13.8	14.7	5.9	11.6	15.3	6.7	10.3	12.2	13.7	30.3	3.3	30.3	11.4	14.3	61.6	23.3	25.4	31.5	12.3	34.8	5.7	12.1	21.5	4.8	49.0	54.6	9.2	10.4	10.9	11.3	13.5	11.8	134.8	6.7	27.4	49.1	7.1	6.1	8.5	6.5	7.2	23.2	5.5	11.4	84.9	10.2	83.2	16.5
CAPN1	"CANP, CANPL1, muCANP, muCL"	ENSG00000014216	"Calpain 1"	P07384	11	65180566-65212006	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		"Hydrolase, Protease, Thiol protease"	"Disease mutation, Hereditary spastic paraplegia, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"RT4: 90.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA005992	Enhanced		Supported	Cytosol		NA	NA		28000000	Cytosol		"HPA005992: AB_1845924"	"unprognostic (2.07e-1)"	"unprognostic (2.15e-1)"	"unprognostic (2.69e-1)"	"unprognostic (1.40e-1)"	"unprognostic (4.06e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.91e-2)"	"unprognostic (2.48e-2)"	"unprognostic (7.23e-2)"	"unprognostic (2.23e-2)"	"prognostic unfavorable (4.30e-4)"	"unprognostic (3.33e-1)"	"prognostic favorable (7.06e-8)"	"unprognostic (5.70e-3)"	"unprognostic (1.51e-1)"	"unprognostic (1.86e-1)"	"unprognostic (2.98e-1)"	22.0	15.6	9.6	23.8	11.6	18.2	18.8	17.7	20.1	25.8	33.3	8.4	23.0	25.4	19.3	30.2	86.9	28.1	39.1	21.4	8.8	11.2	27.8	21.3	19.4	19.5	10.8	9.7	21.4	24.9	13.3	14.1	38.1	16.8	27.3	17.0	15.8	39.7	24.3	24.2	38.9	49.9	16.5	7.7	21.3	20.7	8.3	6.7	32.1	37.5	50.2	53.7	33.7	35.2	16.7	22.8	34.5	24.8	15.7	19.6	28.5	48.4	25.8	7.4	16.4	13.4	17.1	22.5	14.4	22.9	17.0	13.0	16.4	43.6	12.1	24.1	27.3	19.8	71.6	9.6	60.8	5.5	12.9	7.6	28.9	14.9	16.0	13.4	6.8	40.6	18.8	32.7	14.4	7.0	16.0	29.0	8.8	17.2	9.8	13.8	31.1	13.3	21.5	21.3	24.8	23.4	13.2	7.6	7.3	23.0	90.0	13.3	9.8	15.2	58.9	13.9	8.3	25.3	13.4	25.2	13.2	9.0	28.2	6.5	6.0	4.4	14.4	23.1	8.3	14.3	34.3	24.8	34.5	19.6	23.7	15.7	15.6	15.5	17.7	22.8	16.7	9.1	12.5	15.8	15.7	14.0	17.9	16.6	28.5	9.6	11.6	17.7	20.1	8.8	11.2	10.8	9.7	16.8	6.7	23.8	24.7	31.9	110.9	53.1	6.6	17.9	68.8	30.8	33.0	73.3	19.6	201.3	33.2	164.8	0.5	23.3	141.6	0.0	101.4	88.1	42.3	51.8	46.1	31.0	78.5	20.6	42.6	26.4	45.7	0.4	40.3	38.8	45.5	146.9	72.1	33.2	133.6	105.2	47.7	26.9	15.0	38.8	36.4	0.5	2.0	60.2	164.4	49.8	101.5	141.7
CAPN10		ENSG00000142330	"Calpain 10"	Q9HC96	2	240586716-240617705	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		"Hydrolase, Protease, Thiol protease"	"Diabetes mellitus"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Horizontal cells: 46.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004170, HPA056098"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA004170: AB_1078381, HPA056098: AB_2683037"	"unprognostic (1.05e-1)"	"unprognostic (1.13e-2)"	"unprognostic (9.29e-3)"	"unprognostic (6.09e-2)"	"unprognostic (5.44e-3)"	"prognostic favorable (8.47e-5)"	"prognostic unfavorable (4.78e-6)"	"unprognostic (7.48e-3)"	"unprognostic (7.94e-2)"	"unprognostic (1.31e-2)"	"prognostic favorable (7.94e-5)"	"unprognostic (1.46e-1)"	"unprognostic (1.11e-2)"	"unprognostic (1.19e-1)"	"unprognostic (6.88e-2)"	"unprognostic (5.76e-2)"	"unprognostic (5.58e-3)"	9.2	11.8	16.8	12.9	15.1	10.9	6.6	20.5	15.7	8.3	13.6	12.8	10.0	20.8	11.3	8.0	9.7	9.8	10.2	11.5	15.9	10.7	14.2	9.3	8.4	15.3	11.2	18.1	10.0	13.0	8.6	13.2	7.3	11.1	10.6	12.2	12.4	14.6	10.7	6.5	19.5	16.2	8.3	8.1	21.0	15.0	10.7	13.7	15.1	9.3	5.6	13.2	8.3	7.0	1.5	2.0	7.7	1.8	5.8	2.2	0.8	5.2	7.9	7.8	6.0	3.0	2.5	13.6	6.7	2.8	4.5	4.3	5.8	12.5	4.0	2.3	2.3	6.3	8.9	2.0	4.5	2.3	15.1	13.8	7.3	13.1	10.1	4.9	4.7	10.3	2.2	3.1	4.7	1.9	4.6	3.3	11.5	8.1	5.0	1.8	4.6	10.5	18.0	11.7	6.3	5.5	10.0	5.5	8.4	7.0	6.2	19.7	15.4	4.3	6.1	8.5	2.7	3.1	5.8	5.8	7.7	6.6	6.2	8.0	12.3	2.8	7.1	7.3	8.6	7.2	1.7	1.8	3.3	2.0	1.0	0.5	1.5	1.3	2.0	0.8	1.5	1.2	1.8	7.7	5.8	1.1	2.0	2.2	0.8	16.8	15.1	20.5	15.7	15.9	10.7	11.2	18.1	11.1	13.7	3.0	5.9	3.7	6.1	4.0	12.5	8.1	12.7	4.0	3.4	8.7	13.7	4.1	6.6	11.8	1.3	5.5	7.8	0.0	7.9	4.3	3.7	7.6	23.0	3.0	5.9	46.1	10.9	4.9	3.2	2.0	8.3	7.0	1.7	9.0	4.9	11.6	11.2	3.5	8.9	5.1	16.7	0.0	6.2	12.1	8.0	4.5	4.6	5.0	6.0	6.0
CAPN11		ENSG00000137225	"Calpain 11"	Q9UMQ6	6	44158811-44184402	"Enzymes, Predicted intracellular proteins"		"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	33	"testis: 63.7"	"Group enriched"	"Detected in some"	13	"Early spermatids: 16.7;Late spermatids: 7.9;Spermatocytes: 24.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in some"	5	"NTERA-2: 4.4;TIME: 11.1"	"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			"CAB018070, HPA030955"	Enhanced					NA	NA					"CAB018070: AB_2069481, HPA030955: AB_2673672"	"unprognostic (2.20e-2)"	"unprognostic (1.87e-1)"	"unprognostic (1.64e-2)"	"unprognostic (2.75e-1)"	"unprognostic (6.22e-2)"	"unprognostic (3.34e-2)"	"unprognostic (3.99e-2)"	"unprognostic (4.57e-2)"	"unprognostic (1.29e-1)"	"unprognostic (8.96e-2)"	"unprognostic (1.01e-1)"	"unprognostic (2.13e-1)"	"unprognostic (3.62e-6)"	"unprognostic (2.38e-2)"	"unprognostic (3.51e-1)"	"unprognostic (2.27e-2)"	"unprognostic (8.89e-2)"	1.1	0.3	0.1	0.2	0.1	0.2	1.9	0.1	0.1	0.5	0.1	0.1	0.1	0.0	0.2	0.4	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.2	0.1	0.1	0.1	0.1	0.0	0.1	0.3	0.1	0.1	0.0	0.1	0.3	0.1	0.1	0.6	0.3	0.2	0.1	0.1	0.0	63.7	0.1	0.1	0.1	0.1	0.2	0.2	0.3	0.4	1.2	1.3	0.1	0.1	0.8	0.9	0.0	0.0	0.6	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.5	0.6	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	1.5	0.0	0.4	0.4	0.0	0.0	0.0	0.3	4.4	0.0	0.0	0.7	0.2	0.4	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.6	0.0	0.2	11.1	0.5	0.0	0.0	0.0	0.2	0.3	0.0	0.0	0.1	0.1	0.6	0.1	0.1	0.1	0.0	0.0	0.0	0.8	0.0	0.3	0.4	0.1	0.2	1.3	0.1	0.0	1.2	0.0	0.9	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	16.7	0.7	0.9	0.0	0.0	0.0	0.2	0.0	0.0	0.0	1.1	0.0	0.0	1.3	0.0	7.9	0.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.7	0.0	0.0	0.0	0.0	24.2	0.9	0.0	0.0	0.0	0.0	0.0
CAPN12		ENSG00000182472	"Calpain 12"	Q6ZSI9	19	38730187-38769904	"Enzymes, Predicted intracellular proteins"		"Hydrolase, Protease, Thiol protease"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"blood: 24.5;gallbladder: 21.0;liver: 21.8;salivary gland: 34.3"	"Cell type enhanced"	"Detected in many"	8	"Alveolar cells type 2: 27.1;Cholangiocytes: 50.9;T-cells: 25.4"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in some"		"pons and medulla: 2.4"	"Group enriched"	"Detected in many"	7	"basophil: 24.5;NK-cell: 12.7"	"Group enriched"	"Detected in many"	7	"granulocytes: 24.5;NK-cells: 12.7"	"Cell line enriched"	"Detected in some"	5	"HMC-1: 17.6"	"Low region specificity"	"Detected in single"			"Region enhanced"	"Detected in single"		"hippocampal formation: 3.6"	HPA053322			Approved	"Nucleoplasm,Focal adhesion sites"		NA	NA			"Focal adhesion sites"	Nucleoplasm	"HPA053322: AB_2682111"	"unprognostic (1.81e-1)"	"unprognostic (4.48e-2)"	"unprognostic (1.04e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.95e-2)"	"unprognostic (2.81e-2)"	"unprognostic (1.02e-1)"	"unprognostic (6.01e-3)"	"unprognostic (7.20e-2)"	"unprognostic (2.45e-2)"	"unprognostic (1.29e-1)"	"unprognostic (4.01e-2)"	"prognostic unfavorable (5.90e-6)"	"unprognostic (7.04e-2)"	"unprognostic (4.01e-2)"	"unprognostic (3.00e-1)"	"unprognostic (4.59e-2)"	0.6	0.4	0.2	4.7	0.2	0.2	0.7	0.2	0.3	4.2	4.1	0.1	5.6	1.2	1.1	1.0	1.2	3.6	21.0	0.7	1.0	0.4	7.1	21.8	2.0	1.8	0.2	0.1	0.4	5.0	0.2	0.7	0.5	2.4	2.2	0.7	0.4	34.3	3.0	0.3	4.5	1.9	0.5	0.4	4.9	1.6	0.6	0.1	0.4	0.4	1.6	5.2	1.5	1.0	1.7	0.0	24.5	0.0	12.7	2.6	0.7	0.2	1.8	0.1	0.0	0.3	0.1	2.2	0.1	0.0	0.0	0.1	3.2	0.1	0.7	0.1	0.0	0.3	1.3	0.0	0.8	0.0	0.1	0.0	0.3	0.7	0.9	0.0	0.0	17.6	0.8	2.5	0.3	0.0	0.0	0.0	0.0	0.5	0.5	0.3	0.3	0.0	0.0	0.5	1.0	0.0	0.0	0.0	0.2	1.9	0.0	0.1	0.0	0.1	0.4	0.1	0.4	0.1	1.4	0.0	0.0	0.1	0.0	0.4	0.9	0.7	0.0	0.1	0.0	0.7	24.5	0.0	1.8	2.6	0.0	2.5	1.5	0.7	1.3	0.0	1.7	0.0	0.6	0.4	12.7	0.0	0.0	0.5	0.7	0.2	0.2	0.2	0.3	1.0	0.4	0.2	0.1	2.4	0.1	11.9	27.1	15.9	8.0	8.4	1.2	0.6	50.9	5.3	5.7	5.2	0.0	1.5	0.0	9.1	0.4	1.8	4.2	0.0	6.3	8.2	1.1	2.3	4.7	12.7	0.9	0.0	3.5	1.3	1.0	0.2	0.6	2.0	3.3	0.0	18.8	1.7	4.0	3.5	0.4	16.5	0.6	0.0	1.7	0.3	2.4	8.3	2.4	25.4	16.4	4.3
CAPN13	FLJ23523	ENSG00000162949	"Calpain 13"	Q6MZZ7	2	30722771-30820542	"Enzymes, Predicted intracellular proteins"		"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 67.3;pancreas: 20.4;stomach 1: 17.6"	"Cell type enhanced"	"Detected in many"	8	"Club cells: 21.6;Enterocytes: 20.8;Intestinal endocrine cells: 14.5;Undifferentiated cells: 17.1;Urothelial cells: 20.1"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"RT4: 9.0;SK-BR-3: 21.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA029496, HPA029497, HPA030034"	Uncertain		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA029496: AB_2673072, HPA029497: AB_2673073, HPA030034: AB_2673281"	"unprognostic (7.42e-2)"	"unprognostic (1.19e-1)"	"unprognostic (7.01e-3)"	"unprognostic (1.96e-1)"	"unprognostic (8.56e-2)"	"unprognostic (1.51e-1)"	"unprognostic (1.68e-1)"	"unprognostic (1.32e-3)"	"unprognostic (2.17e-1)"	"unprognostic (2.66e-2)"	"unprognostic (1.11e-1)"	"unprognostic (2.49e-1)"	"unprognostic (1.96e-2)"	"unprognostic (3.64e-1)"	"unprognostic (3.32e-2)"	"unprognostic (5.03e-2)"	"unprognostic (4.28e-3)"	0.2	0.0	0.5	0.5	0.4	0.0	4.8	0.2	0.2	6.2	39.6	0.3	0.2	13.0	1.1	0.6	1.1	0.5	7.4	0.2	0.8	0.4	2.0	0.2	9.4	0.2	0.7	0.3	0.4	20.4	0.6	1.2	0.2	0.2	5.2	16.0	0.2	1.0	0.2	0.2	0.1	67.3	1.6	1.0	0.2	17.6	0.2	0.2	0.2	0.2	0.5	1.0	3.3	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.6	9.0	0.1	0.4	0.0	21.7	0.0	0.8	3.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.4	0.2	0.2	0.8	0.4	0.7	0.3	0.2	0.2	6.0	1.9	0.0	7.5	0.0	0.0	1.7	0.0	8.1	21.6	1.8	0.0	0.0	0.0	0.7	0.8	0.0	20.8	0.0	4.8	0.0	0.0	1.9	1.1	0.0	0.0	0.0	14.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.4	0.0	1.5	3.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	17.1	20.1
CAPN14		ENSG00000214711	"Calpain 14"	A8MX76	2	31173056-31233858	"Enzymes, Predicted intracellular proteins"		"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	18	"esophagus: 92.6;lymphoid tissue: 25.0"	"Cell type enriched"	"Detected in some"	4	"Urothelial cells: 8.0"	"Group enriched"	"Detected in some"	7	"cervical cancer: 2.9;head and neck cancer: 2.3;lung cancer: 0.8;stomach cancer: 1.4;urothelial cancer: 0.6"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"memory B-cell: 1.3"	"Lineage enhanced"	"Detected in single"		"B-cells: 1.3"	"Cell line enriched"	"Detected in some"	6	"U-266/70: 7.9"					"Not detected"	"Not detected"									NA	NA						"unprognostic (5.81e-3)"	"unprognostic (1.20e-1)"	"unprognostic (4.57e-2)"	"unprognostic (1.88e-2)"	"unprognostic (3.85e-2)"	"unprognostic (3.30e-1)"	"unprognostic (3.61e-2)"	"unprognostic (4.67e-2)"	"unprognostic (1.71e-1)"	"unprognostic (3.14e-1)"	"unprognostic (3.77e-1)"	"unprognostic (1.60e-1)"	"unprognostic (3.71e-4)"	"unprognostic (8.42e-2)"	"unprognostic (6.84e-2)"	"unprognostic (1.91e-1)"	"unprognostic (4.47e-4)"	0.1	0.1	0.2	0.0	0.3	0.0	0.2	0.5	0.3	1.1	0.1	0.0	0.0	0.0	0.4	0.0	92.6	0.1	0.0	0.2	0.2	0.3	0.1	0.4	0.2	0.0	0.2	0.0	0.2	0.3	0.0	0.2	0.1	0.0	0.2	0.0	0.0	0.3	0.0	0.2	0.1	0.1	0.0	0.1	0.0	0.2	0.1	0.0	0.0	0.2	3.2	25.0	0.2	0.4	1.3	0.0	0.0	0.1	0.0	0.5	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.1	0.1	0.0	0.5	0.1	0.4	0.2	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.1	0.0	0.1	0.3	0.0	0.2	0.0	0.0	0.2	0.0	0.9	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.9	0.4	0.1	0.1	0.0	1.1	0.0	0.0	0.0	0.5	0.0	0.0	1.3	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.2	0.3	0.5	0.3	0.2	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.6	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	1.6	0.0	0.0	0.3	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	8.0
CAPN15	SOLH	ENSG00000103326	"Calpain 15"	O75808	16	527717-554636	"Enzymes, Predicted intracellular proteins"		"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	5	"neutrophil: 15.8"	"Lineage enriched"	"Detected in many"	6	"granulocytes: 15.8"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA011960	Uncertain		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA011960: AB_10610556"	"unprognostic (4.11e-2)"	"unprognostic (1.63e-1)"	"unprognostic (1.14e-1)"	"unprognostic (2.66e-1)"	"unprognostic (7.18e-2)"	"unprognostic (1.12e-2)"	"unprognostic (1.54e-3)"	"unprognostic (8.31e-3)"	"unprognostic (1.32e-1)"	"unprognostic (1.24e-1)"	"unprognostic (1.86e-1)"	"unprognostic (4.02e-2)"	"unprognostic (2.53e-3)"	"unprognostic (2.54e-3)"	"unprognostic (5.91e-2)"	"unprognostic (1.83e-1)"	"unprognostic (9.23e-3)"	9.2	7.7	7.1	13.1	6.8	12.0	12.0	20.4	10.9	5.6	15.7	5.7	8.6	26.1	7.9	5.4	10.7	7.5	13.4	5.9	9.8	2.9	9.7	14.1	8.6	8.2	5.8	4.7	8.2	20.5	4.3	9.1	6.1	5.0	7.2	4.7	3.7	11.7	6.9	11.4	14.3	24.7	7.0	3.4	16.8	21.9	10.8	4.1	9.7	6.9	6.6	11.8	6.4	11.8	2.7	0.5	15.8	1.1	1.1	0.4	0.2	8.4	11.0	1.6	4.8	0.9	1.8	24.5	9.1	2.4	2.6	1.8	14.4	6.2	12.3	8.8	1.6	2.6	11.3	1.0	3.6	0.9	12.7	19.4	10.2	11.3	8.8	3.9	11.9	14.4	2.0	2.1	2.6	1.2	1.5	2.8	7.6	18.6	3.7	0.8	13.1	13.3	13.1	14.2	4.4	10.5	23.3	4.5	12.1	1.7	5.5	10.3	9.4	6.0	8.4	5.1	1.0	6.9	12.5	13.4	8.1	11.4	8.2	11.3	9.8	5.4	10.5	3.5	7.0	5.0	3.0	1.1	0.7	0.2	0.8	0.1	0.3	0.1	0.4	0.3	2.7	0.1	0.2	15.8	1.1	1.0	0.5	0.2	0.2	7.1	6.8	20.4	10.9	9.8	2.9	5.8	4.7	5.0	4.1	3.0	9.6	6.0	3.8	7.9	11.8	2.5	10.2	1.4	3.4	7.0	15.7	3.1	1.7	6.3	15.0	7.2	31.5	0.0	13.3	3.5	6.7	8.6	6.9	15.3	6.0	19.1	4.1	8.0	13.5	5.3	6.9	4.8	1.7	2.8	24.3	7.8	10.5	24.9	4.2	4.1	11.4	0.0	3.8	4.9	6.4	6.9	2.1	7.5	19.9	11.9
CAPN2	"CANPL2, CANPml, mCANP"	ENSG00000162909	"Calpain 2"	P17655	1	223701593-223776018	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Alveolar cells type 1: 366.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA024470	Approved	Approved	Supported	Cytosol		NA	NA		1500000	Cytosol		"HPA024470: AB_1845925"	"unprognostic (2.77e-2)"	"unprognostic (1.27e-3)"	"unprognostic (2.03e-1)"	"unprognostic (3.39e-2)"	"unprognostic (2.12e-1)"	"unprognostic (3.32e-2)"	"unprognostic (1.59e-1)"	"unprognostic (1.10e-1)"	"unprognostic (2.85e-1)"	"unprognostic (1.96e-1)"	"prognostic unfavorable (2.50e-4)"	"unprognostic (1.21e-1)"	"prognostic favorable (2.19e-4)"	"unprognostic (1.61e-1)"	"unprognostic (2.63e-1)"	"unprognostic (2.62e-1)"	"prognostic unfavorable (6.21e-4)"	56.2	41.0	23.8	20.7	22.2	11.1	61.1	26.1	20.9	40.3	44.8	18.3	23.3	14.5	29.1	44.5	56.3	40.1	58.9	33.0	26.5	13.1	41.6	13.3	58.6	18.2	27.4	18.2	32.4	26.8	53.7	12.7	26.4	23.8	27.2	44.4	16.5	62.5	31.9	48.1	16.5	22.7	35.7	32.3	15.9	48.2	17.2	24.7	5.0	29.9	39.7	35.9	28.3	38.8	9.0	41.6	1.7	29.1	6.0	28.7	28.2	46.1	29.6	9.5	6.3	31.7	44.0	9.1	43.7	63.5	31.8	18.1	23.4	37.2	0.0	14.4	48.5	25.0	28.9	10.2	69.1	29.6	11.8	10.6	0.8	15.1	2.9	28.5	2.4	1.5	23.5	22.4	49.5	26.5	57.1	63.0	0.0	13.3	12.4	93.6	0.9	0.1	2.1	5.2	5.7	38.7	3.9	31.0	0.7	54.8	2.7	2.0	11.0	22.5	61.5	13.6	24.0	9.3	11.1	96.9	29.8	24.7	25.6	56.0	3.7	6.9	0.1	74.6	5.2	32.7	1.7	29.1	1.7	28.7	19.5	24.5	9.0	20.0	27.7	41.6	3.6	6.4	17.4	1.5	6.0	17.5	1.9	19.9	28.2	23.8	22.2	26.1	20.9	26.5	13.1	27.4	18.2	23.8	24.7	366.3	110.0	19.7	85.8	42.0	12.0	35.9	96.8	180.7	191.1	50.6	31.4	18.1	154.2	234.2	86.1	110.2	114.4	0.0	171.9	77.1	101.6	155.1	26.6	6.0	36.6	12.7	23.6	33.2	58.4	173.5	71.7	66.7	106.3	13.6	104.2	15.8	261.3	139.7	64.7	17.0	17.0	38.8	112.7	3.0	3.2	24.1	6.9	57.7	90.7	256.2
CAPN3	"CANP3, LGMD2, LGMD2A, nCL-1, p94"	ENSG00000092529	"Calpain 3"	P20807	15	42359500-42412318	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		"Hydrolase, Protease, Thiol protease"	"Disease mutation, Limb-girdle muscular dystrophy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 65.6;skeletal muscle: 210.9"	"Cell type enhanced"	"Detected in many"	20	"Early spermatids: 403.1;Late spermatids: 111.1;Melanocytes: 457.2"	"Cancer enriched"	"Detected in some"	10	"melanoma: 9.1"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enriched"	"Detected in some"	23	"SK-MEL-30: 77.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA040052	Enhanced					NA	NA					"HPA040052: AB_2676821"	"unprognostic (1.06e-2)"	"unprognostic (1.31e-1)"	"unprognostic (4.00e-2)"	"unprognostic (8.71e-2)"	"unprognostic (1.53e-1)"	"unprognostic (1.72e-2)"	"unprognostic (2.11e-4)"	"unprognostic (3.12e-3)"	"unprognostic (2.82e-1)"	"unprognostic (2.47e-1)"	"unprognostic (2.37e-3)"	"unprognostic (3.26e-2)"	"unprognostic (3.91e-4)"	"unprognostic (5.56e-3)"	"unprognostic (2.43e-1)"	"unprognostic (8.93e-3)"	"unprognostic (1.38e-1)"	5.7	1.8	13.0	2.3	32.1	16.7	3.8	3.1	22.9	2.1	2.4	65.6	0.0	2.2	3.1	47.0	4.2	2.5	3.0	3.6	19.9	11.5	22.1	6.3	6.7	3.4	50.7	19.5	3.1	1.4	3.4	1.7	2.0	39.0	3.0	3.2	5.0	3.1	3.1	210.9	19.7	2.3	2.8	52.6	3.3	2.1	4.1	47.3	0.0	1.6	27.6	3.0	2.7	2.3	1.5	1.7	0.9	2.6	1.3	3.2	1.4	0.1	0.2	0.2	0.3	3.3	3.2	0.3	1.2	0.7	0.1	0.2	0.3	0.2	0.0	0.4	0.6	0.1	1.8	0.1	1.3	0.1	0.3	0.3	0.2	0.5	1.0	0.1	0.5	0.6	2.1	2.0	0.2	0.5	0.7	0.0	0.3	0.0	0.9	0.1	0.0	0.0	0.5	0.1	0.0	0.2	0.5	0.0	0.7	0.8	0.5	0.0	0.0	0.0	0.1	77.0	0.3	0.0	1.8	0.3	0.0	0.1	1.6	0.2	0.4	0.7	0.0	0.2	0.9	0.7	0.0	2.6	0.0	2.8	0.6	2.8	0.4	0.3	1.0	1.7	1.5	0.2	3.2	0.9	1.3	0.2	1.6	1.3	1.4	13.0	32.1	3.1	22.9	19.9	11.5	50.7	19.5	39.0	47.3	11.9	34.6	0.0	0.8	17.9	1.5	0.3	0.0	0.0	5.7	1.8	2.0	0.5	1.7	0.0	403.1	0.7	1.6	0.0	0.0	0.4	0.8	0.6	1.1	6.6	24.8	0.0	0.0	2.5	4.5	111.1	4.9	4.6	457.2	1.0	1.8	3.6	0.0	4.5	3.2	36.6	3.7	0.0	0.8	9.4	4.9	7.4	2.7	1.9	1.9	0.7
CAPN5	"ADNIV, HTRA3, nCL-3, VRNI"	ENSG00000149260	"Calpain 5"	O15484	11	77066932-77126155	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		"Hydrolase, Protease, Thiol protease"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"gallbladder: 49.5;intestine: 47.8"	"Cell type enhanced"	"Detected in many"	11	"Enterocytes: 114.7;Mucus-secreting cells: 72.0;Paneth cells: 69.1;Undifferentiated cells: 49.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"gdT-cell: 4.8"	"Lineage enriched"	"Detected in single"	5	"T-cells: 4.8"	"Cell line enhanced"	"Detected in many"		"OE19: 44.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB033237, HPA072319"	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"CAB033237: AB_2069673, HPA072319: AB_2686512"	"unprognostic (6.81e-3)"	"unprognostic (1.31e-1)"	"unprognostic (3.36e-2)"	"prognostic unfavorable (2.16e-6)"	"unprognostic (3.47e-3)"	"unprognostic (1.34e-1)"	"unprognostic (1.13e-1)"	"unprognostic (5.30e-2)"	"unprognostic (2.52e-1)"	"unprognostic (2.21e-2)"	"unprognostic (5.35e-3)"	"unprognostic (4.64e-1)"	"unprognostic (3.17e-3)"	"unprognostic (8.58e-3)"	"unprognostic (3.25e-1)"	"unprognostic (2.31e-2)"	"unprognostic (2.30e-3)"	3.9	7.1	5.6	19.5	5.4	1.5	3.9	6.3	10.8	7.4	34.1	6.0	4.8	32.7	6.3	8.3	18.3	6.6	49.5	4.4	5.4	4.6	8.7	26.8	2.8	1.2	3.7	7.0	15.4	3.2	0.7	3.3	2.6	10.2	9.3	27.9	7.4	4.7	7.5	1.8	1.9	47.8	9.3	4.1	2.2	29.3	22.0	2.3	0.6	3.1	4.6	7.3	9.8	6.3	0.2	0.7	0.0	0.9	0.0	4.8	2.1	0.3	5.5	3.7	3.6	13.9	13.4	0.3	5.5	9.6	5.7	4.2	3.2	1.6	0.2	4.0	9.6	6.5	0.2	1.5	0.4	2.4	0.3	0.3	1.1	0.1	0.3	3.5	0.1	0.3	6.6	0.6	9.2	2.2	8.0	6.6	2.6	0.1	0.1	10.6	7.7	0.9	0.1	3.1	44.2	4.3	0.8	12.5	0.2	1.9	6.9	0.2	6.7	1.3	1.0	2.5	2.4	0.8	0.0	13.7	11.1	6.6	15.3	0.7	0.4	0.7	0.0	5.7	0.1	2.6	0.0	0.7	0.0	4.8	0.9	0.4	0.0	0.5	1.6	0.7	0.2	2.4	2.5	0.0	0.0	0.2	0.3	0.0	2.1	5.6	5.4	6.3	10.8	5.4	4.6	3.7	7.0	10.2	2.3	0.0	0.3	0.8	0.2	1.4	1.5	1.7	28.1	4.0	7.9	22.7	0.0	0.0	1.7	9.0	0.9	2.1	114.7	0.0	29.7	0.4	6.2	2.3	0.0	37.5	0.8	1.6	21.5	2.5	1.8	1.1	11.5	1.2	6.8	0.0	72.0	6.4	15.2	69.1	4.2	5.9	1.8	0.0	2.2	0.4	2.3	0.6	0.0	0.0	49.0	1.4
CAPN6	"CalpM, CANPX, CAPNX"	ENSG00000077274	"Calpain 6"	Q9Y6Q1	X	111245103-111270523	"Cancer-related genes, Enzymes, Predicted intracellular proteins"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"epididymis: 62.9;placenta: 173.5"	"Group enriched"	"Detected in some"	4	"Extravillous trophoblasts: 165.5;Syncytiotrophoblasts: 117.5"	"Cancer enhanced"	"Detected in many"		"endometrial cancer: 25.9"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"NK-cell: 1.2;plasmacytoid DC: 2.0"	"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in some"	4	"HDLM-2: 10.1;NTERA-2: 15.8;SuSa: 14.7"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in single"			HPA040259			Approved	"Nucleoplasm,Centriolar satellite,Cytosol"		NA	NA			"Centriolar satellite"	"Nucleoplasm, Cytosol"	"HPA040259: "	"unprognostic (1.27e-3)"	"unprognostic (2.04e-1)"	"unprognostic (2.69e-2)"	"unprognostic (5.77e-3)"	"unprognostic (2.07e-1)"	"unprognostic (9.93e-2)"	"unprognostic (8.39e-3)"	"unprognostic (1.06e-1)"	"unprognostic (2.08e-1)"	"unprognostic (9.45e-3)"	"unprognostic (5.12e-1)"	"unprognostic (6.25e-2)"	"unprognostic (7.67e-2)"	"unprognostic (6.50e-2)"	"unprognostic (5.02e-3)"	"unprognostic (2.66e-1)"	"unprognostic (6.30e-2)"	1.7	0.0	0.2	1.7	0.2	0.0	6.0	0.3	0.3	3.9	4.2	0.2	23.4	0.2	18.2	62.9	2.4	2.9	2.6	0.4	0.2	0.0	5.1	0.4	0.3	1.1	0.2	0.4	1.9	4.1	0.0	0.2	173.5	0.3	3.6	2.2	2.1	5.6	21.7	1.7	1.0	1.3	2.0	0.3	1.0	7.2	2.8	0.2	0.5	1.7	4.7	2.9	1.4	2.6	0.1	2.0	0.8	0.0	1.2	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	3.2	0.0	0.0	10.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	15.8	0.0	0.0	0.0	0.0	0.1	1.3	0.0	0.1	0.3	0.4	0.3	0.0	14.7	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.8	0.0	0.0	0.0	0.0	0.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	2.0	0.1	0.0	0.2	0.2	0.3	0.3	0.2	0.0	0.2	0.4	0.3	0.2	0.0	0.0	0.0	1.0	0.1	0.0	0.3	10.2	0.0	0.0	7.0	0.0	35.2	3.3	5.0	0.0	0.0	0.0	0.0	0.6	165.5	2.6	0.2	0.0	0.0	6.6	0.0	0.0	0.0	0.0	0.2	0.9	0.0	0.0	0.0	0.3	0.0	2.7	0.0	20.8	0.0	0.0	0.0	0.5	0.0	0.0	0.0	117.5	0.0	0.0	0.3
CAPN7	PalBH	ENSG00000131375	"Calpain 7"	Q9Y6W3	3	15206152-15252918	"Enzymes, Predicted intracellular proteins"		"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	5	"Rod photoreceptor cells: 99.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004745, HPA046617"	Uncertain		Approved	Centrosome,Cytosol		NA	NA			Cytosol	Centrosome	"HPA004745: , HPA046617: AB_2679721"	"unprognostic (2.70e-2)"	"unprognostic (2.79e-1)"	"prognostic favorable (4.85e-5)"	"unprognostic (1.85e-1)"	"unprognostic (1.69e-2)"	"unprognostic (1.41e-2)"	"unprognostic (2.22e-3)"	"unprognostic (2.72e-1)"	"unprognostic (1.42e-1)"	"unprognostic (2.76e-1)"	"unprognostic (1.39e-1)"	"unprognostic (5.29e-2)"	"unprognostic (1.12e-3)"	"unprognostic (3.24e-2)"	"unprognostic (7.84e-2)"	"unprognostic (5.66e-2)"	"unprognostic (1.05e-2)"	16.3	15.0	9.7	12.8	13.4	10.5	18.9	21.7	13.7	18.6	15.5	11.1	14.3	11.8	17.6	15.9	13.4	16.7	10.4	13.8	9.2	8.9	14.8	17.6	17.9	20.0	11.4	8.4	20.6	15.9	20.4	29.0	14.7	11.7	14.7	11.7	15.9	15.9	12.7	33.7	14.9	14.5	19.5	14.1	12.1	15.2	12.1	12.3	19.3	22.6	11.1	14.5	17.7	14.5	6.6	5.1	8.7	7.0	5.8	10.0	5.0	8.7	11.5	9.6	6.0	16.9	13.2	32.8	11.3	13.0	14.1	10.8	8.2	6.3	15.1	7.9	12.8	8.7	6.1	14.1	14.5	12.3	14.4	11.1	18.9	16.2	10.8	12.6	15.1	9.6	9.0	21.2	18.3	9.1	13.4	10.0	14.6	18.2	15.9	13.6	12.7	10.7	6.3	9.2	12.7	11.3	6.2	16.0	10.4	10.5	16.0	7.8	10.1	18.4	10.0	12.5	12.8	17.6	15.9	8.9	12.8	9.7	16.5	13.1	11.1	22.0	7.7	11.6	11.1	11.0	6.3	5.4	8.7	6.4	4.4	10.0	6.6	7.0	5.2	5.1	5.9	9.6	8.8	3.2	5.8	7.0	4.3	5.1	5.0	9.7	13.4	21.7	13.7	9.2	8.9	11.4	8.4	11.7	12.3	11.9	17.6	15.2	14.2	19.1	41.7	27.4	7.6	45.5	27.3	1.8	53.0	17.3	8.3	10.3	11.3	16.8	10.2	23.3	14.8	10.3	16.0	16.9	15.1	14.3	10.6	52.4	20.1	15.4	12.4	11.7	23.0	15.2	20.3	12.6	9.8	37.3	10.8	7.0	24.8	12.2	99.8	38.8	22.8	22.4	14.7	20.3	21.9	17.0	10.3	7.3
CAPN8	nCL-2	ENSG00000203697	"Calpain 8"	A6NHC0	1	223538007-223665734	"Enzymes, Predicted intracellular proteins"		"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"gallbladder: 32.0;stomach 1: 85.8"	"Cell type enhanced"	"Detected in many"	12	"Alveolar cells type 2: 123.4;Club cells: 94.4;Mucus-secreting cells: 49.6"	"Cancer enhanced"	"Detected in many"		"pancreatic cancer: 28.8"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"naive CD8 T-cell: 1.4"	"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in some"	13	"OE19: 51.0;RT4: 30.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA073939			Approved	"Nucleoplasm,Nuclear membrane,Vesicles"		No	NA			"Nucleoplasm, Nuclear membrane, Vesicles"		"HPA073939: AB_2686646"	"unprognostic (4.87e-3)"	"unprognostic (2.58e-1)"	"unprognostic (1.89e-1)"	"unprognostic (2.06e-2)"	"unprognostic (1.32e-2)"	"unprognostic (1.49e-1)"	"unprognostic (7.97e-3)"	"unprognostic (1.19e-1)"	"unprognostic (1.26e-1)"	"unprognostic (8.08e-2)"	"unprognostic (2.72e-3)"	"unprognostic (3.55e-1)"	"unprognostic (4.12e-6)"	"unprognostic (6.95e-2)"	"unprognostic (5.59e-2)"	"unprognostic (3.83e-2)"	"unprognostic (5.44e-3)"	0.2	0.0	0.5	10.3	0.3	0.0	7.5	0.2	0.3	1.0	7.9	0.6	0.2	2.2	0.3	3.3	0.6	0.4	32.0	0.2	0.2	0.1	2.5	0.2	13.0	0.2	0.2	0.2	0.2	8.0	0.0	0.2	0.8	0.2	4.6	9.9	0.2	4.6	0.3	0.3	1.5	4.0	3.2	0.2	0.2	85.8	0.4	0.2	0.3	0.2	1.5	1.2	15.1	3.9	0.4	0.0	1.1	0.0	0.0	1.4	1.5	0.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	1.8	0.0	0.0	0.0	0.1	3.2	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	51.0	1.6	0.0	0.0	0.0	0.6	30.2	0.5	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.4	0.9	0.7	0.0	0.0	0.1	1.4	1.1	0.0	0.0	0.0	0.0	1.5	0.5	0.3	0.2	0.3	0.2	0.1	0.2	0.2	0.2	0.2	26.8	123.4	0.0	6.0	0.1	0.0	2.2	15.3	24.1	94.4	24.4	0.0	0.1	0.0	0.4	1.4	0.0	30.0	0.0	19.7	0.0	0.0	3.3	10.4	0.0	0.5	0.0	2.9	0.0	0.0	3.5	1.7	0.4	0.0	0.0	49.6	0.0	21.9	16.9	3.2	0.0	0.0	0.0	0.1	0.2	0.4	0.0	0.1	0.0	13.2	15.4
CAPN9	"GC36, nCL-4"	ENSG00000135773	"Calpain 9"	O14815	1	230747384-230802003	"Enzymes, Predicted intracellular proteins"		"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"intestine: 17.6;lung: 19.8;stomach 1: 35.8"	"Group enriched"	"Detected in many"	10	"Alveolar cells type 1: 23.8;Mucus-secreting cells: 67.4"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	17	"naive CD4 T-cell: 1.6"	"Lineage enriched"	"Detected in single"	17	"T-cells: 1.6"	"Group enriched"	"Detected in some"	6	"OE19: 11.9;SCLC-21H: 17.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA020398, CAB033483, HPA062050"	Enhanced		Approved	"Golgi apparatus,Vesicles"		NA	NA			Vesicles	"Golgi apparatus"	"CAB033483: AB_1119945, HPA020398: AB_2670429, HPA062050: "	"unprognostic (2.64e-1)"	"unprognostic (1.20e-1)"	"unprognostic (2.60e-2)"	"unprognostic (1.09e-1)"	"unprognostic (2.20e-1)"	"unprognostic (2.49e-2)"	"unprognostic (3.36e-2)"	"unprognostic (2.30e-2)"	"unprognostic (4.61e-2)"	"unprognostic (3.44e-2)"	"unprognostic (9.10e-2)"	"unprognostic (1.60e-1)"	"unprognostic (5.97e-5)"	"unprognostic (1.51e-1)"	"unprognostic (2.08e-1)"	"unprognostic (4.60e-2)"	"unprognostic (2.16e-1)"	0.2	0.7	0.4	7.0	0.3	0.0	0.2	0.3	0.5	0.4	10.4	0.4	0.2	3.9	0.2	0.2	0.7	1.5	12.7	0.2	0.5	0.2	0.2	0.2	19.8	0.2	0.6	0.2	0.3	0.2	0.0	0.6	0.2	0.2	0.8	13.7	0.2	8.1	0.2	1.3	0.0	17.6	0.2	1.1	0.2	35.8	0.2	0.2	0.2	0.2	1.0	7.1	3.7	0.2	0.0	0.0	0.0	0.0	0.0	1.6	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.7	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	1.5	0.1	0.0	0.6	11.9	0.0	0.4	0.0	0.0	0.0	0.1	17.1	0.0	0.0	0.5	0.0	0.1	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.3	0.3	0.4	0.5	0.2	0.6	0.2	0.2	0.2	23.8	4.8	0.0	0.5	0.0	0.0	3.3	0.0	4.0	3.4	0.0	0.0	0.0	0.0	0.2	4.5	0.0	3.5	0.0	0.2	0.0	0.0	0.4	2.3	0.0	0.1	0.0	2.9	0.0	0.0	2.2	0.0	0.0	0.0	0.0	67.4	0.2	1.1	3.5	0.0	0.0	1.6	0.0	0.0	0.0	0.1	0.0	0.0	0.0	2.6	1.0
CARM1	PRMT4	ENSG00000142453	"Coactivator associated arginine methyltransferase 1"	Q86X55	19	10871513-10923070	"Cancer-related genes, Enzymes, Predicted intracellular proteins"	"Host-virus interaction, Transcription, Transcription regulation"	"Chromatin regulator, Methyltransferase, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 64.3"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB032961, HPA043561, HPA048073, HPA069313"	Supported		Enhanced	Nucleoplasm	"Intracellular and membrane"	NA	NA			Nucleoplasm		"CAB032961: AB_2068446, HPA043561: AB_2678554, HPA048073: AB_2680250, HPA069313: "	"unprognostic (9.46e-2)"	"unprognostic (3.61e-1)"	"unprognostic (2.94e-2)"	"unprognostic (2.23e-1)"	"unprognostic (2.69e-2)"	"unprognostic (3.13e-2)"	"unprognostic (1.66e-3)"	"unprognostic (3.76e-2)"	"unprognostic (7.81e-2)"	"unprognostic (6.18e-2)"	"unprognostic (9.31e-2)"	"unprognostic (7.25e-2)"	"prognostic unfavorable (7.88e-6)"	"unprognostic (1.71e-2)"	"unprognostic (6.26e-2)"	"unprognostic (1.00e-1)"	"prognostic unfavorable (8.37e-4)"	12.2	8.8	12.3	12.6	16.1	13.2	9.6	12.5	17.7	15.8	14.0	9.3	9.0	11.5	19.6	9.1	20.5	14.8	12.4	14.7	11.2	7.2	9.3	14.5	8.9	12.4	7.8	10.2	13.0	16.9	8.2	6.9	15.3	9.5	12.6	10.2	12.0	11.4	13.2	64.3	12.5	12.0	15.6	6.6	9.8	11.1	17.5	8.6	9.4	10.0	12.7	15.6	15.8	15.9	1.3	1.6	0.3	1.4	0.1	2.6	0.4	22.6	16.9	24.2	32.8	20.2	27.7	23.2	16.3	28.3	24.2	23.3	26.0	8.3	31.2	19.6	28.4	12.2	21.7	24.7	24.5	15.3	34.9	20.1	9.6	11.0	31.5	17.3	14.4	12.5	18.9	16.0	16.5	20.0	13.8	30.6	24.9	22.9	28.1	14.2	40.9	25.1	12.4	29.9	15.2	28.1	35.1	12.4	36.3	14.6	11.7	17.6	16.9	11.6	14.1	15.7	12.6	14.1	12.4	18.3	29.2	16.5	27.7	19.0	27.4	21.6	27.3	19.2	23.2	12.6	0.0	1.4	0.2	1.2	1.4	0.5	1.3	0.9	2.6	1.3	1.3	1.0	0.9	0.3	0.1	0.7	1.6	0.8	0.4	12.3	16.1	12.5	17.7	11.2	7.2	7.8	10.2	9.5	8.6	8.9	13.5	11.5	4.9	6.9	31.0	0.8	17.8	8.1	6.8	8.7	49.1	16.3	6.6	11.8	25.6	5.7	28.0	46.7	16.9	26.3	10.3	10.9	1.1	23.7	22.3	42.9	26.5	11.1	17.8	13.0	26.2	7.5	5.0	28.9	25.6	10.2	20.3	25.9	18.0	7.3	19.9	6.5	9.2	25.8	16.4	6.0	10.1	4.1	21.2	9.0
CARNMT1	"C9orf41, FLJ25795"	ENSG00000156017	"Carnosine N-methyltransferase 1"	Q8N4J0	9	74981020-75028423	"Enzymes, Predicted intracellular proteins"		"Methyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	7	"Early spermatids: 178.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA026756	Uncertain					NA	NA					"HPA026756: AB_1845824"	"unprognostic (1.59e-1)"	"unprognostic (1.02e-1)"	"unprognostic (2.99e-2)"	"unprognostic (4.81e-2)"	"unprognostic (3.48e-1)"	"unprognostic (1.56e-1)"	"unprognostic (3.22e-2)"	"unprognostic (4.92e-2)"	"unprognostic (3.94e-2)"	"unprognostic (1.15e-1)"	"unprognostic (2.42e-2)"	"unprognostic (1.54e-1)"	"unprognostic (1.25e-2)"	"unprognostic (1.45e-2)"	"unprognostic (3.00e-1)"	"unprognostic (1.85e-1)"	"unprognostic (4.62e-2)"	7.7	8.3	8.0	12.9	17.5	8.4	8.5	22.9	11.6	11.3	13.5	5.7	11.3	14.6	10.0	10.7	15.8	7.8	10.9	7.5	7.6	6.0	14.9	20.2	7.3	10.6	6.3	7.9	8.8	16.5	16.1	12.5	7.6	5.4	10.7	10.5	7.7	13.9	12.3	9.6	10.2	23.3	8.7	6.6	9.9	9.0	22.1	8.6	15.1	16.6	8.7	11.0	9.7	12.8	3.5	1.5	2.1	1.7	3.1	4.7	1.4	14.5	8.8	3.7	9.6	6.2	13.2	13.8	12.9	5.6	5.1	4.7	2.2	10.0	23.1	6.9	9.6	11.0	14.6	11.3	14.2	14.7	20.1	8.7	11.7	9.0	10.2	7.5	21.2	11.6	8.9	7.2	9.7	10.1	7.7	10.4	8.7	9.9	20.9	10.0	4.0	15.5	5.9	17.2	18.2	7.9	7.5	11.1	13.9	13.6	10.5	3.7	2.0	9.9	26.4	5.0	7.1	13.3	6.5	8.0	8.5	11.1	10.2	11.3	14.9	18.9	7.0	13.3	14.8	5.4	0.0	1.0	2.1	3.2	1.7	4.5	3.5	3.2	4.7	1.2	1.9	3.6	3.8	0.4	3.1	1.0	1.5	4.1	1.4	8.0	17.5	22.9	11.6	7.6	6.0	6.3	7.9	5.4	8.6	6.0	9.4	2.2	10.8	0.0	13.1	0.0	17.8	8.1	12.5	26.2	9.8	6.1	21.6	6.2	178.1	6.0	5.4	0.0	10.2	10.9	4.3	11.6	2.3	27.0	7.4	19.1	7.0	9.2	9.8	25.4	6.9	5.1	0.0	4.6	17.0	5.0	8.4	10.5	10.3	25.3	9.8	0.0	0.0	13.1	9.1	0.0	4.2	13.8	14.9	13.2
CARNS1	"ATPGD1, KIAA1394"	ENSG00000172508	"Carnosine synthase 1"	A5YM72	11	67414968-67425607	"Enzymes, Predicted intracellular proteins"		Ligase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	14	"brain: 88.7;skeletal muscle: 64.8"	"Cell type enhanced"	"Detected in some"	21	"Alveolar cells type 1: 3.0;Cardiomyocytes: 11.7;Intestinal endocrine cells: 2.9"	"Group enriched"	"Detected in many"	5	"glioma: 4.1;thyroid cancer: 10.3"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	20	"B-cells: 1.9;NK-cells: 1.3;T-cells: 3.2"	"Cell line enriched"	"Detected in some"	12	"RPMI-8226: 13.1"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			HPA038569	Enhanced				"Intracellular and membrane"	NA	NA					"HPA038569: AB_2676089"	"unprognostic (1.07e-4)"	"unprognostic (4.33e-3)"	"unprognostic (2.00e-2)"	"unprognostic (6.15e-2)"	"unprognostic (9.45e-2)"	"unprognostic (1.05e-1)"	"unprognostic (7.28e-2)"	"unprognostic (7.54e-3)"	"unprognostic (1.29e-1)"	"unprognostic (1.82e-1)"	"unprognostic (5.19e-3)"	"unprognostic (1.00e-1)"	"unprognostic (6.14e-6)"	"unprognostic (3.44e-2)"	"unprognostic (1.33e-1)"	"unprognostic (3.83e-3)"	"unprognostic (8.33e-2)"	2.9	1.3	9.2	1.5	24.3	1.5	1.2	3.0	23.9	1.3	1.4	88.7	0.0	1.5	1.2	2.5	2.0	1.5	1.6	5.3	19.7	10.2	1.2	1.3	1.5	2.1	36.9	14.5	1.4	1.6	2.0	0.4	1.1	30.6	1.8	1.3	0.0	1.3	1.3	64.8	1.3	1.9	1.3	51.1	1.8	2.1	1.1	28.1	0.0	2.3	0.9	1.6	1.1	0.3	1.9	0.1	0.0	0.0	1.3	3.2	0.9	0.1	0.0	0.0	0.2	0.0	0.1	0.0	0.4	0.0	0.2	0.0	0.2	0.3	0.5	0.7	0.2	0.1	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.2	0.2	0.2	0.8	0.0	0.2	0.0	0.3	0.0	0.2	0.1	0.4	0.1	0.1	1.0	0.6	0.2	0.2	0.0	0.1	0.1	13.1	0.0	0.0	0.1	0.2	0.1	0.8	0.2	0.0	0.1	0.0	0.1	0.1	0.2	0.2	0.0	1.0	0.0	0.3	0.2	0.1	0.0	0.0	0.0	0.0	2.9	0.0	1.4	1.7	1.0	3.1	0.1	1.9	1.3	3.2	0.0	1.3	0.0	0.0	0.7	0.9	9.2	24.3	3.0	22.2	19.7	10.2	36.9	14.5	30.6	28.1	3.0	0.3	1.5	0.1	0.2	0.0	11.7	0.0	1.4	1.2	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.5	0.3	0.0	0.0	0.2	0.0	2.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.4	0.0	0.5	0.0	1.7	0.0	0.2	0.6	0.0	1.3	0.0	0.0
CARS	CARS1	ENSG00000110619	"Cysteinyl-tRNA synthetase"	P49589	11	3000922-3057613	"Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Protein biosynthesis"	"Aminoacyl-tRNA synthetase, Ligase"	"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Ciliated cells: 92.3;Early spermatids: 93.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002383, HPA002384, CAB075734, CAB075735, CAB075736, CAB075737"	Enhanced		Enhanced	Cytosol		NA	NA		110000	Cytosol		"CAB075734: AB_2665740, CAB075735: AB_2665741, CAB075736: AB_2665742, CAB075737: AB_2665743, HPA002383: AB_1078399, HPA002384: AB_1846033"	"unprognostic (9.10e-3)"	"unprognostic (1.83e-1)"	"unprognostic (4.16e-3)"	"unprognostic (1.43e-1)"	"unprognostic (1.00e-2)"	"unprognostic (7.97e-2)"	"prognostic unfavorable (5.16e-4)"	"unprognostic (1.41e-2)"	"unprognostic (1.05e-1)"	"unprognostic (8.00e-2)"	"unprognostic (5.51e-2)"	"unprognostic (2.45e-1)"	"prognostic unfavorable (0.00e+0)"	"unprognostic (5.37e-2)"	"unprognostic (1.71e-1)"	"unprognostic (1.48e-1)"	"unprognostic (3.46e-1)"	24.9	15.9	15.8	15.8	17.7	9.0	15.9	9.5	29.1	13.4	16.3	19.1	11.1	15.9	14.0	10.7	16.0	10.8	14.2	12.5	15.3	18.7	10.7	22.1	15.1	17.2	23.3	15.9	14.5	42.5	14.9	15.9	14.0	23.0	10.8	17.6	7.4	20.3	14.8	24.6	18.8	17.8	21.0	16.1	14.8	22.8	13.4	17.3	9.8	23.0	14.5	22.7	14.4	19.4	8.3	13.3	18.0	23.9	16.4	18.1	11.6	7.4	3.8	4.9	14.8	19.3	17.8	4.4	19.1	21.8	13.2	23.9	9.3	17.9	11.6	5.6	24.1	0.0	19.2	16.2	21.7	18.2	33.8	3.7	6.5	6.5	7.1	46.3	13.5	14.4	29.3	17.1	11.4	12.7	0.0	17.4	28.8	10.9	41.0	13.0	11.3	9.5	0.0	18.5	26.5	6.8	4.6	8.2	14.5	0.0	12.5	10.6	14.1	4.7	13.4	20.9	3.8	0.0	0.0	6.0	5.4	5.1	13.5	0.2	30.5	27.8	7.4	0.0	7.1	10.7	7.7	12.0	8.8	15.2	10.5	13.0	8.3	13.6	13.6	13.3	6.0	7.5	12.1	18.0	16.4	23.9	5.2	18.1	11.6	15.8	17.7	9.5	29.1	15.3	18.7	23.3	15.9	23.0	17.3	17.9	31.5	21.7	25.4	12.8	11.7	6.7	2.5	92.3	27.3	10.4	5.9	18.8	8.3	35.4	93.7	13.7	18.6	0.0	34.2	34.8	12.6	16.1	20.7	16.8	18.9	14.3	18.3	13.5	15.1	39.9	11.5	14.7	8.5	14.4	16.9	10.8	37.5	21.0	18.0	13.4	10.0	6.5	14.1	39.5	24.2	10.5	27.0	24.2	14.3	35.5
CARS2	FLJ12118	ENSG00000134905	"Cysteinyl-tRNA synthetase 2, mitochondrial"	Q9HA77	13	110641412-110713603	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Protein biosynthesis"	"Aminoacyl-tRNA synthetase, Ligase"	"Disease mutation, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	8	"Late spermatids: 173.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in all"		"U-87 MG: 65.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041776	Uncertain		Approved	Nucleoplasm,Mitochondria		NA	NA			"Nucleoplasm, Mitochondria"		"HPA041776: AB_2677666"	"unprognostic (2.34e-3)"	"unprognostic (9.50e-2)"	"unprognostic (6.62e-2)"	"prognostic favorable (1.84e-4)"	"unprognostic (1.98e-1)"	"unprognostic (3.54e-3)"	"prognostic unfavorable (1.21e-4)"	"unprognostic (1.90e-1)"	"unprognostic (1.08e-1)"	"unprognostic (7.82e-2)"	"unprognostic (2.11e-3)"	"unprognostic (5.75e-2)"	"prognostic unfavorable (2.49e-5)"	"unprognostic (4.73e-2)"	"unprognostic (3.42e-1)"	"unprognostic (3.21e-1)"	"unprognostic (1.71e-2)"	19.6	28.1	11.9	24.8	13.0	25.6	37.1	18.2	14.5	21.8	20.2	17.6	21.2	17.8	18.5	23.0	20.2	16.8	26.9	26.0	9.9	10.3	17.0	21.4	19.9	26.7	11.3	14.1	17.6	31.7	11.5	19.7	12.5	11.7	17.5	15.0	16.6	19.0	21.3	39.7	16.1	20.1	22.1	11.7	19.7	17.9	11.2	11.4	21.8	19.2	18.5	21.9	16.9	16.7	3.4	4.0	3.1	6.8	0.6	2.2	1.7	35.4	11.8	6.8	16.5	18.1	17.0	9.2	15.8	14.5	16.0	19.7	16.6	16.0	16.6	22.2	17.2	24.4	18.9	11.6	19.8	13.1	15.1	19.3	10.3	25.0	18.9	18.5	25.2	12.6	21.2	15.8	13.9	16.8	11.4	11.4	12.6	7.1	5.2	22.5	8.2	11.2	8.2	5.7	27.2	11.7	16.6	5.0	6.8	17.1	10.4	12.1	9.2	12.7	19.7	18.2	7.6	9.5	28.1	10.2	13.4	5.0	16.9	15.8	9.4	10.7	9.6	65.5	15.1	13.2	0.0	4.7	0.7	2.0	5.1	2.2	3.4	0.6	0.8	4.0	1.4	2.0	1.0	3.1	0.6	6.8	3.4	0.7	1.7	11.9	13.0	18.2	14.5	9.9	10.3	11.3	14.1	11.7	11.4	8.9	15.7	17.6	19.1	11.4	22.3	34.3	12.7	2.7	7.9	26.2	23.6	21.5	43.1	14.9	53.5	10.8	19.0	0.0	4.1	25.5	14.3	16.8	16.1	23.1	25.1	22.3	18.0	9.8	26.7	173.5	19.0	29.2	11.8	13.6	17.0	23.0	12.9	7.0	17.0	29.6	24.7	6.5	18.6	7.2	4.7	11.8	14.1	12.9	22.3	18.2
CASD1	"C7orf12, FLJ21213, FLJ21879"	ENSG00000127995	"CAS1 domain containing 1"	Q96PB1	7	94509219-94557019	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"		"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Bipolar cells: 54.4;Horizontal cells: 63.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044404	Uncertain		Approved	Nucleoplasm		Yes	No			Nucleoplasm		"HPA044404: AB_10964353"	"unprognostic (4.02e-2)"	"unprognostic (4.16e-2)"	"unprognostic (1.43e-1)"	"unprognostic (1.82e-1)"	"unprognostic (7.04e-2)"	"unprognostic (7.90e-2)"	"unprognostic (3.66e-2)"	"unprognostic (2.18e-2)"	"unprognostic (9.83e-2)"	"unprognostic (4.74e-2)"	"unprognostic (4.95e-3)"	"unprognostic (2.16e-2)"	"unprognostic (5.24e-2)"	"unprognostic (4.01e-3)"	"unprognostic (1.93e-1)"	"unprognostic (7.07e-2)"	"unprognostic (2.59e-3)"	8.6	21.6	16.6	7.1	24.2	4.1	13.2	20.5	24.8	10.0	13.2	10.9	7.5	5.0	11.7	12.5	5.1	9.2	8.1	13.6	25.9	22.2	10.2	7.1	9.0	9.2	13.1	16.6	14.1	7.8	12.7	22.8	9.8	20.0	11.8	15.9	8.4	22.6	8.2	11.3	3.7	6.3	9.7	13.7	8.0	6.0	10.1	11.5	7.3	13.2	2.9	8.3	9.0	6.3	1.8	1.1	0.2	0.7	1.8	4.7	0.7	3.0	5.9	20.3	7.5	6.2	7.5	3.4	4.2	7.4	4.6	6.1	3.7	7.6	7.8	11.0	5.6	8.3	1.7	5.1	1.4	9.2	12.4	4.1	6.9	5.0	6.7	5.3	11.4	0.0	6.8	5.4	4.2	6.1	9.1	7.3	9.2	3.7	17.2	11.4	4.5	15.8	6.5	10.4	4.3	4.7	10.9	16.5	6.0	9.4	8.5	7.7	26.3	6.5	12.1	4.1	15.4	3.1	7.2	3.8	11.6	9.2	9.5	6.0	16.5	15.4	16.3	6.3	2.7	7.5	0.0	0.6	0.2	1.9	0.7	4.7	1.8	2.8	2.3	1.1	1.7	2.9	2.2	0.0	1.8	0.6	1.0	1.7	0.7	16.6	24.2	20.5	24.8	25.9	22.2	13.1	16.6	20.0	11.5	26.8	22.9	6.9	5.2	4.0	54.4	17.1	17.8	18.7	17.0	19.2	17.7	9.7	3.3	4.5	2.7	13.3	12.0	0.0	4.8	4.6	9.3	11.8	10.3	10.9	7.4	63.5	6.9	17.2	11.5	4.7	10.6	5.6	23.6	2.8	27.6	25.0	6.1	8.6	9.2	8.8	28.9	19.4	7.1	6.3	11.9	4.0	14.1	7.2	14.1	3.7
CASK	"CAGH39, FGS4, LIN2, TNRC8"	ENSG00000147044	"Calcium/calmodulin dependent serine protein kinase"	O14936	X	41514934-41923645	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"		"Calmodulin-binding, Kinase, Serine/threonine-protein kinase, Transferase"	"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	5	"basophil: 26.3"	"Lineage enriched"	"Detected in many"	11	"granulocytes: 26.3"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB001949, HPA023857"	Enhanced		Approved	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"CAB001949: , HPA023857: AB_1846035"	"unprognostic (6.30e-2)"	"unprognostic (3.78e-2)"	"unprognostic (1.48e-1)"	"unprognostic (2.48e-3)"	"unprognostic (1.56e-1)"	"unprognostic (1.29e-1)"	"unprognostic (1.42e-3)"	"unprognostic (3.58e-1)"	"unprognostic (1.02e-1)"	"unprognostic (5.85e-3)"	"prognostic unfavorable (6.11e-5)"	"unprognostic (1.13e-1)"	"unprognostic (1.05e-1)"	"unprognostic (8.72e-2)"	"unprognostic (1.15e-2)"	"unprognostic (2.13e-2)"	"unprognostic (2.85e-2)"	9.1	15.9	13.9	18.8	12.7	9.8	13.2	14.2	15.7	11.1	22.1	20.0	7.1	27.1	12.2	13.7	17.2	9.9	16.0	7.0	12.1	12.8	14.6	10.8	10.3	13.6	16.3	8.5	13.9	14.2	11.1	9.8	13.4	11.9	10.7	23.8	10.4	15.9	7.7	5.8	12.8	32.9	12.1	10.1	9.6	16.2	2.9	14.3	30.9	9.3	8.1	14.0	11.8	13.1	0.6	0.3	26.3	0.8	2.4	2.3	0.3	10.9	14.0	13.4	8.0	9.1	7.4	4.3	9.6	8.0	5.6	5.2	30.1	17.9	0.1	4.9	11.9	10.2	22.0	14.7	9.8	9.4	9.7	8.2	0.0	12.6	10.6	9.4	1.7	1.5	8.4	26.9	10.7	13.7	11.3	4.6	6.4	0.8	8.5	12.2	12.8	3.1	0.7	12.3	15.8	9.1	5.1	33.0	5.2	12.7	23.8	12.3	6.5	18.0	7.2	5.5	22.6	7.7	0.3	5.3	10.5	10.7	9.0	5.3	3.3	2.1	3.7	10.3	1.2	6.7	26.3	0.8	4.8	0.5	0.7	0.5	0.4	0.6	0.8	0.2	0.6	0.7	0.7	1.1	2.4	0.4	0.3	2.3	0.3	13.9	12.7	14.2	14.2	12.1	12.8	16.3	8.5	11.9	14.3	11.9	14.8	0.9	33.3	29.0	40.5	6.5	10.2	20.1	14.8	7.0	21.6	1.6	43.1	13.2	0.8	10.8	22.7	0.0	12.7	0.7	17.5	19.6	0.0	13.0	16.2	47.7	13.3	4.9	3.5	0.2	9.2	6.8	10.1	0.0	30.6	11.9	17.9	28.1	8.9	17.0	26.0	19.4	14.4	1.6	1.9	28.4	1.4	12.5	36.5	26.9
CASP1	"ICE, IL1BC"	ENSG00000137752	"Caspase 1"	P29466	11	105025443-105035250	"Cancer-related genes, Enzymes, Predicted intracellular proteins"	Apoptosis	"Hydrolase, Protease, Thiol protease"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 64.2;lymphoid tissue: 40.7"	"Cell type enhanced"	"Detected in many"	7	"Hofbauer cells: 83.5;Kupffer cells: 119.3;Macrophages: 125.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 38.4;HBEC3-KT: 18.2;HHSteC: 20.6;U-937: 45.4"	"Region enhanced"	"Detected in many"		"olfactory region: 22.8"	"Low region specificity"	"Detected in all"			"CAB002685, HPA003056"	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			Cytosol	Nucleoplasm	"CAB002685: , HPA003056: AB_1846037"	"unprognostic (1.21e-3)"	"unprognostic (3.02e-1)"	"unprognostic (9.47e-3)"	"unprognostic (1.43e-1)"	"unprognostic (1.47e-1)"	"unprognostic (1.21e-1)"	"unprognostic (5.24e-2)"	"unprognostic (1.97e-1)"	"unprognostic (1.66e-1)"	"unprognostic (6.67e-2)"	"unprognostic (2.75e-2)"	"unprognostic (1.35e-1)"	"prognostic unfavorable (3.11e-4)"	"unprognostic (9.03e-2)"	"unprognostic (2.30e-2)"	"unprognostic (3.18e-1)"	"unprognostic (5.19e-2)"	7.4	3.9	6.6	15.1	17.0	8.2	6.9	3.5	7.0	4.1	12.8	2.2	2.9	34.0	3.0	4.2	10.6	4.3	7.3	4.9	9.3	3.0	6.4	5.8	20.5	16.2	16.7	2.6	4.4	3.4	0.2	3.7	8.7	13.3	6.1	13.9	3.7	7.0	3.2	1.6	9.9	37.2	5.2	17.4	40.7	5.6	1.5	11.0	4.1	3.7	5.6	9.0	9.7	13.2	7.3	39.6	40.5	64.2	11.1	34.3	31.2	0.4	0.1	0.0	1.8	2.0	4.3	0.3	1.9	38.4	4.8	13.5	0.0	0.2	6.2	0.8	2.2	8.9	2.7	0.0	18.2	1.1	4.0	0.0	0.3	0.2	0.4	20.6	7.2	0.0	7.3	12.9	3.9	10.6	12.6	2.1	0.1	0.0	0.0	1.1	0.0	0.2	10.1	0.0	0.0	0.1	6.0	0.1	4.9	0.1	3.0	0.1	0.1	5.7	0.4	8.4	0.0	0.4	16.7	2.4	4.4	0.2	0.4	0.5	0.0	1.7	0.0	2.8	45.4	0.9	12.3	42.8	23.2	25.4	64.2	34.3	7.3	18.1	22.0	39.6	6.0	9.9	16.4	40.5	11.1	64.0	1.4	22.2	31.2	6.6	17.0	3.5	7.0	9.3	3.0	16.7	2.6	13.3	11.0	17.9	35.4	32.0	33.0	23.1	0.0	2.6	12.7	12.0	11.4	10.4	0.0	1.3	1.7	15.7	0.0	24.1	33.9	0.0	11.7	1.0	13.1	5.7	15.1	1.7	83.5	0.0	5.8	17.8	119.3	0.2	3.1	125.6	5.0	34.3	32.1	0.0	4.7	49.2	3.2	1.0	0.1	0.0	5.4	0.0	0.0	19.4	0.9	48.4	29.9	41.4
CASP10	MCH4	ENSG00000003400	"Caspase 10"	Q92851	2	201182881-201229406	"Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	Apoptosis	"Hydrolase, Protease, Thiol protease"	"Cancer-related genes, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"intestine: 42.4"	"Cell type enhanced"	"Detected in many"	5	"Enterocytes: 35.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HUVEC TERT2: 18.0"					"Low region specificity"	"Detected in all"			"CAB003780, HPA017059"	Approved		Approved	"Golgi apparatus,Vesicles"		NA	NA			"Golgi apparatus"	Vesicles	"CAB003780: AB_289592, HPA017059: AB_1846040"	"unprognostic (4.01e-2)"	"unprognostic (8.24e-2)"	"unprognostic (4.80e-1)"	"unprognostic (1.28e-3)"	"unprognostic (4.74e-2)"	"unprognostic (2.25e-1)"	"prognostic unfavorable (8.54e-4)"	"unprognostic (1.73e-2)"	"unprognostic (1.48e-2)"	"unprognostic (3.68e-2)"	"unprognostic (1.91e-1)"	"unprognostic (1.04e-1)"	"prognostic unfavorable (6.05e-7)"	"unprognostic (3.23e-2)"	"unprognostic (2.19e-2)"	"unprognostic (4.49e-2)"	"unprognostic (1.38e-2)"	16.0	3.3	3.4	10.1	3.4	14.9	7.6	1.9	3.3	7.0	17.7	4.4	4.3	18.6	8.3	8.2	10.4	4.9	7.2	4.8	3.6	3.0	10.3	7.8	14.2	10.4	4.1	1.4	3.4	6.1	1.4	2.1	8.5	4.7	5.0	11.9	4.1	6.9	6.9	3.6	5.4	42.4	4.8	5.6	26.1	8.7	2.1	2.5	17.1	6.8	8.2	17.9	9.4	6.1	7.8	6.0	4.7	15.4	7.1	7.1	5.8	2.9	2.4	0.1	0.2	0.1	0.2	5.2	0.5	3.5	0.3	1.4	3.1	6.9	0.2	5.0	1.8	1.2	2.0	0.1	1.6	0.9	1.4	3.3	8.4	2.5	10.4	1.2	5.6	9.1	0.3	1.4	3.8	0.3	0.2	18.0	3.6	10.0	12.4	0.3	0.1	10.7	5.2	0.3	4.1	1.5	5.9	0.3	12.4	6.3	4.2	0.1	0.1	2.8	0.1	1.4	2.3	0.1	5.3	7.3	0.2	0.5	2.4	0.1	13.5	8.0	0.3	3.4	4.3	0.1	4.7	9.6	0.6	6.2	13.5	5.2	7.8	5.2	3.4	5.3	5.0	7.1	6.0	1.9	7.1	15.4	6.0	1.0	5.8	3.4	3.4	1.9	3.3	3.6	3.0	4.1	1.4	4.7	2.5	17.9	7.7	16.2	2.5	5.4	0.0	1.7	7.6	14.7	5.7	8.7	0.0	0.9	1.7	11.0	0.8	24.0	35.4	23.3	9.2	0.6	3.7	3.0	7.0	5.8	8.1	0.0	2.4	20.9	21.0	0.0	0.6	16.1	6.8	11.8	18.2	0.5	8.3	24.6	0.0	6.8	0.3	0.0	2.1	0.0	0.0	4.0	0.3	13.1	11.0	7.9
CASP14	"MGC119078, MGC119079, MICE"	ENSG00000105141	"Caspase 14"	P31944	19	15049384-15058293	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	Differentiation	"Hydrolase, Protease, Thiol protease"	Ichthyosis	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	6	"skin 1: 109.4"	"Cell type enriched"	"Detected in some"	5	"Suprabasal keratinocytes: 83.9"	"Cancer enhanced"	"Detected in many"		"cervical cancer: 62.8"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"neutrophil: 2.3"	"Low lineage specificity"	"Detected in single"			"Cell line enriched"	"Detected in some"	7	"hTCEpi: 33.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"CAB010059, HPA027062"	Enhanced		Approved	Nucleoplasm,Mitochondria,Cytosol		NA	NA		2200000	"Nucleoplasm, Cytosol"	Mitochondria	"CAB010059: AB_626800, HPA027062: AB_2672101"	"unprognostic (1.17e-2)"	"unprognostic (6.44e-3)"		"unprognostic (6.22e-2)"		"unprognostic (2.77e-1)"		"prognostic unfavorable (7.59e-4)"	"unprognostic (9.42e-2)"	"unprognostic (2.19e-2)"	"prognostic unfavorable (5.96e-4)"	"unprognostic (2.68e-1)"		"unprognostic (4.30e-2)"	"unprognostic (1.99e-1)"		"unprognostic (1.97e-1)"	0.2	0.2	0.2	0.0	0.3	0.0	1.9	0.2	0.3	17.9	0.2	0.0	0.8	0.0	1.1	0.3	1.2	0.1	0.0	0.2	0.3	0.2	0.4	0.3	0.2	0.0	0.2	0.0	0.1	0.3	0.0	0.2	0.5	0.0	7.7	0.0	0.0	0.8	2.7	0.3	109.4	0.2	0.0	0.2	0.1	0.2	1.6	0.0	2.3	0.2	0.9	0.0	0.6	4.0	0.8	0.5	2.3	0.6	0.1	0.6	0.0	0.7	0.1	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	4.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	33.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.8	0.6	0.4	0.4	0.2	0.4	0.3	0.6	0.4	0.1	0.8	0.5	0.4	2.3	0.1	0.2	0.5	0.6	0.0	0.2	0.3	0.2	0.3	0.3	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	1.0	16.9	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	2.6	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.3	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	83.9	0.6	0.0	0.0	0.1
CASP2	"ICH1, MGC2181, NEDD2, PPP1R57"	ENSG00000106144	"Caspase 2"	P42575	7	143288215-143307696	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins"	Apoptosis	"Hydrolase, Protease, Thiol protease"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 45.7"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"CAB012175, HPA050678"	Approved		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"CAB012175: , HPA050678: AB_2681214"	"unprognostic (6.96e-2)"	"prognostic favorable (7.38e-4)"	"unprognostic (2.74e-2)"	"unprognostic (7.51e-2)"	"unprognostic (4.24e-2)"	"unprognostic (2.39e-2)"	"prognostic unfavorable (2.34e-4)"	"unprognostic (1.74e-2)"	"unprognostic (1.34e-2)"	"prognostic favorable (2.89e-4)"	"unprognostic (1.91e-2)"	"unprognostic (1.64e-1)"	"prognostic unfavorable (5.01e-6)"	"unprognostic (2.66e-3)"	"unprognostic (9.48e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.64e-1)"	10.5	6.5	6.6	10.7	6.7	26.8	10.2	9.6	10.9	9.6	8.5	9.0	8.2	8.2	10.8	7.8	14.1	8.4	5.7	6.1	5.7	4.1	7.3	5.8	9.8	15.8	6.9	6.1	8.7	8.1	12.1	6.6	11.3	7.3	7.6	10.2	10.1	11.6	5.8	4.3	14.2	14.0	7.4	6.3	18.6	7.5	8.6	6.9	45.7	8.9	8.0	23.0	7.4	10.2	18.5	11.8	33.2	17.7	13.4	21.4	7.6	10.9	10.3	11.6	20.5	6.5	7.7	6.2	11.2	5.1	10.3	11.3	10.2	12.4	20.8	10.7	7.1	7.9	10.8	11.6	8.9	13.8	18.2	8.9	12.3	16.2	7.0	3.5	23.9	15.4	5.3	7.3	12.5	4.4	4.7	8.8	16.4	10.2	13.3	10.9	10.8	41.6	25.2	14.6	10.7	10.5	30.6	6.0	12.7	6.1	9.3	12.7	14.3	22.3	9.7	7.1	8.3	10.6	9.2	9.8	9.2	6.4	16.5	11.2	11.1	10.9	24.2	10.3	28.5	16.7	33.2	10.8	9.3	14.9	11.9	14.6	15.8	20.6	15.4	9.8	18.5	15.4	17.8	12.3	13.4	17.7	11.8	21.4	7.6	6.6	6.7	9.6	10.9	5.7	4.1	6.9	6.1	7.3	6.9	8.9	8.8	17.9	5.4	13.5	4.7	5.3	25.5	2.7	3.4	7.0	7.9	16.2	3.3	7.7	35.5	13.9	6.5	0.0	6.6	12.8	8.7	5.5	9.3	4.4	8.8	6.4	10.3	14.7	15.4	38.5	10.9	12.1	20.3	11.8	10.3	4.0	7.6	3.5	7.8	3.3	14.0	0.0	8.4	10.1	29.4	12.0	4.8	20.8	13.3	6.0
CASP3	"apopain, CPP32, CPP32B, Yama"	ENSG00000164305	"Caspase 3"	P42574	4	184627696-184649509	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins"	Apoptosis	"Hydrolase, Protease, Thiol protease"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 76.7"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	7	"basophil: 76.7;eosinophil: 62.8"	"Lineage enriched"	"Detected in all"	7	"granulocytes: 76.7"	"Cell line enhanced"	"Detected in all"		"Karpas-707: 74.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB000091, HPA002643, CAB008381"	Enhanced		Approved	Nucleoplasm,Mitochondria		NA	NA		310000	Mitochondria	Nucleoplasm	"CAB000091: , CAB008381: AB_590737, HPA002643: AB_1846048"	"unprognostic (1.38e-1)"	"unprognostic (1.06e-1)"	"unprognostic (2.21e-2)"	"prognostic favorable (2.24e-4)"	"unprognostic (2.29e-3)"	"unprognostic (3.58e-2)"	"unprognostic (9.57e-3)"	"unprognostic (5.86e-2)"	"unprognostic (3.56e-2)"	"unprognostic (1.12e-2)"	"unprognostic (1.70e-2)"	"unprognostic (2.41e-1)"	"prognostic unfavorable (2.30e-5)"	"unprognostic (1.41e-2)"	"unprognostic (5.74e-3)"	"unprognostic (1.30e-1)"	"unprognostic (4.05e-3)"	20.7	11.6	10.8	16.9	10.5	16.7	10.0	22.3	9.2	10.4	25.4	12.8	12.5	32.3	13.9	11.5	22.8	8.9	12.0	8.8	10.0	8.8	10.6	18.7	12.4	23.6	10.2	8.5	8.3	10.0	4.6	13.6	29.4	9.7	8.8	20.9	8.2	13.0	10.0	12.6	9.5	49.7	9.3	12.6	26.5	18.7	6.4	10.9	44.7	7.8	13.5	24.3	16.2	11.0	4.2	5.2	76.7	10.6	9.2	9.9	7.0	8.3	4.7	18.7	8.9	11.6	15.5	10.8	25.3	19.2	17.8	10.3	8.5	7.1	11.7	4.0	12.3	8.4	7.2	14.8	9.0	20.3	30.0	8.1	18.7	3.7	19.7	13.9	15.2	17.8	21.1	11.0	11.3	9.1	12.8	22.0	12.1	15.4	74.2	18.3	3.6	24.0	14.2	18.5	9.3	5.9	17.4	8.8	11.3	15.3	13.8	10.7	11.7	10.9	10.0	14.2	19.4	5.4	9.9	14.9	8.1	7.5	6.0	11.7	34.5	32.3	8.0	9.9	10.6	11.5	76.7	4.2	62.8	5.5	6.8	5.7	4.2	5.1	7.8	5.2	3.1	3.9	5.8	5.8	9.2	10.6	4.1	9.9	7.0	10.8	10.5	22.3	9.2	10.0	8.8	10.2	8.5	9.7	10.9	17.9	12.0	18.6	18.8	43.3	17.6	14.1	5.1	25.4	20.5	12.2	0.0	41.4	11.6	16.0	7.6	23.3	28.6	0.0	20.9	27.1	16.9	14.4	17.3	12.9	20.5	12.7	17.3	20.9	25.1	3.2	6.9	17.5	28.7	55.9	34.1	13.8	20.4	19.9	7.1	6.5	10.2	12.9	14.4	7.5	14.2	25.0	43.0	36.2	21.5	31.5
CASP4	"ICE(rel)II, ICH-2, TX"	ENSG00000196954	"Caspase 4"	P49662	11	104942866-104969436	"Cancer-related genes, Enzymes, Predicted intracellular proteins"	"Immunity, Inflammatory response, Innate immunity, Necrosis"	"Hydrolase, Protease, Thiol protease"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"blood: 82.8"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"											"HPA027588, CAB037167"	Approved		Approved	"Plasma membrane,Cytosol"	"Intracellular and membrane"	NA	NA			Cytosol	"Plasma membrane"	"CAB037167: AB_258864, HPA027588: AB_10603781"	"unprognostic (1.19e-2)"	"unprognostic (3.73e-1)"	"unprognostic (3.44e-1)"	"unprognostic (1.99e-2)"	"unprognostic (7.19e-3)"	"unprognostic (2.63e-2)"	"unprognostic (1.26e-2)"	"unprognostic (1.56e-2)"	"unprognostic (5.31e-2)"	"unprognostic (2.71e-1)"	"unprognostic (2.38e-3)"	"unprognostic (8.39e-3)"	"prognostic unfavorable (3.27e-11)"	"unprognostic (6.75e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.79e-2)"	"unprognostic (4.08e-3)"	10.6	6.3	0.5	9.7	0.5	6.1	9.4	0.0	0.0	4.7	3.5			8.9	3.5	5.9	14.1	5.8	7.3	4.9	0.5	0.5	6.7	16.5	14.0	10.5	1.0		7.5	16.8	0.0	3.0	10.7		5.8	4.0		11.2	1.9	1.6	10.4	8.8	4.3	2.0	19.0	8.2	0.2			4.2		11.3	8.2	8.0	20.5	29.3	82.8	43.2	29.6	35.7	46.8	6.4	2.1	0.0	2.8	13.7	31.4	5.3	11.0	21.6	17.8	25.0	5.3	29.1	3.3	23.8	14.3	21.5	10.7	0.0	19.1	17.0	3.8	0.1	8.6	1.6	13.9	33.8	8.7	4.2	28.5	28.6	21.2	29.7	21.3	30.9	0.1	0.2	0.0	13.5	0.6	5.0	10.2	0.0	14.4	6.3	3.8	4.1	2.9	14.9	10.2	0.1	0.0	10.2	7.2	10.1	0.2	2.9	12.7	16.0	18.8	6.5	16.5	7.7	0.0	0.0	0.0	9.6	19.8	13.1	14.9	39.1	7.0	31.5	43.2	34.6	20.5	24.2	30.1	29.3	20.0	14.8	22.0	82.8	29.6	33.5	4.9	35.7	46.8											56.6	57.5	87.2	53.6	49.6	0.0	3.6	40.8	72.3	54.6	21.0	0.0	113.8	13.3	118.8	0.5	68.8	12.0	0.0	164.0	65.7	45.5	29.4	33.5	26.8	101.8	0.0	20.1	65.1	148.5	1.3	27.0	95.5	28.7	63.1	28.2	1.9	153.2	9.9	19.4	30.9	0.1	6.5	22.7	0.2	0.6	40.1	96.9	117.6	17.5	68.0
CASP5	ICE(rel)III	ENSG00000137757	"Caspase 5"	P51878	11	104994235-105023168	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins"	Apoptosis	"Hydrolase, Protease, Thiol protease"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	7	"blood: 22.3;intestine: 31.0;lymphoid tissue: 12.3"	"Cell type enhanced"	"Detected in some"	14	"Enterocytes: 12.9;Mucus-secreting cells: 5.2;Paneth cells: 10.5;Undifferentiated cells: 4.9"	"Group enriched"	"Detected in some"	7	"colorectal cancer: 3.9;stomach cancer: 1.3"	"Low region specificity"	"Detected in some"			"Group enriched"	"Detected in some"	13	"intermediate monocyte: 10.5;neutrophil: 7.8;non-classical monocyte: 22.3"	"Group enriched"	"Detected in many"	14	"granulocytes: 7.8;monocytes: 22.3"	"Cell line enriched"	"Detected in some"	7	"HHSteC: 9.3"															NA	NA						"unprognostic (4.30e-2)"	"unprognostic (8.86e-2)"	"unprognostic (1.07e-1)"	"unprognostic (4.74e-2)"	"unprognostic (1.66e-1)"	"unprognostic (5.22e-2)"	"unprognostic (9.90e-2)"	"unprognostic (8.29e-3)"	"unprognostic (1.47e-1)"	"unprognostic (4.38e-3)"	"unprognostic (7.39e-3)"	"unprognostic (3.25e-1)"	"unprognostic (1.82e-9)"	"unprognostic (7.30e-2)"	"unprognostic (2.67e-3)"	"unprognostic (1.87e-1)"	"unprognostic (1.50e-1)"	0.6	0.3	0.3	11.8	1.0	0.0	0.3	0.2	0.8	0.2	13.3	0.2	0.0	8.2	0.2	0.2	0.3	0.5	0.1	0.4	2.9	0.3	0.4	1.2	2.7	10.5	0.4	0.2	0.2	0.3	0.0	0.9	0.5	2.0	0.4	11.3	0.2	0.3	0.0	0.8	0.2	31.0	1.4	2.1	12.3	0.4	0.3	0.3	0.3	0.3	0.3	0.1	0.9	0.3	0.0	1.0	7.8	22.3	0.0	0.1	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.2	0.0	0.9	0.0	0.6	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.0	9.3	0.0	0.0	0.3	1.2	0.0	0.4	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	1.0	0.0	0.0	10.5	0.1	0.0	0.0	0.0	1.0	0.0	0.0	0.0	7.8	0.0	22.3	0.3	0.0	0.6	0.3	1.0	0.2	0.8	2.9	0.3	0.4	0.2	2.0	0.3	3.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	1.0	0.7	0.0	12.9	0.0	0.2	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	2.7	0.7	0.0	2.4	0.0	0.0	5.2	0.0	0.2	10.5	0.0	0.0	0.0	0.0	0.0	0.5	0.7	0.0	0.0	0.0	4.9	0.0
CASP6	MCH2	ENSG00000138794	"Caspase 6"	P55212	4	109688622-109703583	"Cancer-related genes, Enzymes, Predicted intracellular proteins"	Apoptosis	"Hydrolase, Protease, Thiol protease"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"intestine: 42.8"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"Karpas-707: 39.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB003775, HPA011337, HPA024303"	Enhanced		Supported	Nucleoplasm,Cytosol		NA	NA			Cytosol	Nucleoplasm	"CAB003775: AB_562064, HPA011337: AB_1846053, HPA024303: AB_1846052"	"unprognostic (1.07e-1)"	"unprognostic (1.91e-1)"	"prognostic favorable (2.64e-5)"	"unprognostic (1.45e-2)"	"unprognostic (1.90e-1)"	"unprognostic (1.46e-1)"	"unprognostic (3.03e-3)"	"unprognostic (9.87e-2)"	"unprognostic (2.73e-2)"	"unprognostic (2.59e-3)"	"unprognostic (1.15e-2)"	"unprognostic (6.78e-2)"	"unprognostic (2.44e-1)"	"unprognostic (8.74e-3)"	"unprognostic (2.18e-1)"	"unprognostic (2.41e-1)"	"prognostic favorable (9.93e-4)"	8.1	6.1	3.6	6.7	4.3	5.3	14.3	2.8	3.8	6.9	25.5	2.8	4.5	23.4	5.9	4.3	8.7	5.3	11.7	4.9	4.0	2.0	11.0	14.3	5.6	8.5	5.0	1.6	7.0	13.0	2.3	6.4	4.3	4.5	8.1	19.5	3.4	8.0	10.3	3.4	6.5	42.8	14.0	6.6	9.1	9.2	2.7	4.3	14.5	11.2	3.3	8.4	8.2	12.7	4.4	8.0	8.5	7.0	5.6	21.3	8.0	12.6	4.1	8.5	7.7	6.2	6.1	12.6	7.1	4.9	6.4	6.9	6.8	26.1	1.3	8.3	7.3	8.9	5.9	10.1	11.2	5.1	20.1	6.6	11.1	3.7	6.0	5.0	11.1	7.9	6.7	8.4	6.1	1.5	8.6	12.1	15.1	14.4	39.6	10.3	7.1	28.7	7.0	6.5	8.7	7.5	10.0	5.4	6.9	21.0	12.0	9.0	6.7	7.5	13.6	4.2	10.7	5.8	4.1	10.2	7.1	7.5	3.4	8.0	5.8	10.5	1.4	9.2	13.4	3.6	8.5	5.3	6.3	4.9	4.8	5.3	4.1	17.8	9.3	6.0	4.4	21.3	11.8	1.1	5.6	7.0	8.0	16.4	8.0	3.6	4.3	2.8	3.8	4.0	2.0	5.0	1.6	4.5	4.3	14.9	13.4	8.5	9.5	9.6	5.2	3.3	30.6	25.4	20.5	19.2	5.9	16.7	8.3	35.9	2.0	9.2	52.0	0.0	40.5	34.0	12.1	6.6	9.3	17.8	17.1	0.0	56.7	6.2	8.6	1.6	11.8	8.5	1.7	25.2	48.2	12.8	42.5	56.1	9.2	26.3	1.3	6.5	6.9	1.7	8.3	10.2	4.8	12.8	64.3	7.8
CASP7	"CMH-1, ICE-LAP3, MCH3"	ENSG00000165806	"Caspase 7"	P55210	10	113679162-113730907	"Cancer-related genes, Enzymes, Predicted intracellular proteins"	Apoptosis	"Hydrolase, Protease, Thiol protease"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"intestine: 64.8"	"Cell type enhanced"	"Detected in many"	5	"Enterocytes: 95.7;monocytes: 108.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			CAB025563	Enhanced					NA	NA					"CAB025563: "	"prognostic favorable (2.11e-4)"	"unprognostic (3.18e-2)"	"unprognostic (2.82e-2)"	"unprognostic (2.18e-1)"	"unprognostic (2.85e-1)"	"unprognostic (1.33e-1)"	"unprognostic (2.63e-3)"	"unprognostic (3.96e-1)"	"unprognostic (2.04e-1)"	"unprognostic (1.22e-2)"	"unprognostic (1.07e-1)"	"unprognostic (2.35e-2)"	"prognostic unfavorable (5.90e-4)"	"unprognostic (5.45e-3)"	"unprognostic (2.62e-1)"	"unprognostic (2.86e-1)"	"unprognostic (4.33e-3)"	16.5	7.8	8.6	12.3	8.7	3.4	22.1	4.7	11.3	13.3	35.5	5.9	9.8	30.8	12.6	6.1	12.0	9.5	7.8	9.0	7.6	3.9	14.1	15.7	16.2	12.2	7.3	2.7	11.0	18.4	5.7	9.6	10.2	9.1	11.9	28.5	5.8	21.8	10.5	9.7	10.9	64.8	9.3	12.4	12.3	21.0	4.3	8.0	12.0	8.4	8.1	11.3	10.6	36.6	9.6	8.6	14.6	17.1	5.4	12.2	7.4	11.0	12.0	9.8	5.2	18.0	15.9	6.8	12.9	20.1	23.1	28.9	8.9	19.3	11.8	7.7	11.7	8.6	9.8	12.1	9.7	16.3	18.2	16.3	7.6	8.9	14.9	12.1	8.1	10.1	10.3	6.5	13.1	5.4	10.3	30.4	11.3	2.0	16.1	8.5	15.0	19.1	6.3	1.7	12.5	7.3	19.6	40.0	7.0	18.3	8.2	0.8	5.9	9.9	14.4	6.8	9.8	17.1	7.2	14.6	5.1	9.9	5.4	10.6	11.9	7.4	0.3	5.2	15.2	5.8	14.6	12.5	9.4	9.6	17.1	8.4	9.6	8.3	12.2	8.6	7.3	6.5	8.7	2.1	5.4	14.0	1.1	11.1	7.4	8.6	8.7	4.7	11.3	7.6	3.9	7.3	2.7	9.1	8.0	8.9	10.5	14.3	19.4	17.5	0.6	2.2	15.3	32.1	19.4	21.0	0.0	10.1	10.0	37.1	0.2	17.1	95.7	23.3	34.0	21.2	17.6	27.4	12.7	14.7	15.3	0.0	9.2	12.9	13.3	0.0	8.9	18.5	6.8	108.2	66.5	7.6	35.7	66.6	3.9	19.2	1.6	19.4	12.8	1.0	26.0	12.9	9.2	15.8	32.0	27.1
CASP8	"Casp-8, FLICE, MACH, MCH5"	ENSG00000064012	"Caspase 8"	Q14790	2	201233443-201287711	"Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Apoptosis, Host-virus interaction"	"Hydrolase, Protease, Thiol protease"	"Cancer-related genes, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 52.5"	"Cell type enhanced"	"Detected in many"	5	"T-cells: 55.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001302, CAB002047, HPA005688, HPA006191"	Approved		Supported	Nucleoplasm,Cytosol		No	No			Cytosol	Nucleoplasm	"CAB002047: AB_563465, HPA001302: AB_1846057, HPA005688: AB_1846056, HPA006191: AB_2667535"	"unprognostic (5.21e-3)"	"unprognostic (2.10e-1)"	"unprognostic (1.83e-2)"	"unprognostic (9.69e-3)"	"unprognostic (2.09e-1)"	"unprognostic (5.60e-2)"	"prognostic unfavorable (3.02e-4)"	"unprognostic (2.10e-1)"	"unprognostic (4.79e-2)"	"prognostic favorable (1.25e-4)"	"unprognostic (7.75e-2)"	"unprognostic (5.11e-2)"	"prognostic unfavorable (1.27e-6)"	"unprognostic (7.67e-3)"	"unprognostic (2.43e-1)"	"unprognostic (2.53e-1)"	"unprognostic (4.53e-3)"	14.1	10.6	2.0	31.6	2.6	27.1	10.2	1.4	1.8	7.9	18.5	3.9	7.0	9.6	9.6	12.0	11.7	9.1	12.1	4.4	2.1	2.3	16.4	14.8	17.1	28.3	3.9	1.1	8.2	7.6	1.8	5.9	12.3	3.2	9.8	8.7	4.4	9.6	8.4	2.7	7.4	34.7	5.1	5.0	37.7	7.4	3.8	2.7	43.7	6.7	10.7	43.4	9.6	7.3	13.8	13.7	52.5	17.0	22.2	26.4	12.0	14.5	12.4	3.6	10.1	10.1	14.8	5.6	6.4	6.3	7.6	12.6	16.6	25.4	1.6	14.1	4.9	13.7	7.4	7.9	7.6	15.1	9.4	7.2	14.2	10.1	15.8	8.2	11.0	15.4	12.8	18.8	14.4	11.3	6.4	7.2	12.3	12.7	31.6	6.9	6.0	14.3	11.6	5.9	8.0	11.1	10.8	7.5	25.9	14.3	16.2	1.1	0.5	8.3	13.8	8.2	3.5	3.6	8.6	9.0	8.2	8.6	4.3	5.0	28.7	12.8	9.9	12.3	14.8	7.7	20.7	13.0	24.9	25.0	17.0	23.1	13.8	20.5	26.4	13.7	7.8	13.3	16.9	52.5	22.2	15.6	6.1	24.0	12.0	2.0	2.6	1.4	1.8	2.1	2.3	3.9	1.1	3.2	2.7	23.8	26.1	34.1	10.1	6.6	1.5	1.6	7.6	16.0	18.2	5.2	9.8	7.5	13.3	9.0	5.6	7.1	19.8	0.0	7.3	10.3	3.8	8.1	23.2	10.4	11.2	0.0	4.1	5.5	25.6	0.7	2.3	21.7	6.8	19.8	13.0	0.1	9.6	12.7	0.7	20.0	0.4	0.0	1.4	0.7	0.4	6.8	2.9	55.4	12.1	12.7
CASP9	"APAF-3, ICE-LAP6, MCH6, PPP1R56"	ENSG00000132906	"Caspase 9"	P55211	1	15490832-15526534	"Cancer-related genes, Enzymes, Predicted intracellular proteins"	Apoptosis	"Hydrolase, Protease, Thiol protease"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Syncytiotrophoblasts: 29.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001473, CAB004348, HPA046488"	Approved		Approved	Mitochondria		NA	NA			Mitochondria		"CAB004348: AB_673489, HPA001473: AB_1078401, HPA046488: AB_2679670"	"prognostic favorable (5.91e-4)"	"unprognostic (2.42e-1)"	"unprognostic (8.94e-3)"	"unprognostic (7.84e-2)"	"unprognostic (1.93e-2)"	"unprognostic (8.54e-3)"	"unprognostic (1.90e-3)"	"unprognostic (6.75e-2)"	"unprognostic (2.58e-1)"	"unprognostic (1.29e-1)"	"unprognostic (9.09e-2)"	"unprognostic (1.98e-1)"	"unprognostic (1.39e-2)"	"unprognostic (2.35e-1)"	"unprognostic (3.21e-2)"	"unprognostic (5.48e-2)"	"prognostic favorable (1.67e-5)"	7.4	24.1	7.8	8.2	9.3	8.9	5.5	11.1	8.7	8.3	9.3	10.2	18.9	5.2	11.9	16.5	7.5	13.4	29.1	10.2	8.3	7.2	11.6	9.4	10.8	12.6	10.7	4.3	33.4	29.0	15.6	18.5	14.7	8.8	10.2	6.4	8.7	6.6	19.0	8.2	2.8	13.3	7.8	9.0	11.0	6.7	14.4	7.1	6.2	14.8	7.2	14.6	7.3	8.1	11.2	11.7	23.3	11.2	13.0	5.1	6.1	7.2	10.6	4.1	7.2	9.5	4.7	3.8	5.3	7.0	7.9	10.2	7.4	8.8	10.6	12.5	7.2	10.2	2.6	7.0	5.6	9.2	3.7	8.7	7.6	23.6	7.4	8.8	7.3	8.9	6.5	10.4	12.1	3.7	7.8	8.5	9.6	17.0	9.9	4.7	3.7	2.5	8.3	4.1	10.5	5.9	4.9	10.4	12.3	9.8	4.2	3.6	6.9	7.6	1.8	12.6	9.5	4.5	5.3	3.3	10.6	4.8	11.4	3.5	9.6	14.4	12.0	8.1	8.0	3.5	22.7	11.2	23.3	5.1	8.2	3.7	9.6	3.0	3.6	11.7	11.2	1.7	2.6	16.0	13.0	7.9	5.2	2.8	6.1	7.8	9.3	11.1	8.7	8.3	7.2	10.7	4.3	8.8	7.1	3.0	3.0	4.7	7.9	2.6	3.2	6.7	5.1	10.7	9.1	17.4	5.9	15.4	1.7	6.6	9.9	3.0	6.8	0.0	7.8	9.0	5.0	4.5	1.1	4.3	8.5	4.8	2.9	3.7	4.3	4.1	2.0	8.7	0.0	3.6	5.6	6.5	7.9	5.8	3.5	4.2	6.2	0.0	9.9	15.8	5.7	2.0	29.9	4.9	4.5	5.4
CAT		ENSG00000121691	Catalase	P04040	11	34438925-34472062	"Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"	"Hydrogen peroxide"	"Mitogen, Oxidoreductase, Peroxidase"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 258.3;liver: 184.8"	"Cell type enhanced"	"Detected in many"	5	"Erythroid cells: 350.4;Hepatocytes: 400.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in all"	13	"eosinophil: 258.3"	"Lineage enriched"	"Detected in all"	13	"granulocytes: 258.3"	"Cell line enhanced"	"Detected in many"		"HL-60: 76.4;THP-1: 63.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB001515, HPA051282, HPA055838"	Enhanced		Enhanced	Vesicles		NA	NA		960000000	Vesicles		"CAB001515: AB_384710, HPA051282: AB_2681419, HPA055838: AB_2682937"	"unprognostic (3.62e-2)"	"unprognostic (2.72e-1)"	"unprognostic (3.59e-3)"	"unprognostic (5.43e-2)"	"unprognostic (4.44e-2)"	"unprognostic (5.80e-3)"	"prognostic favorable (9.67e-4)"	"unprognostic (9.95e-3)"	"unprognostic (3.22e-1)"	"unprognostic (7.23e-2)"	"unprognostic (3.34e-2)"	"unprognostic (9.77e-2)"	"prognostic favorable (1.96e-8)"	"unprognostic (1.01e-1)"	"unprognostic (7.31e-2)"	"unprognostic (4.77e-2)"	"unprognostic (6.59e-3)"	70.0	33.0	9.4	10.1	9.6	54.2	36.1	3.1	7.7	15.3	26.6	18.6	15.7	22.2	13.5	9.5	14.8	14.2	19.0	22.4	10.7	5.2	50.4	184.8	26.1	21.3	14.5	6.0	11.0	24.7	7.1	5.0	16.4	10.2	23.2	11.3	11.4	14.5	13.2	27.8	19.7	29.2	11.6	11.3	17.9	15.9	6.2	11.6	23.4	41.7	14.9	11.5	20.4	24.9	7.6	19.9	258.3	17.5	5.5	5.0	17.8	6.2	6.9	5.1	8.0	49.2	21.4	10.8	8.0	10.1	8.9	9.8	3.9	6.3	15.4	7.7	15.7	13.2	14.9	8.5	8.6	9.9	13.5	7.8	13.0	7.4	22.2	5.8	76.4	6.5	11.5	6.0	2.7	1.1	12.6	10.8	9.4	26.9	6.4	11.2	5.9	15.6	13.6	0.0	29.4	16.8	11.1	24.2	12.6	24.5	23.7	2.6	4.1	8.9	14.4	11.8	0.0	20.7	63.8	7.6	5.4	5.2	13.4	4.7	5.2	2.9	3.3	10.6	52.6	3.9	12.5	17.5	258.3	3.2	14.7	3.8	7.6	3.8	3.6	19.9	6.8	3.8	4.0	17.1	5.5	15.5	13.4	5.0	17.8	9.4	9.6	3.1	7.7	10.7	5.2	14.5	6.0	10.2	11.6	211.4	229.6	40.9	69.6	25.6	11.8	38.0	73.9	89.7	77.3	69.8	25.5	60.5	190.6	26.7	2.1	31.6	91.9	350.4	23.0	26.6	50.3	53.0	22.1	400.0	121.0	0.0	46.1	49.7	114.9	3.8	72.5	85.2	25.3	295.8	48.0	21.2	16.4	52.6	72.9	233.4	17.7	77.6	65.1	4.1	9.6	23.7	33.9	35.5	72.9	69.8
CBL	"c-Cbl, CBL2, RNF55"	ENSG00000110395	"Cbl proto-oncogene"	P22681	11	119206276-119313926	"Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase	"Cancer-related genes, Disease mutation, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 40.9"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"neutrophil: 11.8"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004350, HPA027956"	Enhanced		Supported	Cytosol		NA	NA			Cytosol		"CAB004350: AB_2244054, HPA027956: AB_10601094"	"unprognostic (2.52e-1)"	"unprognostic (1.32e-3)"	"unprognostic (1.60e-1)"	"unprognostic (1.15e-1)"	"unprognostic (1.50e-2)"	"unprognostic (2.92e-1)"	"unprognostic (4.10e-3)"	"unprognostic (9.75e-2)"	"unprognostic (1.72e-1)"	"unprognostic (1.52e-1)"	"unprognostic (1.03e-2)"	"unprognostic (5.23e-2)"	"unprognostic (5.21e-2)"	"unprognostic (5.27e-2)"	"unprognostic (1.52e-1)"	"unprognostic (1.12e-1)"	"unprognostic (5.85e-2)"	9.9	5.5	9.1	17.0	11.1	11.1	8.8	10.7	12.0	6.2	7.5	8.7	3.0	5.7	9.9	5.3	7.5	7.4	6.3	5.9	8.0	9.6	5.5	4.0	10.3	16.3	8.1	6.9	6.3	5.6	16.6	4.1	9.1	9.3	5.3	7.5	6.4	5.4	7.1	3.9	7.4	8.6	10.6	8.9	13.3	7.3	32.3	5.1	40.9	6.0	5.5	15.6	7.6	7.7	1.8	3.3	11.8	3.7	0.6	1.9	1.0	6.3	4.8	16.9	10.6	5.1	6.0	10.0	6.9	7.2	6.7	6.6	10.3	7.9	15.1	6.2	8.7	13.8	9.3	11.6	5.9	14.7	8.6	2.7	15.5	3.7	3.1	6.2	18.0	17.7	5.3	6.5	17.0	18.4	7.1	16.5	14.8	12.5	6.3	12.0	6.9	9.6	10.1	8.8	5.7	5.4	10.4	8.5	2.8	5.9	5.1	2.3	7.1	12.8	5.6	4.6	12.1	5.8	15.2	13.7	10.4	7.4	7.2	9.0	2.1	3.1	12.3	4.2	15.6	7.4	0.8	3.2	2.4	1.3	3.7	1.1	1.8	1.6	1.3	3.3	1.8	1.8	1.9	11.8	0.6	3.1	1.8	1.4	1.0	9.1	11.1	10.7	12.0	8.0	9.6	8.1	6.9	9.3	5.1	8.9	8.8	18.8	4.9	16.0	12.4	5.9	7.6	1.4	4.5	10.4	43.2	5.2	1.7	5.8	22.7	17.8	6.3	0.0	5.8	8.0	8.0	6.2	3.5	2.6	15.0	12.7	8.1	19.0	52.9	32.8	7.2	29.9	15.1	5.4	4.3	17.5	8.7	8.6	12.0	3.1	33.8	25.8	17.6	38.1	26.2	19.2	5.8	20.0	4.5	9.5
CBLB	"Cbl-b, RNF56"	ENSG00000114423	"Cbl proto-oncogene B"	Q13191	3	105655461-105869552	"Cancer-related genes, Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"U-138 MG: 23.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA018327, HPA019880"	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			Cytosol	Nucleoplasm	"HPA018327: AB_1846097, HPA019880: AB_1846099"	"unprognostic (2.65e-1)"	"unprognostic (9.42e-2)"	"unprognostic (1.72e-2)"	"unprognostic (2.38e-1)"	"unprognostic (5.89e-3)"	"unprognostic (2.80e-2)"	"unprognostic (8.18e-2)"	"unprognostic (1.10e-1)"	"unprognostic (7.05e-2)"	"unprognostic (1.66e-1)"	"unprognostic (9.29e-2)"	"unprognostic (1.50e-2)"	"unprognostic (1.43e-2)"	"unprognostic (8.21e-2)"	"unprognostic (2.83e-1)"	"unprognostic (1.20e-2)"	"unprognostic (3.09e-2)"	38.4	9.0	3.7	19.5	4.9	15.5	16.3	24.4	3.8	13.7	18.7	5.9	7.7	9.3	13.8	12.2	8.3	12.5	13.4	27.5	3.8	4.8	7.4	6.7	16.3	19.1	4.4	1.9	17.7	6.8	3.4	13.5	25.4	7.9	12.9	8.0	11.6	9.1	6.3	10.3	8.5	13.8	25.6	5.7	16.4	12.4	9.2	5.2	11.6	13.5	7.0	18.0	24.9	24.1	5.1	3.1	2.8	2.1	10.3	9.9	1.6	1.6	2.3	7.7	3.8	8.9	9.0	5.0	5.8	2.9	1.7	2.7	2.9	2.0	3.6	4.0	3.0	2.7	2.9	1.0	1.0	2.1	2.8	2.9	2.0	12.0	1.9	13.1	1.4	1.5	8.6	3.1	4.5	12.3	6.4	5.6	3.7	2.1	11.7	3.6	2.1	2.0	0.9	2.7	2.0	3.3	4.2	2.3	0.6	4.1	7.4	6.0	6.5	6.8	0.8	8.9	5.6	1.7	2.9	3.1	23.9	2.0	3.2	1.4	6.6	0.6	5.7	6.4	1.2	1.5	0.7	1.5	2.8	9.9	0.9	8.8	2.2	5.1	5.6	1.3	5.1	4.4	8.0	1.0	10.3	2.1	3.1	5.6	1.6	3.7	4.9	24.4	3.8	3.8	4.8	4.4	1.9	7.9	5.2	14.9	6.7	21.6	6.8	9.6	44.8	39.9	0.0	10.7	6.8	12.2	25.5	8.9	5.0	6.0	27.4	22.6	8.7	0.0	6.9	53.5	21.6	9.6	8.1	6.7	12.2	3.2	12.1	39.3	11.3	9.0	6.9	10.4	15.1	5.4	16.2	7.4	11.7	7.0	10.3	3.1	27.4	6.5	19.9	9.8	15.8	6.0	38.0	52.3	10.7	3.0
CBLC	"CBL-3, CBL-SL, RNF57"	ENSG00000142273	"Cbl proto-oncogene C"	Q9ULV8	19	44777869-44800634	"Cancer-related genes, Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 66.8"	"Cell type enhanced"	"Detected in many"	8	"Enterocytes: 105.9;Pancreatic endocrine cells: 67.6;Paneth cells: 84.2;Undifferentiated cells: 54.6;Urothelial cells: 56.4"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A-431: 19.0;BEWO: 13.1;CACO-2: 12.9;CAPAN-2: 26.3;HaCaT: 18.4;HBEC3-KT: 16.0;hTCEpi: 12.3;OE19: 16.9;RT4: 16.0;SK-BR-3: 14.6;T-47d: 10.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"CAB008087, HPA035266"	Approved		Approved	Nucleoplasm,Aggresome		NA	NA			Nucleoplasm	Aggresome	"CAB008087: AB_2228531, HPA035266: AB_2674542"	"unprognostic (1.58e-1)"	"unprognostic (2.25e-1)"	"unprognostic (8.21e-3)"	"unprognostic (1.55e-1)"	"unprognostic (3.04e-2)"	"unprognostic (3.91e-2)"	"unprognostic (1.67e-1)"	"unprognostic (2.13e-2)"	"unprognostic (3.82e-1)"	"unprognostic (7.39e-2)"	"unprognostic (1.06e-2)"	"unprognostic (1.85e-1)"	"prognostic favorable (3.11e-6)"	"unprognostic (3.50e-1)"	"unprognostic (8.25e-3)"	"unprognostic (2.90e-2)"	"unprognostic (2.21e-3)"	0.1	0.0	0.5	8.5	0.2	0.0	4.8	0.1	0.4	4.4	39.5	0.1	3.2	29.5	1.7	1.7	22.0	1.4	18.8	0.1	0.6	0.0	4.9	15.1	1.3	0.1	0.1	0.3	0.8	18.1	0.9	0.7	4.1	0.2	6.9	6.9	0.5	11.4	5.2	0.1	20.8	66.8	0.4	0.1	0.1	10.2	1.6	0.1	0.5	1.9	13.2	15.7	7.6	8.9	0.0	0.0	0.0	0.0	0.0	0.8	0.0	19.0	0.0	0.0	0.0	0.0	0.0	13.1	0.0	0.0	0.0	0.0	12.9	26.3	0.0	0.0	0.0	0.0	18.4	0.0	16.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	12.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	16.9	0.0	0.0	0.0	0.0	0.0	16.0	0.1	0.0	0.0	14.6	0.0	0.1	10.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.2	0.1	0.4	0.6	0.0	0.1	0.3	0.2	0.1	0.0	1.6	0.0	28.6	13.4	0.0	0.2	5.1	5.3	11.4	7.0	0.0	4.6	1.7	37.5	0.0	0.1	105.9	0.0	42.7	1.3	0.4	14.4	0.0	8.5	0.3	0.0	16.7	0.0	0.0	0.0	0.0	0.9	0.0	1.0	35.8	0.0	67.6	84.2	0.0	9.9	0.0	0.0	0.4	0.0	1.7	22.5	2.1	0.7	54.6	56.4
CBLL1	"FLJ23109, HAKAI, RNF188"	ENSG00000105879	"Cbl proto-oncogene like 1"	Q75N03	7	107743697-107761667	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	"Developmental protein, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021773, HPA026699"	Enhanced		Supported	"Nuclear speckles"		NA	NA			"Nuclear speckles"		"HPA021773: AB_1846103, HPA026699: AB_1846104"	"unprognostic (1.90e-2)"	"unprognostic (2.25e-1)"	"unprognostic (8.57e-2)"	"unprognostic (3.79e-2)"	"unprognostic (8.16e-2)"	"unprognostic (7.20e-2)"	"unprognostic (1.37e-2)"	"unprognostic (3.96e-3)"	"unprognostic (4.28e-2)"	"unprognostic (2.16e-3)"	"unprognostic (1.29e-1)"	"unprognostic (1.31e-1)"	"unprognostic (2.12e-3)"	"unprognostic (9.12e-2)"	"unprognostic (2.07e-1)"	"unprognostic (1.09e-1)"	"unprognostic (8.71e-2)"	15.8	12.0	11.7	13.6	20.0	38.8	16.8	18.7	19.4	15.3	17.2	19.2	11.6	10.8	22.9	9.7	14.4	14.2	10.2	11.5	11.9	10.7	11.6	12.5	12.9	16.5	12.6	14.3	18.2	15.5	14.5	17.2	13.5	16.5	18.7	13.0	14.7	12.8	19.6	32.6	16.6	14.4	16.2	15.1	15.8	14.7	21.1	13.3	29.0	15.8	11.8	19.3	17.6	12.7	17.9	16.7	32.2	15.7	23.4	40.3	20.1	13.7	15.7	12.2	15.5	11.2	9.8	8.3	10.4	10.8	11.6	11.6	10.6	14.0	19.9	15.0	11.6	19.7	9.8	16.8	12.5	16.0	14.2	10.6	16.2	11.6	8.9	13.0	23.9	15.9	10.1	11.7	15.7	17.2	8.8	12.0	14.1	25.5	17.0	11.1	23.5	32.6	16.2	17.5	11.6	10.7	15.2	13.2	20.6	8.8	12.7	13.0	20.3	15.5	22.7	11.3	14.9	7.7	12.2	11.7	18.2	13.1	17.2	15.8	27.6	30.0	32.3	11.2	14.9	15.3	32.2	14.2	23.3	19.0	14.7	28.0	17.9	30.1	21.8	16.7	17.4	20.9	19.6	21.9	23.4	15.7	9.0	40.3	20.1	11.7	20.0	18.7	19.4	11.9	10.7	12.6	14.3	16.5	13.3	17.9	8.3	18.6	13.2	20.9	11.5	14.9	7.6	5.3	10.3	3.5	3.9	9.0	6.6	8.7	7.0	12.0	7.7	0.0	9.4	7.7	8.2	13.2	12.7	9.4	9.1	9.5	16.1	12.9	21.5	3.6	8.6	10.8	18.6	7.2	7.2	6.8	9.1	14.4	11.0	9.2	13.7	19.4	9.9	22.4	13.0	17.3	8.6	19.8	8.4	16.3
CBLL2	"CT138, FLJ25735, HAKAIL, ZNF645"	ENSG00000175809	"Cbl proto-oncogene like 2"	Q8N7E2	X	22272943-22274461	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in single"	52	"testis: 13.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"																	NA	NA																							0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.5			0.0		0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
CBR1	"CBR, SDR21C1"	ENSG00000159228	"Carbonyl reductase 1"	P16152	21	36069941-36073166	"Enzymes, Plasma proteins, Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"intestine: 176.1"	"Cell type enhanced"	"Detected in all"	8	"Distal tubular cells: 641.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"											"HPA018433, CAB034291"	Enhanced		Approved	Nucleoplasm,Cytosol		NA	NA		12000000	Nucleoplasm	Cytosol	"CAB034291: AB_2070856, HPA018433: AB_1846109"	"prognostic favorable (2.18e-4)"	"unprognostic (9.78e-2)"	"unprognostic (3.25e-2)"	"unprognostic (2.14e-1)"	"unprognostic (6.47e-3)"	"unprognostic (1.69e-1)"	"unprognostic (1.19e-1)"	"unprognostic (6.37e-2)"	"unprognostic (4.56e-2)"	"unprognostic (1.28e-1)"	"unprognostic (7.20e-2)"	"unprognostic (4.00e-1)"	"prognostic favorable (4.75e-4)"	"unprognostic (2.37e-1)"	"unprognostic (2.47e-1)"	"unprognostic (6.13e-3)"	"unprognostic (2.47e-2)"	9.6	22.9	31.7	8.4	41.6	3.7	8.5	12.0	35.8	14.6	63.4	75.9	6.5	176.1	9.3	17.1	40.2	9.6	15.1	7.8	37.7	24.7	35.2	77.2	11.7	8.5	57.3	25.2	10.4	8.0	8.9	7.9	11.7	51.6	16.7	16.8	10.4	23.1	15.0	8.7	34.4	118.1	11.6	48.1	10.0	41.4	5.7	41.9	3.6	11.3	29.8	14.3	12.4	17.1	17.0	29.9	17.1	51.4	19.1	29.2	37.0	25.3	39.1	4.8	12.3	25.1	25.4	0.2	28.5	20.5	15.6	18.7	14.4	14.9	6.4	18.8	26.5	30.1	18.7	9.8	27.9	12.0	31.5	23.1	19.1	22.8	9.8	14.4	10.6	17.6	12.4	35.2	15.1	6.6	17.9	16.6	0.0	0.0	4.7	14.3	25.1	5.3	11.1	0.0	0.0	28.6	0.0	0.1	17.7	41.4	12.7	14.0	12.5	27.5	40.0	32.4	3.9	18.9	14.8	16.7	17.5	7.4	44.3	20.6	32.0	57.9	0.1	32.1	10.6	25.3	1.8	36.6	17.1	18.1	51.4	15.3	17.0	22.7	16.9	29.9	15.6	29.2	21.4	2.5	19.1	38.6	10.4	22.7	37.0	31.7	41.6	12.0	35.8	37.7	24.7	57.3	25.2	51.6	41.9	113.2	54.7	13.0	59.4	113.9	11.9	19.9	81.5	111.1	96.7	90.7	2.0	102.1	641.6	73.2	5.9	17.8	131.2	46.7	60.9	77.8	54.3	48.6	34.6	203.8	78.0	3.2	37.1	54.6	65.5	2.9	113.6	47.2	86.0	102.8	58.6	65.5	81.3	71.8	124.5	200.8	7.4	25.8	60.8	4.2	11.3	108.0	74.6	30.9	77.6	42.0
CBR3	SDR21C2	ENSG00000159231	"Carbonyl reductase 3"	O75828	21	36134912-36146566	"Enzymes, Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"tongue: 68.2"	"Group enriched"	"Detected in many"	4	"Basal glandular cells: 23.4;Basal keratinocytes: 63.1;Glandular cells: 36.1;Leydig cells: 62.7;Melanocytes: 62.4;monocytes: 36.1;Peritubular cells: 71.1;Smooth muscle cells: 20.3;Suprabasal keratinocytes: 40.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	10	"B-cells: 11.9;NK-cells: 4.9;T-cells: 17.9"	"Low cell line specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"basal ganglia: 43.6"	"Low region specificity"	"Detected in all"			HPA018434	Uncertain		Approved	Nucleoplasm,Cytosol		Yes	NA			"Nucleoplasm, Cytosol"		"HPA018434: AB_1846110"	"unprognostic (3.64e-3)"	"unprognostic (2.32e-2)"	"unprognostic (1.48e-1)"	"unprognostic (1.46e-1)"	"unprognostic (2.16e-1)"	"unprognostic (1.18e-3)"	"unprognostic (1.22e-1)"	"unprognostic (2.22e-2)"	"unprognostic (6.12e-2)"	"unprognostic (2.98e-2)"	"unprognostic (3.75e-1)"	"unprognostic (9.10e-2)"	"prognostic unfavorable (5.95e-6)"	"unprognostic (3.13e-1)"	"unprognostic (1.80e-1)"	"unprognostic (3.99e-3)"	"unprognostic (1.94e-1)"	9.2	1.5	5.4	3.0	13.9	0.9	12.2	3.1	4.7	8.6	3.8	1.4	4.1	2.4	5.5	8.8	27.6	4.1	4.9	4.9	3.6	2.9	1.6	0.4	3.5	3.4	3.8	6.1	9.3	1.2	0.3	1.2	2.2	2.5	7.2	2.9	3.3	21.8	4.2	2.4	16.3	2.6	10.5	2.3	1.5	2.7	4.3	2.7	0.9	2.3	68.2	14.1	7.1	8.0	11.9	1.2	0.4	0.5	4.9	17.9	6.2	12.2	3.5	1.5	3.1	12.0	18.6	2.4	13.4	15.9	15.4	12.3	0.1	2.6	0.0	3.9	13.7	5.4	5.7	2.0	2.7	6.2	16.7	6.4	0.5	3.7	0.1	1.0	0.0	0.0	2.6	0.3	10.7	1.4	7.4	9.3	1.4	0.0	0.1	4.5	9.2	1.1	5.4	1.2	3.8	15.5	2.6	2.9	23.9	5.1	5.2	0.8	1.1	10.2	12.5	19.5	0.8	3.7	1.4	6.4	10.0	0.8	11.2	12.9	0.6	0.2	0.0	10.4	0.3	17.9	0.0	0.3	0.0	1.2	0.2	1.5	11.9	13.0	4.0	1.2	10.6	17.9	12.3	0.4	4.9	0.5	0.3	5.1	6.2	5.4	13.9	3.1	4.7	3.6	2.9	3.8	6.1	2.5	2.7	0.0	2.7	0.0	23.4	63.1	0.2	0.2	5.1	5.3	11.4	0.0	0.0	0.9	8.3	3.3	0.5	11.3	1.1	0.0	0.6	0.2	7.7	36.1	5.7	0.0	7.4	0.0	0.0	8.6	3.7	1.1	62.7	5.6	62.4	36.1	8.9	1.4	2.1	1.1	71.1	0.0	0.4	0.0	20.3	0.4	0.2	40.8	0.2	1.3	2.9	11.5
CBS	HIP4	ENSG00000160200	Cystathionine-beta-synthase	P35520	21	43053191-43076943	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Amino-acid biosynthesis, Cysteine biosynthesis"	"Allosteric enzyme, Lyase"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"liver: 55.7;pancreas: 43.0"	"Cell type enhanced"	"Detected in some"	13	"Cardiomyocytes: 3.5;Hepatocytes: 2.6;Melanocytes: 5.0;Smooth muscle cells: 2.3"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	84	"neutrophil: 8.3"	"Lineage enriched"	"Detected in single"	84	"granulocytes: 8.3"	"Cell line enhanced"	"Detected in many"		"BEWO: 40.8;HAP1: 38.9;HHSteC: 52.7;MCF7: 45.1;RPMI-8226: 43.1"									HPA001223	Supported		Approved	Nucleoli,Vesicles		NA	NA			Vesicles	Nucleoli	"HPA001223: AB_1846112"	"unprognostic (4.86e-2)"	"unprognostic (1.48e-2)"	"unprognostic (6.81e-2)"	"unprognostic (1.12e-3)"	"unprognostic (1.32e-1)"	"unprognostic (1.12e-1)"	"unprognostic (9.68e-4)"	"unprognostic (3.62e-1)"	"unprognostic (6.76e-3)"	"unprognostic (1.06e-1)"	"unprognostic (6.50e-2)"	"unprognostic (2.13e-1)"	"unprognostic (1.61e-2)"	"unprognostic (6.73e-3)"	"unprognostic (2.62e-1)"	"unprognostic (1.92e-2)"	"unprognostic (1.02e-1)"	1.3	1.5	6.5	2.4	5.1	0.4	1.0	12.3	6.7	4.8	1.3	2.0	0.8	1.6	0.9	0.8	0.8	2.0	2.1	2.0	5.6	5.5	1.3	55.7	1.7	1.4	4.8	2.8	13.9	43.0	0.3	1.4	1.4	2.3	4.0	0.7	2.8	9.3	3.4	0.8	0.6	2.9	1.4	3.7	0.8	2.7	2.2	3.3	0.8	5.0	0.8	0.9	2.6	0.8	0.0	0.0	8.3	0.0	0.0	0.0	0.0	6.4	3.9	5.1	20.0	11.5	7.4	40.8	8.0	2.0	3.3	3.4	12.0	0.3	0.0	4.3	15.0	0.0	0.4	38.9	2.8	0.6	0.0	4.9	2.7	15.6	14.4	52.7	1.6	3.8	4.5	0.4	3.6	3.2	3.0	8.8	18.9	30.1	22.7	2.5	45.1	2.8	0.0	4.8	14.6	6.8	0.0	0.0	43.1	0.1	3.6	10.6	15.6	17.4	1.0	7.5	4.3	6.2	20.4	1.2	0.2	10.0	0.1	0.8	7.9	6.3	9.0	3.7	2.4	12.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.3	0.0	0.0	0.0	0.0	0.0	6.5	5.1	12.3	5.2	5.6	5.5	4.8	2.8	2.3	3.3	0.0	0.3	0.0	0.0	0.3	0.1	3.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.4	0.4	0.2	0.0	2.6	0.2	0.0	0.0	0.0	0.0	0.0	0.9	0.0	5.0	0.0	0.0	0.3	0.5	0.2	0.0	0.0	0.0	0.0	2.3	0.0	0.6	0.9	0.1	0.0	0.0	0.0
CBSL		ENSG00000274276	"Cystathionine-beta-synthase like"	P0DN79	21	6444869-6468040	"Enzymes, Predicted intracellular proteins"	"Amino-acid biosynthesis, Cysteine biosynthesis"	Lyase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 11.5;liver: 21.2;pancreas: 18.5"	"Not detected"	"Not detected"			"Low cancer specificity"	"Detected in some"							"Cell type enriched"	"Detected in single"	47	"neutrophil: 4.6"	"Lineage enriched"	"Detected in single"	47	"granulocytes: 4.6"	"Cell line enhanced"	"Detected in many"		"AN3-CA: 36.5;NTERA-2: 67.6;SH-SY5Y: 21.6;U-266/70: 21.3"									HPA001223	Supported		Approved	Nucleoli,Vesicles		NA	NA		190000	Vesicles	Nucleoli	"HPA001223: AB_1846112"	"unprognostic (2.39e-1)"	"unprognostic (1.54e-2)"	"unprognostic (1.15e-1)"	"unprognostic (4.78e-3)"	"unprognostic (6.49e-2)"	"unprognostic (1.42e-2)"	"unprognostic (1.28e-2)"	"unprognostic (6.62e-3)"	"unprognostic (1.17e-1)"	"unprognostic (3.62e-2)"	"unprognostic (7.50e-2)"	"unprognostic (1.10e-1)"	"unprognostic (2.04e-1)"	"unprognostic (3.17e-3)"	"unprognostic (8.44e-2)"	"unprognostic (2.46e-1)"	"unprognostic (3.61e-1)"	0.0	0.0		0.0		0.0	0.0		11.5	1.8	0.0			0.4	0.0	0.0	0.0	0.3	0.0	1.0			0.0	21.2	0.0	0.0			1.6	18.5	0.0		0.0		1.8	0.0		0.0	3.5	0.0	0.0	0.8	0.0		0.0	0.0	0.0			5.0		0.0	0.3		0.0	0.0	4.6	0.0	0.0	0.0	0.0	0.0	0.0	12.2	36.5	0.0	0.0	0.4	7.6	4.4	2.8	8.5	0.1	4.9	0.0	0.0	0.0	4.7	3.2	0.0	3.9	1.7	0.0	9.6	0.0	0.0	0.0	0.2	0.0	5.2	4.2	14.2	0.0	7.1	0.0	0.0	0.8	0.2	16.9	0.1	0.0	5.7	0.6	67.6	0.0	0.0	0.0	0.0	0.0	11.0	0.0	14.1	21.6	0.0	1.1	14.7	0.0	0.0	0.0	0.0	0.7	0.0	4.7	1.5	21.3	7.8	0.0	4.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.6	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
CCNB1IP1	"C14orf18, HEI10"	ENSG00000100814	"Cyclin B1 interacting protein 1"	Q9NPC3	14	20311368-20333312	"Cancer-related genes, Enzymes, Predicted intracellular proteins"	"Meiosis, Ubl conjugation pathway"	Transferase	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"hTERT-HME1: 88.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"									NA	NA						"unprognostic (4.79e-2)"	"unprognostic (1.35e-1)"	"unprognostic (1.29e-1)"	"unprognostic (9.37e-2)"	"unprognostic (5.46e-3)"	"unprognostic (2.79e-2)"	"unprognostic (8.43e-2)"	"unprognostic (5.88e-2)"	"unprognostic (1.56e-1)"	"unprognostic (1.88e-2)"	"unprognostic (4.87e-2)"	"unprognostic (4.77e-2)"	"prognostic favorable (5.18e-6)"	"unprognostic (2.12e-1)"	"unprognostic (1.54e-2)"	"unprognostic (4.43e-1)"	"unprognostic (1.52e-1)"	12.6	9.7	10.9	9.8	13.7	14.2	27.2	14.5	16.4	20.3	13.4	13.2	17.2	9.9	20.4	24.2	17.4	18.8	12.4	33.8	11.1	11.2	31.2	34.4	15.4	11.2	13.4	11.1	49.1	20.6	14.5	12.1	14.4	15.9	18.0	14.5	15.8	14.0	12.3	20.6	14.6	10.0	27.6	15.8	11.3	13.0	9.7	13.9	11.2	35.8	15.3	16.1	33.6	17.7	9.3	13.7	3.5	3.1	4.4	10.7	3.0	6.7	5.5	31.5	30.2	16.1	22.2	25.4	8.2	16.6	12.7	16.9	18.7	7.5	23.4	5.5	6.0	12.9	12.1	21.8	15.6	17.3	6.7	18.5	13.8	5.2	17.6	47.5	25.4	13.0	30.2	26.4	9.1	88.5	15.5	9.6	28.4	16.8	18.6	8.3	10.7	14.7	17.3	18.9	14.7	10.6	18.2	15.6	9.8	13.3	9.9	25.1	26.1	5.7	13.3	37.0	18.2	4.2	18.7	4.0	7.3	9.3	8.7	10.7	8.7	10.9	16.0	2.4	21.5	8.3	3.5	3.1	0.0	6.7	1.1	9.1	9.3	7.4	8.3	13.7	8.4	7.7	10.7	0.5	4.4	1.1	13.7	9.9	3.0	10.9	13.7	14.5	16.4	11.1	11.2	13.4	11.1	15.9	13.9	26.8	25.6	34.4	63.5	51.6	3.2	25.0	56.0	4.0	18.2	22.7	19.6	34.7	87.9	23.7	47.1	18.0	13.1	0.0	33.0	56.8	32.0	34.6	34.6	30.1	15.8	1.6	39.6	16.5	17.5	58.8	47.8	23.1	49.0	8.2	37.0	24.9	27.7	14.0	41.4	71.2	15.5	45.3	24.0	49.1	59.6	35.0	28.5	27.7	41.7	43.6
CD38		ENSG00000004468	"CD38 molecule"	P28907	4	15778275-15853230	"Cancer-related genes, CD markers, Enzymes, Predicted intracellular proteins"		"Hydrolase, Receptor, Transferase"	"Cancer-related genes, Diabetes mellitus"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"lymphoid tissue: 94.9;seminal vesicle: 104.1"	"Cell type enhanced"	"Detected in many"	8	"Ciliated cells: 49.5;Erythroid cells: 46.7;granulocytes: 39.1;Kupffer cells: 31.1;T-cells: 30.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"NK-cell: 15.3"	"Group enriched"	"Detected in all"	4	"B-cells: 9.0;dendritic cells: 5.1;NK-cells: 15.3"	"Cell line enhanced"	"Detected in some"		"Daudi: 50.8;Karpas-707: 14.2;MOLT-4: 12.8;REH: 10.3;U-266/70: 11.0;U-698: 9.6"	"Low region specificity"	"Detected in all"							"CAB002493, HPA022132, CAB025255, HPA052381"	Enhanced		Supported	"Plasma membrane"		NA	NA			"Plasma membrane"		"CAB002493: AB_563556, CAB025255: , HPA022132: AB_1846300, HPA052381: AB_2681807"	"unprognostic (1.27e-2)"	"unprognostic (8.06e-3)"	"unprognostic (1.06e-2)"	"prognostic favorable (9.68e-4)"	"unprognostic (1.13e-1)"	"unprognostic (1.82e-3)"	"unprognostic (2.74e-1)"	"unprognostic (8.51e-2)"	"unprognostic (5.87e-2)"	"unprognostic (6.15e-6)"	"unprognostic (5.23e-1)"	"unprognostic (4.34e-1)"	"unprognostic (6.63e-6)"	"unprognostic (1.79e-1)"	"unprognostic (5.74e-2)"	"unprognostic (2.12e-2)"	"unprognostic (2.13e-1)"	4.1	3.3	3.8	17.6	8.5	9.3	2.6	0.7	12.0	1.0	3.2	10.4	14.6	4.3	0.7	0.9	2.3	2.4	1.5	5.0	4.0	4.2	1.2	5.4	4.7	16.1	4.9	3.1	0.6	0.7	0.0	2.5	0.6	3.1	10.8	2.7	4.4	2.8	104.1	14.2	0.5	6.2	0.9	1.8	20.6	2.0	0.7	2.5	94.9	2.8	2.0	13.2	7.6	0.9	9.0	5.1	1.3	2.2	15.3	2.3	3.7	0.0	4.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	50.8	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.0	0.1	14.2	0.0	0.0	12.8	3.1	0.0	0.0	0.0	10.3	0.0	8.0	0.0	0.0	0.0	0.6	0.0	0.0	0.2	0.1	0.0	2.2	0.2	0.0	0.0	0.0	0.0	11.0	0.1	9.6	0.1	2.4	0.1	0.0	1.7	0.0	1.1	2.2	0.3	9.0	1.4	1.2	4.1	6.6	2.3	1.8	1.3	15.3	1.4	5.1	2.1	3.7	3.8	8.5	0.7	6.2	4.0	4.2	4.9	3.1	3.1	2.5	3.0	10.8	23.4	0.4	0.0	0.0	0.8	0.0	49.5	18.2	0.0	9.8	0.2	0.0	0.0	1.6	0.1	0.0	46.7	0.0	0.0	0.5	10.7	39.1	1.3	4.6	0.0	0.0	3.1	31.1	0.0	0.0	10.0	6.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.9	0.0	2.2	1.4	0.0	0.5	30.5	0.7	0.1
CDA	CDD	ENSG00000158825	"Cytidine deaminase"	P32320	1	20588948-20618908	"Enzymes, Plasma proteins, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 126.5;bone marrow: 68.0"	"Cell type enhanced"	"Detected in many"	11	"Enterocytes: 120.2;Hepatocytes: 94.4;Kupffer cells: 118.1;Pancreatic endocrine cells: 70.1;Paneth cells: 48.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"neutrophil: 126.5"	"Lineage enriched"	"Detected in many"	6	"granulocytes: 126.5"	"Cell line enhanced"	"Detected in many"		"A-431: 42.9;CAPAN-2: 28.6;HeLa: 40.6;PC-3: 20.4;SiHa: 51.0;U-937: 18.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			HPA064202	Enhanced		Approved	Nucleoplasm		NA	NA		3700000	Nucleoplasm		"HPA064202: AB_2685211"	"unprognostic (2.38e-1)"	"prognostic unfavorable (5.05e-4)"	"unprognostic (2.86e-1)"	"unprognostic (2.56e-1)"	"unprognostic (8.02e-2)"	"unprognostic (3.84e-3)"	"unprognostic (1.47e-1)"	"unprognostic (1.68e-3)"	"unprognostic (2.64e-1)"	"unprognostic (4.01e-2)"	"prognostic unfavorable (8.56e-5)"	"unprognostic (2.94e-2)"	"unprognostic (5.03e-2)"	"unprognostic (8.47e-3)"	"unprognostic (2.81e-1)"	"unprognostic (3.38e-1)"	"unprognostic (1.89e-3)"	4.0	1.4	1.5	4.0	1.5	68.0	2.2	1.1	2.4	19.0	8.6	1.7	2.0	2.6	6.7	3.5	38.3	2.9	1.8	5.9	1.7	1.6	12.5	42.1	8.4	9.1	2.0	1.3	2.9	0.8	1.2	0.7	30.8	3.5	4.2	10.2	4.5	6.9	1.5	3.2	7.0	24.7	4.3	1.9	11.8	1.2	2.9	0.9	0.9	3.0	23.3	10.5	3.1	16.5	0.0	1.3	126.5	21.7	0.0	0.1	7.1	42.9	4.2	0.0	0.0	0.0	1.3	0.0	3.3	0.9	0.8	3.4	0.2	28.6	0.0	1.6	6.8	1.8	15.1	0.8	11.2	2.2	0.0	0.8	0.0	40.6	5.4	0.3	0.0	0.0	1.9	1.8	8.1	0.0	0.1	0.6	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	5.0	20.4	0.0	0.0	0.4	0.1	0.0	0.0	0.0	51.0	0.0	0.0	0.5	0.0	1.2	0.7	0.0	1.7	3.9	0.2	0.0	0.0	0.0	0.5	18.0	0.0	16.3	21.7	43.3	0.0	11.4	0.1	0.0	0.0	0.0	1.3	0.0	0.0	0.0	126.5	0.0	9.3	0.2	0.0	7.1	1.5	1.5	1.1	2.4	1.7	1.6	2.0	1.3	3.5	0.9	3.0	1.4	0.9	0.2	1.3	0.1	2.8	2.5	0.0	0.0	5.2	0.0	0.2	36.5	2.4	0.6	4.4	120.2	0.0	1.3	2.7	1.0	0.9	0.0	94.4	6.1	0.0	0.0	28.8	118.1	0.8	0.3	3.7	0.0	0.0	12.5	0.0	70.1	48.7	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.0	2.1	1.5	4.9	0.3
CDC14A	"cdc14, Cdc14A1, Cdc14A2, DFNB105"	ENSG00000079335	"Cell division cycle 14A"	Q9UNH5	1	100345001-100520278	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Cell cycle, Cell division, Hearing"	"Hydrolase, Protein phosphatase"	"Deafness, Disease mutation, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 38.2"	"Group enriched"	"Detected in many"	6	"Early spermatids: 165.7;Late spermatids: 161.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"K-562: 30.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA023783	Approved		Supported	"Nucleoplasm,Nuclear bodies,Cytosol"		NA	NA			Nucleoplasm	"Nuclear bodies, Cytosol"	"HPA023783: AB_1846352"	"unprognostic (3.72e-2)"	"unprognostic (2.38e-2)"	"unprognostic (1.84e-2)"	"unprognostic (2.98e-2)"	"unprognostic (1.54e-3)"	"unprognostic (1.38e-1)"	"unprognostic (9.27e-4)"	"unprognostic (4.88e-3)"	"unprognostic (6.30e-2)"	"unprognostic (3.97e-3)"	"unprognostic (8.83e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.79e-3)"	"unprognostic (6.29e-2)"	"unprognostic (2.04e-1)"	"unprognostic (1.49e-2)"	"unprognostic (6.66e-2)"	6.2	2.4	5.8	6.5	5.5	13.7	12.2	1.8	6.2	7.7	11.8	4.8	2.2	7.2	15.1	4.8	3.4	13.7	3.6	4.1	8.8	3.5	6.6	2.4	12.3	15.4	3.8	5.4	5.8	6.7	9.8	8.1	7.6	4.6	10.0	6.3	8.3	7.7	3.9	4.3	5.6	22.6	5.0	3.2	9.6	6.0	38.2	4.7	12.0	6.1	3.4	11.3	5.8	8.4	4.8	6.1	11.6	3.7	3.9	13.0	4.1	2.2	1.8	5.9	6.7	2.2	1.6	4.1	2.9	1.9	2.9	2.3	6.2	1.9	1.1	2.1	1.7	2.3	1.7	4.0	1.6	2.9	2.3	9.9	4.0	1.7	2.0	0.8	5.4	7.1	1.3	0.4	3.1	1.0	1.4	5.1	2.4	30.6	3.5	4.2	1.0	4.3	6.0	3.6	1.4	2.3	4.7	7.6	1.1	2.0	5.1	1.1	1.9	3.0	2.9	4.0	3.0	1.3	7.0	2.2	1.6	3.6	2.7	1.7	1.7	0.6	1.7	1.9	5.0	0.9	11.6	3.7	8.4	7.3	3.3	13.0	4.8	11.3	8.4	3.5	3.1	11.0	5.8	5.5	3.9	2.3	6.1	5.6	4.1	5.8	5.5	1.8	6.2	8.8	3.5	3.8	5.4	4.6	4.7	3.0	5.6	2.2	4.2	3.3	0.2	5.3	0.0	28.1	5.7	1.8	3.9	1.7	0.0	2.7	165.7	9.3	12.8	0.0	1.7	0.8	4.7	6.6	14.0	1.5	2.3	0.0	4.6	6.2	4.6	161.3	4.6	4.3	5.0	5.4	4.7	9.1	2.5	8.7	0.7	1.7	3.6	0.0	2.8	1.9	3.0	2.0	1.8	10.2	2.7	2.3
CDC14B	"Cdc14B1, Cdc14B2, CDC14B3, hCDC14B"	ENSG00000081377	"Cell division cycle 14B"	O60729	9	96490241-96619830	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"DNA damage, DNA repair"	"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"basophil: 9.9"	"Lineage enhanced"	"Detected in many"		"granulocytes: 9.9"	"Cell line enhanced"	"Detected in many"		"ASC diff: 15.2;ASC TERT1: 22.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA013312, HPA064747"	Approved		Supported	Nucleoplasm		NA	NA			Nucleoplasm		"HPA013312: AB_1846354, HPA064747: AB_2732719"	"unprognostic (5.69e-2)"	"unprognostic (9.09e-2)"	"unprognostic (3.50e-2)"	"unprognostic (8.08e-3)"	"unprognostic (4.24e-1)"	"unprognostic (1.19e-2)"	"unprognostic (1.11e-2)"	"unprognostic (4.49e-2)"	"unprognostic (1.63e-2)"	"unprognostic (2.27e-2)"	"unprognostic (2.35e-1)"	"unprognostic (2.75e-1)"	"prognostic favorable (2.97e-10)"	"unprognostic (2.01e-2)"	"unprognostic (2.61e-1)"	"prognostic unfavorable (2.82e-4)"	"unprognostic (7.40e-2)"	7.3	6.2	6.8	3.0	7.5	4.4	15.7	2.4	6.6	5.3	5.0	14.8	7.1	4.5	4.0	3.7	3.5	7.1	5.9	8.2	6.0	4.6	9.1	16.0	4.9	1.8	9.5	4.0	5.8	7.3	17.1	5.2	3.4	7.1	5.7	5.4	8.3	3.8	7.2	2.2	3.3	7.7	4.2	9.3	2.2	9.3	16.9	8.2	0.2	13.6	2.2	2.1	10.4	10.3	1.6	0.0	9.9	0.0	0.1	2.9	0.8	5.2	2.9	3.1	3.2	15.2	22.8	8.5	3.8	5.1	2.5	4.1	9.9	8.3	0.0	3.7	8.0	6.2	5.9	4.4	3.0	3.0	1.3	4.1	0.8	1.0	7.8	2.5	0.0	0.1	9.4	1.5	2.7	2.5	3.0	0.5	0.0	3.0	0.6	3.5	2.5	0.0	0.8	5.8	5.9	2.5	0.0	1.9	0.1	4.0	8.1	0.9	4.9	2.7	0.8	1.5	11.0	0.7	1.7	1.5	2.5	3.0	6.6	2.8	0.1	0.0	0.0	2.7	0.0	6.0	9.9	0.0	3.1	2.9	0.0	1.6	1.6	1.3	2.3	0.0	0.8	2.3	1.4	0.0	0.1	0.0	0.0	1.6	0.8	6.8	7.5	2.4	6.6	6.0	4.6	9.5	4.0	7.1	8.2	6.0	9.1	2.4	7.4	8.0	6.4	14.5	10.2	16.0	14.8	8.7	7.9	5.3	6.6	4.8	28.7	4.7	8.5	0.0	5.7	2.5	9.3	10.2	13.9	27.2	8.6	7.9	2.4	8.0	1.0	27.6	8.3	4.1	8.5	3.6	7.6	10.9	6.9	6.5	11.0	14.1	11.7	25.8	22.0	3.7	5.5	6.8	2.9	5.0	7.2	8.1
CDC25A		ENSG00000164045	"Cell division cycle 25A"	P30304	3	48157146-48188402	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"	"Hydrolase, Protein phosphatase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 13.0;lymphoid tissue: 23.0;testis: 19.4"	"Cell type enriched"	"Detected in some"	5	"Cardiomyocytes: 106.0"	"Cancer enhanced"	"Detected in many"		"testis cancer: 19.0"	"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"memory B-cell: 1.7"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA005855, HPA008803"			Approved	"Nucleoplasm,Golgi apparatus"		NA	NA			Nucleoplasm	"Golgi apparatus"	"HPA005855: AB_1846364, HPA008803: "	"unprognostic (1.49e-1)"	"unprognostic (8.13e-2)"	"unprognostic (1.20e-2)"	"unprognostic (1.43e-3)"	"unprognostic (2.14e-1)"	"unprognostic (9.51e-2)"	"unprognostic (7.05e-7)"	"unprognostic (1.35e-2)"	"unprognostic (4.32e-3)"	"unprognostic (8.92e-3)"	"unprognostic (4.41e-2)"	"unprognostic (9.09e-2)"	"unprognostic (4.41e-3)"	"unprognostic (1.57e-3)"	"unprognostic (1.07e-1)"	"unprognostic (1.29e-1)"	"unprognostic (2.72e-1)"	0.8	1.2	1.1	5.5	1.1	13.0	0.8	0.7	1.2	1.1	3.3	0.6	1.0	1.8	0.6	0.9	3.9	0.4	2.2	0.7	1.3	2.4	1.2	0.9	0.7	4.1	1.4	0.2	2.1	3.6	0.4	2.3	4.2	1.2	1.0	4.0	1.5	1.8	0.5	0.7	0.8	2.1	0.8	0.7	3.6	1.3	19.4	0.2	23.0	1.6	8.8	7.4	0.8	1.3	1.7	0.9	0.5	0.1	0.0	1.0	0.1	7.6	3.8	18.1	9.7	0.6	1.2	12.5	10.6	4.0	13.4	10.9	16.4	4.0	22.8	4.2	2.8	8.5	5.8	30.9	7.3	14.2	7.4	16.3	29.1	6.9	8.1	0.6	20.5	8.5	0.6	1.1	16.6	7.2	1.6	5.0	17.0	23.1	12.1	7.2	4.1	25.6	16.0	26.4	7.0	8.7	11.5	11.9	12.4	3.4	7.2	8.5	10.6	6.6	7.7	3.4	12.0	4.0	14.6	2.5	6.6	10.2	7.3	14.5	6.1	18.2	35.8	4.9	22.9	5.5	0.0	0.0	0.5	0.4	0.0	0.0	1.7	0.6	0.2	0.9	0.0	0.0	1.0	0.0	0.0	0.1	0.5	0.0	0.1	1.1	1.1	0.7	1.2	1.3	2.4	1.4	0.2	1.2	0.2	0.0	0.0	0.0	0.4	0.3	0.0	106.0	0.0	0.0	0.0	0.0	2.0	1.9	0.0	0.5	14.7	0.1	0.3	0.0	0.8	5.7	0.5	0.4	0.0	0.2	2.5	0.0	1.2	1.3	0.3	22.9	1.4	0.0	0.0	0.0	1.5	0.5	0.9	0.0	1.8	0.2	0.4	0.0	0.4	15.8	13.7	0.0	0.2	0.0	3.2	0.3
CDC25B		ENSG00000101224	"Cell division cycle 25B"	P30305	20	3786772-3806121	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"	"Hydrolase, Protein phosphatase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in all"	5	"B-cells: 4.5;NK-cells: 9.3;T-cells: 15.5"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038892, HPA038893, HPA075215"	Enhanced		Uncertain	"Vesicles,Mitotic spindle"		Yes	Yes			Vesicles	"Mitotic spindle"	"HPA038892: AB_2676258, HPA038893: AB_2676259, HPA075215: "	"unprognostic (4.69e-2)"	"unprognostic (5.74e-2)"	"unprognostic (2.93e-2)"	"prognostic unfavorable (4.76e-4)"	"unprognostic (1.13e-1)"	"unprognostic (4.23e-1)"	"prognostic unfavorable (1.19e-4)"	"unprognostic (1.31e-2)"	"unprognostic (4.92e-2)"	"unprognostic (2.74e-1)"	"unprognostic (1.67e-1)"	"unprognostic (6.03e-2)"	"prognostic unfavorable (2.94e-13)"	"unprognostic (1.15e-1)"	"unprognostic (2.38e-1)"	"unprognostic (3.94e-1)"	"unprognostic (9.46e-2)"	12.1	8.7	15.1	27.7	23.3	26.0	28.8	49.6	21.1	13.0	14.7	12.8	4.6	14.9	17.0	10.3	11.7	13.0	18.6	7.5	15.7	12.5	13.3	11.0	33.0	42.8	21.9	12.5	17.3	5.7	7.5	21.0	30.3	13.8	11.0	12.0	7.7	7.4	10.2	6.2	19.8	16.8	14.8	14.7	24.5	14.1	6.3	22.3	33.3	18.7	20.8	31.6	15.3	16.3	4.5	1.3	1.5	1.8	9.3	15.5	5.9	29.0	62.7	8.4	13.9	10.3	10.1	4.2	14.4	21.6	24.1	18.0	10.9	42.1	20.3	6.2	14.7	59.6	42.5	11.3	23.9	11.4	7.8	12.2	10.9	20.1	13.1	41.2	8.4	5.6	9.9	19.2	22.3	26.4	8.2	13.3	10.2	7.0	53.5	14.2	23.3	26.3	12.3	6.2	19.9	26.8	13.8	23.8	14.5	16.4	2.7	6.0	13.1	34.1	32.6	16.7	7.5	11.0	4.4	11.0	12.9	15.7	23.4	19.0	13.1	20.6	8.2	6.6	8.3	12.4	1.5	1.4	0.0	13.6	1.8	12.7	3.5	13.6	13.7	1.3	4.5	11.4	13.2	0.1	9.3	0.9	0.7	15.5	5.9	15.1	23.3	49.6	21.1	15.7	12.5	21.9	12.5	13.8	22.3	8.9	23.7	9.0	5.5	10.0	13.9	6.8	7.6	0.0	3.4	7.0	2.0	5.3	0.0	7.8	0.5	24.0	3.8	23.3	4.2	14.2	13.6	4.7	1.1	11.6	24.4	3.2	7.5	12.9	11.6	1.0	6.6	10.6	16.9	5.4	7.9	8.3	10.4	2.9	8.5	9.4	2.4	0.0	11.3	1.0	11.5	9.8	3.0	25.4	3.5	3.4
CDC25C	"CDC25, PPP1R60"	ENSG00000158402	"Cell division cycle 25C"	P30307	5	138285265-138338355	"Cancer-related genes, Enzymes, Predicted intracellular proteins"	"Cell cycle, Cell division, Host-virus interaction, Mitosis"	"Hydrolase, Protein phosphatase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"lymphoid tissue: 23.3;testis: 22.3"	"Group enriched"	"Detected in some"	4	"Early spermatids: 32.9;Late spermatids: 35.1;Spermatocytes: 36.3"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"NK-cell: 2.1;T-reg: 2.7"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"CAB003800, HPA066991"	Approved		Enhanced	"Nuclear speckles"		No	Yes			"Nuclear speckles"		"CAB003800: AB_562081, HPA066991: AB_2685760"	"unprognostic (2.45e-3)"	"unprognostic (5.89e-3)"	"prognostic favorable (2.49e-4)"	"unprognostic (9.72e-3)"	"unprognostic (2.17e-1)"	"unprognostic (1.53e-1)"	"prognostic unfavorable (3.03e-6)"	"prognostic unfavorable (4.38e-4)"	"unprognostic (5.56e-2)"	"unprognostic (2.08e-1)"	"unprognostic (1.70e-3)"	"unprognostic (1.00e-1)"	"unprognostic (0.00e+0)"	"unprognostic (5.04e-2)"	"unprognostic (1.43e-1)"	"unprognostic (2.59e-1)"	"unprognostic (3.06e-1)"	1.1	0.6	0.3	6.7	0.4	5.2	1.1	0.4	0.6	0.6	3.3	0.1	0.7	3.0	0.3	0.6	2.5	0.2	0.4	0.7	0.4	0.4	0.4	0.6	0.7	2.6	0.4	0.3	0.3	0.3	0.0	0.4	1.9	0.3	0.4	4.0	0.0	1.2	0.7	0.2	1.1	3.7	0.5	0.3	1.7	1.2	22.3	0.2	23.3	0.3	1.8	5.0	0.6	0.9	1.0	0.1	0.7	0.0	2.1	2.7	0.5	13.3	5.6	18.8	14.5	0.4	1.9	4.7	8.1	8.7	18.4	25.4	13.5	26.0	6.2	6.8	4.9	20.2	7.3	15.5	12.4	17.8	5.1	10.6	4.7	7.6	10.0	0.1	3.2	4.9	0.4	0.5	10.9	9.0	1.9	11.8	13.5	6.9	12.3	11.2	7.4	8.7	8.1	4.8	10.6	6.1	5.7	17.2	7.3	3.2	4.1	9.5	5.9	18.1	5.5	8.6	17.3	9.2	6.7	3.5	10.2	8.6	7.0	12.9	7.5	6.1	6.1	4.0	6.8	7.7	0.0	0.0	0.1	0.6	0.0	0.0	1.0	0.5	0.3	0.0	0.2	0.0	0.0	0.7	2.1	0.0	0.1	2.7	0.5	0.3	0.4	0.4	0.6	0.4	0.4	0.4	0.3	0.3	0.2	0.0	0.0	0.0	0.2	0.6	0.0	0.2	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	32.9	0.0	0.3	0.0	0.0	5.7	0.2	0.3	0.0	0.2	2.2	0.0	0.0	0.0	0.3	35.1	1.7	1.2	0.0	1.0	0.6	0.0	0.0	0.3	0.4	0.0	0.0	0.0	0.0	36.3	8.3	0.4	1.1	0.0	1.6	0.1
CDC34	"E2-CDC34, UBC3, UBE2R1"	ENSG00000099804	"Cell division cycle 34"	P49427	19	531712-542092	"Cancer-related genes, Enzymes, Predicted intracellular proteins"	"Cell cycle, Ubl conjugation pathway"	Transferase	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Late spermatids: 170.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"HPA002382, CAB005109, CAB047311, HPA074334"	Approved		Supported	"Nucleoplasm,Nuclear speckles,Cytosol"		NA	NA			"Nucleoplasm, Nuclear speckles"	Cytosol	"CAB005109: AB_2276050, CAB047311: , HPA002382: AB_1846370, HPA074334: "	"unprognostic (4.65e-2)"	"unprognostic (2.02e-1)"	"unprognostic (1.41e-1)"	"unprognostic (8.72e-2)"	"unprognostic (2.84e-1)"	"unprognostic (5.73e-2)"	"prognostic unfavorable (7.57e-4)"	"unprognostic (2.20e-1)"	"unprognostic (3.11e-1)"	"unprognostic (3.83e-2)"	"unprognostic (2.09e-2)"	"unprognostic (3.06e-2)"	"unprognostic (3.02e-2)"	"unprognostic (8.87e-3)"	"unprognostic (9.68e-2)"	"unprognostic (7.82e-3)"	"unprognostic (3.33e-2)"	16.5	15.9	21.3	11.3	19.1	24.7	20.4	25.7	30.9	16.0	20.5	19.5	10.5	15.4	13.3	13.4	15.6	14.5	13.6	35.6	21.1	18.2	12.1	36.0	13.0	9.9	18.5	19.8	17.0	37.4	11.3	17.0	24.9	16.2	17.2	10.6	15.3	26.4	18.5	63.9	19.0	13.2	18.6	14.3	12.7	15.7	43.6	15.0	12.2	13.1	17.0	8.7	19.2	16.4	2.9	2.8	11.5	4.5	1.5	4.1	1.3	18.7	18.8	24.1	19.8	10.9	10.5	24.1	16.9	13.0	18.2	19.0	29.0	11.5	10.3	17.7	12.0	11.0	13.0	18.9	14.2	9.3	16.9	50.8	9.5	12.4	31.4	27.3	13.4	11.6	13.5	21.3	15.4	16.1	14.3	21.7	14.6	40.8	20.8	12.0	26.9	18.3	17.9	30.4	13.9	18.2	16.9	12.4	17.4	13.7	11.2	31.4	23.3	14.7	15.2	28.0	20.7	12.2	19.8	17.7	13.3	15.9	30.9	22.5	20.7	15.9	13.8	18.2	19.0	13.7	4.5	3.5	6.2	2.3	3.4	1.7	2.9	3.2	4.1	2.8	1.7	2.5	2.4	11.5	1.5	4.5	2.3	3.1	1.3	21.3	19.1	25.7	30.9	21.1	18.2	18.5	19.8	16.2	15.0	0.0	4.8	9.7	16.8	41.6	35.9	25.8	38.2	1.4	1.2	14.0	23.6	38.5	11.6	17.9	55.3	20.2	34.4	0.0	17.3	40.4	28.2	30.2	0.0	35.2	23.7	15.9	12.7	14.7	12.6	170.3	16.7	12.9	18.6	10.0	25.9	67.6	35.7	21.2	14.2	15.9	36.1	12.9	30.1	18.4	52.8	47.8	52.7	10.0	21.2	26.8
CDC42BPA	"FLJ23347, KIAA0451, MRCK, MRCKA, PK428"	ENSG00000143776	"CDC42 binding protein kinase alpha"	Q5VT25	1	226989865-227318474	"Enzymes, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	6	"Horizontal cells: 211.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"basophil: 2.0"	"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB070414, HPA071252"	Approved		Approved	"Intermediate filaments"		NA	NA			"Intermediate filaments"		"CAB070414: AB_11156796, HPA071252: AB_2686374"	"unprognostic (3.67e-3)"	"unprognostic (1.45e-1)"	"unprognostic (1.10e-1)"	"unprognostic (2.78e-2)"	"unprognostic (3.04e-1)"	"unprognostic (5.90e-2)"	"unprognostic (7.89e-2)"	"unprognostic (2.27e-1)"	"unprognostic (1.46e-1)"	"unprognostic (3.93e-1)"	"unprognostic (4.88e-2)"	"unprognostic (2.87e-2)"	"unprognostic (7.73e-3)"	"unprognostic (1.35e-1)"	"unprognostic (1.70e-1)"	"unprognostic (9.79e-2)"	"unprognostic (1.21e-2)"	17.2	15.2	19.1	8.6	21.1	3.9	14.0	29.2	20.4	21.1	19.3	16.4	13.1	16.9	15.8	9.9	12.3	12.9	16.6	14.1	21.7	17.7	20.8	17.0	11.7	3.5	20.0	16.3	17.4	15.1	29.3	29.6	14.8	19.3	21.1	12.4	11.0	8.4	18.5	11.9	7.6	17.2	27.6	16.6	8.8	25.2	26.7	19.9	0.7	9.8	7.3	2.5	23.4	23.1	0.1	0.7	2.0	0.1	0.0	0.1	0.0	9.5	9.0	9.7	4.5	9.7	12.0	3.4	11.0	15.6	7.6	8.0	7.3	21.8	0.0	11.8	18.2	5.7	4.4	7.1	6.1	9.3	0.0	5.7	7.4	10.8	2.8	11.0	5.9	3.3	8.4	7.9	12.3	12.4	9.5	25.3	5.9	18.7	0.0	12.3	2.6	0.1	1.0	7.9	12.4	8.7	0.0	16.3	0.0	12.2	18.5	7.0	10.2	18.6	7.8	10.9	6.2	10.1	0.3	25.5	13.9	7.3	15.9	14.5	0.0	0.0	0.0	18.5	0.0	18.6	2.0	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.7	0.0	0.0	19.1	21.1	29.2	20.4	21.7	17.7	20.0	16.3	19.3	19.9	38.7	29.4	1.4	19.9	10.4	96.7	50.6	25.5	21.4	35.2	41.8	111.9	5.2	11.6	22.3	90.9	47.3	45.2	23.3	35.4	6.1	27.8	25.0	6.9	24.5	3.2	211.4	25.3	42.4	7.1	98.3	40.9	6.8	15.1	9.0	24.1	34.1	46.5	54.5	80.2	32.9	64.0	77.6	45.3	40.8	51.3	6.9	1.1	1.3	26.4	26.8
CDC42BPB	"KIAA1124, MRCKB"	ENSG00000198752	"CDC42 binding protein kinase beta"	Q9Y5S2	14	102932379-103057462	"Enzymes, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"intermediate monocyte: 2.0"	"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA022821	Approved					NA	NA		12000			"HPA022821: AB_1846376"	"unprognostic (6.73e-2)"	"unprognostic (2.19e-2)"	"unprognostic (6.99e-2)"	"unprognostic (5.67e-2)"	"unprognostic (1.41e-2)"	"unprognostic (2.19e-1)"	"unprognostic (2.90e-2)"	"prognostic unfavorable (2.38e-4)"	"unprognostic (2.71e-1)"	"unprognostic (1.24e-1)"	"unprognostic (3.46e-2)"	"unprognostic (2.28e-1)"	"prognostic favorable (8.67e-10)"	"unprognostic (2.11e-1)"	"unprognostic (1.86e-1)"	"unprognostic (8.59e-2)"	"unprognostic (7.56e-2)"	32.2	22.7	33.1	14.8	33.2	3.1	19.8	30.3	42.1	26.7	21.8	42.3	21.5	26.0	27.0	18.7	28.3	26.0	28.1	30.7	31.4	25.5	23.7	20.1	26.4	7.9	31.2	28.4	29.7	28.8	32.5	25.9	25.6	27.0	25.1	18.2	23.7	23.0	28.8	17.0	23.8	29.6	28.7	24.3	18.3	25.5	21.8	31.0	2.1	26.3	15.9	12.4	25.2	32.6	0.9	0.2	0.0	2.0	0.0	0.4	0.1	13.3	26.7	17.2	12.6	19.2	22.0	17.4	15.3	16.2	16.3	15.0	9.1	15.8	0.0	16.8	29.8	12.4	17.0	17.7	18.3	17.3	16.3	8.0	7.3	21.6	9.1	20.9	0.0	7.9	19.0	18.9	16.7	16.0	17.2	31.5	3.1	5.9	3.8	15.6	28.0	0.1	1.7	8.2	20.9	22.1	0.0	14.5	0.3	20.8	26.3	12.5	13.7	27.2	10.3	11.5	19.1	15.8	4.7	40.1	15.7	10.5	34.5	14.2	4.9	5.3	3.9	17.6	1.6	15.1	0.0	1.4	0.0	0.0	2.0	0.0	0.9	0.4	0.0	0.2	0.5	0.0	0.0	0.0	0.0	0.5	0.0	0.1	0.1	33.1	33.2	30.3	42.1	31.4	25.5	31.2	28.4	27.0	31.0	53.6	30.2	6.9	10.7	12.9	45.3	25.4	28.1	33.5	33.0	52.4	31.4	10.5	3.3	26.7	14.0	32.3	28.4	0.0	19.0	8.9	18.2	22.0	12.7	16.3	11.2	54.0	24.2	30.1	12.0	4.9	30.0	12.3	11.8	10.0	14.9	28.0	31.1	17.3	51.9	13.5	42.2	6.5	19.6	13.7	16.0	15.9	14.1	1.0	20.9	28.8
CDC42BPG	"DMPK2, HSMDPKIN, kappa-200, MRCKgamma"	ENSG00000171219	"CDC42 binding protein kinase gamma"	Q6DT37	11	64823387-64844569	"Enzymes, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	6	"Club cells: 12.5;Enterocytes: 10.6;Paneth cells: 14.0"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in some"	9	"cerebellum: 19.4"	"Cell type enhanced"	"Detected in single"		"MAIT T-cell: 1.0"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"BEWO: 19.5;HaCaT: 14.6;MCF7: 19.7;RT4: 12.0;SK-BR-3: 12.1;T-47d: 11.9"	"Region enriched"	"Detected in single"	4	"cerebellum: 5.9"	"Low region specificity"	"Detected in single"			"HPA027382, HPA061836"	Enhanced		Supported	Cytosol		NA	NA			Cytosol		"HPA027382: AB_1846378, HPA061836: AB_2684622"	"unprognostic (3.26e-2)"	"unprognostic (1.58e-1)"	"unprognostic (6.00e-2)"	"unprognostic (2.60e-1)"	"unprognostic (1.21e-1)"	"unprognostic (2.50e-1)"	"unprognostic (4.68e-1)"	"unprognostic (5.27e-2)"	"unprognostic (3.91e-2)"	"unprognostic (3.65e-2)"	"unprognostic (1.26e-1)"	"unprognostic (1.81e-1)"	"prognostic favorable (5.99e-13)"	"unprognostic (2.60e-2)"	"unprognostic (1.55e-1)"	"unprognostic (2.14e-2)"	"unprognostic (3.99e-3)"	0.5	2.7	0.8	2.1	0.5	1.1	3.5	19.4	0.8	2.9	9.1	0.8	6.3	8.2	1.0	8.0	14.3	2.9	10.5	0.5	0.7	0.0	3.5	0.5	4.2	0.7	0.5	0.5	1.5	7.9	7.0	6.5	13.0	2.0	4.4	3.4	1.0	14.3	7.6	0.5	22.4	19.7	1.6	0.8	0.8	8.5	2.5	0.7	1.8	3.9	8.1	7.7	5.4	6.3	0.4	0.0	0.0	0.0	0.2	1.0	0.1	5.6	0.8	0.5	0.0	0.0	0.0	19.5	0.0	0.0	0.0	0.0	7.6	4.8	0.1	2.8	0.0	0.2	14.6	0.9	5.7	0.0	0.2	2.2	0.4	3.1	2.4	0.0	0.1	1.4	0.0	7.2	0.1	0.1	0.0	0.0	2.3	3.8	0.0	0.0	19.7	0.1	1.0	1.8	5.3	0.8	0.8	0.3	2.7	3.4	12.0	10.4	0.5	1.8	12.1	0.3	2.9	11.9	0.2	0.0	0.0	2.1	0.0	0.0	1.4	1.3	1.4	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	1.0	0.2	0.3	0.1	0.0	0.4	0.2	0.0	0.0	0.2	0.0	0.0	0.4	0.1	0.8	0.5	19.4	0.8	0.7	0.0	0.5	0.5	2.0	0.7	8.9	6.4	0.0	2.3	5.8	0.0	1.6	2.5	6.7	12.5	1.8	0.0	4.8	0.0	1.7	0.5	0.0	10.6	0.0	5.3	4.1	0.6	2.1	1.1	0.0	0.9	0.0	3.5	0.0	0.0	0.4	0.0	0.2	0.0	1.8	3.3	0.9	2.8	14.0	0.0	0.3	0.0	0.0	0.5	1.7	1.1	7.0	5.6	0.0	3.8	2.0
CDC7	"CDC7L1, HsCdc7, Hsk1, huCdc7"	ENSG00000097046	"Cell division cycle 7"	O00311	1	91500893-91525764	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division"	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	8	"Early spermatids: 28.3;Spermatocytes: 28.4;Spermatogonia: 20.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002669, HPA035831"	Enhanced		Supported	"Nucleoplasm,Cytokinetic bridge,Mitotic spindle"		Yes	No			Nucleoplasm	"Cytokinetic bridge, Mitotic spindle"	"CAB002669: , HPA035831: AB_2674807"	"unprognostic (6.84e-2)"	"unprognostic (6.01e-2)"	"unprognostic (4.64e-2)"	"unprognostic (7.02e-3)"	"unprognostic (5.57e-2)"	"unprognostic (3.57e-3)"	"prognostic unfavorable (3.15e-6)"	"unprognostic (6.52e-2)"	"unprognostic (2.23e-2)"	"unprognostic (1.36e-3)"	"unprognostic (2.04e-2)"	"unprognostic (1.75e-2)"	"prognostic unfavorable (1.89e-15)"	"unprognostic (9.44e-3)"	"unprognostic (2.49e-2)"	"unprognostic (1.09e-1)"	"unprognostic (5.39e-2)"	2.5	3.7	5.7	7.6	8.9	15.4	4.3	19.4	10.3	2.5	4.2	1.4	0.9	4.2	2.8	2.6	4.7	1.7	2.6	1.9	6.8	5.2	3.6	2.3	5.1	11.7	4.0	4.7	3.7	2.4	2.2	12.3	7.9	5.2	2.7	6.8	2.3	2.5	2.3	1.0	6.8	4.9	3.3	5.9	15.1	2.6	21.2	4.7	18.7	2.5	4.5	12.0	4.2	3.0	1.6	3.5	0.1	1.6	2.4	6.5	2.1	14.2	4.2	27.6	7.8	0.6	3.7	8.8	5.4	4.3	10.7	11.7	8.9	5.1	9.9	7.6	3.4	9.3	6.2	18.1	6.1	14.8	16.4	15.5	15.0	12.2	4.1	1.0	16.3	5.5	1.9	1.8	9.8	5.6	1.9	4.1	13.9	19.8	14.5	7.3	5.2	14.0	14.6	22.9	7.8	10.1	17.3	22.9	6.3	4.6	10.7	21.9	8.6	17.1	4.7	9.6	7.1	4.4	8.0	3.4	12.1	10.7	9.4	8.1	5.3	6.7	26.5	4.3	15.9	4.4	0.0	1.6	0.0	5.9	1.2	5.2	1.5	4.5	5.6	3.5	1.6	2.5	5.1	0.1	2.4	0.3	2.1	6.5	2.1	5.7	8.9	19.4	10.3	6.8	5.2	4.0	4.7	5.2	4.7	0.0	0.6	2.2	1.1	5.3	7.6	1.3	0.0	1.4	1.2	1.8	0.0	5.3	3.3	1.1	28.3	2.8	0.2	0.0	2.2	5.1	4.6	0.7	4.6	0.0	2.2	3.2	0.0	3.1	1.8	12.9	0.9	1.0	3.3	1.0	1.3	1.3	1.0	1.1	0.7	0.1	4.7	6.5	3.1	28.4	20.6	3.1	1.8	5.1	2.9	0.9
CDIPT	"PIS, PIS1"	ENSG00000103502	"CDP-diacylglycerol--inositol 3-phosphatidyltransferase"	O14735	16	29858357-29863736	"Enzymes, Predicted membrane proteins"	"Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA056597	Enhanced		Approved	"Nucleoplasm,Nuclear membrane,Plasma membrane"		NA	NA			"Nucleoplasm, Nuclear membrane, Plasma membrane"		"HPA056597: AB_2683182"	"unprognostic (7.81e-2)"	"prognostic favorable (9.40e-4)"	"unprognostic (1.93e-3)"	"unprognostic (8.08e-3)"	"unprognostic (1.50e-2)"	"unprognostic (2.84e-2)"	"unprognostic (7.60e-2)"	"unprognostic (1.09e-2)"	"unprognostic (7.03e-2)"	"unprognostic (8.75e-2)"	"unprognostic (5.56e-3)"	"unprognostic (1.61e-1)"	"unprognostic (6.17e-2)"	"unprognostic (3.36e-2)"	"unprognostic (6.95e-2)"	"unprognostic (1.56e-1)"	"unprognostic (2.48e-1)"	40.4	40.8	24.3	20.2	28.1	15.3	42.9	50.7	39.5	37.1	37.2	21.5	33.9	24.8	33.4	23.0	39.4	30.1	34.5	44.4	23.1	27.9	34.8	66.3	27.1	22.4	24.1	26.4	52.7	40.0	47.1	24.9	43.7	21.8	36.8	16.1	29.3	42.2	38.8	21.0	29.6	32.6	31.8	21.0	25.6	29.5	20.2	16.4	30.4	47.1	19.9	17.3	41.8	42.8	4.8	6.1	20.6	6.5	8.2	8.4	2.7	12.5	27.3	7.7	15.4	42.0	29.1	22.8	22.1	24.8	15.7	15.7	15.9	24.2	8.4	41.9	25.4	13.9	19.8	12.4	14.3	7.2	21.1	25.0	6.0	20.4	23.2	29.3	8.9	15.7	49.2	25.2	21.1	9.7	24.9	19.6	16.1	9.0	21.9	14.1	40.1	12.1	17.7	18.3	13.2	20.3	23.7	9.6	24.5	20.7	12.1	31.7	17.8	11.7	24.9	17.4	14.1	18.6	24.4	17.0	23.3	7.4	18.9	11.3	16.3	18.4	6.0	25.4	14.5	14.0	7.5	6.5	20.6	6.9	4.6	4.6	4.7	6.4	7.3	3.0	4.8	6.3	5.9	16.4	8.2	5.7	6.1	8.4	2.7	24.3	28.1	50.7	39.5	23.1	27.9	24.1	26.4	21.8	16.4	23.8	21.2	20.5	35.7	36.7	46.6	49.2	30.6	18.7	10.3	43.6	43.2	92.1	34.9	59.1	22.5	43.2	44.6	46.7	62.9	107.9	45.5	34.0	13.8	36.5	56.9	55.6	35.8	33.2	37.3	11.0	71.1	25.7	21.9	47.7	34.8	54.4	41.4	37.1	58.0	30.1	42.9	45.3	43.2	8.6	14.0	44.4	61.2	40.6	37.0	35.3
CDK1	"CDC2, CDC28A"	ENSG00000170312	"Cyclin dependent kinase 1"	P06493	10	60778331-60794852	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins, Transporters"	"Apoptosis, Biological rhythms, Cell cycle, Cell division, Host-virus interaction, Mitosis"	"Host cell receptor for virus entry, Kinase, Receptor, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"lymphoid tissue: 88.4"	"Cell type enhanced"	"Detected in many"	18	"Erythroid cells: 280.4;Extravillous trophoblasts: 116.8;Spermatocytes: 104.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"NK-cell: 6.1;T-reg: 5.7"	"Group enriched"	"Detected in many"	5	"dendritic cells: 1.7;NK-cells: 6.1;T-cells: 5.7"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in single"							"HPA003387, CAB003799"	Enhanced		Supported	Nucleoplasm,Cytosol		NA	Yes			Cytosol	Nucleoplasm	"CAB003799: AB_344898, HPA003387: AB_1846356"	"unprognostic (6.34e-2)"	"prognostic favorable (8.81e-4)"	"unprognostic (1.90e-1)"	"unprognostic (6.82e-2)"	"unprognostic (6.67e-2)"	"unprognostic (3.83e-2)"	"prognostic unfavorable (1.10e-6)"	"prognostic unfavorable (7.88e-4)"	"unprognostic (1.30e-2)"	"unprognostic (1.30e-1)"	"prognostic unfavorable (4.15e-6)"	"unprognostic (1.80e-2)"	"prognostic unfavorable (0.00e+0)"	"unprognostic (2.27e-1)"	"unprognostic (2.75e-1)"	"unprognostic (2.13e-1)"	"unprognostic (1.60e-1)"	4.1	2.2	0.8	17.8	2.4	17.8	4.4	0.7	1.6	4.2	6.5	1.1	3.4	6.1	2.9	4.8	19.0	1.5	2.4	2.3	0.9	0.7	3.1	1.7	5.7	15.1	1.7	0.6	2.2	1.0	0.5	4.4	13.3	1.2	1.5	8.3	1.0	3.8	2.9	1.0	4.9	8.3	2.7	2.5	8.3	5.0	13.8	1.2	88.4	1.8	16.7	20.1	3.2	6.9	0.9	1.7	0.0	0.2	6.1	5.7	1.8	48.9	18.6	49.6	19.6	3.2	5.0	20.4	37.0	27.0	45.2	43.6	43.6	43.3	44.9	14.4	10.1	16.6	30.5	33.7	21.5	47.1	31.9	24.6	23.5	18.4	25.3	0.6	36.0	24.3	0.9	2.1	29.2	28.5	10.3	27.1	29.6	35.9	55.3	50.2	13.0	45.3	25.9	21.8	29.6	39.3	39.4	46.2	22.0	17.2	16.3	23.3	20.4	24.9	37.8	19.2	28.1	40.8	22.1	11.1	19.3	41.2	20.3	50.6	21.7	34.8	40.5	16.6	40.4	23.9	0.0	0.0	0.0	0.5	0.2	0.5	0.9	1.5	2.7	0.5	0.5	0.5	1.5	0.0	6.1	0.2	1.7	5.7	1.8	0.8	2.4	0.7	1.6	0.9	0.7	1.7	0.6	1.2	1.2	0.0	2.7	2.2	3.6	35.3	1.0	0.5	0.0	14.7	7.9	17.4	0.0	11.0	3.3	0.7	8.8	4.5	1.7	280.4	0.0	116.8	5.1	1.0	0.0	0.8	46.3	0.0	2.9	9.8	15.3	6.3	2.0	8.8	1.7	1.8	4.0	1.0	0.3	0.0	0.7	2.1	0.5	0.0	1.4	104.2	29.6	16.3	18.4	7.0	5.6	6.0
CDK10	PISSLRE	ENSG00000185324	"Cyclin dependent kinase 10"	Q15131	16	89680737-89696364	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Cilium biogenesis/degradation"	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007451, HPA059634, HPA067060"	Uncertain		Supported	"Nucleoplasm,Midbody,Midbody ring"		Yes	Yes			Nucleoplasm	"Midbody, Midbody ring"	"HPA007451: AB_2732400, HPA059634: AB_2684090, HPA067060: AB_2685772"	"unprognostic (7.89e-2)"	"unprognostic (8.08e-2)"	"unprognostic (3.74e-3)"	"unprognostic (9.87e-2)"	"unprognostic (1.76e-1)"	"unprognostic (3.44e-2)"	"unprognostic (4.53e-1)"	"unprognostic (9.06e-2)"	"unprognostic (2.99e-1)"	"unprognostic (2.13e-1)"	"prognostic favorable (2.69e-4)"	"unprognostic (2.58e-2)"	"unprognostic (2.93e-1)"	"unprognostic (3.32e-2)"	"unprognostic (1.79e-1)"	"unprognostic (6.88e-2)"	"prognostic favorable (3.63e-4)"	12.3	19.9	16.8	16.4	23.8	17.3	10.1	14.8	21.9	11.1	18.3	8.1	16.4	23.4	12.1	21.7	14.4	14.4	19.4	8.7	15.3	12.6	22.2	33.9	11.8	14.0	13.3	19.4	11.3	22.2	21.6	27.7	13.6	15.8	13.6	12.6	8.1	17.2	8.9	17.5	14.1	20.7	9.0	10.7	15.9	19.0	8.7	13.6	8.0	27.1	10.1	12.1	10.8	14.5	7.8	14.5	3.4	15.3	15.2	13.3	8.8	14.7	9.6	7.7	3.1	3.2	6.1	8.1	12.2	6.9	8.7	2.9	7.4	11.2	13.1	6.2	10.5	5.4	10.3	3.3	17.0	5.5	2.9	8.1	5.1	10.8	0.8	13.4	8.3	9.4	7.5	5.7	5.5	8.3	5.8	15.1	8.7	13.4	1.8	9.9	19.2	10.0	23.8	15.8	16.0	7.3	14.6	10.5	18.4	15.6	11.7	7.6	16.5	15.3	7.1	3.6	9.1	16.7	13.2	13.4	5.9	15.3	6.1	8.3	6.6	3.6	4.0	9.0	14.3	8.4	3.2	11.7	3.4	12.9	15.3	10.9	6.8	11.4	8.9	14.5	7.8	13.3	10.9	1.5	15.2	11.2	10.0	8.8	8.8	16.8	23.8	14.8	21.9	15.3	12.6	13.3	19.4	15.8	13.6	11.9	28.2	16.7	22.2	13.7	17.3	4.8	45.9	18.7	9.1	26.2	23.6	25.3	36.5	23.6	5.0	17.5	42.9	0.0	11.0	16.4	18.6	26.1	9.2	37.6	16.3	17.5	65.1	19.6	16.7	5.4	22.2	13.0	18.6	14.4	38.5	10.3	14.2	35.1	11.7	45.1	33.8	6.5	11.3	23.1	29.8	13.6	23.3	17.5	50.1	18.6
CDK11A	"CDC2L2, CDC2L3, CDK11-p110, CDK11-p46, CDK11-p58, p58GTA, PITSLRE"	ENSG00000008128	"Cyclin dependent kinase 11A"	Q9UQ88	1	1702730-1724324	"Enzymes, Predicted intracellular proteins"	"Apoptosis, Cell cycle"	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	4	"Spermatocytes: 104.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"neutrophil: 33.5"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"CAB010467, HPA025061, HPA073626"	Supported		Supported	"Nuclear speckles,Cytosol"		NA	NA			"Nuclear speckles"	Cytosol	"CAB010467: AB_631212, HPA025061: AB_1846407, HPA073626: AB_2686619"	"unprognostic (6.25e-2)"	"unprognostic (8.32e-2)"	"unprognostic (1.47e-2)"	"unprognostic (2.74e-1)"	"unprognostic (9.32e-3)"	"unprognostic (3.54e-2)"	"unprognostic (2.25e-3)"	"unprognostic (7.97e-2)"	"prognostic unfavorable (5.06e-4)"	"unprognostic (1.28e-1)"	"unprognostic (5.58e-3)"	"unprognostic (3.07e-2)"	"prognostic unfavorable (1.15e-6)"	"unprognostic (1.97e-1)"	"unprognostic (5.98e-2)"	"unprognostic (1.54e-1)"	"unprognostic (3.70e-2)"	14.3	14.9	17.2	23.7	26.9	39.7	13.0	35.2	32.7	12.5	16.4	14.3	6.1	29.2	16.5	8.5	12.1	12.6	10.2	10.2	19.4	8.4	11.7	12.5	19.0	20.3	22.6	9.0	16.2	12.9	12.2	27.5	12.9	17.1	14.4	14.6	11.6	12.7	10.3	21.5	15.1	34.9	13.1	26.0	24.2	15.7	16.4	25.1	14.9	14.6	7.6	22.4	13.5	15.2	7.4	11.8	33.5	6.3	4.4	5.5	1.4	16.3	9.9	7.1	6.5	9.4	7.5	7.0	16.1	7.2	8.0	9.4	12.3	15.0	17.4	9.9	4.7	10.4	12.2	6.5	8.4	6.4	13.3	10.6	15.5	18.5	11.0	6.2	17.3	22.4	8.7	5.7	7.0	4.6	9.7	13.8	9.4	18.1	14.6	6.7	9.2	8.0	13.6	9.9	10.0	8.4	14.7	10.8	8.4	6.5	7.4	7.9	11.4	14.1	16.6	19.3	3.6	11.1	7.2	14.0	12.6	12.3	5.6	8.9	20.4	14.8	21.9	4.3	14.0	4.0	16.7	6.3	7.7	5.5	3.4	4.2	6.2	4.7	4.2	2.0	7.4	4.7	4.0	33.5	4.4	3.7	11.8	4.5	1.4	17.2	26.9	35.2	32.7	19.4	8.4	22.6	9.0	17.1	25.1	47.6	54.9	22.4	11.6	12.5	31.1	1.2	12.7	53.5	58.0	14.0	25.5	13.8	8.3	17.1	29.6	20.3	32.5	23.3	13.2	19.0	13.9	10.7	79.0	12.3	10.9	38.1	8.7	11.6	8.2	11.1	32.8	22.6	10.1	23.4	23.2	20.4	21.0	46.0	20.1	9.6	39.2	12.9	9.1	104.7	84.3	12.8	25.5	25.5	18.6	12.9
CDK12	"CRK7, CRKR, CRKRS, KIAA0904"	ENSG00000167258	"Cyclin dependent kinase 12"	Q9NYV4	17	39461511-39564907	"Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	"Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"SK-BR-3: 87.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008038, HPA073305"	Supported		Enhanced	"Nucleoplasm,Nuclear speckles"		NA	NA			"Nucleoplasm, Nuclear speckles"		"HPA008038: AB_1078570, HPA073305: "	"unprognostic (2.02e-1)"	"unprognostic (1.80e-1)"	"unprognostic (2.61e-2)"	"unprognostic (7.56e-2)"	"unprognostic (1.05e-1)"	"unprognostic (3.19e-1)"	"unprognostic (2.56e-3)"	"unprognostic (2.37e-2)"	"unprognostic (3.86e-2)"	"unprognostic (3.00e-3)"	"unprognostic (6.87e-3)"	"unprognostic (1.86e-1)"	"unprognostic (3.06e-2)"	"unprognostic (9.10e-2)"	"unprognostic (1.24e-1)"	"unprognostic (2.22e-2)"	"unprognostic (5.32e-1)"	16.0	13.1	12.4	17.4	9.2	32.4	14.0	23.4	17.8	18.2	17.6	9.6	15.7	11.1	15.7	12.0	16.9	12.2	12.5	11.0	10.1	6.7	10.2	18.5	13.5	15.2	10.9	14.3	17.4	11.3	19.0	12.2	18.4	9.5	12.7	11.7	10.4	15.6	11.1	11.1	17.0	16.5	11.0	10.6	16.3	11.8	18.9	8.3	29.0	15.0	5.4	17.3	16.3	20.5	5.1	4.0	10.4	2.9	6.6	4.0	0.9	8.9	11.1	6.7	6.2	4.9	5.5	6.2	8.1	6.9	11.1	8.3	13.6	5.5	12.7	7.1	8.5	11.3	14.6	13.3	10.2	10.8	8.3	11.4	13.7	7.5	10.5	4.8	18.7	9.6	5.9	7.1	13.5	10.7	4.6	6.7	7.7	23.2	8.4	6.3	4.2	15.3	4.8	7.0	4.4	5.0	10.1	14.4	7.2	4.2	10.7	7.2	4.6	10.3	87.5	7.0	10.1	11.2	8.1	7.2	10.1	8.1	7.0	10.4	6.9	4.9	17.9	7.2	7.9	6.6	10.4	2.9	4.1	4.0	2.2	3.0	2.9	2.5	2.7	1.8	5.1	2.9	2.7	9.7	6.6	1.8	4.0	2.0	0.9	12.4	9.2	23.4	17.8	10.1	6.7	10.9	14.3	9.5	8.3	23.8	26.1	37.7	45.0	57.5	45.4	12.1	35.7	29.4	40.9	36.6	60.9	27.7	11.6	24.4	15.9	29.6	32.0	23.3	23.8	24.7	35.7	62.9	27.8	38.9	23.9	33.4	29.9	27.6	37.0	14.0	34.5	34.5	25.3	27.9	26.9	31.5	36.1	31.6	31.8	12.9	67.7	32.3	33.0	113.1	90.5	60.3	48.7	42.9	28.8	77.9
CDK13	"CDC2L, CDC2L5, CHED, KIAA1791"	ENSG00000065883	"Cyclin dependent kinase 13"	Q14004	7	39949646-40099580	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Host-virus interaction, mRNA processing, mRNA splicing"	"Kinase, Serine/threonine-protein kinase, Transferase"	"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA059241	Uncertain		Supported	"Nuclear speckles,Golgi apparatus,Cytosol"		NA	NA			"Nuclear speckles"	"Golgi apparatus, Cytosol"	"HPA059241: AB_2683956"	"unprognostic (1.99e-1)"	"unprognostic (1.22e-2)"	"unprognostic (2.67e-1)"	"unprognostic (2.72e-1)"	"unprognostic (1.83e-1)"	"unprognostic (1.02e-1)"	"unprognostic (4.18e-3)"	"unprognostic (3.42e-2)"	"unprognostic (8.09e-2)"	"unprognostic (1.13e-2)"	"unprognostic (3.77e-2)"	"unprognostic (8.13e-2)"	"unprognostic (8.20e-2)"	"unprognostic (1.21e-1)"	"unprognostic (3.33e-2)"	"unprognostic (3.53e-1)"	"unprognostic (3.53e-2)"	16.9	15.3	16.0	29.0	14.5	26.7	20.4	23.3	18.2	16.6	18.3	16.4	14.2	11.3	20.3	17.7	20.9	18.1	20.2	13.6	14.3	11.3	14.7	17.5	19.6	21.9	16.5	15.1	24.2	15.3	26.3	15.3	14.8	12.0	15.5	15.5	14.9	17.6	14.5	19.4	16.7	16.3	16.4	11.5	17.4	14.5	20.2	15.7	31.2	23.1	14.6	21.5	18.5	23.6	14.0	3.9	7.9	3.4	5.0	5.0	1.4	15.7	9.4	16.4	15.6	14.8	14.5	11.3	12.6	13.7	11.6	14.6	9.8	10.9	28.6	7.4	13.2	20.4	19.2	13.4	11.1	17.1	14.0	9.9	12.7	11.5	8.8	14.2	19.3	13.9	8.5	14.9	13.2	17.7	13.3	13.6	13.3	21.4	19.8	12.0	8.1	15.3	13.7	23.7	11.1	11.0	17.0	10.9	11.5	10.9	16.0	11.7	17.0	16.0	34.7	11.4	22.2	14.2	24.1	16.1	16.0	15.3	10.3	17.1	16.4	13.8	23.6	11.7	17.5	20.4	7.9	2.7	4.4	5.0	2.2	3.4	7.6	4.8	3.7	1.5	14.0	4.9	4.9	7.6	5.0	3.4	3.9	4.3	1.4	16.0	14.5	23.3	18.2	14.3	11.3	16.5	15.1	12.0	15.7	41.7	63.7	28.9	17.1	19.1	42.3	25.6	30.6	34.8	47.8	29.6	66.8	11.5	6.6	19.1	10.7	22.5	15.9	0.0	13.4	7.5	19.4	16.3	16.2	20.7	11.6	35.0	18.0	20.3	23.2	7.0	24.2	18.3	13.5	15.4	17.7	26.6	24.2	10.5	16.6	11.1	68.4	6.5	15.6	31.4	31.5	22.8	10.2	22.5	18.8	21.7
CDK14	"PFTAIRE1, PFTK1"	ENSG00000058091	"Cyclin dependent kinase 14"	O94921	7	90466424-91210590	"Enzymes, Predicted intracellular proteins"	"Cell cycle, Cell division, Wnt signaling pathway"	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	16	"Early spermatids: 44.0;Horizontal cells: 163.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	7	"basophil: 7.5;memory B-cell: 9.8;naive B-cell: 5.3;neutrophil: 5.6"	"Group enriched"	"Detected in many"	9	"B-cells: 9.8;granulocytes: 7.5"	"Cell line enhanced"	"Detected in many"		"Karpas-707: 31.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA015267	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"HPA015267: AB_1855249"	"prognostic favorable (5.86e-4)"	"unprognostic (3.96e-1)"	"unprognostic (1.91e-2)"	"unprognostic (2.09e-3)"	"unprognostic (1.18e-1)"	"unprognostic (3.45e-1)"	"unprognostic (1.72e-1)"	"unprognostic (4.48e-2)"	"unprognostic (3.60e-2)"	"unprognostic (3.09e-2)"	"unprognostic (2.77e-3)"	"unprognostic (2.91e-2)"	"unprognostic (2.57e-2)"	"prognostic unfavorable (7.79e-4)"	"unprognostic (2.46e-1)"	"unprognostic (2.86e-1)"	"unprognostic (4.39e-3)"	8.2	4.7	19.8	7.1	19.4	6.1	8.3	28.6	34.9	10.6	5.2	3.7	0.6	2.7	8.6	3.2	3.1	12.0	11.9	11.5	25.8	15.5	19.8	12.7	9.2	10.9	17.3	17.4	14.9	14.2	3.8	14.2	5.9	22.8	11.3	3.4	4.3	7.7	7.0	5.4	2.7	3.8	7.4	7.0	7.5	7.4	7.2	4.5	0.9	13.1	1.6	11.9	6.9	6.7	9.8	0.9	7.5	0.7	0.1	0.2	0.6	7.1	0.0	14.3	1.8	13.4	13.7	3.3	6.0	5.7	3.7	4.0	0.1	3.5	25.4	0.7	5.9	5.4	2.1	0.7	8.4	7.1	0.0	3.4	0.0	4.7	0.1	6.2	7.2	0.1	9.7	2.1	10.9	3.9	6.1	4.7	0.1	0.1	31.3	7.4	0.0	0.0	2.8	9.0	0.0	3.9	19.5	19.7	19.3	1.9	1.9	3.2	9.2	15.2	0.0	0.3	6.7	1.9	3.6	11.5	15.9	20.4	13.3	9.2	17.7	13.5	18.1	6.0	9.5	15.5	7.5	0.3	0.5	0.0	0.7	0.0	9.8	0.0	0.0	0.9	5.3	0.0	0.0	5.6	0.1	0.5	0.1	0.2	0.6	19.8	19.4	28.6	34.9	25.8	15.5	17.3	17.4	22.8	4.5	17.9	3.2	27.7	7.4	0.7	5.1	11.1	10.2	4.0	13.6	10.4	0.0	0.2	6.6	9.4	44.0	2.1	0.0	0.0	5.8	0.1	12.5	8.3	0.0	9.6	4.0	163.7	1.7	1.3	5.1	27.0	14.4	4.6	5.0	1.0	0.1	8.8	9.4	0.2	14.9	18.1	9.5	0.0	6.6	3.8	6.5	1.1	0.0	0.5	0.0	2.3
CDK15	"ALS2CR7, PFTAIRE2, PFTK2"	ENSG00000138395	"Cyclin dependent kinase 15"	Q96Q40	2	201790461-201895550	"Enzymes, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"epididymis: 20.2;ovary: 9.8"	"Group enriched"	"Detected in some"	13	"Early spermatids: 23.2;granulocytes: 76.3;Late spermatids: 28.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	52	"basophil: 3.5;eosinophil: 6.9"	"Lineage enriched"	"Detected in single"	69	"granulocytes: 6.9"	"Cell line enhanced"	"Detected in some"		"BJ hTERT+: 14.9;BJ hTERT+ SV40 Large T+ RasG12V: 12.2;HBF TERT88: 18.6;HMC-1: 35.2;LHCN-M2: 10.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA015786	Uncertain		Approved	"Nucleoplasm,Golgi apparatus"		NA	NA			Nucleoplasm	"Golgi apparatus"	"HPA015786: AB_1844780"	"unprognostic (2.51e-1)"	"unprognostic (2.73e-1)"	"unprognostic (2.84e-2)"	"unprognostic (1.30e-2)"	"unprognostic (1.42e-1)"	"unprognostic (2.94e-1)"	"unprognostic (4.79e-2)"	"unprognostic (1.07e-1)"	"unprognostic (1.52e-1)"	"unprognostic (1.52e-2)"	"unprognostic (1.64e-2)"	"unprognostic (1.80e-2)"	"unprognostic (7.38e-2)"	"unprognostic (9.99e-5)"	"unprognostic (6.31e-2)"	"unprognostic (1.48e-2)"	"unprognostic (1.05e-2)"	1.3	0.2	0.1	5.2	0.1	0.0	3.7	0.3	0.1	3.4	2.3	0.1	0.1	0.3	4.1	20.2	1.1	1.0	4.2	0.3	0.1	0.0	0.4	0.1	3.3	0.1	0.1	0.1	9.8	0.2	0.0	0.5	0.1	0.1	2.0	0.7	1.4	0.6	0.3	0.7	1.1	3.0	3.9	0.1	0.1	1.1	2.5	0.1	0.1	0.2	1.2	1.2	1.6	1.0	0.0	0.0	6.9	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.9	1.7	0.0	3.2	14.9	5.6	12.2	0.0	1.5	0.0	0.0	1.3	0.2	0.0	0.0	0.0	18.6	0.0	0.0	1.0	0.0	0.0	0.2	0.0	35.2	2.1	0.0	1.5	0.8	0.2	0.0	0.0	0.0	0.0	10.5	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.3	1.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	3.5	0.0	6.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.3	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	2.2	0.0	0.0	0.2	0.0	0.8	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	23.2	0.0	0.0	0.0	0.0	0.0	0.4	0.0	76.3	0.0	0.0	0.0	0.0	0.0	0.0	28.0	0.3	0.0	3.3	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.5	0.5	0.0	0.1	0.0	0.0	0.0	0.0
CDK16	"FLJ16665, PCTAIRE, PCTAIRE1, PCTGAIRE, PCTK1"	ENSG00000102225	"Cyclin dependent kinase 16"	Q00536	X	47217860-47229997	"Enzymes, Predicted intracellular proteins"	"Differentiation, Spermatogenesis"	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 91.2"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000974, HPA001366, CAB016535"	Approved		Approved	"Plasma membrane,Microtubules,Cytosol"		NA	NA			"Microtubules, Cytosol"	"Plasma membrane"	"CAB016535: AB_785112, HPA000974: AB_2666162, HPA001366: AB_1079584"	"unprognostic (2.37e-3)"	"unprognostic (6.93e-2)"	"unprognostic (2.96e-2)"	"unprognostic (1.16e-3)"	"unprognostic (8.80e-2)"	"unprognostic (2.92e-2)"	"prognostic unfavorable (2.02e-6)"	"unprognostic (2.85e-1)"	"unprognostic (5.59e-2)"	"unprognostic (7.62e-3)"	"unprognostic (1.20e-1)"	"unprognostic (1.09e-1)"	"unprognostic (1.46e-1)"	"unprognostic (1.59e-2)"	"unprognostic (1.83e-1)"	"unprognostic (3.89e-3)"	"unprognostic (2.55e-1)"	22.0	20.1	32.3	13.9	25.0	26.6	17.6	51.5	49.0	17.2	19.3	15.5	17.0	16.4	14.8	12.8	23.8	18.8	14.1	47.3	29.2	18.0	19.9	12.7	14.0	10.8	22.0	21.1	16.7	18.6	22.8	14.9	18.6	28.5	12.7	14.7	13.7	20.1	16.1	91.2	17.0	15.3	18.2	14.8	12.0	14.7	28.7	12.1	10.4	20.9	36.3	12.6	12.9	12.1	8.5	13.5	8.5	10.7	6.3	7.7	5.7	40.6	31.2	30.0	44.3	22.0	18.9	30.0	19.4	23.9	29.5	22.0	35.1	19.8	9.8	12.4	34.7	54.7	23.1	31.9	41.3	19.9	11.7	50.6	10.6	43.9	27.3	28.6	11.1	24.9	23.6	26.4	41.8	50.5	24.7	26.4	10.3	15.7	16.7	25.8	35.4	9.7	25.6	23.5	15.4	33.8	10.3	23.7	17.1	22.2	32.3	25.4	19.2	52.6	40.7	20.0	36.5	36.3	13.7	26.5	19.8	32.4	30.1	23.1	13.2	12.8	9.5	17.4	52.0	22.1	3.1	8.8	8.5	4.8	10.7	6.2	3.8	6.2	7.7	11.6	8.5	5.6	5.8	4.2	6.3	9.6	13.5	6.0	5.7	32.3	25.0	51.5	49.0	29.2	18.0	22.0	21.1	28.5	12.1	0.0	6.7	15.3	27.9	28.8	24.3	37.2	15.3	4.0	4.5	29.6	3.9	23.1	46.4	30.2	25.1	15.7	50.5	0.0	32.2	31.3	23.1	37.6	5.7	14.8	21.7	28.6	26.9	20.3	19.6	46.6	15.8	10.3	32.1	12.6	30.7	16.0	41.5	33.6	12.4	28.2	12.9	0.0	19.8	18.1	16.8	30.4	21.7	10.2	41.6	53.3
CDK17	"PCTAIRE2, PCTK2"	ENSG00000059758	"Cyclin dependent kinase 17"	Q00537	12	96278261-96400560	"Enzymes, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HUVEC TERT2: 44.5;TIME: 53.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA015325	Approved		Approved	Nucleoplasm,Cytosol		Yes	No			"Nucleoplasm, Cytosol"		"HPA015325: AB_1855090"	"unprognostic (4.35e-1)"	"unprognostic (2.79e-1)"	"unprognostic (2.70e-1)"	"unprognostic (3.56e-1)"	"unprognostic (1.50e-1)"	"unprognostic (4.96e-3)"	"unprognostic (5.22e-3)"	"unprognostic (1.23e-1)"	"unprognostic (3.23e-2)"	"unprognostic (2.75e-2)"	"unprognostic (2.44e-1)"	"unprognostic (5.96e-2)"	"prognostic unfavorable (1.09e-6)"	"unprognostic (4.97e-3)"	"unprognostic (1.72e-1)"	"unprognostic (2.92e-2)"	"unprognostic (1.70e-2)"	16.3	9.1	20.6	13.9	47.0	31.5	14.7	17.8	35.7	11.8	12.9	23.6	3.4	9.2	20.7	7.5	11.7	10.9	12.9	9.4	25.3	17.3	9.2	12.4	15.9	15.2	23.8	21.0	12.9	8.0	9.9	7.3	24.3	14.8	11.4	9.8	5.7	7.5	9.3	7.3	9.1	9.3	23.4	19.6	15.8	7.9	19.9	28.0	29.6	9.4	6.1	16.6	11.0	10.7	9.6	5.3	29.1	4.7	16.5	14.8	8.6	4.9	4.2	11.0	2.9	5.4	14.3	7.8	11.1	15.7	9.8	9.3	2.5	2.9	7.4	7.7	8.0	5.3	4.5	6.5	6.9	13.4	7.8	5.0	10.6	2.8	3.5	11.7	5.6	6.1	10.3	7.1	14.5	26.2	17.4	44.5	6.3	7.7	6.0	22.1	3.0	5.3	8.8	4.8	2.4	7.3	9.3	5.9	6.3	11.6	4.2	5.7	3.9	6.5	6.1	8.1	8.7	4.6	5.1	53.3	8.7	3.3	4.6	6.0	8.5	6.5	7.9	3.3	2.4	6.4	29.1	3.4	8.9	12.7	4.7	13.7	9.6	10.4	14.4	5.3	8.8	14.8	12.6	12.8	16.5	4.6	3.9	8.1	8.6	20.6	47.0	17.8	24.6	25.3	17.3	23.8	21.0	14.8	28.0	14.9	6.2	24.4	8.9	23.8	10.8	8.9	5.1	9.4	10.3	8.7	15.7	10.0	0.0	4.6	2.7	42.9	6.0	0.0	3.2	25.8	15.5	10.4	17.4	8.9	10.5	4.8	14.5	35.6	15.3	3.2	9.2	9.4	16.9	7.2	7.4	20.2	5.7	3.5	8.9	6.9	9.2	6.5	27.8	6.5	7.6	22.6	11.4	27.7	5.5	11.8
CDK18	"PCTAIRE3, PCTK3"	ENSG00000117266	"Cyclin dependent kinase 18"	Q07002	1	205504595-205532793	"Enzymes, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 98.7;heart muscle: 58.9"	"Cell type enhanced"	"Detected in many"	12	"Collecting duct cells: 69.8;Paneth cells: 98.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"intermediate monocyte: 2.1"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HBEC3-KT: 20.1;HeLa: 17.7;hTERT-RPE1: 17.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA045429	Approved		Approved	"Actin filaments"		No	No			"Actin filaments"		"HPA045429: AB_10961257"	"unprognostic (7.95e-2)"	"unprognostic (3.42e-1)"	"unprognostic (1.51e-1)"	"unprognostic (1.33e-1)"	"unprognostic (4.38e-2)"	"unprognostic (1.30e-1)"	"unprognostic (7.06e-3)"	"unprognostic (2.93e-1)"	"unprognostic (2.95e-1)"	"unprognostic (1.13e-1)"	"unprognostic (8.89e-2)"	"unprognostic (2.81e-1)"	"prognostic unfavorable (5.07e-6)"	"unprognostic (6.07e-2)"	"unprognostic (1.45e-1)"	"unprognostic (6.12e-2)"	"prognostic favorable (2.81e-5)"	2.6	4.3	13.6	2.7	31.8	1.0	2.4	4.2	25.0	7.6	6.9	38.1	20.2	17.3	3.4	4.0	2.7	5.7	6.4	58.9	22.1	16.2	13.7	4.7	6.5	1.9	47.8	16.7	7.5	10.7	3.7	4.0	9.6	22.1	3.1	6.1	5.3	16.5	23.5	3.9	1.6	15.1	4.8	98.7	3.5	9.1	0.9	36.4	0.4	4.8	1.4	2.5	3.7	4.7	0.1	1.4	0.0	2.1	0.6	0.9	0.6	11.7	0.8	0.1	0.6	0.0	0.0	12.7	0.2	2.4	0.5	3.1	5.3	8.8	7.0	1.8	0.1	1.0	10.6	2.6	20.1	0.5	1.9	2.3	1.6	17.7	5.4	2.3	0.0	0.0	1.3	1.0	0.0	0.4	17.2	0.0	10.0	0.1	8.5	0.1	9.5	0.6	0.3	10.0	3.4	0.4	0.9	0.0	8.8	1.9	7.5	4.1	1.6	3.6	1.7	7.8	14.7	7.9	3.4	0.0	0.0	4.8	0.0	0.0	2.4	1.1	1.4	0.1	5.0	2.0	0.0	0.8	0.0	0.1	2.1	0.9	0.0	0.2	0.0	1.4	0.1	0.3	0.0	0.0	0.6	0.0	0.0	0.0	0.6	13.6	31.8	4.2	19.7	22.1	16.2	47.8	16.7	22.1	36.4	0.0	0.3	0.0	6.7	3.1	4.7	25.0	7.6	0.0	1.2	69.8	0.0	4.9	6.6	15.9	1.6	1.9	20.6	0.0	5.8	1.9	4.8	1.9	0.0	3.9	5.1	0.0	5.8	1.3	1.6	2.8	0.9	3.6	3.3	7.2	12.9	19.1	6.3	98.2	1.4	15.4	1.2	6.5	12.5	1.4	10.0	1.1	1.6	0.5	11.5	5.9
CDK19	"bA346C16.3, CDC2L6, CDK11, KIAA1028"	ENSG00000155111	"Cyclin dependent kinase 19"	Q9BWU1	6	110609978-110815958	"Enzymes, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 31.1"	"Cell type enhanced"	"Detected in many"	6	"Early spermatids: 84.5;Late spermatids: 95.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"neutrophil: 8.5"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA007053	Approved		Approved	Nucleoplasm,Vesicles		NA	NA			"Nucleoplasm, Vesicles"		"HPA007053: AB_1233803"	"unprognostic (1.66e-2)"	"unprognostic (1.84e-1)"	"unprognostic (3.63e-1)"	"unprognostic (3.00e-3)"	"unprognostic (1.62e-1)"	"unprognostic (2.66e-3)"	"prognostic unfavorable (3.56e-4)"	"unprognostic (1.47e-2)"	"unprognostic (2.96e-2)"	"unprognostic (2.00e-3)"	"unprognostic (3.94e-1)"	"unprognostic (4.04e-1)"	"prognostic unfavorable (4.72e-5)"	"unprognostic (1.75e-1)"	"unprognostic (9.78e-2)"	"unprognostic (6.51e-2)"	"unprognostic (9.50e-3)"	5.3	3.3	18.1	6.1	29.4	9.7	6.0	13.8	21.3	6.6	6.3	31.1	2.4	4.8	9.6	3.7	7.8	5.3	7.8	4.1	20.8	10.1	6.3	4.6	6.2	8.0	22.1	12.9	9.7	3.1	8.0	4.1	10.5	14.4	25.8	6.1	3.4	4.5	5.9	3.2	7.9	5.9	7.1	20.8	7.0	6.5	16.4	26.3	6.1	5.8	1.3	8.4	5.9	6.4	1.3	1.8	8.5	2.2	1.3	0.8	0.6	3.6	3.9	13.7	16.5	7.4	10.7	7.1	11.9	12.7	4.5	5.9	4.9	4.1	9.3	4.3	8.3	9.0	2.1	5.2	2.5	10.3	11.5	3.0	15.8	5.8	5.7	4.5	6.4	11.9	7.3	5.6	6.1	9.5	11.3	4.4	7.9	4.8	13.0	9.6	5.9	8.6	9.6	1.3	5.2	2.7	9.2	7.0	3.5	5.2	6.7	7.0	13.0	9.0	7.4	10.6	4.8	2.5	23.6	4.9	9.4	5.0	18.9	7.2	1.4	1.9	8.0	9.9	8.7	9.7	3.3	2.2	1.5	0.8	1.2	0.8	1.1	0.7	0.7	1.8	1.3	0.5	0.7	8.5	1.3	0.7	0.9	0.8	0.6	18.1	29.4	13.8	21.3	20.8	10.1	22.1	12.9	14.4	26.3	3.0	16.2	8.1	13.2	8.8	17.3	6.2	12.7	4.0	7.9	15.7	15.7	5.4	1.7	7.5	84.5	11.7	13.8	0.0	4.1	17.1	10.8	49.2	6.9	10.5	14.4	22.3	12.1	14.7	33.3	95.4	10.0	18.4	25.3	3.6	14.2	34.3	6.0	17.5	15.2	5.6	14.1	6.5	8.5	38.1	14.1	14.2	6.6	12.8	12.9	7.4
CDK2		ENSG00000123374	"Cyclin dependent kinase 2"	P24941	12	55966769-55972784	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, DNA damage, DNA repair, Meiosis, Mitosis"	"Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	9	"Cytotrophoblasts: 78.7;Extravillous trophoblasts: 67.5;Melanocytes: 82.7;Syncytiotrophoblasts: 142.8"	"Cancer enhanced"	"Detected in all"		"melanoma: 88.3"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"SK-MEL-30: 107.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"CAB013115, HPA066915"	Enhanced		Enhanced	Nucleoplasm,Centrosome,Cytosol		NA	NA			Nucleoplasm	"Centrosome, Cytosol"	"CAB013115: AB_2536375, HPA066915: AB_2685748"	"unprognostic (2.36e-2)"	"unprognostic (2.60e-1)"	"unprognostic (3.71e-2)"	"unprognostic (1.83e-2)"	"unprognostic (1.75e-1)"	"prognostic unfavorable (9.94e-4)"	"prognostic unfavorable (8.61e-5)"	"unprognostic (3.48e-2)"	"unprognostic (1.31e-1)"	"unprognostic (4.67e-2)"	"unprognostic (5.38e-3)"	"unprognostic (4.69e-3)"	"prognostic unfavorable (1.46e-10)"	"unprognostic (1.05e-1)"	"unprognostic (1.76e-1)"	"unprognostic (6.16e-2)"	"unprognostic (6.75e-2)"	10.7	7.6	4.5	20.8	6.5	18.7	11.5	4.2	4.3	12.6	11.6	3.5	6.0	6.1	10.7	6.4	13.6	10.8	12.6	10.1	5.4	2.2	8.3	16.7	19.5	12.2	6.0	2.0	14.2	8.3	5.2	4.2	49.0	7.3	10.8	9.1	51.2	9.3	9.9	10.8	14.6	9.3	11.8	5.0	12.5	10.1	7.8	5.1	39.3	9.5	10.7	14.7	16.7	10.1	9.3	10.8	5.2	3.9	4.5	7.6	4.3	16.8	9.1	20.1	11.1	4.1	5.3	37.0	21.0	11.0	26.2	24.5	19.2	16.3	16.1	15.8	7.8	10.5	10.8	15.3	9.2	26.6	18.9	15.0	18.5	15.1	7.3	1.3	14.6	13.4	2.8	2.3	17.7	6.1	7.6	13.2	16.7	17.5	14.7	18.1	13.0	30.3	12.4	8.0	11.5	13.6	29.6	19.3	12.1	7.6	16.6	8.3	10.7	24.0	8.8	107.8	12.0	19.0	10.7	7.3	18.1	17.5	13.9	15.3	8.3	9.6	20.0	10.3	10.7	15.6	5.2	3.6	3.1	7.0	3.9	7.0	9.3	3.2	5.0	2.7	6.1	3.0	5.3	1.7	4.5	1.6	10.8	7.6	4.3	4.5	6.5	4.2	4.3	5.4	2.2	6.0	2.0	7.3	5.1	14.9	3.7	5.2	20.1	24.8	0.0	2.6	12.7	5.3	9.1	1.8	0.0	78.7	1.7	10.5	0.4	15.0	2.1	0.0	5.0	67.5	17.6	10.9	10.4	8.9	11.6	1.6	5.2	8.6	4.8	0.2	13.8	6.3	82.7	47.7	6.3	3.8	9.0	0.0	4.2	3.8	3.4	0.0	14.4	2.9	7.7	27.5	142.8	5.7	6.8	18.0
CDK20	"CCRK, p42"	ENSG00000156345	"Cyclin dependent kinase 20"	Q8IZL9	9	87966441-87974753	"Enzymes, Predicted intracellular proteins"	"Cell cycle, Cell division"	"Developmental protein, Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"Ciliated cells: 25.4;Spermatocytes: 25.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"NK-cell: 7.2"	"Group enriched"	"Detected in many"	7	"NK-cells: 7.2;T-cells: 5.0"	"Cell line enhanced"	"Detected in many"		"SCLC-21H: 14.4;THP-1: 21.7"	"Low region specificity"	"Detected in all"							"HPA007666, HPA027379, HPA027401"	Enhanced		Supported	Nucleoplasm		NA	NA			Nucleoplasm		"HPA007666: AB_10600002, HPA027379: AB_10599939, HPA027401: AB_10601553"	"unprognostic (4.60e-2)"	"unprognostic (6.48e-2)"	"unprognostic (1.69e-2)"	"prognostic favorable (2.59e-4)"	"unprognostic (2.32e-1)"	"unprognostic (4.33e-3)"	"unprognostic (2.81e-4)"	"unprognostic (6.33e-2)"	"unprognostic (1.45e-1)"	"unprognostic (1.34e-1)"	"unprognostic (2.83e-3)"	"unprognostic (4.04e-2)"	"prognostic favorable (2.12e-5)"	"unprognostic (8.24e-3)"	"unprognostic (5.77e-2)"	"unprognostic (3.83e-2)"	"unprognostic (1.42e-2)"	2.6	16.2	10.8	2.4	13.0	1.6	4.1	8.7	17.1	8.7	5.0	6.1	5.1	5.3	7.2	6.0	2.8	19.5	5.6	3.0	8.6	10.7	8.2	3.2	4.0	2.0	5.8	14.3	9.5	4.8	7.6	10.8	3.1	9.3	6.1	3.4	7.7	3.6	8.6	2.1	3.6	7.6	5.5	3.1	1.6	3.7	17.7	5.2	0.8	6.8	1.2	1.1	6.3	3.0	0.1	0.8	0.4	0.8	7.2	5.0	1.3	2.4	3.0	2.4	7.6	1.7	2.4	1.0	2.2	4.2	5.9	5.5	0.7	3.6	0.0	3.3	3.6	10.3	3.1	0.0	2.1	2.4	5.9	2.5	0.0	1.9	0.0	7.4	2.8	3.4	1.9	4.4	9.3	3.8	4.6	0.0	5.3	0.3	0.0	1.7	7.1	1.9	0.8	1.9	5.3	1.1	0.0	0.0	0.1	7.4	2.0	14.4	4.1	2.5	3.0	3.6	0.8	3.3	21.7	0.0	2.6	1.0	0.5	2.4	3.8	3.6	0.0	9.3	1.9	2.8	0.0	0.7	0.4	1.3	0.8	0.5	0.0	3.0	1.9	0.7	0.1	5.0	3.2	0.1	7.2	0.7	0.8	2.7	1.3	10.8	13.0	8.7	17.1	8.6	10.7	5.8	14.3	9.3	5.2	3.0	4.1	0.0	1.5	1.9	5.2	2.0	2.5	25.4	5.7	1.8	2.0	3.6	1.7	4.2	4.7	0.5	5.4	0.0	1.3	1.9	3.3	2.5	1.1	0.9	0.9	7.9	0.0	0.6	0.0	1.7	4.0	1.1	0.0	0.0	2.0	4.8	1.5	0.0	6.3	5.3	13.5	6.5	2.3	25.0	2.9	1.9	3.3	0.5	2.9	0.7
CDK3		ENSG00000250506	"Cyclin dependent kinase 3"	Q00526	17	76000906-76005999	"Enzymes, Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"	10	"Basal keratinocytes: 2.4;Distal tubular cells: 1.7;Ductal cells: 1.4;Exocrine glandular cells: 2.0;Melanocytes: 3.3;Pancreatic endocrine cells: 2.0;Suprabasal keratinocytes: 2.4"	"Low cancer specificity"	"Detected in some"							"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in many"			HPA007420	Uncertain		Approved	Cytosol		NA	NA			Cytosol		"HPA007420: AB_1078490"	"unprognostic (6.77e-2)"	"unprognostic (1.26e-1)"	"unprognostic (3.69e-2)"	"unprognostic (1.87e-3)"	"unprognostic (6.41e-2)"	"unprognostic (1.10e-3)"	"unprognostic (1.61e-2)"	"unprognostic (1.56e-1)"	"unprognostic (8.12e-3)"	"unprognostic (1.34e-1)"	"unprognostic (9.80e-5)"	"unprognostic (1.19e-2)"	"unprognostic (6.75e-7)"	"unprognostic (4.25e-2)"	"unprognostic (1.63e-2)"	"unprognostic (4.68e-1)"	"unprognostic (4.47e-4)"	4.1	3.7	2.7	4.7	2.4	5.5	4.7	4.2	2.4	4.9	4.8			6.5	5.6	5.7	4.0	5.0	4.8	2.6	2.8	3.0	5.9	13.0	5.3	5.5	3.0		6.7	5.9	4.2	8.3	5.0		10.3	5.3		5.2	4.5	0.9	14.7	9.1	4.1	3.9	8.8	5.2	5.6			8.2		5.4	3.8	5.1	1.2	1.8	1.5	1.5	1.7	2.7	1.6	4.2	7.8	11.6	6.1	6.8	8.1	24.2	5.3	3.4	5.9	5.5	6.1	8.9	6.4	4.7	4.6	4.8	9.9	9.3	3.9	3.9	3.3	14.9	13.3	15.5	6.0	5.7	4.6	13.6	7.3	8.6	5.2	4.3	10.6	6.5	4.0	5.9	4.6	3.8	10.9	5.4	20.7	5.8	3.7	8.5	10.0	5.1	5.9	5.5	14.1	8.4	22.6	3.5	11.4	2.6	12.2	15.7	9.5	5.5	16.1	9.5	6.8	5.6	9.6	7.2	6.0	4.9	4.7	3.9	0.0	1.5	0.0	2.1	1.0	0.2	1.2	1.6	1.2	1.8	0.3	2.7	0.5	1.5	1.7	0.6	1.6	2.7	1.6											0.0	0.0	0.0	0.0	2.4	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	1.7	1.4	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	3.3	0.0	0.0	0.0	2.0	0.0	0.0	0.7	0.0	0.0	0.8	0.0	0.0	2.4	0.0	0.0	0.0	0.0
CDK4	PSK-J3	ENSG00000135446	"Cyclin dependent kinase 4"	P11802	12	57747727-57756013	"Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division"	"Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes, Disease mutation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Group enriched"	"Detected in all"	10	"HBEC3-KT: 128.1;LHCN-M2: 141.4;RH-30: 445.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006024, CAB013116, CAB069405"	Supported		Supported	"Nucleoplasm,Nuclear membrane,Nucleoli,Cytosol"		NA	NA			Cytosol	"Nucleoplasm, Nuclear membrane, Nucleoli"	"CAB013116: AB_2536376, CAB069405: AB_1613464, HPA006024: AB_2667497"	"unprognostic (8.88e-2)"	"unprognostic (2.53e-1)"	"unprognostic (5.27e-2)"	"unprognostic (9.01e-2)"	"unprognostic (2.21e-1)"	"unprognostic (1.10e-1)"	"prognostic unfavorable (2.09e-7)"	"unprognostic (7.39e-2)"	"unprognostic (3.23e-3)"	"unprognostic (2.93e-2)"	"unprognostic (3.19e-2)"	"unprognostic (9.10e-2)"	"prognostic unfavorable (3.15e-5)"	"unprognostic (3.32e-1)"	"unprognostic (1.67e-1)"	"unprognostic (3.64e-1)"	"unprognostic (1.57e-2)"	32.2	43.1	13.8	22.2	15.7	24.0	45.0	13.1	17.9	36.3	28.2	20.1	22.8	15.2	51.4	28.1	29.9	31.0	32.3	27.4	14.5	12.1	24.0	36.9	26.8	26.4	18.3	13.7	61.4	54.4	18.9	34.2	25.0	16.0	37.2	26.9	26.2	29.3	24.1	27.8	25.6	20.7	34.1	13.5	27.2	23.9	24.6	17.5	29.2	54.3	32.1	27.5	33.6	30.9	29.6	25.5	2.6	19.9	15.8	32.1	22.2	9.5	11.1	14.6	13.0	13.4	11.8	9.8	5.5	18.0	24.4	20.2	15.8	9.1	13.9	10.0	8.6	14.4	7.4	20.2	128.1	18.5	6.8	9.3	13.0	7.5	11.1	15.7	14.7	9.0	11.6	9.4	14.9	17.2	16.6	15.6	13.3	13.8	12.0	141.4	13.9	14.1	12.0	17.2	10.0	11.2	12.6	445.0	12.9	7.6	15.1	13.3	12.4	9.8	7.4	14.7	10.5	9.8	17.9	7.1	11.4	10.8	12.9	11.1	6.0	9.7	21.4	10.5	13.7	13.7	1.7	14.3	2.6	26.2	19.9	27.0	29.6	23.1	23.7	21.0	28.1	32.1	28.5	1.2	15.8	12.0	25.5	16.6	22.2	13.8	15.7	13.1	17.9	14.5	12.1	18.3	13.7	16.0	17.5	20.8	25.0	32.0	62.9	79.7	15.3	0.5	48.4	4.0	23.9	45.4	9.8	64.6	59.7	71.7	10.1	44.2	11.3	23.3	53.6	108.9	77.4	41.8	68.1	32.1	111.7	17.5	43.8	34.4	23.2	6.8	59.2	34.0	50.6	54.1	33.5	51.3	55.4	7.0	59.4	66.3	15.3	32.3	54.2	25.9	40.3	75.3	39.1	34.1	78.3	32.5
CDK5	PSSALRE	ENSG00000164885	"Cyclin dependent kinase 5"	Q00535	7	151053812-151058530	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Apoptosis, Biological rhythms, Cell cycle, Cell division, Neurogenesis"	"Kinase, Serine/threonine-protein kinase, Transferase"	"Lissencephaly, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 36.1"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB008909, HPA064535"	Enhanced		Supported	"Nucleoplasm,Plasma membrane,Cell Junctions"		NA	NA			"Nucleoplasm, Plasma membrane"	"Cell Junctions"	"CAB008909: , HPA064535: AB_2685280"	"unprognostic (1.21e-1)"	"unprognostic (3.23e-2)"	"unprognostic (4.22e-2)"	"unprognostic (1.43e-1)"	"unprognostic (1.10e-1)"	"unprognostic (3.48e-1)"	"unprognostic (5.67e-3)"	"unprognostic (1.05e-2)"	"unprognostic (1.22e-1)"	"unprognostic (5.78e-3)"	"unprognostic (6.25e-3)"	"unprognostic (3.35e-1)"	"unprognostic (4.47e-2)"	"unprognostic (1.46e-2)"	"unprognostic (1.77e-1)"	"unprognostic (2.88e-1)"	"unprognostic (1.11e-1)"	4.5	11.3	24.4	6.9	30.4	6.1	5.3	13.6	36.1	5.3	6.1	6.7	4.5	7.9	4.5	17.4	6.5	5.0	6.2	5.8	25.0	19.7	9.0	7.7	5.3	6.0	15.4	15.4	3.2	5.8	8.9	7.9	5.3	20.8	5.8	6.3	3.2	6.0	6.3	5.7	6.5	6.2	6.0	8.6	5.2	5.7	3.1	7.7	6.8	6.0	3.6	6.9	6.7	3.1	6.6	21.5	9.0	21.7	9.5	14.9	10.6	11.7	14.1	13.2	21.5	14.6	10.7	6.6	7.8	12.8	15.3	12.6	10.0	11.0	11.6	27.9	9.6	22.8	8.4	21.2	11.8	7.0	9.1	12.6	12.7	12.4	9.9	9.6	10.2	23.9	11.6	8.9	12.6	3.9	21.4	10.3	18.2	12.9	8.5	15.3	22.7	27.6	21.0	14.5	18.9	22.3	13.5	5.4	12.9	13.3	8.9	8.4	35.9	11.2	13.8	14.7	12.6	6.4	9.0	8.7	15.1	3.9	11.3	14.5	19.7	21.5	4.5	23.7	14.8	27.0	7.8	19.0	9.0	6.9	21.7	5.4	6.6	6.8	6.8	21.5	5.9	5.1	6.2	2.8	9.5	16.4	12.8	14.9	10.6	24.4	30.4	13.6	36.1	25.0	19.7	15.4	15.4	20.8	7.7	0.0	5.9	11.5	6.4	3.2	11.5	3.2	7.6	8.1	7.9	10.4	2.0	20.0	33.2	19.0	0.6	6.3	7.1	0.0	16.6	10.2	6.6	5.0	31.0	9.6	37.8	0.0	8.6	6.2	21.6	0.9	4.4	14.3	10.1	20.8	9.1	11.5	18.7	14.4	10.6	24.0	4.7	6.5	5.0	2.6	9.7	5.5	7.6	8.5	9.6	7.6
CDK6	PLSTIRE	ENSG00000105810	"Cyclin dependent kinase 6"	Q00534	7	92604921-92836594	"Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Differentiation"	"Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes, Disease mutation, FDA approved drug targets, Primary microcephaly"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 74.6"	"Cell type enhanced"	"Detected in many"	8	"Early spermatids: 219.8;Late spermatids: 186.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"MOLT-4: 93.5;REH: 45.7"					"Low region specificity"	"Detected in all"			"HPA002637, CAB004363"	Enhanced		Supported	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"CAB004363: AB_627242, HPA002637: AB_1846432"	"unprognostic (1.29e-1)"	"unprognostic (5.98e-3)"	"unprognostic (9.07e-2)"	"unprognostic (2.78e-3)"	"unprognostic (2.56e-2)"	"unprognostic (3.24e-2)"	"unprognostic (3.39e-1)"	"unprognostic (2.42e-3)"	"unprognostic (7.19e-2)"	"unprognostic (7.78e-3)"	"prognostic unfavorable (3.86e-6)"	"unprognostic (4.06e-2)"	"unprognostic (4.09e-3)"	"unprognostic (1.09e-1)"	"unprognostic (7.88e-2)"	"unprognostic (1.93e-1)"	"prognostic unfavorable (2.33e-5)"	6.6	11.3	6.0	9.1	7.5	22.5	5.9	2.4	6.0	7.8	10.0	9.6	5.7	7.5	6.0	5.9	8.5	4.6	7.8	6.6	6.9	4.2	6.5	7.5	7.3	7.4	7.0	5.2	5.0	10.0	25.7	4.2	20.5	7.5	6.1	9.2	4.4	10.9	6.1	2.0	11.6	9.4	9.8	7.5	6.3	10.8	5.4	8.0	74.6	4.3	9.2	10.3	6.7	9.0	3.6	5.6	6.5	4.8	3.9	7.1	2.3	6.2	2.9	8.0	5.1	2.3	2.6	1.7	6.4	4.0	3.2	3.0	7.8	4.8	4.8	3.7	4.3	2.0	3.8	4.4	9.2	7.6	10.5	3.1	12.0	5.5	7.5	1.4	7.4	0.6	2.6	5.0	4.3	20.4	3.0	1.2	19.6	11.5	13.3	5.7	1.2	93.5	0.8	2.5	7.9	2.6	45.7	28.1	8.1	4.4	0.1	4.2	27.3	0.7	2.2	3.7	6.1	0.1	12.3	4.7	10.5	16.5	4.1	12.9	7.1	0.1	6.4	1.5	25.5	13.9	4.9	1.9	6.5	5.2	3.9	5.9	2.0	5.5	5.6	4.0	3.6	7.1	4.0	1.1	3.9	4.8	5.6	2.8	2.3	6.0	7.5	2.4	6.0	6.9	4.2	7.0	5.2	7.5	8.0	23.8	3.0	11.9	19.5	53.5	0.2	14.8	25.5	4.0	27.3	21.0	0.0	42.7	8.3	31.7	219.8	24.1	11.0	0.0	20.1	3.4	21.6	18.1	24.3	18.4	15.0	0.0	16.1	7.4	23.4	186.0	4.6	21.9	18.6	20.8	46.7	0.5	63.1	14.0	3.2	5.1	0.0	6.5	22.1	2.6	46.4	44.2	14.8	20.3	68.3	23.3
CDK7	"CAK, CAK1, CDKN7, MO15, STK1"	ENSG00000134058	"Cyclin dependent kinase 7"	P50613	5	69234795-69277430	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, DNA damage, DNA repair, Transcription, Transcription regulation"	"Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	13	"Cytotrophoblasts: 97.9;Extravillous trophoblasts: 285.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004364, HPA007932, HPA008453"	Enhanced		Supported	"Nucleoplasm,Nucleoli fibrillar center,Plasma membrane,Cytosol"		NA	NA			Nucleoplasm	"Nucleoli fibrillar center, Plasma membrane, Cytosol"	"CAB004364: AB_627243, HPA007932: AB_1078492, HPA008453: "	"unprognostic (3.12e-2)"	"unprognostic (1.23e-1)"	"unprognostic (4.87e-2)"	"unprognostic (4.53e-2)"	"unprognostic (3.29e-2)"	"unprognostic (4.64e-2)"	"unprognostic (2.49e-3)"	"unprognostic (1.64e-2)"	"unprognostic (7.77e-3)"	"unprognostic (1.81e-2)"	"prognostic unfavorable (3.09e-4)"	"unprognostic (3.40e-2)"	"prognostic unfavorable (9.42e-7)"	"unprognostic (2.61e-1)"	"unprognostic (2.38e-1)"	"unprognostic (3.86e-2)"	"unprognostic (1.55e-2)"	7.9	12.9	10.9	6.2	15.2	44.1	14.0	10.8	14.7	9.4	12.7	6.0	6.3	15.8	9.4	8.6	23.4	18.5	16.5	8.1	11.5	9.3	13.8	10.6	10.1	8.8	7.6	9.7	7.7	9.1	3.3	16.2	22.9	11.2	11.2	14.8	6.6	13.2	6.5	15.9	15.4	9.8	12.1	9.2	7.9	13.9	29.0	7.8	12.1	20.0	15.6	15.5	10.7	11.7	15.6	15.0	22.4	11.3	12.4	15.3	7.8	3.6	7.7	1.8	0.5	2.4	11.6	14.7	6.4	7.7	10.7	17.4	16.6	1.9	2.8	10.1	1.7	12.4	2.5	1.4	2.8	5.8	1.3	7.0	0.4	8.1	7.9	0.4	6.7	3.2	14.3	13.8	9.0	2.8	9.4	13.5	15.6	10.3	4.5	4.9	0.7	4.0	14.7	1.7	3.7	7.4	6.6	0.4	1.1	1.6	1.0	0.6	6.5	1.5	5.8	3.4	6.4	11.6	0.6	2.6	0.0	3.2	0.9	5.1	4.8	8.4	3.7	0.8	4.0	0.8	7.3	10.9	22.4	8.6	11.3	14.8	12.4	12.9	15.3	15.0	15.6	11.1	13.2	10.0	12.4	8.0	11.2	12.8	7.8	10.9	15.2	10.8	12.7	11.5	9.3	7.6	9.7	11.2	7.8	14.9	10.4	2.4	16.5	51.3	6.3	8.9	5.1	48.2	10.3	5.2	11.8	97.9	13.3	21.5	6.2	11.3	9.2	0.0	19.0	285.4	10.2	19.9	15.1	6.6	21.2	1.6	2.9	6.7	8.2	3.6	6.9	10.2	6.8	9.0	11.4	9.0	22.5	14.0	6.7	20.7	8.2	25.8	12.2	25.4	15.8	36.6	54.0	9.6	11.8	28.6
CDK8	K35	ENSG00000132964	"Cyclin dependent kinase 8"	P49336	13	26254104-26405238	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Activator, Kinase, Repressor, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"Early spermatids: 55.8;Late spermatids: 83.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044721			Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA044721: AB_2679059"	"unprognostic (3.28e-3)"	"unprognostic (2.25e-3)"	"unprognostic (2.08e-1)"	"unprognostic (3.88e-3)"	"unprognostic (2.30e-2)"	"unprognostic (1.05e-2)"	"unprognostic (6.42e-3)"	"unprognostic (1.85e-2)"	"unprognostic (5.00e-2)"	"unprognostic (8.57e-2)"	"unprognostic (2.52e-1)"	"unprognostic (3.18e-3)"	"unprognostic (2.12e-1)"	"prognostic favorable (9.23e-4)"	"unprognostic (1.43e-2)"	"unprognostic (1.88e-1)"	"unprognostic (6.37e-2)"	7.6	8.8	10.1	10.4	8.5	5.2	5.6	26.9	11.3	5.9	24.0	6.0	13.8	13.8	11.2	6.5	10.0	7.0	11.2	7.6	8.3	7.3	9.4	10.4	6.7	5.2	7.8	7.9	6.1	12.7	8.4	10.2	10.6	8.2	7.8	11.2	4.6	9.0	19.2	9.7	6.1	15.0	12.7	6.0	6.4	11.7	16.3	9.9	12.8	6.4	6.9	7.2	15.5	11.0	1.9	1.7	3.4	1.6	1.0	2.1	1.3	6.9	5.7	11.6	11.8	6.2	7.6	7.2	13.4	9.2	10.0	7.2	16.6	9.7	7.4	5.9	6.9	8.0	8.6	13.3	9.0	12.6	17.1	7.4	14.1	4.6	5.7	4.3	22.0	8.1	5.5	8.7	7.5	12.7	5.5	7.3	12.1	21.8	0.0	9.0	7.4	16.8	10.3	9.2	10.5	7.1	10.6	11.5	5.1	5.8	6.5	9.9	5.8	5.7	10.9	9.8	9.6	3.9	10.1	7.4	6.4	8.2	11.7	7.3	5.7	10.1	13.6	4.0	9.3	7.6	0.4	0.9	3.4	1.1	1.6	1.9	1.0	1.5	2.1	1.7	1.9	2.1	1.7	0.0	1.0	1.2	1.0	0.6	1.3	10.1	8.5	26.9	11.3	8.3	7.3	7.8	7.9	8.2	9.9	8.9	4.1	4.5	6.7	17.5	19.1	5.0	7.6	0.0	5.7	1.8	23.6	7.2	8.3	8.5	55.8	6.8	9.7	0.0	7.2	8.3	9.3	11.0	0.0	5.4	7.1	17.5	8.1	6.2	7.5	83.1	7.2	6.6	8.5	8.2	7.8	7.1	10.6	11.5	7.8	11.5	16.6	6.5	11.3	27.8	17.5	20.8	8.1	6.9	10.5	9.1
CDK9	"C-2k, CDC2L4, PITALRE, TAK"	ENSG00000136807	"Cyclin dependent kinase 9"	P50750	9	127785679-127790787	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"DNA damage, DNA repair, Transcription, Transcription regulation"	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004216, HPA006738"	Supported		Approved	"Nucleoplasm,Cytoplasmic bodies"		NA	NA			Nucleoplasm	"Cytoplasmic bodies"	"CAB004216: AB_627245, HPA006738: AB_1078493"	"unprognostic (3.60e-1)"	"unprognostic (1.71e-1)"	"unprognostic (5.44e-3)"	"unprognostic (1.04e-3)"	"unprognostic (1.93e-1)"	"unprognostic (3.97e-2)"	"unprognostic (2.07e-1)"	"unprognostic (5.84e-2)"	"unprognostic (2.66e-1)"	"unprognostic (8.36e-2)"	"unprognostic (1.24e-3)"	"unprognostic (3.11e-2)"	"prognostic unfavorable (8.92e-4)"	"unprognostic (1.37e-1)"	"unprognostic (1.00e-1)"	"unprognostic (3.52e-2)"	"unprognostic (8.78e-3)"	26.2	27.0	22.8	18.9	22.4	33.9	17.4	31.0	26.8	23.1	21.9	22.9	24.7	16.6	22.5	20.1	22.7	29.1	21.5	22.9	26.3	23.4	18.5	48.7	23.3	26.6	23.4	18.8	43.7	29.1	15.5	28.4	19.8	20.6	20.7	10.8	18.7	20.6	21.6	14.6	26.6	21.4	21.0	17.9	29.0	17.7	22.3	16.1	29.3	25.8	18.3	24.2	17.0	17.6	6.0	8.9	5.1	6.4	18.6	9.9	2.9	9.0	16.4	10.3	11.3	11.7	9.2	13.5	9.3	13.7	9.7	8.8	12.2	10.2	15.9	10.9	10.5	13.4	18.3	6.8	15.2	3.7	14.2	8.1	14.8	17.8	10.0	17.1	14.3	23.8	16.1	18.6	10.3	11.6	12.6	20.0	14.2	12.8	21.3	8.7	23.8	15.6	21.6	22.8	13.7	17.6	45.2	8.8	22.7	14.1	10.1	10.2	12.2	14.0	14.8	8.3	8.4	18.6	13.6	22.9	11.7	13.2	10.0	9.0	38.9	29.9	14.2	10.9	9.8	10.6	3.7	3.4	4.9	9.9	4.5	9.9	3.5	5.6	7.9	4.4	6.0	6.3	7.7	5.1	18.6	6.4	8.9	3.8	2.9	22.8	22.4	31.0	26.8	26.3	23.4	23.4	18.8	20.6	16.1	11.9	14.3	20.4	20.9	21.4	13.1	12.9	15.3	18.7	7.9	10.4	2.0	18.7	13.3	26.6	3.2	26.7	12.9	0.0	32.7	18.8	16.4	18.5	24.3	23.6	20.6	23.8	18.5	31.9	17.0	4.3	18.1	18.9	15.1	64.9	11.8	16.2	30.5	11.8	29.4	12.7	7.5	0.0	22.7	7.5	24.0	19.3	42.9	23.5	13.1	23.1
CDKAL1	FLJ20342	ENSG00000145996	"CDK5 regulatory subunit associated protein 1 like 1"	Q5VV42	6	20534457-21232404	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"tRNA processing"	Transferase	"Diabetes mellitus"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Intestinal endocrine cells: 32.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enriched"	"Detected in all"	5	"SCLC-21H: 67.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA						"unprognostic (9.64e-2)"	"unprognostic (7.23e-3)"	"unprognostic (8.40e-2)"	"prognostic unfavorable (1.03e-4)"	"unprognostic (1.05e-1)"	"unprognostic (1.51e-2)"	"unprognostic (3.47e-2)"	"unprognostic (4.25e-3)"	"unprognostic (6.72e-3)"	"unprognostic (1.61e-3)"	"unprognostic (1.42e-1)"	"unprognostic (3.73e-2)"	"unprognostic (5.79e-3)"	"unprognostic (3.11e-2)"	"unprognostic (1.75e-2)"	"unprognostic (1.83e-2)"	"unprognostic (2.60e-2)"	18.5	9.8	10.9	18.0	12.2	14.7	13.9	24.1	10.6	16.6	11.4	14.6	9.6	8.1	19.4	12.1	12.1	13.5	11.4	10.8	9.0	7.8	10.8	9.7	11.9	13.4	12.4	7.7	16.6	14.1	12.0	29.9	12.6	11.2	10.8	12.0	14.3	15.7	11.0	22.2	15.0	11.4	13.7	13.4	13.9	11.7	11.4	13.8	22.9	17.1	13.6	19.4	13.2	12.6	8.1	5.4	3.3	11.2	12.0	9.7	3.6	2.9	1.8	4.3	5.5	2.4	3.3	4.6	3.1	2.8	4.6	6.2	3.3	2.7	7.1	7.9	2.6	5.0	3.0	5.8	3.2	6.2	12.6	3.2	6.1	3.2	4.6	3.2	6.0	4.2	3.0	3.3	4.4	4.1	2.9	4.2	4.4	7.8	2.9	3.4	2.5	7.5	7.1	3.0	3.0	2.0	4.4	5.7	6.7	5.9	3.4	67.5	3.9	3.5	5.7	4.5	3.8	4.1	3.0	4.1	5.5	3.8	2.1	5.8	4.6	12.2	6.2	2.0	3.4	9.1	1.5	3.6	3.3	7.8	5.9	6.5	8.1	7.7	7.7	4.9	7.8	9.7	8.6	1.9	12.0	11.2	5.4	8.2	3.6	10.9	12.2	24.1	10.6	9.0	7.8	12.4	7.7	11.2	13.8	6.0	2.9	13.0	8.3	9.3	7.2	8.0	7.6	2.7	7.9	7.0	5.9	8.1	10.0	7.2	12.7	9.0	4.4	0.0	6.8	8.6	7.2	4.1	12.7	4.4	6.4	11.1	32.0	8.0	7.1	5.1	8.1	7.4	3.3	14.4	7.4	5.8	7.7	5.5	4.2	7.4	10.3	6.5	5.7	10.3	12.8	9.3	7.6	10.5	6.9	5.4
CDKL1	KKIALRE	ENSG00000100490	"Cyclin dependent kinase like 1"	Q00532	14	50329404-50416461	"Enzymes, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	11	"Alveolar cells type 1: 17.9;Ciliated cells: 34.8"	"Low cancer specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"SK-BR-3: 16.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA059605, HPA065919"	Uncertain		Enhanced	Nucleoplasm,Vesicles		NA	NA			"Nucleoplasm, Vesicles"		"HPA059605: AB_2684080, HPA065919: AB_2685578"	"unprognostic (4.12e-3)"	"unprognostic (3.22e-1)"	"unprognostic (4.54e-2)"	"unprognostic (8.04e-2)"	"unprognostic (1.64e-2)"	"unprognostic (1.02e-1)"	"unprognostic (3.23e-3)"	"unprognostic (9.36e-3)"	"unprognostic (2.63e-1)"	"unprognostic (9.99e-2)"	"unprognostic (1.20e-1)"	"unprognostic (9.36e-2)"	"unprognostic (5.53e-8)"	"unprognostic (1.21e-1)"	"unprognostic (7.96e-2)"	"unprognostic (9.39e-3)"	"unprognostic (3.31e-3)"	7.1	2.1	7.5	1.8	5.1	0.9	3.0	2.7	20.2	14.1	5.9	1.6	2.5	8.4	12.1	2.3	2.6	16.4	2.6	2.9	7.1	2.4	18.8	1.1	4.3	3.0	2.0	12.3	10.5	2.0	1.4	1.4	4.9	2.9	4.0	5.7	1.6	2.5	8.4	1.7	3.0	3.0	7.7	3.1	3.7	2.0	1.9	1.4	1.3	5.0	6.1	2.1	7.0	5.6	5.7	1.3	6.0	2.5	3.8	6.7	2.6	6.1	4.9	0.6	2.4	6.5	7.9	0.3	2.1	3.9	2.2	2.6	2.0	5.8	0.4	2.6	4.6	2.2	4.2	0.9	0.6	2.5	6.7	2.4	6.5	2.1	1.7	7.4	5.9	3.5	1.7	3.6	4.6	10.1	1.8	8.5	6.2	2.7	2.6	1.0	0.3	1.9	3.1	0.7	1.6	2.3	0.7	2.8	1.9	6.9	2.3	1.1	1.3	2.5	16.7	0.6	0.1	0.2	5.0	2.7	5.7	2.9	5.7	4.7	0.9	0.4	0.4	1.0	6.2	7.0	6.0	2.5	4.4	6.3	2.3	6.2	4.6	4.4	6.7	1.3	5.7	3.4	3.7	1.4	3.8	0.3	1.2	4.1	2.6	7.5	5.1	2.7	20.2	7.1	2.4	2.0	12.3	2.9	1.4	17.9	6.9	1.3	3.2	2.7	0.4	0.4	0.0	34.8	4.5	10.4	0.0	0.1	5.0	0.9	0.3	2.1	4.7	0.0	1.6	0.1	4.7	1.2	1.1	0.2	0.3	0.0	1.7	6.7	1.9	0.9	8.3	1.1	0.0	0.0	2.3	0.8	1.2	3.7	3.2	5.5	0.7	0.0	1.3	0.0	0.2	2.4	0.2	2.5	3.4	1.4
CDKL2	"KKIAMRE, P56"	ENSG00000138769	"Cyclin dependent kinase like 2"	Q92772	4	75578005-75630716	"Enzymes, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"testis: 27.7"	"Cell type enhanced"	"Detected in many"	9	"Alveolar cells type 2: 55.4;Ciliated cells: 28.1;Spermatocytes: 46.8"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"memory CD8 T-cell: 1.6"	"Lineage enhanced"	"Detected in single"		"T-cells: 1.6"	"Cell line enhanced"	"Detected in some"		"A-431: 5.7;HEK 293: 3.8;HHSteC: 4.4;RPTEC TERT1: 8.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA040672			Approved	Nucleoplasm,Centrosome		NA	NA			"Nucleoplasm, Centrosome"		"HPA040672: AB_10794744"	"unprognostic (2.07e-1)"	"unprognostic (9.96e-2)"	"unprognostic (6.91e-2)"	"unprognostic (3.80e-5)"	"unprognostic (3.43e-2)"	"unprognostic (2.71e-2)"	"unprognostic (1.59e-1)"	"unprognostic (8.14e-3)"	"unprognostic (1.58e-1)"	"unprognostic (1.62e-1)"	"unprognostic (5.85e-2)"	"unprognostic (1.27e-1)"	"prognostic favorable (6.88e-15)"	"unprognostic (5.91e-2)"	"unprognostic (1.70e-1)"	"unprognostic (1.64e-1)"	"unprognostic (7.52e-2)"	0.7	2.4	7.1	1.2	11.1	0.7	1.2	7.7	13.2	1.7	2.0	6.2	0.0	1.0	1.7	2.3	2.3	4.1	1.4	1.3	5.1	6.7	11.8	0.7	9.2	1.3	7.1	7.0	3.8	1.6	5.7	8.9	0.7	12.5	2.0	2.4	3.4	1.2	2.0	0.7	0.9	0.9	1.5	7.4	0.9	1.5	27.7	6.1	0.0	6.9	0.0	2.0	1.1	0.9	0.4	0.0	0.2	0.0	0.0	1.6	0.1	5.7	0.7	0.3	0.0	0.3	0.3	0.0	0.3	1.8	2.4	2.0	0.5	1.2	0.1	0.9	0.1	2.3	0.8	0.0	0.5	2.3	0.2	3.8	0.0	0.2	0.0	4.4	0.0	0.1	1.5	2.1	0.4	0.8	1.9	0.1	0.0	0.0	0.4	0.9	0.1	0.0	0.0	0.2	0.1	0.2	0.0	0.0	0.0	8.2	0.3	3.1	2.5	0.0	0.0	1.2	2.6	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.4	2.2	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.4	0.4	1.6	0.0	0.0	0.6	0.5	0.2	0.0	0.0	0.0	1.2	0.1	7.1	11.1	7.7	13.2	5.1	6.7	7.1	7.0	12.5	6.1	23.8	55.4	0.0	0.4	0.1	16.6	0.8	0.0	28.1	7.9	8.7	3.9	0.0	6.6	2.0	24.5	0.0	0.0	0.0	0.2	0.5	0.2	0.3	1.1	0.0	0.1	9.5	1.7	0.6	0.0	16.4	1.7	0.5	1.7	0.0	0.2	10.4	0.1	0.0	1.1	20.7	19.5	0.0	0.0	46.8	1.7	0.3	0.2	1.0	2.6	0.1
CDKL3	NKIAMRE	ENSG00000006837	"Cyclin dependent kinase like 3"	Q8IVW4	5	134286350-134371047	"Enzymes, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 33.4"	"Group enriched"	"Detected in many"	8	"Early spermatids: 261.7;Late spermatids: 219.5"	"Low cancer specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			HPA027751			Uncertain	Nucleoplasm,Vesicles		NA	NA			"Nucleoplasm, Vesicles"		"HPA027751: AB_10601256"	"unprognostic (4.70e-2)"	"unprognostic (2.15e-2)"	"unprognostic (2.35e-1)"	"unprognostic (1.48e-1)"	"unprognostic (1.43e-1)"	"unprognostic (3.98e-2)"	"unprognostic (3.43e-3)"	"unprognostic (5.93e-2)"	"unprognostic (2.12e-3)"	"unprognostic (1.49e-1)"	"unprognostic (8.47e-4)"	"unprognostic (2.82e-1)"	"unprognostic (9.85e-4)"	"unprognostic (8.33e-2)"	"unprognostic (4.88e-2)"	"unprognostic (7.10e-3)"	"unprognostic (3.43e-3)"	2.5	2.7	7.0	2.2	7.1	1.6	2.5	7.0	8.5	2.6	2.4	5.9	5.5	2.3	3.9	5.3	2.6	3.7	2.6	6.6	6.1	6.5	4.5	2.8	2.2	2.5	8.0	4.3	3.0	2.4	3.2	6.5	2.2	8.6	2.8	2.6	3.9	2.0	3.2	7.5	2.7	2.5	4.6	8.4	2.7	2.2	33.4	9.3	1.3	3.9	2.1	3.0	2.8	2.2	1.5	2.7	1.0	1.1	1.4	4.0	1.3	1.0	2.1	3.1	2.2	5.4	4.6	1.3	2.9	2.6	1.3	3.2	1.9	1.5	2.7	1.8	1.8	6.0	0.9	2.6	1.8	2.6	2.9	2.0	1.4	2.3	3.3	3.3	0.6	0.9	2.2	4.7	3.9	1.2	2.2	1.3	6.5	1.5	1.2	3.5	1.1	2.1	8.0	2.1	0.6	1.0	3.4	1.3	0.8	1.7	0.9	4.8	1.4	2.1	0.5	3.5	3.7	1.8	1.6	0.9	2.6	0.6	3.5	1.0	3.3	4.4	5.2	4.0	2.1	2.0	0.0	0.9	1.0	0.9	1.1	4.0	1.5	1.4	2.5	2.7	1.0	3.8	3.8	0.2	1.4	0.4	1.6	2.3	1.3	7.0	7.1	7.0	8.5	6.1	6.5	8.0	4.3	8.6	9.3	0.0	3.0	0.0	5.7	9.6	12.7	1.6	0.0	5.3	3.4	5.2	3.9	2.4	8.3	2.6	261.7	3.6	0.5	0.0	4.4	1.6	6.9	4.0	3.5	1.8	3.1	6.4	2.9	3.1	0.6	219.5	4.6	4.0	10.1	2.8	0.7	10.0	1.5	0.9	8.5	6.1	9.6	0.0	5.6	30.5	13.2	9.7	3.8	3.2	1.1	3.3
CDKL4		ENSG00000205111	"Cyclin dependent kinase like 4"	Q5MAI5	2	39175646-39229588	"Enzymes, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"blood: 3.2;testis: 7.9"	"Group enriched"	"Detected in some"	14	"Alveolar cells type 1: 3.0;Ciliated cells: 8.1;Club cells: 3.4;Early spermatids: 8.3;Late spermatids: 4.5;Spermatocytes: 6.5;Spermatogonia: 3.8"	"Not detected"	"Not detected"							"Group enriched"	"Detected in some"	11	"memory B-cell: 1.6;T-reg: 3.2"	"Group enriched"	"Detected in many"	25	"B-cells: 1.6;T-cells: 3.2"	"Cell line enhanced"	"Detected in some"		"HAP1: 1.9;HL-60: 5.0;RT4: 3.4;SH-SY5Y: 6.8"	"Low region specificity"	"Detected in many"							HPA067895	Uncertain					NA	NA					"HPA067895: AB_2685920"	"unprognostic (3.57e-2)"	"unprognostic (3.92e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.98e-2)"	"unprognostic (3.29e-1)"	"unprognostic (7.46e-3)"	"unprognostic (3.26e-2)"	"unprognostic (4.26e-1)"	"unprognostic (3.82e-2)"	"unprognostic (6.13e-3)"	"unprognostic (1.77e-2)"	"unprognostic (8.43e-2)"	"unprognostic (8.45e-4)"	"unprognostic (8.59e-2)"	"unprognostic (4.95e-1)"	"unprognostic (3.08e-1)"	"unprognostic (3.26e-2)"	0.3	1.1	0.3	0.0	0.6	0.0	0.3	0.1	0.7	0.2	0.0			0.0	0.2	0.0	0.0	1.0	0.1	0.1	0.5	0.9	0.2	0.0	0.4	0.1	0.2		0.3	0.3	0.0	1.6	1.2		0.4	0.0		0.0	0.1	0.1	0.2	0.1	0.0	0.1	0.2	0.3	7.9			0.3		0.1	0.1	0.0	1.6	0.0	0.0	0.0	0.0	3.2	0.0	0.1	0.0	0.5	0.4	0.0	0.1	0.1	0.3	0.2	0.0	0.0	0.2	0.1	0.1	0.1	0.3	0.0	0.0	1.9	0.0	0.0	0.1	0.0	0.1	0.3	0.7	0.3	5.0	1.1	0.3	0.0	0.1	0.0	0.2	0.1	0.4	0.0	0.3	0.3	0.0	0.0	0.0	0.5	0.7	0.1	0.0	0.0	0.0	0.2	3.4	0.6	6.8	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.6	0.0	0.0	0.2	0.1	0.0	0.0	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.2	0.0											3.0	0.0	0.0	0.2	0.1	0.0	0.3	0.0	8.1	3.4	0.0	0.0	0.2	0.0	0.2	8.3	0.0	0.0	0.0	0.2	0.4	0.2	0.3	0.0	0.0	0.2	0.0	0.0	0.0	0.0	4.5	0.3	0.0	0.0	0.0	0.0	0.2	0.3	0.0	0.4	0.0	0.3	0.0	0.0	6.5	3.8	0.0	0.0	0.0	0.0	0.0
CDKL5	"CFAP247, EIEE2, STK9"	ENSG00000008086	"Cyclin dependent kinase like 5"	O76039	X	18425583-18653629	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"	"Disease mutation, Epilepsy, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 28.0"	"Cell type enhanced"	"Detected in many"	7	"Horizontal cells: 76.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	5	"basophil: 7.7;eosinophil: 2.1;neutrophil: 4.7"	"Lineage enriched"	"Detected in many"	8	"granulocytes: 7.7"	"Cell line enhanced"	"Detected in many"		"A549: 12.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002847, CAB011577"	Approved		Supported	Nucleoplasm		NA	NA			Nucleoplasm		"CAB011577: AB_727019, HPA002847: AB_1080107"	"unprognostic (7.01e-2)"	"unprognostic (4.86e-2)"	"unprognostic (1.41e-1)"	"unprognostic (1.25e-4)"	"unprognostic (1.17e-1)"	"unprognostic (1.61e-2)"	"unprognostic (1.72e-2)"	"unprognostic (1.67e-1)"	"unprognostic (2.07e-1)"	"unprognostic (9.63e-3)"	"unprognostic (2.05e-3)"	"unprognostic (1.66e-1)"	"prognostic favorable (5.54e-4)"	"unprognostic (7.67e-3)"	"unprognostic (1.29e-1)"	"unprognostic (2.67e-3)"	"unprognostic (1.99e-1)"	3.3	3.2	8.0	1.8	24.7	3.2	4.3	3.9	28.0	5.4	2.7	7.7	1.8	1.5	4.5	2.8	5.2	2.8	3.1	5.0	8.0	3.7	6.3	2.2	6.9	1.4	3.5	13.2	6.7	4.5	6.2	5.0	5.4	5.9	6.7	2.2	2.0	3.9	4.4	3.0	3.5	1.9	4.0	5.7	2.3	4.9	14.0	5.7	1.6	5.1	0.8	2.1	5.6	4.6	0.7	1.0	7.7	1.0	0.5	0.6	0.2	1.7	12.3	3.5	3.1	3.3	4.5	2.5	2.0	3.8	2.8	3.2	4.0	2.3	1.9	0.4	1.3	5.5	0.5	4.0	3.0	5.9	0.5	2.6	0.0	7.1	3.2	1.6	0.1	0.8	2.6	3.1	6.8	7.1	1.7	1.3	2.2	0.1	2.0	4.2	1.7	0.8	0.8	7.2	1.6	3.0	0.7	3.8	0.1	2.5	9.0	0.7	4.5	4.5	1.1	2.2	7.4	1.7	0.7	7.3	4.3	1.9	7.9	1.5	0.3	0.1	0.3	2.4	0.5	4.2	7.7	1.0	2.1	0.6	0.6	0.3	0.2	0.4	0.3	0.3	0.7	0.6	0.6	4.7	0.5	0.6	1.0	0.2	0.2	8.0	24.7	3.9	28.0	8.0	3.7	3.5	13.2	5.9	5.7	23.8	19.0	0.0	8.3	0.8	16.1	12.0	5.1	6.7	9.1	7.0	31.4	20.0	6.6	5.7	27.2	4.5	0.0	0.0	8.1	2.5	3.1	18.1	1.1	3.0	3.7	76.3	2.4	4.9	5.3	41.5	5.5	1.8	0.0	2.8	1.9	27.7	6.6	0.0	4.9	7.5	19.5	32.3	4.2	2.3	9.8	1.1	39.6	0.8	1.5	24.3
CDKN3	"CDI1, KAP"	ENSG00000100526	"Cyclin dependent kinase inhibitor 3"	Q16667	14	54396849-54420218	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Cell cycle"	"Hydrolase, Protein phosphatase"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"testis: 80.3"	"Cell type enriched"	"Detected in many"	4	"Early spermatids: 2056.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"T-reg: 16.1"	"Group enriched"	"Detected in all"	5	"NK-cells: 5.8;T-cells: 16.1"	"Low cell line specificity"	"Detected in all"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"CAB005285, HPA039311, HPA058874"			Enhanced	Cytosol		NA	Yes			Cytosol		"CAB005285: AB_2078884, HPA039311: , HPA058874: AB_2683842"	"unprognostic (3.46e-2)"	"unprognostic (9.95e-2)"	"unprognostic (5.79e-2)"	"unprognostic (6.78e-3)"	"unprognostic (2.73e-1)"	"unprognostic (6.08e-2)"	"unprognostic (1.51e-3)"	"prognostic unfavorable (4.52e-4)"	"unprognostic (2.50e-3)"	"unprognostic (2.85e-3)"	"prognostic unfavorable (7.46e-4)"	"unprognostic (5.89e-2)"	"prognostic unfavorable (0.00e+0)"	"unprognostic (1.71e-1)"	"unprognostic (7.30e-2)"	"unprognostic (7.92e-2)"	"unprognostic (4.31e-2)"	2.4	1.0	1.6	6.5	1.7	12.8	1.5	1.5	2.5	1.0	4.5	0.2	0.2	3.8	0.9	1.1	4.4	0.7	0.9	3.0	1.4	1.9	1.0	1.1	1.1	8.8	1.7	1.9	0.9	0.7	0.0	1.0	2.3	2.8	0.9	5.8	0.9	1.7	0.1	3.9	1.8	4.0	2.2	1.0	2.3	1.8	80.3	0.3	18.3	1.1	6.4	9.5	2.1	1.8	2.0	1.6	1.1	1.4	5.8	16.1	2.9	55.2	21.2	16.3	16.3	2.7	3.3	9.4	13.2	19.5	28.2	31.2	16.0	27.6	27.2	9.7	20.6	29.7	40.7	24.7	16.0	52.7	32.6	11.9	13.8	15.3	26.4	2.0	17.2	9.8	1.2	1.0	17.6	30.7	9.9	17.9	26.4	6.9	34.8	33.8	39.3	23.8	14.0	5.7	54.1	46.0	14.8	14.4	5.9	14.9	12.1	6.7	8.5	24.2	14.3	10.5	12.8	29.6	14.7	6.5	12.5	42.9	19.7	31.2	8.4	9.7	18.7	20.9	24.9	22.8	0.0	1.3	1.1	1.2	1.4	0.6	2.0	5.2	4.3	1.6	0.9	2.7	2.2	0.9	5.8	0.9	1.2	16.1	2.9	1.6	1.7	1.5	2.5	1.4	1.9	1.7	1.9	2.8	0.3	0.0	0.0	0.8	3.1	8.2	1.4	9.3	0.0	0.0	1.2	1.8	2.0	9.8	0.0	2.8	2056.4	2.0	2.9	256.9	2.1	27.0	6.6	2.2	6.9	1.8	31.5	4.8	7.5	4.9	7.5	483.1	19.8	5.7	1.7	3.6	6.2	1.2	2.0	6.2	9.9	1.7	2.3	0.0	2.1	159.2	36.4	5.6	3.4	7.0	12.8	1.4
CDO1		ENSG00000129596	"Cysteine dioxygenase type 1"	Q16878	5	115804733-115816954	"Enzymes, Predicted intracellular proteins"		"Dioxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 142.1;seminal vesicle: 53.7"	"Cell type enhanced"	"Detected in many"	19	"Cytotrophoblasts: 255.3;Hepatocytes: 126.0;Syncytiotrophoblasts: 403.0"	"Group enriched"	"Detected in many"	6	"glioma: 33.6;liver cancer: 74.6"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	20	"memory CD4 T-cell: 4.1;T-reg: 1.2"	"Lineage enriched"	"Detected in single"	41	"T-cells: 4.1"	"Cell line enhanced"	"Detected in some"		"AF22: 23.0;ASC diff: 28.4;ASC TERT1: 11.0;GAMG: 8.3;HAP1: 8.1;NTERA-2: 8.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036573, HPA057503"	Enhanced		Uncertain	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA036573: AB_10696658, HPA057503: AB_2683451"	"unprognostic (2.34e-2)"	"unprognostic (3.31e-2)"	"unprognostic (1.45e-2)"	"unprognostic (2.11e-1)"	"unprognostic (1.77e-1)"	"unprognostic (1.32e-1)"	"prognostic favorable (1.91e-5)"	"unprognostic (1.14e-3)"	"unprognostic (2.63e-1)"	"unprognostic (7.23e-2)"	"unprognostic (9.28e-3)"	"unprognostic (6.69e-2)"	"unprognostic (1.58e-1)"	"unprognostic (2.74e-3)"	"unprognostic (3.06e-2)"	"unprognostic (3.70e-1)"	"unprognostic (2.06e-2)"	31.9	6.2	9.3	1.7	11.2	0.8	9.9	7.6	9.4	3.4	1.5	3.7	36.4	1.0	3.1	42.6	1.8	4.9	3.7	7.6	7.3	9.0	1.7	142.1	3.9	2.3	6.5	5.5	8.7	4.7	1.0	6.5	17.7	14.5	4.0	1.3	19.2	2.8	53.7	3.5	1.1	1.1	2.6	5.3	1.8	1.2	5.0	4.3	0.0	2.8	2.5	1.6	2.4	2.1	0.0	0.0	0.0	0.0	0.0	4.1	0.1	0.0	0.0	23.0	0.0	28.4	11.0	0.1	0.6	0.2	2.2	2.2	0.0	0.0	0.0	0.0	0.2	8.3	0.0	8.1	0.0	3.2	0.0	4.0	0.7	0.0	0.6	0.1	0.0	0.0	4.1	0.0	0.3	0.0	0.6	2.9	0.0	0.0	0.0	2.6	0.0	0.5	0.1	8.5	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	5.3	0.0	0.0	0.0	2.0	0.0	2.5	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	4.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.1	9.3	11.2	7.6	9.4	7.3	9.0	6.5	5.5	14.5	4.3	0.0	2.2	0.0	0.5	0.7	16.3	1.6	0.0	0.0	0.0	1.8	5.9	255.3	0.0	6.0	5.8	3.2	0.0	0.0	0.2	7.4	16.4	1.0	0.0	126.0	20.1	1.6	1.7	21.5	4.9	8.9	84.3	0.2	1.7	1.0	0.0	31.8	0.5	0.0	35.3	0.6	2.9	12.9	3.3	1.5	0.2	1.1	403.0	0.0	0.0	0.1
CDS1		ENSG00000163624	"CDP-diacylglycerol synthase 1"	Q92903	4	84582979-84651338	"Enzymes, Predicted membrane proteins"	"Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism"	"Nucleotidyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 48.0"	"Cell type enhanced"	"Detected in many"	6	"Ciliated cells: 105.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	5	"myeloid DC: 2.1"	"Lineage enriched"	"Detected in single"	5	"dendritic cells: 2.1"	"Cell line enhanced"	"Detected in many"		"CAPAN-2: 20.5;hTCEpi: 25.6;OE19: 19.7;SK-BR-3: 27.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036187, HPA064546"	Enhanced		Approved	"Nucleoplasm,Nuclear membrane"		NA	NA			Nucleoplasm	"Nuclear membrane"	"HPA036187: AB_10601797, HPA064546: AB_2732714"	"unprognostic (8.74e-2)"	"unprognostic (7.11e-2)"	"prognostic favorable (5.22e-4)"	"unprognostic (2.73e-3)"	"unprognostic (1.45e-2)"	"unprognostic (1.73e-1)"	"unprognostic (3.10e-3)"	"unprognostic (3.11e-1)"	"unprognostic (2.62e-1)"	"unprognostic (1.35e-1)"	"unprognostic (1.16e-1)"	"unprognostic (6.67e-2)"	"prognostic favorable (0.00e+0)"	"unprognostic (2.23e-1)"	"unprognostic (1.78e-1)"	"unprognostic (3.06e-1)"	"unprognostic (2.06e-1)"	0.9	4.6	7.4	2.5	10.4	0.4	6.7	13.3	12.9	4.3	16.7	3.3	9.3	24.8	2.0	19.1	17.4	20.5	8.8	0.5	7.4	8.4	11.9	0.6	10.6	0.8	6.4	4.7	5.5	4.5	19.3	7.1	19.7	14.1	6.1	13.6	4.2	11.2	4.3	0.2	12.9	48.0	0.8	2.4	1.0	11.5	5.1	2.3	0.9	19.3	7.9	6.1	3.5	7.4	0.0	2.1	0.0	0.0	0.0	0.4	0.0	11.4	0.2	0.6	0.1	0.0	0.0	12.0	0.0	0.1	0.3	0.2	4.8	20.5	0.0	0.9	0.0	2.4	12.1	3.7	10.2	0.1	0.8	5.7	0.0	1.8	1.1	0.0	0.3	0.8	0.1	25.6	0.0	3.7	0.4	0.0	0.7	0.0	0.0	0.0	8.1	0.1	0.0	1.7	19.7	0.8	0.0	0.0	2.4	5.7	8.7	4.8	0.1	1.3	27.8	0.0	2.3	8.5	0.2	0.0	0.0	0.6	1.2	1.5	0.0	0.0	0.0	1.2	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	7.4	10.4	13.3	12.9	7.4	8.4	6.4	4.7	14.1	2.3	14.9	36.5	0.5	24.3	25.8	16.5	1.6	17.8	105.7	27.3	38.4	9.8	49.0	3.3	23.6	5.9	2.1	44.6	0.0	20.1	9.6	1.5	29.0	0.0	0.0	10.4	20.6	21.5	1.8	2.2	3.1	0.6	5.6	0.0	1.0	45.1	28.4	30.8	31.6	0.4	14.7	28.1	0.0	1.3	2.3	3.8	47.3	47.9	0.0	47.2	32.3
CDS2		ENSG00000101290	"CDP-diacylglycerol synthase 2"	O95674	20	5126786-5197887	"Enzymes, Plasma proteins, Predicted membrane proteins"	"Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism"	"Nucleotidyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"U-266/84: 60.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA019698	Approved		Approved	"Endoplasmic reticulum"		No	No		200000	"Endoplasmic reticulum"		"HPA019698: AB_1846464"	"unprognostic (4.59e-2)"	"unprognostic (1.98e-1)"	"unprognostic (2.39e-1)"	"unprognostic (3.37e-2)"	"unprognostic (1.15e-1)"	"unprognostic (1.99e-1)"	"unprognostic (1.44e-1)"	"unprognostic (3.22e-1)"	"unprognostic (1.71e-2)"	"unprognostic (1.48e-1)"	"unprognostic (3.35e-3)"	"unprognostic (1.65e-1)"	"prognostic favorable (3.53e-9)"	"unprognostic (8.89e-2)"	"unprognostic (3.53e-1)"	"unprognostic (1.38e-1)"	"unprognostic (2.44e-1)"	14.8	16.1	22.2	9.9	25.5	12.1	12.1	36.0	34.5	12.7	11.8	21.4	6.7	5.9	12.9	9.8	10.5	12.5	10.0	26.6	22.0	34.0	16.9	14.2	14.5	10.9	26.7	24.0	10.9	7.2	20.6	15.6	11.1	28.3	15.9	12.3	19.8	8.0	19.7	9.4	6.2	9.9	20.2	16.2	9.8	10.6	13.0	12.5	8.1	14.2	4.6	13.6	11.6	8.2	7.6	7.9	28.3	9.7	6.5	11.1	11.7	9.6	10.8	10.8	5.6	6.4	5.9	4.9	5.3	10.9	8.8	12.7	6.6	9.5	7.3	2.7	9.9	16.0	13.8	8.8	11.1	9.3	7.7	3.0	8.4	3.1	10.1	6.0	5.4	3.2	5.1	6.2	11.5	4.5	7.8	11.7	10.1	4.0	9.5	8.2	1.7	10.8	2.0	5.2	4.7	3.3	9.3	8.7	3.3	5.6	9.4	4.5	6.3	5.9	10.1	13.6	13.7	6.2	2.5	8.5	6.3	5.0	5.6	5.3	8.3	60.6	6.1	2.8	4.3	3.8	24.1	9.7	11.5	10.0	8.0	10.6	7.6	10.2	11.1	7.9	7.4	8.0	7.8	28.3	6.5	7.3	6.3	11.1	11.7	22.2	25.5	36.0	31.6	22.0	34.0	26.7	24.0	28.3	12.5	17.9	14.9	30.8	25.7	15.7	61.3	45.6	25.5	9.4	11.4	31.4	90.3	19.1	5.0	29.0	54.7	32.9	11.8	0.0	19.9	30.4	16.4	18.4	20.7	17.5	51.1	41.3	10.3	27.0	37.0	25.0	15.0	23.1	30.4	28.9	11.5	22.0	25.6	14.8	23.3	13.5	58.9	19.4	53.6	21.6	29.8	13.4	13.6	30.2	12.8	26.9
CDY1	CDY1A	ENSG00000172288	"Chromodomain Y-linked 1"	Q9Y6F8	Y	25622162-25624902	"Enzymes, Predicted intracellular proteins"		"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in single"	47	"testis: 4.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA066682	Supported					NA	NA					"HPA066682: "																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.7			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
CDY1B		ENSG00000172352	"Chromodomain Y-linked 1B"	Q9Y6F8	Y	24045229-24048019	"Enzymes, Predicted intracellular proteins"		"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in single"	72	"testis: 7.2"	"Cell type enhanced"	"Detected in single"	40	"Early spermatids: 1.3"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA066682	Supported					NA	NA					"HPA066682: "																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.2			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
CDY2A	CDY2	ENSG00000182415	"Chromodomain Y-linked 2A"	Q9Y6F7	Y	18025787-18028597	"Enzymes, Predicted intracellular proteins"		"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in some"	50	"epididymis: 3.8;testis: 6.0"	"Cell type enriched"	"Detected in single"	18	"Collecting duct cells: 1.8"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	12	"U-266/84: 1.2"									HPA066682	Supported					NA	NA					"HPA066682: "																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	3.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.0			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
CDY2B	CDY	ENSG00000129873	"Chromodomain Y-linked 2B"	Q9Y6F7	Y	17877410-17880220	"Enzymes, Predicted intracellular proteins"		"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in single"	28	"testis: 2.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA066682	Supported					NA	NA					"HPA066682: "																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
CELA1	ELA1	ENSG00000139610	"Chymotrypsin like elastase family member 1"	Q9UNI1	12	51328443-51346679	"Enzymes, Predicted intracellular proteins, Predicted secreted proteins"		"Hydrolase, Protease, Serine protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	8	"adrenal gland: 6.3;blood: 12.6;pancreas: 11.8"	"Group enriched"	"Detected in some"	6	"Exocrine glandular cells: 15.1;Kupffer cells: 7.5"	"Cancer enhanced"	"Detected in single"		"testis cancer: 0.5"					"Cell type enhanced"	"Detected in many"		"basophil: 9.0;naive CD4 T-cell: 12.6"	"Group enriched"	"Detected in many"	7	"granulocytes: 9.0;T-cells: 12.6"	"Cell line enriched"	"Detected in some"	4	"BEWO: 11.0"	"Low region specificity"	"Detected in all"												"Secreted - unknown location"	NA	NA						"unprognostic (3.54e-2)"	"unprognostic (1.64e-1)"		"unprognostic (4.73e-2)"	"unprognostic (2.73e-1)"	"unprognostic (1.70e-1)"		"unprognostic (1.52e-1)"		"unprognostic (1.13e-1)"	"unprognostic (3.59e-2)"		"unprognostic (3.83e-3)"	"unprognostic (2.52e-1)"	"unprognostic (1.46e-1)"			0.0	6.3	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.2	0.1		0.0	11.8	0.0	0.0	0.7		0.0	0.0		0.0	0.0	0.0	0.0	0.2	0.0	0.1	1.0	0.0	0.6			0.0		0.3	0.0	0.0	0.3	0.9	9.0	1.6	0.2	12.6	1.3	0.0	0.0	0.0	0.0	0.0	0.0	11.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.1	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	9.0	1.6	0.1	1.1	0.8	0.4	0.3	2.7	0.8	0.9	0.0	12.6	5.9	0.2	0.2	0.9	0.0	0.3	1.3											0.0	0.3	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	15.1	1.9	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	7.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.5	0.0	0.0	0.0
CELA2A	ELA2A	ENSG00000142615	"Chymotrypsin like elastase family member 2A"	P08217	1	15456728-15472091	"Enzymes, Predicted secreted proteins"		"Hydrolase, Protease, Serine protease"	"Diabetes mellitus, Disease mutation, Obesity"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	1559	"pancreas: 2376.3"	"Cell type enriched"	"Detected in some"	19	"Exocrine glandular cells: 6761.1"	"Cancer enriched"	"Detected in single"	3819	"pancreatic cancer: 463.9"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	15	"neutrophil: 1.5"	"Lineage enriched"	"Detected in single"	15	"granulocytes: 1.5"	"Cell line enhanced"	"Detected in some"		"HDLM-2: 1.1;HEL: 1.2;HL-60: 1.0;HMC-1: 5.0;K-562: 1.1;U-2 OS: 1.6"														"Secreted to digestive system"	NA	NA						"unprognostic (9.78e-2)"	"unprognostic (3.33e-2)"		"unprognostic (5.60e-2)"	"unprognostic (5.27e-2)"	"unprognostic (3.63e-3)"		"unprognostic (2.35e-1)"	"unprognostic (4.14e-1)"	"unprognostic (1.96e-2)"	"unprognostic (1.38e-1)"	"unprognostic (2.48e-1)"	"unprognostic (3.94e-9)"	"unprognostic (4.10e-2)"		"unprognostic (3.42e-1)"	"unprognostic (3.55e-2)"	0.2	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.2	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.8	2376.3	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.2	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.2	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.7	1.2	0.0	0.0	0.0	1.0	5.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.4	0.0	0.4	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.7	0.1	0.0	0.0	0.0	6761.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	36.1	0.0	0.0	361.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1
CELA2B	"ELA2B, RP11-265F14.2"	ENSG00000215704	"Chymotrypsin like elastase family member 2B"	P08218	1	15465909-15491400	"Enzymes, Predicted intracellular proteins, Predicted secreted proteins"		"Hydrolase, Protease, Serine protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	188	"pancreas: 697.9"	"Cell type enriched"	"Detected in some"	42	"Exocrine glandular cells: 1081.3"	"Cancer enriched"	"Detected in single"	574	"pancreatic cancer: 69.9"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"basophil: 3.7;neutrophil: 1.2"	"Lineage enriched"	"Detected in single"	7	"granulocytes: 3.7"	"Cell line enriched"	"Detected in some"	5	"U-138 MG: 9.3"														"Secreted to digestive system"	NA	NA						"unprognostic (4.36e-3)"	"unprognostic (5.45e-2)"	"unprognostic (6.66e-2)"	"unprognostic (5.31e-3)"	"unprognostic (4.47e-3)"	"unprognostic (1.37e-3)"	"unprognostic (4.66e-2)"	"unprognostic (6.32e-2)"	"unprognostic (2.73e-1)"	"unprognostic (2.44e-1)"	"unprognostic (2.94e-1)"	"unprognostic (3.85e-2)"	"unprognostic (1.22e-6)"	"unprognostic (2.47e-1)"	"unprognostic (6.67e-2)"	"unprognostic (1.88e-1)"	"unprognostic (7.80e-2)"	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	697.9	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	3.7	0.2	0.0	0.5	0.0	0.1	1.5	1.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.5	0.1	0.0	0.2	0.3	0.0	0.0	0.0	0.7	1.0	1.8	0.7	0.3	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.8	0.0	1.4	0.2	1.1	0.0	0.0	0.0	0.0	0.4	0.1	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.2	0.5	0.4	0.0	0.0	9.3	0.0	0.0	0.0	0.9	0.1	0.3	0.4	0.0	0.0	3.7	0.2	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1081.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	25.6	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0
CELA3A	"ELA3, ELA3A"	ENSG00000142789	"Chymotrypsin like elastase family member 3A"	P09093	1	22001656-22012539	"Enzymes, Predicted intracellular proteins, Predicted secreted proteins"		"Hydrolase, Protease, Serine protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	2051	"pancreas: 2541.2"	"Cell type enriched"	"Detected in some"	31	"Exocrine glandular cells: 30160.2"	"Cancer enriched"	"Detected in some"	2497	"pancreatic cancer: 1481.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	24	"MOLT-4: 21.6"									"HPA028086, HPA045650"	Supported		Approved	Cytosol	"Secreted to digestive system"	NA	NA			Cytosol		"HPA028086: AB_2672482, HPA045650: AB_2679407"			"unprognostic (1.27e-1)"	"unprognostic (2.71e-1)"							"unprognostic (1.79e-1)"			"unprognostic (6.32e-2)"	"unprognostic (2.67e-1)"			0.2	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.3	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	1.2	2541.2	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.3	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.4	0.3	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	21.6	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.2	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.4	29.3	0.0	0.0	0.0	30160.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	85.8	0.3	0.0	0.0	164.1	0.0	0.0	964.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0
CELA3B	"CBPP, ELA3B"	ENSG00000219073	"Chymotrypsin like elastase family member 3B"	P08861	1	21977021-21998642	"Enzymes, Predicted intracellular proteins, Predicted secreted proteins"		"Hydrolase, Protease, Serine protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	196	"pancreas: 1614.4"	"Cell type enriched"	"Detected in some"	24	"Exocrine glandular cells: 12399.8"	"Cancer enriched"	"Detected in single"	1218	"pancreatic cancer: 408.8"	"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"											"HPA028086, HPA045650"	Supported		Approved	Cytosol	"Secreted to digestive system"	NA	NA			Cytosol		"HPA028086: AB_2672482, HPA045650: AB_2679407"			"unprognostic (2.89e-1)"	"unprognostic (4.01e-3)"						"unprognostic (6.53e-3)"	"unprognostic (1.30e-1)"	"unprognostic (1.29e-1)"		"unprognostic (6.40e-2)"				0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.6	1614.4	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.2	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.2	0.2	0.1	0.1	0.1	0.1	0.1	0.1	0.1	5.9	5.3	8.2	3.0	2.3	3.2	0.9	0.6	5.0	1.7	1.3	2.5	1.5	2.2	1.2	1.8	1.8	1.7	5.4	2.7	5.5	2.7	1.5	2.2	1.6	1.0	0.5	0.0	2.5	4.1	2.4	4.9	4.0	1.3	1.9	3.2	2.3	2.4	1.5	0.0	2.7	2.5	3.6	2.5	5.6	0.4	2.6	2.2	1.5	1.4	0.9	3.5	3.6	0.9	4.3	0.0	3.6	3.2	1.8	3.5	0.8	0.3	3.7	2.6	2.8	3.7	2.9	1.6	2.3	1.0	4.9	4.8	2.5	1.9	4.8	0.6	5.1	2.5	1.8	3.1	3.0	2.0	3.7	2.2	2.8	1.4	5.9	3.2	3.0	8.2	2.3	1.7	5.3	2.9	0.9	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.6	65.6	0.0	4.9	0.0	12399.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	149.0	0.9	0.0	0.0	105.6	0.0	0.0	510.5	7.0	0.7	0.0	0.0	0.0	0.0	0.3	0.2	0.0	0.0	0.0	0.2	0.0
CEMIP	"HYBID, IR2155535, KIAA1199, TMEM2L"	ENSG00000103888	"Cell migration inducing hyaluronan binding protein"	Q8WUJ3	15	80779343-80951776	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"		"Glycosidase, Hydrolase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"endometrium 1: 33.9;lymphoid tissue: 116.9"	"Group enriched"	"Detected in some"	4	"Bipolar cells: 2.5;Club cells: 7.9;Cone photoreceptor cells: 5.9;Fibroblasts: 7.2;Horizontal cells: 3.2;Intestinal endocrine cells: 4.6;Rod photoreceptor cells: 2.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"BJ: 42.9;BJ hTERT+: 67.9;fHDF/TERT166: 53.9;HSkMC: 37.1;hTERT-RPE1: 40.5;U-138 MG: 19.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"								"Secreted in other tissues"	NA	NA		560000				"unprognostic (1.14e-3)"	"unprognostic (6.80e-2)"	"unprognostic (5.95e-2)"	"unprognostic (3.15e-3)"	"unprognostic (3.49e-3)"	"unprognostic (6.80e-2)"	"unprognostic (5.47e-2)"	"unprognostic (1.22e-1)"	"unprognostic (7.49e-2)"	"unprognostic (1.53e-1)"	"unprognostic (7.24e-2)"	"unprognostic (1.36e-1)"	"unprognostic (5.27e-10)"	"unprognostic (1.82e-2)"	"unprognostic (1.93e-1)"	"unprognostic (1.34e-1)"	"prognostic unfavorable (2.65e-4)"	6.7	2.1	1.7	11.6	5.0	1.7	1.0	6.8	8.9	2.4	6.9	6.4	2.6	1.2	33.9	7.8	7.1	7.0	2.8	6.4	2.2	2.8	1.1	1.0	16.6	116.9	14.1	9.4	5.3	1.4	0.7	9.1	2.9	15.6	2.5	2.4	15.4	5.9	3.2	4.3	6.2	1.6	0.9	13.6	2.0	1.3	3.3	1.1	0.0	4.4	0.7	5.0	6.5	3.1	0.9	1.5	0.6	0.5	0.2	1.3	0.2	0.1	1.6	0.3	0.2	0.1	0.6	0.2	42.9	67.9	1.1	0.9	0.5	0.2	0.2	0.1	53.9	0.2	1.0	0.0	0.1	0.2	0.1	0.4	0.1	0.2	3.5	0.4	0.1	0.2	37.1	0.0	8.4	0.0	40.5	0.0	0.2	0.2	0.1	1.0	0.9	0.1	0.1	0.2	14.2	1.9	0.2	0.0	0.1	0.0	0.7	2.7	0.1	0.7	0.1	3.6	0.6	0.2	0.0	0.2	19.6	0.1	1.4	0.7	0.1	0.1	0.2	2.1	0.3	1.3	0.0	0.3	0.0	0.4	0.4	0.1	0.6	0.0	0.2	0.0	0.9	0.0	0.7	0.6	0.2	0.5	1.5	1.3	0.2	1.7	5.0	6.8	8.9	2.2	2.8	14.1	9.4	15.6	1.1	0.0	1.0	0.0	0.4	0.0	2.5	0.8	0.0	0.0	7.9	0.0	5.9	0.1	0.0	0.0	0.4	0.3	0.0	0.0	0.3	0.1	7.2	0.8	1.1	0.0	0.3	3.2	4.6	0.6	0.0	0.2	0.3	0.0	0.0	0.0	0.5	0.8	0.4	0.0	0.0	0.0	2.2	0.0	0.0	0.2	0.4	0.0	0.2	0.0	0.4	0.9
CEPT1		ENSG00000134255	"Choline/ethanolamine phosphotransferase 1"	Q9Y6K0	1	111139627-111185102	"Enzymes, Predicted membrane proteins, Transporters"	"Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA						"unprognostic (1.16e-1)"	"unprognostic (2.42e-1)"	"unprognostic (1.47e-3)"	"unprognostic (1.83e-2)"	"prognostic favorable (4.96e-4)"	"unprognostic (5.52e-2)"	"unprognostic (1.10e-1)"	"unprognostic (5.61e-2)"	"unprognostic (1.54e-3)"	"unprognostic (1.84e-1)"	"unprognostic (9.20e-3)"	"unprognostic (1.03e-1)"	"unprognostic (4.60e-2)"	"unprognostic (3.58e-2)"	"unprognostic (1.10e-1)"	"unprognostic (5.88e-2)"	"unprognostic (1.27e-2)"	22.4	22.9	16.0	22.2	19.5	5.6	20.1	20.7	19.8	14.9	13.7	22.2	17.5	19.0	18.3	19.1	21.3	16.6	15.3	12.2	17.9	16.0	22.6	39.4	16.5	31.7	22.9	15.1	22.9	17.8	19.6	25.5	22.5	18.2	13.9	18.1	16.9	19.2	12.0	11.2	17.8	20.2	16.3	23.3	34.5	17.5	12.5	21.3	22.3	19.4	11.5	24.7	19.5	17.8	14.6	9.0	4.2	19.1	5.3	9.0	5.5	14.0	5.3	6.3	6.1	25.0	12.3	15.3	15.6	8.9	7.3	8.8	4.6	16.0	16.8	17.3	8.0	9.3	17.4	9.1	12.2	10.5	12.4	14.1	7.3	9.5	10.2	16.7	17.1	10.5	10.0	23.5	5.3	25.5	13.9	9.6	17.5	15.7	11.0	9.5	10.2	17.5	16.9	9.7	22.6	10.9	9.5	20.0	13.6	11.9	8.9	8.3	4.4	14.4	22.0	16.6	12.8	11.7	18.7	8.4	11.9	7.5	25.7	10.4	10.1	10.9	13.1	16.0	15.4	22.5	3.2	7.6	4.2	6.4	13.6	8.4	14.5	7.2	6.7	9.0	14.6	8.4	9.0	1.9	5.3	19.1	7.0	6.2	5.5	16.0	19.5	20.7	19.8	17.9	16.0	22.9	15.1	18.2	21.3	32.8	12.2	37.9	14.6	11.6	26.0	3.6	20.4	21.4	14.8	34.9	33.4	24.6	5.0	11.7	1.7	9.7	16.0	0.0	7.1	16.3	11.4	13.2	18.5	29.7	25.2	27.0	9.8	22.7	40.9	2.2	13.6	19.4	15.1	9.0	13.6	9.4	8.5	14.7	15.9	12.0	20.7	12.9	7.2	12.0	13.2	13.4	15.9	20.0	13.3	12.4
CERK	"dA59H18.2, dA59H18.3, DKFZp434E0211, FLJ21430, FLJ23239, hCERK, KIAA1646, LK4"	ENSG00000100422	"Ceramide kinase"	Q8TCT0	22	46684411-46738261	"Enzymes, Predicted intracellular proteins"		"Kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA064699			Approved	Vesicles		NA	NA			Vesicles		"HPA064699: AB_2685327"	"unprognostic (2.93e-2)"	"unprognostic (1.93e-1)"	"unprognostic (6.52e-2)"	"prognostic unfavorable (4.75e-4)"	"unprognostic (2.67e-2)"	"unprognostic (1.49e-3)"	"unprognostic (8.55e-2)"	"unprognostic (3.60e-2)"	"unprognostic (3.87e-1)"	"unprognostic (1.35e-2)"	"prognostic favorable (2.35e-4)"	"unprognostic (2.26e-1)"	"unprognostic (1.50e-3)"	"unprognostic (1.27e-1)"	"unprognostic (4.78e-1)"	"unprognostic (3.38e-1)"	"prognostic unfavorable (1.58e-4)"	10.6	15.5	10.6	16.7	10.8	14.5	12.9	29.3	21.7	10.8	14.6	9.8	15.8	24.9	14.1	7.5	10.0	15.3	18.9	36.5	11.4	16.8	15.2	12.1	10.6	19.1	21.7	13.1	22.7	23.2	7.2	33.3	7.9	23.9	8.2	12.2	12.3	11.8	11.6	12.8	11.9	25.1	12.5	10.2	14.5	14.0	6.0	6.5	39.2	16.1	8.7	19.5	10.7	17.4	2.0	4.9	3.6	6.9	2.0	16.4	3.6	9.4	5.7	27.8	8.7	16.0	12.1	2.6	16.6	13.0	9.5	6.7	8.3	3.2	13.2	7.8	17.7	5.8	6.2	11.7	7.5	9.8	4.6	12.6	5.9	14.4	10.8	11.1	18.4	1.5	10.1	9.7	10.4	3.6	15.4	28.2	14.2	4.4	17.1	17.4	0.7	12.4	9.2	12.5	3.8	6.3	23.3	31.5	15.0	5.7	0.1	25.9	23.6	8.1	3.9	17.5	6.7	4.3	14.1	25.6	19.7	10.5	14.5	24.0	17.8	21.5	8.3	21.0	10.5	16.0	0.6	2.6	3.0	9.4	6.0	16.4	1.8	9.9	9.0	4.5	2.0	5.8	5.4	3.6	2.0	6.9	4.9	8.6	3.6	10.6	10.8	29.3	21.7	11.4	16.8	21.7	13.1	23.9	6.5	8.9	20.5	11.9	5.1	3.1	21.3	35.3	5.1	0.0	15.9	1.8	5.9	1.9	13.3	11.3	5.0	14.8	26.5	0.0	10.3	1.3	7.3	1.3	9.3	19.8	9.7	25.4	13.8	28.8	27.0	9.4	8.9	13.6	3.3	5.4	2.7	19.0	8.9	15.0	14.2	13.0	10.1	0.0	12.0	0.9	1.6	3.9	1.5	20.8	15.1	0.9
CERS3	"LASS3, MGC27091"	ENSG00000154227	"Ceramide synthase 3"	Q8IU89	15	100400395-100544995	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Lipid biosynthesis, Lipid metabolism"	Transferase	Ichthyosis	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"esophagus: 25.6;skin 1: 29.0;testis: 37.9"	"Cell type enhanced"	"Detected in some"	16	"Basal keratinocytes: 16.8;Early spermatids: 19.4;Late spermatids: 12.5;Spermatocytes: 33.6;Suprabasal keratinocytes: 43.8"	"Cancer enhanced"	"Detected in some"		"head and neck cancer: 14.9"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"naive CD4 T-cell: 3.3"	"Low lineage specificity"	"Detected in many"			"Cell line enriched"	"Detected in some"	6	"hTCEpi: 38.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA006092, HPA024356"	Approved		Supported	Nucleoplasm		NA	NA			Nucleoplasm		"HPA006092: AB_1079236, HPA024356: AB_1852721"	"unprognostic (5.01e-3)"	"unprognostic (3.43e-2)"	"unprognostic (6.47e-4)"	"unprognostic (2.35e-2)"	"unprognostic (5.58e-2)"	"unprognostic (1.68e-1)"	"unprognostic (6.84e-3)"	"unprognostic (3.23e-1)"	"unprognostic (1.43e-1)"	"unprognostic (2.09e-1)"	"unprognostic (1.31e-5)"	"unprognostic (2.65e-1)"	"unprognostic (4.74e-4)"	"unprognostic (1.83e-1)"	"unprognostic (4.33e-2)"	"unprognostic (1.78e-1)"	"unprognostic (4.05e-3)"	0.4	0.0	0.4	0.4	0.4	0.0	1.9	0.4	0.4	6.0	0.4	0.4	0.4	0.0	0.4	0.4	25.6	0.3	0.4	0.4	0.4	0.0	0.4	0.4	0.4	0.4	0.4	0.4	0.4	0.4	0.0	0.4	0.4	0.4	0.4	0.0	0.4	3.6	0.4	0.4	29.0	0.4	0.4	0.4	0.4	0.0	37.9	0.4	0.4	0.4	0.4	8.5	0.4	11.2	0.0	0.0	1.5	0.6	0.0	3.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.1	0.0	6.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	38.8	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	1.5	0.1	0.2	0.2	0.0	0.7	0.3	0.0	0.0	3.3	0.1	0.0	0.0	0.6	0.0	0.0	0.2	0.4	0.4	0.4	0.4	0.4	0.0	0.4	0.4	0.4	0.4	0.0	0.0	0.0	3.6	16.8	0.2	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	19.4	0.1	0.0	0.0	0.0	0.0	0.3	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	12.5	0.6	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.1	33.6	0.4	43.8	0.0	0.0	0.0	7.4
CERS5	"FLJ25304, LASS5, MGC45411, Trh4"	ENSG00000139624	"Ceramide synthase 5"	Q8N5B7	12	50129306-50167533	"Enzymes, Predicted membrane proteins"	"Lipid biosynthesis, Lipid metabolism, Sphingolipid metabolism"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA026589	Approved		Approved	Nucleoplasm,Nucleoli		NA	NA			"Nucleoplasm, Nucleoli"		"HPA026589: AB_1852727"	"unprognostic (1.59e-2)"	"unprognostic (9.83e-2)"	"unprognostic (5.17e-2)"	"unprognostic (3.64e-2)"	"unprognostic (3.02e-1)"	"unprognostic (2.49e-3)"	"prognostic unfavorable (4.63e-5)"	"unprognostic (5.56e-2)"	"unprognostic (1.65e-2)"	"unprognostic (9.26e-2)"	"unprognostic (1.88e-3)"	"unprognostic (5.67e-2)"	"prognostic unfavorable (9.33e-11)"	"unprognostic (8.37e-2)"	"unprognostic (1.03e-1)"	"prognostic favorable (5.76e-5)"	"unprognostic (3.26e-1)"	18.0	13.2	18.3	13.3	21.6	10.9	18.0	38.3	19.6	21.1	15.0	17.5	8.9	6.3	22.6	20.9	14.1	17.7	14.9	9.9	16.7	11.6	16.0	7.8	14.7	15.1	13.9	19.1	22.5	13.8	23.9	22.4	19.7	14.3	15.6	11.5	14.9	14.6	16.2	5.0	21.5	12.2	21.8	10.3	15.7	13.3	11.6	14.4	12.7	15.5	7.0	14.9	18.4	18.3	21.0	26.1	33.5	35.1	29.0	26.3	22.3	9.2	10.4	23.0	6.5	12.8	10.8	19.5	20.5	17.7	19.7	18.7	24.5	14.7	14.0	17.2	29.0	10.3	8.7	10.0	7.9	19.6	22.1	10.2	11.7	8.8	14.8	25.6	11.9	16.0	18.5	12.0	16.2	15.1	25.9	17.9	12.3	8.8	13.0	24.7	16.2	10.3	32.4	14.7	5.2	10.1	13.5	15.0	10.0	25.6	12.0	7.0	11.4	17.4	8.2	27.5	15.8	11.2	13.7	17.1	17.0	11.4	12.7	8.9	12.7	12.1	11.3	13.4	8.3	7.8	24.8	19.0	28.1	26.0	25.5	22.9	17.9	22.9	22.4	18.2	21.0	17.9	24.3	33.5	29.0	35.1	26.1	26.3	22.3	18.3	21.6	38.3	19.6	16.7	11.6	13.9	19.1	14.3	14.4	17.9	17.3	12.1	17.3	15.3	41.7	5.6	15.3	9.4	14.8	14.0	19.6	27.6	6.6	19.6	0.6	14.9	9.1	0.0	12.2	48.5	20.0	10.2	15.0	3.8	17.4	30.2	15.0	15.4	17.0	1.1	15.5	16.5	11.8	30.7	7.0	21.7	14.2	7.0	16.3	6.8	36.1	32.3	17.6	8.1	7.5	12.5	28.1	20.0	6.0	11.3
CES1	"CEH, CES1A1, CES1A2, CES2, HMSE, HMSE1, SES1"	ENSG00000198848	"Carboxylesterase 1"	P23141	16	55802851-55833337	"Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"		"Hydrolase, Serine esterase"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"liver: 355.0"	"Group enriched"	"Detected in many"	7	"Cholangiocytes: 565.6;Hepatocytes: 2145.0"	"Cancer enriched"	"Detected in all"	6	"liver cancer: 711.4"	"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	18	"classical monocyte: 32.6;myeloid DC: 32.9"	"Group enriched"	"Detected in many"	20	"dendritic cells: 32.9;monocytes: 32.6"	"Group enriched"	"Detected in some"	5	"Hep G2: 96.2;THP-1: 103.6"	"Not detected"	"Not detected"							"HPA012023, HPA046717"	Enhanced		Supported	"Endoplasmic reticulum"	"Intracellular and membrane"	No	NA		40000000	"Endoplasmic reticulum"		"HPA012023: AB_1846554, HPA046717: AB_2679770"	"unprognostic (1.04e-2)"	"unprognostic (9.85e-2)"	"unprognostic (2.94e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.55e-3)"	"unprognostic (7.46e-3)"	"unprognostic (1.51e-1)"	"unprognostic (1.42e-1)"	"unprognostic (3.51e-1)"	"unprognostic (5.74e-2)"	"unprognostic (4.62e-2)"	"unprognostic (3.29e-2)"	"unprognostic (1.91e-2)"	"unprognostic (5.32e-2)"	"unprognostic (1.92e-1)"	"unprognostic (2.87e-1)"	"prognostic unfavorable (9.92e-4)"	27.1	1.7	0.3	0.5	0.4	2.1	24.7	0.4	0.6	3.1	8.9	0.5	1.5	2.4	7.3	2.1	4.5	6.7	57.7	8.1	0.3	0.0	0.7	355.0	19.8	2.3	0.3	0.6	3.9	1.3	0.0	0.8	1.1	0.6	11.2	1.0	3.8	3.9	4.0	1.6	1.4	3.5	10.2	0.7	4.4	7.0	1.0	0.3	0.4	1.7	2.3	1.5	8.2	16.1	0.2	32.9	0.2	32.6	0.1	1.6	12.1	0.0	0.6	0.0	0.0	14.4	0.0	0.4	0.0	0.0	0.0	0.0	6.7	0.0	0.0	2.9	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	96.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.2	0.0	0.0	0.0	0.0	0.1	1.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	103.6	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	20.8	0.0	0.0	32.6	0.1	1.3	1.8	0.5	0.2	0.2	1.6	32.9	0.2	0.2	0.4	0.2	0.1	0.4	1.7	0.1	12.1	0.3	0.4	0.4	0.6	0.3	0.0	0.3	0.6	0.6	0.3	14.9	74.9	21.0	2.5	14.8	0.0	0.6	565.6	202.1	28.4	15.7	0.0	0.4	0.0	16.2	77.2	1.5	0.0	70.0	17.2	0.8	45.8	1.1	5.8	2145.0	18.9	0.0	36.2	43.0	88.2	134.3	17.3	20.4	37.1	0.0	0.0	8.3	0.9	0.2	93.0	0.5	0.5	0.0	7.2	0.9	1.0	10.2	0.7	20.3	0.0	1.7
CES2	"CE-2, CES2A1, iCE"	ENSG00000172831	"Carboxylesterase 2"	O00748	16	66934444-66945096	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"		"Hydrolase, Serine esterase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	4	"esophagus: 46.7;intestine: 146.9;liver: 78.6"	"Group enriched"	"Detected in many"	4	"Enterocytes: 912.6;Hepatocytes: 449.6;Paneth cells: 448.9;Undifferentiated cells: 459.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											HPA018897	Enhanced		Approved	"Endoplasmic reticulum,Golgi apparatus,Cytosol"		NA	NA		7500000	"Golgi apparatus"	"Endoplasmic reticulum, Cytosol"	"HPA018897: AB_1846558"	"unprognostic (8.15e-3)"	"unprognostic (1.82e-2)"	"unprognostic (1.32e-1)"	"unprognostic (2.67e-3)"	"unprognostic (2.74e-2)"	"unprognostic (1.38e-1)"	"unprognostic (5.80e-2)"	"unprognostic (1.31e-1)"	"unprognostic (6.93e-2)"	"unprognostic (7.99e-2)"	"unprognostic (1.73e-3)"	"unprognostic (2.66e-2)"	"prognostic favorable (1.50e-5)"	"unprognostic (8.01e-2)"	"unprognostic (1.53e-1)"	"unprognostic (4.14e-2)"	"unprognostic (1.38e-1)"	5.8	15.3	8.5	8.8	11.7	2.4	5.1	13.0	15.9	9.5	42.3	12.1	11.2	146.9	7.0	11.9	46.7	6.1	14.5	15.2	7.4	6.6	22.5	78.6	6.7	4.6	8.2	10.7	8.4	12.0	10.0	6.8	7.3	10.3	9.7	42.6	13.0	12.7	7.9	11.6	8.9	117.3	10.4	5.6	7.8	10.9	8.5	8.2	9.0	11.7	14.1	12.1	7.6	11.6	6.9	8.9	5.0	10.6	7.9	10.7	5.2	6.9	9.1	9.6	12.8	9.5	8.9	7.3	7.9	12.8	9.3	11.9	9.8	11.5	8.1	7.9	10.3	7.0	18.0	7.0	19.9	7.3	7.2	9.7	7.9	5.2	18.4	13.4	10.4	14.0	12.9	37.7	13.2	22.1	11.5	6.9	5.7	11.1	6.0	15.7	4.4	9.3	8.7	5.2	7.5	9.2	11.0	9.7	9.5	26.4	12.1	6.2	8.2	25.8	6.5	6.7	3.9	11.2	12.9	8.5	12.3	6.5	7.6	5.9	12.0	14.3	9.6	18.9	8.2	9.2	4.7	10.4	4.7	10.1	7.8	9.2	6.1	7.7	10.7	8.9	6.9	9.5	8.6	5.0	7.9	10.6	7.7	6.8	5.2	8.5	11.7	13.0	15.9	7.4	6.6	8.2	10.7	10.3	8.2	29.8	24.0	25.9	13.7	17.3	28.5	25.4	137.6	42.8	12.5	50.6	19.6	13.0	31.5	21.9	1.5	9.8	912.6	0.0	29.5	5.6	12.7	14.5	27.6	449.6	16.6	27.0	23.2	25.2	27.6	1.3	17.3	13.9	10.1	5.4	141.3	17.6	37.9	448.9	17.0	124.1	22.7	32.3	11.3	42.6	10.2	17.9	11.3	18.7	459.3	15.2
CES3	"ES31, FLJ21736"	ENSG00000172828	"Carboxylesterase 3"	Q6UWW8	16	66961237-66975148	"Enzymes, Predicted intracellular proteins"		"Hydrolase, Serine esterase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 41.8;liver: 26.7"	"Group enriched"	"Detected in many"	5	"Enterocytes: 66.2;Hepatocytes: 40.9;Intestinal endocrine cells: 18.9;Mucus-secreting cells: 31.1;Paneth cells: 60.4;Undifferentiated cells: 31.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"AN3-CA: 8.1;Daudi: 8.9;JURKAT: 14.6;U-937: 7.6"					"Not detected"	"Not detected"			"HPA041008, HPA041307"	Approved		Approved	"Nuclear membrane,Endoplasmic reticulum"	"Intracellular and membrane"	NA	NA		1200000	"Nuclear membrane, Endoplasmic reticulum"		"HPA041008: AB_2677247, HPA041307: AB_2677400"	"unprognostic (3.91e-3)"	"unprognostic (1.22e-1)"	"unprognostic (1.94e-2)"	"unprognostic (8.99e-3)"	"unprognostic (9.32e-2)"	"unprognostic (7.84e-4)"	"prognostic favorable (7.26e-5)"	"unprognostic (5.67e-3)"	"unprognostic (1.52e-1)"	"unprognostic (2.17e-1)"	"unprognostic (6.43e-2)"	"unprognostic (1.84e-2)"	"unprognostic (1.19e-2)"	"unprognostic (2.18e-2)"	"unprognostic (2.75e-1)"	"unprognostic (3.31e-2)"	"unprognostic (7.41e-2)"	0.5	0.1	0.8	13.3	1.3	0.2	1.0	1.6	1.3	0.6	40.7	0.7	1.4	16.8	0.4	0.7	2.2	1.5	3.0	0.7	1.5	1.0	6.8	26.7	0.9	0.2	0.8	1.1	0.5	7.8	0.0	1.1	0.4	2.2	0.4	17.9	1.1	5.9	0.6	12.9	0.5	41.8	0.5	0.9	0.2	4.6	0.9	0.6	0.5	0.4	2.4	0.5	0.4	0.3	0.7	0.6	2.7	0.6	0.3	0.9	0.2	0.4	3.2	0.4	8.1	0.3	0.2	1.3	0.3	0.2	0.4	0.5	0.5	4.0	8.9	2.7	0.0	0.2	0.7	1.2	0.6	0.1	1.5	6.0	4.4	1.3	2.6	0.1	1.0	0.7	0.3	1.0	0.9	0.2	0.3	0.0	14.6	2.8	1.9	0.3	1.2	1.5	1.6	1.4	2.7	0.5	1.4	0.7	1.4	0.1	0.5	0.4	0.9	0.2	6.1	0.2	0.7	5.4	6.8	0.4	0.4	2.6	0.7	0.2	1.0	3.6	1.3	0.3	7.6	0.2	0.6	0.6	2.7	0.3	0.3	0.5	0.5	0.6	0.4	0.6	0.7	0.9	0.6	2.0	0.3	0.4	0.3	0.9	0.2	0.8	1.3	1.6	1.3	1.5	1.0	0.8	1.1	2.2	0.6	3.0	7.0	0.8	0.0	0.5	0.0	1.0	5.1	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	66.2	0.0	0.8	0.0	0.0	0.2	1.1	40.9	0.2	0.0	18.9	0.0	3.2	2.6	0.0	1.4	0.0	0.0	31.1	0.2	1.0	60.4	1.1	8.2	0.0	0.0	0.0	0.6	1.3	0.3	0.0	0.0	31.9	0.1
CES5A	"CAUXIN, CES4C1, CES5, CES7, FLJ31547"	ENSG00000159398	"Carboxylesterase 5A"	Q6NT32	16	55846154-55956031	"Enzymes, Predicted intracellular proteins, Predicted secreted proteins"		"Hydrolase, Serine esterase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	7	"epididymis: 43.4"	"Group enriched"	"Detected in some"	4	"Cholangiocytes: 2.5;Collecting duct cells: 5.2;Hepatocytes: 5.5"	"Cancer enhanced"	"Detected in single"		"liver cancer: 0.6"	"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	44	"U-266/70: 13.3"	"Not detected"	"Not detected"												"Secreted in male reproductive system"	NA	NA									"unprognostic (2.07e-1)"	"unprognostic (2.55e-1)"	"unprognostic (6.34e-2)"	"unprognostic (4.82e-2)"		"unprognostic (3.78e-1)"	"unprognostic (2.33e-1)"	"unprognostic (3.12e-2)"		"unprognostic (1.72e-7)"	"unprognostic (1.55e-2)"	"unprognostic (2.27e-1)"			0.1	0.1	0.7	0.1	0.6	0.0	0.1	0.1	0.8	0.1	0.1	0.1	3.6	0.0	0.1	43.4	0.1	0.0	1.4	0.1	0.8	0.5	0.1	6.6	0.1	0.1	1.4	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.1	1.2	0.3	0.1	1.2	0.1	0.1	1.8	0.1	0.0	1.7	0.1	0.5	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	13.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.6	0.1	0.8	0.8	0.5	1.4	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.4	2.5	0.0	0.0	5.2	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.5	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
CFB	"BF, BFD, H2-Bf"	ENSG00000243649	"Complement factor B"	P00751	6	31945650-31952084	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins"	"Complement alternate pathway, Immunity, Innate immunity"	"Hydrolase, Protease, Serine protease"	"Age-related macular degeneration, Disease mutation, Hemolytic uremic syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	29	"liver: 461.5"	"Group enriched"	"Detected in many"	8	"Ductal cells: 523.0;Exocrine glandular cells: 173.6;Hepatocytes: 158.3;Pancreatic endocrine cells: 492.1"	"Cancer enhanced"	"Detected in all"		"liver cancer: 78.3"	"Low region specificity"	"Detected in single"			"Cell type enhanced"	"Detected in single"		"plasmacytoid DC: 1.6"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"ASC diff: 6.1;ASC TERT1: 6.0;CAPAN-2: 7.1;EFO-21: 5.3;fHDF/TERT166: 11.6;HSkMC: 19.1"									"HPA000951, HPA001817, HPA001832, CAB016381"	Supported		Approved	"Endoplasmic reticulum,Vesicles,Cell Junctions"	"Secreted to blood"	NA	NA	879000000	180000000000	"Endoplasmic reticulum, Vesicles"	"Cell Junctions"	"CAB016381: AB_627562, HPA000951: AB_2797216, HPA001817: AB_1078779, HPA001832: AB_1078778"	"prognostic favorable (2.76e-5)"	"unprognostic (1.02e-1)"	"unprognostic (1.44e-1)"	"unprognostic (7.94e-2)"	"unprognostic (1.82e-2)"	"unprognostic (8.56e-2)"	"unprognostic (8.08e-3)"	"unprognostic (8.81e-2)"	"unprognostic (3.51e-1)"	"unprognostic (2.26e-2)"	"unprognostic (1.32e-2)"	"unprognostic (6.57e-2)"	"prognostic unfavorable (1.53e-5)"	"unprognostic (1.36e-1)"	"unprognostic (5.13e-2)"	"unprognostic (1.05e-2)"	"unprognostic (3.68e-2)"	9.3	1.0	0.3	4.1	0.4	0.3	2.4	0.2	0.4	1.3	9.0	0.4	0.9	3.2	0.5	3.7	2.2	4.0	8.9	3.3	0.2	0.0	16.1	461.5	2.5	2.1	0.7	0.1	2.8	5.8	0.4	1.0	4.0	1.0	4.0	1.6	2.6	3.1	0.3	0.5	0.5	4.7	2.6	0.6	0.8	4.1	1.4	0.3	0.3	1.8	0.5	1.7	1.6	0.4	0.1	1.6	0.0	0.8	0.0	0.2	0.0	0.0	1.8	0.1	0.1	6.1	6.0	0.0	0.0	0.3	1.6	0.6	0.0	7.1	0.1	5.3	11.6	0.3	0.0	0.0	1.9	1.4	0.4	0.3	0.4	0.3	0.6	0.0	0.7	0.1	19.1	0.1	0.9	0.6	0.6	0.2	0.1	0.2	0.7	0.1	0.1	0.1	0.4	0.3	0.0	0.1	0.2	0.4	0.2	1.7	0.0	0.0	0.0	0.6	1.2	0.2	0.0	0.0	0.2	0.0	0.2	0.5	0.3	0.4	0.6	1.9	0.5	3.2	0.6	0.5	0.0	0.8	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	1.6	0.0	0.0	0.3	0.4	0.2	0.3	0.2	0.0	0.7	0.1	1.0	0.3	0.0	20.0	14.0	0.7	0.7	0.1	0.4	20.4	24.1	40.9	5.2	0.0	0.0	3.3	523.0	0.0	2.4	5.0	0.0	173.6	0.1	6.0	9.0	0.0	158.3	0.8	0.0	2.4	11.6	13.2	0.0	2.6	1.2	0.0	31.5	6.7	0.8	492.1	11.8	0.0	11.2	0.7	0.0	3.8	0.1	0.0	1.6	1.4	1.9	11.2	1.8
CFD	"ADN, DF, PFD"	ENSG00000197766	"Complement factor D"	P00746	19	859643-863630	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted secreted proteins"	"Complement alternate pathway, Immunity, Innate immunity"	"Hydrolase, Protease, Serine protease"	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"Fibroblasts: 1885.6;Leydig cells: 4659.7"	"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in many"		"basophil: 125.0"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 125.0"	"Group enriched"	"Detected in some"	5	"ASC diff: 40.8;THP-1: 57.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"								"Secreted to blood"	NA	NA	732000000	8000000000				"unprognostic (3.00e-2)"	"unprognostic (6.09e-2)"	"unprognostic (2.44e-1)"	"unprognostic (1.22e-3)"	"unprognostic (6.92e-2)"	"unprognostic (5.28e-2)"	"unprognostic (8.11e-3)"	"unprognostic (2.48e-1)"	"unprognostic (1.46e-2)"	"unprognostic (8.10e-2)"	"prognostic favorable (1.77e-4)"	"unprognostic (9.53e-2)"	"prognostic unfavorable (7.09e-4)"	"unprognostic (1.23e-1)"	"unprognostic (4.55e-2)"	"unprognostic (1.92e-2)"	"unprognostic (9.75e-2)"	161.3	4.6	0.0	16.4	0.0	5.6	96.7	0.0	1.7	44.2	35.2	0.2	42.2	10.9	8.9	89.8	54.1	15.6	59.0	102.0	0.0	0.0	1.9	2.3	34.0	6.2	0.0	0.0	13.7	6.0	1.7	0.1	20.2	0.1	102.0	4.3	3.4	22.7	15.1	40.5	35.8	16.5	97.3	0.1	3.7	19.7	33.6	0.0	0.8	52.6	55.6	9.0	83.7	130.3	0.6	5.6	125.0	25.8	0.1	1.0	10.4	0.7	1.9	0.0	0.3	40.8	6.4	2.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	1.5	0.0	0.0	0.6	0.2	0.0	0.0	1.1	2.9	0.0	1.8	0.6	0.6	0.3	1.0	6.4	0.0	0.0	0.0	0.1	0.0	0.7	2.3	0.1	0.0	0.9	0.0	9.2	0.1	0.7	2.9	0.2	0.0	0.9	0.0	0.1	0.3	0.3	0.8	0.2	0.0	0.1	1.2	57.8	0.0	0.0	0.9	0.4	0.1	1.7	0.7	0.0	0.0	3.4	0.0	125.0	18.2	58.8	0.7	20.1	1.0	0.6	0.5	0.9	5.6	0.2	0.7	0.8	43.2	0.1	25.8	0.5	0.3	10.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	8.9	35.0	13.4	57.2	697.8	3.1	53.7	12.7	21.4	23.9	17.4	2.0	31.1	10.0	6.7	18.8	25.9	9.3	0.0	0.0	35.1	1885.6	17.4	16.2	1.3	255.2	1.6	4.1	49.7	345.8	28.7	4659.7	242.8	609.0	5.4	7.5	1.2	1.9	32.5	266.2	2.5	6.3	0.0	277.1	11.8	20.4	643.3	28.7	9.2	18.5	172.1
CFI	"C3b-INA, FI, IF, KAF"	ENSG00000205403	"Complement factor I"	P05156	4	109740694-109802179	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted secreted proteins"	"Complement pathway, Host-virus interaction, Immunity, Innate immunity"	"Hydrolase, Protease, Serine protease"	"Age-related macular degeneration, Disease mutation, Hemolytic uremic syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	11	"kidney: 90.7;liver: 198.4"	"Cell type enhanced"	"Detected in many"	18	"Hepatocytes: 510.3;Muller glia cells: 130.7;Proximal tubular cells: 205.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"CAPAN-2: 29.5;Hep G2: 46.8;HSkMC: 19.5;RPTEC TERT1: 52.4"									"HPA001143, CAB016777, HPA024061"	Supported				"Secreted to blood"	NA	NA		11000000000			"CAB016777: , HPA001143: AB_1078555, HPA024061: AB_1847129"	"unprognostic (1.04e-1)"	"unprognostic (5.79e-2)"	"unprognostic (1.68e-1)"	"unprognostic (6.32e-2)"	"unprognostic (1.55e-2)"	"unprognostic (8.58e-2)"	"unprognostic (2.95e-2)"	"unprognostic (3.00e-1)"	"unprognostic (2.00e-2)"	"unprognostic (5.42e-3)"	"unprognostic (1.41e-1)"	"unprognostic (3.61e-1)"	"unprognostic (8.63e-2)"	"unprognostic (1.29e-1)"	"unprognostic (3.42e-2)"	"unprognostic (1.74e-1)"	"prognostic unfavorable (6.06e-4)"	9.5	13.2	1.5	2.3	1.4	0.0	3.9	0.9	2.5	5.0	4.1	1.1	2.9	4.9	5.0	12.0	4.4	9.7	9.3	6.2	1.6	0.8	90.7	198.4	7.2	3.1	1.8	0.7	10.6	7.6	0.5	3.8	3.2	2.6	3.9	0.7	6.8	3.6	3.6	1.4	0.5	4.6	3.0	3.0	7.8	1.7	3.6	1.6	0.5	5.3	2.3	1.4	3.8	3.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.6	0.7	0.0	0.0	0.0	29.5	0.0	9.4	0.1	0.2	0.0	0.0	0.0	0.0	9.9	0.3	0.0	0.1	46.8	2.0	0.0	0.0	19.5	0.0	0.0	0.0	1.3	1.9	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	52.4	0.1	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	5.7	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	1.4	0.9	2.5	1.6	0.8	1.8	0.7	2.6	1.6	11.9	34.5	6.7	10.2	0.9	2.4	1.9	107.0	2.7	36.4	61.1	2.0	0.1	26.6	36.3	0.2	49.6	1.1	0.0	27.7	0.1	3.8	1.7	3.5	510.3	0.6	1.6	0.0	54.6	14.3	0.2	15.5	1.7	0.0	2.8	0.7	130.7	34.8	2.9	0.0	205.0	5.6	0.0	3.2	0.7	0.5	1.0	0.2	4.4	0.6	10.3
CFLAR	"c-FLIP, CASH, CASP8AP1, Casper, CLARP, FLAME, FLIP, I-FLICE, MRIT"	ENSG00000003402	"CASP8 and FADD like apoptosis regulator"	O15519	2	201116104-201176687	"Cancer-related genes, Enzymes, Predicted intracellular proteins"	"Apoptosis, Host-virus interaction"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	4	"Urothelial cells: 475.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in all"	5	"neutrophil: 79.2"	"Lineage enriched"	"Detected in all"	6	"granulocytes: 79.2"	"Cell line enhanced"	"Detected in all"		"U-266/70: 55.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019044, CAB022157, CAB025216"	Uncertain		Supported	"Nucleoplasm,Nuclear bodies,Plasma membrane,Cytosol"		NA	Yes			"Nucleoplasm, Plasma membrane, Cytosol"	"Nuclear bodies"	"CAB022157: , CAB025216: , HPA019044: AB_10696204"	"unprognostic (4.61e-2)"	"unprognostic (5.32e-2)"	"unprognostic (2.49e-1)"	"unprognostic (1.44e-1)"	"unprognostic (2.95e-2)"	"prognostic favorable (2.79e-4)"	"unprognostic (7.46e-2)"	"unprognostic (9.01e-2)"	"unprognostic (1.76e-1)"	"unprognostic (6.12e-2)"	"unprognostic (3.08e-2)"	"unprognostic (4.91e-2)"	"unprognostic (2.90e-2)"	"unprognostic (7.83e-2)"	"unprognostic (9.13e-2)"	"unprognostic (6.84e-2)"	"unprognostic (2.24e-2)"	35.4	17.6	13.7	29.8	17.4	66.8	31.6	26.9	12.6	20.5	25.7	13.5	31.3	17.5	24.7	27.6	21.0	19.2	22.1	58.1	14.7	7.7	24.9	18.9	58.5	34.3	16.8	8.9	14.6	14.3	9.1	18.7	28.3	12.6	23.2	17.7	20.9	21.8	27.4	113.7	16.7	26.8	30.5	13.8	35.7	19.4	10.9	14.8	17.2	31.2	26.2	31.4	24.1	33.7	5.3	6.6	79.2	12.6	8.7	11.8	7.8	5.2	10.7	7.7	4.5	24.0	18.4	9.5	13.3	23.3	8.8	10.8	12.4	19.7	1.4	12.7	15.5	10.7	3.9	2.4	10.1	14.1	39.4	7.5	7.9	9.2	20.1	16.7	5.9	26.3	20.0	10.0	14.9	13.1	10.8	44.7	1.8	26.7	33.2	16.0	4.4	2.7	23.5	2.6	4.2	8.2	2.8	1.9	11.3	11.0	10.8	1.7	3.1	9.0	7.9	10.5	5.4	5.6	11.0	48.4	18.5	7.7	6.8	6.5	55.3	18.2	8.9	13.1	4.8	9.1	16.3	12.1	13.5	11.7	12.3	10.3	5.3	10.1	11.0	6.6	4.0	6.4	8.3	79.2	8.7	12.6	4.6	11.8	7.8	13.7	17.4	26.9	12.6	14.7	7.7	16.8	8.9	12.6	14.8	419.9	201.2	84.2	185.4	48.7	8.5	172.6	96.8	283.7	216.1	66.3	29.5	63.9	63.0	138.6	55.5	265.4	108.1	23.3	63.2	34.2	70.8	195.5	77.6	86.3	61.3	12.7	91.3	184.1	115.5	33.0	48.1	149.2	92.8	261.5	56.6	31.3	121.1	80.7	46.7	84.8	29.0	38.8	55.6	14.4	10.1	75.3	58.6	209.9	41.3	475.0
CFTR	"ABC35, ABCC7, CF, CFTR/MRP, dJ760C5.1, MRP7, TNR-CFTR"	ENSG00000001626	"Cystic fibrosis transmembrane conductance regulator"	P13569	7	117465784-117715971	"Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Ion transport, Transport"	"Chloride channel, Ion channel, Isomerase"	"Cancer-related genes, Disease mutation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	4	"pancreas: 103.0"	"Cell type enriched"	"Detected in many"	5	"Ductal cells: 325.5"	"Cancer enhanced"	"Detected in many"		"colorectal cancer: 23.9;pancreatic cancer: 28.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	22	"CACO-2: 12.8;MOLT-4: 48.1;U-266/70: 26.3"	"Low region specificity"	"Detected in some"			"Region enriched"	"Detected in single"	5	"olfactory region: 6.3"	"CAB001951, HPA021939, HPA079652"	Enhanced					NA	NA					"CAB001951: , HPA021939: AB_1846578, HPA079652: "	"unprognostic (6.38e-3)"	"unprognostic (9.55e-2)"	"unprognostic (1.77e-2)"	"unprognostic (1.44e-2)"	"unprognostic (8.74e-2)"	"unprognostic (8.57e-2)"	"prognostic unfavorable (9.44e-4)"	"unprognostic (3.20e-3)"	"unprognostic (1.13e-1)"	"unprognostic (8.89e-2)"	"unprognostic (1.55e-2)"	"unprognostic (2.14e-2)"	"unprognostic (4.78e-3)"	"unprognostic (1.24e-1)"	"unprognostic (2.58e-1)"	"unprognostic (9.08e-2)"	"unprognostic (6.64e-2)"	0.4	0.2	0.4	10.5	0.4	0.0	0.3	0.3	0.3	2.5	19.8	0.1	0.8	10.5	0.6	2.1	0.4	0.4	15.8	0.3	0.4	0.3	1.1	1.4	5.7	0.1	0.5	0.1	0.3	103.0	0.0	0.3	0.1	0.1	1.5	12.5	0.1	22.4	0.1	0.3	1.1	24.2	0.3	0.7	0.3	0.6	0.9	0.1	0.1	0.3	0.2	0.3	0.4	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.8	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	48.1	0.0	0.8	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	26.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.4	0.3	0.3	0.4	0.3	0.5	0.1	0.1	0.1	6.0	48.7	0.0	1.7	0.0	0.4	1.2	43.3	9.4	23.9	0.0	0.0	0.0	0.0	325.5	2.9	0.0	19.4	0.0	3.7	0.0	0.1	3.6	1.1	0.2	0.0	0.0	6.9	0.0	0.0	1.6	0.3	0.0	0.0	11.8	11.5	0.6	21.5	37.7	0.0	0.0	0.0	0.0	0.3	1.8	0.4	0.0	0.0	0.0	64.4	3.9
CGAS	"C6orf150, cGAS, MB21D1"	ENSG00000164430	"Cyclic GMP-AMP synthase"	Q8N884	6	73413515-73452276	"Enzymes, Predicted intracellular proteins"	"Antiviral defense, DNA damage, DNA repair, Host-virus interaction, Immunity, Innate immunity"	"DNA-binding, Nucleotidyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"vagina: 32.0"	"Cell type enriched"	"Detected in some"	4	"monocytes: 47.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Karpas-707: 18.6;RH-30: 21.5;RPMI-8226: 22.6"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"HPA031700, HPA031702"	Enhanced		Approved	"Centriolar satellite,Cytosol"		NA	NA			"Centriolar satellite"	Cytosol	"HPA031700: AB_10601693, HPA031702: AB_2673999"	"unprognostic (2.49e-1)"	"unprognostic (2.36e-1)"	"unprognostic (4.61e-2)"	"unprognostic (4.95e-2)"	"unprognostic (2.49e-2)"	"unprognostic (1.81e-1)"	"unprognostic (4.84e-3)"	"unprognostic (1.01e-2)"	"unprognostic (9.80e-2)"	"unprognostic (4.25e-2)"	"unprognostic (2.20e-2)"	"unprognostic (2.77e-1)"	"prognostic unfavorable (2.27e-7)"	"unprognostic (1.93e-3)"	"unprognostic (1.17e-2)"	"unprognostic (1.86e-1)"	"unprognostic (2.78e-1)"	6.5	2.0	2.9	10.5	4.5	18.5	8.1	1.2	3.9	4.7	3.7	3.4	2.1	4.1	5.5	2.8	5.3	3.9	4.3	3.2	2.8	2.9	2.5	1.9	9.6	11.8	7.2	0.6	3.4	3.8	2.3	1.8	4.8	4.4	6.6	3.1	2.2	4.2	2.9	1.9	1.8	5.2	3.6	4.7	12.8	3.5	1.7	4.3	6.2	3.9	4.2	15.5	6.6	32.0	6.3	12.5	13.3	12.9	3.0	6.0	3.9	8.9	3.0	0.1	0.1	0.6	1.3	0.0	4.5	1.9	5.9	6.5	9.9	6.8	0.1	9.8	2.1	3.2	4.6	5.0	0.0	6.3	14.9	0.0	7.8	3.8	0.0	2.1	6.0	5.5	0.9	1.6	5.8	0.0	0.0	1.8	0.0	0.0	18.6	4.3	3.7	0.0	13.6	2.9	1.1	5.5	11.6	21.5	22.6	0.0	3.7	0.1	0.0	7.9	0.2	4.7	0.1	0.0	16.2	2.1	0.0	4.3	3.9	0.1	4.0	8.8	0.1	0.0	8.6	5.9	13.3	9.2	13.2	4.6	12.9	3.6	6.3	6.0	4.6	5.4	4.8	1.4	2.6	5.8	3.0	7.8	12.5	5.8	3.9	2.9	4.5	1.2	3.9	2.8	2.9	7.2	0.6	4.4	4.3	3.0	7.4	0.0	0.0	0.0	0.0	0.0	0.0	5.3	1.2	0.0	0.0	0.1	0.0	1.7	0.0	0.0	0.0	0.0	3.5	0.6	0.0	0.0	4.7	0.0	10.8	0.0	0.0	0.0	0.0	0.0	0.0	5.7	0.0	47.7	0.0	0.0	4.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0
CH25H		ENSG00000138135	"Cholesterol 25-hydroxylase"	O95992	10	89205629-89207314	"Enzymes, Predicted membrane proteins"	"Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis, Steroid metabolism, Sterol biosynthesis, Sterol metabolism"	"Monooxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"brain: 44.4"	"Group enriched"	"Detected in many"	5	"Club cells: 17.0;Smooth muscle cells: 61.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	18	"memory CD8 T-cell: 1.7"	"Lineage enriched"	"Detected in single"	18	"T-cells: 1.7"	"Cell line enhanced"	"Detected in some"		"ASC diff: 7.4;ASC TERT1: 3.8;fHDF/TERT166: 26.3;HSkMC: 6.9"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"									NA	NA						"unprognostic (6.07e-3)"	"unprognostic (2.96e-3)"	"unprognostic (1.57e-1)"	"unprognostic (5.11e-2)"	"unprognostic (2.17e-2)"	"unprognostic (2.02e-1)"	"unprognostic (3.15e-2)"	"unprognostic (2.13e-1)"	"unprognostic (2.54e-1)"	"unprognostic (8.65e-3)"	"unprognostic (7.74e-2)"	"unprognostic (4.76e-2)"	"unprognostic (2.62e-5)"	"unprognostic (2.47e-2)"	"unprognostic (1.40e-1)"	"unprognostic (2.32e-2)"	"unprognostic (2.29e-2)"	18.5	6.8	5.1	8.5	30.7	4.1	7.9	1.0	15.7	5.2	3.6	22.6	2.4	4.3	1.6	17.6	18.4	7.4	18.3	4.2	11.3	6.5	2.8	4.7	17.0	4.6	9.4	1.6	3.4	1.8	2.2	9.8	5.4	44.4	5.7	7.5	5.3	2.3	2.1	2.1	3.2	6.8	6.9	41.9	2.6	6.2	0.6	2.2	7.2	3.0	8.5	5.7	14.0	2.3	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	7.4	3.8	0.0	0.0	2.5	0.6	0.7	0.0	0.0	0.0	0.9	26.3	0.8	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	2.3	0.0	0.0	6.9	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	3.5	0.0	0.1	0.0	0.1	0.0	0.0	2.9	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.1	30.7	1.0	10.6	11.3	6.5	9.4	1.6	44.4	2.2	3.0	4.3	0.0	4.4	6.2	0.0	0.4	0.0	6.7	17.0	0.0	0.0	0.1	0.0	0.0	0.0	7.3	0.0	0.0	0.0	0.1	7.6	0.9	1.1	0.0	7.9	1.6	0.0	3.1	4.7	0.0	0.3	8.7	6.8	0.0	0.0	0.6	0.1	0.0	0.7	0.0	0.3	6.5	61.8	0.0	0.0	5.8	0.1	0.7	0.0	4.7
CHAC1	MGC4504	ENSG00000128965	"ChaC glutathione specific gamma-glutamylcyclotransferase 1"	Q9BUX1	15	40952962-40956519	"Enzymes, Predicted intracellular proteins"	"Apoptosis, Neurogenesis, Notch signaling pathway, Unfolded protein response"	Lyase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"pancreas: 53.0;salivary gland: 39.9;skeletal muscle: 52.4"	"Cell type enhanced"	"Detected in many"	10	"Distal tubular cells: 29.9;Exocrine glandular cells: 24.3;Pancreatic endocrine cells: 16.5;Urothelial cells: 11.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"memory B-cell: 1.8"	"Group enriched"	"Detected in many"	6	"B-cells: 1.8;monocytes: 1.1;T-cells: 1.3"	"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 35.1;HHSteC: 26.8;hTCEpi: 42.4;SK-MEL-30: 30.0;U-266/70: 26.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042708, HPA043505"	Approved		Approved	Mitochondria		NA	NA			Mitochondria		"HPA042708: AB_2678125, HPA043505: AB_2678518"	"unprognostic (6.04e-3)"	"unprognostic (2.81e-2)"	"unprognostic (7.47e-2)"	"unprognostic (2.84e-3)"	"unprognostic (6.57e-3)"	"unprognostic (2.00e-2)"	"unprognostic (5.59e-2)"	"unprognostic (2.43e-1)"	"unprognostic (2.01e-1)"	"unprognostic (1.72e-1)"	"unprognostic (3.11e-1)"	"unprognostic (1.51e-1)"	"prognostic unfavorable (2.23e-7)"	"unprognostic (1.37e-2)"	"unprognostic (1.44e-1)"	"unprognostic (1.67e-2)"	"unprognostic (3.91e-2)"	6.0	1.0	2.6	1.5	2.1	1.7	1.0	1.7	5.6	1.1	1.9	0.3	1.1	1.9	1.1	1.8	18.6	1.5	5.7	2.2	2.6	4.8	3.1	14.1	1.5	1.1	2.6	2.2	11.3	53.0	0.9	1.3	1.1	6.2	1.5	1.1	0.2	39.9	1.3	52.4	1.3	1.5	1.1	5.3	1.1	11.2	0.9	1.0	0.0	1.7	4.7	4.6	2.7	2.7	1.8	0.1	0.2	1.1	0.0	1.3	0.2	2.8	1.9	0.5	8.8	1.4	1.0	3.6	17.0	35.1	1.8	5.0	4.7	0.7	0.8	1.3	1.5	5.6	1.9	3.8	1.4	1.3	3.2	0.7	0.7	0.5	0.0	26.8	2.2	0.0	12.0	42.4	5.5	7.7	0.5	1.7	19.6	2.3	4.0	1.5	1.6	1.6	0.0	1.6	9.7	6.6	1.4	0.0	3.8	0.9	1.1	1.7	2.5	0.5	3.0	30.0	1.1	1.1	16.0	0.5	0.3	5.3	0.4	3.0	26.3	5.6	3.4	1.6	3.1	4.0	0.0	0.4	0.0	1.3	0.4	0.0	1.8	0.2	0.8	0.1	0.0	0.0	1.0	0.2	0.0	1.1	0.0	0.0	0.2	2.6	2.1	1.7	5.6	2.6	4.8	2.6	2.2	6.2	1.0	0.0	1.3	1.5	3.4	2.5	2.3	3.5	2.5	0.0	1.2	0.0	2.0	0.2	29.9	7.5	0.1	0.5	2.8	0.0	24.3	0.2	0.5	5.1	0.0	0.4	0.3	0.0	3.4	1.8	0.8	0.0	0.3	0.4	5.0	1.8	1.5	0.3	16.5	0.3	0.0	0.1	0.4	0.0	0.5	1.4	0.7	3.8	2.9	0.0	1.5	11.8
CHAC2	GCG1	ENSG00000143942	"ChaC cation transport regulator homolog 2"	Q8WUX2	2	53767792-53775196	"Enzymes, Predicted intracellular proteins"		Lyase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"Spermatocytes: 26.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA049235	Approved		Approved	Cytosol		NA	NA			Cytosol		"HPA049235: AB_2680686"	"unprognostic (2.22e-1)"	"unprognostic (1.31e-1)"	"unprognostic (2.11e-2)"	"unprognostic (3.91e-3)"	"unprognostic (1.61e-2)"	"unprognostic (4.74e-3)"	"prognostic unfavorable (3.80e-7)"	"unprognostic (5.52e-2)"	"unprognostic (1.74e-2)"	"unprognostic (1.30e-2)"	"unprognostic (1.36e-2)"	"unprognostic (3.09e-2)"	"unprognostic (4.28e-6)"	"unprognostic (1.52e-1)"	"unprognostic (1.79e-1)"	"unprognostic (1.22e-1)"	"unprognostic (2.55e-1)"	7.2	8.6	6.5	7.1	6.2	9.3	3.6	4.3	4.4	2.6	6.8	2.1	7.7	11.4	2.4	4.4	8.4	1.8	5.3	10.3	6.2	6.1	8.3	9.8	3.4	9.6	5.0	4.2	1.8	4.8	1.5	6.7	1.7	6.9	2.8	6.1	2.8	4.1	4.6	9.8	2.0	9.0	3.5	4.8	10.2	7.0	16.4	3.7	9.5	3.7	4.2	9.8	5.7	5.1	6.6	2.5	1.8	0.9	1.4	6.7	3.0	19.1	6.4	6.8	6.0	3.4	1.7	1.4	8.8	1.8	6.3	7.5	4.4	4.9	16.3	12.9	3.8	9.5	6.9	15.4	10.5	11.1	34.3	13.4	12.9	8.6	7.2	5.2	15.2	5.9	2.1	3.1	11.7	8.9	1.7	12.3	11.3	13.2	9.6	8.3	6.2	18.0	12.7	8.8	8.3	11.5	13.8	14.5	16.5	8.7	5.2	8.5	2.4	10.2	7.6	4.0	4.3	4.6	6.0	5.4	3.7	13.3	14.2	14.2	9.6	12.3	13.9	5.0	19.2	5.1	1.8	0.5	1.1	5.2	0.9	5.5	6.6	5.7	5.8	1.1	5.4	6.7	6.1	1.4	1.4	0.7	2.5	5.1	3.0	6.5	6.2	4.3	4.4	6.2	6.1	5.0	4.2	6.9	3.7	0.0	1.4	11.5	2.8	3.1	0.8	2.8	5.1	1.4	2.3	1.8	0.0	1.7	10.0	5.8	5.3	3.7	2.6	0.0	7.1	0.7	1.6	2.9	1.1	7.5	6.6	1.6	0.0	2.5	1.0	1.7	2.6	2.8	3.3	8.2	3.4	3.3	6.4	0.0	3.9	5.6	5.5	0.0	3.4	26.1	5.1	3.0	0.3	6.9	9.2	3.9
CHAT		ENSG00000070748	"Choline O-acetyltransferase"	P28329	10	49609095-49665104	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Neurotransmitter biosynthesis"	"Acyltransferase, Transferase"	"Congenital myasthenic syndrome, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"brain: 5.4;placenta: 10.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	8	"basal ganglia: 5.4"	"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enriched"	"Detected in some"	11	"NB-4: 15.9"	"Region enhanced"	"Detected in many"		"basal ganglia: 18.4"	"Group enriched"	"Detected in all"	4	"basal ganglia: 7.7;pons and medulla: 8.1"	"CAB002313, HPA048547, CAB079053"	Supported	Supported				NA	NA					"CAB002313: AB_563661, CAB079053: , HPA048547: AB_2680437"					"unprognostic (2.34e-2)"	"unprognostic (6.10e-2)"		"unprognostic (5.28e-2)"		"unprognostic (6.96e-2)"	"unprognostic (2.80e-2)"			"unprognostic (3.98e-1)"	"unprognostic (1.09e-1)"			0.2	0.0	0.2	0.3	5.4	0.0	0.2	0.2	0.2	0.2	0.6	0.2	0.2	1.6	0.2	0.5	0.2	0.0	0.2	0.2	0.2	0.6	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.9	0.0	0.2	10.4	0.2	0.2	0.2	0.2	0.2	0.3	0.2	0.2	1.1	0.2	0.4	0.2	0.0	0.5	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.6	1.0	0.3	0.2	0.6	1.0	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.5	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.6	0.0	0.0	1.1	15.9	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.7	0.0	0.1	0.0	0.7	0.4	0.1	0.0	0.1	0.1	0.3	0.1	0.0	0.1	0.0	0.1	0.0	1.4	0.0	0.0	0.2	0.3	0.4	0.1	0.5	0.3	1.0	0.4	0.1	0.6	0.5	0.3	0.0	0.6	0.1	1.0	0.2	0.0	0.2	5.4	0.2	0.2	0.2	0.6	0.2	0.2	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
CHD1		ENSG00000153922	"Chromodomain helicase DNA binding protein 1"	O14646	5	98853985-98928957	"Disease related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Chromatin regulator, DNA-binding, Helicase, Hydrolase"	"Disease mutation, FDA approved drug targets, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 70.1"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA022236	Approved		Approved	"Nucleoplasm,Nucleoli fibrillar center"		NA	NA			"Nucleoplasm, Nucleoli fibrillar center"		"HPA022236: AB_2670915"	"unprognostic (2.63e-1)"	"unprognostic (2.31e-1)"	"unprognostic (1.09e-2)"	"unprognostic (4.11e-2)"	"unprognostic (7.79e-2)"	"unprognostic (7.15e-2)"	"unprognostic (6.50e-2)"	"unprognostic (1.00e-2)"	"unprognostic (1.79e-1)"	"unprognostic (2.88e-1)"	"unprognostic (4.94e-2)"	"unprognostic (3.15e-1)"	"prognostic unfavorable (7.25e-6)"	"unprognostic (2.69e-1)"	"unprognostic (3.33e-1)"	"unprognostic (1.52e-1)"	"unprognostic (1.17e-1)"	13.0	7.4	5.5	15.8	7.5	41.7	10.2	14.9	5.5	9.4	9.3	4.7	7.9	6.6	11.3	7.5	7.6	10.8	10.6	6.8	4.9	3.1	7.3	10.1	12.1	8.8	8.8	3.2	18.1	8.3	9.3	12.0	11.1	6.4	7.7	7.4	5.6	8.1	11.5	13.2	8.2	12.3	8.3	7.2	17.2	8.6	12.0	7.4	70.1	8.1	5.5	9.3	10.4	11.3	10.1	7.1	16.7	8.2	8.1	8.4	2.2	11.0	10.2	23.9	16.2	8.1	8.4	20.9	11.5	7.5	9.3	12.2	12.6	8.6	9.4	11.2	6.6	15.2	9.2	18.7	12.6	19.5	14.7	14.1	16.6	12.1	9.6	8.9	15.9	12.9	7.2	5.2	16.2	16.4	6.3	11.2	30.8	20.0	14.5	9.3	8.9	31.6	6.9	16.0	3.5	12.4	26.9	16.7	14.0	8.2	10.6	11.2	9.6	14.7	7.7	18.6	13.0	7.5	11.0	12.7	20.1	10.8	12.5	20.2	10.1	10.6	19.9	11.0	16.0	12.0	11.4	8.2	10.7	6.5	7.5	8.2	10.1	6.1	6.1	7.1	9.4	8.4	6.6	16.7	8.1	7.1	5.2	6.3	2.2	5.5	7.5	14.9	5.5	4.9	3.1	8.8	3.2	6.4	7.4	44.7	61.6	41.0	98.1	138.2	37.4	25.7	20.4	61.6	79.6	34.9	41.2	44.3	6.6	31.7	85.6	50.1	37.2	0.0	27.6	32.9	75.7	63.5	85.6	26.0	30.8	31.8	30.5	36.2	71.6	14.8	30.0	68.0	64.1	52.3	28.7	17.0	29.9	35.1	18.0	11.0	50.1	45.3	96.8	51.7	52.7	164.7	75.5	54.3	26.9	58.2
CHD1L	ALC1	ENSG00000131778	"Chromodomain helicase DNA binding protein 1 like"	Q86WJ1	1	147242641-147295766	"Enzymes, Predicted intracellular proteins"	"DNA damage, DNA repair"	"Helicase, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027789, HPA028670"	Enhanced		Supported	Nucleoplasm		NA	NA			Nucleoplasm		"HPA027789: AB_10601099, HPA028670: AB_10601257"	"unprognostic (1.07e-1)"	"unprognostic (3.93e-2)"	"unprognostic (1.97e-1)"	"unprognostic (3.49e-1)"	"unprognostic (1.78e-1)"	"unprognostic (2.58e-2)"	"prognostic unfavorable (3.07e-4)"	"unprognostic (1.86e-2)"	"unprognostic (7.83e-2)"	"unprognostic (1.39e-2)"	"unprognostic (4.97e-2)"	"unprognostic (8.21e-2)"	"prognostic unfavorable (1.31e-9)"	"unprognostic (5.51e-2)"	"unprognostic (3.52e-1)"	"unprognostic (2.74e-2)"	"unprognostic (1.16e-1)"	11.2	12.2	16.1	14.1	16.5	26.9	18.2	23.0	20.0	9.8	16.1	29.5	6.4	18.4	16.0	12.2	10.4	13.4	12.5	9.2	17.3	13.6	11.8	26.1	13.7	16.1	27.3	12.6	9.5	18.5	12.6	17.9	11.8	18.2	13.2	20.0	11.6	9.5	11.9	12.0	15.9	20.9	18.4	24.7	21.3	12.9	27.8	22.2	18.5	8.9	9.4	16.9	8.5	11.9	15.3	19.0	7.6	8.3	8.2	9.1	9.0	19.0	16.5	18.9	12.0	13.3	13.0	15.7	17.1	14.5	16.0	15.1	15.9	13.3	24.8	8.0	17.1	9.8	18.1	16.0	18.6	14.2	24.6	22.4	23.8	13.2	40.5	14.1	30.6	15.3	12.1	9.2	15.8	18.2	13.8	17.5	26.2	27.1	11.6	19.4	21.1	23.2	16.5	24.9	33.1	21.8	26.0	17.5	19.5	15.1	13.6	11.4	19.3	15.4	19.4	14.9	26.1	10.6	44.6	15.9	10.8	16.5	9.7	26.6	10.0	13.8	20.5	22.0	13.5	16.3	7.6	8.1	3.7	9.0	6.8	9.1	12.5	7.9	7.8	19.0	15.3	8.0	8.9	0.8	8.2	8.3	15.8	5.5	9.0	16.1	16.5	23.0	20.0	17.3	13.6	27.3	12.6	18.2	22.2	11.9	17.0	17.4	7.7	10.2	6.5	5.9	15.3	14.7	19.4	5.2	5.9	18.4	18.3	9.2	15.1	12.7	11.7	23.3	7.1	15.4	11.0	9.8	20.8	27.6	18.8	1.6	8.6	3.7	19.8	18.3	6.6	19.1	15.1	13.6	14.8	13.5	9.0	14.0	10.6	11.2	8.8	6.5	10.2	31.2	27.2	9.2	9.8	10.7	18.0	5.8
CHD2	"DKFZp547I1315, DKFZp686E01200, DKFZp781D1727, FLJ38614"	ENSG00000173575	"Chromodomain helicase DNA binding protein 2"	O14647	15	92900189-93028005	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Myogenesis, Transcription, Transcription regulation"	"Chromatin regulator, DNA-binding, Helicase, Hydrolase"	"Disease mutation, Epilepsy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA060744, HPA060960"	Enhanced		Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"HPA060744: AB_2684353, HPA060960: AB_2684398"	"unprognostic (1.65e-2)"	"unprognostic (2.43e-1)"	"unprognostic (2.14e-2)"	"unprognostic (5.98e-2)"	"unprognostic (2.12e-2)"	"unprognostic (3.10e-2)"	"unprognostic (2.67e-2)"	"unprognostic (7.85e-2)"	"unprognostic (7.51e-3)"	"unprognostic (1.14e-1)"	"unprognostic (2.84e-1)"	"unprognostic (1.79e-2)"	"unprognostic (4.64e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.58e-1)"	"unprognostic (3.15e-1)"	"unprognostic (1.70e-2)"	23.7	16.6	18.7	23.6	21.1	66.7	21.8	35.1	22.8	24.1	19.9	19.7	17.6	15.7	26.1	31.9	20.3	18.4	16.8	15.3	18.5	15.7	17.7	17.6	30.4	25.2	22.1	13.9	26.3	20.9	27.5	41.9	33.1	19.1	22.4	16.1	22.1	21.2	19.9	24.3	25.2	24.3	20.3	30.8	26.9	20.8	20.4	22.4	39.5	28.8	11.3	37.4	34.7	19.0	25.5	17.2	34.5	6.3	8.0	17.5	4.6	10.7	5.9	16.0	7.0	10.0	24.6	12.3	10.1	10.4	6.8	8.5	7.5	14.2	2.6	8.5	8.8	11.7	16.1	9.3	10.0	9.6	0.0	5.5	12.8	11.8	6.4	13.4	13.5	10.1	15.5	12.3	8.1	16.6	14.2	11.6	19.1	13.3	30.4	10.3	6.6	7.0	7.0	10.1	5.3	6.6	10.1	14.6	14.5	7.1	14.5	8.9	9.5	17.6	6.5	13.2	16.8	7.3	11.4	18.4	5.6	7.4	4.8	6.4	29.0	11.6	11.1	8.6	8.1	4.9	14.9	6.3	15.0	12.9	3.3	11.8	25.5	12.6	10.1	3.3	23.4	17.5	12.5	34.5	8.0	5.8	17.2	12.3	4.6	18.7	21.1	35.1	22.8	18.5	15.7	22.1	13.9	19.1	22.4	65.5	165.7	52.5	97.7	146.0	66.2	34.7	25.5	105.7	153.6	43.6	86.4	24.4	3.3	30.1	45.6	46.5	39.7	23.3	32.9	20.4	79.4	107.2	94.9	29.8	22.2	54.0	56.9	23.4	43.8	28.3	32.2	70.9	91.1	47.7	34.3	34.1	46.6	37.7	35.3	8.7	80.7	32.3	55.9	14.4	10.0	158.0	50.6	94.7	35.1	111.1
CHD3	"Mi-2a, Mi2-ALPHA, ZFH"	ENSG00000170004	"Chromodomain helicase DNA binding protein 3"	Q12873	17	7884806-7912760	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Chromatin regulator, DNA-binding, Helicase, Hydrolase"	"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043368, HPA076524"	Supported		Approved	"Nucleoplasm,Nucleoli,Centriolar satellite"		No	No			"Nucleoplasm, Nucleoli, Centriolar satellite"		"HPA043368: AB_2678448, HPA076524: AB_2686804"	"unprognostic (1.77e-2)"	"unprognostic (8.01e-2)"	"prognostic unfavorable (2.43e-4)"	"prognostic favorable (7.68e-5)"	"unprognostic (1.53e-1)"	"unprognostic (8.11e-3)"	"unprognostic (2.54e-1)"	"unprognostic (1.11e-1)"	"unprognostic (2.83e-2)"	"unprognostic (5.25e-3)"	"prognostic favorable (8.36e-4)"	"unprognostic (9.11e-2)"	"unprognostic (8.31e-2)"	"unprognostic (3.98e-2)"	"unprognostic (1.50e-1)"	"unprognostic (8.90e-3)"	"unprognostic (2.20e-3)"	10.4	12.9	31.7	24.3	26.0	18.7	12.5	12.1	28.3	41.1	21.1	4.1	22.5	8.2	46.3	16.1	15.1	25.0	20.0	8.7	30.4	14.2	15.2	2.3	13.1	19.0	8.4	28.4	27.3	15.1	28.5	21.0	8.0	10.7	32.9	11.1	20.7	19.4	23.0	3.3	16.2	14.0	23.3	6.9	14.6	15.8	11.3	5.1	40.6	19.7	7.5	17.7	20.6	28.9	1.6	4.0	4.1	3.5	2.7	7.8	3.6	12.2	30.5	17.9	23.7	21.8	18.3	9.6	14.3	19.2	12.1	13.0	5.9	10.3	34.5	10.9	21.0	9.8	16.6	33.6	15.1	15.3	17.5	19.6	16.7	39.6	0.7	11.7	4.8	32.9	24.1	8.1	16.3	10.9	32.3	22.5	15.8	11.1	0.6	11.3	12.1	13.1	5.5	2.8	12.9	11.3	38.6	21.8	5.2	12.1	29.8	12.2	16.5	35.5	13.8	6.9	5.1	15.9	7.8	28.1	26.3	20.7	6.4	20.5	2.6	0.4	19.5	13.4	13.5	22.4	0.6	2.7	4.1	7.0	1.7	5.5	1.5	6.7	6.6	2.1	1.6	7.8	5.1	2.1	2.7	3.5	4.0	3.6	3.6	31.7	26.0	12.1	28.3	30.4	14.2	8.4	28.4	10.7	5.1	29.8	57.4	11.5	44.3	32.4	61.2	9.7	17.8	24.1	37.5	76.8	7.9	15.1	14.9	21.3	8.9	17.5	12.0	0.0	20.6	16.7	30.0	67.6	38.2	2.1	8.4	42.9	54.5	18.4	21.1	13.0	41.1	14.7	8.5	54.1	12.6	11.3	23.7	7.0	53.7	7.5	15.6	25.8	27.2	12.9	50.5	17.9	13.7	34.6	25.9	53.1
CHD4	"Mi-2b, Mi2-BETA"	ENSG00000111642	"Chromodomain helicase DNA binding protein 4"	Q14839	12	6570082-6614524	"Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Chromatin regulator, DNA-binding, Helicase, Hydrolase"	"Cancer-related genes, Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA012008	Supported		Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"HPA012008: AB_1846633"	"unprognostic (6.11e-2)"	"unprognostic (2.26e-2)"	"unprognostic (1.71e-2)"	"unprognostic (6.40e-3)"	"unprognostic (8.99e-2)"	"unprognostic (3.36e-3)"	"prognostic unfavorable (6.03e-6)"	"unprognostic (2.66e-2)"	"unprognostic (1.05e-1)"	"unprognostic (6.85e-2)"	"unprognostic (3.15e-1)"	"unprognostic (3.94e-1)"	"unprognostic (2.06e-1)"	"unprognostic (3.33e-1)"	"unprognostic (1.82e-1)"	"unprognostic (9.84e-2)"	"unprognostic (1.66e-1)"	23.5	34.9	21.9	50.0	33.5	27.2	25.9	29.4	25.1	28.1	29.5	29.3	38.5	18.6	37.2	35.4	29.1	28.0	40.3	52.8	23.5	19.2	29.5	25.0	25.5	30.9	33.6	19.4	34.6	27.4	58.4	25.3	29.5	27.2	21.5	26.0	26.5	24.8	46.2	33.7	31.1	24.4	36.6	30.3	29.4	27.2	29.7	28.9	75.7	38.4	33.7	38.4	34.7	24.3	12.6	16.8	12.8	9.1	13.5	16.7	5.8	20.4	18.7	46.4	17.4	19.0	21.4	27.3	22.7	22.2	25.1	23.2	31.2	15.9	44.1	9.0	25.7	16.4	18.3	43.5	25.0	33.9	33.0	22.4	61.6	29.1	19.4	16.5	48.3	29.6	20.7	12.4	24.3	17.0	31.7	29.3	24.7	48.4	22.0	23.8	25.6	45.8	15.8	44.4	19.0	17.7	39.3	28.5	24.1	15.9	24.2	22.0	28.3	29.2	32.6	22.6	53.2	14.9	27.5	27.2	25.7	54.7	18.8	26.5	35.7	21.2	56.3	17.0	29.5	18.7	9.0	7.7	9.2	12.2	9.1	12.0	10.5	10.3	11.1	7.9	12.6	13.0	12.3	12.8	13.5	8.1	16.8	16.7	5.8	21.9	33.5	29.4	25.1	23.5	19.2	33.6	19.4	27.2	28.9	56.6	102.0	59.1	45.6	60.9	103.2	110.8	66.2	96.4	79.6	83.7	66.8	38.6	11.6	71.4	71.8	70.5	43.4	23.3	62.1	41.7	66.9	40.2	81.1	60.6	61.2	131.9	93.2	49.7	44.2	45.3	60.9	57.6	45.5	56.9	59.2	71.6	76.6	24.6	70.0	30.3	60.2	51.8	73.5	97.0	107.1	59.1	56.9	61.8	61.8	37.3
CHD5		ENSG00000116254	"Chromodomain helicase DNA binding protein 5"	Q8TDI0	1	6101793-6180123	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Differentiation, Neurogenesis, Spermatogenesis, Transcription, Transcription regulation"	"Chromatin regulator, DNA-binding, Helicase, Hydrolase"	"Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 41.4;pituitary gland: 22.3;testis: 16.4"	"Cell type enhanced"	"Detected in some"	17	"Bipolar cells: 60.3;Early spermatids: 202.3;Horizontal cells: 212.9;Late spermatids: 67.4"	"Low cancer specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"SCLC-21H: 17.0;U-2 OS: 7.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA015809			Supported	"Nucleoplasm,Nuclear speckles,Cytosol"		NA	NA			"Nucleoplasm, Nuclear speckles"	Cytosol	"HPA015809: "	"unprognostic (5.03e-4)"	"unprognostic (1.89e-1)"	"unprognostic (2.47e-3)"	"unprognostic (9.40e-6)"	"unprognostic (1.91e-2)"	"unprognostic (2.98e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.09e-1)"	"unprognostic (2.97e-2)"	"unprognostic (1.95e-2)"	"unprognostic (6.64e-4)"	"unprognostic (1.34e-1)"	"unprognostic (1.34e-4)"	"unprognostic (1.16e-1)"	"unprognostic (1.63e-1)"	"unprognostic (1.96e-1)"	"unprognostic (1.98e-1)"	1.1	7.9	19.8	1.3	17.1	1.0	1.0	12.1	41.4	1.2	1.4	0.7	0.0	1.3	1.2	1.2	1.5	1.2	1.2	1.6	15.3	10.1	1.3	1.0	1.2	1.0	4.3	19.1	1.1	1.4	1.3	22.3	1.0	8.0	1.9	1.3	2.3	1.2	4.8	1.2	1.0	1.4	1.2	1.6	1.1	1.2	16.4	0.8	0.0	1.0	0.0	1.0	1.1	0.4	0.1	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.6	0.8	0.0	0.2	0.1	0.1	0.0	0.0	0.1	0.2	2.5	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.5	0.3	1.5	0.0	0.1	0.3	1.3	0.0	0.0	0.0	0.0	17.0	0.2	0.2	0.0	0.0	0.0	2.9	0.1	0.0	0.1	7.6	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	19.8	17.1	12.1	34.2	15.3	10.1	4.3	19.1	8.0	0.8	0.0	0.0	0.0	0.0	0.1	60.3	1.7	0.0	0.0	0.0	3.5	11.8	0.0	0.0	0.0	202.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	212.9	0.0	0.0	0.0	67.4	0.9	0.0	0.0	0.0	0.0	2.0	0.4	0.0	0.4	0.0	48.3	0.0	0.9	3.4	17.0	0.4	0.0	0.0	0.0	0.0
CHD6	"CHD5, dJ620E11.1, FLJ22369, KIAA1335, RIGB"	ENSG00000124177	"Chromodomain helicase DNA binding protein 6"	Q8TD26	20	41402101-41618494	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Host-virus interaction, Transcription, Transcription regulation"	"Chromatin regulator, DNA-binding, Helicase, Hydrolase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Horizontal cells: 143.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA015543			Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA015543: "	"unprognostic (5.13e-3)"	"unprognostic (1.85e-1)"	"unprognostic (1.17e-1)"	"unprognostic (1.27e-1)"	"unprognostic (6.66e-2)"	"unprognostic (1.36e-1)"	"unprognostic (4.72e-3)"	"prognostic favorable (3.42e-4)"	"unprognostic (1.17e-1)"	"unprognostic (3.17e-1)"	"unprognostic (4.75e-2)"	"unprognostic (1.14e-1)"	"unprognostic (2.12e-3)"	"unprognostic (6.66e-2)"	"unprognostic (3.41e-1)"	"unprognostic (1.00e-1)"	"unprognostic (1.14e-2)"	12.1	12.6	16.5	12.7	16.2	18.1	19.4	34.1	24.9	17.4	11.3	16.6	15.4	6.5	20.4	19.9	11.0	16.3	11.7	12.1	15.8	13.9	11.8	10.7	11.7	12.1	14.7	16.8	26.1	12.5	31.4	30.3	12.9	24.3	19.7	10.0	14.2	14.5	17.0	9.4	14.4	10.5	14.4	17.3	12.0	12.3	11.1	18.2	21.4	21.4	6.7	15.3	16.9	15.0	12.0	11.5	15.1	9.3	10.4	10.4	2.3	6.4	7.6	16.5	7.2	9.4	9.7	11.0	5.7	11.7	10.1	12.4	10.5	5.3	7.7	10.3	9.6	11.4	9.6	10.3	9.7	11.6	2.4	5.0	10.6	7.0	10.1	5.3	8.2	5.3	9.7	9.1	7.3	8.2	10.8	8.7	10.9	8.3	8.8	7.8	17.7	13.0	9.0	5.4	4.0	12.9	10.1	19.6	5.5	6.3	15.0	14.9	10.3	17.2	4.6	11.5	12.6	7.9	6.2	9.9	16.0	7.9	8.5	4.9	8.0	6.4	10.0	7.1	4.0	5.0	15.1	6.5	7.1	8.9	6.2	8.9	8.8	7.7	7.3	5.1	12.0	10.4	8.7	0.9	10.4	9.3	11.5	5.9	2.3	16.5	16.2	34.1	24.9	15.8	13.9	14.7	16.8	24.3	18.2	44.7	25.0	32.1	38.2	16.1	123.2	51.6	22.9	45.5	34.2	21.0	88.4	26.6	18.3	19.0	12.5	32.3	4.8	0.0	13.7	22.1	28.6	28.3	20.8	18.7	14.3	143.0	58.3	23.9	21.3	14.0	46.1	23.5	16.9	32.5	27.7	76.4	14.4	14.0	42.8	10.6	137.4	19.4	29.7	22.1	59.7	15.1	27.3	31.9	20.9	22.3
CHD7	"CRG, FLJ20357, FLJ20361, KIAA1416"	ENSG00000171316	"Chromodomain helicase DNA binding protein 7"	Q9P2D1	8	60678778-60868028	"Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"rRNA processing, Transcription, Transcription regulation"	"Chromatin regulator, DNA-binding, Helicase, Hydrolase"	"Cancer-related genes, Disease mutation, Hypogonadotropic hypogonadism, Kallmann syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 47.1"	"Cell type enhanced"	"Detected in many"	8	"Cone photoreceptor cells: 227.8;Muller glia cells: 155.9;Rod photoreceptor cells: 196.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	15	"B-cells: 12.2;granulocytes: 12.6;T-cells: 5.5"	"Cell line enhanced"	"Detected in many"		"AF22: 26.3;SCLC-21H: 24.0"	"Low region specificity"	"Detected in many"			"Region enriched"	"Detected in all"	4	"cerebellum: 110.3"	HPA053075			Supported	Nucleoplasm,Nucleoli		NA	NA			Nucleoplasm	Nucleoli	"HPA053075: AB_2682035"	"unprognostic (3.77e-2)"	"unprognostic (3.28e-3)"	"unprognostic (3.17e-2)"	"prognostic unfavorable (5.34e-5)"	"unprognostic (9.59e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.86e-3)"	"unprognostic (3.41e-2)"	"unprognostic (3.06e-1)"	"unprognostic (2.73e-1)"	"unprognostic (2.46e-1)"	"unprognostic (1.33e-1)"	"unprognostic (9.09e-2)"	"unprognostic (9.21e-2)"	"unprognostic (1.75e-1)"	"unprognostic (8.20e-2)"	"unprognostic (2.17e-1)"	3.9	2.2	7.0	7.9	11.2	25.1	4.1	47.1	9.0	2.3	5.7	13.4	3.1	5.9	2.6	3.2	5.1	3.2	3.1	4.1	8.1	4.3	3.6	3.6	4.7	7.0	8.1	3.3	1.4	6.4	12.4	9.9	5.6	9.9	2.9	5.5	6.4	5.7	2.8	10.3	5.7	6.6	2.4	7.5	6.1	4.5	4.3	12.2	1.6	5.4	2.2	7.3	2.9	5.9	12.2	0.6	12.6	0.6	0.0	5.5	0.4	3.9	2.0	26.3	4.6	0.1	0.0	8.3	0.2	0.0	0.9	0.8	4.9	3.7	7.6	0.5	0.0	1.2	2.4	13.5	3.9	0.8	2.9	7.2	17.9	3.3	6.4	1.1	5.4	3.3	0.5	3.0	0.0	4.4	1.6	3.9	6.2	1.3	6.8	0.6	4.0	8.4	6.2	18.0	3.9	0.9	17.6	6.2	2.4	2.0	4.5	24.0	11.9	0.7	3.0	7.3	9.7	5.3	5.1	4.5	0.3	4.3	0.3	2.1	7.3	4.2	11.9	1.5	0.6	6.7	10.4	0.3	12.6	2.6	0.1	3.3	8.0	2.9	0.9	0.1	12.2	5.5	2.0	7.1	0.0	0.6	0.6	0.2	0.4	7.0	11.2	47.1	6.5	8.1	4.3	8.1	3.3	9.9	12.2	29.8	17.4	46.9	22.3	27.0	32.3	30.7	30.6	20.1	23.9	15.7	227.8	7.1	1.7	15.6	11.9	29.6	17.6	0.0	9.7	5.5	7.1	31.3	38.3	9.5	11.9	66.7	83.8	27.0	12.9	7.6	0.9	10.3	20.3	19.8	30.6	155.9	13.9	22.6	0.4	4.2	196.3	0.0	4.4	4.9	3.4	28.2	5.1	13.8	21.7	25.1
CHD8	"DUPLIN, HELSNF1, KIAA1564"	ENSG00000100888	"Chromodomain helicase DNA binding protein 8"	Q9HCK8	14	21385194-21456126	"Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Transcription, Transcription regulation, Wnt signaling pathway"	"Activator, Chromatin regulator, DNA-binding, Helicase, Hydrolase, Repressor"	"Autism, Autism spectrum disorder, Cancer-related genes, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA052186, HPA076133"			Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"HPA052186: AB_2681754, HPA076133: "	"unprognostic (3.45e-1)"	"unprognostic (9.71e-2)"	"unprognostic (3.31e-1)"	"unprognostic (2.67e-1)"	"unprognostic (1.14e-1)"	"unprognostic (3.43e-1)"	"prognostic unfavorable (4.94e-4)"	"unprognostic (7.31e-2)"	"unprognostic (9.22e-2)"	"prognostic favorable (8.35e-4)"	"unprognostic (1.64e-1)"	"unprognostic (2.63e-2)"	"unprognostic (2.54e-3)"	"unprognostic (2.88e-1)"	"unprognostic (9.24e-2)"	"unprognostic (2.51e-1)"	"unprognostic (8.07e-3)"	13.9	14.5	13.0	14.8	21.5	34.8	17.0	28.9	25.7	15.8	14.4	26.6	14.1	11.1	18.3	13.4	17.4	15.9	11.7	12.3	13.5	13.3	14.0	11.2	15.5	18.5	15.4	15.2	20.7	19.0	34.7	25.3	15.2	20.3	16.3	14.6	19.3	15.7	14.9	16.9	24.5	16.4	17.2	13.1	19.2	16.1	15.2	18.1	29.9	17.4	10.4	24.8	16.6	14.5	12.3	7.8	12.8	7.4	8.7	8.6	3.0	16.5	21.7	24.1	11.2	15.4	13.3	13.6	13.2	15.2	20.1	20.1	18.8	14.4	27.4	8.3	17.6	15.9	20.3	29.4	18.5	25.4	20.9	13.4	24.0	14.5	22.8	14.3	33.2	22.9	17.9	15.1	22.5	16.2	15.6	17.8	21.7	16.7	14.7	15.1	17.8	23.8	13.6	18.4	16.1	18.4	22.4	18.2	9.2	14.9	30.6	17.6	16.9	20.6	16.1	11.4	22.7	11.3	16.1	20.9	16.7	12.8	9.8	15.6	16.7	19.9	27.4	6.7	12.3	16.6	12.8	4.8	12.1	7.7	5.0	8.6	5.8	6.8	7.5	3.3	12.3	7.4	6.4	11.0	8.7	7.4	7.8	5.7	3.0	13.0	21.5	28.9	25.7	13.5	13.3	15.4	15.2	20.3	18.1	35.7	52.5	15.1	10.4	11.2	32.4	18.1	20.4	36.1	43.3	31.4	25.5	12.2	1.7	19.0	1.6	18.0	11.3	23.3	20.2	10.1	9.9	12.1	26.7	12.4	15.0	22.3	26.0	14.1	20.9	2.5	15.0	13.0	10.1	19.8	16.3	19.2	21.3	14.0	16.6	6.3	22.9	0.0	13.3	26.2	22.4	14.4	10.3	22.3	14.7	11.1
CHD9	"BC022889, FLJ12178, KIAA0308"	ENSG00000177200	"Chromodomain helicase DNA binding protein 9"	Q3L8U1	16	53055033-53329150	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Chromatin regulator, DNA-binding, Helicase, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	8	"Cone photoreceptor cells: 473.2;Rod photoreceptor cells: 752.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"plasmacytoid DC: 42.9"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042053, HPA049420, HPA066155"	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA042053: AB_2677823, HPA049420: AB_2680758, HPA066155: "	"unprognostic (3.57e-2)"	"unprognostic (3.73e-2)"	"unprognostic (3.44e-3)"	"unprognostic (2.42e-1)"	"unprognostic (4.34e-2)"	"unprognostic (4.35e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.68e-1)"	"unprognostic (7.75e-3)"	"unprognostic (2.87e-2)"	"unprognostic (3.39e-1)"	"unprognostic (2.35e-2)"	"prognostic favorable (1.84e-4)"	"unprognostic (4.96e-2)"	"unprognostic (1.74e-1)"	"unprognostic (5.09e-2)"	"unprognostic (2.87e-1)"	18.0	12.6	14.5	12.5	17.3	30.3	15.7	49.3	19.6	18.5	13.8	6.6	17.4	8.0	14.2	15.0	14.4	13.5	11.6	12.2	15.9	8.2	16.8	12.3	12.3	9.2	16.0	12.3	18.8	12.9	28.1	39.9	12.3	15.1	13.7	11.5	8.9	17.8	15.3	17.1	14.4	11.1	11.6	20.1	11.6	13.4	7.0	18.7	15.6	17.7	11.2	9.4	13.9	15.1	16.4	42.9	23.7	12.7	12.1	8.8	1.7	5.8	6.8	15.2	12.3	11.3	16.6	2.6	10.7	7.9	5.7	2.5	3.7	5.2	7.8	7.0	8.8	3.9	7.1	7.9	5.6	8.0	2.7	5.9	11.0	6.5	2.4	7.9	15.2	9.2	11.5	5.6	8.3	10.5	7.6	8.4	4.4	12.9	2.6	7.1	2.3	7.6	3.5	5.5	1.7	5.2	26.8	18.2	3.3	3.4	5.5	6.4	7.2	9.5	3.1	7.9	5.7	3.4	7.0	16.2	10.7	5.4	3.9	7.1	8.1	5.6	13.6	7.6	6.6	10.5	23.7	9.2	8.9	5.7	7.6	8.8	12.5	3.9	6.2	5.4	16.4	3.1	4.4	3.0	12.1	12.7	42.9	1.9	1.7	14.5	17.3	49.3	19.6	15.9	8.2	16.0	12.3	15.1	18.7	65.5	56.6	64.3	103.8	50.8	251.0	33.9	43.3	68.3	67.1	85.5	473.2	14.5	39.7	49.7	11.6	77.2	66.9	46.7	32.4	24.2	77.4	86.0	91.5	61.4	61.8	208.2	84.2	88.4	58.8	14.5	100.4	67.6	64.1	74.9	67.1	159.3	29.5	60.4	116.0	47.5	752.2	58.2	73.1	79.9	36.0	65.6	20.8	48.9	69.8	73.2
CHDH		ENSG00000016391	"Choline dehydrogenase"	Q8NE62	3	53812335-53846390	"Enzymes, Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 36.6;liver: 24.0"	"Cell type enhanced"	"Detected in many"	7	"Cholangiocytes: 53.5;Proximal tubular cells: 81.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	8	"basophil: 6.4;T-reg: 2.8"	"Group enriched"	"Detected in many"	15	"granulocytes: 6.4;T-cells: 2.8"	"Cell line enhanced"	"Detected in some"		"CACO-2: 8.0;Hep G2: 24.6;OE19: 17.7;T-47d: 8.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA036633, HPA058130"	Enhanced					NA	NA					"HPA036633: AB_10670841, HPA058130: AB_2683615"	"unprognostic (3.40e-3)"	"unprognostic (1.17e-2)"	"unprognostic (2.26e-3)"	"unprognostic (7.17e-3)"	"unprognostic (9.15e-2)"	"unprognostic (1.17e-3)"	"unprognostic (1.10e-1)"	"unprognostic (1.97e-2)"	"unprognostic (2.75e-1)"	"unprognostic (4.35e-3)"	"unprognostic (4.57e-2)"	"unprognostic (5.12e-2)"	"prognostic favorable (1.88e-8)"	"unprognostic (3.37e-2)"	"unprognostic (2.42e-1)"	"unprognostic (8.26e-2)"	"unprognostic (2.29e-2)"	0.7	2.2	11.6	2.3	9.7	0.9	7.8	12.9	10.2	4.1	8.8	8.2	0.8	8.3	3.2	3.8	1.0	2.8	5.5	3.3	13.8	4.0	36.6	24.0	2.6	1.4	11.9	6.5	1.6	15.5	8.0	5.9	0.8	10.0	5.4	9.4	3.3	13.7	1.5	3.8	1.6	14.0	1.4	6.4	0.7	8.1	4.5	13.0	0.0	4.1	0.1	1.6	0.8	1.0	0.3	0.1	6.4	0.1	0.1	2.8	0.1	0.3	3.3	0.8	0.1	0.0	0.0	3.7	0.2	0.4	0.0	0.0	8.0	0.6	0.3	0.6	0.6	0.1	0.0	5.3	0.0	0.0	0.0	2.8	0.0	1.1	24.6	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.4	0.0	0.0	3.8	0.5	0.0	4.7	0.0	0.1	5.2	17.7	0.6	0.0	1.4	5.6	3.7	2.9	2.2	2.8	1.3	0.1	0.0	0.7	8.1	0.1	0.0	0.0	0.6	0.1	0.7	0.7	1.0	0.0	0.0	0.0	0.0	6.4	0.1	0.1	0.1	0.1	0.1	0.3	0.2	0.1	0.0	0.2	0.1	0.1	0.5	0.1	0.1	0.1	2.8	0.1	11.6	9.7	12.9	10.2	13.8	4.0	11.9	6.5	10.0	13.0	3.0	5.0	2.7	6.1	6.0	16.8	7.6	53.5	6.7	10.3	10.4	13.7	2.5	6.6	15.1	21.5	0.7	23.4	0.0	11.9	1.8	2.1	17.6	6.9	38.9	0.3	1.6	46.0	1.3	1.9	28.5	5.5	1.9	3.3	0.0	34.1	13.4	9.1	17.5	14.5	81.4	14.6	0.0	1.9	3.3	1.9	4.5	0.7	1.5	45.1	1.2
CHEK1	CHK1	ENSG00000149554	"Checkpoint kinase 1"	O14757	11	125625136-125676255	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, DNA damage, DNA repair"	"Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"ductus deferens: 80.0;seminal vesicle: 66.8"	"Cell type enhanced"	"Detected in many"	9	"Cholangiocytes: 33.1;Extravillous trophoblasts: 31.3;Spermatogonia: 60.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"T-reg: 11.7"	"Lineage enriched"	"Detected in many"	6	"T-cells: 11.7"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in single"							HPA044364			Supported	Nucleoplasm,Vesicles		NA	NA			Nucleoplasm	Vesicles	"HPA044364: AB_2678913"	"unprognostic (6.74e-2)"	"unprognostic (3.63e-1)"	"prognostic favorable (3.62e-4)"	"unprognostic (5.54e-2)"	"unprognostic (2.17e-1)"	"unprognostic (1.03e-1)"	"prognostic unfavorable (3.70e-6)"	"unprognostic (3.95e-3)"	"unprognostic (1.26e-3)"	"unprognostic (2.54e-2)"	"prognostic unfavorable (3.10e-6)"	"unprognostic (1.75e-1)"	"prognostic unfavorable (1.04e-8)"	"unprognostic (2.89e-2)"	"unprognostic (2.64e-1)"	"unprognostic (8.16e-2)"	"unprognostic (1.33e-1)"	3.0	2.5	2.5	9.0	2.8	14.9	2.1	1.1	2.2	2.5	5.2	1.3	80.0	5.0	1.9	10.2	6.5	1.7	3.6	1.5	2.4	2.4	3.7	2.0	1.8	9.6	3.0	1.2	3.8	4.0	25.5	3.5	3.8	1.5	2.9	6.3	1.6	2.6	66.8	1.2	2.9	5.2	2.3	3.0	3.6	2.8	7.2	1.5	22.4	1.8	4.5	8.8	3.8	3.3	1.9	1.8	1.9	0.7	1.2	11.7	1.0	13.0	10.6	23.9	14.5	4.9	10.5	10.4	18.3	8.8	11.7	12.6	25.9	28.8	34.0	18.8	7.2	15.6	15.7	14.6	9.6	14.5	21.3	6.7	63.1	8.9	13.2	1.5	32.2	12.0	5.4	2.0	14.8	10.5	7.0	13.9	23.2	32.0	30.0	15.4	6.7	47.8	15.8	24.2	21.3	9.6	29.1	22.3	17.9	10.8	17.4	15.1	16.0	15.0	10.4	4.4	16.9	28.0	10.5	9.3	16.9	14.4	8.1	16.8	6.7	12.0	48.5	6.2	24.3	19.8	1.9	0.5	0.3	1.3	0.7	1.2	1.9	3.5	1.6	1.1	1.5	3.3	2.0	0.4	1.2	0.4	1.8	11.7	1.0	2.5	2.8	1.1	2.2	2.4	2.4	3.0	1.2	1.5	1.5	3.0	0.3	6.0	4.4	5.6	1.4	3.7	33.1	2.7	5.7	7.0	0.0	9.6	3.3	3.7	3.3	1.9	3.3	23.3	1.0	31.3	5.6	2.0	0.0	0.8	9.4	0.0	1.7	4.9	0.0	2.2	1.4	2.4	0.0	4.6	5.6	2.7	2.4	3.7	1.1	6.8	1.5	0.0	4.1	23.3	60.3	4.3	6.5	4.4	12.0	1.4
CHEK2	"bA444G7, CDS1, CHK2, HuCds1, PP1425, RAD53"	ENSG00000183765	"Checkpoint kinase 2"	O96017	22	28687743-28742422	"Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Apoptosis, Cell cycle, Cell division, DNA damage, DNA repair, Mitosis, Transcription, Transcription regulation"	"Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes, Disease mutation, Li-Fraumeni syndrome, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Erythroid cells: 23.3;Spermatogonia: 20.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA001878, CAB002030"	Enhanced		Supported	"Nucleoplasm,Golgi apparatus"		NA	NA			Nucleoplasm	"Golgi apparatus"	"CAB002030: AB_563660, HPA001878: AB_1078514"	"unprognostic (1.54e-1)"	"unprognostic (2.20e-1)"	"unprognostic (5.83e-2)"	"unprognostic (2.93e-2)"	"unprognostic (2.42e-1)"	"unprognostic (3.83e-2)"	"unprognostic (1.49e-3)"	"unprognostic (5.08e-3)"	"unprognostic (3.33e-3)"	"unprognostic (9.62e-3)"	"unprognostic (1.28e-2)"	"unprognostic (3.13e-1)"	"prognostic unfavorable (7.80e-9)"	"unprognostic (2.38e-2)"	"unprognostic (1.78e-1)"	"unprognostic (7.27e-2)"	"unprognostic (6.79e-3)"	5.6	8.3	2.5	13.0	7.0	13.7	5.6	0.7	5.6	6.6	9.8	2.5	4.8	6.8	4.8	10.9	10.0	4.3	6.0	6.0	4.1	2.3	5.3	6.5	7.9	10.1	6.7	1.6	12.9	6.7	1.2	4.2	10.1	5.1	8.3	10.6	8.7	7.0	5.8	2.2	6.3	8.5	5.4	5.0	9.8	5.8	9.7	3.6	13.1	7.5	4.8	13.7	6.2	6.7	11.8	8.7	6.5	8.4	2.9	4.4	3.7	14.9	4.8	13.7	17.0	3.9	19.5	8.8	7.4	8.7	9.8	14.4	12.1	10.2	17.7	6.3	5.2	10.6	14.4	20.8	13.6	11.5	12.6	16.0	23.3	9.2	20.2	3.8	14.7	17.1	8.2	6.3	12.6	11.2	6.0	10.8	14.2	14.0	15.5	9.2	21.0	11.8	23.7	19.3	18.5	12.2	25.6	9.4	20.6	6.1	6.2	8.1	4.6	8.3	14.7	8.2	10.6	10.1	13.6	3.7	7.9	9.5	6.9	3.9	9.4	16.5	34.6	7.5	15.5	10.0	6.5	3.7	1.2	1.1	8.4	2.3	11.8	2.2	2.1	8.7	8.4	4.4	2.8	0.3	2.9	4.1	7.0	2.8	3.7	2.5	7.0	0.7	5.6	4.1	2.3	6.7	1.6	5.1	3.6	8.9	4.5	7.5	4.5	5.7	1.0	1.0	0.0	2.7	4.5	1.8	0.0	10.5	0.0	1.7	4.7	2.2	2.0	23.3	1.2	11.7	8.9	2.3	3.5	0.9	8.4	0.0	1.2	3.1	2.1	0.5	5.8	6.6	1.7	2.8	4.7	0.6	1.3	3.5	4.2	3.2	1.2	0.0	2.8	2.5	20.2	1.9	2.9	4.3	7.9	3.4
CHFR	"FLJ10796, RNF196"	ENSG00000072609	"Checkpoint with forkhead and ring finger domains"	Q96EP1	12	132822187-132956304	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis, Ubl conjugation pathway"	Transferase	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Cone photoreceptor cells: 88.4;Rod photoreceptor cells: 107.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA045768, HPA073826"	Approved		Uncertain	"Nuclear bodies,Microtubules"		NA	NA			"Nuclear bodies, Microtubules"		"HPA045768: , HPA073826: AB_2732242"	"unprognostic (1.46e-1)"	"unprognostic (2.11e-2)"	"unprognostic (1.41e-1)"	"unprognostic (3.86e-2)"	"unprognostic (2.08e-1)"	"unprognostic (2.14e-3)"	"unprognostic (6.56e-4)"	"unprognostic (1.94e-2)"	"unprognostic (2.36e-2)"	"unprognostic (1.25e-1)"	"unprognostic (1.00e-2)"	"unprognostic (3.98e-3)"	"prognostic unfavorable (4.21e-9)"	"unprognostic (5.03e-1)"	"unprognostic (8.46e-2)"	"unprognostic (6.71e-2)"	"unprognostic (1.11e-2)"	13.7	11.4	14.1	19.0	15.0	25.8	12.5	20.0	16.9	12.1	15.2	16.5	13.4	19.0	15.6	16.7	21.6	12.6	14.3	13.7	12.5	9.8	12.8	13.4	17.0	21.7	15.1	12.6	9.6	16.8	9.6	20.6	22.9	13.0	14.3	12.8	15.5	13.9	14.7	21.0	16.7	18.7	17.8	15.1	24.9	16.8	19.2	14.2	22.3	13.5	12.7	18.4	18.6	14.2	6.6	12.1	19.7	17.0	12.3	12.5	10.1	4.4	11.0	9.3	0.8	8.2	10.8	17.3	9.2	7.7	9.8	10.3	8.6	3.8	0.1	8.9	10.7	7.3	7.3	1.1	9.4	5.7	0.6	9.8	14.7	7.5	8.7	17.8	0.6	25.5	14.6	8.5	9.0	6.7	7.1	12.0	1.5	6.2	0.0	6.8	15.0	10.6	11.4	11.1	7.9	8.7	1.4	1.3	4.4	6.5	21.2	9.1	11.6	7.6	7.9	7.1	11.3	14.0	15.1	13.5	0.6	2.2	5.1	3.4	16.1	0.0	2.2	0.0	3.0	8.9	17.6	14.2	19.7	10.8	16.9	10.0	6.6	8.7	11.6	12.1	4.5	8.3	9.1	18.9	12.3	17.0	6.6	12.5	10.1	14.1	15.0	20.0	16.9	12.5	9.8	15.1	12.6	13.0	14.2	11.9	21.6	16.1	4.3	5.5	20.3	8.9	0.0	10.7	19.4	7.0	88.4	10.0	8.3	9.1	51.1	11.3	10.7	0.0	11.9	12.8	7.7	8.7	62.6	7.3	17.2	20.6	20.3	13.5	18.0	58.8	6.9	15.9	10.1	25.2	8.8	8.1	13.4	10.5	8.1	3.4	107.7	19.4	7.3	13.4	19.2	8.4	19.8	21.8	7.3	13.3
CHIA	"AMCase, CHIT2, TSA1902"	ENSG00000134216	"Chitinase, acidic"	Q9BZP6	1	111290862-111320566	"Enzymes, Predicted intracellular proteins"	"Apoptosis, Carbohydrate metabolism, Chitin degradation, Immunity, Inflammatory response, Polysaccharide degradation"	"Glycosidase, Hydrolase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in some"	5	"stomach 1: 66.6"	"Cell type enriched"	"Detected in some"	8	"Alveolar cells type 2: 22.2"	"Cancer enhanced"	"Detected in some"		"lung cancer: 1.8;stomach cancer: 2.0"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"naive B-cell: 1.6"	"Low lineage specificity"	"Detected in single"			"Group enriched"	"Detected in some"	4	"ASC diff: 6.0;HAP1: 3.1"					"Low region specificity"	"Detected in single"			HPA059193	Approved				"Intracellular and membrane"	NA	NA					"HPA059193: AB_2683942"				"unprognostic (8.00e-2)"	"unprognostic (7.08e-2)"			"unprognostic (2.02e-2)"					"unprognostic (4.99e-2)"	"unprognostic (7.93e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.06e-2)"		0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.2	0.1	0.1	0.1	0.0	0.7	0.5	0.8	0.3	0.1	0.1	0.1	0.0	0.5	1.0	13.2	0.2	0.1	0.1	0.1	0.1	0.6	0.5	0.1	0.1	0.1	0.0	0.1	0.1	0.5	0.1	0.0	0.1	0.1	0.1	0.1	66.6	0.5	0.1	0.1	0.5	0.1	0.1	0.1	0.1	1.6	0.7	0.0	0.1	0.6	0.6	0.3	0.0	0.0	0.0	0.0	6.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.1	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.4	0.0	0.6	0.5	0.0	0.0	0.2	0.5	0.1	0.2	0.0	0.0	0.3	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.2	0.6	0.0	0.1	0.5	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.3	0.1	0.1	0.7	0.2	0.2	0.0	1.6	0.6	0.0	0.0	0.6	0.0	0.7	0.0	0.3	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	22.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
CHIT1	"CHI3, CHIT"	ENSG00000133063	"Chitinase 1"	Q13231	1	203212827-203273641	"Candidate cardiovascular disease genes, Enzymes, Plasma proteins, Predicted secreted proteins"	"Carbohydrate metabolism, Chitin degradation, Polysaccharide degradation"	"Glycosidase, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"adipose tissue: 99.9;lymphoid tissue: 106.5"	"Cell type enriched"	"Detected in single"	44	"Hofbauer cells: 42.8"	"Cancer enhanced"	"Detected in many"		"testis cancer: 31.9"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"neutrophil: 2.9;non-classical monocyte: 1.1"	"Group enriched"	"Detected in many"	4	"granulocytes: 2.9;monocytes: 1.1"	"Cell line enhanced"	"Detected in some"		"EFO-21: 2.8;LHCN-M2: 1.7;RH-30: 1.8;U-266/70: 2.3"	"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			"HPA010575, HPA074844"	Enhanced				"Secreted to blood"	NA	NA	26400000	58000000			"HPA010575: AB_1078512, HPA074844: "	"unprognostic (5.80e-3)"	"prognostic favorable (2.02e-4)"	"unprognostic (2.58e-2)"	"unprognostic (2.19e-1)"	"unprognostic (7.87e-2)"	"unprognostic (2.28e-2)"	"unprognostic (7.55e-2)"	"unprognostic (6.36e-3)"	"unprognostic (1.17e-1)"	"unprognostic (3.25e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.56e-3)"	"unprognostic (3.37e-1)"	"unprognostic (1.52e-1)"	"unprognostic (1.06e-1)"	"unprognostic (2.95e-1)"	99.9	0.2	0.2	0.4	0.3	26.7	5.5	0.1	0.3	5.9	0.6	0.5	0.1	0.0	2.5	0.2	0.3	0.1	0.2	0.6	0.2	0.1	0.1	0.4	22.1	106.5	0.4	0.1	1.4	1.1	0.0	0.2	0.4	0.5	0.6	0.5	0.3	0.3	0.1	0.1	0.3	0.7	0.2	9.4	4.3	0.1	0.1	0.1	2.3	0.9	0.2	0.5	0.1	0.3	0.5	0.2	2.9	1.1	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.2	0.0	0.1	2.8	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.8	1.7	0.2	0.0	0.0	0.1	0.0	0.2	0.0	1.8	0.9	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.3	0.0	0.0	2.3	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	2.9	0.0	1.1	0.2	0.0	1.3	0.2	0.3	0.1	0.3	0.2	0.1	0.4	0.1	0.5	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	42.8	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0
CHKA	"CHK, CKI"	ENSG00000110721	"Choline kinase alpha"	P35790	11	68052859-68121444	"Enzymes, Predicted intracellular proteins"	"Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism"	"Kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"Early spermatids: 282.2;Late spermatids: 221.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"eosinophil: 9.5"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in all"		"SK-MEL-30: 57.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA024153, CAB072803"	Approved		Approved	"Endoplasmic reticulum"		NA	NA			"Endoplasmic reticulum"		"CAB072803: , HPA024153: AB_1846664"	"unprognostic (5.16e-2)"	"unprognostic (1.46e-1)"	"unprognostic (2.52e-1)"	"unprognostic (2.51e-1)"	"unprognostic (2.66e-1)"	"unprognostic (2.81e-1)"	"prognostic unfavorable (7.75e-4)"	"unprognostic (2.36e-3)"	"unprognostic (1.66e-3)"	"unprognostic (1.67e-2)"	"unprognostic (1.33e-1)"	"unprognostic (1.99e-1)"	"unprognostic (5.97e-3)"	"unprognostic (5.00e-2)"	"unprognostic (6.06e-2)"	"unprognostic (1.82e-1)"	"unprognostic (4.73e-2)"	8.9	15.5	18.1	6.4	19.5	25.5	18.6	10.2	19.3	10.8	18.2	30.9	28.8	19.0	5.8	19.2	3.9	6.5	10.7	5.4	18.7	15.4	8.0	17.4	11.4	7.5	26.5	12.5	10.4	29.3	9.2	10.0	5.0	21.5	13.5	11.8	17.4	36.9	37.4	3.9	4.2	22.8	8.2	20.9	13.5	18.8	55.9	22.7	3.1	19.9	2.2	5.2	8.7	4.7	1.3	1.5	9.5	2.5	1.6	0.7	0.4	8.0	7.0	8.2	7.9	2.8	1.9	8.3	2.6	4.2	7.2	4.7	30.1	22.8	6.2	9.6	3.7	7.8	5.4	11.5	1.8	5.5	2.8	4.1	7.7	9.2	34.8	7.9	8.1	4.3	3.8	3.1	3.3	1.6	4.1	4.1	4.0	7.2	10.8	3.8	6.2	4.3	22.1	13.2	27.3	4.8	7.0	8.7	17.4	6.1	9.1	6.1	6.5	4.9	25.1	57.8	7.1	10.6	11.2	2.3	4.6	5.8	10.9	3.3	12.7	13.0	10.8	5.0	10.7	4.2	0.0	1.4	9.5	0.2	2.5	0.0	1.3	0.1	0.4	1.5	0.6	0.7	0.5	0.8	1.6	1.5	1.2	0.3	0.4	18.1	19.5	10.2	19.3	18.7	15.4	26.5	12.5	21.5	22.7	41.7	30.1	4.5	14.6	14.1	10.2	2.2	33.1	17.4	14.8	3.5	31.4	6.1	11.6	8.8	282.2	8.5	26.2	0.0	16.5	3.2	9.5	16.9	18.5	16.9	14.9	54.0	26.9	9.2	22.6	221.9	5.8	13.0	21.9	9.0	14.3	20.0	14.9	20.1	2.5	3.7	25.8	0.0	10.3	56.6	19.2	9.2	10.9	2.9	21.7	33.5
CHKB	"CHETK, CHKL"	ENSG00000100288	"Choline kinase beta"	Q9Y259	22	50578949-50601455	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism"	"Kinase, Transferase"	"Congenital muscular dystrophy, Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"monocytes: 73.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HHSteC: 14.7"									HPA018797	Approved		Approved	Cytosol		NA	NA			Cytosol		"HPA018797: AB_1846666"	"unprognostic (6.03e-4)"	"prognostic favorable (4.66e-4)"	"unprognostic (4.31e-2)"	"unprognostic (2.63e-2)"	"unprognostic (2.14e-1)"	"unprognostic (1.42e-2)"	"unprognostic (3.25e-3)"	"unprognostic (1.70e-2)"	"unprognostic (2.00e-1)"	"unprognostic (7.84e-2)"	"unprognostic (5.23e-3)"	"unprognostic (5.43e-2)"	"prognostic unfavorable (1.56e-5)"	"unprognostic (1.33e-1)"	"unprognostic (9.54e-2)"	"unprognostic (1.30e-2)"	"unprognostic (2.18e-3)"	14.1	13.6	12.7	18.9	14.4	14.8	13.0	21.3	13.4	12.9	15.1	13.8	10.4	9.8	10.1	12.5	10.7	16.2	13.6	10.6	10.7	6.8	14.3	9.3	12.6	8.7	14.7	6.1	9.1	8.4	21.9	19.2	12.3	12.7	11.7	6.9	12.8	13.4	12.5	7.8	10.5	16.9	8.0	9.5	18.5	14.8	19.9	15.8	8.5	14.5	6.6	16.5	12.1	10.9	13.6	21.2	15.0	23.9	20.6	18.6	19.5	3.7	1.0	3.0	1.1	3.2	2.1	10.4	4.4	8.8	1.8	2.5	0.0	1.4	1.8	3.4	0.0	1.6	1.7	1.6	0.9	0.3	1.5	4.3	2.4	2.2	0.8	14.7	3.0	6.2	1.0	5.4	0.7	3.7	3.6	9.2	3.9	1.2	4.8	4.9	3.4	2.6	8.4	0.5	2.5	0.6	3.4	0.4	10.4	4.0	2.5	1.5	4.3	3.5	3.4	3.1	2.2	1.2	1.8	2.8	1.7	3.7	1.6	1.3	7.9	0.7	2.3	3.0	2.3	1.8	5.7	23.9	15.0	16.3	21.9	15.5	12.9	15.2	17.3	21.2	13.6	14.4	13.3	5.7	20.6	14.2	19.5	18.6	19.5	12.7	14.4	21.3	13.4	10.7	6.8	14.7	6.1	12.7	15.8	6.0	23.3	12.0	2.2	4.2	5.1	5.9	17.8	10.7	14.8	7.0	3.9	7.5	3.3	26.9	9.1	6.3	18.0	0.0	20.9	12.0	5.8	1.9	18.5	5.5	12.8	7.9	15.1	10.4	20.2	21.1	2.3	8.8	3.3	73.9	16.6	2.8	23.5	23.0	2.8	4.3	4.8	6.5	8.2	11.1	8.7	5.5	7.1	16.0	15.6	1.8
CHPF	"CHSY2, CSS2"	ENSG00000123989	"Chondroitin polymerizing factor"	Q8IZ52	2	219538947-219543787	"Enzymes, Predicted intracellular proteins"		Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	8	"Cytotrophoblasts: 137.8;Extravillous trophoblasts: 162.1;Syncytiotrophoblasts: 259.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"plasmacytoid DC: 11.1"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA035123	Approved		Supported	Vesicles,Centrosome,Cytosol	"Intracellular and membrane"	NA	NA			Cytosol	"Vesicles, Centrosome"	"HPA035123: AB_10602799"	"unprognostic (1.13e-3)"	"prognostic unfavorable (1.57e-4)"	"unprognostic (3.65e-3)"	"unprognostic (2.55e-3)"	"unprognostic (1.86e-3)"	"prognostic unfavorable (1.68e-4)"	"unprognostic (1.37e-1)"	"unprognostic (6.59e-3)"	"unprognostic (7.74e-2)"	"unprognostic (1.19e-2)"	"unprognostic (1.18e-1)"	"unprognostic (6.79e-2)"	"unprognostic (1.64e-1)"	"unprognostic (6.55e-2)"	"unprognostic (1.82e-1)"	"unprognostic (1.17e-1)"	"prognostic unfavorable (2.96e-4)"	8.6	14.1	9.7	8.4	11.8	1.4	6.8	8.5	19.4	22.1	8.6	11.3	23.0	18.4	17.0	24.6	7.9	9.2	17.1	36.3	12.2	10.7	11.3	52.1	11.6	5.4	9.0	10.5	38.1	60.7	16.3	36.9	62.7	10.4	19.3	3.8	27.4	31.6	19.9	4.3	9.0	13.3	9.1	8.3	4.5	15.6	34.2	7.0	3.8	17.9	7.4	10.6	11.9	8.5	1.3	11.1	6.9	0.1	2.1	3.0	0.8	18.8	3.7	2.8	23.5	10.7	16.9	32.2	19.1	16.2	5.4	5.0	10.4	16.6	5.9	41.2	18.5	18.6	24.1	1.8	11.5	0.8	9.1	6.5	2.1	5.3	45.1	15.0	1.8	12.4	22.6	20.4	5.5	5.3	19.7	0.0	2.0	13.0	14.4	5.1	29.5	0.2	4.9	11.6	6.4	14.5	0.0	8.9	11.5	6.5	8.5	6.9	10.6	9.2	9.0	26.2	5.5	3.0	6.4	0.4	20.1	11.0	24.0	9.9	17.4	5.3	2.7	18.4	1.9	20.3	2.1	0.0	6.9	2.4	0.1	3.0	1.3	1.9	1.6	0.0	0.1	2.2	0.8	0.0	2.1	0.0	11.1	1.2	0.8	9.7	11.8	8.5	19.4	12.2	10.7	9.0	10.5	10.4	7.0	0.0	14.6	4.5	19.1	12.9	13.8	27.7	25.5	2.7	6.8	71.5	9.8	137.8	8.3	48.8	3.2	3.5	16.9	0.0	70.1	162.1	52.1	34.2	10.3	49.9	16.5	41.3	41.2	6.7	1.3	5.7	23.0	2.8	64.1	2.8	36.9	62.9	60.3	26.6	59.4	16.4	11.4	25.8	16.5	11.6	5.5	9.7	259.5	7.5	11.3	28.6
CHPF2	"ChSy-3, CSGlcA-T, KIAA1402"	ENSG00000033100	"Chondroitin polymerizing factor 2"	Q9P2E5	7	151232489-151238827	"Enzymes, Predicted intracellular proteins"		Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA020992	Approved		Approved	Nucleoplasm,Cytosol	"Intracellular and membrane"	NA	NA			"Nucleoplasm, Cytosol"		"HPA020992: AB_1847267"	"unprognostic (8.31e-2)"	"unprognostic (2.14e-3)"	"unprognostic (1.02e-3)"	"unprognostic (1.14e-1)"	"unprognostic (4.79e-3)"	"unprognostic (5.25e-2)"	"prognostic unfavorable (9.47e-4)"	"unprognostic (4.07e-1)"	"unprognostic (1.71e-1)"	"unprognostic (4.54e-2)"	"prognostic favorable (2.51e-4)"	"unprognostic (1.04e-1)"	"unprognostic (2.68e-3)"	"unprognostic (2.24e-1)"	"unprognostic (1.49e-1)"	"unprognostic (3.22e-2)"	"unprognostic (8.59e-3)"	13.5	29.3	13.4	19.0	12.9	22.6	19.1	13.1	20.2	15.3	14.4	11.4	20.7	14.9	19.5	16.9	13.3	14.9	17.6	18.8	13.7	12.5	14.9	20.7	17.4	23.4	11.4	17.4	14.4	23.7	16.7	41.5	18.6	11.8	18.5	10.8	12.2	25.4	19.8	7.9	14.2	17.1	17.3	9.4	28.1	20.1	12.9	11.1	16.2	17.5	7.4	13.7	18.9	12.8	2.7	9.5	9.9	5.6	2.6	5.7	3.7	9.0	7.4	5.0	14.5	17.4	17.3	7.5	19.1	29.8	10.4	12.7	4.9	15.4	2.7	33.8	30.3	14.2	11.4	2.2	13.6	4.5	10.4	6.8	2.9	8.1	6.8	16.3	5.8	24.2	26.4	7.7	9.8	3.5	21.6	16.3	4.6	2.7	8.0	16.5	14.9	5.4	22.9	6.6	3.8	8.6	5.1	2.9	9.1	10.1	7.2	5.4	9.6	10.2	10.1	4.8	3.9	3.9	9.6	22.2	11.6	1.9	15.3	16.1	14.8	2.1	4.0	42.1	7.8	15.6	1.2	5.6	7.9	5.7	5.1	5.4	2.7	3.1	5.1	6.3	2.7	2.2	2.3	9.9	2.6	5.0	9.5	3.4	3.7	13.4	12.9	13.1	20.2	13.7	12.5	11.4	17.4	11.8	11.1	8.9	10.2	11.5	4.8	4.0	9.5	1.6	12.7	4.0	4.5	10.4	3.9	9.1	1.7	10.3	0.5	4.7	10.2	23.3	14.5	12.1	9.7	9.5	5.8	8.3	11.2	23.8	8.1	13.5	11.6	0.7	15.8	8.5	6.8	7.2	10.1	4.3	14.8	15.9	14.2	3.3	6.9	19.4	6.2	3.4	1.7	3.9	8.6	12.1	8.1	8.9
CHPT1	CPT1	ENSG00000111666	"Choline phosphotransferase 1"	Q8WUD6	12	101696947-101744140	"Enzymes, Predicted membrane proteins"	"Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"Late spermatids: 497.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"basophil: 19.4;eosinophil: 9.7"	"Lineage enriched"	"Detected in many"	6	"granulocytes: 19.4"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA067643	Approved		Supported	Vesicles		NA	NA			Vesicles		"HPA067643: "	"unprognostic (1.59e-3)"	"unprognostic (1.02e-1)"	"unprognostic (1.91e-1)"	"unprognostic (9.48e-2)"	"unprognostic (3.15e-1)"	"unprognostic (9.17e-2)"	"unprognostic (5.79e-2)"	"unprognostic (4.83e-2)"	"unprognostic (1.12e-1)"	"unprognostic (4.70e-1)"	"unprognostic (5.27e-2)"	"unprognostic (1.16e-2)"	"unprognostic (1.52e-2)"	"unprognostic (3.35e-1)"	"unprognostic (1.72e-1)"	"prognostic favorable (7.41e-4)"	"unprognostic (1.79e-1)"	18.0	21.6	19.3	14.3	20.4	21.4	76.7	12.8	16.7	22.2	40.0	11.0	15.8	36.5	9.3	25.0	10.9	14.7	17.1	71.4	18.5	14.5	30.6	64.6	20.2	30.5	17.8	14.5	11.3	14.2	12.6	7.6	9.6	12.8	16.3	21.0	14.0	53.1	22.8	18.5	13.5	42.9	16.7	17.4	13.0	23.1	28.3	12.6	3.3	26.0	7.4	8.7	17.7	38.7	3.0	2.5	19.4	1.5	3.3	0.8	0.4	3.5	16.5	4.4	9.5	35.8	12.0	12.8	12.9	14.9	13.0	8.4	6.1	2.4	5.4	7.3	17.5	17.9	5.4	27.1	4.5	12.4	8.1	22.9	22.0	8.9	35.7	20.0	10.8	4.4	11.3	1.3	5.8	10.7	19.5	6.4	11.7	31.8	14.0	12.8	8.7	6.4	37.5	11.9	17.1	21.9	5.0	8.8	3.9	5.9	14.0	4.4	3.4	11.9	17.2	32.0	7.3	17.5	7.5	4.7	11.9	6.2	9.3	12.5	8.0	2.4	6.6	9.4	12.6	17.3	19.4	1.5	9.7	0.4	1.2	0.4	3.0	0.8	0.7	2.0	2.0	0.3	0.4	2.2	3.3	1.4	2.5	0.4	0.4	19.3	20.4	12.8	16.7	18.5	14.5	17.8	14.5	12.8	12.6	44.7	22.2	63.5	276.5	33.3	14.2	43.5	114.7	4.0	12.5	61.1	27.5	102.9	59.7	7.2	284.8	18.8	76.4	0.0	11.8	43.5	56.0	122.8	10.4	175.9	50.0	33.4	20.3	18.4	79.5	497.4	79.1	37.8	138.3	1.0	51.0	47.9	10.2	114.8	83.8	145.6	15.2	19.4	33.5	169.9	29.8	37.8	50.5	22.4	79.9	235.4
CHST1	"C6ST, KSGal6ST"	ENSG00000175264	"Carbohydrate sulfotransferase 1"	O43916	11	45648877-45665622	"Enzymes, Predicted intracellular proteins"	"Carbohydrate metabolism, Inflammatory response"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 42.5"	"Group enriched"	"Detected in some"	4	"Early spermatids: 50.9;Sertoli cells: 25.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HUVEC TERT2: 10.3;TIME: 9.8;WM-115: 27.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"								"Intracellular and membrane"	NA	NA						"unprognostic (1.77e-2)"	"unprognostic (1.67e-1)"	"unprognostic (6.37e-3)"	"unprognostic (1.32e-1)"	"unprognostic (2.18e-2)"	"unprognostic (2.50e-1)"	"prognostic unfavorable (3.95e-4)"	"unprognostic (6.22e-2)"	"unprognostic (1.64e-1)"	"unprognostic (1.39e-1)"	"unprognostic (1.09e-1)"	"unprognostic (2.10e-1)"	"prognostic unfavorable (4.64e-7)"	"unprognostic (5.37e-3)"	"unprognostic (1.06e-1)"	"unprognostic (1.30e-1)"	"unprognostic (9.11e-3)"	2.2	8.6	21.2	2.0	21.5	1.2	4.8	2.3	42.5	2.2	1.6	5.0	0.0	1.9	2.5	1.2	1.3	6.5	2.1	2.8	18.6	15.5	2.6	1.5	2.5	2.0	13.6	17.0	4.4	2.5	17.7	4.9	1.7	10.6	1.4	1.2	1.3	14.8	1.6	3.6	1.7	1.7	2.0	2.5	4.7	1.9	3.2	5.5	0.1	9.0	0.4	1.7	2.3	0.8	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.3	0.8	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	3.9	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.1	2.3	0.0	0.0	0.3	0.3	10.3	0.1	0.0	0.0	0.9	0.2	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.1	0.0	0.0	0.5	0.8	0.2	0.0	9.8	2.0	2.9	0.0	0.0	0.0	0.0	0.0	4.2	0.0	27.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	21.2	21.5	2.3	35.8	18.6	15.5	13.6	17.0	10.6	5.5	0.0	0.0	0.0	2.4	0.1	8.6	1.6	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.9	50.9	4.8	0.0	0.0	0.2	0.0	1.9	0.7	0.0	0.0	0.2	0.0	0.0	4.9	0.0	7.6	5.2	0.0	0.0	0.0	0.0	3.7	0.4	0.0	4.6	0.0	0.2	25.8	0.8	6.2	1.4	0.0	0.0	0.0	0.0	0.9
CHST11	"C4ST, C4St-1, C4ST1, HSA269537"	ENSG00000171310	"Carbohydrate sulfotransferase 11"	Q9NPF2	12	104455295-104762014	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Carbohydrate metabolism"	Transferase	"Disease mutation, Dwarfism"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"Exocrine glandular cells: 55.7;monocytes: 81.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"neutrophil: 13.8"	"Lineage enriched"	"Detected in all"	5	"granulocytes: 13.8"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA052828	Approved		Approved	"Golgi apparatus"	"Intracellular and membrane"	NA	NA		22000	"Golgi apparatus"		"HPA052828: AB_2681966"	"unprognostic (6.35e-2)"	"unprognostic (2.68e-3)"	"unprognostic (2.28e-2)"	"unprognostic (7.53e-2)"	"unprognostic (3.45e-2)"	"unprognostic (2.64e-2)"	"unprognostic (1.64e-3)"	"unprognostic (9.21e-3)"	"unprognostic (3.12e-1)"	"unprognostic (9.02e-2)"	"unprognostic (1.22e-2)"	"unprognostic (5.44e-2)"	"prognostic unfavorable (7.59e-11)"	"unprognostic (1.64e-2)"	"unprognostic (5.60e-2)"	"unprognostic (5.40e-3)"	"prognostic unfavorable (8.42e-4)"	6.7	14.3	14.6	21.6	16.6	37.3	4.9	5.7	16.1	6.6	6.2	8.2	9.7	3.9	15.7	16.1	4.4	5.2	11.1	6.6	13.4	11.9	4.4	4.0	15.3	22.5	11.5	6.7	8.7	6.3	1.9	6.8	17.2	10.0	6.4	5.2	16.1	3.3	13.4	1.7	2.7	7.7	12.6	10.5	17.5	8.3	3.3	11.8	26.5	4.3	2.9	15.6	8.5	5.3	2.0	2.6	13.8	1.3	1.3	2.8	0.6	13.5	6.2	2.9	1.8	7.3	3.6	10.2	1.2	0.4	0.6	0.5	0.0	17.7	0.0	2.0	1.8	14.9	3.4	1.7	7.1	0.7	0.1	2.5	18.0	1.6	0.0	1.1	21.0	21.4	1.3	1.0	11.5	1.9	10.8	4.5	25.8	27.8	4.6	1.2	3.3	16.0	24.7	2.4	0.1	2.3	18.2	9.6	4.5	6.0	0.1	4.9	8.0	0.8	9.2	17.0	2.6	2.7	21.3	10.4	2.0	2.2	10.3	11.2	24.0	25.8	3.4	9.4	14.8	20.1	9.3	1.3	9.4	2.8	1.2	1.6	0.9	1.5	2.1	0.7	2.0	0.7	1.8	13.8	1.3	1.1	2.6	2.8	0.6	14.6	16.6	5.7	10.4	13.4	11.9	11.5	6.7	10.0	11.8	14.9	13.3	17.2	13.2	2.5	1.6	4.5	2.5	4.0	7.9	5.2	0.0	28.8	0.0	5.0	0.6	6.3	0.0	0.0	55.7	12.0	9.1	2.7	41.4	0.4	42.1	9.5	0.0	22.1	23.7	1.1	6.9	35.3	3.3	81.2	0.0	1.6	21.1	0.0	15.9	4.8	0.5	6.5	7.2	0.5	2.7	2.5	22.2	36.2	0.0	2.4
CHST12	"C4S-2, C4ST2"	ENSG00000136213	"Carbohydrate sulfotransferase 12"	Q9NRB3	7	2403560-2448483	"Enzymes, Predicted membrane proteins"	"Carbohydrate metabolism"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	5	"Ito cells: 159.0;T-cells: 128.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HMC-1: 26.2;NB-4: 27.1;U-266/70: 38.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041680	Approved		Approved	"Golgi apparatus"		NA	NA		430000	"Golgi apparatus"		"HPA041680: AB_10959789"	"unprognostic (4.12e-2)"	"unprognostic (3.56e-1)"	"unprognostic (3.04e-3)"	"unprognostic (1.59e-1)"	"unprognostic (2.05e-3)"	"unprognostic (7.15e-2)"	"unprognostic (2.01e-3)"	"unprognostic (1.34e-1)"	"unprognostic (3.20e-2)"	"unprognostic (4.88e-2)"	"prognostic favorable (1.32e-5)"	"unprognostic (9.61e-2)"	"unprognostic (1.66e-3)"	"unprognostic (4.90e-2)"	"unprognostic (2.26e-1)"	"unprognostic (1.95e-1)"	"unprognostic (1.55e-1)"	24.2	12.0	9.4	12.1	10.5	14.5	11.2	17.8	16.5	11.9	10.1	13.2	9.0	13.5	14.4	10.6	5.9	11.7	10.9	12.0	8.8	7.7	9.3	6.8	13.6	10.3	10.4	9.2	9.6	17.5	4.9	14.4	9.6	12.7	11.8	4.2	12.3	14.1	11.6	11.9	11.5	10.1	8.1	9.5	25.0	12.4	10.2	8.6	9.0	11.2	4.4	11.8	10.6	10.3	5.7	21.0	16.4	3.5	37.4	30.2	6.7	3.9	4.0	2.5	4.5	3.7	2.7	12.7	7.2	3.4	3.1	4.3	4.5	1.5	3.5	13.6	3.2	6.8	3.2	1.6	1.9	0.9	4.6	8.5	2.4	3.5	5.0	1.7	8.0	26.2	3.7	1.2	2.8	0.3	3.2	3.2	5.9	6.2	12.7	1.4	3.6	8.4	27.1	8.5	1.2	7.3	3.1	3.3	18.3	1.5	2.1	3.0	12.5	3.5	2.6	1.8	2.5	3.3	10.2	5.4	4.6	12.0	9.0	6.3	38.6	14.9	1.6	3.7	4.1	7.9	15.5	3.5	16.4	30.2	2.8	18.9	5.2	10.7	24.5	6.6	5.7	4.5	13.5	1.0	37.4	1.2	21.0	10.2	6.7	9.4	10.5	17.8	16.5	8.8	7.7	10.4	9.2	12.7	8.6	14.9	44.5	41.3	35.2	16.1	44.3	6.7	10.2	17.4	30.7	17.4	62.8	84.2	1.7	17.6	4.4	44.9	6.7	23.3	13.5	8.5	48.9	15.3	36.9	5.9	22.1	44.5	12.2	159.0	21.8	2.7	88.6	20.1	20.3	17.2	9.4	16.0	13.1	7.0	63.6	10.3	46.4	19.4	19.6	27.6	19.4	13.4	111.7	128.5	13.1	9.1
CHST13	C4ST3	ENSG00000180767	"Carbohydrate sulfotransferase 13"	Q8NET6	3	126524283-126543291	"Enzymes, Predicted intracellular proteins"	"Carbohydrate metabolism"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"blood: 46.8;liver: 42.5"	"Cell type enhanced"	"Detected in many"	16	"Early spermatids: 56.2;Hepatocytes: 33.7;Spermatocytes: 29.3"	"Cancer enhanced"	"Detected in many"		"liver cancer: 25.0"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in many"	4	"eosinophil: 46.8"	"Lineage enriched"	"Detected in many"	4	"granulocytes: 46.8"	"Group enriched"	"Detected in some"	8	"CACO-2: 12.5;Hep G2: 22.4;NB-4: 14.9;THP-1: 8.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			HPA067960			Approved	"Golgi apparatus"	"Intracellular and membrane"	NA	NA			"Golgi apparatus"		"HPA067960: "	"unprognostic (5.68e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.32e-2)"	"unprognostic (6.42e-4)"	"unprognostic (2.26e-1)"	"unprognostic (1.05e-1)"	"unprognostic (8.45e-3)"	"unprognostic (1.40e-1)"	"unprognostic (2.04e-1)"	"unprognostic (1.52e-1)"	"unprognostic (2.13e-1)"	"unprognostic (1.98e-1)"	"unprognostic (5.75e-2)"	"unprognostic (5.16e-2)"	"unprognostic (6.68e-2)"	"unprognostic (2.26e-1)"	"unprognostic (1.59e-2)"	0.5	0.2	0.2	0.5	0.3	0.9	0.0	0.2	0.6	0.1	0.9	0.1	0.0	0.8	0.0	1.1	0.1	0.1	0.2	1.1	0.2	0.1	2.6	42.5	0.6	0.6	0.3	0.2	0.4	0.0	0.0	0.0	0.4	0.4	0.2	0.2	0.6	0.5	0.1	0.3	0.0	1.8	0.0	0.3	2.9	0.6	9.7	0.1	0.5	0.1	0.0	0.2	0.1	0.0	0.0	7.0	46.8	10.6	0.0	0.0	3.6	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.5	0.5	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.5	0.2	22.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.9	0.7	0.4	0.0	0.0	0.0	0.3	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	8.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	10.6	46.8	0.0	6.4	0.0	0.0	0.0	0.0	7.0	0.0	0.0	0.0	9.8	0.0	5.2	0.0	0.0	3.6	0.2	0.3	0.2	0.6	0.2	0.1	0.3	0.2	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.6	5.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	56.2	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	33.7	12.3	0.0	1.2	1.3	7.6	3.8	1.4	3.2	0.0	0.0	0.9	0.0	0.0	2.9	1.1	7.9	0.0	0.0	0.0	29.3	2.7	0.0	0.2	0.0	1.6	0.0
CHST14	"D4ST-1, D4ST1, HD4ST"	ENSG00000169105	"Carbohydrate sulfotransferase 14"	Q8NCH0	15	40470998-40474571	"Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins"	"Carbohydrate metabolism"	Transferase	"Disease mutation, Ehlers-Danlos syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"Cytotrophoblasts: 39.3;Extravillous trophoblasts: 26.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA057697, HPA071601"	Enhanced		Approved	"Golgi apparatus"		NA	NA			"Golgi apparatus"		"HPA057697: AB_2683505, HPA071601: AB_2686425"	"unprognostic (5.46e-2)"	"unprognostic (9.23e-2)"	"unprognostic (4.03e-2)"	"unprognostic (2.63e-3)"	"unprognostic (1.44e-1)"	"unprognostic (1.86e-1)"	"unprognostic (2.96e-2)"	"unprognostic (6.94e-2)"	"unprognostic (1.70e-1)"	"unprognostic (9.95e-2)"	"unprognostic (2.84e-1)"	"unprognostic (3.17e-2)"	"unprognostic (5.85e-3)"	"unprognostic (2.01e-3)"	"unprognostic (1.94e-1)"	"unprognostic (6.34e-2)"	"unprognostic (2.25e-2)"	10.3	7.9	7.1	7.5	6.9	2.3	22.7	6.5	7.4	14.9	7.9	6.0	13.8	3.6	17.5	11.1	6.5	12.3	14.1	12.6	5.5	2.9	8.1	9.6	15.9	20.9	8.1	4.5	18.8	11.6	10.2	11.4	22.4	7.1	10.7	3.8	9.8	12.7	17.2	5.5	6.8	7.1	13.3	5.9	10.5	7.3	9.2	6.3	7.5	12.4	8.3	6.1	12.1	18.2	2.1	3.4	8.0	1.9	5.5	4.0	1.1	10.6	7.0	11.3	30.4	17.7	13.7	17.6	10.5	20.0	18.6	17.7	8.5	5.4	1.7	16.1	17.8	33.0	18.3	10.0	5.9	8.8	12.7	5.8	5.4	7.5	8.1	9.6	2.3	14.2	16.7	4.9	6.5	5.0	20.6	16.3	6.3	5.3	6.4	13.8	8.0	3.8	12.2	7.2	3.2	8.2	10.7	14.3	3.0	12.4	5.5	8.2	12.5	9.2	10.4	3.4	14.4	15.1	9.8	13.3	31.6	11.7	9.9	10.4	12.9	8.9	4.9	14.2	8.0	22.7	8.0	1.9	3.6	4.0	1.9	1.1	0.5	2.0	3.4	3.4	2.1	1.8	1.4	0.3	5.5	0.9	1.2	1.3	1.1	7.1	6.9	6.5	7.4	5.5	2.9	8.1	4.5	7.1	6.3	11.9	1.4	2.4	4.3	3.1	0.4	2.5	7.6	4.0	5.7	3.5	0.0	39.3	0.0	6.5	1.4	6.3	0.1	0.0	4.3	26.3	14.6	2.6	4.6	2.6	7.9	1.6	2.4	15.4	5.1	0.9	16.4	4.3	5.0	2.8	1.7	9.3	4.6	0.0	11.0	1.0	0.6	6.5	5.6	8.0	1.6	2.3	11.3	5.4	1.5	1.0
CHST15	"BRAG, GALNAC4S-6ST, KIAA0598"	ENSG00000182022	"Carbohydrate sulfotransferase 15"	Q7LFX5	10	124007666-124093607	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"		Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Ito cells: 49.7;Kupffer cells: 47.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"neutrophil: 29.4"	"Group enriched"	"Detected in many"	10	"granulocytes: 29.4;monocytes: 15.4"	"Cell line enhanced"	"Detected in many"		"Karpas-707: 27.6;REH: 36.3;U-266/70: 25.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA017584	Approved		Approved	Centrosome,Cytosol		NA	NA		560000	Cytosol	Centrosome	"HPA017584: AB_1849437"	"unprognostic (1.19e-1)"	"unprognostic (2.29e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.72e-2)"	"unprognostic (4.12e-2)"	"unprognostic (1.18e-2)"	"unprognostic (1.90e-1)"	"unprognostic (3.02e-2)"	"unprognostic (2.40e-2)"	"unprognostic (7.62e-3)"	"unprognostic (7.90e-2)"	"unprognostic (8.16e-2)"	"prognostic unfavorable (2.22e-7)"	"unprognostic (6.47e-3)"	"unprognostic (7.80e-2)"	"unprognostic (4.63e-3)"	"unprognostic (5.26e-3)"	16.4	10.0	8.7	17.0	20.6	5.7	10.7	3.4	17.9	9.8	15.4	6.6	4.0	8.8	8.6	10.8	11.3	13.1	11.7	6.4	11.3	5.3	9.0	11.9	13.9	35.4	6.5	9.6	35.0	12.6	2.9	7.7	5.9	9.2	8.5	8.3	14.4	8.2	13.4	11.0	8.3	12.5	9.5	9.0	31.5	11.4	4.8	8.7	2.8	19.3	6.1	12.6	12.5	12.0	2.1	2.0	29.4	15.4	0.0	0.1	3.2	12.8	8.7	3.2	0.7	3.2	1.7	0.0	2.6	3.5	1.4	2.0	0.2	7.0	0.0	8.5	10.7	0.9	14.7	0.6	8.5	1.2	0.0	2.4	0.0	3.9	6.4	1.0	0.0	16.6	1.0	9.8	4.0	3.4	3.5	2.8	0.0	0.0	27.6	7.0	7.1	0.0	0.0	2.8	1.9	0.0	36.3	4.4	8.5	7.1	1.2	0.3	0.7	7.0	3.9	0.0	8.4	2.9	0.0	3.3	0.3	0.1	10.1	0.4	25.1	6.0	6.9	0.1	0.0	0.0	0.0	8.8	6.2	0.0	14.0	0.0	2.0	0.0	0.0	1.8	2.1	0.1	0.0	29.4	0.0	15.4	2.0	0.1	3.2	8.7	20.6	3.4	17.9	11.3	5.3	6.5	9.6	9.2	8.7	20.8	11.1	9.7	14.5	14.9	4.4	2.2	7.6	9.4	9.1	19.2	0.0	1.5	0.0	8.2	24.2	10.8	0.0	0.0	0.6	1.9	2.7	14.0	5.7	6.4	9.4	0.0	1.7	49.7	47.8	27.7	9.5	23.2	1.7	1.8	0.0	0.1	5.9	0.0	1.8	0.3	0.3	19.4	11.3	8.4	9.2	10.2	0.8	2.2	0.0	15.2
CHST3	"C6ST, C6ST1"	ENSG00000122863	"Carbohydrate sulfotransferase 3"	Q7LGC8	10	71964365-72013564	"Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins"	"Carbohydrate metabolism"	Transferase	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	6	"Ito cells: 14.7;Leydig cells: 19.0;Peritubular cells: 20.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"U-251 MG: 28.8"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA047523, HPA055704"	Enhanced		Approved	"Golgi apparatus,Cytosol"		NA	NA		510000	"Golgi apparatus, Cytosol"		"HPA047523: AB_2680075, HPA055704: AB_2682891"	"unprognostic (1.10e-2)"	"unprognostic (1.93e-1)"	"unprognostic (1.13e-3)"	"unprognostic (1.16e-3)"	"unprognostic (2.44e-1)"	"unprognostic (4.67e-2)"	"unprognostic (4.79e-2)"	"unprognostic (7.53e-2)"	"unprognostic (7.99e-2)"	"unprognostic (3.71e-2)"	"unprognostic (2.83e-3)"	"unprognostic (5.99e-2)"	"unprognostic (1.40e-2)"	"unprognostic (2.65e-2)"	"unprognostic (7.77e-2)"	"unprognostic (2.56e-2)"	"unprognostic (2.54e-3)"	22.2	11.6	9.2	7.0	19.4	0.7	12.0	2.9	11.6	10.4	9.0	19.4	4.8	1.7	13.7	7.4	8.4	13.6	6.2	11.9	11.3	5.1	8.6	1.8	6.3	2.2	30.1	5.5	25.0	6.1	1.9	4.0	10.0	15.6	10.7	3.3	5.7	6.3	19.5	13.6	7.1	4.0	21.0	16.2	2.9	11.6	19.4	25.2	0.5	7.3	4.8	2.2	7.5	18.5	0.2	0.3	0.8	0.1	0.1	0.2	0.0	6.8	7.4	3.8	9.3	17.3	6.8	0.1	14.5	13.9	8.9	6.0	6.4	13.7	0.0	10.0	17.0	7.2	8.9	3.3	9.9	7.2	0.2	2.5	0.0	12.8	6.1	8.8	0.0	0.0	9.4	11.5	8.8	12.1	17.4	2.6	0.3	2.0	0.0	9.4	0.2	0.0	0.0	1.6	0.2	2.4	0.0	4.6	0.0	12.6	7.0	0.2	3.8	11.0	0.2	10.6	4.8	0.8	1.4	5.4	11.0	12.7	18.3	28.8	0.0	0.0	0.0	8.0	0.0	7.7	0.3	0.1	0.0	0.2	0.0	0.1	0.0	0.1	0.0	0.0	0.2	0.1	0.2	0.8	0.1	0.0	0.3	0.1	0.0	9.2	19.4	2.9	11.6	11.3	5.1	30.1	5.5	15.6	25.2	0.0	3.4	0.0	4.0	2.5	0.0	8.9	5.1	1.4	3.4	7.0	0.0	3.5	3.3	8.2	0.4	3.6	0.0	0.0	2.4	2.2	5.7	3.7	1.1	0.0	0.7	0.0	0.0	14.7	0.6	2.1	19.0	0.4	8.5	1.0	0.0	6.6	7.7	0.0	20.5	2.8	0.0	6.5	9.6	0.5	0.7	2.0	0.9	0.0	0.0	1.4
CHST7	"C6ST-2, C6ST2"	ENSG00000147119	"Carbohydrate sulfotransferase 7"	Q9NS84	X	46573784-46598408	"Enzymes, Predicted intracellular proteins"	"Carbohydrate metabolism"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	12	"monocytes: 91.0;Peritubular cells: 56.6;Sertoli cells: 51.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"T-reg: 15.4"	"Group enriched"	"Detected in many"	10	"granulocytes: 9.4;monocytes: 8.0;T-cells: 15.4"	"Cell line enhanced"	"Detected in many"		"EFO-21: 18.0;HHSteC: 13.4;NTERA-2: 16.1;PC-3: 13.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA003919, HPA030503"	Approved		Approved	Nucleoplasm,Vesicles	"Intracellular and membrane"	NA	NA			"Nucleoplasm, Vesicles"		"HPA003919: AB_10601258, HPA030503: "	"unprognostic (3.16e-1)"	"prognostic favorable (7.20e-4)"	"unprognostic (1.11e-1)"	"unprognostic (2.66e-1)"	"unprognostic (1.82e-2)"	"unprognostic (7.85e-2)"	"unprognostic (9.82e-3)"	"unprognostic (3.52e-2)"	"unprognostic (2.61e-1)"	"unprognostic (2.81e-1)"	"unprognostic (2.39e-3)"	"unprognostic (6.71e-2)"	"unprognostic (1.19e-1)"	"unprognostic (8.85e-3)"	"unprognostic (8.28e-2)"	"unprognostic (1.50e-1)"	"unprognostic (4.39e-2)"	13.1	7.5	4.9	3.8	6.6	4.7	12.1	4.7	10.3	10.5	4.4	3.6	2.5	2.2	5.0	4.1	4.2	3.2	10.7	25.6	4.1	4.0	3.6	11.0	5.4	3.7	4.5	4.7	27.0	3.4	2.4	3.4	5.9	3.6	3.9	2.2	1.4	2.7	3.7	4.3	5.4	3.3	3.5	1.9	17.1	3.4	3.6	1.8	2.4	4.2	1.4	2.0	4.1	8.7	1.0	1.0	9.4	8.0	0.4	15.4	1.6	4.1	3.5	3.0	2.7	8.6	6.0	0.1	5.8	4.2	1.5	2.1	0.9	1.6	0.0	18.0	2.4	1.0	3.1	2.9	1.0	1.3	2.4	6.3	0.8	0.3	3.1	13.4	1.4	0.1	2.1	0.9	2.9	2.4	2.7	4.8	1.9	0.0	3.7	1.1	1.9	0.5	1.8	16.1	0.3	13.4	2.7	2.5	7.5	4.2	0.1	6.9	2.7	0.8	0.2	0.7	7.9	1.0	0.3	1.1	4.9	0.5	2.6	2.7	8.7	1.8	1.3	5.4	0.0	0.3	1.2	1.9	0.6	1.4	5.9	1.3	1.0	5.3	2.5	1.0	0.6	1.1	1.0	9.4	0.4	8.0	0.6	15.4	1.6	4.9	6.6	4.7	10.3	4.1	4.0	4.5	4.7	3.6	1.8	0.0	1.9	3.7	1.7	11.0	0.8	5.5	5.1	1.4	1.2	1.8	0.0	3.4	1.7	2.2	0.0	9.8	1.0	0.0	2.2	3.5	12.2	3.3	0.0	2.9	10.3	3.2	0.0	17.2	8.6	0.0	17.5	7.9	13.5	91.0	2.3	3.8	1.9	1.1	56.6	1.1	0.7	51.8	10.3	0.5	1.2	11.5	1.1	7.5	0.7	1.4
CHSY1	"CSS1, KIAA0990"	ENSG00000131873	"Chondroitin sulfate synthase 1"	Q86X52	15	101175723-101251932	"Disease related genes, Enzymes, Potential drug targets, Predicted secreted proteins"		Transferase	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"placenta: 72.5"	"Cell type enhanced"	"Detected in many"	4	"Smooth muscle cells: 68.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"Karpas-707: 69.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"								"Secreted - unknown location"	NA	NA						"unprognostic (7.28e-2)"	"unprognostic (6.39e-2)"	"unprognostic (9.24e-2)"	"unprognostic (1.55e-1)"	"unprognostic (7.60e-2)"	"unprognostic (9.51e-3)"	"unprognostic (1.46e-1)"	"unprognostic (3.02e-3)"	"unprognostic (1.77e-1)"	"unprognostic (1.32e-2)"	"unprognostic (5.97e-2)"	"unprognostic (1.73e-1)"	"prognostic unfavorable (6.33e-5)"	"unprognostic (3.44e-2)"	"unprognostic (1.02e-1)"	"unprognostic (8.91e-3)"	"unprognostic (5.58e-3)"	23.2	15.6	14.4	14.6	13.7	15.7	17.7	8.5	11.1	17.7	6.5	9.6	8.6	4.9	15.6	11.6	9.1	14.1	19.0	19.0	11.4	7.5	9.0	8.1	20.6	12.4	15.3	5.5	21.9	6.0	5.9	8.7	72.5	12.9	13.6	7.0	12.1	9.8	10.1	7.3	13.7	6.8	16.4	11.9	18.4	9.3	10.8	13.5	8.3	9.7	9.2	8.7	14.3	20.0	1.9	1.5	8.7	2.4	1.2	3.2	1.0	2.8	3.5	11.9	6.0	6.2	8.4	7.9	6.9	6.1	8.4	8.6	3.0	2.3	6.8	4.1	11.5	5.5	7.9	7.9	8.8	9.3	7.6	3.9	13.5	4.0	3.5	7.7	20.5	14.0	7.7	7.4	7.2	6.6	9.6	9.9	3.1	4.9	69.8	6.3	2.4	2.8	14.1	13.7	5.5	2.5	6.4	12.0	10.1	5.8	5.6	2.1	11.3	7.3	3.6	12.5	10.2	4.1	25.5	8.3	13.8	7.9	6.5	14.5	12.4	28.6	4.0	10.7	19.5	10.2	0.0	2.4	5.1	2.9	1.5	3.1	1.7	1.8	3.1	1.5	1.9	1.0	1.9	8.7	1.2	1.6	0.9	3.2	1.0	14.4	13.7	8.5	11.1	11.4	7.5	15.3	5.5	12.9	13.5	0.0	17.8	6.2	17.2	51.4	9.0	7.1	2.5	10.7	11.4	15.7	5.9	5.6	1.7	4.4	0.7	37.9	0.9	23.3	1.9	19.4	44.1	15.0	24.4	4.9	14.0	36.5	2.9	57.7	14.0	1.3	50.9	17.6	25.3	1.0	3.4	9.1	4.6	3.4	44.2	1.9	7.3	45.3	68.0	3.9	7.2	54.6	11.6	8.7	3.1	8.5
CHSY3	"CHSY-2, CSS3"	ENSG00000198108	"Chondroitin sulfate synthase 3"	Q70JA7	5	129904472-130186634	"Enzymes, Predicted intracellular proteins"		Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"	10	"Alveolar cells type 1: 8.9;Ito cells: 4.9;Sertoli cells: 6.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC diff: 12.7;ASC TERT1: 11.3;HSkMC: 7.4;TIME: 6.8;U-138 MG: 13.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA044612	Uncertain				"Intracellular and membrane"	NA	NA					"HPA044612: AB_10795883"	"unprognostic (3.43e-2)"	"unprognostic (6.28e-3)"	"unprognostic (1.76e-2)"	"unprognostic (5.83e-2)"	"unprognostic (5.88e-2)"	"unprognostic (8.17e-2)"	"unprognostic (3.37e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.55e-1)"	"unprognostic (1.22e-1)"	"unprognostic (9.58e-2)"	"unprognostic (3.80e-2)"	"unprognostic (1.08e-6)"	"unprognostic (5.22e-3)"	"unprognostic (9.93e-2)"	"unprognostic (4.61e-3)"	"unprognostic (1.74e-2)"	11.7	1.6	7.0	2.7	8.9	0.3	5.7	0.4	10.4	12.5	1.7	2.1	0.0	1.5	4.2	1.6	1.8	2.6	7.2	3.0	4.8	2.2	1.0	4.8	4.6	1.4	2.1	8.9	1.1	1.1	2.1	0.9	5.6	1.0	1.4	1.6	6.3	1.3	1.8	2.2	2.8	1.3	5.2	1.5	1.9	1.5	1.9	2.1	0.0	2.9	1.3	1.3	3.9	4.4	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	1.1	0.0	12.7	11.3	1.0	2.8	0.1	0.4	0.4	0.0	0.1	0.0	0.2	4.2	0.0	0.0	0.0	0.1	0.0	0.0	1.5	1.7	5.6	0.4	1.2	0.0	0.0	7.4	0.0	0.1	1.1	0.6	3.0	0.0	0.0	1.8	4.9	0.0	0.0	0.0	0.6	0.0	1.2	0.4	5.4	0.0	0.2	0.0	4.4	0.0	0.0	0.0	0.2	1.1	0.2	0.4	6.8	13.6	2.8	0.1	1.8	0.0	0.0	0.0	0.3	0.0	4.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	7.0	8.9	0.4	10.4	4.8	2.2	2.1	8.9	1.0	2.1	8.9	0.6	0.0	0.0	0.5	0.0	0.8	0.0	1.4	0.0	0.0	0.0	0.1	0.0	0.0	0.6	0.7	0.0	0.0	0.0	0.1	2.3	0.0	0.0	2.0	1.4	0.0	0.0	4.9	1.8	0.0	1.1	0.0	3.3	0.0	0.0	1.4	0.0	0.0	0.0	0.1	0.0	6.5	2.5	1.4	0.6	0.3	0.3	0.0	0.0	0.0
CHUK	"IkBKA, IKK-alpha, IKK1, IKKA, NFKBIKA, TCF16"	ENSG00000213341	"Conserved helix-loop-helix ubiquitous kinase"	O15111	10	100188298-100229619	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, RAS pathway related proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001402, CAB004240, CAB018564"	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"CAB004240: AB_627784, CAB018564: AB_649197, HPA001402: AB_1079125"	"unprognostic (8.61e-3)"	"unprognostic (1.70e-1)"	"unprognostic (3.74e-2)"	"unprognostic (3.01e-1)"	"unprognostic (3.02e-2)"	"unprognostic (5.93e-2)"	"unprognostic (4.02e-2)"	"unprognostic (2.09e-1)"	"unprognostic (8.58e-2)"	"unprognostic (8.39e-2)"	"unprognostic (6.73e-2)"	"unprognostic (1.49e-1)"	"prognostic favorable (1.27e-4)"	"unprognostic (2.48e-2)"	"unprognostic (1.95e-1)"	"unprognostic (1.88e-3)"	"unprognostic (2.22e-1)"	16.6	16.6	14.0	14.3	18.9	21.3	14.2	16.0	15.8	11.8	15.0	13.0	13.9	16.1	14.7	12.4	13.5	12.0	11.7	14.5	13.3	17.6	27.2	35.8	14.0	20.8	17.9	6.9	11.4	14.5	19.6	18.2	14.2	16.4	12.9	17.6	9.5	13.9	12.5	23.6	11.0	20.6	16.1	18.6	18.7	15.1	12.5	15.6	22.5	14.5	11.7	15.5	13.8	13.6	3.7	3.4	7.2	4.8	4.0	4.3	1.4	15.8	13.5	13.8	20.6	13.3	12.0	10.6	20.3	20.0	19.0	23.2	15.1	9.4	21.6	12.0	13.8	13.2	15.8	23.0	10.7	21.3	22.9	19.9	14.3	10.7	16.6	11.4	26.4	21.1	9.6	11.5	21.8	21.4	13.2	13.5	17.9	16.2	17.9	20.6	9.6	20.9	16.3	9.0	12.7	9.9	13.7	15.4	9.8	12.0	10.3	8.3	12.3	11.0	8.5	17.6	11.4	17.0	16.2	14.1	11.9	13.4	12.9	23.0	21.1	19.0	21.0	13.0	21.5	9.4	2.6	3.0	5.1	2.4	4.8	4.0	3.7	3.0	4.3	3.4	2.1	3.3	4.2	7.2	4.0	3.2	2.1	2.8	1.4	14.0	18.9	16.0	15.8	13.3	17.6	17.9	6.9	16.4	15.6	11.9	7.8	9.0	4.9	17.5	5.0	6.9	5.1	4.0	4.5	5.2	2.0	5.5	10.0	6.6	6.7	8.3	8.3	0.0	10.3	6.5	5.6	8.2	8.1	13.0	9.4	12.7	5.8	6.2	17.2	6.1	5.8	10.7	6.8	11.8	6.3	4.8	7.9	6.6	5.6	15.3	4.8	19.4	8.1	8.0	13.6	16.7	11.6	7.5	6.0	10.9
CIITA	"C2TA, MHC2TA, NLRA"	ENSG00000179583	"Class II major histocompatibility complex transactivator"	P33076	16	10866222-10943021	"Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Activator, Acyltransferase, Kinase, Transferase"	"Cancer-related genes, Disease mutation, SCID"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 67.2"	"Cell type enhanced"	"Detected in many"	14	"Alveolar cells type 2: 17.9;Macrophages: 36.9;monocytes: 58.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"HDLM-2: 23.3;REH: 40.9;U-266/70: 8.6;U-698: 12.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"CAB016084, HPA054757"	Enhanced		Supported	Nucleoplasm		NA	NA			Nucleoplasm		"CAB016084: AB_627261, HPA054757: "	"unprognostic (1.45e-3)"	"unprognostic (1.38e-2)"	"unprognostic (8.22e-3)"	"unprognostic (1.12e-2)"	"unprognostic (5.66e-2)"	"unprognostic (2.88e-3)"	"unprognostic (2.92e-2)"	"unprognostic (1.55e-2)"	"unprognostic (1.15e-2)"	"unprognostic (1.85e-1)"	"unprognostic (1.23e-1)"	"unprognostic (3.72e-1)"	"unprognostic (1.64e-2)"	"unprognostic (2.72e-2)"	"unprognostic (6.33e-3)"	"unprognostic (2.74e-1)"	"unprognostic (1.05e-2)"	8.0	5.9	4.6	47.7	7.1	4.3	6.8	1.5	5.5	6.3	3.7	10.6	4.2	10.4	8.1	10.4	4.8	5.2	8.1	4.9	4.7	3.5	8.8	2.9	15.0	27.0	9.4	1.1	2.5	3.5	1.9	4.0	1.2	6.6	5.5	4.3	5.5	13.3	4.3	2.9	4.4	17.4	3.7	15.6	25.9	6.2	1.5	7.4	12.6	6.1	5.2	67.2	6.3	6.8	27.3	19.0	6.5	11.9	0.7	0.5	1.7	0.1	0.2	0.3	0.3	0.1	0.0	0.2	0.1	0.0	0.1	0.1	0.3	5.6	5.1	0.8	0.0	0.9	0.9	0.0	0.0	0.1	23.3	0.3	2.9	1.1	0.6	0.0	0.5	0.4	1.0	0.0	0.1	0.0	0.9	0.0	0.3	0.3	2.0	0.1	0.3	0.2	0.4	0.1	0.2	0.1	40.9	0.3	3.6	0.0	1.7	0.9	0.1	0.9	0.3	0.9	0.3	0.5	1.7	0.3	2.1	0.3	0.6	0.2	8.6	0.6	12.1	7.7	0.5	6.9	0.2	11.9	6.5	0.3	9.5	0.1	17.9	0.1	0.5	17.7	27.3	0.1	0.2	2.8	0.7	10.0	19.0	0.4	1.7	4.6	7.1	1.5	5.5	4.7	3.5	9.4	1.1	6.6	7.4	6.0	17.9	12.3	0.3	2.1	0.6	2.8	2.5	2.7	1.2	3.5	0.0	0.1	0.0	2.5	0.6	4.2	3.4	0.0	1.7	0.2	1.0	0.3	10.4	1.0	9.1	0.0	2.4	2.5	15.6	0.0	0.6	36.9	6.8	58.7	0.7	0.4	1.7	0.0	0.0	3.3	0.9	0.0	0.9	0.0	0.0	2.5	0.1	1.0	0.4	0.3
CIT	"CITK, CRIK, KIAA0949, STK21"	ENSG00000122966	"Citron rho-interacting serine/threonine kinase"	O14578	12	119685790-119877291	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Cell cycle, Cell division, Differentiation, Mitosis, Neurogenesis"	"Developmental protein, Kinase, Serine/threonine-protein kinase, Transferase"	"Disease mutation, Primary microcephaly"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 15.3;brain: 35.0"	"Cell type enhanced"	"Detected in many"	14	"Cone photoreceptor cells: 82.5;Early spermatids: 63.4;Late spermatids: 28.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"T-reg: 1.2"	"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in many"							"HPA019082, HPA048812, HPA075506"	Uncertain		Approved	Cytosol		NA	NA			Cytosol		"HPA019082: AB_1846803, HPA048812: AB_2680528, HPA075506: AB_2686752"	"unprognostic (5.64e-2)"	"unprognostic (5.00e-2)"	"unprognostic (8.16e-2)"	"unprognostic (5.12e-3)"	"unprognostic (1.25e-1)"	"unprognostic (3.55e-2)"	"unprognostic (3.61e-6)"	"unprognostic (6.02e-2)"	"unprognostic (7.78e-2)"	"unprognostic (4.42e-1)"	"unprognostic (1.37e-3)"	"unprognostic (4.88e-2)"	"unprognostic (2.55e-3)"	"unprognostic (8.56e-2)"	"unprognostic (1.50e-1)"	"unprognostic (1.70e-1)"	"unprognostic (3.30e-1)"	1.4	4.4	14.7	3.3	14.0	15.3	1.6	12.7	35.0	1.6	4.6	2.9	0.0	4.0	1.3	1.5	3.2	0.9	1.6	1.0	9.8	5.7	5.7	1.4	3.0	3.4	3.2	21.9	0.7	0.7	1.2	2.9	2.6	7.4	1.0	5.3	0.6	1.3	1.0	1.3	5.1	3.5	2.6	5.0	5.6	3.5	8.3	9.5	5.9	1.5	0.1	4.9	1.7	1.7	0.4	0.0	0.0	0.1	0.0	1.2	0.8	15.1	13.7	12.0	11.3	1.1	3.3	7.1	11.7	9.7	12.2	9.2	8.7	6.3	11.0	6.3	9.0	6.0	9.5	8.2	6.8	16.9	7.8	6.0	13.9	8.8	5.4	0.1	7.3	12.8	0.7	0.8	14.6	9.0	4.4	9.3	12.2	8.8	9.3	11.5	7.6	13.2	11.1	6.5	5.7	9.3	12.1	21.9	3.6	2.4	6.7	8.6	4.7	19.4	3.8	9.2	6.3	13.7	5.3	7.1	15.3	14.1	10.4	12.7	6.3	7.1	7.5	10.1	8.1	23.6	0.0	0.0	0.0	0.4	0.1	0.0	0.4	0.3	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.8	14.7	14.0	12.7	35.0	9.8	5.7	3.2	21.9	7.4	9.5	6.0	8.8	0.8	0.6	3.0	7.4	1.6	0.0	1.4	9.1	8.7	82.5	0.9	0.0	0.2	63.4	1.1	0.4	0.0	0.7	4.0	1.1	0.3	1.1	0.8	2.9	0.0	1.7	1.3	1.9	28.5	1.1	1.0	3.3	0.0	1.1	15.4	0.1	0.0	1.1	5.7	15.0	0.0	0.4	11.5	3.5	1.1	0.8	2.5	1.6	1.0
CKB	CKBB	ENSG00000166165	"Creatine kinase B"	P12277	14	103519659-103523111	"Cancer-related genes, Candidate cardiovascular disease genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"		"Kinase, Transferase"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 158.5"	"Cell type enhanced"	"Detected in many"	9	"Bipolar cells: 2313.9;Horizontal cells: 4762.4;Muller glia cells: 3352.8;Rod photoreceptor cells: 2841.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	10	"non-classical monocyte: 50.0"	"Lineage enriched"	"Detected in many"	17	"monocytes: 50.0"	"Cell line enhanced"	"Detected in many"		"CACO-2: 54.3;HEK 293: 138.1;SCLC-21H: 78.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001254, CAB047313"	Enhanced		Supported	Cytosol		No	No		50000000	Cytosol		"CAB047313: , HPA001254: AB_1078528"	"unprognostic (9.97e-2)"	"unprognostic (1.33e-3)"	"unprognostic (4.25e-3)"	"unprognostic (1.10e-1)"	"unprognostic (7.63e-2)"	"unprognostic (3.62e-2)"	"unprognostic (1.64e-1)"	"unprognostic (1.30e-1)"	"unprognostic (4.24e-1)"	"unprognostic (4.60e-2)"	"unprognostic (2.68e-3)"	"unprognostic (9.89e-3)"	"prognostic favorable (4.02e-8)"	"unprognostic (2.62e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.67e-2)"	"unprognostic (2.13e-1)"	32.4	27.3	75.4	10.4	114.6	3.1	5.3	94.3	158.5	29.1	121.5	51.4	23.8	17.6	37.3	8.9	28.6	35.7	17.8	36.4	60.7	43.2	26.7	3.4	12.8	3.6	63.4	93.3	15.8	10.2	20.3	9.7	3.7	63.3	107.5	55.0	43.9	18.3	92.1	19.1	14.4	17.5	53.2	31.9	3.6	66.7	22.1	50.9	0.0	19.8	7.8	3.9	43.0	13.0	0.0	2.9	1.4	50.0	0.0	0.1	0.9	0.3	6.8	27.5	1.4	0.2	0.2	0.5	2.9	0.0	0.3	0.1	54.3	0.8	0.0	3.3	2.1	1.1	6.0	7.9	0.1	0.0	1.2	138.1	10.2	30.3	18.6	1.2	0.0	8.4	1.1	0.0	0.2	0.1	0.4	0.0	0.6	17.8	0.4	0.4	2.3	0.2	0.3	10.7	4.6	21.4	1.8	0.5	28.2	5.0	0.2	78.6	32.3	5.8	1.0	2.1	2.0	2.5	4.2	0.1	0.1	5.3	0.5	12.9	1.3	0.3	0.9	0.7	0.2	1.0	0.3	0.1	1.4	0.0	5.1	0.0	0.0	0.0	0.0	2.9	0.0	0.0	0.1	0.1	0.0	50.0	0.0	0.1	0.9	75.4	114.6	94.3	152.7	60.7	43.2	63.4	93.3	63.3	50.9	181.7	96.3	15.9	251.5	136.6	2313.9	490.2	117.2	301.2	83.0	108.2	1798.5	3.2	1933.1	99.3	397.5	36.5	717.3	0.0	37.5	9.9	100.2	316.9	28.8	6.8	6.9	4762.4	449.5	67.5	3.0	120.4	281.6	32.2	172.1	122.6	614.3	3352.8	99.2	2059.7	1024.0	69.5	2841.9	58.2	193.9	161.4	92.5	153.2	34.8	12.1	562.9	194.5
CKM	CKMM	ENSG00000104879	"Creatine kinase, M-type"	P06732	19	45306414-45322977	"Candidate cardiovascular disease genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"		"Kinase, Transferase"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"skeletal muscle: 1374.7;tongue: 354.9"	"Cell type enriched"	"Detected in some"	137	"Cardiomyocytes: 5083.5"	"Group enriched"	"Detected in many"	33	"head and neck cancer: 64.4;prostate cancer: 14.3"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	9	"classical monocyte: 2.8;intermediate monocyte: 1.1;myeloid DC: 2.1"	"Group enriched"	"Detected in many"	25	"dendritic cells: 2.1;monocytes: 2.8"	"Cell line enriched"	"Detected in some"	4	"SCLC-21H: 37.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA047859	Enhanced					NA	NA		190000000			"HPA047859: AB_2680186"	"unprognostic (3.51e-1)"	"unprognostic (7.63e-2)"	"unprognostic (2.61e-2)"	"unprognostic (4.14e-1)"	"unprognostic (7.68e-3)"	"unprognostic (4.04e-3)"	"unprognostic (1.85e-2)"	"unprognostic (4.23e-2)"	"unprognostic (5.19e-2)"	"unprognostic (1.81e-1)"	"unprognostic (5.00e-1)"	"unprognostic (9.46e-3)"	"unprognostic (9.67e-8)"	"unprognostic (3.23e-1)"	"unprognostic (1.73e-1)"	"unprognostic (2.33e-1)"	"unprognostic (1.95e-1)"	13.9	0.1	0.2	0.1	0.2	0.1	0.4	0.1	0.1	0.1	0.2	0.0	0.0	0.1	0.1	23.5	21.1	0.1	0.1	187.9	0.2	0.1	0.2	0.2	0.2	0.1	0.2	0.0	0.1	0.2	0.1	0.1	0.1	0.0	2.8	0.1	0.8	17.6	0.2	1374.7	0.2	0.2	0.2	0.3	0.1	0.5	0.3	0.0	0.0	11.1	354.9	24.8	0.2	0.1	0.0	2.1	0.0	2.8	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	3.0	0.0	0.1	8.9	6.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	3.3	0.1	0.1	0.0	0.0	37.6	0.0	0.0	0.0	0.0	0.0	0.0	8.6	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.0	1.1	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	1.0	0.2	0.2	0.1	0.1	0.2	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5083.5	0.0	0.0	0.0	0.0	0.0	0.3	10.0	0.0	12.4	0.0	0.0	0.0	0.0	0.7	0.0	0.0	1.1	0.0	5.5	0.0	0.0	0.6	1.9	37.0	1.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.3	15.2	1.8	0.1	0.2	0.0	0.0	0.1
CKMT1A	CKMT1	ENSG00000223572	"Creatine kinase, mitochondrial 1A"	P12532	15	43692886-43699222	"Enzymes, FDA approved drug targets, Predicted intracellular proteins"		"Kinase, Transferase"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 17.2;esophagus: 19.9;intestine: 25.5"	"Cell type enhanced"	"Detected in many"	7	"Cytotrophoblasts: 64.4;Enterocytes: 82.9;Paneth cells: 55.7;Syncytiotrophoblasts: 78.6;Undifferentiated cells: 74.1"	"Low cancer specificity"	"Detected in many"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HaCaT: 39.8;hTCEpi: 18.1;OE19: 43.7;SK-BR-3: 31.3;T-47d: 27.9"									HPA043491	Uncertain				"Intracellular and membrane"	NA	NA		2100000			"HPA043491: AB_2678510"	"unprognostic (2.04e-2)"	"unprognostic (2.53e-2)"	"unprognostic (1.17e-1)"	"unprognostic (4.02e-3)"	"unprognostic (3.80e-1)"	"unprognostic (7.44e-2)"	"unprognostic (2.21e-1)"	"unprognostic (3.10e-1)"	"unprognostic (1.75e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.72e-1)"	"unprognostic (2.51e-2)"	"unprognostic (3.78e-9)"	"unprognostic (3.52e-2)"	"unprognostic (1.03e-1)"	"unprognostic (7.37e-2)"	"unprognostic (1.73e-3)"	0.0	0.7	4.8	1.9	6.3	0.0	2.1	17.2	12.6	1.8	25.5			24.7	0.0	0.0	19.9	0.4	3.0	0.0	5.6	7.9	0.9	0.0	0.0	0.0	5.0		0.0	0.1	2.1	1.4	2.5		0.5	24.1		7.2	0.0	0.0	13.0	21.7	0.9	1.1	0.0	7.8	0.0			0.6		4.4	1.4	4.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.2	0.0	0.3	0.0	9.9	0.0	0.0	0.0	0.0	2.1	6.9	0.0	0.4	0.0	0.6	39.8	5.7	11.7	0.0	0.0	4.3	0.0	0.6	0.1	0.0	0.0	1.8	0.0	18.1	0.0	3.1	0.0	0.0	1.4	1.7	0.0	0.0	9.2	0.0	0.0	2.8	43.7	2.1	0.0	0.0	1.8	1.9	1.4	14.1	5.5	0.0	31.3	2.0	0.8	27.9	0.2	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	8.2	15.8	5.9	0.4	12.7	1.4	5.7	1.8	19.6	64.4	23.2	3.4	0.0	0.1	82.9	0.0	18.3	17.8	0.6	2.2	9.2	0.0	4.0	6.4	17.2	0.0	0.0	0.0	0.0	0.0	5.0	0.0	34.6	1.5	9.9	55.7	0.0	0.3	8.7	0.0	0.3	0.0	0.0	16.2	78.6	0.0	74.1	11.5
CKMT1B	"CKMT, CKMT1, UMTCK"	ENSG00000237289	"Creatine kinase, mitochondrial 1B"	P12532	15	43593054-43604901	"Enzymes, FDA approved drug targets, Predicted intracellular proteins"		"Kinase, Transferase"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 52.7;intestine: 28.1"	"Cell type enhanced"	"Detected in many"	7	"Cytotrophoblasts: 111.7;Enterocytes: 108.3;Paneth cells: 69.6;Syncytiotrophoblasts: 115.3;Undifferentiated cells: 90.6"	"Low cancer specificity"	"Detected in many"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HaCaT: 38.6;hTCEpi: 19.9;OE19: 42.8;SK-BR-3: 47.5;T-47d: 27.7"									HPA043491	Uncertain				"Intracellular and membrane"	NA	NA		2100000			"HPA043491: AB_2678510"	"unprognostic (3.47e-2)"	"unprognostic (9.73e-3)"	"unprognostic (3.10e-1)"	"prognostic unfavorable (2.55e-5)"	"unprognostic (1.29e-1)"	"unprognostic (1.96e-1)"	"unprognostic (5.19e-2)"	"unprognostic (2.84e-1)"	"unprognostic (3.64e-1)"	"unprognostic (5.75e-2)"	"unprognostic (2.39e-1)"	"unprognostic (1.15e-2)"	"unprognostic (2.26e-8)"	"unprognostic (1.71e-2)"	"unprognostic (1.69e-1)"	"unprognostic (4.43e-2)"	"unprognostic (4.36e-2)"	0.0	0.3	5.4	1.6	8.8	0.0	1.6	52.7	13.6	0.7	28.1			22.4	0.0	0.0	13.8	0.2	2.8	0.0	6.8	7.4	0.9	0.0	0.0	0.0	5.4		0.0	0.2	1.4	1.3	3.7		0.6	23.1		4.8	0.0	0.0	7.6	16.2	1.2	1.8	0.0	10.0	0.0			1.7		4.1	1.7	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.1	0.0	9.4	0.0	0.0	0.0	0.0	2.2	6.6	0.0	0.3	0.0	1.9	38.6	7.7	14.8	0.0	0.1	4.5	0.0	0.9	0.9	0.0	0.0	2.2	0.0	19.9	0.0	1.7	0.0	0.0	1.5	2.5	0.0	0.0	9.4	0.0	0.0	3.1	42.8	4.1	0.0	0.0	0.2	0.7	1.0	14.9	5.3	0.2	47.5	2.8	0.6	27.7	0.0	0.0	0.0	0.5	0.0	0.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.3	0.0	8.5	22.2	7.6	0.3	7.6	4.0	1.2	5.2	17.7	111.7	18.3	3.4	0.0	0.1	108.3	0.0	25.5	16.9	0.5	1.7	0.0	0.0	8.1	6.4	20.2	0.0	0.0	0.0	0.0	0.0	3.3	0.0	49.2	2.3	12.5	69.6	0.0	0.5	7.5	0.0	0.2	0.0	0.0	21.7	115.3	0.0	90.6	15.9
CKMT2	SMTCK	ENSG00000131730	"Creatine kinase, mitochondrial 2"	P17540	5	81233285-81266397	"Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"		"Kinase, Transferase"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	13	"heart muscle: 153.2;skeletal muscle: 182.4;tongue: 103.6"	"Cell type enriched"	"Detected in some"	25	"Cardiomyocytes: 792.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in single"	9	"NK-cell: 3.8"	"Lineage enriched"	"Detected in single"	9	"NK-cells: 3.8"	"Cell line enhanced"	"Detected in some"		"ASC diff: 3.7;BEWO: 6.0;Hep G2: 5.2;HHSteC: 4.0;T-47d: 9.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA051880	Enhanced					NA	NA		3200000			"HPA051880: AB_2681650"	"unprognostic (3.64e-3)"	"unprognostic (1.15e-1)"	"unprognostic (2.82e-3)"	"unprognostic (1.88e-2)"	"unprognostic (1.21e-2)"	"unprognostic (2.41e-2)"	"unprognostic (1.73e-2)"	"unprognostic (3.57e-2)"	"unprognostic (2.12e-1)"	"unprognostic (1.03e-1)"	"unprognostic (2.82e-1)"	"unprognostic (1.84e-1)"	"unprognostic (1.60e-2)"	"unprognostic (5.34e-2)"	"unprognostic (2.28e-1)"	"unprognostic (1.76e-1)"	"unprognostic (2.75e-3)"	2.5	5.0	1.3	0.3	1.9	0.2	0.8	0.4	1.2	1.2	0.5	1.2	2.5	0.3	1.3	11.5	3.0	1.2	1.5	153.2	1.5	0.9	2.7	0.3	0.4	0.3	2.3	1.4	1.6	1.3	1.1	0.7	0.3	4.1	2.0	0.3	2.5	9.1	2.1	182.4	0.5	0.6	1.4	2.8	0.4	2.1	0.9	1.5	0.0	3.3	103.6	2.9	1.0	0.6	0.4	0.1	0.0	0.4	3.8	0.3	0.0	0.1	0.9	0.0	0.9	3.7	0.8	6.0	0.1	0.0	0.0	0.0	0.3	0.3	0.7	0.4	0.0	0.9	0.1	0.0	0.0	0.0	0.5	3.2	0.0	0.7	5.2	4.0	0.5	0.2	1.4	0.0	0.0	0.0	0.5	0.0	0.8	0.0	0.6	0.0	0.7	0.2	0.1	0.8	0.0	0.4	0.8	0.9	0.0	0.0	0.1	0.7	0.7	0.5	0.4	0.9	2.3	9.7	0.4	0.8	0.5	0.9	0.5	0.3	0.1	0.1	0.8	0.4	0.5	0.9	0.0	0.2	0.0	0.1	0.4	0.0	0.1	0.3	0.0	0.0	0.4	0.1	0.2	0.0	3.8	0.0	0.1	0.2	0.0	1.3	1.9	0.4	1.2	1.5	0.9	2.3	1.4	4.1	1.5	0.0	0.3	0.0	0.4	0.1	0.7	792.8	7.6	1.4	1.2	12.2	0.0	0.1	31.5	1.6	16.2	5.3	0.0	0.0	0.5	0.4	0.6	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.8	6.6	0.0	3.3	0.0	0.0	1.3	0.2	0.0	14.2	0.6	0.9	0.0	5.9	0.2	0.4	0.1	0.2	0.0	0.2	0.1
CLK1		ENSG00000013441	"CDC like kinase 1"	P49759	2	200853009-200864744	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"		"Kinase, Serine/threonine-protein kinase, Transferase, Tyrosine-protein kinase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB033141, HPA062405"	Approved		Supported	"Nucleoplasm,Nuclear membrane"		NA	NA			"Nucleoplasm, Nuclear membrane"		"CAB033141: AB_1121713, HPA062405: AB_2684753"	"unprognostic (9.79e-2)"	"unprognostic (2.05e-1)"	"unprognostic (2.15e-2)"	"unprognostic (1.63e-1)"	"unprognostic (9.19e-2)"	"unprognostic (4.50e-3)"	"unprognostic (1.52e-1)"	"unprognostic (2.77e-3)"	"unprognostic (1.78e-2)"	"unprognostic (2.09e-2)"	"unprognostic (1.09e-2)"	"unprognostic (5.63e-3)"	"unprognostic (2.03e-3)"	"unprognostic (9.66e-2)"	"unprognostic (2.30e-1)"	"unprognostic (1.18e-1)"	"prognostic favorable (2.28e-4)"	26.3	55.1	27.8	30.5	43.4	97.6	40.2	40.1	40.7	42.2	23.0	19.9	39.1	12.9	29.1	34.5	26.3	19.1	35.8	26.7	31.0	21.9	21.8	35.3	28.2	30.1	56.0	23.1	48.1	20.9	36.6	41.5	40.0	34.4	34.3	16.5	13.7	25.6	37.1	27.3	32.1	14.9	36.8	55.2	32.4	15.1	12.4	52.6	25.0	30.4	20.2	25.6	51.2	71.8	13.2	9.8	26.2	6.2	6.5	14.4	7.4	8.2	6.2	10.4	3.2	11.9	13.1	8.2	9.0	12.8	9.1	12.2	11.6	5.4	2.8	6.1	5.6	5.3	8.9	13.1	4.1	18.7	12.5	11.6	8.5	15.7	14.3	7.1	8.8	14.4	6.0	18.9	11.4	20.2	10.9	5.3	4.5	10.2	37.3	12.9	5.6	10.4	26.8	6.6	5.2	14.2	10.6	12.4	14.8	6.3	5.4	10.5	8.3	7.8	2.9	13.0	6.5	2.4	6.1	8.1	10.2	7.0	9.8	9.8	22.0	9.1	6.5	6.5	7.2	6.9	26.2	6.2	13.3	13.6	4.4	13.1	13.2	12.8	12.1	4.1	10.1	14.4	11.4	12.7	6.5	4.2	9.8	13.0	7.4	27.8	43.4	40.1	40.7	31.0	21.9	56.0	23.1	34.4	52.6	41.7	97.6	120.6	205.3	149.9	55.8	85.6	28.1	76.3	79.6	26.2	94.2	37.9	16.6	25.9	1.9	110.1	100.8	23.3	23.3	39.1	151.1	171.5	133.9	37.6	51.4	49.3	128.8	78.0	91.9	5.1	86.0	167.5	146.8	47.7	56.3	46.1	27.4	66.6	71.1	11.1	91.9	109.9	142.2	31.2	22.0	132.6	75.5	146.6	44.8	153.2
CLK2	clk2	ENSG00000176444	"CDC like kinase 2"	P49760	1	155262868-155278491	"Enzymes, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase, Tyrosine-protein kinase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA055366, HPA059507"	Approved		Enhanced	"Nucleoplasm,Nuclear bodies"		NA	NA			Nucleoplasm	"Nuclear bodies"	"HPA055366: AB_2682795, HPA059507: AB_2684044"	"unprognostic (2.00e-2)"	"unprognostic (1.35e-2)"	"prognostic unfavorable (3.77e-4)"	"unprognostic (2.84e-2)"	"unprognostic (3.16e-1)"	"unprognostic (1.75e-1)"	"prognostic unfavorable (2.82e-4)"	"unprognostic (2.38e-1)"	"unprognostic (2.36e-1)"	"unprognostic (1.36e-2)"	"unprognostic (7.66e-2)"	"unprognostic (3.84e-2)"	"prognostic unfavorable (2.95e-9)"	"unprognostic (1.70e-1)"	"unprognostic (1.40e-1)"	"unprognostic (1.11e-1)"	"prognostic favorable (5.43e-4)"	15.3	16.6	14.6	15.0	19.0	12.9	17.1	33.1	20.2	22.3	18.0	18.7	18.1	14.5	22.6	19.9	15.5	18.2	13.9	11.8	17.1	7.3	17.3	18.2	14.7	22.2	16.9	16.9	24.7	15.9	29.2	21.6	19.2	13.5	22.1	13.5	16.1	16.4	18.2	10.4	21.4	15.6	17.0	13.5	27.0	13.7	13.7	20.3	18.1	22.9	8.0	22.2	16.7	20.1	2.8	1.9	4.8	1.7	0.7	4.1	1.1	5.9	5.1	18.7	5.7	9.4	5.1	16.0	5.3	6.5	4.1	4.2	5.4	4.3	13.0	7.4	3.6	2.2	8.6	9.3	6.9	3.9	9.4	7.3	10.3	5.4	6.9	8.1	12.8	10.4	4.1	6.4	6.0	12.2	11.9	7.2	11.1	14.5	9.0	6.2	10.3	8.7	7.6	12.2	15.0	7.3	9.7	11.3	13.9	10.5	13.4	8.9	12.7	2.0	6.4	4.9	14.7	9.8	15.7	4.7	2.5	6.8	4.6	4.4	17.2	14.7	11.8	5.1	9.2	2.9	4.8	1.7	3.4	2.0	0.8	2.9	2.8	3.4	1.8	1.8	2.4	3.4	4.1	2.1	0.7	0.8	1.9	1.7	1.1	14.6	19.0	33.1	20.2	17.1	7.3	16.9	16.9	13.5	20.3	14.9	22.4	4.8	4.8	4.0	5.8	13.3	12.7	4.0	18.2	7.0	3.9	6.8	0.0	5.2	6.3	8.3	4.3	0.0	3.8	7.3	7.2	3.9	9.3	5.8	6.0	4.8	6.4	8.0	10.5	5.4	7.2	5.8	3.3	7.2	7.9	5.4	4.4	3.5	2.8	2.8	5.7	6.5	3.3	8.3	3.8	4.0	10.4	4.4	6.3	4.3
CLK3	clk3	ENSG00000179335	"CDC like kinase 3"	P49761	15	74598500-74645414	"Enzymes, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase, Tyrosine-protein kinase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA046817	Approved		Supported	"Nucleoplasm,Intermediate filaments"		NA	NA			Nucleoplasm	"Intermediate filaments"	"HPA046817: AB_10964124"	"unprognostic (4.10e-2)"	"unprognostic (8.43e-2)"	"prognostic unfavorable (2.05e-6)"	"unprognostic (1.91e-3)"	"unprognostic (7.91e-2)"	"unprognostic (5.76e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.30e-2)"	"unprognostic (1.95e-1)"	"unprognostic (2.54e-1)"	"unprognostic (8.14e-3)"	"prognostic unfavorable (5.92e-4)"	"unprognostic (1.35e-2)"	"unprognostic (2.24e-1)"	"unprognostic (9.73e-2)"	"unprognostic (2.48e-1)"	"unprognostic (2.25e-2)"	20.9	17.2	15.7	24.7	22.5	62.7	31.1	23.4	18.8	24.9	24.6	23.1	16.4	18.6	24.1	17.7	25.3	17.3	21.2	16.4	17.8	13.5	17.2	16.0	19.6	21.9	29.3	14.5	23.7	21.8	19.0	19.9	27.9	16.7	20.6	14.4	19.9	24.8	20.9	28.4	24.1	20.7	19.8	19.2	23.8	19.6	31.5	23.3	28.8	21.0	12.0	23.7	23.2	19.8	38.9	36.0	60.7	46.0	43.6	43.4	39.7	22.3	14.2	18.8	10.5	24.2	18.6	14.9	15.3	24.2	21.9	26.9	19.3	14.8	20.4	11.4	13.6	30.6	15.8	35.0	14.7	14.3	29.0	19.2	25.0	21.1	13.3	38.5	6.7	19.4	23.2	29.4	28.8	24.0	26.8	24.0	20.8	12.2	14.9	12.7	15.8	19.9	22.7	12.0	22.2	10.1	16.1	9.0	13.4	17.1	16.3	10.6	12.5	12.2	13.6	13.5	15.1	12.9	13.5	11.0	13.0	10.0	8.1	20.0	24.5	19.6	16.8	11.4	33.1	16.4	32.9	34.4	45.0	38.5	37.4	37.4	37.7	41.1	39.7	31.9	38.9	42.1	40.1	60.7	43.6	46.0	36.0	43.4	39.7	15.7	22.5	23.4	18.8	17.8	13.5	29.3	14.5	16.7	23.3	6.0	35.5	20.9	38.8	40.0	34.9	14.9	20.4	17.4	18.2	12.2	53.0	22.9	26.6	29.6	59.6	28.3	37.1	23.3	21.0	31.4	22.7	32.5	20.8	10.9	24.3	27.0	28.2	17.2	24.0	14.8	25.6	28.5	27.0	32.5	24.6	17.7	28.8	28.1	19.1	14.2	42.2	12.9	24.4	37.1	17.5	36.6	49.0	39.2	22.6	53.1
CLK4		ENSG00000113240	"CDC like kinase 4"	Q9HAZ1	5	178602664-178630615	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"		"Kinase, Serine/threonine-protein kinase, Transferase, Tyrosine-protein kinase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"Early spermatids: 288.4;Late spermatids: 350.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA043746	Approved		Approved	"Actin filaments"		No	No			"Actin filaments"		"HPA043746: AB_2678650"	"unprognostic (9.46e-2)"	"unprognostic (2.24e-2)"	"unprognostic (1.48e-1)"	"unprognostic (3.44e-2)"	"unprognostic (1.59e-1)"	"unprognostic (7.16e-3)"	"unprognostic (2.67e-1)"	"unprognostic (2.04e-2)"	"unprognostic (4.37e-2)"	"unprognostic (5.92e-2)"	"unprognostic (2.90e-3)"	"unprognostic (9.62e-3)"	"unprognostic (1.13e-2)"	"unprognostic (1.26e-1)"	"unprognostic (3.38e-1)"	"unprognostic (1.20e-1)"	"unprognostic (1.14e-3)"	12.2	16.4	17.0	17.4	18.4	11.4	17.3	53.8	24.1	17.9	12.2	11.9	18.3	12.4	17.0	16.4	10.5	11.0	13.1	11.4	15.9	9.5	11.8	16.0	10.9	20.3	21.2	12.7	17.4	16.2	15.4	20.2	13.9	16.3	16.7	8.9	10.8	14.4	17.0	20.6	19.5	11.3	11.3	25.8	17.0	11.0	15.7	22.0	15.0	15.8	9.7	12.7	11.4	18.0	13.2	7.8	16.1	6.1	7.7	13.8	5.2	6.7	6.3	5.8	8.4	17.5	14.7	9.7	6.7	7.5	4.0	7.4	6.7	5.5	3.9	5.4	2.8	4.5	9.0	7.5	5.4	6.6	14.1	5.9	1.5	11.8	8.1	6.5	3.1	4.9	6.7	7.8	6.4	8.6	13.2	2.7	2.7	3.5	11.6	5.1	2.8	4.0	11.4	3.0	4.6	3.9	4.0	5.2	5.7	3.9	2.1	6.5	4.4	7.5	4.0	6.9	3.4	4.3	6.6	5.6	8.2	2.9	4.2	7.1	7.6	2.8	3.0	5.9	7.6	4.1	6.5	6.1	12.0	10.0	4.1	13.2	13.2	10.3	8.9	5.9	10.4	13.8	10.6	16.1	7.7	4.4	7.8	9.5	5.2	17.0	18.4	53.8	24.1	15.9	9.5	21.2	12.7	16.3	22.0	14.9	26.7	50.0	37.2	28.3	66.4	19.3	7.6	32.1	23.9	14.0	37.3	16.5	5.0	7.3	288.4	24.8	13.5	23.3	4.1	13.0	20.8	26.1	27.6	11.9	8.8	27.0	5.8	17.2	13.1	350.8	28.4	23.8	15.1	12.6	10.7	34.6	6.5	11.8	27.6	7.7	76.4	19.4	36.0	23.2	17.7	21.5	13.3	34.8	9.1	22.2
CLOCK	"bHLHe8, KAT13D, KIAA0334"	ENSG00000134852	"Clock circadian regulator"	O15516	4	55427903-55547138	"Enzymes, Predicted intracellular proteins, Transcription factors"	"Biological rhythms, DNA damage, Transcription, Transcription regulation"	"Activator, Acyltransferase, DNA-binding, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001867, HPA027565"	Supported		Enhanced	Nucleoplasm,Vesicles		NA	NA			Nucleoplasm	Vesicles	"HPA001867: AB_1078537, HPA027565: AB_1846975"	"unprognostic (1.30e-2)"	"unprognostic (9.02e-2)"	"unprognostic (4.25e-3)"	"unprognostic (2.48e-1)"	"unprognostic (3.94e-2)"	"unprognostic (2.00e-2)"	"unprognostic (1.17e-1)"	"unprognostic (1.30e-1)"	"unprognostic (4.52e-2)"	"unprognostic (4.32e-2)"	"unprognostic (3.01e-2)"	"unprognostic (5.96e-2)"	"unprognostic (4.07e-2)"	"unprognostic (8.31e-2)"	"unprognostic (1.69e-1)"	"unprognostic (5.18e-2)"	"unprognostic (7.16e-2)"	9.3	9.2	7.8	5.8	11.7	1.7	8.4	16.2	14.3	12.5	9.5	5.2	9.2	7.1	10.5	8.4	13.9	8.1	6.7	10.5	7.9	7.9	12.4	9.1	8.2	9.4	7.0	9.8	11.7	8.6	18.7	21.9	8.5	8.4	9.7	8.4	5.6	8.2	9.2	16.1	9.4	12.6	13.8	8.3	9.1	9.6	18.5	5.0	4.0	14.7	5.9	5.2	8.4	17.1	2.5	3.6	0.6	3.0	2.9	4.7	1.4	13.6	5.9	5.4	8.4	8.1	8.2	2.7	14.1	11.6	9.9	9.1	3.7	10.9	3.7	7.3	16.4	7.4	11.4	6.9	10.9	16.7	4.5	2.5	2.9	6.3	4.6	7.2	4.7	3.4	4.8	10.9	13.6	13.4	7.4	9.2	3.1	6.7	7.5	14.8	7.5	2.6	2.7	3.9	11.2	6.9	1.7	6.2	2.4	7.6	7.4	5.3	4.7	10.2	12.6	6.4	4.7	4.2	2.6	12.7	13.4	14.4	4.4	18.9	6.8	4.9	2.3	11.9	4.2	10.6	0.0	3.0	0.6	2.8	3.0	4.7	1.4	3.2	2.5	3.6	2.5	1.9	2.4	0.6	2.9	2.7	2.1	3.1	1.4	7.8	11.7	16.2	14.3	7.9	7.9	7.0	9.8	8.4	5.0	38.7	23.0	9.8	18.1	27.6	61.3	50.4	12.7	12.0	13.6	14.0	41.2	9.5	1.7	11.5	25.0	28.9	20.3	0.0	14.4	5.7	30.8	25.1	3.5	25.9	10.1	31.8	38.2	28.8	12.7	12.1	22.2	14.3	10.1	8.2	19.3	29.6	19.8	15.3	33.9	17.0	39.4	12.9	30.8	56.9	73.3	32.9	4.3	10.2	14.9	46.9
CLP1	"hClp1, HEAB"	ENSG00000172409	"Cleavage and polyadenylation factor I subunit 1"	Q92989	11	57648992-57661868	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"mRNA processing, tRNA processing"	"Kinase, Transferase"	"Disease mutation, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA057770	Supported		Supported	Nucleoplasm		NA	NA			Nucleoplasm		"HPA057770: AB_2683523"	"unprognostic (1.33e-1)"	"unprognostic (7.90e-2)"	"unprognostic (1.11e-3)"	"unprognostic (2.13e-2)"	"unprognostic (4.90e-2)"	"unprognostic (3.58e-1)"	"unprognostic (1.93e-3)"	"unprognostic (1.16e-1)"	"unprognostic (3.01e-1)"	"unprognostic (1.66e-2)"	"unprognostic (8.82e-2)"	"unprognostic (7.58e-2)"	"unprognostic (8.31e-3)"	"unprognostic (3.71e-2)"	"unprognostic (1.75e-1)"	"unprognostic (8.78e-2)"	"unprognostic (3.07e-1)"	10.8	11.7	7.0	11.2	8.8	23.5	9.6	7.2	10.9	8.5	9.3	5.6	7.6	9.0	12.0	10.0	13.6	10.1	6.2	8.1	6.0	4.5	9.9	12.8	8.7	9.9	6.5	5.1	7.3	11.8	7.2	6.8	17.3	6.1	10.5	9.2	5.6	10.3	8.1	16.7	11.8	11.7	11.2	5.0	15.4	11.5	11.3	6.5	15.4	11.8	10.8	13.2	8.8	6.9	16.2	19.0	23.7	19.1	12.8	20.9	11.6	14.2	14.2	14.3	15.1	15.8	10.5	13.6	14.0	15.5	21.1	17.8	13.1	12.9	23.5	17.1	11.6	16.2	17.5	19.7	22.6	23.6	15.9	11.5	12.8	10.2	14.9	12.0	19.5	15.5	11.7	16.1	17.9	12.8	8.6	19.1	11.6	20.6	8.2	17.0	10.1	14.1	22.2	21.9	15.5	15.0	15.1	23.0	25.0	11.3	10.1	7.8	15.2	11.9	12.3	19.1	15.7	22.7	15.0	13.3	11.4	15.4	19.4	11.2	13.2	16.7	25.7	12.4	10.5	12.1	23.7	19.1	19.9	17.6	16.0	20.9	16.2	15.8	17.8	19.0	14.1	18.2	16.6	22.3	12.8	15.7	11.0	16.0	11.6	7.0	8.8	7.2	10.9	6.0	4.5	6.5	5.1	6.1	6.5	8.9	6.1	4.7	9.0	17.2	2.9	2.2	5.1	5.3	9.1	0.0	5.9	13.9	8.3	10.4	21.7	6.7	4.5	0.0	10.2	12.3	8.0	3.5	8.1	4.0	9.5	4.8	2.4	4.9	4.1	1.7	5.2	6.1	8.5	17.2	3.2	3.6	8.3	5.9	8.1	9.0	3.0	6.5	11.3	6.7	13.4	12.7	11.3	7.5	4.7	8.2
CLPB	"ANKCLB, FLJ13152, HSP78, SKD3"	ENSG00000162129	"ClpB homolog, mitochondrial AAA ATPase chaperonin"	Q9H078	11	72285495-72434680	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		Hydrolase	"Cataract, Disease mutation, Epilepsy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	5	"testis: 87.9"	"Cell type enriched"	"Detected in many"	4	"Late spermatids: 4145.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"myeloid DC: 18.3"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039005, HPA039006, HPA064571"	Enhanced					NA	NA					"HPA039005: AB_2676305, HPA039006: AB_10672767, HPA064571: AB_2685290"	"unprognostic (9.36e-2)"	"unprognostic (1.06e-2)"	"unprognostic (2.51e-1)"	"unprognostic (1.23e-1)"	"unprognostic (2.99e-1)"	"unprognostic (2.05e-2)"	"unprognostic (8.22e-2)"	"unprognostic (8.37e-2)"	"unprognostic (2.61e-1)"	"unprognostic (1.02e-1)"	"unprognostic (1.01e-2)"	"unprognostic (1.18e-1)"	"prognostic favorable (8.36e-8)"	"unprognostic (9.29e-2)"	"unprognostic (1.25e-1)"	"unprognostic (5.83e-2)"	"unprognostic (3.28e-2)"	4.4	6.1	5.7	4.8	7.2	7.9	3.4	5.6	10.5	3.1	3.1	6.7	2.5	3.2	3.8	3.1	3.7	2.9	2.9	4.1	4.9	4.1	6.7	8.5	3.7	3.0	5.7	5.9	3.2	5.5	8.6	3.4	6.5	7.9	2.7	3.1	3.1	4.2	3.3	6.5	2.8	2.9	4.5	3.9	3.9	3.7	87.9	6.4	2.7	4.7	1.8	2.9	3.7	3.0	1.6	18.3	4.0	11.7	1.8	2.4	5.2	6.4	18.3	5.7	11.8	7.8	5.8	14.8	6.9	4.2	10.4	7.8	24.4	9.7	16.5	16.0	6.5	18.2	13.7	15.3	15.1	12.8	14.9	11.5	13.9	19.0	14.5	6.7	14.0	24.8	7.6	5.0	18.4	18.6	4.1	11.6	14.6	18.9	11.7	7.4	16.9	12.5	13.3	6.0	21.9	18.3	11.4	8.6	7.1	6.0	11.0	14.4	11.0	9.4	21.7	16.1	7.9	11.2	12.1	9.1	14.8	9.6	15.0	13.3	5.6	8.0	9.4	7.9	11.9	11.3	4.0	11.7	0.6	2.4	9.3	2.4	1.5	1.4	2.1	18.3	1.6	1.8	1.4	1.0	1.8	5.2	3.3	0.8	5.2	5.7	7.2	5.6	10.5	4.9	4.1	5.7	5.9	7.9	6.4	14.9	8.9	9.0	3.7	0.3	2.5	3.1	5.1	6.7	9.1	8.7	3.9	12.5	5.0	12.7	991.0	7.2	4.0	0.0	14.2	13.7	3.1	2.7	3.5	9.7	19.2	3.2	0.0	1.3	10.6	4145.4	23.3	12.7	1.7	7.2	1.0	1.3	10.6	0.8	17.3	17.4	5.7	12.9	2.1	35.9	21.3	1.0	27.7	2.5	1.9	5.1
CLPP		ENSG00000125656	"Caseinolytic mitochondrial matrix peptidase proteolytic subunit"	Q16740	19	6361452-6368910	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		"Hydrolase, Protease, Serine protease"	"Deafness, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA010649	Supported		Supported	Mitochondria		NA	NA			Mitochondria		"HPA010649: AB_1078538"	"unprognostic (2.28e-1)"	"unprognostic (7.14e-2)"	"unprognostic (2.82e-1)"	"unprognostic (4.34e-2)"	"unprognostic (2.17e-2)"	"unprognostic (1.15e-2)"	"unprognostic (6.17e-3)"	"unprognostic (7.43e-2)"	"unprognostic (2.76e-1)"	"unprognostic (1.31e-1)"	"prognostic favorable (6.50e-4)"	"unprognostic (1.21e-1)"	"unprognostic (5.65e-2)"	"unprognostic (6.97e-2)"	"unprognostic (1.83e-1)"	"unprognostic (1.03e-1)"	"unprognostic (5.86e-3)"	22.1	27.3	18.4	22.5	18.8	20.1	19.9	16.6	20.9	16.1	23.2	17.9	22.2	25.4	16.9	15.1	26.6	15.3	19.2	28.9	17.4	16.7	28.5	64.7	15.5	35.5	19.0	15.2	23.7	32.7	11.6	18.5	18.4	13.6	19.1	14.1	18.6	26.3	23.4	73.1	17.8	26.0	14.8	16.7	21.2	21.3	21.1	11.4	54.8	27.0	25.1	25.3	20.7	23.2	29.7	37.5	14.9	20.0	27.6	46.3	32.9	31.6	21.1	15.4	28.1	9.7	13.5	16.0	18.8	13.8	26.8	24.1	16.9	11.6	31.9	29.3	15.0	15.3	19.8	15.3	23.7	10.2	33.1	47.9	23.5	18.6	25.0	26.3	21.2	31.1	17.1	17.4	18.6	20.8	18.4	26.0	42.3	23.3	43.3	17.5	37.0	36.3	22.2	22.2	24.5	49.5	25.6	18.6	48.4	19.9	17.7	25.5	24.5	11.9	29.2	27.6	10.0	15.0	30.4	18.2	17.8	16.5	41.6	35.4	55.6	46.4	30.7	24.3	30.0	28.2	5.5	20.0	10.5	28.0	17.7	33.2	28.3	39.9	34.5	24.1	29.7	35.2	34.1	14.9	27.6	12.1	37.5	46.3	32.9	18.4	18.8	16.6	20.9	17.4	16.7	19.0	15.2	13.6	11.4	20.8	35.7	37.2	49.7	40.0	30.7	40.3	58.6	36.1	17.0	41.8	11.8	60.5	122.7	78.4	82.6	46.3	64.7	23.3	84.4	102.0	37.0	67.2	25.4	81.5	71.6	20.6	33.9	49.1	31.4	188.9	39.4	35.5	52.3	93.8	43.9	34.4	88.0	56.1	40.7	126.3	20.5	12.9	36.0	68.8	45.8	32.4	48.3	53.2	60.6	56.1
CLYBL	CLB	ENSG00000125246	"Citrate lyase beta like"	Q8N0X4	13	99606669-99897134	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"		"Hydrolase, Lyase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 57.7"	"Cell type enhanced"	"Detected in many"	10	"Distal tubular cells: 117.7;Hepatocytes: 75.9;Proximal tubular cells: 93.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"OE19: 29.2;SCLC-21H: 28.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039959, HPA040691"	Enhanced					NA	NA					"HPA039959: AB_10793857, HPA040691: AB_10794746"	"unprognostic (1.25e-2)"	"unprognostic (1.94e-1)"	"unprognostic (2.30e-3)"	"unprognostic (7.57e-3)"	"unprognostic (3.69e-1)"	"unprognostic (2.90e-2)"	"unprognostic (1.57e-3)"	"unprognostic (2.91e-1)"	"unprognostic (2.10e-1)"	"unprognostic (2.34e-1)"	"unprognostic (2.49e-2)"	"unprognostic (2.85e-1)"	"prognostic favorable (6.66e-16)"	"unprognostic (3.74e-2)"	"unprognostic (5.41e-2)"	"unprognostic (4.78e-2)"	"unprognostic (7.82e-2)"	4.2	11.6	6.2	10.4	9.4	2.6	6.0	6.7	6.4	4.6	11.2	3.8	4.8	13.6	5.2	7.6	6.4	4.7	8.3	12.3	5.1	6.3	35.0	57.7	4.7	9.6	7.9	8.6	3.5	15.0	6.1	5.7	2.2	12.5	4.2	12.3	8.9	8.7	5.5	22.2	5.7	12.5	8.6	4.5	5.5	4.8	10.7	4.3	4.6	7.0	13.3	8.2	4.9	4.4	11.0	7.5	1.2	6.7	9.2	16.7	5.5	0.2	1.2	9.0	4.0	4.2	3.9	1.9	0.4	0.8	0.7	1.4	0.2	6.6	1.5	2.6	0.5	1.7	2.0	0.8	1.5	1.0	7.9	1.3	9.9	2.4	6.1	2.9	5.3	0.7	2.1	4.4	0.1	3.4	0.9	1.1	8.3	1.4	5.2	0.8	2.2	2.4	7.4	5.8	29.2	1.8	3.1	0.3	3.6	8.8	0.6	28.8	4.4	1.8	2.0	1.7	3.3	4.3	6.9	0.1	0.4	1.0	0.7	1.4	12.1	2.4	0.3	6.1	7.8	1.2	1.2	3.3	0.3	7.5	6.7	9.0	10.9	13.3	10.6	6.7	11.0	10.3	12.1	0.5	9.2	3.2	7.5	16.7	5.5	6.2	9.4	6.7	6.4	5.1	6.3	7.9	8.6	12.5	4.3	6.0	5.3	4.4	8.9	4.8	1.8	30.3	20.4	4.0	11.4	14.0	2.0	11.2	117.7	9.6	1.2	6.3	18.6	0.0	7.0	2.5	2.6	3.4	5.8	75.9	6.9	0.0	1.2	6.2	7.5	4.0	2.0	7.7	15.1	4.6	8.4	4.5	3.8	14.0	3.9	93.6	4.3	0.0	9.2	3.1	9.1	5.5	6.2	6.9	16.4	5.1
CMA1		ENSG00000092009	"Chymase 1"	P23946	14	24505353-24508265	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"		"Hydrolase, Protease, Serine protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enriched"	"Detected in some"	15	"granulocytes: 52.0"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	4	"T-reg: 1.5"	"Lineage enriched"	"Detected in single"	4	"T-cells: 1.5"	"Cell line enhanced"	"Detected in some"		"HL-60: 1.7;SuSa: 2.5;U-937: 3.1"	"Low region specificity"	"Detected in single"							"CAB000363, HPA052634"	Enhanced		Supported	"Cytosol,Cytoplasmic bodies"	"Secreted to blood"	NA	NA	3000000		"Cytoplasmic bodies"	Cytosol	"CAB000363: AB_2083616, HPA052634: AB_2681892"	"unprognostic (1.37e-1)"	"unprognostic (2.27e-3)"	"unprognostic (2.04e-1)"			"unprognostic (7.07e-3)"	"unprognostic (1.48e-2)"	"unprognostic (1.19e-1)"	"unprognostic (5.79e-2)"	"unprognostic (2.21e-1)"	"unprognostic (8.91e-3)"	"unprognostic (4.19e-3)"	"unprognostic (1.29e-4)"	"unprognostic (2.52e-3)"	"unprognostic (7.78e-2)"	"unprognostic (7.37e-2)"	"unprognostic (4.98e-3)"	12.3	0.2	0.2	2.9	0.2	0.0	15.9	0.2	0.2	7.3	6.2	0.2	1.2	0.1	2.9	6.0	8.3	1.0	10.0	10.3	0.2	0.2	2.0	0.8	1.1	1.6	0.2	0.2	0.6	0.9	0.5	0.5	0.7	0.3	6.0	6.9	3.0	5.9	1.3	1.2	13.0	5.3	6.2	0.2	0.5	2.4	2.7	0.2	1.0	0.4	7.9	3.9	4.1	2.0	0.3	0.0	0.0	0.0	0.0	1.5	0.5	0.0	0.0	1.5	0.0	0.0	0.0	1.5	0.2	0.0	0.0	0.0	0.0	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.8	0.0	1.7	0.6	0.0	0.0	0.0	0.0	0.1	0.0	1.5	0.3	0.0	0.0	0.0	0.0	0.7	0.4	0.0	0.9	1.0	1.1	0.0	0.0	0.4	0.5	0.0	0.0	0.0	0.8	2.5	0.0	0.8	1.4	0.0	0.2	0.3	0.3	0.8	0.9	0.3	0.0	3.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.5	0.5	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.3	0.2	0.0	3.4	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	52.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0
CMAS		ENSG00000111726	"Cytidine monophosphate N-acetylneuraminic acid synthetase"	Q8NFW8	12	22046174-22065674	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Nucleotidyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	8	"Syncytiotrophoblasts: 445.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039905	Supported		Uncertain	Nucleoli,Cytosol		NA	NA			Cytosol	Nucleoli	"HPA039905: AB_10795237"	"unprognostic (5.54e-2)"	"unprognostic (4.10e-2)"	"unprognostic (4.25e-1)"	"unprognostic (5.39e-3)"	"unprognostic (1.94e-2)"	"unprognostic (3.99e-2)"	"unprognostic (2.30e-2)"	"unprognostic (4.17e-3)"	"unprognostic (1.53e-2)"	"unprognostic (1.01e-1)"	"unprognostic (4.44e-1)"	"unprognostic (7.53e-2)"	"prognostic unfavorable (7.19e-4)"	"unprognostic (2.27e-1)"	"unprognostic (1.91e-2)"	"unprognostic (3.65e-1)"	"unprognostic (2.03e-1)"	8.1	28.2	28.1	9.6	31.6	17.6	14.9	16.3	39.3	12.1	34.3	14.5	17.1	29.4	12.8	32.0	33.2	10.0	11.0	18.1	28.8	33.4	12.8	31.9	7.9	9.8	33.9	27.3	11.9	18.6	14.6	14.3	20.2	34.3	17.0	33.1	10.2	14.8	12.9	18.2	12.9	32.9	13.3	18.0	8.5	12.9	30.2	14.8	6.4	10.9	11.9	12.4	11.8	17.2	12.2	19.5	19.4	18.9	22.8	19.9	15.0	19.4	15.8	19.4	9.2	15.3	19.1	28.2	13.6	15.0	14.8	15.7	35.3	22.6	17.3	13.4	11.6	27.3	15.9	11.4	18.9	20.0	22.8	14.4	52.1	12.8	17.7	14.3	13.7	27.7	12.8	18.0	18.8	28.1	20.2	19.6	18.8	32.7	8.8	26.2	25.6	15.8	32.0	46.8	21.8	21.9	11.2	20.3	16.4	17.6	21.4	7.8	13.7	10.7	19.0	15.3	40.7	26.1	18.9	14.2	16.7	13.8	14.7	24.9	6.1	7.8	23.0	27.2	10.8	16.8	10.3	17.9	19.4	13.7	18.9	17.8	12.2	18.6	18.1	19.5	12.1	16.8	17.4	1.8	22.8	16.5	12.3	19.9	15.0	28.1	31.6	16.3	39.3	28.8	33.4	33.9	27.3	34.3	14.8	11.9	13.7	19.0	62.8	26.0	35.2	62.1	28.1	46.8	28.4	22.7	3.9	144.0	64.6	44.6	10.3	38.6	126.2	116.8	73.5	117.3	40.1	92.3	22.0	56.7	56.8	33.4	40.0	38.6	32.1	12.9	23.6	27.0	42.2	49.5	94.4	20.7	65.2	133.3	26.2	64.8	17.4	19.4	37.0	79.6	93.5	38.9	445.4	22.3	85.9	97.2
CMPK1	"CMPK, UMP-CMPK"	ENSG00000162368	"Cytidine/uridine monophosphate kinase 1"	P30085	1	47333797-47378839	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Pyrimidine biosynthesis"	"Kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA053730, HPA058604"	Approved		Supported	Nucleoplasm	"Intracellular and membrane"	NA	NA		2100000	Nucleoplasm		"HPA053730: AB_2682244, HPA058604: AB_2683773"	"unprognostic (2.16e-2)"	"unprognostic (1.16e-1)"	"unprognostic (9.39e-3)"	"unprognostic (1.18e-1)"	"unprognostic (1.09e-3)"	"unprognostic (1.50e-2)"	"unprognostic (1.59e-2)"	"unprognostic (9.88e-2)"	"unprognostic (5.80e-2)"	"unprognostic (2.90e-2)"	"unprognostic (1.71e-2)"	"unprognostic (2.61e-1)"	"unprognostic (1.28e-2)"	"unprognostic (2.58e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.02e-3)"	"unprognostic (7.36e-2)"	35.0	17.0	28.5	30.4	24.4	14.8	72.2	18.0	35.8	26.8	44.8	17.8	20.9	53.7	16.5	19.3	42.2	13.5	39.2	28.6	28.0	31.4	26.2	88.2	36.8	46.2	35.1	16.8	16.2	42.3	19.3	16.6	16.0	25.4	32.8	48.1	16.2	50.8	18.3	30.4	22.2	64.9	46.9	33.1	21.6	35.9	8.6	18.2	25.6	31.7	26.7	28.0	34.0	39.0	11.2	10.6	23.1	12.4	15.0	17.5	12.1	30.8	17.3	22.4	20.0	40.9	47.9	31.7	54.9	33.1	33.4	34.0	15.4	21.4	45.7	28.3	37.2	31.4	21.0	16.5	28.4	45.8	69.1	13.5	35.5	23.9	26.5	26.7	50.6	26.0	26.8	34.4	27.8	31.3	31.6	34.5	17.1	33.5	36.9	43.5	11.3	41.0	23.9	14.2	40.6	24.0	25.6	38.8	34.3	32.5	34.0	20.3	10.7	39.3	45.7	31.5	30.9	11.3	30.2	32.3	41.8	24.2	39.9	45.1	26.9	37.2	31.2	33.0	31.3	28.5	23.1	10.2	18.2	13.6	10.7	17.5	11.2	15.5	16.7	10.6	10.2	14.7	14.0	4.2	15.0	12.4	8.9	16.0	12.1	28.5	24.4	18.0	35.8	28.0	31.4	35.1	16.8	25.4	18.2	65.5	42.5	120.7	103.0	155.9	32.3	44.9	101.9	57.6	33.0	71.5	15.7	70.1	147.6	156.9	1.2	74.2	219.2	46.7	158.3	115.0	53.6	209.9	94.4	215.9	69.9	41.3	112.9	68.2	97.0	4.1	55.0	98.6	241.3	77.5	273.0	40.6	127.4	150.8	65.7	149.9	26.0	84.1	148.0	8.2	27.2	170.5	99.0	139.5	184.6	187.9
CMPK2	"NDK, TYKi, UMP-CMPK2"	ENSG00000134326	"Cytidine/uridine monophosphate kinase 2"	Q5EBM0	2	6840570-6866635	"Enzymes, Predicted intracellular proteins"	"Pyrimidine biosynthesis"	"Kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	4	"Erythroid cells: 70.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"BJ hTERT+ SV40 Large T+: 14.2;BJ hTERT+ SV40 Large T+ RasG12V: 12.9;HEL: 20.1;MOLT-4: 11.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041430	Approved		Supported	Nucleoplasm,Mitochondria		NA	NA			Mitochondria	Nucleoplasm	"HPA041430: AB_10796674"	"unprognostic (2.37e-1)"	"unprognostic (6.07e-2)"	"unprognostic (5.71e-2)"	"prognostic unfavorable (4.71e-4)"	"unprognostic (1.82e-1)"	"unprognostic (5.08e-2)"	"unprognostic (3.80e-2)"	"unprognostic (8.93e-2)"	"unprognostic (6.63e-2)"	"unprognostic (4.54e-3)"	"unprognostic (7.39e-3)"	"unprognostic (1.43e-1)"	"unprognostic (1.09e-3)"	"unprognostic (1.28e-1)"	"unprognostic (1.77e-2)"	"unprognostic (7.69e-2)"	"unprognostic (4.32e-2)"	8.8	3.8	3.0	6.8	8.1	14.5	4.2	0.9	5.0	2.7	4.2	4.0	1.3	5.0	2.5	6.4	1.8	2.3	3.4	3.7	3.3	3.9	4.0	3.1	17.9	13.4	3.2	5.7	1.3	3.7	2.9	3.0	4.7	3.6	2.1	2.2	4.7	20.8	4.3	3.0	1.2	6.1	3.1	3.8	7.9	7.4	9.2	0.4	8.8	3.1	1.6	2.6	2.7	1.6	1.4	1.9	7.8	6.4	0.9	0.7	1.2	0.2	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.2	14.2	12.9	0.0	1.4	3.1	0.8	0.0	3.7	0.2	0.0	0.0	0.0	0.3	0.2	20.1	0.0	0.0	0.0	0.7	1.4	0.0	0.0	0.1	0.0	0.0	0.0	2.0	4.9	0.1	0.0	0.1	11.0	3.7	0.3	0.0	1.1	3.5	0.0	0.0	0.0	0.4	0.3	0.5	0.2	0.0	1.7	0.0	0.0	1.3	0.0	0.0	0.2	0.0	0.0	3.3	0.4	0.0	0.0	3.7	0.9	5.5	2.8	7.8	0.7	6.4	0.4	1.4	0.5	0.4	1.9	0.2	0.5	0.5	1.8	0.9	3.2	0.1	0.6	1.2	3.0	8.1	0.9	5.0	3.3	3.9	3.2	5.7	3.6	0.4	3.0	6.9	2.7	0.8	0.3	1.6	1.4	0.0	4.0	0.0	1.8	0.0	2.0	1.7	2.4	2.5	4.7	5.3	70.0	5.8	2.4	1.9	0.7	2.3	1.3	15.9	0.0	6.9	7.4	6.7	1.1	1.4	5.1	0.0	5.4	1.7	4.6	4.1	1.9	5.3	0.6	0.2	0.0	2.0	0.1	4.1	0.4	0.7	4.3	0.9	1.6
CMTR1	"FTSJD2, ISG95, KIAA0082, MTr1"	ENSG00000137200	"Cap methyltransferase 1"	Q8N1G2	6	37433219-37482827	"Enzymes, Predicted intracellular proteins"	"mRNA capping, mRNA processing"	"Methyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"U-698: 77.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029954, HPA029979, HPA029980"	Enhanced		Enhanced	Nucleoplasm,Vesicles		NA	NA			Nucleoplasm	Vesicles	"HPA029954: AB_10670558, HPA029979: AB_10671363, HPA029980: AB_10671094"	"unprognostic (1.33e-1)"	"unprognostic (2.12e-2)"	"unprognostic (6.43e-2)"	"prognostic unfavorable (1.73e-5)"	"unprognostic (1.00e-1)"	"unprognostic (3.72e-1)"	"unprognostic (1.68e-2)"	"unprognostic (6.43e-3)"	"unprognostic (2.95e-2)"	"unprognostic (9.17e-2)"	"unprognostic (5.24e-3)"	"unprognostic (1.50e-3)"	"unprognostic (3.00e-3)"	"unprognostic (3.27e-2)"	"unprognostic (9.72e-2)"	"unprognostic (2.54e-1)"	"unprognostic (1.14e-2)"	14.4	17.4	23.1	17.3	17.7	22.4	14.6	25.0	25.0	14.5	18.0	15.5	21.3	15.0	19.5	19.4	12.6	16.9	15.0	18.8	17.6	16.1	13.9	16.6	15.2	19.2	16.0	22.7	22.6	18.4	24.4	20.2	20.6	16.9	16.3	13.1	17.1	17.6	17.9	28.9	16.6	16.5	17.6	12.5	21.7	15.9	63.9	17.8	18.4	15.7	14.1	20.7	16.2	14.8	11.1	9.8	8.1	13.2	9.7	11.5	7.8	7.0	6.7	9.7	15.8	11.0	10.1	11.8	8.4	11.7	21.5	24.1	10.1	4.7	14.7	9.6	12.4	20.2	7.9	12.3	8.7	16.5	10.1	10.9	8.1	7.8	11.2	8.5	11.6	5.5	8.7	6.5	11.8	8.5	11.3	10.0	13.7	17.9	10.8	11.2	11.5	14.7	10.4	4.8	4.7	6.4	11.7	11.5	8.4	6.9	8.6	10.7	8.1	9.5	7.3	12.1	7.3	12.4	9.0	9.2	12.9	9.7	5.1	9.4	12.4	6.4	77.6	5.1	12.2	14.1	8.1	10.2	6.4	10.1	13.2	8.5	11.1	8.9	10.7	9.8	8.1	9.9	8.0	6.6	9.7	9.9	8.2	11.5	7.8	23.1	17.7	25.0	25.0	17.6	16.1	16.0	22.7	16.9	17.8	8.9	8.6	7.3	3.4	3.2	13.3	7.9	7.6	13.4	15.9	7.0	31.4	14.0	0.0	4.0	20.1	9.0	4.2	23.3	7.4	6.2	6.4	3.4	3.5	7.4	6.6	11.1	8.1	9.2	5.9	8.3	7.2	7.5	3.3	13.6	7.5	10.1	6.4	3.5	6.3	3.5	10.9	6.5	4.9	14.4	9.9	4.1	17.4	8.7	5.4	2.8
CMTR2	"AFT, FLJ11171, FTSJD1, MTr2"	ENSG00000180917	"Cap methyltransferase 2"	Q8IYT2	16	71281389-71289715	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"mRNA capping, mRNA processing"	"Methyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Early spermatids: 75.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041700, HPA048265"	Uncertain		Approved	"Nuclear speckles,Cell Junctions"		NA	NA			"Cell Junctions"	"Nuclear speckles"	"HPA041700: AB_2677623, HPA048265: AB_2680334"	"unprognostic (1.27e-1)"	"unprognostic (2.49e-2)"	"unprognostic (2.94e-3)"	"unprognostic (1.43e-1)"	"unprognostic (6.30e-2)"	"unprognostic (3.82e-2)"	"unprognostic (1.93e-3)"	"unprognostic (2.86e-2)"	"unprognostic (7.93e-2)"	"unprognostic (3.41e-1)"	"unprognostic (1.85e-2)"	"unprognostic (7.39e-2)"	"prognostic favorable (4.97e-5)"	"unprognostic (9.55e-2)"	"unprognostic (5.99e-2)"	"unprognostic (1.54e-1)"	"unprognostic (5.34e-2)"	10.4	14.9	7.1	11.7	9.0	5.4	15.9	5.3	9.1	10.6	13.4	11.5	15.6	14.1	12.5	16.4	20.4	8.8	11.0	9.0	8.5	6.9	13.5	18.2	10.7	14.7	12.4	3.4	16.2	12.2	12.7	24.3	17.4	9.0	11.9	10.5	10.6	13.6	14.1	8.4	9.9	16.1	9.4	9.5	17.5	8.9	16.0	9.3	20.9	14.3	7.6	15.4	9.6	14.2	11.2	10.3	11.0	8.0	13.1	11.2	8.6	11.5	8.1	11.6	11.5	13.1	11.4	6.5	9.4	9.2	10.7	10.3	4.8	16.0	6.2	11.4	7.4	12.0	11.4	7.1	8.5	13.1	6.5	4.8	17.2	4.7	6.0	16.3	10.2	23.7	8.2	16.2	7.8	10.6	7.8	12.1	12.3	7.5	4.7	17.7	10.3	12.3	17.2	7.2	9.6	4.8	16.6	7.4	13.5	13.2	7.8	7.7	8.6	10.6	9.3	10.4	6.7	13.9	7.4	11.6	12.1	11.2	12.3	7.3	8.7	9.0	11.1	9.1	10.4	10.4	11.0	7.2	7.1	9.8	8.0	11.2	11.2	9.2	10.3	10.3	10.2	10.5	10.3	0.4	13.1	5.2	3.6	8.0	8.6	7.1	9.0	5.3	9.1	8.5	6.9	12.4	3.4	9.0	9.3	3.0	10.2	29.3	13.2	12.6	20.9	6.7	10.2	0.0	6.8	15.7	29.5	18.6	6.6	10.2	75.3	15.7	25.5	0.0	8.3	10.6	10.4	12.0	8.1	23.6	13.9	14.3	17.9	18.4	15.4	21.7	15.5	13.0	1.7	8.2	17.2	17.1	10.3	15.2	11.7	12.9	27.8	6.5	7.4	23.0	11.7	21.2	22.1	25.4	15.5	15.2
CNDP1	"CN1, CPGL2, HsT2308, MGC10825"	ENSG00000150656	"Carnosine dipeptidase 1"	Q96KN2	18	74534440-74587212	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"		"Carboxypeptidase, Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	9	"brain: 60.3;liver: 41.4"	"Cell type enhanced"	"Detected in some"	24	"Early spermatids: 6.1;Hepatocytes: 26.1;Proximal tubular cells: 14.6"	"Group enriched"	"Detected in some"	10	"glioma: 4.4;liver cancer: 1.0;melanoma: 1.3"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enriched"	"Detected in single"	69	"U-266/84: 42.2"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"HPA008933, HPA073283"	Enhanced				"Secreted in brain"	NA	NA		1900000000			"HPA008933: AB_1847033, HPA073283: "	"unprognostic (7.43e-3)"	"unprognostic (6.00e-2)"	"unprognostic (8.55e-3)"	"unprognostic (3.93e-1)"	"unprognostic (1.32e-1)"	"unprognostic (2.17e-2)"	"unprognostic (8.04e-3)"	"unprognostic (1.12e-2)"	"unprognostic (2.81e-1)"	"unprognostic (1.16e-1)"	"unprognostic (1.16e-1)"	"unprognostic (1.66e-1)"	"unprognostic (6.90e-3)"	"unprognostic (1.14e-1)"	"unprognostic (3.30e-2)"	"unprognostic (1.33e-1)"	"unprognostic (1.28e-1)"	1.1	1.2	14.9	1.2	28.2	1.3	1.1	4.5	60.3	1.1	1.1	54.9	0.0	5.7	1.1	2.1	1.1	1.1	1.3	1.1	28.9	15.1	1.9	41.4	1.1	1.2	44.1	12.9	1.1	1.2	1.1	0.1	1.1	50.0	1.2	1.1	0.5	1.1	1.3	2.2	1.1	1.9	1.1	51.1	1.1	1.2	1.4	28.8	0.0	1.3	0.0	1.1	1.1	0.0	0.7	0.7	1.9	0.5	1.0	0.4	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	42.2	0.0	0.0	0.0	0.0	1.3	0.5	0.4	0.4	0.2	0.2	0.3	0.3	0.2	0.1	0.7	0.4	0.4	1.9	1.0	0.2	0.7	0.2	0.2	14.9	28.2	4.5	22.5	28.9	15.1	44.1	12.9	50.0	28.8	0.0	0.0	0.0	0.2	0.1	0.6	0.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	6.1	0.0	0.0	0.0	0.2	0.0	0.4	0.4	0.0	26.1	0.1	0.0	0.0	0.6	0.6	1.7	0.0	0.0	0.0	0.0	0.0	0.8	0.2	0.0	0.0	14.6	0.6	0.0	0.0	0.9	0.5	0.3	0.0	0.5	0.0	0.2
CNDP2	"CN2, CPGL, FLJ10830, HsT2298, PEPA"	ENSG00000133313	"Carnosine dipeptidase 2"	Q96KP4	18	74495816-74523454	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Carboxypeptidase, Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Proximal tubular cells: 371.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"Karpas-707: 76.6;RPMI-8226: 98.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB026196, HPA036898, HPA036899"	Enhanced		Enhanced	Nucleoplasm,Cytosol		NA	NA		2400000	"Nucleoplasm, Cytosol"		"CAB026196: , HPA036898: AB_2675370, HPA036899: AB_2675371"	"unprognostic (2.81e-2)"	"unprognostic (9.96e-2)"	"unprognostic (3.28e-1)"	"unprognostic (1.19e-3)"	"unprognostic (2.57e-2)"	"unprognostic (5.06e-2)"	"unprognostic (2.84e-2)"	"unprognostic (5.35e-2)"	"unprognostic (1.49e-1)"	"unprognostic (9.31e-2)"	"unprognostic (1.56e-3)"	"unprognostic (1.15e-1)"	"prognostic favorable (3.50e-6)"	"unprognostic (2.37e-3)"	"unprognostic (4.65e-3)"	"unprognostic (1.51e-1)"	"unprognostic (1.34e-1)"	19.0	11.5	31.0	19.1	36.0	6.1	16.9	10.4	33.0	39.4	37.6	45.2	27.0	51.3	12.5	35.3	20.4	38.9	25.9	11.6	31.1	26.4	89.0	66.4	22.1	23.0	36.1	24.1	11.4	27.6	15.7	13.7	28.8	27.2	34.7	22.2	14.1	16.9	32.7	7.5	11.8	71.1	10.4	39.4	39.2	27.2	6.5	32.5	10.9	43.9	11.6	21.4	28.4	12.0	29.6	49.0	12.5	44.4	31.4	23.9	30.3	10.2	13.9	10.1	9.5	12.3	7.3	42.4	10.8	10.2	14.8	14.8	8.0	11.1	13.0	13.7	11.7	11.6	15.6	15.3	20.5	10.6	19.4	6.0	12.9	7.0	12.8	18.0	25.2	20.1	11.0	15.8	12.8	23.1	8.4	12.9	15.6	13.6	76.6	9.8	11.5	13.4	12.1	15.2	6.8	8.3	14.6	11.6	98.6	58.2	43.1	11.0	5.8	8.4	60.2	14.4	25.2	25.2	10.4	13.5	15.9	13.5	3.5	7.2	14.3	58.7	17.3	10.8	18.4	13.2	7.8	30.0	12.5	21.8	44.4	23.8	28.9	17.6	20.3	49.0	29.6	19.1	20.7	4.4	31.4	43.1	43.0	23.9	30.3	31.0	36.0	10.4	33.0	31.1	26.4	36.1	24.1	27.2	32.5	68.5	54.2	53.8	35.3	8.1	33.7	22.9	91.7	60.2	38.7	113.4	15.7	128.9	159.2	142.6	2.2	45.9	105.2	0.0	136.1	106.3	20.6	56.1	11.5	102.8	184.6	41.3	62.7	36.8	86.2	3.2	17.3	82.3	16.9	112.8	71.7	80.3	99.7	74.1	15.6	371.2	24.6	12.9	15.9	4.8	7.3	8.4	91.2	36.3	82.5	47.4
CNOT4	"CLONE243, NOT4, NOT4H"	ENSG00000080802	"CCR4-NOT transcription complex subunit 4"	O95628	7	135361795-135510127	"Enzymes, Predicted intracellular proteins, Transcription factors"	"Ubl conjugation pathway"	"RNA-binding, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA005737	Approved					NA	NA					"HPA005737: AB_1078544"	"unprognostic (9.11e-2)"	"unprognostic (2.12e-1)"	"unprognostic (1.30e-1)"	"unprognostic (5.47e-2)"	"unprognostic (3.61e-1)"	"unprognostic (1.64e-2)"	"prognostic unfavorable (1.19e-4)"	"unprognostic (2.82e-2)"	"unprognostic (4.18e-2)"	"prognostic favorable (1.61e-4)"	"unprognostic (9.08e-2)"	"unprognostic (1.00e-2)"	"prognostic favorable (7.67e-6)"	"unprognostic (1.01e-1)"	"unprognostic (6.31e-2)"	"unprognostic (2.23e-1)"	"unprognostic (9.33e-2)"	19.4	14.3	19.8	12.0	23.3	11.1	13.8	31.6	24.6	18.7	15.0	21.9	7.0	11.3	21.1	15.2	15.8	16.7	13.8	18.7	19.2	18.0	16.0	16.0	13.6	14.4	18.5	15.1	24.7	14.1	22.6	28.6	16.1	21.1	15.3	13.4	16.4	16.8	15.6	35.0	15.6	12.3	17.1	22.6	13.7	12.3	25.8	18.5	18.5	21.1	12.3	18.1	16.2	15.7	12.0	10.0	21.5	12.7	16.7	15.5	9.1	13.6	12.9	13.3	17.7	22.1	17.6	9.6	15.4	16.8	13.1	16.4	11.1	14.1	13.7	13.4	13.9	18.6	13.0	16.7	11.6	18.8	15.4	12.9	11.3	11.2	9.9	12.3	12.6	13.5	13.5	14.9	16.8	10.5	15.1	13.4	9.8	19.6	10.9	19.2	17.1	17.3	20.5	17.4	12.6	11.0	11.3	13.1	14.8	15.5	12.6	14.1	16.5	17.9	20.2	11.2	12.9	12.4	14.3	18.1	16.0	9.5	14.8	16.6	16.8	15.8	19.5	16.1	14.9	21.2	21.5	11.5	14.9	14.1	11.5	15.5	11.0	12.0	11.7	10.0	12.0	13.1	12.1	10.7	16.7	12.7	8.0	10.1	9.1	19.8	23.3	31.6	24.6	19.2	18.0	18.5	15.1	21.1	18.5	20.8	41.3	39.1	72.1	60.1	49.7	39.2	25.5	29.4	34.2	34.9	100.1	25.2	59.7	27.4	14.2	43.4	27.3	0.0	18.1	19.0	52.1	62.8	60.2	23.3	22.5	52.4	39.0	36.2	21.4	15.3	60.4	32.6	40.5	50.5	23.7	70.1	25.3	25.9	65.0	41.4	66.1	19.4	57.9	120.0	69.4	66.1	37.3	43.1	24.7	86.4
CNOT6	"CCR4, Ccr4a, KIAA1194"	ENSG00000113300	"CCR4-NOT transcription complex subunit 6"	Q9ULM6	5	180494412-180578405	"Enzymes, Predicted intracellular proteins"	"RNA-mediated gene silencing, Transcription, Transcription regulation, Translation regulation"	"Activator, Exonuclease, Hydrolase, Nuclease, RNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Spermatogonia: 56.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044568	Approved		Approved	Cytosol		NA	NA			Cytosol		"HPA044568: AB_10797257"	"unprognostic (9.41e-3)"	"unprognostic (1.40e-1)"	"unprognostic (2.03e-3)"	"unprognostic (2.55e-1)"	"unprognostic (1.41e-1)"	"unprognostic (2.59e-1)"	"prognostic unfavorable (3.61e-7)"	"unprognostic (1.31e-1)"	"unprognostic (1.10e-2)"	"unprognostic (1.85e-2)"	"unprognostic (2.50e-2)"	"unprognostic (2.35e-2)"	"unprognostic (1.79e-2)"	"unprognostic (1.25e-1)"	"unprognostic (1.26e-1)"	"unprognostic (4.03e-2)"	"unprognostic (3.57e-2)"	10.2	10.1	19.2	15.4	20.2	14.4	13.3	43.9	18.7	12.0	16.4	11.7	9.7	16.2	13.1	12.4	19.6	13.3	12.7	13.0	15.9	11.1	14.1	8.6	13.0	14.3	12.3	14.0	14.8	10.3	13.4	12.7	17.6	12.9	13.9	16.2	14.3	13.4	10.9	8.3	14.4	20.6	13.4	12.3	17.0	13.7	17.6	14.9	25.1	12.6	10.0	18.4	16.9	24.5	2.2	2.5	3.4	5.8	2.1	4.5	1.7	11.1	13.4	27.6	22.0	4.6	5.3	28.5	8.1	5.5	10.9	13.0	16.3	16.4	11.8	12.5	5.3	15.1	11.7	23.0	27.2	12.8	34.5	11.5	12.8	18.1	10.5	6.8	14.9	9.4	4.4	13.2	8.0	17.0	10.2	13.2	13.9	13.6	11.4	10.0	22.9	18.9	9.0	8.1	11.2	6.4	17.5	13.9	8.4	12.0	22.1	20.2	17.1	13.8	18.5	11.8	14.1	23.1	15.1	14.3	11.6	13.4	8.4	14.4	7.4	13.3	12.5	11.0	20.5	9.5	1.5	2.6	3.4	3.8	4.1	4.0	2.0	3.3	2.3	2.4	2.2	4.5	4.4	2.2	2.1	5.8	2.5	2.3	1.7	19.2	20.2	43.9	18.7	15.9	11.1	12.3	14.0	12.9	14.9	26.8	12.0	6.7	5.5	19.3	18.0	9.6	10.2	8.1	6.8	10.4	21.6	7.9	1.7	10.2	5.2	11.9	11.1	0.0	7.8	9.9	10.4	14.0	2.3	5.7	10.6	17.5	13.9	14.7	16.7	7.5	12.0	13.1	10.1	8.2	14.3	13.1	12.9	5.8	17.7	11.8	15.3	25.8	7.3	39.4	56.2	19.4	9.6	12.9	15.1	12.9
CNOT6L	"Ccr4b, DKFZp434K098"	ENSG00000138767	"CCR4-NOT transcription complex subunit 6 like"	Q96LI5	4	77713387-77819615	"Enzymes, Predicted intracellular proteins"	"mRNA processing, RNA-mediated gene silencing, Transcription, Transcription regulation, Translation regulation"	"Exonuclease, Hydrolase, Nuclease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 51.3"	"Cell type enhanced"	"Detected in many"	5	"T-cells: 121.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042688	Uncertain		Supported	Cytosol		NA	NA			Cytosol		"HPA042688: AB_10794384"	"unprognostic (3.91e-1)"	"unprognostic (1.95e-2)"	"unprognostic (7.91e-3)"	"unprognostic (4.10e-2)"	"unprognostic (2.56e-1)"	"unprognostic (3.72e-2)"	"unprognostic (8.79e-2)"	"unprognostic (1.09e-1)"	"unprognostic (5.06e-2)"	"unprognostic (6.86e-2)"	"unprognostic (3.55e-2)"	"unprognostic (1.50e-1)"	"prognostic favorable (1.69e-4)"	"unprognostic (4.51e-2)"	"unprognostic (7.95e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.91e-3)"	13.6	7.8	8.6	21.5	8.2	15.3	11.0	11.1	9.2	7.8	7.3	7.0	4.6	7.5	11.4	6.3	10.2	7.1	8.3	7.5	6.0	5.7	7.7	10.8	12.7	19.2	7.6	7.3	8.8	10.8	14.6	10.0	12.3	6.7	8.4	8.9	10.3	9.9	7.4	9.1	12.2	11.5	8.4	6.9	23.4	7.9	7.3	5.6	51.3	9.1	6.2	21.1	10.7	10.3	7.5	6.1	20.2	9.3	7.4	10.0	4.4	8.8	5.7	7.2	4.8	8.5	7.4	7.1	7.0	9.3	6.3	8.6	2.2	9.9	15.3	8.9	9.8	5.0	5.7	9.3	9.7	8.5	15.3	5.2	14.3	7.9	6.4	5.4	14.2	12.6	4.8	12.6	7.1	13.0	6.0	20.0	11.1	11.9	20.5	7.3	6.0	26.2	7.2	3.3	7.0	1.8	6.5	20.4	10.9	7.2	10.0	8.9	4.3	12.1	11.1	4.9	8.8	3.5	7.3	21.7	6.1	6.8	11.5	3.8	26.3	11.2	19.0	6.6	6.2	4.5	20.2	4.7	10.2	10.0	7.0	10.0	5.3	7.5	7.8	4.5	7.5	7.3	8.5	6.7	7.4	9.3	6.1	6.0	4.4	8.6	8.2	11.1	9.2	6.0	5.7	7.6	7.3	6.7	5.6	20.8	16.0	29.6	11.9	51.4	38.1	14.5	22.9	14.7	28.4	34.9	37.3	22.8	51.4	5.9	3.4	42.7	16.9	0.0	10.5	7.4	21.1	30.3	36.9	27.0	14.9	30.2	25.2	41.7	40.3	2.8	17.3	33.5	23.6	14.4	31.3	20.1	8.9	14.0	12.0	17.0	40.7	32.3	31.7	19.1	30.9	57.7	20.4	121.5	23.0	16.3
CNOT7	CAF1	ENSG00000198791	"CCR4-NOT transcription complex subunit 7"	Q9UIV1	8	17224964-17246878	"Enzymes, Predicted intracellular proteins"	"RNA-mediated gene silencing, Transcription, Transcription regulation, Translation regulation"	"Exonuclease, Hydrolase, Nuclease, Repressor, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA069543			Supported	"Nuclear bodies"		NA	NA			"Nuclear bodies"		"HPA069543: AB_2686148"	"unprognostic (1.55e-1)"	"unprognostic (4.49e-2)"	"prognostic favorable (4.99e-4)"	"unprognostic (4.61e-2)"	"unprognostic (8.45e-2)"	"unprognostic (3.10e-2)"	"unprognostic (1.44e-3)"	"unprognostic (4.54e-2)"	"unprognostic (6.83e-2)"	"unprognostic (4.09e-3)"	"unprognostic (2.51e-1)"	"unprognostic (1.74e-1)"	"unprognostic (3.49e-2)"	"unprognostic (1.72e-1)"	"unprognostic (4.51e-1)"	"unprognostic (2.24e-1)"	"unprognostic (2.52e-1)"	18.3	25.8	28.7	23.8	37.0	24.2	23.3	34.6	31.8	17.5	22.8	15.9	19.8	20.8	22.2	26.1	24.5	20.6	19.8	21.4	22.3	29.3	28.2	36.8	17.9	32.0	22.3	22.5	25.9	28.0	40.4	29.7	25.0	23.1	19.3	24.6	18.2	32.3	22.4	43.2	18.5	22.7	20.6	19.8	27.6	19.0	26.9	22.4	60.6	33.6	19.6	34.3	25.5	19.4	57.8	49.9	46.6	50.7	45.2	67.0	52.2	20.6	25.6	38.5	28.6	16.3	17.2	26.6	26.7	22.8	30.9	27.5	29.9	16.6	28.6	29.4	23.3	49.8	16.6	40.5	33.6	45.3	11.8	19.4	37.5	19.7	32.1	20.9	25.2	23.2	16.3	27.9	26.3	28.3	28.7	36.8	37.9	31.3	31.8	31.1	16.1	61.8	23.5	42.5	38.9	19.6	33.7	28.7	21.4	26.9	45.5	48.7	32.6	18.8	16.7	30.3	33.2	20.1	21.4	24.6	23.2	32.9	25.8	29.8	16.6	52.7	50.0	21.7	24.0	22.8	46.3	43.3	46.6	38.1	50.7	45.3	57.8	52.9	45.2	49.9	57.1	67.0	52.7	37.9	45.2	43.5	44.9	57.5	52.2	28.7	37.0	34.6	31.8	22.3	29.3	22.3	22.5	23.1	22.4	29.8	32.3	80.8	57.6	80.7	97.7	49.1	53.5	56.2	22.7	59.3	88.4	76.2	82.9	70.4	44.6	51.8	30.7	0.0	63.0	95.5	40.9	72.1	42.8	61.4	61.1	23.8	90.3	67.5	70.8	26.1	37.7	46.6	25.3	52.3	67.6	50.4	66.7	77.0	38.2	86.0	166.3	77.6	44.5	77.2	96.3	75.2	71.5	61.0	73.1	64.8
CNOT8	"CAF1, CALIF, hCAF1, POP2"	ENSG00000155508	"CCR4-NOT transcription complex subunit 8"	Q9UFF9	5	154857553-154876793	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"RNA-mediated gene silencing, Transcription, Transcription regulation, Translation regulation"	"Exonuclease, Hydrolase, Nuclease, Repressor, RNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA051398	Approved					NA	NA					"HPA051398: AB_2681468"	"unprognostic (2.51e-1)"	"unprognostic (4.26e-1)"	"unprognostic (1.69e-2)"	"unprognostic (1.48e-1)"	"unprognostic (1.68e-2)"	"unprognostic (1.13e-1)"	"prognostic unfavorable (5.33e-4)"	"unprognostic (1.19e-1)"	"unprognostic (3.62e-2)"	"unprognostic (2.35e-2)"	"unprognostic (1.79e-2)"	"unprognostic (2.80e-1)"	"unprognostic (3.32e-3)"	"unprognostic (2.19e-1)"	"unprognostic (1.84e-1)"	"unprognostic (3.66e-2)"	"prognostic favorable (6.41e-4)"	40.5	28.0	23.6	20.9	23.8	60.1	30.3	20.3	29.2	26.0	23.5	21.3	19.5	19.0	21.1	22.5	18.2	18.2	17.5	17.2	23.2	16.1	17.1	16.6	33.5	30.5	33.0	18.3	20.0	16.2	20.1	17.8	23.9	24.4	17.4	27.5	16.5	24.1	17.5	14.3	28.0	23.7	23.2	25.9	30.7	19.1	24.4	26.2	41.5	36.0	11.3	29.5	24.6	22.8	20.5	33.4	65.4	31.9	20.9	31.5	36.6	12.1	14.1	24.5	26.9	23.4	21.4	18.6	18.8	20.9	20.7	32.2	17.9	27.2	21.4	23.7	16.1	16.6	13.4	16.8	23.3	23.6	10.6	17.4	17.9	21.8	15.9	14.9	41.1	33.3	14.5	20.5	18.4	16.0	21.6	25.4	30.8	15.8	16.2	21.6	14.6	36.3	43.0	13.2	14.2	8.3	30.5	20.7	22.2	16.4	16.9	19.2	28.6	25.2	20.3	23.3	14.3	19.0	33.8	19.7	22.0	13.8	12.0	12.3	15.7	20.1	32.9	15.5	32.8	13.7	55.0	31.9	65.4	19.3	22.6	21.4	20.5	24.0	23.1	33.4	20.4	31.5	22.7	32.2	20.9	17.7	18.0	26.0	36.6	23.6	23.8	20.3	29.2	23.2	16.1	33.0	18.3	24.4	26.2	17.9	32.0	20.1	13.9	28.3	12.5	11.0	7.6	8.1	20.5	15.7	0.0	28.2	14.9	20.2	92.9	31.9	15.8	0.0	17.6	33.4	37.2	20.2	17.3	11.9	24.3	17.5	26.5	27.6	48.1	44.7	42.0	26.9	27.0	40.5	33.2	11.3	24.2	14.0	35.7	9.9	7.4	6.5	19.3	30.2	21.5	36.5	19.1	38.3	25.5	21.4
CNP		ENSG00000173786	"2',3'-cyclic nucleotide 3' phosphodiesterase"	P09543	17	41966741-41977731	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Hydrolase, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	4	"brain: 211.7"	"Cell type enhanced"	"Detected in many"	4	"Distal tubular cells: 106.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"plasmacytoid DC: 49.1"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002672, HPA023266, HPA023278, HPA023280, HPA023338"	Enhanced	Supported	Supported	"Plasma membrane"		NA	NA		730000	"Plasma membrane"		"CAB002672: , HPA023266: AB_1847058, HPA023278: AB_1847060, HPA023280: AB_1847061, HPA023338: AB_1847062"	"unprognostic (2.17e-1)"	"unprognostic (4.48e-2)"	"unprognostic (3.85e-3)"	"unprognostic (1.41e-1)"	"unprognostic (3.09e-1)"	"unprognostic (9.71e-2)"	"unprognostic (2.58e-3)"	"unprognostic (2.08e-1)"	"unprognostic (2.23e-1)"	"unprognostic (1.62e-1)"	"unprognostic (5.76e-3)"	"unprognostic (1.87e-1)"	"unprognostic (2.99e-3)"	"unprognostic (1.60e-1)"	"unprognostic (1.55e-1)"	"unprognostic (8.86e-2)"	"unprognostic (1.10e-3)"	9.1	8.9	51.4	9.5	72.8	6.7	8.1	13.4	125.3	10.3	7.5	211.7	2.3	7.1	8.0	12.7	15.0	9.3	10.8	7.6	78.4	40.7	14.7	9.6	6.7	10.5	86.7	49.0	11.2	9.2	5.8	4.4	7.8	66.7	11.7	6.4	3.6	15.1	13.2	7.6	11.1	6.4	10.1	160.2	7.1	7.4	4.6	63.5	2.1	7.2	2.2	11.2	9.8	5.7	9.9	49.1	7.3	13.1	7.3	7.5	9.1	13.9	23.9	22.7	27.9	19.4	18.3	9.7	17.5	26.9	45.5	51.4	18.7	12.8	14.9	14.1	22.8	23.4	24.1	15.3	11.6	15.8	14.7	19.3	14.4	16.4	32.4	20.9	14.0	13.1	30.1	8.3	24.9	6.1	16.5	20.7	14.9	10.2	12.1	15.8	8.9	35.9	12.7	5.3	7.6	17.0	22.4	33.3	14.5	12.1	14.3	13.3	18.0	22.2	33.4	38.9	11.6	14.9	21.0	20.8	17.7	19.5	24.1	20.6	13.7	15.6	11.8	17.6	10.9	69.2	4.9	12.1	7.3	7.5	13.1	5.9	9.9	6.5	6.0	11.1	7.0	5.9	6.9	2.6	7.3	10.3	49.1	7.2	9.1	51.4	72.8	13.4	93.8	78.4	40.7	86.7	49.0	66.7	63.5	14.9	10.1	20.1	16.4	14.8	20.3	11.3	20.4	13.4	22.7	33.2	5.9	26.2	106.1	40.0	1.0	17.9	18.3	0.0	37.1	41.6	27.2	18.5	9.2	25.9	34.6	47.7	18.9	18.4	13.2	2.8	35.9	14.9	52.3	31.5	12.9	73.9	30.9	17.3	33.9	48.5	23.1	32.3	36.5	3.9	13.0	16.6	10.9	18.7	18.8	16.6
COASY	"CoASY, DPCK, NBP, PPAT"	ENSG00000068120	"Coenzyme A synthase"	Q13057	17	42561467-42566277	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Coenzyme A biosynthesis"	"Kinase, Multifunctional enzyme, Nucleotidyltransferase, Transferase"	"Disease mutation, Neurodegeneration"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA022875, HPA022912, HPA023273"	Approved				"Intracellular and membrane"	NA	NA		10000			"HPA022875: AB_1847066, HPA022912: AB_1847067, HPA023273: AB_1847068"	"unprognostic (2.83e-1)"	"unprognostic (8.35e-2)"	"unprognostic (1.81e-1)"	"prognostic favorable (2.15e-4)"	"unprognostic (1.01e-1)"	"unprognostic (5.72e-2)"	"prognostic unfavorable (7.54e-5)"	"unprognostic (4.06e-2)"	"unprognostic (3.36e-2)"	"unprognostic (2.50e-2)"	"unprognostic (1.50e-1)"	"unprognostic (7.83e-2)"	"unprognostic (1.11e-2)"	"unprognostic (2.49e-2)"	"unprognostic (5.55e-1)"	"unprognostic (1.62e-1)"	"unprognostic (2.16e-1)"	15.4	28.3	14.6	15.5	16.9	18.1	20.6	19.4	25.9	16.9	22.8	16.7	31.9	30.2	17.7	17.0	32.7	21.4	20.4	12.7	14.6	10.2	40.6	66.0	20.7	15.6	14.1	15.1	18.7	33.9	27.2	19.3	18.0	20.5	20.9	18.5	14.5	43.2	36.6	21.2	25.1	32.1	12.3	14.4	27.1	24.7	25.7	14.6	21.5	30.2	22.7	20.9	16.3	18.2	14.6	28.5	21.2	26.2	16.3	18.8	18.0	28.7	46.7	8.7	17.5	19.2	11.2	28.5	12.1	17.4	21.5	15.4	26.8	28.3	16.4	21.6	15.7	22.6	45.5	22.9	26.3	14.4	15.0	39.9	16.5	29.9	42.4	23.2	17.3	23.3	17.2	31.6	21.2	22.5	18.7	20.3	22.0	30.6	22.2	15.2	17.7	21.8	26.2	11.8	39.1	23.9	12.3	30.0	26.9	29.1	20.6	21.0	15.9	11.8	12.0	22.9	18.6	49.9	21.9	12.7	22.1	20.4	17.1	13.0	26.9	37.3	9.4	25.6	17.2	15.1	15.3	24.5	21.2	18.2	26.2	18.8	14.5	14.5	17.2	28.5	14.6	14.1	14.5	16.7	16.3	17.8	19.4	15.3	18.0	14.6	16.9	19.4	25.9	14.6	10.2	14.1	15.1	20.5	14.6	6.0	18.4	43.3	20.2	13.4	15.8	18.7	35.7	17.4	15.9	68.0	0.0	78.3	28.2	39.1	2.6	19.4	49.3	23.3	46.1	42.0	18.3	26.3	10.3	87.6	35.8	31.8	16.7	23.4	21.3	5.6	13.8	17.6	13.5	43.3	29.5	27.4	34.9	32.5	15.6	65.2	17.8	25.8	15.6	32.5	26.5	15.6	64.5	20.3	37.7	27.1
COLGALT1	"FLJ22329, GLT25D1"	ENSG00000130309	"Collagen beta(1-O)galactosyltransferase 1"	Q8NBJ5	19	17555594-17583162	"Enzymes, Predicted intracellular proteins"		"Glycosyltransferase, Transferase"	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Extravillous trophoblasts: 66.0;Hofbauer cells: 81.3;Kupffer cells: 58.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA047821	Approved		Approved	Vesicles	"Intracellular and membrane"	No	No			Vesicles		"HPA047821: AB_2680168"	"unprognostic (2.46e-1)"	"unprognostic (1.16e-1)"	"unprognostic (3.49e-1)"	"unprognostic (1.85e-1)"	"unprognostic (1.17e-1)"	"unprognostic (1.56e-1)"	"prognostic unfavorable (1.65e-5)"	"unprognostic (2.92e-3)"	"unprognostic (2.92e-1)"	"unprognostic (1.66e-3)"	"prognostic unfavorable (1.92e-4)"	"unprognostic (3.89e-2)"	"prognostic unfavorable (0.00e+0)"	"unprognostic (1.43e-2)"	"unprognostic (1.09e-1)"	"unprognostic (8.87e-2)"	"prognostic unfavorable (3.83e-4)"	29.8	11.4	12.1	26.9	16.5	21.3	36.2	15.6	13.1	18.2	18.5	10.8	9.6	12.0	21.9	20.2	17.6	19.2	18.1	21.7	10.8	7.1	11.1	17.8	25.1	46.1	19.4	7.3	19.0	15.2	7.9	8.1	29.6	11.8	12.6	11.6	9.5	12.0	13.0	10.7	16.7	17.3	25.7	11.3	30.9	13.9	11.2	17.9	10.3	11.3	12.7	11.9	19.6	19.1	2.5	11.5	7.6	17.4	1.4	3.6	7.1	23.2	27.5	13.4	18.4	53.2	33.0	21.4	21.8	12.8	28.8	29.9	20.8	36.7	11.9	39.1	38.2	24.6	20.8	13.6	25.3	17.5	6.7	21.8	11.4	35.8	19.7	29.2	27.2	34.9	27.3	22.7	32.2	13.5	11.7	32.3	7.6	23.3	6.0	10.4	10.2	13.7	17.6	9.9	16.9	26.9	14.7	17.1	18.2	6.1	15.5	9.7	7.0	23.4	18.7	22.1	9.1	9.7	39.7	22.5	57.2	16.2	50.7	35.4	10.8	27.3	13.1	33.8	51.9	25.9	1.1	15.0	7.6	3.4	17.4	2.0	2.3	3.2	3.2	11.5	2.5	2.3	3.6	2.4	1.4	12.6	4.4	1.9	7.1	12.1	16.5	15.6	13.1	10.8	7.1	19.4	7.3	11.8	17.9	17.9	30.0	6.0	4.6	17.3	3.6	8.9	5.1	5.3	18.2	10.4	5.9	5.4	0.0	11.4	2.7	14.6	9.7	0.0	6.9	66.0	26.7	5.5	8.1	12.3	81.3	12.7	5.2	9.2	58.8	2.3	17.5	43.3	16.9	8.2	13.7	1.7	10.2	5.8	20.5	4.1	2.9	12.9	17.3	3.1	13.9	18.2	7.0	10.2	15.3	7.5
COLGALT2	"C1orf17, GLT25D2, KIAA0584"	ENSG00000198756	"Collagen beta(1-O)galactosyltransferase 2"	Q8IYK4	1	183929854-184037729	"Enzymes, Predicted intracellular proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 39.0"	"Cell type enhanced"	"Detected in some"	20	"Early spermatids: 38.2;Late spermatids: 52.3;Sertoli cells: 12.9"	"Cancer enhanced"	"Detected in many"		"glioma: 11.5"	"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	11	"basophil: 8.1"	"Lineage enriched"	"Detected in single"	11	"granulocytes: 8.1"	"Cell line enhanced"	"Detected in many"		"Hep G2: 12.7;OE19: 10.2;SK-MEL-30: 13.7;U-251 MG: 13.1;WM-115: 16.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA031749, HPA031750"	Approved		Approved	Nucleoplasm,Vesicles	"Intracellular and membrane"	NA	NA			Nucleoplasm	Vesicles	"HPA031749: AB_10599298, HPA031750: AB_10611252"	"unprognostic (5.44e-3)"	"unprognostic (3.08e-1)"	"unprognostic (6.29e-5)"	"unprognostic (2.08e-1)"	"unprognostic (4.41e-2)"	"unprognostic (1.54e-1)"	"unprognostic (1.16e-1)"	"unprognostic (1.09e-2)"	"unprognostic (2.52e-1)"	"unprognostic (2.00e-1)"	"unprognostic (2.25e-1)"	"unprognostic (1.19e-1)"	"unprognostic (5.13e-9)"	"unprognostic (1.53e-2)"	"unprognostic (1.92e-1)"	"unprognostic (3.21e-2)"	"unprognostic (3.80e-2)"	2.1	9.4	10.8	1.7	16.6	1.9	2.8	10.6	39.0	2.0	3.0	31.3	0.0	1.4	3.0	5.2	1.7	3.5	3.7	11.7	15.3	7.9	1.8	1.0	4.5	1.1	20.2	12.9	2.3	3.5	1.0	1.9	0.8	17.4	8.1	2.0	3.5	4.4	3.7	11.0	1.1	1.4	3.0	21.8	1.3	3.4	5.0	22.5	0.0	5.1	1.8	1.5	2.4	1.4	0.0	0.0	8.1	0.0	0.7	0.6	0.1	0.1	0.0	4.4	0.2	2.3	3.4	0.1	1.2	0.5	0.6	0.7	2.1	0.2	0.0	0.3	3.3	0.8	0.0	4.2	0.0	1.1	4.6	2.3	0.3	0.0	12.7	0.1	4.1	0.0	2.0	0.0	0.6	0.1	6.4	0.0	0.1	4.1	5.4	4.6	0.1	0.2	0.2	3.0	10.2	0.0	0.4	0.0	0.0	0.0	0.9	1.7	2.7	0.2	0.0	13.7	2.9	0.0	0.2	0.0	0.5	0.4	0.0	13.1	8.0	0.0	0.0	0.4	2.0	16.9	8.1	0.0	0.1	0.6	0.0	0.0	0.0	0.2	0.5	0.0	0.0	0.0	0.2	0.0	0.7	0.0	0.0	0.0	0.1	10.8	16.6	10.6	17.2	15.3	7.9	20.2	12.9	17.4	22.5	0.0	0.0	0.0	0.4	0.3	0.8	3.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	38.2	0.9	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.3	52.3	2.0	1.5	1.7	0.0	0.0	4.8	1.0	0.0	3.9	0.2	0.2	12.9	0.5	0.3	0.4	0.4	0.0	3.5	0.0	0.3
COMT		ENSG00000093010	Catechol-O-methyltransferase	P21964	22	19941607-19969975	"Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Catecholamine metabolism, Neurotransmitter degradation"	"Methyltransferase, Transferase"	"FDA approved drug targets, Schizophrenia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 139.3"	"Cell type enhanced"	"Detected in many"	6	"Cytotrophoblasts: 779.9;Syncytiotrophoblasts: 542.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"MCF7: 118.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001169, CAB011233"	Enhanced		Enhanced	"Endoplasmic reticulum,Vesicles"		NA	NA		560000	Vesicles	"Endoplasmic reticulum"	"CAB011233: , HPA001169: AB_1078402"	"unprognostic (5.20e-2)"	"unprognostic (2.73e-2)"	"unprognostic (3.08e-2)"	"prognostic favorable (3.68e-4)"	"unprognostic (2.99e-2)"	"unprognostic (2.32e-3)"	"unprognostic (5.54e-3)"	"unprognostic (9.14e-2)"	"unprognostic (1.39e-1)"	"unprognostic (1.40e-1)"	"unprognostic (2.14e-3)"	"prognostic favorable (5.67e-4)"	"prognostic unfavorable (9.76e-4)"	"unprognostic (2.27e-1)"	"unprognostic (7.09e-2)"	"unprognostic (3.97e-1)"	"unprognostic (1.07e-2)"	18.6	49.0	29.4	14.3	28.8	24.3	27.8	19.6	32.9	22.4	23.4	42.4	36.1	21.0	19.8	33.8	58.1	19.4	36.8	28.1	28.9	22.3	31.1	139.3	30.9	17.0	29.0	18.4	36.3	27.2	14.1	12.7	59.0	23.3	25.7	8.9	24.9	67.3	30.9	21.5	27.7	28.6	15.5	41.0	17.8	24.8	18.2	23.7	11.5	19.2	44.0	32.0	36.3	28.0	11.2	55.1	10.9	60.0	12.9	15.6	28.0	19.1	19.7	2.3	19.5	22.2	19.8	0.8	21.8	27.4	18.7	21.4	16.7	22.4	7.7	9.7	31.1	7.4	26.3	3.7	23.3	5.0	16.7	24.9	13.8	10.5	39.0	41.5	23.0	5.5	25.2	28.9	16.2	16.1	18.0	17.5	12.5	55.7	16.5	15.0	118.8	9.0	41.3	4.8	52.7	6.7	13.6	19.5	10.6	19.7	60.8	9.5	8.4	7.2	61.7	18.0	1.3	13.3	64.7	20.9	33.4	12.8	10.9	16.3	6.1	2.6	6.3	36.0	31.0	23.0	10.2	60.0	10.9	15.6	39.9	12.8	11.2	10.8	12.6	47.7	10.7	9.6	10.6	2.4	12.9	26.6	55.1	13.3	28.0	29.4	28.8	19.6	32.9	28.9	22.3	29.0	18.4	23.3	23.7	116.1	64.8	45.5	189.7	90.7	68.3	29.9	109.5	88.3	85.3	144.8	9.8	779.9	271.9	173.4	3.6	68.7	98.5	0.0	167.1	75.3	99.4	123.4	70.4	231.9	281.1	23.8	81.1	74.9	149.0	7.4	124.3	142.1	227.7	154.1	89.3	151.7	163.3	110.1	169.0	60.7	34.5	135.8	91.5	4.4	5.3	107.9	542.4	36.6	110.1	180.5
COP1	"FLJ10416, RFWD2, RNF200"	ENSG00000143207	"COP1, E3 ubiquitin ligase"	Q8NHY2	1	175944831-176207493	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Cytotrophoblasts: 24.8;Extravillous trophoblasts: 29.0;Syncytiotrophoblasts: 26.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"neutrophil: 13.7"	"Lineage enriched"	"Detected in many"	4	"granulocytes: 13.7"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA						"unprognostic (1.99e-1)"	"unprognostic (3.76e-2)"	"unprognostic (4.17e-2)"	"prognostic unfavorable (3.96e-4)"	"unprognostic (2.95e-2)"	"unprognostic (4.33e-1)"	"unprognostic (2.01e-2)"	"unprognostic (1.10e-1)"	"unprognostic (2.78e-2)"	"unprognostic (3.52e-2)"	"unprognostic (9.24e-2)"	"unprognostic (1.67e-1)"	"unprognostic (1.33e-2)"	"unprognostic (6.68e-2)"	"unprognostic (7.01e-2)"	"unprognostic (1.59e-1)"	"unprognostic (1.55e-1)"	22.4	15.8	14.8	20.1	16.7	19.1	19.3	24.6	19.7	21.4	23.9	15.3	17.7	16.1	23.5	16.5	22.3	14.9	15.5	14.5	12.8	11.6	17.2	22.9	17.8	24.1	13.1	11.3	14.4	20.8	15.6	24.5	17.2	15.7	15.4	26.1	18.1	20.2	21.4	19.2	25.4	22.1	19.7	10.9	27.1	17.5	23.4	15.0	39.3	18.3	15.8	25.0	22.6	17.6	1.5	2.0	13.7	3.4	0.5	2.7	1.0	14.2	7.7	12.5	6.7	12.5	12.9	23.5	11.0	13.5	11.8	11.2	12.9	15.0	29.1	10.9	12.5	8.7	13.4	11.5	16.8	10.6	9.0	7.0	12.3	9.4	12.8	13.2	22.2	14.3	11.3	14.0	11.6	14.8	11.3	16.7	12.4	18.0	11.5	14.0	17.7	13.1	11.7	21.3	25.9	0.8	11.3	10.8	16.9	16.3	43.9	10.0	17.6	12.9	20.6	14.0	21.8	14.6	29.7	16.1	10.0	7.0	13.4	9.4	14.7	25.2	26.4	8.4	13.2	11.5	6.1	2.7	10.1	1.8	3.4	1.4	1.4	2.1	1.4	2.0	1.5	2.7	2.0	13.7	0.5	3.1	1.1	1.5	1.0	14.8	16.7	24.6	19.7	12.8	11.6	13.1	11.3	15.7	15.0	20.8	16.4	0.0	0.0	0.0	0.0	0.0	0.0	8.1	5.7	8.7	0.0	24.8	18.3	12.3	0.0	0.0	0.0	0.0	19.7	29.0	0.0	0.0	7.0	0.0	20.9	0.0	0.0	0.0	0.0	0.0	0.0	5.1	0.0	18.0	0.0	0.0	17.6	0.0	0.0	16.8	0.0	0.0	0.0	0.0	0.0	0.0	26.2	0.0	0.0	0.0
COPS5	"CSN5, JAB1, MOV-34, SGN5"	ENSG00000121022	"COP9 signalosome subunit 5"	Q92905	8	67043079-67083783	"Enzymes, Predicted intracellular proteins"		"Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Early spermatids: 275.9;Late spermatids: 320.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004242, HPA004845, HPA051531"	Supported		Enhanced	Nucleoplasm		NA	NA		27000	Nucleoplasm		"CAB004242: AB_627835, HPA004845: AB_1078557, HPA051531: AB_2681522"	"unprognostic (1.90e-3)"	"unprognostic (1.35e-1)"	"unprognostic (1.61e-1)"	"unprognostic (2.85e-3)"	"unprognostic (2.53e-1)"	"unprognostic (4.16e-2)"	"unprognostic (2.04e-3)"	"unprognostic (1.39e-1)"	"unprognostic (2.15e-2)"	"unprognostic (4.48e-2)"	"unprognostic (4.74e-3)"	"unprognostic (1.96e-2)"	"unprognostic (1.90e-3)"	"unprognostic (2.88e-2)"	"unprognostic (1.76e-1)"	"unprognostic (2.58e-1)"	"unprognostic (1.18e-2)"	20.2	26.3	29.4	19.6	28.6	16.2	28.1	28.5	40.3	18.0	21.7	15.6	20.2	22.0	17.6	21.7	24.0	17.7	15.5	46.8	27.6	27.5	27.4	33.7	16.8	17.5	31.8	29.9	17.0	20.7	23.3	21.7	24.3	33.7	18.3	25.5	9.9	19.6	18.9	64.0	16.8	22.5	23.3	39.2	16.1	20.7	27.4	31.3	19.6	18.5	29.2	22.4	18.3	16.5	20.7	35.1	33.7	30.0	26.5	28.1	22.3	28.8	27.4	23.3	21.3	24.5	26.2	18.5	25.4	20.9	35.3	31.9	17.7	35.6	26.8	11.7	26.2	25.5	24.2	31.2	28.0	39.0	25.7	26.9	38.1	27.5	23.8	23.8	24.0	23.1	23.8	36.0	28.8	37.2	27.3	34.4	28.3	45.0	18.6	31.6	26.8	42.3	42.2	30.9	60.8	31.5	27.2	16.6	21.1	37.4	25.7	14.1	19.5	14.6	28.3	24.6	21.5	46.6	24.8	25.4	18.0	22.2	21.7	19.9	23.4	29.8	35.7	26.2	27.4	24.5	26.0	28.6	33.7	20.8	30.0	21.7	20.7	20.1	23.1	35.1	17.5	21.6	19.1	21.2	26.5	28.3	18.4	28.1	22.3	29.4	28.6	28.5	40.3	27.6	27.5	31.8	29.9	33.7	31.3	20.8	21.3	38.7	36.8	43.8	32.5	99.1	43.3	26.8	29.6	29.6	31.4	115.4	74.6	65.8	275.9	33.7	37.6	0.0	52.3	84.4	39.7	44.8	34.7	33.9	69.9	23.8	32.8	31.9	28.8	320.8	40.0	37.7	27.0	55.9	34.2	45.4	48.3	45.6	48.1	56.1	44.9	32.3	31.6	126.7	59.2	41.5	106.9	39.5	48.7	48.1
COPS6	"CSN6, MOV34-34KD"	ENSG00000168090	"COP9 signalosome subunit 6"	Q7L5N1	7	100088954-100092200	"Enzymes, Predicted intracellular proteins"	"Host-virus interaction"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044315	Approved		Supported	Nucleoplasm	"Intracellular and membrane"	NA	NA		58000	Nucleoplasm		"HPA044315: AB_10959750"	"unprognostic (1.48e-2)"	"unprognostic (2.43e-2)"	"unprognostic (6.56e-3)"	"unprognostic (1.38e-1)"	"unprognostic (5.84e-2)"	"unprognostic (2.09e-2)"	"unprognostic (3.62e-3)"	"unprognostic (2.93e-2)"	"unprognostic (2.00e-1)"	"unprognostic (2.45e-2)"	"unprognostic (4.96e-2)"	"unprognostic (1.25e-1)"	"prognostic unfavorable (6.72e-4)"	"unprognostic (1.20e-1)"	"unprognostic (3.58e-2)"	"unprognostic (8.57e-2)"	"unprognostic (8.77e-2)"	25.4	30.0	37.7	20.2	50.6	19.7	25.6	31.5	43.3	32.5	30.4	26.5	15.1	19.3	31.0	39.8	33.4	33.7	32.4	47.2	31.5	32.1	31.7	41.2	20.1	30.4	33.3	32.6	30.8	42.8	38.1	28.2	29.1	34.1	27.4	26.6	25.0	28.3	35.7	53.1	23.4	19.2	45.2	30.1	22.7	26.9	25.5	30.8	29.4	27.6	21.6	25.8	26.7	24.8	53.4	67.6	58.9	64.0	48.2	69.4	45.3	32.3	46.2	27.7	32.9	24.4	29.2	17.6	29.4	45.3	49.3	36.3	37.7	30.7	22.4	38.1	48.2	55.1	24.8	31.3	49.8	50.0	22.3	49.1	19.1	45.8	29.0	51.1	21.6	19.9	28.8	33.1	53.1	56.8	33.0	67.4	34.8	27.4	32.4	58.0	80.6	47.8	32.2	25.0	47.7	55.5	22.9	46.1	53.4	39.2	30.5	43.5	32.3	30.4	60.2	22.3	38.0	24.8	21.4	35.3	47.6	43.4	56.9	51.7	24.0	26.6	45.9	36.0	29.5	70.2	58.9	61.9	51.7	61.1	64.0	61.2	53.4	61.3	57.8	67.6	49.8	48.3	53.9	24.1	48.2	57.4	50.2	69.4	45.3	37.7	50.6	31.5	43.3	31.5	32.1	33.3	32.6	34.1	30.8	47.6	36.9	81.5	102.7	98.2	102.2	140.2	79.0	83.0	60.3	82.0	49.1	166.8	179.1	109.3	59.3	92.0	58.6	46.7	99.3	110.5	106.3	89.3	89.9	52.9	111.6	90.6	72.3	79.8	61.4	119.0	118.2	67.5	148.5	112.8	58.6	129.0	94.7	59.6	117.8	164.9	114.4	97.0	134.0	70.6	115.8	87.7	115.3	82.8	79.4	85.2
COQ2	"CL640, FLJ26072"	ENSG00000173085	"Coenzyme Q2, polyprenyltransferase"	Q96H96	4	83261536-83284914	"Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins"	"Isoprene biosynthesis, Ubiquinone biosynthesis"	Transferase	"Disease mutation, Neurodegeneration, Parkinsonism, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Hofbauer cells: 45.2;Kupffer cells: 48.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA056599, HPA068727"	Approved		Approved	Cytosol		NA	NA			Cytosol		"HPA056599: AB_2683184, HPA068727: AB_2686022"	"unprognostic (8.26e-2)"	"unprognostic (7.40e-3)"	"unprognostic (3.95e-3)"	"unprognostic (1.55e-1)"	"unprognostic (9.22e-2)"	"unprognostic (5.59e-2)"	"unprognostic (1.26e-2)"	"unprognostic (1.52e-1)"	"unprognostic (4.09e-1)"	"unprognostic (4.16e-2)"	"unprognostic (2.08e-2)"	"unprognostic (2.77e-3)"	"unprognostic (1.56e-2)"	"unprognostic (3.73e-1)"	"unprognostic (1.40e-1)"	"unprognostic (7.82e-2)"	"unprognostic (2.46e-1)"	6.6	25.5	4.9	8.4	7.0	8.9	9.9	1.9	6.0	7.4	12.1	5.8	8.4	7.8	8.0	10.2	13.1	5.4	7.4	17.5	4.3	4.1	8.0	14.9	9.8	9.0	6.5	3.4	8.0	5.9	6.7	12.3	7.2	5.0	6.6	12.5	5.2	12.7	8.5	21.8	13.8	8.2	5.8	6.7	14.1	4.8	6.6	6.7	2.9	10.1	23.9	9.2	6.2	7.4	3.6	11.8	6.0	17.4	3.7	2.0	6.8	11.7	6.9	6.8	12.9	5.3	5.4	4.8	7.6	12.6	14.5	17.0	4.8	17.0	7.9	5.6	13.5	11.5	9.1	11.5	12.4	18.3	8.1	7.3	7.1	9.0	6.7	5.8	14.4	34.2	8.0	7.9	7.0	12.1	4.3	14.4	4.5	4.6	9.5	13.4	12.1	3.8	9.7	5.0	13.9	9.7	6.6	5.3	10.2	21.1	5.7	4.8	3.1	8.7	11.1	3.9	3.2	7.1	7.9	10.0	6.8	7.1	5.1	10.6	2.8	2.3	4.7	13.3	16.9	9.3	1.1	16.3	2.3	1.6	14.4	1.2	3.6	1.8	1.5	11.8	3.5	1.3	2.0	6.0	3.7	17.4	6.2	2.0	6.8	4.9	7.0	1.9	6.0	4.3	4.1	6.5	3.4	5.0	6.7	0.0	3.4	11.8	9.6	6.0	5.2	17.1	5.1	2.7	6.8	8.7	0.0	20.5	26.6	5.8	0.6	3.6	9.6	0.0	9.5	25.6	5.4	9.8	0.0	11.4	45.2	1.6	4.6	12.9	48.6	0.6	3.4	26.3	6.8	1.0	15.2	12.9	4.7	14.0	4.6	8.2	4.2	0.0	4.7	4.3	14.5	11.0	10.4	10.0	23.9	8.9
COQ3	bA9819.1	ENSG00000132423	"Coenzyme Q3, methyltransferase"	Q9NZJ6	6	99369400-99394204	"Enzymes, Predicted intracellular proteins"	"Ubiquinone biosynthesis"	"Methyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Cardiomyocytes: 37.1;Distal tubular cells: 28.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA031273, HPA031274"	Enhanced		Approved	Nucleoplasm,Mitochondria		NA	NA			Nucleoplasm	Mitochondria	"HPA031273: AB_10611107, HPA031274: AB_10602176"	"unprognostic (1.81e-2)"	"unprognostic (2.69e-2)"	"unprognostic (1.45e-2)"	"unprognostic (4.62e-2)"	"unprognostic (2.41e-2)"	"unprognostic (2.16e-2)"	"unprognostic (1.48e-3)"	"unprognostic (1.76e-1)"	"unprognostic (3.40e-1)"	"unprognostic (8.77e-2)"	"unprognostic (9.78e-2)"	"unprognostic (1.09e-1)"	"prognostic favorable (6.86e-5)"	"unprognostic (4.61e-2)"	"unprognostic (1.81e-1)"	"unprognostic (5.45e-2)"	"unprognostic (1.08e-1)"	5.2	7.8	8.6	4.2	10.8	3.2	7.5	13.6	16.3	4.5	8.9	4.5	4.3	6.9	4.3	6.8	8.2	4.5	3.0	21.7	8.2	7.5	10.2	12.4	2.9	7.1	6.9	12.0	6.0	5.7	11.6	7.4	2.5	9.8	6.8	11.0	7.3	11.7	7.6	28.0	5.8	6.3	6.6	4.6	4.8	5.2	2.3	6.0	4.1	4.3	16.8	7.0	7.5	4.6	6.6	8.0	9.4	7.4	9.7	12.5	5.3	12.0	6.9	8.4	11.9	5.5	6.2	11.6	10.4	6.5	15.8	18.3	9.6	5.2	11.8	7.0	7.8	10.2	11.2	14.0	16.3	19.3	12.5	17.9	14.4	9.5	10.3	7.2	20.8	5.7	3.9	10.0	9.3	9.4	3.5	9.6	14.6	21.9	9.0	8.4	11.9	9.1	17.4	10.2	11.9	13.4	4.5	8.6	15.7	12.4	10.5	13.2	7.0	7.2	11.2	13.6	5.9	13.7	13.7	3.4	6.9	10.1	10.6	15.8	3.2	5.9	18.6	8.8	20.2	10.1	9.4	3.3	2.4	6.0	7.4	6.8	6.6	7.6	9.5	8.0	3.1	12.5	9.5	0.5	9.7	6.3	5.2	5.5	5.3	8.6	10.8	13.6	16.3	8.2	7.5	6.9	12.0	9.8	6.0	3.0	3.0	6.1	8.0	3.9	7.1	37.1	7.6	0.0	5.7	3.5	0.0	13.0	28.2	10.0	0.4	4.5	3.2	0.0	9.3	11.0	4.1	2.0	1.1	7.8	5.7	6.4	0.0	3.7	0.6	0.0	7.5	3.3	5.0	1.8	6.5	10.4	7.0	6.0	5.6	8.8	7.8	6.5	8.2	3.4	12.4	3.8	5.3	4.4	9.0	3.1
COQ5	MGC4767	ENSG00000110871	"Coenzyme Q5, methyltransferase"	Q5HYK3	12	120503274-120534434	"Enzymes, Predicted intracellular proteins"	"Ubiquinone biosynthesis"	"Methyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA049487	Approved		Uncertain	Nucleoli,Mitochondria		NA	NA			Nucleoli	Mitochondria	"HPA049487: AB_2680789"	"unprognostic (1.46e-1)"	"unprognostic (1.99e-2)"	"unprognostic (1.32e-1)"	"unprognostic (6.30e-3)"	"unprognostic (2.00e-1)"	"unprognostic (1.66e-1)"	"unprognostic (1.88e-1)"	"unprognostic (1.60e-1)"	"unprognostic (2.01e-2)"	"unprognostic (6.20e-2)"	"unprognostic (1.62e-1)"	"unprognostic (8.37e-2)"	"unprognostic (3.79e-2)"	"unprognostic (2.02e-1)"	"unprognostic (7.73e-2)"	"unprognostic (2.00e-2)"	"unprognostic (3.88e-2)"	14.6	21.7	15.8	16.1	16.7	7.0	29.5	15.6	21.3	12.5	16.4	13.5	21.8	15.7	12.6	16.4	14.0	15.5	13.5	31.9	14.8	13.1	26.0	39.8	17.6	19.1	17.5	15.4	15.1	28.6	14.2	13.4	18.6	19.4	12.7	17.1	11.6	17.9	17.8	58.4	11.1	13.2	14.0	18.5	14.6	12.4	16.9	15.0	17.2	17.7	30.4	15.2	10.1	17.0	21.3	27.4	9.7	19.6	25.1	28.2	22.4	15.9	25.6	23.1	6.6	30.5	23.5	15.9	19.5	12.8	20.0	12.7	10.2	13.5	16.1	23.1	20.4	14.2	17.3	20.5	21.7	20.6	20.1	12.1	21.4	15.7	16.9	24.9	23.3	13.5	22.5	23.5	18.6	22.0	31.3	17.5	31.1	21.0	11.8	23.1	20.9	13.4	26.8	20.3	11.5	19.9	25.0	23.4	23.3	25.7	12.2	17.5	14.1	14.1	7.2	26.5	25.2	36.3	19.3	17.5	13.9	15.9	10.2	12.9	25.5	21.5	18.3	15.8	22.2	16.6	9.4	19.6	9.7	18.8	19.2	18.2	21.1	20.4	19.9	27.4	21.3	28.2	22.3	2.1	25.1	17.9	18.0	24.4	22.4	15.8	16.7	15.6	21.3	14.8	13.1	17.5	15.4	19.4	15.0	11.9	10.9	16.3	10.7	6.9	11.5	26.2	15.3	16.0	7.9	14.0	13.7	60.9	39.7	25.5	42.0	11.7	17.2	23.3	17.3	38.3	14.1	8.4	17.3	37.2	40.3	4.8	14.5	16.0	15.6	14.5	15.3	13.1	21.9	36.1	14.6	11.8	12.3	23.2	17.7	52.6	14.4	6.5	10.3	13.7	15.4	7.9	48.7	17.5	29.2	7.5
COQ8A	"ADCK3, CABC1, COQ8, SCAR9"	ENSG00000163050	"Coenzyme Q8A"	Q8NI60	1	226897536-226987545	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Ubiquinone biosynthesis"	"Kinase, Transferase"	"Disease mutation, Neurodegeneration, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	4	"skeletal muscle: 216.5"	"Cell type enhanced"	"Detected in many"	7	"Alveolar cells type 2: 18.7;Collecting duct cells: 31.4;Exocrine glandular cells: 28.2;monocytes: 19.8;Proximal tubular cells: 20.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HEK 293: 32.8;RPMI-8226: 29.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA061662			Supported	Mitochondria		NA	NA			Mitochondria		"HPA061662: AB_2684578"	"unprognostic (6.37e-3)"	"unprognostic (2.09e-2)"	"unprognostic (2.29e-1)"	"unprognostic (9.06e-2)"	"unprognostic (8.94e-2)"	"unprognostic (2.49e-1)"	"unprognostic (4.42e-2)"	"unprognostic (3.50e-3)"	"unprognostic (1.81e-1)"	"unprognostic (4.02e-1)"	"unprognostic (4.15e-3)"	"unprognostic (8.67e-2)"	"unprognostic (2.40e-2)"	"unprognostic (9.24e-2)"	"unprognostic (2.82e-1)"	"unprognostic (8.88e-2)"	"unprognostic (2.62e-1)"	13.3	25.4	2.8	2.7	4.5	5.3	8.5	14.5	3.9	3.2	7.3	4.1	4.2	6.9	3.6	5.5	7.3	5.0	6.1	41.0	2.7	1.8	3.8	17.7	2.7	4.1	5.0	2.4	7.2	20.3	1.6	1.6	2.0	3.8	6.5	2.0	1.9	7.2	5.0	216.5	4.4	4.4	7.8	2.9	3.5	8.8	3.0	4.7	2.7	4.6	50.2	5.8	10.2	3.5	15.2	9.3	32.3	11.5	9.9	11.8	11.6	3.1	5.8	1.5	4.4	4.7	3.0	23.4	1.5	1.3	2.1	2.8	9.1	5.1	9.4	7.2	1.0	1.2	3.7	2.9	3.3	0.5	9.9	32.8	6.6	4.8	15.0	1.0	9.9	4.0	5.9	5.0	1.7	2.3	2.1	1.0	9.7	11.3	7.8	0.3	4.3	5.7	14.6	6.4	24.3	11.9	5.7	7.0	29.9	0.7	2.4	24.1	9.9	2.9	11.7	8.5	1.7	6.2	13.5	1.2	2.5	2.3	3.4	5.4	17.5	15.3	4.9	2.3	11.3	2.4	19.7	11.5	32.3	8.7	8.6	8.3	12.1	8.5	7.7	9.3	15.2	11.8	9.0	21.9	9.9	6.5	4.1	10.6	11.6	2.8	4.5	14.5	3.9	2.7	1.8	5.0	2.4	3.8	4.7	3.0	18.7	0.0	0.0	0.0	0.0	0.0	0.0	4.0	7.9	31.4	0.0	10.4	13.3	14.2	0.0	0.0	0.0	0.0	28.2	7.8	0.0	0.0	12.8	0.0	12.6	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	19.8	0.0	0.0	14.5	0.0	0.0	20.9	0.0	0.0	0.0	0.0	0.0	0.0	6.4	0.0	0.0	0.0
COQ8B	"ADCK4, COQ8, FLJ12229"	ENSG00000123815	"Coenzyme Q8B"	Q96D53	19	40691529-40718207	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		"Kinase, Transferase"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Alveolar cells type 1: 11.9;Ciliated cells: 16.0;Collecting duct cells: 12.2;Ductal cells: 12.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027229, HPA027277, HPA027279, HPA028303"	Supported		Enhanced	Mitochondria		NA	NA			Mitochondria		"HPA027229: AB_10600100, HPA027277: AB_10599857, HPA027279: AB_10601219, HPA028303: AB_2672551"	"unprognostic (7.57e-2)"	"unprognostic (9.48e-2)"	"unprognostic (1.61e-1)"	"unprognostic (2.36e-2)"	"unprognostic (2.33e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.79e-1)"	"unprognostic (4.63e-2)"	"unprognostic (1.85e-1)"	"unprognostic (2.27e-1)"	"unprognostic (2.82e-2)"	"unprognostic (1.48e-1)"	"unprognostic (2.93e-2)"	"unprognostic (6.18e-2)"	"unprognostic (1.46e-1)"	"unprognostic (7.17e-2)"	"unprognostic (2.65e-2)"	13.6	17.8	21.1	13.1	16.4	11.5	10.0	24.1	19.2	13.6	13.6	18.6	14.8	17.9	15.0	13.2	16.6	26.5	16.7	14.7	15.7	10.7	11.8	15.6	12.1	12.2	15.5	12.1	16.3	19.4	12.6	32.7	7.9	13.2	15.1	5.7	12.3	16.8	17.6	10.3	12.9	18.6	16.2	15.6	12.1	17.5	12.5	16.7	16.8	15.5	6.9	13.2	14.8	11.8	12.9	15.0	17.7	15.6	9.7	13.1	10.5	8.3	34.3	7.0	13.5	6.3	6.1	6.5	7.8	8.5	5.9	6.3	10.7	15.2	11.2	15.1	4.5	7.0	7.3	4.9	8.7	2.1	13.4	10.2	10.7	20.9	5.9	10.8	3.7	16.8	8.0	9.3	4.3	5.2	6.7	6.6	13.9	5.7	6.2	4.1	5.1	4.8	4.5	5.4	9.2	3.6	8.0	9.9	8.5	10.2	14.2	12.6	10.3	10.5	16.1	16.9	4.5	14.4	14.0	6.2	5.1	17.3	3.6	4.6	6.8	5.5	5.7	19.3	4.2	7.0	15.8	15.6	14.6	11.6	15.4	13.1	12.9	9.0	12.4	15.0	11.7	8.9	9.1	17.7	9.7	13.7	8.7	8.8	10.5	21.1	16.4	24.1	19.2	15.7	10.7	15.5	12.1	13.2	16.7	11.9	4.6	0.0	0.0	0.0	0.0	0.0	0.0	16.0	4.5	12.2	0.0	9.4	10.0	12.4	0.0	0.0	0.0	0.0	9.5	7.9	0.0	0.0	1.1	0.0	8.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.8	0.0	0.0	10.4	0.0	0.0	9.8	0.0	0.0	0.0	0.0	0.0	0.0	7.9	0.0	0.0	0.0
CORIN	"ATC2, CRN, Lrp4, PRSC, TMPRSS10"	ENSG00000145244	"Corin, serine peptidase"	Q9Y5Q5	4	47593998-47838106	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"		"Hydrolase, Protease, Serine protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"epididymis: 11.6;heart muscle: 39.5"	"Cell type enriched"	"Detected in some"	5	"Cardiomyocytes: 50.9"	"Low cancer specificity"	"Detected in some"			"Region enriched"	"Detected in single"	5	"pons and medulla: 1.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	4	"ASC TERT1: 32.6"	"Region enhanced"	"Detected in some"		"basal ganglia: 2.7"	"Low region specificity"	"Detected in single"			HPA070941			Approved	"Nuclear bodies,Plasma membrane,Actin filaments"	"Intracellular and membrane"	Yes	No			"Plasma membrane"	"Nuclear bodies, Actin filaments"	"HPA070941: AB_2686324"	"unprognostic (1.05e-1)"	"unprognostic (2.52e-1)"	"unprognostic (1.14e-1)"	"unprognostic (1.93e-1)"	"unprognostic (2.10e-1)"	"unprognostic (3.18e-1)"	"unprognostic (3.58e-4)"	"unprognostic (3.19e-1)"	"unprognostic (3.67e-2)"	"unprognostic (8.22e-2)"	"unprognostic (9.78e-2)"	"unprognostic (6.53e-2)"	"unprognostic (1.18e-1)"	"unprognostic (2.86e-2)"	"unprognostic (5.18e-2)"	"unprognostic (7.22e-2)"	"unprognostic (1.33e-2)"	0.3	0.1	0.3	0.0	0.1	0.0	0.8	0.1	0.1	3.1	0.1	0.1	2.6	0.0	3.4	11.6	0.7	1.2	4.5	39.5	0.0	0.2	2.0	0.0	1.3	0.0	0.2	0.0	0.6	0.1	0.0	1.5	0.6	1.6	1.7	0.0	0.4	0.3	4.6	0.2	5.3	0.4	0.5	0.0	3.5	0.3	3.7	0.0	0.2	0.1	1.7	0.4	0.8	3.2	0.2	0.0	0.5	0.5	0.0	0.3	0.0	0.0	0.0	0.0	0.2	7.5	32.6	0.0	1.4	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	1.5	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.6	1.0	0.0	0.2	0.1	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.5	0.3	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.5	0.0	0.1	0.0	0.0	0.0	0.3	0.1	0.1	0.1	0.0	0.2	0.2	0.0	1.6	0.0	0.0	6.9	0.0	0.2	3.4	0.8	50.9	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	4.5	0.3	0.0	0.0	0.0	0.0	9.3	0.6	0.0	0.0	0.1	0.0	0.0	0.0	0.8	0.8	4.4	0.0	5.0	0.0	0.0	0.7	0.0	0.0	2.5	0.0	0.1	0.0	4.2	3.0	4.6	2.4	0.0	0.0	0.0	0.2
CP		ENSG00000047457	Ceruloplasmin	P00450	3	149162410-149222055	"Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins"	"Copper transport, Ion transport, Transport"	Oxidoreductase	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	20	"liver: 311.1"	"Group enriched"	"Detected in many"	7	"Ciliated cells: 505.9;Club cells: 754.1;Hepatocytes: 1101.0;Muller glia cells: 606.4"	"Cancer enhanced"	"Detected in many"		"liver cancer: 98.3"	"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enriched"	"Detected in some"	9	"EFO-21: 82.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA001834, CAB008591"	Supported				"Secreted to blood"	NA	NA	160000000000	830000000000			"CAB008591: AB_1613734, HPA001834: AB_1078502"	"unprognostic (3.58e-1)"	"unprognostic (4.24e-1)"	"unprognostic (9.61e-2)"	"unprognostic (1.80e-2)"	"unprognostic (4.14e-2)"	"unprognostic (1.02e-2)"	"unprognostic (1.06e-1)"	"unprognostic (2.97e-2)"	"unprognostic (2.07e-1)"	"unprognostic (8.75e-2)"	"unprognostic (6.03e-2)"	"unprognostic (1.70e-1)"	"prognostic unfavorable (1.14e-7)"	"unprognostic (2.68e-2)"	"unprognostic (1.59e-1)"	"unprognostic (2.00e-1)"	"unprognostic (2.70e-1)"	1.8	0.7	2.6	0.6	5.7	0.4	3.5	2.6	3.5	10.5	2.0	2.5	0.0	1.7	2.3	0.3	1.1	1.5	0.5	6.6	3.6	1.7	1.6	311.1	2.1	2.4	4.2	0.9	0.4	1.2	1.4	5.3	1.9	9.4	2.1	2.7	15.5	6.9	0.4	1.2	2.0	2.6	0.7	4.8	3.5	0.7	0.5	4.4	0.0	2.8	0.4	3.0	3.2	2.9	1.3	0.8	0.6	1.0	0.3	1.3	0.4	0.0	4.9	4.9	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	82.2	0.0	8.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.6	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	1.3	0.0	0.0	0.0	0.1	1.8	4.1	0.0	0.0	0.1	0.2	0.0	0.1	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.6	1.0	0.5	0.8	0.6	0.8	0.9	0.4	0.5	0.6	1.3	0.4	1.3	0.4	0.3	0.4	0.8	0.4	0.4	2.6	5.7	2.6	3.5	3.6	1.7	4.2	0.9	9.4	4.4	17.9	59.9	35.0	6.7	3.0	6.0	0.4	86.6	505.9	754.1	8.7	5.9	0.0	0.0	26.9	0.5	5.3	0.0	93.5	17.8	0.2	12.7	23.8	2.3	1101.0	0.6	4.8	0.0	42.4	37.9	0.4	0.3	3.4	0.0	2.8	0.0	606.4	111.7	0.0	0.4	0.1	13.8	0.0	2.6	0.0	0.0	2.3	0.2	4.3	0.0	44.8
CPA1	CPA	ENSG00000091704	"Carboxypeptidase A1"	P15085	7	130380339-130388114	"Enzymes, Predicted intracellular proteins, Predicted secreted proteins"		"Carboxypeptidase, Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	3231	"pancreas: 3541.6"	"Cell type enriched"	"Detected in some"	10	"Exocrine glandular cells: 8426.3"	"Cancer enriched"	"Detected in some"	639	"pancreatic cancer: 1377.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	5	"AN3-CA: 16.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA021836, CAB025197, HPA052215"	Enhanced				"Secreted to digestive system"	NA	NA		17000000			"CAB025197: , HPA021836: AB_1846005, HPA052215: AB_2681764"	"unprognostic (8.41e-2)"			"unprognostic (9.24e-4)"	"unprognostic (5.22e-2)"	"unprognostic (1.76e-1)"	"unprognostic (3.97e-1)"	"unprognostic (1.76e-1)"		"unprognostic (2.27e-1)"	"unprognostic (1.15e-2)"	"unprognostic (1.35e-1)"	"unprognostic (1.34e-6)"	"unprognostic (4.99e-1)"	"unprognostic (1.67e-1)"	"unprognostic (2.16e-1)"	"unprognostic (4.37e-2)"	0.3	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.2	0.1	0.1	0.1	0.1	0.2	0.1	0.1	0.1	0.0	0.1	0.3	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	1.0	3541.6	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.3	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.4	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	16.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.6	1.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	3.0	0.6	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	2.3	0.0	0.3	0.0	1.9	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.1	0.1	0.2	0.1	0.0	0.1	0.1	0.1	0.1	3.0	0.0	0.0	0.5	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.3	5.0	13.2	1.2	0.0	0.0	0.0	8426.3	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	5.9	0.9	0.0	0.0	77.5	0.0	2.3	847.8	0.0	0.7	0.0	0.0	0.0	0.0	0.5	2.4	0.0	1.4	0.0	0.0	0.0
CPA2		ENSG00000158516	"Carboxypeptidase A2"	P48052	7	130266827-130289798	"Enzymes, Predicted secreted proteins"		"Carboxypeptidase, Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	529	"pancreas: 1357.9"	"Cell type enriched"	"Detected in some"	6	"Exocrine glandular cells: 4303.0"	"Cancer enriched"	"Detected in many"	60	"pancreatic cancer: 411.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AN3-CA: 4.5;CACO-2: 7.5;RH-30: 6.2;SCLC-21H: 3.4"	"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			"HPA020342, HPA021317"	Enhanced		Approved	"Golgi apparatus"	"Secreted to digestive system"	NA	NA		1500000	"Golgi apparatus"		"HPA020342: AB_1846007, HPA021317: AB_1846008"	"unprognostic (1.12e-1)"	"unprognostic (3.97e-1)"	"unprognostic (4.21e-2)"	"unprognostic (1.82e-2)"	"unprognostic (1.38e-1)"	"unprognostic (6.76e-2)"		"unprognostic (4.65e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.40e-1)"	"unprognostic (1.84e-1)"	"unprognostic (2.66e-1)"	"unprognostic (3.84e-5)"	"unprognostic (7.52e-2)"	"unprognostic (1.42e-1)"	"unprognostic (7.12e-2)"	"unprognostic (8.48e-2)"	0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.4	0.1	0.1	0.3	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.4	1357.9	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	1.0	0.1	0.2	0.1	2.5	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.9	4.5	0.0	0.1	0.0	0.0	0.0	0.7	0.0	7.5	0.0	0.0	1.0	0.0	0.6	0.0	1.4	0.0	0.1	1.0	0.0	0.0	0.8	0.0	0.1	0.0	0.0	0.1	0.1	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.9	0.0	0.4	0.0	6.2	0.1	0.1	0.7	3.4	0.0	0.2	0.0	2.1	0.3	0.0	0.2	0.0	0.0	1.1	0.8	0.6	0.0	0.7	0.2	0.8	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.3	1.7	6.6	3.8	0.0	0.8	0.0	4303.0	0.0	0.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	6.8	0.3	0.0	0.0	24.4	0.0	2.8	764.8	8.6	0.0	0.0	0.3	0.0	0.0	0.3	1.5	0.1	0.2	0.0	0.2	0.1
CPA3		ENSG00000163751	"Carboxypeptidase A3"	P15088	3	148865256-148897196	"Enzymes, Plasma proteins, Predicted secreted proteins"		"Carboxypeptidase, Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 111.7"	"Cell type enriched"	"Detected in some"	15	"granulocytes: 4120.5"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	1118	"basophil: 111.7"	"Lineage enriched"	"Detected in single"	1118	"granulocytes: 111.7"	"Cell line enriched"	"Detected in some"	43	"HEL: 81.5"	"Low region specificity"	"Detected in single"							"HPA006479, HPA008689, CAB020712"	Enhanced		Approved	"Nucleoplasm,Golgi apparatus"	"Secreted to blood"	NA	NA			"Golgi apparatus"	Nucleoplasm	"CAB020712: , HPA006479: AB_1078396, HPA008689: AB_1846009"	"unprognostic (1.07e-1)"	"unprognostic (3.03e-2)"	"unprognostic (2.66e-3)"	"unprognostic (9.13e-3)"	"unprognostic (3.50e-1)"	"unprognostic (1.18e-3)"	"unprognostic (2.47e-1)"	"unprognostic (1.57e-2)"	"unprognostic (2.14e-1)"	"unprognostic (9.51e-2)"	"unprognostic (1.89e-1)"	"unprognostic (5.30e-3)"	"unprognostic (3.50e-3)"	"unprognostic (5.18e-3)"	"unprognostic (3.24e-2)"	"unprognostic (1.74e-1)"	"unprognostic (1.69e-3)"	12.4	0.6	0.4	12.0	0.4	5.6	6.2	0.4	0.5	25.4	14.1	0.8	4.4	7.1	14.1	21.2	16.5	3.7	50.9	4.5	0.4	0.2	5.8	2.8	37.3	15.2	0.4	0.4	2.0	7.2	0.7	0.8	1.3	0.5	37.3	16.4	8.5	8.8	5.8	1.4	12.7	20.2	24.3	0.4	1.0	13.7	7.1	0.4	3.6	1.4	9.9	7.1	14.0	8.9	0.0	0.0	111.7	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	81.5	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.1	0.1	1.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	111.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.4	0.4	0.4	0.5	0.4	0.2	0.4	0.4	0.5	0.4	29.8	269.3	0.0	0.2	1.4	0.0	0.2	0.0	16.0	31.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.6	0.1	4120.5	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	1.1	0.0	0.0	0.0	0.3
CPA4	CPA3	ENSG00000128510	"Carboxypeptidase A4"	Q9UI42	7	130293134-130324180	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"		"Carboxypeptidase, Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 18.0;skin 1: 41.0"	"Cell type enhanced"	"Detected in some"	18	"Basal keratinocytes: 15.8;Exocrine glandular cells: 45.1;Pancreatic endocrine cells: 12.8;Suprabasal keratinocytes: 27.0"	"Cancer enhanced"	"Detected in many"		"cervical cancer: 10.0;head and neck cancer: 9.8"	"Low region specificity"	"Detected in single"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 29.6;hTERT-RPE1: 55.9;LHCN-M2: 60.1;U-2 OS: 32.8;U-87 MG: 59.0"	"Low region specificity"	"Detected in single"							HPA021030			Approved	Nucleoplasm,Centrosome,Cytosol	"Secreted in other tissues"	NA	Yes		480000	Nucleoplasm	"Centrosome, Cytosol"	"HPA021030: AB_1846010"	"unprognostic (7.60e-3)"	"unprognostic (4.00e-2)"	"unprognostic (1.59e-3)"	"unprognostic (3.63e-3)"	"unprognostic (2.24e-2)"	"unprognostic (2.91e-2)"	"unprognostic (2.78e-2)"	"unprognostic (4.36e-3)"	"unprognostic (3.23e-1)"	"unprognostic (5.79e-2)"	"unprognostic (2.37e-3)"	"unprognostic (6.49e-2)"	"unprognostic (6.21e-10)"	"unprognostic (2.39e-1)"	"unprognostic (1.67e-1)"	"unprognostic (7.56e-2)"	"prognostic unfavorable (1.31e-4)"	2.7	2.3	0.1	0.4	0.4	0.2	2.8	0.1	0.4	8.1	1.1	0.3	0.1	0.1	1.1	1.2	18.0	0.2	0.2	4.4	0.1	1.2	1.2	0.2	0.8	0.3	0.1	0.1	1.8	6.9	0.1	1.1	8.8	0.9	0.3	0.1	0.6	4.4	0.1	0.3	41.0	0.5	0.7	0.7	1.7	0.2	2.2	0.1	0.8	0.1	12.3	2.3	1.7	6.7	0.4	0.4	1.6	0.4	1.5	0.4	0.1	19.4	1.0	0.0	0.0	0.1	0.3	0.0	15.6	29.6	15.9	3.9	0.1	1.7	0.0	3.0	6.6	16.1	1.1	0.0	8.6	16.5	0.0	0.0	0.0	6.3	0.4	0.4	0.0	0.0	0.2	13.9	1.4	2.0	55.9	0.0	0.0	0.0	0.0	60.1	0.0	0.0	0.0	0.1	0.1	2.3	0.0	16.1	0.0	7.5	0.8	0.0	0.0	10.3	4.9	0.1	6.3	0.1	0.0	11.9	3.9	32.8	1.3	1.5	0.0	0.0	0.0	59.0	0.0	0.1	1.0	0.4	0.4	0.4	0.1	0.2	0.3	0.2	0.3	0.0	0.4	0.3	0.3	1.6	1.5	0.2	0.4	0.3	0.1	0.1	0.4	0.1	0.3	0.1	1.2	0.1	0.1	0.9	0.1	3.0	0.3	0.0	0.5	15.8	0.0	0.3	0.0	2.7	2.3	0.0	0.0	3.7	0.0	0.5	0.3	0.1	0.0	0.0	45.1	1.0	1.9	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.3	1.0	0.0	0.0	12.8	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.7	27.0	7.9	0.0	0.0	0.9
CPA5		ENSG00000158525	"Carboxypeptidase A5"	Q8WXQ8	7	130344816-130368730	"Enzymes, Predicted intracellular proteins, Predicted secreted proteins"		"Carboxypeptidase, Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	17	"blood: 25.2;testis: 30.4"	"Group enriched"	"Detected in some"	20	"Early spermatids: 46.3;Late spermatids: 106.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"memory CD4 T-cell: 8.0;naive CD8 T-cell: 20.3;T-reg: 25.2"	"Lineage enriched"	"Detected in single"	114	"T-cells: 25.2"	"Cell line enhanced"	"Detected in some"		"RH-30: 11.2;RT4: 5.1;U-266/84: 8.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA020322			Approved	Nucleoplasm	"Secreted in male reproductive system"	NA	NA			Nucleoplasm		"HPA020322: AB_10960562"	"unprognostic (2.44e-1)"	"unprognostic (3.76e-1)"	"unprognostic (1.50e-1)"	"unprognostic (5.94e-2)"	"unprognostic (4.96e-2)"	"unprognostic (7.10e-3)"	"unprognostic (1.64e-2)"	"unprognostic (1.41e-2)"	"unprognostic (3.26e-1)"	"unprognostic (5.02e-2)"	"unprognostic (5.83e-4)"	"unprognostic (1.43e-1)"	"unprognostic (8.88e-13)"	"unprognostic (5.16e-2)"	"unprognostic (1.32e-1)"	"unprognostic (8.81e-2)"	"unprognostic (3.08e-2)"	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.4	0.1	0.0	0.1	0.1	0.1	0.4	0.1	0.1	0.1	1.6	0.1	0.1	0.1	0.4	0.0	1.0	0.5	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.8	0.4	0.1	0.1	1.6	0.0	30.4	0.1	0.1	0.1	0.1	0.7	0.8	0.1	0.0	0.0	0.2	0.0	0.0	25.2	3.1	0.8	0.0	0.1	0.6	0.0	0.0	0.0	0.4	3.3	0.2	0.4	2.4	0.0	0.0	0.0	0.0	1.1	0.1	0.4	0.7	0.0	0.0	1.9	0.7	0.7	1.2	0.5	0.0	0.0	0.0	1.1	0.0	1.2	1.4	0.0	0.9	0.0	1.6	0.1	0.0	0.4	0.0	0.8	0.0	0.0	0.0	11.2	0.4	1.5	5.1	1.4	0.2	0.0	3.2	0.0	0.1	0.0	0.0	0.0	0.0	2.3	0.0	0.1	0.0	8.4	0.0	0.4	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.3	0.0	8.0	4.1	0.0	0.0	2.1	20.3	0.0	0.0	0.0	0.0	25.2	3.1	0.1	0.1	0.1	0.1	0.1	0.4	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	1.8	0.0	2.8	0.0	0.0	46.3	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	106.9	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	2.6	1.9	0.0	3.9	0.0	0.0	0.0
CPA6	CPAH	ENSG00000165078	"Carboxypeptidase A6"	Q8N4T0	8	67422038-67746385	"Disease related genes, Enzymes, Potential drug targets, Predicted secreted proteins"		"Carboxypeptidase, Hydrolase, Metalloprotease, Protease"	"Disease mutation, Epilepsy"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 16.2;prostate: 10.6;retina: 13.0"	"Cell type enhanced"	"Detected in some"	11	"Basal glandular cells: 26.9;Early spermatids: 15.2;Muller glia cells: 22.3;Pancreatic endocrine cells: 12.5;Urothelial cells: 26.0"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC TERT1: 2.0;CACO-2: 6.2;EFO-21: 3.5;Hep G2: 9.5;OE19: 4.2"	"Region enriched"	"Detected in single"	10	"olfactory region: 15.5"	"Low region specificity"	"Detected in all"								"Secreted to extracellular matrix"	NA	NA						"unprognostic (2.85e-2)"	"unprognostic (1.95e-1)"	"unprognostic (1.72e-2)"	"unprognostic (1.14e-1)"	"unprognostic (2.58e-1)"	"unprognostic (2.24e-1)"	"unprognostic (2.08e-1)"	"unprognostic (2.88e-1)"	"unprognostic (9.35e-2)"	"unprognostic (1.65e-1)"	"unprognostic (5.23e-2)"	"unprognostic (6.99e-2)"	"unprognostic (3.57e-4)"	"unprognostic (9.61e-5)"	"unprognostic (1.75e-1)"	"unprognostic (9.09e-2)"	"unprognostic (1.41e-2)"	0.2	0.1	0.1	9.8	0.1	0.2	0.2	0.1	0.1	9.4	16.2	0.7	0.8	0.2	8.3	1.7	3.7	0.2	0.3	0.1	0.2	0.1	0.3	0.1	0.7	0.1	0.2	0.0	0.1	0.1	0.1	0.2	0.3	0.3	10.6	7.2	13.0	0.1	0.7	0.1	0.2	1.3	3.4	0.7	0.3	0.5	1.3	0.0	0.0	0.2	1.5	0.6	4.1	5.5	0.0	0.6	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.2	0.0	0.0	6.2	0.0	0.0	3.5	0.0	0.2	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	9.5	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.8	0.0	4.2	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	1.7	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.1	0.1	0.1	0.1	0.2	0.1	0.2	0.0	0.3	0.0	0.0	0.0	0.0	26.9	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.2	0.0	0.0	0.0	0.3	0.0	0.0	5.6	0.0	0.0	0.1	1.6	2.4	0.0	0.0	0.5	1.7	0.0	0.0	0.0	0.7	22.3	12.5	2.9	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.6	26.0
CPB1		ENSG00000153002	"Carboxypeptidase B1"	P15086	3	148791102-148860187	"Enzymes, Plasma proteins, Predicted secreted proteins"		"Carboxypeptidase, Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	590	"pancreas: 3628.4"	"Cell type enriched"	"Detected in some"	7	"Exocrine glandular cells: 6332.0"	"Group enriched"	"Detected in some"	312	"breast cancer: 293.8;pancreatic cancer: 641.4"	"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"ASC diff: 2.8;EFO-21: 2.9;HDLM-2: 3.1;U-2 OS: 5.2;U-251 MG: 1.5;U-266/84: 2.4"	"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			"CAB026158, HPA038069, HPA046340"	Enhanced				"Secreted to digestive system"	NA	NA		6600000			"CAB026158: , HPA038069: AB_2675816, HPA046340: AB_2679628"	"unprognostic (6.90e-2)"	"unprognostic (3.79e-2)"	"unprognostic (3.34e-2)"	"unprognostic (2.64e-2)"	"unprognostic (5.58e-2)"	"unprognostic (3.27e-2)"	"unprognostic (6.26e-4)"	"unprognostic (1.90e-1)"	"unprognostic (1.82e-1)"	"unprognostic (1.07e-1)"	"unprognostic (7.59e-2)"	"unprognostic (4.51e-2)"	"unprognostic (5.50e-8)"	"unprognostic (3.08e-1)"	"unprognostic (1.60e-1)"		"unprognostic (4.93e-2)"	0.2	1.7	0.1	0.1	0.2	0.0	0.7	0.1	0.2	0.1	0.1	0.1	0.1	0.2	0.1	0.1	0.1	0.0	0.1	0.2	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	1.2	3628.4	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.2	0.1	0.1	0.0	0.1	0.1	0.1	0.7	0.2	0.4	0.2	0.1	0.1	0.1	0.1	0.1	0.1	1.8	1.1	6.1	1.0	3.1	3.5	0.9	0.0	0.0	0.0	0.0	2.8	0.7	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.8	2.9	0.0	0.0	0.0	0.0	0.0	0.1	3.1	0.5	0.6	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	5.2	0.0	1.5	0.0	2.4	0.6	0.0	0.0	0.0	6.1	0.7	1.1	3.0	0.9	2.2	0.9	1.3	2.6	0.3	1.8	0.9	3.5	4.5	3.1	1.0	1.1	0.6	0.9	0.1	0.2	0.1	0.2	0.1	0.0	0.1	0.1	0.1	0.2	0.0	0.0	0.0	0.2	0.6	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.2	9.9	0.1	0.0	0.0	6332.0	0.0	1.4	6.8	0.0	0.0	0.8	0.0	158.6	0.0	0.0	1.9	0.6	0.0	0.0	31.5	0.0	0.0	954.7	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.3	0.2	0.0	0.0	0.1
CPB2	"CPU, PCPB, TAFI"	ENSG00000080618	"Carboxypeptidase B2"	Q96IY4	13	46053195-46105033	"Enzymes, FDA approved drug targets, Plasma proteins, Predicted secreted proteins"	"Blood coagulation, Fibrinolysis, Hemostasis"	"Carboxypeptidase, Hydrolase, Metalloprotease, Protease"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	82	"liver: 246.8"	"Cell type enriched"	"Detected in some"	8	"Hepatocytes: 1070.7"	"Cancer enriched"	"Detected in some"	112	"liver cancer: 268.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	76	"Hep G2: 62.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA004146	Approved				"Secreted to blood"	NA	NA		14000000000			"HPA004146: AB_1078397"	"unprognostic (3.44e-2)"	"unprognostic (1.25e-1)"	"unprognostic (2.94e-2)"	"unprognostic (1.89e-2)"	"unprognostic (7.69e-2)"	"unprognostic (1.17e-2)"	"prognostic favorable (2.06e-4)"	"unprognostic (1.89e-1)"	"unprognostic (2.74e-1)"	"unprognostic (2.48e-1)"	"unprognostic (3.17e-2)"	"unprognostic (4.83e-2)"	"unprognostic (3.20e-3)"	"unprognostic (1.34e-1)"	"unprognostic (7.10e-2)"	"unprognostic (3.34e-2)"	"unprognostic (9.61e-2)"	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.7	0.0	0.0	0.0	0.0	246.8	3.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.2	0.5	0.5	0.4	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	62.5	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.3	0.0	0.6	0.0	0.0	0.4	0.2	0.1	0.0	0.0	0.4	0.2	0.5	0.4	0.5	0.2	0.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	3.0	24.8	0.0	0.0	0.0	0.0	0.0	127.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1070.7	0.1	0.0	0.0	16.0	15.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.9	0.0	0.0
CPD	GP180	ENSG00000108582	"Carboxypeptidase D"	O75976	17	30378905-30469989	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"		"Carboxypeptidase, Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Cholangiocytes: 178.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"neutrophil: 19.3"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA052796, HPA055465"	Approved		Approved	"Nucleoplasm,Nuclear membrane,Nuclear speckles"		NA	NA		930000	"Nucleoplasm, Nuclear speckles"	"Nuclear membrane"	"HPA052796: AB_2681953, HPA055465: AB_2682823"	"unprognostic (1.05e-1)"	"unprognostic (1.31e-1)"	"unprognostic (3.05e-2)"	"unprognostic (3.62e-2)"	"unprognostic (6.13e-2)"	"unprognostic (1.65e-1)"	"unprognostic (7.97e-3)"	"unprognostic (4.45e-2)"	"unprognostic (2.07e-2)"	"unprognostic (2.96e-1)"	"unprognostic (1.62e-1)"	"unprognostic (3.16e-1)"	"unprognostic (1.58e-1)"	"unprognostic (3.74e-2)"	"unprognostic (7.25e-2)"	"unprognostic (3.36e-1)"	"unprognostic (1.08e-1)"	16.4	8.0	9.8	12.3	12.4	18.1	17.9	9.1	13.3	28.6	16.2	18.5	10.1	12.9	12.6	10.1	10.0	15.2	33.6	10.5	12.8	10.4	13.4	26.8	20.0	14.2	22.1	11.4	7.8	14.7	21.2	14.9	22.3	13.9	11.4	13.3	7.5	59.7	7.9	10.0	7.8	22.0	15.1	25.9	7.9	24.6	25.0	13.5	5.8	37.2	7.7	10.0	11.5	11.6	0.4	3.4	19.3	5.5	2.1	3.8	2.5	12.2	18.7	16.2	16.7	16.9	32.2	5.8	16.9	24.8	11.7	14.5	21.9	7.9	1.5	21.6	19.4	14.9	8.8	10.5	21.4	19.9	5.8	15.0	3.5	11.5	13.5	20.6	22.7	9.2	57.4	9.6	15.0	14.6	19.6	23.8	5.3	6.7	18.1	9.4	2.4	7.3	6.2	4.5	28.2	4.3	7.0	18.8	4.7	22.0	14.0	4.1	10.3	20.2	17.5	8.8	19.8	16.5	15.8	28.3	11.7	7.7	18.2	16.1	7.3	15.2	5.2	15.0	14.9	9.9	2.8	5.5	6.4	3.4	2.8	3.8	0.2	1.7	2.8	3.4	0.4	1.4	1.7	19.3	2.1	2.3	0.4	1.1	2.5	9.8	12.4	9.1	13.3	12.8	10.4	22.1	11.4	13.9	13.5	29.8	19.2	7.5	28.1	19.6	23.1	10.4	178.3	18.7	27.3	27.9	43.2	20.5	1.7	21.2	75.9	48.4	31.6	0.0	21.4	9.1	26.2	58.6	24.2	67.2	14.9	44.5	31.0	51.0	34.9	41.5	15.5	20.5	28.7	10.0	69.1	11.1	30.2	20.1	15.2	17.7	35.0	0.0	22.6	15.6	24.2	16.3	20.1	20.8	31.5	38.6
CPE		ENSG00000109472	"Carboxypeptidase E"	P16870	4	165361194-165498320	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Carboxypeptidase, Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 203.7"	"Group enriched"	"Detected in many"	4	"Bipolar cells: 533.2;Cone photoreceptor cells: 585.1;Glandular cells: 402.2;Intestinal endocrine cells: 564.2;Leydig cells: 463.7;Muller glia cells: 511.1;Peritubular cells: 583.8;Rod photoreceptor cells: 443.0;Sertoli cells: 840.8;Smooth muscle cells: 614.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"T-reg: 1.5"	"Lineage enriched"	"Detected in single"	16	"T-cells: 1.5"	"Cell line enhanced"	"Detected in many"		"Hep G2: 49.0;SCLC-21H: 69.0;SiHa: 101.3;SuSa: 59.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003819, CAB024907"	Supported		Approved	Nucleoplasm,Vesicles,Centrosome	"Intracellular and membrane"	NA	NA		470000	Centrosome	"Nucleoplasm, Vesicles"	"CAB024907: , HPA003819: AB_2667054"	"unprognostic (1.84e-1)"	"unprognostic (5.64e-3)"	"unprognostic (1.61e-1)"	"unprognostic (1.70e-2)"	"unprognostic (2.51e-1)"	"unprognostic (1.44e-2)"	"unprognostic (1.65e-1)"	"unprognostic (9.52e-2)"	"unprognostic (2.91e-3)"	"unprognostic (9.01e-2)"	"unprognostic (4.84e-3)"	"unprognostic (5.56e-3)"	"prognostic unfavorable (2.60e-4)"	"unprognostic (4.35e-3)"	"unprognostic (1.46e-1)"	"unprognostic (2.26e-1)"	"prognostic unfavorable (2.12e-4)"	27.7	33.8	123.1	4.4	135.5	0.9	21.5	82.9	203.7	10.7	9.6	31.6	5.3	5.0	13.3	94.3	16.4	15.7	14.0	19.6	116.9	56.3	12.0	6.3	11.0	7.6	56.9	70.7	23.4	35.5	33.9	40.0	2.2	53.0	66.5	8.8	13.2	12.0	20.1	11.0	5.5	6.2	18.5	40.5	2.8	19.2	30.4	53.3	0.9	40.7	4.3	7.7	6.3	9.4	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	1.3	8.9	1.7	7.1	0.7	0.4	0.0	3.6	1.3	2.9	0.0	0.0	0.0	2.6	0.0	0.3	0.2	3.4	0.7	0.7	0.0	13.0	0.0	3.6	49.0	0.5	0.0	0.0	17.3	3.6	0.0	0.0	17.2	0.0	0.0	0.0	0.3	1.8	2.4	0.0	0.4	5.6	0.0	2.0	0.0	0.0	0.1	0.1	0.5	69.0	22.8	101.3	12.7	0.0	59.1	7.6	0.3	0.0	2.7	7.0	0.2	0.2	3.9	0.0	0.3	2.6	0.1	0.8	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	123.1	135.5	82.9	82.2	116.9	56.3	56.9	70.7	53.0	53.3	0.0	9.3	0.0	67.8	23.2	533.2	32.3	40.8	0.0	3.4	21.0	585.1	0.4	0.0	15.1	5.5	57.1	1.6	0.0	1.5	0.1	129.4	402.2	0.0	7.9	0.8	66.7	564.2	115.4	9.2	11.5	463.7	12.5	82.7	1.8	12.7	511.1	19.3	2.9	583.8	9.6	443.0	840.8	614.9	17.7	9.6	18.2	0.7	1.9	3.7	11.3
CPM		ENSG00000135678	"Carboxypeptidase M"	P14384	12	68842197-68971570	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"		"Carboxypeptidase, Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 56.1"	"Cell type enhanced"	"Detected in many"	11	"Alveolar cells type 1: 333.5;Sertoli cells: 750.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"classical monocyte: 15.5;myeloid DC: 11.9"	"Group enriched"	"Detected in many"	5	"dendritic cells: 11.9;monocytes: 15.5"	"Cell line enhanced"	"Detected in many"		"ASC diff: 29.5;ASC TERT1: 21.0;HSkMC: 37.8;SiHa: 27.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA002657, HPA077243"	Enhanced		Uncertain	Vesicles		NA	NA		5000000	Vesicles		"HPA002657: AB_1078398, HPA077243: "	"unprognostic (1.74e-1)"	"unprognostic (3.11e-1)"	"unprognostic (2.88e-3)"	"prognostic favorable (1.00e-4)"	"unprognostic (4.58e-2)"	"unprognostic (8.61e-2)"	"unprognostic (1.57e-2)"	"unprognostic (2.01e-1)"	"unprognostic (8.42e-2)"	"unprognostic (1.40e-1)"	"unprognostic (1.35e-1)"	"unprognostic (1.42e-1)"	"unprognostic (1.47e-3)"	"unprognostic (8.58e-2)"	"unprognostic (6.85e-2)"	"unprognostic (2.59e-2)"	"unprognostic (1.06e-1)"	56.1	6.6	3.8	5.4	7.0	1.1	37.2	1.2	4.9	6.5	12.9	13.2	0.9	1.6	10.7	6.1	4.1	6.4	6.5	2.9	5.3	3.0	22.1	11.6	24.1	13.0	10.9	4.3	7.5	7.8	3.2	1.0	27.9	5.5	6.2	10.8	2.7	3.2	1.7	8.2	13.0	3.7	2.5	6.7	11.4	5.9	5.8	9.3	1.1	5.1	3.5	4.5	4.4	4.4	2.8	11.9	1.3	15.5	0.3	1.3	4.7	0.0	1.5	0.0	0.0	29.5	21.0	0.3	3.9	0.4	0.7	0.9	1.2	1.6	0.2	3.9	0.5	1.7	0.0	0.5	1.0	1.7	0.0	1.0	0.0	6.4	0.1	0.1	0.4	0.7	37.8	0.2	0.4	0.8	3.5	0.0	0.1	0.0	0.0	3.0	0.6	0.0	0.2	0.6	0.0	2.1	1.2	0.2	0.0	2.9	2.3	0.1	0.0	27.7	4.3	3.3	2.3	0.4	10.3	0.1	0.5	3.2	0.2	0.0	0.1	0.1	5.1	1.7	5.2	2.3	0.3	15.5	0.1	0.1	10.2	0.0	1.4	1.2	0.0	11.9	2.8	0.7	0.1	1.3	0.3	4.7	0.8	1.3	4.7	3.8	7.0	1.2	4.9	5.3	3.0	10.9	4.3	5.5	9.3	333.5	253.0	5.4	2.5	11.0	2.5	1.6	147.7	26.8	114.9	48.8	0.0	22.1	24.9	48.5	13.5	7.1	69.0	0.0	179.6	47.4	3.8	40.7	105.6	33.4	132.7	0.0	10.4	90.2	236.7	12.1	97.2	57.6	10.1	10.8	28.4	65.4	68.6	50.7	74.3	67.7	4.3	750.3	107.2	0.5	1.9	8.7	144.2	7.9	29.3	2.4
CPN1		ENSG00000120054	"Carboxypeptidase N subunit 1"	P15169	10	100042193-100081877	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins"		"Carboxypeptidase, Hydrolase, Metalloprotease, Protease"	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	127	"liver: 76.8"	"Cell type enriched"	"Detected in some"	12	"Hepatocytes: 24.6"	"Group enriched"	"Detected in some"	12	"liver cancer: 26.6;melanoma: 7.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	17	"SK-MEL-30: 56.6"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"								"Secreted to blood"	NA	NA		22000000000						"unprognostic (2.97e-2)"	"unprognostic (2.23e-2)"			"unprognostic (3.93e-2)"		"unprognostic (1.64e-1)"		"unprognostic (6.75e-2)"		"unprognostic (2.93e-2)"	"unprognostic (5.26e-2)"	"unprognostic (2.63e-1)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	76.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	56.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.1	0.0	0.2	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	24.6	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	1.6	2.1	0.0	0.1	0.0	0.1	0.0
CPO		ENSG00000144410	"Carboxypeptidase O"	Q8IVL8	2	206939554-206969474	"Enzymes, Predicted intracellular proteins"		"Carboxypeptidase, Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	7	"intestine: 71.1"	"Cell type enriched"	"Detected in single"	6	"Early spermatids: 1.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	17	"basophil: 10.3"	"Lineage enriched"	"Detected in single"	42	"granulocytes: 10.3"	"Cell line enhanced"	"Detected in some"		"ASC diff: 2.8;hTCEpi: 2.1;hTERT-RPE1: 2.4;NB-4: 3.9;SuSa: 2.5"					"Low region specificity"	"Detected in single"								"Intracellular and membrane"	NA	NA						"unprognostic (9.39e-2)"	"unprognostic (2.64e-1)"	"unprognostic (2.95e-2)"	"unprognostic (5.21e-2)"	"unprognostic (2.28e-1)"	"unprognostic (1.27e-2)"	"unprognostic (1.16e-1)"	"unprognostic (9.06e-2)"	"unprognostic (4.03e-1)"	"unprognostic (1.33e-1)"	"unprognostic (3.75e-3)"	"unprognostic (1.22e-1)"	"unprognostic (3.60e-2)"	"unprognostic (2.52e-1)"	"unprognostic (6.56e-2)"	"unprognostic (4.03e-2)"	"unprognostic (4.89e-2)"	0.2	0.4	0.2	0.1	0.9	0.0	0.3	0.1	0.4	0.2	0.6	0.1	1.1	0.1	0.1	9.4	0.1	0.1	0.1	0.1	0.2	0.5	0.5	0.2	0.1	0.1	0.2	0.1	0.1	0.1	0.6	0.5	0.1	0.1	0.3	0.1	0.1	0.3	0.3	0.2	0.1	71.1	0.2	0.1	0.1	0.1	0.3	0.1	0.1	0.4	0.1	0.1	0.1	0.1	0.0	0.0	10.3	0.0	0.0	0.2	0.0	0.0	0.3	0.3	0.0	2.8	1.0	1.6	0.4	0.0	0.0	0.1	0.3	0.2	0.1	0.7	0.0	0.0	0.0	0.3	0.2	0.1	0.2	0.5	0.0	0.0	0.2	0.0	0.7	0.2	0.8	2.1	0.0	0.0	2.4	0.0	0.7	0.0	0.0	0.2	0.0	0.1	3.9	0.2	0.3	0.6	0.1	0.0	0.2	1.4	0.1	0.3	0.0	0.0	0.3	0.0	2.5	0.2	0.5	0.0	0.0	1.0	0.6	0.3	0.1	0.9	0.0	0.0	0.2	0.5	10.3	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.9	0.1	0.4	0.2	0.5	0.2	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0
CPOX	"CPO, CPX, HCP"	ENSG00000080819	"Coproporphyrinogen oxidase"	P36551	3	98521132-98593723	"Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins"	"Heme biosynthesis, Porphyrin biosynthesis"	Oxidoreductase	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 42.9"	"Cell type enhanced"	"Detected in many"	13	"Erythroid cells: 140.2;Extravillous trophoblasts: 67.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in all"		"HEL: 58.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA015736, HPA054448"			Enhanced	Mitochondria		No	No		140000	Mitochondria		"HPA015736: AB_1847194, HPA054448: AB_2682490"	"unprognostic (2.14e-1)"	"unprognostic (1.04e-1)"	"unprognostic (4.07e-2)"	"unprognostic (6.09e-2)"	"unprognostic (2.71e-1)"	"unprognostic (2.34e-2)"	"unprognostic (8.58e-3)"	"unprognostic (7.14e-2)"	"unprognostic (2.53e-2)"	"unprognostic (2.01e-1)"	"unprognostic (1.10e-2)"	"unprognostic (1.86e-2)"	"prognostic unfavorable (1.04e-5)"	"unprognostic (1.62e-1)"	"unprognostic (2.67e-2)"	"unprognostic (2.15e-2)"	"unprognostic (2.57e-1)"	6.6	8.9	12.6	9.0	29.9	30.2	6.6	10.1	21.1	7.5	8.2	29.6	5.7	17.7	8.8	6.4	14.1	6.4	7.2	6.9	17.5	11.7	5.6	29.3	6.3	9.1	42.9	16.2	9.5	6.9	9.9	5.5	14.8	23.7	7.4	10.3	3.4	7.2	7.2	8.5	10.8	12.3	7.7	32.8	9.1	7.7	3.9	36.0	7.7	6.2	7.0	9.8	8.5	10.4	1.7	1.7	0.0	2.1	2.1	3.0	0.7	16.6	8.1	7.2	12.7	13.5	10.0	20.7	10.8	7.8	11.1	12.7	13.4	5.2	1.7	12.1	5.7	12.3	12.1	8.9	11.6	19.0	5.3	7.8	58.1	4.6	17.3	6.9	12.2	13.8	7.8	9.8	10.5	4.4	13.1	10.6	7.2	11.1	7.5	10.4	5.1	12.3	10.5	8.5	9.3	14.8	8.8	16.4	7.7	9.4	6.9	4.8	4.7	11.4	3.9	32.3	8.4	6.1	7.9	8.8	16.6	16.3	9.5	7.8	11.6	9.1	9.4	16.5	13.5	12.1	0.0	2.1	0.0	1.4	1.0	2.5	1.7	2.4	2.9	1.7	1.5	0.8	3.0	0.0	2.1	0.7	1.1	1.1	0.7	12.6	29.9	10.1	21.1	17.5	11.7	42.9	16.2	23.7	36.0	3.0	8.3	6.9	4.0	6.5	3.4	7.1	2.5	1.4	0.0	3.5	7.9	21.7	1.7	3.0	0.0	5.8	6.4	140.2	1.6	67.8	9.9	4.4	1.1	30.1	11.2	0.0	8.1	11.6	10.8	0.0	6.9	8.9	11.8	10.8	8.6	6.0	2.8	0.0	7.4	5.1	5.3	12.9	9.0	0.0	3.2	8.9	8.9	10.7	9.7	3.7
CPPED1	"CSTP1, FLJ11151"	ENSG00000103381	"Calcineurin like phosphoesterase domain containing 1"	Q9BRF8	16	12659799-12804017	"Enzymes, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 93.6"	"Cell type enhanced"	"Detected in many"	6	"Cytotrophoblasts: 85.5;Syncytiotrophoblasts: 110.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"neutrophil: 93.6"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Hep G2: 45.3;HMC-1: 42.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040938, HPA041970"	Uncertain		Supported	"Plasma membrane,Cytosol"		No	No		380000	Cytosol	"Plasma membrane"	"HPA040938: AB_10673443, HPA041970: AB_2677774"	"prognostic unfavorable (9.72e-4)"	"unprognostic (1.70e-1)"	"unprognostic (2.04e-3)"	"unprognostic (1.05e-2)"	"unprognostic (1.13e-3)"	"unprognostic (3.86e-2)"	"unprognostic (1.35e-1)"	"unprognostic (8.67e-2)"	"unprognostic (1.23e-1)"	"unprognostic (3.26e-2)"	"unprognostic (6.26e-2)"	"unprognostic (3.64e-1)"	"prognostic favorable (1.62e-9)"	"unprognostic (5.05e-2)"	"unprognostic (1.25e-1)"	"unprognostic (2.48e-3)"	"unprognostic (2.40e-2)"	10.9	11.5	8.3	14.3	14.3	9.5	8.5	2.7	11.8	9.2	13.8	20.8	7.4	16.3	8.2	6.2	23.1	7.2	8.9	10.7	11.2	9.5	26.2	31.4	10.4	21.2	20.7	7.7	6.4	4.1	4.3	6.5	36.6	17.6	9.1	11.9	10.2	15.1	7.3	6.4	6.8	20.5	10.0	22.1	27.4	8.1	18.2	13.1	5.8	11.1	8.4	16.9	9.8	9.6	1.5	23.1	93.6	43.7	1.9	1.8	14.6	1.5	9.5	1.0	2.5	4.0	8.5	0.1	17.4	4.7	9.3	7.6	4.6	4.9	2.3	18.0	12.6	4.1	0.1	0.0	4.3	9.7	5.3	2.6	19.7	1.4	45.3	2.5	0.0	42.8	8.5	0.9	0.8	6.7	0.0	13.9	3.2	6.8	1.4	22.8	1.9	1.7	9.1	2.8	0.7	1.3	3.7	6.1	4.9	14.1	3.0	5.0	3.3	0.0	15.8	6.2	5.2	3.4	4.3	20.8	13.5	2.8	0.0	0.0	0.0	0.3	3.6	3.0	10.0	2.8	6.1	30.6	19.3	1.3	43.7	1.1	1.5	1.1	1.4	23.1	1.0	0.3	0.8	93.6	1.9	40.6	5.6	1.8	14.6	8.3	14.3	2.7	11.8	11.2	9.5	20.7	7.7	17.6	13.1	8.9	18.4	13.0	2.9	4.0	3.6	8.2	7.6	10.7	6.8	14.0	7.9	85.5	51.4	33.8	2.3	11.3	13.5	0.0	10.9	10.0	9.3	3.3	52.1	38.5	44.3	9.5	5.8	7.4	74.6	2.3	14.4	42.4	6.8	27.9	7.5	12.5	30.7	13.6	22.6	51.8	5.5	25.8	4.2	1.6	11.5	4.0	110.3	7.4	10.6	1.4
CPQ	"LDP, PGCP"	ENSG00000104324	"Carboxypeptidase Q"	Q9Y646	8	96645227-97149654	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"		"Carboxypeptidase, Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"thyroid gland: 94.4"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"neutrophil: 62.6"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"ASC diff: 37.0;ASC TERT1: 42.5;hTERT-RPE1: 34.7;Karpas-707: 30.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023235, HPA024490"	Enhanced		Supported	"Golgi apparatus,Vesicles"	"Secreted to blood"	NA	NA		51000000	"Golgi apparatus, Vesicles"		"HPA023235: AB_1855257, HPA024490: AB_1855258"	"unprognostic (4.04e-2)"	"unprognostic (5.46e-2)"	"unprognostic (4.45e-2)"	"unprognostic (1.68e-1)"	"unprognostic (1.51e-3)"	"unprognostic (3.98e-3)"	"unprognostic (5.24e-2)"	"unprognostic (2.92e-2)"	"unprognostic (2.67e-2)"	"unprognostic (9.19e-2)"	"unprognostic (2.38e-3)"	"unprognostic (6.16e-3)"	"prognostic favorable (5.40e-5)"	"unprognostic (6.74e-3)"	"unprognostic (8.71e-2)"	"unprognostic (3.21e-2)"	"unprognostic (1.75e-1)"	17.4	12.6	12.5	10.1	18.3	9.5	15.4	8.3	11.3	26.3	16.5	19.4	21.1	9.4	24.5	19.5	9.1	16.8	20.0	24.1	14.0	9.2	26.4	22.1	13.9	12.3	27.6	8.8	35.3	18.8	20.7	14.2	12.4	16.6	18.1	10.9	19.8	10.9	18.6	5.0	9.1	14.1	30.8	15.3	12.9	14.5	7.3	24.5	1.3	94.4	8.1	7.2	16.9	19.3	1.8	12.8	62.6	17.5	6.3	7.3	8.4	0.6	1.9	1.6	0.4	37.0	42.5	0.5	11.3	17.1	4.0	8.4	1.3	0.7	1.0	9.2	17.8	5.8	0.6	0.7	0.8	3.9	10.2	1.5	9.6	1.8	5.6	8.2	2.3	12.5	22.2	2.0	4.6	1.1	34.7	1.8	0.6	9.3	30.9	9.1	0.6	0.3	4.7	1.2	0.8	1.9	2.1	0.3	0.5	8.3	4.3	1.2	0.8	4.0	0.4	8.7	10.1	4.3	9.3	8.1	17.7	2.1	0.8	4.2	3.1	0.7	0.4	11.2	7.7	11.7	5.4	17.5	10.8	7.3	12.0	7.3	1.5	5.5	6.3	12.8	1.8	5.0	6.7	62.6	6.3	11.0	3.7	5.7	8.4	12.5	18.3	8.3	11.3	14.0	9.2	27.6	8.8	16.6	24.5	11.9	12.2	10.4	23.2	17.2	13.3	24.2	48.4	5.3	9.1	45.4	27.5	10.3	14.9	15.7	4.0	23.3	10.7	0.0	9.4	1.2	64.4	11.1	36.9	37.7	48.7	9.5	13.3	50.3	56.8	5.7	67.0	38.8	74.2	14.4	6.1	41.4	11.7	8.6	68.6	42.8	14.9	51.8	32.1	4.7	3.6	11.4	5.0	17.9	10.9	12.0
CPS1		ENSG00000021826	"Carbamoyl-phosphate synthase 1"	P31327	2	210477682-210679107	"Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"	"Urea cycle"	"Allosteric enzyme, Ligase"	"Disease mutation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	9	"liver: 298.3"	"Cell type enriched"	"Detected in many"	72	"Hepatocytes: 1670.2"	"Cancer enriched"	"Detected in many"	8	"liver cancer: 136.1"	"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HeLa: 90.5;SK-BR-3: 27.3"	"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			"CAB003781, HPA021400"	Enhanced		Supported	"Nucleoli,Nucleoli rim"		NA	NA		2100000	"Nucleoli, Nucleoli rim"		"CAB003781: , HPA021400: AB_1847197"	"unprognostic (1.67e-2)"	"unprognostic (3.72e-2)"	"unprognostic (4.02e-2)"	"unprognostic (7.21e-7)"	"unprognostic (3.81e-2)"	"unprognostic (2.52e-1)"	"prognostic favorable (6.93e-5)"	"unprognostic (1.23e-2)"	"unprognostic (2.65e-1)"	"unprognostic (1.35e-2)"	"unprognostic (5.38e-2)"	"unprognostic (1.94e-3)"	"unprognostic (2.38e-4)"	"unprognostic (5.90e-2)"	"unprognostic (1.13e-1)"	"unprognostic (3.14e-2)"	"unprognostic (3.74e-2)"	0.4	0.1	0.5	0.3	1.6	0.0	0.8	0.3	0.7	0.4	0.2	0.7	0.3	31.5	0.3	0.7	0.5	0.2	0.4	0.3	0.5	0.4	0.6	298.3	0.2	0.3	1.5	0.8	0.7	0.2	0.0	0.4	1.1	1.4	0.3	0.0	0.6	0.2	0.2	0.3	0.3	17.2	0.4	2.3	0.3	0.2	1.3	0.5	0.0	0.4	0.4	0.1	0.2	0.4	0.3	0.0	0.0	0.0	0.0	0.8	0.0	0.3	2.4	6.3	4.3	4.2	7.4	6.7	2.3	2.7	2.7	4.2	0.6	0.0	1.0	0.1	2.5	3.8	1.1	0.2	3.8	6.8	0.0	1.9	4.0	90.5	5.6	1.4	2.1	0.0	3.8	2.8	5.3	5.4	6.9	0.3	1.7	4.0	0.3	4.4	1.1	0.1	0.2	2.4	0.0	0.6	0.2	5.8	0.5	5.7	0.0	0.1	0.4	15.8	27.3	3.0	8.5	0.0	0.7	3.0	7.0	2.1	2.1	4.9	0.0	0.3	0.0	4.6	4.4	4.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.3	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.5	1.6	0.3	0.7	0.5	0.4	1.5	0.8	1.4	0.5	11.9	9.6	20.7	0.5	1.9	1.1	0.7	15.3	1.4	6.8	1.8	7.9	0.3	0.0	0.1	23.2	1.4	0.3	23.3	0.2	0.4	2.5	1.2	3.5	1670.2	0.2	0.0	0.0	16.5	22.7	3.6	2.3	1.8	1.7	0.0	0.1	1.4	0.0	0.0	1.1	0.7	2.2	0.0	2.5	0.3	1.1	1.6	17.4	5.0	0.1	0.4
CPT1A	"CPT1, CPT1-L, L-CPT1"	ENSG00000110090	"Carnitine palmitoyltransferase 1A"	P50416	11	68754620-68844410	"Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Fatty acid metabolism, Lipid metabolism, Transport"	"Acyltransferase, Transferase"	"Disease mutation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA008835	Supported		Supported	Mitochondria		NA	NA		790000	Mitochondria		"HPA008835: AB_1078563"	"prognostic unfavorable (3.84e-4)"	"unprognostic (1.38e-3)"	"unprognostic (3.04e-3)"	"unprognostic (2.46e-2)"	"unprognostic (1.45e-1)"	"unprognostic (7.25e-2)"	"unprognostic (2.17e-1)"	"unprognostic (4.99e-2)"	"unprognostic (2.72e-1)"	"unprognostic (1.47e-2)"	"unprognostic (2.92e-2)"	"unprognostic (2.34e-1)"	"prognostic favorable (2.67e-7)"	"unprognostic (9.76e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.49e-1)"	"unprognostic (2.46e-3)"	18.0	18.3	9.9	9.9	12.1	15.8	24.4	7.0	10.3	12.8	31.9	8.2	14.1	33.7	17.0	7.2	11.2	12.8	14.7	14.6	12.0	6.6	30.6	62.0	13.1	10.1	10.5	8.6	17.0	24.4	16.9	13.8	8.7	10.8	15.6	22.0	19.7	12.9	11.4	6.9	10.3	33.4	16.9	8.7	18.9	16.8	10.4	9.0	17.9	13.2	7.5	7.6	11.3	30.2	2.5	11.9	10.6	8.6	5.7	8.8	2.5	8.1	14.5	2.1	14.2	9.3	8.4	0.6	6.5	5.4	5.2	1.0	0.5	27.6	0.0	24.2	17.2	18.2	26.9	18.4	3.9	1.5	13.0	1.8	20.1	15.8	6.7	13.9	11.6	24.3	8.7	1.9	10.4	6.3	7.1	18.3	8.1	2.1	16.5	4.7	23.4	9.4	20.6	0.2	42.2	15.4	26.5	0.3	35.6	12.2	20.4	0.2	9.3	18.0	34.9	5.7	1.4	31.1	11.3	18.4	11.3	0.2	22.6	9.4	12.9	16.4	8.3	11.9	8.6	12.3	9.2	7.8	10.6	8.8	8.6	5.1	2.3	5.5	5.3	5.0	2.5	3.4	7.0	3.8	5.7	7.2	11.9	2.9	2.5	9.9	12.1	7.0	10.3	12.0	6.6	10.5	8.6	10.8	9.0	35.7	36.9	11.5	7.7	8.4	4.9	22.1	28.1	32.1	22.7	22.7	60.9	12.9	16.6	11.2	9.2	25.4	82.1	0.0	8.1	4.1	13.9	7.4	27.8	79.0	14.6	1.6	15.5	37.4	42.3	15.7	8.9	13.5	0.0	11.8	44.9	12.9	9.7	40.3	30.1	9.4	41.0	38.8	16.0	12.1	8.8	6.8	6.5	16.6	59.0	6.4
CPT1B	"CPT1-M, M-CPT1"	ENSG00000205560	"Carnitine palmitoyltransferase 1B"	Q92523	22	50568861-50578465	"Enzymes, Predicted membrane proteins"	"Fatty acid metabolism, Lipid metabolism, Transport"	"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 162.2;skeletal muscle: 59.8"	"Group enriched"	"Detected in many"	6	"Early spermatids: 35.8;Late spermatids: 93.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			HPA079265	Enhanced					NA	NA					"HPA079265: "	"unprognostic (1.66e-1)"	"unprognostic (2.99e-1)"	"unprognostic (6.71e-3)"	"unprognostic (2.53e-2)"	"unprognostic (1.36e-1)"	"unprognostic (1.18e-3)"	"unprognostic (8.89e-2)"	"unprognostic (7.16e-2)"	"unprognostic (5.01e-2)"	"unprognostic (9.50e-2)"	"unprognostic (1.10e-3)"	"unprognostic (9.76e-3)"	"unprognostic (7.37e-2)"	"unprognostic (4.98e-3)"	"unprognostic (1.14e-1)"	"unprognostic (8.43e-2)"	"unprognostic (3.15e-5)"	4.3	1.5	1.7	2.9	2.7	3.3	2.8	9.1	2.0	1.7	3.1	1.8	1.6	3.8	1.6	2.9	3.7	0.9	1.6	162.2	2.1	1.9	4.0	4.2	1.9	3.5	2.5	1.6	1.6	3.1	17.2	4.5	2.3	2.2	2.5	2.9	5.2	4.3	1.6	59.8	3.8	3.7	1.6	2.2	5.0	3.8	19.7	2.3	1.9	5.2	39.6	4.5	2.0	1.6	0.5	2.3	0.7	0.4	2.3	1.6	0.3	5.3	4.9	15.7	5.8	3.6	2.1	12.4	0.6	2.0	2.6	3.0	2.3	4.7	10.6	1.8	1.2	4.1	8.8	8.3	1.9	2.4	4.3	9.2	5.3	14.3	2.4	0.9	5.5	15.4	1.2	14.3	1.9	3.1	9.9	0.5	7.5	1.8	17.9	2.5	7.5	2.1	10.7	3.4	2.7	3.3	9.7	5.1	2.3	6.7	12.6	4.4	8.5	4.0	6.4	6.5	10.1	7.0	11.6	1.1	7.7	8.2	5.1	1.8	15.3	3.5	5.5	3.6	9.8	5.2	0.0	0.4	0.5	1.0	0.1	0.0	0.5	1.6	0.3	2.3	0.2	0.4	0.2	0.7	2.3	0.2	0.3	0.1	0.3	1.7	2.7	9.1	2.0	2.1	1.9	2.5	1.6	2.2	2.3	0.0	11.2	0.0	0.0	0.2	1.8	2.8	2.5	0.0	1.2	3.5	2.0	0.4	0.0	1.6	35.8	0.4	3.9	0.0	1.8	0.5	0.6	0.0	6.9	1.9	0.5	3.2	0.0	0.6	0.0	93.5	0.3	0.7	1.7	10.8	4.9	0.2	1.1	2.5	0.7	0.3	1.6	0.0	0.3	6.9	1.7	0.3	0.3	1.3	3.7	0.0
CPT1C	"CPT1P, CPTIC, FLJ23809"	ENSG00000169169	"Carnitine palmitoyltransferase 1C"	Q8TCG5	19	49690898-49713731	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Fatty acid metabolism, Lipid metabolism"	"Acyltransferase, Transferase"	"Disease mutation, Hereditary spastic paraplegia, Neurodegeneration"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 34.0"	"Cell type enhanced"	"Detected in many"	10	"Bipolar cells: 39.6;Horizontal cells: 30.2;Late spermatids: 17.8;Rod photoreceptor cells: 18.1"	"Cancer enhanced"	"Detected in many"		"glioma: 9.8"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AF22: 18.8;AN3-CA: 15.8;SCLC-21H: 13.1;SH-SY5Y: 33.9;U-87 MG: 14.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA014529, HPA063621"	Approved		Approved	Centrosome		NA	NA			Centrosome		"HPA014529: AB_1847206, HPA063621: AB_2732706"	"unprognostic (1.09e-1)"	"unprognostic (6.25e-2)"	"unprognostic (1.03e-2)"	"unprognostic (5.18e-3)"	"unprognostic (1.73e-1)"	"unprognostic (1.46e-3)"	"unprognostic (1.39e-1)"	"unprognostic (2.54e-1)"	"unprognostic (1.06e-1)"	"unprognostic (2.49e-1)"	"prognostic favorable (1.84e-4)"	"unprognostic (4.36e-1)"	"unprognostic (1.92e-10)"	"unprognostic (9.44e-4)"	"unprognostic (3.35e-2)"	"unprognostic (3.91e-1)"	"unprognostic (4.72e-3)"	3.4	9.3	11.2	3.1	18.9	0.8	1.1	16.3	34.0	4.1	1.9	8.9	0.2	2.7	6.4	5.3	1.8	4.1	7.6	2.8	11.9	12.8	1.6	1.6	2.5	2.6	8.0	13.4	3.8	1.2	0.7	15.6	1.9	11.4	2.8	1.7	7.4	1.5	4.8	1.7	1.5	2.4	7.8	6.6	4.2	1.4	4.1	6.3	0.0	1.7	0.2	1.7	4.4	1.9	0.0	0.0	0.0	0.0	0.0	0.9	0.5	0.0	0.0	18.8	15.8	6.8	5.4	0.0	6.0	11.9	7.7	10.8	0.3	0.0	0.3	0.0	5.9	0.9	1.4	0.0	0.0	4.1	0.2	0.0	0.0	0.0	0.0	11.1	0.0	0.0	6.2	0.0	6.2	0.0	2.0	10.6	0.0	0.0	0.0	0.4	0.3	0.1	0.0	0.8	1.2	3.9	0.0	0.0	0.0	0.4	0.0	13.1	33.9	0.0	0.0	0.0	0.3	0.0	0.0	8.6	0.4	0.1	3.6	3.0	0.1	1.4	0.1	14.2	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.5	11.2	18.9	16.3	23.4	11.9	12.8	8.0	13.4	11.4	6.3	0.0	0.0	0.0	3.3	1.9	39.6	1.2	2.5	0.0	0.0	0.0	15.7	0.8	0.0	0.0	7.9	4.5	0.0	0.0	0.0	3.6	3.1	1.5	0.0	0.0	0.3	30.2	0.0	3.1	1.2	17.8	3.1	0.0	0.0	0.0	0.0	14.9	0.5	0.0	12.4	0.0	18.1	0.0	5.3	2.7	6.9	1.6	0.9	0.0	0.0	0.9
CPT2	"CPT1, CPTASE"	ENSG00000157184	"Carnitine palmitoyltransferase 2"	P23786	1	53196429-53214197	"Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"	"Fatty acid metabolism, Lipid metabolism, Transport"	"Acyltransferase, Transferase"	"Disease mutation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 69.0"	"Cell type enhanced"	"Detected in many"	6	"Cytotrophoblasts: 64.6;Hepatocytes: 80.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028201, HPA028202, HPA028214"	Enhanced		Approved	Nucleoplasm,Nucleoli,Mitochondria		Yes	No			"Nucleoplasm, Mitochondria"	Nucleoli	"HPA028201: AB_10599177, HPA028202: AB_10599942, HPA028214: AB_10601958"	"unprognostic (2.43e-1)"	"unprognostic (2.27e-1)"	"prognostic favorable (5.27e-4)"	"unprognostic (6.48e-2)"	"unprognostic (1.88e-1)"	"unprognostic (9.34e-2)"	"unprognostic (6.48e-2)"	"unprognostic (1.75e-2)"	"unprognostic (2.86e-1)"	"unprognostic (1.67e-1)"	"unprognostic (3.00e-2)"	"unprognostic (8.97e-2)"	"prognostic favorable (1.46e-12)"	"unprognostic (4.00e-2)"	"unprognostic (2.06e-1)"	"unprognostic (1.79e-2)"	"unprognostic (2.95e-2)"	7.5	15.5	5.3	6.8	6.1	2.3	6.5	4.0	7.2	5.1	15.4	9.4	10.7	16.6	5.1	7.6	10.5	5.4	11.3	21.4	4.3	4.5	19.8	69.0	6.9	8.3	5.7	3.7	5.3	15.9	10.7	11.5	18.1	6.4	6.0	15.6	13.8	11.8	12.2	13.6	6.0	18.9	5.5	5.2	10.3	10.1	11.2	4.7	9.7	8.3	7.2	10.3	8.0	4.9	5.9	12.4	10.0	13.1	4.8	8.0	6.5	7.7	3.2	7.5	7.3	6.5	3.8	8.5	4.8	4.9	6.9	6.4	1.6	6.5	13.2	7.3	2.2	7.8	7.7	14.0	11.0	5.9	7.3	8.2	7.5	4.3	1.3	9.5	7.1	7.3	8.2	9.4	5.0	4.2	7.7	4.7	11.7	9.6	4.7	4.2	4.5	5.5	5.8	14.0	14.4	8.6	6.4	7.2	13.9	8.6	7.2	11.2	7.6	9.6	12.2	18.1	18.1	14.2	15.2	4.5	3.9	3.1	6.8	3.9	14.5	8.9	8.1	5.0	8.2	5.7	4.1	8.4	10.0	5.1	12.6	6.2	4.5	4.9	5.9	12.4	5.9	8.0	5.5	5.1	4.8	13.1	6.4	7.0	6.5	5.3	6.1	4.0	7.2	4.3	4.5	5.7	3.7	6.4	4.7	11.9	20.8	8.9	5.1	1.5	3.1	12.4	15.3	4.0	3.4	10.4	13.7	64.6	21.6	10.7	1.1	3.6	39.8	0.0	9.3	16.0	2.8	4.8	2.3	80.0	23.6	14.3	13.9	6.7	13.5	2.1	6.4	8.2	6.8	26.2	26.9	10.5	9.8	21.0	4.9	28.3	9.9	6.5	3.2	29.8	16.3	2.3	45.7	7.1	25.3	4.6
CPVL		ENSG00000106066	"Carboxypeptidase, vitellogenic like"	Q9H3G5	7	28995231-29195451	"Enzymes, Predicted intracellular proteins"		"Carboxypeptidase, Hydrolase, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 111.9;lymphoid tissue: 84.0"	"Cell type enhanced"	"Detected in many"	9	"Hofbauer cells: 263.6;Kupffer cells: 230.2;Macrophages: 292.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"classical monocyte: 95.8;intermediate monocyte: 81.6;myeloid DC: 111.9"	"Group enriched"	"Detected in many"	52	"dendritic cells: 111.9;monocytes: 95.8"	"Cell line enriched"	"Detected in many"	4	"RPTEC TERT1: 131.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"CAB003697, HPA045715, HPA056466"	Enhanced		Supported	"Endoplasmic reticulum"	"Intracellular and membrane"	NA	NA		510000	"Endoplasmic reticulum"		"CAB003697: AB_425990, HPA045715: AB_2679429, HPA056466: AB_2683140"	"unprognostic (4.72e-2)"	"unprognostic (7.08e-2)"	"unprognostic (5.96e-2)"	"prognostic unfavorable (8.56e-6)"	"unprognostic (1.63e-1)"	"unprognostic (2.49e-2)"	"unprognostic (6.85e-3)"	"unprognostic (7.01e-2)"	"unprognostic (1.49e-1)"	"unprognostic (4.98e-2)"	"unprognostic (3.07e-1)"	"unprognostic (4.25e-2)"	"unprognostic (1.56e-2)"	"unprognostic (1.79e-3)"	"unprognostic (2.21e-1)"	"unprognostic (7.46e-3)"	"prognostic unfavorable (4.99e-4)"	19.0	6.2	4.0	15.0	9.1	11.9	7.7	11.6	3.4	9.1	10.0	7.7	4.2	7.6	6.9	20.4	6.4	7.2	10.2	30.2	6.1	4.4	39.1	12.3	13.5	30.5	6.6	2.3	10.1	8.5	0.2	6.1	31.3	20.1	8.4	6.0	15.8	3.5	5.2	7.9	5.1	13.3	8.1	9.7	84.0	4.7	10.6	4.2	29.7	51.9	5.0	8.1	11.0	15.7	0.1	111.9	1.9	95.8	0.5	0.3	74.4	0.2	0.0	3.3	0.0	0.0	0.0	31.5	0.0	0.0	0.3	0.0	9.5	0.0	0.0	15.0	0.1	15.6	0.5	8.4	0.6	0.1	0.0	7.8	10.6	0.1	22.8	0.0	0.0	0.0	0.0	0.9	0.1	0.2	0.0	0.1	4.4	7.1	0.0	0.2	0.0	9.8	0.0	5.2	0.0	2.6	0.0	0.0	0.0	131.9	3.6	1.9	1.5	8.6	20.6	15.9	16.8	2.4	7.9	0.0	0.0	0.1	0.0	1.9	2.9	31.7	0.1	0.0	3.9	3.3	1.0	95.8	0.4	0.2	81.6	0.3	0.1	0.1	0.1	111.9	0.1	0.1	0.1	1.9	0.5	26.0	2.9	0.1	74.4	4.0	9.1	11.6	3.4	6.1	4.4	6.6	2.3	20.1	4.2	6.0	20.2	17.9	1.1	11.1	0.0	63.1	7.6	2.7	4.5	68.0	0.0	103.1	29.9	0.5	15.2	12.6	0.0	0.0	14.2	103.4	14.2	0.2	4.7	0.5	263.6	0.0	1.7	6.7	230.2	6.4	8.6	292.5	10.1	4.6	0.8	0.2	1.2	0.0	2.8	23.9	0.3	0.0	5.7	15.2	103.9	7.8	99.1	0.9	0.9	0.9
CPXM1	"CPX-1, CPX1, CPXM"	ENSG00000088882	"Carboxypeptidase X, M14 family member 1"	Q96SM3	20	2794069-2800637	"Enzymes, Predicted secreted proteins"		"Carboxypeptidase, Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"placenta: 60.3"	"Cell type enhanced"	"Detected in many"	16	"Fibroblasts: 29.4;Leydig cells: 16.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	22	"memory B-cell: 2.3;myeloid DC: 1.4;NK-cell: 3.9;plasmacytoid DC: 1.1"	"Group enriched"	"Detected in many"	26	"B-cells: 2.3;dendritic cells: 1.4;NK-cells: 3.9"	"Cell line enhanced"	"Detected in some"		"AF22: 45.9;HSkMC: 25.0;NB-4: 40.3;REH: 41.1;SH-SY5Y: 30.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"								"Secreted in other tissues"	NA	NA						"unprognostic (7.48e-2)"	"unprognostic (3.61e-1)"	"unprognostic (6.70e-2)"	"unprognostic (1.47e-2)"	"unprognostic (3.41e-1)"	"unprognostic (5.24e-2)"	"unprognostic (1.82e-2)"	"unprognostic (1.84e-2)"	"unprognostic (2.98e-2)"	"unprognostic (9.32e-2)"	"unprognostic (7.02e-2)"	"unprognostic (3.23e-2)"	"prognostic unfavorable (4.62e-10)"	"unprognostic (1.30e-1)"	"unprognostic (1.49e-1)"	"unprognostic (5.55e-3)"	"unprognostic (1.27e-2)"	24.0	2.4	0.5	4.6	1.1	5.6	14.9	0.9	3.7	32.2	7.4	1.3	7.6	0.2	43.6	41.4	1.4	13.6	31.1	14.4	0.5	0.2	4.3	0.6	2.7	1.9	2.1	0.6	20.7	1.7	0.6	2.7	60.3	2.4	8.5	0.2	16.2	2.7	5.3	2.2	5.8	1.4	14.5	1.4	0.5	1.0	10.1	0.3	15.2	8.8	0.7	1.5	23.0	15.2	2.3	1.4	0.0	0.0	3.9	0.0	0.7	0.0	0.0	45.9	0.0	0.0	1.4	0.0	0.1	0.2	0.5	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	3.4	0.0	0.1	0.2	2.3	6.0	0.0	0.0	0.6	0.0	0.9	25.0	0.0	2.1	0.0	0.0	0.0	8.7	2.5	0.0	0.0	0.0	0.1	40.3	9.7	0.0	0.0	41.1	0.0	1.1	0.0	0.0	0.0	30.9	0.0	0.0	0.0	7.7	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.0	1.4	0.0	0.0	0.0	0.0	3.9	0.0	1.1	0.0	0.7	0.5	1.1	0.9	1.1	0.5	0.2	2.1	0.6	2.4	0.3	0.0	0.3	0.5	2.6	2.4	0.0	0.5	0.0	5.3	1.2	3.5	0.0	2.4	0.0	1.9	2.1	0.5	0.0	0.0	0.0	2.1	29.4	0.8	2.3	0.0	6.0	0.0	0.0	1.3	0.0	1.8	16.1	0.3	1.7	1.0	0.0	0.0	0.5	0.0	0.7	0.0	0.0	0.0	1.9	0.0	1.7	1.8	2.7	0.0	0.0	0.9
CPXM2	"CPX2, UNQ676"	ENSG00000121898	"Carboxypeptidase X, M14 family member 2"	Q8N436	10	123706207-123940267	"Enzymes, Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in many"	8	"Early spermatids: 85.6;Late spermatids: 150.5;Peritubular cells: 74.3"	"Low cancer specificity"	"Detected in all"			"Region enhanced"	"Detected in many"		"pons and medulla: 16.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	17	"BJ: 9.8;fHDF/TERT166: 38.3;SuSa: 16.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA048375	Uncertain				"Secreted - unknown location"	NA	NA					"HPA048375: AB_2680377"	"unprognostic (1.50e-1)"	"unprognostic (3.66e-1)"	"unprognostic (2.58e-2)"	"unprognostic (4.02e-3)"	"unprognostic (2.69e-2)"	"unprognostic (6.48e-2)"	"unprognostic (1.32e-2)"	"unprognostic (1.32e-2)"	"unprognostic (1.26e-1)"	"unprognostic (8.57e-2)"	"unprognostic (4.42e-2)"	"unprognostic (2.14e-1)"	"prognostic favorable (9.02e-4)"	"unprognostic (3.48e-2)"	"unprognostic (2.54e-2)"	"unprognostic (1.27e-1)"	"unprognostic (1.16e-3)"	17.0	4.1	0.8	5.0	2.1	0.1	12.3	1.3	1.6	6.4	40.9	6.7	5.7	3.8	12.2	37.8	20.0	9.1	9.4	14.3	1.7	4.0	6.6	1.5	4.6	3.7	6.1	0.7	12.8	3.2	1.9	7.1	11.6	16.9	14.7	4.5	26.5	5.6	8.3	5.0	4.5	9.1	45.5	21.6	13.8	14.4	7.7	3.4	2.6	9.5	11.9	4.0	32.5	20.0	0.0	0.0	0.0	0.2	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.8	0.4	0.6	0.0	0.0	0.0	0.0	0.0	38.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	16.1	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.8	2.1	1.3	1.6	1.7	4.0	6.1	0.7	16.9	3.4	0.0	1.1	0.0	0.0	1.9	0.0	1.4	0.0	0.0	0.0	1.8	0.0	6.6	1.7	0.1	85.6	13.5	0.0	0.0	0.2	0.2	2.3	0.0	0.0	0.0	0.3	1.6	0.0	13.5	0.0	150.5	10.0	0.0	3.3	0.0	0.5	0.0	0.2	0.0	74.3	0.0	0.0	0.0	2.8	1.1	1.9	1.8	4.2	0.0	1.1	0.0
CPZ		ENSG00000109625	"Carboxypeptidase Z"	Q66K79	4	8592660-8619759	"Enzymes, Predicted intracellular proteins, Predicted secreted proteins"	"Wnt signaling pathway"	"Carboxypeptidase, Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"ovary: 63.2"	"Not detected"	"Not detected"			"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 29.5;BJ: 17.0;BJ hTERT+: 22.9;hTERT-RPE1: 13.7;RH-30: 25.1;U-2197: 18.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA078608			Approved	"Plasma membrane"	"Secreted to extracellular matrix"	NA	NA			"Plasma membrane"		"HPA078608: "	"unprognostic (2.58e-1)"	"unprognostic (7.16e-2)"	"unprognostic (4.83e-2)"	"unprognostic (1.42e-1)"	"unprognostic (7.77e-2)"	"unprognostic (2.20e-2)"	"unprognostic (2.98e-1)"	"unprognostic (7.77e-2)"	"unprognostic (2.30e-1)"	"unprognostic (1.95e-2)"	"unprognostic (1.41e-1)"	"unprognostic (1.59e-1)"	"unprognostic (7.23e-8)"	"unprognostic (4.30e-3)"	"unprognostic (3.58e-2)"	"unprognostic (6.13e-4)"	"unprognostic (5.51e-2)"	4.3	0.9	0.3	2.8	1.1	0.0	5.4	1.1	1.6	15.7	1.8	1.5	27.1	0.1	7.9	24.1	3.0	7.4	12.9	2.4	0.4	0.3	1.5	0.8	2.9	0.7	1.5	0.4	63.2	1.1	0.3	2.3	18.9	2.3	4.1	0.5	4.4	0.8	20.6	0.3	5.5	1.2	10.3	1.3	0.7	1.7	4.4	0.1	1.6	3.5	0.1	2.2	9.8	11.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.4	0.1	0.0	0.7	2.2	0.2	29.5	17.0	22.9	6.4	2.6	0.7	0.3	0.0	1.6	9.3	0.1	0.0	0.0	0.0	2.4	0.0	1.2	0.0	0.1	0.3	2.0	0.0	0.0	4.2	0.0	0.0	0.0	13.7	0.0	0.0	0.4	0.0	0.4	2.5	0.0	0.0	3.9	0.1	9.3	0.0	25.1	0.0	0.0	0.5	0.0	0.0	0.6	0.2	0.0	3.8	0.1	0.0	0.0	0.9	1.2	18.3	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	1.1	1.1	1.6	0.4	0.3	1.5	0.4	2.3	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.8	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0
CRAT	CAT1	ENSG00000095321	"Carnitine O-acetyltransferase"	P43155	9	129094810-129111189	"Enzymes, Predicted intracellular proteins, Transporters"	"Fatty acid metabolism, Lipid metabolism, Transport"	"Acyltransferase, Transferase"	Neurodegeneration	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 98.6;testis: 71.7"	"Cell type enhanced"	"Detected in many"	14	"Early spermatids: 149.6;Late spermatids: 410.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019230, HPA020260, HPA022815"	Enhanced		Approved	"Nucleoplasm,Nuclear membrane"		NA	NA		13000	"Nucleoplasm, Nuclear membrane"		"HPA019230: AB_1847212, HPA020260: AB_1847210, HPA022815: AB_2732427"	"unprognostic (5.13e-2)"	"unprognostic (9.79e-3)"	"unprognostic (1.99e-2)"	"prognostic favorable (2.36e-4)"	"unprognostic (2.19e-1)"	"unprognostic (1.14e-1)"	"unprognostic (1.15e-2)"	"unprognostic (2.18e-1)"	"unprognostic (5.11e-2)"	"unprognostic (3.24e-2)"	"unprognostic (3.13e-3)"	"unprognostic (2.03e-1)"	"prognostic favorable (0.00e+0)"	"unprognostic (1.38e-1)"	"unprognostic (9.27e-2)"	"unprognostic (1.26e-2)"	"unprognostic (7.65e-2)"	11.6	13.4	8.4	4.6	9.2	5.9	10.7	7.5	15.9	8.3	15.4	8.6	6.2	24.3	6.5	9.5	9.4	5.4	10.0	17.3	7.7	7.9	12.9	50.0	4.2	3.1	8.3	9.1	7.3	33.1	16.8	3.2	7.9	9.3	10.5	4.4	8.1	14.7	7.9	98.6	7.0	22.8	8.3	5.2	4.6	8.1	71.7	4.4	2.4	8.0	20.2	4.4	9.3	6.8	2.6	11.3	6.0	11.3	6.0	10.0	8.1	0.1	18.3	6.4	13.1	12.0	16.1	9.3	7.8	8.7	9.5	6.0	3.8	7.4	0.7	4.7	13.1	12.7	3.3	1.7	2.8	3.4	11.8	0.4	3.6	9.2	14.7	17.1	0.1	14.0	14.7	0.0	8.0	0.2	12.1	12.4	3.5	1.6	3.8	9.7	3.6	0.3	8.1	1.5	19.8	8.2	9.1	12.3	6.0	9.2	0.3	2.1	6.6	0.0	4.1	2.7	2.1	26.6	4.0	11.1	14.3	1.0	17.9	7.7	13.0	11.0	0.0	16.9	2.2	9.1	2.5	11.3	6.0	5.0	7.4	10.0	2.4	6.9	6.6	11.3	2.6	4.3	4.7	2.9	6.0	7.3	5.3	6.4	8.1	8.4	9.2	7.5	15.9	7.7	7.9	8.3	9.1	9.3	4.4	6.0	3.0	5.4	4.5	2.9	1.4	52.0	20.4	1.4	3.4	3.5	2.0	38.4	14.9	16.6	149.6	12.6	94.4	0.0	19.6	46.4	21.8	14.9	6.9	58.6	18.0	1.6	14.9	14.1	8.1	410.0	20.4	8.8	5.0	9.0	16.9	13.4	12.1	38.6	23.0	41.0	1.4	6.5	14.6	94.3	6.9	4.0	42.1	10.7	22.1	9.9
CREBBP	"CBP, KAT3A, RSTS, RTS"	ENSG00000005339	"CREB binding protein"	Q92793	16	3725054-3880726	"Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Biological rhythms, Host-virus interaction, Transcription, Transcription regulation"	"Activator, Acyltransferase, Transferase"	"Cancer-related genes, Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004212, HPA055861"	Supported		Enhanced	"Nucleoplasm,Nuclear bodies"		No	No			Nucleoplasm	"Nuclear bodies"	"CAB004212: AB_626817, HPA055861: AB_2682948"	"unprognostic (1.17e-1)"	"unprognostic (8.51e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.63e-1)"	"unprognostic (1.49e-1)"	"unprognostic (5.09e-2)"	"unprognostic (9.59e-3)"	"unprognostic (6.98e-2)"	"unprognostic (8.96e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.76e-1)"	"unprognostic (2.84e-1)"	"prognostic favorable (6.24e-5)"	"unprognostic (1.47e-1)"	"unprognostic (1.74e-1)"	"unprognostic (3.97e-2)"	"unprognostic (8.23e-2)"	18.5	10.9	17.2	22.8	17.5	37.0	17.4	42.6	18.8	20.1	17.2	16.8	17.1	9.9	25.1	15.2	14.1	18.9	21.3	14.5	17.1	8.7	11.1	12.3	16.9	14.4	20.5	12.0	31.6	23.4	24.3	13.0	13.3	15.8	18.4	11.6	14.6	14.9	16.7	28.2	20.4	16.4	17.0	13.6	17.4	14.7	29.1	20.2	29.6	19.5	13.8	16.1	19.0	29.9	4.7	2.3	10.6	3.8	2.0	2.7	1.1	5.6	14.5	18.8	8.3	11.5	11.4	9.8	8.1	13.7	14.0	13.7	13.1	10.6	15.6	9.7	15.5	9.0	10.9	21.6	6.7	16.0	26.3	8.7	12.2	13.4	8.3	12.8	12.2	17.6	10.1	6.8	15.6	18.9	8.7	10.5	8.0	13.9	21.4	7.6	19.3	8.1	5.9	15.4	5.4	6.0	38.3	14.9	11.9	5.4	7.6	15.7	10.3	13.9	13.7	8.2	12.7	12.2	12.0	16.3	17.2	17.2	8.8	7.4	10.0	10.8	30.3	3.5	7.3	12.1	2.9	1.7	1.3	2.7	2.2	1.4	4.7	1.3	2.0	1.0	3.3	1.4	1.7	10.6	2.0	3.8	2.3	1.3	1.1	17.2	17.5	42.6	18.8	17.1	8.7	20.5	12.0	15.8	20.2	41.7	45.9	13.8	25.5	49.9	31.9	37.0	43.3	32.1	33.0	10.4	23.6	14.6	5.0	17.4	38.0	35.3	24.0	0.0	17.7	9.4	24.3	32.2	30.0	25.1	17.8	27.0	14.5	32.5	38.7	57.1	52.3	33.5	16.9	27.9	22.4	31.4	22.7	17.3	48.1	10.7	15.8	45.3	36.0	33.1	46.0	51.4	25.7	35.9	23.8	31.6
CRLS1	"C20orf155, CLS1, dJ967N21.6, GCD10"	ENSG00000088766	"Cardiolipin synthase 1"	Q9UJA2	20	6006090-6040053	"Enzymes, Predicted membrane proteins"	"Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 84.2"	"Cell type enhanced"	"Detected in many"	4	"Hepatocytes: 167.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"Hep G2: 72.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA						"unprognostic (1.48e-1)"	"unprognostic (2.97e-1)"	"unprognostic (2.88e-1)"	"unprognostic (8.56e-2)"	"unprognostic (9.64e-3)"	"unprognostic (1.89e-1)"	"unprognostic (1.41e-2)"	"unprognostic (2.65e-2)"	"unprognostic (1.42e-1)"	"unprognostic (2.00e-1)"	"unprognostic (9.89e-3)"	"unprognostic (2.78e-2)"	"unprognostic (1.52e-2)"	"unprognostic (1.83e-2)"	"unprognostic (1.85e-1)"	"unprognostic (9.54e-2)"	"prognostic favorable (8.02e-4)"	23.0	30.4	9.1	13.2	9.2	9.9	15.0	6.8	9.9	11.5	30.4	8.2	18.5	24.0	11.6	10.8	11.7	10.5	17.2	84.2	7.9	7.5	32.9	67.4	16.4	8.3	7.9	7.7	12.6	27.0	10.2	10.1	13.3	9.5	14.4	14.8	9.1	18.3	13.4	48.5	7.2	33.1	10.5	6.8	11.0	19.3	12.3	7.1	13.1	17.2	23.7	9.6	11.7	8.6	4.9	3.7	1.1	2.4	3.6	5.2	1.1	19.7	14.9	9.6	12.3	26.7	24.3	10.3	12.5	16.2	12.9	15.4	19.7	13.6	21.5	9.1	16.1	22.4	12.9	18.3	22.5	19.4	6.1	10.8	29.4	6.0	72.0	18.1	28.0	9.7	14.2	18.0	13.5	23.0	12.0	17.3	12.4	20.5	9.8	14.4	7.9	18.5	24.9	16.8	45.6	11.7	12.2	14.0	22.9	19.3	7.7	15.5	13.2	12.6	31.9	21.3	10.6	10.8	17.9	11.1	14.1	9.9	14.3	16.7	9.7	21.2	22.3	5.7	23.7	13.0	0.0	2.4	1.1	2.6	2.0	5.2	4.9	1.7	2.2	2.6	1.9	3.6	1.9	0.1	3.6	1.0	3.7	1.5	1.1	9.1	9.2	6.8	9.9	7.9	7.5	7.9	7.7	9.5	7.1	20.8	47.1	26.8	35.6	30.0	10.8	90.4	68.8	2.7	11.4	34.9	3.9	40.1	54.7	25.2	142.9	23.9	44.6	0.0	24.8	50.7	32.7	86.4	14.9	167.1	31.2	11.1	27.4	25.2	33.0	73.4	28.1	27.8	25.3	10.8	46.4	39.8	24.6	45.6	23.0	104.4	12.9	12.9	24.5	18.2	18.6	24.3	30.3	22.3	71.8	34.1
CROT	COT	ENSG00000005469	"Carnitine O-octanoyltransferase"	Q9UKG9	7	87345681-87399795	"Enzymes, Plasma proteins, Predicted intracellular proteins, Transporters"	"Fatty acid metabolism, Lipid metabolism, Transport"	"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Cytotrophoblasts: 116.1;Rod photoreceptor cells: 76.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"hTCEpi: 35.3;RT4: 34.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA019052, HPA019364, HPA019365"	Enhanced		Approved	Vesicles		NA	NA			Vesicles		"HPA019052: AB_1847172, HPA019364: AB_1847173, HPA019365: AB_1847174"	"unprognostic (2.80e-2)"	"unprognostic (6.47e-2)"	"unprognostic (1.75e-1)"	"unprognostic (4.56e-2)"	"unprognostic (1.70e-1)"	"unprognostic (2.55e-2)"	"unprognostic (1.84e-1)"	"unprognostic (9.93e-3)"	"unprognostic (2.13e-1)"	"unprognostic (1.13e-1)"	"unprognostic (9.84e-2)"	"unprognostic (3.48e-1)"	"prognostic favorable (2.55e-6)"	"unprognostic (3.52e-2)"	"unprognostic (1.34e-1)"	"unprognostic (7.60e-3)"	"prognostic favorable (4.02e-4)"	4.6	10.1	9.3	5.1	9.6	1.6	10.5	7.4	8.4	9.0	9.4	5.5	24.1	19.6	10.0	12.6	17.0	6.8	8.7	5.9	5.2	5.4	12.3	21.5	4.2	3.4	5.4	6.6	7.2	4.6	15.5	9.1	13.7	5.8	14.8	7.0	9.8	8.3	32.3	7.2	15.0	19.1	8.8	6.8	4.8	4.9	3.8	4.7	7.4	27.1	8.4	8.0	22.4	15.3	2.2	2.3	3.4	5.5	13.0	9.5	3.0	7.2	5.4	6.6	2.3	6.3	5.8	4.9	7.7	7.2	4.7	5.1	2.8	3.8	3.0	6.8	6.5	9.4	9.1	1.1	10.2	6.7	4.3	4.6	6.6	3.8	3.6	4.1	4.1	4.1	4.7	35.3	3.8	3.0	6.0	6.6	5.0	0.3	4.4	12.3	7.1	5.1	4.1	1.4	2.6	8.0	2.3	9.1	0.5	6.0	34.6	1.1	5.2	9.4	10.9	4.9	4.7	6.9	1.5	3.5	10.9	4.7	14.7	7.2	6.7	9.6	4.2	7.3	0.0	6.4	2.0	1.4	3.4	7.4	1.7	9.5	2.2	7.5	6.0	2.0	2.2	6.1	6.6	0.9	13.0	5.5	2.3	6.3	3.0	9.3	9.6	7.4	8.4	5.2	5.4	5.4	6.6	5.8	4.7	20.8	7.7	4.4	49.0	14.9	16.1	13.2	7.6	32.1	36.4	50.6	43.2	116.1	8.3	6.6	18.7	6.5	24.7	0.0	7.6	5.2	7.3	20.4	7.0	28.8	12.0	14.3	7.0	5.5	7.5	33.1	14.7	7.4	18.6	6.4	13.1	24.1	8.0	7.4	13.1	15.3	76.5	6.5	8.3	2.5	3.6	13.4	41.0	7.0	10.9	43.1
CRYL1	"GDH, lambda-CRY, MGC149525, MGC149526"	ENSG00000165475	"Crystallin lambda 1"	Q9Y2S2	13	20403666-20525873	"Enzymes, Plasma proteins, Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"kidney: 104.0;liver: 80.8"	"Cell type enhanced"	"Detected in many"	15	"Distal tubular cells: 411.1;Hepatocytes: 272.9;Proximal tubular cells: 848.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"OE19: 28.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA040403	Enhanced		Approved	"Nucleoplasm,Nucleoli,Golgi apparatus,Plasma membrane"		NA	NA		210000	"Nucleoplasm, Nucleoli"	"Golgi apparatus, Plasma membrane"	"HPA040403: AB_10795632"	"unprognostic (1.84e-1)"	"unprognostic (1.25e-1)"	"unprognostic (3.25e-2)"	"prognostic favorable (1.76e-5)"	"unprognostic (3.10e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.09e-3)"	"unprognostic (4.75e-3)"	"unprognostic (1.19e-1)"	"unprognostic (4.09e-2)"	"unprognostic (2.12e-2)"	"unprognostic (8.80e-2)"	"prognostic favorable (2.30e-9)"	"unprognostic (9.00e-2)"	"unprognostic (1.30e-1)"	"unprognostic (2.39e-2)"	"unprognostic (3.11e-1)"	9.8	8.9	21.5	8.8	22.9	3.5	7.0	10.4	17.4	11.8	35.1	26.7	18.9	61.0	9.2	18.0	7.4	9.3	16.1	9.3	18.8	19.8	104.0	80.8	6.8	5.9	24.5	12.3	7.3	15.4	5.3	10.4	5.6	16.8	11.2	16.5	17.2	13.1	20.1	5.4	4.1	45.7	8.0	32.0	6.5	12.0	2.7	16.4	3.2	11.9	5.6	5.5	8.6	5.9	9.3	25.7	1.8	24.3	6.0	15.6	17.5	3.3	2.9	2.5	18.4	14.1	16.3	2.5	4.7	8.5	2.1	1.7	1.1	3.1	0.0	9.1	6.5	4.8	0.8	2.5	4.2	2.1	8.1	2.0	5.9	0.3	23.0	8.1	1.9	5.4	9.6	2.7	1.5	9.7	7.6	22.3	8.7	0.4	2.3	5.5	12.1	5.1	3.0	0.1	28.9	4.5	2.6	1.6	0.4	17.8	7.1	1.8	2.2	2.8	1.3	21.2	1.3	9.1	7.6	21.3	2.6	1.2	6.3	2.9	3.3	0.6	0.0	4.9	3.3	10.5	1.8	21.8	1.4	10.5	24.3	8.5	9.3	14.0	10.0	25.7	9.1	11.0	10.2	0.7	6.0	20.1	2.8	15.6	17.5	21.5	22.9	10.4	17.4	18.8	19.8	24.5	12.3	16.8	16.4	6.0	6.4	19.9	13.2	9.2	5.0	9.8	48.4	10.7	6.8	73.3	11.8	18.1	411.1	21.5	2.6	23.7	181.3	0.0	27.8	9.4	16.4	23.5	24.3	272.9	59.4	1.6	8.7	49.1	76.7	2.9	24.2	36.1	35.4	11.8	69.9	93.7	32.1	152.6	22.6	848.9	10.8	19.4	12.3	0.9	0.2	8.2	17.4	15.3	78.8	12.2
CRYM	DFNA40	ENSG00000103316	"Crystallin mu"	Q14894	16	21238874-21303083	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		Oxidoreductase	"Deafness, Disease mutation, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 23.7;brain: 61.3;heart muscle: 45.9"	"Cell type enriched"	"Detected in many"	4	"Muller glia cells: 521.3"	"Cancer enhanced"	"Detected in many"		"prostate cancer: 14.6"	"Region enhanced"	"Detected in many"		"basal ganglia: 61.3"	"Cell type enriched"	"Detected in single"	26	"plasmacytoid DC: 23.7"	"Lineage enriched"	"Detected in single"	26	"dendritic cells: 23.7"	"Cell line enriched"	"Detected in some"	4	"RPTEC TERT1: 31.2"	"Group enriched"	"Detected in many"	12	"amygdala: 129.0;basal ganglia: 245.8;cerebral cortex: 127.4;hippocampal formation: 355.0"	"Low region specificity"	"Detected in all"			"HPA019086, HPA030619"	Enhanced		Supported	Cytosol		NA	NA		110000	Cytosol		"HPA019086: AB_1847260, HPA030619: AB_2673551"	"unprognostic (1.32e-1)"	"unprognostic (2.93e-3)"	"unprognostic (8.96e-2)"	"unprognostic (1.44e-1)"	"unprognostic (2.13e-1)"	"unprognostic (4.62e-2)"	"unprognostic (2.88e-1)"	"unprognostic (5.75e-3)"	"unprognostic (2.81e-1)"	"unprognostic (7.37e-2)"	"unprognostic (2.05e-2)"	"unprognostic (5.95e-2)"	"unprognostic (2.11e-3)"	"unprognostic (7.79e-3)"	"unprognostic (2.49e-2)"	"unprognostic (1.87e-3)"	"unprognostic (1.31e-1)"	1.4	0.5	7.6	0.5	61.3	0.5	1.0	15.6	21.2	1.8	2.2	0.0	0.0	0.7	0.8	0.3	2.3	0.5	2.3	45.9	6.5	2.1	17.8	4.2	2.7	0.5	1.0	15.5	0.5	0.8	0.6	3.3	0.3	0.1	10.5	2.6	1.0	4.8	0.3	4.0	1.4	1.0	2.0	0.9	0.5	0.6	1.6	1.2	0.0	0.5	0.0	1.5	8.3	0.8	0.9	23.7	0.0	0.0	0.0	0.0	0.3	0.0	1.2	0.0	0.0	0.0	0.1	0.2	0.0	0.8	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.6	0.2	1.6	0.0	0.0	0.0	0.4	7.2	0.0	0.7	0.0	0.0	0.7	0.3	0.0	0.3	0.5	0.0	0.0	0.1	0.0	0.1	0.2	0.1	0.0	0.3	3.2	0.5	0.1	0.0	0.0	0.2	31.2	0.0	1.2	1.7	0.0	0.0	1.0	1.7	0.0	0.0	0.0	0.2	0.2	2.7	0.0	0.0	0.0	0.1	6.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	23.7	0.0	0.3	7.6	61.3	15.6	20.7	6.5	2.1	1.0	15.5	0.1	1.2	0.0	15.3	1.5	24.8	2.1	5.8	124.1	5.1	20.1	22.7	14.0	3.9	0.0	14.9	0.1	17.0	1.0	5.3	0.0	0.0	0.0	2.2	17.1	1.1	6.0	0.1	1.6	12.6	0.6	0.0	9.6	0.0	0.9	32.1	1.0	19.3	521.3	0.2	0.0	0.0	111.6	17.7	0.0	1.0	4.4	6.3	1.1	0.1	0.0	7.9	58.9
CRYZ		ENSG00000116791	"Crystallin zeta"	Q08257	1	74705482-74733408	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Oxidoreductase, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 100.0;liver: 79.8"	"Cell type enhanced"	"Detected in many"	12	"Collecting duct cells: 151.8;Distal tubular cells: 192.3;Hepatocytes: 184.9;Proximal tubular cells: 384.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"RPTEC TERT1: 98.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021921, HPA023290"	Approved		Supported	Cytosol		NA	NA		7200000	Cytosol		"HPA021921: AB_1847262, HPA023290: AB_1847263"	"unprognostic (3.64e-2)"	"unprognostic (3.38e-2)"	"unprognostic (1.97e-1)"	"unprognostic (1.27e-2)"	"unprognostic (5.32e-3)"	"unprognostic (5.79e-2)"	"unprognostic (6.29e-2)"	"unprognostic (1.04e-1)"	"unprognostic (4.56e-2)"	"unprognostic (1.06e-1)"	"unprognostic (6.38e-3)"	"unprognostic (2.19e-1)"	"unprognostic (1.35e-3)"	"unprognostic (3.12e-1)"	"unprognostic (7.50e-2)"	"unprognostic (2.94e-1)"	"unprognostic (7.32e-2)"	6.0	13.4	7.5	4.6	5.4	0.2	8.8	4.2	5.9	19.8	12.6	3.9	27.1	11.3	11.9	29.1	9.7	11.5	15.7	10.4	6.0	9.0	100.0	79.8	7.1	4.8	6.5	3.5	9.4	26.1	13.2	17.2	3.7	11.1	13.8	4.9	9.4	5.9	21.9	5.6	5.6	19.8	14.1	6.8	5.4	9.5	4.9	5.9	7.1	17.1	7.9	5.8	14.8	15.8	18.2	8.9	4.7	8.6	14.4	21.7	9.0	2.5	24.8	12.8	3.6	14.8	16.2	8.7	8.0	12.7	11.6	13.1	19.4	10.3	13.9	14.1	15.5	20.4	6.9	10.4	10.1	19.0	16.0	4.2	5.8	7.7	38.8	7.8	4.9	11.9	7.5	9.0	18.6	3.4	10.9	9.7	7.7	18.2	5.0	24.2	5.8	8.9	8.3	9.6	20.2	16.2	5.7	12.1	5.1	98.3	7.9	3.5	6.3	1.8	13.5	8.7	15.0	12.1	1.6	4.7	2.8	7.0	8.7	12.0	3.6	6.9	6.8	22.8	1.9	7.9	4.7	5.2	0.9	18.2	7.7	14.7	18.2	17.9	16.7	8.9	13.7	15.7	16.7	0.8	14.4	8.6	7.5	21.7	9.0	7.5	5.4	4.2	5.9	6.0	9.0	6.5	3.5	11.1	5.9	26.8	16.9	14.3	23.5	15.9	2.5	25.7	89.2	16.0	12.5	151.8	2.0	12.7	192.3	42.4	0.3	8.0	12.3	0.0	28.1	14.2	21.7	10.3	13.9	184.9	15.3	0.0	6.4	11.6	12.5	1.1	19.2	10.6	10.1	10.0	13.2	6.8	30.1	9.1	19.4	384.2	2.6	0.0	15.9	1.4	6.8	18.4	6.1	15.2	13.3	12.7
CS		ENSG00000062485	"Citrate synthase"	O75390	12	56271699-56300392	"Citric acid cycle related proteins, Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Tricarboxylic acid cycle"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 125.9"	"Cell type enhanced"	"Detected in many"	7	"Cardiomyocytes: 207.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA038460, HPA038461, CAB075750, CAB075751, CAB075752, CAB075753, CAB075754"	Enhanced		Enhanced	Mitochondria		NA	NA		4400000	Mitochondria		"CAB075750: AB_2665756, CAB075751: AB_2665757, CAB075752: AB_2665758, CAB075753: AB_2665759, CAB075754: AB_2665760, HPA038460: AB_2676023, HPA038461: AB_2676024"	"unprognostic (7.67e-3)"	"unprognostic (3.80e-1)"	"unprognostic (2.59e-2)"	"unprognostic (2.50e-2)"	"unprognostic (2.70e-2)"	"unprognostic (1.25e-1)"	"unprognostic (6.09e-3)"	"unprognostic (3.34e-2)"	"unprognostic (2.43e-1)"	"unprognostic (5.58e-2)"	"unprognostic (2.56e-1)"	"unprognostic (1.97e-2)"	"prognostic favorable (1.17e-4)"	"unprognostic (1.20e-1)"	"unprognostic (2.09e-1)"	"unprognostic (1.30e-2)"	"unprognostic (2.02e-1)"	37.1	35.5	11.9	16.3	20.4	19.3	55.6	28.5	43.8	17.2	27.4	14.1	11.3	25.3	19.9	10.8	31.7	16.5	14.0	79.2	11.2	14.5	26.7	12.3	17.3	30.8	12.3	14.2	16.9	20.7	28.1	14.3	11.9	24.8	16.2	32.7	19.8	23.1	17.5	125.9	22.8	27.0	21.2	15.0	18.4	21.4	7.9	11.1	20.7	17.9	48.2	26.1	22.9	19.1	19.5	37.1	59.6	27.8	15.9	19.7	18.2	35.8	38.8	31.7	41.1	42.1	39.2	20.6	29.9	29.4	52.7	36.8	54.7	35.2	70.1	29.4	37.7	22.6	38.9	87.5	45.0	50.4	24.3	44.5	48.1	28.2	39.4	23.6	58.8	34.6	43.1	43.0	41.3	50.1	43.4	59.1	36.6	49.8	42.1	45.9	28.8	48.7	18.1	25.2	27.2	56.1	47.5	37.2	52.9	32.6	36.4	41.6	27.3	38.7	46.1	30.3	30.8	64.1	34.3	39.2	26.6	37.3	37.5	31.5	27.8	42.3	45.6	24.5	43.4	24.9	14.5	22.0	59.6	15.2	27.8	19.7	19.5	18.3	14.3	37.1	16.7	19.4	15.4	9.8	15.9	27.0	20.5	19.3	18.2	11.9	20.4	28.5	43.8	11.2	14.5	12.3	14.2	24.8	11.1	14.9	33.2	16.0	18.6	34.7	21.7	207.5	22.9	10.7	19.4	12.2	58.9	15.6	29.9	31.3	5.1	27.0	51.5	0.0	38.6	26.0	18.2	26.3	27.6	26.2	31.0	9.5	16.3	17.2	29.2	3.6	18.7	33.5	10.1	27.1	43.6	15.1	37.2	23.0	18.7	17.3	36.0	12.9	25.9	18.4	24.7	45.7	14.1	18.1	64.8	26.5
CSAD	"CSD, PCAP"	ENSG00000139631	"Cysteine sulfinic acid decarboxylase"	Q9Y600	12	53157663-53180909	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Decarboxylase, Lyase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	5	"neutrophil: 16.3"	"Lineage enriched"	"Detected in all"	5	"granulocytes: 16.3"	"Cell line enhanced"	"Detected in many"		"ASC diff: 39.2;T-47d: 23.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039487	Approved				"Intracellular and membrane"	NA	NA					"HPA039487: AB_10672776"	"unprognostic (1.00e-1)"	"unprognostic (3.28e-2)"	"prognostic unfavorable (9.50e-4)"	"unprognostic (1.57e-1)"	"unprognostic (7.99e-2)"	"prognostic favorable (6.33e-4)"	"prognostic favorable (1.37e-4)"	"unprognostic (2.46e-2)"	"unprognostic (7.87e-3)"	"unprognostic (1.01e-1)"	"prognostic favorable (3.39e-4)"	"unprognostic (3.48e-2)"	"prognostic unfavorable (1.93e-6)"	"unprognostic (4.59e-2)"	"unprognostic (3.47e-1)"	"unprognostic (1.38e-1)"	"prognostic favorable (6.81e-6)"	30.3	11.4	23.4	12.4	17.8	24.8	26.0	26.4	20.8	17.8	13.1	23.5	24.7	12.4	27.7	39.4	12.3	16.5	14.6	9.9	19.3	10.2	14.9	39.5	12.7	12.5	18.3	22.4	24.6	15.3	16.4	18.4	9.5	17.6	24.8	12.1	19.5	23.2	19.6	12.9	41.9	12.0	14.8	18.9	16.5	12.4	18.5	18.9	12.1	16.0	9.9	10.2	10.5	16.2	2.1	2.2	16.3	2.0	1.5	3.0	0.4	1.6	3.0	7.2	3.0	39.2	16.2	2.6	6.4	1.4	2.7	2.3	1.8	3.9	2.1	4.9	3.4	0.9	5.6	3.2	5.0	1.6	2.8	3.9	3.4	7.3	3.8	3.5	1.4	2.2	19.8	6.3	4.1	5.1	14.1	2.5	4.6	3.6	19.4	2.6	13.6	0.7	4.0	1.4	0.8	2.8	2.8	0.4	4.9	3.6	4.2	3.7	2.8	6.3	9.1	2.3	4.7	23.8	2.8	5.6	8.0	1.6	2.3	1.8	5.5	1.3	1.1	6.7	3.6	3.2	3.5	2.0	2.2	1.3	1.1	0.8	1.2	1.9	0.8	0.9	2.1	2.5	1.4	16.3	1.5	1.2	2.2	3.0	0.4	23.4	17.8	26.4	20.8	19.3	10.2	18.3	22.4	17.6	18.9	3.0	15.8	22.3	24.0	14.7	28.3	7.8	12.7	14.7	11.4	22.7	15.7	10.2	3.3	9.7	0.2	18.9	19.5	0.0	7.8	5.7	17.7	30.0	9.2	34.8	7.2	25.4	13.8	12.3	11.0	1.1	25.0	11.5	13.5	11.8	12.9	30.0	8.0	28.1	29.0	2.4	27.8	38.8	21.7	50.6	58.8	15.9	7.4	12.5	11.5	20.2
CSF1R	"C-FMS, CD115, CSFR, FMS"	ENSG00000182578	"Colony stimulating factor 1 receptor"	P07333	5	150053291-150113372	"Cancer-related genes, CD markers, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, RAS pathway related proteins"	"Immunity, Inflammatory response, Innate immunity"	"Kinase, Receptor, Transferase, Tyrosine-protein kinase"	"Cancer-related genes, Disease mutation, FDA approved drug targets, Neurodegeneration, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 82.5;lymphoid tissue: 82.6"	"Group enriched"	"Detected in many"	8	"Extravillous trophoblasts: 97.9;Hofbauer cells: 277.3;Kupffer cells: 200.7;Macrophages: 125.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"intermediate monocyte: 60.7;non-classical monocyte: 82.5"	"Lineage enriched"	"Detected in many"	4	"monocytes: 82.5"	"Group enriched"	"Detected in some"	5	"BEWO: 51.8;SK-BR-3: 19.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB008970, HPA012323"	Uncertain		Supported	"Vesicles,Plasma membrane"	"Intracellular and membrane"	NA	NA		1500000000	"Vesicles, Plasma membrane"		"CAB008970: , HPA012323: AB_1848977"	"unprognostic (3.82e-2)"	"unprognostic (1.31e-1)"	"unprognostic (1.86e-3)"	"unprognostic (9.83e-2)"	"unprognostic (1.20e-1)"	"unprognostic (7.33e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.45e-1)"	"unprognostic (9.37e-2)"	"unprognostic (1.11e-2)"	"unprognostic (2.49e-1)"	"unprognostic (1.65e-1)"	"prognostic unfavorable (1.08e-4)"	"unprognostic (3.67e-2)"	"prognostic unfavorable (4.92e-4)"	"unprognostic (1.72e-2)"	"unprognostic (4.61e-2)"	20.9	12.4	18.2	28.1	18.9	1.8	7.7	2.8	13.5	9.3	8.3	25.4	1.1	9.2	5.9	13.1	8.4	7.9	16.1	8.7	16.4	13.7	7.8	15.1	13.7	25.4	21.3	6.0	5.3	5.2	5.9	6.4	52.1	17.1	8.5	8.4	16.8	8.0	8.7	3.0	5.8	14.5	16.2	25.8	82.6	9.0	4.9	23.0	3.1	4.2	2.9	8.2	16.4	4.7	0.0	19.1	2.9	82.5	0.0	0.1	13.9	1.7	0.0	0.0	0.0	0.8	0.2	51.8	0.1	0.0	0.0	0.0	1.5	0.0	2.4	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	1.1	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.7	0.2	0.0	0.0	0.0	0.1	0.0	19.8	0.0	0.8	0.0	7.4	0.0	0.3	0.0	0.0	1.3	0.0	0.1	0.0	2.6	0.9	0.0	0.4	18.1	0.5	0.1	60.7	0.0	0.0	0.0	0.0	19.1	0.0	0.0	0.0	2.9	0.0	82.5	1.4	0.0	13.9	18.2	18.9	2.8	13.4	16.4	13.7	21.3	6.0	17.1	23.0	0.0	6.7	0.5	0.0	2.5	0.0	2.8	5.1	1.4	0.0	0.0	0.0	2.9	0.0	0.0	3.7	2.2	0.0	0.0	0.0	97.9	3.3	0.0	2.3	0.8	277.3	0.0	0.0	4.9	200.7	3.5	1.7	125.7	3.3	1.8	0.0	0.0	0.1	0.0	0.0	0.0	0.4	12.9	1.3	0.5	0.2	1.1	22.1	2.2	0.0	0.0
CSGALNACT1	"ChGn, CSGalNAcT-1, FLJ11264"	ENSG00000147408	"Chondroitin sulfate N-acetylgalactosaminyltransferase 1"	Q8TDX6	8	19404161-19758029	"Enzymes, Predicted intracellular proteins"		Transferase	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"thyroid gland: 57.7"	"Cell type enhanced"	"Detected in many"	6	"Cardiomyocytes: 41.5;Endothelial cells: 33.7;Glandular cells: 33.6"	"Cancer enhanced"	"Detected in all"		"prostate cancer: 22.9"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in all"	6	"B-cells: 20.1;granulocytes: 10.3;T-cells: 25.5"	"Cell line enhanced"	"Detected in some"		"A549: 29.0;BJ hTERT+: 16.3;GAMG: 11.7;RPTEC TERT1: 20.3;U-2197: 18.5;U-87 MG: 13.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA068462			Approved	"Golgi apparatus,Cytosol"	"Intracellular and membrane"	NA	NA			"Golgi apparatus, Cytosol"		"HPA068462: "	"unprognostic (8.90e-2)"	"unprognostic (1.57e-2)"	"unprognostic (4.66e-2)"	"unprognostic (2.58e-1)"	"unprognostic (6.03e-2)"	"unprognostic (3.17e-3)"	"unprognostic (9.78e-2)"	"unprognostic (7.76e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.60e-2)"	"unprognostic (8.22e-2)"	"unprognostic (6.82e-2)"	"unprognostic (1.22e-2)"	"unprognostic (1.89e-1)"	"unprognostic (2.38e-2)"	"unprognostic (1.46e-3)"	"unprognostic (1.02e-2)"	13.8	8.7	22.7	6.0	15.4	6.8	7.2	3.8	21.4	13.0	3.8	9.2	4.0	2.8	7.1	5.9	21.2	8.7	10.8	23.8	17.7	8.2	5.3	2.3	7.9	10.5	9.1	18.7	38.6	10.9	4.2	5.9	25.1	7.0	21.7	2.1	2.6	5.8	7.3	3.9	4.2	4.2	17.2	8.6	6.3	5.4	2.7	10.3	4.0	57.7	4.5	6.1	18.9	9.7	20.1	1.7	10.3	1.2	3.2	25.5	4.8	0.7	29.0	0.2	0.0	4.8	1.1	3.7	0.6	16.3	0.1	0.1	1.4	0.3	0.0	0.0	0.0	11.7	0.3	0.0	0.0	0.1	3.6	0.2	0.0	8.3	0.7	2.1	0.0	0.0	0.4	0.7	0.1	0.1	0.0	5.5	0.0	0.0	0.0	0.0	1.2	1.1	0.1	0.0	3.6	0.9	0.1	0.0	0.0	20.3	0.7	0.1	0.1	8.5	3.4	1.1	0.6	0.0	0.0	0.3	0.4	0.4	18.5	0.2	0.1	0.0	0.0	13.4	1.6	5.6	0.0	1.2	10.3	2.5	0.0	0.3	20.1	11.5	3.9	1.1	6.2	20.6	5.2	7.1	3.2	0.1	1.7	25.5	4.8	22.7	15.4	3.8	21.4	17.7	8.2	9.1	18.7	7.0	10.3	3.0	1.4	8.2	8.2	3.9	0.4	41.5	0.0	2.7	1.2	12.2	9.8	1.4	1.7	3.7	5.5	33.7	0.0	0.0	1.5	13.5	20.0	33.6	0.0	0.0	12.0	17.5	2.9	20.3	21.2	5.9	4.9	5.1	11.8	0.0	0.0	0.9	3.0	0.0	11.3	0.0	1.0	6.5	7.2	0.1	0.0	2.8	7.0	2.2	0.0	2.1
CSGALNACT2	"GALNACT-2, GALNACT2, MGC40204, PRO0082"	ENSG00000169826	"Chondroitin sulfate N-acetylgalactosaminyltransferase 2"	Q8N6G5	10	43138486-43185308	"Enzymes, Predicted intracellular proteins"		Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 80.6"	"Cell type enhanced"	"Detected in many"	5	"Kupffer cells: 62.0;Macrophages: 59.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"hTERT-HME1: 37.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA031540	Approved		Approved	"Endoplasmic reticulum"		NA	NA			"Endoplasmic reticulum"		"HPA031540: AB_10599943"	"unprognostic (1.65e-1)"	"unprognostic (2.70e-2)"	"unprognostic (9.10e-2)"	"unprognostic (6.41e-2)"	"unprognostic (1.95e-1)"	"unprognostic (8.28e-3)"	"unprognostic (2.85e-3)"	"unprognostic (4.95e-2)"	"unprognostic (2.96e-1)"	"unprognostic (3.43e-3)"	"unprognostic (7.65e-2)"	"unprognostic (1.90e-1)"	"prognostic unfavorable (3.53e-7)"	"unprognostic (2.68e-2)"	"unprognostic (1.40e-1)"	"unprognostic (2.47e-1)"	"unprognostic (4.05e-3)"	18.3	8.2	9.0	16.4	13.0	80.6	11.5	10.0	10.9	11.4	12.5	17.6	4.8	6.8	14.7	7.5	9.8	12.8	18.4	11.5	10.0	9.0	8.2	11.3	24.0	25.7	11.0	6.2	16.2	6.3	7.8	15.0	18.3	11.5	10.4	8.9	19.8	7.9	8.6	12.5	8.1	9.6	15.7	14.4	21.1	8.7	6.7	9.6	24.3	9.2	6.6	12.2	17.8	11.0	2.5	11.6	15.2	16.3	8.7	6.3	5.1	4.9	3.3	6.2	5.9	9.7	16.4	1.5	18.1	24.4	8.0	12.5	1.1	5.1	8.2	4.5	16.3	3.8	4.6	5.1	6.8	13.1	9.8	3.8	4.3	3.1	3.4	21.2	9.9	9.0	16.3	7.5	17.8	37.3	10.1	10.2	12.5	1.8	24.7	16.3	2.6	7.5	5.9	2.7	1.7	4.3	4.7	6.2	3.4	7.1	2.6	5.6	11.1	4.7	4.8	11.3	5.6	6.4	8.2	15.0	6.9	10.9	21.5	12.1	6.4	8.9	4.4	14.6	24.3	3.2	10.7	9.8	15.2	6.3	11.4	5.5	2.5	4.9	4.9	11.6	2.2	5.8	4.8	9.0	8.7	16.3	3.4	5.6	5.1	9.0	13.0	10.0	10.9	10.0	9.0	11.0	6.2	11.5	9.6	14.9	16.0	7.2	10.1	15.8	11.9	9.2	2.5	6.7	14.8	10.4	9.8	1.9	0.0	5.4	2.1	14.0	1.4	0.0	6.0	5.6	26.7	10.2	46.2	10.4	15.8	7.9	8.6	14.1	62.0	0.4	15.8	59.7	8.5	7.2	2.1	4.4	9.8	1.7	11.7	3.4	8.3	25.8	25.1	11.7	17.2	10.7	1.3	32.8	1.6	6.0
CSK		ENSG00000103653	"C-terminal Src kinase"	P41240	15	74782057-74803198	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Adaptive immunity, Immunity"	"Kinase, Transferase, Tyrosine-protein kinase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 67.2"	"Cell type enhanced"	"Detected in many"	6	"B-cells: 91.8;Kupffer cells: 77.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB011203, HPA026488, HPA028425"	Approved	Approved	Enhanced	Vesicles,Cytosol		No	No		1500000	"Vesicles, Cytosol"		"CAB011203: AB_259070, HPA026488: AB_1847273, HPA028425: AB_10600899"	"unprognostic (1.05e-1)"	"prognostic favorable (5.14e-5)"	"unprognostic (2.59e-3)"	"prognostic favorable (8.22e-4)"	"unprognostic (4.15e-2)"	"unprognostic (4.11e-2)"	"unprognostic (1.87e-1)"	"unprognostic (2.96e-1)"	"unprognostic (2.20e-1)"	"unprognostic (1.31e-1)"	"unprognostic (4.12e-2)"	"unprognostic (4.61e-2)"	"prognostic unfavorable (1.74e-4)"	"prognostic favorable (1.07e-4)"	"unprognostic (1.44e-1)"	"unprognostic (1.01e-1)"	"unprognostic (6.29e-2)"	9.3	8.0	9.5	39.3	11.0	19.9	12.6	18.7	13.4	12.1	13.5	11.8	7.3	16.1	13.9	6.4	33.3	10.6	11.2	14.0	9.8	8.5	8.0	20.9	15.6	67.2	11.1	7.4	10.5	6.7	6.6	10.4	8.8	12.2	9.8	8.9	9.8	13.2	7.0	8.7	14.9	26.2	8.5	10.9	62.7	13.1	8.1	10.6	62.7	8.1	9.5	47.4	17.4	13.2	35.6	22.8	49.6	46.8	16.3	30.7	19.9	12.9	18.3	9.0	14.7	8.6	6.6	7.7	8.7	8.4	16.6	11.8	16.7	12.0	58.0	11.5	7.8	15.4	13.5	18.8	17.5	4.7	28.1	23.2	49.1	6.7	16.7	11.9	25.6	62.6	9.3	8.7	11.8	10.6	8.3	12.5	27.4	14.1	20.2	9.8	21.9	18.4	15.1	11.1	11.7	13.1	20.5	7.7	42.3	7.6	28.8	14.9	10.3	11.3	23.7	15.1	6.0	16.3	37.8	10.8	20.1	10.6	15.7	15.0	10.8	21.8	59.2	10.4	49.0	13.6	20.7	19.7	49.6	23.4	42.4	20.0	29.4	20.3	23.1	22.8	35.6	15.7	18.4	39.1	16.3	46.8	13.2	30.7	19.9	9.5	11.0	18.7	13.4	9.8	8.5	11.1	7.4	12.2	10.6	3.0	11.6	91.8	7.2	8.2	16.5	8.1	12.7	5.3	6.8	8.7	5.9	6.3	1.7	8.5	10.0	11.5	27.7	0.0	12.0	11.0	7.6	9.3	25.5	25.0	46.4	27.0	9.1	12.3	77.9	2.1	8.3	44.5	8.5	36.9	25.3	6.5	15.2	17.3	7.8	6.8	4.1	6.5	8.5	3.8	11.3	8.0	4.7	60.9	22.8	10.5
CSNK1A1	"CK1, CK1a, CK1alpha, CKIa, CKIalpha"	ENSG00000113712	"Casein kinase 1 alpha 1"	P48729	5	149492197-149551552	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis, Wnt signaling pathway"	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	4	"Suprabasal keratinocytes: 741.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB016680, HPA051334"	Uncertain		Approved	Cytosol		NA	NA			Cytosol		"CAB016680: AB_1614518, HPA051334: AB_2681446"	"unprognostic (4.27e-3)"	"unprognostic (5.85e-3)"	"prognostic favorable (1.15e-4)"	"unprognostic (7.39e-2)"	"unprognostic (2.66e-1)"	"unprognostic (3.14e-1)"	"unprognostic (1.27e-2)"	"unprognostic (5.56e-2)"	"unprognostic (4.38e-1)"	"unprognostic (8.31e-2)"	"prognostic unfavorable (5.79e-4)"	"unprognostic (5.47e-2)"	"unprognostic (1.56e-1)"	"unprognostic (7.92e-2)"	"unprognostic (4.41e-2)"	"unprognostic (6.28e-3)"	"unprognostic (6.92e-2)"	33.5	35.8	26.0	26.9	35.2	71.0	40.2	32.0	39.3	33.8	38.2	28.2	40.5	23.2	41.0	29.4	66.1	31.8	36.0	45.7	24.4	26.1	24.0	30.1	37.5	27.3	28.0	29.8	31.7	23.9	46.9	30.9	28.7	38.0	38.1	31.4	25.5	38.5	39.3	51.4	48.4	31.8	45.8	33.9	23.6	34.2	28.6	24.1	38.6	32.0	53.1	41.1	45.0	40.0	28.6	40.6	47.4	39.6	34.2	41.9	40.8	36.9	24.7	41.6	39.4	43.0	52.7	44.5	52.8	50.2	41.2	43.4	48.1	50.1	19.7	58.5	56.1	44.2	37.8	29.3	71.1	63.0	28.5	17.7	26.7	28.6	22.1	38.7	41.8	43.0	43.1	73.8	46.2	74.5	45.6	47.4	35.6	22.5	29.7	46.4	23.2	38.3	16.9	21.8	40.9	60.2	28.7	33.0	22.4	28.7	64.4	32.1	28.9	39.2	52.6	64.3	38.5	49.3	36.4	47.0	48.5	25.5	32.1	50.3	27.6	35.4	30.4	45.3	30.4	58.6	47.4	36.6	35.4	29.0	38.7	33.1	28.6	36.7	32.9	40.6	23.4	39.9	34.0	31.1	34.2	39.6	24.2	41.9	40.8	26.0	35.2	32.0	39.3	24.4	26.1	28.0	29.8	38.0	24.1	137.0	158.5	75.9	513.8	608.0	132.0	46.4	73.9	278.4	290.0	109.9	60.9	146.8	77.9	135.8	55.7	139.6	98.3	23.3	160.7	185.9	198.0	381.5	112.3	94.7	120.9	143.0	124.9	225.9	143.6	66.9	96.4	139.7	145.1	118.2	136.8	145.0	155.3	98.2	105.0	78.9	100.0	155.2	201.9	125.6	93.5	741.0	293.5	102.2	111.1	404.2
CSNK1A1L	MGC33182	ENSG00000180138	"Casein kinase 1 alpha 1 like"	Q8N752	13	37103259-37105664	"Enzymes, Predicted intracellular proteins"	"Wnt signaling pathway"	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	7	"blood: 10.5;testis: 9.0"	"Group enriched"	"Detected in some"	8	"Early spermatids: 23.1;Late spermatids: 19.5;Spermatocytes: 11.4"	"Not detected"	"Not detected"							"Cell type enriched"	"Detected in single"	40	"neutrophil: 10.5"	"Lineage enriched"	"Detected in single"	42	"granulocytes: 10.5"	"Not detected"	"Not detected"											HPA051334			Uncertain	Cytosol		NA	NA			Cytosol		"HPA051334: AB_2681446"	"unprognostic (1.23e-2)"		"unprognostic (1.59e-1)"	"unprognostic (3.19e-2)"	"unprognostic (3.54e-2)"	"unprognostic (2.40e-2)"		"unprognostic (5.40e-2)"	"unprognostic (8.90e-2)"	"unprognostic (3.47e-1)"	"unprognostic (1.47e-3)"	"unprognostic (4.50e-1)"	"unprognostic (2.02e-1)"	"unprognostic (2.28e-3)"	"unprognostic (3.45e-1)"	"unprognostic (2.38e-1)"		0.0	0.0	0.0	0.3	0.0	1.4	0.0	0.0	0.1	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	9.0			0.0		0.0	0.0	0.0	0.1	0.2	10.5	0.2	0.1	0.2	0.2	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.4	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.3	0.3	0.0	0.0	0.3	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.1	0.1	0.0	0.0	0.6	0.2	0.1	0.1	0.1	0.2	0.1	0.1	0.1	0.1	0.2	0.1	0.2	0.1	10.5	0.1	0.2	0.1	0.2	0.2											0.0	0.0	0.0	1.5	1.5	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	23.1	0.5	0.0	0.0	0.0	0.1	0.4	0.9	0.0	0.0	0.1	0.0	0.0	1.8	0.0	19.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	11.4	1.1	2.4	0.2	0.0	0.0	1.0
CSNK1D	"CKID, CKIdelta, HCKID"	ENSG00000141551	"Casein kinase 1 delta"	P48730	17	82239023-82273731	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Biological rhythms, Wnt signaling pathway"	"Kinase, Serine/threonine-protein kinase, Transferase"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"Early spermatids: 287.2;Late spermatids: 600.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB015410	Approved		Approved	"Nucleoplasm,Nucleoli fibrillar center"		NA	NA			"Nucleoli fibrillar center"	Nucleoplasm	"CAB015410: AB_831049"	"unprognostic (1.07e-2)"	"unprognostic (1.27e-1)"	"unprognostic (2.31e-1)"	"prognostic unfavorable (7.04e-4)"	"unprognostic (2.38e-2)"	"unprognostic (3.43e-2)"	"prognostic unfavorable (2.38e-6)"	"unprognostic (8.05e-2)"	"unprognostic (1.09e-1)"	"unprognostic (5.00e-2)"	"prognostic favorable (9.62e-5)"	"unprognostic (2.23e-3)"	"prognostic unfavorable (8.34e-4)"	"unprognostic (3.54e-1)"	"unprognostic (2.52e-1)"	"unprognostic (5.52e-3)"	"unprognostic (4.74e-2)"	30.1	36.3	30.8	25.9	30.8	21.0	26.3	36.3	42.8	30.9	33.0	27.7	32.9	32.6	37.9	29.8	31.3	38.0	34.9	28.5	26.2	26.9	32.0	33.5	30.1	25.8	27.2	27.8	31.4	42.8	34.2	35.9	32.8	30.3	35.3	19.3	28.4	38.0	37.7	52.3	26.7	42.3	34.1	21.4	36.4	32.5	48.3	24.6	29.2	33.0	31.8	33.7	31.4	26.1	6.4	11.4	29.6	12.1	8.7	7.6	7.1	21.6	25.8	14.7	20.3	19.4	20.8	29.6	31.9	20.1	22.9	21.5	21.2	18.7	19.8	25.3	22.7	24.3	21.0	13.8	32.3	18.5	16.8	33.4	24.6	20.5	22.6	56.4	20.2	18.9	31.4	23.0	15.5	23.2	28.6	33.3	14.7	27.7	10.5	21.6	25.3	26.0	21.2	15.8	25.7	40.7	22.4	18.2	17.6	24.1	34.0	18.2	32.9	38.1	31.8	35.7	21.4	22.8	26.6	35.1	32.9	29.6	28.6	24.2	23.1	11.1	21.2	26.4	17.3	23.8	4.7	11.0	14.6	7.6	12.1	7.4	6.4	5.9	7.3	11.4	5.6	5.0	5.3	29.6	8.7	11.1	5.5	5.2	7.1	30.8	30.8	36.3	42.8	26.2	26.9	27.2	27.8	30.3	24.6	44.7	51.2	45.8	92.5	50.4	45.6	14.1	25.5	64.3	62.6	40.1	25.5	56.2	28.2	62.7	287.2	39.4	93.0	0.0	60.1	78.4	37.7	85.7	57.8	25.6	57.5	90.6	44.4	40.5	51.6	600.1	27.9	56.2	27.0	73.1	56.1	34.9	72.9	48.0	37.8	40.4	47.4	38.8	58.6	35.2	26.6	42.2	105.8	64.7	38.3	96.3
CSNK1E	"CKIE, CKIepsilon, HCKIE"	ENSG00000213923	"Casein kinase 1 epsilon"	P49674	22	38290691-38318084	"Cancer-related genes, Enzymes, Predicted intracellular proteins"	"Biological rhythms"	"Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Urothelial cells: 208.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"plasmacytoid DC: 15.7"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"CAB009626, HPA026288"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"CAB009626: AB_2084517, HPA026288: AB_1847276"	"unprognostic (2.32e-1)"	"unprognostic (8.41e-2)"	"unprognostic (5.14e-2)"	"unprognostic (5.01e-3)"	"unprognostic (1.95e-2)"	"unprognostic (4.50e-3)"	"prognostic unfavorable (8.20e-5)"	"unprognostic (2.08e-3)"	"unprognostic (3.69e-1)"	"unprognostic (1.22e-1)"	"unprognostic (9.63e-2)"	"unprognostic (4.16e-3)"	"prognostic unfavorable (4.67e-6)"	"unprognostic (1.91e-1)"	"unprognostic (1.66e-1)"	"unprognostic (2.58e-1)"	"unprognostic (3.25e-3)"	28.5	22.9	30.7	18.3	32.5	21.4	28.6	40.1	42.6	26.4	21.5	32.3	15.7	19.0	37.3	27.3	23.4	28.0	22.1	28.8	31.7	22.3	17.3	11.8	28.4	17.3	28.6	30.1	38.1	25.4	56.2	29.2	33.1	28.7	26.2	17.4	30.5	23.9	23.1	26.3	35.3	17.1	24.0	23.2	20.9	21.8	13.0	33.9	13.3	21.4	14.2	17.4	25.5	28.8	3.7	15.7	4.8	1.8	5.9	4.0	1.2	23.6	11.5	31.3	30.0	15.7	24.1	23.6	30.9	39.5	28.1	27.3	14.8	18.5	17.8	13.5	29.1	18.9	20.2	23.7	42.7	20.4	28.4	51.7	5.7	38.1	11.3	32.3	12.4	15.2	23.0	36.2	42.8	58.0	36.9	29.8	15.6	12.6	36.8	27.1	15.8	17.3	15.3	22.9	17.2	16.7	32.4	22.4	27.9	25.8	19.9	46.4	18.2	26.3	27.3	30.8	19.4	13.9	18.1	33.9	25.5	27.8	14.7	24.6	16.5	23.6	25.1	37.8	14.0	42.6	3.8	1.8	3.4	3.4	0.8	4.0	2.5	3.8	3.4	1.8	3.7	2.1	3.1	4.8	5.9	0.6	15.7	1.7	1.2	30.7	32.5	40.1	38.8	31.7	22.3	28.6	30.1	28.7	33.9	35.7	17.1	22.2	117.4	69.8	122.3	44.0	38.2	16.0	23.9	22.7	56.9	29.6	6.6	26.6	42.8	62.1	10.7	0.0	35.7	33.5	53.2	138.6	3.5	18.6	19.2	68.3	60.3	44.8	14.9	42.7	79.1	18.5	57.3	11.8	40.8	105.4	42.3	29.6	62.2	4.1	58.4	71.1	106.1	6.0	9.6	91.6	104.9	13.4	31.9	208.0
CSNK1G1	CK1gamma1	ENSG00000169118	"Casein kinase 1 gamma 1"	Q9HCP0	15	64165517-64356259	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Wnt signaling pathway"	"Kinase, Serine/threonine-protein kinase, Transferase"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	12	"Early spermatids: 121.0;Late spermatids: 209.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA018209			Supported	Cytosol		NA	NA			Cytosol		"HPA018209: AB_1847278"	"unprognostic (9.10e-2)"	"unprognostic (8.09e-2)"	"unprognostic (1.20e-1)"	"unprognostic (2.65e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.64e-1)"	"unprognostic (7.90e-3)"	"unprognostic (3.07e-1)"	"unprognostic (1.61e-2)"	"unprognostic (2.02e-1)"	"unprognostic (8.63e-2)"	"unprognostic (3.75e-2)"	"unprognostic (7.51e-2)"	"unprognostic (8.16e-3)"	"unprognostic (1.31e-1)"	"unprognostic (2.59e-2)"	"unprognostic (2.41e-1)"	7.2	7.8	10.2	11.9	15.1	11.6	8.7	12.2	10.6	8.7	7.4	7.6	11.6	7.0	11.1	9.9	15.7	10.8	7.8	5.6	8.9	7.6	8.6	6.0	8.4	9.6	6.6	4.7	8.5	8.8	10.4	16.1	7.2	7.2	6.8	7.9	10.1	8.2	14.5	6.5	10.4	6.8	11.1	5.3	8.2	6.8	41.3	7.3	11.8	11.5	5.6	11.2	8.3	10.6	4.1	4.1	8.8	5.1	5.3	8.0	2.4	5.1	10.9	7.9	10.2	6.8	9.3	7.2	6.4	6.6	10.9	9.8	8.7	10.1	8.1	3.5	10.1	11.4	11.9	20.6	12.9	12.8	15.4	5.3	7.6	8.7	5.8	7.8	14.0	9.0	8.2	17.2	11.1	15.9	9.5	11.9	8.4	9.2	8.5	9.8	7.1	7.1	4.4	7.4	6.8	5.7	12.0	9.9	6.5	8.8	20.8	12.8	7.8	8.4	5.1	7.4	13.6	8.9	5.5	12.8	9.9	11.9	7.9	7.9	9.8	18.9	6.9	9.2	10.3	6.1	0.9	3.6	5.6	5.7	5.1	8.0	3.6	5.1	4.1	2.7	4.1	5.1	4.7	8.8	5.3	4.3	4.1	3.9	2.4	10.2	15.1	12.2	10.6	8.9	7.6	6.6	4.7	7.2	7.3	26.8	9.9	7.1	8.7	10.3	44.6	6.5	5.1	16.0	13.6	5.2	64.8	5.8	1.7	8.2	121.0	8.4	8.4	0.0	6.1	7.4	8.9	7.9	3.5	4.0	9.4	9.5	21.9	9.2	9.7	209.9	5.8	10.3	6.8	10.0	10.0	6.9	9.1	7.0	9.6	8.7	29.5	6.5	8.5	27.2	18.4	13.7	3.4	7.7	10.3	10.1
CSNK1G2	CK1g2	ENSG00000133275	"Casein kinase 1 gamma 2"	P78368	19	1941149-1981338	"Enzymes, Predicted intracellular proteins"	"Wnt signaling pathway"	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	8	"Early spermatids: 218.1;Late spermatids: 503.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA034868, HPA056572"	Uncertain		Approved	Vesicles		NA	NA			Vesicles		"HPA034868: AB_10671235, HPA056572: AB_2683178"	"unprognostic (2.00e-1)"	"unprognostic (2.15e-1)"	"unprognostic (1.83e-1)"	"unprognostic (2.42e-3)"	"unprognostic (6.51e-3)"	"unprognostic (2.27e-3)"	"unprognostic (1.14e-3)"	"unprognostic (2.00e-1)"	"unprognostic (9.42e-2)"	"unprognostic (5.78e-2)"	"unprognostic (4.83e-3)"	"unprognostic (4.09e-3)"	"unprognostic (7.95e-2)"	"unprognostic (4.65e-3)"	"unprognostic (5.09e-1)"	"unprognostic (2.01e-1)"	"unprognostic (1.63e-2)"	18.7	22.2	24.8	34.9	19.5	38.1	16.7	30.8	28.9	14.1	19.0	18.2	18.9	27.0	16.5	19.0	22.1	16.9	20.4	16.0	23.3	18.3	19.3	17.9	21.8	35.1	17.3	21.2	18.6	27.0	11.4	24.4	16.7	18.7	18.7	8.7	19.7	26.6	16.0	29.0	23.3	22.1	15.1	12.7	39.1	24.1	58.5	17.4	20.6	16.5	18.1	32.2	17.1	17.1	4.0	5.9	11.2	14.1	3.5	4.9	2.3	23.3	12.6	17.5	27.5	6.2	11.6	14.7	14.5	9.6	11.1	13.6	10.3	12.8	14.7	12.2	9.2	6.1	16.9	9.4	17.7	4.9	13.3	20.4	10.4	20.5	17.4	9.9	16.5	26.4	11.5	11.7	11.5	7.4	8.5	13.1	18.4	21.7	50.6	7.3	13.6	32.8	21.8	31.8	6.5	14.2	28.6	11.1	23.8	8.3	24.6	28.3	23.2	11.0	18.1	16.0	6.9	11.5	27.3	15.6	14.0	11.0	29.3	16.8	32.7	17.3	18.0	14.2	15.7	14.6	2.8	4.0	5.0	4.9	6.2	3.5	3.9	3.6	4.2	3.9	4.0	2.9	4.1	11.2	3.5	14.1	5.9	2.5	2.3	24.8	19.5	30.8	28.9	23.3	18.3	17.3	21.2	18.7	17.4	14.9	17.0	12.0	15.7	19.5	44.1	10.1	7.6	13.4	14.8	10.4	39.3	9.9	8.3	15.1	218.1	19.9	22.5	0.0	25.3	17.2	15.8	22.1	29.9	14.0	12.9	23.8	29.2	14.1	17.0	503.0	19.0	20.5	13.5	5.4	20.2	21.3	24.4	16.5	17.7	12.6	37.2	12.9	14.4	15.6	13.1	22.1	15.2	27.3	18.0	28.5
CSNK1G3		ENSG00000151292	"Casein kinase 1 gamma 3"	Q9Y6M4	5	123512099-123617045	"Enzymes, Predicted intracellular proteins"	"Wnt signaling pathway"	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Horizontal cells: 85.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA027010	Approved					NA	NA					"HPA027010: AB_10602803"	"unprognostic (1.28e-1)"	"unprognostic (1.88e-1)"	"prognostic favorable (9.90e-5)"	"unprognostic (1.60e-2)"	"unprognostic (1.23e-1)"	"unprognostic (3.07e-1)"	"unprognostic (3.12e-3)"	"unprognostic (1.68e-1)"	"unprognostic (1.06e-1)"	"unprognostic (1.18e-3)"	"unprognostic (9.92e-3)"	"unprognostic (4.92e-1)"	"unprognostic (1.05e-2)"	"unprognostic (3.44e-1)"	"unprognostic (2.52e-1)"	"unprognostic (1.97e-3)"	"unprognostic (4.38e-1)"	20.7	15.0	15.5	21.7	22.7	11.1	37.7	23.7	31.7	18.8	24.0	8.6	11.2	23.5	19.4	18.4	18.8	14.6	17.7	14.0	22.2	18.0	16.2	27.7	29.0	21.8	13.3	17.7	18.7	15.8	18.6	18.1	16.2	16.6	13.2	27.4	9.1	15.3	14.1	15.6	13.4	24.9	18.6	16.1	16.5	18.2	16.4	11.4	17.2	16.2	16.5	17.4	21.9	18.2	13.6	5.3	11.3	5.9	12.7	9.5	5.1	13.1	12.6	19.0	18.0	19.4	21.8	9.4	14.3	17.1	15.8	23.7	11.3	21.1	0.0	18.6	17.1	18.4	9.6	15.2	28.2	27.4	19.8	10.4	9.3	14.7	12.0	17.3	4.8	9.6	18.4	18.4	17.8	33.8	18.9	17.2	6.5	5.2	10.7	13.3	9.1	6.5	6.0	10.7	10.4	8.7	7.3	20.1	12.5	11.8	14.5	16.5	12.0	15.8	10.5	23.1	16.5	13.8	13.7	15.7	23.4	17.6	14.1	15.7	12.0	13.2	11.8	14.0	14.0	15.0	11.3	5.8	2.5	7.1	5.6	9.5	13.6	5.9	6.2	5.3	12.9	6.1	6.4	4.6	12.7	5.9	4.7	7.3	5.1	15.5	22.7	23.7	31.7	22.2	18.0	13.3	17.7	16.6	11.4	20.8	13.1	23.3	20.5	18.3	27.5	18.7	5.1	18.7	12.5	10.4	7.9	7.5	18.3	20.1	6.7	24.5	25.7	0.0	21.9	13.3	21.6	23.4	5.7	20.9	8.5	85.8	31.4	31.9	15.4	9.7	18.4	16.5	15.1	24.4	23.7	25.7	24.4	40.3	18.4	17.0	2.8	0.0	15.5	22.0	52.1	16.4	5.6	27.4	22.3	37.6
CSNK2A1	"Cka1, Cka2"	ENSG00000101266	"Casein kinase 2 alpha 1"	P68400	20	472498-543835	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Apoptosis, Biological rhythms, Cell cycle, Transcription, Transcription regulation, Wnt signaling pathway"	"Kinase, Serine/threonine-protein kinase, Transferase"	"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"CAB020680, HPA059206, HPA061698, CAB069395"	Supported		Supported	Nucleoplasm		NA	NA			Nucleoplasm		"CAB020680: , CAB069395: AB_1611912, HPA059206: AB_2683948, HPA061698: AB_2732667"	"unprognostic (1.19e-1)"	"unprognostic (1.44e-1)"	"unprognostic (5.44e-2)"	"unprognostic (8.28e-3)"	"unprognostic (3.62e-2)"	"unprognostic (2.04e-2)"	"prognostic unfavorable (4.11e-6)"	"unprognostic (4.08e-2)"	"unprognostic (3.89e-1)"	"unprognostic (6.88e-2)"	"unprognostic (1.94e-2)"	"unprognostic (1.16e-1)"	"unprognostic (8.58e-2)"	"unprognostic (1.50e-1)"	"unprognostic (4.47e-1)"	"unprognostic (9.53e-2)"	"unprognostic (7.37e-2)"	21.5	26.7	23.2	20.6	31.3	16.7	24.1	26.3	32.8	22.2	26.1	28.2	19.5	21.9	24.3	15.7	31.9	23.3	17.7	29.2	21.8	21.9	24.5	23.1	18.6	21.9	21.3	22.6	24.9	27.5	27.7	24.6	23.1	29.4	20.7	24.2	19.6	23.8	22.4	58.8	27.0	22.5	23.3	21.3	21.8	26.5	51.6	23.2	30.3	22.4	22.4	25.7	26.2	22.8	19.8	25.4	23.3	27.3	18.7	19.4	15.7	44.4	39.7	36.7	22.6	14.0	24.5	23.8	26.1	26.4	30.3	33.8	40.0	29.2	39.7	16.8	21.5	42.6	34.5	40.3	39.1	43.2	13.9	14.6	53.8	10.6	38.7	24.1	46.7	11.9	22.4	41.4	27.9	77.7	29.7	32.7	34.5	52.8	26.2	27.7	14.7	56.1	16.6	52.5	39.9	27.4	33.4	32.1	32.4	26.1	28.2	38.4	30.6	22.3	43.0	39.7	29.7	28.7	18.3	30.7	32.2	27.6	20.8	38.6	27.2	64.0	39.2	16.1	28.1	32.5	23.3	19.7	22.2	16.1	27.3	19.4	19.8	15.7	15.5	25.4	18.9	16.0	15.0	12.1	18.7	25.2	21.1	16.4	15.7	23.2	31.3	26.3	32.8	21.8	21.9	21.3	22.6	29.4	23.2	59.6	72.9	45.0	31.0	36.5	45.7	53.7	33.1	80.3	85.3	41.8	29.5	35.3	34.9	61.1	104.2	34.8	33.8	0.0	43.6	47.2	34.8	36.9	60.3	26.4	28.9	57.2	33.8	22.1	30.2	104.8	38.0	35.3	13.5	67.7	41.3	34.4	54.4	24.6	34.6	56.2	26.8	51.8	32.5	61.3	54.1	43.8	51.4	32.4	39.1	45.0
CSNK2A2	"CK2alpha', CSNK2A1"	ENSG00000070770	"Casein kinase 2 alpha 2"	P19784	16	58157907-58197920	"Cancer-related genes, Enzymes, Predicted intracellular proteins"	"Apoptosis, Cell cycle, Transcription, Transcription regulation, Wnt signaling pathway"	"Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in all"	5	"Early spermatids: 194.0;Late spermatids: 237.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA						"unprognostic (9.49e-2)"	"unprognostic (1.87e-1)"	"unprognostic (5.45e-2)"	"unprognostic (1.23e-1)"	"unprognostic (2.08e-1)"	"prognostic unfavorable (1.40e-5)"	"prognostic unfavorable (1.80e-4)"	"unprognostic (6.84e-3)"	"unprognostic (2.93e-3)"	"unprognostic (2.40e-1)"	"unprognostic (3.03e-2)"	"unprognostic (1.63e-1)"	"unprognostic (5.89e-2)"	"unprognostic (2.06e-3)"	"unprognostic (7.07e-2)"	"unprognostic (3.23e-1)"	"unprognostic (3.14e-2)"	22.8	14.5	15.2	15.2	14.2	14.8	33.5	11.1	17.0	20.4	22.2	12.6	15.1	11.7	19.0	21.4	20.2	15.8	18.7	19.7	12.8	11.5	16.2	21.1	20.0	28.7	10.8	13.9	23.9	28.1	34.3	14.4	29.1	11.6	22.0	15.0	12.9	15.6	15.2	25.4	50.5	18.0	18.8	11.2	26.6	21.1	69.1	10.2	44.3	25.9	12.0	18.5	28.9	33.8	8.9	8.0	8.7	14.1	12.8	14.5	11.7	18.5	20.9	16.2	19.3	22.9	32.4	28.6	14.4	22.2	28.7	18.2	39.1	15.9	33.9	20.3	20.2	14.3	21.9	29.1	26.0	36.5	11.2	15.9	18.6	14.0	34.9	35.2	30.0	19.1	31.7	39.0	21.7	38.8	29.2	30.0	30.8	37.4	9.9	17.4	12.9	29.6	24.9	26.0	9.5	24.3	40.4	33.1	17.9	21.3	20.7	13.7	15.6	34.5	16.2	27.5	25.5	10.1	25.2	24.6	19.7	23.4	15.4	19.2	22.7	18.6	48.2	17.5	20.8	18.3	8.7	14.1	7.4	11.9	12.4	13.5	8.9	14.2	11.6	8.0	7.8	14.3	14.5	0.7	12.8	10.8	7.6	10.7	11.7	15.2	14.2	11.1	17.0	12.8	11.5	10.8	13.9	11.6	10.2	11.9	16.1	14.2	9.3	26.3	21.2	19.7	10.2	13.4	3.4	8.7	3.9	13.4	6.6	13.1	194.0	21.7	13.4	23.3	14.7	21.3	13.6	13.7	8.1	16.3	14.8	17.5	16.1	16.0	26.2	237.3	13.3	17.6	11.8	6.4	12.3	21.7	19.9	13.1	18.4	11.5	21.4	12.9	15.5	43.2	38.8	25.3	20.5	15.2	15.1	20.1
CSNK2A3	CSNK2A1P	ENSG00000254598	"Casein kinase 2 alpha 3"	Q8NEV1	11	11351942-11353357	"Enzymes, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"	Proto-oncogene	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"	12	"Cardiomyocytes: 11.1"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"A-431: 5.6"									"HPA059206, HPA061698"	Uncertain		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA059206: AB_2683948, HPA061698: AB_2732667"	"unprognostic (3.10e-2)"	"unprognostic (3.39e-1)"	"unprognostic (4.65e-2)"	"unprognostic (1.55e-3)"	"unprognostic (1.82e-2)"	"unprognostic (1.60e-1)"	"unprognostic (6.25e-4)"	"unprognostic (4.36e-2)"	"unprognostic (5.42e-2)"	"unprognostic (1.88e-1)"	"unprognostic (5.46e-3)"	"unprognostic (1.07e-1)"	"unprognostic (1.50e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.32e-1)"	"unprognostic (1.42e-1)"	"unprognostic (3.38e-2)"	4.6	1.6	1.3	2.8	1.3	0.6	1.9	1.6	5.5	2.8	3.8	0.5	2.1	3.4	1.8	3.8	3.4	1.1	1.6	2.3	1.5	1.2	5.4	3.0	3.7	1.0	1.1	0.7	2.0	1.4	0.6	1.7	2.9	2.0	2.2	0.7	2.1	1.7	3.6	5.3	1.9	2.9	2.9	1.2	0.9	1.3	3.5	0.3	3.6	1.6	1.8	2.7	1.8	1.3	0.7	0.9	1.1	0.6	0.8	1.0	1.2	5.6	1.2	0.2	2.1	0.0	0.0	0.7	0.5	0.3	0.3	0.3	0.0	0.3	0.0	0.4	0.0	1.6	1.9	1.0	0.8	0.0	0.2	0.3	0.0	0.2	0.5	0.0	0.2	0.4	0.6	0.4	0.0	0.6	0.1	0.0	0.8	0.4	0.8	0.7	0.6	1.3	0.7	1.7	0.4	3.0	0.9	0.2	1.0	0.6	1.0	0.5	1.2	1.6	3.2	0.6	0.2	1.2	0.4	0.7	0.9	1.2	0.4	0.6	0.5	0.9	0.8	2.6	0.2	2.6	0.7	0.5	1.1	0.6	0.6	0.9	0.7	0.4	0.7	0.9	0.7	1.0	0.3	0.1	0.8	0.6	0.7	0.7	1.2	1.3	1.3	1.6	5.5	1.5	1.2	1.1	0.7	2.0	0.3	3.0	0.3	0.0	0.8	1.5	1.0	11.1	0.0	1.4	1.2	3.5	0.0	0.6	0.0	0.7	1.7	1.6	0.4	0.0	0.7	0.4	0.5	1.0	1.1	0.0	0.2	3.2	1.2	0.6	1.0	1.4	0.6	0.0	0.0	0.0	0.0	0.8	0.4	0.3	0.0	0.6	0.5	0.0	0.7	0.6	0.9	0.9	0.8	0.8	0.4	0.5
CTDNEP1	"DULLARD, HSA011916, NET56"	ENSG00000175826	"CTD nuclear envelope phosphatase 1"	O95476	17	7243591-7252491	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 140.1"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037439, HPA066466"	Uncertain		Approved	"Lipid droplets"		NA	NA			"Lipid droplets"		"HPA037439: AB_10601264, HPA066466: AB_2732745"	"unprognostic (7.11e-2)"	"unprognostic (7.78e-2)"	"unprognostic (1.33e-2)"	"prognostic favorable (6.45e-4)"	"unprognostic (3.12e-1)"	"unprognostic (2.13e-1)"	"unprognostic (4.61e-2)"	"unprognostic (1.50e-2)"	"unprognostic (2.98e-1)"	"unprognostic (9.90e-2)"	"prognostic favorable (1.81e-4)"	"unprognostic (3.37e-1)"	"unprognostic (2.77e-3)"	"unprognostic (1.73e-1)"	"unprognostic (1.43e-1)"	"unprognostic (9.97e-2)"	"unprognostic (2.02e-2)"	27.1	23.1	21.4	22.4	21.0	24.2	38.8	21.8	26.6	25.3	24.8	26.6	16.7	20.8	31.2	22.8	26.6	27.3	18.8	29.0	21.5	12.9	23.8	20.6	26.5	39.4	24.7	17.1	31.1	27.9	30.7	26.1	30.4	20.5	25.2	27.9	20.4	23.0	23.8	140.1	35.5	30.9	26.7	25.6	38.3	24.3	26.6	24.3	43.8	26.0	31.5	34.1	22.4	26.7	13.0	17.3	18.3	11.8	7.2	11.2	3.8	38.9	58.3	32.8	35.2	51.4	63.3	24.9	29.2	48.9	47.1	40.6	27.8	27.3	36.1	31.1	52.1	32.9	32.7	43.0	45.0	52.7	53.6	36.5	25.2	39.2	47.9	47.7	28.6	47.7	51.0	54.8	53.9	57.6	48.5	50.1	35.8	22.5	26.8	44.2	24.6	31.9	30.7	22.8	34.9	24.8	38.9	29.2	28.8	37.4	20.5	12.6	36.2	23.2	23.3	31.1	33.9	22.0	23.6	28.5	34.4	29.6	27.4	54.8	23.2	20.2	18.5	44.2	39.6	35.5	6.3	11.8	18.3	10.5	11.7	8.5	13.0	10.1	11.0	8.4	12.4	7.8	11.2	15.6	7.2	7.7	17.3	9.6	3.8	21.4	21.0	21.8	26.6	21.5	12.9	24.7	17.1	20.5	24.3	23.8	21.0	48.6	41.4	41.9	42.6	10.8	30.6	9.4	25.0	38.4	21.6	54.3	10.0	54.2	3.7	44.4	63.2	0.0	73.6	98.0	42.3	51.3	19.7	33.8	80.8	28.6	70.8	40.5	83.4	5.0	53.5	53.1	27.0	36.9	73.9	45.9	67.9	46.0	44.2	29.3	28.2	25.8	33.0	14.6	35.6	58.6	69.6	36.2	58.8	56.2
CTDP1	FCP1	ENSG00000060069	"CTD phosphatase subunit 1"	Q9Y5B0	18	79679801-79756623	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"	"Hydrolase, Protein phosphatase"	"Cataract, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"Early spermatids: 89.2;Late spermatids: 97.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"eosinophil: 6.4"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB032641, HPA040394, HPA070389"	Approved		Approved	Nucleoplasm,Vesicles		NA	NA			Nucleoplasm	Vesicles	"CAB032641: AB_2261235, HPA040394: AB_10794029, HPA070389: AB_2732155"	"unprognostic (1.71e-1)"	"unprognostic (1.75e-1)"	"unprognostic (1.37e-1)"	"prognostic favorable (6.43e-4)"	"unprognostic (2.64e-2)"	"unprognostic (7.99e-2)"	"unprognostic (3.47e-3)"	"unprognostic (1.83e-1)"	"unprognostic (2.54e-1)"	"unprognostic (1.15e-1)"	"unprognostic (5.21e-3)"	"unprognostic (1.99e-2)"	"prognostic favorable (5.51e-5)"	"unprognostic (5.16e-2)"	"unprognostic (8.58e-2)"	"unprognostic (2.85e-2)"	"unprognostic (4.74e-2)"	10.6	8.2	6.2	12.8	9.5	21.8	9.5	7.5	12.2	7.9	12.0	14.4	5.3	13.4	11.9	9.3	11.4	9.8	10.0	6.6	6.8	5.7	8.9	13.4	10.2	14.4	12.3	5.1	7.7	13.4	4.6	7.9	10.6	9.1	9.1	6.2	8.4	10.6	8.3	12.1	20.9	13.8	8.2	6.8	15.3	12.2	27.2	10.6	26.2	9.4	8.8	14.8	11.4	8.9	0.7	1.5	6.4	1.0	2.4	2.0	0.5	8.1	9.1	5.1	7.2	4.1	3.4	16.9	5.5	4.0	5.0	5.0	6.0	5.2	10.4	2.6	3.6	6.1	10.0	4.3	5.7	2.1	9.6	7.8	5.4	4.5	8.1	5.9	23.7	13.3	5.7	5.5	5.4	2.5	3.1	6.0	7.9	6.5	5.3	1.9	7.3	15.8	18.7	7.9	2.7	12.2	12.3	6.7	12.5	3.7	8.5	7.9	8.1	6.5	6.5	8.7	4.0	5.2	13.9	8.2	8.7	12.6	3.4	5.9	4.5	16.6	10.3	7.4	12.0	6.1	0.0	1.0	6.4	1.3	0.9	1.1	0.7	1.0	2.0	1.5	0.4	1.3	0.7	2.7	2.4	0.9	0.2	0.3	0.5	6.2	9.5	7.5	12.2	6.8	5.7	12.3	5.1	9.1	10.6	0.0	2.6	3.7	4.2	7.6	9.8	3.1	5.1	6.7	3.4	3.5	13.7	7.8	1.7	4.4	89.2	5.2	11.7	23.3	6.2	6.5	4.2	8.1	6.9	5.5	7.7	22.3	5.8	7.4	7.3	97.9	7.2	9.5	6.8	0.0	15.1	7.8	8.0	14.4	9.9	5.7	14.3	0.0	5.1	5.9	6.8	8.8	15.9	13.3	10.6	11.5
CTDSP1	"NLIIF, SCP1"	ENSG00000144579	"CTD small phosphatase 1"	Q9GZU7	2	218398256-218405941	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA062654			Supported	Nucleoplasm		NA	NA			Nucleoplasm		"HPA062654: AB_2684819"	"unprognostic (1.97e-2)"	"unprognostic (4.02e-2)"	"unprognostic (1.67e-3)"	"unprognostic (2.62e-2)"	"unprognostic (1.49e-1)"	"unprognostic (1.82e-2)"	"unprognostic (3.90e-2)"	"unprognostic (8.69e-2)"	"unprognostic (2.98e-1)"	"unprognostic (6.38e-2)"	"unprognostic (3.70e-1)"	"unprognostic (1.79e-1)"	"unprognostic (2.58e-1)"	"unprognostic (6.67e-2)"	"unprognostic (2.62e-1)"	"unprognostic (7.01e-2)"	"unprognostic (1.57e-1)"	32.9	22.5	15.9	21.9	13.9	19.9	41.1	12.2	16.4	34.8	30.7	27.6	31.8	24.2	34.5	30.7	31.3	30.9	43.4	25.9	15.5	8.6	34.1	47.5	30.2	33.2	15.0	13.1	44.9	50.8	28.8	12.6	71.3	15.9	41.5	19.8	35.4	34.3	31.5	23.2	30.5	41.3	33.7	12.4	39.1	34.2	15.1	16.1	33.2	41.0	27.2	29.9	32.5	28.4	3.4	6.6	29.3	12.4	6.7	11.0	7.5	10.3	13.3	7.8	25.8	21.4	20.0	29.6	13.9	20.0	13.4	11.7	17.3	25.8	6.2	12.1	24.5	9.2	21.1	11.6	16.7	6.9	22.2	9.1	23.8	16.3	23.1	25.7	14.6	33.4	22.7	20.4	10.2	11.5	21.3	19.7	9.8	19.3	22.4	14.2	28.9	12.8	42.7	5.5	16.5	13.7	17.7	11.1	13.5	17.1	12.7	5.2	13.1	12.1	26.4	13.1	10.4	14.5	35.2	17.2	21.4	13.1	16.3	6.0	14.4	9.3	14.7	19.1	13.9	11.8	20.3	12.4	29.3	11.0	10.2	7.1	3.4	6.7	7.0	6.6	3.2	4.3	5.7	24.5	6.7	10.4	2.3	5.6	7.5	15.9	13.9	12.2	16.4	15.5	8.6	15.0	13.1	15.9	16.1	41.7	40.2	27.7	26.3	24.3	14.0	27.9	45.9	9.4	20.5	29.6	2.0	35.7	28.2	31.7	1.5	43.6	72.4	46.7	37.2	35.9	36.1	31.8	17.4	49.9	35.0	6.4	20.8	58.3	79.9	2.0	55.0	36.2	32.1	26.2	44.5	46.7	32.1	35.1	41.4	42.5	24.7	25.8	34.0	1.6	4.7	17.8	45.4	46.7	37.6	26.7
CTDSP2	"OS4, PSR2, SCP2"	ENSG00000175215	"CTD small phosphatase 2"	O14595	12	57819927-57846739	"Enzymes, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enriched"	"Detected in all"	5	"RH-30: 169.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA052607	Uncertain		Approved	Nucleoplasm,Mitochondria		NA	NA			Nucleoplasm	Mitochondria	"HPA052607: AB_2681883"	"unprognostic (7.09e-2)"	"unprognostic (2.45e-1)"	"unprognostic (1.84e-2)"	"unprognostic (3.07e-2)"	"unprognostic (4.39e-1)"	"unprognostic (5.57e-2)"	"unprognostic (1.05e-3)"	"unprognostic (2.45e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.06e-2)"	"unprognostic (1.12e-1)"	"unprognostic (4.15e-1)"	"unprognostic (7.38e-3)"	"unprognostic (5.50e-2)"	"unprognostic (6.50e-2)"	"unprognostic (2.18e-1)"	"unprognostic (3.11e-1)"	44.5	43.6	28.2	31.6	34.8	17.6	39.6	57.1	33.4	49.0	48.4	36.7	47.7	24.4	50.4	32.9	38.0	41.9	37.7	34.6	31.2	16.5	32.8	32.6	51.3	31.3	37.1	19.9	52.5	53.9	33.7	25.4	42.9	31.0	40.5	38.6	29.3	45.8	60.9	48.8	39.9	36.1	44.1	25.7	38.1	43.1	21.0	40.9	62.9	40.1	32.8	33.9	46.1	63.0	7.3	9.3	18.7	9.7	8.2	11.5	7.1	11.0	4.8	23.1	14.7	20.8	35.9	7.7	12.0	22.8	11.9	10.7	6.1	18.1	13.6	13.8	25.5	4.6	8.9	9.6	11.7	12.5	4.5	4.1	18.8	7.4	4.9	19.4	8.5	11.0	34.3	12.4	10.8	9.2	25.6	18.6	8.3	9.8	24.1	5.9	5.1	9.1	5.1	11.7	7.0	6.1	12.2	169.3	17.8	9.3	16.1	4.3	9.6	16.7	9.6	14.4	14.7	17.4	14.9	14.9	10.6	11.6	11.9	4.2	7.2	7.7	16.4	11.9	7.9	8.2	11.5	9.7	14.7	6.9	9.0	8.2	7.3	9.9	8.0	9.3	6.5	11.5	8.7	18.7	8.2	7.7	7.7	6.4	7.1	28.2	34.8	57.1	33.4	31.2	16.5	37.1	19.9	31.0	40.9	68.5	36.0	33.5	41.6	60.0	18.7	31.1	79.0	13.4	23.9	45.4	15.7	36.7	13.3	64.0	44.2	58.1	55.7	0.0	117.0	34.7	57.1	49.1	24.3	49.7	36.0	19.1	46.8	80.4	63.9	111.0	48.1	36.8	40.5	66.7	42.3	41.1	88.4	51.8	45.6	23.9	10.8	71.1	55.2	5.8	25.8	66.6	47.0	40.6	35.4	58.0
CTDSPL	"C3orf8, HYA22, PSR1, RBSP3, SCP3"	ENSG00000144677	"CTD small phosphatase like"	O15194	3	37861960-37984469	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Peritubular cells: 92.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"neutrophil: 1.1"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"hTCEpi: 50.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA048325	Approved		Approved	Nucleoplasm,Vesicles		NA	NA		10000	Vesicles	Nucleoplasm	"HPA048325: AB_2680359"	"unprognostic (7.35e-2)"	"unprognostic (1.36e-1)"	"unprognostic (1.21e-1)"	"unprognostic (6.48e-3)"	"unprognostic (1.73e-1)"	"unprognostic (3.35e-2)"	"unprognostic (1.66e-3)"	"unprognostic (4.30e-2)"	"unprognostic (1.96e-1)"	"unprognostic (2.55e-1)"	"unprognostic (2.98e-3)"	"unprognostic (1.20e-1)"	"prognostic favorable (6.22e-14)"	"unprognostic (3.48e-2)"	"unprognostic (6.84e-2)"	"unprognostic (1.94e-1)"	"unprognostic (2.67e-2)"	12.8	6.3	11.1	7.8	12.4	5.6	22.0	30.2	14.1	15.5	19.9	8.0	25.7	9.3	14.5	18.3	16.8	12.2	37.2	18.9	13.1	5.9	26.7	13.3	19.0	4.9	7.8	9.9	13.7	10.2	8.3	9.4	20.6	6.9	17.5	20.3	15.6	45.5	22.4	12.5	34.8	11.2	21.3	8.1	11.3	19.7	8.1	8.3	2.9	10.0	13.9	6.9	19.6	21.7	0.0	0.2	1.1	0.5	0.0	0.5	5.6	15.8	6.9	2.9	9.0	11.3	16.2	21.4	10.9	13.8	7.6	8.9	10.0	13.0	0.0	6.7	13.5	3.1	13.3	7.0	20.7	6.1	0.0	5.5	9.7	7.4	22.6	10.3	0.0	2.4	8.3	50.9	8.0	9.6	8.6	10.6	4.4	3.1	0.0	12.5	5.0	3.9	0.0	11.8	6.5	1.0	4.4	5.5	0.1	24.3	10.6	2.4	7.5	6.0	10.8	12.2	12.1	10.4	2.6	8.4	5.5	7.7	10.2	6.8	0.2	0.0	0.0	6.1	5.4	10.1	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.5	0.1	1.1	0.0	0.0	0.0	0.0	5.6	11.1	12.4	30.2	14.1	13.1	5.9	7.8	9.9	6.9	8.3	62.5	19.3	0.0	13.3	26.8	9.6	33.8	71.4	14.7	31.8	22.7	0.0	27.6	19.9	10.8	21.9	17.5	10.3	0.0	4.2	7.7	21.7	12.0	1.1	13.9	6.3	9.5	43.5	19.0	9.5	32.3	66.4	5.5	8.5	0.0	17.7	7.1	10.0	5.8	92.3	14.9	1.6	25.8	22.7	2.8	15.8	25.1	7.9	2.2	29.9	14.2
CTH		ENSG00000116761	"Cystathionine gamma-lyase"	P32929	1	70411218-70439851	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Amino-acid biosynthesis, Cysteine biosynthesis"	"Calmodulin-binding, Lyase"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	6	"liver: 104.5"	"Cell type enriched"	"Detected in many"	6	"Hepatocytes: 130.7"	"Group enriched"	"Detected in all"	5	"liver cancer: 30.0;testis cancer: 8.1"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"B-cells: 4.5;T-cells: 6.4"	"Cell line enhanced"	"Detected in many"		"HHSteC: 20.2;Karpas-707: 31.3;SK-MEL-30: 40.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021591, HPA023300"	Enhanced					NA	NA		25000			"HPA021591: AB_1847321, HPA023300: AB_1847322"	"unprognostic (3.41e-2)"	"unprognostic (1.36e-1)"	"unprognostic (1.48e-1)"	"unprognostic (2.76e-1)"	"unprognostic (7.66e-2)"	"unprognostic (2.45e-3)"	"prognostic favorable (8.69e-4)"	"unprognostic (1.71e-1)"	"unprognostic (1.95e-1)"	"unprognostic (1.00e-1)"	"unprognostic (1.43e-3)"	"unprognostic (5.05e-3)"	"unprognostic (3.25e-2)"	"unprognostic (1.03e-1)"	"unprognostic (8.97e-2)"	"unprognostic (3.05e-3)"	"unprognostic (1.26e-1)"	2.2	8.3	2.3	1.0	3.2	2.2	2.0	3.7	3.6	1.9	3.3	2.2	1.8	3.3	1.7	1.4	2.7	2.3	1.5	1.6	2.1	2.7	8.2	104.5	2.2	1.0	2.4	2.2	18.3	11.6	1.5	1.7	1.0	3.2	2.9	4.1	11.2	4.8	2.8	2.1	1.0	3.2	1.2	2.4	0.8	3.7	5.4	1.3	0.0	11.4	1.2	1.5	2.7	1.2	4.5	1.3	1.1	0.6	0.6	6.4	1.1	5.1	0.7	3.5	4.9	4.3	2.4	7.8	2.1	1.9	1.8	7.8	1.4	3.2	2.8	1.6	1.5	4.6	2.4	13.5	1.4	3.6	8.6	3.0	3.3	2.6	4.4	20.2	3.7	0.8	3.7	12.2	3.7	4.3	0.7	1.6	5.6	6.5	31.3	1.1	1.4	1.3	0.8	3.6	1.9	2.7	1.3	1.9	7.8	3.6	0.0	1.9	1.6	3.2	3.8	40.8	6.9	1.3	2.1	0.5	0.6	4.0	2.8	1.9	12.1	7.1	1.5	4.8	7.7	1.4	1.1	0.6	0.2	2.5	0.4	4.6	4.5	2.3	3.5	1.0	2.9	6.4	3.1	0.9	0.6	0.5	1.3	0.7	1.1	2.3	3.2	3.7	3.6	2.1	2.7	2.4	2.2	3.2	1.3	6.0	3.5	5.6	6.2	2.3	6.8	1.6	5.1	0.0	1.2	5.2	9.8	0.6	10.0	1.6	14.9	2.0	11.9	0.0	3.5	1.3	2.8	5.2	0.0	130.7	1.0	0.0	2.9	4.3	2.9	3.4	1.1	1.3	18.6	0.0	5.9	4.3	6.4	11.0	3.9	22.0	10.1	0.0	5.5	1.6	0.5	1.8	0.7	4.3	4.3	2.8
CTPS1	"CTPS, GATD5"	ENSG00000171793	"CTP synthase 1"	P17812	1	40979335-41012565	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Immunity, Pyrimidine biosynthesis"	Ligase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Spermatogonia: 42.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB017111, HPA051322"	Enhanced		Approved	"Actin filaments,Cytosol"		NA	Yes			Cytosol	"Actin filaments"	"CAB017111: , HPA051322: AB_2681441"	"unprognostic (6.60e-2)"	"unprognostic (4.44e-2)"	"unprognostic (3.21e-2)"	"unprognostic (2.00e-3)"	"unprognostic (2.14e-1)"	"unprognostic (8.37e-2)"	"unprognostic (1.42e-2)"	"unprognostic (9.72e-3)"	"unprognostic (1.94e-3)"	"unprognostic (1.01e-1)"	"unprognostic (2.04e-2)"	"unprognostic (8.93e-3)"	"unprognostic (1.09e-1)"	"unprognostic (8.21e-3)"	"unprognostic (1.34e-1)"	"unprognostic (4.49e-1)"	"unprognostic (1.89e-2)"	7.1	10.0	4.5	10.8	7.8	9.7	5.1	5.9	9.8	14.4	23.6	5.8	16.3	4.3	25.9	8.4	11.3	21.9	13.4	6.7	4.7	5.1	8.6	26.4	7.0	9.4	7.9	4.7	10.1	6.3	16.8	5.4	7.7	6.2	14.4	9.8	9.1	56.5	19.6	13.2	5.8	13.5	35.8	5.1	7.5	9.0	11.8	6.7	14.6	4.5	11.3	13.2	21.3	9.5	6.0	12.8	0.0	7.3	6.6	7.0	3.8	21.2	19.5	27.6	22.2	7.6	9.5	43.4	37.4	16.1	41.1	27.7	38.3	18.9	39.9	17.0	17.1	11.3	15.0	29.5	27.9	41.1	16.7	22.4	24.4	26.0	12.1	25.0	32.5	19.2	10.4	15.1	42.5	30.6	7.2	18.6	29.3	24.5	17.6	28.7	11.9	35.1	12.1	37.7	17.8	23.2	27.1	33.5	25.8	20.7	19.4	37.1	18.1	23.3	25.1	9.3	28.3	8.7	45.0	15.2	27.2	35.6	18.3	46.4	11.4	13.3	35.5	17.8	25.9	28.3	0.0	4.0	0.0	4.6	7.3	6.6	6.0	5.3	4.8	12.0	3.9	4.4	7.0	0.0	6.6	6.1	12.8	6.6	3.8	4.5	7.8	5.9	9.8	4.7	5.1	7.9	4.7	6.2	6.7	6.0	20.2	17.3	10.5	7.1	9.9	4.2	20.4	2.7	5.7	5.2	5.9	14.6	1.7	15.2	22.6	7.3	2.8	0.0	15.1	21.5	6.6	4.3	1.1	24.5	9.6	11.1	2.9	2.5	2.4	21.2	10.0	6.0	1.7	12.6	2.6	5.2	14.2	0.0	23.3	9.6	4.2	38.8	14.4	9.3	42.5	6.5	4.7	5.7	5.2	5.8
CTPS2		ENSG00000047230	"CTP synthase 2"	Q9NRF8	X	16588003-16712936	"Enzymes, Predicted intracellular proteins"	"Pyrimidine biosynthesis"	Ligase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA017437, HPA075930"	Uncertain		Approved	Mitochondria,Cytosol		NA	NA		14000	"Mitochondria, Cytosol"		"HPA017437: AB_1847326, HPA075930: "	"unprognostic (1.40e-1)"	"unprognostic (6.69e-2)"	"unprognostic (3.37e-2)"	"unprognostic (7.38e-2)"	"unprognostic (1.05e-2)"	"unprognostic (2.11e-1)"	"prognostic unfavorable (2.37e-5)"	"unprognostic (6.57e-3)"	"unprognostic (8.52e-2)"	"unprognostic (4.31e-3)"	"unprognostic (4.43e-1)"	"unprognostic (1.89e-2)"	"unprognostic (7.22e-2)"	"unprognostic (6.04e-2)"	"unprognostic (8.93e-2)"	"unprognostic (5.04e-2)"	"prognostic favorable (4.56e-4)"	10.0	12.0	7.8	11.5	11.9	7.8	13.5	14.3	9.9	17.5	13.3	14.8	10.8	15.6	22.0	10.2	9.6	12.1	11.9	7.2	8.6	7.1	8.1	13.4	8.3	7.9	9.1	6.1	17.9	14.9	22.9	8.5	8.3	9.3	12.8	12.6	14.1	11.8	9.7	5.5	9.2	12.8	14.0	12.3	7.1	11.3	4.4	10.8	11.5	11.8	8.4	10.6	11.8	11.2	1.6	3.3	1.1	6.1	3.8	2.4	1.4	7.6	7.0	11.4	9.5	5.8	4.4	0.1	4.2	3.5	6.8	6.3	7.0	8.0	0.2	13.5	4.3	6.2	6.2	16.0	7.7	8.2	0.0	10.6	4.3	9.8	10.2	3.0	3.1	0.1	4.8	2.6	6.4	5.4	7.7	9.1	0.1	6.1	0.3	6.2	10.1	0.1	2.4	19.6	2.8	8.2	0.1	6.6	2.4	7.3	8.5	7.1	13.1	13.3	1.0	7.6	12.9	18.5	8.9	5.8	3.6	1.9	9.4	3.6	0.2	0.1	25.3	2.8	2.7	3.9	0.4	1.5	1.1	1.3	0.8	2.4	1.6	2.2	1.4	3.3	1.4	1.7	1.7	0.1	3.8	6.1	2.2	2.0	1.4	7.8	11.9	14.3	9.9	8.6	7.1	9.1	6.1	9.3	10.8	8.9	7.0	3.7	5.0	2.9	4.9	5.2	10.2	4.0	9.1	5.2	0.0	2.9	3.3	8.7	2.8	4.9	6.0	0.0	8.4	6.2	3.9	4.8	5.8	7.5	4.5	6.4	10.9	6.7	4.9	5.8	8.3	2.6	8.5	9.0	7.4	3.4	10.3	11.0	3.9	2.2	4.4	6.5	4.1	0.0	0.2	3.3	1.3	3.8	8.1	4.8
CTRB1	CTRB	ENSG00000168925	"Chymotrypsinogen B1"	P17538	16	75219000-75226338	"Enzymes, Predicted intracellular proteins, Predicted secreted proteins"	Digestion	"Hydrolase, Protease, Serine protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"		"Tissue enriched"	"Detected in single"	2272	"pancreas: 1908.8"	"Cell type enriched"	"Detected in some"	12	"Exocrine glandular cells: 26371.2"	"Cancer enriched"	"Detected in some"	1905	"pancreatic cancer: 962.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"EFO-21: 6.4;HDLM-2: 5.0;U-2 OS: 2.5;U-251 MG: 1.6"														"Secreted to digestive system"	NA	NA										"unprognostic (1.76e-1)"				"unprognostic (2.62e-1)"	"unprognostic (3.55e-1)"	"unprognostic (1.57e-1)"	"unprognostic (5.22e-2)"	"unprognostic (4.43e-3)"	"unprognostic (2.96e-1)"		"unprognostic (1.17e-2)"		0.2	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.2	0.2	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.8	1908.8	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.2	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.4	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.7	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.0	6.4	0.0	0.4	0.0	0.0	0.0	0.0	5.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	2.5	0.2	1.6	0.0	0.1	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	26.0	0.0	0.0	0.0	0.0	26371.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	265.1	0.0	0.0	2264.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
CTRB2		ENSG00000168928	"Chymotrypsinogen B2"	Q6GPI1	16	75204096-75207185	"Enzymes, Predicted intracellular proteins, Predicted secreted proteins"	Digestion	"Hydrolase, Protease, Serine protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	5240	"pancreas: 3761.5"	"Cell type enriched"	"Detected in some"	5	"Exocrine glandular cells: 45669.7"	"Cancer enriched"	"Detected in single"	1696	"pancreatic cancer: 540.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"EFO-21: 5.1;HDLM-2: 1.9;U-2 OS: 9.3;U-251 MG: 1.9;U-266/84: 2.6;U-698: 2.4"														"Secreted to digestive system"	NA	NA							"unprognostic (9.41e-4)"			"unprognostic (2.20e-1)"	"unprognostic (1.28e-2)"		"unprognostic (2.10e-1)"	"unprognostic (2.92e-2)"	"unprognostic (2.77e-1)"	"unprognostic (5.95e-2)"	"unprognostic (9.56e-2)"	"unprognostic (3.54e-3)"	"unprognostic (7.06e-2)"	"unprognostic (2.17e-1)"	"unprognostic (7.57e-2)"		0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.2	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.6	3761.5	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.2	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.7	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.3	0.0	5.1	0.0	0.1	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.3	0.0	0.0	0.0	0.0	9.3	0.0	1.9	0.1	2.6	2.4	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.2	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	107.9	1.0	0.0	0.0	0.0	45669.7	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	6.3	0.3	0.0	0.0	376.1	0.0	0.0	8606.5	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
CTRC	"CLCR, ELA4"	ENSG00000162438	"Chymotrypsin C"	Q99895	1	15438439-15449242	"Disease related genes, Enzymes, Potential drug targets, Predicted secreted proteins"		"Hydrolase, Protease, Serine protease"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	417	"pancreas: 1443.7"	"Cell type enriched"	"Detected in some"	5	"Exocrine glandular cells: 5617.8"	"Cancer enriched"	"Detected in some"	168	"pancreatic cancer: 236.0"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"basophil: 3.4"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"A-431: 3.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA046920	Enhanced				"Secreted to digestive system"	NA	NA					"HPA046920: AB_2679865"	"unprognostic (2.62e-2)"	"unprognostic (2.58e-1)"	"unprognostic (1.34e-1)"	"unprognostic (2.81e-1)"	"unprognostic (8.60e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.02e-1)"	"unprognostic (1.23e-1)"	"unprognostic (2.94e-2)"	"unprognostic (7.60e-2)"	"unprognostic (3.34e-1)"	"unprognostic (2.00e-1)"	"unprognostic (9.55e-11)"	"unprognostic (4.98e-2)"	"unprognostic (1.84e-1)"	"unprognostic (1.50e-1)"	"unprognostic (5.99e-3)"	0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.6	1443.7	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.4	0.1	0.1	0.1	0.1	0.1	0.1	0.1	1.1	0.4	3.4	0.7	1.5	0.6	0.1	3.6	0.6	0.5	0.7	0.2	0.0	0.2	0.3	0.4	0.0	0.0	0.0	1.7	0.5	1.1	0.0	0.5	0.5	0.0	0.1	0.2	1.1	0.6	0.4	0.3	0.1	0.9	0.2	1.7	0.3	0.0	0.0	0.0	0.6	0.0	0.7	0.1	1.8	0.2	0.5	1.1	1.7	0.5	0.0	0.0	0.5	0.1	0.3	0.0	0.1	0.4	1.0	0.4	0.2	0.2	0.2	0.3	0.1	0.9	0.4	1.4	0.9	0.3	0.8	1.6	0.3	0.8	0.8	0.3	3.4	0.4	0.4	0.4	0.2	0.2	0.3	0.3	0.6	0.1	1.1	0.3	0.4	1.7	1.5	0.7	0.4	0.2	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.3	0.0	0.1	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.4	0.0	0.1	0.0	0.0	5617.8	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.9	1.7	41.5	0.0	0.0	1090.5	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.3	0.0	0.0	0.0	0.1
CTRL		ENSG00000141086	"Chymotrypsin like"	P40313	16	67927640-67932414	"Enzymes, Predicted secreted proteins"		"Hydrolase, Protease, Serine protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	281	"pancreas: 639.8"	"Group enriched"	"Detected in some"	39	"Exocrine glandular cells: 185.6;Pancreatic endocrine cells: 95.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"HPA034504, HPA034505"	Enhanced				"Secreted to digestive system"	NA	NA					"HPA034504: AB_2674196, HPA034505: AB_10602212"	"unprognostic (3.03e-5)"	"unprognostic (3.53e-3)"	"unprognostic (3.46e-2)"	"unprognostic (1.37e-1)"	"unprognostic (9.66e-2)"	"unprognostic (2.00e-2)"	"unprognostic (1.24e-1)"	"unprognostic (2.23e-1)"	"unprognostic (1.18e-1)"	"unprognostic (6.83e-3)"	"unprognostic (6.41e-2)"	"unprognostic (1.88e-1)"	"unprognostic (3.20e-4)"	"unprognostic (6.69e-2)"	"unprognostic (2.79e-1)"	"unprognostic (2.63e-1)"	"unprognostic (1.29e-3)"	0.1	0.0	0.1	0.1	0.1	0.2	0.1	0.2	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.3	639.8	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.2	0.0	0.2	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.6	1.1	1.1	0.7	0.0	2.2	0.5	0.5	3.7	1.1	0.3	0.2	0.1	1.8	0.3	0.7	1.2	1.3	2.3	1.4	0.7	0.4	0.7	1.2	1.0	5.7	0.7	3.1	1.4	6.4	0.8	1.1	1.4	0.3	0.9	2.5	1.2	0.2	3.9	1.0	0.5	0.0	1.9	1.6	1.0	0.6	1.1	0.7	2.8	6.3	1.3	2.3	2.9	0.5	4.6	0.0	0.9	2.7	1.4	1.3	0.7	0.6	0.9	1.2	4.4	1.7	0.1	2.1	0.5	1.6	6.6	2.8	3.6	0.2	0.8	0.8	0.6	0.7	0.3	1.5	0.7	0.2	0.3	1.1	0.5	0.9	0.6	0.5	2.2	1.1	0.0	0.7	1.1	0.0	0.5	0.1	0.1	0.2	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	185.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	3.6	0.4	0.0	95.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.4	0.1
CTSA	"GSL, PPGB"	ENSG00000064601	"Cathepsin A"	P10619	20	45890144-45898820	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		"Carboxypeptidase, Hydrolase, Protease"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adrenal gland: 125.7"	"Cell type enhanced"	"Detected in many"	4	"Hofbauer cells: 279.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"ASC diff: 113.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB024930, HPA031068, HPA072487"	Enhanced		Enhanced	Vesicles	"Intracellular and membrane"	NA	NA		18000000	Vesicles		"CAB024930: , HPA031068: AB_10601205, HPA072487: "	"unprognostic (8.61e-2)"	"unprognostic (3.37e-1)"	"unprognostic (4.30e-2)"	"unprognostic (2.13e-1)"	"unprognostic (6.42e-2)"	"unprognostic (2.21e-1)"	"prognostic unfavorable (1.95e-4)"	"unprognostic (6.33e-2)"	"unprognostic (9.53e-3)"	"unprognostic (7.19e-2)"	"unprognostic (1.83e-1)"	"unprognostic (6.85e-2)"	"unprognostic (7.57e-2)"	"unprognostic (1.09e-1)"	"unprognostic (6.05e-2)"	"unprognostic (1.71e-1)"	"unprognostic (8.40e-2)"	29.0	125.7	12.0	22.8	19.5	22.1	35.3	11.4	30.0	14.1	50.6	17.4	16.2	29.4	18.2	19.3	20.7	12.7	28.0	32.6	11.5	11.6	88.2	43.8	28.4	38.9	12.3	16.1	23.9	19.2	28.3	16.5	47.7	15.7	18.2	50.5	30.1	20.5	15.1	19.3	28.2	40.6	19.6	11.9	38.8	19.7	14.3	11.2	8.0	18.1	24.9	22.4	23.3	18.7	7.0	16.6	81.1	46.1	12.0	31.2	50.0	14.1	14.5	2.7	12.4	113.6	58.9	6.3	20.3	54.2	22.3	29.1	27.3	38.1	3.0	23.6	38.1	84.2	22.6	7.3	13.7	14.0	5.9	6.8	8.0	10.2	47.5	25.3	12.7	33.2	46.7	16.5	14.4	3.2	55.8	24.2	3.9	7.9	46.7	24.1	29.1	3.2	11.8	2.8	21.6	34.6	5.1	14.1	16.8	17.8	12.5	5.5	5.2	33.9	59.3	56.7	7.3	14.5	18.3	22.3	44.8	10.5	25.3	15.9	23.1	29.1	2.1	80.6	16.9	18.4	60.6	46.1	81.1	7.5	26.6	31.2	7.0	12.9	13.2	16.6	3.6	4.7	6.9	24.7	12.0	17.7	6.6	23.9	50.0	12.0	19.5	11.4	30.0	11.5	11.6	12.3	16.1	15.7	11.2	32.8	24.6	40.4	31.0	21.5	54.2	10.9	58.6	22.7	26.1	68.0	56.9	86.8	33.2	172.8	2.3	41.6	257.8	0.0	146.8	91.1	44.1	21.0	9.2	53.3	279.4	44.5	51.9	105.0	166.6	3.6	30.5	81.3	106.3	136.1	70.2	92.8	127.7	92.2	25.8	168.1	30.9	25.8	46.4	6.2	32.4	19.9	120.5	54.2	85.6	31.9
CTSB		ENSG00000164733	"Cathepsin B"	P07858	8	11842524-11869448	"Cancer-related genes, Candidate cardiovascular disease genes, Enzymes, Plasma proteins, Predicted secreted proteins"		"Hydrolase, Protease, Thiol protease"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"thyroid gland: 297.0"	"Cell type enhanced"	"Detected in all"	11	"Hofbauer cells: 2617.6;Kupffer cells: 1392.4"	"Cancer enhanced"	"Detected in all"		"thyroid cancer: 1446.9"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"basophil: 53.1;classical monocyte: 127.4;intermediate monocyte: 97.0;myeloid DC: 68.0;non-classical monocyte: 54.7;plasmacytoid DC: 95.4"	"Group enriched"	"Detected in all"	5	"dendritic cells: 95.4;granulocytes: 53.1;monocytes: 127.4"	"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 239.8;fHDF/TERT166: 139.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB000457, HPA018156, HPA048998"	Enhanced		Supported	Nucleoli,Vesicles	"Secreted to blood"	NA	NA		130000000	Vesicles	Nucleoli	"CAB000457: , HPA018156: AB_1846069, HPA048998: "	"unprognostic (5.74e-2)"	"unprognostic (4.32e-2)"	"unprognostic (1.38e-2)"	"unprognostic (2.17e-2)"	"unprognostic (2.98e-3)"	"unprognostic (5.96e-2)"	"unprognostic (1.36e-2)"	"unprognostic (1.07e-1)"	"unprognostic (2.82e-2)"	"unprognostic (1.06e-1)"	"unprognostic (7.61e-2)"	"unprognostic (8.30e-2)"	"unprognostic (2.85e-1)"	"unprognostic (7.39e-2)"	"unprognostic (4.12e-2)"	"prognostic favorable (5.76e-4)"	"prognostic unfavorable (9.02e-4)"	227.9	42.1	19.6	67.2	24.4	14.7	67.6	14.9	31.4	76.7	49.1	30.1	22.7	29.9	53.2	44.8	54.2	52.4	43.6	120.7	18.3	23.7	95.6	167.8	94.3	175.1	29.1	16.5	44.2	31.6	13.8	21.6	68.7	24.8	42.6	27.9	33.8	63.7	33.6	41.3	22.8	51.2	51.1	35.9	116.4	26.7	21.5	20.4	18.1	297.0	25.9	38.4	56.8	62.2	7.9	95.4	53.1	127.4	5.3	17.1	108.5	6.4	29.5	3.8	16.2	66.6	74.9	11.8	122.8	239.8	43.0	51.0	14.0	38.4	0.1	17.8	139.3	57.7	35.8	5.2	33.9	27.2	3.2	5.0	9.5	3.4	34.5	67.8	2.1	7.1	82.1	46.2	38.9	34.8	74.9	84.1	2.8	7.9	21.7	35.7	5.2	0.8	3.5	3.2	75.8	9.9	3.4	3.8	16.6	13.1	10.2	1.6	9.6	14.2	7.7	64.0	11.7	12.5	6.4	116.4	73.1	24.8	23.4	22.8	21.6	15.7	0.6	83.9	8.2	34.2	53.1	127.4	16.3	5.2	97.0	7.2	7.9	17.1	5.8	68.0	6.1	9.6	4.1	18.5	5.3	54.7	95.4	13.4	108.5	19.6	24.4	14.9	28.0	18.3	23.7	29.1	16.5	24.8	20.4	101.3	205.9	73.7	364.9	48.5	44.4	251.7	175.8	137.9	227.5	108.2	39.3	224.9	23.2	276.8	13.3	119.6	152.5	210.2	211.7	280.5	149.9	239.1	169.3	203.7	2617.6	55.6	148.7	214.9	1392.4	12.2	70.8	859.7	153.5	399.5	80.9	115.8	264.9	108.7	87.4	331.7	35.7	38.8	121.0	4.8	18.5	35.4	543.3	50.7	114.7	284.4
CTSC	"DPP1, PALS, PLS"	ENSG00000109861	"Cathepsin C"	P53634	11	88293592-88337787	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		"Hydrolase, Protease, Thiol protease"	"Disease mutation, Palmoplantar keratoderma"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 218.6"	"Cell type enhanced"	"Detected in many"	11	"Cytotrophoblasts: 362.7;Hofbauer cells: 897.2;Macrophages: 364.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"BJ hTERT+: 111.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"CAB025364, HPA066610, HPA068434"	Enhanced		Supported	Vesicles	"Intracellular and membrane"	No	No		19000000	Vesicles		"CAB025364: , HPA066610: AB_2685694, HPA068434: AB_2685989"	"unprognostic (4.05e-2)"	"unprognostic (1.35e-1)"	"unprognostic (1.50e-1)"	"unprognostic (1.10e-1)"	"unprognostic (3.70e-2)"	"unprognostic (1.45e-2)"	"prognostic unfavorable (9.30e-5)"	"unprognostic (1.62e-1)"	"unprognostic (1.04e-1)"	"unprognostic (1.56e-2)"	"unprognostic (3.11e-2)"	"unprognostic (3.35e-1)"	"prognostic favorable (4.80e-4)"	"unprognostic (2.93e-1)"	"unprognostic (4.35e-2)"	"unprognostic (8.10e-2)"	"unprognostic (4.07e-2)"	40.7	20.5	6.7	44.5	10.6	12.0	35.3	1.5	5.6	14.0	25.3	7.1	6.2	20.4	16.1	24.0	21.8	16.7	36.6	53.3	6.8	6.5	62.7	18.1	110.1	218.6	12.5	3.6	11.0	24.8	3.8	17.3	43.4	9.4	13.8	33.1	27.0	35.1	5.8	10.0	11.7	28.5	14.2	14.6	86.6	13.5	10.8	9.2	19.5	17.7	25.3	30.0	30.2	16.9	8.5	75.9	52.5	92.6	34.7	42.4	31.2	11.1	11.5	4.5	9.4	12.1	32.9	30.1	76.8	111.7	43.9	31.7	31.1	51.7	17.4	40.9	41.7	10.1	18.1	7.0	32.5	35.0	30.7	12.7	22.7	31.8	35.0	16.2	28.9	15.4	45.8	23.0	33.8	69.4	37.0	43.1	16.9	20.6	21.1	5.3	2.1	13.0	39.9	23.5	75.5	35.6	17.0	4.7	30.9	56.4	18.8	1.2	9.4	12.9	17.1	10.0	27.9	3.8	19.8	20.9	3.0	27.2	20.9	48.8	8.9	12.8	17.7	7.9	60.9	16.6	12.5	32.5	52.5	42.4	69.3	36.5	8.5	19.5	37.8	35.1	4.6	9.9	23.8	37.2	34.7	92.6	75.9	28.4	31.2	6.7	10.6	1.5	5.6	6.8	6.5	12.5	3.6	9.4	9.2	20.8	83.9	64.9	5.0	26.8	1.0	2.5	56.0	80.3	93.3	38.4	0.0	362.7	24.9	14.0	1.2	41.8	29.0	0.0	79.6	130.7	85.3	3.1	72.8	14.0	897.2	0.0	10.9	24.5	290.2	4.0	183.8	364.2	45.5	139.7	15.7	0.6	35.1	69.1	24.1	150.6	0.6	58.2	183.3	3.0	11.5	23.7	190.1	167.5	36.3	14.2
CTSD	"CLN10, CPSD"	ENSG00000117984	"Cathepsin D"	P07339	11	1752752-1764573	"Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins"		"Aspartyl protease, Hydrolase, Protease"	"Alzheimer disease, Cancer-related genes, Disease mutation, Neurodegeneration, Neuronal ceroid lipofuscinosis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	11	"Enterocytes: 1407.0;Hofbauer cells: 3678.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"CAPAN-2: 190.9;hTERT-RPE1: 255.7;SK-BR-3: 182.5"									"CAB000109, HPA003001"	Supported				"Secreted to blood"	NA	NA		540000000			"CAB000109: , HPA003001: AB_1078404"	"unprognostic (9.95e-2)"	"unprognostic (1.62e-1)"	"prognostic unfavorable (2.46e-4)"	"unprognostic (1.09e-1)"	"unprognostic (1.71e-3)"	"unprognostic (2.65e-2)"	"unprognostic (9.40e-3)"	"unprognostic (1.11e-1)"	"unprognostic (1.52e-1)"	"unprognostic (1.12e-3)"	"unprognostic (1.59e-1)"	"unprognostic (1.86e-2)"	"prognostic favorable (4.93e-5)"	"unprognostic (8.98e-2)"	"unprognostic (3.39e-2)"	"unprognostic (2.13e-2)"	"unprognostic (1.60e-1)"	151.9	148.7	21.4	32.8	27.0	83.7	67.7	18.6	47.4	56.3	59.3	41.4	41.9	61.6	25.9	48.2	46.2	34.2	90.0	86.0	25.3	27.6	150.5	163.5	102.6	81.1	49.6	25.7	41.2	62.3	21.3	24.9	56.1	42.8	33.9	33.7	234.4	64.1	42.3	76.2	50.8	90.9	23.3	36.7	87.6	47.0	29.8	29.7	21.1	36.3	42.9	41.4	64.6	43.5	4.9	22.7	51.1	83.8	28.4	26.1	58.7	13.8	37.5	4.3	18.0	54.9	18.8	7.0	10.3	32.0	13.8	16.4	9.3	190.9	3.3	26.6	26.5	103.7	74.7	6.2	11.5	3.8	14.3	13.6	5.1	7.1	11.6	58.0	11.8	54.6	30.2	50.5	7.4	13.7	255.7	10.1	4.4	6.1	20.6	24.4	51.1	3.0	6.6	10.2	56.8	15.1	4.3	5.3	12.5	48.7	43.4	6.0	5.9	12.2	182.5	34.6	6.5	71.4	16.3	12.7	42.1	6.4	5.8	16.4	28.3	35.5	2.1	61.3	31.9	35.2	29.0	83.8	25.2	26.1	47.6	15.1	4.9	12.2	18.3	22.7	3.2	14.3	18.3	51.1	28.4	38.5	19.2	13.5	58.7	21.4	27.0	18.6	47.4	25.3	27.6	49.6	25.7	42.8	29.7	104.2	261.1	102.1	219.0	64.0	155.9	226.4	366.9	115.1	126.3	519.9	104.1	198.5	92.9	592.1	2.7	92.6	1407.0	70.0	321.5	138.5	112.5	108.8	466.1	497.1	3678.7	249.5	153.3	833.5	1087.5	9.0	100.4	573.5	215.9	205.6	341.0	186.6	426.0	610.2	120.6	259.1	69.6	109.9	103.0	22.4	56.8	71.8	394.2	188.4	260.3	345.7
CTSE		ENSG00000196188	"Cathepsin E"	P14091	1	206009264-206023909	"Enzymes, Predicted intracellular proteins"		"Aspartyl protease, Hydrolase, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"gallbladder: 57.9;intestine: 47.3;stomach 1: 153.0"	"Cell type enhanced"	"Detected in some"	14	"Alveolar cells type 1: 98.3;Club cells: 77.3;Exocrine glandular cells: 240.3;Pancreatic endocrine cells: 151.8;Paneth cells: 175.6"	"Group enriched"	"Detected in many"	8	"lung cancer: 68.8;pancreatic cancer: 297.4;stomach cancer: 200.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	44	"OE19: 201.7"	"Not detected"	"Not detected"							"HPA012940, CAB032687"	Enhanced				"Intracellular and membrane"	NA	NA					"CAB032687: AB_637901, HPA012940: AB_2668773"	"unprognostic (1.17e-2)"	"unprognostic (2.45e-1)"	"unprognostic (1.31e-2)"	"unprognostic (2.72e-2)"		"unprognostic (1.35e-2)"	"unprognostic (2.52e-3)"	"unprognostic (1.45e-1)"	"unprognostic (3.29e-2)"	"unprognostic (2.87e-2)"	"unprognostic (1.20e-2)"	"unprognostic (1.39e-1)"	"unprognostic (6.37e-3)"	"unprognostic (1.42e-1)"	"unprognostic (5.45e-2)"	"unprognostic (2.61e-2)"	"prognostic favorable (5.26e-5)"	0.2	0.1	0.1	3.7	0.1	3.0	0.1	0.1	0.1	0.1	47.3	0.3	0.8	29.3	0.1	0.7	0.6	0.5	57.9	0.3	0.1	0.1	0.2	0.2	24.9	0.0	0.1	0.0	0.1	2.2	0.0	0.5	0.0	0.1	1.3	3.2	0.0	0.1	0.0	0.1	0.1	29.7	0.0	0.1	0.2	153.0	0.1	0.0	0.3	4.2	0.0	1.1	1.8	0.4	0.2	0.7	0.0	0.4	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	201.7	0.0	0.0	0.0	0.0	0.0	4.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.2	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.4	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.0	98.3	20.9	0.0	0.1	0.0	0.0	0.4	17.8	13.4	77.3	0.0	0.0	0.0	0.0	44.2	0.0	0.0	5.1	23.3	240.3	0.0	0.0	0.1	0.0	0.0	0.2	0.0	2.4	0.0	0.3	0.0	0.0	0.0	0.0	2.8	8.1	0.0	151.8	175.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.9	0.2
CTSF	"CATSF, CLN13"	ENSG00000174080	"Cathepsin F"	Q9UBX1	11	66563463-66568841	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		"Hydrolase, Protease, Thiol protease"	"Disease mutation, Neurodegeneration, Neuronal ceroid lipofuscinosis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Late spermatids: 256.1;Muller glia cells: 186.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"NK-cells: 7.5;T-cells: 9.7"	"Cell line enhanced"	"Detected in many"		"HSkMC: 28.4;SK-MEL-30: 52.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002141, HPA031431"	Approved		Uncertain	"Vesicles,Plasma membrane,Cytosol"	"Intracellular and membrane"	NA	NA		3600000	Cytosol	"Vesicles, Plasma membrane"	"CAB002141: AB_563471, HPA031431: "	"unprognostic (1.52e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.03e-1)"	"unprognostic (7.22e-3)"	"unprognostic (2.25e-2)"	"unprognostic (6.72e-2)"	"unprognostic (2.67e-2)"	"unprognostic (2.76e-2)"	"unprognostic (3.69e-1)"	"unprognostic (4.14e-1)"	"unprognostic (1.69e-2)"	"unprognostic (9.12e-2)"	"prognostic favorable (8.92e-7)"	"unprognostic (1.36e-2)"	"unprognostic (1.28e-1)"	"unprognostic (3.89e-1)"	"unprognostic (2.42e-1)"	28.1	29.4	24.7	8.0	29.0	1.8	31.1	38.4	47.1	37.3	23.8	32.6	25.2	5.8	38.1	29.8	12.9	34.3	37.3	34.5	25.3	20.5	29.8	45.4	17.3	8.5	28.0	26.0	68.2	23.1	42.6	15.9	20.2	25.4	32.3	8.1	35.0	35.5	37.8	35.8	19.7	9.4	34.6	22.4	10.4	17.8	37.1	30.1	0.8	18.6	14.2	6.3	22.2	21.5	2.1	1.1	0.5	0.7	7.5	9.7	2.4	0.1	9.3	5.0	13.0	21.5	8.7	3.6	6.6	16.7	6.8	4.8	0.0	8.3	0.0	11.1	14.4	0.3	0.9	8.6	2.8	3.6	2.2	0.0	0.3	3.8	0.0	12.0	0.1	5.1	28.4	9.7	1.5	1.1	20.3	4.3	2.7	2.9	1.5	8.5	1.9	0.1	1.1	0.6	5.0	3.4	0.0	1.9	1.6	6.1	0.2	6.0	6.5	17.5	2.0	52.8	0.5	13.3	0.8	2.8	2.8	2.7	3.2	0.7	8.9	0.1	0.0	6.6	0.1	4.1	0.0	0.7	0.4	6.5	0.7	7.0	2.0	5.6	7.3	0.8	2.1	9.7	5.5	0.5	7.5	0.3	1.1	1.7	2.4	24.7	29.0	38.4	47.1	25.3	20.5	28.0	26.0	25.4	30.1	11.9	14.1	3.4	58.6	35.3	99.1	43.9	35.7	2.7	5.7	34.9	39.3	22.1	13.3	8.5	123.6	24.1	0.0	0.0	6.6	8.1	75.7	48.4	9.2	51.3	13.1	127.1	11.5	49.7	15.8	256.1	134.9	9.9	148.5	2.8	3.1	186.2	8.9	1.9	114.5	30.7	63.2	77.6	43.8	164.4	36.6	22.1	19.8	19.2	3.0	26.5
CTSG	CG	ENSG00000100448	"Cathepsin G"	P08311	14	24573522-24576260	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Antibiotic, Antimicrobial, Hydrolase, Protease, Serine protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	19	"bone marrow: 450.3"	"Cell type enriched"	"Detected in some"	9	"granulocytes: 500.2"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	5	"classical monocyte: 6.5;memory CD8 T-cell: 3.5;myeloid DC: 5.1;naive CD8 T-cell: 1.8;neutrophil: 7.1;NK-cell: 5.2;plasmacytoid DC: 5.7"	"Low lineage specificity"	"Detected in many"			"Cell line enriched"	"Detected in some"	7	"THP-1: 448.1"	"Not detected"	"Not detected"							"CAB000110, HPA047737"	Enhanced				"Intracellular and membrane"	NA	NA		67000			"CAB000110: , HPA047737: AB_2680140"	"unprognostic (1.67e-1)"	"unprognostic (2.57e-2)"	"unprognostic (6.92e-2)"	"unprognostic (1.08e-1)"		"prognostic favorable (1.57e-4)"	"unprognostic (4.05e-2)"	"unprognostic (4.13e-2)"	"unprognostic (3.06e-1)"	"unprognostic (2.42e-1)"	"unprognostic (2.60e-2)"	"unprognostic (2.05e-2)"	"unprognostic (1.63e-3)"	"unprognostic (1.07e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.37e-1)"	"prognostic unfavorable (8.91e-4)"	15.1	0.5	0.0	6.0	0.0	450.3	6.0	0.0	0.6	10.0	5.1	0.0	2.8	1.1	6.2	19.7	6.4	0.8	16.7	23.4	0.0	0.0	2.1	2.0	9.2	3.7	0.0	0.0	1.5	3.4	0.8	0.5	3.0	0.0	8.2	3.2	2.6	6.3	6.9	1.1	19.5	8.9	14.9	0.0	10.7	3.2	2.8	0.0	15.6	0.5	12.0	5.1	2.9	3.3	0.0	5.7	7.1	6.5	5.2	3.5	12.9	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.1	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	448.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	66.4	0.0	0.0	6.5	0.0	1.1	1.0	0.0	0.0	1.0	3.5	5.1	0.0	0.0	1.8	7.1	5.2	0.0	5.7	0.0	12.9	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	11.9	58.0	0.0	0.0	5.7	0.0	0.6	0.0	1.4	4.5	0.0	0.0	0.0	0.0	0.0	3.5	0.0	0.0	0.0	0.0	0.1	1.0	0.0	500.2	0.0	0.2	0.0	0.0	0.0	0.0	4.7	0.0	4.7	5.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	3.4	0.0	0.0	0.0	0.0
CTSH	"ACC-4, ACC-5, ACC4, ACC5, CPSB"	ENSG00000103811	"Cathepsin H"	P09668	15	78921058-78949574	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins"		"Hydrolase, Protease, Thiol protease"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lung: 82.6"	"Cell type enhanced"	"Detected in many"	9	"Alveolar cells type 2: 1152.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"classical monocyte: 42.8"	"Group enriched"	"Detected in all"	5	"B-cells: 20.6;dendritic cells: 41.2;monocytes: 42.8"	"Cell line enhanced"	"Detected in many"		"CAPAN-2: 43.1;HaCaT: 31.5;OE19: 31.0;RT4: 119.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"CAB000458, HPA003524"	Enhanced		Supported	"Vesicles,Cytosol,Cytoplasmic bodies"	"Intracellular and membrane"	NA	NA		10000000	"Vesicles, Cytosol, Cytoplasmic bodies"		"CAB000458: , HPA003524: AB_1846075"	"unprognostic (6.47e-2)"	"unprognostic (4.65e-3)"	"unprognostic (1.05e-1)"	"prognostic favorable (6.90e-4)"	"unprognostic (4.37e-2)"	"unprognostic (1.93e-1)"	"unprognostic (7.18e-2)"	"unprognostic (3.30e-3)"	"unprognostic (2.22e-1)"	"unprognostic (5.96e-2)"	"unprognostic (4.10e-2)"	"unprognostic (3.89e-2)"	"unprognostic (6.63e-3)"	"unprognostic (3.83e-1)"	"unprognostic (4.42e-2)"	"unprognostic (2.70e-3)"	"unprognostic (1.79e-3)"	16.7	10.6	9.5	24.2	7.0	5.4	23.9	4.5	9.8	25.1	11.4	17.7	14.7	10.6	10.3	17.1	7.8	13.1	29.2	16.5	14.8	6.7	66.7	18.7	82.6	65.4	12.1	11.6	14.6	25.8	12.3	6.5	7.7	9.4	18.6	6.6	6.7	15.4	15.9	7.0	13.5	16.6	9.8	10.8	20.3	15.6	6.7	15.7	6.6	8.5	4.8	34.8	39.6	13.5	20.6	41.2	1.4	42.8	1.3	7.6	27.3	16.2	1.1	0.4	4.8	1.1	0.0	5.3	1.6	0.6	2.8	1.5	7.1	43.1	5.7	1.8	0.1	3.1	31.5	2.0	7.8	2.3	24.0	0.1	0.1	0.2	16.5	1.7	0.0	1.1	0.8	2.2	0.0	0.0	11.8	0.2	0.7	11.6	0.0	3.9	1.7	3.7	10.0	1.2	31.0	0.3	0.0	0.3	0.9	9.9	119.7	0.5	1.2	7.0	3.9	9.7	2.3	1.6	5.4	2.2	0.0	1.0	0.0	0.7	0.1	12.4	3.1	0.0	10.5	1.7	0.0	42.8	0.4	1.4	28.3	7.6	20.6	4.1	2.1	41.2	12.0	0.4	0.7	1.4	1.3	17.0	4.2	3.1	27.3	9.5	7.0	4.5	9.8	14.8	6.7	12.1	11.6	9.4	15.7	220.3	1152.3	144.6	210.0	21.5	0.8	25.2	351.6	270.4	197.9	349.0	3.9	16.6	71.3	153.3	17.1	109.7	15.8	0.0	128.8	33.6	30.0	89.1	30.2	82.9	261.0	0.0	8.7	15.4	160.1	15.9	67.6	392.5	75.9	476.1	19.5	21.1	69.6	11.5	5.6	352.9	5.6	19.4	17.8	5.0	52.9	16.3	19.6	25.4	37.0	308.4
CTSK	"CTSO, CTSO2, PKND, PYCD"	ENSG00000143387	"Cathepsin K"	P43235	1	150796208-150808323	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"		"Hydrolase, Protease, Thiol protease"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 104.1"	"Cell type enhanced"	"Detected in many"	11	"Basal keratinocytes: 61.1;Leydig cells: 110.1;Melanocytes: 92.8;Peritubular cells: 140.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"classical monocyte: 6.7"	"Lineage enriched"	"Detected in many"	6	"monocytes: 6.7"	"Group enriched"	"Detected in some"	8	"ASC diff: 205.0;ASC TERT1: 75.1;BJ hTERT+: 165.6"	"Low region specificity"	"Detected in all"							HPA050346			Supported	Vesicles	"Intracellular and membrane"	NA	NA			Vesicles		"HPA050346: AB_2681101"	"unprognostic (1.48e-1)"	"unprognostic (9.29e-2)"	"unprognostic (1.21e-1)"	"unprognostic (7.61e-3)"	"unprognostic (5.08e-2)"	"unprognostic (6.57e-2)"	"unprognostic (1.02e-1)"	"unprognostic (6.60e-2)"	"unprognostic (2.11e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.49e-1)"	"unprognostic (3.54e-2)"	"prognostic unfavorable (7.12e-5)"	"unprognostic (6.07e-3)"	"unprognostic (2.98e-2)"	"unprognostic (5.93e-3)"	"unprognostic (6.41e-2)"	104.1	2.4	1.2	6.5	1.6	1.3	79.3	2.4	2.3	70.6	23.6	2.2	10.1	2.7	72.5	25.9	26.5	12.5	53.4	14.7	1.1	1.1	3.4	1.8	8.7	10.4	1.1	1.7	25.4	2.9	0.3	3.0	30.6	2.6	24.2	11.5	56.0	10.9	6.8	19.9	44.0	11.0	26.9	2.0	5.6	8.6	24.1	0.9	1.1	7.1	13.2	10.7	38.0	48.2	0.1	1.0	1.0	6.7	0.5	1.2	1.8	0.1	0.1	0.4	0.3	205.0	75.1	0.2	5.8	165.6	0.4	0.9	0.0	0.1	0.1	0.2	11.4	0.0	0.2	0.0	0.1	0.2	0.1	0.1	0.3	0.1	0.0	1.1	0.1	0.4	14.9	0.5	4.6	0.1	13.1	0.6	0.1	0.0	0.5	0.4	0.3	0.0	0.7	1.1	0.2	0.1	0.0	0.1	0.0	0.4	0.1	0.1	0.7	0.3	0.0	3.1	0.9	0.2	0.2	0.4	0.2	0.1	0.2	0.3	0.7	0.5	1.1	17.4	0.0	1.0	0.0	6.7	1.0	0.7	3.4	0.2	0.0	0.6	0.2	0.4	0.1	0.3	0.5	0.6	0.5	2.0	1.0	1.2	1.8	1.2	1.6	2.4	2.3	1.1	1.1	1.1	1.7	2.6	0.9	3.0	5.8	0.0	0.5	61.1	8.4	1.2	2.5	2.7	5.7	3.5	3.9	1.0	0.0	1.1	0.8	5.2	1.1	0.0	0.2	1.9	31.5	0.9	0.0	0.0	19.2	3.2	1.2	9.8	3.7	1.7	110.1	6.6	92.8	2.8	1.9	2.4	1.3	0.6	140.7	0.0	7.8	12.9	47.6	1.4	0.7	51.7	0.8	0.0	0.9	0.5
CTSL	"CTSL1, FLJ31037"	ENSG00000135047	"Cathepsin L"	P07711	9	87725519-87731393	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins"		"Hydrolase, Protease, Thiol protease"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"placenta: 237.0"	"Cell type enhanced"	"Detected in all"	8	"Cytotrophoblasts: 935.7;Extravillous trophoblasts: 843.2;Hofbauer cells: 1004.8;Ito cells: 672.8;Syncytiotrophoblasts: 1290.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	9	"intermediate monocyte: 31.0;non-classical monocyte: 44.3"	"Lineage enriched"	"Detected in many"	10	"monocytes: 44.3"	"Cell line enhanced"	"Detected in many"		"ASC TERT1: 201.6;HSkMC: 93.2"									"CAB000459, HPA070413"	Enhanced		Approved	"Golgi apparatus,Vesicles"	"Intracellular and membrane"	NA	NA		17000000	"Golgi apparatus, Vesicles"		"CAB000459: AB_2292484, HPA070413: "	"unprognostic (1.05e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.24e-2)"	"unprognostic (1.53e-1)"	"prognostic unfavorable (3.73e-4)"	"unprognostic (1.19e-3)"	"unprognostic (8.12e-3)"	"prognostic unfavorable (5.15e-5)"	"unprognostic (2.09e-1)"	"unprognostic (3.15e-1)"	"unprognostic (6.80e-2)"	"unprognostic (3.21e-1)"	"prognostic favorable (4.34e-4)"	"unprognostic (5.64e-3)"	"unprognostic (2.26e-2)"	"unprognostic (1.72e-1)"	"unprognostic (7.11e-3)"	60.3	21.5	10.4	27.2	24.6	18.4	23.3	6.9	12.3	14.8	23.2	14.1	13.7	9.0	24.1	22.3	11.4	25.7	20.7	37.7	10.7	11.4	65.4	98.0	53.1	80.5	18.9	7.7	25.0	14.3	18.8	18.0	237.0	18.4	19.4	13.0	23.2	22.0	23.5	29.3	9.1	12.0	36.6	16.1	108.1	17.5	14.1	15.7	6.8	19.2	9.4	10.1	41.3	26.5	0.0	1.7	0.1	44.3	0.0	4.3	2.4	6.4	37.4	2.6	4.4	47.1	201.6	15.7	20.8	60.7	17.9	22.4	3.6	5.9	0.0	9.8	26.9	56.7	5.5	3.4	6.8	14.8	0.1	3.3	1.1	10.6	8.7	30.5	0.0	4.5	93.2	11.4	29.2	11.4	15.6	14.1	0.0	12.1	0.0	25.7	10.8	0.0	0.7	4.9	10.1	7.1	1.5	1.5	0.0	12.5	3.4	3.7	4.6	4.3	9.8	23.9	15.6	1.1	7.4	22.0	16.0	8.7	58.4	8.8	1.6	6.0	0.0	58.7	0.0	5.2	0.1	3.5	0.1	0.0	31.0	0.0	0.0	1.8	0.0	1.7	0.0	4.3	0.3	0.1	0.0	44.3	0.1	0.3	2.4	10.4	24.6	6.9	11.7	10.7	11.4	18.9	7.7	18.4	15.7	38.7	60.6	38.5	79.1	33.5	37.4	87.3	84.1	56.2	38.7	71.5	17.7	935.7	23.2	77.5	3.5	75.9	8.6	46.7	82.1	843.2	226.1	43.7	27.8	100.7	1004.8	12.7	11.1	672.8	182.1	10.4	145.3	481.4	60.8	19.8	7.7	78.6	55.2	2.9	176.0	107.8	35.6	90.5	103.2	144.4	46.2	29.6	1290.9	15.3	8.8	43.0
CTSO	CTSO1	ENSG00000256043	"Cathepsin O"	P43234	4	155924118-155953917	"Enzymes, Predicted intracellular proteins"		"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"ASC TERT1: 12.5;HSkMC: 14.8;Karpas-707: 27.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA002041	Approved				"Intracellular and membrane"	NA	NA		24000			"HPA002041: AB_1078408"	"unprognostic (3.96e-3)"	"unprognostic (1.62e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.33e-2)"	"unprognostic (9.10e-3)"	"unprognostic (2.55e-1)"	"unprognostic (3.80e-3)"	"unprognostic (2.07e-1)"	"unprognostic (6.62e-2)"	"unprognostic (1.33e-1)"	"unprognostic (2.20e-1)"	"unprognostic (1.05e-1)"	"unprognostic (7.55e-2)"	"unprognostic (4.87e-3)"	"unprognostic (4.73e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.79e-1)"	13.7	16.4	11.9	12.6	12.0	1.8	14.9	3.7	12.4	16.0	18.5	11.6	10.2	13.3	19.3	27.3	10.8	15.6	16.9	19.7	9.7	8.6	21.2	41.6	26.4	19.4	10.2	6.7	16.3	10.7	13.6	9.4	18.7	9.7	16.1	9.8	24.0	13.8	16.8	5.9	6.2	27.5	14.4	11.4	19.3	10.8	9.0	7.7	5.5	17.1	10.2	10.3	12.4	12.5	7.0	8.9	5.3	14.8	12.0	10.9	8.9	0.3	0.2	1.5	1.6	5.7	12.5	0.0	3.6	7.2	1.3	1.8	0.0	4.6	0.0	0.7	2.4	0.4	0.0	0.0	0.3	0.9	5.3	0.1	0.4	0.0	0.0	5.9	0.7	0.1	14.8	1.3	0.8	0.6	8.4	1.2	0.2	0.0	27.8	4.1	0.3	0.3	0.1	0.3	0.2	0.2	1.7	0.3	1.7	5.4	2.3	0.2	1.7	0.9	3.0	1.1	0.8	1.5	1.0	2.1	4.4	0.2	0.4	1.2	3.2	0.0	0.0	7.9	0.0	5.9	5.3	12.0	0.8	7.9	14.8	10.9	5.8	6.1	7.3	8.9	7.0	6.7	6.8	0.5	12.0	10.7	8.3	6.8	8.9	11.9	12.0	3.7	12.4	9.7	8.6	10.2	6.7	9.7	7.7	35.7	17.3	20.1	9.8	9.3	6.6	4.8	35.7	12.0	14.8	24.4	2.0	16.9	11.6	16.2	0.4	26.9	14.2	0.0	17.8	5.0	32.5	16.5	8.1	50.0	15.1	4.8	6.4	36.8	29.9	0.4	28.1	17.9	28.7	13.6	10.0	15.8	12.5	7.0	23.7	8.4	1.3	19.4	16.4	0.2	1.1	8.0	8.8	13.1	5.6	7.8
CTSS		ENSG00000163131	"Cathepsin S"	P25774	1	150730196-150765957	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 171.4;lymphoid tissue: 111.4"	"Cell type enhanced"	"Detected in many"	13	"Hofbauer cells: 672.3;Kupffer cells: 1992.4;Macrophages: 1161.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	7	"classical monocyte: 171.4;intermediate monocyte: 151.2;myeloid DC: 43.5;neutrophil: 94.5;non-classical monocyte: 138.5"	"Group enriched"	"Detected in all"	9	"dendritic cells: 43.5;granulocytes: 94.5;monocytes: 171.4"	"Cell line enhanced"	"Detected in many"		"CAPAN-2: 21.6;HMC-1: 51.4;U-698: 109.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB000460, HPA002988"	Supported		Approved	Vesicles	"Intracellular and membrane"	NA	NA		19000000	Vesicles		"CAB000460: , HPA002988: AB_1078409"	"unprognostic (7.81e-2)"	"unprognostic (9.04e-2)"	"unprognostic (3.23e-2)"	"unprognostic (3.93e-2)"	"unprognostic (1.52e-1)"	"unprognostic (1.12e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.23e-1)"	"unprognostic (1.59e-1)"	"unprognostic (6.00e-3)"	"unprognostic (1.46e-1)"	"unprognostic (3.89e-1)"	"unprognostic (6.24e-2)"	"unprognostic (7.50e-2)"	"unprognostic (4.14e-2)"	"unprognostic (2.13e-1)"	"unprognostic (2.47e-3)"	41.6	9.3	6.8	32.3	10.3	30.3	9.7	1.9	6.2	4.7	32.9	6.6	5.6	19.6	3.7	12.9	8.8	10.7	15.9	17.3	6.4	5.1	9.6	21.5	55.8	99.5	12.6	2.3	7.6	6.4	0.4	3.4	14.4	9.3	7.5	33.4	6.5	12.9	3.3	3.5	3.8	38.0	6.8	17.1	111.4	13.8	3.8	9.5	12.9	7.6	4.6	22.8	21.5	5.3	11.1	43.5	94.5	171.4	3.3	5.6	145.4	1.0	3.3	0.0	0.0	0.4	0.3	0.3	0.0	3.3	0.2	0.6	0.0	21.6	14.9	1.6	0.1	6.1	0.4	0.0	0.1	0.0	8.3	0.0	6.5	0.1	0.0	0.0	8.9	51.4	0.6	0.0	1.9	0.1	0.1	1.2	0.0	0.6	13.0	0.4	0.0	0.0	6.3	0.0	0.0	0.0	3.7	1.2	18.2	4.0	3.2	0.0	0.1	0.2	0.9	0.3	0.0	0.0	18.2	1.8	1.3	0.2	0.0	0.3	9.0	0.8	109.3	7.6	9.6	0.8	1.2	171.4	16.5	3.2	151.2	3.9	11.1	3.9	3.8	43.5	10.2	3.9	3.6	94.5	3.3	138.5	9.4	5.6	145.4	6.8	10.3	1.9	6.2	6.4	5.1	12.6	2.3	9.3	9.5	101.3	167.2	252.8	20.8	15.0	2.0	3.0	84.1	518.0	134.2	40.1	11.8	3.1	0.0	145.4	5.3	35.1	277.5	0.0	157.6	3.9	26.3	16.7	100.8	19.5	672.3	0.0	40.9	64.4	1992.4	1.7	4.9	1161.7	54.0	251.5	198.9	0.3	150.7	378.7	2.1	4.2	4.1	19.4	7.6	0.2	0.4	13.6	5.1	117.4	149.8	109.8
CTSV	"CTSL2, CTSU"	ENSG00000136943	"Cathepsin V"	O60911	9	97029679-97039643	"Enzymes, Predicted intracellular proteins"		"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"lymphoid tissue: 154.7"	"Cell type enhanced"	"Detected in many"	12	"Cytotrophoblasts: 114.1;Extravillous trophoblasts: 136.0;Syncytiotrophoblasts: 56.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	6	"NK-cell: 4.2;plasmacytoid DC: 15.7"	"Group enriched"	"Detected in many"	42	"dendritic cells: 15.7;NK-cells: 4.2"	"Group enriched"	"Detected in many"	9	"BEWO: 92.0;SuSa: 118.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB017112	Uncertain		Approved	"Nucleoplasm,Nucleoli fibrillar center,Plasma membrane,Cytosol"	"Intracellular and membrane"	NA	NA		260000	"Nucleoli fibrillar center, Cytosol"	"Nucleoplasm, Plasma membrane"	"CAB017112: "	"unprognostic (2.40e-1)"	"unprognostic (2.74e-2)"	"unprognostic (1.50e-1)"	"prognostic favorable (8.41e-4)"	"unprognostic (7.29e-2)"	"unprognostic (5.59e-2)"	"prognostic unfavorable (2.83e-5)"	"unprognostic (7.04e-3)"	"unprognostic (6.06e-2)"	"unprognostic (1.39e-2)"	"prognostic unfavorable (2.87e-4)"	"unprognostic (1.86e-2)"	"unprognostic (1.78e-1)"	"unprognostic (2.41e-2)"	"unprognostic (1.33e-1)"	"unprognostic (3.04e-3)"	"prognostic unfavorable (2.39e-4)"	0.7	0.0	0.4	0.6	0.7	0.0	3.5	0.4	1.0	23.0	1.4	2.0	0.4	0.5	1.5	1.5	9.8	0.6	0.5	0.2	0.8	0.6	9.7	0.4	0.6	0.2	1.5	0.7	0.4	1.1	1.1	0.9	8.7	1.6	0.5	1.6	4.3	5.0	0.6	0.5	25.0	0.6	0.2	3.0	0.2	1.1	32.4	1.0	154.7	0.7	6.3	2.7	0.2	9.9	0.2	15.7	0.2	0.0	4.2	0.0	0.1	5.9	1.8	2.0	5.3	0.1	0.0	92.0	0.0	0.0	1.3	1.0	12.1	5.9	0.0	0.5	0.0	8.8	11.4	9.8	7.2	1.9	0.0	1.3	0.2	0.6	1.8	0.0	0.0	0.8	0.0	2.4	0.3	0.3	0.1	0.4	1.7	0.2	0.0	2.3	2.2	0.1	0.0	12.2	12.0	1.7	0.0	4.4	0.1	1.8	0.7	0.5	0.9	6.0	2.1	2.1	118.9	3.8	0.7	0.0	0.3	6.0	0.0	0.6	1.2	3.2	0.1	0.3	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.2	0.0	0.0	0.2	4.2	0.0	15.7	0.0	0.1	0.4	0.7	0.4	1.0	0.8	0.6	1.5	0.7	1.6	1.0	0.0	0.6	1.5	13.2	27.0	4.4	0.8	0.0	0.0	3.4	1.8	9.8	114.1	1.7	1.2	1.5	1.5	1.2	0.0	0.7	136.0	2.6	7.1	0.0	0.0	11.8	0.0	1.7	0.6	0.0	9.6	3.7	1.6	0.0	0.0	0.9	4.5	0.6	1.7	1.1	11.1	26.0	6.5	0.8	34.6	32.6	10.5	56.3	0.0	3.7	6.4
CTSW		ENSG00000172543	"Cathepsin W"	P56202	11	65879809-65883741	"Enzymes, Plasma proteins, Predicted secreted proteins"		"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 157.2;bone marrow: 41.4"	"Group enriched"	"Detected in many"	10	"granulocytes: 70.4;T-cells: 273.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	8	"gdT-cell: 106.6;MAIT T-cell: 67.7;memory CD8 T-cell: 68.3;naive CD8 T-cell: 51.4;NK-cell: 157.2"	"Group enriched"	"Detected in many"	48	"NK-cells: 157.2;T-cells: 106.6"	"Group enriched"	"Detected in some"	23	"HEL: 38.8;NB-4: 88.8"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in some"			CAB016345	Enhanced				"Secreted to blood"	NA	NA		340000			"CAB016345: AB_626813"	"prognostic favorable (3.06e-4)"	"unprognostic (2.06e-2)"	"unprognostic (2.71e-2)"	"prognostic favorable (8.36e-6)"	"unprognostic (1.21e-1)"	"prognostic favorable (9.89e-4)"	"unprognostic (5.69e-2)"	"unprognostic (1.09e-2)"	"unprognostic (1.25e-3)"	"unprognostic (5.14e-3)"	"unprognostic (2.83e-2)"	"unprognostic (1.59e-1)"	"prognostic unfavorable (8.84e-6)"	"unprognostic (3.86e-2)"	"unprognostic (3.78e-1)"	"unprognostic (1.26e-1)"	"unprognostic (4.01e-3)"	5.2	1.2	0.9	4.9	1.0	41.4	2.3	0.6	0.7	3.9	4.9	0.8	0.5	2.4	8.4	4.0	2.1	2.1	2.5	9.0	0.9	1.0	2.5	6.8	12.7	36.0	1.1	0.6	3.0	1.1	0.0	1.4	10.7	1.4	7.4	2.5	6.3	10.9	1.5	1.9	1.5	5.9	1.7	2.1	33.1	3.3	3.4	0.4	11.1	3.1	1.3	18.2	4.5	2.6	0.4	2.7	2.3	0.3	157.2	106.6	45.7	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	38.8	0.0	0.0	0.0	2.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	2.2	0.0	0.0	0.4	88.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	1.3	0.0	0.0	0.0	0.1	0.3	0.1	0.1	0.0	0.0	2.4	0.0	2.3	0.2	0.3	106.6	0.2	67.7	0.4	11.7	68.3	2.7	0.3	7.0	51.4	2.0	157.2	0.3	1.7	1.6	45.7	0.9	1.0	0.6	0.7	0.9	1.0	1.1	0.6	1.4	0.4	0.0	6.2	3.7	0.4	4.0	0.0	0.4	0.0	1.4	2.3	0.0	0.0	0.1	0.0	0.2	1.8	0.6	0.0	0.0	0.0	0.1	3.2	0.3	70.4	1.7	1.9	0.0	0.0	5.5	5.3	8.8	0.0	7.3	16.9	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.8	0.2	0.9	5.5	0.2	273.8	0.0	0.3
CTSZ	CTSX	ENSG00000101160	"Cathepsin Z"	Q9UBR2	20	58995185-59007247	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	11	"Hofbauer cells: 945.4;Macrophages: 462.5;monocytes: 1072.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"classical monocyte: 3.2;intermediate monocyte: 2.7;memory B-cell: 1.0;myeloid DC: 3.9;naive B-cell: 1.9;neutrophil: 3.5;non-classical monocyte: 2.9;plasmacytoid DC: 2.2"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"fHDF/TERT166: 119.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"CAB025114, HPA049876, HPA053504"	Supported		Supported	Vesicles	"Intracellular and membrane"	NA	NA		85000000	Vesicles		"CAB025114: , HPA049876: AB_2680927, HPA053504: AB_2682172"	"unprognostic (7.30e-2)"	"unprognostic (3.98e-2)"	"unprognostic (4.07e-2)"	"unprognostic (1.11e-3)"	"unprognostic (8.25e-3)"	"unprognostic (1.15e-1)"	"unprognostic (4.12e-2)"	"unprognostic (6.59e-2)"	"unprognostic (1.59e-1)"	"unprognostic (1.22e-1)"	"unprognostic (1.33e-1)"	"unprognostic (5.33e-2)"	"prognostic unfavorable (5.72e-5)"	"unprognostic (1.96e-1)"	"unprognostic (6.92e-2)"	"unprognostic (1.19e-1)"	"unprognostic (2.04e-1)"	70.7	27.9	12.4	40.8	20.4	20.7	51.2	14.6	13.5	25.4	52.8	16.0	19.9	40.8	20.6	25.5	20.1	20.7	22.3	50.1	9.8	13.3	34.9	83.7	54.3	61.2	18.8	10.5	29.7	29.0	30.6	27.6	38.6	19.2	28.8	37.8	31.5	40.3	17.7	20.7	12.9	63.6	26.4	22.1	56.5	19.2	13.8	14.9	18.4	42.4	17.5	35.8	29.8	21.5	1.9	3.9	3.5	3.2	0.3	0.6	0.8	27.6	21.5	0.0	0.0	25.4	29.2	15.2	45.5	50.4	34.9	31.2	41.5	46.5	15.2	30.2	119.6	0.0	22.1	13.7	43.1	23.9	48.6	1.8	13.9	34.8	0.0	26.6	1.6	48.4	24.8	26.0	15.2	18.2	11.6	55.2	0.0	10.0	7.7	23.3	0.0	0.1	15.0	1.7	12.1	21.5	0.3	0.1	18.2	25.5	6.5	0.4	0.3	35.4	41.0	0.1	14.2	18.9	23.6	60.6	0.0	23.6	30.7	0.2	36.7	22.3	2.9	0.4	33.5	0.0	0.0	3.2	0.3	0.6	2.7	0.0	1.0	0.4	0.1	3.9	1.9	0.4	0.1	3.5	0.3	2.9	2.2	0.2	0.8	12.4	20.4	14.6	13.5	9.8	13.3	18.8	10.5	19.2	14.9	14.9	4.0	130.0	51.2	44.8	4.6	17.5	53.5	8.1	5.7	68.0	0.0	34.5	19.9	168.0	2.8	62.8	285.7	23.3	37.2	91.0	58.0	41.9	10.4	307.7	945.4	11.1	26.0	44.2	260.7	3.3	12.0	462.5	96.2	1072.2	50.0	45.9	72.3	98.2	13.1	68.2	4.9	45.3	59.0	1.7	4.5	36.3	34.6	29.9	76.8	46.2
CWC27	"NY-CO-10, SDCCAG-10, SDCCAG10"	ENSG00000153015	"CWC27 spliceosome associated protein homolog"	Q6UX04	5	64768930-65018763	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"			"Disease mutation, Dwarfism, Mental retardation, Retinitis pigmentosa"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	7	"Early spermatids: 197.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA020344, HPA024149, HPA065809"	Approved		Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"HPA020344: AB_1856644, HPA024149: AB_1856645, HPA065809: AB_2685561"	"unprognostic (1.71e-1)"	"unprognostic (6.47e-3)"	"unprognostic (2.79e-2)"	"unprognostic (1.80e-1)"	"unprognostic (8.91e-2)"	"unprognostic (4.00e-3)"	"prognostic unfavorable (5.27e-6)"	"unprognostic (1.58e-2)"	"unprognostic (3.43e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.48e-2)"	"unprognostic (2.04e-1)"	"unprognostic (2.07e-1)"	"unprognostic (2.46e-1)"	"unprognostic (2.05e-1)"	"unprognostic (2.74e-1)"	"unprognostic (7.45e-3)"	15.6	16.4	22.0	14.9	30.4	21.7	16.4	30.1	25.6	16.5	17.5	13.8	14.0	11.8	19.4	15.7	17.3	14.9	13.8	22.1	20.6	19.9	17.5	12.1	12.8	17.0	22.3	20.7	23.3	10.9	21.4	28.8	17.5	26.2	18.6	18.7	11.4	13.3	16.0	24.0	13.8	15.9	24.7	23.3	15.0	13.9	19.6	23.6	22.5	17.2	18.2	18.6	18.6	20.0	15.1	14.6	8.6	11.5	17.0	15.9	9.0	15.2	10.2	18.4	34.0	15.8	19.3	20.5	16.1	13.4	18.0	19.0	17.0	19.4	22.7	28.2	16.7	20.3	9.7	19.2	29.1	32.9	18.9	15.7	17.0	17.2	14.1	24.2	17.8	11.6	12.8	22.4	22.7	28.9	16.0	19.0	26.0	16.5	15.0	17.8	15.2	24.7	16.1	14.9	8.0	12.4	23.0	24.7	23.6	17.1	13.3	21.9	9.7	19.6	8.0	18.1	18.3	17.4	26.2	15.8	10.6	18.7	16.9	25.6	11.7	15.2	22.3	19.9	31.3	18.8	8.6	11.5	7.9	12.8	11.3	15.5	15.1	14.2	15.9	14.6	11.9	15.4	15.9	2.5	17.0	8.5	12.0	15.1	9.0	22.0	30.4	30.1	25.6	20.6	19.9	22.3	20.7	26.2	23.6	8.9	25.8	20.1	22.0	14.5	30.0	55.8	20.4	33.5	14.8	14.0	13.7	36.6	18.3	35.9	197.3	26.9	10.5	23.3	28.8	45.9	24.6	20.8	18.5	10.5	28.6	19.1	28.7	14.1	17.2	37.1	35.6	23.8	13.5	29.7	16.0	31.3	33.5	10.5	33.9	21.9	53.9	32.3	28.4	43.0	28.9	17.6	25.7	23.6	26.6	17.4
CYB5R1	"humb5R2, NQO3A2"	ENSG00000159348	"Cytochrome b5 reductase 1"	Q9UHQ9	1	202961869-202967280	"Enzymes, Predicted intracellular proteins"	"Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis, Steroid metabolism, Sterol biosynthesis, Sterol metabolism"	Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 119.2"	"Cell type enhanced"	"Detected in all"	6	"Basal keratinocytes: 166.3;Syncytiotrophoblasts: 245.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"hTCEpi: 48.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA010641, HPA014147"	Enhanced		Approved	Mitochondria,Cytosol		NA	NA		860000	Mitochondria	Cytosol	"HPA010641: AB_1078600, HPA014147: AB_1847370"	"unprognostic (6.36e-2)"	"unprognostic (8.51e-2)"	"unprognostic (1.16e-2)"	"prognostic favorable (1.14e-4)"	"unprognostic (1.86e-2)"	"unprognostic (4.34e-2)"	"unprognostic (8.46e-2)"	"unprognostic (1.28e-1)"	"unprognostic (4.03e-1)"	"unprognostic (1.03e-1)"	"unprognostic (5.79e-2)"	"unprognostic (2.89e-1)"	"unprognostic (1.73e-2)"	"unprognostic (2.33e-1)"	"unprognostic (6.14e-2)"	"unprognostic (2.37e-3)"	"unprognostic (1.69e-1)"	9.6	14.5	7.8	5.0	8.4	3.9	16.9	6.2	11.0	11.6	7.5	8.7	10.6	4.4	10.1	32.3	13.7	16.4	9.2	33.9	7.3	9.2	15.5	18.4	10.1	11.7	10.0	9.1	10.8	11.1	16.3	11.1	63.8	11.9	10.5	5.0	15.7	14.4	10.1	119.2	28.5	6.9	10.6	7.4	10.8	18.6	20.1	6.7	11.7	13.5	26.4	10.0	13.6	10.1	20.2	21.9	25.7	33.3	17.2	26.5	28.8	8.5	5.3	4.7	9.6	43.9	10.1	46.1	17.1	16.2	11.2	10.0	4.4	10.1	5.3	14.6	17.1	6.2	47.3	3.8	14.7	7.4	7.6	9.7	3.0	6.5	5.0	15.8	2.6	7.6	16.2	48.7	12.3	6.7	9.5	7.3	6.6	8.9	9.6	40.2	10.0	3.2	2.3	3.1	7.7	10.3	5.4	22.7	11.3	10.6	10.2	4.0	5.0	9.6	32.0	13.9	10.7	14.8	5.8	7.1	12.8	5.4	4.8	9.5	9.0	10.6	2.5	14.1	4.0	9.5	11.6	33.3	25.6	16.7	24.2	22.2	13.6	19.3	17.8	21.9	20.2	26.5	18.8	25.7	17.2	15.7	15.1	19.1	28.8	7.8	8.4	6.2	11.0	7.3	9.2	10.0	9.1	11.9	6.7	20.8	24.3	13.0	30.5	166.3	19.6	98.7	33.1	58.9	20.5	27.9	27.5	100.3	6.6	35.7	4.3	29.5	11.9	23.3	41.7	159.6	29.6	19.2	27.7	36.0	54.2	9.5	18.4	23.4	39.9	5.4	27.6	33.5	60.8	9.0	10.9	56.4	53.6	10.5	29.4	32.1	25.9	12.9	34.0	24.6	2.7	137.6	245.4	17.5	14.2	47.8
CYB5R2		ENSG00000166394	"Cytochrome b5 reductase 2"	Q6BCY4	11	7665100-7677222	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis, Steroid metabolism, Sterol biosynthesis, Sterol metabolism"	Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"testis: 58.8"	"Group enriched"	"Detected in many"	5	"Early spermatids: 205.4;Late spermatids: 439.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"eosinophil: 5.9;memory B-cell: 12.2"	"Group enriched"	"Detected in many"	9	"B-cells: 12.2;granulocytes: 5.9"	"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 42.5;BJ hTERT+ SV40 Large T+: 22.7;BJ hTERT+ SV40 Large T+ RasG12V: 20.7;HBF TERT88: 18.2;NTERA-2: 23.9;WM-115: 32.7"	"Low region specificity"	"Detected in many"							"HPA038962, HPA061707"	Enhanced		Approved	"Nucleoplasm,Golgi apparatus"		NA	NA			"Golgi apparatus"	Nucleoplasm	"HPA038962: AB_10675954, HPA061707: AB_2732668"	"unprognostic (1.47e-1)"	"unprognostic (2.56e-2)"	"unprognostic (8.90e-3)"	"unprognostic (4.41e-2)"	"unprognostic (4.13e-3)"	"unprognostic (1.60e-2)"	"unprognostic (4.02e-2)"	"unprognostic (2.48e-1)"	"unprognostic (3.41e-2)"	"unprognostic (1.30e-2)"	"unprognostic (2.64e-3)"	"unprognostic (1.10e-1)"	"unprognostic (4.78e-2)"	"unprognostic (1.40e-1)"	"unprognostic (8.16e-2)"	"unprognostic (1.70e-1)"	"unprognostic (7.01e-2)"	3.3	1.9	9.3	2.8	12.1	1.9	7.7	3.1	12.3	6.6	2.3	26.1	4.2	1.3	10.0	13.1	8.0	5.2	3.4	2.0	11.2	5.3	2.4	2.5	4.6	3.8	22.3	7.3	14.9	2.2	23.1	0.6	6.7	11.6	7.8	2.7	12.2	12.8	11.6	0.8	23.4	1.7	6.8	12.4	2.0	2.2	58.8	14.5	0.2	2.6	6.7	4.9	5.9	7.1	12.2	0.0	5.9	1.0	0.0	0.2	0.7	2.3	1.2	0.5	0.0	0.1	0.6	7.9	14.8	42.5	22.7	20.7	0.2	3.2	0.0	3.5	7.6	7.0	0.2	0.0	0.1	18.2	0.0	0.0	0.0	1.3	0.3	12.3	0.1	2.3	6.2	0.5	0.1	1.2	0.0	1.9	0.0	2.2	0.0	0.1	0.0	0.0	0.0	23.9	2.4	1.1	11.2	0.0	0.0	0.0	1.5	0.0	0.2	0.1	9.5	0.6	4.0	1.6	3.1	0.0	2.1	0.0	0.1	1.1	0.0	0.0	3.5	0.1	0.0	32.7	0.0	1.0	5.9	0.0	0.5	0.0	12.2	0.2	0.0	0.0	2.3	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.7	9.3	12.1	3.1	12.3	11.2	5.3	22.3	7.3	11.6	14.5	20.8	3.2	0.0	7.4	6.3	0.8	1.9	0.0	8.1	2.3	3.5	19.6	4.6	0.0	1.4	205.4	1.0	0.0	0.0	4.2	16.5	7.1	4.8	2.3	1.1	2.3	0.0	0.0	0.0	0.0	439.8	4.4	1.4	5.0	0.0	1.4	0.8	4.6	0.9	5.6	0.0	37.7	12.9	12.6	63.0	5.9	8.8	3.8	0.0	1.4	10.5
CYB5R3	DIA1	ENSG00000100243	"Cytochrome b5 reductase 3"	P00387	22	42617840-42649568	"Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Cholesterol biosynthesis, Cholesterol metabolism, Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis, Steroid metabolism, Sterol biosynthesis, Sterol metabolism"	Oxidoreductase	"Cancer-related genes, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"ASC diff: 117.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA001566	Approved		Supported	"Endoplasmic reticulum"		NA	NA		67000000	"Endoplasmic reticulum"		"HPA001566: AB_1078601"	"unprognostic (4.73e-2)"	"unprognostic (2.93e-1)"	"unprognostic (1.79e-1)"	"unprognostic (1.89e-1)"	"unprognostic (3.05e-1)"	"unprognostic (1.04e-2)"	"prognostic unfavorable (2.13e-5)"	"unprognostic (2.45e-1)"	"unprognostic (8.22e-3)"	"unprognostic (3.01e-1)"	"unprognostic (2.72e-2)"	"unprognostic (6.76e-2)"	"unprognostic (3.33e-3)"	"unprognostic (1.31e-1)"	"unprognostic (1.64e-1)"	"unprognostic (1.92e-1)"	"unprognostic (5.24e-2)"	79.7	57.1	33.2	22.8	32.6	19.3	86.8	19.5	33.1	52.4	31.9	37.6	51.8	25.9	51.9	35.0	39.1	39.3	38.6	86.4	31.3	24.1	43.3	78.2	43.5	30.3	31.8	25.4	58.8	21.9	15.1	27.2	32.1	33.9	40.6	21.3	37.9	29.3	96.4	34.4	43.1	32.5	55.5	36.3	20.2	33.7	44.0	25.9	14.1	30.1	28.4	23.2	43.4	53.5	28.6	37.6	70.3	39.7	14.2	22.3	19.7	16.5	10.6	17.5	10.8	117.8	93.7	10.3	48.8	45.3	36.5	32.6	13.9	13.0	7.8	21.8	90.2	15.8	15.3	11.7	24.1	18.8	8.4	26.2	11.1	18.4	26.8	30.0	15.5	20.8	56.4	19.1	26.2	17.4	26.7	30.1	10.1	9.6	40.9	49.5	18.3	15.2	14.3	7.0	17.3	19.6	11.2	21.3	17.4	28.0	12.2	7.8	10.1	16.1	15.6	17.8	13.5	12.4	15.0	46.1	39.6	24.7	26.6	18.3	10.9	11.7	9.6	46.1	9.0	32.5	26.3	25.7	70.3	19.7	32.4	19.9	28.6	19.1	21.6	37.6	26.4	13.6	14.3	13.4	14.2	39.7	34.3	22.3	19.7	33.2	32.6	19.5	33.1	31.3	24.1	31.8	25.4	33.9	25.9	80.4	44.4	45.6	76.5	97.8	15.9	86.2	112.1	24.1	47.8	57.6	3.9	94.2	41.4	197.4	3.7	128.1	83.6	116.8	93.8	165.0	171.8	78.6	62.2	149.9	98.1	15.9	80.4	125.8	48.8	6.9	235.1	65.2	167.0	156.9	41.0	91.8	117.8	80.6	263.8	100.0	17.3	187.5	253.9	15.8	48.1	98.5	98.6	40.1	48.2	75.8
CYB5R4	"b5+b5R, dJ676J13.1, NCB5OR"	ENSG00000065615	"Cytochrome b5 reductase 4"	Q7L1T6	6	83859643-83967424	"Enzymes, Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 49.6"	"Group enriched"	"Detected in many"	4	"Early spermatids: 150.1;Late spermatids: 277.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"neutrophil: 49.6"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HDLM-2: 36.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA018992	Approved					NA	NA					"HPA018992: AB_1847371"	"unprognostic (4.86e-3)"	"unprognostic (1.16e-1)"	"unprognostic (1.80e-3)"	"unprognostic (1.21e-2)"	"unprognostic (1.72e-1)"	"unprognostic (3.25e-2)"	"unprognostic (1.72e-2)"	"unprognostic (7.94e-2)"	"unprognostic (4.77e-1)"	"unprognostic (6.77e-2)"	"unprognostic (1.39e-2)"	"unprognostic (5.44e-1)"	"unprognostic (6.36e-2)"	"unprognostic (1.95e-1)"	"unprognostic (4.11e-2)"	"unprognostic (2.15e-1)"	"unprognostic (8.15e-2)"	9.3	8.2	4.5	17.9	9.1	23.1	9.6	11.5	8.4	6.3	10.5	8.0	6.2	10.0	7.2	7.6	11.1	6.1	5.3	10.8	4.9	5.0	8.7	8.6	12.3	23.4	10.2	3.4	6.0	8.5	3.6	10.5	12.6	7.3	6.5	8.2	4.3	9.3	4.3	11.9	6.6	11.0	8.8	12.2	18.8	10.8	21.6	9.7	14.2	5.6	6.6	11.9	10.9	7.6	6.9	11.4	49.6	14.6	3.3	5.6	6.3	5.1	4.5	3.2	4.1	1.8	2.4	6.0	3.5	5.2	5.2	7.6	5.8	3.5	9.4	5.5	2.1	14.3	4.3	2.9	4.8	4.0	36.1	6.5	22.7	2.7	3.2	3.4	13.5	20.5	3.0	1.3	3.5	3.7	2.1	2.6	8.5	8.1	7.2	3.7	2.0	3.6	3.8	1.8	4.1	4.2	6.0	11.8	3.4	2.3	5.4	8.5	4.7	4.2	4.2	4.8	2.1	2.4	8.1	3.4	5.3	4.4	10.8	11.0	8.3	12.7	5.2	6.1	9.4	5.8	20.8	14.6	42.2	4.4	12.1	3.5	6.9	3.8	3.9	11.4	6.6	2.5	3.9	49.6	3.3	13.1	4.8	5.6	6.3	4.5	9.1	11.5	8.4	4.9	5.0	10.2	3.4	7.3	9.7	6.0	15.2	26.7	12.4	9.8	12.6	13.4	10.2	13.4	10.3	7.0	15.7	4.8	10.0	22.8	150.1	8.3	13.5	0.0	22.1	16.9	8.2	11.7	24.3	10.5	42.4	12.7	15.5	4.3	52.6	277.8	7.8	46.0	15.1	45.9	13.5	5.7	21.9	14.0	7.1	16.1	19.3	6.5	11.4	23.0	27.4	12.9	9.6	25.4	14.0	17.7
CYB5RL	LOC606495	ENSG00000215883	"Cytochrome b5 reductase like"	Q6IPT4	1	54169651-54200036	"Enzymes, Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Ciliated cells: 9.4"	"Low cancer specificity"	"Detected in many"							"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA042671, HPA060463"	Approved		Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"HPA042671: AB_2678107, HPA060463: AB_2684286"	"unprognostic (2.03e-1)"	"unprognostic (1.36e-1)"	"unprognostic (1.72e-2)"	"unprognostic (1.84e-2)"	"unprognostic (2.15e-1)"	"unprognostic (1.13e-3)"	"unprognostic (1.90e-4)"	"unprognostic (6.45e-3)"	"unprognostic (9.75e-2)"	"unprognostic (2.04e-1)"	"unprognostic (5.93e-2)"	"unprognostic (2.58e-1)"	"unprognostic (2.35e-1)"	"unprognostic (1.80e-2)"	"unprognostic (5.08e-2)"	"unprognostic (5.74e-2)"	"unprognostic (2.86e-1)"	1.7	4.9	1.9	0.8	1.9	1.6	2.4	1.3	1.7	2.5	2.2			2.6	2.5	2.3	2.1	2.9	2.0	3.5	2.1	1.7	2.7	2.6	1.5	2.1	2.3		5.0	4.1	1.8	4.2	1.1		2.1	2.7		3.2	1.4	3.7	3.9	1.5	2.4	1.8	2.5	2.8	1.2			3.1		2.2	2.8	1.8	1.4	1.8	2.6	3.5	3.1	1.5	1.2	3.9	5.3	7.3	7.5	5.9	5.7	2.5	3.1	4.5	6.1	6.6	4.9	4.3	6.6	3.7	2.1	13.9	3.6	11.3	3.3	6.9	7.4	4.6	7.5	8.5	5.0	4.4	6.3	3.8	3.0	4.4	7.2	3.3	4.3	5.3	6.0	8.0	3.1	4.4	4.8	6.3	3.5	7.2	4.5	4.2	10.2	8.9	6.0	2.7	4.5	10.7	5.3	2.1	7.2	6.3	6.1	5.0	4.9	2.4	4.7	3.8	6.9	5.5	4.7	7.5	9.7	5.2	13.6	7.1	2.2	1.8	1.6	1.0	3.5	0.8	1.1	1.5	0.6	1.6	1.4	1.2	1.2	2.6	3.1	0.8	1.8	0.5	1.2											0.0	7.4	0.9	1.0	0.1	3.7	4.2	0.0	9.4	4.5	3.5	3.9	1.5	6.6	2.4	0.0	3.6	0.9	0.0	3.6	1.7	1.5	1.1	2.3	2.1	4.6	0.0	2.4	3.1	1.0	0.6	1.4	1.4	0.0	1.0	0.7	2.0	1.3	0.0	1.8	2.2	3.1	0.0	1.4	0.9	5.3	0.6	0.2	0.5	2.4	0.8
CYLD	"CYLD1, KIAA0849, USPL2"	ENSG00000083799	"CYLD lysine 63 deubiquitinase"	Q9NQC7	16	50742050-50801935	"Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Cell cycle, Immunity, Innate immunity, Ubl conjugation pathway, Wnt signaling pathway"	"Hydrolase, Protease, Thiol protease"	"Cancer-related genes, Disease mutation, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HDLM-2: 47.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB011713, HPA050095"	Approved		Supported	"Nucleoplasm,Centriolar satellite"		Yes	No			"Centriolar satellite"	Nucleoplasm	"CAB011713: AB_731794, HPA050095: AB_2681013"	"unprognostic (9.83e-2)"	"unprognostic (1.17e-2)"	"unprognostic (5.01e-2)"	"unprognostic (2.83e-2)"	"unprognostic (3.84e-1)"	"unprognostic (5.06e-2)"	"unprognostic (3.87e-2)"	"unprognostic (3.24e-2)"	"unprognostic (9.46e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.18e-2)"	"unprognostic (2.32e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.07e-1)"	"unprognostic (3.43e-2)"	"unprognostic (6.83e-2)"	"unprognostic (8.42e-2)"	9.3	16.2	13.9	22.9	26.4	51.1	9.1	14.2	20.9	9.2	10.3	18.8	12.8	10.2	16.1	8.1	15.3	8.5	13.3	12.7	15.7	17.0	9.4	13.2	15.6	30.7	16.3	14.3	11.5	12.2	20.3	27.8	9.8	20.0	11.0	12.7	13.3	12.6	10.9	31.7	12.4	14.2	12.5	16.3	23.4	12.4	22.6	13.7	16.9	16.2	8.0	29.3	14.1	12.6	9.2	10.2	31.4	9.8	13.6	19.1	10.2	9.3	2.9	3.4	3.8	5.4	7.8	3.1	13.8	20.2	14.4	8.5	2.4	4.4	10.7	5.0	13.5	15.7	3.6	4.0	8.4	21.5	47.2	6.1	5.3	5.2	2.0	10.7	5.3	25.3	8.5	6.8	17.4	18.2	13.7	5.8	7.6	2.2	9.4	20.1	1.4	5.2	7.7	3.6	2.9	4.9	4.7	6.9	10.3	4.7	3.2	4.4	3.3	11.7	4.0	3.4	5.4	4.0	6.7	6.5	24.7	5.6	8.6	5.6	24.8	23.5	12.0	18.1	6.0	5.2	31.4	8.6	20.8	10.7	9.8	12.9	9.2	15.8	14.4	10.2	6.2	14.7	11.4	19.4	13.6	9.5	6.2	19.1	10.2	13.9	26.4	14.2	20.9	15.7	17.0	16.3	14.3	20.0	13.7	41.7	25.6	39.6	48.8	106.7	75.4	32.7	25.5	12.0	19.4	17.4	88.4	5.4	5.0	18.3	32.8	37.9	13.4	46.7	16.5	3.8	37.2	52.3	78.5	22.1	19.0	63.5	29.9	21.5	32.3	24.7	23.6	47.1	70.9	34.3	10.3	22.6	15.2	18.7	19.8	10.3	49.3	6.5	34.4	52.6	13.8	135.9	3.4	73.4	12.0	56.3
CYP11A1	"CYP11A, P450SCC"	ENSG00000140459	"Cytochrome P450 family 11 subfamily A member 1"	P05108	15	74337759-74367740	"Disease related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins"	"Cholesterol metabolism, Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis, Steroid metabolism, Steroidogenesis, Sterol metabolism"	"Monooxygenase, Oxidoreductase"	"Disease mutation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	7	"adrenal gland: 145.3;placenta: 157.2"	"Group enriched"	"Detected in some"	5	"Extravillous trophoblasts: 305.6;Syncytiotrophoblasts: 1214.3"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in single"	36	"basal ganglia: 14.8"	"Cell type enriched"	"Detected in single"	37	"basophil: 15.8"	"Lineage enriched"	"Detected in single"	37	"granulocytes: 15.8"	"Group enriched"	"Detected in some"	4	"BEWO: 44.0;HEL: 35.0"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			HPA016436	Enhanced					NA	NA					"HPA016436: AB_1847423"	"unprognostic (8.89e-2)"	"unprognostic (6.96e-2)"	"unprognostic (4.95e-3)"	"unprognostic (9.31e-2)"	"unprognostic (9.42e-4)"	"unprognostic (1.90e-1)"	"unprognostic (1.55e-3)"	"unprognostic (8.06e-2)"	"unprognostic (3.04e-1)"	"unprognostic (2.95e-1)"	"unprognostic (1.77e-2)"	"unprognostic (5.45e-2)"	"unprognostic (9.66e-4)"	"unprognostic (2.40e-2)"	"unprognostic (2.74e-1)"	"unprognostic (3.04e-2)"	"unprognostic (7.95e-2)"	0.4	145.3	0.4	0.1	14.8	0.0	0.4	0.3	0.3	0.2	0.2	7.6	0.1	0.0	0.3	0.5	1.5	0.3	0.0	0.3	0.3	0.2	0.1	0.7	0.1	0.0	0.3	0.2	9.2	0.1	0.0	0.4	157.2	0.2	0.2	0.0	0.3	0.1	0.6	0.3	0.1	0.1	0.3	0.3	5.7	0.1	20.4	0.1	0.0	0.1	0.3	0.7	0.2	0.2	0.0	0.0	15.8	0.0	0.4	0.1	0.1	0.0	0.0	0.0	0.2	0.0	0.3	44.0	0.1	0.0	0.3	0.1	0.0	0.0	0.0	1.0	0.1	0.1	0.0	0.0	0.0	0.2	0.0	0.1	35.0	1.0	0.3	0.2	0.0	0.2	1.5	0.0	0.0	0.0	0.1	0.0	0.0	0.7	0.0	0.0	0.1	0.0	0.1	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	8.9	0.0	0.0	6.9	0.0	0.0	0.0	0.0	0.4	0.2	0.0	0.1	0.0	0.0	0.1	0.0	0.0	15.8	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.4	14.8	0.3	0.3	0.3	0.2	0.3	0.2	0.2	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.4	2.5	0.0	0.0	0.0	0.0	139.8	1.7	0.0	1.4	0.0	0.0	0.0	0.0	305.6	0.6	0.1	0.0	3.4	19.4	0.0	0.0	0.0	0.0	2.9	45.1	0.0	0.0	1.0	0.0	5.1	0.2	0.0	163.4	0.0	0.0	0.0	0.0	3.2	3.1	0.0	1214.3	0.0	0.0	0.0
CYP11B1	"CPN1, CYP11B, FHI, P450C11"	ENSG00000160882	"Cytochrome P450 family 11 subfamily B member 1"	P15538	8	142872356-142879846	"Disease related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins"	"Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis, Steroidogenesis"	"Monooxygenase, Oxidoreductase"	"Congenital adrenal hyperplasia, Disease mutation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	781	"adrenal gland: 224.9"	"Group enriched"	"Detected in some"	119	"Early spermatids: 41.1;Late spermatids: 67.4"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	8	"SCLC-21H: 3.1;SH-SY5Y: 1.3"									"HPA049171, HPA056348, HPA057752"	Supported					NA	NA					"HPA049171: AB_2680661, HPA056348: AB_2683104, HPA057752: AB_2683516"																		0.0	224.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.1	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	41.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	67.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0
CYP11B2	"ALDOS, CPN2, CYP11B, CYP11BL, P-450C18, P450aldo"	ENSG00000179142	"Cytochrome P450 family 11 subfamily B member 2"	P19099	8	142910559-142917843	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Lipid metabolism, Steroid metabolism, Steroidogenesis"	"Monooxygenase, Oxidoreductase"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	259	"adrenal gland: 51.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA049171, HPA056348, HPA057752"	Supported					NA	NA					"HPA049171: AB_2680661, HPA056348: AB_2683104, HPA057752: AB_2683516"																		0.0	51.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
CYP17A1	"CPT7, CYP17, P450C17, S17AH"	ENSG00000148795	"Cytochrome P450 family 17 subfamily A member 1"	P05093	10	102830531-102837533	"Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"	Steroidogenesis	"Lyase, Monooxygenase, Oxidoreductase"	"Congenital adrenal hyperplasia, Disease mutation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"adrenal gland: 425.4"	"Cell type enhanced"	"Detected in some"	17	"Distal tubular cells: 18.3;Early spermatids: 40.8;Proximal tubular cells: 39.5"	"Cancer enriched"	"Detected in many"	5	"liver cancer: 22.7"	"Region enriched"	"Detected in single"	103	"basal ganglia: 19.7"	"Cell type enhanced"	"Detected in single"		"neutrophil: 1.2"	"Lineage enhanced"	"Detected in single"		"granulocytes: 1.2"	"Group enriched"	"Detected in some"	4	"HMC-1: 8.0;SCLC-21H: 3.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA048533	Enhanced				"Intracellular and membrane"	NA	NA					"HPA048533: AB_2680432"	"unprognostic (1.07e-2)"	"unprognostic (8.84e-2)"	"unprognostic (3.01e-2)"	"unprognostic (9.08e-2)"	"unprognostic (1.91e-1)"	"unprognostic (6.29e-2)"	"unprognostic (2.92e-3)"	"unprognostic (2.39e-4)"	"unprognostic (8.26e-2)"	"unprognostic (2.35e-1)"	"unprognostic (5.92e-3)"	"unprognostic (1.13e-1)"	"prognostic favorable (5.43e-7)"	"unprognostic (1.07e-1)"	"unprognostic (5.56e-2)"	"unprognostic (1.66e-2)"	"unprognostic (2.94e-4)"	0.0	425.4	0.0	0.1	19.7	0.0	0.0	0.1	0.1	0.1	0.0	78.5	0.0	0.0	0.1	0.3	0.1	0.1	0.0	0.1	0.0	0.0	6.4	1.7	0.1	0.0	0.0	0.0	3.2	0.1	0.2	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.1	82.3	0.0	0.1	2.2	0.0	0.0	0.1	0.0	0.0	0.0	1.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.0	8.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	1.3	0.0	0.0	0.0	0.0	0.1	0.1	3.1	1.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.2	0.0	0.0	0.0	0.0	19.7	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.6	0.0	0.3	0.1	0.6	0.6	0.0	0.0	0.0	1.8	0.0	0.3	18.3	0.0	40.8	0.0	0.0	0.0	0.2	0.0	0.2	0.2	0.0	3.2	0.1	1.6	0.0	0.0	0.0	8.3	1.7	0.2	0.0	0.0	0.0	0.2	1.2	0.0	0.0	39.5	1.3	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.1
CYP19A1	"ARO, ARO1, aromatase, CPV1, CYAR, CYP19, P-450AROM"	ENSG00000137869	"Cytochrome P450 family 19 subfamily A member 1"	P11511	15	51208057-51338610	"Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins"		"Monooxygenase, Oxidoreductase"	"Cancer-related genes, Disease mutation, FDA approved drug targets, Pseudohermaphroditism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	49	"placenta: 440.1"	"Cell type enriched"	"Detected in some"	36	"Syncytiotrophoblasts: 1678.9"	"Low cancer specificity"	"Detected in single"			"Region enriched"	"Detected in single"	8	"basal ganglia: 5.9"	"Cell type enriched"	"Detected in single"	17	"neutrophil: 1.7"	"Lineage enriched"	"Detected in single"	17	"granulocytes: 1.7"	"Cell line enhanced"	"Detected in some"		"ASC TERT1: 45.7;HDLM-2: 7.9;HSkMC: 15.3;SuSa: 8.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB000355, HPA051194"	Enhanced		Uncertain	Mitochondria		NA	NA			Mitochondria		"CAB000355: , HPA051194: AB_2681381"	"unprognostic (9.41e-2)"	"unprognostic (7.44e-2)"	"unprognostic (9.52e-5)"	"unprognostic (6.81e-2)"	"unprognostic (2.72e-1)"	"unprognostic (4.25e-4)"	"unprognostic (5.18e-5)"	"unprognostic (1.54e-3)"	"unprognostic (2.38e-2)"	"unprognostic (2.52e-1)"	"unprognostic (1.97e-1)"	"unprognostic (5.37e-2)"	"unprognostic (1.54e-5)"	"unprognostic (2.52e-3)"	"unprognostic (2.11e-1)"	"unprognostic (1.40e-2)"	"unprognostic (1.11e-1)"	9.0	4.6	0.2	0.2	5.9	0.1	2.1	0.2	0.3	0.9	0.3	0.3	0.2	0.4	0.2	0.3	0.3	0.2	0.3	1.3	0.2	0.7	0.3	0.2	0.6	0.2	0.2	0.2	4.4	0.6	0.1	0.2	440.1	0.2	0.5	0.1	0.2	0.9	1.4	0.8	2.3	0.2	0.7	0.5	0.5	0.1	3.0	0.2	0.3	3.0	0.2	0.2	1.2	0.5	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	45.7	2.8	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.2	0.1	0.0	0.0	0.0	0.0	7.9	0.0	0.3	0.1	3.7	0.3	0.0	0.0	15.3	0.0	0.1	1.9	0.1	0.0	0.0	0.0	0.3	0.1	0.3	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.1	0.0	8.1	0.0	0.2	0.0	0.1	0.0	0.1	0.0	1.4	0.6	0.0	0.3	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.2	5.9	0.2	0.3	0.2	0.7	0.2	0.2	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	46.8	0.0	0.0	2.2	0.0	0.0	0.0	0.0	6.9	1.4	0.0	0.0	0.0	13.4	0.0	0.0	0.0	1.6	4.5	0.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.0	6.5	0.3	7.7	0.2	0.0	1678.9	0.0	0.0	0.0
CYP1A1	"CP11, CYP1, P1-450, P450-C, P450DX"	ENSG00000140465	"Cytochrome P450 family 1 subfamily A member 1"	P04798	15	74719542-74725610	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis"	"Lyase, Monooxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	7	"liver: 38.3;lung: 144.1;urinary bladder: 40.0"	"Cell type enhanced"	"Detected in some"	21	"Glandular cells: 1.5;Hepatocytes: 6.0;Urothelial cells: 3.2"	"Group enriched"	"Detected in some"	24	"liver cancer: 18.6;urothelial cancer: 54.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"CACO-2: 22.0;hTCEpi: 12.0;HUVEC TERT2: 11.5;SK-BR-3: 9.0;SuSa: 23.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			CAB018654	Uncertain					NA	NA					"CAB018654: AB_2088699"	"unprognostic (1.71e-2)"	"unprognostic (7.86e-2)"	"unprognostic (2.57e-2)"	"unprognostic (2.89e-1)"	"unprognostic (5.45e-3)"	"unprognostic (6.34e-2)"	"unprognostic (3.08e-1)"	"unprognostic (6.24e-3)"	"unprognostic (1.11e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.41e-1)"	"unprognostic (1.03e-1)"	"unprognostic (4.21e-2)"	"unprognostic (6.70e-2)"	"unprognostic (2.20e-1)"	"unprognostic (4.77e-1)"	"unprognostic (1.28e-1)"	9.3	0.4	0.1	0.4	0.2	0.2	7.7	0.2	0.5	2.3	0.7	0.4	3.9	0.5	3.8	4.4	1.2	0.2	11.3	3.0	0.1	0.0	0.7	38.3	144.1	0.2	0.1	0.1	0.5	0.5	0.2	0.1	3.5	0.3	0.2	0.2	0.8	2.1	0.5	1.5	8.1	10.7	5.9	0.2	0.2	0.4	0.3	0.1	0.1	0.8	0.8	8.0	40.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.1	1.3	0.1	0.0	0.3	0.0	7.2	0.0	0.0	0.4	0.2	22.0	0.9	0.2	5.9	0.0	5.4	6.9	0.4	4.4	0.2	0.0	0.6	0.3	1.5	3.2	0.1	0.2	7.1	0.0	12.0	0.1	0.9	0.2	11.5	0.2	1.3	0.2	0.0	0.4	0.0	0.2	0.1	7.2	1.8	0.7	0.0	0.2	0.0	1.4	0.3	0.1	1.0	9.0	2.3	23.3	0.3	0.1	0.6	1.0	0.3	3.2	0.0	0.4	0.1	0.3	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.2	0.2	0.3	0.1	0.0	0.1	0.1	0.3	0.1	0.0	0.0	0.0	0.4	0.5	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	1.5	0.0	6.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.4	0.0	0.0	0.0	3.2
CYP1A2	"CP12, P3-450"	ENSG00000140505	"Cytochrome P450 family 1 subfamily A member 2"	P05177	15	74748844-74756202	"Cancer-related genes, Enzymes, Predicted membrane proteins"	"Fatty acid metabolism, Lipid metabolism, Steroid metabolism, Sterol metabolism"	"Lyase, Monooxygenase, Oxidoreductase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	31	"liver: 143.0"	"Cell type enriched"	"Detected in some"	18	"Hepatocytes: 44.0"	"Group enriched"	"Detected in some"	22	"liver cancer: 25.3;urothelial cancer: 6.5"	"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"SK-BR-3: 6.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			CAB016531	Enhanced					NA	NA					"CAB016531: AB_629359"				"unprognostic (1.54e-4)"			"unprognostic (1.29e-1)"	"unprognostic (1.98e-1)"	"unprognostic (1.74e-1)"	"unprognostic (1.59e-2)"		"unprognostic (1.76e-1)"	"unprognostic (1.17e-2)"	"unprognostic (5.48e-2)"	"unprognostic (2.33e-2)"	"unprognostic (7.41e-2)"	"unprognostic (2.53e-1)"	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.1	1.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	143.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	1.7	1.1	4.5	1.2	1.1	0.7	0.3	1.1	0.9	2.7	2.1	0.2	0.0	1.6	0.7	0.0	0.0	0.2	0.6	1.3	2.2	0.5	0.0	1.8	1.2	0.1	0.2	0.1	0.5	1.2	2.8	1.6	0.8	0.1	1.9	1.1	0.4	0.3	0.1	0.0	0.7	0.2	3.9	1.9	4.0	0.0	0.8	2.5	1.3	1.7	0.9	0.6	2.6	2.4	0.9	0.0	2.2	2.2	1.1	2.1	6.0	0.4	2.3	1.6	1.0	0.4	1.1	1.4	1.1	1.2	1.0	0.7	1.6	1.1	2.4	1.2	3.2	1.2	1.2	0.6	0.6	0.5	0.8	0.7	0.5	0.4	1.7	0.7	0.7	4.5	1.1	0.8	1.1	0.4	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	44.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2
CYP1B1	"CP1B, GLC3A"	ENSG00000138061	"Cytochrome P450 family 1 subfamily B member 1"	Q16678	2	38066973-38109902	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Fatty acid metabolism, Lipid metabolism, Steroid metabolism"	"Lyase, Monooxygenase, Oxidoreductase"	"Disease mutation, Glaucoma, Peters anomaly"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 45.0;lung: 39.2"	"Cell type enhanced"	"Detected in many"	11	"Glandular cells: 345.6;Leydig cells: 147.9;Peritubular cells: 160.5;Urothelial cells: 295.9"	"Low cancer specificity"	"Detected in all"							"Cell type enriched"	"Detected in some"	6	"classical monocyte: 45.0"	"Lineage enriched"	"Detected in many"	22	"monocytes: 45.0"	"Cell line enhanced"	"Detected in many"		"ASC diff: 24.6;ASC TERT1: 26.4;HSkMC: 105.7;hTERT-RPE1: 24.4;SiHa: 49.2;U-87 MG: 26.8"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"CAB011705, HPA026863"	Approved		Uncertain	Mitochondria		NA	NA			Mitochondria		"CAB011705: AB_731810, HPA026863: AB_10600900"	"unprognostic (7.25e-3)"	"unprognostic (2.28e-1)"	"unprognostic (1.24e-3)"	"unprognostic (2.27e-1)"	"unprognostic (2.04e-2)"	"unprognostic (1.68e-1)"	"unprognostic (5.45e-2)"	"unprognostic (1.80e-1)"	"unprognostic (3.38e-1)"	"unprognostic (9.69e-2)"	"unprognostic (4.20e-1)"	"unprognostic (1.84e-1)"	"prognostic unfavorable (4.39e-6)"	"unprognostic (1.87e-3)"	"unprognostic (1.81e-1)"	"unprognostic (6.67e-2)"	"prognostic unfavorable (2.76e-4)"	9.1	3.1	0.5	9.4	1.2	0.0	11.4	1.0	1.2	11.4	2.1	0.7	4.5	0.0	12.8	5.9	3.5	15.0	6.9	17.5	1.2		8.8	3.5	39.2	26.3	3.1	1.0	6.1	3.6	0.0	1.3	0.8	3.3	10.7	0.0	19.3	0.0	13.0	4.8	0.5	1.4	10.6	5.1	15.7	0.3	3.9	0.5	5.1	2.5	1.1	4.2	6.9	2.1	0.0	0.4	2.0	45.0	0.0	0.0	16.2	1.2	13.2	0.4	0.0	24.6	26.4	0.0	0.1	0.8	0.2	2.3	0.0	5.5	0.0	3.6	3.2	0.5	10.8	0.0	0.7	0.4	1.0	0.7	0.0	4.0	0.0	6.8	0.0	0.0	105.7	10.3	5.7	0.2	24.4	0.0	0.0	0.1	0.0	0.1	5.2	0.0	4.0	1.4	1.8	2.5	0.0	0.0	0.0	2.5	0.1	0.1	0.4	49.2	7.2	0.0	1.4	9.1	1.9	0.0	0.2	0.0	20.2	0.0	0.0	0.0	0.0	26.8	0.0	2.2	0.4	45.0	0.0	0.0	7.1	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	2.0	0.0	5.5	0.2	0.0	16.2											17.9	50.6	0.5	98.2	15.8	0.9	2.7	0.0	12.0	35.2	43.6	0.0	0.4	13.3	5.0	11.7	36.8	0.0	0.0	0.5	0.7	41.1	345.6	3.5	9.7	12.6	0.0	1.7	5.5	116.2	8.6	147.9	28.1	16.9	39.7	0.3	0.5	0.4	0.0	160.5	0.8	0.3	19.4	20.8	1.0	1.8	12.4	0.2	0.0	0.8	295.9
CYP21A2	"CA21H, CAH1, CPS1, CYP21, CYP21B, P450c21B"	ENSG00000231852	"Cytochrome P450 family 21 subfamily A member 2"	P08686	6	32038265-32041670	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	Steroidogenesis	"Monooxygenase, Oxidoreductase"	"Congenital adrenal hyperplasia, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	23	"adrenal gland: 170.9"	"Cell type enriched"	"Detected in some"	6	"Hepatocytes: 14.4"	"Cancer enhanced"	"Detected in some"		"liver cancer: 2.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HDLM-2: 11.8;Hep G2: 1.9;Karpas-707: 3.2"					"Not detected"	"Not detected"			"HPA048979, HPA053371"	Enhanced				"Intracellular and membrane"	NA	NA					"HPA048979: AB_2680584, HPA053371: AB_2682131"	"unprognostic (1.03e-2)"	"unprognostic (1.65e-1)"	"unprognostic (1.02e-4)"	"unprognostic (2.58e-1)"	"unprognostic (2.97e-1)"	"unprognostic (2.93e-2)"	"unprognostic (2.76e-2)"	"unprognostic (8.75e-2)"	"unprognostic (1.39e-1)"	"unprognostic (1.71e-1)"	"unprognostic (1.41e-1)"	"unprognostic (1.93e-1)"	"unprognostic (6.67e-7)"	"unprognostic (7.39e-2)"	"unprognostic (5.24e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.82e-1)"	0.1	170.9	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	6.7	0.1	0.0	0.1	0.2	0.1	0.0	0.1	0.1	0.1	0.0	0.3	7.4	0.1	0.1	0.1	0.1	0.2	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	3.6	0.0	0.4	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	11.8	0.3	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.4	1.1	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.1	0.1	0.3	0.3	2.5	1.4	1.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.3	1.1	14.4	0.0	0.0	1.7	0.0	0.0	0.0	0.6	0.0	1.7	0.0	0.0	0.2	0.5	0.0	0.0	1.7	0.4	0.0	0.2	0.5	0.4	0.0	0.0	0.0	0.0	0.0
CYP24A1	"CP24, CYP24, P450-CC24"	ENSG00000019186	"Cytochrome P450 family 24 subfamily A member 1"	Q07973	20	54153449-54173973	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		"Monooxygenase, Oxidoreductase"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 38.8;lymphoid tissue: 25.8;urinary bladder: 31.2"	"Cell type enhanced"	"Detected in some"	11	"Basal glandular cells: 21.1;Basal keratinocytes: 20.3;Club cells: 29.6;Proximal tubular cells: 33.5;Suprabasal keratinocytes: 17.1;Urothelial cells: 39.9"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"memory CD4 T-cell: 1.1;memory CD8 T-cell: 2.0"	"Lineage enriched"	"Detected in single"	20	"T-cells: 2.0"	"Group enriched"	"Detected in some"	16	"A549: 95.1;Hep G2: 27.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA022261, HPA063771"	Enhanced		Supported	"Nucleoplasm,Plasma membrane,Mitochondria"		NA	Yes			"Nucleoplasm, Mitochondria"	"Plasma membrane"	"HPA022261: AB_1847427, HPA063771: AB_2685120"	"unprognostic (1.19e-7)"	"unprognostic (1.73e-1)"	"unprognostic (2.24e-2)"	"unprognostic (7.69e-3)"	"unprognostic (3.30e-1)"	"unprognostic (2.30e-2)"		"unprognostic (1.11e-2)"	"unprognostic (2.12e-1)"	"unprognostic (2.09e-2)"	"unprognostic (5.37e-3)"	"unprognostic (1.23e-1)"	"unprognostic (6.05e-2)"	"unprognostic (5.98e-2)"	"unprognostic (1.36e-1)"	"unprognostic (4.38e-2)"	"unprognostic (2.12e-1)"	0.1	0.1	0.4	0.2	0.7	0.0	2.5	0.1	0.4	2.5	0.1	0.0	0.3	0.0	11.2	0.4	4.4	0.3	0.0	0.1	0.4	0.8	38.8	0.3	1.6	0.1	0.2	0.0	0.1	0.1	0.0	0.7	7.0	0.3	7.0	0.0	0.1	0.3	1.5	0.1	1.0	0.1	0.6	0.2	0.1	0.1	0.3	0.0	0.4	1.4	5.9	25.8	31.2	14.4	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.1	95.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	2.9	0.0	0.7	0.0	0.2	3.6	0.0	0.0	0.0	0.0	0.0	0.0	1.3	27.8	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.0	1.6	0.3	0.0	0.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	3.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	1.1	2.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.7	0.1	0.4	0.4	0.8	0.2	0.0	0.3	0.0	0.0	0.0	1.5	21.1	20.3	0.0	0.3	0.0	8.1	29.6	0.0	0.0	0.0	5.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.0	6.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	33.5	0.0	0.0	0.0	0.0	0.0	17.1	0.1	0.0	0.0	39.9
CYP27A1	"CP27, CTX, CYP27"	ENSG00000135929	"Cytochrome P450 family 27 subfamily A member 1"	Q02318	2	218781749-218815293	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Cholesterol metabolism, Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis, Steroid metabolism, Sterol metabolism"	"Monooxygenase, Oxidoreductase"	"Cataract, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 149.0"	"Cell type enhanced"	"Detected in many"	13	"Hepatocytes: 367.9;Hofbauer cells: 155.3;monocytes: 143.3"	"Cancer enhanced"	"Detected in all"		"liver cancer: 176.9"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	8	"classical monocyte: 38.2;neutrophil: 30.6"	"Group enriched"	"Detected in many"	20	"granulocytes: 30.6;monocytes: 38.2"	"Cell line enhanced"	"Detected in some"		"Hep G2: 74.3;HSkMC: 14.2;RPTEC TERT1: 18.9;SK-MEL-30: 30.5;WM-115: 11.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA059155	Enhanced		Approved	Mitochondria,Cytosol		NA	NA			Mitochondria	Cytosol	"HPA059155: AB_2683933"	"prognostic favorable (1.05e-4)"	"unprognostic (4.21e-2)"	"unprognostic (2.34e-1)"	"unprognostic (1.83e-3)"	"unprognostic (3.71e-3)"	"unprognostic (1.31e-2)"	"prognostic favorable (8.62e-6)"	"unprognostic (6.04e-2)"	"unprognostic (1.73e-1)"	"unprognostic (4.04e-1)"	"unprognostic (1.25e-3)"	"unprognostic (8.76e-3)"	"unprognostic (1.09e-3)"	"unprognostic (1.08e-1)"	"unprognostic (7.51e-2)"	"unprognostic (1.64e-1)"	"unprognostic (1.36e-1)"	14.4	12.3	6.3	4.7	13.4	0.7	5.5	2.4	7.5	6.5	21.9	16.9	24.9	21.0	5.0	5.4	3.5	9.2	5.1	6.9	8.3	6.2	12.6	149.0	22.4	5.6	19.9	5.7	9.5	2.4	6.3	7.1	2.0	12.1	11.6	6.0	15.1	10.0	21.5	10.0	3.9	36.8	5.0	18.8	3.1	3.5	3.7	15.7	3.7	3.1	4.0	7.6	5.5	5.7	0.1	1.7	30.6	38.2	0.0	0.1	10.0	0.0	0.0	0.7	0.0	1.3	0.9	0.1	0.8	3.0	1.0	2.1	3.7	0.1	0.0	1.5	2.1	0.0	0.0	0.0	0.0	0.5	0.3	0.3	0.0	0.1	74.3	4.3	0.1	0.0	14.2	0.1	0.0	0.0	3.5	1.4	0.0	0.0	0.0	2.1	0.0	0.0	0.1	0.8	0.0	0.1	0.0	0.7	0.1	18.9	0.0	0.0	0.0	0.0	0.0	30.5	0.7	0.5	0.7	1.7	0.0	0.1	0.0	1.8	0.0	0.0	0.0	0.0	0.0	11.9	0.0	38.2	0.1	0.0	4.3	0.0	0.1	0.0	0.1	1.7	0.0	0.0	0.0	30.6	0.0	0.3	0.2	0.0	10.0	6.3	13.4	2.4	7.5	8.3	6.2	19.9	5.7	12.1	15.7	3.0	28.2	0.9	44.4	4.6	13.8	5.0	17.8	14.7	12.5	3.5	25.5	0.9	8.3	9.2	0.9	7.1	46.1	0.0	10.8	0.5	20.2	45.1	2.3	367.9	155.3	9.5	23.5	19.6	15.9	0.6	44.0	31.1	47.2	143.3	9.0	29.6	6.6	19.3	25.1	66.2	13.7	0.0	8.5	0.3	0.0	2.8	1.0	2.5	18.7	20.0
CYP27B1	"CYP1, P450c1, PDDR, VDD1"	ENSG00000111012	"Cytochrome P450 family 27 subfamily B member 1"	O15528	12	57762334-57768986	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		"Monooxygenase, Oxidoreductase"	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	10	"kidney: 45.7"	"Group enriched"	"Detected in many"	4	"Exocrine glandular cells: 18.7;monocytes: 39.7;Proximal tubular cells: 25.9"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"MAIT T-cell: 2.4"	"Lineage enriched"	"Detected in single"	25	"T-cells: 2.4"	"Cell line enriched"	"Detected in many"	6	"RH-30: 34.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"									NA	NA						"unprognostic (8.59e-2)"	"unprognostic (1.42e-1)"	"unprognostic (8.89e-2)"	"unprognostic (2.77e-2)"	"unprognostic (4.16e-2)"	"unprognostic (1.03e-2)"	"unprognostic (1.28e-2)"	"unprognostic (1.44e-1)"	"unprognostic (2.10e-2)"	"unprognostic (4.72e-2)"	"unprognostic (2.51e-1)"	"unprognostic (1.17e-2)"	"unprognostic (1.75e-3)"	"unprognostic (4.10e-2)"	"unprognostic (3.19e-2)"	"prognostic unfavorable (6.79e-4)"	"unprognostic (5.67e-3)"	0.5	1.1	0.3	1.4	0.3	1.5	0.6	0.3	0.4	0.4	0.3	0.3	0.9	0.3	0.8	1.0	0.6	0.2	0.8	0.3	0.3	0.1	45.7	0.8	0.8	1.4	0.3	0.3	0.3	3.6	0.7	0.6	0.5	0.3	0.5	0.8	1.1	0.7	0.3	0.3	0.8	0.4	0.3	0.3	0.3	0.7	0.5	0.3	1.0	4.4	0.3	0.8	0.6	0.3	0.0	0.0	0.0	0.0	0.0	2.4	0.1	1.1	0.2	0.6	1.7	0.0	0.3	1.9	0.0	1.7	0.2	0.9	2.0	0.5	2.5	0.2	0.3	0.2	1.7	0.9	2.9	1.1	0.5	0.8	1.6	0.3	0.0	0.1	2.6	2.6	0.0	1.1	1.1	0.1	0.8	0.0	1.7	1.6	5.4	0.0	0.5	0.5	1.1	1.6	0.4	1.6	1.3	34.0	1.3	0.0	0.9	0.7	0.7	1.3	0.0	0.2	0.1	1.3	1.8	0.0	1.4	2.4	1.3	0.9	2.4	2.2	1.3	0.8	3.3	0.8	0.0	0.0	0.0	0.1	0.0	2.4	0.0	0.7	0.5	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.3	0.3	0.4	0.3	0.1	0.3	0.3	0.3	0.3	0.0	0.0	1.3	1.1	4.6	0.2	0.6	0.0	0.0	2.3	0.0	2.0	0.1	1.7	1.6	0.7	0.5	0.4	0.0	18.7	0.4	0.3	0.9	4.6	0.5	2.4	0.0	0.0	0.6	0.0	0.0	0.0	0.9	0.0	39.7	0.5	0.7	7.0	0.0	0.4	25.9	4.9	0.0	1.6	0.2	0.7	2.4	0.1	0.0	0.6	0.4
CYP27C1	FLJ16008	ENSG00000186684	"Cytochrome P450 family 27 subfamily C member 1"	Q4G0S4	2	127184120-127220078	"Enzymes, Predicted intracellular proteins"		"Monooxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skin 1: 10.6"	"Cell type enhanced"	"Detected in some"	10	"Club cells: 7.9;Collecting duct cells: 3.5;Leydig cells: 6.9;Pancreatic endocrine cells: 4.4;Suprabasal keratinocytes: 6.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HaCaT: 8.4;HDLM-2: 12.1;hTERT-RPE1: 12.8;TIME: 12.1;U-138 MG: 12.4;U-251 MG: 8.1"					"Low region specificity"	"Detected in many"			"HPA062460, HPA068731"			Enhanced	Vesicles		NA	NA			Vesicles		"HPA062460: AB_2732683, HPA068731: AB_2686023"	"unprognostic (1.90e-1)"	"unprognostic (4.07e-2)"	"unprognostic (1.15e-1)"	"unprognostic (1.38e-2)"	"unprognostic (3.03e-1)"	"unprognostic (7.75e-3)"	"unprognostic (3.48e-1)"	"unprognostic (2.31e-3)"	"unprognostic (4.38e-2)"	"unprognostic (3.15e-1)"	"unprognostic (1.81e-3)"	"unprognostic (1.11e-1)"	"unprognostic (6.29e-4)"	"unprognostic (3.49e-4)"	"unprognostic (1.83e-1)"	"unprognostic (4.27e-2)"	"unprognostic (8.64e-2)"	2.7	1.0	0.6	2.4	2.4	0.8	0.6	0.4	1.8	5.2	1.9	1.5	0.4	0.5	1.3	0.8	4.4	1.0	1.5	2.0	0.4	0.9	0.4	0.4	0.4	0.6	2.9	0.4	0.4	0.4	0.0	0.4	0.4	0.7	2.2	0.7	4.2	0.4	1.5	0.8	10.6	1.0	0.4	0.4	0.4	0.5	0.7	3.6	0.4	0.4	2.2	1.6	2.7	4.5	1.5	1.3	3.6	1.0	1.8	1.4	0.2	1.3	3.8	1.9	0.1	0.1	0.0	0.2	0.5	3.6	2.0	0.8	0.1	3.0	0.2	0.1	2.2	1.4	8.4	3.1	1.8	0.6	12.1	1.4	0.0	2.1	0.1	0.0	0.1	0.1	0.1	0.1	0.5	1.2	12.8	0.5	0.3	0.1	0.5	2.3	0.1	0.3	0.1	4.3	0.0	1.0	0.1	0.2	0.0	6.3	1.1	0.1	0.7	5.3	0.0	0.0	1.5	0.2	0.1	12.1	12.4	2.2	6.0	8.1	0.2	0.1	0.1	0.1	0.1	0.9	2.4	1.0	0.7	1.2	0.7	1.0	0.9	1.0	0.8	0.3	1.5	1.1	1.4	3.6	1.8	0.7	1.3	0.8	0.2	0.6	2.4	0.4	1.3	0.4	0.9	2.9	0.4	0.7	3.6	0.0	1.1	0.0	1.2	1.5	0.0	0.3	0.0	0.0	7.9	3.5	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.2	0.0	1.4	1.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	6.9	0.0	0.0	0.0	0.0	0.0	4.4	0.0	0.4	0.0	0.0	0.0	0.9	0.1	0.1	6.4	0.0	0.0	0.0	3.0
CYP2A13	"CPAD, CYP2A"	ENSG00000197838	"Cytochrome P450 family 2 subfamily A member 13"	Q16696	19	41088472-41096195	"Enzymes, Predicted intracellular proteins"		"Monooxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	20	"liver: 30.7"	"Cell type enriched"	"Detected in single"	7	"Early spermatids: 3.0"	"Cancer enriched"	"Detected in single"	5	"liver cancer: 2.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HaCaT: 2.1;NTERA-2: 1.6"									"HPA046713, HPA047262"	Supported				"Intracellular and membrane"	NA	NA					"HPA046713: AB_2679767, HPA047262: AB_2680005"	"unprognostic (9.79e-2)"						"unprognostic (1.00e-1)"	"unprognostic (4.51e-3)"		"unprognostic (4.92e-2)"				"unprognostic (1.99e-1)"	"unprognostic (1.49e-1)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.4	1.5	0.0	0.0	0.1	0.0	0.1	0.1	0.0	30.7	1.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.4	0.0	0.0	0.0	0.0	0.0
CYP2A7	CYP2A	ENSG00000198077	"Cytochrome P450 family 2 subfamily A member 7"	P20853	19	40875439-40882752	"Enzymes, Predicted intracellular proteins"		"Monooxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	134	"liver: 53.7"	"Cell type enhanced"	"Detected in some"	29	"Hepatocytes: 29.0;Ito cells: 12.3;Kupffer cells: 5.7"	"Group enriched"	"Detected in some"	238	"breast cancer: 9.2;liver cancer: 25.6"					"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"HL-60: 2.0"									"CAB033510, HPA046713, HPA047262"	Enhanced				"Intracellular and membrane"	NA	NA					"CAB033510: AB_782366, HPA046713: AB_2679767, HPA047262: AB_2680005"	"unprognostic (2.18e-1)"				"unprognostic (3.60e-2)"		"unprognostic (2.65e-3)"	"unprognostic (8.89e-2)"		"unprognostic (1.39e-2)"	"unprognostic (3.95e-1)"	"unprognostic (9.21e-2)"	"unprognostic (8.71e-2)"	"unprognostic (3.99e-2)"		"unprognostic (1.06e-2)"		0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	53.7	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0		0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.2	0.0	0.2	0.0	0.5	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.0	29.0	0.0	0.0	0.0	12.3	5.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7
CYP2C18	"CPCI, CYP2C, CYP2C17, P450IIC17"	ENSG00000108242	"Cytochrome P450 family 2 subfamily C member 18"	P33260	10	94683621-94736190	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Monooxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"intestine: 62.9;liver: 56.1"	"Cell type enriched"	"Detected in some"	6	"Hepatocytes: 113.1"	"Cancer enhanced"	"Detected in many"		"liver cancer: 18.9"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	11	"basophil: 1.7"	"Lineage enriched"	"Detected in single"	11	"granulocytes: 1.7"	"Cell line enhanced"	"Detected in some"		"BEWO: 7.9;hTCEpi: 2.3;OE19: 4.4"														"Intracellular and membrane"	NA	NA						"unprognostic (2.40e-1)"	"unprognostic (1.75e-2)"	"unprognostic (2.69e-1)"	"unprognostic (1.10e-2)"		"unprognostic (1.32e-2)"	"unprognostic (2.57e-1)"	"unprognostic (2.71e-1)"	"unprognostic (9.78e-2)"	"unprognostic (2.28e-1)"	"unprognostic (4.22e-3)"		"unprognostic (1.62e-3)"	"unprognostic (1.29e-1)"	"unprognostic (1.08e-1)"		"unprognostic (6.81e-3)"	0.2	0.0	0.2	0.8	0.2	0.0	0.2	0.2	0.2	2.4	29.2	0.3	0.2	30.2	0.2	0.2	13.5	0.0	6.7	0.2	0.2	0.0	0.2	56.1	0.5	0.2	0.2	0.2	0.2	0.2	0.0	0.2	0.5	0.2	0.2	0.5	0.2	2.4	0.2	0.2	1.7	62.9	0.2	0.2	0.2	19.0	0.2	0.2	0.3	0.2	5.0	3.8	0.2	3.7	0.0	0.0	1.7	0.0	0.0	0.1	0.1	0.0	0.3	0.1	0.3	0.0	0.0	7.9	0.0	0.0	0.0	0.0	0.9	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.2	0.1	0.0	0.0	0.1	0.0	2.3	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.5	0.0	4.4	0.0	0.0	0.0	0.9	0.5	0.2	0.3	0.6	0.2	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.3	0.2	0.6	0.1	0.5	0.0	0.1	0.2	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.2	0.2	0.2	0.2	0.0	0.2	0.2	0.2	0.2	0.0	3.5	0.0	0.0	0.1	0.0	0.0	17.8	0.0	0.0	0.0	0.0	0.1	0.0	0.6	0.0	0.0	14.7	0.0	6.4	0.1	0.0	0.0	0.0	113.1	0.0	0.0	0.0	1.8	1.9	0.0	0.0	0.0	0.0	0.0	0.4	0.0	5.3	3.5	0.0	0.0	0.0	0.0	0.0	0.0	0.2	1.5	1.3	0.0	1.5	0.0
CYP2C19	"CPCJ, CYP2C, P450IIC19"	ENSG00000165841	"Cytochrome P450 family 2 subfamily C member 19"	P33261	10	94762681-94853205	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins"	"Fatty acid metabolism, Lipid metabolism"	"Monooxygenase, Oxidoreductase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	16	"intestine: 47.7;liver: 76.4"	"Cell type enriched"	"Detected in single"	31	"Hepatocytes: 10.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"CACO-2: 1.8;RPMI-8226: 1.6"									HPA015066	Supported				"Intracellular and membrane"	NA	NA					"HPA015066: AB_1847433"			"unprognostic (3.15e-2)"			"unprognostic (2.13e-1)"	"unprognostic (2.48e-1)"				"unprognostic (1.83e-2)"			"unprognostic (1.53e-1)"				0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.2	30.0	0.0	0.0	14.7	0.0	0.0	1.0	0.0	3.7	0.0	0.0	0.0	0.0	76.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	47.7	0.0	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.5	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.6	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	10.5	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
CYP2C8	CPC8	ENSG00000138115	"Cytochrome P450 family 2 subfamily C member 8"	P10632	10	95036772-95069497	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Lipid metabolism, Steroid metabolism"	"Monooxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	131	"liver: 247.5"	"Cell type enriched"	"Detected in some"	10	"Hepatocytes: 1616.5"	"Cancer enriched"	"Detected in some"	82	"liver cancer: 102.3"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	9	"gdT-cell: 1.8"	"Lineage enriched"	"Detected in single"	9	"T-cells: 1.8"	"Cell line enhanced"	"Detected in some"		"Daudi: 1.8;HL-60: 2.7;SiHa: 3.0;U-266/70: 3.0;U-266/84: 2.3"									"HPA013547, HPA013970, HPA015066"	Enhanced				"Intracellular and membrane"	NA	NA					"HPA013547: AB_1847435, HPA013970: AB_1847434, HPA015066: AB_1847433"	"unprognostic (3.33e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.53e-1)"	"unprognostic (1.55e-1)"	"unprognostic (4.41e-2)"	"unprognostic (1.09e-2)"	"unprognostic (1.80e-3)"	"unprognostic (4.29e-2)"	"unprognostic (1.03e-1)"	"unprognostic (3.38e-1)"	"prognostic favorable (9.82e-4)"	"unprognostic (2.85e-1)"	"unprognostic (1.44e-3)"	"unprognostic (2.63e-1)"	"unprognostic (7.88e-2)"	"unprognostic (1.39e-1)"	"unprognostic (4.05e-4)"	0.1	0.1	0.1	0.1	0.2	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	1.0	0.1	0.1	0.2	0.3	247.5	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.3	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.6	0.4	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.2	0.1	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.8	0.0	0.0	0.1	1.1	0.2	0.0	0.2	0.0	0.7	1.0	0.0	1.0	0.5	2.7	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.3	0.4	0.3	0.7	0.1	0.0	0.2	0.0	0.0	0.0	0.8	0.0	0.0	0.4	0.0	0.0	3.0	0.2	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	3.0	2.3	1.2	0.0	0.9	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.2	0.1	0.1	0.1	0.2	0.1	0.1	0.1	0.1	0.0	0.0	21.0	0.0	0.0	0.9	0.2	155.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	4.9	0.0	0.0	70.0	0.2	0.0	0.0	0.1	0.0	1616.5	0.0	4.8	1.7	61.4	65.7	5.1	0.0	0.0	0.0	0.0	0.0	0.2	0.6	0.0	0.0	0.0	1.6	0.0	0.0	2.1	0.6	0.0	0.0	0.0	0.0	0.1
CYP2C9	"CYP2C10, P450IIC9"	ENSG00000138109	"Cytochrome P450 family 2 subfamily C member 9"	P11712	10	94938658-94989391	"Enzymes, Predicted intracellular proteins"	"Lipid metabolism, Steroid metabolism, Sterol metabolism"	"Monooxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"liver: 233.0"	"Cell type enriched"	"Detected in some"	48	"Hepatocytes: 1765.4"	"Cancer enriched"	"Detected in some"	41	"liver cancer: 118.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HL-60: 3.5;NB-4: 1.7;RPMI-8226: 2.5;SiHa: 1.6"									"HPA015066, CAB016123"	Enhanced				"Intracellular and membrane"	NA	NA					"CAB016123: AB_629363, HPA015066: AB_1847433"	"unprognostic (3.37e-1)"	"unprognostic (5.68e-2)"	"unprognostic (9.67e-2)"	"unprognostic (4.16e-2)"		"unprognostic (1.83e-2)"	"prognostic favorable (2.83e-6)"	"unprognostic (2.37e-1)"	"unprognostic (2.05e-2)"		"unprognostic (4.93e-2)"		"unprognostic (1.26e-4)"	"unprognostic (7.55e-2)"	"unprognostic (1.12e-1)"	"unprognostic (2.45e-2)"	"unprognostic (1.24e-2)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	45.8	0.0	0.0	13.6	0.0	0.6	1.1	0.0	1.0	0.0	0.0	0.0	0.5	233.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.2	43.8	0.0	0.0	0.1	2.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.8	0.0	0.5	0.0	0.0	1.1	0.4	0.0	0.0	0.0	0.0	0.1	1.0	0.0	0.1	0.0	3.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	1.7	0.4	0.9	0.0	0.0	0.3	2.5	0.4	0.0	0.1	0.1	1.6	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.9	0.1	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	7.0	0.0	0.0	0.0	0.0	30.6	0.0	0.0	1.8	0.0	0.0	0.0	4.7	0.0	0.0	4.2	23.3	0.6	0.0	0.0	0.0	0.0	1765.4	0.0	0.0	0.0	36.8	31.7	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.6	0.3	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.7	0.3	0.0
CYP2D6	"CPD6, CYP2D, CYP2D7AP, CYP2D7BP, CYP2D7P2, CYP2D8P2, CYP2DL1, P450-DB1, P450C2D"	ENSG00000100197	"Cytochrome P450 family 2 subfamily D member 6"	P10635	22	42126499-42130906	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Cholesterol metabolism, Fatty acid metabolism, Lipid metabolism, Steroid metabolism, Sterol metabolism"	"Monooxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	7	"liver: 78.0"	"Cell type enriched"	"Detected in many"	38	"Hepatocytes: 435.9"	"Cancer enriched"	"Detected in many"	35	"liver cancer: 90.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"Hep G2: 4.4;HMC-1: 6.2;Karpas-707: 1.9;REH: 3.6;T-47d: 2.3;U-266/70: 4.3"									HPA045223	Enhanced		Approved	"Golgi apparatus"		No	No			"Golgi apparatus"		"HPA045223: AB_10962927"	"unprognostic (4.40e-3)"	"unprognostic (7.68e-3)"	"unprognostic (5.45e-2)"	"unprognostic (1.22e-3)"	"unprognostic (1.24e-1)"	"unprognostic (1.29e-4)"	"unprognostic (3.83e-2)"	"unprognostic (7.27e-3)"	"unprognostic (1.13e-1)"	"unprognostic (1.71e-1)"	"unprognostic (4.03e-4)"	"unprognostic (2.11e-2)"	"unprognostic (5.61e-5)"	"unprognostic (3.01e-1)"	"unprognostic (2.23e-1)"	"unprognostic (4.08e-1)"	"unprognostic (4.82e-5)"	0.1	0.2	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	2.2	0.1	0.1	3.5	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	78.0	0.1	0.1	0.1	0.1	0.5	0.3	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.2	0.1	0.1	0.0	11.2	0.1	0.1	0.1	0.1	0.7	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.8	0.1	0.5	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.1	4.4	0.0	0.1	6.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	1.9	0.0	0.3	0.2	0.0	0.6	0.0	0.2	3.6	0.0	1.1	0.0	0.0	0.1	0.3	1.2	0.1	0.0	0.0	2.3	0.0	0.0	0.0	1.7	0.0	0.3	4.3	0.0	0.0	0.0	0.7	0.5	0.0	0.0	0.0	0.0	0.0	0.8	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.6	0.0	0.5	0.5	6.5	0.3	2.5	1.4	0.0	1.8	2.0	0.1	1.7	0.6	2.9	0.3	3.9	0.0	0.5	0.1	0.2	0.5	0.0	435.9	0.1	11.1	1.2	6.7	6.2	11.4	0.0	0.0	0.0	0.0	1.0	0.9	0.5	2.9	1.4	0.5	2.0	0.0	0.2	0.7	0.3	1.0	0.3	0.5	0.8	0.2
CYP2E1	CYP2E	ENSG00000130649	"Cytochrome P450 family 2 subfamily E member 1"	P05181	10	133520406-133561220	"Cancer-related genes, Enzymes, Predicted intracellular proteins"	"Fatty acid metabolism, Lipid metabolism"	"Monooxygenase, Oxidoreductase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	87	"liver: 802.4"	"Cell type enriched"	"Detected in many"	65	"Hepatocytes: 5979.1"	"Cancer enriched"	"Detected in some"	278	"liver cancer: 265.3"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"MAIT T-cell: 3.9;myeloid DC: 9.1"	"Group enriched"	"Detected in many"	17	"dendritic cells: 9.1;T-cells: 3.9"	"Cell line enhanced"	"Detected in many"		"HaCaT: 9.8;HL-60: 7.6;HMC-1: 8.1;NB-4: 20.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA009128, HPA029564"	Enhanced		Approved	"Endoplasmic reticulum,Mitochondria"	"Intracellular and membrane"	NA	NA			"Endoplasmic reticulum, Mitochondria"		"HPA009128: AB_1078613, HPA029564: AB_10602213"	"unprognostic (6.32e-2)"	"unprognostic (1.51e-2)"	"unprognostic (3.83e-5)"	"unprognostic (1.27e-1)"	"unprognostic (3.37e-2)"	"unprognostic (1.26e-1)"	"unprognostic (2.92e-3)"	"unprognostic (6.36e-3)"	"unprognostic (2.41e-2)"	"unprognostic (1.49e-1)"	"unprognostic (1.63e-1)"	"unprognostic (3.21e-2)"	"unprognostic (1.70e-4)"	"unprognostic (1.72e-1)"	"unprognostic (8.36e-2)"	"unprognostic (3.78e-1)"	"unprognostic (9.59e-2)"	0.1	0.0	0.1	0.1	0.2	0.0	0.1	0.6	0.3	0.1	0.1	0.2	0.7	0.0	0.1	0.3	0.8	0.2	1.3	0.1	0.1	0.1	0.3	802.4	0.1	0.1	0.1	0.1	0.1	0.4	0.0	0.1	0.1	0.3	0.1	0.0	0.2	0.1	1.1	0.1	0.6	0.1	0.1	0.1	0.4	0.1	0.3	0.1	0.1	0.2	0.2	1.5	0.1	0.1	0.0	9.1	0.0	0.3	0.2	3.9	0.3	0.1	0.0	0.3	0.9	3.2	1.8	0.7	1.4	4.0	0.0	0.3	0.0	2.4	1.3	0.2	0.4	0.0	9.8	0.0	0.2	0.3	0.2	1.4	1.5	0.1	1.1	0.5	7.6	8.1	0.9	0.2	0.0	0.6	1.7	0.0	2.8	0.5	0.4	0.9	0.6	0.5	20.6	5.6	3.7	0.4	0.3	5.5	0.0	1.8	0.0	0.0	0.0	3.7	0.0	0.6	0.1	0.2	0.8	0.0	1.3	0.4	2.0	0.9	2.0	0.8	2.8	1.3	6.4	0.1	0.0	0.0	0.0	0.1	0.0	3.9	0.0	1.7	1.0	9.1	0.0	0.1	0.0	0.0	0.2	0.3	0.1	0.0	0.3	0.1	0.2	0.6	0.3	0.1	0.1	0.1	0.1	0.3	0.1	0.0	0.6	21.0	0.2	2.1	4.5	2.2	50.9	2.7	2.3	0.0	2.0	0.0	0.0	0.3	1.3	0.4	0.0	23.3	1.2	0.1	0.4	0.5	1.1	5979.1	0.0	7.9	0.0	68.2	91.8	1.9	1.4	0.0	0.0	0.0	0.0	1.0	2.6	0.0	2.5	0.0	5.2	0.0	0.5	3.6	2.2	6.6	0.1	8.7	0.0	0.0
CYP2F1	CYP2F	ENSG00000197446	"Cytochrome P450 family 2 subfamily F member 1"	P24903	19	41114432-41128366	"Enzymes, Predicted intracellular proteins"		"Monooxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"lung: 10.4;lymphoid tissue: 6.1;pituitary gland: 4.6;testis: 4.9"	"Cell type enhanced"	"Detected in some"	29	"Ciliated cells: 22.7;Club cells: 48.9;Spermatocytes: 9.1"	"Cancer enhanced"	"Detected in some"		"testis cancer: 1.0"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	7	"basophil: 1.6"	"Lineage enriched"	"Detected in single"	7	"granulocytes: 1.6"	"Cell line enriched"	"Detected in some"	7	"HMC-1: 7.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"								"Intracellular and membrane"	NA	NA						"unprognostic (2.04e-1)"	"unprognostic (8.79e-2)"	"unprognostic (4.63e-1)"	"unprognostic (4.60e-2)"	"unprognostic (2.54e-1)"	"unprognostic (7.29e-3)"		"unprognostic (6.23e-3)"		"unprognostic (2.87e-2)"	"unprognostic (3.91e-2)"		"unprognostic (1.58e-6)"	"unprognostic (1.59e-1)"	"unprognostic (1.29e-1)"	"unprognostic (9.90e-2)"	"unprognostic (1.50e-1)"	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.4	0.0	0.0	0.0	0.0	0.0	0.0	4.6	0.0	0.0	0.0	0.0	0.0	2.9	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	4.9	0.0	0.0	0.0	3.1	6.1	0.0	2.0	0.0	0.0	1.6	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	22.7	48.9	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.1	4.8	0.0	0.0	0.0	0.0	0.0
CYP2J2		ENSG00000134716	"Cytochrome P450 family 2 subfamily J member 2"	P51589	1	59893308-59926790	"Enzymes, Predicted intracellular proteins"	"Fatty acid metabolism, Lipid metabolism"	"Isomerase, Monooxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 44.9;intestine: 46.6;liver: 74.6"	"Cell type enhanced"	"Detected in many"	15	"Cardiomyocytes: 84.7;Cytotrophoblasts: 107.4;Syncytiotrophoblasts: 201.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"naive CD4 T-cell: 6.0;naive CD8 T-cell: 5.2"	"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in some"	5	"OE19: 9.9;RT4: 36.0;SK-BR-3: 9.7"					"Low region specificity"	"Detected in all"								"Intracellular and membrane"	NA	NA						"unprognostic (3.53e-2)"	"unprognostic (1.22e-2)"	"unprognostic (1.35e-2)"	"unprognostic (1.99e-2)"	"unprognostic (2.51e-2)"	"unprognostic (2.28e-1)"	"unprognostic (1.61e-1)"	"unprognostic (3.16e-1)"	"unprognostic (1.15e-1)"	"unprognostic (2.84e-2)"	"unprognostic (7.29e-2)"	"unprognostic (2.66e-1)"	"prognostic unfavorable (5.54e-7)"	"unprognostic (4.96e-1)"	"unprognostic (8.45e-2)"	"unprognostic (4.25e-1)"	"unprognostic (9.70e-2)"	0.8	0.9	8.8	1.2	12.0	0.7	5.8	7.9	8.5	1.2	13.1	22.1	0.0	17.9	1.2	1.1	7.2	1.1	1.7	44.9	9.1	6.9	2.2	74.6	1.4	0.8	13.2	6.3	0.7	1.8	0.6	0.7	11.9	12.3	2.4	12.0	0.5	7.2	1.0	12.2	5.3	46.6	1.6	10.1	0.7	3.0	0.9	15.5	0.0	0.7	0.5	2.3	5.8	1.8	1.8	1.2	0.0	0.0	0.7	6.0	1.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	1.6	0.0	0.7	0.2	1.6	0.0	0.5	0.0	2.1	0.5	0.0	0.6	0.0	0.0	1.0	0.0	0.0	0.2	0.0	0.0	0.1	0.3	0.5	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.3	1.8	0.0	0.0	0.9	9.9	1.6	0.0	3.8	0.0	2.0	36.0	0.5	2.3	0.0	9.7	0.3	0.1	2.4	0.0	0.0	1.2	1.5	0.0	0.5	1.1	0.1	0.0	0.4	0.0	4.0	0.0	0.0	0.0	0.2	0.0	1.2	1.8	0.7	0.4	0.1	0.9	6.0	5.2	0.0	0.7	0.0	1.2	0.0	1.0	8.8	12.0	7.9	8.5	9.1	6.9	13.2	6.3	12.3	15.5	3.0	2.6	0.5	1.2	0.3	0.0	84.7	12.7	29.4	35.2	0.0	0.0	107.4	0.0	9.1	16.8	0.0	23.8	0.0	0.8	7.3	1.0	0.8	0.0	44.3	6.1	0.0	8.6	0.0	0.6	19.0	0.0	0.0	0.0	1.0	21.4	11.9	1.8	21.0	0.0	2.9	1.0	0.0	0.0	0.3	0.1	1.9	201.5	0.0	23.6	0.9
CYP2R1		ENSG00000186104	"Cytochrome P450 family 2 subfamily R member 1"	Q6VVX0	11	14877440-14892252	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		"Monooxygenase, Oxidoreductase"	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"Early spermatids: 132.6;Late spermatids: 84.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Karpas-707: 21.4"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			HPA042949	Approved				"Intracellular and membrane"	NA	NA					"HPA042949: AB_2678237"	"unprognostic (1.62e-2)"	"unprognostic (1.82e-2)"	"unprognostic (5.90e-2)"	"unprognostic (1.63e-3)"	"unprognostic (2.67e-1)"	"unprognostic (2.19e-1)"	"unprognostic (3.23e-2)"	"unprognostic (7.73e-2)"	"unprognostic (1.70e-1)"	"unprognostic (3.90e-2)"	"unprognostic (2.25e-1)"	"unprognostic (1.21e-1)"	"prognostic unfavorable (2.86e-4)"	"unprognostic (1.01e-1)"	"unprognostic (1.81e-1)"	"unprognostic (1.46e-1)"	"unprognostic (1.44e-2)"	5.4	4.4	3.5	7.4	6.5	6.4	10.1	7.7	6.8	5.4	8.6	4.2	4.6	10.8	4.6	7.9	10.3	4.3	6.9	6.9	4.3	3.4	6.4	9.1	6.3	6.7	5.3	5.8	4.9	12.0	5.1	7.7	2.7	4.7	8.1	8.0	5.6	10.2	5.5	6.2	15.8	12.6	8.7	5.4	9.3	9.5	14.9	6.2	9.3	5.2	9.7	9.1	7.7	6.8	5.6	3.5	4.2	3.8	3.2	8.8	2.0	4.8	3.0	2.9	1.2	1.3	2.1	0.0	1.7	0.9	1.0	1.0	3.5	5.5	6.1	1.4	0.3	3.9	0.0	1.0	2.2	0.4	5.0	4.7	2.7	3.4	0.2	4.5	4.6	2.8	2.0	8.7	0.0	3.6	0.9	1.1	7.6	4.0	21.4	0.7	1.2	5.0	9.4	2.8	3.5	2.8	3.6	2.2	9.0	1.1	0.5	2.5	3.9	3.6	4.5	4.1	2.0	3.3	1.8	3.1	3.0	3.7	1.8	2.2	10.6	12.3	7.2	4.2	6.1	2.7	4.2	3.7	2.7	5.9	3.2	8.8	3.0	4.7	3.5	3.0	5.6	6.8	5.6	0.6	3.2	3.8	3.5	5.6	2.0	3.5	6.5	7.7	6.8	4.3	3.4	5.3	5.8	4.7	6.2	11.9	3.7	8.1	12.1	5.3	2.7	3.9	7.6	1.4	4.5	5.2	5.9	0.2	5.0	6.6	132.6	4.9	8.4	0.0	14.6	0.1	3.6	6.3	3.5	4.9	5.2	1.6	6.4	6.2	6.3	84.5	2.0	7.9	13.5	5.4	5.4	4.6	9.3	3.5	3.9	5.0	4.2	12.9	4.2	8.9	14.0	5.8	0.0	20.3	7.3	5.8
CYP2S1		ENSG00000167600	"Cytochrome P450 family 2 subfamily S member 1"	Q96SQ9	19	41193049-41207539	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Fatty acid metabolism, Lipid metabolism"	"Isomerase, Lyase, Monooxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 33.1;gallbladder: 29.1;intestine: 62.7;stomach 1: 45.9"	"Cell type enhanced"	"Detected in many"	7	"Cytotrophoblasts: 16.5;Enterocytes: 23.2;Mucus-secreting cells: 29.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	9	"classical monocyte: 9.5;myeloid DC: 33.1"	"Group enriched"	"Detected in many"	121	"dendritic cells: 33.1;monocytes: 9.5"	"Cell line enhanced"	"Detected in many"		"A549: 31.3;CACO-2: 16.1;HaCaT: 16.8;NTERA-2: 23.7;OE19: 51.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"HPA049227, HPA069248"	Approved		Supported	"Endoplasmic reticulum"		NA	NA			"Endoplasmic reticulum"		"HPA049227: AB_2680681, HPA069248: AB_2732128"	"unprognostic (1.49e-2)"	"unprognostic (7.45e-2)"	"unprognostic (2.45e-2)"	"unprognostic (6.03e-2)"	"unprognostic (3.93e-2)"	"unprognostic (7.46e-2)"	"unprognostic (1.27e-2)"	"unprognostic (4.85e-2)"	"unprognostic (2.18e-1)"	"unprognostic (1.54e-2)"	"unprognostic (6.25e-3)"	"unprognostic (1.25e-1)"	"prognostic unfavorable (1.60e-6)"	"unprognostic (1.06e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.02e-1)"	"unprognostic (7.66e-2)"	1.2	0.8	0.8	2.3	1.0	0.5	0.6	0.1	1.0	1.7	18.3	1.2	0.5	37.6	0.3	0.9	10.1	2.4	29.1	1.0	1.4	1.6	0.9	2.1	3.8	3.3	5.6	0.4	0.8	0.6	0.0	0.9	1.6	4.5	0.9	7.2	1.1	3.8	0.3	0.1	2.0	62.7	0.6	1.1	4.0	45.9	0.5	1.2	2.6	0.4	15.8	21.0	3.2	2.7	0.0	33.1	0.0	9.5	0.0	0.1	3.9	1.2	31.3	0.0	0.0	0.0	0.0	1.5	0.2	0.2	0.3	0.0	16.1	4.5	0.0	3.7	0.2	0.0	16.8	5.5	8.5	0.1	0.0	0.1	4.2	1.7	5.8	6.6	0.0	0.1	0.2	0.4	0.4	0.2	0.0	0.2	1.4	1.9	0.1	0.0	0.6	0.1	0.0	23.7	51.4	4.1	0.0	0.0	0.3	0.5	6.7	0.0	0.2	3.1	0.0	0.0	9.7	4.1	1.6	3.6	0.0	1.3	0.6	0.0	0.1	0.0	0.0	0.1	0.7	0.0	0.0	9.5	0.0	0.0	2.3	0.1	0.0	0.0	0.0	33.1	0.0	0.0	0.0	0.0	0.0	1.2	1.3	0.0	3.9	0.8	1.0	0.1	1.0	1.4	1.6	5.6	0.4	4.5	1.2	0.0	8.6	0.0	1.6	2.3	0.0	0.8	0.0	8.1	7.9	1.8	0.0	16.5	0.0	0.8	0.3	0.0	23.2	0.0	0.9	0.6	1.3	0.4	1.1	0.0	12.8	0.0	0.0	0.6	4.7	0.0	0.0	11.5	0.0	8.2	29.0	0.0	13.8	14.8	0.0	0.0	0.0	0.0	0.3	0.1	0.4	2.5	8.6	0.0	13.9	0.1
CYP2U1	SPG49	ENSG00000155016	"Cytochrome P450 family 2 subfamily U member 1"	Q7Z449	4	107931369-107953457	"Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins"		"Monooxygenase, Oxidoreductase"	"Disease mutation, Hereditary spastic paraplegia, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	10	"lymphoid tissue: 122.7"	"Cell type enhanced"	"Detected in many"	4	"Melanocytes: 18.6;Peritubular cells: 16.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041622, HPA046754, HPA064827"	Uncertain		Approved	"Nucleoplasm,Golgi apparatus,Vesicles"		NA	NA			"Golgi apparatus"	"Nucleoplasm, Vesicles"	"HPA041622: AB_2677583, HPA046754: AB_2679787, HPA064827: AB_2685362"	"unprognostic (3.54e-1)"	"unprognostic (2.45e-1)"	"unprognostic (3.08e-1)"	"unprognostic (2.84e-1)"	"unprognostic (5.16e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.36e-2)"	"unprognostic (1.20e-3)"	"unprognostic (3.19e-1)"	"unprognostic (8.97e-3)"	"unprognostic (5.41e-3)"	"unprognostic (3.02e-1)"	"prognostic favorable (2.75e-5)"	"prognostic unfavorable (6.97e-4)"	"unprognostic (1.19e-1)"	"unprognostic (1.17e-2)"	"unprognostic (1.11e-1)"	8.6	7.9	7.7	4.4	9.1	0.4	7.3	11.3	9.2	7.8	7.3	7.0	4.1	4.0	9.5	4.6	6.3	9.8	6.6	8.8	7.1	7.9	6.4	6.8	6.6	6.7	8.3	5.2	12.0	2.6	10.3	8.1	2.7	7.8	12.4	4.7	8.6	4.5	11.0	4.3	3.1	6.0	12.3	7.0	8.5	4.6	3.9	7.4	122.7	4.7	3.5	5.4	7.3	5.3	2.6	2.7	0.7	5.9	1.6	1.7	0.4	2.5	1.2	3.4	6.3	18.8	9.0	0.5	10.8	16.3	6.6	10.5	0.0	1.7	6.9	0.8	6.4	5.2	0.1	5.3	4.0	10.4	1.9	1.6	1.4	2.4	0.3	7.5	2.0	0.0	10.1	3.4	3.1	2.1	13.5	2.5	7.8	0.1	3.3	5.5	1.8	7.4	0.0	3.5	0.2	3.0	4.2	4.1	0.0	2.1	4.3	6.7	5.0	2.7	4.7	11.5	3.0	2.3	1.0	6.8	4.3	0.5	6.1	4.3	14.0	13.2	2.2	3.5	0.0	4.8	0.0	0.3	0.7	1.2	1.1	0.9	2.0	0.9	1.0	2.2	2.6	1.7	1.3	0.0	1.6	5.9	2.7	0.0	0.4	7.7	9.1	11.3	6.9	7.1	7.9	8.3	5.2	7.8	7.4	3.0	3.8	3.2	3.2	1.0	4.3	3.4	2.5	13.4	3.4	8.7	3.9	0.4	0.0	0.9	9.6	5.8	2.6	0.0	1.7	0.3	5.1	1.7	4.6	6.8	1.9	1.6	2.9	6.7	6.1	6.1	16.4	4.6	18.6	3.6	1.1	9.9	0.4	0.0	16.6	2.4	3.3	0.0	5.2	0.9	4.3	1.3	0.2	1.3	1.6	0.7
CYP39A1		ENSG00000146233	"Cytochrome P450 family 39 subfamily A member 1"	Q9NYL5	6	46549580-46652830	"Enzymes, Predicted membrane proteins"	"Cholesterol metabolism, Lipid metabolism, Steroid metabolism, Sterol metabolism"	"Monooxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 52.2"	"Cell type enhanced"	"Detected in many"	13	"Hepatocytes: 58.9"	"Cancer enhanced"	"Detected in many"		"prostate cancer: 11.9"	"Region enriched"	"Detected in many"	8	"cerebellum: 19.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"Daudi: 6.9;hTCEpi: 15.5;OE19: 6.7;SiHa: 9.3;U-698: 10.9"	"Region enhanced"	"Detected in many"		"olfactory region: 24.1"	"Low region specificity"	"Detected in all"									NA	NA						"unprognostic (1.33e-1)"	"unprognostic (1.62e-2)"	"unprognostic (8.46e-3)"	"unprognostic (5.89e-2)"	"unprognostic (1.06e-1)"	"unprognostic (2.08e-1)"	"unprognostic (1.03e-1)"	"unprognostic (5.78e-2)"	"unprognostic (1.61e-1)"	"unprognostic (4.99e-2)"	"unprognostic (7.33e-2)"	"unprognostic (6.11e-2)"	"prognostic favorable (1.86e-4)"	"unprognostic (1.54e-1)"	"unprognostic (5.48e-2)"	"unprognostic (1.43e-1)"	"unprognostic (1.20e-1)"	2.6	2.0	1.7	2.9	1.9	0.0	2.9	19.3	1.9	3.6	1.9	1.5	6.4	0.4	1.9	12.0	4.9	2.3	3.4	4.8	1.6	1.1	3.3	52.2	2.6	0.2	2.3	0.9	6.5	8.7	8.6	8.3	0.2	2.3	8.2	1.9	8.0	21.0	1.8	0.5	8.5	1.4	1.7	2.2	0.6	2.7	3.3	0.9	0.0	9.4	2.3	2.1	2.5	10.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.4	0.3	2.0	0.3	0.0	0.0	0.0	1.2	0.4	0.1	0.0	0.6	6.9	5.0	0.0	1.0	1.9	0.9	1.6	0.0	0.0	3.0	0.0	1.8	2.0	4.7	0.0	0.0	0.5	15.5	0.0	1.8	1.4	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.1	6.7	1.7	0.5	1.3	0.1	3.3	4.4	0.8	0.0	9.3	0.0	0.2	0.5	1.7	0.0	0.0	0.2	1.0	0.0	0.1	0.0	0.0	10.9	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	1.9	19.3	1.9	1.6	1.1	2.3	0.9	2.3	0.9	14.9	1.0	0.0	7.1	3.5	0.2	4.6	10.2	8.1	4.5	3.5	2.0	0.0	5.0	1.6	11.8	2.3	0.5	0.0	0.3	0.9	1.7	12.3	0.0	58.9	0.2	0.0	0.0	0.0	1.9	15.3	5.8	0.2	3.3	0.0	3.1	8.0	0.9	2.9	8.9	4.1	1.5	0.0	2.1	0.7	0.1	13.4	0.0	0.0	2.3	6.0
CYP3A4	CYP3A3	ENSG00000160868	"Cytochrome P450 family 3 subfamily A member 4"	P08684	7	99756960-99784265	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis, Steroid metabolism, Sterol metabolism"	"Monooxygenase, Oxidoreductase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	45	"intestine: 145.3;liver: 464.6"	"Cell type enriched"	"Detected in some"	45	"Hepatocytes: 2276.5"	"Cancer enriched"	"Detected in some"	240	"liver cancer: 351.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 4.2;NB-4: 4.5;RPMI-8226: 6.7;SCLC-21H: 2.6;SH-SY5Y: 5.0"									"CAB033671, HPA072245, HPA075539"	Enhanced		Approved	Vesicles,Cytosol		NA	NA			Cytosol	Vesicles	"CAB033671: AB_782375, HPA072245: , HPA075539: "	"unprognostic (4.55e-2)"	"unprognostic (8.95e-2)"	"unprognostic (8.08e-2)"	"unprognostic (1.63e-1)"	"unprognostic (5.89e-2)"	"unprognostic (5.37e-2)"	"unprognostic (7.07e-3)"	"unprognostic (9.09e-2)"	"unprognostic (8.27e-3)"	"unprognostic (4.92e-2)"	"unprognostic (3.78e-2)"	"unprognostic (6.42e-2)"	"unprognostic (1.89e-8)"	"unprognostic (2.59e-1)"	"unprognostic (1.75e-2)"	"unprognostic (9.79e-2)"	"unprognostic (6.82e-2)"	0.1	0.4	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	145.3	0.1	0.1	56.0	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.0	0.2	464.6	0.1	0.1	0.1	0.1	0.1	6.8	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.3	0.2	126.7	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.4	0.2	0.6	0.2	0.6	0.2	0.2	0.0	0.1	0.0	0.0	0.0	0.0	4.2	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	1.4	0.1	0.2	0.0	1.9	0.4	0.0	1.2	0.0	0.4	0.0	0.0	0.1	0.5	0.0	0.5	0.0	0.1	4.5	0.3	0.0	0.0	0.0	2.2	6.7	0.0	0.5	2.6	5.0	0.5	0.0	0.0	0.0	0.1	0.0	0.8	0.0	0.0	1.4	0.0	0.7	0.1	0.7	0.1	0.7	0.1	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.1	0.2	0.6	0.6	0.0	0.2	0.2	0.2	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.0	4.3	1.0	0.3	0.0	0.3	40.8	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.3	0.0	2.6	46.7	0.8	0.0	0.0	0.5	0.0	2276.5	0.0	0.0	0.0	39.3	50.2	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.1	0.3	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.6	0.1	0.0	0.4	0.9
CYP3A43		ENSG00000021461	"Cytochrome P450 family 3 subfamily A member 43"	Q9HB55	7	99828013-99866102	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"		"Monooxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in some"	4	"liver: 32.5"	"Cell type enhanced"	"Detected in some"	15	"Early spermatids: 6.3;granulocytes: 2.3;Hepatocytes: 6.8;Late spermatids: 2.5"	"Cancer enriched"	"Detected in single"	18	"liver cancer: 1.4"	"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in some"											"HPA066463, HPA072245, HPA075539"	Enhanced		Approved	Vesicles,Cytosol		NA	NA			Cytosol	Vesicles	"HPA066463: AB_2685670, HPA072245: , HPA075539: "	"unprognostic (1.20e-3)"	"unprognostic (4.74e-2)"	"unprognostic (3.64e-3)"		"unprognostic (7.24e-2)"	"unprognostic (2.52e-1)"	"prognostic favorable (3.41e-4)"	"unprognostic (1.68e-2)"	"unprognostic (1.44e-1)"	"unprognostic (2.38e-1)"	"unprognostic (1.12e-1)"	"unprognostic (6.45e-2)"	"unprognostic (1.23e-2)"	"unprognostic (6.46e-2)"	"unprognostic (5.90e-2)"	"unprognostic (3.10e-1)"	"unprognostic (6.37e-4)"	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.3	0.1	0.1	0.1	0.1	0.0	0.2	0.9	0.1	0.0	0.1	0.1	0.1	0.0	0.2	32.5	0.1	0.1	0.1	0.1	0.1	8.0	0.0	2.2	0.1	0.1	1.3	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.5	0.1	0.1	0.0	0.5	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.6	0.5	1.6	0.6	0.3	0.6	0.2	0.1	0.0	0.9	0.3	1.1	0.2	0.2	0.0	0.2	0.2	0.2	1.2	0.7	1.5	0.3	0.3	0.1	1.3	0.2	0.0	0.7	0.2	0.5	0.9	1.5	1.3	0.3	0.9	1.3	0.0	0.7	0.0	0.0	0.6	0.5	0.1	1.0	1.0	0.0	0.0	0.0	0.6	0.4	0.3	0.0	0.9	0.0	0.2	0.8	1.6	0.5	0.4	0.6	1.7	0.0	0.7	0.5	0.0	1.6	0.5	0.2	1.1	0.7	1.1	1.2	0.1	0.8	0.4	0.2	1.5	0.6	0.4	0.6	0.2	0.3	0.3	0.3	0.2	0.1	0.6	0.5	0.5	1.6	0.3	0.2	0.5	0.4	0.2	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.4	0.2	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	6.3	0.2	0.0	0.0	0.0	0.0	0.0	0.5	2.3	6.8	0.1	1.6	0.0	0.0	0.0	2.5	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.9	0.2	0.3	0.0	0.0	0.0	0.0
CYP3A5	"CP35, P450PCN3, PCN3"	ENSG00000106258	"Cytochrome P450 family 3 subfamily A member 5"	P20815	7	99648194-99680026	"Cancer-related genes, Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Lipid metabolism, Steroid metabolism"	"Monooxygenase, Oxidoreductase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"intestine: 72.9;liver: 73.4;stomach 1: 21.3"	"Cell type enhanced"	"Detected in many"	11	"Cholangiocytes: 346.5;Enterocytes: 640.5;Hepatocytes: 330.1;Urothelial cells: 352.8"	"Cancer enhanced"	"Detected in many"		"liver cancer: 38.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"CACO-2: 8.3;CAPAN-2: 5.6;Hep G2: 5.7;OE19: 23.6"									"HPA072245, HPA075539"			Approved	Vesicles,Cytosol		NA	NA			Cytosol	Vesicles	"HPA072245: , HPA075539: "	"unprognostic (2.13e-1)"	"unprognostic (4.36e-2)"	"unprognostic (4.04e-2)"	"unprognostic (1.00e-1)"	"unprognostic (1.06e-2)"	"unprognostic (2.73e-1)"	"prognostic favorable (3.72e-5)"	"unprognostic (1.37e-3)"	"unprognostic (1.21e-2)"	"unprognostic (7.29e-3)"	"unprognostic (3.85e-1)"	"unprognostic (4.05e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.00e-1)"	"unprognostic (1.93e-1)"	"unprognostic (2.39e-4)"	"unprognostic (6.58e-3)"	1.0	3.3	0.4	2.0	0.5	0.0	1.3	0.6	0.6	1.9	32.6	0.6	1.0	30.3	0.7	0.5	5.2	0.5	8.2	0.4	0.4	0.0	6.8	73.4	2.4	0.8	0.4	0.4	0.6	12.1	0.0	1.8	0.6	0.8	4.9	5.1	0.4	0.6	1.3	0.4	4.3	72.9	0.6	0.5	0.4	21.3	0.7	0.4	0.5	0.4	2.2	4.0	3.0	2.7	0.0	0.2	0.1	0.6	0.0	0.7	0.2	0.0	2.1	0.0	0.0	0.4	0.5	0.0	0.0	0.0	0.0	0.0	8.3	5.6	0.0	0.3	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.7	0.1	0.0	0.1	0.0	1.8	0.0	0.0	0.0	0.0	0.0	1.7	0.1	0.0	0.1	0.0	0.3	0.2	23.6	0.0	0.1	0.0	0.6	0.5	0.4	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.2	0.7	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.6	0.0	0.0	0.2	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.2	0.4	0.5	0.6	0.6	0.4	0.0	0.4	0.4	0.8	0.4	11.9	11.3	11.2	107.3	41.0	13.1	1.0	346.5	14.7	12.5	3.5	11.8	1.3	0.0	58.0	1.7	2.5	640.5	46.7	44.6	1.0	3.8	166.5	9.3	330.1	0.6	7.9	52.5	9.8	8.3	0.0	2.3	4.6	3.3	7.2	117.1	6.0	69.5	210.5	2.5	4.2	20.2	0.0	3.5	6.8	4.2	51.6	1.3	12.9	85.2	352.8
CYP3A7	"CP37, P450-HFLA"	ENSG00000160870	"Cytochrome P450 family 3 subfamily A member 7"	P24462	7	99684957-99735196	"Enzymes, Predicted membrane proteins"	"Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis"	"Monooxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	21	"liver: 82.6"	"Cell type enriched"	"Detected in some"	7	"Cholangiocytes: 135.0"	"Cancer enriched"	"Detected in some"	43	"liver cancer: 38.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"BEWO: 1.9;BJ hTERT+: 3.3;Hep G2: 6.4;HHSteC: 3.7;RT4: 1.9"									"HPA072245, HPA075539"			Approved	Vesicles,Cytosol		NA	NA			Cytosol	Vesicles	"HPA072245: , HPA075539: "	"unprognostic (8.10e-3)"	"unprognostic (1.45e-1)"	"unprognostic (3.12e-1)"	"unprognostic (5.47e-2)"	"unprognostic (1.73e-1)"	"unprognostic (1.44e-1)"	"unprognostic (4.41e-2)"	"unprognostic (1.50e-1)"	"unprognostic (1.34e-2)"	"unprognostic (8.28e-2)"	"unprognostic (8.18e-2)"	"unprognostic (1.97e-1)"	"unprognostic (1.06e-11)"	"unprognostic (2.02e-2)"	"unprognostic (5.87e-2)"	"unprognostic (2.97e-1)"	"unprognostic (1.34e-3)"	0.1	0.4	0.1	0.1	0.0	0.0	2.6	0.1	0.1	0.0	0.7	0.0	0.0	0.1	0.3	0.1	0.2	0.0	3.9	0.0	0.1	0.0	2.8	82.6	0.6	0.0	0.0	0.1	0.1	0.3	0.0	0.0	0.2	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.1	1.5	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.3	0.0	0.0	0.4	1.9	0.0	3.3	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.3	6.4	3.7	0.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.1	0.0	0.0	0.8	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.3	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	1.1	0.0	0.0	0.0	135.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	18.4	0.1	0.0	0.0	4.9	3.7	0.0	0.0	0.0	3.3	0.0	0.0	0.0	0.2	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1
CYP3A7-CYP3A51P		ENSG00000282301	"CYP3A7-CYP3A51P readthrough"	P24462	7	99685226-99735093	"Enzymes, Predicted membrane proteins"	"Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis"	"Monooxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	21	"liver: 73.9"	"Cell type enriched"	"Detected in some"	7	"Cholangiocytes: 7.6"									"Cell type enhanced"	"Detected in single"		"eosinophil: 1.1"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"ASC TERT1: 4.3;U-87 MG: 2.6"									"HPA072245, HPA075539"			Approved	Vesicles,Cytosol		NA	NA			Cytosol	Vesicles	"HPA072245: , HPA075539: "																		0.0	0.1	0.0	0.0	0.0	0.0	2.3	0.0	0.1	0.0	0.6	0.0	0.0	0.4	0.0	0.0	0.1	0.0	3.5	0.0	0.0		1.1	73.9	0.5	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	1.3	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.2	1.1	0.0	0.0	0.5	0.0	0.3	0.5	1.6	0.5	0.2	4.3	0.0	0.6	0.2	0.0	0.0	0.0	1.3	0.1	0.4	0.0	0.1	0.3	0.0	0.0	0.0	0.4	0.9	1.4	1.9	0.0	0.0	0.5	0.3	0.4	0.4	0.0	0.4	0.5	0.0	0.8	0.5	1.1	0.1	0.2	1.2	0.5	0.2	0.5	0.2	0.1	0.4	1.5	0.0	0.0	0.4	0.2	0.0	0.5	0.6	0.6	0.0	0.1	0.4	0.3	0.5	0.5	0.6	0.9	0.7	0.1	2.6	0.7	0.1	0.0	0.0	1.1	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.2	0.1	0.0											0.0	0.0	0.0	0.1	0.0	0.0	0.0	7.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
CYP46A1	CYP46	ENSG00000036530	"Cytochrome P450 family 46 subfamily A member 1"	Q9Y6A2	14	99684304-99727301	"Enzymes, Predicted intracellular proteins"	"Cholesterol metabolism, Lipid metabolism, Steroid metabolism, Sterol metabolism"	"Monooxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	7	"brain: 49.2"	"Cell type enhanced"	"Detected in many"	14	"Cone photoreceptor cells: 62.8;Muller glia cells: 24.1;Rod photoreceptor cells: 25.1"	"Cancer enriched"	"Detected in single"	5	"glioma: 1.7"	"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	23	"plasmacytoid DC: 7.0"	"Lineage enriched"	"Detected in single"	23	"dendritic cells: 7.0"	"Group enriched"	"Detected in some"	4	"AF22: 4.4;U-937: 12.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"								"Intracellular and membrane"	NA	NA						"unprognostic (2.16e-1)"	"unprognostic (4.30e-1)"	"unprognostic (2.50e-5)"	"unprognostic (9.48e-5)"	"unprognostic (1.15e-1)"	"unprognostic (5.92e-2)"	"unprognostic (3.45e-2)"	"unprognostic (1.06e-1)"	"unprognostic (5.37e-2)"	"unprognostic (4.01e-2)"	"unprognostic (1.32e-5)"	"unprognostic (5.21e-2)"	"unprognostic (2.44e-4)"	"unprognostic (5.97e-4)"	"unprognostic (1.59e-1)"	"unprognostic (1.15e-2)"	"unprognostic (3.88e-3)"	3.0	3.3	13.8	1.3	47.3	1.0	1.2	2.6	49.2	1.4	1.1	3.7	0.0	1.2	1.9	2.0	1.1	1.6	1.4	6.2	15.7	9.9	2.0	1.5	1.3	1.6	7.1	10.0	2.1	2.3	2.7	5.3	1.0	3.8	1.8	1.1	0.6	2.5	1.7	2.0	1.1	1.0	1.9	3.1	1.0	1.0	2.1	6.1	0.4	1.8	0.0	1.1	1.1	0.1	0.0	7.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	4.4	1.0	0.3	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.4	0.5	0.5	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.1	0.0	0.3	0.0	1.4	0.0	0.2	0.0	1.0	0.0	0.0	0.2	0.0	0.6	0.2	0.0	0.1	0.2	0.0	0.4	0.0	0.3	0.0	0.0	1.5	0.1	1.9	0.0	0.1	0.0	1.0	0.0	0.3	0.0	0.0	0.2	12.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	7.0	0.0	0.0	13.8	47.3	2.6	21.5	15.7	9.9	7.1	10.0	3.8	6.1	3.0	5.9	0.0	6.3	1.4	10.6	6.1	2.5	1.4	3.4	1.8	62.8	0.1	1.7	0.1	0.5	4.1	0.0	0.0	1.0	0.2	2.6	3.1	1.1	2.9	0.4	7.9	0.0	3.7	2.2	0.4	4.4	1.4	3.3	1.8	0.0	24.1	0.1	0.0	3.9	3.7	25.1	0.0	2.7	8.0	3.7	1.3	0.1	0.5	0.0	2.3
CYP4A11	"CYP4A2, CYP4AII"	ENSG00000187048	"Cytochrome P450 family 4 subfamily A member 11"	Q02928	1	46929177-46941484	"Enzymes, Predicted membrane proteins"	"Fatty acid metabolism, Lipid metabolism"	"Monooxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	78	"kidney: 36.5;liver: 141.0"	"Group enriched"	"Detected in some"	6	"Hepatocytes: 433.3;Proximal tubular cells: 109.9"	"Cancer enriched"	"Detected in some"	5	"liver cancer: 73.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HEL: 1.4;HL-60: 1.2;RH-30: 1.3;SiHa: 1.6;U-698: 2.3;U-937: 1.6"															NA	NA						"unprognostic (9.05e-2)"	"unprognostic (4.98e-2)"		"unprognostic (4.43e-2)"	"unprognostic (4.11e-1)"	"unprognostic (7.81e-5)"	"unprognostic (5.10e-3)"	"unprognostic (1.16e-2)"	"unprognostic (1.83e-2)"	"unprognostic (1.92e-2)"	"unprognostic (1.90e-1)"	"unprognostic (1.12e-1)"	"unprognostic (4.59e-2)"	"unprognostic (5.86e-2)"	"unprognostic (1.96e-1)"	"unprognostic (3.00e-3)"	"unprognostic (1.68e-2)"	0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	1.1	0.1	0.1	0.1	0.1	0.4	0.1	0.0	0.3	0.1	0.1	0.0	36.5	141.0	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.4	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.2	0.2	0.3	0.1	0.8	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.8	0.4	0.0	0.3	0.4	0.0	0.2	0.1	1.1	0.0	1.4	0.0	0.4	0.0	1.2	0.5	0.0	0.3	0.3	0.0	0.0	0.1	0.0	0.8	0.4	0.0	0.0	0.0	0.0	0.6	0.0	0.5	0.5	1.3	0.6	0.0	0.0	0.0	0.4	1.6	0.1	0.0	0.0	0.0	0.3	0.5	0.0	0.1	0.1	0.0	0.0	0.0	2.3	0.0	1.6	0.1	0.0	0.3	0.0	0.0	0.3	0.1	0.0	0.3	0.1	0.2	0.0	0.2	0.8	0.2	0.1	0.0	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	43.3	0.0	0.0	7.0	0.0	0.0	14.9	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	433.3	0.0	0.0	0.0	6.2	6.2	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	109.9	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0
CYP4A22		ENSG00000162365	"Cytochrome P450 family 4 subfamily A member 22"	Q5TCH4	1	47137435-47149741	"Enzymes, Predicted membrane proteins"		"Monooxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"liver: 71.0"	"Cell type enriched"	"Detected in some"	13	"Hepatocytes: 99.2"	"Cancer enriched"	"Detected in some"	13	"liver cancer: 20.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"RH-30: 5.1;SuSa: 2.6"															NA	NA						"unprognostic (5.34e-2)"	"unprognostic (1.24e-1)"		"unprognostic (3.19e-2)"			"unprognostic (2.88e-3)"	"unprognostic (2.76e-3)"		"unprognostic (1.50e-3)"	"unprognostic (2.21e-1)"	"unprognostic (2.75e-1)"	"unprognostic (1.93e-2)"	"unprognostic (5.29e-3)"	"unprognostic (1.02e-1)"	"unprognostic (1.71e-1)"	"unprognostic (8.59e-4)"	0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.3	0.1	0.1	0.0	0.1	1.2	0.1	0.0	0.1	0.1	0.1	0.0	14.4	71.0	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.6	0.1	0.4	0.2	0.1	0.6	0.0	0.0	0.1	0.5	0.1	0.0	0.1	0.2	0.1	0.0	0.0	0.0	0.4	0.5	0.5	0.2	0.1	0.0	0.2	0.3	0.0	0.1	0.2	0.2	0.1	0.5	0.0	0.0	0.6	0.6	0.2	0.0	0.1	0.2	0.0	0.1	0.3	0.2	0.5	0.1	0.1	0.4	0.4	0.4	0.0	0.0	0.0	5.1	0.0	0.0	0.4	0.5	0.2	0.3	0.1	0.0	2.6	0.4	0.6	0.7	0.2	0.1	0.2	0.0	0.0	0.5	0.6	0.2	1.1	0.0	0.0	0.2	0.4	0.5	0.0	0.4	0.5	0.5	0.6	0.1	0.6	0.5	0.6	0.0	0.1	0.0	0.1	0.2	0.0	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	5.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	99.2	0.0	0.0	0.0	1.8	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
CYP4B1		ENSG00000142973	"Cytochrome P450 family 4 subfamily B member 1"	P13584	1	46757838-46819413	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"		"Monooxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lung: 92.0"	"Group enriched"	"Detected in some"	5	"Alveolar cells type 1: 1140.4;Ciliated cells: 602.3;Club cells: 304.8"	"Cancer enhanced"	"Detected in many"		"urothelial cancer: 56.9"	"Region enhanced"	"Detected in single"		"midbrain: 1.7"	"Cell type enriched"	"Detected in single"	11	"memory CD4 T-cell: 1.1"	"Lineage enriched"	"Detected in single"	11	"T-cells: 1.1"	"Cell line enriched"	"Detected in some"	8	"RT4: 81.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA004331	Approved		Supported	Vesicles		NA	NA			Vesicles		"HPA004331: AB_1078616"	"unprognostic (2.29e-2)"	"prognostic favorable (5.99e-4)"	"unprognostic (7.01e-2)"	"unprognostic (1.11e-1)"	"unprognostic (2.28e-1)"	"unprognostic (8.31e-2)"	"unprognostic (1.16e-2)"	"unprognostic (1.98e-2)"	"unprognostic (2.65e-1)"	"unprognostic (2.59e-1)"	"unprognostic (6.12e-2)"	"unprognostic (5.46e-2)"	"unprognostic (7.33e-2)"	"unprognostic (1.80e-1)"	"unprognostic (1.15e-1)"	"unprognostic (1.22e-3)"	"unprognostic (6.69e-3)"	41.6	2.2	0.0	0.6	0.1	0.3	45.5	0.1	0.3	9.5	6.7	0.1	7.2	0.7	2.1	2.8	17.9	18.5	0.8	13.5	0.0	0.0	1.4	0.2	92.0	1.5	1.7	0.1	3.3	0.9	0.5	4.8	0.9	0.8	15.4	0.5	2.8	5.0	6.9	14.4	10.4	3.4	6.8	3.5	0.5	3.0	1.7	0.1	0.7	12.7	4.5	5.7	36.5	18.9	0.0	0.0	0.0	0.0	0.0	1.1	0.4	0.0	0.0	0.0	0.0	5.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.7	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	10.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	81.5	0.0	0.0	0.0	3.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.1	0.1	0.2	0.0	0.0	1.7	0.1	0.8	0.1	1140.4	70.0	0.0	114.6	0.5	0.0	4.8	0.0	602.3	304.8	0.0	0.0	0.9	0.0	0.0	0.5	2.1	0.0	0.0	0.0	0.2	4.7	3.9	5.8	0.0	0.6	0.0	0.0	2.5	0.0	0.8	0.6	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.0	3.6	0.7	0.0	0.0	142.5
CYP4F11		ENSG00000171903	"Cytochrome P450 family 4 subfamily F member 11"	Q9HBI6	19	15912367-15934867	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Fatty acid metabolism, Lipid metabolism"	"Monooxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"liver: 88.6"	"Cell type enhanced"	"Detected in many"	17	"Ductal cells: 13.3;Hepatocytes: 48.8;Urothelial cells: 13.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"intermediate monocyte: 1.2"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"A-431: 7.6;CAPAN-2: 30.3;EFO-21: 11.4;Hep G2: 14.7;RPMI-8226: 7.9;RT4: 9.1"									"HPA017265, CAB033648, HPA058960"	Enhanced				"Intracellular and membrane"	NA	NA					"CAB033648: AB_2088410, HPA017265: AB_1847451, HPA058960: AB_2683862"	"prognostic favorable (4.05e-4)"	"unprognostic (4.12e-2)"	"unprognostic (1.79e-1)"	"unprognostic (5.99e-2)"	"unprognostic (5.92e-3)"	"unprognostic (1.06e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.65e-1)"	"unprognostic (2.33e-1)"	"unprognostic (1.19e-1)"	"prognostic unfavorable (9.28e-4)"	"unprognostic (4.44e-2)"	"unprognostic (9.50e-3)"	"unprognostic (2.14e-2)"	"unprognostic (2.24e-1)"	"unprognostic (2.78e-2)"	"unprognostic (4.64e-2)"	0.4	2.2	3.6	0.5	4.4	0.5	1.7	1.8	5.4	1.1	2.5	4.4	0.0	7.5	0.5	11.8	7.9	2.2	12.9	0.4	3.9	1.4	4.9	88.6	2.4	0.4	2.1	3.8	0.3	3.5	0.2	0.6	0.2	8.3	2.4	1.9	0.6	2.6	3.4	0.5	0.8	15.7	0.2	9.7	0.9	2.7	1.0	3.0	0.0	2.2	2.8	1.8	4.8	2.0	0.1	0.1	0.8	1.2	0.0	0.2	0.1	7.6	1.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	30.3	0.1	11.4	0.0	6.5	0.9	0.0	3.9	0.0	0.0	0.0	0.0	2.3	14.7	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	6.1	0.0	1.1	0.0	0.1	0.0	6.7	0.0	0.0	0.1	7.9	2.1	9.1	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.0	1.1	0.1	0.1	0.1	0.3	0.1	0.2	0.9	0.0	0.8	0.5	0.0	0.1	1.2	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.2	0.3	0.0	0.7	0.1	0.0	0.1	3.6	4.4	1.8	5.4	3.9	1.4	2.1	3.8	8.3	3.0	0.0	0.0	0.0	7.8	0.1	0.0	0.3	0.0	4.0	1.2	8.7	0.0	0.0	1.7	13.3	0.0	0.0	5.3	0.0	9.9	0.0	0.0	7.8	0.0	48.8	0.0	0.0	1.2	0.0	1.6	0.0	0.3	0.0	0.0	0.0	3.0	2.5	7.5	2.9	0.0	5.4	0.0	0.0	0.2	0.0	0.0	0.3	0.0	0.0	1.7	13.3
CYP4F2		ENSG00000186115	"Cytochrome P450 family 4 subfamily F member 2"	P78329	19	15878023-15898120	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Fatty acid metabolism, Lipid metabolism"	"Monooxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	7	"intestine: 69.1;liver: 102.9"	"Cell type enriched"	"Detected in some"	8	"Hepatocytes: 132.0"	"Cancer enriched"	"Detected in some"	9	"liver cancer: 29.6"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	12	"basophil: 8.5"	"Lineage enriched"	"Detected in single"	86	"granulocytes: 8.5"	"Cell line enriched"	"Detected in some"	4	"Hep G2: 9.0"									"HPA014048, HPA017265, HPA058960"	Supported				"Intracellular and membrane"	NA	NA					"HPA014048: AB_1847452, HPA017265: AB_1847451, HPA058960: AB_2683862"	"unprognostic (7.46e-3)"	"unprognostic (3.58e-1)"	"unprognostic (3.01e-1)"	"unprognostic (9.39e-2)"	"unprognostic (1.74e-1)"	"unprognostic (2.87e-2)"	"unprognostic (4.55e-3)"	"unprognostic (6.52e-2)"	"unprognostic (2.05e-1)"	"unprognostic (4.64e-2)"	"unprognostic (9.82e-2)"	"unprognostic (2.92e-1)"	"unprognostic (8.69e-4)"	"unprognostic (3.24e-1)"	"unprognostic (1.89e-1)"		"unprognostic (7.79e-3)"	0.1	0.1	0.2	0.5	0.1	0.0	0.2	0.1	0.2	0.2	10.1	0.2	0.1	24.5	0.1	8.8	0.2	0.1	1.8	0.1	0.2	0.1	11.9	102.9	0.1	0.1	0.1	0.1	0.1	0.2	0.0	0.1	0.1	0.2	1.9	0.0	0.1	0.1	0.2	0.1	0.5	69.1	0.1	0.2	0.2	0.2	0.3	0.1	0.1	0.1	0.1	0.1	0.4	0.3	0.0	0.0	8.5	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.3	0.7	0.1	0.3	0.1	0.0	0.0	0.6	0.0	0.3	0.0	0.0	0.1	0.0	0.2	9.0	0.0	1.0	0.5	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.5	1.6	0.1	0.0	0.1	0.3	0.6	0.8	0.1	0.4	0.4	0.9	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.4	0.2	0.0	0.4	0.0	0.0	0.0	0.1	0.0	8.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.1	0.2	0.2	0.1	0.1	0.1	0.2	0.1	0.0	0.0	0.0	0.1	0.3	0.0	0.5	5.1	0.0	0.0	0.0	0.0	0.0	1.7	0.0	6.2	0.0	16.2	0.0	0.3	0.0	0.0	0.6	0.0	132.0	0.0	0.0	1.7	0.6	3.9	11.0	0.0	0.0	0.0	0.0	3.6	0.0	0.0	5.8	0.0	14.7	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	3.0	0.1
CYP4F3	"CYP4F, LTB4H"	ENSG00000186529	"Cytochrome P450 family 4 subfamily F member 3"	Q08477	19	15640897-15662825	"Enzymes, Predicted intracellular proteins"	"Fatty acid metabolism, Lipid metabolism"	"Monooxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"liver: 159.2"	"Cell type enriched"	"Detected in many"	6	"Hepatocytes: 506.3"	"Cancer enhanced"	"Detected in many"		"liver cancer: 30.6"	"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in single"	68	"neutrophil: 33.1"	"Lineage enriched"	"Detected in single"	166	"granulocytes: 33.1"	"Cell line enhanced"	"Detected in some"		"CAPAN-2: 20.0;HaCaT: 9.1;Hep G2: 10.9;OE19: 29.3"									HPA058960	Approved					NA	NA					"HPA058960: AB_2683862"	"unprognostic (1.73e-2)"	"unprognostic (9.70e-3)"	"unprognostic (1.21e-1)"	"unprognostic (1.16e-3)"	"unprognostic (5.40e-1)"	"unprognostic (1.57e-1)"	"unprognostic (7.15e-3)"	"unprognostic (5.19e-2)"	"unprognostic (2.12e-1)"	"unprognostic (3.61e-2)"	"unprognostic (1.26e-2)"	"unprognostic (2.32e-1)"	"unprognostic (1.59e-3)"	"unprognostic (2.36e-1)"	"unprognostic (1.12e-1)"	"unprognostic (1.07e-2)"	"unprognostic (2.07e-1)"	0.4	0.1	0.3	0.3	1.5	24.8	0.1	0.1	2.2	2.1	3.4	6.5	0.0	3.1	0.1	0.4	8.6	0.3	19.8	0.2	0.8	0.2	23.7	159.2	0.7	0.0	0.4	1.9	0.1	0.2	0.0	0.2	0.0	1.6	0.3	0.5	0.0	1.3	0.1	0.1	1.2	13.4	0.1	1.0	2.6	1.7	0.2	1.8	0.0	0.1	1.1	0.8	1.8	2.7	0.0	0.0	33.1	0.1	0.0	0.0	0.0	0.2	4.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	20.0	0.0	0.1	0.0	0.0	9.1	0.0	0.1	0.0	0.3	0.0	0.1	1.9	10.9	0.0	0.1	0.1	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	29.3	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.6	0.0	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	33.1	0.0	0.0	0.0	0.0	0.0	0.3	1.5	0.1	2.2	0.8	0.2	0.4	1.9	1.6	1.8	8.9	5.9	5.1	2.3	0.9	0.0	0.8	91.7	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.1	13.5	23.3	0.2	0.1	0.3	1.7	1.1	506.3	0.0	0.0	50.9	6.2	10.2	0.4	0.0	0.4	0.0	0.0	5.6	0.0	2.5	7.0	0.0	31.2	0.0	0.0	0.2	0.0	0.1	5.6	0.0	0.8	8.3	10.8
CYP4F8		ENSG00000186526	"Cytochrome P450 family 4 subfamily F member 8"	P98187	19	15615218-15630638	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Fatty acid metabolism, Lipid metabolism"	"Monooxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in some"	155	"ductus deferens: 265.6;seminal vesicle: 360.6"	"Cell type enhanced"	"Detected in some"	14	"Glandular cells: 1.7;granulocytes: 1.1;Urothelial cells: 2.4"	"Group enriched"	"Detected in some"	31	"breast cancer: 2.5;prostate cancer: 3.3;urothelial cancer: 10.4"					"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	9	"OE19: 2.1;RT4: 1.6;SK-BR-3: 4.4"									HPA058960	Approved					NA	NA					"HPA058960: AB_2683862"	"unprognostic (1.70e-2)"	"unprognostic (5.46e-3)"	"unprognostic (3.21e-2)"	"unprognostic (3.97e-6)"		"unprognostic (3.51e-3)"				"unprognostic (2.72e-1)"	"unprognostic (1.15e-1)"	"unprognostic (8.25e-2)"		"unprognostic (1.15e-2)"			"unprognostic (1.02e-3)"	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	265.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	360.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	4.4	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.8	0.0	0.4	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.0	1.7	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	2.4
CYP4V2	CYP4AH1	ENSG00000145476	"Cytochrome P450 family 4 subfamily V member 2"	Q6ZWL3	4	186191520-186213456	"Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins"	"Lipid metabolism, Sensory transduction, Vision"	"Monooxygenase, Oxidoreductase"	"Corneal dystrophy, Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 64.7"	"Cell type enhanced"	"Detected in many"	7	"Hepatocytes: 92.7;Muller glia cells: 64.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"Karpas-707: 13.1;SK-MEL-30: 19.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA029122	Approved		Approved	"Nuclear speckles"		NA	NA			"Nuclear speckles"		"HPA029122: AB_10601806"	"unprognostic (1.65e-1)"	"unprognostic (5.37e-2)"	"unprognostic (2.35e-1)"	"prognostic favorable (5.86e-4)"	"unprognostic (1.45e-1)"	"unprognostic (1.02e-1)"	"prognostic favorable (1.85e-4)"	"unprognostic (6.66e-2)"	"unprognostic (5.84e-2)"	"unprognostic (2.05e-1)"	"unprognostic (6.49e-2)"	"unprognostic (9.89e-2)"	"prognostic favorable (1.49e-7)"	"unprognostic (3.25e-2)"	"unprognostic (8.96e-2)"	"unprognostic (1.02e-1)"	"unprognostic (3.14e-2)"	6.6	16.6	7.8	5.0	12.4	1.6	5.5	8.9	7.5	6.7	8.0	8.9	4.9	11.4	5.7	4.2	5.2	6.2	13.7	7.4	7.7	4.6	21.6	64.7	7.3	4.1	7.7	9.0	6.3	12.1	30.8	16.1	3.0	6.7	5.6	8.2	19.1	6.2	9.1	3.3	2.8	14.7	6.4	7.0	7.5	5.2	3.2	7.4	4.4	11.9	2.1	3.8	8.0	5.1	2.3	2.5	0.0	6.2	1.3	4.0	1.5	2.6	1.8	0.6	0.0	11.3	4.6	0.1	3.8	8.1	1.4	2.0	0.0	10.9	1.0	0.5	2.5	5.7	1.3	1.3	1.2	0.4	6.5	1.3	4.1	0.4	0.5	3.4	2.2	2.0	4.2	0.5	1.4	0.7	4.7	0.1	4.2	1.6	13.1	4.7	2.3	2.5	0.6	1.4	1.1	0.0	2.1	0.5	1.1	4.6	5.2	2.8	4.1	0.9	0.0	19.4	0.2	1.9	3.5	4.2	3.0	0.7	3.3	1.6	0.0	0.0	0.5	9.0	8.3	3.6	0.0	1.2	0.0	4.0	4.1	2.5	1.0	2.5	3.4	1.5	2.3	2.7	2.3	0.0	1.3	6.2	2.5	2.1	1.5	7.8	12.4	8.9	7.5	7.7	4.6	7.7	9.0	6.7	7.4	6.0	7.8	8.3	3.1	2.3	31.1	15.3	45.9	12.0	10.3	14.0	29.5	1.8	8.3	16.1	2.4	5.5	19.2	0.0	19.5	1.7	8.4	5.5	6.9	92.7	11.5	4.8	16.3	9.2	11.2	1.7	4.6	7.1	3.3	0.0	19.1	64.2	11.0	10.5	6.0	31.8	27.1	0.0	10.2	8.1	5.4	2.8	0.8	10.7	8.9	5.0
CYP4X1	MGC40051	ENSG00000186377	"Cytochrome P450 family 4 subfamily X member 1"	Q8N118	1	47023568-47050751	"Enzymes, Predicted membrane proteins"		"Monooxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"cervix, uterine: 38.1"	"Cell type enriched"	"Detected in many"	6	"Ciliated cells: 156.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC diff: 3.7;CACO-2: 6.2;NTERA-2: 2.9;SCLC-21H: 3.8;T-47d: 13.5"	"Low region specificity"	"Detected in all"							HPA017661	Approved					NA	NA					"HPA017661: AB_2669633"	"unprognostic (1.19e-1)"	"unprognostic (2.28e-2)"	"unprognostic (1.53e-1)"	"unprognostic (1.78e-2)"	"unprognostic (9.88e-2)"	"unprognostic (1.56e-3)"	"unprognostic (2.30e-1)"	"unprognostic (2.34e-2)"	"unprognostic (1.10e-2)"	"unprognostic (2.35e-2)"	"unprognostic (1.46e-1)"	"unprognostic (2.76e-2)"	"unprognostic (3.03e-2)"	"unprognostic (1.79e-3)"	"unprognostic (3.65e-2)"	"unprognostic (8.56e-2)"	"unprognostic (5.03e-2)"	7.9	3.6	9.0	1.1	14.9	0.5	16.0	7.1	16.9	38.1	2.0	1.6	2.5	2.1	3.6	3.2	12.0	9.7	2.0	6.7	4.8	10.6	6.3	10.0	8.9	2.0	3.3	13.5	1.7	2.0	2.0	4.1	1.5	7.8	8.0	2.3	17.6	23.7	3.4	4.5	5.0	1.8	2.4	2.0	1.0	14.3	4.2	0.9	0.0	4.0	6.9	8.8	3.9	5.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	3.7	0.2	0.1	0.0	0.1	0.0	0.0	6.2	0.0	0.0	0.7	0.0	1.7	0.0	0.0	0.0	0.0	0.5	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.3	2.2	0.0	0.0	0.9	0.1	0.0	0.1	0.3	0.0	0.0	0.0	0.0	2.9	1.0	0.0	0.0	0.5	0.0	0.6	0.2	3.8	0.0	0.0	0.3	0.0	0.2	13.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.0	14.9	7.1	16.9	4.8	10.6	3.3	13.5	7.8	0.9	20.8	10.5	0.0	23.5	2.3	0.9	1.0	0.0	156.6	27.3	0.0	0.0	0.0	0.0	0.3	6.0	2.3	0.0	0.0	0.6	0.0	1.9	10.7	0.0	2.5	2.9	0.0	0.0	0.6	0.3	5.6	9.8	0.6	5.0	0.0	0.0	0.0	0.2	0.0	19.4	1.3	0.7	0.0	14.5	0.0	1.5	1.3	0.1	0.0	0.6	26.2
CYP4Z1	CYP4A20	ENSG00000186160	"Cytochrome P450 family 4 subfamily Z member 1"	Q86W10	1	47067488-47118319	"Enzymes, Predicted membrane proteins"		"Monooxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	9	"breast: 23.1"	"Cell type enriched"	"Detected in some"	4	"Alveolar cells type 1: 8.9"	"Cancer enriched"	"Detected in some"	50	"breast cancer: 42.3"	"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	39	"HDLM-2: 13.7;SK-BR-3: 5.9"															NA	NA						"unprognostic (4.11e-2)"	"unprognostic (2.57e-2)"	"unprognostic (2.46e-1)"	"unprognostic (5.12e-2)"	"unprognostic (1.37e-1)"	"unprognostic (4.33e-4)"	"unprognostic (1.10e-1)"	"unprognostic (3.53e-3)"		"unprognostic (7.76e-3)"	"unprognostic (1.21e-1)"	"unprognostic (3.53e-1)"	"unprognostic (6.82e-3)"	"unprognostic (5.09e-3)"	"unprognostic (3.88e-2)"	"unprognostic (6.46e-2)"	"unprognostic (3.49e-3)"	2.5	0.2	0.4	0.4	0.9	0.0	23.1	0.4	2.0	1.0	0.4	0.4	0.4	0.0	0.4	0.8	0.8	0.7	0.4	0.4	0.4	1.8	0.4	1.5	2.1	0.4	0.4	0.4	0.4	0.4	0.3	0.4	0.4	0.7	1.3	0.0	0.4	1.5	0.8	0.5	2.2	0.4	0.4	0.4	0.4	0.2	1.0	0.4	0.6	0.4	0.4	0.5	0.6	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	5.9	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.9	0.4	2.0	0.4	1.8	0.4	0.4	0.7	0.4	8.9	0.6	0.0	0.4	0.1	0.0	0.2	0.0	1.4	1.2	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6
CYP51A1	"CP51, CYP51, CYPL1, LDM, P450-14DM, P450L1"	ENSG00000001630	"Cytochrome P450 family 51 subfamily A member 1"	Q16850	7	92112151-92142952	"Enzymes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Cholesterol biosynthesis, Cholesterol metabolism, Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis, Steroid metabolism, Sterol biosynthesis, Sterol metabolism"	"Monooxygenase, Oxidoreductase"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 80.9"	"Cell type enhanced"	"Detected in many"	11	"Alveolar cells type 1: 62.5;Alveolar cells type 2: 133.7;Club cells: 77.3;Early spermatids: 70.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"GAMG: 96.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041325, HPA043508"	Enhanced		Enhanced	"Endoplasmic reticulum"		NA	NA			"Endoplasmic reticulum"		"HPA041325: AB_2677411, HPA043508: AB_2678520"	"unprognostic (6.68e-2)"	"prognostic unfavorable (6.12e-4)"	"unprognostic (3.48e-2)"	"unprognostic (1.18e-2)"	"unprognostic (7.82e-2)"	"unprognostic (3.60e-2)"	"unprognostic (1.02e-1)"	"unprognostic (1.97e-1)"	"unprognostic (9.84e-2)"	"unprognostic (1.36e-1)"	"unprognostic (9.75e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.59e-9)"	"unprognostic (1.82e-1)"	"unprognostic (2.73e-1)"	"unprognostic (5.13e-2)"	"unprognostic (1.09e-3)"	10.3	27.0	16.7	8.1	22.1	10.5	15.5	13.3	32.0	11.8	21.1	32.9	6.3	33.1	9.1	15.3	23.4	7.1	10.3	9.9	18.6	20.8	18.6	80.9	22.2	5.0	17.2	13.7	21.0	20.2	32.4	11.9	8.8	47.1	18.2	16.9	17.1	11.0	7.7	4.3	12.8	28.8	8.3	43.7	7.3	18.1	35.7	19.5	2.3	14.1	18.7	10.0	9.0	13.2	14.2	14.1	3.5	13.9	6.7	10.7	7.1	21.4	10.5	26.6	17.0	18.7	30.7	3.8	7.3	22.1	9.5	26.0	25.3	39.3	18.7	11.6	12.6	96.2	18.8	23.1	46.1	11.1	7.8	16.4	5.4	11.2	19.0	25.6	11.0	8.1	22.2	21.0	37.1	39.0	8.4	9.7	3.8	20.2	43.2	11.1	22.0	2.3	10.2	19.8	8.8	10.5	7.6	5.5	42.2	43.0	36.4	18.7	12.5	15.5	30.9	22.6	12.6	11.2	13.2	11.5	13.0	14.6	18.8	9.5	14.7	13.1	17.1	10.0	14.6	16.6	1.8	9.7	3.5	10.7	13.9	7.1	14.2	7.6	8.4	14.1	10.7	7.2	9.2	1.5	6.7	8.3	12.4	5.8	7.1	16.7	22.1	13.3	32.0	18.6	20.8	17.2	13.7	47.1	19.5	62.5	133.7	7.5	1.0	2.3	2.1	1.2	7.6	28.1	77.3	1.8	2.0	1.3	1.7	9.2	70.7	2.1	14.4	23.3	17.0	0.8	1.8	1.3	27.7	4.2	1.3	0.0	10.4	8.6	6.6	27.7	3.4	2.1	0.0	1.0	12.0	1.9	12.3	10.4	1.4	1.7	1.8	0.0	2.8	3.2	1.5	4.6	3.7	1.0	11.5	2.1
CYP7A1	CYP7	ENSG00000167910	"Cytochrome P450 family 7 subfamily A member 1"	P22680	8	58490178-58500236	"Enzymes, Predicted intracellular proteins"	"Cholesterol metabolism, Lipid metabolism, Steroid metabolism, Sterol metabolism"	"Monooxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	70	"liver: 50.4"	"Cell type enriched"	"Detected in single"	12	"Hepatocytes: 4.7"	"Cancer enriched"	"Detected in single"	96	"liver cancer: 28.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"BJ hTERT+: 1.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"									NA	NA						"unprognostic (5.20e-2)"			"unprognostic (1.93e-2)"	"unprognostic (1.77e-2)"		"prognostic favorable (3.19e-4)"	"unprognostic (7.60e-2)"	"unprognostic (5.31e-2)"	"unprognostic (1.50e-1)"	"unprognostic (1.18e-1)"	"unprognostic (2.64e-1)"	"unprognostic (8.43e-3)"	"unprognostic (3.01e-1)"	"unprognostic (1.57e-2)"	"unprognostic (1.51e-1)"		0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	50.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.3	0.5	0.0	0.0	1.4	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.2	0.0	0.1	0.9	0.0	0.2	0.5	0.0	0.4	0.1	0.2	0.0	0.2	0.2	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.5	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0
CYP7B1	SPG5A	ENSG00000172817	"Cytochrome P450 family 7 subfamily B member 1"	O75881	8	64587763-64798761	"Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins"	"Cholesterol metabolism, Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis, Steroid metabolism, Sterol metabolism"	"Monooxygenase, Oxidoreductase"	"Disease mutation, Hereditary spastic paraplegia, Intrahepatic cholestasis, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	4	"Melanocytes: 16.9;Smooth muscle cells: 16.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	36	"basophil: 6.4;eosinophil: 6.2"	"Lineage enriched"	"Detected in single"	36	"granulocytes: 6.4"	"Cell line enhanced"	"Detected in some"		"HSkMC: 16.9;NTERA-2: 3.2;SH-SY5Y: 6.2;WM-115: 12.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA017761	Uncertain					NA	NA					"HPA017761: AB_1847455"	"unprognostic (3.19e-2)"	"unprognostic (1.91e-1)"	"unprognostic (1.50e-1)"	"unprognostic (6.89e-3)"	"unprognostic (1.07e-1)"	"unprognostic (5.80e-3)"	"unprognostic (3.80e-1)"	"unprognostic (5.50e-2)"	"unprognostic (6.11e-3)"	"unprognostic (2.46e-1)"	"unprognostic (1.61e-1)"	"unprognostic (3.19e-2)"	"unprognostic (1.87e-2)"	"unprognostic (2.38e-3)"	"unprognostic (4.00e-1)"	"unprognostic (3.04e-3)"	"unprognostic (6.75e-3)"	10.1	8.5	5.0	7.5	12.2	0.8	9.8	2.1	10.8	8.7	3.8	20.7	3.5	2.4	4.1	3.9	10.8	5.4	8.0	6.6	5.8	4.2	10.0	24.6	11.0	5.7	5.0	7.8	5.6	8.2	31.0	4.4	1.7	13.5	5.8	4.8	7.3	6.6	7.1	1.8	6.7	3.5	6.1	12.6	19.1	3.9	3.2	7.5	0.2	16.2	5.5	3.8	8.4	10.1	0.0	0.1	6.4	0.0	0.0	0.1	0.0	1.9	0.8	1.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.3	0.3	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.5	0.0	0.0	16.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.2	0.0	0.0	0.0	0.0	0.0	0.4	0.0	2.1	6.2	0.0	0.1	2.6	1.1	0.0	1.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.5	6.4	0.0	6.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	5.0	12.2	2.1	10.8	5.8	4.2	5.0	7.8	13.5	7.5	0.0	4.3	0.0	6.1	9.4	5.5	2.0	0.0	1.4	1.2	7.0	2.0	0.0	3.3	3.3	6.0	1.4	0.0	0.0	4.4	0.1	7.2	3.7	12.7	7.8	0.2	3.2	1.7	2.5	0.3	5.7	5.5	0.0	16.9	1.8	0.0	8.1	1.4	0.0	4.6	2.9	0.5	12.9	16.1	1.7	3.0	11.0	0.0	1.0	0.0	2.6
CYP8B1	CYP12	ENSG00000180432	"Cytochrome P450 family 8 subfamily B member 1"	Q9UNU6	3	42856005-42876165	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"		"Monooxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	20	"liver: 132.7"	"Cell type enriched"	"Detected in some"	57	"Hepatocytes: 737.2"	"Cancer enriched"	"Detected in some"	46	"liver cancer: 69.6"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"basophil: 1.4"	"Lineage enriched"	"Detected in single"	5	"granulocytes: 1.4"	"Group enriched"	"Detected in some"	5	"BEWO: 6.8;HEL: 1.7;Hep G2: 2.6;SK-BR-3: 3.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"									NA	NA						"unprognostic (1.58e-2)"	"unprognostic (5.41e-2)"	"unprognostic (6.38e-2)"	"unprognostic (1.15e-2)"	"unprognostic (8.95e-2)"	"unprognostic (1.42e-3)"	"unprognostic (4.47e-3)"	"unprognostic (1.49e-1)"	"unprognostic (9.85e-2)"	"unprognostic (4.04e-3)"	"unprognostic (5.86e-3)"	"unprognostic (2.74e-1)"	"unprognostic (3.37e-1)"	"unprognostic (1.03e-1)"	"unprognostic (3.63e-1)"	"unprognostic (3.19e-1)"	"unprognostic (1.24e-1)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.7	0.0	0.0	0.1	0.0	0.0	0.0	6.7	132.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	1.4	0.2	0.1	0.2	0.1	0.4	0.7	0.3	0.2	0.0	0.0	6.8	0.1	0.0	0.0	0.0	0.5	0.3	0.2	0.3	0.0	0.4	0.3	0.0	0.0	0.0	0.0	0.2	1.7	0.2	2.6	0.0	0.7	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.4	0.4	0.2	0.0	0.4	0.2	0.0	0.3	0.1	0.4	0.5	0.6	0.3	0.3	0.5	0.1	0.0	0.6	3.1	0.3	0.4	0.3	0.1	0.3	0.3	0.6	0.3	0.2	0.4	0.1	0.3	0.3	0.4	0.1	1.4	0.2	0.3	0.1	0.1	0.1	0.0	0.1	0.2	0.0	0.2	0.1	0.1	0.9	0.1	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	10.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	737.2	0.1	0.0	0.0	10.4	10.5	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0
DAO	DAMOX	ENSG00000110887	"D-amino acid oxidase"	P14920	12	108858932-108901043	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		Oxidoreductase	Schizophrenia	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	39	"brain: 37.0;kidney: 39.0;liver: 64.2"	"Group enriched"	"Detected in some"	11	"Hepatocytes: 41.2;Proximal tubular cells: 75.6"	"Cancer enriched"	"Detected in some"	9	"liver cancer: 13.2"	"Group enriched"	"Detected in many"	5	"cerebellum: 37.0;pons and medulla: 31.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 1.3;ASC TERT1: 1.3;BEWO: 1.5;Hep G2: 4.5;HL-60: 1.8;HMC-1: 1.3;RH-30: 1.2"	"Group enriched"	"Detected in some"	10	"cerebellum: 74.4;pons and medulla: 21.1"	"Group enriched"	"Detected in many"	4	"cerebellum: 54.0;midbrain: 31.9;pons and medulla: 55.4;thalamus: 16.3"	"HPA038653, HPA038654"	Enhanced				"Intracellular and membrane"	NA	NA					"HPA038653: AB_10673016, HPA038654: AB_10673285"	"unprognostic (1.50e-1)"	"unprognostic (5.61e-2)"	"unprognostic (1.43e-1)"	"unprognostic (2.91e-1)"	"unprognostic (2.18e-1)"	"unprognostic (2.99e-2)"	"unprognostic (2.31e-3)"	"unprognostic (8.02e-2)"	"unprognostic (2.88e-2)"	"unprognostic (9.59e-2)"	"unprognostic (9.07e-2)"	"unprognostic (7.13e-2)"	"prognostic favorable (4.11e-4)"	"unprognostic (3.44e-3)"	"unprognostic (8.96e-2)"	"unprognostic (2.67e-1)"	"unprognostic (2.17e-1)"	0.3	0.2	0.0	0.2	2.7	0.2	0.2	37.0	0.7	0.2	0.9	11.5	0.0	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.8	0.9	39.0	64.2	0.3	0.2	6.4	0.5	0.2	0.3	0.2	0.0	0.2	31.2	0.2	1.1	0.0	0.2	0.2	0.2	0.2	0.2	0.3	35.9	0.2	0.2	0.2	0.4	0.0	0.2	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	1.3	1.5	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.5	0.0	1.8	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	1.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.7	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	37.0	0.5	0.8	0.9	6.4	0.5	31.2	0.4	0.0	0.0	0.9	0.0	0.0	0.5	0.4	0.0	0.0	0.0	1.8	0.0	0.6	3.3	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	41.2	0.2	0.0	0.0	1.8	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.3	0.0	75.6	5.3	0.0	0.0	0.0	0.0	0.0	3.9	0.0	0.0	0.0
DAPK1	"DAPK, ROCO3"	ENSG00000196730	"Death associated protein kinase 1"	P53355	9	87497228-87708633	"Cancer-related genes, Enzymes, Predicted membrane proteins"	"Apoptosis, Translation regulation"	"Calmodulin-binding, Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"placenta: 94.7"	"Cell type enhanced"	"Detected in many"	5	"Alveolar cells type 2: 65.3;Ito cells: 79.2;Kupffer cells: 64.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"classical monocyte: 5.3;eosinophil: 6.9;intermediate monocyte: 11.9;myeloid DC: 4.0;non-classical monocyte: 11.7;plasmacytoid DC: 5.3"	"Group enriched"	"Detected in many"	55	"dendritic cells: 5.3;granulocytes: 6.9;monocytes: 11.9"	"Cell line enhanced"	"Detected in many"		"HMC-1: 38.8;HUVEC TERT2: 22.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB037302, HPA040472, HPA048436"	Approved		Approved	Centrosome		NA	NA			Centrosome		"CAB037302: AB_1078622, HPA040472: AB_2677001, HPA048436: AB_2680390"	"unprognostic (2.55e-1)"	"unprognostic (1.47e-1)"	"prognostic unfavorable (2.48e-5)"	"unprognostic (2.77e-1)"	"unprognostic (1.74e-1)"	"unprognostic (3.47e-2)"	"unprognostic (1.74e-1)"	"unprognostic (1.75e-1)"	"unprognostic (1.88e-2)"	"unprognostic (5.77e-3)"	"unprognostic (2.19e-2)"	"unprognostic (2.77e-3)"	"unprognostic (8.31e-3)"	"unprognostic (8.76e-2)"	"unprognostic (2.40e-1)"	"unprognostic (1.68e-1)"	"unprognostic (1.09e-3)"	14.6	4.9	10.4	8.8	25.5	3.8	4.1	2.9	17.6	8.1	16.6	6.5	8.1	7.8	8.7	16.1	4.5	12.2	21.6	4.1	12.4	8.1	14.7	21.3	28.6	8.5	4.6	10.4	32.7	21.2	4.8	16.6	94.7	6.6	5.1	7.5	5.9	9.3	7.3	1.5	3.7	11.0	8.1	4.8	16.4	15.0	6.3	7.3	34.5	7.2	1.5	5.2	13.2	10.5	0.1	5.3	6.9	11.9	0.1	0.1	2.1	0.0	18.3	8.8	6.2	0.2	0.1	14.0	1.2	1.7	7.2	8.2	2.6	0.1	0.1	1.8	0.3	0.1	17.1	5.4	0.4	3.1	0.1	4.4	8.8	2.5	8.9	7.9	0.0	38.8	0.5	2.9	1.3	0.5	11.3	22.0	2.5	6.6	3.7	6.0	0.5	2.6	0.0	10.0	16.9	0.0	0.7	7.8	0.0	20.1	18.3	4.0	4.5	0.0	1.8	7.7	13.5	0.0	5.8	0.1	0.0	0.1	0.0	0.0	14.6	3.0	0.0	0.1	2.4	1.2	1.3	5.3	6.9	0.0	11.9	0.0	0.1	0.0	0.0	4.0	0.0	0.0	0.1	1.6	0.1	11.7	5.3	0.0	2.1	10.4	25.5	2.9	17.6	12.4	8.1	4.6	10.4	6.6	7.3	47.6	65.3	5.9	0.6	3.2	19.8	1.9	40.8	16.0	40.9	21.0	2.0	5.6	1.7	27.2	1.2	13.0	2.1	0.0	20.1	14.4	11.4	3.9	23.1	16.3	21.3	17.5	0.0	79.2	64.1	2.2	13.8	42.1	11.8	30.7	7.7	14.5	31.5	1.7	12.7	5.9	2.9	0.0	2.3	3.9	4.1	2.8	11.9	0.7	2.8	9.3
DAPK2	"DRP-1, MGC119312"	ENSG00000035664	"Death associated protein kinase 2"	Q9UIK4	15	63907036-64072033	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	Apoptosis	"Calmodulin-binding, Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 51.8;skeletal muscle: 46.1"	"Cell type enhanced"	"Detected in many"	8	"Alveolar cells type 1: 80.4;Enterocytes: 44.6;Late spermatids: 59.2"	"Cancer enriched"	"Detected in many"	15	"thyroid cancer: 30.3"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	13	"basophil: 19.1;eosinophil: 51.8;neutrophil: 16.4"	"Lineage enriched"	"Detected in many"	23	"granulocytes: 51.8"	"Cell line enhanced"	"Detected in many"		"ASC diff: 10.1;HaCaT: 8.4;HMC-1: 17.2;MCF7: 8.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA071581			Supported	"Golgi apparatus,Vesicles"		NA	NA			"Golgi apparatus, Vesicles"		"HPA071581: AB_2686421"	"unprognostic (3.20e-2)"	"unprognostic (4.07e-2)"	"unprognostic (4.23e-2)"	"unprognostic (1.95e-3)"	"unprognostic (2.88e-2)"	"unprognostic (1.30e-2)"	"unprognostic (2.32e-1)"	"prognostic favorable (5.63e-4)"	"unprognostic (1.04e-1)"	"unprognostic (3.18e-1)"	"unprognostic (9.21e-2)"	"unprognostic (8.51e-2)"	"unprognostic (4.77e-7)"	"unprognostic (5.98e-2)"	"unprognostic (1.45e-1)"	"unprognostic (3.20e-3)"	"unprognostic (9.07e-2)"	8.2	1.6	2.6	6.8	5.0	10.3	5.2	1.4	3.9	3.6	16.6	12.0	8.3	14.2	1.7	1.5	2.1	1.2	1.7	17.6	3.6	2.0	2.2	1.4	14.0	2.5	6.8	3.0	0.7	1.7	1.1	1.1	0.3	4.7	3.1	4.7	1.9	4.8	4.8	46.1	4.6	25.8	1.2	3.4	4.7	6.9	2.0	6.5	1.1	22.3	8.7	3.3	2.1	9.6	0.3	2.2	51.8	0.0	0.7	0.6	0.3	2.8	2.0	5.7	1.4	10.1	0.4	0.1	1.9	6.1	1.0	1.1	0.9	1.4	0.2	0.6	6.1	3.4	8.4	3.5	0.1	0.6	0.2	0.1	1.1	3.9	0.1	0.1	0.1	17.2	1.1	7.3	0.4	0.2	6.6	0.6	0.1	0.4	0.1	0.7	8.7	0.0	0.3	0.6	2.8	2.0	2.6	0.0	0.3	0.0	2.8	0.4	0.3	0.4	1.1	0.0	1.4	4.8	0.4	0.4	0.8	1.0	1.3	1.6	0.6	0.2	0.0	0.0	2.7	0.2	19.1	0.0	51.8	0.6	0.0	0.2	0.3	0.1	0.5	0.0	0.1	0.0	0.4	16.4	0.7	0.0	2.2	0.0	0.3	2.6	5.0	1.4	3.9	3.6	2.0	6.8	3.0	4.7	6.5	80.4	21.1	2.7	6.6	10.3	0.0	34.6	2.5	2.7	19.4	0.0	0.0	0.1	1.7	7.8	19.1	2.8	44.6	0.0	30.2	0.1	3.1	14.5	15.0	0.8	0.4	4.8	8.1	8.6	1.2	59.2	2.8	1.4	0.0	0.0	13.0	1.6	13.0	28.8	5.3	0.3	0.1	12.9	2.1	0.9	3.4	3.6	0.1	14.9	16.9	10.7
DAPK3	"ZIP, ZIPK"	ENSG00000167657	"Death associated protein kinase 3"	O43293	19	3958453-3971123	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Apoptosis, Transcription, Transcription regulation, Translation regulation"	"Activator, Chromatin regulator, Kinase, Serine/threonine-protein kinase, Transferase"	"Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028569, HPA064809"	Approved		Supported	Nucleoplasm		NA	NA			Nucleoplasm		"HPA028569: AB_10794319, HPA064809: AB_2685357"	"unprognostic (5.72e-2)"	"unprognostic (3.28e-2)"	"unprognostic (3.34e-3)"	"prognostic favorable (2.01e-5)"	"unprognostic (1.83e-1)"	"unprognostic (2.37e-1)"	"unprognostic (7.72e-3)"	"unprognostic (2.16e-1)"	"unprognostic (2.46e-2)"	"unprognostic (4.95e-2)"	"unprognostic (1.84e-3)"	"unprognostic (7.64e-2)"	"prognostic unfavorable (6.49e-4)"	"unprognostic (9.92e-2)"	"unprognostic (1.41e-1)"	"unprognostic (5.48e-2)"	"unprognostic (2.14e-1)"	18.8	10.2	12.6	16.6	16.4	10.0	17.2	14.5	29.5	22.5	30.1	13.6	11.5	18.5	33.1	11.5	20.2	18.5	21.9	49.2	12.4	11.0	10.9	11.0	24.5	11.6	11.9	16.8	18.8	21.7	11.1	14.6	26.0	19.7	21.3	6.9	18.2	15.3	25.8	45.2	17.8	17.0	38.8	10.6	14.7	23.3	15.7	12.7	11.8	11.4	11.6	12.9	26.7	17.8	15.0	14.7	23.9	15.6	17.3	19.5	11.0	25.7	20.5	12.8	16.1	9.6	10.9	19.8	35.6	28.7	29.1	19.2	37.7	7.8	14.3	17.5	31.2	20.5	20.6	12.5	20.2	10.6	20.9	20.8	5.7	25.1	21.6	30.6	13.8	21.7	24.7	25.3	26.4	15.2	17.5	24.1	9.8	18.1	24.9	17.7	16.8	13.7	10.4	19.9	10.5	16.5	17.2	18.9	13.3	17.5	20.3	20.3	14.1	24.0	28.9	20.4	15.7	20.8	10.9	45.1	37.5	17.0	33.5	44.4	27.8	22.8	16.5	29.8	14.5	19.9	22.1	14.2	23.9	19.5	15.6	14.0	13.5	14.8	17.9	12.6	15.0	11.3	10.8	23.9	17.3	10.6	14.7	17.6	11.0	12.6	16.4	14.5	29.5	12.4	11.0	11.9	16.8	19.7	12.7	23.8	10.9	16.6	82.6	89.4	12.3	27.3	17.8	5.3	7.9	10.4	2.0	40.8	14.9	91.0	24.5	19.4	61.2	0.0	75.9	65.4	32.8	38.1	20.7	6.0	20.1	11.1	26.2	20.3	16.7	17.7	21.0	12.0	35.4	33.3	33.0	11.1	89.1	42.1	21.2	11.5	10.2	32.3	50.1	15.2	15.6	62.7	77.9	17.5	20.3	41.6
DARS		ENSG00000115866	"Aspartyl-tRNA synthetase"	P14868	2	135906677-135986100	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Protein biosynthesis"	"Aminoacyl-tRNA synthetase, Ligase"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA020451, HPA029804, HPA029805"	Enhanced		Enhanced	Cytosol		NA	NA		160000	Cytosol		"HPA020451: AB_1847479, HPA029804: AB_10599178, HPA029805: AB_10601994"	"unprognostic (6.13e-2)"	"unprognostic (8.16e-3)"	"unprognostic (5.54e-2)"	"unprognostic (5.36e-2)"	"unprognostic (7.63e-2)"	"unprognostic (1.91e-2)"	"prognostic unfavorable (2.39e-6)"	"unprognostic (2.98e-3)"	"prognostic unfavorable (7.57e-4)"	"unprognostic (6.00e-3)"	"prognostic unfavorable (6.54e-4)"	"unprognostic (2.78e-1)"	"prognostic unfavorable (1.24e-5)"	"unprognostic (1.04e-1)"	"unprognostic (9.12e-2)"	"unprognostic (3.94e-3)"	"unprognostic (2.00e-1)"	30.3	29.7	35.0	27.6	35.5	19.7	34.9	18.0	28.3	27.6	25.4	25.6	26.9	14.8	30.1	26.7	44.4	26.9	19.6	29.8	29.0	28.8	34.6	35.5	19.7	32.3	32.1	25.6	34.0	27.0	26.4	24.5	31.7	23.8	31.0	20.3	20.6	26.6	28.3	45.1	30.6	21.4	42.4	33.8	29.8	23.6	12.8	25.0	42.0	33.0	33.1	36.7	45.3	30.2	48.6	30.5	11.2	18.8	36.6	42.7	30.6	47.9	19.7	16.8	17.8	18.8	23.6	38.6	24.0	26.9	26.3	25.8	42.5	20.9	56.0	37.6	19.7	19.2	27.7	25.8	31.0	47.8	25.6	23.1	34.1	19.5	44.1	24.3	45.5	22.7	22.7	25.1	29.3	26.5	33.6	14.5	26.3	36.5	17.9	21.8	22.5	34.9	39.2	19.8	19.5	18.8	42.6	36.6	39.1	31.6	18.7	12.0	22.8	18.4	16.7	18.7	18.0	18.3	32.5	10.8	23.0	23.0	16.9	23.8	49.3	26.8	60.2	36.2	34.7	14.2	6.0	18.8	11.2	27.5	18.3	41.2	48.6	41.3	36.0	30.5	43.8	42.7	37.0	7.3	36.6	14.0	29.2	36.9	30.6	35.0	35.5	18.0	23.8	29.0	28.8	32.1	25.6	23.8	25.0	56.6	49.0	70.0	90.1	67.0	59.0	74.7	38.2	48.2	51.2	43.6	31.4	98.6	77.9	93.1	1.7	54.2	20.6	23.3	71.9	123.6	68.6	66.4	31.2	58.6	82.4	50.9	37.0	53.4	79.2	4.0	64.2	52.3	59.1	111.0	39.3	83.6	78.4	23.0	72.2	75.2	23.7	51.8	71.3	25.1	45.4	63.2	114.1	63.3	53.4	76.3
DARS2	FLJ10514	ENSG00000117593	"Aspartyl-tRNA synthetase 2, mitochondrial"	Q6PI48	1	173824503-173858546	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Protein biosynthesis"	"Aminoacyl-tRNA synthetase, Ligase"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Erythroid cells: 23.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA026506, HPA026528"	Enhanced		Supported	Nucleoplasm,Mitochondria		NA	NA			Mitochondria	Nucleoplasm	"HPA026506: AB_1847482, HPA026528: AB_1847483"	"unprognostic (3.14e-2)"	"unprognostic (1.52e-1)"	"unprognostic (1.06e-1)"	"unprognostic (8.85e-3)"	"unprognostic (1.33e-1)"	"unprognostic (1.14e-2)"	"unprognostic (1.05e-3)"	"unprognostic (4.10e-3)"	"unprognostic (2.20e-1)"	"unprognostic (1.42e-1)"	"unprognostic (6.17e-2)"	"unprognostic (1.15e-1)"	"prognostic favorable (1.74e-4)"	"unprognostic (3.30e-1)"	"unprognostic (1.90e-1)"	"unprognostic (1.13e-1)"	"unprognostic (4.73e-3)"	17.0	22.2	6.3	10.1	8.1	5.4	9.0	7.5	8.6	7.8	15.1	6.7	8.3	11.7	10.4	6.1	13.4	6.4	5.9	11.2	5.5	6.0	21.9	14.8	8.2	11.0	6.4	4.2	9.5	14.9	18.1	15.3	10.9	10.0	8.5	16.6	10.2	10.2	6.2	10.6	6.0	16.1	6.2	9.0	11.4	11.3	8.4	6.9	26.1	12.2	6.3	12.5	9.7	8.1	9.3	9.0	4.8	10.7	5.0	9.3	5.2	29.0	19.4	12.1	7.5	9.2	13.1	15.5	12.8	10.6	18.5	14.2	18.2	26.1	15.7	17.5	10.2	12.2	29.8	33.4	21.6	25.3	17.9	16.4	13.6	9.7	12.6	9.0	11.5	12.4	9.5	9.9	18.7	19.1	5.9	18.4	11.9	27.5	12.4	15.4	8.0	14.6	6.5	23.4	32.5	17.4	17.2	15.4	28.9	16.8	9.7	15.9	14.5	14.0	31.3	20.2	19.0	32.8	15.2	8.1	9.5	15.0	13.1	20.4	9.7	24.5	18.2	5.5	12.7	20.5	4.4	7.0	4.8	6.6	10.7	9.3	9.3	7.2	5.8	9.0	7.3	7.7	4.8	0.7	5.0	7.4	3.7	5.1	5.2	6.3	8.1	7.5	8.6	5.5	6.0	6.4	4.2	10.0	6.9	3.0	1.9	4.3	3.6	1.5	2.2	10.5	7.6	1.4	3.4	5.2	0.0	7.3	6.6	3.9	1.9	3.2	4.5	23.3	2.3	13.0	3.4	2.3	5.7	4.3	8.9	3.2	4.1	1.3	3.5	1.0	2.8	5.0	1.7	6.4	5.0	2.4	3.6	0.0	1.4	6.4	2.7	0.0	2.3	5.7	6.4	1.4	3.5	2.9	6.0	2.5
DBH	DBM	ENSG00000123454	"Dopamine beta-hydroxylase"	P09172	9	133636360-133659344	"Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"	"Catecholamine biosynthesis"	"Monooxygenase, Oxidoreductase"	"Disease mutation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	9	"adrenal gland: 86.6;brain: 36.2;liver: 35.6"	"Cell type enriched"	"Detected in single"	43	"Ito cells: 17.2"	"Low cancer specificity"	"Detected in some"			"Region enriched"	"Detected in single"	45	"pons and medulla: 36.2"	"Cell type enhanced"	"Detected in single"		"naive CD4 T-cell: 2.0"	"Lineage enriched"	"Detected in single"	21	"T-cells: 2.0"	"Cell line enriched"	"Detected in single"	340	"SH-SY5Y: 206.1"	"Region enriched"	"Detected in some"	6	"pons and medulla: 23.2"	"Region enriched"	"Detected in single"	38	"pons and medulla: 25.1"	"HPA002130, HPA005960, HPA070789"	Enhanced		Supported	"Endoplasmic reticulum,Vesicles"	"Intracellular and membrane"	NA	NA		2000000000	Vesicles	"Endoplasmic reticulum"	"HPA002130: AB_2666554, HPA005960: AB_1078628, HPA070789: AB_2686312"	"unprognostic (1.93e-3)"	"unprognostic (7.52e-3)"	"unprognostic (8.53e-2)"	"unprognostic (2.10e-2)"	"unprognostic (2.18e-3)"	"unprognostic (3.38e-3)"	"unprognostic (3.39e-3)"	"unprognostic (3.97e-2)"	"unprognostic (1.71e-1)"	"unprognostic (8.99e-2)"	"unprognostic (5.80e-2)"	"unprognostic (7.69e-2)"	"unprognostic (2.81e-7)"	"unprognostic (9.31e-2)"	"unprognostic (6.77e-2)"	"unprognostic (1.49e-2)"	"unprognostic (5.06e-3)"	0.7	86.6	0.1	0.3	0.1	0.0	0.0	0.1	0.8	0.3	0.0	1.9	0.7	0.1	0.1	0.0	0.0	0.1	0.1	0.1	0.0	0.1	0.5	35.6	0.3	0.6	0.0	0.0	0.1	1.3	0.0	0.6	0.4	36.2	0.8	0.0	1.0	0.2	5.9	0.0	0.0	0.2	0.0	1.4	0.4	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.8	0.5	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.6	0.5	0.0	0.0	0.2	206.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.8	0.0	0.1	0.0	0.0	36.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	17.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
DBT		ENSG00000137992	"Dihydrolipoamide branched chain transacylase E2"	P11182	1	100186919-100249834	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		"Acyltransferase, Transferase"	"Disease mutation, Maple syrup urine disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Cardiomyocytes: 62.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA026481, HPA026485, HPA026533"	Enhanced		Supported	Mitochondria		NA	NA			Mitochondria		"HPA026481: AB_1847504, HPA026485: AB_1847505, HPA026533: AB_1847506"	"unprognostic (1.23e-1)"	"unprognostic (1.23e-1)"	"unprognostic (3.67e-2)"	"unprognostic (5.29e-2)"	"unprognostic (1.92e-2)"	"unprognostic (1.63e-1)"	"unprognostic (3.88e-2)"	"unprognostic (1.65e-2)"	"unprognostic (6.01e-2)"	"unprognostic (1.21e-1)"	"unprognostic (2.37e-2)"	"unprognostic (2.90e-1)"	"prognostic favorable (8.79e-12)"	"unprognostic (1.63e-1)"	"unprognostic (3.77e-1)"	"unprognostic (9.67e-2)"	"unprognostic (9.92e-2)"	8.6	14.1	8.3	5.0	13.6	3.9	8.7	8.0	11.8	8.5	7.8	7.9	13.6	6.6	9.8	6.6	13.6	8.6	5.2	18.1	8.6	7.3	22.2	29.1	8.0	5.3	10.2	8.2	9.1	13.7	10.2	12.3	7.3	9.4	12.0	7.6	5.2	11.3	8.3	15.7	8.1	5.8	11.2	8.6	6.0	12.6	5.7	8.2	9.6	13.0	8.7	6.3	12.8	7.7	4.4	2.6	3.3	3.1	4.0	5.0	2.1	11.7	5.8	5.3	10.8	11.7	10.3	12.4	8.0	6.5	7.2	8.7	12.0	4.5	10.7	11.7	4.8	4.6	10.5	11.8	8.5	9.0	11.2	6.8	7.7	11.1	5.9	10.1	10.1	3.7	10.0	9.4	5.9	9.3	6.5	6.7	10.0	12.4	11.7	5.7	2.7	8.4	3.3	11.2	7.8	11.5	8.2	19.4	8.0	7.9	10.6	9.4	5.8	17.8	15.9	13.4	9.8	12.5	6.3	7.7	7.1	4.7	9.1	7.2	8.2	8.3	5.5	8.4	6.2	3.1	3.3	2.2	1.8	4.9	3.1	5.0	4.4	4.4	4.2	2.2	4.1	4.5	4.2	2.1	4.0	2.7	2.6	3.4	2.1	8.3	13.6	8.0	11.8	8.6	7.3	10.2	8.2	9.4	8.2	20.8	28.4	16.7	5.9	6.1	21.3	62.5	20.4	16.0	9.1	12.2	37.3	16.0	43.1	8.1	0.6	6.7	8.1	0.0	7.2	10.3	7.5	7.4	2.3	43.1	7.4	14.3	8.7	10.4	7.5	0.9	14.1	7.8	3.3	6.4	12.5	15.6	6.7	3.5	19.8	26.5	20.8	6.5	8.1	2.4	5.5	6.4	6.9	10.0	12.7	4.6
DCAF1	"KIAA0800, MGC102804, VPRBP"	ENSG00000145041	"DDB1 and CUL4 associated factor 1"	Q9Y4B6	3	51395867-51500002	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction, Transcription, Transcription regulation, Ubl conjugation pathway"	"Chromatin regulator, Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Alveolar cells type 2: 8.8;Ciliated cells: 9.4;Club cells: 12.5;Syncytiotrophoblasts: 8.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036142, HPA052445, HPA053203"	Approved		Supported	"Nucleoplasm,Nucleoli fibrillar center"		No	No			Nucleoplasm	"Nucleoli fibrillar center"	"HPA036142: AB_10669666, HPA052445: AB_2681835, HPA053203: AB_2682080"	"unprognostic (7.51e-2)"	"unprognostic (3.19e-1)"	"unprognostic (3.71e-3)"	"unprognostic (1.26e-1)"	"unprognostic (5.15e-2)"	"unprognostic (9.75e-2)"	"unprognostic (2.58e-2)"	"unprognostic (1.24e-1)"	"unprognostic (8.75e-2)"	"unprognostic (2.15e-1)"	"unprognostic (2.89e-2)"	"unprognostic (2.21e-2)"	"prognostic favorable (7.45e-5)"	"unprognostic (5.49e-2)"	"unprognostic (5.00e-1)"	"unprognostic (6.81e-2)"	"unprognostic (1.64e-1)"	13.3	12.5	11.5	16.3	12.3	12.9	12.2	17.9	12.5	9.6	10.3	11.0	12.5	7.6	13.1	10.1	11.3	9.2	8.4	8.8	9.6	6.8	11.0	11.1	10.9	13.0	11.1	9.1	11.9	11.1	24.8	12.9	15.4	10.3	10.1	10.9	8.6	12.5	11.8	28.1	14.1	11.8	10.4	9.1	11.9	10.7	50.7	10.9	18.5	14.2	7.6	16.7	12.5	16.5	7.3	6.4	3.3	6.0	7.3	10.7	6.2	10.8	13.4	13.0	11.8	11.8	9.4	12.4	12.2	9.2	13.2	13.0	14.6	10.6	26.5	6.8	9.6	20.3	9.6	24.5	10.9	17.2	18.4	12.1	22.7	18.3	12.5	8.6	29.5	16.5	6.2	12.7	17.1	12.5	8.7	10.2	14.7	13.2	17.3	10.3	11.1	22.5	12.0	13.7	13.0	14.7	9.6	14.0	17.5	10.3	17.0	6.8	12.1	13.5	12.5	7.4	10.0	8.5	12.6	12.8	10.9	14.6	17.9	18.7	11.8	15.9	27.3	12.7	20.3	8.9	3.2	4.0	3.3	9.4	4.5	10.7	7.1	8.1	8.0	6.4	7.3	8.9	7.3	1.0	7.3	6.0	5.2	8.7	6.2	11.5	12.3	17.9	12.5	9.6	6.8	11.1	9.1	10.3	10.9	3.0	8.8	0.0	0.0	0.0	0.0	0.0	0.0	9.4	12.5	3.5	0.0	6.6	1.7	5.9	0.0	0.0	0.0	0.0	5.8	4.8	0.0	0.0	5.8	0.0	6.3	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.0	4.6	0.0	0.0	6.5	0.0	0.0	5.4	0.0	0.0	0.0	0.0	0.0	0.0	8.8	0.0	0.0	0.0
DCK		ENSG00000156136	"Deoxycytidine kinase"	P27707	4	70992538-71030914	"Enzymes, FDA approved drug targets, Predicted intracellular proteins"		"Kinase, Transferase"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 80.9"	"Cell type enhanced"	"Detected in many"	9	"Erythroid cells: 186.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"Daudi: 60.9;U-698: 49.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA059609, HPA062773"	Enhanced		Supported	Nucleoplasm		NA	NA			Nucleoplasm		"HPA059609: AB_2684082, HPA062773: AB_2684865"	"unprognostic (9.16e-2)"	"unprognostic (2.44e-1)"	"unprognostic (5.24e-3)"	"unprognostic (4.77e-2)"	"unprognostic (3.95e-1)"	"unprognostic (6.45e-2)"	"prognostic unfavorable (6.90e-7)"	"unprognostic (3.04e-2)"	"unprognostic (7.19e-2)"	"unprognostic (8.28e-2)"	"unprognostic (4.51e-1)"	"unprognostic (1.33e-1)"	"unprognostic (3.37e-2)"	"unprognostic (4.47e-2)"	"unprognostic (6.82e-2)"	"unprognostic (1.33e-1)"	"unprognostic (2.27e-2)"	8.0	8.3	11.9	30.9	16.8	17.2	6.9	11.4	14.8	5.6	8.6	10.4	2.6	7.6	7.5	4.4	8.8	5.5	6.1	5.5	12.3	13.1	5.8	4.8	9.7	42.8	11.7	10.3	6.0	5.0	3.6	4.2	7.9	11.1	5.9	10.4	6.4	6.3	4.0	6.8	7.9	12.4	7.5	17.6	17.5	8.2	5.6	8.6	80.9	8.3	3.8	39.9	9.5	6.5	27.9	34.2	17.5	12.7	18.5	24.9	25.1	6.7	4.5	9.9	5.9	3.1	5.5	5.7	17.5	6.5	13.9	11.6	2.9	14.8	60.9	7.6	7.2	8.1	3.9	8.8	5.5	18.8	12.9	5.4	12.6	5.2	4.6	3.2	25.1	16.3	2.7	6.7	8.4	5.1	6.8	7.9	17.3	5.0	23.2	15.8	3.9	31.0	9.9	4.7	11.5	5.5	26.4	20.1	4.8	6.9	4.7	8.8	9.4	6.6	12.9	7.7	4.7	5.8	13.2	6.3	15.7	11.8	13.1	9.4	8.8	5.8	49.4	10.9	15.7	11.6	13.1	10.7	17.5	16.2	12.7	20.3	27.9	21.8	20.0	14.3	26.4	23.4	23.5	5.4	18.5	12.1	34.2	24.9	25.1	11.9	16.8	11.4	14.8	12.3	13.1	11.7	10.3	11.1	8.6	0.0	11.3	75.5	8.0	38.1	13.6	4.6	7.6	1.4	3.4	12.2	5.9	9.8	24.9	17.7	0.4	14.3	9.0	186.9	5.6	16.0	12.9	9.5	23.0	5.3	33.7	17.5	20.2	21.5	48.3	1.1	7.8	41.6	43.9	68.5	17.2	14.3	8.9	7.0	9.6	6.1	8.2	6.5	20.6	34.4	28.8	37.9	3.8	61.7	14.3	6.2
DCLK1	"DCAMKL1, DCDC3A, DCLK, KIAA0369"	ENSG00000133083	"Doublecortin like kinase 1"	O15075	13	35768652-36131306	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Differentiation, Neurogenesis"	"Developmental protein, Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"brain: 76.5"	"Cell type enriched"	"Detected in many"	4	"Muller glia cells: 84.2"	"Cancer enhanced"	"Detected in many"		"glioma: 12.4"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC diff: 16.7;ASC TERT1: 15.8;fHDF/TERT166: 12.9;GAMG: 19.8;HAP1: 10.0;HSkMC: 14.6;NTERA-2: 20.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB012405, HPA015040, HPA015655"	Enhanced		Approved	Nucleoplasm,Cytosol		NA	NA		11000	Nucleoplasm	Cytosol	"CAB012405: , HPA015040: AB_2669141, HPA015655: AB_2669265"	"unprognostic (2.29e-1)"	"unprognostic (2.56e-1)"	"unprognostic (7.45e-2)"	"unprognostic (1.30e-2)"	"unprognostic (1.99e-1)"	"unprognostic (2.35e-2)"	"unprognostic (1.48e-1)"	"unprognostic (3.30e-2)"	"unprognostic (1.66e-1)"	"unprognostic (1.74e-1)"	"unprognostic (7.72e-2)"	"unprognostic (2.85e-1)"	"prognostic unfavorable (4.42e-4)"	"unprognostic (1.93e-3)"	"unprognostic (1.29e-1)"	"unprognostic (1.34e-1)"	"unprognostic (1.14e-4)"	13.9	3.3	14.3	4.2	25.0	1.1	8.6	8.6	76.5	12.2	3.5	8.6	0.5	2.0	6.4	5.8	5.8	3.3	7.1	5.8	21.9	21.9	1.9	1.2	3.0	4.3	11.9	22.5	6.4	2.1	1.5	7.4	1.1	13.9	4.7	4.4	0.5	2.5	4.7	1.9	4.7	2.7	17.0	10.4	4.6	2.5	2.2	8.5	0.0	2.1	1.4	2.9	5.0	3.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	3.8	0.0	16.7	15.8	0.0	0.1	0.2	0.1	0.1	0.0	0.0	0.0	0.0	12.9	19.8	0.0	10.0	0.2	0.0	0.0	0.6	0.0	0.4	0.0	0.6	0.0	0.0	14.6	7.3	0.3	0.2	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	20.7	0.0	0.2	0.0	1.1	0.0	0.5	0.0	4.1	2.5	0.0	0.0	1.2	6.1	0.0	0.0	0.0	0.0	3.4	4.3	0.7	0.1	0.0	0.0	1.4	0.0	3.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.3	25.0	8.6	45.8	21.9	21.9	11.9	22.5	13.9	8.5	8.9	1.1	0.0	1.0	13.5	2.2	5.1	0.0	4.0	4.5	3.5	3.9	0.0	0.0	0.0	1.3	2.9	0.0	0.0	0.0	0.0	9.3	0.5	0.0	0.0	0.1	9.5	0.0	0.6	0.3	0.9	19.2	0.0	13.5	0.0	0.0	84.2	0.3	0.0	3.9	0.2	2.1	6.5	16.8	1.6	0.7	8.4	0.0	0.0	0.0	1.3
DCLK2	"DCAMKL2, DCDC3, DCDC3B, DCK2, MGC45428"	ENSG00000170390	"Doublecortin like kinase 2"	Q8N568	4	150078274-150257457	"Enzymes, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"brain: 60.5"	"Cell type enhanced"	"Detected in many"	10	"Bipolar cells: 18.2;Cone photoreceptor cells: 15.7;Horizontal cells: 33.4;Muller glia cells: 39.2"	"Cancer enriched"	"Detected in many"	17	"glioma: 53.3"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"naive B-cell: 2.5;plasmacytoid DC: 1.5"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"AF22: 18.6;BJ: 8.4;BJ hTERT+: 19.4;fHDF/TERT166: 8.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA015770	Enhanced	Approved				NA	NA					"HPA015770: AB_1847509"	"unprognostic (7.37e-2)"	"unprognostic (1.56e-3)"	"unprognostic (9.30e-2)"	"unprognostic (1.49e-2)"	"unprognostic (4.06e-1)"	"unprognostic (6.24e-3)"	"unprognostic (1.90e-1)"	"unprognostic (7.38e-3)"	"unprognostic (2.18e-1)"	"prognostic favorable (3.25e-4)"	"prognostic favorable (2.48e-4)"	"unprognostic (6.87e-2)"	"unprognostic (3.93e-3)"	"unprognostic (3.74e-3)"	"unprognostic (4.53e-2)"	"unprognostic (1.48e-1)"	"unprognostic (1.45e-2)"	2.9	3.9	23.3	2.1	23.5	1.6	2.0	9.3	60.5	3.1	2.8	16.5	0.8	2.8	4.3	3.5	3.0	2.8	4.0	14.4	23.5	17.5	2.9	1.8	2.7	1.6	14.9	14.5	4.3	3.5	1.4	4.7	2.9	20.2	3.9	3.5	2.1	2.0	3.6	2.3	2.1	2.7	6.4	23.4	2.1	2.2	4.2	15.9	0.0	4.1	0.0	1.5	3.3	2.0	2.5	1.5	0.0	0.5	0.0	0.0	0.0	0.8	3.2	18.6	2.9	0.0	0.9	0.3	8.4	19.4	2.8	0.6	0.1	0.0	0.0	0.3	8.5	2.8	0.0	2.7	0.0	3.5	3.8	1.6	0.0	4.9	0.0	4.0	0.5	0.5	0.5	0.0	1.7	0.2	1.7	0.9	0.5	0.0	0.0	1.9	0.1	0.3	0.0	0.4	0.2	1.0	0.0	2.1	0.7	0.0	0.8	7.1	6.8	3.5	2.6	0.8	1.6	0.0	0.0	1.6	2.6	1.0	1.7	0.9	0.8	0.0	0.0	2.4	0.1	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.3	2.5	0.0	0.0	0.0	0.0	0.5	1.5	0.0	0.0	23.3	23.5	9.3	19.3	23.5	17.5	14.9	14.5	20.2	15.9	0.0	0.0	0.0	0.1	0.5	18.2	9.1	2.5	0.0	1.2	3.5	15.7	0.0	0.0	0.3	0.0	5.6	0.0	0.0	0.6	0.0	2.2	0.9	4.6	0.0	1.3	33.4	2.9	8.6	0.0	0.0	1.7	1.0	5.0	0.0	0.2	39.2	0.2	0.0	3.5	0.3	8.9	12.9	4.1	0.1	0.2	0.5	0.2	0.0	1.3	0.1
DCLK3	"DCAMKL3, DCDC3C, KIAA1765"	ENSG00000163673	"Doublecortin like kinase 3"	Q9C098	3	36712422-36764349	"Enzymes, Predicted membrane proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"brain: 10.0;testis: 8.0"	"Cell type enriched"	"Detected in some"	5	"Early spermatids: 24.4"	"Cancer enhanced"	"Detected in single"		"testis cancer: 1.2"	"Region enhanced"	"Detected in many"		"basal ganglia: 10.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"NTERA-2: 3.4;SCLC-21H: 3.3;SH-SY5Y: 2.7;U-2 OS: 1.9;U-2197: 2.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA040685	Approved					NA	NA					"HPA040685: AB_2732487"	"unprognostic (9.09e-3)"	"unprognostic (1.41e-3)"	"unprognostic (2.75e-1)"	"unprognostic (2.66e-2)"	"unprognostic (2.41e-1)"	"unprognostic (1.80e-1)"	"unprognostic (1.40e-2)"	"unprognostic (1.08e-2)"	"unprognostic (1.96e-2)"	"unprognostic (1.86e-2)"	"unprognostic (2.05e-1)"	"unprognostic (7.07e-2)"	"unprognostic (6.11e-5)"	"unprognostic (7.94e-3)"	"unprognostic (5.80e-2)"	"unprognostic (3.25e-3)"	"unprognostic (1.36e-2)"	1.1	0.4	2.6	1.4	10.0	0.3	0.1	0.1	2.3	0.5	0.2	0.3	0.0	0.5	0.3	0.1	0.1	0.2	0.6	0.9	1.4	0.9	0.0	0.1	0.3	0.2	0.6	0.0	0.0	0.2	0.4	1.8	1.1	0.4	0.3	0.3	1.3	1.7	0.2	2.7	0.4	0.4	0.9	0.7	0.1	0.0	8.0	3.2	0.0	0.9	0.0	0.3	0.5	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.2	0.9	0.0	3.4	0.0	0.0	0.0	0.0	0.0	0.0	0.2	3.3	2.7	0.1	0.3	0.0	0.2	0.0	0.4	0.3	0.0	1.9	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	2.6	10.0	0.1	2.3	1.4	0.9	0.6	0.0	0.4	3.2	0.0	0.0	0.0	0.0	0.0	5.0	1.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	24.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	5.2	0.3	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	1.7	0.0	0.7	0.7	0.2	0.0	0.0	0.0	0.0	0.0
DCP2	NUDT20	ENSG00000172795	"Decapping mRNA 2"	Q8IU60	5	112976702-113020970	"Enzymes, Predicted intracellular proteins"	"Nonsense-mediated mRNA decay"	"Hydrolase, RNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 52.9"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB011677, HPA057676"	Approved		Approved	"Nucleoplasm,Cell Junctions,Cytoplasmic bodies"		NA	NA			"Nucleoplasm, Cytoplasmic bodies"	"Cell Junctions"	"CAB011677: AB_731858, HPA057676: AB_2683500"	"unprognostic (2.76e-1)"	"unprognostic (3.27e-1)"	"unprognostic (2.79e-1)"	"unprognostic (3.09e-1)"	"unprognostic (1.28e-1)"	"unprognostic (3.86e-3)"	"prognostic unfavorable (4.84e-4)"	"unprognostic (1.87e-1)"	"unprognostic (3.64e-2)"	"unprognostic (6.26e-2)"	"unprognostic (1.15e-1)"	"unprognostic (9.30e-2)"	"prognostic unfavorable (2.66e-5)"	"unprognostic (8.39e-2)"	"unprognostic (2.84e-1)"	"unprognostic (3.25e-2)"	"unprognostic (5.75e-2)"	8.0	7.5	8.1	16.3	9.5	22.9	15.0	16.8	10.9	9.1	6.6	6.4	6.6	6.3	10.5	6.8	7.4	8.0	6.5	6.1	8.1	8.9	8.1	8.1	13.2	19.8	6.9	6.1	12.8	6.2	7.0	12.2	40.2	8.3	8.1	7.3	6.5	9.6	8.6	8.3	9.8	8.7	7.3	7.4	19.9	6.7	6.8	6.5	52.9	7.0	4.1	20.0	8.7	9.1	5.1	6.5	16.3	8.3	3.9	5.9	3.2	3.6	3.1	14.1	11.3	2.8	3.1	22.8	3.3	2.7	4.2	6.1	14.6	7.8	19.1	5.3	1.9	3.4	4.5	16.2	4.5	5.1	5.1	7.0	17.9	2.7	5.8	3.2	10.9	9.3	2.9	3.1	5.1	5.1	4.0	7.1	14.7	13.2	7.5	3.8	4.6	16.0	11.6	12.2	2.2	1.9	15.7	13.4	7.1	6.5	9.3	3.3	7.0	4.6	5.2	6.7	15.3	15.4	14.6	4.6	4.7	8.4	2.4	5.0	5.1	11.2	14.6	2.7	15.3	3.6	12.2	7.2	5.5	4.0	7.1	5.5	5.1	4.9	4.2	6.5	3.6	4.6	4.7	16.3	3.9	8.3	3.5	5.9	3.2	8.1	9.5	16.8	10.9	8.1	8.9	6.9	6.1	8.3	6.5	17.9	15.6	38.9	16.7	24.6	21.6	11.4	5.1	18.7	22.7	19.2	74.6	53.4	16.6	8.9	23.5	21.8	10.0	0.0	10.3	41.1	27.2	25.6	18.5	5.9	27.7	27.0	15.5	27.6	71.2	42.2	17.5	46.5	25.3	36.9	9.1	34.4	12.8	10.5	10.3	11.2	35.2	6.5	17.9	29.3	19.0	23.2	53.9	38.8	11.3	37.6
DCPS	"HINT-5, HSL1, HSPC015"	ENSG00000110063	"Decapping enzyme, scavenger"	Q96C86	11	126303752-126345749	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	Hydrolase	"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"OE19: 51.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039632, HPA058597"	Supported		Supported	Nucleoplasm,Cytosol		NA	NA		1400000	Nucleoplasm	Cytosol	"HPA039632: AB_10794200, HPA058597: AB_2683770"	"unprognostic (1.45e-1)"	"unprognostic (5.48e-3)"	"unprognostic (1.76e-1)"	"unprognostic (3.55e-2)"	"unprognostic (5.22e-2)"	"unprognostic (1.26e-1)"	"unprognostic (1.96e-1)"	"unprognostic (2.90e-1)"	"unprognostic (5.57e-2)"	"unprognostic (1.91e-2)"	"unprognostic (4.83e-2)"	"unprognostic (5.00e-2)"	"unprognostic (5.25e-2)"	"unprognostic (2.24e-2)"	"unprognostic (8.04e-2)"	"unprognostic (7.67e-2)"	"unprognostic (3.40e-2)"	11.1	13.1	6.8	14.4	8.2	13.5	9.2	8.5	14.5	12.1	10.6	6.8	8.0	7.8	12.4	9.6	14.4	9.9	13.9	10.9	5.5	6.1	13.3	39.6	9.9	18.5	6.3	5.8	11.8	17.2	7.0	9.5	14.1	6.8	12.7	11.7	13.3	17.4	9.4	21.8	11.3	9.7	11.3	7.1	21.9	9.6	13.4	6.5	22.0	12.7	18.5	22.1	15.1	9.8	13.2	39.5	3.2	14.3	7.8	14.6	7.1	9.5	6.0	7.5	12.4	5.8	7.8	6.3	5.1	7.5	7.8	7.9	11.3	19.7	13.0	19.2	8.1	5.1	11.2	10.6	16.0	5.2	24.7	5.7	19.1	6.8	9.8	12.6	20.5	17.3	7.9	10.1	9.9	13.5	3.9	10.4	10.9	7.7	22.4	8.5	13.8	13.0	23.5	5.2	51.3	20.6	9.1	11.0	24.8	7.5	10.7	9.7	7.4	15.4	12.6	9.3	4.7	21.4	12.8	6.6	12.2	5.7	5.8	9.5	9.0	8.3	13.5	3.5	35.5	30.7	1.7	9.2	3.2	8.8	14.3	8.2	13.2	8.5	9.0	15.4	9.0	6.0	6.8	0.5	7.8	12.6	39.5	14.6	7.1	6.8	8.2	8.5	14.5	5.5	6.1	6.3	5.8	6.8	6.5	11.9	12.8	34.4	16.6	6.2	6.5	4.5	53.5	16.0	5.7	40.1	0.0	37.0	48.0	17.0	5.4	8.7	5.2	0.0	25.4	38.8	12.7	9.2	16.2	22.8	26.1	3.2	7.0	7.4	13.7	1.7	15.8	10.4	16.9	14.4	9.7	7.8	16.6	14.0	17.3	10.8	7.1	19.4	11.3	11.2	28.0	7.9	22.7	27.7	13.4	19.7
DCST1	FLJ32785	ENSG00000163357	"DC-STAMP domain containing 1"	Q5T197	1	155033824-155050930	"Enzymes, Predicted membrane proteins"	"Immunity, Innate immunity, Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in some"	7	"retina: 18.2;skin 1: 6.8;testis: 10.7"	"Cell type enhanced"	"Detected in some"	19	"Cone photoreceptor cells: 11.8;Early spermatids: 23.4;Late spermatids: 15.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"HaCaT: 4.9;HeLa: 4.1;RPMI-8226: 5.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA060314	Uncertain					NA	NA					"HPA060314: AB_2684250"	"unprognostic (1.44e-1)"	"unprognostic (7.66e-2)"	"unprognostic (3.77e-2)"	"unprognostic (1.05e-4)"	"unprognostic (3.58e-2)"	"unprognostic (8.75e-4)"	"unprognostic (1.46e-2)"	"unprognostic (2.66e-1)"	"unprognostic (6.01e-3)"	"unprognostic (2.22e-1)"	"unprognostic (6.62e-2)"	"unprognostic (1.89e-2)"	"unprognostic (8.33e-15)"	"unprognostic (7.77e-2)"	"unprognostic (2.22e-1)"	"unprognostic (2.38e-1)"	"unprognostic (1.23e-1)"	0.2	0.0	0.1	0.1	0.1	0.0	0.3	0.1	0.1	0.2	0.1	0.1	0.1	1.7	0.1	0.1	0.4	0.2	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.2	0.1	0.0	0.1	0.1	0.1	0.2	0.0	18.2	0.7	0.1	0.1	6.8	1.6	0.1	0.1	0.2	0.4	10.7	0.1	0.1	0.1	0.1	0.1	0.1	0.5	0.8	0.8	0.9	1.2	0.0	1.0	0.1	1.5	0.7	2.7	1.5	0.1	0.0	1.0	0.6	0.0	0.0	0.0	0.7	3.3	1.6	0.5	0.0	0.7	4.9	0.0	0.0	0.0	1.2	0.4	0.4	4.1	0.3	0.0	1.2	0.7	0.0	0.2	0.0	0.0	0.0	0.0	0.2	1.1	2.3	0.0	1.0	0.0	0.3	0.2	0.2	2.2	0.0	1.1	5.6	0.0	0.8	0.9	1.8	0.6	1.8	0.2	1.1	3.5	0.1	0.0	0.4	0.2	0.8	0.4	1.0	0.8	0.3	0.7	1.6	0.0	0.0	0.2	0.9	0.1	0.0	0.0	0.8	0.4	0.2	0.3	0.0	1.0	0.2	0.2	0.0	1.2	0.8	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.2	1.2	0.6	0.0	1.4	2.3	0.0	11.8	0.0	0.0	0.0	23.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.7	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	4.3	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0
DCT	TYRP2	ENSG00000080166	"Dopachrome tautomerase"	P40126	13	94436808-94479682	"Enzymes, Predicted membrane proteins"	"Melanin biosynthesis"	Isomerase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	58	"retina: 151.5;skin 1: 54.2"	"Cell type enriched"	"Detected in some"	25	"Melanocytes: 3369.1"	"Cancer enriched"	"Detected in some"	215	"melanoma: 155.5"	"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	259	"SK-MEL-30: 76.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA010742, HPA010743, HPA010800, CAB017634"	Enhanced		Supported	"Vesicles,Plasma membrane"		NA	NA			"Plasma membrane"	Vesicles	"CAB017634: AB_1130818, HPA010742: , HPA010743: AB_1847519, HPA010800: AB_1847520"	"unprognostic (5.99e-2)"	"unprognostic (1.67e-2)"	"unprognostic (1.54e-2)"	"unprognostic (3.17e-2)"	"unprognostic (2.45e-2)"	"unprognostic (3.35e-2)"	"unprognostic (2.15e-2)"	"unprognostic (2.81e-2)"	"unprognostic (6.07e-2)"	"unprognostic (1.81e-1)"	"unprognostic (3.64e-3)"	"unprognostic (1.06e-2)"	"unprognostic (6.18e-5)"	"unprognostic (6.97e-2)"	"unprognostic (9.87e-2)"	"unprognostic (1.22e-3)"	"unprognostic (2.42e-1)"	0.2	0.2	0.5	0.1	1.5	0.1	1.7	0.2	0.6	0.2	0.1	0.3	0.1	0.0	0.2	0.5	0.1	0.8	0.1	0.1	0.4	0.5	0.1	0.1	0.1	0.1	0.3	0.1	0.2	0.1	0.1	1.4	0.1	0.3	0.2	0.0	151.5	1.4	0.2	0.2	54.2	0.2	0.1	0.8	0.1	0.0	0.3	0.4	0.1	0.1	0.3	0.2	0.1	0.1	0.0	0.2	0.0	0.0	0.0	0.8	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	76.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.2	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.5	1.5	0.2	0.6	0.4	0.5	0.3	0.1	0.3	0.4	0.0	0.0	0.0	0.1	135.3	0.7	0.8	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	12.6	0.1	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	16.0	0.9	0.0	3369.1	0.0	0.0	2.4	0.0	0.0	0.7	0.0	0.2	0.0	0.9	0.5	0.2	29.2	0.0	0.0	0.0	0.0
DCTD		ENSG00000129187	"DCMP deaminase"	P32321	4	182890060-182917936	"Enzymes, Predicted intracellular proteins"	"Nucleotide biosynthesis"	"Allosteric enzyme, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA035894	Approved		Approved	Nucleoplasm,Cytosol		NA	NA		13000	"Nucleoplasm, Cytosol"		"HPA035894: AB_10673488"	"unprognostic (1.26e-1)"	"unprognostic (9.80e-3)"	"unprognostic (3.15e-2)"	"unprognostic (3.78e-3)"	"unprognostic (3.13e-3)"	"unprognostic (2.20e-2)"	"unprognostic (2.01e-2)"	"unprognostic (4.59e-3)"	"unprognostic (2.62e-2)"	"unprognostic (1.80e-1)"	"unprognostic (1.40e-2)"	"unprognostic (1.20e-1)"	"prognostic favorable (1.81e-4)"	"unprognostic (1.35e-1)"	"unprognostic (1.59e-1)"	"unprognostic (3.89e-2)"	"unprognostic (1.12e-1)"	24.8	46.2	24.7	19.9	23.8	12.9	27.3	11.6	28.3	27.1	20.4	17.3	22.6	16.4	26.0	20.1	30.9	25.9	40.9	25.8	22.5	22.2	25.7	47.6	25.8	29.4	21.1	20.3	35.9	51.7	28.3	25.3	18.9	21.3	23.7	21.5	30.0	26.4	22.8	24.8	19.4	19.1	27.4	25.6	24.9	27.2	11.8	16.7	15.0	52.9	21.3	26.0	24.5	25.1	31.9	24.8	23.7	25.7	30.8	36.8	22.7	22.7	21.0	21.4	19.8	32.4	44.3	28.1	43.9	39.2	31.5	19.5	21.3	44.2	7.9	10.9	42.7	21.5	11.3	15.6	27.4	29.0	38.3	11.8	36.5	12.2	25.3	34.8	35.5	22.9	36.8	29.2	27.6	28.8	31.9	26.9	17.5	36.2	79.2	41.8	16.6	23.0	21.7	17.0	9.2	18.3	25.1	15.3	15.3	25.4	27.3	21.2	13.1	20.7	17.9	20.5	20.8	13.7	18.6	31.3	26.2	20.2	12.6	33.4	30.4	16.4	10.1	28.9	23.3	30.8	23.7	22.0	19.7	29.2	25.7	36.8	31.9	25.6	29.7	24.8	21.7	25.5	26.7	1.6	30.8	24.9	19.1	21.9	22.7	24.7	23.8	11.6	28.3	22.5	22.2	21.1	20.3	21.3	16.7	11.9	15.0	31.7	28.8	22.6	4.3	20.6	38.2	18.7	11.4	31.4	3.9	16.6	31.5	61.9	6.3	32.1	15.5	23.3	47.4	19.9	41.7	29.4	22.0	38.0	48.4	3.2	13.9	25.2	29.6	13.2	40.9	29.6	25.3	38.7	28.6	31.5	60.2	10.5	33.2	34.1	6.3	32.3	28.2	9.3	15.4	20.1	6.1	27.4	29.9	34.5
DCTPP1	"CDA03, MGC5627, RS21C6, XTP3TPA"	ENSG00000179958	"DCTP pyrophosphatase 1"	Q9H773	16	30423619-30430075	"Enzymes, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA002832	Uncertain		Approved	Nucleoplasm,Cytosol		NA	Yes		270000	"Nucleoplasm, Cytosol"		"HPA002832: AB_1080615"	"prognostic unfavorable (1.64e-5)"	"unprognostic (1.61e-1)"	"unprognostic (1.99e-3)"	"unprognostic (1.17e-2)"	"unprognostic (1.36e-1)"	"unprognostic (4.09e-2)"	"prognostic unfavorable (6.28e-4)"	"unprognostic (2.23e-1)"	"unprognostic (1.07e-1)"	"unprognostic (4.35e-2)"	"unprognostic (2.43e-2)"	"unprognostic (3.65e-2)"	"prognostic favorable (9.71e-9)"	"unprognostic (1.10e-3)"	"unprognostic (8.78e-3)"	"unprognostic (1.10e-2)"	"unprognostic (2.53e-1)"	15.3	15.8	14.8	25.0	13.2	12.5	20.7	15.5	19.2	12.1	37.4	10.3	11.3	20.7	14.1	14.4	19.7	18.9	28.1	23.3	12.1	12.6	27.0	25.3	11.2	27.6	13.3	16.6	16.6	25.2	16.4	7.7	16.3	11.4	15.4	40.3	10.6	20.5	21.1	28.3	16.1	22.9	13.9	11.3	22.5	16.4	9.9	7.8	21.3	22.6	26.0	25.0	13.2	13.0	47.3	30.9	19.0	24.5	23.1	26.2	25.3	26.6	32.7	14.9	19.2	4.2	5.7	13.8	12.8	7.7	19.4	19.8	24.6	22.8	36.1	27.0	8.0	12.4	21.0	30.9	25.1	24.3	19.0	48.8	21.0	15.0	32.0	5.5	37.5	32.8	6.6	14.3	21.6	12.5	5.9	19.9	19.4	26.4	12.7	13.7	46.5	44.5	42.1	19.7	27.0	26.4	63.2	16.6	47.0	22.4	17.3	31.8	18.0	8.5	30.5	12.0	10.2	26.3	16.1	10.0	15.0	13.4	19.3	23.0	8.4	25.0	46.0	9.9	31.2	17.5	19.0	12.4	11.7	18.8	22.1	26.2	47.3	24.2	21.3	28.7	40.2	21.8	21.0	1.5	23.1	24.5	30.9	24.1	25.3	14.8	13.2	15.5	19.2	12.1	12.6	13.3	16.6	11.4	7.8	17.9	14.6	32.0	37.1	80.1	23.9	33.1	61.1	20.1	19.4	41.8	7.9	81.7	107.8	107.5	10.2	47.2	79.9	0.0	108.6	68.9	31.5	41.3	31.1	18.1	68.6	14.3	37.0	25.2	16.6	36.0	18.1	35.6	45.5	108.2	103.3	19.7	78.9	105.2	18.7	54.0	16.3	19.4	35.0	2.8	33.6	70.1	23.2	25.9	124.8	43.2
DCXR	"DCR, KIDCR, SDR20C1"	ENSG00000169738	"Dicarbonyl and L-xylulose reductase"	Q7Z4W1	17	82035136-82037732	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Carbohydrate metabolism, Glucose metabolism, Xylose metabolism"	Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	5	"liver: 293.8"	"Group enriched"	"Detected in all"	5	"Distal tubular cells: 688.1;Hepatocytes: 2593.4;Proximal tubular cells: 1817.7"	"Cancer enhanced"	"Detected in all"		"liver cancer: 305.9"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"Hep G2: 65.1;MCF7: 80.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023371, HPA023863"	Enhanced		Uncertain	Nucleoli,Microtubules		NA	NA		2700000	"Nucleoli, Microtubules"		"HPA023371: AB_1847530, HPA023863: AB_1847531"	"unprognostic (3.33e-2)"	"unprognostic (1.67e-3)"	"unprognostic (3.75e-1)"	"unprognostic (1.16e-2)"	"unprognostic (1.19e-1)"	"unprognostic (8.43e-2)"	"unprognostic (4.54e-3)"	"unprognostic (1.86e-2)"	"unprognostic (3.05e-1)"	"unprognostic (2.56e-2)"	"prognostic favorable (4.70e-4)"	"unprognostic (1.72e-1)"	"prognostic favorable (2.13e-4)"	"unprognostic (1.81e-1)"	"unprognostic (1.36e-1)"	"unprognostic (2.64e-1)"	"unprognostic (1.10e-2)"	12.7	6.1	12.8	4.3	12.1	5.7	12.2	9.0	15.1	9.9	9.5	8.4	18.1	7.8	4.4	62.7	11.7	6.1	4.8	11.8	9.8	9.7	50.8	293.8	10.5	5.3	14.4	7.3	8.1	13.0	6.7	7.2	9.0	13.4	22.3	5.4	7.8	19.3	14.0	22.5	8.6	6.8	3.6	8.4	4.4	14.9	8.7	9.7	8.3	15.6	12.6	9.1	7.5	6.4	32.8	52.7	25.3	33.1	35.2	43.7	35.8	8.9	12.4	5.7	10.3	23.1	5.8	15.2	4.6	6.0	12.7	8.7	21.8	3.9	18.6	9.0	6.4	1.6	10.6	10.4	9.3	4.4	3.9	26.8	17.8	9.3	65.1	24.7	13.7	21.9	8.4	11.5	4.0	14.6	2.7	7.1	11.1	20.2	13.6	6.7	80.0	11.4	32.8	6.6	40.3	13.1	10.5	7.7	24.2	9.4	12.8	16.0	9.4	6.5	55.1	8.0	3.6	41.3	13.5	3.6	6.7	8.4	9.1	8.6	13.9	10.2	8.8	5.8	15.0	4.9	13.9	33.1	25.3	24.7	30.6	23.6	28.6	30.8	23.6	52.7	32.8	43.7	31.9	16.5	35.2	28.0	42.5	33.1	35.8	12.8	12.1	9.0	15.1	9.8	9.7	14.4	7.3	13.4	9.7	47.6	155.8	118.2	185.0	52.0	15.8	102.4	124.9	20.1	28.4	169.3	17.7	343.4	688.1	41.9	5.1	35.2	135.9	23.3	37.0	376.5	68.0	203.5	64.5	2593.4	145.3	20.6	52.6	88.4	114.9	15.1	65.6	57.1	170.4	47.7	117.0	81.8	32.4	105.2	44.6	1817.7	18.5	19.4	66.5	6.6	48.3	64.0	286.5	126.9	129.4	155.9
DDAH1	DDAH	ENSG00000153904	"Dimethylarginine dimethylaminohydrolase 1"	O94760	1	85318481-85578363	"Enzymes, Plasma proteins, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 61.6"	"Cell type enhanced"	"Detected in many"	8	"Proximal tubular cells: 219.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"memory B-cell: 1.3;naive B-cell: 1.0"	"Lineage enhanced"	"Detected in single"		"B-cells: 1.3"	"Cell line enhanced"	"Detected in many"		"OE19: 36.9;SH-SY5Y: 35.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006308, HPA071064"	Enhanced		Approved	"Nucleoli,Plasma membrane,Cytosol"		NA	NA		140000	"Plasma membrane, Cytosol"	Nucleoli	"HPA006308: AB_1847532, HPA071064: "	"unprognostic (1.44e-2)"	"unprognostic (2.43e-1)"	"prognostic favorable (5.99e-4)"	"unprognostic (6.82e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.62e-2)"	"unprognostic (2.55e-1)"	"unprognostic (3.85e-2)"	"unprognostic (2.57e-1)"	"unprognostic (1.02e-2)"	"unprognostic (3.62e-2)"	"unprognostic (1.56e-1)"	"prognostic favorable (5.21e-6)"	"unprognostic (5.37e-2)"	"unprognostic (9.06e-2)"	"unprognostic (5.81e-2)"	"unprognostic (1.56e-2)"	4.3	14.3	43.9	5.8	44.9	0.7	6.6	14.4	37.2	7.7	22.1	20.7	4.3	21.1	6.0	33.8	4.9	18.4	12.2	6.4	29.5	24.1	61.6	39.9	11.8	1.1	24.9	37.0	3.4	13.8	13.0	7.2	3.1	13.8	13.1	21.4	4.1	8.5	6.2	13.8	2.8	19.9	7.4	8.1	4.1	15.6	9.3	11.0	0.0	14.1	1.0	1.2	6.0	3.0	1.3	0.4	0.0	0.0	0.0	0.0	0.0	18.3	2.3	6.5	1.2	10.9	9.2	0.8	21.7	13.2	7.7	8.2	26.1	4.9	0.0	9.1	24.6	7.6	5.3	23.5	4.5	9.9	0.0	9.0	0.0	6.2	9.1	3.9	16.7	1.0	7.7	0.4	6.5	4.1	9.8	12.3	0.0	0.0	1.8	19.8	1.5	0.8	0.0	7.8	36.9	6.8	0.0	15.2	0.2	33.0	13.7	18.3	35.6	2.8	16.5	2.6	9.7	8.9	1.2	24.0	6.8	5.5	1.6	15.1	0.0	0.0	0.0	0.3	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	43.9	44.9	14.4	37.2	29.5	24.1	24.9	37.0	13.8	11.0	32.8	31.3	4.2	4.0	12.2	2.7	11.4	68.8	30.8	13.6	66.3	3.9	1.7	106.1	15.6	17.1	4.5	78.7	0.0	26.7	0.8	23.5	37.8	0.0	94.3	0.9	0.0	32.8	9.2	2.2	18.4	14.7	1.5	11.8	1.0	77.8	59.7	34.2	73.6	70.4	219.6	8.0	12.9	18.9	5.0	5.6	12.5	0.7	3.3	85.4	6.5
DDAH2	G6A	ENSG00000213722	"Dimethylarginine dimethylaminohydrolase 2"	O95865	6	31727038-31730617	"Enzymes, Plasma proteins, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"ASC diff: 10.7;ASC TERT1: 13.4;EFO-21: 17.1;fHDF/TERT166: 10.6;SK-MEL-30: 10.7;U-2 OS: 12.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA012389, HPA012509"	Uncertain		Supported	Mitochondria		NA	NA		1800000	Mitochondria		"HPA012389: , HPA012509: AB_1847533"	"unprognostic (2.29e-2)"	"unprognostic (1.38e-1)"	"unprognostic (4.49e-2)"	"unprognostic (2.39e-1)"	"unprognostic (1.44e-1)"	"unprognostic (7.67e-2)"	"unprognostic (1.50e-2)"	"unprognostic (1.10e-1)"	"unprognostic (2.62e-1)"	"unprognostic (8.78e-2)"	"unprognostic (1.01e-1)"	"unprognostic (1.09e-1)"	"unprognostic (1.02e-1)"	"unprognostic (9.42e-2)"	"unprognostic (2.32e-1)"	"unprognostic (2.24e-2)"	"unprognostic (2.72e-2)"	24.3	7.8	12.5	11.1	10.3	5.5	22.7	3.1	7.8	32.1	17.0	7.9	12.9	2.6	34.6	22.0	18.4	18.1	26.7	20.7	11.8	10.8	16.9	12.9	37.4	16.5	10.6	6.6	22.5	4.3	3.0	6.2	13.7	13.1	19.8	5.4	13.0	18.1	13.2	6.8	15.1	22.3	27.1	18.9	21.4	11.4	7.3	9.9	14.1	35.4	17.1	8.9	16.3	23.4	2.9	5.5	8.0	2.7	2.3	0.5	0.3	0.4	6.6	0.2	1.4	10.7	13.4	0.7	0.6	0.3	0.4	0.1	4.4	0.7	0.2	17.1	10.6	0.0	0.8	0.0	6.2	0.0	0.1	9.0	0.5	0.5	0.1	0.3	0.9	0.0	8.6	0.1	0.8	0.1	0.7	0.1	9.7	0.2	2.3	0.0	3.6	0.5	2.5	0.1	1.4	0.2	0.3	0.5	0.0	7.6	0.7	0.4	1.0	0.3	0.0	10.7	0.7	0.7	0.9	1.2	0.8	12.7	0.2	0.1	2.7	9.3	2.5	7.4	1.5	0.2	8.0	0.8	7.7	0.5	2.6	0.3	2.9	0.2	0.3	1.5	2.5	0.1	0.1	1.3	2.3	2.7	5.5	0.4	0.3	12.5	10.3	3.1	7.8	11.8	10.8	10.6	6.6	13.1	9.9	26.8	17.1	39.8	83.5	59.4	4.0	32.5	38.2	33.5	17.0	78.5	27.5	13.7	150.9	113.3	87.7	94.4	114.4	0.0	28.5	24.3	96.9	77.4	109.8	27.2	186.9	0.0	143.9	57.7	101.8	14.7	167.1	97.2	97.8	79.4	47.6	79.4	71.2	98.2	143.9	116.9	22.9	103.5	127.7	2.6	12.4	51.8	15.1	33.1	63.1	53.8
DDC	AADC	ENSG00000132437	"Dopa decarboxylase"	P20711	7	50458436-50565457	"Disease related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins"	"Catecholamine biosynthesis"	"Decarboxylase, Lyase"	"Disease mutation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	7	"intestine: 90.1;kidney: 68.1"	"Group enriched"	"Detected in many"	5	"Intestinal endocrine cells: 394.4;Proximal tubular cells: 366.2;Rod photoreceptor cells: 456.4"	"Low cancer specificity"	"Detected in many"			"Group enriched"	"Detected in some"	4	"midbrain: 7.9;pons and medulla: 3.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	8	"CACO-2: 17.2;Hep G2: 15.1;OE19: 26.4;SCLC-21H: 43.6;SH-SY5Y: 45.3"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	10	"midbrain: 90.4;pons and medulla: 40.7"	HPA017742	Enhanced		Approved	"Actin filaments"		NA	NA		380000	"Actin filaments"		"HPA017742: AB_1847832"	"unprognostic (1.04e-1)"	"unprognostic (3.68e-2)"	"unprognostic (2.57e-2)"	"unprognostic (3.49e-5)"	"unprognostic (1.17e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.28e-1)"	"unprognostic (5.15e-2)"	"unprognostic (4.69e-2)"	"unprognostic (5.44e-2)"	"unprognostic (9.36e-3)"	"unprognostic (5.24e-2)"	"unprognostic (1.76e-3)"	"unprognostic (1.60e-1)"	"unprognostic (3.55e-1)"	"unprognostic (7.65e-2)"	"unprognostic (1.16e-1)"	0.3	10.9	0.3	3.0	0.7	0.0	0.3	0.3	0.4	0.3	36.7	0.4	0.3	33.5	0.3	1.8	0.3	0.0	0.7	0.3	0.3	1.3	68.1	11.7	0.7	0.3	7.9	0.3	0.4	9.8	0.0	0.3	0.3	3.4	0.4	8.1	0.4	0.3	0.3	0.3	0.1	90.1	0.3	0.3	0.3	4.3	0.6	0.5	0.3	0.3	0.4	0.3	0.4	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	17.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.1	0.0	0.0	3.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	26.4	0.0	0.0	0.0	0.2	0.4	0.0	43.6	45.3	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.7	0.3	0.4	0.3	1.3	7.9	0.3	3.4	0.5	0.0	9.8	0.8	0.0	0.0	81.1	0.4	5.1	0.0	1.2	3.5	39.3	0.0	21.6	0.0	3.6	0.0	72.8	0.0	0.7	0.1	0.0	0.4	0.0	58.7	0.1	3.2	394.4	1.3	1.3	4.3	0.0	0.0	0.0	0.0	30.4	24.1	0.2	26.6	0.0	366.2	456.4	0.0	0.0	3.6	0.4	0.0	0.1	0.0	46.0	0.0
DDO		ENSG00000203797	"D-aspartate oxidase"	Q99489	6	110391771-110415562	"Enzymes, Predicted membrane proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	8	"Cardiomyocytes: 14.1;Muller glia cells: 9.1;Proximal tubular cells: 9.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"intermediate monocyte: 4.9;myeloid DC: 7.3"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"GAMG: 10.9;RPMI-8226: 14.2;U-937: 15.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037525, HPA037526"	Enhanced		Enhanced	Cytosol		NA	NA			Cytosol		"HPA037525: AB_2675523, HPA037526: AB_10672352"	"unprognostic (1.37e-1)"	"unprognostic (1.54e-1)"	"unprognostic (6.51e-2)"	"unprognostic (1.30e-2)"	"unprognostic (2.00e-1)"	"unprognostic (3.28e-2)"	"unprognostic (3.71e-2)"	"unprognostic (1.01e-2)"	"unprognostic (2.05e-1)"	"unprognostic (2.91e-1)"	"unprognostic (6.97e-2)"	"unprognostic (1.43e-1)"	"prognostic favorable (8.69e-5)"	"unprognostic (3.51e-4)"	"unprognostic (3.36e-3)"	"unprognostic (1.27e-3)"	"unprognostic (9.06e-2)"	3.7	11.0	5.2	1.1	12.1	1.6	3.3	1.9	5.5	2.7	3.6	10.8	4.9	8.6	2.7	5.4	1.2	6.1	3.9	21.0	6.9	3.4	12.3	12.8	3.9	1.3	8.0	6.1	1.2	5.5	18.6	1.9	2.1	8.0	2.9	3.9	2.3	4.9	3.2	11.3	0.8	7.9	5.6	7.7	2.6	1.9	0.4	8.2	0.0	3.3	5.7	0.5	3.6	1.6	0.0	7.3	0.1	4.9	1.7	0.0	1.5	0.1	0.0	0.0	0.1	0.0	0.2	1.0	0.1	5.0	1.2	0.8	0.0	0.0	0.0	0.7	0.7	10.9	0.0	0.0	0.0	2.2	4.5	0.0	4.6	0.0	3.9	1.6	0.0	0.0	0.1	0.0	2.5	0.1	2.2	0.0	0.0	0.0	1.8	4.1	0.0	0.0	0.2	0.0	0.0	0.1	0.1	2.8	14.2	0.0	4.5	0.1	0.1	0.0	0.4	0.6	0.0	0.7	1.0	0.8	1.0	0.1	0.0	2.3	0.1	0.3	0.0	1.9	15.8	0.0	0.1	4.6	0.0	0.0	4.9	0.0	0.0	0.0	0.0	7.3	0.0	0.0	0.0	0.1	1.7	1.6	0.0	0.0	1.5	5.2	12.1	1.9	5.5	6.9	3.4	8.0	6.1	8.0	8.2	0.0	0.0	0.0	0.8	0.0	0.0	14.1	0.0	1.4	0.0	0.0	2.0	0.1	3.3	2.8	0.0	0.3	2.7	0.0	1.9	0.1	0.3	0.3	0.0	4.4	1.8	0.0	4.1	2.5	4.0	0.0	0.3	1.1	0.0	1.0	5.9	9.1	1.2	6.0	0.0	9.9	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	3.5	0.3
DDR1	"CAK, CD167, EDDR1, NEP, NTRK4, PTK3A, RTK6"	ENSG00000204580	"Discoidin domain receptor tyrosine kinase 1"	Q08345	6	30876421-30900156	"CD markers, Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Lactation, Pregnancy"	"Kinase, Receptor, Transferase, Tyrosine-protein kinase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Muller glia cells: 145.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HaCaT: 31.8;HBEC3-KT: 24.5;RT4: 32.5;T-47d: 36.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB010162, CAB025656, HPA057194"	Approved		Approved	"Nucleoplasm,Cell Junctions"	"Intracellular and membrane"	NA	NA		2100000	"Nucleoplasm, Cell Junctions"		"CAB010162: AB_2092090, CAB025656: , HPA057194: "	"unprognostic (2.11e-2)"	"unprognostic (9.31e-2)"	"unprognostic (1.01e-1)"	"unprognostic (1.09e-1)"	"unprognostic (2.07e-1)"	"unprognostic (7.75e-3)"	"unprognostic (6.43e-2)"	"unprognostic (1.92e-1)"	"unprognostic (1.73e-1)"	"unprognostic (1.42e-1)"	"unprognostic (1.50e-1)"	"unprognostic (4.41e-2)"	"prognostic favorable (3.31e-10)"	"unprognostic (1.42e-1)"	"unprognostic (2.53e-1)"	"unprognostic (5.49e-3)"	"unprognostic (4.09e-2)"	6.7	11.3	23.5	7.9	36.2	2.2	12.5	6.8	42.2	9.7	25.2	57.4	17.6	16.8	7.7	10.5	30.5	31.7	18.9	8.7	27.8	20.8	19.8	3.5	13.2	3.1	55.7	19.8	11.3	20.9	28.2	14.6	13.3	34.7	17.7	14.9	4.0	28.3	20.5	9.1	41.3	32.1	3.1	43.2	5.1	52.2	5.1	37.0	8.7	20.9	10.5	7.6	16.3	16.6	1.8	0.4	0.0	0.2	0.0	1.8	0.9	19.7	6.5	9.2	1.9	0.6	0.9	5.7	0.5	0.1	0.3	0.0	8.7	10.5	0.1	11.0	1.7	9.6	31.8	2.0	24.5	0.1	10.9	3.5	0.0	6.0	2.3	1.8	0.0	0.4	1.2	12.7	0.1	0.2	5.8	0.7	0.5	5.7	0.2	1.4	12.5	0.7	0.0	1.6	10.9	1.3	1.3	6.9	0.7	4.7	32.5	1.6	0.9	1.8	14.7	7.1	3.2	36.5	0.2	1.5	4.6	4.3	0.4	4.6	0.2	0.0	0.8	3.0	0.0	4.0	0.0	0.2	0.0	1.1	0.0	0.8	0.4	0.2	0.7	0.4	1.8	1.2	1.8	0.0	0.0	0.0	0.4	0.0	0.9	23.5	36.2	6.8	25.0	27.8	20.8	55.7	19.8	34.7	37.0	32.8	24.0	2.2	62.3	47.2	5.2	19.9	38.2	33.5	31.8	85.5	0.0	53.4	5.0	115.9	10.8	4.9	88.3	23.3	66.9	19.7	6.5	54.7	1.1	0.4	5.4	6.4	44.4	1.8	0.8	16.6	7.8	2.2	15.1	22.6	55.1	145.4	62.4	74.8	4.9	5.6	7.4	6.5	8.9	0.7	4.5	45.4	38.9	0.0	54.4	76.8
DDR2	"NTRKR3, TKT, TYRO10"	ENSG00000162733	"Discoidin domain receptor tyrosine kinase 2"	Q16832	1	162631373-162787400	"Cancer-related genes, CD markers, Disease related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins"	Osteogenesis	"Kinase, Receptor, Transferase, Tyrosine-protein kinase"	"Cancer-related genes, Disease mutation, Dwarfism, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	8	"Fibroblasts: 84.7;Leydig cells: 58.4;Peritubular cells: 83.1;Smooth muscle cells: 68.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"gdT-cell: 1.1;MAIT T-cell: 1.3"	"Lineage enriched"	"Detected in single"	5	"T-cells: 1.3"	"Cell line enhanced"	"Detected in many"		"ASC diff: 61.7;ASC TERT1: 61.0;BJ hTERT+: 45.1;fHDF/TERT166: 32.3;HSkMC: 43.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA070112			Supported	"Plasma membrane,Actin filaments"		Yes	No		850000	"Plasma membrane, Actin filaments"		"HPA070112: AB_2686229"	"unprognostic (4.12e-2)"	"unprognostic (2.73e-1)"	"unprognostic (6.97e-3)"	"unprognostic (4.52e-2)"	"unprognostic (1.17e-1)"	"unprognostic (8.16e-2)"	"unprognostic (1.81e-1)"	"unprognostic (1.19e-1)"	"unprognostic (6.62e-2)"	"unprognostic (2.24e-2)"	"unprognostic (1.00e-1)"	"unprognostic (1.15e-1)"	"prognostic unfavorable (1.73e-7)"	"unprognostic (1.56e-3)"	"unprognostic (8.26e-3)"	"unprognostic (7.57e-2)"	"unprognostic (4.10e-3)"	42.1	43.5	4.7	10.9	6.9	0.2	15.6	7.9	7.1	30.3	30.4	9.0	18.6	3.3	24.2	17.7	25.0	13.4	16.6	15.4	7.9	4.7	4.0	3.3	8.9	5.1	12.9	3.4	26.4	2.2	2.1	4.0	6.6	12.7	21.8	9.1	30.7	6.4	19.3	5.2	6.1	10.1	34.3	19.7	3.4	14.1	8.3	7.5	0.0	8.6	12.8	4.1	29.0	18.3	0.1	0.2	0.0	0.0	0.2	1.3	0.0	0.1	0.0	0.0	16.3	61.7	61.0	0.2	24.0	45.1	10.5	15.1	0.0	0.0	0.0	0.0	32.3	2.1	0.0	0.0	0.1	14.4	12.9	0.1	0.0	0.1	0.0	26.8	0.0	0.0	43.3	0.1	18.5	0.5	17.0	12.1	0.1	0.1	5.1	9.6	0.0	0.0	0.0	0.1	0.0	0.1	0.0	6.9	0.1	0.0	0.0	0.0	9.9	0.0	0.0	0.8	0.9	0.0	0.0	0.6	16.8	3.7	8.5	3.3	0.7	1.3	0.0	15.2	0.0	17.0	0.0	0.0	0.0	1.1	0.0	1.3	0.0	0.8	0.1	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	4.7	6.9	7.9	7.1	7.9	4.7	12.9	3.4	12.7	7.5	3.0	2.9	0.0	2.4	11.2	3.1	23.3	2.5	4.0	1.2	0.0	0.0	0.5	0.0	0.5	6.9	21.3	2.0	0.0	1.5	0.4	84.7	4.1	1.1	3.0	1.1	0.0	1.2	24.5	2.1	4.0	58.4	1.5	21.9	0.0	0.7	19.0	1.5	1.7	83.1	0.9	2.9	38.8	68.4	0.9	0.9	7.5	0.8	1.3	0.6	3.3
DDT	DDCT	ENSG00000099977	"D-dopachrome tautomerase"	P30046	22	23971365-23980469	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Melanin biosynthesis"	Lyase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 52.8;liver: 58.4"	"Cell type enriched"	"Detected in all"	5	"Hepatocytes: 4710.9"	"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HEK 293: 68.5"									"HPA049871, HPA074115"	Enhanced		Approved	Mitochondria		NA	NA			Mitochondria		"HPA049871: AB_2680926, HPA074115: "	"unprognostic (1.77e-2)"	"unprognostic (1.13e-1)"	"unprognostic (1.40e-1)"	"unprognostic (1.22e-2)"	"unprognostic (8.09e-2)"	"unprognostic (4.00e-3)"	"unprognostic (2.02e-3)"	"unprognostic (6.58e-2)"	"unprognostic (4.66e-2)"	"unprognostic (2.23e-2)"	"unprognostic (1.96e-1)"	"unprognostic (6.06e-3)"	"unprognostic (1.12e-1)"	"unprognostic (7.34e-2)"	"unprognostic (3.30e-1)"	"unprognostic (3.81e-1)"	"unprognostic (2.61e-3)"	9.7	6.6	5.4	3.4	4.8	8.8	4.5	2.1	4.4	3.0	9.8			11.8	2.7	4.3	5.8	2.8	1.4	7.7	4.2	4.0	11.3	58.4	3.2	2.9	5.4		4.1	14.4	1.3	1.8	2.5		5.8	6.4		7.1	4.4	10.4	3.7	11.6	2.0	4.6	3.2	8.2	1.2			3.7		2.7	4.3	3.2	30.4	52.8	27.8	38.0	23.8	29.0	28.6	27.1	11.6	4.0	9.4	7.7	6.8	24.5	7.9	5.3	6.9	7.2	10.2	7.9	26.0	7.4	4.1	10.2	22.5	10.0	9.8	4.5	11.0	68.5	15.6	15.8	22.2	7.8	34.2	15.7	6.8	7.5	6.9	6.1	8.0	7.4	4.1	14.1	10.5	6.9	13.3	7.5	31.0	12.1	24.0	35.0	16.5	7.5	37.1	12.3	10.0	13.7	13.2	16.3	30.9	23.2	5.7	7.8	10.8	8.5	7.2	16.0	7.3	8.2	32.4	10.7	16.3	14.1	12.7	13.8	20.7	38.0	27.8	19.9	32.4	20.3	30.4	24.1	21.1	35.7	28.4	21.9	21.3	24.2	23.8	29.6	52.8	29.0	28.6											77.4	62.3	170.5	177.4	123.4	46.7	20.4	580.9	78.9	76.2	230.3	84.4	209.3	608.5	198.5	156.1	122.0	650.8	116.8	322.3	247.0	92.9	222.4	128.0	4710.9	242.3	41.3	249.4	161.4	217.6	261.8	108.4	147.1	150.1	220.0	322.2	63.3	238.6	309.5	104.0	969.7	70.4	77.6	140.0	72.1	40.3	164.4	250.7	154.1	488.9	247.4
DDX1	DBP-RB	ENSG00000079785	"DEAD-box helicase 1"	Q92499	2	15591178-15631111	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Antiviral defense, Host-virus interaction, Immunity, Innate immunity, mRNA processing, Transcription, Transcription regulation, tRNA processing"	"Activator, DNA-binding, Exonuclease, Helicase, Hydrolase, Nuclease, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	5	"Cardiomyocytes: 352.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB012280, HPA034502, HPA034503"	Enhanced		Supported	Nucleoplasm,Cytosol		NA	NA		46000	Nucleoplasm	Cytosol	"CAB012280: , HPA034502: AB_10794321, HPA034503: AB_10795025"	"unprognostic (9.94e-2)"	"unprognostic (2.95e-2)"	"unprognostic (3.07e-2)"	"unprognostic (8.36e-3)"	"unprognostic (9.28e-3)"	"unprognostic (1.56e-2)"	"prognostic unfavorable (9.09e-9)"	"unprognostic (2.55e-1)"	"unprognostic (2.05e-1)"	"unprognostic (4.81e-3)"	"unprognostic (3.89e-2)"	"unprognostic (2.03e-1)"	"prognostic favorable (9.69e-4)"	"unprognostic (3.80e-1)"	"unprognostic (1.34e-1)"	"unprognostic (4.94e-2)"	"unprognostic (1.20e-3)"	23.8	28.2	29.3	17.6	35.0	17.1	30.1	35.3	37.2	25.1	24.5	15.0	20.5	21.0	24.3	25.6	27.7	21.0	15.8	47.6	34.7	25.3	35.8	35.2	17.8	16.0	24.5	36.9	23.6	27.6	42.1	41.2	28.1	35.1	22.2	28.1	14.8	23.9	24.5	67.5	24.5	25.9	31.0	21.0	17.1	24.1	19.2	23.0	23.0	29.6	24.8	21.5	26.1	19.8	18.7	22.8	19.2	25.1	23.0	26.6	19.9	19.3	29.7	42.2	31.5	36.7	32.2	48.7	40.7	34.2	40.1	33.8	47.4	20.0	50.3	19.8	46.9	29.6	29.5	57.7	39.1	42.5	21.4	37.5	55.1	39.7	59.7	27.6	45.0	25.9	25.0	26.9	33.4	32.1	25.4	36.1	23.8	56.0	16.6	39.5	27.1	24.6	34.0	54.3	48.9	25.1	29.7	63.9	36.4	45.9	39.0	34.1	42.6	27.8	29.4	37.0	31.6	20.4	19.1	29.1	33.7	34.8	21.1	45.9	21.7	37.7	67.9	30.3	36.1	31.3	19.2	20.0	11.5	20.2	25.1	21.3	18.7	23.4	23.4	22.8	18.0	26.6	23.6	3.1	23.0	23.2	19.5	21.6	19.9	29.3	35.0	35.3	37.2	34.7	25.3	24.5	36.9	35.1	23.0	74.5	45.2	27.6	50.5	35.7	56.6	352.9	63.7	95.0	68.2	85.5	49.1	96.2	121.0	87.1	11.9	56.2	48.4	23.3	104.7	96.0	66.4	31.2	54.4	106.7	46.5	42.9	50.1	40.5	25.3	12.7	67.3	39.1	47.2	31.5	56.7	55.3	88.0	59.6	73.6	95.2	67.2	58.2	49.9	167.4	57.2	36.9	67.1	26.6	62.9	32.7
DDX10	"Dbp4, HRH-J8"	ENSG00000178105	"DEAD-box helicase 10"	Q13206	11	108665025-108940930	"Cancer-related genes, Enzymes, Predicted intracellular proteins"		"Helicase, Hydrolase, RNA-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Cone photoreceptor cells: 90.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"U-698: 58.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA004691	Approved		Approved	Nucleoli		NA	NA			Nucleoli		"HPA004691: AB_1078629"	"unprognostic (9.49e-2)"	"unprognostic (9.32e-2)"	"unprognostic (1.34e-1)"	"unprognostic (2.58e-1)"	"unprognostic (7.97e-2)"	"unprognostic (1.48e-2)"	"prognostic unfavorable (2.52e-5)"	"unprognostic (2.86e-2)"	"unprognostic (1.23e-2)"	"unprognostic (1.06e-1)"	"prognostic unfavorable (5.75e-4)"	"unprognostic (1.00e-1)"	"prognostic favorable (2.14e-5)"	"unprognostic (5.20e-2)"	"unprognostic (1.98e-1)"	"unprognostic (4.64e-1)"	"unprognostic (2.43e-3)"	14.0	11.9	17.3	15.0	20.3	10.4	15.5	20.5	18.3	14.3	12.2	8.1	11.7	8.8	18.4	12.8	12.6	16.8	8.8	12.1	13.5	11.5	19.6	12.5	10.6	13.1	12.2	16.3	18.6	18.0	16.7	22.2	12.9	13.1	12.4	13.3	7.9	10.6	14.7	13.6	14.8	9.1	16.8	13.3	15.0	11.3	25.1	12.6	13.8	13.4	8.8	14.2	14.3	18.8	11.6	8.4	1.4	6.7	9.4	11.3	4.3	7.4	7.3	6.9	9.7	6.9	5.6	7.2	8.0	4.3	9.7	9.6	20.8	10.9	25.3	15.1	6.1	10.5	8.3	19.8	9.7	14.0	9.6	8.9	17.1	4.3	7.7	12.3	17.4	8.2	5.0	7.6	11.0	13.8	5.8	8.8	6.6	24.0	2.8	9.5	4.8	14.6	14.7	9.0	14.0	11.1	12.5	11.3	23.6	6.0	6.4	12.9	6.8	11.2	9.9	4.2	9.7	12.0	6.1	9.2	10.2	10.4	9.7	10.8	4.3	7.5	58.4	3.5	21.1	10.3	1.4	5.0	1.0	8.6	6.7	11.3	10.4	7.5	10.1	8.4	11.6	8.1	7.8	0.7	9.4	6.4	8.2	6.3	4.3	17.3	20.3	20.5	18.3	13.5	11.5	12.2	16.3	13.1	12.6	14.9	30.3	22.6	17.3	25.2	21.1	18.2	7.6	18.7	22.7	3.5	90.3	21.4	16.6	13.2	28.6	19.8	2.9	0.0	18.3	17.8	17.6	12.7	13.9	10.2	13.1	17.5	14.5	9.2	9.2	5.9	27.3	18.2	6.8	18.0	7.8	8.9	15.1	3.5	20.1	46.2	25.2	12.9	15.6	64.4	44.6	25.3	21.6	14.4	13.6	12.2
DDX11	"CHL1, CHLR1, KRG2, WABS"	ENSG00000013573	"DEAD/H-box helicase 11"	Q96FC9	12	31073845-31104791	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"DNA damage, DNA repair, DNA replication, Host-virus interaction, Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding, Helicase, Hydrolase, RNA-binding"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Rod photoreceptor cells: 25.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			HPA065197	Supported		Supported	"Nucleoplasm,Nucleoli fibrillar center,Centrosome"		No	Yes			Nucleoplasm	"Nucleoli fibrillar center, Centrosome"	"HPA065197: AB_2685430"	"unprognostic (6.10e-2)"	"unprognostic (1.48e-2)"	"unprognostic (1.02e-1)"	"unprognostic (5.09e-2)"	"unprognostic (1.45e-1)"	"unprognostic (2.79e-3)"	"prognostic unfavorable (2.40e-4)"	"unprognostic (4.87e-2)"	"unprognostic (3.89e-3)"	"unprognostic (3.53e-1)"	"unprognostic (5.66e-2)"	"unprognostic (1.25e-1)"	"prognostic unfavorable (5.23e-8)"	"unprognostic (1.89e-2)"	"unprognostic (3.64e-2)"	"unprognostic (1.02e-1)"	"unprognostic (8.03e-3)"	6.3	5.3	6.4	8.0	8.7	21.0	5.9	18.1	10.5	7.6	6.1	6.0	8.8	7.1	11.0	3.7	7.6	7.5	5.1	4.0	7.0	2.7	6.5	7.0	4.9	14.9	8.4	4.6	9.6	19.0	7.7	9.3	5.6	7.1	8.0	8.6	5.0	11.3	7.1	8.8	14.2	12.1	8.0	6.7	10.9	8.0	8.2	9.4	33.2	7.2	6.4	11.1	5.8	7.8	5.8	4.9	1.3	7.3	4.3	5.5	1.9	12.5	12.2	14.2	12.7	2.2	4.8	20.9	7.8	3.9	9.1	9.8	14.5	21.4	16.4	10.9	4.1	8.5	12.4	11.2	10.7	7.3	15.0	23.0	19.5	20.3	8.9	0.8	13.7	12.7	4.5	4.8	11.6	9.1	5.9	4.4	19.7	9.5	36.8	6.5	10.4	23.5	20.5	29.9	15.3	6.6	18.9	22.2	22.8	4.8	14.3	10.2	7.5	8.0	12.3	3.9	24.8	10.4	8.7	3.6	8.0	15.7	15.4	14.1	14.9	11.5	39.2	9.4	11.0	7.2	0.0	2.3	1.3	4.2	2.5	3.3	5.2	4.0	3.1	3.1	5.8	4.1	5.5	1.1	4.3	7.3	4.9	3.4	1.9	6.4	8.7	18.1	10.5	7.0	2.7	8.4	4.6	7.1	9.4	3.0	7.4	12.7	4.5	5.4	7.7	2.2	5.1	6.7	5.7	0.0	13.7	5.2	0.0	2.2	1.3	3.0	4.0	0.0	2.9	5.8	4.3	5.0	5.7	6.6	4.3	7.9	0.0	6.2	4.6	0.9	6.6	4.6	6.8	5.4	5.0	2.3	2.5	2.9	4.2	1.1	25.5	0.0	3.5	3.2	17.6	5.6	2.2	6.9	7.4	4.1
DDX17	P72	ENSG00000100201	"DEAD-box helicase 17"	Q92841	22	38483440-38507660	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Antiviral defense, Immunity, mRNA processing, mRNA splicing, RNA-mediated gene silencing, rRNA processing, Transcription, Transcription regulation"	"Helicase, Hydrolase, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB024908, HPA063142"	Supported		Supported	"Nuclear speckles"	"Intracellular and membrane"	NA	NA		90000	"Nuclear speckles"		"CAB024908: , HPA063142: AB_2684949"	"unprognostic (1.46e-2)"	"unprognostic (5.99e-3)"	"unprognostic (4.24e-3)"	"unprognostic (6.67e-2)"	"unprognostic (1.06e-2)"	"unprognostic (1.02e-2)"	"unprognostic (1.36e-2)"	"prognostic favorable (6.06e-4)"	"unprognostic (1.17e-1)"	"unprognostic (5.51e-1)"	"unprognostic (2.52e-2)"	"unprognostic (2.73e-2)"	"unprognostic (1.89e-2)"	"unprognostic (2.19e-2)"	"unprognostic (1.76e-1)"	"unprognostic (4.31e-2)"	"unprognostic (3.19e-3)"	49.7	43.1	46.3	49.2	54.5	19.8	50.8	69.7	52.0	47.7	53.3	56.5	54.4	33.1	58.5	82.9	37.5	52.2	46.1	39.9	47.0	31.2	34.3	41.9	41.5	52.6	64.0	37.7	67.8	41.5	68.5	83.7	49.4	46.0	46.2	36.8	51.4	43.9	51.8	89.2	60.3	38.7	52.7	47.1	54.1	39.7	24.6	63.1	69.3	59.8	29.2	47.7	54.5	52.9	10.3	12.4	23.7	9.5	4.0	9.9	6.1	29.7	28.9	59.0	35.4	39.1	45.1	30.8	25.4	25.4	37.1	36.1	27.6	24.9	57.8	17.5	33.2	23.6	33.0	64.5	36.0	41.5	56.9	36.8	35.9	48.4	33.0	42.0	45.8	42.8	31.4	47.3	24.2	41.8	53.1	42.3	27.9	37.1	65.5	29.4	19.4	32.2	39.1	38.0	43.3	14.1	58.5	32.9	35.4	35.3	39.8	34.1	20.1	39.8	31.5	42.0	47.3	27.2	35.5	34.3	31.7	19.8	20.2	19.1	50.6	35.0	49.8	41.0	29.7	39.0	8.5	9.5	11.0	9.9	7.3	9.4	9.0	8.0	7.1	6.8	10.3	5.8	7.5	23.7	4.0	6.8	12.4	7.9	6.1	46.3	54.5	69.7	52.0	47.0	31.2	64.0	37.7	46.0	63.1	199.5	293.3	141.2	174.3	198.5	453.4	121.4	180.9	248.9	260.5	268.7	331.8	105.4	28.2	86.0	34.1	224.8	142.5	23.3	77.8	81.8	163.6	205.3	193.1	180.6	98.1	303.5	226.7	240.6	191.5	27.7	299.7	152.5	146.8	97.4	162.3	302.5	92.9	133.3	262.0	57.6	548.6	284.6	173.1	96.3	66.0	244.7	116.6	128.3	119.9	237.1
DDX18	"Has1, MrDb"	ENSG00000088205	"DEAD-box helicase 18"	Q9NVP1	2	117814650-117832379	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Helicase, Hydrolase, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"U-698: 90.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035400, HPA041056"	Approved		Enhanced	"Nucleoli,Nucleoli rim,Mitotic chromosome"		Yes	No			"Nucleoli, Nucleoli rim, Mitotic chromosome"		"HPA035400: AB_10672091, HPA041056: AB_2677277"	"unprognostic (1.44e-1)"	"unprognostic (2.22e-2)"	"unprognostic (5.63e-2)"	"prognostic unfavorable (2.64e-4)"	"unprognostic (2.06e-1)"	"unprognostic (1.77e-3)"	"prognostic unfavorable (3.07e-4)"	"unprognostic (8.80e-2)"	"unprognostic (1.66e-3)"	"unprognostic (1.44e-1)"	"unprognostic (1.42e-2)"	"unprognostic (4.94e-2)"	"unprognostic (8.51e-2)"	"unprognostic (1.45e-1)"	"unprognostic (1.53e-1)"	"unprognostic (7.28e-2)"	"unprognostic (5.65e-2)"	35.3	21.3	20.5	28.7	26.0	17.4	31.2	27.1	25.6	31.2	27.9	16.7	21.6	20.9	32.0	22.9	27.8	28.5	21.3	22.9	19.6	19.1	32.0	40.3	24.1	35.0	25.5	22.9	36.3	29.5	21.0	25.9	25.0	25.0	25.0	30.3	11.5	24.2	26.6	37.0	24.9	26.3	28.3	30.8	46.5	26.2	22.9	31.1	40.7	31.3	23.9	37.6	37.6	23.7	22.2	20.5	9.4	18.5	17.2	23.6	16.3	22.0	10.0	15.0	13.5	8.9	8.0	24.8	13.1	10.4	18.1	16.0	24.6	14.6	32.5	21.5	10.8	16.8	17.1	29.0	16.9	26.8	16.5	20.3	31.0	9.4	24.7	12.4	41.4	16.2	8.3	15.7	23.0	23.3	9.2	10.8	16.9	33.8	14.1	13.8	13.7	22.6	21.6	37.6	18.7	15.2	19.7	23.4	28.4	12.0	13.1	14.4	24.5	15.2	16.8	17.0	15.9	10.6	22.9	8.3	16.2	23.9	11.4	23.5	16.3	20.2	90.0	11.9	19.6	7.2	6.2	13.8	9.4	16.2	17.3	20.6	22.2	19.3	18.5	12.5	19.1	23.6	20.7	3.6	17.2	18.5	20.5	15.0	16.3	20.5	26.0	27.1	25.6	19.6	19.1	25.5	22.9	25.0	31.1	89.3	53.4	123.6	65.7	171.3	131.1	44.8	122.3	89.7	94.4	115.1	78.5	95.4	99.5	87.4	10.8	105.7	49.3	23.3	99.4	101.8	89.3	52.4	108.5	162.0	78.1	77.9	54.6	103.7	79.2	10.1	98.7	99.7	87.7	93.8	85.3	76.8	106.8	59.6	97.6	93.5	118.7	64.7	108.2	111.4	127.7	140.4	74.3	107.1	93.0	50.8
DDX19A	"DDX19L, FLJ11126"	ENSG00000168872	"DEAD-box helicase 19A"	Q9NUU7	16	70346829-70373383	"Enzymes, Predicted intracellular proteins, Transporters"		"Helicase, Hydrolase, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA045252, HPA066668"	Approved		Uncertain	Nucleoplasm		NA	NA			Nucleoplasm		"HPA045252: AB_10961128, HPA066668: "	"unprognostic (3.11e-2)"	"unprognostic (1.93e-1)"	"unprognostic (9.07e-2)"	"unprognostic (3.95e-2)"	"unprognostic (2.18e-2)"	"prognostic unfavorable (2.38e-4)"	"prognostic unfavorable (8.05e-5)"	"unprognostic (1.45e-1)"	"unprognostic (1.59e-1)"	"unprognostic (1.67e-1)"	"unprognostic (1.30e-1)"	"unprognostic (5.87e-2)"	"unprognostic (1.24e-1)"	"unprognostic (2.01e-2)"	"unprognostic (1.49e-1)"	"unprognostic (3.01e-2)"	"unprognostic (6.68e-3)"	18.4	20.6	14.5	15.5	19.7	9.8	18.1	16.6	19.6	16.9	19.2	19.2	17.8	9.3	22.0	14.2	19.2	17.1	16.1	22.1	18.6	13.5	16.6	24.8	14.4	18.0	17.1	15.5	21.6	22.5	31.7	17.4	21.8	15.1	15.4	14.4	14.2	14.4	21.1	51.5	15.8	13.5	25.9	15.4	14.1	17.2	9.7	13.7	17.1	19.7	14.4	18.4	19.5	15.5	8.1	14.2	7.9	11.4	8.2	10.3	8.8	13.2	15.0	15.8	16.0	23.8	16.2	15.1	16.9	17.4	26.8	20.9	22.5	9.9	22.2	16.1	17.8	12.7	15.2	28.3	16.8	22.2	7.4	15.4	11.6	12.3	27.6	21.5	20.2	9.7	19.9	12.1	24.4	19.2	13.2	17.0	16.2	27.9	5.8	16.0	19.0	22.4	16.8	25.5	15.8	9.2	27.8	10.6	30.4	16.2	8.2	13.0	17.5	43.3	9.5	12.7	17.1	17.4	12.9	11.5	18.7	14.8	11.8	16.0	16.4	24.6	48.9	12.6	18.5	18.3	7.9	11.4	5.8	10.2	10.7	9.4	7.7	8.9	10.0	14.2	8.1	9.9	10.3	0.7	8.2	9.6	7.3	7.5	8.8	14.5	19.7	16.6	19.6	18.6	13.5	17.1	15.5	15.1	13.7	14.9	20.2	21.7	15.7	8.9	31.9	16.2	28.1	13.4	22.7	10.4	31.4	18.9	8.3	11.1	1.4	13.8	6.6	23.3	12.1	13.1	12.8	16.7	17.3	15.3	12.3	22.3	13.8	14.7	14.5	1.3	24.2	11.8	10.1	17.2	8.8	18.0	11.6	8.6	11.7	10.6	31.0	25.8	15.5	12.2	16.4	8.9	14.4	12.9	11.3	15.9
DDX19B	"DBP5, DDX19"	ENSG00000157349	"DEAD-box helicase 19B"	Q9UMR2	16	70289663-70335283	"Enzymes, Plasma proteins, Predicted intracellular proteins, Transporters"		"Helicase, Hydrolase, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"Early spermatids: 170.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB037229, CAB037284, HPA046380, HPA066668"	Approved		Uncertain	Nucleoplasm		NA	NA			Nucleoplasm		"CAB037229: AB_1840791, CAB037284: AB_1840792, HPA046380: AB_2679645, HPA066668: "	"unprognostic (2.91e-2)"	"unprognostic (5.37e-2)"	"unprognostic (6.48e-2)"	"unprognostic (3.55e-2)"	"unprognostic (3.98e-2)"	"unprognostic (4.05e-2)"	"unprognostic (2.93e-2)"	"unprognostic (1.98e-2)"	"unprognostic (1.40e-1)"	"unprognostic (1.05e-1)"	"unprognostic (6.33e-2)"	"unprognostic (4.07e-1)"	"unprognostic (7.95e-2)"	"unprognostic (2.19e-1)"	"unprognostic (3.50e-1)"	"unprognostic (1.04e-1)"	"unprognostic (6.32e-2)"	22.2	18.6	8.8	16.6	12.7	19.4	20.1	30.4	16.3	13.1	16.7	14.6	13.8	14.4	15.0	13.9	16.0	13.2	15.2	15.0	8.3	8.3	15.9	33.9	16.6	15.3	10.5	10.7	14.6	21.6	20.3	17.9	12.0	13.2	13.8	18.2	19.3	16.8	15.2	24.8	26.9	16.6	15.7	10.1	17.8	18.5	64.3	12.3	17.4	18.0	16.9	20.8	16.2	13.9	21.1	21.1	27.0	28.6	22.1	35.4	22.5	2.0	12.4	17.7	16.0	9.8	13.1	15.3	10.0	14.2	22.0	23.0	26.4	15.3	16.2	9.5	12.6	8.9	12.2	0.1	5.7	22.8	6.7	11.3	9.6	8.1	21.6	21.1	20.5	9.3	16.1	11.3	16.7	12.7	9.1	16.8	5.0	9.7	7.0	13.4	14.2	0.0	29.7	11.1	7.7	5.2	28.4	9.6	23.4	13.1	11.5	11.6	15.3	23.6	5.4	12.7	8.1	12.1	18.2	10.2	10.4	9.3	8.6	9.2	15.1	7.8	37.7	3.4	16.8	13.4	27.0	22.1	19.0	23.2	28.6	22.3	21.1	20.9	25.3	21.1	19.0	19.0	18.0	4.1	22.1	17.7	6.5	35.4	22.5	8.8	12.7	30.4	16.3	8.3	8.3	10.5	10.7	13.2	12.3	11.9	17.9	27.3	15.3	8.4	17.8	6.6	12.7	29.4	20.5	10.4	11.8	16.5	26.6	35.6	170.5	17.5	27.5	0.0	57.8	18.6	16.1	14.9	10.5	12.4	25.9	9.5	21.1	11.6	14.6	32.4	19.2	19.7	3.3	43.3	14.6	16.0	37.9	34.5	14.9	17.4	15.7	12.9	12.3	78.8	7.4	9.2	26.4	25.5	20.3	15.7
DDX20	"DP103, GEMIN3"	ENSG00000064703	"DEAD-box helicase 20"	Q9UHI6	1	111755245-111768016	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	"DNA-binding, Helicase, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	6	"testis: 81.7"	"Group enriched"	"Detected in many"	13	"Early spermatids: 570.4;Late spermatids: 538.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA005516, CAB015427"	Enhanced		Supported	"Nucleoplasm,Nuclear bodies,Cytosol"	"Intracellular and membrane"	NA	NA			"Nucleoplasm, Nuclear bodies"	Cytosol	"CAB015427: AB_629518, HPA005516: AB_1849612"	"unprognostic (3.71e-2)"	"unprognostic (5.25e-2)"	"prognostic favorable (9.85e-5)"	"unprognostic (8.73e-2)"	"unprognostic (2.51e-2)"	"unprognostic (7.09e-2)"	"prognostic unfavorable (6.35e-6)"	"unprognostic (1.17e-1)"	"unprognostic (5.87e-2)"	"unprognostic (7.46e-3)"	"unprognostic (4.21e-1)"	"unprognostic (5.22e-2)"	"unprognostic (1.05e-3)"	"unprognostic (2.60e-2)"	"unprognostic (2.01e-1)"	"unprognostic (4.23e-1)"	"unprognostic (1.30e-2)"	3.1	2.8	2.9	2.7	4.3	5.9	9.8	5.8	5.1	2.7	2.6	1.8	2.6	2.0	4.0	2.9	2.6	3.7	1.7	2.0	4.3	1.6	2.7	2.4	4.1	3.8	2.4	1.9	3.9	2.9	4.0	3.9	2.7	3.4	2.9	2.6	1.2	2.6	2.7	5.1	2.5	3.5	2.9	5.6	4.5	2.8	81.7	3.3	5.1	3.2	1.7	4.1	2.9	5.0	11.9	7.4	12.7	7.4	10.5	14.1	7.8	11.4	4.7	12.2	11.0	8.8	7.0	11.4	11.2	8.7	16.1	15.7	7.0	4.0	26.8	8.8	7.6	5.7	9.2	14.4	11.3	18.0	12.2	13.0	13.0	9.2	7.2	8.8	12.8	9.6	7.0	9.9	13.7	13.9	4.5	11.1	10.5	12.4	9.8	12.2	10.8	15.7	13.0	15.3	6.9	9.6	15.4	20.1	6.7	10.5	9.0	12.7	11.5	10.8	13.5	18.0	10.6	8.4	13.6	9.8	9.8	14.5	17.5	13.0	4.9	6.9	20.5	10.2	13.2	22.1	12.7	7.0	6.9	10.0	7.3	13.3	11.9	11.7	11.8	7.4	10.1	14.1	12.3	5.0	10.5	7.4	5.2	11.7	7.8	2.9	4.3	5.8	5.1	4.3	1.6	2.4	1.9	3.4	3.3	11.9	6.5	3.7	7.8	9.6	12.2	5.9	2.5	13.4	12.5	5.2	2.0	8.6	3.3	8.9	570.4	7.1	2.4	0.0	6.0	6.8	4.8	3.0	7.0	4.9	8.0	6.4	4.1	3.7	9.1	538.8	15.3	8.7	1.7	3.6	5.7	6.3	6.3	2.9	12.4	6.9	8.9	6.5	10.3	41.2	25.6	6.4	4.2	7.0	5.8	5.5
DDX21	"GURDB, RH-II/GU"	ENSG00000165732	"DExD-box helicase 21"	Q9NR30	10	68956128-68985073	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Antiviral defense, Immunity, Innate immunity, rRNA processing, Transcription"	"Helicase, Hydrolase, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	4	"Suprabasal keratinocytes: 515.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036592, HPA036593"	Enhanced		Enhanced	"Nucleoplasm,Nucleoli rim,Mitotic chromosome"		Yes	No		14000	"Nucleoli rim, Mitotic chromosome"	Nucleoplasm	"HPA036592: AB_10673625, HPA036593: AB_2675208"	"unprognostic (3.04e-1)"	"unprognostic (6.81e-3)"	"unprognostic (1.13e-2)"	"unprognostic (1.21e-2)"	"unprognostic (1.75e-2)"	"unprognostic (6.71e-3)"	"unprognostic (1.34e-2)"	"unprognostic (1.99e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.92e-1)"	"prognostic unfavorable (3.12e-4)"	"unprognostic (1.64e-1)"	"unprognostic (1.39e-2)"	"unprognostic (9.33e-2)"	"unprognostic (5.41e-2)"	"unprognostic (1.24e-2)"	"unprognostic (5.74e-3)"	37.5	16.0	10.0	26.6	13.3	46.8	24.4	8.0	11.8	18.5	20.1	7.2	16.2	13.3	18.7	13.7	28.3	20.1	17.6	19.1	11.4	8.0	25.1	48.0	25.9	24.4	14.9	7.2	30.2	27.9	15.6	20.7	22.8	18.3	14.0	17.6	5.9	18.0	17.8	61.2	22.5	18.5	19.0	20.4	43.5	19.0	12.9	13.3	27.1	18.1	24.1	25.8	33.2	22.4	12.6	11.5	17.1	17.3	7.7	15.0	6.2	33.1	19.7	11.5	35.6	10.4	13.8	24.4	22.8	18.4	29.5	25.1	63.7	22.8	50.0	14.1	18.9	13.9	29.6	44.3	28.4	39.6	15.5	31.2	35.0	14.0	26.4	22.3	83.2	33.3	14.1	37.0	35.2	59.0	13.7	21.4	18.8	66.6	25.0	20.7	15.1	32.6	18.1	31.5	15.8	42.1	29.2	18.9	24.6	19.6	17.9	23.9	25.6	20.5	45.5	26.6	14.5	25.8	17.5	22.0	17.3	24.6	23.2	40.0	28.9	38.2	73.9	14.4	63.2	11.7	5.0	9.7	17.1	8.4	15.0	15.0	12.6	10.9	11.0	11.5	10.4	10.3	11.3	4.5	7.7	17.3	10.8	7.9	6.2	10.0	13.3	8.0	11.8	11.4	8.0	14.9	7.2	18.3	13.3	95.3	139.8	208.1	223.1	488.7	27.0	59.4	112.1	83.0	195.7	68.0	39.3	72.5	61.3	111.8	41.5	139.6	52.0	23.3	160.6	118.9	142.8	222.8	164.0	182.5	102.7	23.8	83.2	113.5	149.3	13.6	82.8	170.5	118.1	66.7	97.0	22.8	171.9	92.1	72.5	73.0	27.4	25.8	155.6	101.9	142.2	515.4	115.0	93.8	113.1	301.9
DDX23	"prp28, PRPF28, SNRNP100, U5-100K"	ENSG00000174243	"DEAD-box helicase 23"	Q9BUQ8	12	48829764-48852842	"Enzymes, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	"Helicase, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038680, HPA039037"	Approved		Supported	Nucleoplasm,Nucleoli		NA	NA			"Nucleoplasm, Nucleoli"		"HPA038680: AB_10795401, HPA039037: AB_2676317"	"unprognostic (1.32e-3)"	"unprognostic (8.90e-2)"	"unprognostic (8.92e-2)"	"unprognostic (7.12e-2)"	"unprognostic (5.34e-2)"	"unprognostic (1.47e-1)"	"prognostic unfavorable (3.03e-5)"	"unprognostic (3.54e-2)"	"unprognostic (5.68e-2)"	"unprognostic (2.19e-2)"	"unprognostic (1.69e-1)"	"unprognostic (8.34e-2)"	"unprognostic (5.94e-2)"	"unprognostic (9.78e-2)"	"unprognostic (6.88e-2)"	"unprognostic (2.59e-2)"	"unprognostic (1.44e-1)"	26.1	26.5	29.5	35.6	34.2	19.4	27.2	32.8	35.6	26.7	32.8	23.3	27.5	27.9	31.0	22.3	31.0	31.1	25.2	25.1	29.8	20.3	25.2	37.7	27.7	35.2	26.5	25.3	36.2	30.4	32.2	28.1	34.4	25.0	29.9	32.6	24.7	31.1	27.0	44.4	30.6	32.3	29.4	24.1	40.0	30.6	24.9	32.0	46.8	28.2	29.8	38.9	28.9	47.9	12.0	11.5	19.6	13.3	11.2	19.8	10.6	22.0	50.5	24.0	25.4	24.0	16.6	25.5	27.4	21.1	31.1	19.8	49.1	29.5	27.9	30.1	22.7	29.4	20.0	52.0	24.9	26.7	43.7	27.6	37.0	43.0	22.1	12.9	37.3	33.7	16.0	22.4	33.0	19.8	21.4	25.5	24.8	48.9	25.0	22.6	30.7	35.3	35.4	35.7	31.4	24.0	37.8	28.4	22.2	18.4	31.1	29.6	17.3	27.4	31.5	11.4	25.7	30.8	34.3	22.8	23.6	17.3	11.6	21.7	18.9	26.3	33.7	20.0	26.3	12.9	17.1	11.1	19.6	19.5	13.3	19.8	12.0	14.5	17.6	10.8	11.4	14.0	16.9	11.9	11.2	8.9	11.5	13.1	10.6	29.5	34.2	32.8	35.6	29.8	20.3	26.5	25.3	25.0	32.0	23.8	25.5	22.4	12.7	11.4	16.9	17.1	22.9	44.2	31.8	12.2	23.6	22.5	13.3	22.3	6.9	21.0	23.3	23.3	33.5	24.6	16.2	21.2	17.4	16.3	16.7	14.3	13.4	17.8	9.9	4.1	22.7	15.0	13.5	24.4	22.7	24.3	28.9	31.6	20.8	10.2	24.0	19.4	18.4	33.8	36.1	13.2	22.2	24.2	23.9	17.1
DDX24		ENSG00000089737	"DEAD-box helicase 24"	Q9GZR7	14	94048291-94081245	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Helicase, Hydrolase, RNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"epididymis: 103.0"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA002554	Uncertain		Approved	Nucleoli,Cytosol		NA	NA			"Nucleoli, Cytosol"		"HPA002554: AB_1078631"	"unprognostic (7.48e-2)"	"unprognostic (3.02e-2)"	"unprognostic (8.95e-2)"	"unprognostic (2.12e-1)"	"unprognostic (2.31e-1)"	"unprognostic (4.06e-3)"	"unprognostic (8.81e-2)"	"unprognostic (2.66e-3)"	"unprognostic (2.77e-1)"	"unprognostic (2.28e-2)"	"unprognostic (1.60e-3)"	"unprognostic (4.13e-2)"	"prognostic favorable (3.06e-9)"	"prognostic unfavorable (2.89e-4)"	"unprognostic (6.15e-2)"	"unprognostic (1.23e-1)"	"unprognostic (5.66e-2)"	18.0	45.5	19.7	13.7	41.3	53.3	18.5	31.4	40.8	17.4	20.9	21.9	14.3	13.6	23.2	103.0	20.1	18.9	21.3	28.6	25.0	31.3	36.3	30.1	16.4	27.4	22.0	29.0	21.4	12.5	8.3	32.0	11.2	38.7	16.0	14.6	17.4	15.9	17.7	28.5	23.4	12.6	17.9	21.8	18.1	15.0	38.5	17.4	14.3	25.3	11.8	25.8	21.7	14.9	4.1	3.1	10.6	3.3	6.2	5.3	5.0	3.8	1.1	7.2	4.6	4.3	5.7	1.7	10.8	9.1	14.1	12.7	1.4	2.5	17.9	4.1	2.4	4.2	2.5	7.4	0.6	15.4	7.8	0.4	9.5	2.1	5.8	3.6	13.7	4.2	0.9	4.1	2.6	2.5	4.7	2.3	3.4	4.9	5.3	6.0	10.8	4.1	11.7	4.8	1.2	0.1	5.5	16.7	2.1	10.2	1.4	5.7	5.3	10.6	2.6	5.0	1.3	4.2	4.9	6.9	4.0	2.7	5.1	3.3	2.1	13.8	19.3	5.8	7.5	3.1	10.6	3.3	2.5	5.0	2.6	1.4	2.9	2.9	3.0	2.0	4.1	5.3	5.3	2.6	6.2	2.5	3.1	3.3	5.0	19.7	41.3	31.4	40.8	25.0	31.3	22.0	29.0	38.7	17.4	157.8	151.6	175.7	121.2	162.3	169.0	198.2	58.6	192.7	154.7	139.6	123.7	76.5	230.5	124.3	63.9	107.4	65.5	116.8	86.3	59.9	133.4	81.0	147.1	96.2	75.0	219.3	93.7	105.0	83.4	46.7	214.3	119.2	94.5	181.3	57.7	131.2	82.3	69.1	230.2	135.3	189.8	161.7	156.5	383.4	396.2	127.2	131.4	217.1	54.9	94.1
DDX25	GRTH	ENSG00000109832	"DEAD-box helicase 25"	Q9UHL0	11	125903348-125943702	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Differentiation, mRNA transport, Spermatogenesis, Translation regulation, Transport"	"Developmental protein, Helicase, Hydrolase, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"brain: 17.3;testis: 64.2"	"Group enriched"	"Detected in some"	5	"Early spermatids: 250.3;Spermatocytes: 190.6"	"Cancer enhanced"	"Detected in some"		"glioma: 1.0"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"neutrophil: 3.3"	"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in some"	5	"JURKAT: 16.8;NTERA-2: 11.4;SCLC-21H: 9.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA020137	Enhanced		Approved	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA020137: AB_1847552"	"unprognostic (5.78e-3)"	"unprognostic (9.75e-3)"	"unprognostic (7.93e-2)"	"unprognostic (5.09e-3)"	"unprognostic (1.11e-2)"	"unprognostic (1.78e-2)"	"unprognostic (1.54e-1)"	"unprognostic (2.91e-3)"	"unprognostic (6.24e-5)"	"unprognostic (2.57e-1)"	"unprognostic (2.44e-3)"	"unprognostic (3.89e-1)"	"unprognostic (3.44e-3)"	"unprognostic (1.44e-1)"	"unprognostic (1.76e-1)"	"unprognostic (9.72e-2)"	"unprognostic (1.69e-1)"	0.7	2.8	8.7	0.8	13.2	0.9	0.8	7.9	17.3	0.8	0.8	2.0	0.0	1.0	0.9	0.9	0.8	0.9	0.8	0.7	8.4	7.1	2.7	0.8	0.8	0.8	4.8	8.9	1.2	1.8	2.6	7.1	0.9	5.9	0.9	0.8	2.3	0.8	1.0	0.8	1.6	0.8	0.7	3.4	0.9	1.0	64.2	3.0	0.0	4.3	0.0	0.8	0.7	0.2	0.6	0.5	3.3	0.3	1.3	0.5	0.1	0.0	0.0	2.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.8	0.0	0.2	0.2	1.2	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.2	0.0	0.0	0.5	0.0	0.0	0.0	0.0	16.8	0.0	0.3	0.0	0.5	1.6	0.0	11.4	0.5	0.0	0.4	0.0	0.0	0.0	0.1	9.2	2.1	0.1	0.0	1.6	1.6	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.6	2.1	0.3	0.6	0.3	0.2	0.2	0.4	0.5	0.2	0.1	0.6	0.4	0.3	3.3	1.3	0.2	0.5	0.1	0.1	8.7	13.2	7.9	12.5	8.4	7.1	4.8	8.9	5.9	3.0	0.0	0.3	0.0	0.7	0.1	18.2	0.8	0.0	0.0	0.0	0.0	15.7	0.0	3.3	0.1	250.3	0.9	0.0	0.0	0.2	0.1	0.3	0.5	0.0	0.5	0.1	15.9	0.0	0.6	0.0	41.7	3.4	0.1	0.0	0.0	0.0	16.0	0.1	0.0	4.6	1.8	16.0	0.0	0.1	190.6	24.5	0.0	0.0	0.0	0.0	0.1
DDX27	"dJ686N3.1, DRS1"	ENSG00000124228	"DEAD-box helicase 27"	Q96GQ7	20	49219295-49244077	"Enzymes, Predicted intracellular proteins"	"Ribosome biogenesis, rRNA processing"	"Helicase, Hydrolase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA047087	Uncertain		Approved	Nucleoli		Yes	No			Nucleoli		"HPA047087: AB_10964059"	"unprognostic (4.47e-2)"	"unprognostic (2.41e-2)"	"unprognostic (3.13e-1)"	"prognostic unfavorable (1.44e-5)"	"unprognostic (2.82e-1)"	"unprognostic (7.12e-2)"	"prognostic unfavorable (6.70e-7)"	"unprognostic (2.28e-1)"	"unprognostic (9.53e-2)"	"unprognostic (2.74e-1)"	"unprognostic (7.18e-2)"	"unprognostic (5.84e-3)"	"prognostic unfavorable (1.73e-4)"	"unprognostic (1.26e-1)"	"unprognostic (4.32e-1)"	"unprognostic (1.99e-2)"	"unprognostic (1.27e-1)"	22.0	22.5	21.9	33.0	23.2	40.9	23.6	34.8	26.3	24.3	26.4	16.3	20.4	23.2	26.2	19.1	26.5	23.9	27.1	19.2	22.6	17.3	25.9	21.0	20.1	32.3	19.9	18.8	37.4	27.3	25.9	25.6	23.9	21.2	22.0	22.1	14.4	22.9	24.3	32.9	27.8	33.6	20.0	20.7	34.1	22.9	25.0	24.0	30.6	23.5	19.4	35.3	24.0	27.2	30.4	28.0	22.2	24.2	18.2	26.7	18.6	20.2	19.3	9.9	7.6	11.0	10.2	28.2	13.5	11.1	42.6	19.8	62.7	22.7	24.1	25.2	10.9	37.0	28.8	22.0	21.6	31.7	8.5	12.9	18.3	16.2	30.4	16.2	23.1	21.5	10.8	25.4	24.8	19.1	9.7	7.0	19.0	24.9	13.4	13.8	13.6	24.3	30.6	18.7	24.8	25.1	21.0	24.6	22.2	15.4	15.7	12.9	15.3	37.6	54.4	22.6	14.3	28.8	26.9	8.8	27.4	24.1	22.9	28.0	15.3	16.5	31.6	17.5	18.5	17.6	11.1	19.8	22.2	21.7	21.2	22.8	29.4	20.6	19.7	23.3	30.4	26.7	20.3	8.1	18.2	24.2	28.0	26.3	18.6	21.9	23.2	34.8	26.3	22.6	17.3	19.9	18.8	21.2	24.0	26.8	43.1	49.7	41.1	31.7	24.0	22.7	20.4	40.2	45.5	31.4	13.7	49.9	16.6	46.3	131.4	24.2	38.6	0.0	38.0	41.7	28.8	24.4	110.8	20.3	29.9	27.0	29.7	12.3	16.4	107.1	36.8	41.8	18.6	43.3	30.5	32.3	46.2	37.4	31.8	34.2	27.6	25.8	29.7	67.4	60.0	28.1	62.4	50.1	43.2	37.1
DDX28	"FLJ11282, MDDX28"	ENSG00000182810	"DEAD-box helicase 28"	Q9NUL7	16	68021274-68023442	"Enzymes, Predicted intracellular proteins"	"Ribosome biogenesis"	"Helicase, Hydrolase, RNA-binding, rRNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	10	"Syncytiotrophoblasts: 83.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041911, HPA053585"	Approved		Supported	Nucleoli,Mitochondria,Cytosol		No	No			"Mitochondria, Cytosol"	Nucleoli	"HPA041911: AB_10794161, HPA053585: AB_2682200"	"unprognostic (8.11e-2)"	"unprognostic (1.18e-1)"	"unprognostic (6.10e-3)"	"unprognostic (8.03e-2)"	"unprognostic (1.58e-1)"	"unprognostic (8.69e-2)"	"unprognostic (8.46e-2)"	"unprognostic (9.58e-2)"	"unprognostic (2.19e-1)"	"unprognostic (7.63e-2)"	"unprognostic (8.14e-3)"	"unprognostic (8.53e-2)"	"prognostic favorable (2.07e-10)"	"unprognostic (1.58e-2)"	"unprognostic (6.21e-2)"	"unprognostic (2.23e-1)"	"unprognostic (2.47e-1)"	9.8	12.7	6.2	6.7	8.3	19.7	7.1	6.0	12.9	8.3	7.2	6.4	6.8	5.2	7.5	7.3	9.7	7.1	7.0	9.2	5.2	5.9	8.9	12.4	5.8	18.4	6.4	5.1	8.6	13.3	6.8	4.6	17.1	6.6	6.1	6.0	7.8	6.3	5.2	16.2	9.9	7.9	5.3	3.0	11.1	7.0	11.5	2.7	14.6	10.2	7.3	10.6	8.0	4.8	17.8	18.0	22.9	19.1	17.0	22.9	16.6	6.1	9.2	4.5	5.4	6.3	3.5	10.6	4.2	6.3	10.7	7.6	8.9	9.8	23.2	6.5	5.2	5.8	11.2	6.4	10.2	6.3	3.1	10.6	8.4	4.8	9.2	8.5	13.1	9.0	6.9	11.2	8.8	8.1	3.7	5.9	15.7	14.9	3.6	4.7	13.8	13.7	18.5	11.1	6.3	6.8	13.5	4.2	24.8	7.5	7.2	9.5	6.4	17.2	4.9	9.3	5.4	9.5	14.4	4.2	4.7	4.0	6.7	6.9	8.2	9.9	22.3	5.8	10.1	6.4	17.7	19.1	22.9	15.7	18.8	17.3	12.6	14.6	16.9	18.0	17.8	22.9	16.9	6.3	17.0	18.5	9.0	13.8	16.6	6.2	8.3	6.0	12.9	5.2	5.9	6.4	5.1	6.6	2.7	6.0	5.0	7.5	13.5	8.1	4.8	3.1	2.5	2.7	5.7	3.5	0.0	24.0	11.6	9.5	5.9	6.0	1.7	0.0	8.5	9.4	4.2	3.1	3.5	9.7	15.4	3.2	4.6	4.3	10.3	3.1	4.6	6.6	6.8	11.8	2.8	7.2	7.2	4.5	3.2	14.6	3.4	12.9	4.1	20.6	15.1	9.4	83.5	10.1	5.8	10.3
DDX31	"FLJ13633, FLJ14578, FLJ23349, PPP1R25"	ENSG00000125485	"DEAD-box helicase 31"	Q9H8H2	9	132592997-132670401	"Enzymes, Predicted intracellular proteins"		"Helicase, Hydrolase, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Intestinal endocrine cells: 23.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA020891			Supported	"Nucleoli,Golgi apparatus,Vesicles"		NA	NA			Nucleoli	"Golgi apparatus, Vesicles"	"HPA020891: "	"unprognostic (5.71e-2)"	"unprognostic (1.76e-2)"	"unprognostic (2.56e-1)"	"unprognostic (7.91e-2)"	"unprognostic (5.79e-2)"	"unprognostic (9.94e-2)"	"prognostic unfavorable (1.68e-7)"	"unprognostic (1.34e-1)"	"unprognostic (2.02e-2)"	"unprognostic (1.66e-1)"	"unprognostic (3.90e-2)"	"unprognostic (9.57e-3)"	"unprognostic (4.57e-3)"	"unprognostic (2.24e-2)"	"unprognostic (1.22e-1)"	"unprognostic (1.38e-1)"	"unprognostic (2.03e-1)"	6.8	6.9	8.2	15.3	11.2	6.0	12.3	18.4	8.5	7.5	6.6	9.4	12.6	5.0	8.9	8.8	9.8	8.8	7.5	5.4	6.3	6.3	8.4	9.2	12.0	15.1	9.1	5.7	16.9	17.3	10.0	8.8	5.8	9.8	9.2	8.0	7.4	12.7	12.6	12.9	14.0	7.2	12.7	12.9	8.7	6.8	15.2	8.3	6.8	22.7	10.8	13.8	7.2	12.6	5.0	4.5	1.9	2.7	3.1	6.9	3.0	7.0	13.2	6.4	8.8	7.9	7.1	12.6	7.6	7.5	12.0	9.2	14.6	14.6	17.7	6.9	7.1	12.5	19.8	20.2	8.9	9.7	10.8	7.5	9.6	11.7	7.6	9.5	17.0	7.8	6.3	12.2	12.3	17.3	4.6	7.8	13.2	17.6	6.9	9.9	15.2	11.8	9.3	15.9	21.0	13.5	12.5	11.4	20.3	10.9	6.8	11.6	8.3	13.9	12.4	10.5	7.8	25.9	5.0	6.6	20.4	9.2	11.5	11.7	3.4	10.7	13.8	7.3	10.8	15.3	0.0	1.9	1.9	5.7	2.7	4.7	4.2	5.5	4.4	4.5	5.0	6.9	5.1	0.3	3.1	1.9	2.8	3.6	3.0	8.2	11.2	18.4	8.5	6.3	6.3	9.1	5.7	9.8	8.3	6.0	5.9	3.4	3.1	4.9	3.4	3.1	0.0	6.7	15.9	7.0	3.9	4.6	1.7	4.1	2.1	3.9	0.7	0.0	4.6	5.8	2.6	4.1	1.1	3.2	4.6	1.6	23.6	3.1	2.4	2.4	16.7	2.8	1.7	4.6	3.7	1.5	4.7	0.0	12.4	4.3	3.1	0.0	2.1	11.2	15.7	5.5	2.5	4.1	5.7	2.6
DDX39A	"BAT1L, DDX39, DDXL, URH49"	ENSG00000123136	"DExD-box helicase 39A"	O00148	19	14408819-14419383	"Enzymes, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	"Helicase, Hydrolase, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 60.7"	"Cell type enhanced"	"Detected in many"	7	"Early spermatids: 238.8;Late spermatids: 232.5;Spermatocytes: 336.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA055334	Approved		Approved	"Nuclear speckles"		NA	NA			"Nuclear speckles"		"HPA055334: AB_2682787"	"unprognostic (1.31e-1)"	"prognostic favorable (6.86e-4)"	"unprognostic (2.41e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.12e-1)"	"unprognostic (5.20e-2)"	"unprognostic (2.55e-3)"	"unprognostic (1.92e-1)"	"unprognostic (1.87e-1)"	"unprognostic (8.81e-2)"	"unprognostic (1.64e-1)"	"unprognostic (3.09e-2)"	"prognostic unfavorable (1.50e-10)"	"unprognostic (1.55e-3)"	"unprognostic (8.57e-2)"	"unprognostic (3.92e-1)"	"unprognostic (7.38e-3)"	10.9	8.5	7.2	20.6	11.4	41.4	10.5	9.1	7.9	8.2	10.9	11.0	4.4	13.0	9.4	7.2	15.9	7.0	8.1	7.8	6.6	6.1	9.7	12.1	10.3	31.2	12.6	5.0	7.4	8.8	3.0	7.4	10.5	10.0	7.3	8.9	5.2	7.9	4.4	7.9	10.6	12.8	6.8	9.4	23.4	10.4	60.7	10.3	39.9	8.4	16.3	26.1	10.3	8.8	36.7	36.6	7.7	28.5	21.5	39.7	33.6	32.9	27.1	13.9	26.9	5.7	4.2	13.6	14.7	8.1	30.6	18.9	27.5	17.9	63.7	15.6	12.1	16.4	20.4	34.2	23.8	12.5	22.3	17.9	68.4	31.6	19.7	10.1	37.2	30.6	5.8	5.4	19.8	8.1	4.5	16.0	23.4	42.0	28.1	17.0	39.9	63.7	55.2	26.6	32.2	41.5	44.2	24.6	37.3	10.9	27.1	32.4	17.9	10.9	22.8	16.5	9.5	25.2	36.3	14.9	27.1	16.9	44.5	32.8	29.2	51.2	65.6	30.4	40.6	27.0	6.8	25.9	7.7	35.6	28.5	30.5	36.7	28.4	28.2	36.6	33.2	24.9	26.7	7.7	21.5	23.4	22.6	39.7	33.6	7.2	11.4	9.1	7.9	6.6	6.1	12.6	5.0	10.0	10.3	14.9	27.9	70.7	37.1	67.5	10.3	9.4	17.8	21.4	18.2	5.2	0.0	37.6	31.5	37.9	238.8	33.8	44.6	23.3	57.3	97.5	36.2	30.0	89.1	10.6	78.7	11.1	24.6	27.6	51.6	232.5	24.5	64.4	47.2	70.3	24.3	13.8	42.5	28.1	17.7	22.6	3.9	19.4	54.6	336.3	94.8	62.0	50.1	65.4	35.5	32.5
DDX39B	"BAT1, D6S81E, UAP56"	ENSG00000198563	"DExD-box helicase 39B"	Q13838	6	31530219-31542448	"Enzymes, Plasma proteins, Predicted intracellular proteins, Transporters"	"mRNA processing, mRNA splicing, mRNA transport, Transport"	"Helicase, Hydrolase, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HEK 293: 40.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB034012, HPA055334, HPA058450"	Enhanced		Enhanced	"Nuclear speckles"		NA	NA		120000	"Nuclear speckles"		"CAB034012: AB_2243237, HPA055334: AB_2682787, HPA058450: AB_2683721"	"unprognostic (2.78e-2)"	"unprognostic (1.30e-2)"	"unprognostic (6.86e-3)"	"unprognostic (3.44e-2)"	"unprognostic (3.22e-2)"	"unprognostic (5.13e-3)"	"unprognostic (2.89e-2)"	"unprognostic (1.19e-2)"	"unprognostic (4.89e-3)"	"unprognostic (1.25e-1)"	"unprognostic (2.81e-2)"	"unprognostic (3.53e-3)"	"prognostic unfavorable (1.11e-6)"	"unprognostic (2.85e-1)"	"unprognostic (1.72e-1)"	"unprognostic (1.90e-2)"	"prognostic favorable (1.43e-5)"	27.1	31.0	16.1	33.3	20.6	11.3	29.1	37.3	22.7	34.9	35.4	31.8	25.6	8.2	53.4	75.4	40.2	43.5	23.8	28.3	16.3	12.8	25.3	28.6	29.1	26.5	19.2	15.6	49.8	36.8	17.6	50.6	25.9	19.7	35.3	19.3	35.3	26.4	34.4	39.0	24.7	33.2	25.8	30.8	39.9	27.7	21.3	17.8	45.5	31.2	30.5	37.1	32.9	27.7	5.1	8.5	3.8	6.2	3.4	7.4	5.5	3.0	16.3	13.5	6.6	13.7	11.8	7.8	3.5	3.9	10.1	9.1	4.1	4.0	3.1	11.8	16.9	14.1	5.6	15.3	26.0	9.6	2.7	40.9	5.5	4.8	9.7	4.5	7.5	6.1	18.2	15.6	10.2	32.1	18.0	6.3	18.0	24.1	2.5	8.4	2.1	6.6	27.4	5.7	6.0	2.9	5.6	6.0	3.7	20.4	4.0	6.2	17.2	6.9	3.1	4.0	13.2	2.3	6.5	3.5	1.3	4.9	1.3	9.0	10.3	12.8	25.3	0.8	10.5	5.4	3.5	6.1	3.8	5.4	6.2	6.7	4.5	6.8	6.5	8.5	5.1	7.4	6.8	3.4	3.4	5.6	6.5	7.3	5.5	16.1	20.6	37.3	22.7	16.3	12.8	19.2	15.6	19.7	17.8	20.8	37.5	38.9	22.5	12.8	19.8	3.5	7.6	48.2	27.3	3.5	21.6	11.5	5.0	7.9	0.9	17.1	14.7	0.0	7.0	10.1	12.1	18.4	34.8	5.8	8.7	14.3	16.6	10.4	8.9	2.2	15.0	21.5	8.5	8.2	7.4	10.4	7.8	9.3	11.0	4.1	27.3	25.8	12.7	6.0	5.9	11.8	14.2	27.4	8.6	20.7
DDX3X	"DBX, DDX14, DDX3, HLP2"	ENSG00000215301	"DEAD-box helicase 3, X-linked"	O00571	X	41333284-41364472	"Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Apoptosis, Chromosome partition, Host-virus interaction, Immunity, Innate immunity, Ribosome biogenesis, Transcription, Transcription regulation, Translation regulation"	"DNA-binding, Helicase, Hydrolase, RNA-binding"	"Cancer-related genes, Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	5	"Late spermatids: 631.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001648, HPA005631, HPA059585"	Supported	Supported	Approved	Nucleoplasm,Cytosol		NA	NA		110000	Cytosol	Nucleoplasm	"HPA001648: AB_1078635, HPA005631: AB_1078633, HPA059585: AB_2684073"	"unprognostic (2.42e-2)"	"unprognostic (1.11e-1)"	"unprognostic (8.01e-3)"	"unprognostic (1.66e-1)"	"unprognostic (8.12e-2)"	"unprognostic (6.43e-2)"	"unprognostic (1.17e-3)"	"unprognostic (1.88e-1)"	"unprognostic (9.80e-2)"	"unprognostic (1.40e-1)"	"unprognostic (3.25e-2)"	"unprognostic (2.05e-1)"	"unprognostic (1.51e-1)"	"unprognostic (2.95e-1)"	"unprognostic (4.77e-1)"	"unprognostic (9.44e-2)"	"unprognostic (2.93e-2)"	80.9	49.3	26.1	40.0	34.5	49.3	46.5	31.1	36.2	52.4	43.3	35.1	21.3	29.5	56.4	25.9	53.5	56.3	42.6	47.6	30.8	24.5	55.6	77.9	45.3	40.4	41.4	29.0	60.1	30.9	68.7	60.2	79.9	37.9	30.0	29.2	30.8	37.4	26.5	63.4	42.2	54.0	57.2	53.9	46.1	43.0	27.0	39.0	49.2	45.6	44.0	42.6	55.8	50.2	13.1	20.5	32.0	21.6	17.3	21.5	17.9	45.8	51.1	47.7	26.2	56.2	47.7	29.1	33.5	47.1	34.4	27.6	52.5	30.9	0.5	23.9	37.4	41.4	31.0	58.3	47.1	57.3	27.2	45.4	29.2	50.8	31.5	29.2	54.7	52.5	34.5	33.4	57.9	56.0	38.5	53.9	25.7	53.6	28.9	31.9	34.7	34.4	17.1	45.9	24.4	20.6	40.4	50.8	37.4	32.4	61.9	32.6	49.4	75.8	38.9	40.1	50.2	35.0	37.2	48.6	35.5	37.9	37.9	39.7	33.7	40.0	45.3	35.7	33.2	33.6	22.5	20.2	17.5	14.8	21.1	21.5	13.1	14.5	16.3	20.5	9.0	16.3	15.1	32.0	17.3	21.6	6.9	14.3	17.9	26.1	34.5	31.1	36.2	30.8	24.5	41.4	29.0	37.9	39.0	80.4	161.8	98.4	138.2	234.8	74.1	130.3	81.5	65.6	85.3	55.8	123.7	79.4	36.5	59.8	317.8	170.8	178.1	116.8	73.8	80.3	155.2	122.4	162.7	142.1	107.7	57.2	176.3	120.3	200.6	631.6	61.5	160.4	121.4	72.1	136.1	88.8	86.2	143.8	59.1	71.7	117.4	71.1	155.5	15.7	55.7	291.5	144.6	132.3	100.9	182.7
DDX3Y	DBY	ENSG00000067048	"DEAD-box helicase 3, Y-linked"	O15523	Y	12904108-12920478	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		"DNA-binding, Helicase, Hydrolase, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	9	"Early spermatids: 237.5;Late spermatids: 436.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Daudi: 41.3;HEL: 42.1;U-266/84: 34.9;U-698: 30.7"	"Low region specificity"	"Detected in all"							"HPA001648, HPA005631, HPA059583"	Enhanced	Supported	Supported	Nucleoplasm,Cytosol		NA	NA			Cytosol	Nucleoplasm	"HPA001648: AB_1078635, HPA005631: AB_1078633, HPA059583: "			"unprognostic (3.89e-2)"		"unprognostic (1.70e-1)"	"prognostic favorable (4.70e-5)"	"unprognostic (6.50e-2)"	"unprognostic (4.74e-2)"	"unprognostic (2.22e-2)"		"unprognostic (4.17e-2)"	"unprognostic (3.37e-2)"	"unprognostic (9.61e-2)"	"unprognostic (2.58e-3)"	"unprognostic (1.74e-1)"	"unprognostic (2.66e-2)"	"unprognostic (7.87e-2)"	12.0	10.5	4.9	29.5	14.1	46.1	8.7	17.0	16.3	0.4	24.4	12.6	31.5	7.6	0.4	29.7	12.2	0.4	14.2	10.8	5.6	7.1	8.9	26.5	20.0	17.7	5.7	0.0	0.4	14.5	0.4	12.2	14.0	20.2	26.7	15.8	15.1	20.4	32.6	17.7	8.4	16.0	40.7	6.2	34.3	8.9	41.9	0.0	26.9	10.8	21.4	19.3	14.4	0.0	6.1	8.8	6.5	7.1	6.5	8.4	3.8	0.1	7.7	0.0	0.0	0.0	0.0	5.6	18.9	13.5	10.0	12.3	0.0	0.0	41.3	0.0	18.6	0.0	0.0	0.0	0.0	17.6	10.3	0.0	42.1	0.0	12.4	9.9	0.0	0.0	10.5	11.8	0.0	0.0	0.0	0.0	4.2	0.0	0.0	11.8	0.0	16.3	0.0	7.5	0.0	0.0	0.0	5.0	7.6	10.6	11.4	12.4	0.0	0.0	0.0	13.8	12.7	0.0	9.8	13.5	15.5	0.0	0.0	12.4	22.3	34.9	30.7	1.9	0.0	0.0	1.6	6.2	5.7	8.4	7.1	7.7	6.1	6.4	7.1	8.8	5.9	7.8	6.5	6.5	6.5	4.6	2.5	5.7	3.8	4.9	14.1	17.0	16.3	5.6	7.1	5.7	0.0	20.2	0.0	44.7	70.4	32.3	85.6	83.6	48.4	24.1	12.7	117.8	50.0	8.7	39.3	34.0	5.0	8.7	237.5	56.2	0.0	0.0	0.2	11.4	45.1	53.9	88.1	0.6	15.6	39.7	15.3	28.3	37.0	436.7	35.9	93.0	25.3	15.4	3.7	57.0	8.2	0.0	37.1	14.7	46.4	19.4	59.7	36.2	65.8	70.3	31.6	51.1	0.0	62.4
DDX4	VASA	ENSG00000152670	"DEAD-box helicase 4"	Q9NQI0	5	55738017-55817157	"Enzymes, Predicted intracellular proteins"	"Differentiation, Meiosis, RNA-mediated gene silencing, Spermatogenesis"	"Developmental protein, Helicase, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	171	"testis: 60.4"	"Group enriched"	"Detected in some"	4	"Early spermatids: 435.1;Late spermatids: 140.2;Spermatocytes: 312.4"	"Cancer enriched"	"Detected in single"	37	"testis cancer: 3.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 6.1;HEK 293: 1.6;NB-4: 1.0;PC-3: 3.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"CAB026170, HPA037763, HPA037764"	Enhanced					NA	NA					"CAB026170: , HPA037763: AB_2675652, HPA037764: AB_2675653"	"unprognostic (1.49e-1)"	"unprognostic (1.15e-2)"		"unprognostic (1.54e-1)"	"unprognostic (2.58e-1)"	"unprognostic (3.80e-2)"	"unprognostic (3.03e-1)"	"unprognostic (5.35e-2)"	"unprognostic (3.91e-1)"	"unprognostic (3.77e-2)"	"unprognostic (3.28e-1)"	"unprognostic (5.73e-2)"	"unprognostic (5.43e-7)"	"unprognostic (4.84e-2)"	"unprognostic (1.12e-1)"	"unprognostic (5.60e-2)"	"unprognostic (1.55e-1)"	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	60.4	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.3	0.1	0.0	0.0	6.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	1.6	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	3.4	0.0	0.1	0.0	0.7	0.4	0.3	0.0	0.0	0.0	0.0	0.4	0.0	0.3	0.0	0.0	0.0	0.3	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	435.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	140.2	5.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	3.5	0.0	0.0	0.0	0.0	312.4	73.7	0.0	0.0	0.0	0.0	0.0
DDX41	"ABS, MGC8828"	ENSG00000183258	"DEAD-box helicase 41"	Q9UJV9	5	177511577-177517469	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	"Helicase, Hydrolase, RNA-binding"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA017911, HPA048803"	Supported		Supported	Nucleoplasm,Nucleoli		NA	NA			Nucleoplasm	Nucleoli	"HPA017911: AB_1847558, HPA048803: AB_2680527"	"unprognostic (2.52e-1)"	"unprognostic (1.51e-1)"	"unprognostic (7.57e-2)"	"unprognostic (1.02e-1)"	"unprognostic (2.34e-1)"	"unprognostic (2.61e-2)"	"unprognostic (4.21e-3)"	"unprognostic (2.60e-2)"	"unprognostic (1.92e-1)"	"unprognostic (1.25e-1)"	"unprognostic (2.89e-2)"	"unprognostic (4.47e-2)"	"prognostic unfavorable (2.21e-6)"	"unprognostic (1.41e-1)"	"unprognostic (1.22e-1)"	"unprognostic (2.23e-1)"	"unprognostic (1.75e-1)"	17.9	22.7	27.0	25.1	30.7	17.2	16.5	22.8	39.2	19.1	21.2	16.9	18.5	25.5	19.5	16.5	23.0	22.1	17.1	15.3	29.3	20.1	23.7	29.3	16.8	19.9	22.1	24.8	21.2	18.0	22.2	15.1	22.1	27.4	16.3	15.4	19.0	19.0	17.5	36.6	21.7	26.8	16.7	14.8	21.9	19.7	16.8	15.4	24.9	22.9	18.2	23.5	19.6	18.4	15.9	22.5	16.4	22.8	18.6	20.6	18.0	21.2	24.3	13.3	15.7	13.7	16.3	44.9	19.1	11.6	14.1	10.4	39.6	19.8	23.9	29.1	18.0	24.7	17.4	17.4	43.7	9.6	57.0	21.8	30.3	24.7	23.5	18.2	31.3	32.2	15.9	15.4	13.3	17.9	12.0	17.9	23.9	26.2	17.0	16.5	45.8	26.1	15.4	23.5	19.9	19.7	28.4	16.2	28.1	15.7	24.8	15.8	17.3	20.3	27.0	22.8	8.1	18.9	45.8	19.1	25.7	15.2	16.4	29.7	20.5	24.0	40.7	28.2	34.6	16.9	10.6	22.8	16.4	16.1	21.5	20.6	15.9	16.0	15.3	22.5	14.1	14.8	15.5	7.7	18.6	21.4	10.2	15.6	18.0	27.0	30.7	22.8	39.2	29.3	20.1	22.1	24.8	27.4	15.4	23.8	19.1	26.4	18.3	18.7	17.4	7.1	25.5	14.7	15.9	8.7	2.0	40.7	34.9	39.1	8.4	20.3	22.6	23.3	34.4	49.6	19.5	16.0	28.9	16.3	43.7	7.9	10.9	12.3	22.2	16.2	13.8	21.8	11.8	41.5	23.7	15.8	29.9	20.1	19.8	28.9	9.4	12.9	20.6	24.2	23.2	17.8	31.4	22.3	26.3	16.3
DDX42	"RHELP, RNAHP, SF3b125, SF3B8"	ENSG00000198231	"DEAD-box helicase 42"	Q86XP3	17	63773603-63819317	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Helicase, Hydrolase, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023447, HPA023571, HPA025941"	Approved		Enhanced	"Nuclear speckles"		NA	NA			"Nuclear speckles"		"HPA023447: AB_1847560, HPA023571: AB_1847561, HPA025941: AB_1847562"	"unprognostic (3.46e-1)"	"unprognostic (7.11e-2)"	"unprognostic (8.44e-2)"	"unprognostic (1.29e-1)"	"unprognostic (2.49e-2)"	"unprognostic (3.17e-2)"	"prognostic unfavorable (2.84e-4)"	"unprognostic (1.06e-1)"	"unprognostic (4.73e-2)"	"unprognostic (1.90e-1)"	"unprognostic (2.54e-2)"	"unprognostic (1.34e-2)"	"prognostic unfavorable (9.26e-4)"	"unprognostic (3.02e-1)"	"unprognostic (2.42e-1)"	"unprognostic (7.35e-2)"	"unprognostic (1.55e-2)"	32.4	28.2	27.1	26.3	39.4	24.2	32.5	34.1	40.7	39.1	31.2	33.7	20.9	23.0	39.2	30.7	26.1	34.4	35.1	25.6	25.6	26.7	23.0	25.7	26.4	27.5	29.6	35.8	43.5	41.8	36.8	26.2	30.7	34.1	39.0	28.0	28.8	34.0	35.6	44.7	29.2	26.7	37.7	27.3	26.9	30.5	28.6	21.5	33.2	26.1	21.8	33.7	42.6	25.4	7.6	5.0	8.4	4.4	6.7	6.6	2.8	30.9	32.6	29.3	30.1	29.8	24.1	31.7	30.5	27.5	28.0	27.5	30.6	20.5	43.4	12.0	34.1	23.2	24.9	33.1	27.1	37.1	12.7	21.7	32.6	31.6	37.1	29.4	37.7	22.4	30.7	25.9	25.3	30.8	23.8	27.7	22.5	36.2	18.4	28.3	25.3	36.0	21.1	28.0	24.9	17.5	31.5	50.5	22.2	25.5	36.6	18.5	35.1	23.0	41.6	26.0	43.3	28.5	31.2	29.4	41.4	25.3	16.7	35.8	20.6	16.5	40.0	21.3	20.9	21.7	2.6	3.9	8.4	6.2	3.2	6.6	4.1	5.2	6.1	5.0	7.6	6.6	6.4	2.9	6.7	4.4	3.0	3.1	2.8	27.1	39.4	34.1	40.7	25.6	26.7	29.6	35.8	34.1	21.5	74.5	54.3	18.8	21.3	27.7	38.2	41.5	22.9	75.0	64.8	34.9	35.3	28.4	11.6	24.6	7.1	33.8	21.4	0.0	23.3	19.4	28.9	33.4	29.0	26.8	20.2	47.7	39.1	29.4	29.5	9.8	45.1	26.6	13.5	54.1	34.3	42.7	31.2	24.6	47.4	18.9	43.5	38.8	36.0	46.6	53.5	26.0	22.9	19.5	33.8	26.7
DDX43	"CT13, DKFZp434H2114, HAGE"	ENSG00000080007	"DEAD-box helicase 43"	Q9NXZ2	6	73394748-73417569	"Enzymes, Predicted intracellular proteins"		"Helicase, Hydrolase, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"testis: 35.2"	"Group enriched"	"Detected in many"	6	"Spermatocytes: 50.6;Spermatogonia: 31.3"	"Cancer enriched"	"Detected in many"	15	"testis cancer: 13.0"	"Low region specificity"	"Detected in some"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"BEWO: 9.0;CAPAN-2: 15.1;HHSteC: 4.2;MCF7: 2.8;U-2 OS: 9.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA031381	Enhanced					NA	NA					"HPA031381: AB_10601885"	"unprognostic (4.03e-3)"	"unprognostic (8.20e-2)"	"unprognostic (2.06e-1)"	"unprognostic (1.01e-1)"	"unprognostic (2.19e-1)"	"unprognostic (3.59e-4)"	"unprognostic (1.64e-2)"	"unprognostic (3.11e-2)"	"unprognostic (1.20e-1)"	"unprognostic (2.15e-1)"	"unprognostic (3.12e-1)"	"unprognostic (3.08e-1)"	"unprognostic (1.19e-3)"	"unprognostic (1.02e-1)"	"unprognostic (2.68e-1)"	"unprognostic (1.58e-1)"	"unprognostic (8.78e-2)"	1.3	0.7	0.6	1.0	0.7	0.7	1.9	0.4	0.8	0.8	2.6	1.2	2.1	1.4	1.0	0.4	1.1	0.7	6.1	1.2	0.7	0.6	0.8	1.0	1.6	0.9	1.0	0.0	2.9	1.9	0.1	0.7	5.7	3.3	1.8	0.7	1.5	4.3	2.2	0.4	1.4	1.7	3.0	1.9	1.2	2.4	35.2	0.7	0.4	1.8	1.3	1.9	1.7	0.7	2.3	0.8	2.9	0.9	1.6	3.3	0.7	0.0	0.0	0.0	0.0	0.0	0.0	9.0	0.5	0.0	0.0	0.0	0.1	15.1	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	4.2	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	9.7	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.4	2.9	3.3	0.9	2.6	2.3	2.5	2.8	0.8	2.3	1.3	0.4	0.6	1.6	0.8	0.2	1.4	0.7	0.6	0.7	0.4	0.8	0.7	0.6	1.0	0.0	3.3	0.7	3.0	4.8	0.5	1.1	2.4	0.3	0.4	0.0	1.4	3.4	0.0	0.0	6.5	0.0	0.4	2.2	2.2	0.0	0.0	0.8	2.9	1.1	0.4	0.0	0.0	2.2	0.0	0.0	0.0	0.0	3.3	2.0	1.8	3.3	1.0	0.0	0.4	1.3	0.0	1.1	1.4	0.9	0.0	0.4	50.6	31.3	1.3	5.0	2.5	0.0	0.7
DDX46	"FLJ25329, KIAA0801, Prp5, PRPF5"	ENSG00000145833	"DEAD-box helicase 46"	Q7L014	5	134758771-134855133	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	"Helicase, Hydrolase, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036554, HPA057501"	Supported		Supported	"Nucleoli fibrillar center,Nuclear speckles"		NA	NA			"Nuclear speckles"	"Nucleoli fibrillar center"	"HPA036554: AB_10673621, HPA057501: AB_2683449"	"unprognostic (1.88e-1)"	"unprognostic (1.21e-1)"	"prognostic favorable (9.01e-6)"	"unprognostic (7.00e-2)"	"unprognostic (3.37e-2)"	"unprognostic (1.71e-2)"	"unprognostic (2.04e-3)"	"unprognostic (1.07e-1)"	"unprognostic (1.60e-2)"	"unprognostic (5.05e-2)"	"unprognostic (9.21e-2)"	"unprognostic (6.02e-2)"	"unprognostic (9.70e-3)"	"unprognostic (4.36e-2)"	"unprognostic (4.35e-2)"	"unprognostic (1.64e-2)"	"unprognostic (4.50e-2)"	22.2	21.8	18.8	29.4	23.8	22.7	22.7	39.0	24.8	25.1	21.4	17.5	18.6	19.0	26.8	19.8	23.7	21.0	15.8	18.3	17.7	13.0	22.9	22.7	21.6	26.6	22.9	15.1	25.8	24.2	27.2	37.5	22.1	21.7	19.0	24.2	12.8	23.9	23.3	46.6	26.3	23.0	24.6	27.8	30.0	22.2	17.8	25.9	40.4	22.1	21.0	29.1	23.1	28.9	27.0	23.5	34.6	19.9	19.4	20.4	9.7	26.0	23.9	17.1	22.2	6.7	7.5	23.6	17.5	13.6	18.5	20.9	36.2	19.1	32.9	15.1	11.7	19.7	16.2	25.1	16.7	21.9	22.1	22.8	39.6	26.2	14.6	5.8	35.9	21.4	6.7	9.1	19.5	11.0	7.9	14.6	26.6	33.6	14.2	13.7	12.4	30.9	14.0	23.5	15.2	10.8	27.0	44.7	16.6	10.1	22.6	20.3	19.4	24.5	11.6	12.6	20.8	18.2	20.6	18.1	19.7	13.7	15.0	34.6	11.2	30.3	43.7	13.6	34.2	12.4	25.7	19.9	27.6	20.0	17.5	18.0	22.0	19.6	19.8	15.2	27.0	20.4	20.3	34.6	19.4	15.7	23.5	17.1	9.7	18.8	23.8	39.0	24.8	17.7	13.0	22.9	15.1	21.7	25.9	71.5	105.7	105.4	97.5	101.1	127.7	65.7	58.6	77.6	91.0	97.7	78.5	115.9	48.0	74.4	33.8	94.6	63.5	46.7	93.1	132.3	81.3	98.0	97.2	105.0	85.5	114.4	88.5	70.0	102.8	19.1	103.6	110.8	54.0	131.7	71.2	91.8	98.0	56.1	106.4	70.1	171.0	97.0	97.9	194.9	273.4	119.7	131.5	115.4	84.3	132.0
DDX47	"DKFZp564O176, FLJ30012, HQ0256, RRP3"	ENSG00000213782	"DEAD-box helicase 47"	Q9H0S4	12	12813316-12829981	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Apoptosis, mRNA processing, mRNA splicing, rRNA processing"	"Helicase, Hydrolase, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Ductal cells: 21.7;Exocrine glandular cells: 15.4;monocytes: 16.2;Pancreatic endocrine cells: 18.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA014855	Approved		Supported	Nucleoli		NA	NA			Nucleoli		"HPA014855: AB_1847567"	"unprognostic (3.14e-2)"	"unprognostic (1.21e-1)"	"unprognostic (2.11e-1)"	"unprognostic (1.75e-2)"	"unprognostic (2.38e-1)"	"unprognostic (4.91e-2)"	"unprognostic (5.84e-4)"	"unprognostic (1.96e-1)"	"unprognostic (1.11e-2)"	"unprognostic (1.13e-3)"	"unprognostic (2.79e-1)"	"unprognostic (3.49e-3)"	"unprognostic (6.55e-9)"	"unprognostic (1.68e-1)"	"unprognostic (1.27e-1)"	"unprognostic (3.24e-1)"	"unprognostic (8.20e-6)"	29.3	24.1	19.9	21.6	25.6	31.0	29.1	27.4	26.9	26.7	26.2	28.2	21.4	16.0	33.7	21.0	28.9	27.5	17.9	22.6	20.0	19.4	29.6	38.1	23.2	26.1	28.2	19.9	33.7	31.0	25.8	23.8	27.6	25.1	29.2	24.2	25.5	27.1	27.7	40.6	28.1	20.4	34.1	21.4	25.6	28.0	26.8	29.8	29.7	39.4	27.9	33.7	35.7	26.7	22.0	25.0	3.5	19.1	16.6	26.0	14.0	39.7	17.2	16.9	13.7	16.7	16.4	28.9	17.1	19.7	36.6	34.3	26.0	25.7	20.5	6.7	23.2	22.7	26.0	24.2	19.7	41.3	28.9	17.4	18.7	12.8	14.8	14.2	21.3	12.1	15.8	18.8	21.7	18.0	28.8	28.1	16.2	18.1	4.6	20.0	14.2	17.2	14.8	74.3	18.5	10.6	19.2	32.9	12.4	22.3	28.7	7.4	18.8	20.8	13.4	17.0	43.8	5.4	16.1	12.6	14.8	35.9	9.5	25.7	6.5	11.8	37.1	15.7	11.2	17.0	3.3	14.4	3.5	21.8	19.1	26.0	22.0	19.4	20.1	25.0	21.2	25.8	24.2	1.7	16.6	18.2	14.7	18.7	14.0	19.9	25.6	27.4	26.9	20.0	19.4	28.2	19.9	25.1	29.8	3.0	8.0	0.9	2.5	1.9	0.8	0.1	0.0	10.7	13.6	0.0	0.0	1.3	1.7	21.7	0.1	1.6	2.0	0.0	15.4	1.6	1.0	1.6	11.5	0.8	0.7	0.0	4.6	1.3	0.6	0.0	0.6	1.3	0.0	16.2	4.5	1.4	18.4	2.9	0.4	0.6	1.3	6.5	0.5	0.2	0.6	1.6	1.1	5.0	6.2	2.0
DDX49	"Dbp8, FLJ10432"	ENSG00000105671	"DEAD-box helicase 49"	Q9Y6V7	19	18919675-18928633	"Enzymes, Predicted intracellular proteins"		"Helicase, Hydrolase, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041870, HPA048093"	Enhanced		Approved	Mitochondria		NA	NA			Mitochondria		"HPA041870: AB_2677717, HPA048093: AB_2680262"	"unprognostic (3.51e-1)"	"prognostic favorable (2.01e-6)"	"unprognostic (2.28e-2)"	"unprognostic (1.28e-1)"	"unprognostic (8.56e-2)"	"unprognostic (1.60e-2)"	"prognostic unfavorable (7.05e-4)"	"unprognostic (4.12e-2)"	"unprognostic (2.41e-3)"	"unprognostic (8.67e-2)"	"unprognostic (6.46e-3)"	"unprognostic (5.13e-2)"	"prognostic unfavorable (7.44e-5)"	"unprognostic (3.93e-2)"	"unprognostic (2.99e-2)"	"unprognostic (4.97e-2)"	"unprognostic (3.24e-1)"	14.8	16.8	17.6	17.3	16.9	28.3	18.0	17.0	30.7	15.3	15.8	19.0	14.8	19.5	15.6	13.2	23.4	16.5	12.2	18.2	19.2	12.9	15.5	25.6	13.0	19.3	15.7	14.8	15.7	26.8	13.0	11.1	23.3	16.2	15.5	10.3	13.5	24.3	15.8	27.2	23.6	18.7	12.7	16.8	16.7	15.7	19.7	16.3	23.4	18.8	16.6	18.7	16.4	15.6	8.2	25.0	13.5	19.5	14.1	14.0	9.7	15.8	16.5	6.7	21.0	9.8	7.9	25.2	10.1	6.8	17.9	14.5	18.8	16.1	20.8	30.9	10.0	5.7	13.6	14.9	13.8	5.1	6.3	39.6	10.2	17.9	16.3	23.3	26.1	14.2	15.7	13.3	14.2	15.0	5.0	8.1	16.6	19.2	14.9	6.3	35.5	18.9	12.2	21.8	17.2	40.3	21.0	11.2	22.5	9.6	10.0	23.6	24.3	13.3	13.2	16.1	3.7	13.5	12.6	10.4	8.7	9.8	31.5	16.5	19.6	23.4	19.0	11.0	30.2	13.6	10.5	17.7	13.5	12.8	19.5	10.6	8.1	9.7	9.6	25.0	8.2	9.7	10.2	7.9	14.1	12.6	11.2	14.0	9.7	17.6	16.9	17.0	30.7	19.2	12.9	15.7	14.8	16.2	16.3	3.0	7.7	21.6	16.0	20.0	17.5	12.5	15.3	8.1	12.5	17.4	3.9	39.6	31.5	25.8	28.0	10.8	42.3	0.0	45.8	41.7	17.9	16.3	18.4	13.9	29.8	9.5	24.8	8.0	19.8	81.0	19.8	18.3	25.3	26.2	20.9	16.0	25.6	30.6	18.7	21.4	20.9	19.4	20.2	29.7	36.4	24.7	35.2	15.8	30.7	17.3
DDX5	"G17P1, HLR1, p68"	ENSG00000108654	"DEAD-box helicase 5"	P17844	17	64499616-64508199	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins"	"Biological rhythms, mRNA processing, mRNA splicing, Transcription, Transcription regulation"	"Helicase, Hydrolase, RNA-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB005868, HPA020043, HPA071154"	Supported		Supported	Nucleoplasm,Nucleoli		No	No		150000	"Nucleoplasm, Nucleoli"		"CAB005868: AB_446484, HPA020043: AB_1847572, HPA071154: "	"unprognostic (6.64e-2)"	"unprognostic (6.98e-2)"	"prognostic favorable (2.12e-4)"	"unprognostic (8.94e-2)"	"unprognostic (5.08e-2)"	"unprognostic (9.85e-2)"	"unprognostic (5.80e-2)"	"unprognostic (1.61e-2)"	"unprognostic (3.17e-2)"	"unprognostic (4.71e-2)"	"unprognostic (3.03e-3)"	"unprognostic (1.44e-1)"	"unprognostic (4.00e-1)"	"unprognostic (2.08e-1)"	"unprognostic (2.37e-1)"	"unprognostic (2.17e-1)"	"unprognostic (9.28e-3)"	91.6	61.4	46.9	80.0	68.0	108.3	94.7	61.6	58.9	81.6	81.1	53.3	104.2	27.4	106.7	94.5	64.5	96.9	101.4	53.9	48.5	30.6	53.1	68.0	84.8	70.9	62.8	44.1	74.0	49.3	88.9	110.5	56.6	73.1	59.5	55.4	50.9	62.2	103.6	77.6	59.7	54.7	113.1	71.0	67.6	69.0	39.7	57.8	82.1	81.1	77.7	69.3	91.0	63.9	46.9	59.6	66.4	66.2	40.3	60.8	109.8	55.1	20.8	63.0	39.9	58.4	55.0	40.1	54.7	70.6	67.1	67.2	22.5	33.8	80.9	31.4	71.8	47.8	32.9	67.8	62.9	75.9	28.7	48.7	52.6	15.9	17.2	42.8	66.9	56.1	61.9	54.3	61.3	47.8	37.4	71.6	69.9	41.7	69.1	51.7	32.8	139.9	19.5	36.7	50.9	64.3	87.6	66.6	56.9	41.1	26.5	44.3	74.3	53.1	51.5	66.6	56.7	48.2	37.7	50.3	40.8	45.6	43.9	56.6	38.6	76.1	142.8	43.2	32.9	48.1	66.4	62.5	66.4	53.7	56.9	60.8	46.9	42.9	51.7	59.6	46.8	44.5	43.1	37.8	40.3	66.2	37.0	50.2	109.8	46.9	68.0	61.6	58.9	48.5	30.6	62.8	44.1	73.1	57.8	497.3	661.1	481.3	1231.3	781.2	369.6	221.7	262.4	725.4	624.4	350.7	316.1	372.7	283.5	416.6	432.3	643.3	503.6	116.8	366.6	307.8	528.8	417.0	836.7	222.3	399.0	397.3	638.0	483.1	539.2	80.3	384.6	631.0	410.0	779.1	366.4	576.1	376.0	445.4	411.5	208.8	514.0	485.0	599.5	374.0	341.8	652.0	741.9	719.3	310.9	1106.4
DDX50	"GU2, GUB, MGC3199, RH-II/GuB"	ENSG00000107625	"DExD-box helicase 50"	Q9BQ39	10	68901278-68946847	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Helicase, Hydrolase, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037388, HPA037389, HPA058196"	Approved		Enhanced	Nucleoli		NA	NA			Nucleoli		"HPA037388: AB_10671752, HPA037389: AB_2675450, HPA058196: AB_2683635"	"unprognostic (2.05e-1)"	"unprognostic (3.36e-1)"	"unprognostic (9.90e-2)"	"unprognostic (9.75e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.23e-1)"	"unprognostic (1.47e-3)"	"unprognostic (2.62e-1)"	"unprognostic (1.97e-1)"	"unprognostic (8.78e-2)"	"unprognostic (4.57e-2)"	"unprognostic (1.44e-1)"	"unprognostic (4.22e-3)"	"unprognostic (1.22e-2)"	"unprognostic (2.38e-2)"	"unprognostic (4.91e-2)"	"unprognostic (1.02e-1)"	25.0	17.8	16.7	25.5	19.2	14.7	24.8	20.8	17.0	26.5	25.3	13.1	24.0	12.9	30.0	22.6	24.0	23.0	17.5	20.3	15.7	15.0	18.6	16.1	16.4	24.5	17.6	15.0	35.3	24.1	24.9	35.2	23.0	16.1	30.0	18.1	12.6	19.5	25.0	26.6	18.3	17.4	31.9	18.3	22.0	19.9	25.6	17.3	33.0	26.1	21.5	25.7	35.4	27.2	14.2	10.3	10.7	12.2	13.8	20.2	10.9	19.3	12.5	22.2	27.5	18.9	24.8	14.2	20.7	22.8	18.7	17.7	28.0	16.9	25.2	12.5	18.2	11.7	17.4	21.5	15.2	23.5	22.1	16.3	13.5	12.4	12.2	19.1	28.1	16.9	19.0	15.9	17.8	49.8	33.6	15.0	22.0	24.1	15.4	23.0	15.5	26.9	27.0	12.9	18.6	28.1	23.3	25.3	4.6	14.7	11.6	15.5	21.4	15.2	17.8	22.8	21.6	20.7	18.3	13.0	14.6	17.1	16.5	28.1	20.9	18.8	21.4	15.7	29.4	8.5	5.5	7.8	10.7	15.0	12.2	18.3	13.6	18.5	15.4	10.3	14.2	20.2	17.7	2.7	13.8	9.6	10.2	16.1	10.9	16.7	19.2	20.8	17.0	15.7	15.0	17.6	15.0	16.1	17.3	17.9	17.1	30.4	30.5	10.5	42.7	23.6	20.4	29.4	34.2	19.2	37.3	35.2	48.0	24.1	57.6	24.3	8.9	0.0	21.8	33.0	25.7	18.5	40.6	13.5	20.5	35.0	15.5	22.1	18.1	12.1	33.6	21.7	11.8	39.7	18.2	20.9	20.8	18.4	36.7	25.1	51.1	19.4	28.1	54.0	56.0	12.5	34.4	41.5	21.3	16.8
DDX51		ENSG00000185163	"DEAD-box helicase 51"	Q8N8A6	12	132136594-132144335	"Enzymes, Predicted intracellular proteins"	"Ribosome biogenesis, rRNA processing"	"Helicase, Hydrolase, RNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Horizontal cells: 31.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039503	Uncertain		Approved	Nucleoplasm,Nucleoli,Cytosol		NA	NA			"Nucleoplasm, Nucleoli"	Cytosol	"HPA039503: AB_10796328"	"unprognostic (2.84e-3)"	"unprognostic (1.69e-2)"	"unprognostic (1.43e-1)"	"unprognostic (2.84e-1)"	"unprognostic (8.66e-2)"	"unprognostic (4.00e-2)"	"prognostic unfavorable (4.73e-4)"	"unprognostic (1.13e-1)"	"unprognostic (1.42e-1)"	"unprognostic (4.88e-1)"	"unprognostic (3.05e-3)"	"unprognostic (5.31e-2)"	"unprognostic (3.97e-2)"	"unprognostic (2.48e-1)"	"unprognostic (4.69e-2)"	"unprognostic (3.28e-1)"	"unprognostic (1.65e-3)"	10.5	8.5	12.7	12.7	17.1	17.2	10.3	23.5	18.9	8.8	8.4	11.8	10.6	7.8	11.5	12.2	8.5	12.4	10.0	8.1	11.6	9.9	9.5	7.2	8.9	11.1	10.5	16.9	19.6	14.8	10.1	9.8	7.2	11.8	9.3	7.3	8.9	10.7	12.4	13.8	18.0	8.2	10.4	10.5	10.6	9.3	6.7	12.0	9.5	9.9	7.1	10.4	9.3	8.6	2.5	2.3	2.6	2.1	1.6	2.0	1.0	6.2	10.1	4.2	5.3	4.0	3.9	8.0	4.8	2.9	7.2	3.0	6.2	3.1	10.9	4.2	2.9	1.7	6.6	10.5	7.7	3.5	2.6	10.1	12.9	5.4	2.0	4.9	9.0	7.5	3.4	5.7	4.0	3.6	8.1	3.8	12.2	9.5	3.6	2.1	6.2	11.0	18.5	7.4	5.3	17.4	13.1	5.8	12.1	4.9	5.0	10.3	5.4	5.3	7.5	5.3	3.7	6.6	8.3	6.7	2.7	8.3	6.6	11.1	10.2	5.9	12.8	5.6	6.9	6.3	1.1	2.1	1.2	2.0	1.0	0.7	1.5	1.3	0.9	0.6	2.5	1.2	1.6	2.6	1.6	1.0	2.3	0.6	1.0	12.7	17.1	23.5	18.9	11.6	9.9	10.5	16.9	11.8	12.0	3.0	15.9	3.0	6.8	11.1	27.9	4.0	10.2	4.0	13.6	3.5	23.6	6.0	1.7	4.0	0.9	7.7	3.5	0.0	4.5	4.9	6.5	7.3	5.8	6.4	4.9	31.8	8.1	7.4	6.2	0.7	7.8	5.7	10.1	3.6	8.3	11.1	5.4	7.0	7.8	2.9	27.4	0.0	6.4	5.7	9.4	12.3	3.4	6.9	12.1	5.8
DDX52	ROK1	ENSG00000278053	"DExD-box helicase 52"	Q9Y2R4	17	37609739-37643464	"Enzymes, Predicted intracellular proteins"		"Helicase, Hydrolase, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Early spermatids: 210.7"	"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA056173	Uncertain		Supported	Nucleoplasm,Nucleoli		NA	NA			"Nucleoplasm, Nucleoli"		"HPA056173: AB_2683056"	"unprognostic (1.05e-2)"	"unprognostic (1.85e-1)"	"prognostic favorable (9.41e-4)"	"unprognostic (4.26e-2)"	"unprognostic (9.96e-3)"	"unprognostic (6.77e-2)"	"prognostic unfavorable (2.44e-6)"	"unprognostic (5.10e-2)"	"unprognostic (2.94e-2)"	"unprognostic (2.79e-1)"	"unprognostic (7.50e-2)"	"unprognostic (2.43e-1)"	"unprognostic (2.36e-1)"	"unprognostic (6.95e-2)"	"unprognostic (5.58e-1)"	"unprognostic (1.26e-2)"	"unprognostic (1.28e-1)"	6.4	4.5	4.3	5.3	5.5	9.1	4.6	8.1	6.5	6.9	6.1	4.8	5.0	5.9	7.8	10.7	6.7	3.5	5.0	3.0	4.5		9.4	7.1	4.2	5.1	5.4	3.1	6.3	4.4	6.2	8.8	5.8	6.5	6.1	6.0	4.0	4.1	4.8	6.7	6.0	10.6	4.8	6.2	5.7	4.8	4.8	4.9	8.7	5.7	5.8	6.1	6.0	6.9	4.0	5.7	3.5	4.2	3.5	4.7	1.5	4.8	9.9	1.0	9.8	5.5	4.9	4.2	6.5	5.8	8.6	8.3	5.0	1.8	2.7	4.5	4.3	1.8	4.4	10.9	7.1	11.5	6.5	12.3	6.1	6.2	4.0	5.4	7.8	3.2	5.1	7.3	5.6	6.9	4.1	9.8	2.7	0.8	1.9	5.0	1.5	11.7	4.0	5.6	2.7	0.4	7.6	8.6	5.0	9.7	5.4	7.2	5.8	7.8	1.8	4.8	5.7	3.4	6.0	6.6	7.0	4.4	3.6	7.4	2.4	3.9	5.5	5.7	4.9	5.5	3.4	3.2	3.5	4.2	4.2	3.3	3.6	4.0	3.5	2.3	4.0	3.4	4.7	2.8	3.5	2.4	5.7	3.1	1.5											38.7	19.5	26.1	27.2	30.7	28.6	28.7	28.1	28.1	38.7	26.2	31.4	30.7	29.9	64.6	210.7	26.3	24.7	0.0	45.3	25.7	21.9	24.4	26.5	32.8	22.8	44.5	25.2	29.4	23.8	70.2	22.7	23.7	16.9	47.7	26.7	23.2	47.9	21.0	22.6	32.3	32.6	25.8	12.6	28.9	57.6	29.1	20.9	34.4	36.5	43.1
DDX53	"CAGE, CT26"	ENSG00000184735	"DEAD-box helicase 53"	Q86TM3	X	22999961-23003589	"Enzymes, Predicted intracellular proteins"		"Helicase, Hydrolase, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	33	"testis: 11.5"	"Cell type enriched"	"Detected in some"	5	"Early spermatids: 47.4"	"Cancer enhanced"	"Detected in single"		"testis cancer: 0.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"GAMG: 4.6;K-562: 6.3;RPMI-8226: 3.3;U-2197: 2.1;U-266/84: 14.1"					"Low region specificity"	"Detected in many"			HPA003186			Supported	Nucleoplasm,Nucleoli,Cytosol		NA	NA			Nucleoplasm	"Nucleoli, Cytosol"	"HPA003186: AB_1078637"														"unprognostic (5.76e-1)"	"unprognostic (1.12e-1)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.3	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	4.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	2.1	0.0	0.4	14.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	47.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	6.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	10.0	8.8	0.0	0.0	0.0	0.0	0.0
DDX54	"APR-5, DP97, MGC2835"	ENSG00000123064	"DEAD-box helicase 54"	Q8TDD1	12	113157174-113185479	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Helicase, Hydrolase, RNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028244, HPA070786"	Approved		Approved	"Nucleoplasm,Nucleoli,Golgi apparatus"		NA	NA			"Nucleoplasm, Nucleoli, Golgi apparatus"		"HPA028244: AB_10603885, HPA070786: AB_2686311"	"unprognostic (1.61e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.23e-1)"	"unprognostic (8.54e-2)"	"unprognostic (8.57e-2)"	"unprognostic (6.39e-2)"	"prognostic unfavorable (1.39e-4)"	"unprognostic (2.23e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.08e-1)"	"unprognostic (1.01e-1)"	"unprognostic (4.83e-2)"	"unprognostic (1.15e-1)"	"unprognostic (2.29e-2)"	"unprognostic (2.01e-1)"	"unprognostic (2.22e-1)"	"unprognostic (1.24e-1)"	17.2	17.6	9.2	20.7	12.8	25.4	17.2	9.9	13.6	17.9	16.4	12.4	18.1	20.3	18.0	19.4	19.5	17.2	17.9	20.1	8.8	7.9	22.3	28.6	14.0	19.9	8.1	9.4	22.4	27.0	18.3	7.4	22.6	10.0	16.6	9.0	13.4	17.4	13.9	45.4	18.7	19.4	14.8	8.1	22.2	16.1	11.4	8.6	26.6	23.1	21.6	22.2	16.7	17.5	12.1	13.3	8.0	15.2	11.9	13.0	10.0	26.8	28.1	10.5	19.3	7.0	8.5	27.1	14.6	13.6	20.0	11.0	28.9	13.1	34.9	17.2	12.2	14.9	20.0	18.6	19.0	7.6	20.0	22.8	20.9	15.1	19.7	12.4	34.9	24.8	13.9	15.1	19.3	11.9	16.4	16.3	21.2	30.3	12.5	10.2	24.8	30.0	49.8	24.5	18.9	20.0	22.3	15.5	35.6	10.9	28.1	13.6	12.4	20.7	31.8	13.2	9.0	27.3	27.3	12.1	17.0	19.0	20.1	30.4	18.3	20.8	39.2	15.0	19.5	17.8	8.0	10.0	2.3	12.4	15.2	13.0	11.6	11.4	12.2	13.3	12.1	11.8	12.5	0.6	11.9	9.8	10.0	9.4	10.0	9.2	12.8	9.9	13.6	8.8	7.9	8.1	9.4	10.0	8.6	29.8	28.0	32.1	27.0	15.3	20.2	12.4	20.4	10.7	21.6	12.2	2.0	51.4	21.6	35.0	0.9	19.7	30.2	23.3	43.1	46.0	18.7	23.5	24.3	35.5	34.5	25.4	27.1	15.4	31.7	2.1	27.3	23.0	11.8	23.4	28.6	23.8	38.0	38.2	22.6	34.9	18.1	6.5	18.9	15.4	18.9	17.1	60.5	37.3	38.2	32.3
DDX55	KIAA1595	ENSG00000111364	"DEAD-box helicase 55"	Q8NHQ9	12	123602077-123620941	"Enzymes, Predicted intracellular proteins"		"Helicase, Hydrolase, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039962, HPA044101"	Approved		Enhanced	Nucleoplasm,Nucleoli		NA	NA			Nucleoli	Nucleoplasm	"HPA039962: AB_2676774, HPA044101: AB_2678810"	"unprognostic (1.14e-1)"	"unprognostic (2.30e-2)"	"unprognostic (2.29e-1)"	"unprognostic (3.71e-3)"	"unprognostic (1.92e-1)"	"unprognostic (2.31e-1)"	"prognostic unfavorable (2.11e-9)"	"unprognostic (1.60e-1)"	"unprognostic (4.49e-2)"	"unprognostic (7.39e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.67e-3)"	"prognostic unfavorable (8.97e-12)"	"unprognostic (9.15e-3)"	"unprognostic (2.94e-1)"	"unprognostic (3.47e-2)"	"unprognostic (1.23e-3)"	15.0	13.5	12.3	16.4	14.0	27.7	16.3	21.4	13.9	13.0	13.2	15.7	16.2	12.0	14.7	13.2	14.2	15.0	11.8	8.8	11.4	10.9	10.2	17.8	11.2	19.9	15.6	10.3	17.5	25.9	13.8	20.3	12.3	14.4	14.4	14.5	11.9	15.2	12.6	12.6	21.4	12.9	11.9	10.5	18.8	11.6	11.2	14.8	16.9	12.2	12.5	16.5	11.9	23.1	13.4	12.8	7.3	10.0	12.2	15.7	8.5	10.1	14.5	11.1	11.2	9.6	7.6	16.8	12.6	4.6	11.3	7.8	16.4	7.5	15.1	10.1	5.5	10.2	12.6	16.9	9.4	13.2	11.3	15.3	20.4	16.0	12.1	7.3	25.0	16.1	6.4	10.0	13.4	15.5	8.8	8.1	12.3	20.8	8.0	7.9	10.5	24.5	34.1	17.2	11.8	14.4	18.5	11.9	9.8	7.9	17.7	13.2	11.0	10.3	13.4	17.2	9.7	23.8	16.2	8.3	9.8	12.9	15.9	15.6	14.8	18.3	27.4	9.3	18.0	16.6	2.8	9.2	7.3	12.0	10.0	12.7	13.4	11.6	12.5	7.5	11.3	15.7	14.7	5.6	12.2	5.9	12.8	9.1	8.5	12.3	14.0	21.4	13.9	11.4	10.9	15.6	10.3	14.4	14.8	20.8	11.5	9.0	8.3	9.7	18.5	2.2	7.6	13.4	10.3	7.0	21.6	11.2	6.6	9.6	42.5	10.5	5.1	46.7	10.4	13.9	10.1	8.4	24.3	8.5	12.6	14.3	6.9	6.2	6.6	50.7	15.8	7.9	6.8	4.6	10.5	15.6	11.6	7.0	13.8	5.4	25.4	6.5	8.5	17.9	19.6	14.8	6.4	10.2	8.3	7.8
DDX56	NOH61	ENSG00000136271	"DEAD-box helicase 56"	Q9NY93	7	44565417-44575051	"Enzymes, Predicted intracellular proteins"	"Ribosome biogenesis, rRNA processing"	"Helicase, Hydrolase, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019749, CAB037320"	Uncertain		Supported	"Nucleoli,Mitotic chromosome"		NA	NA			Nucleoli	"Mitotic chromosome"	"CAB037320: , HPA019749: AB_1847579"	"unprognostic (3.28e-1)"	"unprognostic (1.05e-1)"	"unprognostic (5.00e-2)"	"unprognostic (1.93e-1)"	"unprognostic (6.08e-3)"	"unprognostic (2.12e-3)"	"prognostic unfavorable (1.38e-5)"	"unprognostic (5.17e-2)"	"unprognostic (2.76e-1)"	"unprognostic (7.07e-2)"	"unprognostic (1.00e-2)"	"unprognostic (6.01e-3)"	"prognostic unfavorable (8.41e-7)"	"unprognostic (2.60e-1)"	"unprognostic (2.88e-2)"	"unprognostic (1.50e-1)"	"unprognostic (4.90e-2)"	12.8	12.0	10.3	12.4	11.9	12.4	9.2	13.6	18.9	11.9	10.0	12.2	8.6	11.9	12.8	10.3	13.1	12.6	12.5	9.3	10.6	9.9	17.7	29.2	8.9	13.2	10.4	9.3	15.0	22.5	13.1	11.9	12.3	12.2	14.1	9.0	11.0	16.9	11.5	16.9	16.3	11.4	8.4	8.8	12.1	10.6	14.6	10.9	14.5	13.8	16.7	15.1	9.2	10.3	12.8	16.0	6.9	16.5	15.7	12.3	12.7	7.6	20.5	1.6	4.4	2.0	2.0	6.8	7.3	3.7	8.3	7.3	13.2	7.6	13.5	9.5	2.7	11.4	13.1	3.3	7.3	1.5	5.0	20.8	8.9	13.0	10.1	3.6	9.3	5.0	2.9	5.3	7.4	4.6	1.5	4.2	5.0	18.3	3.8	5.3	10.1	4.7	8.6	11.1	6.6	19.3	3.8	7.2	5.3	4.7	8.2	5.2	8.4	9.6	15.0	5.5	1.3	10.9	9.6	8.9	6.8	9.9	4.6	18.3	12.4	19.0	19.4	7.5	11.4	9.5	6.9	11.8	4.3	9.9	15.3	12.3	11.5	10.7	11.1	16.0	12.8	12.3	10.3	0.4	15.7	16.5	7.7	10.1	12.7	10.3	11.9	13.6	18.9	10.6	9.9	10.4	9.3	12.2	10.9	14.9	25.3	16.0	20.1	15.1	25.2	10.8	12.7	24.1	34.2	21.0	13.7	48.6	23.2	34.9	39.1	23.8	26.9	0.0	28.4	38.8	18.4	15.9	27.7	27.7	31.4	6.4	17.7	18.4	10.1	30.0	19.5	17.4	13.5	32.5	19.6	20.6	31.1	20.1	18.7	40.8	23.2	12.9	20.6	30.2	29.0	17.3	39.5	18.7	27.0	18.1
DDX58	"DKFZp434J1111, FLJ13599, RIG-I"	ENSG00000107201	"DExD/H-box helicase 58"	O95786	9	32455705-32526324	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Antiviral defense, Host-virus interaction, Immunity, Innate immunity"	"Helicase, Hydrolase, RNA-binding"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+ SV40 Large T+: 45.5;BJ hTERT+ SV40 Large T+ RasG12V: 47.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB012643, HPA047193"	Uncertain		Approved	"Plasma membrane,Cytosol"		No	No			"Plasma membrane"	Cytosol	"CAB012643: , HPA047193: AB_2679978"	"unprognostic (1.10e-1)"	"unprognostic (4.65e-2)"	"unprognostic (6.56e-2)"	"prognostic unfavorable (5.46e-4)"	"unprognostic (2.45e-1)"	"unprognostic (2.37e-1)"	"unprognostic (8.15e-2)"	"unprognostic (4.57e-2)"	"unprognostic (2.82e-1)"	"unprognostic (6.48e-3)"	"unprognostic (1.00e-2)"	"unprognostic (3.35e-1)"	"prognostic unfavorable (4.66e-4)"	"unprognostic (2.22e-2)"	"unprognostic (3.68e-2)"	"unprognostic (1.05e-2)"	"unprognostic (1.26e-1)"	27.7	8.2	5.7	14.5	7.9	5.6	11.3	4.2	5.7	9.9	9.5	5.2	9.1	7.2	12.7	11.7	10.8	7.6	10.3	7.1	6.0	5.1	14.7	8.5	13.7	14.3	6.3	4.5	9.2	7.7	6.6	10.2	14.8	7.5	12.1	8.1	5.5	12.4	5.8	8.3	10.7	16.1	10.8	7.7	13.8	8.0	4.5	6.4	35.4	13.0	7.4	9.7	9.9	9.4	4.9	2.0	24.8	5.7	6.1	6.5	3.0	2.9	1.1	1.6	0.9	3.9	4.1	2.5	1.8	8.9	45.5	47.6	1.2	2.6	0.8	3.2	1.6	14.7	2.4	1.8	2.0	6.4	7.3	0.6	2.8	2.5	2.0	3.2	1.8	2.2	2.8	0.7	5.2	1.6	3.5	8.3	2.2	0.6	0.6	6.0	0.4	2.6	4.7	1.3	0.6	1.3	2.4	1.2	0.3	6.9	1.6	1.2	0.8	2.6	1.1	5.0	1.1	1.9	1.6	9.4	1.4	1.3	1.1	0.9	0.1	0.5	0.6	2.0	0.8	0.9	8.5	3.8	10.3	6.2	5.7	5.5	4.8	5.6	5.6	2.0	4.9	5.1	5.6	24.8	6.1	3.9	0.1	6.5	3.0	5.7	7.9	4.2	5.7	6.0	5.1	6.3	4.5	7.5	6.4	20.8	9.1	5.4	4.4	3.8	3.7	4.4	2.5	8.1	6.8	1.8	2.0	4.5	0.0	17.2	2.0	14.5	14.6	0.0	10.6	6.7	5.1	4.6	4.7	6.4	5.0	6.4	2.9	8.6	6.9	0.0	6.1	6.7	0.0	2.8	2.9	9.4	12.8	5.8	5.6	6.5	2.7	6.5	6.6	0.5	1.5	4.6	2.1	9.2	1.9	4.3
DDX59	"DKFZP564B1023, ZNHIT5"	ENSG00000118197	"DEAD-box helicase 59"	Q5T1V6	1	200623896-200669969	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		"Helicase, Hydrolase, RNA-binding"	"Ciliopathy, Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA047166	Approved		Approved	"Nucleoplasm,Actin filaments"		NA	NA			"Nucleoplasm, Actin filaments"		"HPA047166: AB_2679966"	"unprognostic (1.99e-1)"	"unprognostic (1.60e-1)"	"unprognostic (3.44e-2)"	"unprognostic (4.87e-2)"	"unprognostic (1.18e-2)"	"unprognostic (1.13e-1)"	"unprognostic (3.05e-2)"	"unprognostic (4.83e-2)"	"unprognostic (3.40e-3)"	"unprognostic (2.43e-3)"	"unprognostic (4.16e-1)"	"unprognostic (2.16e-1)"	"prognostic unfavorable (9.02e-4)"	"unprognostic (1.62e-1)"	"unprognostic (1.65e-1)"	"unprognostic (6.66e-2)"	"unprognostic (5.98e-2)"	14.0	14.4	12.1	16.4	14.8	23.7	22.7	16.7	11.2	14.5	11.6	10.8	12.6	8.1	15.8	17.6	12.0	13.8	11.4	18.0	12.0	9.9	13.6	15.1	11.8	15.1	15.1	6.7	17.1	21.6	13.9	10.7	46.5	12.8	14.1	12.5	15.0	19.4	12.9	28.6	21.5	12.4	14.0	17.2	20.9	10.4	9.9	14.5	18.5	15.1	10.1	13.2	12.8	12.7	12.2	9.5	23.1	16.2	12.4	15.6	7.9	9.4	10.9	12.7	10.6	5.7	10.0	28.3	10.6	9.5	11.4	9.3	3.4	11.1	9.6	5.4	8.4	9.3	9.0	7.1	10.8	8.1	30.3	7.3	7.3	14.0	10.1	11.5	10.5	13.6	10.7	16.4	8.6	23.5	9.5	8.7	13.8	9.2	14.3	11.0	10.9	6.3	15.8	13.4	5.7	8.9	5.3	8.8	18.5	12.2	11.0	7.7	20.0	16.8	17.5	18.6	17.2	15.1	14.8	7.8	9.6	5.4	9.5	10.9	10.9	14.2	12.7	9.2	6.6	16.4	23.1	10.3	19.0	13.0	8.9	10.6	12.2	10.9	11.7	8.5	11.5	11.3	10.3	18.2	12.4	16.2	9.5	15.6	7.9	12.1	14.8	16.7	11.2	12.0	9.9	15.1	6.7	12.8	14.5	17.9	19.0	14.5	11.1	14.3	3.3	15.9	5.1	10.7	7.9	7.0	2.0	18.5	13.3	7.5	2.0	15.9	7.4	0.0	7.3	22.7	10.8	10.1	19.7	6.4	11.5	6.4	1.2	10.4	8.6	0.2	7.5	11.7	5.0	17.2	10.7	8.5	7.9	8.0	12.7	8.4	6.0	0.0	12.3	12.1	19.0	13.7	36.6	13.1	8.8	8.6
DDX6	"HLR2, RCK"	ENSG00000110367	"DEAD-box helicase 6"	P26196	11	118747766-118791149	"Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		"Helicase, Hydrolase, RNA-binding"	"Cancer-related genes, Disease mutation, Mental retardation, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004668, HPA024201, HPA026644"	Approved		Supported	"Cytosol,Cytoplasmic bodies"		NA	NA			"Cytoplasmic bodies"	Cytosol	"CAB004668: AB_436960, HPA024201: AB_10603562, HPA026644: AB_1847582"	"unprognostic (1.26e-1)"	"unprognostic (1.40e-1)"	"unprognostic (1.89e-1)"	"unprognostic (3.40e-2)"	"unprognostic (4.12e-2)"	"unprognostic (5.82e-2)"	"prognostic unfavorable (6.56e-4)"	"unprognostic (3.43e-1)"	"unprognostic (1.48e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.00e-1)"	"unprognostic (7.76e-2)"	"unprognostic (1.98e-1)"	"unprognostic (4.91e-3)"	"unprognostic (1.88e-1)"	"unprognostic (9.58e-2)"	"unprognostic (4.55e-2)"	29.8	23.0	25.0	24.1	41.0	43.3	25.1	41.9	39.2	26.9	23.2	29.4	14.5	17.1	30.1	22.9	31.8	23.4	17.5	26.8	25.5	25.1	22.8	24.6	23.4	32.2	21.9	27.1	38.2	27.9	30.9	43.2	26.1	29.6	24.9	20.8	25.4	26.8	22.9	43.8	23.9	24.1	27.8	30.4	30.6	21.2	19.9	24.0	46.0	27.9	19.4	42.8	33.0	25.7	12.2	6.5	17.8	10.3	7.2	12.6	5.7	11.9	16.3	26.3	25.9	23.1	23.7	17.2	16.2	21.3	15.1	14.4	23.7	18.4	27.4	17.1	26.5	15.1	19.1	30.6	23.7	24.4	20.6	6.1	52.9	10.5	19.3	15.3	37.9	20.4	25.0	17.5	22.4	36.4	19.9	24.0	18.5	24.3	39.8	21.3	32.6	27.5	17.6	18.7	16.9	12.0	30.3	21.3	21.9	17.7	31.0	17.4	24.0	30.6	24.6	9.7	20.6	28.7	14.9	27.4	25.1	13.8	14.3	16.3	12.4	16.1	32.7	10.0	18.2	21.4	10.5	4.1	11.6	10.1	5.7	12.6	11.4	9.9	10.4	4.7	12.2	12.4	10.8	17.8	7.2	10.3	6.5	8.9	5.7	25.0	41.0	41.9	39.2	25.5	25.1	21.9	27.1	29.6	24.0	56.6	60.1	71.3	62.3	26.9	78.4	105.7	35.7	40.2	43.3	41.8	47.1	31.3	26.6	28.5	3.7	65.3	48.0	46.7	30.5	30.1	37.5	44.5	49.8	37.6	33.8	58.8	82.4	58.9	51.1	8.2	50.0	42.0	32.1	73.1	55.4	81.3	38.8	65.4	42.5	35.6	75.0	38.8	41.9	66.1	72.8	26.7	64.0	103.8	45.4	65.9
DDX60	FLJ20035	ENSG00000137628	"DExD/H-box helicase 60"	Q8IY21	4	168216293-168318807	"Enzymes, Predicted intracellular proteins"	"Antiviral defense, Immunity, Innate immunity"	"Helicase, Hydrolase, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Alveolar cells type 1: 32.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+ SV40 Large T+: 22.8;BJ hTERT+ SV40 Large T+ RasG12V: 22.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			HPA046952	Approved		Supported	"Intermediate filaments,Cytosol"		No	No			Cytosol	"Intermediate filaments"	"HPA046952: AB_10963572"	"unprognostic (4.05e-2)"	"unprognostic (2.87e-1)"	"unprognostic (7.22e-3)"	"unprognostic (7.71e-2)"	"unprognostic (2.30e-1)"	"unprognostic (2.65e-2)"	"unprognostic (1.50e-2)"	"unprognostic (3.15e-2)"	"unprognostic (3.06e-1)"	"unprognostic (8.69e-3)"	"prognostic unfavorable (3.35e-4)"	"unprognostic (1.65e-1)"	"unprognostic (4.03e-2)"	"unprognostic (2.48e-1)"	"unprognostic (3.02e-1)"	"unprognostic (3.20e-2)"	"unprognostic (2.44e-1)"	18.0	8.3	4.1	18.5	5.0	4.4	9.0	1.3	3.8	11.4	14.8	4.3	5.1	8.8	10.8	15.2	10.7	8.1	11.5	8.5	3.7	3.5	10.0	8.8	21.6	18.7	4.2	3.2	20.3	5.5	8.8	6.7	25.5	5.6	11.6	14.3	9.0	15.6	6.2	5.6	7.9	16.7	11.2	6.1	18.9	29.2	5.7	3.9	23.2	14.5	6.0	9.3	8.2	7.2	4.1	2.5	3.2	6.3	7.6	10.0	3.5	5.6	1.2	2.8	1.1	2.1	7.8	3.2	1.9	13.7	22.8	22.1	0.0	12.4	0.0	1.1	3.0	10.5	4.7	0.3	4.5	6.6	4.3	0.6	8.8	4.8	0.0	10.3	3.3	2.2	7.0	2.0	5.8	1.3	5.5	8.5	4.2	0.0	1.7	2.8	0.3	5.0	2.4	0.5	0.8	1.6	3.4	1.5	0.1	6.7	3.4	0.6	0.6	3.6	1.0	13.7	0.2	0.9	4.2	5.6	1.4	1.5	0.5	1.4	1.0	0.2	0.0	4.3	3.8	4.0	3.2	2.8	2.6	8.5	5.1	10.0	4.1	6.7	8.0	2.5	3.3	6.8	8.5	2.8	7.6	6.3	0.2	5.5	3.5	4.1	5.0	1.3	3.8	3.7	3.5	4.2	3.2	5.6	3.9	32.8	6.2	5.0	4.0	3.8	0.7	7.1	10.2	14.7	12.5	12.2	0.0	6.4	5.0	7.0	1.7	10.3	10.7	0.0	5.9	8.5	5.0	3.8	26.5	3.8	5.8	0.0	2.9	15.4	4.1	1.4	7.5	8.8	3.3	0.0	13.6	8.0	8.7	7.2	8.9	3.3	3.0	6.5	3.8	0.9	0.7	2.4	2.4	10.1	5.8	3.1
DDX60L	FLJ31033	ENSG00000181381	"DExD/H-box 60 like"	Q5H9U9	4	168356735-168537786	"Enzymes, Predicted intracellular proteins"		"Helicase, Hydrolase, RNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"neutrophil: 22.5"	"Group enriched"	"Detected in all"	4	"granulocytes: 22.5;monocytes: 7.8"	"Cell line enhanced"	"Detected in many"		"BJ hTERT+ SV40 Large T+: 23.3"									"HPA043211, HPA055501"	Approved		Approved	"Plasma membrane,Cytosol"		NA	NA			"Plasma membrane, Cytosol"		"HPA043211: AB_10794390, HPA055501: AB_2682838"	"unprognostic (8.86e-2)"	"unprognostic (2.77e-1)"	"unprognostic (1.16e-1)"	"unprognostic (2.45e-1)"	"unprognostic (2.38e-1)"	"unprognostic (3.20e-2)"	"unprognostic (1.05e-1)"	"unprognostic (7.94e-2)"	"unprognostic (1.78e-1)"	"unprognostic (4.19e-2)"	"prognostic unfavorable (3.04e-5)"	"unprognostic (1.70e-1)"	"prognostic unfavorable (2.94e-4)"	"unprognostic (1.13e-1)"	"unprognostic (8.80e-2)"	"unprognostic (8.93e-2)"	"unprognostic (1.69e-1)"	12.7	5.0	2.8	13.1	3.1	33.0	9.9	1.4	3.2	7.2	8.4	3.2	2.7	6.0	9.2	7.9	3.8	6.9	6.7	6.0	2.4	2.4	4.5	6.0	25.8	17.7	3.8	1.4	7.3	5.1	4.4	5.2	32.6	3.4	5.0	6.5	6.8	7.0	5.7	3.3	4.3	14.0	5.3	4.2	11.9	9.5	2.7	3.1	25.3	5.8	3.5	8.1	4.9	6.8	1.6	2.4	22.5	7.8	1.7	3.7	1.6	6.1	3.6	1.4	0.6	3.7	10.8	7.0	6.2	13.1	23.3	16.2	0.0	14.5	0.1	0.3	6.3	12.7	2.4	0.6	3.7	6.8	3.5	0.5	13.6	4.0	0.3	4.5	5.5	3.4	3.0	1.1	8.4	0.7	4.9	16.4	3.1	0.2	0.1	14.9	0.1	4.9	3.5	0.3	0.6	3.1	2.7	3.2	0.0	2.2	3.6	0.2	1.9	11.0	1.3	6.2	0.2	1.0	7.8	17.5	1.2	8.2	2.9	2.1	5.9	0.9	0.0	4.1	16.5	1.8	1.6	4.0	3.5	2.7	6.3	3.7	0.9	2.7	2.7	2.4	1.6	2.2	2.3	22.5	1.7	7.8	0.0	3.6	1.6	2.8	3.1	1.4	3.2	2.4	2.4	3.8	1.4	3.4	3.1	8.9	7.9	0.0	2.1	0.9	1.3	8.1	5.1	12.0	3.4	3.5	21.6	4.5	0.0	6.8	10.7	13.1	11.6	0.0	8.7	29.4	7.0	2.6	8.1	5.4	22.5	0.0	0.0	9.2	23.2	3.6	3.1	29.7	0.0	26.2	13.2	3.2	17.0	14.0	3.9	3.3	16.8	6.5	3.3	0.5	1.3	2.0	5.9	8.7	3.8	1.4
DECR1	"DECR, SDR18C1"	ENSG00000104325	"2,4-dienoyl-CoA reductase 1"	Q16698	8	90001405-90052092	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Fatty acid metabolism, Lipid metabolism"	Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 120.2"	"Cell type enhanced"	"Detected in many"	4	"Distal tubular cells: 338.2;Proximal tubular cells: 333.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enriched"	"Detected in many"	4	"SK-BR-3: 132.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023160, HPA023162, HPA023238"	Enhanced		Supported	Mitochondria,Cytosol		No	No		740000	Mitochondria	Cytosol	"HPA023160: AB_1847585, HPA023162: AB_1847586, HPA023238: AB_1847587"	"prognostic unfavorable (1.49e-4)"	"unprognostic (5.76e-3)"	"unprognostic (8.37e-3)"	"unprognostic (6.13e-3)"	"unprognostic (2.01e-1)"	"unprognostic (4.45e-2)"	"unprognostic (1.68e-2)"	"unprognostic (8.23e-2)"	"unprognostic (1.02e-1)"	"unprognostic (1.55e-1)"	"unprognostic (9.12e-2)"	"unprognostic (1.42e-1)"	"prognostic favorable (1.79e-7)"	"unprognostic (1.40e-1)"	"unprognostic (1.73e-2)"	"unprognostic (1.16e-1)"	"prognostic favorable (6.06e-4)"	26.9	45.7	13.2	18.1	17.6	9.2	15.6	10.3	14.5	13.0	29.0	10.4	11.8	32.4	11.9	13.7	16.2	8.5	12.6	70.0	15.4	9.0	44.8	120.2	12.9	14.0	12.5	12.8	12.7	14.4	22.2	16.8	5.8	13.6	11.0	22.9	9.5	15.7	9.9	37.9	12.5	42.7	11.5	11.9	20.1	12.7	17.0	14.5	20.3	15.0	32.1	15.3	11.6	10.6	23.4	52.3	37.2	42.8	19.8	31.3	27.8	10.5	6.0	17.8	20.1	12.5	20.3	3.8	9.3	16.1	6.1	9.5	2.4	10.5	8.1	7.4	11.1	5.5	8.0	6.6	9.4	10.2	12.2	0.7	19.3	5.4	9.6	15.6	4.2	4.0	16.0	7.3	4.8	8.1	15.1	18.0	12.9	20.1	16.0	29.0	12.1	12.0	6.2	1.1	22.4	18.2	10.2	4.7	14.4	29.8	26.6	0.8	6.7	14.0	132.5	11.1	0.5	17.0	10.9	16.3	10.3	4.9	13.5	5.5	8.1	6.1	9.5	9.8	9.6	13.1	15.0	31.5	10.2	21.4	42.8	22.6	23.4	20.1	21.8	52.3	19.2	21.3	21.0	37.2	19.8	37.2	20.4	31.3	27.8	13.2	17.6	10.3	14.5	15.4	9.0	12.5	12.8	13.6	14.5	71.5	50.7	52.5	52.8	36.7	12.7	229.8	79.0	71.0	51.2	68.0	2.0	44.0	338.2	106.7	118.9	49.7	161.9	0.0	82.2	42.9	47.8	37.6	48.5	196.2	104.2	30.2	100.6	52.2	85.9	33.7	79.1	96.9	81.0	80.2	84.9	41.0	80.5	101.7	48.4	333.3	6.5	71.1	40.1	118.4	23.4	35.9	34.3	71.9	118.0	55.4
DECR2	"PDCR, SDR17C1"	ENSG00000242612	"2,4-dienoyl-CoA reductase 2"	Q9NUI1	16	401826-412487	"Enzymes, Predicted intracellular proteins"	"Fatty acid metabolism, Lipid metabolism"	Oxidoreductase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	4	"liver: 68.2"	"Cell type enhanced"	"Detected in many"	6	"Hepatocytes: 103.3;Proximal tubular cells: 98.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA047631			Approved	Peroxisomes,Microtubules		NA	NA			Peroxisomes	Microtubules	"HPA047631: "	"unprognostic (2.74e-2)"	"unprognostic (3.84e-1)"	"unprognostic (1.83e-1)"	"unprognostic (4.44e-3)"	"unprognostic (1.77e-1)"	"unprognostic (7.45e-2)"	"unprognostic (2.38e-2)"	"unprognostic (1.17e-1)"	"unprognostic (1.91e-1)"	"unprognostic (3.02e-2)"	"unprognostic (3.11e-2)"	"unprognostic (3.38e-1)"	"unprognostic (1.12e-1)"	"unprognostic (3.40e-1)"	"unprognostic (2.21e-1)"	"unprognostic (1.94e-1)"	"unprognostic (4.22e-3)"	5.7	10.8	3.2	4.3	4.0	3.5	4.0	3.8	5.0	2.9	10.2	2.7	5.0	14.2	4.0	7.3	4.1	2.5	7.8	4.4	2.8	2.3	16.9	68.2	4.3	3.9	2.0	3.0	2.6	9.7	1.8	2.6	2.3	2.0	4.1	2.4	3.0	6.2	5.6	15.9	2.9	14.4	5.1	1.9	1.9	5.9	4.1	1.8	1.2	1.7	4.3	2.9	2.7	2.2	3.3	9.5	0.4	6.1	2.7	5.1	3.9	1.1	11.1	1.4	6.6	1.3	3.0	4.2	3.4	2.5	2.9	3.0	7.0	7.6	3.8	7.3	4.2	1.7	2.5	1.1	2.8	0.4	8.4	3.6	0.9	5.4	16.6	8.7	3.4	5.4	4.3	2.1	1.9	2.4	3.3	3.6	4.4	2.3	3.5	2.4	11.6	1.9	4.7	4.1	4.2	5.8	4.5	0.5	6.9	2.9	2.9	2.9	4.5	6.4	7.2	3.7	0.5	10.3	4.2	7.5	2.5	2.7	3.5	2.6	5.0	3.9	1.6	3.4	5.1	8.1	0.0	6.1	0.4	3.6	5.6	2.5	2.8	2.2	2.4	6.5	3.3	5.1	3.0	0.3	2.7	4.5	9.5	1.7	3.9	3.2	4.0	3.8	5.0	2.8	2.3	2.0	3.0	2.0	1.8	11.9	14.4	4.2	8.0	3.4	2.0	7.0	17.8	12.0	9.1	19.2	0.0	28.2	33.2	28.8	1.8	5.8	56.4	46.7	34.2	4.7	8.9	4.3	12.7	103.3	11.0	3.2	12.0	6.7	6.7	5.5	6.1	5.3	5.0	15.4	26.4	5.8	28.8	35.1	6.3	98.2	2.7	0.0	6.2	1.8	5.7	5.3	10.5	2.2	34.3	2.7
DEGS1	"DEGS-1, Des-1, DES1, FADS7, MLD"	ENSG00000143753	"Delta 4-desaturase, sphingolipid 1"	O15121	1	224175756-224193441	"Enzymes, Predicted membrane proteins"	"Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism"	Oxidoreductase	"Disease mutation, Leukodystrophy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skin 1: 164.4"	"Cell type enhanced"	"Detected in all"	5	"Basal keratinocytes: 218.5;Cytotrophoblasts: 229.8;Suprabasal keratinocytes: 280.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			HPA076422			Supported	Mitochondria		NA	NA			Mitochondria		"HPA076422: AB_2686799"	"unprognostic (2.34e-2)"	"unprognostic (6.91e-2)"	"unprognostic (2.48e-2)"	"prognostic unfavorable (7.74e-5)"	"unprognostic (1.50e-1)"	"unprognostic (2.74e-1)"	"prognostic unfavorable (4.29e-5)"	"unprognostic (7.70e-2)"	"unprognostic (2.31e-1)"	"unprognostic (3.20e-1)"	"unprognostic (3.63e-1)"	"unprognostic (1.27e-1)"	"prognostic unfavorable (6.83e-7)"	"unprognostic (2.87e-1)"	"unprognostic (1.61e-1)"	"unprognostic (3.86e-2)"	"prognostic unfavorable (2.53e-4)"	19.2	10.7	14.7	14.1	15.7	20.0	28.6	11.9	17.8	17.8	17.0	19.9	15.8	15.0	17.2	13.4	16.1	13.1	13.5	16.6	15.1	16.4	12.8	17.3	16.1	24.5	22.0	17.4	14.4	9.3	11.8	15.1	40.1	17.9	27.6	9.4	15.9	14.8	20.1	7.6	164.4	12.1	23.3	22.1	13.0	14.6	9.2	19.3	7.7	19.7	12.3	15.7	15.5	24.9	31.7	39.5	43.6	25.7	16.1	24.4	16.8	14.9	10.6	14.0	10.4	61.0	39.4	10.9	42.0	47.3	29.5	35.5	9.8	11.5	11.9	54.6	38.0	17.9	15.9	16.3	14.3	32.8	17.4	29.1	8.6	11.7	5.9	37.1	17.2	18.7	39.2	32.0	27.1	15.3	30.9	29.1	6.6	12.6	13.2	37.8	5.5	8.7	9.3	17.4	8.2	15.7	8.0	19.8	7.7	37.5	4.1	9.1	14.7	22.3	35.2	22.2	26.8	11.9	25.1	26.5	28.4	9.0	32.6	40.9	9.4	11.1	11.0	30.6	8.6	31.8	32.3	22.3	43.6	12.7	25.7	24.4	23.9	21.5	17.5	39.5	31.7	17.1	15.0	26.1	16.1	17.4	13.2	22.0	16.8	14.7	15.7	11.9	17.8	15.1	16.4	22.0	17.4	17.9	19.3	77.4	27.7	37.9	37.6	218.5	30.5	15.7	12.7	22.7	20.5	10.4	13.7	229.8	11.6	30.3	15.3	49.6	4.2	23.3	38.8	36.5	83.9	44.4	103.9	18.1	85.9	17.5	14.3	60.2	49.3	8.5	58.4	80.4	65.8	75.7	5.0	21.7	25.8	5.8	74.6	25.8	15.9	103.5	85.6	67.0	42.8	280.0	166.4	61.0	5.6	12.9
DEGS2	"C14orf66, DES2, FADS8"	ENSG00000168350	"Delta 4-desaturase, sphingolipid 2"	Q6QHC5	14	100143957-100160163	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Lipid biosynthesis, Lipid metabolism"	Oxidoreductase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 44.5;skin 1: 30.6"	"Cell type enhanced"	"Detected in many"	7	"Ciliated cells: 77.6;Collecting duct cells: 78.5;Intestinal endocrine cells: 53.2;Undifferentiated cells: 46.7"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"cerebellum: 22.9"	"Cell type enhanced"	"Detected in many"		"memory B-cell: 11.9"	"Group enriched"	"Detected in many"	5	"B-cells: 11.9;granulocytes: 6.4"	"Group enriched"	"Detected in some"	16	"OE19: 29.1;T-47d: 45.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA046644			Approved	Nucleoplasm,Nucleoli		NA	NA			"Nucleoplasm, Nucleoli"		"HPA046644: AB_2797231"	"unprognostic (8.18e-2)"	"unprognostic (3.83e-3)"	"unprognostic (2.33e-1)"	"unprognostic (1.32e-2)"	"unprognostic (3.55e-1)"	"unprognostic (4.91e-2)"	"unprognostic (1.53e-1)"	"unprognostic (1.13e-2)"	"unprognostic (2.43e-1)"	"unprognostic (1.20e-1)"	"unprognostic (1.64e-1)"	"unprognostic (1.38e-1)"	"prognostic favorable (7.94e-7)"	"unprognostic (1.03e-3)"	"unprognostic (1.26e-1)"	"unprognostic (1.14e-1)"	"prognostic favorable (1.66e-4)"	0.4	0.3	2.0	2.3	4.6	0.5	5.8	22.9	6.4	5.3	20.2	1.8	0.6	20.8	3.4	4.6	20.9	1.9	13.3	0.3	2.0	1.5	8.7	17.2	2.6	0.8	2.4	1.4	0.8	13.0	0.3	1.6	0.6	2.7	2.5	4.2	0.8	4.5	2.3	0.5	30.6	44.5	0.7	1.9	0.5	17.9	0.7	0.7	0.0	2.4	7.3	11.1	7.1	5.2	11.9	0.7	6.4	0.5	0.2	1.8	0.8	0.0	0.1	0.0	0.1	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.2	1.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.2	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.6	0.0	0.0	1.7	0.1	0.1	0.0	29.1	0.0	0.1	0.0	1.5	0.0	0.7	2.2	0.0	0.0	1.3	0.0	0.0	45.3	0.4	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	3.7	0.5	6.4	1.8	0.0	0.0	11.9	0.1	0.8	0.7	5.9	0.0	1.2	0.2	0.2	0.0	0.1	0.0	0.8	2.0	4.6	22.9	6.4	2.0	1.5	2.4	1.4	2.7	0.7	3.0	5.3	0.0	2.8	1.5	4.4	0.4	38.2	77.6	11.4	78.5	0.0	5.9	1.7	13.4	1.0	0.9	31.3	0.0	1.3	1.5	0.3	1.1	9.2	0.2	1.6	0.0	53.2	0.6	1.9	1.5	0.3	1.0	0.0	0.0	43.3	1.2	2.8	43.8	0.0	0.1	24.4	0.0	0.2	0.9	1.9	13.4	31.2	1.3	46.7	17.4
DERA	"CGI-26, DEOC"	ENSG00000023697	"Deoxyribose-phosphate aldolase"	Q9Y315	12	15911172-16037282	"Enzymes, Predicted intracellular proteins"		Lyase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA055897			Supported	Nucleoplasm		NA	NA		180000	Nucleoplasm		"HPA055897: AB_2682963"	"unprognostic (3.05e-1)"	"unprognostic (1.26e-1)"	"unprognostic (1.06e-2)"	"unprognostic (7.26e-2)"	"unprognostic (8.12e-2)"	"unprognostic (7.74e-2)"	"unprognostic (1.36e-1)"	"unprognostic (1.47e-2)"	"unprognostic (2.76e-1)"	"unprognostic (1.87e-1)"	"prognostic unfavorable (1.32e-4)"	"unprognostic (2.13e-1)"	"unprognostic (1.09e-1)"	"unprognostic (8.74e-2)"	"unprognostic (2.17e-2)"	"prognostic favorable (3.64e-5)"	"unprognostic (3.66e-2)"	20.3	12.0	10.5	10.8	10.8	7.5	11.5	5.2	7.7	11.3	30.3	11.4	12.7	20.2	21.5	14.7	20.0	8.2	11.1	11.7	10.1	9.1	40.9	51.5	13.6	14.1	12.5	6.5	5.8	16.9	6.6	27.5	12.3	11.3	9.2	21.2	11.0	11.4	11.3	15.3	12.4	46.7	10.4	14.6	14.6	10.5	5.5	11.0	13.8	26.6	16.7	14.3	10.1	13.1	12.4	30.2	14.1	28.2	17.1	14.9	15.7	19.0	15.8	12.4	10.9	8.4	19.2	25.4	11.1	10.5	15.2	19.5	19.0	35.4	13.0	9.9	14.2	13.7	13.5	13.4	14.3	27.0	21.7	7.8	11.5	7.9	17.9	12.1	12.1	7.8	12.8	16.6	12.4	25.5	12.9	21.9	11.1	1.6	4.0	27.6	7.0	9.0	10.1	27.0	10.7	7.8	13.8	27.2	8.1	38.1	6.9	9.0	15.3	21.0	7.0	21.9	51.1	37.9	15.2	21.6	16.2	10.7	7.4	11.9	4.3	6.3	22.4	20.8	12.2	11.9	5.4	24.4	14.1	7.2	27.1	7.9	12.4	7.8	7.7	30.2	11.4	8.6	6.9	6.5	17.1	28.2	16.5	14.9	15.7	10.5	10.8	5.2	7.7	10.1	9.1	12.5	6.5	11.3	11.0	41.7	25.0	18.6	24.3	26.1	5.0	11.4	22.9	21.4	22.7	12.2	13.7	54.5	92.9	55.2	33.8	25.2	49.7	0.0	52.2	57.8	21.3	17.5	8.1	44.5	53.2	3.2	25.4	30.7	32.6	3.0	22.7	32.0	69.2	55.9	43.0	20.9	60.6	45.0	28.7	104.3	25.2	6.5	18.6	5.0	14.7	22.6	59.6	10.0	39.9	24.7
DESI2	"C1orf121, CGI-146, FAM152A, FLJ21998, PNAS-4, PPPDE1"	ENSG00000121644	"Desumoylating isopeptidase 2"	Q9BSY9	1	244652935-244709033	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	"Hydrolase, Protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Spermatocytes: 160.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA049950			Approved	Vesicles		NA	NA			Vesicles		"HPA049950: AB_2680969"	"unprognostic (1.13e-1)"	"unprognostic (2.07e-1)"	"unprognostic (1.05e-1)"	"unprognostic (3.09e-1)"	"unprognostic (1.96e-1)"	"unprognostic (5.40e-2)"	"unprognostic (1.95e-2)"	"unprognostic (7.62e-2)"	"unprognostic (1.38e-3)"	"unprognostic (1.51e-1)"	"unprognostic (4.47e-3)"	"unprognostic (1.45e-1)"	"prognostic unfavorable (4.25e-5)"	"unprognostic (4.52e-2)"	"unprognostic (8.27e-2)"	"unprognostic (2.27e-2)"	"unprognostic (9.49e-2)"	16.4	13.3	6.4	16.1	12.9	10.5	19.9	17.4	6.5	18.5	19.4	7.6	14.6	10.9	27.7	12.8	14.7	12.4	12.7	27.6	6.5	5.8	9.6	13.5	28.4	11.5	7.7	3.2	16.3	10.0	14.8	11.8	20.4	6.9	14.9	13.1	17.8	12.1	14.8	16.2	11.6	17.5	23.2	6.6	14.3	14.9	49.2	7.4	16.8	25.8	14.5	14.7	16.8	14.4	8.0	4.8	9.1	4.0	3.9	5.6	1.2	24.5	9.2	18.1	15.6	20.8	21.8	22.7	14.3	25.0	14.3	13.2	16.3	11.7	43.8	19.6	17.8	8.3	10.8	22.1	16.2	19.7	14.9	16.2	11.1	6.9	12.2	18.2	19.0	13.4	15.1	22.1	19.0	24.0	13.8	20.0	19.9	16.7	24.4	21.4	4.3	17.4	10.2	41.0	23.3	22.4	12.4	27.4	16.6	10.9	10.3	16.0	21.5	20.3	10.1	17.8	15.2	10.5	14.5	21.7	16.3	17.0	22.0	24.8	24.8	31.9	25.8	13.1	20.6	29.6	4.6	3.0	9.1	4.0	3.9	4.2	8.0	4.2	5.6	4.8	4.7	5.5	5.4	2.5	3.9	4.0	4.2	5.2	1.2	6.4	12.9	17.4	6.5	6.5	5.8	7.7	3.2	6.9	7.4	80.4	41.8	24.3	26.4	49.1	34.2	21.2	28.1	13.4	25.0	17.4	19.6	25.5	18.3	18.2	124.1	27.0	18.6	0.0	29.2	33.3	29.2	39.4	6.9	20.2	21.2	38.1	15.0	23.4	25.4	74.9	32.2	17.4	15.1	26.2	17.8	21.8	26.3	25.9	48.8	13.5	25.0	38.8	32.4	160.4	90.2	36.1	36.2	20.2	25.5	51.9
DGAT1	"ARGP1, DGAT"	ENSG00000185000	"Diacylglycerol O-acyltransferase 1"	O75907	8	144314584-144326910	"Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins"		"Acyltransferase, Transferase"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	9	"intestine: 161.0"	"Cell type enhanced"	"Detected in many"	13	"Enterocytes: 291.1;Paneth cells: 112.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"Hep G2: 15.8;PC-3: 17.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB032853	Enhanced		Approved	"Nucleoli,Endoplasmic reticulum"		NA	NA			"Endoplasmic reticulum"	Nucleoli	"CAB032853: AB_2090798"	"unprognostic (9.24e-3)"	"unprognostic (1.61e-1)"	"unprognostic (1.75e-2)"	"unprognostic (2.23e-1)"	"unprognostic (3.49e-2)"	"unprognostic (2.30e-1)"	"unprognostic (1.11e-1)"	"unprognostic (1.42e-2)"	"unprognostic (5.10e-2)"	"unprognostic (2.78e-2)"	"unprognostic (6.88e-2)"	"unprognostic (3.52e-1)"	"unprognostic (2.65e-3)"	"unprognostic (3.83e-2)"	"unprognostic (1.69e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.67e-3)"	11.8	18.5	3.6	5.7	4.7	6.4	6.8	6.6	5.6	3.3	60.2	4.0	6.4	44.7	3.9	3.6	5.5	3.1	7.9	6.3	3.7	2.7	6.7	14.4	3.8	3.1	4.1	2.7	3.3	3.9	5.0	4.0	4.3	3.6	3.4	6.3	4.1	5.9	4.3	10.0	4.8	161.0	3.6	2.6	5.3	5.7	10.7	4.2	5.1	3.8	6.2	5.0	4.7	3.4	0.7	2.2	2.8	2.0	0.3	1.7	0.8	3.8	4.2	2.0	3.6	3.2	1.3	2.3	2.8	2.7	2.6	1.8	9.7	2.6	1.5	10.7	1.7	1.3	3.3	1.6	3.8	0.6	2.8	4.0	2.8	3.4	15.8	2.3	0.7	2.9	1.8	2.9	1.7	1.9	1.8	2.0	4.9	2.2	3.6	1.7	3.2	4.8	3.1	0.9	9.2	17.6	6.3	0.8	2.5	2.4	2.1	2.0	3.4	3.6	4.4	1.8	0.8	2.5	2.7	1.6	1.4	4.9	2.8	2.2	2.1	0.4	0.6	1.5	4.9	2.3	0.0	2.0	2.8	1.2	1.3	1.7	0.7	0.9	1.1	2.2	0.5	0.7	0.3	2.3	0.3	1.7	1.1	0.7	0.8	3.6	4.7	6.6	5.6	3.7	2.7	4.1	2.7	3.6	4.2	14.9	21.3	6.5	9.8	7.1	24.2	17.9	15.3	4.0	7.9	17.4	27.5	10.2	1.7	6.8	13.4	13.5	291.1	0.0	10.4	8.3	7.1	8.8	6.9	49.5	16.5	17.5	22.4	10.4	25.4	16.4	6.4	15.0	5.0	1.0	70.1	18.1	11.4	112.2	6.3	6.8	21.9	0.0	10.5	25.1	15.9	8.2	13.7	8.5	84.8	18.4
DGAT2		ENSG00000062282	"Diacylglycerol O-acyltransferase 2"	Q96PD7	11	75759512-75801535	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Glycerol metabolism, Lipid biosynthesis, Lipid metabolism"	"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 104.3;blood: 68.9;liver: 81.3"	"Cell type enhanced"	"Detected in many"	19	"Early spermatids: 192.0;Hepatocytes: 104.6;Late spermatids: 49.3;Spermatocytes: 45.4;Spermatogonia: 49.4"	"Cancer enhanced"	"Detected in many"		"liver cancer: 19.9"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	11	"eosinophil: 26.3;neutrophil: 68.9"	"Lineage enriched"	"Detected in many"	16	"granulocytes: 68.9"	"Cell line enhanced"	"Detected in many"		"ASC diff: 30.3;HDLM-2: 22.0;Hep G2: 22.9;OE19: 44.2"	"Low region specificity"	"Detected in all"							HPA013351			Approved	Vesicles,Cytosol		NA	NA			"Vesicles, Cytosol"		"HPA013351: AB_1847630"	"unprognostic (2.28e-1)"	"unprognostic (3.69e-1)"	"unprognostic (9.38e-2)"	"prognostic unfavorable (2.84e-4)"	"unprognostic (3.63e-1)"	"unprognostic (4.99e-2)"	"unprognostic (1.10e-2)"	"unprognostic (7.59e-2)"	"unprognostic (4.46e-1)"	"unprognostic (4.12e-3)"	"unprognostic (2.87e-1)"	"unprognostic (2.99e-1)"	"unprognostic (1.49e-7)"	"unprognostic (2.03e-1)"	"unprognostic (2.85e-1)"	"unprognostic (2.74e-2)"	"unprognostic (5.60e-2)"	104.3	1.3	1.9	12.5	6.8	1.7	30.4	0.1	4.2	1.0	11.8	0.6	0.4	3.6	0.5	0.6	6.3	0.7	6.3	6.0	1.0	1.2	1.0	81.3	1.8	16.1	0.6	1.2	0.6	1.3	0.4	0.6	0.5	1.0	1.0	1.4	1.2	9.9	0.6	1.3	34.1	8.1	0.9	0.6	3.7	3.3	13.6	0.5	1.0	2.4	3.9	4.5	4.0	2.7	1.5	1.1	68.9	4.2	0.0	0.0	0.9	4.6	2.3	0.1	4.0	30.3	2.4	0.3	0.4	0.5	0.6	0.3	16.7	4.9	7.4	6.2	0.1	4.4	0.1	0.6	2.3	1.6	22.0	0.4	0.5	1.6	22.9	0.3	2.6	2.6	10.1	12.4	2.7	3.9	1.6	0.4	7.5	0.4	10.1	0.2	3.0	1.7	5.7	1.3	44.2	10.9	0.0	0.0	8.7	0.4	12.9	8.3	0.5	4.2	0.7	1.0	1.0	1.6	9.3	0.5	5.3	2.6	0.1	3.2	5.9	13.2	9.9	3.8	8.4	9.0	3.0	4.2	26.3	0.0	0.8	0.0	1.5	0.0	0.0	1.1	1.2	0.0	0.0	68.9	0.0	0.8	0.3	0.0	0.9	1.9	6.8	0.1	4.2	1.0	1.2	0.6	1.2	1.0	0.5	6.0	4.8	3.4	0.8	1.0	0.6	3.4	0.0	1.4	1.2	0.0	2.0	0.5	0.0	1.4	192.0	0.3	0.4	0.0	0.4	0.1	0.8	2.0	0.0	104.6	2.3	1.6	1.2	1.3	5.6	49.3	2.0	1.7	1.7	0.0	5.0	0.5	2.1	2.6	0.7	1.7	0.0	6.5	0.3	45.4	49.4	6.9	0.7	0.0	3.4	4.2
DGKA	"DAGK, DAGK1, DGK-alpha"	ENSG00000065357	"Diacylglycerol kinase alpha"	P23743	12	55927319-55954027	"Enzymes, Predicted intracellular proteins"	"Lipid metabolism"	"Kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 117.1"	"Cell type enhanced"	"Detected in many"	6	"Enterocytes: 38.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HBEC3-KT: 42.2;hTERT-HME1: 44.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041645, HPA045462"	Approved		Approved	Nucleoplasm,Vesicles,Mitochondria		NA	NA			Vesicles	"Nucleoplasm, Mitochondria"	"HPA041645: AB_2677595, HPA045462: AB_2679335"	"unprognostic (1.12e-3)"	"unprognostic (1.43e-2)"	"unprognostic (1.62e-2)"	"unprognostic (2.63e-2)"	"unprognostic (5.23e-2)"	"unprognostic (2.04e-1)"	"unprognostic (3.62e-1)"	"unprognostic (3.31e-2)"	"unprognostic (5.28e-2)"	"unprognostic (1.94e-1)"	"unprognostic (1.82e-2)"	"unprognostic (2.46e-1)"	"prognostic unfavorable (1.66e-5)"	"unprognostic (4.06e-1)"	"unprognostic (1.00e-1)"	"unprognostic (1.47e-1)"	"unprognostic (7.02e-2)"	4.9	4.7	7.1	31.8	8.2	9.7	4.8	6.0	10.8	8.4	13.4	3.6	3.1	20.5	6.9	4.1	42.0	4.9	7.9	3.8	4.6	2.4	3.9	1.5	7.6	28.6	2.1	4.1	4.9	6.4	6.2	3.1	10.2	3.3	10.6	11.0	4.1	16.2	5.3	1.0	33.0	27.2	5.7	3.7	23.1	4.8	4.4	2.6	117.1	4.5	9.6	57.0	13.0	15.1	7.6	4.0	5.4	2.8	5.2	30.2	10.9	6.7	4.3	3.0	4.0	7.5	9.8	0.9	15.2	15.6	6.0	4.4	2.0	11.5	3.8	3.6	10.1	2.0	12.4	3.2	42.2	7.2	3.2	0.7	6.1	9.1	1.1	6.5	1.9	6.0	8.4	22.8	8.3	44.8	20.0	12.2	22.7	0.7	5.9	16.1	0.7	12.5	2.4	0.6	5.6	5.1	5.8	1.0	0.6	14.2	19.5	0.5	1.7	5.0	0.2	0.5	8.2	2.7	2.0	10.9	3.9	2.8	0.8	0.5	0.7	0.3	9.2	4.7	5.2	1.1	5.2	2.8	5.4	6.5	2.0	11.7	7.6	24.3	11.7	4.0	6.4	30.2	18.1	5.2	5.2	1.2	4.0	26.7	10.9	7.1	8.2	6.0	10.8	4.6	2.4	2.1	4.1	3.3	2.6	3.0	6.2	15.6	8.5	13.4	0.8	2.0	0.0	0.0	11.4	5.2	0.0	13.4	0.0	4.1	6.5	3.3	38.4	0.0	8.4	4.0	3.8	8.2	6.9	0.0	3.7	0.0	2.4	4.9	4.1	4.7	3.4	10.2	0.0	16.2	7.5	4.9	15.8	6.2	2.8	0.1	0.4	6.5	3.1	3.8	2.7	12.2	22.1	20.6	5.2	18.0
DGKB	"DAGK2, DGK, DGK-BETA, KIAA0718"	ENSG00000136267	"Diacylglycerol kinase beta"	Q9Y6T7	7	14145049-14974777	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"brain: 37.7"	"Cell type enhanced"	"Detected in some"	21	"Bipolar cells: 16.8;Club cells: 3.4;Sertoli cells: 6.5"	"Cancer enriched"	"Detected in single"	11	"glioma: 1.7"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"AF22: 2.8;fHDF/TERT166: 5.7;hTEC/SVTERT24-B: 2.2;SCLC-21H: 2.9;SH-SY5Y: 2.1;U-266/70: 7.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA020321		Supported				NA	NA					"HPA020321: "	"unprognostic (9.89e-2)"	"unprognostic (9.72e-5)"	"unprognostic (1.45e-1)"	"unprognostic (2.88e-3)"	"unprognostic (4.32e-2)"	"unprognostic (3.37e-1)"	"unprognostic (7.34e-2)"	"unprognostic (5.91e-2)"	"unprognostic (6.19e-2)"	"unprognostic (8.87e-2)"	"unprognostic (2.72e-2)"	"unprognostic (1.18e-1)"	"unprognostic (5.98e-2)"	"unprognostic (2.37e-3)"	"unprognostic (6.13e-2)"	"unprognostic (1.33e-1)"	"unprognostic (1.11e-4)"	1.1	5.2	11.5	1.1	37.7	0.8	0.8	1.3	34.0	4.9	1.6	1.4	0.0	0.9	6.1	0.9	1.6	2.7	1.3	1.4	10.5	4.3	2.6	1.1	0.8	0.8	2.2	11.3	0.8	0.9	0.8	1.8	0.7	4.8	1.1	1.7	0.0	0.9	0.9	1.2	0.9	1.2	3.1	3.5	0.8	0.8	0.9	7.9	0.0	0.9	0.0	0.8	1.5	0.6	0.7	0.6	1.3	0.3	0.6	0.5	0.1	0.1	0.0	2.8	0.1	0.0	0.2	0.1	0.0	1.2	0.0	0.3	0.2	0.0	0.1	0.0	5.7	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.3	0.3	0.1	0.0	0.1	0.1	0.0	0.0	2.2	0.0	0.1	0.0	0.0	0.1	0.5	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.1	0.0	0.4	0.0	0.0	2.9	2.1	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.3	1.0	0.0	0.0	7.6	0.0	0.0	0.1	0.1	0.1	0.7	0.3	0.3	0.5	0.2	0.4	0.3	0.5	0.2	0.1	0.7	0.5	0.4	1.3	0.6	0.2	0.6	0.2	0.1	11.5	37.7	1.3	19.1	10.5	4.3	2.2	11.3	4.8	7.9	0.0	0.0	0.0	0.2	0.1	16.8	1.2	0.0	0.0	3.4	0.0	0.0	0.1	0.0	0.0	2.0	0.1	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.0	1.1	0.1	1.7	0.0	0.0	0.0	0.0	0.0	0.0	2.0	1.2	6.5	1.4	0.2	0.2	0.4	0.0	0.0	0.0	0.3
DGKD	"DGKdelta, KIAA0145"	ENSG00000077044	"Diacylglycerol kinase delta"	Q16760	2	233354507-233472104	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Endocytosis, Protein transport, Transport"	"Kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Cone photoreceptor cells: 58.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HeLa: 22.3;U-698: 22.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027530, HPA049101"	Approved		Supported	Cytosol		NA	NA			Cytosol		"HPA027530: AB_2672320, HPA049101: AB_2680630"	"unprognostic (1.84e-1)"	"unprognostic (2.19e-2)"	"unprognostic (7.76e-3)"	"unprognostic (1.92e-2)"	"unprognostic (5.69e-2)"	"unprognostic (6.24e-2)"	"prognostic unfavorable (1.69e-5)"	"unprognostic (2.25e-1)"	"unprognostic (1.17e-3)"	"unprognostic (6.03e-2)"	"unprognostic (5.76e-2)"	"unprognostic (1.00e-1)"	"prognostic unfavorable (4.07e-8)"	"unprognostic (1.78e-1)"	"unprognostic (7.18e-2)"	"unprognostic (1.22e-1)"	"unprognostic (5.94e-3)"	5.9	3.6	10.0	10.9	12.4	26.3	5.3	34.3	7.9	3.7	7.8	8.9	12.4	8.1	5.8	12.6	2.7	5.5	8.0	6.4	9.6	4.3	3.1	3.3	9.3	14.0	11.7	4.3	8.6	3.0	2.3	3.7	8.9	7.2	6.0	8.4	6.2	4.9	8.0	25.4	2.9	10.9	7.3	11.1	10.3	19.4	17.4	8.3	4.5	7.6	1.3	13.5	5.6	10.1	6.6	1.0	5.9	2.0	1.8	3.4	2.5	3.2	8.1	4.7	3.0	2.2	2.2	7.3	1.9	1.7	1.8	1.9	14.0	3.2	5.9	1.0	3.1	12.6	3.3	5.2	2.3	3.0	8.8	4.9	8.2	22.3	4.7	2.8	7.1	8.9	3.1	5.0	2.3	4.5	3.4	2.0	5.7	5.8	1.3	2.0	3.1	5.7	7.4	2.5	6.0	4.6	11.6	8.8	4.7	1.5	3.8	7.3	5.3	6.6	3.6	3.4	3.8	1.5	12.6	1.9	3.9	7.2	2.4	5.9	4.7	3.0	22.6	3.4	11.0	3.1	1.7	2.0	5.9	3.3	0.8	1.6	6.3	1.0	2.9	1.0	6.6	2.3	3.4	2.0	1.8	1.4	0.6	0.5	2.5	10.0	12.4	34.3	7.9	9.6	4.3	11.7	4.3	7.2	8.3	29.8	37.4	31.8	6.6	7.9	25.6	18.6	0.0	6.7	18.2	0.0	58.9	13.3	0.0	3.3	11.9	19.6	32.0	0.0	4.0	0.6	5.8	15.0	5.7	5.4	5.7	7.9	2.4	4.9	15.7	31.1	6.1	9.8	8.5	2.8	25.7	12.8	16.0	12.4	4.2	2.0	45.5	19.4	18.6	14.0	24.0	3.1	2.1	19.2	17.3	7.8
DGKE	"DAGK6, DGK"	ENSG00000153933	"Diacylglycerol kinase epsilon"	P52429	17	56834099-56869567	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"		"Kinase, Transferase"	"Disease mutation, Hemolytic uremic syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"Bipolar cells: 167.4;Cone photoreceptor cells: 178.7;Rod photoreceptor cells: 165.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"Karpas-707: 43.5;MOLT-4: 14.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA017167	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"HPA017167: AB_1847638"	"unprognostic (1.19e-2)"	"unprognostic (2.11e-2)"	"unprognostic (2.69e-1)"	"prognostic favorable (3.92e-5)"	"unprognostic (4.20e-2)"	"unprognostic (4.87e-2)"	"unprognostic (3.37e-1)"	"unprognostic (4.27e-2)"	"unprognostic (1.19e-3)"	"unprognostic (4.75e-2)"	"unprognostic (6.07e-3)"	"unprognostic (2.68e-1)"	"unprognostic (2.55e-2)"	"unprognostic (1.99e-1)"	"unprognostic (2.17e-1)"	"unprognostic (1.26e-1)"	"unprognostic (3.69e-3)"	7.8	4.9	7.8	8.3	17.7	5.5	5.2	21.3	18.6	9.5	7.4	4.4	5.6	5.4	13.3	8.9	5.0	8.2	9.4	4.9	7.4	9.2	4.2	4.9	8.1	9.3	5.6	10.0	7.3	6.5	9.5	14.5	5.5	9.9	8.9	7.0	17.4	4.3	7.3	2.4	3.4	7.1	9.3	6.8	12.7	6.4	12.5	5.4	14.5	8.3	2.5	8.6	6.5	15.3	2.4	2.4	1.2	0.8	1.9	4.5	0.8	1.7	1.6	1.5	0.1	0.3	0.5	0.7	2.9	2.3	2.0	2.3	3.8	2.1	2.5	3.6	1.5	1.0	2.1	3.6	1.6	4.1	8.0	4.7	3.2	4.0	2.5	1.7	6.2	4.5	0.9	2.0	2.1	4.2	1.8	2.7	7.4	2.6	43.5	2.4	2.5	14.5	3.5	1.1	2.2	4.9	4.5	6.3	5.9	2.0	3.8	2.4	1.6	2.3	1.2	0.1	1.0	2.7	3.0	2.4	0.5	2.7	0.8	0.4	5.7	11.7	1.7	1.7	3.6	0.1	0.3	0.5	0.0	2.7	0.4	2.0	2.4	1.9	2.3	0.6	0.9	1.9	2.5	1.2	1.9	0.8	2.4	4.5	0.8	7.8	17.7	21.3	18.6	7.4	9.2	5.6	10.0	9.9	5.4	3.0	5.9	2.2	10.2	7.9	167.4	5.5	15.3	1.4	4.5	15.7	178.7	3.2	0.0	6.5	13.1	23.3	3.4	0.0	4.0	2.2	4.3	13.9	0.0	3.8	1.9	7.9	10.9	32.5	5.6	7.4	4.0	4.1	3.3	2.8	7.1	13.8	4.9	5.5	4.9	0.0	165.4	6.5	10.3	25.4	18.5	5.8	2.9	13.8	4.6	8.8
DGKG	DAGK3	ENSG00000058866	"Diacylglycerol kinase gamma"	P49619	3	186105668-186362237	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 53.4"	"Group enriched"	"Detected in many"	6	"Cardiomyocytes: 16.2;Ito cells: 27.6;Muller glia cells: 7.5;Sertoli cells: 12.9;Smooth muscle cells: 16.7"	"Cancer enhanced"	"Detected in some"		"glioma: 2.8"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"classical monocyte: 4.2;eosinophil: 2.4;intermediate monocyte: 2.4;myeloid DC: 2.9;neutrophil: 5.3;non-classical monocyte: 2.8"	"Group enriched"	"Detected in many"	6	"dendritic cells: 2.9;granulocytes: 5.3;monocytes: 4.2"	"Cell line enhanced"	"Detected in some"		"HDLM-2: 20.2;HL-60: 6.4;U-266/84: 7.7;U-87 MG: 12.8;U-937: 6.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA036577	Approved		Supported	"Vesicles,Plasma membrane"		NA	NA			"Vesicles, Plasma membrane"		"HPA036577: AB_10672358"	"unprognostic (2.23e-1)"	"unprognostic (1.97e-1)"	"unprognostic (1.56e-2)"	"unprognostic (3.24e-5)"	"unprognostic (2.70e-1)"	"unprognostic (6.09e-4)"	"unprognostic (1.21e-3)"	"unprognostic (3.80e-2)"	"unprognostic (5.88e-2)"	"unprognostic (1.50e-1)"	"unprognostic (1.94e-1)"	"unprognostic (5.09e-2)"	"unprognostic (8.05e-7)"	"unprognostic (3.47e-3)"	"unprognostic (7.19e-2)"	"unprognostic (1.41e-1)"	"unprognostic (9.16e-3)"	3.1	6.9	13.4	3.1	7.1	14.5	1.9	53.4	23.1	2.7	3.5	6.2	1.1	3.0	1.9	14.6	8.5	7.7	2.2	15.0	15.3	7.4	3.1	2.1	4.3	2.1	7.4	11.3	2.0	1.6	4.7	7.5	13.5	25.2	3.1	2.1	7.8	1.9	4.0	2.4	1.4	2.7	5.3	5.6	2.0	3.3	1.2	7.1	0.0	2.5	0.0	2.1	4.8	2.4	0.6	2.9	5.3	4.2	0.0	0.0	1.3	2.7	4.2	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.0	2.4	0.0	2.9	0.2	0.0	0.0	0.0	20.2	0.0	2.7	0.0	2.9	0.0	6.4	0.3	0.0	0.0	1.3	0.0	0.0	0.0	0.5	0.0	0.4	0.3	0.1	0.1	2.2	0.4	0.0	1.2	1.4	0.0	2.3	0.0	0.0	0.5	0.0	0.8	0.0	1.7	0.0	0.1	4.2	0.0	0.0	0.7	2.1	2.4	0.0	7.7	0.0	12.8	6.0	2.3	0.0	4.2	2.4	0.0	2.4	0.0	0.6	0.0	0.0	2.9	0.3	0.0	0.0	5.3	0.0	2.8	0.5	0.0	1.3	13.4	7.1	53.4	14.7	15.3	7.4	7.4	11.3	25.2	7.1	0.0	1.7	1.5	0.1	0.3	0.0	16.2	0.0	0.0	0.0	1.8	0.0	0.0	0.0	1.2	2.4	0.0	0.0	0.0	1.1	0.0	0.2	0.1	0.0	0.0	1.9	1.6	0.0	27.6	2.7	2.0	1.7	2.3	0.0	1.0	0.0	7.5	0.7	0.0	0.4	0.8	0.0	12.9	16.7	0.0	0.0	0.4	0.1	0.0	0.0	0.4
DGKH	DGKeta	ENSG00000102780	"Diacylglycerol kinase eta"	Q86XP1	13	42040036-42256578	"Enzymes, Predicted intracellular proteins"		"Kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Urothelial cells: 105.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA039533, HPA040355, HPA061538"	Uncertain		Supported	"Vesicles,Plasma membrane"		NA	NA			"Plasma membrane"	Vesicles	"HPA039533: AB_10795145, HPA040355: AB_10796452, HPA061538: "	"unprognostic (2.80e-1)"	"unprognostic (7.03e-2)"	"unprognostic (1.30e-1)"	"unprognostic (5.69e-2)"	"unprognostic (1.55e-3)"	"unprognostic (7.62e-2)"	"unprognostic (1.04e-2)"	"unprognostic (9.60e-2)"	"unprognostic (7.00e-3)"	"unprognostic (4.37e-2)"	"unprognostic (1.86e-1)"	"unprognostic (2.41e-1)"	"unprognostic (3.43e-3)"	"unprognostic (1.03e-1)"	"unprognostic (1.67e-1)"	"unprognostic (4.93e-2)"	"unprognostic (1.43e-2)"	4.9	2.8	3.3	4.9	12.7	2.3	8.3	9.6	6.2	5.2	6.4	3.4	7.9	3.1	9.4	14.0	5.2	5.9	6.8	10.2	9.0	2.7	6.0	6.8	9.5	4.0	3.5	4.0	4.3	4.2	1.4	3.5	8.9	3.6	4.6	6.9	5.5	7.7	4.8	5.8	6.2	5.1	8.3	3.5	6.1	4.0	7.0	4.3	2.2	4.3	2.0	2.9	8.1	6.0	1.4	1.5	4.3	1.3	0.7	1.7	0.2	4.9	5.8	4.8	3.7	1.8	4.1	0.5	3.2	2.5	2.1	2.6	0.5	4.3	3.9	3.9	3.3	7.4	11.0	4.1	7.1	3.2	3.3	11.5	7.0	3.1	0.4	2.3	2.9	2.0	1.5	7.2	4.0	16.4	3.1	9.4	5.1	2.8	2.7	3.6	4.7	3.0	1.6	1.9	4.8	4.0	4.7	3.9	2.7	7.0	15.0	2.7	2.5	2.9	3.7	2.7	1.9	3.4	8.2	9.1	4.0	3.6	4.3	4.3	1.4	1.3	4.5	2.2	2.7	2.8	2.4	1.3	0.6	1.1	0.9	1.2	0.8	1.7	1.7	0.3	1.4	1.0	1.6	4.3	0.7	0.7	1.5	1.1	0.2	3.3	12.7	9.6	6.2	9.0	2.7	3.5	4.0	3.6	4.3	20.8	28.6	1.9	54.1	54.8	48.5	7.1	25.5	69.6	39.8	10.4	3.9	3.3	1.7	10.6	21.9	28.0	13.6	0.0	6.3	1.8	13.3	64.9	7.0	2.6	5.8	1.6	45.5	27.0	7.5	14.9	3.1	16.5	8.5	9.0	22.6	15.5	17.7	14.4	8.5	7.3	2.2	25.8	35.8	2.3	2.6	29.0	2.4	5.1	18.0	105.9
DGKI	DGK-IOTA	ENSG00000157680	"Diacylglycerol kinase iota"	O75912	7	137381037-137847092	"Enzymes, Predicted intracellular proteins"		"Kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 19.8;thyroid gland: 32.1"	"Group enriched"	"Detected in some"	5	"Bipolar cells: 40.2;Horizontal cells: 42.9"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BJ: 4.0;GAMG: 4.5;hTEC/SVTERT24-B: 4.2;SCLC-21H: 6.8;U-2197: 18.8;U-87 MG: 7.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA						"unprognostic (1.76e-1)"	"unprognostic (1.22e-1)"	"unprognostic (6.66e-3)"	"unprognostic (1.76e-1)"	"unprognostic (6.08e-2)"	"unprognostic (1.42e-1)"	"unprognostic (9.62e-2)"	"unprognostic (2.23e-1)"	"unprognostic (1.09e-1)"	"unprognostic (9.01e-2)"	"unprognostic (8.74e-2)"	"unprognostic (4.46e-2)"	"unprognostic (5.98e-5)"	"unprognostic (2.85e-3)"	"unprognostic (1.85e-1)"	"unprognostic (1.26e-2)"	"unprognostic (1.73e-3)"	1.5	1.3	5.0	1.1	19.8	0.7	1.1	11.4	12.7	0.8	0.9	2.6	0.0	0.9	1.4	0.9	0.9	0.9	1.9	5.0	4.6	3.3	1.7	0.7	0.8	0.8	2.8	9.0	0.8	0.7	0.8	6.0	0.8	6.6	1.0	0.9	10.8	1.0	1.1	0.7	0.9	0.9	2.7	2.5	0.8	0.8	1.9	5.8	0.0	32.1	0.0	0.8	1.1	0.3	0.2	0.2	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.5	0.0	1.0	0.9	0.0	4.0	0.2	0.1	0.3	0.0	0.0	0.0	0.0	1.3	4.5	0.0	0.0	0.0	0.6	0.0	0.0	0.1	0.1	0.0	1.0	0.0	0.1	0.2	0.0	4.2	0.1	0.8	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	6.8	2.9	0.0	0.0	0.5	0.3	0.0	0.0	0.3	1.6	0.6	18.8	0.9	0.1	0.0	0.0	7.0	0.0	1.2	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	5.0	19.8	11.4	12.7	4.6	3.3	2.8	9.0	6.6	5.8	0.0	0.0	0.0	0.2	1.0	40.2	9.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.1	0.7	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.6	42.9	0.0	0.0	0.0	1.7	0.9	0.0	0.0	0.0	0.0	1.9	0.0	0.0	1.4	0.3	3.0	0.0	1.0	0.2	0.2	0.5	0.0	0.0	0.0	0.0
DGKK		ENSG00000274588	"Diacylglycerol kinase kappa"	Q5KSL6	X	50365409-50470738	"Enzymes, Predicted intracellular proteins"		"Kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	10	"adrenal gland: 9.8;brain: 29.6;pituitary gland: 33.5"	"Cell type enhanced"	"Detected in single"	20	"Late spermatids: 1.1"	"Not detected"	"Not detected"							"Group enriched"	"Detected in some"	6	"gdT-cell: 2.4;memory CD8 T-cell: 2.4"	"Lineage enriched"	"Detected in single"	25	"T-cells: 2.4"	"Cell line enriched"	"Detected in some"	19	"Hep G2: 27.9"	"Region enhanced"	"Detected in some"		"hypothalamus: 12.9"	"Group enriched"	"Detected in many"	6	"basal ganglia: 3.5;hypothalamus: 1.8;midbrain: 4.3;pons and medulla: 1.1"							NA	NA						"unprognostic (3.99e-1)"		"unprognostic (1.18e-1)"	"unprognostic (4.18e-3)"	"unprognostic (1.23e-1)"		"unprognostic (5.83e-3)"	"unprognostic (9.58e-2)"		"unprognostic (2.41e-2)"	"unprognostic (1.62e-2)"	"unprognostic (2.06e-1)"	"unprognostic (4.28e-3)"	"unprognostic (3.89e-2)"	"unprognostic (1.20e-1)"	"unprognostic (9.49e-2)"	"unprognostic (4.64e-3)"	0.1	9.8	0.0	0.0	29.6	0.2	0.3	0.0	1.1	0.0	0.0	0.0	0.1	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.2		0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	33.5	0.0	0.9	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.1	0.1	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	27.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.5											0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0
DGKQ	"DAGK, DAGK4, DAGK7"	ENSG00000145214	"Diacylglycerol kinase theta"	P52824	4	958887-986895	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	8	"Enterocytes: 28.3;Paneth cells: 31.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA026797, CAB033835"	Uncertain					NA	NA					"CAB033835: AB_2091307, HPA026797: AB_10600902"	"unprognostic (7.39e-2)"	"unprognostic (1.66e-1)"	"unprognostic (1.76e-1)"	"unprognostic (2.64e-2)"	"unprognostic (1.14e-1)"	"unprognostic (5.08e-2)"	"unprognostic (3.37e-1)"	"unprognostic (6.39e-2)"	"unprognostic (2.90e-2)"	"unprognostic (1.06e-1)"	"unprognostic (6.45e-2)"	"unprognostic (1.06e-2)"	"unprognostic (9.77e-2)"	"unprognostic (3.08e-3)"	"unprognostic (4.38e-2)"	"unprognostic (2.65e-2)"	"unprognostic (1.65e-3)"	6.4	9.3	15.9	10.7	13.8	10.4	6.9	21.6	17.4	5.4	14.7	7.9	6.9	27.0	6.3	3.8	7.9	5.3	10.3	4.5	15.0	12.1	8.4	8.9	6.9	12.3	9.7	12.3	5.1	9.8	5.5	8.2	4.4	10.2	7.0	8.4	6.7	12.1	5.8	3.7	13.0	28.0	5.9	5.2	12.7	8.6	6.8	7.7	9.1	6.7	3.8	8.7	6.6	7.0	1.3	1.9	4.0	1.4	5.3	5.0	1.8	4.2	6.8	3.0	10.0	3.6	3.0	11.1	8.0	4.6	4.6	4.6	4.9	8.4	5.6	6.8	5.1	9.4	4.8	1.7	5.6	1.1	4.4	5.3	8.7	6.3	8.5	6.3	3.7	11.7	5.7	9.6	3.8	1.8	3.9	5.6	11.8	6.5	0.7	3.5	6.3	7.7	21.7	5.3	11.7	11.6	12.5	0.9	0.6	5.0	5.9	1.9	5.1	2.8	3.2	8.4	2.4	7.5	9.1	8.1	8.0	3.8	9.0	5.3	15.5	6.6	4.3	6.9	8.1	7.2	4.0	1.4	2.9	5.0	1.1	2.3	1.1	1.8	4.1	0.9	1.3	1.9	3.4	0.9	5.3	1.1	1.9	1.1	1.8	15.9	13.8	21.6	17.4	15.0	12.1	9.7	12.3	10.2	7.7	3.0	1.9	0.5	1.2	2.5	2.9	2.0	7.6	2.7	1.2	3.5	3.9	0.4	0.0	2.6	0.3	2.8	28.3	0.0	4.2	1.6	2.2	2.1	0.0	4.7	2.2	3.2	7.5	1.8	2.6	0.7	3.7	2.6	3.3	3.6	15.3	2.5	4.1	31.7	2.5	0.9	0.8	0.0	1.6	1.1	5.9	3.3	0.6	7.0	11.1	3.0
DGKZ	"DAGK5, DAGK6, DGK-ZETA, hDGKzeta"	ENSG00000149091	"Diacylglycerol kinase zeta"	Q13574	11	46332905-46380554	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 50.7"	"Cell type enhanced"	"Detected in many"	4	"Extravillous trophoblasts: 84.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA051336	Enhanced	Supported	Supported	"Nuclear speckles"		NA	NA			"Nuclear speckles"		"HPA051336: AB_2681448"	"unprognostic (2.85e-2)"	"unprognostic (3.90e-2)"	"unprognostic (2.39e-1)"	"unprognostic (1.65e-1)"	"unprognostic (1.40e-1)"	"unprognostic (4.12e-2)"	"unprognostic (3.08e-3)"	"unprognostic (1.31e-1)"	"unprognostic (1.03e-2)"	"unprognostic (2.49e-2)"	"unprognostic (3.66e-3)"	"unprognostic (8.18e-2)"	"prognostic unfavorable (4.74e-5)"	"unprognostic (1.48e-3)"	"unprognostic (7.75e-2)"	"unprognostic (3.61e-2)"	"unprognostic (7.84e-3)"	8.6	6.7	34.5	11.8	27.4	28.0	6.8	22.6	50.7	7.5	7.4	8.5	2.5	21.0	6.1	4.3	7.1	6.3	6.7	16.0	48.0	9.2	5.3	3.3	8.3	20.7	9.4	26.7	5.0	17.3	7.0	18.6	8.4	7.5	5.9	4.2	4.8	24.1	7.0	42.8	8.3	23.2	5.6	7.2	15.6	9.9	5.0	7.5	14.2	4.1	9.1	9.9	7.6	5.0	0.9	12.3	11.2	11.8	7.7	7.5	8.1	11.9	10.7	7.2	10.8	3.8	4.3	33.7	9.3	7.0	9.9	8.7	12.7	5.5	15.4	6.8	9.7	10.9	14.0	8.7	13.5	3.5	15.4	20.3	10.0	7.8	9.3	6.9	18.9	20.3	5.8	6.4	5.4	7.4	5.1	10.9	12.8	14.0	9.5	7.0	31.5	18.2	29.7	21.1	17.3	16.4	21.8	12.6	6.5	3.0	11.7	49.8	8.5	10.7	35.9	7.3	4.8	25.8	23.9	12.2	13.1	14.2	20.6	16.8	6.3	7.1	12.6	17.9	17.2	12.1	11.2	11.8	5.8	7.5	6.1	4.5	0.4	4.7	6.3	12.3	0.9	4.9	5.0	9.8	7.7	5.9	5.9	4.5	8.1	34.5	27.4	22.6	50.7	48.0	9.2	9.4	26.7	7.5	7.5	3.0	10.0	17.1	20.8	11.7	19.2	20.9	10.2	1.4	4.5	8.7	19.6	12.7	8.3	11.4	5.4	22.4	36.9	0.0	41.8	84.0	10.8	14.0	20.7	7.8	43.9	15.9	49.4	57.1	44.7	5.4	12.0	18.5	11.8	19.8	18.9	5.8	26.8	45.6	7.8	15.4	9.2	32.3	11.3	7.0	13.2	8.2	22.9	57.3	18.0	14.7
DGLUCY	"C14orf159, FLJ39975"	ENSG00000133943	"D-glutamate cyclase"	Q7Z3D6	14	91060333-91225632	"Enzymes, Predicted intracellular proteins"		Lyase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 82.9"	"Cell type enhanced"	"Detected in many"	6	"Alveolar cells type 1: 26.8;Collecting duct cells: 27.9;Cytotrophoblasts: 25.8;Hofbauer cells: 28.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"neutrophil: 57.9"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"							"HPA041423, HPA052932"	Approved		Supported	Cytosol		NA	NA			Cytosol		"HPA041423: AB_10795540, HPA052932: AB_2681991"	"unprognostic (5.02e-2)"	"unprognostic (1.01e-2)"	"unprognostic (1.56e-1)"	"prognostic favorable (4.28e-4)"	"unprognostic (1.28e-1)"	"unprognostic (2.26e-1)"	"unprognostic (3.58e-2)"	"prognostic favorable (9.48e-5)"	"unprognostic (3.56e-1)"	"prognostic favorable (7.28e-4)"	"unprognostic (2.30e-1)"	"unprognostic (1.74e-1)"	"prognostic favorable (3.77e-15)"	"unprognostic (1.50e-1)"	"unprognostic (9.51e-2)"	"unprognostic (2.75e-2)"	"unprognostic (2.57e-3)"	12.5	18.7	23.4	15.9	23.1	10.7	9.3	27.3	22.6	14.6	16.7	18.1	16.0	13.8	16.8	13.1	16.0	21.9	12.5	63.9	18.8	16.6	20.1	13.1	13.7	11.2	20.1	19.2	13.4	9.3	29.3	14.2	9.2	19.0	13.3	17.0	11.3	17.4	22.3	82.9	13.9	12.3	20.0	18.5	17.3	18.9	12.2	21.6	11.2	16.8	29.1	14.1	19.4	11.4	9.4	19.8	57.9	19.3	5.6	12.0	7.0	2.7	7.5	3.8	9.2	15.7	14.9	10.0	2.9	8.1	9.0	9.3	4.8	21.6	18.7	21.7	8.6	11.8	8.3	10.5	11.4	3.7	10.3	4.4	12.5	3.8	6.2	23.0	12.8	18.3	22.9	4.9	4.9	1.9	11.9	16.0	10.5	6.2	25.5	8.5	0.7	10.0	12.1	7.7	0.3	0.7	17.2	7.4	13.6	15.3	11.8	10.6	5.4	4.8	8.4	3.5	4.1	14.9	10.8	11.4	2.7	2.4	8.0	2.7	14.7	10.4	6.3	14.0	16.7	1.8	13.7	13.6	8.1	8.8	19.3	9.0	9.4	5.9	7.2	19.8	7.0	4.9	6.0	57.9	5.6	15.5	6.2	12.0	7.0	23.4	23.1	27.3	22.6	18.8	16.6	20.1	19.2	19.0	21.6	26.8	16.0	0.0	0.0	0.0	0.0	0.0	0.0	9.4	10.3	27.9	0.0	25.8	18.3	11.9	0.0	0.0	0.0	0.0	5.1	13.7	0.0	0.0	7.0	0.0	28.5	0.0	0.0	0.0	0.0	0.0	0.0	9.6	0.0	12.6	0.0	0.0	7.0	0.0	0.0	13.4	0.0	0.0	0.0	0.0	0.0	0.0	14.1	0.0	0.0	0.0
DGUOK	dGK	ENSG00000114956	"Deoxyguanosine kinase"	Q16854	2	73926826-73958961	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		"Kinase, Transferase"	"Disease mutation, Neuropathy, Primary mitochondrial disease, Progressive external ophthalmoplegia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA034766, HPA057246"	Approved					NA	NA					"HPA034766: AB_10669850, HPA057246: AB_2683381"	"unprognostic (3.40e-1)"	"unprognostic (2.43e-1)"	"unprognostic (1.45e-2)"	"unprognostic (2.94e-2)"	"unprognostic (1.20e-1)"	"unprognostic (4.17e-2)"	"unprognostic (2.14e-2)"	"unprognostic (1.37e-2)"	"unprognostic (4.10e-3)"	"unprognostic (5.07e-2)"	"unprognostic (1.41e-1)"	"unprognostic (9.84e-2)"	"prognostic unfavorable (8.69e-7)"	"unprognostic (3.86e-1)"	"unprognostic (2.21e-2)"	"unprognostic (5.98e-2)"	"prognostic favorable (7.47e-4)"	23.8	34.8	25.8	26.2	32.3	26.3	33.7	18.4	33.7	26.1	28.0	23.6	24.9	19.4	30.7	40.9	26.6	35.4	28.0	24.5	28.3	26.5	26.7	31.7	24.7	37.2	23.5	22.6	35.5	20.9	11.2	39.9	30.6	27.1	28.6	34.1	25.2	22.5	28.2	14.1	29.2	29.3	25.8	23.5	33.1	23.6	34.3	17.9	41.7	29.0	21.8	44.2	27.2	27.4	43.5	36.4	50.5	31.4	30.0	42.3	31.3	15.8	27.0	28.1	25.0	18.2	20.1	13.8	10.6	21.4	25.6	23.7	34.2	19.2	30.0	10.1	15.6	28.0	12.6	31.9	20.6	30.7	16.4	19.2	23.5	10.2	38.7	26.9	21.6	24.0	18.8	19.5	18.7	22.1	18.6	18.1	33.5	24.0	13.8	29.3	19.4	20.2	38.1	28.5	21.6	19.8	26.1	28.2	20.0	20.3	18.5	32.3	31.6	10.3	10.2	27.2	14.0	12.3	12.3	16.9	16.4	26.4	14.2	19.2	11.3	10.9	30.2	23.7	23.3	34.8	41.3	27.4	50.5	25.3	31.4	29.8	40.6	31.4	27.9	32.4	43.5	42.3	33.1	22.5	30.0	30.8	36.4	29.3	31.3	25.8	32.3	18.4	33.7	28.3	26.5	23.5	22.6	27.1	17.9	29.8	42.6	116.6	116.4	65.9	50.7	16.9	84.1	46.8	45.5	57.6	5.9	137.2	71.3	91.0	9.5	69.4	61.1	23.3	131.5	130.2	91.1	97.5	55.5	62.5	82.3	49.3	108.6	71.8	80.4	10.5	86.6	94.7	104.6	165.1	87.5	62.8	129.3	87.7	81.7	95.0	33.2	90.5	82.4	111.2	113.9	72.8	104.1	113.0	95.7	113.2
DHCR24	"DCE, KIAA0018, seladin-1"	ENSG00000116133	"24-dehydrocholesterol reductase"	Q15392	1	54849633-54887218	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Cholesterol biosynthesis, Cholesterol metabolism, Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis, Steroid metabolism, Sterol biosynthesis, Sterol metabolism"	Oxidoreductase	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adrenal gland: 164.5;liver: 119.6"	"Cell type enhanced"	"Detected in many"	13	"Alveolar cells type 2: 733.4;Hepatocytes: 888.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"ASC diff: 132.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA017981, CAB037247, HPA063005"	Enhanced					NA	NA					"CAB037247: AB_796187, HPA017981: AB_2732422, HPA063005: AB_2684919"	"unprognostic (2.88e-1)"	"unprognostic (1.80e-2)"	"unprognostic (4.99e-3)"	"prognostic unfavorable (1.05e-5)"	"unprognostic (1.69e-1)"	"unprognostic (2.61e-1)"	"unprognostic (1.54e-2)"	"unprognostic (1.85e-1)"	"unprognostic (1.68e-1)"	"unprognostic (1.86e-1)"	"unprognostic (6.18e-3)"	"unprognostic (3.35e-1)"	"unprognostic (7.82e-3)"	"unprognostic (5.48e-2)"	"unprognostic (1.83e-1)"	"unprognostic (1.70e-1)"	"unprognostic (3.97e-2)"	10.6	164.5	6.6	3.9	22.1	0.7	22.0	6.5	27.5	7.7	11.1	43.8	1.2	11.9	2.2	1.1	40.8	12.3	8.6	3.7	12.0	9.2	6.4	119.6	40.9	2.0	36.2	13.0	7.8	4.6	28.4	2.6	4.4	47.9	26.1	8.3	4.8	20.2	2.1	24.6	47.6	7.3	2.7	71.7	24.3	17.6	14.1	31.1	1.7	4.3	17.1	14.3	2.5	13.0	5.4	7.0	7.3	3.1	3.7	9.0	5.5	40.5	7.5	26.5	32.0	132.8	28.6	6.2	11.7	20.3	16.9	34.9	41.6	25.7	6.5	23.6	10.2	53.9	39.0	31.7	61.7	15.1	0.9	19.9	36.1	17.7	49.7	21.6	15.0	8.4	20.8	53.9	52.2	9.7	8.3	8.3	15.3	26.3	0.0	6.2	17.0	3.2	13.2	73.3	11.0	20.5	0.0	6.7	19.9	92.9	32.9	18.3	6.7	22.2	42.0	15.3	29.3	54.7	17.5	7.6	5.6	16.5	8.1	22.1	2.8	6.4	11.2	4.1	25.9	7.3	7.3	2.4	1.1	9.0	3.1	0.5	5.4	4.0	4.2	7.0	2.4	3.9	4.7	0.1	3.7	1.0	4.2	0.7	5.5	6.6	22.1	6.5	27.5	12.0	9.2	36.2	13.0	47.9	31.1	276.9	733.4	19.9	13.4	27.9	4.4	9.0	165.6	95.0	154.7	64.6	0.0	33.0	3.3	46.7	12.8	10.6	64.2	93.5	65.4	27.5	19.8	70.0	30.2	888.0	22.6	4.8	23.1	154.7	70.4	40.3	13.0	6.1	13.5	10.8	30.6	3.7	38.4	26.0	7.4	11.2	4.4	0.0	4.7	1.7	14.0	70.3	25.6	7.0	24.8	34.0
DHCR7	SLOS	ENSG00000172893	"7-dehydrocholesterol reductase"	Q9UBM7	11	71428193-71452868	"Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins"	"Cholesterol biosynthesis, Cholesterol metabolism, Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis, Steroid metabolism, Sterol biosynthesis, Sterol metabolism"	Oxidoreductase	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 64.8"	"Cell type enhanced"	"Detected in many"	6	"Exocrine glandular cells: 43.9;Hepatocytes: 67.2;Syncytiotrophoblasts: 45.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044280	Approved		Supported	"Endoplasmic reticulum"		NA	NA			"Endoplasmic reticulum"		"HPA044280: AB_10794893"	"unprognostic (1.76e-1)"	"unprognostic (1.50e-3)"	"unprognostic (1.32e-2)"	"unprognostic (7.16e-3)"	"unprognostic (2.69e-1)"	"unprognostic (2.18e-3)"	"unprognostic (8.57e-3)"	"unprognostic (3.02e-2)"	"unprognostic (4.91e-2)"	"unprognostic (1.13e-1)"	"unprognostic (1.08e-2)"	"unprognostic (5.45e-2)"	"prognostic favorable (6.93e-7)"	"unprognostic (1.73e-1)"	"unprognostic (1.01e-1)"	"unprognostic (8.15e-2)"	"prognostic unfavorable (5.67e-4)"	8.0	40.1	12.1	5.6	14.5	19.0	16.8	5.3	22.8	5.5	9.3	27.9	8.8	20.8	4.0	27.3	14.6	5.2	5.8	10.7	13.7	13.2	7.1	64.8	12.0	2.7	20.6	12.3	21.5	7.3	14.0	7.0	3.7	23.4	10.0	6.6	16.6	10.0	3.9	5.4	22.9	15.8	4.5	20.5	5.9	8.5	17.7	15.5	2.8	5.4	12.1	7.7	4.3	7.4	6.3	6.2	3.5	1.9	4.6	12.1	5.7	21.2	19.3	18.9	20.9	8.9	13.8	5.9	8.8	23.5	7.5	20.5	71.9	70.0	14.9	14.0	8.4	67.3	41.0	22.5	47.6	7.9	5.6	16.9	5.7	16.3	30.7	22.8	10.6	2.7	15.9	21.1	28.2	19.4	6.2	11.1	19.5	26.6	31.8	7.5	57.2	8.7	12.0	27.1	21.1	11.5	7.9	26.6	64.0	28.2	32.2	25.7	9.6	8.4	27.8	20.0	9.6	26.9	5.8	10.4	2.0	11.4	0.6	10.5	10.5	12.7	15.9	6.0	18.9	8.5	3.5	1.9	1.7	9.7	1.2	11.8	6.3	8.2	9.0	2.5	5.4	10.5	12.1	1.0	4.6	1.2	6.2	5.1	5.7	12.1	14.5	5.3	22.8	13.7	13.2	20.6	12.3	23.4	15.5	3.0	12.6	6.7	7.1	0.7	6.8	11.3	10.2	5.3	9.1	21.0	11.8	13.8	6.6	29.1	0.1	6.6	7.8	0.0	43.9	21.8	9.3	14.2	0.0	67.2	9.8	0.0	9.1	6.2	3.7	0.0	7.8	3.0	5.0	9.0	11.8	20.9	19.8	7.0	4.6	2.9	8.0	12.9	2.5	0.6	5.9	1.0	45.3	10.2	14.5	7.1
DHDDS	"DS, FLJ13102, HDS, RP59"	ENSG00000117682	"Dehydrodolichyl diphosphate synthase subunit"	Q86SQ9	1	26432282-26471294	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Lipid metabolism"	Transferase	"Disease mutation, Epilepsy, Mental retardation, Retinitis pigmentosa"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	11	"Cone photoreceptor cells: 241.5;Rod photoreceptor cells: 101.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA026721, HPA026727"	Uncertain		Uncertain	"Plasma membrane"		NA	NA			"Plasma membrane"		"HPA026721: AB_1847643, HPA026727: AB_1847644"	"unprognostic (1.11e-2)"	"unprognostic (5.43e-2)"	"unprognostic (5.12e-2)"	"unprognostic (9.81e-2)"	"unprognostic (6.71e-2)"	"unprognostic (7.23e-2)"	"unprognostic (1.32e-3)"	"unprognostic (3.81e-3)"	"unprognostic (2.40e-1)"	"unprognostic (5.42e-2)"	"unprognostic (4.51e-2)"	"unprognostic (3.40e-2)"	"prognostic favorable (4.08e-7)"	"unprognostic (9.42e-2)"	"unprognostic (2.85e-1)"	"unprognostic (2.22e-1)"	"unprognostic (2.95e-1)"	31.8	14.4	11.2	10.8	15.9	6.4	15.0	45.9	18.8	10.4	23.1	12.5	8.3	12.2	15.4	21.9	18.9	9.2	10.9	14.8	9.7	10.7	16.2	15.3	9.5	10.3	12.1	15.8	9.8	14.7	23.2	15.5	13.1	20.6	9.6	23.9	22.0	56.9	9.1	10.3	13.1	12.2	11.3	7.6	10.5	14.2	12.9	8.9	9.7	12.1	11.1	16.9	10.6	9.8	11.1	11.2	11.8	19.5	8.1	11.6	8.2	14.9	12.2	8.1	11.1	16.8	14.1	14.0	25.6	16.0	19.8	19.8	18.8	16.5	16.9	15.7	23.9	14.5	10.9	10.9	20.0	19.0	10.3	5.8	16.8	30.3	13.8	15.8	18.3	24.8	19.3	11.9	27.3	15.4	13.3	24.9	11.1	12.0	18.6	18.1	10.2	9.3	7.7	12.8	21.0	16.4	11.2	14.4	14.4	10.7	14.1	11.4	9.1	17.2	19.0	11.3	11.7	14.3	10.3	31.7	13.8	13.4	25.9	14.6	22.7	30.4	18.2	21.7	23.0	13.4	6.5	13.4	7.1	11.6	19.5	8.4	11.1	7.7	7.5	11.2	9.3	6.5	9.0	11.8	8.1	18.0	9.1	7.3	8.2	11.2	15.9	45.9	18.8	9.7	10.7	12.1	15.8	20.6	8.9	8.9	5.6	17.5	7.9	4.0	31.4	13.7	12.7	8.1	10.3	14.0	241.5	15.5	10.0	17.0	55.9	9.0	44.5	0.0	12.6	19.4	8.2	11.0	18.5	11.5	21.3	14.3	20.1	11.1	7.3	16.4	9.8	9.7	10.1	48.7	32.2	15.3	14.8	42.1	7.1	20.3	101.1	0.0	10.3	9.3	13.5	4.4	21.3	10.0	14.0	11.1
DHDH	HUM2DD	ENSG00000104808	"Dihydrodiol dehydrogenase"	Q9UQ10	19	48933682-48944969	"Enzymes, Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in some"	4	"intestine: 32.4;kidney: 18.0"	"Cell type enriched"	"Detected in many"	5	"Proximal tubular cells: 56.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"basophil: 5.8;naive CD4 T-cell: 4.8"	"Group enriched"	"Detected in many"	31	"granulocytes: 5.8;T-cells: 4.8"	"Cell line enhanced"	"Detected in many"		"JURKAT: 6.3;U-266/70: 6.4;U-266/84: 5.0"					"Low region specificity"	"Detected in all"			HPA044131	Approved		Approved	"Nucleoplasm,Actin filaments"		NA	NA			"Nucleoplasm, Actin filaments"		"HPA044131: AB_10966968"	"unprognostic (1.54e-1)"	"unprognostic (2.72e-2)"	"unprognostic (1.07e-1)"	"prognostic unfavorable (9.91e-4)"	"unprognostic (3.33e-3)"	"unprognostic (1.45e-1)"	"unprognostic (5.81e-6)"	"unprognostic (1.56e-2)"	"unprognostic (5.88e-2)"	"unprognostic (4.96e-2)"	"unprognostic (3.30e-2)"	"unprognostic (5.08e-2)"	"prognostic favorable (3.15e-4)"	"unprognostic (2.93e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.67e-1)"	"unprognostic (1.54e-1)"	0.3	0.5	1.5	0.1	2.1	0.1	0.2	1.8	1.5	0.1	8.2	0.2	0.1	10.6	0.2	0.4	0.8	0.3	0.8	0.1	2.7	2.0	18.0	0.7	1.9	0.2	0.4	0.4	0.5	0.4	0.2	2.1	1.3	0.6	3.5	0.1	1.2	0.8	0.2	0.3	0.2	32.4	0.1	0.9	1.8	0.7	2.8	0.1	0.4	0.1	0.5	0.7	1.1	0.3	0.1	0.0	5.8	0.0	0.0	4.8	0.5	2.8	0.0	0.2	1.4	0.8	0.6	1.1	0.0	0.4	0.5	1.4	2.7	2.2	0.0	0.5	0.0	1.8	0.8	0.9	2.0	0.9	1.0	2.2	3.9	0.9	1.0	0.0	0.0	0.9	0.5	0.2	1.1	0.0	0.7	0.0	6.3	1.2	0.4	0.0	0.6	0.0	0.2	0.6	4.0	1.8	1.4	0.2	1.9	0.3	0.9	4.2	2.3	0.5	0.3	0.9	0.3	1.9	0.1	0.0	0.0	1.7	0.6	0.1	6.4	5.0	1.6	1.3	0.0	0.4	5.8	0.0	0.9	1.6	0.0	0.8	0.0	1.6	0.7	0.0	0.1	4.8	3.1	0.1	0.0	0.0	0.0	1.2	0.5	1.5	2.1	1.8	1.5	2.7	2.0	0.4	0.4	0.6	0.1	3.0	5.4	0.0	2.6	0.7	1.3	0.4	0.0	0.0	4.5	3.5	0.0	0.1	8.3	1.3	0.5	0.6	1.7	0.0	0.3	0.1	0.5	5.2	1.1	0.0	10.9	0.0	0.0	0.0	0.8	1.4	0.0	0.0	0.0	0.0	0.7	1.5	1.2	2.9	0.0	56.2	4.3	0.0	0.1	0.0	0.6	0.1	0.1	0.0	0.6	2.6
DHFR		ENSG00000228716	"Dihydrofolate reductase"	P00374	5	80626228-80654983	"Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins"	"Methotrexate resistance, One-carbon metabolism"	"Oxidoreductase, RNA-binding"	"Cancer-related genes, Disease mutation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	10	"Erythroid cells: 163.5;Spermatocytes: 92.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"CAB037129, HPA051465"	Uncertain		Approved	Mitochondria		NA	Yes			Mitochondria		"CAB037129: AB_439683, HPA051465: AB_2681494"	"unprognostic (1.44e-2)"	"unprognostic (1.03e-2)"	"unprognostic (2.24e-3)"	"unprognostic (2.91e-3)"	"unprognostic (3.27e-1)"	"unprognostic (1.32e-1)"	"unprognostic (2.83e-2)"	"unprognostic (2.35e-2)"	"unprognostic (2.02e-2)"	"unprognostic (4.19e-3)"	"unprognostic (1.83e-2)"	"unprognostic (2.55e-1)"	"unprognostic (1.15e-2)"	"unprognostic (1.82e-2)"	"unprognostic (2.49e-1)"	"unprognostic (1.57e-1)"	"unprognostic (1.09e-1)"	17.7	6.1	16.0	11.6	13.9	28.3	10.9	10.2	14.0	7.5	12.6	18.1	11.7	14.5	5.9	9.0	9.8	4.7	6.9	9.7	17.3	14.4	13.1	35.5	8.6	23.2	18.9	9.4	7.5	4.9	9.6	7.2	8.5	13.0	5.9	15.5	8.6	8.0	8.4	10.4	5.9	14.5	7.3	25.3	9.1	7.4	10.5	11.5	13.4	9.2	2.3	22.8	7.9	6.1	2.4	3.3	3.5	2.6	2.1	4.0	2.1	19.8	13.8	35.1	25.9	6.6	7.0	12.9	15.9	12.2	27.8	32.1	13.1	24.0	40.4	7.0	9.2	22.7	14.0	45.1	20.5	45.0	17.9	27.8	19.3	23.0	12.1	1.4	22.5	8.6	4.8	2.1	24.9	2.8	4.7	13.4	29.7	21.7	31.1	28.1	19.9	55.4	9.1	17.7	9.9	8.1	36.0	68.9	40.0	16.0	12.7	28.7	20.0	22.5	10.5	11.4	18.6	20.8	22.3	8.0	8.8	13.4	24.6	30.4	14.6	29.2	43.7	19.7	45.8	22.6	0.8	1.2	1.1	2.3	2.6	1.1	2.1	2.7	3.2	1.9	2.4	2.1	2.7	3.5	2.1	1.7	3.3	4.0	2.1	16.0	13.9	10.2	14.0	17.3	14.4	18.9	9.4	13.0	11.5	6.0	9.4	21.6	5.3	6.2	3.7	13.2	7.6	8.1	6.8	14.0	2.0	13.0	8.3	6.6	4.3	3.6	20.0	163.5	3.3	35.4	9.5	2.1	2.3	41.2	36.1	3.2	4.7	9.2	13.2	4.6	13.0	8.3	0.0	2.8	11.1	10.0	4.3	5.8	15.2	33.5	3.4	12.9	9.0	92.4	48.0	4.8	11.1	10.1	21.0	3.7
DHFR2	"DHFRL1, DHFRP4, FLJ16119"	ENSG00000178700	"Dihydrofolate reductase 2"	Q86XF0	3	94047836-94063389	"Enzymes, Predicted intracellular proteins"	"One-carbon metabolism"	Oxidoreductase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	11	"Alveolar cells type 1: 11.9;Ciliated cells: 16.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enriched"	"Detected in many"	13	"hTERT-RPE1: 61.0"									HPA051465	Uncertain		Approved	Mitochondria		NA	NA			Mitochondria		"HPA051465: AB_2681494"	"unprognostic (1.16e-1)"	"unprognostic (1.15e-1)"	"unprognostic (1.10e-2)"	"unprognostic (3.50e-2)"	"unprognostic (2.07e-1)"	"unprognostic (1.38e-1)"	"unprognostic (5.92e-2)"	"unprognostic (1.33e-1)"	"unprognostic (1.12e-1)"	"unprognostic (4.62e-2)"	"unprognostic (2.95e-1)"	"unprognostic (1.52e-1)"	"prognostic favorable (2.30e-6)"	"unprognostic (1.63e-1)"	"unprognostic (1.79e-1)"	"unprognostic (1.13e-1)"	"unprognostic (2.96e-2)"	6.6	8.0	9.7	5.2	10.9	2.2	7.7	5.2	13.2	9.8	6.3	15.2	2.8	5.8	11.7	9.9	5.3	9.4	7.6	5.1	9.8	8.1	10.6	9.3	7.1	7.3	10.2	6.9	15.3	10.8	15.4	13.1	4.5	12.2	9.5	6.7	6.2	6.6	8.9	2.8	5.8	10.1	9.0	12.6	9.4	6.6	8.2	8.6	16.9	10.3	4.8	6.4	7.3	6.2	5.0	4.1	3.8	3.3	2.8	7.3	2.5	1.3	2.1	1.6	1.6	2.3	2.9	0.6	2.1	2.3	1.1	1.2	0.4	2.2	0.9	1.4	1.1	1.4	1.9	1.2	1.5	1.7	3.0	0.7	1.1	1.0	1.2	2.3	0.7	1.3	2.9	2.0	1.2	1.6	61.0	1.1	4.6	0.5	2.1	1.4	1.7	3.9	0.4	1.3	3.9	2.6	1.0	2.1	1.5	1.5	0.7	2.0	2.1	3.1	0.8	3.5	1.3	2.1	1.1	1.7	1.7	2.9	0.7	0.8	1.6	1.5	1.3	1.7	2.0	2.3	3.6	2.2	3.8	3.8	3.2	7.3	3.8	5.1	6.1	1.4	5.0	6.9	6.2	3.5	2.8	3.3	4.1	6.1	2.5	9.7	10.9	5.2	13.2	9.8	8.1	10.2	6.9	12.2	8.6	11.9	4.3	0.0	0.0	0.0	0.0	0.0	0.0	16.0	3.4	3.5	0.0	2.0	3.3	4.8	0.0	0.0	0.0	0.0	4.8	1.5	0.0	0.0	2.3	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	4.6	0.0	0.0	4.6	0.0	0.0	5.2	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0
DHODH		ENSG00000102967	"Dihydroorotate dehydrogenase (quinone)"	Q02127	16	72008588-72027664	"Disease related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Pyrimidine biosynthesis"	Oxidoreductase	"Disease mutation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	5	"liver: 72.4"	"Cell type enriched"	"Detected in many"	5	"Hepatocytes: 106.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA010123, HPA011942"	Approved		Enhanced	Nucleoplasm,Mitochondria,Cytosol		NA	NA			Mitochondria	"Nucleoplasm, Cytosol"	"HPA010123: AB_1847648, HPA011942: AB_1847649"	"unprognostic (4.88e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.90e-1)"	"unprognostic (2.12e-2)"	"unprognostic (1.41e-3)"	"unprognostic (2.10e-1)"	"unprognostic (4.27e-2)"	"unprognostic (1.31e-2)"	"unprognostic (1.26e-1)"	"unprognostic (2.68e-1)"	"unprognostic (2.14e-1)"	"unprognostic (6.40e-2)"	"unprognostic (9.26e-3)"	"unprognostic (1.98e-1)"	"unprognostic (1.97e-1)"	"unprognostic (1.14e-1)"	"unprognostic (1.81e-1)"	5.9	4.2	4.7	8.8	5.1	2.9	5.0	2.7	5.0	5.9	4.4	6.1	1.4	3.4	6.6	2.3	5.1	5.2	2.3	11.5	4.3	3.0	6.6	72.4	3.4	5.5	4.8	2.7	6.2	9.9	7.1	4.0	2.6	5.2	3.9	4.8	5.9	6.0	4.4	11.7	4.0	3.0	7.5	4.0	3.5	3.4	4.3	5.4	4.0	3.6	7.1	5.1	3.5	3.3	11.2	13.4	3.9	8.1	9.3	12.9	6.8	7.4	15.5	4.5	7.5	2.4	3.2	8.6	6.4	2.6	9.7	7.5	12.2	6.8	16.8	8.7	3.5	5.4	7.9	8.9	6.9	11.5	3.8	8.4	9.2	7.5	12.0	6.8	12.7	6.8	3.1	7.1	11.7	12.3	3.1	7.0	11.4	14.0	3.1	5.9	19.8	12.0	12.2	10.2	12.7	6.1	15.2	5.9	17.7	5.8	4.9	5.4	6.3	8.6	9.2	4.2	5.8	8.2	6.4	3.0	8.9	5.5	8.4	9.3	5.9	10.9	28.4	4.6	14.0	8.1	3.9	8.1	0.9	9.3	7.7	12.7	11.2	8.9	9.0	13.3	10.6	12.4	12.9	2.1	9.3	5.6	13.4	7.1	6.8	4.7	5.1	2.7	5.0	4.3	3.0	4.8	2.7	5.2	5.4	3.0	9.6	9.5	6.4	4.9	5.7	12.1	7.6	9.4	1.2	7.0	3.9	12.0	5.0	6.6	2.1	6.7	0.7	0.0	4.4	9.6	6.0	5.0	8.1	106.1	6.9	3.2	1.2	2.5	5.3	2.3	2.6	3.4	11.8	3.6	4.4	4.8	5.2	2.9	2.1	20.1	4.2	0.0	9.9	7.9	8.0	3.3	2.4	5.0	6.2	4.1
DHPS	MIG13	ENSG00000095059	"Deoxyhypusine synthase"	P49366	19	12675717-12681902	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Hypusine biosynthesis"	Transferase	"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA014461, HPA029413"	Approved		Approved	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			Nucleoplasm	"Plasma membrane, Cytosol"	"HPA014461: AB_1847651, HPA029413: AB_10602217"	"unprognostic (4.17e-2)"	"unprognostic (2.55e-2)"	"unprognostic (2.05e-2)"	"unprognostic (2.61e-1)"	"unprognostic (3.10e-1)"	"unprognostic (1.01e-2)"	"unprognostic (3.06e-1)"	"unprognostic (2.42e-1)"	"unprognostic (1.85e-1)"	"unprognostic (3.59e-2)"	"unprognostic (1.20e-2)"	"unprognostic (4.85e-2)"	"unprognostic (3.05e-2)"	"unprognostic (2.46e-3)"	"unprognostic (1.32e-1)"	"unprognostic (1.56e-1)"	"unprognostic (8.83e-2)"	16.4	30.3	26.9	18.6	31.2	17.0	24.8	43.3	38.8	20.7	25.7	27.5	25.3	23.1	20.9	16.9	21.3	32.3	18.2	26.0	26.3	28.0	23.4	30.3	18.9	24.2	27.5	28.0	34.8	32.0	28.8	32.6	23.2	22.4	24.1	24.5	20.2	24.8	24.6	65.1	25.6	21.5	24.5	29.1	19.5	24.2	13.3	26.3	31.9	24.9	22.9	26.9	23.5	19.2	39.6	29.5	35.8	30.5	27.8	38.1	29.7	20.6	15.3	24.8	13.1	11.1	18.5	5.8	13.3	19.5	25.4	25.6	10.9	10.1	21.4	15.1	14.5	23.4	12.6	17.0	18.8	17.6	18.8	12.0	14.3	16.7	14.2	13.7	17.1	22.9	14.8	23.2	15.3	26.5	25.8	17.8	42.8	13.0	15.3	18.5	41.1	30.4	24.8	19.4	27.0	26.0	20.2	9.3	30.9	19.5	11.1	32.4	43.9	13.4	19.5	22.6	15.7	18.0	28.6	8.9	29.9	12.1	29.2	20.2	48.8	52.5	14.5	18.4	21.0	28.2	14.5	27.0	35.8	24.7	24.2	25.9	39.6	28.9	25.6	29.0	36.9	38.1	28.1	9.7	27.8	30.5	29.5	34.3	29.7	26.9	31.2	43.3	38.8	26.3	28.0	27.5	28.0	22.4	26.3	38.7	21.2	44.9	67.5	49.3	77.6	7.7	22.9	34.8	9.1	31.4	43.2	43.4	72.9	48.6	15.6	35.9	36.2	0.0	32.3	43.6	36.5	53.0	23.1	29.4	38.0	39.7	39.6	18.4	36.3	21.8	41.7	38.3	47.2	71.3	54.9	114.9	45.5	63.3	32.5	75.5	92.9	45.3	55.6	29.6	70.0	44.5	60.1	50.3	52.4	59.7
DHRS11	"MGC4172, SDR24C1"	ENSG00000278535	"Dehydrogenase/reductase 11"	Q6UWP2	17	36591798-36600806	"Enzymes, Predicted intracellular proteins"	"Lipid metabolism, Steroid metabolism"	Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	15	"intestine: 88.0"	"Cell type enhanced"	"Detected in many"	16	"Cone photoreceptor cells: 121.7;Enterocytes: 380.9;Paneth cells: 114.5;Undifferentiated cells: 112.5"	"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041226, HPA048236, HPA053623"	Enhanced		Approved	"Golgi apparatus,Cytosol"	"Intracellular and membrane"	NA	NA		11000	Cytosol	"Golgi apparatus"	"HPA041226: AB_2677372, HPA048236: AB_2680322, HPA053623: AB_2682209"	"unprognostic (2.00e-3)"	"unprognostic (1.22e-2)"	"unprognostic (1.06e-2)"	"unprognostic (3.74e-1)"	"unprognostic (1.61e-3)"	"unprognostic (2.03e-2)"	"unprognostic (1.78e-1)"	"unprognostic (1.80e-2)"	"unprognostic (3.67e-1)"	"unprognostic (5.94e-2)"	"unprognostic (1.33e-2)"	"unprognostic (4.11e-2)"	"prognostic favorable (3.24e-4)"	"unprognostic (1.45e-1)"	"unprognostic (1.70e-1)"	"unprognostic (2.16e-2)"	"unprognostic (9.35e-2)"	1.3	0.6	1.2	4.1	2.4	0.4	0.7	0.5	5.7	0.4	38.7	0.4	0.4	42.7	0.4	0.1	1.2	1.1	1.4	2.0	0.5		2.5	1.7	0.1	0.0	0.0	2.4	0.1	2.8	1.5	0.2	0.0	1.6	0.5	12.4	2.8	2.1	0.8	2.0	0.8	88.0	0.9	0.1	0.0	1.1	2.2	0.3	0.0	1.3	1.3	1.0	0.4	0.0	0.9	0.2	0.9	0.7	0.1	2.7	0.1	6.7	6.0	2.9	7.6	0.6	1.8	5.6	2.0	1.4	6.5	5.9	9.8	5.4	0.7	1.4	2.0	2.7	7.0	6.1	4.2	6.6	3.5	11.6	1.7	5.8	18.9	3.1	2.0	0.6	0.9	3.9	4.5	3.3	1.4	5.0	6.9	15.8	5.9	3.5	5.9	6.5	3.6	2.2	7.9	2.3	8.1	7.1	11.2	6.6	5.7	6.1	2.6	7.2	7.4	16.6	4.7	10.2	1.8	1.8	0.9	9.3	4.9	5.1	9.7	8.1	2.3	3.3	4.8	2.9	0.4	0.5	0.9	1.0	0.7	0.1	0.4	1.0	0.6	0.1	0.9	1.3	0.9	0.5	0.1	0.1	0.2	2.7	0.1											0.0	1.0	1.9	6.8	3.8	17.5	8.4	0.0	1.4	0.0	7.0	121.7	6.4	49.7	8.1	18.9	4.8	380.9	23.3	9.9	3.7	2.7	10.9	0.0	11.5	3.0	15.9	11.6	3.1	2.2	23.8	3.7	2.3	18.6	4.6	59.2	11.6	6.1	114.5	4.9	26.7	62.6	0.0	3.5	26.3	5.2	5.3	5.8	1.3	112.5	13.2
DHRS3	"RDH17, retSDR1, Rsdr1, SDR1, SDR16C1"	ENSG00000162496	"Dehydrogenase/reductase 3"	O75911	1	12567910-12617731	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	5	"Late spermatids: 235.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	10	"gdT-cell: 33.5;MAIT T-cell: 24.2;memory CD4 T-cell: 18.3;memory CD8 T-cell: 15.7;myeloid DC: 8.6;naive CD4 T-cell: 31.6;naive CD8 T-cell: 19.7;NK-cell: 13.8"	"Group enriched"	"Detected in many"	9	"dendritic cells: 8.6;NK-cells: 13.8;T-cells: 33.5"	"Cell line enhanced"	"Detected in many"		"A549: 27.6;CAPAN-2: 56.6;hTERT-RPE1: 55.9;SK-BR-3: 30.4;WM-115: 52.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA010844	Supported		Approved	Nucleoli,Mitochondria		NA	NA			"Nucleoli, Mitochondria"		"HPA010844: AB_1847653"	"unprognostic (7.83e-2)"	"unprognostic (2.11e-1)"	"unprognostic (1.82e-2)"	"unprognostic (1.74e-3)"	"unprognostic (1.87e-1)"	"unprognostic (3.68e-2)"	"unprognostic (2.25e-3)"	"unprognostic (5.06e-2)"	"unprognostic (3.40e-2)"	"unprognostic (5.18e-2)"	"unprognostic (1.29e-2)"	"unprognostic (1.92e-1)"	"unprognostic (1.80e-1)"	"unprognostic (1.02e-1)"	"unprognostic (1.76e-1)"	"prognostic favorable (2.65e-4)"	"unprognostic (5.48e-2)"	22.7	4.4	6.3	6.2	8.6	2.5	30.6	4.0	7.9	16.7	16.3	3.4	9.2	13.6	7.6	15.5	19.0	12.2	11.2	16.1	6.8	8.6	12.3	45.6	11.6	8.3	9.0	4.5	11.8	20.3	0.5	8.9	11.5	9.8	16.3	5.6	20.3	11.8	14.3	10.2	5.6	18.9	11.1	9.8	4.2	12.3	5.2	4.2	3.1	40.5	5.4	5.2	21.0	9.4	0.2	8.6	2.1	0.3	13.8	33.5	15.6	4.8	27.6	0.0	12.2	16.0	1.3	3.2	1.6	0.0	0.0	0.1	3.3	56.6	0.0	1.3	16.2	4.9	22.3	6.0	3.1	0.0	0.0	9.9	4.3	2.8	15.4	2.4	0.0	0.0	8.1	3.7	0.0	0.1	55.9	5.2	0.1	6.5	0.0	0.1	0.8	1.1	0.2	1.8	5.2	11.2	0.1	0.0	5.6	0.0	9.5	0.3	0.5	9.3	30.4	1.7	3.9	2.9	1.2	3.8	0.1	0.6	8.5	0.1	0.8	0.0	0.0	6.4	0.3	52.5	2.1	0.2	0.0	33.5	0.1	24.2	0.2	18.3	15.7	8.6	0.2	31.6	19.7	1.7	13.8	0.3	1.0	0.5	15.6	6.3	8.6	4.0	7.9	6.8	8.6	9.0	4.5	9.8	4.2	89.3	49.3	3.7	141.7	22.8	0.8	31.9	38.2	58.9	55.7	19.2	17.7	22.8	19.9	81.6	86.2	36.5	70.9	23.3	142.3	39.4	26.7	66.3	15.1	157.8	60.3	0.0	24.1	62.0	40.2	235.9	21.0	19.3	6.8	17.2	30.8	13.7	112.0	49.1	9.2	39.4	2.0	0.0	30.1	1.4	1.4	23.6	22.0	22.3	29.9	124.6
DHRS4	"FLJ11008, humNRDR, SCAD-SRL, SDR-SRL, SDR25C2"	ENSG00000157326	"Dehydrogenase/reductase 4"	Q9BTZ2	14	23953586-23969279	"Enzymes, Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"											HPA023972	Uncertain		Approved	"Nuclear membrane,Vesicles"		NA	NA			Vesicles	"Nuclear membrane"	"HPA023972: AB_1854890"	"unprognostic (1.21e-2)"	"unprognostic (2.59e-1)"	"unprognostic (3.46e-2)"	"unprognostic (3.79e-3)"	"unprognostic (1.97e-1)"	"unprognostic (1.66e-1)"	"unprognostic (7.35e-3)"	"unprognostic (1.61e-3)"	"unprognostic (2.66e-1)"	"unprognostic (1.19e-2)"	"unprognostic (1.06e-2)"	"unprognostic (7.65e-2)"	"prognostic favorable (4.55e-6)"	"unprognostic (2.03e-2)"	"unprognostic (1.48e-1)"	"unprognostic (2.03e-1)"	"unprognostic (5.68e-2)"	15.8	18.5	8.3	10.3	13.7	5.9	15.4	4.4	9.6	11.0	22.2	10.2	12.1	30.3	13.7	11.7	17.2	8.3	16.3	16.3	9.0	6.6	65.8	40.3	12.6	13.6	14.0	7.7	12.6	20.6	7.3	9.7	8.9	9.3	17.0	12.4	12.0	17.5	14.4	25.3	16.6	35.2	14.4	9.6	12.4	12.9	13.5	12.6	6.9	17.1	16.1	11.1	10.0	14.8	9.7	22.0	2.6	25.5	7.9	10.6	14.9	7.7	15.7	5.4	8.8	8.6	9.6	0.1	14.6	7.7	5.8	4.6	3.3	8.3	6.6	7.8	7.2	4.0	9.2	4.3	6.0	5.2	17.8	8.9	4.0	13.2	18.3	5.2	5.7	24.6	9.5	7.5	4.8	10.6	6.6	7.2	9.9	5.9	15.8	7.9	26.3	10.4	5.4	5.3	9.0	15.8	16.9	9.5	21.8	6.0	9.0	10.5	8.8	14.0	9.1	6.9	3.6	8.4	7.7	13.4	7.2	7.6	7.4	4.7	12.1	11.2	1.8	6.3	6.5	7.2	2.4	25.5	2.6	8.9	21.0	10.6	9.7	10.1	8.9	22.0	8.3	10.3	9.9	1.1	7.9	11.1	18.5	8.6	14.9	8.3	13.7	4.4	9.6	9.0	6.6	14.0	7.7	9.3	12.6	14.9	26.2	4.7	9.5	11.1	4.7	30.1	7.6	32.1	31.8	14.0	0.0	8.3	66.3	5.2	39.4	10.8	35.9	0.0	8.6	4.2	11.6	9.3	12.8	64.8	26.6	6.4	18.5	16.0	34.4	43.6	10.3	34.4	5.0	3.6	41.8	12.8	6.6	7.0	16.3	63.7	1.6	6.5	11.3	27.0	2.0	11.7	3.2	14.1	63.5	9.0
DHTKD1	"CMT2Q, DKFZP762M115, KIAA1630, MGC3090"	ENSG00000181192	"Dehydrogenase E1 and transketolase domain containing 1"	Q96HY7	10	12068972-12123225	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	Glycolysis	Oxidoreductase	"Charcot-Marie-Tooth disease, Disease mutation, Neurodegeneration, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 69.5"	"Group enriched"	"Detected in many"	4	"Hepatocytes: 213.4;Proximal tubular cells: 55.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"T-47d: 45.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037949, HPA037950, HPA066098"	Enhanced		Supported	Mitochondria		NA	NA			Mitochondria		"HPA037949: AB_2675752, HPA037950: AB_10673650, HPA066098: AB_2685617"	"unprognostic (3.76e-2)"	"unprognostic (8.08e-3)"	"unprognostic (2.24e-1)"	"unprognostic (1.15e-1)"	"unprognostic (1.34e-1)"	"unprognostic (3.04e-3)"	"unprognostic (3.83e-3)"	"unprognostic (5.01e-2)"	"unprognostic (5.34e-2)"	"unprognostic (3.02e-3)"	"unprognostic (3.46e-1)"	"unprognostic (1.56e-1)"	"prognostic favorable (3.43e-4)"	"unprognostic (2.12e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.74e-2)"	"unprognostic (2.88e-3)"	5.7	6.3	6.5	4.7	6.6	2.2	5.0	5.7	7.2	5.5	5.7	9.8	5.0	4.5	4.7	5.0	5.1	4.2	4.5	7.7	5.3	4.8	23.8	69.5	4.2	6.9	7.5	5.2	7.1	16.6	5.4	4.1	4.7	6.2	7.6	6.3	7.2	9.7	7.1	10.5	3.6	4.3	3.5	6.1	5.1	6.1	4.4	6.6	10.1	6.8	6.7	8.0	5.2	4.1	9.5	12.5	16.8	11.0	10.2	4.1	3.3	11.4	8.8	13.2	10.5	8.2	4.9	16.0	5.8	3.7	10.4	9.2	5.6	6.9	8.3	1.9	3.6	4.8	16.3	13.8	4.5	11.9	4.6	6.2	4.5	3.5	4.3	8.1	1.8	1.7	6.0	3.5	6.0	2.4	4.1	5.6	10.1	7.0	6.7	2.8	22.2	6.0	3.2	7.3	10.6	2.1	10.3	4.3	7.0	6.7	2.7	3.4	15.5	11.4	20.4	6.8	14.8	45.0	6.5	2.5	3.4	2.5	7.0	4.2	6.0	4.2	5.3	4.3	3.2	5.6	16.8	4.8	10.7	3.2	6.8	3.4	9.5	2.5	2.1	8.6	7.8	2.5	3.3	14.0	10.2	11.0	12.5	4.1	3.3	6.5	6.6	5.7	7.2	5.3	4.8	7.5	5.2	6.2	6.6	11.9	32.1	21.6	5.5	4.6	11.5	26.6	25.5	5.3	6.8	15.7	9.8	22.3	16.6	9.3	2.6	7.4	10.3	0.0	9.7	18.5	6.6	11.2	8.1	213.4	8.4	25.4	10.9	11.6	11.9	3.1	11.5	11.3	5.0	13.6	19.6	10.8	9.7	10.5	11.3	55.4	18.7	12.9	5.0	5.6	3.6	5.3	11.3	7.1	15.0	6.2
DHX15	"DBP1, DDX15, HRH2, PRP43, PRPF43, PrPp43p"	ENSG00000109606	"DEAH-box helicase 15"	O43143	4	24517441-24584550	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	"Helicase, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA047047	Approved		Enhanced	"Nuclear speckles"		NA	NA		30000	"Nuclear speckles"		"HPA047047: AB_2679916"	"unprognostic (4.46e-3)"	"unprognostic (2.47e-2)"	"prognostic favorable (5.74e-4)"	"unprognostic (3.35e-1)"	"unprognostic (5.30e-2)"	"unprognostic (5.74e-2)"	"unprognostic (2.06e-3)"	"unprognostic (5.53e-3)"	"unprognostic (1.51e-1)"	"unprognostic (1.39e-1)"	"unprognostic (3.60e-2)"	"unprognostic (8.68e-3)"	"unprognostic (7.77e-3)"	"unprognostic (2.51e-3)"	"unprognostic (2.19e-1)"	"unprognostic (1.59e-1)"	"unprognostic (5.41e-3)"	34.3	29.6	23.2	32.1	27.5	42.5	33.0	38.0	27.6	31.1	31.9	29.5	24.1	22.8	37.5	23.4	40.8	30.6	22.9	32.6	22.8	18.8	30.0	29.5	31.2	34.7	29.4	17.7	36.5	35.9	42.5	32.8	39.2	27.4	28.2	37.7	22.4	34.1	24.9	36.5	36.0	30.7	30.7	22.8	32.4	32.4	21.0	27.9	58.3	33.5	31.6	43.0	35.4	35.7	20.3	26.7	31.4	24.1	24.5	28.8	17.7	30.1	29.6	49.1	24.3	24.2	23.6	29.3	35.2	31.0	37.2	37.0	30.0	36.7	55.5	21.7	28.8	43.4	25.3	63.1	42.4	58.0	20.3	29.9	48.1	32.4	24.2	14.2	49.5	33.2	19.7	25.5	36.2	24.5	23.9	31.0	26.2	45.0	22.4	42.1	22.8	64.9	33.2	53.4	30.2	26.9	42.8	57.6	25.9	44.3	43.5	42.2	26.4	27.3	26.3	24.7	36.8	28.8	25.7	28.3	31.6	20.8	23.8	41.0	17.0	28.6	66.4	21.1	40.5	37.5	31.4	20.2	18.8	21.1	20.6	28.8	19.9	23.6	24.5	26.7	20.3	24.9	23.7	9.7	24.5	24.1	17.8	25.8	17.7	23.2	27.5	38.0	27.6	22.8	18.8	29.4	17.7	27.4	27.9	71.5	53.1	27.6	56.7	87.6	28.3	26.0	28.1	49.5	71.7	26.2	21.6	64.7	31.5	51.9	23.9	49.1	52.6	0.0	36.1	61.0	55.6	53.7	55.4	42.4	39.4	25.4	58.2	47.3	49.9	11.8	36.5	48.1	45.5	36.1	59.4	22.6	47.7	37.4	37.8	26.9	28.3	25.8	58.7	54.9	45.5	87.4	73.8	35.5	57.5	79.7
DHX16	"DBP2, DDX16, Prp2, PRPF2"	ENSG00000204560	"DEAH-box helicase 16"	O60231	6	30653119-30673037	"Enzymes, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	"Helicase, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA051455	Supported		Supported	Nucleoplasm		NA	NA			Nucleoplasm		"HPA051455: AB_2681491"	"unprognostic (7.04e-2)"	"unprognostic (1.37e-1)"	"unprognostic (7.29e-2)"	"unprognostic (7.46e-2)"	"unprognostic (1.48e-1)"	"unprognostic (1.94e-1)"	"unprognostic (4.36e-3)"	"unprognostic (1.13e-1)"	"unprognostic (2.66e-2)"	"unprognostic (3.11e-1)"	"unprognostic (8.58e-2)"	"unprognostic (1.24e-2)"	"unprognostic (9.77e-3)"	"unprognostic (4.42e-2)"	"unprognostic (1.51e-1)"	"unprognostic (2.64e-1)"	"unprognostic (8.73e-3)"	12.8	15.8	12.7	16.8	14.0	12.1	14.4	16.8	14.9	13.3	16.2	12.3	15.8	19.3	16.3	13.3	14.9	14.4	14.6	12.4	11.4	7.1	18.0	19.2	13.9	18.2	13.6	8.6	15.6	19.1	24.3	16.6	11.3	13.5	16.4	13.6	14.4	18.0	18.2	23.2	18.4	19.8	16.4	11.0	22.6	14.9	36.8	14.9	18.8	21.6	12.1	16.5	13.2	15.3	4.5	5.9	8.7	7.6	7.1	5.8	4.4	9.7	4.1	6.0	9.3	6.8	4.7	7.1	8.1	6.5	11.7	9.1	9.2	4.0	7.4	7.6	7.2	8.8	9.4	9.8	7.3	9.4	10.4	8.1	7.3	7.4	5.1	6.0	18.4	9.8	4.2	7.1	9.5	8.2	4.7	3.6	9.4	12.1	7.3	5.8	8.1	5.2	9.3	5.7	5.2	5.7	8.8	6.4	7.9	6.2	7.7	7.1	5.8	9.0	9.5	6.6	5.6	7.2	5.6	3.9	7.5	5.2	7.3	11.8	8.7	13.4	7.2	3.6	10.1	9.6	6.0	6.0	8.7	5.8	7.5	5.3	4.4	5.3	4.8	5.9	4.5	4.4	5.0	5.8	7.1	7.6	4.8	5.1	4.4	12.7	14.0	16.8	14.9	11.4	7.1	13.6	8.6	13.5	14.9	20.8	18.1	15.7	10.1	9.6	11.0	13.3	7.6	41.5	26.1	5.2	37.3	16.9	8.3	15.7	71.1	9.2	13.9	23.3	16.1	16.8	9.6	8.3	39.5	7.5	12.3	4.8	5.8	9.8	10.5	36.4	13.3	13.6	5.0	22.6	11.7	9.8	18.4	24.6	11.7	7.8	49.9	19.4	12.2	73.1	30.6	9.4	16.0	16.6	10.1	9.1
DHX29	DDX29	ENSG00000067248	"DExH-box helicase 29"	Q7Z478	5	55256245-55307722	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Protein biosynthesis"	"Helicase, Hydrolase, Initiation factor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038317, HPA038318"	Approved		Approved	Cytosol	"Intracellular and membrane"	NA	NA			Cytosol		"HPA038317: AB_10673169, HPA038318: AB_10672589"	"unprognostic (3.43e-2)"	"unprognostic (5.09e-1)"	"unprognostic (2.21e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.17e-1)"	"unprognostic (2.80e-1)"	"unprognostic (2.37e-3)"	"unprognostic (1.72e-1)"	"unprognostic (6.66e-2)"	"unprognostic (1.76e-2)"	"unprognostic (3.79e-2)"	"unprognostic (1.30e-1)"	"unprognostic (4.57e-3)"	"unprognostic (4.01e-1)"	"unprognostic (3.85e-1)"	"unprognostic (4.78e-3)"	"unprognostic (9.40e-2)"	14.6	16.2	15.1	12.2	16.6	9.8	16.3	22.0	16.9	17.3	18.4	9.2	20.2	11.3	17.4	12.8	18.5	13.6	11.7	22.1	12.8	9.6	22.4	20.6	15.2	11.8	13.7	11.9	13.8	15.3	30.3	30.7	17.7	16.3	18.9	13.3	7.8	15.2	24.3	31.8	15.9	14.7	18.5	13.1	14.3	14.8	10.2	16.6	15.6	20.9	12.0	11.9	19.9	14.4	18.5	25.9	32.4	19.6	16.0	18.8	6.3	22.1	15.6	13.0	17.2	21.5	18.0	16.0	23.7	18.7	17.4	18.1	12.7	14.5	13.0	21.6	26.5	22.8	16.4	20.5	23.0	25.0	5.2	11.6	11.9	14.5	8.9	12.3	7.9	12.7	15.8	14.2	18.6	11.2	12.2	22.9	10.6	14.5	9.9	20.8	15.3	13.9	8.0	11.1	6.4	17.5	6.8	20.5	21.4	15.1	15.3	12.1	8.3	23.4	12.9	11.7	13.7	18.3	14.7	20.0	16.0	13.5	14.3	17.2	9.5	14.3	17.6	19.7	13.8	18.0	32.4	16.3	15.9	13.5	16.4	15.1	18.5	16.9	15.0	12.1	17.6	18.8	15.8	15.2	16.0	19.6	25.9	13.9	6.3	15.1	16.6	22.0	16.9	12.8	9.6	13.7	11.9	16.3	16.6	65.5	35.2	25.3	32.1	33.4	77.9	67.4	48.4	33.5	66.0	61.1	39.3	58.7	46.4	45.2	32.2	35.9	31.5	93.5	53.9	43.6	42.1	40.8	30.1	40.5	36.0	39.7	36.9	21.5	25.0	13.6	43.1	37.1	27.0	36.1	33.2	34.7	50.0	25.9	49.8	84.5	77.5	51.8	44.2	87.3	127.3	41.5	68.0	27.7	35.1	33.6
DHX30	"DDX30, FLJ11214, KIAA0890"	ENSG00000132153	"DExH-box helicase 30"	Q7L2E3	3	47802909-47850195	"Enzymes, Predicted intracellular proteins"	"Ribosome biogenesis"	"Helicase, Hydrolase, RNA-binding"	"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA034806	Supported		Supported	Mitochondria,Cytosol		NA	NA			Mitochondria	Cytosol	"HPA034806: AB_10601364"	"unprognostic (2.00e-1)"	"unprognostic (8.37e-2)"	"unprognostic (3.27e-1)"	"unprognostic (2.14e-2)"	"unprognostic (3.04e-1)"	"unprognostic (1.62e-1)"	"unprognostic (1.27e-3)"	"unprognostic (1.14e-1)"	"unprognostic (1.16e-1)"	"unprognostic (1.74e-1)"	"unprognostic (1.10e-3)"	"unprognostic (1.42e-2)"	"prognostic favorable (1.37e-6)"	"unprognostic (4.12e-2)"	"unprognostic (1.43e-1)"	"unprognostic (2.81e-1)"	"unprognostic (2.22e-1)"	18.4	18.7	22.1	18.5	31.1	23.6	18.3	31.2	43.5	22.3	17.8	26.9	15.5	17.3	23.3	14.8	21.0	24.8	17.9	21.3	19.1	19.8	18.6	19.3	16.7	22.0	20.4	28.0	27.1	21.2	37.3	24.8	20.6	23.6	20.4	13.0	22.0	20.4	23.6	27.1	26.2	16.1	18.8	15.3	21.2	18.7	54.4	18.4	23.8	20.1	15.2	16.9	18.6	17.6	9.9	13.0	9.8	10.5	8.2	16.1	11.6	8.1	20.7	20.5	21.1	9.5	7.9	14.0	15.4	13.2	26.6	19.2	23.8	17.4	26.5	12.1	15.0	18.5	12.5	30.3	21.5	9.5	18.0	36.3	23.1	30.5	23.2	16.5	21.5	24.0	13.8	13.7	28.1	19.8	10.5	17.3	24.5	32.5	17.1	12.4	22.0	27.3	23.6	22.8	10.8	35.4	18.2	11.0	23.5	13.3	20.7	16.9	22.5	15.0	21.4	11.1	10.3	15.0	22.6	12.0	16.1	20.9	18.1	28.2	20.7	25.8	24.0	16.7	18.8	19.9	9.8	10.1	7.2	15.0	10.3	13.0	9.9	12.7	16.1	13.0	9.3	12.1	13.0	1.5	8.2	10.5	7.8	14.3	11.6	22.1	31.1	31.2	43.5	19.1	19.8	20.4	28.0	23.6	18.4	35.7	44.3	33.3	22.5	16.1	46.6	31.3	35.7	42.8	28.4	48.8	41.2	35.6	56.3	33.4	93.4	33.1	32.4	23.3	31.3	18.8	20.4	23.6	23.1	43.3	30.5	55.6	38.5	23.4	27.7	89.2	23.0	28.0	18.6	25.2	23.6	39.2	38.5	29.6	28.3	56.9	46.8	32.3	19.4	136.8	41.1	17.3	24.7	23.5	30.9	22.7
DHX32	"DDX32, DHLP1, FLJ10694, FLJ10889"	ENSG00000089876	"DEAH-box helicase 32 (putative)"	Q7L7V1	10	125836337-125896436	"Enzymes, Predicted intracellular proteins"		"Helicase, Hydrolase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Early spermatids: 69.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA048872	Approved					NA	NA					"HPA048872: AB_2680540"	"unprognostic (1.05e-1)"	"unprognostic (3.02e-1)"	"unprognostic (3.97e-2)"	"unprognostic (6.40e-2)"	"unprognostic (2.40e-1)"	"unprognostic (3.57e-1)"	"unprognostic (1.55e-2)"	"unprognostic (9.88e-2)"	"unprognostic (2.85e-1)"	"unprognostic (6.89e-3)"	"prognostic unfavorable (9.49e-5)"	"prognostic unfavorable (6.34e-4)"	"unprognostic (4.61e-3)"	"unprognostic (5.03e-2)"	"unprognostic (8.62e-2)"	"unprognostic (1.98e-1)"	"unprognostic (2.49e-1)"	15.4	16.3	7.8	10.2	9.7	4.0	18.0	7.3	11.5	10.5	20.1	12.1	11.2	11.4	10.6	14.0	20.6	8.6	13.1	27.3	7.6	7.5	12.1	14.5	10.1	16.8	10.3	7.0	18.1	23.5	11.7	9.5	19.3	8.9	13.1	24.5	12.8	17.9	8.4	16.0	18.5	16.1	9.1	9.8	12.2	21.7	20.6	9.5	8.0	13.6	10.7	10.0	13.0	12.6	6.8	2.3	3.2	3.5	4.5	5.3	0.9	27.3	15.1	10.2	21.0	13.6	12.6	18.3	12.1	28.2	11.1	12.5	3.5	27.2	0.1	9.1	14.1	12.3	20.0	4.6	20.4	9.2	13.8	9.1	3.4	7.8	5.3	15.1	6.6	11.3	12.4	21.5	10.9	24.6	20.0	16.1	0.1	9.4	0.1	10.7	12.3	0.1	10.4	7.7	13.4	10.5	0.1	16.6	5.9	16.2	12.7	1.4	7.5	11.2	20.3	16.6	13.9	7.4	5.9	14.4	8.7	5.3	11.0	10.7	10.8	10.5	0.2	15.7	0.1	4.4	0.3	3.0	3.2	2.7	3.5	2.2	6.8	1.3	1.1	2.3	3.2	5.3	2.1	0.1	4.5	1.7	1.3	0.4	0.9	7.8	9.7	7.3	11.5	7.6	7.5	10.3	7.0	8.9	9.5	14.9	12.1	4.7	11.4	4.4	12.6	22.1	10.2	6.7	13.6	7.0	21.6	16.9	13.3	27.9	69.4	9.2	15.7	0.0	32.3	23.7	6.3	19.4	11.5	9.6	10.3	11.1	4.1	6.7	7.3	19.5	9.8	6.1	6.8	4.6	41.9	30.9	41.9	20.1	15.9	13.5	14.5	12.9	8.2	31.9	5.6	6.0	37.0	4.4	19.5	21.7
DHX33	"DDX33, DKFZp762F2011, FLJ21972"	ENSG00000005100	"DEAH-box helicase 33"	Q9H6R0	17	5440912-5469060	"Enzymes, Predicted intracellular proteins"		"Helicase, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA073875	Supported		Supported	Nucleoli		NA	NA			Nucleoli		"HPA073875: AB_2686638"	"unprognostic (4.96e-2)"	"unprognostic (1.35e-1)"	"unprognostic (3.41e-2)"	"unprognostic (2.51e-2)"	"unprognostic (9.24e-2)"	"unprognostic (1.90e-1)"	"unprognostic (1.49e-2)"	"unprognostic (6.15e-2)"	"unprognostic (3.11e-2)"	"unprognostic (3.80e-1)"	"unprognostic (2.10e-1)"	"prognostic unfavorable (6.10e-4)"	"unprognostic (1.03e-1)"	"unprognostic (4.66e-1)"	"unprognostic (3.55e-1)"	"unprognostic (4.69e-2)"	"unprognostic (3.37e-2)"	10.0	10.4	11.6	11.0	14.6	7.0	12.9	15.8	22.0	9.0	8.7	14.1	8.6	8.6	12.4	7.9	11.2	11.2	9.2	7.7	9.7	7.0	8.2	13.4	8.0	10.1	11.0	13.2	11.1	12.1	16.5	7.3	11.5	10.3	10.0	10.7	11.3	10.4	10.8	13.9	12.5	8.7	11.1	8.0	11.1	9.6	10.1	11.7	8.4	9.5	9.4	10.3	9.6	9.5	3.7	3.4	2.6	3.5	3.0	2.5	0.7	10.3	15.4	9.8	17.6	4.1	8.4	12.3	10.3	6.4	15.9	12.8	9.6	4.5	25.5	7.2	8.4	6.3	12.3	20.0	16.1	20.4	8.2	19.2	10.1	12.6	16.3	8.2	13.5	9.1	7.1	9.8	16.9	23.2	4.7	11.7	12.4	13.4	12.6	8.7	7.3	13.6	7.4	21.8	6.9	7.8	18.3	14.5	13.8	7.2	8.1	8.6	12.4	10.7	9.3	15.9	8.7	7.2	7.1	10.9	11.0	11.6	8.7	21.7	4.7	5.1	13.1	7.8	16.0	15.7	0.6	3.5	1.8	2.2	1.4	2.1	2.5	2.5	1.4	1.4	3.7	2.5	2.4	2.6	3.0	1.3	3.4	1.8	0.7	11.6	14.6	15.8	22.0	9.7	7.0	11.0	13.2	10.3	11.7	11.9	10.4	3.0	12.0	18.7	16.4	13.4	20.4	5.3	11.4	7.0	19.6	7.3	1.7	6.5	40.0	11.1	5.7	0.0	13.2	7.9	14.1	7.4	3.5	25.4	5.4	12.7	8.7	12.3	15.3	4.8	7.2	8.2	13.5	1.0	10.6	14.7	9.5	3.5	9.2	6.3	10.1	0.0	11.3	11.2	15.2	17.3	4.2	4.5	11.0	10.8
DHX34	"DDX34, KIAA0134"	ENSG00000134815	"DExH-box helicase 34"	Q14147	19	47349281-47382704	"Enzymes, Predicted intracellular proteins"		"Helicase, Hydrolase, RNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	8	"Late spermatids: 48.6;Spermatocytes: 24.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	6	"neutrophil: 13.5"	"Lineage enriched"	"Detected in many"	6	"granulocytes: 13.5"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042159, HPA043558"	Uncertain		Uncertain	"Nucleoplasm,Intermediate filaments"		NA	NA			"Nucleoplasm, Intermediate filaments"		"HPA042159: AB_10963066, HPA043558: AB_10961262"	"unprognostic (1.26e-1)"	"unprognostic (5.17e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.64e-1)"	"unprognostic (1.08e-1)"	"unprognostic (3.06e-3)"	"prognostic unfavorable (8.63e-6)"	"unprognostic (9.14e-2)"	"unprognostic (4.74e-2)"	"unprognostic (5.11e-2)"	"unprognostic (4.76e-3)"	"unprognostic (2.02e-2)"	"prognostic unfavorable (3.16e-6)"	"unprognostic (7.38e-2)"	"unprognostic (1.59e-1)"	"unprognostic (2.72e-1)"	"unprognostic (7.21e-3)"	6.8	6.9	12.6	11.0	11.5	20.3	6.6	18.7	13.3	8.2	5.9	9.1	8.9	7.7	10.4	5.3	8.3	9.0	5.7	6.0	11.2	6.4	7.2	10.9	8.9	7.9	12.3	8.4	13.3	12.9	7.8	14.2	7.8	11.4	8.9	4.6	8.5	9.9	8.3	7.8	11.8	7.0	6.6	10.5	13.5	6.7	21.8	12.5	5.6	9.6	4.6	9.6	7.3	11.2	1.5	1.9	13.5	2.2	0.8	1.8	1.1	7.2	19.1	4.7	9.2	4.1	2.8	9.0	5.8	1.9	6.0	5.4	12.2	7.2	11.2	5.9	3.2	6.5	10.7	6.5	7.6	3.1	9.3	17.7	11.7	10.4	9.2	4.6	9.0	5.0	3.6	6.2	10.1	5.7	3.9	4.0	5.1	19.4	4.9	4.0	8.6	8.9	22.6	9.8	9.5	11.5	9.9	3.7	6.7	3.2	9.8	8.4	5.2	7.1	7.1	4.7	5.6	6.4	5.8	4.5	7.0	9.1	4.4	10.2	7.4	10.2	10.4	5.6	6.6	8.2	1.0	2.0	0.8	1.3	2.2	1.2	1.2	1.0	1.8	1.9	1.5	1.6	0.7	13.5	0.8	1.7	1.5	0.6	1.1	12.6	11.5	18.7	13.3	11.2	6.4	12.3	8.4	11.4	12.5	6.0	7.2	2.2	5.1	6.6	7.7	2.8	0.0	6.7	3.4	7.0	2.0	4.2	0.0	4.3	20.8	3.1	3.4	0.0	2.8	4.7	3.0	5.1	3.5	4.4	6.7	0.0	3.5	3.1	5.9	48.6	4.9	10.4	1.7	3.6	3.9	1.5	3.1	2.9	4.6	1.4	5.1	6.5	3.6	24.5	11.7	6.4	4.2	3.2	4.3	5.2
DHX35	"C20orf15, DDX35, FLJ22759, KAIA0875"	ENSG00000101452	"DEAH-box helicase 35"	Q9H5Z1	20	38962299-39039723	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	"Helicase, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA054451, HPA062700"	Uncertain		Approved	"Nucleoplasm,Nuclear bodies,Centrosome"		No	No			"Nuclear bodies"	"Nucleoplasm, Centrosome"	"HPA054451: AB_2682491, HPA062700: AB_2684838"	"unprognostic (8.31e-2)"	"unprognostic (2.34e-2)"	"unprognostic (5.51e-2)"	"prognostic unfavorable (4.25e-5)"	"unprognostic (1.29e-2)"	"unprognostic (8.38e-2)"	"prognostic unfavorable (5.63e-6)"	"unprognostic (9.83e-2)"	"unprognostic (2.21e-1)"	"unprognostic (6.22e-2)"	"unprognostic (4.47e-2)"	"unprognostic (5.67e-2)"	"unprognostic (8.57e-2)"	"unprognostic (1.88e-2)"	"unprognostic (1.66e-1)"	"unprognostic (1.11e-1)"	"unprognostic (3.31e-1)"	10.4	7.3	9.7	6.9	14.6	13.9	9.8	9.7	14.3	12.2	23.2	14.8	10.7	9.9	19.7	13.9	13.9	12.5	9.2	16.9	9.0	5.8	10.4	7.5	8.7	12.6	8.2	6.7	13.9	6.5	12.1	13.5	8.4	10.9	13.3	14.3	12.4	10.4	12.6	12.5	11.1	12.4	14.7	9.9	8.4	13.4	12.5	9.4	12.1	8.5	7.6	11.2	15.9	11.8	4.6	6.7	2.0	4.9	5.8	8.2	4.4	7.3	4.5	12.0	4.9	4.6	6.0	8.5	4.4	7.9	10.2	7.8	21.2	7.2	8.5	7.9	8.4	7.9	11.7	8.3	13.0	10.1	2.1	4.1	11.3	10.1	12.0	5.5	13.1	5.9	7.0	8.4	9.0	8.4	6.3	4.5	14.5	11.4	4.9	5.4	6.0	21.4	10.1	6.9	13.4	9.9	10.5	17.5	6.8	3.7	8.5	10.6	8.3	12.1	7.3	11.2	7.8	10.0	10.8	4.4	14.7	8.1	5.8	9.2	4.9	6.4	8.8	8.6	6.0	7.6	0.0	4.9	2.0	5.3	4.5	5.2	4.6	4.5	5.6	6.7	4.3	8.2	4.3	1.0	5.8	3.8	2.4	2.8	4.4	9.7	14.6	9.7	14.3	9.0	5.8	8.2	6.7	10.9	9.4	0.0	3.0	0.8	1.2	0.5	5.8	4.8	5.1	4.0	4.5	1.8	3.9	3.1	1.7	2.5	2.9	2.4	3.3	0.0	1.0	2.0	2.4	2.1	8.1	5.5	4.3	4.8	5.2	5.5	3.7	0.4	5.8	3.1	3.3	2.8	6.2	2.6	1.7	2.9	6.0	1.7	4.6	0.0	2.3	1.7	10.0	1.8	2.5	1.7	4.4	1.0
DHX36	"DDX36, KIAA1488, MLEL1"	ENSG00000174953	"DEAH-box helicase 36"	Q9H2U1	3	154272546-154324497	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Antiviral defense, Differentiation, Immunity, Innate immunity, Transcription, Transcription regulation, Translation regulation, Transport"	"Activator, Developmental protein, DNA-binding, Helicase, Hydrolase, Repressor, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	4	"Early spermatids: 381.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA035399	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			Cytosol	Nucleoplasm	"HPA035399: AB_10670115"	"unprognostic (8.04e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.86e-1)"	"unprognostic (3.50e-3)"	"unprognostic (2.67e-2)"	"unprognostic (3.22e-1)"	"unprognostic (8.80e-3)"	"unprognostic (1.03e-1)"	"unprognostic (7.51e-2)"	"unprognostic (1.26e-1)"	"unprognostic (3.94e-2)"	"unprognostic (3.90e-2)"	"unprognostic (2.72e-1)"	"unprognostic (5.09e-2)"	"unprognostic (5.27e-1)"	"unprognostic (4.96e-2)"	"unprognostic (1.37e-1)"	16.3	14.0	11.5	14.1	27.5	12.6	15.7	19.0	21.3	17.9	14.7	10.3	12.4	10.7	20.4	10.6	14.5	14.3	13.7	23.9	13.4	12.7	16.7	17.1	14.6	17.0	12.2	15.0	20.0	13.7	34.0	36.2	16.4	20.1	15.7	12.2	9.3	15.5	20.5	53.4	14.7	14.3	15.1	13.7	18.9	13.4	28.3	11.3	24.3	20.4	13.4	17.1	20.7	15.6	6.3	5.9	3.1	5.7	4.8	6.9	1.1	27.0	18.5	25.1	14.4	11.9	16.7	12.5	17.7	17.8	20.2	24.1	18.8	21.8	26.2	28.7	15.5	18.6	17.5	23.6	15.0	31.8	25.1	15.6	19.0	15.9	10.7	20.2	26.4	16.7	18.8	12.7	21.6	26.6	11.0	17.3	16.3	17.8	15.1	18.6	13.2	21.8	5.8	33.4	14.4	17.8	22.7	21.2	37.8	14.5	19.2	23.6	25.1	18.4	19.6	25.7	17.9	20.1	13.5	19.5	21.2	13.4	19.8	35.3	28.4	18.3	37.9	17.1	13.9	22.4	1.9	2.7	3.1	6.9	2.8	4.4	4.7	6.1	4.7	2.3	6.3	5.8	6.0	1.1	4.8	5.7	5.9	5.4	1.1	11.5	27.5	19.0	21.3	13.4	12.7	12.2	15.0	20.1	11.3	53.6	78.8	70.6	103.5	82.5	148.4	52.9	61.1	50.9	96.7	57.6	121.7	106.5	33.2	60.5	381.7	74.4	34.4	23.3	54.3	56.1	68.1	82.0	99.5	71.8	54.2	146.2	88.2	62.6	59.6	255.9	102.4	80.8	50.6	65.9	47.0	93.9	58.1	42.4	114.2	44.2	123.0	77.6	80.4	174.2	142.0	72.6	309.5	99.1	47.7	105.0
DHX37	"DDX37, Dhr1, KIAA1517, MGC2695, MGC4322"	ENSG00000150990	"DEAH-box helicase 37"	Q8IY37	12	124946825-124989122	"Enzymes, Predicted intracellular proteins"		"Helicase, Hydrolase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA047607	Approved		Approved	"Nuclear membrane"		NA	NA			"Nuclear membrane"		"HPA047607: AB_2680101"	"unprognostic (1.83e-1)"	"unprognostic (1.12e-1)"	"unprognostic (3.10e-1)"	"unprognostic (1.32e-1)"	"unprognostic (1.27e-1)"	"unprognostic (2.11e-1)"	"prognostic unfavorable (9.54e-10)"	"unprognostic (2.38e-2)"	"unprognostic (5.14e-2)"	"unprognostic (2.90e-2)"	"unprognostic (2.07e-1)"	"unprognostic (3.16e-2)"	"unprognostic (8.28e-3)"	"unprognostic (1.40e-2)"	"unprognostic (2.27e-1)"	"unprognostic (2.85e-2)"	"unprognostic (2.73e-1)"	9.5	9.2	8.6	12.7	12.1	29.6	9.3	5.7	12.1	8.9	7.9	11.8	6.0	10.2	11.6	6.5	11.2	9.8	10.7	12.4	7.3	5.4	7.4	10.7	8.2	13.3	11.6	7.4	12.7	14.4	4.7	5.7	6.7	10.5	8.7	5.7	5.6	9.1	7.3	22.7	15.8	9.5	7.7	7.5	12.2	9.1	6.8	11.1	7.8	8.9	9.7	11.5	9.7	13.6	4.3	1.6	0.2	2.5	1.4	2.5	1.4	7.4	21.5	3.8	11.8	3.8	4.3	9.7	2.6	3.9	8.6	6.9	27.1	5.2	18.3	10.0	3.1	11.5	10.4	9.9	5.8	3.1	15.8	18.4	9.0	12.2	10.7	5.4	11.8	16.3	4.0	6.6	14.9	2.4	3.4	5.0	9.3	18.9	5.1	5.1	11.0	16.7	12.4	13.8	8.0	13.0	12.3	3.7	9.1	3.7	17.0	6.7	3.3	7.0	7.6	5.7	2.7	8.5	10.5	5.9	10.0	7.5	14.2	17.3	11.7	14.7	18.1	6.6	6.9	12.5	0.0	0.6	0.0	1.5	2.0	2.2	4.3	1.8	2.5	1.6	0.2	0.9	0.8	0.2	1.4	2.5	1.2	0.9	1.4	8.6	12.1	5.7	12.1	7.3	5.4	11.6	7.4	10.5	11.1	3.0	6.9	8.2	2.2	3.8	2.6	3.2	0.0	2.7	4.5	0.0	0.0	3.7	3.3	4.3	1.5	3.6	3.3	0.0	5.3	4.8	3.5	3.1	5.8	6.0	4.6	12.7	8.6	1.8	6.9	1.5	4.9	4.5	0.0	6.4	6.7	2.0	7.2	0.0	2.5	3.9	1.8	6.5	2.7	1.4	5.6	3.4	2.4	4.4	7.3	2.8
DHX38	"DDX38, hPrp16, KIAA0224, PRP16, PRPF16"	ENSG00000140829	"DEAH-box helicase 38"	Q92620	16	72093562-72112912	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	"Helicase, Hydrolase"	"Disease mutation, Retinitis pigmentosa"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA041347, HPA041604"	Uncertain		Supported	Nucleoplasm		NA	NA			Nucleoplasm		"HPA041347: AB_10796571, HPA041604: AB_2677577"	"unprognostic (2.38e-1)"	"unprognostic (1.89e-1)"	"unprognostic (1.24e-2)"	"unprognostic (3.25e-2)"	"unprognostic (1.07e-1)"	"unprognostic (1.01e-1)"	"unprognostic (6.32e-3)"	"unprognostic (8.50e-3)"	"unprognostic (6.97e-2)"	"unprognostic (1.45e-1)"	"unprognostic (7.92e-2)"	"unprognostic (1.28e-3)"	"unprognostic (4.20e-3)"	"unprognostic (2.68e-1)"	"unprognostic (9.46e-2)"	"unprognostic (2.40e-1)"	"unprognostic (2.40e-2)"	21.8	16.5	21.1	22.2	25.0	35.1	20.5	36.0	29.4	18.6	19.5	23.5	19.4	20.1	24.1	13.5	21.1	19.9	18.1	19.2	24.1	13.7	17.3	20.8	20.6	26.1	24.1	20.7	29.0	17.3	36.6	18.7	19.3	20.9	18.3	17.2	17.9	20.4	16.4	33.0	27.2	23.0	23.5	22.5	27.3	19.4	17.5	27.8	24.6	20.8	23.2	23.1	20.5	21.4	10.4	8.1	8.3	10.6	11.8	14.9	6.3	14.5	21.7	15.7	8.8	13.7	10.6	20.7	13.2	12.9	19.7	15.2	26.2	14.6	19.4	11.8	19.8	11.0	19.2	18.2	18.1	15.3	9.7	19.6	14.9	18.4	35.7	12.8	17.5	27.0	14.7	16.7	26.5	19.2	10.5	17.0	14.1	22.0	9.2	12.1	44.8	16.7	19.9	19.8	9.3	12.5	21.6	10.9	19.2	9.5	13.9	14.2	15.6	16.9	8.1	9.3	9.5	14.7	14.6	19.2	19.0	16.9	13.8	14.3	22.8	18.0	37.3	17.9	12.2	14.8	7.4	7.9	8.3	14.9	10.6	13.7	10.4	9.3	10.7	8.1	8.2	10.4	10.8	8.2	11.8	6.6	7.4	10.9	6.3	21.1	25.0	36.0	29.4	24.1	13.7	24.1	20.7	20.9	27.8	23.8	30.1	24.7	9.7	10.9	28.0	7.5	15.3	21.4	30.7	14.0	15.7	11.7	0.0	11.7	6.6	18.0	21.3	0.0	17.7	11.6	13.5	9.4	40.6	11.6	12.9	28.6	29.3	14.1	13.9	9.1	26.7	18.7	8.5	14.4	20.2	18.0	18.2	15.8	23.7	6.5	35.4	19.4	13.3	22.7	15.8	11.2	17.0	23.5	17.1	9.9
DHX40	"ARG147, DDX40, FLJ22060, PAD"	ENSG00000108406	"DEAH-box helicase 40"	Q8IX18	17	59565525-59608345	"Enzymes, Predicted intracellular proteins"		"Helicase, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044350	Uncertain		Supported	Nucleoplasm		NA	NA			Nucleoplasm		"HPA044350: AB_10960560"	"unprognostic (1.58e-2)"	"unprognostic (3.10e-1)"	"prognostic favorable (4.05e-5)"	"unprognostic (4.09e-2)"	"unprognostic (5.23e-2)"	"unprognostic (2.84e-1)"	"unprognostic (4.57e-3)"	"unprognostic (7.53e-3)"	"unprognostic (2.86e-2)"	"unprognostic (1.80e-1)"	"unprognostic (7.23e-2)"	"unprognostic (3.08e-1)"	"unprognostic (9.48e-3)"	"unprognostic (2.22e-1)"	"unprognostic (1.25e-2)"	"unprognostic (1.11e-1)"	"unprognostic (3.10e-1)"	22.4	24.2	16.2	14.0	18.1	19.5	24.8	21.7	18.4	21.4	16.5	17.5	23.7	12.8	27.0	25.0	19.3	24.8	16.5	19.8	17.1	19.5	29.5	13.1	16.7	16.8	17.9	14.7	29.7	21.0	51.3	45.8	21.9	19.0	21.6	15.4	13.7	19.3	27.8	20.4	21.3	12.3	18.9	19.9	15.6	17.2	28.4	16.8	26.1	28.2	16.0	15.5	26.0	19.7	5.4	6.9	18.8	6.6	4.2	10.6	6.1	11.7	21.6	27.5	17.8	16.8	17.4	15.2	10.6	20.4	16.3	18.5	8.4	11.7	15.4	30.0	15.3	17.3	8.7	19.6	15.0	25.3	12.2	28.6	14.1	16.2	9.4	13.1	16.9	6.6	13.3	13.8	13.7	13.4	26.8	17.3	15.2	11.8	14.3	11.0	21.3	20.8	10.5	10.4	14.5	15.8	20.0	19.3	16.8	16.4	9.5	19.5	48.2	19.2	7.6	19.5	14.0	24.7	10.0	14.1	19.7	24.5	7.0	10.4	17.7	19.4	9.9	23.1	11.8	13.4	8.5	6.6	10.5	8.1	6.5	10.6	5.1	5.9	5.8	6.9	5.4	5.9	6.9	18.8	4.2	4.4	3.5	6.0	6.1	16.2	18.1	21.7	18.4	17.1	19.5	17.9	14.7	19.0	16.8	8.9	18.1	9.6	9.0	17.2	11.9	20.3	22.9	61.6	30.7	45.4	17.7	6.9	10.0	15.3	32.5	20.4	12.2	0.0	14.6	7.3	13.9	12.6	3.5	23.8	7.9	47.7	17.7	24.5	16.1	12.2	23.3	12.4	18.6	2.8	17.7	18.8	12.6	11.5	25.1	25.0	13.4	32.3	13.2	56.5	50.9	19.3	10.5	16.6	15.8	9.2
DHX57	DDX57	ENSG00000163214	"DExH-box helicase 57"	Q6P158	2	38797729-38875934	"Enzymes, Predicted intracellular proteins"		"Helicase, Hydrolase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	16	"Early spermatids: 120.8;Late spermatids: 273.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA036160	Uncertain		Approved	"Nucleoli,Intermediate filaments,Microtubules,Cytosol"		NA	NA			"Intermediate filaments, Microtubules"	"Nucleoli, Cytosol"	"HPA036160: AB_10670711"	"unprognostic (6.78e-2)"	"unprognostic (3.08e-1)"	"unprognostic (3.49e-2)"	"unprognostic (2.03e-3)"	"unprognostic (3.25e-2)"	"unprognostic (3.43e-1)"	"prognostic unfavorable (3.32e-6)"	"unprognostic (1.75e-2)"	"unprognostic (2.74e-1)"	"unprognostic (1.45e-1)"	"unprognostic (7.35e-2)"	"unprognostic (1.82e-2)"	"unprognostic (2.55e-2)"	"unprognostic (1.47e-1)"	"unprognostic (3.88e-2)"	"unprognostic (7.03e-3)"	"unprognostic (1.77e-1)"	9.6	11.2	9.7	8.5	16.7	7.0	10.4	11.9	16.4	14.1	9.4	9.9	9.8	4.2	13.9	17.1	8.4	11.2	9.5	9.3	9.6	11.0	11.2	7.2	7.9	9.2	8.9	9.5	13.2	9.5	18.9	17.9	11.2	13.1	10.5	9.2	11.6	7.8	14.2	11.5	11.1	6.9	11.8	7.7	9.9	7.9	27.7	8.3	13.9	11.8	8.1	11.1	10.5	8.3	7.1	5.2	1.7	10.1	3.3	6.0	4.2	16.9	13.6	15.3	11.5	10.1	12.4	12.5	11.8	11.7	11.2	11.1	10.9	5.2	5.0	11.9	12.0	12.7	8.8	17.2	13.1	18.5	20.5	12.7	9.7	9.2	14.9	9.1	10.2	5.6	11.8	7.9	14.5	9.1	7.9	14.9	3.7	12.4	7.1	12.1	12.4	10.2	9.4	19.0	7.3	8.1	5.1	20.2	9.8	10.3	6.5	12.6	18.6	11.8	12.2	13.8	11.2	8.6	5.6	11.5	11.2	13.0	8.5	12.7	7.4	8.3	2.1	8.7	7.1	7.4	1.7	10.1	1.7	4.5	6.9	6.0	5.7	4.0	3.5	5.2	7.1	4.8	3.0	0.5	3.3	8.0	1.7	3.3	4.2	9.7	16.7	11.9	16.4	9.6	11.0	8.9	9.5	13.1	8.3	3.0	7.5	8.2	2.2	2.4	23.0	5.9	5.1	28.1	13.6	22.7	53.0	6.0	0.0	6.9	120.8	4.3	1.6	23.3	6.4	5.8	5.6	1.6	10.4	5.7	6.1	17.5	11.3	9.2	13.6	273.7	14.7	9.5	1.7	5.4	5.5	11.2	6.9	3.5	13.1	4.9	28.3	0.0	3.9	15.2	6.4	2.3	2.4	6.9	5.1	1.3
DHX58	"D11LGP2, LGP2"	ENSG00000108771	"DExH-box helicase 58"	Q96C10	17	42101404-42112733	"Enzymes, Predicted intracellular proteins"	"Antiviral defense, Host-virus interaction, Immunity, Innate immunity"	"Helicase, Hydrolase, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	6	"monocytes: 65.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+ SV40 Large T+: 24.6;BJ hTERT+ SV40 Large T+ RasG12V: 28.8;SK-MEL-30: 14.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA018670, HPA019570"	Approved		Approved	"Nucleoplasm,Golgi apparatus,Cytosol"		NA	NA			"Golgi apparatus, Cytosol"	Nucleoplasm	"HPA018670: AB_1847665, HPA019570: AB_1847666"	"prognostic favorable (3.45e-4)"	"unprognostic (1.03e-2)"	"unprognostic (3.56e-3)"	"unprognostic (1.54e-2)"	"unprognostic (2.45e-2)"	"unprognostic (4.82e-2)"	"unprognostic (2.05e-3)"	"unprognostic (5.45e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.15e-1)"	"unprognostic (6.02e-2)"	"unprognostic (3.72e-1)"	"unprognostic (1.27e-2)"	"unprognostic (8.65e-2)"	"unprognostic (8.01e-2)"	"unprognostic (2.31e-1)"	"unprognostic (4.31e-3)"	12.7	16.3	6.7	15.3	7.8	11.1	9.8	2.8	8.4	7.9	9.8	9.6	15.0	8.2	9.6	16.2	8.7	12.0	12.6	5.3	6.5	5.3	11.0	20.9	21.7	14.4	5.9	9.0	12.9	7.4	4.3	9.6	7.0	8.2	10.6	5.0	13.4	18.0	17.1	6.9	7.8	10.5	9.2	7.9	17.1	9.1	10.7	5.1	17.2	7.5	5.6	12.9	10.9	7.6	6.4	7.6	8.6	12.0	7.6	7.1	5.9	1.2	0.0	0.0	0.7	6.2	5.4	0.2	1.7	11.9	24.6	28.8	0.1	7.7	0.1	1.8	2.8	5.6	1.0	0.1	1.9	0.9	4.8	0.1	2.0	1.1	0.4	7.0	1.8	4.6	8.7	3.2	2.1	2.1	4.3	2.9	12.5	0.0	6.8	1.3	0.0	11.0	2.3	0.2	0.3	0.0	4.0	0.0	0.5	2.7	4.5	0.2	0.0	0.8	3.1	14.0	0.0	4.2	1.9	1.2	1.2	0.0	0.4	0.6	2.3	1.9	0.1	2.5	1.7	1.3	3.1	9.9	8.6	4.5	12.0	6.5	6.4	6.4	4.0	7.6	4.9	7.1	5.3	4.0	7.6	10.5	2.5	5.5	5.9	6.7	7.8	2.8	8.4	6.5	5.3	5.9	9.0	8.2	5.1	8.9	4.3	2.7	4.8	1.3	0.6	0.8	5.1	8.1	6.8	7.0	0.0	2.8	1.7	4.9	5.4	4.5	2.4	0.0	6.0	2.8	2.8	5.0	1.1	10.5	8.8	0.0	0.0	5.5	6.0	8.3	8.1	5.0	3.3	65.9	2.8	2.0	5.1	4.9	8.5	3.8	0.6	0.0	2.3	9.6	0.7	1.4	0.7	7.7	1.6	1.8
DHX8	"DDX8, Dhr2, HRH1, PRP22, PRPF22"	ENSG00000067596	"DEAH-box helicase 8"	Q14562	17	43483865-43544463	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	"Helicase, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA049285	Approved		Supported	"Nucleoplasm,Nuclear bodies"	"Intracellular and membrane"	NA	NA			Nucleoplasm	"Nuclear bodies"	"HPA049285: AB_2680698"	"unprognostic (2.99e-1)"	"unprognostic (4.42e-2)"	"unprognostic (5.64e-2)"	"unprognostic (9.02e-2)"	"unprognostic (1.25e-1)"	"unprognostic (3.09e-1)"	"unprognostic (1.28e-3)"	"unprognostic (9.43e-2)"	"unprognostic (2.58e-1)"	"unprognostic (3.40e-2)"	"unprognostic (2.26e-2)"	"unprognostic (2.47e-1)"	"unprognostic (1.50e-1)"	"unprognostic (4.04e-1)"	"unprognostic (5.08e-3)"	"unprognostic (2.60e-1)"	"unprognostic (6.28e-2)"	21.9	18.6	17.5	17.0	22.9	47.8	22.3	21.6	29.8	20.3	21.0	25.3	17.2	17.1	26.1	28.4	26.6	17.9	16.7	18.5	18.1	18.7	18.5	20.1	19.8	21.0	20.8	19.7	19.5	17.4	35.4	23.0	21.7	22.7	22.1	24.6	20.1	21.7	21.7	25.2	32.9	22.0	24.6	19.2	27.3	19.5	34.6	20.6	40.8	20.5	17.8	28.9	19.4	22.6	11.5	16.3	23.3	20.4	9.5	14.9	9.8	12.5	35.7	19.4	24.1	19.4	19.8	10.7	13.2	27.9	29.2	28.1	16.2	12.8	17.4	12.3	25.9	21.0	17.0	29.1	23.2	34.3	18.2	23.0	14.7	27.2	25.1	16.6	25.5	22.4	9.9	19.7	24.0	26.4	14.1	25.9	22.9	16.3	17.2	22.6	13.7	32.3	22.7	15.8	15.3	13.7	19.7	37.0	17.9	19.8	26.4	16.8	25.3	14.8	8.5	11.8	24.4	19.8	25.2	17.6	22.8	12.4	16.4	19.7	12.9	15.3	19.7	18.9	15.9	18.2	23.3	15.2	17.2	13.7	20.4	13.6	11.5	11.4	14.9	16.3	10.6	11.2	10.9	19.2	9.5	19.6	8.4	11.7	9.8	17.5	22.9	21.6	29.8	18.1	18.7	20.8	19.7	22.7	20.6	6.0	12.9	15.2	5.8	10.5	15.7	11.9	12.7	12.0	22.7	21.0	17.7	7.9	11.6	14.1	16.1	13.5	8.9	0.0	15.3	7.0	11.1	7.5	13.9	13.1	9.6	6.4	25.6	12.9	13.3	8.1	11.5	12.0	16.9	17.2	13.1	10.1	15.6	11.5	10.3	10.1	18.6	19.4	11.1	24.9	14.5	11.7	17.7	16.0	10.2	14.4
DHX9	"DDX9, LKP, RHA"	ENSG00000135829	"DExH-box helicase 9"	Q08211	1	182839369-182887751	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins"	"Biological rhythms, DNA replication, Host-virus interaction, Immunity, Inflammatory response, Innate immunity, mRNA processing, mRNA splicing, mRNA transport, RNA-mediated gene silencing, Transcription, Transcription regulation, Transcription termination, Translation regulation, Transport"	"Activator, DNA-binding, Helicase, Hydrolase, RNA-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB011819, HPA028050, HPA055684"	Supported		Supported	Nucleoplasm,Nucleoli		NA	NA		97000	Nucleoplasm	Nucleoli	"CAB011819: AB_777725, HPA028050: AB_10603564, HPA055684: AB_2682885"	"unprognostic (8.14e-2)"	"unprognostic (9.32e-2)"	"unprognostic (1.84e-2)"	"unprognostic (4.80e-2)"	"unprognostic (1.58e-1)"	"unprognostic (7.40e-2)"	"prognostic unfavorable (3.17e-4)"	"unprognostic (9.98e-2)"	"prognostic unfavorable (6.04e-4)"	"unprognostic (2.76e-1)"	"unprognostic (2.88e-2)"	"unprognostic (5.53e-2)"	"unprognostic (7.51e-2)"	"unprognostic (1.43e-1)"	"unprognostic (1.70e-1)"	"unprognostic (3.17e-1)"	"unprognostic (1.99e-1)"	30.2	25.9	25.7	28.5	28.6	68.9	32.9	42.5	33.1	31.9	24.5	23.3	25.2	19.8	38.2	24.2	27.7	30.6	19.7	22.9	24.4	22.6	36.2	31.4	27.8	32.0	34.2	23.1	37.5	24.9	51.8	35.8	28.5	28.0	25.7	30.1	21.1	28.2	29.4	27.6	26.6	27.0	31.6	25.3	32.8	26.5	29.4	37.4	68.3	30.1	31.6	41.2	32.4	31.9	16.8	22.9	12.0	17.4	14.7	21.9	15.0	35.7	35.0	50.3	27.6	26.3	20.4	49.7	31.7	29.1	46.1	31.3	39.1	27.6	57.4	31.0	28.4	27.6	31.0	76.3	34.3	51.7	23.3	37.9	38.2	28.7	26.4	14.8	55.3	26.2	18.1	17.3	45.2	12.3	20.9	36.0	29.5	60.0	20.6	36.9	31.4	55.9	13.6	63.7	38.5	21.6	51.0	46.9	32.8	29.8	41.6	36.3	41.6	44.9	28.4	18.5	44.2	33.3	31.3	28.1	28.6	32.0	29.0	42.9	21.7	35.4	68.1	18.0	30.4	38.8	5.6	16.0	12.0	19.2	17.4	21.9	16.8	16.8	17.6	22.9	14.6	18.4	19.9	6.5	14.7	14.3	11.1	15.4	15.0	25.7	28.6	42.5	33.1	24.4	22.6	34.2	23.1	28.0	37.4	38.7	64.9	41.5	53.0	47.7	55.9	37.2	35.7	72.3	69.4	48.8	49.1	40.4	16.6	39.6	17.1	44.9	31.7	0.0	43.7	37.7	35.9	40.6	42.8	24.3	35.2	27.0	51.6	38.1	37.7	32.0	55.8	34.4	28.7	27.1	33.8	42.7	42.4	25.9	44.2	33.5	72.8	38.8	45.7	63.0	65.2	41.3	41.4	32.4	45.7	48.7
DICER1	"Dicer, HERNA, K12H4.8-LIKE, KIAA0928, MNG1"	ENSG00000100697	"Dicer 1, ribonuclease III"	Q9UPY3	14	95086228-95158010	"Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"RNA-mediated gene silencing"	"Endonuclease, Helicase, Hydrolase, Nuclease, RNA-binding"	"Cancer-related genes, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000694, CAB068185"	Approved		Supported	Cytosol		NA	NA			Cytosol		"CAB068185: AB_2665650, HPA000694: AB_1078661"	"unprognostic (2.97e-1)"	"unprognostic (2.70e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.72e-1)"	"unprognostic (6.75e-2)"	"unprognostic (9.62e-2)"	"unprognostic (1.96e-2)"	"unprognostic (7.73e-2)"	"unprognostic (1.21e-1)"	"unprognostic (8.52e-3)"	"unprognostic (5.73e-2)"	"unprognostic (9.22e-2)"	"unprognostic (4.22e-2)"	"unprognostic (9.07e-2)"	"unprognostic (2.58e-1)"	"unprognostic (6.04e-3)"	"unprognostic (3.74e-2)"	23.2	12.5	18.4	22.4	33.3	20.5	23.2	28.5	29.9	19.0	18.1	31.4	22.4	13.0	20.8	20.6	23.4	18.5	16.2	15.3	22.0	14.1	19.5	23.6	22.4	20.3	29.7	19.6	23.8	19.8	26.9	30.9	29.9	23.2	20.3	19.7	14.5	19.5	18.9	28.0	20.7	17.3	19.0	26.8	20.7	17.1	20.6	32.0	17.0	23.8	14.7	20.3	20.7	24.1	2.5	1.8	10.7	7.2	1.2	3.3	1.0	12.9	13.6	25.4	9.4	6.6	9.9	20.1	10.7	6.5	6.8	8.3	17.2	10.0	14.7	11.6	10.0	7.1	15.3	20.1	10.1	14.4	22.7	9.0	22.2	7.4	12.4	6.6	13.6	13.6	9.2	8.3	9.2	14.1	5.9	10.2	11.6	9.3	13.1	11.5	18.2	15.2	9.0	7.2	9.1	6.7	12.1	20.8	8.1	9.1	20.7	21.1	11.9	10.8	11.1	12.2	14.1	12.6	10.0	10.1	5.3	10.5	10.2	12.0	14.9	21.3	20.8	5.5	11.0	9.4	3.1	3.0	1.2	1.6	3.1	3.3	1.9	1.5	1.2	1.8	2.5	1.5	1.3	10.7	1.2	7.2	1.6	1.6	1.0	18.4	33.3	28.5	29.9	22.0	14.1	29.7	19.6	23.2	32.0	50.6	47.2	32.6	39.2	24.4	99.7	34.3	38.2	32.1	51.2	43.6	53.0	39.4	5.0	30.3	19.8	39.1	29.6	23.3	19.9	20.7	34.6	55.9	11.5	50.5	41.7	101.7	44.3	41.1	94.2	12.0	50.3	46.8	21.9	19.0	30.6	35.0	28.4	23.0	49.5	22.6	68.5	32.3	35.0	34.9	52.5	24.1	21.5	23.0	31.6	49.7
DIMT1	"DIMT1L, HSA9761"	ENSG00000086189	"DIM1 dimethyladenosine transferase 1 homolog"	Q9UNQ2	5	62387254-62403939	"Enzymes, Predicted intracellular proteins"	"rRNA processing"	"Methyltransferase, RNA-binding, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042944	Approved		Supported	"Nucleoplasm,Nucleoli,Nucleoli rim,Cytosol"		NA	NA			"Nucleoli, Nucleoli rim"	"Nucleoplasm, Cytosol"	"HPA042944: AB_2678234"	"unprognostic (1.58e-1)"	"unprognostic (2.27e-1)"	"unprognostic (6.02e-3)"	"unprognostic (7.16e-2)"	"unprognostic (8.95e-3)"	"unprognostic (1.73e-2)"	"prognostic unfavorable (6.93e-4)"	"unprognostic (8.88e-2)"	"unprognostic (1.18e-2)"	"unprognostic (1.62e-1)"	"unprognostic (5.31e-2)"	"unprognostic (3.70e-1)"	"prognostic unfavorable (8.90e-12)"	"unprognostic (8.89e-2)"	"unprognostic (2.89e-1)"	"unprognostic (1.49e-1)"	"unprognostic (5.15e-2)"	16.7	14.0	18.9	16.7	17.0	10.6	18.9	11.5	23.5	18.6	11.8	12.4	11.8	11.0	16.2	11.9	20.1	14.2	15.3	19.7	19.1	17.0	11.9	16.3	11.7	22.5	18.8	8.5	17.8	28.4	8.9	13.4	16.7	12.3	18.8	9.5	10.0	16.1	18.3	17.9	12.2	11.9	24.6	20.2	22.1	10.2	10.7	9.8	16.3	19.0	19.0	19.2	21.7	13.2	7.9	7.7	5.0	5.6	7.0	13.2	6.1	14.6	8.8	16.1	21.0	11.9	15.8	16.0	18.7	7.1	14.5	15.4	14.2	15.6	30.1	17.2	13.9	15.7	11.4	10.8	11.1	18.4	21.3	18.9	20.6	11.5	11.8	14.3	16.9	15.9	13.7	9.0	14.1	13.8	14.4	12.6	19.8	20.9	13.9	14.8	14.7	24.9	26.1	15.5	6.5	18.5	16.1	16.2	41.5	13.1	13.5	18.0	15.8	16.0	15.0	16.0	12.0	12.1	15.9	13.9	10.0	10.4	14.2	25.6	18.4	19.1	27.1	15.2	30.5	14.8	5.0	3.1	2.3	7.7	5.6	11.7	7.9	10.4	9.3	5.0	6.6	13.2	11.0	0.8	7.0	4.3	7.7	9.3	6.1	18.9	17.0	11.5	14.7	19.1	17.0	18.8	8.5	12.3	9.8	3.0	7.4	18.2	65.3	45.2	5.5	27.9	22.9	13.4	21.6	14.0	9.8	38.5	18.3	24.9	5.1	26.8	3.6	0.0	19.6	38.1	27.3	43.1	12.7	10.9	28.5	0.0	4.6	16.5	16.1	3.6	26.7	17.5	27.0	21.6	11.7	6.0	17.2	2.9	19.1	22.7	4.1	6.5	49.9	12.6	21.1	33.1	29.9	25.4	15.7	57.8
DIO1	TXDI1	ENSG00000211452	"Iodothyronine deiodinase 1"	P49895	1	53891239-53911086	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Thyroid hormones biosynthesis"	Oxidoreductase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	32	"kidney: 36.1;liver: 50.8;thyroid gland: 67.7"	"Cell type enhanced"	"Detected in some"	22	"Cholangiocytes: 17.8;Hepatocytes: 52.9;Proximal tubular cells: 83.0"	"Group enriched"	"Detected in many"	8	"liver cancer: 44.7;thyroid cancer: 43.7"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"myeloid DC: 1.5"	"Low lineage specificity"	"Detected in single"			"Group enriched"	"Detected in some"	26	"Hep G2: 17.0;SK-BR-3: 41.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"									NA	NA						"unprognostic (4.89e-2)"	"unprognostic (4.86e-2)"	"unprognostic (1.81e-2)"	"unprognostic (1.21e-2)"	"unprognostic (1.06e-1)"	"unprognostic (2.68e-2)"	"unprognostic (3.91e-3)"	"unprognostic (6.96e-4)"	"unprognostic (6.94e-2)"	"unprognostic (4.83e-2)"	"unprognostic (8.81e-2)"	"unprognostic (1.43e-1)"	"unprognostic (3.50e-3)"	"unprognostic (9.99e-3)"	"unprognostic (3.78e-2)"	"prognostic unfavorable (5.44e-4)"	"unprognostic (3.59e-2)"	0.1	0.0	0.1	0.1	0.1	0.0	0.2	0.1	0.1	0.1	0.1	0.2	0.1	0.0	0.1	0.1	0.1	1.0	0.1	0.1	0.1	0.0	36.1	50.8	0.4	0.1	0.2	0.1	0.4	0.1	0.0	0.1	0.2	0.2	0.1	0.0	0.1	0.4	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.2	0.1	0.1	67.7	0.1	0.1	0.1	0.1	0.0	1.5	0.0	0.6	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.5	0.1	0.0	17.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.1	0.0	41.3	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.6	0.0	0.0	0.1	0.0	0.0	0.1	0.0	1.5	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.0	0.2	0.1	0.2	0.1	0.0	0.0	0.5	0.0	0.0	0.0	13.7	17.8	0.0	0.0	0.0	0.0	0.2	10.0	0.0	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	52.9	0.4	0.0	0.0	0.6	2.4	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	83.0	0.0	0.0	0.0	0.1	0.2	0.0	1.9	0.0	0.0	0.0
DIO2	"SelY, TXDI2"	ENSG00000211448	"Iodothyronine deiodinase 2"	Q92813	14	80197527-80387757	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Thyroid hormones biosynthesis"	Oxidoreductase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"cervix, uterine: 67.7;thyroid gland: 128.7"	"Group enriched"	"Detected in many"	14	"Extravillous trophoblasts: 495.6;Muller glia cells: 220.7"	"Cancer enhanced"	"Detected in many"		"thyroid cancer: 34.8"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BJ: 26.7;fHDF/TERT166: 14.7;HeLa: 30.6;HHSteC: 15.2;SiHa: 55.9;SK-BR-3: 11.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA048002			Approved	"Nucleoplasm,Vesicles,Plasma membrane"		NA	NA			"Nucleoplasm, Vesicles"	"Plasma membrane"	"HPA048002: AB_2680230"	"unprognostic (1.22e-1)"	"unprognostic (1.69e-1)"	"prognostic favorable (1.67e-4)"	"prognostic favorable (4.62e-6)"	"unprognostic (2.76e-1)"	"unprognostic (1.22e-1)"	"unprognostic (2.22e-1)"	"unprognostic (2.17e-1)"	"unprognostic (2.07e-1)"	"unprognostic (8.78e-2)"	"unprognostic (3.68e-2)"	"unprognostic (2.48e-1)"	"unprognostic (1.00e-3)"	"unprognostic (5.08e-2)"	"unprognostic (3.43e-1)"	"unprognostic (8.40e-2)"	"unprognostic (7.15e-2)"	1.3	1.8	13.0	0.9	12.3	0.7	6.1	1.0	19.7	67.7	1.2	1.6	1.9	1.2	15.6	1.1	36.1	0.9	2.5	4.7	14.2	2.7	2.4	0.7	1.2	1.0	4.1	7.6	0.7	1.3	0.9	35.9	5.9	13.2	5.0	1.3	13.1	17.7	12.4	3.0	3.3	1.2	2.4	1.2	0.9	2.5	2.5	1.4	0.0	128.7	15.8	12.0	2.6	13.7	0.0	0.1	0.7	0.1	0.0	0.0	0.0	0.0	3.4	0.0	0.0	0.1	0.4	0.0	26.7	5.7	2.4	0.3	0.0	0.1	0.0	0.1	14.7	0.1	0.5	0.9	0.0	1.9	0.0	0.0	0.0	30.6	0.0	15.2	0.0	0.0	1.7	0.0	0.5	0.0	1.3	0.5	0.0	0.0	0.2	0.1	0.6	0.0	0.0	0.5	0.0	0.1	0.2	1.2	0.0	0.0	0.2	0.0	0.0	55.9	11.7	0.1	2.5	0.0	0.0	0.3	0.1	2.4	5.6	6.7	0.9	0.0	0.0	2.5	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.1	0.0	0.0	13.0	12.3	1.0	19.7	14.2	2.7	4.1	7.6	13.2	1.4	0.0	0.3	0.0	0.1	2.6	2.9	1.1	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	18.5	1.4	0.0	0.0	0.0	495.6	26.0	0.2	0.0	0.0	8.2	1.6	0.0	0.6	1.0	9.6	3.1	0.3	5.0	0.0	0.0	220.7	0.6	0.0	3.9	0.0	6.2	0.0	8.2	3.3	0.6	2.6	23.6	0.0	0.0	0.0
DIO3	TXDI3	ENSG00000197406	"Iodothyronine deiodinase 3"	P55073	14	101561351-101563452	"Enzymes, FDA approved drug targets, Predicted membrane proteins"	"Thyroid hormones biosynthesis"	Oxidoreductase	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"cervix, uterine: 40.9;placenta: 17.6"	"Group enriched"	"Detected in some"	4	"Fibroblasts: 8.0;Leydig cells: 10.0;Muller glia cells: 6.6;Peritubular cells: 7.1;Syncytiotrophoblasts: 23.7"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in single"		"basal ganglia: 1.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	10	"AF22: 35.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA073684			Supported	Vesicles		NA	NA			Vesicles		"HPA073684: "	"unprognostic (4.52e-3)"	"unprognostic (1.80e-1)"	"unprognostic (3.04e-3)"	"unprognostic (3.48e-1)"	"unprognostic (5.16e-2)"	"unprognostic (1.50e-1)"	"unprognostic (4.24e-2)"	"unprognostic (8.11e-2)"	"unprognostic (2.58e-1)"	"unprognostic (6.24e-2)"	"unprognostic (2.34e-1)"	"unprognostic (2.52e-1)"	"unprognostic (7.46e-5)"	"unprognostic (4.82e-3)"	"unprognostic (2.43e-1)"	"unprognostic (1.11e-4)"	"unprognostic (9.80e-3)"	4.5	0.2	0.2	1.7	1.8	0.0	3.5	0.1	0.8	40.9	1.6	0.1	1.0	0.0	3.4	2.2	1.9	3.5	2.9	1.6	0.7	0.0	0.9	2.7	1.4	7.1	0.1	0.1	9.2	4.1	0.0	0.6	17.6	0.3	1.6	0.4	12.6	0.8	2.5	2.2	1.9	0.7	0.9	0.1	2.5	0.7	1.0	0.1	0.1	3.6	1.1	0.4	6.9	8.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	35.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.6	0.9	0.5	0.0	0.0	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	1.8	0.1	0.6	0.7	0.0	0.1	0.1	0.3	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.4	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.5	0.1	0.0	0.9	0.0	0.0	2.1	8.0	0.3	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0	10.0	0.0	0.0	1.0	0.0	6.6	0.6	0.0	7.1	0.0	0.1	0.0	1.2	0.0	0.0	0.1	23.7	0.0	0.0	0.1
DLAT	"DLTA, PDC-E2"	ENSG00000150768	"Dihydrolipoamide S-acetyltransferase"	P10515	11	112024814-112064390	"Citric acid cycle related proteins, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Carbohydrate metabolism, Glucose metabolism, Tricarboxylic acid cycle"	"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 55.4"	"Cell type enhanced"	"Detected in many"	7	"Cardiomyocytes: 95.8;Distal tubular cells: 63.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB003782, HPA040786, HPA062766"	Supported		Supported	Mitochondria		NA	NA			Mitochondria		"CAB003782: , HPA040786: AB_2677136, HPA062766: AB_2684864"	"unprognostic (4.57e-3)"	"unprognostic (1.75e-1)"	"prognostic favorable (6.19e-6)"	"unprognostic (7.68e-2)"	"unprognostic (2.41e-1)"	"unprognostic (1.70e-2)"	"prognostic unfavorable (7.49e-5)"	"unprognostic (8.68e-2)"	"unprognostic (5.36e-2)"	"unprognostic (2.93e-1)"	"unprognostic (2.23e-3)"	"unprognostic (6.25e-2)"	"prognostic favorable (1.95e-14)"	"unprognostic (5.82e-2)"	"unprognostic (4.12e-2)"	"unprognostic (2.17e-1)"	"unprognostic (6.15e-2)"	14.1	10.7	10.6	8.8	11.9	4.8	10.9	10.5	14.2	6.7	13.3	6.3	7.8	12.4	6.3	8.1	12.2	7.2	6.4	55.4	10.4	13.5	19.1	12.0	6.6	8.7	11.2	9.7	7.9	6.0	15.8	7.8	8.3	13.0	8.3	13.5	7.6	10.4	9.9	41.0	7.2	13.0	6.6	7.3	6.9	8.1	7.3	4.2	12.7	10.7	22.1	8.8	7.5	6.7	9.2	9.1	7.9	8.9	7.2	10.3	8.0	6.1	6.2	8.3	11.0	11.6	8.7	9.9	8.5	4.9	9.4	10.7	19.7	18.2	25.3	16.7	7.7	12.8	13.3	17.2	9.1	10.7	9.1	10.8	16.1	6.6	12.1	8.3	20.3	9.2	10.5	10.0	9.4	9.5	7.2	8.5	12.5	26.2	12.1	11.0	4.8	9.2	24.3	9.7	15.8	12.1	14.3	11.2	28.5	17.2	6.5	15.9	9.7	10.2	28.9	6.4	9.9	21.4	12.6	5.7	9.4	10.2	9.4	10.9	4.0	6.3	38.4	2.6	22.2	7.3	7.9	6.6	4.7	8.3	8.9	9.5	9.2	8.2	8.9	9.1	7.5	10.3	8.3	0.5	7.2	8.9	7.4	8.8	8.0	10.6	11.9	10.5	14.2	10.4	13.5	11.2	9.7	13.0	4.2	11.9	12.6	16.4	7.1	10.0	7.6	95.8	12.7	32.1	7.9	10.4	0.0	17.8	63.0	16.0	3.0	8.3	19.1	0.0	10.1	34.1	8.5	6.3	3.5	14.3	16.4	7.9	16.6	5.5	12.3	2.3	5.8	7.9	16.9	18.0	18.5	8.6	12.5	3.5	10.3	29.2	10.5	0.0	11.3	21.6	15.8	8.5	14.5	8.6	24.8	9.1
DLD	"DLDH, GCSL, LAD"	ENSG00000091140	"Dihydrolipoamide dehydrogenase"	P09622	7	107890970-107931730	"Citric acid cycle related proteins, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		Oxidoreductase	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	6	"Cardiomyocytes: 284.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044849	Supported		Approved	Nucleoplasm,Mitochondria		NA	NA		16000000	Mitochondria	Nucleoplasm	"HPA044849: AB_2679111"	"unprognostic (2.01e-3)"	"unprognostic (2.26e-1)"	"unprognostic (1.27e-2)"	"unprognostic (9.27e-2)"	"unprognostic (5.01e-3)"	"unprognostic (9.27e-2)"	"unprognostic (2.48e-1)"	"unprognostic (2.83e-2)"	"unprognostic (1.19e-1)"	"unprognostic (3.95e-2)"	"unprognostic (9.43e-2)"	"unprognostic (7.35e-2)"	"prognostic favorable (7.58e-9)"	"unprognostic (4.08e-2)"	"unprognostic (1.88e-1)"	"unprognostic (4.45e-3)"	"unprognostic (1.18e-1)"	25.7	37.9	14.5	12.7	25.4	12.0	15.2	16.6	27.2	13.2	28.0	10.6	12.2	20.9	13.6	9.6	25.6	11.6	12.7	69.1	16.4	14.4	40.7	37.9	11.0	13.0	16.7	20.1	15.1	14.8	24.6	22.4	15.4	29.3	14.7	26.8	12.8	19.4	14.4	71.5	13.8	29.5	23.7	10.6	17.4	23.0	10.6	10.7	18.7	17.0	31.8	16.9	20.1	11.7	13.5	30.4	45.8	37.8	22.9	19.4	20.2	40.1	32.6	18.1	31.1	26.0	23.0	20.5	23.1	19.5	26.9	20.9	38.0	22.6	39.3	39.9	24.5	44.0	26.7	36.3	32.6	40.7	26.2	21.6	27.6	43.2	27.1	20.0	45.4	28.5	26.2	23.7	28.6	15.6	17.1	32.3	33.0	68.9	29.3	29.2	45.1	37.1	32.9	21.5	48.5	23.7	26.8	29.0	53.3	36.8	60.0	22.5	23.8	37.8	64.0	34.0	37.6	24.4	38.9	20.4	29.8	24.4	57.9	35.1	22.2	42.3	26.4	28.0	48.5	30.7	36.5	22.3	45.8	17.5	28.2	18.5	13.5	17.7	17.3	30.4	12.3	18.7	19.4	14.0	22.9	37.8	10.5	16.8	20.2	14.5	25.4	16.6	27.2	16.4	14.4	16.7	20.1	29.3	10.7	26.8	16.5	23.1	30.6	27.8	45.9	284.8	61.1	37.5	18.2	75.0	21.6	94.8	192.3	59.5	3.8	30.0	47.9	46.7	49.3	49.9	26.3	23.6	26.5	77.8	61.0	20.6	29.4	27.6	36.8	5.6	21.6	34.1	35.4	65.9	39.3	31.3	37.7	56.1	39.6	134.4	33.4	25.8	43.4	41.2	52.4	28.2	90.6	27.7	64.6	28.5
DLST	DLTS	ENSG00000119689	"Dihydrolipoamide S-succinyltransferase"	P36957	14	74881891-74903745	"Citric acid cycle related proteins, Enzymes, Predicted intracellular proteins"	"Tricarboxylic acid cycle"	"Acyltransferase, Transferase"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003010	Supported		Approved	Nucleoplasm,Mitochondria		NA	NA		800000	"Nucleoplasm, Mitochondria"		"HPA003010: AB_1078679"	"unprognostic (1.62e-1)"	"unprognostic (3.01e-1)"	"unprognostic (2.45e-3)"	"unprognostic (6.36e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.21e-2)"	"unprognostic (1.16e-1)"	"unprognostic (5.83e-2)"	"unprognostic (3.03e-1)"	"unprognostic (1.37e-1)"	"unprognostic (2.12e-2)"	"unprognostic (1.18e-1)"	"prognostic favorable (1.13e-12)"	"unprognostic (3.29e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.66e-1)"	"unprognostic (4.55e-3)"	32.2	38.6	12.0	22.7	19.9	28.5	31.3	19.1	25.6	31.2	36.0	18.5	15.9	24.7	26.3	28.3	31.4	19.2	29.7	47.6	10.8	11.8	43.7	45.1	20.8	26.7	13.5	13.7	21.5	27.1	25.8	16.2	25.2	19.7	20.9	26.8	19.2	22.3	20.1	59.2	26.9	43.2	32.9	11.4	20.8	24.3	21.0	10.4	23.5	27.2	49.8	28.4	26.9	21.1	3.8	6.3	8.4	4.3	7.7	5.3	3.2	25.8	27.0	20.7	14.6	32.5	36.9	31.7	33.8	34.4	34.6	32.4	26.5	28.1	26.3	14.4	38.8	15.6	29.2	34.8	33.4	36.6	19.0	14.6	21.5	22.6	23.2	33.6	15.2	14.8	37.7	29.3	33.5	41.4	31.2	35.6	11.9	16.4	17.9	37.5	34.7	18.0	21.6	17.7	45.7	25.4	23.1	30.4	14.5	42.9	31.8	24.6	20.9	31.9	42.6	22.0	19.3	39.0	22.0	31.5	21.1	27.6	25.7	23.1	12.7	13.2	23.1	30.8	15.8	22.0	8.4	3.0	5.0	5.0	4.3	4.5	3.8	4.5	3.9	4.7	2.7	4.0	5.3	3.0	7.7	3.9	6.3	4.4	3.2	12.0	19.9	19.1	25.6	10.8	11.8	13.5	13.7	19.7	10.4	6.0	4.5	20.7	19.3	23.5	17.5	23.4	20.4	2.7	3.4	19.2	29.5	33.7	48.0	32.5	6.2	14.6	39.3	0.0	22.3	30.6	23.8	21.8	20.7	37.3	28.4	12.7	14.3	24.5	16.2	3.4	16.7	16.5	21.9	36.1	28.3	8.5	35.0	25.9	19.4	51.5	20.0	25.8	17.9	9.3	11.7	24.8	66.5	20.3	36.1	20.8
DMGDH		ENSG00000132837	"Dimethylglycine dehydrogenase"	Q9UI17	5	78997606-79236038	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		Oxidoreductase	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	11	"kidney: 50.2;liver: 81.8"	"Cell type enhanced"	"Detected in many"	16	"Early spermatids: 25.2;Hepatocytes: 84.9;Late spermatids: 27.1;Proximal tubular cells: 59.0"	"Group enriched"	"Detected in some"	12	"liver cancer: 15.6;renal cancer: 12.0"	"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BJ hTERT+: 5.7;Hep G2: 11.5;hTEC/SVTERT24-B: 3.6;Karpas-707: 3.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA036441, HPA036442, HPA077849"	Enhanced		Supported	Mitochondria		NA	NA		440000	Mitochondria		"HPA036441: AB_2675124, HPA036442: AB_10669792, HPA077849: AB_2686859"	"unprognostic (3.11e-2)"	"unprognostic (3.36e-1)"	"unprognostic (6.70e-2)"	"unprognostic (1.81e-1)"	"unprognostic (3.15e-1)"	"unprognostic (2.52e-3)"	"prognostic favorable (5.32e-5)"	"unprognostic (2.21e-1)"	"unprognostic (3.05e-2)"	"unprognostic (3.19e-2)"	"unprognostic (1.07e-4)"	"unprognostic (1.89e-1)"	"prognostic favorable (1.17e-5)"	"unprognostic (2.03e-2)"	"unprognostic (9.75e-4)"	"unprognostic (1.46e-1)"	"unprognostic (2.26e-1)"	2.8	2.2	0.8	0.8	1.3	0.0	1.5	0.4	0.6	0.5	0.5	0.7	1.9	0.1	0.9	5.9	0.4	0.4	0.6	1.3	0.8	0.8	50.2	81.8	0.1	0.1	0.8	0.3	1.0	0.5	0.3	2.1	0.0	1.1	0.9	0.1	2.7	0.4	1.1	0.6	0.2	0.3	2.0	1.7	0.0	0.4	1.2	0.2	0.0	1.5	0.8	0.1	1.0	0.3	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.1	0.5	0.5	1.4	0.4	0.3	5.7	1.3	2.3	0.0	0.1	0.0	0.4	1.8	0.0	0.0	0.1	0.0	1.9	0.3	0.0	0.0	0.0	11.5	3.2	0.0	0.0	2.7	3.3	3.6	2.6	2.5	0.0	1.3	0.0	3.6	0.9	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.6	0.3	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	3.3	0.1	0.2	0.0	0.0	0.0	0.4	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.8	1.3	0.4	0.6	0.8	0.8	0.8	0.3	1.1	0.2	0.0	0.6	1.4	0.4	0.1	1.5	0.8	2.5	2.7	0.0	8.7	2.0	0.2	16.6	0.4	25.2	0.6	0.5	0.0	0.6	0.1	0.8	0.9	0.0	84.9	0.1	0.0	1.2	1.3	2.4	27.1	2.3	0.4	0.0	0.0	1.1	3.5	0.7	0.6	2.5	59.0	4.1	0.0	0.1	3.4	5.2	0.3	0.2	0.5	0.6	0.7
DMPK	"DM, DM1, DM1PK, DMK, MDPK, MT-PK"	ENSG00000104936	"DM1 protein kinase"	Q09013	19	45769717-45782552	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"	Cataract	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 79.6"	"Cell type enhanced"	"Detected in many"	9	"Sertoli cells: 58.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"gdT-cell: 2.2"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"RH-30: 44.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA007164, HPA008905"	Enhanced		Approved	Vesicles,Cytosol		NA	NA			Cytosol	Vesicles	"HPA007164: AB_1078687, HPA008905: AB_1078685"	"unprognostic (7.44e-2)"	"unprognostic (2.66e-1)"	"unprognostic (1.76e-3)"	"unprognostic (2.61e-3)"	"unprognostic (1.29e-1)"	"unprognostic (5.46e-2)"	"unprognostic (8.67e-2)"	"unprognostic (1.50e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.67e-1)"	"prognostic favorable (9.39e-5)"	"unprognostic (1.93e-1)"	"unprognostic (1.60e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.18e-1)"	"unprognostic (3.03e-2)"	"unprognostic (4.24e-3)"	9.0	18.7	5.1	9.7	6.3	1.7	4.9	8.8	6.2	16.5	23.4	4.4	15.6	8.7	21.2	15.0	31.2	13.7	20.3	56.7	5.0	5.3	4.9	2.2	6.5	4.1	4.8	6.5	8.4	33.3	3.1	10.7	6.8	5.6	16.3	3.8	22.0	6.1	19.7	79.6	5.1	11.3	65.1	4.2	5.3	12.0	5.9	4.0	1.1	6.1	36.6	5.0	44.9	8.2	1.5	0.0	0.0	0.8	0.3	2.2	0.0	7.2	10.2	12.1	7.5	8.2	11.5	7.3	16.4	12.1	6.6	6.4	1.2	3.9	2.3	2.5	18.7	5.3	10.7	3.5	1.6	2.5	11.4	10.7	0.9	12.7	1.7	8.0	0.1	4.1	16.6	5.7	5.7	2.8	16.3	3.0	1.2	7.2	5.9	9.5	8.1	1.1	2.8	7.2	3.2	2.2	3.7	44.7	3.8	3.5	8.4	6.5	10.5	8.9	18.8	5.3	6.9	15.4	3.6	9.2	7.7	7.6	7.2	12.0	11.4	9.7	2.3	7.0	1.0	10.7	0.0	0.0	0.0	2.2	0.8	0.5	0.3	0.7	0.2	0.0	1.5	0.4	0.1	0.0	0.3	0.0	0.0	0.0	0.0	5.1	6.3	8.8	6.2	5.0	5.3	4.8	6.5	5.6	4.0	0.0	2.1	0.9	7.0	7.1	4.9	3.1	2.5	0.0	2.3	3.5	7.9	2.3	1.7	2.4	1.4	6.0	3.6	0.0	15.0	1.5	12.7	3.3	0.0	0.9	0.7	4.8	9.7	10.4	1.2	1.4	6.6	0.5	6.8	0.0	5.5	2.2	5.0	3.5	21.9	22.0	7.6	58.2	23.7	6.3	6.0	5.9	1.4	5.0	3.6	3.7
DNA2	"DNA2L, KIAA0083"	ENSG00000138346	"DNA replication helicase/nuclease 2"	P51530	10	68414064-68472121	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"DNA damage, DNA repair, DNA replication"	"DNA-binding, Endonuclease, Helicase, Hydrolase, Multifunctional enzyme, Nuclease"	"Disease mutation, Dwarfism, Mental retardation, Primary mitochondrial disease, Progressive external ophthalmoplegia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	7	"lymphoid tissue: 49.1"	"Cell type enriched"	"Detected in many"	5	"Erythroid cells: 70.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	6	"NK-cell: 5.5"	"Lineage enriched"	"Detected in single"	6	"NK-cells: 5.5"	"Low cell line specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA037487, HPA057526"	Approved		Supported	Mitochondria		No	No			Mitochondria		"HPA037487: AB_10672493, HPA057526: AB_2683456"	"unprognostic (1.79e-1)"	"unprognostic (1.35e-1)"	"unprognostic (4.37e-3)"	"unprognostic (4.60e-3)"	"unprognostic (1.53e-1)"	"unprognostic (1.86e-2)"	"unprognostic (4.50e-5)"	"unprognostic (3.36e-2)"	"unprognostic (4.70e-2)"	"unprognostic (3.72e-2)"	"unprognostic (1.30e-2)"	"unprognostic (3.29e-4)"	"unprognostic (1.09e-10)"	"unprognostic (3.43e-2)"	"unprognostic (1.98e-1)"	"unprognostic (9.36e-2)"	"unprognostic (1.23e-2)"	1.6	1.2	2.0	13.7	2.4	7.0	3.0	6.2	3.8	1.6	4.5	1.1	0.8	3.5	3.0	1.8	3.2	1.0	2.4	2.0	2.5	2.2	3.4	6.2	3.3	8.4	2.9	5.0	1.9	2.4	1.1	2.3	4.0	1.7	3.0	5.0	0.9	2.3	0.8	2.3	2.9	5.2	1.9	3.0	5.2	2.6	7.0	1.4	49.1	1.5	5.1	10.8	2.3	2.0	0.4	0.1	0.9	0.1	5.5	0.6	0.1	13.9	7.2	16.5	11.6	1.9	1.3	11.6	6.9	5.8	9.9	12.2	17.2	9.1	14.3	2.6	2.1	3.8	8.6	9.4	3.6	12.0	8.8	7.1	8.7	4.5	6.6	0.5	14.9	9.4	1.0	1.5	7.0	2.1	2.5	4.4	9.5	12.7	13.0	5.7	4.9	23.0	10.8	11.6	5.9	13.6	18.0	11.4	4.6	4.2	6.5	7.5	9.0	9.5	12.1	2.3	12.2	9.3	6.3	1.8	3.8	11.9	4.8	13.1	6.6	7.4	21.4	3.2	14.3	5.0	0.0	0.0	0.9	0.2	0.0	0.2	0.4	0.2	0.6	0.1	0.4	0.3	0.3	0.1	5.5	0.1	0.0	0.4	0.1	2.0	2.4	6.2	3.8	2.5	2.2	2.9	5.0	1.7	1.4	6.0	0.6	0.0	0.7	2.1	2.2	7.3	2.5	0.0	1.2	1.8	5.9	2.0	0.0	0.5	1.6	0.7	1.3	70.0	0.8	3.8	1.9	3.2	0.0	4.4	1.8	0.0	1.2	1.3	2.2	3.1	0.6	0.0	0.0	0.0	1.3	0.2	0.7	0.0	0.7	0.4	3.6	0.0	1.0	5.0	14.2	1.5	1.0	1.5	2.3	0.9
DNAJC6	"KIAA0473, PARK19"	ENSG00000116675	"DnaJ heat shock protein family (Hsp40) member C6"	O75061	1	65248219-65415869	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		"Chaperone, Hydrolase, Protein phosphatase"	"Disease mutation, Neurodegeneration, Parkinson disease, Parkinsonism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	8	"brain: 91.4"	"Cell type enhanced"	"Detected in many"	11	"Bipolar cells: 29.6;Cardiomyocytes: 26.1;Erythroid cells: 23.3;Horizontal cells: 49.3;Rod photoreceptor cells: 21.6"	"Cancer enhanced"	"Detected in many"		"glioma: 5.9"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"gdT-cell: 1.5"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 21.2;HEL: 56.7;K-562: 22.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031182, HPA054917"	Enhanced		Approved	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			Cytosol	"Nucleoplasm, Plasma membrane"	"HPA031182: AB_10611957, HPA054917: AB_2682641"	"unprognostic (6.99e-2)"	"unprognostic (2.00e-3)"	"unprognostic (3.19e-1)"	"unprognostic (7.94e-7)"	"unprognostic (1.59e-1)"	"unprognostic (7.61e-3)"	"unprognostic (1.87e-4)"	"unprognostic (2.98e-1)"	"unprognostic (1.89e-1)"	"unprognostic (4.14e-1)"	"unprognostic (4.22e-3)"	"unprognostic (1.53e-1)"	"prognostic favorable (2.81e-4)"	"unprognostic (1.43e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.36e-1)"	"unprognostic (8.67e-3)"	2.1	12.1	18.6	2.2	28.5	5.0	2.0	24.2	91.4	2.2	2.8	26.9	0.0	2.3	1.9	1.8	1.7	2.4	2.3	9.0	25.0	26.7	8.5	1.6	2.7	1.6	28.8	23.8	1.9	3.4	2.1	7.5	8.0	40.5	2.5	3.0	2.2	1.7	2.1	1.6	2.1	2.3	2.2	28.7	3.2	2.9	3.2	21.1	0.0	3.0	0.0	1.7	1.8	0.6	0.5	0.5	0.0	0.0	0.6	1.5	0.3	3.5	1.0	0.0	1.6	0.8	0.2	8.4	7.1	11.6	11.7	11.5	0.9	0.1	3.4	0.6	2.9	2.9	0.9	5.1	1.1	9.2	21.2	2.4	56.7	1.9	0.2	0.0	1.9	1.4	1.0	0.8	1.1	5.0	2.2	0.2	2.8	22.0	0.4	2.4	0.6	0.7	0.0	2.3	0.0	0.8	0.0	1.7	0.1	8.9	0.0	14.2	9.7	4.1	5.6	1.9	14.1	2.7	0.1	2.2	1.7	1.2	0.2	2.0	2.1	1.4	1.0	4.8	1.4	2.9	0.0	0.0	0.0	1.5	0.0	0.1	0.5	0.5	0.9	0.0	0.0	0.4	0.6	0.0	0.6	0.0	0.5	0.0	0.3	18.6	28.5	24.2	37.4	25.0	26.7	28.8	23.8	40.5	21.1	0.0	0.3	0.0	0.2	1.1	29.6	26.1	0.0	0.0	0.0	0.0	13.7	4.8	1.7	0.8	1.8	0.7	0.0	23.3	0.6	1.9	1.7	1.3	0.0	0.0	1.1	49.3	6.9	0.0	0.0	1.4	0.0	0.8	6.8	1.8	1.3	3.1	0.4	0.0	0.0	5.9	21.6	0.0	2.3	1.0	2.3	0.3	6.2	0.0	0.5	0.1
DNASE1	DNL1	ENSG00000213918	"Deoxyribonuclease 1"	P24855	16	3611728-3680143	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins"	Apoptosis	"Actin-binding, Endonuclease, Hydrolase, Nuclease"	"Systemic lupus erythematosus"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"intestine: 26.7"	"Cell type enhanced"	"Detected in many"	5	"Distal tubular cells: 48.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA010703	Enhanced		Supported	Vesicles	"Secreted in other tissues"	NA	NA		160000	Vesicles		"HPA010703: AB_10600806"	"unprognostic (5.18e-2)"	"unprognostic (1.78e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.74e-1)"	"unprognostic (2.38e-1)"	"unprognostic (1.90e-2)"	"unprognostic (3.73e-2)"	"unprognostic (3.82e-1)"	"unprognostic (3.20e-1)"	"unprognostic (9.91e-2)"	"unprognostic (1.69e-3)"	"unprognostic (5.37e-2)"	"unprognostic (1.37e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.74e-1)"	"unprognostic (1.45e-1)"	"prognostic favorable (1.14e-4)"	1.5	1.4	1.5	2.6	1.6	1.7	1.5	3.8	2.5	2.2	12.2	1.8	1.5	14.9	1.5	2.2	3.4	1.2	2.5	1.5	1.5	1.2	11.4	1.5	1.5	4.4	1.5	1.5	2.0	13.7	1.6	12.2	1.9	3.1	5.1	2.1	1.5	3.3	1.5	1.5	3.9	26.7	1.5	1.5	2.3	6.0	2.7	1.5	1.5	1.6	2.6	3.8	1.9	2.3	4.5	2.2	9.2	2.0	1.9	3.4	1.0	2.5	5.8	10.2	5.3	3.0	2.6	4.8	4.0	0.7	3.3	4.8	6.9	6.1	10.7	3.3	0.6	7.0	4.2	3.6	1.1	3.5	4.6	5.6	3.7	8.6	4.5	1.5	2.6	8.7	2.1	4.3	4.4	1.1	5.2	2.2	9.0	9.3	4.7	2.8	10.4	5.3	11.5	6.2	7.4	3.1	12.6	4.6	5.2	2.8	2.2	7.2	6.7	3.0	9.2	1.7	5.3	9.1	6.6	3.0	6.1	4.5	3.8	2.3	4.3	6.1	18.5	1.7	4.9	5.8	4.3	2.0	5.3	3.0	1.3	1.9	2.5	2.3	2.4	1.0	4.5	2.7	3.4	9.2	1.9	1.2	2.2	2.4	1.0	1.5	1.6	3.8	2.5	1.5	1.2	1.5	1.5	3.1	1.5	8.9	10.1	2.4	8.5	2.4	27.4	4.8	5.1	9.4	11.4	15.7	21.6	6.6	48.0	4.5	16.1	4.5	12.7	0.0	9.7	3.3	5.1	9.8	2.3	1.5	3.2	23.8	13.7	4.9	2.7	34.9	7.8	3.8	1.7	11.8	11.3	12.8	4.3	11.2	7.4	1.4	18.3	0.0	4.2	15.1	17.5	3.3	5.1	10.5	15.3	5.3
DNASE2	"DNL, DNL2"	ENSG00000105612	"Deoxyribonuclease 2, lysosomal"	O00115	19	12875211-12881468	"Enzymes, Predicted intracellular proteins"	Apoptosis	"Developmental protein, Endonuclease, Hydrolase, Nuclease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	8	"Hofbauer cells: 210.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA066185	Enhanced				"Intracellular and membrane"	NA	NA		720000			"HPA066185: AB_2685632"	"unprognostic (9.62e-2)"	"unprognostic (2.19e-3)"	"unprognostic (8.97e-2)"	"unprognostic (7.45e-2)"	"unprognostic (1.56e-2)"	"unprognostic (4.37e-1)"	"unprognostic (6.70e-2)"	"unprognostic (5.01e-3)"	"unprognostic (5.42e-2)"	"unprognostic (4.85e-2)"	"unprognostic (1.40e-1)"	"unprognostic (5.12e-2)"	"unprognostic (4.37e-2)"	"unprognostic (2.58e-2)"	"unprognostic (4.69e-2)"	"unprognostic (3.57e-1)"	"unprognostic (1.98e-1)"	18.7	22.1	13.1	17.0	13.4	4.8	16.9	6.0	12.9	21.2	22.8	15.9	15.8	14.6	19.6	27.9	22.7	17.0	20.6	18.0	11.5	9.4	17.1	40.7	37.4	34.5	14.9	7.7	20.0	33.3	21.2	18.9	28.1	11.6	18.4	13.5	22.6	24.9	18.0	16.6	20.5	15.9	14.6	13.1	24.1	20.9	9.4	11.0	20.0	36.4	13.6	26.9	20.5	14.8	11.8	10.3	20.1	37.8	21.9	26.6	19.6	16.5	8.4	0.7	22.7	25.0	13.1	14.8	8.5	23.7	8.7	22.2	0.7	11.9	7.9	24.8	15.3	19.6	19.4	8.9	8.9	4.9	21.9	9.8	3.5	10.0	4.3	20.2	7.1	32.9	12.8	21.2	6.9	10.8	22.9	13.0	11.2	3.1	32.8	5.8	21.5	6.9	3.9	1.4	18.1	15.1	4.4	4.0	17.4	9.5	7.0	4.8	7.4	12.8	18.6	31.6	3.6	27.5	6.5	7.8	18.1	5.7	18.1	7.8	35.9	36.8	9.8	30.2	6.5	9.2	20.1	25.5	3.6	22.3	33.8	18.4	11.6	19.6	23.6	5.0	11.8	17.6	19.2	14.8	21.9	37.8	10.3	26.6	19.6	13.1	13.4	6.0	12.9	11.5	9.4	14.9	7.7	11.6	11.0	23.8	19.0	35.0	21.7	12.9	7.3	8.4	25.5	32.1	13.6	34.9	3.9	50.1	3.3	55.2	0.4	15.7	14.7	0.0	51.5	79.5	24.6	17.3	21.9	22.5	210.0	4.8	15.7	19.6	67.4	1.5	29.7	32.9	43.9	34.3	11.5	38.2	37.2	77.0	31.5	6.1	2.4	12.9	13.7	0.5	5.1	10.8	40.2	27.4	24.3	12.9
DNASE2B	DLAD	ENSG00000137976	"Deoxyribonuclease 2 beta"	Q8WZ79	1	84398532-84415018	"Enzymes, Predicted intracellular proteins"		"Endonuclease, Hydrolase, Nuclease"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in some"	6	"salivary gland: 98.7"	"Cell type enhanced"	"Detected in some"	17	"Ciliated cells: 1.4;Early spermatids: 1.6;Glandular cells: 2.3;Hofbauer cells: 5.7;Late spermatids: 2.4;Paneth cells: 1.7"	"Cancer enhanced"	"Detected in some"		"prostate cancer: 9.3"	"Region enhanced"	"Detected in single"		"basal ganglia: 2.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AN3-CA: 1.6;HL-60: 1.0;HUVEC TERT2: 2.1;SK-MEL-30: 2.6;U-266/70: 1.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"								"Intracellular and membrane"	NA	NA						"unprognostic (2.24e-1)"	"unprognostic (3.57e-2)"	"unprognostic (2.77e-1)"	"unprognostic (1.22e-1)"	"unprognostic (4.70e-2)"	"unprognostic (3.70e-1)"	"unprognostic (2.86e-1)"	"unprognostic (1.62e-2)"	"unprognostic (9.87e-2)"	"unprognostic (7.90e-2)"	"unprognostic (2.72e-1)"	"unprognostic (1.15e-1)"	"unprognostic (3.82e-5)"	"unprognostic (5.38e-2)"	"unprognostic (1.97e-1)"	"unprognostic (6.79e-2)"	"unprognostic (3.08e-3)"	16.2	0.1	0.2	0.1	2.2	0.1	0.3	0.0	0.3	0.2	0.2	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.2	0.1	0.3	0.6	0.1	0.2	13.0	1.2	0.3	0.0	0.3	0.4	0.0	0.4	0.1	0.2	2.9	0.3	0.0	98.7	0.1	1.8	0.0	0.1	0.1	1.7	0.5	0.6	0.3	0.0	0.1	0.1	0.4	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.6	0.0	0.4	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.4	2.1	0.1	0.0	0.2	0.0	0.3	0.3	0.0	0.0	0.3	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	2.6	0.2	0.0	0.0	0.0	0.0	0.2	0.4	0.0	1.3	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	2.2	0.0	0.3	0.3	0.6	0.3	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.0	5.7	0.0	1.2	0.0	0.6	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0
DNM1	DNM	ENSG00000106976	"Dynamin 1"	Q05193	9	128191655-128255248	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	Endocytosis	"Hydrolase, Motor protein"	"Disease mutation, Epilepsy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	11	"brain: 133.5"	"Group enriched"	"Detected in many"	10	"Bipolar cells: 113.1;Cone photoreceptor cells: 84.4;Horizontal cells: 47.7;Rod photoreceptor cells: 70.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"A549: 49.8;U-87 MG: 19.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB005920, HPA049910, HPA061801"	Enhanced		Supported	Nucleoplasm		NA	NA		440000	Nucleoplasm		"CAB005920: , HPA049910: AB_2680948, HPA061801: AB_2797266"	"unprognostic (3.25e-2)"	"unprognostic (5.49e-2)"	"unprognostic (1.34e-3)"	"unprognostic (3.95e-2)"	"unprognostic (4.57e-2)"	"unprognostic (1.16e-1)"	"unprognostic (3.60e-3)"	"unprognostic (1.20e-1)"	"unprognostic (5.53e-2)"	"unprognostic (6.53e-2)"	"unprognostic (6.62e-3)"	"unprognostic (6.30e-1)"	"unprognostic (9.58e-2)"	"unprognostic (1.10e-1)"	"unprognostic (2.02e-1)"	"unprognostic (3.07e-3)"	"unprognostic (1.10e-3)"	5.9	6.1	31.5	3.3	36.9	2.3	4.6	57.7	133.5	11.7	3.0	2.5	0.0	2.4	4.6	2.7	3.3	6.3	9.0	2.7	33.4	24.0	2.9	1.8	2.5	2.5	18.3	33.0	1.6	4.7	3.2	5.5	2.7	33.0	2.9	2.9	4.3	2.6	3.1	2.3	4.6	3.3	4.4	5.1	1.6	2.6	4.0	1.8	0.0	1.9	0.4	2.3	3.6	3.7	0.3	0.4	0.5	0.3	0.0	0.3	0.7	3.3	49.8	4.5	1.1	1.4	15.2	0.2	3.1	7.5	6.3	2.6	0.6	1.0	0.0	4.3	6.5	0.2	6.0	0.7	0.3	3.5	0.0	4.8	3.1	7.1	0.2	1.0	0.4	2.2	4.0	0.1	4.9	0.0	6.1	0.0	2.9	1.1	0.2	0.0	1.4	0.2	1.0	4.8	0.8	9.1	5.9	0.1	1.5	0.9	0.0	6.5	10.9	10.6	0.3	0.4	0.6	0.1	4.3	0.2	0.2	14.4	14.5	6.3	0.4	0.1	0.3	19.0	0.1	1.0	0.0	0.3	0.0	0.3	0.0	0.0	0.3	0.0	0.1	0.4	0.2	0.2	0.1	0.5	0.0	0.0	0.0	0.0	0.7	31.5	36.9	57.7	71.8	33.4	24.0	18.3	33.0	33.0	1.8	0.0	0.0	0.0	1.6	7.0	113.1	2.0	7.6	1.4	1.2	0.0	84.4	0.2	1.7	0.7	0.5	1.5	0.6	0.0	0.7	0.2	3.9	0.7	1.1	0.5	8.0	47.7	0.0	0.0	0.8	0.4	2.6	1.9	3.3	1.0	0.1	8.1	1.0	2.9	1.4	3.4	70.6	0.0	4.1	0.3	1.3	6.6	0.7	0.7	0.6	0.5
DNM1L	"DRP1, DVLP, DYMPLE, HDYNIV, VPS1"	ENSG00000087470	"Dynamin 1 like"	O00429	12	32679200-32745650	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Biological rhythms, Endocytosis, Necrosis"	Hydrolase	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009952, HPA039324"	Approved		Enhanced	Vesicles,Cytosol		NA	NA		10000000	Cytosol	Vesicles	"CAB009952: AB_2093533, HPA039324: AB_2676443"	"unprognostic (2.64e-2)"	"unprognostic (2.94e-1)"	"unprognostic (1.10e-3)"	"unprognostic (1.12e-1)"	"unprognostic (5.09e-1)"	"unprognostic (4.06e-2)"	"prognostic unfavorable (6.27e-6)"	"unprognostic (8.68e-2)"	"unprognostic (2.25e-2)"	"unprognostic (1.04e-2)"	"unprognostic (1.71e-1)"	"unprognostic (2.63e-1)"	"unprognostic (4.06e-1)"	"unprognostic (1.00e-1)"	"unprognostic (8.17e-2)"	"unprognostic (7.48e-2)"	"unprognostic (1.57e-2)"	15.4	16.2	24.9	14.8	34.4	22.3	14.3	40.5	37.8	13.0	14.5	12.4	14.9	12.3	16.5	16.5	19.8	13.3	11.9	25.4	26.1	28.1	19.4	12.8	11.2	13.8	23.4	23.2	14.1	9.8	28.7	18.8	16.0	27.9	19.3	16.0	12.1	11.1	21.1	25.6	11.8	11.0	21.7	21.7	11.6	12.2	23.1	14.9	13.4	15.2	17.4	15.8	16.9	12.2	5.9	17.0	5.0	14.6	7.2	7.9	7.1	21.3	21.4	22.4	23.0	18.2	18.6	43.4	24.1	18.5	22.8	21.1	29.9	16.4	28.8	16.9	21.7	23.3	19.3	23.6	27.7	27.4	15.2	19.2	32.8	20.6	16.5	15.0	23.2	17.3	16.8	14.1	24.0	24.8	21.9	27.5	15.0	23.6	12.5	26.0	8.3	9.2	19.5	47.3	13.6	10.5	15.7	42.2	19.7	19.2	29.5	19.6	20.1	25.6	17.6	18.7	52.0	20.2	15.9	24.8	19.4	19.6	45.5	22.3	8.8	23.7	30.0	18.9	15.6	14.7	5.0	9.7	3.1	5.6	14.6	6.8	5.9	6.0	5.9	17.0	5.2	7.3	7.9	1.7	7.2	13.6	5.4	6.1	7.1	24.9	34.4	40.5	37.8	26.1	28.1	23.4	23.2	27.9	14.9	35.7	38.5	29.4	27.6	26.7	71.7	69.9	20.4	26.8	40.9	24.4	123.7	25.6	26.6	27.7	51.2	34.9	15.4	0.0	21.8	50.9	25.9	26.7	49.7	14.8	27.0	119.2	29.3	25.2	33.3	58.7	24.7	32.4	13.5	44.1	18.9	66.0	35.1	14.0	28.7	19.5	150.0	19.4	37.0	66.2	50.8	24.1	30.1	27.7	23.8	31.5
DNM2	"CMT2M, CMTDI1, CMTDIB, DI-CMTB, DYN2, DYNII"	ENSG00000079805	"Dynamin 2"	P50570	19	10718079-10833488	"Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters"	"Endocytosis, Phagocytosis"	"Hydrolase, Motor protein"	"Cancer-related genes, Charcot-Marie-Tooth disease, Disease mutation, Neurodegeneration, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA054246	Supported		Approved	"Golgi apparatus,Cytosol"		NA	NA		500000	"Golgi apparatus, Cytosol"		"HPA054246: AB_2682427"	"unprognostic (2.30e-1)"	"unprognostic (5.23e-2)"	"unprognostic (4.72e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.76e-1)"	"prognostic favorable (8.91e-4)"	"prognostic unfavorable (3.63e-4)"	"unprognostic (1.03e-1)"	"unprognostic (3.79e-1)"	"unprognostic (1.89e-1)"	"unprognostic (4.75e-2)"	"unprognostic (5.35e-2)"	"unprognostic (5.47e-2)"	"unprognostic (5.40e-3)"	"unprognostic (2.68e-1)"	"unprognostic (1.61e-1)"	"unprognostic (1.99e-3)"	23.8	32.6	18.5	29.3	31.2	53.4	20.4	25.7	29.7	20.1	51.4	57.5	46.0	32.1	20.4	16.8	29.9	19.7	27.0	35.0	20.8	18.0	38.5	25.1	39.2	28.2	48.3	18.0	17.9	32.2	19.5	20.0	32.3	32.2	24.0	42.5	24.5	24.7	37.7	46.6	40.6	50.8	18.6	43.1	37.6	48.2	23.3	36.4	39.1	23.5	21.1	41.5	35.7	31.5	3.4	11.1	8.6	9.8	10.1	5.8	4.6	35.0	29.0	21.3	16.9	22.0	21.5	27.3	23.5	22.3	34.8	29.6	28.9	23.2	25.5	42.3	25.3	16.6	30.8	29.0	25.5	29.2	31.2	23.0	48.9	25.9	32.3	27.1	26.8	46.4	22.1	19.7	26.6	25.1	21.2	33.8	26.3	39.3	43.9	21.4	42.5	37.3	25.6	24.2	41.6	35.2	37.9	23.1	28.7	22.9	52.9	30.7	20.1	26.8	23.0	16.8	24.8	18.4	32.0	30.6	38.3	13.0	53.7	31.0	36.4	37.1	23.5	28.6	41.1	18.9	3.0	4.5	8.6	5.6	8.2	5.1	3.4	4.2	5.8	5.3	3.1	2.4	4.1	8.5	10.1	9.8	11.1	4.8	4.6	18.5	31.2	25.7	29.7	20.8	18.0	48.3	18.0	32.2	36.4	29.8	21.1	33.5	15.2	20.6	26.5	23.8	15.3	5.3	18.2	48.8	21.6	21.9	43.1	30.7	37.5	27.5	130.4	0.0	27.6	96.1	18.2	17.4	18.5	18.7	42.3	41.3	20.7	20.3	22.9	75.8	15.5	40.5	18.6	50.5	92.3	16.0	35.8	87.7	26.2	31.5	27.7	25.8	19.8	8.0	13.3	27.6	26.5	39.9	56.9	19.7
DNM3	KIAA0820	ENSG00000197959	"Dynamin 3"	Q9UQ16	1	171841498-172418466	"Enzymes, Plasma proteins, Predicted intracellular proteins"	Endocytosis	"Hydrolase, Motor protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 47.3"	"Cell type enhanced"	"Detected in many"	9	"Bipolar cells: 19.5;Cone photoreceptor cells: 27.5;Endothelial cells: 14.6;Rod photoreceptor cells: 28.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"T-reg: 4.0"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HEL: 18.2;HMC-1: 8.5;RPTEC TERT1: 15.7;U-251 MG: 11.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA064121			Approved	"Golgi apparatus"		NA	NA			"Golgi apparatus"		"HPA064121: AB_2685193"	"unprognostic (8.21e-2)"	"unprognostic (6.80e-3)"	"unprognostic (1.68e-1)"	"unprognostic (1.41e-2)"	"unprognostic (8.84e-2)"	"unprognostic (2.07e-1)"	"unprognostic (9.52e-3)"	"unprognostic (6.46e-2)"	"unprognostic (5.52e-2)"	"unprognostic (2.96e-2)"	"unprognostic (2.45e-2)"	"unprognostic (3.37e-1)"	"unprognostic (6.10e-4)"	"unprognostic (1.60e-3)"	"unprognostic (1.35e-1)"	"unprognostic (2.22e-1)"	"unprognostic (2.70e-3)"	5.0	19.3	14.1	2.3	28.3	2.6	3.4	41.4	39.7	6.8	2.7	26.8	0.0	1.9	5.9	3.1	3.0	6.0	5.1	3.0	14.3	16.3	5.8	1.4	7.5	2.5	19.6	17.7	4.6	2.6	3.5	10.3	1.6	47.3	3.6	2.7	2.9	3.7	3.6	2.5	4.0	2.4	5.7	16.4	3.6	5.3	5.4	22.1	0.0	3.4	0.0	2.2	4.3	3.6	0.7	0.7	1.1	0.4	1.0	4.0	3.8	0.6	2.0	1.6	0.3	1.2	0.8	0.0	0.4	1.0	0.8	1.0	0.0	3.0	0.0	6.3	0.9	1.0	0.2	1.2	2.3	0.7	0.8	2.4	18.2	3.0	0.0	0.1	0.3	8.5	0.6	0.4	1.0	0.5	0.9	0.4	1.6	0.0	0.3	0.3	0.0	1.1	0.1	4.7	7.5	1.4	1.2	8.2	0.0	15.7	0.1	3.2	0.6	2.2	0.6	0.2	0.6	0.0	0.7	0.2	2.3	3.2	1.9	11.3	3.1	0.5	0.1	2.2	0.9	0.8	0.0	0.4	0.0	0.7	0.0	0.9	0.7	1.0	0.5	0.7	0.0	1.2	1.5	1.1	1.0	0.3	0.0	4.0	3.8	14.1	28.3	41.4	31.6	14.3	16.3	19.6	17.7	47.3	22.1	0.0	5.0	0.0	1.2	2.2	19.5	2.1	0.0	1.4	0.0	0.0	27.5	0.0	3.3	0.3	6.5	14.6	0.0	0.0	0.3	0.1	3.3	0.4	1.1	0.0	0.7	7.9	0.0	4.3	0.0	2.3	1.7	1.3	0.0	0.0	0.4	3.1	1.6	0.0	2.5	0.5	28.5	0.0	1.4	5.0	0.3	1.5	0.2	0.0	0.5	0.9
DNMT1	"CXXC9, DNMT, MCMT"	ENSG00000130816	"DNA methyltransferase 1"	P26358	19	10133345-10231286	"Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, Chromatin regulator, DNA-binding, Methyltransferase, Repressor, Transferase"	"Deafness, Disease mutation, FDA approved drug targets, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	7	"Cytotrophoblasts: 329.4;Spermatocytes: 249.6;Syncytiotrophoblasts: 270.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002694, CAB005876"	Enhanced		Supported	Nucleoplasm		NA	Yes			Nucleoplasm		"CAB005876: AB_731983, HPA002694: AB_1847810"	"unprognostic (3.51e-1)"	"unprognostic (1.20e-2)"	"unprognostic (1.26e-2)"	"unprognostic (1.40e-1)"	"unprognostic (3.62e-1)"	"unprognostic (7.59e-3)"	"prognostic unfavorable (1.46e-4)"	"unprognostic (2.90e-1)"	"unprognostic (4.23e-3)"	"unprognostic (1.10e-2)"	"unprognostic (1.07e-1)"	"unprognostic (1.11e-2)"	"unprognostic (1.28e-3)"	"unprognostic (7.81e-3)"	"unprognostic (1.73e-1)"	"unprognostic (8.11e-2)"	"unprognostic (1.46e-1)"	12.1	7.6	9.8	20.2	10.8	31.9	11.5	27.1	14.4	12.0	8.6	10.0	4.3	8.1	12.1	8.0	12.0	11.5	7.8	8.0	9.3	8.1	6.9	9.2	11.8	29.7	12.5	7.9	11.1	6.2	10.2	8.8	32.5	8.7	8.3	10.7	7.8	9.3	6.5	6.8	10.8	11.3	11.2	9.1	11.0	9.0	19.9	12.6	31.4	9.5	8.8	28.8	11.4	9.7	12.6	19.0	10.2	13.4	25.0	18.2	6.8	24.3	15.4	19.7	16.7	7.3	7.5	42.3	16.5	13.1	23.8	23.9	14.9	13.3	40.8	10.4	10.1	12.0	16.1	21.7	12.9	24.4	16.0	32.3	59.1	13.8	7.7	3.2	24.0	24.0	5.0	2.5	20.8	8.2	7.2	12.9	12.6	23.4	25.2	17.7	16.2	35.1	32.8	25.9	11.0	22.5	35.6	20.7	22.4	7.5	15.4	21.0	16.3	20.0	9.0	6.4	12.6	9.4	12.2	9.7	40.0	13.7	24.2	24.4	20.6	21.5	48.3	11.6	22.4	31.0	10.2	13.4	3.3	18.2	13.2	15.9	7.9	14.6	12.5	11.3	12.6	16.6	12.3	3.1	25.0	7.9	19.0	12.9	6.8	9.8	10.8	27.1	14.4	9.3	8.1	12.5	7.9	8.7	12.6	6.0	24.5	38.8	19.1	26.3	66.8	11.9	7.6	48.2	29.6	21.0	53.0	329.4	11.6	20.3	42.9	33.0	4.7	93.5	12.4	56.3	25.7	12.5	34.8	12.1	68.9	62.0	15.1	24.5	28.2	38.6	25.9	51.5	13.5	45.1	16.3	39.9	15.7	11.5	26.9	7.6	50.4	12.9	22.0	249.6	179.2	19.6	270.7	54.2	37.6	14.1
DNMT3A		ENSG00000119772	"DNA methyltransferase 3 alpha"	Q9Y6K1	2	25227855-25342590	"Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transcription factors"		"Chromatin regulator, DNA-binding, Methyltransferase, Repressor, Transferase"	"Cancer-related genes, Disease mutation, Dwarfism, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	8	"Cone photoreceptor cells: 119.8;Horizontal cells: 90.6;Rod photoreceptor cells: 144.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"NTERA-2: 25.7;REH: 25.4;SH-SY5Y: 31.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009469, HPA026588"	Approved		Supported	Nucleoplasm		NA	NA			Nucleoplasm		"CAB009469: AB_2093990, HPA026588: AB_1847812"	"unprognostic (2.38e-1)"	"unprognostic (2.94e-1)"	"unprognostic (5.65e-2)"	"prognostic unfavorable (1.55e-4)"	"unprognostic (8.38e-2)"	"unprognostic (7.27e-2)"	"prognostic unfavorable (1.58e-4)"	"unprognostic (2.24e-1)"	"unprognostic (7.25e-2)"	"unprognostic (2.72e-1)"	"prognostic favorable (1.18e-4)"	"unprognostic (2.35e-2)"	"prognostic unfavorable (2.49e-4)"	"unprognostic (1.43e-1)"	"unprognostic (1.87e-1)"	"unprognostic (1.14e-1)"	"unprognostic (2.70e-2)"	7.8	12.4	13.7	12.7	15.5	10.8	8.6	21.6	20.1	9.0	12.7	14.5	7.6	9.1	13.0	12.2	8.0	9.6	8.9	8.2	12.3	6.7	9.4	6.9	9.5	13.6	15.3	10.1	18.3	12.1	6.3	12.6	20.8	10.7	9.3	9.2	12.0	8.5	9.2	29.1	6.6	11.4	11.3	7.9	17.5	11.6	6.6	15.2	20.8	9.1	10.5	11.8	9.8	8.4	3.0	4.1	4.9	4.1	8.7	8.3	2.3	1.1	3.5	14.9	3.6	1.6	1.2	19.5	1.0	0.9	2.0	1.6	8.8	5.7	0.0	2.2	1.9	1.6	1.0	1.6	2.2	1.2	3.7	2.6	6.4	5.3	10.5	3.9	1.3	4.1	3.6	1.1	2.6	0.9	3.9	8.3	14.5	7.3	1.4	1.5	8.5	13.9	15.1	25.7	5.9	1.9	25.4	16.4	2.1	1.2	1.5	8.8	31.3	1.2	8.4	2.6	13.4	1.0	6.7	2.8	2.5	3.3	0.6	1.3	3.2	2.2	8.6	0.9	3.8	2.6	4.7	1.8	3.1	5.2	3.0	7.0	2.3	3.4	4.9	2.0	3.0	8.3	6.6	4.9	8.7	4.1	4.1	2.8	2.3	13.7	15.5	21.6	20.1	12.3	6.7	15.3	10.1	10.7	15.2	6.0	13.3	10.0	8.3	4.6	74.9	13.7	5.1	9.4	12.5	19.2	119.8	30.2	5.0	13.8	1.5	14.6	5.3	0.0	8.5	9.4	14.7	11.7	36.9	5.5	19.8	90.6	12.6	6.2	10.5	1.1	17.8	11.9	6.8	4.6	11.5	22.7	9.2	10.5	14.5	5.6	144.9	19.4	8.2	2.3	13.4	2.3	26.9	18.7	11.0	6.7
DNMT3B		ENSG00000088305	"DNA methyltransferase 3 beta"	Q9UBC3	20	32762385-32809356	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Transcription factors"		"Activator, DNA-binding, Methyltransferase, Repressor, Transferase"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 17.7;testis: 23.3"	"Cell type enhanced"	"Detected in some"	7	"Cytotrophoblasts: 3.7;Extravillous trophoblasts: 3.8;Horizontal cells: 4.8;Sertoli cells: 6.5;Syncytiotrophoblasts: 4.0"	"Cancer enriched"	"Detected in all"	25	"testis cancer: 111.7"	"Low region specificity"	"Detected in some"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"BEWO: 55.3;CACO-2: 20.8;HEL: 21.7;K-562: 20.8;NTERA-2: 74.7;SuSa: 41.2"					"Low region specificity"	"Detected in some"			"HPA001595, HPA001803, CAB069896"	Enhanced		Supported	Nucleoplasm		NA	Yes			Nucleoplasm		"CAB069896: AB_2094115, HPA001595: AB_1847814, HPA001803: "	"unprognostic (7.65e-3)"	"unprognostic (3.52e-3)"	"unprognostic (1.17e-1)"	"prognostic unfavorable (5.04e-4)"	"unprognostic (3.42e-1)"	"unprognostic (7.27e-2)"	"unprognostic (4.39e-4)"	"unprognostic (4.18e-3)"	"unprognostic (8.60e-3)"	"unprognostic (8.48e-2)"	"unprognostic (6.79e-2)"	"unprognostic (4.65e-2)"	"prognostic unfavorable (1.87e-7)"	"unprognostic (6.62e-2)"	"unprognostic (1.00e-1)"	"unprognostic (1.50e-1)"	"unprognostic (6.55e-2)"	1.1	0.8	0.9	2.5	0.9	4.7	2.4	4.5	1.4	1.6	2.1	0.7	0.5	0.9	1.3	4.7	1.6	1.1	1.6	1.8	0.8	0.7	2.7	1.2	1.2	1.9	0.9	0.5	1.2	7.5	2.5	1.1	2.8	0.8	1.1	0.8	1.2	3.5	1.6	0.5	5.5	0.8	1.0	0.5	1.3	1.1	23.3	0.8	17.7	2.6	1.7	2.5	2.7	2.2	0.7	1.0	0.0	0.2	0.9	1.3	0.1	0.8	1.1	6.0	1.4	0.1	0.5	55.3	0.7	0.5	0.8	0.8	20.8	0.9	2.1	2.2	0.3	0.9	0.5	3.9	0.3	0.6	0.2	3.1	21.7	0.7	3.9	0.2	0.9	2.2	0.5	0.4	1.2	0.2	0.4	1.4	1.3	20.8	0.6	0.3	3.3	3.3	18.4	74.7	1.9	0.7	3.3	1.0	0.5	2.0	0.9	1.9	1.2	1.3	1.9	0.5	41.2	1.2	1.1	0.3	1.2	2.8	0.6	0.5	1.3	0.6	0.8	0.5	5.9	0.5	0.0	0.2	0.0	0.1	0.1	0.1	0.7	0.2	0.0	1.0	0.0	1.3	0.0	0.0	0.9	0.1	0.9	0.0	0.1	0.9	0.9	4.5	1.4	0.8	0.7	0.9	0.5	0.8	0.8	0.0	1.0	0.0	0.1	0.8	1.4	1.1	0.0	0.0	1.2	0.0	2.0	3.7	0.0	0.9	0.0	0.4	0.0	0.0	0.5	3.8	0.9	0.6	0.0	0.0	0.6	4.8	0.0	0.6	0.0	0.2	0.0	0.1	0.0	0.0	0.2	0.8	1.1	0.0	0.4	0.6	2.1	6.5	0.4	0.0	2.5	1.1	4.0	0.0	0.8	0.0
DNPEP	"ASPEP, DAP"	ENSG00000123992	"Aspartyl aminopeptidase"	Q9ULA0	2	219373527-219400022	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"		"Aminopeptidase, Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"Early spermatids: 334.9;Late spermatids: 344.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036398, HPA044860"	Enhanced		Supported	Cytosol		NA	NA		6200000	Cytosol		"HPA036398: AB_10970915, HPA044860: AB_10961275"	"unprognostic (3.71e-1)"	"unprognostic (6.45e-2)"	"unprognostic (1.26e-1)"	"unprognostic (1.05e-2)"	"unprognostic (1.55e-2)"	"unprognostic (2.75e-1)"	"unprognostic (2.54e-3)"	"unprognostic (3.34e-2)"	"unprognostic (2.44e-1)"	"unprognostic (3.49e-2)"	"unprognostic (1.61e-1)"	"unprognostic (6.13e-2)"	"unprognostic (1.67e-1)"	"unprognostic (5.63e-3)"	"unprognostic (3.49e-1)"	"unprognostic (2.50e-1)"	"unprognostic (1.85e-3)"	20.1	12.3	8.8	15.5	10.4	7.2	20.0	7.2	9.3	16.5	30.4	8.6	13.8	27.9	15.1	13.3	16.9	15.3	16.6	22.9	10.4	6.8	21.2	33.5	15.5	11.7	10.5	7.2	19.4	19.0	9.7	11.0	28.5	9.4	21.0	15.8	15.9	18.7	14.7	36.6	14.6	50.3	12.9	6.8	17.5	15.2	33.7	9.3	11.3	15.0	20.0	17.4	20.7	13.1	11.6	16.1	5.8	15.0	15.7	15.7	10.9	16.2	8.9	5.5	16.2	14.5	12.0	43.5	8.1	16.4	21.1	22.4	24.6	21.4	10.0	17.5	16.8	27.1	15.9	6.5	18.5	7.6	19.4	4.7	16.0	9.1	26.7	38.6	13.3	11.5	19.5	19.7	21.7	18.2	13.6	14.4	13.4	18.0	15.9	10.8	35.3	20.2	14.8	9.0	23.2	5.6	26.3	12.5	13.1	11.8	25.3	6.9	9.3	9.4	31.1	11.4	10.0	9.1	14.7	8.0	20.3	16.8	10.6	11.6	17.9	10.5	7.0	28.9	12.7	8.6	5.8	13.2	5.4	13.6	15.0	15.4	10.2	11.0	15.0	16.1	11.6	12.0	15.7	1.0	15.7	12.2	5.8	12.6	10.9	8.8	10.4	7.2	9.3	10.4	6.8	10.5	7.2	9.4	9.3	11.9	15.6	23.5	61.6	34.3	15.9	28.8	33.1	8.1	11.4	24.4	31.4	76.5	41.4	49.0	334.9	40.7	74.6	0.0	57.6	79.5	42.3	44.7	24.2	41.8	45.2	9.5	46.1	28.8	28.6	344.5	48.6	32.0	30.4	58.7	90.9	28.2	48.4	66.2	38.5	58.6	36.0	25.8	49.1	17.0	16.6	39.1	55.5	30.8	58.7	65.4
DNTT	TDT	ENSG00000107447	"DNA nucleotidylexotransferase"	P04053	10	96304396-96338564	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Terminal addition"	"Nucleotidyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	7	"lymphoid tissue: 171.0"	"Group enriched"	"Detected in some"	4	"Early spermatids: 10.3;Late spermatids: 4.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	14	"naive B-cell: 1.2;naive CD4 T-cell: 4.5"	"Group enriched"	"Detected in many"	15	"B-cells: 1.2;T-cells: 4.5"	"Group enriched"	"Detected in some"	5	"MOLT-4: 49.7;REH: 172.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA036532, HPA044194"			Supported	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA036532: , HPA044194: AB_10960525"								"unprognostic (4.24e-1)"					"unprognostic (1.00e-1)"		"unprognostic (2.60e-2)"	"unprognostic (1.86e-2)"		0.0	0.0	0.1	0.1	0.3	24.7	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.1	0.0	0.0	0.3	0.2	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.3	0.0	2.7	0.0	171.0	0.6	0.0	2.1	0.0	0.0	1.2	0.1	0.0	0.0	0.0	4.5	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	24.4	0.0	0.0	0.0	0.0	49.7	0.0	0.0	0.0	0.0	172.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	1.2	4.5	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.1	0.3	0.0	0.1	0.1	0.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.7	0.0	0.0	4.5	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0
DOHH	"HLRC1, MGC4293"	ENSG00000129932	"Deoxyhypusine hydroxylase"	Q9BU89	19	3490822-3500940	"Enzymes, Predicted intracellular proteins"	"Hypusine biosynthesis"	"Monooxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"							"Low region specificity"	"Detected in all"			"HPA041953, HPA076271"	Approved		Approved	Nucleoplasm,Nucleoli,Cytosol		NA	NA			Cytosol	"Nucleoplasm, Nucleoli"	"HPA041953: AB_10795386, HPA076271: "	"unprognostic (1.28e-1)"	"unprognostic (1.18e-1)"	"unprognostic (8.63e-2)"	"prognostic favorable (2.24e-4)"	"unprognostic (3.66e-1)"	"unprognostic (2.01e-2)"	"unprognostic (9.45e-2)"	"unprognostic (7.26e-2)"	"unprognostic (4.65e-2)"	"unprognostic (1.13e-1)"	"prognostic favorable (3.58e-4)"	"unprognostic (9.87e-3)"	"unprognostic (1.14e-3)"	"unprognostic (4.35e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.66e-1)"	"unprognostic (3.76e-3)"	8.1	6.5	10.5	6.6	13.0	9.3	3.4	5.5	13.0	3.9	5.5	6.9	2.6	18.9	3.7	4.1	4.1	3.1	4.9	5.1	14.9	9.1	6.0	6.4	4.0	4.5	18.2	6.2	3.8	7.6	3.8	3.9	3.8	8.4	5.1	2.0	3.2	6.0	4.0	23.1	7.0	12.3	2.4	25.5	5.9	7.3	4.2	6.1	4.7	2.9	7.8	4.5	3.1	4.7	11.6	11.0	1.8	6.6	6.9	12.3	4.4	9.2	11.0	1.7	3.6	0.9	1.1	7.4	8.8	1.8	4.3	3.4	15.3	3.8	7.2	6.9	1.3	3.9	9.6	2.7	3.0	0.9	10.6	12.4	7.5	6.2	18.2	3.5	10.0	10.5	1.2	3.0	4.2	1.8	1.5	2.2	8.0	16.3	8.5	1.7	10.5	10.8	11.4	9.8	3.7	14.9	12.3	4.0	10.4	2.6	5.2	10.5	7.7	6.2	5.5	8.8	0.8	7.5	5.5	5.0	5.4	7.4	14.3	16.1	11.3	8.2	9.6	6.4	22.8	6.4	1.1	5.3	1.8	6.2	6.2	8.1	8.1	8.5	12.3	8.7	11.6	12.3	10.4	0.3	6.9	6.6	11.0	9.6	4.4	10.5	13.0	5.5	13.0	14.9	9.1	18.2	6.2	8.4	6.1	6.0	2.1	18.5	14.9	20.9	17.4	7.1	10.2	1.4	2.3	5.2	9.8	25.8	18.3	21.7	7.1	12.1	9.7	0.0	18.5	26.0	13.9	16.8	13.8	8.2	19.0	23.8	12.6	11.1	7.2	17.2	13.0	8.6	18.6	24.4	11.0	13.1	19.1	14.4	14.2	23.9	11.8	0.0	13.7	11.1	12.3	24.1	29.1	12.8	16.1	15.3
DOLK	"DK1, KIAA1094, TMEM15"	ENSG00000175283	"Dolichol kinase"	Q9UPQ8	9	128945530-128947619	"Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins"		"Kinase, Transferase"	"Congenital disorder of glycosylation, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA066767, HPA068706"			Supported	Nucleoplasm,Nucleoli,Cytosol		NA	NA			"Nucleoplasm, Nucleoli"	Cytosol	"HPA066767: AB_2732751, HPA068706: AB_2732118"	"unprognostic (6.35e-2)"	"unprognostic (2.69e-1)"	"unprognostic (2.63e-1)"	"unprognostic (1.30e-3)"	"unprognostic (3.55e-1)"	"unprognostic (2.81e-3)"	"unprognostic (8.90e-3)"	"unprognostic (3.26e-1)"	"unprognostic (1.02e-1)"	"unprognostic (3.01e-1)"	"unprognostic (8.83e-3)"	"unprognostic (1.83e-2)"	"prognostic favorable (5.53e-4)"	"unprognostic (3.20e-2)"	"unprognostic (1.06e-1)"	"prognostic favorable (6.88e-5)"	"unprognostic (6.13e-3)"	11.0	20.2	7.9	7.8	13.8	1.4	9.5	7.0	18.6	9.8	8.6	14.9	7.1	8.8	12.4	16.8	10.9	10.8	10.8	12.0	7.6	9.9	17.5	22.0	10.6	10.6	8.1	6.7	13.2	16.9	19.2	8.0	19.5	16.3	12.3	8.0	14.2	15.5	12.8	7.9	11.4	10.9	11.1	5.9	11.6	12.4	22.4	6.0	12.5	11.0	11.9	12.1	10.4	7.3	9.4	14.2	5.6	16.4	9.8	13.7	9.0	5.1	19.3	6.8	10.1	20.2	10.7	9.3	10.8	17.5	13.3	9.9	15.1	8.2	2.8	5.7	15.6	18.8	36.7	9.3	13.5	6.9	4.7	8.1	3.5	13.3	10.9	20.5	3.8	6.3	14.8	12.5	14.3	7.9	7.8	12.9	4.1	8.6	4.6	14.3	25.4	3.1	3.2	8.8	14.8	12.0	3.2	9.0	11.2	11.9	7.8	6.3	7.0	14.3	11.8	6.3	6.7	20.6	5.1	10.7	12.0	4.3	15.1	8.8	4.4	10.8	2.9	11.3	3.5	9.1	2.3	13.5	5.6	10.2	13.3	9.1	9.4	9.2	11.2	14.2	9.2	12.1	12.3	2.1	9.8	16.4	8.1	13.7	9.0	7.9	13.8	7.0	18.6	7.6	9.9	8.1	6.7	16.3	6.0	6.0	2.6	1.5	3.2	1.5	9.0	3.0	7.6	6.7	3.4	7.0	7.9	21.7	0.0	14.1	10.7	8.3	6.2	0.0	12.3	14.0	5.6	3.1	1.1	8.3	11.4	4.8	1.2	17.2	6.9	2.8	11.2	2.7	3.3	1.8	3.8	11.2	10.4	5.8	5.6	7.2	6.5	0.0	4.1	24.0	14.9	1.1	15.2	1.9	5.5	1.7
DOLPP1	LSFR2	ENSG00000167130	"Dolichyldiphosphatase 1"	Q86YN1	9	129081100-129090438	"Enzymes, Predicted membrane proteins"		Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Enterocytes: 26.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA019179	Approved		Approved	"Vesicles,Intermediate filaments"		NA	NA			Vesicles	"Intermediate filaments"	"HPA019179: AB_1847827"	"unprognostic (1.32e-2)"	"unprognostic (1.23e-1)"	"unprognostic (3.89e-1)"	"unprognostic (6.12e-3)"	"unprognostic (3.11e-1)"	"unprognostic (2.63e-2)"	"unprognostic (3.18e-1)"	"unprognostic (3.10e-2)"	"unprognostic (6.96e-2)"	"unprognostic (7.12e-2)"	"unprognostic (1.65e-1)"	"unprognostic (4.37e-3)"	"unprognostic (7.59e-3)"	"unprognostic (2.38e-2)"	"unprognostic (1.35e-1)"	"unprognostic (4.69e-2)"	"unprognostic (5.34e-2)"	6.4	12.8	10.0	6.8	10.6	7.7	6.8	11.7	19.3	8.3	17.1	17.7	8.6	28.6	6.0	7.4	18.8	6.6	9.2	4.1	10.1	10.7	9.4	21.8	6.7	6.6	13.2	10.6	7.7	10.5	10.4	6.9	11.6	12.5	10.0	14.2	6.1	10.3	5.8	5.2	10.3	27.7	6.3	15.2	8.5	11.8	12.2	11.0	9.4	6.3	8.5	9.1	7.8	8.0	8.8	12.5	9.8	8.3	7.9	21.7	7.2	4.1	16.0	15.7	14.4	5.3	4.5	18.2	10.3	6.0	19.6	11.0	20.6	13.9	8.1	9.1	6.4	15.0	30.3	16.1	8.6	8.3	9.4	9.9	10.6	10.8	15.7	9.4	11.0	13.2	4.9	12.1	12.8	10.2	4.5	8.7	15.1	17.5	8.1	5.5	21.0	12.5	11.4	13.5	30.9	13.0	14.8	12.7	14.5	7.1	6.7	18.0	11.8	13.0	11.8	4.3	9.6	21.7	7.3	7.1	16.9	8.1	15.9	13.9	10.1	19.4	12.3	7.5	2.2	11.1	4.4	6.8	9.8	8.9	8.1	21.7	8.8	10.9	10.8	8.5	6.0	11.1	10.5	1.4	7.9	8.3	12.5	10.1	7.2	10.0	10.6	11.7	19.3	10.1	10.7	13.2	10.6	12.5	11.0	6.0	4.6	3.7	2.9	2.1	3.2	1.6	5.1	0.0	2.3	1.8	5.9	16.9	1.7	5.9	0.5	2.4	26.6	0.0	8.4	11.4	3.3	2.7	5.7	17.0	6.5	3.2	3.5	6.2	3.8	0.4	2.0	2.3	5.0	4.6	9.0	9.1	5.4	13.3	3.9	3.8	3.4	0.0	3.1	4.5	8.7	3.4	13.7	3.8	12.2	3.4
DOT1L	"DOT1, KIAA1814, KMT4"	ENSG00000104885	"DOT1 like histone lysine methyltransferase"	Q8TEK3	19	2164149-2232578	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Chromatin regulator, DNA-binding, Methyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 64.7"	"Cell type enhanced"	"Detected in many"	5	"Cone photoreceptor cells: 62.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA011875, HPA071217, HPA074977"	Approved		Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"HPA011875: AB_2668552, HPA071217: AB_2686364, HPA074977: "	"unprognostic (1.41e-2)"	"unprognostic (1.44e-1)"	"unprognostic (2.26e-1)"	"prognostic favorable (1.69e-4)"	"unprognostic (1.08e-1)"	"prognostic favorable (6.00e-4)"	"unprognostic (2.53e-3)"	"unprognostic (2.21e-1)"	"unprognostic (1.57e-2)"	"unprognostic (1.67e-2)"	"unprognostic (5.25e-3)"	"unprognostic (8.18e-3)"	"unprognostic (2.56e-1)"	"unprognostic (1.73e-3)"	"unprognostic (1.43e-1)"	"unprognostic (1.12e-1)"	"unprognostic (1.67e-1)"	7.3	8.8	7.0	10.7	11.7	20.1	5.1	20.6	11.7	4.5	7.9	9.8	6.0	13.5	6.4	4.9	8.3	5.4	6.9	5.7	7.0	3.6	9.5	8.5	10.0	8.4	11.9	5.3	6.5	10.8	3.6	8.3	11.6	7.1	5.7	4.9	9.5	6.1	7.4	9.8	9.9	13.0	4.2	6.7	10.4	13.3	64.7	9.7	10.5	9.2	7.0	9.1	4.8	5.3	0.7	1.0	3.0	0.9	2.8	1.4	0.6	12.2	6.6	22.4	12.2	1.7	2.5	29.5	7.0	1.5	3.8	3.1	8.4	4.6	14.4	3.4	4.5	3.3	11.0	7.4	3.9	1.8	7.3	9.3	13.2	10.8	8.2	2.7	18.9	24.4	2.4	2.9	7.4	3.8	3.1	3.1	8.2	16.0	15.1	3.0	7.0	15.1	20.9	17.3	7.8	11.8	15.6	6.3	9.9	2.1	5.8	15.0	11.6	4.9	14.6	9.2	6.2	6.7	14.5	4.4	10.7	9.8	15.8	13.4	14.0	18.3	10.0	10.6	13.1	6.2	0.5	0.7	3.0	0.9	0.3	1.4	0.7	0.8	0.2	0.9	0.7	0.5	0.3	0.3	2.8	0.9	1.0	0.1	0.6	7.0	11.7	20.6	11.7	7.0	3.6	11.9	5.3	7.1	9.7	29.8	18.9	9.9	9.3	15.8	25.0	5.2	20.4	6.7	6.8	8.7	62.8	5.3	3.3	10.1	25.8	7.1	25.4	0.0	10.4	11.3	11.0	12.4	5.8	13.1	9.3	12.7	20.0	6.7	11.9	11.9	2.8	14.6	11.8	5.4	10.8	7.3	14.1	14.0	3.2	2.2	26.6	0.0	8.1	28.3	23.5	17.3	13.6	4.9	11.7	14.2
DPAGT1	"ALG7, CDG-Ij, D11S366, DGPT, DPAGT, DPAGT2, GPT"	ENSG00000172269	"Dolichyl-phosphate N-acetylglucosaminephosphotransferase 1"	Q9H3H5	11	119096503-119108331	"Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins"		"Glycosyltransferase, Transferase"	"Congenital disorder of glycosylation, Congenital myasthenic syndrome, Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA053878	Approved					NA	NA					"HPA053878: AB_2682288"	"unprognostic (1.66e-2)"	"unprognostic (3.14e-3)"	"unprognostic (1.76e-1)"	"unprognostic (7.83e-3)"	"unprognostic (6.50e-2)"	"unprognostic (8.53e-3)"	"prognostic unfavorable (2.03e-5)"	"unprognostic (2.52e-1)"	"unprognostic (3.95e-1)"	"unprognostic (9.05e-2)"	"unprognostic (2.08e-2)"	"unprognostic (7.12e-2)"	"unprognostic (2.19e-3)"	"unprognostic (1.87e-3)"	"unprognostic (1.08e-2)"	"unprognostic (2.52e-2)"	"unprognostic (4.57e-2)"	13.0	20.0	6.8	9.7	6.7	5.5	10.0	5.2	9.3	13.2	13.1	8.5	13.0	11.0	10.9	12.0	14.5	11.6	11.3	8.3	5.9	5.8	12.5	53.0	10.0	6.9	7.5	3.6	11.6	32.1	18.4	5.8	12.5	7.4	10.6	11.1	8.1	26.3	13.6	8.0	6.9	15.3	10.6	6.4	12.2	11.9	5.4	8.0	7.7	11.8	7.2	12.4	16.1	8.3	10.1	16.4	9.2	14.4	7.6	11.8	8.0	5.2	13.4	4.7	14.4	18.0	10.8	6.4	9.7	10.2	6.5	9.8	13.1	22.4	11.3	15.3	13.8	16.1	17.1	13.1	17.6	7.5	6.2	7.1	20.1	4.3	16.0	14.9	12.7	10.1	13.9	14.7	17.7	24.7	6.9	15.1	5.4	12.4	21.8	14.6	16.8	3.1	7.7	5.3	37.8	15.0	5.2	6.4	15.7	16.8	12.5	6.3	6.4	7.1	23.7	3.9	9.2	32.0	5.2	7.7	16.2	6.1	7.2	5.1	3.1	8.4	3.7	3.0	16.3	12.5	9.2	14.4	1.4	9.8	13.2	11.8	10.1	7.5	9.7	16.4	7.3	6.0	6.0	1.4	7.6	11.5	15.2	6.7	8.0	6.8	6.7	5.2	9.3	5.9	5.8	7.5	3.6	7.4	8.0	6.0	7.2	16.2	12.6	11.7	6.2	4.5	25.5	21.4	7.9	14.0	13.7	29.2	3.3	26.6	0.9	13.6	12.9	0.0	11.6	36.9	7.2	12.6	12.7	21.2	25.7	3.2	9.8	14.7	12.3	1.1	13.0	11.7	8.5	20.8	18.1	6.7	14.5	13.6	7.8	10.0	3.5	0.0	8.6	4.4	11.3	10.9	19.7	8.7	18.3	11.9
DPEP1		ENSG00000015413	"Dipeptidase 1"	P16444	16	89613308-89638456	"Enzymes, FDA approved drug targets, Predicted intracellular proteins"	"Lipid metabolism"	"Dipeptidase, Hydrolase, Metalloprotease, Protease"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	11	"intestine: 161.7;kidney: 52.2;pancreas: 100.5"	"Cell type enhanced"	"Detected in many"	26	"Leydig cells: 268.4;Peritubular cells: 1144.5;Proximal tubular cells: 391.6"	"Cancer enriched"	"Detected in many"	8	"colorectal cancer: 107.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"CACO-2: 5.2;Hep G2: 20.3;HHSteC: 9.2;U-937: 28.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA009426, HPA012783"	Enhanced		Approved	"Nucleoplasm,Cell Junctions"	"Intracellular and membrane"	NA	NA		270000	"Nucleoplasm, Cell Junctions"		"HPA009426: AB_1847842, HPA012783: AB_1847843"	"unprognostic (3.31e-2)"	"unprognostic (3.86e-1)"	"unprognostic (1.37e-1)"	"unprognostic (1.95e-2)"	"unprognostic (1.91e-2)"	"unprognostic (4.93e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.89e-1)"	"unprognostic (3.45e-2)"	"unprognostic (5.18e-1)"	"unprognostic (8.68e-2)"	"unprognostic (1.27e-1)"	"prognostic favorable (6.84e-4)"	"unprognostic (6.12e-3)"	"unprognostic (1.92e-1)"	"unprognostic (5.23e-2)"	"unprognostic (3.93e-2)"	0.1	0.4	0.1	0.9	0.1	0.0	0.1	0.1	0.1	1.5	53.6	0.1	0.4	16.1	0.2	3.4	0.3	0.1	0.9	0.1	0.1	0.1	52.2	0.1	0.3	0.9	0.1	0.1	0.2	100.5	0.0	0.2	0.1	0.2	0.1	0.0	0.2	0.3	0.4	0.1	0.4	161.7	0.1	0.1	0.9	0.2	9.8	0.1	0.2	0.1	0.1	0.5	0.6	0.3	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.5	0.1	0.0	1.1	0.1	2.8	0.0	0.0	0.0	0.0	5.2	0.1	0.0	1.9	0.0	0.0	0.0	0.1	0.0	0.0	1.3	0.4	0.0	0.0	20.3	9.2	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.2	0.6	0.7	2.1	0.0	0.0	0.0	1.8	0.0	0.0	0.6	0.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.9	0.0	0.0	0.1	0.1	0.0	28.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.2	0.1	3.0	2.6	14.9	0.0	0.5	3.3	0.3	0.0	0.0	1.2	22.7	0.0	0.1	48.0	0.3	10.3	0.1	4.2	0.0	171.7	0.3	4.5	0.0	1.1	0.0	0.5	0.0	8.5	1.8	0.0	29.1	268.4	1.7	5.0	1.8	1.9	0.0	43.8	11.5	1144.5	391.6	0.1	6.5	0.3	15.6	2.9	0.3	0.3	0.5	1.2	0.0
DPEP2		ENSG00000167261	"Dipeptidase 2"	Q9H4A9	16	67987394-68000586	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Lipid metabolism"	"Dipeptidase, Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 105.1"	"Cell type enhanced"	"Detected in many"	9	"Hofbauer cells: 29.3;Kupffer cells: 40.0;Macrophages: 33.7;Syncytiotrophoblasts: 45.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"basophil: 43.5;eosinophil: 105.1;neutrophil: 47.3"	"Lineage enriched"	"Detected in all"	7	"granulocytes: 105.1"	"Cell line enhanced"	"Detected in some"		"HEL: 4.4;HMC-1: 19.9;NB-4: 4.3;U-937: 6.6"					"Low region specificity"	"Detected in many"			HPA035644	Approved					NA	NA		260000000			"HPA035644: AB_10670164"	"unprognostic (8.81e-2)"	"unprognostic (7.84e-5)"	"unprognostic (1.35e-1)"	"unprognostic (1.42e-2)"	"unprognostic (1.92e-1)"	"unprognostic (6.66e-3)"	"unprognostic (1.03e-1)"	"unprognostic (5.47e-2)"	"unprognostic (3.69e-2)"	"unprognostic (1.68e-1)"	"unprognostic (6.01e-2)"	"unprognostic (1.46e-1)"	"unprognostic (3.91e-2)"	"unprognostic (5.75e-2)"	"prognostic unfavorable (8.47e-4)"	"unprognostic (7.78e-3)"	"unprognostic (3.91e-2)"	7.8	0.9	1.3	7.1	2.4	13.0	3.5	0.7	2.5	1.5	2.6	2.4	1.1	1.7	4.1	4.1	1.8	2.0	6.8	2.4	1.6	1.3	2.0	2.0	11.4	10.4	2.1	2.0	0.7	0.9	0.1	0.9	19.4	2.7	2.4	2.4	5.1	2.8	0.4	1.6	1.2	10.1	2.3	3.3	26.4	1.6	2.5	1.6	3.5	2.5	3.8	11.1	6.3	1.5	5.0	4.3	105.1	15.3	5.6	4.9	5.7	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.4	0.0	0.0	0.0	1.4	0.4	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.5	0.0	4.4	0.0	0.1	0.0	0.1	19.9	0.0	0.1	0.0	0.0	0.1	0.1	1.4	0.3	0.1	0.0	0.0	0.1	4.3	0.0	0.0	0.2	0.2	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	1.1	0.6	0.0	0.0	0.0	0.0	1.1	0.5	0.3	0.0	6.6	0.0	43.5	10.7	105.1	2.3	13.0	2.7	4.1	4.0	1.9	4.3	5.0	4.9	2.5	47.3	5.6	15.3	0.6	4.0	5.7	1.3	2.4	0.7	2.5	1.6	1.3	2.1	2.0	2.7	1.6	0.0	12.2	15.6	0.0	1.8	0.0	1.1	0.0	2.7	2.3	0.0	0.0	7.7	0.0	0.0	0.3	2.2	0.0	0.0	0.0	0.6	1.6	0.0	2.3	0.0	29.3	0.0	0.0	17.2	40.0	0.9	0.0	33.7	3.3	1.8	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.2	6.5	6.1	1.1	45.2	13.8	0.0	0.1
DPEP3		ENSG00000141096	"Dipeptidase 3"	Q9H4B8	16	67975663-67980829	"Enzymes, Predicted intracellular proteins"		"Dipeptidase, Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	6	"testis: 56.7"	"Group enriched"	"Detected in some"	7	"Spermatocytes: 154.2;Spermatogonia: 290.0"	"Group enriched"	"Detected in many"	10	"melanoma: 3.7;ovarian cancer: 16.9;testis cancer: 5.7"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"neutrophil: 9.2;NK-cell: 2.3"	"Group enriched"	"Detected in many"	7	"granulocytes: 9.2;NK-cells: 2.3"	"Cell line enriched"	"Detected in single"	11	"U-266/70: 4.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA031870, HPA058607"	Enhanced				"Intracellular and membrane"	NA	NA		16000000			"HPA031870: AB_2674079, HPA058607: AB_2683775"	"unprognostic (9.93e-2)"	"unprognostic (2.81e-3)"	"unprognostic (1.86e-1)"	"unprognostic (9.52e-2)"	"unprognostic (3.61e-2)"	"unprognostic (1.37e-2)"	"unprognostic (1.55e-1)"	"unprognostic (6.52e-2)"	"unprognostic (1.09e-1)"	"unprognostic (2.05e-2)"	"unprognostic (3.49e-3)"	"unprognostic (9.97e-2)"	"unprognostic (1.56e-1)"	"unprognostic (3.15e-3)"	"unprognostic (1.13e-1)"	"unprognostic (3.98e-2)"	"unprognostic (1.51e-1)"	0.2	0.0	0.1	0.4	0.4	1.0	0.6	0.1	0.3	0.0	0.1	0.1	0.0	0.2	0.0	0.4	0.0	0.0	0.6	0.0	0.3	0.1	0.0	0.1	0.2	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.9	0.1	0.0	0.2	0.3	0.1	0.1	0.0	0.5	0.0	0.4	1.4	0.2	56.7	0.1	0.0	0.0	0.2	0.1	0.2	0.0	0.8	0.1	9.2	0.5	2.3	0.8	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.9	0.2	0.0	0.0	0.0	0.0	0.0	0.4	1.3	0.0	0.5	0.3	0.4	0.0	0.0	0.1	0.8	0.8	0.3	9.2	2.3	0.1	0.0	0.0	0.3	0.1	0.4	0.1	0.3	0.3	0.1	0.1	0.0	0.9	0.1	0.0	0.0	0.5	0.0	0.1	0.0	0.8	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	13.9	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	1.9	30.4	4.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.0	25.8	0.0	154.2	290.0	0.0	0.2	0.0	0.0	0.0
DPH1	"DPH2L, DPH2L1, OVCA1"	ENSG00000108963	"Diphthamide biosynthesis 1"	Q9BZG8	17	2030110-2043430	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		Transferase	"Disease mutation, Dwarfism, Ectodermal dysplasia, Hypotrichosis, Mental retardation, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"	9	"Alveolar cells type 2: 8.6;Club cells: 4.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA069750, HPA073864"	Approved		Approved	"Nucleoplasm,Cell Junctions"		NA	NA			Nucleoplasm	"Cell Junctions"	"HPA069750: AB_2686188, HPA073864: "	"unprognostic (5.54e-2)"	"unprognostic (1.99e-1)"	"unprognostic (1.62e-1)"	"unprognostic (1.86e-2)"	"unprognostic (1.50e-2)"	"unprognostic (1.46e-1)"	"unprognostic (2.21e-1)"	"unprognostic (1.10e-1)"	"unprognostic (3.93e-2)"	"unprognostic (2.30e-1)"	"prognostic favorable (1.78e-5)"	"unprognostic (2.74e-3)"	"unprognostic (2.10e-2)"	"unprognostic (1.03e-1)"	"unprognostic (3.40e-1)"	"unprognostic (7.30e-2)"	"unprognostic (1.41e-1)"	16.6	22.9	17.6	19.0	22.7	10.3	17.0	38.6	26.5	17.8	17.1	17.2	21.1	17.0	22.2	17.0	17.9	29.0	22.6	20.2	14.1	13.1	21.4	32.7	15.7	22.7	17.0	21.6	25.2	29.4	28.4	42.9	17.3	15.4	26.1	13.3	21.3	25.7	23.9	33.3	29.0	17.3	18.9	11.4	17.8	18.4	19.5	19.9	17.5	21.0	25.8	19.0	17.2	16.0	11.3	9.3	0.7	6.8	5.6	12.0	5.5	9.1	16.1	4.4	10.7	13.8	10.1	12.2	12.1	18.2	20.6	13.4	15.4	7.5	17.9	15.7	35.8	7.9	7.3	14.8	13.6	11.2	4.6	33.9	4.1	7.6	9.2	13.1	5.2	6.8	15.1	13.9	16.5	13.4	14.7	9.3	10.4	14.0	7.4	8.1	12.1	9.1	3.4	4.1	11.2	16.5	10.6	3.1	13.9	9.2	5.7	8.3	9.7	10.9	12.5	12.1	4.3	18.1	4.3	6.4	14.4	6.6	17.7	10.9	7.3	5.0	4.4	14.2	7.1	5.0	0.0	4.6	0.7	9.5	6.8	10.4	11.3	7.8	8.6	9.3	9.5	12.0	8.7	0.3	5.6	4.6	6.7	10.4	5.5	17.6	22.7	38.6	26.5	14.1	13.1	17.0	21.6	15.4	19.9	3.0	8.6	0.0	0.8	0.3	1.9	1.3	0.0	2.7	4.5	0.0	2.0	1.2	0.0	0.4	0.9	0.6	0.4	0.0	0.5	0.7	1.3	0.5	2.3	0.0	0.5	1.6	0.0	0.6	0.0	1.0	0.6	1.0	0.0	0.0	0.3	1.0	0.0	0.0	0.4	0.4	3.0	0.0	1.2	0.7	0.3	0.3	1.1	0.7	0.4	0.6
DPH2	DPH2L2	ENSG00000132768	"DPH2 homolog"	Q9BQC3	1	43970000-43973369	"Enzymes, Predicted intracellular proteins"		Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA045796	Uncertain		Approved	Nucleoplasm		Yes	No			Nucleoplasm		"HPA045796: AB_2679456"	"unprognostic (2.41e-1)"	"unprognostic (1.15e-1)"	"unprognostic (4.20e-3)"	"unprognostic (9.13e-3)"	"unprognostic (3.83e-2)"	"unprognostic (1.30e-1)"	"prognostic unfavorable (1.17e-8)"	"unprognostic (1.38e-1)"	"unprognostic (1.81e-1)"	"unprognostic (3.72e-1)"	"unprognostic (2.49e-1)"	"unprognostic (3.42e-3)"	"unprognostic (2.60e-1)"	"prognostic favorable (1.37e-4)"	"unprognostic (1.38e-1)"	"unprognostic (2.41e-2)"	"unprognostic (6.37e-2)"	9.6	12.7	13.5	12.4	14.1	7.5	9.8	7.9	18.8	8.3	12.0	12.4	5.9	8.9	9.4	7.5	15.2	10.8	11.5	11.6	11.6	6.3	11.5	21.7	8.5	14.1	13.6	9.3	9.1	21.1	10.4	10.6	8.3	9.7	9.8	11.9	5.8	11.6	9.2	33.4	13.1	9.9	11.2	7.6	13.7	10.6	14.7	12.3	10.8	8.9	14.6	13.5	10.3	7.8	9.0	10.2	0.5	9.2	9.8	10.1	5.8	9.9	11.5	5.2	11.0	3.9	4.1	17.5	5.3	5.8	13.9	11.4	14.6	9.8	16.8	9.1	5.5	7.2	11.5	17.4	15.1	7.5	11.5	15.2	17.3	14.4	15.1	10.3	19.9	9.8	6.3	16.9	16.4	9.1	4.2	9.6	13.4	21.8	9.5	6.9	11.6	17.6	11.0	35.9	16.7	13.2	15.2	11.9	27.2	8.7	8.0	17.9	20.7	7.0	17.8	12.9	7.3	7.5	13.8	6.2	6.7	15.4	11.8	21.1	23.3	38.5	17.2	6.0	22.2	9.8	0.0	6.6	0.3	6.7	9.2	9.9	9.0	6.8	6.9	10.2	8.8	7.0	10.1	0.5	9.8	4.7	8.5	6.6	5.8	13.5	14.1	7.9	18.8	11.6	6.3	13.6	9.3	9.7	12.3	0.0	3.7	17.1	9.7	20.4	6.3	8.5	10.2	6.7	3.4	1.8	9.8	12.3	5.0	14.8	0.3	6.0	2.5	0.0	16.3	12.3	7.0	9.4	4.6	4.2	7.7	3.2	11.5	3.1	1.8	0.9	7.8	5.0	5.0	10.8	6.5	4.5	11.7	0.0	3.5	7.3	5.5	0.0	11.2	8.6	27.1	23.7	7.2	6.9	11.8	8.0
DPH5	CGI-30	ENSG00000117543	"Diphthamide biosynthesis 5"	Q9H2P9	1	100989623-101026088	"Enzymes, Predicted intracellular proteins"		"Methyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA046439, HPA076234"	Approved		Approved	"Nucleoli,Golgi apparatus"		NA	NA			"Golgi apparatus"	Nucleoli	"HPA046439: AB_2679667, HPA076234: AB_2797274"	"unprognostic (1.31e-1)"	"unprognostic (3.37e-2)"	"unprognostic (1.98e-2)"	"unprognostic (7.82e-2)"	"unprognostic (1.22e-2)"	"unprognostic (2.23e-1)"	"unprognostic (2.81e-2)"	"unprognostic (3.57e-2)"	"unprognostic (8.59e-2)"	"unprognostic (8.12e-2)"	"unprognostic (1.37e-2)"	"unprognostic (2.56e-1)"	"unprognostic (1.58e-2)"	"unprognostic (2.15e-1)"	"unprognostic (7.09e-2)"	"unprognostic (1.88e-1)"	"unprognostic (9.00e-2)"	12.6	21.5	11.2	9.1	19.0	7.9	21.4	10.4	11.9	17.3	12.8	11.5	13.2	6.8	20.6	19.0	16.1	19.3	10.0	19.2	11.2	11.9	14.1	18.1	8.5	15.2	11.9	11.4	39.0	28.4	15.5	31.7	9.3	12.3	15.3	13.7	10.8	16.1	12.7	16.8	11.5	9.2	15.4	16.7	13.6	11.5	9.2	11.3	22.2	18.4	15.5	17.7	14.4	14.7	12.1	8.4	3.3	6.2	14.9	16.2	6.7	9.6	8.8	13.1	12.8	16.2	46.2	11.3	8.5	14.0	12.5	10.6	10.5	2.4	17.0	11.4	7.2	7.8	6.3	14.6	13.0	18.4	7.1	10.7	8.9	8.5	19.9	25.3	10.8	4.7	31.0	18.9	11.7	38.0	24.1	18.6	11.8	19.9	5.4	18.8	8.3	13.2	10.6	10.6	5.2	13.8	12.2	19.1	9.8	14.1	7.4	15.2	7.4	4.7	13.1	37.7	10.4	8.5	6.4	9.4	7.4	10.4	10.7	11.2	6.4	7.4	10.4	10.1	10.2	2.7	3.3	5.1	2.6	11.1	5.5	15.1	12.1	12.3	12.1	8.4	9.6	16.2	14.8	1.9	14.9	6.2	6.2	8.2	6.7	11.2	19.0	10.4	11.9	11.2	11.9	11.9	11.4	12.3	11.3	6.0	10.5	39.8	17.8	14.1	5.0	21.8	17.8	20.1	7.9	7.0	0.0	22.0	19.9	12.0	1.2	11.3	3.4	0.0	15.9	23.6	15.8	9.8	25.3	25.4	17.0	1.6	9.8	13.5	29.4	1.5	25.0	11.3	11.8	26.2	11.4	15.8	10.5	17.5	13.1	22.8	6.2	6.5	10.3	16.4	16.4	15.7	10.9	20.0	23.2	6.3
DPH6	"ATPBD4, MGC14798"	ENSG00000134146	"Diphthamine biosynthesis 6"	Q7L8W6	15	35217345-35546193	"Enzymes, Predicted intracellular proteins"		Ligase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042976, HPA055496"	Approved		Enhanced	"Nucleoplasm,Nucleoli,Nucleoli rim"		NA	NA			"Nucleoli, Nucleoli rim"	Nucleoplasm	"HPA042976: AB_10964890, HPA055496: AB_2682835"	"unprognostic (9.78e-2)"	"unprognostic (1.45e-1)"	"unprognostic (1.92e-1)"	"unprognostic (1.14e-1)"	"unprognostic (1.82e-1)"	"unprognostic (1.45e-2)"	"unprognostic (1.60e-1)"	"unprognostic (9.94e-2)"	"unprognostic (1.76e-1)"	"unprognostic (1.49e-3)"	"unprognostic (7.92e-3)"	"unprognostic (1.13e-1)"	"unprognostic (4.65e-6)"	"unprognostic (9.70e-2)"	"unprognostic (5.61e-2)"	"unprognostic (2.18e-2)"	"unprognostic (7.44e-2)"	13.3	12.7	8.0	6.8	16.1	6.4	15.3	11.6	15.8	14.7	9.2	15.5	10.8	8.5	23.9	17.1	14.7	11.5	10.5	14.4	7.8	7.2	14.7	11.2	8.7	9.3	9.7	12.0	16.7	19.5	15.8	31.7	11.1	13.4	8.5	10.2	14.6	11.5	14.7	24.9	15.2	8.7	16.8	11.1	8.3	9.6	11.3	10.6	7.1	15.3	16.5	10.0	11.0	11.3	8.4	6.3	0.3	6.5	13.2	10.8	4.4	10.5	5.7	9.6	8.1	1.7	7.9	9.4	4.0	7.0	9.7	5.1	7.6	9.9	3.3	9.8	3.7	11.8	12.2	11.1	11.5	11.6	2.6	7.0	12.3	6.5	12.0	10.3	6.5	8.0	6.6	14.6	3.9	18.9	6.0	9.3	7.1	13.5	13.4	8.9	4.1	8.0	6.1	8.5	16.1	5.3	10.0	9.0	4.5	8.4	13.5	7.0	6.9	7.5	8.4	6.4	5.9	29.0	9.1	2.8	9.5	9.2	9.4	6.3	12.0	19.0	8.3	8.2	11.3	9.0	0.0	6.5	0.3	6.2	6.0	7.7	8.4	8.3	8.6	6.3	6.5	10.8	9.5	0.3	13.2	5.6	5.4	5.4	4.4	8.0	16.1	11.6	15.8	7.8	7.2	9.7	12.0	13.4	10.6	14.9	6.9	12.6	16.6	27.5	31.5	11.0	17.8	5.3	17.0	8.7	37.3	22.9	11.6	12.0	2.1	9.5	10.1	23.3	21.1	18.8	11.6	7.6	3.5	7.3	15.0	17.5	5.2	6.7	10.0	1.6	13.0	10.9	15.1	15.4	6.0	16.6	15.1	7.0	6.3	16.4	22.2	0.0	11.3	8.3	15.1	20.3	18.9	5.0	9.2	11.1
DPH7	"C9orf112, FLJ90634, RRT2, WDR85"	ENSG00000148399	"Diphthamide biosynthesis 7"	Q9BTV6	9	137554904-137578935	"Enzymes, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Rod photoreceptor cells: 57.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA022911	Uncertain		Approved	"Nuclear bodies"		Yes	No			"Nuclear bodies"		"HPA022911: AB_1858823"	"unprognostic (1.43e-1)"	"unprognostic (4.81e-2)"	"unprognostic (3.41e-2)"	"unprognostic (2.25e-2)"	"unprognostic (1.19e-1)"	"unprognostic (6.60e-3)"	"unprognostic (1.48e-2)"	"unprognostic (1.78e-1)"	"unprognostic (2.14e-2)"	"unprognostic (9.48e-2)"	"prognostic favorable (6.52e-4)"	"unprognostic (2.10e-2)"	"prognostic unfavorable (1.52e-5)"	"unprognostic (2.30e-3)"	"unprognostic (3.06e-2)"	"unprognostic (2.15e-1)"	"prognostic favorable (3.23e-4)"	8.2	12.7	12.1	14.0	16.4	8.2	10.7	15.9	17.8	13.3	12.7	21.5	14.3	5.9	14.2	17.8	9.4	18.2	10.3	12.6	14.0	7.6	11.1	11.0	10.4	13.0	19.1	11.5	17.3	20.8	14.1	14.9	10.5	12.8	15.6	11.9	10.8	16.1	15.4	9.6	13.5	12.2	14.6	9.0	16.0	11.8	10.1	18.6	11.2	13.8	5.8	13.9	10.9	11.7	10.8	14.2	15.6	9.2	9.3	13.5	8.8	7.1	7.5	12.2	10.9	8.8	6.7	14.1	7.1	6.9	12.0	10.2	14.9	7.1	14.0	12.8	7.4	8.9	17.1	14.1	12.1	9.6	11.2	16.5	5.9	10.1	5.4	10.0	13.2	12.7	6.9	10.8	8.0	15.2	9.8	15.9	11.1	11.8	7.5	8.3	20.2	10.0	14.4	14.0	25.8	15.9	17.9	6.4	11.4	9.9	6.7	13.9	12.6	10.9	9.3	7.9	7.7	13.4	13.1	7.5	9.5	7.7	10.9	13.6	6.2	11.9	15.6	4.9	9.1	8.9	15.6	8.9	9.7	10.9	9.2	11.6	10.8	13.5	12.7	10.4	9.5	11.5	11.7	2.3	9.3	6.4	14.2	9.3	8.8	12.1	16.4	15.9	17.8	14.0	7.6	19.1	11.5	12.8	18.6	6.0	14.0	13.7	10.0	14.8	19.0	12.6	5.1	9.4	7.9	1.8	47.1	18.3	3.3	8.7	1.3	11.7	5.1	0.0	8.1	11.4	11.8	10.7	10.4	5.8	10.5	15.9	6.4	8.6	5.7	4.5	15.3	6.9	8.5	10.8	10.6	17.1	10.1	8.0	14.9	4.2	57.2	19.4	13.0	20.5	25.6	16.6	10.2	16.2	13.9	9.1
DPM1	"CDGIE, MPDS"	ENSG00000000419	"Dolichyl-phosphate mannosyltransferase subunit 1, catalytic"	O60762	20	50934867-50958555	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		"Glycosyltransferase, Transferase"	"Congenital disorder of glycosylation, Congenital muscular dystrophy, Disease mutation, Dystroglycanopathy"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			HPA051818	Approved					NA	NA					"HPA051818: AB_2681624"	"unprognostic (2.21e-2)"	"unprognostic (4.94e-2)"	"unprognostic (1.16e-1)"	"unprognostic (4.24e-3)"	"unprognostic (1.65e-1)"	"unprognostic (3.27e-2)"	"prognostic unfavorable (1.94e-6)"	"unprognostic (1.10e-1)"	"unprognostic (7.49e-2)"	"unprognostic (2.53e-2)"	"unprognostic (1.29e-2)"	"unprognostic (3.61e-2)"	"unprognostic (3.02e-3)"	"unprognostic (4.98e-2)"	"unprognostic (2.59e-1)"	"unprognostic (3.58e-1)"	"unprognostic (2.74e-1)"	32.3	39.7	20.2	23.3	30.0	32.9	29.0	22.5	35.1	31.1	28.1	21.3	28.9	24.0	29.9	32.9	36.0	25.6	24.0	38.7	22.2	21.5	41.7	54.0	24.2	33.0	21.6	17.2	30.8	38.9	21.2	35.1	43.9	31.4	29.8	28.9	22.8	35.9	31.5	44.7	27.1	35.6	24.9	21.1	38.6	30.4	25.6	21.7	36.1	34.5	49.1	36.4	35.3	28.3	20.7	25.0	22.2	19.6	20.3	25.1	15.7	35.1	14.3	22.1	13.1	19.2	21.9	24.3	13.9	16.0	27.0	21.4	64.3	28.5	21.5	30.4	18.0	37.5	40.5	17.7	33.1	27.5	10.3	14.1	22.3	18.5	43.3	27.4	35.2	13.4	18.7	49.0	18.7	19.5	17.6	20.6	23.0	33.5	27.2	26.8	15.5	31.9	37.3	22.5	33.5	32.6	17.7	32.3	28.4	26.9	21.3	16.6	18.2	36.1	53.2	46.5	17.6	36.3	41.8	17.0	34.7	28.9	20.4	28.7	19.4	24.6	30.8	38.3	23.6	15.7	12.2	16.8	18.6	19.0	19.6	23.0	20.7	21.8	20.3	21.9	19.3	23.7	25.1	22.2	20.3	18.9	25.0	21.0	15.7	20.2	30.0	22.5	35.1	22.2	21.5	21.6	17.2	31.4	21.7	17.9	40.2	52.1	126.5	103.5	11.0	36.2	20.4	77.6	43.3	29.6	2.0	133.8	99.5	63.9	164.3	51.0	28.1	0.0	64.4	83.7	58.2	65.2	73.8	70.4	77.2	4.8	22.5	57.7	38.4	28.0	52.6	51.7	47.2	68.5	43.2	26.1	60.1	46.0	48.4	73.6	10.2	71.1	61.3	110.0	113.4	92.2	205.3	55.3	48.2	127.0
DPP10	"DPL2, DPPY, DPRP3"	ENSG00000175497	"Dipeptidyl peptidase like 10"	Q8N608	2	114442299-115845752	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"			Asthma	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"adrenal gland: 15.6;brain: 30.3;pancreas: 23.4"	"Cell type enhanced"	"Detected in many"	9	"Cholangiocytes: 5.1;Early spermatids: 10.4;Extravillous trophoblasts: 7.3"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 5.1;HAP1: 7.6;HMC-1: 5.4;JURKAT: 4.1;NTERA-2: 4.6;RT4: 8.1;SCLC-21H: 12.0;SH-SY5Y: 4.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA048767	Uncertain					NA	NA					"HPA048767: AB_2680515"	"unprognostic (1.19e-1)"		"unprognostic (2.55e-2)"	"unprognostic (1.84e-1)"	"unprognostic (1.77e-2)"	"unprognostic (1.29e-1)"		"unprognostic (2.03e-2)"	"unprognostic (6.59e-2)"	"unprognostic (2.92e-1)"	"unprognostic (5.35e-2)"	"unprognostic (2.95e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.03e-2)"	"unprognostic (8.33e-2)"	"unprognostic (7.61e-2)"	"unprognostic (4.22e-2)"	0.7	15.6	13.4	1.1	15.9	0.9	0.9	1.9	30.3	1.3	3.6	7.9	0.0	2.4	1.4	0.8	0.8	0.9	1.9	0.8	17.5	9.9	1.1	0.9	1.0	0.7	7.1	21.3	0.9	23.4	0.7	1.5	1.8	10.8	0.8	4.6	0.0	1.0	0.8	0.7	0.9	2.4	1.9	12.7	0.7	1.5	2.1	10.3	0.0	1.6	0.0	0.8	0.7	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.4	0.0	0.0	0.0	0.0	0.0	0.0	4.1	0.1	0.0	0.0	0.0	0.0	0.0	4.6	0.0	0.0	0.0	0.0	0.0	0.0	8.1	12.0	4.8	0.0	0.0	0.0	1.5	0.0	0.5	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.4	15.9	1.9	30.3	17.5	9.9	7.1	21.3	10.8	10.3	0.0	0.0	0.0	0.0	0.0	2.7	1.4	5.1	0.0	1.2	0.0	0.0	1.1	0.0	0.0	10.4	0.0	0.4	0.0	2.3	7.3	0.2	0.0	0.0	0.0	0.3	4.8	4.1	0.6	0.0	4.3	0.3	0.0	1.7	0.0	1.3	1.4	1.2	0.0	0.0	0.0	0.5	0.0	0.0	1.7	1.1	0.0	3.7	0.0	2.9	0.0
DPP3		ENSG00000254986	"Dipeptidyl peptidase 3"	Q9NY33	11	66480013-66509657	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Aminopeptidase, Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035780, HPA035781"	Approved		Supported	Cytosol		NA	NA		2600000	Cytosol		"HPA035780: AB_2674778, HPA035781: AB_10669529"	"unprognostic (5.74e-2)"	"unprognostic (1.16e-3)"	"unprognostic (2.62e-3)"	"unprognostic (4.77e-2)"	"unprognostic (1.99e-1)"	"unprognostic (5.44e-3)"	"unprognostic (1.67e-3)"	"unprognostic (1.25e-3)"	"unprognostic (1.73e-2)"	"unprognostic (9.87e-2)"	"unprognostic (1.02e-2)"	"unprognostic (3.87e-1)"	"unprognostic (5.85e-2)"	"prognostic favorable (1.34e-4)"	"unprognostic (1.81e-2)"	"unprognostic (3.43e-1)"	"unprognostic (5.66e-2)"	10.4	13.0	5.2	16.8	12.1	10.9	16.9	13.7	11.5	7.3	18.5	9.1	10.3	15.3	10.5	6.8	15.6	7.1	15.7	8.4	9.3	5.9	18.4	31.1	9.8	20.0	9.5	10.6	5.1	11.6	11.2	6.9	10.9	7.4	10.3	16.9	5.7	17.6	8.5	15.8	9.4	15.5	10.0	10.6	12.5	11.8	15.5	6.7	16.1	10.5	10.8	14.0	11.4	8.6	7.5	19.7	12.2	24.4	18.2	17.9	9.9	28.7	25.1	11.6	12.9	9.7	10.5	18.1	16.3	22.0	22.1	14.8	31.5	24.2	16.8	55.7	18.4	18.9	26.0	18.5	20.0	14.3	31.8	8.4	21.8	11.7	18.5	15.0	26.4	36.4	14.8	19.6	16.6	8.2	9.6	16.9	17.7	15.2	10.0	20.1	32.7	30.7	26.9	19.7	28.3	15.3	21.7	11.7	27.5	19.0	24.8	22.0	18.9	13.9	16.3	21.8	11.4	25.2	15.4	17.5	13.3	14.4	14.5	15.9	8.4	15.2	19.1	17.6	12.6	16.2	9.6	11.3	12.2	13.7	24.4	8.4	7.5	10.3	11.4	19.7	7.2	6.3	9.2	2.0	18.2	16.0	13.7	17.9	9.9	5.2	12.1	13.7	11.5	9.3	5.9	9.5	10.6	7.4	6.7	14.9	10.4	20.5	13.8	5.4	10.0	2.8	15.3	9.4	4.5	22.7	9.8	41.2	11.6	43.1	21.0	5.5	31.6	0.0	53.9	28.6	7.1	11.6	1.1	12.4	33.3	6.4	17.9	4.3	7.9	5.3	2.0	12.8	15.1	46.9	17.1	16.1	36.9	21.5	4.9	22.4	61.1	12.9	4.6	7.5	22.2	5.3	30.1	14.9	23.0	17.3
DPP4	"ADCP2, CD26, DPPIV"	ENSG00000197635	"Dipeptidyl peptidase 4"	P27487	2	161992241-162074542	"CD markers, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"	"Cell adhesion"	"Aminopeptidase, Hydrolase, Protease, Receptor, Serine protease"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 133.1;parathyroid gland: 75.5"	"Cell type enhanced"	"Detected in many"	9	"Cytotrophoblasts: 134.1;Proximal tubular cells: 80.1;Syncytiotrophoblasts: 143.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"Cell type enhanced"	"Detected in many"		"MAIT T-cell: 26.7"	"Lineage enriched"	"Detected in many"	10	"T-cells: 26.7"	"Cell line enhanced"	"Detected in many"		"ASC diff: 42.8;ASC TERT1: 43.4;BJ hTERT+: 39.8;RPTEC TERT1: 58.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"CAB045970, HPA068778, HPA071236"	Enhanced				"Secreted in other tissues"	NA	NA		170000000			"CAB045970: AB_11140529, HPA068778: , HPA071236: "	"unprognostic (4.47e-2)"	"unprognostic (4.47e-2)"	"unprognostic (8.89e-2)"	"unprognostic (3.36e-1)"	"unprognostic (7.25e-2)"	"unprognostic (5.40e-2)"	"unprognostic (2.78e-1)"	"unprognostic (3.54e-2)"	"unprognostic (3.58e-1)"	"unprognostic (4.73e-1)"	"unprognostic (2.36e-1)"	"prognostic unfavorable (1.98e-4)"	"prognostic favorable (1.35e-6)"	"unprognostic (4.68e-2)"	"unprognostic (6.33e-2)"	"prognostic favorable (4.99e-4)"	"unprognostic (1.21e-2)"	9.5	2.9	0.3	3.2	0.5	0.0	5.0	0.3	1.4	2.2	50.0	0.2	36.9	19.1	2.2	3.5	1.2	1.2	5.2	2.1	0.4	0.3	29.1	12.2	5.4	2.1	0.4	0.2	2.7	1.8	75.5	0.3	24.0	0.2	21.1	2.8	0.6	46.9	38.8	2.4	4.4	133.1	0.9	0.8	5.0	1.2	0.6	0.1	6.2	1.0	1.4	1.1	1.0	2.6	0.1	2.1	0.3	0.0	2.6	26.7	2.5	0.0	0.0	0.1	0.0	42.8	43.4	0.1	7.9	39.8	2.2	7.7	8.0	0.2	0.0	3.0	13.7	7.4	0.2	0.1	0.0	1.3	2.5	0.1	0.0	0.0	11.9	17.4	0.0	0.0	4.9	0.0	13.4	0.1	2.0	1.3	0.1	0.0	0.0	0.7	0.0	0.7	0.1	0.4	0.3	16.4	0.0	0.0	0.1	58.0	0.0	0.0	0.1	0.0	0.0	0.0	0.9	0.0	0.0	7.1	4.6	0.2	0.2	0.0	0.0	0.0	0.0	4.7	0.0	0.0	0.0	0.0	0.0	3.2	0.0	26.7	0.1	8.3	5.2	0.6	0.0	8.3	3.3	0.3	2.6	0.0	2.1	0.9	2.5	0.3	0.5	0.3	1.4	0.4	0.3	0.4	0.2	0.2	0.1	6.0	17.5	0.0	0.3	3.7	1.7	4.0	12.7	4.0	4.5	14.0	9.8	134.1	1.7	3.1	13.0	3.9	21.3	0.0	0.0	52.7	45.7	38.3	12.8	39.9	12.7	0.0	53.0	12.3	1.6	6.2	0.0	4.6	5.0	1.0	11.0	0.0	0.9	11.4	0.0	80.1	0.0	0.0	1.0	2.1	0.8	3.6	143.8	11.4	12.8	0.3
DPP6	"DPL1, DPPX"	ENSG00000130226	"Dipeptidyl peptidase like 6"	P42658	7	153887097-154894285	"Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins, Transporters"			"Disease mutation, Mental retardation, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 45.7;endometrium 1: 24.5;thyroid gland: 24.1"	"Cell type enhanced"	"Detected in many"	11	"Early spermatids: 13.3;Horizontal cells: 30.2;Late spermatids: 16.0;Melanocytes: 15.1;Muller glia cells: 18.7"	"Cancer enriched"	"Detected in some"	11	"glioma: 12.1"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Cell line enriched"	"Detected in some"	9	"NTERA-2: 11.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA050509	Enhanced	Supported				NA	NA					"HPA050509: AB_2681150"	"unprognostic (1.29e-1)"	"unprognostic (3.55e-2)"	"unprognostic (5.68e-2)"	"unprognostic (5.86e-2)"	"unprognostic (1.53e-2)"	"unprognostic (2.28e-1)"	"unprognostic (2.73e-1)"	"unprognostic (5.83e-4)"	"unprognostic (1.55e-1)"	"unprognostic (2.98e-1)"	"unprognostic (7.45e-3)"	"unprognostic (4.04e-3)"	"unprognostic (2.94e-3)"	"unprognostic (1.85e-4)"	"unprognostic (1.05e-1)"	"unprognostic (4.61e-3)"	"unprognostic (6.11e-2)"	1.6	7.2	15.4	1.4	32.5	1.3	1.5	26.6	45.7	2.3	6.8	8.7	0.0	1.6	24.5	3.1	1.5	4.6	1.3	1.4	26.6	15.2	3.6	1.2	2.2	1.3	14.0	22.7	1.3	4.0	1.2	4.9	1.3	18.8	1.5	2.4	0.4	1.3	8.1	4.6	3.7	2.0	15.8	7.2	4.2	3.5	7.9	10.0	0.0	24.1	0.0	1.2	1.3	0.4	0.6	0.6	1.9	0.9	0.9	0.7	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.3	0.2	11.3	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.6	1.2	0.0	0.1	0.0	0.5	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.1	1.9	0.4	0.7	0.4	0.6	0.7	0.6	0.6	0.4	0.4	0.6	0.7	0.7	1.6	0.9	0.9	0.6	0.5	0.3	15.4	32.5	26.6	32.4	26.6	15.2	14.0	22.7	18.8	10.0	0.0	0.0	0.0	0.4	3.0	9.3	5.9	0.0	1.4	2.3	0.0	0.0	0.0	0.0	0.1	13.3	0.0	0.0	0.0	3.6	0.0	0.3	0.1	0.0	0.0	0.2	30.2	9.9	0.0	0.0	16.0	1.1	0.0	15.1	0.0	0.2	18.7	0.5	0.0	3.5	0.3	6.0	0.0	0.3	0.9	1.7	1.4	0.0	0.0	0.0	0.1
DPP7	"DPP2, DPPII"	ENSG00000176978	"Dipeptidyl peptidase 7"	Q9UHL4	9	137110542-137115177	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Aminopeptidase, Hydrolase, Protease, Serine protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	8	"Late spermatids: 751.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"RPMI-8226: 57.2;THP-1: 54.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021282, CAB025541, HPA059381"	Enhanced		Supported	"Golgi apparatus,Vesicles"	"Intracellular and membrane"	NA	NA		1300000	"Golgi apparatus, Vesicles"		"CAB025541: , HPA021282: AB_1847673, HPA059381: AB_2683999"	"unprognostic (1.15e-1)"	"unprognostic (5.54e-2)"	"prognostic unfavorable (6.07e-6)"	"unprognostic (6.78e-3)"	"unprognostic (1.25e-1)"	"unprognostic (8.33e-2)"	"unprognostic (7.49e-2)"	"unprognostic (6.10e-2)"	"unprognostic (2.28e-2)"	"unprognostic (5.71e-3)"	"prognostic favorable (8.31e-5)"	"unprognostic (7.99e-2)"	"unprognostic (1.46e-2)"	"unprognostic (2.56e-2)"	"unprognostic (1.72e-1)"	"unprognostic (2.15e-1)"	"unprognostic (1.02e-1)"	28.1	45.2	23.7	23.4	35.3	31.8	20.8	23.5	27.5	21.5	22.0	24.9	40.7	23.2	17.5	35.8	19.1	27.0	30.2	44.7	24.6	29.2	21.0	29.9	25.6	34.8	29.7	25.9	14.3	55.4	23.3	42.5	21.9	24.2	28.8	6.9	32.8	73.1	41.6	25.3	26.9	17.8	22.8	21.7	29.1	24.4	30.9	26.8	18.9	41.2	17.5	24.7	21.3	16.6	20.0	60.8	12.2	43.1	19.2	36.8	38.2	6.9	11.0	0.9	0.9	13.6	10.9	1.4	10.5	17.2	7.0	4.6	10.4	5.7	13.7	11.5	6.9	0.3	15.0	8.0	2.1	0.3	13.4	0.5	6.3	15.2	0.3	30.5	16.9	35.2	13.4	8.3	3.0	6.3	10.2	9.1	17.0	13.8	10.7	4.6	19.2	8.5	16.2	3.7	25.2	10.8	12.5	0.1	57.2	11.1	7.7	17.6	12.2	12.1	31.9	29.7	0.2	11.4	54.9	11.0	17.9	6.1	11.3	7.2	13.2	7.5	3.7	21.4	10.3	8.0	6.8	43.1	12.2	34.4	37.6	35.5	19.7	31.1	29.6	41.7	20.0	28.1	25.1	2.6	19.2	22.6	60.8	36.8	38.2	23.7	35.3	23.5	27.5	24.6	29.2	29.7	25.9	24.2	26.8	50.6	79.4	78.5	85.1	59.5	68.6	52.7	58.6	42.8	46.6	50.6	33.4	44.8	31.5	93.8	230.4	57.3	44.4	23.3	59.4	85.7	82.6	106.0	74.8	62.7	275.2	114.4	84.6	55.3	148.6	751.7	143.8	125.9	158.6	165.1	27.0	123.1	65.3	48.9	159.1	69.0	73.5	51.8	56.5	57.7	46.0	56.8	43.0	127.1	37.4	74.0
DPP8	"DP8, DPRP1, FLJ14920, FLJ20283, MGC26191, MSTP141"	ENSG00000074603	"Dipeptidyl peptidase 8"	Q6V1X1	15	65442463-65517704	"Enzymes, Plasma proteins, Predicted intracellular proteins"	Apoptosis	"Aminopeptidase, Hydrolase, Protease, Serine protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA008706	Approved		Supported	Cytosol		NA	NA			Cytosol		"HPA008706: AB_1078665"	"unprognostic (3.65e-1)"	"unprognostic (2.38e-2)"	"unprognostic (2.15e-1)"	"unprognostic (1.13e-1)"	"unprognostic (1.24e-1)"	"unprognostic (8.60e-2)"	"unprognostic (2.98e-1)"	"unprognostic (2.46e-1)"	"unprognostic (2.52e-2)"	"unprognostic (1.81e-1)"	"unprognostic (4.09e-2)"	"unprognostic (3.60e-2)"	"unprognostic (1.99e-2)"	"unprognostic (1.01e-1)"	"unprognostic (7.58e-2)"	"unprognostic (8.56e-2)"	"unprognostic (2.59e-1)"	15.6	16.1	16.4	14.9	18.8	16.2	13.9	22.9	24.9	15.5	14.5	15.0	12.7	18.0	15.9	13.9	13.1	11.1	12.4	18.8	15.1	14.6	16.0	9.9	13.3	16.0	15.4	11.8	16.2	11.7	22.2	14.5	15.9	21.7	13.5	15.8	13.9	15.6	20.8	30.5	14.2	16.5	16.2	17.5	17.2	13.2	29.9	15.8	22.5	17.4	12.5	16.0	16.2	13.2	10.7	8.1	20.0	10.8	6.1	10.3	5.3	9.6	15.6	10.3	10.3	11.6	16.6	8.8	15.5	18.4	13.9	13.4	6.7	8.3	17.0	12.2	19.4	9.5	17.9	19.8	11.2	17.1	14.3	12.3	16.3	12.0	6.4	12.1	21.0	16.1	12.4	10.7	11.3	10.7	11.7	15.2	13.2	11.1	15.8	17.1	7.8	11.2	7.7	7.0	9.8	8.0	14.9	19.0	16.5	11.4	21.0	7.3	12.9	10.1	10.2	15.6	10.6	9.4	12.6	19.2	18.7	13.0	8.8	16.5	20.5	26.8	17.2	14.1	21.2	13.4	20.0	9.1	11.1	9.9	9.2	10.3	9.2	8.6	9.5	8.1	10.7	8.6	9.2	18.3	6.1	10.8	7.5	8.9	5.3	16.4	18.8	22.9	24.4	15.1	14.6	15.4	11.8	21.7	15.8	32.8	24.7	23.1	12.5	11.8	24.3	36.8	25.5	22.7	27.3	14.0	35.3	16.6	19.9	19.2	44.1	27.4	20.3	0.0	26.0	12.3	17.3	17.3	25.6	14.7	18.7	27.0	24.9	43.0	34.3	48.6	27.0	25.3	21.9	30.7	28.3	29.5	29.2	21.0	27.6	24.1	27.0	19.4	17.5	62.7	22.3	17.7	14.8	26.2	24.3	20.9
DPP9		ENSG00000142002	"Dipeptidyl peptidase 9"	Q86TI2	19	4675224-4724673	"Enzymes, Predicted intracellular proteins"		"Aminopeptidase, Hydrolase, Protease, Serine protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"monocytes: 59.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HBEC3-KT: 64.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA036059	Approved		Supported	Cytosol		NA	NA			Cytosol		"HPA036059: AB_10671240"	"prognostic favorable (4.96e-4)"	"unprognostic (4.16e-2)"	"unprognostic (2.03e-1)"	"prognostic favorable (6.21e-5)"	"unprognostic (5.67e-2)"	"unprognostic (8.30e-2)"	"unprognostic (1.66e-1)"	"unprognostic (1.23e-1)"	"unprognostic (8.85e-2)"	"unprognostic (6.38e-2)"	"unprognostic (1.93e-1)"	"unprognostic (3.39e-2)"	"prognostic unfavorable (3.38e-8)"	"prognostic favorable (7.72e-5)"	"unprognostic (1.55e-1)"	"unprognostic (4.22e-1)"	"unprognostic (1.80e-1)"	18.1	11.9	11.7	24.3	14.0	25.8	13.7	13.0	12.5	12.6	16.3	14.2	15.8	18.3	15.3	10.5	17.4	11.6	13.5	19.7	11.0	7.2	13.5	38.6	19.3	20.7	14.7	7.1	13.5	15.5	9.5	9.8	15.2	11.7	14.0	13.1	14.2	13.1	12.9	46.4	21.5	18.9	14.2	9.3	21.0	14.7	7.1	13.9	24.3	14.6	16.3	17.0	16.0	21.7	10.3	9.0	10.0	10.5	13.4	13.8	8.0	23.8	19.0	5.6	8.8	8.6	12.1	10.2	14.0	18.7	23.6	15.4	17.1	18.5	11.3	10.6	18.1	15.9	16.3	11.4	64.4	14.5	14.5	11.1	8.3	10.4	14.6	13.2	14.4	18.0	9.2	15.0	36.9	21.9	20.2	21.3	7.9	11.3	25.3	20.4	6.5	16.7	9.3	11.5	9.4	28.3	10.5	12.0	13.2	12.3	16.4	8.0	7.2	12.0	21.9	9.2	6.1	6.0	12.0	17.1	21.2	9.2	32.8	27.9	17.6	18.3	11.3	20.7	16.7	17.7	10.0	8.8	9.4	13.8	10.5	10.5	10.3	6.4	11.2	9.0	6.8	6.3	9.9	4.7	13.4	7.8	4.3	11.3	8.0	11.7	14.0	13.0	12.5	11.0	7.2	14.7	7.1	11.7	13.9	26.8	29.1	13.7	11.9	7.0	17.1	12.0	10.2	10.7	11.4	3.5	35.3	10.0	3.3	10.7	1.5	13.5	25.1	0.0	10.9	15.2	7.6	11.0	16.2	35.9	17.2	22.3	12.0	16.5	14.6	2.5	9.2	20.7	5.0	59.5	15.3	8.4	19.7	21.0	8.9	4.5	30.0	19.4	8.1	7.6	6.9	4.8	13.0	18.7	13.7	11.9
DPYD	DPD	ENSG00000188641	"Dihydropyrimidine dehydrogenase"	Q12882	1	97077743-97995000	"Disease related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins"		Oxidoreductase	"Disease mutation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	11	"Hepatocytes: 50.8;Kupffer cells: 129.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB033241, HPA045210"	Uncertain					NA	NA		1300000			"CAB033241: AB_2094323, HPA045210: AB_2679256"	"unprognostic (2.33e-2)"	"unprognostic (1.69e-1)"	"unprognostic (9.82e-3)"	"unprognostic (1.04e-1)"	"unprognostic (1.13e-2)"	"unprognostic (8.81e-2)"	"unprognostic (2.86e-1)"	"unprognostic (3.05e-1)"	"unprognostic (1.56e-1)"	"unprognostic (9.29e-2)"	"prognostic unfavorable (6.27e-4)"	"unprognostic (6.54e-2)"	"unprognostic (5.32e-2)"	"unprognostic (1.43e-1)"	"unprognostic (3.43e-2)"	"unprognostic (3.71e-1)"	"unprognostic (2.25e-1)"	24.9	15.4	8.8	17.0	20.9	7.4	18.4	2.0	11.2	17.9	15.6	20.3	6.4	17.0	13.7	10.8	19.0	13.5	20.5	13.3	8.3	6.1	10.5	52.2	26.0	25.7	25.3	7.1	20.4	9.7	15.5	18.4	8.0	13.9	11.6	8.4	6.2	16.7	11.6	6.7	7.7	22.4	15.5	15.0	27.7	12.0	6.0	22.2	27.4	13.5	10.0	10.4	16.3	19.6	2.6	14.3	28.3	28.1	5.7	7.3	8.0	7.7	2.2	2.8	0.0	15.9	27.4	0.0	12.7	11.6	11.8	8.8	0.0	3.3	4.1	18.7	11.7	1.8	1.9	0.0	2.9	21.8	4.0	2.6	3.5	4.2	0.0	7.1	1.5	0.2	21.6	1.1	9.4	10.8	25.1	9.6	2.4	0.1	13.2	6.1	0.0	8.1	2.2	0.3	0.0	2.7	0.0	13.6	6.4	14.5	0.0	4.1	3.2	10.8	0.9	0.1	0.3	0.0	3.5	11.0	25.7	1.8	20.6	25.0	1.1	0.0	0.0	3.7	4.5	20.3	6.3	28.1	1.7	5.5	13.0	7.3	0.9	6.5	5.3	14.3	2.6	6.2	5.4	28.3	5.7	10.7	0.4	7.0	8.0	8.8	20.9	2.0	11.2	8.3	6.1	25.3	7.1	13.9	22.2	14.9	33.7	3.0	8.0	6.8	1.9	3.1	30.6	6.7	12.5	7.0	0.0	0.2	5.0	2.1	5.8	11.7	4.0	0.0	5.5	0.1	11.7	5.8	9.2	50.8	17.3	0.0	2.9	17.8	129.0	2.0	31.1	44.1	3.3	10.0	3.7	4.8	3.9	2.3	17.7	5.6	0.0	12.9	9.5	1.2	1.7	4.8	0.1	10.8	3.0	8.8
DPYS	DHPase	ENSG00000147647	Dihydropyrimidinase	Q14117	8	104330324-104467053	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		Hydrolase	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	15	"kidney: 42.2;liver: 103.6"	"Group enriched"	"Detected in some"	15	"Hepatocytes: 429.9;Proximal tubular cells: 408.7"	"Group enriched"	"Detected in some"	21	"liver cancer: 57.6;renal cancer: 11.6"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"intermediate monocyte: 1.2"	"Lineage enriched"	"Detected in single"	13	"monocytes: 1.2"	"Cell line enhanced"	"Detected in some"		"HDLM-2: 2.7;HSkMC: 2.4;U-266/84: 2.0;U-698: 1.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA024785	Enhanced					NA	NA		89000			"HPA024785: AB_1847856"	"unprognostic (1.54e-3)"	"unprognostic (2.33e-1)"		"unprognostic (1.47e-1)"	"unprognostic (2.18e-1)"	"unprognostic (2.69e-1)"	"unprognostic (2.38e-3)"	"unprognostic (4.16e-4)"	"unprognostic (1.56e-1)"	"unprognostic (3.53e-2)"	"unprognostic (3.85e-3)"	"unprognostic (2.43e-1)"	"unprognostic (4.81e-2)"	"unprognostic (9.56e-3)"	"unprognostic (2.72e-1)"	"unprognostic (2.02e-1)"	"unprognostic (1.86e-1)"	2.5	0.6	0.1	0.0	0.1	0.0	0.1	0.0	0.3	0.2	2.1	0.1	0.0	0.0	0.0	1.6	0.1	0.2	1.3	0.0	0.0	0.1	42.2	103.6	0.2	0.0	0.1	0.0	0.2	0.0	0.3	0.3	0.1	0.1	0.9	0.0	0.2	4.7	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.3	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.5	0.0	0.4	0.0	0.0	0.0	0.6	0.7	0.7	0.0	0.0	0.0	1.2	0.0	0.0	2.7	0.0	0.1	0.0	0.2	0.0	1.3	1.1	2.4	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	1.4	0.0	0.7	0.0	0.1	0.6	1.3	1.4	0.0	0.0	0.1	0.0	0.1	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	2.0	1.5	0.0	0.7	0.0	0.0	0.7	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.3	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.0	4.3	0.0	0.0	0.0	0.4	28.1	0.0	0.0	19.2	0.0	0.0	23.2	0.0	9.9	0.0	0.0	23.3	0.0	0.0	0.6	2.5	0.0	429.9	1.3	0.0	0.0	6.2	6.2	9.7	0.9	0.7	0.0	0.0	0.0	0.4	0.1	0.0	0.0	408.7	0.0	0.0	0.0	0.7	0.7	0.0	0.0	0.0	0.0	0.0
DQX1	FLJ23757	ENSG00000144045	"DEAQ-box RNA dependent ATPase 1"	Q8TE96	2	74518131-74526336	"Enzymes, Predicted intracellular proteins"		"Helicase, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	11	"intestine: 41.0"	"Cell type enhanced"	"Detected in some"	15	"Enterocytes: 21.9;Mucus-secreting cells: 12.7;Paneth cells: 11.8;Undifferentiated cells: 10.6"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"plasmacytoid DC: 1.4"	"Low lineage specificity"	"Detected in single"			"Group enriched"	"Detected in some"	5	"HBEC3-KT: 5.9;Hep G2: 16.6;hTCEpi: 6.1;OE19: 14.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA039158	Enhanced		Approved	"Plasma membrane,Cytosol"		NA	NA			"Plasma membrane, Cytosol"		"HPA039158: AB_10960125"	"unprognostic (2.17e-1)"	"unprognostic (1.43e-1)"	"unprognostic (1.20e-2)"	"unprognostic (9.95e-2)"	"unprognostic (2.20e-1)"	"unprognostic (1.18e-1)"	"unprognostic (6.49e-2)"	"unprognostic (3.93e-1)"	"unprognostic (4.54e-2)"	"unprognostic (1.68e-1)"	"unprognostic (7.67e-2)"	"unprognostic (2.21e-2)"	"unprognostic (0.00e+0)"	"unprognostic (1.13e-2)"	"unprognostic (1.36e-1)"	"unprognostic (1.29e-1)"	"unprognostic (6.16e-3)"	0.1	0.0	0.1	2.1	0.2	0.0	0.1	0.1	0.1	0.8	13.3	0.2	0.1	14.7	0.1	0.1	3.7	0.2	3.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	1.0	0.1	0.2	5.1	0.1	0.6	0.1	0.1	1.5	41.0	0.3	0.1	0.2	2.9	0.1	0.1	0.2	0.1	0.7	1.5	1.1	1.4	0.7	1.4	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.5	0.0	0.3	0.0	0.0	0.0	0.6	0.1	5.9	0.0	0.0	0.3	0.4	0.1	16.6	0.0	0.2	0.3	0.0	6.1	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.2	0.0	0.1	0.3	14.1	0.0	0.1	0.1	0.1	0.0	1.1	0.0	0.1	0.0	2.3	0.0	1.1	0.6	0.0	0.0	0.7	0.1	0.1	0.0	0.1	0.2	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.1	0.2	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.5	0.1	0.3	0.0	5.3	1.2	0.0	2.0	1.2	0.0	0.0	0.0	0.0	21.9	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.2	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.7	0.5	0.1	11.8	0.0	0.0	0.8	0.0	0.0	0.1	0.2	0.0	0.9	0.0	10.6	0.2
DROSHA	"Etohi2, HSA242976, RN3, RNASE3L, RNASEN"	ENSG00000113360	"Drosha ribonuclease III"	Q9NRR4	5	31400497-31532196	"Cancer-related genes, Enzymes, Predicted intracellular proteins"	"Ribosome biogenesis, RNA-mediated gene silencing"	"Endonuclease, Hydrolase, Nuclease, RNA-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA031150			Supported	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA031150: AB_2673761"	"unprognostic (8.37e-3)"	"unprognostic (1.81e-1)"	"unprognostic (9.56e-2)"	"prognostic unfavorable (6.79e-4)"	"unprognostic (5.40e-2)"	"unprognostic (6.03e-2)"	"prognostic unfavorable (1.39e-4)"	"unprognostic (3.11e-1)"	"unprognostic (4.08e-2)"	"unprognostic (9.08e-2)"	"unprognostic (1.86e-1)"	"unprognostic (5.43e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.74e-1)"	"unprognostic (2.39e-1)"	"unprognostic (6.94e-2)"	"unprognostic (2.32e-2)"	15.7	16.8	18.4	17.7	32.1	12.2	16.1	33.7	33.7	17.4	16.3	19.1	12.2	15.9	22.3	25.8	16.0	18.2	14.1	15.2	16.6	15.1	15.3	11.7	13.9	17.8	13.6	16.4	26.7	17.8	23.9	38.9	17.0	18.9	17.2	19.2	23.7	17.5	19.2	23.6	16.0	17.5	16.9	19.4	16.8	16.0	12.8	16.4	25.6	21.9	13.4	19.8	18.2	16.2	4.7	6.4	3.3	4.8	4.8	6.4	3.1	12.4	15.7	17.4	23.6	9.3	11.4	25.1	16.5	8.1	15.4	11.5	16.5	16.2	14.0	19.0	12.1	17.9	10.9	21.4	12.5	17.2	13.1	15.1	17.2	51.6	11.9	8.4	19.2	51.4	8.9	8.8	17.2	8.3	11.8	13.1	15.0	21.8	6.6	13.4	12.4	18.5	14.4	16.4	10.1	12.6	16.8	33.3	10.1	8.7	14.2	9.1	12.0	41.9	17.2	10.1	16.2	15.8	11.1	11.4	14.9	17.3	13.3	15.6	12.1	19.8	15.4	10.3	21.7	14.2	1.8	2.4	3.3	5.2	2.6	5.5	4.2	5.4	6.0	5.2	4.7	6.4	4.4	0.8	4.8	4.8	6.4	5.1	3.1	18.4	32.1	33.7	33.7	16.6	15.1	13.6	16.4	18.9	16.4	11.9	14.7	3.0	4.6	3.2	18.2	21.0	7.6	20.1	15.9	5.2	0.0	6.6	3.3	7.2	2.5	6.2	7.3	0.0	7.0	6.4	7.4	5.0	9.2	5.1	6.7	6.4	10.9	9.2	7.8	4.3	10.0	3.2	1.7	9.0	10.1	10.5	7.8	8.6	12.4	4.2	16.8	6.5	4.7	5.8	8.4	3.0	4.1	5.7	10.0	5.1
DSE	"DS-Epi1, DSEPI, SART2"	ENSG00000111817	"Dermatan sulfate epimerase"	Q9UL01	6	116254173-116444860	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"		Isomerase	"Disease mutation, Ehlers-Danlos syndrome"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Kupffer cells: 85.3;Macrophages: 81.1;monocytes: 97.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"myeloid DC: 8.9"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"							"HPA014764, HPA052151"	Uncertain		Approved	Nucleoplasm,Cytosol	"Intracellular and membrane"	NA	NA			Nucleoplasm	Cytosol	"HPA014764: AB_1856587, HPA052151: AB_2681746"	"unprognostic (1.28e-1)"	"prognostic unfavorable (3.36e-4)"	"unprognostic (1.38e-1)"	"unprognostic (3.23e-3)"	"unprognostic (1.21e-1)"	"unprognostic (1.48e-2)"	"unprognostic (6.76e-2)"	"unprognostic (1.02e-2)"	"unprognostic (7.81e-2)"	"prognostic unfavorable (6.34e-4)"	"unprognostic (5.11e-2)"	"unprognostic (1.54e-1)"	"prognostic unfavorable (1.50e-4)"	"unprognostic (6.19e-3)"	"unprognostic (2.54e-2)"	"unprognostic (2.06e-1)"	"unprognostic (1.10e-2)"	32.3	10.6	7.4	22.3	10.7	13.1	34.8	5.4	7.7	16.0	12.8	4.9	9.9	5.3	11.7	18.5	13.5	15.3	12.9	16.1	8.1	4.3	11.2	10.4	17.7	13.1	9.8	4.5	21.0	4.0	15.4	20.9	21.7	13.1	13.0	7.1	14.3	9.3	9.4	8.5	16.9	10.7	12.8	16.1	24.9	7.6	10.9	9.0	8.3	8.7	10.9	8.3	14.6	29.4	3.6	8.9	2.5	3.9	0.2	1.1	1.2	10.5	2.3	7.9	7.4	21.5	14.2	9.0	12.5	29.4	15.7	23.1	0.0	3.0	0.3	1.1	21.8	15.8	20.3	1.1	29.4	20.6	10.9	4.8	0.7	3.4	0.1	24.0	0.5	0.5	30.1	12.7	17.4	17.1	8.2	9.2	2.7	0.2	4.8	7.5	0.3	1.4	0.6	4.2	0.0	0.6	1.8	7.3	5.0	10.4	0.7	2.6	2.0	12.1	0.0	0.3	5.7	0.1	1.2	3.4	15.9	4.6	3.9	10.0	1.0	0.3	0.5	8.4	1.3	1.8	0.7	3.1	0.1	1.0	3.9	0.6	3.2	0.9	0.4	8.9	3.6	1.1	0.4	2.5	0.2	2.2	4.2	0.2	1.2	7.4	10.7	5.4	7.7	8.1	4.3	9.8	4.5	13.1	9.0	14.9	2.6	18.6	20.6	46.1	4.1	7.0	5.1	18.7	18.2	3.5	0.0	2.0	6.6	4.0	39.9	11.9	0.0	0.0	7.5	3.7	35.5	14.2	22.0	3.8	39.5	1.6	1.2	57.7	85.3	19.2	50.9	81.1	10.1	97.4	0.7	3.9	9.5	0.0	28.3	6.1	3.0	32.3	29.2	2.6	5.1	34.9	4.1	6.5	1.0	42.4
DSTYK	"DustyPK, KIAA0472, RIP5, RIPK5"	ENSG00000133059	"Dual serine/threonine and tyrosine protein kinase"	Q6XUX3	1	205142505-205211566	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase, Tyrosine-protein kinase"	"Disease mutation, Hereditary spastic paraplegia, Neurodegeneration"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	5	"Horizontal cells: 84.2;Melanocytes: 86.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044140	Approved		Uncertain	"Nuclear speckles,Intermediate filaments,Cytosol"		NA	NA			"Nuclear speckles, Intermediate filaments"	Cytosol	"HPA044140: AB_10965031"	"unprognostic (1.42e-2)"	"unprognostic (1.07e-2)"	"unprognostic (7.92e-2)"	"unprognostic (1.02e-3)"	"unprognostic (1.39e-1)"	"unprognostic (2.66e-1)"	"unprognostic (1.43e-2)"	"unprognostic (9.01e-2)"	"unprognostic (1.81e-1)"	"unprognostic (1.06e-1)"	"unprognostic (2.25e-3)"	"unprognostic (1.20e-1)"	"unprognostic (3.26e-2)"	"unprognostic (7.80e-2)"	"unprognostic (1.93e-1)"	"unprognostic (1.55e-1)"	"prognostic unfavorable (8.73e-5)"	6.4	9.2	13.8	4.4	13.3	19.6	8.2	20.4	16.4	8.4	6.5	6.8	4.2	3.3	10.5	7.4	6.7	9.2	5.4	5.7	10.7	9.0	9.3	2.5	7.3	5.4	8.1	11.8	14.0	5.9	22.0	11.0	7.1	12.2	7.2	4.6	9.2	6.2	8.8	14.6	14.0	4.8	8.8	11.0	7.0	5.3	11.5	9.2	7.1	8.4	3.6	5.3	7.6	6.4	3.5	3.1	9.8	3.5	4.8	5.1	1.6	6.9	4.5	4.9	5.9	7.1	12.0	3.4	8.7	8.7	9.1	6.2	2.0	3.8	5.1	2.6	14.6	5.0	4.9	5.3	5.6	9.3	2.4	5.7	9.3	6.0	2.2	6.4	2.6	5.0	7.0	8.5	9.3	8.9	10.9	6.6	3.7	12.0	3.5	7.2	4.7	2.0	2.3	5.2	1.3	5.4	1.8	8.8	4.5	6.1	4.4	2.7	5.3	7.4	7.7	24.3	5.9	5.6	3.4	6.6	5.7	5.7	8.6	5.7	3.6	2.5	3.0	6.6	3.6	20.3	9.8	3.5	6.0	4.6	2.5	4.3	2.7	3.4	3.8	3.1	3.5	5.1	3.7	5.1	4.8	1.8	2.3	2.0	1.6	13.8	13.3	20.4	16.4	10.7	9.0	8.1	11.8	12.2	9.2	26.8	13.3	11.1	5.8	13.3	46.4	9.5	12.7	29.4	17.0	15.7	31.4	5.9	5.0	10.9	8.6	14.9	3.2	23.3	7.8	4.9	18.1	8.2	23.1	7.4	7.8	84.2	12.2	24.5	20.2	17.3	15.3	13.1	86.0	10.0	5.8	50.7	8.5	3.5	17.0	6.2	34.9	25.8	12.0	20.0	12.7	12.2	2.2	14.9	7.6	5.6
DTD1	"bA379J5.3, bA555E18.1, C20orf88, DUEB, HARS2, MGC119131, MGC41905, pqn-68"	ENSG00000125821	"D-tyrosyl-tRNA deacylase 1"	Q8TEA8	20	18587893-18766644	"Enzymes, Predicted intracellular proteins"	"DNA replication"	"DNA-binding, Hydrolase, RNA-binding, tRNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Spermatogonia: 137.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"											HPA040981	Uncertain		Uncertain	Nucleoli,Cytosol		NA	NA		180000	"Nucleoli, Cytosol"		"HPA040981: AB_10673268"	"unprognostic (3.32e-1)"	"unprognostic (1.05e-1)"	"unprognostic (1.82e-1)"	"unprognostic (5.94e-2)"	"unprognostic (1.83e-1)"	"unprognostic (2.90e-1)"	"unprognostic (1.27e-3)"	"unprognostic (9.67e-2)"	"unprognostic (1.72e-1)"	"unprognostic (1.81e-1)"	"unprognostic (6.84e-2)"	"unprognostic (1.32e-1)"	"unprognostic (9.09e-3)"	"unprognostic (2.42e-1)"	"unprognostic (8.44e-2)"	"unprognostic (2.59e-2)"	"unprognostic (8.53e-2)"	14.9	17.7	25.2	13.6	26.5	13.6	19.7	22.4	35.4	13.5	13.7	22.2	10.5	10.6	14.4	17.2	18.8	14.5	11.1	16.7	24.7	29.5	20.1	9.4	13.7	15.5	25.2	30.4	19.1	19.7	20.3	23.7	12.7	27.3	13.6	16.0	17.1	17.6	12.4	22.5	17.6	9.8	15.0	30.9	12.7	16.3	20.6	14.4	4.8	29.5	24.9	17.4	13.4	12.6	20.9	27.5	29.9	20.6	16.4	22.5	12.6	18.7	21.1	20.8	20.4	8.9	16.6	11.6	16.6	15.4	13.2	14.5	13.8	14.7	0.0	11.4	15.4	18.5	10.6	16.6	35.2	13.9	9.1	11.9	20.9	4.8	22.9	28.2	16.2	11.3	13.1	28.3	14.9	55.0	11.3	22.4	3.6	13.0	24.4	19.2	27.5	3.4	29.5	19.3	14.2	46.5	0.0	31.0	15.8	20.1	10.1	28.5	21.5	8.9	24.7	42.8	9.5	14.0	10.1	22.1	17.5	9.5	22.3	22.4	19.6	19.4	10.4	12.0	19.0	14.5	29.9	14.5	10.4	22.2	20.6	22.2	20.9	21.7	22.5	27.5	17.8	16.0	16.7	17.1	16.4	20.5	6.4	16.1	12.6	25.2	26.5	22.4	35.4	24.7	29.5	25.2	30.4	27.3	14.4	32.8	20.0	24.2	32.6	20.9	39.1	17.3	30.6	25.4	17.0	40.1	2.0	25.2	36.5	64.2	24.1	30.8	7.3	0.0	76.4	30.7	25.8	26.4	41.5	10.4	41.2	41.3	22.3	24.5	20.4	17.6	16.7	29.6	40.5	48.7	19.7	48.4	68.4	24.6	18.4	51.2	30.2	0.0	17.5	60.6	137.5	31.1	10.4	30.5	24.3	23.6
DTD2	"C14orf126, MGC9912"	ENSG00000129480	"D-tyrosyl-tRNA deacylase 2 (putative)"	Q96FN9	14	31446036-31457510	"Enzymes, Predicted intracellular proteins"		"Hydrolase, RNA-binding, tRNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											HPA001117	Approved		Approved	Vesicles		NA	NA			Vesicles		"HPA001117: AB_2666204"	"unprognostic (2.56e-3)"	"unprognostic (9.38e-2)"	"unprognostic (1.27e-3)"	"unprognostic (3.24e-2)"	"unprognostic (8.45e-2)"	"prognostic unfavorable (9.33e-4)"	"unprognostic (3.04e-2)"	"unprognostic (1.64e-1)"	"unprognostic (8.74e-3)"	"unprognostic (2.91e-1)"	"unprognostic (5.28e-2)"	"unprognostic (6.96e-2)"	"unprognostic (1.24e-1)"	"unprognostic (2.32e-1)"	"unprognostic (3.06e-2)"	"unprognostic (1.22e-2)"	"prognostic unfavorable (5.74e-6)"	11.9	11.0	12.4	6.8	16.0	2.9	13.1	9.1	19.6	6.7	6.8	15.2	3.8	5.6	8.0	7.7	9.9	7.5	6.9	6.0	13.2	11.0	8.6	11.6	10.0	8.0	13.6	8.9	8.6	9.9	8.3	9.6	6.2	13.3	8.8	8.2	7.1	10.3	6.1	2.3	8.2	5.3	8.3	10.9	6.7	5.7	14.6	9.9	12.3	9.4	2.8	7.8	7.5	6.5	6.4	6.6	3.5	4.8	6.9	9.1	4.8	8.4	7.2	6.3	8.2	11.6	9.9	4.3	7.8	7.7	6.2	5.5	3.9	8.2	16.2	5.4	8.9	6.7	8.2	9.9	8.8	10.7	8.7	4.4	4.6	5.2	21.7	12.5	9.3	5.7	11.1	10.0	5.5	12.5	5.2	9.1	9.8	9.0	7.8	8.2	10.2	13.4	8.4	8.5	14.7	7.5	9.1	4.6	8.4	11.6	7.4	9.4	6.2	12.8	16.7	9.0	5.6	15.3	4.9	6.5	6.9	6.0	5.5	6.7	9.6	17.9	15.8	3.0	8.6	11.0	3.5	4.8	1.7	4.0	4.1	5.6	4.9	5.9	4.3	6.6	6.4	9.1	6.0	3.0	6.9	2.0	4.0	2.9	4.8	12.4	16.0	9.1	19.6	13.2	11.0	13.6	8.9	13.3	9.9	8.9	7.0	5.2	5.4	4.6	4.3	3.6	7.6	5.3	4.5	3.5	7.9	7.4	3.3	4.8	3.3	3.5	2.7	0.0	5.4	5.3	5.8	4.4	1.1	11.1	4.5	4.8	2.9	1.3	6.4	5.1	6.9	2.9	3.3	2.8	5.9	9.5	4.9	3.5	7.8	6.8	8.3	0.0	6.7	8.1	2.5	4.6	2.3	2.9	7.5	3.8
DTX1	"hDx-1, RNF140"	ENSG00000135144	"Deltex E3 ubiquitin ligase 1"	Q86Y01	12	113056709-113098028	"Enzymes, Predicted intracellular proteins"	"Notch signaling pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 9.7;lymphoid tissue: 13.3"	"Cell type enriched"	"Detected in many"	15	"Horizontal cells: 162.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"naive B-cell: 2.3"	"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in some"	12	"Daudi: 40.9;REH: 16.8;U-698: 41.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA051249, HPA055275"	Approved		Supported	"Nucleoplasm,Nuclear bodies,Cytosol"		NA	NA			"Nucleoplasm, Cytosol"	"Nuclear bodies"	"HPA051249: , HPA055275: AB_2682769"	"unprognostic (2.13e-3)"	"unprognostic (3.20e-3)"	"unprognostic (4.24e-4)"	"unprognostic (2.01e-1)"	"unprognostic (7.48e-3)"	"unprognostic (1.59e-3)"	"unprognostic (2.49e-3)"	"unprognostic (1.81e-1)"	"unprognostic (9.55e-2)"	"unprognostic (6.87e-2)"	"unprognostic (2.19e-1)"	"unprognostic (1.58e-1)"	"prognostic unfavorable (3.02e-5)"	"unprognostic (2.41e-2)"	"unprognostic (4.70e-1)"	"unprognostic (1.63e-1)"	"unprognostic (4.78e-3)"	9.7	2.3	6.1	8.9	7.0	3.2	3.9	7.3	8.3	0.8	0.7	1.1	0.5	1.6	2.0	0.5	1.2	1.7	1.0	2.7	5.4	5.9	1.7	6.4	0.5	13.3	3.7	4.2	0.5	2.0	0.0	2.2	0.9	4.6	0.8	0.2	1.4	3.2	0.5	0.5	0.5	2.2	0.5	1.1	9.8	1.0	4.9	0.5	0.5	1.3	0.5	8.1	0.5	0.5	2.3	0.0	0.0	0.0	1.0	0.6	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	40.9	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.2	0.0	0.0	0.1	1.7	0.0	0.8	0.0	0.0	16.8	0.0	1.0	0.0	0.0	1.0	2.7	0.1	0.1	1.0	0.0	0.0	0.1	0.4	0.0	1.6	0.0	0.0	0.2	0.0	41.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.7	0.5	0.0	0.0	2.3	0.6	0.0	0.0	1.0	0.0	0.0	0.0	0.2	6.1	7.0	7.3	7.1	5.4	5.9	3.7	4.2	4.6	0.5	0.0	0.0	2.9	0.0	0.9	1.5	0.7	0.0	0.0	0.0	1.8	7.9	0.0	6.6	1.6	0.6	0.7	0.0	0.0	0.0	0.0	0.8	0.1	6.9	10.5	0.6	162.1	0.0	0.0	0.0	1.1	7.2	0.0	3.3	0.0	0.0	10.3	0.2	0.0	7.1	0.0	2.1	0.0	0.9	0.7	1.2	0.4	0.0	0.0	0.0	0.0
DTX2	"KIAA1528, RNF58"	ENSG00000091073	"Deltex E3 ubiquitin ligase 2"	Q86UW9	7	76461676-76505995	"Enzymes, Predicted intracellular proteins"	"Notch signaling pathway, Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 19.1;esophagus: 19.2"	"Cell type enhanced"	"Detected in many"	4	"Urothelial cells: 51.5"	"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"A549: 28.3;CAPAN-2: 46.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042931	Approved		Supported	"Nucleoplasm,Nuclear membrane"		NA	Yes			"Nucleoplasm, Nuclear membrane"		"HPA042931: AB_2678227"	"unprognostic (1.72e-1)"	"unprognostic (1.73e-1)"	"unprognostic (1.62e-2)"	"unprognostic (1.58e-2)"	"prognostic unfavorable (8.47e-4)"	"unprognostic (2.85e-2)"	"unprognostic (1.28e-3)"	"unprognostic (7.54e-2)"	"unprognostic (4.76e-2)"	"unprognostic (2.28e-2)"	"unprognostic (2.10e-2)"	"unprognostic (6.56e-2)"	"prognostic unfavorable (1.13e-8)"	"unprognostic (2.87e-2)"	"unprognostic (1.53e-1)"	"unprognostic (1.50e-1)"	"unprognostic (1.19e-2)"	2.9	1.3	0.4	4.8	0.5	1.5	3.2	0.4	0.2	4.8	5.7			4.1	3.0	0.0	19.2	3.2	3.8	1.8	0.5	0.5	1.6	2.8	3.2	3.9	0.7		2.7	4.3	3.8	2.1	1.8		4.6	3.2		10.5	1.3	2.8	11.6	5.5	1.3	1.1	4.9	6.1	8.3			2.7		4.0	4.6	8.8	7.0	14.7	19.1	14.1	3.3	9.0	6.4	12.9	28.3	4.2	6.2	2.4	2.3	9.1	2.8	2.4	3.1	4.3	7.9	46.8	4.0	2.0	2.8	16.4	9.7	2.2	13.4	1.9	9.0	4.8	2.3	5.8	6.9	3.2	3.3	5.8	4.2	8.2	8.0	4.3	2.4	2.3	7.2	7.0	6.1	3.7	6.3	5.1	11.6	6.1	9.8	4.3	5.6	3.9	7.2	1.4	10.1	1.7	3.5	4.5	7.8	3.8	3.9	7.8	8.9	2.4	17.5	8.4	5.9	11.2	4.6	5.4	4.6	3.8	3.6	9.0	12.4	9.2	13.3	7.6	10.9	5.5	6.0	6.4	7.5	8.4	7.0	6.6	6.9	19.1	3.3	14.1	14.7	9.0	6.4											6.0	5.3	7.3	17.3	30.1	2.6	1.7	5.1	29.4	18.2	7.0	7.9	16.0	3.3	16.6	13.7	4.7	27.5	0.0	9.5	11.1	6.0	16.5	3.5	3.2	18.8	3.2	8.7	9.2	11.1	6.7	5.2	11.6	6.8	9.0	26.8	5.0	19.5	35.3	4.6	2.9	8.7	6.5	4.1	9.2	10.1	30.9	31.5	8.3	21.7	51.5
DTX3	"FLJ34766, RNF154"	ENSG00000178498	"Deltex E3 ubiquitin ligase 3"	Q8N9I9	12	57604622-57609804	"Enzymes, Predicted intracellular proteins"	"Notch signaling pathway, Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Horizontal cells: 66.7"	"Cancer enhanced"	"Detected in all"		"glioma: 54.0"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	6	"NK-cells: 2.0;T-cells: 5.5"	"Cell line enhanced"	"Detected in many"		"hTERT-RPE1: 31.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA059654	Approved		Approved	"Nucleoplasm,Nucleoli,Golgi apparatus"		No	No			"Nucleoplasm, Nucleoli"	"Golgi apparatus"	"HPA059654: AB_2684097"	"unprognostic (2.31e-2)"	"unprognostic (8.80e-2)"	"unprognostic (2.06e-2)"	"unprognostic (3.68e-1)"	"unprognostic (3.35e-1)"	"unprognostic (2.58e-2)"	"unprognostic (6.91e-2)"	"prognostic favorable (9.87e-4)"	"unprognostic (1.84e-1)"	"unprognostic (4.26e-2)"	"prognostic favorable (1.44e-4)"	"unprognostic (8.62e-2)"	"unprognostic (5.44e-3)"	"unprognostic (7.99e-2)"	"unprognostic (8.81e-2)"	"unprognostic (9.51e-2)"	"unprognostic (3.48e-2)"	7.2	18.8	22.7	9.0	35.2	3.5	9.4	47.8	53.6	17.6	22.8	23.7	11.0	6.7	29.7	30.6	9.7	31.8	14.1	20.5	23.8	19.8	11.4	2.4	12.2	11.0	18.3	28.4	36.3	12.0	23.9	32.7	16.0	22.5	21.1	10.1	20.4	13.2	29.5	10.9	7.9	9.4	28.7	16.9	11.2	11.2	7.8	21.6	6.8	16.8	5.1	8.8	11.8	13.5	0.3	0.6	0.0	0.0	2.0	5.5	1.8	3.1	8.2	24.4	0.0	0.0	0.0	0.1	5.0	12.9	11.0	11.2	4.2	13.2	4.4	7.6	10.8	0.1	5.1	0.0	0.6	7.8	11.0	1.5	2.5	12.6	4.4	18.8	0.0	0.0	9.3	6.1	8.4	0.1	31.5	12.3	0.0	0.0	15.0	8.4	6.8	13.4	0.1	19.2	2.5	0.7	0.0	20.3	0.2	1.0	8.2	17.7	28.1	3.9	1.1	2.4	6.1	14.1	6.7	0.0	14.4	5.8	6.6	7.1	24.6	18.4	0.0	9.2	0.0	7.5	0.0	0.0	0.0	5.5	0.0	1.3	0.3	2.1	2.5	0.2	0.3	1.9	3.5	0.0	2.0	0.0	0.6	4.2	1.8	22.7	35.2	47.8	53.6	23.8	19.8	18.3	28.4	22.5	21.6	14.9	14.1	2.2	9.6	5.6	45.2	9.4	5.1	32.1	15.9	12.2	47.1	0.3	11.6	7.6	1.0	4.5	0.0	0.0	1.7	0.2	9.3	8.6	5.7	0.8	0.6	66.7	15.0	14.1	1.6	1.6	31.7	0.5	3.3	1.0	1.1	25.9	3.3	0.0	29.7	2.9	41.2	45.3	29.3	3.5	4.1	2.5	1.0	10.1	0.3	2.5
DTX3L	"BBAP, RNF143"	ENSG00000163840	"Deltex E3 ubiquitin ligase 3L"	Q8TDB6	3	122564238-122575203	"Enzymes, Predicted intracellular proteins"	"Antiviral defense, DNA damage, DNA repair, Host-virus interaction, Immunity, Innate immunity, Protein transport, Transport, Ubl conjugation pathway"	"Chromatin regulator, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+ SV40 Large T+: 34.2;BJ hTERT+ SV40 Large T+ RasG12V: 42.4;GAMG: 32.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA010570	Uncertain		Supported	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"HPA010570: AB_1847877"	"unprognostic (8.15e-2)"	"unprognostic (7.36e-3)"	"unprognostic (5.04e-2)"	"unprognostic (3.74e-3)"	"unprognostic (9.51e-2)"	"unprognostic (9.22e-2)"	"unprognostic (1.82e-1)"	"unprognostic (1.11e-2)"	"unprognostic (9.23e-2)"	"unprognostic (1.43e-1)"	"prognostic unfavorable (8.99e-4)"	"unprognostic (2.76e-2)"	"unprognostic (2.33e-2)"	"unprognostic (7.77e-2)"	"unprognostic (9.28e-2)"	"unprognostic (3.33e-2)"	"unprognostic (2.61e-2)"	32.3	13.0	5.9	22.7	8.4	8.1	11.2	2.0	6.8	14.2	18.5	5.9	6.0	14.8	14.0	12.8	17.9	12.0	15.1	21.5	5.0	5.1	17.3	39.2	21.3	18.3	6.4	3.3	21.7	18.5	10.3	13.9	22.2	6.5	20.9	12.1	7.6	13.9	9.8	14.6	6.2	31.8	10.8	9.7	35.2	12.4	4.9	6.9	24.8	23.9	8.0	18.3	17.0	22.1	6.4	6.5	21.9	13.6	7.8	10.2	6.7	11.1	3.4	1.0	2.9	4.6	10.6	3.8	2.9	10.7	34.2	42.4	3.3	11.4	1.2	5.7	4.7	32.9	11.2	3.4	4.6	7.5	9.4	1.3	9.7	2.6	3.5	9.0	4.9	7.6	9.1	5.5	5.1	2.9	6.5	6.4	6.2	1.2	6.9	2.5	3.4	12.0	3.5	0.6	3.4	6.3	13.4	7.8	2.1	8.7	7.2	1.4	1.5	6.0	2.7	21.6	0.7	3.1	6.3	7.9	3.9	5.5	0.3	3.7	2.5	1.4	5.9	6.8	6.5	4.0	12.5	8.5	8.7	9.3	13.6	10.2	5.9	7.8	10.0	6.5	6.4	7.1	7.6	21.9	7.8	13.5	0.7	7.4	6.7	5.9	8.4	2.0	6.8	5.0	5.1	6.4	3.3	6.5	6.9	29.8	25.5	10.7	7.5	7.9	0.2	4.4	20.4	16.0	15.9	7.0	0.0	3.1	0.0	21.6	1.5	16.6	25.5	0.0	27.9	13.8	9.6	16.0	15.1	50.5	24.2	0.0	17.7	24.5	34.9	0.6	7.8	19.5	5.0	20.8	21.5	5.0	28.4	11.5	8.5	11.1	0.2	32.3	6.6	0.9	0.7	5.3	1.5	13.4	16.9	18.6
DTX4	"KIAA0937, RNF155"	ENSG00000110042	"Deltex E3 ubiquitin ligase 4"	Q9Y2E6	11	59171430-59208587	"Enzymes, Predicted intracellular proteins"	"Notch signaling pathway, Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 42.8"	"Cell type enhanced"	"Detected in many"	5	"Cholangiocytes: 33.1;Muller glia cells: 28.1"	"Cancer enhanced"	"Detected in all"		"thyroid cancer: 63.6"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"plasmacytoid DC: 6.1"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"BEWO: 27.3;CACO-2: 14.8;CAPAN-2: 15.7;OE19: 15.1;RT4: 41.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA056760, HPA059294"	Approved		Approved	Vesicles		NA	NA			Vesicles		"HPA056760: AB_2683228, HPA059294: AB_2683969"	"unprognostic (3.23e-2)"	"unprognostic (1.57e-1)"	"unprognostic (1.10e-2)"	"unprognostic (4.98e-2)"	"unprognostic (4.97e-2)"	"unprognostic (5.03e-1)"	"unprognostic (2.92e-1)"	"unprognostic (1.06e-1)"	"unprognostic (3.75e-1)"	"unprognostic (1.14e-1)"	"unprognostic (5.69e-2)"	"unprognostic (3.04e-1)"	"prognostic unfavorable (8.94e-4)"	"unprognostic (5.51e-2)"	"unprognostic (2.51e-1)"	"prognostic favorable (5.81e-4)"	"unprognostic (2.57e-3)"	7.0	2.2	8.9	7.6	12.8	8.2	7.9	14.0	16.5	8.9	17.7	29.8	1.4	16.7	4.3	2.3	3.7	6.5	9.5	2.1	10.7	10.9	6.5	23.9	17.7	5.2	15.3	8.8	16.3	5.9	1.7	3.3	15.3	24.8	5.6	18.4	7.7	16.0	3.7	1.5	4.2	14.3	3.6	42.8	5.0	12.2	1.9	9.1	0.8	12.4	2.3	6.7	19.8	14.7	3.3	6.1	3.1	1.0	0.1	0.1	0.2	2.0	2.3	13.5	0.2	3.8	0.2	27.3	0.2	1.1	0.1	0.1	14.8	15.7	4.8	0.9	0.3	0.5	7.0	4.1	5.1	0.0	0.3	0.2	0.0	2.7	4.7	1.0	0.4	0.9	0.6	8.5	0.0	0.2	0.9	0.0	0.9	0.0	0.5	0.6	1.1	0.2	0.0	6.9	15.1	0.6	1.6	11.9	0.5	1.1	41.0	0.0	0.0	10.4	2.7	0.3	3.6	2.0	0.2	0.1	0.0	2.1	0.0	0.0	0.1	0.0	0.5	0.1	1.2	1.1	1.5	1.0	0.7	0.1	1.0	0.0	2.2	0.1	0.0	1.4	3.3	0.0	0.0	3.1	0.1	0.5	6.1	0.0	0.2	8.9	12.8	14.0	16.5	10.7	10.9	15.3	8.8	24.8	9.1	17.9	15.6	2.4	2.4	1.4	1.4	1.1	33.1	12.0	18.2	7.0	0.0	12.2	0.0	6.5	0.3	2.0	19.7	0.0	4.4	16.4	5.2	2.1	1.1	17.4	3.2	0.0	4.7	3.7	2.6	0.0	3.7	1.6	5.0	1.0	10.0	28.1	8.4	17.3	3.2	9.1	1.1	0.0	0.4	0.2	1.5	1.1	4.6	0.8	13.7	22.1
DTYMK	"CDC8, TMPK, TYMK"	ENSG00000168393	"Deoxythymidylate kinase"	P23919	2	241675742-241686991	"Enzymes, Predicted intracellular proteins"	"Nucleotide biosynthesis"	"Kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	5	"Extravillous trophoblasts: 118.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042593, HPA042719"	Approved		Approved	Mitochondria		NA	NA			Mitochondria		"HPA042593: AB_10959590, HPA042719: AB_10960633"	"unprognostic (1.90e-1)"	"unprognostic (6.95e-2)"	"unprognostic (4.14e-1)"	"unprognostic (8.61e-2)"	"unprognostic (1.89e-1)"	"unprognostic (9.45e-2)"	"prognostic unfavorable (1.73e-5)"	"unprognostic (1.44e-2)"	"unprognostic (2.64e-2)"	"unprognostic (5.50e-2)"	"unprognostic (2.60e-2)"	"unprognostic (6.94e-2)"	"prognostic unfavorable (1.22e-4)"	"unprognostic (7.13e-2)"	"unprognostic (6.81e-2)"	"unprognostic (5.07e-2)"	"unprognostic (9.19e-2)"	12.4	17.6	11.6	17.3	15.0	29.1	14.4	14.5	12.4	10.0	13.8	16.5	9.3	12.0	12.4	9.7	20.0	9.7	10.2	9.4	9.0	6.5	15.5	19.5	10.5	21.0	14.0	9.5	9.5	13.6	5.0	8.8	10.4	11.8	11.5	11.7	10.8	9.6	10.0	6.7	17.9	13.0	13.0	9.5	18.8	13.5	11.1	15.1	20.7	9.4	16.1	17.9	11.7	11.9	19.8	21.1	12.0	24.7	15.7	21.8	15.7	25.1	27.8	24.2	30.7	8.0	8.7	25.6	20.6	15.5	27.5	32.4	12.7	30.5	12.2	6.4	16.6	32.8	21.2	22.2	25.1	14.8	28.7	26.4	26.1	23.3	24.1	6.6	16.5	21.7	6.1	6.8	26.5	10.8	8.4	26.4	17.7	29.4	10.3	29.1	26.2	30.5	28.7	23.8	28.2	23.4	26.1	35.6	17.0	15.9	14.6	29.2	18.3	13.4	20.6	16.5	7.7	18.7	29.6	17.1	40.1	28.8	25.5	38.0	11.6	12.2	34.2	32.1	26.5	46.6	12.0	14.9	9.5	17.4	24.7	16.8	19.2	16.1	18.2	10.5	19.8	16.0	14.7	2.5	15.7	18.8	21.1	21.8	15.7	11.6	15.0	14.5	12.4	9.0	6.5	14.0	9.5	11.8	15.1	8.9	4.3	11.9	17.5	13.5	18.2	9.2	25.5	8.1	11.4	24.4	2.0	48.5	18.3	37.3	1.8	17.5	9.3	46.7	29.4	118.6	22.0	17.5	15.0	16.6	74.0	4.8	13.8	20.9	13.1	2.0	15.3	23.4	21.9	57.7	19.9	16.3	27.3	14.0	18.0	27.5	14.2	25.8	16.1	27.6	57.7	10.5	23.0	15.8	34.8	12.0
DUOX1	"LNOX1, NOXEF1, THOX1"	ENSG00000137857	"Dual oxidase 1"	Q9NRD9	15	45129933-45165576	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Hydrogen peroxide, Thyroid hormones biosynthesis"	"Oxidoreductase, Peroxidase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lung: 48.7"	"Cell type enhanced"	"Detected in many"	11	"Alveolar cells type 1: 77.4;Alveolar cells type 2: 116.2"	"Cancer enhanced"	"Detected in many"		"thyroid cancer: 32.4"	"Low region specificity"	"Detected in some"			"Cell type enhanced"	"Detected in some"		"plasmacytoid DC: 1.5"	"Low lineage specificity"	"Detected in single"			"Group enriched"	"Detected in some"	5	"HaCaT: 34.6;hTCEpi: 16.8;RT4: 19.3"	"Not detected"	"Not detected"			"Region enriched"	"Detected in many"	5	"cerebellum: 17.5"	HPA023544	Approved					NA	NA					"HPA023544: AB_1847878"	"unprognostic (2.85e-2)"	"prognostic favorable (4.31e-6)"	"unprognostic (2.49e-2)"	"unprognostic (8.84e-3)"	"unprognostic (1.44e-2)"	"unprognostic (3.27e-2)"	"unprognostic (1.23e-1)"	"unprognostic (2.57e-2)"	"unprognostic (5.87e-2)"	"unprognostic (6.02e-3)"	"unprognostic (5.13e-2)"	"unprognostic (1.19e-1)"	"unprognostic (8.91e-3)"	"unprognostic (2.23e-1)"	"unprognostic (3.06e-2)"	"unprognostic (1.14e-2)"	"unprognostic (3.03e-1)"	0.4	5.2	0.5	0.4	0.8	0.0	2.0	1.2	0.9	18.9	0.6	2.4	43.3	0.1	2.2	37.8	38.3	6.0	6.2	1.1	0.6	0.1	0.2	0.1	48.7	0.1	1.0	0.5	1.2	0.1	1.8	0.9	2.5	0.9	4.8	0.0	4.3	9.8	19.2	0.8	34.2	0.3	1.6	0.5	0.1	18.0	1.0	1.1	0.7	31.9	35.9	31.9	6.2	13.1	0.2	1.5	0.5	0.5	0.1	0.4	0.0	4.3	0.0	0.3	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	34.6	0.0	3.2	0.0	0.4	0.2	0.0	0.4	0.0	0.0	0.0	0.2	0.0	16.8	0.0	1.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.6	0.0	0.0	0.0	19.3	0.4	0.8	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.5	0.4	0.5	0.0	0.1	0.3	0.0	1.1	0.2	0.2	0.0	0.0	0.1	0.1	1.5	0.2	0.0	0.5	0.8	1.2	0.9	0.6	0.1	1.0	0.5	0.9	1.1	77.4	116.2	6.7	13.0	9.8	20.8	2.0	10.2	38.8	34.2	3.5	7.9	3.8	0.0	3.4	0.5	2.9	2.7	0.0	4.8	0.6	5.2	5.8	8.1	1.7	1.1	6.4	20.8	8.6	5.1	0.0	3.1	5.8	15.1	1.8	3.4	4.1	3.3	4.2	3.5	0.3	2.6	0.0	2.7	2.8	2.3	15.7	3.1	10.1	2.3	23.7
DUOX2	"LNOX2, P138-TOX, P138(TOX), THOX2"	ENSG00000140279	"Dual oxidase 2"	Q9NRD8	15	45092650-45114344	"Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins, Transporters"	"Hydrogen peroxide, Thyroid hormones biosynthesis"	"Oxidoreductase, Peroxidase"	"Congenital hypothyroidism, Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"ductus deferens: 151.5;gallbladder: 80.4"	"Cell type enhanced"	"Detected in many"	18	"Ductal cells: 151.4;Exocrine glandular cells: 106.5;Pancreatic endocrine cells: 346.5;Urothelial cells: 98.5"	"Cancer enhanced"	"Detected in many"		"thyroid cancer: 60.0"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	13	"basophil: 1.3"	"Lineage enriched"	"Detected in single"	13	"granulocytes: 1.3"	"Cell line enriched"	"Detected in some"	8	"HaCaT: 11.8"	"Region enhanced"	"Detected in single"		"basal ganglia: 1.3"	"Not detected"	"Not detected"									NA	NA						"unprognostic (3.19e-1)"	"unprognostic (7.51e-2)"	"unprognostic (3.77e-2)"	"unprognostic (5.99e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.40e-2)"	"unprognostic (7.93e-2)"	"unprognostic (3.32e-1)"	"unprognostic (1.42e-1)"	"unprognostic (4.49e-2)"	"unprognostic (9.59e-3)"	"unprognostic (7.11e-2)"	"unprognostic (5.32e-5)"	"unprognostic (1.71e-1)"	"unprognostic (1.62e-2)"	"unprognostic (4.12e-2)"	"unprognostic (1.63e-2)"	0.1	0.6	0.1	8.4	0.3	0.0	0.1	0.1	0.2	5.1	3.2	0.2	151.5	0.3	0.4	0.8	10.9	0.0	80.4	0.3	0.1	0.0	0.3	0.8	1.2	0.1	0.1	0.1	0.2	0.8	0.0	0.1	0.2	0.2	3.4	1.4	0.4	7.3	1.2	0.6	2.1	3.5	0.6	0.1	0.1	14.9	0.5	0.1	0.1	29.0	6.1	6.6	20.4	9.6	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.6	0.0	0.0	11.8	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	1.3	0.0	0.3	0.2	0.4	0.1	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.1	0.2	0.1	0.0	0.1	0.1	0.2	0.1	44.7	41.2	0.0	1.9	1.6	0.4	1.6	68.8	21.4	37.5	0.0	0.0	0.0	0.0	151.4	0.5	0.0	4.3	0.0	106.5	0.0	0.5	3.8	30.2	0.0	0.1	0.0	1.2	0.0	0.0	0.0	0.3	0.9	0.0	9.0	4.1	0.1	346.5	4.2	0.0	0.0	0.3	0.0	3.1	0.7	0.3	1.6	0.0	0.0	2.1	98.5
DUPD1	DUSP27	ENSG00000188716	"Dual specificity phosphatase and pro isomerase domain containing 1"	Q68J44	10	75037836-75058514	"Enzymes, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	71	"skeletal muscle: 38.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"NB-4: 1.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA042964	Uncertain					NA	NA					"HPA042964: AB_10795764"						"unprognostic (1.05e-2)"				"unprognostic (1.77e-1)"					"unprognostic (2.34e-1)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.2	0.0		0.5	0.0	38.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0		0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.4	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
DUSP1	"CL100, HVH1, MKP-1, PTPN10"	ENSG00000120129	"Dual specificity phosphatase 1"	P28562	5	172768090-172771195	"Cancer-related genes, Enzymes, Predicted intracellular proteins"	"Cell cycle, Stress response"	"Hydrolase, Protein phosphatase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	5	"neutrophil: 326.0"	"Lineage enriched"	"Detected in all"	10	"granulocytes: 326.0"	"Cell line enhanced"	"Detected in many"		"HHSteC: 43.7;hTCEpi: 76.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA069577			Approved	Nucleoli,Cytosol		NA	NA			Nucleoli	Cytosol	"HPA069577: AB_2686156"	"unprognostic (1.51e-1)"	"unprognostic (1.24e-1)"	"unprognostic (9.73e-2)"	"unprognostic (8.17e-2)"	"unprognostic (4.64e-1)"	"unprognostic (1.58e-3)"	"unprognostic (4.18e-2)"	"unprognostic (6.94e-2)"	"unprognostic (3.11e-1)"	"unprognostic (1.43e-2)"	"unprognostic (2.23e-1)"	"unprognostic (1.51e-2)"	"unprognostic (2.76e-2)"	"prognostic unfavorable (3.11e-5)"	"unprognostic (2.69e-1)"	"unprognostic (2.35e-2)"	"unprognostic (1.41e-3)"	158.4	78.0	12.4	68.5	14.0	89.7	91.8	17.4	14.9	81.4	37.1	32.4	48.5	9.4	55.4	71.6	82.7	94.8	138.8	49.2	12.5	11.4	29.8	115.4	135.0	43.5	30.6	9.7	69.4	34.4	26.6	40.8	93.7	29.3	67.1	34.2	61.0	38.1	192.8	54.8	116.1	27.6	65.0	29.5	36.1	53.6	45.9	18.7	10.8	90.4	104.1	46.9	69.0	109.7	2.4	11.5	326.0	31.8	4.5	9.8	14.0	2.1	5.5	1.7	2.4	38.1	22.3	2.9	35.4	10.3	23.8	9.6	6.0	2.6	0.7	10.3	24.8	27.4	0.9	1.7	8.7	11.2	19.4	4.7	0.4	12.0	2.5	43.7	0.2	0.8	21.3	76.4	10.8	17.6	12.4	7.4	1.5	1.8	13.9	15.3	2.5	1.1	1.0	1.5	1.6	1.6	41.1	3.2	6.4	16.9	1.1	7.5	3.1	9.6	16.3	1.2	7.6	1.4	0.4	19.5	16.9	8.4	16.4	2.7	2.9	1.6	0.6	15.1	0.3	0.6	33.3	24.6	69.8	3.9	25.0	9.8	2.4	3.5	4.0	11.5	2.1	1.7	1.9	326.0	4.5	31.8	0.6	2.8	14.0	12.4	14.0	17.4	14.9	12.5	11.4	30.6	9.7	29.3	18.7	381.2	398.8	474.0	769.9	1136.9	64.0	181.6	236.9	45.5	126.3	200.7	25.5	239.6	48.0	361.0	67.1	510.4	567.7	46.7	76.6	355.3	824.5	763.6	295.5	297.9	967.3	46.1	687.8	403.9	1172.3	21.1	356.4	1745.4	514.5	55.9	830.1	603.1	188.6	648.8	292.4	25.4	177.1	756.7	886.8	11.8	23.0	1710.3	486.7	546.6	309.1	534.2
DUSP10	"MKP-5, MKP5"	ENSG00000143507	"Dual specificity phosphatase 10"	Q9Y6W6	1	221701424-221742176	"Enzymes, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 35.4"	"Cell type enhanced"	"Detected in many"	9	"granulocytes: 135.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"NK-cell: 15.1"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"ASC diff: 19.2;HaCaT: 42.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA016758	Approved		Supported	"Nucleoplasm,Golgi apparatus,Cytosol"		No	No			Nucleoplasm	"Golgi apparatus, Cytosol"	"HPA016758: AB_1847880"	"unprognostic (1.55e-1)"	"unprognostic (2.73e-1)"	"unprognostic (1.44e-1)"	"unprognostic (6.65e-2)"	"unprognostic (3.83e-2)"	"unprognostic (2.85e-3)"	"prognostic favorable (5.42e-4)"	"unprognostic (2.89e-1)"	"unprognostic (3.89e-2)"	"unprognostic (9.68e-2)"	"unprognostic (2.38e-2)"	"unprognostic (1.05e-1)"	"prognostic unfavorable (3.69e-4)"	"unprognostic (4.18e-2)"	"unprognostic (2.57e-1)"	"unprognostic (8.88e-3)"	"unprognostic (1.97e-2)"	7.4	4.7	6.0	7.1	11.2	23.2	8.2	5.9	11.1	5.7	10.8	21.1	0.3	2.1	4.9	2.7	7.0	8.5	7.6	3.8	7.2	4.0	2.8	35.4	8.0	9.0	14.0	5.6	2.8	18.3	1.8	2.5	4.5	8.4	3.6	4.9	8.5	9.5	1.7	21.0	8.0	6.2	9.7	10.1	6.4	4.5	3.9	14.1	5.6	5.3	10.6	8.6	8.5	4.1	0.8	5.4	4.6	4.2	15.1	12.7	1.6	6.1	2.6	0.2	0.2	19.2	9.9	0.2	4.1	10.8	6.9	5.3	0.1	1.7	4.8	1.4	10.7	5.0	42.3	0.9	4.0	6.0	12.3	0.5	8.2	1.2	0.7	4.5	3.6	5.6	13.8	2.9	7.4	7.5	3.2	0.2	1.2	0.8	1.7	6.5	0.1	0.7	2.8	0.6	1.3	0.3	0.4	11.7	0.3	2.3	3.7	15.8	1.2	0.5	0.5	17.5	2.5	0.9	2.1	1.5	3.5	0.9	5.3	5.1	2.9	2.0	2.6	5.4	1.6	3.6	4.6	4.2	0.2	3.6	3.7	3.3	0.7	2.5	2.5	5.4	0.8	0.8	1.5	0.3	15.1	1.4	0.2	12.7	1.6	6.0	11.2	5.9	11.1	7.2	4.0	14.0	5.6	8.4	14.1	0.0	1.7	1.9	12.6	45.2	4.5	3.3	10.2	8.1	6.8	3.5	19.6	2.2	0.0	27.3	29.1	6.3	1.0	0.0	7.8	2.7	8.3	10.9	135.7	50.4	22.0	1.6	42.1	1.8	11.0	2.7	23.0	23.9	21.9	13.6	9.9	13.5	21.9	0.0	12.0	0.7	32.3	0.0	5.1	3.8	2.0	36.1	2.9	29.9	2.2	14.4
DUSP12	"DUSP1, YVH1"	ENSG00000081721	"Dual specificity phosphatase 12"	Q9UNI6	1	161749758-161757238	"Enzymes, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA008840	Uncertain		Supported	Nucleoplasm		NA	NA			Nucleoplasm		"HPA008840: AB_1847884"	"unprognostic (3.51e-2)"	"unprognostic (2.62e-1)"	"unprognostic (1.05e-1)"	"unprognostic (2.01e-2)"	"unprognostic (2.11e-1)"	"unprognostic (4.04e-2)"	"prognostic unfavorable (1.99e-5)"	"unprognostic (1.86e-1)"	"unprognostic (1.06e-2)"	"unprognostic (2.25e-3)"	"unprognostic (9.52e-2)"	"unprognostic (2.42e-3)"	"prognostic unfavorable (1.55e-7)"	"unprognostic (1.17e-1)"	"unprognostic (1.84e-1)"	"unprognostic (3.25e-2)"	"unprognostic (2.42e-1)"	15.6	12.1	15.0	16.0	17.2	37.8	21.2	27.2	20.3	14.0	14.2	13.9	16.6	11.7	19.5	14.0	12.7	15.6	12.1	11.9	12.6	12.7	14.0	11.4	14.1	18.5	18.6	13.1	18.4	16.7	10.7	18.7	16.4	14.7	13.6	16.0	15.2	13.8	15.1	8.6	12.6	14.4	16.5	12.0	17.4	13.8	8.2	19.4	11.1	15.9	9.4	18.4	14.4	14.1	16.0	17.8	18.7	15.4	23.1	19.4	10.6	18.2	17.3	18.9	12.7	10.1	11.0	17.9	14.6	19.1	22.6	17.5	24.5	16.1	11.1	15.3	17.7	14.2	13.2	14.7	17.9	22.0	14.5	13.0	9.9	15.7	15.9	21.4	21.1	9.9	14.8	19.7	19.6	35.3	12.8	15.7	15.6	17.6	12.2	16.2	17.0	12.3	24.0	30.2	19.4	25.1	18.1	18.5	18.2	12.7	22.5	12.1	25.7	12.4	20.8	24.2	21.7	18.1	24.4	10.9	19.5	18.2	15.2	31.1	20.6	17.0	26.5	12.1	21.4	19.2	18.7	13.9	10.2	16.1	15.4	19.4	15.5	18.1	15.3	17.8	16.0	17.5	19.1	5.5	23.1	9.2	8.2	15.3	10.6	15.0	17.2	27.2	20.3	12.6	12.7	18.6	13.1	14.7	19.4	17.9	10.9	26.6	12.4	12.0	14.1	4.4	7.6	4.0	12.5	7.0	7.9	18.4	18.3	17.8	3.2	19.6	5.3	0.0	21.0	18.7	16.5	15.2	17.4	6.6	17.6	9.5	10.9	16.5	25.1	0.5	8.1	14.3	10.1	19.0	9.7	11.1	16.9	5.8	16.6	14.6	15.6	0.0	20.0	10.6	12.0	11.4	14.8	20.1	11.8	10.7
DUSP13	"BEDP, DUSP13A, DUSP13B, FLJ32450, TMDP"	ENSG00000079393	"Dual specificity phosphatase 13"	"Q6B8I1, Q9UII6"	10	75094432-75109221	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"skeletal muscle: 75.2;testis: 18.6;tongue: 26.0"	"Cell type enriched"	"Detected in some"	6	"Early spermatids: 345.5"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	39	"neutrophil: 3.9"	"Lineage enriched"	"Detected in single"	39	"granulocytes: 3.9"	"Cell line enhanced"	"Detected in some"		"BEWO: 5.0;EFO-21: 5.9;Hep G2: 12.2;K-562: 4.7;LHCN-M2: 10.9;RH-30: 9.3"	"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"									NA	NA						"unprognostic (1.79e-1)"	"unprognostic (2.39e-2)"		"unprognostic (2.39e-1)"	"unprognostic (7.07e-2)"	"unprognostic (1.66e-3)"	"unprognostic (2.47e-3)"	"unprognostic (8.63e-2)"	"unprognostic (1.97e-1)"	"unprognostic (2.63e-2)"	"unprognostic (1.27e-1)"	"unprognostic (3.92e-1)"	"unprognostic (2.22e-7)"	"unprognostic (1.93e-2)"	"unprognostic (1.54e-1)"	"unprognostic (4.81e-1)"	"unprognostic (2.09e-2)"	0.8	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	3.3	1.2	0.0	0.0	5.6	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.3	0.0	0.0	2.3	0.0	75.2	0.1	0.0	0.0	0.0	0.1	0.0	18.6	0.0	0.0	1.0	26.0	1.9	0.0	0.1	0.0	0.0	3.9	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	5.0	0.0	0.0	0.0	0.0	1.1	0.1	0.0	5.9	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.1	12.2	0.0	0.0	0.0	1.0	1.1	0.0	0.0	0.0	0.0	0.0	4.7	0.0	10.9	0.6	0.0	0.0	0.7	0.1	0.0	0.0	9.3	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.2	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.2	1.4	0.0	10.6	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	345.5	0.0	0.0	0.0	0.2	0.7	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	54.1	0.9	0.0	0.0	0.0	0.0	0.0	0.3	0.0	1.8	0.0	0.0	0.0	0.0	2.6	2.7	1.8	2.5	0.0	0.0	0.1
DUSP14	"MKP-L, MKP6"	ENSG00000276023	"Dual specificity phosphatase 14"	O95147	17	37489831-37513501	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	5	"Basal glandular cells: 152.9;Basal keratinocytes: 159.6;Cytotrophoblasts: 141.3"	"Low cancer specificity"	"Detected in all"							"Cell type enhanced"	"Detected in single"		"neutrophil: 3.2"	"Lineage enriched"	"Detected in single"	6	"granulocytes: 3.2"	"Cell line enhanced"	"Detected in many"		"BJ hTERT+ SV40 Large T+: 10.9;BJ hTERT+ SV40 Large T+ RasG12V: 12.7;HBF TERT88: 18.3;U-138 MG: 8.7;WM-115: 10.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA019911	Approved		Approved	Nucleoplasm,Cytosol		NA	NA		44000	"Nucleoplasm, Cytosol"		"HPA019911: AB_1847888"	"unprognostic (1.32e-1)"	"unprognostic (3.06e-1)"	"unprognostic (2.19e-2)"	"unprognostic (1.57e-1)"	"unprognostic (4.60e-1)"	"unprognostic (3.22e-2)"	"unprognostic (3.43e-3)"	"unprognostic (2.02e-3)"	"unprognostic (2.18e-1)"	"unprognostic (2.59e-1)"	"unprognostic (7.02e-3)"	"unprognostic (3.81e-1)"	"prognostic unfavorable (6.97e-9)"	"unprognostic (7.93e-2)"	"unprognostic (1.97e-1)"	"unprognostic (1.73e-1)"	"unprognostic (1.41e-3)"	4.7	3.7	3.3	2.1	6.6	1.1	3.9	1.8	8.0	3.3	1.0	1.5	0.1	0.7	2.7	1.2	7.2	11.7	5.1	2.6	2.3		2.1	6.5	2.4	1.0	1.9	2.5	3.0	2.9	1.7	3.3	11.6	2.6	1.4	1.4	1.6	2.8	1.1	1.7	8.4	0.9	3.5	2.7	1.7	1.0	3.5	0.8	2.3	8.3	6.1	4.3	1.9	1.0	0.5	0.0	3.2	0.0	0.4	0.4	0.5	1.7	0.1	0.4	0.8	0.0	0.5	1.5	8.2	6.2	10.9	12.7	0.9	1.9	0.1	0.7	5.9	0.1	1.4	0.1	4.8	18.3	0.1	0.6	0.0	1.1	2.0	0.8	0.4	1.3	4.8	2.9	3.8	2.0	0.6	0.2	0.2	0.4	0.0	8.0	0.3	0.8	0.2	0.2	0.0	0.0	0.7	0.5	0.2	2.7	0.7	1.3	0.1	0.4	0.7	1.2	3.2	0.6	1.0	0.8	8.7	2.0	0.1	4.1	0.0	0.2	0.1	0.0	0.0	10.5	0.0	0.0	0.9	0.4	0.0	0.2	0.5	0.1	0.0	0.0	0.2	0.3	0.2	3.2	0.4	0.0	0.0	0.0	0.5											6.0	4.8	5.9	152.9	159.6	6.2	14.2	5.1	52.2	26.1	7.0	7.9	141.3	24.9	33.6	35.0	22.7	0.0	0.0	13.2	71.8	47.7	52.8	87.4	10.2	17.0	14.3	2.4	14.7	2.8	40.7	12.7	10.4	59.1	43.3	1.0	9.0	46.1	1.1	5.6	11.8	18.7	0.0	52.6	28.9	29.2	80.9	56.8	6.4	0.8	72.6
DUSP15	"bA243J16.5, bA243J16.6, C20orf57, FLJ20645, VHY"	ENSG00000149599	"Dual specificity phosphatase 15"	Q9H1R2	20	31847637-31870747	"Enzymes, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"testis: 75.1"	"Group enriched"	"Detected in many"	5	"Distal tubular cells: 232.1;Early spermatids: 237.5;Late spermatids: 743.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	14	"naive B-cell: 1.6"	"Lineage enriched"	"Detected in single"	14	"B-cells: 1.6"	"Cell line enhanced"	"Detected in some"		"CACO-2: 5.4;REH: 17.7;SH-SY5Y: 5.1;SK-MEL-30: 4.4;U-2 OS: 4.3"					"Low region specificity"	"Detected in all"			HPA076649	Enhanced		Approved	"Plasma membrane,Cytosol"		NA	NA			"Plasma membrane, Cytosol"		"HPA076649: AB_2686811"	"unprognostic (3.84e-2)"	"unprognostic (2.30e-1)"	"unprognostic (2.28e-1)"	"unprognostic (9.01e-3)"	"unprognostic (3.88e-2)"	"unprognostic (2.36e-1)"	"unprognostic (1.47e-2)"	"unprognostic (2.24e-2)"	"unprognostic (1.43e-1)"	"unprognostic (1.76e-1)"	"unprognostic (1.48e-5)"	"unprognostic (7.31e-2)"	"prognostic favorable (5.40e-7)"	"unprognostic (2.79e-2)"	"unprognostic (1.93e-1)"	"unprognostic (3.11e-3)"	"unprognostic (2.55e-1)"	1.1	2.1	2.8	0.6	4.0	0.5	1.3	1.2	3.7	1.6	0.8	4.2	6.9	0.9	1.4	10.4	0.6	0.7	1.1	2.7	2.8	3.1	15.4	0.6	0.8	1.0	4.9	2.3	2.1	1.8	10.6	2.7	1.1	5.9	1.9	0.5	5.3	2.1	9.3	2.4	0.7	1.0	2.3	5.2	1.0	1.1	75.1	1.4	0.0	3.5	0.1	0.6	0.7	0.8	1.6	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.2	0.2	1.6	0.0	0.3	0.0	0.0	0.0	0.9	0.0	5.4	0.1	1.1	2.2	0.3	3.0	0.0	0.4	0.0	0.0	0.0	0.6	0.5	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.3	0.0	3.8	0.7	0.0	0.0	17.7	2.1	0.1	0.0	0.0	2.5	5.1	2.9	0.0	4.4	0.2	1.3	1.1	0.0	0.0	4.3	0.0	0.0	1.9	0.0	0.0	0.0	0.6	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	4.0	1.2	3.7	2.8	3.1	4.9	2.3	5.9	1.4	0.0	0.0	0.0	1.0	0.6	0.5	2.0	2.5	0.0	0.0	17.4	3.9	0.0	232.1	1.7	237.5	0.7	0.0	0.0	0.9	0.1	2.4	0.7	0.0	0.0	0.5	6.4	1.7	3.1	0.0	743.6	8.1	0.8	6.8	1.0	0.0	2.7	0.9	0.0	10.3	33.5	0.2	0.0	1.0	85.0	5.2	0.1	0.1	0.0	0.0	0.1
DUSP16	"KIAA1700, MKP-7, MKP7"	ENSG00000111266	"Dual specificity phosphatase 16"	Q9BY84	12	12474210-12562383	"Enzymes, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Alveolar cells type 2: 56.3;Intestinal endocrine cells: 47.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"T-reg: 6.9"	"Lineage enriched"	"Detected in many"	5	"T-cells: 6.9"	"Cell line enhanced"	"Detected in many"		"NTERA-2: 23.7;RT4: 21.6;SuSa: 19.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA020326	Approved		Supported	Nucleoplasm		NA	NA			Nucleoplasm		"HPA020326: AB_1847890"	"unprognostic (8.05e-2)"	"unprognostic (9.47e-2)"	"unprognostic (1.49e-3)"	"unprognostic (4.14e-2)"	"unprognostic (9.86e-2)"	"prognostic favorable (1.01e-4)"	"unprognostic (1.75e-2)"	"unprognostic (3.52e-2)"	"unprognostic (1.13e-2)"	"unprognostic (2.11e-1)"	"unprognostic (1.78e-1)"	"unprognostic (2.82e-1)"	"unprognostic (2.34e-3)"	"unprognostic (6.35e-3)"	"unprognostic (2.42e-1)"	"unprognostic (1.46e-1)"	"unprognostic (5.76e-2)"	6.4	32.8	6.3	14.8	7.5	3.4	12.5	16.4	7.1	8.8	13.1	6.7	9.5	13.6	11.0	9.1	9.5	6.8	12.3	5.8	6.7	5.4	6.6	34.2	17.0	13.2	8.0	3.6	8.5	13.9	11.6	31.4	21.3	7.7	13.9	11.7	9.2	17.4	9.5	8.3	7.9	20.1	5.7	9.1	12.2	9.9	8.6	9.2	40.7	10.8	6.8	16.7	10.9	13.4	0.1	0.2	1.4	0.1	0.1	6.9	0.5	2.7	4.0	5.1	2.7	1.8	2.3	8.5	1.6	3.7	4.1	5.9	11.9	5.2	0.2	0.9	1.8	7.2	1.8	9.0	1.5	5.8	8.7	4.5	0.4	4.3	13.3	3.8	0.8	1.8	1.8	4.5	3.3	10.7	4.6	3.1	4.6	2.3	7.3	0.3	5.9	1.0	0.6	23.7	7.1	1.3	1.2	1.7	4.9	2.5	21.6	7.8	7.4	6.5	8.7	4.3	19.7	3.3	1.5	2.8	1.8	5.4	1.1	1.9	5.2	6.0	0.9	2.5	1.8	2.5	0.0	0.0	0.0	1.1	0.1	4.6	0.1	3.2	1.5	0.2	0.1	1.1	0.7	1.4	0.1	0.0	0.0	6.9	0.5	6.3	7.5	16.4	7.1	6.7	5.4	8.0	3.6	7.7	9.2	26.8	56.3	2.9	13.7	2.5	4.2	11.2	17.8	16.0	14.8	3.5	2.0	8.1	0.0	11.0	1.1	6.3	28.9	0.0	21.0	2.7	4.1	30.4	23.1	28.4	4.4	6.4	47.6	6.7	8.3	2.0	5.5	2.6	5.0	4.6	7.1	37.1	19.9	17.6	6.3	4.1	4.8	0.0	3.1	1.6	5.8	1.6	25.2	13.4	16.1	12.8
DUSP18	DUSP20	ENSG00000167065	"Dual specificity phosphatase 18"	Q8NEJ0	22	30652051-30667890	"Enzymes, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	13	"Early spermatids: 103.5;Late spermatids: 252.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"CAB034070, HPA051349"	Uncertain		Supported	Nucleoplasm		Yes	No			Nucleoplasm		"CAB034070: AB_2094867, HPA051349: AB_2681450"	"unprognostic (1.11e-1)"	"unprognostic (2.34e-2)"	"unprognostic (3.49e-3)"	"unprognostic (4.88e-3)"	"unprognostic (1.88e-1)"	"unprognostic (9.12e-2)"	"unprognostic (3.77e-4)"	"unprognostic (1.83e-1)"	"unprognostic (1.61e-1)"	"unprognostic (3.53e-2)"	"unprognostic (9.62e-2)"	"unprognostic (4.87e-2)"	"unprognostic (1.23e-3)"	"unprognostic (6.55e-2)"	"unprognostic (1.97e-1)"	"unprognostic (4.56e-2)"	"unprognostic (1.02e-1)"	5.2	3.9	10.1	7.1	9.7	4.9	5.3	4.1	8.3	5.6	10.1	11.4	4.6	7.8	6.1	8.4	7.5	18.5	8.0	3.8	8.7	7.8	5.5	2.3	9.9	7.2	8.4	3.9	4.4	6.6	5.2	19.5	3.6	9.5	4.6	11.5	4.7	6.1	4.3	2.0	7.9	11.0	6.4	9.0	6.9	8.3	30.8	10.2	8.0	5.8	3.4	7.6	6.0	6.1	6.4	11.2	21.7	13.9	4.3	8.1	4.7	5.3	5.8	2.6	6.5	6.6	13.1	2.5	5.1	5.9	5.2	5.6	3.1	5.7	3.5	3.6	6.4	6.6	4.0	1.6	4.1	5.8	10.0	6.4	1.8	2.0	2.0	2.8	7.5	5.9	3.7	5.8	8.6	3.1	5.8	15.9	4.3	1.8	3.2	5.6	4.6	4.1	1.8	1.0	6.6	3.5	3.0	1.7	1.3	6.3	3.7	6.7	3.8	5.3	2.1	3.7	3.6	4.7	2.1	11.4	10.7	5.8	2.7	2.9	2.3	2.7	1.8	12.1	1.3	5.4	18.3	10.4	19.4	5.9	12.5	4.6	6.4	6.8	5.4	11.2	6.2	4.6	5.5	21.7	4.3	13.9	6.4	8.1	4.7	10.1	9.7	4.1	8.3	8.7	7.8	8.4	3.9	9.5	10.2	17.9	4.8	6.0	10.2	19.1	2.6	1.9	7.6	64.3	11.4	5.2	43.2	1.0	3.3	7.4	103.5	9.0	14.8	0.0	8.2	3.0	9.3	7.5	6.9	0.9	7.3	1.6	34.1	9.8	12.7	252.1	7.8	16.2	8.5	6.4	18.0	9.2	7.0	14.0	6.3	3.0	16.3	6.5	7.2	68.7	18.8	18.6	0.8	8.6	18.5	6.4
DUSP19	"DUSP17, SKRP1"	ENSG00000162999	"Dual specificity phosphatase 19"	Q8WTR2	2	183078559-183100005	"Enzymes, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	9	"Ciliated cells: 20.1;Early spermatids: 10.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HEL: 10.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA021501	Approved		Approved	Nucleoplasm		Yes	No			Nucleoplasm		"HPA021501: AB_1847892"	"unprognostic (1.24e-1)"	"unprognostic (2.13e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.64e-1)"	"unprognostic (5.18e-2)"	"unprognostic (2.44e-1)"	"unprognostic (1.21e-1)"	"unprognostic (1.88e-1)"	"unprognostic (8.30e-2)"	"unprognostic (1.49e-2)"	"unprognostic (3.33e-2)"	"unprognostic (6.53e-2)"	"unprognostic (5.80e-3)"	"unprognostic (6.97e-2)"	"unprognostic (2.91e-2)"	"unprognostic (2.16e-2)"	"unprognostic (2.75e-2)"	2.8	4.6	9.2	2.0	16.3	1.0	3.0	2.9	9.6	3.4	4.7	2.2	3.8	3.5	6.8	9.2	4.2	8.4	3.5	7.4	17.4	3.4	4.7	3.0	3.4	2.3	3.3	6.8	4.4	4.3	7.7	10.6	2.7	3.7	4.2	3.0	3.0	2.8	5.4	3.8	3.4	3.0	8.6	2.9	4.0	9.1	10.4	4.7	6.2	4.6	1.1	1.9	4.0	2.7	4.1	1.5	2.0	0.8	2.2	3.2	1.3	0.1	2.4	2.9	1.4	3.9	2.2	0.0	1.1	1.8	4.6	1.6	2.3	3.0	1.0	6.0	1.2	3.3	0.3	5.7	0.8	3.5	5.8	3.2	10.6	1.8	1.6	1.7	2.6	6.5	1.7	0.5	2.3	1.1	2.9	2.6	0.0	3.1	1.6	2.7	1.0	5.0	2.5	2.4	1.0	2.0	4.9	4.5	0.3	1.0	1.1	3.6	1.5	4.0	1.7	2.9	0.2	0.8	1.0	2.0	2.5	2.1	1.7	0.9	2.0	2.4	0.1	3.1	0.4	3.7	2.0	0.5	1.9	2.3	0.8	2.3	4.1	2.1	3.1	0.6	2.2	2.7	2.7	1.3	2.2	0.4	1.5	3.2	1.3	9.2	16.3	2.9	9.6	17.4	3.4	3.3	6.8	3.7	4.7	0.0	2.7	1.7	1.2	0.9	1.7	6.5	2.5	20.1	2.3	1.8	2.0	2.0	5.0	0.6	10.4	1.0	1.6	0.0	0.6	1.2	1.3	0.9	1.1	1.0	0.6	1.6	2.4	1.8	0.6	4.6	1.7	0.1	0.0	1.8	2.0	4.5	0.5	2.5	2.5	2.3	1.0	0.0	1.4	4.7	3.1	1.4	0.6	0.0	2.1	1.3
DUSP2	PAC-1	ENSG00000158050	"Dual specificity phosphatase 2"	Q05923	2	96143166-96145440	"Enzymes, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"seminal vesicle: 151.1"	"Cell type enhanced"	"Detected in many"	12	"Melanocytes: 136.7;T-cells: 346.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"gdT-cell: 46.1"	"Group enriched"	"Detected in all"	10	"NK-cells: 29.6;T-cells: 46.1"	"Cell line enhanced"	"Detected in many"		"Daudi: 15.3;HeLa: 13.9;JURKAT: 14.2;Karpas-707: 17.5;NB-4: 14.5;RT4: 17.4;SCLC-21H: 15.5;U-698: 21.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA071920			Supported	"Nucleoplasm,Nuclear membrane"		NA	NA			"Nuclear membrane"	Nucleoplasm	"HPA071920: AB_2686472"	"unprognostic (2.69e-3)"	"unprognostic (6.70e-3)"	"unprognostic (1.15e-1)"	"unprognostic (5.46e-3)"	"unprognostic (3.32e-2)"	"unprognostic (8.54e-2)"	"unprognostic (1.36e-1)"	"unprognostic (1.15e-1)"	"unprognostic (2.86e-1)"	"unprognostic (3.66e-2)"	"unprognostic (3.10e-1)"	"unprognostic (6.30e-2)"	"prognostic unfavorable (4.97e-5)"	"unprognostic (1.82e-1)"	"unprognostic (2.41e-1)"	"unprognostic (3.94e-2)"	"unprognostic (1.31e-3)"	6.4	3.1	2.0	13.1	4.3	51.3	2.9	1.3	4.3	4.8	3.9	1.9	7.9	0.8	4.3	18.3	4.1	3.0	8.8	7.4	3.0	1.4	5.5	3.4	15.9	19.0	1.8	0.8	3.0	1.7	0.4	14.6	0.6	2.0	10.7	1.1	2.8	2.0	151.1	1.8	9.8	4.7	3.7	1.6	16.4	2.1	3.3	0.7	43.4	2.4	2.6	12.2	24.6	14.1	3.9	2.3	1.4	2.2	29.6	46.1	7.5	1.5	0.0	0.1	0.1	0.2	0.3	2.3	1.9	0.0	2.8	2.7	4.4	0.3	15.3	5.6	2.1	0.0	1.1	3.8	0.0	0.5	0.2	0.0	0.3	13.9	0.0	1.0	6.3	1.3	0.5	1.0	0.4	0.0	0.0	0.0	14.2	0.0	17.5	0.1	2.6	12.5	14.5	3.4	0.4	5.4	0.0	0.2	12.1	0.1	17.4	15.5	0.8	0.7	0.2	2.8	0.0	1.0	7.2	0.0	0.0	4.1	0.0	0.9	1.2	1.8	21.0	0.0	6.9	0.1	0.5	0.9	0.2	46.1	2.2	22.6	3.9	11.4	41.4	2.3	2.6	7.8	23.9	1.4	29.6	1.8	0.6	3.4	7.5	2.0	4.3	1.3	4.3	3.0	1.4	1.8	0.8	2.0	0.7	0.0	10.6	47.7	90.1	86.0	22.1	33.5	2.5	0.0	1.2	8.7	21.6	0.8	1.7	0.9	0.7	8.2	3.3	0.0	1.2	1.1	24.2	63.5	105.8	2.8	75.6	0.0	84.2	8.6	27.5	0.7	1.7	90.7	136.7	0.0	12.3	1.3	0.9	2.9	1.8	1.0	2.5	0.0	35.3	0.5	4.3	95.9	1.4	346.4	21.8	28.5
DUSP21		ENSG00000189037	"Dual specificity phosphatase 21"	Q9H596	X	44844004-44844888	"Enzymes, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	36	"testis: 15.9"	"Group enriched"	"Detected in some"	54	"Early spermatids: 58.8;Late spermatids: 167.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"CACO-2: 1.7;K-562: 2.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"									NA	NA																				"unprognostic (5.17e-2)"			0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	15.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	58.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	167.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	2.1	0.6	0.0	0.0	0.0	0.0	0.0
DUSP22	"JKAP, JSP1, MKPX, VHX"	ENSG00000112679	"Dual specificity phosphatase 22"	Q9NRW4	6	291630-351355	"Enzymes, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"RPMI-8226: 71.9;U-266/70: 36.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA031394	Approved		Approved	Nucleoplasm,Vesicles		NA	NA			"Nucleoplasm, Vesicles"		"HPA031394: AB_10604114"	"unprognostic (7.34e-3)"	"unprognostic (7.94e-3)"	"unprognostic (1.37e-2)"	"unprognostic (1.14e-1)"	"unprognostic (3.46e-1)"	"unprognostic (1.70e-2)"	"unprognostic (9.08e-3)"	"unprognostic (2.48e-1)"	"unprognostic (9.06e-2)"	"unprognostic (5.56e-3)"	"unprognostic (3.10e-2)"	"unprognostic (3.04e-1)"	"unprognostic (1.77e-1)"	"unprognostic (3.97e-2)"	"unprognostic (3.07e-1)"	"unprognostic (2.35e-1)"	"unprognostic (1.09e-1)"	24.8	13.1	22.0	24.6	31.3	19.4	28.7	12.1	27.5	18.1	29.0	29.8	18.8	21.2	20.6	25.2	29.8	15.0	20.4	31.0	22.6	17.4	16.0	20.3	24.6	27.4	33.5	16.1	13.9	27.9	10.8	14.8	25.9	25.5	16.1	15.9	16.9	20.9	15.5	32.0	30.6	21.8	23.4	29.2	30.0	21.4	41.3	30.0	9.2	19.9	19.0	27.9	22.8	27.4	21.6	18.0	16.3	17.5	2.9	8.2	9.8	3.6	2.2	4.8	7.2	5.6	6.2	6.4	2.7	2.2	2.4	2.9	2.4	4.1	7.7	6.6	2.8	5.1	2.5	6.0	5.0	1.7	18.4	6.9	5.2	1.8	6.6	2.8	1.8	6.8	4.6	15.2	1.7	3.2	4.0	6.8	6.6	4.8	25.7	2.0	2.1	2.7	6.7	2.9	2.7	5.2	5.4	3.3	71.9	4.5	1.6	8.3	3.2	2.3	0.9	7.9	11.0	4.9	2.4	9.3	2.2	2.9	2.2	1.6	36.6	25.8	10.7	0.8	5.1	4.9	16.3	17.5	6.9	5.0	14.0	3.5	21.6	3.9	5.1	18.0	17.5	3.6	5.1	12.0	2.9	12.6	15.4	8.2	9.8	22.0	31.3	12.1	27.5	22.6	17.4	33.5	16.1	25.5	30.0	14.9	17.6	38.7	19.8	23.6	5.2	35.3	10.2	26.8	25.0	5.2	0.0	9.1	18.3	21.3	11.0	33.7	13.8	0.0	45.0	6.9	17.8	14.6	32.3	22.1	25.5	0.0	9.1	22.7	40.0	14.8	14.4	35.8	43.9	83.8	13.0	9.8	28.3	14.0	8.9	14.6	2.6	25.8	27.2	30.7	73.7	32.4	5.5	15.0	14.5	23.5
DUSP23	"DUSP25, FLJ20442"	ENSG00000158716	"Dual specificity phosphatase 23"	Q9BVJ7	1	159780932-159782543	"Enzymes, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"kidney: 88.0"	"Cell type enhanced"	"Detected in many"	8	"Exocrine glandular cells: 394.0;Proximal tubular cells: 620.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HSkMC: 46.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028211, HPA045792"	Approved		Supported	Nucleoplasm		NA	NA			Nucleoplasm		"HPA028211: AB_2672522, HPA045792: AB_10961133"	"unprognostic (1.52e-1)"	"unprognostic (4.12e-1)"	"unprognostic (1.40e-3)"	"unprognostic (3.33e-2)"	"unprognostic (4.36e-2)"	"unprognostic (3.22e-1)"	"prognostic unfavorable (3.06e-4)"	"unprognostic (3.16e-1)"	"unprognostic (4.62e-1)"	"unprognostic (3.33e-3)"	"unprognostic (4.72e-2)"	"unprognostic (3.75e-2)"	"prognostic unfavorable (2.59e-5)"	"unprognostic (8.58e-2)"	"unprognostic (2.84e-2)"	"unprognostic (7.47e-2)"	"unprognostic (1.39e-1)"	25.0	28.0	7.6	9.3	10.5	11.2	27.3	4.4	9.0	15.5	15.9	5.9	6.6	17.2	12.2	15.0	21.2	10.9	12.6	14.9	7.8	5.2	88.0	80.8	12.1	15.4	8.5	4.6	12.3	21.5	12.5	4.3	7.4	9.6	18.0	9.1	9.5	37.8	10.9	32.8	15.8	16.1	7.7	9.6	8.7	11.0	9.7	7.3	5.7	27.0	17.4	11.4	10.5	19.1	13.6	59.7	49.9	43.2	21.3	24.0	24.0	12.2	13.2	0.1	0.0	12.9	11.1	0.1	5.0	4.1	5.9	4.6	5.4	14.1	0.0	30.0	5.5	1.3	0.5	3.4	4.5	3.2	3.0	1.5	16.9	4.8	0.0	19.3	10.2	13.0	46.8	12.3	3.8	13.9	4.3	22.6	0.0	7.7	6.2	8.3	22.2	1.0	0.4	22.9	22.1	18.9	0.0	0.0	5.8	7.2	2.1	5.8	12.8	9.1	20.0	23.4	2.4	12.9	16.0	16.5	4.9	0.2	0.6	0.0	4.4	10.3	0.1	8.3	8.2	3.7	20.0	43.2	49.9	24.0	33.4	13.3	13.6	18.1	22.5	59.7	9.8	11.0	16.4	43.2	21.3	22.1	13.6	15.7	24.0	7.6	10.5	4.4	9.0	7.8	5.2	8.5	4.6	9.6	7.3	38.7	65.7	25.0	97.5	66.2	8.4	26.4	94.3	38.8	83.0	48.8	5.9	13.5	222.2	148.8	39.6	154.1	106.2	0.0	394.0	20.1	31.9	94.9	53.1	219.9	155.2	1.6	34.0	66.3	86.6	5.5	24.5	94.8	40.5	32.5	101.6	59.7	258.6	101.7	14.9	620.9	7.1	12.9	32.0	3.2	13.0	65.1	4.8	43.7	91.6	102.1
DUSP26	"DUSP24, MGC1136"	ENSG00000133878	"Dual specificity phosphatase 26"	Q9BV47	8	33591332-33600106	"Enzymes, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"skeletal muscle: 147.1"	"Cell type enhanced"	"Detected in some"	12	"Bipolar cells: 76.1;Cardiomyocytes: 54.3;Cone photoreceptor cells: 39.3;Rod photoreceptor cells: 58.5"	"Cancer enhanced"	"Detected in some"		"glioma: 6.7"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"memory B-cell: 1.5"	"Lineage enriched"	"Detected in single"	16	"B-cells: 1.5"	"Cell line enriched"	"Detected in some"	4	"SCLC-21H: 46.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA018221	Approved		Supported	Nucleoplasm		NA	NA			Nucleoplasm		"HPA018221: AB_2669813"	"unprognostic (2.77e-4)"	"unprognostic (2.70e-2)"	"unprognostic (2.70e-3)"	"unprognostic (5.47e-3)"	"unprognostic (2.01e-1)"	"unprognostic (1.24e-1)"	"unprognostic (1.62e-1)"	"unprognostic (2.53e-2)"	"unprognostic (2.81e-1)"	"unprognostic (1.39e-1)"	"unprognostic (4.10e-3)"	"unprognostic (1.78e-2)"	"unprognostic (2.28e-1)"	"unprognostic (1.52e-2)"	"unprognostic (1.14e-1)"	"unprognostic (8.15e-2)"	"unprognostic (5.80e-2)"	1.3	9.3	11.5	1.4	13.1	1.1	1.2	18.2	14.8	1.1	1.7	4.2	0.0	2.4	1.5	3.4	3.0	2.3	1.5	20.1	9.1	15.9	1.6	1.0	1.7	1.1	10.6	8.8	15.1	2.2	1.0	14.0	1.0	7.6	2.6	1.5	4.4	1.5	1.3	147.1	1.0	1.9	2.0	10.0	1.2	2.6	1.6	3.8	0.0	1.1	27.0	1.3	1.4	0.1	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.2	0.0	0.0	46.2	11.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.1	0.0	0.0	1.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.5	13.1	18.2	14.8	9.1	15.9	10.6	8.8	7.6	3.8	0.0	0.0	0.0	0.2	0.0	76.1	54.3	0.0	0.0	0.0	0.0	39.3	0.0	18.3	0.3	2.8	0.0	0.0	0.0	0.4	0.0	0.0	0.3	0.0	0.0	0.0	23.8	24.6	0.0	0.0	4.4	0.0	0.0	1.7	0.0	0.0	13.3	1.6	0.0	5.6	0.8	58.5	0.0	0.9	0.3	0.1	0.0	0.0	0.0	0.0	0.0
DUSP28	"DUSP26, VHP"	ENSG00000188542	"Dual specificity phosphatase 28"	Q4G0W2	2	240560054-240564014	"Enzymes, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Spermatocytes: 41.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"U-266/70: 13.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA047456, CAB069448"	Uncertain		Uncertain	"Nuclear speckles,Cytosol"		NA	NA			"Nuclear speckles"	Cytosol	"CAB069448: , HPA047456: AB_10961145"	"unprognostic (1.88e-2)"	"unprognostic (9.29e-2)"	"unprognostic (4.86e-2)"	"unprognostic (2.32e-1)"	"unprognostic (1.65e-1)"	"unprognostic (1.07e-2)"	"unprognostic (1.09e-2)"	"unprognostic (7.56e-3)"	"unprognostic (4.13e-3)"	"unprognostic (3.71e-2)"	"prognostic favorable (1.84e-4)"	"unprognostic (9.85e-2)"	"unprognostic (1.80e-3)"	"unprognostic (6.99e-2)"	"unprognostic (2.52e-1)"	"unprognostic (2.59e-1)"	"unprognostic (2.10e-3)"	1.8	2.8	2.7	3.0	3.4	7.9	3.5	6.3	3.7	3.1	2.6	3.3	6.5	2.9	2.6	5.0	3.5	3.1	4.4	16.3	2.8	2.7	3.2	3.4	2.5	6.1	3.5	2.4	2.6	10.2	2.6	5.0	3.2	2.8	4.3	2.8	2.7	3.7	2.4	21.2	4.9	4.2	4.3	2.2	5.9	4.2	8.2	2.3	2.6	4.4	13.4	4.2	2.8	4.5	3.8	3.3	10.7	2.1	2.7	3.3	2.0	1.7	1.6	2.2	2.6	1.4	0.8	2.4	1.9	1.2	1.5	1.1	1.0	4.5	2.7	1.0	1.2	2.3	5.1	1.7	0.7	1.6	3.4	6.4	3.9	3.4	2.5	1.0	2.5	6.7	1.7	1.8	1.0	1.3	2.9	0.7	3.9	2.7	3.3	1.3	1.9	3.1	4.0	1.4	2.6	1.4	3.8	4.8	3.6	1.1	2.9	4.9	2.7	1.8	1.9	2.2	1.4	2.4	4.4	1.7	3.5	2.9	2.2	1.7	13.2	3.8	4.4	2.2	1.9	2.8	10.7	2.1	0.7	2.7	1.4	3.0	2.1	2.8	2.8	1.2	3.8	3.3	3.0	3.6	2.7	1.5	3.3	2.2	2.0	2.7	3.4	6.3	3.6	2.8	2.7	3.5	2.4	2.8	2.3	0.0	5.0	5.1	6.9	3.3	6.3	12.9	12.7	6.7	1.2	12.2	3.9	6.4	13.3	4.1	27.6	3.1	11.8	0.0	5.1	4.0	4.1	8.4	6.9	6.6	10.0	7.9	8.1	2.5	10.3	29.8	2.8	7.0	6.8	8.2	8.1	7.4	3.9	11.8	1.4	11.2	6.6	6.5	5.6	41.1	17.6	4.6	5.8	12.5	10.1	6.8
DUSP3	VHR	ENSG00000108861	"Dual specificity phosphatase 3"	P51452	17	43766121-43778988	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 106.9"	"Cell type enhanced"	"Detected in many"	7	"Cardiomyocytes: 242.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	8	"dendritic cells: 19.5;granulocytes: 5.2;monocytes: 17.0"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA063616			Supported	Nucleoplasm,Cytosol		NA	NA		1300000	Nucleoplasm	Cytosol	"HPA063616: AB_2685061"	"unprognostic (1.52e-1)"	"unprognostic (3.18e-2)"	"unprognostic (1.10e-1)"	"unprognostic (8.54e-2)"	"unprognostic (1.04e-3)"	"prognostic unfavorable (3.00e-4)"	"unprognostic (4.83e-2)"	"unprognostic (8.98e-2)"	"unprognostic (5.13e-1)"	"unprognostic (6.01e-2)"	"unprognostic (1.78e-1)"	"unprognostic (8.40e-3)"	"prognostic favorable (5.49e-5)"	"unprognostic (2.67e-3)"	"unprognostic (5.45e-2)"	"unprognostic (1.94e-1)"	"unprognostic (1.37e-2)"	17.1	17.8	23.1	10.2	20.8	4.6	22.0	14.3	28.6	12.8	28.4	11.1	16.7	13.4	17.5	18.7	23.6	10.6	19.3	64.0	21.5	18.1	27.1	39.9	17.2	9.0	17.6	19.1	9.1	19.2	27.5	11.4	15.0	17.1	22.6	13.1	14.3	11.1	36.6	106.9	8.9	15.2	31.1	12.7	14.5	19.6	8.0	10.8	1.2	13.9	22.8	6.5	20.7	24.1	1.7	19.5	5.2	17.0	0.9	1.7	5.8	10.5	19.2	7.4	7.9	21.6	11.6	6.3	8.0	19.2	18.8	22.8	18.4	7.1	1.6	12.7	15.0	39.0	9.2	11.4	9.8	19.9	3.6	8.7	5.3	8.8	15.0	26.4	0.6	5.6	10.7	17.8	14.5	12.6	20.6	13.1	5.4	4.8	1.8	21.9	7.6	2.7	2.7	3.4	15.1	14.0	3.4	22.3	4.0	26.1	11.2	4.1	7.5	9.4	6.3	23.6	21.3	28.1	14.9	13.6	21.3	14.5	30.2	13.2	9.8	13.0	0.4	25.3	7.5	7.1	5.2	17.0	3.5	1.0	8.9	1.7	1.7	1.5	1.2	19.5	1.6	1.2	1.1	4.1	0.9	10.8	8.2	0.9	5.8	23.1	20.8	14.3	28.6	21.5	18.1	17.6	19.1	17.1	10.8	23.8	16.8	7.2	42.9	19.9	16.3	242.3	48.4	14.7	9.1	40.1	23.6	14.4	34.9	42.9	73.8	32.1	42.0	0.0	50.5	17.5	18.4	41.2	38.1	99.4	73.0	19.1	34.9	27.6	34.5	128.1	13.6	40.3	10.1	32.5	17.6	14.8	50.2	28.1	24.8	69.4	16.6	32.3	35.5	2.4	2.9	25.2	37.6	6.4	14.6	32.8
DUSP4	"HVH2, MKP-2, TYP"	ENSG00000120875	"Dual specificity phosphatase 4"	Q13115	8	29333064-29350668	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"ductus deferens: 46.7;pancreas: 78.6;seminal vesicle: 63.5"	"Cell type enhanced"	"Detected in many"	7	"Basal glandular cells: 94.6;monocytes: 131.7;Pancreatic endocrine cells: 166.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in some"	8	"T-reg: 9.6"	"Lineage enriched"	"Detected in single"	18	"T-cells: 9.6"	"Cell line enhanced"	"Detected in many"		"A549: 29.9;OE19: 27.1;SK-MEL-30: 46.1;WM-115: 37.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA061967			Supported	Nucleoplasm		NA	NA			Nucleoplasm		"HPA061967: AB_2684648"	"unprognostic (1.92e-1)"	"unprognostic (5.97e-3)"	"unprognostic (3.24e-1)"	"unprognostic (6.54e-2)"	"unprognostic (2.18e-2)"	"unprognostic (7.66e-3)"	"unprognostic (7.30e-2)"	"unprognostic (7.08e-2)"	"unprognostic (1.83e-2)"	"unprognostic (9.73e-3)"	"unprognostic (9.60e-3)"	"unprognostic (3.15e-2)"	"prognostic unfavorable (4.19e-4)"	"unprognostic (6.88e-2)"	"unprognostic (1.62e-1)"	"unprognostic (1.08e-2)"	"unprognostic (6.07e-2)"	10.9	3.4	1.2	3.6	1.1	3.4	17.1	4.8	2.7	4.6	1.7	1.0	46.7	0.8	3.2	0.7	1.6	1.3	13.1	1.5	4.6	0.8	0.7	0.4	3.7	1.8	0.8	0.8	1.2	78.6	0.1	3.7	17.7	0.7	4.3	0.9	17.1	8.9	63.5	2.7	3.5	1.3	1.5	1.1	0.6	20.6	1.7	0.2	3.9	1.2	2.0	4.7	7.4	3.0	0.0	0.5	0.0	0.0	0.2	9.6	0.1	11.1	29.9	17.8	0.8	2.2	0.0	1.5	2.3	12.7	7.0	3.1	0.3	5.7	0.0	6.3	1.0	4.9	3.6	0.2	7.7	4.2	0.3	0.6	0.0	1.0	0.2	0.0	0.1	14.6	1.4	5.1	2.1	13.1	15.4	5.7	0.1	0.1	1.3	14.0	12.6	0.0	2.0	3.1	27.1	18.4	0.3	0.5	2.3	16.1	5.9	0.1	9.8	3.2	15.2	46.1	0.3	3.2	0.3	16.0	5.1	0.0	0.0	1.6	3.5	0.4	0.0	15.6	2.6	37.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.4	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.5	9.6	0.1	1.2	1.1	4.8	2.7	4.6	0.8	0.8	0.8	0.7	0.2	0.0	3.2	1.4	94.6	10.8	34.2	1.9	28.1	29.4	15.9	0.0	11.8	2.7	0.0	64.0	3.5	10.8	0.4	0.0	66.9	37.5	8.4	20.9	5.8	0.0	19.5	41.3	93.8	19.6	5.0	19.7	0.3	25.0	62.4	131.7	7.6	0.9	166.3	0.0	0.0	0.0	2.8	12.9	12.2	0.6	0.4	10.5	14.9	8.5	2.2	92.0
DUSP5	HVH3	ENSG00000138166	"Dual specificity phosphatase 5"	Q16690	10	110497838-110511544	"Enzymes, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"Basal glandular cells: 372.8;Urothelial cells: 958.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"gdT-cell: 3.4;non-classical monocyte: 8.8;plasmacytoid DC: 13.3"	"Group enriched"	"Detected in many"	19	"dendritic cells: 13.3;monocytes: 8.8;T-cells: 3.4"	"Cell line enhanced"	"Detected in many"		"hTERT-HME1: 87.7;Karpas-707: 34.0;U-266/70: 48.5"	"Region enhanced"	"Detected in many"		"cerebellum: 68.0"	"Region enriched"	"Detected in many"	5	"cerebellum: 41.9"							NA	NA						"unprognostic (1.25e-1)"	"unprognostic (3.57e-1)"	"unprognostic (5.19e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.76e-2)"	"unprognostic (3.27e-3)"	"unprognostic (6.35e-2)"	"prognostic unfavorable (8.30e-6)"	"unprognostic (1.70e-2)"	"unprognostic (4.60e-2)"	"unprognostic (2.91e-2)"	"unprognostic (1.20e-2)"	"unprognostic (4.20e-3)"	"unprognostic (3.79e-1)"	"unprognostic (3.78e-3)"	"unprognostic (2.32e-1)"	"unprognostic (9.09e-2)"	13.7	11.0	2.8	12.4	5.1	14.5	11.2	19.8	5.2	15.1	12.5	3.3	7.7	5.4	9.1	8.8	55.5	5.6	24.2	11.3	5.2	3.3	9.1	13.1	12.1	9.3	2.9	2.8	6.5	3.9	5.5	8.0	45.1	5.6	15.6	12.4	21.0	9.4	10.0	1.8	6.5	17.6	10.3	7.1	11.4	10.2	13.1	2.1	4.8	7.8	21.9	47.8	31.6	14.3	0.2	13.3	0.4	8.8	0.0	3.4	0.5	4.4	3.0	0.6	1.5	2.4	10.2	2.2	10.6	24.0	5.7	6.9	1.9	6.0	0.5	2.0	2.5	12.2	1.4	0.6	5.5	9.3	12.7	0.3	2.4	0.5	1.1	9.1	0.6	3.2	3.9	7.6	18.2	87.7	2.5	3.5	0.2	0.4	34.0	17.0	1.2	0.1	1.8	2.0	0.4	4.6	0.0	1.3	7.8	19.5	8.7	0.3	0.8	0.7	1.7	3.5	5.7	0.9	0.7	5.5	1.9	1.3	4.6	5.0	48.5	8.6	1.2	7.5	3.3	1.3	0.4	0.2	0.0	3.4	2.0	1.2	0.2	1.8	1.0	0.9	0.0	0.0	1.1	0.1	0.0	8.8	13.3	0.0	0.5	2.8	5.1	19.8	5.2	5.2	3.3	2.9	2.8	5.6	2.1	3.0	8.5	17.2	372.8	58.6	8.2	28.2	7.6	0.0	18.2	33.2	5.9	30.4	5.0	26.2	1.0	35.0	36.5	0.0	4.2	9.9	26.3	104.8	3.5	4.0	9.3	0.0	46.8	165.1	18.3	1.9	1.4	20.8	150.1	76.7	7.8	2.5	31.7	14.0	0.7	0.3	10.6	0.0	31.1	1.0	9.1	89.1	114.9	25.9	7.6	958.4
DUSP6	"MKP-3, PYST1"	ENSG00000139318	"Dual specificity phosphatase 6"	Q16828	12	89347232-89353271	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"	"Disease mutation, Hypogonadotropic hypogonadism, Kallmann syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 125.0"	"Cell type enhanced"	"Detected in many"	9	"Alveolar cells type 2: 270.1;granulocytes: 438.5;Kupffer cells: 216.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"basophil: 125.0"	"Group enriched"	"Detected in many"	11	"granulocytes: 125.0;monocytes: 79.7"	"Cell line enhanced"	"Detected in many"		"AN3-CA: 82.0;NB-4: 58.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB017566, HPA053188, HPA064692"	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"CAB017566: AB_647991, HPA053188: , HPA064692: "	"unprognostic (7.35e-2)"	"unprognostic (1.50e-2)"	"unprognostic (5.77e-2)"	"prognostic favorable (7.21e-4)"	"unprognostic (2.35e-3)"	"unprognostic (2.10e-3)"	"unprognostic (3.76e-2)"	"unprognostic (1.42e-1)"	"unprognostic (8.63e-2)"	"unprognostic (1.67e-2)"	"unprognostic (3.15e-3)"	"unprognostic (2.09e-1)"	"unprognostic (5.91e-3)"	"unprognostic (1.28e-2)"	"unprognostic (3.95e-2)"	"unprognostic (1.86e-2)"	"unprognostic (2.84e-1)"	37.7	7.5	7.2	15.9	11.7	41.3	24.1	3.4	14.7	11.6	12.4	6.2	5.8	6.1	9.8	8.7	12.0	15.4	25.1	16.2	10.5	6.5	17.1	38.4	28.2	13.3	6.9	7.4	7.5	12.2	15.0	13.7	19.7	7.9	17.4	15.3	44.4	64.3	6.3	12.0	8.5	14.6	11.3	7.1	28.4	10.3	4.8	6.4	6.1	21.0	13.3	17.8	15.2	6.9	1.2	9.2	125.0	79.7	1.2	0.9	32.4	1.1	1.1	24.4	82.0	21.1	18.0	0.0	8.8	11.2	1.8	1.3	7.2	1.3	0.0	2.1	3.7	3.4	9.4	0.1	22.0	2.5	0.1	0.1	3.6	0.2	11.4	15.0	15.7	40.2	3.5	7.7	15.5	14.5	18.4	40.7	0.4	0.0	3.8	5.6	0.5	0.5	58.8	14.8	28.0	20.0	40.0	3.0	1.5	25.2	23.7	0.4	17.4	0.2	0.1	46.7	8.7	1.2	8.8	10.9	6.0	0.1	1.1	4.2	0.6	3.2	0.1	24.9	11.1	38.0	125.0	49.5	22.4	0.9	79.7	0.4	0.2	0.2	0.3	9.2	1.2	0.1	0.3	22.5	1.2	74.4	1.2	0.6	32.4	7.2	11.7	3.4	14.7	10.5	6.5	6.9	7.4	7.9	6.4	95.3	270.1	20.5	66.1	80.7	1.2	8.1	53.5	22.7	111.5	171.0	31.4	63.9	14.9	10.9	1.1	97.2	31.9	0.0	11.9	2.9	29.6	20.6	438.5	128.2	43.3	1.6	18.4	173.1	216.2	1.4	1.4	140.4	11.8	1.8	11.0	9.0	12.3	7.4	3.2	23.5	2.0	25.8	8.5	1.2	1.1	21.7	41.2	18.5	12.8	23.4
DUSP7	"MKP-X, PYST2"	ENSG00000164086	"Dual specificity phosphatase 7"	Q16829	3	52048919-52056550	"Enzymes, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	12	"Basal keratinocytes: 104.2;Suprabasal keratinocytes: 118.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"hTCEpi: 41.4;hTERT-HME1: 35.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA073007	Approved					NA	NA					"HPA073007: "	"unprognostic (1.19e-1)"	"unprognostic (1.89e-1)"	"unprognostic (1.66e-1)"	"unprognostic (1.04e-1)"	"unprognostic (1.88e-1)"	"unprognostic (6.16e-3)"	"unprognostic (2.32e-2)"	"unprognostic (2.75e-1)"	"unprognostic (1.44e-1)"	"unprognostic (8.67e-3)"	"unprognostic (7.38e-3)"	"unprognostic (7.74e-3)"	"prognostic unfavorable (8.84e-6)"	"unprognostic (4.86e-2)"	"unprognostic (1.24e-1)"	"unprognostic (2.29e-2)"	"unprognostic (9.46e-2)"	5.5	5.9	7.8	4.3	8.5	1.6	3.7	6.5	19.2	8.6	2.9	15.3	3.4	2.4	5.6	2.4	22.0	4.4	5.3	8.3	7.3	4.8	3.6	2.5	7.0	5.6	9.9	10.0	4.7	4.3	3.9	3.8	8.9	4.9	4.0	2.3	4.6	5.2	5.3	11.4	24.1	3.5	4.2	4.8	10.7	3.7	5.4	9.2	3.2	3.4	15.0	8.6	5.8	14.7	1.0	7.5	1.7	10.7	2.3	8.2	1.7	7.6	1.6	1.9	4.4	6.3	5.5	2.3	7.7	14.8	7.7	5.6	2.1	3.9	2.1	2.1	11.4	3.9	9.0	7.4	28.0	5.3	1.8	3.0	10.0	3.9	3.7	5.1	8.9	6.1	5.7	41.4	9.9	35.3	5.3	7.3	6.2	5.7	6.1	6.1	2.1	6.6	12.7	4.8	2.1	14.0	5.6	1.7	5.6	3.2	3.3	2.4	7.2	3.4	3.2	5.4	1.6	1.1	21.6	9.5	14.9	9.6	15.6	23.5	2.9	2.7	3.4	8.2	15.1	4.7	0.9	3.9	1.7	6.0	10.7	8.2	1.0	7.2	4.3	5.0	0.6	5.3	4.8	1.4	2.3	10.0	7.5	4.6	1.7	7.8	8.5	6.5	19.2	7.3	4.8	9.9	10.0	4.9	9.2	8.9	0.6	1.5	23.5	104.2	4.7	15.3	0.0	1.4	5.7	0.0	0.0	0.4	1.7	3.3	1.1	11.3	0.7	0.0	2.3	3.4	9.0	3.2	0.0	0.4	6.7	0.0	2.4	28.3	10.7	0.0	8.1	8.3	20.3	0.0	2.9	0.9	7.4	0.0	4.6	0.9	1.0	25.8	15.1	3.2	4.3	118.3	1.0	4.5	2.9	24.4
DUSP8	"C11orf81, FLJ42958, HB5, HVH-5"	ENSG00000184545	"Dual specificity phosphatase 8"	Q13202	11	1554044-1571920	"Enzymes, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"brain: 30.2"	"Cell type enhanced"	"Detected in many"	10	"Bipolar cells: 101.5;Cone photoreceptor cells: 45.2;Horizontal cells: 85.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 2.2;MCF7: 6.2;SH-SY5Y: 5.5;U-251 MG: 2.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA020071	Approved		Approved	Cytosol		NA	NA			Cytosol		"HPA020071: AB_1847903"	"unprognostic (2.29e-1)"	"unprognostic (4.15e-2)"	"unprognostic (1.96e-1)"	"unprognostic (4.00e-2)"	"unprognostic (1.35e-1)"	"unprognostic (7.58e-3)"	"unprognostic (6.08e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.44e-3)"	"unprognostic (1.81e-1)"	"unprognostic (4.04e-3)"	"unprognostic (1.82e-1)"	"prognostic favorable (2.75e-6)"	"unprognostic (1.51e-1)"	"unprognostic (1.57e-1)"	"unprognostic (8.65e-2)"	"unprognostic (6.30e-2)"	6.3	2.2	18.8	3.2	18.8	7.5	3.5	20.0	30.2	1.9	4.3	4.2	1.4	1.7	5.9	4.8	3.5	4.0	5.4	5.7	16.6	9.3	2.6	3.7	3.6	3.5	5.5	11.2	2.2	12.7	1.7	10.8	2.8	5.1	3.0	4.1	2.7	5.1	2.7	6.1	3.2	6.3	9.3	3.6	6.3	4.3	2.4	5.1	0.0	2.6	2.2	2.3	2.7	1.6	0.1	0.1	0.0	0.0	0.0	0.7	0.0	1.8	0.8	1.0	0.1	0.0	0.1	2.2	0.1	1.2	0.4	1.2	0.0	0.0	0.1	0.0	0.3	0.0	1.2	0.0	0.2	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.4	0.2	0.4	0.0	0.1	0.1	0.0	1.8	0.0	6.2	0.0	0.4	0.0	0.0	1.9	0.1	0.1	0.7	0.0	0.2	0.0	5.5	0.0	0.0	0.6	0.0	0.0	0.1	0.0	0.2	0.0	1.0	2.3	0.0	0.1	0.1	0.6	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.7	0.0	0.1	0.1	0.4	0.0	0.0	0.0	0.1	0.0	0.0	18.8	18.8	20.0	30.2	16.6	9.3	5.5	11.2	5.1	5.1	3.0	0.6	0.0	5.6	8.8	101.5	5.2	5.1	0.0	0.0	12.2	45.2	0.1	1.7	6.9	0.2	2.2	22.7	0.0	9.6	0.4	4.5	12.8	0.0	0.4	0.4	85.8	40.5	1.3	0.0	0.0	0.6	0.3	5.0	1.8	20.2	16.0	9.8	17.5	0.4	1.1	36.7	6.5	5.1	0.2	0.4	4.3	4.9	1.3	16.8	9.8
DUSP9	"MKP-4, MKP4"	ENSG00000130829	"Dual specificity phosphatase 9"	Q99956	X	153642492-153651326	"Enzymes, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	10	"kidney: 23.0;placenta: 63.1"	"Group enriched"	"Detected in some"	14	"Cytotrophoblasts: 876.9;Distal tubular cells: 616.8;Syncytiotrophoblasts: 1451.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	9	"Hep G2: 90.8"	"Low region specificity"	"Detected in some"			"Group enriched"	"Detected in many"	6	"amygdala: 4.4;basal ganglia: 2.7;cerebral cortex: 3.5;hippocampal formation: 3.7;hypothalamus: 3.6"	HPA003336	Enhanced		Approved	"Endoplasmic reticulum"		NA	NA			"Endoplasmic reticulum"		"HPA003336: AB_1078709"	"unprognostic (4.64e-2)"	"unprognostic (6.48e-2)"	"unprognostic (4.87e-2)"	"prognostic unfavorable (1.60e-4)"	"unprognostic (1.52e-2)"	"unprognostic (2.74e-3)"	"unprognostic (9.36e-3)"	"unprognostic (6.15e-2)"	"unprognostic (2.81e-1)"	"unprognostic (3.03e-1)"	"unprognostic (1.29e-2)"	"unprognostic (1.38e-2)"	"unprognostic (2.68e-7)"	"unprognostic (4.49e-2)"	"unprognostic (2.08e-1)"	"unprognostic (2.77e-2)"	"unprognostic (5.52e-2)"	0.2	0.1	3.2	0.2	4.4	0.1	0.3	0.2	2.0	0.2	0.1	0.7	0.0	0.2	0.1	0.3	0.3	0.2	0.1	0.2	2.5	0.6	23.0	0.7	0.2	0.2	1.1	0.6	1.9	0.5	0.1	0.0	63.1	0.9	0.2	0.1	0.0	0.8	1.5	0.1	0.2	0.2	0.1	0.5	0.2	0.2	1.1	0.8	0.0	0.1	0.0	0.2	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.2	0.0	8.2	0.0	0.0	2.6	0.0	0.0	0.0	0.0	1.6	0.5	0.0	4.0	0.0	0.3	1.8	10.1	0.2	0.0	0.2	1.8	0.0	0.7	90.8	0.0	0.0	1.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.5	0.0	0.2	0.2	0.4	3.7	0.0	0.0	0.0	0.0	2.3	0.1	0.3	0.6	0.7	0.3	0.2	0.1	0.9	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.2	4.4	0.2	2.0	2.5	0.6	1.1	0.6	0.9	0.8	0.0	0.0	0.0	0.6	0.6	0.0	1.8	0.0	0.0	0.0	10.4	0.0	876.9	616.8	0.1	0.0	0.0	0.0	0.0	0.0	57.4	0.2	0.3	0.0	0.8	72.5	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	2.1	0.0	0.0	0.0	0.7	8.3	0.0	1451.1	0.0	0.0	0.9
DUT	dUTPase	ENSG00000128951	"Deoxyuridine triphosphatase"	P33316	15	48331011-48343373	"Enzymes, Predicted intracellular proteins"	"Nucleotide metabolism"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA054422, HPA060360"	Enhanced		Supported	Nucleoplasm		No	Yes			Nucleoplasm		"HPA054422: AB_2682483, HPA060360: AB_2684262"	"unprognostic (1.82e-1)"	"unprognostic (3.49e-2)"	"unprognostic (7.89e-2)"	"unprognostic (5.27e-2)"	"unprognostic (2.20e-1)"	"unprognostic (7.17e-2)"	"unprognostic (1.65e-1)"	"unprognostic (1.16e-2)"	"unprognostic (4.42e-3)"	"unprognostic (1.87e-2)"	"unprognostic (4.25e-1)"	"unprognostic (3.54e-2)"	"unprognostic (3.68e-2)"	"unprognostic (4.23e-2)"	"unprognostic (1.47e-1)"	"unprognostic (2.09e-2)"	"unprognostic (1.71e-2)"	26.9	32.9	23.2	51.1	31.8	69.0	31.9	31.7	27.6	26.8	26.3	24.4	27.2	14.5	29.8	31.8	33.7	26.9	28.2	35.5	23.2	26.5	25.4	19.8	25.7	44.7	25.3	23.6	33.4	22.2	23.7	30.7	26.0	22.5	30.3	24.3	28.1	27.5	26.1	25.6	27.3	22.6	25.6	23.9	30.1	25.8	31.9	20.7	120.3	40.5	37.7	43.2	23.5	28.4	34.5	32.3	17.0	24.5	22.2	40.2	24.3	26.1	8.2	20.1	19.0	14.1	15.0	12.0	27.8	17.7	25.7	31.9	9.5	18.1	73.0	15.0	15.2	21.0	36.0	21.1	19.0	25.2	51.4	21.8	59.6	21.7	12.9	7.8	62.4	28.4	9.2	12.9	17.4	9.2	16.7	17.0	43.7	32.2	41.5	18.9	10.6	55.8	73.5	12.7	26.7	15.9	45.5	44.0	76.7	16.9	17.8	29.2	29.7	20.6	16.7	23.8	21.4	23.6	49.8	14.1	26.9	26.0	32.0	36.4	33.5	69.7	71.9	20.3	107.2	29.5	11.3	19.5	17.0	21.7	19.3	28.1	34.5	38.9	34.2	28.2	31.6	40.2	26.5	11.1	22.2	24.5	32.3	34.4	24.3	23.2	31.8	31.7	27.6	23.2	26.5	25.3	23.6	22.5	20.7	50.6	29.3	108.7	177.4	159.5	41.9	99.9	84.1	24.1	61.4	99.5	13.7	138.0	172.5	82.7	26.1	112.3	21.0	140.2	40.7	245.0	140.4	116.4	84.1	71.8	150.1	77.9	92.4	100.1	85.2	25.7	171.2	102.9	146.8	57.7	93.4	81.1	44.6	42.1	166.9	204.1	36.1	155.2	162.6	380.2	218.4	147.3	81.2	113.3	168.7	147.0
DYRK1A	"DYRK, DYRK1, MNBH"	ENSG00000157540	"Dual specificity tyrosine phosphorylation regulated kinase 1A"	Q13627	21	37365573-37526358	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Host-virus interaction"	"Kinase, Serine/threonine-protein kinase, Transferase, Tyrosine-protein kinase"	"Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA015323, HPA015810"	Approved		Approved	"Nucleoli fibrillar center,Cytosol"		NA	NA			Cytosol	"Nucleoli fibrillar center"	"HPA015323: AB_1847922, HPA015810: AB_1847921"	"unprognostic (2.71e-1)"	"unprognostic (3.35e-2)"	"unprognostic (1.27e-1)"	"unprognostic (5.62e-2)"	"unprognostic (4.17e-2)"	"unprognostic (1.41e-1)"	"unprognostic (1.67e-1)"	"unprognostic (9.28e-2)"	"unprognostic (1.02e-1)"	"unprognostic (1.51e-1)"	"unprognostic (9.95e-2)"	"unprognostic (7.39e-2)"	"unprognostic (9.09e-2)"	"unprognostic (1.07e-1)"	"unprognostic (2.92e-2)"	"unprognostic (3.14e-1)"	"unprognostic (1.40e-2)"	20.0	18.5	19.2	23.4	20.0	49.7	19.9	31.6	24.6	23.7	23.0	16.3	17.6	15.4	24.4	18.7	16.8	19.4	19.0	23.2	18.8	17.9	16.9	16.1	24.8	27.3	15.5	17.8	25.7	17.8	31.0	25.1	25.0	14.0	17.6	18.1	18.5	18.7	22.7	39.8	20.1	18.7	22.7	13.8	24.1	18.5	23.5	16.3	60.9	22.7	17.4	22.1	22.7	29.3	3.0	3.3	6.0	2.5	1.3	3.8	0.8	10.4	8.1	16.6	11.6	7.9	8.6	14.7	9.3	11.8	9.4	9.9	11.5	9.2	14.0	6.3	16.2	12.4	7.1	12.1	9.0	11.1	21.4	5.2	41.4	13.5	7.0	11.8	16.3	15.2	8.7	10.8	12.2	18.7	10.8	9.7	19.8	15.6	32.5	9.8	10.4	21.4	11.2	17.5	10.3	4.8	27.8	9.1	12.9	9.8	13.6	17.1	9.6	21.1	14.5	14.5	5.8	13.5	15.2	12.4	12.9	3.9	8.0	7.7	22.1	17.1	20.0	10.2	18.4	14.0	5.5	1.5	2.0	3.4	2.1	2.1	2.8	3.6	2.6	1.8	3.0	3.8	3.7	6.0	1.3	2.5	3.3	3.1	0.8	19.2	20.0	31.6	24.6	18.8	17.9	15.5	17.8	14.0	16.3	17.9	21.0	14.9	21.8	33.3	28.8	68.6	17.8	18.7	21.6	10.4	25.5	8.2	0.0	11.5	21.3	24.8	20.2	23.3	12.6	9.6	20.6	24.7	24.3	15.3	13.8	44.5	20.5	28.3	24.3	15.3	15.0	20.8	23.6	6.4	16.5	15.6	16.7	20.4	18.4	8.1	19.4	12.9	24.5	15.8	14.0	27.7	12.8	30.6	13.6	28.3
DYRK1B	MIRK	ENSG00000105204	"Dual specificity tyrosine phosphorylation regulated kinase 1B"	Q9Y463	19	39825350-39834201	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase, Tyrosine-protein kinase"	"Diabetes mellitus, Obesity"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 89.1"	"Group enriched"	"Detected in many"	14	"Early spermatids: 145.5;Late spermatids: 469.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"SH-SY5Y: 13.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028522, HPA028786"	Uncertain		Supported	"Nucleoplasm,Mitotic chromosome"		Yes	No			Nucleoplasm	"Mitotic chromosome"	"HPA028522: AB_2672656, HPA028786: AB_10670831"	"unprognostic (2.22e-2)"	"unprognostic (9.86e-2)"	"unprognostic (4.55e-2)"	"unprognostic (3.45e-3)"	"unprognostic (1.96e-1)"	"unprognostic (1.13e-2)"	"unprognostic (2.25e-1)"	"unprognostic (2.39e-1)"	"unprognostic (6.02e-2)"	"unprognostic (3.67e-2)"	"unprognostic (8.93e-2)"	"unprognostic (4.22e-2)"	"prognostic favorable (8.83e-4)"	"unprognostic (9.73e-2)"	"unprognostic (1.12e-1)"	"unprognostic (2.53e-2)"	"unprognostic (3.88e-2)"	4.8	7.9	7.4	3.7	10.2	5.0	4.0	10.1	13.1	4.5	4.2	7.4	6.1	6.2	6.4	12.3	6.7	8.0	4.6	9.0	6.6	6.1	6.1	3.2	5.4	5.1	4.4	6.7	6.1	5.2	7.1	12.3	3.8	6.4	5.5	3.4	6.7	5.5	5.8	89.1	6.3	5.1	3.9	3.4	5.9	5.2	28.8	4.6	11.2	6.4	25.3	5.3	5.6	4.1	4.7	8.3	4.8	3.2	6.2	7.0	2.6	0.4	8.6	8.4	5.9	4.8	4.5	0.7	2.7	1.7	2.5	2.3	0.8	3.3	1.3	10.6	3.2	0.1	2.9	1.2	1.9	2.2	4.9	7.3	0.6	5.4	0.8	4.0	0.3	1.8	6.1	1.2	0.8	2.8	8.2	0.6	3.3	1.4	1.9	0.4	4.3	1.9	0.8	2.0	2.5	2.0	0.9	0.1	0.6	5.4	2.1	12.2	13.8	4.2	4.2	0.2	4.7	4.1	0.5	4.2	1.1	1.9	0.9	0.8	3.1	1.0	0.9	7.1	0.8	0.4	1.2	3.1	3.2	5.9	3.2	7.0	4.7	4.0	5.9	3.5	3.5	2.2	3.5	4.8	6.2	2.9	8.3	4.2	2.6	7.4	10.2	10.1	13.1	6.6	6.1	4.4	6.7	6.4	4.6	0.0	1.1	13.7	3.6	3.1	14.9	5.3	5.1	1.4	0.0	15.7	19.6	1.8	8.3	11.7	145.5	5.7	9.1	0.0	3.7	1.5	4.0	5.4	1.1	3.0	4.9	9.5	19.5	6.2	9.2	469.8	6.6	2.7	5.0	3.6	9.4	8.1	8.6	8.6	4.9	11.2	13.0	0.0	2.3	22.4	14.0	2.5	1.1	6.9	8.5	3.2
DYRK2		ENSG00000127334	"Dual specificity tyrosine phosphorylation regulated kinase 2"	Q92630	12	67648338-67665406	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Apoptosis, Ubl conjugation pathway"	"Kinase, Serine/threonine-protein kinase, Transferase, Tyrosine-protein kinase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Enterocytes: 72.1;Horizontal cells: 76.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA027230, HPA056902"	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA027230: AB_1847925, HPA056902: AB_2683271"	"unprognostic (5.86e-3)"	"unprognostic (4.18e-1)"	"unprognostic (4.08e-3)"	"unprognostic (2.56e-3)"	"unprognostic (1.18e-2)"	"unprognostic (1.69e-1)"	"unprognostic (3.37e-3)"	"unprognostic (7.83e-2)"	"unprognostic (2.83e-2)"	"unprognostic (1.22e-1)"	"unprognostic (1.04e-1)"	"unprognostic (3.47e-1)"	"unprognostic (2.12e-2)"	"unprognostic (2.03e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.57e-1)"	"unprognostic (1.35e-1)"	12.2	5.3	4.5	20.1	4.8	8.6	8.1	4.4	6.6	10.1	21.3	4.1	8.3	13.7	14.6	9.6	9.6	9.1	16.9	26.1	4.7	3.2	6.3	4.6	10.1	17.9	4.0	3.3	7.6	8.5	3.6	4.4	13.0	5.0	7.1	15.3	6.6	7.2	6.6	23.7	9.4	26.0	11.2	5.3	10.3	14.0	4.4	3.9	34.3	7.6	12.5	17.2	11.1	12.2	2.7	1.9	5.9	1.3	6.9	6.8	1.6	13.8	7.8	11.7	8.4	5.9	8.1	9.4	14.1	9.2	6.9	3.9	10.3	7.7	25.8	17.4	20.3	4.2	16.1	9.3	5.5	7.4	11.1	12.2	4.1	5.2	3.9	2.3	9.4	9.1	6.6	7.9	18.6	14.9	11.7	3.8	11.0	5.1	13.5	8.8	7.9	8.0	4.6	10.1	9.0	12.6	21.5	11.6	11.4	8.0	17.4	15.5	18.3	5.9	7.9	8.1	8.3	5.4	7.9	5.7	11.0	10.4	7.5	11.1	6.5	1.0	14.3	10.5	6.4	11.3	3.2	0.5	5.9	5.2	1.3	4.0	2.7	3.9	6.8	1.9	2.7	3.3	6.1	0.7	6.9	1.3	0.8	3.1	1.6	4.5	4.8	4.4	6.6	4.7	3.2	4.0	3.3	5.0	3.9	8.9	12.2	6.4	9.1	10.1	17.2	33.5	22.9	12.0	10.3	1.8	21.6	2.7	0.0	17.2	0.4	10.5	72.1	0.0	15.8	6.4	18.2	11.3	5.7	4.7	14.1	76.3	23.6	6.2	11.6	1.6	10.6	9.8	8.5	6.4	50.5	15.3	15.6	48.2	12.4	7.5	21.9	12.9	21.1	2.5	8.7	14.2	3.8	21.0	26.7	28.1
DYRK3	"hYAK3-2, RED, REDK"	ENSG00000143479	"Dual specificity tyrosine phosphorylation regulated kinase 3"	O43781	1	206635536-206684419	"Enzymes, Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"	"Kinase, Serine/threonine-protein kinase, Transferase, Tyrosine-protein kinase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 38.2"	"Cell type enriched"	"Detected in many"	6	"Early spermatids: 160.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	15	"plasmacytoid DC: 6.1"	"Lineage enriched"	"Detected in single"	15	"dendritic cells: 6.1"	"Cell line enhanced"	"Detected in many"		"hTERT-HME1: 35.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA075041			Supported	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA075041: AB_2686730"	"unprognostic (6.51e-2)"	"unprognostic (1.24e-2)"	"unprognostic (3.36e-2)"	"unprognostic (2.03e-1)"	"unprognostic (2.81e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.20e-4)"	"unprognostic (2.69e-1)"	"unprognostic (3.91e-1)"	"unprognostic (2.71e-1)"	"unprognostic (2.79e-3)"	"unprognostic (2.52e-1)"	"prognostic unfavorable (9.41e-7)"	"unprognostic (2.38e-1)"	"unprognostic (2.04e-1)"	"unprognostic (1.99e-2)"	"unprognostic (7.62e-3)"	7.1	2.7	4.2	4.2	3.5	6.2	7.7	1.3	2.7	5.6	2.7	2.6	3.7	1.2	7.6	5.1	2.7	6.2	12.8	16.3	6.0	3.4	3.4	7.4	5.0	1.6	2.6	2.0	7.6	5.2	2.8	11.2	1.2	4.6	4.5	1.5	4.1	5.5	3.0	2.1	2.0	2.1	7.5	2.7	1.8	3.7	38.2	3.1	5.1	11.9	3.0	1.7	5.4	7.6	0.0	6.1	0.0	0.1	0.0	0.3	0.0	2.5	3.5	0.8	4.9	8.7	7.8	0.1	8.2	18.1	7.5	9.7	0.2	1.3	3.7	1.2	9.6	13.2	0.7	4.2	6.6	8.0	0.0	2.8	5.4	4.4	0.8	13.8	3.7	3.5	5.5	4.3	12.9	35.7	7.7	5.8	5.7	10.4	0.7	11.5	0.9	8.2	2.1	6.9	0.2	6.5	20.4	2.6	0.0	2.4	0.1	5.0	3.7	7.3	0.3	10.0	1.0	0.9	0.9	4.3	15.7	5.9	7.6	6.8	2.9	1.1	4.4	9.3	4.1	1.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.1	0.0	0.0	4.2	3.5	1.3	2.7	6.0	3.4	2.6	2.0	4.6	3.1	3.0	5.1	0.5	10.3	5.8	0.1	10.3	2.5	13.4	5.7	1.8	9.8	0.0	0.0	3.0	160.9	4.2	0.0	0.0	1.9	0.1	7.3	3.2	0.0	1.1	0.9	0.0	2.4	2.5	1.5	27.7	3.7	1.9	8.5	1.8	0.3	3.0	1.4	0.0	1.8	1.0	7.4	6.5	10.3	17.6	3.4	3.1	0.3	0.0	0.2	3.5
DYRK4		ENSG00000010219	"Dual specificity tyrosine phosphorylation regulated kinase 4"	Q9NR20	12	4562204-4615302	"Enzymes, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase, Tyrosine-protein kinase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in all"	9	"testis: 85.9"	"Group enriched"	"Detected in many"	7	"Early spermatids: 369.7;Late spermatids: 289.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA028065, HPA056073"	Enhanced		Enhanced	Vesicles		No	No			Vesicles		"HPA028065: AB_10601212, HPA056073: AB_2683028"	"unprognostic (2.50e-1)"	"unprognostic (1.55e-1)"	"unprognostic (1.22e-1)"	"unprognostic (3.56e-3)"	"unprognostic (2.62e-1)"	"unprognostic (4.07e-3)"	"unprognostic (2.03e-2)"	"unprognostic (4.69e-2)"	"unprognostic (1.29e-1)"	"unprognostic (7.13e-2)"	"unprognostic (1.22e-2)"	"unprognostic (2.46e-1)"	"prognostic unfavorable (6.52e-6)"	"unprognostic (1.86e-1)"	"unprognostic (9.71e-2)"	"unprognostic (1.04e-1)"	"unprognostic (3.98e-2)"	1.6	2.1	2.3	2.1	1.8	1.6	2.8	1.9	2.3	2.6	2.1	2.2	2.3	1.7	2.5	9.1	1.6	2.0	1.7	1.7	1.8	1.8	1.9	2.0	2.2	2.5	1.9	2.5	2.2	2.3	2.9	2.7	2.9	2.3	2.3	2.7	2.4	2.3	3.4	1.6	1.9	2.4	2.1	2.7	4.3	1.7	85.9	2.1	1.6	4.3	1.6	2.0	2.4	1.6	7.6	2.7	1.3	5.2	1.1	1.6	1.6	1.9	3.0	3.8	4.1	5.8	7.2	4.6	2.3	4.6	5.3	5.8	0.6	3.1	5.7	0.3	6.5	3.6	4.0	2.9	4.3	4.2	4.3	6.6	4.0	0.8	3.3	16.4	3.4	3.2	4.9	9.2	3.7	12.2	9.9	7.4	6.3	1.6	6.5	4.7	4.0	3.2	8.5	5.2	1.0	1.7	0.7	2.7	2.4	6.4	1.8	0.0	1.5	0.4	2.3	3.3	8.7	1.8	3.1	0.5	6.2	4.9	0.6	2.9	1.9	2.3	3.4	3.3	5.4	3.2	0.6	2.8	1.3	1.0	2.2	1.1	7.6	1.5	1.6	2.7	5.8	1.6	1.6	0.1	1.1	5.2	1.4	1.1	1.6	2.3	1.8	1.9	2.3	1.8	1.8	1.9	2.5	2.3	2.1	11.9	14.4	11.1	13.1	7.9	20.7	19.4	5.1	12.0	13.6	15.7	9.8	12.9	26.6	22.0	369.7	9.3	4.0	0.0	23.8	10.1	17.5	12.6	17.3	9.2	41.7	12.7	5.2	9.2	15.7	289.4	14.1	15.9	15.1	18.0	47.3	16.6	22.1	15.8	29.7	28.1	17.0	6.5	15.6	20.0	31.5	6.6	8.2	17.3	15.6	9.8
DZIP3	"hRUL138, PPP1R66"	ENSG00000198919	"DAZ interacting zinc finger protein 3"	Q86Y13	3	108589682-108694846	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Ubl conjugation pathway"	"RNA-binding, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"pituitary gland: 57.4"	"Cell type enhanced"	"Detected in many"	10	"Ciliated cells: 183.4;Cone photoreceptor cells: 308.3;Spermatocytes: 314.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035066, HPA049232"	Approved		Approved	Vesicles		No	No			Vesicles		"HPA035066: AB_10601549, HPA049232: AB_2680684"	"unprognostic (1.14e-1)"	"unprognostic (1.90e-1)"	"unprognostic (7.68e-2)"	"unprognostic (3.12e-2)"	"unprognostic (2.15e-1)"	"unprognostic (2.37e-2)"	"unprognostic (3.33e-1)"	"unprognostic (5.16e-2)"	"unprognostic (2.74e-1)"	"unprognostic (3.76e-2)"	"unprognostic (2.59e-3)"	"unprognostic (5.38e-2)"	"prognostic favorable (3.65e-4)"	"unprognostic (6.06e-2)"	"unprognostic (2.78e-2)"	"unprognostic (5.51e-3)"	"unprognostic (3.81e-2)"	4.6	9.3	14.1	4.5	25.7	3.1	5.0	14.5	23.7	5.2	4.4	5.8	2.1	2.8	7.4	9.7	3.8	17.4	5.4	10.8	13.2	18.5	10.5	3.9	6.0	8.4	10.3	16.0	10.3	4.9	10.3	57.4	4.5	20.3	9.2	4.5	4.0	3.3	7.0	10.1	3.4	3.6	7.9	9.2	7.0	6.0	29.9	8.0	10.4	12.0	2.8	7.0	5.0	3.5	6.8	1.8	5.2	1.6	11.7	6.5	1.8	6.5	6.0	17.0	10.2	7.6	7.9	5.8	4.1	8.2	6.9	9.4	8.3	4.5	11.8	8.9	4.4	14.9	2.4	9.7	3.5	14.7	4.3	4.1	5.4	2.2	5.7	4.5	2.1	3.1	8.2	1.9	6.4	8.0	7.1	4.3	7.6	5.1	5.8	13.1	5.9	5.3	2.3	10.4	3.4	4.3	6.8	14.0	1.1	5.8	3.2	11.5	11.0	6.9	0.7	7.4	16.0	10.2	1.8	4.9	6.2	9.5	1.2	3.6	6.7	3.8	23.0	4.7	1.7	7.5	5.2	0.7	1.4	5.0	1.0	6.0	6.8	5.1	6.1	0.6	6.0	4.5	6.0	0.1	11.7	1.6	1.8	6.5	1.8	14.1	25.7	14.5	23.7	13.2	18.5	10.3	16.0	20.3	8.0	11.9	13.8	8.3	8.5	6.6	67.2	33.6	2.5	183.4	29.6	31.4	308.3	19.8	11.6	8.1	23.6	8.2	3.9	0.0	8.1	7.3	13.9	8.8	8.1	3.6	7.8	73.1	50.7	6.7	7.3	46.6	16.1	6.2	6.8	14.4	6.1	33.9	8.4	3.5	16.6	15.3	32.1	19.4	9.2	314.4	93.7	6.5	12.4	18.5	6.3	4.3
E4F1	E4F	ENSG00000167967	"E4F transcription factor 1"	Q66K89	16	2223566-2235742	"Enzymes, Predicted intracellular proteins, Transcription factors"	"Cell cycle, Cell division, Growth regulation, Host-virus interaction, Mitosis, Transcription, Transcription regulation, Ubl conjugation pathway"	"DNA-binding, Repressor, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA052042, HPA069007, HPA071325, HPA072309"	Enhanced		Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"HPA052042: AB_2681705, HPA069007: , HPA071325: AB_2686390, HPA072309: "	"unprognostic (3.05e-1)"	"prognostic favorable (9.13e-4)"	"unprognostic (7.31e-2)"	"unprognostic (4.57e-3)"	"unprognostic (2.89e-1)"	"prognostic favorable (1.10e-4)"	"unprognostic (9.16e-2)"	"unprognostic (4.23e-2)"	"unprognostic (3.08e-1)"	"unprognostic (1.87e-1)"	"unprognostic (1.29e-2)"	"unprognostic (8.49e-3)"	"prognostic unfavorable (5.50e-4)"	"unprognostic (1.85e-1)"	"unprognostic (1.03e-1)"	"unprognostic (5.12e-1)"	"unprognostic (8.93e-3)"	12.4	12.8	18.1	13.8	15.4	21.0	21.0	26.1	18.9	10.8	10.7	11.9	9.3	13.4	14.8	10.4	11.4	10.9	13.5	9.8	14.3	10.7	11.7	12.9	10.0	13.4	16.7	16.4	13.8	17.0	11.6	14.8	12.0	12.8	15.5	5.0	8.7	20.7	13.7	26.7	23.2	14.7	10.3	9.8	18.8	15.9	14.6	17.2	13.3	17.3	9.3	10.6	10.5	13.4	11.5	11.6	15.2	14.2	8.5	14.7	9.3	6.1	11.8	5.0	9.7	2.9	2.7	11.9	8.6	4.0	6.0	4.0	18.9	9.5	9.0	9.3	3.3	3.3	8.4	4.1	4.4	1.1	9.7	14.6	6.4	19.0	10.2	5.7	8.1	11.3	4.0	5.1	5.4	2.5	3.4	4.0	7.9	14.9	6.3	2.2	17.1	10.6	17.3	11.1	3.8	11.0	19.7	5.4	15.5	3.7	4.4	12.6	9.2	10.5	13.1	6.0	1.9	11.4	11.6	7.1	7.1	9.4	7.1	7.2	12.3	5.9	18.2	3.0	5.8	7.2	7.5	10.7	14.6	14.7	13.1	12.5	11.5	12.0	13.6	11.6	11.5	13.2	11.9	15.2	8.5	14.2	7.0	14.1	9.3	18.1	15.4	26.1	18.9	14.3	10.7	16.7	16.4	12.8	17.2	14.9	8.0	14.5	6.7	6.4	13.9	3.5	5.1	4.0	12.5	10.4	35.3	16.5	10.0	9.5	11.4	7.8	14.4	0.0	9.1	14.7	8.0	8.1	2.3	8.9	11.0	28.6	24.8	6.7	6.1	3.3	10.6	7.6	6.8	9.0	15.3	9.1	9.7	10.5	15.2	6.8	14.0	12.9	9.2	14.8	15.2	7.9	11.2	8.7	11.8	6.0
EARS2	"KIAA1970, MSE1"	ENSG00000103356	"Glutamyl-tRNA synthetase 2, mitochondrial"	Q5JPH6	16	23522014-23557731	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Protein biosynthesis"	"Aminoacyl-tRNA synthetase, Ligase, RNA-binding"	"Disease mutation, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Erythroid cells: 23.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043289, HPA043633"	Approved		Approved	Nucleoplasm,Mitochondria		NA	NA			Mitochondria	Nucleoplasm	"HPA043289: AB_10963932, HPA043633: AB_10959901"	"unprognostic (3.10e-2)"	"unprognostic (1.60e-1)"	"unprognostic (3.65e-3)"	"unprognostic (4.20e-1)"	"unprognostic (3.57e-1)"	"unprognostic (4.64e-2)"	"unprognostic (2.73e-1)"	"unprognostic (2.91e-2)"	"unprognostic (1.16e-1)"	"unprognostic (2.99e-2)"	"prognostic unfavorable (7.20e-4)"	"unprognostic (8.09e-2)"	"prognostic favorable (3.16e-6)"	"unprognostic (2.48e-1)"	"unprognostic (1.80e-1)"	"unprognostic (1.19e-1)"	"unprognostic (4.29e-2)"	8.4	19.0	11.0	8.5	19.0	2.7	13.6	13.4	16.8	11.1	10.0	10.8	12.7	6.4	11.4	10.2	10.5	13.1	7.8	14.9	10.9	11.9	14.5	18.3	7.3	8.1	9.9	14.0	12.0	18.9	32.7	10.9	12.4	10.3	11.3	11.0	8.8	16.4	11.7	17.3	11.1	6.9	8.3	9.3	7.6	9.2	12.6	10.4	6.3	14.5	9.0	11.0	8.6	16.9	3.0	6.2	0.5	5.5	10.6	7.9	3.3	8.2	16.8	7.9	12.7	5.5	7.9	9.6	9.2	7.0	11.4	9.5	12.2	8.4	11.5	9.5	8.5	7.1	9.3	29.7	16.9	10.9	4.6	14.4	6.7	10.3	20.6	8.9	7.4	8.4	8.5	10.1	10.2	14.4	8.6	5.1	11.6	20.7	6.1	8.1	17.5	7.3	5.3	20.8	11.8	5.9	13.2	9.1	22.1	14.4	7.2	14.1	10.4	7.2	13.6	7.3	13.3	18.4	8.3	4.0	9.0	8.0	9.9	11.6	11.2	10.6	9.3	9.1	10.3	13.3	0.0	2.8	0.3	4.2	3.6	7.9	3.0	4.7	4.3	6.2	3.0	4.6	4.5	0.5	10.6	5.5	4.5	3.4	3.3	11.0	19.0	13.4	16.8	10.9	11.9	9.9	14.0	10.3	10.4	8.9	5.1	3.0	3.5	1.9	3.8	9.8	2.5	6.7	2.3	3.5	2.0	12.9	5.0	6.5	2.1	3.5	1.3	23.3	3.1	9.9	3.3	3.5	5.7	10.5	6.3	7.9	5.2	4.3	1.8	1.9	2.3	3.1	5.0	6.4	5.5	2.8	4.1	0.0	1.8	6.8	3.7	0.0	1.9	4.3	10.4	2.6	9.5	2.5	5.5	2.7
EBP	"CDPX2, CHO2, CPX, CPXD"	ENSG00000147155	"Emopamil binding protein (sterol isomerase)"	Q15125	X	48521158-48528716	"Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins"	"Cholesterol biosynthesis, Cholesterol metabolism, Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis, Steroid metabolism, Sterol biosynthesis, Sterol metabolism"	Isomerase	"Cataract, Disease mutation, Dwarfism, Ichthyosis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 74.1"	"Cell type enhanced"	"Detected in all"	7	"Hepatocytes: 389.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003130	Approved		Supported	"Endoplasmic reticulum"		NA	NA			"Endoplasmic reticulum"		"HPA003130: AB_1078717"	"unprognostic (1.90e-1)"	"unprognostic (2.64e-2)"	"unprognostic (2.80e-1)"	"unprognostic (6.27e-2)"	"unprognostic (3.41e-1)"	"unprognostic (1.64e-1)"	"unprognostic (1.13e-1)"	"unprognostic (1.15e-1)"	"unprognostic (1.34e-1)"	"unprognostic (1.87e-1)"	"unprognostic (4.72e-2)"	"unprognostic (1.47e-1)"	"unprognostic (5.14e-2)"	"unprognostic (4.04e-2)"	"unprognostic (5.39e-2)"	"unprognostic (4.13e-1)"	"unprognostic (1.36e-1)"	3.7	33.2	5.3	4.3	5.7	10.5	10.5	10.1	6.3	8.6	19.6	2.8	3.4	17.2	4.0	3.7	20.6	3.9	4.5	21.7	4.7	4.3	12.8	74.1	14.9	13.0	3.5	8.0	4.8	11.7	6.0	3.7	4.2	8.8	8.6	15.7	5.2	8.7	4.8	3.5	9.1	30.0	5.6	7.0	7.9	8.1	5.4	2.8	9.0	4.6	9.8	10.4	5.0	10.0	17.1	22.9	21.5	12.6	13.3	29.9	18.1	33.6	7.1	18.9	11.3	10.5	7.8	6.1	8.6	7.2	11.5	16.6	14.1	56.2	18.2	6.1	6.0	11.3	37.9	31.6	46.7	8.7	14.0	15.8	9.2	9.5	12.1	7.7	33.8	22.8	7.6	17.0	15.3	11.4	2.9	7.6	12.9	11.7	17.3	9.4	14.7	18.8	20.7	19.0	9.7	23.4	13.0	1.9	51.6	28.1	6.0	16.1	8.1	31.8	16.4	4.5	12.6	18.0	8.1	8.0	5.9	10.0	22.7	9.4	7.4	11.6	18.4	13.7	34.1	5.6	17.4	8.9	21.5	29.9	11.7	25.1	17.1	22.2	27.5	12.3	12.6	20.1	25.5	1.8	13.3	12.6	22.9	22.4	18.1	5.3	5.7	10.1	6.3	4.7	4.3	3.5	8.0	8.8	2.8	29.8	39.6	41.7	45.2	33.0	23.7	36.3	81.5	22.7	21.6	50.6	7.9	40.6	33.2	80.2	5.4	24.3	135.6	46.7	207.1	93.9	32.6	42.4	40.3	389.0	57.0	7.9	28.8	28.8	26.6	7.8	12.4	34.4	35.4	47.7	72.4	13.4	126.3	129.8	13.8	76.4	15.9	12.9	20.6	8.6	20.0	39.6	31.4	74.7	134.2	61.7
ECE1	ECE	ENSG00000117298	"Endothelin converting enzyme 1"	P42892	1	21217247-21345504	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"		"Hydrolase, Metalloprotease, Protease"	"Disease mutation, Hirschsprung disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"parathyroid gland: 114.4"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"neutrophil: 21.5"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HUVEC TERT2: 103.3;TIME: 91.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001490, HPA013616"	Enhanced					NA	NA		2100000			"HPA001490: AB_1078718, HPA013616: AB_1847963"	"unprognostic (7.90e-2)"	"unprognostic (1.01e-1)"	"unprognostic (1.48e-1)"	"unprognostic (1.99e-2)"	"unprognostic (1.49e-2)"	"unprognostic (1.46e-1)"	"unprognostic (5.24e-2)"	"unprognostic (1.23e-1)"	"unprognostic (6.20e-2)"	"unprognostic (1.92e-3)"	"unprognostic (1.04e-1)"	"unprognostic (2.56e-1)"	"unprognostic (7.70e-2)"	"unprognostic (3.55e-2)"	"unprognostic (9.10e-2)"	"unprognostic (1.97e-2)"	"unprognostic (1.97e-2)"	44.0	49.9	10.3	18.7	14.5	17.3	33.7	3.6	15.6	29.5	27.5	19.2	11.2	12.4	24.0	10.5	15.6	19.1	23.0	30.9	12.4	8.0	14.9	41.8	30.1	14.4	13.9	13.4	34.2	42.1	114.4	21.6	27.0	14.6	27.9	14.6	26.5	14.7	11.4	15.2	14.8	23.2	24.1	13.2	23.5	18.9	19.1	14.7	9.5	23.2	10.7	19.1	34.2	37.0	4.6	2.0	21.5	7.5	1.0	6.1	4.2	13.8	9.3	12.0	6.0	17.4	18.6	6.9	20.7	36.1	11.3	10.4	6.7	42.8	5.0	52.1	20.8	24.4	5.9	4.9	9.9	9.9	12.6	4.1	7.2	14.4	5.4	23.2	1.0	1.8	9.7	11.6	17.4	8.7	30.9	103.3	4.1	1.4	2.7	9.5	2.9	2.1	1.6	3.6	3.9	7.3	2.5	6.9	7.2	17.6	2.5	4.1	10.0	20.5	12.1	8.9	6.8	8.7	3.0	91.7	25.5	12.4	11.2	11.9	4.1	7.0	5.8	52.9	2.4	30.7	0.1	5.8	2.2	2.2	7.5	3.3	4.6	4.6	3.5	0.5	3.1	3.1	1.9	21.5	1.0	5.2	2.0	6.1	4.2	10.3	14.5	3.6	15.6	12.4	8.0	13.9	13.4	14.6	14.7	17.9	9.8	18.9	17.1	18.0	1.9	16.1	7.6	10.7	28.4	22.7	0.0	3.6	5.0	21.9	1.1	83.9	51.8	23.3	49.4	26.8	34.3	33.0	18.4	32.5	3.1	0.0	24.2	95.8	8.2	1.7	40.3	5.1	6.8	27.9	10.9	57.2	80.7	84.2	51.9	7.4	4.7	38.8	42.9	1.1	4.7	14.1	8.8	10.7	20.9	38.3
ECEL1	"DINE, XCE"	ENSG00000171551	"Endothelin converting enzyme like 1"	O95672	2	232479827-232487828	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"		"Hydrolase, Metalloprotease, Protease"	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 28.6;ovary: 57.1"	"Group enriched"	"Detected in some"	19	"Muller glia cells: 76.3;Peritubular cells: 19.8"	"Cancer enhanced"	"Detected in many"		"endometrial cancer: 12.9"	"Region enriched"	"Detected in many"	5	"hypothalamus: 28.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"AN3-CA: 30.1;HeLa: 15.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA067560, HPA069756, HPA077424"	Approved	Supported	Approved	"Nucleoplasm,Nuclear membrane,Nucleoli"		NA	NA			Nucleoplasm	"Nuclear membrane, Nucleoli"	"HPA067560: , HPA069756: , HPA077424: "	"unprognostic (1.21e-2)"	"unprognostic (1.06e-2)"	"unprognostic (4.39e-1)"	"unprognostic (4.62e-3)"	"unprognostic (2.80e-1)"	"unprognostic (9.96e-4)"	"unprognostic (7.56e-3)"	"unprognostic (1.22e-1)"	"unprognostic (9.89e-3)"	"unprognostic (8.49e-2)"	"unprognostic (1.54e-1)"	"unprognostic (2.89e-1)"	"unprognostic (1.24e-5)"	"unprognostic (3.09e-2)"	"unprognostic (3.68e-1)"	"unprognostic (7.84e-2)"	"unprognostic (5.45e-2)"	0.9	2.6	0.5	0.9	4.0	0.2	0.4	0.7	1.2	0.3	0.4	0.5	0.1	0.3	0.6	4.9	0.3	1.7	1.0	1.1	0.1	28.6	1.0	0.7	0.2	1.2	0.3	0.1	57.1	0.6	0.3	8.9	0.4	5.5	0.3	0.2	11.5	0.3	1.2	1.8	0.3	0.3	1.1	4.5	2.0	0.3	0.8	1.6	0.1	0.5	0.3	0.5	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	30.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.4	0.3	0.0	0.1	0.0	0.4	0.0	0.0	0.0	2.7	0.0	15.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	2.1	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	3.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	4.0	0.7	1.2	0.1	28.6	0.3	0.1	5.5	1.6	0.0	0.0	0.0	0.0	0.0	2.6	1.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.1	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	1.4	0.0	0.0	0.0	0.0	76.3	0.2	0.0	19.8	0.0	1.7	0.0	2.1	0.2	1.7	0.0	0.0	0.0	0.0	0.0
ECHDC1	dJ351K20.2	ENSG00000093144	"Ethylmalonyl-CoA decarboxylase 1"	Q9NTX5	6	127288710-127343609	"Enzymes, Plasma proteins, Predicted intracellular proteins"		Lyase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035445, HPA035446"	Uncertain		Approved	Vesicles		NA	NA			Vesicles		"HPA035445: AB_10669860, HPA035446: AB_2732468"	"unprognostic (9.57e-2)"	"unprognostic (1.63e-2)"	"unprognostic (2.46e-3)"	"unprognostic (1.34e-1)"	"unprognostic (4.09e-1)"	"unprognostic (3.68e-2)"	"unprognostic (5.03e-3)"	"unprognostic (4.89e-3)"	"unprognostic (4.97e-2)"	"unprognostic (1.76e-1)"	"unprognostic (3.99e-1)"	"unprognostic (9.97e-2)"	"unprognostic (8.21e-3)"	"unprognostic (6.83e-2)"	"unprognostic (2.86e-1)"	"unprognostic (1.39e-1)"	"unprognostic (1.40e-2)"	40.1	16.8	20.8	16.5	23.1	6.8	21.9	16.6	21.4	18.6	27.2	12.0	12.8	21.9	13.7	15.5	20.6	11.4	16.1	20.0	19.4	18.0	44.4	44.3	26.8	17.8	27.3	16.5	11.9	14.2	14.5	16.1	17.0	23.1	19.8	26.3	15.1	22.2	14.5	22.0	13.3	25.8	30.1	27.3	14.1	18.1	8.3	20.9	20.7	42.4	14.2	19.4	24.2	22.6	13.2	29.6	13.4	31.2	6.4	11.6	16.9	15.9	12.8	18.4	16.9	27.3	26.0	15.6	26.2	31.8	22.6	28.8	22.2	12.2	24.3	22.5	24.8	25.6	13.2	0.0	19.6	28.6	14.4	12.3	32.3	17.2	35.2	24.3	43.1	18.2	29.3	23.7	21.0	17.9	20.5	20.4	17.9	40.0	14.7	30.0	15.1	28.5	20.0	15.1	8.0	15.9	13.4	22.6	19.9	41.1	19.8	21.1	20.6	14.7	0.5	35.9	14.6	0.5	50.5	21.1	13.9	22.3	35.0	29.1	19.0	38.0	31.9	25.4	37.8	32.6	6.2	31.2	10.0	11.0	25.6	11.6	12.8	9.5	10.8	29.6	13.2	11.6	11.6	13.4	6.4	17.9	22.6	9.6	16.9	20.8	23.1	16.6	21.4	19.4	18.0	27.3	16.5	23.1	20.9	89.3	91.1	32.9	31.3	23.2	25.4	53.7	25.5	48.2	87.6	29.6	29.5	92.5	107.8	66.8	54.2	29.5	50.2	0.0	69.9	70.0	41.4	25.3	42.7	52.3	76.6	27.0	13.3	22.1	48.0	20.2	30.5	56.1	33.7	19.0	31.2	28.6	47.4	28.1	29.4	160.1	37.1	25.8	25.6	26.9	22.6	19.9	54.8	31.9	50.3	46.0
ECHS1	SCEH	ENSG00000127884	"Enoyl-CoA hydratase, short chain 1"	P30084	10	133362480-133373689	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Fatty acid metabolism, Lipid metabolism"	Lyase	"Disease mutation, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 148.2"	"Cell type enhanced"	"Detected in all"	11	"Hepatocytes: 1338.6;Proximal tubular cells: 2021.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB003783, HPA021995, HPA022476"	Enhanced		Enhanced	Mitochondria		NA	NA		1500000	Mitochondria		"CAB003783: , HPA021995: AB_1847974, HPA022476: AB_1847975"	"unprognostic (3.68e-1)"	"unprognostic (2.46e-3)"	"unprognostic (9.57e-2)"	"unprognostic (4.70e-2)"	"unprognostic (1.59e-1)"	"unprognostic (3.14e-1)"	"unprognostic (2.51e-3)"	"unprognostic (2.30e-1)"	"unprognostic (1.82e-2)"	"unprognostic (2.28e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.27e-1)"	"prognostic favorable (8.57e-5)"	"unprognostic (2.84e-2)"	"unprognostic (1.19e-2)"	"unprognostic (3.04e-2)"	"unprognostic (2.50e-2)"	36.5	18.7	16.6	9.1	16.6	5.0	15.2	8.2	18.3	8.8	21.8	13.0	34.7	22.8	9.5	14.1	16.5	12.2	17.4	29.8	14.6	11.5	62.1	148.2	6.3	7.8	14.8	10.3	11.6	16.3	9.2	11.0	12.8	11.1	13.9	14.0	11.0	40.2	38.4	35.7	8.8	32.1	9.9	11.9	7.3	11.0	10.2	10.2	3.9	16.2	17.5	13.0	11.2	7.8	39.4	53.7	18.3	45.7	33.5	32.1	44.5	28.9	36.3	19.8	49.3	28.7	18.6	18.1	21.3	28.2	29.8	25.2	79.7	28.1	21.8	18.5	23.9	15.6	27.2	25.7	21.6	21.6	16.7	45.0	21.8	22.0	56.6	24.2	28.1	15.5	20.7	18.7	19.7	25.2	26.5	26.3	15.9	19.6	19.2	28.9	68.6	14.0	55.0	13.8	45.9	43.6	24.2	24.0	11.6	36.8	37.1	12.8	20.3	22.0	36.6	27.7	11.9	28.5	27.2	21.1	13.4	19.5	27.9	28.0	14.4	8.8	24.8	31.9	15.4	11.1	17.0	41.7	18.3	24.9	45.7	32.1	39.4	28.1	27.1	53.7	32.2	28.9	27.9	4.4	33.5	34.3	23.2	26.0	44.5	16.6	16.6	8.2	18.3	14.6	11.5	14.8	10.3	11.1	10.2	41.7	72.4	78.2	79.8	60.7	58.8	224.4	180.9	62.9	56.9	165.7	5.9	406.8	479.1	144.4	24.0	65.0	374.4	46.7	88.5	126.6	74.8	83.9	89.0	1338.6	193.8	42.9	126.4	78.5	88.6	29.7	71.9	72.7	128.2	149.7	152.5	112.9	99.9	252.6	86.3	2021.6	42.1	84.1	76.9	50.6	40.1	66.7	250.1	49.0	276.7	103.8
ECI1	DCI	ENSG00000167969	"Enoyl-CoA delta isomerase 1"	P42126	16	2239395-2252300	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Fatty acid metabolism, Lipid metabolism"	Isomerase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 90.3"	"Cell type enhanced"	"Detected in many"	5	"Distal tubular cells: 255.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041746, HPA043227"	Enhanced		Enhanced	Mitochondria		NA	NA		11000000	Mitochondria		"HPA041746: AB_10960693, HPA043227: AB_10960273"	"unprognostic (4.99e-2)"	"prognostic favorable (3.04e-5)"	"unprognostic (3.75e-1)"	"unprognostic (2.92e-3)"	"unprognostic (8.90e-2)"	"unprognostic (2.85e-2)"	"prognostic favorable (1.07e-4)"	"unprognostic (1.98e-1)"	"unprognostic (2.17e-1)"	"unprognostic (5.14e-3)"	"unprognostic (6.32e-2)"	"unprognostic (2.66e-2)"	"prognostic favorable (8.99e-8)"	"unprognostic (2.61e-2)"	"unprognostic (3.31e-1)"	"unprognostic (1.97e-1)"	"unprognostic (6.08e-3)"	15.7	12.5	12.5	9.8	10.8	9.1	16.8	12.8	11.3	10.9	27.6	9.7	20.3	30.9	10.6	16.7	15.5	13.4	17.3	56.4	10.1	10.3	36.5	57.4	10.3	10.7	12.4	8.8	10.8	30.4	11.1	11.9	10.6	13.0	13.4	8.4	16.3	40.9	19.1	90.3	10.4	31.2	14.1	10.1	8.0	17.2	8.4	9.6	10.4	38.7	25.4	10.5	14.4	11.5	7.6	6.5	3.9	7.1	5.8	6.7	1.7	7.3	17.7	6.8	27.8	2.6	3.7	25.5	7.4	5.2	6.2	9.1	31.1	22.7	10.7	18.7	4.6	4.4	18.3	7.9	7.1	0.8	18.5	40.7	3.3	16.5	38.4	23.8	9.6	1.5	6.8	16.8	5.1	11.1	4.4	6.1	0.2	17.7	22.7	2.1	30.4	0.9	14.4	15.7	11.9	17.9	33.6	7.3	51.4	11.7	8.4	23.4	14.8	18.1	34.1	22.5	3.5	22.0	17.1	5.0	4.8	18.1	5.2	8.3	25.2	14.8	17.4	6.3	8.9	6.8	3.2	6.8	2.7	3.8	7.1	6.0	7.6	5.5	2.9	5.5	7.4	6.7	5.6	3.9	5.8	4.2	6.5	6.7	1.7	12.5	10.8	12.8	11.3	10.1	10.3	12.4	8.8	13.0	9.6	3.0	23.3	31.8	94.0	18.9	51.2	90.1	94.3	9.4	14.8	73.3	41.2	151.4	255.4	28.6	6.2	23.5	150.2	0.0	31.7	67.6	25.6	72.7	5.7	199.4	41.4	20.6	43.7	26.4	26.7	4.2	22.7	23.7	37.1	14.4	73.5	52.4	28.1	70.2	22.6	187.7	57.7	0.0	30.2	2.5	15.8	19.4	91.9	17.5	89.4	98.4
ECI2	"ACBD2, DRS1, HCA88, PECI"	ENSG00000198721	"Enoyl-CoA delta isomerase 2"	O75521	6	4115689-4135597	"Enzymes, Predicted intracellular proteins"		Isomerase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 102.3"	"Cell type enhanced"	"Detected in all"	8	"Distal tubular cells: 363.1;Proximal tubular cells: 504.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"							"Low region specificity"	"Detected in all"			"HPA022130, HPA031626"	Enhanced		Enhanced	Peroxisomes,Mitochondria		NA	NA			"Peroxisomes, Mitochondria"		"HPA022130: AB_1855176, HPA031626: AB_2673965"	"unprognostic (2.36e-1)"	"unprognostic (1.76e-2)"	"unprognostic (1.71e-2)"	"unprognostic (1.04e-2)"	"unprognostic (1.00e-2)"	"prognostic unfavorable (2.85e-4)"	"unprognostic (1.17e-3)"	"unprognostic (4.97e-2)"	"unprognostic (9.49e-2)"	"unprognostic (3.95e-3)"	"unprognostic (3.17e-2)"	"unprognostic (5.75e-2)"	"prognostic favorable (2.04e-6)"	"unprognostic (1.40e-1)"	"unprognostic (1.23e-1)"	"unprognostic (8.45e-2)"	"unprognostic (1.34e-1)"	17.9	29.2	13.2	7.3	17.4	4.5	17.0	8.9	9.5	15.7	18.0	10.7	14.9	16.2	15.2	26.2	10.6	12.7	12.4	32.1	10.3	11.1	56.8	102.3	7.4	8.9	13.3	7.2	19.0	59.2	8.9	17.2	11.1	10.3	14.6	14.0	13.3	9.0	10.5	45.7	5.6	22.7	10.3	11.9	10.1	23.2	11.9	9.3	13.3	17.7	26.6	7.5	12.6	8.9	20.6	25.1	7.0	16.2	25.5	27.7	16.7	17.8	9.7	16.3	35.3	20.5	30.5	2.0	25.3	25.9	27.6	24.7	7.3	2.7	0.7	31.9	27.5	25.1	9.4	18.4	14.7	40.2	6.7	21.1	9.4	13.7	39.3	11.9	8.5	4.7	20.9	9.0	23.5	13.2	37.6	57.5	30.4	30.8	6.9	26.1	7.1	24.0	21.2	11.0	1.7	34.8	23.3	20.2	0.3	14.9	3.6	0.3	7.6	1.5	10.6	22.3	30.8	24.5	4.0	58.0	20.8	11.4	18.4	15.0	10.5	18.8	1.8	10.7	7.5	16.1	6.9	15.5	7.0	18.9	11.5	25.9	19.9	22.3	26.4	25.1	20.6	27.7	27.1	0.4	25.5	16.2	19.2	23.6	16.7	13.2	17.4	8.9	9.5	10.3	11.1	13.3	7.2	10.3	9.3	26.8	25.1	23.1	44.0	16.3	13.3	158.2	86.6	121.8	59.1	34.9	11.8	242.5	363.1	46.4	49.2	44.3	33.7	46.7	154.5	15.1	57.4	23.5	22.0	167.8	55.4	17.5	50.1	41.7	22.4	39.8	58.7	24.7	33.7	36.1	38.2	54.7	71.1	41.2	47.7	504.9	43.8	25.8	23.7	25.7	33.2	11.2	85.2	49.0	60.0	20.4
EDEM3	C1orf22	ENSG00000116406	"ER degradation enhancing alpha-mannosidase like protein 3"	Q9BZQ6	1	184690231-184754913	"Enzymes, Predicted intracellular proteins"	"Unfolded protein response"	Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA025754, HPA025755, HPA027297"	Approved		Approved	"Endoplasmic reticulum"	"Intracellular and membrane"	NA	NA			"Endoplasmic reticulum"		"HPA025754: AB_1845638, HPA025755: AB_1845639, HPA027297: AB_2672205"	"unprognostic (1.74e-1)"	"unprognostic (1.64e-2)"	"unprognostic (3.08e-2)"	"unprognostic (2.67e-2)"	"unprognostic (2.30e-1)"	"unprognostic (3.10e-2)"	"unprognostic (7.52e-3)"	"unprognostic (1.82e-1)"	"unprognostic (7.06e-2)"	"unprognostic (1.66e-1)"	"unprognostic (1.66e-1)"	"unprognostic (3.53e-2)"	"prognostic unfavorable (1.63e-6)"	"unprognostic (4.72e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.08e-2)"	"unprognostic (2.01e-1)"	12.5	12.6	10.8	11.3	13.8	6.4	11.1	15.2	11.8	13.2	17.6	7.5	10.8	16.0	11.7	7.7	10.9	10.2	10.4	10.4	9.1	8.2	9.6	27.8	13.3	8.9	13.5	8.4	8.8	27.3	18.4	26.4	17.9	10.6	12.3	21.3	7.6	18.3	14.3	20.8	7.1	14.4	10.6	13.3	9.5	31.3	6.2	11.5	15.8	11.5	6.3	10.6	11.6	16.1	2.7	5.9	7.4	6.8	4.0	6.3	3.4	6.6	5.0	7.0	6.1	25.4	26.2	11.3	13.5	9.4	5.2	5.4	2.6	19.3	4.6	14.8	10.2	5.2	9.1	6.6	7.0	7.6	4.5	5.4	6.1	5.3	3.7	9.8	15.9	9.0	14.9	8.7	12.5	11.2	9.7	13.8	12.5	16.0	21.7	9.8	5.5	12.7	8.3	9.7	15.1	4.7	5.6	5.3	15.8	7.5	4.7	7.8	11.1	6.6	11.5	9.3	12.1	10.8	25.0	16.2	7.4	3.4	15.7	11.3	33.3	12.8	6.2	9.9	18.2	16.2	7.4	6.8	4.1	2.9	6.7	5.1	2.7	4.5	3.5	5.9	2.0	6.3	3.3	6.9	4.0	6.3	3.0	3.0	3.4	10.8	13.8	15.2	11.8	9.1	8.2	13.5	8.4	10.6	11.5	17.9	13.4	12.2	6.8	14.8	27.8	13.7	10.2	22.7	23.9	14.0	23.6	10.6	0.0	11.1	14.7	22.4	27.1	0.0	30.7	9.0	21.5	26.1	20.7	38.0	11.5	20.6	29.4	20.9	41.6	5.6	19.0	19.1	18.6	4.6	60.6	8.0	21.3	21.0	17.0	8.1	14.2	19.4	14.1	14.3	8.1	17.9	16.2	13.1	29.1	15.2
EEF2K	eEF-2K	ENSG00000103319	"Eukaryotic elongation factor 2 kinase"	O00418	16	22206282-22288732	"Enzymes, Predicted intracellular proteins"		"Calmodulin-binding, Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Late spermatids: 60.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HaCaT: 4.0;HMC-1: 4.8;NB-4: 4.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB007818, HPA056061"	Approved		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"CAB007818: AB_598150, HPA056061: AB_2683021"	"unprognostic (4.79e-2)"	"unprognostic (6.10e-1)"	"unprognostic (3.89e-2)"	"unprognostic (3.49e-1)"	"unprognostic (1.94e-2)"	"unprognostic (5.09e-3)"	"unprognostic (1.40e-1)"	"unprognostic (2.24e-2)"	"unprognostic (1.74e-1)"	"unprognostic (8.50e-2)"	"unprognostic (2.01e-2)"	"unprognostic (9.07e-3)"	"prognostic unfavorable (2.38e-4)"	"unprognostic (2.86e-1)"	"unprognostic (1.11e-1)"	"unprognostic (1.24e-1)"	"unprognostic (1.80e-1)"	16.8	5.5	5.3	8.6	3.7	7.6	12.4	17.5	4.8	14.3	10.7	1.3	9.4	5.6	13.2	8.3	6.1	8.2	12.5	9.0	3.2	3.3	3.7	5.5	9.2	6.7	2.4	4.9	6.4	8.1	3.3	3.0	6.4	4.9	12.5	4.6	4.4	12.4	20.5	16.2	37.5	5.1	15.5	1.6	6.1	6.4	4.6	3.1	4.0	4.4	11.5	6.7	13.3	14.2	0.7	2.3	2.2	0.9	1.3	1.6	0.1	0.1	0.0	0.0	0.0	1.1	1.3	1.0	0.0	0.0	0.2	0.0	0.7	0.0	1.0	0.4	0.0	0.0	4.0	0.6	0.0	0.0	0.4	0.0	1.6	0.7	2.7	0.0	3.8	4.8	0.0	1.0	0.3	0.3	0.9	0.2	0.2	0.5	3.4	0.0	0.0	0.2	4.1	0.4	1.1	0.0	1.0	2.6	0.7	1.2	0.0	1.0	1.6	0.0	0.0	0.4	0.3	0.6	1.2	1.3	2.4	0.9	3.7	0.1	0.8	0.4	1.1	2.8	2.8	0.4	1.5	0.8	0.6	0.5	0.9	0.7	0.4	0.3	0.2	0.2	0.7	0.7	0.3	2.2	1.3	0.5	2.3	1.6	0.1	5.3	3.7	17.5	4.8	3.2	3.3	2.4	4.9	4.9	3.1	20.8	14.1	9.5	7.8	11.2	47.9	16.2	15.3	18.7	12.5	8.7	13.7	15.1	0.0	4.0	41.4	9.5	8.5	0.0	11.6	10.1	9.3	6.6	28.8	14.5	16.0	1.6	2.9	16.0	11.5	60.9	13.3	8.1	8.5	7.2	10.9	7.7	9.6	25.9	14.9	3.0	19.6	6.5	10.3	0.9	3.6	20.1	6.5	7.5	6.8	3.9
EGFR	"ERBB, ERBB1"	ENSG00000146648	"Epidermal growth factor receptor"	P00533	7	55019021-55211628	"Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins, RAS pathway related proteins"	"Host-virus interaction"	"Developmental protein, Host cell receptor for virus entry, Kinase, Receptor, Transferase, Tyrosine-protein kinase"	"Cancer-related genes, Disease mutation, FDA approved drug targets, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"placenta: 102.3"	"Cell type enhanced"	"Detected in many"	8	"Cytotrophoblasts: 207.2;Syncytiotrophoblasts: 315.1"	"Cancer enhanced"	"Detected in all"		"glioma: 136.0"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in many"	12	"A-431: 345.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"CAB000035, HPA001200, HPA018530, CAB068186, CAB073534"	Enhanced		Enhanced	"Plasma membrane,Cell Junctions"	"Secreted to blood"	NA	NA	4740000	93000000	"Plasma membrane, Cell Junctions"		"CAB000035: , CAB068186: AB_2665679, CAB073534: , HPA001200: AB_1078723, HPA018530: AB_1848044"	"unprognostic (2.62e-2)"	"unprognostic (9.56e-3)"	"unprognostic (1.59e-1)"	"unprognostic (7.51e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.27e-2)"	"unprognostic (6.11e-2)"	"unprognostic (4.88e-2)"	"unprognostic (2.85e-2)"	"unprognostic (3.30e-3)"	"unprognostic (1.78e-3)"	"unprognostic (1.04e-1)"	"unprognostic (1.93e-3)"	"unprognostic (6.98e-3)"	"unprognostic (1.72e-1)"	"unprognostic (6.62e-2)"	"prognostic unfavorable (2.04e-5)"	16.2	8.4	4.9	7.5	6.8	0.1	39.8	5.1	8.5	13.8	7.8	3.3	10.7	3.6	8.2	11.7	15.6	8.8	8.5	4.8	6.8	2.7	7.6	23.5	14.2	2.3	4.1	3.9	10.4	10.1	1.8	2.1	102.3	5.6	10.9	6.7	9.2	15.4	12.9	10.7	32.5	6.3	15.5	3.5	3.3	7.8	5.5	5.9	3.2	12.8	15.5	8.0	10.2	28.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	345.9	4.4	1.1	1.5	7.1	4.4	1.2	3.4	4.6	2.1	1.6	0.8	3.7	0.2	0.8	2.9	9.0	13.9	0.0	15.3	2.5	0.1	0.2	0.0	1.9	0.2	1.8	0.0	0.0	2.1	14.0	5.3	28.6	3.1	0.2	0.0	0.0	0.0	4.5	0.2	0.0	0.0	0.3	1.3	2.2	0.0	0.6	0.0	2.6	3.7	0.0	1.3	2.9	3.5	0.7	1.2	0.3	0.8	1.0	1.9	0.5	14.9	3.2	0.0	0.3	0.2	2.6	0.1	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.9	6.8	5.1	6.6	6.8	2.7	4.1	3.9	5.6	5.9	89.3	37.5	4.2	67.7	76.2	1.5	7.3	53.5	16.0	59.1	21.0	5.9	207.2	0.0	30.6	4.6	10.9	15.9	23.3	21.0	36.6	45.3	37.8	0.0	77.4	24.2	0.0	4.1	6.7	7.0	2.2	118.8	1.3	16.9	2.8	25.3	106.1	41.7	17.3	125.5	14.0	2.3	77.6	23.1	1.6	2.7	78.5	315.1	0.0	20.0	46.4
EGLN1	"C1orf12, HIFPH2, PHD2, SM-20, ZMYND6"	ENSG00000135766	"Egl-9 family hypoxia inducible factor 1"	Q9GZT9	1	231363751-231425044	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		"Dioxygenase, Oxidoreductase"	"Congenital erythrocytosis, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"blood: 14.9;skeletal muscle: 46.9"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"							"Cell type enhanced"	"Detected in some"		"neutrophil: 14.9"	"Lineage enriched"	"Detected in many"	10	"granulocytes: 14.9"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA022129	Approved					NA	NA					"HPA022129: AB_1848046"	"unprognostic (4.20e-1)"	"prognostic unfavorable (2.99e-7)"	"unprognostic (8.86e-2)"	"unprognostic (1.26e-1)"	"unprognostic (3.87e-1)"	"unprognostic (1.67e-1)"	"unprognostic (1.20e-1)"	"unprognostic (3.87e-3)"	"unprognostic (1.91e-1)"	"unprognostic (3.99e-1)"	"unprognostic (6.63e-2)"	"unprognostic (9.71e-2)"	"unprognostic (3.82e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.55e-1)"	"unprognostic (5.65e-2)"	"unprognostic (1.81e-2)"	4.9	4.2	4.4	1.4	4.5	0.8	3.5	3.6	4.3	3.0	3.3			3.9	3.1	2.6	3.5	2.3	2.9	7.0	4.4	3.5	5.2	7.2	1.6	1.6	4.1		4.1	4.4	5.5	2.1	4.4		2.6	2.8		2.3	3.5	46.9	5.6	3.9	2.8	4.1	3.0	2.0	1.3			2.8		1.8	2.5	2.7	0.6	0.7	14.9	1.4	0.7	1.1	0.3	13.5	13.0	4.2	8.0	11.0	7.6	4.6	6.7	9.8	9.3	12.8	9.5	10.8	4.1	11.7	9.5	7.1	6.8	5.9	7.8	16.5	5.8	14.8	2.0	5.4	8.1	7.8	9.6	2.7	6.0	7.2	6.3	7.8	13.6	12.1	4.4	9.2	7.7	8.8	2.6	2.3	3.6	5.0	8.2	7.3	5.0	5.8	5.0	11.8	4.8	4.2	11.3	8.3	10.9	22.0	2.8	5.8	27.5	14.3	10.9	6.0	10.9	12.5	19.1	11.6	3.7	15.2	3.6	15.2	4.1	0.6	2.5	0.7	0.9	0.5	0.6	0.8	0.6	0.7	0.6	0.9	1.1	14.9	0.7	1.4	0.6	0.6	0.3											17.9	21.0	17.1	13.9	52.0	29.6	107.6	71.4	9.4	10.3	17.4	35.3	14.4	29.9	33.2	0.9	34.6	39.6	0.0	31.0	19.9	31.2	15.1	9.3	63.5	14.7	58.8	12.2	28.8	20.9	3.4	15.0	24.1	25.3	8.2	24.3	55.9	37.0	28.6	21.5	37.2	42.8	19.4	30.9	8.6	21.6	50.3	8.7	18.1	19.3	17.0
EGLN2	"HIFPH1, PHD1"	ENSG00000269858	"Egl-9 family hypoxia inducible factor 2"	Q96KS0	19	40798996-40808433	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Dioxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	12	"Early spermatids: 208.8;Late spermatids: 575.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA056649			Supported	Nucleoplasm		NA	NA			Nucleoplasm		"HPA056649: AB_2683203"	"unprognostic (1.11e-2)"	"prognostic favorable (2.88e-4)"	"unprognostic (9.40e-3)"	"unprognostic (6.01e-2)"	"unprognostic (6.03e-2)"	"unprognostic (6.47e-3)"	"unprognostic (1.51e-2)"	"unprognostic (4.74e-2)"	"unprognostic (1.67e-1)"	"unprognostic (1.95e-1)"	"prognostic favorable (4.81e-4)"	"unprognostic (7.10e-2)"	"unprognostic (7.48e-2)"	"unprognostic (1.69e-1)"	"unprognostic (1.35e-1)"	"unprognostic (9.99e-2)"	"unprognostic (1.38e-3)"	27.4	24.3	24.8	24.7	28.5	23.3	33.5	22.6	28.9	22.2	21.2	21.9	26.4	17.8	24.2	17.8	16.7	18.6	23.4	18.6	25.5	18.7	18.4	19.1	31.6	29.0	21.8	25.7	22.8	16.6	10.6	16.9	42.5	16.9	20.9	15.3	16.5	19.4	25.7	15.5	13.4	16.8	28.1	15.0	42.4	18.0	74.1	18.0	14.4	29.7	17.2	22.7	19.6	25.1	25.1	16.3	68.2	21.5	15.1	30.2	26.5	16.6	45.3	21.0	20.4	27.4	20.1	13.7	18.2	15.3	26.1	28.7	37.4	16.9	14.9	15.5	21.8	23.7	10.8	26.5	20.8	14.0	18.6	15.0	19.8	26.4	14.1	29.5	15.2	27.0	24.6	22.2	24.9	14.3	16.5	32.0	16.4	28.0	14.0	27.4	11.9	28.0	25.2	18.2	26.4	15.8	26.2	10.4	10.1	28.1	25.7	19.4	17.7	29.8	23.6	24.1	18.8	31.1	41.5	29.6	32.7	23.7	13.4	21.4	7.0	10.2	26.2	23.9	22.2	24.2	20.9	19.1	46.8	24.1	21.5	25.3	23.2	28.5	24.9	16.3	25.1	30.2	25.2	68.2	15.1	19.9	11.9	25.6	26.5	24.8	28.5	22.6	28.9	25.5	18.7	21.8	25.7	16.9	18.0	20.8	12.6	13.6	49.3	43.4	36.7	18.6	28.1	2.7	14.8	3.5	13.7	50.5	0.0	14.1	208.8	56.4	58.0	23.3	8.8	21.0	50.6	59.3	17.3	25.1	58.5	20.6	43.0	62.6	37.2	575.5	58.4	26.7	38.8	20.8	28.8	16.5	12.3	49.1	49.1	1.1	12.9	38.8	30.7	124.4	56.4	33.5	110.9	40.2	33.0	59.3
EGLN3	"HIFPH3, PHD3"	ENSG00000129521	"Egl-9 family hypoxia inducible factor 3"	Q9H6Z9	14	33924231-34462774	"Enzymes, Predicted intracellular proteins"	"Apoptosis, DNA damage"	"Dioxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"heart muscle: 49.6;skin 1: 44.1"	"Cell type enhanced"	"Detected in many"	10	"Basal keratinocytes: 189.9;Cardiomyocytes: 91.5;Suprabasal keratinocytes: 202.4;Syncytiotrophoblasts: 86.2"	"Cancer enhanced"	"Detected in all"		"renal cancer: 50.9"	"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	10	"plasmacytoid DC: 19.0"	"Lineage enriched"	"Detected in many"	16	"dendritic cells: 19.0"	"Cell line enhanced"	"Detected in many"		"RH-30: 18.1;RPTEC TERT1: 15.5;RT4: 48.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA064895			Supported	Cytosol		NA	NA			Cytosol		"HPA064895: AB_2685384"	"unprognostic (3.58e-2)"	"unprognostic (4.76e-3)"	"unprognostic (1.75e-1)"	"unprognostic (8.87e-2)"	"unprognostic (6.88e-2)"	"unprognostic (1.38e-2)"	"prognostic unfavorable (2.14e-5)"	"unprognostic (1.39e-3)"	"unprognostic (3.44e-2)"	"unprognostic (1.79e-1)"	"unprognostic (2.93e-2)"	"unprognostic (2.90e-1)"	"prognostic unfavorable (2.50e-4)"	"unprognostic (1.37e-1)"	"unprognostic (5.21e-2)"	"unprognostic (4.71e-2)"	"unprognostic (6.30e-2)"	6.3	0.8	12.9	4.8	10.6	0.4	6.0	3.0	11.9	7.3	14.3	13.4	4.9	19.3	5.9	2.8	10.4	5.4	7.8	49.6	10.9	7.3	6.1	2.4	3.0	3.0	10.7	8.1	2.5	6.5	0.4	1.5	19.6	9.9	9.9	11.3	3.5	4.2	11.3	9.7	44.1	21.7	11.7	9.7	2.8	19.9	1.0	12.5	3.4	1.2	1.3	5.3	25.6	16.1	0.0	19.0	1.2	0.0	0.8	1.0	0.6	12.0	3.1	0.3	13.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	3.3	0.0	4.1	0.0	0.3	0.3	6.0	11.7	0.0	1.2	3.2	3.2	8.9	0.4	0.0	0.0	0.1	1.6	5.9	0.0	0.0	0.0	0.0	0.9	6.4	0.0	0.1	1.0	0.2	0.0	9.8	10.4	1.1	0.0	18.1	4.3	15.5	48.6	2.5	2.8	0.8	4.7	1.3	7.7	4.8	0.0	0.0	0.1	1.3	0.0	0.7	0.1	2.6	0.0	2.9	0.0	0.2	0.0	0.0	1.2	0.0	0.0	0.0	0.0	1.0	0.8	1.9	0.0	0.1	0.0	0.1	0.8	0.0	19.0	0.0	0.6	12.9	10.6	3.0	9.8	10.9	7.3	10.7	8.1	9.9	12.5	0.0	1.1	0.5	43.6	189.9	4.5	91.5	5.1	22.7	1.2	8.7	2.0	4.2	8.3	14.2	1.1	18.4	46.6	0.0	6.0	63.3	14.3	12.5	1.1	0.0	2.7	1.6	15.5	12.9	1.0	4.7	2.3	3.8	38.8	1.0	24.2	10.5	32.3	25.2	0.7	14.0	2.0	0.0	7.2	0.5	0.3	202.4	86.2	1.5	10.0	11.9
EHHADH	ECHD	ENSG00000113790	"Enoyl-CoA hydratase and 3-hydroxyacyl CoA dehydrogenase"	Q08426	3	185190624-185281990	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Fatty acid metabolism, Lipid metabolism"	"Isomerase, Lyase, Multifunctional enzyme, Oxidoreductase"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"kidney: 37.1;liver: 91.2"	"Group enriched"	"Detected in many"	7	"Hepatocytes: 227.5;Proximal tubular cells: 124.0"	"Group enriched"	"Detected in all"	7	"liver cancer: 42.2;renal cancer: 25.4"	"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"T-47d: 16.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036401, HPA042021"	Enhanced					NA	NA					"HPA036401: AB_10670165, HPA042021: AB_2677801"	"unprognostic (1.20e-1)"	"unprognostic (5.99e-2)"	"unprognostic (2.17e-3)"	"unprognostic (2.69e-2)"	"unprognostic (6.82e-2)"	"unprognostic (1.48e-1)"	"unprognostic (4.79e-3)"	"unprognostic (1.25e-1)"	"unprognostic (1.73e-1)"	"unprognostic (3.89e-2)"	"unprognostic (3.19e-3)"	"unprognostic (1.87e-1)"	"prognostic favorable (1.28e-5)"	"unprognostic (1.93e-1)"	"unprognostic (1.53e-1)"	"unprognostic (2.96e-2)"	"unprognostic (2.80e-1)"	4.1	1.2	1.2	1.7	1.4	0.1	1.5	0.5	1.2	1.7	6.4	0.8	0.4	5.2	1.0	2.0	2.9	0.8	3.0	3.2	1.2	0.9	37.1	91.2	1.9	1.0	1.7	0.7	0.8	2.5	2.7	0.9	1.3	2.1	1.7	2.6	8.3	2.7	0.4	0.7	1.1	9.9	1.0	1.4	1.7	2.4	0.9	0.9	1.4	2.1	1.7	1.2	1.8	1.0	1.5	6.0	0.2	2.2	2.7	2.7	1.1	8.3	3.5	1.0	0.0	5.3	4.5	1.1	4.0	1.2	2.6	3.0	15.2	5.3	0.0	15.9	4.0	1.0	4.1	0.0	3.3	5.5	11.1	3.7	5.9	0.9	15.4	3.5	0.7	0.1	6.4	4.3	2.7	2.4	3.6	3.8	0.0	3.8	4.3	5.0	4.3	0.1	3.5	2.1	3.0	4.4	0.0	7.1	0.3	11.0	4.7	3.2	4.6	7.8	4.6	7.3	9.1	16.8	6.9	1.8	1.7	2.6	1.3	0.3	1.2	3.8	0.3	0.6	2.6	2.8	0.2	2.2	0.0	1.6	2.1	1.0	1.5	1.1	2.4	6.0	0.2	1.6	2.7	0.1	2.7	2.0	2.4	1.4	1.1	1.2	1.4	0.5	1.2	1.2	0.9	1.7	0.7	2.1	0.9	14.9	7.5	13.7	1.5	1.3	0.2	17.9	25.5	4.0	4.5	19.2	3.9	7.2	16.6	2.0	0.1	2.8	13.8	0.0	5.9	2.1	1.5	1.8	0.0	227.5	3.7	0.0	7.5	12.3	12.4	0.0	0.6	1.3	3.3	15.4	11.6	1.7	3.3	8.6	0.4	124.0	0.9	0.0	2.0	3.9	4.1	0.4	1.1	3.2	10.6	1.6
EHMT1	"bA188C12.1, EHMT1-IT1, Eu-HMTase1, FLJ12879, FLJ40292, KIAA1876, KMT1D"	ENSG00000181090	"Euchromatic histone lysine methyltransferase 1"	Q9H9B1	9	137618963-137870016	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		"Chromatin regulator, Methyltransferase, Transferase"	"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Late spermatids: 119.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA060022, HPA074729"	Approved		Supported	"Nucleoplasm,Nuclear bodies"		No	No			"Nucleoplasm, Nuclear bodies"		"HPA060022: AB_2684190, HPA074729: "	"unprognostic (1.18e-1)"	"unprognostic (1.64e-1)"	"unprognostic (1.19e-2)"	"prognostic favorable (6.56e-4)"	"unprognostic (1.03e-1)"	"prognostic favorable (8.91e-4)"	"unprognostic (5.87e-2)"	"unprognostic (1.74e-2)"	"unprognostic (4.18e-3)"	"unprognostic (2.34e-1)"	"unprognostic (2.26e-2)"	"unprognostic (7.55e-3)"	"unprognostic (2.01e-2)"	"unprognostic (6.58e-3)"	"unprognostic (4.24e-1)"	"unprognostic (7.12e-3)"	"unprognostic (7.75e-2)"	16.6	18.3	16.4	23.2	22.3	24.9	17.1	23.7	20.4	16.3	20.7	21.6	20.4	17.1	22.0	13.0	17.9	18.5	20.0	12.1	12.8	9.6	12.7	14.9	14.9	25.0	27.8	12.1	21.4	13.6	15.1	16.2	17.9	18.6	16.9	12.4	19.1	16.5	18.0	23.1	17.3	17.9	21.5	12.5	22.1	16.4	30.8	21.5	22.3	18.9	11.0	22.2	19.2	15.7	20.0	19.0	25.0	13.7	13.1	15.6	6.9	11.1	22.4	25.1	23.3	10.7	11.1	21.1	14.8	9.4	10.8	8.9	14.6	14.0	34.3	14.4	11.2	13.1	24.1	15.0	16.2	8.6	19.2	10.6	14.5	22.4	9.3	9.3	22.0	17.4	9.9	11.4	13.1	12.8	8.0	17.8	13.0	21.7	11.9	7.7	25.8	25.8	10.9	24.5	17.7	14.9	33.2	21.6	19.8	9.1	20.6	22.3	18.1	28.1	19.8	6.4	18.8	22.2	17.8	16.7	12.8	13.3	19.6	14.0	7.6	21.1	28.3	9.5	11.8	13.8	13.6	13.7	16.3	15.6	11.7	10.0	13.3	13.5	13.3	10.4	20.0	13.3	11.8	25.0	13.1	12.0	19.0	11.1	6.9	16.4	22.3	23.7	20.4	12.8	9.6	27.8	12.1	18.6	21.5	17.9	16.3	36.9	20.3	15.5	38.3	24.3	17.8	21.4	22.7	21.0	49.1	18.6	3.3	20.9	68.8	24.8	19.8	0.0	18.3	18.0	18.4	25.8	17.4	28.8	17.0	47.7	27.0	17.8	23.4	119.3	33.1	16.5	11.8	23.4	20.2	23.1	20.1	25.9	35.3	11.9	48.0	12.9	15.3	58.1	54.9	17.7	22.2	23.3	20.5	22.0
EHMT2	"BAT8, C6orf30, Em:AF134726.3, G9A, KMT1C, NG36/G9a"	ENSG00000204371	"Euchromatic histone lysine methyltransferase 2"	Q96KQ7	6	31879759-31897687	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Chromatin regulator, Methyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"HL-60: 10.3;NTERA-2: 15.8;U-266/84: 12.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA050550, HPA060259"	Supported		Supported	"Nucleoplasm,Nuclear speckles"	"Intracellular and membrane"	NA	NA			"Nuclear speckles"	Nucleoplasm	"HPA050550: AB_2681170, HPA060259: AB_2684234"	"unprognostic (3.11e-2)"	"unprognostic (2.72e-1)"	"unprognostic (4.39e-2)"	"unprognostic (1.92e-2)"	"unprognostic (5.44e-2)"	"unprognostic (3.51e-2)"	"prognostic unfavorable (1.79e-4)"	"unprognostic (3.55e-2)"	"unprognostic (7.41e-2)"	"unprognostic (1.01e-1)"	"unprognostic (5.89e-2)"	"unprognostic (1.88e-1)"	"unprognostic (9.78e-3)"	"unprognostic (8.72e-2)"	"unprognostic (1.84e-1)"	"unprognostic (2.25e-1)"	"unprognostic (9.03e-2)"	9.4	12.2	13.1	9.6	21.4	7.6	6.3	17.1	17.5	8.0	7.7	12.3	8.4	14.6	15.0	11.7	18.0	7.6	8.1	7.6	12.3	12.4	5.3	4.4	8.5	6.9	12.6	10.6	10.6	13.2	2.2	8.1	6.0	10.3	10.4	4.3	7.2	5.6	9.6	5.2	5.5	10.1	9.6	8.4	9.1	9.8	7.6	14.9	14.6	9.5	4.8	7.2	8.7	7.6	0.3	0.6	0.0	0.7	0.1	1.1	1.3	0.0	3.6	6.4	0.0	2.8	1.5	4.1	2.8	2.3	3.2	2.6	0.0	0.0	0.0	6.3	4.5	3.3	0.0	0.0	6.9	1.5	4.2	9.6	0.0	0.0	0.0	0.0	10.3	0.0	3.9	1.1	0.0	0.0	0.0	0.0	6.1	0.0	0.0	0.0	0.0	7.3	0.0	15.8	0.0	0.0	6.9	0.0	0.0	1.2	0.0	0.0	0.0	0.0	1.8	5.3	2.7	0.0	0.0	3.0	3.4	2.6	5.7	0.0	9.1	12.4	3.0	3.9	0.0	0.0	0.0	0.3	0.0	0.4	0.1	0.2	0.1	0.8	0.6	0.3	0.3	1.1	1.1	0.0	0.1	0.7	0.6	0.2	1.3	13.1	21.4	17.1	16.5	12.3	12.4	12.6	10.6	10.3	14.9	14.9	11.8	22.3	5.6	7.4	59.2	4.5	22.9	9.4	19.4	24.4	39.3	19.7	6.6	12.9	33.8	11.9	8.9	0.0	10.6	12.5	13.2	5.8	13.9	6.4	14.1	36.5	21.7	20.3	9.1	44.9	25.3	9.9	18.6	16.2	15.5	28.2	11.0	5.8	21.5	7.8	48.2	25.8	8.5	6.1	30.6	9.7	4.7	14.9	15.0	2.6
EIF2AK1	"HRI, KIAA1369"	ENSG00000086232	"Eukaryotic translation initiation factor 2 alpha kinase 1"	Q9BQI3	7	6022244-6059230	"Enzymes, Predicted intracellular proteins"		"Kinase, Protein synthesis inhibitor, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	7	"Cytotrophoblasts: 180.9;Syncytiotrophoblasts: 310.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA016496, CAB022082, HPA061675"	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"CAB022082: , HPA016496: AB_1848057, HPA061675: AB_2684583"	"unprognostic (7.15e-3)"	"unprognostic (2.00e-2)"	"unprognostic (1.45e-1)"	"unprognostic (2.91e-1)"	"unprognostic (6.70e-2)"	"unprognostic (9.69e-3)"	"prognostic unfavorable (6.99e-4)"	"unprognostic (2.36e-1)"	"unprognostic (2.54e-1)"	"unprognostic (1.07e-2)"	"unprognostic (1.48e-1)"	"unprognostic (8.96e-2)"	"unprognostic (2.53e-1)"	"unprognostic (1.99e-1)"	"unprognostic (5.45e-2)"	"unprognostic (9.02e-2)"	"unprognostic (1.06e-2)"	21.0	38.2	31.7	25.4	32.7	62.8	26.9	23.9	41.1	22.8	34.5	31.0	20.8	26.5	22.6	28.6	28.4	23.4	21.5	40.0	29.9	30.0	32.0	46.3	22.1	23.3	33.3	30.3	23.0	32.4	61.9	25.4	43.9	33.4	26.4	34.9	23.4	46.4	26.3	31.6	28.9	29.9	17.8	35.6	25.4	34.7	16.3	22.6	37.1	29.0	17.4	29.6	22.4	20.1	11.7	7.5	17.4	7.4	10.4	10.6	4.8	41.8	26.4	21.2	32.2	20.3	18.4	27.9	21.6	19.7	19.3	24.5	24.2	28.3	32.8	23.7	23.7	34.7	29.6	27.5	19.7	24.9	20.3	42.2	33.8	28.7	36.4	16.7	28.7	30.9	14.7	24.9	18.2	19.7	20.4	20.5	25.9	54.0	31.7	18.1	41.9	15.7	36.7	26.6	24.4	29.8	34.7	22.3	38.5	24.6	20.5	26.4	47.5	41.5	55.5	18.4	30.9	41.8	35.2	19.6	11.1	41.5	19.5	22.9	32.3	32.2	33.5	22.4	37.9	32.1	10.6	7.4	17.4	9.5	5.9	6.4	11.7	7.4	10.6	7.5	7.7	8.6	7.7	4.1	10.4	6.5	6.6	8.8	4.8	31.7	32.7	23.9	41.1	29.9	30.0	33.3	30.3	33.4	22.6	35.7	43.2	44.9	27.9	21.2	28.0	44.8	43.3	34.8	29.6	41.8	15.7	180.9	56.3	48.3	6.9	22.4	43.3	116.8	39.3	64.2	22.2	37.8	19.7	55.5	47.3	30.2	37.0	20.3	29.0	11.9	31.9	31.4	23.6	59.5	60.3	40.2	46.9	35.1	35.3	51.5	23.0	12.9	17.0	32.5	42.3	19.6	310.3	35.0	47.0	25.5
EIF2AK2	"EIF2AK1, PKR, PPP1R83, PRKR"	ENSG00000055332	"Eukaryotic translation initiation factor 2 alpha kinase 2"	P19525	2	37099210-37157065	"Enzymes, Predicted intracellular proteins"	"Antiviral defense, Host-virus interaction, Immunity, Innate immunity, Transcription, Transcription regulation"	"Kinase, RNA-binding, Serine/threonine-protein kinase, Transferase, Tyrosine-protein kinase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB003845, HPA019795, HPA063893"	Approved		Enhanced	Cytosol		NA	NA			Cytosol		"CAB003845: AB_562332, HPA019795: AB_1848060, HPA063893: AB_2685144"	"unprognostic (1.70e-2)"	"unprognostic (2.26e-1)"	"unprognostic (1.62e-1)"	"prognostic unfavorable (3.77e-4)"	"unprognostic (1.66e-1)"	"unprognostic (1.04e-1)"	"unprognostic (1.77e-3)"	"unprognostic (8.42e-2)"	"unprognostic (8.02e-2)"	"unprognostic (4.67e-2)"	"prognostic unfavorable (2.08e-4)"	"unprognostic (1.19e-1)"	"unprognostic (3.15e-3)"	"unprognostic (3.33e-1)"	"unprognostic (1.74e-1)"	"unprognostic (4.65e-2)"	"unprognostic (5.32e-2)"	25.5	14.2	15.9	16.3	15.5	36.4	13.9	16.4	19.0	14.7	13.7	9.9	9.3	14.5	17.2	21.5	12.1	12.8	15.4	10.7	13.7	19.2	12.2	11.5	13.7	10.7	14.3	15.0	18.7	11.7	19.2	21.1	18.2	17.3	15.0	12.8	10.2	23.0	17.8	7.1	6.7	15.2	16.2	14.0	15.5	14.3	5.1	12.8	14.1	13.6	8.1	10.6	14.8	15.5	8.8	6.9	27.6	10.8	8.6	9.9	3.3	23.3	12.0	7.4	9.3	8.1	11.2	14.6	12.3	17.7	39.0	37.6	13.7	13.9	12.5	16.1	13.5	46.4	13.9	12.7	12.5	17.5	27.4	6.7	13.7	9.1	8.9	8.0	13.0	0.1	9.1	4.9	15.6	11.3	6.8	9.7	5.5	9.5	12.6	8.8	10.4	16.7	6.7	7.7	3.9	8.6	16.9	18.1	6.2	7.3	9.0	8.3	8.8	15.1	11.0	23.7	6.5	5.6	3.7	12.5	15.8	16.8	6.8	19.8	9.3	15.3	0.2	7.6	8.9	13.8	17.1	8.2	11.1	8.9	10.6	9.0	8.8	7.5	8.1	6.9	7.0	6.1	7.5	27.6	8.6	10.8	4.7	9.9	3.3	15.9	15.5	16.4	19.0	13.7	19.2	14.3	15.0	17.3	12.8	62.5	27.7	15.7	36.6	17.3	37.2	25.3	33.1	53.5	58.0	21.0	13.7	40.9	18.3	31.1	1.7	56.2	26.2	0.0	42.4	72.4	35.3	31.0	39.4	15.8	34.3	44.5	14.5	29.4	21.6	2.1	52.9	24.7	20.3	23.4	22.2	48.9	41.0	24.6	79.2	28.5	24.1	38.8	34.2	2.6	3.4	8.8	34.1	30.2	26.2	36.3
EIF2AK3	"PEK, PERK"	ENSG00000172071	"Eukaryotic translation initiation factor 2 alpha kinase 3"	Q9NZJ5	2	88556741-88627576	"Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins"	"Stress response, Translation regulation, Unfolded protein response"	"Kinase, Serine/threonine-protein kinase, Transferase"	"Diabetes mellitus, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Melanocytes: 30.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in all"		"Daudi: 38.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009204, HPA015737"	Approved					NA	NA					"CAB009204: AB_2230863, HPA015737: AB_1848062"	"unprognostic (7.25e-3)"	"unprognostic (5.35e-2)"	"unprognostic (3.03e-3)"	"unprognostic (9.32e-2)"	"unprognostic (9.39e-3)"	"unprognostic (3.25e-2)"	"unprognostic (2.27e-2)"	"unprognostic (3.46e-3)"	"unprognostic (9.84e-2)"	"unprognostic (3.50e-1)"	"unprognostic (1.89e-1)"	"unprognostic (2.31e-1)"	"unprognostic (2.06e-1)"	"unprognostic (2.92e-1)"	"unprognostic (9.80e-2)"	"unprognostic (3.60e-3)"	"unprognostic (2.90e-3)"	12.7	10.3	7.2	12.3	7.6	18.6	10.7	8.8	6.6	15.8	10.7	6.1	20.9	7.3	9.6	12.4	9.5	8.9	8.5	11.1	5.7	5.5	11.5	15.9	10.4	9.3	7.9	5.0	8.8	36.7	18.5	18.4	14.4	8.3	11.4	12.6	7.3	28.0	20.9	12.7	8.9	10.8	7.0	7.5	11.1	19.0	4.6	7.3	8.7	15.7	6.3	17.3	21.5	19.2	6.6	2.6	1.5	0.7	1.6	2.4	0.6	4.9	3.3	7.2	4.7	13.3	9.3	11.5	7.1	9.2	5.1	7.5	7.4	3.6	38.2	4.3	4.9	7.9	4.5	5.2	4.0	7.5	13.4	3.4	4.1	3.3	7.5	8.3	5.0	9.7	3.5	6.4	4.7	10.2	7.6	5.5	4.5	2.4	13.7	3.9	5.6	4.7	4.0	5.3	9.3	3.8	18.5	10.0	6.8	6.3	9.4	5.6	7.7	4.2	10.9	7.2	9.1	4.0	3.0	4.3	4.4	4.7	9.9	4.4	25.7	12.9	27.0	6.2	4.6	5.9	1.1	0.7	1.5	1.7	0.6	1.9	4.7	1.7	2.4	0.9	6.6	1.5	1.1	0.2	1.6	0.2	2.6	1.4	0.6	7.2	7.6	8.8	6.6	5.7	5.5	7.9	5.0	8.3	7.3	8.9	6.9	11.2	8.5	18.0	6.0	4.8	17.8	4.0	1.2	12.2	7.9	3.7	0.0	3.3	0.1	7.7	8.6	0.0	5.5	5.9	13.0	14.2	1.1	11.3	4.1	1.6	13.1	9.8	5.7	0.4	6.9	6.4	30.4	1.0	26.4	2.9	8.4	8.5	5.3	2.6	1.8	0.0	10.3	2.6	3.4	15.9	5.6	7.5	5.1	12.1
EIF2AK4	"GCN2, KIAA1338"	ENSG00000128829	"Eukaryotic translation initiation factor 2 alpha kinase 4"	Q9P2K8	15	39934146-40035591	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Activation of host autophagy by virus, Adaptive immunity, Antiviral defense, Cell cycle, Growth arrest, Host-virus interaction, Immunity, Neurogenesis, Stress response, Translation regulation"	"Activator, Kinase, RNA-binding, Serine/threonine-protein kinase, Transferase, tRNA-binding"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"plasmacytoid DC: 32.9"	"Group enriched"	"Detected in all"	4	"dendritic cells: 32.9;monocytes: 9.3"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA011811	Approved		Approved	Cytosol		NA	NA			Cytosol		"HPA011811: AB_2668543"	"unprognostic (3.10e-1)"	"unprognostic (4.78e-3)"	"unprognostic (5.97e-2)"	"unprognostic (7.18e-2)"	"unprognostic (1.05e-2)"	"unprognostic (3.32e-2)"	"unprognostic (1.18e-1)"	"unprognostic (3.18e-1)"	"unprognostic (1.36e-1)"	"unprognostic (1.21e-1)"	"unprognostic (1.38e-2)"	"unprognostic (7.27e-2)"	"unprognostic (2.38e-1)"	"unprognostic (1.27e-2)"	"unprognostic (6.47e-2)"	"unprognostic (2.31e-2)"	"unprognostic (5.11e-3)"	20.7	16.5	20.2	19.4	27.3	20.2	36.0	22.4	27.3	16.8	16.3	13.6	17.1	12.2	35.7	17.9	17.8	18.1	19.4	18.2	19.5	20.5	15.4	22.7	22.5	16.6	18.6	14.2	20.1	21.5	20.3	34.7	20.5	17.6	22.0	14.6	17.9	16.7	20.3	20.4	20.7	12.2	24.3	14.6	16.1	16.4	11.5	15.1	17.7	24.1	10.6	15.9	27.0	14.4	5.0	32.9	4.2	9.3	3.8	4.5	2.4	14.0	6.8	12.1	18.2	19.9	33.6	11.5	19.8	22.8	16.3	16.1	9.6	6.1	7.5	10.4	26.9	21.8	15.0	16.1	24.0	22.7	35.3	8.1	15.9	12.5	11.6	17.1	9.6	11.0	26.5	16.5	15.5	27.9	23.0	22.6	15.8	11.7	7.1	32.0	4.7	8.0	13.2	7.4	12.5	15.1	9.7	16.8	12.3	20.2	9.6	6.3	9.7	14.2	8.6	12.3	12.3	12.1	16.6	24.0	21.7	16.5	10.8	12.8	9.8	17.7	2.3	15.2	13.2	30.3	4.2	5.8	4.0	3.6	6.7	3.1	3.5	4.0	4.1	8.4	5.0	4.5	4.2	1.7	3.8	9.3	32.9	2.7	2.4	20.2	27.3	22.4	27.3	19.5	20.5	18.6	14.2	17.6	15.1	14.9	23.6	17.2	22.6	10.6	28.5	28.8	22.9	13.4	26.1	15.7	11.8	29.7	11.6	22.9	1.0	27.0	7.3	0.0	22.0	29.4	26.2	25.6	23.1	20.8	27.4	27.0	13.8	23.4	28.6	2.4	39.1	46.9	30.4	32.5	20.8	31.3	33.9	10.5	37.4	15.1	22.8	45.3	18.6	9.8	29.6	12.7	12.7	15.8	27.6	17.2
EIF3F	"eIF3-epsilon, eIF3-p47, eIF3f, EIF3S5"	ENSG00000175390	"Eukaryotic translation initiation factor 3 subunit F"	O00303	11	7970251-8001862	"Enzymes, Predicted intracellular proteins"	"Protein biosynthesis, Ubl conjugation pathway"	"Hydrolase, Initiation factor, Protease, Thiol protease"	"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA049250	Approved					NA	NA		18000			"HPA049250: AB_2680692"	"unprognostic (1.11e-2)"	"unprognostic (1.42e-1)"	"unprognostic (8.46e-2)"	"unprognostic (1.15e-2)"	"unprognostic (8.50e-2)"	"unprognostic (2.26e-1)"	"prognostic unfavorable (6.86e-4)"	"unprognostic (1.16e-1)"	"unprognostic (1.97e-1)"	"unprognostic (1.74e-1)"	"unprognostic (3.11e-1)"	"unprognostic (2.04e-1)"	"unprognostic (1.57e-1)"	"unprognostic (5.66e-2)"	"unprognostic (2.61e-1)"	"unprognostic (8.36e-2)"	"unprognostic (8.78e-2)"	38.2	28.5	19.8	40.4	22.0	36.6	50.8	16.4	22.7	44.4	41.4	23.2	35.0	25.4	40.6	35.7	45.8	41.1	42.6	38.6	17.0	14.7	29.7	32.2	33.9	82.2	19.9	20.4	74.6	67.4	23.0	23.5	28.9	17.8	45.0	31.2	26.2	49.2	29.7	71.4	56.8	31.7	54.2	20.1	37.1	40.9	42.5	20.0	88.5	50.8	47.7	51.6	48.0	55.5	60.4	48.1	14.7	35.6	34.7	65.7	70.3	30.3	19.5	31.4	23.3	40.3	75.3	29.2	24.3	35.6	26.6	26.6	20.3	42.1	53.5	12.8	29.7	26.1	22.0	21.2	45.9	33.7	15.7	39.7	23.2	23.3	30.1	69.1	29.7	23.4	60.1	44.7	15.0	49.7	49.4	32.9	32.0	18.9	22.8	33.3	20.4	34.6	39.9	28.5	26.8	29.1	44.1	18.0	20.7	26.7	31.4	20.9	43.5	13.7	23.9	25.6	28.0	20.0	22.6	24.9	18.7	28.3	12.4	17.9	21.0	27.5	26.5	19.7	14.7	25.0	14.0	35.2	14.7	31.9	35.6	44.7	60.4	54.6	39.8	48.1	53.7	65.7	48.3	5.4	34.7	32.9	34.6	60.5	70.3	19.8	22.0	16.4	22.7	17.0	14.7	19.9	20.4	17.8	20.0	101.3	120.9	368.1	288.7	310.1	69.7	83.7	221.7	100.4	105.8	75.0	49.1	562.0	248.7	238.1	348.2	252.8	135.7	70.0	385.2	576.6	282.7	202.6	161.6	136.4	301.0	42.9	201.8	203.1	365.6	632.9	227.9	316.4	234.5	473.5	241.1	83.9	327.6	228.0	184.9	219.6	63.1	97.0	272.0	108.2	90.1	384.9	471.2	365.7	352.3	377.1
EIF4A1	"DDX2A, EIF-4A, EIF4A"	ENSG00000161960	"Eukaryotic translation initiation factor 4A1"	P60842	17	7572706-7579005	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction, Protein biosynthesis"	"Helicase, Hydrolase, Initiation factor, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Basal keratinocytes: 1192.5;Suprabasal keratinocytes: 1078.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB011689, HPA068286"	Uncertain		Approved	Cytosol		NA	NA		2300000	Cytosol		"CAB011689: AB_732122, HPA068286: AB_2685968"	"unprognostic (1.49e-2)"	"unprognostic (2.41e-1)"	"unprognostic (8.00e-2)"	"unprognostic (2.17e-1)"	"unprognostic (2.49e-1)"	"unprognostic (2.12e-3)"	"unprognostic (7.25e-2)"	"unprognostic (2.89e-2)"	"unprognostic (2.72e-2)"	"unprognostic (2.11e-2)"	"unprognostic (2.65e-2)"	"unprognostic (5.19e-3)"	"prognostic unfavorable (1.76e-8)"	"unprognostic (1.91e-1)"	"unprognostic (5.96e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.13e-2)"	56.5	49.0	19.3	41.4	19.8	51.4	80.2	13.6	26.6	40.4	45.6	28.5	26.4	28.7	45.9	30.2	76.4	43.4	39.2	33.5	18.5	17.1	34.2	58.0	46.3	135.7	27.7	12.9	55.2	77.0	19.8	28.8	45.2	21.8	36.2	44.0	33.0	65.8	30.7	36.5	48.4	30.9	46.5	33.4	46.8	42.2	31.6	21.8	91.5	34.7	73.8	67.7	42.5	40.8	35.1	143.6	29.1	115.7	47.1	60.3	170.1	85.9	117.9	79.1	71.6	71.2	83.3	73.8	83.0	94.4	154.0	119.1	119.0	39.0	117.7	64.0	87.0	67.6	77.2	167.7	127.8	166.0	38.1	124.3	66.3	76.7	132.2	109.0	67.7	67.1	110.3	66.1	129.3	132.3	92.1	115.5	66.8	67.6	24.4	110.8	90.4	70.3	58.2	67.8	89.0	81.7	66.4	59.7	56.5	107.6	79.1	41.8	81.2	74.8	50.4	104.0	61.8	55.9	52.1	82.5	81.4	56.8	52.0	166.9	24.0	33.4	77.1	87.5	83.4	89.2	19.6	115.7	29.1	37.0	102.6	60.3	35.1	40.0	39.5	143.6	28.9	39.4	39.6	12.1	47.1	75.7	54.8	49.2	170.1	19.3	19.8	13.6	26.6	18.5	17.1	27.7	12.9	21.8	21.8	107.2	246.6	70.7	485.7	1192.5	106.4	4.8	71.4	168.6	257.0	69.8	110.0	292.0	129.3	287.6	27.4	250.8	114.3	0.0	199.9	314.2	406.1	269.6	140.3	57.2	188.0	100.1	111.9	143.1	130.1	33.1	149.0	241.8	688.4	127.2	116.0	108.1	249.6	126.3	102.6	131.4	109.7	148.8	550.1	57.5	86.6	1078.3	532.6	174.8	147.8	417.5
EIF4A2	"BM-010, DDX2B, EIF4A, EIF4F"	ENSG00000156976	"Eukaryotic translation initiation factor 4A2"	Q14240	3	186783205-186789900	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction, Protein biosynthesis"	"Helicase, Hydrolase, Initiation factor, RNA-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"CAB011690, HPA068286"	Uncertain		Approved	Cytosol		NA	NA		1000000	Cytosol		"CAB011690: AB_732123, HPA068286: AB_2685968"	"unprognostic (1.49e-1)"	"unprognostic (9.62e-2)"	"unprognostic (3.78e-2)"	"unprognostic (9.50e-3)"	"unprognostic (2.82e-2)"	"unprognostic (1.10e-2)"	"unprognostic (4.46e-2)"	"unprognostic (6.27e-2)"	"unprognostic (4.32e-3)"	"unprognostic (1.00e-1)"	"unprognostic (6.39e-2)"	"unprognostic (3.99e-2)"	"unprognostic (6.36e-2)"	"unprognostic (3.22e-1)"	"unprognostic (3.03e-1)"	"unprognostic (4.67e-2)"	"unprognostic (2.62e-2)"	34.6	66.1	61.2	27.7	79.9	1.9	53.5	121.1	111.5	65.1	52.1	26.5	30.1	30.3	73.1	45.5	44.5	73.9	45.1	83.7	58.4	71.9	63.9	43.5	33.7	36.1	48.9	61.7	142.0	59.0	30.9	84.1	47.3	69.6	57.9	40.1	31.8	43.7	62.8	126.7	19.8	35.6	57.1	41.9	32.5	39.0	32.9	39.5	23.9	67.8	36.4	35.4	61.1	51.7	55.1	19.3	39.4	24.8	33.0	63.4	51.3	10.1	5.1	21.4	3.5	82.7	78.0	6.6	18.3	16.5	19.4	25.6	18.9	3.7	22.7	102.5	26.2	35.9	17.1	31.5	7.7	34.3	21.2	16.6	36.6	6.8	25.3	32.4	7.7	25.7	52.2	37.0	5.6	46.7	98.7	34.4	19.2	12.3	38.3	63.1	1.7	12.2	3.8	21.3	41.0	24.6	15.7	15.2	13.8	38.5	12.4	42.2	8.5	29.7	20.5	38.9	56.7	32.0	28.2	25.1	15.4	7.7	14.8	11.2	30.5	43.2	10.4	10.6	8.1	7.2	39.4	16.0	18.5	28.5	18.2	45.3	55.1	41.9	34.8	19.3	46.1	63.4	50.2	11.0	33.0	24.8	17.4	38.6	51.3	61.2	79.9	121.1	111.5	58.4	71.9	48.9	61.7	69.6	39.5	110.2	187.7	337.3	695.6	613.2	269.9	244.1	206.4	220.8	192.2	247.7	60.9	410.2	560.3	199.1	25.8	233.7	293.3	23.3	81.4	227.6	351.3	637.4	309.0	119.2	199.9	368.7	391.5	183.0	192.6	37.8	357.2	230.1	327.3	376.9	296.7	294.3	160.6	364.6	444.5	452.5	161.0	232.8	455.3	100.9	174.0	540.1	514.8	331.3	287.0	611.0
EIF4A3	"DDX48, EIF4AIII, Fal1, KIAA0111"	ENSG00000141543	"Eukaryotic translation initiation factor 4A3"	P38919	17	80135214-80147183	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters"	"mRNA processing, mRNA splicing, mRNA transport, Nonsense-mediated mRNA decay, rRNA processing, Translation regulation, Transport"	"Helicase, Hydrolase, RNA-binding"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			HPA021878	Supported		Supported	Nucleoplasm		NA	NA		73000	Nucleoplasm		"HPA021878: AB_1848090"	"unprognostic (7.24e-2)"	"unprognostic (7.33e-3)"	"prognostic favorable (3.57e-5)"	"unprognostic (1.29e-2)"	"unprognostic (2.95e-1)"	"unprognostic (2.52e-2)"	"prognostic unfavorable (1.68e-5)"	"prognostic unfavorable (1.87e-4)"	"unprognostic (3.71e-1)"	"unprognostic (5.06e-2)"	"unprognostic (4.64e-2)"	"unprognostic (2.64e-2)"	"unprognostic (9.78e-3)"	"unprognostic (5.81e-2)"	"unprognostic (9.20e-2)"	"unprognostic (1.38e-2)"	"unprognostic (2.91e-3)"	27.3	37.0	19.6	23.6	21.5	71.7	22.0	20.3	19.8	24.2	23.8	16.9	19.2	16.2	24.9	18.0	41.5	29.4	17.1	24.2	17.8	12.3	24.5	20.3	21.6	25.4	16.8	19.7	37.5	16.8	17.1	21.9	38.3	13.1	24.7	20.9	14.7	22.1	31.2	19.8	31.2	18.6	18.5	13.7	25.5	20.4	35.1	19.3	30.7	26.9	26.4	30.6	28.9	25.8	38.7	80.4	33.1	41.9	30.2	38.9	48.3	48.1	43.2	28.6	21.1	22.0	13.4	25.0	25.6	18.2	36.3	29.2	46.0	22.5	44.1	17.2	22.3	26.0	32.1	39.1	27.3	40.4	16.2	41.0	27.6	34.2	49.6	21.7	49.7	29.0	20.5	14.0	30.4	24.7	14.7	29.6	25.8	36.7	28.6	21.4	36.8	44.8	25.3	30.7	44.4	40.0	37.1	57.9	34.8	17.7	41.2	39.8	21.7	35.2	68.9	29.5	28.1	45.0	33.5	20.3	22.5	28.9	33.1	40.3	25.1	21.6	81.4	18.2	31.4	23.0	25.7	41.1	33.1	26.7	41.9	34.5	38.7	34.5	30.8	50.3	31.6	32.0	30.7	24.4	30.2	32.9	80.4	38.9	48.3	19.6	21.5	20.3	19.8	17.8	12.3	16.8	19.7	13.1	19.3	38.7	49.5	57.4	240.8	251.5	20.3	50.7	30.6	36.1	62.6	27.9	15.7	121.7	54.7	70.9	25.8	58.9	51.0	23.3	101.3	178.8	96.2	78.8	91.1	26.0	94.7	6.4	57.8	30.7	62.3	10.0	62.2	81.9	97.8	83.8	45.6	43.1	73.7	52.7	46.7	47.7	27.1	84.1	170.0	87.7	109.4	261.3	219.0	53.3	56.0	264.3
EIF5B	"DKFZp434I036, FLJ10524, IF2, KIAA0741"	ENSG00000158417	"Eukaryotic translation initiation factor 5B"	O60841	2	99337353-99401326	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Protein biosynthesis"	"Hydrolase, Initiation factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA034648, HPA040095"	Approved		Approved	"Plasma membrane,Cytosol"		NA	NA		11000	Cytosol	"Plasma membrane"	"HPA034648: AB_10601902, HPA040095: AB_2676843"	"unprognostic (1.23e-1)"	"unprognostic (6.94e-2)"	"unprognostic (2.01e-1)"	"unprognostic (5.03e-2)"	"unprognostic (4.65e-2)"	"unprognostic (5.88e-3)"	"prognostic unfavorable (7.15e-10)"	"unprognostic (6.80e-2)"	"unprognostic (9.84e-3)"	"prognostic favorable (8.99e-4)"	"unprognostic (1.68e-2)"	"unprognostic (2.36e-1)"	"prognostic unfavorable (1.42e-6)"	"unprognostic (6.89e-2)"	"unprognostic (3.24e-2)"	"unprognostic (1.43e-1)"	"unprognostic (7.93e-3)"	24.5	16.0	25.2	22.4	32.6	11.5	22.6	27.7	26.0	23.7	25.1	10.5	19.9	14.8	19.4	28.7	30.8	14.5	15.0	61.7	26.0	22.3	28.8	32.1	17.9	19.2	26.9	23.0	22.3	24.6	26.8	27.5	26.4	28.5	26.0	20.3	7.1	22.3	29.1	105.8	25.3	19.3	31.5	37.6	27.0	20.7	22.6	33.8	17.8	18.2	29.2	22.8	40.1	31.9	15.9	20.2	11.6	12.1	14.1	14.9	4.5	34.1	17.1	19.5	25.4	23.7	28.1	32.4	30.2	19.0	20.1	20.1	39.3	24.4	39.2	26.2	22.4	23.9	19.6	34.1	29.2	35.6	23.6	20.4	47.1	17.5	51.7	18.8	46.0	29.1	18.9	20.6	27.9	28.6	17.3	29.2	24.1	51.9	19.6	28.9	27.7	29.1	42.7	30.4	22.5	25.2	25.5	29.1	31.9	41.2	28.7	16.6	15.7	16.4	37.8	24.3	38.8	15.3	30.4	32.0	31.3	30.7	16.3	26.8	14.6	20.6	32.0	22.7	51.1	23.0	11.6	8.8	9.8	12.7	9.5	14.9	15.3	13.4	12.5	6.4	15.9	13.2	14.0	2.3	14.1	12.1	20.2	9.0	4.5	25.2	32.6	27.7	26.0	26.0	22.3	26.9	23.0	28.5	33.8	101.3	209.4	134.1	138.3	285.5	99.2	532.6	145.2	179.3	205.9	326.2	47.1	126.1	122.7	191.6	558.1	145.8	91.2	116.8	202.2	178.1	139.3	179.5	165.5	428.2	118.4	73.1	151.6	136.2	112.7	88.6	115.3	122.6	135.0	171.3	133.7	81.8	227.8	86.3	165.2	160.8	108.6	271.7	161.7	293.6	551.3	283.8	151.7	127.0	125.6	200.5
ELAC1	D29	ENSG00000141642	"ElaC ribonuclease Z 1"	Q9H777	18	50967991-50988121	"Enzymes, Predicted intracellular proteins"	"tRNA processing"	"Endonuclease, Hydrolase, Nuclease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA040867, HPA066483"	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA040867: AB_10697716, HPA066483: AB_2685675"	"unprognostic (1.05e-2)"	"unprognostic (1.65e-1)"	"unprognostic (6.95e-3)"	"unprognostic (1.75e-2)"	"unprognostic (8.61e-2)"	"unprognostic (5.96e-2)"	"unprognostic (3.25e-1)"	"unprognostic (3.03e-3)"	"unprognostic (5.87e-2)"	"unprognostic (2.82e-3)"	"unprognostic (3.67e-3)"	"unprognostic (6.36e-2)"	"prognostic favorable (8.43e-8)"	"unprognostic (3.54e-2)"	"unprognostic (1.12e-1)"	"unprognostic (2.59e-2)"	"unprognostic (3.87e-2)"	8.7	15.0	7.7	7.7	9.7	3.3	9.4	7.1	11.9	8.0	9.1	12.8	12.1	7.6	11.3	20.1	7.5	10.0	9.6	7.2	7.3	8.3	12.4	15.2	7.6	11.2	7.6	7.2	8.8	19.5	17.1	15.7	12.3	8.7	9.9	10.8	13.7	20.1	12.2	6.8	7.7	11.7	8.3	7.1	10.8	10.1	16.7	3.9	10.1	15.6	7.0	9.9	8.7	6.6	14.2	12.4	7.8	9.1	16.1	15.7	8.1	7.0	4.9	13.0	11.0	14.6	6.2	5.5	7.8	10.3	7.3	5.2	1.8	6.7	5.5	5.4	7.2	5.8	7.2	4.0	8.2	5.0	12.0	1.1	6.8	1.8	1.3	8.6	17.0	4.9	7.8	6.6	3.9	9.1	5.8	7.6	8.0	6.9	13.8	12.9	3.2	5.9	5.1	6.5	6.0	2.2	6.7	4.6	10.2	8.5	3.0	7.7	8.8	6.4	1.1	12.4	5.7	6.0	13.1	6.7	9.6	5.0	2.8	5.2	12.9	10.8	7.3	8.9	5.7	12.0	4.1	7.8	7.8	13.2	9.1	14.6	14.2	12.7	12.9	12.4	13.6	12.4	15.7	0.9	16.1	8.7	10.4	10.0	8.1	7.7	9.7	7.1	11.9	7.3	8.3	7.6	7.2	8.7	3.9	6.0	6.2	8.5	4.6	2.2	7.1	5.6	5.1	10.7	3.4	3.5	2.0	20.4	16.6	12.5	16.4	5.8	8.8	0.0	12.0	13.8	5.4	6.3	8.1	13.9	13.7	4.8	9.9	8.0	6.6	12.8	4.6	5.2	5.0	10.8	8.3	10.8	10.1	7.0	6.7	17.7	7.4	0.0	5.9	27.3	9.4	3.0	15.8	5.0	9.5	3.4
ELAC2	"FLJ10530, HPC2"	ENSG00000006744	"ElaC ribonuclease Z 2"	Q9BQ52	17	12992391-13018187	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"tRNA processing"	"Endonuclease, Hydrolase, Nuclease"	"Disease mutation, Primary mitochondrial disease, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"SuSa: 96.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA019535	Approved		Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"HPA019535: AB_1848106"	"unprognostic (4.24e-3)"	"unprognostic (2.26e-1)"	"unprognostic (1.11e-1)"	"prognostic favorable (3.24e-6)"	"unprognostic (8.64e-2)"	"unprognostic (1.53e-1)"	"unprognostic (1.65e-1)"	"unprognostic (2.47e-1)"	"unprognostic (2.22e-1)"	"unprognostic (3.98e-1)"	"unprognostic (5.31e-3)"	"unprognostic (3.09e-1)"	"unprognostic (5.31e-3)"	"unprognostic (2.21e-1)"	"unprognostic (1.15e-1)"	"unprognostic (8.09e-2)"	"unprognostic (3.70e-2)"	20.3	35.9	15.2	17.2	23.5	13.8	18.6	16.9	30.0	17.5	21.2	24.6	17.9	15.8	22.1	13.1	25.9	19.5	19.6	28.1	14.2	14.3	23.5	34.8	14.2	19.4	18.2	19.5	20.3	24.5	27.5	14.0	21.2	20.5	20.7	25.1	19.4	19.1	26.2	49.2	20.7	18.7	26.6	15.6	25.5	22.8	29.5	17.1	28.1	20.7	20.1	25.9	23.0	16.3	19.9	23.5	9.4	20.4	24.0	25.1	20.9	14.7	23.6	16.3	18.2	13.1	12.8	9.9	16.2	13.0	26.5	17.9	18.9	7.9	26.8	17.7	15.4	10.0	20.0	29.6	18.8	26.6	13.9	29.9	15.7	18.4	12.4	9.7	13.4	21.7	11.4	16.0	20.6	19.2	11.9	18.5	15.9	21.4	8.2	20.1	13.1	23.6	13.4	13.5	28.3	15.8	16.6	28.0	16.8	15.0	13.3	8.4	12.3	20.6	13.4	8.3	96.8	13.3	5.8	18.0	32.8	10.9	13.0	23.8	5.1	9.5	10.8	13.0	14.3	11.9	9.4	14.7	9.3	21.4	20.1	23.0	19.9	20.7	21.3	23.5	17.4	21.5	19.2	2.2	24.0	20.4	13.3	25.1	20.9	15.2	23.5	16.9	30.0	14.2	14.3	18.2	19.5	20.5	17.1	6.0	13.3	13.7	8.6	9.2	10.1	22.9	15.3	10.7	5.7	15.7	2.0	52.4	16.6	22.1	5.2	12.0	10.9	0.0	22.4	24.6	15.4	8.8	9.2	21.8	24.4	11.1	8.1	12.3	14.6	4.2	9.8	10.2	13.5	18.0	10.0	13.8	23.0	16.1	20.1	15.6	10.9	51.8	13.3	25.0	27.4	12.7	28.0	13.8	16.6	7.1
ELANE	"ELA2, HLE, HNE, NE"	ENSG00000197561	"Elastase, neutrophil expressed"	P08246	19	851014-856247	"Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted secreted proteins"		"Hydrolase, Protease, Serine protease"	"Cancer-related genes, Disease mutation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	8	"bone marrow: 244.3"	"Cell type enhanced"	"Detected in some"	9	"Basal keratinocytes: 7.7;Fibroblasts: 5.7;Kupffer cells: 5.6;Leydig cells: 5.8;Melanocytes: 6.8;Suprabasal keratinocytes: 6.5"	"Group enriched"	"Detected in some"	7	"pancreatic cancer: 3.5;stomach cancer: 3.7"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	9	"classical monocyte: 3.2;neutrophil: 6.9"	"Group enriched"	"Detected in many"	9	"granulocytes: 6.9;monocytes: 3.2"	"Cell line enriched"	"Detected in some"	65	"THP-1: 197.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"CAB015409, HPA066836"	Enhanced				"Secreted to blood"	NA	NA		59000			"CAB015409: AB_831596, HPA066836: AB_2685733"	"unprognostic (3.46e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.42e-3)"	"unprognostic (2.09e-2)"	"unprognostic (1.80e-3)"	"unprognostic (3.43e-2)"	"unprognostic (3.92e-1)"	"unprognostic (6.38e-3)"	"unprognostic (5.80e-1)"	"unprognostic (2.54e-2)"	"unprognostic (4.06e-2)"	"unprognostic (3.48e-2)"	"unprognostic (1.19e-10)"	"unprognostic (6.27e-3)"	"unprognostic (4.00e-2)"	"unprognostic (2.76e-2)"	"unprognostic (4.75e-3)"	1.5	0.3	0.1	0.3	0.1	244.3	1.6	0.2	0.6	0.3	0.6	0.7	0.0	0.3	0.3	0.7	0.5	0.6	0.8	31.2	0.0	0.0	0.3	1.5	17.8	1.6	0.0	0.0	0.3	1.8	0.3	0.4	4.7	0.5	1.4	0.3	1.0	0.7	0.3	1.1	2.1	0.5	0.5	0.0	22.5	0.5	0.3	0.0	23.0	2.3	0.9	0.3	1.0	0.2	0.0	0.0	6.9	3.2	0.0	0.5	11.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	197.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.0	0.0	0.0	3.2	0.0	0.5	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.9	0.0	0.0	0.0	0.0	11.2	0.1	0.1	0.2	0.6	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	7.7	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.7	5.7	0.0	0.0	0.5	0.2	0.0	0.0	0.0	5.6	0.0	5.8	0.0	6.8	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	1.7	0.2	0.0	6.5	0.0	0.0	0.0	0.0
ELOVL1	Ssc1	ENSG00000066322	"ELOVL fatty acid elongase 1"	Q9BW60	1	43363397-43368074	"Enzymes, Predicted membrane proteins"	"Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism"	Transferase	"Disease mutation, Ichthyosis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 101.5"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB033426, HPA056557"	Enhanced		Supported	"Endoplasmic reticulum"		NA	Yes			"Endoplasmic reticulum"		"CAB033426: AB_2099896, HPA056557: AB_2683173"	"unprognostic (5.23e-2)"	"prognostic unfavorable (3.63e-5)"	"unprognostic (8.00e-2)"	"unprognostic (8.45e-2)"	"unprognostic (7.60e-2)"	"unprognostic (7.40e-2)"	"prognostic unfavorable (2.79e-7)"	"unprognostic (4.74e-2)"	"unprognostic (1.33e-1)"	"unprognostic (4.37e-1)"	"prognostic unfavorable (8.51e-4)"	"unprognostic (1.83e-1)"	"unprognostic (2.88e-2)"	"unprognostic (1.41e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.73e-1)"	"unprognostic (9.00e-2)"	21.2	15.6	16.2	15.3	25.3	18.3	24.1	6.8	32.5	16.1	23.6	101.5	11.7	20.7	14.1	13.0	46.6	15.1	17.3	11.5	30.3	18.3	26.6	23.8	22.9	22.7	51.4	14.1	9.3	18.3	16.7	8.4	20.9	45.6	21.6	20.1	8.6	20.6	21.6	6.8	54.0	21.7	20.7	99.5	17.2	22.8	8.4	37.2	7.2	23.9	15.6	21.7	20.4	22.6	30.9	61.1	46.9	54.8	30.5	32.3	48.8	23.8	26.9	5.2	10.3	35.6	33.5	16.3	28.3	35.7	36.1	29.1	23.8	41.9	16.5	22.0	44.3	31.2	27.5	18.4	34.8	22.2	21.2	12.4	21.4	18.6	17.2	30.9	18.4	22.9	25.6	39.6	42.6	47.1	27.1	36.1	6.5	14.8	12.6	41.3	17.6	4.3	15.5	7.6	31.1	27.9	9.7	13.9	20.1	45.5	29.1	6.4	6.7	16.7	59.7	23.8	16.2	28.1	18.4	29.8	30.6	19.4	37.0	35.8	6.3	6.8	7.9	29.8	18.9	27.5	29.0	54.8	46.9	32.3	50.6	28.6	30.9	30.7	31.4	61.1	25.5	20.1	28.1	38.2	30.5	48.1	42.9	31.4	48.8	16.2	25.3	6.8	32.5	30.3	18.3	51.4	14.1	45.6	37.2	17.9	8.4	18.1	20.4	13.9	5.4	3.6	45.9	5.3	7.9	38.4	9.8	79.2	6.6	86.7	2.5	28.7	74.3	70.0	86.6	103.3	20.2	33.0	20.7	13.7	66.2	3.2	18.4	23.4	47.0	3.4	18.7	37.1	11.8	129.8	30.5	12.4	99.9	40.7	24.1	21.3	8.4	19.4	15.3	6.7	8.6	27.0	80.2	24.6	36.9	43.7
ELOVL2	Ssc2	ENSG00000197977	"ELOVL fatty acid elongase 2"	Q9NXB9	6	10980759-11044314	"Enzymes, Predicted membrane proteins"	"Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 18.6;liver: 43.1;parathyroid gland: 19.9;placenta: 28.4"	"Cell type enhanced"	"Detected in many"	9	"Cone photoreceptor cells: 27.5;Extravillous trophoblasts: 17.8;Hepatocytes: 13.2;Sertoli cells: 19.4"	"Group enriched"	"Detected in many"	8	"breast cancer: 11.9;glioma: 25.8;liver cancer: 24.0;melanoma: 14.2;prostate cancer: 9.6"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+ SV40 Large T+ RasG12V: 17.0;GAMG: 17.5;HBF TERT88: 16.4;Hep G2: 12.5;RH-30: 17.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA						"prognostic favorable (6.73e-5)"	"unprognostic (4.20e-1)"	"unprognostic (1.64e-1)"	"unprognostic (1.28e-5)"	"unprognostic (4.06e-2)"	"unprognostic (4.09e-3)"	"unprognostic (1.89e-1)"	"unprognostic (5.73e-2)"	"unprognostic (1.63e-1)"	"unprognostic (2.56e-1)"	"unprognostic (6.92e-3)"	"unprognostic (1.78e-2)"	"unprognostic (1.04e-12)"	"unprognostic (9.98e-4)"	"unprognostic (8.86e-2)"	"unprognostic (3.41e-1)"	"unprognostic (9.47e-2)"	1.4	1.3	10.7	1.7	11.5	0.6	4.7	5.8	12.2	0.6	0.6	8.8	0.0	0.7	0.9	2.5	0.8	0.6	1.1	3.1	6.4	4.8	0.7	43.1	0.7	0.9	7.1	7.1	0.7	2.6	19.9	2.8	28.4	8.0	5.0	0.6	5.9	1.1	0.9	1.3	0.7	0.8	1.1	18.6	0.5	0.6	9.3	4.0	0.0	2.0	0.0	1.3	1.6	0.2	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	2.9	11.2	0.0	0.0	0.0	6.4	0.2	0.5	9.9	17.0	0.0	0.0	0.0	0.0	0.6	17.5	0.0	11.7	0.0	16.4	0.0	10.1	0.1	0.2	12.5	0.5	0.2	2.7	0.1	0.0	7.6	0.0	0.6	0.0	0.5	0.6	0.0	0.2	0.0	6.4	0.1	2.1	0.0	9.6	8.9	17.8	0.0	0.0	0.1	4.5	5.1	0.0	0.0	4.1	9.5	2.0	5.0	0.0	0.0	0.0	0.0	3.9	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	10.7	11.5	5.8	10.9	6.4	4.8	7.1	7.1	8.0	4.0	0.0	0.0	0.0	0.0	0.1	1.8	0.6	5.1	0.0	0.0	0.0	27.5	1.6	0.0	4.8	8.6	0.7	0.0	0.0	0.8	17.8	7.2	2.1	0.0	13.2	1.1	0.0	0.0	0.0	0.0	12.4	0.9	0.0	0.0	0.0	0.0	3.9	1.1	0.0	0.4	0.0	10.2	19.4	0.3	12.1	7.9	0.0	1.4	0.0	0.0	0.0
ELOVL3	CIG-30	ENSG00000119915	"ELOVL fatty acid elongase 3"	Q9HB03	10	102226328-102229589	"Enzymes, Predicted membrane proteins"	"Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"skin 1: 24.6"	"Cell type enhanced"	"Detected in some"	11	"Ito cells: 1.3;Kupffer cells: 2.4;Smooth muscle cells: 2.0;Spermatogonia: 2.7"	"Cancer enhanced"	"Detected in many"		"testis cancer: 10.6"	"Low region specificity"	"Detected in some"			"Group enriched"	"Detected in some"	11	"classical monocyte: 9.4;intermediate monocyte: 3.1;myeloid DC: 2.6;non-classical monocyte: 6.6"	"Group enriched"	"Detected in many"	12	"dendritic cells: 2.6;monocytes: 9.4"	"Cell line enhanced"	"Detected in some"		"ASC diff: 8.3;ASC TERT1: 8.3;HSkMC: 12.2;NB-4: 9.4;SiHa: 18.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA036236	Enhanced		Approved	Vesicles,Cytosol		NA	NA			"Vesicles, Cytosol"		"HPA036236: AB_10601550"	"unprognostic (1.52e-2)"	"unprognostic (6.76e-2)"	"unprognostic (1.84e-2)"	"prognostic unfavorable (6.25e-5)"	"unprognostic (8.23e-3)"	"unprognostic (9.82e-2)"	"unprognostic (2.17e-4)"	"unprognostic (4.27e-2)"	"unprognostic (2.28e-1)"	"unprognostic (5.56e-2)"	"unprognostic (1.84e-2)"	"unprognostic (5.36e-3)"	"unprognostic (2.66e-9)"	"unprognostic (1.04e-1)"	"unprognostic (2.81e-1)"	"unprognostic (1.97e-1)"	"unprognostic (1.79e-1)"	6.3	1.1	1.2	2.1	2.4	3.6	7.3	0.4	0.9	0.2	0.2	0.0	0.0	0.0	0.9	0.3	0.3	0.3	2.5	2.5	0.6	0.2	0.5	0.2	1.8	0.1	0.7	0.0	0.2	0.2	0.0	1.8	2.4	1.1	0.3	0.2	1.6	3.4	1.7	1.7	24.6	0.3	0.0	0.2	0.8	0.2	6.8	0.0	0.0	0.2	2.8	0.0	0.6	2.6	0.0	2.6	0.5	9.4	0.0	0.0	1.9	2.6	0.2	0.1	6.6	8.3	8.3	2.4	0.1	0.2	0.3	0.4	0.4	2.5	0.0	0.3	0.0	0.0	0.0	5.0	0.1	0.4	0.0	0.0	0.1	0.3	0.6	0.3	0.0	0.1	12.2	1.4	3.0	0.0	0.0	0.0	0.8	0.1	3.0	0.7	0.0	0.0	9.4	0.1	0.9	0.9	0.0	4.3	0.0	1.7	0.0	0.0	0.3	18.9	0.8	0.6	0.5	6.9	2.2	0.0	1.3	0.0	0.3	0.2	0.4	5.8	0.0	3.0	5.4	0.0	0.0	9.4	0.0	0.0	3.1	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.5	0.0	6.6	0.0	0.0	1.9	1.2	2.4	0.4	0.9	0.6	0.2	0.7	0.0	1.1	0.0	0.0	0.6	0.0	0.4	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.4	0.9	0.1	0.0	0.0	0.2	0.0	0.0	1.3	2.4	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	2.0	0.0	2.7	0.1	0.2	0.0	0.0	0.0
ELOVL4	"CT118, SCA34, STGD2, STGD3"	ENSG00000118402	"ELOVL fatty acid elongase 4"	Q9GZR5	6	79914812-79947580	"Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins"	"Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism"	Transferase	"Disease mutation, Ichthyosis, Mental retardation, Neurodegeneration, Spinocerebellar ataxia, Stargardt disease"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 92.6;skin 1: 41.9"	"Group enriched"	"Detected in many"	4	"Cone photoreceptor cells: 139.4;Rod photoreceptor cells: 278.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	6	"MAIT T-cell: 19.1"	"Lineage enriched"	"Detected in single"	191	"T-cells: 19.1"	"Cell line enhanced"	"Detected in many"		"JURKAT: 25.2;MOLT-4: 19.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA						"unprognostic (1.67e-2)"	"unprognostic (8.58e-3)"	"unprognostic (2.38e-2)"	"unprognostic (3.08e-6)"	"unprognostic (1.49e-1)"	"unprognostic (2.10e-1)"	"unprognostic (1.27e-1)"	"unprognostic (1.39e-1)"	"unprognostic (1.85e-1)"	"unprognostic (3.46e-1)"	"unprognostic (6.91e-3)"	"unprognostic (3.39e-1)"	"unprognostic (1.38e-2)"	"unprognostic (3.45e-3)"	"unprognostic (1.66e-1)"	"unprognostic (1.77e-1)"	"prognostic unfavorable (6.27e-4)"	1.2	2.6	6.0	1.6	8.8	0.6	4.7	16.0	15.5	2.2	1.4	2.3	0.2	1.1	2.8	1.6	11.0	0.9	2.2	0.9	8.4	10.4	1.9	0.6	0.7	0.9	6.3	4.8	2.3	1.0	10.7	7.6	2.2	19.3	4.7	1.6	15.5	3.0	2.3	0.7	41.9	1.3	3.2	3.5	1.0	1.0	5.8	2.3	92.6	2.0	4.4	2.2	1.8	2.6	0.0	0.0	0.0	0.0	0.0	19.1	0.6	0.0	0.5	6.7	7.4	5.6	5.4	1.0	3.4	3.8	2.9	6.4	0.9	0.0	0.0	0.6	4.7	12.1	0.7	8.6	4.8	2.2	0.0	11.2	0.2	1.4	0.0	5.2	2.6	1.0	4.4	1.8	3.0	3.1	4.2	4.8	25.2	0.0	0.0	6.1	1.1	19.2	0.0	6.4	0.0	3.5	0.0	9.6	0.0	0.1	0.0	8.9	2.6	3.7	5.9	1.0	4.8	2.3	0.2	0.4	1.3	2.6	2.0	2.6	4.5	8.9	0.0	3.1	0.0	2.0	0.0	0.0	0.0	1.8	0.0	19.1	0.0	2.6	3.1	0.0	0.0	0.5	1.3	0.0	0.0	0.0	0.0	0.2	0.6	6.0	8.8	16.0	13.5	8.4	10.4	6.3	4.8	19.3	2.3	0.0	0.0	0.0	2.3	10.1	47.3	0.4	0.0	0.0	4.5	0.0	139.4	0.8	0.0	0.1	4.5	0.8	0.0	0.0	0.0	1.6	3.2	2.0	0.0	0.0	0.2	39.7	8.5	0.0	0.0	1.8	1.1	0.0	3.3	0.0	0.0	35.8	0.0	0.0	3.2	2.3	278.2	0.0	5.3	13.5	7.8	33.1	0.8	0.5	0.0	0.7
ELOVL5	"dJ483K16.1, HELO1, SCA38"	ENSG00000012660	"ELOVL fatty acid elongase 5"	Q9NYP7	6	53267398-53349179	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism"	Transferase	"Disease mutation, Neurodegeneration, Spinocerebellar ataxia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Glandular cells: 250.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB017042, HPA047752, HPA054197"	Enhanced		Enhanced	"Endoplasmic reticulum"		NA	NA			"Endoplasmic reticulum"		"CAB017042: , HPA047752: AB_2680147, HPA054197: AB_2682413"	"unprognostic (7.33e-2)"	"unprognostic (5.80e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.92e-2)"	"unprognostic (1.16e-1)"	"unprognostic (5.01e-2)"	"unprognostic (3.06e-1)"	"unprognostic (2.19e-1)"	"unprognostic (4.38e-2)"	"unprognostic (1.43e-2)"	"unprognostic (3.23e-1)"	"unprognostic (6.40e-2)"	"prognostic unfavorable (1.94e-6)"	"unprognostic (1.58e-1)"	"unprognostic (5.12e-2)"	"prognostic unfavorable (6.80e-4)"	"unprognostic (2.76e-2)"	75.7	48.7	17.9	24.2	22.0	33.9	78.8	13.3	22.1	18.2	13.9	38.3	91.2	9.7	15.7	18.0	10.8	16.5	18.0	14.6	18.3	17.5	13.5	36.8	24.4	33.6	41.1	12.3	13.1	5.7	8.1	11.6	13.6	26.4	45.2	6.7	16.1	9.4	88.4	3.6	11.4	17.3	18.0	46.4	18.5	9.5	34.8	29.1	28.7	17.6	5.6	33.6	16.6	19.4	23.8	18.1	60.7	11.3	8.4	25.3	10.4	25.3	18.5	32.5	59.3	86.2	50.1	13.8	29.6	33.3	23.9	33.6	16.4	29.4	28.8	21.5	30.7	37.6	15.0	32.0	27.1	35.9	24.2	22.5	28.4	17.3	22.8	47.4	22.4	20.8	46.2	21.3	23.9	30.1	24.2	26.5	57.5	35.4	16.8	17.2	2.7	66.5	19.9	17.5	0.9	14.2	26.0	22.3	10.0	45.0	15.2	30.3	20.8	24.5	12.8	24.8	22.1	29.2	21.0	25.1	26.3	23.4	46.8	38.9	14.1	13.0	21.9	13.7	32.6	18.6	9.0	11.3	40.7	8.8	8.1	14.2	21.6	14.7	10.6	18.1	23.8	7.2	6.7	60.7	8.4	9.6	4.8	25.3	10.4	17.9	22.0	13.3	20.2	18.3	17.5	41.1	12.3	26.4	29.1	74.5	46.1	107.2	78.7	46.5	7.7	20.2	22.9	49.5	31.8	12.2	2.0	21.5	13.3	32.0	79.1	51.7	5.1	0.0	31.8	46.1	52.2	250.9	98.0	83.9	32.1	7.9	24.0	41.1	61.4	135.1	19.2	53.0	45.5	16.2	0.6	75.7	19.7	0.6	30.1	34.2	5.2	64.7	88.4	20.7	10.4	53.2	26.1	87.3	4.3	62.0
ELOVL6	"FLJ23378, LCE, MGC5487"	ENSG00000170522	"ELOVL fatty acid elongase 6"	Q9H5J4	4	110045846-110199199	"Enzymes, Predicted membrane proteins"	"Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 43.9"	"Cell type enhanced"	"Detected in many"	6	"Cone photoreceptor cells: 35.3;Hepatocytes: 43.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"gdT-cell: 4.8;MAIT T-cell: 4.9;memory CD4 T-cell: 2.1;memory CD8 T-cell: 3.2;naive CD8 T-cell: 2.3;NK-cell: 5.6"	"Group enriched"	"Detected in many"	20	"NK-cells: 5.6;T-cells: 4.9"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042355	Uncertain					NA	NA					"HPA042355: AB_10796577"	"unprognostic (3.92e-2)"	"unprognostic (9.47e-2)"	"prognostic favorable (6.74e-4)"	"unprognostic (8.09e-2)"	"unprognostic (2.06e-2)"	"unprognostic (1.08e-3)"	"unprognostic (4.16e-1)"	"unprognostic (3.01e-3)"	"unprognostic (4.03e-1)"	"unprognostic (1.47e-1)"	"unprognostic (2.33e-1)"	"unprognostic (1.90e-2)"	"unprognostic (2.28e-2)"	"unprognostic (1.21e-1)"	"unprognostic (2.12e-1)"	"unprognostic (1.86e-1)"	"unprognostic (5.32e-2)"	7.6	9.8	7.7	7.9	9.4	3.7	7.9	10.9	12.3	4.0	14.5	8.6	0.9	11.8	3.4	2.7	16.6	2.9	11.1	8.1	6.6	5.9	6.4	43.9	3.3	2.2	7.5	9.4	2.0	2.5	10.6	7.1	2.6	15.7	3.0	14.1	4.3	6.9	3.2	1.4	12.3	10.2	5.7	20.0	1.9	16.9	1.3	7.3	1.1	2.3	7.9	4.0	6.0	5.0	0.1	0.0	0.2	0.1	5.6	4.9	0.8	13.4	8.0	29.3	7.3	19.7	20.7	15.0	9.4	4.6	3.3	7.4	3.9	23.7	1.1	0.8	7.2	11.3	12.6	22.2	27.5	7.7	4.6	6.4	15.2	8.7	10.2	12.2	14.8	9.9	18.0	6.4	16.8	8.0	10.9	6.5	1.6	18.1	31.5	7.3	7.1	3.4	1.5	13.4	8.2	4.8	2.3	11.5	3.9	21.4	10.1	5.2	11.2	4.8	32.0	4.1	13.9	5.4	0.1	2.4	6.7	7.9	11.2	11.4	1.5	4.9	24.9	10.2	0.0	1.7	0.2	0.1	0.1	4.8	0.0	4.9	0.1	2.1	3.2	0.0	0.1	0.7	2.3	0.2	5.6	0.0	0.0	0.2	0.8	7.7	9.4	10.9	12.3	6.6	5.9	7.5	9.4	15.7	7.3	0.0	5.6	0.0	2.3	1.5	22.3	2.4	7.6	1.4	6.8	10.4	35.3	1.2	5.0	6.1	3.7	1.1	16.0	0.0	7.3	21.6	3.9	2.4	5.8	43.3	1.6	25.4	2.9	4.3	2.7	2.7	1.1	0.7	0.0	0.0	12.4	4.4	12.1	24.6	1.1	5.6	15.9	6.5	3.8	0.2	1.2	6.0	1.7	12.8	12.4	4.4
ELOVL7	FLJ23563	ENSG00000164181	"ELOVL fatty acid elongase 7"	A1L3X0	5	60751791-60844389	"Enzymes, Predicted membrane proteins"	"Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	6	"Basal keratinocytes: 27.6;Suprabasal keratinocytes: 33.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	5	"basophil: 3.8;neutrophil: 2.9"	"Lineage enriched"	"Detected in single"	15	"granulocytes: 3.8"	"Cell line enhanced"	"Detected in many"		"GAMG: 24.0;HEL: 20.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA036337	Approved					NA	NA					"HPA036337: AB_10670797"	"unprognostic (6.34e-2)"	"unprognostic (1.96e-2)"	"unprognostic (1.51e-2)"	"prognostic unfavorable (3.87e-5)"	"unprognostic (3.84e-1)"	"unprognostic (1.66e-1)"	"unprognostic (1.60e-2)"	"unprognostic (1.02e-1)"	"unprognostic (1.76e-1)"	"unprognostic (1.79e-1)"	"unprognostic (2.37e-1)"	"unprognostic (2.10e-1)"	"prognostic favorable (1.54e-9)"	"unprognostic (6.95e-2)"	"unprognostic (1.01e-3)"	"unprognostic (2.94e-1)"	"unprognostic (6.30e-3)"	9.9	5.3	11.4	2.1	15.2	1.1	21.4	7.5	12.4	4.0	7.9	15.0	1.4	10.5	2.8	2.1	5.0	2.4	17.5	1.1	13.8	10.9	15.0	1.2	3.7	2.3	19.0	7.7	0.8	7.6	17.2	3.3	3.1	16.7	20.4	10.8	4.2	3.9	1.5	0.9	23.0	18.9	3.6	26.2	0.9	2.9	1.0	11.7	0.0	15.4	5.0	3.7	5.7	5.0	0.1	0.1	3.8	0.2	0.1	0.1	5.8	11.0	4.1	0.0	0.3	0.0	0.0	10.4	0.0	2.3	1.4	4.9	5.3	11.8	0.0	5.0	0.0	24.0	0.6	7.0	4.5	2.1	15.2	3.7	20.0	0.4	1.7	0.1	1.6	8.5	0.1	8.2	0.1	7.2	0.5	0.0	3.5	3.1	4.0	0.0	9.6	0.0	0.1	1.3	1.0	0.0	0.8	1.2	0.6	10.9	10.6	4.4	0.7	6.1	4.9	2.7	1.2	8.1	0.3	0.1	0.9	5.1	0.1	3.8	10.5	10.4	0.1	7.5	0.4	0.2	3.8	0.2	0.6	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.1	2.9	0.1	0.1	0.1	0.0	5.8	11.4	15.2	7.5	12.4	13.8	10.9	19.0	7.7	16.7	11.7	11.9	1.9	0.0	8.3	27.6	3.0	0.7	20.4	2.7	7.9	12.2	0.0	0.1	5.0	6.7	0.0	2.6	11.9	0.0	2.7	0.0	1.5	15.5	12.7	0.0	0.1	0.0	4.6	0.0	0.0	0.0	0.0	0.9	10.1	2.8	15.9	2.9	5.8	9.9	0.0	7.5	7.3	0.0	1.0	0.1	1.3	33.4	2.4	0.0	11.5	7.8
ELP3	"FLJ10422, KAT9"	ENSG00000134014	"Elongator acetyltransferase complex subunit 3"	Q9H9T3	8	28089673-28191156	"Enzymes, Predicted intracellular proteins"	"Neurogenesis, Transcription, Transcription regulation, tRNA processing"	"Acyltransferase, RNA-binding, Transferase, tRNA-binding"	"Amyotrophic lateral sclerosis, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA025297, HPA025812"	Uncertain		Enhanced	Cytosol		NA	NA			Cytosol		"HPA025297: , HPA025812: AB_10601369"	"unprognostic (1.29e-2)"	"unprognostic (1.26e-2)"	"prognostic favorable (9.25e-4)"	"unprognostic (3.49e-3)"	"unprognostic (5.73e-2)"	"unprognostic (1.10e-1)"	"unprognostic (6.95e-2)"	"unprognostic (2.07e-2)"	"unprognostic (7.66e-2)"	"unprognostic (1.22e-2)"	"unprognostic (3.89e-1)"	"unprognostic (3.46e-2)"	"prognostic favorable (1.31e-5)"	"unprognostic (2.29e-1)"	"unprognostic (1.94e-1)"	"unprognostic (1.39e-1)"	"unprognostic (1.71e-1)"	14.8	15.3	18.7	11.5	23.4	6.7	19.4	20.0	27.4	33.4	14.8	21.8	35.2	10.8	27.3	14.4	12.8	18.6	17.5	16.0	17.7	19.0	19.1	22.8	13.6	15.4	17.6	13.6	18.9	12.6	14.3	17.4	12.7	23.3	15.9	18.0	13.9	11.1	36.1	28.8	13.4	12.3	16.0	15.8	16.1	12.1	15.0	15.5	16.0	19.9	13.8	20.3	14.7	12.0	16.2	12.2	11.6	18.2	15.8	20.8	11.0	14.5	15.2	11.6	11.1	17.2	15.1	8.3	7.5	13.6	17.7	15.8	12.6	6.2	27.4	11.8	14.4	15.7	9.9	12.8	17.8	20.9	4.9	5.3	18.4	10.1	20.9	15.4	9.9	13.7	15.9	27.6	12.1	18.7	12.8	16.5	21.3	20.7	17.0	18.0	9.0	21.1	16.9	13.1	14.0	5.3	16.0	11.3	10.5	17.6	12.0	7.0	12.2	8.5	7.3	14.3	11.1	13.9	11.5	11.6	12.1	15.9	12.6	10.8	7.2	11.5	21.0	12.0	11.2	12.3	11.6	10.1	8.2	19.4	14.4	20.8	12.5	16.6	18.3	11.8	16.2	15.0	17.0	2.8	15.8	18.2	12.2	15.6	11.0	18.7	23.4	20.0	27.4	17.7	19.0	17.6	13.6	23.3	15.5	3.0	10.1	10.4	6.7	2.4	6.7	14.6	7.6	13.4	12.5	7.0	21.6	12.5	6.6	10.5	5.9	8.7	7.7	0.0	8.6	12.1	6.4	6.2	8.1	14.7	13.2	14.3	1.2	9.8	11.5	2.7	7.8	7.2	1.7	7.2	8.1	8.7	8.4	8.6	9.6	11.1	11.1	0.0	6.6	11.4	16.1	2.0	8.7	11.5	9.9	5.1
ENGASE	FLJ21865	ENSG00000167280	Endo-beta-N-acetylglucosaminidase	Q8NFI3	17	79074939-79088599	"Enzymes, Predicted intracellular proteins"		"Glycosidase, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"vagina: 51.4"	"Cell type enhanced"	"Detected in many"	5	"Cone photoreceptor cells: 33.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"T-reg: 2.1"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"SK-BR-3: 25.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA021551	Enhanced		Approved	Centrosome,Cytosol		No	No			Cytosol	Centrosome	"HPA021551: AB_1848156"	"unprognostic (7.49e-2)"	"unprognostic (1.42e-1)"	"unprognostic (5.65e-2)"	"unprognostic (6.16e-2)"	"unprognostic (1.89e-2)"	"unprognostic (5.08e-3)"	"unprognostic (9.62e-2)"	"unprognostic (4.09e-2)"	"unprognostic (9.07e-2)"	"unprognostic (7.00e-3)"	"prognostic favorable (2.60e-4)"	"unprognostic (4.79e-2)"	"prognostic unfavorable (8.97e-6)"	"unprognostic (8.38e-3)"	"unprognostic (6.03e-1)"	"unprognostic (2.06e-2)"	"prognostic favorable (8.73e-5)"	10.0	10.1	9.5	20.7	18.4	8.9	11.4	7.0	13.9	10.9	15.1	12.4	8.8	20.3	11.4	6.8	6.5	10.6	8.6	10.3	9.3	5.8	9.2	10.2	10.1	10.7	16.8	8.5	16.3	9.3	11.3	9.8	8.1	13.6	12.3	12.5	10.7	12.1	9.6	35.4	11.9	17.3	7.3	11.9	24.9	11.4	3.9	14.0	8.1	13.6	7.0	9.1	17.5	51.4	0.2	0.7	0.0	1.1	0.0	2.1	0.6	4.5	9.8	3.4	6.3	3.6	1.5	6.6	3.5	1.8	2.9	2.0	5.2	5.0	0.0	4.2	3.5	4.8	6.8	5.4	3.8	1.6	2.7	7.3	4.1	10.0	3.1	2.7	4.7	7.8	4.1	5.3	2.5	2.8	5.6	3.0	8.9	5.9	2.9	1.8	3.9	0.4	4.5	1.5	9.5	8.8	8.6	11.7	3.0	1.5	12.9	2.9	5.7	5.6	25.9	2.6	5.3	9.1	4.4	3.9	5.6	4.2	4.8	3.4	6.9	1.2	2.0	2.3	8.7	4.0	0.0	0.7	0.0	0.0	1.1	0.9	0.0	0.1	0.4	0.7	0.2	0.0	0.0	0.0	0.0	0.5	0.6	2.1	0.6	9.5	18.4	7.0	13.9	9.3	5.8	16.8	8.5	13.6	14.0	0.0	13.6	6.4	3.8	3.9	10.7	4.8	7.6	0.0	6.8	10.4	33.4	4.2	0.0	3.5	1.5	6.5	16.4	0.0	3.6	3.8	4.8	7.4	4.7	10.6	7.5	7.9	25.1	9.8	10.8	1.0	3.1	8.2	0.0	5.4	15.9	5.6	2.5	11.5	1.8	1.7	24.7	12.9	6.0	2.2	1.4	5.1	5.6	5.7	18.8	4.1
ENO1	"ENO1L1, MBP-1, MPB1, PPH"	ENSG00000074800	"Enolase 1"	P06733	1	8861000-8879250	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins"	"Glycolysis, Plasminogen activation, Transcription, Transcription regulation"	"DNA-binding, Lyase, Repressor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	5	"monocytes: 2408.5;Muller glia cells: 2654.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"CAB018614, HPA068284, HPA068721, CAB069394"	Supported		Enhanced	"Plasma membrane,Cytosol"		NA	NA		490000000	"Plasma membrane, Cytosol"		"CAB018614: AB_2099061, CAB069394: , HPA068284: , HPA068721: AB_2732119"	"unprognostic (6.51e-3)"	"unprognostic (9.50e-3)"	"unprognostic (3.56e-2)"	"unprognostic (1.86e-1)"	"prognostic unfavorable (2.71e-4)"	"unprognostic (1.82e-2)"	"prognostic unfavorable (1.30e-8)"	"unprognostic (2.37e-2)"	"unprognostic (5.58e-2)"	"unprognostic (9.72e-2)"	"unprognostic (1.67e-2)"	"unprognostic (1.46e-1)"	"unprognostic (7.53e-2)"	"unprognostic (6.20e-2)"	"unprognostic (1.97e-1)"	"unprognostic (2.22e-1)"	"unprognostic (1.36e-3)"	68.6	57.7	92.7	94.9	109.6	121.8	73.4	46.6	119.4	47.3	63.8	74.6	21.7	71.3	44.9	24.2	138.2	52.2	55.0	45.2	79.1	70.7	180.4	165.4	64.8	80.3	74.9	62.7	58.2	31.6	52.7	35.5	70.5	88.6	38.6	66.4	62.6	106.1	69.1	45.0	74.6	70.3	84.0	56.4	80.0	44.3	31.7	48.8	98.8	55.4	91.0	119.3	73.5	62.9	38.7	114.1	22.1	105.4	55.5	63.7	159.3	182.3	159.4	76.9	65.8	64.4	71.9	69.7	99.1	109.9	213.7	200.9	102.1	105.9	131.5	132.4	119.3	87.5	90.0	130.6	264.6	218.0	89.7	138.0	111.0	161.9	126.7	96.7	221.2	68.4	74.2	80.3	169.2	257.3	161.8	136.8	67.1	121.6	51.4	138.5	90.3	83.4	118.4	83.9	65.5	160.0	86.4	114.6	214.7	252.9	43.5	104.0	64.2	116.3	169.4	122.3	96.7	84.8	66.3	125.1	148.0	131.1	126.2	168.6	146.8	104.1	199.5	229.8	181.4	124.2	13.9	105.4	20.8	52.3	75.8	59.1	38.7	55.8	53.8	114.1	32.7	45.6	47.8	22.1	55.5	72.4	31.2	63.7	159.3	92.7	109.6	46.6	119.4	79.1	70.7	74.9	62.7	88.6	48.8	259.1	414.8	250.1	443.8	370.0	168.1	63.1	310.8	202.1	440.2	575.7	66.8	1020.4	784.2	1640.5	217.6	199.3	508.9	23.3	1210.7	1855.9	354.5	232.4	289.9	288.6	1045.8	456.1	181.6	141.8	389.1	532.9	158.8	475.7	425.1	2408.5	221.4	2654.1	1226.2	336.6	126.9	717.5	187.6	148.8	217.3	150.6	148.2	305.6	837.7	297.2	410.6	403.0
ENO2		ENSG00000111674	"Enolase 2"	P09104	12	6913745-6923698	"Cancer-related genes, Candidate cardiovascular disease genes, Enzymes, Plasma proteins, Predicted intracellular proteins"	Glycolysis	Lyase	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"brain: 119.2"	"Group enriched"	"Detected in many"	4	"Bipolar cells: 242.1;Cone photoreceptor cells: 294.5;Horizontal cells: 405.2;Rod photoreceptor cells: 613.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"gdT-cell: 8.2;MAIT T-cell: 9.7;memory B-cell: 5.6;memory CD4 T-cell: 10.8;memory CD8 T-cell: 9.6;naive B-cell: 3.3;naive CD4 T-cell: 7.1;naive CD8 T-cell: 7.4;neutrophil: 6.2;T-reg: 5.5"	"Group enriched"	"Detected in many"	7	"B-cells: 5.6;granulocytes: 6.2;T-cells: 10.8"	"Cell line enhanced"	"Detected in many"		"hTERT-RPE1: 94.8;U-87 MG: 70.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB000063, HPA068284, HPA068721, CAB073539, CAB079023"	Enhanced	Supported	Supported	"Plasma membrane,Cytosol"		NA	NA		89000000	"Plasma membrane, Cytosol"		"CAB000063: AB_2099322, CAB073539: , CAB079023: , HPA068284: , HPA068721: AB_2732119"	"unprognostic (8.96e-2)"	"unprognostic (8.28e-2)"	"prognostic unfavorable (6.96e-4)"	"unprognostic (1.28e-1)"	"unprognostic (7.95e-3)"	"unprognostic (1.39e-2)"	"prognostic unfavorable (5.15e-4)"	"unprognostic (1.48e-1)"	"unprognostic (9.43e-2)"	"unprognostic (1.58e-1)"	"unprognostic (1.98e-1)"	"unprognostic (2.02e-2)"	"prognostic unfavorable (7.89e-11)"	"unprognostic (7.61e-2)"	"unprognostic (3.06e-1)"	"unprognostic (8.10e-3)"	"unprognostic (1.24e-1)"	4.2	20.7	31.2	8.3	48.0	4.0	4.9	115.2	119.2	7.6	7.9	10.9	2.6	4.9	11.7	6.3	5.9	9.4	8.0	10.3	30.2	39.2	3.5	2.0	10.1	10.5	29.6	47.4	3.7	4.1	19.1	15.5	4.8	47.7	8.0	7.4	28.6	3.1	15.3	2.1	5.8	6.0	15.2	15.7	5.8	6.4	3.2	13.3	1.7	14.2	0.3	10.3	7.1	5.0	5.6	1.0	6.2	0.2	0.4	10.8	4.5	12.2	7.7	2.8	0.1	4.2	4.5	0.2	9.5	6.1	14.1	21.7	1.4	1.0	17.2	1.5	4.1	18.6	1.8	29.3	2.6	21.4	34.4	2.7	23.8	7.9	10.3	3.0	1.3	28.6	2.3	0.1	10.4	2.1	94.8	2.9	22.5	1.5	0.2	9.4	1.6	11.1	1.5	14.9	5.3	4.4	12.4	2.3	3.8	6.9	1.6	22.5	15.8	2.5	0.1	16.2	14.3	0.7	0.7	3.7	12.3	13.0	16.6	12.2	12.6	12.6	2.5	70.7	0.0	2.5	1.3	0.0	0.1	8.2	0.0	9.7	5.6	10.8	9.6	0.0	3.3	7.1	7.4	6.2	0.4	0.2	1.0	5.5	4.5	31.2	48.0	115.2	91.3	30.2	39.2	29.6	47.4	47.7	13.3	32.8	30.1	5.4	2.3	5.6	242.1	12.0	0.0	21.4	10.3	12.2	294.5	0.2	0.0	16.0	0.3	7.1	0.0	0.0	1.5	0.3	6.6	1.7	65.8	0.0	1.7	405.2	23.0	6.2	0.0	0.0	5.2	2.5	11.8	5.4	0.0	91.6	10.4	0.2	9.2	0.0	613.6	12.9	21.7	1.8	1.3	1.9	0.2	11.4	0.4	1.6
ENO3		ENSG00000108515	"Enolase 3"	P13929	17	4948092-4957131	"Candidate cardiovascular disease genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	Glycolysis	Lyase	"Disease mutation, Glycogen storage disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	12	"skeletal muscle: 638.2;tongue: 320.3"	"Group enriched"	"Detected in many"	8	"Cardiomyocytes: 511.6;monocytes: 134.3"	"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"HDLM-2: 71.7;HeLa: 30.7;HMC-1: 30.3;RH-30: 49.3;RPMI-8226: 25.8"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"HPA000793, HPA068284, HPA068721"	Enhanced		Supported	"Plasma membrane,Cytosol"		Yes	No		100000000	"Plasma membrane, Cytosol"		"HPA000793: AB_1078742, HPA068284: , HPA068721: AB_2732119"	"unprognostic (7.35e-2)"	"unprognostic (5.25e-2)"	"prognostic unfavorable (7.33e-4)"	"unprognostic (1.57e-1)"	"unprognostic (1.29e-1)"	"unprognostic (5.86e-2)"	"unprognostic (5.68e-2)"	"unprognostic (2.08e-2)"	"unprognostic (8.12e-2)"	"unprognostic (1.42e-1)"	"unprognostic (6.04e-3)"	"unprognostic (2.21e-2)"	"unprognostic (4.63e-2)"	"unprognostic (5.34e-2)"	"unprognostic (3.48e-1)"	"unprognostic (2.15e-1)"	"unprognostic (4.50e-2)"	7.6	0.3	0.2	0.6	0.2	0.7	0.5	0.6	0.2	0.2	0.4	0.0	0.1	0.8	0.4	8.5	8.6	0.4	0.1	38.3	0.2	0.1	0.5	5.0	0.4	0.5	0.2	0.0	0.4	0.3	0.3	0.5	0.2	0.1	2.1	0.1	1.2	11.8	0.1	638.2	0.3	0.7	0.4	0.2	0.8	0.4	0.5	0.0	0.6	4.8	320.3	10.5	0.3	0.3	13.3	21.0	27.1	24.8	18.5	23.3	36.0	2.9	6.3	2.9	2.7	2.5	0.7	6.9	5.1	0.7	0.3	0.3	3.0	2.0	5.4	7.0	0.4	0.9	3.7	1.0	0.4	0.3	71.7	5.8	5.2	30.7	4.5	0.9	1.6	30.3	4.2	1.0	0.5	1.0	2.6	0.3	6.2	2.4	9.9	1.5	1.6	1.9	6.3	3.7	0.8	2.6	8.5	49.3	25.8	0.7	1.9	1.8	6.9	3.3	2.8	3.7	2.0	2.6	1.7	1.6	3.0	5.7	1.3	3.8	7.0	3.9	4.4	1.7	5.1	3.0	13.5	15.6	27.1	21.8	22.5	14.7	13.3	18.7	20.3	21.0	11.1	12.3	19.7	19.7	18.5	24.8	16.6	23.3	36.0	0.2	0.2	0.6	0.2	0.2	0.1	0.2	0.0	0.1	0.0	0.0	2.6	2.9	1.0	1.8	3.2	511.6	0.0	0.0	2.3	5.2	3.9	4.3	0.0	1.4	1.3	2.2	4.3	0.0	0.7	3.1	3.6	1.0	8.1	38.1	4.4	3.2	0.0	3.1	3.8	2.7	0.3	4.5	1.7	134.3	2.3	1.5	1.3	1.7	0.4	5.4	2.4	6.5	0.9	8.6	3.9	1.6	2.7	4.3	2.1	0.6
ENO4	"AC023283.3, C10orf134"	ENSG00000188316	"Enolase family member 4"	A6NNW6	10	116849512-116911788	"Enzymes, Predicted intracellular proteins"	Glycolysis	Lyase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 12.1;epididymis: 12.6;fallopian tube: 13.6"	"Cell type enhanced"	"Detected in some"	16	"Ciliated cells: 36.1;Cone photoreceptor cells: 21.6;Early spermatids: 11.9"	"Low cancer specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"naive B-cell: 1.8"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"HaCaT: 2.7;MCF7: 8.3;T-47d: 5.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA037937, HPA037938"	Enhanced		Approved	Nucleoplasm,Mitochondria		NA	NA			Mitochondria	Nucleoplasm	"HPA037937: AB_10697089, HPA037938: AB_2675746"	"unprognostic (2.92e-3)"	"unprognostic (1.39e-1)"	"unprognostic (1.07e-1)"	"unprognostic (6.55e-4)"	"unprognostic (8.38e-5)"	"unprognostic (1.88e-1)"	"unprognostic (2.21e-1)"	"unprognostic (5.18e-2)"	"unprognostic (1.22e-1)"	"unprognostic (2.23e-2)"	"unprognostic (3.74e-3)"	"unprognostic (2.06e-1)"	"unprognostic (2.20e-3)"	"unprognostic (1.18e-1)"	"unprognostic (9.77e-3)"	"unprognostic (9.87e-5)"	"unprognostic (1.08e-2)"	0.7	2.1	4.3	0.6	4.3	0.2	2.2	2.6	3.6	1.7	1.0	8.0	0.9	0.3	4.3	12.6	1.4	13.6	1.3	0.5	6.4	4.7	2.3	2.7	3.9	1.2	4.1	4.8	4.2	3.2	3.7	3.4	0.5	12.1	2.1	0.8	3.0	1.6	1.2	0.2	1.1	0.5	0.9	4.4	0.5	0.8	8.8	1.9	0.2	4.2	0.0	0.6	1.8	0.5	1.8	1.0	0.0	0.6	0.0	1.2	0.1	1.5	0.5	0.6	0.1	0.0	0.0	0.0	0.0	0.7	0.6	0.0	0.3	1.1	0.0	0.9	2.1	0.2	2.7	0.0	0.7	0.8	0.0	1.5	0.0	1.0	0.3	0.0	0.0	0.0	0.1	0.6	0.6	0.0	0.9	0.1	1.1	0.1	0.0	0.7	8.3	0.0	0.0	1.5	0.0	0.2	0.0	0.0	0.0	1.2	0.6	0.9	0.0	2.2	0.1	0.0	1.8	5.2	0.0	0.5	0.0	0.8	0.4	1.1	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.6	0.0	0.0	0.4	0.0	1.6	0.2	0.0	0.3	1.8	0.2	0.0	0.0	0.0	0.2	1.0	1.2	0.1	4.3	4.3	2.6	3.6	6.4	4.7	4.1	4.8	12.1	1.9	0.0	0.0	0.0	0.2	0.1	4.4	0.2	0.0	36.1	0.0	0.0	21.6	0.2	0.0	0.3	11.9	0.0	0.0	0.0	0.2	0.1	0.2	0.1	0.0	0.0	0.0	4.8	1.7	0.0	0.0	8.8	1.1	0.1	0.0	1.0	0.0	1.3	0.2	0.0	0.7	0.6	9.0	0.0	0.2	7.6	2.7	0.0	0.1	0.0	0.1	0.0
ENOPH1	"E1, MASA, mtnC"	ENSG00000145293	"Enolase-phosphatase 1"	Q9UHY7	4	82430562-82461091	"Enzymes, Predicted intracellular proteins"	"Amino-acid biosynthesis, Methionine biosynthesis"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 66.2"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004985, HPA044607"	Enhanced		Approved	"Nucleoplasm,Nuclear bodies"		NA	NA		140000	Nucleoplasm	"Nuclear bodies"	"CAB004985: AB_426046, HPA044607: AB_2679019"	"unprognostic (6.64e-3)"	"unprognostic (3.05e-1)"	"unprognostic (6.77e-3)"	"unprognostic (1.05e-3)"	"unprognostic (1.46e-1)"	"unprognostic (1.68e-3)"	"prognostic unfavorable (1.74e-5)"	"unprognostic (9.99e-3)"	"unprognostic (1.18e-1)"	"unprognostic (2.17e-1)"	"unprognostic (1.59e-1)"	"unprognostic (2.05e-1)"	"unprognostic (9.30e-3)"	"unprognostic (3.68e-2)"	"unprognostic (2.22e-1)"	"unprognostic (6.52e-3)"	"unprognostic (3.52e-2)"	10.2	15.4	43.4	12.1	37.1	14.3	16.3	22.9	38.8	13.8	12.7	34.7	5.1	12.2	10.5	23.3	13.5	10.4	9.0	11.1	44.2	34.9	20.8	13.3	11.1	16.0	47.5	26.4	12.9	14.6	17.8	11.7	17.7	31.0	17.2	15.3	8.9	11.4	11.9	9.8	13.1	11.0	11.1	66.2	12.8	13.2	6.1	29.4	14.2	18.0	8.2	18.6	10.7	9.5	13.0	14.1	4.3	10.4	14.4	20.2	12.2	18.5	12.3	22.1	13.7	13.5	13.3	24.2	21.6	14.5	19.8	17.7	22.4	20.8	37.0	22.7	16.4	21.7	10.0	29.2	27.4	35.9	22.2	13.6	22.4	12.0	29.8	21.9	37.0	19.4	12.8	29.1	20.7	24.6	14.3	20.0	23.5	28.9	20.4	25.8	23.9	40.8	22.0	20.3	47.0	10.0	29.1	33.9	20.1	32.3	18.4	31.3	19.1	12.3	37.3	27.5	20.7	16.8	17.9	14.7	24.6	18.3	24.3	28.5	23.5	20.1	46.1	15.9	23.1	33.0	3.4	8.7	4.3	14.4	10.4	18.0	13.0	17.3	16.5	12.7	11.0	20.2	16.2	0.7	14.4	8.8	14.1	18.4	12.2	43.4	37.1	22.9	38.4	44.2	34.9	47.5	26.4	31.0	29.4	14.9	8.0	28.1	32.4	60.9	36.5	11.3	12.7	12.0	15.9	12.2	15.7	71.0	74.6	41.8	4.1	24.5	12.6	0.0	22.6	47.0	29.3	32.2	38.0	10.2	49.6	27.0	28.2	13.5	22.1	4.1	24.5	27.7	37.1	45.1	21.1	46.8	34.7	8.6	22.6	42.5	27.7	12.9	30.9	6.8	22.6	56.0	39.0	34.8	25.8	31.0
ENOSF1	"HSRTSBETA, rTS, TYMSAS"	ENSG00000132199	"Enolase superfamily member 1"	Q7L5Y1	18	670324-712676	"Enzymes, Predicted intracellular proteins"		"Isomerase, Lyase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Proximal tubular cells: 181.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			HPA047829	Enhanced					NA	NA					"HPA047829: AB_2680170"	"prognostic favorable (2.27e-4)"	"unprognostic (8.03e-2)"	"unprognostic (2.02e-2)"	"unprognostic (7.87e-3)"	"unprognostic (1.85e-1)"	"unprognostic (4.29e-2)"	"unprognostic (6.48e-3)"	"unprognostic (1.55e-2)"	"unprognostic (3.50e-3)"	"unprognostic (1.33e-3)"	"unprognostic (2.44e-2)"	"unprognostic (5.07e-3)"	"unprognostic (8.02e-2)"	"unprognostic (1.72e-1)"	"unprognostic (1.36e-1)"	"unprognostic (5.03e-2)"	"unprognostic (1.31e-2)"	8.5	22.0	5.4	11.7	9.4	11.0	10.7	2.2	7.6	12.3	12.7	26.1	15.9	12.1	11.8	10.9	10.4	10.4	11.6	10.0	6.3	5.6	36.7	26.0	15.0	10.4	10.2	6.0	9.6	13.3	13.1	19.8	8.9	12.3	16.3	11.5	18.4	16.4	19.6	9.9	8.3	13.8	14.6	7.0	10.1	12.3	6.5	9.8	12.7	21.2	7.8	8.3	8.8	7.7	2.3	4.3	2.4	3.4	2.9	7.0	2.5	4.1	13.7	7.2	6.5	3.7	3.1	5.2	5.6	6.9	3.6	5.3	12.4	11.7	6.7	1.9	5.3	5.5	3.2	9.5	8.2	2.6	3.2	4.9	10.9	15.6	7.2	13.3	19.2	2.7	5.8	9.3	3.7	6.3	1.5	7.9	12.9	7.4	6.9	5.5	12.3	11.6	5.9	5.8	19.4	7.5	5.8	1.8	18.5	10.8	17.7	8.2	2.9	13.6	11.6	2.6	2.7	3.9	13.9	6.4	1.9	5.0	8.6	1.7	12.6	11.1	11.0	14.8	7.6	2.6	0.0	1.6	2.4	7.0	3.4	6.9	2.3	4.9	4.1	2.5	0.8	6.9	5.6	0.1	2.9	1.6	4.3	3.4	2.5	5.4	9.4	2.2	7.6	6.3	5.6	10.2	6.0	12.3	9.8	32.8	79.3	9.0	26.1	10.5	35.7	15.7	25.5	93.7	52.4	45.4	110.0	37.7	97.8	27.3	5.8	15.7	35.9	0.0	12.7	21.5	19.5	28.9	21.9	51.4	33.4	0.0	23.7	25.2	8.4	4.9	21.9	20.8	18.6	16.2	32.4	43.5	19.2	42.1	26.5	181.7	106.8	12.9	11.8	11.7	32.1	10.7	31.6	17.0	43.8	18.2
ENPEP	"CD249, gp160"	ENSG00000138792	"Glutamyl aminopeptidase"	Q07075	4	110365733-110565285	"CD markers, Enzymes, Plasma proteins, Predicted membrane proteins"		"Aminopeptidase, Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 165.1;kidney: 63.8"	"Cell type enhanced"	"Detected in many"	14	"Proximal tubular cells: 153.4;Sertoli cells: 155.2;Smooth muscle cells: 60.8;Syncytiotrophoblasts: 49.0"	"Cancer enriched"	"Detected in many"	8	"renal cancer: 41.0"	"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 4.2;HEK 293: 11.4;MOLT-4: 2.7;SuSa: 8.6"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			HPA005128	Enhanced					NA	NA		37000000			"HPA005128: AB_1844795"	"unprognostic (2.73e-3)"	"unprognostic (2.84e-3)"	"unprognostic (5.16e-3)"	"unprognostic (3.48e-1)"	"unprognostic (2.90e-1)"	"unprognostic (8.74e-2)"	"unprognostic (3.34e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.35e-2)"	"unprognostic (1.22e-1)"	"unprognostic (1.93e-1)"	"unprognostic (9.47e-2)"	"unprognostic (4.49e-3)"	"unprognostic (3.43e-3)"	"unprognostic (1.52e-2)"	"unprognostic (8.46e-2)"	"unprognostic (2.49e-3)"	5.8	1.0	0.4	0.4	0.6	0.0	2.8	0.3	1.0	1.1	54.4	0.4	0.7	11.1	5.3	2.4	0.8	1.4	1.1	2.3	0.5	0.3	63.8	14.5	2.7	0.5	0.4	0.3	1.0	1.0	33.3	0.8	4.4	0.5	1.4	0.0	0.8	0.6	0.5	2.3	0.4	165.1	3.1	0.5	4.7	0.7	0.4	0.4	1.4	2.4	2.0	0.4	1.0	1.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.3	0.1	0.0	0.1	0.2	4.2	0.6	0.0	0.2	0.3	0.1	0.0	0.0	0.2	0.1	0.0	0.0	0.2	0.0	0.1	0.0	11.4	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	1.5	2.7	0.5	0.5	0.1	0.0	0.2	0.0	0.4	0.0	0.4	0.1	0.2	0.0	2.0	0.0	8.6	0.0	0.0	0.0	0.0	0.0	0.3	0.0	1.1	2.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.6	0.3	1.0	0.5	0.3	0.4	0.3	0.5	0.4	0.0	1.3	0.0	0.1	1.4	0.0	3.3	0.0	0.0	0.0	10.4	0.0	33.0	14.9	0.0	0.4	1.4	2.6	0.0	0.0	2.7	19.7	0.1	0.0	24.1	2.4	0.0	1.7	1.8	0.3	0.0	0.6	0.6	0.0	0.0	0.8	0.0	0.0	0.8	0.4	153.4	0.0	155.2	60.8	0.0	0.2	0.9	49.0	1.3	1.1	0.1
ENPP1	"M6S1, NPPS, PC-1, PCA1, PDNP1"	ENSG00000197594	"Ectonucleotide pyrophosphatase/phosphodiesterase 1"	P22413	6	131808016-131895155	"CD markers, Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins, Predicted secreted proteins"	Biomineralization	Hydrolase	"Diabetes mellitus, Disease mutation, Obesity"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	12	"Hepatocytes: 80.9;Peritubular cells: 65.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"Cell type enhanced"	"Detected in some"		"NK-cell: 4.6"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"ASC diff: 23.1;LHCN-M2: 13.8;U-138 MG: 18.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"CAB032904, HPA062066"	Enhanced				"Secreted - unknown location"	NA	NA		2500000			"CAB032904: AB_2099635, HPA062066: AB_2684674"	"unprognostic (1.47e-1)"	"unprognostic (1.23e-1)"	"unprognostic (2.15e-1)"	"unprognostic (1.60e-3)"	"unprognostic (2.40e-1)"	"unprognostic (1.11e-1)"	"unprognostic (2.00e-1)"	"unprognostic (1.60e-2)"	"unprognostic (7.22e-3)"	"unprognostic (8.96e-2)"	"unprognostic (1.95e-1)"	"unprognostic (3.00e-1)"	"unprognostic (2.61e-2)"	"unprognostic (1.41e-1)"	"unprognostic (1.96e-1)"	"unprognostic (1.84e-1)"	"unprognostic (3.28e-3)"	17.2	2.1	0.5	1.9	0.5	0.0	30.5	0.6	0.4	8.5	2.8	1.6	8.3	1.1	25.7	7.1	1.5	6.4	2.6	1.9	0.5	0.7	10.9	19.4	2.0	0.7	1.1	0.0	7.3	17.5	22.2	27.0	28.9	0.8	3.3	1.2	13.4	5.4	6.5	2.1	1.7	2.6	6.8	2.0	1.2	1.7	4.6	0.3	2.0	13.2	6.9	1.4	3.2	7.7	0.6	2.2	1.4	0.3	4.6	1.7	0.1	0.0	0.8	0.8	0.0	23.1	3.6	0.0	6.0	6.1	2.3	6.4	2.6	0.7	0.0	0.5	3.8	4.8	0.0	0.8	0.1	9.9	0.2	1.1	0.0	0.7	7.7	0.7	0.0	2.8	5.9	0.2	6.4	0.2	2.7	2.8	0.5	0.0	1.2	13.8	1.6	0.0	0.0	5.2	1.0	0.9	0.0	6.7	0.1	0.1	0.3	2.3	0.0	0.1	0.8	2.7	4.0	2.5	0.0	1.8	18.5	0.7	1.3	5.8	2.2	0.0	0.0	8.4	0.0	2.3	1.4	0.2	0.3	0.3	0.2	1.7	0.3	0.3	0.3	2.2	0.6	0.3	0.3	1.0	4.6	0.3	0.3	0.2	0.1	0.5	0.5	0.6	0.4	0.5	0.7	1.1	0.0	0.8	0.3	0.0	1.7	1.5	10.5	1.3	4.0	2.8	5.1	0.0	0.0	1.8	0.0	2.0	5.0	0.1	3.9	1.9	7.7	0.0	8.8	1.3	25.4	3.4	0.0	80.9	4.3	1.6	0.0	2.5	3.3	4.7	23.3	1.3	1.7	0.0	8.6	4.4	7.9	3.5	65.7	15.6	0.3	12.9	10.5	1.4	1.3	1.1	5.1	0.0	1.7	1.6
ENPP2	"ATX, PD-IALPHA, PDNP2"	ENSG00000136960	"Ectonucleotide pyrophosphatase/phosphodiesterase 2"	Q13822	8	119557086-119673453	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Chemotaxis, Lipid degradation, Lipid metabolism"	Hydrolase	"Cancer-related genes, Obesity"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 103.7;placenta: 79.0"	"Cell type enhanced"	"Detected in many"	6	"Cholangiocytes: 38.2;Fibroblasts: 51.0;Hofbauer cells: 50.0;Intestinal endocrine cells: 51.9;Melanocytes: 43.9;Proximal tubular cells: 45.6"	"Cancer enhanced"	"Detected in all"		"renal cancer: 46.7"	"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	5	"basophil: 26.8"	"Lineage enriched"	"Detected in many"	7	"granulocytes: 26.8"	"Cell line enhanced"	"Detected in some"		"AF22: 25.2;ASC diff: 34.5;ASC TERT1: 73.7;BJ hTERT+: 42.4;fHDF/TERT166: 27.3;HSkMC: 33.8;U-2197: 24.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023700, HPA053652"	Approved		Approved	"Nucleoplasm,Golgi apparatus,Actin filaments"	"Intracellular and membrane"	NA	NA		1100000000	"Nucleoplasm, Golgi apparatus"	"Actin filaments"	"HPA023700: AB_1848170, HPA053652: AB_2682218"	"unprognostic (1.17e-2)"	"unprognostic (6.29e-2)"	"unprognostic (3.63e-2)"	"unprognostic (3.93e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.37e-1)"	"unprognostic (9.70e-3)"	"unprognostic (7.14e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.26e-1)"	"prognostic favorable (2.07e-5)"	"unprognostic (5.54e-2)"	"unprognostic (3.14e-1)"	"unprognostic (2.37e-1)"	"unprognostic (5.18e-2)"	"unprognostic (2.37e-2)"	"unprognostic (1.50e-1)"	29.9	15.4	24.0	18.2	42.0	0.7	26.2	4.4	33.3	19.6	8.1	103.7	1.7	20.8	44.8	6.4	2.9	18.7	12.7	3.6	39.8	21.5	24.9	8.9	13.5	31.0	71.5	20.9	5.3	5.2	0.9	4.1	79.0	59.7	8.5	10.6	67.6	3.4	9.2	3.0	5.4	12.1	28.9	102.4	17.3	8.3	9.7	63.9	3.6	3.7	0.8	26.1	13.4	5.7	0.2	3.8	26.8	0.1	0.2	1.8	0.3	0.0	0.0	25.2	0.0	34.5	73.7	0.0	23.2	42.4	10.0	9.6	0.0	0.0	0.0	0.3	27.3	0.0	0.0	0.5	0.0	7.1	1.8	0.7	0.0	0.0	0.6	15.4	0.0	0.1	33.8	0.2	20.4	1.0	0.1	0.1	0.0	0.0	4.1	0.5	0.0	0.0	0.1	1.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.5	0.0	0.0	0.0	1.0	0.0	0.0	0.0	20.3	0.4	24.4	0.1	0.2	0.0	0.0	17.1	0.1	0.5	26.8	0.1	5.2	0.0	0.0	0.0	0.2	0.2	0.0	0.5	0.0	1.8	0.6	0.3	0.2	0.0	3.8	0.0	0.3	24.0	42.0	4.4	33.3	39.8	21.5	71.5	20.9	59.7	63.9	11.9	5.1	3.2	0.5	9.4	1.1	1.2	38.2	6.7	1.2	1.8	0.0	3.4	1.7	0.0	34.3	16.3	0.9	0.0	0.0	1.5	51.0	0.1	5.8	0.4	50.0	0.0	51.9	19.0	12.5	3.6	2.8	8.9	43.9	0.0	0.6	3.3	1.2	0.3	3.2	45.6	1.2	0.0	5.1	1.1	0.4	4.5	5.4	0.5	0.6	0.9
ENPP3	"B10, CD203c, gp130RB13-6, PD-IBETA, PDNP3"	ENSG00000154269	"Ectonucleotide pyrophosphatase/phosphodiesterase 3"	O14638	6	131628442-131747418	"CD markers, Enzymes, Predicted intracellular proteins, Predicted secreted proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"ductus deferens: 29.0;intestine: 45.4;seminal vesicle: 70.7"	"Cell type enhanced"	"Detected in many"	20	"Enterocytes: 9.0;granulocytes: 33.7;Proximal tubular cells: 8.2"	"Cancer enriched"	"Detected in many"	8	"renal cancer: 49.6"	"Low region specificity"	"Detected in single"			"Cell type enriched"	"Detected in single"	74	"basophil: 18.2"	"Lineage enriched"	"Detected in single"	74	"granulocytes: 18.2"	"Group enriched"	"Detected in some"	18	"HEL: 5.2;Hep G2: 17.0;HMC-1: 7.6"	"Low region specificity"	"Detected in some"							HPA043772	Enhanced				"Secreted - unknown location"	NA	NA		480000			"HPA043772: AB_10795616"	"unprognostic (2.74e-1)"	"unprognostic (1.99e-2)"	"unprognostic (1.84e-1)"	"unprognostic (5.41e-3)"	"unprognostic (6.07e-2)"	"unprognostic (4.86e-5)"	"unprognostic (1.13e-1)"	"unprognostic (7.20e-3)"	"unprognostic (1.17e-1)"	"unprognostic (1.13e-1)"	"unprognostic (2.21e-3)"	"unprognostic (2.34e-1)"	"prognostic unfavorable (1.96e-4)"	"unprognostic (2.80e-2)"	"unprognostic (7.85e-2)"	"unprognostic (2.29e-1)"	"unprognostic (1.31e-3)"	0.8	7.9	0.5	2.0	0.5	0.0	4.0	2.1	0.4	19.0	18.5	0.2	29.0	9.3	6.2	7.2	0.5	2.3	1.8	0.2	0.4	0.7	11.9	2.7	1.7	0.2	0.5	0.2	0.9	0.2	0.0	0.5	0.4	0.2	3.7	4.8	0.6	14.9	70.7	0.2	0.8	45.4	1.9	0.4	0.5	0.7	1.0	0.2	4.1	0.5	1.2	0.5	0.9	1.2	0.0	0.0	18.2	0.0	0.2	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.5	0.1	5.2	0.0	17.0	0.0	0.1	7.6	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.1	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.2	0.1	0.0	0.0	18.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.5	0.5	2.1	0.4	0.4	0.7	0.5	0.2	0.2	0.2	0.0	1.4	0.0	2.8	0.0	0.0	0.2	0.0	2.7	1.2	0.0	0.0	0.0	1.7	0.0	1.3	0.3	9.0	0.0	0.0	0.0	0.5	4.6	33.7	1.7	0.1	0.0	0.0	0.6	0.6	0.0	1.1	0.2	1.7	0.0	1.1	0.0	0.0	2.3	0.7	8.2	0.0	0.0	0.0	1.8	0.8	0.5	0.1	0.5	5.2	1.1
ENPP4	"AP3Aase, KIAA0879, NPP4"	ENSG00000001561	"Ectonucleotide pyrophosphatase/phosphodiesterase 4"	Q9Y6X5	6	46129993-46146699	"Enzymes, Predicted membrane proteins"	"Blood coagulation, Hemostasis"	Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Alveolar cells type 1: 71.5;Ciliated cells: 57.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"U-266/70: 15.0;U-266/84: 17.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA016594	Approved					NA	NA					"HPA016594: AB_1848171"	"unprognostic (9.87e-2)"	"unprognostic (1.74e-1)"	"unprognostic (2.75e-2)"	"unprognostic (2.01e-1)"	"unprognostic (2.92e-1)"	"unprognostic (1.90e-1)"	"unprognostic (8.13e-2)"	"unprognostic (5.51e-3)"	"unprognostic (1.98e-1)"	"unprognostic (1.26e-1)"	"unprognostic (8.51e-2)"	"unprognostic (4.36e-1)"	"prognostic favorable (6.95e-7)"	"unprognostic (1.82e-2)"	"unprognostic (1.83e-1)"	"unprognostic (2.62e-2)"	"unprognostic (2.56e-1)"	12.7	12.5	14.8	6.2	21.9	30.2	14.3	10.1	20.6	9.8	10.5	19.3	31.9	9.5	3.8	10.9	4.8	9.9	7.3	12.9	19.8	15.7	16.8	9.0	17.9	6.9	30.8	15.6	3.4	10.4	22.2	14.1	3.2	23.9	15.0	11.6	7.1	17.5	30.8	20.9	3.6	8.7	8.6	43.2	11.5	12.3	7.1	22.2	4.8	11.3	7.3	5.6	8.0	5.9	3.1	1.8	0.9	2.7	4.6	11.0	3.1	0.0	0.7	0.5	1.0	0.0	0.0	0.0	1.1	1.1	2.7	0.2	1.2	9.0	10.0	8.8	1.4	6.8	0.1	2.8	0.4	0.5	12.0	7.5	5.5	0.0	0.0	0.4	6.8	10.2	1.4	0.0	0.0	0.0	0.7	0.9	7.1	0.0	0.0	1.0	1.1	5.0	0.6	1.8	11.1	0.3	3.8	1.8	3.7	5.7	1.1	12.3	0.0	0.0	1.9	0.0	2.9	5.1	2.8	0.0	0.0	4.7	0.2	7.4	15.0	17.1	3.4	7.1	0.0	0.9	0.0	0.4	0.9	11.0	1.3	6.4	3.1	4.1	7.9	1.7	1.5	4.0	7.0	0.3	4.6	2.7	1.8	1.4	3.1	14.8	21.9	10.1	20.6	19.8	15.7	30.8	15.6	23.9	22.2	71.5	24.8	5.1	2.8	0.8	8.7	16.9	10.2	57.6	38.7	27.9	13.7	0.3	0.0	13.0	12.6	6.7	16.0	0.0	10.7	0.2	3.5	18.9	15.1	7.3	5.4	25.4	15.1	1.8	15.8	21.4	1.1	10.5	3.3	22.6	14.4	23.1	8.0	16.5	10.6	11.4	6.1	0.0	4.2	8.6	8.7	0.5	0.2	13.8	8.9	6.8
ENPP6	MGC33971	ENSG00000164303	"Ectonucleotide pyrophosphatase/phosphodiesterase 6"	Q6UWR7	4	184088706-184221230	"Enzymes, Predicted intracellular proteins"	"Lipid degradation, Lipid metabolism"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 35.2;kidney: 30.8"	"Group enriched"	"Detected in some"	5	"Peritubular cells: 33.2;Proximal tubular cells: 21.8"	"Cancer enriched"	"Detected in some"	5	"glioma: 3.0"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in some"	7	"HDLM-2: 1.9;Karpas-707: 6.4;SH-SY5Y: 7.3;U-266/70: 6.0;U-266/84: 3.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA042740, HPA069197"	Enhanced		Approved	"Golgi apparatus"	"Intracellular and membrane"	NA	NA		68000	"Golgi apparatus"		"HPA042740: AB_10793984, HPA069197: "	"unprognostic (4.81e-4)"	"unprognostic (1.47e-1)"	"unprognostic (3.54e-2)"	"unprognostic (1.24e-1)"	"unprognostic (2.56e-1)"	"unprognostic (6.69e-3)"	"unprognostic (3.07e-2)"	"unprognostic (1.27e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.09e-1)"	"unprognostic (7.60e-3)"	"unprognostic (3.04e-2)"	"unprognostic (1.72e-1)"	"unprognostic (2.98e-2)"	"unprognostic (2.82e-1)"	"unprognostic (3.93e-3)"	"unprognostic (2.01e-1)"	0.5	0.6	2.0	1.1	8.0	1.1	1.0	1.7	6.7	0.5	1.3	35.2	0.4	2.0	0.5	6.9	1.3	0.5	0.8	0.5	5.4	3.5	30.8	0.4	0.6	1.1	26.1	3.3	13.7	0.3	0.3	4.1	0.4	19.5	2.7	1.3	7.7	0.9	6.9	0.4	0.5	2.5	0.4	28.2	1.2	1.5	2.7	14.0	0.0	0.5	0.0	3.1	0.9	0.7	0.9	0.8	2.2	0.9	1.5	0.6	0.1	0.0	0.2	0.1	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.4	0.1	0.0	0.0	0.0	1.9	0.0	0.7	0.3	0.1	0.1	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	6.4	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.1	0.1	0.3	0.4	0.0	0.2	7.3	0.0	0.0	0.0	0.7	0.0	0.0	0.2	0.2	0.1	0.0	0.1	6.0	3.2	0.1	0.1	0.1	0.0	2.2	0.9	0.6	0.5	0.5	0.6	0.7	0.4	0.3	0.1	0.9	0.4	0.5	1.7	1.5	0.3	0.8	0.5	0.1	2.0	8.0	1.7	6.7	5.4	3.5	26.1	3.3	19.5	14.0	0.0	0.0	0.0	0.2	0.0	0.0	0.9	0.0	0.0	0.0	1.8	0.0	0.0	3.3	0.9	0.8	0.2	0.0	0.0	0.2	0.0	0.2	0.1	5.7	0.0	0.2	0.0	0.0	0.0	0.6	0.0	3.7	0.0	1.7	1.8	0.0	0.0	0.0	0.0	33.2	21.8	0.0	0.0	0.1	0.0	0.7	0.0	0.0	0.0	0.0	0.3
ENPP7	"alk-SMase, NPP7"	ENSG00000182156	"Ectonucleotide pyrophosphatase/phosphodiesterase 7"	Q6UWV6	17	79730919-79742222	"Enzymes, Predicted intracellular proteins"	"Lipid metabolism"	Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"intestine: 71.1"	"Group enriched"	"Detected in some"	5	"Hepatocytes: 8.5;Proximal tubular cells: 7.3"	"Cancer enriched"	"Detected in some"	6	"liver cancer: 6.4"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"memory B-cell: 1.3"	"Low lineage specificity"	"Detected in single"			"Group enriched"	"Detected in some"	5	"Hep G2: 2.9;Karpas-707: 5.2;U-266/70: 7.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA024603	Approved				"Intracellular and membrane"	NA	NA		440000			"HPA024603: AB_1848174"	"unprognostic (4.00e-2)"	"unprognostic (1.16e-2)"	"unprognostic (6.49e-2)"	"unprognostic (4.83e-2)"	"unprognostic (1.55e-1)"	"unprognostic (2.65e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.01e-1)"		"unprognostic (8.45e-4)"	"unprognostic (4.83e-2)"		"unprognostic (1.18e-2)"	"unprognostic (1.52e-2)"	"unprognostic (5.21e-2)"	"unprognostic (1.25e-1)"	"unprognostic (1.80e-2)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	22.6	0.0	0.0	21.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.5	14.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	71.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.4	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	2.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.2	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.5	0.0	1.0	0.0	0.1	0.1	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.1	0.9	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.7	1.3	0.1	0.4	0.0	0.9	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	7.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
ENTPD1	"ATPDase, CD39, NTPDase-1, SPG64"	ENSG00000138185	"Ectonucleoside triphosphate diphosphohydrolase 1"	P49961	10	95711779-95869695	"CD markers, Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins"		Hydrolase	"Disease mutation, Hereditary spastic paraplegia, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"endometrium 1: 59.4"	"Cell type enhanced"	"Detected in many"	8	"B-cells: 45.3;Endothelial cells: 46.6;Kupffer cells: 77.1;Macrophages: 80.4;monocytes: 46.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"eosinophil: 37.4"	"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in some"	7	"HDLM-2: 57.3;Karpas-707: 47.1"									"CAB002494, HPA014067"	Enhanced		Uncertain	Microtubules		NA	NA			Microtubules		"CAB002494: AB_563557, HPA014067: AB_1848178"	"unprognostic (1.14e-1)"	"unprognostic (1.01e-2)"	"unprognostic (3.11e-1)"	"unprognostic (5.67e-2)"	"unprognostic (9.68e-3)"	"unprognostic (3.45e-3)"	"unprognostic (6.31e-2)"	"unprognostic (5.26e-3)"	"unprognostic (2.73e-1)"	"unprognostic (1.28e-2)"	"unprognostic (6.40e-2)"	"unprognostic (1.41e-1)"	"prognostic unfavorable (5.33e-5)"	"unprognostic (9.79e-2)"	"unprognostic (2.30e-1)"	"prognostic favorable (7.89e-4)"	"unprognostic (5.09e-2)"	10.4	7.5	7.4	16.2	8.4	15.6	8.8	7.6	6.9	18.9	12.7	13.1	8.7	5.8	59.4	12.8	13.2	15.6	22.2	6.8	7.4	7.4	6.2	3.9	14.8	14.5	8.5	4.9	10.3	2.8	3.0	4.3	24.0	9.9	14.7	9.1	10.8	6.7	12.7	3.3	5.5	12.2	37.2	17.9	25.3	7.5	5.4	7.2	3.5	13.4	12.5	21.1	25.2	12.4	6.0	11.8	37.4	15.2	0.5	5.1	4.6	0.1	0.3	0.9	0.8	0.0	0.0	0.5	0.5	0.4	0.0	0.0	0.5	0.1	1.0	0.6	0.0	1.4	0.3	0.0	0.0	0.0	57.3	0.7	0.6	0.4	0.7	0.0	1.5	0.2	0.0	0.0	0.2	0.0	0.3	7.5	0.3	0.6	47.1	0.0	0.6	0.4	1.5	0.6	0.6	0.2	2.4	0.4	0.7	0.5	0.2	0.7	1.1	0.3	1.1	0.8	0.6	0.5	1.6	0.8	0.4	0.2	0.6	0.6	6.7	0.9	0.0	0.6	3.1	0.2	0.1	15.2	37.4	0.1	10.7	0.3	6.0	0.6	0.3	11.8	4.6	0.1	0.1	26.7	0.5	2.4	0.7	5.1	4.6	7.4	8.4	7.6	6.9	7.4	7.4	8.5	4.9	9.9	7.2	0.0	1.4	45.3	0.3	7.9	1.4	8.5	0.0	1.4	1.2	1.8	2.0	0.4	1.7	0.0	5.9	46.6	0.0	0.0	1.8	1.7	8.7	0.4	3.5	0.0	23.2	0.0	0.0	11.6	77.1	6.1	0.6	80.4	15.1	46.9	0.0	0.7	0.2	0.2	2.8	0.3	0.7	6.5	32.0	6.2	4.3	9.8	13.2	14.6	0.4	0.2
ENTPD3	"CD39L3, HB6, NTPDase-3"	ENSG00000168032	"Ectonucleoside triphosphate diphosphohydrolase 3"	O75355	3	40387156-40428619	"Enzymes, Predicted membrane proteins"		Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"cervix, uterine: 26.2;pancreas: 37.3"	"Group enriched"	"Detected in many"	4	"Exocrine glandular cells: 19.8;Pancreatic endocrine cells: 5.7;Sertoli cells: 19.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	5	"plasmacytoid DC: 7.4"	"Lineage enriched"	"Detected in many"	5	"dendritic cells: 7.4"	"Cell line enhanced"	"Detected in some"		"HaCaT: 3.8;HBEC3-KT: 12.7;hTCEpi: 8.6;RT4: 18.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"									NA	NA						"unprognostic (1.00e-1)"	"unprognostic (1.54e-2)"	"unprognostic (2.75e-2)"	"unprognostic (9.84e-3)"	"unprognostic (2.27e-2)"	"unprognostic (2.04e-1)"	"unprognostic (1.80e-1)"	"unprognostic (1.18e-2)"	"unprognostic (8.40e-2)"	"unprognostic (9.88e-3)"	"unprognostic (4.72e-2)"	"unprognostic (2.08e-1)"	"unprognostic (3.25e-1)"	"unprognostic (6.53e-2)"	"unprognostic (5.99e-2)"	"unprognostic (1.68e-1)"	"unprognostic (1.23e-1)"	4.6	2.2	5.7	1.7	25.9	0.5	2.1	5.4	15.8	26.2	3.3	0.6	1.9	1.7	4.0	4.4	7.5	1.3	3.6	1.4	4.9	6.3	3.6	0.5	4.8	0.9	4.0	6.3	2.6	37.3	1.7	4.2	2.9	14.5	5.3	3.6	2.8	21.2	5.1	1.7	3.2	1.6	2.5	1.7	5.1	8.8	1.3	4.8	0.0	7.0	5.6	4.8	13.7	2.9	0.5	7.4	1.4	0.3	0.9	0.8	0.1	0.1	0.0	0.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.8	0.0	0.2	0.0	0.1	3.8	0.0	12.7	0.3	0.7	0.4	0.7	0.5	0.2	0.0	0.0	0.0	0.1	8.6	0.0	0.0	0.0	0.0	0.8	0.1	0.2	0.0	0.5	0.0	0.1	0.1	0.3	1.1	0.1	0.0	0.3	1.6	18.3	1.9	0.4	0.8	1.4	0.3	0.4	0.7	0.0	0.4	0.2	0.1	0.0	0.0	0.2	0.4	0.0	1.1	0.1	0.1	1.4	0.2	0.0	0.2	0.3	0.8	0.3	0.2	0.3	0.0	0.5	0.6	0.6	0.0	0.9	0.2	7.4	0.6	0.1	5.7	25.9	5.4	15.8	4.9	6.3	4.0	6.3	14.5	4.8	3.0	3.4	0.0	1.0	2.1	0.0	0.4	0.0	1.4	2.3	0.0	0.0	0.0	0.0	2.0	0.3	0.0	0.0	0.0	19.8	0.0	0.2	2.3	0.0	0.0	0.1	0.0	2.4	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	3.3	5.7	0.0	0.7	0.0	0.6	19.4	3.1	0.3	0.1	1.9	0.0	0.0	0.0	3.7
ENTPD4	"KIAA0392, LALP70, LAP70, LYSAL1, NTPDase-4, UDPase"	ENSG00000197217	"Ectonucleoside triphosphate diphosphohydrolase 4"	Q9Y227	8	23385783-23457695	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											HPA017655	Supported		Approved	Vesicles		NA	NA		28000	Vesicles		"HPA017655: AB_1848181"	"unprognostic (2.83e-2)"	"unprognostic (1.50e-2)"	"unprognostic (1.23e-3)"	"unprognostic (1.38e-1)"	"unprognostic (5.06e-2)"	"unprognostic (7.86e-3)"	"unprognostic (2.00e-2)"	"unprognostic (2.99e-3)"	"unprognostic (2.07e-2)"	"unprognostic (8.74e-2)"	"unprognostic (2.82e-1)"	"unprognostic (1.20e-1)"	"unprognostic (4.55e-2)"	"unprognostic (1.39e-1)"	"unprognostic (1.11e-1)"	"unprognostic (6.62e-2)"	"unprognostic (3.72e-2)"	16.3	11.5	15.0	21.9	19.8	25.7	15.3	20.3	27.4	15.2	18.5	14.7	15.7	17.0	18.8	17.9	13.3	12.7	14.4	21.0	14.5	12.8	13.0	14.4	19.9	26.0	16.2	12.2	14.7	26.5	30.4	25.2	19.3	20.6	17.6	20.2	18.0	19.5	13.7	14.9	12.2	26.1	16.1	14.5	26.9	19.1	18.7	15.8	17.0	15.8	9.3	30.7	16.7	16.7	9.7	8.0	15.9	9.5	4.4	10.7	6.8	9.3	12.9	16.3	11.2	14.2	18.1	16.6	15.0	14.3	10.2	16.0	18.5	12.5	15.9	10.9	15.1	15.7	11.4	7.3	13.6	19.6	3.8	5.1	8.4	8.0	6.4	11.6	4.4	16.7	11.1	16.6	13.5	14.5	24.9	14.6	12.4	5.8	14.6	17.2	4.2	6.4	5.4	9.5	12.0	4.7	6.4	16.3	4.8	13.0	11.1	13.0	12.4	5.6	8.2	11.0	33.9	6.0	6.3	18.0	18.6	18.4	20.8	11.0	11.7	4.9	20.7	24.9	5.3	18.6	14.9	6.0	13.7	8.5	9.5	10.0	9.7	8.3	9.1	8.0	6.7	10.7	8.3	15.9	4.4	6.9	7.3	6.5	6.8	15.0	19.8	20.3	27.4	14.5	12.8	16.2	12.2	20.6	15.8	17.9	34.6	17.1	9.5	5.8	30.2	20.4	7.6	14.7	28.4	14.0	13.7	12.6	0.0	13.8	6.9	13.7	17.8	23.3	14.7	13.0	12.7	14.2	16.3	10.5	10.5	44.5	16.6	11.1	11.0	15.7	6.6	15.2	11.8	12.6	15.2	18.9	18.1	11.9	8.1	3.7	34.2	12.9	12.3	20.7	21.1	4.8	16.9	15.0	10.5	13.9
ENTPD5	"CD39L4, NTPDase-5, PCPH"	ENSG00000187097	"Ectonucleoside triphosphate diphosphohydrolase 5"	O75356	14	73958010-74019399	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"		Hydrolase	Proto-oncogene	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"intestine: 52.0;kidney: 43.1;liver: 71.4"	"Cell type enhanced"	"Detected in many"	8	"Enterocytes: 99.9;Hepatocytes: 120.9;Mucus-secreting cells: 67.4"	"Cancer enhanced"	"Detected in all"		"prostate cancer: 39.9"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"basophil: 15.0;eosinophil: 8.3"	"Lineage enriched"	"Detected in many"	6	"granulocytes: 15.0"	"Cell line enhanced"	"Detected in all"		"RT4: 34.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA002927	Enhanced				"Secreted to blood"	NA	NA		5000000			"HPA002927: AB_1078744"	"unprognostic (4.19e-1)"	"unprognostic (9.63e-3)"	"unprognostic (3.11e-2)"	"unprognostic (2.06e-2)"	"unprognostic (1.98e-1)"	"unprognostic (3.87e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.19e-1)"	"unprognostic (3.34e-1)"	"unprognostic (6.01e-2)"	"unprognostic (6.20e-2)"	"unprognostic (2.55e-1)"	"prognostic favorable (3.95e-5)"	"unprognostic (1.25e-1)"	"unprognostic (5.06e-2)"	"unprognostic (1.76e-1)"	"unprognostic (6.92e-3)"	3.0	3.6	2.8	9.4	3.8	1.7	3.5	3.0	4.0	2.4	25.8	5.8	3.1	19.3	3.0	2.7	4.5	2.4	6.6	2.6	2.8	2.3	43.1	71.4	2.3	1.3	3.5	2.3	3.3	5.9	1.8	2.7	2.2	5.5	10.2	29.6	3.2	4.7	1.5	3.8	2.7	52.0	3.9	5.5	3.2	11.8	4.5	2.5	2.1	2.7	3.0	3.3	9.5	3.0	1.6	1.6	15.0	2.1	0.6	2.5	1.2	5.4	4.4	5.0	9.3	10.0	9.5	5.8	5.7	4.7	3.8	4.4	3.3	6.6	6.2	2.9	7.8	3.7	6.5	5.0	8.3	4.3	5.2	2.4	4.6	3.2	18.1	9.7	2.7	5.4	7.7	8.4	5.4	11.2	5.4	7.6	10.2	5.1	9.4	5.6	7.7	3.1	3.3	1.5	4.9	9.6	3.5	4.8	3.0	6.7	34.5	3.6	3.7	9.7	7.7	5.5	4.0	11.1	2.5	6.4	7.7	8.0	4.6	4.2	6.1	9.5	5.0	4.9	5.1	6.9	15.0	1.2	8.3	2.5	2.1	1.3	1.3	1.3	1.7	1.6	1.6	2.1	2.1	0.2	0.6	1.3	0.8	1.4	1.2	2.8	3.8	3.0	4.0	2.8	2.3	3.5	2.3	5.5	2.5	14.9	7.9	6.7	4.8	3.3	6.1	4.8	12.7	5.3	10.3	7.0	3.9	6.4	21.6	5.1	13.9	5.4	99.9	0.0	11.3	5.7	4.9	39.5	1.1	120.9	5.5	9.5	15.5	11.6	7.0	8.7	2.6	5.1	5.0	6.4	67.4	4.8	7.4	54.7	5.3	50.1	12.0	12.9	4.1	20.1	18.3	3.0	2.7	4.9	41.0	12.3
ENTPD6	"CD39L2, dJ738P15.3, IL6ST2, NTPDase-6"	ENSG00000197586	"Ectonucleoside triphosphate diphosphohydrolase 6 (putative)"	O75354	20	25195693-25226729	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"SK-MEL-30: 76.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA015491, HPA069555"	Approved		Supported	"Golgi apparatus"	"Secreted to blood"	NA	NA		18000	"Golgi apparatus"		"HPA015491: AB_2669200, HPA069555: AB_2686152"	"unprognostic (3.24e-1)"	"unprognostic (1.27e-2)"	"unprognostic (5.91e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.76e-1)"	"unprognostic (4.44e-1)"	"unprognostic (2.10e-3)"	"unprognostic (7.41e-3)"	"unprognostic (2.74e-3)"	"unprognostic (1.17e-1)"	"unprognostic (2.14e-1)"	"unprognostic (1.03e-1)"	"unprognostic (8.14e-3)"	"unprognostic (1.78e-2)"	"unprognostic (2.74e-1)"	"unprognostic (4.86e-2)"	"unprognostic (4.48e-2)"	12.7	19.7	21.8	11.3	46.5	6.7	12.8	33.1	49.1	9.8	31.3	12.1	12.8	31.6	9.4	10.1	9.0	12.5	18.3	27.5	24.9	25.0	13.4	12.9	11.0	7.4	15.1	29.2	16.1	25.6	11.7	20.5	13.2	15.4	25.5	24.5	9.0	36.8	9.7	15.1	6.8	32.2	9.9	8.2	8.3	24.7	16.1	10.5	9.4	10.4	6.1	8.3	10.2	7.1	7.2	17.1	3.0	16.0	8.8	17.9	12.9	20.7	32.9	9.0	17.3	11.4	14.3	19.4	17.1	12.4	14.8	13.7	17.6	16.1	12.6	25.8	16.4	29.0	27.2	11.0	26.0	9.9	7.7	9.8	10.2	5.0	39.7	17.1	13.6	15.8	13.4	14.5	18.7	14.2	10.9	11.9	12.3	13.3	22.0	11.0	19.9	12.7	8.4	5.7	17.3	25.8	7.2	28.2	28.8	18.6	13.0	14.4	7.5	4.7	28.9	76.8	8.7	21.1	11.5	12.8	17.3	18.0	14.2	20.1	13.8	11.1	5.5	12.4	9.0	32.5	0.0	16.0	3.0	12.7	10.7	17.9	6.1	11.4	10.4	17.1	7.2	12.2	10.6	0.7	8.8	4.8	12.0	10.6	12.9	21.8	46.5	33.1	49.1	24.9	25.0	15.1	29.2	15.4	10.5	17.9	31.6	13.4	14.5	8.8	16.7	4.3	28.1	8.1	7.9	17.4	9.8	53.2	8.3	33.5	18.1	5.8	66.6	0.0	35.1	18.5	10.3	22.0	3.5	13.0	22.9	23.8	32.6	17.2	15.4	46.1	19.0	16.9	10.1	17.2	55.2	3.9	28.8	57.5	39.6	11.0	7.9	6.5	5.9	3.2	9.1	5.3	50.0	8.4	60.2	10.1
ENTPD8	"NTPDase-8, UNQ2492"	ENSG00000188833	"Ectonucleoside triphosphate diphosphohydrolase 8"	Q5MY95	9	137434364-137441816	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"intestine: 48.1"	"Group enriched"	"Detected in some"	6	"Enterocytes: 107.0;Mucus-secreting cells: 160.6;Paneth cells: 49.1"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"CAPAN-2: 9.1;OE19: 3.0;RPMI-8226: 8.8;T-47d: 4.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			HPA021509	Enhanced		Approved	Nucleoplasm,Vesicles,Cytosol		NA	NA			"Nucleoplasm, Cytosol"	Vesicles	"HPA021509: AB_1848185"	"unprognostic (3.85e-2)"	"unprognostic (8.33e-2)"	"unprognostic (2.11e-1)"	"unprognostic (1.82e-1)"	"unprognostic (1.30e-1)"	"unprognostic (1.40e-1)"	"unprognostic (6.46e-3)"	"unprognostic (8.70e-2)"	"unprognostic (3.87e-2)"	"unprognostic (8.48e-2)"	"unprognostic (1.69e-1)"	"unprognostic (2.34e-2)"	"unprognostic (1.08e-5)"	"prognostic favorable (7.17e-4)"	"unprognostic (2.17e-1)"	"unprognostic (1.15e-1)"	"unprognostic (1.78e-1)"	0.4	0.0	0.4	2.6	0.4	0.0	0.4	0.4	0.4	0.4	19.2	0.4	0.4	18.5	0.4	0.4	0.4	0.3	2.2	0.4	0.5	0.0	2.1	9.8	0.8	0.4	0.4	0.4	0.4	1.8	0.0	4.2	0.5	0.4	0.4	7.5	0.8	4.1	0.4	0.4	0.0	48.1	0.4	0.4	0.4	6.1	0.4	0.4	0.6	0.4	0.4	0.4	0.4	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.1	0.4	0.0	0.0	0.4	0.0	0.0	0.0	0.2	2.0	9.1	0.0	0.6	0.0	0.7	0.1	0.0	0.0	0.0	1.5	0.2	0.0	0.6	0.4	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.6	0.4	0.0	0.0	0.1	0.0	1.6	0.0	0.2	0.1	3.0	0.4	0.0	0.0	8.8	1.4	0.0	0.3	0.9	0.2	0.0	0.1	0.7	4.8	0.2	0.1	0.0	2.4	0.4	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.4	0.4	0.4	0.5	0.0	0.4	0.4	0.4	0.4	0.0	0.0	0.0	0.2	0.0	0.0	0.3	12.7	0.0	0.0	19.2	0.0	0.0	0.0	0.8	0.0	0.0	107.0	0.0	6.8	0.1	0.0	1.0	0.0	8.2	0.1	0.0	3.5	0.0	0.0	0.0	0.3	0.0	0.0	0.0	160.6	0.0	0.5	49.1	0.0	4.4	0.0	0.0	0.0	0.0	0.5	0.0	0.2	0.0	12.7	0.6
EOGT	"AER61, C3orf64, FLJ33770"	ENSG00000163378	"EGF domain specific O-linked N-acetylglucosamine transferase"	Q5NDL2	3	68975214-69013961	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"		"Glycosyltransferase, Transferase"	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Peritubular cells: 38.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HUVEC TERT2: 39.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA019460	Approved		Approved	"Nucleoplasm,Nuclear membrane,Cytosol"	"Intracellular and membrane"	NA	NA			"Nucleoplasm, Nuclear membrane"	Cytosol	"HPA019460: AB_1844628"	"unprognostic (2.62e-1)"	"unprognostic (3.72e-1)"	"unprognostic (1.07e-1)"	"unprognostic (1.95e-2)"	"unprognostic (8.96e-2)"	"unprognostic (6.30e-2)"	"unprognostic (2.18e-3)"	"unprognostic (6.66e-2)"	"unprognostic (1.13e-2)"	"unprognostic (2.57e-1)"	"unprognostic (1.68e-1)"	"unprognostic (3.57e-1)"	"prognostic unfavorable (8.97e-5)"	"unprognostic (7.41e-2)"	"unprognostic (4.67e-1)"	"unprognostic (3.44e-2)"	"unprognostic (2.04e-1)"	14.9	5.8	3.4	10.1	4.4	3.0	11.9	2.5	4.8	16.8	12.1	4.4	10.2	4.8	23.3	10.4	15.1	11.4	18.1	18.2	3.9	3.6	6.6	5.5	15.8	9.6	4.2	5.0	12.7	7.8	3.9	5.5	15.2	5.1	18.9	5.8	8.7	14.0	24.0	28.0	6.1	7.7	29.4	4.9	10.2	10.1	7.4	2.4	8.3	5.4	14.2	7.3	27.0	9.8	1.7	3.4	5.5	2.2	3.3	9.2	1.8	8.2	2.8	5.4	6.6	7.7	15.2	4.0	11.2	13.7	7.1	9.4	3.7	4.7	0.4	1.7	12.1	6.1	2.7	3.7	14.6	9.0	26.7	2.6	8.6	6.3	5.3	8.6	4.8	3.6	12.6	12.4	9.2	11.7	8.7	39.1	0.3	2.3	5.1	23.8	2.1	0.7	1.5	6.3	2.7	1.3	0.3	5.7	3.5	6.1	19.0	0.5	3.0	12.9	1.0	10.1	6.0	2.8	6.6	20.7	20.1	6.1	2.3	10.8	2.6	8.4	4.0	8.0	7.5	11.2	5.5	2.2	0.0	3.0	1.9	3.5	1.7	4.8	6.4	3.4	1.2	4.1	4.1	0.3	3.3	0.7	0.6	9.2	1.8	3.4	4.4	2.5	4.8	3.9	3.6	4.2	5.0	5.1	2.4	11.9	10.1	1.5	10.1	6.4	2.2	13.7	7.6	8.1	14.8	1.8	15.7	0.8	0.0	4.0	13.9	15.0	2.5	0.0	7.0	3.8	7.5	7.5	0.0	3.8	5.9	0.0	5.8	21.5	5.1	12.0	2.8	7.7	8.5	9.0	3.4	1.3	9.0	2.9	38.2	1.5	4.8	0.0	23.8	1.1	2.4	4.0	0.7	4.4	2.5	5.8
EP300	"KAT3B, p300"	ENSG00000100393	"E1A binding protein p300"	Q09472	22	41091786-41180079	"Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Biological rhythms, Cell cycle, Host-virus interaction, Transcription, Transcription regulation"	"Acyltransferase, Transferase"	"Cancer-related genes, Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB000146, HPA003128, HPA004112"	Supported		Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"CAB000146: AB_2533138, HPA003128: AB_1078745, HPA004112: AB_1078746"	"unprognostic (7.67e-2)"	"unprognostic (5.56e-2)"	"unprognostic (2.29e-1)"	"unprognostic (2.52e-1)"	"unprognostic (6.10e-3)"	"unprognostic (1.66e-1)"	"unprognostic (2.21e-2)"	"unprognostic (2.13e-1)"	"unprognostic (1.54e-1)"	"unprognostic (8.97e-2)"	"unprognostic (1.74e-2)"	"unprognostic (8.54e-2)"	"prognostic favorable (7.45e-5)"	"unprognostic (7.97e-2)"	"unprognostic (1.41e-1)"	"unprognostic (1.01e-1)"	"unprognostic (8.66e-2)"	16.8	14.8	19.1	13.9	15.5	45.3	14.5	33.0	20.6	14.8	16.8	15.6	18.9	11.1	18.1	11.6	16.8	15.7	16.5	10.7	16.6	8.3	11.5	12.2	14.1	12.9	16.9	12.7	20.2	15.7	26.4	14.5	27.7	13.8	13.2	12.2	12.3	15.3	17.9	19.5	18.2	17.4	13.8	12.7	15.9	14.7	20.6	18.6	29.3	16.9	10.9	14.1	18.7	22.5	4.3	4.4	9.8	3.9	5.7	3.9	2.3	15.7	11.3	19.2	11.9	12.2	13.2	17.2	7.6	11.0	11.4	11.0	14.4	5.8	16.4	6.7	15.0	10.5	12.7	27.7	10.4	12.7	15.9	18.4	12.3	13.0	11.2	13.9	29.2	13.9	12.9	10.9	16.5	13.8	10.0	12.6	9.5	13.0	22.6	9.0	5.8	8.4	9.1	13.8	19.8	7.9	17.3	9.0	10.2	10.8	20.9	6.1	6.5	26.9	13.7	13.1	16.7	9.7	17.0	16.3	11.4	13.8	8.1	10.8	15.5	7.3	25.6	8.4	9.0	10.8	5.0	3.2	3.0	3.7	3.9	3.2	4.3	3.6	3.9	4.4	2.9	3.1	2.6	9.8	5.7	2.1	3.0	2.6	2.3	19.1	15.5	33.0	20.6	16.6	8.3	16.9	12.7	13.8	18.6	62.5	45.1	44.7	19.0	21.9	43.6	25.4	53.5	29.4	18.2	24.4	33.4	15.3	3.3	13.2	12.6	27.2	22.2	46.7	16.0	15.4	23.4	24.1	24.3	24.1	15.9	23.8	23.7	34.4	59.8	3.4	26.7	31.6	8.5	20.8	23.1	31.8	20.2	26.6	28.7	9.2	31.1	25.8	15.6	20.6	29.9	22.6	25.3	26.6	20.3	30.6
EPHA1	"EPH, EPHT, EPHT1"	ENSG00000146904	"EPH receptor A1"	P21709	7	143390289-143408892	"Cancer-related genes, Enzymes, Plasma proteins, Predicted membrane proteins"	"Angiogenesis, Cell adhesion"	"Kinase, Receptor, Transferase, Tyrosine-protein kinase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"parathyroid gland: 104.4"	"Cell type enhanced"	"Detected in many"	8	"Early spermatids: 16.5"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in single"		"pons and medulla: 1.1"	"Group enriched"	"Detected in some"	6	"memory CD4 T-cell: 3.4;naive CD4 T-cell: 6.9;naive CD8 T-cell: 5.1"	"Lineage enriched"	"Detected in single"	9	"T-cells: 6.9"	"Cell line enhanced"	"Detected in some"		"CACO-2: 10.5;HaCaT: 9.8;HBEC3-KT: 8.0;MCF7: 8.7;NTERA-2: 32.7"	"Not detected"	"Not detected"							CAB026144	Uncertain					NA	NA		24000000			"CAB026144: "	"unprognostic (1.54e-2)"	"unprognostic (3.04e-2)"	"unprognostic (2.07e-1)"	"unprognostic (4.58e-3)"	"unprognostic (5.82e-3)"	"unprognostic (2.45e-2)"	"unprognostic (9.56e-2)"	"unprognostic (1.81e-2)"	"unprognostic (5.09e-1)"	"unprognostic (7.59e-3)"	"unprognostic (6.54e-2)"	"unprognostic (3.24e-3)"	"prognostic favorable (1.14e-6)"	"unprognostic (3.73e-2)"	"unprognostic (3.28e-2)"	"unprognostic (1.91e-1)"	"unprognostic (1.21e-1)"	0.4	0.4	0.0	2.0	0.1	0.5	1.2	0.9	0.3	5.7	7.9	0.0	3.3	3.3	0.9	1.4	29.3	1.6	7.9	0.4	0.0	0.0	2.8	10.6	2.9	5.8	0.0	0.0	1.2	2.9	104.4	1.3	5.5	1.1	2.1	0.9	1.3	5.8	3.9	0.3	9.5	12.3	0.4	0.2	0.5	1.8	0.8	0.0	5.1	6.0	16.4	17.2	1.6	11.8	0.0	0.7	0.2	0.1	0.2	6.9	1.6	5.0	0.0	0.0	0.0	0.0	0.0	4.8	0.0	0.0	0.0	0.0	10.5	4.2	0.0	0.0	0.0	0.0	9.8	0.0	8.0	0.0	0.0	0.0	1.0	0.0	1.0	0.0	0.4	0.0	0.0	2.6	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	8.7	0.0	1.1	32.7	5.1	0.0	0.0	0.0	0.0	0.7	4.0	0.1	0.0	0.0	4.9	0.0	2.0	2.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.1	0.1	0.1	0.0	0.1	0.0	3.4	0.9	0.4	0.0	6.9	5.1	0.2	0.2	0.0	0.7	0.2	1.6	0.0	0.1	0.9	0.1	0.0	0.0	0.0	0.0	1.1	0.0	0.0	2.1	0.0	5.0	1.8	0.0	0.8	2.5	0.0	3.4	7.0	0.0	1.5	0.0	3.9	16.5	0.0	6.5	0.0	3.7	2.0	0.4	2.1	0.0	7.6	0.4	0.0	1.2	0.0	0.0	7.5	0.6	0.0	0.0	0.0	3.7	0.3	5.1	6.8	0.0	1.1	0.0	0.0	0.0	0.2	1.2	3.1	0.8	0.0	6.0	5.0
EPHA10	"FLJ16103, FLJ33655"	ENSG00000183317	"EPH receptor A10"	Q5JZY3	1	37713880-37765133	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"		"Kinase, Receptor, Transferase, Tyrosine-protein kinase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 15.6;intestine: 12.6;testis: 24.8"	"Group enriched"	"Detected in many"	4	"Cone photoreceptor cells: 86.4;Early spermatids: 49.4;Late spermatids: 147.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"BEWO: 5.2;HDLM-2: 19.6;SCLC-21H: 9.1"									HPA027497	Uncertain				"Intracellular and membrane"	NA	NA					"HPA027497: AB_10601158"	"unprognostic (9.27e-2)"	"unprognostic (1.21e-1)"	"unprognostic (2.94e-2)"	"unprognostic (1.24e-6)"	"unprognostic (1.06e-1)"	"unprognostic (1.11e-2)"	"unprognostic (5.39e-2)"	"unprognostic (1.25e-1)"	"unprognostic (2.55e-2)"	"unprognostic (1.40e-1)"	"unprognostic (7.06e-3)"	"unprognostic (1.50e-1)"	"unprognostic (8.81e-5)"	"unprognostic (2.55e-2)"	"unprognostic (2.97e-2)"	"unprognostic (2.67e-1)"	"unprognostic (3.04e-2)"	0.4	1.1	5.8	1.7	15.6	0.7	1.9	1.3	10.5	0.6	12.6	3.6	0.2	5.8	0.5	6.8	0.8	1.8	2.1	0.4	4.6	7.4	0.5	0.4	0.5	0.6	3.5	5.0	0.4	5.1	1.1	10.8	0.4	6.4	1.4	10.3	1.6	2.4	0.7	0.4	0.6	7.3	1.0	2.3	0.5	5.3	24.8	2.1	0.0	1.0	0.0	0.5	0.6	0.3	0.4	0.3	1.5	0.3	0.8	0.7	0.1	1.5	1.0	0.0	0.0	0.0	0.0	5.2	0.0	0.0	0.0	0.0	1.7	2.8	0.0	0.4	0.0	0.3	0.1	0.1	0.0	0.0	19.6	0.8	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.7	0.0	1.1	0.0	0.2	0.7	2.1	0.6	0.0	0.0	0.4	0.3	1.7	9.1	0.4	1.1	0.0	0.0	0.2	2.9	0.1	0.0	0.0	1.0	0.1	0.0	1.8	1.2	0.0	0.0	0.0	0.1	1.4	0.2	0.1	0.7	0.1	0.4	0.4	0.3	0.3	0.1	0.4	0.6	0.7	1.5	0.8	0.3	0.3	0.2	0.1	5.8	15.6	1.3	10.5	4.6	7.4	3.5	5.0	6.4	2.1	0.0	0.3	0.0	0.0	0.1	5.0	1.4	0.0	0.0	0.0	0.0	86.4	0.0	0.0	0.4	49.4	0.0	9.0	0.0	2.1	0.0	0.0	0.2	0.0	0.0	0.0	11.1	18.0	0.0	0.0	147.5	1.7	0.0	0.0	0.0	9.3	0.3	2.1	23.5	0.4	0.0	3.0	0.0	0.0	8.2	2.5	0.0	0.0	0.0	8.3	0.1
EPHA2	ECK	ENSG00000142627	"EPH receptor A2"	P29317	1	16124337-16156087	"Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Predicted membrane proteins, RAS pathway related proteins"	"Angiogenesis, Apoptosis, Cell adhesion, Differentiation, Host-virus interaction"	"Host cell receptor for virus entry, Kinase, Receptor, Transferase, Tyrosine-protein kinase"	"Cancer-related genes, Cataract, Disease mutation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 51.2"	"Cell type enhanced"	"Detected in many"	8	"Basal keratinocytes: 179.7;Suprabasal keratinocytes: 217.2;Urothelial cells: 155.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in single"	115	"plasmacytoid DC: 11.4"	"Lineage enriched"	"Detected in single"	115	"dendritic cells: 11.4"	"Cell line enhanced"	"Detected in many"		"CAPAN-2: 42.4;EFO-21: 40.9;PC-3: 48.6;U-251 MG: 49.8;WM-115: 54.6"					"Low region specificity"	"Detected in all"			CAB010464			Supported	"Nuclear speckles,Golgi apparatus,Plasma membrane,Cell Junctions"		NA	NA			"Plasma membrane, Cell Junctions"	"Nuclear speckles, Golgi apparatus"	"CAB010464: AB_631436"	"unprognostic (9.41e-2)"	"unprognostic (1.67e-1)"	"unprognostic (4.13e-2)"	"unprognostic (1.67e-2)"	"unprognostic (6.22e-2)"	"unprognostic (9.12e-2)"	"unprognostic (5.24e-2)"	"unprognostic (1.29e-3)"	"unprognostic (2.52e-2)"	"unprognostic (7.05e-3)"	"unprognostic (1.52e-3)"	"unprognostic (2.77e-1)"	"unprognostic (2.65e-2)"	"unprognostic (2.08e-1)"	"unprognostic (1.73e-1)"	"unprognostic (4.77e-3)"	"unprognostic (4.40e-2)"	6.7	3.4	1.3	3.1	2.6	0.0	5.2	0.5	2.1	12.1	4.9	1.6	1.9	4.3	7.8	3.8	51.2	4.6	16.7	6.4	1.1	0.8	5.7	8.2	6.6	4.7	2.7	1.3	4.5	10.2	2.2	2.8	8.9	3.4	5.8	2.6	5.4	31.0	2.8	3.4	12.7	13.1	2.7	3.0	2.8	6.8	2.4	1.2	1.2	5.7	21.8	25.5	15.2	18.5	0.0	11.4	0.0	0.0	0.0	0.0	0.0	15.6	31.7	8.8	4.2	0.6	0.7	5.2	9.5	13.4	17.2	10.9	13.2	42.4	0.0	40.9	5.4	21.3	6.4	2.1	21.9	6.0	0.0	1.4	0.0	9.2	8.4	11.3	0.0	0.0	1.0	8.2	9.3	20.7	27.0	18.3	0.0	0.0	0.0	10.9	5.0	0.0	0.0	4.2	11.8	48.6	0.0	8.0	0.0	18.2	8.1	0.0	1.3	18.4	4.5	1.2	4.8	0.6	0.1	22.6	6.1	16.5	0.4	49.8	0.0	0.1	0.1	4.7	0.0	54.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.4	0.0	0.0	1.3	2.6	0.5	2.1	1.1	0.8	2.7	1.3	3.4	1.2	50.6	28.9	0.5	100.5	179.7	0.6	5.8	40.8	37.5	33.0	8.7	3.9	8.1	0.0	31.3	5.4	17.5	57.1	0.0	12.5	0.9	7.0	56.8	5.7	19.8	1.6	0.0	2.9	32.5	2.8	0.0	3.1	4.6	25.3	1.8	19.6	5.8	62.9	20.1	0.0	1.4	2.0	32.3	17.6	0.0	0.7	217.2	6.3	0.0	17.7	155.0
EPHA3	"ETK, ETK1, HEK, HEK4, TYRO4"	ENSG00000044524	"EPH receptor A3"	P29320	3	89107524-89482134	"Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion"	"Kinase, Receptor, Transferase, Tyrosine-protein kinase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"prostate: 39.0"	"Group enriched"	"Detected in some"	5	"Fibroblasts: 12.2;Horizontal cells: 19.1;Peritubular cells: 7.8;Rod photoreceptor cells: 16.9;Sertoli cells: 6.5;Smooth muscle cells: 20.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	6	"AF22: 66.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"CAB010462, HPA069390"	Approved		Supported	"Nucleoplasm,Nuclear membrane,Plasma membrane,Actin filaments,Cytosol"	"Intracellular and membrane"	NA	NA			"Nuclear membrane, Plasma membrane, Cytosol"	"Nucleoplasm, Actin filaments"	"CAB010462: AB_2099218, HPA069390: "	"unprognostic (1.48e-3)"	"unprognostic (2.30e-2)"	"unprognostic (4.95e-2)"	"unprognostic (1.90e-1)"	"unprognostic (2.96e-2)"	"unprognostic (1.47e-2)"	"unprognostic (2.03e-1)"	"unprognostic (9.10e-3)"	"unprognostic (1.24e-3)"	"unprognostic (7.43e-2)"	"unprognostic (1.83e-1)"	"unprognostic (2.23e-1)"	"prognostic unfavorable (3.28e-7)"	"unprognostic (3.63e-2)"	"unprognostic (1.88e-2)"	"unprognostic (4.05e-2)"	"unprognostic (1.20e-2)"	9.7	1.1	2.3	1.7	4.5	0.2	5.1	1.3	8.7	12.3	5.8	0.6	1.4	2.2	13.9	1.3	6.3	2.6	17.2	10.0	2.2	2.5	1.5	4.4	2.7	3.0	2.5	3.4	4.2	2.8	1.2	3.4	17.5	11.9	39.0	5.9	5.4	3.8	6.8	1.7	1.7	3.5	17.3	2.9	1.2	3.7	1.3	2.0	0.0	16.3	6.0	3.0	11.8	12.2	0.3	0.1	0.5	0.1	0.3	0.2	0.0	0.0	0.0	66.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	3.8	0.0	0.2	0.0	0.8	0.0	0.0	4.1	0.0	0.0	0.6	0.7	0.0	1.3	0.0	0.0	0.2	0.0	0.8	0.0	0.1	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.1	0.0	0.0	11.8	0.0	0.0	0.0	0.6	0.0	0.5	0.2	0.1	0.2	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.3	0.0	0.0	0.5	0.3	0.1	0.1	0.0	0.0	2.3	4.5	1.3	8.7	2.2	2.5	2.5	3.4	11.9	2.0	0.0	0.0	0.0	0.3	0.5	1.5	2.1	0.0	0.0	0.0	0.0	2.0	0.2	0.0	0.0	1.3	1.1	0.0	0.0	0.0	0.1	12.2	0.1	0.0	0.0	0.1	19.1	0.0	0.6	0.0	1.3	2.0	0.0	0.0	0.0	0.0	2.9	0.0	0.0	7.8	0.0	16.9	6.5	20.6	0.0	0.0	0.3	0.5	0.0	0.0	0.0
EPHA4	"Hek8, TYRO1"	ENSG00000116106	"EPH receptor A4"	P54764	2	221418027-221574202	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion, Neurogenesis"	"Developmental protein, Kinase, Receptor, Transferase, Tyrosine-protein kinase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 29.6"	"Cell type enhanced"	"Detected in many"	6	"Cardiomyocytes: 25.0;Pancreatic endocrine cells: 18.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	8	"basophil: 3.0;gdT-cell: 3.4;MAIT T-cell: 3.4;memory B-cell: 2.5;memory CD4 T-cell: 5.0;memory CD8 T-cell: 3.3;naive B-cell: 1.8;naive CD4 T-cell: 1.9;NK-cell: 6.0;T-reg: 2.1"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"AF22: 35.8;ASC diff: 15.8;CACO-2: 26.2;U-2197: 17.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			CAB028368	Enhanced					NA	NA		8400000			"CAB028368: AB_2099353"	"unprognostic (1.28e-1)"	"unprognostic (5.87e-2)"	"unprognostic (2.28e-1)"	"unprognostic (2.46e-2)"	"unprognostic (5.99e-2)"	"unprognostic (1.33e-1)"	"unprognostic (7.05e-4)"	"unprognostic (1.80e-2)"	"unprognostic (2.40e-1)"	"prognostic unfavorable (9.56e-4)"	"unprognostic (1.12e-1)"	"unprognostic (2.85e-2)"	"prognostic favorable (5.67e-4)"	"unprognostic (3.12e-2)"	"unprognostic (1.96e-1)"	"unprognostic (2.36e-1)"	"unprognostic (8.66e-2)"	7.1	1.8	8.1	1.9	18.3	3.5	5.2	14.7	29.6	4.9	5.9	3.1	3.2	1.1	6.5	3.1	5.0	6.6	3.3	16.7	19.9	4.4	5.2	0.9	3.7	2.5	2.4	16.4	11.7	1.2	2.0	1.2	1.7	4.9	5.9	4.7	0.8	3.7	6.7	3.1	12.8	4.1	8.2	2.1	3.3	4.0	11.4	2.6	0.5	9.8	3.7	3.2	4.6	4.9	2.5	0.2	3.0	0.0	6.0	5.0	0.7	1.1	1.1	35.8	0.0	15.8	9.8	0.0	8.5	3.7	7.7	2.8	26.2	0.4	0.0	0.0	11.8	0.0	3.1	5.5	0.0	3.2	4.2	3.0	0.0	0.3	0.0	0.4	0.0	0.6	3.9	1.9	2.4	0.0	4.8	7.2	0.0	0.0	0.0	2.0	4.2	0.1	0.0	2.5	2.6	0.8	0.0	3.9	0.0	12.0	1.9	6.3	0.0	2.8	0.6	0.6	3.0	1.3	0.0	0.0	0.8	1.5	17.5	0.4	0.0	0.0	0.0	3.2	0.0	1.6	3.0	0.0	0.0	3.4	0.0	3.4	2.5	5.0	3.3	0.0	1.8	1.9	0.3	0.2	6.0	0.0	0.2	2.1	0.7	8.1	18.3	14.7	29.6	19.9	4.4	2.4	16.4	4.9	2.6	0.0	5.4	0.8	0.4	5.5	10.2	25.0	7.6	1.4	3.4	8.7	0.0	0.0	6.6	0.2	2.0	11.7	0.1	0.0	0.2	0.0	3.9	1.2	1.1	0.0	0.3	1.6	3.4	12.3	0.0	4.3	1.1	0.2	6.8	0.0	14.0	6.3	18.0	0.0	8.1	1.5	2.7	0.0	7.2	6.7	1.3	10.9	0.0	1.0	6.8	1.8
EPHA5	"CEK7, EHK1, Hek7, TYRO4"	ENSG00000145242	"EPH receptor A5"	P54756	4	65319563-65670495	"Enzymes, Predicted membrane proteins"	Neurogenesis	"Kinase, Receptor, Transferase, Tyrosine-protein kinase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 25.5"	"Cell type enhanced"	"Detected in some"	14	"Early spermatids: 12.1;Late spermatids: 12.5;Muller glia cells: 6.4"	"Cancer enhanced"	"Detected in some"		"glioma: 0.8"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"hTERT-RPE1: 7.8;PC-3: 7.1;TIME: 9.5;U-138 MG: 19.9;U-2197: 12.1;U-251 MG: 15.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"									NA	NA						"unprognostic (1.02e-2)"	"unprognostic (4.22e-2)"	"unprognostic (2.38e-1)"	"unprognostic (4.89e-4)"	"unprognostic (7.43e-4)"	"unprognostic (1.60e-1)"		"unprognostic (6.68e-3)"	"unprognostic (2.49e-1)"	"unprognostic (1.12e-1)"	"unprognostic (1.03e-2)"	"unprognostic (9.25e-2)"		"unprognostic (5.88e-3)"	"unprognostic (2.55e-2)"	"unprognostic (5.97e-4)"	"unprognostic (3.81e-3)"	0.9	2.7	17.6	1.0	9.0	0.8	0.8	1.9	25.5	5.9	1.2	1.5	1.8	0.9	1.9	0.9	1.1	1.0	0.9	2.7	17.3	6.8	0.9	0.8	1.1	0.9	5.4	13.2	6.2	0.8	0.8	6.5	2.7	10.2	4.2	1.1	2.6	1.2	4.1	0.8	1.2	0.9	1.4	17.7	1.5	1.1	2.2	0.7	0.0	3.0	0.0	0.8	1.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.6	0.0	0.6	0.3	0.0	0.3	0.9	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.2	0.0	3.3	0.0	3.8	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	7.8	0.2	0.0	0.0	1.2	1.9	0.0	0.0	0.0	0.0	0.0	7.1	0.0	2.2	0.4	0.0	0.0	0.8	0.0	0.0	0.0	3.2	0.0	0.0	0.0	9.5	19.9	2.5	12.1	15.3	0.0	0.0	0.0	2.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	17.6	9.0	1.9	24.7	17.3	6.8	5.4	13.2	10.2	0.7	0.0	0.0	0.0	0.0	0.5	0.6	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.1	0.0	0.0	0.0	0.0	0.0	0.2	0.9	0.0	0.0	0.1	1.6	0.0	0.0	0.0	12.5	0.9	0.0	3.3	0.0	0.0	6.4	0.0	0.0	0.0	0.0	1.4	0.0	0.4	1.0	0.2	0.1	0.0	0.0	0.0	0.0
EPHA6	FLJ35246	ENSG00000080224	"EPH receptor A6"	Q9UF33	3	96814581-97752460	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"		"Kinase, Receptor, Transferase, Tyrosine-protein kinase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 27.9;ovary: 13.2;testis: 15.5"	"Group enriched"	"Detected in some"	67	"Early spermatids: 305.1;Late spermatids: 156.3"	"Low cancer specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"HEK 293: 8.2;U-266/70: 24.9"	"Low region specificity"	"Detected in many"							"HPA007397, HPA058047"	Uncertain		Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"HPA007397: AB_2667821, HPA058047: AB_2683588"	"unprognostic (9.87e-2)"	"unprognostic (1.67e-2)"	"unprognostic (3.42e-4)"	"unprognostic (7.21e-5)"	"unprognostic (8.51e-2)"	"unprognostic (1.32e-1)"		"unprognostic (1.82e-2)"	"unprognostic (3.14e-1)"	"unprognostic (1.87e-1)"	"unprognostic (1.34e-1)"	"unprognostic (2.22e-1)"	"unprognostic (1.71e-4)"	"unprognostic (1.93e-3)"	"unprognostic (1.76e-1)"	"unprognostic (1.48e-2)"	"unprognostic (7.14e-3)"	0.8	0.5	8.7	0.5	9.8	0.3	0.8	27.9	9.9	2.2	5.8	1.1	0.3	0.6	2.2	1.0	2.1	4.2	2.1	1.1	15.4	1.3	1.3	0.5	0.5	0.4	1.1	6.8	13.2	1.4	0.7	0.6	0.5	5.7	2.5	1.8	0.2	0.6	1.7	0.4	0.5	1.1	3.2	0.8	0.4	1.7	15.5	2.8	0.0	4.3	0.0	0.5	2.1	1.7	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	8.2	0.0	2.1	0.0	0.0	2.0	0.0	0.0	0.4	0.0	0.8	0.8	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.7	0.9	0.0	0.0	0.0	0.0	0.5	0.0	0.1	0.0	2.1	0.0	0.8	24.9	0.0	0.0	0.0	0.0	1.5	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.7	9.8	27.9	9.9	15.4	1.3	1.1	6.8	5.7	2.8	0.0	0.0	0.0	0.1	0.2	0.8	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	305.1	0.0	0.0	0.0	0.0	0.0	0.6	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	156.3	2.8	0.0	0.0	0.0	0.0	0.9	0.1	0.0	1.4	0.6	0.2	0.0	0.1	3.4	2.3	0.0	0.1	0.0	0.0	0.0
EPHA7	Hek11	ENSG00000135333	"EPH receptor A7"	Q15375	6	93240020-93419547	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Apoptosis, Neurogenesis"	"Developmental protein, Kinase, Receptor, Transferase, Tyrosine-protein kinase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"parathyroid gland: 110.4"	"Group enriched"	"Detected in some"	4	"Bipolar cells: 14.1;Cardiomyocytes: 10.8;Early spermatids: 3.7;Horizontal cells: 11.1;Proximal tubular cells: 11.5"	"Cancer enhanced"	"Detected in many"		"renal cancer: 6.4"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"AF22: 8.9;HEK 293: 25.5;RH-30: 24.4;THP-1: 20.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB010496	Approved				"Intracellular and membrane"	NA	NA		340000			"CAB010496: AB_2099673"	"unprognostic (3.34e-1)"	"unprognostic (7.82e-2)"	"unprognostic (1.41e-1)"	"unprognostic (9.32e-2)"	"unprognostic (1.19e-1)"	"unprognostic (3.56e-2)"		"unprognostic (1.62e-2)"	"unprognostic (4.07e-1)"	"unprognostic (4.16e-2)"	"unprognostic (3.19e-2)"	"unprognostic (5.69e-2)"	"unprognostic (1.69e-1)"	"unprognostic (1.74e-2)"	"unprognostic (1.35e-1)"	"unprognostic (1.56e-2)"	"unprognostic (4.82e-2)"	1.3	1.3	6.0	1.7	24.6	1.2	2.2	21.6	8.6	2.4	24.6	0.0	0.1	2.5	2.0	7.5	14.7	1.7	3.1	4.2	13.8	2.9	6.9	1.3	1.5	1.3	2.4	5.8	3.0	1.3	110.4	5.6	1.6	6.7	17.9	3.6	0.4	8.2	1.9	1.3	1.4	6.5	20.2	4.8	4.7	14.9	2.1	4.4	0.0	1.3	0.0	1.3	9.7	5.9	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.5	8.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	25.5	0.0	2.5	0.0	0.0	0.0	0.0	0.3	0.0	3.7	0.0	0.0	0.0	0.0	0.0	0.0	4.0	0.0	0.0	0.0	0.5	0.0	0.6	4.5	24.4	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.1	0.0	20.8	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	6.0	24.6	21.6	8.6	13.8	2.9	2.4	5.8	6.7	4.4	0.0	0.0	0.0	0.4	0.3	14.1	10.8	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	3.7	0.7	0.0	0.0	0.0	0.0	2.3	0.3	0.0	0.0	0.1	11.1	0.0	0.0	0.0	2.1	0.9	0.0	0.0	0.0	0.0	0.8	0.1	0.0	0.0	11.5	0.9	0.0	0.8	0.2	0.7	0.9	0.0	0.0	0.0	0.0
EPHA8	"EEK, Hek3"	ENSG00000070886	"EPH receptor A8"	P29322	1	22563564-22603594	"Cancer-related genes, Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion, Neurogenesis"	"Developmental protein, Kinase, Receptor, Transferase, Tyrosine-protein kinase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"adrenal gland: 9.4;brain: 5.3;lymphoid tissue: 10.3;pancreas: 8.3;testis: 3.5"	"Cell type enhanced"	"Detected in some"	15	"Bipolar cells: 5.2;Early spermatids: 2.5;Horizontal cells: 3.2;Late spermatids: 3.9;Rod photoreceptor cells: 8.0"	"Low cancer specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	12	"SCLC-21H: 37.3"	"Low region specificity"	"Detected in many"			"Region enriched"	"Detected in many"	5	"cerebellum: 25.0"	"CAB009660, HPA031433"	Uncertain				"Intracellular and membrane"	NA	NA					"CAB009660: AB_2099696, HPA031433: AB_10601371"	"unprognostic (8.58e-2)"	"unprognostic (8.59e-2)"	"unprognostic (3.72e-1)"	"unprognostic (1.15e-2)"	"unprognostic (4.69e-4)"	"unprognostic (3.58e-1)"		"unprognostic (7.14e-2)"	"unprognostic (1.52e-1)"	"unprognostic (4.75e-2)"	"unprognostic (9.80e-2)"	"unprognostic (2.10e-1)"	"unprognostic (9.84e-14)"	"unprognostic (2.14e-3)"	"unprognostic (1.69e-1)"	"unprognostic (2.76e-1)"	"unprognostic (8.68e-2)"	0.2	9.4	1.6	0.2	3.1	0.2	0.1	1.8	3.9	0.2	0.2	2.2	0.0	1.7	0.1	0.3	0.2	0.1	0.2	0.2	2.0	2.6	0.1	0.1	0.2	0.2	2.1	4.1	0.1	8.3	0.2	1.7	0.1	5.3	0.2	0.2	1.6	0.8	0.2	0.3	0.4	0.2	0.1	1.3	10.3	0.2	3.5	0.6	0.0	0.2	0.0	0.1	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	37.3	3.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	1.6	3.1	1.8	3.9	2.0	2.6	2.1	4.1	5.3	0.6	0.0	0.0	0.0	0.0	0.0	5.2	0.6	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	3.2	0.0	0.0	0.0	3.9	0.0	0.0	0.0	0.0	0.0	0.5	0.2	0.0	0.4	0.0	8.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0
EPHB1	"EPHT2, Hek6"	ENSG00000154928	"EPH receptor B1"	P54762	3	134597801-135260467	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion, Neurogenesis"	"Kinase, Receptor, Transferase, Tyrosine-protein kinase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"brain: 74.7"	"Cell type enhanced"	"Detected in some"	14	"Cone photoreceptor cells: 9.8;Early spermatids: 30.2;Late spermatids: 26.8;Muller glia cells: 16.2"	"Cancer enriched"	"Detected in many"	6	"glioma: 7.0"	"Region enhanced"	"Detected in all"		"cerebellum: 74.7"	"Group enriched"	"Detected in some"	33	"neutrophil: 15.9;plasmacytoid DC: 15.4"	"Group enriched"	"Detected in many"	33	"dendritic cells: 15.4;granulocytes: 15.9"	"Group enriched"	"Detected in some"	4	"HDLM-2: 34.7;HMC-1: 20.6;RPTEC TERT1: 9.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA067740	Enhanced		Approved	"Endoplasmic reticulum,Plasma membrane,Cytosol"		NA	NA			"Endoplasmic reticulum, Plasma membrane, Cytosol"		"HPA067740: AB_2685895"	"unprognostic (1.99e-1)"	"unprognostic (3.45e-1)"	"unprognostic (2.52e-1)"	"unprognostic (1.41e-6)"	"unprognostic (6.52e-2)"	"unprognostic (1.31e-1)"	"unprognostic (1.07e-1)"	"unprognostic (8.15e-2)"	"unprognostic (9.88e-2)"	"unprognostic (1.55e-1)"	"unprognostic (1.11e-1)"	"unprognostic (1.75e-1)"	"unprognostic (1.04e-1)"	"unprognostic (4.82e-2)"	"unprognostic (1.78e-1)"	"unprognostic (1.37e-3)"	"unprognostic (4.88e-4)"	2.0	1.5	9.0	1.8	16.6	1.5	5.5	74.7	23.6	3.6	3.4	3.4	3.1	2.8	4.1	2.0	3.8	2.8	3.3	1.1	9.4	5.3	2.3	2.9	1.0	3.3	2.8	7.0	1.7	1.1	0.6	3.8	0.9	7.1	3.3	1.4	1.9	3.9	5.1	7.4	6.0	1.7	1.7	6.0	3.4	1.3	16.7	6.0	0.0	11.6	2.9	3.3	4.5	2.6	0.0	15.4	15.9	0.0	0.0	0.4	0.1	0.0	0.0	4.8	0.0	0.1	0.0	0.1	3.6	0.0	0.2	0.0	0.0	0.0	0.6	1.0	1.9	0.3	0.0	3.2	0.0	0.7	34.7	0.4	2.6	0.0	0.0	0.0	0.0	20.6	0.0	0.0	0.0	0.0	0.2	0.1	0.2	0.1	0.2	2.6	0.1	0.1	0.1	1.4	0.6	0.0	0.0	0.5	0.1	9.4	0.0	0.6	0.1	0.0	0.0	0.0	0.7	0.1	0.4	0.2	0.6	2.0	0.3	4.3	0.1	0.2	0.2	0.1	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.9	0.0	0.0	15.4	0.0	0.1	9.0	16.6	74.7	19.0	9.4	5.3	2.8	7.0	7.1	6.0	0.0	0.0	0.9	0.0	3.3	1.2	1.0	0.0	0.0	0.0	0.0	9.8	0.0	0.0	0.8	30.2	0.6	0.0	0.0	0.3	0.0	0.2	0.1	0.0	5.8	0.4	0.0	0.0	0.0	0.0	26.8	0.6	0.0	1.7	0.0	0.0	16.2	0.6	0.0	0.0	0.0	0.9	0.0	0.8	0.4	0.9	5.1	0.0	0.0	0.0	0.1
EPHB2	"DRT, EPHT3, ERK, Hek5, Tyro5"	ENSG00000133216	"EPH receptor B2"	P29323	1	22710839-22921500	"Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	Neurogenesis	"Developmental protein, Kinase, Receptor, Transferase, Tyrosine-protein kinase"	"Cancer-related genes, Disease mutation, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 25.0"	"Cell type enhanced"	"Detected in many"	11	"Ductal cells: 42.3;Intestinal endocrine cells: 46.8;Mucus-secreting cells: 53.6;Pancreatic endocrine cells: 38.4;Undifferentiated cells: 82.9"	"Cancer enhanced"	"Detected in many"		"colorectal cancer: 23.7"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"classical monocyte: 2.5;intermediate monocyte: 2.1"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"GAMG: 34.4;HUVEC TERT2: 29.7;TIME: 29.4;U-251 MG: 25.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"CAB013647, HPA071200"	Approved		Supported	"Nucleoplasm,Plasma membrane"	"Intracellular and membrane"	No	No		290000	"Plasma membrane"	Nucleoplasm	"CAB013647: , HPA071200: AB_2686360"	"unprognostic (2.47e-2)"	"unprognostic (2.43e-2)"	"prognostic favorable (4.98e-4)"	"prognostic unfavorable (1.05e-5)"	"unprognostic (3.99e-2)"	"unprognostic (8.91e-3)"	"unprognostic (1.23e-1)"	"unprognostic (2.33e-3)"	"unprognostic (1.56e-1)"	"unprognostic (7.73e-2)"	"unprognostic (1.23e-2)"	"unprognostic (2.15e-2)"	"unprognostic (2.16e-4)"	"unprognostic (1.45e-1)"	"unprognostic (8.07e-2)"	"unprognostic (2.58e-1)"	"unprognostic (3.46e-2)"	3.7	2.9	3.4	15.4	5.4	0.9	2.5	1.9	8.2	3.8	23.9	16.2	4.6	21.6	2.5	3.2	1.1	5.4	4.4	5.4	5.6	6.5	3.5	1.1	3.0	5.5	12.7	3.8	17.9	5.4	6.1	5.4	12.0	8.2	3.3	25.0	2.2	6.6	4.0	0.7	1.8	22.6	4.0	12.1	3.3	2.3	2.9	9.3	0.1	8.4	1.0	2.1	5.3	3.3	0.1	0.6	0.3	2.5	0.1	0.1	0.4	15.9	6.7	6.5	10.4	0.6	0.6	0.0	3.7	0.2	11.3	2.4	2.3	6.4	0.2	8.0	1.6	34.4	15.1	4.4	21.7	3.0	0.0	1.6	0.0	0.7	0.0	6.8	0.0	1.6	2.2	7.0	20.2	0.1	10.0	29.7	0.9	0.6	0.0	2.2	2.3	0.3	0.1	1.5	17.8	4.4	1.9	6.7	0.3	5.5	1.5	7.1	7.4	6.5	0.2	0.0	0.6	0.4	0.2	29.4	4.5	11.8	11.4	25.5	0.0	0.1	0.0	8.4	0.3	0.1	0.3	2.5	0.1	0.1	2.1	0.0	0.0	0.0	0.0	0.6	0.1	0.1	0.1	0.3	0.1	0.1	0.1	0.1	0.4	3.4	5.4	1.9	8.2	5.6	6.5	12.7	3.8	8.2	9.3	3.0	0.0	0.0	1.5	0.7	11.6	1.2	12.7	1.4	3.4	0.0	0.0	0.4	0.0	42.3	2.3	0.5	6.8	0.0	6.8	2.2	1.5	1.4	0.0	0.5	9.1	6.4	46.8	0.6	7.5	0.4	0.9	3.7	0.0	0.0	53.6	20.9	38.4	3.5	0.7	0.0	1.7	0.0	1.7	0.5	2.6	0.4	0.9	0.0	82.9	1.0
EPHB3	"ETK2, Hek2, Tyro6"	ENSG00000182580	"EPH receptor B3"	P54753	3	184561784-184582409	"Cancer-related genes, Enzymes, Predicted membrane proteins"	"Angiogenesis, Neurogenesis"	"Developmental protein, Kinase, Receptor, Transferase, Tyrosine-protein kinase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"pancreas: 49.3"	"Cell type enhanced"	"Detected in many"	10	"Intestinal endocrine cells: 68.8;Mucus-secreting cells: 39.5;Suprabasal keratinocytes: 31.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	5	"classical monocyte: 1.1;myeloid DC: 3.1"	"Group enriched"	"Detected in many"	5	"dendritic cells: 3.1;monocytes: 1.1"	"Cell line enhanced"	"Detected in many"		"BEWO: 17.0;HaCaT: 23.4;OE19: 16.1;SK-BR-3: 18.1;T-47d: 12.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA007698, HPA008184, CAB034350"	Enhanced					NA	NA		20000			"CAB034350: AB_2262377, HPA007698: AB_1848205, HPA008184: AB_1848206"	"unprognostic (2.94e-2)"	"unprognostic (5.88e-2)"	"unprognostic (2.17e-2)"	"unprognostic (7.80e-2)"	"unprognostic (1.52e-1)"	"unprognostic (9.19e-2)"	"unprognostic (8.35e-2)"	"unprognostic (1.94e-1)"	"unprognostic (5.51e-2)"	"unprognostic (1.76e-1)"	"unprognostic (7.42e-2)"	"unprognostic (3.31e-1)"	"prognostic unfavorable (7.88e-5)"	"unprognostic (8.83e-3)"	"unprognostic (3.03e-2)"	"unprognostic (9.59e-3)"	"unprognostic (2.10e-3)"	1.4	0.9	4.5	5.0	2.6	0.5	9.0	9.7	5.7	22.7	8.8	2.3	1.7	5.7	10.0	1.9	19.9	3.0	9.7	1.6	4.7	1.8	1.7	1.0	4.7	1.0	3.3	3.7	9.0	49.3	1.1	1.7	6.3	7.2	7.7	9.7	3.8	27.7	3.5	0.7	32.3	5.6	3.5	1.3	1.2	16.0	1.1	4.0	0.2	1.0	15.7	8.4	4.0	13.6	0.0	3.1	0.3	1.1	0.0	0.4	0.4	3.7	1.3	8.8	0.9	2.7	0.2	17.0	0.6	1.1	1.3	0.7	1.2	0.1	0.0	1.7	3.6	0.6	23.4	3.1	1.1	0.3	0.1	0.7	0.0	0.2	0.0	0.2	0.0	0.2	0.7	7.7	1.0	0.1	0.4	0.0	0.0	0.0	0.0	0.6	9.9	0.0	3.8	0.9	16.1	1.4	0.8	5.3	0.0	0.0	3.4	1.1	1.3	0.7	18.1	0.8	4.8	12.0	0.1	0.0	2.1	3.1	1.1	1.4	0.0	0.0	0.1	0.2	0.0	8.3	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	3.1	0.0	0.1	0.4	0.3	0.0	0.0	0.0	0.0	0.4	4.5	2.6	9.7	5.7	4.7	1.8	3.3	3.7	7.2	4.0	3.0	2.4	0.0	6.9	21.4	0.0	1.4	2.5	1.4	2.3	0.0	0.0	8.1	1.7	0.3	0.4	0.6	3.5	0.0	1.4	14.8	8.4	5.5	4.6	0.0	17.9	14.3	68.8	3.1	0.3	0.0	2.6	1.0	0.0	1.0	39.5	0.1	2.4	7.0	5.6	0.1	0.8	0.0	2.1	0.5	0.6	31.2	13.6	0.0	27.1	19.5
EPHB4	"HTK, Tyro11"	ENSG00000196411	"EPH receptor B4"	P54760	7	100802565-100827521	"Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	Angiogenesis	"Developmental protein, Kinase, Receptor, Transferase, Tyrosine-protein kinase"	"Cancer-related genes, Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"Cytotrophoblasts: 50.1;Endothelial cells: 43.5;Ito cells: 106.8;Syncytiotrophoblasts: 172.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"classical monocyte: 3.6;neutrophil: 7.4"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB013537	Uncertain					NA	NA		1000000			"CAB013537: "	"prognostic unfavorable (8.56e-4)"	"unprognostic (1.05e-2)"	"prognostic unfavorable (4.33e-4)"	"unprognostic (1.33e-1)"	"unprognostic (5.23e-2)"	"unprognostic (3.43e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.01e-1)"	"unprognostic (2.73e-1)"	"unprognostic (1.84e-1)"	"unprognostic (8.16e-3)"	"unprognostic (1.43e-1)"	"unprognostic (9.51e-3)"	"unprognostic (6.63e-2)"	"unprognostic (3.13e-1)"	"unprognostic (2.07e-2)"	"prognostic unfavorable (8.84e-4)"	14.0	20.7	1.8	4.2	2.9	2.2	17.1	1.9	3.0	29.1	9.5	2.9	14.6	4.1	28.8	10.3	11.0	13.1	35.0	19.0	3.4	1.1	16.8	29.8	16.5	12.0	2.2	0.9	24.6	11.6	5.6	3.1	35.5	3.2	13.7	5.4	11.6	10.8	14.7	5.1	14.2	7.0	12.4	2.2	50.5	8.6	12.2	2.1	2.3	10.2	13.1	7.0	7.7	21.5	0.0	1.6	7.4	3.6	0.0	0.0	1.2	12.6	11.2	11.2	32.6	7.2	4.6	33.3	5.0	10.8	7.8	10.2	9.2	9.7	1.6	22.7	5.1	10.9	13.2	4.9	13.1	4.1	2.1	9.1	0.4	6.5	14.3	4.2	0.2	0.3	5.4	19.7	4.9	11.6	8.6	29.1	0.5	23.9	0.6	6.3	22.1	0.2	4.9	19.2	18.7	16.9	17.2	5.5	2.9	9.9	6.7	0.0	9.7	7.6	3.6	7.4	16.3	9.0	2.2	24.4	9.7	15.4	17.9	7.3	0.1	0.2	0.5	1.4	4.1	17.6	0.0	3.6	0.0	0.0	0.9	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	7.4	0.0	0.2	0.3	0.0	1.2	1.8	2.9	1.9	3.0	3.4	1.1	2.2	0.9	3.2	2.1	8.9	13.0	6.4	8.7	18.2	0.0	3.6	10.2	1.4	5.7	5.2	0.0	50.1	0.0	9.9	20.9	43.5	2.4	0.0	5.7	7.3	7.4	8.7	1.1	18.1	8.1	0.0	2.9	106.8	5.6	8.1	7.5	1.1	3.3	1.0	14.8	1.5	17.1	7.0	3.9	3.7	0.0	6.5	5.0	1.0	12.4	15.6	172.7	1.7	17.9	7.1
EPHX1	EPHX	ENSG00000143819	"Epoxide hydrolase 1"	P07099	1	225810092-225845563	"Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Aromatic hydrocarbons catabolism, Detoxification"	Hydrolase	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adrenal gland: 156.4;liver: 265.0"	"Cell type enhanced"	"Detected in many"	12	"Hepatocytes: 721.1;Leydig cells: 288.2"	"Cancer enriched"	"Detected in all"	6	"liver cancer: 1047.0"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"classical monocyte: 6.6"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"ASC diff: 157.2;SiHa: 74.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA020593, HPA048847"	Enhanced					NA	NA		83000			"HPA020593: AB_10601373, HPA048847: AB_2680538"	"unprognostic (2.85e-2)"	"unprognostic (2.52e-2)"	"unprognostic (2.00e-2)"	"unprognostic (2.53e-3)"	"unprognostic (2.50e-1)"	"unprognostic (6.60e-2)"	"unprognostic (3.92e-2)"	"prognostic favorable (7.02e-5)"	"unprognostic (1.02e-1)"	"unprognostic (2.53e-2)"	"unprognostic (1.01e-1)"	"prognostic favorable (1.32e-4)"	"unprognostic (8.10e-2)"	"unprognostic (1.80e-1)"	"unprognostic (1.65e-1)"	"unprognostic (5.15e-2)"	"unprognostic (1.88e-2)"	39.5	156.4	16.8	5.7	20.1	3.4	31.3	8.3	25.1	31.3	12.6	28.7	15.3	16.6	21.8	15.7	24.9	26.2	17.8	11.5	16.3	11.2	36.8	265.0	24.1	6.9	17.1	14.5	45.6	85.0	39.5	14.0	5.4	23.6	25.9	8.4	27.3	26.3	21.3	16.4	8.8	9.6	18.6	10.7	8.3	12.1	22.7	12.6	3.6	24.9	15.6	14.9	20.9	32.3	0.5	2.2	0.5	6.6	1.4	1.3	2.3	4.5	43.3	1.7	15.9	157.2	16.4	3.4	5.2	6.6	3.8	5.3	8.9	46.0	0.1	19.7	19.6	4.3	5.0	4.7	2.5	1.5	1.0	8.2	3.2	18.3	49.9	17.1	2.0	1.9	15.3	5.7	10.7	1.0	14.9	2.8	1.9	2.2	4.0	6.7	5.3	1.9	3.7	9.3	21.7	12.2	4.2	2.0	13.1	11.4	28.5	14.9	1.9	74.7	26.8	6.9	4.3	19.9	5.8	8.2	6.5	5.2	8.7	8.3	1.3	6.8	0.6	9.7	2.1	8.5	0.0	6.6	0.2	0.5	1.9	0.9	0.3	0.9	0.5	1.5	0.5	1.3	1.0	0.5	1.4	0.8	2.2	0.7	2.3	16.8	20.1	8.3	25.1	16.3	11.2	17.1	14.5	23.6	12.6	0.0	12.3	2.9	88.1	17.4	7.0	1.4	96.8	16.0	12.5	48.8	27.5	40.2	14.9	84.0	9.3	77.9	28.9	23.3	63.2	4.5	52.6	51.6	5.7	721.1	118.3	1.6	10.4	74.9	24.4	15.1	288.2	14.5	40.5	8.2	13.8	96.3	71.3	21.0	149.6	79.4	10.3	219.9	78.5	3.1	3.6	15.4	19.1	10.2	31.9	79.3
EPHX2		ENSG00000120915	"Epoxide hydrolase 2"	P34913	8	27490779-27545564	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Aromatic hydrocarbons catabolism, Detoxification, Lipid metabolism"	"Hydrolase, Multifunctional enzyme"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 83.9;liver: 87.6"	"Cell type enhanced"	"Detected in many"	7	"Distal tubular cells: 152.5;Proximal tubular cells: 198.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"naive CD4 T-cell: 39.2"	"Lineage enriched"	"Detected in many"	24	"T-cells: 39.2"	"Group enriched"	"Detected in many"	4	"JURKAT: 50.5;K-562: 17.8;OE19: 36.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023094, HPA023660"	Enhanced		Enhanced	Cytosol		NA	NA		720000	Cytosol		"HPA023094: AB_1848214, HPA023660: AB_1848215"	"unprognostic (1.30e-1)"	"prognostic favorable (2.45e-4)"	"unprognostic (2.99e-2)"	"unprognostic (3.62e-2)"	"unprognostic (1.76e-2)"	"unprognostic (3.30e-3)"	"unprognostic (1.26e-3)"	"unprognostic (3.31e-3)"	"unprognostic (1.46e-1)"	"unprognostic (3.55e-2)"	"unprognostic (4.14e-3)"	"unprognostic (1.98e-1)"	"prognostic favorable (1.98e-10)"	"unprognostic (9.82e-2)"	"unprognostic (1.73e-1)"	"unprognostic (8.12e-2)"	"unprognostic (2.26e-1)"	4.8	25.1	4.8	14.3	6.0	0.4	8.3	5.6	3.3	7.6	56.2	6.1	21.8	29.8	10.3	15.1	15.2	11.3	9.4	7.8	4.1	4.8	44.2	87.6	4.6	5.0	5.8	3.2	11.4	25.3	11.6	14.6	2.9	10.5	17.9	15.6	13.3	18.0	22.7	8.5	11.5	83.9	13.1	4.5	3.5	6.7	5.4	3.9	45.7	7.5	13.2	11.7	7.0	7.4	1.6	0.0	0.0	0.0	1.4	39.2	7.6	5.3	3.6	2.3	2.9	0.1	0.0	1.7	0.4	0.3	0.2	0.0	2.8	3.6	0.0	2.1	1.3	1.2	3.8	0.4	0.9	0.1	0.0	1.7	7.9	0.4	8.7	1.3	0.0	1.6	3.2	3.9	0.0	0.4	0.9	0.1	50.5	17.8	0.0	0.0	1.6	5.1	0.2	3.7	36.3	6.2	0.0	0.0	0.1	3.2	0.8	1.9	5.9	4.3	5.2	5.2	1.8	7.9	1.5	0.0	0.0	1.4	0.6	0.0	4.6	3.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	2.9	0.0	4.0	1.6	12.5	4.5	0.0	0.9	39.2	18.0	0.0	1.4	0.0	0.0	9.4	7.6	4.8	6.0	5.6	3.3	4.1	4.8	5.8	3.2	10.5	3.9	6.0	13.4	4.7	14.5	10.5	33.3	21.0	15.3	24.1	10.3	26.2	74.6	18.1	152.5	4.7	6.3	6.0	93.2	0.0	5.7	2.6	7.2	27.0	5.7	98.6	1.8	31.8	22.4	10.4	3.5	2.4	27.6	0.8	5.0	2.8	54.7	84.9	4.3	74.7	17.7	198.6	56.3	0.0	12.0	1.5	7.0	15.9	6.9	5.7	88.0	6.7
EPHX3	"ABHD9, FLJ22408"	ENSG00000105131	"Epoxide hydrolase 3"	Q9H6B9	19	15226919-15233435	"Enzymes, Predicted intracellular proteins"	"Lipid metabolism"	Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 34.8;lymphoid tissue: 29.6;skin 1: 33.1;tongue: 39.6"	"Group enriched"	"Detected in many"	4	"Suprabasal keratinocytes: 37.9;Urothelial cells: 18.6"	"Cancer enhanced"	"Detected in many"		"cervical cancer: 30.5"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"intermediate monocyte: 4.2;non-classical monocyte: 4.9"	"Group enriched"	"Detected in many"	18	"dendritic cells: 2.8;monocytes: 4.9"	"Cell line enhanced"	"Detected in some"		"EFO-21: 4.0;NTERA-2: 3.7;OE19: 12.9;SuSa: 5.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA012842	Uncertain		Approved	Nucleoplasm	"Intracellular and membrane"	NA	NA			Nucleoplasm		"HPA012842: AB_10601648"	"unprognostic (1.39e-1)"	"unprognostic (1.16e-2)"	"unprognostic (1.54e-2)"	"unprognostic (1.74e-1)"	"unprognostic (8.24e-2)"	"prognostic favorable (2.27e-5)"	"unprognostic (8.83e-3)"	"unprognostic (1.50e-1)"	"unprognostic (3.90e-1)"	"unprognostic (4.36e-2)"	"unprognostic (4.25e-2)"	"unprognostic (1.06e-1)"	"unprognostic (3.43e-1)"	"unprognostic (3.68e-2)"	"unprognostic (1.48e-1)"	"unprognostic (1.30e-2)"	"unprognostic (6.01e-2)"	0.2	0.1	0.1	0.2	0.3	0.1	1.0	0.1	0.3	12.5	0.2	0.2	0.4	0.1	0.9	0.3	34.8	1.1	1.7	0.1	0.5	0.1	1.6	0.2	1.6	0.0	0.2	0.0	0.6	0.0	2.2	2.4	0.2	0.4	1.5	0.1	0.6	3.4	0.6	0.2	33.1	0.2	0.2	0.2	1.2	0.5	2.7	0.2	2.4	0.2	39.6	29.6	2.8	13.6	0.0	2.8	0.2	4.9	0.0	0.0	0.5	0.1	0.3	0.6	0.1	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.4	0.5	0.3	4.0	0.1	0.2	0.2	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.3	0.0	0.3	0.0	0.2	0.3	0.0	0.0	0.0	0.1	0.2	0.3	0.0	0.6	0.0	0.5	3.7	12.9	0.5	0.0	0.0	0.0	0.1	0.8	1.6	0.2	0.0	0.1	0.0	5.7	0.0	0.0	0.0	0.2	0.5	0.0	0.2	0.0	0.3	0.5	0.0	0.1	0.1	0.0	1.2	0.0	0.0	4.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.0	4.9	2.8	0.0	0.5	0.1	0.3	0.1	0.3	0.5	0.1	0.2	0.0	0.4	0.2	0.0	0.6	0.0	1.5	6.3	0.2	0.3	2.5	1.4	0.0	5.2	0.0	1.5	1.7	0.5	0.3	0.1	0.0	0.0	0.0	2.5	0.7	2.0	0.0	0.0	0.6	0.0	0.0	1.3	1.3	0.0	0.0	1.4	0.0	1.0	0.0	3.1	0.3	0.0	0.0	0.0	0.0	0.0	1.2	2.1	2.1	37.9	2.2	0.0	0.0	18.6
EPM2A	"LD, LDE"	ENSG00000112425	"EPM2A, laforin glucan phosphatase"	O95278	6	145382535-145736023	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Autophagy, Carbohydrate metabolism, Glycogen metabolism"	"Hydrolase, Protein phosphatase"	"Disease mutation, Epilepsy, Glycogen storage disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 60.9"	"Cell type enhanced"	"Detected in many"	7	"Cardiomyocytes: 23.5;Early spermatids: 28.2;Horizontal cells: 28.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"NK-cell: 5.4"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"Daudi: 20.3"	"Low region specificity"	"Detected in all"							"HPA053643, HPA055468"			Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"HPA053643: AB_2797247, HPA055468: AB_2797252"	"unprognostic (2.37e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.99e-1)"	"unprognostic (3.34e-3)"	"unprognostic (2.92e-3)"	"unprognostic (1.22e-1)"	"unprognostic (2.15e-2)"	"unprognostic (1.63e-1)"	"unprognostic (2.37e-2)"	"unprognostic (1.50e-1)"	"unprognostic (1.52e-4)"	"unprognostic (2.28e-1)"	"prognostic favorable (4.08e-7)"	"unprognostic (4.12e-4)"	"unprognostic (2.17e-1)"	"unprognostic (2.99e-3)"	"unprognostic (1.23e-1)"	5.4	6.0	8.8	1.9	9.0	2.2	3.6	4.0	8.9	3.9	11.1	8.6	2.5	3.4	4.8	4.8	8.9	4.3	3.9	19.4	9.6	8.7	8.0	5.7	3.5	3.4	11.9	5.5	5.9	2.9	5.5	3.3	2.0	9.6	6.2	3.4	5.6	3.1	9.2	60.9	2.4	3.3	13.9	13.6	2.5	4.6	3.3	7.1	3.7	4.2	15.7	2.9	10.4	6.0	1.4	1.0	0.3	1.4	5.4	2.4	1.0	1.1	1.7	3.3	6.3	8.2	2.5	1.4	3.0	3.5	2.8	3.4	1.5	1.7	20.3	2.5	3.5	3.4	1.8	1.2	1.3	2.5	7.9	1.7	3.3	2.4	2.5	5.0	11.3	2.0	2.1	6.8	1.7	0.6	3.7	2.0	4.8	1.4	5.2	3.5	2.6	7.5	2.4	3.4	3.0	1.7	4.3	3.0	5.9	2.5	1.7	6.1	6.1	5.3	3.2	7.0	3.1	1.8	6.5	4.3	2.8	1.4	2.6	2.3	3.8	3.8	8.2	2.4	2.7	4.4	0.0	0.1	0.1	0.4	1.4	1.1	1.3	1.1	0.9	1.0	1.4	1.2	2.4	0.3	5.4	0.3	0.9	0.2	1.0	8.8	9.0	4.0	8.9	9.6	8.7	11.9	5.5	9.6	7.1	6.0	1.0	3.2	0.8	0.8	7.9	23.5	5.1	2.7	3.4	1.8	5.9	0.7	10.0	0.9	28.2	1.5	0.3	0.0	2.0	0.6	1.2	1.3	2.3	5.8	2.0	28.6	1.2	1.3	1.5	14.1	2.8	3.1	6.8	0.0	1.5	7.5	1.1	1.1	2.1	6.3	6.7	0.0	2.0	1.6	1.3	0.4	0.3	0.0	1.0	0.3
EPRS	"EARS, GLUPRORS, PARS, QARS, QPRS"	ENSG00000136628	"Glutamyl-prolyl-tRNA synthetase"	P07814	1	219968601-220046658	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Protein biosynthesis, Translation regulation"	"Aminoacyl-tRNA synthetase, Ligase, Multifunctional enzyme, RNA-binding"	"Disease mutation, Leukodystrophy, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA026490, HPA030052"	Enhanced		Enhanced	Cytosol		NA	NA		29000	Cytosol		"HPA026490: AB_1855979, HPA030052: AB_10601466"	"prognostic unfavorable (7.25e-4)"	"unprognostic (1.19e-2)"	"unprognostic (3.94e-2)"	"unprognostic (2.60e-2)"	"unprognostic (7.98e-3)"	"unprognostic (1.12e-2)"	"unprognostic (3.41e-3)"	"unprognostic (1.32e-1)"	"unprognostic (1.76e-1)"	"unprognostic (1.30e-1)"	"unprognostic (7.13e-2)"	"unprognostic (5.12e-2)"	"unprognostic (2.32e-2)"	"unprognostic (2.18e-1)"	"unprognostic (1.38e-1)"	"unprognostic (2.85e-1)"	"prognostic unfavorable (2.62e-4)"	25.0	20.4	16.8	18.6	22.2	13.2	20.6	24.2	26.3	19.3	20.4	15.4	13.6	15.8	17.8	15.3	25.2	15.9	11.9	20.1	15.9	18.0	23.3	31.6	17.4	20.8	21.7	16.1	21.3	32.7	47.1	38.6	15.7	34.9	14.3	23.2	9.4	64.0	16.3	42.9	19.6	23.3	18.9	24.7	22.3	20.1	13.2	20.8	28.0	25.1	25.7	23.4	18.3	16.3	14.7	15.4	6.4	16.6	14.2	19.8	10.7	30.1	19.2	13.9	38.0	29.6	32.9	34.9	39.5	27.7	25.7	28.9	22.7	24.4	57.9	22.0	41.6	10.4	32.3	34.9	31.8	34.6	28.3	22.2	31.5	25.9	19.4	32.4	52.2	27.0	23.7	40.9	32.8	41.1	21.5	28.1	28.0	54.1	45.7	25.1	14.9	22.4	12.7	26.9	35.7	39.8	23.8	24.6	56.6	23.5	13.3	33.1	26.0	23.1	38.3	40.3	20.8	35.4	57.1	24.9	12.3	22.7	37.6	36.7	31.0	35.2	49.0	28.3	37.6	38.8	4.2	11.9	6.4	14.0	16.6	19.8	14.7	14.1	15.6	15.4	11.5	15.9	16.3	0.4	14.2	13.7	5.0	13.5	10.7	16.8	22.2	24.2	26.3	15.9	18.0	21.7	16.1	34.9	20.8	65.5	52.5	37.9	33.6	17.6	45.2	67.4	15.3	69.6	69.4	29.6	62.8	36.3	18.3	58.3	19.1	33.8	24.4	23.3	87.1	48.7	27.0	24.9	47.4	18.8	38.0	39.7	29.4	22.1	23.8	7.4	43.7	27.7	20.3	53.3	32.2	45.5	61.8	14.4	44.6	21.4	47.0	38.8	27.8	57.6	34.9	17.8	30.6	29.8	41.8	29.3
EPX	"EPO, EPP, EPX-PEN"	ENSG00000121053	"Eosinophil peroxidase"	P11678	17	58192737-58205174	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Hydrogen peroxide"	"Oxidoreductase, Peroxidase"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"bone marrow: 27.2;lymphoid tissue: 15.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"Cell type enriched"	"Detected in single"	41	"eosinophil: 5.5"	"Lineage enriched"	"Detected in single"	41	"granulocytes: 5.5"	"Cell line enriched"	"Detected in some"	69	"NB-4: 74.4"	"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			HPA076792	Enhanced					NA	NA					"HPA076792: "	"unprognostic (5.67e-2)"	"unprognostic (1.73e-2)"	"unprognostic (3.36e-2)"	"unprognostic (3.30e-1)"	"unprognostic (2.18e-1)"	"unprognostic (1.34e-3)"	"unprognostic (4.83e-1)"	"unprognostic (3.16e-2)"	"unprognostic (1.41e-1)"	"unprognostic (1.52e-2)"	"unprognostic (1.71e-4)"	"unprognostic (7.38e-2)"	"unprognostic (1.64e-1)"	"unprognostic (2.02e-1)"	"unprognostic (5.43e-2)"	"unprognostic (1.02e-2)"	"unprognostic (1.73e-1)"	0.1	0.1	0.3	0.2	0.8	27.2	0.1	2.0	0.6	0.1	0.1	0.5	0.1	0.1	0.4	0.1	0.1	0.2	0.1	1.4	0.3	0.3	0.1	0.2	4.2	0.4	0.2	0.1	0.2	0.1	0.0	0.3	0.2	0.6	0.1	0.0	0.1	0.3	0.1	0.1	0.5	0.1	0.1	0.2	4.5	0.1	0.1	0.1	15.5	0.1	0.1	0.1	0.1	0.1	0.0	0.0	5.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	1.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	74.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	5.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.8	2.0	0.6	0.3	0.3	0.2	0.1	0.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
ERAP1	"A-LAP, ARTS-1, ERAAP1, KIAA0525, PILS-AP"	ENSG00000164307	"Endoplasmic reticulum aminopeptidase 1"	Q9NZ08	5	96760810-96808100	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Adaptive immunity, Immunity"	"Aminopeptidase, Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB025095, HPA042317"	Approved		Approved	"Nucleoplasm,Plasma membrane,Cytosol"	"Secreted to blood"	NA	NA		27000000	"Nucleoplasm, Cytosol"	"Plasma membrane"	"CAB025095: , HPA042317: AB_2677946"	"unprognostic (2.33e-3)"	"unprognostic (3.45e-1)"	"unprognostic (1.84e-3)"	"unprognostic (1.34e-1)"	"unprognostic (1.86e-1)"	"unprognostic (4.38e-1)"	"unprognostic (1.88e-3)"	"unprognostic (5.37e-2)"	"unprognostic (1.45e-1)"	"unprognostic (7.94e-2)"	"unprognostic (4.52e-2)"	"unprognostic (3.23e-1)"	"unprognostic (7.09e-2)"	"unprognostic (1.36e-1)"	"unprognostic (3.93e-2)"	"unprognostic (1.19e-1)"	"unprognostic (5.14e-2)"	23.8	13.6	9.3	22.7	11.9	11.6	23.3	14.2	14.6	14.5	23.8	10.1	11.2	30.8	14.7	13.4	12.3	14.3	19.9	16.1	9.7	6.8	13.3	23.7	17.8	16.4	13.5	7.6	15.5	16.5	11.1	39.4	28.2	11.4	13.4	21.9	8.5	13.9	15.2	23.1	17.7	39.7	10.6	17.1	19.5	16.5	5.4	13.8	55.5	13.5	9.8	17.8	15.9	14.1	14.9	15.2	19.8	17.5	19.8	21.8	10.7	7.4	4.7	6.4	6.0	35.4	34.7	18.6	5.5	17.7	13.3	23.3	5.9	27.0	22.3	11.5	10.6	18.7	7.6	5.3	11.2	8.3	40.2	2.2	7.2	3.2	4.0	40.6	3.4	13.4	14.4	4.9	15.2	4.7	19.6	18.2	14.5	3.7	21.6	7.9	3.5	32.0	3.6	3.2	0.9	3.1	23.8	8.7	11.1	9.9	11.5	2.4	1.6	8.7	5.9	8.5	4.6	5.1	16.6	14.5	11.4	3.9	1.9	9.0	8.1	15.1	17.3	12.2	11.8	6.7	19.8	13.2	15.6	21.2	11.4	19.7	13.0	18.5	18.2	9.5	14.9	21.8	17.4	14.4	19.8	17.5	15.2	12.3	10.7	9.3	11.9	14.2	14.6	9.7	6.8	13.5	7.6	11.4	13.8	8.9	12.3	13.7	12.1	22.1	11.6	8.5	10.2	22.7	14.8	8.7	2.0	8.0	0.0	10.8	20.0	11.3	25.8	0.0	13.4	9.1	16.1	9.2	14.0	27.0	16.2	3.2	9.9	18.4	31.2	5.2	9.2	18.5	6.8	21.6	25.9	9.7	11.2	17.5	15.2	5.0	7.2	0.0	9.5	1.2	0.7	9.7	7.7	20.0	19.1	12.2
ERAP2	"L-RAP, LRAP"	ENSG00000164308	"Endoplasmic reticulum aminopeptidase 2"	Q6P179	5	96875939-96919716	"Enzymes, Predicted intracellular proteins, Predicted secreted proteins"	"Adaptive immunity, Immunity"	"Aminopeptidase, Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"B-cells: 63.4;T-cells: 53.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"CAPAN-2: 49.1;GAMG: 30.0;hTEC/SVTERT24-B: 23.7;MOLT-4: 26.2;TIME: 51.5"					"Low region specificity"	"Detected in all"			"CAB025618, HPA034498, HPA064360"	Enhanced		Approved	"Golgi apparatus"	"Secreted to blood"	NA	NA		7400000	"Golgi apparatus"		"CAB025618: , HPA034498: AB_2674191, HPA064360: "	"unprognostic (4.62e-2)"	"unprognostic (1.60e-1)"	"unprognostic (4.98e-2)"	"unprognostic (1.56e-1)"	"unprognostic (3.14e-1)"	"unprognostic (8.71e-2)"	"unprognostic (2.60e-2)"	"unprognostic (1.17e-2)"	"unprognostic (5.03e-2)"	"unprognostic (1.40e-1)"	"prognostic unfavorable (1.20e-4)"	"unprognostic (1.01e-1)"	"unprognostic (9.54e-3)"	"unprognostic (6.59e-2)"	"unprognostic (8.48e-2)"	"unprognostic (4.65e-2)"	"unprognostic (3.05e-1)"	9.0	6.0	3.1	21.6	3.8	3.5	7.4	2.2	3.5	9.6	37.0	3.1	6.2	17.0	8.3	10.3	12.4	5.7	5.6	5.8	3.3	2.6	8.6	10.8	16.8	30.8	4.2	0.5	18.2	5.9	1.4	11.1	13.6	3.6	9.4	3.1	7.0	9.3	3.5	4.1	4.9	22.4	5.1	8.7	37.6	9.2	2.6	3.1	32.5	11.3	9.6	24.4	11.8	8.7	16.4	10.7	10.9	15.3	24.0	22.4	14.1	0.5	0.6	0.4	0.2	0.5	1.0	0.1	2.1	3.7	2.0	3.3	2.1	49.1	2.9	9.7	3.1	30.0	0.7	0.2	17.8	1.6	1.0	2.1	0.1	0.7	2.0	0.7	10.8	5.2	7.3	3.3	23.7	0.1	0.3	1.3	7.3	0.0	7.3	5.6	0.3	26.2	5.4	0.0	0.0	1.0	11.7	4.2	7.7	14.2	4.1	0.9	0.0	0.3	0.2	4.1	0.1	1.7	0.4	51.5	1.0	0.3	2.7	6.3	7.1	6.1	1.0	14.3	1.4	0.2	10.9	6.5	7.8	14.2	15.3	18.1	16.4	20.2	17.6	10.7	9.6	22.4	17.0	2.2	24.0	14.4	3.5	18.2	14.1	3.1	3.8	2.2	3.5	3.3	2.6	4.2	0.5	3.6	3.1	29.8	18.3	63.4	8.3	5.0	1.4	3.5	7.6	9.4	15.9	41.8	0.0	10.0	0.0	5.0	0.2	29.2	40.8	0.0	21.9	14.9	15.1	3.1	6.9	14.3	12.0	0.0	1.7	20.3	17.4	0.0	9.8	22.3	6.8	7.2	21.5	7.5	14.1	24.6	7.4	5.7	2.0	0.0	8.2	0.9	0.7	2.6	5.6	53.6	20.6	8.1
ERBB2	"CD340, HER-2, HER2, NEU, NGL"	ENSG00000141736	"Erb-b2 receptor tyrosine kinase 2"	P04626	17	39687914-39730426	"Cancer-related genes, CD markers, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Transcription, Transcription regulation"	"Activator, Kinase, Receptor, Transferase, Tyrosine-protein kinase"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	6	"Collecting duct cells: 129.1;Enterocytes: 93.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"gdT-cell: 8.8"	"Lineage enriched"	"Detected in many"	4	"T-cells: 8.8"	"Group enriched"	"Detected in many"	41	"OE19: 366.2;SK-BR-3: 179.8"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB000043, HPA001060, HPA001338, HPA001383, CAB020416, CAB062555"	Enhanced		Enhanced	"Plasma membrane,Cytosol"		NA	NA		430000	"Plasma membrane"	Cytosol	"CAB000043: AB_2335701, CAB020416: AB_442047, CAB062555: AB_2665610, HPA001060: AB_2666185, HPA001338: AB_2666279, HPA001383: AB_1078500"	"unprognostic (1.97e-1)"	"unprognostic (6.60e-3)"	"unprognostic (6.21e-2)"	"prognostic unfavorable (8.99e-8)"	"unprognostic (2.96e-2)"	"unprognostic (1.40e-2)"	"unprognostic (1.97e-2)"	"unprognostic (9.04e-2)"	"unprognostic (1.79e-2)"	"unprognostic (1.20e-3)"	"prognostic unfavorable (9.17e-4)"	"unprognostic (3.92e-1)"	"prognostic favorable (2.41e-14)"	"unprognostic (9.29e-2)"	"unprognostic (1.40e-1)"	"unprognostic (3.75e-2)"	"unprognostic (1.96e-1)"	5.8	2.4	5.2	10.4	7.0	0.1	20.1	4.2	7.0	19.1	46.5	9.1	55.2	21.6	14.9	18.7	40.9	22.7	26.6	24.8	6.3	3.1	37.5	21.5	17.6	3.7	5.1	5.6	19.3	16.2	27.7	8.1	60.8	7.5	23.6	16.6	15.9	28.7	58.1	8.9	35.3	47.2	10.9	4.5	4.0	17.1	6.5	3.7	2.8	35.7	20.8	22.9	19.7	20.3	1.3	0.3	2.1	0.4	0.9	8.8	2.2	2.1	2.5	2.9	1.8	3.5	2.4	3.9	1.5	2.5	3.3	2.8	1.9	5.8	0.1	3.1	3.5	1.8	6.7	0.1	3.4	1.5	0.2	2.2	0.1	2.0	3.1	2.0	0.0	0.0	2.4	3.2	2.0	1.2	3.2	1.3	0.1	0.3	0.1	2.4	3.3	0.3	0.1	5.2	366.2	0.6	0.2	1.1	0.3	3.4	6.7	0.5	0.1	2.9	179.8	0.9	3.7	5.0	0.1	0.1	1.7	2.2	2.1	0.9	0.3	0.1	0.1	0.1	0.0	5.6	1.6	0.4	0.8	8.8	0.3	0.7	0.9	0.5	2.5	0.3	1.3	1.0	2.5	2.1	0.9	0.2	0.2	0.4	2.2	5.2	7.0	4.2	7.0	6.3	3.1	5.1	5.6	7.5	3.7	38.7	34.4	1.3	21.0	12.5	4.3	13.5	30.6	10.7	15.9	129.1	11.8	9.7	6.6	27.1	0.3	4.6	93.2	0.0	22.3	75.4	11.0	33.4	0.0	10.4	3.5	6.4	15.0	12.3	2.4	0.7	17.0	1.8	10.1	1.0	56.6	30.9	26.2	42.1	21.5	20.7	5.9	0.0	10.3	7.1	5.3	16.6	19.0	2.2	63.0	28.1
ERBB3	"HER3, LCCS2"	ENSG00000065361	"Erb-b2 receptor tyrosine kinase 3"	P21860	12	56076799-56103505	"Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"		"Kinase, Receptor, Transferase, Tyrosine-protein kinase"	"Cancer-related genes, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	5	"Cholangiocytes: 180.9;Enterocytes: 163.1;Paneth cells: 165.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"basophil: 5.3"	"Lineage enriched"	"Detected in many"	4	"granulocytes: 5.3"	"Cell line enhanced"	"Detected in many"		"Hep G2: 30.9;MCF7: 20.2;OE19: 31.8;RT4: 24.2;SK-BR-3: 28.4;SK-MEL-30: 37.9;T-47d: 31.5;WM-115: 40.2"	"Low region specificity"	"Detected in many"							"CAB025331, HPA045396"	Uncertain		Supported	"Plasma membrane,Actin filaments"	"Secreted - unknown location"	NA	NA		420000	"Plasma membrane"	"Actin filaments"	"CAB025331: , HPA045396: AB_2679312"	"unprognostic (2.97e-1)"	"unprognostic (2.71e-2)"	"unprognostic (1.91e-1)"	"unprognostic (8.97e-2)"	"unprognostic (1.63e-1)"	"unprognostic (1.07e-3)"	"unprognostic (2.31e-3)"	"unprognostic (2.66e-2)"	"unprognostic (9.89e-2)"	"unprognostic (4.30e-2)"	"unprognostic (4.76e-3)"	"unprognostic (5.77e-2)"	"unprognostic (1.06e-2)"	"unprognostic (4.56e-2)"	"unprognostic (1.57e-1)"	"unprognostic (6.72e-3)"	"unprognostic (2.07e-2)"	1.1	1.4	11.6	12.6	16.5	0.6	26.8	2.0	16.7	6.8	40.5	40.3	12.0	37.7	2.8	7.5	29.4	5.7	22.9	3.4	18.6	9.0	16.5	33.9	13.4	0.5	23.5	9.3	0.9	21.5	11.4	1.0	15.4	14.9	16.8	29.7	5.5	36.8	22.3	1.1	30.7	41.3	3.2	27.4	0.5	32.9	1.2	23.8	0.0	4.5	7.4	8.5	11.8	14.4	0.9	0.7	5.3	0.6	1.2	1.2	0.2	10.0	0.6	0.8	0.3	0.0	0.0	16.4	0.8	1.9	1.1	1.1	5.5	18.2	0.0	0.2	0.2	0.1	8.6	1.2	1.9	0.6	0.2	0.8	0.0	0.3	30.9	0.0	0.0	0.1	0.4	2.5	0.2	0.0	0.2	0.0	0.1	0.7	0.3	0.1	20.2	0.1	0.3	2.8	31.8	0.4	0.1	1.9	0.5	2.1	24.2	0.9	0.3	0.7	28.4	37.9	2.7	31.5	0.1	0.0	0.1	1.1	0.6	0.1	0.2	0.1	0.1	0.1	0.0	40.2	5.3	0.4	0.8	0.9	0.4	0.4	0.4	0.7	0.3	0.3	0.9	0.6	1.2	3.3	1.2	0.6	0.7	0.8	0.2	11.6	16.5	2.0	16.7	18.6	9.0	23.5	9.3	14.9	23.8	110.2	61.2	1.3	13.0	16.3	1.5	1.4	180.9	21.4	61.4	33.2	2.0	44.4	1.7	41.9	0.9	2.2	163.1	0.0	77.1	73.6	2.7	83.4	1.1	83.9	5.5	0.0	89.5	6.7	1.9	0.0	1.4	1.7	52.3	2.8	134.3	11.3	75.9	165.5	0.0	31.8	1.1	6.5	1.7	2.4	2.3	32.2	84.1	1.5	124.3	62.5
ERBB4	"ALS19, HER4"	ENSG00000178568	"Erb-b2 receptor tyrosine kinase 4"	Q15303	2	211375717-212538841	"Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Apoptosis, Lactation, Transcription, Transcription regulation"	"Activator, Developmental protein, Kinase, Receptor, Transferase, Tyrosine-protein kinase"	"Amyotrophic lateral sclerosis, Cancer-related genes, Disease mutation, FDA approved drug targets, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"fallopian tube: 24.5"	"Cell type enhanced"	"Detected in many"	10	"Bipolar cells: 11.2;Cardiomyocytes: 15.3;Ciliated cells: 26.8;Club cells: 17.0;Collecting duct cells: 12.2;Muller glia cells: 12.4"	"Cancer enhanced"	"Detected in many"		"breast cancer: 4.1"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 9.6;EFO-21: 7.2;HEK 293: 5.3;RPTEC TERT1: 7.8;SCLC-21H: 4.4;T-47d: 7.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB000276, HPA012016, CAB025522"	Enhanced					NA	NA		140000			"CAB000276: , CAB025522: , HPA012016: AB_1846541"	"unprognostic (1.48e-1)"	"unprognostic (3.28e-1)"	"unprognostic (4.31e-3)"	"unprognostic (1.76e-3)"	"unprognostic (3.59e-1)"	"unprognostic (2.75e-1)"	"unprognostic (2.88e-1)"	"unprognostic (9.56e-2)"	"unprognostic (2.07e-1)"	"unprognostic (4.67e-3)"	"unprognostic (1.07e-1)"	"unprognostic (3.61e-1)"	"unprognostic (7.14e-3)"	"unprognostic (1.49e-3)"	"unprognostic (1.41e-1)"	"unprognostic (1.14e-1)"	"unprognostic (4.11e-2)"	1.6	1.9	15.1	1.2	15.0	1.0	13.4	18.6	14.1	7.8	1.1	7.6	8.8	1.1	1.5	1.2	1.3	24.5	1.2	7.0	14.3	6.5	11.9	1.1	2.9	1.2	7.8	10.7	1.3	2.4	10.8	5.1	1.3	8.8	1.7	1.1	2.0	9.7	18.1	3.8	1.8	1.2	1.1	7.3	1.2	1.5	7.6	12.0	0.0	4.5	1.1	1.2	1.4	0.7	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	9.6	0.2	0.0	0.0	0.0	0.0	0.3	0.5	0.1	0.0	0.0	0.0	7.2	1.0	0.0	0.4	0.2	0.0	0.0	0.1	5.3	0.0	1.7	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	2.8	0.0	0.0	0.5	0.0	7.8	0.4	4.4	0.2	0.0	0.1	0.1	0.1	7.1	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.1	15.0	18.6	14.1	14.3	6.5	7.8	10.7	8.8	12.0	0.0	9.3	0.0	0.8	0.6	11.2	15.3	0.0	26.8	17.0	12.2	0.0	0.0	5.0	0.4	4.1	0.1	0.0	0.0	0.4	0.1	0.2	2.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.3	1.7	0.0	3.3	0.0	0.0	12.4	0.0	0.0	0.4	0.0	1.4	6.5	3.1	1.9	1.5	1.1	0.0	0.0	0.0	1.0
ERCC2	"EM9, MAG, MGC102762, MGC126218, MGC126219, TFIIH, XPD"	ENSG00000104884	"ERCC excision repair 2, TFIIH core complex helicase subunit"	P18074	19	45349837-45370918	"Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Chromosome partition, DNA damage, DNA repair, Host-virus interaction, Transcription, Transcription regulation"	"DNA-binding, Helicase, Hydrolase"	"Cancer-related genes, Cataract, Cockayne syndrome, Deafness, Disease mutation, Dwarfism, Ichthyosis, Xeroderma pigmentosum"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Spermatocytes: 33.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB005375, HPA038057, HPA069266"	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"CAB005375: AB_2100152, HPA038057: AB_2675810, HPA069266: AB_2686104"	"unprognostic (1.10e-1)"	"unprognostic (5.48e-1)"	"unprognostic (5.08e-2)"	"unprognostic (9.92e-3)"	"unprognostic (1.35e-1)"	"unprognostic (1.23e-2)"	"unprognostic (1.67e-3)"	"unprognostic (1.46e-1)"	"unprognostic (3.41e-1)"	"unprognostic (1.06e-1)"	"prognostic favorable (3.26e-4)"	"unprognostic (3.36e-2)"	"unprognostic (2.44e-3)"	"unprognostic (1.94e-1)"	"unprognostic (5.47e-1)"	"unprognostic (8.99e-2)"	"unprognostic (3.45e-2)"	7.4	15.6	11.4	10.6	17.7	6.7	7.1	9.5	23.8	9.4	8.1	11.7	7.8	7.9	11.7	6.0	6.7	10.0	10.1	7.9	9.4	9.1	8.7	13.2	6.5	9.9	8.2	10.5	9.5	13.1	12.9	10.9	7.2	14.0	8.2	6.4	12.5	9.5	11.8	15.9	10.7	7.1	11.2	5.3	9.7	8.3	17.2	7.8	10.8	10.2	5.1	8.3	9.3	6.6	7.8	17.2	5.0	13.9	11.3	9.8	8.7	12.6	6.2	12.9	18.1	7.7	9.1	6.8	18.0	12.4	23.3	17.9	14.3	8.7	4.5	10.3	17.5	8.5	6.5	9.0	15.1	8.9	10.9	14.8	7.7	11.7	15.1	16.3	12.2	13.6	10.5	2.4	26.6	15.1	13.0	13.5	13.0	18.6	5.1	16.0	6.1	7.1	8.1	5.9	11.6	10.9	13.8	9.2	3.8	6.7	11.2	7.5	8.2	16.0	11.3	6.4	10.2	10.7	16.2	17.5	22.3	12.2	9.4	40.0	11.9	6.8	6.5	6.6	7.4	9.8	0.0	13.3	5.0	7.7	13.9	9.8	7.8	7.4	7.4	17.2	5.8	7.1	7.4	0.4	11.3	10.9	8.3	7.4	8.7	11.4	17.7	9.5	23.8	9.4	9.1	8.2	10.5	14.0	7.8	6.0	4.3	3.6	3.9	5.6	0.0	6.0	10.2	6.7	5.7	5.2	0.0	9.4	11.6	7.6	4.1	3.8	2.9	0.0	7.0	10.0	6.8	3.5	0.0	11.5	9.8	0.0	6.9	9.2	7.3	2.2	6.1	4.6	3.3	1.8	7.8	0.0	6.2	3.5	7.4	11.3	0.0	0.0	5.2	33.8	11.0	5.0	4.0	2.9	7.7	3.3
ERCC3	"BTF2, GTF2H, RAD25, TFIIH, XPB"	ENSG00000163161	"ERCC excision repair 3, TFIIH core complex helicase subunit"	P19447	2	127257290-127294176	"Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"DNA damage, DNA repair, Host-virus interaction, Transcription, Transcription regulation"	"DNA-binding, Helicase, Hydrolase"	"Cancer-related genes, Cockayne syndrome, Deafness, Disease mutation, Dwarfism, Ichthyosis, Xeroderma pigmentosum"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB037153, HPA046077"	Approved		Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"CAB037153: AB_796181, HPA046077: AB_2679527"	"unprognostic (2.31e-1)"	"unprognostic (1.15e-1)"	"unprognostic (3.03e-2)"	"unprognostic (1.07e-3)"	"unprognostic (1.05e-1)"	"unprognostic (8.85e-2)"	"prognostic unfavorable (1.62e-7)"	"unprognostic (2.74e-1)"	"unprognostic (9.13e-3)"	"unprognostic (9.25e-2)"	"unprognostic (1.25e-1)"	"unprognostic (2.46e-2)"	"prognostic unfavorable (4.30e-6)"	"unprognostic (3.71e-1)"	"unprognostic (8.50e-2)"	"unprognostic (5.73e-2)"	"unprognostic (3.92e-2)"	17.4	20.0	26.1	23.8	28.9	20.5	21.0	35.9	32.0	22.1	19.4	19.7	17.1	11.5	21.6	15.7	19.1	23.6	20.4	20.4	23.2	18.8	17.5	17.4	19.4	23.1	19.7	25.8	23.3	22.4	32.0	26.4	16.3	21.5	20.1	17.1	18.3	18.0	21.8	30.1	19.7	17.3	26.1	16.0	24.5	17.4	39.5	20.1	24.1	19.3	15.8	25.9	22.4	20.8	11.8	13.9	7.2	9.7	18.8	16.2	11.7	22.2	15.3	19.0	20.1	21.1	14.5	23.5	20.5	26.6	33.2	32.2	23.4	16.3	16.9	17.0	18.7	21.5	20.0	28.9	21.6	28.9	26.4	25.9	21.2	18.7	24.6	15.7	18.4	23.1	15.0	20.3	38.3	16.4	21.2	21.3	22.2	20.6	11.1	20.9	22.0	26.2	19.8	27.6	14.5	23.9	21.6	21.8	14.0	18.5	20.8	23.0	24.8	17.5	26.7	26.8	22.7	14.4	21.1	16.9	20.0	22.9	18.1	24.3	19.9	38.8	26.5	17.7	8.9	21.3	6.6	9.5	7.2	16.0	9.7	16.2	11.5	11.8	13.5	13.9	11.8	15.8	10.9	3.1	18.8	7.9	11.3	16.1	11.7	26.1	28.9	35.9	32.0	23.2	18.8	19.7	25.8	21.5	20.1	20.8	13.4	8.2	8.1	6.8	0.0	10.5	5.1	32.1	22.7	7.0	0.0	15.9	1.7	12.0	3.5	14.3	4.9	0.0	13.1	10.3	12.0	6.2	9.3	7.8	12.5	0.0	5.8	12.3	12.6	3.1	15.3	9.2	8.5	12.6	8.2	0.0	12.9	5.8	12.0	7.0	0.0	12.9	8.5	34.7	27.5	8.3	12.2	13.8	9.9	5.6
ERCC6L	"FLJ20105, PICH, RAD26L"	ENSG00000186871	"ERCC excision repair 6 like, spindle assembly checkpoint helicase"	Q2NKX8	X	72204657-72239047	"Enzymes, Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"	"DNA-binding, Helicase, Hydrolase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 13.1"	"Cell type enhanced"	"Detected in some"	11	"Cholangiocytes: 2.5;Extravillous trophoblasts: 1.5;Spermatocytes: 1.7;Spermatogonia: 2.0"	"Cancer enhanced"	"Detected in many"		"testis cancer: 11.0"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in some"	5	"NK-cell: 5.3"	"Lineage enriched"	"Detected in many"	5	"NK-cells: 5.3"	"Low cell line specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA050492	Approved		Uncertain	Nucleoplasm,Centrosome,Cytosol		No	No			Centrosome	"Nucleoplasm, Cytosol"	"HPA050492: AB_2681145"	"prognostic unfavorable (1.80e-4)"	"unprognostic (2.93e-1)"	"unprognostic (1.95e-2)"	"unprognostic (5.76e-3)"	"unprognostic (2.43e-1)"	"unprognostic (2.36e-1)"	"unprognostic (9.23e-6)"	"unprognostic (8.63e-3)"	"unprognostic (1.57e-2)"	"unprognostic (1.99e-2)"	"unprognostic (3.68e-5)"	"unprognostic (4.61e-2)"	"unprognostic (0.00e+0)"	"unprognostic (2.97e-3)"	"unprognostic (9.56e-2)"	"unprognostic (1.17e-1)"	"unprognostic (6.41e-2)"	0.4	0.5	0.2	3.1	0.2	6.0	3.0	0.9	0.8	1.5	2.2	0.2	0.2	1.5	0.9	0.8	4.6	0.6	1.0	0.2	0.2	0.3	0.5	0.5	0.8	4.7	0.7	0.2	1.2	0.5	0.0	0.6	0.9	0.9	0.7	2.5	0.2	1.1	0.2	2.6	1.3	2.1	0.5	1.3	4.0	1.5	2.0	0.2	13.1	0.5	2.8	5.6	0.7	1.6	0.5	0.3	0.5	0.2	5.3	1.1	0.4	11.0	9.7	8.9	5.6	0.6	1.1	4.9	11.9	5.5	10.4	11.0	7.9	6.9	17.9	4.5	4.2	14.1	9.2	16.8	8.8	18.6	10.2	12.2	6.2	3.4	4.6	0.0	12.0	8.7	0.1	0.5	14.5	2.7	1.7	5.8	9.1	8.1	4.4	10.6	8.7	11.4	7.0	16.2	10.8	15.0	9.6	16.0	3.2	2.6	6.9	7.4	5.3	8.8	5.9	2.2	7.6	4.5	2.7	3.5	7.1	11.4	13.3	7.7	3.5	5.3	15.5	5.0	8.3	7.0	0.0	0.2	0.5	0.1	0.1	0.6	0.2	0.5	0.1	0.1	0.5	0.4	1.1	0.3	5.3	0.2	0.3	1.1	0.4	0.2	0.2	0.9	0.8	0.2	0.3	0.7	0.2	0.9	0.2	0.0	0.0	0.8	0.2	0.2	0.0	0.4	2.5	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.2	0.0	0.0	0.0	0.0	1.5	0.2	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.7	2.0	0.1	0.3	0.0	0.1	0.1
ERMP1	"FLJ23309, FXNA, KIAA1815"	ENSG00000099219	"Endoplasmic reticulum metallopeptidase 1"	Q7Z2K6	9	5765076-5833117	"Enzymes, Predicted membrane proteins"		"Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"parathyroid gland: 57.6"	"Cell type enhanced"	"Detected in many"	8	"Collecting duct cells: 69.8;Urothelial cells: 55.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"NK-cell: 4.7"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"RPTEC TERT1: 27.5;RT4: 53.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA055582	Approved					NA	NA					"HPA055582: "	"unprognostic (1.93e-2)"	"unprognostic (3.40e-1)"	"unprognostic (2.76e-2)"	"unprognostic (5.93e-2)"	"unprognostic (2.97e-1)"	"unprognostic (8.59e-2)"	"unprognostic (4.30e-3)"	"unprognostic (2.81e-1)"	"unprognostic (5.46e-2)"	"unprognostic (4.83e-3)"	"unprognostic (3.14e-2)"	"unprognostic (2.88e-2)"	"prognostic favorable (5.83e-10)"	"unprognostic (1.41e-1)"	"unprognostic (4.00e-1)"	"unprognostic (5.77e-2)"	"unprognostic (1.36e-1)"	4.0	12.0	5.3	3.6	13.8	1.6	4.8	7.3	12.3	8.5	8.2	20.5	1.5	3.4	4.9	2.9	12.7	4.9	8.8	7.1	6.8	5.8	18.8	3.5	4.7	2.7	18.3	7.0	5.6	4.4	57.6	3.3	5.7	17.0	4.8	8.4	6.9	12.8	3.4	5.2	6.8	4.8	3.2	15.9	2.5	9.1	5.9	11.5	4.6	19.1	4.6	7.2	18.7	8.1	0.2	0.3	0.9	0.5	4.7	2.0	0.3	15.3	15.0	0.6	1.8	7.8	7.5	8.0	1.7	3.9	0.8	0.7	3.6	9.4	3.6	6.8	2.9	9.2	11.0	3.2	10.2	1.2	18.9	2.6	19.1	7.9	7.0	1.7	5.4	7.5	3.8	4.5	0.7	4.5	10.3	10.6	1.6	2.3	3.4	0.9	7.0	0.2	2.1	2.3	9.6	2.9	0.5	1.9	4.8	27.5	53.7	3.5	1.1	2.5	18.1	2.8	9.0	12.0	6.9	6.3	0.5	1.8	1.1	5.5	3.2	4.5	1.8	2.3	4.5	1.4	0.6	0.3	0.9	1.3	0.5	2.0	0.2	0.6	0.3	0.0	0.0	0.5	0.5	0.0	4.7	0.2	0.3	0.5	0.3	5.3	13.8	7.3	12.3	6.8	5.8	18.3	7.0	17.0	11.5	6.0	0.6	0.0	11.5	2.6	3.5	12.6	20.4	5.3	4.5	69.8	9.8	5.8	0.0	3.6	19.1	5.0	9.1	0.0	2.6	5.6	2.6	6.9	9.2	5.1	5.4	3.2	10.9	3.1	1.3	31.7	2.8	3.3	1.7	1.0	10.0	3.5	3.4	27.9	4.6	2.8	2.1	6.5	1.9	7.2	4.1	4.0	3.4	4.4	10.3	55.0
ERN1	"IRE1, IRE1P"	ENSG00000178607	"Endoplasmic reticulum to nucleus signaling 1"	O75460	17	64039142-64130819	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Apoptosis, Transcription, Transcription regulation, Unfolded protein response"	"Hydrolase, Kinase, Multifunctional enzyme, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Intestinal endocrine cells: 76.4;Melanocytes: 70.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"basophil: 12.9;MAIT T-cell: 12.2"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"Karpas-707: 41.3;RPMI-8226: 18.5;U-266/70: 39.0"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"CAB009495, HPA027730"	Supported					NA	Yes					"CAB009495: AB_2098712, HPA027730: AB_10602494"	"unprognostic (2.52e-1)"	"unprognostic (1.16e-2)"	"unprognostic (1.89e-1)"	"unprognostic (4.05e-3)"	"unprognostic (3.63e-2)"	"unprognostic (2.81e-2)"	"unprognostic (9.14e-2)"	"unprognostic (2.72e-2)"	"unprognostic (4.55e-1)"	"unprognostic (6.17e-2)"	"unprognostic (2.95e-1)"	"unprognostic (1.33e-1)"	"prognostic unfavorable (1.68e-4)"	"unprognostic (4.65e-1)"	"unprognostic (1.89e-1)"	"unprognostic (1.36e-2)"	"unprognostic (3.11e-2)"	5.5	24.9	2.2	10.6	1.6	8.0	7.7	2.3	1.8	15.8	10.0	3.5	36.1	5.1	11.9	15.0	7.4	7.9	10.6	4.1	1.9	1.7	6.4	21.5	12.3	12.6	2.1	1.6	14.7	44.1	2.9	32.8	10.1	1.8	6.6	3.9	5.0	23.2	34.9	4.2	6.6	11.5	4.1	2.2	9.9	8.8	2.8	1.6	11.6	7.5	5.9	16.7	10.0	7.7	0.1	5.7	12.9	0.7	3.0	12.2	1.0	2.2	1.8	0.9	2.4	2.2	1.8	4.5	1.9	4.3	1.3	1.2	1.2	1.2	2.9	1.3	1.4	2.1	1.5	1.2	1.9	3.3	0.8	1.1	2.6	0.9	1.8	13.9	1.2	0.9	2.1	5.3	3.7	11.8	1.9	2.5	2.8	1.8	41.3	1.2	1.5	1.8	0.5	0.4	2.1	1.6	2.0	2.0	18.5	1.1	3.0	3.2	2.0	1.8	3.1	4.5	1.8	1.7	2.7	2.4	1.1	2.7	2.6	1.2	39.0	10.2	2.2	2.1	1.4	1.9	12.9	0.7	0.2	4.6	0.4	12.2	0.1	3.0	3.2	0.3	0.1	0.7	1.3	3.3	3.0	0.2	5.7	0.7	1.0	2.2	1.6	2.3	1.8	1.9	1.7	2.1	1.6	1.8	1.6	0.0	42.2	9.0	42.2	19.6	3.2	5.6	15.3	6.7	7.9	12.2	5.9	6.5	1.7	9.4	1.8	10.8	7.1	0.0	24.0	6.6	16.0	38.4	8.1	21.3	7.7	3.2	76.4	14.1	12.1	1.1	4.4	18.6	70.9	8.2	7.8	4.0	16.0	7.6	5.6	3.7	26.0	0.0	15.1	3.9	4.1	39.4	45.9	42.7	7.6	52.1
ERN2	IRE1b	ENSG00000134398	"Endoplasmic reticulum to nucleus signaling 2"	Q76MJ5	16	23690326-23713500	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Apoptosis, Transcription, Transcription regulation"	"Hydrolase, Kinase, Multifunctional enzyme, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"gallbladder: 64.5;stomach 1: 30.0"	"Cell type enhanced"	"Detected in some"	20	"Cholangiocytes: 28.1;Enterocytes: 26.1;Mucus-secreting cells: 126.1;Paneth cells: 28.8;Undifferentiated cells: 53.3"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"basophil: 3.6"	"Low lineage specificity"	"Detected in many"			"Cell line enriched"	"Detected in some"	6	"OE19: 30.5"	"Region enhanced"	"Detected in single"		"hypothalamus: 0.7"	"Not detected"	"Not detected"			HPA076875	Approved				"Intracellular and membrane"	NA	NA					"HPA076875: "	"unprognostic (1.06e-1)"	"unprognostic (5.20e-2)"	"unprognostic (3.45e-1)"	"unprognostic (2.98e-2)"	"unprognostic (3.83e-2)"	"unprognostic (1.13e-2)"	"unprognostic (7.67e-4)"	"unprognostic (1.31e-1)"	"unprognostic (1.16e-1)"	"unprognostic (4.93e-2)"	"unprognostic (7.34e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.14e-9)"	"unprognostic (1.48e-1)"	"unprognostic (2.14e-1)"	"unprognostic (1.06e-1)"	"unprognostic (3.13e-3)"	0.1	0.3	0.1	8.1	0.2	0.0	0.1	0.1	0.2	11.4	17.3	0.2	0.1	7.0	1.1	0.1	0.9	0.1	64.5	0.1	0.1	0.0	0.2	0.1	1.0	0.5	0.1	0.1	0.1	0.5	0.0	0.8	0.1	0.1	2.6	12.6	0.2	14.0	0.1	0.1	0.1	11.8	0.9	0.1	0.1	30.0	0.1	0.1	0.2	0.1	2.2	7.6	6.3	3.9	0.9	0.6	3.6	0.4	1.5	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	5.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.7	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	30.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.6	0.4	0.5	0.3	0.3	0.2	0.3	0.3	0.3	0.1	0.9	0.3	0.4	2.1	1.5	0.2	0.6	0.1	0.1	0.1	0.2	0.1	0.2	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.6	0.0	1.0	0.0	0.0	0.4	28.1	4.0	6.8	0.0	0.0	0.2	0.0	0.6	0.1	0.0	26.1	0.0	1.8	0.0	0.0	1.0	4.6	0.0	0.1	0.0	10.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	126.1	0.0	19.2	28.8	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	53.3	10.4
ESD		ENSG00000139684	"Esterase D"	P10768	13	46771256-46797232	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Hydrolase, Serine esterase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039700	Approved		Approved	"Nucleoplasm,Golgi apparatus,Cytosol"		NA	NA		16000000	"Golgi apparatus"	"Nucleoplasm, Cytosol"	"HPA039700: AB_10697553"	"unprognostic (3.05e-1)"	"prognostic unfavorable (5.01e-4)"	"unprognostic (7.66e-2)"	"unprognostic (1.75e-1)"	"unprognostic (1.63e-1)"	"prognostic unfavorable (2.16e-4)"	"unprognostic (1.73e-2)"	"unprognostic (3.31e-1)"	"unprognostic (1.01e-1)"	"unprognostic (2.12e-2)"	"unprognostic (1.49e-2)"	"unprognostic (1.08e-1)"	"unprognostic (2.91e-2)"	"unprognostic (2.71e-2)"	"unprognostic (2.18e-1)"	"unprognostic (6.44e-2)"	"unprognostic (1.37e-3)"	58.5	30.9	32.0	28.6	29.8	24.2	44.5	23.7	32.0	54.4	37.3	29.0	34.2	31.8	53.2	50.4	54.1	40.6	30.3	45.6	30.7	29.3	58.8	82.2	28.2	31.4	31.7	32.1	61.3	24.9	27.5	47.5	26.4	28.6	55.2	41.7	32.5	31.5	45.2	47.4	29.7	38.4	50.8	37.4	31.1	32.1	32.4	26.7	65.5	78.9	50.9	31.7	62.5	36.9	30.1	48.7	15.1	37.1	29.8	35.7	26.4	22.1	12.9	39.1	26.9	45.9	75.9	10.5	31.9	46.3	44.5	34.7	21.8	27.2	25.2	9.6	38.2	33.3	22.7	43.0	37.7	57.0	28.8	44.7	32.6	13.0	33.5	37.6	63.6	14.0	51.8	35.0	28.7	38.7	53.7	41.7	43.5	31.8	6.8	73.6	21.7	56.4	42.3	10.1	28.7	24.5	44.9	23.0	17.0	63.1	9.0	19.4	22.0	14.2	12.1	25.6	28.1	23.2	36.5	27.8	16.4	19.4	31.5	29.4	4.6	9.9	21.8	35.4	36.5	21.9	7.7	37.1	15.1	15.0	31.5	24.6	30.1	30.0	23.0	40.8	25.3	35.7	27.9	4.3	29.8	28.0	48.7	24.9	26.4	32.0	29.8	23.7	32.0	30.7	29.3	31.7	32.1	28.6	26.7	50.6	42.5	68.7	203.4	119.1	47.0	89.2	124.9	77.6	61.4	146.5	39.3	134.7	305.1	153.5	36.2	95.8	72.1	46.7	90.4	115.2	195.1	96.4	94.6	148.9	197.0	20.6	104.5	112.3	138.2	18.5	247.9	128.5	156.9	100.0	108.9	147.8	82.8	115.8	198.7	400.9	62.5	148.8	210.1	67.4	44.1	113.0	62.2	82.2	173.0	130.7
ESPL1	"ESP1, KIAA0165, SEPA"	ENSG00000135476	"Extra spindle pole bodies like 1, separase"	Q14674	12	53268299-53293643	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Chromosome partition"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 17.9;lymphoid tissue: 30.3"	"Cell type enhanced"	"Detected in some"	6	"Enterocytes: 4.1;Hepatocytes: 4.9;Proximal tubular cells: 5.6;Spermatocytes: 6.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Cell type enriched"	"Detected in single"	5	"T-reg: 1.8"	"Lineage enriched"	"Detected in single"	5	"T-cells: 1.8"	"Low cell line specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"CAB012185, HPA073188"	Approved		Supported	Nucleoplasm,Vesicles		NA	Yes			Nucleoplasm	Vesicles	"CAB012185: AB_304056, HPA073188: "	"unprognostic (1.57e-1)"	"unprognostic (3.56e-2)"	"unprognostic (3.84e-2)"	"prognostic unfavorable (5.32e-5)"	"unprognostic (2.91e-1)"	"unprognostic (1.11e-1)"	"prognostic unfavorable (2.01e-5)"	"prognostic unfavorable (7.14e-4)"	"unprognostic (1.59e-2)"	"unprognostic (2.48e-1)"	"unprognostic (4.17e-3)"	"unprognostic (1.18e-2)"	"unprognostic (7.42e-13)"	"prognostic favorable (7.10e-4)"	"unprognostic (2.39e-1)"	"unprognostic (7.41e-2)"	"unprognostic (1.42e-1)"	0.7	0.4	0.2	7.1	0.4	7.2	0.3	0.2	0.5	3.9	2.3	0.4	0.8	4.2	0.6	0.7	17.9	0.2	0.5	1.0	1.1	0.1	1.0	0.9	0.7	4.1	0.2	0.2	0.3	0.2	0.0	0.2	3.0	0.6	0.4	1.5	0.6	2.6	0.2	0.2	2.7	4.4	0.5	0.2	3.0	0.8	10.9	0.3	30.3	0.3	2.5	7.8	0.7	6.2	0.0	0.0	0.4	0.1	0.0	1.8	0.0	12.6	12.9	13.8	11.3	0.3	1.2	8.5	8.3	4.2	14.3	9.1	7.0	11.1	22.8	4.6	3.4	8.4	10.5	16.0	4.9	7.5	7.1	16.2	15.3	11.7	5.3	0.0	9.6	12.7	0.4	0.3	8.3	4.1	1.4	7.3	11.3	20.5	20.6	4.2	13.1	15.0	8.2	11.2	7.5	7.0	14.1	14.8	9.5	2.0	5.3	10.0	7.7	7.0	10.3	5.4	6.8	17.0	6.4	3.3	7.2	14.0	6.0	11.4	15.3	14.2	15.4	4.1	9.1	13.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.1	0.0	1.8	0.0	0.2	0.4	0.2	0.5	1.1	0.1	0.2	0.2	0.6	0.3	0.0	0.0	0.0	0.1	0.8	0.0	0.8	0.0	0.0	0.0	3.5	0.0	0.7	0.0	0.2	0.6	0.4	4.1	0.0	0.0	1.9	1.0	0.3	0.0	4.9	2.1	0.0	3.4	1.3	0.6	1.1	0.0	1.3	0.0	0.0	1.2	0.0	1.0	0.2	0.4	5.6	0.0	0.0	0.4	6.5	2.7	0.5	0.2	0.0	3.1	0.5
ETFDH	ETFQO	ENSG00000171503	"Electron transfer flavoprotein dehydrogenase"	Q16134	4	158672125-158709623	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Electron transport, Transport"	Oxidoreductase	"Disease mutation, Glutaricaciduria"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 72.8"	"Cell type enhanced"	"Detected in all"	6	"Cardiomyocytes: 138.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041978	Enhanced					NA	NA					"HPA041978: AB_10795605"	"unprognostic (7.19e-2)"	"unprognostic (2.28e-1)"	"unprognostic (2.90e-2)"	"unprognostic (5.92e-3)"	"unprognostic (1.91e-1)"	"unprognostic (8.45e-2)"	"unprognostic (1.23e-3)"	"unprognostic (7.17e-2)"	"unprognostic (2.01e-1)"	"unprognostic (4.55e-2)"	"unprognostic (1.71e-2)"	"unprognostic (5.76e-2)"	"prognostic favorable (5.76e-10)"	"unprognostic (2.51e-1)"	"unprognostic (2.07e-1)"	"unprognostic (8.85e-3)"	"unprognostic (1.74e-1)"	11.3	20.1	7.0	3.9	8.6	2.8	12.9	10.3	8.2	5.1	12.5	6.5	6.1	23.0	5.7	6.4	10.9	4.3	5.2	47.8	7.2	5.0	17.3	72.8	4.3	2.9	8.0	5.3	5.0	8.9	11.4	8.8	9.0	8.5	5.2	10.5	7.4	7.2	5.6	33.7	7.7	20.4	8.5	4.8	4.8	9.2	4.1	8.4	4.9	6.0	17.5	5.4	5.8	6.1	5.8	11.0	24.5	13.5	6.2	9.2	5.4	5.7	3.6	6.0	10.8	25.9	15.5	2.9	10.1	10.2	7.5	7.3	2.0	12.7	14.0	2.2	12.2	7.8	6.7	11.5	10.1	10.6	22.2	8.4	12.8	8.2	3.4	11.3	11.0	12.3	14.3	12.7	8.1	6.9	11.5	14.6	9.5	7.1	26.5	12.0	5.9	10.7	5.5	2.3	16.9	8.8	8.6	2.0	9.8	11.2	5.0	9.1	3.5	10.1	20.2	9.6	5.7	13.7	8.5	6.5	6.1	3.1	8.9	5.2	14.9	18.5	9.5	12.6	9.3	6.5	2.5	13.5	24.5	6.7	13.3	8.1	5.8	6.3	6.8	11.0	5.4	7.8	6.6	4.6	6.2	11.7	8.4	9.2	5.4	7.0	8.6	10.3	8.2	7.2	5.0	8.0	5.3	8.5	8.4	11.9	9.3	20.1	42.9	29.3	26.0	138.5	12.7	10.7	12.5	17.4	60.9	18.8	24.9	11.1	2.6	18.0	45.5	46.7	10.2	7.3	20.8	16.4	4.7	70.6	11.7	23.8	17.2	12.3	7.8	3.6	21.3	13.7	8.5	7.2	18.2	11.7	10.7	23.7	22.3	23.7	43.8	32.3	23.1	37.2	33.4	32.2	35.9	18.3	21.5	33.8
ETHE1	"HSCO, YF13H12"	ENSG00000105755	"ETHE1, persulfide dioxygenase"	O95571	19	43506719-43527244	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		"Dioxygenase, Oxidoreductase"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"intestine: 80.7"	"Cell type enhanced"	"Detected in many"	8	"Enterocytes: 485.2;Paneth cells: 571.2;Undifferentiated cells: 334.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 49.1;OE19: 77.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028360, HPA029028, HPA029029"	Enhanced		Enhanced	Mitochondria		No	No		13000	Mitochondria		"HPA028360: AB_10599297, HPA029028: AB_10602092, HPA029029: AB_10601998"	"unprognostic (8.04e-2)"	"unprognostic (3.33e-1)"	"unprognostic (1.50e-2)"	"unprognostic (2.45e-1)"	"unprognostic (8.34e-2)"	"unprognostic (1.25e-2)"	"unprognostic (2.58e-1)"	"prognostic unfavorable (9.58e-4)"	"unprognostic (7.75e-2)"	"unprognostic (2.28e-1)"	"unprognostic (5.47e-2)"	"unprognostic (3.24e-1)"	"unprognostic (1.01e-1)"	"unprognostic (5.27e-2)"	"unprognostic (1.75e-1)"	"unprognostic (9.72e-3)"	"unprognostic (2.73e-2)"	7.7	10.5	5.2	28.3	6.3	13.1	8.8	4.5	6.7	10.9	80.7	4.6	9.6	27.4	7.1	12.2	28.2	7.1	18.4	8.9	4.4	4.1	19.0	21.3	11.4	15.5	5.6	4.9	7.4	12.7	3.0	7.2	16.7	5.1	12.0	72.1	5.6	18.5	6.7	9.4	9.1	40.3	11.8	4.5	11.0	13.2	3.3	4.7	12.0	26.2	23.3	24.4	10.9	13.3	7.9	35.8	7.4	24.3	9.9	20.2	15.1	11.5	15.3	3.1	10.9	17.1	11.6	1.2	18.0	49.1	15.5	15.9	4.5	11.8	0.0	13.5	17.2	4.9	9.4	4.5	27.1	4.1	5.8	1.4	2.9	6.6	12.7	7.7	4.3	4.1	11.9	21.3	6.0	16.8	20.5	11.5	11.2	1.9	19.5	7.6	7.8	5.0	4.0	0.8	77.6	7.4	5.7	1.3	2.5	33.7	24.1	0.0	3.9	4.6	16.5	10.8	5.3	5.0	7.2	9.6	2.5	10.7	3.0	3.3	5.5	4.3	0.3	10.9	17.9	12.9	7.4	24.3	0.6	17.2	12.7	20.0	7.9	20.2	16.3	35.8	3.4	15.6	14.8	0.7	9.9	8.5	7.1	19.4	15.1	5.2	6.3	4.5	6.7	4.4	4.1	5.6	4.9	5.1	4.7	20.8	18.9	42.5	70.4	30.7	9.5	8.3	53.5	14.7	17.0	52.4	0.0	162.0	46.4	62.5	0.4	49.6	485.2	0.0	56.4	70.8	54.7	70.7	36.9	78.8	100.9	4.8	61.2	36.8	100.2	1.6	16.4	79.3	75.9	58.7	224.1	9.4	73.6	571.2	15.2	90.3	4.6	19.4	61.2	1.8	5.5	20.3	77.3	53.3	334.8	123.3
ETNK1	"EKI, EKI1"	ENSG00000139163	"Ethanolamine kinase 1"	Q9HBU6	12	22625075-22690665	"Cancer-related genes, Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism"	"Kinase, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Early spermatids: 201.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA010712, HPA029407"	Approved		Approved	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Nucleoplasm, Plasma membrane, Cytosol"		"HPA010712: AB_2668349, HPA029407: AB_2673026"	"unprognostic (2.06e-1)"	"unprognostic (7.48e-2)"	"unprognostic (1.23e-3)"	"unprognostic (2.19e-1)"	"unprognostic (8.79e-3)"	"unprognostic (1.31e-2)"	"prognostic unfavorable (5.85e-4)"	"unprognostic (3.98e-3)"	"unprognostic (8.30e-2)"	"unprognostic (7.97e-3)"	"unprognostic (2.01e-1)"	"unprognostic (1.64e-2)"	"unprognostic (4.53e-3)"	"unprognostic (2.77e-1)"	"unprognostic (2.91e-1)"	"unprognostic (3.01e-1)"	"prognostic favorable (1.75e-4)"	15.7	17.7	15.2	41.1	19.4	13.7	16.9	19.7	22.2	12.9	33.2	16.4	14.6	27.2	16.6	24.1	14.7	13.1	27.3	10.4	15.6	23.9	22.0	30.2	19.6	18.5	17.2	15.8	17.2	14.9	15.8	30.6	13.4	18.9	13.8	19.5	15.9	16.7	14.7	8.2	17.8	24.5	10.0	17.1	18.3	53.7	22.3	17.5	33.4	17.6	8.2	16.5	14.2	18.6	16.2	10.7	28.1	17.6	14.0	15.7	13.4	6.7	14.0	15.6	14.4	11.3	11.4	11.6	8.0	6.0	8.3	8.6	10.8	17.1	20.1	7.2	5.2	8.7	5.1	13.7	3.8	15.0	16.7	11.1	16.6	6.2	9.3	10.8	15.9	15.3	7.4	3.7	11.2	9.5	13.3	10.3	7.9	19.9	8.5	11.0	4.6	17.3	32.4	30.2	8.7	9.2	15.6	13.8	16.1	13.8	9.2	5.0	8.8	8.7	7.6	12.5	22.4	11.8	15.4	8.8	6.6	10.6	8.9	12.0	6.2	7.7	21.6	8.4	10.4	11.0	28.1	11.7	12.1	12.9	17.5	12.7	16.2	14.1	11.9	10.7	13.0	15.7	15.5	11.5	14.0	17.6	9.7	15.3	13.4	15.2	19.4	19.7	22.2	15.6	23.9	17.2	15.8	18.9	17.5	44.7	25.1	40.9	63.3	128.1	40.4	11.0	53.5	72.3	35.2	41.8	47.1	27.9	23.2	26.3	201.9	28.7	55.0	0.0	39.6	20.3	28.6	70.5	33.5	38.4	37.5	25.4	103.9	27.6	78.9	26.1	22.5	44.7	64.1	22.6	52.6	21.4	29.0	46.1	20.1	26.4	35.5	38.8	44.3	47.7	15.1	148.8	63.0	39.2	36.0	60.2
ETNK2	"EKI2, FLJ10761"	ENSG00000143845	"Ethanolamine kinase 2"	Q9NVF9	1	204131062-204152003	"Enzymes, Predicted intracellular proteins"	"Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism"	"Kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"kidney: 65.9;liver: 80.5;testis: 45.0"	"Group enriched"	"Detected in many"	5	"Early spermatids: 370.3;Late spermatids: 1080.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"gdT-cell: 4.8;MAIT T-cell: 4.6;memory CD4 T-cell: 1.3;memory CD8 T-cell: 2.9;naive CD4 T-cell: 2.9;naive CD8 T-cell: 3.6;NK-cell: 1.5"	"Group enriched"	"Detected in many"	11	"NK-cells: 1.5;T-cells: 4.8"	"Cell line enhanced"	"Detected in many"		"hTCEpi: 26.4;MCF7: 25.5"	"Low region specificity"	"Detected in many"			"Region enriched"	"Detected in some"	8	"basal ganglia: 24.7"	HPA057167	Enhanced					NA	NA					"HPA057167: AB_2683358"	"unprognostic (1.64e-1)"	"unprognostic (4.17e-2)"	"unprognostic (2.56e-2)"	"unprognostic (7.81e-2)"	"prognostic unfavorable (4.11e-4)"	"unprognostic (1.95e-1)"	"unprognostic (1.99e-2)"	"unprognostic (1.13e-1)"	"unprognostic (9.39e-3)"	"unprognostic (4.28e-2)"	"unprognostic (6.54e-2)"	"unprognostic (4.35e-2)"	"prognostic favorable (6.50e-4)"	"unprognostic (5.50e-3)"	"unprognostic (4.69e-2)"	"unprognostic (2.00e-2)"	"unprognostic (1.20e-1)"	3.3	2.3	4.0	0.8	4.7	0.9	6.3	0.9	4.0	5.1	1.6	1.9	6.5	0.8	3.1	11.0	8.3	4.9	1.9	2.6	2.6	2.5	65.9	80.5	1.2	2.0	2.7	1.9	13.1	4.3	6.2	8.8	2.3	2.7	3.8	0.9	4.8	7.6	7.8	0.6	5.1	0.8	2.4	1.5	2.4	1.1	45.0	1.9	1.1	4.0	3.9	12.9	3.8	6.2	0.2	0.0	0.2	0.2	1.5	4.8	1.0	5.2	1.8	5.3	10.1	2.0	0.6	5.3	5.4	12.0	7.5	3.3	9.0	2.6	0.2	9.1	1.3	8.8	4.7	9.4	7.6	5.2	0.2	8.4	0.1	1.0	13.8	8.0	0.2	0.3	2.7	26.4	1.6	0.3	3.9	5.4	5.7	0.7	0.2	0.9	25.5	1.5	0.1	11.1	0.2	4.0	0.4	6.3	0.2	6.5	2.0	1.4	7.6	3.4	16.1	2.5	17.6	15.6	0.3	0.3	2.1	11.7	0.4	3.9	0.2	0.1	0.2	0.1	0.2	3.0	0.1	0.2	0.0	4.8	0.0	4.6	0.0	1.3	2.9	0.0	0.2	2.9	3.6	0.2	1.5	0.1	0.0	0.7	1.0	4.0	4.7	0.9	4.0	2.6	2.5	2.7	1.9	2.7	1.9	0.0	0.0	0.5	9.8	3.7	1.8	0.9	5.1	2.7	0.0	3.5	3.9	4.8	33.2	8.0	370.3	1.0	0.0	0.0	5.6	7.9	5.7	10.1	9.2	156.9	0.7	0.0	1.2	1.8	5.1	1080.2	27.0	0.6	10.1	0.0	0.0	2.6	4.6	0.0	39.6	120.8	0.8	0.0	3.8	9.3	5.9	2.0	7.9	0.9	0.0	8.3
ETNPPL	AGXT2L1	ENSG00000164089	"Ethanolamine-phosphate phospho-lyase"	Q8TBG4	4	108742040-108763054	"Enzymes, Predicted intracellular proteins"		Lyase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"brain: 53.5;liver: 111.0"	"Group enriched"	"Detected in some"	7	"Cardiomyocytes: 9.4;Hepatocytes: 22.6;Muller glia cells: 6.4"	"Group enriched"	"Detected in some"	23	"glioma: 7.9;liver cancer: 21.7"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HeLa: 11.0;Hep G2: 4.3;NTERA-2: 2.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA044546, HPA072938"	Approved		Approved	Nucleoplasm		Yes	NA			Nucleoplasm		"HPA044546: AB_10962867, HPA072938: AB_2686560"	"unprognostic (5.20e-3)"	"unprognostic (1.33e-1)"		"unprognostic (3.93e-1)"	"prognostic favorable (9.52e-5)"		"unprognostic (5.93e-3)"	"unprognostic (3.91e-2)"	"unprognostic (2.82e-1)"	"unprognostic (6.32e-2)"	"unprognostic (2.70e-2)"	"unprognostic (1.30e-1)"	"unprognostic (3.40e-2)"	"unprognostic (1.93e-1)"	"unprognostic (1.59e-1)"	"unprognostic (1.42e-2)"	"unprognostic (9.48e-2)"	1.2	1.9	50.8	1.3	51.3	1.2	1.3	7.9	53.5	1.3	1.2	13.4	0.0	1.3	1.4	1.2	1.3	1.2	1.4	3.2	37.5	20.1	6.2	111.0	1.2	1.2	26.0	28.7	1.3	1.2	1.4	0.1	1.2	15.7	1.2	1.2	0.5	19.9	1.3	1.6	1.2	1.2	1.2	7.3	1.6	10.4	1.5	18.7	0.0	1.9	0.0	1.2	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	1.0	0.1	11.0	4.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.5	0.0	2.2	0.0	0.5	0.0	0.1	0.0	0.0	0.0	1.2	0.0	0.3	0.0	0.9	0.1	0.2	0.0	0.1	0.0	0.4	0.0	0.1	0.0	0.0	0.1	0.1	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	50.8	51.3	7.9	24.9	37.5	20.1	26.0	28.7	15.7	18.7	0.0	0.0	0.0	0.0	0.0	0.0	9.4	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	22.6	0.0	0.0	0.0	0.6	1.0	1.3	0.0	0.0	0.0	0.0	0.0	6.4	0.0	0.0	0.0	1.9	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0
EXD2	"C14orf114, EXDL2, FLJ10738"	ENSG00000081177	"Exonuclease 3'-5' domain containing 2"	Q9NVH0	14	69191511-69244020	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"DNA damage, DNA repair"	"Exonuclease, Hydrolase, Nuclease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Spermatocytes: 31.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002906, HPA005848"	Uncertain		Approved	"Intermediate filaments,Mitochondria"		NA	NA			Mitochondria	"Intermediate filaments"	"HPA002906: AB_1078767, HPA005848: AB_1078768"	"unprognostic (3.36e-2)"	"unprognostic (1.61e-2)"	"unprognostic (1.25e-1)"	"unprognostic (1.71e-1)"	"unprognostic (2.63e-1)"	"unprognostic (2.85e-1)"	"prognostic unfavorable (8.47e-4)"	"unprognostic (9.91e-2)"	"unprognostic (8.03e-2)"	"unprognostic (2.46e-1)"	"unprognostic (4.64e-2)"	"unprognostic (8.97e-2)"	"prognostic favorable (2.08e-9)"	"unprognostic (1.16e-1)"	"unprognostic (3.06e-2)"	"unprognostic (8.75e-2)"	"unprognostic (2.14e-2)"	8.1	7.7	14.3	5.0	19.0	2.3	10.6	20.4	20.1	15.8	8.8	21.7	10.2	7.2	14.4	13.6	10.7	14.5	8.6	8.9	13.8	12.0	11.5	6.0	9.0	4.0	13.7	13.3	12.4	24.9	21.9	13.2	8.0	13.9	11.4	10.0	9.6	17.0	12.1	10.3	7.0	6.8	11.0	20.7	5.8	8.7	20.0	12.6	5.0	12.4	5.2	5.9	10.5	7.9	4.1	7.4	10.9	3.4	3.6	6.0	3.1	19.1	9.0	7.0	10.3	4.3	5.2	8.9	9.6	8.1	9.0	11.9	7.6	13.6	0.0	7.1	10.0	5.5	10.9	7.7	9.7	10.2	4.8	9.2	5.6	3.4	4.5	16.9	4.1	5.4	10.5	16.1	9.1	6.0	5.5	12.6	4.9	3.5	7.4	8.5	9.7	2.3	6.3	7.6	10.3	9.1	0.0	6.7	6.7	13.2	7.1	13.7	12.2	7.2	15.0	7.0	7.9	20.1	3.6	10.0	8.4	6.0	6.7	4.9	5.7	7.6	0.0	0.0	4.5	6.2	10.9	3.4	2.9	3.3	1.9	6.0	4.1	3.5	3.3	7.4	2.4	4.2	6.0	0.4	3.6	1.7	5.8	2.4	3.1	14.3	19.0	20.4	20.1	13.8	12.0	13.7	13.3	13.9	12.6	11.9	7.5	3.2	4.2	2.9	9.4	10.3	5.1	9.4	9.1	0.0	7.9	7.1	5.0	10.0	2.4	4.4	3.2	0.0	7.6	3.8	4.6	4.8	1.1	4.7	5.6	9.5	5.8	10.4	5.9	1.8	5.8	1.8	3.3	9.0	8.7	6.8	9.0	7.0	11.3	4.8	8.7	0.0	3.9	31.0	8.7	3.8	2.4	0.5	6.9	3.0
EXT1	"LGCR, LGS, ttv"	ENSG00000182197	"Exostosin glycosyltransferase 1"	Q16394	8	117794490-118111853	"Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"		"Glycosyltransferase, Transferase"	"Cancer-related genes, Disease mutation, Hereditary multiple exostoses, Tumor suppressor"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 66.4"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 55.5;fHDF/TERT166: 56.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044394	Uncertain					NA	Yes		9600000			"HPA044394: AB_10963838"	"unprognostic (1.29e-2)"	"prognostic unfavorable (7.04e-4)"	"unprognostic (2.73e-2)"	"unprognostic (2.02e-3)"	"unprognostic (2.19e-1)"	"unprognostic (7.55e-2)"	"unprognostic (1.99e-1)"	"prognostic unfavorable (1.20e-5)"	"unprognostic (1.70e-1)"	"unprognostic (3.01e-2)"	"unprognostic (1.31e-2)"	"unprognostic (6.58e-2)"	"unprognostic (1.27e-2)"	"unprognostic (9.84e-2)"	"unprognostic (9.49e-2)"	"prognostic unfavorable (4.64e-4)"	"unprognostic (1.85e-1)"	13.8	11.9	5.8	20.5	4.6	2.1	16.5	7.3	7.4	13.3	17.1	4.1	8.7	23.2	11.5	12.5	11.2	8.8	19.3	14.4	4.6	3.1	8.8	66.4	19.9	8.3	3.0	6.8	10.4	17.9	7.1	6.4	15.6	4.8	9.8	16.0	13.2	9.8	13.3	4.2	12.3	32.0	16.8	4.3	20.1	11.5	5.0	2.7	8.7	12.0	10.3	7.2	11.0	18.5	0.8	1.7	1.2	4.5	0.7	2.4	1.0	17.3	5.0	7.6	3.0	13.7	11.1	3.5	32.5	55.5	24.0	22.1	5.2	1.7	0.3	14.6	56.1	17.9	11.0	3.3	19.1	33.8	6.5	5.6	0.7	4.7	4.1	6.4	0.0	1.2	6.9	5.1	29.1	26.8	30.1	14.7	1.6	0.4	4.8	11.1	1.4	0.8	0.0	2.4	9.2	6.5	0.0	2.8	0.5	9.4	6.3	2.4	2.2	5.0	2.3	4.8	20.2	3.2	0.2	19.5	20.2	18.6	18.6	9.5	2.8	2.7	1.6	18.8	0.0	5.4	0.3	4.4	0.2	0.2	4.5	1.3	0.8	0.5	0.6	1.0	0.1	0.5	0.9	1.2	0.7	2.2	1.7	2.4	1.0	5.8	4.6	7.3	7.4	4.6	3.1	3.0	6.8	4.8	2.7	17.9	5.9	1.4	18.7	48.7	21.1	6.2	28.1	5.3	6.8	7.0	13.7	5.2	0.0	34.9	1.3	16.6	42.3	0.0	17.2	3.2	32.1	10.0	6.9	22.6	2.2	9.5	4.6	17.8	28.9	1.6	16.1	5.4	18.6	5.4	20.7	6.0	21.6	14.0	33.9	5.0	24.5	0.0	28.1	0.5	4.3	41.4	10.2	2.2	21.2	17.9
EXT2	SOTV	ENSG00000151348	"Exostosin glycosyltransferase 2"	Q93063	11	44095549-44245429	"Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted membrane proteins"		"Glycosyltransferase, Transferase"	"Cancer-related genes, Disease mutation, Epilepsy, Hereditary multiple exostoses, Mental retardation, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA078409			Supported	"Golgi apparatus"		NA	NA		20000000	"Golgi apparatus"		"HPA078409: AB_2686884"	"unprognostic (5.87e-2)"	"unprognostic (3.05e-3)"	"unprognostic (3.48e-2)"	"unprognostic (3.94e-1)"	"unprognostic (1.42e-1)"	"prognostic unfavorable (2.50e-4)"	"unprognostic (1.77e-3)"	"unprognostic (2.22e-2)"	"unprognostic (1.97e-1)"	"unprognostic (2.05e-1)"	"unprognostic (1.74e-3)"	"unprognostic (3.70e-2)"	"prognostic unfavorable (5.36e-6)"	"unprognostic (7.07e-3)"	"unprognostic (2.97e-1)"	"unprognostic (3.85e-1)"	"unprognostic (1.36e-2)"	24.5	19.5	11.6	17.2	18.5	6.6	25.8	14.5	23.0	26.8	25.0	15.5	17.5	17.6	37.1	25.5	16.7	26.0	23.4	22.7	11.7	13.0	19.2	36.3	22.3	16.8	11.8	12.3	29.3	21.8	25.7	17.3	58.0	16.2	23.7	20.6	22.9	24.7	22.8	16.9	20.2	34.0	35.0	12.2	18.7	19.3	20.0	11.4	16.2	24.7	16.7	13.0	20.2	23.2	6.7	14.9	13.0	12.0	17.8	17.6	9.8	13.1	18.2	9.9	30.7	45.6	33.6	13.6	40.8	51.1	24.2	33.0	12.9	9.1	9.1	18.6	47.8	25.6	21.0	10.5	29.0	29.3	18.2	14.5	8.4	9.6	9.9	18.0	8.4	18.1	26.0	19.2	14.6	22.9	28.5	34.3	8.7	11.2	16.4	17.6	10.1	5.8	5.1	10.6	16.8	13.0	7.3	28.2	4.6	14.0	12.5	7.1	7.9	25.8	10.6	6.8	18.3	17.6	9.0	31.0	32.7	21.4	32.0	26.2	7.4	9.7	6.7	21.5	6.5	34.9	9.3	11.9	13.0	15.6	12.0	17.6	6.4	12.5	14.4	14.9	6.7	11.9	11.7	2.6	17.8	8.5	5.1	9.6	9.8	11.6	18.5	14.5	23.0	11.7	13.0	11.8	12.3	16.2	11.4	14.9	8.8	10.5	13.2	13.5	11.5	9.2	5.1	5.3	10.3	12.2	13.7	27.3	5.0	28.2	30.2	16.7	20.5	0.0	20.6	30.2	24.4	17.7	5.8	15.5	16.2	12.7	1.7	21.5	11.9	17.4	25.3	7.7	5.0	10.0	14.0	16.6	21.7	14.0	26.9	7.0	14.3	19.4	16.9	36.9	21.7	11.0	29.5	7.5	13.3	14.6
EXTL1	"EXTL, MGC70794"	ENSG00000158008	"Exostosin like glycosyltransferase 1"	Q92935	1	26019884-26036464	"Enzymes, Predicted intracellular proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"brain: 21.1;heart muscle: 6.0;skeletal muscle: 20.5"	"Cell type enhanced"	"Detected in some"	14	"Bipolar cells: 6.2;Cardiomyocytes: 2.9;Horizontal cells: 9.5;Melanocytes: 6.8"	"Cancer enriched"	"Detected in some"	13	"melanoma: 21.7"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	10	"WM-115: 58.8"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA010726, HPA037749"	Approved		Approved	Vesicles,Centrosome	"Intracellular and membrane"	NA	NA		68000	Centrosome	Vesicles	"HPA010726: , HPA037749: AB_10805350"	"unprognostic (2.00e-1)"	"unprognostic (1.10e-2)"	"unprognostic (8.16e-3)"	"unprognostic (1.47e-2)"	"unprognostic (2.47e-2)"	"unprognostic (6.14e-3)"	"unprognostic (3.78e-2)"	"unprognostic (1.99e-1)"	"unprognostic (1.99e-1)"	"unprognostic (6.70e-2)"	"unprognostic (1.44e-2)"	"unprognostic (3.46e-1)"	"unprognostic (1.12e-2)"	"unprognostic (1.40e-3)"	"unprognostic (2.27e-2)"	"unprognostic (2.91e-1)"	"unprognostic (1.35e-2)"	0.6	2.1	15.3	0.6	9.5	0.5	2.0	1.1	21.1	1.3	0.6	1.4	0.0	0.7	2.5	0.7	1.5	1.7	1.2	6.0	12.7	3.7	0.7	0.5	0.7	0.8	3.7	7.9	2.3	1.0	0.5	0.5	1.0	2.9	1.2	0.6	2.7	0.8	0.9	20.5	1.6	0.7	2.9	2.7	2.2	0.6	1.0	0.8	0.0	0.9	3.2	0.6	0.9	0.2	0.1	0.1	0.0	0.0	0.0	0.8	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.8	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.9	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	58.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.8	0.3	0.0	0.0	0.0	0.1	0.0	0.1	15.3	9.5	1.1	21.1	12.7	3.7	3.7	7.9	2.9	0.8	0.0	0.0	0.0	0.0	0.1	6.2	2.9	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	9.5	0.0	0.0	0.0	0.4	1.4	0.0	6.8	0.0	0.0	0.6	0.0	0.0	2.5	0.0	1.4	0.0	0.3	0.2	0.2	0.0	0.8	0.0	0.0	0.0
EXTL2		ENSG00000162694	"Exostosin like glycosyltransferase 2"	Q9UBQ6	1	100872372-100895998	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	10	"Cytotrophoblasts: 175.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB020716, HPA068921"	Approved		Approved	Nucleoplasm,Cytosol	"Intracellular and membrane"	NA	NA		83000000	Nucleoplasm	Cytosol	"CAB020716: , HPA068921: AB_2686058"	"unprognostic (3.14e-1)"	"unprognostic (6.34e-2)"	"unprognostic (1.50e-2)"	"unprognostic (8.20e-2)"	"unprognostic (9.07e-3)"	"unprognostic (1.25e-1)"	"prognostic unfavorable (1.64e-5)"	"unprognostic (7.81e-3)"	"unprognostic (1.10e-2)"	"unprognostic (1.28e-1)"	"unprognostic (3.61e-2)"	"unprognostic (3.00e-1)"	"unprognostic (3.17e-2)"	"unprognostic (6.84e-2)"	"unprognostic (7.83e-2)"	"unprognostic (1.24e-2)"	"unprognostic (4.34e-2)"	7.5	23.0	9.8	4.1	19.9	1.7	10.4	14.7	22.8	13.4	8.7	8.1	9.9	4.5	16.7	13.1	6.0	10.1	10.3	8.2	9.5	13.3	11.2	10.0	7.6	3.4	14.0	12.0	18.8	7.7	17.5	18.7	21.8	20.1	12.3	7.1	8.6	6.0	11.4	5.3	5.9	4.6	15.4	11.4	5.4	6.2	9.7	16.3	6.4	9.3	5.0	3.4	9.0	6.2	2.1	7.4	3.3	1.1	5.3	5.6	1.9	5.2	2.7	20.1	21.0	22.3	16.5	12.8	9.0	14.9	7.1	15.9	2.6	4.0	5.8	8.8	8.3	5.6	5.1	7.3	7.7	14.4	11.8	5.1	7.1	9.7	7.2	7.3	11.0	3.8	19.5	2.7	14.2	2.8	15.0	25.9	7.4	8.9	0.7	17.9	2.7	5.8	6.1	25.3	4.7	6.1	4.2	20.7	4.7	7.6	4.0	8.3	23.6	6.9	1.8	16.2	15.3	4.3	5.0	10.8	17.8	10.5	11.4	9.5	6.2	5.5	3.6	28.3	11.4	5.8	3.3	0.8	0.0	5.6	1.1	2.8	1.9	1.9	3.7	2.5	2.1	2.1	4.8	0.2	5.3	0.9	7.4	0.0	1.9	9.8	19.9	14.7	22.8	9.5	13.3	14.0	12.0	20.1	16.3	11.9	5.9	2.2	11.4	7.6	20.3	9.7	10.2	29.4	14.8	14.0	33.4	175.5	10.0	5.2	19.7	10.8	2.0	0.0	1.8	25.1	33.5	5.4	17.3	14.7	21.3	3.2	9.1	15.4	7.0	27.2	23.3	3.6	21.9	10.0	3.9	18.6	2.5	2.9	32.5	10.8	17.8	12.9	16.5	29.8	8.1	7.0	62.1	6.9	6.3	3.0
EXTL3	"botv, REGR"	ENSG00000012232	"Exostosin like glycosyltransferase 3"	O43909	8	28600469-28755599	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"		"Glycosyltransferase, Transferase"	"Disease mutation, Dwarfism, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"neutrophil: 10.0"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB025387	Approved					NA	NA					"CAB025387: "	"unprognostic (1.35e-1)"	"unprognostic (1.31e-1)"	"unprognostic (5.53e-2)"	"unprognostic (1.19e-3)"	"unprognostic (9.83e-2)"	"unprognostic (2.41e-1)"	"prognostic unfavorable (1.14e-5)"	"unprognostic (4.25e-2)"	"unprognostic (9.29e-3)"	"unprognostic (1.05e-1)"	"unprognostic (5.10e-3)"	"unprognostic (1.19e-3)"	"prognostic favorable (2.47e-5)"	"unprognostic (1.34e-1)"	"unprognostic (1.73e-1)"	"unprognostic (8.91e-2)"	"unprognostic (1.39e-2)"	12.1	19.0	15.4	7.9	19.5	4.0	11.6	14.8	26.9	11.3	10.5	16.2	8.8	6.3	15.0	7.9	14.0	13.7	9.6	34.6	15.4	13.4	8.5	6.7	10.1	5.9	11.6	18.1	12.2	13.0	26.1	13.8	15.7	12.9	10.2	6.5	15.2	8.8	14.8	20.7	13.5	6.8	19.8	11.7	9.3	9.6	14.3	10.8	5.4	9.2	8.7	5.9	12.2	9.5	0.8	2.4	10.0	2.3	1.0	3.6	1.5	19.4	14.7	32.9	16.9	9.0	9.3	7.2	14.7	14.9	9.4	7.9	12.5	7.0	5.3	21.3	17.9	13.4	13.1	15.1	24.2	10.1	3.8	8.3	7.4	7.4	6.3	5.2	3.6	21.3	10.4	16.4	7.1	6.6	8.4	20.0	8.0	6.8	6.8	7.3	3.7	6.5	2.4	22.3	6.5	6.0	7.9	14.1	3.0	16.1	12.6	7.0	12.3	6.2	3.9	8.4	10.8	3.7	4.5	15.2	12.3	29.0	11.3	12.4	3.7	7.3	6.0	10.3	4.5	10.9	4.0	2.0	3.3	3.6	2.3	2.1	0.6	1.3	1.9	2.4	0.8	1.1	0.9	10.0	1.0	2.3	2.3	0.8	1.5	15.4	19.5	14.8	26.9	15.4	13.4	11.6	18.1	12.9	10.8	3.0	4.1	0.8	2.1	4.4	14.9	21.3	5.1	2.7	2.3	1.8	23.6	3.3	3.3	9.0	14.8	6.4	2.8	0.0	9.2	15.1	5.8	4.1	5.7	6.6	3.7	7.9	4.1	6.2	5.3	6.4	9.2	3.3	5.0	1.8	2.2	5.8	9.7	3.1	13.4	3.2	14.7	25.8	6.2	4.3	7.0	2.6	1.8	5.0	2.4	2.1
EYA1	BOR	ENSG00000104313	"EYA transcriptional coactivator and phosphatase 1"	Q99502	8	71197433-71592025	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"DNA damage, DNA repair, Transcription, Transcription regulation"	"Activator, Chromatin regulator, Developmental protein, Hydrolase, Protein phosphatase"	"Deafness, Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"parathyroid gland: 45.5;pituitary gland: 30.8"	"Group enriched"	"Detected in some"	8	"Cardiomyocytes: 7.5;Ciliated cells: 12.0;Club cells: 9.1;Early spermatids: 3.9;Late spermatids: 4.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in many"	4	"NK-cell: 9.8"	"Lineage enriched"	"Detected in many"	4	"NK-cells: 9.8"	"Cell line enhanced"	"Detected in some"		"AN3-CA: 16.8;RH-30: 13.0;SH-SY5Y: 31.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA028917			Supported	"Nucleoplasm,Nuclear bodies"		NA	NA			"Nucleoplasm, Nuclear bodies"		"HPA028917: AB_2672826"	"unprognostic (3.74e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.15e-1)"	"unprognostic (1.72e-3)"	"unprognostic (5.95e-2)"	"unprognostic (9.17e-2)"	"unprognostic (2.91e-4)"	"unprognostic (1.98e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.81e-1)"	"unprognostic (9.72e-2)"	"unprognostic (1.13e-1)"	"unprognostic (4.22e-12)"	"unprognostic (1.06e-2)"	"unprognostic (1.84e-1)"	"unprognostic (3.81e-4)"	"unprognostic (1.25e-2)"	1.0	1.1	2.8	0.6	16.8	0.5	0.6	0.2	6.8	4.0	0.6	1.9	0.0	0.7	0.6	2.2	1.0	2.5	0.8	4.6	2.8	2.2	0.6	0.5	1.0	0.6	2.9	2.8	0.8	0.6	45.5	30.8	0.6	4.2	12.4	0.7	15.3	1.2	4.6	3.2	0.6	0.7	3.9	0.4	0.7	0.9	1.3	5.1	4.4	0.9	2.9	0.6	3.5	5.7	0.8	1.9	1.8	2.3	9.8	2.3	0.2	0.1	0.0	3.8	16.8	0.0	0.0	0.0	0.1	1.6	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.5	1.0	0.0	0.0	2.7	0.0	1.2	0.0	0.0	0.3	0.0	3.7	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.3	0.6	0.0	0.0	0.0	1.2	0.0	0.9	0.0	13.0	5.5	0.0	0.0	1.3	31.6	0.0	0.0	1.0	3.7	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	3.8	0.0	1.2	1.8	0.3	0.6	0.9	0.9	1.9	0.8	0.7	1.9	0.7	0.8	1.3	1.4	1.6	9.8	2.3	1.9	2.3	0.2	2.8	16.8	0.2	2.8	2.8	2.2	2.9	2.8	4.2	5.1	0.0	0.0	0.0	0.0	0.1	0.0	7.5	0.0	12.0	9.1	0.0	0.0	0.6	0.0	0.0	3.9	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	4.3	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.2	0.0	0.0	0.0	0.7	1.0	0.1	0.5	0.0	0.0	0.0
EYA2	EAB1	ENSG00000064655	"EYA transcriptional coactivator and phosphatase 2"	O00167	20	46894624-47188844	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"DNA damage, DNA repair, Transcription, Transcription regulation"	"Activator, Chromatin regulator, Developmental protein, Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"cervix, uterine: 47.4"	"Cell type enhanced"	"Detected in many"	11	"Basal glandular cells: 40.0;Club cells: 18.2;Cytotrophoblasts: 21.2;Urothelial cells: 36.7"	"Cancer enhanced"	"Detected in many"		"endometrial cancer: 69.3"	"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	16	"memory B-cell: 2.4"	"Lineage enriched"	"Detected in single"	16	"B-cells: 2.4"	"Cell line enhanced"	"Detected in some"		"HBEC3-KT: 13.7;SCLC-21H: 20.9;SK-BR-3: 9.3;U-266/70: 38.9;U-266/84: 47.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA027024, HPA059291"	Uncertain		Supported	Cytosol		NA	NA			Cytosol		"HPA027024: AB_1848334, HPA059291: AB_2683967"	"unprognostic (1.08e-1)"	"unprognostic (5.71e-3)"	"unprognostic (4.03e-1)"	"prognostic favorable (4.30e-5)"	"unprognostic (3.32e-2)"	"unprognostic (1.72e-1)"	"unprognostic (4.94e-3)"	"unprognostic (1.10e-1)"	"unprognostic (1.21e-1)"	"unprognostic (1.21e-1)"	"unprognostic (2.54e-1)"	"unprognostic (2.65e-1)"	"unprognostic (7.06e-2)"	"unprognostic (2.15e-1)"	"unprognostic (2.78e-1)"	"unprognostic (4.17e-3)"	"unprognostic (1.56e-1)"	10.5	2.0	6.5	2.6	7.4	0.8	13.4	2.4	6.5	47.4	6.4	3.8	21.0	1.0	15.7	10.7	25.9	28.2	2.2	4.3	7.0	4.1	5.2	1.8	2.3	1.3	6.3	4.9	5.2	2.4	11.5	4.7	5.9	9.1	18.5	3.2	15.4	28.6	27.3	2.1	4.2	1.1	2.3	7.2	1.1	8.2	4.9	5.1	14.3	21.4	3.6	14.0	5.5	17.3	2.4	0.0	0.0	0.1	0.0	0.0	0.2	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.6	0.9	0.7	0.1	13.7	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.1	0.7	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	2.5	0.0	0.0	0.2	0.0	0.0	0.0	0.3	0.2	0.0	0.0	20.9	0.0	0.0	9.3	0.0	1.1	1.8	0.1	0.0	0.0	1.7	0.1	3.1	38.9	47.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	6.5	7.4	2.4	6.5	7.0	4.1	6.3	4.9	9.1	5.1	0.0	0.0	0.0	40.0	0.6	0.2	0.5	0.0	6.7	18.2	0.0	5.9	21.2	0.0	0.7	0.0	0.1	0.0	0.0	0.0	1.8	4.7	9.2	1.1	2.4	5.8	0.0	1.2	0.6	0.0	0.0	0.0	0.2	3.3	4.6	0.2	0.0	0.7	1.7	0.7	4.4	0.3	0.0	1.4	0.2	0.7	0.3	9.0	0.0	1.5	36.7
EYA3	DKFZp686C132	ENSG00000158161	"EYA transcriptional coactivator and phosphatase 3"	Q99504	1	27970344-28088696	"Enzymes, Predicted intracellular proteins"	"DNA damage, DNA repair, Transcription, Transcription regulation"	"Activator, Chromatin regulator, Developmental protein, Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Early spermatids: 72.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA052432, HPA062889"	Uncertain		Supported	Nucleoplasm		Yes	No			Nucleoplasm		"HPA052432: AB_2681831, HPA062889: AB_2684895"	"unprognostic (3.57e-1)"	"unprognostic (2.61e-1)"	"unprognostic (2.85e-1)"	"unprognostic (8.74e-2)"	"unprognostic (1.39e-1)"	"prognostic favorable (5.11e-4)"	"unprognostic (1.39e-3)"	"unprognostic (2.21e-1)"	"unprognostic (4.81e-2)"	"unprognostic (1.00e-1)"	"unprognostic (9.13e-2)"	"unprognostic (8.98e-2)"	"prognostic favorable (3.15e-6)"	"unprognostic (5.17e-2)"	"unprognostic (2.79e-1)"	"unprognostic (7.60e-2)"	"unprognostic (6.11e-2)"	12.8	10.0	14.9	24.0	12.9	8.6	13.3	21.9	13.8	14.7	10.2	14.4	12.8	10.7	14.4	12.4	19.4	11.8	8.1	11.7	10.6	11.8	21.6	11.3	12.5	15.6	11.1	8.8	12.4	12.9	20.9	29.2	13.8	12.9	11.8	11.7	16.4	11.8	13.1	14.5	16.3	12.2	10.5	10.1	14.2	10.0	20.6	13.7	17.4	17.3	12.2	25.0	10.7	13.8	8.6	12.4	10.5	11.2	10.4	12.1	2.6	10.5	4.4	9.0	6.7	10.6	8.2	5.1	7.7	7.4	9.1	9.0	4.3	6.5	16.7	8.6	5.2	3.4	10.4	16.6	6.4	10.8	8.8	9.3	19.0	9.0	7.7	6.3	18.3	17.5	5.0	5.8	10.0	6.8	7.9	11.6	6.2	17.4	6.5	8.1	4.6	11.7	12.3	18.9	8.4	5.9	8.9	16.6	10.6	10.7	5.9	10.4	5.7	8.3	5.2	7.4	7.6	4.3	4.9	11.1	11.0	5.9	10.1	6.3	9.7	9.7	15.5	7.9	17.9	4.8	7.5	11.2	10.5	12.1	10.4	10.8	8.6	9.5	8.7	12.4	7.6	8.3	9.4	9.7	10.4	8.3	7.7	8.2	2.6	14.9	12.9	21.9	13.8	10.6	11.8	11.1	8.8	12.9	13.7	8.9	9.6	18.4	9.6	15.9	17.4	7.5	2.5	1.4	5.7	24.4	15.7	11.8	13.3	9.9	72.6	10.8	8.6	0.0	7.9	11.4	10.4	8.5	11.5	6.8	8.8	17.5	19.7	15.4	12.3	29.7	9.5	14.3	11.8	10.0	9.2	9.1	11.2	10.2	5.6	11.6	18.9	12.9	8.5	40.6	26.0	19.9	9.2	25.4	8.9	9.9
EYA4	"CMD1J, DFNA10"	ENSG00000112319	"EYA transcriptional coactivator and phosphatase 4"	O95677	6	133240598-133532120	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"DNA damage, DNA repair, Transcription, Transcription regulation"	"Activator, Chromatin regulator, Developmental protein, Hydrolase, Protein phosphatase"	"Cardiomyopathy, Deafness, Disease mutation, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"skeletal muscle: 65.6"	"Cell type enhanced"	"Detected in some"	20	"Alveolar cells type 1: 11.9;Cardiomyocytes: 13.7;Collecting duct cells: 43.6;monocytes: 12.6"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"A549: 12.7;GAMG: 13.2;HeLa: 35.6;RH-30: 12.1;U-87 MG: 12.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA004805, HPA038771, HPA038772"	Enhanced		Approved	Nucleoplasm		No	NA			Nucleoplasm		"HPA004805: AB_10669750, HPA038771: AB_10671865, HPA038772: AB_10673119"	"unprognostic (1.60e-1)"	"unprognostic (3.34e-1)"	"unprognostic (1.27e-1)"	"unprognostic (2.04e-9)"	"unprognostic (1.64e-1)"	"unprognostic (3.08e-2)"	"unprognostic (3.44e-2)"	"unprognostic (7.21e-2)"	"unprognostic (9.07e-2)"	"unprognostic (2.04e-2)"	"unprognostic (2.80e-1)"	"unprognostic (2.29e-1)"	"unprognostic (8.27e-4)"	"unprognostic (1.82e-3)"	"unprognostic (6.67e-2)"	"unprognostic (9.55e-2)"	"unprognostic (2.51e-2)"	1.6	3.0	1.2	0.2	1.3	0.1	2.4	0.4	1.2	9.7	0.6	2.5	11.1	0.4	2.6	1.9	0.7	8.3	0.7	6.2	1.5	1.2	6.1	0.4	2.0	0.2	2.1	0.8	1.6	0.4	0.2	7.2	0.2	3.5	6.6	0.4	2.7	0.8	13.9	65.6	0.4	0.5	1.9	3.5	0.6	0.7	7.4	1.4	1.8	2.5	5.5	0.7	2.6	5.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.7	1.2	0.0	0.0	0.0	0.0	0.0	10.2	0.2	1.5	0.0	0.0	0.0	10.0	0.0	13.2	0.0	7.7	3.3	0.0	0.0	10.0	1.3	35.6	0.0	0.3	0.0	3.5	2.6	0.0	7.3	2.3	1.7	0.0	0.0	0.0	5.4	4.1	0.0	0.0	0.0	0.0	0.1	0.7	0.1	12.1	0.0	0.0	1.9	1.9	2.0	0.1	0.0	5.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	9.1	3.7	1.6	0.0	12.6	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	1.3	0.4	1.2	1.5	1.2	2.1	0.8	3.5	1.4	11.9	2.6	0.0	0.1	0.1	0.0	13.7	0.0	0.0	3.4	43.6	0.0	0.0	0.0	0.1	2.7	0.0	0.0	0.0	0.2	0.0	0.7	0.1	0.0	0.0	0.0	0.0	1.7	0.6	1.3	2.0	0.6	0.0	0.0	12.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	4.6	6.6	0.0	0.0	0.0	0.0	0.1
EZH1	"KIAA0388, KMT6B"	ENSG00000108799	"Enhancer of zeste 1 polycomb repressive complex 2 subunit"	Q92800	17	42700275-42745049	"Cancer-related genes, Enzymes, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Chromatin regulator, Methyltransferase, Repressor, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	13	"Rod photoreceptor cells: 268.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"ASC diff: 32.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA005478, HPA077684"	Supported		Supported	Nucleoplasm		NA	NA			Nucleoplasm		"HPA005478: AB_1848340, HPA077684: AB_2732356"	"unprognostic (1.01e-1)"	"unprognostic (6.02e-2)"	"unprognostic (2.19e-2)"	"unprognostic (8.57e-2)"	"unprognostic (1.89e-1)"	"unprognostic (1.84e-3)"	"unprognostic (1.76e-2)"	"unprognostic (1.18e-2)"	"unprognostic (1.25e-1)"	"unprognostic (1.55e-3)"	"unprognostic (5.22e-3)"	"unprognostic (4.11e-3)"	"unprognostic (1.48e-2)"	"unprognostic (4.60e-2)"	"unprognostic (3.29e-1)"	"unprognostic (5.39e-2)"	"unprognostic (4.74e-2)"	21.7	10.4	15.0	10.1	25.0	9.9	18.7	39.6	26.1	18.4	15.1	21.4	10.0	9.7	29.8	21.2	10.6	18.8	9.7	17.2	19.0	11.2	13.6	5.3	12.6	14.0	13.7	22.0	38.2	8.1	20.0	19.1	9.3	25.6	13.1	12.1	21.5	10.7	19.3	25.4	16.0	14.0	16.4	19.9	16.0	10.6	8.6	16.7	11.9	15.0	7.5	14.9	16.0	15.9	6.2	6.0	18.8	5.4	4.8	8.3	2.3	5.5	5.8	8.0	5.5	32.1	19.4	6.8	8.9	8.2	7.4	7.6	2.7	6.9	8.4	5.6	9.4	7.3	12.6	5.2	5.9	10.7	9.3	9.3	2.9	10.8	3.3	11.0	6.2	7.0	11.1	10.8	5.6	13.6	13.0	6.0	8.5	7.6	11.9	6.5	2.3	10.1	8.0	2.2	5.1	3.0	6.6	8.2	8.9	7.7	5.9	5.5	4.4	4.9	2.4	5.9	11.9	8.5	4.0	6.2	8.0	3.3	9.3	5.6	12.5	6.3	5.0	5.7	6.5	4.0	10.2	5.2	6.9	5.9	5.4	8.3	5.7	5.2	6.0	1.9	6.2	7.7	5.7	18.8	4.8	3.3	6.0	5.7	2.3	15.0	25.0	39.6	26.1	19.0	11.2	13.7	22.0	25.6	16.7	8.9	17.3	10.7	12.1	4.6	67.2	34.7	17.8	38.8	17.0	12.2	62.8	6.1	8.3	9.2	0.4	12.2	6.7	46.7	6.4	2.6	7.5	7.2	19.7	6.7	7.7	44.5	12.5	15.4	11.6	1.1	28.7	10.6	1.7	20.8	4.2	32.0	9.4	6.0	32.2	8.1	268.1	51.8	13.3	9.3	8.8	5.4	9.0	15.9	6.8	7.6
EZH2	"ENX-1, EZH1, KMT6, KMT6A"	ENSG00000106462	"Enhancer of zeste 2 polycomb repressive complex 2 subunit"	Q15910	7	148807383-148884321	"Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Biological rhythms, Transcription, Transcription regulation"	"Chromatin regulator, Methyltransferase, Repressor, Transferase"	"Cancer-related genes, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 25.5;lymphoid tissue: 44.1"	"Cell type enhanced"	"Detected in many"	8	"Early spermatids: 72.2;Spermatocytes: 126.7;Spermatogonia: 62.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB009589	Enhanced		Supported	Nucleoplasm		NA	NA			Nucleoplasm		"CAB009589: "	"unprognostic (2.42e-1)"	"unprognostic (3.95e-3)"	"unprognostic (1.57e-1)"	"unprognostic (3.30e-3)"	"unprognostic (1.33e-1)"	"unprognostic (3.85e-3)"	"prognostic unfavorable (2.11e-6)"	"unprognostic (2.21e-2)"	"prognostic unfavorable (1.96e-4)"	"unprognostic (2.32e-3)"	"unprognostic (1.58e-3)"	"unprognostic (1.69e-3)"	"prognostic unfavorable (8.18e-12)"	"prognostic favorable (6.97e-4)"	"unprognostic (1.83e-1)"	"unprognostic (2.12e-1)"	"unprognostic (6.67e-2)"	2.0	1.7	1.8	10.6	1.6	25.5	1.4	4.9	2.7	2.6	4.8	1.1	0.1	3.8	1.7	2.8	11.0	0.9	3.0	0.9	0.8	0.6	1.7	3.3	2.3	12.6	1.3	0.3	2.2	3.8	0.6	1.7	3.4	1.4	1.4	5.1	1.8	3.2	1.6	3.7	6.4	4.8	1.5	1.2	5.8	2.7	19.6	1.3	44.1	0.9	5.5	12.4	2.6	3.5	1.5	4.7	1.3	3.9	8.5	10.3	1.7	17.0	8.0	27.3	18.2	0.8	1.4	14.9	13.3	5.4	11.0	11.1	12.0	19.7	30.2	6.5	5.0	10.0	10.5	14.0	4.6	14.0	43.2	14.0	12.9	9.9	9.3	2.2	28.6	10.6	1.2	2.6	8.2	4.4	3.3	6.4	29.3	27.3	20.1	9.8	19.3	55.6	23.9	21.7	15.0	10.8	34.4	15.3	18.7	5.1	8.2	26.1	16.6	16.7	12.7	4.4	7.3	9.3	12.3	3.9	11.7	5.4	23.3	23.8	18.0	19.6	30.4	10.7	19.6	22.9	0.5	2.2	1.3	1.7	1.5	1.3	1.5	3.4	2.9	4.7	0.8	1.9	1.2	0.2	8.5	3.9	1.0	10.3	1.7	1.8	1.6	4.9	2.7	0.8	0.6	1.3	0.3	1.4	1.3	0.0	7.9	6.7	5.7	23.6	4.8	6.5	2.5	14.7	7.9	7.0	33.4	13.6	3.3	9.1	72.2	7.1	6.7	23.3	7.4	29.5	10.8	4.4	21.8	1.3	10.4	14.3	8.6	4.3	8.9	19.2	2.8	10.9	13.5	19.0	10.2	2.0	10.1	9.3	0.7	1.0	21.1	6.5	9.9	126.7	62.4	25.3	25.5	18.7	18.6	4.0
F10		ENSG00000126218	"Coagulation factor X"	P00742	13	113122814-113149529	"Candidate cardiovascular disease genes, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted secreted proteins"	"Blood coagulation, Hemostasis"	"Hydrolase, Protease, Serine protease"	"Disease mutation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"liver: 116.7"	"Cell type enhanced"	"Detected in many"	12	"Hepatocytes: 174.9;Leydig cells: 199.9;Peritubular cells: 222.0"	"Cancer enriched"	"Detected in many"	11	"liver cancer: 95.4"	"Low region specificity"	"Detected in single"			"Cell type enhanced"	"Detected in single"		"MAIT T-cell: 1.0"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"BJ: 8.5;BJ hTERT+: 6.8;CACO-2: 7.2;fHDF/TERT166: 7.6;Hep G2: 33.5;HHSteC: 7.0;SH-SY5Y: 16.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"								"Secreted to blood"	NA	NA		16000000000				"unprognostic (4.18e-2)"	"unprognostic (1.07e-1)"	"unprognostic (7.62e-2)"	"unprognostic (9.88e-2)"	"unprognostic (9.44e-2)"	"unprognostic (1.15e-2)"	"unprognostic (4.90e-2)"	"unprognostic (1.02e-2)"	"unprognostic (2.54e-1)"	"unprognostic (1.24e-1)"	"prognostic favorable (1.82e-5)"	"unprognostic (6.39e-2)"	"prognostic unfavorable (5.14e-5)"	"unprognostic (6.60e-2)"	"unprognostic (1.21e-1)"	"unprognostic (3.87e-2)"	"unprognostic (2.23e-3)"	8.1	3.7	0.3	2.9	0.7	0.0	5.4	0.4	0.8	20.3	5.9	0.6	7.6	4.5	12.6	21.4	4.5	9.9	10.0	18.4	0.5	0.5	2.3	116.7	4.9	1.6	0.5	0.7	18.2	3.0	0.0	1.7	3.6	1.0	18.1	0.7	6.9	2.0	6.1	2.6	7.8	7.6	11.7	0.6	1.3	3.2	9.5	0.6	0.6	3.1	5.6	1.8	7.8	10.3	0.0	0.0	0.0	0.0	0.9	1.0	0.3	0.0	0.0	1.5	0.2	4.9	5.0	0.0	8.5	6.8	0.5	0.2	7.2	0.0	0.0	0.3	7.6	0.8	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	33.5	7.0	0.0	0.2	4.9	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.8	0.1	0.0	0.1	0.0	0.7	0.1	0.1	0.0	0.0	0.0	0.1	0.6	16.6	0.0	0.3	0.0	0.3	0.3	0.1	0.0	0.0	0.4	0.1	0.0	0.1	0.0	0.0	0.1	0.1	0.3	0.0	0.0	0.0	0.2	0.0	1.0	0.0	0.1	0.0	0.0	0.0	0.1	0.3	0.0	0.9	0.0	0.0	0.0	0.3	0.3	0.7	0.4	0.8	0.5	0.5	0.5	0.7	1.0	0.6	0.0	0.0	0.0	0.0	14.0	1.0	4.8	7.6	0.0	0.0	1.8	0.0	0.6	0.0	0.0	2.6	2.1	0.3	0.0	0.0	0.6	66.0	0.1	1.1	174.9	1.2	6.4	17.1	9.8	4.5	5.6	199.9	0.3	18.6	1.0	1.4	3.8	0.5	2.9	222.0	5.6	1.1	51.8	54.2	2.1	1.1	13.4	0.9	2.5	0.9	0.2
F11	FXI	ENSG00000088926	"Coagulation factor XI"	P03951	4	186265945-186288806	"Candidate cardiovascular disease genes, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Blood coagulation, Hemostasis"	"Heparin-binding, Hydrolase, Protease, Serine protease"	"Disease mutation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"liver: 88.9"	"Cell type enhanced"	"Detected in some"	27	"Alveolar cells type 2: 19.3;Distal tubular cells: 10.0;Hepatocytes: 59.9"	"Cancer enriched"	"Detected in some"	13	"liver cancer: 16.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	11	"Hep G2: 14.0"	"Not detected"	"Not detected"							HPA039808			Approved	Vesicles	"Secreted to blood"	NA	NA		4400000000	Vesicles		"HPA039808: AB_2676693"			"unprognostic (1.28e-1)"		"unprognostic (3.15e-1)"		"prognostic favorable (3.29e-5)"	"unprognostic (1.88e-1)"			"unprognostic (2.08e-1)"	"unprognostic (2.11e-1)"	"unprognostic (1.85e-3)"	"unprognostic (2.91e-2)"	"unprognostic (7.65e-2)"			0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.3	2.7	0.1	0.1	5.5	0.2	0.3	0.1	0.1	4.8	0.1	0.1	0.1	10.2	88.9	2.8	0.1	0.1	0.1	0.1	19.0	0.0	0.2	0.1	0.3	0.1	0.0	0.4	0.1	0.1	0.1	0.1	6.1	0.1	0.1	0.1	0.1	0.1	0.2	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	14.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.1	0.4	0.2	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.3	0.2	0.0	19.3	0.0	0.0	0.0	0.0	0.3	2.5	0.0	4.5	1.8	0.0	0.0	10.0	0.8	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	59.9	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	3.3	0.0	0.0	4.7	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
F12		ENSG00000131187	"Coagulation factor XII"	P00748	5	177402140-177409576	"Candidate cardiovascular disease genes, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted secreted proteins"	"Blood coagulation, Fibrinolysis, Hemostasis"	"Hydrolase, Protease, Serine protease"	"Disease mutation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	26	"liver: 180.1"	"Cell type enriched"	"Detected in many"	8	"Hepatocytes: 391.6"	"Cancer enriched"	"Detected in many"	21	"liver cancer: 171.0"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"classical monocyte: 2.5;eosinophil: 6.9"	"Group enriched"	"Detected in many"	5	"granulocytes: 6.9;monocytes: 2.5"	"Cell line enhanced"	"Detected in some"		"HDLM-2: 8.7;MCF7: 11.1;PC-3: 8.2;SH-SY5Y: 5.6;U-937: 5.8"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in some"			HPA003825	Approved				"Secreted to blood"	NA	NA	1040000	6600000000			"HPA003825: AB_1078790"	"unprognostic (9.75e-2)"	"unprognostic (1.71e-1)"	"unprognostic (2.93e-1)"	"unprognostic (4.47e-2)"	"unprognostic (1.01e-1)"	"unprognostic (2.32e-1)"	"prognostic favorable (4.63e-5)"	"unprognostic (6.97e-2)"	"unprognostic (1.26e-2)"	"unprognostic (3.96e-2)"	"unprognostic (4.41e-1)"	"unprognostic (6.54e-2)"	"prognostic unfavorable (7.09e-4)"	"unprognostic (4.11e-2)"	"unprognostic (3.69e-1)"	"unprognostic (3.40e-6)"	"unprognostic (6.48e-2)"	0.1	0.0	0.1	0.1	0.1	0.7	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.2	0.0	0.1	0.1	0.1	0.1	0.2	180.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.5	1.0	6.9	2.5	0.7	0.3	1.0	0.8	2.0	0.0	0.6	0.0	0.0	0.2	0.0	0.1	0.0	0.0	2.3	1.4	0.0	0.4	0.0	0.3	1.4	0.7	0.4	0.0	8.7	1.9	1.4	0.3	0.9	0.2	0.7	3.1	0.2	1.3	0.1	0.4	0.1	0.2	2.1	0.4	3.3	0.0	11.1	0.1	2.6	0.0	2.6	8.2	0.6	0.2	1.9	1.1	0.0	2.6	5.6	0.3	1.0	0.7	0.0	0.4	0.0	0.0	0.2	1.1	0.0	0.3	0.5	0.0	0.1	0.1	5.8	0.6	0.0	2.5	6.9	0.3	0.1	0.2	0.5	0.3	0.2	0.1	0.2	0.0	0.1	0.9	0.7	0.9	1.0	0.0	1.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	8.5	7.4	29.5	0.4	0.8	17.8	0.0	0.0	1.8	3.9	0.0	0.0	6.1	19.4	0.7	34.8	0.0	3.5	0.2	0.9	2.0	0.0	391.6	0.5	0.0	9.9	17.8	13.2	32.7	0.6	1.8	8.5	1.0	5.5	0.2	9.4	20.1	0.0	9.1	0.5	0.0	0.7	13.0	12.8	47.4	0.1	0.7	30.8	5.8
F13A1	F13A	ENSG00000124491	"Coagulation factor XIII A chain"	P00488	6	6144085-6321013	"Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Blood coagulation, Hemostasis"	"Acyltransferase, Transferase"	"Cancer-related genes, Disease mutation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"placenta: 110.1"	"Cell type enriched"	"Detected in many"	6	"Hofbauer cells: 646.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"classical monocyte: 27.6;myeloid DC: 33.7"	"Group enriched"	"Detected in many"	5	"dendritic cells: 33.7;monocytes: 27.6"	"Cell line enhanced"	"Detected in some"		"AF22: 15.7;LHCN-M2: 5.8;RH-30: 29.5"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"HPA001804, CAB002155"	Enhanced				"Secreted to blood"	NA	NA		1400000000			"CAB002155: AB_564077, HPA001804: AB_1078792"	"unprognostic (4.44e-1)"	"unprognostic (5.90e-2)"	"unprognostic (2.65e-2)"	"unprognostic (3.93e-2)"	"unprognostic (5.02e-2)"	"unprognostic (3.75e-2)"	"unprognostic (5.27e-2)"	"unprognostic (1.96e-1)"	"unprognostic (2.68e-2)"	"unprognostic (6.84e-3)"	"unprognostic (4.96e-2)"	"unprognostic (1.97e-1)"	"prognostic unfavorable (6.61e-6)"	"unprognostic (2.79e-2)"	"unprognostic (1.52e-1)"	"unprognostic (1.57e-1)"	"unprognostic (2.54e-3)"	56.6	19.4	2.2	11.4	6.5	3.1	57.9	2.2	1.8	13.3	21.8	2.6	2.5	2.2	4.7	35.6	13.4	16.8	12.6	55.4	2.0	2.2	17.5	1.3	14.5	52.7	5.8	1.4	10.2	8.9	5.3	9.3	110.1	7.5	16.4	15.1	11.6	11.5	3.3	18.5	10.4	10.6	20.1	5.0	5.1	11.5	16.7	2.5	2.7	22.4	8.3	6.1	23.7	6.5	0.0	33.7	6.6	27.6	0.0	0.1	63.5	0.0	0.0	15.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	5.8	0.0	0.0	0.1	0.0	0.0	0.0	0.0	29.5	0.5	0.0	0.0	0.2	0.2	0.1	0.0	0.0	0.1	0.0	2.6	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	5.7	27.6	0.2	0.1	4.9	0.1	0.0	0.0	0.0	33.7	0.0	0.0	0.0	6.6	0.0	0.1	2.4	0.0	63.5	2.2	6.5	2.2	1.8	2.0	2.2	5.8	1.4	7.5	2.5	0.0	3.4	0.8	0.0	16.7	0.0	7.5	10.2	4.0	0.0	0.0	0.0	4.0	0.0	0.0	3.8	4.7	0.0	0.0	0.0	3.4	16.5	0.0	1.1	0.8	646.4	0.0	0.0	4.3	113.2	4.2	4.0	57.6	18.6	1.0	0.0	0.7	0.1	0.0	0.7	3.1	4.1	58.2	9.2	1.4	1.0	13.2	8.5	0.0	0.0	0.0
F2		ENSG00000180210	"Coagulation factor II, thrombin"	P00734	11	46719180-46739506	"Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Acute phase, Blood coagulation, Hemostasis"	"Hydrolase, Protease, Serine protease"	"Cancer-related genes, Disease mutation, FDA approved drug targets, Thrombophilia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	593	"liver: 324.8"	"Cell type enriched"	"Detected in some"	37	"Hepatocytes: 904.6"	"Cancer enriched"	"Detected in some"	110	"liver cancer: 508.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	21	"Hep G2: 78.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"CAB016780, HPA051476, HPA054698"	Enhanced				"Secreted to blood"	NA	NA	108000000000	43000000000			"CAB016780: , HPA051476: AB_2681498, HPA054698: AB_2682578"	"unprognostic (1.98e-1)"	"unprognostic (2.52e-1)"	"unprognostic (2.64e-2)"	"unprognostic (1.85e-1)"	"unprognostic (2.29e-1)"	"unprognostic (2.81e-1)"	"unprognostic (2.23e-2)"	"unprognostic (3.94e-2)"		"unprognostic (5.79e-2)"	"unprognostic (8.29e-2)"	"unprognostic (4.46e-2)"	"prognostic unfavorable (6.75e-12)"	"unprognostic (5.65e-3)"	"unprognostic (5.80e-2)"		"unprognostic (1.54e-3)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	324.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.1	0.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.7	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	78.4	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.5	0.0	0.5	0.0	0.1	0.4	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.0	0.0	0.0	0.0	0.6	22.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	904.6	0.0	0.0	0.0	24.5	19.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0
F7		ENSG00000057593	"Coagulation factor VII"	P08709	13	113105788-113120681	"Candidate cardiovascular disease genes, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted secreted proteins"	"Blood coagulation, Hemostasis"	"Hydrolase, Protease, Serine protease"	"Disease mutation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	39	"liver: 68.0"	"Cell type enriched"	"Detected in some"	6	"Hepatocytes: 131.2"	"Cancer enriched"	"Detected in some"	17	"liver cancer: 41.4"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	15	"gdT-cell: 1.7;MAIT T-cell: 1.2;memory CD8 T-cell: 1.6"	"Lineage enriched"	"Detected in single"	17	"T-cells: 1.7"	"Group enriched"	"Detected in some"	9	"CACO-2: 16.6;Hep G2: 10.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA004826			Approved	Mitochondria	"Secreted to blood"	NA	NA	351000000	1500000000	Mitochondria		"HPA004826: AB_10602805"	"unprognostic (2.06e-1)"	"unprognostic (2.55e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.34e-1)"	"unprognostic (3.27e-1)"	"unprognostic (1.91e-1)"	"unprognostic (1.50e-3)"	"unprognostic (3.81e-1)"	"unprognostic (4.36e-3)"	"unprognostic (1.16e-1)"	"unprognostic (4.19e-3)"	"unprognostic (1.15e-1)"	"unprognostic (1.35e-3)"	"unprognostic (3.36e-3)"	"unprognostic (1.09e-1)"	"unprognostic (2.86e-1)"	"unprognostic (1.47e-1)"	0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.2	0.4	0.2	0.1	0.1	0.1	0.3	0.1	0.2	0.1	0.2	0.1	0.1	0.1	0.1	0.1	68.0	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.3	0.1	0.1	0.1	0.0	0.4	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	1.7	0.1	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	16.6	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	10.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.7	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.2	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.7	0.0	1.2	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.2	0.4	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	2.4	0.0	0.0	0.6	0.4	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	23.3	0.2	0.0	0.5	0.0	0.0	131.2	0.1	0.0	0.0	3.7	3.1	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.1	0.1	0.0	0.1	0.1	0.9	0.1	0.1	0.5	0.0	0.0
F9	FIX	ENSG00000101981	"Coagulation factor IX"	P00740	X	139530758-139563458	"Candidate cardiovascular disease genes, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted secreted proteins"	"Blood coagulation, Hemostasis"	"Hydrolase, Protease, Serine protease"	"Disease mutation, FDA approved drug targets, Hemophilia, Thrombophilia"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	2334	"liver: 233.6"	"Cell type enriched"	"Detected in some"	20	"Hepatocytes: 475.1"	"Cancer enriched"	"Detected in single"	1354	"liver cancer: 67.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HL-60: 1.8;RH-30: 2.0;SiHa: 1.6;U-698: 1.1"	"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"								"Secreted to blood"	NA	NA		11000000000										"prognostic favorable (6.69e-4)"											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	233.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	1.8	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	1.6	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.3	0.0	1.1	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.0	0.0	0.0	0.0	0.2	17.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	23.3	0.0	0.0	0.0	0.0	0.0	475.1	0.0	0.0	0.0	15.4	17.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
FAAH	FAAH-1	ENSG00000117480	"Fatty acid amide hydrolase"	O00519	1	46394265-46413848	"Enzymes, Predicted membrane proteins"	"Lipid degradation, Lipid metabolism"	Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Enterocytes: 68.0;Late spermatids: 88.3;Spermatocytes: 73.1"	"Cancer enhanced"	"Detected in all"		"prostate cancer: 68.2"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"eosinophil: 19.1"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"BEWO: 22.2;OE19: 10.7;RT4: 23.9;SK-BR-3: 12.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA007425	Approved		Approved	Cytosol		NA	NA			Cytosol		"HPA007425: AB_1078820"	"unprognostic (6.12e-2)"	"unprognostic (2.04e-1)"	"unprognostic (2.51e-2)"	"prognostic favorable (1.51e-4)"	"unprognostic (1.72e-1)"	"unprognostic (4.97e-2)"	"unprognostic (2.00e-1)"	"unprognostic (6.64e-3)"	"unprognostic (2.91e-2)"	"unprognostic (2.33e-1)"	"unprognostic (4.39e-3)"	"unprognostic (9.86e-2)"	"prognostic favorable (4.25e-5)"	"prognostic favorable (3.63e-5)"	"unprognostic (2.66e-1)"	"unprognostic (9.97e-2)"	"unprognostic (5.00e-3)"	6.1	7.7	11.2	2.5	22.0	7.9	7.9	20.4	21.9	6.9	15.0	40.7	10.1	18.0	3.1	8.2	4.9	10.6	4.6	2.9	14.7	11.7	12.0	18.3	6.7	2.1	19.1	19.3	2.7	18.2	15.1	10.6	3.5	17.6	33.3	12.8	7.4	12.8	8.6	7.1	10.1	17.8	2.3	23.6	2.0	14.3	30.9	18.8	5.6	24.9	3.5	3.5	5.7	4.2	0.1	6.0	19.1	4.7	0.3	0.4	0.9	2.8	0.7	0.4	0.5	0.7	0.5	22.2	0.6	0.3	0.3	0.5	4.1	6.6	0.2	2.3	0.4	0.2	9.4	0.4	1.3	0.1	1.2	3.1	0.0	0.1	1.9	0.5	0.8	1.6	0.4	6.4	0.2	0.8	0.2	0.0	0.5	0.1	0.5	0.0	5.9	0.4	1.2	1.8	10.7	0.2	0.5	0.2	0.1	5.2	23.9	2.8	2.1	3.2	12.4	0.1	0.6	8.5	8.2	0.0	0.0	0.3	0.6	0.4	1.2	0.5	0.3	0.1	7.6	0.2	0.0	4.7	19.1	0.3	1.2	0.1	0.0	0.3	0.1	5.7	0.1	0.4	0.4	0.2	0.3	0.6	6.0	0.1	0.9	11.2	22.0	20.4	21.9	14.7	11.7	19.1	19.3	17.6	18.8	20.8	10.4	4.2	27.1	4.6	12.6	2.2	25.5	4.0	10.3	21.0	41.2	14.4	0.0	12.8	35.5	1.8	68.0	0.0	5.6	6.3	2.4	27.0	0.0	29.2	2.6	1.6	14.9	0.6	3.2	88.3	6.9	2.9	5.0	0.0	33.1	6.3	5.0	40.4	4.2	19.5	11.4	0.0	2.7	73.1	7.7	5.3	10.4	0.0	48.5	12.3
FAAH2	"AMDD, FAAH-2, FLJ31204, RP11-479E16.1"	ENSG00000165591	"Fatty acid amide hydrolase 2"	Q6GMR7	X	57286706-57489196	"Enzymes, Predicted intracellular proteins"	"Lipid degradation, Lipid metabolism"	Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"pancreas: 43.6;pituitary gland: 42.8"	"Cell type enhanced"	"Detected in many"	5	"Ciliated cells: 24.1"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in many"	8	"cerebellum: 18.0"	"Cell type enhanced"	"Detected in many"		"T-reg: 13.6"	"Lineage enriched"	"Detected in many"	8	"T-cells: 13.6"	"Cell line enhanced"	"Detected in many"		"CAPAN-2: 10.7;HDLM-2: 9.6;RPMI-8226: 19.4;U-266/70: 16.3;U-266/84: 8.3"															NA	NA						"unprognostic (1.37e-1)"	"unprognostic (1.78e-2)"	"unprognostic (7.68e-2)"	"unprognostic (2.29e-2)"	"unprognostic (1.02e-1)"	"unprognostic (4.51e-2)"	"unprognostic (7.93e-3)"	"unprognostic (4.47e-2)"	"unprognostic (1.94e-1)"	"prognostic favorable (5.99e-4)"	"unprognostic (1.77e-1)"	"unprognostic (2.03e-1)"	"prognostic favorable (2.47e-13)"	"unprognostic (9.16e-3)"	"unprognostic (2.27e-1)"	"prognostic favorable (2.66e-4)"	"prognostic favorable (6.83e-5)"	1.0	1.4	1.0	6.8	1.5	0.0	6.7	18.0	1.0	3.5	3.9	0.2	3.8	2.6	1.4	4.7	5.5	5.8	2.4	0.6	1.2	2.3	9.7	20.1	3.5	5.7	1.1	0.5	1.9	43.6	12.7	42.8	1.4	1.8	9.3	3.6	3.8	9.1	5.3	0.3	10.0	6.4	0.6	1.1	2.3	4.1	0.6	0.3	8.5	15.3	2.7	11.0	3.0	3.6	1.8	1.0	0.3	0.0	0.7	13.6	1.5	2.5	0.2	0.0	0.1	0.1	0.1	2.4	0.0	0.0	0.0	0.0	1.8	10.7	0.1	3.1	0.0	0.0	0.4	0.8	1.9	0.0	9.6	5.2	0.3	2.5	0.7	0.0	1.1	0.0	0.0	3.2	0.0	0.0	0.1	0.0	1.0	1.2	4.8	0.0	1.0	0.5	0.0	1.8	2.2	0.0	0.0	1.8	19.4	6.3	3.4	1.8	0.1	0.1	3.0	0.0	4.6	3.0	0.0	0.0	0.0	0.2	0.0	0.1	16.3	8.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.7	0.0	4.7	1.8	7.7	3.2	0.0	0.6	7.5	0.9	0.3	0.7	0.0	1.0	13.6	1.5	1.0	1.5	18.0	1.0	1.2	2.3	1.1	0.5	1.8	0.3	3.0	5.6	0.0	11.2	2.4	3.1	0.3	2.5	24.1	6.8	5.2	17.7	4.4	8.3	8.3	0.0	0.0	3.9	0.0	12.2	2.1	0.5	10.4	0.0	9.0	0.6	1.6	12.7	0.6	0.0	0.0	0.6	0.0	3.3	1.0	5.6	1.2	11.6	3.4	0.4	4.5	12.2	0.0	0.1	0.0	0.0	5.8	4.7	2.5	4.7	9.0
FADS2	"D6D, DES6, FADSD6, LLCDL2, SLL0262, TU13"	ENSG00000134824	"Fatty acid desaturase 2"	O95864	11	61792980-61867354	"Enzymes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Electron transport, Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism, Transport"	Oxidoreductase	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"ductus deferens: 204.5;seminal vesicle: 98.8"	"Cell type enhanced"	"Detected in many"	5	"monocytes: 34.3;Muller glia cells: 29.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"ASC TERT1: 151.3;HBEC3-KT: 90.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA006741	Approved					NA	NA					"HPA006741: AB_1078796"	"unprognostic (2.37e-2)"	"unprognostic (1.02e-1)"	"unprognostic (8.34e-2)"	"unprognostic (4.33e-3)"	"unprognostic (4.63e-2)"	"unprognostic (2.42e-2)"	"unprognostic (4.51e-2)"	"unprognostic (4.35e-3)"	"unprognostic (2.01e-1)"	"unprognostic (4.21e-2)"	"unprognostic (8.95e-3)"	"unprognostic (7.80e-2)"	"prognostic unfavorable (1.00e-7)"	"unprognostic (6.19e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.41e-2)"	"prognostic unfavorable (3.42e-4)"	7.1	85.9	34.3	10.0	31.7	7.5	20.2	10.1	48.5	23.7	4.9	28.6	204.5	9.3	19.9	10.3	3.2	8.9	6.6	8.2	24.4	29.9	3.8	38.0	9.7	6.7	28.1	20.1	8.6	3.1	41.5	11.8	12.8	26.4	32.0	4.3	16.7	5.0	98.8	3.0	26.1	3.6	39.3	17.9	3.3	3.6	10.4	24.0	8.4	2.5	3.2	9.2	10.6	6.5	3.5	13.3	6.9	9.0	6.3	9.4	3.8	1.4	53.2	79.1	43.7	72.0	151.3	20.6	8.9	80.5	13.1	35.8	3.3	17.8	0.3	1.2	19.6	19.9	1.5	51.7	90.4	5.6	0.6	1.1	30.2	10.6	7.8	56.8	1.8	1.7	56.8	2.7	47.6	4.3	19.6	38.7	28.4	1.7	24.5	6.0	1.3	17.0	10.0	34.5	0.0	14.0	23.0	1.4	74.4	52.0	0.4	23.5	28.6	5.8	0.1	2.3	19.5	2.2	22.3	15.6	1.4	14.2	0.9	1.2	11.4	10.0	4.0	1.4	10.1	16.0	4.5	5.7	6.9	9.4	9.0	2.2	1.6	3.5	5.0	10.5	3.5	2.0	4.4	3.1	6.3	7.5	13.3	3.0	3.8	34.3	31.7	10.1	25.2	24.4	29.9	28.1	20.1	26.4	24.0	8.9	13.1	0.0	1.0	1.4	6.9	3.6	2.5	0.0	6.8	3.5	3.9	1.6	0.0	5.8	1.5	2.9	0.0	0.0	15.7	18.4	8.5	18.5	4.7	12.9	16.1	4.8	5.2	3.1	3.2	3.5	23.9	3.8	8.5	34.3	0.0	29.9	4.9	0.0	22.3	0.2	13.0	0.0	10.8	0.9	0.5	0.5	2.6	4.4	0.6	0.7
FAH		ENSG00000103876	"Fumarylacetoacetate hydrolase"	P16930	15	80152490-80186946	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Phenylalanine catabolism, Tyrosine catabolism"	Hydrolase	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 109.4"	"Group enriched"	"Detected in many"	4	"Hepatocytes: 250.1;Hofbauer cells: 63.7;Proximal tubular cells: 236.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HHSteC: 76.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA041370, HPA044093"	Enhanced		Approved	Nucleoplasm,Cytosol		NA	NA		230000000	Cytosol	Nucleoplasm	"HPA041370: AB_2677438, HPA044093: AB_2678806"	"unprognostic (3.15e-1)"	"unprognostic (5.65e-2)"	"unprognostic (1.64e-1)"	"unprognostic (6.16e-2)"	"unprognostic (2.33e-3)"	"prognostic unfavorable (8.51e-4)"	"unprognostic (1.19e-2)"	"unprognostic (5.83e-2)"	"unprognostic (2.51e-2)"	"unprognostic (5.21e-2)"	"unprognostic (1.80e-1)"	"unprognostic (1.23e-1)"	"unprognostic (2.17e-2)"	"unprognostic (4.21e-2)"	"unprognostic (2.99e-1)"	"unprognostic (2.93e-1)"	"unprognostic (8.98e-2)"	32.1	17.8	4.6	6.1	3.6	4.7	22.8	2.3	3.3	4.7	8.6	3.1	8.3	4.1	5.1	14.8	4.4	6.8	7.1	6.8	4.1	2.8	18.9	109.4	7.9	6.2	4.0	2.1	7.2	6.5	4.8	4.4	2.3	3.5	4.9	3.4	2.4	5.3	5.4	7.7	2.4	7.6	4.4	5.9	6.0	3.3	9.7	3.0	2.3	4.2	4.9	3.9	4.1	6.1	0.1	16.0	16.9	11.7	3.6	5.8	6.1	4.5	7.6	3.1	3.9	14.7	15.1	7.8	5.8	13.3	6.2	5.3	4.6	8.4	0.0	9.6	12.2	8.6	6.7	11.2	13.9	6.0	2.9	6.3	38.8	4.5	23.8	76.6	18.3	21.5	26.1	8.6	5.3	9.6	20.3	8.6	8.9	16.2	8.3	11.5	6.9	5.0	9.1	2.2	3.5	8.7	2.8	4.5	29.1	17.8	5.5	0.1	1.9	6.5	18.0	18.2	5.3	13.7	12.5	29.9	11.3	7.1	6.0	9.8	7.6	15.5	3.1	23.5	42.9	6.3	16.9	11.7	1.9	5.8	4.9	1.5	0.1	1.6	3.9	16.0	0.0	2.0	1.8	0.7	3.6	4.8	1.2	1.5	6.1	4.6	3.6	2.3	3.3	4.1	2.8	4.0	2.1	3.5	3.0	3.0	14.4	5.2	13.1	6.1	0.4	12.0	10.2	5.3	4.5	31.4	0.0	32.5	44.7	8.5	6.3	2.5	15.8	23.3	3.1	9.0	17.2	8.6	42.5	250.1	63.7	0.0	4.1	11.1	20.0	10.6	9.2	23.1	18.6	3.6	11.8	3.5	4.6	14.4	7.4	236.8	0.3	0.0	8.1	1.5	2.1	5.0	18.4	8.7	22.4	12.8
FAHD1	"C16orf36, DKFZP566J2046"	ENSG00000180185	"Fumarylacetoacetate hydrolase domain containing 1"	Q6P587	16	1826941-1840207	"Enzymes, Predicted intracellular proteins"		"Hydrolase, Lyase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	7	"Proximal tubular cells: 175.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB025530, HPA043226, HPA043534"	Enhanced		Enhanced	Nucleoplasm,Mitochondria		NA	NA			Mitochondria	Nucleoplasm	"CAB025530: , HPA043226: AB_2678370, HPA043534: AB_2678535"	"unprognostic (3.71e-1)"	"unprognostic (1.25e-2)"	"prognostic favorable (8.27e-4)"	"unprognostic (1.99e-1)"	"unprognostic (6.74e-2)"	"unprognostic (1.01e-3)"	"unprognostic (2.89e-2)"	"unprognostic (4.32e-1)"	"unprognostic (1.13e-1)"	"unprognostic (5.36e-2)"	"unprognostic (1.65e-1)"	"unprognostic (1.38e-1)"	"prognostic favorable (2.80e-14)"	"unprognostic (1.02e-1)"	"unprognostic (1.66e-1)"	"unprognostic (1.26e-1)"	"unprognostic (3.31e-2)"	10.4	17.0	10.4	6.7	9.9	6.5	9.2	8.6	12.7	6.8	21.7	9.3	8.2	26.7	9.8	10.9	14.8	5.8	10.2	15.8	10.9	11.4	46.8	43.6	5.6	5.2	10.1	9.4	7.9	17.4	9.0	11.1	10.4	9.9	8.1	11.1	8.5	9.1	9.8	20.2	12.4	24.8	6.9	8.8	6.3	14.9	6.9	9.5	4.7	12.5	19.0	5.7	9.9	7.9	18.5	23.1	8.6	27.5	19.6	16.0	13.7	8.4	19.1	9.1	16.1	12.1	8.8	5.7	13.9	6.9	9.3	10.2	12.2	8.8	5.4	11.7	8.6	14.4	17.4	7.1	11.2	8.4	8.2	16.9	4.8	16.5	28.1	11.8	8.3	9.4	11.6	14.7	8.5	5.7	7.9	12.1	6.6	5.0	5.7	11.6	38.7	4.5	12.6	5.4	7.8	14.3	10.4	12.4	15.2	33.4	10.6	17.8	14.8	18.2	14.7	21.8	6.4	21.5	5.7	17.6	15.3	10.9	9.0	7.5	8.2	17.2	6.4	9.7	6.1	6.5	6.5	23.5	8.6	14.4	27.5	13.0	18.5	14.5	15.7	23.1	16.9	16.0	14.9	2.0	19.6	19.1	17.9	14.7	13.7	10.4	9.9	8.6	12.7	10.9	11.4	10.1	9.4	9.9	9.5	23.8	16.0	12.3	12.4	12.5	20.0	37.0	22.9	17.4	17.0	40.1	25.5	18.6	43.1	43.5	88.6	14.7	72.1	23.3	34.0	12.3	14.7	9.4	4.7	30.5	26.4	17.5	28.2	8.0	8.1	38.9	13.6	18.2	15.1	23.4	22.1	16.9	34.9	30.9	14.5	175.3	22.4	12.9	14.1	7.0	8.3	21.0	12.8	10.7	41.2	8.1
FAM105A	"FLJ11127, NET20"	ENSG00000145569	"Family with sequence similarity 105 member A"	Q9NUU6	5	14581775-14615007	"Enzymes, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 35.4"	"Cell type enhanced"	"Detected in many"	6	"Alveolar cells type 1: 89.3;Hofbauer cells: 83.6;Intestinal endocrine cells: 59.1;Kupffer cells: 69.4;Spermatogonia: 57.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HeLa: 14.0;HMC-1: 44.0;OE19: 12.3;THP-1: 12.2;U-937: 20.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA046638	Uncertain		Approved	Nucleoli,Cytosol		NA	NA			"Nucleoli, Cytosol"		"HPA046638: AB_2679731"	"unprognostic (1.47e-1)"	"unprognostic (6.64e-3)"	"unprognostic (1.92e-2)"	"unprognostic (1.15e-3)"	"unprognostic (6.26e-2)"	"unprognostic (1.13e-3)"	"unprognostic (2.33e-2)"	"unprognostic (2.27e-2)"	"unprognostic (6.44e-2)"	"unprognostic (2.42e-1)"	"prognostic favorable (1.02e-4)"	"unprognostic (2.13e-1)"	"unprognostic (1.33e-2)"	"unprognostic (2.38e-2)"	"prognostic unfavorable (7.62e-4)"	"unprognostic (3.14e-1)"	"unprognostic (8.79e-3)"	5.1	3.5	4.0	7.9	4.9	35.4	5.2	3.1	5.1	6.3	15.4	9.0	4.5	8.3	3.0	5.6	2.9	3.1	4.1	3.0	3.9	4.3	5.2	1.9	28.8	16.7	6.1	3.8	4.0	13.3	1.9	8.7	6.7	7.9	12.6	17.3	10.3	3.1	13.5	1.3	2.6	13.7	3.3	10.8	13.2	5.4	4.4	4.1	3.5	27.2	3.0	6.2	7.1	5.8	0.1	26.7	6.9	26.2	14.1	9.6	16.2	0.0	0.6	1.2	0.0	0.2	0.0	5.3	1.5	1.4	0.4	0.7	1.9	1.4	0.0	0.8	0.7	2.2	0.1	2.6	1.2	0.6	0.8	3.6	3.4	14.0	0.3	1.3	0.0	44.0	0.1	0.3	0.2	0.0	0.0	0.0	2.2	0.0	5.5	0.1	1.1	0.0	1.2	1.9	12.3	9.4	0.4	0.5	1.6	0.0	10.5	4.6	5.1	0.7	0.5	0.0	1.3	0.5	12.2	0.0	0.6	3.4	0.2	1.1	0.0	0.0	0.0	0.8	20.8	0.2	0.0	26.2	0.1	4.5	12.4	6.0	0.1	5.7	6.1	26.7	0.1	7.8	7.5	6.9	14.1	9.4	19.7	9.6	16.2	4.0	4.9	3.1	5.1	3.9	4.3	6.1	3.8	7.9	4.1	89.3	8.2	0.9	4.4	7.4	0.7	0.0	2.5	0.0	3.4	0.0	0.0	0.7	0.0	0.0	1.1	6.3	22.2	0.0	0.0	1.5	5.9	7.8	49.6	0.2	83.6	0.0	59.1	4.3	69.4	2.0	4.0	37.7	11.8	0.0	39.6	2.5	0.0	37.1	3.2	0.0	0.9	0.0	3.8	20.5	57.7	5.9	1.1	30.5	41.5	2.7
FAM20C	"DKFZp547D065, DMP4, G-CK, IMAGE:4942737"	ENSG00000177706	"FAM20C, golgi associated secretory pathway kinase"	Q8IXL6	7	192969-260745	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted secreted proteins"	Biomineralization	"Kinase, Serine/threonine-protein kinase, Transferase"	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"salivary gland: 80.6"	"Cell type enhanced"	"Detected in many"	7	"Collecting duct cells: 52.4;Hepatocytes: 80.0;Hofbauer cells: 49.0;Peritubular cells: 53.0;Proximal tubular cells: 46.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"classical monocyte: 1.6"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"HSkMC: 50.3;hTERT-RPE1: 39.1;U-87 MG: 31.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA019823			Approved	"Nucleoplasm,Golgi apparatus"	"Secreted in other tissues"	NA	NA		160000000	"Golgi apparatus"	Nucleoplasm	"HPA019823: AB_1848389"	"unprognostic (1.94e-1)"	"prognostic unfavorable (8.89e-4)"	"unprognostic (3.15e-2)"	"unprognostic (1.03e-2)"	"unprognostic (3.33e-3)"	"unprognostic (2.47e-2)"	"unprognostic (7.86e-2)"	"unprognostic (2.45e-3)"	"unprognostic (3.35e-2)"	"prognostic unfavorable (9.40e-6)"	"unprognostic (1.97e-3)"	"unprognostic (2.49e-1)"	"unprognostic (3.08e-3)"	"unprognostic (1.94e-2)"	"unprognostic (3.92e-2)"	"unprognostic (2.16e-2)"	"unprognostic (3.83e-3)"	27.5	10.2	10.8	19.3	16.6	3.3	25.6	7.4	14.9	8.3	20.1	13.5	15.1	12.9	9.5	6.9	11.1	9.7	15.0	15.0	8.8	7.2	31.8	31.6	12.7	5.1	16.9	5.6	11.8	14.8	2.6	9.2	7.2	15.8	15.0	4.6	8.8	80.6	11.8	20.4	6.8	16.5	17.0	17.0	6.9	20.0	5.9	14.8	0.4	9.6	8.4	4.4	20.5	17.5	0.0	0.6	0.0	1.6	0.2	0.0	0.0	13.3	6.5	0.2	9.3	11.9	19.7	0.0	11.9	20.2	6.5	5.2	0.7	8.2	0.0	6.6	17.8	8.8	11.6	1.0	0.5	1.6	2.8	0.6	0.0	3.1	3.5	9.0	0.0	0.9	50.3	1.5	0.2	0.7	39.1	4.5	0.0	0.0	0.1	1.7	1.8	0.0	0.7	6.3	0.1	0.4	1.5	0.3	0.0	4.8	0.0	3.1	0.1	12.4	0.0	1.8	1.2	8.8	6.1	12.5	8.1	4.0	6.9	3.6	0.0	0.0	0.0	31.0	0.8	23.1	0.0	1.6	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	10.8	16.6	7.4	14.9	8.8	7.2	16.9	5.6	15.8	14.8	6.0	3.2	2.4	1.9	9.0	20.6	8.1	33.1	5.3	0.0	52.4	0.0	0.5	5.0	1.3	0.0	2.4	3.5	0.0	4.1	0.6	13.5	6.8	3.5	80.0	49.0	1.6	11.3	9.8	15.6	1.1	15.0	14.7	1.7	11.8	4.2	16.6	6.5	3.5	53.0	46.8	8.0	12.9	15.3	0.2	0.7	7.0	0.5	0.0	7.3	1.4
FAM213B	"C1orf93, MGC26818"	ENSG00000157870	"Family with sequence similarity 213 member B"	Q8TBF2	1	2586491-2591469	"Enzymes, Predicted intracellular proteins"	"Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism, Prostaglandin biosynthesis, Prostaglandin metabolism"	Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"SK-BR-3: 26.7;U-2197: 22.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA006403	Approved	Approved	Approved	Nucleoplasm,Cytosol		NA	NA			Cytosol	Nucleoplasm	"HPA006403: AB_1853870"	"unprognostic (1.81e-2)"	"unprognostic (2.25e-1)"	"unprognostic (2.03e-1)"	"unprognostic (2.83e-1)"	"unprognostic (1.32e-1)"	"unprognostic (1.52e-1)"	"prognostic unfavorable (1.62e-4)"	"unprognostic (1.20e-1)"	"unprognostic (8.76e-2)"	"unprognostic (3.09e-2)"	"unprognostic (1.24e-3)"	"unprognostic (2.76e-1)"	"prognostic favorable (1.28e-4)"	"unprognostic (5.22e-3)"	"unprognostic (2.03e-1)"	"unprognostic (7.91e-3)"	"unprognostic (2.20e-2)"	6.0	9.1	14.7	5.7	14.9	3.8	4.6	7.4	20.0	7.9	15.4	6.2	5.2	22.0	4.5	6.7	5.7	10.5	23.7	3.2	15.0	15.5	7.4	3.5	6.0	5.8	11.7	11.0	7.1	4.6	4.4	4.3	8.4	10.7	5.7	7.4	9.0	5.3	7.7	1.8	6.1	20.2	4.8	6.5	7.4	11.7	3.3	4.7	5.4	5.2	0.9	5.2	6.3	3.5	2.1	2.2	1.5	2.3	7.5	6.3	3.2	7.7	4.3	4.4	4.8	2.1	2.4	0.6	7.0	2.9	6.6	2.9	3.1	9.1	2.0	7.1	4.5	2.7	6.5	3.9	4.9	2.2	5.8	2.0	4.8	3.3	4.9	5.1	2.7	1.4	3.5	2.5	4.6	1.7	3.1	9.3	3.6	6.5	3.1	6.6	5.6	6.3	1.2	5.3	9.0	16.6	6.9	6.5	5.1	6.9	3.9	5.9	9.8	6.0	26.7	8.0	1.1	4.6	1.0	13.5	5.8	6.7	22.9	2.6	2.9	4.3	1.4	5.4	9.2	1.1	1.5	2.0	1.1	3.8	2.3	6.3	2.1	4.2	4.1	2.2	1.5	3.5	5.4	1.5	7.5	2.0	1.0	5.6	3.2	14.7	14.9	7.4	20.0	15.0	15.5	11.7	11.0	10.7	4.7	3.0	1.7	3.9	4.5	3.7	11.0	4.5	12.7	10.7	6.8	33.2	0.0	0.4	6.6	24.6	0.6	11.6	37.6	0.0	8.8	0.4	4.0	3.7	0.0	2.6	8.0	22.3	15.1	12.3	4.9	1.1	4.9	7.6	6.8	8.2	25.7	6.0	31.4	38.2	3.9	11.8	5.2	19.4	8.1	0.9	11.1	4.5	0.6	6.9	32.8	7.0
FAN1	"KIAA1018, MTMR15"	ENSG00000198690	"FANCD2 and FANCI associated nuclease 1"	Q9Y2M0	15	30903852-30943108	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"DNA damage, DNA repair"	"Endonuclease, Exonuclease, Hydrolase, Nuclease"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA048198			Supported	"Nucleoplasm,Cytokinetic bridge,Cytosol"		NA	NA			Nucleoplasm	"Cytokinetic bridge, Cytosol"	"HPA048198: AB_2680311"	"unprognostic (7.18e-3)"	"unprognostic (5.63e-2)"	"unprognostic (1.96e-1)"	"unprognostic (3.30e-2)"	"unprognostic (6.99e-2)"	"unprognostic (2.86e-1)"	"unprognostic (1.97e-1)"	"unprognostic (1.19e-1)"	"unprognostic (5.94e-2)"	"unprognostic (3.53e-2)"	"unprognostic (3.53e-2)"	"unprognostic (9.67e-2)"	"prognostic favorable (1.42e-6)"	"unprognostic (3.73e-1)"	"unprognostic (1.19e-1)"	"unprognostic (8.93e-3)"	"unprognostic (1.29e-1)"	5.9	8.9	11.6	6.9	17.4	6.3	12.7	19.6	18.4	15.0	11.4	17.7	11.9	4.6	11.6	22.9	6.5	8.5	8.5	13.0	12.6	11.0	14.7	14.4	6.9	5.5	18.5	11.8	12.5	18.2	7.2	17.0	10.6	15.4	16.4	9.7	8.6	17.3	8.3	16.8	9.3	6.7	11.5	13.0	7.3	8.5	9.4	15.0	5.1	14.3	6.3	5.8	9.0	9.1	4.0	3.6	0.6	1.7	4.5	5.4	1.6	6.3	10.9	3.6	2.0	12.9	11.5	2.4	4.5	1.9	4.8	5.0	7.5	3.3	1.4	8.0	4.8	10.0	12.9	6.1	9.4	4.7	5.1	2.9	1.1	11.2	1.3	5.6	0.9	6.1	3.4	7.0	2.9	7.6	10.4	2.3	6.6	5.4	10.0	7.8	1.4	9.9	4.4	2.8	10.2	2.5	8.4	11.8	2.7	7.0	5.0	8.3	5.8	9.9	6.8	3.5	13.6	6.1	7.6	8.2	15.0	3.6	4.1	5.7	13.8	9.6	1.7	6.5	4.8	1.3	0.1	0.8	0.6	3.7	1.3	4.7	2.8	3.5	1.7	2.7	4.0	5.4	2.8	0.3	4.5	1.7	3.6	3.2	1.6	11.6	17.4	19.6	18.4	12.6	11.0	18.5	11.8	15.4	15.0	14.9	9.6	0.8	4.9	3.7	20.0	15.7	0.0	16.0	13.6	8.7	19.6	5.5	8.3	3.3	8.7	6.7	3.8	0.0	2.5	1.8	3.5	4.6	8.1	11.0	3.2	25.4	7.5	8.0	4.1	5.8	9.8	4.1	5.0	2.8	9.7	14.7	3.3	2.9	6.3	5.1	24.3	6.5	4.2	19.5	12.9	2.0	3.4	6.9	8.3	3.1
FANCL	"FAAP43, FLJ10335, PHF9, Pog"	ENSG00000115392	"Fanconi anemia complementation group L"	Q9NW38	2	58159243-58241372	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"DNA damage, DNA repair, Ubl conjugation pathway"	Transferase	"Fanconi anemia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"pituitary gland: 62.5"	"Cell type enhanced"	"Detected in many"	4	"Spermatocytes: 47.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB033842, HPA036685, HPA036686"	Supported		Approved	"Nuclear bodies,Vesicles"		NA	Yes			"Nuclear bodies"	Vesicles	"CAB033842: AB_1122766, HPA036685: AB_10672474, HPA036686: AB_10670844"	"unprognostic (3.02e-1)"	"unprognostic (5.52e-2)"	"unprognostic (2.19e-1)"	"unprognostic (2.02e-3)"	"unprognostic (6.24e-2)"	"unprognostic (2.92e-2)"	"prognostic unfavorable (2.81e-7)"	"unprognostic (4.71e-2)"	"unprognostic (2.63e-2)"	"unprognostic (1.31e-2)"	"unprognostic (3.50e-1)"	"unprognostic (1.17e-2)"	"prognostic unfavorable (1.12e-7)"	"unprognostic (1.50e-1)"	"unprognostic (1.39e-1)"	"unprognostic (9.08e-3)"	"prognostic favorable (7.80e-5)"	6.3	29.2	16.0	11.2	22.9	10.6	16.2	7.1	18.1	11.6	9.6	30.7	7.9	9.2	16.6	15.7	8.6	11.7	9.8	10.2	17.0	23.5	7.1	16.7	7.7	10.9	25.0	15.2	21.3	10.8	16.8	62.5	10.0	33.5	11.6	12.4	13.7	14.8	9.1	6.5	14.4	10.1	11.3	23.4	12.0	10.5	14.7	28.2	8.6	14.2	6.9	12.0	10.1	12.7	10.8	7.1	5.6	6.9	8.8	5.5	2.7	18.5	13.5	27.6	13.5	4.9	6.5	14.7	13.6	8.5	13.5	17.6	11.9	23.3	12.8	17.7	4.4	18.6	10.8	15.3	10.3	22.6	30.1	24.2	21.0	19.0	16.1	5.3	20.2	11.6	4.8	4.9	9.9	3.9	12.0	10.6	9.2	19.5	11.7	9.2	9.4	7.1	25.1	29.8	29.7	2.8	13.5	21.0	10.0	11.8	18.3	31.3	15.7	19.4	8.0	12.7	15.5	7.4	13.6	6.2	12.1	18.2	8.8	15.0	12.1	7.6	7.5	25.7	13.7	18.3	2.7	3.7	5.6	4.9	6.9	3.8	10.8	4.1	5.4	7.1	10.0	1.4	3.1	1.1	8.8	4.9	6.5	5.5	2.7	16.0	22.9	7.1	18.1	17.0	23.5	25.0	15.2	33.5	28.2	17.9	18.3	5.8	13.7	9.2	12.4	13.2	5.1	20.1	10.3	8.7	3.9	25.0	10.0	6.9	1.7	10.5	7.3	0.0	3.6	12.2	8.9	6.8	10.4	10.4	9.4	7.9	8.6	10.4	8.5	1.7	10.0	6.9	25.3	9.0	16.3	20.3	4.6	13.1	13.4	4.1	18.8	12.9	8.1	47.7	30.4	5.9	6.2	5.0	13.6	5.9
FANCM	"FAAP250, KIAA1596"	ENSG00000187790	"Fanconi anemia complementation group M"	Q8IYD8	14	45135940-45200890	"Enzymes, Predicted intracellular proteins"	"DNA damage, DNA repair"	"DNA-binding, Helicase, Hydrolase"	"Disease mutation, Premature ovarian failure"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"Early spermatids: 55.9;Late spermatids: 151.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA055144			Supported	Nucleoplasm		NA	NA			Nucleoplasm		"HPA055144: AB_2682715"	"unprognostic (8.40e-2)"	"unprognostic (6.70e-2)"	"unprognostic (3.99e-2)"	"unprognostic (4.32e-2)"	"unprognostic (2.15e-1)"	"unprognostic (2.31e-3)"	"unprognostic (2.66e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.57e-2)"	"unprognostic (8.52e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.23e-2)"	"unprognostic (7.55e-2)"	"unprognostic (2.90e-1)"	"unprognostic (1.71e-1)"	"unprognostic (8.94e-2)"	"unprognostic (1.13e-2)"	4.7	3.9	3.9	4.4	8.4	9.8	5.7	8.2	7.9	5.7	3.5	4.9	4.9	2.6	6.7	4.8	4.5	4.2	3.7	3.8	3.4	3.3	4.1	3.1	3.3	6.6	3.2	3.6	6.2	3.3	4.5	4.5	4.4	9.3	3.5	3.8	4.8	4.1	4.8	4.2	5.2	3.5	3.8	3.4	8.9	3.2	15.4	4.2	15.2	3.3	2.9	6.4	3.8	4.3	6.7	3.2	7.6	3.6	2.0	4.1	1.1	7.8	6.8	8.1	7.5	6.4	4.0	6.5	10.3	4.0	8.1	10.5	11.0	6.0	10.3	5.9	2.4	4.6	10.6	9.5	4.4	11.1	7.5	5.2	4.7	7.7	6.0	1.2	12.3	6.1	2.3	1.6	8.1	5.1	1.8	6.9	6.7	8.5	9.1	6.7	7.8	9.0	8.8	3.2	6.0	11.5	8.4	12.6	4.7	3.3	5.6	7.4	1.9	9.1	7.5	3.8	5.4	8.0	5.7	5.4	11.8	11.1	10.8	7.7	4.6	8.3	10.3	2.3	7.6	7.0	7.6	1.3	4.6	4.0	3.6	2.2	6.7	2.5	1.5	1.0	4.2	4.1	3.5	2.1	2.0	1.7	3.2	1.7	1.1	3.9	8.4	8.2	7.9	3.4	3.3	3.2	3.6	9.3	4.2	0.0	1.9	1.5	1.2	2.4	5.2	6.7	2.5	0.0	3.4	1.8	2.0	6.7	0.0	1.6	55.9	2.7	1.0	0.0	2.3	2.8	2.3	0.8	1.1	1.7	3.0	3.2	0.0	5.5	3.7	151.5	8.3	2.7	3.3	4.6	1.6	4.4	1.5	0.0	4.9	1.5	6.1	6.5	4.1	23.6	14.4	1.6	1.9	3.3	2.6	0.3
FAP	DPPIV	ENSG00000078098	"Fibroblast activation protein alpha"	Q12884	2	162170684-162245151	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Angiogenesis, Apoptosis, Cell adhesion"	"Hydrolase, Protease, Serine protease"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"endometrium 1: 30.0"	"Group enriched"	"Detected in many"	6	"Fibroblasts: 25.9;Muller glia cells: 68.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC diff: 45.4;ASC TERT1: 48.2;BJ hTERT+: 38.0;hTERT-RPE1: 48.7;U-138 MG: 38.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			HPA059739	Uncertain				"Secreted to blood"	NA	NA		34000000			"HPA059739: AB_2684117"	"unprognostic (7.48e-3)"	"unprognostic (7.87e-3)"	"unprognostic (4.10e-2)"	"unprognostic (5.04e-2)"	"unprognostic (1.49e-2)"	"prognostic unfavorable (4.82e-4)"	"unprognostic (2.01e-2)"	"unprognostic (1.05e-2)"	"unprognostic (3.30e-2)"	"unprognostic (4.89e-2)"	"unprognostic (4.59e-2)"	"unprognostic (3.52e-1)"	"unprognostic (7.32e-11)"	"unprognostic (1.72e-3)"	"unprognostic (9.84e-3)"	"unprognostic (7.97e-2)"	"unprognostic (4.49e-3)"	19.8	0.7	2.6	3.2	1.2	0.0	7.5	0.6	3.7	17.6	4.5	0.4	4.0	0.1	30.0	13.7	4.1	5.1	14.9	5.2	3.1	0.9	2.0	0.9	4.7	0.8	2.6	1.2	4.1	2.3	0.5	1.0	17.0	1.9	4.1	1.5	2.4	5.3	3.9	8.1	2.9	1.4	17.9	2.2	0.9	1.7	9.8	3.4	0.0	3.5	9.0	0.8	12.4	4.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	45.4	48.2	0.0	18.5	38.0	3.9	5.9	0.0	0.0	0.0	0.1	7.0	0.0	0.0	0.0	1.2	1.9	0.0	0.0	0.0	0.2	0.0	4.6	0.0	0.0	15.5	0.2	6.4	1.2	48.7	0.0	0.0	0.0	0.0	12.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.9	0.0	1.9	0.0	0.0	0.0	19.0	38.7	0.7	9.4	0.0	0.0	0.0	0.0	8.7	0.0	10.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	1.2	0.6	3.7	3.1	0.9	2.6	1.2	1.9	3.4	0.0	0.0	0.0	0.1	3.9	0.7	0.3	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.2	3.9	2.9	0.0	0.0	0.2	1.6	25.9	0.1	0.0	0.0	0.8	1.6	4.7	2.5	0.0	2.3	7.8	0.3	3.3	0.0	0.0	68.0	1.6	0.0	0.0	0.6	1.5	0.0	1.4	0.2	0.0	3.8	1.5	0.0	0.0	0.0
FAR1	"FLJ22728, MLSTD2, SDR10E1"	ENSG00000197601	"Fatty acyl-CoA reductase 1"	Q8WVX9	11	13668670-13732346	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Lipid biosynthesis, Lipid metabolism"	Oxidoreductase	"Cataract, Disease mutation, Epilepsy, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	4	"Late spermatids: 125.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA017322	Approved		Supported	Peroxisomes		NA	NA			Peroxisomes		"HPA017322: AB_1848424"	"unprognostic (3.96e-2)"	"unprognostic (1.92e-1)"	"prognostic favorable (2.27e-4)"	"unprognostic (1.38e-1)"	"unprognostic (1.34e-1)"	"unprognostic (4.62e-2)"	"unprognostic (3.66e-1)"	"unprognostic (3.30e-1)"	"unprognostic (2.79e-1)"	"unprognostic (3.60e-2)"	"unprognostic (2.59e-2)"	"unprognostic (1.84e-2)"	"unprognostic (2.97e-2)"	"unprognostic (2.52e-1)"	"unprognostic (2.22e-1)"	"unprognostic (2.22e-1)"	"unprognostic (2.37e-3)"	16.3	11.1	19.0	14.2	28.2	42.7	13.7	24.4	24.0	17.3	20.9	33.8	11.1	24.7	17.4	17.1	38.1	12.7	9.2	13.9	20.4	16.1	9.7	3.3	13.9	12.2	32.8	24.0	16.7	15.8	25.1	16.5	15.8	30.0	14.1	25.1	10.0	14.6	10.9	11.4	8.0	13.4	20.2	47.8	13.9	39.4	12.8	32.2	13.2	13.2	17.2	15.0	16.7	22.1	2.8	15.8	21.8	13.7	5.0	4.5	4.0	27.0	17.7	17.5	13.6	16.8	19.4	9.6	24.2	9.7	17.9	19.1	18.5	23.4	34.8	10.9	19.3	26.7	29.6	25.8	24.5	27.6	10.2	21.0	14.9	16.1	0.1	16.2	29.8	12.1	14.7	25.3	12.9	38.9	13.3	17.5	17.7	23.2	10.4	14.7	13.7	22.0	9.0	9.1	34.5	25.7	19.5	22.4	9.7	17.3	44.0	13.5	9.8	22.9	21.9	11.9	21.1	13.4	18.7	21.7	24.8	21.1	22.7	20.2	5.8	19.8	29.5	15.7	9.1	14.9	4.6	13.7	15.0	4.5	11.9	3.1	2.1	2.2	3.8	15.8	2.8	2.0	3.4	21.8	5.0	9.4	2.4	2.8	4.0	19.0	28.2	24.4	24.0	20.4	16.1	32.8	24.0	30.0	32.2	32.8	19.7	8.2	20.6	28.6	44.7	23.2	5.1	9.4	21.6	21.0	39.3	21.4	5.0	12.6	98.3	26.3	45.7	23.3	22.2	15.2	24.6	24.0	38.1	1.6	29.3	44.5	34.5	35.0	52.6	125.1	24.7	35.6	33.7	16.2	26.0	22.1	23.3	37.4	24.1	7.0	50.8	25.8	27.8	36.7	26.8	17.3	8.2	16.6	38.8	32.4
FAR2	"FLJ10462, MLSTD1, SDR10E2"	ENSG00000064763	"Fatty acyl-CoA reductase 2"	Q96K12	12	29149103-29340980	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Lipid biosynthesis, Lipid metabolism"	Oxidoreductase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	5	"Syncytiotrophoblasts: 162.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"eosinophil: 23.7"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HEL: 26.3;HUVEC TERT2: 30.8;NB-4: 26.4;SK-BR-3: 32.5;TIME: 25.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA015884	Approved		Approved	"Nucleoli,Golgi apparatus"		NA	NA			"Golgi apparatus"	Nucleoli	"HPA015884: AB_1853998"	"unprognostic (6.32e-2)"	"unprognostic (2.40e-2)"	"unprognostic (1.50e-3)"	"unprognostic (3.33e-3)"	"unprognostic (2.41e-1)"	"unprognostic (4.13e-3)"	"unprognostic (4.30e-2)"	"unprognostic (1.18e-1)"	"unprognostic (3.11e-2)"	"unprognostic (6.37e-2)"	"unprognostic (5.70e-3)"	"unprognostic (1.92e-1)"	"prognostic unfavorable (4.93e-4)"	"unprognostic (2.10e-1)"	"unprognostic (2.23e-1)"	"unprognostic (1.33e-1)"	"unprognostic (5.22e-3)"	9.4	7.2	9.8	6.9	17.4	12.0	7.6	5.1	18.2	4.6	25.7	3.2	6.1	13.3	6.2	29.4	6.0	3.7	4.2	5.4	12.8	10.9	4.0	3.1	8.6	6.7	9.4	10.4	2.1	2.6	1.0	2.9	19.2	6.6	2.8	22.3	4.1	4.8	1.7	4.5	8.7	14.0	6.0	5.1	12.3	3.7	8.4	5.9	7.2	3.5	4.5	2.3	6.6	4.3	0.9	4.0	23.7	11.5	1.8	7.6	4.4	0.9	1.8	1.8	0.4	2.6	10.1	0.8	7.6	9.0	2.1	2.0	3.0	10.3	1.3	2.0	1.0	1.5	0.5	4.7	0.0	0.5	0.6	11.8	26.3	4.2	0.9	5.4	10.5	8.8	2.8	0.0	3.2	4.1	5.4	30.8	1.0	2.3	1.0	0.3	0.3	6.7	26.4	7.1	0.5	20.1	5.6	2.9	1.1	9.5	2.6	3.1	2.8	1.7	32.5	12.9	3.8	1.5	9.9	25.0	5.7	1.7	2.0	3.3	1.6	1.7	0.6	9.1	13.8	4.9	1.3	11.5	23.7	2.7	6.9	1.8	0.9	4.5	3.2	4.0	0.7	1.5	1.7	20.7	1.8	3.7	1.5	7.6	4.4	9.8	17.4	5.1	18.2	12.8	10.9	9.4	10.4	6.6	5.9	0.0	3.5	0.0	0.1	1.1	1.9	8.7	0.0	4.0	2.3	0.0	0.0	14.0	0.0	0.0	16.3	11.1	22.3	0.0	0.2	16.9	4.3	0.4	10.4	0.0	16.4	4.8	6.9	3.7	19.8	4.2	1.1	7.2	15.1	1.0	19.9	0.4	1.9	31.9	0.4	0.3	1.1	0.0	3.3	0.2	0.9	0.3	162.1	4.4	19.4	0.1
FARS2	"dJ236A3.1, FARS1"	ENSG00000145982	"Phenylalanyl-tRNA synthetase 2, mitochondrial"	O95363	6	5261044-5771580	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Protein biosynthesis"	"Aminoacyl-tRNA synthetase, Ligase"	"Disease mutation, Hereditary spastic paraplegia, Neurodegeneration, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Early spermatids: 61.5;Late spermatids: 54.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA018148, HPA028836"	Approved					NA	NA					"HPA018148: AB_1848426, HPA028836: AB_10601377"	"unprognostic (2.73e-1)"	"unprognostic (4.08e-3)"	"prognostic favorable (5.14e-4)"	"unprognostic (2.68e-1)"	"unprognostic (1.94e-2)"	"unprognostic (5.34e-3)"	"unprognostic (1.82e-1)"	"unprognostic (4.31e-3)"	"unprognostic (7.18e-2)"	"unprognostic (1.02e-2)"	"unprognostic (8.91e-2)"	"unprognostic (2.50e-1)"	"prognostic favorable (1.24e-6)"	"unprognostic (2.81e-2)"	"unprognostic (2.83e-1)"	"unprognostic (2.02e-2)"	"unprognostic (1.57e-1)"	14.2	19.0	10.6	16.5	14.5	13.2	14.8	16.5	18.8	14.7	13.5	16.4	13.4	9.6	15.3	12.7	13.7	19.8	11.6	19.0	10.5	9.0	18.4	18.5	13.0	21.8	8.9	15.0	11.7	14.0	18.9	29.2	11.4	10.6	12.2	15.2	19.3	15.3	13.5	22.8	15.4	13.0	13.2	8.5	15.0	13.9	15.4	11.0	20.6	19.7	16.0	22.0	13.1	12.9	13.9	16.8	3.2	10.3	14.9	17.5	10.9	8.3	8.1	8.7	9.3	10.8	13.0	7.2	9.3	10.9	12.0	11.9	10.9	6.5	11.8	14.4	8.9	11.7	8.4	11.1	14.9	12.6	35.2	7.4	4.7	7.2	9.4	5.6	11.3	7.0	10.3	14.7	13.8	9.8	7.1	14.5	13.4	13.9	2.7	8.8	8.6	12.0	12.5	5.3	13.0	7.8	12.0	10.8	23.2	11.5	10.0	14.9	7.5	8.5	6.8	10.4	11.9	13.6	12.3	8.2	13.2	6.0	7.6	11.8	5.7	19.7	6.4	7.2	6.7	16.2	0.1	9.4	3.2	15.6	10.3	13.9	13.9	14.1	14.5	16.8	11.3	15.6	15.5	0.7	14.9	7.3	9.9	17.5	10.9	10.6	14.5	16.5	18.8	10.5	9.0	8.9	15.0	10.6	11.0	8.9	13.6	6.7	13.6	13.2	8.5	15.7	10.2	24.1	2.3	8.7	2.0	16.3	23.2	12.0	61.5	10.7	6.2	0.0	11.4	17.4	9.5	7.3	21.9	10.6	13.8	0.0	10.3	10.4	15.2	54.1	5.8	10.0	5.0	10.0	8.1	11.3	7.1	10.5	6.7	25.4	9.3	0.0	7.3	7.9	9.1	11.5	8.9	20.1	10.8	9.7
FARSA	"CML33, FARSL, FARSLA"	ENSG00000179115	"Phenylalanyl-tRNA synthetase alpha subunit"	Q9Y285	19	12922479-12934037	"Enzymes, Predicted intracellular proteins"	"Protein biosynthesis"	"Aminoacyl-tRNA synthetase, Ligase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA001911	Enhanced		Approved	Cytosol		NA	NA		11000	Cytosol		"HPA001911: AB_1848427"	"unprognostic (1.52e-1)"	"prognostic favorable (8.23e-4)"	"unprognostic (2.71e-1)"	"prognostic unfavorable (9.22e-4)"	"unprognostic (1.16e-2)"	"unprognostic (1.28e-1)"	"unprognostic (4.93e-3)"	"unprognostic (5.76e-2)"	"unprognostic (2.86e-1)"	"unprognostic (1.24e-1)"	"unprognostic (1.21e-1)"	"unprognostic (1.45e-2)"	"unprognostic (1.45e-3)"	"prognostic favorable (8.32e-4)"	"unprognostic (2.59e-1)"	"unprognostic (8.25e-2)"	"unprognostic (1.84e-2)"	18.0	20.7	24.8	23.6	29.5	23.5	15.4	24.6	49.2	17.7	24.0	18.3	14.9	22.1	16.1	13.1	26.6	21.2	16.3	24.9	23.9	30.1	23.0	39.6	13.4	27.6	25.6	28.1	19.1	26.7	17.8	21.0	22.9	29.1	18.5	15.0	14.8	25.1	20.4	33.3	27.8	18.8	15.3	17.2	21.2	18.9	17.1	18.6	32.7	24.4	15.2	22.0	19.5	15.2	34.7	42.2	28.9	41.2	38.3	40.2	39.7	29.1	27.6	11.1	23.9	7.7	7.3	20.0	21.0	13.6	30.1	23.7	33.8	12.4	32.3	33.8	11.8	12.2	22.4	27.0	24.0	11.0	18.9	40.7	25.3	24.3	26.7	25.0	48.8	33.4	10.0	17.7	23.2	18.7	9.9	16.3	32.9	38.2	6.8	12.6	39.2	57.9	60.7	34.6	18.1	46.9	30.0	11.5	41.4	15.8	17.2	34.8	31.9	14.1	24.4	14.9	5.4	19.2	29.7	15.6	24.5	10.8	37.2	39.0	45.2	38.5	33.6	22.2	44.1	25.3	17.3	39.2	28.9	32.5	41.2	40.2	31.9	32.0	30.2	42.2	34.7	32.9	31.2	2.5	38.3	30.4	34.1	29.4	39.7	24.8	29.5	24.6	49.2	23.9	30.1	25.6	28.1	29.1	18.6	8.9	21.3	25.9	20.3	22.6	23.5	22.1	2.5	13.4	13.6	22.7	9.8	74.5	49.7	50.2	3.9	18.0	20.6	23.3	40.4	65.4	18.4	19.3	23.1	22.9	56.1	17.5	21.9	17.2	26.9	7.5	17.5	19.2	32.1	52.3	22.0	19.4	40.6	24.6	12.4	43.4	13.0	6.5	20.6	14.6	41.5	25.7	80.9	27.7	31.6	19.5
FARSB	"FARSLB, FRSB, PheHB"	ENSG00000116120	"Phenylalanyl-tRNA synthetase beta subunit"	Q9NSD9	2	222570536-222656337	"Enzymes, Predicted intracellular proteins"	"Protein biosynthesis"	"Aminoacyl-tRNA synthetase, Ligase"	"Disease mutation, Mental retardation, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA036677, HPA036678, HPA061398"	Enhanced		Supported	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA036677: AB_2675242, HPA036678: AB_10673504, HPA061398: AB_2684504"	"unprognostic (9.95e-3)"	"unprognostic (1.86e-3)"	"unprognostic (7.02e-2)"	"unprognostic (7.42e-3)"	"unprognostic (1.90e-1)"	"unprognostic (1.15e-1)"	"prognostic unfavorable (6.45e-10)"	"unprognostic (8.89e-3)"	"unprognostic (4.51e-2)"	"unprognostic (3.63e-2)"	"unprognostic (5.25e-3)"	"unprognostic (6.25e-2)"	"prognostic unfavorable (3.21e-5)"	"unprognostic (1.36e-1)"	"unprognostic (4.38e-2)"	"unprognostic (2.10e-1)"	"prognostic unfavorable (1.25e-4)"	15.7	10.8	11.9	12.6	23.5	11.5	16.0	15.1	28.5	11.6	17.3	13.7	5.9	15.9	14.2	11.7	19.1	10.8	7.2	13.4	13.7	15.1	11.7	18.3	9.0	12.0	11.6	18.0	16.7	18.6	15.0	15.7	8.8	29.4	11.2	20.7	9.6	12.3	11.5	33.2	14.1	11.5	14.9	9.7	10.3	13.9	15.6	11.2	15.6	11.9	17.1	14.2	11.8	12.0	16.3	16.0	1.2	11.4	18.5	20.0	14.6	22.2	13.1	15.3	20.0	14.0	20.1	23.6	22.7	14.4	22.5	18.4	33.2	12.3	10.9	17.3	16.6	18.7	18.8	29.4	25.5	33.1	16.3	15.2	25.1	14.8	21.1	21.8	36.5	10.4	13.4	20.0	25.6	39.4	8.0	21.2	19.3	37.7	22.6	27.3	20.8	21.8	20.7	19.5	26.9	16.4	21.5	36.8	35.4	18.4	14.6	24.8	8.1	9.5	16.7	19.6	19.5	15.5	15.4	11.5	19.3	15.9	27.6	27.4	10.8	10.8	39.9	15.0	24.6	20.1	0.2	8.5	1.2	11.4	10.3	16.8	16.3	15.4	14.0	16.0	14.0	20.0	17.2	0.9	18.5	11.4	8.0	13.3	14.6	11.9	23.5	15.1	28.5	13.7	15.1	11.6	18.0	29.4	11.2	6.0	5.4	20.0	16.1	11.0	15.1	26.0	2.5	16.0	10.3	21.0	3.9	30.6	29.9	19.9	43.7	9.9	12.3	0.0	26.1	35.9	12.8	11.4	4.7	16.2	24.6	3.2	20.1	7.4	9.7	57.3	14.1	10.8	6.8	9.0	19.0	9.8	18.6	7.0	18.7	20.7	17.1	6.5	16.5	59.3	37.3	12.4	18.5	13.3	40.3	12.0
FASN	"FAS, SDR27X1"	ENSG00000169710	"Fatty acid synthase"	P49327	17	82078333-82098332	"Cancer-related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"	"Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism"	"Hydrolase, Lyase, Multifunctional enzyme, Oxidoreductase, Transferase"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adipose tissue: 147.6"	"Cell type enhanced"	"Detected in many"	9	"Alveolar cells type 2: 103.0;Hepatocytes: 169.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"SK-BR-3: 155.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB005192, HPA006461, CAB015417, HPA056108"	Enhanced		Enhanced	"Plasma membrane,Cytosol"		No	No		1600000	"Plasma membrane, Cytosol"		"CAB005192: AB_2101095, CAB015417: AB_2231427, HPA006461: AB_1848437, HPA056108: AB_2683039"	"unprognostic (3.35e-2)"	"prognostic unfavorable (1.42e-5)"	"unprognostic (9.69e-3)"	"unprognostic (4.09e-2)"	"unprognostic (3.46e-3)"	"unprognostic (1.55e-2)"	"unprognostic (3.09e-2)"	"unprognostic (4.74e-3)"	"unprognostic (3.15e-1)"	"unprognostic (3.15e-1)"	"unprognostic (2.87e-3)"	"unprognostic (1.05e-1)"	"prognostic unfavorable (7.16e-5)"	"unprognostic (4.50e-2)"	"unprognostic (9.62e-2)"	"unprognostic (1.35e-2)"	"unprognostic (7.03e-3)"	147.6	7.8	8.2	14.2	11.5	11.1	57.5	19.1	23.0	6.6	27.7	17.0	14.1	8.2	4.7	14.2	17.1	4.3	19.4	6.3	7.9	6.7	3.7	30.8	26.8	9.8	7.3	11.5	6.4	10.4	6.7	15.3	8.4	21.7	28.8	3.4	7.6	16.9	10.8	7.5	17.2	6.5	4.6	8.4	5.1	11.9	6.6	8.8	1.9	5.1	10.7	5.4	8.0	6.6	0.5	1.4	0.0	0.8	0.2	1.9	0.8	23.6	24.8	11.5	7.9	18.7	12.7	24.7	4.7	6.1	5.0	9.2	25.9	16.1	7.9	3.9	3.6	14.0	19.7	11.1	21.7	0.9	3.7	48.3	16.3	18.5	34.6	5.3	8.8	2.5	12.1	5.7	12.7	3.0	1.7	5.6	7.4	24.6	7.0	1.7	40.9	9.5	14.0	22.4	3.7	14.4	8.5	6.5	15.6	5.6	30.3	28.7	16.0	6.9	155.8	12.6	4.4	27.8	16.8	9.7	7.3	15.1	6.0	11.3	9.5	2.1	8.1	4.4	9.6	10.8	0.0	0.8	0.0	1.2	0.5	0.7	0.5	1.9	1.4	1.4	0.2	0.7	0.6	0.0	0.2	0.4	1.1	0.6	0.8	8.2	11.5	19.1	23.0	7.9	6.7	7.3	11.5	21.7	8.8	23.8	103.0	0.8	10.3	6.9	24.9	4.8	25.5	6.7	10.3	10.4	5.9	28.9	3.3	18.9	1.2	4.5	20.8	23.3	24.9	65.8	10.4	65.5	12.7	169.2	11.7	28.6	17.4	11.1	6.9	1.3	15.3	5.0	16.9	8.2	18.9	12.3	16.1	17.5	10.6	5.5	9.5	0.0	9.6	1.9	13.9	12.0	24.7	10.7	18.3	17.5
FASTK	FAST	ENSG00000164896	"Fas activated serine/threonine kinase"	Q14296	7	151076593-151080866	"Enzymes, Predicted intracellular proteins"	Apoptosis	"Kinase, RNA-binding, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 89.5"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031621, CAB032539"	Approved		Supported	"Nuclear speckles,Mitochondria"		NA	NA			Mitochondria	"Nuclear speckles"	"CAB032539: AB_2101115, HPA031621: AB_10611966"	"unprognostic (7.67e-2)"	"unprognostic (6.41e-3)"	"prognostic unfavorable (4.73e-4)"	"unprognostic (2.60e-1)"	"unprognostic (1.75e-3)"	"unprognostic (2.03e-3)"	"unprognostic (1.14e-3)"	"unprognostic (1.01e-1)"	"unprognostic (1.24e-1)"	"unprognostic (4.66e-2)"	"prognostic favorable (3.99e-4)"	"unprognostic (3.49e-2)"	"unprognostic (2.79e-2)"	"unprognostic (4.12e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.09e-1)"	"unprognostic (8.17e-2)"	13.8	16.8	18.8	15.7	19.0	6.4	10.2	19.0	26.4	18.0	20.6	13.4	20.3	21.2	12.4	14.6	20.3	16.7	16.8	35.7	17.6	12.9	17.7	25.6	9.5	10.4	12.0	15.0	14.4	20.7	20.2	21.8	18.5	12.0	16.8	10.6	14.0	21.7	17.9	89.5	14.4	25.8	11.3	9.2	14.9	14.8	10.6	10.9	11.2	16.8	28.1	16.9	17.4	11.8	15.4	26.0	19.7	22.3	13.1	19.0	14.5	15.9	18.6	5.9	14.2	22.1	10.0	9.9	12.8	17.4	10.9	13.1	12.8	13.7	3.8	17.5	17.3	20.1	10.3	5.7	15.3	2.9	10.9	10.2	4.6	4.6	10.8	28.1	3.2	10.5	13.0	22.5	12.6	9.3	8.9	12.8	9.5	6.8	8.0	12.6	31.9	7.8	9.2	9.9	19.8	21.8	5.2	7.1	11.8	14.8	10.9	7.1	7.4	16.9	26.2	17.0	5.3	14.1	12.7	10.4	13.9	3.0	13.0	11.3	21.4	13.0	2.4	27.7	7.2	15.9	10.5	22.3	19.7	16.4	21.7	17.1	13.7	17.3	16.9	19.4	15.4	19.0	16.3	4.8	13.1	20.8	26.0	18.7	14.5	18.8	19.0	19.0	26.4	17.6	12.9	12.0	15.0	12.0	10.9	0.0	6.5	32.8	35.2	21.9	39.2	16.5	28.1	2.7	12.5	24.4	23.6	42.5	72.9	43.5	7.1	22.2	63.6	0.0	41.8	23.0	34.8	27.1	39.1	31.6	38.4	35.0	43.1	22.7	26.6	11.6	33.6	25.5	89.4	34.3	42.5	51.0	35.5	39.6	32.2	50.2	48.9	12.9	27.8	47.1	68.2	22.1	50.6	38.4	50.8	26.7
FBP1	FBP	ENSG00000165140	"Fructose-bisphosphatase 1"	P09467	9	94603133-94640249	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Carbohydrate metabolism, Gluconeogenesis"	"Allosteric enzyme, Hydrolase"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 248.1;lung: 87.8"	"Cell type enhanced"	"Detected in many"	13	"Hepatocytes: 322.6;Proximal tubular cells: 631.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"Cell type enhanced"	"Detected in many"		"eosinophil: 73.5"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"HaCaT: 20.5;MCF7: 64.2;RT4: 42.1;SK-BR-3: 12.3;U-698: 30.5"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"HPA005857, HPA012513, CAB033869"	Enhanced		Approved	Mitochondria		NA	NA		23000000	Mitochondria		"CAB033869: AB_1121520, HPA005857: AB_1848445, HPA012513: AB_1848446"	"unprognostic (4.95e-2)"	"unprognostic (1.40e-2)"	"unprognostic (1.40e-1)"	"prognostic favorable (5.16e-4)"	"unprognostic (1.13e-2)"	"unprognostic (1.37e-1)"	"prognostic favorable (1.79e-4)"	"unprognostic (6.94e-3)"	"unprognostic (4.52e-2)"	"unprognostic (7.79e-2)"	"unprognostic (7.59e-2)"	"unprognostic (1.12e-1)"	"prognostic favorable (6.86e-7)"	"unprognostic (6.91e-2)"	"unprognostic (3.22e-2)"	"unprognostic (1.07e-1)"	"prognostic favorable (1.64e-5)"	19.3	5.8	0.6	2.3	0.9	1.1	7.0	0.4	0.8	2.2	48.8	0.7	17.6	40.7	0.6	2.5	0.7	0.9	9.7	1.3	0.8	0.5	34.6	248.1	87.8	8.9	0.9	0.7	1.0	8.1	17.1	1.9	1.0	1.0	6.4	3.0	1.5	9.1	17.7	0.5	1.7	60.4	3.1	1.2	2.8	10.4	1.0	0.8	0.5	4.3	1.0	1.1	22.4	9.6	0.6	17.1	73.5	30.7	2.8	3.3	5.2	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	1.0	0.0	0.0	0.1	0.0	20.5	0.0	0.0	0.0	0.0	0.0	0.1	0.8	0.2	0.0	0.3	5.2	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	64.2	0.0	1.1	0.2	10.4	2.3	0.0	0.2	0.4	0.0	42.1	0.2	1.2	0.1	12.3	0.0	0.2	7.3	1.8	0.0	0.0	0.2	0.2	0.0	0.0	0.2	30.5	0.0	0.3	0.0	10.6	13.0	73.5	1.5	30.7	2.3	0.6	0.9	0.9	17.1	0.6	3.3	1.6	2.3	2.8	16.3	6.1	0.4	5.2	0.6	0.9	0.4	0.8	0.8	0.5	0.9	0.7	1.0	0.8	71.5	142.5	10.2	6.5	0.7	0.0	0.6	107.0	13.4	68.2	59.3	0.0	9.7	94.5	14.4	0.0	1.8	32.6	23.3	56.4	1.6	1.7	17.4	45.2	322.6	187.5	0.0	30.7	11.1	49.8	0.8	1.4	103.2	11.8	0.0	49.9	2.1	23.8	68.4	3.9	631.0	0.0	6.5	1.2	0.6	0.1	0.9	8.5	13.1	59.5	51.2
FBP2		ENSG00000130957	"Fructose-bisphosphatase 2"	O00757	9	94558720-94593793	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Carbohydrate metabolism, Gluconeogenesis"	"Allosteric enzyme, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	8	"brain: 33.7;skeletal muscle: 134.7;tongue: 45.6"	"Cell type enhanced"	"Detected in some"	29	"Exocrine glandular cells: 1.2;Spermatogonia: 3.8"	"Low cancer specificity"	"Detected in some"			"Region enriched"	"Detected in single"	36	"pons and medulla: 33.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 7.1;CACO-2: 3.6;HMC-1: 4.0;MCF7: 5.3;OE19: 5.0;PC-3: 3.7;SiHa: 4.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA012513, HPA077371"	Enhanced		Approved	"Plasma membrane,Cytosol"		NA	NA			"Plasma membrane, Cytosol"		"HPA012513: AB_1848446, HPA077371: "	"unprognostic (3.88e-2)"	"unprognostic (3.54e-4)"	"unprognostic (2.38e-1)"	"unprognostic (6.03e-2)"		"unprognostic (2.21e-1)"	"unprognostic (1.54e-2)"	"unprognostic (9.40e-4)"	"unprognostic (3.95e-3)"	"unprognostic (5.11e-2)"	"unprognostic (2.39e-2)"	"unprognostic (4.69e-2)"	"unprognostic (2.53e-1)"	"unprognostic (1.36e-2)"	"unprognostic (2.03e-1)"		"unprognostic (1.48e-4)"	2.0	0.4	0.1	0.0	0.1	0.0	0.2	0.1	0.9	0.1	0.1	3.8	4.4	1.0	0.1	1.0	1.6	0.1	0.0	0.1	0.7	0.1	0.1	0.1	0.2	0.1	0.1	0.0	0.1	1.2	4.1	0.1	0.0	33.7	0.2	0.0	5.0	1.4	1.8	134.7	0.1	0.1	0.1	0.2	0.1	9.0	0.4	0.0	0.0	0.2	45.6	2.7	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	2.3	0.0	2.5	0.0	0.0	7.1	0.0	0.0	0.1	0.0	3.6	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.2	0.0	1.9	2.0	0.0	0.0	4.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	5.3	0.0	0.0	0.0	5.0	3.7	0.0	0.0	0.1	0.0	2.4	0.6	0.1	4.9	1.1	0.0	0.2	0.4	0.1	0.0	0.0	2.3	2.2	0.0	0.0	0.1	1.0	0.2	0.0	3.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.9	0.7	0.1	0.1	0.0	33.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	3.8	0.0	0.1	0.0	0.0	0.0
FBXO18	"FBH1, Fbx18, FLJ14590"	ENSG00000134452	"F-box protein, helicase, 18"	Q8NFZ0	10	5890203-5937594	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted membrane proteins"	"DNA damage, DNA repair, Ubl conjugation pathway"	"DNA-binding, Helicase, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA002844	Supported					NA	NA					"HPA002844: AB_1078829"	"unprognostic (3.14e-2)"	"unprognostic (1.55e-1)"	"unprognostic (6.35e-3)"	"unprognostic (4.42e-2)"	"unprognostic (3.37e-2)"	"unprognostic (8.98e-3)"	"prognostic unfavorable (7.73e-7)"	"unprognostic (1.89e-1)"	"unprognostic (2.42e-1)"	"unprognostic (3.37e-2)"	"unprognostic (1.56e-2)"	"unprognostic (2.23e-1)"	"unprognostic (6.91e-3)"	"unprognostic (3.69e-1)"	"unprognostic (4.35e-2)"	"unprognostic (1.24e-1)"	"unprognostic (9.54e-2)"	21.3	30.6	21.0	22.4	28.2	18.8	32.7	23.0	21.8	23.5	21.9	18.1	26.3	21.7	30.6	21.2	23.8	28.7	22.8	35.1	21.0	13.4	20.4	23.2	22.5	24.2	19.4	18.0	27.5	26.2	23.3	24.5	23.6	22.5	23.9	22.1	23.1	21.0	24.8	23.6	26.2	23.4	27.5	13.5	29.7	22.4	27.1	20.1	36.8	22.8	14.9	23.3	23.8	33.8	6.1	6.1	4.8	3.2	7.2	9.2	2.5	14.5	15.9	15.0	16.3	34.5	22.9	13.5	16.8	11.6	16.8	18.8	18.7	13.4	13.6	11.1	24.5	8.0	21.8	20.1	17.9	15.2	14.7	14.9	13.1	12.6	15.9	23.7	6.5	12.7	28.6	17.5	21.2	9.4	21.3	28.3	18.7	22.9	14.5	17.7	22.0	15.5	9.5	6.8	25.3	9.0	17.2	7.1	22.7	16.3	11.9	8.5	12.8	17.3	15.8	23.4	18.0	16.0	13.1	17.6	10.7	12.1	28.2	12.9	14.8	11.7	7.6	14.5	9.6	7.5	0.0	3.2	4.8	3.2	2.5	2.1	4.9	3.3	4.1	3.0	6.1	4.0	2.9	2.1	7.2	1.9	6.1	9.2	2.5	21.0	28.2	23.0	21.8	21.0	13.4	19.4	18.0	22.5	20.1	20.8	15.4	5.2	13.7	19.6	18.1	0.0	17.8	9.4	4.5	0.0	33.4	16.4	0.0	0.0	12.0	17.5	18.0	0.0	0.0	16.7	19.1	17.5	15.1	18.4	13.9	30.2	16.7	39.9	18.1	5.2	24.7	12.3	21.9	0.0	15.6	19.9	0.0	14.4	29.0	0.0	19.5	51.8	15.1	23.1	31.2	22.1	26.8	8.7	20.3	13.7
FDFT1		ENSG00000079459	"Farnesyl-diphosphate farnesyltransferase 1"	P37268	8	11795573-11839309	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Cholesterol biosynthesis, Cholesterol metabolism, Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis, Steroid metabolism, Sterol biosynthesis, Sterol metabolism"	"Multifunctional enzyme, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA008874	Approved		Supported	"Endoplasmic reticulum"		NA	NA			"Endoplasmic reticulum"		"HPA008874: AB_1078844"	"unprognostic (2.33e-1)"	"unprognostic (2.60e-1)"	"prognostic favorable (4.92e-5)"	"unprognostic (1.29e-2)"	"unprognostic (1.46e-2)"	"unprognostic (1.71e-1)"	"unprognostic (8.10e-2)"	"unprognostic (1.01e-1)"	"unprognostic (2.39e-1)"	"unprognostic (2.45e-1)"	"unprognostic (2.31e-3)"	"unprognostic (2.57e-1)"	"prognostic favorable (6.59e-9)"	"unprognostic (2.28e-1)"	"unprognostic (4.06e-2)"	"unprognostic (3.86e-1)"	"unprognostic (2.06e-1)"	20.8	44.3	26.3	22.7	27.7	30.6	57.5	19.5	43.6	27.6	41.7	45.9	20.0	44.6	26.9	29.1	59.4	27.5	19.9	27.1	29.8	32.1	24.9	45.9	30.7	23.4	36.2	34.4	22.9	18.0	17.1	18.2	22.1	47.4	38.8	32.9	32.4	46.5	20.6	71.2	38.4	30.2	18.0	56.5	18.4	35.4	41.3	40.5	25.9	24.7	32.2	25.4	25.8	34.2	44.0	30.5	42.2	19.6	22.6	31.0	29.0	21.6	10.5	47.1	18.8	10.2	17.5	14.3	8.5	14.5	9.0	18.7	14.7	26.8	30.1	4.2	8.5	52.3	18.0	23.3	71.0	7.3	5.0	24.9	14.1	8.0	35.0	21.7	7.3	9.9	15.7	18.0	20.1	10.0	6.9	11.3	35.0	20.3	39.7	8.8	14.1	25.7	17.4	41.2	18.0	6.2	15.8	10.9	61.8	41.8	78.8	15.1	9.4	7.4	12.6	21.3	18.7	20.7	21.3	14.1	4.2	10.5	1.9	5.3	8.2	20.7	32.8	7.4	24.8	12.4	42.2	19.6	22.6	21.6	17.2	20.8	44.0	22.7	21.2	30.5	35.3	21.5	20.3	18.6	22.6	11.7	22.7	31.0	29.0	26.3	27.7	19.5	43.6	29.8	32.1	36.2	34.4	47.4	40.5	50.6	130.3	65.1	88.1	46.6	14.4	61.6	107.0	89.7	86.4	75.0	13.7	242.8	74.6	133.2	225.3	35.0	92.9	46.7	248.7	118.9	42.5	90.7	54.4	67.1	77.6	11.1	75.9	16.5	49.7	171.1	71.4	48.9	96.2	125.4	83.9	56.6	133.6	63.2	50.2	63.4	19.7	51.8	62.1	181.7	75.9	77.7	146.3	48.4	83.2	141.3
FDPS		ENSG00000160752	"Farnesyl diphosphate synthase"	P14324	1	155308748-155320666	"Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"	"Cholesterol biosynthesis, Cholesterol metabolism, Host-virus interaction, Isoprene biosynthesis, Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis, Steroid metabolism, Sterol biosynthesis, Sterol metabolism"	Transferase	"Disease mutation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HBEC3-KT: 149.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA028200	Approved		Approved	Nucleoplasm,Cytosol		NA	NA		2000000	Cytosol	Nucleoplasm	"HPA028200: AB_10612109"	"unprognostic (1.23e-1)"	"unprognostic (8.46e-3)"	"unprognostic (2.47e-2)"	"unprognostic (6.57e-2)"	"unprognostic (4.58e-2)"	"unprognostic (2.84e-2)"	"prognostic unfavorable (7.35e-4)"	"unprognostic (4.21e-2)"	"unprognostic (6.78e-3)"	"unprognostic (1.64e-3)"	"unprognostic (7.19e-2)"	"unprognostic (2.25e-2)"	"unprognostic (1.11e-2)"	"unprognostic (8.25e-2)"	"unprognostic (2.07e-1)"	"unprognostic (5.65e-2)"	"unprognostic (8.44e-2)"	21.0	57.8	19.3	17.6	26.5	16.5	19.8	12.8	32.2	19.0	25.0	22.6	14.5	45.9	18.0	21.7	41.4	16.7	18.8	19.6	18.6	23.4	23.7	100.8	25.7	19.2	19.5	24.3	15.2	27.5	15.6	12.3	20.2	47.3	16.5	29.7	20.5	29.2	12.9	15.7	29.3	32.3	18.9	23.0	17.7	23.4	15.1	16.5	25.1	19.5	41.7	27.3	13.7	20.8	41.1	39.7	49.4	37.1	45.3	45.5	48.3	36.0	19.6	72.1	26.0	16.9	62.0	25.7	17.2	34.1	27.5	44.8	31.7	85.9	27.5	41.9	15.0	65.7	40.3	42.9	149.6	25.8	15.0	30.7	15.9	35.0	38.3	27.8	25.8	18.3	44.1	23.7	43.7	22.0	12.5	47.9	40.8	28.5	74.2	28.6	38.7	33.0	25.1	43.3	26.8	28.7	28.5	31.3	76.3	72.5	24.1	28.1	24.0	17.7	32.3	29.7	42.9	23.3	70.2	34.8	15.4	18.9	9.5	31.4	31.5	24.2	49.1	15.0	27.6	24.2	30.5	36.0	49.4	39.4	37.1	35.0	41.1	34.8	39.8	39.7	34.2	31.5	39.3	16.5	45.3	27.2	31.4	45.5	48.3	19.3	26.5	12.8	32.2	18.6	23.4	19.5	24.3	47.3	16.5	68.5	144.0	64.8	78.5	32.6	65.5	1.4	107.0	85.6	83.0	50.6	58.9	177.4	116.0	154.2	171.3	113.0	197.2	93.5	286.2	162.6	57.3	89.5	62.2	111.9	95.6	52.4	68.5	133.8	57.6	52.3	56.4	56.4	91.1	217.4	74.5	75.0	194.9	143.8	66.1	113.5	78.0	71.1	63.8	41.9	15.5	52.2	120.0	77.8	106.3	110.3
FDXR	ADXR	ENSG00000161513	"Ferredoxin reductase"	P22570	17	74862497-74873031	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Cholesterol metabolism, Electron transport, Lipid metabolism, Steroid metabolism, Sterol metabolism, Transport"	Oxidoreductase	"Deafness, Disease mutation, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adrenal gland: 93.9"	"Cell type enhanced"	"Detected in many"	5	"Cytotrophoblasts: 47.2;Syncytiotrophoblasts: 38.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BEWO: 30.1;Hep G2: 55.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB008597, CAB009818, HPA044393, HPA053673"	Enhanced		Enhanced	Mitochondria		NA	NA			Mitochondria		"CAB008597: AB_1615557, CAB009818: AB_2102601, HPA044393: AB_2678927, HPA053673: AB_2682225"	"unprognostic (2.69e-2)"	"unprognostic (1.17e-3)"	"unprognostic (7.51e-2)"	"prognostic favorable (2.38e-4)"	"unprognostic (3.43e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.53e-1)"	"unprognostic (1.68e-2)"	"unprognostic (2.29e-1)"	"unprognostic (1.50e-1)"	"unprognostic (1.09e-1)"	"unprognostic (6.30e-2)"	"unprognostic (1.42e-2)"	"unprognostic (1.19e-2)"	"unprognostic (4.50e-2)"	"unprognostic (4.03e-2)"	"unprognostic (2.13e-1)"	1.7	93.9	2.6	2.1	3.1	1.3	1.8	8.4	2.7	2.1	4.6	3.2	6.4	2.6	2.6	23.8	8.7	6.6	6.1	1.9	3.4	1.7	2.7	4.1	4.4	1.7	2.9	3.5	7.1	3.9	2.3	1.5	2.6	3.6	3.3	2.1	0.9	5.3	4.2	7.9	5.6	2.5	2.0	4.4	9.7	2.2	32.1	3.0	3.9	2.0	7.7	3.7	3.0	3.0	5.4	7.4	4.8	6.4	10.0	15.2	5.6	4.0	21.6	3.2	3.6	2.3	3.1	30.1	4.8	5.3	2.9	5.8	6.0	3.5	9.6	0.8	2.0	1.6	8.3	2.3	6.0	0.8	9.1	5.0	7.3	3.5	55.1	6.5	1.6	25.5	10.1	6.8	3.0	1.0	2.3	14.7	3.6	11.5	1.6	4.4	17.1	6.2	3.3	1.8	3.8	4.7	3.4	5.4	5.1	2.4	6.8	1.7	4.0	3.3	7.2	3.5	3.8	15.7	1.5	6.8	2.0	17.9	3.1	2.4	4.4	0.7	2.1	5.4	2.5	6.7	1.8	6.4	4.8	6.2	4.3	5.3	5.4	5.6	7.3	7.4	2.8	4.9	6.1	2.1	10.0	3.2	1.4	15.2	5.6	2.6	3.1	8.4	2.7	3.4	1.7	2.9	3.5	3.6	3.0	3.0	4.6	3.7	12.8	8.7	4.9	3.4	5.1	21.4	5.7	8.7	3.9	47.2	5.0	9.7	5.2	2.8	14.8	0.0	6.8	14.1	6.1	4.3	5.7	12.5	18.6	3.2	6.8	12.3	4.6	12.2	5.5	3.6	5.0	3.6	10.8	10.9	8.3	21.0	4.2	16.3	4.9	0.0	6.4	7.1	7.6	15.8	38.6	8.5	17.6	13.1
FECH		ENSG00000066926	Ferrochelatase	P22830	18	57548283-57586772	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Heme biosynthesis, Porphyrin biosynthesis"	Lyase	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 87.9"	"Group enriched"	"Detected in many"	5	"Distal tubular cells: 132.6;Erythroid cells: 210.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA044100, HPA048177"	Approved					NA	NA					"HPA044100: AB_2678809, HPA048177: AB_2680300"	"unprognostic (2.30e-1)"	"unprognostic (3.17e-2)"	"unprognostic (4.59e-3)"	"unprognostic (6.85e-2)"	"unprognostic (7.60e-2)"	"unprognostic (1.08e-1)"	"unprognostic (3.86e-2)"	"unprognostic (3.34e-2)"	"unprognostic (2.85e-2)"	"unprognostic (2.43e-1)"	"unprognostic (1.92e-1)"	"unprognostic (2.36e-1)"	"prognostic favorable (2.38e-10)"	"unprognostic (1.10e-1)"	"unprognostic (8.30e-2)"	"unprognostic (4.05e-3)"	"unprognostic (3.58e-2)"	10.0	18.0	9.9	6.5	14.1	87.9	9.9	7.9	17.4	7.9	9.5	23.1	8.0	7.6	10.5	7.9	13.6	8.5	6.9	17.6	10.4	9.7	28.2	28.3	7.2	9.8	12.0	13.9	9.1	9.5	11.4	8.8	14.8	15.6	14.5	9.3	12.1	10.1	11.1	36.2	8.6	7.2	12.3	11.7	10.6	8.5	5.8	13.1	18.4	11.6	10.8	7.1	12.1	8.8	4.2	12.4	14.9	10.9	13.8	9.3	9.1	7.4	20.3	7.4	12.0	4.8	10.9	13.2	10.6	10.9	15.4	13.8	5.4	6.8	3.3	10.9	14.5	8.0	9.5	11.0	8.9	12.4	19.4	11.7	24.6	14.1	11.1	12.3	17.1	44.9	11.3	9.5	9.5	4.4	8.3	11.5	20.7	34.9	14.0	8.6	8.8	17.8	3.6	5.6	4.3	8.8	12.8	10.4	20.0	15.3	14.0	7.5	11.3	13.7	14.8	6.2	6.9	14.1	7.2	9.1	5.4	7.1	2.1	7.7	41.1	17.6	7.2	8.7	8.4	9.0	14.0	9.6	14.9	9.3	10.9	6.7	4.2	5.7	8.3	12.4	2.6	4.2	5.9	0.7	13.8	10.2	9.5	5.9	9.1	9.9	14.1	7.9	17.4	10.4	9.7	12.0	13.9	15.6	13.1	6.0	8.8	5.2	4.9	2.3	3.7	19.8	20.4	9.4	5.7	5.2	3.9	32.2	132.6	15.0	0.4	6.0	5.9	210.2	14.3	16.4	10.4	5.2	16.1	22.9	28.7	7.9	2.4	3.1	6.1	0.7	9.2	10.0	1.7	19.8	3.6	15.1	10.4	5.1	6.7	11.3	4.2	0.0	5.1	2.6	3.8	2.8	20.3	8.3	5.6	3.1
FER	"PPP1R74, TYK3"	ENSG00000151422	"FER tyrosine kinase"	P16591	5	108747822-109196841	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Kinase, Transferase, Tyrosine-protein kinase"	Proto-oncogene	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	8	"Early spermatids: 123.9;granulocytes: 91.4;Late spermatids: 142.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enriched"	"Detected in many"	5	"RPMI-8226: 45.1"	"Low region specificity"	"Detected in all"							"HPA007641, CAB022464"	Approved		Supported	Cytosol		NA	NA			Cytosol		"CAB022464: , HPA007641: AB_1078845"	"unprognostic (1.72e-1)"	"unprognostic (1.66e-2)"	"unprognostic (1.74e-1)"	"unprognostic (2.46e-3)"	"unprognostic (4.72e-2)"	"unprognostic (5.65e-2)"	"unprognostic (6.81e-2)"	"unprognostic (7.39e-2)"	"unprognostic (1.05e-1)"	"unprognostic (8.36e-3)"	"unprognostic (7.36e-2)"	"unprognostic (8.05e-2)"	"prognostic favorable (5.55e-4)"	"unprognostic (3.83e-3)"	"unprognostic (3.22e-1)"	"unprognostic (1.03e-1)"	"unprognostic (3.99e-3)"	13.4	5.7	5.5	6.1	13.4	1.8	5.2	6.0	5.0	9.7	6.7	1.4	16.8	2.5	6.5	19.3	8.2	4.6	5.3	4.6	4.8	4.8	7.2	3.6	12.2	1.9	4.9	2.2	7.2	3.0	18.5	15.9	5.7	3.1	6.8	3.6	5.0	4.5	21.9	5.0	6.6	3.5	7.2	6.2	8.1	4.1	15.9	2.6	3.9	10.2	12.8	2.8	7.7	9.0	10.5	5.4	8.0	5.1	1.2	2.8	1.1	4.7	1.6	5.8	9.2	3.5	5.4	3.7	5.7	5.6	3.4	4.0	9.7	2.9	7.6	3.6	6.9	4.3	3.4	3.1	7.2	7.6	3.2	4.2	5.1	7.4	3.5	2.3	2.7	4.3	3.2	4.0	8.1	9.2	3.4	5.0	7.4	6.3	5.7	4.3	1.3	2.1	0.8	0.8	0.4	3.4	1.7	5.6	45.1	3.3	1.6	1.9	2.8	9.4	0.5	6.1	3.8	2.2	1.2	7.3	6.5	5.0	3.3	4.5	4.8	7.2	3.0	4.1	0.9	3.0	8.0	5.1	5.4	1.7	3.1	2.8	10.5	1.0	1.8	2.8	3.8	1.6	2.0	0.4	1.2	2.4	5.4	2.1	1.1	5.5	13.4	6.0	4.2	4.8	4.8	4.9	2.2	3.1	2.6	74.5	27.0	2.4	9.8	26.0	16.3	18.6	12.7	40.2	33.0	14.0	17.7	3.0	1.7	11.7	123.9	13.3	3.2	0.0	5.2	8.9	10.4	8.2	91.4	1.6	6.8	17.5	8.1	22.1	10.5	142.5	17.8	10.6	13.5	12.6	3.7	10.9	7.7	3.6	16.6	5.4	16.6	6.5	9.9	4.3	9.1	15.4	2.6	9.2	3.8	4.9
FES	FPS	ENSG00000182511	"FES proto-oncogene, tyrosine kinase"	P07332	15	90883695-90895776	"Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		"Kinase, Transferase, Tyrosine-protein kinase"	"Cancer-related genes, Proto-oncogene, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 60.8;lymphoid tissue: 49.7"	"Cell type enhanced"	"Detected in many"	11	"Hofbauer cells: 40.6;Kupffer cells: 93.1;Macrophages: 37.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"eosinophil: 60.8"	"Group enriched"	"Detected in many"	4	"dendritic cells: 32.6;granulocytes: 60.8;monocytes: 30.5"	"Cell line enhanced"	"Detected in many"		"HEL: 21.3;HL-60: 19.0;HMC-1: 40.7;NB-4: 24.9;THP-1: 37.4;U-937: 16.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA001376	Approved		Approved	Nucleoplasm,Vesicles,Cytosol		NA	NA			"Nucleoplasm, Cytosol"	Vesicles	"HPA001376: AB_1078847"	"unprognostic (1.07e-2)"	"unprognostic (2.54e-2)"	"prognostic unfavorable (5.78e-4)"	"unprognostic (2.31e-2)"	"unprognostic (4.05e-3)"	"unprognostic (7.33e-2)"	"unprognostic (1.74e-1)"	"unprognostic (2.22e-1)"	"unprognostic (1.58e-3)"	"unprognostic (1.35e-1)"	"unprognostic (4.66e-2)"	"unprognostic (5.15e-3)"	"unprognostic (1.78e-3)"	"unprognostic (2.53e-3)"	"unprognostic (6.08e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.40e-1)"	14.9	3.4	4.8	9.7	4.1	38.3	12.7	2.4	5.7	6.8	5.4	3.2	4.7	3.0	7.4	5.6	4.9	7.6	7.3	7.9	4.2	2.2	5.2	11.8	12.7	23.3	3.7	0.9	6.4	3.7	1.8	2.7	8.1	7.2	7.7	2.4	5.3	33.8	6.3	3.4	3.5	5.2	5.4	6.9	49.7	4.3	3.2	4.7	3.1	7.2	4.1	4.5	7.2	9.4	1.1	32.6	60.8	30.5	9.3	0.1	13.8	0.1	0.2	0.3	3.6	1.0	3.1	6.1	0.9	0.0	1.8	1.0	0.9	0.0	2.3	0.1	2.0	0.0	0.5	0.6	0.1	0.5	1.2	0.3	21.3	0.0	3.8	2.1	19.0	40.7	3.1	0.0	2.6	0.0	0.0	10.8	3.2	0.6	0.0	0.0	6.9	0.6	24.9	1.0	0.8	0.0	2.8	0.0	0.0	0.0	0.1	0.1	0.0	0.0	1.0	0.9	1.1	0.0	37.4	8.4	0.0	3.7	0.1	0.0	0.0	2.7	0.8	0.1	16.1	0.8	10.4	30.5	60.8	0.1	17.6	0.0	1.1	0.0	0.0	32.6	0.9	0.0	0.0	20.0	9.3	7.3	12.9	0.0	13.8	4.8	4.1	2.4	5.7	4.2	2.2	3.7	0.9	7.2	4.7	3.0	8.0	6.4	4.7	3.4	0.0	2.5	5.1	0.0	0.0	1.8	0.0	4.5	3.3	4.8	1.1	24.5	0.4	0.0	3.9	3.8	6.2	4.0	28.8	8.2	40.6	0.0	2.9	22.7	93.1	4.7	8.3	37.3	6.8	27.1	2.1	2.3	2.0	0.0	9.6	1.3	1.9	12.9	7.2	3.5	9.1	2.5	3.8	10.2	2.6	5.2
FGFR1	"BFGFR, CD331, CEK, FLG, FLT2, H2, H3, H4, H5, KAL2, N-SAM"	ENSG00000077782	"Fibroblast growth factor receptor 1"	P11362	8	38411138-38468834	"Cancer-related genes, CD markers, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, RAS pathway related proteins, Transporters"	"Transcription, Transcription regulation"	"Heparin-binding, Kinase, Receptor, Transferase, Tyrosine-protein kinase"	"Cancer-related genes, Craniosynostosis, Disease mutation, Dwarfism, FDA approved drug targets, Holoprosencephaly, Hypogonadotropic hypogonadism, Kallmann syndrome, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"Leydig cells: 177.8;Muller glia cells: 106.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"AN3-CA: 111.2;BJ hTERT+: 50.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB033614, HPA056402"	Approved					NA	NA		120000000			"CAB033614: AB_783377, HPA056402: AB_2683118"	"unprognostic (9.53e-2)"	"unprognostic (7.33e-2)"	"unprognostic (2.44e-1)"	"unprognostic (1.35e-2)"	"unprognostic (4.23e-3)"	"unprognostic (7.02e-2)"	"unprognostic (6.59e-2)"	"unprognostic (2.77e-1)"	"unprognostic (1.81e-1)"	"unprognostic (3.99e-2)"	"unprognostic (7.97e-3)"	"unprognostic (4.59e-2)"	"unprognostic (7.69e-2)"	"unprognostic (6.87e-3)"	"unprognostic (5.60e-2)"	"unprognostic (4.59e-3)"	"unprognostic (1.05e-3)"	41.1	8.6	12.5	14.5	12.2	7.2	39.5	45.0	10.5	36.0	31.5	10.1	11.6	5.5	29.3	20.6	22.9	29.4	32.4	31.7	12.8	10.1	11.8	5.4	18.6	9.7	11.4	14.3	42.0	51.2	11.5	22.3	28.4	20.0	28.2	10.8	35.8	14.0	31.6	12.0	12.9	14.4	52.4	15.6	4.5	16.4	16.4	8.5	11.3	12.6	13.0	9.8	39.6	41.2	1.6	0.7	1.8	1.1	0.8	5.7	0.7	2.4	9.4	41.1	111.2	25.5	18.2	27.1	25.3	50.7	17.6	18.4	6.1	1.4	0.3	7.0	24.2	22.6	0.0	19.4	1.2	20.4	6.6	4.3	0.0	1.6	6.0	14.4	5.9	0.1	16.5	0.1	14.3	2.9	9.5	16.9	1.4	2.3	0.1	8.3	2.9	17.4	2.0	28.9	0.3	3.9	16.0	4.3	0.0	8.5	0.0	1.6	3.6	4.5	0.2	1.0	21.5	2.3	1.1	10.6	11.5	6.4	31.8	6.0	0.4	0.8	0.0	13.6	0.3	6.0	1.4	1.1	0.4	5.7	0.3	3.9	0.7	2.7	3.7	0.1	1.6	1.5	4.1	1.8	0.8	0.5	0.7	2.2	0.7	12.5	12.2	45.0	10.5	12.8	10.1	11.4	14.3	20.0	8.5	3.0	12.0	0.0	68.4	27.9	1.3	48.2	17.8	1.4	9.1	8.7	3.9	6.5	0.0	23.4	14.2	57.3	0.0	0.0	56.3	69.1	85.6	80.3	8.1	0.9	19.7	20.6	24.0	47.3	3.2	9.3	177.8	7.5	32.1	2.8	0.0	106.2	29.8	0.0	93.7	8.0	2.4	12.9	68.0	1.4	11.3	17.2	8.7	6.4	0.4	8.4
FGFR2	"BEK, CD332, CEK3, CFD1, ECT1, JWS, K-SAM, KGFR, TK14, TK25"	ENSG00000066468	"Fibroblast growth factor receptor 2"	P21802	10	121478334-121598458	"Cancer-related genes, CD markers, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins, RAS pathway related proteins"	Apoptosis	"Heparin-binding, Kinase, Receptor, Transferase, Tyrosine-protein kinase"	"Cancer-related genes, Craniosynostosis, Disease mutation, Ectodermal dysplasia, FDA approved drug targets, Lacrimo-auriculo-dento-digital syndrome, Mental retardation, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 74.8"	"Cell type enhanced"	"Detected in many"	16	"Cholangiocytes: 191.1;Club cells: 52.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	15	"basophil: 10.8;eosinophil: 4.6"	"Lineage enriched"	"Detected in single"	35	"granulocytes: 10.8"	"Cell line enhanced"	"Detected in some"		"AN3-CA: 58.9;BEWO: 19.8;CACO-2: 15.4;HaCaT: 17.8;HAP1: 19.1;NTERA-2: 18.9;T-47d: 15.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB010886, HPA035305"	Uncertain		Supported	"Nucleoplasm,Vesicles,Cell Junctions"	"Secreted - unknown location"	NA	NA		500000	"Cell Junctions"	"Nucleoplasm, Vesicles"	"CAB010886: AB_259379, HPA035305: AB_10672862"	"unprognostic (5.53e-2)"	"prognostic favorable (8.79e-4)"	"unprognostic (1.08e-1)"	"unprognostic (5.23e-2)"	"unprognostic (1.73e-1)"	"prognostic favorable (9.32e-4)"	"unprognostic (1.53e-1)"	"unprognostic (4.96e-3)"	"unprognostic (1.74e-1)"	"unprognostic (1.56e-1)"	"unprognostic (1.07e-1)"	"unprognostic (3.74e-2)"	"unprognostic (1.01e-1)"	"unprognostic (6.11e-2)"	"unprognostic (2.54e-1)"	"unprognostic (6.93e-2)"	"unprognostic (2.25e-1)"	2.1	8.8	16.4	3.0	30.3	0.0	9.9	15.8	21.3	6.8	14.1	55.7	5.6	4.2	22.0	6.6	10.2	12.5	12.5	1.4	20.6	11.1	11.4	16.1	13.1	1.0	41.2	13.3	7.4	12.8	25.5	2.5	6.2	30.2	11.7	8.7	16.4	23.8	24.3	0.4	45.4	4.7	18.3	74.8	0.5	9.3	2.9	32.1	0.8	23.4	1.6	3.4	6.9	8.5	0.1	0.1	10.8	0.1	0.1	0.3	0.0	2.2	0.1	9.2	58.9	0.0	0.0	19.8	0.1	0.0	0.0	0.0	15.4	0.3	0.0	4.2	0.9	0.0	17.8	19.1	4.0	0.0	0.0	4.1	0.0	0.0	0.3	0.4	0.0	3.8	0.0	8.5	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	3.5	0.0	0.0	18.9	2.7	0.0	0.0	0.0	2.3	5.7	5.0	0.1	0.1	0.1	10.8	0.0	11.5	15.8	0.0	0.0	0.1	2.9	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.1	10.8	0.1	4.6	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.1	0.5	0.1	0.0	0.1	0.0	0.0	16.4	30.3	15.8	21.3	20.6	11.1	41.2	13.3	30.2	32.1	17.9	31.8	0.0	29.5	35.6	0.0	2.7	191.1	18.7	52.4	34.9	0.0	12.6	0.0	4.0	2.9	0.5	2.6	0.0	0.2	2.7	17.5	9.8	0.0	4.3	2.0	0.0	2.4	3.1	0.3	6.5	1.1	1.3	5.0	1.0	32.0	1.6	0.6	1.4	5.6	11.5	0.1	0.0	2.1	0.9	7.7	24.2	3.3	1.5	3.0	27.7
FGFR3	"ACH, CD333, CEK2, JTK4"	ENSG00000068078	"Fibroblast growth factor receptor 3"	P22607	4	1793293-1808872	"Cancer-related genes, CD markers, Disease related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, RAS pathway related proteins"	Apoptosis	"Kinase, Receptor, Transferase, Tyrosine-protein kinase"	"Cancer-related genes, Craniosynostosis, Deafness, Disease mutation, Dwarfism, Ectodermal dysplasia, FDA approved drug targets, Lacrimo-auriculo-dento-digital syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"skin 1: 131.7"	"Cell type enhanced"	"Detected in many"	9	"Basal keratinocytes: 92.2;Cholangiocytes: 94.3;Suprabasal keratinocytes: 77.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"CACO-2: 19.3;HaCaT: 15.1;Hep G2: 32.5;NTERA-2: 15.8;RT4: 19.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004231, HPA067204"	Enhanced		Supported	"Endoplasmic reticulum"	"Intracellular and membrane"	NA	NA		670000	"Endoplasmic reticulum"		"CAB004231: AB_627596, HPA067204: AB_2685804"	"unprognostic (1.34e-1)"	"unprognostic (5.29e-3)"	"unprognostic (1.49e-1)"	"prognostic unfavorable (3.77e-4)"	"unprognostic (5.90e-2)"	"unprognostic (1.24e-3)"	"unprognostic (7.22e-2)"	"unprognostic (2.54e-1)"	"unprognostic (1.99e-1)"	"unprognostic (2.17e-1)"	"unprognostic (1.38e-1)"	"unprognostic (2.88e-2)"	"unprognostic (1.30e-1)"	"unprognostic (9.11e-3)"	"unprognostic (1.98e-1)"	"unprognostic (4.74e-2)"	"unprognostic (1.97e-1)"	1.5	1.5	24.7	1.7	30.3	1.6	4.2	10.2	22.0	4.1	4.9	15.8	3.4	9.9	1.8	2.7	26.9	2.0	5.0	2.0	21.6	11.7	9.6	7.4	4.5	1.3	17.6	21.5	1.1	23.0	1.2	3.0	5.6	15.1	3.7	3.8	1.7	3.8	9.0	1.7	131.7	7.4	1.3	9.0	2.1	4.9	8.1	10.6	0.1	1.3	8.5	7.3	8.5	10.1	0.1	0.6	0.1	0.1	0.2	0.3	0.0	0.0	1.5	9.2	2.6	0.0	0.1	9.4	1.1	0.1	0.4	0.2	19.3	0.4	0.0	7.7	0.3	0.4	15.1	2.6	0.1	0.1	0.1	9.7	6.0	1.5	32.5	0.0	0.0	0.2	0.0	5.1	0.1	0.0	0.0	0.0	0.9	6.5	0.0	0.0	9.6	0.4	0.2	15.8	8.8	0.0	0.5	0.5	0.1	1.3	19.3	2.7	0.7	0.8	1.6	0.0	11.1	9.0	1.1	0.4	0.0	0.9	0.2	0.6	0.0	0.0	0.0	0.1	0.7	0.5	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.2	0.0	0.6	0.1	0.0	24.7	30.3	10.2	22.0	21.6	11.7	17.6	21.5	15.1	10.6	0.0	23.8	2.4	3.6	92.2	0.0	2.0	94.3	0.0	21.6	14.0	0.0	0.4	0.0	4.8	5.4	0.9	20.6	0.0	0.6	9.2	7.0	3.3	0.0	27.0	0.5	0.0	4.1	14.7	1.2	0.4	0.6	1.2	11.8	1.0	20.7	0.2	0.4	17.3	0.4	7.5	0.6	0.0	2.8	0.4	17.9	77.5	0.7	0.0	13.0	11.8
FGFR4	"CD334, JTK2"	ENSG00000160867	"Fibroblast growth factor receptor 4"	P22455	5	177086886-177098144	"Cancer-related genes, CD markers, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, RAS pathway related proteins, Transporters"		"Kinase, Receptor, Transferase, Tyrosine-protein kinase"	"Cancer-related genes, Disease mutation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"gallbladder: 33.6;kidney: 37.7;liver: 45.3"	"Cell type enhanced"	"Detected in many"	11	"Cholangiocytes: 50.9;Hepatocytes: 23.7;Proximal tubular cells: 19.5;Sertoli cells: 19.4;Undifferentiated cells: 33.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Cell type enhanced"	"Detected in some"		"neutrophil: 3.0"	"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"CACO-2: 43.0;Hep G2: 43.0;RH-30: 69.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"CAB005196, HPA027273, HPA027369, HPA028251"	Approved				"Intracellular and membrane"	NA	NA		4300000			"CAB005196: AB_631512, HPA027273: AB_10600212, HPA027369: AB_10599427, HPA028251: AB_10601221"	"unprognostic (1.96e-1)"	"unprognostic (2.10e-2)"	"unprognostic (1.12e-1)"	"unprognostic (9.06e-3)"	"unprognostic (2.87e-1)"	"unprognostic (1.95e-2)"	"unprognostic (7.85e-3)"	"unprognostic (9.19e-2)"	"unprognostic (4.25e-1)"	"unprognostic (4.46e-2)"	"unprognostic (1.16e-1)"	"unprognostic (3.48e-2)"	"unprognostic (1.78e-1)"	"unprognostic (1.71e-3)"	"unprognostic (2.41e-1)"	"unprognostic (5.75e-2)"	"unprognostic (4.68e-2)"	0.5	5.7	0.7	14.3	0.6	0.1	1.6	2.6	0.5	2.8	10.4	0.9	0.7	13.5	0.9	4.8	1.6	1.7	33.6	0.7	0.8	0.3	37.7	45.3	25.3	2.5	0.7	1.0	13.6	26.0	0.0	0.7	1.3	0.8	4.0	3.7	2.0	1.6	0.3	4.3	0.5	17.3	1.6	0.8	11.2	5.4	2.9	0.4	0.3	0.8	2.3	0.7	1.9	3.6	1.1	0.9	3.0	1.1	0.4	0.4	0.0	0.7	12.1	0.2	2.9	0.0	0.0	5.9	0.0	0.0	0.0	0.0	43.0	1.6	1.3	5.6	0.0	0.6	0.6	2.4	0.4	0.0	0.7	2.8	0.1	0.6	43.0	1.3	0.1	1.0	0.2	0.0	2.1	0.0	0.0	0.0	0.8	4.0	0.1	0.9	9.8	0.0	0.8	7.3	7.6	1.0	1.9	69.1	7.2	5.8	0.1	0.4	0.7	0.4	3.1	1.4	1.6	2.9	0.6	0.2	0.0	5.8	0.0	0.1	0.4	0.4	0.7	0.0	0.2	0.5	1.5	1.1	0.4	0.4	0.3	0.3	1.1	0.4	0.0	0.1	0.6	0.4	0.4	3.0	0.4	0.3	0.9	0.2	0.0	0.7	0.6	2.6	0.5	0.8	0.3	0.7	1.0	0.8	0.4	0.0	0.0	0.8	0.6	0.6	0.4	0.8	50.9	0.0	0.0	3.5	0.0	1.1	3.3	8.4	0.1	0.1	10.6	0.0	4.4	3.2	1.7	0.3	0.0	23.7	0.3	0.0	4.1	2.5	0.8	0.0	0.6	0.0	0.0	1.0	5.2	0.9	3.6	2.9	1.4	19.5	0.1	19.4	0.5	1.6	12.8	0.4	7.3	0.0	33.6	0.6
FGR	"c-fgr, p55c-fgr, SRC2"	ENSG00000000938	"FGR proto-oncogene, Src family tyrosine kinase"	P09769	1	27612064-27635277	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Immunity, Innate immunity"	"Kinase, Transferase, Tyrosine-protein kinase"	Proto-oncogene	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"adipose tissue: 20.8;blood: 68.0;bone marrow: 73.6;lung: 30.9;lymphoid tissue: 54.3"	"Cell type enhanced"	"Detected in many"	19	"Hofbauer cells: 58.9;Kupffer cells: 187.9;Macrophages: 86.1;T-cells: 45.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Group enriched"	"Detected in some"	4	"Daudi: 30.1;U-266/70: 55.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA002024	Enhanced		Approved	"Plasma membrane,Aggresome"		NA	NA			"Plasma membrane"	Aggresome	"HPA002024: AB_1078503"	"unprognostic (2.66e-2)"	"unprognostic (1.51e-2)"	"unprognostic (6.32e-2)"	"unprognostic (9.74e-3)"	"unprognostic (6.66e-3)"	"unprognostic (6.71e-2)"	"unprognostic (5.77e-2)"	"unprognostic (1.25e-1)"	"unprognostic (1.81e-2)"	"unprognostic (7.45e-2)"	"unprognostic (2.79e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.94e-2)"	"unprognostic (6.26e-2)"	"unprognostic (3.93e-2)"	"unprognostic (2.30e-1)"	"unprognostic (8.12e-3)"	20.8	2.6	2.2	23.6	4.5	73.6	5.6	1.1	4.2	2.9	2.8	1.5	4.2	1.6	4.0	2.3	2.2	6.3	5.3	8.5	2.6	2.3	3.0	4.2	30.9	34.1	6.6	1.7	1.9	2.4	0.4	1.2	3.3	4.2	2.5	1.8	2.1	2.9	2.6	4.4	1.7	3.7	6.4	4.8	54.3	2.5	2.6	4.1	1.9	2.9	2.5	7.8	5.1	6.1	13.3	28.9	40.8	68.0	36.3	29.6	55.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	30.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.5	10.7	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	1.3	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.5	0.0	0.0	0.0	0.0	0.0	55.9	0.7	2.3	0.0	6.8	0.0	3.1	52.4	32.3	29.6	68.0	1.7	7.7	2.6	13.6	28.9	13.3	1.3	12.8	40.8	36.3	55.6	1.3	0.1	55.0	2.2	4.5	1.1	4.2	2.6	2.3	6.6	1.7	4.2	4.1	6.0	30.7	12.5	0.5	2.5	0.0	1.6	2.5	2.7	10.3	1.8	0.0	0.4	0.0	0.0	0.2	11.5	0.0	0.0	0.2	0.5	1.4	0.3	12.7	0.9	58.9	0.0	0.0	4.3	187.9	0.4	0.3	86.1	1.7	7.2	0.0	0.1	0.0	0.2	0.0	0.1	0.0	0.0	1.0	0.2	0.5	1.0	0.8	45.8	0.0	0.9
FH	fumarase	ENSG00000091483	"Fumarate hydratase"	P07954	1	241497603-241519761	"Cancer-related genes, Citric acid cycle related proteins, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"DNA damage, DNA repair, Tricarboxylic acid cycle"	Lyase	"Cancer-related genes, Disease mutation, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 93.4"	"Cell type enhanced"	"Detected in all"	4	"Early spermatids: 161.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB017785, HPA025770, HPA025948, HPA027341"	Enhanced	Supported	Enhanced	Mitochondria		NA	NA		2800000	Mitochondria		"CAB017785: , HPA025770: AB_10599603, HPA025948: AB_10602177, HPA027341: AB_10601222"	"unprognostic (1.03e-2)"	"unprognostic (3.82e-2)"	"unprognostic (9.46e-3)"	"unprognostic (2.18e-1)"	"unprognostic (2.10e-1)"	"unprognostic (2.07e-1)"	"unprognostic (2.28e-2)"	"unprognostic (1.55e-1)"	"unprognostic (5.14e-2)"	"unprognostic (1.85e-2)"	"unprognostic (1.27e-2)"	"unprognostic (1.09e-1)"	"prognostic favorable (2.76e-7)"	"unprognostic (1.05e-1)"	"unprognostic (1.05e-1)"	"unprognostic (4.41e-2)"	"unprognostic (1.24e-2)"	14.3	28.1	15.7	10.4	20.2	9.3	13.3	15.7	24.4	10.5	22.7	9.9	16.7	23.2	13.7	10.7	17.7	10.3	9.5	59.0	22.9	13.9	35.0	93.4	9.9	13.3	15.2	19.4	9.4	13.9	25.2	11.4	14.3	18.4	12.3	24.4	10.2	18.4	20.6	65.1	13.4	21.4	14.7	14.4	11.1	17.5	14.0	11.7	13.8	12.3	45.2	13.4	13.4	11.2	16.0	26.4	4.5	18.8	10.4	13.9	8.9	29.3	24.6	23.3	21.0	22.9	27.1	37.0	36.4	28.5	41.1	25.8	35.1	18.3	18.6	24.1	27.8	18.0	41.8	35.6	27.0	35.8	21.3	11.5	17.5	26.0	30.0	20.6	40.8	15.9	19.6	16.9	23.0	26.0	14.4	25.2	41.2	53.1	24.1	29.9	14.6	35.1	27.3	24.8	42.8	52.8	29.1	25.5	83.6	39.6	24.9	30.0	26.0	30.6	36.3	23.2	16.8	27.7	27.7	24.8	18.5	23.8	32.6	60.5	21.6	23.1	22.6	20.6	46.9	26.5	4.5	12.8	2.7	9.7	18.8	12.6	16.0	11.4	9.0	26.4	14.1	13.9	12.7	0.7	10.4	15.7	13.2	13.2	8.9	15.7	20.2	15.7	24.4	22.9	13.9	15.2	19.4	18.4	11.7	35.7	27.5	27.0	18.6	17.7	23.0	151.3	33.1	30.8	22.7	22.7	13.7	91.1	66.3	49.6	161.2	17.9	46.4	23.3	39.2	43.6	21.6	16.1	18.5	73.1	45.3	33.4	17.2	11.6	12.6	20.1	22.2	26.8	23.6	29.7	35.6	28.0	29.4	35.1	25.1	58.8	32.6	38.8	21.7	82.8	44.5	16.3	138.9	12.9	60.7	16.3
FHIT	"AP3Aase, FRA3B"	ENSG00000189283	"Fragile histidine triad"	P49789	3	59749310-61251459	"Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Apoptosis, Transcription, Transcription regulation"	Hydrolase	"Cancer-related genes, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"Late spermatids: 138.8;Proximal tubular cells: 112.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	5	"naive CD4 T-cell: 38.3"	"Lineage enriched"	"Detected in all"	14	"T-cells: 38.3"	"Cell line enhanced"	"Detected in many"		"RPMI-8226: 12.1;U-266/70: 24.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002684, HPA018840, HPA018909"	Enhanced		Approved	"Nucleoli fibrillar center,Plasma membrane"		NA	NA			"Nucleoli fibrillar center, Plasma membrane"		"CAB002684: , HPA018840: AB_1848538, HPA018909: AB_1848537"	"unprognostic (2.36e-3)"	"unprognostic (6.38e-2)"	"unprognostic (1.59e-1)"	"unprognostic (4.42e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.08e-2)"	"unprognostic (1.18e-1)"	"unprognostic (3.16e-2)"	"unprognostic (2.77e-2)"	"unprognostic (8.49e-2)"	"unprognostic (2.36e-1)"	"unprognostic (6.77e-2)"	"prognostic favorable (1.36e-4)"	"unprognostic (1.54e-1)"	"unprognostic (5.96e-2)"	"unprognostic (1.29e-2)"	"unprognostic (1.80e-2)"	6.4	24.0	13.7	8.0	17.5	9.0	12.1	4.7	13.3	7.9	8.0	21.0	12.4	8.2	6.2	9.5	5.1	9.2	13.0	14.9	15.3	13.8	30.9	10.7	5.2	9.3	19.5	9.3	8.9	11.8	16.3	15.2	4.1	14.4	5.8	7.8	14.0	11.4	9.9	11.6	7.0	7.6	9.1	17.1	6.0	8.1	10.5	18.2	3.7	15.6	5.7	6.9	7.3	6.1	1.6	2.4	1.8	1.8	2.6	38.3	4.7	0.0	0.0	1.0	0.0	0.6	0.0	1.7	0.1	0.1	0.0	0.0	1.8	3.1	2.6	0.5	0.1	1.9	0.0	10.1	2.1	0.0	1.4	3.5	2.2	1.3	4.2	2.7	5.7	0.1	6.9	4.2	0.1	5.1	0.2	0.0	2.8	1.7	8.4	0.1	2.5	10.2	4.6	0.8	8.7	0.6	7.6	0.0	12.1	11.3	1.4	2.1	2.9	1.0	7.0	6.6	4.1	0.4	0.1	0.0	1.2	0.4	0.1	1.6	24.7	7.5	0.0	2.7	0.0	1.5	1.8	1.8	0.2	0.9	1.2	0.5	1.6	6.9	0.7	2.2	1.4	38.3	6.7	0.3	2.6	0.4	2.4	7.4	4.7	13.7	17.5	4.7	13.3	15.3	13.8	19.5	9.3	14.4	18.2	6.0	8.8	14.1	16.1	6.8	12.4	9.2	33.1	2.7	3.4	26.2	55.0	33.8	66.3	17.3	41.1	6.2	12.3	0.0	4.1	6.5	4.3	10.2	5.7	20.8	17.6	28.6	7.5	11.6	6.7	138.8	17.8	9.6	11.8	6.4	11.4	17.8	11.6	14.0	9.2	112.3	19.5	0.0	3.1	18.1	6.4	9.8	27.3	7.5	17.2	19.0
FICD	"HIP13, HYPE"	ENSG00000198855	"FIC domain containing"	Q9BVA6	12	108515185-108525837	"Enzymes, Predicted intracellular proteins"	"Unfolded protein response"	"Hydrolase, Nucleotidyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	9	"Early spermatids: 65.6;Late spermatids: 37.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021390, HPA071134"	Approved		Approved	Nucleoplasm	"Intracellular and membrane"	NA	NA			Nucleoplasm		"HPA021390: AB_1851340, HPA071134: AB_2686347"	"unprognostic (1.00e-1)"	"unprognostic (8.76e-2)"	"unprognostic (1.76e-2)"	"prognostic favorable (4.61e-5)"	"unprognostic (6.92e-2)"	"unprognostic (2.68e-2)"	"unprognostic (5.73e-2)"	"unprognostic (2.84e-2)"	"unprognostic (8.68e-2)"	"unprognostic (2.57e-1)"	"unprognostic (3.15e-2)"	"unprognostic (1.19e-1)"	"unprognostic (7.66e-2)"	"unprognostic (1.56e-2)"	"unprognostic (6.22e-2)"	"unprognostic (3.12e-2)"	"unprognostic (3.65e-2)"	4.2	9.6	5.6	6.1	8.2	3.0	4.5	4.0	6.7	8.5	3.8	7.3	10.5	3.9	4.6	15.8	2.3	4.1	4.1	3.5	5.4	5.9	5.2	16.4	5.0	4.9	8.9	5.1	4.8	27.9	4.8	15.3	7.9	6.0	6.1	3.6	10.2	19.7	7.9	2.6	3.4	3.3	4.6	7.5	4.8	5.1	8.5	6.6	5.4	13.6	1.0	6.2	4.1	4.5	5.0	15.2	10.9	5.4	3.1	8.0	1.8	1.9	4.8	2.0	3.9	4.7	3.3	5.4	12.7	6.7	6.0	4.2	3.0	1.9	2.7	4.8	6.0	7.1	2.5	2.1	1.4	5.3	4.5	3.1	1.5	3.7	4.2	18.5	2.2	5.7	1.5	3.0	8.4	12.1	7.4	4.3	2.5	1.0	9.1	5.3	4.4	2.9	2.3	2.1	2.0	8.0	1.7	2.6	6.5	2.8	3.8	1.9	1.3	5.7	2.7	6.2	3.0	4.2	2.2	4.8	6.2	2.2	10.8	4.8	18.2	2.9	0.9	8.5	2.0	4.3	10.9	2.8	4.2	6.8	4.8	8.0	5.0	5.0	6.2	2.7	3.3	2.9	5.6	5.5	3.1	5.4	15.2	3.1	1.8	5.6	8.2	4.0	6.7	5.4	5.9	8.9	5.1	6.0	6.6	0.0	3.0	1.5	2.9	0.7	5.2	1.7	5.1	2.7	0.0	7.0	2.0	4.9	5.0	3.7	65.6	3.7	1.6	0.0	8.1	3.9	4.7	7.7	13.8	4.9	5.7	12.7	1.7	4.9	1.8	37.2	3.1	4.7	6.8	3.6	2.5	14.7	7.6	0.8	9.2	1.8	8.3	12.9	2.7	7.2	6.8	2.9	26.0	4.5	1.6	4.2
FKBP10	"FKBP6, FLJ20683, FLJ22041, FLJ23833, hFKBP65"	ENSG00000141756	"FK506 binding protein 10"	Q96AY3	17	41812680-41823217	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		"Isomerase, Rotamase"	"Disease mutation, Osteogenesis imperfecta"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	8	"Fibroblasts: 83.0;Leydig cells: 43.4;Peritubular cells: 42.1;Sertoli cells: 58.2;Smooth muscle cells: 43.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"NK-cell: 2.0"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"fHDF/TERT166: 72.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA051171, HPA057021"	Enhanced		Approved	Mitochondria	"Intracellular and membrane"	NA	NA		5500	Mitochondria		"HPA051171: AB_2681371, HPA057021: AB_2683312"	"unprognostic (8.30e-2)"	"prognostic unfavorable (4.16e-4)"	"unprognostic (9.05e-2)"	"unprognostic (1.71e-2)"	"unprognostic (4.77e-2)"	"unprognostic (2.95e-2)"	"unprognostic (1.14e-2)"	"unprognostic (9.98e-2)"	"unprognostic (2.21e-2)"	"unprognostic (7.57e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.87e-1)"	"prognostic unfavorable (0.00e+0)"	"unprognostic (1.34e-2)"	"unprognostic (5.77e-2)"	"prognostic unfavorable (3.43e-5)"	"prognostic unfavorable (4.99e-4)"	16.9	16.5	6.6	13.2	7.2	0.2	14.9	3.4	8.4	43.0	11.5	6.0	15.8	3.8	42.7	39.0	14.0	21.4	28.6	19.2	5.6	3.6	10.3	3.2	16.2	17.1	5.3	6.7	35.5	13.5	24.7	22.7	33.8	5.2	21.3	5.7	17.1	6.5	17.0	9.6	8.8	7.6	27.9	5.5	7.9	8.5	15.1	5.7	1.2	16.9	9.5	8.1	24.4	19.2	0.3	0.0	0.0	0.0	2.0	0.9	0.1	0.0	16.2	15.0	49.1	52.8	61.7	13.2	66.9	67.0	25.2	21.8	8.4	0.6	0.0	0.9	72.6	6.4	0.1	8.9	17.8	10.7	4.4	13.5	6.4	18.3	24.0	57.7	0.0	0.0	66.2	0.0	20.6	15.8	48.4	21.4	0.0	0.2	2.3	21.0	21.1	0.0	0.0	11.7	34.3	5.5	1.3	17.7	2.1	4.3	0.0	3.7	13.1	0.1	48.1	22.4	19.8	7.5	0.4	24.2	30.4	15.8	20.2	10.2	0.1	0.0	0.0	41.7	0.0	29.0	0.0	0.0	0.0	0.2	0.0	0.0	0.3	0.1	0.9	0.0	0.0	0.1	0.1	0.0	2.0	0.0	0.0	0.0	0.1	6.6	7.2	3.4	5.8	5.6	3.6	5.3	6.7	5.2	5.7	0.0	7.4	0.0	10.9	7.6	0.8	1.6	2.5	0.0	2.3	0.0	0.0	6.3	0.0	8.8	0.5	23.9	0.0	0.0	4.2	23.1	83.0	4.1	0.0	0.0	4.2	14.3	0.0	34.4	0.0	1.9	43.4	2.2	15.1	0.0	1.4	29.2	3.0	0.0	42.1	0.0	1.0	58.2	43.4	0.5	8.3	4.4	10.0	0.0	0.6	1.7
FKBP11	FKBP19	ENSG00000134285	"FK506 binding protein 11"	Q9NYL4	12	48921518-48926474	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"		"Isomerase, Rotamase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"pancreas: 175.6;salivary gland: 62.0"	"Cell type enhanced"	"Detected in all"	7	"Exocrine glandular cells: 145.3;Melanocytes: 258.1;T-cells: 152.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"MAIT T-cell: 37.6"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HHSteC: 44.0;Karpas-707: 40.1;OE19: 56.1;RPMI-8226: 40.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA041709	Enhanced		Approved	Centrosome		NA	NA			Centrosome		"HPA041709: AB_10794487"	"unprognostic (7.45e-3)"	"unprognostic (8.62e-2)"	"unprognostic (2.40e-1)"	"prognostic favorable (7.09e-4)"	"unprognostic (1.70e-2)"	"unprognostic (2.00e-1)"	"unprognostic (3.46e-2)"	"unprognostic (1.75e-1)"	"unprognostic (7.64e-2)"	"unprognostic (3.49e-3)"	"unprognostic (1.24e-1)"	"unprognostic (1.46e-1)"	"prognostic unfavorable (0.00e+0)"	"unprognostic (2.15e-1)"	"unprognostic (4.51e-1)"	"unprognostic (2.79e-1)"	"unprognostic (1.54e-1)"	5.6	4.6	1.1	8.2	1.4	3.7	3.7	0.9	2.2	7.5	6.9	0.9	21.6	9.2	4.4	12.9	4.4	4.8	8.1	3.4	1.3	2.4	4.8	38.4	5.8	16.6	1.0	1.3	3.7	175.6	0.2	12.3	3.3	1.6	4.8	6.3	1.9	62.0	20.9	1.4	1.7	7.6	2.9	1.0	18.7	10.0	1.9	0.9	2.2	4.7	4.9	14.5	8.2	4.3	11.1	8.3	1.1	0.3	5.1	37.6	7.3	2.0	2.7	0.5	0.7	12.0	18.2	1.0	15.9	22.8	17.6	20.8	10.2	11.4	30.9	0.5	25.9	0.2	8.5	5.5	7.0	9.1	6.5	1.1	1.1	2.9	0.1	44.0	0.6	0.8	20.3	13.5	13.5	25.1	7.5	9.9	10.5	0.4	40.1	6.4	5.8	4.6	1.1	1.4	56.1	5.1	12.7	0.7	40.1	2.2	0.4	6.5	1.9	5.3	7.9	3.5	0.6	0.4	0.9	7.9	3.4	0.6	0.3	0.3	23.5	19.4	15.7	2.1	0.7	5.6	0.9	0.2	0.6	22.5	0.3	37.6	11.1	15.6	17.7	0.3	4.8	9.4	14.4	1.1	5.1	0.1	8.3	6.4	7.3	1.1	1.4	0.9	2.2	1.3	2.4	1.0	1.3	1.6	0.9	14.9	18.4	30.6	44.0	25.1	4.9	1.7	35.7	28.1	19.4	8.7	37.3	19.0	6.6	17.0	15.1	19.7	11.7	46.7	145.3	59.9	74.1	89.1	12.7	90.3	9.7	1.6	24.1	49.1	14.2	13.2	25.6	9.7	258.1	5.4	84.9	1.5	80.1	7.0	13.1	12.2	15.0	6.5	22.1	8.0	6.8	18.6	35.4	152.0	40.1	37.6
FKBP14	"FKBP22, FLJ20731"	ENSG00000106080	"FK506 binding protein 14"	Q9NWM8	7	30010587-30026684	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		"Isomerase, Rotamase"	"Deafness, Ehlers-Danlos syndrome"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA013329, HPA026829"	Uncertain		Approved	"Nucleoplasm,Golgi apparatus,Cytosol"	"Intracellular and membrane"	NA	NA			Cytosol	"Nucleoplasm, Golgi apparatus"	"HPA013329: AB_1848613, HPA026829: AB_10601651"	"prognostic unfavorable (1.60e-4)"	"unprognostic (1.12e-3)"	"unprognostic (6.84e-2)"	"unprognostic (1.23e-2)"	"unprognostic (2.36e-1)"	"unprognostic (1.41e-3)"	"prognostic unfavorable (6.87e-4)"	"unprognostic (6.06e-2)"	"unprognostic (7.00e-2)"	"unprognostic (6.99e-2)"	"unprognostic (2.05e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.93e-3)"	"prognostic unfavorable (4.57e-4)"	"unprognostic (1.15e-1)"	"unprognostic (2.07e-3)"	"prognostic unfavorable (4.25e-4)"	8.8	7.4	8.7	9.2	7.3	5.1	8.8	17.6	7.7	14.9	7.8	4.1	6.9	4.2	12.1	14.2	8.0	8.1	8.5	9.8	7.1	5.2	5.4	9.2	7.6	8.1	9.2	5.2	13.0	9.8	8.6	27.8	10.7	7.1	9.8	6.9	8.4	7.6	10.9	3.3	6.4	5.3	18.8	8.1	6.7	7.2	4.2	7.1	2.6	5.6	5.9	7.7	13.4	8.7	1.6	3.3	2.7	1.2	1.0	1.6	0.6	3.4	2.6	7.4	17.2	19.3	24.8	3.4	17.7	16.6	6.2	12.1	2.2	2.2	1.2	8.4	15.5	7.6	7.6	4.1	6.4	12.4	0.6	5.9	2.8	5.0	6.5	9.8	2.0	4.9	15.5	6.7	10.8	12.8	14.6	13.7	1.8	4.5	2.6	11.1	1.4	1.0	2.4	3.9	3.8	4.8	0.0	5.0	4.0	6.1	3.1	1.9	6.5	6.2	14.2	4.3	9.2	3.2	2.6	11.0	6.6	7.7	11.3	7.0	3.9	4.0	2.1	9.4	1.9	20.6	1.9	1.2	1.2	1.3	0.8	1.0	1.1	1.6	1.1	2.2	1.6	1.5	1.3	2.7	1.0	0.5	3.3	1.4	0.6	8.7	7.3	17.6	7.7	7.1	5.2	9.2	5.2	7.1	7.1	17.9	16.5	3.7	19.2	24.4	15.5	13.5	7.6	2.7	10.3	17.4	25.5	9.5	1.7	6.7	0.3	7.4	3.3	0.0	3.2	24.1	26.4	15.0	2.3	6.6	5.3	14.3	1.2	8.6	2.8	0.0	12.0	5.8	10.1	2.8	7.9	31.5	5.3	14.4	19.4	2.9	19.8	6.5	10.5	0.7	3.3	15.9	13.2	4.3	4.8	24.8
FKBP1A	"FKBP-12, FKBP1, FKBP12, FKBP12C, PKC12, PPIASE"	ENSG00000088832	"FK506 binding protein 1A"	P62942	20	1368978-1393172	"Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"		"Isomerase, Rotamase"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"dendritic cells: 63.6;granulocytes: 88.4;monocytes: 94.3"	"Cell line enhanced"	"Detected in all"		"HUVEC TERT2: 152.2;TIME: 176.4"									"CAB004639, HPA051798"	Uncertain					NA	NA		16000000			"CAB004639: AB_425434, HPA051798: AB_2681615"	"unprognostic (4.09e-2)"	"unprognostic (2.29e-1)"	"unprognostic (5.22e-3)"	"unprognostic (1.28e-2)"	"unprognostic (2.66e-1)"	"unprognostic (7.18e-3)"	"prognostic unfavorable (3.44e-7)"	"unprognostic (7.05e-3)"	"unprognostic (2.76e-1)"	"unprognostic (8.81e-2)"	"unprognostic (5.12e-3)"	"unprognostic (6.65e-2)"	"prognostic unfavorable (6.69e-5)"	"unprognostic (1.97e-2)"	"unprognostic (2.06e-1)"	"unprognostic (1.21e-1)"	"unprognostic (1.47e-1)"	106.0	42.4	67.3	55.0	114.8	44.4	63.5	15.8	55.8	33.2	39.7	22.1	33.8	32.7	45.5	45.9	42.7	33.8	32.0	36.4	51.7	30.6	41.9	41.7	59.2	84.1	26.0	36.5	41.7	57.7	20.6	21.7	65.0	22.5	34.4	49.4	21.4	30.8	40.6	38.9	31.5	37.1	56.0	23.3	68.0	33.0	21.1	28.4	47.4	62.2	39.7	48.3	48.1	37.0	13.3	63.6	88.4	94.3	14.5	18.6	84.3	71.4	19.8	15.8	22.8	53.5	67.2	20.8	45.4	30.8	36.4	33.8	19.8	27.8	29.3	14.6	42.3	52.9	32.9	20.4	83.1	47.9	8.4	22.1	30.0	9.3	37.6	32.9	34.8	16.7	39.0	26.5	33.7	34.8	42.5	152.2	33.0	27.4	15.1	42.8	8.9	34.0	48.0	33.9	25.3	38.8	29.2	27.6	35.4	47.0	18.1	26.3	19.9	22.4	45.3	75.2	22.1	17.7	29.7	176.4	135.4	22.7	28.8	33.5	7.5	16.3	30.6	23.3	35.4	29.9	23.9	79.4	88.4	11.5	94.3	10.2	12.8	13.9	13.2	63.6	13.3	14.8	14.2	77.9	14.5	90.3	31.6	18.6	84.3	67.3	114.8	15.8	55.8	51.7	30.6	26.0	36.5	22.5	28.4	80.4	70.6	192.2	178.9	233.8	16.6	52.9	173.3	66.9	58.0	164.0	0.0	249.8	202.2	393.2	31.1	486.6	196.8	23.3	297.3	496.2	197.8	189.6	142.9	99.4	651.5	33.4	317.5	445.0	487.0	41.0	185.2	363.6	229.5	390.5	244.5	40.1	382.3	768.7	153.1	245.7	11.0	135.8	189.1	153.9	133.6	261.7	193.6	124.6	263.1	202.2
FKBP1B	"FKBP12.6, FKBP1L, FKBP9, OTK4, PPIase"	ENSG00000119782	"FK506 binding protein 1B"	P68106	2	24049701-24063681	"Enzymes, Predicted intracellular proteins"		"Isomerase, Rotamase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 31.1;intestine: 24.9"	"Cell type enhanced"	"Detected in many"	4	"Pancreatic endocrine cells: 37.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"T-reg: 5.4"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"Hep G2: 21.9;NTERA-2: 21.3;SH-SY5Y: 15.5;SuSa: 23.9;TIME: 18.6"	"Low region specificity"	"Detected in all"							"HPA045572, HPA051798"	Uncertain		Approved	Vesicles		NA	NA			Vesicles		"HPA045572: AB_2732521, HPA051798: AB_2681615"	"unprognostic (3.01e-3)"	"unprognostic (3.35e-1)"	"unprognostic (7.05e-2)"	"unprognostic (9.89e-3)"	"unprognostic (1.47e-2)"	"unprognostic (2.10e-1)"	"unprognostic (2.23e-2)"	"unprognostic (9.19e-2)"	"unprognostic (1.29e-1)"	"unprognostic (2.90e-1)"	"unprognostic (9.55e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.12e-1)"	"unprognostic (7.53e-2)"	"unprognostic (3.43e-2)"	"unprognostic (2.85e-2)"	"unprognostic (1.45e-1)"	2.9	5.9	25.0	2.8	30.7	1.9	5.9	15.7	23.1	5.1	7.2	1.6	7.4	24.9	3.6	4.2	4.5	4.5	7.1	3.4	31.1	14.0	4.4	4.6	9.0	2.2	13.0	19.7	4.6	4.9	6.4	2.8	5.6	7.9	5.1	4.6	2.4	3.3	9.2	1.1	3.6	6.7	4.0	5.2	1.8	13.3	1.6	4.4	0.6	5.0	1.1	3.2	7.1	3.5	1.5	2.2	4.4	0.8	0.3	5.4	1.1	0.1	0.9	8.5	0.0	5.4	2.1	3.0	2.8	2.9	1.2	1.8	0.5	1.0	0.0	2.1	5.0	7.7	3.3	12.5	9.8	0.8	1.4	8.0	2.9	0.1	21.9	2.0	0.0	7.0	2.0	2.3	2.9	0.6	7.3	7.9	3.3	0.7	0.0	2.8	0.0	0.9	0.0	21.3	0.7	1.5	1.5	0.7	0.0	0.9	0.5	2.1	15.5	0.1	0.0	2.7	23.9	0.5	1.0	18.6	0.0	2.6	0.1	0.6	0.5	0.2	0.0	3.1	0.0	0.6	1.3	0.8	4.4	0.3	0.7	0.0	0.3	0.6	0.5	2.2	1.5	0.0	0.2	0.1	0.3	0.0	0.4	5.4	1.1	25.0	30.7	15.7	23.1	31.1	14.0	13.0	19.7	7.9	4.4	0.0	5.0	0.0	11.5	8.1	1.2	0.4	28.1	1.4	0.0	7.0	0.0	4.5	11.6	24.5	0.4	9.3	9.3	0.0	33.8	22.1	7.8	15.8	1.1	9.8	6.2	1.6	9.1	11.1	3.4	1.8	2.6	9.4	27.0	19.8	7.9	12.1	37.4	28.1	3.9	4.1	2.5	25.8	11.2	1.4	3.0	6.5	4.3	0.0	3.4	14.5
FKBP2	"FKBP-13, PPIase"	ENSG00000173486	"FK506 binding protein 2"	P26885	11	64241003-64244132	"Enzymes, Predicted intracellular proteins"		"Isomerase, Rotamase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"plasmacytoid DC: 119.6"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB025561, HPA049405"	Enhanced		Approved	"Plasma membrane"	"Intracellular and membrane"	No	No		400000	"Plasma membrane"		"CAB025561: , HPA049405: AB_2680749"	"unprognostic (4.94e-2)"	"unprognostic (1.12e-1)"	"unprognostic (5.77e-2)"	"unprognostic (2.66e-3)"	"unprognostic (7.40e-2)"	"unprognostic (1.92e-2)"	"unprognostic (8.64e-2)"	"unprognostic (1.62e-1)"	"unprognostic (3.23e-1)"	"unprognostic (5.91e-3)"	"unprognostic (5.86e-2)"	"unprognostic (7.18e-2)"	"unprognostic (1.70e-2)"	"unprognostic (1.58e-1)"	"unprognostic (5.23e-1)"	"unprognostic (2.30e-1)"	"unprognostic (3.57e-2)"	18.2	35.8	28.9	20.2	35.5	12.1	20.2	18.8	27.1	31.3	28.0	20.3	87.8	39.0	24.4	102.7	20.8	25.5	30.3	28.0	29.7	35.7	40.3	89.6	18.8	17.0	39.3	24.8	22.1	107.2	34.0	57.2	59.2	29.0	26.1	21.9	19.4	59.3	116.6	11.8	18.5	30.2	19.7	28.5	20.9	31.1	19.8	20.6	12.4	63.2	18.6	18.8	21.3	23.9	21.3	119.6	29.0	25.4	20.0	30.7	15.5	24.2	32.0	17.3	35.0	37.5	21.4	24.6	29.4	29.9	22.3	20.7	31.5	54.7	18.0	46.9	36.1	30.5	31.8	13.7	24.4	10.6	22.3	11.9	19.9	42.6	32.1	49.3	16.5	28.0	24.9	36.4	29.5	32.6	32.2	17.7	16.3	14.9	53.9	26.4	40.1	18.0	26.1	20.2	41.7	28.9	16.1	17.1	65.5	40.3	24.4	24.2	21.1	20.2	57.2	32.4	12.7	22.0	14.3	16.7	26.8	23.9	42.6	15.7	32.8	10.2	14.6	35.9	17.4	30.3	29.0	24.5	3.4	24.1	25.4	30.7	21.3	19.2	23.3	23.2	20.5	13.0	18.1	9.1	20.0	20.8	119.6	7.1	15.5	28.9	35.5	18.8	27.1	29.7	35.7	39.3	24.8	29.0	20.6	137.0	150.2	102.0	207.7	146.1	76.1	98.2	310.8	108.4	116.0	369.9	21.6	256.2	349.8	239.2	83.7	136.1	585.6	23.3	222.4	308.7	201.1	281.8	142.9	635.0	211.8	30.2	328.9	152.9	95.0	70.2	213.2	169.2	285.1	186.7	264.4	122.7	276.9	273.5	239.7	629.6	65.3	181.1	142.1	273.8	237.0	146.9	518.9	105.4	226.6	265.6
FKBP3	"FKBP-25, PPIase"	ENSG00000100442	"FK506 binding protein 3"	Q00688	14	45115600-45135319	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Isomerase, Rotamase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 113.3"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000864, CAB012232, CAB012520"	Supported		Supported	Cytosol		NA	NA		980000	Cytosol		"CAB012232: , CAB012520: AB_873554, HPA000864: AB_1078873"	"unprognostic (7.77e-2)"	"unprognostic (1.47e-1)"	"unprognostic (3.18e-1)"	"unprognostic (9.72e-2)"	"unprognostic (1.25e-1)"	"unprognostic (9.82e-3)"	"unprognostic (3.58e-3)"	"unprognostic (2.28e-1)"	"unprognostic (5.04e-3)"	"unprognostic (1.22e-3)"	"unprognostic (7.47e-2)"	"unprognostic (6.92e-3)"	"unprognostic (1.00e-1)"	"unprognostic (3.07e-1)"	"unprognostic (1.51e-1)"	"unprognostic (1.00e-2)"	"unprognostic (1.47e-1)"	11.7	13.2	28.1	10.2	40.7	9.8	15.5	25.1	32.1	12.0	14.6	11.4	8.3	13.2	9.9	20.4	14.6	8.8	9.1	31.3	26.0	24.4	16.5	20.5	8.0	14.6	23.2	23.8	9.9	10.9	15.0	17.1	14.0	22.9	17.9	15.2	6.6	10.7	12.2	113.3	11.3	13.9	12.8	19.6	9.9	10.6	13.5	22.4	12.7	12.4	24.2	16.5	12.7	9.3	19.5	27.5	13.5	17.4	15.4	19.4	13.0	37.3	41.6	60.6	31.9	27.0	29.4	23.9	23.0	26.4	36.3	40.1	36.3	32.1	19.9	24.3	25.9	20.6	31.1	45.0	29.6	51.9	28.7	26.8	16.4	32.3	46.9	26.6	28.2	17.7	27.7	30.9	21.1	19.7	33.6	47.3	31.7	23.6	15.1	43.1	45.6	45.3	37.9	30.7	41.9	39.5	43.6	44.7	24.2	58.1	43.2	37.0	14.5	36.8	22.9	35.2	47.7	53.6	21.2	30.4	27.8	48.1	14.5	17.6	25.4	45.1	31.0	16.8	19.5	25.9	11.6	14.6	13.5	13.0	17.2	15.7	19.5	17.5	17.6	21.8	13.6	16.8	18.8	2.3	15.4	17.4	27.5	19.4	13.0	28.1	40.7	25.1	32.1	26.0	24.4	23.2	23.8	22.9	22.4	38.7	36.9	49.1	82.5	42.5	68.8	177.9	45.9	77.6	69.4	89.0	9.8	264.9	213.9	116.4	165.9	49.2	61.3	0.0	64.1	95.4	67.9	74.9	51.0	84.7	113.7	38.1	53.9	39.3	36.8	297.6	74.8	68.0	65.8	155.9	63.2	57.4	80.6	52.6	91.9	168.1	44.8	103.5	53.3	145.7	112.4	41.9	138.0	47.9	83.1	70.8
FKBP4	"FKBP52, FKBP59"	ENSG00000004478	"FK506 binding protein 4"	Q02790	12	2794953-2805423	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Chaperone, Isomerase, Rotamase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	4	"vagina: 209.6"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006148, CAB017441, HPA062857"	Supported		Enhanced	Nucleoplasm,Cytosol		NA	NA		110000	Cytosol	Nucleoplasm	"CAB017441: AB_10618759, HPA006148: AB_1078875, HPA062857: AB_2684883"	"unprognostic (1.46e-2)"	"unprognostic (1.73e-2)"	"unprognostic (1.31e-2)"	"prognostic unfavorable (7.65e-4)"	"unprognostic (1.97e-1)"	"unprognostic (1.07e-1)"	"prognostic unfavorable (6.12e-5)"	"prognostic unfavorable (1.44e-4)"	"unprognostic (3.43e-1)"	"unprognostic (3.25e-2)"	"unprognostic (1.72e-1)"	"unprognostic (3.14e-1)"	"unprognostic (3.89e-2)"	"unprognostic (1.59e-2)"	"unprognostic (1.76e-1)"	"unprognostic (1.59e-1)"	"unprognostic (2.22e-1)"	16.2	21.6	26.0	13.7	30.7	13.3	40.7	50.4	31.9	19.9	22.6	22.8	36.2	13.1	20.1	30.7	34.2	25.7	16.4	20.4	25.0	32.5	31.6	31.3	15.8	11.7	44.7	23.4	23.9	30.3	30.1	19.5	32.0	39.4	30.2	25.3	11.5	30.1	31.6	33.5	25.3	16.1	26.4	25.2	11.5	25.3	36.0	42.1	15.6	47.1	16.5	18.5	17.4	209.6	13.8	6.0	10.9	13.7	8.4	14.0	9.9	15.3	34.2	9.9	16.6	12.3	7.3	47.5	15.1	5.4	25.0	16.9	34.0	18.8	20.5	4.3	9.7	17.4	21.1	61.5	20.5	30.1	37.5	39.4	22.6	25.1	12.0	9.5	17.6	6.2	6.6	18.8	29.5	29.6	14.9	14.5	20.8	20.7	29.3	10.0	44.1	30.9	16.0	84.3	45.3	24.7	18.6	17.4	12.3	21.0	19.6	14.3	20.5	17.5	47.8	7.6	64.7	64.4	12.0	7.7	12.3	38.7	13.8	38.0	7.3	11.2	30.3	10.9	26.4	12.5	10.9	10.8	5.9	12.5	9.8	14.0	13.3	11.1	11.8	6.0	13.8	11.8	13.7	1.5	8.4	13.7	5.3	10.1	9.9	26.0	30.7	50.4	31.9	25.0	32.5	44.7	23.4	39.4	42.1	6.0	8.6	47.9	182.5	127.9	60.2	11.7	40.8	16.0	12.5	50.6	70.7	148.6	131.0	77.3	90.2	33.8	86.8	0.0	22.4	85.7	62.6	189.3	39.1	41.9	54.7	92.2	101.7	12.3	15.0	26.1	32.2	42.7	87.7	52.3	61.6	41.8	62.2	84.2	36.4	112.7	51.3	84.1	88.6	179.1	92.0	116.1	186.7	20.2	77.5	121.3
FKBP5	"FKBP51, FKBP54, P54, PPIase, Ptg-10"	ENSG00000096060	"FK506 binding protein 5"	Q13451	6	35573585-35728583	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins"		"Chaperone, Isomerase, Rotamase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 277.2"	"Cell type enhanced"	"Detected in many"	7	"Kupffer cells: 325.8;Peritubular cells: 205.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"ASC diff: 103.4;ASC TERT1: 64.4;HHSteC: 81.0;HSkMC: 97.8;hTCEpi: 49.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009315, HPA031092, HPA031093, HPA031095"	Enhanced		Enhanced	Nucleoplasm		No	No			Nucleoplasm		"CAB009315: AB_2278350, HPA031092: AB_10600195, HPA031093: AB_10601748, HPA031095: AB_2673734"	"unprognostic (2.09e-3)"	"unprognostic (1.70e-1)"	"unprognostic (1.44e-2)"	"unprognostic (1.17e-2)"	"unprognostic (1.02e-1)"	"unprognostic (1.93e-1)"	"unprognostic (4.72e-1)"	"unprognostic (6.30e-3)"	"unprognostic (3.70e-3)"	"unprognostic (1.47e-1)"	"unprognostic (1.69e-1)"	"unprognostic (1.73e-1)"	"unprognostic (7.48e-3)"	"unprognostic (2.18e-3)"	"unprognostic (8.31e-2)"	"unprognostic (4.22e-2)"	"unprognostic (6.90e-3)"	78.8	20.7	9.5	14.2	15.6	4.9	36.7	2.4	10.9	16.5	29.0	5.1	29.8	2.2	18.6	16.9	29.2	19.4	17.9	26.3	10.6	4.2	44.9	30.7	19.7	55.9	15.7	3.6	27.2	43.7	8.6	33.8	6.0	13.1	18.3	8.2	11.8	30.4	25.1	277.2	20.2	36.7	18.6	18.2	32.3	25.0	14.3	12.4	20.1	24.2	9.8	16.8	22.5	18.4	4.0	30.6	24.9	31.2	11.8	42.3	39.9	5.0	2.2	9.7	14.4	103.4	64.4	0.1	2.7	0.1	1.8	4.1	3.8	0.9	25.0	2.6	0.5	1.5	0.0	5.7	12.1	4.3	9.8	5.5	10.7	1.9	5.3	81.0	6.7	1.1	97.8	49.2	3.1	29.7	1.9	10.5	5.0	11.4	10.2	19.0	3.2	27.9	12.6	2.5	1.1	1.6	12.4	2.5	12.2	8.0	3.0	3.7	2.2	2.2	2.6	0.5	2.2	14.3	7.9	23.2	2.6	2.3	0.3	3.8	4.6	5.3	31.7	0.8	13.2	1.0	13.7	31.2	19.4	20.0	27.0	23.8	3.0	28.2	20.8	30.6	4.0	42.3	30.2	24.9	11.8	12.0	9.2	10.3	39.9	9.5	15.6	2.4	10.9	10.6	4.2	15.7	3.6	13.1	12.4	11.9	9.9	41.7	52.1	15.7	1.7	110.1	79.0	21.4	13.6	5.2	0.0	0.6	19.9	0.5	8.8	66.1	19.7	163.5	6.9	0.9	22.2	38.7	36.0	165.7	28.8	0.0	20.1	130.8	325.8	11.8	149.0	56.5	6.8	91.0	17.5	3.7	3.3	9.3	205.4	16.3	18.2	142.3	28.8	11.6	19.2	18.6	0.3	117.1	19.5	19.5
FKBP7	FKBP23	ENSG00000079150	"FK506 binding protein 7"	Q9Y680	2	178463664-178478600	"Enzymes, Predicted intracellular proteins"		"Isomerase, Rotamase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	10	"Early spermatids: 116.0;Fibroblasts: 67.2;Leydig cells: 59.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"ASC diff: 52.8;ASC TERT1: 32.8;HSkMC: 22.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA008707	Approved	Supported	Approved	"Endoplasmic reticulum"	"Intracellular and membrane"	NA	NA			"Endoplasmic reticulum"		"HPA008707: AB_1848624"	"unprognostic (1.33e-1)"	"unprognostic (1.89e-2)"	"unprognostic (1.43e-1)"	"unprognostic (1.67e-1)"	"unprognostic (5.61e-2)"	"unprognostic (1.44e-1)"	"unprognostic (1.25e-1)"	"unprognostic (1.48e-1)"	"unprognostic (1.34e-2)"	"unprognostic (1.83e-2)"	"unprognostic (6.05e-2)"	"unprognostic (8.96e-3)"	"prognostic unfavorable (4.61e-6)"	"unprognostic (3.50e-3)"	"unprognostic (1.34e-2)"	"unprognostic (4.19e-3)"	"unprognostic (1.10e-1)"	9.6	4.6	1.5	4.3	4.1	0.7	11.1	3.5	2.3	20.5	6.9	1.0	10.0	1.8	21.4	21.9	8.4	12.4	12.8	12.1	1.5	1.5	5.5	7.4	6.8	5.2	4.0	1.8	34.6	4.3	1.5	11.1	8.2	2.9	19.5	4.2	7.1	4.9	9.7	4.4	4.0	3.9	19.9	3.9	3.0	5.3	8.3	2.2	2.2	8.7	8.0	2.3	15.5	9.9	2.8	5.8	0.2	1.6	1.2	2.8	0.8	0.0	0.6	6.1	9.0	52.8	32.8	0.5	10.9	18.1	2.0	6.4	0.1	0.6	1.7	2.4	19.9	1.8	0.1	2.3	0.9	3.5	1.4	1.3	1.7	2.5	1.7	8.1	1.1	1.3	22.0	0.5	8.0	1.1	14.7	6.5	2.1	0.8	1.1	8.4	0.1	1.9	1.9	1.2	1.1	0.9	2.5	10.7	2.3	2.7	0.2	3.2	10.6	2.3	0.0	1.8	4.5	0.1	2.1	6.0	3.7	2.3	4.3	1.0	2.1	2.2	0.8	6.8	2.7	8.0	0.0	1.1	0.1	2.3	1.6	2.8	2.8	2.0	1.6	5.8	1.7	2.2	2.4	0.2	1.2	0.0	4.5	2.2	0.8	1.5	4.1	3.5	2.3	1.5	1.5	4.0	1.8	2.9	2.2	6.0	2.6	2.2	6.7	6.3	4.6	12.6	2.5	2.7	3.4	7.0	0.0	6.2	1.7	9.1	116.0	18.6	0.1	0.0	7.4	18.5	67.2	3.6	13.9	9.8	5.3	4.8	1.2	13.5	4.3	22.0	59.2	4.8	16.9	1.8	4.8	3.7	4.0	0.0	45.6	3.5	3.3	6.5	39.2	3.7	5.5	5.1	4.2	5.0	2.6	3.4
FKBP8	"FKBP38, FKBPr38"	ENSG00000105701	"FK506 binding protein 8"	Q14318	19	18531751-18544077	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Apoptosis, Host-virus interaction"	"Isomerase, Rotamase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	7	"Late spermatids: 972.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	5	"eosinophil: 32.5;neutrophil: 31.0"	"Lineage enriched"	"Detected in all"	5	"granulocytes: 32.5"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB025346, HPA045177"	Supported		Supported	"Endoplasmic reticulum,Mitochondria,Cytosol"		NA	NA			Mitochondria	"Endoplasmic reticulum, Cytosol"	"CAB025346: , HPA045177: AB_2679244"	"unprognostic (1.61e-1)"	"unprognostic (1.33e-1)"	"prognostic unfavorable (1.24e-4)"	"unprognostic (8.93e-2)"	"unprognostic (2.73e-1)"	"unprognostic (9.22e-2)"	"unprognostic (2.54e-2)"	"unprognostic (2.26e-1)"	"unprognostic (2.10e-2)"	"unprognostic (1.49e-1)"	"prognostic favorable (7.76e-4)"	"unprognostic (8.51e-2)"	"unprognostic (1.61e-1)"	"unprognostic (2.97e-1)"	"unprognostic (6.89e-2)"	"unprognostic (1.12e-2)"	"unprognostic (2.32e-1)"	44.3	38.1	75.9	27.5	82.1	82.5	26.5	43.4	113.7	35.2	31.9	41.2	34.6	31.1	31.4	27.2	48.7	39.3	34.5	43.4	69.6	62.1	28.9	42.7	34.3	31.1	55.3	54.3	56.1	60.4	28.8	42.2	36.6	51.2	36.5	12.9	31.9	73.1	46.1	56.7	35.1	31.6	34.6	46.3	36.7	31.9	49.5	26.9	32.1	38.8	24.2	30.7	36.3	45.8	4.3	4.3	32.5	6.9	3.1	6.6	9.1	36.9	26.5	20.8	39.5	21.5	33.8	52.2	29.9	31.9	22.9	31.8	25.1	50.5	21.2	48.7	36.7	15.4	20.1	12.8	41.7	6.5	25.8	60.9	19.8	34.6	30.2	37.0	19.6	43.6	44.1	40.2	20.6	13.1	44.1	23.5	41.3	41.4	50.5	19.9	61.6	35.6	58.7	42.5	33.2	38.5	37.4	17.3	72.4	30.8	24.2	23.1	42.1	21.0	17.3	37.3	16.5	20.4	57.2	27.4	28.7	26.2	55.9	22.7	38.6	22.2	24.6	64.8	31.5	25.4	6.3	5.6	32.5	6.0	5.8	5.5	4.1	6.1	6.6	4.3	4.3	4.7	5.3	31.0	3.1	6.9	4.3	6.0	9.1	75.9	82.1	43.4	113.7	69.6	62.1	55.3	54.3	51.2	26.9	8.9	1.4	107.1	128.1	84.6	57.2	2.0	71.4	2.7	5.7	96.0	13.7	219.4	210.5	151.9	314.6	76.6	289.8	233.6	111.8	173.9	174.8	132.3	54.0	55.9	208.7	93.8	197.7	79.8	159.9	972.7	188.7	127.3	192.3	254.3	108.6	104.6	130.6	224.5	155.6	222.1	41.3	97.0	149.9	203.6	97.7	103.1	261.7	163.0	127.0	126.6
FKBP9	"FKBP60, FKBP63"	ENSG00000122642	"FK506 binding protein 9"	O95302	7	32957404-33006931	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Isomerase, Rotamase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"neutrophil: 7.4"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"ASC TERT1: 58.4;fHDF/TERT166: 71.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA012595, HPA055256"	Approved		Approved	"Golgi apparatus,Vesicles,Mitochondria"	"Intracellular and membrane"	No	No			"Golgi apparatus, Mitochondria"	Vesicles	"HPA012595: AB_1848629, HPA055256: AB_2682761"	"unprognostic (1.23e-2)"	"prognostic unfavorable (4.22e-4)"	"unprognostic (6.94e-2)"	"unprognostic (6.25e-3)"	"prognostic unfavorable (5.80e-4)"	"prognostic unfavorable (2.02e-4)"	"prognostic unfavorable (8.69e-4)"	"unprognostic (3.40e-2)"	"unprognostic (9.59e-2)"	"unprognostic (2.58e-1)"	"unprognostic (3.63e-2)"	"unprognostic (3.30e-2)"	"unprognostic (1.36e-2)"	"unprognostic (6.31e-2)"	"unprognostic (1.97e-1)"	"unprognostic (8.90e-3)"	"prognostic unfavorable (7.02e-6)"	35.4	21.1	9.7	12.5	13.6	0.9	43.7	4.5	16.3	33.6	18.3	9.3	16.8	8.8	31.3	30.9	23.7	24.1	28.8	44.4	9.7	11.9	18.2	10.1	30.6	17.5	10.8	9.7	25.9	26.0	12.9	16.0	35.2	13.2	23.7	21.2	30.4	16.0	25.6	17.1	28.0	13.4	37.0	12.8	10.7	17.4	16.3	6.4	2.9	18.9	19.4	11.1	23.7	23.6	0.4	1.4	7.4	4.1	0.3	0.1	0.9	7.1	13.6	5.3	21.9	50.4	58.4	7.1	38.7	40.3	12.8	20.4	5.9	17.0	0.0	15.8	71.8	20.5	14.0	7.8	18.9	14.7	0.0	2.3	1.2	14.6	5.8	21.0	0.0	2.1	37.9	11.5	11.4	11.1	30.5	16.1	0.0	2.7	1.4	26.0	6.9	0.0	3.6	1.1	14.3	7.2	0.0	14.3	0.0	14.3	2.4	5.0	12.1	22.1	11.3	13.7	14.1	7.9	3.5	21.5	21.0	20.2	13.0	8.8	4.6	8.9	0.0	20.5	0.0	41.7	1.5	4.1	0.9	0.1	2.6	0.1	0.4	0.1	0.0	1.4	0.3	0.1	0.1	7.4	0.3	0.7	0.3	0.0	0.9	9.7	13.6	4.5	16.3	9.7	11.9	10.8	9.7	13.2	6.4	11.9	20.0	0.0	12.5	30.5	7.7	38.3	15.3	6.7	7.9	17.4	9.8	17.1	5.0	16.3	0.5	65.3	16.9	0.0	36.7	25.2	46.6	8.5	5.7	10.5	6.7	11.1	11.7	58.9	6.2	0.7	33.9	4.5	57.3	3.6	27.2	34.3	30.2	17.5	51.9	7.4	4.5	45.3	51.9	0.9	0.9	25.0	11.0	1.3	21.4	8.6
FLAD1	"FAD1, PP591"	ENSG00000160688	"Flavin adenine dinucleotide synthetase 1"	Q8NFF5	1	154983338-154993111	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		"Nucleotidyltransferase, Transferase"	"Disease mutation, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028476, HPA028486, HPA028563"	Approved		Supported	"Plasma membrane,Cytosol"		NA	NA			"Plasma membrane, Cytosol"		"HPA028476: AB_10599974, HPA028486: AB_10600206, HPA028563: AB_10602286"	"unprognostic (2.64e-1)"	"unprognostic (2.60e-1)"	"unprognostic (2.72e-1)"	"unprognostic (3.84e-2)"	"unprognostic (7.34e-2)"	"unprognostic (1.45e-1)"	"prognostic unfavorable (3.04e-4)"	"unprognostic (1.31e-1)"	"unprognostic (2.32e-1)"	"unprognostic (8.08e-2)"	"unprognostic (6.51e-2)"	"unprognostic (9.74e-2)"	"prognostic unfavorable (2.55e-6)"	"unprognostic (1.67e-2)"	"unprognostic (5.06e-2)"	"unprognostic (5.50e-2)"	"unprognostic (1.17e-2)"	16.5	16.5	20.3	15.5	18.9	12.1	17.4	15.9	20.8	14.1	16.4	19.3	14.7	19.6	15.9	21.2	19.8	16.7	11.8	16.1	18.2	10.4	19.0	36.5	13.5	20.0	20.8	15.6	14.5	19.0	13.6	12.0	18.5	15.9	18.7	19.0	16.1	16.2	16.3	26.3	23.3	23.9	17.6	12.4	22.9	16.1	19.1	18.9	15.7	20.8	18.4	22.0	15.5	15.4	25.1	24.5	15.2	24.1	14.9	26.4	22.7	13.0	20.9	13.3	22.7	11.6	8.6	25.4	9.9	8.2	14.4	12.4	18.6	16.1	15.2	20.0	9.1	7.5	17.1	25.6	20.5	9.4	15.8	19.2	12.3	16.6	13.1	15.9	17.8	16.1	12.3	26.9	16.4	17.6	7.0	16.7	16.3	19.8	12.4	12.2	28.1	12.2	12.5	29.1	28.4	21.7	20.7	6.6	34.9	13.7	18.2	22.5	30.9	15.5	35.1	19.5	27.0	30.0	27.1	10.5	9.1	12.5	11.6	15.5	19.4	24.0	26.2	10.9	14.5	14.5	15.2	23.0	14.8	24.0	20.9	26.4	25.1	22.1	22.7	24.1	20.5	20.5	20.2	5.2	14.9	24.1	24.5	23.3	22.7	20.3	18.9	15.9	20.8	18.2	10.4	20.8	15.6	15.9	18.9	8.9	8.8	15.9	13.2	23.6	15.2	34.3	20.4	16.0	11.4	24.4	5.9	36.7	26.6	22.3	20.5	11.2	23.6	23.3	24.5	35.2	12.7	16.8	8.1	24.5	24.6	14.3	11.5	9.8	14.6	61.7	9.5	14.0	13.5	41.5	18.3	19.0	20.5	17.5	9.2	27.4	14.7	6.5	13.3	20.0	17.9	24.1	30.1	16.0	19.9	17.0
FLT1	"FLT, VEGFR1"	ENSG00000102755	"Fms related tyrosine kinase 1"	P17948	13	28300344-28495145	"Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins, RAS pathway related proteins"	"Angiogenesis, Chemotaxis, Differentiation"	"Developmental protein, Kinase, Receptor, Transferase, Tyrosine-protein kinase"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	8	"placenta: 155.3"	"Cell type enhanced"	"Detected in many"	16	"Extravillous trophoblasts: 778.4;Ito cells: 284.2;Syncytiotrophoblasts: 942.6"	"Cancer enhanced"	"Detected in all"		"renal cancer: 28.7"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	4	"memory B-cell: 1.1;naive B-cell: 3.7;neutrophil: 2.1"	"Group enriched"	"Detected in many"	5	"B-cells: 3.7;granulocytes: 2.1"	"Cell line enhanced"	"Detected in some"		"BJ: 17.4;BJ hTERT+: 13.8;HMC-1: 86.4;HUVEC TERT2: 15.6;WM-115: 31.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA011740, HPA014290, CAB068189, CAB068190"	Enhanced		Supported	"Plasma membrane,Actin filaments"	"Secreted to blood"	NA	NA	876000	54000	"Plasma membrane"	"Actin filaments"	"CAB068189: AB_2665636, CAB068190: AB_2665637, HPA011740: AB_1858737, HPA014290: AB_1858738"	"unprognostic (3.33e-2)"	"unprognostic (3.52e-3)"	"unprognostic (1.13e-3)"	"unprognostic (5.02e-2)"	"unprognostic (3.65e-1)"	"unprognostic (5.03e-2)"	"unprognostic (8.25e-2)"	"unprognostic (2.27e-3)"	"unprognostic (9.91e-2)"	"unprognostic (6.61e-2)"	"unprognostic (2.33e-1)"	"unprognostic (1.57e-1)"	"prognostic unfavorable (2.19e-4)"	"unprognostic (4.20e-2)"	"unprognostic (6.00e-2)"	"unprognostic (1.57e-1)"	"unprognostic (6.32e-2)"	18.9	4.0	9.9	4.0	14.3	1.2	13.5	8.0	15.9	7.1	4.6	3.5	1.7	3.5	7.2	2.2	3.4	4.0	6.9	18.3	11.4	7.3	10.3	7.6	12.3	2.5	10.3	3.2	5.1	5.4	13.4	3.7	155.3	13.8	5.1	3.1	9.1	3.0	5.0	12.5	2.6	3.4	7.3	9.6	7.2	4.6	6.8	10.2	0.0	19.1	3.8	2.8	7.6	9.2	3.7	0.5	2.1	0.1	0.2	0.4	0.2	0.0	0.0	0.0	0.1	0.1	0.2	0.0	17.4	13.8	6.3	3.7	0.0	0.0	0.0	0.0	2.2	0.0	0.0	1.6	0.0	11.2	0.0	0.4	0.0	0.0	0.0	0.0	0.0	86.4	0.1	0.0	0.0	0.2	0.0	15.6	1.4	0.4	0.0	0.0	0.0	1.0	0.8	9.2	0.0	0.0	0.6	0.0	0.0	0.0	0.0	2.0	0.1	0.0	0.0	0.0	11.4	0.0	0.0	1.5	0.0	0.3	0.0	0.0	0.5	0.2	0.0	0.1	0.0	31.0	0.2	0.1	0.1	0.1	0.1	0.0	1.1	0.1	0.1	0.0	3.7	0.4	0.4	2.1	0.2	0.1	0.5	0.2	0.2	9.9	14.3	8.0	15.9	11.4	7.3	10.3	3.2	13.8	10.2	0.0	8.9	2.2	0.5	3.7	5.9	12.6	5.1	2.7	1.2	0.0	3.9	155.4	1.7	0.0	116.6	192.1	0.0	0.0	0.0	778.4	17.5	1.1	1.1	2.1	28.1	1.6	0.0	284.2	16.1	130.7	17.3	5.3	0.0	0.0	0.0	172.0	0.0	0.0	45.6	0.0	7.3	90.5	6.6	12.9	2.8	4.3	942.6	2.9	0.0	0.5
FLT3	"CD135, FLK2, STK1"	ENSG00000122025	"Fms related tyrosine kinase 3"	P36888	13	28003274-28100592	"Cancer-related genes, CD markers, Disease related genes, Enzymes, FDA approved drug targets, Predicted membrane proteins, RAS pathway related proteins"	"Host-virus interaction"	"Kinase, Receptor, Transferase, Tyrosine-protein kinase"	"Cancer-related genes, Disease mutation, FDA approved drug targets, Proto-oncogene"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 29.9;brain: 19.3;lymphoid tissue: 15.0"	"Cell type enhanced"	"Detected in some"	25	"Kupffer cells: 29.6;Macrophages: 12.4;monocytes: 55.9"	"Cancer enhanced"	"Detected in some"		"breast cancer: 1.8"	"Region enhanced"	"Detected in many"		"cerebellum: 19.3"	"Group enriched"	"Detected in some"	11	"myeloid DC: 29.9;plasmacytoid DC: 12.1"	"Lineage enriched"	"Detected in many"	16	"dendritic cells: 29.9"	"Group enriched"	"Detected in some"	11	"REH: 28.5;THP-1: 17.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA047539			Approved	"Endoplasmic reticulum"		NA	NA		180000	"Endoplasmic reticulum"		"HPA047539: AB_2680080"	"unprognostic (2.19e-3)"	"unprognostic (3.16e-3)"	"unprognostic (6.54e-3)"	"unprognostic (9.96e-2)"	"unprognostic (3.88e-1)"	"unprognostic (3.96e-7)"	"unprognostic (7.99e-3)"	"unprognostic (1.65e-2)"	"unprognostic (5.37e-2)"	"unprognostic (1.01e-2)"	"unprognostic (1.96e-1)"	"unprognostic (1.03e-1)"	"unprognostic (4.56e-2)"	"unprognostic (3.65e-1)"	"unprognostic (3.91e-2)"	"unprognostic (2.51e-1)"	"unprognostic (2.22e-1)"	0.9	0.6	0.6	7.2	1.1	7.5	2.6	19.3	3.5	0.9	1.2	0.1	0.1	0.4	0.8	0.8	1.0	1.2	4.6	0.5	0.9	1.7	2.8	0.7	2.7	15.0	1.8	1.1	0.5	5.7	0.0	0.4	0.0	7.4	0.6	1.4	0.1	2.3	0.6	0.4	1.2	3.0	1.3	4.4	8.8	0.9	1.2	0.0	8.2	0.6	0.0	5.8	2.4	0.7	0.1	29.9	1.4	1.8	0.8	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	2.1	0.5	0.0	0.0	28.5	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	17.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	1.8	1.4	0.0	0.3	0.0	0.1	0.0	0.0	29.9	0.0	0.0	0.0	0.0	0.8	0.0	12.1	0.0	1.2	0.6	1.1	19.3	3.5	0.9	1.7	1.8	1.1	7.4	0.0	0.0	0.0	0.8	0.0	0.2	0.0	0.3	2.5	0.0	0.0	0.0	0.0	0.0	0.0	2.2	3.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.5	0.0	0.0	1.3	29.6	1.6	0.0	12.4	1.7	55.9	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.5	0.5	0.0	0.0	0.0	0.0
FLT4	"PCL, VEGFR3"	ENSG00000037280	"Fms related tyrosine kinase 4"	P35916	5	180601506-180649624	"Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins, RAS pathway related proteins"	Angiogenesis	"Kinase, Receptor, Transferase, Tyrosine-protein kinase"	"Cancer-related genes, Disease mutation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"placenta: 56.3"	"Group enriched"	"Detected in some"	5	"Extravillous trophoblasts: 31.7;Ito cells: 65.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in some"	5	"MAIT T-cell: 7.7"	"Lineage enriched"	"Detected in single"	35	"T-cells: 7.7"	"Cell line enhanced"	"Detected in some"		"AN3-CA: 8.3;BEWO: 10.1;HEK 293: 12.5;HUVEC TERT2: 8.1;JURKAT: 10.0;T-47d: 11.9;TIME: 12.6"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"CAB000099, HPA046519, HPA067906, HPA074389"	Approved		Supported	"Nuclear speckles,Plasma membrane,Cell Junctions"	"Secreted to blood"	NA	NA		270000000	"Nuclear speckles, Plasma membrane"	"Cell Junctions"	"CAB000099: , HPA046519: AB_2732527, HPA067906: AB_2732775, HPA074389: "	"unprognostic (7.35e-2)"	"unprognostic (1.63e-1)"	"unprognostic (9.45e-3)"	"unprognostic (3.81e-1)"	"unprognostic (9.26e-2)"	"unprognostic (3.20e-3)"	"unprognostic (1.13e-2)"	"unprognostic (1.80e-2)"	"unprognostic (2.19e-1)"	"unprognostic (1.70e-1)"	"unprognostic (2.13e-2)"	"unprognostic (3.69e-1)"	"unprognostic (1.88e-2)"	"unprognostic (9.41e-3)"	"unprognostic (1.83e-1)"	"unprognostic (8.26e-2)"	"unprognostic (1.32e-1)"	14.8	7.1	1.6	4.9	6.0	0.7	28.5	1.3	2.7	6.3	7.3	1.9	2.1	3.1	7.3	6.2	5.7	9.2	5.3	6.4	1.7	0.9	11.7	10.2	14.1	23.6	2.0	0.8	5.8	2.3	2.3	6.2	56.3	2.1	4.9	1.4	6.7	3.3	4.4	4.8	2.8	4.7	4.7	1.5	14.5	2.4	3.5	2.0	0.3	19.4	4.4	2.3	6.1	14.7	0.0	0.1	0.2	0.0	0.0	7.7	0.2	0.1	2.0	2.7	8.3	0.0	0.0	10.1	0.2	0.1	0.0	0.0	0.3	0.3	0.2	0.8	0.1	0.5	0.3	2.8	0.1	0.2	0.1	12.5	1.0	0.4	0.4	0.1	7.4	0.2	0.2	0.0	0.1	0.3	0.3	8.1	10.0	0.3	0.3	1.7	4.5	0.1	0.4	5.8	0.2	0.5	6.5	0.0	0.1	0.1	0.2	0.2	0.9	0.1	0.2	0.0	2.7	11.9	0.2	12.6	0.1	5.9	0.2	0.1	0.2	0.1	0.0	0.0	0.2	0.1	0.1	0.0	0.0	0.9	0.0	7.7	0.0	0.4	1.6	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.1	0.0	0.2	1.6	6.0	1.3	2.7	1.7	0.9	2.0	0.8	2.1	2.0	0.0	1.7	0.9	0.2	0.8	0.0	4.5	0.0	0.0	1.2	0.0	0.0	0.3	0.0	0.0	0.2	9.2	0.0	0.0	0.0	31.7	0.6	0.2	2.3	0.4	1.1	0.0	0.0	65.1	5.7	0.0	0.3	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.1	4.3	1.0	0.8	0.7	0.0	0.1
FMO1		ENSG00000010932	"Flavin containing monooxygenase 1"	Q01740	1	171248471-171285978	"Enzymes, Predicted membrane proteins"		"Monooxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"kidney: 70.4"	"Cell type enriched"	"Detected in some"	12	"Proximal tubular cells: 142.2"	"Cancer enriched"	"Detected in many"	8	"renal cancer: 18.0"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	36	"naive B-cell: 3.5"	"Lineage enriched"	"Detected in single"	36	"B-cells: 3.5"	"Cell line enriched"	"Detected in some"	7	"HSkMC: 22.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			HPA078132	Approved					NA	NA					"HPA078132: "	"unprognostic (1.04e-1)"	"unprognostic (1.05e-2)"	"unprognostic (5.87e-2)"	"unprognostic (1.34e-1)"	"unprognostic (5.32e-3)"	"unprognostic (1.89e-2)"	"unprognostic (1.04e-1)"	"unprognostic (4.04e-1)"	"unprognostic (9.16e-2)"	"unprognostic (9.03e-2)"	"unprognostic (1.36e-2)"	"unprognostic (2.23e-1)"	"prognostic favorable (2.81e-4)"	"unprognostic (6.49e-4)"	"unprognostic (1.40e-1)"	"unprognostic (3.58e-1)"	"unprognostic (1.37e-1)"	3.4	3.6	0.1	0.1	0.3	0.0	5.6	0.1	0.4	5.6	0.8	0.3	0.8	0.0	2.5	3.0	5.0	3.3	1.8	0.9	0.1	0.0	70.4	1.0	0.8	0.1	0.1	0.1	5.9	2.4	0.1	1.1	0.8	0.2	1.1	0.0	4.0	4.2	1.5	0.1	4.0	14.4	1.5	0.1	0.1	0.5	1.6	0.1	1.8	1.7	5.3	10.3	1.4	1.1	3.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.9	1.1	0.0	0.0	1.2	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	22.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.1	0.4	0.1	0.0	0.1	0.1	0.2	0.1	0.0	0.0	0.0	0.4	2.9	0.0	8.7	5.1	0.0	0.0	3.5	0.0	0.2	11.6	0.0	0.6	0.0	0.0	0.0	0.0	0.0	8.8	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	1.0	10.0	0.0	1.7	0.0	0.3	0.0	0.0	0.0	2.5	142.2	0.0	6.5	1.4	0.0	0.0	1.9	0.7	0.0	0.0	0.0
FMO2		ENSG00000094963	"Flavin containing monooxygenase 2"	Q99518	1	171185208-171211230	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"		"Monooxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 40.0;esophagus: 35.3;lung: 53.0"	"Group enriched"	"Detected in many"	6	"Alveolar cells type 1: 428.8;Club cells: 348.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	57	"ASC diff: 24.6;ASC TERT1: 11.2;HSkMC: 29.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA028261	Approved					NA	NA					"HPA028261: AB_10601012"	"unprognostic (1.85e-2)"	"unprognostic (3.14e-2)"	"unprognostic (7.44e-2)"	"unprognostic (3.75e-2)"	"unprognostic (2.80e-1)"	"unprognostic (1.37e-2)"	"unprognostic (1.66e-3)"	"unprognostic (3.00e-2)"	"unprognostic (2.74e-1)"	"unprognostic (1.58e-2)"	"unprognostic (1.16e-1)"	"unprognostic (4.28e-1)"	"unprognostic (1.53e-1)"	"unprognostic (1.26e-3)"	"unprognostic (3.47e-1)"	"unprognostic (1.62e-1)"	"unprognostic (3.83e-2)"	40.0	11.8	1.2	1.7	4.4	0.0	22.5	1.5	0.6	7.6	5.0	0.6	2.9	0.3	1.9	3.5	35.3	6.7	2.0	17.4	1.8	1.2	9.4	1.8	53.0	5.7	3.9	1.2	6.1	2.1	1.8	7.0	0.0	2.4	6.0	0.7	8.3	14.0	1.3	7.6	1.7	1.5	2.5	1.9	0.4	2.4	3.3	1.3	0.4	5.8	6.8	5.5	5.0	10.2	0.7	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	24.6	11.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	29.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	1.2	4.4	1.5	0.6	1.8	1.2	3.9	1.2	2.4	1.3	428.8	20.8	0.0	5.3	0.3	0.2	6.9	0.0	62.9	348.1	1.8	0.0	0.0	0.0	0.0	2.7	5.3	0.0	0.0	0.0	0.0	0.6	3.0	3.5	0.0	0.0	0.0	0.0	4.3	0.0	2.3	0.9	0.9	0.0	0.0	0.0	0.0	0.7	0.0	0.0	8.4	0.2	0.0	3.4	0.3	0.0	0.0	0.0	0.0	0.0	1.1
FMO3		ENSG00000007933	"Flavin containing monooxygenase 3"	P31513	1	171090877-171117819	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"		"Monooxygenase, Oxidoreductase"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	18	"liver: 170.2"	"Cell type enriched"	"Detected in some"	12	"Hepatocytes: 378.8"	"Cancer enriched"	"Detected in many"	13	"liver cancer: 94.9"	"Region enriched"	"Detected in single"	5	"pons and medulla: 1.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"ASC diff: 25.4;ASC TERT1: 19.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA013750	Enhanced					NA	NA					"HPA013750: AB_1848968"	"unprognostic (1.87e-2)"	"unprognostic (6.30e-2)"	"unprognostic (1.00e-1)"	"unprognostic (6.81e-3)"	"unprognostic (2.64e-1)"	"unprognostic (1.31e-3)"	"prognostic favorable (3.46e-4)"	"prognostic favorable (5.60e-5)"	"unprognostic (2.95e-1)"	"unprognostic (9.34e-2)"	"unprognostic (3.02e-1)"	"unprognostic (7.21e-2)"	"prognostic unfavorable (1.13e-4)"	"unprognostic (1.84e-1)"	"unprognostic (2.59e-1)"	"unprognostic (3.45e-1)"	"unprognostic (7.27e-2)"	9.5	2.0	0.0	0.8	0.2	0.0	1.3	0.1	0.1	0.2	0.8	0.1	0.1	0.3	0.6	1.2	1.7	2.3	0.3	0.8	0.0	0.1	6.4	170.2	3.7	1.5	0.2	0.0	0.9	0.7	0.3	2.7	0.0	1.4	0.2	0.1	3.6	0.9	0.1	1.9	0.8	0.4	0.2	0.1	0.1	0.6	0.5	0.1	0.0	0.8	1.2	2.6	0.2	0.0	0.7	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	25.4	19.2	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.3	0.0	5.3	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.1	0.1	0.0	0.1	0.2	0.0	1.4	0.1	11.9	0.3	0.9	0.3	0.3	0.0	0.3	5.1	32.1	27.3	0.0	0.0	0.0	0.0	0.0	0.1	1.3	0.0	0.0	0.0	0.0	0.9	0.1	0.0	378.8	0.0	0.0	0.0	4.9	6.9	0.0	0.3	0.0	1.7	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.1	6.5	3.8	0.0	0.0	0.4	0.0	0.0	0.0	0.0
FMO4	FMO2	ENSG00000076258	"Flavin containing monooxygenase 4"	P31512	1	171314208-171342084	"Enzymes, Predicted membrane proteins"		"Monooxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 33.8;liver: 42.2"	"Cell type enhanced"	"Detected in many"	10	"Distal tubular cells: 24.9;Hepatocytes: 19.8;Proximal tubular cells: 33.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"EFO-21: 7.9;HSkMC: 9.3"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"HPA049100, HPA072438"	Approved		Approved	Vesicles,Cytosol		NA	NA			"Vesicles, Cytosol"		"HPA049100: AB_2680629, HPA072438: "	"unprognostic (1.83e-2)"	"unprognostic (1.17e-1)"	"unprognostic (6.18e-2)"	"unprognostic (3.01e-2)"	"unprognostic (8.27e-2)"	"unprognostic (4.13e-1)"	"prognostic favorable (1.09e-4)"	"prognostic favorable (7.45e-4)"	"unprognostic (3.12e-2)"	"unprognostic (2.15e-1)"	"unprognostic (5.99e-2)"	"unprognostic (2.90e-1)"	"prognostic favorable (6.96e-4)"	"unprognostic (1.03e-1)"	"unprognostic (1.69e-1)"	"unprognostic (7.45e-3)"	"unprognostic (1.95e-1)"	5.3	3.6	1.4	5.1	4.8	0.9	4.5	0.6	2.7	4.5	6.0	4.8	3.1	4.2	3.0	10.0	4.6	3.8	4.6	6.3	2.3	1.5	33.8	42.2	3.4	2.8	7.5	2.8	4.1	3.2	5.5	5.0	2.3	3.7	3.9	3.7	6.7	2.7	2.0	1.6	2.9	16.1	2.0	7.0	3.8	3.9	2.0	6.2	2.7	4.5	3.3	3.4	2.9	3.7	5.3	2.9	0.9	4.0	3.9	4.9	2.0	0.1	0.0	0.4	0.6	5.5	5.0	0.2	1.1	5.0	1.6	1.7	0.8	7.2	4.4	7.9	0.0	2.6	0.3	0.8	1.3	2.2	2.1	1.1	0.0	0.0	0.1	0.8	0.9	1.0	9.3	3.2	0.6	1.3	0.6	0.3	2.2	0.2	3.3	0.7	1.0	2.1	1.9	0.5	1.3	1.6	0.4	0.5	2.5	3.5	0.0	0.2	0.0	1.5	1.5	3.0	5.7	3.1	1.3	0.1	1.3	0.4	1.4	1.0	4.0	1.3	2.7	2.4	1.5	1.1	0.6	2.6	0.9	2.5	4.0	1.8	3.1	2.4	3.3	2.2	5.3	3.3	2.5	0.5	3.9	2.7	2.9	4.9	2.0	1.4	4.8	0.6	2.7	2.3	1.5	7.5	2.8	3.7	6.2	0.0	1.6	0.5	3.8	2.5	0.0	3.5	2.5	6.7	0.0	8.7	0.0	2.1	24.9	1.6	4.0	0.9	8.6	0.0	1.2	1.2	3.1	1.1	1.1	19.8	3.2	0.0	1.2	1.8	5.7	0.4	1.4	2.3	5.0	1.8	1.9	1.5	0.9	0.0	0.4	33.2	0.0	0.0	1.2	0.2	0.2	1.4	1.6	0.5	1.4	1.7
FMO5		ENSG00000131781	"Flavin containing monooxygenase 5"	P49326	1	147175351-147243050	"Cancer-related genes, Enzymes, Predicted intracellular proteins, Predicted membrane proteins"		"Monooxygenase, Oxidoreductase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"intestine: 61.1;liver: 119.4;stomach 1: 38.6"	"Cell type enhanced"	"Detected in many"	17	"Cholangiocytes: 117.2;Hepatocytes: 260.8"	"Cancer enriched"	"Detected in many"	7	"liver cancer: 43.0"	"Group enriched"	"Detected in many"	6	"basal ganglia: 5.5;cerebral cortex: 4.5;midbrain: 17.1;pons and medulla: 5.2;thalamus: 6.0"	"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"Hep G2: 29.0;HMC-1: 6.6;THP-1: 7.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA012373	Enhanced		Supported	"Endoplasmic reticulum,Cytosol"		NA	NA			"Endoplasmic reticulum, Cytosol"		"HPA012373: AB_1848975"	"unprognostic (2.70e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.33e-1)"	"unprognostic (2.06e-2)"	"unprognostic (1.39e-1)"	"unprognostic (3.96e-2)"	"unprognostic (2.43e-2)"	"unprognostic (2.94e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.85e-2)"	"unprognostic (2.93e-1)"	"unprognostic (1.13e-1)"	"prognostic favorable (1.34e-6)"	"unprognostic (3.77e-1)"	"unprognostic (1.38e-1)"	"unprognostic (1.85e-1)"	"unprognostic (4.11e-2)"	1.1	2.4	1.1	1.9	5.5	0.2	8.6	0.6	4.5	1.3	61.1	1.5	0.8	12.5	1.0	1.3	0.7	1.1	8.5	1.0	1.3	0.5	9.0	119.4	17.0	0.8	17.1	0.5	1.0	11.9	8.8	4.9	0.6	5.2	1.9	8.2	0.5	9.7	0.6	0.4	4.2	53.6	0.9	7.1	1.2	38.6	1.2	6.0	0.2	1.1	1.5	0.5	1.9	0.8	9.2	4.9	6.2	12.1	1.0	2.0	3.6	0.1	0.7	0.5	0.1	1.9	0.5	0.7	0.4	0.4	0.2	0.6	0.4	1.5	0.3	0.5	0.4	0.1	0.3	0.0	0.0	0.0	1.0	0.1	1.2	0.0	29.0	0.6	1.0	6.6	0.9	0.1	0.3	0.0	0.3	0.4	0.2	0.1	0.1	1.1	1.0	0.2	0.5	2.1	3.6	0.5	0.3	0.3	0.2	2.4	0.4	0.4	0.2	0.6	2.0	0.9	1.0	1.4	7.4	0.7	0.0	0.2	0.6	0.0	0.2	0.0	0.2	0.7	0.3	0.2	6.2	12.1	3.5	2.0	5.6	0.3	3.6	0.5	0.6	4.9	9.2	0.3	1.3	1.2	1.0	1.6	2.4	1.4	3.6	1.1	5.5	0.6	4.5	1.3	0.5	17.1	0.5	5.2	6.0	8.9	48.6	8.5	3.5	1.4	2.0	1.4	117.2	21.4	13.6	14.0	0.0	1.2	6.6	4.3	5.9	2.7	52.0	0.0	5.1	0.9	1.3	4.1	5.7	260.8	3.2	3.2	6.4	3.1	10.1	4.1	2.6	2.6	27.0	0.0	25.3	0.3	5.7	28.1	1.4	41.5	1.3	0.0	0.8	1.8	0.7	1.4	1.1	4.3	16.4	6.2
FNTA	"FPTA, PGGT1A, PTAR2"	ENSG00000168522	"Farnesyltransferase, CAAX box, alpha"	P49354	8	43034194-43085788	"Enzymes, Predicted intracellular proteins"		"Prenyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB010149, HPA018830"	Approved		Approved	Cytosol		NA	NA		220000	Cytosol		"CAB010149: AB_2106299, HPA018830: AB_1848992"	"unprognostic (2.09e-1)"	"unprognostic (1.35e-1)"	"unprognostic (2.90e-1)"	"unprognostic (1.86e-3)"	"unprognostic (2.64e-1)"	"unprognostic (4.70e-3)"	"unprognostic (1.83e-2)"	"unprognostic (3.69e-2)"	"unprognostic (1.70e-2)"	"unprognostic (5.37e-2)"	"unprognostic (3.25e-2)"	"unprognostic (4.10e-1)"	"prognostic unfavorable (2.94e-12)"	"unprognostic (3.63e-2)"	"unprognostic (2.33e-1)"	"unprognostic (3.19e-2)"	"unprognostic (1.29e-3)"	32.5	21.5	25.3	20.9	31.9	15.3	29.8	21.2	28.8	26.7	25.7	36.9	25.0	23.7	23.7	29.4	28.0	22.9	18.1	32.6	25.6	23.1	24.0	30.5	22.7	27.4	43.3	23.8	21.5	26.0	17.9	24.7	32.6	33.4	25.1	22.5	14.1	23.6	25.9	45.2	29.7	20.4	23.9	75.9	22.9	20.9	18.3	36.8	26.0	25.4	26.8	28.1	27.1	29.8	11.7	11.7	11.1	8.9	13.9	11.9	5.3	24.0	11.9	16.5	5.3	29.0	37.8	13.7	14.0	16.4	16.4	15.1	19.3	18.6	28.3	10.8	17.6	21.8	13.2	20.3	23.3	19.3	7.4	13.4	22.1	8.1	16.6	37.8	9.0	11.9	29.2	38.1	11.8	33.8	23.7	28.1	15.3	26.8	16.6	18.0	2.8	21.6	13.8	28.5	20.4	8.7	18.9	26.2	15.2	22.5	17.9	9.8	15.2	18.2	15.1	24.0	19.5	19.2	17.1	22.6	5.5	7.2	22.3	14.9	15.6	13.1	27.6	14.5	17.5	12.9	3.0	6.6	11.1	8.7	8.9	10.3	11.7	9.1	11.7	11.7	11.6	11.9	11.9	1.6	13.9	6.7	11.0	11.5	5.3	25.3	31.9	21.2	28.8	25.6	23.1	43.3	23.8	33.4	36.8	53.6	16.9	34.6	70.9	78.0	21.6	35.9	28.1	41.5	27.3	31.4	35.3	121.1	59.7	61.9	33.1	51.7	30.3	23.3	61.0	105.3	62.9	62.6	32.3	25.4	71.6	19.1	30.9	49.1	38.3	40.9	44.5	50.7	89.4	75.7	36.2	36.3	57.6	42.1	56.6	40.2	53.7	51.8	48.7	59.3	32.4	83.6	173.5	55.4	39.1	62.6
FNTB	FPTB	ENSG00000257365	"Farnesyltransferase, CAAX box, beta"	P49356	14	64986720-65062652	"Enzymes, Predicted intracellular proteins"		"Prenyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	5	"brain: 75.0"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA062743	Uncertain		Approved	Centrosome		NA	NA			Centrosome		"HPA062743: AB_2684861"	"unprognostic (2.79e-1)"	"unprognostic (1.50e-2)"	"unprognostic (1.54e-1)"	"unprognostic (8.57e-3)"	"unprognostic (1.88e-1)"	"unprognostic (6.88e-2)"	"prognostic unfavorable (6.03e-4)"	"unprognostic (6.21e-2)"	"unprognostic (3.11e-2)"	"unprognostic (1.46e-2)"	"unprognostic (1.70e-2)"	"unprognostic (2.11e-1)"	"unprognostic (2.49e-3)"	"unprognostic (2.36e-2)"	"unprognostic (3.60e-1)"	"unprognostic (5.56e-2)"	"unprognostic (1.11e-3)"	7.4	9.0	6.3	4.9	21.9	2.3	7.8	11.4	13.7	8.0	6.3	24.3	6.2	5.6	6.4	6.6	13.5	9.0	5.1	12.0	8.1	7.9	8.0	5.6	7.0	5.1	34.0	7.2	7.4	5.9	13.6	7.9	8.2	25.4	8.9	7.9	4.4	8.0	9.6	14.3	10.3	5.1	11.6	75.0	4.6	5.7	9.0	22.2	4.7	5.6	5.8	7.3	7.4	7.8	2.4	6.4	12.3	10.3	2.8	8.8	5.3	18.7	13.6	10.6	6.0	6.8	6.0	7.8	10.8	8.0	12.3	12.7	7.2	7.7	3.2	6.2	11.4	6.8	12.5	25.5	8.4	10.1	4.5	7.2	12.7	3.7	10.5	4.4	4.3	17.6	5.1	7.3	5.3	2.9	11.5	10.2	5.9	6.8	4.6	7.1	12.4	6.5	7.2	4.6	11.6	13.9	6.4	9.9	4.0	8.4	6.9	6.8	6.7	6.7	13.3	14.7	8.8	12.2	7.5	8.0	8.9	18.4	4.0	6.9	2.4	2.7	3.2	10.3	5.6	20.5	12.3	10.3	9.2	3.6	8.6	8.8	2.4	5.5	4.3	6.4	1.9	4.5	3.3	2.7	2.8	4.3	4.9	5.1	5.3	6.3	21.9	11.4	13.7	8.1	7.9	34.0	7.2	25.4	22.2	11.9	2.1	0.0	2.9	2.2	4.4	6.1	2.5	1.4	6.8	3.5	2.0	13.7	0.0	5.9	5.2	2.9	3.3	0.0	4.2	12.8	5.8	5.0	0.0	7.3	7.0	4.8	7.5	5.5	9.5	4.5	5.2	3.4	5.0	7.2	5.5	7.0	4.0	0.0	8.1	4.6	4.0	19.4	2.7	2.1	3.2	3.1	6.9	2.5	5.0	2.6
FOLH1	"FOLH, GCP2, GCPII, NAALAD1, NAALAdase, PSM, PSMA"	ENSG00000086205	"Folate hydrolase 1"	Q04609	11	49146635-49208670	"Cancer-related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"		"Carboxypeptidase, Dipeptidase, Hydrolase, Metalloprotease, Multifunctional enzyme, Protease"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 37.7;intestine: 111.2;prostate: 33.8"	"Cell type enhanced"	"Detected in some"	16	"Glandular cells: 41.1;Hepatocytes: 24.1;Muller glia cells: 17.3;Proximal tubular cells: 22.6"	"Cancer enriched"	"Detected in many"	27	"prostate cancer: 142.7"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"HAP1: 5.4;RPMI-8226: 3.8;SK-BR-3: 4.5;TIME: 2.9;U-2 OS: 2.7;WM-115: 5.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB001451, HPA010593"	Enhanced					NA	NA					"CAB001451: AB_563979, HPA010593: AB_1079685"	"unprognostic (1.33e-1)"	"unprognostic (1.19e-1)"	"unprognostic (1.24e-1)"	"prognostic favorable (5.24e-5)"	"unprognostic (2.55e-1)"	"unprognostic (8.31e-2)"	"prognostic favorable (4.25e-4)"	"unprognostic (1.32e-1)"	"unprognostic (2.09e-2)"	"unprognostic (2.67e-3)"	"unprognostic (2.13e-2)"	"unprognostic (2.72e-1)"	"prognostic unfavorable (1.30e-6)"	"unprognostic (4.81e-2)"	"unprognostic (7.27e-2)"	"unprognostic (4.74e-3)"	"unprognostic (4.04e-1)"	1.2	1.0	10.4	0.9	16.4	0.8	2.5	1.4	12.7	1.4	67.6	37.7	0.0	111.2	1.3	0.8	1.2	2.1	5.0	0.7	16.9	8.7	6.1	15.7	1.1	0.9	19.0	9.1	1.0	0.7	0.7	0.4	0.7	17.7	33.8	0.8	0.6	20.7	0.8	0.6	1.2	61.1	1.0	33.0	1.5	1.0	0.9	16.2	0.0	1.0	0.0	0.8	1.2	0.5	0.9	0.1	0.3	0.8	1.4	1.2	0.0	0.3	0.0	0.1	0.0	0.0	0.0	2.7	0.3	0.0	0.0	0.0	0.0	0.9	0.2	0.7	0.0	0.2	0.2	5.4	0.5	0.0	1.3	1.0	0.0	0.5	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.2	0.0	0.2	0.0	1.1	0.0	0.0	0.0	1.1	1.0	0.2	0.0	0.4	0.3	3.8	0.0	0.0	0.4	1.7	0.0	4.5	1.0	0.6	1.0	0.0	2.9	0.2	2.7	0.4	0.3	0.1	0.5	0.1	0.0	0.9	5.4	0.1	0.8	0.3	0.9	0.6	0.2	0.6	1.2	0.5	0.0	0.9	0.7	0.3	0.2	1.4	0.5	0.1	0.4	0.0	10.4	16.4	1.4	12.7	16.9	8.7	19.0	9.1	17.7	16.2	0.0	1.1	0.0	0.8	0.2	0.0	0.1	0.0	0.0	2.3	0.0	0.0	0.0	6.6	0.0	3.5	0.3	0.0	0.0	0.0	0.0	0.4	41.1	0.0	24.1	0.1	0.0	0.0	3.1	0.0	1.0	1.4	0.0	3.3	0.0	0.0	17.3	0.0	0.0	0.4	22.6	0.2	0.0	0.3	0.2	1.6	0.6	0.0	0.0	0.0	0.5
FPGS		ENSG00000136877	"Folylpolyglutamate synthase"	Q05932	9	127794597-127814327	"Enzymes, Predicted intracellular proteins"	"One-carbon metabolism"	Ligase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA050488	Approved				"Intracellular and membrane"	NA	NA					"HPA050488: AB_2681143"	"unprognostic (6.37e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.02e-1)"	"prognostic favorable (9.08e-4)"	"unprognostic (1.25e-1)"	"unprognostic (2.67e-1)"	"unprognostic (1.00e-1)"	"unprognostic (1.89e-1)"	"unprognostic (6.25e-2)"	"unprognostic (2.63e-1)"	"unprognostic (1.16e-1)"	"unprognostic (6.97e-2)"	"unprognostic (1.76e-1)"	"unprognostic (8.54e-3)"	"unprognostic (2.61e-1)"	"unprognostic (1.58e-1)"	"unprognostic (1.55e-2)"	18.2	25.0	6.0	17.4	7.1	14.8	18.9	7.9	6.9	13.9	16.6	9.2	16.6	9.3	16.8	19.2	12.2	17.1	20.0	19.2	6.1	5.9	12.5	44.0	14.9	25.6	8.1	6.6	41.3	24.0	6.6	8.9	6.7	7.7	12.8	6.3	9.9	12.3	18.9	30.4	7.9	10.3	12.6	5.4	17.6	12.4	10.1	7.7	13.6	11.1	15.2	16.0	14.7	9.2	15.5	19.9	1.0	11.8	20.4	21.1	10.2	13.6	9.5	5.4	11.7	8.5	9.3	16.9	10.9	12.9	13.9	10.6	9.8	22.3	17.0	14.2	14.7	9.3	25.8	6.7	14.8	4.5	18.5	8.8	13.2	11.9	12.0	20.3	24.3	11.3	13.0	8.5	13.2	17.7	11.7	16.5	16.0	14.8	11.0	14.2	17.3	21.1	18.1	15.8	15.0	29.1	44.0	9.1	29.5	20.0	11.0	8.2	14.0	31.3	15.3	2.1	2.3	9.2	10.3	24.9	7.2	10.3	20.9	21.6	12.3	5.2	13.6	15.7	11.3	10.5	0.1	7.8	1.0	21.1	11.8	18.9	12.2	12.6	18.2	15.6	15.5	10.4	13.7	0.4	20.4	11.6	19.9	13.1	10.2	6.0	7.1	7.9	6.9	6.1	5.9	8.1	6.6	7.7	7.7	20.8	29.1	20.1	17.5	9.3	5.4	18.0	33.1	6.7	19.4	8.7	13.7	13.4	10.0	43.0	3.1	16.3	13.6	0.0	46.4	18.3	16.9	18.0	30.1	61.4	27.0	4.8	22.0	16.5	12.7	2.1	17.5	18.2	8.5	71.3	10.9	6.3	54.2	10.5	6.7	15.9	6.5	12.9	16.5	6.5	16.6	7.8	12.4	22.3	22.2	28.6
FPGT	GFPP	ENSG00000254685	"Fucose-1-phosphate guanylyltransferase"	O14772	1	74198212-74234086	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Nucleotidyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA072331			Uncertain	Vesicles		NA	NA			Vesicles		"HPA072331: "	"unprognostic (1.53e-1)"	"unprognostic (1.94e-1)"	"unprognostic (8.18e-3)"	"unprognostic (4.32e-2)"	"unprognostic (5.14e-2)"	"unprognostic (2.46e-1)"	"prognostic unfavorable (2.30e-4)"	"unprognostic (1.86e-1)"	"unprognostic (5.14e-2)"	"unprognostic (2.58e-1)"	"unprognostic (7.59e-2)"	"unprognostic (1.33e-1)"	"unprognostic (3.59e-3)"	"unprognostic (1.44e-1)"	"unprognostic (7.88e-2)"	"unprognostic (3.53e-2)"	"unprognostic (1.91e-1)"	14.6	11.6	10.9	9.1	12.6	3.4	13.0	19.0	15.8	15.9	11.7	13.0	7.5	11.5	17.7	11.1	15.7	15.4	13.3	12.8	10.9	7.1	15.9	13.7	10.8	8.0	15.5	10.6	14.1	10.2	14.2	27.7	10.6	14.4	11.1	11.3	10.6	11.7	9.1	15.7	12.0	12.0	11.8	16.3	11.0	12.3	8.7	13.9	6.6	20.0	6.8	9.2	17.9	12.9	4.3	9.2	15.2	14.9	3.8	5.4	7.4	9.3	7.7	5.8	8.5	13.5	12.7	8.7	12.2	8.2	8.5	10.0	4.3	7.0	5.7	15.1	7.2	9.6	7.8	10.4	11.2	13.5	11.5	4.4	12.9	9.4	7.3	11.3	9.8	10.0	10.4	14.5	8.4	4.0	5.8	8.7	8.0	13.3	6.9	13.2	2.5	5.4	2.0	6.3	12.0	7.0	5.8	13.7	8.0	7.4	6.8	6.1	6.1	9.0	13.3	14.0	1.9	16.0	11.2	7.8	3.7	7.1	20.2	9.2	7.5	5.4	7.6	15.0	9.7	12.5	12.0	14.9	15.2	4.3	14.5	5.0	3.6	4.4	3.9	9.2	4.3	4.9	4.4	4.4	3.8	12.5	0.9	5.4	7.4	10.9	12.6	19.0	15.8	10.9	7.1	15.5	10.6	14.4	13.9	6.0	2.7	0.5	3.7	6.1	7.0	8.7	10.2	9.4	2.3	10.4	2.0	11.0	16.6	5.0	6.1	5.2	9.3	0.0	6.3	9.1	5.8	2.7	4.7	7.9	13.3	3.2	5.8	6.7	9.8	5.7	9.5	10.6	5.0	3.6	7.6	8.4	5.6	7.0	5.3	12.4	4.5	25.8	5.2	8.1	10.6	5.6	5.1	1.8	7.2	1.7
FRK	"GTK, PTK5, RAK"	ENSG00000111816	"Fyn related Src family tyrosine kinase"	P42685	6	115931149-116060758	"Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"		"Kinase, Transferase, Tyrosine-protein kinase"	"FDA approved drug targets, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 41.4"	"Cell type enhanced"	"Detected in many"	7	"Early spermatids: 73.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"OE19: 19.0;RT4: 8.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"CAB025217, HPA030479, HPA072590"	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"CAB025217: , HPA030479: AB_2732457, HPA072590: "	"unprognostic (7.70e-3)"	"unprognostic (1.99e-2)"	"unprognostic (1.11e-1)"	"unprognostic (4.68e-3)"	"unprognostic (1.96e-1)"	"unprognostic (3.49e-2)"	"unprognostic (2.09e-1)"	"unprognostic (1.58e-1)"	"unprognostic (4.23e-2)"	"unprognostic (5.82e-3)"	"unprognostic (1.45e-1)"	"unprognostic (7.54e-2)"	"prognostic favorable (9.66e-7)"	"unprognostic (1.52e-2)"	"unprognostic (1.34e-1)"	"unprognostic (2.02e-2)"	"unprognostic (1.10e-1)"	1.5	2.2	0.8	3.0	1.3	1.3	2.6	0.5	0.8	6.4	21.4	0.2	10.2	6.8	1.6	9.0	10.5	2.8	7.3	3.3	1.2	0.8	23.7	19.6	5.6	0.6	1.5	0.5	2.4	5.9	0.3	3.8	2.7	0.8	4.1	5.5	0.8	9.2	6.1	2.9	2.0	41.4	2.5	2.4	1.0	5.5	1.8	0.5	1.2	1.0	5.2	7.4	5.0	3.6	2.2	1.2	3.8	1.2	1.4	2.3	0.3	2.5	4.2	0.7	1.0	0.3	0.3	0.8	0.6	0.2	0.0	0.1	3.3	4.1	1.1	3.9	0.6	0.6	6.1	0.3	1.2	0.1	3.5	0.4	1.4	3.6	2.8	0.2	1.0	0.9	0.3	1.7	0.4	0.4	0.5	0.2	0.7	0.7	2.6	1.0	1.4	0.8	0.6	1.1	19.0	0.7	1.2	3.7	1.3	5.2	8.0	0.9	1.0	0.9	5.4	0.5	1.1	1.6	0.8	1.0	1.2	1.2	0.9	0.6	4.0	2.8	1.8	1.2	0.7	0.8	3.2	1.0	1.0	1.9	0.6	2.3	1.1	1.4	1.7	0.4	2.2	1.1	1.4	3.8	1.4	1.2	1.2	1.0	0.3	0.8	1.3	0.5	0.7	1.2	0.8	1.5	0.5	0.8	0.5	0.0	10.1	0.0	15.3	2.4	0.7	8.4	12.7	22.7	15.9	22.7	0.0	4.3	10.0	16.5	73.1	0.3	35.5	0.0	14.3	3.8	3.5	20.3	3.5	19.2	0.8	6.4	19.0	1.8	0.6	17.7	0.6	0.5	0.0	1.8	13.0	0.3	19.1	20.1	1.1	22.5	0.0	12.9	7.5	1.4	0.7	2.8	0.7	0.5	16.1	34.6
FTCD		ENSG00000160282	"Formimidoyltransferase cyclodeaminase"	O95954	21	46136262-46155567	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Histidine metabolism"	"Lyase, Multifunctional enzyme, Transferase"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"liver: 126.8"	"Cell type enhanced"	"Detected in many"	16	"Hepatocytes: 338.0;Late spermatids: 92.6;Proximal tubular cells: 322.0"	"Cancer enriched"	"Detected in some"	8	"liver cancer: 87.3"	"Low region specificity"	"Detected in single"			"Cell type enhanced"	"Detected in single"		"T-reg: 2.5"	"Lineage enriched"	"Detected in single"	25	"T-cells: 2.5"	"Cell line enriched"	"Detected in some"	29	"Hep G2: 45.4"									"HPA020073, HPA030928, HPA030929, HPA036114"	Enhanced		Approved	"Plasma membrane,Cytosol"		No	NA		580000	Cytosol	"Plasma membrane"	"HPA020073: AB_1849005, HPA030928: AB_2673664, HPA030929: AB_2673665, HPA036114: AB_2674947"	"unprognostic (1.71e-1)"	"unprognostic (2.27e-1)"	"unprognostic (4.62e-5)"	"unprognostic (2.90e-2)"	"unprognostic (1.13e-1)"	"unprognostic (2.96e-1)"	"prognostic favorable (1.70e-4)"	"unprognostic (1.85e-1)"	"unprognostic (2.67e-1)"	"unprognostic (1.99e-1)"	"prognostic favorable (6.78e-5)"	"unprognostic (1.80e-1)"	"prognostic favorable (5.78e-4)"	"unprognostic (3.80e-2)"	"unprognostic (3.60e-1)"	"unprognostic (9.37e-2)"	"unprognostic (2.10e-1)"	0.2	0.0	0.6	0.2	1.6	0.0	0.2	0.2	0.7	0.2	0.3	0.2	0.2	0.3	0.2	2.0	0.2	0.0	0.2	0.2	0.5	0.4	25.9	126.8	0.2	0.2	0.4	0.2	0.2	1.0	0.0	0.2	0.2	0.2	0.3	0.0	0.2	0.2	0.2	0.2	0.0	0.4	0.2	0.2	0.2	0.1	1.5	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.0	0.0	0.0	0.0	0.0	2.5	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	1.5	0.0	0.1	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.0	45.4	0.0	0.3	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.3	0.0	0.0	1.0	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.2	0.0	0.1	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.5	0.5	0.0	0.0	0.5	0.7	0.0	0.0	0.0	0.0	2.5	0.1	0.6	1.6	0.2	0.7	0.5	0.4	0.4	0.2	0.2	0.2	0.0	0.0	24.9	0.0	0.1	1.0	1.0	68.8	0.0	0.0	8.7	0.0	0.0	39.7	0.0	75.4	0.6	0.0	0.0	0.0	0.0	0.8	0.5	0.0	338.0	0.1	3.2	0.0	22.7	22.3	92.6	2.8	0.0	0.0	0.0	0.0	0.1	0.0	0.0	2.5	322.0	0.4	0.0	0.1	10.7	12.2	0.4	0.0	6.9	0.0	0.0
FTH1	"FHC, FTH, FTHL6, PIG15, PLIF"	ENSG00000167996	"Ferritin heavy chain 1"	P02794	11	61959718-61967660	"Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"	"Iron storage"	Oxidoreductase	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 756.2"	"Cell type enhanced"	"Detected in all"	9	"monocytes: 52379.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"neutrophil: 756.2"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"ASC diff: 555.5;HHSteC: 578.8"	"Low region specificity"	"Detected in all"							CAB008623	Approved		Approved	Microtubules		NA	NA		9000000	Microtubules		"CAB008623: "	"unprognostic (7.15e-2)"	"unprognostic (1.52e-2)"	"unprognostic (2.27e-1)"	"unprognostic (2.00e-2)"	"unprognostic (2.53e-1)"	"prognostic unfavorable (7.56e-5)"	"prognostic unfavorable (6.18e-4)"	"unprognostic (3.08e-2)"	"unprognostic (2.48e-2)"	"unprognostic (6.65e-2)"	"unprognostic (2.44e-2)"	"unprognostic (8.13e-2)"	"prognostic unfavorable (5.20e-5)"	"unprognostic (2.99e-1)"	"unprognostic (4.89e-2)"	"unprognostic (3.44e-1)"	"unprognostic (5.83e-2)"	155.1	118.0	177.6	138.9	92.6	162.0	302.9	38.5	163.7	104.2	142.4	97.8	72.0	72.2	81.6	102.4	88.8	70.6	83.5	236.1	124.7	91.2	113.5	128.2	297.3	394.0	118.5	110.6	81.7	150.8	49.7	46.7	70.1	77.5	60.9	138.5	79.5	180.5	65.1	124.1	42.5	110.0	140.0	182.1	84.4	81.0	67.8	88.2	58.5	100.3	64.1	48.9	106.7	94.0	69.5	163.3	756.2	424.5	30.7	69.2	284.2	65.4	183.8	28.0	74.1	555.5	269.1	154.7	60.1	258.0	61.3	61.9	22.2	90.9	7.6	381.6	172.8	234.7	112.1	25.0	49.7	39.8	31.2	12.3	38.1	254.7	145.1	578.8	17.8	59.9	364.4	244.0	122.3	230.1	194.4	76.7	44.1	56.7	87.4	214.0	88.5	20.0	29.2	47.9	229.9	310.8	19.9	34.6	54.5	313.4	178.2	23.8	30.2	206.4	22.7	97.7	96.5	40.4	24.1	85.4	191.7	45.9	84.8	37.7	15.1	52.0	23.4	261.3	8.0	45.6	401.9	297.7	247.4	40.8	367.6	40.2	68.6	58.3	40.4	163.3	69.5	49.3	38.2	756.2	30.7	424.5	121.2	69.2	284.2	177.6	92.6	38.5	163.7	124.7	91.2	118.5	110.6	77.5	88.2	1223.8	3688.2	1741.3	6882.7	4581.6	811.0	10.8	4076.4	2049.0	1899.5	1819.7	540.0	3704.8	9226.3	8116.7	214.1	3238.4	10084.1	4345.2	9486.9	4714.1	4023.6	8092.3	6278.5	3801.3	17699.0	697.6	2425.9	2794.1	10131.9	335.0	4320.5	19898.9	6750.0	52379.0	4287.5	3515.6	10476.1	8248.3	3589.2	14886.0	2120.1	2050.2	6618.7	591.9	960.7	3108.0	3865.9	1625.8	5251.4	8218.4
FTMT	MtF	ENSG00000181867	"Ferritin mitochondrial"	Q8N4E7	5	121851955-121852833	"Enzymes, Predicted intracellular proteins"	"Iron storage"	Oxidoreductase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	59	"testis: 68.0"	"Cell type enriched"	"Detected in some"	9	"Early spermatids: 604.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"neutrophil: 1.1"	"Low lineage specificity"	"Detected in single"			"Cell line enriched"	"Detected in single"	4	"HDLM-2: 3.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"									NA	NA																				"unprognostic (4.39e-2)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	68.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	1.1	0.6	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.6	0.3	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	1.1	0.0	0.2	0.1	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	604.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	65.4	5.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.2	0.0	0.0	0.0	0.0	4.6	2.4	0.0	0.0	0.0	0.0	0.0
FTSJ1	"CDLIV, JM23, MRX44, MRX9, SPB1, TRM7, TRMT7"	ENSG00000068438	"FtsJ RNA methyltransferase homolog 1"	Q9UET6	X	48476021-48486364	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"tRNA processing"	"Methyltransferase, Transferase"	"Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Late spermatids: 56.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA002718	Approved		Approved	Cytosol		NA	NA			Cytosol		"HPA002718: AB_1078914"	"unprognostic (2.56e-2)"	"unprognostic (1.24e-2)"	"unprognostic (1.44e-1)"	"unprognostic (3.37e-1)"	"unprognostic (2.13e-1)"	"unprognostic (6.77e-2)"	"prognostic unfavorable (1.74e-5)"	"unprognostic (1.95e-2)"	"unprognostic (2.39e-1)"	"unprognostic (3.96e-3)"	"unprognostic (2.06e-3)"	"unprognostic (7.82e-2)"	"prognostic unfavorable (5.24e-10)"	"unprognostic (2.61e-1)"	"unprognostic (1.49e-1)"	"unprognostic (1.56e-2)"	"unprognostic (1.23e-1)"	17.6	19.4	12.3	18.2	21.6	18.4	17.1	18.7	21.2	23.3	11.7	13.6	20.8	10.7	18.5	12.6	19.0	15.9	12.8	15.0	9.9	10.3	15.9	21.3	16.9	22.9	13.6	9.2	17.4	36.6	13.9	16.2	11.3	14.9	13.3	10.6	12.4	20.8	18.6	17.3	18.0	12.0	16.6	11.0	19.6	17.8	14.6	15.2	17.2	20.0	24.8	18.6	17.3	17.2	17.1	16.8	10.7	16.1	15.9	26.9	15.1	25.8	17.9	6.9	27.3	9.9	10.4	11.3	12.7	12.3	18.7	14.8	10.7	36.4	15.1	9.6	19.4	11.8	17.6	13.7	44.9	8.4	11.5	12.9	9.6	22.7	12.0	28.1	13.2	24.4	9.6	22.8	23.4	23.1	10.4	13.0	17.4	8.1	12.6	24.1	14.7	17.0	9.4	15.5	11.1	30.8	13.9	22.6	31.3	17.5	8.8	9.3	9.2	20.2	11.2	9.3	8.4	12.8	7.6	12.7	14.8	20.1	30.7	15.5	17.1	13.3	10.9	32.7	24.8	15.4	9.2	14.1	10.7	21.9	16.1	26.9	17.1	18.9	22.1	16.8	16.9	17.3	21.9	2.0	15.9	15.1	11.6	17.5	15.1	12.3	21.6	18.7	21.2	9.9	10.3	13.6	9.2	14.9	15.2	6.0	11.2	14.1	9.5	11.3	4.5	5.6	7.6	17.4	14.8	7.0	2.0	4.8	14.9	20.1	37.9	9.9	5.4	0.0	16.0	22.0	10.8	7.7	8.1	4.4	15.8	3.2	5.2	6.2	10.2	56.9	10.0	11.0	5.0	8.2	8.9	5.2	41.1	0.0	8.1	7.3	5.5	12.9	13.5	6.8	10.1	9.5	4.8	10.0	8.1	16.2
FUCA1		ENSG00000179163	"Alpha-L-fucosidase 1"	P04066	1	23845077-23868294	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		"Glycosidase, Hydrolase"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	5	"Enterocytes: 182.1;Paneth cells: 168.7;Syncytiotrophoblasts: 167.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"CAPAN-2: 56.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA046542, HPA056371"	Enhanced				"Intracellular and membrane"	NA	NA		65000000			"HPA046542: AB_2679691, HPA056371: AB_2683108"	"unprognostic (6.94e-3)"	"unprognostic (6.53e-2)"	"unprognostic (2.68e-3)"	"prognostic favorable (2.45e-4)"	"unprognostic (5.64e-3)"	"unprognostic (2.59e-3)"	"unprognostic (1.56e-2)"	"unprognostic (1.79e-3)"	"unprognostic (4.99e-1)"	"unprognostic (2.18e-2)"	"unprognostic (2.05e-1)"	"unprognostic (4.23e-2)"	"prognostic favorable (5.70e-13)"	"unprognostic (3.75e-2)"	"unprognostic (4.35e-2)"	"unprognostic (1.54e-2)"	"unprognostic (2.13e-3)"	15.8	18.0	4.6	24.1	7.1	0.9	8.9	4.2	8.1	13.1	30.2	6.9	28.4	20.4	9.9	35.7	8.7	12.7	22.6	15.0	4.7	6.4	28.9	39.3	20.7	66.7	4.8	4.7	19.4	15.5	12.2	10.9	31.9	8.0	15.2	33.5	13.8	22.6	18.5	6.9	6.6	42.3	7.4	7.1	32.3	14.8	15.6	2.9	11.6	27.3	8.0	25.1	23.6	7.8	8.3	15.2	16.8	34.8	14.4	9.9	19.0	5.3	3.6	0.7	11.0	1.5	0.1	3.8	5.7	11.9	6.0	11.2	4.9	56.8	8.0	14.4	7.2	6.6	3.2	5.3	12.1	7.9	5.6	8.8	6.6	3.3	10.9	5.1	0.6	22.0	5.5	6.9	2.2	2.9	19.5	2.4	4.6	3.0	0.1	7.1	5.8	1.6	5.9	1.8	16.2	5.8	9.0	0.0	8.7	22.2	13.8	3.8	3.7	16.4	6.4	8.6	6.6	4.7	2.6	0.6	2.0	3.2	13.6	1.9	10.0	10.1	2.9	5.1	19.9	3.2	13.7	34.8	16.8	9.9	34.5	8.5	8.3	7.2	8.4	15.2	4.7	7.0	8.2	4.3	14.4	28.7	8.8	7.0	19.0	4.6	7.1	4.2	8.1	4.7	6.4	4.8	4.7	8.0	2.9	23.8	22.9	10.4	24.6	3.2	3.4	5.7	40.8	24.1	30.7	80.3	0.0	146.1	13.3	48.0	39.6	10.1	182.1	0.0	44.7	19.3	14.8	27.9	8.1	29.4	139.0	0.0	10.4	23.9	89.5	15.5	21.6	35.0	8.5	9.0	39.6	13.3	29.7	168.7	18.4	28.4	4.8	6.5	5.6	78.8	10.6	2.5	167.7	13.8	63.2	33.2
FUCA2	"dJ20N2.5, MGC1314"	ENSG00000001036	"Alpha-L-fucosidase 2"	Q9BTY2	6	143494811-143511690	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"		"Glycosidase, Hydrolase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031659, HPA031661"	Approved				"Secreted to blood"	NA	NA		53000000			"HPA031659: AB_10600661, HPA031661: AB_10601681"	"unprognostic (1.83e-2)"	"unprognostic (1.70e-3)"	"unprognostic (1.11e-2)"	"unprognostic (1.01e-2)"	"unprognostic (4.89e-2)"	"unprognostic (1.41e-2)"	"prognostic unfavorable (2.70e-9)"	"unprognostic (1.54e-3)"	"unprognostic (1.08e-1)"	"unprognostic (7.79e-2)"	"unprognostic (2.89e-1)"	"unprognostic (1.90e-1)"	"unprognostic (8.76e-3)"	"unprognostic (9.18e-2)"	"unprognostic (2.69e-1)"	"unprognostic (7.25e-2)"	"unprognostic (5.07e-2)"	22.6	32.6	10.3	14.2	16.2	11.6	24.1	6.2	11.4	18.5	21.2	17.6	23.1	22.0	17.9	24.8	11.9	17.2	25.0	25.6	11.6	11.8	34.1	45.7	21.7	30.0	20.4	8.7	21.9	32.6	52.3	14.4	40.7	16.9	12.0	28.4	21.4	18.9	24.5	6.7	9.3	29.5	14.6	18.5	20.3	20.4	11.0	16.1	3.6	17.9	8.7	10.3	16.7	15.0	4.1	22.9	9.3	29.3	9.7	6.7	14.9	23.3	13.7	11.9	21.7	17.8	35.0	22.7	22.1	23.7	27.3	46.5	26.1	23.5	0.0	16.6	29.6	8.6	0.1	6.0	2.9	38.0	20.9	23.0	7.8	25.6	39.3	25.7	0.0	4.0	18.6	17.5	24.4	10.6	23.3	27.7	0.0	27.8	12.3	30.7	27.6	0.0	18.2	15.5	10.7	18.9	0.0	25.1	17.3	32.4	14.6	9.0	5.9	24.3	16.3	19.8	9.6	8.0	19.3	16.2	16.3	13.8	40.6	42.5	4.5	4.9	0.1	18.8	14.4	5.6	9.3	29.3	8.7	4.9	28.8	5.6	4.1	3.6	4.1	22.9	2.5	1.6	3.0	2.0	9.7	20.0	3.5	6.7	14.9	10.3	16.2	6.2	11.4	11.6	11.8	20.4	8.7	16.9	16.1	38.7	28.1	11.5	10.0	10.0	2.5	22.9	30.6	22.7	15.9	24.4	0.0	45.1	10.0	64.9	1.4	23.4	39.4	23.3	109.4	92.6	60.3	14.4	36.9	31.6	98.2	1.6	9.2	25.8	46.4	0.9	61.9	43.0	40.5	41.5	35.4	11.3	60.3	28.1	42.8	36.9	0.8	6.5	23.7	3.7	3.6	6.9	38.8	12.9	49.1	15.7
FUK	FLJ39408	ENSG00000157353	Fucokinase	Q8N0W3	16	70454421-70480274	"Enzymes, Predicted intracellular proteins"		"Kinase, Transferase"	"Congenital disorder of glycosylation, Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041971	Approved		Approved	Vesicles		NA	NA			Vesicles		"HPA041971: AB_10795648"	"unprognostic (4.55e-1)"	"unprognostic (3.21e-1)"	"unprognostic (1.73e-2)"	"unprognostic (3.95e-2)"	"unprognostic (3.79e-2)"	"unprognostic (2.64e-2)"	"unprognostic (8.79e-3)"	"unprognostic (1.26e-1)"	"unprognostic (1.49e-1)"	"unprognostic (1.57e-1)"	"unprognostic (4.82e-3)"	"unprognostic (4.85e-2)"	"prognostic favorable (8.91e-4)"	"unprognostic (2.49e-2)"	"unprognostic (9.68e-2)"	"unprognostic (8.89e-2)"	"prognostic favorable (8.38e-4)"	6.7	11.3	11.5	9.8	13.2	8.5	7.3	13.9	13.5	7.5	12.1	15.5	15.1	18.5	8.3	11.5	8.2	10.8	9.4	7.2	9.4	7.4	13.1	11.9	8.1	9.1	12.5	12.4	10.5	12.2	17.1	16.4	11.0	9.8	9.1	7.7	12.9	10.8	9.4	9.0	13.0	13.1	6.3	9.3	9.7	12.2	6.1	12.5	7.2	12.0	4.2	11.1	7.6	6.8	4.3	3.2	3.9	4.4	2.9	6.7	2.5	3.1	4.4	2.6	5.7	1.5	1.8	9.9	1.8	2.9	2.4	3.1	3.9	10.3	2.2	8.8	1.7	0.7	4.5	1.8	4.5	1.5	4.2	6.3	2.9	8.0	4.5	3.8	3.7	2.2	3.0	5.3	1.8	4.5	3.6	4.5	4.3	5.4	2.7	1.8	9.8	4.4	8.5	1.6	5.1	2.5	6.5	0.6	9.7	6.1	5.5	4.2	5.1	10.2	3.5	5.2	2.1	15.0	7.2	4.7	1.9	2.5	4.1	2.1	9.6	4.5	4.5	3.4	3.5	4.2	0.6	4.4	1.8	4.8	2.5	4.1	1.9	4.8	4.8	2.7	4.3	6.7	3.1	3.9	2.9	2.8	3.2	3.2	2.5	11.5	13.2	13.9	13.5	9.4	7.4	12.5	12.4	9.8	12.5	3.0	8.1	1.5	1.7	1.0	5.0	4.5	2.5	0.0	3.4	15.7	3.9	4.7	1.7	4.5	0.8	3.6	15.4	0.0	6.3	2.2	2.5	2.6	0.0	5.8	4.2	9.5	4.1	7.4	3.8	1.1	2.8	2.1	1.7	3.6	10.7	4.5	4.5	11.5	6.0	5.5	7.3	0.0	1.7	4.2	2.0	2.4	4.3	2.9	13.6	1.3
FUOM	"C10orf125, FLJ26016, FucM, FucU"	ENSG00000148803	"Fucose mutarotase"	A2VDF0	10	133355154-133358035	"Enzymes, Predicted intracellular proteins"		Isomerase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 68.3"	"Cell type enhanced"	"Detected in many"	12	"Enterocytes: 183.8;Hepatocytes: 452.0;Hofbauer cells: 152.7;Proximal tubular cells: 264.0"	"Cancer enhanced"	"Detected in all"		"liver cancer: 61.0"	"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039207	Uncertain					NA	NA		2500000			"HPA039207: AB_10795033"	"unprognostic (1.15e-2)"	"unprognostic (1.16e-1)"	"unprognostic (4.48e-2)"	"unprognostic (7.19e-2)"	"unprognostic (4.82e-1)"	"unprognostic (2.66e-2)"	"unprognostic (1.66e-2)"	"unprognostic (2.45e-1)"	"unprognostic (6.25e-2)"	"unprognostic (7.56e-2)"	"unprognostic (4.50e-2)"	"unprognostic (8.67e-2)"	"unprognostic (3.65e-2)"	"unprognostic (4.02e-2)"	"unprognostic (1.50e-1)"	"unprognostic (4.88e-3)"	"unprognostic (1.65e-1)"	4.9	3.3	1.9	7.1	2.1	2.2	4.5	1.1	2.4	2.2	15.2	2.6	4.9	20.5	2.1	6.3	3.6	2.8	5.8	6.8	1.6	1.3	14.2	68.3	7.5	6.7	2.1	0.9	3.7	6.9	0.8	2.3	2.0	3.0	2.4	2.2	6.7	18.8	3.0	1.9	2.6	28.3	2.4	1.7	9.7	3.0	2.4	1.2	2.8	2.4	3.3	6.1	2.9	2.6	13.0	28.7	2.1	25.6	5.7	6.0	10.1	11.1	3.5	6.9	14.1	2.0	4.9	12.5	8.9	10.4	3.3	4.1	22.4	6.2	0.0	10.4	6.8	0.0	0.6	2.5	3.1	0.3	4.0	2.4	10.9	5.4	24.1	10.3	11.9	7.4	5.0	0.1	1.3	0.7	1.5	4.6	11.3	10.4	14.8	6.9	11.0	1.8	16.0	4.8	6.6	1.6	10.4	0.2	6.4	3.7	0.0	0.7	5.5	3.3	10.2	12.2	3.7	0.1	18.4	9.1	0.0	9.4	0.0	0.0	7.8	1.2	7.7	2.8	4.9	3.4	0.0	25.6	2.1	6.0	25.6	5.6	12.6	5.4	5.0	20.7	13.0	5.8	5.0	1.2	5.7	5.4	28.7	3.5	10.1	1.9	2.1	1.1	2.4	1.6	1.3	2.1	0.9	3.0	1.2	6.0	10.6	30.7	8.0	10.8	0.0	11.4	25.5	2.7	6.8	8.7	0.0	8.9	26.6	11.7	2.9	12.8	183.8	0.0	10.8	7.3	21.6	10.1	26.5	452.0	152.7	0.0	2.9	25.8	94.2	7.2	9.5	67.5	25.3	76.7	19.9	2.3	15.4	112.3	3.5	264.0	1.0	12.9	9.0	10.9	12.1	8.7	5.5	20.8	22.4	7.6
FURIN	"FUR, PACE, PCSK3, SPC1"	ENSG00000140564	"Furin, paired basic amino acid cleaving enzyme"	P09958	15	90868592-90883458	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Host-virus interaction"	"Hydrolase, Protease, Serine protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	9	"liver: 118.4;placenta: 158.9;salivary gland: 337.9"	"Cell type enhanced"	"Detected in many"	5	"Exocrine glandular cells: 102.2;Hepatocytes: 114.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009499, HPA067869"	Enhanced		Supported	"Nucleoplasm,Golgi apparatus"	"Intracellular and membrane"	NA	NA		41000	"Golgi apparatus"	Nucleoplasm	"CAB009499: AB_2105095, HPA067869: "	"unprognostic (2.46e-1)"	"unprognostic (2.73e-2)"	"unprognostic (7.33e-2)"	"unprognostic (2.30e-2)"	"unprognostic (4.11e-3)"	"unprognostic (4.37e-2)"	"unprognostic (8.11e-2)"	"prognostic unfavorable (1.58e-4)"	"unprognostic (2.24e-1)"	"unprognostic (9.92e-3)"	"unprognostic (1.78e-1)"	"unprognostic (1.96e-1)"	"unprognostic (4.52e-3)"	"unprognostic (4.57e-2)"	"unprognostic (4.46e-2)"	"unprognostic (4.27e-3)"	"unprognostic (8.20e-2)"	8.3	3.3	3.0	7.5	3.6	16.6	5.9	5.0	4.4	4.1	6.6	2.8	3.5	5.7	4.9	10.8	4.7	4.4	3.9	6.9	3.1	1.8	6.4	118.4	9.5	3.1	2.8	2.7	4.2	22.5	3.8	7.2	158.9	3.5	9.3	2.2	3.0	337.9	4.7	8.7	9.0	5.9	3.1	3.0	8.2	6.0	5.3	2.9	4.8	8.9	5.5	4.1	4.4	4.3	1.5	3.3	10.3	3.3	3.1	1.9	2.0	14.4	8.8	2.0	8.9	14.5	9.4	22.7	18.2	13.9	7.5	5.3	12.9	15.8	0.5	46.8	13.2	13.5	26.0	4.0	9.4	1.6	41.6	10.3	25.3	15.8	16.8	7.7	3.5	41.7	10.6	10.6	8.5	3.9	18.3	24.0	4.2	19.3	2.5	5.0	9.9	1.3	11.4	6.3	12.2	2.6	2.2	7.7	3.3	11.7	11.0	4.0	2.7	15.4	8.4	12.8	9.9	3.0	9.2	35.4	8.5	18.2	13.0	26.6	4.5	25.6	1.2	16.2	11.4	17.2	7.5	3.3	10.3	1.9	1.1	1.4	1.5	1.2	1.2	2.1	1.0	0.6	0.8	7.4	3.1	0.7	3.3	0.9	2.0	3.0	3.6	5.0	4.4	3.1	1.8	2.8	2.7	3.5	2.9	3.0	30.9	6.7	7.5	17.2	11.9	15.0	10.2	1.4	5.7	21.0	23.6	16.5	0.0	44.3	0.4	25.5	23.8	23.3	102.2	11.4	12.3	26.5	15.1	114.9	22.3	7.9	36.4	23.4	26.1	0.2	10.3	24.1	15.1	7.2	27.3	11.7	83.4	21.8	10.3	5.6	25.2	25.8	12.5	2.3	3.4	20.1	70.5	11.7	16.1	13.9
FUT1	"H, HSC"	ENSG00000174951	"Fucosyltransferase 1 (H blood group)"	P19526	19	48748011-48755390	"Blood group antigen proteins, Enzymes, Predicted membrane proteins"		"Blood group antigen, Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"pancreas: 19.5"	"Cell type enhanced"	"Detected in many"	8	"Cholangiocytes: 5.1;Endothelial cells: 5.1;Ito cells: 8.6;Melanocytes: 5.0;Pancreatic endocrine cells: 4.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"CACO-2: 8.2;HEL: 10.2;hTCEpi: 8.1;RT4: 9.8"	"Not detected"	"Not detected"													NA	NA						"unprognostic (2.90e-2)"	"unprognostic (3.09e-2)"	"unprognostic (8.05e-3)"	"unprognostic (4.65e-3)"	"unprognostic (2.92e-3)"	"unprognostic (8.73e-2)"	"unprognostic (2.58e-2)"	"unprognostic (3.34e-2)"	"unprognostic (2.36e-1)"	"unprognostic (1.38e-1)"	"unprognostic (4.19e-2)"	"unprognostic (1.29e-1)"	"prognostic favorable (3.99e-4)"	"unprognostic (1.33e-1)"	"unprognostic (3.22e-2)"	"unprognostic (8.67e-3)"	"unprognostic (3.98e-2)"	2.5	0.8	0.9	0.9	0.9	1.5	1.6	3.5	1.4	0.9	0.9	0.9	0.9	1.0	0.9	0.9	1.5	1.2	0.9	1.4	0.9	0.2	1.1	0.9	6.8	0.9	0.9	0.9	0.9	19.5	1.0	1.7	2.8	0.9	0.9	0.0	0.9	0.9	0.9	0.9	0.8	0.9	0.9	0.9	3.4	7.6	0.9	0.9	0.9	1.0	0.9	0.9	0.9	0.9	0.9	0.9	3.3	0.7	1.5	0.6	0.3	3.3	0.1	0.1	0.2	0.0	0.0	1.7	0.2	0.1	0.2	0.2	8.2	4.8	0.3	0.4	0.2	0.8	5.5	1.6	5.1	0.1	0.0	0.8	10.2	0.4	0.1	2.4	0.4	4.5	0.0	8.1	0.4	3.7	0.1	3.6	1.8	0.5	1.5	0.0	3.8	0.2	6.2	1.0	6.5	0.5	0.3	0.0	1.6	0.3	9.8	7.7	0.5	0.4	7.1	0.1	0.4	4.6	0.2	3.5	0.3	2.5	0.2	0.3	1.4	3.6	1.0	0.1	0.3	0.3	3.3	0.7	0.5	0.5	0.3	0.3	0.8	0.6	0.4	0.3	0.9	0.6	0.5	2.1	1.5	0.3	0.9	0.2	0.3	0.9	0.9	3.5	1.4	0.9	0.2	0.9	0.9	0.9	0.9	3.0	1.7	0.0	0.6	2.3	0.3	0.8	5.1	0.0	1.2	0.0	2.0	0.3	1.7	1.1	0.0	5.1	0.0	0.0	1.9	0.2	1.0	0.9	1.1	0.0	0.3	0.0	1.2	8.6	1.0	0.0	0.9	1.5	5.0	0.0	0.4	0.0	4.9	0.0	0.0	0.0	0.3	0.0	0.6	0.0	0.1	1.5	0.3	0.0	0.0	0.4
FUT2	"SE, Se2, SEC2, sej"	ENSG00000176920	"Fucosyltransferase 2"	Q10981	19	48695971-48705950	"Blood group antigen proteins, Enzymes, Predicted membrane proteins"		"Blood group antigen, Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 41.3;salivary gland: 58.1"	"Cell type enhanced"	"Detected in many"	12	"Cholangiocytes: 43.3;Enterocytes: 109.6;Exocrine glandular cells: 41.1;Mucus-secreting cells: 39.5;Paneth cells: 73.7;Undifferentiated cells: 44.3"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in some"	5	"cerebellum: 8.7"	"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Group enriched"	"Detected in some"	6	"CAPAN-2: 34.7;OE19: 38.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA014402	Uncertain		Uncertain	"Plasma membrane,Cytosol"		NA	NA			"Plasma membrane, Cytosol"		"HPA014402: AB_1849194"	"unprognostic (2.95e-2)"	"unprognostic (6.07e-2)"	"unprognostic (2.80e-3)"	"unprognostic (4.63e-3)"	"unprognostic (2.63e-1)"	"prognostic favorable (5.83e-4)"	"unprognostic (6.30e-3)"	"unprognostic (6.55e-3)"	"unprognostic (1.58e-1)"	"unprognostic (8.44e-2)"	"unprognostic (7.89e-2)"	"unprognostic (5.11e-1)"	"unprognostic (4.04e-2)"	"unprognostic (6.52e-3)"	"unprognostic (1.73e-1)"	"unprognostic (3.12e-1)"	"unprognostic (2.87e-1)"	0.4	0.6	0.7	5.3	0.8	0.0	0.8	8.7	1.6	9.3	25.0	0.3	13.9	24.1	1.3	0.1	16.0	1.2	23.3	0.5	0.7	0.7	0.8	0.4	1.1	0.1	0.7	0.1	1.0	7.5	0.0	1.5	0.2	0.7	1.2	10.9	0.1	58.1	14.5	0.5	2.6	41.3	0.4	0.7	0.6	15.8	0.7	0.2	0.5	0.6	16.1	19.3	3.1	5.4	1.7	1.8	3.5	1.0	1.4	2.5	0.6	0.9	0.9	0.2	0.5	0.0	0.0	0.1	0.1	0.0	0.0	0.0	4.1	34.7	0.3	0.2	0.0	0.2	6.1	0.0	0.0	0.0	0.3	0.2	0.3	0.2	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.5	0.0	0.6	0.0	0.4	0.0	0.4	0.4	0.8	0.2	38.7	0.3	0.3	0.1	1.5	0.0	0.3	1.8	0.2	0.1	0.3	0.0	0.2	5.2	0.0	0.1	0.1	0.2	0.2	0.1	0.3	0.2	0.0	0.1	0.2	0.1	3.5	0.8	0.4	2.0	0.7	1.1	1.5	2.3	1.0	0.5	1.7	2.1	0.7	3.4	1.4	1.0	1.8	2.5	0.6	0.7	0.8	8.7	1.6	0.7	0.7	0.7	0.1	0.7	0.2	0.0	1.1	0.0	2.5	0.8	2.7	0.4	43.3	12.0	10.3	19.2	2.0	0.0	1.7	5.5	0.5	0.3	109.6	0.0	41.1	0.0	0.2	2.5	0.0	0.0	0.1	0.0	10.9	0.0	0.3	0.0	0.0	0.0	1.7	0.0	39.5	0.8	25.6	73.7	0.0	0.0	3.8	0.0	0.2	0.2	0.2	1.3	0.1	2.2	44.3	14.7
FUT3	"CD174, LE"	ENSG00000171124	"Fucosyltransferase 3 (Lewis blood group)"	P21217	19	5842888-5851474	"Blood group antigen proteins, Enzymes, Predicted intracellular proteins, Predicted membrane proteins"		"Blood group antigen, Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 53.6;intestine: 49.3;lymphoid tissue: 38.4"	"Cell type enhanced"	"Detected in many"	12	"Enterocytes: 106.6;Mucus-secreting cells: 61.1;Paneth cells: 66.6;Undifferentiated cells: 39.4"	"Cancer enhanced"	"Detected in many"		"colorectal cancer: 41.4"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"plasmacytoid DC: 1.6"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"A-431: 29.9;hTCEpi: 4.7;OE19: 13.4;RH-30: 10.1;SK-BR-3: 4.8"									HPA046966	Supported					NA	NA					"HPA046966: AB_2679879"	"prognostic unfavorable (6.86e-4)"	"unprognostic (2.59e-1)"	"unprognostic (1.06e-1)"	"unprognostic (9.12e-2)"	"unprognostic (8.58e-3)"	"unprognostic (1.63e-3)"	"unprognostic (3.88e-2)"	"unprognostic (2.03e-2)"	"unprognostic (4.02e-2)"	"unprognostic (3.98e-2)"	"unprognostic (4.21e-2)"	"unprognostic (2.99e-1)"	"prognostic favorable (8.22e-7)"	"unprognostic (5.66e-3)"	"unprognostic (9.56e-2)"	"unprognostic (4.30e-2)"	"unprognostic (1.07e-1)"	0.2	0.1	0.2	14.5	0.2	0.0	0.4	0.2	0.2	10.9	40.4	0.2	32.5	18.8	0.4	0.5	53.6	0.7	21.5	0.1	0.2	0.2	3.8	0.9	5.1	0.1	0.2	0.1	0.5	4.7	0.0	0.3	0.6	0.1	1.0	18.1	0.2	27.5	31.6	0.1	1.0	49.3	1.0	0.2	0.1	8.1	1.3	0.1	0.3	0.1	14.9	38.4	2.9	16.1	0.2	1.6	0.8	0.6	0.0	0.5	0.0	29.9	0.0	0.1	0.1	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.0	3.4	0.0	0.4	0.0	0.0	1.3	0.0	0.2	0.0	0.1	0.1	0.0	0.0	0.2	0.0	0.0	0.1	0.0	4.7	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.1	13.4	0.0	0.0	10.1	1.0	0.0	0.5	0.0	0.1	0.0	4.8	0.1	0.0	0.1	0.3	0.0	0.1	0.0	0.1	0.2	0.2	0.2	0.0	0.0	0.1	0.0	0.0	0.6	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.0	0.8	0.0	0.0	1.6	0.5	0.0	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.1	0.1	0.1	0.0	4.5	0.0	1.8	0.0	1.4	0.3	12.7	2.7	2.3	0.0	0.0	0.0	0.0	33.7	4.3	0.0	106.6	0.0	12.8	0.1	0.0	0.5	9.2	0.2	0.0	0.0	13.2	0.0	0.0	5.5	0.0	0.0	0.0	0.0	61.1	1.4	29.6	66.6	0.0	12.0	32.6	0.0	0.1	0.0	0.2	0.0	0.2	0.0	39.4	16.0
FUT5	FUC-TV	ENSG00000130383	"Fucosyltransferase 5"	Q11128	19	5865826-5870540	"Enzymes, Predicted membrane proteins"		"Glycosyltransferase, Transferase"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"bone marrow: 3.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"MCF7: 1.8;SH-SY5Y: 3.0;U-266/70: 1.7"									HPA046966	Uncertain					NA	NA					"HPA046966: AB_2679879"				"unprognostic (7.72e-2)"	"unprognostic (3.59e-1)"		"unprognostic (5.03e-2)"			"unprognostic (1.20e-1)"								0.2	0.1	1.0	0.1	0.5	3.6	0.1	0.0	0.4	0.1	0.1			0.1	0.1	0.1	0.5	0.3	0.3	1.1	0.4	0.3	0.2	1.1	0.1	0.2	0.9		0.2	0.5	0.1	0.3	0.1		0.1	0.1		0.4	0.1	1.2	0.5	0.1	0.1	0.8	0.2	0.1	1.6			0.1		0.2	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.5	0.0	0.3	0.1	0.0	0.7	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	3.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.7	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.1	0.0	0.0	0.0	0.0
FUT6	"FCT3A, FLJ40754, FT1A, FucT-VI"	ENSG00000156413	"Fucosyltransferase 6"	P51993	19	5830610-5839731	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 40.8;intestine: 44.4;lymphoid tissue: 33.9;salivary gland: 37.0"	"Cell type enhanced"	"Detected in some"	13	"Enterocytes: 54.8;Mucus-secreting cells: 33.5;Proximal tubular cells: 29.8;Undifferentiated cells: 19.9"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"basophil: 3.7;neutrophil: 1.2;NK-cell: 2.1"	"Group enriched"	"Detected in many"	7	"granulocytes: 3.7;NK-cells: 2.1"	"Group enriched"	"Detected in some"	5	"Hep G2: 14.9;RPMI-8226: 5.6"									"HPA043707, HPA046966"	Approved		Supported	"Golgi apparatus"		NA	NA			"Golgi apparatus"		"HPA043707: AB_2678628, HPA046966: AB_2679879"	"unprognostic (3.65e-2)"	"unprognostic (3.00e-3)"	"unprognostic (2.13e-3)"	"unprognostic (2.78e-3)"	"unprognostic (6.35e-2)"	"prognostic favorable (2.12e-4)"	"unprognostic (8.02e-2)"	"unprognostic (6.68e-3)"	"unprognostic (4.01e-2)"	"unprognostic (8.53e-2)"	"unprognostic (2.62e-2)"	"unprognostic (4.94e-2)"	"prognostic favorable (3.17e-8)"	"unprognostic (1.05e-2)"	"unprognostic (1.38e-1)"	"unprognostic (2.40e-1)"	"unprognostic (1.27e-1)"	0.2	0.2	0.2	7.2	0.2	0.1	0.8	0.2	0.2	9.2	26.4	0.0	9.5	15.6	0.7	7.6	40.8	0.6	25.4	0.2	0.2	0.2	27.2	6.5	1.3	0.2	0.2	0.0	0.2	2.2	0.0	0.8	0.0	0.0	0.3	6.9	0.0	37.0	19.1	0.2	0.2	44.4	0.2	0.2	0.2	2.8	0.3	0.0	0.0	0.2	16.4	33.9	0.2	12.4	0.4	0.3	3.7	0.3	2.1	0.3	0.3	0.2	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.4	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	1.5	0.2	14.9	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	1.8	0.0	0.0	1.2	5.6	0.4	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.2	0.1	0.0	0.1	0.1	0.1	0.0	0.2	0.2	0.0	0.0	0.3	0.1	3.7	0.3	0.4	0.2	0.1	0.1	0.1	0.3	0.2	0.1	0.4	0.3	0.2	1.2	2.1	0.1	0.3	0.1	0.3	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.0	0.0	0.0	0.0	0.3	0.0	0.4	0.0	0.3	0.3	15.3	1.4	0.0	1.8	0.0	0.1	3.3	4.7	0.2	0.0	54.8	0.0	0.3	0.1	0.3	0.2	0.0	4.9	0.1	0.0	4.7	0.6	0.0	0.0	0.3	0.0	0.0	0.0	33.5	0.5	1.6	15.6	0.0	29.8	12.1	0.0	0.1	0.6	0.5	0.1	0.0	0.0	19.9	1.4
FUT8		ENSG00000033170	"Fucosyltransferase 8"	Q9BYC5	14	65410592-65744121	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"		"Glycosyltransferase, Transferase"	"Congenital disorder of glycosylation, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"B-cells: 13.5;NK-cells: 12.0;T-cells: 8.2"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB017129, HPA043410"	Enhanced		Approved	"Nucleoplasm,Golgi apparatus,Cytosol"		NA	NA			"Golgi apparatus"	"Nucleoplasm, Cytosol"	"CAB017129: , HPA043410: AB_2678467"	"unprognostic (1.67e-1)"	"unprognostic (1.63e-1)"	"unprognostic (3.28e-2)"	"unprognostic (1.65e-3)"	"unprognostic (2.10e-1)"	"unprognostic (5.61e-2)"	"unprognostic (1.41e-1)"	"unprognostic (8.81e-2)"	"unprognostic (2.00e-2)"	"unprognostic (1.33e-3)"	"unprognostic (8.09e-2)"	"unprognostic (1.94e-1)"	"unprognostic (1.04e-3)"	"unprognostic (1.40e-1)"	"unprognostic (2.94e-1)"	"unprognostic (1.40e-1)"	"unprognostic (8.28e-3)"	7.2	7.6	16.2	12.0	21.1	3.3	9.4	24.1	18.1	6.7	9.8	29.1	16.1	15.4	8.7	5.0	6.5	14.0	10.1	5.2	19.8	12.9	6.2	2.9	7.0	11.2	20.5	11.2	7.2	10.5	6.2	5.2	18.8	17.3	5.4	10.4	7.1	33.7	13.7	3.5	4.9	15.1	9.5	39.8	8.5	27.6	13.1	23.6	8.4	7.5	2.4	15.2	14.4	5.6	13.5	2.2	0.5	1.7	12.0	8.2	2.5	34.4	6.8	3.3	30.3	14.6	11.0	20.5	11.1	17.0	7.7	8.6	5.3	12.7	9.2	9.5	10.9	21.2	2.6	7.8	3.0	11.8	34.0	3.4	9.2	2.5	6.9	7.5	2.0	7.6	27.7	2.0	10.6	5.0	33.8	19.5	4.5	3.4	7.8	5.5	17.7	9.8	5.1	4.4	16.0	23.9	6.7	2.9	5.3	13.8	9.7	7.0	5.3	5.9	2.8	2.4	20.7	2.8	3.3	42.5	10.1	10.9	4.5	8.9	15.7	6.0	21.9	20.5	3.6	3.2	0.5	1.7	0.5	3.5	0.6	3.5	13.5	5.6	5.1	2.2	6.8	6.1	6.0	0.2	12.0	1.1	2.2	8.2	2.5	16.2	21.1	24.1	17.3	19.8	12.9	20.5	11.2	17.3	23.6	11.9	33.3	42.9	6.7	10.8	10.6	5.6	10.2	16.0	22.7	12.2	3.9	38.8	0.0	7.7	28.3	11.3	6.8	0.0	28.1	24.2	15.8	5.7	7.0	3.2	11.0	7.9	5.2	15.4	12.1	10.9	11.8	7.0	1.7	1.8	17.5	35.8	36.1	8.5	12.7	7.8	8.0	0.0	10.3	31.6	26.2	8.5	11.8	13.8	9.4	4.6
FXN	"CyaY, FA, FARR, FRDA, X25"	ENSG00000165060	Frataxin	Q16595	9	69035259-69120427	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Transporters"	"Heme biosynthesis, Ion transport, Iron storage, Iron transport, Transport"	Oxidoreductase	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Hepatocytes: 60.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB022164, HPA068304"	Supported		Supported	Mitochondria,Cytosol		NA	NA			Mitochondria	Cytosol	"CAB022164: , HPA068304: AB_2685970"	"unprognostic (3.38e-2)"	"unprognostic (1.54e-1)"	"unprognostic (7.47e-2)"	"unprognostic (2.37e-3)"	"unprognostic (4.08e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.07e-1)"	"unprognostic (1.07e-1)"	"unprognostic (1.99e-1)"	"unprognostic (4.19e-2)"	"unprognostic (2.53e-1)"	"unprognostic (2.71e-3)"	"unprognostic (1.10e-1)"	"unprognostic (9.06e-2)"	"unprognostic (1.67e-1)"	"unprognostic (4.74e-2)"	8.7	19.9	10.8	9.1	9.8	21.9	11.8	13.9	11.0	8.3	9.3	12.3	11.6	6.6	12.4	11.7	9.2	9.6	7.2	20.2	8.7	10.1	10.2	40.2	9.5	12.8	11.7	8.5	16.8	25.9	18.8	8.6	8.4	10.5	9.9	11.6	12.1	11.9	13.6	25.1	5.2	7.2	16.6	8.9	12.9	9.2	13.3	9.7	3.7	11.1	9.5	9.6	10.5	7.9	15.8	17.7	2.0	18.5	24.2	28.3	19.1	11.3	9.6	15.8	7.6	7.2	10.7	15.3	8.2	7.3	12.6	9.7	5.1	7.4	20.4	6.4	8.5	13.0	12.4	18.6	18.8	15.9	23.8	21.3	28.6	6.3	37.8	12.4	20.9	12.5	11.9	15.2	12.6	13.7	4.5	16.8	12.6	21.5	20.0	11.6	11.1	5.9	9.2	21.3	23.1	19.2	14.1	10.8	13.9	14.5	9.4	12.2	5.5	8.4	5.5	8.6	11.6	6.2	6.5	10.0	8.3	14.4	10.8	11.9	5.6	4.8	12.1	3.9	17.3	8.2	2.0	16.7	0.1	21.5	18.5	16.3	15.8	22.0	21.2	17.7	10.3	28.3	27.1	0.8	24.2	14.1	15.0	17.0	19.1	10.8	9.8	13.9	11.0	8.7	10.1	11.7	8.5	10.5	9.7	3.0	11.5	20.6	17.3	8.7	6.2	39.9	7.6	5.3	3.4	14.0	3.9	35.6	18.3	16.1	2.0	11.7	3.1	0.0	12.7	16.7	14.6	12.0	6.9	60.1	30.0	0.0	6.9	8.0	14.6	4.6	14.7	15.5	16.9	14.4	11.5	8.3	15.0	0.0	12.4	20.7	1.0	12.9	17.6	3.8	31.7	7.0	12.2	13.1	15.6	11.9
FYN	"MGC45350, SLK, SYN"	ENSG00000010810	"FYN proto-oncogene, Src family tyrosine kinase"	P06241	6	111660332-111873452	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Adaptive immunity, Host-virus interaction, Immunity"	"Developmental protein, Kinase, Transferase, Tyrosine-protein kinase"	Proto-oncogene	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	9	"Proximal tubular cells: 145.7;T-cells: 208.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	17	"NK-cells: 15.3;T-cells: 43.2"	"Cell line enhanced"	"Detected in many"		"U-2197: 105.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB005034, CAB018387, HPA023887, HPA063770"	Approved		Enhanced	"Plasma membrane,Cytosol"		NA	NA		2000000	"Plasma membrane"	Cytosol	"CAB005034: AB_562117, CAB018387: AB_627642, HPA023887: AB_1849226, HPA063770: AB_2685119"	"unprognostic (8.62e-3)"	"unprognostic (8.25e-2)"	"unprognostic (2.11e-1)"	"unprognostic (2.00e-2)"	"unprognostic (1.51e-1)"	"unprognostic (2.43e-2)"	"prognostic favorable (1.84e-4)"	"unprognostic (4.60e-2)"	"unprognostic (2.89e-2)"	"unprognostic (2.92e-1)"	"prognostic favorable (4.78e-4)"	"unprognostic (1.43e-1)"	"prognostic unfavorable (1.43e-4)"	"unprognostic (6.95e-2)"	"unprognostic (3.10e-1)"	"unprognostic (6.62e-3)"	"unprognostic (2.40e-1)"	29.1	7.2	49.2	29.0	38.4	16.3	18.1	33.9	62.1	25.7	12.1	33.7	4.1	10.1	21.8	21.4	10.2	32.0	19.4	21.2	39.4	34.0	9.5	12.2	25.2	57.2	35.7	23.1	18.6	4.4	15.0	12.5	17.7	25.6	9.6	10.0	11.0	6.4	8.4	7.0	16.5	19.0	24.2	30.9	39.8	15.4	10.1	31.3	34.8	27.5	5.6	38.5	22.6	19.3	1.6	1.7	0.7	1.5	15.3	43.2	10.7	1.9	0.3	34.9	5.8	26.7	16.4	0.6	5.5	17.5	4.7	8.5	0.2	0.3	3.9	3.6	10.7	4.1	0.2	4.9	7.6	9.2	0.1	12.8	10.7	2.6	0.5	15.8	3.6	3.7	15.8	11.6	17.7	15.2	12.4	19.2	19.2	0.9	27.3	16.8	0.2	17.1	3.3	5.0	0.6	3.5	5.4	4.7	0.2	0.0	1.7	24.5	9.9	1.0	0.4	23.3	8.1	0.2	10.8	12.2	14.3	2.6	105.3	3.5	3.9	3.5	6.0	26.9	8.4	24.8	0.2	1.5	0.0	34.1	1.2	43.2	1.1	21.2	37.5	1.7	1.6	7.0	18.7	0.7	15.3	0.9	1.0	17.6	10.7	49.2	38.4	33.9	35.3	39.4	34.0	35.7	23.1	25.6	31.3	0.0	11.7	18.8	1.9	15.1	53.9	9.2	12.7	5.3	3.4	7.0	0.0	2.2	14.9	8.1	2.8	56.2	3.5	0.0	0.9	2.1	36.8	1.4	51.8	59.3	2.8	44.5	12.7	71.8	42.5	0.9	24.5	33.6	35.4	3.6	2.4	88.8	6.3	0.0	6.7	145.7	7.8	12.9	23.1	2.6	4.3	11.7	43.5	208.1	1.2	0.9
G2E3	"FLJ20333, KIAA1333, PHF7B"	ENSG00000092140	"G2/M-phase specific E3 ubiquitin protein ligase"	Q7L622	14	30559123-30620063	"Enzymes, Predicted intracellular proteins"	"Apoptosis, Ubl conjugation pathway"	"Developmental protein, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 39.6"	"Group enriched"	"Detected in all"	7	"Early spermatids: 712.5;Late spermatids: 198.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA001601	Uncertain		Approved	"Golgi apparatus,Vesicles,Cytosol"		NA	NA			Cytosol	"Golgi apparatus, Vesicles"	"HPA001601: AB_1079198"	"unprognostic (4.75e-2)"	"unprognostic (6.31e-2)"	"unprognostic (2.27e-2)"	"unprognostic (4.86e-2)"	"unprognostic (9.10e-2)"	"unprognostic (3.99e-2)"	"unprognostic (5.44e-6)"	"unprognostic (1.17e-2)"	"unprognostic (2.81e-2)"	"unprognostic (1.86e-1)"	"unprognostic (3.13e-2)"	"unprognostic (1.35e-1)"	"unprognostic (1.00e-1)"	"unprognostic (1.67e-1)"	"unprognostic (1.23e-1)"	"unprognostic (2.32e-2)"	"unprognostic (2.12e-2)"	7.6	5.1	5.6	7.6	14.2	8.5	6.6	10.8	10.4	8.1	5.8	5.8	4.2	5.9	8.5	4.8	7.0	5.4	4.5	4.9	6.7	5.2	5.4	5.5	5.4	8.6	7.3	4.9	7.1	5.7	6.0	10.9	6.9	7.6	6.0	6.1	5.3	5.9	7.1	5.2	6.1	5.8	6.7	7.1	7.9	5.4	39.6	8.8	20.9	7.3	4.8	9.5	6.0	8.3	11.5	8.1	16.5	12.5	7.9	12.4	5.0	21.2	9.7	21.8	10.0	7.1	8.7	18.4	20.0	7.2	12.1	13.7	9.4	12.9	17.9	6.4	10.9	9.9	17.9	20.8	11.4	24.7	14.7	8.5	9.8	10.6	17.2	6.3	18.9	12.5	5.4	4.6	9.7	22.1	11.4	14.3	13.4	12.1	14.9	17.0	12.4	12.6	4.7	18.2	16.8	17.1	11.7	0.0	4.9	7.1	13.2	18.5	12.5	16.1	10.9	4.6	13.1	12.5	6.4	10.7	13.0	13.8	9.5	13.0	8.6	25.1	21.4	3.9	9.5	19.2	16.5	7.5	14.1	9.6	9.7	12.4	10.8	9.4	7.7	6.4	11.5	12.0	10.1	6.8	7.9	12.5	8.1	7.3	5.0	5.6	14.2	10.8	10.4	6.7	5.2	7.3	4.9	7.6	8.8	17.9	7.0	27.4	17.9	19.5	31.8	8.7	10.2	9.4	14.8	5.2	23.6	12.4	8.3	8.6	712.5	15.2	6.3	46.7	6.1	19.3	15.0	16.9	16.2	6.4	12.2	33.4	13.3	17.8	14.5	198.8	15.3	11.7	8.5	7.2	12.7	14.1	9.7	10.2	13.4	11.1	31.9	51.8	15.6	69.3	43.2	22.2	8.4	15.0	10.4	19.7
G3BP1	"G3BP, HDH-VIII"	ENSG00000145907	"G3BP stress granule assembly factor 1"	Q13283	5	151771045-151812785	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction, Immunity, Innate immunity, Transport"	"DNA-binding, Endonuclease, Helicase, Hydrolase, Nuclease, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004052, CAB037068"	Supported		Supported	Cytosol		NA	NA		150000	Cytosol		"CAB037068: AB_1840864, HPA004052: AB_1849348"	"unprognostic (1.31e-1)"	"unprognostic (3.94e-2)"	"unprognostic (1.19e-3)"	"unprognostic (1.28e-2)"	"unprognostic (1.05e-1)"	"unprognostic (3.09e-2)"	"unprognostic (1.03e-3)"	"unprognostic (1.83e-2)"	"unprognostic (1.44e-1)"	"unprognostic (1.36e-1)"	"unprognostic (2.06e-3)"	"unprognostic (1.23e-2)"	"prognostic unfavorable (3.33e-4)"	"unprognostic (1.97e-1)"	"unprognostic (1.33e-1)"	"unprognostic (2.11e-2)"	"unprognostic (3.88e-2)"	36.7	27.5	21.1	29.1	23.7	12.2	29.7	24.3	21.4	28.5	23.4	27.7	19.6	18.1	29.9	19.3	40.7	26.5	20.7	24.8	21.7	21.2	30.7	44.1	25.9	36.8	31.8	16.7	38.2	30.6	29.9	29.9	27.9	24.9	24.5	27.2	22.6	24.1	19.7	66.4	25.3	22.8	27.0	27.4	28.9	20.6	27.4	25.8	57.1	28.9	37.0	42.3	27.7	34.8	25.6	19.9	19.5	19.1	29.4	40.0	32.1	37.7	29.5	36.4	15.9	46.4	25.2	42.0	37.5	34.0	48.4	57.5	54.2	49.0	70.5	55.2	34.8	42.3	35.9	54.9	72.8	63.5	19.5	26.4	43.6	27.3	36.3	26.5	54.5	28.8	25.1	39.8	42.1	41.7	19.8	39.9	28.5	34.1	34.8	47.4	20.3	45.9	24.2	40.6	27.5	30.3	42.2	46.0	33.6	31.8	37.6	34.4	24.9	35.5	51.7	54.3	35.9	41.3	30.3	43.4	35.0	40.8	33.1	68.1	21.7	29.9	55.5	26.3	42.0	63.1	19.5	13.9	13.0	25.7	19.1	40.0	25.6	34.4	28.7	18.0	21.9	33.0	32.9	6.1	29.4	16.8	19.9	34.0	32.1	21.1	23.7	24.3	21.4	21.7	21.2	31.8	16.7	24.9	25.8	17.9	30.0	62.3	74.5	212.8	33.8	51.5	48.4	65.6	61.4	61.1	15.7	86.5	66.3	65.2	35.3	78.7	31.9	23.3	45.9	73.7	92.5	76.9	72.7	138.2	69.1	54.0	48.1	74.9	78.1	21.9	60.1	59.1	82.7	88.4	55.3	50.3	51.8	38.6	53.7	64.9	35.6	38.8	106.6	46.3	99.0	224.2	56.3	61.0	68.9	82.6
G6PC	"G6PT, GSD1a"	ENSG00000131482	"Glucose-6-phosphatase catalytic subunit"	P35575	17	42900797-42913369	"Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins"	Gluconeogenesis	Hydrolase	"Disease mutation, Glycogen storage disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	9	"liver: 305.4"	"Cell type enriched"	"Detected in some"	5	"Hepatocytes: 125.4"	"Cancer enriched"	"Detected in some"	72	"liver cancer: 151.8"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"naive B-cell: 2.2"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"RH-30: 2.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA052324	Enhanced					NA	NA					"HPA052324: AB_2681790"				"unprognostic (4.23e-2)"	"unprognostic (1.49e-2)"		"prognostic favorable (5.42e-5)"				"unprognostic (8.37e-2)"		"prognostic favorable (3.79e-5)"	"unprognostic (4.79e-2)"	"unprognostic (6.46e-2)"		"unprognostic (2.56e-3)"	0.1	0.1	0.1	0.0	0.1	0.0	0.1	0.1	0.1	0.1	5.0	0.0	0.0	5.8	0.1	0.0	0.1	0.1	1.9	0.1	0.1	0.1	23.7	305.4	0.1	0.0	0.1	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.1	33.7	0.0	0.1	0.2	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.1	2.2	0.5	1.1	0.2	0.5	0.4	0.0	0.4	0.2	0.2	0.5	0.6	0.0	0.7	0.2	0.2	0.0	0.1	0.2	0.3	0.7	0.2	0.3	0.2	0.4	0.0	0.0	0.2	0.3	0.1	0.1	0.5	0.8	0.0	1.3	0.0	0.1	0.0	0.1	0.1	0.1	0.0	0.4	0.5	0.7	0.0	0.1	0.5	1.2	0.3	0.0	0.3	0.6	2.2	0.2	0.1	0.7	0.4	0.6	0.7	0.3	0.0	0.5	0.1	0.0	0.0	0.0	0.3	0.3	0.0	0.7	0.2	1.0	0.3	1.4	0.2	1.1	0.2	0.1	0.3	0.1	0.2	1.0	0.2	0.2	0.0	2.2	0.4	0.4	1.1	0.5	0.1	0.5	0.4	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.3	22.9	0.0	0.0	1.8	0.0	0.0	1.7	0.2	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	125.4	0.1	0.0	0.0	3.7	4.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	23.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1
G6PC2	IGRP	ENSG00000152254	"Glucose-6-phosphatase catalytic subunit 2"	Q9NQR9	2	168901240-168910000	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	Gluconeogenesis	Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in some"	35	"pancreas: 28.8;retina: 12.1"	"Cell type enriched"	"Detected in some"	13	"Muller glia cells: 70.6"	"Cancer enriched"	"Detected in single"	92	"pancreatic cancer: 9.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"EFO-21: 1.0;SCLC-21H: 1.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"									NA	NA						"unprognostic (6.42e-2)"				"unprognostic (2.39e-2)"		"unprognostic (6.04e-2)"		"unprognostic (9.05e-2)"		"unprognostic (2.97e-1)"		"unprognostic (3.10e-2)"	"unprognostic (1.54e-2)"	"unprognostic (1.87e-1)"			0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	28.8	0.0	0.0	0.0	0.1	0.0	0.0	12.1	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.1	0.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.6	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	70.6	0.5	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
G6PC3	UGRP	ENSG00000141349	"Glucose-6-phosphatase catalytic subunit 3"	Q9BUM1	17	44070735-44076344	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	Gluconeogenesis	Hydrolase	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA067052			Supported	"Endoplasmic reticulum"		NA	NA			"Endoplasmic reticulum"		"HPA067052: AB_2685771"	"unprognostic (9.13e-2)"	"unprognostic (2.28e-1)"	"unprognostic (3.61e-1)"	"prognostic favorable (1.11e-4)"	"unprognostic (1.88e-3)"	"unprognostic (3.16e-1)"	"prognostic unfavorable (9.61e-4)"	"unprognostic (2.79e-1)"	"unprognostic (2.43e-1)"	"unprognostic (1.15e-2)"	"unprognostic (2.59e-2)"	"unprognostic (1.85e-3)"	"unprognostic (1.87e-3)"	"unprognostic (4.53e-2)"	"unprognostic (3.06e-2)"	"unprognostic (2.35e-1)"	"unprognostic (4.49e-2)"	25.4	38.1	25.8	15.6	25.4	11.1	23.4	12.9	35.3	25.3	17.8	37.8	28.3	21.1	22.0	50.9	14.4	27.7	20.5	22.2	25.4	37.8	42.8	15.3	18.7	29.8	32.9	21.3	28.1	29.1	38.4	37.7	22.2	34.0	26.1	15.2	37.4	27.7	33.8	22.9	9.9	17.7	17.8	33.1	19.7	18.2	20.7	16.0	18.5	35.1	11.4	14.8	21.4	14.0	5.9	33.4	3.1	19.0	7.2	6.1	6.5	10.2	61.3	21.4	34.5	22.8	17.0	15.1	11.7	24.2	27.6	18.5	25.3	16.6	23.6	17.0	26.2	19.0	17.7	16.3	25.1	13.2	12.1	25.2	13.0	41.5	46.1	23.7	11.6	16.4	22.3	12.1	26.1	18.4	16.8	22.8	10.1	13.3	30.1	20.6	28.6	5.7	18.0	26.8	13.4	39.9	11.9	13.4	54.7	37.4	24.1	25.8	22.8	13.0	15.6	15.0	25.3	43.0	11.8	22.8	27.3	14.5	7.3	16.3	20.1	14.3	6.7	30.4	10.2	34.7	1.2	15.2	3.1	4.6	19.0	5.6	5.5	3.6	4.4	24.6	5.9	4.6	6.1	0.5	7.2	11.1	33.4	3.5	6.5	25.8	25.4	12.9	35.3	25.4	37.8	32.9	21.3	34.0	16.0	3.0	11.7	11.1	13.2	2.3	9.0	5.9	15.3	16.0	13.6	38.4	11.8	55.8	11.6	46.4	3.3	15.6	15.1	0.0	43.1	32.6	15.4	16.0	17.4	5.0	51.3	4.8	22.1	18.4	20.6	4.0	18.7	18.3	13.5	22.6	12.2	34.1	31.2	14.0	21.5	29.3	7.9	12.9	8.6	27.2	28.1	2.3	35.6	8.2	16.9	12.9
G6PD	G6PD1	ENSG00000160211	"Glucose-6-phosphate dehydrogenase"	P11413	X	154531391-154547572	"Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Carbohydrate metabolism, Glucose metabolism"	Oxidoreductase	"Cancer-related genes, Disease mutation, Hereditary hemolytic anemia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 83.1"	"Cell type enhanced"	"Detected in many"	6	"monocytes: 130.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"eosinophil: 77.3"	"Lineage enriched"	"Detected in all"	5	"granulocytes: 77.3"	"Cell line enhanced"	"Detected in all"		"A549: 229.1;MCF7: 86.9"					"Low region specificity"	"Detected in all"			"HPA000247, HPA000834"	Enhanced		Enhanced	"Centriolar satellite,Cytosol"		No	No		12000000	Cytosol	"Centriolar satellite"	"HPA000247: AB_1078978, HPA000834: AB_1078977"	"unprognostic (1.73e-2)"	"unprognostic (1.53e-3)"	"unprognostic (1.13e-2)"	"unprognostic (1.02e-1)"	"unprognostic (7.78e-2)"	"unprognostic (4.34e-2)"	"prognostic unfavorable (9.45e-13)"	"unprognostic (2.78e-2)"	"unprognostic (1.66e-1)"	"unprognostic (1.76e-2)"	"unprognostic (1.09e-1)"	"unprognostic (3.66e-1)"	"unprognostic (2.89e-3)"	"unprognostic (2.83e-1)"	"unprognostic (1.94e-1)"	"unprognostic (1.47e-1)"	"unprognostic (7.25e-2)"	21.9	29.4	10.4	15.6	10.7	51.4	18.2	8.4	14.7	12.2	7.5	13.6	4.8	7.2	14.0	13.2	29.0	11.0	24.7	10.1	8.8	10.1	15.4	3.7	20.8	31.0	10.3	8.0	19.8	7.9	5.9	20.7	9.2	10.9	11.3	7.3	17.8	13.9	8.6	4.4	11.3	7.3	17.5	11.1	20.3	9.9	83.1	9.5	22.5	24.6	44.8	25.7	24.1	19.0	3.6	7.6	77.3	16.2	12.7	10.3	11.8	15.7	229.1	4.7	18.1	19.9	27.1	4.2	11.0	31.5	11.2	19.4	10.5	5.9	10.1	17.1	25.0	45.4	14.0	7.3	18.6	5.8	10.3	5.1	10.7	51.9	23.6	38.8	10.8	36.9	13.1	5.5	21.9	4.7	17.6	23.3	7.5	6.4	4.4	20.3	86.9	6.9	7.7	3.4	50.2	17.0	6.8	2.7	11.1	33.8	19.6	4.8	6.0	10.9	42.8	9.2	6.4	6.4	9.0	27.6	7.1	25.0	9.9	16.9	5.4	7.0	17.4	19.7	7.2	14.5	29.3	16.2	77.3	10.3	13.6	6.6	3.4	2.7	7.4	7.6	3.6	3.5	5.9	27.1	12.7	11.1	3.5	3.5	11.8	10.4	10.7	8.4	14.7	8.8	10.1	10.3	8.0	10.9	9.5	0.0	17.1	21.3	18.5	11.1	5.7	0.8	20.4	4.0	0.0	10.4	17.7	26.0	24.9	35.4	8.1	12.8	18.6	23.3	25.6	33.4	18.8	16.7	38.0	0.8	41.6	31.8	9.1	16.0	63.9	10.4	24.2	25.3	18.6	130.8	9.6	11.9	34.1	9.1	15.2	11.9	24.6	6.5	12.3	10.1	34.9	12.0	30.3	39.5	9.9	26.5
GAA		ENSG00000171298	"Glucosidase alpha, acid"	P10253	17	80101556-80119879	"Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"		"Glycosidase, Hydrolase"	"Disease mutation, FDA approved drug targets, Glycogen storage disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Extravillous trophoblasts: 125.7;Syncytiotrophoblasts: 139.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"classical monocyte: 23.8;eosinophil: 8.4;intermediate monocyte: 20.0;myeloid DC: 15.6;neutrophil: 10.8;non-classical monocyte: 24.7"	"Group enriched"	"Detected in all"	9	"dendritic cells: 15.6;granulocytes: 10.8;monocytes: 24.7"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA026970, HPA029126"	Enhanced		Approved	Vesicles		NA	NA		3000000	Vesicles		"HPA026970: AB_2672065, HPA029126: AB_2672918"	"unprognostic (1.13e-1)"	"unprognostic (1.11e-1)"	"prognostic unfavorable (7.66e-4)"	"unprognostic (2.94e-2)"	"unprognostic (1.14e-2)"	"unprognostic (7.96e-2)"	"unprognostic (2.05e-2)"	"unprognostic (1.19e-1)"	"unprognostic (2.90e-1)"	"unprognostic (1.43e-1)"	"unprognostic (1.29e-2)"	"unprognostic (2.76e-1)"	"unprognostic (1.46e-1)"	"unprognostic (7.02e-2)"	"unprognostic (2.38e-1)"	"unprognostic (1.78e-2)"	"unprognostic (1.18e-1)"	27.5	19.6	13.8	17.0	14.8	11.3	18.6	14.3	23.0	14.9	16.5	23.4	21.7	19.4	20.1	50.9	13.9	18.2	23.5	21.4	13.5	17.6	27.9	44.2	34.0	30.2	18.1	16.1	14.6	29.4	28.8	24.7	84.1	14.9	22.3	7.2	21.9	27.5	22.1	26.3	18.3	15.4	17.2	16.6	35.8	17.4	30.7	14.6	13.9	21.9	14.9	13.5	24.0	13.4	1.4	15.6	10.8	24.7	1.1	1.8	9.8	11.4	22.4	4.4	14.5	13.9	14.0	28.9	7.2	13.3	5.5	4.5	6.6	18.7	4.1	19.2	5.6	4.7	4.9	1.4	8.3	1.3	5.3	16.7	0.0	3.8	23.7	24.2	0.5	13.7	30.1	12.0	10.3	3.6	11.2	9.7	11.2	4.1	17.3	4.1	26.5	1.9	2.7	9.2	2.8	15.7	10.0	15.2	7.0	4.4	12.0	5.1	14.7	9.4	10.5	12.9	2.8	30.0	16.4	6.2	20.4	11.0	14.7	2.6	41.4	11.5	1.2	6.5	10.7	12.8	0.1	23.8	8.4	1.5	20.0	1.8	1.3	1.2	1.6	15.6	1.4	1.4	0.9	10.8	1.1	24.7	3.8	0.8	9.8	13.8	14.8	14.3	23.0	13.5	17.6	18.1	16.1	14.9	14.6	17.9	45.3	3.9	14.4	10.0	15.6	14.3	30.6	5.3	17.0	14.0	7.9	106.8	5.0	23.0	42.5	17.4	18.6	0.0	13.8	125.7	30.3	19.9	8.1	23.1	92.2	11.1	5.8	29.4	107.0	25.5	22.2	64.5	23.6	31.5	14.3	28.7	9.4	17.5	18.0	18.2	16.5	6.5	10.3	18.4	26.8	7.3	139.0	7.7	15.5	10.8
GAD1	GAD	ENSG00000128683	"Glutamate decarboxylase 1"	Q99259	2	170813213-170861151	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Neurotransmitter biosynthesis"	"Decarboxylase, Lyase"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"brain: 53.9"	"Cell type enhanced"	"Detected in many"	7	"Cone photoreceptor cells: 9.8;Distal tubular cells: 6.6"	"Cancer enhanced"	"Detected in many"		"endometrial cancer: 4.4"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HaCaT: 10.8;HEL: 34.9"	"Low region specificity"	"Detected in all"			"Region enriched"	"Detected in all"	4	"olfactory region: 888.9"	"CAB004415, HPA048871, HPA058412, CAB078176"	Enhanced	Supported	Approved	"Vesicles,Plasma membrane,Cytosol"		NA	NA			"Vesicles, Plasma membrane, Cytosol"		"CAB004415: AB_627650, CAB078176: AB_2665792, HPA048871: , HPA058412: AB_2683710"	"unprognostic (1.28e-1)"	"prognostic favorable (7.31e-4)"	"unprognostic (1.87e-2)"	"prognostic favorable (8.61e-4)"	"unprognostic (1.12e-1)"	"unprognostic (3.05e-1)"	"unprognostic (4.97e-7)"	"unprognostic (1.51e-1)"	"unprognostic (7.72e-2)"	"unprognostic (4.27e-4)"	"unprognostic (6.75e-2)"	"unprognostic (9.18e-3)"	"unprognostic (6.90e-5)"	"unprognostic (2.93e-2)"	"unprognostic (6.57e-2)"	"unprognostic (1.56e-2)"	"unprognostic (3.08e-3)"	1.2	2.0	14.5	0.9	28.1	3.7	1.0	10.6	53.9	1.8	1.0	3.1	0.0	1.0	2.6	5.5	1.2	1.1	1.0	1.0	10.8	24.4	6.0	1.0	1.1	1.1	8.6	17.5	1.1	1.1	9.5	2.8	1.4	6.0	1.8	1.0	1.3	1.0	1.3	0.9	1.0	1.1	1.0	2.6	1.0	1.0	4.0	3.4	0.0	1.1	0.0	1.2	1.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.9	0.4	0.0	3.8	0.0	0.0	0.0	0.2	0.0	1.4	0.9	2.5	3.6	0.0	0.5	0.2	1.7	10.8	1.2	0.3	0.8	1.4	7.4	34.9	3.0	0.1	0.0	0.1	0.6	0.0	3.1	0.0	1.2	0.3	0.0	0.3	9.0	0.1	0.4	0.8	0.0	0.0	4.3	5.2	3.8	0.5	2.6	0.2	4.7	5.0	3.7	1.2	6.6	0.0	1.8	0.3	0.1	0.0	0.0	6.5	0.9	1.3	3.8	0.0	0.0	0.0	6.3	1.7	8.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.5	28.1	10.6	36.7	10.8	24.4	8.6	17.5	6.0	3.4	0.0	0.0	0.0	1.4	0.2	3.8	1.1	0.0	0.0	0.0	0.0	9.8	0.0	6.6	4.2	4.3	0.3	0.0	0.0	4.7	0.1	0.2	0.8	0.0	0.0	3.0	4.8	2.9	0.0	0.3	3.6	0.6	0.2	0.0	0.0	0.0	3.9	4.2	0.0	0.0	0.0	5.4	0.0	0.8	3.2	4.7	0.1	0.5	0.0	0.0	0.3
GAD2	GAD65	ENSG00000136750	"Glutamate decarboxylase 2"	Q05329	10	26216307-26304558	"Enzymes, Predicted intracellular proteins"	"Neurotransmitter biosynthesis"	"Decarboxylase, Lyase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"brain: 66.2"	"Cell type enriched"	"Detected in some"	11	"Pancreatic endocrine cells: 35.1"	"Group enriched"	"Detected in some"	21	"glioma: 0.7;pancreatic cancer: 3.0;testis cancer: 1.2"	"Region enhanced"	"Detected in all"		"basal ganglia: 66.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	12	"MOLT-4: 5.2;SCLC-21H: 11.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA044637, CAB078177"	Enhanced					NA	NA					"CAB078177: AB_2665779, HPA044637: AB_10794053"		"unprognostic (8.67e-2)"			"unprognostic (1.11e-1)"						"unprognostic (4.93e-2)"		"unprognostic (2.52e-5)"	"unprognostic (5.44e-2)"	"unprognostic (8.08e-2)"			1.0	0.9	6.3	0.9	66.2	1.0	0.9	5.6	28.7	0.9	0.9	1.4	0.0	1.2	0.9	1.1	0.9	0.9	0.9	0.9	5.2	13.2	1.0	0.9	0.9	0.9	5.4	10.0	0.9	12.9	0.9	0.4	0.9	6.8	1.2	1.0	0.0	0.9	0.9	0.9	1.3	1.1	0.9	1.3	0.9	1.2	1.7	8.1	0.0	0.9	0.0	0.9	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	5.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.7	0.1	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	6.3	66.2	5.6	18.2	5.2	13.2	5.4	10.0	6.8	8.1	0.0	0.0	0.0	0.0	0.0	2.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	3.2	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	35.1	0.0	0.0	0.0	0.4	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.0
GADL1		ENSG00000144644	"Glutamate decarboxylase like 1"	Q6ZQY3	3	30726200-30894765	"Enzymes, Predicted intracellular proteins"		"Decarboxylase, Lyase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in many"	6	"skeletal muscle: 21.6"	"Cell type enhanced"	"Detected in some"	18	"Club cells: 2.3;Collecting duct cells: 1.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HAP1: 9.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA039160, HPA040229"	Uncertain		Approved	"Plasma membrane,Cytosol"		NA	NA			"Plasma membrane, Cytosol"		"HPA039160: AB_10796222, HPA040229: AB_10796118"	"unprognostic (4.96e-2)"	"unprognostic (1.30e-2)"	"unprognostic (9.83e-2)"	"unprognostic (1.39e-2)"	"unprognostic (5.60e-2)"	"unprognostic (7.32e-2)"		"unprognostic (5.05e-3)"	"unprognostic (8.37e-2)"	"unprognostic (1.23e-2)"	"unprognostic (2.02e-3)"	"unprognostic (1.63e-1)"	"unprognostic (1.98e-5)"	"unprognostic (8.81e-2)"	"unprognostic (4.54e-2)"	"unprognostic (4.39e-1)"	"unprognostic (1.06e-1)"	0.5	0.3	0.2	0.2	0.3	1.0	0.4	0.5	0.7	0.4	0.2	0.0	0.0	0.1	0.2	1.6	1.4	0.2	2.0	2.3	0.2	0.3	0.7	0.2	1.6	0.3	0.3	0.8	0.5	0.3	0.1	0.6	0.5	2.1	0.5	0.1	0.3	0.3	0.0	21.6	0.8	0.2	2.5	0.7	0.5	0.2	1.1	0.0	0.0	1.2	3.3	0.7	0.5	0.3	1.7	0.5	1.9	0.8	0.5	1.3	0.3	1.3	0.3	0.8	1.1	0.9	0.5	1.6	0.6	0.3	0.3	0.2	1.3	1.2	1.1	0.5	0.2	0.7	0.9	9.9	0.3	0.4	1.7	0.5	1.6	1.6	0.5	0.4	0.9	3.4	0.4	0.6	0.7	0.3	1.0	0.6	1.0	1.2	4.1	0.9	1.1	0.7	1.3	1.9	0.7	0.5	1.9	2.1	1.0	1.0	1.5	1.2	1.0	1.2	0.7	2.9	1.2	1.2	0.8	5.1	1.5	1.4	1.9	0.7	1.6	0.8	0.7	0.6	0.9	1.9	1.9	0.7	0.8	1.0	0.6	0.8	1.2	0.9	0.6	0.4	1.7	1.1	1.0	1.7	0.5	0.8	0.5	1.3	0.3	0.2	0.3	0.5	0.7	0.2	0.3	0.3	0.8	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.0	0.0	2.3	1.8	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0
GAK	DNAJC26	ENSG00000178950	"Cyclin G associated kinase"	O14976	4	849276-932373	"Enzymes, Predicted intracellular proteins"	"Cell cycle"	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027405, HPA027459, HPA027463"	Approved		Supported	"Golgi apparatus,Vesicles"		NA	NA			"Golgi apparatus"	Vesicles	"HPA027405: AB_10611111, HPA027459: AB_10599948, HPA027463: AB_10601959"	"unprognostic (1.55e-1)"	"unprognostic (1.66e-1)"	"unprognostic (2.46e-1)"	"unprognostic (3.24e-3)"	"unprognostic (1.07e-1)"	"unprognostic (3.50e-3)"	"unprognostic (1.68e-1)"	"unprognostic (7.07e-2)"	"unprognostic (1.39e-2)"	"unprognostic (3.34e-1)"	"unprognostic (3.03e-2)"	"unprognostic (3.33e-3)"	"prognostic favorable (1.70e-6)"	"unprognostic (1.09e-3)"	"unprognostic (1.79e-1)"	"unprognostic (6.26e-2)"	"prognostic favorable (7.41e-4)"	16.5	18.9	16.8	42.2	22.7	29.9	16.7	32.4	27.7	18.0	32.5	19.7	18.6	48.2	22.4	18.6	23.7	20.5	26.8	11.4	16.2	13.9	25.0	22.1	22.2	22.4	17.6	19.4	21.1	33.0	19.5	18.9	16.6	17.9	20.3	15.2	16.9	70.8	20.6	26.2	25.6	41.1	15.2	14.3	30.9	39.2	28.6	18.5	23.6	19.7	19.2	22.3	18.9	18.9	4.7	7.1	10.8	19.3	4.0	8.5	6.9	15.9	12.8	7.8	13.3	7.9	6.8	20.2	15.1	9.1	10.4	8.7	16.2	22.8	13.6	10.3	9.1	18.8	13.9	8.1	12.5	4.9	13.8	14.2	15.7	12.9	12.1	14.8	16.0	24.8	9.8	10.8	10.5	5.1	6.6	11.4	16.2	16.9	17.3	7.0	15.4	27.0	41.3	14.0	17.0	23.5	22.4	9.1	12.1	8.4	13.0	13.5	14.7	8.8	11.2	10.5	6.9	18.0	13.8	18.6	14.5	8.5	14.7	20.1	28.0	18.7	15.1	16.4	19.6	13.3	2.6	9.0	10.8	8.5	8.9	7.4	4.7	5.6	5.7	6.0	4.0	3.2	4.7	6.7	4.0	19.3	7.1	5.0	6.9	16.8	22.7	32.4	27.7	16.2	13.9	17.6	19.4	17.9	18.5	23.8	28.6	15.3	12.6	15.0	27.8	9.5	15.3	16.0	22.7	24.4	60.9	16.1	8.3	16.1	102.1	20.4	83.6	0.0	24.3	13.5	15.3	23.7	17.4	25.9	31.3	11.1	28.3	21.5	37.8	102.9	23.3	25.0	15.1	16.2	53.5	15.6	29.1	45.8	17.7	26.4	25.2	19.4	15.3	30.2	26.3	19.4	26.0	27.3	45.3	36.3
GAL3ST1	CST	ENSG00000128242	"Galactose-3-O-sulfotransferase 1"	Q99999	22	30554635-30574587	"Enzymes, Predicted intracellular proteins"	"Lipid metabolism, Sphingolipid metabolism"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"brain: 28.7;gallbladder: 13.4;intestine: 25.1;kidney: 13.3;stomach 1: 7.2"	"Cell type enhanced"	"Detected in many"	10	"Cholangiocytes: 38.2;Enterocytes: 17.4;Muller glia cells: 29.4;Proximal tubular cells: 18.9"	"Cancer enriched"	"Detected in many"	6	"renal cancer: 38.7"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"A549: 22.7;CACO-2: 6.3;EFO-21: 12.3;K-562: 5.3;OE19: 8.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001220, HPA077138"	Approved		Uncertain	Nucleoplasm,Vesicles	"Intracellular and membrane"	NA	NA			Vesicles	Nucleoplasm	"HPA001220: AB_1078933, HPA077138: "	"unprognostic (2.69e-2)"	"unprognostic (3.12e-4)"	"unprognostic (5.93e-2)"	"unprognostic (1.08e-2)"	"unprognostic (2.32e-1)"	"unprognostic (6.50e-3)"	"unprognostic (1.53e-2)"	"unprognostic (2.23e-1)"	"unprognostic (2.89e-1)"	"unprognostic (5.18e-2)"	"unprognostic (1.19e-1)"	"unprognostic (4.43e-2)"	"prognostic unfavorable (1.79e-4)"	"unprognostic (2.33e-1)"	"unprognostic (4.23e-2)"	"unprognostic (1.24e-1)"	"unprognostic (3.56e-2)"	0.8	0.6	8.4	0.7	9.6	1.2	0.8	1.4	12.3	1.4	11.3	25.8	0.0	24.2	1.3	2.3	0.8	2.2	13.4	0.5	12.1	8.3	13.3	1.6	1.5	0.9	14.0	2.6	1.2	2.9	0.6	0.5	1.3	12.4	1.2	2.8	0.3	1.0	1.9	1.9	2.1	25.1	0.7	28.7	0.7	7.2	2.5	7.8	0.0	0.6	0.0	0.4	1.0	0.7	2.3	2.8	2.3	0.7	0.3	0.8	0.0	0.1	22.7	0.4	0.2	0.0	0.0	1.7	0.0	0.1	0.0	0.0	6.3	3.1	0.3	12.3	0.0	0.4	0.2	0.0	0.0	0.0	0.2	0.8	0.3	0.2	4.1	0.5	0.1	0.3	0.2	0.0	0.1	0.1	0.0	0.0	0.3	5.3	0.6	0.0	0.1	0.3	0.9	3.3	8.5	0.3	0.2	0.1	0.6	0.9	0.1	0.3	1.5	0.0	0.4	0.2	0.6	0.1	0.1	0.6	0.2	0.1	0.2	0.0	2.0	1.2	0.3	0.1	0.1	0.2	0.9	0.7	0.1	0.4	0.5	0.7	1.8	0.7	0.8	0.2	2.3	0.5	0.8	2.3	0.3	0.3	2.8	0.1	0.0	8.4	9.6	1.4	10.3	12.1	8.3	14.0	2.6	12.4	7.8	0.0	0.0	0.0	0.1	0.3	0.7	0.6	38.2	0.0	0.0	3.5	0.0	0.0	13.3	5.6	0.9	0.1	17.4	0.0	9.7	0.0	0.0	0.2	0.0	1.3	0.1	0.0	10.5	0.0	0.8	0.6	1.4	0.0	0.0	0.0	7.4	29.4	4.6	7.0	2.1	18.9	1.1	0.0	0.0	3.1	7.5	0.3	0.2	0.0	8.0	0.0
GALC		ENSG00000054983	Galactosylceramidase	P54803	14	87837820-87993665	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Lipid degradation, Lipid metabolism, Sphingolipid metabolism"	"Glycosidase, Hydrolase"	"Disease mutation, Leukodystrophy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"granulocytes: 66.9;Kupffer cells: 62.6;Late spermatids: 61.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"CAPAN-2: 35.4;HMC-1: 33.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB022196	Approved				"Intracellular and membrane"	NA	NA		16000			"CAB022196: "	"unprognostic (1.27e-1)"	"unprognostic (1.40e-1)"	"unprognostic (1.33e-1)"	"unprognostic (1.37e-1)"	"unprognostic (2.16e-2)"	"unprognostic (9.39e-2)"	"unprognostic (3.08e-1)"	"unprognostic (9.70e-2)"	"unprognostic (1.73e-1)"	"unprognostic (6.56e-2)"	"unprognostic (8.44e-3)"	"unprognostic (8.08e-2)"	"unprognostic (1.84e-2)"	"unprognostic (6.00e-2)"	"unprognostic (2.13e-1)"	"unprognostic (6.80e-2)"	"unprognostic (2.72e-2)"	13.8	17.7	21.2	13.2	32.2	18.9	15.4	16.3	25.5	12.3	15.8	28.8	9.6	30.3	10.7	12.1	6.5	20.1	17.4	19.6	22.0	19.5	20.5	11.1	23.0	18.0	30.7	20.1	17.3	13.6	14.4	12.6	15.6	24.9	14.1	16.9	13.3	8.9	10.1	9.3	9.4	30.2	9.3	33.8	14.3	14.9	21.6	26.1	8.6	23.5	5.8	7.3	12.6	11.4	1.7	5.7	20.8	10.5	9.4	16.3	6.4	0.0	8.3	3.1	0.0	10.3	9.3	0.0	3.8	7.7	3.6	4.3	4.5	35.4	2.2	11.5	3.7	0.0	0.5	0.0	0.4	4.4	1.1	0.2	12.2	0.3	0.0	8.5	0.0	33.5	9.1	2.8	2.4	0.0	1.5	9.7	0.0	4.0	1.7	6.0	0.8	0.0	1.8	2.8	14.5	0.9	0.0	0.2	0.1	5.7	3.3	2.9	6.7	10.4	1.7	0.0	7.7	8.6	8.4	8.2	0.0	5.6	2.4	0.0	1.8	3.3	0.0	1.0	2.8	8.0	12.8	9.5	20.8	7.5	10.5	16.3	1.7	5.7	7.2	5.7	0.8	4.2	4.9	7.8	9.4	8.0	1.0	3.2	6.4	21.2	32.2	16.3	25.5	22.0	19.5	30.7	20.1	24.9	26.1	23.8	21.3	10.5	4.6	7.4	10.4	9.9	15.3	9.4	7.9	14.0	11.8	4.7	3.3	8.0	38.1	11.3	12.4	0.0	9.9	9.6	10.8	7.8	66.9	5.0	23.9	3.2	5.8	18.4	62.6	61.8	15.0	19.6	10.1	27.1	13.0	9.0	11.8	14.8	9.6	5.8	10.6	0.0	7.2	10.0	8.7	10.0	5.5	20.0	12.9	5.7
GALE	SDR1E1	ENSG00000117308	UDP-galactose-4-epimerase	Q14376	1	23795599-23800804	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Carbohydrate metabolism, Galactose metabolism"	Isomerase	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Mucus-secreting cells: 119.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA007340			Approved	Nucleoplasm,Cytosol		NA	NA			Cytosol	Nucleoplasm	"HPA007340: AB_1078934"	"unprognostic (1.65e-1)"	"unprognostic (1.78e-1)"	"unprognostic (5.25e-2)"	"unprognostic (1.41e-2)"	"unprognostic (3.03e-3)"	"unprognostic (1.17e-2)"	"unprognostic (3.19e-3)"	"unprognostic (1.84e-1)"	"unprognostic (1.59e-1)"	"unprognostic (2.65e-1)"	"unprognostic (1.56e-2)"	"unprognostic (1.34e-1)"	"unprognostic (2.25e-1)"	"unprognostic (7.51e-2)"	"unprognostic (2.12e-1)"	"prognostic favorable (2.68e-4)"	"unprognostic (1.41e-2)"	4.4	5.5	4.8	5.6	6.1	1.8	5.0	4.3	8.7	9.1	22.3	3.2	12.4	20.0	3.0	6.0	26.2	6.4	34.7	3.7	4.0	4.1	18.2	26.1	7.7	3.9	3.7	5.2	2.4	15.9	7.7	3.5	29.4	3.5	4.8	23.8	5.5	32.1	6.9	1.7	3.9	30.4	4.1	3.6	8.6	46.7	3.4	2.6	3.7	2.3	9.8	19.6	8.1	8.4	3.1	10.6	2.0	18.6	19.4	5.2	4.7	16.3	19.7	7.9	12.5	2.9	4.2	7.7	11.2	15.2	19.9	14.9	18.0	55.1	3.9	15.8	6.5	26.7	18.2	7.0	28.7	15.1	8.3	4.5	11.0	10.0	19.5	30.1	4.7	3.3	8.9	15.1	18.3	46.0	20.1	17.0	8.5	12.2	1.0	14.1	17.5	7.8	5.1	2.2	23.0	19.2	9.3	7.7	4.9	32.2	11.0	3.1	7.0	20.3	18.4	19.9	9.4	13.5	3.9	9.3	14.5	21.7	14.9	13.7	5.1	12.2	5.1	15.4	20.2	7.8	1.1	7.7	1.7	5.1	15.5	5.2	3.1	3.1	4.1	10.6	1.0	3.6	2.5	2.0	19.4	18.6	3.0	5.1	4.7	4.8	6.1	4.3	8.7	4.0	4.1	3.7	5.2	3.5	2.6	11.9	33.5	8.2	17.9	6.8	14.3	3.1	40.8	12.0	19.4	38.4	15.7	47.8	29.9	42.8	20.5	9.8	92.2	0.0	103.0	85.9	6.3	18.2	10.4	31.8	81.7	7.9	11.6	9.2	3.7	5.1	4.4	12.2	23.6	29.7	119.4	20.6	62.8	84.5	3.2	64.1	13.1	0.0	5.3	14.6	9.7	4.3	80.6	7.5	58.2	38.3
GALK1	GALK	ENSG00000108479	"Galactokinase 1"	P51570	17	75751594-75765711	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Carbohydrate metabolism, Galactose metabolism"	"Kinase, Transferase"	"Cataract, Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 36.7"	"Cell type enhanced"	"Detected in many"	5	"Hepatocytes: 107.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007094, HPA016960"	Approved		Approved	"Golgi apparatus,Cytosol"		NA	NA		8600	Cytosol	"Golgi apparatus"	"HPA007094: AB_1078939, HPA016960: AB_1849430"	"unprognostic (1.16e-1)"	"unprognostic (1.33e-2)"	"unprognostic (1.81e-2)"	"unprognostic (2.94e-2)"	"unprognostic (1.00e-1)"	"unprognostic (2.21e-1)"	"unprognostic (1.29e-1)"	"unprognostic (7.82e-2)"	"unprognostic (2.26e-1)"	"unprognostic (7.04e-2)"	"unprognostic (1.06e-1)"	"unprognostic (2.35e-2)"	"prognostic unfavorable (1.55e-6)"	"unprognostic (3.04e-1)"	"unprognostic (1.71e-1)"	"unprognostic (2.77e-1)"	"prognostic unfavorable (1.62e-5)"	6.4	3.3	3.8	6.2	4.4	3.6	14.2	4.6	5.1	4.7	9.3	3.7	3.5	15.9	4.7	5.0	9.0	4.8	3.8	7.2	3.6	3.6	12.3	31.6	4.7	11.7	4.3	3.8	5.2	16.0	1.9	2.6	4.6	3.2	4.7	1.3	3.6	14.9	4.7	5.4	6.2	17.3	3.7	4.0	7.2	5.3	5.7	3.3	7.6	3.3	5.1	4.8	3.6	5.0	10.6	36.7	20.7	30.2	5.7	9.4	14.6	8.1	30.7	1.9	8.6	2.7	6.8	7.2	6.6	5.5	6.8	6.4	17.0	1.6	12.7	8.3	3.5	5.0	4.8	2.0	1.9	0.7	5.5	19.2	7.9	11.6	28.5	9.3	5.3	17.6	6.1	2.7	3.4	1.5	3.4	15.8	7.2	6.2	7.8	4.1	34.9	14.6	19.9	2.1	3.8	15.9	17.5	21.4	21.1	3.8	3.3	4.2	11.6	5.6	14.5	14.4	1.5	11.8	8.7	13.9	10.1	9.7	9.6	5.8	19.7	4.8	3.2	11.3	12.4	7.8	2.6	30.2	8.3	9.4	25.5	8.5	10.6	7.8	8.6	27.2	6.8	4.2	6.2	20.7	5.7	20.2	36.7	8.7	14.6	3.8	4.4	4.6	5.1	3.6	3.6	4.3	3.8	3.2	3.3	14.9	11.7	15.8	8.2	7.7	6.8	17.6	20.4	0.0	3.4	12.2	0.0	41.6	58.0	23.3	0.6	17.9	12.3	0.0	47.9	88.4	28.2	7.0	27.6	107.1	49.1	3.2	8.1	30.7	45.2	3.6	28.7	28.4	37.1	27.9	13.6	15.8	25.0	25.1	22.6	75.3	6.2	6.5	12.3	1.2	22.0	10.9	35.4	15.0	24.0	7.6
GALK2	GK2	ENSG00000156958	"Galactokinase 2"	Q01415	15	49155656-49367869	"Enzymes, Predicted intracellular proteins"		"Kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043564, HPA048267"	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"HPA043564: AB_2678557, HPA048267: AB_2680335"	"unprognostic (2.27e-2)"	"unprognostic (1.45e-1)"	"unprognostic (2.38e-1)"	"prognostic favorable (7.31e-4)"	"unprognostic (3.04e-1)"	"unprognostic (9.78e-2)"	"unprognostic (2.66e-1)"	"unprognostic (1.95e-1)"	"unprognostic (2.30e-1)"	"unprognostic (8.67e-3)"	"unprognostic (2.25e-2)"	"unprognostic (2.43e-1)"	"prognostic favorable (1.88e-5)"	"unprognostic (2.33e-1)"	"unprognostic (9.79e-2)"	"unprognostic (2.13e-2)"	"unprognostic (1.93e-1)"	12.7	24.9	10.2	9.2	15.3	6.5	12.4	15.7	15.3	14.7	16.3	15.3	25.6	21.5	16.0	9.9	11.5	13.5	9.9	14.2	11.3	10.3	32.3	28.4	12.7	8.0	16.2	9.4	11.5	18.5	19.4	34.2	10.8	15.3	11.1	17.9	13.2	12.2	16.3	12.5	11.6	17.9	11.8	13.9	12.8	13.9	9.2	14.8	14.6	16.7	10.9	11.5	10.3	11.6	9.6	10.4	24.2	11.3	12.8	23.1	8.7	6.3	7.4	3.4	4.5	8.8	13.7	10.0	6.6	8.8	6.6	7.8	9.4	6.7	2.0	5.3	6.9	8.2	9.3	13.5	9.4	9.3	11.4	4.0	11.8	7.0	7.9	9.6	8.1	3.7	7.1	17.3	7.0	17.5	7.6	13.3	4.9	11.8	11.5	7.1	6.8	5.9	6.5	1.4	19.3	7.1	7.2	4.2	30.6	12.2	6.0	4.1	2.7	7.3	15.2	12.4	7.1	7.5	7.9	7.2	6.4	4.4	26.3	6.2	9.5	32.7	3.9	10.0	31.1	8.8	24.2	10.6	18.6	12.8	11.3	13.6	9.6	13.1	12.6	10.4	6.7	10.5	10.7	5.4	12.8	10.8	9.2	23.1	8.7	10.2	15.3	15.7	15.3	11.3	10.3	16.2	9.4	15.3	14.8	3.0	9.3	11.5	12.7	4.9	12.6	1.1	30.6	30.8	9.1	5.2	35.3	12.4	24.9	15.8	5.0	7.1	15.5	23.3	11.4	23.6	8.9	10.4	2.3	24.2	17.8	14.3	8.6	22.7	14.6	3.1	10.6	11.0	13.5	13.6	22.6	10.3	11.8	17.0	10.6	37.9	24.8	0.0	7.5	19.1	5.4	5.5	21.5	10.8	15.8	9.5
GALM		ENSG00000143891	"Galactose mutarotase"	Q96C23	2	38665910-38741237	"Enzymes, Predicted intracellular proteins"	"Carbohydrate metabolism"	Isomerase	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adrenal gland: 54.2"	"Cell type enhanced"	"Detected in many"	8	"Enterocytes: 102.0;Proximal tubular cells: 198.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"T-reg: 29.7"	"Group enriched"	"Detected in all"	5	"granulocytes: 13.2;T-cells: 29.7"	"Cell line enhanced"	"Detected in many"		"Karpas-707: 27.8;U-266/70: 31.3"	"Low region specificity"	"Detected in all"							"HPA035472, HPA035473, HPA064835"	Enhanced		Approved	Nucleoplasm		NA	NA		570000	Nucleoplasm		"HPA035472: AB_10669906, HPA035473: AB_2674642, HPA064835: AB_2732723"	"unprognostic (5.02e-2)"	"unprognostic (1.10e-1)"	"unprognostic (2.67e-1)"	"unprognostic (9.20e-2)"	"unprognostic (1.88e-2)"	"unprognostic (9.99e-3)"	"unprognostic (1.63e-2)"	"unprognostic (2.80e-3)"	"unprognostic (1.87e-1)"	"unprognostic (7.17e-2)"	"unprognostic (6.65e-2)"	"unprognostic (6.45e-2)"	"prognostic favorable (9.06e-5)"	"unprognostic (1.70e-2)"	"unprognostic (1.62e-1)"	"unprognostic (4.34e-1)"	"prognostic favorable (1.32e-4)"	11.2	54.2	3.1	10.4	2.5	0.7	4.6	1.9	2.7	5.9	28.4	2.5	44.3	22.7	6.8	11.8	3.4	11.6	13.3	7.7	2.5	1.8	39.1	28.8	5.8	6.4	2.4	1.9	6.4	7.9	10.4	2.4	3.1	2.9	8.1	10.7	15.3	7.9	29.1	4.6	2.2	39.8	5.4	3.3	4.1	5.0	4.7	2.1	6.4	7.4	3.3	9.3	6.5	5.2	2.8	4.5	13.2	2.1	2.3	29.7	5.3	0.0	10.6	3.3	0.0	11.1	6.5	5.9	1.3	4.0	3.0	4.9	11.9	5.6	4.1	7.9	5.9	6.0	1.7	4.6	0.3	6.0	18.7	7.7	2.2	2.9	23.7	4.0	0.9	0.1	4.5	0.1	6.8	0.0	4.2	3.4	0.0	6.3	27.8	5.5	0.3	9.1	14.8	5.0	22.6	3.5	5.7	0.2	8.0	3.9	18.4	0.6	4.7	0.0	7.6	5.4	4.4	3.6	2.1	1.3	1.0	0.2	7.3	0.4	31.3	21.1	0.1	6.9	2.6	0.1	13.2	2.1	1.8	10.2	1.5	15.0	2.8	16.0	14.8	4.5	2.5	5.8	5.0	5.1	2.3	0.2	0.4	29.7	5.3	3.1	2.5	1.9	2.7	2.5	1.8	2.4	1.9	2.9	2.1	26.8	11.2	12.5	6.5	6.0	2.9	17.3	22.9	24.1	9.1	66.3	0.0	17.0	21.6	9.1	0.8	9.3	102.0	0.0	13.3	25.1	14.3	6.4	6.9	40.4	91.8	3.2	12.7	6.2	12.3	0.5	18.7	36.1	16.9	12.6	36.5	34.6	10.1	63.0	91.9	198.6	7.1	6.5	9.6	1.0	2.1	5.3	5.3	24.5	72.8	4.7
GALNS	"GALNAC6S, GAS"	ENSG00000141012	"Galactosamine (N-acetyl)-6-sulfatase"	P34059	16	88813734-88856970	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		Hydrolase	"Disease mutation, Dwarfism, Mucopolysaccharidosis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Spermatocytes: 49.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in all"	4	"dendritic cells: 7.1;granulocytes: 19.3;monocytes: 11.2"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB026404, HPA042433, HPA074225"	Supported		Approved	Cytosol	"Intracellular and membrane"	NA	NA		2400000	Cytosol		"CAB026404: , HPA042433: AB_2732499, HPA074225: "	"unprognostic (3.16e-1)"	"unprognostic (9.98e-2)"	"unprognostic (4.03e-3)"	"unprognostic (2.26e-1)"	"unprognostic (1.11e-1)"	"unprognostic (8.08e-3)"	"prognostic unfavorable (3.66e-4)"	"unprognostic (4.15e-3)"	"unprognostic (1.32e-1)"	"unprognostic (4.84e-3)"	"unprognostic (2.00e-1)"	"unprognostic (3.53e-2)"	"unprognostic (4.12e-3)"	"unprognostic (4.24e-2)"	"unprognostic (5.54e-2)"	"unprognostic (3.59e-2)"	"unprognostic (6.84e-2)"	11.9	14.9	9.3	11.2	11.1	25.0	14.8	12.9	15.4	11.1	15.5	11.5	8.8	13.3	9.0	19.9	10.2	14.8	12.7	12.5	11.2	13.9	13.7	17.8	14.7	10.6	11.8	5.2	11.9	7.3	9.9	13.2	15.6	11.6	10.5	8.3	7.1	10.6	9.0	7.1	10.0	17.2	9.4	9.4	10.4	9.5	27.4	8.8	7.9	14.5	6.1	9.0	11.1	13.0	2.1	7.1	19.3	11.2	2.4	3.1	4.7	2.5	19.6	2.8	20.1	22.7	10.9	19.7	8.2	12.8	9.0	7.0	10.2	17.0	3.2	17.4	13.4	13.6	15.1	4.1	6.5	5.5	2.1	6.5	2.0	8.0	5.8	15.3	1.5	13.3	15.2	12.7	10.1	2.8	12.9	7.7	3.5	4.4	1.9	5.3	15.0	4.1	6.5	6.6	6.5	9.1	8.7	2.5	5.4	5.6	6.0	7.4	5.7	19.5	1.8	9.7	7.2	12.7	14.4	14.4	19.8	15.1	20.2	4.5	2.0	1.9	5.5	21.5	13.3	11.7	0.9	11.2	19.3	3.1	8.0	2.6	2.1	1.8	2.7	7.1	0.9	1.7	2.1	14.2	2.4	5.6	3.0	3.0	4.7	9.3	11.1	12.9	15.4	11.2	13.9	11.8	5.2	11.6	8.8	14.9	4.5	1.9	6.4	5.8	3.9	6.7	2.5	26.8	7.9	3.5	5.9	7.9	3.3	5.3	14.3	4.9	12.3	0.0	3.0	11.4	10.2	5.7	1.1	5.7	17.8	23.8	11.5	7.4	13.9	28.0	6.6	8.0	6.8	20.8	6.9	8.5	5.4	12.4	6.3	4.5	9.7	6.5	9.2	49.5	33.7	5.0	13.3	5.7	8.6	5.1
GALNT1	GalNAc-T1	ENSG00000141429	"Polypeptide N-acetylgalactosaminyltransferase 1"	Q10472	18	35581117-35711834	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HUVEC TERT2: 83.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA012628	Uncertain				"Intracellular and membrane"	NA	NA		1600000			"HPA012628: AB_1849439"	"unprognostic (9.81e-2)"	"unprognostic (1.01e-1)"	"unprognostic (4.39e-2)"	"unprognostic (2.73e-1)"	"unprognostic (2.08e-1)"	"unprognostic (2.83e-2)"	"unprognostic (1.96e-2)"	"unprognostic (7.06e-2)"	"unprognostic (2.03e-2)"	"unprognostic (1.51e-2)"	"unprognostic (3.00e-2)"	"unprognostic (1.00e-1)"	"unprognostic (3.47e-2)"	"unprognostic (4.38e-2)"	"unprognostic (2.74e-2)"	"unprognostic (1.07e-2)"	"unprognostic (8.60e-2)"	15.0	14.2	11.3	11.4	16.0	9.7	24.2	14.3	12.3	15.1	18.7	11.3	8.3	18.9	10.3	13.7	31.8	8.9	13.0	18.4	15.3	9.7	12.9	21.8	12.0	27.4	14.9	13.3	10.5	22.2	4.6	15.0	22.9	12.5	11.7	18.7	15.7	28.3	8.4	19.9	27.6	24.7	15.8	13.7	17.9	11.9	9.8	12.6	13.8	13.5	16.0	17.3	32.3	19.3	6.2	6.7	11.1	9.1	6.6	5.8	2.0	7.9	8.7	10.3	9.5	20.5	19.5	13.7	8.3	8.9	7.8	7.1	5.1	15.5	9.4	9.0	8.9	7.4	6.1	5.0	15.9	12.4	10.9	4.6	11.9	17.0	11.9	10.3	25.8	15.9	13.2	15.3	12.1	13.5	23.2	83.6	7.7	3.5	12.5	30.1	6.3	7.6	9.8	10.6	8.2	4.1	9.5	13.5	4.5	31.9	37.0	5.6	11.0	14.8	10.9	8.8	20.6	8.3	20.4	29.0	14.4	5.8	9.4	9.1	18.0	8.5	18.0	10.1	17.7	7.4	8.4	5.4	11.1	5.1	6.7	5.8	6.2	3.6	4.7	6.1	3.8	3.4	4.9	6.4	6.6	9.1	6.7	3.6	2.0	11.3	16.0	14.3	12.3	15.3	9.7	14.9	13.3	12.5	12.6	74.5	36.1	27.6	22.2	26.6	29.5	34.2	53.5	32.1	38.7	15.7	11.8	24.2	6.6	34.8	1.0	29.2	87.1	0.0	34.3	79.6	43.7	55.6	19.7	61.0	64.0	81.0	37.4	37.4	52.6	1.5	17.5	39.7	18.6	13.6	54.1	102.4	42.0	48.9	17.0	17.6	23.9	12.9	21.7	3.7	14.3	71.8	27.8	22.0	69.9	39.7
GALNT10	GalNAc-T10	ENSG00000164574	"Polypeptide N-acetylgalactosaminyltransferase 10"	Q86SR1	5	154190730-154420984	"Enzymes, Predicted intracellular proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"ovary: 43.7"	"Cell type enhanced"	"Detected in many"	4	"Peritubular cells: 47.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"hTERT-RPE1: 74.0;TIME: 40.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA007525	Approved		Approved	"Nucleoplasm,Golgi apparatus,Plasma membrane"	"Intracellular and membrane"	NA	NA		830000	"Plasma membrane"	"Nucleoplasm, Golgi apparatus"	"HPA007525: AB_1849443"	"unprognostic (6.99e-2)"	"unprognostic (4.33e-2)"	"unprognostic (9.85e-2)"	"prognostic favorable (3.33e-6)"	"unprognostic (1.63e-1)"	"unprognostic (6.98e-2)"	"unprognostic (6.95e-3)"	"unprognostic (2.38e-1)"	"unprognostic (3.34e-1)"	"prognostic unfavorable (5.69e-4)"	"unprognostic (2.88e-3)"	"unprognostic (2.63e-1)"	"unprognostic (1.54e-1)"	"unprognostic (7.76e-3)"	"unprognostic (1.22e-1)"	"unprognostic (1.61e-2)"	"unprognostic (3.08e-1)"	9.5	13.5	8.4	15.4	9.1	10.1	8.7	3.2	6.2	15.9	10.6	14.4	1.0	8.8	4.9	11.5	5.9	9.2	17.8	7.7	6.9	7.5	6.8	3.4	10.1	11.5	7.2	5.2	43.7	9.2	14.1	9.7	5.2	10.1	8.3	9.4	31.6	11.6	2.4	5.6	4.0	12.4	14.1	7.7	16.7	13.8	4.3	9.2	5.6	10.6	4.2	9.3	7.5	10.0	4.7	3.1	5.7	3.8	3.9	7.5	2.1	6.2	21.4	5.2	4.5	11.1	9.9	4.0	18.1	10.1	7.2	6.9	3.0	14.4	4.1	12.8	30.4	12.9	1.1	2.4	14.1	6.6	10.6	1.7	11.2	4.1	4.0	8.5	2.4	10.9	12.3	3.3	5.8	8.6	74.0	13.8	3.1	2.5	13.0	12.3	6.5	0.2	1.6	2.0	17.6	4.4	1.2	2.7	4.1	10.0	4.3	0.7	1.7	8.0	30.0	2.3	8.0	11.6	1.8	40.5	17.6	4.2	4.3	19.2	3.7	3.6	2.2	11.5	4.8	5.3	3.4	2.7	5.3	7.5	3.6	6.6	4.5	4.3	4.8	3.1	4.7	1.9	5.3	5.7	3.9	3.8	2.7	3.5	2.1	8.4	9.1	3.2	6.2	6.9	7.5	7.2	5.2	10.1	9.2	8.9	36.1	12.3	3.5	4.2	3.5	4.1	5.1	0.0	12.5	14.0	3.9	0.6	8.3	9.3	10.6	13.4	15.5	23.3	26.2	1.2	9.1	9.9	10.3	4.7	7.2	0.0	2.9	19.0	15.4	16.0	35.4	9.7	0.0	6.4	16.1	20.8	26.5	11.5	47.0	2.9	11.4	6.5	7.3	1.7	3.1	3.1	0.7	13.8	9.3	2.8
GALNT11	GalNAc-T11	ENSG00000178234	"Polypeptide N-acetylgalactosaminyltransferase 11"	Q8NCW6	7	152025674-152122347	"Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins"	"Notch signaling pathway"	"Glycosyltransferase, Transferase"	Heterotaxy	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"kidney: 82.0"	"Cell type enhanced"	"Detected in many"	7	"Bipolar cells: 116.5;Proximal tubular cells: 163.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039330	Uncertain					NA	NA					"HPA039330: AB_10795249"	"unprognostic (6.09e-2)"	"unprognostic (1.22e-1)"	"unprognostic (4.98e-2)"	"unprognostic (3.48e-2)"	"prognostic unfavorable (9.54e-4)"	"unprognostic (1.76e-1)"	"unprognostic (9.10e-3)"	"unprognostic (1.56e-3)"	"unprognostic (1.38e-1)"	"unprognostic (3.65e-1)"	"unprognostic (3.82e-2)"	"unprognostic (1.64e-1)"	"prognostic favorable (2.24e-6)"	"unprognostic (1.33e-1)"	"unprognostic (1.17e-1)"	"unprognostic (2.97e-1)"	"unprognostic (9.51e-2)"	10.7	9.4	11.1	5.1	18.7	3.8	10.4	20.8	21.8	9.1	7.5	11.4	7.1	5.1	9.6	9.2	9.8	8.3	9.3	9.2	11.4	9.3	82.0	7.1	9.6	4.9	7.0	13.4	10.6	29.7	19.3	10.5	15.9	34.1	12.0	6.5	21.7	7.8	9.8	8.8	8.3	6.9	9.5	6.5	8.5	7.6	7.3	4.4	4.6	12.5	5.6	6.4	9.4	8.1	6.3	8.3	8.2	12.5	15.7	19.3	8.7	10.6	9.6	14.2	15.8	32.9	32.5	14.6	8.5	9.8	7.2	6.8	7.7	11.3	0.0	22.3	13.8	20.1	5.0	6.7	12.1	8.9	8.8	10.0	2.1	8.7	6.7	10.8	9.6	11.4	28.6	15.6	6.0	5.0	12.6	13.0	7.5	10.7	0.1	18.0	9.2	8.2	8.7	11.6	16.8	7.7	0.0	6.2	0.3	23.7	16.5	12.6	16.8	14.2	6.9	11.5	15.8	10.3	8.3	11.7	9.7	3.4	12.2	9.3	3.2	4.0	0.1	20.2	9.4	33.0	5.8	8.3	8.2	19.3	9.4	19.0	6.3	10.7	17.7	8.3	3.8	9.2	14.0	4.4	15.7	12.5	2.5	7.9	8.7	11.1	18.7	20.8	21.8	11.4	9.3	7.0	13.4	34.1	4.4	11.9	18.5	17.9	21.5	9.3	116.5	24.0	10.2	20.1	11.4	33.2	25.5	66.9	51.4	15.4	3.0	20.7	7.7	0.0	16.2	11.7	25.1	24.5	13.9	13.5	21.9	71.5	21.9	25.8	16.5	2.9	18.4	11.5	16.9	15.4	9.0	30.9	11.9	7.0	33.9	163.9	35.9	0.0	21.7	17.7	13.8	10.3	30.3	22.0	8.5	15.4
GALNT12	GalNAc-T12	ENSG00000119514	"Polypeptide N-acetylgalactosaminyltransferase 12"	Q8IXK2	9	98807699-98850081	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		"Glycosyltransferase, Transferase"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"epididymis: 34.7"	"Cell type enhanced"	"Detected in many"	13	"Mucus-secreting cells: 122.4"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in all"	5	"cerebellum: 17.7"	"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"OE19: 41.8;U-2197: 54.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			HPA048292	Enhanced				"Intracellular and membrane"	NA	NA		15000			"HPA048292: AB_2680343"	"unprognostic (7.85e-3)"	"unprognostic (1.50e-1)"	"unprognostic (2.33e-1)"	"unprognostic (1.47e-2)"	"unprognostic (2.97e-3)"	"unprognostic (4.10e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.03e-1)"	"unprognostic (2.03e-2)"	"unprognostic (1.97e-1)"	"unprognostic (2.61e-2)"	"unprognostic (7.71e-2)"	"prognostic favorable (3.24e-4)"	"unprognostic (9.05e-2)"	"unprognostic (1.92e-1)"	"unprognostic (1.60e-3)"	"unprognostic (6.87e-2)"	7.5	1.7	1.0	9.5	2.3	0.6	3.7	17.7	1.6	4.0	29.6	1.7	7.4	14.6	1.8	34.7	15.2	3.2	20.5	1.1	1.4	1.6	2.9	0.4	13.8	1.1	3.3	1.0	1.0	9.2	4.0	3.1	1.0	2.7	4.2	24.8	4.0	15.2	6.6	1.1	2.6	22.4	15.4	1.3	1.5	23.5	3.4	1.1	2.8	9.3	8.1	23.9	9.0	3.4	0.8	0.4	1.6	0.0	2.2	2.5	0.4	1.7	1.3	1.1	4.5	3.4	2.7	0.0	0.4	0.7	0.7	1.5	0.2	7.2	0.0	1.7	0.3	4.1	12.6	1.0	0.4	0.5	8.4	0.6	0.8	0.0	0.0	0.1	0.5	0.1	1.3	0.3	2.1	0.0	0.9	0.8	6.4	9.6	0.0	0.2	4.5	0.8	1.5	5.6	41.8	1.8	2.1	0.1	0.0	0.8	2.5	4.2	0.4	0.1	10.3	1.0	2.7	1.5	1.4	1.4	0.0	0.1	54.3	0.0	0.7	1.5	0.7	12.7	0.0	0.3	0.0	0.0	1.6	1.4	0.0	2.5	0.1	1.9	0.8	0.2	0.8	2.3	1.5	0.1	2.2	0.0	0.4	0.1	0.4	1.0	2.3	17.7	1.6	1.4	1.6	3.3	1.0	2.7	1.1	3.0	22.6	0.9	1.3	2.2	0.9	0.5	25.5	13.4	14.8	10.4	15.7	0.9	0.0	6.4	1.4	0.7	29.9	0.0	21.7	1.5	5.6	10.5	2.3	0.0	2.1	0.0	19.1	0.0	0.3	1.1	2.0	1.7	0.0	0.0	122.4	0.3	23.8	31.7	7.1	3.0	0.1	0.0	1.2	4.7	12.1	1.1	0.9	3.8	33.7	8.2
GALNT13	"GalNAc-T13, KIAA1918"	ENSG00000144278	"Polypeptide N-acetylgalactosaminyltransferase 13"	Q8IUC8	2	153871913-154453849	"Enzymes, Predicted intracellular proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 39.0"	"Cell type enhanced"	"Detected in some"	20	"Alveolar cells type 1: 23.8;Bipolar cells: 15.1;Cone photoreceptor cells: 49.1;Horizontal cells: 68.3"	"Cancer enriched"	"Detected in some"	5	"glioma: 4.4"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"eosinophil: 2.2"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"SH-SY5Y: 28.2;U-251 MG: 7.4;WM-115: 21.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA060775	Approved					NA	NA					"HPA060775: AB_2684358"	"unprognostic (1.97e-1)"	"unprognostic (3.43e-3)"	"unprognostic (2.47e-2)"	"unprognostic (1.00e-3)"	"unprognostic (4.21e-3)"	"unprognostic (7.73e-3)"	"unprognostic (6.50e-2)"	"unprognostic (8.17e-2)"	"unprognostic (3.57e-1)"	"unprognostic (9.15e-2)"	"unprognostic (3.83e-2)"	"unprognostic (3.09e-2)"	"unprognostic (5.17e-2)"	"unprognostic (2.05e-5)"	"unprognostic (8.61e-3)"	"unprognostic (1.52e-1)"	"unprognostic (2.05e-1)"	3.0	7.7	8.5	0.7	6.2	0.6	1.4	39.0	29.1	3.1	0.9	7.9	0.6	0.7	3.1	2.3	0.7	1.0	1.1	0.6	7.8	8.9	0.6	0.4	3.4	0.4	8.3	3.1	1.1	1.0	0.5	3.1	1.0	10.5	3.6	1.0	1.1	10.9	2.6	1.7	0.8	0.8	2.0	10.4	0.5	1.1	1.3	4.3	0.0	0.4	0.0	0.5	1.5	0.2	0.2	0.6	2.2	0.9	0.2	0.8	0.0	0.0	3.2	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	3.4	0.0	0.0	0.0	1.8	0.0	3.3	1.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	5.5	0.0	0.0	0.0	0.3	0.6	0.0	0.0	0.1	4.7	0.1	4.4	0.0	0.2	0.6	0.0	0.0	4.8	28.2	0.1	0.0	0.0	0.5	0.0	0.0	0.0	0.0	1.2	0.1	7.4	0.3	0.0	0.0	4.6	0.0	21.1	0.0	0.9	2.2	0.0	0.6	0.0	0.0	0.0	0.0	0.1	0.2	0.1	0.8	0.1	0.2	0.0	0.6	0.4	0.0	8.5	6.2	39.0	7.4	7.8	8.9	8.3	3.1	10.5	4.3	23.8	1.4	0.0	0.0	0.1	15.1	0.8	0.0	0.0	2.3	0.0	49.1	0.0	0.0	0.0	1.5	0.1	0.0	0.0	0.2	0.0	1.8	0.0	0.0	0.0	0.1	68.3	3.4	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.9	0.2	0.0	0.0	0.0	0.4	0.0	0.2	0.5	0.4	0.1	0.0	0.0	0.0	0.0
GALNT14	"FLJ12691, GalNac-T10, GalNac-T14"	ENSG00000158089	"Polypeptide N-acetylgalactosaminyltransferase 14"	Q96FL9	2	30910467-31155202	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"kidney: 42.7"	"Cell type enhanced"	"Detected in some"	18	"Distal tubular cells: 11.6;Ito cells: 11.1;Proximal tubular cells: 39.7"	"Cancer enriched"	"Detected in many"	7	"renal cancer: 45.9"	"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in some"	7	"neutrophil: 10.6"	"Lineage enriched"	"Detected in many"	7	"granulocytes: 10.6"	"Cell line enhanced"	"Detected in many"		"A549: 13.1;RPMI-8226: 15.2;RPTEC TERT1: 22.4;RT4: 16.6;SCLC-21H: 12.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA030138			Approved	"Nucleoplasm,Golgi apparatus"		NA	NA		9400	"Golgi apparatus"	Nucleoplasm	"HPA030138: AB_2673332"	"unprognostic (5.69e-2)"	"unprognostic (1.35e-1)"	"unprognostic (2.05e-2)"	"unprognostic (2.82e-3)"	"unprognostic (3.85e-2)"	"unprognostic (2.10e-2)"	"unprognostic (3.32e-1)"	"unprognostic (7.58e-2)"	"unprognostic (1.96e-1)"	"unprognostic (2.80e-1)"	"unprognostic (1.22e-3)"	"unprognostic (1.12e-1)"	"unprognostic (3.18e-3)"	"unprognostic (5.18e-3)"	"unprognostic (2.67e-2)"	"unprognostic (2.56e-1)"	"unprognostic (9.51e-3)"	1.2	1.5	1.5	0.9	3.7	4.3	1.1	1.8	9.6	1.4	0.6	1.8	0.3	0.6	0.6	1.0	10.2	1.1	3.7	0.4	1.6	1.5	42.7	1.2	0.6	2.6	1.2	2.3	0.9	2.7	7.6	5.7	0.2	0.9	1.7	0.2	2.1	1.7	0.2	0.4	1.9	3.1	0.7	0.8	1.8	0.6	1.6	0.3	0.1	1.1	1.0	4.2	2.0	1.4	1.4	0.0	10.6	0.0	0.0	0.0	0.1	11.1	13.1	0.0	0.0	0.0	0.0	0.0	3.7	2.0	2.5	0.3	0.0	0.0	10.4	3.8	0.2	0.0	0.0	0.4	0.5	0.4	0.3	1.3	5.8	0.0	0.0	0.0	8.4	0.0	0.1	2.3	0.0	8.6	0.1	0.0	0.3	0.0	9.3	0.0	5.1	0.0	0.0	6.2	0.0	0.0	7.3	0.0	15.2	22.4	16.6	12.3	8.9	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	9.8	0.0	0.2	0.9	2.8	0.0	0.0	5.3	0.4	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	10.6	0.0	0.0	0.0	0.0	0.1	1.5	3.7	1.8	9.6	1.6	1.5	1.2	2.3	0.9	0.3	0.0	0.0	0.8	3.8	2.5	0.2	0.4	0.0	0.0	1.2	8.7	0.0	0.0	11.6	2.5	5.3	0.6	0.4	0.0	0.3	0.0	0.2	0.8	0.0	0.0	0.1	0.0	0.0	11.1	0.6	5.8	0.0	0.0	0.0	0.0	0.0	0.2	1.7	0.0	0.0	39.7	0.3	6.5	0.8	0.4	3.4	0.6	0.0	0.0	0.0	1.0
GALNT15	"GALNT7, GALNTL2, pp-GalNAc-T15"	ENSG00000131386	"Polypeptide N-acetylgalactosaminyltransferase 15"	Q8N3T1	3	16174649-16231992	"Enzymes, Predicted intracellular proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 66.7;brain: 52.3"	"Cell type enhanced"	"Detected in some"	15	"Early spermatids: 19.5;Endothelial cells: 15.2;Ito cells: 39.9;Muller glia cells: 48.3"	"Cancer enriched"	"Detected in many"	5	"glioma: 21.3"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"ASC diff: 44.9;ASC TERT1: 44.3;HSkMC: 33.7"	"Group enriched"	"Detected in many"	4	"cerebellum: 10.7;pons and medulla: 6.7"	"Low region specificity"	"Detected in all"			HPA017076	Uncertain		Approved	"Golgi apparatus,Cytosol"	"Intracellular and membrane"	NA	NA		25000	"Golgi apparatus"	Cytosol	"HPA017076: AB_1849458"	"unprognostic (3.87e-1)"	"unprognostic (4.84e-4)"	"unprognostic (6.39e-2)"	"unprognostic (8.77e-3)"	"unprognostic (2.77e-1)"	"unprognostic (2.52e-1)"	"unprognostic (7.40e-4)"	"unprognostic (4.24e-1)"	"unprognostic (2.24e-1)"	"unprognostic (8.28e-6)"	"unprognostic (5.13e-2)"	"unprognostic (2.58e-1)"	"unprognostic (2.66e-2)"	"unprognostic (1.37e-3)"	"unprognostic (1.88e-1)"	"unprognostic (8.51e-2)"	"unprognostic (1.78e-3)"	66.7	5.3	7.6	2.6	17.4	1.1	22.8	2.3	31.5	3.9	8.6	28.1	1.1	2.8	3.5	3.3	11.4	5.3	5.2	7.3	14.8	6.6	8.3	2.8	3.1	3.4	38.9	8.4	8.4	3.2	1.6	1.0	35.5	24.8	4.9	3.8	1.3	8.0	4.1	17.3	11.6	5.3	10.5	52.3	12.8	4.6	8.1	19.9	0.0	6.3	1.6	1.5	16.6	23.5	0.6	0.9	0.9	0.3	0.3	0.4	0.3	0.0	0.0	0.0	0.0	44.9	44.3	0.0	1.0	0.7	0.0	0.1	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	33.7	0.0	0.4	0.5	0.3	0.6	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	1.2	7.8	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.5	0.2	0.3	0.2	0.2	0.1	0.4	0.2	0.3	0.0	0.6	0.4	0.2	0.9	0.3	0.3	0.9	0.3	0.3	7.6	17.4	2.3	13.6	14.8	6.6	38.9	8.4	24.8	19.9	0.0	1.7	0.0	0.5	0.5	0.8	1.6	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	19.5	15.2	0.0	0.0	0.0	0.0	2.9	1.2	1.1	0.2	0.1	0.0	0.0	39.9	0.6	10.6	1.7	0.2	0.0	0.0	0.0	48.3	0.2	0.0	0.7	0.0	3.1	0.0	1.2	10.2	0.5	0.6	0.0	0.0	0.0	0.1
GALNT16	"GalNAc-T16, GALNTL1, KIAA1130"	ENSG00000100626	"Polypeptide N-acetylgalactosaminyltransferase 16"	Q8N428	14	69259277-69357033	"Enzymes, Predicted intracellular proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enriched"	"Detected in some"	4	"Cardiomyocytes: 38.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"AF22: 7.4;ASC diff: 9.8;hTEC/SVTERT24-B: 13.9;hTERT-RPE1: 14.2;SCLC-21H: 7.3;U-2 OS: 16.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA059136, HPA075325"	Approved		Approved	Vesicles,Cytosol		NA	NA		250000	"Vesicles, Cytosol"		"HPA059136: AB_2683919, HPA075325: "	"unprognostic (9.71e-3)"	"unprognostic (7.47e-2)"	"unprognostic (4.02e-1)"	"unprognostic (2.30e-2)"	"unprognostic (6.71e-2)"	"unprognostic (5.72e-3)"	"unprognostic (3.18e-3)"	"unprognostic (1.22e-1)"	"unprognostic (1.02e-1)"	"unprognostic (1.28e-2)"	"unprognostic (3.62e-4)"	"unprognostic (1.31e-2)"	"prognostic favorable (5.23e-6)"	"unprognostic (5.38e-3)"	"unprognostic (3.34e-2)"	"unprognostic (3.93e-2)"	"unprognostic (7.96e-5)"	13.6	15.5	20.0	2.9	17.9	0.8	14.5	16.1	21.7	7.8	4.1	5.0	4.0	3.2	6.4	6.0	5.1	6.5	4.8	27.6	18.3	27.2	5.6	3.0	4.2	4.2	6.6	25.2	2.8	5.6	4.0	4.1	1.2	13.0	4.6	3.4	1.7	28.9	6.6	5.3	7.0	5.0	11.3	8.7	14.3	2.4	3.3	3.3	0.0	3.5	6.3	2.2	5.0	3.8	0.5	0.2	1.3	0.5	0.3	0.3	0.2	0.0	0.6	7.4	0.2	9.8	4.5	0.0	1.0	0.0	1.3	1.9	0.4	0.0	0.0	0.2	1.2	0.6	0.0	2.4	0.0	0.2	0.1	5.1	0.0	0.1	0.3	0.1	0.0	0.5	0.4	0.0	13.9	0.0	14.2	0.8	0.0	0.0	0.0	2.3	0.3	0.0	0.0	1.4	0.0	0.1	0.0	3.9	0.0	0.5	0.0	7.3	2.4	1.6	0.3	0.0	0.3	0.2	0.0	0.1	1.5	16.7	1.9	1.5	0.0	0.0	0.0	1.5	0.0	0.0	0.9	0.5	0.1	0.1	0.2	0.2	0.2	0.2	0.1	0.0	0.5	0.3	0.2	1.3	0.3	0.1	0.2	0.1	0.2	20.0	17.9	16.1	16.2	18.3	27.2	6.6	25.2	13.0	3.3	0.0	0.0	0.0	0.5	3.7	1.9	38.2	0.0	0.0	0.0	0.0	2.0	0.1	3.3	0.0	6.4	0.1	0.0	0.0	0.0	0.0	5.2	0.4	0.0	0.0	0.2	0.0	0.0	0.0	0.0	8.4	0.9	0.0	3.3	0.0	0.0	0.2	0.0	0.0	3.5	0.0	0.6	6.5	9.2	0.7	1.9	2.9	0.0	0.0	0.0	0.4
GALNT17	"GalNAc-T17, GalNAc-T19, GalNAc-T5L, GALNTL3, ppGalNAc-T17, WBSCR17"	ENSG00000185274	"Polypeptide N-acetylgalactosaminyltransferase 17"	Q6IS24	7	71132169-71713600	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		"Glycosyltransferase, Transferase"	"Williams-Beuren syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 42.9"	"Cell type enhanced"	"Detected in single"	28	"Collecting duct cells: 1.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 9.6;NTERA-2: 7.2;RPMI-8226: 8.0;SK-BR-3: 30.5;SuSa: 10.0"	"Low region specificity"	"Detected in all"							"HPA013624, HPA047986"	Approved		Uncertain	"Nucleoplasm,Nucleoli,Nuclear bodies,Golgi apparatus"		NA	NA			"Nucleoplasm, Golgi apparatus"	"Nucleoli, Nuclear bodies"	"HPA013624: AB_1858787, HPA047986: "	"unprognostic (2.79e-2)"	"unprognostic (6.83e-2)"	"unprognostic (5.54e-2)"	"unprognostic (3.66e-3)"	"unprognostic (1.50e-1)"	"unprognostic (2.62e-1)"	"unprognostic (6.41e-2)"	"unprognostic (5.18e-2)"	"unprognostic (1.00e-1)"	"prognostic favorable (4.60e-4)"	"unprognostic (2.00e-1)"	"unprognostic (4.73e-1)"	"unprognostic (1.96e-2)"	"unprognostic (9.63e-3)"	"prognostic favorable (3.91e-4)"	"unprognostic (1.92e-1)"	"unprognostic (7.94e-3)"	1.8	7.8	8.2	2.1	13.9	0.5	1.2	25.7	42.9	2.3	4.9	1.7	1.9	0.8	7.9	4.6	8.9	4.4	2.7	19.4	13.2	4.6	2.3	0.6	3.5	0.5	2.1	12.0	22.3	9.4	0.6	4.1	0.7	4.5	9.1	1.4	1.2	1.7	8.3	1.9	0.8	1.5	12.3	1.2	3.3	1.1	3.8	0.8	0.3	9.4	0.0	1.8	10.3	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	7.2	0.0	0.0	0.0	0.0	8.0	0.0	0.0	0.5	0.0	0.0	30.5	0.0	10.0	0.0	0.0	0.0	0.0	2.6	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.2	13.9	25.7	22.5	13.2	4.6	2.1	12.0	4.5	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
GALNT18	"GalNAc-T18, GALNT15, GALNTL4, MGC71806"	ENSG00000110328	"Polypeptide N-acetylgalactosaminyltransferase 18"	Q6P9A2	11	11270876-11622005	"Enzymes, Predicted membrane proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	5	"Alveolar cells type 1: 41.7;Cytotrophoblasts: 37.3;Endothelial cells: 34.9;Muller glia cells: 44.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	17	"gdT-cell: 1.7"	"Lineage enriched"	"Detected in single"	17	"T-cells: 1.7"	"Cell line enhanced"	"Detected in many"		"A-431: 18.9;HaCaT: 24.2;HBEC3-KT: 16.9;PC-3: 17.0;RPMI-8226: 17.7;SK-BR-3: 22.1;U-87 MG: 16.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA012955, HPA070681"	Approved		Approved	"Golgi apparatus,Vesicles,Cytosol"		NA	NA		200000	"Golgi apparatus"	"Vesicles, Cytosol"	"HPA012955: AB_1849460, HPA070681: "	"unprognostic (1.26e-1)"	"unprognostic (2.80e-1)"	"unprognostic (3.69e-2)"	"prognostic unfavorable (1.29e-4)"	"unprognostic (7.37e-2)"	"unprognostic (1.22e-1)"	"unprognostic (6.42e-3)"	"unprognostic (6.68e-2)"	"unprognostic (6.04e-2)"	"unprognostic (2.05e-1)"	"unprognostic (5.24e-2)"	"unprognostic (1.70e-1)"	"unprognostic (2.66e-3)"	"unprognostic (3.54e-2)"	"unprognostic (1.63e-1)"	"unprognostic (2.10e-1)"	"unprognostic (1.81e-2)"	18.6	6.0	15.5	4.9	13.5	0.8	9.1	21.3	16.2	7.0	13.3	5.8	8.3	3.9	15.0	6.4	7.8	7.6	12.6	21.9	13.1	7.0	19.7	6.6	31.2	5.8	10.0	12.1	3.8	9.5	9.1	4.3	26.6	12.8	8.2	4.3	7.1	10.4	11.5	6.1	7.6	4.9	15.0	6.5	4.0	4.1	13.3	8.4	0.7	39.2	5.6	4.2	10.3	9.1	0.0	0.0	0.0	0.0	0.0	1.7	0.3	18.9	6.9	0.9	4.2	0.0	0.0	0.1	2.1	5.2	0.2	0.0	0.7	2.5	0.0	1.5	0.0	2.6	24.2	4.6	16.9	0.0	0.0	6.8	0.0	0.0	0.0	0.2	0.0	0.0	0.1	7.0	0.0	6.4	0.0	0.0	8.6	0.0	0.0	0.9	4.6	0.2	0.0	0.7	0.0	17.0	0.0	0.0	17.7	13.1	2.3	0.3	1.9	3.5	22.1	0.1	0.6	4.6	0.0	0.0	0.3	3.8	0.1	0.1	0.0	0.0	0.0	16.0	0.0	4.6	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	15.5	13.5	21.3	16.2	13.1	7.0	10.0	12.1	12.8	8.4	41.7	5.8	0.0	5.8	4.9	0.8	7.3	22.9	12.0	14.8	19.2	2.0	37.3	13.3	18.3	2.1	34.9	0.0	0.0	3.4	2.2	2.8	9.8	1.1	2.6	2.3	0.0	0.0	22.1	1.5	0.7	1.4	0.5	1.7	0.0	0.0	44.1	5.8	0.0	2.8	28.1	1.8	12.9	5.2	0.5	1.0	4.6	12.9	0.0	0.8	1.0
GALNT2	GalNAc-T2	ENSG00000143641	"Polypeptide N-acetylgalactosaminyltransferase 2"	Q10471	1	230057990-230282124	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 140.3"	"Cell type enhanced"	"Detected in many"	4	"Exocrine glandular cells: 114.0;Extravillous trophoblasts: 106.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"WM-115: 90.9"					"Low region specificity"	"Detected in all"			HPA011222	Supported		Supported	"Golgi apparatus"	"Intracellular and membrane"	NA	NA		11000000	"Golgi apparatus"		"HPA011222: AB_1849446"	"unprognostic (1.26e-1)"	"prognostic unfavorable (1.22e-6)"	"unprognostic (1.15e-2)"	"unprognostic (1.35e-2)"	"unprognostic (8.70e-3)"	"unprognostic (7.77e-3)"	"unprognostic (1.25e-1)"	"prognostic unfavorable (8.48e-8)"	"unprognostic (2.93e-1)"	"unprognostic (1.93e-1)"	"unprognostic (1.70e-2)"	"unprognostic (9.65e-2)"	"prognostic unfavorable (2.79e-13)"	"unprognostic (3.79e-3)"	"unprognostic (1.49e-1)"	"unprognostic (3.64e-2)"	"unprognostic (1.89e-1)"	19.5	25.6	11.1	19.6	10.1	6.9	20.4	7.7	12.5	11.7	12.7	9.1	10.5	11.3	13.7	11.5	11.5	13.2	17.0	13.9	12.5	8.5	17.5	140.3	13.2	20.4	8.4	9.0	24.8	35.9	4.3	7.3	16.6	12.6	10.8	7.5	10.5	11.1	9.6	42.2	8.4	11.3	14.6	13.6	9.5	18.0	12.7	8.2	28.4	10.7	10.7	7.0	14.9	13.1	6.7	13.5	3.5	10.1	2.7	5.3	6.3	16.2	21.7	12.8	15.1	24.6	21.0	26.4	30.7	19.1	12.5	12.0	9.3	30.9	4.1	22.9	16.2	29.2	31.7	8.4	25.8	10.5	41.0	11.0	12.5	48.5	10.4	13.4	4.7	24.6	30.0	12.8	16.7	6.7	27.5	14.6	23.2	15.5	6.3	13.8	4.4	24.6	4.8	17.5	10.9	20.7	27.5	18.3	12.6	12.3	19.3	4.0	15.1	31.1	1.6	18.7	7.1	9.9	9.0	34.6	12.3	23.7	27.7	24.3	21.0	12.0	9.2	31.6	9.6	90.9	1.1	10.1	3.5	4.7	9.6	3.6	3.8	2.9	4.7	7.9	6.7	2.8	5.3	3.2	2.7	9.6	13.5	3.4	6.3	11.1	10.1	7.7	11.8	12.5	8.5	8.4	9.0	12.6	8.2	14.9	14.7	24.2	16.5	13.6	27.5	13.9	22.9	9.4	15.9	22.7	31.4	5.3	5.0	41.3	43.0	13.8	16.1	0.0	114.0	106.1	24.4	21.9	12.7	80.2	23.0	27.0	16.1	15.4	38.3	19.2	33.1	18.8	23.6	47.7	17.9	11.2	87.4	17.6	27.6	18.9	69.7	12.9	11.3	3.6	10.6	6.9	13.8	15.2	15.3	14.0
GALNT3	"GalNAc-T3, HFTC, HHS"	ENSG00000115339	"Polypeptide N-acetylgalactosaminyltransferase 3"	Q14435	2	165747591-165794682	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"		"Glycosyltransferase, Transferase"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	9	"Glandular cells: 138.4;Pancreatic endocrine cells: 131.2;Urothelial cells: 275.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"CAPAN-2: 27.6;HaCaT: 31.9;HBEC3-KT: 21.5;hTCEpi: 30.4;OE19: 67.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			HPA007613	Enhanced		Supported	"Golgi apparatus"		NA	NA		88000	"Golgi apparatus"		"HPA007613: AB_1078941"	"unprognostic (1.95e-1)"	"prognostic unfavorable (2.08e-4)"	"unprognostic (1.16e-3)"	"unprognostic (2.78e-1)"	"unprognostic (3.22e-2)"	"prognostic unfavorable (4.10e-4)"	"unprognostic (4.13e-2)"	"unprognostic (4.47e-2)"	"unprognostic (2.74e-1)"	"unprognostic (6.44e-2)"	"unprognostic (3.62e-3)"	"unprognostic (1.33e-1)"	"unprognostic (1.14e-2)"	"unprognostic (1.79e-2)"	"unprognostic (3.54e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.57e-1)"	1.5	1.7	1.5	6.3	1.7	14.6	12.0	2.2	1.7	11.9	21.3	3.6	6.5	15.5	2.4	8.8	23.4	15.7	26.4	0.9	1.9	2.1	15.1	2.1	15.3	0.6	4.2	1.2	6.4	31.2	3.0	23.0	7.0	4.2	13.8	21.2	1.7	35.7	5.4	0.7	6.7	37.4	0.5	4.8	23.3	28.9	17.6	3.3	1.5	37.6	15.1	20.8	11.7	9.3	3.3	7.5	21.1	5.7	5.8	5.3	2.3	17.1	0.0	0.1	0.0	0.0	0.6	11.4	3.7	1.5	1.5	3.9	10.6	27.6	0.1	0.0	0.0	0.0	31.9	0.0	21.5	3.2	0.2	3.0	0.0	3.1	0.0	0.1	3.2	0.1	0.1	30.4	0.0	8.1	0.7	0.0	0.5	0.0	14.3	1.2	12.3	0.0	1.3	0.0	67.1	1.7	0.0	0.0	0.5	5.7	14.3	1.7	0.0	0.0	15.5	3.4	0.7	6.9	0.1	0.1	0.0	0.2	0.0	0.0	7.3	3.6	0.3	0.0	3.3	0.1	21.1	3.1	13.8	5.3	4.5	4.1	3.3	1.7	3.3	5.3	3.1	0.6	1.9	10.5	5.8	5.7	7.5	2.9	2.3	1.5	1.7	2.2	1.7	1.9	2.1	4.2	1.2	4.2	3.3	11.9	24.2	0.5	78.9	33.8	0.3	0.3	22.9	61.6	27.3	62.8	0.0	7.8	3.3	50.9	60.2	2.4	50.9	0.0	99.9	18.6	2.9	138.4	45.0	0.5	6.4	0.0	22.5	1.3	1.6	5.0	2.3	7.1	15.1	7.2	119.6	18.4	131.2	40.3	0.4	2.5	1.0	6.5	2.1	30.9	1.1	36.1	9.4	13.8	47.7	275.5
GALNT4	GalNAc-T4	ENSG00000257594	"Polypeptide N-acetylgalactosaminyltransferase 4"	Q8N4A0	12	89519408-89524806	"Enzymes, Predicted intracellular proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"	23	"Alveolar cells type 2: 1.1;Ciliated cells: 5.3;Club cells: 3.4"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"PC-3: 18.8"									HPA076116			Approved	"Golgi apparatus"		NA	NA		270000	"Golgi apparatus"		"HPA076116: AB_2686778"	"unprognostic (2.96e-2)"	"unprognostic (7.65e-3)"	"unprognostic (8.76e-2)"	"unprognostic (3.94e-5)"	"unprognostic (3.50e-1)"	"unprognostic (4.87e-2)"	"unprognostic (2.02e-1)"	"unprognostic (2.92e-2)"	"unprognostic (2.78e-1)"	"unprognostic (4.07e-2)"	"unprognostic (1.28e-2)"	"unprognostic (2.24e-1)"	"unprognostic (5.81e-6)"	"unprognostic (2.34e-1)"	"unprognostic (1.91e-1)"	"unprognostic (9.65e-2)"	"unprognostic (2.52e-1)"	5.0	2.4	4.0	5.8	3.2	3.9	2.6	1.4	3.4	11.1	14.3	3.7	2.7	11.1	9.5	1.9	3.7	7.7	15.8	2.9	1.9	1.7	8.3	5.6	3.2	1.7	4.4	1.1	4.3	8.6	1.1	5.9	2.9	3.7	2.9	11.4	3.3	22.6	1.2	1.1	1.8	20.8	2.0	2.6	7.5	21.0	1.4	3.7	0.2	2.7	2.0	8.2	4.1	2.8	2.8	3.4	5.9	7.5	7.3	5.8	2.7	2.5	7.8	2.7	15.1	5.6	8.1	1.9	6.3	2.9	2.6	2.7	3.0	4.9	0.0	1.5	4.7	0.9	4.0	0.8	4.1	4.4	6.6	1.7	3.2	1.4	2.4	2.6	2.9	7.1	3.6	1.8	5.3	2.3	5.8	8.2	0.4	1.9	1.4	4.0	2.0	0.2	5.6	1.8	5.6	18.8	0.6	0.5	1.2	7.7	8.1	0.1	1.2	0.8	4.3	5.7	2.7	8.4	2.8	7.6	5.4	1.9	3.3	2.0	1.3	2.3	1.2	2.7	1.4	3.1	5.9	5.2	2.4	3.2	7.4	5.8	1.9	1.8	2.4	3.4	2.8	2.6	2.3	5.0	7.3	7.5	1.2	1.9	2.7	4.0	3.2	1.4	3.4	1.9	1.7	4.4	1.1	3.7	3.7	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	5.3	3.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
GALNT5	GalNAc-T5	ENSG00000136542	"Polypeptide N-acetylgalactosaminyltransferase 5"	Q7Z7M9	2	157257598-157314211	"Enzymes, Predicted intracellular proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 28.2"	"Cell type enhanced"	"Detected in many"	13	"Alveolar cells type 1: 145.9;Mucus-secreting cells: 66.8;Urothelial cells: 121.3"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in some"	6	"cerebellum: 28.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A-431: 23.6;BJ: 15.5;BJ hTERT+: 27.8;CAPAN-2: 13.6;fHDF/TERT166: 32.4;HaCaT: 27.7;K-562: 16.0;LHCN-M2: 27.7;U-138 MG: 14.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA008963, HPA009035"	Approved		Approved	"Nucleoli,Golgi apparatus,Vesicles,Cytosol"		NA	NA		630000	"Golgi apparatus, Cytosol"	"Nucleoli, Vesicles"	"HPA008963: AB_1078942, HPA009035: AB_1078943"	"unprognostic (6.34e-3)"	"unprognostic (9.31e-2)"	"unprognostic (2.11e-2)"	"unprognostic (9.89e-2)"	"unprognostic (3.19e-2)"	"unprognostic (2.46e-2)"	"unprognostic (4.63e-3)"	"unprognostic (1.88e-1)"	"unprognostic (1.09e-1)"	"unprognostic (6.93e-2)"	"unprognostic (4.01e-3)"	"unprognostic (1.78e-1)"	"unprognostic (1.15e-2)"	"unprognostic (6.27e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.88e-1)"	"unprognostic (9.48e-3)"	0.4	0.2	0.2	1.5	0.2	0.5	1.1	28.2	0.2	7.5	12.0	0.7	0.0	2.3	0.5	0.5	9.0	0.2	17.1	0.9	0.4	0.2	0.3	0.2	15.5	0.0	0.2	0.0	0.3	1.5	0.0	6.8	0.1	4.4	1.6	16.1	0.3	18.9	0.2	0.2	0.5	8.4	0.8	0.3	0.3	15.2	0.5	0.0	0.1	0.3	12.2	11.7	2.3	6.6	0.2	0.1	0.2	0.1	0.1	0.5	0.0	23.6	2.6	0.0	0.0	1.0	8.3	0.0	15.5	27.8	0.2	0.6	1.1	13.6	0.0	0.0	32.4	0.0	27.7	0.5	5.4	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.0	0.1	0.0	0.5	0.0	0.0	0.0	16.0	0.0	27.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.4	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.0	0.1	0.2	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.1	0.1	0.1	0.0	0.2	0.5	0.1	0.2	0.1	0.1	0.1	0.2	0.0	0.2	0.2	28.2	0.2	0.4	0.2	0.2	0.0	4.4	0.0	145.9	29.7	0.0	10.3	0.7	0.0	0.4	2.5	5.3	36.4	0.0	0.0	0.0	0.0	0.8	5.1	0.0	18.6	23.3	2.9	0.0	2.1	7.3	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.6	3.3	2.8	66.8	0.0	31.4	31.7	0.0	0.0	0.0	0.0	0.1	2.6	0.2	0.1	0.0	0.0	20.7	121.3
GALNT6	GalNAc-T6	ENSG00000139629	"Polypeptide N-acetylgalactosaminyltransferase 6"	Q8NCL4	12	51351247-51392867	"Enzymes, Predicted intracellular proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"stomach 1: 35.4"	"Cell type enriched"	"Detected in many"	4	"granulocytes: 164.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"eosinophil: 23.8"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 33.6;CACO-2: 33.2;OE19: 28.5;SK-BR-3: 33.8"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA011762, HPA017086"	Enhanced		Approved	"Nucleoplasm,Golgi apparatus"	"Intracellular and membrane"	NA	NA		2900000	"Nucleoplasm, Golgi apparatus"		"HPA011762: AB_1849450, HPA017086: AB_1849452"	"unprognostic (2.03e-1)"	"unprognostic (6.65e-2)"	"unprognostic (2.26e-2)"	"prognostic favorable (9.85e-4)"	"unprognostic (1.35e-2)"	"unprognostic (1.18e-1)"	"unprognostic (7.15e-3)"	"unprognostic (2.05e-1)"	"unprognostic (2.27e-2)"	"prognostic favorable (5.40e-4)"	"unprognostic (1.88e-2)"	"unprognostic (5.25e-2)"	"unprognostic (7.13e-4)"	"unprognostic (5.65e-3)"	"unprognostic (3.18e-1)"	"unprognostic (2.16e-2)"	"unprognostic (1.18e-2)"	3.1	1.8	4.0	4.1	9.5	4.4	10.6	1.0	5.1	19.5	13.4	15.4	0.5	11.8	0.9	14.4	2.8	3.7	6.8	0.8	7.1	3.6	2.5	0.8	4.1	4.0	14.4	3.6	1.4	6.3	0.4	1.6	9.9	5.8	1.3	3.9	0.9	23.8	6.3	0.6	5.5	16.9	0.8	8.3	5.5	35.4	0.8	9.7	6.6	1.8	2.3	6.6	2.2	2.2	2.9	3.7	23.8	6.5	10.8	3.4	2.8	11.5	1.2	0.2	0.0	0.0	0.1	18.5	19.3	33.6	8.3	5.6	33.2	6.1	0.1	1.8	10.9	0.0	11.1	0.6	8.4	5.2	2.6	1.2	7.3	0.2	0.2	0.3	3.9	26.1	0.7	7.8	7.4	7.1	0.0	20.3	4.2	1.6	0.3	0.0	22.6	12.4	2.9	1.6	28.5	20.9	0.0	0.0	3.3	6.5	0.8	0.1	7.4	0.1	33.8	0.0	3.9	18.8	1.7	23.9	0.0	4.2	0.0	0.0	0.6	0.1	1.0	2.3	8.7	0.1	4.5	4.4	23.8	3.4	3.7	1.4	0.8	1.7	2.6	3.7	2.9	2.7	2.3	0.8	10.8	6.5	3.1	1.1	2.8	4.0	9.5	1.0	5.1	7.1	3.6	14.4	3.6	5.8	9.7	3.0	3.7	15.2	2.7	2.6	0.4	0.8	2.5	10.7	14.8	1.8	0.0	11.3	3.3	2.7	1.6	1.4	20.4	0.0	9.8	40.7	1.7	5.0	164.7	0.0	13.2	0.0	0.0	2.5	12.0	1.0	0.0	11.8	1.7	1.0	14.2	0.0	15.6	26.2	0.4	1.8	0.0	0.0	0.9	0.2	1.2	8.2	4.0	8.7	9.2	5.4
GALNT8	GALNAC-T8	ENSG00000130035	"Polypeptide N-acetylgalactosaminyltransferase 8"	"Q9NY28, P17658"	12	4720341-4851927	"Enzymes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Glycosyltransferase, Ion channel, Potassium channel, Transferase, Voltage-gated channel"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"brain: 12.7;intestine: 33.2;testis: 18.5"	"Group enriched"	"Detected in some"	6	"Early spermatids: 74.9;Late spermatids: 88.4;Mucus-secreting cells: 32.6"	"Cancer enhanced"	"Detected in some"		"testis cancer: 2.8"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"T-reg: 3.0"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"Karpas-707: 26.1;NTERA-2: 9.3;SuSa: 11.2;U-266/84: 7.5"					"Not detected"	"Not detected"			"HPA012638, HPA073461"	Enhanced		Approved	"Golgi apparatus,Vesicles"	"Intracellular and membrane"	Yes	No			"Golgi apparatus, Vesicles"		"HPA012638: AB_2294503, HPA073461: AB_2686604"	"unprognostic (2.36e-2)"	"unprognostic (1.95e-1)"	"unprognostic (1.13e-2)"	"unprognostic (1.75e-2)"	"unprognostic (6.24e-2)"	"unprognostic (2.87e-1)"	"unprognostic (2.59e-2)"	"unprognostic (3.79e-1)"	"unprognostic (2.72e-1)"	"unprognostic (5.76e-2)"	"unprognostic (8.06e-5)"	"unprognostic (1.16e-2)"	"unprognostic (6.67e-5)"	"unprognostic (5.18e-2)"	"unprognostic (2.59e-2)"	"unprognostic (2.53e-1)"	"unprognostic (1.33e-2)"	1.1	2.2	5.3	2.2	6.5	0.5	3.1	1.4	12.7	1.0	15.5	9.4	0.0	7.2	0.9	0.4	0.7	1.2	1.1	3.7	8.0	1.7	1.2	0.8	0.9	1.0	5.7	9.6	1.6	0.9	0.2	3.7	0.5	6.0	1.1	33.2	0.1	1.0	0.9	0.7	0.9	14.7	2.1	3.5	1.2	1.3	18.5	11.5	0.0	0.8	0.5	0.9	1.2	0.9	1.0	0.7	0.1	0.1	0.9	3.0	0.0	0.0	0.0	1.4	0.1	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.4	0.0	0.7	0.0	0.0	0.2	0.8	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.0	0.0	26.1	0.0	0.0	0.2	0.1	9.3	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	11.2	0.0	0.0	0.0	0.0	3.4	0.0	0.0	0.3	7.5	0.7	0.0	0.0	0.0	0.0	0.1	0.0	1.8	0.0	0.4	0.3	0.7	1.2	0.0	1.0	0.0	0.1	0.1	0.9	0.0	0.7	3.0	0.0	5.3	6.5	1.4	12.7	8.0	1.7	5.7	9.6	6.0	11.5	6.0	0.3	0.0	0.0	0.0	1.2	3.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	74.9	0.0	0.9	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.1	0.0	6.3	0.0	0.0	88.4	1.4	0.0	0.0	0.0	32.6	0.1	0.3	0.0	2.5	1.0	0.3	6.5	0.0	11.6	3.6	0.0	0.0	0.0	1.8	0.0
GALNT9	GALNAC-T9	ENSG00000182870	"Polypeptide N-acetylgalactosaminyltransferase 9"	Q9HCQ5	12	132196372-132329349	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in many"	7	"brain: 52.4"	"Cell type enhanced"	"Detected in some"	25	"Bipolar cells: 7.3;Collecting duct cells: 26.2;Proximal tubular cells: 5.0"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	7	"memory B-cell: 2.6;naive B-cell: 1.5"	"Lineage enriched"	"Detected in single"	9	"B-cells: 2.6"	"Cell line enriched"	"Detected in some"	4	"U-87 MG: 26.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA075016			Approved	Vesicles		NA	NA			Vesicles		"HPA075016: AB_2686729"	"unprognostic (1.13e-1)"	"unprognostic (3.47e-2)"	"unprognostic (1.47e-1)"	"unprognostic (6.44e-2)"	"unprognostic (1.03e-1)"	"unprognostic (6.53e-2)"	"unprognostic (2.65e-1)"	"unprognostic (1.32e-2)"	"unprognostic (2.03e-1)"	"unprognostic (1.64e-3)"	"unprognostic (2.85e-1)"	"unprognostic (6.62e-2)"	"unprognostic (5.17e-2)"	"unprognostic (1.89e-1)"	"unprognostic (1.71e-1)"	"unprognostic (3.89e-2)"	"unprognostic (5.69e-2)"	2.6	2.2	9.3	1.0	6.7	0.6	0.5	52.4	27.9	1.1	0.8	0.8	0.0	1.1	1.8	7.7	0.5	1.9	0.7	0.6	12.9	6.8	3.2	0.5	0.9	1.3	4.3	10.8	1.3	0.4	1.9	2.7	0.5	6.9	1.0	0.6	0.3	1.2	1.7	0.5	0.9	1.0	0.6	1.7	1.2	0.7	0.9	1.1	0.0	6.1	0.0	0.4	0.7	0.1	2.6	0.0	0.0	0.0	0.0	0.3	0.1	0.0	1.6	0.0	0.4	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	5.0	0.0	0.7	0.0	6.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.2	0.1	0.0	0.2	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.1	0.0	0.1	26.6	0.1	0.2	0.0	0.0	0.0	0.3	0.0	0.0	2.6	0.1	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	9.3	6.7	52.4	20.2	12.9	6.8	4.3	10.8	6.9	1.1	0.0	1.1	0.0	0.4	0.0	7.3	0.8	0.0	0.0	0.0	26.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	1.0	0.4	1.1	0.0	0.2	3.2	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.8	0.1	0.0	1.8	5.0	2.1	0.0	0.5	0.0	0.0	0.1	0.1	0.0	0.0	0.8
GALNTL6	"GalNAc-T6L, GALNT17"	ENSG00000174473	"Polypeptide N-acetylgalactosaminyltransferase like 6"	Q49A17	4	171812254-173041559	"Enzymes, Predicted intracellular proteins"		"Glycosyltransferase, Transferase"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"brain: 9.5;lymphoid tissue: 7.3;testis: 6.4"	"Group enriched"	"Detected in some"	5	"Club cells: 3.4;Early spermatids: 11.9;Exocrine glandular cells: 3.7;Late spermatids: 13.6;Melanocytes: 5.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	5	"memory B-cell: 4.5;naive B-cell: 1.6"	"Lineage enriched"	"Detected in single"	8	"B-cells: 4.5"	"Cell line enhanced"	"Detected in some"		"hTERT-RPE1: 3.2;Karpas-707: 2.2;SCLC-21H: 2.3;SK-MEL-30: 1.8;U-266/70: 2.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA031019	Uncertain				"Intracellular and membrane"	NA	NA					"HPA031019: AB_10601653"	"unprognostic (6.84e-2)"	"unprognostic (1.28e-1)"	"unprognostic (2.01e-2)"	"unprognostic (5.73e-2)"	"unprognostic (7.50e-2)"	"unprognostic (8.32e-2)"	"unprognostic (3.25e-1)"	"unprognostic (9.55e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.83e-1)"	"unprognostic (2.06e-1)"	"unprognostic (2.80e-1)"	"unprognostic (1.79e-2)"	"unprognostic (1.90e-1)"	"unprognostic (1.11e-2)"	"unprognostic (4.84e-3)"	"unprognostic (1.73e-2)"	0.2	0.7	3.9	1.2	8.3	1.1	0.7	1.0	9.5	3.3	1.0	0.6	0.0	0.7	0.3	0.3	0.2	0.3	0.5	0.5	3.6	4.1	0.3	0.5	0.5	1.3	7.6	2.4	0.1	0.5	0.1	0.0	0.1	1.8	2.2	0.7	1.3	0.3	0.2	0.5	0.6	1.2	0.3	0.5	7.3	2.9	6.4	1.2	0.0	0.5	1.1	0.4	0.5	0.6	4.5	0.5	0.0	0.2	0.0	0.0	0.0	0.0	1.6	0.5	0.1	0.0	0.2	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.2	0.2	0.0	0.0	0.1	0.2	0.0	0.7	1.1	0.0	1.2	0.0	0.3	0.6	0.0	0.0	0.0	3.2	0.0	0.3	0.7	2.2	0.2	1.0	0.3	0.5	1.3	0.2	0.0	0.0	0.1	0.0	0.0	0.0	2.3	0.9	0.0	0.5	1.8	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.1	2.6	0.0	0.0	0.3	0.1	1.6	0.0	0.2	0.0	0.0	0.0	0.0	4.5	0.0	0.0	0.5	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.9	8.3	1.0	5.9	3.6	4.1	7.6	2.4	1.8	1.2	0.0	1.0	0.0	0.0	0.2	0.6	1.1	0.0	0.0	3.4	0.0	0.0	0.0	0.0	0.0	11.9	0.0	0.0	0.0	3.7	0.0	0.0	0.8	0.0	0.0	0.1	0.0	0.0	0.0	0.6	13.6	0.3	0.0	5.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	1.6	0.9	0.3	0.0	0.0	0.1	0.1
GALT		ENSG00000213930	"Galactose-1-phosphate uridylyltransferase"	P07902	9	34638133-34651035	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Carbohydrate metabolism, Galactose metabolism"	"Nucleotidyltransferase, Transferase"	"Cataract, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 47.0"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004868, HPA005729"	Enhanced		Approved	Cytosol		NA	NA		120000	Cytosol		"HPA004868: AB_1079130, HPA005729: AB_1079131"	"unprognostic (2.38e-1)"	"unprognostic (8.92e-2)"	"unprognostic (1.45e-3)"	"unprognostic (1.54e-1)"	"unprognostic (5.46e-2)"	"unprognostic (1.22e-1)"	"unprognostic (2.94e-1)"	"unprognostic (2.13e-1)"	"unprognostic (3.97e-2)"	"unprognostic (1.13e-2)"	"prognostic favorable (3.11e-5)"	"unprognostic (9.68e-2)"	"prognostic favorable (6.25e-6)"	"unprognostic (7.90e-2)"	"unprognostic (2.74e-1)"	"unprognostic (3.56e-1)"	"unprognostic (7.75e-2)"	6.3	16.1	8.0	13.8	12.5	7.4	6.6	9.3	7.3	8.5	19.4	5.8	12.4	18.1	7.2	8.4	7.7	6.5	10.5	10.9	6.7	8.6	11.8	47.0	6.8	10.8	9.0	6.0	8.7	7.6	12.1	10.3	21.7	7.5	7.2	6.8	11.0	12.5	13.4	9.5	14.4	26.1	5.9	5.0	9.4	8.1	2.6	7.1	11.3	8.5	7.2	10.6	7.0	6.5	16.3	15.9	10.9	17.5	20.5	21.1	13.1	5.0	6.7	6.1	2.5	8.4	8.5	7.1	3.7	10.7	3.9	4.5	8.3	4.7	5.6	3.9	4.5	1.5	2.7	1.1	10.4	0.7	8.4	4.5	2.3	13.4	8.4	8.2	1.3	3.0	12.3	6.6	2.5	3.1	8.3	9.5	7.4	1.9	6.2	6.3	4.4	4.8	9.5	2.1	5.8	1.2	7.4	5.6	3.0	10.8	7.0	1.4	5.4	4.7	9.4	5.1	4.6	8.4	7.3	1.4	1.8	3.3	3.3	0.0	3.5	2.0	1.2	4.1	4.0	9.9	10.9	17.5	8.3	12.1	15.0	16.7	16.3	19.8	16.3	15.9	9.3	12.2	12.0	3.3	20.5	14.1	13.3	21.1	13.1	8.0	12.5	9.3	7.3	6.7	8.6	9.0	6.0	7.5	7.1	6.0	23.4	12.3	13.7	19.3	40.6	20.7	15.3	6.7	10.3	15.7	45.2	59.8	24.9	16.7	6.9	12.0	18.0	0.0	6.5	29.6	13.1	4.5	19.7	52.9	21.0	44.5	15.6	20.3	11.9	31.3	17.0	13.3	20.3	14.4	15.1	18.9	8.5	21.8	13.1	29.4	37.0	6.5	10.1	4.2	4.7	17.7	49.4	23.3	19.8	7.8
GAMT	"PIG2, TP53I2"	ENSG00000130005	"Guanidinoacetate N-methyltransferase"	Q14353	19	1397026-1401570	"Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"		"Methyltransferase, Transferase"	"Disease mutation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 73.0;skeletal muscle: 222.2"	"Cell type enhanced"	"Detected in many"	14	"Hepatocytes: 641.0;Proximal tubular cells: 334.2"	"Cancer enriched"	"Detected in all"	5	"liver cancer: 173.2"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Hep G2: 52.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA051806	Approved					NA	NA		38000			"HPA051806: AB_2681619"	"unprognostic (3.25e-1)"	"unprognostic (7.74e-3)"	"unprognostic (3.22e-2)"	"unprognostic (6.32e-2)"	"unprognostic (4.35e-2)"	"unprognostic (1.86e-1)"	"unprognostic (2.92e-2)"	"unprognostic (2.80e-2)"	"unprognostic (1.14e-1)"	"unprognostic (2.27e-1)"	"unprognostic (3.41e-2)"	"unprognostic (7.10e-2)"	"unprognostic (6.36e-2)"	"prognostic unfavorable (6.57e-4)"	"unprognostic (1.78e-1)"	"unprognostic (1.82e-1)"	"unprognostic (1.54e-2)"	5.1	4.6	9.1	1.5	8.7	2.2	3.2	5.1	11.4	2.3	1.4	15.1	5.1	1.3	2.0	31.3	5.3	3.8	2.6	10.8	9.2	7.7	8.0	73.0	1.5	2.0	8.7	5.2	3.8	47.0	5.4	4.9	1.6	5.9	5.6	1.1	4.5	9.1	4.7	222.2	6.0	1.4	2.1	8.8	2.1	3.2	7.7	4.5	5.6	3.3	26.7	2.8	1.9	1.7	15.7	23.0	6.9	2.6	8.0	21.6	7.7	6.3	7.2	7.8	17.5	9.8	11.9	10.6	7.6	12.6	9.9	9.0	16.3	4.6	3.4	5.3	9.0	1.2	2.7	12.2	4.7	2.6	24.1	13.9	10.4	6.0	52.0	5.8	0.2	3.6	13.2	1.7	10.5	0.0	13.7	2.1	13.1	14.7	8.2	16.0	6.5	30.3	3.5	8.8	3.2	22.9	30.4	6.9	24.1	11.6	5.9	2.6	18.2	0.6	4.4	9.4	5.2	20.1	14.4	3.7	10.8	11.2	0.6	3.4	36.9	7.1	5.7	10.0	13.7	12.4	1.6	1.2	6.9	9.9	1.6	13.9	10.6	13.7	12.2	5.4	15.7	21.6	16.1	0.8	8.0	2.6	23.0	7.5	7.7	9.1	8.7	5.1	11.4	9.2	7.7	8.7	5.2	5.9	4.5	0.0	7.4	17.2	31.8	52.3	38.7	89.3	129.9	1.4	3.4	15.7	53.0	28.0	77.9	26.6	4.1	7.8	0.0	23.3	29.0	35.1	26.0	27.5	4.6	641.0	61.9	17.5	6.9	21.5	25.6	12.0	77.6	9.9	30.4	6.4	1.1	39.8	21.8	0.0	131.2	334.2	60.1	32.3	40.1	2.7	29.6	37.5	10.1	20.0	0.8	11.1
GANAB	"G2AN, GIIA, GluII, KIAA0088"	ENSG00000089597	"Glucosidase II alpha subunit"	Q14697	11	62624826-62646726	"Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"		"Glycosidase, Hydrolase"	"Disease mutation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA026874, HPA061426"	Enhanced		Approved	"Endoplasmic reticulum"	"Intracellular and membrane"	NA	NA		37000000	"Endoplasmic reticulum"		"HPA026874: AB_1849745, HPA061426: AB_2684516"	"unprognostic (2.12e-1)"	"unprognostic (5.95e-3)"	"unprognostic (4.35e-2)"	"unprognostic (2.12e-1)"	"unprognostic (1.20e-2)"	"unprognostic (3.65e-2)"	"prognostic unfavorable (1.27e-5)"	"unprognostic (5.80e-3)"	"unprognostic (1.09e-1)"	"unprognostic (1.79e-1)"	"unprognostic (1.68e-3)"	"unprognostic (5.91e-2)"	"unprognostic (1.01e-3)"	"unprognostic (3.81e-2)"	"unprognostic (1.82e-2)"	"unprognostic (1.39e-1)"	"prognostic unfavorable (9.54e-4)"	33.6	34.6	16.2	23.3	20.7	17.9	30.1	19.9	31.0	38.9	31.5	29.8	43.4	26.0	44.0	38.6	29.2	34.2	33.8	32.6	17.2	16.5	35.9	91.5	31.4	30.2	21.7	19.5	49.0	51.4	56.6	27.3	61.1	20.0	29.4	32.6	33.7	43.5	40.7	28.2	24.5	39.8	37.4	19.5	37.4	31.2	27.7	20.2	41.8	45.6	25.2	34.0	36.0	29.4	14.6	17.5	16.5	18.8	22.5	20.0	17.6	42.5	37.3	46.7	84.6	72.1	63.1	50.6	48.0	72.1	66.5	57.5	31.1	79.2	29.2	97.1	84.8	52.9	58.2	56.3	53.9	68.9	23.5	24.3	28.8	51.2	12.9	53.3	44.6	36.3	61.2	35.0	66.1	69.4	84.2	61.6	30.0	40.8	52.7	59.7	37.4	23.2	14.5	39.5	35.0	30.3	31.0	56.0	73.3	32.6	34.8	24.7	33.5	68.6	44.5	51.1	52.5	58.3	38.1	46.3	66.6	42.6	52.2	44.6	52.9	61.2	22.3	73.1	24.0	64.7	16.5	15.0	14.4	20.0	18.8	20.0	14.6	13.8	15.9	17.5	13.1	17.9	16.3	7.0	22.5	16.4	11.6	13.0	17.6	16.2	20.7	19.9	31.0	17.2	16.5	21.7	19.5	20.0	20.2	11.9	26.8	19.7	22.3	25.1	29.5	6.5	61.1	10.7	7.9	64.6	56.9	71.8	5.0	43.0	15.3	31.5	35.1	0.0	36.9	114.6	43.7	31.3	10.5	80.2	51.7	33.4	30.6	51.5	41.2	11.0	54.1	24.9	33.7	36.9	50.5	40.2	38.3	25.9	64.0	24.2	33.9	32.3	26.7	18.4	48.6	27.4	67.1	24.2	55.2	26.0
GANC		ENSG00000214013	"Glucosidase alpha, neutral C"	Q8TET4	15	42273233-42356935	"Enzymes, FDA approved drug targets, Predicted intracellular proteins"		"Glycosidase, Hydrolase"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Alveolar cells type 2: 36.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA016949, HPA051522"	Approved		Approved	Cytosol		NA	NA			Cytosol		"HPA016949: AB_1849465, HPA051522: "	"unprognostic (8.83e-2)"	"unprognostic (1.68e-1)"	"unprognostic (2.24e-1)"	"unprognostic (3.04e-3)"	"unprognostic (2.51e-2)"	"unprognostic (9.85e-2)"	"unprognostic (2.49e-2)"	"prognostic favorable (9.76e-4)"	"unprognostic (1.73e-1)"	"unprognostic (1.43e-1)"	"unprognostic (1.66e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.14e-1)"	"unprognostic (1.05e-2)"	"unprognostic (3.14e-1)"	"unprognostic (1.55e-2)"	"unprognostic (3.74e-2)"	13.3	14.0	12.5	17.3	20.7	17.6	14.4	16.6	14.2	15.8	14.3	25.6	15.4	11.7	17.9	26.0	20.7	12.9	13.0	12.4	13.4	10.4	13.5	18.0	30.5	13.8	25.0	13.7	18.8	13.1	17.4	20.5	10.8	19.8	13.1	17.8	18.3	20.4	13.7	23.9	13.9	15.4	15.9	25.1	15.5	13.1	24.5	22.6	17.4	16.8	12.3	18.3	16.2	16.3	17.6	12.2	9.3	10.1	4.0	7.4	4.7	6.2	3.2	7.9	8.6	9.6	13.6	5.0	13.7	14.8	15.1	12.7	4.7	4.4	3.4	7.5	13.8	10.5	13.0	9.5	14.6	10.5	8.5	4.4	8.5	8.6	9.2	8.1	8.2	7.4	9.2	8.7	6.1	10.5	8.5	10.2	8.7	8.8	9.6	11.9	1.3	5.5	9.1	4.9	2.7	4.2	10.6	9.3	11.8	11.4	5.8	6.0	8.5	7.7	6.7	4.8	4.5	2.5	19.4	9.2	15.9	4.2	13.1	8.2	10.4	13.7	6.9	7.5	15.1	8.7	9.3	9.3	7.4	3.7	10.1	5.0	16.2	5.7	6.9	12.2	17.6	7.4	4.4	5.0	4.0	8.1	9.6	5.5	4.7	12.5	20.7	16.6	14.2	13.4	10.4	25.0	13.7	19.8	22.6	17.9	36.3	8.3	15.1	9.3	5.1	6.9	2.5	12.0	10.3	1.8	9.8	4.4	5.0	4.3	9.0	4.0	8.4	0.0	3.3	4.2	4.5	6.5	10.4	9.0	6.0	3.2	4.1	7.4	11.6	3.0	6.6	10.3	13.5	11.8	5.5	10.4	5.0	16.5	6.0	6.3	6.5	12.9	5.2	14.2	14.4	4.5	2.4	5.0	7.5	21.3
GAPDH	GAPD	ENSG00000111640	"Glyceraldehyde-3-phosphate dehydrogenase"	P04406	12	6533927-6538374	"Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"	"Apoptosis, Glycolysis, Translation regulation"	"Oxidoreductase, Transferase"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	5	"skeletal muscle: 1236.8"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"CAB005197, CAB016392, HPA040067, HPA061280"	Supported		Supported	"Nuclear membrane,Vesicles,Plasma membrane,Cytosol"		No	No		2200000000	"Plasma membrane, Cytosol"	"Nuclear membrane, Vesicles"	"CAB005197: AB_641107, CAB016392: AB_627678, HPA040067: AB_10965903, HPA061280: AB_2684463"	"unprognostic (3.03e-1)"	"unprognostic (2.62e-3)"	"unprognostic (3.58e-2)"	"unprognostic (4.20e-1)"	"unprognostic (9.73e-3)"	"unprognostic (1.77e-3)"	"prognostic unfavorable (1.79e-6)"	"unprognostic (2.89e-3)"	"unprognostic (2.86e-1)"	"unprognostic (2.06e-2)"	"unprognostic (9.50e-3)"	"unprognostic (4.52e-1)"	"prognostic unfavorable (6.25e-10)"	"unprognostic (2.33e-1)"	"unprognostic (4.28e-1)"	"unprognostic (1.40e-1)"	"unprognostic (1.26e-2)"	50.0	59.4	104.1	57.6	101.0	195.5	38.4	58.0	151.3	49.4	73.3	80.7	24.0	75.8	37.3	46.8	146.9	50.2	58.0	215.1	95.0	95.5	88.4	221.0	41.3	90.1	111.8	58.0	62.0	27.0	66.1	46.1	98.2	115.9	48.3	76.7	74.5	60.8	63.2	1236.8	54.4	74.4	68.0	95.6	50.7	41.1	36.4	35.9	101.9	38.3	238.7	105.3	89.5	50.5	57.9	171.0	110.0	201.6	60.5	108.8	271.9	188.4	332.6	95.9	149.5	93.6	154.4	209.1	143.2	204.0	209.6	218.8	234.7	129.4	220.4	28.3	168.8	159.1	107.3	89.1	332.2	145.5	193.2	96.8	121.9	208.7	199.3	126.2	197.0	98.1	129.1	108.5	206.0	232.8	501.3	230.7	161.2	65.4	46.4	238.1	376.0	224.4	103.7	354.5	226.1	110.8	182.6	170.9	104.9	238.5	230.6	68.0	109.1	126.4	329.8	190.3	285.1	51.5	139.2	143.9	163.6	197.8	84.4	247.4	105.5	76.7	284.0	346.8	124.9	256.0	110.0	201.6	37.0	74.1	103.2	65.3	57.9	77.9	74.4	171.0	32.2	44.1	51.2	106.5	60.5	92.3	25.2	108.8	271.9	104.1	101.0	58.0	151.3	95.0	95.5	111.8	58.0	115.9	35.9	220.3	245.0	821.1	1485.4	1615.7	992.1	33.2	1355.4	275.7	444.7	970.1	392.7	4082.4	2934.5	4447.1	583.7	1564.4	2836.9	443.9	3299.5	7140.5	1484.6	1124.2	551.6	1346.2	3470.6	2218.3	1273.2	1144.2	2599.6	1556.8	823.5	2367.4	4003.5	3613.2	2061.2	5234.8	4742.6	2687.7	965.3	5345.0	1026.0	1131.8	2133.1	429.6	390.5	1399.2	3925.6	1271.1	3009.6	2464.1
GAPDHS	"GAPD2, GAPDH-2, GAPDS"	ENSG00000105679	"Glyceraldehyde-3-phosphate dehydrogenase, spermatogenic"	O14556	19	35533412-35545316	"Enzymes, Plasma proteins, Predicted intracellular proteins"	Glycolysis	Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	35	"testis: 154.6"	"Cell type enriched"	"Detected in some"	4	"Late spermatids: 6946.0"	"Cancer enriched"	"Detected in single"	97	"melanoma: 13.3"	"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"A549: 16.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA042666	Enhanced		Approved	Nucleoplasm,Centrosome		NA	NA			Nucleoplasm	Centrosome	"HPA042666: AB_2678104"	"unprognostic (3.74e-1)"	"unprognostic (1.59e-1)"			"unprognostic (7.41e-2)"			"unprognostic (1.56e-1)"	"unprognostic (2.06e-1)"	"unprognostic (1.04e-1)"	"unprognostic (8.81e-2)"			"unprognostic (2.96e-1)"	"unprognostic (1.03e-1)"	"unprognostic (6.45e-3)"	"unprognostic (2.37e-1)"	0.3	0.5	0.3	0.8	0.3	0.2	0.3	0.3	0.4	0.3	0.3	0.3	0.3	0.6	0.5	1.6	0.6	0.2	0.8	0.8	0.3	0.3	0.3	0.3	0.3	1.6	0.3	0.3	0.7	1.3	0.0	0.3	0.3	0.3	0.3	0.0	4.2	1.3	0.3	0.3	4.4	0.6	0.3	0.3	1.2	0.4	154.6	0.3	0.3	3.6	0.3	0.3	0.6	0.3	2.1	1.0	1.2	0.8	1.4	2.0	0.8	4.5	16.5	4.6	6.9	0.0	0.0	3.9	1.3	0.0	0.0	0.0	10.0	7.6	7.5	2.2	0.0	1.9	5.5	0.0	0.0	0.0	7.3	8.0	5.0	10.5	5.1	0.1	4.5	6.0	0.0	0.0	0.0	0.0	2.9	0.0	7.3	12.0	4.4	0.0	14.1	1.7	2.1	6.2	2.9	2.2	5.3	3.2	5.8	0.0	4.5	8.3	3.7	1.7	4.2	4.9	3.3	3.4	1.9	1.5	5.3	6.0	1.3	1.9	12.3	3.3	4.4	2.9	8.1	1.9	0.0	0.8	1.2	1.1	0.6	2.0	1.1	0.4	1.9	1.0	2.1	1.1	1.2	0.0	1.4	0.3	0.8	0.3	0.8	0.3	0.3	0.3	0.3	0.3	0.3	0.3	0.3	0.3	0.3	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1712.2	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	1.3	0.0	6946.0	23.0	0.0	42.2	0.0	0.0	0.0	0.0	0.0	26.9	0.0	0.0	25.8	0.2	30.4	13.5	0.1	0.0	0.0	0.0	0.0
GARS	"CMT2D, DSMAV, GlyRS, SMAD1"	ENSG00000106105	"Glycyl-tRNA synthetase"	P41250	7	30594681-30634033	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Protein biosynthesis"	"Aminoacyl-tRNA synthetase, Hydrolase, Ligase, Transferase"	"Charcot-Marie-Tooth disease, Disease mutation, Neurodegeneration, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA017896, HPA019097"	Enhanced		Supported	Cytosol	"Intracellular and membrane"	NA	NA		660000	Cytosol		"HPA017896: AB_1849478, HPA019097: AB_1849480"	"prognostic unfavorable (1.02e-4)"	"unprognostic (2.46e-2)"	"unprognostic (5.45e-2)"	"prognostic unfavorable (8.48e-4)"	"unprognostic (2.04e-1)"	"unprognostic (1.57e-3)"	"prognostic unfavorable (8.95e-5)"	"unprognostic (7.31e-3)"	"unprognostic (4.76e-1)"	"unprognostic (4.00e-3)"	"unprognostic (1.77e-1)"	"unprognostic (4.45e-2)"	"prognostic unfavorable (1.70e-5)"	"unprognostic (3.92e-1)"	"unprognostic (3.40e-2)"	"unprognostic (6.32e-2)"	"prognostic unfavorable (3.04e-5)"	25.8	27.3	24.5	26.2	28.5	24.6	32.4	31.1	44.7	21.5	23.7	17.0	11.5	17.2	24.1	23.3	43.7	18.6	18.4	25.7	21.1	26.8	27.6	57.2	27.9	28.0	22.9	28.4	35.4	49.4	44.4	33.3	24.3	37.6	17.2	30.2	14.1	28.7	21.6	35.6	33.2	18.1	30.1	17.6	23.5	30.5	29.7	14.9	28.6	31.4	33.9	38.4	22.8	25.7	22.5	26.4	21.2	27.2	15.3	27.6	21.2	33.5	16.6	14.8	52.3	27.6	41.5	28.0	50.2	45.5	25.9	52.5	22.1	16.8	56.5	15.2	61.1	40.7	26.6	36.8	31.9	45.6	13.5	17.2	26.1	13.6	18.6	87.7	38.4	23.1	39.5	56.0	37.1	44.1	18.4	33.2	52.5	51.7	65.9	41.1	20.7	33.4	26.6	39.8	31.0	31.8	16.9	13.0	43.9	29.7	15.2	17.8	29.9	13.4	37.6	71.4	27.6	33.5	58.9	30.4	12.3	41.3	24.7	31.7	65.2	54.6	66.5	43.0	58.2	57.8	21.2	19.0	17.7	23.2	25.8	23.7	22.5	23.7	25.1	26.4	19.3	25.5	27.6	5.6	15.3	27.2	18.0	25.9	21.2	24.5	28.5	31.1	44.7	21.1	26.8	22.9	28.4	37.6	14.9	38.7	27.4	35.6	34.3	29.9	23.3	30.7	25.5	14.7	27.3	19.2	21.6	41.1	28.2	79.9	48.1	24.6	13.9	0.0	131.2	61.8	33.2	32.2	40.3	27.0	39.9	17.5	25.2	31.9	25.5	44.0	21.6	32.4	32.1	57.7	36.9	20.2	111.3	7.0	21.5	31.8	15.7	12.9	30.0	71.9	80.1	24.1	33.3	25.4	22.3	44.7
GART	"GARS-AIRS-GART, PGFT, PRGS"	ENSG00000159131	"Phosphoribosylglycinamide formyltransferase, phosphoribosylglycinamide synthetase, phosphoribosylaminoimidazole synthetase"	P22102	21	33503931-33543491	"Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"	"Purine biosynthesis"	"Ligase, Multifunctional enzyme, Transferase"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002119, HPA005779"	Approved		Approved	Mitochondria,Cytosol		NA	NA		1300000	Cytosol	Mitochondria	"HPA002119: AB_1849482, HPA005779: AB_1849484"	"unprognostic (3.77e-2)"	"unprognostic (2.25e-2)"	"unprognostic (4.51e-3)"	"unprognostic (1.72e-2)"	"unprognostic (2.30e-2)"	"prognostic unfavorable (5.05e-5)"	"prognostic unfavorable (9.82e-5)"	"unprognostic (2.50e-2)"	"unprognostic (2.76e-3)"	"unprognostic (2.92e-1)"	"prognostic unfavorable (2.19e-4)"	"unprognostic (1.98e-3)"	"prognostic unfavorable (3.95e-6)"	"unprognostic (1.36e-2)"	"unprognostic (2.31e-1)"	"unprognostic (2.28e-1)"	"unprognostic (1.57e-1)"	24.9	24.7	16.0	20.0	22.3	14.2	22.2	14.5	20.3	16.2	20.1	20.5	13.3	18.9	21.7	15.9	28.1	19.9	14.3	19.3	16.4	14.9	19.2	33.6	18.3	24.4	21.9	14.6	21.0	30.6	21.6	22.9	23.1	21.0	16.4	26.9	19.5	18.6	16.1	33.2	17.6	19.1	23.5	17.9	21.4	21.9	47.0	21.7	40.8	20.0	19.4	32.8	21.6	17.6	18.7	19.5	9.7	20.9	27.1	21.1	13.3	30.2	14.4	21.3	23.6	15.7	16.2	24.0	19.6	16.7	23.0	24.4	27.3	25.7	40.3	11.7	13.1	30.1	16.0	44.7	30.8	33.6	21.1	26.6	60.8	17.2	17.8	21.5	33.7	16.0	14.3	21.6	27.1	39.9	11.7	21.7	32.6	70.6	25.9	20.7	14.5	35.6	22.6	46.6	44.2	17.0	29.7	39.8	57.0	18.4	16.2	22.7	20.5	27.2	21.4	25.4	20.6	27.2	21.7	15.9	15.6	18.7	13.5	21.0	25.8	35.6	44.0	16.4	39.7	23.1	5.3	15.2	9.7	17.3	20.9	21.1	18.7	16.9	17.9	19.5	14.4	17.7	17.4	7.0	27.1	17.7	14.7	20.6	13.3	16.0	22.3	14.5	20.3	16.4	14.9	21.9	14.6	21.0	21.7	17.9	17.5	28.9	32.0	40.9	17.7	16.9	2.5	14.7	26.1	14.0	33.4	35.3	19.9	22.6	9.1	20.1	11.8	0.0	20.8	29.3	16.6	18.9	7.0	17.1	21.0	4.8	12.6	16.5	18.7	2.2	16.1	16.9	11.8	17.2	15.1	12.9	24.5	10.5	17.0	11.3	25.4	12.9	25.0	50.8	27.2	40.1	21.4	17.5	20.8	38.9
GATD1	"FLJ34283, PDDC1"	ENSG00000177225	"Glutamine amidotransferase like class 1 domain containing 1"	Q8NB37	11	767220-777488	"Enzymes, Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	10	"Alveolar cells type 1: 41.7;Alveolar cells type 2: 23.2;Collecting duct cells: 21.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HEK 293: 50.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA008812	Uncertain		Supported	Nucleoplasm	"Secreted - unknown location"	NA	NA			Nucleoplasm		"HPA008812: AB_10962724"	"unprognostic (3.39e-1)"	"unprognostic (2.48e-2)"	"unprognostic (1.31e-1)"	"unprognostic (3.58e-2)"	"unprognostic (2.82e-2)"	"unprognostic (3.03e-2)"	"prognostic unfavorable (3.98e-4)"	"unprognostic (3.50e-2)"	"unprognostic (2.19e-1)"	"unprognostic (5.67e-2)"	"unprognostic (5.23e-3)"	"unprognostic (4.89e-3)"	"prognostic favorable (3.79e-5)"	"unprognostic (2.84e-2)"	"unprognostic (8.40e-2)"	"unprognostic (6.11e-2)"	"unprognostic (6.61e-3)"	16.7	36.5	26.6	16.3	24.9	10.6	19.1	30.9	29.8	15.1	15.0	20.7	19.8	23.3	17.7	22.4	16.6	18.8	20.0	16.7	27.0	26.2	19.8	18.6	15.3	15.6	25.8	19.4	21.9	16.6	15.5	22.9	16.4	22.0	18.6	10.5	15.8	20.0	23.8	19.2	27.2	21.5	12.6	21.7	17.2	19.1	17.5	21.5	12.8	17.0	13.0	11.5	11.9	14.3	4.0	9.5	1.3	8.7	1.7	4.7	2.8	16.8	9.8	9.4	10.1	4.4	6.8	9.1	10.0	4.4	9.3	8.3	7.0	26.4	9.2	3.7	6.6	10.1	18.1	7.0	8.9	4.7	11.7	50.6	5.6	14.7	14.8	7.6	10.5	12.0	9.7	9.9	4.0	6.1	8.6	7.1	10.7	13.7	8.4	5.2	4.9	11.8	11.3	9.0	5.5	18.0	13.0	6.4	11.5	8.2	3.8	24.4	9.6	9.7	13.9	6.8	2.6	12.0	6.9	13.0	10.1	7.6	5.4	7.7	10.1	5.1	11.7	15.3	14.0	8.2	1.3	7.0	1.3	4.7	8.7	3.4	4.0	4.5	4.4	9.5	3.5	3.9	2.6	0.7	1.7	3.5	5.5	2.1	2.8	26.6	24.9	30.9	27.7	27.0	26.2	25.8	19.4	22.0	21.5	41.7	23.2	0.0	0.0	0.0	0.0	0.0	0.0	13.4	13.6	21.0	0.0	11.0	5.0	9.7	0.0	0.0	0.0	0.0	6.5	6.9	0.0	0.0	5.8	0.0	11.6	0.0	0.0	0.0	0.0	0.0	0.0	3.4	0.0	8.2	0.0	0.0	11.7	0.0	0.0	11.0	0.0	0.0	0.0	0.0	0.0	0.0	8.0	0.0	0.0	0.0
GATM	AGAT	ENSG00000171766	"Glycine amidinotransferase"	P50440	15	45361124-45402327	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		Transferase	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	9	"kidney: 186.3;liver: 252.2;pancreas: 286.1"	"Group enriched"	"Detected in many"	8	"Hepatocytes: 1105.8;Proximal tubular cells: 2889.0"	"Cancer enhanced"	"Detected in all"		"liver cancer: 135.2"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"memory B-cell: 12.8;myeloid DC: 6.9;naive B-cell: 5.9;plasmacytoid DC: 6.8"	"Group enriched"	"Detected in many"	6	"B-cells: 12.8;dendritic cells: 6.9"	"Group enriched"	"Detected in some"	4	"RH-30: 57.1;RT4: 15.0;U-266/70: 35.3;U-266/84: 44.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA026077	Enhanced		Supported	Mitochondria		Yes	NA		620000	Mitochondria		"HPA026077: AB_1849528"	"unprognostic (1.91e-1)"	"unprognostic (1.33e-2)"	"unprognostic (2.77e-2)"	"unprognostic (6.57e-2)"	"unprognostic (9.43e-2)"	"unprognostic (1.67e-2)"	"unprognostic (6.99e-3)"	"unprognostic (1.04e-1)"	"unprognostic (4.51e-2)"	"unprognostic (3.36e-2)"	"unprognostic (1.33e-1)"	"unprognostic (5.67e-2)"	"prognostic favorable (1.38e-4)"	"unprognostic (1.09e-1)"	"unprognostic (4.07e-2)"	"unprognostic (3.60e-2)"	"unprognostic (1.80e-1)"	1.8	2.5	18.5	1.6	14.7	0.6	2.9	11.4	16.2	1.5	3.1	24.9	0.3	17.8	1.3	2.2	3.0	1.7	5.0	5.5	15.2	10.3	186.3	252.2	1.2	2.1	20.6	14.3	17.6	286.1	0.7	1.2	7.8	14.5	1.7	1.7	1.5	5.5	2.1	13.5	13.9	10.8	2.7	26.1	3.5	10.0	8.0	18.4	0.7	6.6	2.5	3.1	2.2	2.0	12.8	6.9	0.3	1.5	0.1	1.5	0.8	3.4	1.7	1.2	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.4	5.8	9.0	0.3	0.0	1.5	0.6	4.5	0.1	0.1	0.4	0.0	0.7	0.1	0.0	0.2	5.2	0.7	0.2	0.2	0.0	0.1	0.0	0.1	2.1	0.1	0.2	0.0	0.1	0.6	0.1	3.2	7.9	0.0	0.1	57.1	0.4	0.9	15.0	6.6	1.1	1.8	0.1	0.3	0.6	0.8	5.9	0.0	0.0	0.1	0.0	1.7	35.3	44.6	0.2	0.5	0.1	0.4	0.0	1.1	0.3	0.3	1.5	0.0	12.8	0.0	0.3	6.9	5.9	0.0	1.5	0.0	0.1	0.6	6.8	0.0	0.8	18.5	14.7	11.4	16.2	15.2	10.3	20.6	14.3	14.5	18.4	3.0	0.6	33.0	12.7	48.2	8.6	29.5	191.1	2.7	5.7	68.0	0.0	1.0	250.4	36.2	7.4	7.8	4.2	23.3	255.7	0.9	9.9	3.9	3.5	1105.8	69.7	7.9	0.0	20.9	55.8	11.0	4.0	39.6	21.9	5.4	0.2	18.7	151.7	0.3	3.2	2889.0	4.0	6.5	11.3	22.9	7.4	116.9	1.5	6.9	0.4	15.5
GBA	"GBA1, GLUC"	ENSG00000177628	"Glucosylceramidase beta"	P04062	1	155234452-155244699	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Cholesterol metabolism, Lipid metabolism, Sphingolipid metabolism, Steroid metabolism, Sterol metabolism"	"Glycosidase, Glycosyltransferase, Hydrolase, Transferase"	"Disease mutation, Gaucher disease, Ichthyosis, Neurodegeneration, Parkinson disease, Parkinsonism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"parathyroid gland: 101.2"	"Cell type enhanced"	"Detected in many"	4	"Hofbauer cells: 57.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006667, CAB037171, CAB037289"	Supported				"Intracellular and membrane"	NA	NA		200000			"CAB037171: AB_1078958, CAB037289: AB_1078957, HPA006667: AB_1078979"	"unprognostic (6.03e-2)"	"unprognostic (6.02e-2)"	"unprognostic (3.41e-1)"	"unprognostic (2.42e-1)"	"unprognostic (6.00e-3)"	"unprognostic (2.97e-1)"	"unprognostic (1.04e-3)"	"unprognostic (4.76e-2)"	"unprognostic (1.22e-1)"	"unprognostic (6.02e-2)"	"unprognostic (1.73e-1)"	"unprognostic (1.33e-1)"	"unprognostic (1.47e-1)"	"unprognostic (1.76e-1)"	"unprognostic (3.04e-2)"	"unprognostic (3.15e-1)"	"unprognostic (2.94e-2)"	19.2	29.7	14.8	13.9	24.5	21.9	15.3	8.7	33.4	16.5	20.1	25.2	18.1	13.8	16.9	30.4	18.9	12.7	16.5	13.6	15.8	18.9	31.8	24.6	17.9	15.4	18.5	16.5	13.1	19.2	101.2	32.1	46.2	28.1	14.4	23.5	25.3	22.3	24.3	6.0	21.6	16.6	17.7	19.3	24.5	14.6	9.7	13.1	13.7	22.2	8.7	17.5	16.3	15.2	7.3	13.9	17.9	22.3	6.6	14.0	12.4	8.5	16.6	5.9	8.0	62.2	13.7	6.8	15.2	54.1	22.7	28.7	9.7	31.5	5.9	16.9	35.6	36.4	17.5	8.3	10.8	12.1	12.5	5.8	4.9	11.0	5.2	17.8	5.8	20.8	17.9	9.1	47.7	7.2	24.0	20.1	5.2	5.2	10.1	26.6	18.6	7.2	2.7	3.8	14.1	11.8	6.1	9.7	24.4	15.2	6.6	5.7	7.8	13.3	31.9	33.7	11.4	23.9	14.2	15.3	17.1	7.6	21.4	12.1	20.2	17.0	4.6	29.9	5.3	13.1	12.2	21.6	9.1	13.4	22.3	8.7	7.3	10.3	9.0	13.9	5.5	7.4	7.8	17.9	6.6	21.2	7.8	14.0	12.4	14.8	24.5	8.7	33.4	15.8	18.9	18.5	16.5	28.1	13.1	3.0	3.2	4.5	5.7	5.4	3.4	7.9	17.8	6.7	2.3	12.2	2.0	27.5	3.3	26.2	1.1	11.3	17.3	0.0	28.1	23.9	12.9	8.2	6.9	20.7	57.7	4.8	14.0	20.9	39.9	2.2	9.2	13.9	25.3	28.9	13.1	13.2	25.6	19.8	8.5	17.0	5.4	0.0	6.7	4.8	5.7	3.9	49.7	9.6	11.6	4.3
GBA2	"AD035, DKFZp762K054, KIAA1605, SPG46"	ENSG00000070610	"Glucosylceramidase beta 2"	Q9HCG7	9	35736866-35749228	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Cholesterol metabolism, Lipid metabolism, Sphingolipid metabolism, Steroid metabolism, Sterol metabolism"	"Glycosidase, Glycosyltransferase, Hydrolase, Transferase"	"Disease mutation, Hereditary spastic paraplegia, Neurodegeneration"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Cone photoreceptor cells: 108.0;Rod photoreceptor cells: 95.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA024026	Approved		Approved	"Nucleoplasm,Golgi apparatus,Cytosol"		NA	NA			"Nucleoplasm, Golgi apparatus"	Cytosol	"HPA024026: AB_1849530"	"unprognostic (3.34e-2)"	"unprognostic (2.90e-1)"	"unprognostic (2.99e-1)"	"unprognostic (1.06e-2)"	"unprognostic (1.41e-1)"	"unprognostic (5.83e-3)"	"unprognostic (2.20e-2)"	"unprognostic (2.09e-2)"	"unprognostic (3.99e-2)"	"unprognostic (8.69e-2)"	"prognostic favorable (6.00e-4)"	"unprognostic (9.01e-3)"	"prognostic favorable (1.24e-11)"	"unprognostic (7.62e-3)"	"unprognostic (2.94e-1)"	"unprognostic (7.69e-2)"	"prognostic favorable (6.60e-4)"	15.6	19.3	28.9	17.0	23.3	11.0	24.3	42.3	41.6	14.8	35.1	17.0	28.4	41.5	19.0	22.3	16.6	16.8	21.4	34.6	22.4	21.0	34.8	25.0	20.9	17.3	23.7	19.5	16.4	20.9	27.9	27.1	19.3	36.6	23.9	32.8	28.4	27.7	25.5	46.1	23.5	51.1	23.3	21.0	23.4	26.9	11.6	19.5	10.9	25.4	15.5	16.4	18.2	16.9	5.6	6.8	12.2	6.1	3.1	7.3	3.1	7.9	13.2	18.2	17.6	8.9	5.4	18.5	10.8	8.5	11.0	11.7	14.6	6.4	8.5	7.9	6.6	23.8	8.3	17.4	7.3	5.6	12.1	11.9	9.2	34.4	15.6	9.8	13.6	22.8	9.3	13.7	9.3	9.8	26.9	28.8	8.6	8.9	16.4	10.2	7.9	3.7	14.1	18.8	16.2	20.9	6.8	7.3	7.2	15.3	18.8	14.9	19.9	6.1	15.2	10.7	23.3	10.4	12.4	20.1	12.0	14.5	10.2	13.1	11.2	7.1	7.1	15.0	5.0	9.3	12.2	4.4	2.9	6.0	6.1	4.1	5.0	5.8	7.3	4.2	5.6	3.7	3.2	4.9	3.1	3.7	6.8	4.0	3.1	28.9	23.3	42.3	41.6	22.4	21.0	23.7	19.5	36.6	19.5	11.9	10.1	8.0	16.1	6.5	73.4	10.9	20.4	21.4	14.8	26.2	108.0	8.7	18.3	9.9	12.7	13.7	68.4	0.0	10.4	7.6	7.4	14.9	13.9	16.3	7.9	49.3	34.3	26.4	15.4	17.0	11.5	10.1	11.8	7.2	32.8	15.5	12.6	56.1	9.2	16.5	95.2	12.9	9.9	8.6	4.9	8.7	18.5	12.5	30.3	22.5
GBE1		ENSG00000114480	"1,4-alpha-glucan branching enzyme 1"	Q04446	3	81489699-81762161	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Glycogen biosynthesis"	"Glycosyltransferase, Transferase"	"Disease mutation, Glycogen storage disease, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 56.9"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"ASC diff: 61.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038073, HPA038074, HPA038075"	Enhanced		Approved	Cytosol		NA	NA		5900000	Cytosol		"HPA038073: AB_10673040, HPA038074: AB_10672403, HPA038075: AB_10674545"	"unprognostic (3.10e-1)"	"unprognostic (1.02e-3)"	"unprognostic (6.76e-2)"	"unprognostic (1.05e-2)"	"unprognostic (3.48e-2)"	"unprognostic (1.89e-1)"	"unprognostic (9.01e-3)"	"unprognostic (1.17e-2)"	"unprognostic (2.65e-1)"	"unprognostic (1.50e-1)"	"unprognostic (2.19e-2)"	"unprognostic (5.68e-2)"	"unprognostic (1.46e-1)"	"unprognostic (5.36e-2)"	"unprognostic (4.42e-1)"	"unprognostic (2.83e-3)"	"unprognostic (3.78e-3)"	23.1	22.4	2.2	7.8	4.2	5.6	19.2	4.2	4.6	6.4	7.7	5.2	5.2	4.1	8.4	4.9	7.5	4.9	11.5	19.7	3.6	4.3	14.0	36.3	11.3	7.5	7.9	3.4	8.2	5.7	8.2	11.6	11.4	8.4	5.7	4.5	9.9	8.0	10.1	56.9	5.9	6.3	7.2	6.1	8.0	4.5	4.6	4.1	5.4	6.5	11.2	4.5	9.6	10.0	11.6	13.6	14.5	11.4	13.0	7.2	6.1	12.1	7.3	2.4	34.9	61.4	46.7	4.4	20.2	28.8	12.1	20.6	1.4	3.2	13.6	8.9	24.8	7.2	1.4	2.0	9.3	28.6	6.4	1.1	4.2	15.2	4.5	42.3	14.3	3.7	34.4	6.9	19.5	20.1	30.5	26.9	1.6	3.3	7.9	39.4	3.5	2.4	17.0	2.4	3.4	11.2	4.5	11.1	16.0	8.6	4.1	1.2	1.6	13.2	3.8	4.1	3.7	2.7	11.8	37.3	25.1	5.9	17.6	18.6	36.1	4.1	5.0	40.9	9.6	10.2	6.3	11.4	14.5	5.6	10.4	5.4	11.0	6.0	5.9	13.6	11.6	7.0	7.2	11.0	13.0	10.8	4.5	5.0	6.1	2.2	4.2	4.2	4.6	3.6	4.3	7.9	3.4	8.4	4.1	14.9	11.3	7.2	17.9	27.2	15.9	51.9	15.3	13.4	10.3	29.6	0.0	25.8	34.9	29.0	29.2	28.5	9.6	0.0	21.8	58.4	22.2	15.3	42.7	67.1	23.2	28.6	21.2	14.1	14.5	11.6	16.1	15.1	23.6	12.6	6.9	9.6	34.4	6.8	12.4	46.6	16.8	32.3	41.6	6.5	5.1	18.6	45.9	10.0	7.3	12.4
GCAT	KBL	ENSG00000100116	"Glycine C-acetyltransferase"	O75600	22	37807905-37817176	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"pancreas: 81.6"	"Cell type enhanced"	"Detected in many"	5	"Distal tubular cells: 68.0;Hepatocytes: 55.7;Proximal tubular cells: 62.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"HPA020460, HPA063924"	Approved		Supported	"Nucleoplasm,Nuclear speckles,Mitochondria"		Yes	No			Nucleoplasm	"Nuclear speckles, Mitochondria"	"HPA020460: AB_1849548, HPA063924: "	"unprognostic (1.61e-1)"	"unprognostic (1.80e-2)"	"unprognostic (8.38e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.10e-2)"	"unprognostic (4.17e-2)"	"unprognostic (2.40e-1)"	"unprognostic (1.37e-2)"	"unprognostic (3.56e-2)"	"unprognostic (2.76e-3)"	"unprognostic (1.12e-1)"	"unprognostic (2.51e-1)"	"unprognostic (1.36e-3)"	"unprognostic (8.00e-2)"	"unprognostic (1.97e-1)"	"unprognostic (4.73e-3)"	"unprognostic (3.99e-1)"	2.9	6.0	8.9	2.4	8.8	8.1	4.2	8.3	12.3	4.5	4.7	5.2	8.0	3.5	3.0	4.0	6.3	3.9	6.0	21.5	8.6	8.4	8.1	19.1	2.3	2.1	10.1	7.4	4.0	81.6	3.5	3.7	2.2	7.4	12.2	3.5	4.3	12.0	5.0	10.3	3.2	3.2	3.1	6.3	1.1	4.4	5.9	4.3	2.8	10.7	9.3	4.3	3.3	2.2	0.3	2.5	0.8	1.3	2.3	7.1	2.8	8.8	2.3	5.9	33.9	12.3	10.0	4.2	12.7	13.4	9.7	8.2	5.1	1.0	2.8	6.0	5.7	5.7	5.2	5.9	9.0	2.2	1.2	10.8	6.2	7.4	20.3	20.1	10.9	8.1	11.7	5.5	6.4	14.1	3.1	7.9	11.4	15.7	3.3	4.5	7.8	11.4	20.2	2.5	13.9	9.4	12.0	1.3	16.2	12.2	7.0	12.3	8.4	9.9	16.1	6.8	2.2	12.9	5.3	5.9	9.8	5.3	6.5	4.4	10.8	5.3	5.8	6.7	10.2	10.2	0.2	1.3	0.8	1.5	1.2	0.6	0.3	3.4	1.0	2.4	0.1	7.1	2.9	0.6	2.3	0.8	2.5	3.3	2.8	8.9	8.8	8.3	12.3	8.6	8.4	10.1	7.4	7.4	4.3	6.0	12.5	2.9	15.2	6.9	9.8	43.3	7.6	4.0	6.8	10.4	3.9	12.8	68.0	6.1	3.6	5.6	6.3	0.0	8.8	17.8	7.5	19.5	9.2	55.7	4.0	7.9	2.4	3.1	2.2	4.3	3.4	1.6	20.3	1.8	23.9	17.3	6.8	3.5	9.2	62.4	1.9	6.5	10.8	13.4	27.1	5.3	23.2	4.9	25.5	11.2
GCDH	ACAD5	ENSG00000105607	"Glutaryl-CoA dehydrogenase"	Q92947	19	12891026-12914207	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		Oxidoreductase	"Disease mutation, Glutaricaciduria"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 62.6"	"Cell type enhanced"	"Detected in many"	7	"Hepatocytes: 102.5;Proximal tubular cells: 94.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043252, HPA048492"	Enhanced		Supported	Mitochondria		NA	NA			Mitochondria		"HPA043252: AB_2678390, HPA048492: AB_2680418"	"unprognostic (2.46e-1)"	"unprognostic (1.64e-3)"	"unprognostic (6.79e-3)"	"unprognostic (8.07e-3)"	"unprognostic (8.20e-3)"	"unprognostic (3.14e-2)"	"prognostic favorable (7.28e-5)"	"prognostic favorable (3.35e-4)"	"unprognostic (1.62e-1)"	"unprognostic (3.03e-2)"	"unprognostic (7.50e-3)"	"unprognostic (7.46e-2)"	"prognostic favorable (6.79e-8)"	"unprognostic (7.09e-3)"	"unprognostic (3.42e-1)"	"unprognostic (5.32e-2)"	"unprognostic (1.59e-1)"	12.5	12.1	11.4	8.6	13.3	8.2	9.5	11.5	14.0	9.5	10.5	15.5	8.6	9.1	11.7	7.3	9.1	10.5	7.5	19.8	9.3	8.0	20.2	62.6	6.3	12.1	15.5	14.1	13.7	12.3	7.9	8.7	4.9	9.7	10.4	6.9	9.6	14.7	9.7	17.5	6.6	8.1	8.2	8.7	8.6	11.3	4.9	11.8	13.0	10.9	13.7	9.0	12.0	6.6	10.9	14.5	7.2	8.1	21.7	20.6	12.3	11.2	6.3	6.8	12.5	9.9	5.0	6.3	8.4	5.0	9.8	7.5	11.5	4.8	16.3	15.9	4.6	4.9	7.1	9.3	7.2	4.9	14.0	9.9	10.5	10.9	14.1	11.4	19.7	8.4	6.3	9.0	6.9	7.5	4.0	8.4	19.3	25.4	5.1	4.9	12.3	23.1	17.3	7.7	9.8	16.2	22.1	6.9	31.7	5.7	5.2	15.0	9.0	11.8	10.4	7.2	4.5	8.0	13.1	6.0	8.0	6.0	14.9	8.1	27.5	13.9	17.2	5.6	22.6	6.9	7.2	8.1	4.6	11.7	7.1	11.6	10.7	15.0	13.7	14.5	10.9	20.6	15.5	2.0	21.7	5.3	8.6	12.5	12.3	11.4	13.3	11.5	14.0	9.3	8.0	15.5	14.1	9.7	11.8	3.0	4.0	29.5	12.5	7.0	13.8	9.2	20.4	6.7	1.2	10.4	23.6	13.5	44.7	12.0	2.2	4.9	11.4	23.3	9.8	18.6	8.7	10.2	6.9	102.5	18.9	7.9	15.0	13.5	13.0	1.2	12.0	6.9	16.9	27.1	10.8	16.7	9.8	8.6	12.0	94.5	12.2	0.0	7.8	7.2	6.4	4.5	13.6	15.0	19.3	11.8
GCH1	"DYT14, DYT5, DYT5a, GCH, GTPCH1"	ENSG00000131979	"GTP cyclohydrolase 1"	P30793	14	54842008-54902852	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Tetrahydrobiopterin biosynthesis"	"Allosteric enzyme, Hydrolase"	"Disease mutation, Dystonia, Parkinsonism, Phenylketonuria"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 26.8;liver: 58.2"	"Cell type enhanced"	"Detected in many"	12	"Hepatocytes: 82.5;Intestinal endocrine cells: 203.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"non-classical monocyte: 11.5"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"BEWO: 11.8;Daudi: 13.3;SH-SY5Y: 29.7"	"Low region specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"midbrain: 15.7"	HPA028612	Approved		Supported	"Nucleoplasm,Nuclear membrane,Cytosol"		No	No			Nucleoplasm	"Nuclear membrane, Cytosol"	"HPA028612: AB_10602135"	"unprognostic (3.77e-2)"	"unprognostic (2.67e-3)"	"unprognostic (6.73e-2)"	"unprognostic (2.39e-1)"	"unprognostic (9.26e-2)"	"unprognostic (1.27e-1)"	"unprognostic (7.26e-2)"	"unprognostic (1.75e-1)"	"unprognostic (3.97e-1)"	"prognostic favorable (8.69e-4)"	"prognostic favorable (1.41e-4)"	"unprognostic (1.23e-1)"	"unprognostic (1.96e-2)"	"unprognostic (7.22e-3)"	"unprognostic (1.76e-2)"	"unprognostic (2.23e-1)"	"prognostic favorable (6.67e-4)"	4.8	5.2	1.3	5.7	4.5	26.8	2.1	0.6	1.1	2.2	5.5	1.2	1.5	7.5	1.8	1.9	3.8	1.3	1.6	1.5	1.6	4.3	7.9	58.2	11.6	6.7	2.9	0.7	1.4	3.2	0.3	2.5	2.5	2.8	2.9	4.0	5.2	2.5	4.7	1.4	2.5	9.1	2.0	1.7	10.0	4.2	3.6	1.1	13.0	2.3	2.0	8.5	2.9	2.5	1.6	3.0	0.4	11.5	2.3	3.2	1.3	1.9	0.6	0.7	3.5	0.0	0.0	11.8	0.0	1.2	0.8	2.2	0.9	0.6	13.3	3.3	0.1	1.8	2.0	5.7	0.9	0.0	5.2	5.0	0.3	0.2	1.9	5.7	0.0	1.2	1.4	1.6	1.9	0.0	0.0	0.4	9.1	0.8	0.0	0.0	6.8	7.2	0.2	1.1	2.9	4.5	5.9	1.4	0.0	1.7	2.8	5.9	29.7	2.5	1.5	0.7	0.3	5.7	1.6	0.2	0.1	2.0	3.7	2.3	5.7	4.3	3.2	2.5	4.6	0.0	0.0	3.0	0.2	3.0	6.3	2.5	0.8	1.6	2.1	3.0	1.6	3.2	1.8	0.4	2.3	11.5	0.1	2.3	1.3	1.3	4.5	0.6	1.1	1.6	4.3	2.9	0.7	2.8	1.1	3.0	4.5	8.1	28.1	66.2	0.0	3.3	5.1	2.7	7.9	5.2	2.0	1.8	6.6	8.3	0.4	11.7	16.0	23.3	8.1	40.5	8.2	17.3	0.0	82.5	5.6	0.0	203.8	6.2	24.0	0.6	0.3	13.3	10.1	6.4	15.2	0.3	9.8	14.0	4.6	38.4	0.2	0.0	15.5	1.1	4.7	66.6	3.5	22.3	8.9	32.9
GCK	"HK4, MODY2"	ENSG00000106633	Glucokinase	P35557	7	44144271-44198170	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	Glycolysis	"Allosteric enzyme, Kinase, Transferase"	"Diabetes mellitus, Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"pituitary gland: 46.8"	"Cell type enhanced"	"Detected in some"	8	"Bipolar cells: 5.5;Cardiomyocytes: 3.1;Fibroblasts: 3.9;Horizontal cells: 4.8;Muller glia cells: 3.0;Smooth muscle cells: 4.3"	"Cancer enhanced"	"Detected in some"		"liver cancer: 4.0"	"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"memory B-cell: 4.4;naive CD4 T-cell: 4.8"	"Group enriched"	"Detected in many"	17	"B-cells: 4.4;T-cells: 4.8"	"Cell line enriched"	"Detected in some"	6	"SCLC-21H: 12.3"	"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			"HPA007034, HPA007093"	Approved		Approved	"Golgi apparatus,Cytosol"		NA	NA			"Golgi apparatus, Cytosol"		"HPA007034: AB_1079050, HPA007093: AB_1079051"	"unprognostic (3.09e-1)"	"unprognostic (2.99e-2)"	"unprognostic (3.32e-2)"	"unprognostic (6.64e-7)"	"unprognostic (8.00e-2)"	"unprognostic (2.75e-1)"	"unprognostic (1.07e-2)"	"unprognostic (2.68e-1)"	"unprognostic (1.24e-1)"	"unprognostic (5.48e-2)"	"unprognostic (8.11e-3)"	"unprognostic (3.08e-1)"	"unprognostic (3.79e-3)"	"unprognostic (2.01e-2)"	"unprognostic (3.24e-1)"	"unprognostic (4.36e-2)"	"unprognostic (1.53e-1)"	1.1	0.5	3.2	0.7	2.8	0.0	0.7	9.5	3.7	1.4	1.4	1.3	0.7	0.3	1.5	1.5	0.7	2.3	0.9	7.1	2.1	7.5	0.7	8.7	0.7	0.7	2.9	1.2	2.2	2.9	0.0	46.8	3.3	1.6	0.8	0.5	0.8	0.7	1.6	0.7	1.2	0.7	0.7	1.7	0.7	0.9	0.7	0.7	0.7	0.7	0.7	0.7	0.7	0.9	4.4	0.2	0.0	0.0	0.0	4.8	0.7	0.0	0.0	0.1	0.0	0.2	0.1	0.0	0.2	0.2	0.6	0.4	0.0	0.0	0.0	0.1	0.8	0.0	0.0	0.3	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.5	0.1	0.6	0.9	0.0	1.1	0.0	0.0	0.1	0.7	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	12.3	2.2	1.7	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.3	0.1	0.0	1.1	0.0	0.3	0.0	0.0	0.0	0.2	0.0	0.6	4.4	1.6	0.4	0.2	0.7	4.8	0.9	0.0	0.0	0.0	0.0	0.0	0.7	3.2	2.8	9.5	2.4	2.1	7.5	2.9	1.2	1.6	0.7	0.0	0.0	0.0	0.7	1.0	5.5	3.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.2	3.9	0.3	0.0	0.6	0.6	4.8	2.4	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	3.0	0.1	0.0	2.1	0.0	0.8	0.0	4.3	0.2	0.9	0.1	0.7	0.0	0.0	0.1
GCLC	"GCS, GLCL, GLCLC"	ENSG00000001084	"Glutamate-cysteine ligase catalytic subunit"	P48506	6	53497341-53616970	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Glutathione biosynthesis"	Ligase	"Disease mutation, Hereditary hemolytic anemia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 69.2"	"Cell type enhanced"	"Detected in many"	9	"Hepatocytes: 102.4;Intestinal endocrine cells: 212.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"NK-cell: 8.0"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"A549: 49.2;Hep G2: 42.0;OE19: 68.1;RT4: 45.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009569, HPA036359, HPA036360"	Approved		Approved	Nucleoplasm,Nucleoli,Cytosol		NA	NA		3600000	Nucleoplasm	"Nucleoli, Cytosol"	"CAB009569: AB_675582, HPA036359: AB_10672243, HPA036360: AB_10669789"	"unprognostic (8.41e-2)"	"unprognostic (1.27e-2)"	"unprognostic (5.65e-2)"	"unprognostic (2.42e-1)"	"unprognostic (1.58e-1)"	"unprognostic (2.76e-1)"	"unprognostic (2.60e-1)"	"unprognostic (7.50e-2)"	"unprognostic (9.94e-3)"	"unprognostic (4.67e-3)"	"unprognostic (1.30e-1)"	"unprognostic (5.23e-2)"	"prognostic favorable (3.83e-6)"	"unprognostic (3.78e-2)"	"unprognostic (8.91e-2)"	"prognostic unfavorable (8.24e-4)"	"unprognostic (2.30e-2)"	15.8	11.1	12.9	9.0	16.0	14.4	13.0	5.4	15.1	6.8	16.2	21.6	8.2	18.9	9.2	5.3	20.0	29.1	14.9	7.4	13.1	10.6	15.4	69.2	12.9	10.1	21.6	12.2	6.2	12.4	6.6	5.4	6.2	13.0	13.0	12.2	5.2	11.2	10.1	7.0	8.6	14.8	11.9	13.6	16.8	14.8	5.2	17.5	3.1	14.1	32.4	10.6	34.4	12.3	1.6	4.2	2.2	1.9	8.0	2.3	0.6	7.3	49.2	4.0	9.5	4.8	2.2	5.4	3.7	6.0	2.8	3.3	7.2	17.1	14.0	7.1	3.3	21.5	10.5	12.3	27.1	3.8	11.0	7.6	9.3	9.5	42.0	5.5	12.3	5.8	3.4	11.5	3.1	14.1	3.7	4.2	12.3	5.1	4.4	1.3	7.7	10.5	4.9	7.5	68.1	4.6	3.5	2.5	12.3	9.1	45.4	11.7	5.7	6.2	10.0	6.5	6.1	6.8	5.8	5.9	2.5	8.8	6.4	5.5	5.9	9.1	8.1	6.3	8.8	4.2	2.2	1.1	0.6	1.2	1.9	0.8	1.6	1.0	2.3	4.2	1.0	0.6	1.3	0.5	8.0	1.8	3.0	1.6	0.6	12.9	16.0	5.4	11.9	13.1	10.6	21.6	12.2	13.0	17.5	0.0	3.7	7.8	42.9	30.9	12.8	17.8	25.5	48.2	47.8	0.0	23.6	5.2	10.0	12.8	1.4	13.5	19.9	46.7	11.0	6.5	8.7	44.8	2.3	102.4	19.8	7.9	212.1	9.2	60.1	1.0	6.1	16.4	8.5	6.4	16.3	13.8	17.1	8.5	8.9	19.8	4.0	12.9	10.3	3.3	8.1	21.8	6.5	10.7	13.8	89.1
GCNT1	"C2GNT, NACGT2, NAGCT2"	ENSG00000187210	"Glucosaminyl (N-acetyl) transferase 1, core 2"	Q02742	9	76419850-76507416	"Enzymes, Predicted intracellular proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 32.0;parathyroid gland: 57.8"	"Cell type enhanced"	"Detected in many"	5	"Intestinal endocrine cells: 26.5;Kupffer cells: 29.1;Undifferentiated cells: 26.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"eosinophil: 16.8"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HHSteC: 26.3;HSkMC: 22.3;U-2197: 18.7"	"Group enriched"	"Detected in some"	6	"cerebellum: 8.2;olfactory region: 30.1"	"Low region specificity"	"Detected in all"			"HPA003522, HPA003523, HPA031151"	Uncertain		Supported	"Nuclear speckles"		NA	NA		72000	"Nuclear speckles"		"HPA003522: , HPA003523: , HPA031151: AB_10602904"	"unprognostic (3.14e-1)"	"unprognostic (2.01e-1)"	"unprognostic (2.19e-1)"	"prognostic favorable (8.44e-4)"	"unprognostic (5.53e-2)"	"unprognostic (2.41e-1)"	"unprognostic (1.65e-2)"	"unprognostic (3.37e-2)"	"unprognostic (2.40e-1)"	"unprognostic (2.63e-1)"	"unprognostic (1.90e-1)"	"unprognostic (3.06e-1)"	"unprognostic (3.02e-3)"	"unprognostic (4.21e-1)"	"unprognostic (2.00e-1)"	"unprognostic (2.80e-1)"	"prognostic unfavorable (4.96e-4)"	5.6	1.1	1.6	7.9	3.9	2.2	8.2	10.9	2.7	5.3	24.5	0.7	3.0	23.2	5.2	1.2	2.1	1.8	4.1	3.1	2.1	1.4	1.4	1.0	4.5	9.2	1.6	2.1	0.9	2.0	57.8	1.9	3.9	1.0	4.9	4.6	0.5	9.1	1.8	0.8	1.5	32.0	2.5	1.2	7.6	18.6	1.4	0.6	2.8	16.9	1.2	6.4	2.4	3.3	9.4	4.7	16.8	6.4	4.7	1.9	1.6	2.4	0.2	0.1	0.0	3.1	15.2	3.7	10.2	4.6	8.3	5.9	2.5	0.6	1.7	1.0	7.6	1.6	2.2	5.2	4.2	9.3	1.2	0.8	4.3	0.2	0.4	26.3	3.1	1.5	22.3	1.1	8.0	8.7	6.8	7.6	2.2	0.0	1.8	8.2	3.8	1.7	5.1	4.8	6.4	0.6	2.8	5.1	0.8	9.7	4.5	1.1	0.0	1.2	1.4	0.0	3.8	0.0	2.2	3.1	5.2	3.4	18.7	4.4	2.6	0.5	0.0	10.5	5.4	1.3	4.3	2.7	16.8	1.3	6.4	0.4	1.3	1.5	1.3	4.7	9.4	0.2	1.0	0.9	4.7	5.7	2.3	1.9	1.6	1.6	3.9	10.9	2.7	2.1	1.4	1.6	2.1	1.0	0.6	0.0	1.7	2.2	3.5	0.8	0.0	0.8	0.0	9.4	9.1	3.5	0.0	1.6	0.0	1.3	19.4	4.2	16.9	0.0	22.1	17.9	4.1	9.1	10.4	0.0	7.4	0.0	26.5	6.2	29.1	9.7	0.0	11.2	1.7	1.0	12.5	0.0	8.5	15.6	1.1	1.3	0.1	0.0	1.0	1.8	2.4	0.3	15.9	4.3	26.5	0.9
GCNT2	"bA360O19.2, bA421M1.1, CCAT, GCNT5, IGNT, II, NACGT1, NAGCT1, ULG3"	ENSG00000111846	"Glucosaminyl (N-acetyl) transferase 2, I-branching enzyme (I blood group)"	Q8N0V5	6	10492223-10629368	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"		"Glycosyltransferase, Transferase"	"Cataract, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 25.1"	"Cell type enhanced"	"Detected in many"	7	"Alveolar cells type 1: 71.5;Melanocytes: 47.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"EFO-21: 26.4;Hep G2: 11.0;SuSa: 10.2"	"Region enriched"	"Detected in many"	4	"basal ganglia: 54.8"	"Low region specificity"	"Detected in all"			HPA026776	Approved		Approved	"Golgi apparatus"		No	No		560000	"Golgi apparatus"		"HPA026776: AB_1849573"	"unprognostic (2.47e-1)"	"unprognostic (6.87e-3)"	"unprognostic (3.12e-1)"	"unprognostic (1.42e-2)"	"unprognostic (9.31e-2)"	"unprognostic (2.51e-1)"	"unprognostic (4.11e-2)"	"unprognostic (2.39e-1)"	"unprognostic (1.27e-1)"	"unprognostic (2.11e-2)"	"unprognostic (6.28e-4)"	"unprognostic (3.96e-2)"	"unprognostic (1.58e-3)"	"unprognostic (6.54e-2)"	"unprognostic (6.32e-2)"	"unprognostic (1.13e-1)"	"unprognostic (1.53e-1)"	2.0	0.9	2.5	7.9	2.8	0.7	12.7	7.6	1.9	6.0	13.0	2.0	0.9	7.8	5.6	1.3	3.7	1.7	2.8	11.8	2.2	2.4	19.6	14.3	10.4	3.3	2.4	0.4	0.9	5.5	1.0	6.2	3.1	4.0	21.9	3.7	8.1	7.4	0.9	2.3	2.5	25.1	2.6	2.2	4.2	8.3	9.0	2.9	0.9	2.4	1.2	7.2	2.0	3.0	2.1	2.5	4.2	3.1	0.5	0.4	0.7	4.2	3.5	1.2	2.9	0.0	0.0	3.5	0.0	3.1	0.8	0.2	6.2	3.2	2.4	26.4	0.0	1.8	0.1	0.3	3.2	1.8	1.6	0.9	0.5	1.9	11.0	0.0	1.1	3.0	0.0	0.0	0.3	0.0	1.7	7.0	0.0	0.3	0.0	0.3	0.0	0.0	2.3	4.0	0.0	2.4	0.1	2.4	3.8	9.4	2.3	2.6	1.8	0.0	9.2	8.9	10.2	0.1	0.4	5.9	0.5	0.4	0.0	3.4	0.0	0.0	1.7	0.6	0.2	1.4	4.2	3.1	1.3	0.3	2.3	0.1	2.1	0.3	0.4	2.5	1.3	0.4	0.4	0.2	0.5	0.8	0.6	0.2	0.7	2.5	2.8	7.6	1.9	2.2	2.4	2.4	0.4	4.0	2.9	71.5	26.7	12.3	5.5	4.0	4.3	14.9	2.5	30.8	28.4	7.0	0.0	22.4	10.0	2.4	3.3	5.8	28.4	23.3	22.4	1.0	1.1	21.1	2.3	31.1	12.9	3.2	2.4	8.6	6.3	6.0	0.3	6.9	47.2	9.0	2.8	2.9	9.0	1.7	0.0	8.8	0.5	0.0	0.4	1.9	20.4	1.5	9.2	0.0	7.2	7.0
GCNT3	"C2/4GnT, C2GnT-M, C2GnT2"	ENSG00000140297	"Glucosaminyl (N-acetyl) transferase 3, mucin type"	O95395	15	59594875-59640239	"Enzymes, Predicted membrane proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"gallbladder: 29.6;intestine: 103.3;salivary gland: 27.4"	"Cell type enhanced"	"Detected in many"	11	"Collecting duct cells: 99.5;Ductal cells: 59.9;Enterocytes: 119.9;Pancreatic endocrine cells: 45.2;Paneth cells: 59.6"	"Cancer enhanced"	"Detected in many"		"pancreatic cancer: 29.8"	"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"A549: 54.4;EFO-21: 9.4;Hep G2: 10.9;OE19: 27.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA011154	Enhanced		Approved	"Golgi apparatus,Vesicles"		NA	NA			"Golgi apparatus"	Vesicles	"HPA011154: AB_1078961"	"unprognostic (5.09e-2)"	"unprognostic (2.39e-1)"	"unprognostic (5.92e-2)"	"prognostic favorable (1.78e-4)"	"unprognostic (3.99e-3)"	"unprognostic (2.02e-2)"	"prognostic unfavorable (6.49e-5)"	"unprognostic (1.69e-1)"	"unprognostic (1.31e-1)"	"unprognostic (2.34e-1)"	"unprognostic (1.64e-2)"	"unprognostic (1.63e-1)"	"unprognostic (4.02e-3)"	"unprognostic (1.48e-1)"	"unprognostic (1.06e-2)"	"unprognostic (4.65e-2)"	"unprognostic (2.43e-1)"	0.3	0.5	0.3	8.8	0.4	0.0	0.3	0.3	0.3	5.3	37.6	0.3	0.3	25.4	1.3	0.4	8.7	0.7	29.6	0.3	0.3	0.2	9.9	0.4	0.7	0.3	0.3	0.3	1.1	1.7	0.0	0.4	1.0	0.5	1.0	33.4	0.3	27.4	0.3	0.3	0.2	103.3	0.9	0.3	0.3	6.5	1.7	0.3	0.5	0.7	5.2	15.5	0.7	14.0	1.2	1.4	3.4	0.8	1.1	0.7	0.1	0.0	54.4	0.0	0.0	0.0	0.3	0.0	0.0	2.8	0.0	0.0	2.3	2.2	0.2	9.4	0.0	3.6	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.1	10.9	0.0	0.1	0.1	0.1	1.3	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.5	0.2	0.0	0.0	0.1	27.6	0.1	0.1	0.0	0.2	3.8	0.4	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	2.7	0.0	0.1	0.1	0.2	3.4	0.1	0.0	2.6	0.8	0.6	0.7	0.4	0.4	0.6	0.5	0.3	0.2	1.2	0.4	0.6	3.4	1.1	0.4	1.4	0.5	0.1	0.3	0.4	0.3	0.3	0.3	0.2	0.3	0.3	0.5	0.3	0.0	2.1	0.0	6.7	0.0	0.0	0.5	12.7	0.0	0.0	99.5	0.0	0.0	0.0	59.9	7.6	0.0	119.9	0.0	13.4	0.0	0.0	4.7	0.0	0.0	0.1	0.0	7.5	0.0	0.3	13.3	0.0	0.0	0.0	1.8	18.6	0.0	45.2	59.6	0.0	3.3	0.0	6.5	0.0	0.9	0.1	0.0	0.0	0.0	30.8	43.7
GCNT4	C2GNT3	ENSG00000176928	"Glucosaminyl (N-acetyl) transferase 4, core 2"	Q9P109	5	75025346-75030899	"Enzymes, Predicted intracellular proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 13.6;intestine: 13.1;stomach 1: 10.4"	"Cell type enhanced"	"Detected in many"	10	"Cholangiocytes: 35.7;Cytotrophoblasts: 27.4;Syncytiotrophoblasts: 20.4"	"Low cancer specificity"	"Detected in many"							"Cell type enhanced"	"Detected in many"		"basophil: 13.6"	"Group enriched"	"Detected in many"	54	"granulocytes: 13.6;T-cells: 11.6"	"Cell line enriched"	"Detected in some"	5	"RT4: 26.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA037431	Approved		Supported	"Nucleoplasm,Golgi apparatus"		No	NA			"Golgi apparatus"	Nucleoplasm	"HPA037431: AB_10670382"	"unprognostic (1.88e-2)"	"unprognostic (5.63e-2)"	"unprognostic (6.05e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.12e-1)"	"unprognostic (4.98e-2)"	"unprognostic (4.11e-3)"	"unprognostic (1.63e-2)"	"unprognostic (3.47e-1)"	"unprognostic (2.20e-2)"	"unprognostic (4.49e-3)"	"unprognostic (6.04e-2)"	"prognostic favorable (1.93e-7)"	"unprognostic (8.39e-2)"	"unprognostic (1.93e-1)"	"unprognostic (6.06e-2)"	"unprognostic (5.82e-2)"	0.6	0.6	0.3	1.0	0.7	0.0	0.9	0.0	2.3	1.1	1.1			13.1	1.4	0.6	1.3	1.1	2.5	0.3	0.3	0.1	1.8	0.4	1.0	1.7	0.1		0.9	3.0	8.4	0.1	3.0		1.0	0.2		0.5	2.4	1.0	1.5	10.8	0.7	0.0	0.6	10.4	1.0			0.5		1.1	6.4	2.0	0.0	0.0	13.6	0.1	0.2	11.6	1.6	0.2	0.1	1.0	1.6	1.8	0.6	0.1	2.0	5.2	1.0	0.9	2.5	0.1	0.0	0.2	1.5	0.6	0.7	1.0	1.8	0.2	0.0	0.0	0.8	0.2	0.2	0.8	0.0	0.0	0.3	2.9	0.1	0.4	0.0	0.0	1.5	0.0	0.3	0.1	0.0	1.4	0.0	0.4	5.7	0.0	0.0	0.0	2.6	0.2	26.6	0.0	0.0	0.2	0.0	0.0	5.4	0.0	0.0	0.0	0.5	0.1	0.7	0.1	0.0	0.0	0.0	0.3	0.0	0.1	13.6	0.0	0.0	0.9	0.0	3.5	0.0	8.1	2.6	0.0	0.0	8.1	5.9	0.1	0.2	0.1	0.0	11.6	1.6											3.0	5.3	0.0	5.5	0.6	0.0	0.4	35.7	0.0	4.5	12.2	0.0	27.4	8.3	6.1	0.1	1.0	6.7	0.0	3.7	0.7	1.1	1.5	7.0	0.8	2.1	0.0	0.0	4.9	0.8	0.0	3.7	0.0	0.0	1.0	0.5	0.0	4.9	1.7	2.5	0.6	0.0	6.5	0.9	0.0	0.2	0.1	20.4	0.0	0.6	4.1
GDA		ENSG00000119125	"Guanine deaminase"	Q9Y2T3	9	72114595-72257193	"Enzymes, Plasma proteins, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 33.8;intestine: 54.5;liver: 27.6"	"Group enriched"	"Detected in many"	7	"Enterocytes: 113.2;Hepatocytes: 49.7;Paneth cells: 91.2;Proximal tubular cells: 84.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"A-431: 11.1;EFO-21: 44.1;HeLa: 15.4;hTCEpi: 20.6;OE19: 50.0"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	11	"amygdala: 39.7;basal ganglia: 31.5;cerebral cortex: 63.2;hippocampal formation: 79.5;olfactory region: 28.4"	"HPA019352, HPA024099, HPA030387"	Enhanced		Approved	Nucleoplasm		No	NA		1300000	Nucleoplasm		"HPA019352: AB_1855593, HPA024099: AB_1855594, HPA030387: AB_10602351"	"unprognostic (2.64e-2)"	"unprognostic (7.10e-2)"	"unprognostic (2.83e-2)"	"unprognostic (2.92e-1)"	"unprognostic (4.35e-2)"	"unprognostic (8.45e-2)"	"unprognostic (2.00e-1)"	"unprognostic (5.60e-2)"	"unprognostic (3.26e-1)"	"unprognostic (1.32e-1)"	"unprognostic (1.55e-1)"	"unprognostic (5.56e-2)"	"prognostic favorable (2.66e-5)"	"unprognostic (2.23e-1)"	"unprognostic (6.70e-2)"	"unprognostic (2.77e-1)"	"unprognostic (8.30e-4)"	0.5	1.7	26.7	1.8	27.7	0.5	0.5	0.4	33.8	1.0	20.6	0.9	7.7	47.4	2.4	0.6	0.5	4.7	13.1	0.5	25.7	15.0	21.4	27.6	0.5	0.5	2.9	27.4	0.4	1.7	10.8	1.7	10.3	0.8	0.4	5.5	0.0	0.4	4.1	1.1	1.6	54.5	0.5	0.6	0.5	2.0	1.0	0.2	0.0	0.4	1.0	2.6	3.4	0.5	1.4	0.5	3.0	0.7	1.0	1.0	0.1	11.1	1.4	0.0	0.0	0.0	0.0	0.2	0.0	8.1	0.0	0.0	1.0	6.3	0.0	44.1	0.0	0.0	1.0	0.0	0.0	0.0	0.1	0.0	0.0	15.4	0.0	0.0	0.0	0.0	0.0	20.6	0.0	0.2	0.0	0.0	0.0	2.9	0.0	0.0	0.0	0.0	0.0	0.0	50.0	0.0	0.0	0.0	0.3	0.3	2.5	0.0	0.2	0.8	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	3.0	0.7	0.3	1.0	0.6	0.3	0.6	0.5	0.4	0.3	1.4	0.7	0.7	1.9	1.0	0.4	0.5	0.5	0.1	26.7	27.7	0.4	33.8	25.7	15.0	2.9	27.4	0.8	0.2	0.0	0.3	1.7	0.5	0.0	0.0	0.6	12.7	0.0	0.0	0.0	0.0	0.1	3.3	9.2	1.0	0.0	113.2	0.0	9.7	1.0	0.4	0.6	0.0	49.7	0.2	0.0	4.6	1.3	1.0	0.0	0.3	0.0	0.0	1.0	11.2	0.0	4.4	91.2	0.0	84.2	0.0	0.0	0.3	0.4	4.2	0.1	1.6	0.0	7.8	0.8
GDE1	MIR16	ENSG00000006007	"Glycerophosphodiester phosphodiesterase 1"	Q9NZC3	16	19501689-19522145	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	5	"Syncytiotrophoblasts: 226.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA077420			Approved	Vesicles		NA	NA			Vesicles		"HPA077420: "	"unprognostic (1.69e-1)"	"unprognostic (5.13e-2)"	"prognostic favorable (3.12e-4)"	"unprognostic (1.47e-1)"	"unprognostic (1.83e-1)"	"unprognostic (4.10e-3)"	"prognostic unfavorable (7.52e-5)"	"unprognostic (2.10e-2)"	"unprognostic (1.40e-2)"	"unprognostic (4.31e-2)"	"unprognostic (2.60e-3)"	"unprognostic (9.92e-2)"	"prognostic favorable (3.12e-5)"	"unprognostic (8.36e-2)"	"unprognostic (9.69e-3)"	"unprognostic (1.88e-1)"	"unprognostic (3.36e-2)"	20.3	18.5	30.6	11.7	34.3	17.5	23.9	13.5	32.2	18.1	31.0	24.5	23.0	22.7	15.0	22.6	19.0	13.4	17.5	40.7	31.1	17.5	21.1	21.3	22.1	13.1	29.2	20.6	9.9	28.3	35.3	13.9	15.5	20.8	21.4	32.5	12.5	20.4	24.9	42.4	18.5	20.8	27.2	25.3	10.1	22.8	14.8	23.8	9.6	17.9	21.7	12.7	22.8	12.4	4.6	7.4	23.9	12.4	3.7	7.4	4.6	14.8	17.9	9.8	11.7	47.6	17.6	14.2	15.4	26.4	12.0	14.9	10.2	26.6	11.1	19.8	22.3	13.2	12.9	13.7	18.1	14.6	12.1	21.2	9.3	17.6	21.9	28.9	12.2	8.7	18.5	29.4	12.8	15.0	22.3	16.1	14.5	5.1	11.6	13.0	26.8	10.7	11.3	11.5	23.3	13.9	15.4	18.1	16.1	29.7	22.8	11.5	10.5	14.9	17.9	14.2	15.9	18.3	14.7	16.9	10.2	9.1	13.4	9.4	10.9	10.2	7.8	15.6	18.2	9.0	23.9	11.8	6.4	5.7	10.5	7.3	4.6	6.8	6.6	7.4	3.7	3.6	5.7	19.8	3.7	12.4	4.6	7.4	4.6	30.6	34.3	13.5	32.2	31.1	17.5	29.2	20.6	20.8	23.8	35.7	72.1	27.9	29.4	20.8	14.8	63.5	35.7	26.8	26.1	8.7	25.5	63.8	19.9	79.5	27.6	16.8	94.2	23.3	143.1	66.0	28.2	77.4	3.5	20.0	53.4	30.2	32.1	17.8	30.7	51.5	26.4	32.5	23.6	22.6	50.6	19.8	66.9	87.7	35.7	39.2	21.5	12.9	25.5	71.0	39.2	25.7	226.1	21.8	61.0	49.4
GDPD1	"FLJ37451, GDE4"	ENSG00000153982	"Glycerophosphodiester phosphodiesterase domain containing 1"	Q8N9F7	17	59220467-59275967	"Enzymes, Predicted membrane proteins"		Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 22.3"	"Cell type enhanced"	"Detected in many"	9	"Early spermatids: 28.4;Spermatocytes: 31.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HEL: 22.6;K-562: 12.8;SCLC-21H: 14.3"	"Low region specificity"	"Detected in all"													NA	NA						"unprognostic (8.33e-2)"	"unprognostic (6.63e-3)"	"unprognostic (2.68e-2)"	"unprognostic (5.98e-3)"	"unprognostic (7.12e-2)"	"unprognostic (5.35e-2)"	"unprognostic (4.85e-6)"	"prognostic favorable (2.98e-4)"	"unprognostic (2.00e-1)"	"unprognostic (1.36e-2)"	"unprognostic (1.24e-3)"	"unprognostic (2.73e-1)"	"unprognostic (1.15e-1)"	"unprognostic (2.25e-3)"	"unprognostic (4.72e-2)"	"unprognostic (1.32e-2)"	"unprognostic (6.28e-3)"	1.5	3.6	9.4	1.8	13.1	2.3	3.5	16.6	22.3	2.5	3.9	9.2	0.9	10.7	2.8	1.9	1.7	3.2	3.8	2.2	10.6	13.2	4.2	2.0	4.3	1.7	9.3	10.3	2.2	2.3	14.8	3.1	9.2	15.1	4.4	3.1	2.0	4.1	3.0	2.6	2.8	7.8	2.9	7.1	2.8	10.4	13.0	8.9	3.2	5.5	0.3	2.0	3.6	1.7	1.5	2.9	4.5	3.0	3.0	3.5	1.0	0.8	1.4	4.8	3.5	0.6	0.5	3.6	0.5	1.9	0.7	3.6	0.0	1.7	2.2	5.2	0.1	2.9	0.7	8.1	1.0	2.1	4.0	8.4	22.6	0.5	3.2	1.8	1.3	4.4	0.8	4.9	2.0	0.5	2.3	2.6	5.2	12.8	1.3	0.8	0.8	3.9	0.3	1.0	7.0	1.2	2.7	0.4	2.1	2.5	1.4	14.3	4.2	1.4	0.4	5.4	1.7	4.0	1.4	3.0	0.2	1.6	0.1	0.5	4.3	3.1	0.8	1.2	1.5	2.1	4.5	1.9	0.8	2.2	3.0	1.7	0.7	2.2	3.2	0.9	1.5	3.0	3.5	2.0	3.0	2.3	2.9	1.2	1.0	9.4	13.1	16.6	17.7	10.6	13.2	9.3	10.3	15.1	8.9	3.0	5.1	0.0	1.1	0.5	5.8	2.4	0.0	6.7	12.5	5.2	9.8	0.2	0.0	1.6	28.4	1.1	1.3	0.0	1.6	4.9	0.4	1.2	0.0	0.4	1.6	6.4	1.2	0.6	1.0	5.1	0.6	1.8	1.7	2.8	1.2	1.7	1.5	2.0	1.4	0.3	3.8	0.0	1.2	31.7	4.3	0.4	1.9	1.5	0.9	1.4
GDPD2	"FLJ20207, GDE3, OBDPF"	ENSG00000130055	"Glycerophosphodiester phosphodiesterase domain containing 2"	Q9HCC8	X	70423031-70433390	"Enzymes, Predicted membrane proteins"		Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"epididymis: 22.5;intestine: 19.5;lymphoid tissue: 37.5;skin 1: 33.2"	"Cell type enhanced"	"Detected in some"	16	"Basal keratinocytes: 50.5;Enterocytes: 47.9;Muller glia cells: 24.7"	"Cancer enhanced"	"Detected in many"		"glioma: 10.8"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"neutrophil: 1.4"	"Low lineage specificity"	"Detected in single"			"Group enriched"	"Detected in some"	7	"AF22: 9.4;NTERA-2: 20.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"									NA	NA						"unprognostic (1.53e-3)"	"unprognostic (5.79e-2)"	"unprognostic (5.37e-2)"	"unprognostic (5.00e-7)"	"unprognostic (3.15e-3)"	"unprognostic (3.65e-2)"	"unprognostic (2.86e-2)"	"unprognostic (4.66e-2)"	"unprognostic (1.19e-1)"	"unprognostic (8.40e-2)"	"unprognostic (8.45e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.35e-2)"	"unprognostic (5.41e-2)"	"unprognostic (5.52e-2)"	"unprognostic (2.22e-1)"	"unprognostic (8.91e-2)"	0.4	0.4	6.8	0.6	5.7	0.4	1.0	1.1	4.0	0.3	13.0	8.2	8.3	8.0	0.4	22.5	0.4	0.5	0.5	0.8	7.6	4.0	0.6	0.3	0.4	0.4	4.3	5.6	0.4	0.4	0.3	2.6	0.4	8.4	0.3	3.0	0.2	1.1	0.6	0.6	33.2	19.5	0.4	1.5	37.5	1.6	0.3	4.9	0.0	0.4	0.6	0.3	1.0	0.3	0.4	0.1	1.4	0.2	0.1	0.2	0.0	0.0	0.0	9.4	0.0	0.0	0.0	1.6	0.1	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.1	2.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.3	0.0	0.2	20.2	0.6	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.7	0.0	0.0	0.2	0.1	0.1	0.0	0.0	0.2	0.2	0.0	0.1	0.0	0.2	0.2	0.2	0.0	0.1	0.1	0.2	0.2	0.1	0.1	0.0	0.4	0.1	0.1	1.4	0.1	0.1	0.1	0.0	0.0	6.8	5.7	1.1	4.0	7.6	4.0	4.3	5.6	8.4	4.9	0.0	0.0	0.0	0.0	50.5	0.1	1.4	0.0	0.0	0.0	0.0	0.0	6.0	0.0	0.0	0.0	0.0	47.9	0.0	0.0	3.1	0.5	0.0	0.0	0.0	0.4	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	24.7	0.1	2.9	0.0	0.0	0.5	0.0	0.0	0.0	0.0	10.7	2.7	0.0	1.5	0.1
GDPGP1	C15orf58	ENSG00000183208	"GDP-D-glucose phosphorylase 1"	Q6ZNW5	15	90233808-90245811	"Enzymes, Predicted intracellular proteins"		"Guanine-nucleotide releasing factor, Hydrolase, Nucleotidyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Cholangiocytes: 12.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA048189, HPA059841"	Approved		Approved	Cytosol		NA	NA			Cytosol		"HPA048189: AB_2680307, HPA059841: AB_2684138"	"prognostic favorable (6.32e-4)"	"unprognostic (1.85e-1)"	"unprognostic (2.17e-1)"	"unprognostic (2.42e-2)"	"unprognostic (2.14e-1)"	"unprognostic (1.18e-1)"	"unprognostic (1.18e-1)"	"unprognostic (2.58e-1)"	"unprognostic (3.68e-2)"	"unprognostic (4.46e-3)"	"unprognostic (1.53e-1)"	"unprognostic (3.00e-1)"	"unprognostic (1.82e-2)"	"unprognostic (2.93e-3)"	"unprognostic (8.43e-2)"	"unprognostic (1.87e-1)"	"unprognostic (1.02e-3)"	3.9	9.2	9.8	5.7	9.8	5.1	4.8	9.9	12.4	4.4	10.7	8.0	7.2	10.1	5.0	7.5	6.2	9.4	6.0	10.8	12.9	7.1	7.7	12.2	5.8	6.1	5.9	11.6	6.1	9.1	11.9	10.2	2.1	8.8	7.5	14.8	7.2	9.9	10.0	12.5	4.5	9.4	5.8	5.1	8.2	6.9	9.5	8.4	8.5	7.6	3.1	7.8	7.2	3.9	8.3	4.6	7.4	5.2	6.7	7.8	2.9	3.3	13.0	1.6	4.8	5.0	1.0	4.4	3.0	1.9	4.0	3.8	3.8	12.9	8.1	5.9	2.3	2.9	5.5	5.1	3.4	1.6	7.2	8.7	7.2	7.5	5.5	5.3	3.9	4.8	1.3	2.4	2.8	1.5	4.5	4.6	4.8	2.6	3.2	2.3	7.4	2.9	1.9	2.0	9.9	5.4	5.1	1.2	4.1	4.6	6.4	5.1	2.3	4.8	7.4	5.0	3.1	8.5	4.0	4.6	2.1	2.3	3.0	2.9	6.6	7.6	3.6	4.6	3.3	3.8	6.8	4.6	2.2	6.6	5.2	5.6	4.8	6.2	7.8	4.1	8.3	6.7	6.2	7.4	6.7	4.1	4.6	7.5	2.9	9.8	9.8	9.9	12.4	12.9	7.1	5.9	11.6	8.8	8.4	0.0	2.7	1.4	1.9	0.0	3.8	6.0	12.7	4.0	1.2	7.0	5.9	2.1	3.3	3.5	1.8	0.7	4.0	0.0	5.3	1.0	1.0	1.9	3.5	4.4	3.7	1.6	5.2	1.8	2.8	1.9	2.6	3.4	0.0	1.8	3.8	3.3	3.8	5.7	2.1	4.4	3.5	0.0	0.5	2.7	2.7	0.3	0.3	2.2	3.7	1.6
GFER	"ALR, ERV1, HERV1, HPO1, HPO2, HSS"	ENSG00000127554	"Growth factor, augmenter of liver regeneration"	P55789	16	1984207-1987749	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		"Growth factor, Oxidoreductase"	"Cataract, Deafness, Disease mutation, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"Early spermatids: 165.5;Enterocytes: 236.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA041227, HPA063553"	Approved		Enhanced	Mitochondria,Cytosol	"Intracellular and membrane"	NA	NA			"Mitochondria, Cytosol"		"HPA041227: AB_10795538, HPA063553: AB_2685038"	"unprognostic (5.35e-2)"	"unprognostic (2.11e-2)"	"unprognostic (3.08e-1)"	"unprognostic (4.42e-2)"	"unprognostic (3.15e-1)"	"unprognostic (2.63e-1)"	"unprognostic (1.27e-2)"	"unprognostic (1.42e-1)"	"unprognostic (1.11e-2)"	"unprognostic (2.30e-1)"	"unprognostic (1.56e-1)"	"unprognostic (5.93e-2)"	"prognostic favorable (4.06e-4)"	"unprognostic (4.93e-2)"	"unprognostic (3.64e-1)"	"unprognostic (3.56e-1)"	"unprognostic (1.09e-2)"	9.7	12.2	9.7	15.2	9.9	10.7	14.8	15.2	12.5	8.1	24.8	10.8	15.2	29.6	10.1	10.2	11.0	10.2	16.1	17.8	9.8	9.7	13.7	33.5	17.1	18.1	10.7	9.7	9.4	43.8	19.2	10.9	18.0	8.0	11.9	18.0	10.5	22.5	12.5	27.5	8.3	33.2	9.2	9.6	15.2	12.8	20.0	7.8	7.7	15.1	15.0	11.4	12.4	17.1	16.1	9.1	9.8	12.7	7.8	17.7	7.7	11.4	18.3	15.0	12.2	6.3	12.7	19.5	13.3	13.0	18.8	15.4	26.3	19.2	6.4	18.2	9.9	11.0	17.3	11.4	17.6	11.9	20.0	23.4	8.9	18.0	29.8	11.5	12.9	16.8	8.1	13.7	16.4	14.8	11.9	8.8	13.9	13.8	21.6	13.6	27.0	14.6	13.9	24.1	9.7	18.3	32.1	11.5	20.9	19.1	9.0	13.2	12.6	18.0	38.4	14.2	8.1	18.3	13.8	8.1	18.3	20.4	10.2	22.9	36.7	19.8	18.5	6.1	8.8	15.4	3.1	12.6	9.8	9.2	10.5	9.9	16.1	12.6	15.6	9.1	13.4	11.5	7.9	1.1	7.8	12.7	4.0	17.7	7.7	9.7	9.9	15.2	12.5	9.8	9.7	10.7	9.7	8.0	7.8	3.0	7.0	36.5	18.9	14.2	10.7	14.9	25.5	8.1	1.2	8.7	0.0	34.0	29.9	38.0	165.5	17.1	236.0	23.3	70.3	48.9	16.9	17.7	12.7	53.9	39.8	7.9	26.2	20.9	29.7	100.1	16.1	25.1	21.9	45.1	48.7	7.8	54.6	92.1	11.7	50.8	7.9	12.9	18.9	45.9	23.0	12.9	31.4	35.2	62.4	23.3
GFPT1	"GFA, GFAT, GFAT1, GFPT"	ENSG00000198380	"Glutamine--fructose-6-phosphate transaminase 1"	Q06210	2	69319769-69387254	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Biological rhythms"	"Aminotransferase, Transferase"	"Congenital myasthenic syndrome, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Mucus-secreting cells: 215.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA047240			Approved	"Nucleoplasm,Nucleoli,Nucleoli fibrillar center"		NA	NA			"Nucleoplasm, Nucleoli"	"Nucleoli fibrillar center"	"HPA047240: "	"unprognostic (4.38e-3)"	"unprognostic (8.20e-2)"	"prognostic favorable (7.13e-5)"	"unprognostic (2.97e-1)"	"unprognostic (1.32e-1)"	"unprognostic (2.40e-2)"	"unprognostic (1.08e-2)"	"unprognostic (2.11e-1)"	"unprognostic (2.99e-1)"	"unprognostic (3.14e-1)"	"unprognostic (4.84e-2)"	"unprognostic (5.00e-2)"	"unprognostic (3.83e-2)"	"unprognostic (9.49e-2)"	"unprognostic (1.78e-1)"	"unprognostic (1.63e-1)"	"unprognostic (2.58e-1)"	16.7	11.4	6.4	12.7	7.8	5.6	18.3	7.8	10.1	16.8	27.0	6.4	41.2	14.5	10.1	18.7	11.6	9.5	19.4	11.3	6.0	9.8	17.8	49.1	14.1	4.7	6.5	5.7	11.1	34.9	13.9	39.6	36.5	7.0	17.2	27.5	7.7	39.7	34.0	9.2	6.1	28.2	8.7	6.2	8.2	24.6	13.9	4.8	8.5	35.2	7.7	18.1	10.6	16.2	5.6	4.1	5.9	3.4	4.1	6.8	3.0	9.6	6.7	8.7	5.4	24.2	16.7	18.7	18.5	17.2	8.7	11.1	21.4	8.8	8.7	6.7	17.1	10.9	4.7	10.8	5.6	14.4	7.9	4.1	10.1	5.0	22.1	28.7	6.9	4.0	10.5	27.6	16.9	32.4	12.1	8.1	7.5	8.4	14.2	17.0	5.7	7.2	7.2	11.2	19.9	5.6	7.3	18.0	4.4	14.2	7.7	5.3	3.0	6.9	12.8	24.7	18.7	5.1	4.3	12.4	7.8	10.4	13.3	8.8	10.2	6.8	6.6	12.7	4.7	8.9	5.9	2.8	3.4	6.8	3.2	6.5	5.6	6.1	6.6	3.6	3.4	6.1	5.6	1.3	4.1	3.4	4.1	4.3	3.0	6.4	7.8	7.8	10.1	6.0	9.8	6.5	5.7	7.0	4.8	47.6	43.8	21.6	18.1	25.2	14.6	39.1	43.3	62.9	45.5	41.8	11.8	23.5	14.9	29.0	71.7	15.1	126.6	0.0	78.9	58.2	37.0	83.5	24.2	49.7	15.2	6.4	72.2	19.6	8.8	12.1	21.6	14.3	50.6	39.7	215.3	10.9	58.8	74.8	26.5	24.3	13.7	19.4	31.7	89.0	45.3	18.3	28.7	16.6	120.1	30.1
GFPT2	GFAT2	ENSG00000131459	"Glutamine-fructose-6-phosphate transaminase 2"	O94808	5	180300690-180353387	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"		"Aminotransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 65.6"	"Cell type enhanced"	"Detected in many"	9	"Fibroblasts: 28.9;Peritubular cells: 17.7;Smooth muscle cells: 16.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"MAIT T-cell: 7.1"	"Lineage enriched"	"Detected in single"	49	"T-cells: 7.1"	"Cell line enhanced"	"Detected in many"		"ASC diff: 24.3;ASC TERT1: 41.6;GAMG: 30.6;HSkMC: 26.7;hTEC/SVTERT24-B: 49.5;U-87 MG: 86.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA056892, HPA059910"	Uncertain		Approved	Vesicles		NA	NA			Vesicles		"HPA056892: AB_2683266, HPA059910: AB_2684157"	"unprognostic (3.48e-1)"	"prognostic unfavorable (9.09e-4)"	"unprognostic (1.91e-2)"	"unprognostic (1.08e-2)"	"unprognostic (6.28e-2)"	"unprognostic (3.39e-3)"	"unprognostic (3.05e-1)"	"prognostic unfavorable (2.95e-4)"	"unprognostic (7.65e-2)"	"unprognostic (2.73e-2)"	"unprognostic (4.50e-2)"	"unprognostic (2.94e-2)"	"prognostic unfavorable (2.58e-14)"	"unprognostic (3.67e-3)"	"unprognostic (1.23e-2)"	"prognostic unfavorable (3.47e-4)"	"unprognostic (1.52e-3)"	65.6	3.9	4.5	15.8	5.6	0.9	11.0	17.0	9.2	10.0	9.2	9.3	5.4	2.1	9.0	16.7	5.9	15.9	14.6	16.4	7.1	3.8	2.8	2.6	11.0	3.1	6.2	6.8	17.5	11.1	3.5	2.5	6.0	8.4	7.7	3.6	2.9	4.0	8.0	6.0	4.0	5.0	10.0	17.2	1.7	6.6	6.3	7.7	0.0	5.6	5.4	3.5	14.3	14.6	0.0	0.1	0.0	0.0	0.1	7.1	0.2	0.0	5.4	4.2	5.5	24.3	41.6	0.4	0.6	0.1	0.4	0.1	0.1	0.0	0.0	0.3	4.5	30.6	0.0	2.3	0.0	0.2	0.5	0.8	0.0	2.6	0.0	10.1	0.0	0.0	26.7	0.2	49.5	0.1	8.4	8.0	0.2	0.0	0.0	21.2	0.7	0.0	0.0	9.1	0.0	2.4	0.1	0.0	0.0	0.0	0.0	0.2	0.3	8.3	0.1	0.3	5.2	0.3	0.0	3.8	13.7	2.1	8.8	10.0	0.0	0.0	0.0	86.1	0.0	0.3	0.0	0.0	0.0	1.4	0.0	7.1	0.0	0.8	2.4	0.1	0.0	0.8	1.1	0.0	0.1	0.0	0.1	0.0	0.2	4.5	5.6	17.0	9.2	7.1	3.8	6.2	6.8	8.4	7.7	3.0	4.5	0.0	0.3	6.5	0.0	2.2	0.0	2.7	5.7	1.8	0.0	0.9	1.7	0.8	4.5	0.6	0.0	0.0	0.7	0.4	28.9	0.9	1.1	0.0	0.4	0.0	0.0	1.8	0.8	2.0	9.5	1.8	8.5	0.0	0.0	5.2	0.5	0.0	17.7	0.3	0.0	0.0	16.5	9.1	5.3	3.8	2.3	3.8	0.0	0.4
GGACT	A2LD1	ENSG00000134864	"Gamma-glutamylamine cyclotransferase"	Q9BVM4	13	100530164-100589528	"Enzymes, Predicted intracellular proteins"		Lyase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 47.0"	"Cell type enhanced"	"Detected in many"	10	"Proximal tubular cells: 65.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enriched"	"Detected in many"	5	"SCLC-21H: 55.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA065320	Enhanced					NA	NA		75000			"HPA065320: AB_2685466"	"unprognostic (1.93e-1)"	"unprognostic (5.33e-2)"	"unprognostic (2.32e-1)"	"unprognostic (1.30e-3)"	"unprognostic (9.12e-3)"	"unprognostic (1.64e-2)"	"unprognostic (1.58e-2)"	"unprognostic (2.07e-2)"	"unprognostic (7.41e-2)"	"unprognostic (2.81e-1)"	"unprognostic (3.03e-2)"	"unprognostic (2.45e-1)"	"unprognostic (1.95e-2)"	"unprognostic (3.09e-2)"	"unprognostic (1.07e-1)"	"unprognostic (3.37e-2)"	"unprognostic (2.57e-1)"	3.6	6.6	3.2	3.4	3.4	0.9	3.4	2.6	4.5	2.0	4.9	3.6	1.7	5.7	4.0	3.4	2.8	2.5	5.5	1.7	2.6	2.2	47.0	10.9	2.4	4.6	3.5	2.1	2.5	9.8	1.8	1.9	2.1	4.4	2.4	3.4	4.1	12.0	14.2	2.7	3.1	6.7	3.4	4.3	6.1	4.4	11.0	3.3	3.7	2.5	5.0	6.4	2.5	2.5	5.2	4.2	1.0	7.5	8.0	8.3	4.2	5.6	0.7	4.6	5.0	3.9	6.1	2.0	3.5	0.9	0.6	1.6	0.0	5.1	0.5	2.0	2.5	0.1	0.3	0.7	1.0	0.2	7.9	3.1	2.3	0.5	0.3	5.6	3.3	7.8	7.2	4.0	0.1	0.3	0.0	2.3	2.6	1.2	0.1	0.9	0.3	0.5	0.4	0.2	10.8	1.5	0.3	1.1	0.6	5.7	0.9	55.0	2.1	1.1	2.5	2.5	4.5	2.4	11.2	2.2	0.0	0.0	1.2	0.9	3.0	1.6	0.2	0.3	2.5	2.5	0.0	5.1	1.0	7.9	7.2	7.3	5.2	6.4	8.3	4.2	5.0	4.0	5.9	0.0	8.0	7.5	3.0	6.5	4.2	3.2	3.4	2.6	4.5	2.6	2.2	3.5	2.1	4.4	3.3	0.0	1.0	10.4	3.4	2.4	1.1	0.8	0.0	0.0	2.3	7.0	13.7	9.8	6.6	8.4	4.1	3.1	5.3	0.0	9.0	10.2	2.8	2.2	5.7	13.2	10.5	1.6	7.5	4.3	7.8	6.7	2.6	3.6	0.0	8.2	4.5	4.8	8.0	2.9	3.5	65.3	2.1	6.5	0.9	18.2	10.5	1.8	3.7	5.0	7.1	1.6
GGCT	"C7orf24, CRF21, GCTG, Ggc, MGC3077"	ENSG00000006625	Gamma-glutamylcyclotransferase	O75223	7	30496621-30504844	"Enzymes, Plasma proteins, Predicted intracellular proteins"		Lyase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Cytotrophoblasts: 343.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA020735, HPA029914"	Approved					NA	NA		2400000			"HPA020735: AB_1845754, HPA029914: AB_10602321"	"prognostic unfavorable (7.68e-4)"	"unprognostic (2.66e-1)"	"unprognostic (2.51e-2)"	"unprognostic (2.62e-1)"	"unprognostic (2.54e-3)"	"unprognostic (5.80e-2)"	"prognostic unfavorable (7.23e-4)"	"unprognostic (1.33e-3)"	"unprognostic (2.19e-2)"	"unprognostic (6.42e-3)"	"unprognostic (2.66e-3)"	"unprognostic (1.68e-1)"	"unprognostic (2.27e-2)"	"unprognostic (1.19e-1)"	"unprognostic (8.12e-3)"	"unprognostic (2.00e-3)"	"unprognostic (9.92e-2)"	30.8	18.6	15.5	14.5	15.9	10.2	26.4	10.8	25.6	12.6	20.2	7.3	19.3	16.7	10.4	59.6	33.4	13.5	22.5	12.2	14.6	12.4	22.0	18.7	14.6	13.6	11.6	14.4	15.2	17.2	14.9	11.4	18.5	15.0	14.3	21.9	8.0	23.9	19.2	12.6	29.8	16.8	14.2	9.9	13.2	13.3	8.1	5.8	11.0	28.7	32.1	18.9	17.4	19.1	14.8	21.7	5.6	12.8	15.3	16.4	10.1	40.4	10.6	17.3	23.3	7.3	13.3	20.2	13.8	5.4	13.3	16.2	14.1	14.2	26.2	9.2	5.2	15.1	51.6	18.2	14.5	17.5	5.0	20.1	18.5	21.5	18.5	9.6	31.0	14.3	12.9	11.7	13.9	18.0	4.6	13.4	12.6	26.2	15.1	10.5	22.4	18.7	42.0	25.1	41.6	17.2	18.9	20.1	26.0	12.8	37.0	22.0	22.2	12.4	77.7	14.8	23.5	49.8	29.5	8.0	8.8	16.5	16.6	27.0	11.1	26.2	20.2	6.8	42.2	16.3	5.6	12.8	4.2	9.6	12.5	13.3	14.8	12.7	12.3	21.7	11.7	12.3	11.9	0.7	15.3	7.3	19.1	16.4	10.1	15.5	15.9	10.8	25.6	14.6	12.4	11.6	14.4	15.0	5.8	14.9	29.6	26.1	44.9	68.5	23.0	43.7	20.4	81.7	51.2	41.8	3.9	343.3	104.5	74.5	21.3	42.7	45.1	0.0	69.7	113.6	40.1	51.8	26.5	45.3	113.3	31.8	27.2	28.8	40.5	6.6	23.0	53.5	59.1	21.6	78.5	20.5	50.0	49.1	36.7	159.0	11.6	25.8	43.2	13.5	16.0	65.4	113.4	30.2	117.6	52.0
GGCX	VKCFD1	ENSG00000115486	"Gamma-glutamyl carboxylase"	P38435	2	85544723-85561547	"Disease related genes, Enzymes, FDA approved drug targets, Predicted membrane proteins"		Lyase	"Disease mutation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	5	"liver: 74.8"	"Cell type enhanced"	"Detected in all"	6	"Hepatocytes: 132.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA018284	Enhanced					NA	NA					"HPA018284: AB_1849641"	"unprognostic (4.88e-3)"	"unprognostic (1.13e-2)"	"unprognostic (1.22e-2)"	"prognostic unfavorable (1.82e-6)"	"unprognostic (5.67e-2)"	"unprognostic (1.85e-3)"	"unprognostic (2.96e-2)"	"unprognostic (3.77e-2)"	"unprognostic (5.64e-2)"	"unprognostic (2.18e-2)"	"unprognostic (6.45e-3)"	"unprognostic (5.23e-2)"	"unprognostic (8.17e-3)"	"unprognostic (7.85e-2)"	"unprognostic (2.59e-1)"	"unprognostic (7.63e-3)"	"unprognostic (9.38e-2)"	7.1	7.8	4.8	4.2	6.3	1.6	10.8	6.3	6.6	6.4	4.9	5.4	8.3	4.0	6.3	8.1	6.5	5.9	7.0	6.8	5.4	3.6	9.0	74.8	8.1	5.4	5.4	5.0	7.0	11.4	15.1	5.6	13.8	5.9	6.3	5.5	5.8	7.4	7.9	6.8	4.9	5.5	7.2	5.1	4.5	6.0	3.6	5.7	3.4	8.5	5.3	5.4	7.3	6.0	0.9	4.9	6.0	7.2	2.2	3.2	3.2	6.8	11.2	8.0	8.9	40.4	11.5	17.8	12.3	14.6	9.1	13.0	19.3	8.5	2.5	12.6	20.2	11.4	11.3	5.7	15.5	10.1	4.4	7.8	4.5	7.5	18.2	15.0	2.8	4.2	14.3	9.2	18.5	12.6	15.1	12.9	4.4	5.3	3.6	26.4	9.0	1.4	2.1	3.7	19.4	9.7	2.6	18.8	6.2	12.7	13.3	3.0	5.1	11.0	21.9	11.4	14.2	10.7	2.7	11.8	11.7	10.3	11.4	8.4	2.9	7.9	2.1	11.3	2.9	16.4	6.0	7.2	3.6	3.2	7.2	3.0	0.7	1.3	1.2	4.9	0.9	3.2	3.0	3.2	2.2	4.4	4.0	1.9	3.2	4.8	6.3	6.3	6.6	5.4	3.6	5.4	5.0	5.9	5.7	26.8	38.9	20.9	16.3	16.7	19.1	20.2	35.7	14.7	17.0	27.9	15.7	51.8	6.6	24.1	3.2	18.0	14.4	23.3	34.3	40.8	26.7	15.3	15.1	132.3	27.6	7.9	13.8	24.5	21.6	1.3	18.7	22.6	20.3	28.9	15.2	19.0	23.2	12.4	19.1	21.4	28.4	6.5	16.5	16.9	8.1	13.2	45.0	14.9	15.8	18.8
GGH		ENSG00000137563	"Gamma-glutamyl hydrolase"	Q92820	8	63015079-63039171	"Enzymes, Plasma proteins, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"kidney: 42.5;liver: 59.5"	"Cell type enhanced"	"Detected in many"	10	"Cytotrophoblasts: 501.9;Early spermatids: 395.4;Syncytiotrophoblasts: 631.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	4	"plasmacytoid DC: 18.2"	"Lineage enriched"	"Detected in all"	4	"dendritic cells: 18.2"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB019296, HPA025226"	Approved				"Intracellular and membrane"	NA	NA		1400000000			"CAB019296: , HPA025226: AB_1849645"	"unprognostic (9.29e-2)"	"unprognostic (1.22e-1)"	"unprognostic (5.48e-3)"	"prognostic unfavorable (3.99e-7)"	"unprognostic (5.57e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.14e-1)"	"prognostic unfavorable (1.65e-4)"	"unprognostic (1.95e-2)"	"unprognostic (1.60e-1)"	"unprognostic (2.11e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.69e-2)"	"unprognostic (9.62e-3)"	"unprognostic (1.50e-1)"	"unprognostic (2.36e-1)"	"unprognostic (6.50e-2)"	3.5	3.6	7.4	4.7	8.6	12.3	11.8	15.5	9.9	3.5	17.6	1.5	1.0	3.7	2.6	3.7	11.0	1.6	2.8	5.9	7.9	7.6	42.5	59.5	3.5	5.0	4.7	7.0	1.9	4.2	1.0	1.6	17.7	14.8	1.9	26.4	2.2	6.5	1.8	1.7	11.1	3.6	4.2	7.6	3.7	3.2	14.0	3.8	5.2	1.4	14.5	7.6	3.9	6.6	4.1	18.2	2.1	1.9	2.9	1.4	1.4	20.0	19.3	19.8	3.0	19.5	8.2	14.6	12.4	21.2	19.7	28.5	27.0	35.6	13.7	3.5	15.3	33.2	16.8	19.6	20.7	29.2	27.8	14.8	22.5	10.4	18.2	3.7	10.5	13.5	6.0	5.9	19.8	9.5	12.5	23.7	14.0	12.0	50.3	36.8	11.3	5.1	10.5	9.3	44.9	18.3	15.3	19.3	18.4	15.2	7.0	7.9	13.6	18.0	19.7	18.8	19.1	21.7	11.7	12.5	21.2	23.8	20.3	22.2	23.6	24.0	16.1	32.7	0.0	37.3	0.0	1.9	2.1	1.1	1.1	0.5	4.1	1.3	1.3	0.6	1.9	1.0	1.3	1.8	2.9	1.2	18.2	1.4	1.4	7.4	8.6	15.5	9.9	7.9	7.6	4.7	7.0	14.8	3.8	14.9	8.2	22.6	16.2	26.9	1.7	1.6	17.8	14.7	14.8	21.0	0.0	501.9	31.5	20.1	395.4	8.3	17.2	46.7	6.4	234.3	29.8	8.2	10.4	171.3	65.1	0.0	12.7	15.4	18.7	97.7	5.5	15.0	23.6	54.1	74.6	20.3	6.2	8.6	7.8	214.6	1.1	25.8	10.8	73.7	141.6	37.6	631.0	10.1	104.6	12.5
GGPS1	GGPPS1	ENSG00000152904	"Geranylgeranyl diphosphate synthase 1"	O95749	1	235327350-235344532	"Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"	"Isoprene biosynthesis"	Transferase	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Early spermatids: 164.1;Late spermatids: 214.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA029472	Enhanced					NA	NA					"HPA029472: AB_10696206"	"unprognostic (7.45e-2)"	"unprognostic (3.18e-2)"	"unprognostic (1.25e-1)"	"unprognostic (2.23e-2)"	"unprognostic (1.43e-1)"	"unprognostic (3.10e-3)"	"prognostic unfavorable (6.69e-4)"	"unprognostic (4.50e-2)"	"unprognostic (3.66e-2)"	"unprognostic (3.77e-3)"	"unprognostic (2.66e-2)"	"unprognostic (8.77e-3)"	"unprognostic (1.95e-2)"	"unprognostic (1.99e-1)"	"unprognostic (3.35e-2)"	"unprognostic (1.41e-1)"	"unprognostic (1.70e-2)"	24.5	24.8	26.8	16.2	25.7	6.8	33.4	30.1	28.7	24.9	23.1	19.9	21.8	19.8	22.8	30.3	24.1	20.9	19.2	21.8	25.4	25.8	26.4	20.0	18.9	18.3	24.4	22.0	23.5	16.0	19.0	29.3	24.2	25.8	29.0	23.2	15.9	27.8	21.9	26.8	19.0	20.6	24.9	28.3	20.4	20.1	42.5	25.6	22.6	27.9	21.2	20.0	26.9	17.9	28.5	22.2	33.9	35.9	22.1	31.3	26.0	16.6	9.0	22.7	17.0	17.7	25.6	8.9	14.9	20.8	9.8	13.9	7.0	26.6	11.3	21.6	16.3	16.0	13.6	12.0	15.3	13.1	11.5	22.4	9.6	8.6	11.8	20.0	11.8	8.2	16.6	27.6	13.3	18.0	17.4	17.4	19.1	22.9	10.2	12.9	9.8	14.6	14.1	19.4	44.2	4.7	9.0	7.1	12.8	27.4	9.0	18.2	25.2	11.1	25.6	21.3	8.7	31.9	18.8	14.7	11.8	8.9	19.9	13.9	17.8	21.5	13.8	14.9	13.3	21.1	26.6	22.8	33.9	24.8	26.8	24.9	28.5	31.3	26.4	22.2	23.4	29.2	26.5	20.6	22.1	35.9	18.4	30.0	26.0	26.8	25.7	30.1	28.7	25.4	25.8	24.4	22.0	25.8	25.6	29.8	37.5	16.7	58.0	35.4	29.3	20.4	20.4	17.4	15.9	19.2	41.2	26.1	61.3	31.7	164.1	29.1	23.6	0.0	25.0	30.3	35.7	57.0	23.2	12.4	23.9	46.1	16.7	28.3	22.2	214.2	33.1	33.8	64.1	33.3	21.8	38.1	25.9	24.1	32.9	45.5	48.9	25.8	42.4	62.3	46.6	35.5	39.4	32.6	20.4	46.7
GGT1	"CD224, D22S672, D22S732, GGT"	ENSG00000100031	"Gamma-glutamyltransferase 1"	P19440	22	24583750-24629005	"Candidate cardiovascular disease genes, CD markers, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Glutathione biosynthesis"	"Acyltransferase, Hydrolase, Protease, Transferase"	"Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 54.1;seminal vesicle: 41.7"	"Group enriched"	"Detected in many"	6	"Alveolar cells type 1: 74.5;Alveolar cells type 2: 21.4;Cholangiocytes: 40.8;Ductal cells: 54.8;Enterocytes: 80.7;Hepatocytes: 34.1;Pancreatic endocrine cells: 33.5;Paneth cells: 23.0;Proximal tubular cells: 32.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 35.6;Karpas-707: 52.5;OE19: 37.9;RPMI-8226: 51.6;RPTEC TERT1: 48.0"									"HPA045635, HPA047534, HPA065444"	Supported		Uncertain	Vesicles	"Intracellular and membrane"	NA	NA		4600000	Vesicles		"HPA045635: AB_2679400, HPA047534: AB_2680079, HPA065444: AB_2685491"	"unprognostic (8.13e-3)"	"unprognostic (4.76e-1)"	"unprognostic (8.29e-2)"	"unprognostic (1.28e-2)"	"unprognostic (3.70e-2)"	"unprognostic (1.43e-2)"	"unprognostic (5.60e-3)"	"unprognostic (1.68e-1)"	"unprognostic (2.21e-1)"	"prognostic favorable (7.44e-4)"	"unprognostic (4.55e-2)"	"unprognostic (2.55e-2)"	"prognostic favorable (4.83e-4)"	"unprognostic (1.44e-2)"	"unprognostic (5.37e-2)"	"unprognostic (1.74e-1)"	"unprognostic (6.10e-2)"	1.6	0.5	1.7	1.7	2.2	2.7	8.2	2.3	2.6	7.3	7.9	1.6	23.7	22.3	1.4	19.9	1.2	0.8	12.2	2.0	1.8	1.2	54.1	29.2	14.3	3.2	1.7	1.6	1.3	17.3	0.0	1.6	1.4	2.2	14.7	2.4	1.4	8.7	41.7	0.9	1.1	20.9	1.7	1.9	4.7	6.6	5.0	2.1	2.4	4.8	1.6	5.5	2.1	1.1	3.3	7.5	15.9	14.6	6.6	8.6	6.6	0.2	19.3	0.2	0.0	0.0	0.1	0.5	0.1	0.6	0.2	0.2	2.6	4.2	0.2	4.3	0.0	3.8	2.8	1.4	0.2	0.1	35.6	2.9	0.1	8.6	14.0	1.5	0.3	11.9	0.4	0.2	0.6	0.4	0.3	0.1	5.3	2.0	52.5	0.2	0.4	0.3	14.6	1.4	37.9	0.2	0.2	2.2	51.6	48.0	0.6	0.2	0.3	0.1	9.3	0.2	5.5	9.3	11.1	2.2	3.5	2.3	10.8	0.3	15.8	5.9	0.2	7.4	15.0	0.1	5.2	14.6	0.4	1.4	6.8	5.2	3.3	7.7	3.4	7.5	0.3	1.0	1.9	15.9	6.6	5.5	0.1	8.6	6.6	1.7	2.2	2.3	2.6	1.8	1.2	1.7	1.6	2.2	2.1	74.5	21.4	3.4	0.1	0.7	0.4	0.4	40.8	2.7	7.9	1.8	0.0	0.9	1.7	54.8	1.1	0.1	80.7	0.0	7.2	0.3	1.3	3.0	5.7	34.1	4.7	0.0	1.2	2.5	3.0	4.1	0.0	2.9	1.7	5.4	2.5	2.0	33.5	23.0	0.4	32.7	0.0	0.0	0.2	0.6	0.7	0.4	0.7	3.2	4.2	0.0
GGT5	"GGT-REL, GGTLA1"	ENSG00000099998	"Gamma-glutamyltransferase 5"	P36269	22	24219654-24245142	"Enzymes, Predicted intracellular proteins"	"Glutathione biosynthesis, Leukotriene biosynthesis"	"Acyltransferase, Hydrolase, Protease, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	19	"Ito cells: 44.2;Sertoli cells: 181.1;Smooth muscle cells: 82.1"	"Low cancer specificity"	"Detected in all"							"Group enriched"	"Detected in some"	5	"basophil: 4.0;eosinophil: 7.5;neutrophil: 1.9"	"Lineage enriched"	"Detected in single"	8	"granulocytes: 7.5"	"Group enriched"	"Detected in some"	4	"ASC diff: 39.5;ASC TERT1: 30.1;HHSteC: 56.4;HSkMC: 65.0;TIME: 25.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA008121, CAB032489"	Uncertain		Approved	"Nucleoli fibrillar center"	"Intracellular and membrane"	NA	NA		18000000	"Nucleoli fibrillar center"		"CAB032489: AB_2111010, HPA008121: AB_1078965"	"unprognostic (8.14e-2)"	"unprognostic (2.53e-1)"	"unprognostic (5.66e-2)"	"unprognostic (9.94e-2)"	"unprognostic (8.13e-2)"	"unprognostic (8.21e-2)"	"unprognostic (2.33e-2)"	"unprognostic (2.90e-1)"	"unprognostic (1.81e-2)"	"unprognostic (1.07e-1)"	"unprognostic (8.37e-2)"	"unprognostic (7.94e-2)"	"prognostic unfavorable (6.36e-5)"	"prognostic unfavorable (4.06e-4)"	"prognostic unfavorable (6.97e-4)"	"unprognostic (1.79e-1)"	"unprognostic (8.33e-2)"	20.2	14.8	2.0	5.2	3.5	0.0	13.2	0.5	4.2	10.7	4.0			5.7	7.9	3.6	2.1	10.2	12.1	14.0	2.4	3.4	13.1	13.7	5.1	12.4	4.7		3.9	5.0	2.2	6.0	3.2		6.5	3.4		5.4	6.8	2.5	5.3	7.2	10.1	2.7	4.8	5.6	1.2			17.2		5.2	6.3	9.3	0.1	0.4	7.5	0.9	0.8	0.1	0.4	0.0	0.3	0.0	0.0	39.5	30.1	0.2	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	1.3	0.1	5.2	56.4	0.6	1.4	65.0	0.0	0.7	0.7	0.0	10.6	0.1	0.1	0.1	10.1	0.1	0.0	4.9	0.6	0.1	0.0	0.0	0.9	0.1	1.1	0.0	0.0	1.4	0.0	1.7	0.0	5.6	0.2	0.3	25.2	0.0	0.5	0.0	0.0	0.0	0.3	0.0	0.9	1.1	0.0	4.0	0.9	7.5	0.1	0.4	0.0	0.0	0.0	0.0	0.4	0.1	0.0	0.0	1.9	0.8	0.0	0.1	0.0	0.4											3.0	16.5	0.5	3.1	6.3	0.0	4.8	0.0	2.7	11.4	0.0	0.0	0.2	0.0	0.1	0.5	37.5	0.0	0.0	0.2	0.1	8.7	1.3	1.1	0.0	1.6	0.0	0.0	44.2	1.2	2.6	33.6	2.9	3.3	5.4	0.0	0.2	0.3	0.0	22.3	0.0	0.4	181.1	82.1	0.3	0.4	3.9	0.2	0.0	0.0	0.9
GGT6	FLJ90165	ENSG00000167741	"Gamma-glutamyltransferase 6"	Q6P531	17	4556927-4560818	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Glutathione biosynthesis"	"Acyltransferase, Hydrolase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 40.4;salivary gland: 52.7"	"Cell type enhanced"	"Detected in many"	10	"Enterocytes: 136.8;Mucus-secreting cells: 63.3;Paneth cells: 98.2;Undifferentiated cells: 77.9"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"basophil: 3.5"	"Lineage enriched"	"Detected in single"	5	"granulocytes: 3.5"	"Group enriched"	"Detected in some"	8	"RT4: 30.5;SK-BR-3: 10.4;T-47d: 32.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA023362, HPA027213"	Approved					NA	NA		33000			"HPA023362: AB_1848955, HPA027213: AB_10601326"	"unprognostic (2.23e-2)"	"unprognostic (1.20e-2)"	"unprognostic (2.14e-3)"	"unprognostic (4.51e-2)"	"unprognostic (9.71e-2)"	"unprognostic (7.67e-3)"	"unprognostic (1.29e-1)"	"prognostic favorable (4.35e-4)"	"unprognostic (2.10e-1)"	"unprognostic (2.33e-1)"	"unprognostic (3.07e-2)"	"unprognostic (5.06e-2)"	"prognostic favorable (9.42e-7)"	"unprognostic (1.56e-1)"	"unprognostic (5.71e-2)"	"unprognostic (9.17e-2)"	"unprognostic (8.07e-3)"	0.3	0.4	0.3	12.7	0.3	0.0	3.2	0.3	0.4	4.1	24.9	0.4	1.0	17.0	0.9	15.9	25.2	3.0	7.7	0.3	0.3	0.1	18.8	0.6	4.2	0.3	0.3	0.3	1.5	28.6	0.0	1.0	0.4	0.4	5.7	12.7	0.4	52.7	3.7	0.3	25.2	40.4	2.8	0.3	0.3	8.7	0.8	0.3	1.0	0.7	19.6	18.8	16.5	8.2	0.6	0.7	3.5	0.5	0.6	0.5	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	3.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	30.5	0.1	0.1	0.0	10.4	0.0	0.0	32.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	3.5	0.5	0.2	0.4	0.3	0.2	0.3	0.5	0.3	0.1	0.6	0.5	0.4	1.9	0.6	0.5	0.7	0.4	0.0	0.3	0.3	0.3	0.4	0.3	0.1	0.3	0.3	0.4	0.3	32.8	5.8	2.2	16.1	3.7	0.0	0.2	17.8	33.5	29.6	22.7	2.0	0.0	18.3	16.4	0.0	0.0	136.8	0.0	33.4	0.0	0.3	3.4	0.0	0.0	0.1	0.0	5.8	0.0	0.0	0.0	0.6	1.3	0.0	3.6	63.3	0.2	14.4	98.2	0.0	32.1	0.2	0.0	1.0	0.0	0.1	18.2	0.0	0.5	77.9	19.7
GGT7	"D20S101, dJ18C9.2, GGTL3, GGTL5"	ENSG00000131067	"Gamma-glutamyltransferase 7"	Q9UJ14	20	34844720-34872860	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Glutathione biosynthesis"	"Acyltransferase, Hydrolase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Bipolar cells: 38.6;Horizontal cells: 38.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA013204, HPA013339"	Approved		Approved	Nucleoplasm,Vesicles		NA	NA		1500000	Vesicles	Nucleoplasm	"HPA013204: AB_1850347, HPA013339: AB_2668816"	"unprognostic (1.32e-3)"	"unprognostic (2.33e-1)"	"unprognostic (9.31e-2)"	"prognostic unfavorable (1.26e-5)"	"unprognostic (1.27e-1)"	"unprognostic (6.55e-2)"	"unprognostic (1.46e-3)"	"unprognostic (2.49e-2)"	"unprognostic (3.49e-1)"	"unprognostic (1.16e-2)"	"unprognostic (3.34e-3)"	"unprognostic (3.61e-2)"	"unprognostic (5.00e-3)"	"unprognostic (1.81e-1)"	"unprognostic (1.63e-1)"	"unprognostic (5.50e-2)"	"unprognostic (2.00e-1)"	6.8	6.7	21.6	6.7	23.7	2.9	8.5	42.6	29.1	9.5	11.5	9.7	14.3	9.8	12.3	19.5	6.4	10.5	11.4	13.8	19.7	17.0	9.9	7.2	9.0	10.3	11.2	32.1	13.4	19.5	20.8	18.3	8.5	19.2	11.4	9.6	6.9	18.8	15.3	31.6	11.1	9.0	9.6	11.0	8.3	12.9	5.0	15.6	4.9	16.3	4.3	8.2	9.3	8.5	6.1	2.6	1.5	3.0	3.2	12.8	1.8	2.2	3.3	17.0	17.4	13.4	12.0	15.1	9.4	9.6	7.8	11.6	17.4	11.1	0.0	11.2	7.3	7.9	1.5	7.3	4.1	5.1	0.7	13.1	6.7	5.9	9.1	12.0	0.3	11.1	17.4	4.7	8.7	4.0	23.3	0.6	8.9	5.0	1.2	5.3	3.8	1.7	3.4	3.9	3.8	1.7	0.0	11.6	10.7	11.3	3.3	9.9	11.6	4.8	7.7	12.1	6.7	5.9	6.1	0.2	26.8	10.7	2.5	5.3	13.1	1.7	0.8	31.5	0.6	9.8	1.5	3.0	1.4	7.4	2.0	2.1	5.6	6.3	2.8	2.6	6.1	12.8	8.9	0.3	3.2	0.7	1.4	4.8	1.8	21.6	23.7	42.6	29.1	19.7	17.0	11.2	32.1	19.2	15.6	3.0	2.4	0.9	17.1	6.5	38.6	1.6	22.9	1.4	3.4	17.4	11.8	18.6	0.0	13.9	2.1	2.1	10.5	0.0	4.9	9.8	11.9	9.2	2.3	10.2	4.0	38.1	10.4	0.6	1.9	0.5	11.5	2.4	10.1	3.6	16.0	9.4	6.7	14.0	7.4	5.1	16.9	6.5	8.6	11.1	10.6	3.8	14.1	4.1	17.8	12.0
GK	"GK1, GKD"	ENSG00000198814	"Glycerol kinase"	P32189	X	30653359-30731456	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Glycerol metabolism"	"Kinase, Transferase"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 51.4;intestine: 37.9;kidney: 35.4;liver: 40.7"	"Cell type enhanced"	"Detected in many"	7	"Enterocytes: 80.4;Macrophages: 98.4;Proximal tubular cells: 143.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	8	"neutrophil: 51.4"	"Lineage enriched"	"Detected in all"	8	"granulocytes: 51.4"	"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 22.5;Hep G2: 27.3"									HPA060687	Supported					NA	NA					"HPA060687: AB_2684343"	"unprognostic (8.78e-3)"	"unprognostic (8.41e-3)"	"unprognostic (1.28e-2)"	"unprognostic (3.77e-2)"	"unprognostic (3.15e-1)"	"unprognostic (4.15e-3)"	"unprognostic (5.52e-2)"	"unprognostic (1.42e-2)"	"unprognostic (3.85e-1)"	"unprognostic (8.56e-3)"	"unprognostic (1.30e-2)"	"unprognostic (1.58e-2)"	"prognostic favorable (3.24e-9)"	"unprognostic (1.59e-1)"	"unprognostic (9.35e-2)"	"unprognostic (4.57e-3)"	"unprognostic (4.11e-3)"	2.8	4.9	2.4	17.0	7.6	1.6	1.8	2.5	4.7	3.0	7.5	2.7	1.5	28.4	2.5	4.0	4.9	2.7	7.9	4.9	4.6	2.6	35.4	40.7	11.7	8.1	3.8	2.5	2.0	1.9	3.2	5.3	2.3	4.1	1.9	3.4	2.9	6.6	0.6	1.4	3.1	37.9	1.9	6.0	6.4	2.0	2.0	2.2	5.4	2.2	3.8	4.5	4.3	1.7	1.7	4.0	51.4	6.6	1.2	3.2	1.6	2.6	2.1	2.7	4.8	1.7	6.6	1.1	6.4	22.5	4.7	5.3	3.4	2.4	7.5	1.0	2.4	4.2	0.1	5.1	2.1	6.2	4.8	5.7	4.4	4.2	27.3	10.8	8.2	9.6	4.0	3.2	14.8	14.0	1.2	3.6	5.9	2.3	10.7	1.2	3.8	6.3	8.8	4.6	2.9	2.4	8.8	4.3	7.7	3.5	8.8	2.9	3.7	5.6	5.7	12.5	2.9	6.5	5.9	1.4	3.4	1.4	0.1	2.9	5.6	6.0	7.3	5.9	5.4	3.4	1.3	6.6	2.2	0.5	2.0	0.4	0.8	0.9	0.6	4.0	1.7	0.5	0.6	51.4	1.2	2.4	1.2	3.2	1.6	2.4	7.6	2.5	4.7	4.6	2.6	3.8	2.5	4.1	2.2	14.9	24.3	9.1	8.9	6.2	4.1	3.9	10.2	56.2	20.5	7.0	15.7	1.0	29.9	19.8	39.8	3.6	80.4	0.0	9.5	1.0	3.8	12.9	13.9	33.1	30.8	4.8	11.6	4.3	33.0	23.1	1.1	98.4	13.5	44.1	11.5	36.9	13.5	17.5	2.1	143.3	17.9	0.0	4.7	9.9	1.5	14.8	0.7	17.3	7.8	22.6
GK2	"GKP2, GKTA"	ENSG00000196475	"Glycerol kinase 2"	Q14410	4	79406352-79408293	"Enzymes, Plasma proteins, Predicted membrane proteins"	"Glycerol metabolism"	"Kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	90	"testis: 61.0"	"Group enriched"	"Detected in some"	6	"Early spermatids: 439.5;Late spermatids: 112.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	52	"SCLC-21H: 9.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA060687	Uncertain					NA	NA					"HPA060687: AB_2684343"															"unprognostic (1.31e-1)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	61.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	439.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	112.5	3.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	44.6	2.7	0.0	0.0	0.0	0.0	0.0
GK3P	"GKP3, GKTB"	ENSG00000229894	"Glycerol kinase 3 pseudogene"	Q14409	4	165277812-165279679	"Enzymes, Predicted membrane proteins"	"Glycerol metabolism"	"Kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	6	"testis: 17.0"	"Cell type enriched"	"Detected in single"	17	"Distal tubular cells: 1.7"	"Not detected"	"Not detected"							"Cell type enriched"	"Detected in single"	12	"neutrophil: 2.9"	"Lineage enriched"	"Detected in single"	12	"granulocytes: 2.9"	"Cell line enhanced"	"Detected in single"		"TIME: 1.1"									HPA060687	Uncertain					NA	NA					"HPA060687: AB_2684343"	"unprognostic (1.34e-1)"	"unprognostic (2.41e-1)"	"unprognostic (3.01e-2)"		"unprognostic (1.17e-2)"	"unprognostic (2.11e-2)"	"unprognostic (3.94e-1)"	"unprognostic (1.61e-1)"	"unprognostic (2.04e-1)"	"unprognostic (6.19e-2)"			"unprognostic (6.99e-2)"	"unprognostic (4.63e-2)"	"unprognostic (2.02e-1)"	"unprognostic (4.56e-1)"	"unprognostic (3.34e-4)"	0.0	0.0		0.0		0.4	0.0		0.0	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.0			0.0	0.0	0.0		0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	17.0			0.0		0.0	0.0		0.0	0.1	2.9	0.2	0.0	0.1	0.0	0.3	0.0	0.0	0.2	0.0	0.0	0.2	0.4	0.0	0.0	0.0	0.5	0.0	0.3	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.6	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.2	0.0	0.0	0.3	0.4	0.0	0.0	0.2	1.1	0.0	0.1	0.0	0.1	0.0	0.4	0.9	0.0	0.0	0.7	0.0	0.2	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	2.9	0.0	0.1	0.0	0.1	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
GK5	MGC40579	ENSG00000175066	"Glycerol kinase 5 (putative)"	Q6ZS86	3	142157527-142225607	"Enzymes, Predicted intracellular proteins"	"Glycerol metabolism"	"Kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042606, HPA057998"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"HPA042606: AB_10795509, HPA057998: AB_2683573"	"unprognostic (7.79e-2)"	"unprognostic (5.15e-2)"	"unprognostic (2.02e-2)"	"unprognostic (1.33e-1)"	"unprognostic (3.07e-2)"	"unprognostic (3.60e-2)"	"unprognostic (9.89e-3)"	"unprognostic (3.13e-1)"	"unprognostic (2.77e-2)"	"unprognostic (1.76e-2)"	"unprognostic (7.76e-2)"	"unprognostic (2.03e-1)"	"unprognostic (1.12e-2)"	"unprognostic (2.10e-3)"	"unprognostic (4.49e-2)"	"unprognostic (1.32e-1)"	"unprognostic (5.59e-3)"	6.1	12.2	5.6	5.7	7.2	10.8	10.9	9.0	9.4	11.5	10.9	8.4	11.5	14.4	10.9	14.8	7.9	7.2	8.3	5.4	5.5	4.1	5.7	3.1	6.2	3.5	9.3	6.0	11.5	4.8	5.4	20.3	3.7	12.6	13.5	11.8	6.7	14.8	14.7	5.0	8.8	14.0	9.4	11.6	3.5	8.1	6.2	5.3	4.6	7.4	4.2	6.1	8.5	6.7	1.3	1.1	3.6	5.3	3.8	3.8	0.5	11.0	2.8	4.0	2.7	8.3	15.9	6.9	3.7	2.6	4.1	2.6	4.2	6.1	8.0	3.3	3.5	4.5	4.7	4.6	3.5	5.4	2.8	4.4	5.2	6.6	3.1	4.5	5.9	6.9	6.5	3.1	2.7	3.6	2.6	2.3	9.2	4.5	4.9	7.3	7.1	5.2	4.9	2.6	7.4	3.2	4.9	4.3	2.9	4.2	6.9	3.9	2.9	10.2	10.8	3.3	2.5	15.0	3.9	2.5	3.2	2.7	7.1	4.0	5.1	4.9	8.1	5.8	3.7	5.4	3.6	1.1	0.7	3.8	0.9	1.9	0.5	1.3	1.4	0.8	1.3	1.0	1.7	3.2	3.8	5.3	1.1	0.6	0.5	5.6	7.2	9.0	9.4	5.5	4.1	9.3	6.0	12.6	5.3	35.7	27.8	0.0	11.1	3.5	30.1	9.3	15.3	21.4	27.3	26.2	27.5	11.1	6.6	12.3	2.0	5.9	31.1	0.0	17.9	6.4	7.8	21.5	8.1	11.1	5.0	14.3	26.9	2.5	10.0	3.6	31.4	8.2	3.3	1.0	51.9	13.2	13.9	39.1	43.9	5.1	35.7	25.8	4.9	4.2	4.7	3.4	5.7	17.5	38.6	11.6
GLA	GALA	ENSG00000102393	"Galactosidase alpha"	P06280	X	101397803-101407925	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		"Glycosidase, Hydrolase"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Hofbauer cells: 85.3;Melanocytes: 84.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HMC-1: 81.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000237, HPA000966"	Enhanced				"Intracellular and membrane"	NA	NA		910000			"HPA000237: AB_1078968, HPA000966: AB_1078969"	"unprognostic (7.27e-3)"	"unprognostic (1.47e-2)"	"unprognostic (1.57e-2)"	"unprognostic (2.94e-1)"	"unprognostic (1.60e-1)"	"unprognostic (3.15e-2)"	"prognostic unfavorable (5.62e-5)"	"unprognostic (2.53e-1)"	"unprognostic (3.42e-1)"	"unprognostic (1.89e-1)"	"unprognostic (2.97e-2)"	"unprognostic (3.27e-2)"	"unprognostic (2.73e-2)"	"prognostic favorable (6.16e-4)"	"unprognostic (1.13e-1)"	"unprognostic (5.44e-2)"	"unprognostic (2.21e-1)"	21.1	22.2	5.2	10.0	6.3	15.6	19.2	6.2	5.7	10.8	12.7	7.3	23.2	14.8	11.7	14.1	9.4	11.5	9.1	10.5	5.2	6.3	28.7	18.9	18.7	12.0	9.4	3.2	9.7	8.3	9.8	10.5	17.9	8.6	8.3	11.2	9.4	9.5	47.7	5.9	8.9	21.3	10.8	11.9	20.8	8.5	4.9	5.8	10.2	8.3	13.4	11.2	12.2	8.9	5.4	15.9	12.8	20.9	3.0	6.1	10.1	7.2	28.4	8.2	8.4	19.0	7.4	3.7	8.3	13.0	15.9	45.3	15.4	11.2	8.0	17.7	8.5	37.5	17.3	16.1	9.0	13.8	4.9	12.0	4.4	23.6	18.1	4.9	6.1	81.0	6.5	2.9	18.3	5.3	4.4	12.8	4.9	6.8	17.7	15.1	12.9	6.1	12.7	12.0	17.3	11.5	4.4	10.1	19.5	23.2	14.7	3.0	5.1	19.3	8.2	7.7	14.2	3.8	12.6	7.3	5.5	6.6	13.1	6.7	5.4	6.2	6.1	9.5	10.2	6.1	9.5	20.8	6.2	4.6	20.9	6.1	5.4	3.7	5.7	15.9	4.9	3.8	4.7	12.8	3.0	20.8	6.7	4.3	10.1	5.2	6.3	6.2	5.7	5.2	6.3	9.4	3.2	8.6	5.8	14.9	12.2	18.9	23.0	26.9	3.8	6.7	0.0	22.7	17.0	10.4	5.9	35.6	14.9	19.5	2.6	19.0	23.9	0.0	16.1	22.7	43.3	16.3	30.1	5.7	85.3	7.9	32.5	5.5	21.1	0.8	10.3	80.3	84.4	37.9	6.8	17.7	15.1	17.5	17.0	7.9	4.6	6.5	71.0	6.0	5.5	20.7	63.2	10.7	12.3	13.2
GLB1	"EBP, ELNR1"	ENSG00000170266	"Galactosidase beta 1"	P16278	3	32996608-33097230	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		"Glycosidase, Hydrolase"	"Disease mutation, Gangliosidosis, Mucopolysaccharidosis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BEWO: 139.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB008382, HPA040610, HPA069503"	Enhanced		Supported	"Golgi apparatus,Vesicles"	"Intracellular and membrane"	NA	NA		1700000	Vesicles	"Golgi apparatus"	"CAB008382: AB_590642, HPA040610: AB_2677039, HPA069503: AB_2686142"	"unprognostic (1.51e-2)"	"unprognostic (3.66e-2)"	"unprognostic (5.02e-3)"	"unprognostic (9.66e-3)"	"unprognostic (9.61e-3)"	"unprognostic (1.04e-1)"	"unprognostic (2.31e-3)"	"unprognostic (1.32e-1)"	"unprognostic (2.08e-1)"	"unprognostic (1.16e-1)"	"unprognostic (2.06e-1)"	"unprognostic (2.08e-1)"	"prognostic favorable (1.14e-5)"	"unprognostic (3.05e-1)"	"unprognostic (2.33e-1)"	"unprognostic (2.20e-1)"	"unprognostic (5.85e-2)"	17.3	33.1	9.6	14.9	14.7	9.5	18.4	8.9	19.8	18.3	21.9	12.1	19.8	21.2	18.3	55.0	12.7	15.2	25.8	13.7	9.7	10.0	35.0	33.2	24.3	25.0	9.2	9.7	18.3	25.3	28.4	16.4	26.5	14.0	13.6	23.7	23.5	21.1	17.7	6.1	12.9	28.3	15.6	9.8	21.4	22.7	10.0	8.0	8.3	26.9	7.7	19.5	18.4	13.6	11.1	45.2	22.7	39.2	6.8	20.9	20.9	5.8	10.0	6.5	7.7	39.9	20.7	139.7	9.3	25.2	12.0	15.4	14.2	13.8	2.8	8.3	19.0	8.9	5.6	6.1	11.9	8.9	16.3	5.1	11.2	6.0	7.3	20.5	7.7	11.4	23.9	11.4	10.8	6.4	23.6	18.4	3.9	10.1	10.9	13.1	6.8	4.6	5.1	4.4	12.2	4.4	4.0	4.3	13.2	12.9	8.5	2.0	6.8	12.0	19.4	11.7	12.0	12.9	20.4	10.7	7.7	5.4	10.5	7.9	8.6	13.7	0.9	16.2	11.2	5.8	10.5	39.2	22.7	8.3	34.6	11.8	11.1	10.2	9.1	45.2	10.0	5.4	6.5	15.5	6.8	23.7	9.5	20.9	20.9	9.6	14.7	8.9	19.8	9.7	10.0	9.2	9.7	14.0	8.0	17.9	22.3	15.9	10.2	5.4	11.3	7.1	35.7	14.7	17.0	26.2	5.9	80.5	23.2	42.1	22.3	10.5	31.5	0.0	31.3	47.6	24.4	11.4	26.5	36.5	70.6	4.8	16.3	18.4	38.2	3.1	14.1	38.3	13.5	81.2	22.4	20.0	27.0	39.5	19.8	24.2	15.0	12.9	10.8	1.1	7.2	3.0	41.1	20.0	28.4	8.4
GLCE	"HSEPI, KIAA0836"	ENSG00000138604	"Glucuronic acid epimerase"	O94923	15	69160584-69272217	"Enzymes, Plasma proteins, Predicted intracellular proteins"		Isomerase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 58.4"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Region enriched"	"Detected in all"	4	"cerebellum: 58.4"	"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	7	"dendritic cells: 4.0;monocytes: 4.4;T-cells: 4.0"	"Cell line enhanced"	"Detected in many"		"HUVEC TERT2: 50.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040481, HPA048216"	Uncertain		Approved	Mitochondria	"Intracellular and membrane"	NA	NA		78000	Mitochondria		"HPA040481: AB_2677004, HPA048216: AB_2680317"	"unprognostic (1.30e-1)"	"unprognostic (2.39e-1)"	"unprognostic (1.20e-3)"	"unprognostic (7.77e-2)"	"unprognostic (1.58e-1)"	"unprognostic (5.55e-3)"	"unprognostic (1.00e-1)"	"unprognostic (2.84e-1)"	"unprognostic (1.48e-1)"	"unprognostic (2.56e-1)"	"unprognostic (7.47e-2)"	"unprognostic (1.41e-1)"	"unprognostic (2.40e-2)"	"unprognostic (1.53e-1)"	"unprognostic (6.00e-2)"	"unprognostic (5.23e-1)"	"unprognostic (4.07e-2)"	8.3	12.2	6.5	4.9	14.2	0.6	8.8	58.4	12.1	8.4	12.1	12.4	7.8	13.5	6.3	6.9	10.2	5.9	7.2	5.5	5.8	8.5	13.3	16.0	8.4	5.3	9.4	8.1	12.9	5.9	9.0	12.0	12.6	14.4	5.7	14.0	10.8	11.7	8.9	4.1	9.8	11.2	6.8	10.2	4.0	8.8	6.1	7.6	5.4	4.1	8.4	5.8	6.3	5.6	0.6	4.0	0.1	4.4	0.5	4.0	1.9	3.9	3.5	2.4	4.2	8.2	7.8	0.8	7.4	9.9	5.8	11.0	2.9	10.0	2.4	3.7	6.0	7.3	6.0	5.2	4.8	11.8	0.9	5.7	4.0	6.7	3.0	7.9	1.7	8.2	5.3	3.3	7.1	8.1	4.2	50.9	1.8	1.6	2.6	10.8	2.4	1.0	3.0	1.2	4.0	2.5	2.4	9.8	3.0	5.3	4.2	7.7	1.6	7.6	4.7	15.7	1.7	3.4	2.4	17.7	5.6	6.9	6.1	6.5	1.1	1.5	0.5	5.6	2.9	8.0	0.0	4.4	0.1	0.7	3.4	1.2	0.6	1.8	0.8	3.6	0.5	1.2	1.5	0.1	0.5	4.4	4.0	4.0	1.9	6.5	14.2	58.4	12.1	5.8	8.5	9.4	8.1	14.4	7.6	0.0	12.5	5.7	9.1	4.2	10.3	6.2	7.6	25.4	5.7	10.4	9.8	20.3	5.0	10.4	3.2	13.9	15.7	0.0	12.1	9.9	5.9	4.9	2.3	24.6	13.5	7.9	19.5	16.5	14.6	3.3	5.8	7.7	8.5	11.8	26.4	12.9	12.9	23.4	16.6	14.0	15.4	12.9	3.9	13.0	13.4	5.6	27.6	4.4	26.5	12.1
GLDC	"GCSP, NKH"	ENSG00000178445	"Glycine decarboxylase"	P23378	9	6532464-6645783	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		Oxidoreductase	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"kidney: 22.3;liver: 40.3;placenta: 10.6"	"Cell type enhanced"	"Detected in many"	17	"Cytotrophoblasts: 59.4;Extravillous trophoblasts: 35.6;Hepatocytes: 126.2;Syncytiotrophoblasts: 38.4"	"Cancer enhanced"	"Detected in many"		"testis cancer: 41.4"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"BEWO: 66.8;CACO-2: 15.9;HMC-1: 14.5;RPTEC TERT1: 27.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA002318, HPA052887"	Enhanced		Supported	Nucleoplasm,Mitochondria		NA	NA		570000	Mitochondria	Nucleoplasm	"HPA002318: AB_1849700, HPA052887: AB_2681980"	"unprognostic (6.73e-2)"	"unprognostic (1.19e-1)"	"unprognostic (6.50e-2)"	"prognostic unfavorable (5.24e-5)"	"unprognostic (1.50e-1)"	"unprognostic (7.87e-2)"	"unprognostic (1.81e-1)"	"unprognostic (1.50e-1)"	"unprognostic (2.40e-1)"	"unprognostic (1.74e-1)"	"unprognostic (2.47e-2)"	"unprognostic (2.69e-1)"	"prognostic favorable (3.50e-4)"	"unprognostic (1.65e-2)"	"unprognostic (1.27e-1)"	"unprognostic (5.62e-3)"	"unprognostic (1.17e-2)"	0.2	0.3	3.9	1.0	3.4	0.4	0.4	3.1	5.6	0.3	0.8	1.6	0.0	0.7	0.4	4.2	1.4	0.6	0.6	0.1	2.9	2.2	22.3	40.3	0.8	1.1	1.9	2.9	0.3	0.1	0.0	1.7	10.6	2.1	0.4	0.3	3.2	0.9	0.8	0.9	1.5	0.6	0.1	1.9	0.8	0.8	1.1	1.8	0.0	2.6	0.0	1.9	0.8	0.0	2.9	0.7	2.3	0.5	0.8	0.6	1.1	0.1	1.3	0.6	7.2	0.0	0.1	66.8	0.0	0.0	0.0	0.0	15.9	0.1	0.1	1.6	0.0	0.2	0.1	0.0	0.1	0.0	0.3	3.8	0.0	0.0	10.6	0.0	0.0	14.5	0.0	0.0	0.5	0.0	0.2	2.7	1.2	0.0	0.1	0.3	0.3	0.2	0.0	7.8	1.2	1.2	0.3	0.0	0.1	27.7	0.3	6.4	3.3	0.0	6.2	0.0	4.1	1.4	0.0	0.9	0.1	0.2	0.8	0.3	0.3	9.2	0.0	0.2	0.7	1.5	1.5	0.5	0.5	0.5	0.3	0.5	2.9	0.6	0.4	0.1	0.9	0.4	0.5	2.3	0.8	0.5	0.7	0.2	1.1	3.9	3.4	3.1	5.6	2.9	2.2	1.9	2.9	2.1	1.8	0.0	0.0	4.3	0.0	0.0	0.3	0.6	7.6	0.0	0.0	29.6	0.0	59.4	5.0	0.0	8.8	0.0	0.0	0.0	0.2	35.6	0.0	0.0	0.0	126.2	6.1	0.0	0.0	3.1	2.1	9.0	0.3	0.0	0.0	0.0	0.0	8.6	0.1	0.0	0.0	29.3	0.2	0.0	0.3	4.4	5.0	0.0	38.4	0.5	0.0	0.0
GLO1	GLOD1	ENSG00000124767	"Glyoxalase I"	Q04760	6	38675925-38703141	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins"		Lyase	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enriched"	"Detected in all"	4	"HMC-1: 249.9"	"Low region specificity"	"Detected in all"							"CAB040541, CAB040542, HPA059791"	Enhanced		Supported	"Nucleoplasm,Plasma membrane,Cytosol"		No	No		1600000	"Nucleoplasm, Plasma membrane, Cytosol"		"CAB040541: , CAB040542: , HPA059791: AB_2684126"	"unprognostic (4.33e-2)"	"unprognostic (1.09e-1)"	"unprognostic (4.37e-2)"	"unprognostic (1.08e-2)"	"unprognostic (3.96e-3)"	"unprognostic (2.51e-1)"	"prognostic unfavorable (5.21e-4)"	"unprognostic (5.09e-2)"	"unprognostic (2.10e-2)"	"unprognostic (1.28e-2)"	"unprognostic (2.61e-2)"	"unprognostic (8.71e-2)"	"unprognostic (1.20e-2)"	"unprognostic (9.29e-2)"	"unprognostic (1.83e-1)"	"unprognostic (2.54e-1)"	"unprognostic (6.21e-2)"	22.2	30.5	42.1	19.5	42.3	11.4	32.0	25.4	42.3	27.1	42.1	19.7	22.9	48.1	25.3	49.2	28.2	31.5	17.8	39.2	37.8	37.7	37.1	65.3	30.7	31.6	38.9	29.7	37.6	25.9	33.2	12.6	26.7	40.6	74.0	22.7	21.7	21.7	28.2	57.5	31.3	64.3	28.9	37.6	25.6	21.3	12.9	21.4	19.8	32.6	42.5	24.3	28.6	24.7	25.9	28.6	8.5	15.6	10.8	24.4	14.7	18.5	8.6	24.8	24.6	11.8	21.3	21.9	16.2	15.4	22.8	23.8	20.9	7.1	20.7	12.8	12.9	27.2	12.3	21.2	20.9	28.9	18.8	32.7	30.6	11.1	19.5	17.7	11.6	249.9	18.2	12.9	21.6	15.5	14.9	24.6	14.7	24.1	13.8	21.3	15.7	18.1	14.8	17.8	16.6	16.9	15.8	30.0	13.5	20.8	14.1	19.3	19.5	11.4	15.9	30.5	17.8	18.4	58.4	10.1	17.8	16.4	15.4	25.6	10.9	20.5	56.8	6.4	30.1	28.5	8.5	9.8	6.9	18.0	15.6	24.4	24.7	18.1	18.3	18.3	25.9	17.1	17.9	1.2	10.8	12.1	28.6	15.7	14.7	42.1	42.3	25.4	42.3	37.8	37.7	38.9	29.7	40.6	21.4	122.1	136.6	86.9	79.7	57.5	55.3	121.3	48.4	88.3	91.0	85.5	19.6	91.3	210.5	107.2	3.6	70.9	36.2	0.0	64.3	264.4	68.8	192.8	67.2	86.8	68.4	65.2	35.1	200.1	112.1	4.7	77.6	69.2	99.5	129.8	41.3	160.8	66.2	35.7	103.3	107.3	50.7	45.3	65.9	11.9	15.7	77.0	61.2	59.9	55.5	125.1
GLS	"GLS1, KIAA0838"	ENSG00000115419	Glutaminase	O94925	2	190880827-190965552	"Enzymes, Predicted intracellular proteins"		Hydrolase	"Cataract, Disease mutation, Epilepsy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"kidney: 127.9"	"Cell type enhanced"	"Detected in all"	6	"Collecting duct cells: 371.6;Proximal tubular cells: 372.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"EFO-21: 141.8;RPTEC TERT1: 65.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA036223	Enhanced		Supported	Mitochondria	"Intracellular and membrane"	No	No		25000	Mitochondria		"HPA036223: AB_10669984"	"unprognostic (7.45e-2)"	"unprognostic (3.42e-2)"	"unprognostic (3.21e-1)"	"prognostic unfavorable (3.45e-4)"	"unprognostic (1.17e-1)"	"unprognostic (2.08e-3)"	"unprognostic (2.51e-3)"	"unprognostic (4.24e-2)"	"unprognostic (1.59e-1)"	"unprognostic (2.40e-1)"	"unprognostic (8.01e-2)"	"unprognostic (9.06e-2)"	"unprognostic (5.41e-2)"	"unprognostic (1.62e-1)"	"unprognostic (5.03e-2)"	"unprognostic (2.13e-1)"	"unprognostic (4.12e-1)"	16.5	37.3	37.8	20.4	24.7	10.7	34.3	43.8	47.3	11.9	13.1	5.8	8.9	36.9	14.6	11.9	7.6	11.0	17.7	15.7	23.3	22.8	127.9	5.3	22.6	25.4	20.6	36.8	14.1	17.0	26.4	10.1	14.8	35.1	9.4	13.1	10.8	9.0	13.9	7.4	13.0	40.9	15.5	11.7	19.3	8.7	6.9	12.1	15.0	17.7	8.0	22.9	14.1	16.1	5.2	5.0	6.0	2.1	3.9	9.4	1.5	6.4	7.1	5.0	6.6	15.7	11.0	13.0	19.2	14.6	14.0	16.1	8.7	6.4	13.2	141.8	40.5	7.1	8.4	8.8	7.5	20.6	32.5	5.7	21.9	10.5	10.7	14.4	12.7	10.3	9.9	7.9	11.0	7.5	14.0	18.1	5.5	10.1	26.9	31.1	3.4	8.6	12.3	13.4	3.8	11.7	11.0	12.9	11.4	65.2	11.8	6.9	7.2	26.2	5.8	24.4	18.7	2.3	7.9	12.9	20.3	14.9	10.1	23.2	8.7	19.8	18.1	7.3	10.5	16.1	6.0	1.5	2.5	5.5	2.1	9.4	4.8	6.5	7.0	2.2	5.2	6.8	8.1	3.0	3.9	1.4	5.0	5.6	1.5	37.8	24.7	43.8	47.3	23.3	22.8	20.6	36.8	35.1	12.1	175.7	95.7	52.1	47.3	155.0	91.0	32.2	30.6	16.0	40.9	371.6	198.3	3.3	43.1	22.6	4.4	51.8	120.5	23.3	20.9	10.2	63.7	42.0	35.8	4.9	25.8	25.4	56.7	57.7	27.2	3.6	26.4	55.5	84.4	88.4	25.7	10.0	29.5	31.6	40.7	372.1	117.6	19.4	70.9	10.7	11.0	142.3	3.3	62.3	28.1	52.1
GLS2	"GA, GLS, hLGA, LGA"	ENSG00000135423	"Glutaminase 2"	Q9UI32	12	56470944-56488414	"Enzymes, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"liver: 92.2"	"Cell type enriched"	"Detected in many"	5	"Hepatocytes: 52.1"	"Cancer enhanced"	"Detected in single"		"liver cancer: 1.7"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	29	"B-cells: 1.8;T-cells: 3.8"	"Cell line enhanced"	"Detected in some"		"Daudi: 25.6;RPMI-8226: 4.6;SCLC-21H: 7.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA038608	Uncertain					NA	NA					"HPA038608: AB_10673176"	"unprognostic (5.59e-2)"	"unprognostic (1.51e-2)"	"unprognostic (8.73e-2)"	"unprognostic (7.15e-2)"	"unprognostic (1.23e-2)"	"unprognostic (9.56e-2)"	"unprognostic (3.27e-3)"	"unprognostic (1.98e-6)"	"unprognostic (1.55e-1)"	"unprognostic (5.33e-2)"	"unprognostic (1.29e-2)"	"unprognostic (1.52e-1)"	"unprognostic (5.65e-5)"	"unprognostic (1.42e-2)"	"unprognostic (2.59e-1)"	"unprognostic (9.02e-2)"	"unprognostic (4.44e-2)"	0.9	1.7	5.7	1.0	8.6	0.9	1.4	12.8	15.0	1.0	1.2	0.2	0.0	1.0	1.2	2.0	1.4	2.8	0.9	1.0	4.2	4.1	1.6	92.2	1.4	1.2	1.9	9.7	1.2	15.8	3.0	6.2	0.8	8.6	1.4	1.7	2.5	1.4	2.0	0.9	2.0	1.0	1.1	3.2	1.1	1.4	1.1	1.4	0.0	1.4	0.0	1.4	1.1	0.8	1.8	0.0	0.0	0.0	0.0	3.8	1.4	4.1	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	3.5	0.9	25.6	0.5	0.0	0.0	0.6	0.0	3.8	0.0	0.0	3.8	0.0	0.3	4.1	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.5	0.0	1.8	0.8	0.4	0.0	0.1	4.6	2.7	1.8	7.3	0.4	0.8	0.3	0.0	0.7	3.6	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	3.3	1.8	3.3	1.0	0.0	0.6	3.8	3.5	0.0	0.0	0.0	0.0	0.6	1.4	5.7	8.6	12.8	15.0	4.2	4.1	1.9	9.7	8.6	1.4	0.0	2.4	1.9	4.2	1.4	9.5	0.0	0.0	2.7	6.8	0.0	5.9	0.1	6.6	0.4	0.0	0.3	0.0	0.0	1.6	0.0	0.1	1.5	1.1	52.1	0.1	3.2	1.2	1.3	1.5	0.0	0.9	0.0	1.7	0.0	0.0	2.3	0.8	0.0	0.0	0.5	10.2	0.0	0.0	0.0	1.0	1.0	0.2	0.0	0.2	0.3
GLUD1	"GDH, GLUD"	ENSG00000148672	"Glutamate dehydrogenase 1"	P00367	10	87050486-87094866	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		Oxidoreductase	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 182.4"	"Cell type enhanced"	"Detected in all"	6	"Hepatocytes: 357.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"Hep G2: 108.1"									"HPA042492, HPA044839, HPA061369"	Approved		Supported	Mitochondria	"Intracellular and membrane"	NA	NA		26000000	Mitochondria		"HPA042492: AB_2678024, HPA044839: AB_2679107, HPA061369: AB_2684494"	"unprognostic (1.48e-1)"	"unprognostic (1.26e-2)"	"unprognostic (3.55e-1)"	"unprognostic (1.07e-1)"	"prognostic favorable (3.81e-4)"	"unprognostic (1.31e-1)"	"unprognostic (1.91e-2)"	"unprognostic (5.50e-2)"	"unprognostic (2.06e-1)"	"unprognostic (4.57e-3)"	"prognostic unfavorable (1.76e-5)"	"unprognostic (1.13e-1)"	"prognostic favorable (1.44e-6)"	"unprognostic (2.29e-1)"	"unprognostic (4.23e-2)"	"unprognostic (7.19e-2)"	"unprognostic (4.27e-2)"	15.5	21.5	57.8	9.9	54.5	5.9	23.2	13.4	37.9	12.1	14.5	19.9	5.5	18.4	10.9	7.5	17.0	11.5	12.6	16.7	44.1	35.3	56.2	182.4	13.1	11.5	40.6	30.8	17.5	15.2	8.7	6.6	13.5	31.1	26.5	14.6	8.1	10.0	13.3	9.2	15.3	19.8	14.0	22.7	10.2	12.2	6.4	33.2	12.6	16.1	8.7	13.1	14.0	9.5	9.2	15.8	9.2	14.6	13.7	11.9	5.9	24.5	19.8	15.6	26.4	29.7	36.6	17.1	19.4	33.6	18.8	20.7	45.8	24.1	27.6	15.9	28.3	10.8	38.7	20.3	19.5	20.2	19.9	16.0	13.4	11.9	108.1	66.3	31.3	19.4	25.2	36.9	20.9	62.6	28.7	22.4	21.8	13.5	25.0	20.3	17.8	28.2	28.1	17.8	26.7	16.0	21.4	19.9	18.0	54.1	20.1	8.0	15.0	17.4	13.8	24.7	15.7	19.0	22.1	22.2	9.8	8.7	19.8	19.7	15.0	15.4	33.0	23.6	35.9	5.8	5.5	13.8	9.2	8.7	11.1	10.9	9.2	11.8	10.6	15.8	8.8	10.6	8.5	1.3	13.7	14.6	5.9	11.9	5.9	57.8	54.5	13.4	37.9	44.1	35.3	40.6	30.8	31.1	33.2	20.8	19.2	40.4	53.0	94.2	20.7	49.8	53.5	17.4	45.5	57.6	35.3	77.3	132.6	27.7	11.2	45.6	54.7	46.7	29.4	52.4	55.2	96.0	43.7	357.2	63.1	14.3	37.8	50.3	67.1	18.7	81.4	68.2	99.5	30.7	44.6	133.3	37.2	42.1	85.2	119.8	60.1	64.7	76.2	9.6	6.4	107.0	39.8	55.4	40.7	75.9
GLUD2	GLUDP1	ENSG00000182890	"Glutamate dehydrogenase 2"	P49448	X	121047588-121050080	"Enzymes, Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 11.3;testis: 31.9"	"Cell type enhanced"	"Detected in some"	6	"Cytotrophoblasts: 2.7;Hepatocytes: 3.2;Proximal tubular cells: 2.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"HAP1: 8.0;K-562: 8.8;SK-MEL-30: 11.3;THP-1: 5.6;WM-115: 12.7"									"HPA042492, HPA044839, HPA061369"	Uncertain		Approved	Mitochondria		NA	NA			Mitochondria		"HPA042492: AB_2678024, HPA044839: AB_2679107, HPA061369: AB_2684494"	"unprognostic (1.44e-1)"	"unprognostic (5.49e-2)"	"unprognostic (1.90e-2)"	"unprognostic (1.39e-2)"	"unprognostic (1.27e-3)"	"unprognostic (1.29e-1)"	"unprognostic (1.77e-2)"	"unprognostic (1.24e-1)"	"unprognostic (2.23e-1)"	"unprognostic (2.42e-1)"	"unprognostic (2.61e-1)"	"unprognostic (2.35e-1)"	"prognostic favorable (1.98e-4)"	"unprognostic (1.04e-2)"	"unprognostic (1.49e-2)"	"unprognostic (4.77e-3)"	"unprognostic (5.96e-2)"	3.1	2.5	4.8	0.8	7.3	0.5	1.6	2.2	3.5	1.1	0.7	2.0	0.6	0.6	1.0	5.2	0.7	1.0	1.6	1.5	5.7	1.8	4.7	11.3	0.9	0.9	2.7	6.2	0.7	1.5	0.7	0.7	2.7	4.3	0.8	0.6	0.2	0.9	3.1	0.7	0.8	1.0	1.0	1.5	0.5	0.9	31.9	4.1	0.0	1.4	0.0	0.8	0.8	0.6	0.8	1.2	0.7	1.1	1.2	0.7	0.4	0.0	2.1	0.5	0.0	0.0	0.0	0.1	0.6	0.6	0.1	0.3	0.0	1.1	0.0	0.8	0.0	0.0	0.0	8.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	3.9	2.2	0.0	0.0	0.0	0.0	0.0	0.0	8.8	0.0	0.0	1.7	0.0	0.0	1.6	4.4	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	3.4	11.3	0.3	2.7	5.6	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	12.7	0.6	0.8	0.7	0.4	1.1	0.7	0.8	0.7	0.7	1.2	0.4	0.7	0.5	0.0	1.2	1.1	0.2	0.7	0.4	4.8	7.3	2.2	3.5	5.7	1.8	2.7	6.2	4.3	4.1	0.0	0.0	0.0	0.4	0.0	0.0	2.0	0.0	0.0	0.0	0.0	2.0	2.7	1.7	0.1	1.8	0.0	0.0	0.0	0.3	0.3	0.6	0.3	0.0	3.2	0.5	0.0	0.0	0.0	1.9	1.5	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.0	2.4	0.0	0.0	0.0	0.9	1.1	0.1	2.1	0.0	0.0	0.1
GLUL	GLNS	ENSG00000135821	"Glutamate-ammonia ligase"	P15104	1	182381704-182392206	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	Angiogenesis	"Ligase, Transferase"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"Late spermatids: 6809.8;Muller glia cells: 5699.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"neutrophil: 92.2"	"Lineage enriched"	"Detected in all"	4	"granulocytes: 92.2"	"Cell line enhanced"	"Detected in many"		"ASC diff: 141.5;ASC TERT1: 100.1;HSkMC: 86.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007316, HPA007571, CAB008636"	Approved		Supported	"Plasma membrane,Mitochondria,Cytosol"		NA	NA		28000	"Mitochondria, Cytosol"	"Plasma membrane"	"CAB008636: AB_1616669, HPA007316: AB_888438, HPA007571: AB_1078980"	"prognostic favorable (4.81e-4)"	"unprognostic (1.52e-3)"	"unprognostic (3.89e-1)"	"unprognostic (3.32e-1)"	"unprognostic (1.25e-1)"	"unprognostic (9.52e-2)"	"unprognostic (7.58e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.26e-1)"	"unprognostic (8.92e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.17e-1)"	"unprognostic (1.38e-2)"	"unprognostic (4.17e-2)"	"unprognostic (2.06e-1)"	"unprognostic (5.55e-2)"	"unprognostic (4.53e-3)"	173.3	19.2	83.7	37.2	91.0	47.6	63.1	48.5	80.7	41.9	20.4	49.9	9.4	6.2	20.5	29.7	54.0	31.6	26.2	23.5	74.0	48.7	15.6	64.9	39.5	36.9	71.0	48.8	66.2	49.0	7.4	8.9	41.8	70.6	17.4	23.3	39.3	30.4	25.5	159.8	27.9	16.4	30.5	51.3	36.1	71.4	24.0	55.2	8.6	63.9	15.5	24.2	34.7	32.2	2.5	11.0	92.2	21.1	3.4	6.3	18.6	3.0	1.2	14.0	0.0	141.5	100.1	10.3	5.1	16.6	3.1	2.8	7.4	3.1	2.6	5.6	9.9	2.8	7.0	6.1	36.4	2.6	7.0	17.0	34.3	5.8	14.3	7.5	15.1	27.4	86.5	43.7	3.9	46.4	4.7	6.2	8.4	28.8	1.5	11.0	1.7	23.5	14.5	10.4	4.2	6.5	8.5	3.7	4.4	5.4	13.3	9.6	6.3	1.4	18.7	2.0	11.7	18.2	19.1	4.6	0.1	0.2	0.0	1.1	0.5	0.3	0.0	2.7	8.6	0.5	43.6	21.1	54.9	6.3	20.5	2.6	1.6	4.5	5.2	11.0	2.5	2.3	3.9	92.2	3.4	17.1	6.1	1.7	18.6	83.7	91.0	48.5	80.7	74.0	48.7	71.0	48.8	70.6	55.2	116.1	193.4	39.3	480.1	119.7	83.9	198.1	163.1	242.2	133.1	78.5	49.1	126.6	63.0	92.2	1437.2	175.0	45.7	210.2	99.7	54.7	230.2	354.1	758.5	179.4	734.4	41.3	312.5	129.5	692.2	6809.8	451.3	662.6	129.9	48.7	226.1	5699.1	116.5	83.4	352.5	40.4	128.3	90.5	209.3	38.8	52.4	112.0	196.8	96.9	130.8	1061.5
GLYAT	"ACGNAT, GAT"	ENSG00000149124	Glycine-N-acyltransferase	Q6IB77	11	58640426-58731974	"Enzymes, Predicted intracellular proteins"	Detoxification	"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	9	"kidney: 91.2;liver: 115.1"	"Group enriched"	"Detected in some"	7	"Hepatocytes: 306.5;Proximal tubular cells: 1137.1"	"Group enriched"	"Detected in some"	158	"liver cancer: 21.7;renal cancer: 25.4"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"neutrophil: 2.9"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Region enhanced"	"Detected in single"		"pons and medulla: 0.7"					"HPA040251, HPA044094"	Enhanced					NA	NA					"HPA040251: AB_2676902, HPA044094: AB_2678807"	"unprognostic (2.15e-2)"				"unprognostic (9.38e-4)"	"unprognostic (4.60e-2)"	"unprognostic (1.65e-3)"		"unprognostic (1.83e-1)"		"unprognostic (1.60e-1)"		"prognostic favorable (1.31e-6)"	"unprognostic (2.69e-1)"				11.1	0.0	0.1	0.1	0.1	0.0	1.8	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	4.5	0.1	0.0	0.1	0.2	0.1	0.0	91.2	115.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.3	0.1	0.2	0.0	0.1	0.1	0.1	0.1	0.0	0.3	0.1	0.1	0.1	0.1	0.1	0.1	0.3	1.1	0.7	2.9	0.7	0.2	0.8	0.0	1.5	0.6	1.0	3.3	3.3	2.1	2.1	0.9	0.9	1.5	0.9	0.4	2.0	2.4	1.4	1.4	0.5	1.5	2.3	2.4	2.0	0.1	0.7	3.2	0.6	3.4	2.4	1.8	1.8	2.4	7.6	2.6	2.7	1.3	2.9	1.8	0.9	1.3	3.7	1.2	2.1	3.5	3.0	2.4	1.0	1.4	2.2	0.5	6.8	1.6	0.8	2.5	1.7	1.4	1.4	3.1	2.4	1.5	1.7	1.9	2.0	2.1	1.2	1.5	2.2	1.1	0.6	4.6	2.0	1.0	0.7	0.3	0.4	0.3	0.4	0.1	0.4	0.8	0.2	1.1	0.5	0.5	2.9	0.2	0.3	0.7	0.5	0.0	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.0	2.9	0.0	0.0	0.0	0.2	10.2	0.0	0.0	29.6	0.0	0.0	104.5	0.0	5.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	306.5	0.0	0.0	0.0	9.2	8.2	4.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1137.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0
GLYATL1	"FLJ34646, MGC15397"	ENSG00000166840	"Glycine-N-acyltransferase like 1"	Q969I3	11	58905398-59043527	"Enzymes, Predicted intracellular proteins"		"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	4	"liver: 113.8"	"Cell type enhanced"	"Detected in some"	31	"Distal tubular cells: 91.2;Hepatocytes: 198.3;Proximal tubular cells: 523.1"	"Group enriched"	"Detected in some"	8	"liver cancer: 14.1;prostate cancer: 13.3;renal cancer: 10.1"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	4	"naive CD4 T-cell: 1.3"	"Lineage enriched"	"Detected in single"	4	"T-cells: 1.3"	"Cell line enhanced"	"Detected in some"		"CACO-2: 3.9;Daudi: 9.7;RPTEC TERT1: 3.3;U-2197: 2.5"									HPA039501	Supported		Uncertain	"Golgi apparatus,Cytosol"		NA	NA			"Golgi apparatus"	Cytosol	"HPA039501: AB_2676545"	"unprognostic (9.46e-3)"	"unprognostic (5.33e-2)"	"unprognostic (3.90e-5)"	"unprognostic (3.93e-3)"	"unprognostic (3.54e-3)"	"unprognostic (2.17e-1)"	"prognostic favorable (3.69e-4)"	"unprognostic (3.62e-1)"	"unprognostic (2.51e-1)"	"unprognostic (1.05e-1)"	"unprognostic (2.08e-1)"	"unprognostic (2.92e-1)"	"prognostic favorable (3.03e-5)"	"unprognostic (1.50e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.86e-2)"	"unprognostic (4.55e-2)"	0.0	0.0	0.1	0.0	0.2	0.0	0.3	0.0	0.1	0.1	0.0	0.1	0.0	0.2	0.0	0.8	0.1	0.1	0.1	0.0	0.0	0.1	27.7	113.8	0.1	0.0	0.2	0.0	0.2	0.2	0.9	0.1	0.0	0.5	2.1	0.0	0.5	1.0	0.0	0.0	0.2	0.1	0.0	0.2	0.0	0.3	0.0	0.1	1.0	0.0	0.1	0.3	0.0	0.0	0.3	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.1	0.0	0.4	1.3	0.0	0.5	0.2	1.1	0.9	3.9	0.0	9.7	0.0	0.7	0.8	0.0	0.0	0.0	1.7	0.0	0.4	0.3	0.0	0.2	0.3	0.0	0.0	0.0	0.0	0.1	0.6	2.2	0.0	0.2	0.0	0.1	0.4	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.4	3.3	0.0	0.2	0.0	0.2	0.2	0.0	0.4	0.0	0.0	0.0	1.2	0.1	2.5	1.7	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.1	0.0	0.1	0.2	0.0	0.5	0.1	0.0	0.0	2.4	0.0	0.0	0.0	0.3	17.8	0.0	0.0	14.0	0.0	0.0	91.2	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	1.8	0.0	198.3	0.0	0.0	0.0	1.8	6.1	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.2	0.0	0.0	523.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.4	0.1
GLYATL2	"BXMAS2-10, MGC24009"	ENSG00000156689	"Glycine-N-acyltransferase like 2"	Q8WU03	11	58834065-58904215	"Enzymes, Predicted intracellular proteins"		"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"breast: 11.2;cervix, uterine: 18.8;lymphoid tissue: 9.9;salivary gland: 25.8"	"Cell type enhanced"	"Detected in some"	16	"Basal glandular cells: 2.2;Glandular cells: 1.9;Melanocytes: 1.7;Sertoli cells: 6.5;Suprabasal keratinocytes: 1.8;Urothelial cells: 1.8"	"Cancer enhanced"	"Detected in many"		"breast cancer: 16.7;endometrial cancer: 15.7"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"neutrophil: 2.1"	"Lineage enriched"	"Detected in single"	5	"granulocytes: 2.1"	"Cell line enhanced"	"Detected in some"		"BJ hTERT+: 5.9;BJ hTERT+ SV40 Large T+ RasG12V: 4.2;HAP1: 6.6;SK-BR-3: 15.8;U-2197: 7.6"					"Not detected"	"Not detected"			"HPA060292, HPA065454"	Uncertain		Approved	Mitochondria		NA	NA			Mitochondria		"HPA060292: AB_2684245, HPA065454: "	"unprognostic (1.02e-2)"	"unprognostic (3.79e-3)"	"unprognostic (8.11e-4)"	"prognostic favorable (9.05e-7)"	"unprognostic (1.05e-1)"	"unprognostic (8.41e-2)"	"unprognostic (2.66e-2)"	"unprognostic (9.98e-3)"	"unprognostic (1.27e-1)"	"unprognostic (9.18e-3)"	"unprognostic (1.64e-1)"	"unprognostic (1.59e-1)"	"unprognostic (7.42e-5)"	"unprognostic (7.79e-3)"	"unprognostic (8.28e-2)"	"unprognostic (9.11e-3)"	"unprognostic (2.31e-2)"	0.4	0.0	0.4	0.1	0.2	0.0	11.2	0.1	0.3	18.8	0.1	0.1	0.1	0.1	1.2	0.1	0.8	0.1	6.6	0.2	0.3	0.4	0.1	0.1	0.6	0.2	0.6	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.7	0.0	0.1	25.8	0.1	0.1	1.2	0.1	0.1	1.5	1.1	0.1	0.1	0.1	0.1	0.1	4.4	9.9	0.1	0.3	0.4	0.1	2.1	0.4	0.2	0.2	0.9	0.0	0.0	0.5	0.0	0.9	3.1	0.0	1.9	5.9	2.6	4.2	0.0	0.0	0.2	0.0	1.6	1.2	0.5	6.6	0.0	2.2	0.0	1.3	0.0	0.0	0.0	0.2	0.0	0.3	0.6	0.0	0.6	0.2	2.4	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.3	0.2	15.8	0.0	0.0	0.0	0.0	0.0	2.2	0.1	7.6	2.3	0.0	0.0	0.1	0.0	0.0	0.8	0.8	0.2	0.2	0.2	0.4	0.0	0.1	0.1	0.0	0.0	0.4	0.1	0.1	2.1	0.2	0.0	0.1	0.0	0.9	0.4	0.2	0.1	0.3	0.3	0.4	0.6	0.1	0.1	0.1	0.0	0.0	0.0	2.2	0.9	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.7	1.9	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	6.5	1.0	0.0	0.0	1.8	0.0	0.0	0.0	1.8
GLYCTK	"HBEBP2, HBEBP4"	ENSG00000168237	"Glycerate kinase"	Q8IVS8	3	52287089-52293476	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		"Kinase, Transferase"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	5	"liver: 108.4"	"Cell type enhanced"	"Detected in many"	14	"Erythroid cells: 46.7;Hepatocytes: 151.6;Proximal tubular cells: 59.6"	"Cancer enriched"	"Detected in all"	6	"liver cancer: 52.7"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"CACO-2: 19.0;Hep G2: 25.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA006913	Approved		Approved	"Golgi apparatus,Cytosol,Rods & Rings"		NA	NA			Cytosol	"Golgi apparatus, Rods & Rings"	"HPA006913: AB_1078993"	"unprognostic (1.51e-2)"	"unprognostic (2.55e-1)"	"unprognostic (1.25e-1)"	"unprognostic (3.46e-2)"	"unprognostic (1.18e-1)"	"prognostic favorable (1.64e-4)"	"unprognostic (2.72e-2)"	"unprognostic (2.84e-2)"	"unprognostic (7.73e-3)"	"unprognostic (1.82e-1)"	"unprognostic (3.36e-3)"	"unprognostic (2.15e-1)"	"unprognostic (3.30e-2)"	"unprognostic (3.42e-1)"	"unprognostic (3.77e-1)"	"unprognostic (3.82e-2)"	"unprognostic (9.00e-3)"	6.4	4.9	1.9	8.4	5.0	5.2	4.8	2.7	6.2	2.3	7.9	7.1	4.2	23.8	4.3	4.8	2.8	2.5	7.2	2.7	1.9	2.2	10.7	108.4	3.1	6.5	2.5	4.9	2.3	3.6	1.9	2.5	3.1	3.9	2.8	3.5	4.7	3.2	3.0	7.0	1.9	17.8	1.9	1.8	5.5	6.0	2.7	1.8	3.3	3.1	2.4	5.9	2.7	2.2	8.3	9.1	10.9	9.5	5.7	11.8	6.3	2.3	5.6	3.0	1.1	16.1	2.2	1.8	2.5	2.6	4.8	3.5	19.0	1.9	5.9	1.6	2.2	3.6	1.5	1.7	6.2	0.9	1.6	2.0	8.3	6.7	25.2	1.6	2.7	5.0	2.2	3.1	7.0	2.7	1.6	9.0	4.8	2.3	4.3	3.6	1.7	4.6	2.2	1.6	12.2	4.6	1.6	2.7	8.9	4.8	3.2	2.2	2.2	2.4	1.3	2.5	0.9	3.2	1.3	3.9	3.7	4.4	2.4	4.8	4.6	3.1	3.9	2.6	4.5	2.8	3.0	9.5	10.9	11.8	5.1	6.1	8.3	9.0	10.3	9.1	5.7	6.8	10.1	7.8	5.7	6.1	5.6	11.7	6.3	1.9	5.0	2.7	6.2	1.9	2.2	2.5	4.9	3.9	1.8	6.0	2.7	9.3	2.6	0.3	1.4	1.2	15.3	1.4	2.3	8.7	0.0	6.7	16.6	4.3	0.1	4.4	29.7	46.7	5.4	4.3	2.1	2.5	1.1	151.6	11.4	0.0	22.4	12.9	16.5	0.0	1.1	7.2	3.3	6.4	9.1	1.0	3.5	34.5	0.0	59.6	1.5	0.0	0.2	0.2	7.7	1.1	9.3	10.2	11.5	3.1
GMDS	"GMD, SDR3E1"	ENSG00000112699	"GDP-mannose 4,6-dehydratase"	O60547	6	1623806-2245692	"Enzymes, Predicted intracellular proteins"		Lyase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	8	"Enterocytes: 143.7;Mucus-secreting cells: 229.6;Undifferentiated cells: 123.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"OE19: 70.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA031528	Enhanced					NA	NA		41000			"HPA031528: AB_10601016"	"unprognostic (5.94e-2)"	"unprognostic (3.92e-2)"	"unprognostic (1.12e-1)"	"prognostic favorable (5.89e-4)"	"unprognostic (4.37e-1)"	"unprognostic (1.53e-1)"	"unprognostic (1.10e-3)"	"unprognostic (7.15e-2)"	"unprognostic (2.29e-1)"	"unprognostic (8.02e-2)"	"unprognostic (2.38e-1)"	"unprognostic (4.41e-1)"	"prognostic favorable (5.93e-4)"	"unprognostic (2.45e-1)"	"unprognostic (2.84e-1)"	"unprognostic (6.68e-2)"	"unprognostic (1.12e-1)"	5.1	4.0	6.6	29.6	8.7	3.2	7.6	6.0	6.8	12.9	34.9	2.7	10.4	42.1	4.1	6.4	29.2	4.9	38.5	4.9	5.6	4.6	9.3	15.1	7.8	11.8	4.1	3.7	4.3	27.1	19.3	8.9	3.0	4.0	8.6	34.2	6.3	40.4	7.6	3.3	4.9	43.7	4.4	3.1	6.0	38.4	9.0	3.4	9.3	5.6	9.0	19.6	6.1	6.7	10.5	13.9	6.8	12.3	12.0	12.4	7.3	13.0	3.0	2.2	15.5	3.6	9.8	5.3	3.6	7.6	6.8	6.4	6.7	7.6	6.2	11.2	3.9	6.7	5.1	6.7	12.8	7.9	8.5	8.1	6.0	3.4	31.4	4.0	9.6	6.7	10.8	4.4	5.3	11.2	6.6	7.9	21.4	3.9	2.9	4.3	7.4	13.2	11.4	3.3	70.9	10.4	6.9	5.0	32.0	16.4	17.2	12.4	2.9	3.3	5.2	8.0	10.5	4.8	6.1	3.4	5.2	3.9	5.2	6.4	6.6	9.3	6.6	3.4	6.7	6.9	6.8	12.3	1.4	7.9	7.6	10.6	10.5	9.5	7.8	13.9	5.5	8.3	11.1	3.8	12.0	6.1	5.8	12.4	7.3	6.6	8.7	6.0	6.8	5.6	4.6	4.1	3.7	4.0	3.4	0.0	5.0	14.9	13.0	3.8	4.4	2.4	15.3	13.4	5.7	36.6	0.0	15.2	101.2	29.5	3.9	19.6	143.7	0.0	61.4	22.6	9.3	41.6	4.6	9.9	12.1	7.9	107.1	16.0	7.3	3.6	11.2	7.1	21.9	16.2	229.6	3.1	49.3	77.7	15.6	27.3	0.6	12.9	10.7	4.2	35.3	5.4	14.0	18.1	123.8	40.1
GMPPB	KIAA1851	ENSG00000173540	"GDP-mannose pyrophosphorylase B"	Q9Y5P6	3	49716844-49723951	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		"Nucleotidyltransferase, Transferase"	"Congenital muscular dystrophy, Disease mutation, Dystroglycanopathy, Limb-girdle muscular dystrophy"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA014657	Uncertain					NA	NA		10000			"HPA014657: AB_1849852"	"unprognostic (3.48e-2)"	"unprognostic (9.84e-2)"	"unprognostic (2.77e-2)"	"prognostic favorable (6.19e-6)"	"unprognostic (1.01e-2)"	"unprognostic (5.11e-3)"	"unprognostic (1.54e-2)"	"unprognostic (4.01e-3)"	"unprognostic (1.04e-1)"	"unprognostic (1.99e-2)"	"unprognostic (5.01e-3)"	"unprognostic (5.73e-2)"	"prognostic favorable (3.17e-4)"	"unprognostic (1.60e-1)"	"unprognostic (1.79e-1)"	"unprognostic (1.67e-1)"	"unprognostic (1.22e-1)"	7.5	17.1	7.6	17.5	8.1	7.4	9.7	4.3	9.6	14.4	13.2	7.2	28.7	12.1	11.5	23.2	15.3	12.6	13.3	10.9	5.2	4.7	13.1	41.3	12.9	15.9	8.3	6.8	10.1	32.0	8.9	23.0	15.3	6.9	16.6	11.3	7.9	50.8	37.2	7.2	8.2	12.2	7.9	4.3	16.8	18.1	6.9	5.8	16.5	16.8	8.6	17.5	8.8	9.3	13.4	34.5	10.1	11.1	5.5	11.2	8.1	17.8	17.5	12.7	7.7	10.2	7.7	13.0	20.7	12.3	21.0	19.9	11.3	13.3	10.5	9.2	12.9	13.0	10.3	10.6	22.3	7.1	9.4	8.7	7.5	19.4	13.3	23.5	11.3	12.1	5.4	9.6	29.7	23.7	6.8	18.9	12.1	5.6	17.3	12.1	13.5	15.4	5.8	7.0	13.3	21.1	5.3	6.4	18.0	11.6	16.8	8.4	8.9	9.4	23.0	6.8	6.5	13.1	7.5	13.1	15.2	14.7	20.5	22.1	20.0	5.4	7.4	16.0	8.0	17.4	10.1	8.6	3.7	10.8	11.0	11.0	13.4	9.5	11.2	8.2	10.3	7.3	8.8	2.2	5.5	11.1	34.5	6.3	8.1	7.6	8.1	4.3	9.6	5.2	4.7	8.3	6.8	6.9	5.8	8.9	15.0	22.9	17.2	0.7	3.1	3.8	12.7	24.1	5.7	17.4	2.0	26.1	24.9	33.3	4.8	8.3	35.4	0.0	44.5	49.4	8.2	47.6	0.0	24.1	35.8	6.4	16.0	11.6	8.9	7.2	14.4	10.5	1.7	62.3	28.8	5.2	32.1	25.9	7.1	19.3	5.4	0.0	3.8	17.4	10.6	1.5	66.5	17.8	26.8	29.7
GMPR		ENSG00000137198	"Guanosine monophosphate reductase"	P36959	6	16238580-16295549	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Purine metabolism"	Oxidoreductase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 103.3"	"Cell type enhanced"	"Detected in many"	10	"Distal tubular cells: 72.9;Erythroid cells: 186.9;Glandular cells: 74.5;Melanocytes: 87.7;Peritubular cells: 76.0"	"Cancer enhanced"	"Detected in all"		"melanoma: 95.4"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"basophil: 7.8;NK-cell: 8.3"	"Group enriched"	"Detected in many"	5	"granulocytes: 7.8;monocytes: 4.2;NK-cells: 8.3"	"Cell line enhanced"	"Detected in many"		"HEL: 46.2;HMC-1: 78.9;SK-MEL-30: 17.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000904, HPA021476"	Uncertain					NA	NA		3800000			"HPA000904: AB_1078998, HPA021476: AB_1849858"	"unprognostic (2.74e-1)"	"unprognostic (1.05e-1)"	"unprognostic (2.14e-1)"	"unprognostic (4.97e-3)"	"unprognostic (3.52e-2)"	"unprognostic (1.05e-1)"	"unprognostic (3.06e-1)"	"prognostic favorable (8.07e-4)"	"unprognostic (4.12e-1)"	"prognostic favorable (2.06e-4)"	"unprognostic (3.15e-1)"	"unprognostic (2.86e-1)"	"prognostic favorable (2.94e-5)"	"unprognostic (3.01e-1)"	"unprognostic (1.81e-1)"	"unprognostic (7.31e-2)"	"unprognostic (2.17e-1)"	2.8	7.3	14.6	1.4	11.0	9.6	6.5	3.8	6.9	2.7	3.7	9.1	2.0	1.5	4.2	7.9	2.5	22.4	1.9	31.5	13.3	11.5	10.3	2.7	3.7	2.5	14.0	5.7	15.7	7.4	4.4	6.8	3.4	21.3	25.5	1.8	22.0	5.2	4.2	103.3	4.3	1.5	4.3	11.8	3.3	8.3	25.1	10.9	1.4	2.7	16.2	1.5	2.0	1.2	0.7	1.3	7.8	4.2	8.3	1.0	14.1	0.0	0.0	0.0	0.0	0.7	0.5	0.0	0.9	3.8	6.8	13.9	0.3	0.1	0.0	2.2	1.4	4.8	0.0	1.6	0.2	1.1	0.0	1.2	46.2	0.0	0.0	3.0	0.2	78.9	0.9	0.7	2.1	0.0	5.6	12.2	0.1	10.3	0.0	1.2	0.9	0.0	0.9	0.4	0.0	1.8	0.0	10.4	0.0	9.0	1.3	2.3	0.3	0.4	0.8	17.6	3.1	0.7	0.3	3.0	0.1	0.0	0.3	1.8	0.5	0.0	0.0	0.2	4.9	5.3	7.8	2.9	0.4	0.6	4.2	1.0	0.2	0.1	0.4	1.3	0.7	0.0	0.2	3.0	8.3	1.3	1.2	0.0	14.1	14.6	11.0	3.8	6.9	13.3	11.5	14.0	5.7	21.3	10.9	0.0	0.0	0.5	29.7	4.5	0.9	50.8	22.9	8.1	2.3	19.2	0.0	23.1	72.9	10.6	10.2	5.8	0.8	186.9	4.4	2.8	6.1	74.5	56.3	2.9	8.0	0.0	7.5	11.1	2.2	8.5	31.9	4.3	87.7	10.8	2.3	7.3	3.2	0.3	76.0	10.4	0.4	0.0	8.5	4.7	17.0	1.6	5.7	1.3	2.5	5.8
GMPR2		ENSG00000100938	"Guanosine monophosphate reductase 2"	Q9P2T1	14	24232422-24239242	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Purine metabolism"	Oxidoreductase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000904, HPA067884, HPA068782"	Uncertain		Approved	Nucleoplasm,Nucleoli		No	No		160000	Nucleoplasm	Nucleoli	"HPA000904: AB_1078998, HPA067884: AB_2685916, HPA068782: AB_2686032"	"unprognostic (1.95e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.34e-1)"	"unprognostic (1.03e-1)"	"unprognostic (9.86e-2)"	"unprognostic (5.98e-2)"	"unprognostic (3.24e-1)"	"unprognostic (5.21e-3)"	"unprognostic (9.24e-2)"	"unprognostic (3.08e-1)"	"unprognostic (7.88e-2)"	"unprognostic (1.16e-1)"	"prognostic favorable (2.21e-5)"	"unprognostic (2.30e-1)"	"unprognostic (1.96e-1)"	"unprognostic (2.29e-1)"	"unprognostic (1.12e-2)"	18.9	44.2	19.6	14.6	24.2	11.5	26.2	13.6	31.7	22.5	21.1	25.1	20.3	21.3	18.8	26.3	17.8	28.7	23.4	15.0	20.1	21.9	39.1	26.3	19.0	18.1	23.0	21.2	26.1	26.9	49.1	22.4	22.7	26.0	20.3	21.6	21.9	22.6	23.7	16.1	14.4	21.7	18.2	20.3	25.5	21.2	10.6	19.1	21.6	43.0	11.2	21.0	21.8	17.6	7.5	14.4	32.3	14.0	7.6	14.9	11.0	9.2	10.6	14.3	9.3	16.6	23.5	13.1	10.9	19.4	15.3	19.6	12.4	7.3	12.3	9.9	15.9	9.8	12.8	15.8	23.6	21.9	11.6	11.6	9.7	6.6	45.2	15.6	15.8	15.2	22.0	16.9	8.1	16.8	21.4	24.8	17.7	5.6	11.6	15.4	17.2	15.7	14.2	11.1	13.6	13.8	11.9	9.7	10.1	21.1	15.2	10.1	14.4	7.8	17.2	14.6	15.2	14.9	12.7	12.7	7.3	5.8	9.5	7.9	25.9	24.8	8.1	6.0	12.1	7.0	9.0	14.0	7.2	10.1	11.2	10.7	7.5	10.2	11.2	14.4	7.1	9.1	10.2	32.3	7.6	11.3	6.5	14.9	11.0	19.6	24.2	13.6	31.7	20.1	21.9	23.0	21.2	26.0	19.1	23.8	16.0	23.8	32.5	9.7	16.4	10.5	40.8	33.5	25.0	50.6	3.9	53.9	86.2	34.2	9.9	19.0	34.2	0.0	29.0	39.0	17.4	19.6	31.1	22.4	45.3	17.5	9.9	11.6	32.6	7.7	26.7	30.1	20.3	23.4	20.4	34.1	30.5	30.6	23.7	96.9	13.6	25.8	25.8	15.2	9.6	9.4	41.2	23.0	27.6	21.0
GMPS	GATD7	ENSG00000163655	"Guanine monophosphate synthase"	P49915	3	155870536-155944026	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"GMP biosynthesis, Purine biosynthesis"	Ligase	Proto-oncogene	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	7	"Early spermatids: 191.9;Late spermatids: 149.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA046630			Approved	Cytosol		No	No			Cytosol		"HPA046630: AB_2679727"	"unprognostic (3.89e-2)"	"unprognostic (2.02e-2)"	"unprognostic (1.59e-2)"	"prognostic unfavorable (5.54e-5)"	"unprognostic (2.30e-1)"	"unprognostic (1.35e-2)"	"prognostic unfavorable (8.73e-7)"	"unprognostic (1.71e-2)"	"unprognostic (3.52e-2)"	"unprognostic (1.77e-2)"	"prognostic unfavorable (1.04e-4)"	"unprognostic (2.58e-2)"	"unprognostic (2.79e-2)"	"unprognostic (2.89e-2)"	"unprognostic (3.78e-1)"	"unprognostic (3.55e-3)"	"unprognostic (8.79e-2)"	15.9	18.3	10.4	19.7	14.0	24.6	22.4	22.1	24.9	16.1	13.9	9.8	15.3	10.3	17.5	15.4	19.5	14.0	10.8	15.3	9.2	7.7	11.0	14.7	15.8	19.5	9.3	12.1	15.7	23.5	19.1	14.1	13.5	14.8	13.0	15.3	9.0	21.6	18.6	16.6	21.0	12.6	16.1	8.9	14.6	15.4	60.9	10.5	28.3	13.6	12.5	18.4	15.9	18.5	11.1	17.2	10.9	18.1	19.0	20.7	10.8	56.8	22.5	30.6	25.0	12.5	19.8	29.5	24.3	22.5	32.1	32.5	41.0	38.4	41.1	29.0	18.7	24.6	28.0	26.0	25.5	44.2	23.8	20.0	43.8	16.5	22.2	14.3	44.5	17.1	14.6	15.7	24.8	38.0	17.1	19.6	22.4	30.8	15.8	23.8	38.2	36.1	23.6	29.3	31.3	16.7	35.5	36.3	49.6	16.5	25.1	18.3	17.0	27.0	38.7	24.2	22.0	40.5	29.4	13.8	21.3	17.3	30.0	48.9	22.1	13.6	70.3	21.4	33.2	18.9	10.9	10.4	7.2	17.3	13.1	20.7	11.1	16.8	15.7	17.2	8.8	16.8	15.8	1.4	19.0	18.1	9.5	17.6	10.8	10.4	14.0	22.1	24.9	9.2	7.7	9.3	12.1	14.8	10.5	17.9	19.8	20.4	39.9	35.4	21.9	14.1	15.3	13.4	22.7	7.0	2.0	33.4	21.6	24.9	191.9	28.5	8.4	23.3	25.9	43.0	27.2	23.6	28.8	11.1	26.5	20.6	6.9	14.7	18.3	149.6	21.3	24.7	21.9	29.7	17.8	17.3	20.4	10.5	23.3	22.3	7.7	19.4	31.6	80.1	54.5	33.4	25.7	24.9	24.7	34.5
GNE	"IBM2, Uae1"	ENSG00000159921	"Glucosamine (UDP-N-acetyl)-2-epimerase/N-acetylmannosamine kinase"	Q9Y223	9	36214441-36277056	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"		"Allosteric enzyme, Hydrolase, Kinase, Multifunctional enzyme, Transferase"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 55.0;salivary gland: 45.3"	"Cell type enhanced"	"Detected in many"	9	"Hepatocytes: 95.4;Mucus-secreting cells: 67.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"RPTEC TERT1: 47.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007045, HPA027258"	Approved		Supported	Cytosol		NA	NA			Cytosol		"HPA007045: AB_1079003, HPA027258: AB_1849873"	"unprognostic (7.54e-2)"	"unprognostic (1.61e-2)"	"unprognostic (1.07e-3)"	"unprognostic (7.28e-2)"	"unprognostic (7.00e-2)"	"unprognostic (1.85e-2)"	"unprognostic (2.78e-3)"	"unprognostic (5.39e-2)"	"unprognostic (1.73e-1)"	"unprognostic (1.70e-2)"	"unprognostic (2.88e-3)"	"unprognostic (4.20e-2)"	"prognostic favorable (9.28e-11)"	"unprognostic (2.90e-1)"	"unprognostic (8.28e-2)"	"unprognostic (2.95e-1)"	"unprognostic (1.72e-2)"	7.7	6.7	6.0	6.5	8.3	8.3	16.6	11.1	12.1	7.9	20.7	7.0	4.6	2.9	8.0	3.9	7.6	6.7	5.2	7.6	7.8	6.8	6.8	55.0	5.5	6.0	6.0	7.8	9.8	8.4	4.1	7.0	20.2	10.2	10.1	30.1	4.8	45.3	5.0	10.5	3.7	7.2	11.7	10.9	4.5	4.9	3.4	5.3	3.2	4.6	4.2	7.9	8.6	7.9	3.9	2.2	1.2	2.7	2.4	4.2	1.8	4.4	19.9	8.9	7.6	10.1	10.1	12.9	6.2	7.9	8.6	11.1	4.8	14.2	5.8	6.6	10.3	22.4	1.7	6.7	2.0	9.6	10.9	0.6	5.0	11.7	6.6	6.9	0.1	14.3	6.6	2.0	14.3	13.5	6.3	3.6	9.0	6.3	12.1	8.3	0.7	8.1	2.6	5.1	2.8	11.2	6.7	7.5	1.6	47.6	8.2	7.6	6.9	6.6	2.3	5.7	3.3	2.1	5.1	5.2	5.7	5.9	6.8	5.4	5.3	11.3	3.2	7.8	4.3	8.1	0.7	1.7	0.9	2.7	2.2	1.8	2.4	3.4	2.9	1.4	3.9	4.0	4.2	1.2	2.4	2.7	2.2	1.5	1.8	6.0	8.3	11.1	12.1	7.8	6.8	6.0	7.8	10.2	5.3	8.9	10.6	4.5	2.8	1.6	7.9	5.9	10.2	18.7	14.8	8.7	5.9	7.5	1.7	9.3	2.8	4.5	18.3	0.0	5.2	7.3	5.1	7.6	9.3	95.4	2.7	11.1	11.1	8.0	5.0	2.3	10.0	4.3	1.7	6.4	67.2	2.0	4.2	23.0	6.0	1.7	6.2	12.9	4.1	1.1	2.7	1.4	16.6	5.0	21.2	5.6
GNMT		ENSG00000124713	"Glycine N-methyltransferase"	Q14749	6	42960758-42963880	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		"Methyltransferase, Transferase"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	11	"liver: 83.9;pancreas: 100.1"	"Cell type enriched"	"Detected in many"	34	"Hepatocytes: 729.0"	"Group enriched"	"Detected in many"	20	"liver cancer: 69.6;prostate cancer: 49.8"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"plasmacytoid DC: 3.2"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"Hep G2: 10.5;SCLC-21H: 12.4;T-47d: 7.9"	"Region enriched"	"Detected in some"	4	"cerebellum: 17.7"	"Not detected"	"Not detected"			HPA027501	Enhanced		Approved	Cytosol		NA	NA		150000	Cytosol		"HPA027501: AB_1849879"	"unprognostic (1.53e-2)"	"unprognostic (8.02e-4)"	"unprognostic (3.11e-2)"	"unprognostic (4.24e-3)"	"unprognostic (3.91e-2)"	"unprognostic (6.40e-4)"	"prognostic favorable (1.86e-4)"	"unprognostic (4.08e-6)"	"unprognostic (1.01e-1)"	"unprognostic (2.67e-2)"	"unprognostic (1.63e-3)"	"unprognostic (2.52e-1)"	"unprognostic (3.50e-3)"	"unprognostic (1.03e-1)"	"unprognostic (1.99e-1)"	"unprognostic (2.49e-2)"	"unprognostic (4.92e-2)"	0.3	0.1	0.2	0.2	0.2	0.7	1.8	0.5	0.5	0.3	0.5	0.2	1.3	0.0	0.2	0.9	0.3	0.1	0.2	1.3	0.2	0.2	0.3	83.9	1.3	0.1	0.1	0.2	0.4	100.1	0.0	2.5	0.1	0.4	5.2	0.0	0.9	8.2	0.9	0.6	0.1	0.2	0.4	0.1	0.3	6.5	0.6	0.1	0.2	0.9	0.3	0.4	0.2	0.1	0.7	3.2	2.0	0.9	0.0	1.2	0.3	0.5	0.4	1.8	5.1	0.6	0.2	0.3	0.4	2.0	0.8	1.2	0.1	0.1	1.7	0.2	0.4	0.9	0.6	0.3	0.3	0.2	2.0	1.6	1.3	1.0	10.5	0.0	1.1	2.4	0.4	0.0	0.4	0.2	1.2	0.0	3.8	1.5	1.9	0.3	2.3	2.0	3.7	0.2	0.5	0.5	1.7	1.6	1.0	0.9	0.2	12.4	1.7	0.1	1.7	0.6	0.5	7.9	3.6	0.4	0.9	0.9	0.5	1.0	1.3	1.2	1.5	0.2	2.1	1.0	0.0	0.8	0.1	0.2	0.9	0.1	0.7	0.3	0.3	0.9	0.1	0.6	1.2	2.0	0.0	0.1	3.2	0.3	0.3	0.2	0.2	0.5	0.5	0.2	0.2	0.1	0.2	0.4	0.1	0.0	2.1	3.4	4.2	0.2	1.2	4.5	15.3	5.3	0.0	1.8	0.0	0.1	3.3	0.4	0.2	0.1	0.0	0.0	0.7	0.1	0.2	16.1	0.0	729.0	0.5	1.6	0.0	16.5	21.5	0.0	0.9	0.3	0.0	0.0	0.0	0.3	0.9	0.0	2.5	2.2	0.3	0.0	0.7	0.5	0.6	0.1	0.1	0.0	0.0	1.6
GNPAT	"DAP-AT, DAPAT, DHAPAT"	ENSG00000116906	"Glyceronephosphate O-acyltransferase"	O15228	1	231241207-231277973	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		"Acyltransferase, Transferase"	"Cataract, Disease mutation, Dwarfism, Rhizomelic chondrodysplasia punctata"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA						"unprognostic (8.87e-2)"	"unprognostic (3.28e-2)"	"unprognostic (3.36e-2)"	"unprognostic (2.56e-2)"	"unprognostic (5.25e-3)"	"unprognostic (1.91e-1)"	"unprognostic (5.07e-2)"	"unprognostic (6.72e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.48e-2)"	"unprognostic (2.68e-1)"	"prognostic unfavorable (8.29e-6)"	"unprognostic (5.69e-2)"	"unprognostic (1.66e-1)"	"unprognostic (4.48e-2)"	"unprognostic (2.68e-1)"	14.7	20.1	18.3	17.9	17.0	9.6	34.6	18.9	17.8	12.6	18.6	14.7	16.6	18.9	13.9	16.0	14.5	18.4	13.5	39.3	16.9	13.9	16.7	19.5	20.3	24.4	17.1	15.0	15.3	26.7	14.3	15.0	12.3	16.5	15.3	16.3	10.8	20.6	18.0	61.1	14.9	19.1	24.7	17.7	13.5	18.0	26.5	15.0	16.2	13.6	20.2	15.9	14.4	13.6	23.7	23.8	23.4	30.3	16.4	23.9	18.5	14.8	16.6	23.6	17.8	19.4	28.8	15.9	12.6	14.3	13.4	15.4	21.2	18.6	21.4	15.9	18.8	14.1	16.1	15.6	17.1	19.8	24.2	14.3	15.4	16.3	30.5	19.8	26.2	12.3	20.0	21.0	13.8	15.6	17.5	31.3	21.5	22.5	20.6	27.7	4.8	23.3	15.2	37.8	42.2	19.1	25.7	31.6	25.0	16.7	11.1	15.7	22.4	21.1	11.9	18.3	9.8	20.8	41.7	16.3	13.6	12.8	19.6	31.2	26.7	33.9	24.7	19.6	22.2	25.2	17.7	24.1	23.4	16.5	24.0	19.0	23.2	21.6	21.6	23.8	23.7	19.1	17.4	9.5	16.4	30.3	11.3	23.9	18.5	18.3	17.0	18.9	17.8	16.9	13.9	17.1	15.0	16.5	15.0	23.8	14.4	37.4	17.0	11.9	22.4	48.8	28.1	29.4	17.0	26.2	37.3	21.3	14.9	34.5	55.1	21.5	15.8	0.0	37.7	16.2	18.4	21.6	11.5	23.2	24.4	11.1	27.1	16.0	21.2	86.2	23.6	22.5	11.8	25.2	19.8	22.6	34.7	35.1	25.1	22.8	23.3	19.4	22.5	39.6	31.0	12.2	10.4	23.2	31.5	16.0
GNPDA1	"GNPDA, GNPI, GPI, HLN, KIAA0060"	ENSG00000113552	"Glucosamine-6-phosphate deaminase 1"	P46926	5	141991749-142013041	"Enzymes, Predicted intracellular proteins"	"Carbohydrate metabolism"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Hofbauer cells: 107.2;Proximal tubular cells: 73.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"GAMG: 90.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000499, HPA046891"	Uncertain		Approved	"Golgi apparatus,Vesicles"		NA	NA		970000	Vesicles	"Golgi apparatus"	"HPA000499: AB_1079005, HPA046891: AB_2679857"	"unprognostic (1.85e-1)"	"unprognostic (1.17e-1)"	"unprognostic (6.79e-2)"	"unprognostic (1.04e-1)"	"unprognostic (9.51e-2)"	"unprognostic (8.89e-3)"	"prognostic unfavorable (2.60e-6)"	"unprognostic (1.66e-1)"	"unprognostic (2.26e-1)"	"unprognostic (3.45e-1)"	"unprognostic (3.09e-1)"	"unprognostic (1.58e-1)"	"unprognostic (2.61e-1)"	"unprognostic (1.16e-1)"	"unprognostic (5.82e-2)"	"unprognostic (9.66e-2)"	"unprognostic (2.05e-3)"	15.6	28.2	13.9	10.0	19.1	4.3	18.7	12.6	22.5	16.5	13.7	13.2	11.7	18.0	24.8	34.0	10.7	11.9	13.7	10.6	12.3	16.1	46.2	10.2	11.0	21.8	14.1	16.5	20.7	7.7	15.1	19.9	18.9	13.4	17.8	14.0	17.1	10.6	18.9	16.5	9.0	18.8	18.4	10.9	18.2	9.5	16.3	10.8	12.4	18.2	9.2	11.8	23.6	11.2	7.9	20.6	5.0	22.7	5.6	32.7	14.7	9.5	14.0	5.5	27.0	18.8	12.7	12.8	7.6	18.3	20.2	23.0	20.9	11.4	0.0	17.4	5.4	90.8	10.1	25.4	22.6	17.9	7.3	10.9	7.0	8.2	14.9	33.4	19.4	9.3	15.2	13.4	12.8	34.4	15.1	21.1	18.7	8.3	25.9	21.6	6.0	14.7	2.2	20.5	14.4	28.3	5.7	17.8	21.3	19.4	26.5	4.8	12.7	15.1	15.7	28.8	16.8	12.8	6.1	10.0	11.8	8.0	18.1	10.7	14.5	27.8	10.7	17.3	6.6	10.3	0.0	19.4	2.6	15.7	22.7	32.7	7.9	12.8	14.4	20.6	3.7	15.5	16.5	5.0	5.6	20.4	11.6	10.6	14.7	13.9	19.1	12.6	22.5	12.3	16.1	14.1	16.5	13.4	10.8	8.9	9.3	7.5	31.0	5.4	9.7	10.9	15.3	8.1	20.5	17.4	7.9	22.9	29.9	25.3	0.9	13.0	9.9	0.0	12.2	39.3	11.5	18.6	11.5	5.9	107.2	6.4	14.5	17.2	52.5	2.5	18.4	36.7	13.5	23.4	6.6	35.2	18.7	6.0	25.1	73.4	6.3	0.0	8.1	5.1	16.8	6.5	24.8	17.0	8.3	32.4
GNPDA2	SB52	ENSG00000163281	"Glucosamine-6-phosphate deaminase 2"	Q8TDQ7	4	44682200-44726595	"Enzymes, Predicted intracellular proteins"	"Carbohydrate metabolism"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000499, HPA046891"	Uncertain		Approved	"Golgi apparatus,Vesicles"		NA	NA		710000	Vesicles	"Golgi apparatus"	"HPA000499: AB_1079005, HPA046891: AB_2679857"	"unprognostic (1.91e-1)"	"unprognostic (2.76e-1)"	"unprognostic (1.04e-1)"	"unprognostic (1.16e-1)"	"unprognostic (1.90e-2)"	"unprognostic (3.29e-1)"	"unprognostic (1.55e-3)"	"unprognostic (1.02e-1)"	"unprognostic (1.33e-1)"	"unprognostic (9.57e-2)"	"unprognostic (9.75e-3)"	"unprognostic (1.03e-1)"	"unprognostic (1.28e-3)"	"unprognostic (4.18e-2)"	"unprognostic (6.86e-2)"	"unprognostic (1.63e-2)"	"unprognostic (3.13e-2)"	12.3	13.7	14.8	11.2	21.5	7.3	14.9	47.5	24.5	15.2	12.3	7.3	8.7	8.0	17.5	15.3	11.2	13.3	10.8	17.8	14.5	13.9	14.3	4.3	10.0	11.7	13.7	17.6	24.2	8.1	13.0	29.9	6.6	16.5	15.7	8.5	11.5	9.8	16.2	10.9	10.2	8.7	16.6	12.7	11.4	9.9	11.1	11.3	10.0	18.9	8.4	10.2	13.5	11.0	11.6	3.3	5.8	4.1	8.4	11.4	4.4	9.0	6.3	6.8	5.7	10.7	14.9	2.2	16.1	17.5	10.4	9.7	3.2	11.2	7.9	9.4	13.8	17.9	3.1	6.3	15.0	11.7	10.5	7.1	11.2	10.3	5.6	11.9	11.7	10.5	17.4	10.6	10.6	8.0	13.4	15.4	10.3	6.7	10.4	19.5	0.4	14.0	6.6	3.2	5.9	11.8	9.3	14.5	4.4	10.3	5.4	11.7	9.5	7.0	4.1	15.2	3.5	8.8	7.0	15.8	14.2	13.3	22.9	18.3	13.6	21.4	11.3	23.3	8.4	12.6	5.8	2.3	4.5	9.7	3.3	11.3	11.6	9.1	9.0	3.3	10.4	11.4	10.9	1.1	8.4	4.1	2.6	9.6	4.4	14.8	21.5	47.5	24.5	14.5	13.9	13.7	17.6	16.5	11.3	8.9	2.9	11.8	7.4	11.1	14.3	11.7	0.0	4.0	6.8	14.0	7.9	0.9	13.3	10.5	24.9	11.4	1.7	23.3	13.1	1.0	15.9	4.1	15.1	1.6	4.3	12.7	6.4	11.1	1.9	2.4	15.0	3.5	8.5	3.6	4.2	18.1	10.0	3.5	22.3	11.6	16.3	12.9	14.4	16.2	27.2	9.4	0.5	16.0	4.2	4.1
GNPNAT1	"FLJ10607, Gpnat1"	ENSG00000100522	"Glucosamine-phosphate N-acetyltransferase 1"	Q96EK6	14	52775194-52791668	"Enzymes, Predicted intracellular proteins"		"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 47.3"	"Cell type enhanced"	"Detected in many"	5	"Hepatocytes: 81.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA044647	Approved					NA	NA		17000			"HPA044647: AB_10795986"	"unprognostic (4.55e-3)"	"unprognostic (1.19e-2)"	"unprognostic (4.47e-3)"	"unprognostic (5.18e-3)"	"unprognostic (4.23e-1)"	"unprognostic (1.52e-2)"	"unprognostic (1.21e-1)"	"unprognostic (3.19e-3)"	"unprognostic (1.03e-1)"	"unprognostic (6.81e-2)"	"prognostic unfavorable (8.52e-5)"	"unprognostic (5.82e-2)"	"unprognostic (3.22e-3)"	"unprognostic (2.16e-2)"	"unprognostic (1.68e-1)"	"unprognostic (1.31e-1)"	"unprognostic (4.05e-2)"	13.4	6.9	6.4	6.7	6.6	2.1	10.6	9.2	9.2	10.0	11.2	4.6	6.8	9.3	8.1	6.4	8.4	6.3	9.3	6.3	5.8	6.3	11.5	47.3	6.4	8.6	5.4	5.2	9.3	28.4	6.9	12.4	6.5	7.1	10.1	14.0	4.1	22.2	4.7	9.4	4.8	8.5	8.2	6.3	7.3	12.0	12.5	4.2	3.6	5.4	6.0	7.1	7.3	7.2	6.1	5.1	6.6	5.7	7.7	8.4	4.2	33.0	13.2	10.5	11.9	11.4	25.8	17.3	21.6	13.9	18.9	19.5	15.0	19.6	18.8	12.1	21.3	9.0	13.4	20.1	21.7	32.7	10.7	10.8	12.6	12.7	18.6	16.5	14.0	6.8	10.8	18.6	31.9	34.2	9.7	21.0	12.0	12.1	4.6	24.1	28.7	16.7	7.3	11.0	43.3	23.3	11.6	4.9	11.3	17.8	17.7	10.8	14.8	17.8	24.2	15.4	7.5	27.6	4.8	23.4	19.2	20.1	33.8	16.6	4.8	9.3	8.3	9.0	9.2	11.1	6.6	2.2	0.1	7.1	2.7	8.4	6.1	7.3	6.2	5.1	5.4	8.4	6.8	0.7	7.7	5.7	3.2	8.4	4.2	6.4	6.6	9.2	9.2	5.8	6.3	5.4	5.2	7.1	4.2	14.9	8.9	6.0	18.9	17.1	10.1	3.4	25.5	16.0	13.6	12.2	3.9	21.4	28.2	29.2	16.2	12.4	8.5	0.0	32.6	61.8	19.0	28.0	6.9	81.6	14.0	3.2	5.2	9.2	7.1	5.4	18.1	8.3	6.8	4.6	38.1	5.0	34.9	14.0	17.0	12.2	6.5	19.4	14.6	24.2	4.1	18.6	10.2	7.7	25.6	33.5
GNPTAB	"GNPTA, KIAA1208, MGC4170"	ENSG00000111670	"N-acetylglucosamine-1-phosphate transferase alpha and beta subunits"	Q3T906	12	101745497-101830938	"Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"		Transferase	"Cancer-related genes, Disease mutation, Mucolipidosis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"granulocytes: 118.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA014558, HPA042343"	Approved		Supported	"Golgi apparatus"		NA	NA		47000	"Golgi apparatus"		"HPA014558: AB_2732409, HPA042343: "	"unprognostic (6.72e-2)"	"unprognostic (1.66e-1)"	"unprognostic (8.71e-3)"	"prognostic favorable (8.48e-4)"	"unprognostic (1.39e-1)"	"unprognostic (8.37e-2)"	"unprognostic (2.73e-1)"	"unprognostic (8.57e-2)"	"unprognostic (3.73e-2)"	"unprognostic (1.09e-2)"	"unprognostic (2.28e-2)"	"unprognostic (2.00e-1)"	"unprognostic (6.86e-2)"	"unprognostic (3.44e-1)"	"unprognostic (1.02e-1)"	"unprognostic (5.44e-2)"	"unprognostic (4.98e-2)"	15.2	6.5	21.9	11.9	23.0	15.2	12.2	13.9	25.6	14.0	21.3	10.3	5.9	10.3	9.0	6.5	11.7	7.1	11.0	15.9	17.9	13.7	11.0	7.3	19.6	20.3	14.4	13.0	6.6	11.4	29.9	9.0	10.8	10.9	15.6	22.5	11.3	37.6	10.2	10.8	18.1	14.5	11.7	13.1	15.4	15.2	7.4	10.8	24.5	10.5	8.6	12.6	14.7	14.8	3.9	5.8	5.9	3.4	14.2	16.4	2.7	8.2	8.0	3.0	5.1	25.3	12.0	9.3	11.8	24.3	11.7	15.4	6.1	5.8	17.3	8.5	16.1	9.6	10.8	13.8	15.1	18.3	8.1	7.3	7.4	7.4	8.7	4.7	6.7	15.0	9.3	8.4	11.1	6.6	29.2	20.4	13.9	11.5	5.2	10.9	12.5	20.2	9.5	10.3	10.2	5.8	4.8	15.4	23.2	18.8	21.5	6.5	5.3	19.5	14.0	27.7	11.7	14.3	4.4	20.1	11.1	6.0	9.2	6.5	14.2	14.5	9.9	12.6	10.0	6.8	5.9	3.1	3.4	16.4	2.9	5.4	2.4	3.6	8.9	5.8	3.9	4.6	7.1	1.2	14.2	3.4	5.8	2.6	2.7	21.9	23.0	13.9	25.6	17.9	13.7	14.4	13.0	10.9	10.8	56.6	54.2	24.1	31.6	14.9	24.2	36.8	20.4	9.4	29.6	21.0	23.6	20.7	6.6	9.5	0.4	12.7	22.0	0.0	13.2	12.5	11.8	33.9	118.0	8.3	40.7	7.9	17.3	8.0	31.8	2.2	15.8	35.6	40.5	40.5	27.1	29.3	13.7	74.8	12.0	13.3	35.5	0.0	10.3	8.9	30.9	12.5	7.3	61.8	37.4	40.8
GNS		ENSG00000135677	"Glucosamine (N-acetyl)-6-sulfatase"	P15586	12	64713445-64759447	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		Hydrolase	"Disease mutation, Mucopolysaccharidosis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Kupffer cells: 167.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"non-classical monocyte: 50.0"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA013695, CAB026011, HPA048508"	Enhanced				"Intracellular and membrane"	NA	NA		940000			"CAB026011: , HPA013695: AB_1849741, HPA048508: AB_2680423"	"unprognostic (8.07e-2)"	"unprognostic (2.39e-1)"	"unprognostic (2.76e-1)"	"unprognostic (1.05e-2)"	"prognostic unfavorable (7.76e-4)"	"unprognostic (9.33e-2)"	"prognostic unfavorable (1.94e-5)"	"unprognostic (1.26e-1)"	"unprognostic (4.03e-1)"	"unprognostic (2.62e-3)"	"unprognostic (3.04e-2)"	"unprognostic (3.30e-2)"	"unprognostic (3.28e-3)"	"unprognostic (1.42e-1)"	"unprognostic (3.77e-2)"	"unprognostic (1.09e-1)"	"unprognostic (3.04e-1)"	57.0	96.7	9.0	18.2	10.1	7.4	47.5	7.7	11.6	22.6	19.1	15.4	17.7	11.5	27.1	27.4	14.3	18.7	21.9	33.0	9.0	10.7	48.9	36.7	26.6	48.8	9.6	8.7	32.7	16.0	32.2	16.6	43.5	15.5	18.6	12.8	38.2	17.9	17.1	18.2	13.5	21.6	23.6	10.8	33.6	16.5	19.3	8.4	9.1	31.4	10.4	11.7	23.9	18.2	3.0	18.2	12.9	50.0	3.9	7.0	19.0	7.8	12.1	10.0	16.4	50.3	30.3	21.3	18.2	42.5	21.7	24.0	11.1	10.7	3.3	23.8	23.2	25.6	6.5	9.9	10.4	24.6	9.9	7.2	7.9	9.9	7.1	22.9	5.9	70.9	29.0	12.9	22.1	10.1	68.8	40.0	4.6	5.5	23.8	31.7	6.3	1.4	3.4	3.9	19.9	10.3	4.6	15.6	10.3	18.9	23.1	6.8	7.3	23.7	11.5	16.5	13.8	20.6	7.9	36.9	21.4	11.3	20.7	10.6	22.6	26.9	2.9	30.8	11.5	14.5	8.8	30.3	5.9	7.0	37.0	5.2	3.0	3.8	5.3	18.2	2.4	4.0	4.0	12.9	3.9	50.0	4.3	2.8	19.0	9.0	10.1	7.7	11.6	9.0	10.7	9.6	8.7	15.5	8.4	44.7	34.3	16.7	7.2	14.7	9.2	56.5	25.5	21.4	18.2	97.7	17.7	15.9	1.7	27.2	23.8	39.4	30.9	0.0	12.9	14.7	22.9	22.9	46.2	54.2	72.6	15.9	40.3	68.7	167.4	19.5	32.2	65.5	15.1	24.4	18.5	23.6	21.5	16.4	35.0	61.7	6.0	6.5	18.9	10.9	7.8	11.3	24.4	10.1	15.8	16.1
GOT1	AST1	ENSG00000120053	"Glutamic-oxaloacetic transaminase 1"	P17174	10	99396870-99430624	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins"	"Amino-acid biosynthesis"	"Aminotransferase, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 116.9;liver: 82.9;skeletal muscle: 102.1"	"Cell type enhanced"	"Detected in all"	9	"Cardiomyocytes: 398.1;Distal tubular cells: 203.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA064532, HPA072629"	Enhanced		Supported	Nucleoplasm,Cytosol		NA	Yes		130000000	Nucleoplasm	Cytosol	"HPA064532: AB_2685279, HPA072629: AB_2686540"	"unprognostic (6.40e-2)"	"prognostic favorable (6.23e-4)"	"unprognostic (5.99e-2)"	"unprognostic (2.84e-2)"	"unprognostic (2.82e-1)"	"unprognostic (2.96e-2)"	"unprognostic (5.25e-2)"	"unprognostic (1.08e-3)"	"unprognostic (6.67e-2)"	"unprognostic (1.45e-1)"	"unprognostic (1.79e-2)"	"unprognostic (1.79e-1)"	"prognostic favorable (3.72e-13)"	"unprognostic (1.93e-2)"	"unprognostic (4.23e-1)"	"unprognostic (6.85e-2)"	"unprognostic (1.00e-1)"	3.3	14.0	15.7	3.6	32.1	2.0	5.9	22.9	56.4	13.5	12.0	9.7	5.9	14.7	3.4	7.0	10.3	4.6	12.2	116.9	19.4	19.0	34.6	82.9	3.5	3.4	17.8	16.4	3.8	8.2	15.9	4.9	3.7	49.9	5.9	14.7	9.0	12.4	7.2	102.1	4.5	12.7	5.4	7.7	3.6	10.1	9.3	4.7	3.3	11.7	31.3	7.1	4.9	4.0	10.6	21.4	3.9	16.8	11.4	15.6	8.8	17.2	9.6	11.3	28.6	8.7	7.5	32.0	14.2	26.1	24.7	27.1	21.7	14.1	16.9	4.9	11.9	21.0	21.7	25.8	18.7	27.4	5.8	11.0	6.4	12.3	28.2	46.5	18.3	11.0	11.9	20.2	21.0	57.1	16.8	12.0	11.2	16.5	26.5	15.8	15.6	9.8	13.8	7.2	27.0	13.4	10.7	10.8	17.6	43.2	9.5	4.9	7.2	10.7	15.2	52.9	17.4	29.0	6.3	5.5	6.3	14.1	6.8	16.2	18.9	22.3	17.3	16.6	9.6	8.4	2.4	5.3	3.9	12.4	14.7	11.4	10.6	13.5	12.9	12.9	10.2	10.2	14.5	0.5	11.4	16.8	21.4	15.6	8.8	15.7	32.1	22.9	56.4	19.4	19.0	17.8	16.4	49.9	4.7	14.9	14.4	29.9	39.5	10.5	86.5	398.1	96.8	26.8	14.8	69.8	58.9	29.8	203.9	43.4	86.1	13.5	75.3	46.7	27.1	14.9	9.9	11.6	32.2	145.9	26.2	71.5	18.9	17.2	11.6	9.5	10.3	9.5	47.2	14.4	30.8	29.4	25.5	30.3	13.4	123.7	55.6	12.9	14.1	28.9	11.5	9.2	46.1	12.1	50.2	36.7
GOT2	"KAT4, KATIV, KYAT4, mitAAT"	ENSG00000125166	"Glutamic-oxaloacetic transaminase 2"	P00505	16	58707131-58734357	"Cancer-related genes, Candidate cardiovascular disease genes, Enzymes, Plasma proteins, Predicted intracellular proteins, Transporters"	"Lipid transport, Transport"	"Aminotransferase, Transferase"	"Cancer-related genes, Disease mutation, Epilepsy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 167.8"	"Cell type enhanced"	"Detected in many"	8	"Cardiomyocytes: 269.3;Hepatocytes: 145.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA018139	Enhanced				"Intracellular and membrane"	NA	NA		7000000			"HPA018139: AB_1849903"	"unprognostic (1.50e-2)"	"unprognostic (4.79e-2)"	"unprognostic (2.73e-3)"	"unprognostic (2.63e-3)"	"unprognostic (3.02e-2)"	"prognostic unfavorable (1.61e-4)"	"prognostic favorable (5.75e-5)"	"unprognostic (1.12e-2)"	"unprognostic (3.19e-1)"	"unprognostic (3.72e-2)"	"unprognostic (2.27e-1)"	"unprognostic (3.00e-1)"	"prognostic favorable (2.90e-9)"	"unprognostic (1.16e-1)"	"unprognostic (1.48e-1)"	"unprognostic (5.56e-2)"	"unprognostic (2.22e-1)"	6.1	21.0	12.7	8.0	19.1	5.5	10.7	19.4	35.7	10.6	15.9	16.0	33.3	10.6	10.4	19.5	17.7	13.5	8.9	78.1	15.8	16.7	24.6	85.5	7.1	11.1	16.2	17.8	8.7	8.8	27.0	13.0	7.3	27.7	17.2	18.8	23.4	13.0	20.5	167.8	10.4	9.4	13.5	12.3	8.0	13.6	10.8	9.9	10.7	12.3	53.9	15.0	15.5	11.2	14.3	17.6	3.5	9.9	14.5	24.5	14.3	27.6	37.6	19.8	24.1	14.4	13.0	26.0	21.3	22.7	42.0	23.1	32.5	25.0	61.9	25.3	23.5	18.4	40.9	42.4	41.3	53.6	17.0	38.9	16.6	20.5	36.3	18.3	26.7	15.4	12.6	23.5	26.4	23.1	24.0	42.1	30.0	33.4	6.4	21.3	24.7	33.2	25.8	26.9	18.5	73.0	36.5	30.2	59.4	39.6	40.7	31.7	23.0	40.7	43.9	15.3	18.7	22.1	8.7	16.9	15.3	28.0	11.9	27.0	14.9	13.8	50.7	16.3	26.8	15.4	2.3	9.9	3.5	15.2	8.6	23.5	14.3	18.0	18.4	17.6	10.6	16.7	15.3	0.9	14.5	8.5	15.5	24.5	14.3	12.7	19.1	19.4	35.7	15.8	16.7	16.2	17.8	27.7	9.9	8.9	12.0	18.2	27.1	28.4	31.7	269.3	33.1	13.4	14.8	34.9	72.6	40.0	48.0	48.1	3.5	16.6	29.5	23.3	36.8	30.5	15.1	29.5	13.9	145.0	34.4	19.1	19.8	25.8	17.4	5.6	16.7	14.4	23.6	9.0	29.0	15.2	34.5	5.8	21.2	51.6	42.1	0.0	14.7	11.2	14.7	26.2	19.8	14.4	49.8	58.8
GPAM	"GPAT1, KIAA1560, MGC26846"	ENSG00000119927	"Glycerol-3-phosphate acyltransferase, mitochondrial"	Q9HCL2	10	112149864-112215377	"Enzymes, Predicted membrane proteins"	"Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism"	"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adipose tissue: 107.3;liver: 56.6"	"Group enriched"	"Detected in many"	5	"Hepatocytes: 165.5;Horizontal cells: 42.9"	"Cancer enriched"	"Detected in all"	5	"liver cancer: 20.5"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in all"		"ASC diff: 76.6;Hep G2: 20.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA046339, HPA060090"	Approved		Approved	Mitochondria		NA	NA			Mitochondria		"HPA046339: AB_2679627, HPA060090: AB_2684202"	"unprognostic (1.82e-1)"	"unprognostic (6.28e-2)"	"unprognostic (1.13e-1)"	"unprognostic (1.30e-1)"	"unprognostic (6.80e-2)"	"unprognostic (8.75e-2)"	"unprognostic (1.40e-2)"	"unprognostic (2.16e-2)"	"unprognostic (4.59e-1)"	"unprognostic (4.80e-1)"	"unprognostic (2.37e-2)"	"unprognostic (5.44e-2)"	"prognostic favorable (4.54e-6)"	"unprognostic (2.84e-1)"	"unprognostic (4.41e-2)"	"unprognostic (2.52e-2)"	"unprognostic (1.37e-1)"	107.3	17.2	11.4	2.6	12.1	1.8	30.8	6.6	11.0	2.0	3.2	6.5	5.1	2.2	4.1	32.1	2.4	1.9	3.0	5.8	12.2	2.9	2.4	56.6	2.2	2.3	7.2	7.3	3.5	2.8	3.2	2.3	1.8	5.6	2.3	2.6	12.0	6.8	2.9	3.6	1.8	3.3	3.4	3.8	1.7	2.4	2.8	7.2	2.8	6.1	2.4	2.3	3.2	1.6	3.2	2.0	0.5	1.2	1.1	3.4	1.0	2.8	2.1	2.9	3.8	76.6	2.8	3.8	2.7	3.1	1.9	1.5	5.0	1.7	2.0	1.5	1.9	1.8	3.6	4.6	2.3	3.7	1.4	2.4	1.8	2.3	20.6	2.3	3.2	1.0	13.4	3.9	3.5	7.1	15.0	1.7	2.8	2.3	1.8	2.2	1.6	2.7	2.5	2.4	1.6	3.0	2.7	7.6	1.4	1.3	1.9	1.2	3.6	3.7	1.8	4.2	2.8	1.8	1.1	1.3	2.3	1.4	2.8	4.2	1.8	2.0	4.2	2.6	2.8	1.7	0.0	1.0	0.5	2.5	1.2	3.2	1.9	1.9	1.9	1.2	3.2	2.0	3.4	0.0	1.1	1.0	2.0	1.9	1.0	11.4	12.1	6.6	11.0	12.2	2.9	7.2	7.3	5.6	7.2	8.9	19.0	7.8	0.6	0.3	5.8	15.7	17.8	5.3	5.7	5.2	9.8	4.6	1.7	2.5	0.4	4.5	1.7	0.0	2.8	2.1	2.5	1.2	2.3	165.5	2.5	42.9	1.2	5.5	8.9	0.4	4.9	2.1	1.7	0.0	3.8	6.0	2.6	2.9	11.3	2.7	8.9	6.5	1.9	2.9	3.2	0.1	1.6	3.2	4.5	0.5
GPAT2	CT123	ENSG00000186281	"Glycerol-3-phosphate acyltransferase 2, mitochondrial"	Q6NUI2	2	96021946-96039451	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism"	"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	23	"Sertoli cells: 97.0;Smooth muscle cells: 18.3;Spermatocytes: 27.9"	"Low cancer specificity"	"Detected in many"							"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"BJ: 7.1;BJ hTERT+ SV40 Large T+: 17.5;BJ hTERT+ SV40 Large T+ RasG12V: 10.4;HBF TERT88: 4.0;OE19: 11.9;U-2 OS: 10.0"	"Low region specificity"	"Detected in single"							HPA036841	Uncertain		Approved	Mitochondria		NA	NA			Mitochondria		"HPA036841: AB_10601479"	"unprognostic (1.42e-2)"	"unprognostic (2.39e-2)"	"unprognostic (6.69e-2)"	"unprognostic (3.83e-1)"	"unprognostic (1.44e-1)"	"unprognostic (2.38e-3)"	"unprognostic (4.99e-2)"	"unprognostic (3.28e-2)"	"unprognostic (1.70e-1)"	"unprognostic (1.44e-2)"	"unprognostic (5.96e-2)"	"unprognostic (4.67e-2)"	"unprognostic (7.43e-6)"	"unprognostic (2.11e-1)"	"unprognostic (7.68e-2)"	"unprognostic (3.49e-1)"	"unprognostic (3.65e-1)"	4.3	1.1	1.5	1.9	3.1	1.5	3.6	0.2	1.6	0.8	1.0			0.0	1.1	5.1	0.9	1.0	2.2	3.9	1.1	0.7	0.5	0.5	1.3	3.2	1.2		0.9	1.1	0.0	0.2	2.0		0.6	1.5		1.8	4.9	1.4	0.5	1.3	2.4	2.3	4.4	3.0	7.3			1.2		2.6	2.6	0.8	4.3	1.1	0.5	2.5	0.2	3.0	1.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	7.1	0.0	17.5	10.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.0	0.0	0.0	0.0	0.3	0.0	2.6	0.0	0.0	0.2	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	11.9	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	10.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.5	2.6	1.9	2.8	4.3	1.3	2.0	1.1	4.1	0.8	3.0	0.0	0.2	2.5	0.0	1.3	1.5											0.0	0.6	2.4	0.6	0.9	0.7	1.6	2.5	0.0	0.0	1.8	0.0	0.1	1.7	1.7	1.5	2.9	0.4	0.0	1.6	0.2	2.2	0.5	1.1	0.0	2.2	7.9	0.0	6.7	1.0	4.3	0.6	1.0	1.7	1.0	0.7	0.9	0.8	0.6	0.0	0.0	0.2	97.0	18.3	27.9	16.8	0.1	0.1	0.7	1.3	1.6
GPAT3	"AGPAT10, AGPAT9, HMFN0839, LPAAT-theta, MAG1, MGC11324"	ENSG00000138678	"Glycerol-3-phosphate acyltransferase 3"	Q53EU6	4	83535914-83605875	"Enzymes, Predicted membrane proteins"	"Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism"	"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 47.2;kidney: 43.7"	"Cell type enhanced"	"Detected in many"	8	"Basal glandular cells: 41.3;Early spermatids: 68.5;Proximal tubular cells: 50.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"basophil: 42.0"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"CAPAN-2: 51.6;GAMG: 39.2;HMC-1: 19.0;U-87 MG: 22.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA029414, CAB033749"	Approved		Uncertain	"Plasma membrane,Cytosol"		NA	NA			"Plasma membrane, Cytosol"		"CAB033749: AB_2224941, HPA029414: AB_10601562"	"unprognostic (9.51e-2)"	"unprognostic (1.43e-2)"	"unprognostic (5.67e-2)"	"unprognostic (1.70e-1)"	"unprognostic (3.50e-3)"	"unprognostic (2.61e-2)"	"unprognostic (2.05e-1)"	"unprognostic (1.25e-1)"	"unprognostic (1.09e-2)"	"unprognostic (4.30e-2)"	"unprognostic (1.12e-1)"	"unprognostic (2.92e-1)"	"prognostic favorable (2.71e-9)"	"unprognostic (3.74e-1)"	"unprognostic (3.45e-2)"	"unprognostic (2.53e-3)"	"prognostic unfavorable (8.21e-4)"	7.9	0.7	0.7	5.2	1.4	5.2	17.5	4.2	2.9	3.7	18.0	1.2	1.3	20.2	3.0	2.1	5.1	2.1	6.0	24.8	1.2	2.2	43.7	9.0	3.2	4.5	1.9	0.8	12.9	1.7	11.8	5.8	1.2	9.5	2.6	5.7	1.3	3.6	1.9	35.9	1.9	47.2	3.7	3.0	4.3	7.4	4.6	1.4	0.9	26.6	14.6	3.4	4.5	7.2	0.0	23.2	42.0	9.7	0.5	1.8	2.9	9.8	9.7	0.0	0.1	0.5	1.2	0.2	0.7	1.4	0.2	0.2	0.7	51.6	0.0	1.1	1.8	39.2	2.2	4.6	0.9	0.1	0.6	2.2	0.0	3.1	9.5	1.4	2.8	19.0	0.6	0.0	0.3	1.1	3.8	4.8	2.7	7.9	7.8	0.2	1.0	0.7	0.7	0.2	14.5	4.2	0.1	2.2	3.7	9.8	0.6	0.2	0.0	1.9	2.0	5.4	0.5	0.4	0.5	0.2	2.3	4.2	2.3	9.3	0.4	0.6	0.0	22.6	5.6	17.2	42.0	9.7	1.0	0.2	7.7	1.8	0.0	1.0	0.6	23.2	0.0	0.7	0.3	26.4	0.5	6.1	0.1	0.6	2.9	0.7	1.4	4.2	2.9	1.2	2.2	1.9	0.8	9.5	1.4	6.0	5.0	0.0	41.3	0.0	0.0	0.0	7.6	2.7	9.1	10.4	0.0	0.2	13.3	1.6	68.5	0.6	21.6	0.0	5.9	1.0	0.1	25.8	7.0	11.9	15.3	4.8	1.2	5.5	16.7	17.2	1.1	28.3	0.0	5.4	4.8	0.0	6.6	8.0	0.7	50.3	0.2	6.5	0.0	8.8	1.7	0.0	0.8	0.0	2.1	25.4
GPAT4	"AGPAT6, DKFZp586M1819, LPAAT-zeta, TSARG7"	ENSG00000158669	"Glycerol-3-phosphate acyltransferase 4"	Q86UL3	8	41577187-41625001	"Enzymes, Predicted membrane proteins"	"Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism"	"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA016471	Approved					NA	NA					"HPA016471: AB_1844649"	"unprognostic (3.05e-2)"	"unprognostic (4.05e-2)"	"unprognostic (4.24e-2)"	"prognostic unfavorable (9.37e-4)"	"unprognostic (7.45e-2)"	"unprognostic (2.99e-3)"	"unprognostic (5.08e-2)"	"unprognostic (5.11e-2)"	"unprognostic (3.79e-2)"	"prognostic unfavorable (2.20e-4)"	"unprognostic (1.98e-2)"	"prognostic favorable (4.15e-4)"	"unprognostic (1.73e-3)"	"unprognostic (3.16e-2)"	"unprognostic (3.35e-1)"	"unprognostic (2.04e-2)"	"prognostic favorable (5.65e-4)"	15.7	27.4	14.4	17.8	17.2	16.6	28.1	43.8	21.9	16.9	14.0	23.1	22.7	13.0	22.8	12.0	13.1	14.6	15.8	14.1	14.0	13.1	20.8	26.7	18.7	13.8	18.5	13.6	16.6	17.3	35.7	22.3	23.3	20.5	15.1	15.1	21.0	20.8	15.5	42.1	14.5	14.6	23.0	18.0	17.5	17.8	15.5	16.6	15.2	14.5	12.4	19.4	16.6	14.9	9.1	18.9	10.8	15.0	4.9	12.1	11.1	14.7	16.4	19.7	15.4	21.6	26.3	17.3	32.2	27.7	24.4	25.6	11.0	29.8	20.6	22.6	26.5	30.1	8.6	23.0	14.5	31.7	22.0	12.7	24.0	18.3	10.1	12.6	2.5	34.7	16.5	10.7	25.4	9.2	21.0	25.1	20.6	17.9	24.3	25.0	6.3	22.4	6.5	21.0	27.3	8.8	13.2	19.7	11.1	14.8	22.2	12.9	17.8	12.5	17.3	34.5	23.6	24.0	16.3	18.2	25.3	17.8	28.9	24.0	13.1	17.6	22.5	20.8	14.2	24.7	10.8	15.0	6.6	12.1	14.3	11.3	8.3	9.3	11.9	18.9	9.1	8.5	8.2	3.5	4.9	12.0	7.1	8.7	11.1	14.4	17.2	43.8	21.9	14.0	13.1	18.5	13.6	20.5	16.6	3.0	37.7	8.0	11.2	0.0	15.6	0.0	30.6	10.7	25.0	10.4	9.8	29.1	3.3	35.3	36.6	18.0	10.2	70.0	34.4	34.1	9.3	25.6	2.3	53.8	22.9	14.3	16.4	20.9	29.5	44.4	11.8	16.4	0.0	37.9	19.7	12.7	36.5	14.0	9.9	23.5	12.1	6.5	0.0	3.0	13.4	0.0	33.8	10.2	13.3	13.6
GPCPD1	"GDE5, GDPD6, KIAA1434"	ENSG00000125772	"Glycerophosphocholine phosphodiesterase 1"	Q9NPB8	20	5544404-5611026	"Enzymes, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	6	"Early spermatids: 145.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"hTERT-HME1: 26.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042987			Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA042987: AB_2678254"	"unprognostic (2.25e-2)"	"unprognostic (2.45e-2)"	"unprognostic (3.41e-1)"	"prognostic favorable (1.30e-4)"	"unprognostic (2.93e-2)"	"unprognostic (8.10e-2)"	"unprognostic (1.63e-1)"	"unprognostic (1.39e-2)"	"unprognostic (3.76e-2)"	"unprognostic (1.67e-1)"	"unprognostic (1.46e-1)"	"unprognostic (1.18e-1)"	"prognostic unfavorable (3.73e-4)"	"unprognostic (1.56e-1)"	"unprognostic (1.22e-1)"	"unprognostic (1.51e-1)"	"unprognostic (2.30e-2)"	12.9	12.9	10.6	21.8	17.6	56.7	12.7	29.6	28.2	12.2	8.8	9.1	36.7	7.4	12.5	10.5	10.6	12.6	13.2	12.6	12.2	10.1	8.1	8.1	43.6	30.6	13.1	8.9	18.1	8.9	4.5	10.3	13.4	19.4	9.6	10.6	11.0	34.2	31.2	31.8	9.1	15.1	21.5	14.6	24.9	8.8	8.1	4.0	12.1	13.4	17.0	17.5	13.7	9.8	4.2	4.5	16.2	7.1	3.6	4.6	3.4	3.8	7.3	5.0	4.0	3.3	3.9	5.7	6.1	4.9	3.5	2.4	3.8	3.0	8.6	1.1	3.4	3.2	1.3	6.2	12.1	3.4	1.8	2.0	11.8	0.8	4.4	16.0	7.2	5.4	8.3	15.8	2.1	26.1	3.6	3.7	5.4	6.7	4.5	3.2	2.1	6.5	3.9	2.7	6.8	4.2	4.7	6.0	3.1	4.8	3.2	1.9	2.5	2.7	11.9	5.7	5.2	2.8	20.3	4.1	3.0	2.2	8.2	3.9	4.3	7.4	9.2	0.9	8.9	3.3	2.6	7.1	9.0	4.0	5.5	3.1	4.2	3.0	3.3	4.5	3.8	4.6	3.1	16.2	3.6	5.5	2.0	2.4	3.4	10.6	17.6	29.6	28.2	12.2	10.1	13.1	8.9	19.4	4.0	20.8	56.2	34.4	13.7	14.7	16.4	35.1	15.3	13.4	31.8	21.0	5.9	24.1	3.3	10.4	145.3	24.3	12.0	70.0	7.9	13.9	20.4	21.1	42.7	15.3	42.6	11.1	18.9	20.9	80.0	39.0	5.2	52.4	10.1	10.0	20.3	9.1	6.0	8.6	3.2	6.3	19.4	6.5	35.6	39.0	9.5	24.0	40.7	32.0	10.4	44.4
GPD1		ENSG00000167588	"Glycerol-3-phosphate dehydrogenase 1"	P21695	12	50103819-50111319	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		Oxidoreductase	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 116.3;skeletal muscle: 106.9"	"Group enriched"	"Detected in many"	5	"Hepatocytes: 94.2;Proximal tubular cells: 265.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	4	"ASC diff: 53.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044620	Enhanced					NA	NA		3800000			"HPA044620: AB_10796803"	"unprognostic (2.65e-2)"	"unprognostic (5.60e-2)"	"unprognostic (3.28e-2)"	"unprognostic (3.37e-2)"	"unprognostic (3.26e-1)"	"unprognostic (2.54e-1)"	"unprognostic (1.45e-3)"	"unprognostic (7.19e-2)"	"unprognostic (9.42e-2)"	"unprognostic (1.58e-1)"	"unprognostic (2.24e-2)"	"unprognostic (3.24e-1)"	"unprognostic (1.37e-1)"	"unprognostic (9.58e-2)"	"unprognostic (3.37e-1)"	"unprognostic (1.14e-1)"	"unprognostic (1.12e-2)"	116.3	1.2	2.4	3.6	3.0	0.3	44.9	1.6	3.9	0.3	13.4	12.2	0.4	16.2	0.3	3.0	1.2	0.3	8.1	3.9	4.3	2.7	30.6	31.4	4.0	1.6	6.8	1.2	0.2	1.8	2.3	0.3	0.2	13.5	0.5	0.9	0.1	17.7	0.5	106.9	2.0	23.5	0.5	24.7	0.2	0.8	0.3	2.0	0.0	0.7	14.1	0.3	1.1	0.3	0.7	0.8	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	53.5	0.0	0.1	0.0	0.0	0.0	0.0	10.8	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.2	9.9	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.3	0.3	0.1	0.0	0.0	0.0	0.1	0.0	1.4	0.0	0.0	0.0	11.9	0.1	0.0	0.2	0.0	0.0	0.6	0.4	0.0	0.7	0.0	0.0	0.0	0.1	0.1	0.0	0.2	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.8	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	2.4	3.0	1.6	3.9	4.3	2.7	6.8	1.2	13.5	2.0	3.0	2.7	7.4	0.2	0.0	2.9	4.8	12.7	0.0	2.3	5.2	7.9	0.0	36.5	0.3	0.0	0.0	7.8	0.0	0.6	0.0	0.0	0.1	0.0	94.2	2.4	3.2	1.2	1.8	0.3	0.0	0.0	0.2	1.7	1.8	4.2	2.7	0.6	5.8	0.0	265.1	1.7	0.0	0.0	0.0	0.0	0.4	0.0	0.0	1.1	0.1
GPD1L	KIAA0089	ENSG00000152642	"Glycerol-3-phosphate dehydrogenase 1 like"	Q8N335	3	32105689-32168713	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		Oxidoreductase	"Brugada syndrome, Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 65.5"	"Cell type enhanced"	"Detected in many"	11	"Cardiomyocytes: 142.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BEWO: 51.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA						"unprognostic (1.23e-1)"	"unprognostic (3.12e-2)"	"prognostic favorable (7.05e-4)"	"unprognostic (2.63e-1)"	"unprognostic (9.67e-3)"	"unprognostic (2.24e-1)"	"prognostic unfavorable (1.35e-5)"	"prognostic favorable (5.71e-5)"	"unprognostic (2.49e-2)"	"unprognostic (1.74e-1)"	"unprognostic (2.00e-1)"	"unprognostic (1.53e-1)"	"prognostic favorable (3.33e-15)"	"unprognostic (1.50e-1)"	"unprognostic (1.99e-1)"	"unprognostic (2.31e-3)"	"unprognostic (5.51e-3)"	14.6	18.8	7.4	4.5	12.2	2.9	13.3	8.3	15.7	10.0	16.1	7.2	5.3	10.6	7.1	6.7	17.0	11.0	6.7	49.5	8.3	8.4	14.2	1.4	12.7	6.1	8.2	11.7	7.5	9.0	7.9	5.7	8.3	10.8	25.1	15.2	8.5	15.2	18.0	65.5	5.4	15.5	14.5	11.6	4.9	11.9	3.2	6.3	0.8	16.9	22.5	9.6	22.4	9.0	1.9	6.6	6.5	4.1	8.3	10.1	3.2	4.0	3.6	1.3	5.8	18.8	4.5	51.2	3.2	1.1	3.7	2.6	3.9	2.0	7.1	5.0	2.2	4.5	4.7	8.6	3.3	4.4	3.0	7.9	4.0	5.7	6.0	4.7	10.4	14.8	13.6	4.5	3.5	4.6	3.6	6.0	5.9	2.8	2.3	2.7	5.3	4.5	3.4	0.8	9.9	16.8	8.4	5.9	14.4	5.6	24.4	5.7	5.7	2.6	22.6	9.0	1.9	14.7	5.1	3.1	4.0	2.0	6.3	8.7	1.8	0.7	7.0	9.2	8.1	2.2	0.4	3.2	6.5	4.3	4.1	10.1	1.9	5.5	5.1	6.6	1.7	3.2	4.7	1.9	8.3	2.5	5.3	10.0	3.2	7.4	12.2	8.3	15.7	8.3	8.4	8.2	11.7	10.8	6.3	26.8	33.2	2.2	3.8	4.0	3.6	142.4	5.1	10.7	14.8	8.7	2.0	30.5	33.2	1.8	7.4	8.7	36.9	0.0	3.2	5.6	6.4	16.3	39.2	0.4	8.3	1.6	7.5	7.4	5.9	13.3	5.5	4.7	8.5	0.0	21.4	29.9	3.8	14.0	12.0	15.3	3.6	0.0	7.3	0.5	1.9	6.0	22.7	10.2	20.6	5.2
GPD2		ENSG00000115159	"Glycerol-3-phosphate dehydrogenase 2"	P43304	2	156435290-156613735	"Enzymes, Plasma proteins, Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Early spermatids: 81.5;Late spermatids: 75.7;Urothelial cells: 62.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"classical monocyte: 6.5;eosinophil: 3.1;intermediate monocyte: 3.3;myeloid DC: 5.1;neutrophil: 2.3;non-classical monocyte: 4.3"	"Group enriched"	"Detected in many"	5	"dendritic cells: 5.1;granulocytes: 3.1;monocytes: 6.5"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008012, HPA045506"	Enhanced		Supported	Mitochondria	"Intracellular and membrane"	NA	NA		7600000	Mitochondria		"HPA008012: AB_1079013, HPA045506: AB_2679355"	"unprognostic (1.30e-1)"	"unprognostic (2.50e-1)"	"unprognostic (1.08e-1)"	"unprognostic (4.79e-3)"	"unprognostic (3.25e-1)"	"unprognostic (2.39e-2)"	"prognostic unfavorable (1.44e-4)"	"unprognostic (1.75e-1)"	"unprognostic (1.57e-1)"	"unprognostic (1.86e-1)"	"unprognostic (2.60e-3)"	"unprognostic (6.67e-2)"	"unprognostic (6.02e-3)"	"unprognostic (1.73e-1)"	"unprognostic (1.89e-1)"	"unprognostic (2.41e-1)"	"unprognostic (1.01e-2)"	12.7	5.5	19.6	12.4	21.4	11.4	15.2	23.1	16.3	10.9	17.6	8.8	8.1	13.7	9.1	5.0	23.1	18.4	8.6	6.2	18.7	12.7	7.7	3.4	11.4	9.0	11.3	11.8	9.0	7.4	26.6	11.0	7.9	10.3	10.8	17.8	6.8	21.5	7.5	21.2	12.0	24.9	5.9	9.4	10.6	17.1	9.5	8.3	6.7	11.8	17.6	14.0	10.1	10.5	0.5	5.1	3.1	6.5	0.7	0.9	2.7	17.5	11.3	7.1	10.7	14.9	19.0	0.0	22.5	13.8	14.4	17.3	22.2	16.1	3.1	14.6	11.7	5.9	20.2	13.0	20.1	18.4	10.8	4.6	2.6	20.6	0.0	5.2	4.8	5.9	9.0	6.4	24.8	12.4	9.1	10.9	1.6	5.5	0.8	18.0	10.3	0.1	0.4	12.7	6.6	15.0	5.5	4.5	4.1	16.9	22.0	12.6	4.5	20.0	15.1	13.1	11.9	5.1	12.6	10.6	2.8	12.0	12.2	15.8	0.6	0.1	0.1	15.5	1.3	21.5	0.6	6.5	3.1	0.5	3.3	0.9	0.3	0.3	0.9	5.1	0.5	0.7	0.5	2.3	0.7	4.3	0.5	0.9	2.7	19.6	21.4	23.1	16.3	18.7	12.7	11.3	11.8	10.3	8.3	17.9	10.5	5.1	17.9	17.7	4.3	11.3	10.2	10.7	10.3	21.0	5.9	7.0	1.7	8.3	81.5	8.4	22.3	0.0	11.6	12.6	7.8	44.4	12.7	1.8	19.2	4.8	16.7	11.6	14.5	75.7	11.2	13.3	23.6	6.4	14.3	4.3	13.0	20.4	6.7	3.4	9.5	0.0	5.7	1.6	2.0	18.7	9.3	6.9	16.6	62.5
GPHN	KIAA1385	ENSG00000171723	Gephyrin	Q9NQX3	14	66507407-67181803	"Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Molybdenum cofactor biosynthesis"	"Multifunctional enzyme, Transferase"	"Cancer-related genes, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Cone photoreceptor cells: 49.1;Hepatocytes: 42.9;Horizontal cells: 41.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003116, CAB004419, HPA024694"	Enhanced		Uncertain	"Cytoplasmic bodies"		NA	NA			"Cytoplasmic bodies"		"CAB004419: AB_627670, HPA003116: AB_1078963, HPA024694: AB_1849616"	"unprognostic (8.37e-2)"	"unprognostic (2.53e-2)"	"unprognostic (2.42e-1)"	"unprognostic (1.20e-1)"	"unprognostic (5.14e-2)"	"unprognostic (4.89e-3)"	"unprognostic (8.29e-2)"	"unprognostic (1.41e-2)"	"unprognostic (1.42e-1)"	"unprognostic (2.23e-1)"	"unprognostic (2.49e-2)"	"unprognostic (8.54e-2)"	"prognostic favorable (5.25e-12)"	"unprognostic (9.81e-2)"	"unprognostic (2.27e-1)"	"unprognostic (7.50e-2)"	"prognostic unfavorable (4.61e-5)"	13.0	12.4	26.1	10.9	31.1	5.2	17.1	40.9	31.2	11.0	18.2	9.3	15.6	11.1	12.3	20.8	8.6	7.5	8.2	11.9	26.4	22.9	34.5	49.0	14.1	7.3	18.3	11.5	7.2	22.9	17.4	24.5	5.8	13.9	11.1	13.2	7.4	10.8	21.3	23.4	10.7	10.8	11.6	16.4	5.6	13.5	7.8	16.2	3.1	12.2	10.0	6.8	7.4	15.1	3.1	3.0	0.5	2.5	2.3	6.2	1.5	22.2	4.4	7.8	8.5	9.2	7.8	5.0	6.3	3.1	6.5	6.5	1.3	10.0	0.0	1.1	3.1	3.3	7.9	7.8	12.3	8.6	6.8	8.4	6.6	6.3	13.6	4.8	3.7	9.8	6.7	7.3	1.8	7.2	2.7	7.5	8.3	4.5	8.4	3.6	11.9	6.5	13.9	3.3	16.8	10.1	0.0	15.0	6.4	10.5	4.4	13.8	5.4	4.3	18.9	6.9	2.2	10.1	6.4	2.8	6.5	14.5	6.4	6.5	11.2	4.8	0.1	5.1	0.5	6.3	0.0	1.3	0.5	3.9	2.5	6.2	2.4	4.9	2.9	1.9	3.1	3.5	3.3	0.0	2.3	1.9	3.0	5.3	1.5	26.1	31.1	40.9	27.0	26.4	22.9	18.3	11.5	13.9	16.2	6.0	9.6	5.4	8.3	4.1	33.5	10.9	7.6	1.4	13.6	1.8	49.1	2.8	11.6	4.1	2.5	9.0	5.1	0.0	4.7	2.1	4.1	6.7	0.0	42.9	3.1	41.3	5.8	19.0	7.6	3.6	10.3	2.7	1.7	0.0	11.9	10.4	2.9	7.0	5.3	14.9	34.2	0.0	6.2	10.9	8.9	5.1	1.7	4.9	8.9	6.0
GPI	"AMF, NLK"	ENSG00000105220	"Glucose-6-phosphate isomerase"	P06744	19	34359480-34402413	"Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"	"Gluconeogenesis, Glycolysis"	"Cytokine, Growth factor, Isomerase"	"Cancer-related genes, Disease mutation, Hereditary hemolytic anemia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	11	"Early spermatids: 321.8;Late spermatids: 797.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"CAB018655, HPA024305, CAB040563, HPA052171"	Enhanced		Supported	"Nucleoplasm,Plasma membrane,Cytosol"	"Secreted to blood"	No	No		140000000	"Plasma membrane, Cytosol"	Nucleoplasm	"CAB018655: AB_2112653, CAB040563: , HPA024305: AB_1849922, HPA052171: AB_2681748"	"unprognostic (1.03e-1)"	"unprognostic (8.39e-3)"	"unprognostic (2.39e-2)"	"unprognostic (1.38e-2)"	"unprognostic (4.52e-2)"	"unprognostic (6.45e-3)"	"unprognostic (1.95e-2)"	"unprognostic (8.52e-3)"	"unprognostic (3.18e-1)"	"unprognostic (1.45e-1)"	"unprognostic (4.93e-2)"	"unprognostic (2.75e-1)"	"unprognostic (3.24e-3)"	"unprognostic (2.62e-2)"	"unprognostic (2.43e-1)"	"unprognostic (2.60e-3)"	"unprognostic (2.88e-2)"	62.1	66.6	43.4	27.6	58.2	83.3	34.8	62.6	88.7	20.6	36.6	20.8	23.7	48.2	21.1	20.6	45.3	24.2	33.5	107.2	42.0	45.6	51.3	77.9	19.6	29.6	39.3	64.3	22.5	21.4	66.9	33.7	20.4	50.2	23.7	37.2	36.2	34.6	33.9	144.7	29.4	44.3	34.2	22.8	23.1	26.7	19.7	19.0	23.8	26.1	68.5	32.6	32.5	25.2	16.2	26.3	74.8	40.9	14.5	27.5	24.6	76.8	108.3	9.5	74.2	31.2	23.2	22.7	29.7	23.5	37.5	45.2	61.0	27.3	50.7	44.1	29.0	25.5	53.6	57.3	64.5	42.6	56.3	23.2	65.0	52.2	64.2	20.2	84.2	42.4	31.8	26.7	44.2	23.0	47.4	35.0	34.4	33.1	40.1	26.3	65.2	36.6	29.5	25.7	69.7	38.4	34.3	25.1	95.7	46.9	51.8	51.9	30.2	59.8	105.5	21.6	17.8	23.9	26.9	30.1	14.2	31.2	40.1	45.7	74.2	42.1	46.0	47.2	64.1	28.6	38.5	22.9	74.8	22.5	35.2	27.5	16.2	20.7	25.5	26.3	13.3	17.5	20.7	1.6	14.5	40.9	8.7	21.6	24.6	43.4	58.2	62.6	88.7	42.0	45.6	39.3	64.3	50.2	19.0	26.8	40.2	23.1	22.0	23.0	92.5	198.3	38.2	21.4	25.0	54.1	70.7	38.6	97.8	77.9	321.8	30.6	90.3	0.0	57.9	60.0	36.8	27.8	22.0	68.1	78.6	224.1	61.2	47.9	41.6	797.8	34.2	41.9	33.7	45.9	67.6	28.6	75.7	25.9	28.7	79.1	62.2	19.4	38.7	6.9	7.6	28.7	32.8	47.1	102.1	32.5
GPLD1		ENSG00000112293	"Glycosylphosphatidylinositol specific phospholipase D1"	P80108	6	24424565-24495205	"Enzymes, Plasma proteins, Predicted secreted proteins"		Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	7	"liver: 61.6"	"Cell type enhanced"	"Detected in many"	15	"Bipolar cells: 17.5;Cone photoreceptor cells: 64.8;Hepatocytes: 55.7"	"Cancer enriched"	"Detected in some"	11	"liver cancer: 6.8"	"Region enriched"	"Detected in many"	4	"cerebellum: 8.5"	"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"Daudi: 10.5;U-698: 10.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB008625, HPA012500"	Uncertain				"Secreted to blood"	NA	NA	103000000000	3700000000			"CAB008625: AB_1621070, HPA012500: AB_1849931"	"unprognostic (6.80e-3)"	"unprognostic (2.27e-1)"	"unprognostic (1.59e-1)"	"unprognostic (4.81e-5)"	"unprognostic (3.65e-1)"	"unprognostic (1.02e-1)"	"prognostic favorable (1.12e-4)"	"unprognostic (6.37e-4)"	"unprognostic (7.93e-2)"	"unprognostic (2.86e-2)"	"unprognostic (6.07e-4)"	"unprognostic (2.68e-1)"	"unprognostic (5.28e-4)"	"unprognostic (2.20e-1)"	"unprognostic (9.98e-2)"	"unprognostic (3.73e-2)"	"unprognostic (1.22e-1)"	2.2	0.4	0.8	0.6	1.2	0.3	0.6	8.5	1.8	0.6	0.6	0.6	0.6	0.1	0.8	0.6	0.6	0.4	0.6	0.6	0.6	1.9	0.6	61.6	0.6	0.6	0.7	0.6	0.7	0.6	1.5	1.3	0.6	0.6	1.0	0.1	0.6	0.6	3.3	0.7	4.8	0.6	0.8	0.6	0.6	0.3	0.8	0.6	6.6	1.6	0.6	0.7	1.0	1.0	1.1	1.6	0.4	0.2	0.1	1.8	0.0	0.7	1.3	1.2	1.9	0.0	0.1	3.0	0.1	0.3	0.4	0.3	5.4	0.1	10.5	1.2	0.2	0.3	0.0	1.7	0.3	0.2	1.3	3.5	1.5	1.4	4.4	0.0	1.8	0.2	0.1	0.2	0.1	0.0	1.2	0.0	2.6	0.7	0.5	0.3	0.7	1.0	0.6	4.0	0.7	0.5	2.0	0.3	0.1	0.4	5.2	3.3	3.5	1.1	0.1	0.5	0.9	0.5	0.5	0.1	1.3	1.3	0.1	1.4	3.1	4.8	10.7	0.2	0.5	0.5	0.4	0.2	0.1	0.4	0.1	1.4	0.6	0.3	0.2	0.0	1.1	0.3	1.8	0.4	0.1	0.1	1.6	0.2	0.0	0.8	1.2	8.5	1.8	0.6	1.9	0.7	0.6	0.6	0.6	0.0	3.0	0.0	0.4	0.0	17.5	10.1	0.0	1.4	2.3	1.8	64.8	0.2	0.0	0.3	3.0	1.0	0.0	0.0	0.3	0.3	0.3	0.3	0.0	55.7	0.1	14.3	1.7	0.6	1.3	2.3	2.8	0.0	0.0	0.0	0.3	4.3	0.1	0.0	3.2	0.3	10.5	0.0	0.5	0.5	5.3	0.5	0.0	0.0	0.4	2.2
GPT	"ALT1, GPT1"	ENSG00000167701	"Glutamic--pyruvic transaminase"	P24298	8	144502973-144507174	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Aminotransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 56.8;skeletal muscle: 27.0"	"Cell type enhanced"	"Detected in many"	14	"Enterocytes: 117.6;Erythroid cells: 70.0;Hepatocytes: 219.3;Proximal tubular cells: 85.9"	"Cancer enriched"	"Detected in many"	7	"liver cancer: 38.6"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	5	"intermediate monocyte: 2.3;non-classical monocyte: 2.9"	"Lineage enriched"	"Detected in single"	6	"monocytes: 2.9"	"Cell line enhanced"	"Detected in many"		"HaCaT: 4.4;Hep G2: 4.8;Karpas-707: 5.8;U-266/70: 6.1"	"Low region specificity"	"Detected in all"							"HPA031059, HPA031060, CAB032997, CAB032999"	Enhanced					NA	NA		15000000			"CAB032997: AB_2261949, CAB032999: AB_2095427, HPA031059: AB_10600214, HPA031060: AB_10602178"	"unprognostic (8.22e-3)"	"unprognostic (2.52e-2)"	"unprognostic (2.39e-1)"	"unprognostic (1.89e-1)"	"unprognostic (3.38e-1)"	"unprognostic (1.37e-2)"	"prognostic favorable (1.47e-5)"	"unprognostic (9.42e-2)"	"unprognostic (2.19e-1)"	"unprognostic (1.32e-1)"	"unprognostic (4.41e-1)"	"unprognostic (9.22e-2)"	"prognostic favorable (2.19e-4)"	"unprognostic (2.83e-2)"	"unprognostic (2.82e-1)"	"unprognostic (1.23e-1)"	"unprognostic (1.98e-2)"	9.0	0.8	1.7	8.7	2.2	1.1	3.9	1.5	2.3	0.2	17.4	2.0	4.6	10.9	0.2	1.7	0.9	0.5	19.8	16.9	1.7	0.9	8.7	56.8	0.2	0.2	1.3	2.2	0.4	3.6	0.5	1.1	0.1	2.0	0.7	3.5	1.6	17.0	2.7	27.0	6.1	19.2	0.2	0.7	0.4	8.6	0.8	1.6	0.0	0.6	13.9	3.3	0.3	0.5	0.0	0.5	0.0	2.9	0.0	0.0	0.0	0.5	1.5	0.4	1.2	0.9	0.0	1.3	0.8	0.0	0.0	0.0	0.5	1.9	0.8	0.7	0.0	0.1	4.4	0.0	0.0	0.0	1.5	2.8	0.7	2.6	4.8	0.0	0.1	0.8	0.0	0.4	0.0	0.0	0.7	0.0	1.0	0.5	5.8	0.0	2.6	0.9	0.9	0.7	1.1	1.0	0.9	0.3	3.1	0.0	1.9	1.2	1.8	0.5	1.5	0.2	0.3	3.9	0.3	0.4	0.4	1.3	1.3	0.2	6.1	0.4	0.4	0.8	1.9	0.4	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	2.9	0.0	0.0	0.0	1.7	2.2	1.5	2.3	1.7	0.9	1.3	2.2	2.0	1.6	0.0	0.0	14.9	1.1	1.4	1.0	6.5	20.4	0.0	0.0	7.0	0.0	0.0	18.3	1.0	17.0	0.0	117.6	70.0	2.1	2.2	0.2	1.1	9.2	219.3	0.1	3.2	2.4	11.6	8.2	39.1	0.6	0.0	1.7	0.0	32.3	13.8	1.4	42.1	0.4	85.9	2.0	0.0	0.1	0.7	0.4	4.0	0.0	3.8	23.4	1.1
GPT2	ALT2	ENSG00000166123	"Glutamic--pyruvic transaminase 2"	Q8TD30	16	46884378-46931297	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		"Aminotransferase, Transferase"	"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"pancreas: 103.0;skeletal muscle: 60.9"	"Cell type enhanced"	"Detected in many"	8	"Hepatocytes: 105.1;Muller glia cells: 57.6;Syncytiotrophoblasts: 69.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"memory B-cell: 4.2"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"Hep G2: 49.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA051514	Approved		Approved	Mitochondria		No	No			Mitochondria		"HPA051514: AB_2681516"	"unprognostic (1.65e-2)"	"unprognostic (3.32e-2)"	"unprognostic (2.87e-1)"	"unprognostic (3.87e-2)"	"unprognostic (3.41e-1)"	"unprognostic (1.27e-1)"	"unprognostic (1.95e-3)"	"unprognostic (3.44e-2)"	"unprognostic (6.12e-2)"	"prognostic favorable (3.17e-4)"	"unprognostic (1.90e-1)"	"unprognostic (1.30e-1)"	"unprognostic (1.56e-1)"	"unprognostic (1.44e-2)"	"unprognostic (4.86e-1)"	"unprognostic (3.54e-3)"	"unprognostic (3.18e-1)"	19.9	4.1	20.2	2.1	17.8	1.9	6.4	3.9	15.1	2.5	3.4	11.8	10.0	1.3	2.1	13.4	30.8	3.7	4.4	3.0	13.4	8.0	9.8	40.4	1.4	2.1	12.9	7.8	1.5	103.0	4.3	4.3	1.8	11.3	10.2	2.6	1.5	27.6	8.5	60.9	14.9	1.7	1.9	11.3	1.4	15.4	6.0	12.3	0.7	3.6	19.0	14.6	1.9	2.1	4.2	1.4	1.3	0.7	0.0	0.4	0.4	13.0	6.0	7.6	29.0	10.8	2.3	13.9	9.1	3.4	9.9	6.2	20.4	5.5	9.2	8.0	6.5	5.0	10.5	13.7	13.5	6.6	4.3	6.7	3.2	3.4	49.2	7.4	23.1	3.0	5.0	11.9	9.6	15.0	6.6	4.8	17.7	2.6	7.4	3.2	23.4	4.5	19.3	8.1	16.2	17.2	0.1	8.4	21.4	4.0	6.5	23.8	12.2	4.7	24.4	12.4	3.2	6.2	21.1	3.5	6.9	13.5	4.5	7.3	35.6	10.8	26.1	10.6	15.0	3.7	1.3	0.7	0.0	0.3	0.0	0.0	4.2	0.0	0.3	1.4	2.5	0.4	0.2	0.0	0.0	0.2	0.0	0.0	0.4	20.2	17.8	3.9	15.1	13.4	8.0	12.9	7.8	11.3	12.3	6.0	4.3	3.0	4.2	14.2	13.4	14.7	12.7	0.0	6.8	17.4	21.6	7.1	10.0	7.8	9.4	1.6	5.5	0.0	26.2	22.2	7.7	12.4	3.5	105.1	3.3	6.4	12.6	4.3	3.5	17.1	4.4	2.4	8.5	1.0	7.4	57.6	23.6	4.9	14.5	29.4	5.9	0.0	1.4	2.2	19.2	14.3	69.7	1.5	3.2	3.8
GPX2	GSHPX-GI	ENSG00000176153	"Glutathione peroxidase 2"	P18283	14	64939152-64942905	"Cancer-related genes, Enzymes, Predicted intracellular proteins"		"Oxidoreductase, Peroxidase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"gallbladder: 126.9;liver: 195.2"	"Cell type enhanced"	"Detected in many"	9	"Cholangiocytes: 484.1;Hepatocytes: 821.3;Mucus-secreting cells: 410.2;Undifferentiated cells: 621.9;Urothelial cells: 833.9"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"NK-cell: 2.4"	"Low lineage specificity"	"Detected in single"			"Cell line enriched"	"Detected in some"	4	"OE19: 309.4"	"Region enhanced"	"Detected in single"		"pons and medulla: 1.3"	"Not detected"	"Not detected"			HPA003545	Enhanced		Approved	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA003545: AB_10962695"	"unprognostic (3.54e-1)"	"unprognostic (1.08e-2)"	"unprognostic (1.51e-1)"	"unprognostic (1.90e-3)"	"unprognostic (4.75e-3)"	"prognostic unfavorable (5.10e-4)"	"unprognostic (2.96e-2)"	"unprognostic (2.93e-2)"	"unprognostic (7.87e-2)"	"unprognostic (1.54e-2)"	"unprognostic (8.45e-2)"	"unprognostic (1.44e-1)"	"unprognostic (2.77e-2)"	"unprognostic (4.39e-2)"	"unprognostic (3.39e-2)"	"unprognostic (6.66e-4)"	"unprognostic (1.73e-2)"	0.1	0.0	0.1	23.8	0.2	0.0	0.8	0.2	0.1	5.5	50.4	0.5	2.0	14.4	0.3	1.0	53.0	0.6	126.9	0.2	0.1	0.2	29.4	195.2	2.0	0.1	0.1	0.1	0.9	7.0	0.0	0.2	0.1	0.2	16.8	71.6	0.1	59.7	4.1	0.3	3.9	35.4	5.6	0.2	0.1	57.8	0.4	0.1	0.5	0.2	44.0	7.4	56.3	15.0	0.2	0.0	0.5	0.8	2.4	0.1	0.0	0.0	71.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.6	0.0	0.4	0.0	0.1	19.9	0.0	0.3	0.0	0.0	0.0	0.0	0.0	66.7	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	309.4	0.0	0.0	0.0	0.0	0.0	47.5	21.5	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.8	0.0	0.1	0.1	0.0	0.0	0.2	0.0	0.0	0.5	2.4	0.0	0.0	0.0	0.0	0.1	0.2	0.2	0.1	0.1	0.2	0.1	0.1	0.2	0.1	0.0	0.0	11.8	173.3	8.9	0.1	0.4	484.1	2.7	2.3	22.7	0.0	0.1	10.0	152.1	13.5	0.5	203.5	0.0	233.6	0.1	0.4	34.2	13.8	821.3	0.0	0.0	110.6	14.1	19.9	38.7	0.9	0.3	0.0	5.4	410.2	0.0	220.5	261.9	0.0	18.9	0.6	0.0	1.0	0.5	0.0	8.4	0.0	6.9	621.9	833.9
GPX3		ENSG00000211445	"Glutathione peroxidase 3"	P22352	5	151020438-151028993	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"		"Oxidoreductase, Peroxidase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"kidney: 844.2;thyroid gland: 424.1"	"Group enriched"	"Detected in many"	4	"Muller glia cells: 3198.5;Proximal tubular cells: 9534.8"	"Cancer enhanced"	"Detected in all"		"thyroid cancer: 856.0"	"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	5	"neutrophil: 16.7"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 16.7"	"Cell line enriched"	"Detected in some"	12	"ASC diff: 427.5"	"Region enhanced"	"Detected in many"		"hypothalamus: 279.6"	"Group enriched"	"Detected in many"	4	"basal ganglia: 67.2;hypothalamus: 176.5;midbrain: 58.6;pons and medulla: 52.3"	CAB069456	Approved				"Secreted to blood"	NA	NA	5090000000	10000000000			"CAB069456: AB_1616682"	"unprognostic (4.03e-1)"	"unprognostic (7.35e-2)"	"unprognostic (5.05e-3)"	"unprognostic (9.01e-2)"	"unprognostic (1.41e-2)"	"unprognostic (8.13e-2)"	"unprognostic (1.39e-2)"	"unprognostic (1.62e-1)"	"unprognostic (5.75e-3)"	"unprognostic (2.70e-3)"	"unprognostic (8.17e-3)"	"unprognostic (1.14e-2)"	"unprognostic (2.95e-1)"	"prognostic unfavorable (1.65e-4)"	"unprognostic (2.14e-1)"	"unprognostic (5.11e-2)"	"unprognostic (1.26e-1)"	177.5	21.9	1.2	6.6	5.5	1.6	310.9	3.1	6.3	26.2	33.9	5.1	6.5	7.5	11.8	16.8	44.4	27.0	17.3	108.1	2.7	5.0	844.2	64.1	88.2	43.8	3.9	1.8	28.8	13.0	5.5	32.3	44.8	17.6	41.3	8.3	160.8	14.8	12.4	56.7	18.7	18.5	48.5	3.5	29.6	19.5	23.6	1.2	0.5	424.1	19.0	9.8	58.8	164.2	0.0	3.5	16.7	3.6	0.0	0.2	1.2	0.1	0.5	0.4	0.1	427.5	0.3	0.4	0.1	0.0	0.4	0.1	9.1	0.2	0.0	11.7	0.2	0.1	0.1	2.1	23.0	0.3	0.3	0.1	0.0	0.2	9.9	16.4	0.0	0.2	36.1	2.2	0.0	0.0	0.5	0.6	0.0	0.0	0.0	0.5	1.6	0.0	0.0	0.7	0.0	0.0	0.0	0.2	0.0	4.0	0.2	0.6	0.6	0.0	1.7	0.1	1.9	2.3	0.1	0.1	0.1	1.0	0.2	0.0	0.1	0.7	0.1	0.3	0.1	0.0	0.0	3.6	0.1	0.0	1.4	0.2	0.0	0.0	0.0	3.5	0.0	0.0	0.0	16.7	0.0	0.1	0.0	0.0	1.2	1.2	5.5	3.1	3.6	2.7	5.0	3.9	1.8	17.6	1.2	8.9	50.9	26.2	69.3	16.5	21.7	621.6	15.3	28.1	26.1	615.9	41.2	663.5	1502.1	3.9	2.4	100.8	0.7	0.0	42.8	818.8	102.8	81.4	10.5	137.7	137.1	15.9	43.8	697.9	65.5	7.5	413.6	35.5	21.9	1.0	5.6	3198.5	11.1	7.0	38.5	9534.8	68.9	672.6	191.9	3.8	10.7	18.9	1478.3	13.8	0.6	29.7
GPX4	"MCSP, PHGPx"	ENSG00000167468	"Glutathione peroxidase 4"	P36969	19	1103926-1106791	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		"Developmental protein, Oxidoreductase, Peroxidase"	Dwarfism	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enriched"	"Detected in all"	4	"Late spermatids: 13901.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB008630, HPA047224, HPA058546"	Enhanced		Approved	Nucleoplasm,Mitochondria	"Intracellular and membrane"	NA	NA		220000	"Nucleoplasm, Mitochondria"		"CAB008630: AB_1616685, HPA047224: AB_2679990, HPA058546: AB_2683749"	"unprognostic (8.42e-3)"	"prognostic favorable (7.18e-4)"	"unprognostic (8.14e-3)"	"prognostic favorable (1.84e-5)"	"unprognostic (1.00e-1)"	"unprognostic (8.72e-2)"	"unprognostic (2.53e-3)"	"unprognostic (8.49e-2)"	"unprognostic (2.69e-2)"	"unprognostic (1.47e-1)"	"prognostic favorable (7.72e-4)"	"unprognostic (1.29e-1)"	"prognostic favorable (8.61e-4)"	"unprognostic (1.61e-2)"	"unprognostic (2.20e-1)"	"unprognostic (6.67e-3)"	"unprognostic (2.96e-2)"	163.0	76.4	63.3	27.1	73.7	33.3	102.3	33.5	83.7	53.3	49.1	42.4	33.8	56.9	27.2	74.7	35.6	38.4	46.9	64.4	54.2	60.2	75.3	119.0	44.7	41.7	74.6	47.3	47.1	35.1	33.1	54.7	46.4	49.3	44.7	25.5	82.3	61.6	46.9	98.2	36.3	58.5	43.6	46.5	32.4	27.7	170.4	36.5	29.9	52.8	49.8	39.2	51.2	47.0	56.7	64.0	85.2	85.2	28.4	58.5	110.5	28.7	32.7	47.3	100.0	143.5	85.1	52.7	22.8	82.3	43.5	44.4	66.7	39.0	10.4	24.9	46.0	36.8	32.4	27.6	33.0	21.3	58.3	49.9	19.6	29.4	94.1	83.5	23.0	31.5	84.4	50.3	22.0	37.1	78.5	60.8	36.5	27.4	26.3	35.9	73.8	38.9	39.5	44.8	64.1	52.8	53.9	6.4	30.1	47.2	71.5	40.8	25.8	44.7	42.4	46.4	30.3	41.4	56.3	51.4	46.3	30.8	79.3	28.5	92.2	62.5	24.3	43.6	46.2	26.5	75.6	85.2	85.2	37.0	62.0	43.0	56.7	54.3	38.6	64.0	47.8	58.5	41.7	42.4	28.4	68.3	44.1	46.8	110.5	63.3	73.7	33.5	83.7	54.2	60.2	74.6	47.3	49.3	36.5	166.7	171.0	287.8	409.7	453.0	334.7	225.6	313.4	467.1	233.2	448.4	92.3	508.2	1349.6	448.1	3338.1	251.8	690.8	163.5	318.5	1086.5	512.4	561.5	339.3	667.2	1047.6	197.0	381.4	302.0	479.7	13901.3	356.4	828.7	642.7	2643.8	270.1	239.3	473.5	361.2	294.2	2040.3	183.4	239.3	381.6	862.4	171.8	408.3	818.0	223.7	258.1	558.8
GPX5		ENSG00000224586	"Glutathione peroxidase 5"	O75715	6	28525925-28534952	"Enzymes, Predicted secreted proteins"		"Oxidoreductase, Peroxidase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in some"	5	"epididymis: 27.7"	"Group enriched"	"Detected in some"	32	"Early spermatids: 10.4;Late spermatids: 26.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	7	"BEWO: 1.0;NB-4: 2.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"								"Secreted in male reproductive system"	NA	NA																	"unprognostic (3.34e-2)"			"unprognostic (3.74e-2)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	27.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	26.5	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0
GPX6	GPXP3	ENSG00000198704	"Glutathione peroxidase 6"	P59796	6	28503296-28528215	"Enzymes, Predicted secreted proteins"		"Oxidoreductase, Peroxidase"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in some"	5	"epididymis: 9.3"	"Cell type enhanced"	"Detected in some"	22	"Early spermatids: 2.5;Late spermatids: 2.2"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"CACO-2: 1.0;HEL: 1.6"	"Region enriched"	"Detected in single"	16	"basal ganglia: 21.3"	"Not detected"	"Not detected"								"Secreted in male reproductive system"	NA	NA																				"unprognostic (2.99e-2)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	9.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.1	0.0	0.0	0.4	0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9			0.0		0.0	0.0	0.0	0.1	0.1	0.4	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.2	0.0	0.0	0.0	0.4	0.4	0.0	0.0	0.0	0.3	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.9	0.2	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.1	0.1	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.7	0.0	0.0	0.0	0.0	0.0
GPX7	"FLJ14777, GPX6, NPGPx"	ENSG00000116157	"Glutathione peroxidase 7"	Q96SL4	1	52602372-52609051	"Disease related genes, Enzymes, Potential drug targets, Predicted secreted proteins"		"Oxidoreductase, Peroxidase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"fHDF/TERT166: 22.8;HEL: 21.0;REH: 25.0;RPMI-8226: 42.2;THP-1: 33.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"								"Secreted to blood"	NA	NA						"unprognostic (5.87e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.78e-1)"	"unprognostic (7.43e-3)"	"unprognostic (3.18e-1)"	"unprognostic (5.64e-2)"	"unprognostic (6.12e-3)"	"unprognostic (1.73e-1)"	"unprognostic (4.42e-2)"	"unprognostic (8.18e-2)"	"unprognostic (4.17e-1)"	"unprognostic (2.48e-3)"	"prognostic unfavorable (2.26e-5)"	"unprognostic (1.14e-2)"	"unprognostic (9.24e-2)"	"unprognostic (3.08e-2)"	"unprognostic (5.44e-2)"	8.6	9.4	6.9	10.1	7.5	13.8	10.4	5.8	5.8	13.7	9.6	6.6	6.2	2.8	14.8	6.8	5.5	11.1	12.0	11.0	5.2	4.9	9.9	5.5	7.3	12.8	5.5	4.2	14.1	18.3	9.9	15.4	32.9	6.8	11.1	5.1	10.0	7.7	9.2	9.3	5.7	6.5	9.7	5.2	9.3	6.0	7.8	5.2	22.6	20.5	7.9	14.1	14.0	8.2	13.6	29.8	2.0	0.6	12.0	19.8	9.3	0.0	0.0	6.2	11.5	2.3	6.7	0.0	4.2	0.2	5.1	5.3	4.0	0.0	0.0	3.4	22.8	0.0	0.0	9.8	0.0	2.8	0.0	0.0	21.0	1.2	3.7	8.4	0.0	0.0	15.5	0.0	0.8	0.0	0.0	7.7	0.1	0.0	0.0	9.5	0.0	1.0	10.9	10.7	0.0	0.0	25.0	0.0	42.2	0.4	0.0	4.7	9.3	11.1	0.0	7.2	1.0	0.0	33.4	0.4	0.0	1.3	1.3	0.0	0.0	0.0	15.6	0.0	0.0	3.8	0.0	0.6	2.0	9.9	0.1	13.6	13.6	15.1	11.6	2.2	13.3	19.8	12.8	0.3	12.0	0.0	29.8	10.8	9.3	6.9	7.5	5.8	5.8	5.2	4.9	5.5	4.2	6.8	5.2	3.0	5.6	19.2	9.6	1.9	0.9	3.7	10.2	10.7	9.1	3.5	0.0	18.6	5.0	11.2	5.0	4.4	0.0	0.0	13.7	18.3	24.5	4.9	1.1	3.4	10.3	4.8	1.2	20.9	1.8	4.9	14.1	5.2	6.8	4.6	0.7	7.7	6.1	0.0	12.7	2.6	0.5	12.9	4.1	10.0	8.1	2.9	13.0	7.9	0.0	3.3
GPX8	"EPLA847, UNQ847"	ENSG00000164294	"Glutathione peroxidase 8 (putative)"	Q8TED1	5	55160118-55167071	"Enzymes, Predicted intracellular proteins"		"Oxidoreductase, Peroxidase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	15	"Extravillous trophoblasts: 185.8;Fibroblasts: 64.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 52.6;fHDF/TERT166: 49.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA036720	Enhanced		Approved	"Plasma membrane,Actin filaments,Cytosol"		NA	NA			"Plasma membrane, Cytosol"	"Actin filaments"	"HPA036720: AB_2675269"	"unprognostic (4.85e-2)"	"unprognostic (1.23e-2)"	"unprognostic (6.53e-2)"	"unprognostic (1.92e-2)"	"unprognostic (2.31e-2)"	"unprognostic (9.74e-3)"	"unprognostic (1.78e-2)"	"unprognostic (1.63e-3)"	"unprognostic (2.07e-2)"	"unprognostic (4.34e-2)"	"unprognostic (4.31e-2)"	"unprognostic (8.68e-2)"	"prognostic unfavorable (5.13e-9)"	"prognostic unfavorable (7.96e-4)"	"unprognostic (8.11e-2)"	"unprognostic (1.16e-2)"	"unprognostic (2.63e-2)"	12.6	7.1	0.8	5.8	1.0	0.0	12.2	0.5	0.7	31.4	6.8	1.7	17.3	1.3	23.6	34.5	13.3	13.2	11.2	12.1	1.0	0.9	13.7	2.6	7.3	5.6	1.1	0.9	31.5	5.0	4.5	3.2	40.9	4.0	24.2	4.7	17.8	7.3	16.7	5.0	5.1	4.4	14.1	3.3	7.5	4.9	10.2	0.5	0.7	28.4	11.0	5.4	15.8	19.7	1.0	0.7	2.4	0.5	0.6	0.9	0.2	7.1	5.9	13.0	12.6	34.3	39.0	7.1	36.2	52.6	20.4	40.7	0.6	16.2	0.0	38.6	49.2	17.4	6.1	7.7	10.5	28.0	0.0	3.2	0.3	10.6	1.3	10.8	0.0	0.0	27.6	10.5	12.4	6.5	19.2	23.6	0.0	0.2	0.0	23.1	2.2	0.0	0.0	5.9	0.2	8.4	0.0	7.4	0.0	12.5	0.2	0.0	0.3	12.1	0.9	12.8	15.5	11.6	0.7	21.2	10.9	12.0	16.1	19.4	0.0	0.0	0.0	17.3	0.0	23.6	1.4	0.5	0.3	0.5	0.3	0.5	0.6	0.5	0.5	0.2	1.0	0.9	0.9	2.4	0.6	0.3	0.7	0.2	0.2	0.8	1.0	0.5	0.7	1.0	0.9	1.1	0.9	4.0	0.5	0.0	0.6	0.0	4.8	6.4	0.0	2.6	0.0	14.7	13.6	24.4	0.0	48.1	5.0	12.0	0.4	13.5	0.0	0.0	34.7	185.8	64.1	2.1	4.6	0.0	9.1	0.0	0.0	19.0	0.0	0.2	47.5	1.3	23.6	1.8	3.6	6.6	18.2	0.0	37.4	0.2	0.2	12.9	11.2	0.1	0.1	5.4	11.1	0.7	0.8	1.8
GRHPR	"GLXR, PH2"	ENSG00000137106	"Glyoxylate and hydroxypyruvate reductase"	Q9UBQ7	9	37422666-37436990	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	4	"liver: 172.0"	"Cell type enhanced"	"Detected in all"	9	"Hepatocytes: 748.4;Proximal tubular cells: 664.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA022971, HPA078575"	Enhanced		Approved	Nucleoplasm,Cytosol		NA	NA		1400000	Cytosol	Nucleoplasm	"HPA022971: AB_1849975, HPA078575: "	"prognostic favorable (7.00e-5)"	"unprognostic (6.84e-2)"	"unprognostic (2.62e-1)"	"unprognostic (2.64e-3)"	"unprognostic (5.78e-3)"	"unprognostic (3.04e-1)"	"unprognostic (1.02e-3)"	"unprognostic (1.22e-1)"	"unprognostic (2.24e-1)"	"unprognostic (4.49e-2)"	"unprognostic (5.88e-2)"	"unprognostic (2.36e-1)"	"prognostic favorable (5.39e-9)"	"unprognostic (1.04e-1)"	"unprognostic (2.11e-1)"	"unprognostic (1.15e-1)"	"unprognostic (1.79e-1)"	12.8	33.7	16.3	13.8	17.4	9.9	12.3	9.5	22.3	12.1	17.6	27.5	11.6	17.2	14.3	18.1	17.6	12.9	18.1	29.2	15.8	14.7	41.9	172.0	9.7	13.8	20.0	16.5	17.0	15.5	9.5	8.8	13.2	15.5	14.2	10.2	13.5	21.6	14.0	40.0	14.8	14.6	14.2	19.4	10.0	13.3	13.0	18.7	9.5	15.1	25.2	13.6	13.4	11.7	30.6	33.2	17.8	30.3	28.9	25.9	22.4	31.9	46.2	26.2	23.9	24.1	26.8	26.5	25.6	34.0	35.0	38.1	17.4	13.9	30.7	15.1	30.0	26.2	14.5	15.0	33.4	20.9	41.0	18.8	18.0	43.0	30.9	38.1	17.1	18.7	31.9	29.4	20.2	26.1	29.6	30.3	21.0	32.9	12.7	30.7	24.5	16.6	17.6	15.9	29.2	20.1	16.4	19.2	17.0	46.6	18.2	10.9	19.6	22.0	42.1	23.9	24.7	23.7	22.1	32.9	19.2	30.9	13.3	22.1	10.1	7.7	20.5	27.3	9.9	28.1	17.8	30.2	15.0	19.4	30.3	16.2	28.6	20.7	22.0	33.2	30.6	20.4	17.3	7.0	28.9	24.7	29.8	25.9	22.4	16.3	17.4	9.5	22.3	15.8	14.7	20.0	16.5	15.5	18.7	53.6	20.9	43.5	39.7	38.5	33.3	86.0	219.1	29.4	26.1	48.8	19.6	128.8	210.5	67.4	10.2	41.4	82.6	46.7	77.8	76.0	63.3	42.0	49.6	748.4	97.6	22.3	59.7	76.1	83.4	10.4	69.0	49.3	75.9	86.6	59.5	85.7	64.8	60.5	92.6	664.7	23.4	77.6	62.6	17.5	16.2	49.2	74.4	37.9	71.9	35.2
GRK1	"GPRK1, RHOK, RK"	ENSG00000185974	"G protein-coupled receptor kinase 1"	Q15835	13	113667155-113737735	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Sensory transduction, Vision"	"Kinase, Serine/threonine-protein kinase, Transferase"	"Congenital stationary night blindness, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	12	"retina: 51.5"	"Group enriched"	"Detected in some"	26	"Cone photoreceptor cells: 53.0;Rod photoreceptor cells: 86.9"	"Cancer enhanced"	"Detected in single"		"thyroid cancer: 0.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"SCLC-21H: 1.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA035200, HPA059376"	Enhanced					NA	NA					"HPA035200: AB_2674515, HPA059376: AB_2683996"	"unprognostic (7.93e-2)"	"unprognostic (2.50e-1)"	"unprognostic (1.87e-1)"	"unprognostic (1.24e-5)"	"unprognostic (1.76e-3)"	"unprognostic (1.53e-1)"		"unprognostic (3.59e-2)"		"unprognostic (2.21e-2)"	"unprognostic (1.84e-3)"	"unprognostic (2.00e-2)"	"unprognostic (4.02e-2)"	"unprognostic (6.91e-2)"	"unprognostic (6.18e-2)"	"unprognostic (6.11e-2)"		0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	51.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	4.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.2	0.9	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.5	0.0	0.0	0.0	0.0	53.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.0	86.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
GRK2	"ADRBK1, BARK1"	ENSG00000173020	"G protein-coupled receptor kinase 2"	P25098	11	67266410-67286556	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 78.2"	"Cell type enhanced"	"Detected in many"	8	"Alveolar cells type 2: 26.5;granulocytes: 19.8;Hofbauer cells: 31.0;monocytes: 15.4;Pancreatic endocrine cells: 22.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"NB-4: 56.3;REH: 74.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB005021, CAB037248, HPA048330"	Enhanced		Approved	Vesicles		NA	NA			Vesicles		"CAB005021: AB_562360, CAB037248: AB_1078280, HPA048330: AB_2680361"	"unprognostic (5.58e-2)"	"unprognostic (1.75e-1)"	"unprognostic (2.01e-2)"	"unprognostic (5.33e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.29e-3)"	"unprognostic (3.31e-2)"	"unprognostic (6.17e-2)"	"unprognostic (1.11e-1)"	"unprognostic (6.35e-2)"	"unprognostic (2.22e-1)"	"unprognostic (2.55e-2)"	"prognostic unfavorable (1.25e-4)"	"unprognostic (3.66e-1)"	"unprognostic (2.40e-1)"	"unprognostic (4.04e-2)"	"unprognostic (5.19e-3)"	13.1	10.7	24.5	35.8	17.0	78.2	17.0	32.9	35.3	12.8	17.2	12.2	12.6	17.5	11.4	9.9	20.2	12.6	17.6	13.6	21.9	17.4	13.0	14.1	19.1	42.8	13.4	19.0	9.8	10.4	9.7	12.2	12.7	15.7	17.8	16.2	9.3	17.4	20.8	20.8	23.5	26.3	12.2	12.5	59.6	17.4	6.8	11.1	35.9	10.1	13.6	37.5	17.1	15.5	4.1	6.0	21.0	18.3	3.8	5.3	7.4	7.6	5.4	5.3	8.9	4.3	3.9	5.3	4.6	4.4	6.3	5.2	12.0	12.8	39.5	7.4	4.2	8.4	10.4	7.7	6.2	3.3	48.1	4.8	22.4	6.2	5.4	5.3	47.0	45.0	3.5	7.3	5.0	6.7	4.7	8.0	16.2	8.1	20.3	5.4	14.3	26.1	56.3	6.6	23.1	8.2	74.7	10.5	11.7	6.4	10.1	10.7	5.8	6.8	10.0	16.3	3.4	9.2	51.1	4.4	5.0	6.6	6.3	5.1	12.9	11.9	35.4	6.5	27.9	4.5	6.9	10.3	10.5	5.3	15.9	4.0	3.8	4.0	4.3	6.0	4.1	3.2	3.1	21.0	3.8	18.3	5.3	2.6	7.4	24.5	17.0	32.9	35.3	21.9	17.4	13.4	19.0	15.7	11.1	3.0	26.5	0.0	0.0	0.0	0.0	0.0	0.0	1.4	7.9	5.2	0.0	7.8	1.7	9.4	0.0	0.0	0.0	0.0	10.9	5.1	0.0	0.0	19.8	0.0	31.0	0.0	0.0	0.0	0.0	0.0	0.0	13.1	0.0	15.4	0.0	0.0	22.7	0.0	0.0	4.4	0.0	0.0	0.0	0.0	0.0	0.0	8.0	0.0	0.0	0.0
GRK3	"ADRBK2, BARK2"	ENSG00000100077	"G protein-coupled receptor kinase 3"	P35626	22	25564849-25729294	"Enzymes, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 28.0"	"Cell type enhanced"	"Detected in many"	10	"Alveolar cells type 2: 44.1;Club cells: 30.7;Extravillous trophoblasts: 22.7;Hofbauer cells: 25.0;monocytes: 47.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	9	"classical monocyte: 4.8;eosinophil: 5.6;intermediate monocyte: 8.0;memory B-cell: 4.9;myeloid DC: 3.7;naive B-cell: 6.2;non-classical monocyte: 7.4;plasmacytoid DC: 3.2"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 20.4;JURKAT: 33.6;SH-SY5Y: 18.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA000804	Uncertain		Approved	"Nucleoplasm,Plasma membrane"		NA	NA			Nucleoplasm	"Plasma membrane"	"HPA000804: AB_1078281"	"unprognostic (1.02e-1)"	"unprognostic (4.38e-2)"	"unprognostic (5.68e-3)"	"unprognostic (4.33e-2)"	"unprognostic (2.09e-1)"	"unprognostic (3.67e-2)"	"unprognostic (3.29e-1)"	"unprognostic (1.78e-2)"	"unprognostic (1.97e-1)"	"unprognostic (3.54e-1)"	"unprognostic (1.95e-3)"	"unprognostic (5.79e-2)"	"unprognostic (1.01e-3)"	"unprognostic (1.74e-1)"	"unprognostic (2.87e-3)"	"unprognostic (1.89e-2)"	"prognostic favorable (1.29e-4)"	28.0	6.0	11.9	12.4	10.8	7.0	11.3	7.9	18.9	4.7	4.0	3.1	0.7	3.0	5.7	3.1	2.7	9.1	5.0	4.6	15.7	8.3	3.0	3.4	9.4	14.1	9.7	9.8	4.1	8.4	4.4	8.2	4.5	9.6	8.2	4.3	4.8	3.7	1.9	1.4	4.1	6.1	6.2	4.9	23.2	4.0	14.8	2.7	11.6	4.5	1.3	15.2	6.7	2.5	6.2	3.7	5.6	8.0	0.0	0.4	1.6	0.0	1.9	5.8	1.9	4.1	0.5	8.5	0.6	1.8	1.8	3.2	3.0	3.3	10.6	0.1	0.1	5.2	0.1	5.8	4.3	5.5	20.4	3.8	4.9	0.6	6.7	0.1	15.8	8.3	1.0	3.0	1.3	2.3	0.3	0.3	33.6	0.5	0.0	2.1	2.6	11.3	1.1	4.1	5.7	0.0	5.1	9.3	1.8	0.0	3.1	13.7	18.5	1.0	0.0	4.4	5.6	1.6	6.3	0.1	0.0	12.0	0.1	2.3	1.2	4.2	8.3	7.8	5.6	1.8	0.6	4.8	5.6	0.0	8.0	0.3	4.9	0.0	0.3	3.7	6.2	0.1	0.2	0.3	0.0	7.4	3.2	0.4	1.6	11.9	10.8	7.9	18.9	15.7	8.3	9.7	9.8	9.6	2.7	14.9	44.1	0.0	0.0	0.0	0.0	0.0	0.0	12.0	30.7	0.0	0.0	1.5	1.7	7.0	0.0	0.0	0.0	0.0	1.6	22.7	0.0	0.0	17.4	0.0	25.0	0.0	0.0	0.0	0.0	0.0	0.0	10.5	0.0	47.7	0.0	0.0	3.4	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.0
GRK4	"GPRK2L, GPRK4"	ENSG00000125388	"G protein-coupled receptor kinase 4"	P32298	4	2963608-3040747	"Enzymes, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 41.2"	"Group enriched"	"Detected in many"	5	"Cone photoreceptor cells: 115.8;Early spermatids: 282.7;Late spermatids: 377.5;Spermatocytes: 110.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA028737, HPA057023"	Approved		Approved	Lysosomes		NA	NA			Lysosomes		"HPA028737: AB_2672757, HPA057023: AB_2683313"	"unprognostic (1.86e-2)"	"unprognostic (2.88e-1)"	"unprognostic (1.03e-1)"	"unprognostic (9.51e-3)"	"unprognostic (3.65e-1)"	"unprognostic (1.84e-1)"	"unprognostic (1.21e-1)"	"unprognostic (2.39e-1)"	"unprognostic (1.79e-1)"	"unprognostic (1.87e-1)"	"unprognostic (3.90e-4)"	"unprognostic (3.20e-1)"	"unprognostic (1.01e-2)"	"unprognostic (4.74e-2)"	"unprognostic (2.17e-1)"	"unprognostic (1.17e-1)"	"unprognostic (1.89e-1)"	3.4	3.6	5.4	1.6	5.1	1.7	4.8	12.5	5.9	3.0	2.1	4.2	1.0	1.5	2.7	3.1	2.4	2.0	3.0	5.6	5.2	4.8	2.8	2.3	2.4	1.6	5.3	5.3	3.4	7.9	3.9	6.2	2.2	5.9	2.4	2.0	3.1	4.0	2.9	5.0	2.9	1.7	2.8	5.4	1.9	2.5	41.2	3.7	1.6	4.1	1.6	1.7	2.5	3.3	1.2	2.5	4.5	2.0	1.6	1.7	1.0	2.5	0.9	3.0	8.7	7.4	7.1	1.9	4.9	2.1	2.8	2.4	2.4	0.8	5.6	2.1	7.7	5.4	0.8	4.0	4.0	2.5	3.8	4.0	6.1	3.5	2.8	4.4	2.4	2.2	4.8	6.3	4.9	2.3	3.1	5.2	6.0	5.7	7.4	6.5	2.8	5.2	5.2	2.4	3.5	6.9	6.6	3.9	2.2	2.6	3.1	17.6	5.4	2.9	1.3	4.4	2.2	6.7	3.8	6.0	7.6	2.0	5.1	4.3	7.6	4.3	4.3	3.7	5.4	2.5	4.5	1.1	2.1	1.1	2.0	1.4	1.1	0.7	0.7	0.3	1.2	1.7	1.6	4.0	1.6	0.7	2.5	0.4	1.0	5.4	5.1	12.5	5.9	5.2	4.8	5.3	5.3	5.9	3.7	3.0	9.0	0.0	2.5	10.0	48.5	9.0	7.6	1.4	7.9	3.5	115.8	1.8	11.6	2.4	282.7	3.8	1.0	0.0	3.3	3.5	9.9	1.5	5.7	2.5	3.0	17.5	9.9	3.1	2.2	377.5	12.0	3.2	6.8	2.8	1.7	10.3	1.8	0.0	7.8	3.6	48.9	6.5	4.4	110.9	13.6	9.9	2.5	4.4	1.2	2.3
GRK5	GPRK5	ENSG00000198873	"G protein-coupled receptor kinase 5"	P34947	10	119207589-119459742	"Enzymes, Predicted intracellular proteins"	"Apoptosis, Wnt signaling pathway"	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	8	"Alveolar cells type 1: 53.6;Sertoli cells: 58.2;Smooth muscle cells: 37.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 35.6;HUVEC TERT2: 28.2;OE19: 27.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB025579, HPA046838"	Approved		Supported	"Nuclear membrane,Nuclear speckles,Plasma membrane"		NA	NA			"Nuclear membrane, Nuclear speckles"	"Plasma membrane"	"CAB025579: , HPA046838: AB_2679833"	"unprognostic (1.09e-1)"	"unprognostic (3.47e-1)"	"unprognostic (1.19e-1)"	"unprognostic (6.02e-2)"	"unprognostic (6.56e-2)"	"unprognostic (3.74e-2)"	"unprognostic (4.62e-2)"	"unprognostic (3.69e-1)"	"unprognostic (4.11e-1)"	"unprognostic (1.06e-1)"	"unprognostic (3.70e-1)"	"unprognostic (2.32e-1)"	"prognostic unfavorable (2.38e-7)"	"unprognostic (1.10e-1)"	"unprognostic (3.27e-2)"	"unprognostic (1.55e-2)"	"unprognostic (1.90e-2)"	15.9	8.3	3.4	16.8	7.8	2.7	10.2	6.5	5.0	12.5	18.8	3.9	4.5	12.4	13.4	12.2	8.1	7.7	19.5	45.4	4.2	4.2	4.3	5.7	27.6	8.8	3.7	2.5	16.5	3.5	26.2	6.3	24.0	4.5	7.5	6.4	5.6	5.0	6.7	12.8	4.7	10.4	10.8	4.8	17.0	13.9	3.5	4.7	9.8	8.9	10.7	8.6	9.5	13.6	9.3	2.2	6.5	3.7	0.2	11.3	4.2	3.9	2.3	5.9	6.0	13.5	13.0	1.7	7.6	35.6	4.7	2.7	1.9	5.7	4.2	1.8	11.9	8.3	0.9	2.5	8.4	3.1	16.7	2.1	0.7	4.9	7.5	9.3	0.2	2.1	1.8	1.2	9.6	1.4	5.7	28.2	2.6	0.4	4.1	1.7	0.6	3.9	3.8	0.8	27.1	5.9	1.4	0.8	1.0	0.7	1.6	1.9	5.4	2.6	1.2	7.3	3.6	0.1	1.0	8.5	2.6	1.8	15.5	3.0	0.9	4.5	2.6	5.4	4.7	2.4	0.9	3.7	6.5	5.3	3.2	0.4	9.3	7.7	3.8	2.2	9.1	11.3	5.0	5.0	0.2	0.9	0.0	9.2	4.2	3.4	7.8	6.5	5.0	4.2	4.2	3.7	2.5	4.5	4.7	53.6	5.9	13.7	0.5	1.4	3.4	14.6	0.0	1.4	2.3	3.5	0.0	2.4	0.0	1.0	11.8	24.8	0.9	0.0	2.7	13.7	12.4	0.6	4.6	1.7	3.6	1.6	4.6	21.5	10.4	2.9	4.0	5.1	6.8	0.0	0.7	0.0	1.7	0.2	4.2	0.4	0.7	58.2	37.3	1.4	1.7	2.0	11.0	10.2	0.3	0.9
GRK6	GPRK6	ENSG00000198055	"G protein-coupled receptor kinase 6"	P43250	5	177403204-177442901	"Enzymes, Predicted intracellular proteins"	"Wnt signaling pathway"	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 68.1"	"Cell type enhanced"	"Detected in many"	4	"Late spermatids: 57.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA015327, HPA018903"	Approved		Approved	Mitochondria		NA	NA		7500	Mitochondria		"HPA015327: AB_1850334, HPA018903: AB_1850335"	"unprognostic (1.06e-1)"	"unprognostic (3.39e-2)"	"unprognostic (4.46e-2)"	"unprognostic (3.87e-2)"	"unprognostic (2.35e-3)"	"unprognostic (1.53e-1)"	"prognostic unfavorable (5.66e-6)"	"unprognostic (2.63e-1)"	"unprognostic (6.45e-2)"	"unprognostic (8.96e-2)"	"prognostic favorable (1.22e-4)"	"unprognostic (1.74e-2)"	"unprognostic (1.99e-2)"	"unprognostic (1.83e-3)"	"unprognostic (1.15e-1)"	"unprognostic (4.00e-2)"	"unprognostic (3.47e-1)"	6.8	5.5	7.8	26.8	7.3	68.1	10.2	7.7	10.9	5.9	9.2	6.6	5.0	10.9	8.0	6.0	11.0	6.6	9.3	6.2	8.0	7.3	5.7	6.6	11.1	37.6	7.1	10.7	6.1	12.1	3.5	5.6	4.9	6.7	8.1	5.5	5.0	10.8	5.2	7.4	7.7	14.5	7.8	5.4	34.3	9.1	10.5	5.1	32.3	5.3	6.4	26.5	11.4	6.5	9.2	5.7	32.1	22.6	17.4	11.7	9.1	12.1	13.3	4.8	21.1	1.4	2.4	20.7	8.9	4.7	11.3	11.2	30.8	10.4	14.5	13.7	4.7	16.7	8.9	7.5	20.5	4.4	39.6	23.4	12.8	10.8	10.4	7.9	17.2	16.3	3.8	5.1	11.2	6.6	2.8	6.3	26.7	13.3	52.3	3.4	34.8	17.7	18.1	8.3	6.1	14.7	17.0	7.8	20.9	3.3	9.9	11.2	15.2	7.4	13.1	17.3	2.3	10.4	19.0	8.0	9.2	13.8	9.8	22.4	15.1	18.3	11.8	6.2	28.2	8.9	4.5	9.5	32.1	11.7	16.5	8.4	9.2	9.8	10.7	5.5	9.2	10.4	9.0	23.2	17.4	22.6	5.7	11.7	9.1	7.8	7.3	7.7	10.9	8.0	7.3	7.1	10.7	6.7	5.1	0.0	2.1	37.2	46.6	21.1	9.5	2.0	7.6	0.0	3.4	3.5	5.9	10.9	13.3	3.9	31.4	4.5	11.3	23.3	7.1	10.5	8.0	37.0	14.9	5.3	18.5	15.9	10.9	8.6	27.3	57.4	5.8	20.0	13.5	1.8	13.4	6.1	8.1	13.3	4.9	6.9	7.3	12.9	10.3	2.2	3.6	17.8	10.6	41.1	16.3	52.8
GRK7	GPRK7	ENSG00000114124	"G protein-coupled receptor kinase 7"	Q8WTQ7	3	141778148-141818490	"Enzymes, Predicted intracellular proteins"	"Sensory transduction, Vision"	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"blood: 2.4"	"Cell type enriched"	"Detected in some"	168	"Cone photoreceptor cells: 310.2"	"Not detected"	"Not detected"							"Cell type enhanced"	"Detected in single"		"neutrophil: 2.4"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"BEWO: 4.1;HeLa: 1.5;U-937: 1.8"					"Not detected"	"Not detected"			"HPA075093, HPA078232"	Enhanced		Approved	Mitochondria		NA	NA			Mitochondria		"HPA075093: , HPA078232: "	"unprognostic (1.11e-1)"	"unprognostic (1.70e-2)"	"unprognostic (3.35e-3)"	"unprognostic (1.22e-2)"	"unprognostic (1.13e-1)"	"unprognostic (1.60e-1)"	"unprognostic (1.39e-2)"	"unprognostic (5.08e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.31e-2)"	"unprognostic (3.46e-2)"	"unprognostic (1.20e-1)"	"unprognostic (2.53e-8)"	"unprognostic (3.08e-1)"	"unprognostic (1.99e-1)"	"unprognostic (3.11e-1)"	"unprognostic (2.91e-1)"	0.2	0.5	0.3	0.5	0.4	1.5	0.2	0.9	0.3	0.2	0.1			0.4	0.3	0.0	0.3	0.3	0.0	0.2	0.3	0.3	0.2	0.0	0.2	0.2	0.2		0.6	0.3	0.7	0.2	0.2		0.3	0.0		0.4	0.2	1.6	1.5	0.4	0.0	0.2	0.4	0.1	1.0			0.1		0.3	0.1	0.3	0.7	0.2	2.4	0.4	0.5	0.6	0.1	0.0	0.1	0.1	0.6	0.4	0.0	4.1	0.1	0.0	0.0	0.1	0.2	0.6	0.2	0.2	0.1	0.0	0.1	0.1	0.0	0.1	0.5	0.5	0.2	1.5	0.2	0.0	0.4	0.3	0.1	1.1	0.0	0.1	0.0	0.0	0.3	0.2	0.2	0.0	0.2	0.2	0.7	0.4	0.2	0.2	0.2	0.1	0.2	0.0	0.5	0.3	0.4	0.2	0.0	0.0	0.2	0.5	0.2	0.2	0.2	0.2	0.0	0.0	0.2	0.0	0.2	0.1	1.8	0.2	0.2	0.4	0.3	0.4	0.2	0.6	0.6	0.5	0.3	0.1	0.7	0.5	0.5	2.4	0.5	0.3	0.2	0.2	0.1											0.0	0.0	0.0	0.1	0.3	1.0	0.2	0.0	0.0	0.0	0.0	310.2	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	1.0	0.1	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0
GSK3A		ENSG00000105723	"Glycogen synthase kinase 3 alpha"	P49840	19	42230186-42242625	"Cancer-related genes, Enzymes, Predicted intracellular proteins"	"Carbohydrate metabolism, Glycogen metabolism, Neurogenesis, Wnt signaling pathway"	"Kinase, Serine/threonine-protein kinase, Signal transduction inhibitor, Transferase"	"Alzheimer disease, Cancer-related genes, Diabetes mellitus"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004422, HPA028423"	Approved		Approved	Cytosol		NA	NA			Cytosol		"CAB004422: AB_627680, HPA028423: AB_10612116"	"unprognostic (5.46e-2)"	"unprognostic (1.50e-1)"	"unprognostic (1.45e-1)"	"prognostic unfavorable (4.02e-4)"	"unprognostic (1.35e-1)"	"unprognostic (3.96e-2)"	"prognostic unfavorable (1.13e-4)"	"unprognostic (3.80e-3)"	"unprognostic (2.27e-1)"	"unprognostic (2.87e-1)"	"unprognostic (4.99e-2)"	"unprognostic (3.36e-1)"	"unprognostic (2.69e-1)"	"unprognostic (2.77e-2)"	"unprognostic (4.49e-2)"	"unprognostic (7.22e-2)"	"unprognostic (8.22e-3)"	15.3	19.8	31.0	16.8	38.0	14.4	12.0	31.4	62.2	15.9	16.8	24.3	11.4	28.6	16.9	18.0	17.3	16.7	11.8	21.3	31.3	23.6	17.5	13.1	14.2	15.0	21.8	26.3	20.0	19.3	16.1	14.2	14.7	31.7	15.8	16.1	15.5	18.1	20.3	41.0	25.1	27.0	18.5	18.0	14.5	14.7	19.1	17.7	16.6	15.8	11.9	15.8	15.8	15.5	1.6	2.2	4.0	1.9	1.7	2.0	1.0	23.4	41.6	23.8	22.1	14.3	12.8	10.1	16.5	15.8	21.9	19.8	15.6	14.9	17.0	17.1	12.9	20.6	10.8	19.6	19.2	15.4	13.7	31.4	17.7	13.3	15.4	18.8	20.0	21.6	12.5	20.4	17.9	20.5	19.0	19.8	12.7	29.6	25.3	18.7	28.4	25.9	17.7	17.6	36.7	17.2	23.7	13.8	13.0	20.2	24.6	27.8	28.1	22.6	29.7	15.0	17.1	17.2	26.5	17.6	22.6	17.0	13.1	29.2	25.9	29.7	13.2	26.2	20.2	24.7	2.5	1.5	1.6	2.0	1.9	1.4	1.2	1.2	1.3	1.4	1.6	0.7	1.5	4.0	1.7	1.1	2.2	1.0	1.0	31.0	38.0	31.4	62.2	31.3	23.6	21.8	26.3	31.7	17.7	6.0	21.0	14.9	15.9	21.9	42.9	10.9	10.2	1.4	6.8	15.7	58.9	20.8	3.3	12.4	6.3	20.2	39.2	0.0	14.9	21.1	14.6	22.2	2.3	12.4	17.7	57.2	22.4	16.5	18.9	8.8	16.4	16.9	15.1	6.4	28.2	37.9	18.9	22.9	15.6	13.1	40.2	6.5	16.5	10.2	16.6	24.6	36.8	12.8	23.8	23.5
GSK3B		ENSG00000082701	"Glycogen synthase kinase 3 beta"	P49841	3	119821323-120094417	"Enzymes, Predicted intracellular proteins"	"Biological rhythms, Carbohydrate metabolism, Differentiation, Glycogen metabolism, Neurogenesis, Wnt signaling pathway"	"Developmental protein, Kinase, Serine/threonine-protein kinase, Signal transduction inhibitor, Transferase"	"Alzheimer disease, Diabetes mellitus"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Horizontal cells: 135.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB016263, HPA028017"	Approved		Supported	Nucleoplasm		No	No		81000	Nucleoplasm		"CAB016263: AB_2279451, HPA028017: AB_10600708"	"unprognostic (1.09e-2)"	"unprognostic (2.62e-1)"	"unprognostic (1.40e-1)"	"unprognostic (2.17e-3)"	"unprognostic (1.15e-1)"	"unprognostic (4.86e-2)"	"prognostic unfavorable (8.20e-5)"	"unprognostic (3.39e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.67e-2)"	"unprognostic (1.05e-3)"	"unprognostic (6.79e-2)"	"prognostic favorable (1.52e-4)"	"unprognostic (2.39e-1)"	"unprognostic (2.58e-1)"	"unprognostic (1.28e-2)"	"unprognostic (1.16e-1)"	17.6	17.6	17.4	13.8	21.3	25.0	13.7	32.7	28.3	15.8	16.0	15.6	7.1	15.5	14.5	12.6	20.3	12.4	14.4	20.8	17.1	22.4	15.7	21.7	17.1	17.5	17.0	22.6	14.0	14.9	25.0	19.2	24.1	18.1	13.9	17.9	14.9	18.5	11.7	23.9	21.6	18.2	17.1	13.4	26.3	13.3	30.8	14.4	46.5	17.4	8.4	14.1	14.2	15.7	1.7	2.0	10.6	3.1	1.4	3.0	1.0	28.7	13.9	23.3	13.5	15.5	15.8	22.6	16.2	31.2	15.6	14.3	15.0	11.8	11.7	10.0	23.1	18.1	19.7	11.0	31.5	24.3	7.9	3.1	17.0	10.4	11.2	17.7	17.5	22.9	15.9	21.2	16.6	34.0	12.7	17.1	15.5	7.2	22.8	20.4	15.6	18.5	4.9	12.7	11.0	14.4	7.4	19.9	11.2	11.3	20.6	17.6	10.9	19.1	13.9	18.7	23.8	17.2	11.8	21.9	22.4	25.3	7.0	9.6	15.1	13.9	22.6	13.9	11.7	17.8	4.3	2.9	7.5	2.4	2.6	2.1	1.1	2.0	3.0	2.0	1.7	2.0	1.5	10.6	1.4	3.1	1.6	1.3	1.0	17.4	21.3	32.7	28.3	17.1	22.4	17.0	22.6	18.1	14.4	29.8	26.1	16.6	27.4	45.2	58.2	34.8	17.8	13.4	17.0	17.4	56.9	22.4	10.0	21.7	114.4	21.8	32.1	0.0	28.0	43.2	22.6	25.0	17.3	20.3	19.0	135.1	25.8	23.9	27.9	40.1	12.0	22.7	33.7	24.4	23.3	27.6	35.4	22.6	18.7	11.5	40.3	12.9	20.0	34.2	22.5	35.9	35.9	24.1	20.4	35.8
GSR		ENSG00000104687	"Glutathione-disulfide reductase"	P00390	8	30678061-30727999	"Cancer-related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"		Oxidoreductase	"Cancer-related genes, Disease mutation, FDA approved drug targets, Hereditary hemolytic anemia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Enterocytes: 61.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001538, CAB008632, HPA064806"	Approved		Supported	Cytosol		NA	NA		110000000	Cytosol		"CAB008632: AB_1616690, HPA001538: AB_1078986, HPA064806: "	"unprognostic (1.23e-1)"	"prognostic favorable (3.37e-4)"	"prognostic favorable (4.08e-5)"	"unprognostic (2.89e-3)"	"unprognostic (1.62e-1)"	"unprognostic (3.50e-1)"	"prognostic unfavorable (3.26e-5)"	"unprognostic (3.61e-2)"	"unprognostic (1.01e-1)"	"unprognostic (4.15e-2)"	"unprognostic (2.83e-2)"	"unprognostic (6.92e-3)"	"prognostic favorable (1.80e-4)"	"unprognostic (2.31e-3)"	"unprognostic (2.26e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.29e-1)"	8.9	14.4	6.8	10.7	9.1	7.9	6.2	9.1	11.8	18.6	18.7	7.1	18.4	20.4	13.2	12.0	19.4	8.8	17.3	11.9	5.0	5.7	27.9	17.8	10.8	9.7	4.9	6.0	11.8	17.6	22.9	7.2	8.9	6.8	16.4	17.2	10.9	12.0	17.4	14.7	6.5	31.8	9.3	4.5	13.6	17.7	7.9	4.2	17.0	9.2	11.8	12.0	23.9	14.5	2.5	4.7	19.0	5.7	2.6	7.3	2.1	11.6	49.4	8.0	6.2	8.6	9.7	7.7	5.2	11.5	7.4	10.0	14.5	6.2	22.8	25.8	6.7	22.0	13.1	12.1	11.3	8.2	5.9	11.2	23.0	17.1	48.5	23.2	7.0	37.0	16.1	7.1	11.1	4.5	8.1	10.5	14.5	19.0	10.1	16.7	10.6	24.7	8.2	14.2	48.3	8.8	9.4	9.2	11.0	14.8	29.6	6.1	7.8	7.2	16.8	12.5	11.2	7.2	8.0	14.3	3.1	8.6	7.3	7.7	5.6	6.2	14.7	9.9	9.9	10.1	19.0	4.6	11.5	4.2	4.2	7.3	2.5	3.8	4.6	4.7	2.0	2.4	3.1	6.5	2.6	5.7	2.9	3.2	2.1	6.8	9.1	9.1	11.8	5.0	5.7	4.9	6.0	6.8	4.2	3.0	21.0	15.2	10.5	3.8	6.1	21.4	30.6	9.4	14.8	12.2	15.7	11.8	8.3	9.6	6.9	8.0	61.3	0.0	17.1	5.3	5.4	23.6	5.8	37.6	15.4	3.2	32.7	15.4	38.4	14.1	6.6	12.8	8.5	5.4	52.8	11.8	14.3	34.0	10.3	14.4	7.5	6.5	6.2	1.2	4.4	4.6	5.4	11.3	38.8	23.0
GSS		ENSG00000100983	"Glutathione synthetase"	P48637	20	34928433-34956027	"Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"	"Glutathione biosynthesis"	Ligase	"Disease mutation, FDA approved drug targets, Hereditary hemolytic anemia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA054508, HPA059315"	Enhanced		Supported	Nucleoplasm		NA	NA		23000000	Nucleoplasm		"HPA054508: AB_2682509, HPA059315: AB_2683976"	"unprognostic (5.80e-2)"	"unprognostic (1.50e-1)"	"unprognostic (1.14e-1)"	"unprognostic (7.21e-2)"	"unprognostic (3.63e-2)"	"unprognostic (5.68e-2)"	"prognostic unfavorable (7.21e-5)"	"unprognostic (2.90e-2)"	"unprognostic (8.52e-2)"	"unprognostic (3.64e-1)"	"unprognostic (6.49e-2)"	"unprognostic (1.50e-1)"	"prognostic favorable (7.31e-6)"	"unprognostic (3.35e-3)"	"unprognostic (1.96e-1)"	"unprognostic (1.42e-3)"	"unprognostic (1.52e-1)"	12.9	29.8	14.7	13.2	21.0	16.0	16.2	9.2	27.6	12.7	26.9	17.2	28.9	20.0	11.5	47.5	25.6	18.5	18.3	14.6	15.0	15.9	30.5	30.9	12.1	11.7	15.1	15.1	11.6	10.3	17.5	15.6	27.2	15.3	18.6	27.6	15.4	19.1	19.4	10.7	19.1	21.4	12.9	13.3	13.3	15.7	16.8	9.2	17.0	18.0	12.0	21.0	14.4	13.9	7.3	24.3	7.9	21.3	15.2	18.3	14.9	18.2	22.2	10.9	15.3	12.7	13.2	15.5	15.6	14.4	24.6	20.4	40.7	22.3	12.9	20.8	16.0	23.8	17.4	15.9	39.7	20.8	6.0	9.0	51.0	14.1	40.4	17.9	12.8	18.0	13.9	42.5	23.1	39.1	11.0	17.4	17.6	24.6	10.6	29.8	20.1	20.4	18.2	6.4	24.1	28.7	18.8	21.9	30.7	35.2	18.7	21.4	12.5	27.5	25.8	20.5	6.2	31.7	11.7	13.7	28.3	16.1	18.6	13.4	10.8	10.0	14.2	24.1	14.1	16.8	7.9	20.3	4.6	18.0	21.3	16.1	7.3	14.5	18.3	24.3	5.2	16.9	14.3	5.3	15.2	19.0	13.5	17.5	14.9	14.7	21.0	9.2	27.6	15.0	15.9	15.1	15.1	15.3	9.2	17.9	8.0	10.4	28.7	23.4	20.6	14.0	30.6	8.1	12.5	24.4	9.8	69.5	21.6	40.0	44.5	14.6	44.5	0.0	41.7	42.0	15.3	18.9	17.3	23.3	52.3	33.4	22.5	5.5	16.2	108.3	9.5	20.4	15.1	40.5	44.4	26.6	32.4	28.8	17.3	95.3	15.4	25.8	12.2	16.4	14.7	21.1	41.0	20.3	70.9	22.9
GSTA1		ENSG00000243955	"Glutathione S-transferase alpha 1"	P08263	6	52791664-52803910	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Isomerase, Oxidoreductase, Peroxidase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	8	"adrenal gland: 119.4;intestine: 202.4;kidney: 79.7;liver: 214.4;testis: 78.2"	"Cell type enhanced"	"Detected in many"	13	"Cholangiocytes: 614.0;Ciliated cells: 837.9;Exocrine glandular cells: 1419.6;Hepatocytes: 628.5;Pancreatic endocrine cells: 1010.1;Proximal tubular cells: 2005.4"	"Group enriched"	"Detected in many"	6	"liver cancer: 555.4;renal cancer: 135.0"	"Region enriched"	"Detected in single"	6	"basal ganglia: 4.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	13	"Hep G2: 89.9"									"HPA004342, HPA048934, HPA053817"	Supported		Supported	Cytosol		NA	NA	27800000		Cytosol		"HPA004342: AB_1078987, HPA048934: AB_2680563, HPA053817: AB_2630367"	"unprognostic (4.84e-3)"	"unprognostic (2.40e-2)"	"unprognostic (3.40e-1)"	"unprognostic (4.78e-2)"	"unprognostic (1.72e-1)"	"unprognostic (1.26e-1)"	"unprognostic (1.00e-2)"	"prognostic favorable (8.66e-4)"	"unprognostic (5.75e-2)"	"unprognostic (6.90e-3)"	"unprognostic (3.00e-1)"	"unprognostic (8.27e-2)"	"prognostic unfavorable (3.71e-4)"	"unprognostic (1.21e-1)"	"unprognostic (4.26e-3)"	"unprognostic (1.02e-1)"	"unprognostic (2.16e-2)"	0.6	119.4	0.6	0.7	4.2	0.0	0.6	0.6	0.7	0.8	64.3	4.3	0.6	59.9	0.6	1.2	0.7	6.9	16.4	0.6	0.6	0.0	79.7	214.4	7.1	0.6	0.6	0.6	8.5	16.9	0.0	0.7	0.9	0.7	1.8	0.2	1.0	2.6	0.8	0.6	0.1	202.4	0.6	0.6	0.6	10.7	78.2	0.6	0.7	0.6	2.1	4.4	0.6	0.6	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	6.7	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	89.9	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.1	0.0	0.0	0.3	0.7	0.0	0.0	0.7	1.1	0.1	0.0	0.0	0.5	0.0	0.0	0.1	0.2	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.6	4.2	0.6	0.7	0.6	0.0	0.6	0.6	0.7	0.6	6.0	7.7	0.0	2.8	0.0	0.0	0.0	614.0	837.9	106.9	69.8	0.0	0.1	454.3	72.7	8.0	0.0	11.8	46.7	1419.6	0.0	0.0	51.4	2.3	628.5	0.1	0.0	2.9	23.4	22.6	21.8	60.7	4.4	0.0	22.6	33.3	0.0	1010.1	6.0	4.2	2005.4	0.0	0.0	0.0	5.6	3.4	0.0	0.5	4.3	29.3	42.0
GSTA2	GST2	ENSG00000244067	"Glutathione S-transferase alpha 2"	P09210	6	52750089-52763569	"Enzymes, Predicted intracellular proteins"		Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"kidney: 63.4;liver: 192.2;pancreas: 54.1"	"Cell type enhanced"	"Detected in many"	15	"Cholangiocytes: 338.8;Ciliated cells: 780.3;Pancreatic endocrine cells: 549.6;Proximal tubular cells: 368.8"	"Group enriched"	"Detected in many"	16	"liver cancer: 124.6;renal cancer: 48.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	13	"CACO-2: 20.7;Hep G2: 15.9"									"HPA004342, HPA048934, HPA053817"	Supported		Supported	Cytosol		NA	NA			Cytosol		"HPA004342: AB_1078987, HPA048934: AB_2680563, HPA053817: AB_2630367"	"unprognostic (1.14e-1)"		"unprognostic (1.20e-1)"	"unprognostic (2.72e-2)"			"unprognostic (1.15e-1)"	"unprognostic (6.43e-3)"		"unprognostic (2.41e-1)"	"unprognostic (1.30e-1)"	"unprognostic (1.15e-1)"	"prognostic unfavorable (1.17e-4)"	"unprognostic (4.34e-2)"	"unprognostic (1.91e-1)"		"unprognostic (6.54e-2)"	0.2	1.1	0.2	0.2	0.2	0.0	0.2	0.2	0.2	0.2	6.4	0.2	0.2	13.4	0.2	0.3	0.2	0.0	9.9	0.2	0.2	0.0	63.4	192.2	5.3	0.2	0.2	0.2	0.3	54.1	0.0	0.2	0.3	0.2	0.7	0.0	0.2	0.3	0.2	0.2	0.0	27.6	0.2	0.2	0.2	1.5	14.1	0.2	0.2	0.2	0.2	0.3	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.0	0.0	0.0	20.7	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.9	0.0	15.9	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.1	0.0	1.4	0.0	0.0	0.5	0.3	0.0	0.0	0.0	0.1	0.6	0.0	0.0	0.5	0.0	0.0	0.2	0.5	0.3	0.4	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.2	0.2	0.2	0.2	0.2	0.0	0.2	0.2	0.2	0.2	0.0	5.9	0.5	0.1	0.0	0.0	0.0	338.8	780.3	46.6	15.7	0.0	0.0	180.8	6.3	4.5	0.0	0.0	0.0	201.6	0.1	0.0	5.3	0.0	50.4	0.1	0.0	0.0	1.3	1.6	6.5	1.1	1.3	0.0	9.0	0.4	0.0	549.6	0.0	0.4	368.8	0.0	0.0	0.0	1.4	0.4	0.0	0.0	0.0	0.1	1.0
GSTA3		ENSG00000174156	"Glutathione S-transferase alpha 3"	Q16772	6	52896639-52909685	"Enzymes, Predicted intracellular proteins"		Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"adrenal gland: 36.5;fallopian tube: 32.4;placenta: 51.9"	"Group enriched"	"Detected in some"	8	"Cytotrophoblasts: 121.8;Syncytiotrophoblasts: 430.9"	"Low cancer specificity"	"Detected in some"			"Region enhanced"	"Detected in single"		"pons and medulla: 2.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 2.1;CACO-2: 1.2;HAP1: 2.3;HEK 293: 1.2;SK-BR-3: 2.1;SuSa: 5.2"									"HPA004342, HPA048934, HPA053817"	Approved		Supported	Cytosol		NA	NA			Cytosol		"HPA004342: AB_1078987, HPA048934: AB_2680563, HPA053817: AB_2630367"	"unprognostic (7.51e-2)"			"unprognostic (7.06e-3)"		"unprognostic (3.10e-1)"	"unprognostic (5.53e-2)"	"unprognostic (4.38e-3)"	"unprognostic (2.86e-3)"	"unprognostic (1.81e-1)"		"unprognostic (1.41e-1)"		"unprognostic (1.93e-1)"	"unprognostic (9.35e-2)"			0.2	36.5	0.2	0.2	0.6	0.0	0.7	0.3	0.2	0.9	0.2	1.0	0.2	0.0	0.3	6.6	0.2	32.4	0.2	0.2	0.2	0.2	0.2	0.2	1.3	0.2	0.2	0.2	3.8	0.2	1.1	0.2	51.9	2.1	0.2	0.0	0.5	0.6	0.2	0.2	12.5	0.2	0.2	0.2	0.2	1.0	6.4	0.3	0.2	0.2	0.9	0.2	0.2	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.9	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	2.1	0.0	5.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.6	0.3	0.2	0.2	0.2	0.2	0.2	2.1	0.3	0.0	0.6	0.0	0.0	0.9	0.0	0.0	0.0	33.5	10.3	0.0	0.0	121.8	0.0	0.0	0.9	0.0	0.0	0.0	0.0	6.4	0.2	0.0	1.1	0.2	13.5	0.0	0.0	0.0	0.0	1.3	1.4	0.0	23.6	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.5	8.5	430.9	0.0	0.0	0.0
GSTA4		ENSG00000170899	"Glutathione S-transferase alpha 4"	O15217	6	52977948-52995378	"Enzymes, Predicted intracellular proteins"		Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adrenal gland: 105.4"	"Cell type enhanced"	"Detected in many"	10	"Cytotrophoblasts: 233.2;Syncytiotrophoblasts: 376.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	6	"non-classical monocyte: 17.4"	"Lineage enriched"	"Detected in many"	6	"monocytes: 17.4"	"Cell line enhanced"	"Detected in many"		"AF22: 32.5;ASC TERT1: 32.2"					"Low region specificity"	"Detected in all"			HPA048934	Approved					NA	NA					"HPA048934: AB_2680563"	"unprognostic (5.13e-3)"	"unprognostic (2.75e-1)"	"unprognostic (5.04e-2)"	"unprognostic (1.38e-1)"	"unprognostic (5.24e-2)"	"unprognostic (3.63e-3)"	"unprognostic (1.81e-1)"	"unprognostic (1.63e-2)"	"unprognostic (5.05e-3)"	"unprognostic (9.26e-2)"	"unprognostic (3.31e-3)"	"unprognostic (2.29e-2)"	"unprognostic (1.34e-2)"	"unprognostic (2.21e-1)"	"unprognostic (4.07e-3)"	"unprognostic (1.53e-1)"	"unprognostic (1.13e-1)"	6.3	105.4	15.0	3.4	27.0	0.8	12.2	23.8	29.6	11.2	6.7	13.2	4.3	7.2	12.2	21.0	18.6	8.8	7.8	6.7	16.7	17.8	10.7	11.3	15.1	2.8	11.7	19.2	18.4	10.2	29.1	27.3	16.2	21.6	14.0	8.5	15.5	13.9	10.1	10.6	45.2	6.6	8.9	11.3	5.1	12.1	12.7	6.8	0.9	8.5	18.4	9.4	5.9	13.6	2.8	1.9	0.0	17.4	3.1	3.1	0.9	0.4	3.4	32.5	26.5	18.7	32.2	2.9	4.8	11.2	3.1	5.2	4.9	0.1	0.3	3.2	8.7	3.5	1.4	22.9	4.4	4.0	0.8	10.4	1.1	2.8	17.3	13.8	0.0	0.7	27.4	6.7	4.1	3.3	10.0	19.0	5.7	4.1	5.1	10.4	0.0	0.4	0.1	12.2	19.4	5.9	0.9	13.7	5.8	11.1	0.5	14.5	21.0	0.1	3.4	8.3	17.0	0.8	1.0	10.0	3.4	8.0	3.3	3.6	7.1	0.8	0.1	5.2	0.6	3.6	0.0	0.0	0.0	3.1	1.0	2.0	0.9	0.8	1.5	0.8	2.8	0.6	0.9	0.0	3.1	17.4	1.9	0.9	0.9	15.0	27.0	23.8	29.6	16.7	17.8	11.7	19.2	21.6	6.8	47.6	58.1	0.0	20.6	40.0	37.9	8.4	12.7	20.1	23.9	26.2	0.0	233.2	46.4	9.4	1.1	16.8	6.3	23.3	7.7	97.4	41.6	38.0	5.7	19.0	55.1	35.0	23.0	25.8	2.7	6.5	38.6	3.5	91.1	3.6	29.1	70.2	16.8	7.0	36.7	36.1	10.2	19.4	25.4	5.4	9.1	118.4	376.6	5.0	17.0	11.1
GSTA5		ENSG00000182793	"Glutathione S-transferase alpha 5"	Q7RTV2	6	52831655-52846095	"Enzymes, Predicted intracellular proteins"		Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in single"		"testis: 1.3"	"Cell type enriched"	"Detected in single"	5	"Distal tubular cells: 1.7"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA004342, HPA048934, HPA053817"	Uncertain		Approved	Cytosol		NA	NA			Cytosol		"HPA004342: AB_1078987, HPA048934: AB_2680563, HPA053817: AB_2630367"							"unprognostic (1.97e-2)"			"unprognostic (2.83e-1)"								0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.9	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0
GSTK1	GST13	ENSG00000197448	"Glutathione S-transferase kappa 1"	Q9Y2Q3	7	143244093-143270854	"Enzymes, Plasma proteins, Predicted intracellular proteins"		Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	6	"Late spermatids: 923.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"							"HPA006311, HPA022904"	Supported		Supported	Peroxisomes		NA	NA		1300000	Peroxisomes		"HPA006311: AB_1849786, HPA022904: AB_1849787"	"prognostic favorable (4.41e-6)"	"unprognostic (2.40e-1)"	"unprognostic (6.53e-2)"	"unprognostic (4.49e-3)"	"unprognostic (2.92e-2)"	"unprognostic (1.15e-2)"	"unprognostic (1.37e-1)"	"unprognostic (2.99e-1)"	"unprognostic (1.43e-1)"	"unprognostic (3.76e-3)"	"unprognostic (1.99e-2)"	"unprognostic (7.27e-2)"	"prognostic favorable (2.10e-6)"	"unprognostic (2.66e-2)"	"unprognostic (2.94e-1)"	"unprognostic (9.13e-2)"	"unprognostic (2.15e-2)"	38.0	45.3	14.0	45.3	19.9	29.0	43.0	5.6	19.6	30.4	69.0	19.9	35.7	58.0	24.8	39.8	37.8	27.4	55.2	56.4	15.0	13.1	67.6	97.1	35.4	52.2	24.3	16.3	22.7	39.9	46.2	20.7	41.5	23.9	28.0	43.5	34.4	72.9	35.8	38.9	30.0	91.0	22.2	17.5	58.5	34.8	18.9	20.8	27.1	48.0	56.6	50.3	29.4	26.6	32.8	57.1	35.7	75.4	22.3	99.0	95.2	27.3	19.7	2.8	24.6	43.6	62.7	13.1	16.2	27.8	14.5	29.0	11.9	70.3	15.6	23.1	23.4	21.9	41.6	10.8	25.3	12.7	30.0	11.7	12.7	14.8	18.6	30.1	15.3	20.8	56.5	31.2	16.7	11.9	21.7	38.5	20.5	17.8	19.1	38.8	21.1	15.6	27.8	6.5	53.4	29.9	13.5	0.4	30.8	50.2	15.1	11.4	15.6	29.7	48.4	24.6	17.7	23.3	21.5	22.7	7.9	7.3	20.6	13.7	32.7	15.3	3.5	28.6	61.8	16.2	35.7	67.9	25.8	41.1	74.8	39.6	32.8	76.4	52.4	57.1	21.9	39.5	38.1	21.2	22.3	75.4	23.9	99.0	95.2	14.0	19.9	5.6	19.6	15.0	13.1	24.3	16.3	23.9	20.8	65.5	100.3	104.0	135.2	101.4	10.8	146.0	216.6	120.5	84.2	115.1	11.8	257.6	247.1	119.7	471.4	96.3	424.2	23.3	105.8	108.4	95.9	76.6	140.9	263.3	268.7	7.9	147.4	136.2	267.9	923.0	67.3	177.0	143.4	164.1	202.4	80.8	97.6	394.4	47.7	486.1	13.7	84.1	117.9	6.2	8.8	101.8	153.7	238.2	288.1	173.8
GSTM1	"GST1, H-B, MU"	ENSG00000134184	"Glutathione S-transferase mu 1"	P09488	1	109687814-109709039	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins"		Transferase	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 163.2;seminal vesicle: 101.4"	"Cell type enhanced"	"Detected in many"	6	"Alveolar cells type 1: 8.9;Ciliated cells: 9.4;Club cells: 11.4;Ito cells: 8.0;Kupffer cells: 10.1"	"Cancer enhanced"	"Detected in all"		"urothelial cancer: 63.1"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"HEL: 26.9;HeLa: 32.1;HHSteC: 25.7;hTEC/SVTERT24-B: 23.2;HUVEC TERT2: 19.7;MOLT-4: 34.6"									"CAB022669, CAB047357, HPA048652, HPA055972, HPA055973"	Approved		Approved	"Cytokinetic bridge,Cytosol"		NA	NA			Cytosol	"Cytokinetic bridge"	"CAB022669: , CAB047357: , HPA048652: AB_2680478, HPA055972: AB_2682992, HPA055973: AB_2682993"	"unprognostic (2.22e-2)"	"unprognostic (5.35e-2)"	"unprognostic (3.87e-3)"	"unprognostic (3.20e-1)"	"unprognostic (4.95e-2)"	"unprognostic (1.03e-1)"	"unprognostic (3.56e-2)"	"unprognostic (1.81e-1)"	"unprognostic (2.41e-1)"	"unprognostic (6.55e-2)"	"unprognostic (2.34e-1)"	"unprognostic (3.45e-1)"	"unprognostic (3.17e-2)"	"unprognostic (2.12e-1)"	"unprognostic (1.36e-1)"	"unprognostic (2.18e-1)"	"unprognostic (4.72e-3)"	14.5	25.4	15.2	6.9	15.6	2.9	8.2	5.6	19.2	22.0	7.8	16.9	0.0	7.7	9.8	20.2	22.5	13.8	8.2	6.4	14.4	6.8	14.1	163.2	7.7	1.0	7.8	32.1	29.0	18.2	41.4	5.3	2.9	8.2	38.1	6.6	25.7	11.8	101.4	25.1	18.8	17.7	18.2	6.8	21.7	7.5	15.1	11.2	10.9	7.6	1.6	14.5	30.8	19.5	14.6	34.9	14.1	18.9	13.3	17.3	10.0	0.0	0.1	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.2	2.2	8.2	0.0	12.9	0.0	0.4	0.0	0.1	0.2	0.0	0.1	26.9	32.1	0.5	25.7	0.0	0.2	0.0	0.0	23.2	0.1	15.4	19.7	15.8	0.0	18.0	0.8	0.0	34.6	0.2	17.3	0.0	0.0	0.1	0.1	3.4	2.8	0.0	1.7	0.2	0.0	0.1	0.1	0.8	0.3	14.2	0.0	11.5	0.6	0.2	0.0	14.4	19.0	1.1	9.9	0.3	0.6	0.7	12.2	14.1	14.8	18.9	15.7	14.6	15.8	13.7	34.9	14.6	16.5	15.6	1.0	13.3	7.4	19.2	17.3	10.0	15.2	15.6	5.6	19.2	14.4	6.8	7.8	32.1	8.2	11.2	8.9	5.0	0.0	1.0	1.5	0.0	5.6	5.1	9.4	11.4	0.0	0.0	0.0	0.0	0.4	0.0	0.7	0.0	0.0	0.0	0.0	1.7	0.0	2.3	0.6	0.1	0.0	0.0	8.0	10.1	0.0	3.4	0.8	0.0	1.0	0.0	2.3	0.8	0.0	2.1	0.0	0.0	0.0	0.6	0.2	0.2	1.4	0.0	5.3	0.0	0.1
GSTM2	GST4	ENSG00000213366	"Glutathione S-transferase mu 2"	P28161	1	109668022-109709551	"Enzymes, Predicted intracellular proteins"		Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	14	"Cardiomyocytes: 56.8;Ciliated cells: 17.4;Club cells: 20.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"ASC TERT1: 41.4;HSkMC: 41.0"									"CAB040547, HPA055972, HPA055973"	Approved		Supported	Vesicles,Cytosol		NA	NA		930000	Cytosol	Vesicles	"CAB040547: , HPA055972: AB_2682992, HPA055973: AB_2682993"	"unprognostic (2.51e-3)"	"unprognostic (1.28e-1)"	"unprognostic (2.04e-2)"	"unprognostic (2.57e-2)"	"unprognostic (2.20e-1)"	"unprognostic (5.04e-2)"	"unprognostic (7.31e-2)"	"prognostic favorable (9.70e-5)"	"unprognostic (1.51e-2)"	"unprognostic (7.43e-2)"	"unprognostic (1.80e-3)"	"unprognostic (2.94e-1)"	"unprognostic (1.48e-3)"	"unprognostic (1.07e-2)"	"unprognostic (1.87e-1)"	"unprognostic (2.32e-1)"	"unprognostic (2.14e-1)"	23.8	27.3	30.7	14.7	48.3	5.7	31.7	13.7	25.0	36.4	20.9	19.9	54.3	14.5	24.0	37.1	15.4	31.4	15.7	35.2	32.5	21.7	15.9	6.0	11.1	7.5	17.0	21.1	90.1	17.8	20.4	40.2	5.8	22.4	30.7	10.7	36.0	26.6	87.5	88.5	39.2	13.6	22.0	24.9	10.7	16.4	9.2	28.9	6.7	20.4	25.6	8.7	20.2	31.0	5.2	16.5	16.0	3.5	8.9	20.9	5.8	0.0	1.2	13.0	13.3	15.5	41.4	2.5	8.2	14.5	7.6	9.7	2.3	0.0	0.3	8.8	20.6	6.2	0.0	1.0	0.0	9.9	0.5	0.3	4.7	0.1	3.1	10.5	0.4	8.7	41.0	0.3	11.3	0.0	20.5	5.4	3.9	1.3	0.2	16.5	0.1	6.3	8.1	2.4	0.2	11.1	7.9	0.0	0.0	2.3	0.2	2.8	6.4	0.0	0.3	4.2	8.1	13.2	2.3	0.1	8.4	0.4	12.1	0.6	4.1	6.0	0.5	12.7	0.1	0.1	1.0	2.2	16.0	1.9	3.5	1.8	5.2	5.3	2.0	12.7	3.7	20.9	8.9	1.3	8.9	2.1	16.5	4.5	5.8	30.7	48.3	13.7	25.0	32.5	21.7	17.0	21.1	22.4	28.9	0.0	3.7	1.5	1.9	4.2	1.5	56.8	2.5	17.4	20.5	3.5	0.0	0.3	0.0	0.1	1.2	2.4	0.3	0.0	0.0	0.2	3.3	0.6	2.3	0.6	1.2	3.2	0.0	1.3	1.5	6.8	14.4	1.0	5.0	0.0	0.8	11.0	0.1	0.0	9.9	0.8	0.2	6.5	3.1	0.4	0.4	2.5	0.5	4.3	0.4	0.7
GSTM3	GST5	ENSG00000134202	"Glutathione S-transferase mu 3"	P21266	1	109733932-109741038	"Cancer-related genes, Enzymes, Predicted intracellular proteins"		Transferase	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"seminal vesicle: 115.3;testis: 96.0"	"Cell type enhanced"	"Detected in many"	16	"Early spermatids: 1724.2;Late spermatids: 2908.0;Spermatocytes: 818.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"naive CD4 T-cell: 11.1"	"Group enriched"	"Detected in many"	7	"granulocytes: 4.1;T-cells: 11.1"	"Cell line enhanced"	"Detected in many"		"SK-BR-3: 45.7;T-47d: 96.9;WM-115: 37.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"CAB017130, HPA035190, CAB040583, HPA055972"	Enhanced		Approved	Cytosol		NA	NA		560000	Cytosol		"CAB017130: , CAB040583: , HPA035190: AB_10795023, HPA055972: AB_2682992"	"unprognostic (2.13e-2)"	"unprognostic (2.76e-2)"	"unprognostic (1.95e-1)"	"unprognostic (5.87e-2)"	"unprognostic (1.25e-1)"	"unprognostic (7.28e-2)"	"unprognostic (3.28e-3)"	"unprognostic (1.98e-1)"	"prognostic unfavorable (1.89e-4)"	"unprognostic (3.45e-1)"	"unprognostic (1.51e-1)"	"unprognostic (2.30e-1)"	"unprognostic (6.16e-3)"	"unprognostic (1.38e-2)"	"unprognostic (1.21e-2)"	"unprognostic (1.90e-2)"	"unprognostic (3.48e-2)"	7.5	11.3	21.4	2.9	27.8	0.9	23.1	8.5	18.4	15.4	11.7	9.9	51.0	12.6	9.0	67.2	11.1	8.8	12.3	27.6	14.0	14.4	54.0	5.3	5.2	2.4	9.6	22.0	32.3	26.5	7.3	9.4	5.8	30.7	13.6	5.6	13.4	4.5	115.3	15.5	15.0	7.5	15.9	13.3	3.3	14.2	96.0	6.4	0.1	15.8	15.6	3.3	17.4	12.0	0.6	0.8	4.1	0.3	1.0	11.1	1.4	0.0	1.3	9.9	0.0	13.5	8.3	1.7	10.7	1.8	11.8	11.5	4.3	0.3	0.0	6.2	5.4	8.2	0.5	2.0	4.4	16.4	0.0	2.9	10.0	32.5	6.4	14.4	0.0	23.3	8.3	5.4	17.7	0.0	13.1	14.5	12.4	0.9	0.1	5.3	5.8	2.7	0.2	1.1	0.0	18.6	0.0	6.4	0.4	3.3	23.0	17.5	9.4	22.4	45.7	2.1	3.0	96.9	14.6	11.4	0.1	4.3	12.0	7.0	1.5	2.4	0.0	0.1	0.0	37.6	0.8	0.3	4.1	4.2	0.1	1.2	0.6	5.3	3.1	0.1	0.6	11.1	5.5	2.0	1.0	0.2	0.8	2.3	1.4	21.4	27.8	8.5	18.4	14.0	14.4	9.6	22.0	30.7	6.4	6.0	11.5	8.1	96.3	127.5	19.3	82.7	40.8	1.4	17.0	211.1	5.9	13.4	679.8	74.2	1724.2	31.5	27.6	0.0	131.2	7.7	152.1	47.5	9.2	2.5	8.6	14.3	48.5	54.0	6.6	2908.0	356.9	16.6	57.3	5.4	23.4	255.3	110.8	25.9	259.6	35.7	14.3	187.5	89.7	818.6	48.1	93.8	8.6	7.9	40.9	29.8
GSTM4		ENSG00000168765	"Glutathione S-transferase mu 4"	Q03013	1	109656081-109674836	"Enzymes, Predicted intracellular proteins"	"Lipid metabolism"	"Lyase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"intestine: 85.3"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	9	"eosinophil: 69.8"	"Lineage enriched"	"Detected in all"	9	"granulocytes: 69.8"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"							"HPA048652, HPA055972, HPA055973"	Approved		Approved	"Cytokinetic bridge,Cytosol"		NA	NA		660000	Cytosol	"Cytokinetic bridge"	"HPA048652: AB_2680478, HPA055972: AB_2682992, HPA055973: AB_2682993"	"prognostic favorable (9.96e-5)"	"unprognostic (1.96e-3)"	"unprognostic (7.49e-2)"	"unprognostic (9.92e-3)"	"unprognostic (1.48e-1)"	"unprognostic (1.08e-2)"	"unprognostic (8.47e-2)"	"unprognostic (3.48e-2)"	"unprognostic (1.20e-1)"	"unprognostic (4.76e-2)"	"unprognostic (3.73e-1)"	"unprognostic (1.44e-1)"	"unprognostic (1.46e-1)"	"unprognostic (1.92e-2)"	"unprognostic (2.20e-1)"	"unprognostic (1.41e-1)"	"unprognostic (2.47e-2)"	12.5	17.6	14.0	12.3	20.2	3.6	10.9	12.9	24.7	12.6	33.2	18.0	9.4	85.3	12.1	15.3	15.9	11.0	14.5	14.7	13.7	12.3	27.2	22.0	7.4	10.1	14.8	16.9	31.4	12.2	23.1	9.9	5.1	15.8	14.7	23.2	20.5	15.4	26.3	47.4	10.6	77.2	19.0	16.1	16.2	14.7	11.8	14.0	4.0	14.9	14.5	12.8	22.2	14.2	3.6	7.8	69.8	3.0	2.5	3.1	2.3	5.3	2.4	4.3	32.5	9.7	15.0	5.5	1.7	14.0	4.1	5.4	17.1	0.6	5.0	6.7	7.7	8.0	5.5	11.1	5.8	2.6	7.4	0.0	10.9	10.1	15.3	15.8	3.7	13.2	9.5	5.8	5.2	0.0	11.5	3.3	12.9	5.0	7.5	2.8	5.0	3.1	16.4	3.3	22.5	13.0	6.7	2.4	7.3	16.0	3.8	3.1	7.2	0.0	28.2	21.8	3.4	7.6	8.0	1.4	4.7	18.7	5.2	2.5	11.2	19.6	0.4	15.6	5.5	13.3	2.0	2.9	69.8	2.7	3.0	1.6	3.6	2.0	3.1	7.8	2.8	2.0	2.3	0.4	2.5	0.7	2.7	2.8	2.3	14.0	20.2	12.9	24.7	13.7	12.3	14.8	16.9	15.8	14.0	8.9	2.4	13.5	21.7	16.1	5.5	25.8	25.5	10.7	7.9	29.6	0.0	18.5	86.2	40.9	2.6	9.0	85.7	0.0	50.8	15.9	20.4	8.2	20.7	21.9	30.0	4.8	6.9	16.0	14.6	4.7	27.9	17.0	38.8	15.4	33.9	22.1	36.3	28.8	23.3	64.5	4.7	32.3	32.0	5.7	6.9	13.4	7.3	17.8	57.6	10.4
GSTM5		ENSG00000134201	"Glutathione S-transferase mu 5"	P46439	1	109712255-109775428	"Enzymes, Predicted intracellular proteins"		Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	6	"breast: 237.6;ovary: 66.1"	"Group enriched"	"Detected in many"	6	"Leydig cells: 132.9;Muller glia cells: 217.3;Peritubular cells: 119.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"plasmacytoid DC: 5.7"	"Group enriched"	"Detected in many"	5	"dendritic cells: 5.7;T-cells: 1.9"	"Group enriched"	"Detected in some"	7	"fHDF/TERT166: 18.0;HHSteC: 7.7;HSkMC: 8.3"									"HPA048652, HPA055972, HPA055973"	Approved		Uncertain	"Cytokinetic bridge,Cytosol"		NA	NA			Cytosol	"Cytokinetic bridge"	"HPA048652: AB_2680478, HPA055972: AB_2682992, HPA055973: AB_2682993"	"unprognostic (1.46e-2)"	"unprognostic (8.64e-3)"	"unprognostic (5.58e-2)"	"unprognostic (1.42e-1)"	"unprognostic (5.34e-3)"	"unprognostic (8.09e-2)"	"unprognostic (9.64e-4)"	"unprognostic (1.31e-2)"	"unprognostic (1.44e-1)"	"unprognostic (9.16e-2)"	"unprognostic (3.31e-1)"	"unprognostic (1.92e-2)"	"unprognostic (1.42e-2)"	"unprognostic (3.74e-2)"	"unprognostic (4.39e-2)"	"unprognostic (3.03e-3)"	"unprognostic (1.40e-1)"	5.8	3.5	25.7	2.6	23.4	1.6	237.6	15.8	24.6	27.2	4.2	14.0	4.7	2.1	14.0	12.0	4.8	19.8	9.0	4.8	24.9	6.2	2.9	2.1	5.7	2.6	4.9	17.9	66.1	2.7	1.6	2.7	1.6	8.9	12.8	4.0	23.0	3.9	11.9	2.4	3.7	3.5	9.8	11.0	3.5	3.9	5.1	11.9	0.0	2.6	2.1	3.2	10.5	16.1	0.0	5.7	0.6	0.2	0.7	1.9	0.9	0.0	0.0	0.0	0.0	1.6	1.6	0.3	0.9	0.0	0.2	0.1	0.0	0.0	0.0	0.0	18.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	7.7	0.0	0.1	8.3	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.2	0.6	0.1	0.1	0.1	0.0	0.0	0.1	1.3	0.0	0.2	0.2	0.0	0.7	0.0	5.7	1.9	0.9	25.7	23.4	15.8	24.6	24.9	6.2	4.9	17.9	8.9	11.9	0.0	0.3	0.0	0.5	6.0	2.0	0.6	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	8.2	0.8	0.0	0.0	0.0	0.1	12.3	0.1	0.0	0.0	0.2	0.0	0.0	7.4	1.2	9.9	132.9	0.6	10.1	0.0	0.0	217.3	0.0	0.0	119.5	0.0	5.8	25.8	7.6	1.9	1.1	5.6	0.0	0.0	0.0	0.1
GSTO1	"GSTTLp28, P28"	ENSG00000148834	"Glutathione S-transferase omega 1"	P78417	10	104235356-104267459	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Oxidoreductase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 137.3"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"SK-MEL-30: 123.8"	"Low region specificity"	"Detected in all"							"HPA037603, HPA037604"	Enhanced		Approved	Nucleoplasm,Cytosol		NA	NA		200000000	Cytosol	Nucleoplasm	"HPA037603: AB_2675574, HPA037604: AB_10672283"	"prognostic favorable (6.95e-4)"	"unprognostic (9.23e-2)"	"unprognostic (1.43e-2)"	"unprognostic (6.83e-2)"	"unprognostic (7.16e-2)"	"prognostic unfavorable (8.83e-4)"	"unprognostic (1.38e-2)"	"unprognostic (1.84e-1)"	"unprognostic (9.23e-3)"	"unprognostic (4.57e-2)"	"unprognostic (7.65e-2)"	"unprognostic (2.13e-1)"	"prognostic unfavorable (2.11e-4)"	"unprognostic (1.86e-2)"	"unprognostic (1.29e-1)"	"unprognostic (5.51e-3)"	"unprognostic (5.82e-2)"	29.6	31.9	19.9	21.8	24.4	35.8	20.0	15.0	24.3	17.8	29.7	16.8	17.8	36.3	16.5	21.4	22.6	15.2	24.7	67.9	19.7	21.5	32.7	137.3	32.0	35.7	23.2	23.1	19.7	21.2	18.6	23.2	26.3	17.0	18.2	20.8	18.0	25.3	21.2	42.7	13.3	41.0	21.4	18.9	26.8	19.8	7.0	14.2	30.8	32.9	24.0	16.8	28.0	18.8	18.7	55.4	85.5	68.3	21.8	25.5	68.0	31.7	21.8	16.9	28.8	23.7	45.3	7.3	41.5	73.7	27.6	30.0	27.3	34.0	28.3	18.0	27.5	35.2	18.3	11.0	36.8	29.1	14.1	26.4	20.9	15.5	59.6	42.5	26.7	35.1	34.3	15.7	40.0	48.3	39.3	52.7	26.5	42.9	17.7	57.7	17.3	20.7	37.6	15.6	34.4	15.2	15.3	11.1	11.9	40.9	20.4	8.4	10.5	13.4	9.6	123.8	29.8	10.5	21.5	48.6	32.7	17.1	50.8	36.9	0.3	0.4	0.2	61.3	46.5	12.9	85.5	68.3	19.2	18.3	57.2	22.0	18.7	22.6	23.4	55.4	15.0	19.7	19.8	19.5	21.8	43.9	25.7	25.5	68.0	19.9	24.4	15.0	24.3	19.7	21.5	23.2	23.1	17.0	14.2	71.5	58.2	98.7	286.1	83.2	26.3	290.4	244.5	58.9	78.5	96.0	19.6	399.2	281.8	289.2	13.5	118.6	130.2	70.0	215.9	135.5	154.5	94.2	142.1	611.8	643.1	22.3	99.4	338.8	323.0	12.0	106.2	397.5	119.8	265.1	129.8	50.2	258.3	117.9	106.1	410.6	24.7	148.8	123.7	5.4	2.6	68.8	92.8	101.2	167.3	176.7
GSTO2		ENSG00000065621	"Glutathione S-transferase omega 2"	Q9H4Y5	10	104268873-104304945	"Enzymes, Predicted intracellular proteins"		"Oxidoreductase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"Distal tubular cells: 112.7;Early spermatids: 313.3;Late spermatids: 338.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"CAPAN-2: 24.0;hTCEpi: 20.9;hTERT-HME1: 22.7;MCF7: 13.7;OE19: 24.7;T-47d: 17.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA048141	Approved					NA	NA					"HPA048141: AB_2680281"	"unprognostic (5.77e-2)"	"unprognostic (6.69e-2)"	"unprognostic (7.15e-2)"	"unprognostic (1.80e-1)"	"unprognostic (2.48e-1)"	"unprognostic (3.11e-2)"	"unprognostic (3.12e-1)"	"unprognostic (2.15e-1)"	"unprognostic (7.42e-2)"	"unprognostic (5.28e-2)"	"unprognostic (1.44e-1)"	"unprognostic (1.02e-1)"	"prognostic favorable (7.10e-7)"	"unprognostic (4.56e-2)"	"unprognostic (3.92e-2)"	"unprognostic (1.75e-2)"	"unprognostic (3.47e-1)"	0.9	3.8	7.5	2.2	15.7	2.1	13.1	2.1	9.8	6.7	6.8	6.9	15.5	6.2	4.3	16.7	11.0	10.6	6.7	1.0	4.6	4.8	10.6	3.3	3.7	0.6	3.5	7.6	7.1	37.3	18.1	24.0	1.3	3.2	10.6	8.8	9.4	13.2	18.0	1.8	12.3	6.0	2.8	3.2	1.0	9.8	30.3	5.4	1.7	10.7	9.6	4.5	5.9	6.7	1.3	1.0	5.1	0.7	2.9	3.7	0.8	9.2	0.8	0.2	0.4	0.3	0.8	1.1	4.4	8.1	2.2	2.4	0.2	24.0	1.2	4.2	0.5	0.3	12.7	0.3	5.4	0.6	0.5	1.7	0.2	2.1	1.3	2.1	0.3	0.3	1.7	20.9	0.1	22.7	0.8	0.4	0.9	0.7	1.9	0.6	13.7	0.1	0.2	0.8	24.7	0.8	0.3	0.3	0.3	5.8	6.9	0.4	0.5	3.1	2.3	1.3	0.6	17.9	0.1	1.1	0.7	3.6	0.4	0.2	1.6	3.3	0.2	0.7	0.4	0.2	0.5	0.5	2.4	1.3	0.7	1.3	1.0	1.9	0.8	0.2	1.3	2.1	1.3	5.1	2.9	0.3	1.0	3.7	0.8	7.5	15.7	2.1	9.8	4.6	4.8	3.5	7.6	3.2	5.4	3.0	18.9	0.8	44.7	30.3	18.2	2.1	22.9	26.8	33.0	38.4	15.7	12.3	112.7	24.0	313.3	3.5	17.0	0.0	55.1	8.2	2.3	28.3	2.3	2.8	1.6	0.0	52.1	14.7	3.4	338.1	2.6	2.3	16.9	3.6	32.1	9.4	27.8	35.1	9.2	22.7	22.3	6.5	1.0	9.6	7.5	41.4	5.6	4.4	42.1	33.3
GSTP1	"FAEES3, GST3, GSTP"	ENSG00000084207	"Glutathione S-transferase pi 1"	P09211	11	67583595-67586656	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins"		Transferase	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"hTCEpi: 252.4;OE19: 379.4"					"Low region specificity"	"Detected in all"			"HPA019779, HPA019869"	Enhanced		Supported	Mitochondria,Cytosol		No	No		120000000	"Mitochondria, Cytosol"		"HPA019779: AB_1849799, HPA019869: AB_1849801"	"unprognostic (9.81e-2)"	"unprognostic (6.52e-2)"	"unprognostic (7.24e-2)"	"unprognostic (2.72e-2)"	"unprognostic (1.06e-2)"	"unprognostic (1.30e-3)"	"unprognostic (3.27e-1)"	"unprognostic (4.98e-2)"	"unprognostic (1.28e-1)"	"unprognostic (5.16e-3)"	"unprognostic (2.14e-3)"	"unprognostic (9.37e-2)"	"unprognostic (5.72e-2)"	"unprognostic (7.78e-2)"	"unprognostic (2.23e-1)"	"unprognostic (6.72e-3)"	"unprognostic (1.48e-1)"	24.2	25.3	20.2	23.8	21.7	46.2	39.5	15.5	19.8	51.8	51.9	23.5	125.4	35.2	43.5	41.9	181.6	60.8	51.1	45.3	18.3	23.5	44.2	5.9	61.0	39.4	25.5	19.9	33.4	60.7	44.1	33.8	57.9	46.0	37.0	17.9	59.9	50.2	110.8	33.7	58.5	34.0	30.1	22.8	25.1	48.5	15.4	15.4	29.8	91.6	131.5	75.6	40.8	79.5	25.3	191.4	12.4	168.2	70.1	40.7	167.2	57.6	78.7	38.4	59.6	29.7	33.5	35.4	25.2	33.9	38.5	30.0	144.5	60.6	0.1	57.9	39.9	34.5	84.4	103.5	111.0	10.9	40.2	37.6	2.8	57.2	0.0	44.0	18.9	33.7	41.5	252.4	30.7	29.7	28.5	57.8	41.6	62.5	16.1	30.1	0.2	43.4	52.9	73.4	379.4	33.8	40.5	6.4	0.1	61.4	0.1	13.0	37.2	35.3	11.5	114.2	31.7	0.1	31.9	31.1	17.8	45.2	37.2	18.2	10.0	62.4	21.1	20.2	31.4	36.9	2.3	168.2	12.4	40.7	125.7	15.0	25.3	18.4	33.3	191.4	24.3	15.3	27.3	7.0	70.1	79.4	76.2	18.3	167.2	20.2	21.7	15.5	19.8	18.3	23.5	25.5	19.9	46.0	15.4	1072.0	720.7	317.1	1402.4	769.0	173.6	263.2	1108.3	2518.8	1170.4	1167.2	31.4	2000.9	1530.2	1548.4	3.0	432.0	610.1	46.7	1274.3	1522.1	711.2	802.7	262.2	7.2	793.1	66.7	353.7	365.8	595.7	9.3	529.8	867.5	1452.6	2663.7	867.8	370.2	1415.0	772.2	376.2	1617.9	188.6	355.7	676.5	3.2	63.0	928.1	1376.1	396.6	983.6	3031.0
GSTT2B	GSTT2P	ENSG00000133433	"Glutathione S-transferase theta 2B (gene/pseudogene)"	P0CG30	22	23957414-23961186	"Enzymes, Predicted intracellular proteins"		Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	7	"breast: 83.4"	"Cell type enhanced"	"Detected in many"	6	"Distal tubular cells: 24.9;Erythroid cells: 23.3;Hepatocytes: 27.7;Muller glia cells: 19.5;Peritubular cells: 26.9"	"Low cancer specificity"	"Detected in all"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AN3-CA: 22.6;HHSteC: 33.3;SK-MEL-30: 23.0;T-47d: 25.5"									HPA000750	Uncertain		Supported	Nucleoplasm,Cytosol		No	No			Cytosol	Nucleoplasm	"HPA000750: AB_1849804"	"prognostic favorable (5.06e-4)"	"unprognostic (5.14e-2)"	"unprognostic (1.90e-1)"	"unprognostic (4.51e-2)"	"unprognostic (7.13e-2)"	"unprognostic (8.41e-3)"	"unprognostic (2.58e-1)"	"unprognostic (7.99e-2)"	"unprognostic (1.15e-1)"	"unprognostic (1.92e-1)"	"unprognostic (1.76e-2)"	"unprognostic (4.11e-1)"	"unprognostic (1.18e-2)"	"unprognostic (2.04e-1)"	"unprognostic (1.07e-1)"	"unprognostic (1.48e-2)"	"unprognostic (2.19e-3)"	1.6	11.7	2.7	0.7	1.9	0.0	83.4	0.0	4.2	2.6	1.5			0.1	1.7	2.9	2.6	1.4	1.1	2.4	1.7	2.9	1.3	6.1	2.0	0.1	2.5		3.1	3.2	0.9	3.6	0.8		6.1	0.2		1.2	2.5	1.3	11.4	0.7	2.7	1.4	0.9	2.6	0.5			2.5		0.1	0.7	1.2	0.0	0.0	0.0	0.3	0.0	0.0	0.3	6.5	0.3	0.0	22.6	0.5	0.6	0.9	3.2	1.8	4.6	4.8	9.7	0.0	0.0	5.1	7.9	12.0	9.5	0.0	10.0	2.1	0.0	0.8	0.3	12.7	1.5	33.3	0.0	3.6	13.7	1.6	13.2	2.7	13.3	3.7	0.0	0.0	0.0	2.7	0.1	0.0	0.0	0.1	0.3	4.8	0.0	16.8	0.0	10.2	0.0	0.4	9.5	3.1	0.0	23.0	0.0	25.5	0.3	12.3	3.8	2.6	0.5	2.4	0.0	0.0	0.0	2.4	0.0	9.3	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3											3.0	2.2	0.0	8.7	0.0	3.5	0.1	2.5	0.0	2.3	0.0	0.0	1.2	24.9	7.2	0.4	1.6	0.0	23.3	7.9	3.6	0.1	7.9	1.1	27.7	8.3	0.0	1.2	15.4	4.0	1.3	9.2	0.2	0.0	5.4	0.4	19.5	4.7	0.0	26.9	3.8	2.6	6.5	0.3	0.5	0.4	0.0	1.5	0.0	0.0	2.3
GSTZ1	"GSTZ1-1, MAAI, MAI"	ENSG00000100577	"Glutathione S-transferase zeta 1"	O43708	14	77320884-77331597	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Phenylalanine catabolism, Tyrosine catabolism"	"Isomerase, Multifunctional enzyme, Transferase"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	4	"liver: 90.4"	"Cell type enhanced"	"Detected in many"	9	"Hepatocytes: 348.1;Late spermatids: 326.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"MCF7: 60.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA004701	Approved		Approved	Nucleoplasm,Cytosol		NA	NA		62000	Cytosol	Nucleoplasm	"HPA004701: AB_1078990"	"prognostic favorable (4.93e-4)"	"unprognostic (1.08e-1)"	"unprognostic (2.56e-1)"	"unprognostic (2.16e-3)"	"unprognostic (4.55e-1)"	"unprognostic (3.03e-2)"	"unprognostic (8.03e-3)"	"unprognostic (1.98e-1)"	"unprognostic (2.18e-1)"	"prognostic favorable (3.73e-4)"	"unprognostic (7.90e-2)"	"unprognostic (1.73e-1)"	"prognostic favorable (1.12e-7)"	"unprognostic (1.00e-1)"	"unprognostic (1.11e-1)"	"unprognostic (4.12e-1)"	"unprognostic (4.92e-2)"	4.6	12.9	5.6	5.9	6.8	2.8	8.5	2.1	9.0	5.0	8.1	10.8	7.5	8.1	4.1	9.5	9.0	5.5	8.0	5.5	5.4	5.0	8.9	90.4	4.4	10.7	6.9	6.9	2.8	7.1	9.3	5.1	11.0	5.8	8.0	8.0	9.5	22.5	4.7	14.8	7.4	7.2	3.8	7.9	5.0	5.9	18.2	5.2	8.6	8.3	14.3	8.9	4.9	4.5	8.2	15.3	7.2	16.0	3.4	5.6	5.0	6.5	12.5	9.9	7.0	6.3	8.7	16.8	4.1	4.2	7.7	10.9	4.2	16.5	14.6	5.9	4.8	4.8	8.4	6.7	7.9	7.4	7.7	6.7	7.1	4.8	8.9	9.9	2.6	5.9	8.1	8.6	4.4	7.5	4.3	6.6	8.7	5.9	13.5	5.1	60.8	4.0	5.5	2.9	22.6	10.0	7.0	10.4	11.3	11.7	8.0	10.9	9.9	9.1	18.2	12.9	5.8	29.7	3.9	4.5	6.0	20.4	6.8	3.0	10.1	10.8	12.8	15.6	4.0	7.5	6.6	11.1	7.2	1.9	16.0	1.9	6.4	3.4	2.8	15.3	8.2	2.9	2.4	1.1	3.4	13.5	10.4	5.6	5.0	5.6	6.8	2.1	9.0	5.4	5.0	6.9	6.9	5.8	5.2	6.0	8.1	12.7	18.0	11.8	6.8	12.0	50.9	10.7	5.7	8.7	3.9	76.5	39.7	34.9	105.1	8.7	47.2	23.3	59.7	57.9	10.6	19.8	3.5	348.1	39.6	15.9	27.6	9.8	28.3	326.5	10.9	14.4	16.9	35.1	36.9	20.9	39.0	38.6	5.6	58.4	11.2	0.0	10.3	33.5	24.7	12.3	63.7	7.7	45.9	17.7
GTF2F2	"BTF4, RAP30, TFIIF"	ENSG00000188342	"General transcription factor IIF subunit 2"	P13984	13	45120515-45284909	"Enzymes, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"DNA-binding, Helicase, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA006912	Supported		Supported	Nucleoplasm,Microtubules		NA	NA			Nucleoplasm	Microtubules	"HPA006912: AB_1080256"	"unprognostic (3.39e-1)"	"unprognostic (2.65e-2)"	"unprognostic (3.27e-1)"	"unprognostic (1.29e-1)"	"unprognostic (4.51e-2)"	"prognostic unfavorable (1.65e-5)"	"unprognostic (3.67e-2)"	"unprognostic (3.17e-1)"	"unprognostic (3.36e-2)"	"unprognostic (2.53e-3)"	"unprognostic (2.31e-2)"	"unprognostic (4.76e-2)"	"unprognostic (1.25e-1)"	"unprognostic (2.09e-1)"	"unprognostic (6.53e-3)"	"unprognostic (3.94e-2)"	"unprognostic (6.44e-3)"	15.1	24.7	23.5	21.1	23.6	22.5	20.9	12.0	21.0	16.3	21.8	14.8	18.5	14.9	16.8	23.4	21.8	12.0	15.9	27.5	21.4	21.1	18.3	16.0	15.1	17.5	22.9	19.0	17.3	14.6	16.5	27.5	23.9	18.2	16.7	21.2	18.2	20.8	20.2	32.0	31.5	12.9	28.2	19.5	17.8	15.2	22.2	24.2	22.6	19.2	27.7	19.9	20.5	19.0	15.4	16.3	24.9	15.3	16.1	12.9	8.5	15.5	5.8	11.1	8.2	6.8	10.1	9.2	17.2	11.3	17.5	17.2	9.8	24.5	15.7	9.7	12.5	17.1	17.4	16.6	13.8	25.7	11.8	14.4	18.5	7.8	12.8	10.9	20.5	10.6	8.4	21.2	13.1	22.2	19.9	11.2	12.3	13.1	5.9	47.1	8.7	15.0	23.6	13.2	25.1	14.4	14.1	8.4	9.0	38.2	5.5	5.9	9.9	8.7	8.6	14.3	10.9	7.0	16.8	8.8	14.8	12.6	11.7	29.3	3.8	5.2	15.7	17.2	13.2	15.4	12.0	14.2	24.9	9.7	14.1	11.5	15.3	11.3	11.5	16.3	15.4	12.9	12.6	19.8	16.1	15.3	12.7	12.3	8.5	23.5	23.6	12.0	21.0	21.4	21.1	22.9	19.0	18.2	24.2	38.7	28.0	38.3	76.6	66.6	18.2	68.7	10.2	33.5	33.0	10.4	3.9	28.1	41.4	45.9	94.3	28.4	21.3	23.3	28.9	40.9	31.4	27.4	39.2	17.8	42.4	7.9	27.1	12.3	27.1	62.8	22.5	37.1	72.6	31.5	24.5	34.7	38.8	25.9	29.7	30.5	18.5	6.5	27.8	59.2	80.1	63.6	28.3	27.1	37.6	64.0
GTF3C4	"KAT12, TFIIIC90"	ENSG00000125484	"General transcription factor IIIC subunit 4"	Q9UKN8	9	132670035-132694955	"Enzymes, Predicted intracellular proteins"	Transcription	"Acyltransferase, DNA-binding, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA069369			Supported	Nucleoplasm,Mitochondria		No	No			Nucleoplasm	Mitochondria	"HPA069369: AB_2686130"	"unprognostic (7.02e-2)"	"unprognostic (9.01e-2)"	"unprognostic (1.31e-1)"	"unprognostic (4.10e-2)"	"unprognostic (8.20e-2)"	"unprognostic (2.78e-1)"	"unprognostic (3.71e-3)"	"unprognostic (1.69e-2)"	"unprognostic (1.58e-1)"	"unprognostic (1.76e-1)"	"unprognostic (4.77e-1)"	"unprognostic (1.92e-2)"	"prognostic favorable (2.99e-4)"	"unprognostic (1.65e-1)"	"unprognostic (1.23e-1)"	"unprognostic (2.35e-1)"	"unprognostic (1.54e-2)"	6.9	8.5	12.3	6.6	11.6	7.8	11.6	23.8	13.9	10.8	8.0	7.0	5.6	5.3	10.2	9.3	11.4	9.5	7.4	7.8	8.7	8.1	8.7	7.4	8.9	10.9	9.4	11.6	15.0	8.4	16.6	10.1	9.7	8.9	8.9	7.7	7.6	11.3	8.4	11.6	14.5	6.6	8.6	5.6	6.3	8.1	16.9	6.4	11.6	13.3	5.3	9.3	8.8	7.9	2.3	2.1	1.5	1.5	2.1	3.1	0.9	8.5	12.2	15.5	13.3	7.7	9.1	11.2	8.2	10.9	11.7	8.6	14.9	6.4	13.3	5.6	10.7	10.9	19.8	23.7	13.5	13.0	8.0	9.8	11.2	17.6	6.3	7.6	16.5	7.1	7.0	10.3	12.0	15.7	7.1	10.0	8.9	18.2	6.8	8.4	14.0	10.1	7.7	19.7	13.0	11.9	10.0	18.9	11.7	8.6	7.2	21.6	14.6	14.8	15.0	9.1	10.1	20.9	6.8	10.4	19.4	10.9	8.8	12.3	2.8	6.4	14.8	8.2	10.4	11.9	0.1	1.5	1.2	2.5	1.3	2.0	2.3	2.2	3.1	1.2	2.2	2.3	2.4	1.5	2.1	1.2	2.1	2.0	0.9	12.3	11.6	23.8	13.9	8.7	8.1	9.4	11.6	8.9	6.4	17.9	8.6	7.8	6.7	27.2	15.0	11.2	2.5	18.7	6.8	3.5	13.7	6.2	6.6	7.2	4.8	9.0	3.5	0.0	5.4	6.0	11.5	9.1	1.1	7.8	5.4	19.1	12.6	7.4	7.3	2.1	17.5	4.6	3.3	2.8	7.4	11.3	5.8	7.0	18.0	5.6	16.9	0.0	7.6	15.1	12.6	35.0	5.4	6.1	8.0	4.6
GUCY1A1	"GC-SA3, GUC1A3, GUCY1A3"	ENSG00000164116	"Guanylate cyclase 1 soluble subunit alpha 1"	Q02108	4	155666711-155732349	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"cGMP biosynthesis"	Lyase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"parathyroid gland: 55.2"	"Cell type enhanced"	"Detected in some"	16	"Alveolar cells type 2: 41.4;Club cells: 12.5;Collecting duct cells: 10.4;Distal tubular cells: 16.6;Ductal cells: 15.1;Proximal tubular cells: 10.2"	"Cancer enhanced"	"Detected in all"		"prostate cancer: 24.9"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"NK-cell: 7.6;non-classical monocyte: 9.2;plasmacytoid DC: 11.6"	"Group enriched"	"Detected in many"	27	"dendritic cells: 11.6;monocytes: 9.2;NK-cells: 7.6"	"Cell line enhanced"	"Detected in some"		"HAP1: 6.1;HEK 293: 5.0;Karpas-707: 8.7;MOLT-4: 15.9;RPTEC TERT1: 10.9;RT4: 12.7;SH-SY5Y: 8.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB010887, HPA056004, HPA058617"	Uncertain		Supported	Nucleoplasm		NA	NA		6100	Nucleoplasm		"CAB010887: AB_259901, HPA056004: AB_2683007, HPA058617: AB_2732624"	"unprognostic (4.81e-3)"	"unprognostic (2.60e-1)"	"unprognostic (3.03e-1)"	"unprognostic (2.15e-1)"	"unprognostic (1.99e-2)"	"unprognostic (7.77e-3)"	"unprognostic (1.07e-1)"	"prognostic favorable (2.38e-4)"	"unprognostic (1.85e-3)"	"unprognostic (6.46e-2)"	"unprognostic (3.42e-2)"	"unprognostic (7.16e-2)"	"prognostic unfavorable (7.59e-4)"	"unprognostic (1.60e-2)"	"prognostic unfavorable (3.59e-4)"	"unprognostic (2.27e-1)"	"unprognostic (6.55e-3)"	10.9	5.3	12.4	10.2	19.9	0.9	11.1	3.4	11.6	13.7	31.2	7.3	2.8	5.6	14.7	6.0	7.0	6.8	8.3	21.0	9.0	7.2	11.6	5.1	13.2	7.3	4.7	12.5	5.4	8.5	55.2	5.8	16.3	6.3	17.2	6.9	39.7	7.0	9.8	4.5	3.6	10.1	18.8	6.6	8.5	12.9	2.1	8.5	4.5	8.1	7.3	5.9	6.4	10.6	0.1	11.6	0.3	9.2	7.6	0.1	1.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	6.1	0.0	0.0	0.0	5.0	1.1	0.0	0.0	0.0	0.0	0.0	0.7	0.1	0.0	0.0	0.1	0.0	3.3	0.0	8.7	0.0	0.0	15.9	0.0	0.0	0.0	0.2	3.5	0.0	2.6	10.9	12.7	2.2	8.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.1	0.3	0.0	2.3	0.1	0.0	0.0	0.0	2.5	0.1	0.0	0.0	0.0	7.6	9.2	11.6	0.0	1.0	12.4	19.9	3.4	11.6	9.0	7.2	4.7	12.5	6.3	8.5	8.9	41.4	0.0	0.0	0.0	0.0	0.0	0.0	4.0	12.5	10.4	0.0	0.4	16.6	15.1	0.0	0.0	0.0	0.0	1.7	0.3	0.0	0.0	3.5	0.0	3.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	10.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0
GUCY1A2	"GC-SA2, GUC1A2"	ENSG00000152402	"Guanylate cyclase 1 soluble subunit alpha 2"	P33402	11	106674012-107018524	"Enzymes, FDA approved drug targets, Predicted intracellular proteins"	"cGMP biosynthesis"	Lyase	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"endometrium 1: 23.0;placenta: 23.6"	"Cell type enhanced"	"Detected in many"	16	"Muller glia cells: 27.1;Sertoli cells: 103.5;Smooth muscle cells: 57.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BJ hTERT+: 12.5;BJ hTERT+ SV40 Large T+ RasG12V: 14.6;HBF TERT88: 7.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB009534	Uncertain					NA	NA					"CAB009534: AB_2279509"	"unprognostic (7.53e-2)"	"unprognostic (6.67e-2)"	"unprognostic (7.99e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.08e-1)"	"unprognostic (1.22e-2)"	"unprognostic (1.23e-2)"	"unprognostic (1.24e-1)"	"unprognostic (6.53e-3)"	"unprognostic (9.70e-3)"	"unprognostic (8.00e-2)"	"unprognostic (2.03e-1)"	"prognostic unfavorable (3.02e-5)"	"unprognostic (2.48e-4)"	"unprognostic (1.62e-1)"	"unprognostic (3.50e-2)"	"unprognostic (1.09e-2)"	5.5	3.3	4.6	1.3	10.9	0.6	3.9	4.3	10.7	19.2	1.5	1.2	1.1	0.9	23.0	5.0	1.3	8.4	2.6	3.8	4.6	4.0	3.2	2.8	11.8	1.6	3.7	5.3	3.9	6.2	1.8	1.5	23.6	5.5	3.2	1.3	1.4	1.4	10.1	4.1	1.4	1.2	18.0	2.4	7.9	1.0	2.8	5.4	0.0	2.4	3.0	1.0	2.2	5.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	4.3	0.0	0.2	2.6	2.4	0.3	12.5	1.6	14.6	0.0	0.0	0.0	0.0	0.9	0.4	0.0	0.2	0.0	7.8	0.0	1.2	0.0	0.1	0.0	0.2	0.0	1.7	0.7	0.0	1.9	0.2	0.0	0.9	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.5	3.8	0.0	0.8	0.5	0.9	0.2	4.8	4.0	3.3	0.9	1.3	0.0	0.0	0.0	0.1	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.6	10.9	4.3	9.9	4.6	4.0	3.7	5.3	5.5	5.4	0.0	0.3	0.0	1.4	1.4	23.1	5.9	0.0	0.0	0.0	3.5	11.8	0.1	0.0	3.2	2.2	3.9	0.0	0.0	0.2	0.0	6.1	1.1	0.0	0.0	0.3	17.5	0.0	2.5	0.6	4.9	22.7	0.0	3.3	0.0	0.0	27.1	0.5	0.0	23.7	0.0	4.0	103.5	57.5	0.9	1.5	1.0	0.2	0.0	0.0	1.2
GUCY1B1	"GC-S-beta-1, GC-SB3, GUC1B3, GUCY1B3"	ENSG00000061918	"Guanylate cyclase 1 soluble subunit beta 1"	Q02153	4	155758992-155807591	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"cGMP biosynthesis"	Lyase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"parathyroid gland: 71.6"	"Cell type enhanced"	"Detected in some"	14	"Alveolar cells type 1: 6.0;Collecting duct cells: 8.7;Ductal cells: 14.1;Proximal tubular cells: 19.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	8	"intermediate monocyte: 5.6;non-classical monocyte: 17.8"	"Lineage enriched"	"Detected in many"	12	"monocytes: 17.8"	"Cell line enhanced"	"Detected in many"		"HEL: 25.3;Karpas-707: 13.4;MOLT-4: 16.0;RPTEC TERT1: 25.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB010890, HPA020870"	Approved		Approved	Cytosol		NA	NA		5200	Cytosol		"CAB010890: AB_259911, HPA020870: AB_1850444"	"unprognostic (1.44e-1)"	"unprognostic (1.25e-1)"	"unprognostic (3.55e-2)"	"unprognostic (9.10e-3)"	"unprognostic (4.69e-2)"	"unprognostic (1.41e-2)"	"unprognostic (6.88e-2)"	"unprognostic (6.69e-3)"	"unprognostic (3.03e-3)"	"unprognostic (1.47e-1)"	"unprognostic (8.37e-2)"	"unprognostic (2.84e-1)"	"prognostic unfavorable (2.42e-4)"	"unprognostic (7.35e-3)"	"prognostic unfavorable (3.23e-4)"	"unprognostic (2.14e-1)"	"unprognostic (6.36e-3)"	8.8	5.4	18.7	9.8	42.0	1.8	5.5	12.2	36.8	8.1	14.9	5.7	0.4	4.2	11.3	4.7	5.9	9.5	9.2	12.2	16.1	25.0	9.2	5.4	9.4	6.6	14.5	23.2	3.7	7.4	71.6	3.8	28.0	20.6	9.8	6.2	5.8	3.2	8.7	3.8	2.2	5.9	16.3	6.7	7.2	8.9	2.1	5.5	2.6	4.6	2.4	5.1	8.0	6.8	0.2	1.4	1.1	17.8	0.9	0.0	4.8	0.0	0.2	3.6	0.0	1.2	6.8	0.0	1.1	2.0	0.1	0.0	0.0	0.0	0.0	1.7	0.6	2.9	0.0	7.4	0.1	0.4	0.0	2.7	25.3	0.0	0.0	0.7	0.0	0.0	3.0	0.2	0.0	0.1	2.5	0.0	5.7	0.0	13.4	1.8	1.1	16.0	0.0	0.2	0.0	1.9	1.8	0.5	0.4	25.7	2.4	0.4	4.5	0.0	0.1	0.0	3.7	0.0	0.0	0.0	4.2	0.9	7.2	5.3	0.1	0.0	0.0	9.2	0.0	0.0	1.1	0.4	0.3	0.0	5.6	0.0	0.1	0.0	0.0	1.4	0.2	0.0	0.0	0.4	0.9	17.8	1.2	0.0	4.8	18.7	42.0	12.2	36.8	16.1	25.0	14.5	23.2	20.6	5.5	6.0	4.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.7	0.0	0.5	5.0	14.1	0.0	0.0	0.0	0.0	3.5	0.1	0.0	0.0	1.1	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	5.1	0.0	0.0	19.8	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0
GUCY2C	"GUC2C, STAR"	ENSG00000070019	"Guanylate cyclase 2C"	P25092	12	14612632-14696585	"Disease related genes, Enzymes, FDA approved drug targets, Predicted membrane proteins, Transporters"	"cGMP biosynthesis"	"Lyase, Receptor"	"Disease mutation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	19	"intestine: 85.1"	"Cell type enhanced"	"Detected in some"	21	"Enterocytes: 37.2;Intestinal endocrine cells: 169.6;Mucus-secreting cells: 61.9;Paneth cells: 99.3;Undifferentiated cells: 41.2"	"Group enriched"	"Detected in many"	5	"colorectal cancer: 23.9;stomach cancer: 9.1"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"memory B-cell: 4.3"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"AN3-CA: 3.7;BEWO: 2.2;CACO-2: 3.2;CAPAN-2: 4.6;SiHa: 4.2"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"HPA037655, HPA073759"	Uncertain		Uncertain	Vesicles		NA	NA			Vesicles		"HPA037655: AB_10672388, HPA073759: "	"unprognostic (1.08e-1)"	"unprognostic (2.12e-1)"	"unprognostic (3.58e-2)"	"unprognostic (2.11e-2)"	"unprognostic (1.60e-2)"	"unprognostic (5.67e-3)"	"prognostic unfavorable (1.37e-5)"	"unprognostic (9.14e-2)"	"unprognostic (1.49e-2)"	"unprognostic (2.95e-1)"	"unprognostic (1.58e-1)"	"unprognostic (5.40e-2)"	"unprognostic (2.35e-4)"	"unprognostic (8.02e-2)"	"unprognostic (1.64e-1)"	"unprognostic (1.33e-1)"	"unprognostic (1.98e-1)"	0.2	0.1	0.2	3.4	0.2	0.0	0.2	0.2	0.2	0.2	38.8	0.2	0.2	28.0	0.3	0.2	0.4	0.2	0.3	0.4	0.2	0.1	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.5	0.0	0.2	0.2	0.2	0.2	17.5	0.2	0.5	0.2	0.2	1.0	85.1	0.3	0.2	0.2	0.5	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.3	4.3	0.7	2.7	1.7	0.0	0.0	0.6	1.1	0.1	0.0	3.7	0.0	0.0	2.2	0.2	0.0	0.0	0.0	3.2	4.6	0.7	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.7	0.0	0.4	0.4	0.0	0.0	0.0	0.0	0.5	0.1	0.6	0.0	0.6	4.2	0.3	0.0	1.1	0.4	0.1	0.0	0.0	0.0	0.9	0.1	1.3	0.8	1.3	0.0	0.0	0.1	0.0	1.7	0.0	0.0	0.5	0.0	4.3	0.0	0.0	0.7	2.3	0.0	0.0	2.7	0.0	0.0	0.7	0.0	0.6	0.2	0.2	0.2	0.2	0.2	0.1	0.2	0.2	0.2	0.2	0.0	0.0	1.5	0.0	0.5	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	37.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	169.6	0.0	0.8	0.0	0.0	0.0	0.0	0.0	61.9	0.0	0.3	99.3	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	41.2	0.0
GUCY2D	"CORD6, CYGD, GUC1A4, GUC2D, LCA, LCA1, retGC, RETGC-1, ROS-GC1"	ENSG00000132518	"Guanylate cyclase 2D, retinal"	Q02846	17	8002594-8020339	"Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins, Transporters"	"cGMP biosynthesis, Sensory transduction, Vision"	Lyase	"Cone-rod dystrophy, Congenital stationary night blindness, Disease mutation, Leber congenital amaurosis"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"blood: 10.6;retina: 33.3"	"Group enriched"	"Detected in some"	5	"Cone photoreceptor cells: 58.9;Rod photoreceptor cells: 55.6"	"Low cancer specificity"	"Detected in single"			"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	31	"plasmacytoid DC: 10.6"	"Lineage enriched"	"Detected in single"	53	"dendritic cells: 10.6"	"Cell line enriched"	"Detected in some"	4	"JURKAT: 11.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"									NA	NA						"unprognostic (3.57e-4)"	"unprognostic (5.05e-1)"	"unprognostic (1.49e-1)"	"unprognostic (9.75e-5)"	"unprognostic (5.94e-2)"	"unprognostic (1.86e-1)"	"unprognostic (4.44e-2)"	"unprognostic (3.81e-2)"	"unprognostic (2.92e-1)"	"unprognostic (2.26e-1)"	"unprognostic (7.54e-2)"	"unprognostic (4.44e-1)"	"unprognostic (7.59e-5)"	"unprognostic (1.05e-1)"	"unprognostic (3.46e-1)"	"unprognostic (3.08e-1)"	"unprognostic (1.07e-1)"	0.1	0.0	0.1	0.3	0.1	0.5	0.1	0.1	0.2	0.1	0.1	0.2	0.1	0.0	0.1	0.2	0.5	0.1	0.1	0.1	0.1	0.2	0.1	0.1	0.2	1.3	0.3	0.1	0.2	0.1	0.0	0.1	0.1	0.1	0.4	0.0	33.3	0.4	0.1	0.1	0.4	0.1	0.1	0.1	0.6	0.1	5.0	0.1	0.2	0.1	0.1	0.9	0.1	0.2	0.0	10.6	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	2.5	0.3	0.1	0.0	0.0	0.0	0.0	11.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	10.6	0.0	0.0	0.1	0.1	0.1	0.2	0.1	0.2	0.3	0.1	0.1	0.1	0.0	0.0	0.0	1.2	0.3	2.4	1.6	0.0	0.0	0.0	0.0	58.9	1.2	1.7	0.1	6.8	0.0	0.0	0.0	0.0	0.5	0.0	1.5	0.0	0.8	1.1	0.0	0.0	0.0	0.3	11.0	0.0	0.0	0.0	1.0	0.0	2.5	0.2	0.0	0.4	0.5	55.6	0.0	0.0	0.2	0.0	0.3	1.8	0.0	0.0	0.4
GUCY2F	"CYGF, GC-F, GUC2DL, RetGC-2, ROS-GC2"	ENSG00000101890	"Guanylate cyclase 2F, retinal"	P51841	X	109372906-109482072	"Enzymes, Plasma proteins, Predicted membrane proteins"	"cGMP biosynthesis, Sensory transduction, Vision"	Lyase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	10	"retina: 23.1"	"Cell type enriched"	"Detected in some"	33	"Rod photoreceptor cells: 33.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"THP-1: 4.5;U-266/70: 1.6;U-937: 1.5"	"Not detected"	"Not detected"			"Region enhanced"	"Detected in single"		"hypothalamus: 0.4"							NA	NA									"unprognostic (1.91e-1)"	"unprognostic (4.45e-2)"									"unprognostic (2.96e-1)"	"unprognostic (2.23e-1)"			0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.2	1.6	0.0	0.0	0.0	0.0	0.4	0.0	0.0	2.3	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.0	23.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.5	0.0	0.0	0.0	0.0	0.1	1.6	0.0	0.1	0.0	1.5	0.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	33.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
GUK1		ENSG00000143774	"Guanylate kinase 1"	Q16774	1	228139962-228148984	"Enzymes, Predicted intracellular proteins"		"Kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA028118, HPA048587, HPA068324"	Approved		Uncertain	Nucleoplasm,Cytosol		NA	NA		240000	Nucleoplasm	Cytosol	"HPA028118: AB_2756308, HPA048587: AB_2680453, HPA068324: "	"unprognostic (9.15e-2)"	"unprognostic (2.63e-2)"	"unprognostic (3.60e-3)"	"unprognostic (7.91e-2)"	"unprognostic (8.54e-3)"	"unprognostic (1.24e-1)"	"unprognostic (3.55e-3)"	"unprognostic (2.05e-1)"	"unprognostic (3.47e-1)"	"unprognostic (7.32e-2)"	"unprognostic (3.38e-2)"	"unprognostic (5.28e-2)"	"prognostic unfavorable (8.85e-5)"	"unprognostic (2.91e-1)"	"unprognostic (5.41e-1)"	"unprognostic (2.39e-2)"	"unprognostic (6.12e-2)"	44.6	38.2	106.4	32.5	76.0	76.7	43.0	25.2	74.4	31.5	33.3	30.1	27.3	41.5	26.3	34.1	77.0	28.0	42.5	61.6	93.1	43.9	31.9	43.5	34.6	39.0	60.0	52.9	24.7	62.2	12.8	26.0	29.2	40.1	25.5	12.1	37.4	66.5	29.4	35.8	59.6	42.1	34.8	49.6	36.1	44.3	22.2	34.9	27.5	31.6	29.3	24.1	45.9	44.5	43.9	97.7	110.1	62.9	55.8	83.7	84.5	57.5	20.3	9.0	27.7	27.1	32.6	45.0	38.4	19.7	22.4	17.6	11.6	40.1	21.7	45.6	25.0	18.8	38.3	7.7	42.1	2.4	33.0	59.7	12.9	50.1	25.2	49.3	14.6	22.7	45.2	25.7	15.6	12.6	16.1	30.2	47.0	34.7	34.7	18.3	48.0	65.8	31.5	28.1	28.2	88.0	25.2	16.9	57.6	21.1	27.1	29.6	53.1	24.7	42.4	49.6	2.4	31.3	31.5	52.7	40.9	27.0	59.9	63.1	32.0	34.6	24.0	51.5	23.8	41.2	55.5	57.1	110.1	77.3	59.8	75.2	43.9	64.8	83.7	48.9	36.6	48.7	61.1	74.9	55.8	62.9	97.7	64.6	84.5	106.4	76.0	25.2	74.4	93.1	43.9	60.0	52.9	40.1	34.9	56.6	78.2	181.8	216.6	586.3	182.4	113.0	193.6	93.7	91.0	225.1	675.4	207.7	588.6	495.6	100.8	397.7	599.7	607.3	597.7	329.8	327.6	443.3	180.0	320.2	368.6	103.3	258.9	305.7	236.3	483.4	216.3	309.1	492.6	406.6	288.0	169.2	724.2	491.0	229.1	543.7	445.9	245.8	394.4	82.0	73.0	629.1	219.5	279.1	243.7	436.5
GUSB		ENSG00000169919	"Glucuronidase beta"	P08236	7	65960684-65982314	"Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		"Glycosidase, Hydrolase"	"Cancer-related genes, Disease mutation, Mucopolysaccharidosis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"Karpas-707: 56.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036322, HPA036323"	Approved		Supported	Vesicles	"Intracellular and membrane"	NA	NA		48000	Vesicles		"HPA036322: AB_10670796, HPA036323: AB_2675059"	"unprognostic (1.54e-2)"	"unprognostic (6.49e-2)"	"unprognostic (1.18e-2)"	"unprognostic (3.50e-1)"	"unprognostic (2.58e-2)"	"unprognostic (4.46e-2)"	"unprognostic (2.89e-1)"	"unprognostic (1.56e-3)"	"unprognostic (1.32e-1)"	"unprognostic (2.32e-1)"	"unprognostic (7.00e-3)"	"unprognostic (1.91e-1)"	"unprognostic (3.34e-2)"	"unprognostic (8.83e-3)"	"unprognostic (1.98e-1)"	"unprognostic (5.06e-1)"	"unprognostic (1.45e-1)"	23.5	12.0	3.7	7.9	5.5	20.7	25.4	5.7	4.4	10.4	14.6	7.7	22.0	10.0	10.4	12.2	9.3	7.6	11.1	8.0	3.7	2.9	11.8	50.4	15.3	12.3	6.3	3.1	8.6	17.1	9.0	7.3	30.0	4.5	12.1	11.4	9.9	17.2	11.8	5.9	10.0	16.1	8.3	3.9	17.5	11.0	7.9	5.8	14.7	17.7	5.9	13.0	9.2	7.4	9.7	27.7	22.1	36.0	15.2	11.5	15.8	17.0	6.6	6.5	14.5	22.1	13.2	9.4	5.4	15.1	11.9	11.0	9.5	17.6	7.8	8.5	6.9	6.2	6.9	4.2	6.5	7.1	7.3	8.5	10.6	10.0	6.4	10.8	22.7	17.7	9.1	7.0	6.9	9.0	14.2	10.4	4.5	16.1	56.5	7.7	12.4	8.3	24.4	4.3	26.0	5.5	8.6	15.0	44.2	7.5	10.3	9.5	8.4	14.5	33.9	18.9	7.6	18.9	22.6	7.3	14.6	13.2	5.5	13.5	32.1	38.5	13.1	10.9	30.2	17.7	7.4	28.1	22.1	11.5	36.0	10.3	9.7	9.0	10.2	27.7	7.8	6.2	7.3	4.5	15.2	30.0	11.3	11.3	15.8	3.7	5.5	5.7	4.4	3.7	2.9	6.3	3.1	4.5	5.8	47.6	56.2	18.6	26.4	16.0	13.7	8.3	25.5	48.2	37.5	27.9	7.9	72.3	5.0	32.4	47.6	31.3	41.1	23.3	26.7	48.8	48.3	25.5	35.8	64.7	114.3	15.9	41.2	39.9	74.2	36.8	40.0	72.1	37.1	43.3	42.3	27.3	25.9	48.9	26.9	19.2	17.7	25.8	22.6	41.3	28.8	12.9	56.0	34.6	40.6	25.3
GXYLT1	"FLJ43151, GLT8D3"	ENSG00000151233	"Glucoside xylosyltransferase 1"	Q4G148	12	42081845-42144879	"Enzymes, Predicted intracellular proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"								"Intracellular and membrane"	NA	NA		3000000				"unprognostic (1.09e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.53e-1)"	"unprognostic (5.07e-1)"	"unprognostic (1.22e-1)"	"unprognostic (9.89e-2)"	"unprognostic (5.22e-3)"	"unprognostic (1.77e-2)"	"unprognostic (4.42e-3)"	"unprognostic (1.46e-2)"	"unprognostic (1.64e-2)"	"unprognostic (3.20e-1)"	"unprognostic (1.92e-2)"	"unprognostic (8.16e-2)"	"unprognostic (2.93e-1)"	"unprognostic (3.96e-2)"	"prognostic favorable (3.91e-4)"	9.1	7.6	9.7	8.3	10.9	9.4	8.6	12.5	8.9	8.7	5.9	9.7	5.2	5.9	8.6	5.8	7.7	7.9	6.1	6.4	8.1	6.2	9.7	18.4	8.8	7.0	8.7	4.4	10.4	7.9	11.2	25.6	16.0	11.5	7.5	7.4	9.0	8.6	8.2	5.5	6.3	8.1	5.5	7.4	9.2	6.7	13.4	7.8	6.0	13.2	2.8	9.0	7.6	7.8	1.4	2.7	4.9	4.0	2.4	2.0	0.9	6.6	5.7	6.5	6.4	4.7	12.3	24.6	15.0	10.1	11.2	11.4	13.1	13.7	5.8	11.8	8.2	8.0	3.1	10.9	4.8	20.8	9.6	12.4	9.6	4.7	10.6	7.4	10.3	9.1	9.4	4.2	17.0	7.6	6.7	14.7	6.7	6.0	10.3	14.2	4.6	6.6	6.3	7.9	2.5	5.4	3.1	13.2	5.1	6.8	10.0	3.4	5.7	10.7	6.1	8.8	12.8	12.5	8.1	12.6	8.0	27.3	4.6	9.4	13.6	15.3	7.4	10.8	28.1	4.9	0.3	1.8	4.9	1.2	3.6	0.8	1.1	1.9	1.6	2.7	1.4	1.7	1.5	1.4	2.4	4.0	0.9	2.0	0.9	9.7	10.9	12.5	8.9	8.1	6.2	8.7	4.4	11.5	7.8	14.9	12.9	15.7	9.7	2.9	8.7	6.7	2.5	10.7	9.1	33.2	7.9	33.2	1.7	8.5	1.0	15.5	9.2	0.0	9.1	33.4	15.5	12.9	19.5	27.6	12.2	14.3	2.9	21.5	15.8	2.8	10.9	9.8	5.0	15.4	8.4	10.8	7.5	10.5	7.1	3.6	14.6	12.9	6.4	25.6	29.1	3.9	38.1	20.3	8.6	10.3
GXYLT2	GLT8D4	ENSG00000172986	"Glucoside xylosyltransferase 2"	A0PJZ3	3	72888073-72998138	"Enzymes, Predicted intracellular proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	14	"Early spermatids: 37.7;Fibroblasts: 14.2;Late spermatids: 17.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"plasmacytoid DC: 3.0"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"GAMG: 14.6;JURKAT: 14.1;MOLT-4: 22.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA068429	Uncertain		Approved	"Nucleoplasm,Cytokinetic bridge,Midbody ring"		Yes	No			Nucleoplasm	"Cytokinetic bridge, Midbody ring"	"HPA068429: AB_2685988"	"unprognostic (9.43e-2)"	"unprognostic (8.87e-3)"	"unprognostic (1.90e-1)"	"unprognostic (4.77e-2)"	"unprognostic (3.33e-2)"	"unprognostic (7.04e-2)"	"unprognostic (4.79e-3)"	"unprognostic (5.29e-2)"	"unprognostic (5.25e-2)"	"unprognostic (5.10e-2)"	"unprognostic (2.00e-1)"	"unprognostic (7.33e-2)"	"prognostic unfavorable (1.46e-7)"	"unprognostic (3.22e-3)"	"unprognostic (4.70e-1)"	"unprognostic (2.51e-1)"	"prognostic unfavorable (2.42e-5)"	8.7	7.2	3.1	6.2	4.0	2.1	5.2	1.1	4.0	10.2	4.5	8.1	3.4	0.9	8.4	9.3	4.2	6.7	12.4	20.6	3.4	2.4	2.2	1.0	5.2	2.4	5.6	4.7	24.8	11.9	2.8	3.8	4.9	4.2	11.3	2.7	10.7	8.0	5.2	2.2	2.6	2.5	12.0	5.4	1.0	2.6	8.4	4.7	14.9	12.1	3.7	2.3	12.2	6.9	0.4	3.0	1.7	0.1	0.8	1.4	0.1	0.1	1.1	0.0	7.2	6.6	13.0	1.1	1.1	2.7	2.6	6.4	0.3	0.8	0.0	2.0	3.0	14.6	0.1	0.7	1.4	2.5	0.0	0.8	0.0	4.8	7.7	8.4	3.0	0.0	12.5	0.7	6.3	1.0	3.9	0.0	14.1	3.5	0.1	1.5	1.6	22.3	0.1	4.3	0.1	1.4	0.1	6.1	0.0	0.8	1.1	0.7	3.3	6.2	0.3	0.8	1.4	2.4	0.9	0.0	2.8	9.0	8.7	4.1	0.6	0.1	0.1	7.3	1.4	4.9	0.4	0.1	0.2	0.2	0.1	0.2	0.2	0.2	0.1	0.1	0.4	0.2	0.2	1.7	0.8	0.1	3.0	1.4	0.1	3.1	4.0	1.1	4.0	3.4	2.4	5.6	4.7	4.2	4.7	3.0	1.6	0.0	1.5	1.6	0.6	9.8	2.5	1.4	1.2	0.0	0.0	0.1	0.0	0.0	37.7	0.0	0.9	0.0	1.0	0.2	14.2	1.3	0.0	0.0	0.3	0.0	3.4	1.3	0.0	17.8	7.5	0.3	0.0	0.0	2.3	2.5	1.2	0.0	6.7	0.4	0.4	0.0	1.0	2.9	3.2	0.4	0.7	0.0	1.5	0.4
GYG1	GYG	ENSG00000163754	"Glycogenin 1"	P46976	3	148991341-149027668	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Glycogen biosynthesis"	Transferase	"Disease mutation, Glycogen storage disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 113.0"	"Cell type enhanced"	"Detected in many"	7	"Cardiomyocytes: 202.8;Early spermatids: 172.2;Late spermatids: 292.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030497, HPA073229"	Supported		Approved	Vesicles		NA	NA			Vesicles		"HPA030497: AB_10602326, HPA073229: "	"unprognostic (2.68e-2)"	"unprognostic (6.31e-3)"	"unprognostic (3.21e-1)"	"unprognostic (1.81e-1)"	"unprognostic (6.19e-2)"	"unprognostic (1.49e-2)"	"prognostic unfavorable (6.15e-5)"	"unprognostic (2.55e-2)"	"unprognostic (2.71e-1)"	"unprognostic (1.10e-1)"	"unprognostic (7.75e-3)"	"unprognostic (1.29e-1)"	"unprognostic (3.56e-2)"	"unprognostic (1.27e-2)"	"unprognostic (1.96e-1)"	"unprognostic (1.05e-1)"	"unprognostic (4.79e-2)"	10.8	7.9	7.0	8.5	8.5	55.7	10.0	9.2	7.5	10.6	31.0	6.0	11.9	4.8	15.6	15.4	18.1	11.1	12.0	32.0	8.0	9.0	8.5	6.3	9.1	14.7	11.6	7.1	13.3	14.3	6.5	7.8	6.5	10.0	16.3	7.6	7.7	11.3	19.4	113.0	4.7	8.4	32.5	8.1	13.6	12.8	47.3	7.4	4.2	9.4	39.6	8.5	28.7	14.6	7.0	26.7	16.8	26.7	17.7	32.5	17.5	18.8	12.2	9.1	10.2	25.3	26.5	12.4	27.8	23.2	40.6	38.1	15.9	19.3	0.0	13.8	32.2	21.7	5.8	23.9	12.3	41.1	6.3	10.3	14.4	5.8	18.0	22.9	14.6	21.8	14.5	20.1	13.4	17.0	21.2	23.3	9.5	8.8	34.3	23.3	33.2	2.8	11.7	10.9	14.6	10.0	8.0	13.8	27.0	11.2	17.7	7.5	3.5	14.7	20.3	15.8	9.0	20.1	15.6	19.3	20.8	6.2	14.9	20.3	31.2	17.3	13.4	17.6	22.6	6.7	7.2	23.4	16.8	17.4	24.5	32.5	7.0	11.6	18.1	26.7	5.1	6.3	10.7	11.6	17.7	26.7	10.7	15.9	17.5	7.0	8.5	9.2	7.5	8.0	9.0	11.6	7.1	10.0	7.4	11.9	12.0	15.2	20.5	10.8	7.4	202.8	10.2	16.0	11.4	31.4	17.7	31.4	23.2	37.5	172.2	32.3	12.4	0.0	67.2	38.6	32.6	36.2	17.4	13.9	84.7	6.4	13.8	43.0	102.9	292.0	49.2	51.1	38.8	27.9	13.4	81.1	32.6	13.3	72.2	12.2	4.9	64.7	60.5	46.6	19.8	13.0	24.5	62.3	12.1	16.9
GYG2	GN-2	ENSG00000056998	"Glycogenin 2"	O15488	X	2828788-2882820	"Enzymes, Predicted intracellular proteins"	"Glycogen biosynthesis"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"adipose tissue: 76.7;brain: 21.2;breast: 30.4"	"Cell type enhanced"	"Detected in many"	11	"Hepatocytes: 15.8;Intestinal endocrine cells: 19.5"	"Cancer enhanced"	"Detected in all"		"melanoma: 42.6"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"AF22: 17.1;Hep G2: 13.7;NTERA-2: 16.9;SK-MEL-30: 36.5;SuSa: 27.1"					"Low region specificity"	"Detected in all"			"HPA005495, HPA064686"	Enhanced		Approved	Nucleoplasm,Nucleoli,Cytosol		No	No			"Nucleoli, Cytosol"	Nucleoplasm	"HPA005495: AB_1079035, HPA064686: AB_2685323"	"unprognostic (4.45e-2)"	"unprognostic (4.21e-2)"	"unprognostic (6.41e-3)"	"unprognostic (8.50e-2)"	"unprognostic (2.07e-3)"	"unprognostic (5.16e-1)"	"unprognostic (1.74e-2)"	"unprognostic (1.18e-1)"	"unprognostic (7.43e-3)"	"unprognostic (6.74e-2)"	"prognostic favorable (3.01e-5)"	"unprognostic (9.76e-2)"	"unprognostic (6.10e-5)"	"unprognostic (1.78e-1)"	"unprognostic (5.05e-3)"	"unprognostic (5.41e-2)"	"unprognostic (6.60e-2)"	76.7	1.4	4.6	1.3	4.6	0.5	30.4	2.1	3.7	2.1	3.5	8.2	0.7	1.2	4.2	0.9	1.0	3.6	1.7	1.7	3.9	2.9	1.4	9.9	0.7	0.7	5.5	2.9	1.9	3.2	0.4	0.5	1.6	12.9	2.7	2.0	4.2	2.8	4.4	0.5	1.2	1.3	2.8	21.2	0.5	2.2	0.8	5.1	0.0	1.3	0.5	0.6	2.9	1.4	1.0	0.6	0.6	0.4	1.2	0.7	0.0	0.0	5.2	17.1	0.0	10.2	0.0	12.4	0.5	3.0	3.0	3.8	12.7	0.3	0.0	1.4	2.1	3.1	0.0	9.6	0.2	2.9	0.1	2.7	0.0	0.2	13.7	3.0	0.0	4.2	3.7	0.1	0.3	0.0	0.0	0.0	0.0	0.1	0.0	3.1	0.8	0.0	0.4	16.9	0.1	0.0	2.8	5.7	0.0	0.0	0.0	0.0	0.3	0.0	0.1	36.5	27.1	1.6	10.4	0.0	0.0	3.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.3	0.3	0.2	0.7	0.5	0.4	0.3	0.1	1.0	0.3	0.2	0.6	1.2	0.4	0.6	0.4	0.0	4.6	4.6	2.1	3.7	3.9	2.9	5.5	2.9	12.9	5.1	0.0	0.0	0.0	0.9	0.3	0.9	0.6	2.5	0.0	0.0	0.0	3.9	5.3	5.0	0.8	0.3	0.0	0.2	0.0	3.4	7.0	1.9	1.7	0.0	15.8	0.9	0.0	19.5	0.0	1.3	0.0	0.6	0.0	3.3	0.0	1.3	1.8	2.8	0.0	2.8	2.1	0.0	0.0	0.9	0.3	0.4	0.3	1.9	0.0	2.0	0.5
GYS1	"GSY, GYS"	ENSG00000104812	"Glycogen synthase 1"	P13807	19	48968125-48993310	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Glycogen biosynthesis"	"Allosteric enzyme, Glycosyltransferase, Transferase"	"Diabetes mellitus, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 106.1"	"Cell type enhanced"	"Detected in many"	9	"Cardiomyocytes: 62.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB007793, HPA041598"	Enhanced		Approved	Microtubules,Cytosol		NA	NA		10000	"Microtubules, Cytosol"		"CAB007793: AB_562291, HPA041598: AB_2677571"	"unprognostic (3.37e-1)"	"unprognostic (3.07e-1)"	"unprognostic (1.02e-1)"	"unprognostic (1.83e-1)"	"unprognostic (1.92e-1)"	"unprognostic (2.04e-2)"	"unprognostic (6.83e-3)"	"unprognostic (2.41e-2)"	"unprognostic (1.12e-1)"	"unprognostic (3.30e-2)"	"unprognostic (1.30e-1)"	"unprognostic (4.49e-2)"	"prognostic unfavorable (3.46e-4)"	"unprognostic (4.04e-2)"	"unprognostic (6.76e-2)"	"unprognostic (5.87e-3)"	"unprognostic (3.81e-2)"	9.7	7.3	5.1	6.1	6.5	16.0	10.6	11.3	6.2	5.3	7.3	6.2	5.8	6.1	6.2	6.9	11.5	5.9	6.1	37.3	6.8	4.0	7.2	4.3	5.0	6.3	5.3	5.5	6.8	4.4	6.4	5.1	5.0	5.9	8.7	6.1	12.4	7.2	7.6	106.1	8.1	6.1	6.8	6.0	5.8	7.3	2.2	5.5	6.4	5.2	42.6	9.0	7.9	6.9	6.7	15.9	8.2	10.5	12.8	10.9	7.3	28.7	11.5	8.5	11.7	19.9	7.8	16.9	20.0	14.1	21.1	24.7	11.2	9.4	12.0	12.2	19.5	5.6	20.6	14.2	25.4	18.5	7.4	20.6	9.9	14.7	9.9	11.2	10.8	7.4	19.2	12.2	13.5	11.5	18.3	17.6	12.7	6.9	16.1	26.4	10.9	13.4	9.4	4.5	12.5	13.2	11.4	14.9	11.8	20.9	30.9	5.3	7.4	17.8	23.3	4.7	11.9	12.3	11.3	13.6	25.9	10.0	11.6	21.6	13.3	13.8	5.9	26.4	9.5	5.8	8.2	10.5	7.5	8.8	6.3	10.9	6.7	7.6	8.2	15.9	5.5	6.3	5.6	4.4	12.8	8.5	8.6	10.1	7.3	5.1	6.5	11.3	6.2	6.8	4.0	5.3	5.5	5.9	5.5	0.0	13.9	2.2	3.1	4.5	2.2	62.1	5.1	6.7	3.4	0.0	15.7	7.4	0.0	6.9	0.2	5.4	9.5	0.0	5.9	22.2	4.6	4.3	4.6	4.4	7.1	0.0	6.9	9.8	6.5	0.7	4.9	3.8	6.8	8.2	11.8	2.7	8.9	10.4	5.3	4.8	11.1	0.0	7.6	1.7	3.1	3.6	3.3	4.4	9.8	3.1
GYS2		ENSG00000111713	"Glycogen synthase 2"	P54840	12	21536189-21604847	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Glycogen biosynthesis"	"Allosteric enzyme, Glycosyltransferase, Transferase"	"Disease mutation, Glycogen storage disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	9	"liver: 75.1"	"Cell type enriched"	"Detected in some"	46	"Hepatocytes: 57.8"	"Cancer enriched"	"Detected in single"	29	"liver cancer: 12.6"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	7	"naive CD4 T-cell: 1.4"	"Lineage enriched"	"Detected in single"	8	"T-cells: 1.4"	"Cell line enhanced"	"Detected in some"		"CACO-2: 5.2;HEL: 1.9;SuSa: 1.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA039482	Approved					NA	NA					"HPA039482: AB_10795107"	"unprognostic (7.22e-3)"	"unprognostic (2.85e-2)"	"unprognostic (8.88e-2)"	"unprognostic (1.78e-2)"	"unprognostic (5.68e-2)"	"unprognostic (3.16e-1)"	"prognostic favorable (7.62e-5)"	"unprognostic (1.06e-1)"	"unprognostic (1.29e-1)"	"unprognostic (1.68e-1)"	"unprognostic (4.68e-2)"	"unprognostic (2.15e-1)"	"unprognostic (1.13e-1)"	"unprognostic (4.22e-2)"	"unprognostic (6.53e-2)"	"unprognostic (1.85e-1)"	"unprognostic (2.66e-4)"	8.4	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	1.2	0.1	0.0	0.0	0.0	0.0	0.0	2.9	0.0	0.2	0.0	0.0	0.0	0.1	75.1	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.2	0.2	2.4	0.0	0.1	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.5	0.0	0.2	0.1	0.1	0.0	0.1	0.0	0.0	5.2	0.0	0.2	0.0	0.0	0.1	0.0	0.4	0.0	0.4	0.2	0.6	1.9	0.2	0.0	0.3	0.5	0.4	0.5	0.2	0.0	0.4	0.1	0.0	0.3	0.0	0.1	0.6	0.0	0.3	0.3	0.2	0.0	0.0	0.5	0.2	0.0	1.0	0.1	0.0	0.0	0.2	0.0	0.0	1.5	0.0	0.1	0.2	0.1	0.4	0.0	0.1	0.2	0.1	0.2	0.1	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	57.8	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
GZMA	"CTLA3, HFSP"	ENSG00000145649	"Granzyme A"	P12544	5	55102648-55110252	"Enzymes, Predicted secreted proteins"	"Apoptosis, Cytolysis"	"Hydrolase, Protease, Serine protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"blood: 92.3;intestine: 31.0;lymphoid tissue: 40.9"	"Cell type enriched"	"Detected in many"	28	"T-cells: 796.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	13	"gdT-cell: 92.3;MAIT T-cell: 90.8;memory CD4 T-cell: 25.4;memory CD8 T-cell: 89.3;naive CD8 T-cell: 50.5;NK-cell: 61.9"	"Group enriched"	"Detected in many"	38	"NK-cells: 61.9;T-cells: 92.3"	"Cell line enhanced"	"Detected in some"		"HL-60: 8.4;JURKAT: 6.3;REH: 1.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"HPA054134, HPA076751"	Enhanced				"Secreted to blood"	NA	NA					"HPA054134: AB_2682395, HPA076751: "	"prognostic favorable (7.27e-4)"	"unprognostic (7.29e-3)"	"unprognostic (1.50e-2)"	"prognostic favorable (6.44e-6)"	"unprognostic (2.96e-3)"	"unprognostic (1.85e-3)"	"unprognostic (8.30e-3)"	"unprognostic (1.15e-2)"	"unprognostic (5.15e-3)"	"unprognostic (3.03e-2)"	"unprognostic (1.77e-1)"	"unprognostic (3.09e-1)"	"prognostic unfavorable (1.26e-6)"	"unprognostic (5.91e-2)"	"unprognostic (5.57e-1)"	"unprognostic (5.73e-3)"	"unprognostic (3.33e-3)"	4.3	1.8	1.1	16.3	1.2	10.0	2.5	0.7	0.8	3.9	12.5	0.9	1.3	10.3	5.2	2.9	2.9	2.9	9.6	4.5	1.1	1.1	4.6	5.2	11.8	20.3	1.7	0.9	3.0	5.8	0.0	1.9	5.8	1.5	3.4	6.3	4.5	5.1	1.3	2.6	1.2	31.0	2.5	2.6	40.9	3.9	1.1	0.6	1.9	3.1	4.2	11.1	6.6	2.9	0.2	0.2	2.0	0.3	61.9	92.3	52.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.4	0.4	0.0	0.0	0.0	0.0	0.0	0.0	6.3	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.2	0.0	1.9	0.1	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.0	0.2	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.3	92.3	0.2	90.8	0.2	25.4	89.3	0.2	0.1	5.2	50.5	2.0	61.9	0.3	0.2	2.9	52.0	1.1	1.2	0.7	0.8	1.1	1.1	1.7	0.9	1.5	0.6	3.0	28.1	9.2	0.0	0.3	0.0	0.7	2.5	5.3	5.7	0.0	0.0	0.1	0.0	0.0	0.0	0.7	1.3	0.0	0.0	0.1	0.8	0.1	7.0	2.4	0.2	0.0	0.0	12.3	16.8	0.0	0.0	1.3	3.3	0.0	0.6	0.0	0.0	0.3	0.0	2.2	0.0	0.0	0.4	0.0	0.0	1.3	0.6	796.9	0.5	0.0
GZMB	"CCPI, CGL-1, CGL1, CSP-B, CSPB, CTLA1, CTSGL1, HLP, SECT"	ENSG00000100453	"Granzyme B"	P10144	14	24630954-24634267	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Apoptosis, Cytolysis"	"Hydrolase, Protease, Serine protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	9	"blood: 298.5"	"Cell type enriched"	"Detected in many"	4	"T-cells: 243.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Cell type enriched"	"Detected in many"	5	"plasmacytoid DC: 298.5"	"Lineage enriched"	"Detected in many"	5	"dendritic cells: 298.5"	"Cell line enriched"	"Detected in some"	5	"HMC-1: 21.2"									"CAB000376, HPA003418"	Enhanced				"Secreted to blood"	NA	NA					"CAB000376: AB_323716, HPA003418: AB_1079020"	"prognostic favorable (7.27e-4)"	"unprognostic (2.82e-3)"	"unprognostic (8.54e-2)"	"prognostic favorable (1.58e-5)"	"unprognostic (2.07e-3)"	"unprognostic (1.48e-3)"	"unprognostic (4.43e-2)"	"unprognostic (8.25e-2)"	"unprognostic (3.70e-2)"	"unprognostic (3.05e-3)"	"unprognostic (4.26e-2)"	"unprognostic (1.58e-1)"	"prognostic unfavorable (1.10e-7)"	"unprognostic (1.24e-1)"	"unprognostic (1.48e-1)"	"unprognostic (1.29e-1)"	"unprognostic (2.71e-3)"	6.4	0.7	0.8	8.0	1.1	26.4	3.2	0.7	0.7	1.6	3.0	0.5	1.3	0.8	3.9	1.5	4.0	1.0	3.1	4.8	0.7	2.4	2.1	5.7	21.7	16.7	1.1	0.0	1.4	0.7	0.0	1.0	7.5	0.8	2.6	0.9	4.0	2.7	2.3	3.5	0.6	2.9	1.8	1.5	33.0	3.5	0.9	0.4	6.1	4.4	5.3	16.8	6.0	1.5	0.2	298.5	2.0	0.2	19.9	60.5	53.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	21.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.1	0.1	0.0	0.0	3.9	0.0	0.0	0.0	0.7	2.9	0.3	0.1	0.2	60.5	0.1	0.7	0.2	4.6	28.4	0.2	0.1	1.4	28.7	2.0	19.9	0.2	298.5	0.1	53.6	0.8	1.1	0.7	0.7	0.7	2.4	1.1	0.0	0.8	0.4	6.0	57.5	21.4	0.2	2.5	0.0	0.4	0.0	8.1	13.6	0.0	0.0	0.1	0.0	0.1	0.0	2.2	0.0	0.0	0.0	0.0	1.6	0.2	16.3	1.1	0.2	0.0	0.0	3.1	2.1	0.0	0.0	5.5	40.5	0.0	0.0	0.0	0.1	0.2	0.0	2.1	0.0	0.0	0.5	0.0	0.0	3.6	0.2	243.7	0.2	0.1
GZMH	"CCP-X, CGL-2, CSP-C, CTLA1, CTSGL2"	ENSG00000100450	"Granzyme H"	P20718	14	24606480-24609699	"Enzymes, Predicted secreted proteins"	Cytolysis	"Hydrolase, Protease, Serine protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"blood: 134.9"	"Cell type enriched"	"Detected in some"	9	"T-cells: 79.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	6	"gdT-cell: 134.9;memory CD4 T-cell: 41.8;memory CD8 T-cell: 109.7;naive CD8 T-cell: 102.7"	"Lineage enriched"	"Detected in many"	8	"T-cells: 134.9"	"Cell line enhanced"	"Detected in some"		"Hep G2: 1.5;JURKAT: 1.8;RPMI-8226: 2.0;THP-1: 1.4;U-266/70: 4.5"					"Low region specificity"	"Detected in many"			HPA029200	Enhanced				"Secreted to blood"	NA	NA					"HPA029200: AB_10602908"	"unprognostic (3.72e-3)"	"unprognostic (1.47e-3)"	"unprognostic (5.35e-2)"	"prognostic favorable (2.00e-6)"	"unprognostic (8.80e-2)"	"unprognostic (1.65e-3)"	"unprognostic (2.08e-3)"	"unprognostic (1.13e-1)"	"unprognostic (1.62e-2)"	"unprognostic (4.41e-2)"	"unprognostic (1.14e-1)"	"unprognostic (2.68e-1)"	"prognostic unfavorable (1.74e-6)"	"unprognostic (1.23e-1)"	"unprognostic (1.80e-1)"	"unprognostic (3.35e-2)"	"unprognostic (2.77e-3)"	3.6	3.1	1.1	5.0	1.2	16.5	3.6	0.5	1.0	1.9	3.1	0.4	0.2	0.9	1.0	2.7	2.6	1.8	8.1	4.8	1.0	1.1	1.7	3.6	16.4	11.5	2.6	1.3	3.0	1.1	0.0	3.7	1.6	1.2	4.5	1.1	5.1	5.4	4.2	4.5	0.8	2.2	2.0	3.1	22.6	2.5	2.5	0.7	0.2	2.5	3.4	6.4	5.1	1.9	0.4	3.2	1.8	0.3	17.6	134.9	82.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	4.5	0.0	0.1	0.0	0.4	0.9	1.8	0.2	0.1	134.9	0.2	2.4	0.4	41.8	109.7	0.2	0.2	13.9	102.7	1.5	17.6	0.3	3.2	0.3	82.9	1.1	1.2	0.5	1.0	1.0	1.1	2.6	1.3	1.2	0.7	0.0	5.8	3.0	0.0	1.0	0.0	0.9	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.7	0.1	1.1	0.8	0.1	0.0	0.0	9.2	2.7	0.0	0.0	0.2	3.3	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.4	0.0	0.0	1.6	0.0	79.8	0.0	0.0
GZMK	"PRSS, TRYP2"	ENSG00000113088	"Granzyme K"	P49863	5	55024253-55034570	"Enzymes, Predicted secreted proteins"		"Hydrolase, Protease, Serine protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"blood: 95.8;lymphoid tissue: 37.3"	"Cell type enriched"	"Detected in some"	11	"T-cells: 137.0"	"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in many"		"MAIT T-cell: 95.8;memory CD8 T-cell: 59.0"	"Group enriched"	"Detected in many"	191	"NK-cells: 56.9;T-cells: 95.8"	"Cell line enriched"	"Detected in single"	10	"JURKAT: 5.0"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"HPA063181, HPA065895"	Enhanced				"Secreted to blood"	NA	NA					"HPA063181: AB_2684955, HPA065895: "	"prognostic favorable (8.68e-4)"	"unprognostic (3.26e-3)"	"unprognostic (2.23e-2)"	"unprognostic (1.83e-3)"	"unprognostic (2.61e-2)"	"unprognostic (1.12e-3)"	"unprognostic (1.03e-3)"	"unprognostic (8.13e-3)"	"unprognostic (3.50e-2)"	"unprognostic (4.53e-2)"	"unprognostic (9.74e-2)"	"unprognostic (1.96e-1)"	"prognostic unfavorable (1.06e-4)"	"unprognostic (2.04e-1)"	"unprognostic (2.42e-1)"	"unprognostic (1.21e-2)"	"unprognostic (1.00e-1)"	3.5	1.6	0.6	10.5	0.6	3.6	3.1	0.5	0.5	4.1	3.7	0.2	1.7	0.4	3.2	2.6	2.8	1.8	7.4	1.6	0.6	0.7	4.3	4.1	10.2	37.3	0.7	0.2	2.1	1.5	0.0	1.0	0.9	0.5	6.6	1.9	2.9	5.7	2.1	0.8	0.8	7.4	0.8	1.6	36.4	2.4	2.1	0.3	3.3	3.1	2.7	28.2	4.9	2.6	0.0	0.1	0.4	0.1	56.9	95.8	9.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.3	5.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.1	21.1	0.1	95.8	0.0	13.2	59.0	0.0	0.0	0.6	10.5	0.4	56.9	0.1	0.1	0.8	9.9	0.6	0.6	0.5	0.5	0.6	0.7	0.7	0.2	0.5	0.3	3.0	12.4	0.0	0.0	1.3	0.0	0.0	5.1	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.5	0.0	2.3	1.0	0.2	0.0	0.0	8.0	8.7	0.2	0.0	1.3	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.5	0.2	137.0	0.0	0.0
GZMM	"LMET1, MET1"	ENSG00000197540	"Granzyme M"	P51124	19	544034-549924	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Apoptosis, Cytolysis, Immunity, Innate immunity"	"Hydrolase, Protease, Serine protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 79.2;lymphoid tissue: 28.6"	"Cell type enriched"	"Detected in some"	8	"T-cells: 184.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Cell type enhanced"	"Detected in many"		"gdT-cell: 79.2"	"Group enriched"	"Detected in many"	31	"NK-cells: 22.7;T-cells: 79.2"	"Cell line enhanced"	"Detected in some"		"EFO-21: 4.6;HDLM-2: 3.7;HMC-1: 4.6;JURKAT: 7.5;MOLT-4: 3.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA015624	Enhanced				"Secreted to blood"	NA	NA					"HPA015624: AB_2669245"	"unprognostic (2.97e-3)"	"unprognostic (2.29e-3)"	"unprognostic (7.53e-2)"	"prognostic favorable (1.89e-4)"	"unprognostic (1.07e-1)"	"prognostic favorable (1.87e-7)"	"unprognostic (2.35e-1)"	"unprognostic (7.46e-2)"	"unprognostic (1.67e-1)"	"unprognostic (4.98e-2)"	"unprognostic (4.53e-2)"	"unprognostic (7.94e-2)"	"prognostic unfavorable (1.21e-4)"	"unprognostic (1.32e-1)"	"unprognostic (9.51e-2)"	"unprognostic (2.69e-3)"	"unprognostic (9.94e-2)"	1.8	1.0	0.7	13.6	0.9	15.6	1.0	4.3	1.4	1.0	3.5	0.2	0.1	1.8	1.0	2.9	2.0	1.1	4.7	1.6	0.7	0.6	1.1	2.6	4.8	15.1	0.7	0.4	0.8	0.4	0.0	0.9	1.6	0.5	1.7	0.1	1.5	12.0	0.3	0.8	0.7	5.1	0.5	1.1	21.1	3.0	1.5	0.4	28.6	1.4	1.1	10.9	1.1	1.2	0.4	0.4	1.6	0.2	22.7	79.2	27.0	0.1	0.6	0.1	0.3	0.2	0.0	0.6	0.0	0.1	0.1	0.0	0.5	0.2	0.1	4.6	0.0	0.1	0.1	0.0	0.0	0.0	3.7	0.4	0.0	0.6	0.2	0.5	0.4	4.6	0.2	0.0	0.1	0.0	0.0	0.1	7.5	1.4	0.3	0.0	1.0	3.0	1.3	0.8	0.2	0.7	0.3	0.0	0.0	0.0	0.2	0.1	0.2	0.0	0.0	0.3	0.1	0.0	0.1	0.0	0.0	0.7	0.8	0.0	0.9	0.3	1.0	0.3	0.7	0.3	0.8	0.1	0.1	79.2	0.2	49.8	0.1	26.4	63.6	0.1	0.4	25.8	53.1	1.6	22.7	0.2	0.4	12.2	27.0	0.7	0.9	4.3	1.4	0.7	0.6	0.7	0.4	0.5	0.4	0.0	0.0	0.8	0.0	2.7	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.8	0.4	0.0	23.3	0.3	0.3	1.9	0.0	0.0	0.8	0.2	0.0	0.0	2.5	2.8	0.8	0.0	1.6	1.7	0.0	0.1	1.5	0.2	0.0	0.0	0.7	1.4	0.0	0.2	0.1	0.7	1.3	0.5	184.9	0.0	0.1
H6PD	GDH	ENSG00000049239	"Hexose-6-phosphate dehydrogenase/glucose 1-dehydrogenase"	O95479	1	9234775-9271337	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Carbohydrate metabolism, Glucose metabolism"	"Hydrolase, Multifunctional enzyme, Oxidoreductase"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 116.9"	"Cell type enhanced"	"Detected in many"	7	"Hepatocytes: 132.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"ASC diff: 29.2;ASC TERT1: 33.5;HSkMC: 32.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004824, HPA005440"	Approved		Uncertain	Cytosol	"Intracellular and membrane"	NA	NA		91000000	Cytosol		"HPA004824: AB_1079037, HPA005440: AB_1079036"	"unprognostic (4.83e-3)"	"unprognostic (3.91e-2)"	"unprognostic (1.18e-1)"	"unprognostic (3.49e-1)"	"unprognostic (5.53e-3)"	"unprognostic (2.86e-2)"	"unprognostic (8.35e-2)"	"unprognostic (5.18e-2)"	"unprognostic (9.73e-2)"	"unprognostic (1.26e-3)"	"unprognostic (2.16e-2)"	"unprognostic (7.35e-3)"	"unprognostic (8.20e-2)"	"unprognostic (3.61e-1)"	"unprognostic (1.30e-1)"	"unprognostic (8.65e-2)"	"unprognostic (1.95e-1)"	18.3	16.1	4.1	10.7	5.5	4.8	12.2	4.1	6.3	16.6	11.9	10.5	8.2	6.3	22.0	18.0	11.1	15.6	11.9	11.9	3.7	3.0	7.0	116.9	12.2	11.1	6.8	2.6	38.3	10.6	8.0	8.7	14.9	6.0	11.6	5.3	11.8	29.8	8.1	24.7	20.7	10.4	10.2	6.6	10.7	9.9	12.4	5.5	16.2	12.6	12.9	14.1	12.2	10.1	4.5	3.7	4.1	6.3	3.1	4.7	3.0	3.9	3.2	2.8	10.5	29.2	33.5	2.7	3.9	9.8	2.9	4.6	0.6	8.1	4.3	4.6	6.1	3.7	4.1	0.7	1.9	4.3	12.9	0.9	0.0	1.0	2.6	16.3	1.4	1.7	32.9	3.8	7.0	4.6	6.5	13.4	2.4	1.1	7.5	5.7	2.3	1.5	3.2	1.5	2.9	1.9	0.5	0.3	3.6	3.8	1.6	0.9	5.0	5.2	4.1	4.9	2.0	3.1	7.0	13.3	10.1	1.7	2.5	1.1	10.0	2.9	1.0	16.9	6.3	6.4	3.5	6.2	0.9	4.7	6.3	3.7	3.5	3.5	4.1	2.8	4.5	3.4	3.2	4.1	3.1	5.8	3.7	2.8	3.0	4.1	5.5	4.1	6.3	3.7	3.0	6.8	2.6	6.0	5.5	23.8	29.3	11.2	11.1	12.7	18.1	13.0	58.6	10.7	12.5	19.2	25.5	9.0	0.0	15.8	0.8	14.7	15.1	0.0	18.5	6.5	24.0	16.2	3.5	132.8	11.5	15.9	7.5	17.8	18.0	1.5	44.5	10.3	11.8	64.9	15.2	11.2	20.1	17.5	34.6	8.2	11.5	0.0	9.2	4.7	4.6	11.2	4.9	13.8	24.1	11.4
HAAO		ENSG00000162882	"3-hydroxyanthranilate 3,4-dioxygenase"	P46952	2	42767089-42792593	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Pyridine nucleotide biosynthesis"	"Dioxygenase, Oxidoreductase"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 78.7"	"Group enriched"	"Detected in many"	6	"Hepatocytes: 199.6;Proximal tubular cells: 138.8"	"Group enriched"	"Detected in all"	5	"liver cancer: 46.5;renal cancer: 13.9"	"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"myeloid DC: 15.7"	"Group enriched"	"Detected in many"	5	"dendritic cells: 15.7;granulocytes: 12.6;monocytes: 11.8"	"Cell line enhanced"	"Detected in some"		"CACO-2: 9.0;Hep G2: 31.8;REH: 6.6;THP-1: 6.0"	"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			"HPA036394, HPA042024"	Enhanced					NA	NA		150000			"HPA036394: AB_10673131, HPA042024: AB_2677803"	"unprognostic (6.97e-3)"	"unprognostic (1.86e-2)"	"unprognostic (1.63e-2)"	"unprognostic (4.44e-2)"	"unprognostic (1.78e-1)"	"unprognostic (7.23e-3)"	"prognostic favorable (5.77e-4)"	"unprognostic (6.20e-2)"	"unprognostic (7.58e-2)"	"unprognostic (5.10e-2)"	"unprognostic (1.26e-1)"	"unprognostic (2.68e-2)"	"unprognostic (1.05e-1)"	"unprognostic (8.67e-2)"	"unprognostic (1.37e-1)"	"unprognostic (2.56e-1)"	"unprognostic (2.03e-1)"	2.9	1.8	1.6	6.8	1.2	0.7	3.5	0.4	1.1	5.8	11.9	1.9	3.5	5.8	3.6	6.2	2.7	3.2	2.7	2.2	0.9	0.8	10.9	78.7	1.8	2.1	1.4	1.6	5.0	8.6	1.7	1.6	3.8	1.4	6.5	2.9	12.1	1.4	3.1	0.9	1.6	24.5	6.5	1.5	1.8	2.4	1.7	0.9	1.6	2.0	1.3	1.9	4.3	3.2	2.8	15.7	12.6	11.8	0.5	0.0	3.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.6	3.1	9.0	0.1	0.0	0.1	0.4	0.0	0.0	3.2	0.0	0.5	0.0	1.1	3.6	0.0	31.8	0.3	1.2	0.1	1.6	0.0	0.3	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.1	1.8	0.1	0.0	6.6	0.7	0.1	0.0	0.0	0.1	0.0	0.4	0.7	0.0	0.9	0.0	6.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	5.7	11.8	12.6	0.0	7.0	0.0	2.2	0.0	0.0	15.7	2.8	0.0	0.0	3.7	0.5	1.8	5.1	0.0	3.5	1.6	1.2	0.4	1.1	0.9	0.8	1.4	1.6	1.4	0.9	0.0	1.4	0.9	5.2	3.5	0.0	0.4	12.7	0.0	0.0	1.8	0.0	1.0	14.9	5.1	0.0	0.5	20.2	0.0	11.5	0.6	8.4	2.0	30.0	199.6	18.5	0.0	6.4	4.9	12.9	0.0	11.5	4.9	5.0	7.2	8.7	2.1	7.7	18.1	9.9	138.8	0.2	12.9	12.3	0.1	0.5	4.3	1.0	1.7	11.3	1.6
HABP2	"FSAP, HABP, HGFAL, PHBP"	ENSG00000148702	"Hyaluronan binding protein 2"	Q14520	10	113550837-113589602	"Candidate cardiovascular disease genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins"		"Hydrolase, Protease, Serine protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"liver: 135.4"	"Group enriched"	"Detected in some"	13	"Cholangiocytes: 122.3;Hepatocytes: 184.9"	"Cancer enriched"	"Detected in many"	5	"liver cancer: 92.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"OE19: 33.5;RPTEC TERT1: 27.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA019518	Uncertain				"Secreted to blood"	NA	NA	20200000000	3200000000			"HPA019518: AB_1850467"	"unprognostic (3.89e-2)"	"unprognostic (6.15e-2)"	"unprognostic (1.33e-1)"	"unprognostic (1.24e-1)"	"unprognostic (1.45e-1)"	"unprognostic (6.92e-2)"	"unprognostic (1.01e-1)"	"unprognostic (5.86e-3)"	"unprognostic (1.67e-1)"	"unprognostic (9.78e-2)"	"unprognostic (5.10e-2)"	"unprognostic (4.77e-2)"	"unprognostic (9.18e-3)"	"unprognostic (2.62e-3)"	"unprognostic (2.11e-1)"	"unprognostic (3.22e-1)"	"unprognostic (9.05e-3)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.1	0.0	0.0	0.6	0.6	0.3	0.0	0.4	26.4	0.4	0.0	0.0	20.9	135.4	0.2	0.0	0.0	0.0	0.8	11.6	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.2	0.0	0.0	0.1	2.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.7	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	33.5	0.0	0.0	0.0	0.0	27.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.9	11.5	0.0	0.0	0.0	0.2	122.3	0.0	0.0	1.8	0.0	0.0	3.3	10.0	0.3	0.0	0.0	0.0	3.2	0.0	0.0	0.0	0.0	184.9	0.7	0.0	0.0	6.7	4.7	0.0	0.0	0.0	0.0	0.0	0.0	0.8	3.7	0.0	0.0	8.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1
HACD1	"CAP, PTPLA"	ENSG00000165996	"3-hydroxyacyl-CoA dehydratase 1"	B0YJ81	10	17589032-17617377	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism"	"Developmental protein, Lyase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 80.1"	"Cell type enhanced"	"Detected in many"	16	"Cardiomyocytes: 116.4;Collecting duct cells: 29.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	10	"T-reg: 27.6"	"Lineage enriched"	"Detected in many"	16	"T-cells: 27.6"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA						"unprognostic (2.73e-2)"	"unprognostic (3.26e-2)"	"unprognostic (3.54e-1)"	"unprognostic (2.62e-2)"	"unprognostic (4.10e-1)"	"unprognostic (5.67e-3)"	"unprognostic (4.21e-2)"	"unprognostic (3.04e-2)"	"unprognostic (2.38e-1)"	"unprognostic (1.70e-2)"	"unprognostic (2.61e-2)"	"unprognostic (3.43e-1)"	"unprognostic (2.46e-2)"	"unprognostic (2.93e-2)"	"unprognostic (3.40e-2)"	"unprognostic (1.10e-1)"	"unprognostic (6.49e-2)"	6.6	4.7	2.1	3.8	3.9	5.4	12.6	3.4	3.1	5.1	17.6	3.9	7.4	2.3	13.1	6.0	12.6	6.5	4.8	80.1	2.4	3.7	3.6	1.1	7.9	1.1	5.1	1.8	3.9	2.5	0.6	2.4	1.5	3.8	8.8	3.3	9.4	2.1	13.2	22.8	2.5	4.2	21.5	4.8	1.5	9.4	3.0	3.4	2.6	5.9	6.2	1.2	12.6	9.8	0.6	1.6	1.7	0.5	1.6	27.6	0.7	10.8	9.3	2.6	12.8	11.9	2.3	0.2	15.4	9.3	20.2	19.1	6.2	13.2	0.1	2.3	25.0	29.1	2.7	6.6	4.7	11.2	7.1	3.9	25.0	6.7	16.9	15.5	0.1	1.9	5.5	6.6	11.6	4.5	15.6	3.9	13.4	0.2	0.5	26.5	7.8	18.4	2.5	5.6	0.8	2.5	16.6	2.7	0.3	7.9	2.1	2.9	7.5	13.1	0.2	21.6	8.6	9.3	6.2	3.7	11.9	6.9	7.2	7.0	0.4	0.3	0.1	8.7	2.8	1.6	1.7	0.5	0.4	0.6	0.1	0.1	0.2	2.8	0.5	1.6	0.6	0.5	0.4	1.6	1.6	0.1	0.8	27.6	0.7	2.1	3.9	3.4	2.8	2.4	3.7	5.1	1.8	3.8	3.4	26.8	12.9	0.0	16.5	0.0	0.6	116.4	2.5	1.4	4.5	29.6	0.0	0.5	3.3	13.0	8.3	4.8	0.0	0.0	6.9	1.6	2.3	12.0	5.8	0.8	5.0	0.0	3.5	11.6	3.5	1.6	1.7	2.4	0.0	1.0	2.3	0.2	18.1	0.0	0.7	2.0	0.5	0.0	25.7	5.5	5.1	0.0	2.5	0.0	3.8	5.5
HACD2	PTPLB	ENSG00000206527	"3-hydroxyacyl-CoA dehydratase 2"	Q6Y1H2	3	123490820-123585185	"Enzymes, Predicted membrane proteins"	"Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism"	Lyase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"SiHa: 65.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB019282	Approved					NA	NA					"CAB019282: "	"unprognostic (3.04e-2)"	"unprognostic (2.51e-1)"	"unprognostic (6.11e-2)"	"unprognostic (2.65e-3)"	"unprognostic (5.36e-2)"	"unprognostic (6.04e-2)"	"unprognostic (1.32e-2)"	"unprognostic (1.95e-2)"	"unprognostic (1.96e-1)"	"unprognostic (1.22e-1)"	"prognostic unfavorable (9.59e-5)"	"unprognostic (6.90e-2)"	"unprognostic (7.03e-3)"	"unprognostic (1.48e-1)"	"unprognostic (3.85e-2)"	"unprognostic (1.94e-2)"	"unprognostic (2.59e-2)"	43.2	9.7	18.0	11.2	30.0	5.7	16.6	20.5	18.7	14.1	20.4	28.6	7.4	21.2	12.4	13.5	18.8	9.9	12.2	9.9	20.7	13.4	20.7	34.3	13.8	14.1	29.4	12.0	13.8	13.4	15.6	12.5	11.1	18.5	22.1	20.4	7.3	15.5	10.2	5.6	23.2	30.8	12.3	24.9	9.6	15.3	13.3	25.7	9.1	16.0	10.5	19.7	10.9	16.6	4.9	6.4	2.4	3.5	2.9	5.3	2.4	19.6	11.2	7.7	5.6	24.2	5.4	28.7	14.1	5.9	14.7	10.7	22.8	17.5	11.4	10.2	13.5	17.1	43.2	13.8	17.7	15.6	7.2	4.6	7.9	10.5	17.7	7.9	10.5	7.9	7.5	45.7	7.1	20.0	23.1	7.6	7.9	1.6	11.4	8.8	15.3	4.9	3.1	9.9	24.0	9.9	7.6	8.5	12.1	17.8	12.7	13.6	4.2	65.7	14.1	9.0	11.7	14.6	5.4	5.9	15.4	11.6	15.4	13.7	6.8	8.6	9.4	6.9	7.4	8.2	1.5	3.5	2.4	3.6	2.8	5.3	3.4	4.8	4.6	6.4	4.9	4.4	4.3	1.1	2.9	2.2	3.7	5.3	2.4	18.0	30.0	20.5	18.7	20.7	13.4	29.4	12.0	18.5	25.7	6.0	35.5	13.7	26.4	0.0	8.3	12.6	15.3	5.3	28.4	43.6	5.9	20.9	6.6	13.4	12.7	13.7	18.6	0.0	16.5	13.3	10.4	36.8	3.5	42.9	20.1	1.6	15.2	14.7	20.2	7.3	10.6	17.1	0.0	16.2	21.7	13.5	16.4	21.0	16.6	13.9	12.9	6.5	8.8	8.1	20.5	0.0	5.6	11.7	24.7	26.3
HACD3	"B-ind1, HSPC121, PTPLAD1"	ENSG00000074696	"3-hydroxyacyl-CoA dehydratase 3"	Q9P035	15	65530418-65578352	"Enzymes, Predicted membrane proteins"	"Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism"	Lyase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA014837, HPA060347"	Enhanced		Enhanced	"Endoplasmic reticulum"		NA	NA		27000	"Endoplasmic reticulum"		"HPA014837: AB_1855914, HPA060347: AB_2684260"	"unprognostic (1.51e-2)"	"unprognostic (2.89e-1)"	"unprognostic (2.29e-1)"	"unprognostic (2.18e-1)"	"unprognostic (3.52e-1)"	"unprognostic (1.92e-2)"	"unprognostic (1.67e-1)"	"unprognostic (2.28e-1)"	"unprognostic (3.36e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.73e-1)"	"unprognostic (2.57e-1)"	"prognostic favorable (3.09e-5)"	"unprognostic (3.44e-2)"	"unprognostic (5.33e-2)"	"unprognostic (1.10e-2)"	"unprognostic (2.04e-2)"	9.6	37.4	31.0	7.4	36.0	6.2	33.3	28.6	37.6	18.5	12.5	24.2	10.1	12.2	13.1	19.4	8.4	14.3	14.7	5.9	29.2	44.8	35.0	50.0	12.7	7.2	36.5	26.0	21.7	12.6	22.5	33.9	15.9	45.9	18.5	15.1	17.9	11.6	15.8	3.3	11.7	12.0	12.2	41.5	8.5	29.0	13.9	19.7	8.9	30.7	5.6	8.3	18.8	10.4	13.0	9.0	2.7	6.1	11.7	19.9	11.2	19.4	43.6	48.5	24.2	30.6	18.5	23.0	21.6	18.7	24.6	27.8	33.4	29.2	24.5	18.9	23.4	30.7	53.9	78.2	18.0	22.1	13.6	43.6	19.5	21.9	36.4	15.5	24.1	15.0	18.9	13.5	16.8	12.2	23.8	23.9	14.7	25.5	9.3	39.6	23.2	17.8	18.8	41.3	52.2	14.8	20.2	41.1	27.6	35.1	33.9	29.3	25.9	23.3	26.3	24.4	47.7	26.7	12.8	18.9	31.3	27.6	15.3	29.9	18.2	54.0	34.6	20.9	23.6	18.7	2.7	3.9	1.2	17.6	5.8	19.9	13.0	16.1	16.6	6.8	13.0	18.9	18.5	0.4	11.7	6.1	9.0	12.4	11.2	31.0	36.0	28.6	34.1	29.2	44.8	36.5	26.0	45.9	19.7	59.6	49.7	22.9	50.2	0.0	116.3	6.4	61.1	66.9	51.2	167.5	94.2	155.3	21.6	61.1	83.6	35.9	7.7	46.7	39.9	101.8	47.3	63.7	15.1	153.2	44.7	131.9	42.1	42.4	18.0	21.8	80.8	16.2	0.0	3.6	25.8	78.8	35.8	14.0	83.1	44.0	65.7	77.6	27.2	123.2	116.2	0.0	94.6	13.1	52.6	77.6
HACD4	"Em:AL662879.1, PTPLAD2"	ENSG00000188921	"3-hydroxyacyl-CoA dehydratase 4"	Q5VWC8	9	20999515-21031636	"Enzymes, Predicted membrane proteins"	"Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism"	Lyase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	8	"Alveolar cells type 1: 44.7;Ciliated cells: 89.7;Hofbauer cells: 50.9;Kupffer cells: 90.6;Macrophages: 52.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 15.8;HDLM-2: 9.6;TIME: 7.9;U-937: 12.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA058666	Uncertain					NA	NA					"HPA058666: AB_2683793"	"unprognostic (1.71e-1)"	"unprognostic (2.58e-2)"	"unprognostic (5.47e-2)"	"unprognostic (1.70e-2)"	"unprognostic (7.66e-2)"	"unprognostic (1.87e-2)"	"unprognostic (2.21e-1)"	"unprognostic (1.28e-2)"	"unprognostic (1.11e-4)"	"prognostic favorable (3.14e-4)"	"unprognostic (8.72e-2)"	"unprognostic (1.63e-1)"	"prognostic unfavorable (6.77e-4)"	"unprognostic (3.89e-3)"	"unprognostic (7.33e-2)"	"unprognostic (1.77e-2)"	"unprognostic (2.00e-3)"	4.3	7.9	4.9	9.2	7.1	16.3	10.3	3.3	3.1	8.9	10.1	2.6	1.2	3.2	6.9	5.6	10.7	6.5	7.6	7.5	4.1	3.2	3.3	1.8	24.1	18.2	5.2	1.8	6.5	1.9	4.0	2.3	9.9	3.7	5.9	5.0	6.3	3.6	3.8	1.5	4.7	7.5	11.5	9.6	10.1	5.4	1.8	5.5	19.9	4.1	6.2	7.9	5.1	5.6	1.2	8.4	13.6	8.8	3.0	3.0	3.9	3.7	1.1	0.4	0.1	0.0	0.1	0.1	3.4	15.8	2.8	3.2	0.0	0.0	3.4	1.9	6.7	0.0	1.0	0.2	1.4	3.5	9.6	0.1	0.0	1.2	0.0	2.2	2.8	3.0	6.4	6.2	2.5	0.0	0.0	0.9	3.9	0.0	2.0	0.5	0.1	0.0	3.9	0.8	0.0	0.0	0.0	0.0	0.1	0.1	0.5	0.6	0.0	0.8	0.3	0.0	2.3	2.8	5.3	7.9	0.0	0.0	0.2	0.1	0.1	0.1	0.1	0.0	12.1	0.1	13.6	7.1	11.4	2.2	8.8	2.0	1.2	2.4	2.5	8.4	1.2	1.7	2.4	10.2	3.0	8.5	0.9	3.0	3.9	4.9	7.1	3.3	3.1	4.1	3.2	5.2	1.8	3.7	5.5	44.7	6.7	16.7	9.5	0.0	1.4	1.6	0.0	89.7	20.5	12.2	0.0	10.0	5.0	0.5	0.4	3.3	0.0	0.0	0.4	30.5	7.8	3.2	3.5	1.3	50.9	0.0	0.0	9.8	90.6	0.0	3.4	52.2	0.0	14.4	0.0	6.7	0.1	0.0	1.1	5.1	1.5	12.9	7.3	0.3	1.3	0.0	4.2	28.8	0.1	3.8
HACE1	KIAA1320	ENSG00000085382	"HECT domain and ankyrin repeat containing E3 ubiquitin protein ligase 1"	Q8IYU2	6	104728093-104859919	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Cell cycle, Transcription, Transcription regulation, Ubl conjugation pathway"	Transferase	"Disease mutation, Hereditary spastic paraplegia, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"placenta: 41.9"	"Cell type enhanced"	"Detected in many"	8	"Cone photoreceptor cells: 43.2;Rod photoreceptor cells: 30.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA046071			Supported	"Nuclear bodies,Endoplasmic reticulum"		NA	NA			"Endoplasmic reticulum"	"Nuclear bodies"	"HPA046071: AB_2679524"	"unprognostic (6.32e-2)"	"unprognostic (3.77e-2)"	"unprognostic (2.93e-2)"	"unprognostic (1.12e-2)"	"unprognostic (3.75e-2)"	"unprognostic (3.75e-3)"	"unprognostic (1.22e-3)"	"unprognostic (4.63e-2)"	"unprognostic (7.41e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.56e-2)"	"unprognostic (2.25e-1)"	"prognostic unfavorable (1.17e-5)"	"unprognostic (1.12e-2)"	"unprognostic (2.06e-1)"	"prognostic unfavorable (7.50e-4)"	"unprognostic (1.75e-1)"	6.4	5.4	12.7	3.7	16.1	4.3	6.1	15.5	13.1	6.6	4.8	6.8	2.5	3.6	8.5	2.9	8.1	5.4	5.0	5.2	7.5	8.6	9.4	2.9	5.7	3.5	8.8	9.6	6.4	3.8	12.0	7.4	41.9	10.2	6.1	3.3	7.7	6.2	6.9	4.4	4.8	3.6	6.5	9.5	4.1	3.9	14.1	8.9	5.4	7.1	2.7	3.9	6.4	5.8	2.9	2.4	2.2	2.9	2.2	3.9	1.6	3.6	2.5	10.9	13.6	6.5	8.7	12.9	7.3	11.3	4.6	7.0	2.3	2.1	2.1	3.3	5.5	7.9	2.5	2.7	5.0	9.8	8.4	6.9	7.2	2.3	3.1	6.5	6.2	2.4	5.8	4.6	6.0	5.1	6.1	7.6	8.7	6.9	2.3	9.1	2.6	4.6	3.7	4.7	2.7	2.5	7.3	12.4	0.8	3.7	6.2	5.8	8.8	3.9	4.1	2.1	7.3	2.6	8.5	8.0	3.7	3.1	10.0	6.9	3.3	3.7	7.0	3.9	5.9	6.8	0.0	1.9	2.2	3.7	2.9	3.9	2.9	3.7	3.6	1.9	2.7	3.9	3.0	0.4	2.2	1.5	2.4	1.2	1.6	12.7	16.1	15.5	13.1	7.5	8.6	8.8	9.6	10.2	8.9	3.0	0.6	0.0	1.6	4.1	11.4	6.3	2.5	0.0	4.5	5.2	43.2	7.5	1.7	1.7	3.1	6.7	1.3	0.0	1.3	4.6	4.8	2.2	1.1	2.5	4.6	15.9	1.7	4.3	2.2	3.3	5.8	2.4	1.7	4.6	1.4	5.8	1.1	2.9	3.5	4.1	30.6	6.5	6.6	12.5	2.7	4.1	5.3	2.2	2.1	1.8
HADH	"HADH1, HADHSC, SCHAD"	ENSG00000138796	"Hydroxyacyl-CoA dehydrogenase"	Q16836	4	107989714-108035175	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Fatty acid metabolism, Lipid metabolism"	Oxidoreductase	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 98.3"	"Cell type enhanced"	"Detected in all"	4	"Enterocytes: 244.0;Hepatocytes: 229.1;Proximal tubular cells: 241.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039588, HPA043888"	Supported		Supported	Mitochondria		No	No		8700000	Mitochondria		"HPA039588: AB_10673425, HPA043888: AB_2678716"	"unprognostic (1.73e-1)"	"unprognostic (3.32e-3)"	"unprognostic (3.05e-3)"	"unprognostic (8.86e-3)"	"unprognostic (1.83e-1)"	"unprognostic (6.83e-2)"	"unprognostic (9.26e-3)"	"unprognostic (1.55e-2)"	"unprognostic (9.22e-2)"	"unprognostic (3.24e-2)"	"unprognostic (2.96e-1)"	"unprognostic (1.18e-2)"	"prognostic favorable (0.00e+0)"	"unprognostic (1.67e-1)"	"unprognostic (4.22e-2)"	"unprognostic (5.67e-2)"	"unprognostic (1.88e-2)"	36.6	19.5	8.5	15.6	9.2	6.1	41.7	5.4	9.7	15.2	29.7	10.6	9.4	23.3	18.3	13.3	20.5	15.7	12.4	98.3	7.8	8.1	37.2	60.3	10.6	8.8	10.0	7.0	17.1	17.8	9.8	6.8	5.1	9.2	15.6	25.0	11.6	20.4	12.5	64.6	9.0	37.1	19.6	10.2	8.0	19.1	12.6	7.2	40.9	16.1	38.0	13.1	14.2	10.6	18.6	22.6	5.6	10.7	20.2	13.0	8.9	8.7	8.2	17.7	12.9	42.7	13.8	8.6	12.9	19.2	14.0	13.8	5.9	16.5	49.8	6.9	10.5	9.1	11.8	23.6	17.8	15.5	15.2	12.3	11.6	15.6	13.0	6.8	24.4	5.4	14.3	9.5	9.9	9.1	11.5	9.4	35.0	14.3	26.5	15.8	15.9	41.4	9.7	8.4	38.7	10.9	31.6	24.9	24.9	15.1	35.6	21.5	12.3	12.4	44.5	12.7	10.8	21.2	19.3	5.2	9.9	5.6	13.9	7.0	15.0	17.3	21.6	13.5	16.6	7.6	0.0	6.1	5.6	10.1	7.8	12.5	18.6	11.4	12.1	19.7	15.5	13.0	13.0	0.7	20.2	10.7	22.6	10.0	8.9	8.5	9.2	5.4	9.7	7.8	8.1	10.0	7.0	9.2	7.2	26.8	26.0	29.0	45.8	13.9	7.3	194.2	61.1	81.7	36.4	33.2	3.9	27.5	135.9	37.9	159.1	14.3	244.0	46.7	28.1	33.2	15.5	29.6	10.4	229.1	96.2	6.4	31.2	19.0	32.4	78.4	42.8	17.2	20.3	6.4	71.1	24.6	30.7	84.2	33.2	241.4	5.7	38.8	30.8	25.1	20.1	15.8	14.2	16.2	172.2	38.7
HADHA	"GBP, LCEH, LCHAD, MTPA"	ENSG00000084754	"Hydroxyacyl-CoA dehydrogenase trifunctional multienzyme complex subunit alpha"	P40939	2	26190635-26244726	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Fatty acid metabolism, Lipid metabolism"	"Lyase, Multifunctional enzyme, Oxidoreductase, Transferase"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA015536, HPA056070"	Approved		Enhanced	Mitochondria		NA	NA		2700000	Mitochondria		"HPA015536: AB_1850473, HPA056070: AB_2683026"	"unprognostic (2.02e-1)"	"unprognostic (1.38e-2)"	"unprognostic (2.55e-1)"	"unprognostic (3.43e-1)"	"unprognostic (2.67e-2)"	"unprognostic (3.23e-2)"	"unprognostic (1.25e-2)"	"unprognostic (2.02e-1)"	"unprognostic (5.16e-2)"	"unprognostic (3.45e-1)"	"unprognostic (3.81e-1)"	"unprognostic (1.16e-1)"	"prognostic favorable (3.68e-5)"	"unprognostic (7.97e-2)"	"unprognostic (1.71e-1)"	"unprognostic (2.87e-3)"	"unprognostic (2.64e-2)"	41.6	35.3	18.1	13.1	19.5	17.0	23.9	17.4	16.9	20.2	44.9	26.5	15.7	48.1	21.1	15.3	30.8	20.5	15.1	80.0	15.6	15.5	41.3	71.7	17.7	19.3	21.6	13.1	27.3	37.5	29.8	23.5	21.3	24.8	21.9	32.2	23.6	21.1	16.6	117.5	23.3	66.4	25.1	27.8	24.0	24.1	18.7	19.0	25.2	25.1	41.3	24.6	26.9	18.8	15.3	28.9	12.4	32.2	13.5	17.6	26.0	23.6	21.1	13.9	22.7	55.2	34.5	11.8	18.5	20.0	19.1	16.6	26.6	23.0	15.6	12.2	32.6	19.7	15.1	24.3	35.9	17.3	35.0	29.8	23.4	22.4	44.3	19.0	29.4	17.2	35.3	23.6	27.1	27.3	20.0	32.0	16.8	31.8	31.7	24.6	29.0	12.8	33.0	11.9	17.8	40.7	11.9	30.0	33.5	21.9	28.5	9.8	19.5	21.8	22.7	25.1	11.3	12.1	28.6	29.3	11.1	16.5	16.7	13.6	10.4	20.6	27.8	17.4	34.9	13.4	8.1	27.7	12.4	12.3	32.2	14.8	15.3	14.2	15.0	28.9	11.2	16.7	15.3	7.4	13.5	28.0	11.0	17.6	26.0	18.1	19.5	17.4	16.9	15.6	15.5	21.6	13.1	24.8	19.0	83.4	81.9	90.4	122.8	79.0	34.1	285.8	71.4	101.7	126.3	73.3	49.1	149.8	111.0	102.7	26.5	92.1	406.5	23.3	94.5	78.0	88.0	61.7	134.2	168.3	142.3	19.1	87.7	68.7	130.6	58.2	85.7	124.9	77.6	129.0	139.2	61.8	86.9	196.4	79.2	150.1	61.9	51.8	104.9	121.4	35.2	90.3	108.0	105.4	168.5	92.1
HADHB	MTPB	ENSG00000138029	"Hydroxyacyl-CoA dehydrogenase trifunctional multienzyme complex subunit beta"	P55084	2	26243170-26290468	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Fatty acid metabolism, Lipid metabolism"	"Acyltransferase, Transferase"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 126.0;skeletal muscle: 155.6"	"Cell type enhanced"	"Detected in all"	9	"Cardiomyocytes: 922.0;Distal tubular cells: 441.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA037539, HPA037540, HPA066099"	Enhanced		Supported	Mitochondria		No	No		1100000	Mitochondria		"HPA037539: AB_10671374, HPA037540: AB_2675531, HPA066099: AB_2685618"	"unprognostic (5.15e-2)"	"unprognostic (8.72e-2)"	"unprognostic (8.21e-2)"	"unprognostic (8.67e-2)"	"unprognostic (7.70e-2)"	"unprognostic (2.59e-2)"	"unprognostic (7.29e-2)"	"unprognostic (9.70e-2)"	"unprognostic (2.01e-1)"	"unprognostic (2.09e-1)"	"unprognostic (2.03e-1)"	"unprognostic (8.94e-2)"	"prognostic favorable (1.37e-9)"	"unprognostic (2.47e-1)"	"unprognostic (2.50e-1)"	"unprognostic (2.88e-1)"	"unprognostic (9.68e-2)"	23.3	45.5	24.8	11.0	24.7	9.9	16.6	16.6	17.4	13.8	21.4	31.1	19.3	43.6	17.1	16.2	20.6	13.9	12.6	126.0	18.0	20.0	45.8	62.4	12.8	16.1	34.8	18.3	16.2	23.7	19.9	13.1	12.6	27.8	15.8	22.8	19.9	27.2	15.9	155.6	13.2	35.0	20.3	29.5	15.3	19.5	15.8	23.8	10.6	22.4	44.9	14.5	18.5	12.8	20.2	45.2	21.5	49.1	23.8	26.8	33.9	23.1	18.3	12.8	22.9	79.0	43.7	13.0	19.5	29.9	20.1	19.7	21.8	22.6	11.6	13.7	31.9	22.6	18.3	21.2	27.6	24.7	26.1	18.5	26.6	10.9	42.7	33.9	21.5	20.4	42.3	45.5	20.9	34.0	34.3	37.2	18.0	22.3	18.8	41.9	17.0	12.0	41.5	8.9	34.8	19.9	13.3	42.2	22.0	41.3	32.9	6.1	21.1	33.4	38.1	51.2	16.0	23.6	38.4	25.7	19.0	19.9	17.8	14.0	14.1	21.2	20.4	21.8	34.3	18.8	21.0	49.1	18.9	14.2	43.4	18.1	20.2	19.3	17.6	45.2	14.8	18.0	16.3	21.5	23.8	33.2	15.3	26.8	33.9	24.8	24.7	16.6	17.4	18.0	20.0	34.8	18.3	27.8	23.8	44.7	32.2	48.9	103.6	55.2	29.0	922.0	127.4	46.8	42.1	92.5	53.0	177.3	441.0	96.4	60.4	68.1	196.9	116.8	50.2	61.8	59.6	61.5	62.2	218.5	127.1	12.7	71.9	67.5	100.7	74.5	52.3	80.0	84.4	77.5	85.7	52.4	56.5	91.7	59.1	244.7	72.5	71.1	92.4	75.6	46.1	47.8	156.1	48.0	100.9	85.2
HAGH	"GLO2, GLXII, HAGH1"	ENSG00000063854	"Hydroxyacylglutathione hydrolase"	Q16775	16	1795620-1827194	"Enzymes, Plasma proteins, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 91.4"	"Cell type enhanced"	"Detected in all"	7	"Proximal tubular cells: 487.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043041, HPA061143"	Approved					NA	NA		3000000			"HPA043041: AB_2678284, HPA061143: AB_2684439"	"unprognostic (3.11e-1)"	"prognostic favorable (5.82e-5)"	"unprognostic (2.54e-1)"	"unprognostic (1.93e-2)"	"unprognostic (5.84e-2)"	"unprognostic (1.54e-1)"	"prognostic favorable (5.33e-6)"	"unprognostic (5.78e-3)"	"unprognostic (3.34e-2)"	"unprognostic (7.69e-2)"	"unprognostic (3.34e-3)"	"unprognostic (1.60e-1)"	"prognostic favorable (1.81e-6)"	"unprognostic (1.20e-1)"	"unprognostic (6.24e-2)"	"unprognostic (7.18e-3)"	"prognostic favorable (5.19e-4)"	14.8	36.9	24.9	7.8	26.7	26.2	16.4	26.8	35.3	9.7	12.9	13.6	19.6	17.6	6.8	13.0	11.7	11.8	9.9	50.9	28.0	24.5	38.8	91.4	14.5	8.5	23.2	24.5	6.3	24.6	17.1	19.7	9.2	18.5	12.4	9.5	11.9	12.5	16.2	67.1	11.0	17.1	11.7	20.7	10.1	13.1	33.8	13.7	7.4	14.1	18.3	7.2	9.7	18.2	13.7	28.9	27.7	36.5	10.9	18.3	12.5	11.5	17.5	15.8	17.9	13.9	5.5	14.3	14.5	13.5	22.4	18.1	9.0	10.1	2.4	29.8	12.4	15.4	12.6	15.0	14.5	6.7	23.9	24.1	4.4	17.9	25.6	20.0	5.8	24.3	6.7	31.2	11.2	7.7	19.8	19.2	30.4	5.8	21.7	7.0	19.0	15.0	12.6	6.0	11.9	16.2	12.7	10.0	27.2	28.7	5.2	21.3	18.4	15.9	20.4	31.1	12.5	15.0	19.5	14.6	6.8	8.5	14.2	16.6	24.6	23.2	7.1	11.6	5.4	10.9	14.4	15.3	27.7	12.6	25.8	9.2	13.7	16.2	12.9	13.7	12.4	15.8	13.2	13.5	10.9	36.5	28.9	18.3	12.5	24.9	26.7	26.8	35.3	28.0	24.5	23.2	24.5	18.5	13.7	8.9	32.9	46.9	39.2	21.2	110.6	73.4	58.6	26.8	11.4	43.6	60.9	45.4	134.3	38.1	141.4	30.0	81.5	280.4	33.8	33.2	26.9	51.0	30.0	169.8	67.1	130.3	38.1	41.7	39.3	41.7	43.4	47.0	52.3	57.7	36.1	79.2	45.7	70.2	51.6	487.6	102.8	71.1	36.8	224.6	49.5	39.9	57.4	54.2	35.0	42.0
HAL	HIS	ENSG00000084110	"Histidine ammonia-lyase"	P42357	12	95972662-95996365	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Histidine metabolism"	Lyase	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	7	"blood: 29.5;liver: 96.8;skin 1: 26.9"	"Group enriched"	"Detected in some"	13	"Erythroid cells: 46.7;Hepatocytes: 134.4"	"Cancer enriched"	"Detected in some"	11	"liver cancer: 23.7"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in many"		"basophil: 20.1;neutrophil: 29.5"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 29.5"	"Cell line enhanced"	"Detected in some"		"BEWO: 3.2;NB-4: 4.0;THP-1: 15.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA038547, HPA038548"	Enhanced		Approved	Cytosol		NA	NA		67000	Cytosol		"HPA038547: AB_10669541, HPA038548: AB_10673175"	"unprognostic (3.39e-1)"	"unprognostic (4.46e-2)"	"unprognostic (1.53e-2)"	"unprognostic (1.46e-1)"	"unprognostic (2.32e-2)"	"unprognostic (1.20e-2)"	"unprognostic (5.05e-2)"	"unprognostic (2.80e-2)"	"unprognostic (1.52e-1)"	"unprognostic (1.33e-2)"	"unprognostic (9.41e-2)"	"unprognostic (2.45e-1)"	"unprognostic (1.31e-3)"	"unprognostic (1.89e-2)"	"unprognostic (3.74e-1)"	"unprognostic (4.03e-2)"	"unprognostic (2.87e-2)"	0.5	0.0	0.1	1.1	0.3	4.4	0.9	0.1	0.3	0.3	0.2	0.1	0.1	0.1	1.1	0.3	0.5	0.2	0.3	0.2	0.1	0.0	0.2	96.8	1.7	2.3	0.5	0.1	0.3	0.5	0.0	7.4	0.4	0.2	0.2	0.0	0.1	0.2	0.1	0.2	26.9	0.2	0.2	0.3	2.7	0.1	0.2	0.2	0.1	0.2	0.9	1.3	0.2	0.5	0.0	1.4	29.5	6.3	0.3	0.1	1.6	0.6	0.0	0.2	0.1	0.0	0.0	3.2	0.0	0.2	0.1	0.2	0.0	0.1	0.9	0.0	0.0	0.0	0.2	0.3	0.1	0.1	0.2	0.5	0.4	0.2	0.0	0.0	0.6	0.7	0.0	0.9	0.4	0.4	0.1	0.3	0.4	0.0	0.2	0.1	0.0	0.2	4.0	1.3	0.1	0.7	0.3	0.1	0.1	0.1	0.8	0.2	0.4	0.5	0.1	0.0	0.1	0.0	15.5	0.2	0.1	0.2	0.2	0.2	0.7	0.7	0.2	0.0	2.4	0.0	20.1	6.3	0.9	0.0	2.2	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	29.5	0.3	5.1	0.1	0.1	1.6	0.1	0.3	0.1	0.3	0.1	0.0	0.5	0.1	0.2	0.2	0.0	1.4	0.0	0.1	0.1	0.0	0.5	2.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	46.7	0.2	0.2	0.0	0.1	0.0	134.4	0.3	0.0	0.0	1.8	6.8	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.3	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.2	0.1
HAO1	"GOX, GOX1"	ENSG00000101323	"Hydroxyacid oxidase 1"	Q9UJM8	20	7882981-7940474	"Enzymes, Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	594	"liver: 121.8"	"Cell type enriched"	"Detected in some"	44	"Hepatocytes: 293.3"	"Cancer enriched"	"Detected in some"	184	"liver cancer: 93.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HL-60: 1.7;RH-30: 2.3;U-251 MG: 2.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA049552, HPA072442"	Enhanced					NA	NA		200000			"HPA049552: AB_2680814, HPA072442: "					"unprognostic (4.88e-2)"		"unprognostic (2.87e-3)"				"unprognostic (1.08e-2)"	"unprognostic (1.25e-1)"						0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	121.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.1	0.0	0.8	0.0	0.4	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	293.3	0.0	0.0	0.0	6.7	6.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
HAO2	"GIG16, HAOX2"	ENSG00000116882	"Hydroxyacid oxidase 2"	Q9NYQ3	1	119368779-119394130	"Enzymes, Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	60	"kidney: 65.1;liver: 90.2"	"Group enriched"	"Detected in some"	6	"Hepatocytes: 210.7;Proximal tubular cells: 261.6"	"Group enriched"	"Detected in some"	26	"liver cancer: 25.6;renal cancer: 11.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 1.2;BJ hTERT+: 1.2;HL-60: 2.0;SiHa: 1.5;U-698: 1.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA050355			Approved	Vesicles,Cytosol		NA	NA			Cytosol	Vesicles	"HPA050355: "	"unprognostic (1.13e-1)"	"unprognostic (1.68e-2)"	"unprognostic (2.07e-1)"	"unprognostic (1.00e-1)"	"unprognostic (6.22e-2)"	"unprognostic (5.33e-3)"	"unprognostic (2.80e-2)"	"unprognostic (3.27e-1)"	"unprognostic (3.15e-1)"	"unprognostic (3.17e-1)"	"unprognostic (1.41e-1)"	"unprognostic (1.73e-1)"	"prognostic favorable (4.92e-4)"	"unprognostic (9.66e-2)"	"unprognostic (1.79e-1)"	"unprognostic (2.89e-2)"	"unprognostic (5.14e-4)"	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.2	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.0	65.1	90.2	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.2	0.1	0.1	0.1	1.2	0.2	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	1.2	0.0	0.3	0.2	0.0	0.0	1.2	0.0	0.0	0.0	0.4	0.7	0.3	0.0	0.0	0.4	0.0	0.0	0.0	0.4	0.3	0.5	0.0	0.6	0.8	2.0	0.4	0.0	0.2	0.0	0.9	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.2	0.8	0.2	1.2	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.1	0.1	0.2	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.9	0.0	0.0	0.0	0.2	2.5	0.0	0.0	10.4	0.0	0.0	41.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	210.7	0.1	0.0	0.0	3.1	4.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	261.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
HARS	USH3B	ENSG00000170445	"Histidyl-tRNA synthetase"	P12081	5	140673904-140691862	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Protein biosynthesis"	"Aminoacyl-tRNA synthetase, Ligase"	"Charcot-Marie-Tooth disease, Deafness, Disease mutation, Neurodegeneration, Neuropathy, Retinitis pigmentosa, Usher syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA036539	Approved		Enhanced	Cytosol		NA	NA		52000	Cytosol		"HPA036539: AB_10669796"	"unprognostic (9.35e-2)"	"unprognostic (9.95e-2)"	"unprognostic (1.62e-3)"	"unprognostic (1.65e-2)"	"unprognostic (2.33e-1)"	"unprognostic (8.57e-2)"	"prognostic unfavorable (1.96e-7)"	"unprognostic (6.50e-2)"	"unprognostic (1.46e-1)"	"unprognostic (3.82e-2)"	"unprognostic (1.28e-2)"	"unprognostic (2.40e-1)"	"unprognostic (3.46e-2)"	"unprognostic (2.99e-1)"	"unprognostic (1.25e-1)"	"unprognostic (6.26e-2)"	"unprognostic (1.36e-1)"	22.4	24.5	28.5	21.1	35.5	18.1	21.0	41.1	46.3	20.6	22.7	20.0	23.6	17.4	21.6	23.5	26.9	23.7	17.5	25.1	29.5	35.9	20.6	34.2	16.7	22.4	36.9	33.0	24.7	25.2	29.5	38.7	15.0	38.2	21.7	24.8	13.6	22.1	27.9	27.1	33.9	16.4	28.0	21.0	18.3	18.8	16.6	23.5	17.6	19.4	20.3	28.5	19.9	20.9	16.8	22.1	10.7	22.9	25.2	29.4	23.4	20.6	30.2	18.2	39.7	23.2	25.3	19.2	33.3	24.0	38.5	36.0	54.9	17.5	27.5	29.3	37.3	31.1	21.7	27.6	53.5	36.3	23.3	34.1	19.8	39.2	34.8	28.8	31.1	17.0	26.7	16.8	41.9	23.9	23.0	38.6	17.1	17.3	22.9	40.0	35.5	22.1	29.0	14.3	16.7	19.9	20.5	26.4	22.4	30.9	26.4	28.6	27.7	27.6	40.2	26.2	18.3	29.6	17.5	32.2	36.1	13.9	20.3	44.8	23.1	27.4	27.8	27.4	26.1	24.7	6.7	14.1	10.7	29.4	20.8	26.3	16.8	25.8	27.3	22.1	14.8	28.2	26.9	4.3	25.2	22.9	15.6	22.1	23.4	28.5	35.5	41.1	46.3	29.5	35.9	36.9	33.0	38.2	23.5	14.9	19.4	29.8	29.5	27.2	27.3	7.7	20.4	14.7	15.9	26.2	13.7	35.0	38.1	46.0	30.2	30.6	23.2	0.0	37.0	41.1	27.2	20.1	15.1	76.4	31.4	28.6	24.8	26.4	17.5	15.9	23.3	22.3	35.4	61.3	22.2	20.7	37.7	23.0	32.5	33.8	20.0	45.3	41.8	29.6	30.4	28.4	30.1	30.2	25.5	25.7
HARS2	"HARSL, HARSR, HO3"	ENSG00000112855	"Histidyl-tRNA synthetase 2, mitochondrial"	P49590	5	140691426-140699318	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Protein biosynthesis"	"Aminoacyl-tRNA synthetase, Ligase"	"Deafness, Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA035941	Approved		Approved	Cytosol	"Intracellular and membrane"	NA	NA			Cytosol		"HPA035941: AB_10671237"	"prognostic unfavorable (6.49e-4)"	"unprognostic (3.15e-2)"	"prognostic favorable (6.19e-4)"	"unprognostic (1.79e-2)"	"unprognostic (1.78e-1)"	"unprognostic (8.30e-3)"	"prognostic unfavorable (2.92e-4)"	"unprognostic (7.77e-2)"	"unprognostic (1.88e-1)"	"unprognostic (5.26e-2)"	"unprognostic (1.58e-1)"	"unprognostic (2.68e-2)"	"unprognostic (1.85e-1)"	"unprognostic (5.40e-2)"	"unprognostic (1.51e-1)"	"unprognostic (2.49e-1)"	"unprognostic (1.31e-2)"	17.1	23.8	14.2	22.9	19.4	13.4	25.0	24.7	19.0	15.0	21.6	16.6	19.7	17.7	20.2	16.9	16.7	14.9	16.7	25.2	15.7	12.6	19.6	14.5	21.4	25.2	15.5	11.2	17.4	13.6	22.9	21.1	15.8	14.4	14.3	24.4	16.4	16.4	15.4	32.7	18.3	17.2	15.6	12.9	18.5	17.9	15.1	15.6	16.5	15.8	13.9	18.8	20.6	18.4	13.7	12.0	22.9	15.0	22.8	17.6	9.7	10.9	24.7	10.7	27.5	12.2	16.2	17.7	14.1	16.1	19.9	17.4	22.6	13.8	13.9	22.8	15.6	19.6	13.9	14.8	26.5	18.4	13.9	12.2	10.1	23.7	14.9	11.8	13.5	14.9	15.2	18.1	19.4	22.0	16.1	14.3	14.7	9.3	13.1	19.2	13.9	13.2	16.8	12.3	8.3	15.6	13.5	10.9	14.0	18.6	25.6	14.9	21.4	20.5	33.3	27.9	16.3	29.4	13.5	17.4	17.9	9.9	9.9	18.6	13.0	18.9	13.4	14.1	15.6	17.8	22.9	10.5	21.3	16.2	15.0	17.5	13.7	15.6	16.2	12.0	12.5	16.4	17.6	12.1	22.8	11.4	9.5	15.3	9.7	14.2	19.4	24.7	19.0	15.7	12.6	15.5	11.2	14.4	15.6	3.0	4.3	10.4	3.8	3.1	4.8	16.5	2.5	9.4	6.8	5.2	0.0	16.4	11.6	11.9	0.9	7.1	6.7	0.0	14.0	15.3	6.3	3.7	2.3	5.9	8.8	0.0	7.5	6.7	7.8	1.7	8.6	8.3	3.3	12.6	7.2	7.7	13.2	10.5	9.9	6.7	5.2	0.0	7.2	6.4	14.1	3.4	12.0	7.5	11.2	3.9
HAS1	HAS	ENSG00000105509	"Hyaluronan synthase 1"	Q92839	19	51713112-51723994	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins, Transporters"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 23.7;lymphoid tissue: 13.7;ovary: 23.6"	"Cell type enhanced"	"Detected in some"	13	"Basal keratinocytes: 23.7;Fibroblasts: 9.0;Melanocytes: 8.5;Smooth muscle cells: 24.7;Suprabasal keratinocytes: 15.6"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	10	"eosinophil: 5.9;neutrophil: 1.6"	"Lineage enriched"	"Detected in single"	15	"granulocytes: 5.9"	"Cell line enriched"	"Detected in some"	4	"U-87 MG: 51.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA067602	Approved		Supported	"Nucleoplasm,Plasma membrane"		NA	NA			"Plasma membrane"	Nucleoplasm	"HPA067602: AB_2685871"	"unprognostic (3.56e-2)"	"unprognostic (1.19e-1)"	"unprognostic (4.43e-2)"	"unprognostic (5.26e-4)"	"unprognostic (7.17e-3)"	"unprognostic (7.05e-2)"	"unprognostic (1.02e-1)"	"unprognostic (5.49e-4)"	"unprognostic (4.80e-2)"	"unprognostic (1.99e-2)"	"unprognostic (8.43e-2)"	"unprognostic (1.72e-1)"	"unprognostic (2.30e-11)"	"unprognostic (9.12e-4)"	"unprognostic (8.99e-2)"	"unprognostic (3.73e-4)"	"unprognostic (2.43e-2)"	23.7	0.5	0.6	13.7	1.3	2.8	1.0	1.5	1.9	0.6	1.2	0.4	1.1	0.1	0.8	2.5	1.3	5.8	5.5	5.9	1.4	2.0	0.3	0.6	4.5	0.3	0.6	0.3	23.6	2.2	0.0	0.3	0.3	0.6	0.4	0.5	1.0	0.3	1.2	2.1	2.7	4.0	3.6	0.9	0.7	0.7	0.9	0.3	0.3	0.3	0.8	0.3	1.8	0.3	0.1	0.1	5.9	0.1	0.0	0.3	0.1	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	1.4	0.0	12.0	0.0	0.0	0.0	0.0	0.0	0.1	3.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.3	0.0	0.0	0.0	0.0	51.0	0.0	0.1	0.0	0.1	5.9	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.3	0.0	1.6	0.0	0.0	0.1	0.0	0.1	0.6	1.3	1.5	1.7	1.4	2.0	0.6	0.3	0.6	0.3	0.0	2.6	0.0	0.1	23.7	4.2	0.6	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	9.0	0.1	2.3	0.0	0.2	0.0	0.0	0.0	0.3	0.0	0.3	0.3	8.5	0.0	0.0	0.1	0.2	0.0	0.4	0.0	0.6	0.0	24.7	0.0	0.1	15.6	0.1	0.0	0.0	0.1
HAS2		ENSG00000170961	"Hyaluronan synthase 2"	Q92819	8	121612116-121641390	"Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 22.8"	"Cell type enhanced"	"Detected in many"	17	"Basal glandular cells: 44.7;Fibroblasts: 34.9;Melanocytes: 28.7;Urothelial cells: 95.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"HBF TERT88: 34.7;hTEC/SVTERT24-B: 33.4;LHCN-M2: 44.3;U-138 MG: 87.1;U-251 MG: 25.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA052060			Approved	"Nuclear speckles"		NA	NA			"Nuclear speckles"		"HPA052060: AB_2681712"	"unprognostic (7.01e-2)"	"unprognostic (1.34e-2)"	"unprognostic (4.07e-2)"	"unprognostic (4.65e-2)"	"unprognostic (1.17e-1)"	"unprognostic (2.91e-2)"	"unprognostic (5.33e-2)"	"unprognostic (2.57e-3)"	"unprognostic (3.44e-2)"	"unprognostic (1.34e-1)"	"unprognostic (8.19e-3)"	"unprognostic (1.24e-1)"	"unprognostic (1.66e-7)"	"unprognostic (1.47e-3)"	"unprognostic (3.67e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.54e-3)"	22.8	0.9	1.6	9.1	2.4	0.0	5.5	0.8	1.7	4.0	8.5	2.0	0.0	2.6	1.5	2.5	4.8	3.9	7.7	8.3	1.7	1.7	1.2	2.7	6.5	4.5	1.8	0.6	1.2	1.8	0.3	0.7	2.1	5.7	4.3	5.6	2.7	1.9	0.1	2.7	3.8	9.5	3.7	4.2	0.3	2.3	3.2	2.6	0.4	1.7	5.5	2.1	5.7	1.4	0.0	0.2	0.7	0.2	0.3	0.1	0.0	0.0	0.6	0.0	0.0	1.0	2.6	0.0	4.9	3.7	6.5	11.2	0.0	0.0	0.0	0.0	4.4	0.0	0.8	0.0	0.0	34.7	0.0	0.1	0.0	0.1	0.0	4.4	0.0	0.0	6.8	0.0	33.4	3.0	0.1	0.0	0.0	0.0	0.0	44.3	0.0	0.0	0.0	0.0	0.0	0.7	0.0	5.7	0.0	0.0	0.4	0.0	0.1	2.1	0.0	1.1	2.0	0.0	0.0	0.0	87.1	0.3	8.1	25.8	0.0	0.0	0.0	1.8	0.0	1.7	0.5	0.2	0.2	0.0	0.2	0.1	0.0	0.0	0.1	0.1	0.0	0.1	0.1	0.7	0.3	0.2	0.2	0.1	0.0	1.6	2.4	0.8	1.7	1.7	1.7	1.8	0.6	5.7	2.6	0.0	0.0	0.0	44.7	14.4	0.0	1.2	0.0	0.0	0.0	3.5	0.0	0.1	0.0	0.7	12.7	2.2	0.0	0.0	0.0	0.0	34.9	5.5	13.8	0.0	0.2	0.0	1.2	0.0	0.0	1.6	1.7	1.6	28.7	0.0	1.3	0.0	2.6	0.0	0.0	0.0	0.0	0.0	10.8	0.2	0.0	10.5	0.1	0.0	3.3	95.7
HAS3		ENSG00000103044	"Hyaluronan synthase 3"	O00219	16	69105564-69118719	"Enzymes, Predicted membrane proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 22.6;urinary bladder: 22.9"	"Cell type enhanced"	"Detected in many"	14	"Basal keratinocytes: 144.1;Suprabasal keratinocytes: 138.5;Urothelial cells: 89.2"	"Group enriched"	"Detected in many"	8	"cervical cancer: 17.1;head and neck cancer: 44.9;lung cancer: 23.3;urothelial cancer: 31.1"	"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"HaCaT: 14.4;PC-3: 76.9;RT4: 30.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA031554, CAB033850"	Supported		Approved	Microtubules		NA	NA			Microtubules		"CAB033850: AB_2116418, HPA031554: AB_10670703"	"unprognostic (3.26e-2)"	"unprognostic (1.22e-1)"	"unprognostic (5.12e-2)"	"unprognostic (1.19e-1)"	"unprognostic (2.16e-1)"	"unprognostic (7.59e-3)"	"unprognostic (2.86e-3)"	"unprognostic (1.84e-1)"	"unprognostic (3.70e-1)"	"unprognostic (1.77e-1)"	"prognostic unfavorable (5.36e-4)"	"unprognostic (2.46e-1)"	"unprognostic (3.27e-3)"	"unprognostic (3.25e-2)"	"unprognostic (1.32e-1)"	"unprognostic (2.21e-2)"	"unprognostic (3.40e-3)"	0.4	0.2	0.4	0.4	1.0	0.3	5.5	1.1	1.3	3.3	3.7	0.4	0.4	1.9	0.8	1.1	22.6	0.7	3.5	2.4	0.6	0.6	1.2	0.7	18.0	0.4	0.4	0.4	0.9	2.2	0.1	1.0	3.3	1.1	3.5	2.3	0.6	7.6	2.1	0.6	5.7	2.1	1.4	0.4	0.4	9.0	2.0	0.4	0.5	4.0	11.7	11.1	22.9	13.6	1.5	1.2	2.2	1.4	0.4	2.0	1.1	0.9	4.8	0.3	0.2	0.1	0.1	1.8	0.3	0.1	0.2	0.1	1.0	2.5	0.2	0.6	0.1	1.1	14.4	0.8	8.6	0.3	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.2	0.1	2.4	0.3	0.8	1.1	0.1	0.1	0.0	0.1	0.0	0.5	0.3	0.1	4.3	5.0	76.9	0.5	0.0	0.0	7.9	30.4	5.4	0.2	0.5	0.0	0.1	0.9	0.2	0.2	0.1	0.2	0.2	8.4	0.5	0.3	0.2	0.0	0.3	0.0	0.1	0.8	1.4	2.2	1.4	0.7	1.3	0.7	1.1	0.5	1.2	1.5	2.0	0.7	0.5	0.4	1.1	1.0	1.5	1.1	0.4	1.0	1.1	1.3	0.6	0.6	0.4	0.4	1.1	0.4	0.0	25.0	0.0	35.3	144.1	1.4	1.4	0.0	0.0	4.5	0.0	2.0	0.9	0.0	3.2	10.2	2.0	2.0	0.0	3.1	0.7	0.8	9.4	0.0	0.0	0.3	0.0	0.0	1.3	0.0	17.0	1.1	0.6	3.3	0.0	0.3	0.1	2.3	0.0	0.4	0.6	0.9	0.0	2.5	0.6	0.4	138.5	0.2	0.5	1.5	89.2
HASPIN	GSG2	ENSG00000177602	"Histone H3 associated protein kinase"	Q8TF76	17	3723903-3726699	"Enzymes, Predicted intracellular proteins"	"Cell cycle"	"Chromatin regulator, Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"bone marrow: 7.5;lymphoid tissue: 26.7;testis: 26.7"	"Cell type enriched"	"Detected in single"	5	"Extravillous trophoblasts: 2.7"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA027422, HPA030698"	Approved		Supported	Nucleoplasm		NA	NA			Nucleoplasm		"HPA027422: AB_10601812, HPA030698: AB_2673575"	"unprognostic (1.15e-2)"	"unprognostic (2.78e-2)"	"unprognostic (7.06e-2)"	"unprognostic (2.14e-2)"	"unprognostic (8.05e-2)"	"unprognostic (2.81e-1)"	"unprognostic (1.01e-4)"	"unprognostic (1.57e-2)"	"unprognostic (6.60e-2)"	"unprognostic (1.77e-1)"	"unprognostic (2.75e-3)"	"unprognostic (3.82e-3)"	"unprognostic (0.00e+0)"	"unprognostic (5.65e-3)"	"unprognostic (3.09e-2)"	"unprognostic (1.31e-1)"	"unprognostic (1.73e-1)"	1.2	0.3	0.3	11.8	0.6	7.5	1.8	0.5	0.3	0.5	1.5	0.2	0.0	2.2	0.3	0.4	2.8	0.6	1.3	0.6	0.2	0.2	0.8	0.4	2.6	5.8	0.4	0.0	0.4	0.5	0.0	0.3	1.3	0.2	0.7	1.5	0.2	1.0	0.0	1.2	0.9	3.6	0.4	1.2	4.9	1.7	26.7	0.3	26.7	0.7	1.7	7.3	0.8	1.0	2.8	1.5	2.1	0.6	0.0	1.2	0.4	7.5	8.3	7.7	8.6	0.5	1.0	6.4	7.0	5.3	13.8	13.6	6.5	3.1	18.6	4.0	3.8	5.5	12.3	13.8	6.7	13.2	0.1	11.5	9.2	6.7	3.8	0.3	5.3	9.5	0.6	0.5	10.3	6.4	1.6	6.3	14.8	8.1	16.4	6.9	3.9	10.7	3.1	6.7	5.8	5.7	11.2	9.7	5.0	2.0	5.3	3.1	4.5	6.1	4.2	2.4	7.0	4.2	5.0	3.2	6.1	7.0	6.8	12.1	3.1	3.5	9.0	3.6	7.7	7.3	0.4	0.6	2.1	0.2	0.5	0.2	0.7	0.8	0.0	1.1	2.8	1.2	0.2	0.2	0.0	0.0	1.5	0.1	0.4	0.3	0.6	0.5	0.3	0.2	0.2	0.4	0.0	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0
HAT1	KAT1	ENSG00000128708	"Histone acetyltransferase 1"	O14929	2	171922448-171983682	"Enzymes, Predicted intracellular proteins"		"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036788, CAB037191"	Supported		Supported	Nucleoplasm		NA	NA			Nucleoplasm		"CAB037191: AB_477070, HPA036788: AB_10672267"	"unprognostic (1.76e-1)"	"unprognostic (1.01e-2)"	"unprognostic (7.39e-3)"	"unprognostic (8.24e-3)"	"unprognostic (2.76e-1)"	"unprognostic (1.54e-1)"	"prognostic unfavorable (5.72e-5)"	"unprognostic (2.71e-2)"	"unprognostic (9.08e-3)"	"unprognostic (3.69e-2)"	"unprognostic (1.56e-2)"	"unprognostic (1.24e-1)"	"unprognostic (3.23e-2)"	"unprognostic (6.89e-2)"	"unprognostic (1.80e-1)"	"unprognostic (3.97e-2)"	"unprognostic (6.69e-2)"	24.3	23.7	14.3	20.8	21.4	30.9	25.7	18.4	16.7	17.6	18.2	14.0	17.7	11.8	20.7	15.6	21.3	17.7	14.8	26.2	16.7	13.0	27.5	22.1	18.8	26.9	21.2	12.9	21.8	23.0	22.3	32.2	21.1	21.4	20.8	19.3	13.1	25.5	15.6	53.9	18.6	15.8	22.9	20.5	22.5	20.2	15.9	21.5	35.4	26.1	31.8	27.8	22.1	16.9	21.0	16.0	29.9	32.1	25.9	28.1	19.2	34.2	16.4	29.0	26.5	15.4	16.0	20.5	35.8	23.9	39.6	41.4	38.0	23.8	38.5	23.2	21.6	33.6	27.3	31.4	29.3	61.2	21.7	31.1	33.9	27.1	34.3	7.5	42.8	21.3	9.5	17.0	52.2	17.5	12.5	24.9	26.9	35.1	25.3	44.9	23.9	33.5	39.2	24.1	41.8	17.2	26.9	36.6	26.1	23.5	34.6	18.6	15.3	30.0	16.8	30.4	23.4	23.4	43.5	12.6	35.6	27.5	29.9	36.0	11.1	25.6	45.3	24.0	30.7	30.8	23.8	21.1	29.9	20.8	24.5	25.8	21.0	22.1	21.3	16.0	18.4	22.2	24.2	24.0	25.9	32.1	8.2	28.1	19.2	14.3	21.4	18.4	16.7	16.7	13.0	21.2	12.9	21.4	21.5	32.8	31.1	44.9	101.4	65.9	23.1	47.4	17.8	45.5	30.7	26.2	31.4	65.0	69.6	36.4	42.5	37.9	16.0	23.3	40.9	71.6	41.6	50.0	40.3	18.4	45.8	27.0	13.7	28.3	32.7	8.9	28.4	37.8	30.4	19.0	18.1	49.8	25.8	18.2	34.6	35.3	35.7	38.8	59.0	45.9	63.7	46.0	48.7	40.6	27.7	61.2
HCCS	"CCHL, MLS"	ENSG00000004961	"Holocytochrome c synthase"	P53701	X	11111301-11123078	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		Lyase	"Disease mutation, Microphthalmia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA002946	Approved		Enhanced	Mitochondria	"Intracellular and membrane"	NA	NA			Mitochondria		"HPA002946: AB_1079041"	"prognostic unfavorable (8.69e-5)"	"unprognostic (6.89e-3)"	"unprognostic (8.46e-3)"	"unprognostic (4.92e-2)"	"unprognostic (1.34e-1)"	"unprognostic (5.44e-2)"	"prognostic unfavorable (1.35e-5)"	"unprognostic (9.18e-2)"	"unprognostic (2.73e-1)"	"unprognostic (2.52e-2)"	"unprognostic (2.10e-2)"	"unprognostic (1.60e-1)"	"prognostic favorable (6.17e-8)"	"unprognostic (2.66e-2)"	"unprognostic (1.52e-1)"	"unprognostic (2.04e-1)"	"unprognostic (1.93e-2)"	10.6	14.2	8.8	9.0	12.7	11.8	9.6	11.0	17.7	6.7	15.5	7.4	8.0	17.2	8.5	5.5	15.8	6.9	9.8	36.9	8.4	8.3	15.9	19.0	9.5	10.1	8.2	11.1	10.0	11.4	11.5	10.0	12.8	10.6	7.8	15.2	9.3	12.8	8.0	41.6	13.8	14.4	10.4	6.3	12.3	12.2	10.5	6.0	10.3	10.8	16.4	11.8	11.4	17.3	18.1	28.4	13.3	29.7	8.4	11.1	8.7	23.2	26.7	12.5	12.0	11.8	11.4	13.3	23.4	17.9	29.6	25.4	31.0	17.0	14.4	12.1	18.8	33.0	21.6	25.9	22.4	29.0	13.5	20.3	14.5	34.3	15.4	20.9	15.7	17.7	11.1	17.5	28.2	19.3	16.0	21.0	11.1	26.8	16.8	19.9	31.5	11.4	12.8	22.7	14.1	29.0	11.2	25.1	28.4	19.9	18.3	9.0	10.7	23.4	25.5	15.0	27.6	19.7	11.4	20.6	19.2	10.4	49.2	19.9	12.3	12.6	19.2	15.5	12.7	18.4	10.1	22.5	13.3	9.9	29.7	9.5	18.1	9.7	8.9	28.4	15.5	8.5	11.1	6.2	8.4	24.8	25.9	10.4	8.7	8.8	12.7	11.0	17.7	8.4	8.3	8.2	11.1	10.6	6.0	6.0	4.5	22.9	41.8	48.7	5.1	47.6	20.4	16.0	15.9	15.7	0.0	29.4	43.1	32.7	3.8	15.8	37.0	23.3	25.6	30.7	17.7	30.5	12.7	15.3	36.7	7.9	10.4	12.3	22.9	1.3	12.4	23.8	23.6	31.5	20.2	8.7	46.3	31.6	9.9	30.7	7.1	6.5	25.0	13.4	25.4	40.3	34.2	13.8	28.1	88.7
HCK	JTK9	ENSG00000101336	"HCK proto-oncogene, Src family tyrosine kinase"	P08631	20	32052188-32101856	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Exocytosis, Host-virus interaction, Immunity, Inflammatory response, Innate immunity, Phagocytosis"	"Kinase, Transferase, Tyrosine-protein kinase"	Proto-oncogene	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"blood: 107.1;lymphoid tissue: 72.6"	"Group enriched"	"Detected in many"	8	"Hofbauer cells: 131.2;Kupffer cells: 133.2;Macrophages: 170.5;monocytes: 221.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	15	"classical monocyte: 50.8;eosinophil: 62.5;intermediate monocyte: 96.5;myeloid DC: 31.6;neutrophil: 73.0;non-classical monocyte: 107.1"	"Group enriched"	"Detected in many"	15	"dendritic cells: 31.6;granulocytes: 73.0;monocytes: 107.1"	"Group enriched"	"Detected in some"	8	"THP-1: 23.1;U-937: 66.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB005195, HPA063768"	Approved		Supported	"Vesicles,Plasma membrane"		NA	NA			"Vesicles, Plasma membrane"		"CAB005195: AB_631619, HPA063768: AB_2685118"	"unprognostic (6.22e-2)"	"unprognostic (6.16e-3)"	"unprognostic (2.26e-2)"	"unprognostic (7.98e-2)"	"unprognostic (8.83e-2)"	"unprognostic (5.50e-2)"	"unprognostic (4.09e-2)"	"unprognostic (1.72e-2)"	"unprognostic (4.34e-2)"	"unprognostic (1.59e-1)"	"unprognostic (4.08e-2)"	"unprognostic (1.21e-1)"	"prognostic unfavorable (1.66e-4)"	"unprognostic (4.92e-2)"	"unprognostic (4.42e-2)"	"unprognostic (6.95e-2)"	"unprognostic (1.12e-1)"	12.3	5.8	5.9	40.8	13.1	20.8	4.0	1.8	5.3	3.0	5.8	6.1	0.9	5.9	2.5	5.7	3.1	5.9	6.5	8.8	6.0	3.7	4.0	7.9	20.9	50.3	11.2	1.2	3.4	2.8	0.7	2.9	8.8	8.0	3.8	5.9	3.1	4.1	1.9	3.1	2.8	7.8	10.2	9.1	72.6	3.7	2.6	8.2	5.8	3.3	1.2	16.4	9.4	3.5	4.7	31.6	73.0	107.1	1.1	0.1	40.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.3	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	5.7	0.0	0.0	0.0	1.6	0.1	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.3	0.0	23.1	0.0	0.0	0.1	0.0	0.0	0.7	0.1	3.4	0.0	66.3	0.0	0.5	50.8	62.5	0.1	96.5	0.1	4.7	0.1	0.1	31.6	3.7	0.1	0.0	73.0	1.1	107.1	2.8	0.1	40.2	5.9	13.1	1.8	5.3	6.0	3.7	11.2	1.2	8.0	8.2	6.0	21.8	10.3	3.5	2.7	0.0	1.7	2.5	2.7	6.8	7.0	0.0	0.8	1.7	0.0	0.2	1.4	0.0	0.0	0.5	0.7	1.3	0.0	5.8	0.8	131.2	0.0	1.7	1.8	133.2	0.0	0.0	170.5	1.7	221.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.2	1.0	1.4	0.5	0.0	4.6
HDAC1	"GON-10, HD1, RPD3L1"	ENSG00000116478	"Histone deacetylase 1"	Q13547	1	32292086-32333635	"Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"	"Biological rhythms, Transcription, Transcription regulation"	"Chromatin regulator, Hydrolase, Repressor"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"CAB005017, HPA029693, CAB068191"	Enhanced		Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"CAB005017: AB_2248344, CAB068191: AB_2665664, HPA029693: AB_10601659"	"unprognostic (2.51e-2)"	"unprognostic (9.10e-2)"	"unprognostic (2.92e-1)"	"unprognostic (2.98e-1)"	"unprognostic (9.15e-2)"	"unprognostic (3.57e-3)"	"prognostic unfavorable (5.76e-7)"	"unprognostic (9.57e-2)"	"unprognostic (5.02e-2)"	"unprognostic (3.47e-2)"	"unprognostic (7.06e-2)"	"unprognostic (4.44e-2)"	"prognostic unfavorable (1.04e-5)"	"unprognostic (6.86e-2)"	"unprognostic (3.78e-1)"	"unprognostic (7.16e-2)"	"unprognostic (1.72e-1)"	13.8	22.8	12.8	33.5	14.8	15.0	21.1	5.1	13.0	21.9	35.7	16.0	34.8	22.2	24.6	17.5	40.6	21.0	43.8	12.4	12.5	8.5	21.1	21.5	17.2	33.3	14.7	8.6	27.7	20.5	17.2	27.1	24.4	12.2	25.2	33.9	18.0	27.8	31.3	6.6	16.9	32.7	22.1	13.3	32.6	27.8	20.0	16.7	59.4	36.8	21.2	51.1	26.0	25.1	47.7	32.1	59.8	44.6	42.4	49.2	54.7	29.4	18.0	11.6	23.0	6.8	8.1	24.1	20.9	23.4	28.0	25.9	32.9	53.1	45.4	38.8	23.0	28.5	34.4	35.5	28.4	31.1	42.4	35.3	31.3	21.6	25.2	16.0	55.4	45.4	14.6	15.6	21.7	14.4	22.0	21.2	59.5	41.0	18.1	12.3	22.4	63.1	31.2	26.8	35.2	46.1	43.6	27.5	20.2	30.3	42.6	9.1	11.5	34.8	23.5	43.8	47.7	27.7	43.1	24.5	18.7	21.9	5.7	50.8	11.0	23.7	62.3	15.4	46.0	24.2	37.0	27.7	59.8	43.2	35.5	35.4	47.7	42.4	46.1	32.1	44.3	49.2	45.7	19.9	42.4	44.6	20.1	42.5	54.7	12.8	14.8	5.1	13.0	12.5	8.5	14.7	8.6	12.2	16.7	23.8	38.4	50.1	48.1	22.0	15.5	18.2	56.0	80.3	48.9	64.6	15.7	81.3	81.2	57.2	10.0	40.9	97.1	0.0	65.1	93.0	21.5	29.1	29.0	28.2	38.0	11.1	82.9	63.8	40.8	5.9	38.0	31.0	27.0	42.3	101.3	32.1	65.7	108.7	41.8	25.9	13.9	58.2	37.7	45.1	76.2	22.2	78.1	50.7	115.8	49.8
HDAC10	DKFZP761B039	ENSG00000100429	"Histone deacetylase 10"	Q969S8	22	50245183-50251405	"Cancer-related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Autophagy, DNA damage, DNA recombination, DNA repair"	Hydrolase	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HMC-1: 19.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB045977	Supported					NA	NA					"CAB045977: AB_11124034"	"unprognostic (1.53e-1)"	"prognostic favorable (4.46e-4)"	"unprognostic (1.43e-2)"	"prognostic favorable (2.45e-5)"	"unprognostic (2.71e-2)"	"unprognostic (3.70e-2)"	"unprognostic (6.15e-3)"	"unprognostic (5.48e-2)"	"unprognostic (3.28e-1)"	"unprognostic (2.56e-2)"	"prognostic favorable (9.25e-4)"	"unprognostic (4.93e-2)"	"prognostic unfavorable (4.74e-11)"	"unprognostic (2.21e-2)"	"unprognostic (2.52e-2)"	"unprognostic (1.43e-2)"	"unprognostic (1.38e-3)"	8.9	9.3	10.1	14.7	10.3	16.9	6.8	10.9	8.8	8.6	13.9	4.7	14.6	12.9	7.7	13.5	10.2	7.9	13.1	4.0	8.4	6.1	11.4	15.1	8.2	12.5	4.9	8.8	7.8	15.0	6.4	13.2	7.0	6.1	10.2	3.7	8.8	18.6	12.9	9.2	12.1	14.2	7.1	4.4	17.1	14.2	2.4	4.7	16.1	9.3	7.6	19.2	8.2	7.7	1.1	3.1	5.4	4.2	1.1	1.9	2.5	4.2	2.4	0.6	3.5	3.0	2.4	7.8	2.8	2.4	1.6	0.9	4.4	4.6	2.7	4.0	2.1	1.5	7.0	1.5	4.2	0.3	3.5	3.9	5.9	6.2	7.3	5.3	6.9	19.3	5.0	3.1	1.5	0.9	3.2	3.0	5.6	4.1	4.2	1.4	13.0	3.8	17.3	1.4	4.5	5.2	9.2	2.3	17.0	2.5	7.1	1.9	4.6	2.9	1.0	4.9	0.8	8.0	11.2	4.7	2.8	4.0	4.7	1.7	5.2	1.8	2.3	4.5	4.4	2.1	0.8	4.0	5.4	1.9	4.2	1.6	1.0	0.9	1.2	3.1	1.1	0.8	1.0	2.0	1.1	2.3	2.7	1.6	2.5	10.1	10.3	10.9	8.8	8.4	6.1	4.9	8.8	6.1	4.7	0.0	4.3	9.8	4.4	7.7	5.4	0.6	7.6	4.0	2.3	14.0	15.7	9.3	6.6	5.7	1.8	5.6	25.6	0.0	3.4	13.2	8.5	3.2	4.7	6.7	18.7	0.0	20.1	9.2	21.1	6.3	10.3	10.8	8.5	17.2	14.6	2.6	5.7	17.0	7.4	13.3	6.8	0.0	3.7	0.9	2.3	8.3	8.6	30.6	14.4	3.1
HDAC11		ENSG00000163517	"Histone deacetylase 11"	Q96DB2	3	13479724-13506424	"Enzymes, FDA approved drug targets, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Chromatin regulator, Hydrolase, Repressor"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in many"	6	"Early spermatids: 300.6;Late spermatids: 525.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"SK-BR-3: 27.9;T-47d: 24.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA						"unprognostic (5.22e-2)"	"unprognostic (3.58e-2)"	"unprognostic (1.83e-1)"	"unprognostic (5.69e-3)"	"unprognostic (1.76e-1)"	"unprognostic (4.71e-2)"	"prognostic unfavorable (1.20e-5)"	"unprognostic (4.50e-2)"	"unprognostic (5.67e-3)"	"unprognostic (1.78e-2)"	"unprognostic (9.87e-2)"	"unprognostic (3.94e-1)"	"prognostic favorable (7.88e-10)"	"unprognostic (3.63e-2)"	"unprognostic (1.65e-1)"	"unprognostic (1.46e-1)"	"unprognostic (1.39e-3)"	4.8	7.6	24.6	3.2	31.7	0.7	5.8	7.6	30.6	8.8	7.1	29.2	3.8	8.9	6.5	5.1	9.5	10.1	6.5	19.6	24.4	19.0	9.9	2.1	6.4	3.0	25.4	20.7	12.5	18.8	10.4	7.7	3.4	16.5	8.2	5.1	6.6	12.8	9.7	35.1	13.2	9.6	5.4	19.9	3.0	4.9	24.0	20.3	1.5	9.9	4.9	3.7	4.4	6.6	1.4	2.3	7.5	3.3	11.4	4.5	2.3	6.9	4.5	4.8	3.9	7.1	6.2	3.6	4.6	3.2	4.6	3.1	2.2	5.8	0.5	5.5	6.4	7.3	5.3	2.8	8.3	3.0	3.0	2.6	1.3	1.9	6.3	8.0	0.1	2.5	5.2	15.6	5.1	3.9	8.6	3.3	4.3	2.7	1.3	4.3	7.0	0.8	0.9	1.3	4.5	12.0	0.9	6.9	2.0	9.6	5.1	0.8	3.6	6.6	27.9	13.2	4.1	24.6	1.6	3.1	3.9	7.9	7.7	2.7	0.9	2.5	0.1	1.2	1.0	2.2	0.2	3.3	7.5	4.5	1.8	3.1	1.4	4.1	3.5	2.3	0.6	4.1	2.7	1.4	11.4	0.7	2.3	3.3	2.3	24.6	31.7	7.6	23.0	24.4	19.0	25.4	20.7	16.5	20.3	8.9	5.3	0.0	7.4	10.2	8.7	71.4	10.2	9.4	3.4	10.4	0.0	15.7	16.6	11.3	300.6	4.5	28.8	0.0	10.0	2.1	7.6	4.5	1.1	2.6	5.2	9.5	8.5	7.4	4.3	525.1	15.0	3.1	8.5	6.4	14.8	17.7	10.6	16.9	14.5	14.2	5.8	0.0	6.9	10.2	6.0	9.3	4.8	4.3	18.5	5.0
HDAC2	"RPD3, YAF1"	ENSG00000196591	"Histone deacetylase 2"	Q92769	6	113933028-114011308	"Cancer-related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"	"Biological rhythms, Transcription, Transcription regulation"	"Chromatin regulator, Hydrolase, Repressor"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB005054, HPA011727"	Supported		Supported	Nucleoplasm		NA	NA			Nucleoplasm		"CAB005054: AB_562295, HPA011727: AB_1850540"	"prognostic unfavorable (7.07e-4)"	"unprognostic (1.44e-1)"	"unprognostic (2.67e-1)"	"unprognostic (2.56e-2)"	"unprognostic (2.61e-2)"	"unprognostic (1.89e-2)"	"prognostic unfavorable (5.39e-10)"	"unprognostic (2.03e-1)"	"unprognostic (2.63e-2)"	"unprognostic (9.00e-2)"	"unprognostic (2.01e-1)"	"unprognostic (3.92e-1)"	"unprognostic (1.84e-2)"	"unprognostic (1.96e-1)"	"unprognostic (2.42e-1)"	"unprognostic (9.80e-2)"	"unprognostic (3.51e-1)"	25.8	33.8	25.8	30.1	31.3	34.9	58.7	32.8	36.5	32.1	30.7	25.6	32.2	22.0	38.7	36.7	36.3	32.7	23.3	27.6	26.5	26.9	31.6	22.2	29.9	41.5	29.6	26.5	39.2	31.5	31.7	45.1	38.1	27.9	32.1	36.1	17.5	29.3	39.0	33.9	30.8	26.1	36.1	31.1	30.7	29.9	47.4	27.4	64.0	35.1	31.3	32.5	33.1	47.3	27.0	35.7	28.2	32.6	26.3	32.6	24.3	24.6	17.0	79.6	45.7	20.5	23.5	33.3	29.5	24.1	34.8	41.7	45.1	18.2	20.4	24.6	26.5	35.8	19.4	54.0	29.8	58.7	29.0	37.3	49.1	22.1	26.0	27.4	49.8	22.2	18.9	20.1	37.0	34.8	34.1	40.5	36.1	63.1	20.7	57.6	20.7	44.6	45.1	45.0	26.4	23.5	30.3	39.7	18.7	35.9	29.8	53.3	45.2	23.3	22.0	24.5	50.0	16.0	58.1	32.7	22.2	25.5	23.2	48.8	16.5	21.7	48.8	18.8	48.0	37.6	23.1	27.6	28.2	21.1	26.6	28.1	27.0	25.9	22.7	35.7	22.3	32.6	29.7	16.3	26.3	32.6	30.9	24.5	24.3	25.8	31.3	32.8	36.5	26.5	26.9	29.6	26.5	27.9	27.4	53.6	49.8	31.2	71.8	170.6	26.7	56.1	33.1	81.7	79.6	50.6	3.9	139.9	36.5	140.8	72.3	70.5	33.4	140.2	91.3	114.1	97.6	61.7	53.2	30.8	91.5	14.3	96.4	47.9	63.7	84.2	76.8	67.2	79.2	128.0	68.7	30.1	115.2	49.1	63.3	52.8	23.5	38.8	84.5	123.0	166.8	168.8	173.7	50.7	90.3	79.6
HDAC3	"HD3, RPD3, RPD3-2"	ENSG00000171720	"Histone deacetylase 3"	O15379	5	141620876-141636870	"Enzymes, FDA approved drug targets, Predicted intracellular proteins"	"Biological rhythms, Transcription, Transcription regulation"	"Chromatin regulator, Hydrolase, Repressor"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB005583, HPA052052, CAB072336"	Supported		Supported	"Nucleoplasm,Golgi apparatus"		NA	NA			Nucleoplasm	"Golgi apparatus"	"CAB005583: AB_562296, CAB072336: , HPA052052: AB_2681708"	"unprognostic (6.65e-2)"	"unprognostic (1.96e-1)"	"prognostic favorable (3.39e-4)"	"unprognostic (1.17e-1)"	"unprognostic (1.24e-1)"	"unprognostic (1.07e-1)"	"unprognostic (1.19e-2)"	"unprognostic (3.16e-1)"	"unprognostic (5.56e-2)"	"unprognostic (2.45e-2)"	"prognostic favorable (3.95e-4)"	"unprognostic (1.12e-1)"	"prognostic unfavorable (2.65e-6)"	"unprognostic (1.85e-1)"	"unprognostic (1.63e-2)"	"unprognostic (2.28e-3)"	"unprognostic (2.17e-1)"	15.9	28.8	19.6	12.2	17.6	18.1	18.6	22.6	20.8	15.6	14.1	11.2	13.1	10.6	17.3	17.6	22.8	16.3	14.0	16.8	18.0	8.9	14.5	23.3	24.4	36.4	13.4	14.2	17.3	24.7	20.9	17.3	14.3	18.8	13.6	14.4	13.6	17.5	13.7	24.5	26.7	15.2	17.2	10.8	20.1	15.5	11.9	12.6	18.5	14.4	9.6	23.7	17.5	17.0	22.1	46.7	16.4	22.6	14.1	23.1	16.9	21.3	14.5	27.0	40.9	26.1	20.8	17.5	15.6	34.3	35.4	50.8	31.0	18.3	31.1	20.2	20.2	25.2	18.6	27.1	36.5	43.9	26.5	29.1	24.3	13.3	17.6	18.4	29.2	22.3	17.7	23.5	20.5	26.8	18.4	22.8	28.1	23.7	16.6	22.3	20.2	32.4	25.3	23.8	13.3	11.5	23.5	28.2	22.4	18.9	21.5	22.6	18.3	20.6	21.4	25.7	17.9	22.8	18.5	11.5	22.0	13.8	16.8	25.5	13.5	16.6	29.3	18.5	27.8	18.8	13.2	22.4	16.4	15.9	22.6	20.8	22.1	19.8	19.2	46.7	20.1	21.7	18.0	9.5	14.1	19.0	23.9	23.1	16.9	19.6	17.6	22.6	20.8	18.0	8.9	13.4	14.2	18.8	12.6	8.9	10.4	32.3	23.0	39.3	30.6	12.3	15.3	5.3	11.4	12.2	56.9	47.2	18.3	28.5	7.6	20.2	15.4	0.0	31.4	44.3	29.3	18.8	18.4	14.8	34.9	47.7	17.2	20.9	15.4	3.4	20.8	33.0	30.4	66.7	17.7	27.7	27.2	14.0	20.8	15.7	30.4	25.8	24.0	22.3	24.5	44.9	51.1	31.9	22.7	26.5
HDAC4	"BDMR, HA6116, HD4, HDAC-4, HDAC-A, HDACA, KIAA0288"	ENSG00000068024	"Histone deacetylase 4"	P56524	2	239048168-239401654	"Disease related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Chromatin regulator, Hydrolase, Repressor"	"Autism spectrum disorder, FDA approved drug targets, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 54.6"	"Cell type enhanced"	"Detected in many"	10	"Early spermatids: 73.9;Late spermatids: 47.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	6	"basophil: 10.5;classical monocyte: 7.4;neutrophil: 28.3"	"Group enriched"	"Detected in many"	8	"granulocytes: 28.3;monocytes: 7.4"	"Cell line enhanced"	"Detected in many"		"JURKAT: 30.4;MOLT-4: 28.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA048723, HPA071448"	Approved		Supported	"Nucleoplasm,Nuclear speckles,Cytosol"		NA	NA			"Nuclear speckles"	"Nucleoplasm, Cytosol"	"HPA048723: AB_2680501, HPA071448: "	"unprognostic (1.54e-1)"	"unprognostic (1.76e-2)"	"unprognostic (1.33e-1)"	"unprognostic (1.18e-3)"	"unprognostic (2.43e-2)"	"unprognostic (2.39e-3)"	"unprognostic (3.06e-4)"	"unprognostic (1.00e-1)"	"unprognostic (1.24e-1)"	"prognostic unfavorable (6.33e-4)"	"prognostic favorable (1.13e-4)"	"unprognostic (1.40e-1)"	"unprognostic (4.82e-3)"	"unprognostic (2.40e-1)"	"unprognostic (3.26e-2)"	"unprognostic (1.32e-2)"	"unprognostic (6.04e-2)"	7.9	6.8	6.1	6.8	5.2	17.1	4.6	6.4	12.3	11.3	21.4	4.6	4.3	2.5	10.2	6.4	8.8	9.0	24.6	5.2	5.0	6.0	3.2	3.1	4.2	4.3	6.1	5.4	8.5	5.8	4.9	8.3	2.5	5.2	7.5	4.8	8.3	3.7	7.3	54.6	6.9	6.5	15.8	4.2	5.4	7.0	8.1	4.3	6.5	4.8	13.2	5.6	10.2	4.6	0.5	1.7	28.3	7.4	2.1	1.2	0.4	3.8	3.8	4.9	5.9	2.8	4.7	5.8	4.0	2.7	3.2	3.1	1.7	7.0	1.8	1.6	3.4	4.6	3.8	3.4	1.6	1.6	10.6	1.8	2.8	4.7	5.6	3.7	4.3	2.6	3.2	4.1	5.9	4.7	1.6	3.4	30.4	4.0	4.1	1.5	4.7	28.1	5.9	3.8	4.8	2.0	7.3	9.2	2.8	3.7	4.9	3.9	6.9	5.6	2.5	9.8	2.9	1.3	11.9	5.4	3.7	0.3	6.4	5.4	2.9	2.7	3.5	5.4	6.0	7.4	10.5	7.4	1.1	0.9	2.4	1.1	0.5	0.9	0.8	0.8	0.5	0.5	1.0	28.3	2.1	1.0	1.7	1.2	0.4	6.1	5.2	6.4	7.5	5.0	6.0	6.1	5.4	5.2	4.3	3.0	9.0	3.7	2.2	7.0	11.5	10.1	7.6	0.0	3.4	10.4	2.0	1.2	0.0	2.4	73.9	5.8	4.5	0.0	1.8	1.5	8.0	5.0	2.3	5.8	2.9	15.9	5.8	13.5	22.7	47.3	10.9	5.5	5.0	0.0	5.5	10.1	1.7	0.0	11.7	1.2	7.1	0.0	5.6	2.2	2.1	8.4	1.1	8.7	5.7	2.2
HDAC5	"FLJ90614, KIAA0600, NY-CO-9"	ENSG00000108840	"Histone deacetylase 5"	Q9UQL6	17	44076746-44123702	"Cancer-related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Chromatin regulator, Hydrolase, Repressor"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"Cone photoreceptor cells: 111.9;Syncytiotrophoblasts: 182.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB019400, HPA030991"	Approved		Supported	"Nuclear speckles,Golgi apparatus,Cytosol"		NA	NA			"Nuclear speckles"	"Golgi apparatus, Cytosol"	"CAB019400: AB_2116626, HPA030991: AB_10795286"	"unprognostic (1.30e-2)"	"prognostic favorable (6.14e-4)"	"unprognostic (6.65e-2)"	"unprognostic (8.06e-2)"	"unprognostic (3.49e-1)"	"unprognostic (3.52e-2)"	"prognostic unfavorable (3.12e-5)"	"unprognostic (8.80e-3)"	"unprognostic (3.80e-2)"	"unprognostic (2.37e-2)"	"unprognostic (4.91e-3)"	"unprognostic (4.30e-1)"	"prognostic favorable (3.30e-5)"	"unprognostic (1.51e-2)"	"unprognostic (3.11e-1)"	"unprognostic (6.00e-2)"	"unprognostic (1.76e-2)"	15.6	17.6	24.9	7.9	15.8	13.2	18.1	35.9	25.8	16.5	8.8	19.6	9.5	8.4	15.0	11.9	20.1	16.9	11.3	24.4	22.1	24.2	8.6	6.3	13.6	8.8	24.7	22.1	24.5	16.1	28.2	17.5	23.0	19.3	13.6	5.5	11.7	14.2	11.9	42.6	34.0	9.7	12.4	20.5	13.8	9.3	10.3	18.1	7.6	15.0	9.8	8.2	14.9	20.4	7.6	9.4	17.9	13.6	3.5	4.9	5.0	3.6	2.4	6.5	1.5	12.7	9.8	23.6	9.8	24.4	4.9	8.0	5.2	3.9	5.7	3.9	23.2	7.3	2.9	7.6	4.2	2.1	8.8	12.4	11.1	7.8	12.0	5.4	3.6	15.7	13.9	7.2	5.6	7.0	8.4	4.0	4.6	8.2	11.6	28.3	2.8	5.9	10.9	7.1	2.8	5.6	22.9	18.2	14.7	0.5	1.6	17.0	8.9	2.8	12.0	13.3	10.1	17.1	21.0	2.2	12.3	7.9	2.8	4.9	19.2	16.0	6.8	7.1	4.5	5.8	7.1	7.3	7.7	4.9	11.6	3.5	6.6	3.9	4.9	9.4	7.6	4.1	3.5	17.9	3.5	13.6	8.3	3.5	5.0	24.9	15.8	35.9	25.8	22.1	24.2	24.7	22.1	19.3	18.1	11.9	13.6	10.4	30.2	26.0	84.0	21.0	12.7	5.3	7.9	19.2	111.9	12.7	18.3	13.6	17.9	18.3	11.2	0.0	7.5	47.4	24.1	34.1	11.6	9.0	19.6	77.9	44.2	20.3	12.1	8.7	44.8	13.6	13.5	9.0	13.7	17.3	12.1	15.8	41.1	6.4	58.6	64.7	41.8	2.3	33.8	28.7	182.4	17.5	11.2	18.5
HDAC6	"FLJ16239, HD6, JM21, KIAA0901, PPP1R90"	ENSG00000094631	"Histone deacetylase 6"	Q9UBN7	X	48801377-48824982	"Disease related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins"	"Autophagy, Transcription, Transcription regulation"	"Actin-binding, Chromatin regulator, Hydrolase, Repressor"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003714, CAB004236, HPA026321"	Supported		Supported	Nucleoplasm		NA	NA		39000	Nucleoplasm		"CAB004236: AB_627708, HPA003714: AB_1850544, HPA026321: AB_1850546"	"unprognostic (9.53e-2)"	"unprognostic (1.59e-1)"	"unprognostic (2.66e-2)"	"unprognostic (2.42e-2)"	"unprognostic (2.82e-2)"	"unprognostic (4.11e-3)"	"unprognostic (2.17e-2)"	"unprognostic (1.16e-1)"	"unprognostic (7.68e-2)"	"unprognostic (2.83e-1)"	"unprognostic (1.16e-3)"	"unprognostic (2.33e-2)"	"unprognostic (6.10e-2)"	"unprognostic (1.47e-1)"	"unprognostic (6.60e-2)"	"unprognostic (2.34e-1)"	"prognostic favorable (3.34e-4)"	14.6	13.7	23.4	12.8	29.8	19.0	14.4	34.2	30.1	12.7	14.1	24.4	14.9	16.9	16.0	14.7	13.1	15.7	11.7	11.9	21.7	24.8	32.8	43.3	15.1	13.9	27.2	22.4	18.7	15.5	26.7	24.4	15.1	27.0	12.3	15.9	15.1	12.2	15.3	18.2	11.3	16.1	15.0	20.9	15.3	14.2	24.7	22.4	19.0	15.7	9.5	14.0	11.7	12.1	5.7	9.7	6.3	12.4	4.0	5.8	5.0	15.1	12.9	25.3	9.6	10.2	9.3	17.1	7.2	6.2	14.0	13.8	12.4	13.0	14.6	7.0	8.2	17.9	10.8	15.3	7.7	12.1	13.6	9.7	20.0	15.4	12.7	9.6	9.2	31.0	13.5	12.6	10.9	13.2	12.5	11.6	18.5	21.9	16.2	8.8	5.3	13.0	14.4	9.4	6.9	12.3	11.2	27.2	15.0	8.0	6.6	13.0	12.8	14.6	4.4	8.7	34.3	18.3	8.6	9.4	10.9	14.1	14.9	6.9	14.9	14.8	10.6	11.1	11.9	10.8	0.0	5.8	6.3	5.8	9.7	4.1	4.3	4.0	4.2	8.6	5.7	3.9	3.7	2.9	4.0	12.4	9.7	4.4	5.0	23.4	29.8	34.2	30.1	21.7	24.8	27.2	22.4	27.0	22.4	17.9	30.9	11.7	10.4	6.6	37.4	9.5	12.7	9.4	20.5	17.4	47.1	9.6	16.6	6.3	37.4	7.7	17.6	0.0	6.4	10.4	8.4	7.6	5.8	45.7	9.7	38.1	13.8	11.6	10.0	14.2	13.0	9.2	5.0	15.4	11.6	26.8	6.8	11.5	10.6	39.4	33.8	12.9	8.0	31.5	13.0	5.1	8.1	6.7	13.6	6.4
HDAC7	"DKFZP586J0917, HDAC7A"	ENSG00000061273	"Histone deacetylase 7"	Q8WUI4	12	47782722-47833132	"Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Chromatin regulator, Hydrolase, Repressor"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 85.8"	"Cell type enhanced"	"Detected in many"	4	"Ito cells: 87.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	5	"neutrophil: 10.5"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 10.5"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA004775			Supported	Cytosol		NA	NA			Cytosol		"HPA004775: AB_1850548"	"unprognostic (3.83e-1)"	"unprognostic (9.49e-3)"	"unprognostic (1.37e-2)"	"unprognostic (4.46e-2)"	"unprognostic (6.56e-3)"	"unprognostic (2.22e-2)"	"unprognostic (2.50e-3)"	"unprognostic (1.26e-1)"	"prognostic unfavorable (5.16e-4)"	"unprognostic (1.28e-1)"	"unprognostic (2.07e-1)"	"unprognostic (2.38e-2)"	"prognostic unfavorable (8.25e-4)"	"unprognostic (6.24e-2)"	"unprognostic (4.38e-2)"	"unprognostic (9.69e-2)"	"prognostic favorable (4.65e-4)"	26.0	21.6	8.2	22.7	10.8	17.3	24.4	8.4	10.7	28.2	20.7	8.7	15.4	8.0	27.9	21.5	19.2	25.2	22.1	16.5	10.3	4.3	17.7	5.1	27.6	21.1	8.2	8.0	25.4	8.9	23.7	11.5	17.5	10.0	20.1	4.1	17.6	16.3	18.9	12.5	19.7	13.9	24.9	10.3	23.1	14.9	9.5	11.5	85.8	20.9	12.9	21.0	24.8	25.0	1.4	0.6	10.5	1.9	1.7	1.5	1.8	14.2	9.7	10.1	16.5	7.9	22.1	9.1	14.0	10.9	10.2	6.7	12.9	13.5	28.6	46.8	12.7	5.0	13.2	2.3	10.9	3.7	13.4	4.8	9.8	9.5	3.0	8.6	3.0	0.4	14.4	3.8	10.1	5.5	18.4	21.0	16.4	10.3	11.7	6.4	6.2	28.1	7.5	14.1	3.1	10.8	21.7	5.4	10.3	4.3	9.3	2.9	6.9	10.7	5.0	5.1	6.8	4.7	4.1	23.8	20.9	22.7	17.0	9.9	26.5	19.2	22.7	8.6	14.5	6.8	0.0	1.9	0.0	1.5	0.8	1.5	1.4	1.3	1.1	0.6	1.1	1.5	1.0	10.5	1.7	0.7	0.5	0.6	1.8	8.2	10.8	8.4	10.7	10.3	4.3	8.2	8.0	10.0	11.5	38.7	36.7	31.8	21.0	12.2	18.0	11.5	30.6	5.3	22.7	34.9	0.0	3.9	1.7	29.4	13.4	71.6	1.1	0.0	19.7	2.5	28.8	40.0	8.1	0.4	13.7	27.0	7.0	87.8	29.5	4.9	50.9	11.5	13.5	12.6	9.7	13.6	47.3	9.7	31.1	2.9	3.2	25.8	20.6	0.9	3.1	18.9	2.4	26.6	7.6	38.2
HDAC8	"HDACL1, MRXS6, RPD3, WTS"	ENSG00000147099	"Histone deacetylase 8"	Q9BY41	X	72329516-72573103	"Disease related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Chromatin regulator, Hydrolase, Repressor"	"Disease mutation, FDA approved drug targets, Mental retardation, Obesity"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA048560	Supported		Approved	"Nucleoplasm,Plasma membrane"		NA	NA			"Nucleoplasm, Plasma membrane"		"HPA048560: AB_2680442"	"unprognostic (1.42e-1)"	"unprognostic (6.62e-3)"	"unprognostic (3.20e-2)"	"unprognostic (9.24e-3)"	"unprognostic (1.10e-1)"	"unprognostic (1.10e-1)"	"unprognostic (4.64e-2)"	"unprognostic (6.03e-2)"	"unprognostic (1.58e-1)"	"unprognostic (2.81e-2)"	"unprognostic (3.17e-2)"	"unprognostic (9.68e-2)"	"unprognostic (8.42e-2)"	"unprognostic (2.33e-3)"	"unprognostic (9.10e-2)"	"unprognostic (7.15e-3)"	"unprognostic (2.12e-3)"	9.6	22.5	14.7	9.9	16.2	10.2	12.4	31.4	20.6	12.6	10.4	13.9	11.5	8.6	12.3	28.2	11.0	9.4	9.4	12.6	15.0	15.2	16.8	18.6	10.2	9.6	14.9	9.4	12.8	15.9	13.6	22.0	11.2	19.3	13.3	12.8	14.3	12.2	10.3	10.4	9.3	8.4	13.1	12.2	9.5	10.7	3.6	14.0	8.0	15.0	8.2	11.9	10.4	10.1	9.4	12.8	19.7	13.2	7.7	11.4	7.7	12.5	17.1	12.6	17.4	17.3	12.9	8.7	7.3	14.1	11.2	12.7	12.4	12.9	8.7	23.0	10.0	17.5	9.2	23.5	14.2	14.9	14.3	16.7	11.5	22.0	14.4	9.5	19.1	20.4	13.5	10.4	13.7	10.3	15.9	17.2	11.7	12.8	24.4	14.9	15.8	8.9	25.1	17.5	19.3	24.8	12.2	16.2	15.6	19.5	13.2	9.0	19.7	17.1	13.7	17.5	16.4	6.9	16.3	12.9	9.2	13.3	13.2	8.1	9.4	15.0	11.1	12.5	21.1	11.9	7.2	13.2	19.7	8.8	11.8	6.9	9.4	9.5	7.3	12.8	9.1	7.6	7.1	0.7	7.7	10.5	4.8	11.4	7.7	14.7	16.2	31.4	20.6	15.0	15.2	14.9	9.4	19.3	14.0	3.0	18.8	8.1	10.0	5.5	16.0	10.8	12.7	13.4	10.3	7.0	41.2	14.3	8.3	11.9	0.5	10.5	8.1	0.0	10.7	11.6	8.6	13.3	11.5	9.7	13.8	22.3	8.7	11.6	7.8	1.3	10.9	10.6	6.8	6.4	9.1	10.8	10.1	2.9	9.9	17.8	16.8	25.8	9.5	5.1	0.7	5.5	11.3	11.4	9.7	10.9
HDAC9	"HD7, HDAC, HDAC7B, KIAA0744, MITR"	ENSG00000048052	"Histone deacetylase 9"	Q9UKV0	7	18086949-19002416	"Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Chromatin regulator, Hydrolase, Repressor"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	16	"Early spermatids: 197.2;Late spermatids: 49.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"myeloid DC: 29.5"	"Group enriched"	"Detected in many"	9	"B-cells: 21.8;dendritic cells: 29.5;monocytes: 9.7"	"Cell line enhanced"	"Detected in many"		"HAP1: 55.1;hTERT-HME1: 26.4;SH-SY5Y: 22.0;U-698: 21.8;WM-115: 22.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA028926	Uncertain		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA028926: AB_10602327"	"unprognostic (2.06e-2)"	"unprognostic (2.67e-1)"	"unprognostic (2.30e-1)"	"unprognostic (1.17e-1)"	"unprognostic (2.74e-1)"	"unprognostic (5.54e-2)"	"unprognostic (2.20e-2)"	"unprognostic (2.32e-1)"	"unprognostic (2.21e-1)"	"unprognostic (2.45e-1)"	"unprognostic (5.01e-1)"	"unprognostic (7.58e-2)"	"unprognostic (1.29e-1)"	"unprognostic (3.94e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.02e-1)"	"unprognostic (6.87e-3)"	10.7	13.5	12.6	10.7	16.2	5.9	8.4	19.1	16.9	11.6	7.4	11.3	7.5	3.8	17.8	6.7	4.7	10.5	7.5	14.9	13.1	12.0	3.9	3.1	5.7	18.9	13.9	14.9	3.0	2.7	3.0	17.7	6.8	11.2	12.5	6.2	9.7	6.9	16.5	15.5	3.8	8.4	14.4	17.6	17.4	9.1	8.7	18.2	2.9	5.5	5.4	19.3	7.1	9.6	21.8	29.5	0.5	9.7	2.0	2.1	4.5	12.5	0.0	2.1	0.0	0.3	2.8	0.0	0.7	7.4	3.1	5.3	0.1	4.1	5.4	13.9	8.3	17.1	1.9	55.1	1.0	8.1	0.0	0.3	0.0	0.0	0.0	0.0	1.1	0.0	1.0	1.0	9.8	26.4	2.7	0.1	0.8	0.0	8.4	4.3	0.0	0.5	1.1	6.7	0.0	1.2	1.5	0.8	3.1	1.7	3.3	3.9	22.0	0.1	0.1	4.0	3.3	0.2	4.9	0.5	11.4	3.6	0.6	7.1	9.7	4.1	21.8	3.0	0.5	22.5	0.1	9.7	0.0	1.7	6.7	1.7	21.8	0.6	0.8	29.5	16.3	0.0	0.9	0.5	2.0	3.8	6.4	2.1	4.5	12.6	16.2	19.1	16.9	13.1	12.0	13.9	14.9	11.2	18.2	6.0	3.2	26.4	0.4	2.2	32.0	12.1	0.0	1.4	4.5	0.0	15.7	0.1	3.3	6.6	197.2	11.1	0.0	0.0	0.6	0.1	5.7	1.4	1.1	0.8	10.5	19.1	6.9	13.5	45.7	49.8	1.4	31.1	15.1	0.0	0.4	5.0	7.0	0.2	0.7	0.0	27.3	6.5	6.9	10.3	8.8	1.8	0.1	8.7	0.0	2.0
HDC		ENSG00000140287	"Histidine decarboxylase"	P19113	15	50241947-50266026	"Enzymes, Predicted intracellular proteins"	"Catecholamine biosynthesis"	"Decarboxylase, Lyase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in many"	8	"blood: 83.5;brain: 36.0;epididymis: 36.9"	"Cell type enriched"	"Detected in some"	7	"granulocytes: 556.0"	"Low cancer specificity"	"Detected in some"			"Region enriched"	"Detected in single"	52	"hypothalamus: 36.0"	"Cell type enriched"	"Detected in single"	835	"basophil: 83.5"	"Lineage enriched"	"Detected in single"	835	"granulocytes: 83.5"	"Group enriched"	"Detected in some"	4	"HEL: 61.2;HMC-1: 147.3"	"Region enriched"	"Detected in many"	5	"hypothalamus: 51.5"	"Low region specificity"	"Detected in all"			HPA038891	Enhanced		Approved	"Nuclear bodies"		NA	NA			"Nuclear bodies"		"HPA038891: AB_10673231"	"unprognostic (4.97e-2)"	"unprognostic (7.42e-2)"	"unprognostic (1.43e-4)"	"unprognostic (1.08e-1)"	"unprognostic (6.16e-2)"	"unprognostic (3.93e-7)"	"unprognostic (4.18e-5)"	"unprognostic (8.79e-3)"	"unprognostic (1.48e-1)"	"unprognostic (8.46e-2)"	"unprognostic (4.60e-2)"	"unprognostic (1.05e-1)"	"unprognostic (2.53e-1)"	"unprognostic (7.20e-2)"	"unprognostic (9.78e-2)"	"unprognostic (2.15e-1)"	"unprognostic (1.50e-1)"	1.7	0.2	0.2	5.1	0.4	2.4	1.1	0.2	0.3	2.7	1.9	0.2	1.2	2.1	3.1	36.9	2.7	0.6	6.6	2.1	0.2	36.0	0.6	0.8	4.9	2.3	0.6	0.1	0.4	0.5	0.3	0.7	0.2	0.3	2.2	1.9	3.0	0.9	1.3	1.8	1.8	2.4	5.4	0.2	0.4	6.9	2.4	0.2	0.4	0.3	0.4	1.7	1.8	2.7	0.0	0.0	83.5	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	61.2	0.0	0.0	0.0	0.1	147.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	23.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	83.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.4	0.2	0.3	0.2	36.0	0.6	0.1	0.3	0.2	11.9	81.4	0.0	0.0	0.7	0.5	0.3	0.0	8.1	13.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	556.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.6	0.0	0.0	0.0	0.0
HDDC3	MGC45386	ENSG00000184508	"HD domain containing 3"	Q8N4P3	15	90929964-90935196	"Enzymes, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA040895	Approved		Approved	Nucleoplasm,Cytosol		No	No			"Nucleoplasm, Cytosol"		"HPA040895: AB_10795494"	"unprognostic (1.03e-1)"	"unprognostic (3.78e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.29e-2)"	"unprognostic (1.10e-1)"	"unprognostic (3.75e-2)"	"unprognostic (2.53e-1)"	"unprognostic (3.57e-1)"	"unprognostic (1.28e-1)"	"unprognostic (5.93e-3)"	"unprognostic (1.08e-1)"	"unprognostic (1.91e-2)"	"unprognostic (3.43e-2)"	"unprognostic (2.26e-1)"	"unprognostic (4.86e-2)"	"unprognostic (3.15e-1)"	"unprognostic (4.65e-1)"	14.3	18.8	16.3	8.9	17.1	10.7	11.3	10.3	17.6	8.2	13.1	9.3	12.6	12.4	5.4	12.8	7.7	12.7	7.1	15.2	12.9	12.3	14.7	18.3	7.8	9.0	14.6	12.5	10.3	30.3	15.1	10.4	10.4	11.0	8.7	11.1	9.7	24.8	14.0	14.2	9.3	17.1	6.1	11.4	13.1	11.2	4.5	8.2	11.8	12.0	10.1	10.7	7.5	7.5	19.9	25.3	5.6	15.6	16.4	21.5	14.3	6.7	8.3	2.9	3.5	6.7	6.8	4.9	4.5	6.2	4.3	6.3	4.1	14.0	12.7	4.8	3.8	3.4	10.5	6.1	10.6	3.6	16.1	12.9	16.0	3.2	9.3	13.7	6.1	7.9	5.9	16.8	7.8	14.0	6.8	9.4	10.6	12.7	11.5	3.8	9.8	8.3	5.3	2.4	25.5	8.5	7.0	1.1	20.3	8.8	7.1	7.4	4.7	3.8	10.7	11.4	6.4	16.2	16.5	5.3	2.7	5.9	4.4	5.8	18.8	21.1	8.8	9.8	12.0	7.9	5.6	11.8	4.7	14.0	15.6	18.4	19.9	18.4	16.2	15.9	17.5	21.5	15.7	2.8	16.4	14.2	25.3	17.4	14.3	16.3	17.1	10.3	17.6	12.9	12.3	14.6	12.5	11.0	8.2	26.8	6.1	27.0	11.4	4.9	12.4	0.8	43.3	20.1	19.4	15.7	3.9	39.0	64.6	34.0	3.9	14.7	23.8	23.3	49.1	27.5	8.7	13.1	6.9	33.8	39.5	14.3	19.1	15.4	12.9	2.4	13.3	18.0	13.5	48.7	31.2	29.5	27.9	30.6	11.0	53.5	35.3	6.5	7.3	16.3	14.0	7.3	20.3	17.5	34.4	10.3
HECTD1	KIAA1131	ENSG00000092148	"HECT domain E3 ubiquitin protein ligase 1"	Q9ULT8	14	31100112-31207804	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	5	"Urothelial cells: 267.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002929, HPA054461"	Approved		Enhanced	Nucleoplasm,Nucleoli		NA	NA			"Nucleoplasm, Nucleoli"		"HPA002929: AB_1850574, HPA054461: AB_2682496"	"unprognostic (6.71e-2)"	"unprognostic (4.86e-2)"	"unprognostic (5.31e-2)"	"unprognostic (1.25e-1)"	"unprognostic (1.64e-1)"	"unprognostic (6.99e-2)"	"unprognostic (1.32e-1)"	"unprognostic (7.03e-2)"	"unprognostic (2.29e-2)"	"unprognostic (3.13e-2)"	"unprognostic (3.60e-3)"	"unprognostic (1.51e-1)"	"prognostic favorable (1.20e-6)"	"unprognostic (6.53e-2)"	"unprognostic (1.22e-1)"	"unprognostic (1.07e-1)"	"unprognostic (9.91e-3)"	22.0	22.3	14.2	21.0	16.8	22.0	18.5	22.3	18.9	19.4	17.9	15.2	20.2	11.5	17.6	15.7	30.4	16.1	15.2	26.2	13.5	14.3	18.0	35.2	15.0	14.1	14.5	14.5	18.2	15.1	34.8	20.5	27.0	18.8	16.8	15.5	16.8	18.9	16.4	88.5	24.3	16.3	15.6	13.7	16.4	18.8	18.9	14.4	16.7	24.8	23.0	18.6	18.6	22.3	10.6	9.3	12.6	8.6	8.9	8.1	3.3	28.8	18.1	15.9	9.9	50.4	26.4	15.2	17.7	17.9	15.8	13.7	13.5	15.7	22.7	18.8	32.3	11.3	19.6	21.2	16.0	24.1	13.9	8.7	23.2	14.9	54.0	23.5	24.1	17.0	23.2	22.1	17.8	28.0	22.0	29.1	13.5	16.6	10.5	24.6	23.7	9.3	10.3	12.1	25.3	16.5	17.3	18.4	9.9	24.7	30.0	11.8	13.9	25.9	18.0	15.7	20.2	18.9	15.6	29.1	18.4	14.4	13.2	15.0	11.5	16.4	25.6	8.7	12.2	15.5	12.6	8.6	11.3	7.1	7.1	8.1	7.2	8.0	6.3	9.3	10.6	6.7	6.6	4.4	8.9	5.3	7.8	8.0	3.3	14.2	16.8	22.3	18.9	13.5	14.3	14.5	14.5	18.8	14.4	44.7	63.3	37.1	68.0	76.9	78.2	103.0	22.9	155.2	84.2	68.0	92.3	53.4	10.0	37.6	2.9	56.2	38.8	23.3	31.4	36.2	49.1	82.9	31.3	79.7	25.8	62.0	46.8	39.9	39.7	6.7	63.9	34.4	32.1	29.7	30.4	36.8	41.9	28.1	70.0	20.0	175.8	45.3	41.2	53.4	107.2	100.5	117.1	37.4	37.3	267.3
HECTD2	FLJ37306	ENSG00000165338	"HECT domain E3 ubiquitin protein ligase 2"	Q5U5R9	10	91409280-91514829	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Cone photoreceptor cells: 25.5;Horizontal cells: 27.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	7	"NK-cell: 6.7"	"Lineage enriched"	"Detected in many"	7	"NK-cells: 6.7"	"Cell line enhanced"	"Detected in many"		"AF22: 21.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA037767	Approved		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA037767: AB_10671378"	"unprognostic (6.35e-2)"	"unprognostic (1.33e-1)"	"unprognostic (3.26e-2)"	"unprognostic (3.34e-1)"	"unprognostic (6.65e-3)"	"unprognostic (1.10e-2)"	"unprognostic (9.37e-4)"	"unprognostic (1.42e-1)"	"unprognostic (1.59e-1)"	"unprognostic (2.31e-1)"	"unprognostic (2.54e-3)"	"unprognostic (4.44e-2)"	"prognostic unfavorable (1.67e-5)"	"unprognostic (6.98e-3)"	"unprognostic (1.39e-1)"	"unprognostic (1.93e-1)"	"unprognostic (5.84e-2)"	8.7	8.8	16.5	6.9	17.9	2.4	10.8	20.3	19.5	14.3	10.1	5.1	9.1	4.6	17.2	16.6	8.3	12.1	11.4	8.1	11.9	8.7	7.3	4.7	8.7	4.7	5.8	11.3	16.8	7.4	14.4	18.6	10.2	6.5	24.8	7.6	7.5	7.7	24.3	7.7	6.8	6.0	18.4	6.8	5.3	7.5	9.7	6.4	2.9	9.8	5.1	3.6	13.7	10.5	0.6	0.4	0.1	0.8	6.7	1.0	0.5	4.1	2.1	21.4	8.8	4.7	5.2	3.8	3.4	4.5	6.9	6.3	0.2	3.9	0.0	2.9	3.4	4.0	0.3	5.8	2.4	8.5	4.4	7.2	2.4	15.0	1.3	2.4	0.4	1.6	5.3	2.2	5.0	4.3	9.7	5.1	5.1	3.1	10.7	10.6	1.9	2.5	1.3	8.9	0.4	2.1	6.4	14.1	2.4	4.8	1.2	5.0	5.4	6.6	1.5	6.7	6.9	9.7	1.4	5.4	6.9	4.8	0.5	6.3	0.7	1.4	5.9	6.1	0.0	4.0	0.0	0.1	0.0	1.0	0.8	0.6	0.2	0.5	0.7	0.4	0.6	0.5	0.6	0.1	6.7	0.2	0.0	0.1	0.5	16.5	17.9	20.3	19.5	11.9	8.7	5.8	11.3	6.5	6.4	0.0	3.2	0.0	7.0	5.5	21.3	6.5	5.1	5.3	5.7	5.2	25.5	0.3	18.3	2.4	1.5	8.3	0.7	0.0	3.0	0.3	11.3	4.2	3.5	0.8	5.3	27.0	8.6	9.2	7.0	1.5	11.2	3.8	6.8	3.6	3.0	12.0	2.5	0.6	13.4	1.3	8.2	12.9	7.6	6.7	8.1	3.9	0.3	1.5	1.3	3.0
HECTD3	FLJ21156	ENSG00000126107	"HECT domain E3 ubiquitin protein ligase 3"	Q5T447	1	45002540-45011329	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Enterocytes: 34.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA027467	Approved					NA	NA		34000			"HPA027467: AB_10600710"	"unprognostic (1.86e-1)"	"unprognostic (1.19e-2)"	"unprognostic (2.39e-1)"	"unprognostic (1.58e-1)"	"unprognostic (1.18e-1)"	"unprognostic (2.05e-1)"	"prognostic unfavorable (2.14e-5)"	"unprognostic (1.74e-2)"	"unprognostic (2.92e-2)"	"unprognostic (7.42e-2)"	"unprognostic (2.47e-1)"	"unprognostic (8.39e-2)"	"unprognostic (2.65e-1)"	"unprognostic (7.52e-2)"	"unprognostic (3.35e-1)"	"prognostic favorable (1.85e-6)"	"unprognostic (3.19e-1)"	18.4	16.9	9.6	16.7	11.1	9.2	25.9	12.4	14.8	11.2	38.0	14.8	11.7	34.1	12.4	12.4	16.7	9.1	14.6	8.7	9.9	8.4	16.4	22.9	10.5	11.3	10.9	7.9	14.1	24.1	22.9	8.0	11.8	10.8	10.4	19.5	9.7	27.0	15.4	24.2	20.1	59.3	12.0	9.9	14.0	13.9	11.7	9.7	11.9	13.3	14.8	12.5	13.8	12.0	8.7	9.9	10.4	15.1	5.0	10.9	7.5	11.1	10.1	6.5	10.5	22.9	14.4	12.9	10.7	16.2	11.8	13.4	14.4	3.5	5.2	9.1	17.5	26.5	10.5	15.4	11.1	10.6	9.8	11.9	8.4	14.7	12.6	20.1	6.5	14.2	15.5	19.1	20.1	7.9	12.3	26.3	9.2	18.8	5.9	15.0	9.5	8.2	5.3	8.9	12.6	15.5	9.9	11.8	7.5	17.3	13.2	15.7	6.5	14.4	25.0	12.7	17.2	8.1	6.1	19.6	13.7	11.0	16.9	12.1	7.6	8.9	2.9	21.9	7.1	6.7	9.4	10.4	10.4	10.9	15.1	9.1	8.7	8.9	9.3	9.9	5.1	7.5	8.9	4.0	5.0	8.2	7.5	9.0	7.5	9.6	11.1	12.4	14.8	9.9	8.4	10.9	7.9	10.8	9.7	3.0	8.0	3.0	2.3	3.4	5.3	5.5	7.6	0.0	6.8	5.2	5.9	6.1	1.7	8.5	1.0	4.6	34.5	23.3	13.5	12.8	6.0	2.1	5.8	10.5	12.1	6.4	2.4	5.5	16.5	1.3	13.6	5.4	3.3	8.2	13.7	3.9	11.3	23.0	9.2	5.5	5.9	6.5	4.1	4.5	7.7	5.4	5.0	5.0	11.5	2.0
HECW1	"KIAA0322, NEDL1"	ENSG00000002746	"HECT, C2 and WW domain containing E3 ubiquitin protein ligase 1"	Q76N89	7	43112599-43566001	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 24.0;kidney: 15.4"	"Group enriched"	"Detected in some"	4	"Early spermatids: 118.3;Horizontal cells: 42.9;Late spermatids: 44.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"neutrophil: 7.0"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"A549: 5.5;GAMG: 4.9;U-266/70: 15.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007203, HPA007593, HPA007609"	Approved		Supported	Cytosol		NA	NA			Cytosol		"HPA007203: AB_2667776, HPA007593: AB_1852305, HPA007609: AB_2117518"	"unprognostic (1.40e-1)"	"unprognostic (2.85e-3)"	"unprognostic (2.57e-1)"	"unprognostic (4.39e-1)"	"unprognostic (2.43e-2)"	"unprognostic (2.80e-2)"	"unprognostic (8.65e-4)"	"unprognostic (6.93e-2)"	"unprognostic (7.30e-2)"	"unprognostic (7.31e-2)"	"unprognostic (3.43e-2)"	"unprognostic (2.67e-2)"	"unprognostic (1.43e-3)"	"unprognostic (1.64e-2)"	"unprognostic (5.23e-3)"	"unprognostic (1.89e-2)"	"unprognostic (2.42e-2)"	0.7	0.5	10.3	0.8	12.1	1.4	0.8	13.6	24.0	0.6	0.8	1.1	0.0	0.4	0.8	1.7	2.6	0.5	4.0	0.4	3.9	4.1	15.4	0.6	0.6	1.3	3.8	15.5	1.0	0.4	1.7	0.4	0.6	10.2	3.2	0.5	0.6	1.0	0.8	1.8	2.1	0.6	0.7	1.4	0.6	1.0	3.7	1.6	0.0	1.5	0.0	0.8	1.2	0.6	2.4	1.6	7.0	1.7	1.6	0.7	0.1	0.1	5.5	0.6	0.8	0.0	0.0	0.0	1.6	2.8	0.1	0.7	0.0	0.0	0.2	3.1	2.7	4.9	0.4	0.0	0.0	0.2	0.2	0.9	0.0	0.4	0.2	0.2	1.3	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.2	0.1	3.0	0.0	0.0	0.0	0.0	2.4	0.1	0.9	0.5	0.0	0.0	0.0	0.1	0.2	0.7	0.5	0.1	0.0	0.3	0.4	0.0	0.0	0.8	1.1	1.3	0.4	15.7	0.5	0.0	3.5	0.4	0.0	6.4	1.7	1.1	0.7	1.0	0.5	1.0	0.7	0.3	0.2	2.4	0.6	0.7	7.0	1.6	0.9	1.6	0.2	0.1	10.3	12.1	13.6	24.0	3.9	4.1	3.8	15.5	10.2	1.6	0.0	0.0	0.0	0.3	0.3	13.6	1.2	0.0	0.0	0.0	0.0	3.9	0.0	0.0	0.0	118.3	0.3	2.0	0.0	0.0	0.1	0.8	0.5	0.0	0.0	0.0	42.9	0.0	0.6	0.0	44.2	0.3	0.4	0.0	0.0	0.0	0.5	0.0	0.6	0.4	15.9	1.8	0.0	0.8	2.1	2.5	0.3	0.0	0.5	0.4	0.3
HECW2	"KIAA1301, NEDL2"	ENSG00000138411	"HECT, C2 and WW domain containing E3 ubiquitin protein ligase 2"	Q9P2P5	2	196189099-196593692	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enriched"	"Detected in many"	7	"Ito cells: 134.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"neutrophil: 7.7;non-classical monocyte: 5.2"	"Group enriched"	"Detected in many"	9	"granulocytes: 7.7;monocytes: 5.2"	"Cell line enhanced"	"Detected in many"		"HDLM-2: 27.2;HUVEC TERT2: 15.3;SCLC-21H: 17.8;TIME: 20.1;U-138 MG: 12.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA034609	Enhanced					NA	NA					"HPA034609: AB_10669993"	"unprognostic (2.65e-2)"	"unprognostic (3.89e-1)"	"unprognostic (1.42e-1)"	"unprognostic (9.00e-3)"	"unprognostic (2.55e-1)"	"unprognostic (4.28e-2)"	"unprognostic (7.63e-3)"	"unprognostic (1.23e-1)"	"unprognostic (2.61e-2)"	"unprognostic (7.05e-2)"	"unprognostic (4.16e-2)"	"unprognostic (2.27e-1)"	"prognostic unfavorable (5.18e-5)"	"unprognostic (8.05e-3)"	"unprognostic (5.20e-2)"	"unprognostic (1.49e-1)"	"unprognostic (4.48e-2)"	8.8	3.3	6.7	2.6	12.6	0.6	4.2	15.7	17.2	4.6	1.2	11.6	0.0	1.1	3.0	1.0	5.5	6.3	4.8	14.0	6.7	4.3	3.4	5.6	16.4	3.5	8.2	9.3	1.3	2.1	14.7	5.9	15.5	9.5	1.5	1.3	1.2	2.2	1.3	2.7	2.7	1.7	3.1	5.8	11.6	2.1	5.8	8.8	0.0	7.9	1.6	4.2	2.4	2.5	0.6	0.7	7.7	5.2	0.0	0.1	0.1	0.0	0.8	1.2	0.0	0.7	2.4	0.9	1.5	4.0	1.2	1.5	0.1	0.0	0.7	0.3	7.3	1.9	1.7	0.5	0.1	2.5	27.2	0.9	0.0	1.1	0.1	0.1	0.2	0.2	0.6	0.7	9.1	3.2	2.3	15.3	0.0	0.1	0.0	3.7	1.0	0.0	0.3	1.4	0.1	0.6	0.0	0.3	0.0	0.0	0.0	17.8	1.4	1.1	0.2	0.0	0.2	0.0	0.1	20.1	12.3	0.8	2.6	0.3	0.1	0.0	0.7	3.1	0.0	0.1	0.2	0.5	1.3	0.0	1.9	0.0	0.5	0.1	0.0	0.7	0.6	0.1	0.0	7.7	0.0	5.2	0.0	0.1	0.1	6.7	12.6	15.7	17.2	6.7	4.3	8.2	9.3	9.5	8.8	0.0	8.9	2.7	0.2	1.9	7.8	14.2	0.0	1.4	0.0	0.0	0.0	0.1	0.0	0.0	9.7	18.0	0.0	0.0	0.0	0.2	1.0	0.1	1.1	1.5	0.1	0.0	2.4	134.4	11.6	3.6	0.0	1.1	3.3	1.0	0.0	12.5	0.1	0.0	2.5	0.0	0.9	0.0	2.1	0.5	6.4	1.4	0.1	1.9	0.0	0.4
HELB		ENSG00000127311	"DNA helicase B"	Q8NG08	12	66302545-66347645	"Enzymes, Predicted intracellular proteins"	"DNA damage, DNA repair"	"Helicase, Hydrolase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	5	"T-cells: 20.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA						"unprognostic (1.33e-1)"	"unprognostic (1.67e-1)"	"unprognostic (1.97e-1)"	"unprognostic (9.06e-3)"	"unprognostic (8.65e-2)"	"unprognostic (1.34e-2)"	"unprognostic (2.00e-1)"	"unprognostic (5.22e-2)"	"unprognostic (1.20e-1)"	"unprognostic (2.13e-1)"	"unprognostic (1.10e-1)"	"unprognostic (2.45e-1)"	"unprognostic (1.39e-6)"	"unprognostic (3.97e-3)"	"unprognostic (9.19e-4)"	"unprognostic (1.93e-1)"	"unprognostic (9.50e-3)"	3.4	2.1	1.6	12.2	3.9	6.8	2.9	1.3	3.1	2.6	2.7	2.1	1.4	2.3	2.9	2.1	2.7	1.6	2.0	1.8	1.9	1.8	2.7	3.7	4.6	9.9	2.9	0.5	3.0	1.6	2.1	11.9	1.8	4.5	3.1	2.8	0.6	2.9	1.2	1.8	2.8	4.5	1.6	4.7	6.8	3.5	1.8	3.1	11.0	2.8	0.8	8.2	2.6	3.7	1.1	0.9	4.7	0.8	1.6	3.0	0.6	1.3	2.9	1.7	2.0	0.6	1.7	2.3	0.9	0.4	0.9	1.0	2.1	2.2	2.0	2.3	0.7	1.1	1.8	1.4	1.2	1.1	4.2	2.2	5.2	2.5	2.1	1.2	3.9	2.6	1.6	0.5	1.4	1.7	1.3	1.1	4.6	2.0	6.3	1.1	2.1	1.4	6.6	3.2	1.3	1.0	1.6	2.4	4.1	1.4	1.1	1.5	1.8	2.3	2.5	1.4	3.1	0.9	5.6	1.2	1.2	2.3	1.8	1.7	5.9	2.3	1.1	1.7	3.4	2.2	4.7	0.8	2.2	1.6	0.5	2.2	0.5	2.2	2.0	0.3	1.1	3.0	2.2	2.1	1.6	0.4	0.9	1.9	0.6	1.6	3.9	1.3	3.1	1.9	1.8	2.9	0.5	4.5	3.1	0.0	6.9	11.0	2.3	0.6	3.0	3.4	0.0	5.3	11.4	0.0	11.8	2.5	1.7	1.2	0.2	4.5	4.3	0.0	1.0	1.8	2.8	6.5	2.3	2.4	2.7	12.7	4.6	4.9	7.8	0.4	3.1	4.3	3.3	2.8	4.9	2.8	1.7	3.5	0.7	2.4	6.9	0.0	2.1	0.7	1.0	1.5	2.1	20.3	4.9	2.0
HELQ	Hel308	ENSG00000163312	"Helicase, POLQ like"	Q8TDG4	4	83407343-83455856	"Enzymes, Predicted intracellular proteins"	"DNA damage, DNA repair"	"DNA-binding, Helicase, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036852, HPA036853"	Approved		Approved	"Nucleoplasm,Nuclear speckles"		NA	NA			"Nuclear speckles"	Nucleoplasm	"HPA036852: AB_2675349, HPA036853: AB_10672102"	"unprognostic (4.58e-2)"	"unprognostic (3.25e-2)"	"unprognostic (1.12e-2)"	"unprognostic (1.12e-1)"	"unprognostic (4.80e-2)"	"unprognostic (5.56e-2)"	"unprognostic (1.14e-1)"	"unprognostic (5.13e-3)"	"unprognostic (7.14e-2)"	"unprognostic (8.62e-2)"	"prognostic favorable (9.07e-4)"	"unprognostic (2.03e-1)"	"prognostic favorable (2.76e-4)"	"unprognostic (3.54e-2)"	"unprognostic (1.43e-1)"	"unprognostic (1.57e-1)"	"unprognostic (1.37e-1)"	10.5	20.8	6.3	12.2	7.8	7.2	10.4	12.6	9.2	10.7	9.8	9.3	8.2	5.6	9.9	8.7	8.2	9.1	9.0	10.5	6.2	5.7	11.9	10.0	8.0	15.3	6.8	5.7	17.4	8.1	13.3	20.7	11.7	9.0	11.4	7.2	11.0	10.0	10.4	14.6	8.7	9.8	8.0	8.4	14.4	8.4	10.7	7.4	18.5	14.3	8.3	13.4	10.2	9.2	10.1	4.6	6.8	4.7	5.5	9.7	2.9	4.3	3.3	7.1	4.6	8.7	9.2	3.7	6.5	9.8	8.5	8.4	3.1	4.5	12.2	5.2	5.6	5.8	4.4	8.6	4.8	8.9	7.0	3.8	7.3	5.4	4.2	5.6	8.8	18.0	7.1	6.5	6.7	7.0	7.5	6.7	8.2	9.6	10.7	8.6	5.1	8.0	6.3	3.6	6.9	2.4	6.2	8.2	4.3	7.0	2.7	5.8	4.8	6.3	6.9	7.1	7.1	4.3	9.5	5.1	6.4	5.6	8.2	5.1	9.9	4.2	10.3	5.4	6.7	7.1	5.4	3.7	6.8	5.7	4.0	5.4	5.8	6.3	6.4	4.6	10.1	9.7	8.7	2.3	5.5	4.7	4.5	7.8	2.9	6.3	7.8	12.6	9.2	6.2	5.7	6.8	5.7	9.0	7.4	3.0	9.4	10.0	8.0	3.8	9.2	9.2	7.6	22.7	7.9	5.2	7.9	9.6	10.0	5.1	20.9	7.1	3.5	0.0	4.8	8.1	6.4	4.9	7.0	4.0	9.1	6.4	0.0	10.4	5.6	5.8	12.0	8.4	6.8	7.2	4.5	9.1	4.7	6.0	7.4	8.8	13.2	0.0	8.2	20.0	12.8	3.3	9.6	13.1	5.2	4.7
HENMT1	"C1orf59, FLJ30525, HEN1"	ENSG00000162639	"HEN methyltransferase 1"	Q5T8I9	1	108648290-108661526	"Enzymes, Predicted intracellular proteins"	"RNA-mediated gene silencing"	"Methyltransferase, RNA-binding, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 28.8;testis: 45.2"	"Group enriched"	"Detected in many"	4	"Spermatocytes: 118.4;Spermatogonia: 74.4;T-cells: 38.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"JURKAT: 25.7;MOLT-4: 23.6;NB-4: 26.4;U-937: 34.8"	"Low region specificity"	"Detected in many"			"Region enriched"	"Detected in single"	15	"cerebellum: 18.1"	"HPA028464, HPA028497"	Uncertain		Approved	"Plasma membrane,Focal adhesion sites"		NA	NA			"Plasma membrane, Focal adhesion sites"		"HPA028464: AB_10600103, HPA028497: AB_10601552"	"unprognostic (1.82e-1)"	"prognostic favorable (2.56e-4)"	"prognostic favorable (9.95e-4)"	"unprognostic (2.92e-3)"	"unprognostic (1.91e-1)"	"unprognostic (3.88e-3)"	"unprognostic (2.01e-2)"	"unprognostic (1.49e-1)"	"unprognostic (7.01e-2)"	"unprognostic (1.25e-1)"	"unprognostic (2.95e-1)"	"unprognostic (1.19e-1)"	"prognostic unfavorable (2.48e-5)"	"unprognostic (2.53e-1)"	"unprognostic (2.43e-1)"	"unprognostic (2.18e-1)"	"unprognostic (1.65e-1)"	3.5	2.2	6.7	5.1	10.2	7.7	5.5	3.6	11.6	6.1	4.4	4.2	1.4	3.4	2.8	3.4	1.9	1.8	4.5	3.1	9.5	10.1	1.8	1.4	4.9	9.8	8.2	5.6	3.8	1.5	0.6	3.9	3.8	10.7	2.7	6.6	1.3	2.4	2.6	2.0	2.6	5.2	2.5	6.9	8.0	3.2	45.2	2.5	10.3	1.7	1.2	7.3	5.5	1.6	5.4	10.6	18.2	12.0	22.9	28.8	15.9	5.8	3.0	0.2	0.0	0.2	0.2	0.0	1.4	0.5	3.5	0.5	8.8	9.3	0.0	3.2	2.6	0.0	0.0	0.0	0.0	2.2	1.9	0.0	15.0	11.3	0.0	3.0	8.8	13.4	2.9	0.1	0.7	0.0	0.0	0.7	25.7	0.0	6.7	0.1	14.9	23.6	26.4	8.7	4.7	1.3	10.3	0.0	0.5	0.0	6.4	14.7	0.0	12.6	3.5	0.0	0.9	0.0	19.8	0.1	0.0	11.7	6.4	0.0	4.1	5.1	0.0	0.0	34.8	0.1	16.0	8.8	18.2	28.8	10.1	26.0	5.4	14.2	26.0	10.6	2.9	11.8	21.7	8.6	22.9	12.0	8.5	13.1	15.9	6.7	10.2	3.6	11.6	9.5	10.1	8.2	5.6	10.7	2.5	0.0	0.6	0.0	1.4	1.4	3.8	1.5	17.8	1.4	1.2	5.2	0.0	10.4	3.3	2.8	8.7	2.6	3.9	0.0	1.2	16.4	3.1	0.6	6.9	0.4	14.0	0.0	4.7	6.7	11.7	17.0	4.6	8.5	1.7	7.2	2.5	2.0	1.9	6.8	2.8	0.7	2.6	6.5	2.8	118.4	74.4	1.4	4.3	38.3	5.6	2.5
HERC1	"p532, p619"	ENSG00000103657	"HECT and RLD domain containing E3 ubiquitin protein ligase family member 1"	Q15751	15	63608618-63833942	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Transport, Ubl conjugation pathway"	"Guanine-nucleotide releasing factor, Transferase"	"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA049749	Uncertain					NA	NA					"HPA049749: AB_2680866"	"unprognostic (9.72e-2)"	"unprognostic (7.51e-2)"	"unprognostic (3.43e-1)"	"unprognostic (3.80e-1)"	"unprognostic (2.35e-1)"	"prognostic favorable (4.87e-5)"	"unprognostic (1.53e-1)"	"unprognostic (2.15e-2)"	"unprognostic (3.02e-2)"	"unprognostic (2.89e-3)"	"prognostic favorable (3.66e-4)"	"unprognostic (1.24e-1)"	"prognostic favorable (1.36e-6)"	"unprognostic (2.87e-1)"	"unprognostic (3.36e-2)"	"unprognostic (9.04e-3)"	"unprognostic (3.94e-1)"	14.4	11.7	20.3	12.9	23.5	28.9	15.5	30.4	29.7	17.4	15.3	14.7	13.8	7.0	15.8	8.9	10.3	10.7	12.1	17.6	19.4	14.3	11.9	11.4	14.9	15.2	12.8	23.7	23.8	11.5	44.8	20.1	12.7	19.1	11.4	11.8	11.0	11.4	14.0	31.7	14.6	13.9	15.7	11.7	17.4	13.5	13.5	15.8	16.6	17.2	11.3	15.3	12.9	11.6	9.8	7.0	17.6	5.7	2.8	6.6	1.4	7.5	9.9	11.1	3.8	19.7	12.7	3.7	6.0	7.7	6.2	7.2	6.1	3.0	11.3	5.5	11.2	5.7	8.3	17.9	5.1	8.5	8.7	6.1	24.5	14.1	4.4	3.2	18.1	14.7	9.0	5.0	8.7	8.6	5.4	13.0	7.7	24.6	5.0	5.3	12.3	6.3	3.6	5.5	5.8	5.1	6.9	12.3	6.6	2.5	18.7	10.0	5.0	10.6	7.2	6.3	14.0	3.6	7.2	14.5	8.1	7.5	6.9	7.8	5.6	9.5	7.9	4.6	13.5	2.8	17.6	3.7	7.4	5.0	3.3	3.8	5.3	5.5	4.4	3.2	9.8	5.6	5.6	12.9	2.8	5.7	7.0	6.6	1.4	20.3	23.5	30.4	29.7	19.4	14.3	12.8	23.7	19.1	15.8	6.0	36.1	26.8	9.3	13.3	57.2	57.0	7.6	18.7	20.5	21.0	62.8	7.2	1.7	8.7	18.5	26.3	11.5	0.0	12.2	9.1	17.5	12.6	48.6	17.9	15.0	81.0	9.8	51.5	39.1	12.5	25.6	22.8	18.6	23.4	12.8	25.1	10.8	13.6	37.4	13.2	54.8	6.5	17.8	45.5	28.9	13.4	7.4	34.8	12.0	9.3
HERC2	"D15F37S1, jdf2, p528"	ENSG00000128731	"HECT and RLD domain containing E3 ubiquitin protein ligase 2"	O95714	15	28111040-28322152	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"DNA damage, DNA repair, Ubl conjugation pathway"	Transferase	"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HEL: 33.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB017188, HPA048389, HPA074166"	Approved		Supported	"Plasma membrane,Cytosol"		NA	NA			Cytosol	"Plasma membrane"	"CAB017188: , HPA048389: AB_2680382, HPA074166: "	"unprognostic (1.59e-1)"	"unprognostic (1.44e-1)"	"unprognostic (1.92e-1)"	"unprognostic (6.64e-2)"	"unprognostic (6.62e-2)"	"unprognostic (5.74e-2)"	"unprognostic (9.17e-2)"	"unprognostic (2.08e-1)"	"unprognostic (1.87e-1)"	"unprognostic (4.11e-2)"	"unprognostic (9.40e-3)"	"unprognostic (3.60e-2)"	"prognostic favorable (1.41e-7)"	"unprognostic (7.66e-2)"	"unprognostic (2.10e-1)"	"unprognostic (2.34e-2)"	"unprognostic (1.71e-1)"	2.5	3.3	3.2	2.2	4.5	3.9	3.1	7.0	5.7	3.2	4.6			2.7	4.4	1.7	2.8	4.1	2.1	4.6	3.5	3.6	3.3	1.6	2.5	2.1	3.8		8.5	3.6	9.2	3.5	2.7		3.0	3.0		2.3	3.3	8.2	3.1	3.1	4.1	4.1	2.3	3.4	3.2			5.6		2.4	3.3	2.3	1.0	1.1	0.5	0.4	0.2	1.1	0.4	5.2	10.3	7.2	3.0	6.0	4.5	2.0	3.8	4.5	4.9	4.7	5.3	0.7	5.2	4.6	6.4	7.4	5.3	7.6	3.7	3.6	3.2	4.9	33.3	12.0	1.7	2.3	7.8	2.7	3.7	2.9	5.8	7.3	3.1	6.4	4.4	12.8	2.2	4.6	2.4	1.7	2.6	2.1	4.0	4.5	6.2	10.3	0.4	1.7	11.3	7.9	4.6	9.1	2.6	3.0	3.9	3.0	9.2	9.6	9.1	5.9	3.5	5.6	1.4	2.0	4.9	4.2	3.7	4.8	0.0	0.4	0.5	1.1	0.1	0.6	0.5	0.2	0.5	1.1	1.0	0.9	0.5	0.0	0.2	0.3	0.9	0.4	0.4											20.8	19.7	23.1	13.0	14.5	100.9	54.0	28.1	17.4	25.0	61.1	139.4	22.6	1.7	24.7	11.1	39.4	24.9	0.0	26.5	13.6	21.3	18.7	3.5	30.6	16.6	116.0	27.0	36.8	21.8	10.6	52.0	17.3	65.8	26.2	29.8	46.8	29.3	31.6	49.1	16.6	140.1	64.7	24.7	57.9	59.4	18.3	14.9	30.2	30.9	10.1
HERC3	KIAA0032	ENSG00000138641	"HECT and RLD domain containing E3 ubiquitin protein ligase 3"	Q15034	4	88592423-88708542	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	7	"Cone photoreceptor cells: 104.1;Rod photoreceptor cells: 59.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"fHDF/TERT166: 27.6;hTERT-HME1: 37.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039170	Approved		Approved	Cytosol		NA	NA			Cytosol		"HPA039170: AB_10673414"	"unprognostic (2.21e-2)"	"unprognostic (1.65e-2)"	"unprognostic (9.28e-3)"	"unprognostic (3.24e-1)"	"unprognostic (6.26e-2)"	"unprognostic (1.88e-2)"	"unprognostic (1.30e-2)"	"unprognostic (1.85e-2)"	"unprognostic (9.77e-2)"	"unprognostic (6.51e-3)"	"unprognostic (3.48e-3)"	"unprognostic (2.58e-2)"	"prognostic favorable (5.65e-7)"	"unprognostic (1.83e-1)"	"unprognostic (3.21e-2)"	"unprognostic (1.67e-1)"	"unprognostic (1.16e-2)"	12.7	13.3	16.9	13.0	27.1	21.0	15.3	37.8	20.1	14.4	12.0	17.9	11.6	11.2	12.0	10.5	16.8	10.7	12.1	22.0	15.2	13.7	15.8	13.0	15.0	15.3	21.9	15.0	12.7	9.7	33.8	16.1	10.0	21.1	22.0	13.4	22.0	14.0	14.0	17.3	19.1	12.8	13.8	16.3	15.7	12.9	3.6	21.5	16.6	15.7	12.6	16.4	13.3	16.7	5.2	7.0	18.2	9.7	3.1	9.0	3.9	7.3	1.1	1.4	2.4	7.9	16.7	4.7	8.3	15.4	8.7	5.8	1.9	8.6	7.8	4.0	27.6	4.0	2.6	2.0	7.6	8.3	3.4	2.3	5.4	3.3	1.2	4.5	13.4	9.8	7.9	9.4	8.3	37.6	4.9	9.6	4.1	3.9	3.4	17.7	2.2	9.2	3.2	0.4	4.8	2.0	10.4	9.7	3.2	5.6	1.4	1.9	1.9	9.6	6.1	3.2	2.4	1.0	6.0	15.0	9.9	5.4	9.3	6.2	6.5	1.6	4.5	6.2	6.1	4.1	5.7	5.7	7.7	4.7	6.2	5.5	5.2	5.5	4.7	7.0	4.9	8.2	5.8	18.2	3.1	9.7	2.4	9.0	3.9	16.9	27.1	37.8	20.1	15.2	13.7	21.9	15.0	21.1	21.5	6.0	5.8	8.8	7.9	31.9	24.1	18.5	7.6	4.0	2.3	8.7	104.1	5.8	1.7	3.6	2.6	9.3	9.2	23.3	7.9	13.2	7.3	12.5	15.1	11.0	8.3	30.2	26.5	8.6	27.9	2.7	7.8	17.3	13.5	2.8	10.1	9.2	7.4	8.6	12.4	5.0	59.1	6.5	11.3	3.0	7.0	44.4	6.2	13.1	5.2	10.4
HERC4	"DKFZP564G092, KIAA1593"	ENSG00000148634	"HECT and RLD domain containing E3 ubiquitin protein ligase 4"	Q5GLZ8	10	67921899-68075348	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Differentiation, Spermatogenesis, Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"BJ: 55.9;fHDF/TERT166: 62.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA045453, HPA070301"	Uncertain		Supported	"Nucleoli fibrillar center,Cytosol"		NA	NA			Cytosol	"Nucleoli fibrillar center"	"HPA045453: AB_10961917, HPA070301: AB_2686247"	"unprognostic (3.66e-2)"	"unprognostic (6.31e-2)"	"unprognostic (1.58e-1)"	"unprognostic (2.30e-1)"	"unprognostic (1.42e-1)"	"unprognostic (4.23e-2)"	"unprognostic (3.51e-2)"	"unprognostic (1.01e-3)"	"unprognostic (3.54e-1)"	"unprognostic (8.57e-2)"	"unprognostic (4.94e-3)"	"unprognostic (2.25e-2)"	"prognostic unfavorable (3.86e-5)"	"unprognostic (1.17e-1)"	"unprognostic (2.40e-1)"	"unprognostic (3.98e-1)"	"unprognostic (2.31e-2)"	25.3	29.4	21.9	28.0	28.4	14.6	22.7	30.5	24.9	24.2	20.5	22.2	26.7	20.0	28.1	24.3	22.2	19.2	20.2	20.5	21.9	22.7	20.6	24.5	20.6	30.2	30.9	14.8	24.5	17.1	25.2	35.6	23.8	26.8	19.4	23.9	17.8	17.7	24.1	19.6	20.9	25.8	23.0	28.7	27.0	17.3	22.2	33.6	23.6	19.5	13.8	28.3	24.7	47.9	7.7	10.4	13.5	9.3	9.9	11.5	6.5	22.8	8.2	5.1	8.6	13.4	18.4	4.6	55.9	34.6	21.0	13.6	4.6	10.8	8.0	4.4	62.8	13.1	12.1	5.7	8.3	28.4	5.2	2.8	3.7	13.5	3.5	7.1	4.5	6.6	9.0	9.7	11.2	10.0	26.4	13.0	4.5	3.9	4.1	32.3	9.8	3.2	5.3	3.0	5.3	14.3	4.3	2.1	2.8	9.5	6.5	2.5	2.8	18.2	7.8	7.9	11.1	4.8	5.7	17.7	11.1	6.2	27.2	9.6	2.8	3.3	5.1	20.3	8.7	3.8	13.5	9.3	11.1	8.2	7.9	11.5	7.7	9.1	9.8	10.4	7.5	8.8	9.0	11.7	9.9	7.6	2.7	10.6	6.5	21.9	28.4	30.5	24.9	21.9	22.7	30.9	14.8	26.8	33.6	44.7	27.7	32.0	24.8	44.8	51.3	21.2	12.7	17.4	15.9	17.4	41.2	23.4	6.6	17.2	55.0	28.7	37.8	0.0	10.6	35.6	22.1	32.9	30.0	21.3	20.3	50.9	21.2	31.3	32.9	34.9	24.7	27.8	16.9	16.2	25.6	23.2	28.7	31.6	18.0	18.2	45.2	6.5	25.8	22.4	10.2	53.2	13.0	27.3	17.7	45.1
HERC6	FLJ20637	ENSG00000138642	"HECT and RLD domain containing E3 ubiquitin protein ligase family member 6"	Q8IVU3	4	88378739-88443111	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"BJ hTERT+ SV40 Large T+: 47.0;BJ hTERT+ SV40 Large T+ RasG12V: 35.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA035846	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			Cytosol	Nucleoplasm	"HPA035846: AB_10673487"	"unprognostic (1.95e-2)"	"unprognostic (2.71e-1)"	"unprognostic (2.23e-2)"	"unprognostic (2.67e-2)"	"unprognostic (8.61e-2)"	"unprognostic (2.98e-2)"	"unprognostic (2.78e-2)"	"unprognostic (3.27e-1)"	"unprognostic (1.49e-1)"	"unprognostic (5.95e-2)"	"unprognostic (1.52e-2)"	"unprognostic (6.22e-2)"	"prognostic favorable (7.14e-5)"	"unprognostic (1.80e-1)"	"unprognostic (2.59e-1)"	"unprognostic (8.43e-3)"	"unprognostic (3.77e-2)"	8.0	7.5	7.8	7.2	10.2	7.3	6.3	2.1	14.6	13.6	6.3	5.9	3.4	5.4	13.2	9.6	23.9	10.4	11.2	9.8	7.7	8.4	10.4	5.0	8.3	4.6	7.3	15.8	9.8	6.3	5.2	8.4	7.1	8.5	9.1	6.5	7.2	28.4	5.7	2.9	4.3	7.1	8.5	5.6	8.0	7.3	3.9	5.3	9.0	5.9	7.6	7.8	7.2	13.8	3.6	2.7	4.5	6.4	5.6	13.4	4.2	2.6	1.7	0.1	0.3	0.1	1.6	0.5	0.3	8.8	47.0	35.0	0.1	3.3	0.0	0.6	0.8	7.6	1.0	4.3	2.2	3.1	5.3	0.9	2.4	1.5	0.2	1.5	4.3	1.7	2.1	0.5	3.6	0.1	2.8	1.3	2.0	0.0	0.6	1.0	1.5	2.0	1.3	0.6	2.3	0.9	1.3	0.0	0.1	3.2	3.2	0.1	1.1	3.2	1.1	5.2	2.4	1.9	0.8	0.4	0.6	0.9	0.1	0.8	0.1	0.0	0.0	2.1	1.0	2.1	4.4	3.1	4.5	6.7	3.1	13.4	3.6	9.4	6.5	2.7	2.7	7.5	5.1	1.9	5.6	6.4	0.3	11.8	4.2	7.8	10.2	2.1	14.6	7.7	8.4	7.3	15.8	8.5	5.3	11.9	8.8	2.4	4.4	2.5	11.4	10.6	5.1	16.0	10.3	5.2	15.7	4.9	0.0	6.6	0.9	8.4	5.2	0.0	15.0	1.3	3.7	8.2	5.7	2.1	4.3	1.6	1.7	4.3	3.7	1.3	4.0	2.2	5.0	4.6	2.9	4.3	9.1	3.1	5.3	3.6	1.0	6.5	2.0	0.5	1.1	1.0	2.1	7.7	1.7	6.2
HEXA		ENSG00000213614	"Hexosaminidase subunit alpha"	P06865	15	72340919-72376476	"Candidate cardiovascular disease genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		"Glycosidase, Hydrolase"	"Disease mutation, Gangliosidosis, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Hofbauer cells: 207.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"											"HPA018082, HPA054583"	Supported		Supported	Vesicles,Cytosol	"Intracellular and membrane"	NA	NA		20000000	Vesicles	Cytosol	"HPA018082: , HPA054583: AB_2682531"	"unprognostic (1.51e-2)"	"unprognostic (1.73e-2)"	"unprognostic (3.41e-1)"	"prognostic favorable (5.63e-8)"	"unprognostic (6.58e-2)"	"unprognostic (1.32e-2)"	"unprognostic (1.34e-2)"	"unprognostic (2.82e-2)"	"unprognostic (3.75e-1)"	"unprognostic (1.09e-1)"	"unprognostic (1.59e-2)"	"unprognostic (9.98e-2)"	"unprognostic (3.98e-1)"	"unprognostic (7.05e-3)"	"unprognostic (3.02e-2)"	"unprognostic (4.73e-2)"	"unprognostic (8.69e-2)"	30.1	37.4	23.1	18.0	22.9	35.5	37.8	23.3	28.1	30.6	20.5	19.4	30.1	18.5	25.9	65.7	11.7	21.8	29.2	33.8	23.4	12.8	34.6	29.5	43.9	31.4	24.9	21.1	20.9	22.2	18.1	22.9	37.9	18.8	18.1	26.0	26.9	24.8	22.0	17.7	17.9	24.6	23.4	21.4	31.5	22.6	18.0	22.9	12.1	31.2	11.1	16.4	26.7	17.1	16.1	37.9	22.4	32.7	17.8	18.1	21.3	7.5	12.8	5.5	10.6	45.5	51.9	7.9	10.6	53.8	23.0	36.8	6.7	55.4	6.3	10.2	21.3	12.0	15.1	14.6	6.7	14.6	5.1	5.8	7.9	12.7	11.6	35.2	18.9	22.7	44.1	20.2	10.0	17.9	42.2	21.0	9.4	12.2	39.2	30.6	6.5	4.1	9.5	3.1	24.7	0.1	4.2	12.0	14.2	25.7	11.9	4.8	5.3	26.5	25.1	59.9	11.7	4.6	23.9	10.6	34.5	14.4	31.7	11.2	20.9	28.2	6.5	12.5	25.3	16.7	8.9	32.7	22.4	18.1	13.7	15.8	16.1	12.0	15.8	37.9	15.6	9.5	14.0	3.1	17.8	4.8	14.4	10.7	21.3	23.1	22.9	23.3	28.1	23.4	12.8	24.9	21.1	18.8	22.9	59.6	55.5	41.1	30.3	19.7	40.2	22.6	35.7	17.4	28.4	62.8	100.1	116.3	51.4	65.3	16.3	43.0	46.2	0.0	33.3	55.3	62.5	30.5	29.9	37.8	207.1	25.4	45.3	44.2	76.0	10.5	68.7	108.5	89.4	50.5	39.4	48.4	43.8	84.5	42.1	55.5	56.1	45.3	20.6	20.4	28.2	13.7	131.8	47.5	44.4	25.0
HEXB		ENSG00000049860	"Hexosaminidase subunit beta"	P07686	5	74640023-74722647	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		"Glycosidase, Hydrolase"	"Disease mutation, Gangliosidosis, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"placenta: 174.3"	"Cell type enhanced"	"Detected in many"	6	"Cytotrophoblasts: 395.6;Hofbauer cells: 319.1;Syncytiotrophoblasts: 412.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"ASC diff: 108.4;GAMG: 90.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA055409, HPA056010"	Enhanced				"Intracellular and membrane"	NA	NA		43000000			"HPA055409: AB_2682808, HPA056010: AB_2683008"	"unprognostic (3.45e-1)"	"unprognostic (5.84e-2)"	"unprognostic (1.85e-2)"	"unprognostic (8.72e-2)"	"unprognostic (1.12e-2)"	"unprognostic (6.44e-3)"	"prognostic unfavorable (3.36e-8)"	"unprognostic (2.21e-1)"	"unprognostic (5.01e-2)"	"unprognostic (1.58e-3)"	"unprognostic (6.45e-2)"	"unprognostic (2.27e-1)"	"unprognostic (1.07e-1)"	"unprognostic (1.58e-1)"	"unprognostic (1.31e-2)"	"unprognostic (9.67e-2)"	"unprognostic (1.64e-2)"	48.0	21.9	7.7	13.6	11.6	11.1	26.1	7.4	11.2	25.8	34.2	9.5	18.0	21.6	22.1	77.3	20.6	17.3	28.1	46.3	7.1	9.1	30.4	44.5	40.9	19.3	8.5	6.7	22.7	30.4	21.8	14.3	174.3	9.3	22.6	26.3	21.0	34.6	13.3	21.0	15.3	33.6	21.0	8.7	20.5	20.7	16.2	6.1	10.8	33.7	15.2	15.4	24.0	19.7	8.9	59.8	23.8	65.9	7.6	16.4	42.9	20.3	16.0	5.6	18.5	108.4	33.5	18.2	25.0	81.1	24.4	53.0	18.8	26.6	0.0	19.8	20.5	90.2	16.4	6.0	25.4	32.3	11.4	10.8	2.6	15.5	14.1	31.8	2.2	22.0	29.5	15.0	25.6	17.2	38.5	27.9	6.4	7.5	33.3	26.7	20.6	2.6	5.1	5.2	19.3	7.2	6.2	8.1	26.5	16.8	18.6	3.6	4.5	19.4	13.2	24.1	10.1	13.9	15.1	16.6	16.1	4.0	29.6	23.0	15.4	26.5	0.1	36.7	20.0	29.2	14.5	65.9	18.6	14.2	24.5	16.4	8.9	11.7	13.1	59.8	5.5	11.2	10.9	23.8	7.6	14.6	18.0	13.7	42.9	7.7	11.6	7.4	11.2	7.1	9.1	8.5	6.7	9.3	6.1	38.7	35.5	39.5	70.4	39.0	9.5	18.9	63.7	20.1	18.2	27.9	7.9	395.6	16.6	123.0	1.1	60.6	71.9	0.0	111.0	143.1	100.1	65.8	69.2	62.8	319.1	9.5	21.9	83.4	134.6	1.7	78.9	151.2	69.2	83.8	50.0	34.8	68.2	51.8	67.8	65.5	10.6	45.3	54.5	0.2	1.1	28.4	412.8	37.3	76.2	54.8
HEXDC	FLJ23825	ENSG00000169660	"Hexosaminidase D"	Q8WVB3	17	82418318-82442645	"Enzymes, Predicted intracellular proteins"		"Glycosidase, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"pancreas: 72.9"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"plasmacytoid DC: 30.3"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA022834, HPA023379, HPA027844"	Uncertain		Approved	"Nucleoli fibrillar center,Mitochondria"		NA	NA			"Nucleoli fibrillar center, Mitochondria"		"HPA022834: AB_1850641, HPA023379: AB_1850643, HPA027844: AB_10600711"	"unprognostic (8.69e-3)"	"prognostic favorable (7.70e-4)"	"unprognostic (7.92e-2)"	"unprognostic (1.53e-1)"	"unprognostic (3.51e-2)"	"prognostic favorable (2.71e-4)"	"unprognostic (1.31e-1)"	"unprognostic (2.11e-2)"	"unprognostic (2.71e-1)"	"unprognostic (1.14e-2)"	"prognostic favorable (5.57e-4)"	"unprognostic (9.04e-3)"	"unprognostic (1.83e-1)"	"unprognostic (3.81e-2)"	"unprognostic (2.92e-1)"	"unprognostic (1.24e-1)"	"prognostic favorable (2.52e-5)"	12.7	8.5	7.1	16.6	9.3	14.3	8.7	13.2	7.3	10.1	7.6	8.8	12.8	8.0	10.0	11.1	7.9	10.3	9.4	5.7	7.2	4.6	9.9	11.6	12.4	11.6	12.8	5.5	13.6	72.9	10.2	14.6	5.7	7.4	14.1	4.2	7.0	13.3	9.2	20.4	11.3	12.3	6.0	6.1	15.6	8.8	4.7	11.4	8.6	11.7	8.6	10.7	8.3	8.8	5.9	30.3	3.3	11.5	11.9	9.8	4.4	3.0	7.7	3.4	5.3	10.4	9.0	10.5	3.9	4.8	4.1	4.7	2.7	10.4	8.1	4.3	1.6	2.8	4.3	2.0	2.3	1.9	5.6	13.1	3.6	6.8	4.5	9.3	2.4	9.3	6.4	2.3	1.1	4.2	5.6	5.3	6.2	4.6	2.8	1.1	7.0	8.4	9.0	3.1	5.6	4.7	10.0	2.9	15.8	3.1	4.6	4.8	10.2	8.1	5.3	7.3	1.6	8.5	9.2	5.3	2.7	5.1	2.0	2.7	12.7	2.4	6.0	2.1	6.9	2.7	3.3	1.7	2.7	9.8	11.5	6.5	4.6	2.2	3.4	2.0	5.9	3.5	5.1	3.0	11.9	4.9	30.3	1.4	4.4	7.1	9.3	13.2	7.3	7.2	4.6	12.8	5.5	7.4	11.4	3.0	8.5	8.3	9.5	4.1	19.2	4.4	12.7	9.4	12.5	17.4	17.7	4.7	8.3	5.4	1.2	8.0	16.8	0.0	8.2	5.3	6.2	10.5	10.3	12.9	13.7	39.7	13.3	16.0	9.5	2.1	33.1	11.5	5.0	16.2	14.4	18.7	5.8	10.1	23.3	6.1	29.0	19.4	6.2	6.0	10.2	2.0	3.3	12.9	12.0	7.5
HFM1	"FLJ36760, FLJ39011, MER3, SEC63D1"	ENSG00000162669	"HFM1, ATP dependent DNA helicase homolog"	A2PYH4	1	91260766-91404869	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	Meiosis	"Helicase, Hydrolase"	"Disease mutation, Premature ovarian failure"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 11.3;testis: 19.9"	"Cell type enhanced"	"Detected in some"	22	"Early spermatids: 10.1;Spermatocytes: 40.0;Spermatogonia: 7.8"	"Cancer enhanced"	"Detected in single"		"testis cancer: 0.9"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 9.3;AN3-CA: 4.9;K-562: 5.0;SCLC-21H: 3.1;SH-SY5Y: 3.8;U-266/70: 4.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA035036, HPA035557"			Supported	"Golgi apparatus,Vesicles"		NA	NA			"Golgi apparatus, Vesicles"		"HPA035036: AB_2797224, HPA035557: AB_10696507"	"unprognostic (1.35e-2)"	"unprognostic (9.39e-2)"	"unprognostic (1.17e-1)"	"unprognostic (2.83e-4)"	"unprognostic (2.05e-2)"	"unprognostic (1.52e-1)"	"unprognostic (7.43e-3)"	"unprognostic (1.79e-1)"	"unprognostic (7.75e-2)"	"unprognostic (7.97e-2)"	"unprognostic (1.76e-4)"	"unprognostic (2.81e-2)"	"unprognostic (1.06e-2)"	"unprognostic (2.89e-3)"	"unprognostic (2.78e-2)"	"unprognostic (1.77e-4)"	"unprognostic (9.59e-2)"	0.8	0.7	2.6	0.3	4.1	0.4	0.8	11.3	4.4	1.7	0.9	1.5	2.7	0.6	3.7	2.5	0.4	1.2	0.6	1.0	2.3	0.9	1.3	0.4	0.5	1.6	0.7	1.4	6.4	1.2	0.1	7.8	0.9	3.9	1.1	0.7	2.7	1.0	2.0	2.3	0.4	0.5	1.7	4.7	0.7	0.6	19.9	1.5	0.0	2.7	0.5	0.4	0.7	2.0	0.2	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.2	9.3	4.9	0.0	0.2	0.1	0.5	0.2	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.8	0.1	0.0	0.0	0.0	0.0	1.9	1.0	0.0	0.1	0.2	1.2	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.1	5.0	0.0	0.0	0.0	0.6	0.2	2.4	0.0	0.0	0.3	1.4	0.1	0.0	0.0	3.1	3.8	0.0	0.0	1.3	2.6	0.0	0.8	0.1	0.0	1.0	0.9	0.1	4.4	0.2	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	2.6	4.1	11.3	4.4	2.3	0.9	0.7	1.4	3.9	1.5	0.0	0.6	0.0	0.0	0.0	3.7	2.6	0.0	0.0	0.0	0.0	5.9	0.4	0.0	0.2	10.1	0.3	0.0	0.0	0.2	0.1	0.2	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	3.1	3.7	0.0	0.0	0.0	0.0	3.1	0.1	0.0	2.1	0.0	6.4	0.0	0.3	40.0	7.8	0.0	0.0	0.0	0.0	0.0
HGD	"AKU, HGO"	ENSG00000113924	"Homogentisate 1,2-dioxygenase"	Q93099	3	120628173-120682571	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Phenylalanine catabolism, Tyrosine catabolism"	"Dioxygenase, Oxidoreductase"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"liver: 176.7"	"Group enriched"	"Detected in many"	4	"Hepatocytes: 460.4;Proximal tubular cells: 326.4"	"Cancer enhanced"	"Detected in many"		"liver cancer: 119.8"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	6	"neutrophil: 2.8"	"Lineage enriched"	"Detected in single"	7	"granulocytes: 2.8"	"Cell line enhanced"	"Detected in some"		"EFO-21: 20.1;Hep G2: 38.7;OE19: 68.2;RPTEC TERT1: 50.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA047374, HPA052359"	Enhanced		Approved	"Golgi apparatus"		NA	NA		210000	"Golgi apparatus"		"HPA047374: AB_2680019, HPA052359: AB_2681798"	"unprognostic (1.36e-1)"	"unprognostic (9.89e-2)"	"unprognostic (3.93e-2)"	"prognostic favorable (1.78e-4)"	"unprognostic (1.56e-1)"	"unprognostic (2.05e-1)"	"unprognostic (5.65e-3)"	"unprognostic (7.20e-2)"	"unprognostic (6.05e-2)"	"unprognostic (2.41e-3)"	"unprognostic (2.68e-2)"	"unprognostic (1.16e-1)"	"unprognostic (4.29e-3)"	"unprognostic (8.57e-2)"	"unprognostic (1.78e-1)"	"unprognostic (3.71e-3)"	"unprognostic (1.43e-1)"	0.2	0.2	0.2	0.6	0.6	0.0	1.8	0.2	0.5	3.7	7.2	0.3	1.4	4.7	0.6	4.0	0.2	0.4	11.5	0.3	0.2	0.1	33.3	176.7	0.7	0.3	0.2	0.2	0.3	6.9	0.0	0.4	0.3	0.3	6.7	2.7	5.9	3.3	1.0	0.4	0.3	15.0	0.3	0.4	0.3	3.9	0.3	0.2	0.2	8.1	0.3	0.3	0.2	0.2	0.0	0.3	2.8	0.4	0.0	0.0	5.1	0.0	2.5	1.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	11.3	2.6	0.0	20.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	38.7	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	68.2	0.0	0.0	0.0	0.0	50.3	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.1	0.4	0.4	0.0	0.2	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	2.8	0.0	0.1	0.0	0.0	5.1	0.2	0.6	0.2	0.5	0.2	0.1	0.2	0.2	0.3	0.2	0.0	1.3	26.4	0.5	0.0	0.2	0.3	73.9	0.0	0.0	26.2	2.0	0.0	87.9	3.5	0.0	0.0	22.2	23.3	15.6	0.0	0.0	6.7	1.1	460.4	0.2	0.0	42.1	18.4	11.1	0.0	0.0	0.0	0.0	1.8	14.1	2.7	17.1	25.9	0.0	326.4	0.0	0.0	0.2	0.0	0.0	0.0	0.0	4.4	7.0	0.2
HGF	"DFNB39, F-TCF, HGFB, HPTA, SF"	ENSG00000019991	"Hepatocyte growth factor"	P14210	7	81699008-81770438	"Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted secreted proteins, RAS pathway related proteins"		"Growth factor, Serine protease homolog"	"Cancer-related genes, Deafness, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"placenta: 116.9"	"Cell type enhanced"	"Detected in many"	9	"Fibroblasts: 19.8;Ito cells: 40.5;Muller glia cells: 30.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in many"	4	"basophil: 33.5"	"Lineage enriched"	"Detected in many"	4	"granulocytes: 33.5"	"Cell line enhanced"	"Detected in some"		"ASC TERT1: 45.8;HHSteC: 35.8;HL-60: 20.1;hTEC/SVTERT24-B: 22.5;Karpas-707: 62.0;U-87 MG: 16.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"CAB010333, HPA040360, HPA044088"	Approved				"Secreted to blood"	NA	NA	4110000				"CAB010333: AB_647965, HPA040360: AB_2676939, HPA044088: AB_2678804"	"unprognostic (5.24e-2)"	"unprognostic (6.77e-2)"	"unprognostic (1.72e-2)"	"unprognostic (5.12e-2)"	"unprognostic (1.85e-2)"	"unprognostic (7.45e-5)"	"unprognostic (1.66e-1)"	"unprognostic (9.28e-3)"	"unprognostic (3.28e-2)"	"unprognostic (2.97e-2)"	"unprognostic (2.74e-1)"	"unprognostic (5.29e-2)"	"prognostic unfavorable (5.59e-4)"	"unprognostic (7.90e-3)"	"unprognostic (2.92e-2)"	"unprognostic (1.14e-2)"	"unprognostic (2.06e-2)"	6.2	10.6	1.4	2.9	1.2	4.6	4.8	0.5	4.5	5.1	4.0	0.4	2.9	1.5	5.2	3.1	2.9	4.0	7.1	9.3	3.6	1.3	7.3	27.5	15.8	2.0	1.3	1.4	3.2	1.4	1.6	4.3	116.9	1.9	10.8	1.9	2.0	2.2	3.2	1.4	0.9	1.8	15.1	6.0	6.6	2.3	2.0	0.9	0.5	5.3	1.4	1.4	10.5	21.5	0.0	2.0	33.5	7.6	0.0	0.0	1.5	0.0	0.0	0.0	0.0	5.7	45.8	0.0	0.1	8.5	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	35.8	20.1	0.1	10.8	0.0	22.5	0.0	0.0	0.5	0.0	0.0	62.0	0.1	0.0	0.0	13.9	0.0	0.0	0.0	0.2	0.0	1.8	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.8	0.1	0.5	0.0	0.0	0.0	0.0	0.0	0.0	16.4	4.2	0.0	33.5	6.6	1.6	0.0	7.6	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	1.3	0.0	6.7	0.4	0.0	1.5	1.4	1.2	0.5	4.5	3.6	1.3	1.3	1.4	1.9	0.9	0.0	5.5	0.0	0.3	0.9	0.1	0.8	2.5	0.0	1.2	0.0	0.0	4.6	0.0	0.0	11.8	6.3	0.0	0.0	0.0	3.2	19.8	0.2	1.1	0.5	17.6	0.0	0.0	40.5	14.3	1.7	17.0	5.5	1.7	3.6	0.0	30.6	0.0	0.0	10.3	0.0	0.3	12.9	13.8	0.0	0.1	0.1	10.1	0.0	0.0	0.1
HGFAC	"HGFA, HGFAP"	ENSG00000109758	"HGF activator"	Q04756	4	3441887-3449495	"Cancer-related genes, Enzymes, Plasma proteins, Predicted secreted proteins"		"Hydrolase, Protease, Serine protease"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	141	"liver: 128.0"	"Group enriched"	"Detected in some"	14	"Early spermatids: 70.8;Hepatocytes: 52.3;Late spermatids: 115.2"	"Cancer enriched"	"Detected in some"	22	"liver cancer: 26.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	8	"Hep G2: 10.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA058279, HPA059076"	Enhanced				"Secreted to blood"	NA	NA	7590000	11000000000			"HPA058279: AB_2683665, HPA059076: AB_2683898"	"unprognostic (2.70e-2)"	"unprognostic (8.20e-2)"	"unprognostic (1.57e-1)"	"unprognostic (1.86e-1)"	"unprognostic (1.36e-1)"	"unprognostic (1.39e-2)"	"unprognostic (2.85e-3)"	"unprognostic (5.37e-3)"	"unprognostic (5.90e-2)"	"unprognostic (1.81e-1)"	"unprognostic (8.54e-3)"	"unprognostic (5.52e-2)"	"prognostic unfavorable (9.31e-4)"	"unprognostic (2.87e-1)"	"unprognostic (2.24e-1)"	"unprognostic (9.49e-2)"	"unprognostic (3.74e-4)"	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.1	0.0	0.0	0.1	0.0	0.1	128.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.2	0.0	0.1	0.1	0.0	0.0	0.0	0.4	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.1	0.6	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	10.9	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.6	0.2	0.0	1.3	0.7	0.4	0.1	0.0	0.0	0.6	1.1	0.0	0.0	0.3	0.3	0.1	0.0	0.0	0.5	0.8	0.0	0.1	0.3	0.3	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.4	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.4	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	70.8	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	52.3	0.0	3.2	0.0	2.5	3.5	115.2	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	1.1	0.3	0.0	0.0	0.0	5.7	1.3	0.0	0.0	0.0	0.0	0.0
HGSNAT	"FLJ32731, HGNAT, TMEM76"	ENSG00000165102	"Heparan-alpha-glucosaminide N-acetyltransferase"	Q68CP4	8	43140455-43202855	"Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins, Transporters"		"Acyltransferase, Transferase"	"Disease mutation, Mucopolysaccharidosis, Retinitis pigmentosa"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"							HPA029578	Approved					NA	NA					"HPA029578: AB_10602423"	"unprognostic (5.35e-2)"	"unprognostic (4.61e-2)"	"unprognostic (4.31e-2)"	"unprognostic (1.36e-1)"	"prognostic unfavorable (5.46e-4)"	"unprognostic (3.94e-3)"	"unprognostic (1.10e-1)"	"unprognostic (6.54e-3)"	"unprognostic (5.02e-2)"	"prognostic favorable (6.33e-5)"	"unprognostic (2.55e-2)"	"unprognostic (5.48e-3)"	"unprognostic (2.03e-1)"	"unprognostic (1.27e-2)"	"unprognostic (1.55e-1)"	"unprognostic (1.72e-1)"	"unprognostic (3.45e-2)"	24.8	16.9	21.4	16.0	18.8	16.0	29.6	18.5	20.6	28.5	17.8	20.3	24.5	15.4	27.5	29.7	20.4	24.0	22.1	18.7	18.0	16.5	16.9	19.9	21.8	14.9	12.9	19.8	31.1	28.8	26.5	24.8	25.6	15.7	21.6	14.7	20.9	20.7	20.7	11.9	29.5	18.1	25.3	18.2	14.9	18.6	8.5	11.7	9.1	21.9	18.4	18.2	21.1	23.2	2.3	14.5	8.3	8.0	8.2	3.1	4.0	11.7	15.9	4.0	8.0	32.8	24.8	6.0	13.4	16.0	9.8	8.7	2.2	17.3	7.1	9.3	18.6	7.0	6.8	1.7	8.1	5.7	2.8	3.2	7.0	10.1	3.9	10.5	1.5	1.1	16.6	11.7	5.4	11.2	15.7	17.3	3.1	3.2	10.0	17.8	5.3	6.3	3.1	3.8	7.0	2.4	0.7	7.3	3.5	16.1	9.9	2.1	6.3	17.5	5.6	7.7	8.9	19.4	9.0	20.2	15.1	2.5	9.3	5.5	8.1	7.6	2.6	12.1	2.8	9.2	0.2	8.0	8.3	2.8	5.0	3.1	1.8	2.3	2.8	14.5	2.3	1.7	1.9	3.0	8.2	7.2	1.9	1.5	4.0	21.4	18.8	18.5	20.6	18.0	16.5	12.9	19.8	15.7	11.7	14.9	32.2	9.1	18.6	16.0	43.5	9.6	22.9	14.7	6.8	48.8	47.1	30.0	3.3	25.0	0.4	30.9	25.7	0.0	24.4	35.2	27.7	19.3	8.1	19.2	26.1	23.8	23.2	42.4	29.7	1.4	32.5	31.5	18.6	19.0	24.3	19.7	25.8	17.5	29.7	9.7	37.8	25.8	22.6	1.2	1.9	18.4	25.2	15.2	18.7	14.3
HIBADH	NS5ATP1	ENSG00000106049	"3-hydroxyisobutyrate dehydrogenase"	P31937	7	27525442-27662995	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Branched-chain amino acid catabolism"	Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	9	"Distal tubular cells: 460.9;Proximal tubular cells: 261.0;Syncytiotrophoblasts: 227.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019522, HPA021002"	Enhanced					NA	NA		780000			"HPA019522: AB_1850690, HPA021002: AB_1850692"	"unprognostic (6.76e-2)"	"unprognostic (1.09e-1)"	"unprognostic (7.50e-2)"	"unprognostic (9.79e-2)"	"unprognostic (1.72e-1)"	"unprognostic (2.28e-3)"	"unprognostic (7.22e-3)"	"unprognostic (3.14e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.06e-1)"	"unprognostic (1.73e-1)"	"unprognostic (2.05e-2)"	"prognostic favorable (5.56e-11)"	"unprognostic (2.49e-2)"	"unprognostic (5.47e-2)"	"unprognostic (3.38e-2)"	"unprognostic (3.39e-2)"	17.7	40.3	8.4	9.4	10.0	2.1	23.8	9.3	9.2	13.7	16.5	8.7	8.3	10.0	15.3	12.0	8.8	14.0	11.9	36.2	6.7	7.4	45.8	56.5	8.3	8.3	9.8	7.0	12.6	20.2	24.8	12.5	27.7	10.6	15.8	10.3	19.6	15.5	14.8	31.4	7.5	17.2	19.6	7.5	6.6	11.6	14.5	7.2	8.1	26.3	17.7	5.6	15.2	10.8	12.5	12.9	5.4	14.7	14.0	17.2	11.1	19.2	12.4	7.7	13.1	21.1	31.0	8.8	13.2	22.4	12.9	14.4	6.8	20.7	7.9	10.8	21.5	23.3	17.1	9.2	17.6	17.1	5.5	11.1	4.5	17.7	25.7	19.3	5.4	4.4	29.2	14.4	9.5	29.3	28.1	18.5	10.1	16.0	7.7	30.5	7.6	5.6	8.0	8.3	28.5	17.8	5.8	8.6	8.1	26.4	12.5	8.6	8.7	25.4	41.0	17.9	19.9	19.9	10.8	11.1	7.6	15.7	12.6	7.7	15.1	10.4	4.8	11.6	17.0	21.8	2.3	11.7	5.4	12.0	14.7	16.1	12.5	13.4	13.7	12.9	11.4	17.2	13.9	2.1	14.0	13.4	5.9	8.4	11.1	8.4	10.0	9.3	9.2	6.7	7.4	9.8	7.0	10.6	7.2	8.9	5.4	12.3	31.3	18.9	14.6	93.6	38.2	32.1	12.5	45.4	3.9	134.5	460.9	26.7	46.7	20.2	28.4	23.3	25.6	107.8	49.5	40.5	2.3	140.3	46.4	22.3	15.0	21.5	26.9	46.3	41.4	16.6	62.4	10.8	26.7	29.8	25.8	24.6	34.6	261.0	9.4	45.3	37.6	28.1	48.2	13.6	227.8	11.7	39.7	43.5
HIBCH		ENSG00000198130	"3-hydroxyisobutyryl-CoA hydrolase"	Q6NVY1	2	190189735-190344193	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Branched-chain amino acid catabolism"	Hydrolase	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Proximal tubular cells: 262.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036540, HPA036541, HPA067080"	Enhanced		Enhanced	Mitochondria		NA	NA		90000	Mitochondria		"HPA036540: AB_10673355, HPA036541: AB_2675182, HPA067080: "	"unprognostic (3.60e-3)"	"unprognostic (3.88e-2)"	"unprognostic (6.81e-2)"	"unprognostic (2.36e-3)"	"unprognostic (3.38e-1)"	"unprognostic (2.78e-3)"	"unprognostic (1.96e-1)"	"unprognostic (1.89e-1)"	"unprognostic (2.88e-1)"	"prognostic favorable (1.22e-4)"	"unprognostic (7.32e-2)"	"unprognostic (1.37e-2)"	"prognostic favorable (1.04e-10)"	"unprognostic (1.34e-1)"	"unprognostic (3.73e-1)"	"unprognostic (1.36e-1)"	"unprognostic (4.18e-3)"	13.7	38.6	18.1	10.1	19.5	5.0	15.8	16.4	18.7	16.3	15.8	14.5	13.0	24.7	17.0	13.0	20.2	10.2	10.0	13.7	18.5	12.7	65.7	56.8	7.6	8.2	20.1	10.8	9.5	29.5	35.8	24.7	7.8	21.0	11.7	18.7	15.0	10.6	12.2	17.5	23.7	16.5	11.3	18.2	9.0	10.4	10.6	22.2	10.5	17.4	15.4	9.3	12.5	49.2	24.2	15.1	14.6	7.6	17.3	20.0	7.3	9.8	7.6	16.3	10.3	15.4	13.6	9.0	10.7	5.7	10.1	11.0	23.5	8.7	15.0	15.3	9.2	7.2	18.9	17.2	14.7	15.3	21.5	13.4	20.0	15.9	20.5	5.2	14.2	7.4	11.0	7.9	11.8	2.1	14.8	16.3	14.3	24.2	13.1	11.0	9.1	14.5	16.4	5.1	13.4	15.5	18.0	11.7	38.0	22.8	29.9	12.4	11.7	9.2	13.2	30.2	24.8	14.9	11.1	11.5	10.7	10.0	7.2	7.5	8.4	17.8	12.5	9.7	12.4	8.4	12.9	6.7	14.6	11.9	7.6	12.8	24.2	13.3	12.5	11.1	18.7	14.2	18.2	3.5	17.3	5.7	15.1	20.0	7.3	18.1	19.5	16.4	18.7	18.5	12.7	20.1	10.8	21.0	22.2	20.8	19.6	31.1	98.9	49.7	35.7	23.4	40.8	28.1	28.4	34.9	96.2	40.5	97.8	21.8	145.2	29.2	35.8	0.0	25.6	16.9	26.6	30.4	10.3	97.2	29.6	23.8	36.2	76.7	17.4	44.8	32.2	15.7	43.9	14.4	25.9	37.9	16.2	17.3	42.8	262.7	51.0	38.8	26.4	17.5	27.2	35.5	16.7	21.3	53.3	81.2
HIF1AN	"DKFZp762F1811, FIH1, FLJ20615, FLJ22027"	ENSG00000166135	"Hypoxia inducible factor 1 alpha subunit inhibitor"	Q9NWT6	10	100529072-100559998	"Enzymes, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Dioxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA048742, HPA065302, CAB069903"	Supported		Supported	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"CAB069903: AB_10000508, HPA048742: AB_2680507, HPA065302: AB_2685458"	"unprognostic (4.07e-2)"	"unprognostic (7.75e-2)"	"unprognostic (2.35e-2)"	"unprognostic (3.83e-2)"	"unprognostic (1.67e-2)"	"unprognostic (1.21e-1)"	"unprognostic (8.07e-3)"	"unprognostic (8.82e-2)"	"unprognostic (2.54e-1)"	"unprognostic (1.41e-3)"	"unprognostic (1.54e-2)"	"unprognostic (3.05e-2)"	"unprognostic (3.01e-2)"	"unprognostic (3.09e-2)"	"unprognostic (9.92e-2)"	"unprognostic (1.41e-1)"	"unprognostic (3.24e-2)"	8.8	12.7	11.6	11.9	10.8	7.6	12.9	9.5	14.1	9.2	10.7	11.5	8.8	9.7	11.6	10.4	11.1	9.6	12.5	16.0	10.2	9.4	10.3	8.8	9.3	12.3	13.0	9.5	14.5	14.3	17.1	10.6	10.2	10.8	10.7	9.3	9.2	10.6	12.1	46.8	13.3	10.6	14.9	9.7	11.1	10.0	17.9	10.3	13.5	8.1	14.8	12.3	10.8	10.8	9.7	8.5	16.9	14.0	10.1	11.3	9.3	9.1	9.7	13.1	13.2	20.4	8.5	11.4	9.8	23.7	14.6	17.2	15.0	7.9	9.9	8.9	14.6	10.8	10.7	11.5	8.8	15.9	10.9	7.0	9.4	8.6	11.4	10.6	11.3	12.6	8.3	8.9	14.1	15.5	20.6	8.2	13.3	4.1	5.6	16.3	9.6	12.1	7.4	4.3	7.8	4.7	8.8	16.3	4.8	10.1	12.3	5.0	8.3	8.4	5.2	9.2	11.5	17.8	6.1	6.8	7.5	9.7	7.3	9.8	7.6	7.7	7.6	12.4	9.3	5.5	13.1	8.8	16.9	9.8	12.4	9.6	9.7	10.1	9.0	8.5	7.5	9.8	9.9	9.3	10.1	14.0	3.1	11.3	9.3	11.6	10.8	9.5	14.1	10.2	9.4	13.0	9.5	10.8	10.3	0.0	6.2	14.3	9.8	9.7	16.8	34.6	12.7	4.0	5.7	10.4	15.7	23.3	8.3	15.7	15.4	9.0	14.8	0.0	12.1	15.1	7.1	8.2	5.8	8.7	13.0	23.8	12.7	7.4	17.7	39.0	10.3	10.4	3.3	16.2	11.3	14.3	15.3	14.0	11.3	14.7	21.9	6.5	12.2	39.9	22.2	10.2	27.3	11.7	11.4	8.4
HIPK1	"KIAA0630, MGC26642, MGC33446, MGC33548, Myak, Nbak2"	ENSG00000163349	"Homeodomain interacting protein kinase 1"	Q86Z02	1	113929192-113977869	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Transcription, Transcription regulation"	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 90.1"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"MCF7: 62.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA016664	Approved		Supported	Nucleoplasm,Centrosome,Cytosol		NA	NA			"Nucleoplasm, Cytosol"	Centrosome	"HPA016664: AB_1850725"	"unprognostic (2.98e-1)"	"unprognostic (3.94e-2)"	"unprognostic (4.89e-3)"	"unprognostic (2.52e-2)"	"unprognostic (6.47e-2)"	"unprognostic (9.84e-3)"	"unprognostic (4.64e-3)"	"unprognostic (7.22e-2)"	"unprognostic (7.52e-2)"	"unprognostic (1.45e-2)"	"unprognostic (1.26e-1)"	"unprognostic (1.15e-1)"	"unprognostic (8.63e-2)"	"unprognostic (1.84e-1)"	"unprognostic (2.64e-1)"	"unprognostic (1.94e-2)"	"unprognostic (1.99e-2)"	15.1	16.8	21.2	14.7	23.0	90.1	13.6	38.1	20.4	20.4	14.4	20.7	14.5	10.2	15.5	14.2	18.7	27.3	17.5	27.9	22.9	17.2	14.8	13.8	19.3	14.7	15.0	16.4	18.7	16.8	20.7	23.8	13.8	21.3	14.4	15.2	20.7	13.0	14.9	19.7	18.5	13.4	15.1	18.3	15.9	14.8	33.5	21.3	47.2	23.3	13.1	15.5	17.3	26.7	2.3	6.2	9.8	4.2	4.3	6.0	2.3	8.2	6.7	9.3	7.1	10.9	5.7	6.3	5.7	6.9	8.1	7.8	7.7	3.2	11.1	7.8	9.0	3.0	5.6	12.0	6.6	11.8	8.0	6.0	16.1	8.4	8.1	9.1	12.8	20.0	6.2	9.7	10.4	10.6	7.7	12.0	19.7	11.0	12.0	11.6	62.4	16.8	7.3	9.5	6.2	6.0	10.2	27.3	3.9	7.3	7.1	4.1	5.5	10.4	11.2	7.3	10.8	6.5	18.5	11.6	8.0	10.8	13.0	8.6	7.5	5.8	9.6	9.0	10.4	18.2	3.4	4.2	8.2	5.5	3.7	5.2	1.7	4.9	4.9	3.1	2.3	5.0	6.0	9.8	4.3	2.6	6.2	3.6	2.3	21.2	23.0	38.1	20.4	22.9	17.2	15.0	16.4	21.3	21.3	50.6	37.0	12.9	14.8	54.6	47.6	27.1	22.9	64.3	20.5	26.2	66.8	9.7	5.0	12.5	82.7	29.3	18.8	70.0	18.3	7.9	25.0	26.7	45.1	33.6	19.9	69.9	35.7	23.9	54.6	73.8	20.4	35.5	20.3	15.4	24.2	28.9	17.0	17.3	35.0	13.4	60.3	25.8	37.0	35.4	26.0	70.4	11.9	47.3	22.4	23.0
HIPK2		ENSG00000064393	"Homeodomain interacting protein kinase 2"	Q9H2X6	7	139561570-139777778	"Enzymes, Plasma proteins, Predicted membrane proteins"	"Apoptosis, DNA damage, Transcription, Transcription regulation"	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 66.1"	"Cell type enhanced"	"Detected in many"	4	"Horizontal cells: 209.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	6	"basophil: 17.8"	"Lineage enriched"	"Detected in many"	6	"granulocytes: 17.8"	"Cell line enhanced"	"Detected in many"		"HDLM-2: 42.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA007611	Supported		Supported	Nucleoplasm		NA	NA			Nucleoplasm		"HPA007611: AB_1850730"	"unprognostic (1.35e-3)"	"unprognostic (1.49e-2)"	"unprognostic (1.65e-1)"	"unprognostic (7.65e-2)"	"unprognostic (5.50e-2)"	"unprognostic (9.44e-2)"	"unprognostic (2.76e-1)"	"unprognostic (4.66e-2)"	"unprognostic (1.44e-1)"	"unprognostic (2.76e-2)"	"unprognostic (3.42e-3)"	"unprognostic (4.58e-2)"	"prognostic favorable (9.99e-4)"	"unprognostic (1.38e-1)"	"unprognostic (7.82e-2)"	"unprognostic (3.93e-3)"	"unprognostic (1.03e-2)"	19.6	9.8	58.8	7.4	53.6	14.4	12.6	8.5	39.8	5.5	7.4	54.5	5.2	8.2	4.7	5.2	10.2	9.9	5.5	30.5	60.0	39.9	28.2	17.5	8.6	5.3	66.1	16.4	6.6	12.3	17.2	7.6	10.8	26.4	10.7	5.8	9.4	11.5	7.1	21.6	3.2	6.2	4.8	56.2	7.3	15.4	2.6	38.6	1.7	10.4	2.8	4.9	6.8	7.4	0.6	0.5	17.8	2.9	0.2	1.4	0.5	4.1	18.5	8.6	5.2	21.0	15.1	1.0	2.3	2.3	2.6	2.7	1.3	2.3	0.0	5.3	4.3	16.0	0.2	3.9	6.0	6.5	42.6	1.6	19.0	3.0	6.5	11.8	5.2	5.2	22.9	3.9	11.8	17.8	6.1	6.4	3.6	11.0	5.2	19.8	3.1	6.5	3.7	2.2	2.3	12.7	7.8	4.7	0.5	11.7	0.7	5.2	4.8	5.2	0.1	2.6	1.6	2.9	2.1	21.5	9.1	4.3	10.5	11.3	25.8	15.3	3.7	18.6	2.8	4.9	17.8	1.1	2.7	0.2	0.9	0.3	0.6	0.5	0.1	0.5	0.3	1.4	0.4	1.5	0.2	2.9	0.2	0.0	0.5	58.8	53.6	8.5	25.2	60.0	39.9	66.1	16.4	26.4	38.6	14.9	31.1	34.2	22.5	8.2	100.5	179.2	58.6	29.4	29.6	61.1	143.3	6.0	29.9	26.8	2.4	43.9	23.1	0.0	58.5	1.5	18.6	91.5	42.8	127.8	14.7	209.7	64.5	159.0	115.1	3.1	12.0	28.9	42.2	32.5	35.2	61.0	53.9	17.5	17.7	62.8	59.6	45.3	63.6	0.9	1.7	8.3	8.0	30.2	23.3	40.0
HIPK3	"DYRK6, FIST3, PKY, YAK1"	ENSG00000110422	"Homeodomain interacting protein kinase 3"	Q9H422	11	33256672-33357023	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Apoptosis, Transcription, Transcription regulation"	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Cardiomyocytes: 138.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA028069	Approved		Supported	"Nuclear bodies,Cytosol"		NA	NA			Cytosol	"Nuclear bodies"	"HPA028069: AB_10601815"	"unprognostic (2.41e-3)"	"unprognostic (1.02e-1)"	"unprognostic (4.61e-1)"	"unprognostic (5.74e-2)"	"unprognostic (2.09e-1)"	"unprognostic (1.78e-2)"	"unprognostic (1.63e-1)"	"unprognostic (7.29e-2)"	"unprognostic (1.61e-1)"	"unprognostic (2.78e-1)"	"unprognostic (2.18e-1)"	"unprognostic (2.68e-1)"	"unprognostic (3.29e-3)"	"unprognostic (7.89e-3)"	"unprognostic (1.80e-1)"	"unprognostic (1.87e-1)"	"unprognostic (2.48e-2)"	46.3	13.4	12.7	15.9	15.9	12.7	49.2	11.7	13.7	23.6	24.8	11.9	15.9	9.9	28.3	22.8	22.9	24.1	18.8	69.0	13.4	11.8	23.4	21.1	20.2	20.9	15.5	8.2	23.6	15.4	49.7	21.2	20.5	15.2	23.2	12.8	15.6	18.8	18.1	45.9	18.7	25.0	32.9	15.9	20.1	20.5	14.7	14.2	15.2	37.9	26.0	14.4	33.6	34.6	3.1	11.3	17.6	10.1	3.3	4.4	3.7	9.5	9.1	6.9	7.8	32.1	20.3	6.9	10.1	11.8	8.3	7.0	10.0	7.0	10.4	8.6	12.4	4.2	12.3	5.2	11.3	11.7	15.0	8.1	10.4	10.3	7.6	13.3	11.2	6.6	19.0	22.3	3.2	9.3	8.6	10.0	7.6	3.3	20.8	13.3	5.0	9.2	7.8	1.7	8.6	5.5	12.4	24.5	10.3	13.6	15.0	1.0	5.8	13.7	15.8	9.4	7.8	17.8	20.6	12.9	13.0	8.9	14.9	7.2	11.4	17.9	10.9	6.3	11.8	12.1	6.6	10.1	4.8	3.5	7.6	4.4	2.4	3.2	3.7	11.3	3.1	2.9	3.5	17.6	3.3	8.6	1.4	3.2	3.7	12.7	15.9	11.7	13.7	13.4	11.8	15.5	8.2	15.2	14.2	11.9	40.1	19.6	37.7	59.1	15.0	138.1	28.1	60.2	40.9	31.4	17.7	14.6	5.0	10.7	17.4	81.2	34.9	0.0	21.3	10.5	36.9	34.5	13.9	44.7	26.7	30.2	35.6	49.7	100.8	22.3	39.7	52.2	55.6	6.4	26.9	10.8	18.6	21.6	35.3	28.4	23.7	51.8	63.4	10.0	7.6	65.6	12.9	17.3	20.1	42.6
HIPK4	FLJ32818	ENSG00000160396	"Homeodomain interacting protein kinase 4"	Q8NE63	19	40379271-40390187	"Enzymes, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"testis: 34.7"	"Group enriched"	"Detected in some"	31	"Early spermatids: 64.9;Late spermatids: 23.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in single"		"NK-cell: 1.1"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"A549: 3.1;AN3-CA: 2.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"									NA	NA						"unprognostic (2.07e-2)"	"unprognostic (6.25e-2)"	"unprognostic (2.58e-2)"	"unprognostic (5.53e-3)"	"unprognostic (4.00e-2)"	"unprognostic (1.36e-1)"	"unprognostic (3.69e-2)"	"unprognostic (2.52e-3)"	"unprognostic (1.08e-1)"	"unprognostic (7.48e-3)"	"unprognostic (8.85e-2)"	"unprognostic (9.09e-2)"	"unprognostic (3.06e-2)"	"unprognostic (8.71e-3)"	"unprognostic (3.64e-2)"	"unprognostic (2.03e-2)"	"unprognostic (4.63e-2)"	0.3	0.1	2.3	0.3	7.4	0.2	0.3	1.2	5.7	0.3	0.3	0.3	0.3	0.2	0.4	0.3	0.5	0.2	0.3	0.8	2.9	0.3	0.3	0.3	0.3	0.3	0.3	0.3	0.3	0.3	0.1	0.3	0.3	0.3	0.3	0.1	0.3	0.4	0.3	1.4	0.2	0.3	0.3	0.3	0.3	0.1	34.7	0.3	0.3	0.3	0.3	0.3	0.3	0.3	0.0	0.7	0.0	0.4	1.1	0.3	0.1	0.1	3.1	0.2	2.4	0.2	0.3	0.0	0.7	1.1	0.8	0.4	0.0	0.0	0.0	0.2	0.6	0.0	0.0	0.2	0.0	0.1	0.4	0.3	0.0	0.1	0.0	0.0	0.0	0.3	0.5	1.2	0.3	0.3	0.2	0.1	0.4	0.3	0.0	0.2	0.7	0.1	0.1	0.1	0.1	0.4	0.1	0.3	0.3	0.0	0.4	0.0	0.3	0.4	0.1	0.0	0.0	0.4	0.1	0.6	1.3	1.3	1.1	0.0	0.8	0.6	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.7	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.1	2.3	7.4	1.2	3.5	2.9	0.3	0.3	0.3	0.3	0.3	0.0	0.0	0.0	0.2	0.5	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	64.9	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	23.0	1.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.7	0.0	0.0	0.0	0.2	0.5	0.6	0.3	0.0	0.0	0.0	0.1
HK1		ENSG00000156515	"Hexokinase 1"	P19367	10	69269984-69401884	"Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Glycolysis, Immunity, Inflammatory response, Innate immunity"	"Allosteric enzyme, Kinase, Transferase"	"Cancer-related genes, Charcot-Marie-Tooth disease, Disease mutation, Mental retardation, Neurodegeneration, Neuropathy, Retinitis pigmentosa"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"Early spermatids: 307.9;Horizontal cells: 287.6;Late spermatids: 870.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007043, HPA007044, CAB010052"	Supported		Supported	Mitochondria		NA	NA		16000000	Mitochondria		"CAB010052: AB_627721, HPA007043: AB_1850652, HPA007044: AB_1079049"	"unprognostic (8.80e-2)"	"unprognostic (1.78e-1)"	"unprognostic (2.03e-1)"	"unprognostic (2.00e-3)"	"unprognostic (1.15e-2)"	"prognostic unfavorable (3.39e-6)"	"unprognostic (1.23e-1)"	"unprognostic (1.97e-1)"	"unprognostic (4.29e-2)"	"unprognostic (1.16e-1)"	"unprognostic (3.93e-3)"	"unprognostic (1.12e-1)"	"unprognostic (1.37e-3)"	"unprognostic (7.25e-2)"	"unprognostic (1.40e-2)"	"unprognostic (2.00e-3)"	"unprognostic (3.86e-2)"	17.5	10.5	21.1	19.9	30.4	23.5	15.8	40.0	48.6	16.6	16.9	10.1	7.6	6.3	13.5	9.4	44.8	15.2	12.6	61.6	19.8	23.3	10.8	4.4	17.2	14.3	19.8	31.3	9.0	4.6	12.5	14.7	22.6	31.3	25.5	15.4	21.2	21.5	26.8	62.1	30.7	8.6	25.6	9.7	13.3	20.3	28.9	10.6	18.9	33.6	32.6	23.0	25.8	23.1	11.4	25.5	17.8	39.3	8.9	23.0	29.6	17.7	10.1	13.6	12.9	15.2	11.4	8.6	17.7	46.6	23.7	25.7	2.9	2.0	1.3	14.0	29.7	17.2	15.6	12.7	39.6	22.7	11.8	9.9	44.2	10.8	0.2	17.3	0.8	33.5	17.2	23.1	33.9	75.8	29.8	24.6	6.6	73.7	9.3	32.4	29.5	5.1	2.2	20.8	9.1	45.1	7.8	8.3	0.1	16.4	21.0	13.9	16.4	20.2	39.4	11.7	20.1	21.5	2.9	25.2	35.5	16.2	19.5	24.7	11.3	7.4	3.1	46.0	23.3	10.2	17.8	27.3	13.4	14.0	39.3	23.0	11.4	16.2	15.8	25.5	6.8	14.5	11.5	6.6	8.9	39.3	2.9	17.8	29.6	21.1	30.4	40.0	48.6	19.8	23.3	19.8	31.3	31.3	10.6	23.8	29.6	15.8	44.3	42.8	67.3	110.0	7.6	32.1	31.8	26.2	51.1	51.0	11.6	26.4	307.9	34.4	10.3	23.3	26.9	78.8	26.0	25.9	22.0	0.8	45.7	287.6	18.0	25.8	31.3	870.1	14.1	40.6	35.4	24.4	21.8	29.7	36.4	11.5	17.3	0.7	85.2	19.4	42.8	4.3	4.4	45.2	99.4	25.4	12.6	42.9
HK2		ENSG00000159399	"Hexokinase 2"	P52789	2	74833981-74893359	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins"	Glycolysis	"Allosteric enzyme, Kinase, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	6	"Early spermatids: 87.9;Enterocytes: 116.3;Paneth cells: 86.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"eosinophil: 26.2"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"U-87 MG: 54.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA028587, HPA061711"	Enhanced		Supported	Vesicles,Centrosome,Mitochondria,Cytosol		NA	NA			"Mitochondria, Cytosol"	"Vesicles, Centrosome"	"HPA028587: AB_10602605, HPA061711: "	"unprognostic (1.28e-1)"	"unprognostic (1.52e-3)"	"unprognostic (3.02e-1)"	"unprognostic (3.63e-2)"	"unprognostic (1.69e-1)"	"unprognostic (7.21e-2)"	"prognostic unfavorable (3.65e-4)"	"unprognostic (2.85e-2)"	"unprognostic (2.57e-1)"	"unprognostic (2.17e-1)"	"unprognostic (4.43e-3)"	"unprognostic (2.24e-2)"	"prognostic unfavorable (1.37e-4)"	"unprognostic (1.20e-1)"	"unprognostic (1.17e-1)"	"unprognostic (1.42e-1)"	"unprognostic (7.67e-2)"	27.0	2.2	4.4	9.5	5.0	20.4	10.8	0.7	4.5	5.3	23.2	7.3	5.7	1.3	2.6	40.1	13.6	4.8	9.1	8.3	2.8	2.3	2.1	1.4	16.5	5.0	8.5	1.1	14.9	3.5	1.1	1.7	13.2	5.4	4.0	19.2	9.6	10.3	0.5	29.3	9.7	8.9	1.7	10.9	7.4	8.7	24.8	7.4	4.3	7.1	22.3	9.2	29.0	8.3	0.8	6.2	26.2	7.1	0.0	0.8	2.0	16.5	0.1	3.8	14.0	32.9	3.4	14.3	6.4	9.4	7.3	10.5	13.2	3.0	12.0	6.2	3.0	9.4	5.7	17.5	13.6	21.2	3.4	3.7	16.3	3.8	18.2	10.4	23.8	26.9	5.8	14.8	13.8	24.3	8.2	3.4	6.9	14.2	0.0	2.1	11.8	5.7	24.4	13.9	15.7	11.5	9.3	8.1	9.3	4.4	23.4	2.8	13.7	4.1	20.9	8.2	5.8	1.1	3.8	2.8	23.3	4.1	9.6	11.7	8.3	2.3	6.0	54.3	17.5	6.0	6.6	7.1	26.2	0.1	5.7	0.3	0.6	0.4	0.1	6.2	0.8	0.7	0.7	5.9	0.0	3.7	0.1	0.8	2.0	4.4	5.0	0.7	4.5	2.8	2.3	8.5	1.1	5.4	7.4	14.9	37.6	2.9	5.5	45.8	6.2	6.0	7.6	0.0	6.8	5.2	78.5	0.7	0.0	4.4	87.9	3.6	116.3	0.0	3.8	12.3	8.5	17.2	21.9	0.0	15.7	20.6	37.5	1.3	14.6	32.5	13.6	18.9	21.9	1.0	32.2	4.3	18.4	86.0	7.4	0.0	43.3	12.9	2.3	3.1	4.5	49.8	6.9	2.2	19.9	69.9
HK3		ENSG00000160883	"Hexokinase 3"	P52790	5	176880869-176899332	"Enzymes, Plasma proteins, Predicted intracellular proteins"	Glycolysis	"Allosteric enzyme, Kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 76.2;bone marrow: 55.0;lymphoid tissue: 40.6"	"Group enriched"	"Detected in some"	13	"Hofbauer cells: 32.3;Kupffer cells: 47.9;Macrophages: 21.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Cell type enhanced"	"Detected in many"		"basophil: 76.2"	"Group enriched"	"Detected in many"	11	"granulocytes: 76.2;monocytes: 31.4"	"Cell line enriched"	"Detected in some"	4	"U-937: 21.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA056743	Enhanced					NA	NA		1700000			"HPA056743: AB_2683222"	"unprognostic (4.22e-2)"	"unprognostic (4.07e-2)"	"unprognostic (1.23e-1)"	"unprognostic (8.63e-2)"	"unprognostic (2.02e-2)"	"unprognostic (1.39e-1)"	"unprognostic (8.69e-2)"	"unprognostic (2.11e-1)"	"unprognostic (5.37e-2)"	"unprognostic (1.39e-1)"	"unprognostic (1.96e-2)"	"unprognostic (3.82e-1)"	"prognostic unfavorable (3.84e-8)"	"unprognostic (7.02e-2)"	"unprognostic (6.01e-3)"	"unprognostic (1.46e-1)"	"unprognostic (5.42e-2)"	9.2	2.6	0.6	8.5	1.0	55.0	1.3	0.3	1.2	0.4	1.7	0.3	0.0	0.9	0.8	2.6	1.9	3.0	0.9	5.4	0.6	0.3	1.6	4.1	16.3	24.1	1.2	0.5	1.2	1.0	0.0	0.4	2.9	0.5	0.9	0.6	0.9	0.9	0.1	0.8	0.3	1.6	3.4	0.6	40.6	1.2	0.6	0.2	1.3	1.5	0.2	1.2	1.8	5.3	0.0	5.1	76.2	31.4	0.0	0.0	6.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	4.8	0.1	0.3	0.0	0.0	0.0	0.0	3.8	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.0	21.3	0.0	76.2	15.4	32.9	0.0	29.5	0.0	0.0	0.0	0.0	5.1	0.0	0.0	0.0	5.4	0.0	31.4	0.2	0.0	6.0	0.6	1.0	0.3	1.2	0.6	0.3	1.2	0.5	0.5	0.2	0.0	1.4	0.9	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.1	0.2	32.3	0.0	0.0	0.6	47.9	0.0	0.0	21.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.2	0.1	0.1	0.2	0.0	0.0	0.0
HKDC1	"FLJ22761, FLJ37767"	ENSG00000156510	"Hexokinase domain containing 1"	Q2TB90	10	69220303-69267559	"Enzymes, Predicted intracellular proteins"	Glycolysis	"Kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"intestine: 77.4"	"Cell type enhanced"	"Detected in many"	25	"Cholangiocytes: 30.6;Ductal cells: 30.8;Enterocytes: 44.0;Muller glia cells: 172.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Cell type enhanced"	"Detected in some"		"naive CD4 T-cell: 8.3;T-reg: 6.6"	"Lineage enriched"	"Detected in single"	29	"T-cells: 8.3"	"Cell line enhanced"	"Detected in some"		"A549: 14.8;CACO-2: 21.1;CAPAN-2: 41.7;EFO-21: 12.9;GAMG: 17.4;Hep G2: 12.2;RPTEC TERT1: 31.2"	"Region enhanced"	"Detected in some"		"cerebral cortex: 12.2"	"Low region specificity"	"Detected in all"			"HPA064198, HPA064230"	Enhanced		Enhanced	Mitochondria		No	No			Mitochondria		"HPA064198: AB_2685210, HPA064230: AB_2685219"	"unprognostic (1.29e-2)"	"unprognostic (2.26e-2)"	"unprognostic (1.86e-1)"	"unprognostic (8.47e-2)"	"unprognostic (1.55e-1)"	"unprognostic (3.05e-1)"	"unprognostic (6.31e-3)"	"unprognostic (5.03e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.19e-1)"	"unprognostic (1.23e-3)"	"unprognostic (3.11e-1)"	"unprognostic (1.04e-3)"	"unprognostic (1.35e-1)"	"unprognostic (2.24e-1)"	"unprognostic (2.10e-3)"	"unprognostic (2.19e-1)"	0.2	0.0	0.9	1.2	1.6	0.0	0.2	0.8	1.4	0.5	29.8	0.5	0.2	29.9	0.5	1.0	0.3	2.5	11.2	0.2	0.5	0.6	15.6	4.6	1.3	0.3	0.3	0.2	1.0	4.7	0.0	0.5	0.2	0.4	0.2	2.3	12.0	0.2	0.2	0.2	0.0	77.4	0.2	0.2	0.2	0.4	0.6	0.2	0.2	5.2	0.2	0.2	0.2	0.2	0.0	0.0	0.0	0.0	0.2	8.3	1.6	0.4	14.8	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	21.1	41.7	0.0	12.9	0.1	17.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	12.2	1.0	0.0	0.0	0.0	0.1	0.1	1.2	0.2	0.0	4.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	4.3	0.5	0.0	0.4	0.0	31.2	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.1	0.6	0.1	0.2	0.0	0.0	0.0	3.1	0.0	0.2	0.0	0.0	0.0	0.9	0.0	0.7	0.0	4.4	1.4	0.0	0.0	8.3	3.2	0.0	0.2	0.0	0.0	6.6	1.6	0.9	1.6	0.8	0.4	0.5	0.6	0.3	0.2	0.4	0.2	3.0	3.7	0.8	0.0	0.0	1.0	0.8	30.6	0.0	0.0	15.7	0.0	0.0	1.7	30.8	0.4	0.0	44.0	0.0	6.3	0.0	0.0	0.0	0.0	0.0	0.1	3.2	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	1.5	172.8	19.9	7.0	0.0	9.5	4.0	0.0	0.3	0.0	0.2	0.0	0.0	0.0	1.2	0.1
HLCS	HCS	ENSG00000159267	"Holocarboxylase synthetase"	P50747	21	36750888-36990236	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		"Ligase, Multifunctional enzyme"	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA017379	Approved		Approved	Cytosol		NA	NA			Cytosol		"HPA017379: AB_1850768"	"prognostic unfavorable (7.72e-4)"	"unprognostic (2.41e-1)"	"unprognostic (3.93e-2)"	"unprognostic (2.05e-1)"	"unprognostic (2.75e-1)"	"unprognostic (1.44e-2)"	"unprognostic (5.08e-2)"	"unprognostic (2.67e-1)"	"unprognostic (1.54e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.31e-1)"	"unprognostic (7.44e-2)"	"unprognostic (2.43e-1)"	"unprognostic (2.55e-1)"	"unprognostic (2.67e-2)"	"unprognostic (1.85e-3)"	"unprognostic (3.02e-1)"	6.3	9.6	7.1	9.8	10.3	2.9	10.6	12.2	8.5	7.7	7.2	10.3	12.1	5.7	6.4	9.4	7.1	8.1	9.9	5.3	8.4	8.0	9.1	16.4	6.7	5.8	10.2	6.0	5.5	15.6	23.3	23.9	9.9	9.4	12.8	6.4	11.7	9.9	11.6	13.5	4.3	8.1	7.3	10.6	4.5	7.6	7.7	5.1	4.9	14.3	6.1	8.0	9.2	4.9	3.9	5.3	3.2	10.0	8.5	7.8	2.9	18.0	6.7	10.1	7.3	12.1	11.0	9.9	11.0	10.6	5.0	5.6	7.2	8.5	9.8	5.3	15.9	10.4	6.2	5.1	8.4	4.5	19.5	10.5	14.5	6.6	4.6	14.4	7.8	7.5	8.7	13.0	7.6	20.3	9.6	6.3	9.6	15.6	25.1	12.7	10.9	3.5	3.6	15.8	12.4	9.4	6.1	5.8	7.9	7.8	18.2	7.1	7.4	14.5	6.7	11.1	8.3	11.8	8.0	8.5	7.3	2.2	6.6	6.0	24.3	14.9	6.1	10.5	9.8	8.4	3.2	2.1	1.6	7.8	4.0	6.1	2.6	4.5	5.2	2.0	3.9	5.4	5.5	2.7	8.5	10.0	5.3	2.7	2.9	7.1	10.3	12.2	8.5	8.4	8.0	10.2	6.0	9.4	5.1	8.9	12.2	0.5	8.0	3.0	12.5	3.2	15.3	6.7	9.1	12.2	21.6	6.8	6.6	6.7	4.4	2.2	4.0	0.0	6.9	4.9	3.0	9.1	5.7	14.9	3.9	17.5	5.8	4.3	3.1	2.9	4.0	3.4	0.0	3.6	6.5	6.3	7.2	2.9	6.7	5.6	13.6	0.0	6.4	4.4	8.7	3.4	4.2	2.5	5.2	5.4
HLTF	"HIP116A, HLTF1, RNF80, SMARCA3, SNF2L3"	ENSG00000071794	"Helicase like transcription factor"	Q14527	3	149030127-149086554	"Enzymes, Predicted intracellular proteins"	"Transcription, Ubl conjugation pathway"	"Activator, Chromatin regulator, DNA-binding, Helicase, Hydrolase, Multifunctional enzyme, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Bipolar cells: 88.3;Spermatocytes: 110.2;Spermatogonia: 89.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA015284, HPA049001"	Uncertain		Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"HPA015284: AB_1857263, HPA049001: AB_2680594"	"unprognostic (3.21e-2)"	"unprognostic (3.46e-2)"	"unprognostic (6.81e-2)"	"unprognostic (1.95e-3)"	"unprognostic (4.29e-1)"	"unprognostic (1.29e-1)"	"prognostic unfavorable (7.27e-4)"	"unprognostic (3.01e-2)"	"unprognostic (2.13e-2)"	"unprognostic (2.27e-1)"	"unprognostic (4.78e-2)"	"unprognostic (9.00e-3)"	"unprognostic (1.39e-1)"	"unprognostic (2.94e-1)"	"unprognostic (3.42e-1)"	"unprognostic (2.83e-2)"	"unprognostic (1.07e-2)"	10.2	22.1	12.6	8.4	17.6	9.0	12.4	29.3	23.8	11.1	11.0	12.4	6.2	4.8	12.4	9.6	7.1	10.8	8.6	16.5	15.8	16.6	15.6	16.3	7.1	9.8	15.7	19.0	17.6	12.0	16.5	25.1	7.3	29.9	14.7	7.0	11.3	9.3	11.1	9.7	5.1	6.6	12.7	19.0	7.5	8.7	37.7	14.0	17.1	19.0	4.8	9.6	10.0	7.8	8.4	9.2	8.8	2.3	5.4	10.4	3.5	24.6	12.0	17.2	13.4	11.5	14.9	1.7	16.7	10.0	12.4	14.5	9.7	17.2	15.9	20.5	7.7	24.3	0.7	23.0	6.6	20.8	8.8	11.2	38.2	9.4	3.9	7.2	10.0	15.9	9.4	3.6	9.2	5.4	19.0	7.1	26.0	13.3	10.4	16.9	12.4	20.5	15.4	12.9	12.5	15.1	23.8	19.3	2.5	10.2	8.0	17.0	10.0	25.4	11.8	23.0	9.5	35.2	9.8	5.0	14.6	8.8	20.5	18.2	15.4	8.6	20.8	14.3	13.7	5.6	8.8	1.3	4.0	5.6	2.1	10.4	8.4	4.9	7.2	3.9	5.4	7.2	7.4	0.2	5.4	2.3	9.2	4.4	3.5	12.6	17.6	29.3	23.8	15.8	16.6	15.7	19.0	29.9	14.0	23.8	14.8	13.8	7.6	4.9	88.3	34.8	17.8	30.8	21.6	29.6	39.3	6.6	29.9	7.9	9.5	10.8	1.3	0.0	7.3	8.2	10.6	11.9	53.2	14.9	7.6	44.5	4.7	15.4	4.0	5.8	31.4	7.5	5.0	3.6	6.2	35.2	6.8	2.8	30.4	15.6	75.2	12.9	14.1	110.2	89.0	3.8	1.4	13.8	6.6	4.3
HM13	"dJ324O17.1, H13, IMP1, IMPAS, PSENL3, PSL3, SPP, SPPL1"	ENSG00000101294	"Histocompatibility minor 13"	Q8TCT9	20	31514428-31577923	"Enzymes, Plasma proteins, Predicted membrane proteins"		"Hydrolase, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	5	"Hofbauer cells: 292.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA045089, HPA056062"	Enhanced		Supported	"Endoplasmic reticulum"		NA	NA			"Endoplasmic reticulum"		"HPA045089: AB_10962054, HPA056062: AB_2683022"	"unprognostic (8.03e-2)"	"unprognostic (2.11e-2)"	"unprognostic (5.03e-2)"	"unprognostic (1.59e-1)"	"unprognostic (2.82e-1)"	"unprognostic (5.87e-3)"	"prognostic unfavorable (1.95e-5)"	"unprognostic (2.66e-2)"	"unprognostic (2.14e-2)"	"unprognostic (2.55e-1)"	"unprognostic (2.30e-1)"	"unprognostic (8.10e-2)"	"prognostic unfavorable (4.64e-12)"	"unprognostic (3.77e-2)"	"unprognostic (1.57e-1)"	"unprognostic (1.85e-1)"	"unprognostic (8.17e-2)"	25.2	34.3	9.2	20.1	11.1	19.8	36.4	10.2	17.5	37.9	17.0	13.2	64.7	18.1	23.3	40.7	39.2	21.4	24.1	17.9	9.3	13.0	30.2	121.3	25.5	38.7	10.8	9.8	20.8	132.3	24.4	28.6	45.9	14.5	22.4	16.3	15.4	149.6	84.3	13.1	15.0	17.8	17.9	11.0	22.0	25.3	11.7	9.0	15.5	33.5	21.5	30.5	18.1	21.4	16.7	48.2	50.1	65.3	19.4	29.8	52.6	24.8	26.3	10.6	15.6	48.3	31.1	36.5	42.6	39.9	29.1	30.0	52.1	29.9	16.1	57.4	46.4	38.5	45.5	14.9	28.6	19.1	8.1	20.1	35.5	19.1	31.2	53.8	20.2	14.3	28.4	18.7	24.6	33.7	29.4	22.5	10.6	15.6	63.9	27.0	29.4	17.3	14.6	12.2	40.8	45.0	11.0	49.9	74.9	28.1	13.3	13.9	16.9	43.5	42.0	34.4	11.0	32.6	19.3	27.3	44.3	23.6	44.6	23.9	41.3	24.5	12.7	60.4	72.9	39.1	18.4	65.3	31.8	21.7	64.0	29.8	16.7	20.5	20.9	46.0	12.6	13.8	16.2	50.1	19.4	58.6	48.2	18.1	52.6	9.2	11.1	10.2	17.5	9.3	13.0	10.8	9.8	14.5	9.0	47.6	55.6	31.3	46.0	29.8	39.1	11.5	58.6	38.8	43.3	50.6	115.8	131.4	11.6	140.0	12.3	43.8	63.3	23.3	146.7	111.1	86.5	75.1	40.5	74.0	292.9	41.3	59.0	58.3	73.4	10.6	56.1	83.9	62.4	38.7	63.2	49.7	138.8	42.7	41.1	44.1	38.7	32.3	39.1	21.7	29.0	30.9	178.6	56.7	51.9	55.3
HMBS	"PBGD, PORC, UPS"	ENSG00000256269	"Hydroxymethylbilane synthase"	P08397	11	119084866-119093549	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Heme biosynthesis, Porphyrin biosynthesis"	Transferase	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 75.2"	"Cell type enriched"	"Detected in many"	16	"Erythroid cells: 794.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006114, HPA050659"	Supported		Approved	"Lipid droplets"		NA	NA		28000000	"Lipid droplets"		"HPA006114: AB_1079067, HPA050659: AB_2681206"	"unprognostic (6.24e-2)"	"unprognostic (9.10e-3)"	"unprognostic (1.42e-2)"	"unprognostic (4.98e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.30e-1)"	"unprognostic (2.29e-3)"	"unprognostic (2.81e-1)"	"unprognostic (2.18e-1)"	"unprognostic (1.13e-2)"	"unprognostic (6.83e-2)"	"unprognostic (5.06e-2)"	"unprognostic (2.90e-3)"	"unprognostic (3.91e-3)"	"unprognostic (9.53e-2)"	"unprognostic (1.32e-1)"	"unprognostic (6.11e-2)"	5.5	11.0	5.3	6.2	9.3	75.2	8.6	5.2	8.0	5.5	8.3	6.0	6.0	7.9	6.9	7.9	9.4	5.5	6.4	11.5	5.9	5.5	9.9	22.2	5.8	14.5	8.8	4.5	3.7	21.2	7.9	5.9	9.7	8.4	5.5	9.2	4.1	10.1	7.2	17.4	6.0	7.9	6.8	9.7	10.4	7.1	7.4	7.5	6.0	8.4	13.0	9.3	5.7	4.8	7.7	19.1	12.0	14.0	3.8	7.4	9.4	9.2	14.1	6.8	12.0	5.4	6.8	10.2	7.4	8.3	10.9	9.4	17.5	14.7	14.3	16.6	9.4	10.3	13.2	10.1	14.4	7.0	9.8	10.4	23.6	5.7	12.8	10.1	8.8	7.7	7.4	9.2	17.2	13.2	4.8	5.0	13.5	34.9	6.4	8.6	37.2	8.5	17.0	7.6	17.1	9.0	9.9	6.7	14.0	11.0	8.5	7.5	10.2	5.9	9.3	6.5	5.1	15.9	12.2	4.7	8.3	6.3	8.1	8.6	3.5	4.1	8.5	5.5	11.6	9.8	12.0	14.0	1.4	5.1	12.2	6.7	7.7	4.8	5.7	19.1	7.2	7.4	5.6	0.4	3.8	7.3	12.3	4.9	9.4	5.3	9.3	5.2	8.0	5.9	5.5	8.8	4.5	8.4	7.5	8.9	7.0	9.3	7.6	7.0	4.7	12.6	7.6	10.7	4.5	10.4	25.5	50.1	16.6	18.3	1.2	4.9	8.5	794.3	27.0	50.5	8.4	10.8	2.3	20.2	25.6	9.5	12.7	6.7	10.8	1.8	5.5	10.1	13.5	15.4	15.5	5.7	19.8	8.6	8.1	18.1	24.3	0.0	8.2	1.1	24.4	7.0	19.5	4.1	27.6	5.9
HMGCL	HL	ENSG00000117305	"3-hydroxymethyl-3-methylglutaryl-CoA lyase"	P35914	1	23801885-23838620	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		Lyase	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 81.4"	"Cell type enhanced"	"Detected in many"	5	"Hepatocytes: 147.7;Proximal tubular cells: 159.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA004727	Enhanced				"Intracellular and membrane"	NA	NA		120000			"HPA004727: AB_1079074"	"unprognostic (8.24e-2)"	"unprognostic (3.21e-2)"	"prognostic favorable (7.67e-4)"	"unprognostic (1.23e-3)"	"unprognostic (5.47e-3)"	"unprognostic (1.26e-1)"	"unprognostic (2.04e-1)"	"unprognostic (3.85e-2)"	"unprognostic (1.08e-1)"	"unprognostic (2.24e-1)"	"unprognostic (3.05e-1)"	"unprognostic (8.24e-2)"	"prognostic favorable (5.07e-8)"	"unprognostic (1.72e-1)"	"unprognostic (2.46e-2)"	"unprognostic (8.60e-2)"	"unprognostic (3.39e-3)"	7.4	18.5	6.4	8.2	6.6	1.6	14.3	4.3	7.7	7.6	13.9	9.0	12.0	12.0	6.2	13.2	9.1	9.7	12.8	11.2	5.9	6.0	30.3	81.4	8.8	11.1	7.5	7.1	6.1	15.2	13.1	7.8	8.5	7.9	8.7	14.2	10.0	8.9	11.5	15.2	7.0	15.4	11.7	9.3	8.6	10.8	7.2	6.1	8.3	14.5	8.1	8.3	8.8	6.7	24.1	27.7	40.8	33.8	24.5	21.2	26.8	10.5	6.1	6.9	5.1	28.0	21.4	2.6	8.4	14.7	9.1	11.1	3.8	20.5	5.5	17.3	13.0	7.4	8.5	8.2	13.6	9.9	11.2	6.2	7.4	5.4	8.7	36.2	2.8	4.9	24.8	20.2	11.9	23.0	24.5	12.3	10.5	7.5	7.8	16.6	10.8	4.5	5.7	1.7	28.9	8.5	6.4	5.6	10.2	21.4	5.5	5.8	5.1	10.9	4.1	18.5	9.5	13.0	7.2	9.2	7.5	4.6	13.7	3.6	11.2	5.5	4.9	18.7	10.7	8.8	40.8	32.4	30.1	18.4	30.4	20.1	21.9	20.0	21.2	27.7	24.1	20.3	19.4	12.2	24.5	33.8	20.6	20.8	26.8	6.4	6.6	4.3	7.7	5.9	6.0	7.5	7.1	7.9	6.1	11.9	21.7	21.7	27.4	5.3	24.1	30.3	43.3	28.1	12.5	47.1	17.7	37.1	101.2	42.9	1.5	21.1	59.4	0.0	21.2	21.2	16.6	28.0	17.3	147.7	52.8	33.4	8.6	31.3	25.4	3.2	20.1	21.3	20.3	60.5	44.3	33.5	28.9	49.2	23.0	159.0	20.1	6.5	18.9	4.1	3.3	5.6	34.6	15.2	47.0	22.5
HMGCLL1	"bA418P12.1, DKFZP434G1411"	ENSG00000146151	"3-hydroxymethyl-3-methylglutaryl-CoA lyase like 1"	Q8TB92	6	55434369-55579214	"Enzymes, Predicted intracellular proteins"		Lyase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 18.4;pituitary gland: 14.8"	"Cell type enriched"	"Detected in some"	4	"Bipolar cells: 14.1"	"Low cancer specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	5	"SCLC-21H: 11.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA						"unprognostic (2.74e-3)"		"unprognostic (1.54e-2)"	"unprognostic (4.08e-3)"	"unprognostic (6.11e-2)"	"unprognostic (1.41e-1)"	"unprognostic (9.54e-3)"	"unprognostic (8.97e-3)"		"unprognostic (2.12e-2)"	"unprognostic (9.27e-3)"	"unprognostic (4.11e-2)"	"unprognostic (1.18e-4)"	"unprognostic (3.13e-3)"	"unprognostic (7.57e-2)"	"unprognostic (2.55e-1)"	"unprognostic (1.52e-1)"	2.2	7.7	7.7	0.9	14.5	0.5	3.4	10.1	18.4	2.2	1.7	3.1	0.3	0.8	0.8	0.6	2.5	1.5	1.8	4.1	8.7	12.6	2.2	1.8	5.7	1.1	9.1	10.0	1.3	3.6	0.8	14.8	12.5	14.6	7.0	2.2	4.8	2.1	2.9	2.4	0.6	2.4	1.6	10.1	0.6	2.9	5.5	3.3	0.0	0.9	0.0	1.0	2.7	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.7	0.3	0.0	0.0	0.0	2.3	0.9	0.0	0.0	0.0	0.6	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.7	14.5	10.1	12.6	8.7	12.6	9.1	10.0	14.6	3.3	0.0	2.2	0.0	0.0	0.0	14.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.1	0.0	0.0	3.1	0.0	0.4	0.3	0.0	0.0	0.0	0.0	1.5	0.5	0.0	0.0	0.0	1.4	0.0	3.4	0.7	0.0	0.0	0.0	0.0	0.0	0.0
HMGCR		ENSG00000113161	"3-hydroxy-3-methylglutaryl-CoA reductase"	P04035	5	75336329-75362104	"Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Cholesterol biosynthesis, Cholesterol metabolism, Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis, Steroid metabolism, Sterol biosynthesis, Sterol metabolism"	Oxidoreductase	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Suprabasal keratinocytes: 80.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008338, CAB016797"	Approved					NA	NA					"CAB016797: , HPA008338: AB_10960401"	"unprognostic (5.07e-2)"	"unprognostic (1.65e-2)"	"unprognostic (3.65e-3)"	"unprognostic (1.02e-2)"	"unprognostic (1.65e-3)"	"unprognostic (1.02e-1)"	"unprognostic (1.45e-1)"	"unprognostic (4.41e-2)"	"unprognostic (5.45e-2)"	"unprognostic (1.90e-2)"	"unprognostic (1.41e-1)"	"unprognostic (3.99e-2)"	"prognostic favorable (9.42e-6)"	"unprognostic (2.44e-1)"	"unprognostic (2.55e-2)"	"unprognostic (3.64e-3)"	"unprognostic (4.37e-2)"	5.6	28.9	12.4	8.7	31.1	12.1	16.4	14.4	36.3	13.9	23.0	10.9	7.1	18.9	9.0	14.4	35.0	6.5	8.2	4.0	21.8	16.5	12.1	53.5	12.1	7.0	9.8	19.4	15.2	8.4	16.2	11.4	9.2	29.6	12.4	19.7	7.8	12.4	4.5	3.4	36.1	19.0	6.8	17.0	7.9	14.6	14.0	8.8	13.9	12.5	23.2	12.4	6.2	18.1	4.3	12.5	23.2	11.0	9.5	6.5	5.1	15.3	6.0	61.4	21.1	13.0	25.2	15.4	4.4	12.4	9.0	20.1	22.6	37.8	13.7	16.1	7.1	58.9	19.4	31.9	51.8	9.6	4.6	11.7	10.5	9.1	17.5	19.2	8.7	7.7	16.3	30.5	31.5	15.6	4.5	7.2	19.7	11.2	21.0	14.2	10.0	16.0	8.8	26.2	3.9	4.5	11.3	18.4	19.6	37.1	35.8	21.3	9.7	9.7	10.1	8.8	22.1	10.0	22.9	8.4	4.9	7.3	5.2	7.5	6.7	8.5	18.9	7.1	17.1	10.1	6.7	11.0	6.3	6.1	6.9	5.1	4.3	4.6	6.4	12.5	4.2	4.5	6.2	23.2	9.5	7.4	3.9	6.5	5.1	12.4	31.1	14.4	36.3	21.8	16.5	9.8	19.4	29.6	8.8	17.9	33.4	7.5	8.5	36.9	20.9	5.7	12.7	32.1	22.7	26.2	17.7	16.3	3.3	12.1	38.1	7.6	33.8	0.0	18.8	21.6	10.5	13.9	24.2	22.5	11.5	38.1	41.2	9.8	19.3	19.5	8.6	12.3	15.1	2.8	50.6	10.3	11.9	20.1	5.6	6.3	13.1	12.9	8.2	21.0	14.0	80.0	39.0	8.7	20.2	17.3
HMGCS1	HMGCS	ENSG00000112972	"3-hydroxy-3-methylglutaryl-CoA synthase 1"	Q01581	5	43289395-43313512	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Cholesterol biosynthesis, Cholesterol metabolism, Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis, Steroid metabolism, Sterol biosynthesis, Sterol metabolism"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 117.0"	"Cell type enhanced"	"Detected in many"	5	"Suprabasal keratinocytes: 206.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"AF22: 120.5;GAMG: 80.3;HBEC3-KT: 69.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB032907, HPA036913, HPA036914"	Approved		Supported	"Nucleoplasm,Plasma membrane,Cytosol"		No	No		310000	"Nucleoplasm, Cytosol"	"Plasma membrane"	"CAB032907: AB_2118319, HPA036913: AB_2675380, HPA036914: AB_10671751"	"unprognostic (1.31e-1)"	"unprognostic (5.12e-3)"	"unprognostic (6.82e-3)"	"unprognostic (4.59e-2)"	"unprognostic (8.39e-2)"	"unprognostic (2.49e-2)"	"unprognostic (1.03e-1)"	"unprognostic (3.14e-2)"	"unprognostic (1.27e-2)"	"unprognostic (3.13e-1)"	"unprognostic (6.40e-3)"	"unprognostic (9.15e-2)"	"prognostic favorable (3.87e-6)"	"unprognostic (1.09e-1)"	"unprognostic (9.22e-2)"	"unprognostic (3.03e-2)"	"unprognostic (2.37e-2)"	6.0	16.5	13.3	8.1	24.4	4.3	12.8	8.4	38.2	16.9	15.5	16.9	9.5	27.8	6.8	11.5	53.0	4.1	7.5	5.1	19.4	18.8	10.5	117.0	26.9	6.2	10.4	20.7	15.4	8.4	10.8	5.0	6.9	59.3	12.9	14.2	13.0	18.5	7.7	5.0	25.2	17.1	6.3	25.8	4.4	13.4	9.8	8.1	3.3	7.5	58.1	23.3	6.1	21.4	9.3	7.8	6.9	7.7	6.7	7.9	3.3	14.9	7.2	120.5	13.8	7.0	27.9	8.1	2.4	9.5	3.4	6.9	12.5	21.6	15.9	5.4	3.4	80.3	11.8	30.0	69.5	3.6	3.4	36.0	5.9	6.6	16.9	11.1	12.8	4.2	15.3	8.4	18.1	7.2	2.1	3.5	14.8	10.5	43.5	2.8	6.9	11.5	15.6	21.6	6.0	3.8	8.3	16.9	17.6	53.4	23.2	10.3	5.0	12.3	6.2	3.6	18.2	9.6	17.0	4.2	2.6	13.0	2.7	2.2	5.9	8.9	21.7	2.3	15.4	2.3	5.5	4.0	3.7	5.6	7.4	5.6	9.3	6.2	7.9	7.8	7.5	5.3	7.3	6.9	6.7	7.7	6.5	5.7	3.3	13.3	24.4	8.4	32.1	19.4	18.8	10.4	20.7	59.3	8.1	62.5	124.5	45.6	35.9	96.3	27.9	7.4	56.0	48.2	36.4	45.4	49.1	20.4	11.6	30.6	5.0	19.7	86.8	0.0	52.0	35.5	35.0	65.2	59.8	78.4	20.7	46.1	88.4	23.4	20.8	1.8	11.8	17.2	25.3	78.5	44.0	19.7	36.3	30.9	13.4	17.7	43.3	0.0	24.9	14.1	7.8	206.6	37.2	20.1	31.2	65.0
HMGCS2		ENSG00000134240	"3-hydroxy-3-methylglutaryl-CoA synthase 2"	P54868	1	119747996-119768905	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Cholesterol biosynthesis, Cholesterol metabolism, Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis, Steroid metabolism, Sterol biosynthesis, Sterol metabolism"	Transferase	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"liver: 257.0"	"Cell type enhanced"	"Detected in many"	24	"Hepatocytes: 901.4;Mucus-secreting cells: 249.3;Undifferentiated cells: 248.3"	"Cancer enhanced"	"Detected in many"		"liver cancer: 441.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	12	"OE19: 35.4;RT4: 63.6"	"Low region specificity"	"Detected in all"							"HPA027423, HPA027442, CAB032906"	Enhanced		Supported	Mitochondria		NA	NA		820000	Mitochondria		"CAB032906: AB_2118322, HPA027423: AB_2672266, HPA027442: AB_2672277"	"unprognostic (2.57e-1)"	"unprognostic (1.12e-1)"	"unprognostic (3.93e-2)"	"unprognostic (7.62e-2)"		"unprognostic (1.49e-2)"	"prognostic favorable (2.43e-7)"	"unprognostic (9.68e-2)"	"unprognostic (3.21e-2)"	"prognostic favorable (2.17e-4)"	"unprognostic (1.20e-1)"	"unprognostic (6.42e-2)"	"prognostic favorable (3.43e-5)"	"unprognostic (9.57e-2)"	"unprognostic (2.31e-1)"	"unprognostic (5.00e-2)"	"unprognostic (1.54e-3)"	0.3	0.1	0.3	8.7	0.3	0.0	20.6	0.3	0.3	0.3	30.8	0.4	0.3	13.8	0.3	0.3	0.7	0.1	4.4	42.0	0.4	0.0	7.4	257.0	0.8	0.3	0.3	0.3	0.3	1.4	0.0	0.3	0.8	0.7	3.8	19.8	18.9	5.1	0.3	1.4	1.8	12.2	1.9	0.3	0.3	8.1	6.1	0.3	0.4	0.3	0.6	2.1	7.4	3.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	4.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	35.4	0.0	0.0	0.2	0.2	0.0	63.6	0.0	0.2	0.1	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.3	0.3	0.4	0.0	0.3	0.3	0.7	0.3	3.0	6.7	7.5	3.6	0.1	0.0	4.5	68.8	0.0	0.0	29.6	0.0	0.2	0.0	0.0	1.5	0.0	76.1	0.0	0.0	0.1	0.0	10.3	4.6	901.4	0.2	0.0	70.2	16.0	17.8	2.7	1.4	0.0	5.0	0.0	249.3	0.0	0.1	126.7	0.0	0.3	0.0	6.5	0.0	0.5	0.4	0.3	7.9	0.0	248.3	15.4
HMOX1	"bK286B10, HO-1"	ENSG00000100292	"Heme oxygenase 1"	P09601	22	35380361-35394214	"Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	Apoptosis	Oxidoreductase	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 209.8"	"Cell type enhanced"	"Detected in many"	15	"Hofbauer cells: 439.8;Kupffer cells: 915.4;monocytes: 247.9;Syncytiotrophoblasts: 419.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"classical monocyte: 17.7;intermediate monocyte: 40.5;non-classical monocyte: 53.4"	"Lineage enriched"	"Detected in many"	6	"monocytes: 53.4"	"Cell line enhanced"	"Detected in many"		"BEWO: 108.8;GAMG: 71.3;U-138 MG: 63.5;U-87 MG: 61.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA000635, CAB017444"	Enhanced		Uncertain	"Golgi apparatus,Plasma membrane"		NA	NA		17000	"Golgi apparatus, Plasma membrane"		"CAB017444: AB_10617276, HPA000635: AB_1079089"	"unprognostic (3.12e-1)"	"unprognostic (1.00e-1)"	"unprognostic (9.42e-2)"	"unprognostic (6.94e-2)"	"unprognostic (5.57e-2)"	"unprognostic (2.47e-2)"	"prognostic unfavorable (1.59e-4)"	"unprognostic (7.56e-2)"	"unprognostic (1.71e-1)"	"unprognostic (4.91e-2)"	"unprognostic (1.62e-1)"	"unprognostic (2.76e-1)"	"unprognostic (1.95e-3)"	"unprognostic (1.91e-1)"	"unprognostic (4.82e-2)"	"unprognostic (2.26e-1)"	"unprognostic (7.54e-2)"	28.4	10.3	4.1	12.5	8.7	16.3	13.8	0.8	20.6	5.7	12.0	6.1	0.6	22.0	2.5	8.5	8.8	9.8	9.8	10.2	4.1	3.1	23.0	63.7	54.0	76.3	12.5	1.3	28.6	8.8	0.5	2.7	21.1	7.5	3.6	4.9	3.3	3.5	0.8	21.9	13.8	22.8	6.9	11.2	209.8	4.6	5.9	7.6	3.6	4.2	7.3	8.3	6.7	10.2	4.8	7.9	8.4	53.4	1.1	0.3	10.1	1.4	22.1	0.2	4.5	18.1	5.3	108.8	10.2	6.0	4.8	5.2	9.8	1.3	0.0	2.3	8.3	71.3	1.2	1.3	0.2	1.5	36.6	1.1	0.5	6.7	20.0	25.2	1.3	6.9	16.6	0.4	31.7	2.1	7.7	14.4	0.0	0.0	10.6	15.3	1.1	0.0	0.5	2.2	13.6	2.5	0.1	1.9	3.4	3.4	11.9	0.3	0.3	26.4	2.3	1.7	9.6	1.0	0.3	5.4	63.5	2.8	10.3	9.9	6.6	8.5	1.0	61.6	0.6	1.0	2.0	17.7	1.2	0.2	40.5	0.0	4.8	0.1	0.3	7.9	0.5	0.0	0.0	8.4	1.1	53.4	0.2	0.2	10.1	4.1	8.7	0.8	4.8	4.1	3.1	12.5	1.3	7.5	7.6	3.0	21.3	13.8	5.9	14.5	0.0	3.1	10.2	1.4	0.0	5.2	0.0	39.4	18.3	10.3	1.6	20.2	43.4	0.0	1.3	204.4	21.6	85.9	11.5	19.5	439.8	0.0	15.3	30.7	915.4	1.3	28.7	175.5	33.7	247.9	5.3	0.2	8.7	10.5	4.9	128.1	0.4	0.0	16.5	0.9	2.7	13.7	419.8	10.0	4.1	91.1
HMOX2	HO-2	ENSG00000103415	"Heme oxygenase 2"	P30519	16	4474690-4510347	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"Early spermatids: 438.7;Late spermatids: 1517.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB025464, HPA040611"	Supported		Approved	Vesicles,Cytosol		NA	NA		1200000	"Vesicles, Cytosol"		"CAB025464: , HPA040611: AB_10961034"	"unprognostic (3.33e-1)"	"unprognostic (3.58e-2)"	"unprognostic (1.11e-1)"	"prognostic favorable (7.91e-4)"	"unprognostic (2.74e-1)"	"unprognostic (4.27e-2)"	"unprognostic (6.23e-2)"	"unprognostic (5.77e-2)"	"unprognostic (1.43e-2)"	"unprognostic (3.60e-1)"	"unprognostic (7.74e-3)"	"unprognostic (9.87e-2)"	"prognostic favorable (8.98e-6)"	"unprognostic (3.51e-2)"	"unprognostic (4.14e-2)"	"unprognostic (1.65e-2)"	"unprognostic (2.64e-1)"	19.4	19.2	32.1	15.7	50.7	13.6	16.6	19.7	38.6	13.3	17.9	22.9	12.2	23.5	11.9	18.7	36.6	15.6	19.7	57.2	29.3	22.0	32.2	39.7	15.8	20.8	27.3	35.1	12.5	22.4	20.6	14.7	12.5	36.5	12.1	19.9	8.6	16.0	10.0	20.1	16.6	19.3	16.6	27.2	23.3	29.7	48.1	28.2	8.7	13.8	16.7	25.3	16.5	15.0	14.5	14.5	48.7	8.9	18.7	35.8	25.8	24.9	10.7	6.3	13.8	19.1	9.8	10.6	17.3	8.5	14.7	12.8	13.5	17.0	11.6	19.4	15.8	10.3	15.2	20.0	37.0	16.7	14.8	13.6	8.4	10.3	18.3	12.9	18.2	14.4	15.3	12.4	17.0	12.5	12.3	26.9	14.0	13.6	5.9	13.5	31.0	15.0	14.3	9.7	24.1	10.1	16.0	11.2	24.3	20.4	16.5	10.8	6.3	13.8	29.3	18.6	12.6	18.2	10.2	26.3	8.3	12.3	35.6	8.8	7.3	9.0	25.6	5.3	15.1	10.5	13.7	7.4	48.7	35.2	8.9	29.9	14.5	32.7	35.8	14.5	13.0	31.7	32.7	26.1	18.7	6.5	8.2	30.0	25.8	32.1	50.7	19.7	38.6	29.3	22.0	27.3	35.1	36.5	28.2	32.8	46.9	52.0	27.0	48.7	27.1	59.3	33.1	30.8	38.7	34.9	19.6	64.6	109.5	72.8	438.7	41.7	76.2	0.0	78.6	57.9	43.8	31.4	19.6	78.8	59.5	27.0	30.5	66.3	24.7	1517.1	42.0	39.8	59.1	33.3	27.6	51.0	91.4	52.6	52.6	178.2	20.2	71.1	77.6	151.1	90.1	45.0	32.2	90.0	41.2	25.1
HNMT		ENSG00000150540	"Histamine N-methyltransferase"	P50135	2	137964020-138016364	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		"Methyltransferase, Transferase"	"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Hofbauer cells: 259.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	19	"classical monocyte: 34.6;intermediate monocyte: 26.7;myeloid DC: 20.9;non-classical monocyte: 14.6"	"Group enriched"	"Detected in many"	22	"dendritic cells: 20.9;monocytes: 34.6"	"Cell line enhanced"	"Detected in many"		"Hep G2: 60.9;HSkMC: 24.9;RT4: 31.6;SuSa: 31.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035480, HPA035481, HPA073754"	Approved		Approved	Nucleoplasm,Centrosome,Cytosol		NA	NA		64000	"Nucleoplasm, Cytosol"	Centrosome	"HPA035480: AB_2674645, HPA035481: AB_10672094, HPA073754: "	"unprognostic (1.32e-1)"	"unprognostic (3.53e-1)"	"unprognostic (5.44e-2)"	"unprognostic (2.09e-2)"	"unprognostic (2.81e-1)"	"unprognostic (2.33e-1)"	"unprognostic (2.29e-2)"	"unprognostic (6.02e-2)"	"unprognostic (5.69e-2)"	"unprognostic (1.43e-1)"	"prognostic unfavorable (3.41e-4)"	"unprognostic (5.24e-2)"	"unprognostic (1.34e-2)"	"unprognostic (1.76e-2)"	"unprognostic (5.34e-2)"	"unprognostic (1.21e-1)"	"prognostic favorable (4.68e-4)"	41.4	5.8	12.2	12.3	11.1	3.3	28.8	10.7	11.3	27.6	16.3	8.6	13.9	8.7	22.2	21.4	11.6	14.6	21.6	14.7	12.7	7.8	33.4	74.2	21.9	17.0	13.7	9.2	33.1	14.1	24.5	5.5	14.3	11.2	22.3	17.7	8.7	14.1	20.1	4.9	8.1	11.1	13.2	14.8	18.5	11.5	11.7	14.6	1.0	7.3	8.5	6.5	21.3	12.0	0.5	20.9	1.2	34.6	0.1	0.2	9.2	0.2	0.3	1.5	4.1	17.5	18.8	0.1	1.1	1.7	0.1	0.7	7.8	4.4	0.2	13.8	4.5	0.3	0.4	3.2	0.0	0.0	0.2	1.6	0.1	13.0	60.9	7.9	0.0	0.2	24.9	0.0	6.2	0.0	1.4	4.4	0.1	0.2	0.3	13.1	0.9	0.0	0.2	7.8	10.4	1.6	0.1	0.5	0.0	18.8	31.6	0.1	0.4	5.9	7.7	0.0	31.3	0.2	14.3	1.2	1.3	3.4	1.8	4.4	0.1	0.0	0.2	5.9	7.5	0.9	0.8	34.6	0.2	0.2	26.7	0.1	0.5	0.1	0.1	20.9	0.3	0.1	0.2	1.2	0.1	14.6	0.6	0.2	9.2	12.2	11.1	10.7	11.3	12.7	7.8	13.7	9.2	11.2	14.6	26.8	39.0	13.7	77.1	31.6	0.5	1.6	140.1	52.2	86.4	57.6	0.0	45.4	104.5	84.7	1.2	4.9	45.2	0.0	42.0	69.7	45.8	47.7	0.0	146.0	259.0	0.0	15.7	23.4	235.2	1.6	121.7	155.2	54.0	68.5	65.8	22.3	57.9	100.1	99.0	189.5	0.5	77.6	52.5	0.5	0.6	22.6	31.5	5.0	76.2	102.7
HOGA1	"C10orf65, DHDPS2, DHDPSL, FLJ37472, NPL2"	ENSG00000241935	"4-hydroxy-2-oxoglutarate aldolase 1"	Q86XE5	10	97584323-97612802	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		Lyase	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 39.8;liver: 31.0"	"Cell type enhanced"	"Detected in some"	16	"Cholangiocytes: 35.7;Distal tubular cells: 24.9;Hepatocytes: 41.0;Proximal tubular cells: 71.6"	"Group enriched"	"Detected in many"	5	"liver cancer: 4.5;renal cancer: 9.7"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Group enriched"	"Detected in some"	4	"AN3-CA: 6.1;EFO-21: 7.3;Hep G2: 19.0;RPTEC TERT1: 23.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA039466	Approved					NA	NA		15000			"HPA039466: AB_2676522"	"unprognostic (6.44e-2)"	"unprognostic (3.64e-2)"	"unprognostic (7.50e-2)"	"unprognostic (2.05e-1)"	"unprognostic (1.44e-1)"	"unprognostic (3.29e-2)"	"unprognostic (1.16e-2)"	"unprognostic (2.59e-3)"	"unprognostic (4.72e-1)"	"unprognostic (2.37e-1)"	"unprognostic (1.28e-1)"	"unprognostic (6.80e-2)"	"prognostic favorable (9.08e-4)"	"unprognostic (2.20e-1)"	"unprognostic (1.80e-1)"	"unprognostic (2.94e-3)"	"unprognostic (7.20e-4)"	3.3	5.4	3.3	0.6	3.8	0.8	2.1	7.0	4.3	0.8	0.6	8.2	1.5	0.7	0.9	4.0	1.3	2.0	3.8	10.1	4.2	2.8	39.8	31.0	0.9	0.7	9.3	5.2	0.6	12.0	2.0	2.4	0.6	7.2	1.3	0.6	3.6	1.8	2.2	2.0	1.2	0.6	0.8	8.2	0.7	0.6	0.7	6.9	0.0	1.8	4.1	0.6	0.8	0.6	2.1	1.7	4.4	1.2	1.2	1.3	0.5	0.3	2.8	0.1	6.1	1.2	0.3	0.1	0.1	0.2	0.1	0.0	2.3	0.3	0.2	7.3	0.1	0.3	2.0	0.1	0.2	0.1	0.2	3.2	0.1	1.1	19.0	0.8	0.2	0.2	0.3	0.6	0.2	0.1	1.5	0.3	0.1	0.1	0.4	0.5	1.2	0.1	0.2	0.2	0.2	0.0	0.2	0.5	0.4	23.3	0.4	0.5	0.9	0.1	1.1	0.7	0.2	2.1	0.1	0.3	0.7	0.2	0.4	0.2	0.4	0.7	0.1	1.5	0.3	0.1	2.4	1.1	1.2	1.2	0.9	1.0	1.1	1.3	0.9	0.5	2.1	1.1	1.2	4.4	1.2	1.2	1.7	0.9	0.5	3.3	3.8	7.0	3.9	4.2	2.8	9.3	5.2	7.2	6.9	0.0	0.0	0.0	0.6	0.1	0.1	5.3	35.7	5.3	0.0	8.7	0.0	0.0	24.9	4.4	2.9	0.0	0.0	0.0	0.2	0.0	0.3	0.1	0.0	41.0	0.1	1.6	0.0	0.0	1.8	12.3	0.0	0.0	1.7	0.0	0.0	2.0	0.5	0.0	0.0	71.6	0.3	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1
HP		ENSG00000257017	Haptoglobin	P00738	16	72054592-72061055	"Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins"	"Acute phase, Immunity"	"Antibiotic, Antimicrobial, Antioxidant, Serine protease homolog"	"Cancer-related genes, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	37	"liver: 1156.9"	"Cell type enriched"	"Detected in many"	51	"Hepatocytes: 52541.7"	"Cancer enriched"	"Detected in many"	81	"liver cancer: 1297.4"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"classical monocyte: 20.0;eosinophil: 30.9"	"Group enriched"	"Detected in many"	7	"granulocytes: 30.9;monocytes: 20.0"	"Group enriched"	"Detected in some"	5	"Hep G2: 66.2;HSkMC: 37.9"									"CAB003787, HPA047750"	Enhanced		Approved	Vesicles	"Secreted to blood"	NA	NA	998000000000	140000000000	Vesicles		"CAB003787: , HPA047750: AB_2680146"	"unprognostic (6.38e-3)"	"unprognostic (7.73e-3)"	"unprognostic (1.23e-1)"	"unprognostic (2.41e-2)"	"unprognostic (2.34e-3)"	"unprognostic (2.07e-1)"	"unprognostic (7.79e-3)"	"unprognostic (1.37e-1)"	"unprognostic (2.31e-1)"	"unprognostic (1.84e-1)"	"unprognostic (6.30e-2)"	"unprognostic (8.18e-2)"	"prognostic unfavorable (6.94e-13)"	"unprognostic (4.34e-4)"	"unprognostic (1.80e-1)"	"unprognostic (6.61e-2)"	"unprognostic (2.49e-2)"	9.8	0.0	0.3	0.4	0.3	4.4	0.3	0.3	0.3	1.5	0.4	0.3	0.3	0.0	0.3	0.5	0.3	1.1	0.3	3.0	0.3	0.0	0.4	1156.9	1.4	0.4	0.3	0.3	0.3	0.5	0.0	0.5	0.3	0.3	0.3	0.0	0.3	0.3	0.3	0.3	0.0	0.3	0.3	0.3	1.4	0.0	0.3	0.3	0.3	0.3	0.3	0.3	0.3	0.5	0.0	3.5	30.9	20.0	0.0	0.0	5.0	0.0	0.0	0.0	0.0	2.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	2.5	0.1	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	3.4	0.0	66.2	0.1	9.5	1.8	37.9	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.6	0.1	0.8	0.0	0.0	0.3	7.1	0.0	0.0	0.0	0.0	0.0	4.8	0.0	0.0	0.0	0.0	2.1	1.4	0.0	0.2	0.0	0.0	1.2	0.0	4.5	0.0	3.7	0.0	2.6	20.0	30.9	0.0	0.8	0.0	0.0	0.0	0.0	3.5	0.0	0.0	0.0	5.8	0.0	0.9	0.0	0.0	5.0	0.3	0.3	0.3	0.3	0.3	0.0	0.3	0.3	0.3	0.3	17.9	220.1	295.8	0.8	0.1	0.2	72.5	853.5	10.7	10.3	0.0	0.0	0.0	0.0	0.0	0.1	6.8	0.0	864.3	9.6	0.0	0.2	0.2	3.5	52541.7	2.4	0.0	0.0	971.0	1021.7	0.0	9.5	0.0	1.7	0.0	0.0	1.2	0.0	0.0	0.0	0.5	0.1	0.0	0.9	0.0	0.0	0.3	0.1	23.0	0.0	0.0
HPD	"4-HPPD, 4HPPD, GLOD3, PPD"	ENSG00000158104	"4-hydroxyphenylpyruvate dioxygenase"	P32754	12	121839527-121863596	"Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"	"Phenylalanine catabolism, Tyrosine catabolism"	"Dioxygenase, Oxidoreductase"	"Disease mutation, FDA approved drug targets, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"liver: 267.5"	"Group enriched"	"Detected in some"	9	"Hepatocytes: 1077.2;Proximal tubular cells: 1892.6"	"Cancer enriched"	"Detected in many"	100	"liver cancer: 540.9"	"Region enriched"	"Detected in single"	29	"pons and medulla: 13.7"	"Group enriched"	"Detected in many"	4	"eosinophil: 9.8;neutrophil: 4.8;plasmacytoid DC: 5.0"	"Group enriched"	"Detected in many"	5	"dendritic cells: 5.0;granulocytes: 9.8"	"Cell line enriched"	"Detected in some"	30	"Hep G2: 107.2"	"Region enriched"	"Detected in single"	8	"amygdala: 0.4"	"Not detected"	"Not detected"			"HPA038321, HPA038322"	Enhanced		Uncertain	"Nuclear speckles"		NA	NA		23000000	"Nuclear speckles"		"HPA038321: AB_2675957, HPA038322: AB_10670778"	"unprognostic (3.01e-2)"	"unprognostic (2.30e-1)"	"unprognostic (4.81e-3)"	"unprognostic (1.42e-3)"	"unprognostic (1.10e-2)"	"unprognostic (9.08e-2)"	"unprognostic (1.13e-2)"	"unprognostic (8.84e-2)"	"unprognostic (5.58e-2)"	"unprognostic (6.14e-3)"	"unprognostic (9.72e-3)"	"unprognostic (8.61e-3)"	"unprognostic (7.16e-2)"	"unprognostic (1.97e-1)"	"unprognostic (4.12e-1)"	"unprognostic (3.06e-2)"	"unprognostic (2.34e-1)"	0.1	0.5	0.0	0.1	0.1	0.0	0.4	0.1	0.3	0.2	0.1	2.1	0.3	0.0	0.3	0.4	0.1	0.7	0.2	0.3	0.4	0.0	51.3	267.5	0.2	0.4	0.1	0.0	0.7	0.7	0.0	0.1	0.0	13.7	0.5	0.0	3.8	0.0	0.8	0.2	0.0	0.1	0.4	0.2	0.2	0.1	0.8	0.1	0.0	0.1	0.1	0.1	0.6	0.2	0.1	5.0	9.8	1.4	0.0	0.3	0.3	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	1.1	107.2	2.5	0.3	3.5	0.8	0.0	0.0	0.0	0.3	0.0	0.1	0.1	0.0	0.2	0.2	0.0	0.1	2.1	0.0	0.0	0.0	0.3	0.1	0.0	0.3	0.0	0.0	0.3	0.0	0.0	1.5	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.2	0.0	0.0	0.8	9.8	0.0	1.0	0.1	0.1	0.1	0.1	1.3	0.1	0.3	0.2	4.8	0.0	1.4	5.0	0.0	0.3	0.0	0.1	0.1	0.3	0.4	0.0	0.1	0.0	13.7	0.1	0.0	0.0	18.3	0.0	0.0	0.0	0.3	48.4	0.0	0.0	87.2	0.0	0.6	164.2	0.3	33.1	0.0	0.0	0.0	14.8	0.2	0.0	0.0	0.0	1077.2	0.3	0.0	0.0	33.2	23.4	97.3	2.3	0.0	0.0	0.0	0.0	0.0	0.2	0.0	4.9	1892.6	0.0	0.0	0.0	1.7	1.1	0.0	0.9	0.0	0.0	0.0
HPGD	SDR36C1	ENSG00000164120	"15-hydroxyprostaglandin dehydrogenase"	P15428	4	174490177-174523154	"Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Fatty acid metabolism, Lipid metabolism, Prostaglandin metabolism"	Oxidoreductase	"Cancer-related genes, Disease mutation, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"placenta: 193.3"	"Cell type enhanced"	"Detected in many"	13	"Enterocytes: 273.6;Extravillous trophoblasts: 488.8;granulocytes: 816.1;Urothelial cells: 266.0"	"Cancer enhanced"	"Detected in many"		"urothelial cancer: 52.4"	"Region enriched"	"Detected in single"	4	"pons and medulla: 3.8"	"Group enriched"	"Detected in many"	5	"basophil: 37.7;T-reg: 15.1"	"Group enriched"	"Detected in many"	71	"granulocytes: 37.7;T-cells: 15.1"	"Cell line enhanced"	"Detected in some"		"A549: 27.7;ASC diff: 17.2;HEL: 60.6;RT4: 94.3;SuSa: 20.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004919, HPA005679"	Enhanced		Supported	Nucleoplasm,Cytosol		No	NA			Cytosol	Nucleoplasm	"HPA004919: AB_1079081, HPA005679: AB_1079080"	"unprognostic (1.23e-3)"	"unprognostic (1.61e-1)"	"unprognostic (5.96e-2)"	"unprognostic (1.25e-1)"	"unprognostic (1.09e-2)"	"unprognostic (2.53e-2)"	"unprognostic (1.27e-1)"	"unprognostic (2.23e-1)"	"unprognostic (1.08e-1)"	"unprognostic (4.28e-2)"	"unprognostic (3.54e-3)"	"unprognostic (2.34e-2)"	"prognostic favorable (3.20e-4)"	"unprognostic (2.44e-1)"	"unprognostic (2.59e-1)"	"unprognostic (1.37e-4)"	"unprognostic (2.33e-2)"	5.1	2.6	0.5	7.9	0.6	0.0	24.6	0.4	0.6	23.0	73.3	0.5	2.5	22.9	13.4	7.5	32.0	4.5	10.7	1.2	0.6	0.7	8.5	63.7	22.9	7.9	0.8	0.5	2.3	0.4	0.0	0.9	193.3	3.8	20.1	8.4	4.6	3.0	1.1	1.6	15.3	64.5	9.3	0.5	2.9	36.3	1.9	0.5	5.5	0.4	5.0	7.9	61.2	31.8	0.1	0.2	37.7	0.1	0.3	15.1	1.0	0.0	27.7	0.0	0.0	17.2	1.0	0.0	0.0	0.0	0.0	0.0	8.0	0.0	0.0	0.0	0.0	0.0	2.5	2.5	0.0	0.0	0.0	0.5	60.6	2.1	0.0	0.0	0.3	0.1	0.9	0.4	0.0	0.0	0.0	0.0	3.8	0.0	0.0	0.0	0.0	0.2	0.0	0.2	15.8	1.4	2.8	0.0	0.2	5.7	94.3	0.1	0.1	0.0	0.2	0.6	20.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.3	0.0	0.0	0.0	0.0	0.0	37.7	0.1	5.4	3.7	0.0	5.7	0.1	1.9	1.6	0.2	0.0	0.6	1.5	0.4	0.3	0.0	0.0	15.1	1.0	0.5	0.6	0.4	0.6	0.6	0.7	0.8	0.5	3.8	0.5	14.9	46.1	5.2	57.7	15.3	3.1	0.4	43.3	5.3	20.5	21.0	0.0	25.6	18.3	2.4	1.1	0.5	273.6	0.0	86.5	488.8	12.1	51.1	816.1	165.7	20.7	0.0	8.1	18.4	16.1	0.2	18.4	10.6	72.6	1.0	48.2	0.0	26.0	217.5	0.0	68.8	0.6	0.0	6.6	0.4	0.4	19.6	47.4	50.3	31.0	266.0
HPGDS	"GSTS, GSTS1, GSTS1-1, H-PGDS, PGD2, PGDS"	ENSG00000163106	"Hematopoietic prostaglandin D synthase"	O60760	4	94298535-94342876	"Enzymes, Predicted intracellular proteins"	"Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism, Prostaglandin biosynthesis, Prostaglandin metabolism"	"Isomerase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"placenta: 24.8"	"Group enriched"	"Detected in many"	10	"granulocytes: 1000.1;Hofbauer cells: 476.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	25	"basophil: 15.8"	"Lineage enriched"	"Detected in single"	25	"granulocytes: 15.8"	"Group enriched"	"Detected in some"	8	"HEL: 32.4;HMC-1: 9.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			HPA024035	Enhanced		Approved	Nucleoplasm,Vesicles,Cytosol		NA	NA		170000	"Vesicles, Cytosol"	Nucleoplasm	"HPA024035: AB_1855743"	"unprognostic (5.71e-2)"	"unprognostic (5.80e-3)"	"unprognostic (1.17e-1)"	"unprognostic (5.36e-3)"	"unprognostic (2.76e-1)"	"unprognostic (2.38e-4)"	"unprognostic (1.01e-2)"	"unprognostic (4.41e-3)"	"unprognostic (1.35e-1)"	"unprognostic (7.75e-4)"	"unprognostic (1.44e-1)"	"unprognostic (1.14e-1)"	"unprognostic (5.15e-3)"	"unprognostic (4.07e-2)"	"unprognostic (6.48e-2)"	"unprognostic (2.61e-2)"	"unprognostic (6.14e-2)"	14.3	2.9	8.0	1.6	12.1	1.6	5.8	2.0	7.7	5.4	6.9	4.4	0.2	7.5	4.7	3.3	4.1	2.5	9.3	3.0	8.4	3.6	2.5	1.3	12.7	0.9	9.6	2.4	1.5	1.8	1.7	1.5	24.8	9.0	6.4	7.5	2.9	3.8	2.2	1.4	5.8	8.6	5.8	14.6	1.4	4.4	1.8	12.1	1.5	1.2	2.8	1.5	4.5	3.5	0.0	0.1	15.8	0.0	0.0	0.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	32.4	0.0	0.0	0.0	2.5	9.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.8	0.0	0.3	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.1	8.0	12.1	2.0	7.7	8.4	3.6	9.6	2.4	9.0	12.1	11.9	75.3	0.0	0.8	3.7	0.0	0.0	0.0	2.7	6.8	0.0	0.0	2.8	0.0	0.0	0.0	0.4	0.0	0.0	0.0	2.5	4.1	4.0	1000.1	0.0	476.4	0.0	6.8	0.0	3.9	0.0	0.3	14.5	3.3	0.0	0.0	0.0	0.1	0.3	0.4	0.0	0.0	0.0	0.1	0.0	0.1	4.6	4.6	0.0	0.0	0.1
HPN	TMPRSS1	ENSG00000105707	Hepsin	P05981	19	35040506-35066571	"Cancer-related genes, Enzymes, Predicted intracellular proteins, Predicted membrane proteins"		"Hydrolase, Protease, Serine protease"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	9	"kidney: 55.4;liver: 146.5;pancreas: 80.1"	"Group enriched"	"Detected in many"	7	"Hepatocytes: 406.8;Proximal tubular cells: 178.8"	"Cancer enhanced"	"Detected in many"		"liver cancer: 127.5"	"Low region specificity"	"Detected in single"			"Cell type enhanced"	"Detected in some"		"memory CD8 T-cell: 1.2;naive CD8 T-cell: 1.2"	"Lineage enriched"	"Detected in single"	5	"T-cells: 1.2"	"Group enriched"	"Detected in some"	9	"EFO-21: 19.8;Hep G2: 28.1;T-47d: 13.7"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			HPA006804	Approved					NA	NA		1000000			"HPA006804: AB_1079046"	"unprognostic (6.74e-3)"	"unprognostic (6.00e-2)"	"unprognostic (4.10e-2)"	"unprognostic (1.16e-1)"	"unprognostic (2.72e-1)"	"unprognostic (9.96e-2)"	"unprognostic (4.22e-3)"	"unprognostic (1.27e-1)"	"unprognostic (4.13e-3)"	"unprognostic (9.54e-2)"	"unprognostic (3.54e-1)"	"unprognostic (1.16e-1)"	"prognostic favorable (5.45e-5)"	"unprognostic (1.22e-1)"	"unprognostic (1.52e-1)"	"unprognostic (1.12e-1)"	"unprognostic (7.96e-2)"	0.2	0.0	0.3	0.1	0.5	0.0	3.2	0.4	1.1	0.3	0.3	0.2	8.4	0.2	1.1	10.7	0.1	1.9	3.2	0.7	0.6	0.3	55.4	146.5	4.9	0.1	0.9	0.2	0.4	80.1	2.6	3.2	0.2	0.4	5.3	0.0	0.4	4.1	8.5	8.5	0.0	0.2	0.1	0.9	0.3	6.9	0.8	0.3	0.1	4.3	0.4	0.2	0.3	0.1	0.2	0.2	0.0	0.1	0.0	1.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	2.1	0.0	0.1	19.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	28.1	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.1	0.2	0.0	0.0	0.0	2.0	0.1	0.1	0.0	0.1	0.3	13.7	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.2	0.0	0.1	0.0	1.0	0.0	0.6	0.2	0.5	1.2	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.2	0.0	0.3	0.3	0.5	0.4	1.1	0.6	0.3	0.9	0.2	0.4	0.3	8.9	26.7	17.7	4.9	0.1	4.5	2.4	35.7	0.0	2.3	31.4	0.0	0.0	44.7	3.3	7.0	0.3	0.0	0.0	23.6	0.3	0.2	7.9	2.3	406.8	0.8	0.0	2.4	8.0	10.0	20.0	0.0	0.5	0.0	1.0	1.7	1.3	23.4	0.0	0.4	178.8	0.5	0.0	0.0	0.0	0.0	0.0	0.7	1.5	0.0	0.5
HPR		ENSG00000261701	"Haptoglobin-related protein"	P00739	16	72063224-72077246	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"		"Serine protease homolog"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	10	"liver: 151.4"	"Cell type enriched"	"Detected in some"	18	"Hepatocytes: 430.8"	"Cancer enriched"	"Detected in some"	53	"liver cancer: 185.1"					"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enriched"	"Detected in some"	14	"Hep G2: 33.6"									HPA047750	Supported		Approved	Vesicles	"Secreted to blood"	NA	NA	49000000000	77000000000	Vesicles		"HPA047750: AB_2680146"	"unprognostic (2.43e-1)"		"unprognostic (4.69e-2)"	"unprognostic (5.97e-3)"	"unprognostic (2.42e-1)"		"unprognostic (2.32e-3)"	"unprognostic (2.36e-1)"		"unprognostic (1.66e-1)"	"unprognostic (8.21e-2)"	"unprognostic (2.30e-1)"	"unprognostic (3.44e-6)"	"unprognostic (2.09e-2)"	"unprognostic (1.45e-1)"	"unprognostic (1.29e-1)"		0.2	0.0	1.3	0.0	1.6	0.0	0.0	0.0	0.6	0.1	0.0			0.1	0.0	0.1	0.0	0.0	0.1	15.2	0.7	0.8	0.1	151.4	0.0	0.1	2.1		0.4	0.0	0.0	0.0	0.0		0.0	0.0		0.0	0.1	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.2			0.0		0.0	0.0	0.0	1.1	2.9	1.1	1.0	0.4	2.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	33.6	1.6	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.8	1.1	1.3	1.0	0.1	0.5	0.4	0.4	0.3	1.1	2.0	1.1	0.3	0.4	0.3	2.9	2.3	0.3											0.0	9.8	0.0	0.0	0.1	0.0	14.9	17.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	23.3	0.2	0.0	0.2	0.0	0.0	430.8	0.0	0.0	0.0	9.8	7.3	2.1	9.2	0.0	0.0	0.0	0.0	5.2	0.0	0.0	4.9	4.8	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0
HPRT1	"HGPRT, HPRT"	ENSG00000165704	"Hypoxanthine phosphoribosyltransferase 1"	P00492	X	134460153-134520513	"Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"	"Purine salvage"	"Glycosyltransferase, Transferase"	"Disease mutation, FDA approved drug targets, Gout"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Distal tubular cells: 192.3;monocytes: 181.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"							"HPA006360, CAB012200"	Enhanced		Supported	Cytosol		NA	NA		15000000	Cytosol		"CAB012200: AB_297217, HPA006360: AB_1079082"	"unprognostic (2.02e-1)"	"unprognostic (2.18e-1)"	"unprognostic (1.46e-1)"	"unprognostic (2.32e-3)"	"unprognostic (8.55e-2)"	"prognostic unfavorable (1.35e-5)"	"unprognostic (1.58e-2)"	"unprognostic (4.77e-3)"	"unprognostic (4.93e-2)"	"unprognostic (2.02e-2)"	"unprognostic (7.05e-2)"	"unprognostic (1.38e-3)"	"unprognostic (6.00e-2)"	"unprognostic (2.12e-1)"	"unprognostic (2.04e-1)"	"unprognostic (2.70e-2)"	"unprognostic (1.51e-1)"	7.9	14.9	31.0	12.6	30.2	25.3	11.3	24.2	49.8	7.5	13.7	5.8	9.8	11.0	7.9	36.2	10.3	9.4	8.1	12.8	27.6	37.3	18.4	24.7	7.3	15.9	23.5	28.9	9.8	20.2	9.9	18.6	8.8	34.4	8.8	13.2	9.7	7.1	9.5	10.7	8.0	14.2	9.5	9.8	8.7	17.1	39.7	4.9	13.7	12.3	8.6	15.9	10.8	7.5	13.5	19.7	10.1	18.5	19.9	29.3	12.6	31.4	15.1	4.3	8.8	9.6	13.9	13.0	16.8	16.2	21.5	28.4	13.6	20.2	35.6	38.3	10.9	25.7	19.3	27.7	23.0	37.2	29.5	51.9	19.3	21.5	13.8	9.5	41.5	17.8	10.2	8.7	19.2	30.6	11.9	24.8	21.2	14.8	0.9	16.8	32.1	32.0	36.0	8.8	37.1	40.8	19.2	21.8	36.5	25.9	15.3	27.2	14.8	12.1	9.9	11.4	12.2	8.4	17.4	12.2	14.6	11.0	41.9	41.7	13.6	23.5	0.2	18.0	46.1	8.0	2.2	11.6	10.1	11.6	18.5	16.7	12.3	17.3	15.3	19.7	13.5	14.3	15.1	2.9	19.9	17.2	8.2	29.3	12.6	31.0	30.2	24.2	49.8	27.6	37.3	23.5	28.9	34.4	4.9	17.9	8.0	31.0	44.7	35.1	39.0	20.7	33.1	24.1	15.9	54.1	3.9	12.2	192.3	35.3	6.9	29.4	17.7	0.0	28.2	23.6	24.0	37.5	34.6	18.1	62.7	23.8	26.4	15.4	61.4	18.0	37.7	64.9	52.3	181.3	22.6	23.4	31.4	22.6	25.1	21.6	59.2	51.8	47.2	74.7	143.7	33.9	5.0	61.0	37.4	39.6
HPSE	"HPA, HPSE1, HSE1"	ENSG00000173083	Heparanase	Q9Y251	4	83292461-83335153	"Enzymes, Predicted secreted proteins"	"Cell adhesion"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	11	"Hofbauer cells: 15.9;Kupffer cells: 27.7;Macrophages: 10.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"classical monocyte: 17.8;neutrophil: 12.8"	"Group enriched"	"Detected in many"	5	"granulocytes: 12.8;monocytes: 17.8"	"Cell line enhanced"	"Detected in many"		"Karpas-707: 23.3;OE19: 20.5"	"Region enhanced"	"Detected in some"		"olfactory region: 4.5"	"Low region specificity"	"Detected in all"			"CAB009813, HPA055344"			Supported	Nucleoplasm,Vesicles	"Secreted to extracellular matrix"	No	No		9700000	Nucleoplasm	Vesicles	"CAB009813: AB_2120854, HPA055344: "	"unprognostic (6.57e-2)"	"unprognostic (1.22e-2)"	"unprognostic (9.13e-2)"	"unprognostic (5.92e-3)"	"unprognostic (1.12e-1)"	"unprognostic (1.25e-1)"	"unprognostic (1.24e-2)"	"unprognostic (5.65e-2)"	"unprognostic (7.06e-2)"	"unprognostic (1.90e-1)"	"unprognostic (1.50e-1)"	"unprognostic (9.62e-3)"	"unprognostic (3.27e-1)"	"unprognostic (2.78e-1)"	"unprognostic (3.04e-3)"	"unprognostic (4.15e-2)"	"unprognostic (3.70e-3)"	4.9	5.1	3.0	6.8	3.5	2.2	1.2	0.8	2.4	3.6	6.2	7.1	0.0	2.3	2.9	2.8	14.5	5.7	3.0	5.8	3.2	1.5	3.0	5.6	8.2	16.1	7.1	1.4	7.5	1.1	15.5	2.3	11.3	3.4	1.1	7.0	0.7	12.5	2.1	0.7	6.9	3.6	2.1	7.0	19.0	2.4	6.0	2.8	1.6	1.4	16.9	9.7	2.4	4.9	0.3	1.9	12.8	17.8	1.4	3.4	4.8	7.6	0.3	0.0	1.0	1.8	0.5	0.0	0.9	4.2	1.9	8.1	0.2	5.7	0.2	1.4	2.1	13.0	7.4	9.7	1.3	3.4	0.7	0.9	2.0	5.5	0.1	1.0	1.3	4.6	0.8	2.9	1.3	9.2	0.8	10.2	1.3	0.0	23.3	0.8	1.6	0.1	0.1	0.4	20.5	1.4	0.0	0.3	0.3	5.3	0.2	5.5	0.0	10.6	5.9	0.8	1.5	0.8	1.8	11.8	0.8	2.7	0.8	0.9	0.3	3.6	0.1	6.1	6.2	1.4	0.2	17.8	0.0	1.0	6.7	0.7	0.2	1.9	0.7	1.9	0.3	1.4	1.2	12.8	1.4	0.9	0.1	3.4	4.8	3.0	3.5	0.8	2.4	3.2	1.5	7.1	1.4	3.4	2.8	6.0	4.1	0.0	2.6	3.1	0.0	0.4	0.0	2.7	3.4	1.8	0.0	0.5	0.0	1.3	0.6	0.6	5.1	0.0	1.2	2.3	0.6	1.5	0.0	0.2	15.9	0.0	6.3	3.1	27.7	0.0	0.6	10.2	0.0	0.0	2.9	0.0	0.8	8.0	0.0	0.0	0.0	0.0	0.6	0.0	0.5	3.1	1.3	3.2	4.6	3.7
HS3ST1	3OST1	ENSG00000002587	"Heparan sulfate-glucosamine 3-sulfotransferase 1"	O14792	4	11393150-11429765	"Enzymes, Predicted intracellular proteins"		Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 27.4;gallbladder: 31.9;ovary: 30.3"	"Cell type enhanced"	"Detected in many"	6	"Ciliated cells: 64.3;Club cells: 83.0;granulocytes: 93.6;Peritubular cells: 84.8;Urothelial cells: 90.2"	"Low cancer specificity"	"Detected in many"			"Group enriched"	"Detected in many"	8	"cerebellum: 27.4;cerebral cortex: 9.0"	"Group enriched"	"Detected in some"	39	"memory B-cell: 7.3;naive B-cell: 15.8;plasmacytoid DC: 22.3"	"Group enriched"	"Detected in many"	99	"B-cells: 15.8;dendritic cells: 22.3"	"Cell line enhanced"	"Detected in some"		"A-431: 4.5;CAPAN-2: 14.4;HaCaT: 4.3;RPTEC TERT1: 12.6;RT4: 10.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA002237	Approved		Approved	Vesicles	"Intracellular and membrane"	NA	NA			Vesicles		"HPA002237: AB_1079085"	"unprognostic (1.10e-1)"	"unprognostic (2.66e-1)"	"unprognostic (4.01e-2)"	"prognostic favorable (7.73e-4)"	"unprognostic (3.32e-2)"	"unprognostic (8.90e-3)"	"unprognostic (4.21e-1)"	"unprognostic (2.08e-1)"	"unprognostic (2.22e-1)"	"unprognostic (1.32e-1)"	"unprognostic (1.77e-2)"	"unprognostic (1.08e-1)"	"prognostic favorable (5.99e-8)"	"unprognostic (9.99e-2)"	"unprognostic (1.42e-1)"	"unprognostic (1.57e-1)"	"prognostic favorable (8.67e-4)"	2.3	2.9	1.6	2.8	2.2	2.8	2.0	27.4	9.0	3.3	2.7	1.1	3.6	3.5	4.3	5.0	10.2	4.3	31.9	2.2	1.7	1.8	10.4	0.9	3.4	2.1	1.9	1.5	30.3	1.1	0.7	8.9	1.0	2.4	3.2	1.7	1.7	3.7	2.4	0.7	0.8	2.9	1.7	2.2	3.0	7.0	3.0	0.3	3.8	1.8	7.0	7.4	7.3	2.4	15.8	22.3	0.1	0.1	0.0	0.1	0.6	4.5	0.8	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	14.4	0.0	0.4	0.0	0.0	4.3	0.0	2.5	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.7	0.3	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.9	0.9	1.2	1.0	0.0	0.0	12.6	10.3	3.8	0.0	0.0	0.1	0.5	0.2	0.0	0.0	2.0	0.7	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.1	0.1	7.3	0.0	0.0	0.3	15.8	0.0	0.0	0.0	0.0	0.0	22.3	0.0	0.6	1.6	2.2	27.4	9.0	1.7	1.8	1.9	1.5	2.4	0.3	3.0	8.0	2.2	9.8	8.0	1.5	2.4	15.3	64.3	83.0	19.2	3.9	0.5	0.0	17.1	0.8	23.4	3.0	0.0	1.8	31.9	5.0	4.1	93.6	0.0	37.3	1.6	2.4	9.2	2.7	0.8	8.1	9.0	1.7	7.2	5.6	39.8	32.0	2.6	84.8	3.7	2.2	0.0	6.4	6.0	5.5	7.0	1.1	0.9	3.7	90.2
HS3ST2	3OST2	ENSG00000122254	"Heparan sulfate-glucosamine 3-sulfotransferase 2"	Q9Y278	16	22814177-22916338	"Enzymes, Predicted intracellular proteins"		Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in many"	4	"adipose tissue: 12.7;brain: 38.2;lung: 13.4"	"Cell type enhanced"	"Detected in some"	17	"Basal keratinocytes: 3.2;Bipolar cells: 3.5;Hofbauer cells: 13.5;Peritubular cells: 5.3;Smooth muscle cells: 4.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"HaCaT: 10.5;SH-SY5Y: 18.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA017736	Approved					NA	NA					"HPA017736: AB_1851095"	"unprognostic (4.09e-2)"	"unprognostic (2.90e-3)"	"unprognostic (5.97e-3)"	"unprognostic (3.46e-3)"	"prognostic unfavorable (1.57e-4)"	"unprognostic (2.00e-1)"	"unprognostic (1.05e-1)"	"unprognostic (2.17e-3)"	"unprognostic (1.83e-1)"	"unprognostic (2.75e-2)"	"unprognostic (1.95e-1)"	"unprognostic (2.45e-1)"	"prognostic favorable (1.35e-4)"	"unprognostic (4.89e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.35e-1)"	"unprognostic (3.00e-2)"	12.7	1.7	3.8	1.1	6.5	1.1	2.4	0.5	38.2	2.0	1.4	0.3	0.3	1.0	1.0	1.0	1.2	1.0	1.1	3.8	7.8	4.3	1.0	2.2	13.4	2.1	2.2	8.4	4.5	1.0	1.0	0.4	1.2	1.5	2.0	1.4	5.0	2.9	1.1	1.0	2.0	1.0	1.2	1.0	1.1	1.1	1.1	0.0	0.0	1.8	0.4	1.0	1.5	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	10.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	18.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.8	6.5	0.5	19.1	7.8	4.3	2.2	8.4	1.5	0.0	0.0	0.0	0.0	0.1	3.2	3.5	0.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.6	0.0	0.0	0.0	0.2	0.2	0.9	0.0	0.0	13.5	0.0	0.0	0.6	0.6	0.7	1.1	0.4	0.0	0.0	0.0	0.0	0.6	0.0	5.3	0.0	0.6	0.0	4.1	0.0	0.0	1.8	0.2	0.0	0.0	0.7
HS3ST3A1	"30ST3A1, 3OST3A1"	ENSG00000153976	"Heparan sulfate-glucosamine 3-sulfotransferase 3A1"	Q9Y663	17	13495689-13601927	"Enzymes, Predicted intracellular proteins"		Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in some"	7	"Horizontal cells: 25.4;Ito cells: 8.0;Leydig cells: 12.7"	"Low cancer specificity"	"Detected in many"			"Group enriched"	"Detected in some"	4	"basal ganglia: 1.0;cerebral cortex: 2.2;pons and medulla: 3.0"	"Cell type enhanced"	"Detected in many"		"T-reg: 5.1"	"Group enriched"	"Detected in many"	6	"dendritic cells: 3.9;T-cells: 5.1"	"Cell line enhanced"	"Detected in many"		"PC-3: 17.2;U-251 MG: 47.9;U-87 MG: 29.7"									"HPA062518, HPA071530"	Uncertain		Approved	Microtubules		NA	NA			Microtubules		"HPA062518: AB_2684789, HPA071530: AB_2686411"	"unprognostic (2.88e-3)"	"unprognostic (4.21e-2)"	"unprognostic (8.35e-2)"	"unprognostic (3.50e-2)"	"unprognostic (1.48e-3)"	"unprognostic (4.44e-2)"	"unprognostic (2.01e-1)"	"unprognostic (4.46e-3)"	"unprognostic (2.12e-4)"	"unprognostic (1.12e-2)"	"unprognostic (8.52e-2)"	"unprognostic (1.55e-1)"	"unprognostic (1.85e-9)"	"unprognostic (1.83e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.33e-3)"	"unprognostic (4.70e-3)"	1.3	3.3	0.2	2.8	1.0	1.5	2.3	0.1	2.2	7.8	1.6	0.3	5.8	2.3	3.3	1.3	8.1	1.9	1.3	3.8	0.3	0.2	1.7	3.4	2.2	9.3	0.1	0.4	12.1	0.4	0.0	1.2	6.8	3.0	9.9	0.5	2.0	3.3	8.6	0.9	1.1	1.7	0.4	1.3	11.7	1.0	2.9	0.0	0.6	0.6	6.3	12.7	1.4	5.3	0.1	3.9	0.5	0.1	0.7	5.1	0.8	0.0	0.1	1.2	0.0	0.8	2.2	2.0	7.7	1.6	1.3	0.8	0.0	0.2	0.0	1.0	4.2	0.0	0.0	0.0	0.0	1.0	0.4	7.9	2.0	0.6	0.7	0.6	0.0	0.5	2.0	0.0	3.4	0.7	1.7	0.0	0.1	7.6	0.0	1.3	1.0	0.0	1.3	1.4	0.0	17.2	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.7	0.0	0.2	0.0	1.2	0.1	0.0	47.9	0.0	0.0	0.0	29.7	0.0	3.6	0.0	0.0	0.0	1.7	0.0	0.8	0.0	1.2	1.4	0.0	0.1	1.4	1.4	0.5	0.7	0.1	3.9	5.1	0.8	0.2	1.0	0.1	2.2	0.3	0.2	0.1	0.4	3.0	0.0	0.0	0.0	0.0	0.0	0.6	0.1	0.6	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.3	0.3	0.7	0.0	0.0	0.2	0.0	0.4	0.0	0.0	0.0	1.2	25.4	0.0	8.0	1.0	0.0	12.7	0.0	0.0	0.0	0.0	1.0	0.7	0.0	2.1	0.0	0.1	0.0	1.4	0.1	0.0	0.5	0.1	0.0	0.0	0.0
HS3ST3B1	"30ST3B1, 3OST3B1"	ENSG00000125430	"Heparan sulfate-glucosamine 3-sulfotransferase 3B1"	Q9Y662	17	14301083-14349404	"Enzymes, Predicted intracellular proteins"		Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"blood: 20.6;liver: 29.1;lymphoid tissue: 26.6;placenta: 33.5;salivary gland: 12.6"	"Cell type enhanced"	"Detected in many"	6	"Cone photoreceptor cells: 37.3;Hepatocytes: 32.1;Ito cells: 34.4;Syncytiotrophoblasts: 30.3"	"Low cancer specificity"	"Detected in many"			"Group enriched"	"Detected in some"	4	"cerebral cortex: 2.7;pons and medulla: 6.0"	"Cell type enhanced"	"Detected in many"		"plasmacytoid DC: 20.6"	"Group enriched"	"Detected in many"	5	"dendritic cells: 20.6;T-cells: 14.7"	"Cell line enhanced"	"Detected in many"		"AF22: 15.5;BEWO: 11.1;Hep G2: 13.5;HSkMC: 15.4;U-251 MG: 14.2"									HPA064126			Approved	Vesicles		NA	NA			Vesicles		"HPA064126: AB_2685194"	"unprognostic (1.74e-1)"	"unprognostic (1.13e-1)"	"unprognostic (2.29e-2)"	"unprognostic (5.55e-3)"	"unprognostic (2.85e-3)"	"unprognostic (5.22e-2)"	"unprognostic (5.03e-3)"	"unprognostic (1.79e-1)"	"unprognostic (2.93e-1)"	"unprognostic (8.13e-3)"	"unprognostic (8.80e-2)"	"unprognostic (1.13e-1)"	"unprognostic (1.02e-3)"	"unprognostic (7.77e-3)"	"unprognostic (9.46e-2)"	"unprognostic (1.91e-1)"	"unprognostic (1.54e-3)"	1.4	1.4	0.6	8.7	0.8	1.3	3.0	0.9	2.7	3.8	1.8	0.0	0.8	1.4	1.0	0.3	2.8	1.7	2.6	2.0	0.6	0.7	3.6	29.1	3.7	26.6	0.6	0.0	4.7	1.3	0.4	1.4	33.5	6.0	2.4	1.9	5.3	12.6	2.5	1.8	2.2	2.5	0.6	2.9	4.9	1.4	0.7	0.0	13.2	1.5	2.5	5.9	1.5	5.3	0.4	20.6	0.5	0.4	3.8	14.7	2.7	0.0	0.3	15.5	0.0	4.7	5.3	11.1	4.4	6.4	4.0	4.2	0.0	0.1	0.0	0.0	6.0	0.0	0.0	0.4	2.4	2.0	1.3	3.2	0.3	2.0	13.5	6.2	0.5	2.3	15.4	0.8	1.4	3.7	0.9	0.0	0.8	4.6	0.0	3.2	0.8	0.7	0.6	0.5	0.1	0.4	2.7	0.5	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	2.2	0.3	0.4	0.0	3.9	0.0	0.0	14.2	0.0	0.0	0.0	3.0	0.0	0.9	0.1	0.2	0.0	6.3	0.4	5.0	0.4	7.6	4.9	0.4	0.4	7.7	7.5	0.5	3.8	0.4	20.6	14.7	2.7	0.6	0.8	0.9	2.7	0.6	0.7	0.6	0.0	6.0	0.0	0.0	0.6	1.4	0.2	10.2	2.0	2.2	2.5	4.0	1.2	7.0	37.3	5.1	0.0	0.6	11.1	2.5	0.0	0.0	0.2	10.4	9.0	0.7	0.0	32.1	1.4	7.9	0.0	34.4	3.7	1.4	2.6	4.3	1.7	1.8	0.0	6.0	0.1	0.0	1.1	0.0	15.2	12.9	2.7	0.6	0.4	12.9	30.3	11.7	0.0	0.1
HS3ST4	3OST4	ENSG00000182601	"Heparan sulfate-glucosamine 3-sulfotransferase 4"	Q9Y661	16	25692026-26137688	"Enzymes, Predicted membrane proteins"		Transferase		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in some"	5	"brain: 23.9"	"Cell type enriched"	"Detected in single"	8	"Bipolar cells: 5.8"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"NTERA-2: 5.5;SCLC-21H: 2.3;SuSa: 1.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"									NA	NA						"unprognostic (1.09e-2)"	"unprognostic (1.87e-1)"	"unprognostic (2.95e-1)"		"unprognostic (2.24e-1)"	"unprognostic (1.43e-3)"		"unprognostic (1.27e-1)"		"unprognostic (3.84e-1)"	"unprognostic (8.81e-3)"	"unprognostic (6.71e-2)"		"unprognostic (2.39e-1)"	"unprognostic (1.92e-1)"	"unprognostic (2.51e-2)"	"unprognostic (3.67e-2)"	0.7	0.8	6.9	0.6	9.3	0.6	5.1	6.8	23.9	1.1	0.6	2.6	0.0	0.6	0.7	1.3	0.9	0.7	0.6	0.6	11.5	10.0	0.7	0.6	0.6	0.6	5.9	10.8	0.7	0.6	0.6	0.1	0.6	14.3	2.0	0.6	0.3	0.8	0.6	0.6	0.7	0.6	0.6	2.2	3.7	1.1	1.3	1.5	0.0	0.6	0.0	0.8	1.0	0.2	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.5	0.0	5.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.1	1.5	0.0	0.0	0.1	0.0	0.8	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	6.9	9.3	6.8	13.4	11.5	10.0	5.9	10.8	14.3	1.5	0.0	0.0	0.0	0.4	0.0	5.8	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1
HS3ST5	3-OST-5	ENSG00000249853	"Heparan sulfate-glucosamine 3-sulfotransferase 5"	Q8IZT8	6	114055586-114343045	"Enzymes, Plasma proteins, Predicted intracellular proteins"		Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"brain: 13.1;seminal vesicle: 9.4;skeletal muscle: 10.1"	"Cell type enhanced"	"Detected in some"	20	"Bipolar cells: 5.0;Collecting duct cells: 10.4;Cone photoreceptor cells: 17.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"PC-3: 5.0;RT4: 9.2;SCLC-21H: 17.8;U-266/70: 4.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA021823, HPA064677"	Approved					NA	NA					"HPA021823: AB_1851100, HPA064677: AB_2685318"	"unprognostic (1.19e-1)"	"unprognostic (2.63e-2)"	"unprognostic (2.81e-2)"	"unprognostic (1.04e-2)"	"unprognostic (1.72e-2)"	"unprognostic (3.00e-2)"		"unprognostic (7.98e-4)"	"unprognostic (5.39e-2)"	"unprognostic (6.29e-2)"	"unprognostic (1.61e-1)"	"unprognostic (1.91e-1)"	"unprognostic (5.72e-2)"	"unprognostic (3.28e-2)"	"unprognostic (3.01e-1)"	"unprognostic (3.48e-1)"	"unprognostic (1.53e-2)"	0.5	1.9	3.3	0.9	13.1	1.3	0.5	0.6	11.9	0.8	1.0	9.1	3.5	0.7	0.8	0.5	0.6	0.6	0.7	0.5	4.2	3.5	0.9	0.5	1.1	0.5	6.1	2.7	0.6	1.3	0.5	0.3	0.6	7.8	0.7	0.9	0.6	0.7	9.4	10.1	1.3	1.2	0.9	7.5	0.5	1.2	0.9	8.0	0.0	0.6	0.0	0.5	2.5	0.2	0.0	0.6	0.0	0.1	0.0	0.0	0.0	0.1	0.0	3.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.2	0.4	0.0	0.0	0.0	0.0	0.1	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.8	2.5	5.0	0.0	1.0	0.0	0.0	9.2	17.8	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.8	0.0	0.1	4.5	0.0	0.0	0.0	0.0	2.8	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	3.3	13.1	0.6	5.7	4.2	3.5	6.1	2.7	7.8	8.0	0.0	0.0	0.0	0.0	1.1	5.0	0.7	0.0	0.0	0.0	10.4	17.7	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	3.4	0.0	0.0	0.0	0.1	0.0	0.6	0.0	0.0	0.0	1.4	0.0	0.0	0.7	0.4	0.0	0.1	0.0	0.0	0.2
HS3ST6	HS3ST5	ENSG00000162040	"Heparan sulfate-glucosamine 3-sulfotransferase 6"	Q96QI5	16	1911463-1918440	"Enzymes, Predicted intracellular proteins"		Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"esophagus: 18.8;skin 1: 15.0"	"Cell type enhanced"	"Detected in some"	15	"Horizontal cells: 20.6;Suprabasal keratinocytes: 8.0;Urothelial cells: 17.7"	"Cancer enhanced"	"Detected in many"		"urothelial cancer: 4.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"A549: 2.8;HaCaT: 2.8;U-2 OS: 1.8"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"									NA	NA						"unprognostic (5.72e-2)"	"prognostic favorable (3.73e-4)"		"unprognostic (1.30e-1)"		"unprognostic (1.20e-2)"		"unprognostic (1.19e-2)"	"unprognostic (3.10e-1)"	"unprognostic (4.99e-3)"		"unprognostic (2.10e-2)"		"unprognostic (6.55e-3)"	"unprognostic (2.42e-1)"	"unprognostic (3.61e-1)"	"unprognostic (2.26e-1)"	0.1	0.1	0.1	0.0	0.1	0.0	0.5	0.1	0.1	6.6	0.4	0.0	0.4	0.0	0.3	0.9	18.8	1.2	0.0	0.1	0.1	0.1	0.2	0.1	1.9	0.1	0.1	0.0	0.5	0.1	0.0	0.2	1.9	0.0	3.6	0.0	0.6	0.4	0.1	0.3	15.0	0.1	1.0	0.1	0.1	0.1	0.1	0.0	2.1	0.1	2.7	3.2	6.7	2.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.1	2.8	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.3	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	3.8	1.3	0.0	0.3	0.0	0.0	0.0	1.8	0.0	0.1	0.0	0.0	2.5	0.0	0.4	0.0	0.0	0.2	4.1	1.4	0.0	0.0	0.2	20.6	0.0	0.0	0.0	0.7	0.0	0.0	3.3	0.0	0.3	0.0	0.0	2.9	0.0	0.0	0.0	0.0	0.3	0.0	0.0	8.0	0.1	0.0	0.8	17.7
HSD11B1	"HSD11, HSD11B, SDR26C1"	ENSG00000117594	"Hydroxysteroid 11-beta dehydrogenase 1"	P28845	1	209686178-209734950	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Lipid metabolism, Steroid metabolism"	Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	7	"liver: 183.4"	"Cell type enriched"	"Detected in many"	13	"Hepatocytes: 560.1"	"Cancer enriched"	"Detected in all"	28	"liver cancer: 197.4"	"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"memory CD4 T-cell: 9.2"	"Lineage enriched"	"Detected in single"	20	"T-cells: 9.2"	"Cell line enriched"	"Detected in some"	5	"ASC diff: 151.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA047729	Enhanced					NA	NA		77000			"HPA047729: AB_2680135"	"unprognostic (1.08e-3)"	"unprognostic (2.13e-1)"	"unprognostic (2.32e-1)"	"unprognostic (1.40e-1)"	"unprognostic (1.57e-1)"	"unprognostic (3.68e-1)"	"unprognostic (2.02e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.30e-1)"	"unprognostic (3.63e-2)"	"unprognostic (8.35e-3)"	"unprognostic (8.69e-2)"	"prognostic unfavorable (1.97e-10)"	"unprognostic (3.41e-2)"	"unprognostic (3.91e-2)"	"unprognostic (6.45e-2)"	"unprognostic (1.59e-2)"	4.6	1.6	1.1	3.0	3.1	0.3	2.4	9.9	3.9	0.6	1.0	1.6	2.7	0.5	0.8	8.7	1.5	0.9	1.9	3.0	1.8	0.9	2.6	183.4	7.2	1.3	8.2	2.0	12.6	0.9	0.3	1.5	26.5	3.3	7.1	0.9	1.5	0.6	3.0	1.5	6.3	0.9	2.7	1.3	3.5	1.4	2.3	2.5	0.0	1.0	0.6	0.6	3.9	1.4	0.2	0.0	0.2	0.1	0.4	9.2	0.8	0.0	0.0	0.0	0.0	151.9	15.8	0.0	0.0	5.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.4	0.0	0.0	0.0	0.0	0.0	0.0	31.7	0.0	0.0	0.8	0.0	1.0	0.0	0.1	0.0	0.0	0.0	7.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.9	1.2	0.6	0.0	0.0	0.0	0.2	0.0	0.0	0.8	0.2	0.0	0.0	0.1	0.0	0.3	0.0	0.6	0.2	9.2	2.0	0.0	0.0	0.2	0.0	0.2	0.4	0.0	0.0	2.4	0.8	1.1	3.1	9.9	3.9	1.8	0.9	8.2	2.0	3.3	2.5	3.0	0.0	2.4	0.5	0.1	0.0	0.8	43.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.6	0.0	0.0	0.0	0.0	0.0	10.8	0.5	0.0	560.1	8.7	0.0	0.0	8.6	8.9	2.2	27.0	2.2	0.0	1.0	0.0	15.4	0.2	0.0	7.4	0.0	0.3	0.0	2.1	0.0	0.2	0.1	0.2	0.5	0.0	1.6
HSD17B1	"EDH17B2, EDHB17, HSD17, MGC138140, SDR28C1"	ENSG00000108786	"Hydroxysteroid 17-beta dehydrogenase 1"	P14061	17	42549214-42555213	"Enzymes, Predicted intracellular proteins"	"Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis"	Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	25	"placenta: 217.6"	"Cell type enriched"	"Detected in many"	5	"Syncytiotrophoblasts: 1251.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enriched"	"Detected in many"	8	"BEWO: 89.7"	"Low region specificity"	"Detected in single"							"HPA021032, HPA065296"	Enhanced		Supported	Cytosol		NA	NA			Cytosol		"HPA021032: AB_1844345, HPA065296: AB_2685457"	"unprognostic (1.13e-1)"	"unprognostic (1.40e-2)"	"unprognostic (1.68e-2)"	"unprognostic (9.25e-2)"	"unprognostic (1.73e-1)"	"unprognostic (3.88e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.10e-1)"	"unprognostic (9.35e-2)"	"unprognostic (6.04e-2)"	"unprognostic (2.88e-5)"	"unprognostic (2.17e-1)"	"unprognostic (1.30e-1)"	"unprognostic (2.60e-2)"	"unprognostic (5.09e-1)"	"unprognostic (4.98e-1)"	"unprognostic (1.32e-2)"	2.8	1.5	2.0	1.7	2.1	1.1	1.8	2.7	3.1	1.3	1.3	1.3	1.3	1.9	1.5	1.3	4.3	1.4	1.3	1.4	2.4	1.4	1.4	1.3	1.3	1.6	2.4	1.3	5.8	2.6	0.2	1.4	217.6	1.3	1.5	0.2	1.3	2.9	1.3	3.5	4.1	1.9	1.3	1.9	2.1	2.0	2.3	1.3	1.3	1.8	1.3	1.3	1.3	1.8	6.0	5.5	7.5	8.6	6.1	5.4	5.5	1.6	1.8	0.9	4.6	0.6	0.1	89.7	1.2	0.0	0.0	0.0	1.0	0.9	0.0	1.2	0.0	1.0	2.6	0.1	0.7	0.0	2.4	2.8	1.2	1.1	1.5	0.2	1.0	1.4	0.2	2.6	0.1	0.5	1.5	0.0	1.3	1.7	0.4	0.0	1.6	1.3	1.1	0.4	0.6	0.8	1.3	1.1	0.8	0.1	1.4	1.3	1.8	0.7	9.1	1.4	1.0	11.0	0.8	1.4	1.4	1.8	1.0	0.8	2.6	1.5	0.6	0.6	0.9	1.1	3.6	7.6	7.5	4.9	8.6	5.3	5.6	5.4	5.1	5.5	6.0	5.1	4.4	7.2	6.1	5.3	4.3	3.7	5.5	2.0	2.1	2.7	1.5	2.4	1.4	2.4	1.3	1.3	1.3	0.0	2.1	0.5	6.3	2.7	8.7	2.4	2.5	4.0	2.3	5.2	11.8	250.4	19.9	1.5	1.0	4.1	3.2	0.0	4.9	23.6	3.4	13.0	2.3	5.6	26.4	9.5	4.1	4.9	0.8	1.7	1.7	0.5	1.7	1.0	2.4	9.0	2.0	2.5	3.2	10.5	8.2	0.0	2.8	0.7	2.6	6.5	1251.0	1.3	1.9	8.4
HSD17B10	"17b-HSD10, ABAD, CAMR, ERAB, HADH2, MHBD, MRPP2, MRXS10, SDR5C1"	ENSG00000072506	"Hydroxysteroid 17-beta dehydrogenase 10"	Q99714	X	53431258-53434373	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"tRNA processing"	Oxidoreductase	"Disease mutation, Mental retardation, Neurodegeneration"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	4	"Hepatocytes: 343.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA001432	Approved					NA	NA		1800000			"HPA001432: AB_1078740"	"unprognostic (1.27e-1)"	"prognostic favorable (2.80e-4)"	"unprognostic (2.60e-1)"	"unprognostic (2.15e-1)"	"unprognostic (2.10e-1)"	"unprognostic (1.30e-1)"	"unprognostic (8.37e-2)"	"unprognostic (5.24e-2)"	"unprognostic (1.02e-1)"	"unprognostic (8.64e-3)"	"unprognostic (4.08e-3)"	"unprognostic (2.04e-1)"	"unprognostic (1.95e-2)"	"unprognostic (8.38e-2)"	"unprognostic (3.07e-3)"	"unprognostic (2.92e-1)"	"unprognostic (9.51e-2)"	20.9	29.8	13.2	19.1	14.5	16.4	15.9	7.9	14.0	16.9	20.6	16.2	20.2	17.2	17.1	19.0	31.3	14.8	19.6	42.6	11.9	14.0	33.9	96.7	12.7	21.6	16.1	9.7	21.0	32.7	12.5	18.4	25.0	14.9	15.3	19.4	13.0	23.2	17.8	35.4	22.9	17.4	18.6	14.8	19.7	17.4	8.6	14.0	25.6	28.4	39.0	26.0	16.1	17.9	30.4	53.2	12.8	38.2	27.7	33.3	32.9	22.3	38.3	18.7	34.7	18.4	8.1	28.3	13.9	13.9	37.1	24.4	39.3	19.3	38.2	12.7	15.9	24.1	23.5	60.2	28.1	20.4	30.2	33.8	18.0	54.9	32.5	30.9	33.9	28.2	17.3	26.7	28.7	16.1	8.1	27.1	34.4	25.7	30.3	17.2	78.9	30.0	51.0	51.8	30.3	49.5	30.7	34.6	67.6	28.5	24.8	33.1	43.6	40.0	47.9	25.3	24.9	50.4	31.6	12.1	15.9	25.3	33.1	21.0	24.8	34.5	47.2	22.1	71.4	23.4	12.8	38.2	11.4	27.0	36.7	27.8	30.0	25.1	26.7	53.2	30.4	21.1	22.2	3.2	27.7	26.8	29.0	33.3	32.9	13.2	14.5	7.9	14.0	11.9	14.0	16.1	9.7	14.9	14.0	44.7	34.1	58.8	68.9	76.7	11.0	53.6	96.8	29.4	30.7	96.0	3.9	152.6	240.4	110.3	1.3	54.5	72.5	116.8	117.5	226.1	88.0	68.7	56.4	343.1	121.0	12.7	100.4	52.8	71.2	4.5	72.5	86.0	91.1	131.7	59.9	45.2	90.4	42.1	89.1	333.9	11.4	77.6	85.6	15.1	62.3	101.6	126.8	78.8	78.6	62.3
HSD17B11	"17-BETA-HSD11, 17-BETA-HSDXI, DHRS8, PAN1B, RetSDR2, SDR16C2"	ENSG00000198189	"Hydroxysteroid 17-beta dehydrogenase 11"	Q8NBQ5	4	87336610-87391386	"Enzymes, Predicted intracellular proteins"	"Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis"	Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 100.1;intestine: 81.3"	"Cell type enhanced"	"Detected in many"	5	"Enterocytes: 489.8;Paneth cells: 501.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"neutrophil: 100.1"	"Group enriched"	"Detected in all"	4	"granulocytes: 100.1;monocytes: 25.8"	"Cell line enhanced"	"Detected in many"		"CAPAN-2: 68.5"	"Low region specificity"	"Detected in all"							HPA021608	Enhanced		Supported	"Lipid droplets"	"Intracellular and membrane"	NA	NA		14000	"Lipid droplets"		"HPA021608: AB_1847660"	"unprognostic (4.53e-2)"	"unprognostic (1.61e-1)"	"unprognostic (2.35e-2)"	"unprognostic (4.14e-2)"	"unprognostic (9.68e-2)"	"unprognostic (1.92e-1)"	"unprognostic (3.35e-1)"	"unprognostic (3.70e-2)"	"unprognostic (1.78e-1)"	"unprognostic (8.53e-2)"	"unprognostic (1.24e-3)"	"unprognostic (1.83e-1)"	"unprognostic (2.65e-3)"	"unprognostic (5.53e-2)"	"unprognostic (2.13e-2)"	"unprognostic (2.44e-2)"	"unprognostic (1.04e-2)"	22.0	23.8	11.1	15.5	8.4	23.6	18.9	23.8	12.8	19.6	58.3	7.2	9.5	53.0	19.1	15.7	6.5	14.6	26.3	9.0	10.1	6.4	18.1	57.4	25.3	14.7	14.2	7.9	18.0	24.5	3.0	12.6	11.4	9.7	15.5	36.2	5.7	6.7	9.0	6.4	6.2	81.3	15.2	14.2	12.2	11.6	11.6	10.6	15.8	8.1	8.4	8.2	21.0	15.9	7.7	14.2	100.1	25.8	10.4	10.3	18.7	0.2	10.7	5.2	13.1	16.1	22.2	7.4	5.8	9.1	3.8	7.0	8.9	68.5	0.0	11.2	5.9	3.6	0.2	15.2	1.2	4.2	16.9	3.2	14.7	5.9	30.0	9.1	26.2	27.5	15.7	0.4	5.2	1.8	12.1	7.3	6.4	15.3	7.6	7.0	0.4	5.3	32.1	8.9	33.3	1.8	14.7	4.8	17.3	10.5	16.4	1.7	16.7	11.4	0.3	19.5	7.0	0.0	25.6	6.1	2.6	11.8	10.5	3.0	3.7	1.5	1.6	4.9	18.6	17.8	61.0	25.8	55.9	8.7	18.4	10.3	7.7	8.8	9.0	14.2	6.6	8.1	9.0	100.1	10.4	15.2	4.8	9.9	18.7	11.1	8.4	23.8	12.8	10.1	6.4	14.2	7.9	9.7	10.6	291.8	133.2	72.8	64.6	24.8	1.2	4.4	310.8	75.0	111.5	41.8	2.0	27.4	21.6	38.6	0.9	71.4	489.8	0.0	51.8	45.8	75.4	36.7	98.1	303.2	118.3	17.5	90.0	101.9	213.8	0.9	96.4	169.0	64.1	36.1	155.1	34.2	52.9	501.0	55.9	148.1	3.9	71.1	54.2	2.6	13.1	18.7	12.5	110.7	226.2	80.0
HSD17B12	"KAR, SDR12C1"	ENSG00000149084	"Hydroxysteroid 17-beta dehydrogenase 12"	Q53GQ0	11	43680558-43856617	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis"	Oxidoreductase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA016427	Approved					NA	NA		200000			"HPA016427: AB_1844347"	"unprognostic (1.93e-1)"	"unprognostic (1.92e-2)"	"unprognostic (1.53e-1)"	"unprognostic (1.62e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.14e-3)"	"prognostic unfavorable (2.76e-4)"	"unprognostic (2.99e-1)"	"unprognostic (3.31e-2)"	"unprognostic (9.16e-3)"	"unprognostic (5.16e-2)"	"unprognostic (7.54e-2)"	"prognostic favorable (2.10e-8)"	"unprognostic (6.87e-2)"	"unprognostic (1.49e-1)"	"unprognostic (2.43e-1)"	"unprognostic (2.28e-2)"	27.2	32.6	33.5	16.6	31.9	10.5	30.4	12.8	33.1	26.3	30.7	31.4	29.3	32.0	22.3	25.3	24.3	20.1	28.0	36.9	30.9	31.1	42.9	59.8	25.8	19.9	38.5	21.4	22.4	26.4	66.6	29.4	19.4	45.7	26.4	29.4	26.6	25.3	22.9	16.1	18.2	30.8	23.3	44.9	23.5	25.6	17.6	24.4	15.2	32.4	32.5	17.5	19.4	18.6	12.8	18.7	9.8	12.7	13.5	15.0	9.6	9.0	14.8	16.5	16.7	55.3	52.6	10.8	23.4	23.1	16.3	17.8	17.9	19.1	22.7	16.6	21.0	27.0	35.7	11.5	29.5	20.2	4.2	21.3	10.5	8.3	15.6	28.1	32.5	30.1	32.3	22.7	16.4	46.8	20.8	22.5	14.3	9.9	37.9	14.0	5.2	8.6	14.5	30.2	11.4	10.8	14.6	24.5	25.6	31.1	22.4	6.0	13.6	31.3	26.4	22.8	16.2	18.9	26.2	21.5	17.6	6.9	45.7	27.3	19.5	24.5	13.6	19.1	5.8	13.2	6.1	12.2	5.5	11.0	12.7	11.7	11.0	8.8	9.2	18.7	12.8	15.0	12.9	9.8	13.5	6.5	15.1	5.0	9.6	33.5	31.9	12.8	30.8	30.9	31.1	38.5	21.4	45.7	24.4	59.6	94.5	60.7	41.7	28.2	71.5	81.5	76.5	89.7	64.8	48.8	72.6	50.4	23.2	87.7	47.4	65.0	71.5	23.3	72.4	37.6	41.7	54.4	152.4	109.0	55.3	114.4	132.6	70.0	43.0	14.4	31.7	49.6	37.1	32.5	68.5	118.3	65.6	45.6	53.4	39.7	63.0	77.6	48.4	11.4	11.5	40.0	62.6	27.4	93.1	38.3
HSD17B2	"HSD17, SDR9C2"	ENSG00000086696	"Hydroxysteroid 17-beta dehydrogenase 2"	P37059	16	82035004-82098534	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis"	Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 83.1;liver: 52.9;placenta: 110.8"	"Cell type enhanced"	"Detected in many"	14	"Cholangiocytes: 137.6;Enterocytes: 250.1;Hepatocytes: 98.5;Paneth cells: 199.9"	"Cancer enhanced"	"Detected in many"		"liver cancer: 10.9"	"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"BJ hTERT+: 22.4;Hep G2: 17.8;hTERT-HME1: 10.7;OE19: 32.8;RT4: 36.8;TIME: 20.6"	"Group enriched"	"Detected in some"	5	"midbrain: 2.6;pons and medulla: 3.5"	"Not detected"	"Not detected"			"HPA021826, HPA050235"	Enhanced		Approved	"Endoplasmic reticulum"		NA	NA			"Endoplasmic reticulum"		"HPA021826: AB_10961148, HPA050235: AB_2681059"	"unprognostic (1.50e-1)"	"unprognostic (2.53e-2)"	"unprognostic (1.42e-1)"	"unprognostic (6.48e-2)"	"unprognostic (2.58e-1)"	"unprognostic (1.77e-1)"	"unprognostic (4.29e-2)"	"unprognostic (2.60e-1)"	"unprognostic (7.35e-2)"	"unprognostic (6.05e-3)"	"unprognostic (4.98e-2)"	"unprognostic (7.35e-2)"	"unprognostic (6.31e-4)"	"unprognostic (5.39e-2)"	"unprognostic (1.14e-1)"	"unprognostic (4.30e-2)"	"prognostic favorable (3.83e-4)"	0.7	0.1	0.2	4.1	0.2	0.0	3.9	0.2	0.3	0.7	41.3	0.3	0.2	71.3	0.6	0.2	1.7	0.2	13.3	0.2	0.2	0.2	2.8	52.9	1.0	0.2	0.2	0.2	0.2	16.0	0.0	0.6	110.8	0.4	3.1	9.4	21.3	9.4	0.2	0.3	1.8	83.1	1.5	0.2	0.2	3.2	0.2	0.2	0.2	0.2	1.1	1.3	21.4	6.6	1.3	1.4	3.6	1.1	1.0	0.7	0.1	0.1	0.0	0.1	0.0	0.0	0.3	0.2	0.0	22.4	0.0	0.0	4.1	0.6	0.0	4.5	0.0	0.0	0.2	0.0	0.9	0.0	0.0	0.0	0.1	0.1	17.8	0.1	0.1	0.1	0.0	1.2	0.0	10.7	0.2	0.3	0.0	0.0	0.1	3.3	0.0	0.0	0.3	0.1	32.8	8.1	0.0	0.0	0.4	0.4	36.8	0.2	0.6	0.0	1.0	0.1	0.0	0.0	0.0	20.6	0.2	0.2	0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.0	1.6	1.1	0.6	0.7	0.5	0.4	0.6	0.4	0.4	0.3	1.3	0.4	0.6	3.6	1.0	0.6	1.4	0.3	0.1	0.2	0.2	0.2	0.3	0.2	0.2	0.2	0.2	0.4	0.2	3.0	3.8	0.0	2.7	0.3	0.1	0.4	137.6	6.7	2.3	0.0	0.0	2.1	0.0	47.5	0.1	0.2	250.1	0.0	5.5	1.5	3.1	1.8	0.0	98.5	3.0	0.0	2.9	3.1	2.4	0.8	0.0	0.0	1.7	0.0	19.3	42.0	13.6	199.9	0.0	1.0	0.6	0.0	0.3	0.0	0.0	1.0	5.4	0.0	33.8	10.0
HSD17B3	SDR12C2	ENSG00000130948	"Hydroxysteroid 17-beta dehydrogenase 3"	P37058	9	96235306-96302152	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis"	Oxidoreductase	"Disease mutation, Pseudohermaphroditism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	7	"testis: 41.9"	"Cell type enriched"	"Detected in some"	8	"Leydig cells: 100.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"HBEC3-KT: 5.0;HEL: 4.4;U-2 OS: 8.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA056833	Enhanced		Approved	Vesicles		NA	NA			Vesicles		"HPA056833: AB_2683252"	"unprognostic (2.78e-1)"	"unprognostic (6.61e-3)"	"unprognostic (1.03e-1)"	"unprognostic (5.76e-2)"	"unprognostic (1.15e-1)"	"unprognostic (1.55e-1)"	"unprognostic (3.08e-2)"	"unprognostic (6.15e-2)"	"unprognostic (1.74e-1)"	"unprognostic (5.13e-2)"	"unprognostic (3.26e-4)"	"unprognostic (3.45e-1)"	"unprognostic (5.48e-8)"	"unprognostic (8.47e-3)"	"unprognostic (1.15e-1)"	"unprognostic (7.24e-2)"	"unprognostic (3.11e-2)"	0.5	0.4	1.0	0.5	1.0	0.4	0.5	0.5	0.9	0.8	0.5	0.5	0.5	0.4	0.5	0.5	0.5	1.3	0.5	0.5	1.7	0.5	1.0	6.3	0.5	0.5	1.6	0.5	0.5	1.3	0.4	0.5	0.5	0.5	0.8	0.4	0.5	0.5	0.5	0.5	0.5	1.1	0.5	1.9	0.5	0.4	41.9	0.5	0.5	4.5	0.5	0.5	0.5	0.5	0.0	0.3	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.0	0.0	0.0	0.0	4.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.6	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	1.0	1.0	0.5	0.9	1.7	0.5	1.6	0.5	0.5	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.5	0.4	0.3	0.0	0.4	0.0	0.2	0.1	0.0	1.6	0.0	0.0	1.7	0.0	0.0	7.8	100.1	0.0	0.0	0.0	0.2	0.5	0.1	0.0	12.0	0.0	0.2	0.0	0.5	0.3	1.9	0.3	0.1	0.0	0.2	0.0
HSD17B4	"DBP, MFE-2, SDR8C1"	ENSG00000133835	"Hydroxysteroid 17-beta dehydrogenase 4"	P51659	5	119452443-119637199	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Fatty acid metabolism, Lipid metabolism"	"Isomerase, Lyase, Oxidoreductase"	"Deafness, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Hepatocytes: 203.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021302, HPA021311, HPA021479"	Enhanced		Enhanced	Peroxisomes		NA	NA		6900000	Peroxisomes		"HPA021302: AB_1844350, HPA021311: AB_1844351, HPA021479: AB_1844352"	"unprognostic (1.03e-1)"	"unprognostic (1.05e-1)"	"prognostic favorable (1.33e-4)"	"unprognostic (3.21e-2)"	"unprognostic (1.24e-2)"	"unprognostic (3.12e-2)"	"unprognostic (2.83e-3)"	"unprognostic (5.47e-2)"	"unprognostic (1.54e-1)"	"unprognostic (2.03e-2)"	"unprognostic (1.02e-1)"	"unprognostic (3.85e-1)"	"prognostic favorable (6.31e-6)"	"unprognostic (1.60e-1)"	"unprognostic (8.26e-2)"	"unprognostic (1.80e-1)"	"unprognostic (6.65e-3)"	25.1	42.4	22.1	15.5	21.3	6.4	46.0	12.3	23.6	27.8	30.1	24.1	83.8	28.6	16.2	20.7	24.6	15.1	20.6	27.3	23.8	21.2	31.3	116.3	30.5	16.7	27.0	21.7	15.1	29.9	33.2	20.5	19.0	23.9	20.9	25.2	10.7	20.0	86.2	20.7	19.2	30.5	15.6	33.6	16.9	20.7	8.1	25.5	10.8	48.9	17.3	14.5	24.1	25.3	6.1	11.1	31.4	13.6	3.2	4.2	5.3	17.8	15.4	29.0	38.4	72.4	34.0	15.3	17.4	23.5	16.5	30.1	12.7	29.8	23.9	35.9	18.8	24.3	18.0	21.3	37.9	25.8	26.1	19.7	31.4	16.8	24.2	18.4	9.9	49.2	29.6	15.9	17.7	16.7	19.4	28.2	16.5	10.7	13.9	17.9	15.5	15.1	6.4	21.5	44.1	10.9	19.3	29.1	25.8	26.4	49.4	21.9	18.9	40.9	6.4	19.0	28.7	23.7	16.7	20.0	16.2	11.1	17.8	14.2	7.1	14.8	8.8	18.4	26.5	15.9	31.4	13.6	24.7	3.4	8.0	4.2	6.1	3.2	2.9	11.1	5.8	3.1	2.9	2.4	3.2	7.8	6.9	2.0	5.3	22.1	21.3	12.3	23.6	23.8	21.2	27.0	21.7	23.9	25.5	68.5	94.4	20.8	34.3	13.3	18.5	62.9	81.5	24.1	47.8	34.9	13.7	57.8	71.3	28.8	7.4	26.4	50.3	0.0	31.4	21.8	24.2	32.2	65.9	203.2	70.1	14.3	31.7	31.3	50.9	9.3	31.9	35.3	8.5	103.6	42.6	44.1	23.2	24.6	48.1	50.5	15.4	6.5	20.0	15.9	22.2	15.1	54.3	13.1	51.1	31.4
HSD17B6	"HSE, RODH, SDR9C6"	ENSG00000025423	"Hydroxysteroid 17-beta dehydrogenase 6"	O14756	12	56752161-56787790	"Enzymes, Predicted intracellular proteins"	"Lipid metabolism, Steroid metabolism"	Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	18	"liver: 241.2"	"Cell type enriched"	"Detected in many"	10	"Hepatocytes: 1569.2"	"Cancer enriched"	"Detected in many"	5	"liver cancer: 170.3"	"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"Karpas-707: 11.8;U-266/84: 14.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA059141	Enhanced		Approved	Nucleoplasm,Vesicles		NA	NA			"Nucleoplasm, Vesicles"		"HPA059141: AB_2683922"	"unprognostic (7.70e-2)"	"unprognostic (8.76e-2)"	"unprognostic (5.08e-2)"	"unprognostic (1.92e-2)"	"unprognostic (2.01e-1)"	"unprognostic (3.79e-2)"	"prognostic favorable (6.32e-4)"	"unprognostic (1.06e-2)"	"unprognostic (3.21e-1)"	"unprognostic (1.44e-1)"	"unprognostic (1.35e-1)"	"unprognostic (6.74e-2)"	"unprognostic (2.50e-10)"	"unprognostic (1.26e-1)"	"unprognostic (1.79e-1)"	"unprognostic (1.08e-1)"	"unprognostic (1.05e-1)"	1.1	0.5	3.6	1.4	5.2	0.2	0.3	1.2	2.4	9.4	3.3	0.5	2.6	0.6	4.1	0.7	1.6	0.9	2.6	0.4	1.6	1.4	0.5	241.2	8.7	0.3	2.0	2.6	1.1	0.3	0.2	0.0	0.9	0.6	7.9	1.3	1.4	0.2	10.2	0.2	0.2	0.7	11.3	1.0	6.2	0.8	3.2	0.8	0.0	13.3	0.0	0.3	9.9	2.3	2.0	2.0	0.1	1.3	0.1	3.4	0.8	0.3	0.7	1.7	0.3	1.7	1.2	2.0	3.6	3.1	1.7	1.7	0.4	0.4	10.2	1.5	0.4	0.5	0.3	5.3	0.9	1.0	6.5	2.0	3.2	1.0	0.5	1.1	1.6	5.3	0.9	0.3	1.0	0.5	0.5	0.0	9.0	0.9	11.8	0.8	2.1	4.6	1.0	6.6	0.6	0.6	6.3	0.7	2.5	0.2	1.2	9.7	2.0	1.7	3.1	0.8	0.6	0.5	1.3	0.3	0.8	0.8	3.6	0.9	10.3	14.6	6.7	1.2	5.9	0.6	0.0	0.2	0.1	3.0	0.6	3.4	2.0	2.5	2.4	0.6	1.1	3.3	2.2	0.0	0.1	1.3	2.0	2.8	0.8	3.6	5.2	1.2	2.4	1.6	1.4	2.0	2.6	0.6	0.8	160.8	89.7	28.7	2.3	1.1	0.2	0.2	35.7	2.7	17.0	0.0	0.0	1.3	0.0	0.0	2.5	0.4	0.0	23.3	0.0	2.4	4.8	9.9	0.0	1569.2	0.3	0.0	0.0	31.3	41.1	1.5	11.5	0.1	0.0	1.8	0.3	1.0	0.1	0.0	1.4	0.0	0.6	12.9	3.7	13.6	10.6	1.4	0.3	4.4	0.3	0.9
HSD17B7	"PRAP, SDR37C1"	ENSG00000132196	"Hydroxysteroid 17-beta dehydrogenase 7"	P56937	1	162790702-162812817	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis"	Oxidoreductase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 16.3;liver: 16.8"	"Cell type enhanced"	"Detected in many"	5	"Cone photoreceptor cells: 58.9"	"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA047496	Approved					NA	NA					"HPA047496: AB_2680068"	"unprognostic (2.93e-1)"	"unprognostic (1.36e-2)"	"unprognostic (6.03e-2)"	"unprognostic (1.12e-1)"	"unprognostic (2.34e-1)"	"unprognostic (1.63e-3)"	"unprognostic (2.57e-1)"	"unprognostic (2.51e-2)"	"unprognostic (1.36e-1)"	"unprognostic (1.38e-1)"	"unprognostic (1.94e-1)"	"unprognostic (1.37e-1)"	"prognostic unfavorable (8.47e-5)"	"unprognostic (6.25e-2)"	"unprognostic (1.90e-1)"	"unprognostic (6.35e-2)"	"unprognostic (3.17e-2)"	1.9	9.2	1.4	2.0	1.0	0.7	4.3	1.4	1.9	2.8	2.9			3.1	2.1	4.4	4.7	2.2	1.6	1.6	1.9	2.6	2.2	16.8	4.3	3.7	1.5		3.6	2.6	2.5	4.1	1.8		2.8	4.0		3.1	1.3	2.0	3.6	3.1	1.8	3.2	2.9	2.9	0.6			2.8		3.9	2.2	2.8	12.5	9.6	15.8	7.4	7.0	16.3	10.5	6.3	6.5	17.3	7.7	10.0	10.8	11.3	2.6	8.3	5.1	10.2	9.0	20.6	15.3	5.9	2.2	31.0	10.3	15.7	22.2	5.3	6.7	8.4	3.9	4.9	14.1	8.3	6.9	6.9	6.5	12.4	19.6	6.4	4.0	8.4	10.7	7.3	10.6	4.3	4.5	8.9	7.4	11.0	12.3	8.1	5.0	10.4	9.8	18.0	10.2	14.8	7.7	4.1	4.0	3.9	15.6	6.5	8.8	4.9	2.3	5.6	3.5	5.0	6.5	6.4	15.2	3.7	0.6	5.7	15.8	6.0	11.2	13.9	6.1	14.6	12.5	10.5	13.4	6.5	10.9	13.0	13.1	5.0	7.0	7.4	9.6	16.3	10.5											0.0	23.8	19.9	22.2	9.7	23.0	2.0	15.3	18.7	15.9	10.4	58.9	14.2	3.3	11.4	1.7	11.7	10.9	0.0	23.7	12.6	13.1	20.2	4.7	22.5	11.6	11.1	5.8	7.4	2.8	1.0	6.4	13.0	16.9	10.0	7.9	14.1	12.6	14.0	6.7	9.3	42.9	0.0	11.3	2.1	5.4	11.0	16.0	20.2	8.5	11.5
HSD17B8	"D6S2245E, FABGL, H2-KE6, HKE6, KE6, RING2, SDR30C1"	ENSG00000204228	"Hydroxysteroid 17-beta dehydrogenase 8"	Q92506	6	33204642-33206831	"Enzymes, Predicted intracellular proteins"	"Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis"	Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"pancreas: 47.8"	"Cell type enhanced"	"Detected in many"	5	"Distal tubular cells: 106.1;Proximal tubular cells: 106.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"RPMI-8226: 14.8;T-47d: 9.6;U-266/70: 14.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042132	Enhanced					NA	NA		52000			"HPA042132: AB_10793978"	"prognostic favorable (9.99e-4)"	"unprognostic (4.24e-1)"	"unprognostic (2.43e-1)"	"unprognostic (1.48e-1)"	"unprognostic (2.10e-1)"	"unprognostic (8.11e-2)"	"prognostic favorable (1.90e-5)"	"unprognostic (1.50e-3)"	"unprognostic (3.12e-1)"	"unprognostic (1.34e-2)"	"unprognostic (1.58e-1)"	"unprognostic (1.89e-1)"	"prognostic favorable (2.18e-12)"	"unprognostic (2.82e-2)"	"unprognostic (5.57e-1)"	"unprognostic (3.09e-1)"	"unprognostic (3.23e-2)"	3.5	11.5	4.1	5.4	4.1	3.0	6.1	3.4	5.9	5.3	12.4	5.3	17.7	6.6	3.2	14.7	11.3	8.1	8.6	11.0	4.1	3.7	13.9	24.0	8.1	7.7	5.3	4.6	3.3	47.8	12.8	6.6	3.5	4.7	4.5	5.6	9.3	16.7	30.1	14.6	10.6	11.2	4.1	5.3	5.4	5.8	5.1	2.4	10.3	11.2	15.5	10.7	5.3	5.2	4.8	4.8	0.4	3.1	4.1	7.8	6.0	1.1	2.1	1.0	1.3	0.3	0.6	0.4	0.1	0.7	0.0	0.0	1.5	2.5	7.0	2.0	0.1	0.3	4.2	1.0	3.2	0.1	1.2	1.2	0.3	2.0	3.8	3.0	0.0	0.5	0.7	4.3	0.0	7.4	0.0	0.3	2.5	0.1	6.8	0.6	2.3	5.2	0.1	0.3	3.3	0.9	3.0	0.1	14.8	4.1	0.1	2.0	1.1	0.4	5.6	1.3	0.7	9.6	0.2	0.1	0.2	1.2	0.0	0.0	14.6	7.0	2.6	0.4	0.1	0.2	0.0	1.4	0.4	4.8	3.1	7.8	4.8	7.2	7.3	2.8	3.1	7.6	7.8	0.1	4.1	3.1	4.8	5.2	6.0	4.1	4.1	3.4	5.9	4.1	3.7	5.3	4.6	4.7	2.4	17.9	16.3	6.7	21.5	26.4	10.3	24.3	38.2	26.8	14.8	21.0	5.9	25.7	106.1	24.6	5.1	8.5	30.9	23.3	28.3	10.1	10.0	13.7	6.9	60.4	14.9	1.6	17.2	6.7	8.9	11.1	6.9	10.0	47.2	10.0	23.7	28.7	19.1	21.0	5.6	106.8	11.8	0.0	5.9	7.5	5.5	32.5	14.5	14.0	43.6	21.3
HSD3B1	"HSD3B, HSDB3, SDR11E1"	ENSG00000203857	"Hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 1"	P14060	1	119507198-119515054	"Enzymes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Lipid metabolism, Steroid metabolism, Steroidogenesis"	"Isomerase, Multifunctional enzyme, Oxidoreductase"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	19	"placenta: 231.4"	"Group enriched"	"Detected in some"	23	"Extravillous trophoblasts: 115.9;Syncytiotrophoblasts: 419.8"	"Cancer enhanced"	"Detected in single"		"urothelial cancer: 1.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"CACO-2: 36.4;SuSa: 16.3"									"HPA043261, HPA043264, HPA044028"	Supported		Approved	"Nucleoli,Endoplasmic reticulum,Cytokinetic bridge"		NA	NA			"Nucleoli, Endoplasmic reticulum"	"Cytokinetic bridge"	"HPA043261: AB_2630368, HPA043264: AB_2678398, HPA044028: AB_2678781"			"unprognostic (1.53e-1)"				"unprognostic (7.11e-2)"					"unprognostic (1.15e-1)"		"unprognostic (1.04e-1)"			"prognostic favorable (4.59e-5)"	0.1	0.6	0.0	0.0	0.3	0.0	0.7	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.6	0.1	0.0	0.0	0.0	0.1	0.5	0.0	0.0	231.4	0.1	0.0	0.1	0.0	0.0	0.0	0.0	4.5	11.9	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.6	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.1	0.0	0.0	0.0	36.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.4	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	4.0	0.4	0.5	16.3	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.5	0.0	0.0	0.0	0.0	0.7	0.0	0.0	115.9	0.0	0.0	0.0	0.0	6.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	419.8	0.0	0.0	0.0
HSD3B2	SDR11E2	ENSG00000203859	"Hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 2"	P26439	1	119414931-119423035	"Disease related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins"	Steroidogenesis	"Isomerase, Multifunctional enzyme, Oxidoreductase"	"Congenital adrenal hyperplasia, Disease mutation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"adrenal gland: 223.2"	"Cell type enhanced"	"Detected in some"	17	"Enterocytes: 1.6;Exocrine glandular cells: 1.1;Peritubular cells: 2.5"	"Cancer enhanced"	"Detected in single"		"testis cancer: 0.6"	"Region enriched"	"Detected in single"	198	"basal ganglia: 19.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"SCLC-21H: 1.5;SH-SY5Y: 1.4;SK-MEL-30: 5.1;SuSa: 1.9;TIME: 1.2;WM-115: 3.2"									"HPA043261, HPA043264, HPA044028"	Supported		Uncertain	"Nucleoli,Endoplasmic reticulum,Cytokinetic bridge"		NA	NA			"Nucleoli, Endoplasmic reticulum"	"Cytokinetic bridge"	"HPA043261: AB_2630368, HPA043264: AB_2678398, HPA044028: AB_2678781"	"unprognostic (3.56e-1)"		"unprognostic (1.85e-1)"		"unprognostic (2.80e-1)"		"unprognostic (2.72e-2)"		"unprognostic (8.87e-2)"	"unprognostic (3.91e-2)"	"unprognostic (3.43e-2)"	"unprognostic (1.94e-1)"	"unprognostic (6.51e-2)"	"unprognostic (1.97e-2)"	"unprognostic (1.55e-1)"			0.0	223.2	0.0	0.8	19.8	0.0	0.0	0.0	0.0	0.0	0.5	43.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.9	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	3.6	0.2	0.0	0.0	0.0	1.9	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.6	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.5	1.4	0.0	0.0	5.1	1.9	0.0	0.0	1.2	0.2	0.1	0.1	0.7	0.0	0.0	0.0	0.8	0.0	3.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	19.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	1.6	0.0	1.1	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.5	0.0	2.5	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0
HSD3B7	"C(27)-3BETA-HSD, SDR11E3"	ENSG00000099377	"Hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 7"	Q9H2F3	16	30985207-30989152	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	Steroidogenesis	Oxidoreductase	"Disease mutation, Intrahepatic cholestasis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 74.1"	"Cell type enhanced"	"Detected in many"	5	"Hepatocytes: 52.9;Hofbauer cells: 55.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	22	"basophil: 24.5;eosinophil: 13.5"	"Lineage enriched"	"Detected in single"	29	"granulocytes: 24.5"	"Cell line enhanced"	"Detected in many"		"HDLM-2: 31.6;Hep G2: 23.1;HMC-1: 35.9;U-2197: 34.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA015965, HPA050521, HPA060847"	Uncertain		Enhanced	"Lipid droplets"		NA	NA			"Lipid droplets"		"HPA015965: , HPA050521: AB_2681155, HPA060847: AB_2684379"	"unprognostic (5.41e-3)"	"unprognostic (4.14e-3)"	"prognostic unfavorable (5.95e-4)"	"unprognostic (2.62e-2)"	"unprognostic (5.06e-3)"	"unprognostic (1.47e-2)"	"unprognostic (3.52e-2)"	"unprognostic (1.85e-1)"	"unprognostic (2.04e-2)"	"unprognostic (1.76e-1)"	"unprognostic (3.20e-2)"	"unprognostic (2.81e-1)"	"prognostic unfavorable (1.60e-6)"	"unprognostic (2.45e-1)"	"unprognostic (1.12e-1)"	"unprognostic (1.58e-1)"	"unprognostic (1.79e-1)"	21.6	11.2	2.5	7.5	4.7	1.8	7.3	2.7	4.0	4.9	8.3	4.6	2.8	11.2	5.3	6.4	9.4	4.4	7.4	5.2	3.1	1.6	25.6	74.1	6.4	5.6	3.5	1.4	9.3	17.7	5.6	2.6	6.1	3.7	5.9	3.2	2.9	4.5	2.6	5.1	7.8	13.3	6.7	4.8	8.3	4.8	3.6	3.7	1.0	2.9	4.5	4.6	8.0	3.9	0.1	0.8	24.5	0.8	0.2	0.0	0.3	7.0	8.1	0.8	4.1	2.9	10.7	0.5	8.8	14.0	1.7	3.6	0.6	12.3	0.4	2.9	10.8	0.3	2.1	0.8	1.3	0.9	31.6	1.9	0.5	6.4	23.1	2.7	0.1	35.9	5.1	2.2	8.4	1.7	4.1	0.8	0.4	1.6	0.3	6.6	15.1	0.2	5.0	0.6	3.0	1.1	0.8	2.8	7.8	5.4	0.4	3.0	1.5	1.1	5.8	0.8	0.4	11.2	0.5	4.1	3.7	1.0	34.9	0.9	0.6	5.1	0.4	14.3	0.9	0.3	24.5	0.8	13.5	0.0	0.1	0.0	0.0	0.0	0.0	0.8	0.1	0.0	0.0	0.6	0.2	0.0	0.3	0.0	0.3	2.5	4.7	2.7	4.0	3.1	1.6	3.5	1.4	3.7	3.7	3.0	6.2	2.7	2.2	7.0	0.7	1.6	25.5	1.4	0.0	14.0	0.0	1.7	13.3	34.6	37.8	6.5	20.6	0.0	26.8	2.6	9.0	2.5	9.2	52.9	55.1	1.6	7.5	6.7	7.9	1.1	6.1	14.8	13.5	21.6	7.2	1.9	19.4	11.2	4.9	33.2	0.4	12.9	9.0	0.6	1.1	11.0	1.1	1.0	15.7	2.4
HSPA5	"BiP, GRP78"	ENSG00000044574	"Heat shock protein family A (Hsp70) member 5"	P11021	9	125234853-125241330	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters"		"Chaperone, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	4	"Basal glandular cells: 1106.3;Syncytiotrophoblasts: 1110.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HHSteC: 200.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB005221, HPA038845, HPA038846"	Enhanced		Approved	Cytosol	"Intracellular and membrane"	NA	NA		1000000000	Cytosol		"CAB005221: AB_631616, HPA038845: AB_10673477, HPA038846: AB_10673478"	"unprognostic (3.98e-2)"	"unprognostic (2.50e-3)"	"unprognostic (6.64e-2)"	"unprognostic (9.60e-3)"	"unprognostic (1.54e-3)"	"unprognostic (6.02e-3)"	"unprognostic (9.08e-3)"	"unprognostic (9.11e-3)"	"unprognostic (4.50e-2)"	"unprognostic (7.45e-3)"	"unprognostic (1.49e-1)"	"unprognostic (8.96e-2)"	"prognostic unfavorable (3.05e-4)"	"unprognostic (1.03e-1)"	"unprognostic (1.34e-1)"	"unprognostic (7.28e-2)"	"unprognostic (3.66e-2)"	44.2	40.3	26.3	40.8	38.4	125.0	58.8	19.5	26.9	37.7	29.3	19.8	47.0	25.5	31.6	75.3	34.1	31.1	25.5	72.7	23.3	28.6	60.4	147.6	43.6	32.7	34.3	14.3	36.2	110.3	41.1	47.6	62.6	43.5	34.3	33.0	16.5	84.9	40.7	23.9	32.3	38.3	33.8	28.2	33.8	35.1	33.0	41.5	23.2	219.3	21.7	29.8	50.4	75.1	33.3	53.8	57.4	55.3	51.9	63.0	90.0	35.5	24.0	31.7	41.8	37.9	43.9	74.7	64.1	50.9	47.7	56.0	37.2	71.1	41.1	40.0	46.7	103.4	45.5	28.3	57.2	51.3	23.8	14.3	24.6	30.1	67.1	200.5	33.5	46.6	27.0	112.4	38.2	167.8	50.6	74.0	8.7	18.2	57.5	34.6	26.3	14.7	23.7	35.8	87.0	24.2	14.0	32.3	66.6	46.2	23.5	16.4	29.2	40.7	43.7	65.3	51.1	45.0	24.5	49.6	29.1	28.3	29.7	29.7	60.2	57.4	34.8	70.6	28.3	43.8	57.4	55.3	44.3	61.9	54.8	63.0	33.3	45.7	57.7	48.6	24.9	37.6	46.6	44.3	51.9	35.5	53.8	31.2	90.0	26.3	38.4	19.5	26.9	23.3	28.6	34.3	14.3	43.5	41.5	172.7	228.8	134.1	1106.3	260.1	93.3	493.6	73.9	190.1	253.6	106.4	331.8	423.2	38.1	330.8	34.2	189.6	316.5	46.7	227.7	576.5	389.6	402.8	329.8	324.2	392.1	60.4	487.5	159.0	114.8	42.9	162.3	280.8	172.1	141.5	125.9	124.7	293.4	101.7	164.1	109.1	122.6	116.4	222.8	360.8	228.7	206.6	1110.2	140.9	109.4	772.3
HSPD1	"GroEL, HSP60, SPG13"	ENSG00000144381	"Heat shock protein family D (Hsp60) member 1"	P10809	2	197486581-197516737	"Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Host-virus interaction"	"Chaperone, Isomerase"	"Cancer-related genes, Disease mutation, Hereditary spastic paraplegia, Leukodystrophy, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"vagina: 162.6"	"Cell type enhanced"	"Detected in all"	5	"Basal glandular cells: 1171.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA001523, CAB002775, HPA050025, CAB072816"	Supported		Enhanced	Mitochondria		NA	NA		53000000	Mitochondria		"CAB002775: , CAB072816: , HPA001523: AB_1079028, HPA050025: AB_2680995"	"unprognostic (2.79e-2)"	"unprognostic (1.72e-2)"	"unprognostic (5.21e-2)"	"prognostic unfavorable (1.61e-4)"	"unprognostic (2.59e-1)"	"unprognostic (3.57e-3)"	"prognostic unfavorable (2.25e-4)"	"unprognostic (3.51e-2)"	"unprognostic (9.91e-2)"	"unprognostic (8.63e-3)"	"unprognostic (3.47e-2)"	"unprognostic (7.83e-3)"	"unprognostic (5.64e-3)"	"unprognostic (1.73e-2)"	"unprognostic (1.52e-1)"	"unprognostic (2.61e-2)"	"unprognostic (4.10e-2)"	28.5	125.2	28.7	23.4	31.8	21.0	55.9	18.2	24.3	17.4	30.3	17.8	23.3	28.9	17.5	18.5	27.2	25.3	16.3	24.0	24.2	27.8	67.1	147.5	22.4	25.3	35.5	16.1	30.2	50.6	32.5	25.9	27.1	33.6	25.9	37.2	11.9	17.6	21.0	36.4	13.7	32.0	23.6	32.4	22.7	25.2	10.9	35.8	22.7	38.7	29.4	30.3	33.3	162.6	25.6	30.3	6.2	29.3	23.1	33.5	22.2	41.2	50.8	42.6	38.2	29.2	30.6	62.0	43.0	22.7	51.8	38.0	170.3	24.9	125.5	56.1	22.4	64.2	42.2	166.7	47.4	73.5	30.8	66.9	89.1	82.2	197.1	27.5	98.7	28.0	34.5	55.0	45.9	80.9	36.5	40.6	69.3	109.7	49.2	38.0	52.8	61.2	99.9	84.2	54.3	106.3	73.7	52.6	90.6	54.4	43.2	55.8	31.7	43.1	46.7	55.2	91.1	32.3	58.6	18.1	32.2	44.7	41.4	67.9	27.6	60.7	104.2	37.8	59.7	34.5	4.5	19.7	5.3	15.5	29.3	28.8	25.6	25.0	21.8	30.3	21.0	33.5	29.0	6.2	23.1	25.8	20.2	19.7	22.2	28.7	31.8	18.2	24.3	24.2	27.8	35.5	16.1	33.6	35.8	154.9	133.3	218.4	1171.9	219.0	70.0	213.1	150.3	448.3	361.7	75.0	241.5	780.7	318.3	195.2	4.9	145.2	151.1	70.0	125.9	299.2	219.4	456.8	297.3	264.5	289.1	90.6	262.9	61.4	70.1	9.9	120.8	249.2	155.3	160.5	166.4	117.0	164.4	153.9	106.8	589.7	103.4	84.1	310.2	68.2	82.2	181.0	837.2	136.4	347.8	853.1
HTRA1	"ARMD7, HtrA, IGFBP5-protease, PRSS11"	ENSG00000166033	"HtrA serine peptidase 1"	Q92743	10	122461525-122514908	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins"		"Growth factor binding, Hydrolase, Protease, Serine protease"	"Age-related macular degeneration, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	14	"Horizontal cells: 591.1;Muller glia cells: 269.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"classical monocyte: 2.4;memory CD4 T-cell: 1.6"	"Group enriched"	"Detected in many"	20	"monocytes: 2.4;T-cells: 1.6"	"Cell line enhanced"	"Detected in many"		"ASC diff: 203.0;ASC TERT1: 75.4;fHDF/TERT166: 68.7;HSkMC: 132.4;LHCN-M2: 100.6;U-87 MG: 83.1"	"Low region specificity"	"Detected in all"							HPA036655	Approved		Supported	"Plasma membrane"	"Secreted to blood"	NA	NA	24800000	2600000	"Plasma membrane"		"HPA036655: AB_10671966"	"unprognostic (3.84e-1)"	"unprognostic (3.42e-2)"	"unprognostic (1.57e-2)"	"unprognostic (1.86e-2)"	"unprognostic (1.22e-3)"	"unprognostic (8.71e-3)"	"unprognostic (2.33e-2)"	"unprognostic (3.83e-1)"	"unprognostic (7.22e-2)"	"unprognostic (3.36e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.54e-1)"	"prognostic unfavorable (7.90e-7)"	"unprognostic (7.12e-3)"	"unprognostic (9.13e-2)"	"unprognostic (1.69e-1)"	"prognostic unfavorable (5.62e-6)"	40.8	21.8	64.5	9.1	79.0	0.5	48.2	16.2	62.8	50.4	19.3	60.8	7.2	5.6	47.6	67.0	15.6	19.5	78.7	28.7	50.8	35.4	34.7	60.4	14.6	9.1	62.7	32.5	111.3	14.5	37.6	26.9	114.1	41.9	19.5	14.0	20.7	19.3	31.5	7.5	29.6	9.3	40.5	46.5	10.5	12.9	9.8	49.5	1.7	13.3	8.5	7.1	41.5	27.3	0.0	0.0	0.0	2.4	0.0	1.6	0.7	0.0	3.5	1.6	0.4	203.0	75.4	0.0	8.7	15.9	3.6	1.9	0.0	0.0	0.0	2.4	68.7	5.6	1.0	0.6	9.9	0.5	0.0	0.4	0.0	5.8	0.0	10.3	0.0	0.0	132.4	36.4	2.1	17.0	41.7	16.7	0.0	0.0	0.1	100.6	1.7	0.0	0.0	1.7	0.0	5.5	0.0	0.1	0.0	23.0	0.1	0.1	0.3	21.9	0.0	9.4	7.8	0.7	0.0	10.9	25.6	0.3	11.5	7.4	0.0	0.0	0.0	83.1	0.0	12.0	0.0	2.4	0.0	0.6	0.0	0.4	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	64.5	79.0	16.2	54.6	50.8	35.4	62.7	32.5	41.9	49.5	20.8	8.6	0.0	31.0	39.2	55.4	23.4	10.2	14.7	0.0	61.1	51.1	15.8	0.0	2.1	2.5	64.7	0.0	0.0	3.9	127.5	77.4	8.5	1.1	85.6	53.0	591.1	0.0	54.6	17.2	3.1	29.4	7.2	43.9	12.6	0.1	269.0	4.2	0.2	72.9	18.8	110.5	6.5	59.8	0.1	0.2	26.7	73.3	4.5	0.2	12.7
HTRA2	"OMI, PARK13, PRSS25"	ENSG00000115317	"HtrA serine peptidase 2"	O43464	2	74529377-74533348	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted membrane proteins"	Apoptosis	"Hydrolase, Protease, Serine protease"	"Disease mutation, Epilepsy, Neurodegeneration, Parkinson disease, Parkinsonism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Erythroid cells: 116.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004004, HPA006602, HPA027366"	Uncertain		Supported	Mitochondria		NA	NA			Mitochondria		"CAB004004: AB_326421, HPA006602: AB_2667622, HPA027366: AB_1851301"	"unprognostic (3.09e-1)"	"unprognostic (4.06e-2)"	"unprognostic (2.82e-1)"	"unprognostic (2.58e-2)"	"unprognostic (1.56e-1)"	"unprognostic (1.37e-1)"	"prognostic unfavorable (7.77e-8)"	"unprognostic (2.12e-3)"	"unprognostic (4.18e-1)"	"unprognostic (1.15e-1)"	"unprognostic (4.57e-2)"	"unprognostic (8.15e-2)"	"unprognostic (7.23e-3)"	"unprognostic (4.03e-1)"	"unprognostic (1.73e-1)"	"unprognostic (1.72e-1)"	"unprognostic (2.06e-2)"	16.4	12.7	10.6	14.9	11.3	18.9	12.9	10.7	17.7	12.3	12.8	12.6	9.7	12.6	12.9	6.9	10.7	10.6	9.0	12.9	11.6	8.7	13.1	11.4	11.3	13.2	10.8	11.9	18.7	12.9	10.5	9.0	10.4	13.5	11.6	5.5	10.2	13.1	9.2	17.6	9.0	12.6	11.8	9.1	17.3	11.8	13.9	12.6	12.2	16.8	12.6	9.3	10.4	15.2	12.9	9.4	5.9	8.1	5.5	7.8	7.0	8.0	5.0	5.7	5.0	7.9	3.2	15.4	7.0	3.7	4.2	2.5	9.2	3.6	7.3	5.5	4.0	11.8	9.1	6.8	8.0	1.1	16.4	13.6	14.6	4.8	8.1	7.4	6.8	10.7	3.8	5.4	8.0	6.8	6.8	5.3	12.3	19.1	10.8	3.2	5.3	12.6	14.4	4.8	9.6	14.3	8.6	16.3	8.0	3.5	3.3	6.7	8.0	3.8	8.6	13.3	3.4	3.9	6.6	3.7	7.4	9.1	14.9	15.6	13.3	4.4	4.7	6.4	10.8	5.9	5.9	8.1	4.8	7.3	6.2	7.8	12.9	7.3	6.2	9.4	11.6	6.3	6.4	3.2	5.5	4.7	6.6	7.4	7.0	10.6	11.3	10.7	17.7	11.6	8.7	10.8	11.9	13.5	12.6	0.0	3.7	23.9	16.6	18.3	12.1	0.8	17.8	9.4	9.1	10.4	0.0	20.6	29.9	26.3	24.4	29.4	13.6	116.8	15.4	31.8	26.6	15.0	26.5	10.6	27.5	9.5	8.6	16.5	9.5	32.5	23.0	17.8	28.7	36.1	10.3	19.0	22.8	14.2	19.4	29.1	11.9	25.8	26.4	55.8	34.3	19.3	16.9	25.4	19.8	12.9
HTRA3	"Prsp, Tasp"	ENSG00000170801	"HtrA serine peptidase 3"	P83110	4	8269765-8307111	"Enzymes, Predicted secreted proteins"		"Hydrolase, Protease, Serine protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 57.9"	"Group enriched"	"Detected in some"	7	"Cardiomyocytes: 14.0;Fibroblasts: 45.9;Leydig cells: 40.3;Peritubular cells: 40.3"	"Low cancer specificity"	"Detected in all"			"Region enriched"	"Detected in single"	9	"basal ganglia: 8.2"	"Cell type enhanced"	"Detected in single"		"neutrophil: 1.3"	"Low lineage specificity"	"Detected in single"			"Cell line enriched"	"Detected in some"	5	"U-2197: 64.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA021187, HPA063810"	Approved		Approved	Vesicles	"Secreted in female reproductive system"	NA	NA			Vesicles		"HPA021187: AB_1851311, HPA063810: AB_2685129"	"unprognostic (5.87e-2)"	"unprognostic (1.40e-2)"	"unprognostic (2.89e-2)"	"unprognostic (9.32e-2)"	"unprognostic (1.84e-1)"	"unprognostic (3.09e-2)"	"unprognostic (1.12e-3)"	"unprognostic (5.29e-2)"	"unprognostic (3.81e-2)"	"unprognostic (1.15e-1)"	"unprognostic (1.95e-2)"	"unprognostic (2.79e-1)"	"prognostic unfavorable (1.61e-9)"	"unprognostic (1.65e-3)"	"unprognostic (2.56e-2)"	"prognostic unfavorable (1.29e-4)"	"unprognostic (1.34e-2)"	23.7	1.8	0.6	7.3	8.2	5.3	35.6	0.7	0.9	12.3	9.4	0.8	5.4	3.7	19.6	26.6	14.4	7.9	19.8	57.9	0.7	0.3	1.7	1.6	15.4	4.3	0.8	0.9	30.7	2.8	0.0	5.1	9.6	0.9	15.4	2.0	8.6	6.6	3.0	12.9	9.0	6.7	50.1	0.8	1.8	6.8	7.2	0.6	1.3	9.3	11.6	3.0	28.7	12.7	0.0	0.4	1.3	0.3	0.0	0.0	0.1	0.0	0.3	0.4	0.0	2.1	3.9	0.1	0.8	0.0	1.0	0.2	0.0	0.0	0.0	4.8	2.1	0.5	0.0	0.4	0.0	0.3	0.0	0.8	0.4	5.0	0.0	2.2	0.0	0.2	0.4	0.0	1.4	0.0	0.6	3.4	0.0	0.1	0.0	3.5	0.0	0.0	12.2	2.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	5.6	0.1	9.1	0.1	0.0	10.6	0.0	0.4	2.7	0.5	1.7	64.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	1.3	0.0	0.2	0.0	0.0	0.1	0.6	8.2	0.7	0.9	0.7	0.3	0.8	0.9	0.9	0.6	0.0	0.0	0.0	0.3	4.6	0.0	14.0	0.0	0.0	1.2	0.0	0.0	0.5	0.0	0.0	0.6	3.1	0.0	0.0	0.0	3.7	45.9	0.1	0.0	0.0	1.1	0.0	0.0	4.3	0.0	0.5	40.3	0.9	0.0	0.0	0.0	0.0	0.2	0.0	40.3	0.0	0.0	0.0	5.1	0.2	0.9	4.5	1.1	0.0	0.0	0.1
HTRA4	FLJ90724	ENSG00000169495	"HtrA serine peptidase 4"	P83105	8	38974164-38988662	"Enzymes, Predicted secreted proteins"		"Hydrolase, Protease, Serine protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	13	"placenta: 55.2"	"Cell type enriched"	"Detected in some"	9	"Extravillous trophoblasts: 319.8"	"Cancer enhanced"	"Detected in some"		"testis cancer: 2.5"	"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enriched"	"Detected in some"	23	"BEWO: 72.8"	"Region enhanced"	"Detected in some"		"hippocampal formation: 2.3"	"Low region specificity"	"Detected in some"			HPA045402	Enhanced				"Secreted in female reproductive system"	NA	NA					"HPA045402: AB_2679316"	"unprognostic (1.20e-1)"	"unprognostic (5.83e-4)"	"unprognostic (8.02e-2)"	"unprognostic (2.13e-2)"	"unprognostic (8.20e-2)"	"unprognostic (2.42e-2)"	"unprognostic (1.80e-1)"	"unprognostic (7.40e-3)"	"unprognostic (1.40e-1)"	"unprognostic (5.14e-4)"	"unprognostic (1.01e-1)"	"unprognostic (8.68e-2)"	"unprognostic (1.42e-1)"	"unprognostic (4.58e-1)"	"unprognostic (5.19e-3)"	"unprognostic (2.39e-3)"	"unprognostic (1.19e-3)"	2.6	1.1	0.2	0.3	0.2	3.4	0.9	0.2	0.4	1.2	0.5	0.2	1.9	0.0	2.3	0.5	0.5	0.1	0.2	0.2	0.2	0.0	0.2	0.2	4.3	1.0	0.2	0.2	0.4	0.3	0.4	0.5	55.2	0.4	0.5	0.3	1.8	0.8	0.5	0.6	0.4	0.6	0.3	1.8	2.5	0.1	0.4	0.2	0.2	0.6	0.2	0.8	0.5	0.9	3.1	2.2	2.5	1.0	1.0	1.7	0.0	0.1	0.1	0.1	0.2	0.3	0.2	72.8	0.2	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.3	0.2	0.1	0.1	0.2	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.2	0.2	0.3	0.1	0.1	0.5	0.1	0.1	0.0	0.1	0.4	0.2	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.2	0.1	0.2	0.1	0.1	0.0	3.1	0.1	0.2	0.0	0.3	0.2	0.1	0.1	0.2	0.1	0.1	0.1	0.3	0.1	1.5	0.8	2.3	1.4	0.7	1.7	1.5	1.3	1.2	0.6	3.1	1.3	1.4	2.5	1.0	1.0	2.2	1.4	0.0	0.2	0.2	0.2	0.4	0.2	0.0	0.2	0.2	0.4	0.2	0.0	0.0	0.0	1.1	0.1	0.5	0.4	0.0	0.0	0.0	0.0	2.0	2.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	319.8	0.2	1.2	0.0	0.0	10.7	1.6	0.0	2.5	0.3	0.0	0.0	1.5	1.7	0.0	0.0	0.6	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	33.8	0.0	0.2	0.7
HUNK		ENSG00000142149	"Hormonally up-regulated Neu-associated kinase"	P57058	21	31873315-32044633	"Enzymes, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	6	"Cholangiocytes: 17.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"AF22: 10.6;BEWO: 13.0;RH-30: 14.4;SCLC-21H: 11.7;SiHa: 10.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027295, HPA027372"	Approved		Approved	"Nucleoplasm,Plasma membrane"		NA	NA			"Nucleoplasm, Plasma membrane"		"HPA027295: AB_2672203, HPA027372: AB_2672239"	"unprognostic (9.09e-3)"	"unprognostic (7.29e-2)"	"unprognostic (1.42e-1)"	"unprognostic (5.95e-3)"	"unprognostic (1.99e-1)"	"unprognostic (2.12e-4)"	"unprognostic (4.00e-2)"	"unprognostic (6.90e-2)"	"unprognostic (5.07e-1)"	"unprognostic (2.27e-1)"	"unprognostic (9.09e-2)"	"unprognostic (1.13e-1)"	"prognostic favorable (7.48e-5)"	"unprognostic (8.84e-2)"	"unprognostic (2.22e-1)"	"unprognostic (1.39e-1)"	"unprognostic (6.69e-2)"	1.7	1.9	2.7	2.9	3.5	0.5	2.1	3.2	6.4	1.1	5.9	0.2	12.6	2.4	9.0	3.4	1.1	3.3	1.0	1.7	3.7	3.2	6.0	1.3	1.7	0.7	1.2	2.1	1.8	15.7	0.2	4.7	7.6	1.4	4.0	6.5	9.1	1.5	11.1	0.6	5.0	4.4	4.1	0.9	0.4	2.1	1.8	0.2	0.4	1.1	2.2	1.0	3.8	7.7	1.0	0.7	1.7	0.5	0.5	0.5	0.1	0.0	3.0	10.6	0.1	0.0	0.0	13.0	1.0	0.0	0.2	0.0	4.2	0.1	0.0	0.4	4.9	0.2	0.1	6.2	0.0	0.0	0.0	3.2	0.0	2.8	2.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	3.7	0.0	0.0	0.0	0.9	0.2	0.9	8.0	0.0	0.1	0.1	14.4	0.0	1.1	0.0	11.7	7.8	10.3	0.8	0.4	7.7	4.3	1.1	0.0	0.0	7.5	0.0	0.0	0.1	0.0	1.4	0.0	0.0	5.0	0.8	0.5	0.5	0.5	0.3	0.3	0.5	0.5	0.3	0.2	1.0	0.5	0.5	1.7	0.5	0.3	0.7	0.4	0.1	2.7	3.5	3.2	6.4	3.7	3.2	1.2	2.1	1.4	0.2	6.0	7.8	0.0	1.8	4.5	4.3	3.2	17.8	1.4	4.5	7.0	2.0	8.1	0.0	3.8	0.0	0.9	2.7	0.0	2.9	11.6	10.6	1.6	0.0	0.9	2.3	3.2	4.7	0.0	0.0	0.0	0.3	0.0	3.3	0.0	3.9	11.4	2.6	2.9	0.0	1.5	1.2	0.0	1.4	0.9	0.7	5.1	5.1	0.0	9.0	0.8
HUWE1	"Ib772, KIAA0312, UREB1"	ENSG00000086758	"HECT, UBA and WWE domain containing 1, E3 ubiquitin protein ligase"	Q7Z6Z7	X	53532096-53686729	"Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Biological rhythms, Differentiation, DNA damage, DNA repair, Ubl conjugation pathway"	"DNA-binding, Transferase"	"Cancer-related genes, Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002548, CAB022718"	Approved		Enhanced	Nucleoplasm,Cytosol		NA	NA		3400	"Nucleoplasm, Cytosol"		"CAB022718: , HPA002548: AB_1080489"	"unprognostic (4.73e-2)"	"unprognostic (9.06e-2)"	"unprognostic (1.31e-1)"	"unprognostic (1.59e-2)"	"unprognostic (6.64e-2)"	"unprognostic (3.16e-2)"	"unprognostic (1.33e-2)"	"unprognostic (2.21e-1)"	"unprognostic (3.56e-1)"	"unprognostic (5.51e-2)"	"unprognostic (1.33e-1)"	"unprognostic (8.89e-2)"	"unprognostic (8.10e-3)"	"unprognostic (2.17e-1)"	"unprognostic (1.32e-1)"	"unprognostic (3.67e-2)"	"unprognostic (2.45e-1)"	24.6	28.2	27.7	23.8	43.3	22.4	28.0	37.0	41.1	31.8	25.9	34.3	26.6	17.1	31.9	52.4	27.4	26.5	23.1	27.1	28.0	31.8	30.3	26.2	20.3	23.1	30.0	30.2	43.3	27.8	59.8	34.2	27.2	34.6	27.3	22.7	25.6	26.4	29.6	59.1	50.1	22.1	33.9	23.9	26.6	25.7	28.4	27.7	32.4	27.6	20.7	28.6	27.0	22.9	5.1	7.2	8.2	7.0	6.9	8.9	3.5	50.2	31.0	20.2	14.2	35.4	21.2	24.9	15.1	19.5	16.0	16.7	23.6	16.2	26.4	10.3	27.5	28.8	24.2	45.6	25.3	21.9	38.0	20.2	21.0	27.8	18.3	32.5	31.4	12.9	20.2	19.0	38.3	44.1	15.8	27.6	20.7	20.9	17.1	20.7	31.0	17.0	17.6	27.6	13.8	22.3	15.7	27.8	16.0	26.5	34.9	16.9	12.2	42.7	19.1	13.6	39.5	27.3	15.3	35.1	14.7	21.1	21.0	19.2	15.0	14.8	23.0	15.7	30.8	21.1	4.0	4.7	8.2	7.2	3.8	8.9	5.1	6.9	7.6	6.7	5.1	4.9	4.9	4.2	6.9	7.0	7.2	5.7	3.5	27.7	43.3	37.0	41.1	28.0	31.8	30.0	30.2	34.6	27.7	47.6	43.2	23.8	25.3	26.8	53.1	98.6	45.9	37.5	36.4	38.4	47.1	26.9	1.7	35.4	22.3	29.2	24.7	0.0	30.4	29.3	24.4	33.4	20.9	43.1	21.9	77.9	45.8	31.3	25.6	21.6	26.2	26.1	25.3	40.5	28.4	20.9	40.0	17.3	36.7	12.2	31.9	12.9	33.0	17.1	43.7	36.4	31.7	37.1	29.2	40.4
HYAL1	"FUS2, HYAL-1, LUCA1, NAT6"	ENSG00000114378	"Hyaluronoglucosaminidase 1"	Q12794	3	50299889-50312381	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins"		"Glycosidase, Hydrolase"	"Disease mutation, Mucopolysaccharidosis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 105.8"	"Cell type enhanced"	"Detected in many"	15	"Hepatocytes: 116.0;Proximal tubular cells: 50.7"	"Cancer enhanced"	"Detected in all"		"liver cancer: 37.8"	"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"neutrophil: 7.3"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 7.3"	"Group enriched"	"Detected in some"	4	"Hep G2: 45.8;SK-BR-3: 13.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA002112	Uncertain				"Secreted to blood"	NA	NA		15000			"HPA002112: AB_1857412"	"unprognostic (1.39e-1)"	"unprognostic (8.68e-2)"	"prognostic favorable (2.07e-4)"	"unprognostic (5.23e-2)"	"unprognostic (3.18e-1)"	"unprognostic (8.71e-2)"	"unprognostic (9.35e-2)"	"unprognostic (3.59e-2)"	"unprognostic (6.56e-2)"	"unprognostic (1.31e-1)"	"unprognostic (6.65e-3)"	"unprognostic (1.16e-1)"	"prognostic favorable (1.56e-11)"	"unprognostic (4.51e-2)"	"unprognostic (5.89e-2)"	"unprognostic (1.95e-1)"	"unprognostic (1.90e-2)"	4.9	6.3	1.0	0.9	1.3	0.0	8.4	0.9	1.4	2.9	1.8	1.7	1.3	1.2	3.5	3.5	5.8	1.9	19.3	18.2	1.1	0.5	25.0	105.8	11.3	2.5	1.2	0.9	1.9	3.1	8.0	0.8	1.3	2.9	1.4	1.0	3.1	3.6	1.2	5.2	5.8	1.4	2.7	1.2	28.0	7.2	1.7	0.8	0.2	3.1	4.2	1.0	1.3	4.3	1.2	1.1	7.3	0.9	0.7	1.5	0.2	1.3	0.8	0.1	0.4	0.2	0.3	0.2	0.0	0.1	0.0	0.2	5.2	1.4	0.0	0.4	0.2	0.3	3.1	0.1	0.2	0.0	0.0	0.0	0.1	3.9	45.8	2.1	0.3	0.3	1.9	6.6	0.0	0.2	0.4	1.3	0.1	0.1	0.2	0.1	0.2	0.0	0.1	0.3	3.3	0.2	0.0	0.1	0.1	2.7	0.1	0.1	1.0	0.0	13.3	0.1	1.2	1.0	0.1	0.9	0.3	0.3	0.2	0.1	0.1	0.1	0.2	0.1	0.3	0.1	2.2	0.9	2.9	0.7	0.3	1.5	0.9	0.7	1.0	0.4	1.2	1.5	0.8	7.3	0.7	0.7	1.1	0.9	0.2	1.0	1.3	0.9	1.4	1.1	0.5	1.2	0.9	2.9	0.8	17.9	14.4	0.0	0.2	2.6	1.1	19.5	17.8	1.4	0.0	10.4	3.9	0.0	19.9	13.8	7.3	16.5	0.7	0.0	13.2	0.0	1.0	0.2	0.0	116.0	0.1	0.0	1.7	30.1	4.0	6.7	2.0	0.9	0.0	0.0	0.8	0.2	7.9	0.0	1.1	50.7	0.5	6.5	2.3	0.0	1.0	2.8	0.6	0.0	0.2	1.6
HYAL2	"LuCa-2, LUCA2"	ENSG00000068001	"Hyaluronoglucosaminidase 2"	Q12891	3	50317790-50322906	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"		"Glycosidase, Hydrolase, Receptor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 107.0"	"Group enriched"	"Detected in many"	4	"Endothelial cells: 160.0;Ito cells: 253.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in all"	4	"HUVEC TERT2: 68.6;TIME: 93.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA036436	Uncertain					NA	NA					"HPA036436: AB_10670104"	"unprognostic (9.97e-3)"	"unprognostic (2.60e-1)"	"unprognostic (1.44e-1)"	"unprognostic (5.10e-3)"	"unprognostic (3.44e-1)"	"unprognostic (7.41e-2)"	"unprognostic (7.93e-2)"	"unprognostic (4.70e-1)"	"unprognostic (1.44e-1)"	"unprognostic (6.76e-2)"	"unprognostic (2.36e-1)"	"unprognostic (3.01e-1)"	"unprognostic (2.63e-3)"	"unprognostic (7.36e-2)"	"unprognostic (2.72e-1)"	"unprognostic (7.02e-3)"	"unprognostic (5.62e-2)"	46.5	16.4	5.4	11.0	13.9	1.2	52.1	3.5	7.6	16.0	9.5	6.6	9.0	7.3	18.8	11.3	16.0	16.5	19.9	33.6	11.1	6.0	35.7	20.2	61.1	25.6	7.5	4.0	13.6	11.2	7.9	11.9	34.4	16.3	10.3	4.8	20.4	10.9	9.7	11.6	9.7	9.9	15.1	8.0	107.0	10.2	8.6	5.5	1.1	23.2	16.0	8.3	14.8	20.2	0.9	4.4	8.6	11.3	2.0	3.4	2.6	4.9	7.3	12.0	12.2	7.4	6.5	7.8	5.9	7.7	8.0	6.3	8.3	14.6	1.3	20.2	8.0	15.9	5.2	4.5	10.9	2.1	2.7	3.9	1.7	6.8	12.6	6.4	1.4	4.8	10.1	9.2	8.1	2.6	7.3	68.6	3.4	3.2	1.5	6.6	6.7	3.2	3.0	14.0	4.3	11.3	2.9	2.4	4.8	9.9	4.4	3.2	10.5	5.8	6.0	5.9	4.2	6.6	3.7	93.9	9.7	9.9	6.5	8.8	2.8	4.4	4.0	5.7	4.7	14.0	0.0	8.0	8.6	1.3	11.3	2.8	0.9	1.1	3.4	4.4	0.9	0.4	0.6	7.6	2.0	10.4	3.3	1.4	2.6	5.4	13.9	3.5	7.6	11.1	6.0	7.5	4.0	16.3	5.5	17.9	6.9	3.0	22.2	11.6	6.2	6.5	17.8	4.0	2.3	31.4	5.9	25.4	10.0	47.4	4.0	160.0	12.7	0.0	34.5	32.3	14.1	25.0	0.0	9.7	38.3	7.9	7.0	253.5	15.5	4.2	22.7	8.6	16.9	8.2	10.7	19.8	35.0	14.0	20.8	10.5	5.5	38.8	13.3	5.9	45.9	11.0	27.3	5.7	15.0	28.5
HYAL3	"LUCA-3, LUCA14, Minna14"	ENSG00000186792	"Hyaluronoglucosaminidase 3"	O43820	3	50292831-50299468	"Enzymes, Predicted intracellular proteins, Predicted secreted proteins"	Fertilization	"Glycosidase, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	4	"blood: 26.9;bone marrow: 48.8;brain: 12.5;testis: 31.1"	"Group enriched"	"Detected in many"	16	"Early spermatids: 73.0;Late spermatids: 206.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"basophil: 12.1;eosinophil: 26.9"	"Lineage enriched"	"Detected in all"	6	"granulocytes: 26.9"	"Cell line enhanced"	"Detected in many"		"HEL: 22.4;HMC-1: 40.2;THP-1: 41.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA049402	Uncertain				"Secreted to blood"	NA	NA					"HPA049402: AB_2680746"	"unprognostic (1.21e-3)"	"unprognostic (2.55e-2)"	"unprognostic (5.45e-2)"	"unprognostic (8.19e-2)"	"unprognostic (3.07e-1)"	"unprognostic (1.65e-2)"	"unprognostic (7.98e-3)"	"unprognostic (7.36e-2)"	"unprognostic (1.58e-1)"	"unprognostic (3.41e-2)"	"unprognostic (5.40e-2)"	"unprognostic (5.71e-2)"	"unprognostic (2.61e-1)"	"unprognostic (8.09e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.40e-1)"	"prognostic unfavorable (2.12e-5)"	3.5	4.2	6.3	3.1	8.8	48.8	3.3	11.4	12.5	4.2	3.6	3.8	6.1	3.8	2.7	5.1	5.6	3.7	5.4	3.4	6.4	5.6	2.9	7.0	3.2	4.2	5.3	5.6	4.3	3.7	2.6	3.1	3.6	11.1	4.9	2.9	3.7	6.7	5.6	3.9	3.0	4.1	4.6	3.4	2.8	6.6	31.1	2.7	3.0	3.3	5.1	3.7	4.8	3.8	1.1	4.2	26.9	2.1	1.0	2.2	1.2	2.2	2.6	1.5	1.7	3.1	1.6	0.9	2.5	2.2	3.2	2.4	3.5	2.4	2.0	1.2	2.9	4.9	2.5	2.7	5.9	1.2	4.6	1.4	22.4	6.8	2.8	2.2	2.4	40.2	3.3	4.5	3.2	2.1	2.3	3.2	2.2	1.7	2.5	1.5	1.3	0.9	14.2	1.1	2.6	6.6	1.0	2.0	3.6	3.8	1.0	1.8	2.1	3.6	2.9	2.0	1.8	1.9	41.3	4.3	2.7	1.9	8.6	1.4	1.2	2.5	1.5	2.4	8.6	2.2	12.1	2.1	26.9	0.7	1.1	1.2	0.9	2.2	1.0	4.2	1.1	0.6	0.8	0.7	1.0	0.7	1.1	1.3	1.2	6.3	8.8	11.4	12.5	6.4	5.6	5.3	5.6	11.1	2.7	3.0	1.4	0.0	2.2	2.7	1.5	0.3	0.0	1.4	4.5	3.5	3.9	2.5	8.3	4.5	73.0	3.4	0.3	0.0	0.6	4.1	1.8	2.3	6.9	1.0	2.0	4.8	4.1	7.4	1.8	206.1	1.7	2.8	3.3	9.0	1.2	1.5	3.1	0.0	2.5	1.9	0.4	6.5	3.1	4.3	3.8	3.1	2.5	1.3	1.6	3.0
HYAL4		ENSG00000106302	"Hyaluronoglucosaminidase 4"	Q2M3T9	7	123828983-123877478	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"		"Glycosidase, Hydrolase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"placenta: 7.1;skeletal muscle: 8.3"	"Group enriched"	"Detected in some"	7	"Cytotrophoblasts: 4.0;Extravillous trophoblasts: 5.9;Spermatogonia: 2.8;Syncytiotrophoblasts: 1.8"	"Cancer enriched"	"Detected in single"	48	"testis cancer: 8.4"					"Cell type enhanced"	"Detected in some"		"neutrophil: 3.3"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"BEWO: 4.5;CAPAN-2: 7.2;RT4: 17.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA029453	Uncertain					NA	NA					"HPA029453: AB_10601432"	"unprognostic (5.19e-5)"	"unprognostic (4.18e-2)"	"unprognostic (4.82e-2)"	"unprognostic (2.20e-1)"		"unprognostic (4.14e-2)"		"unprognostic (2.60e-1)"	"unprognostic (8.24e-2)"	"unprognostic (5.26e-2)"	"unprognostic (8.15e-3)"	"unprognostic (3.30e-1)"	"unprognostic (1.02e-2)"	"unprognostic (1.19e-1)"	"unprognostic (2.57e-1)"	"unprognostic (2.57e-1)"	"unprognostic (5.55e-3)"	0.1	0.3	0.0	0.0	0.0	0.7	0.2	0.0	0.5	0.0	0.1			0.0	0.1	0.4	0.4	0.2	0.0	0.4	0.0	0.0	0.6	0.1	0.4	0.0	0.0		0.1	0.6	0.0	0.1	7.1		0.2	0.0		1.2	0.0	8.3	1.4	0.2	0.0	0.1	1.0	0.2	3.4			0.4		1.5	1.0	0.1	1.3	0.6	3.3	0.6	1.0	0.9	0.1	0.3	0.6	0.1	0.4	0.0	0.0	4.5	0.0	0.0	0.0	0.0	0.0	7.2	0.3	0.4	0.0	0.7	1.0	0.0	0.0	0.0	0.2	0.0	0.0	1.1	0.1	0.0	0.0	0.2	0.0	0.7	0.0	0.0	0.0	0.0	0.4	0.0	0.4	0.0	0.0	0.1	0.1	0.1	0.3	0.0	0.1	0.2	0.1	0.0	17.0	0.2	0.1	0.0	1.0	0.0	1.4	0.4	0.2	2.4	0.1	0.4	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.6	0.5	0.4	0.6	0.5	0.5	0.4	0.5	0.5	0.2	1.3	0.7	0.9	3.3	1.0	0.6	0.6	0.3	0.1											0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	4.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	5.9	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.4	2.8	0.0	1.8	0.0	0.0	0.1
HYI	HT036	ENSG00000178922	"Hydroxypyruvate isomerase (putative)"	Q5T013	1	43451003-43453989	"Enzymes, Predicted intracellular proteins"		Isomerase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"ductus deferens: 130.4;seminal vesicle: 80.0"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"plasmacytoid DC: 21.6"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HUVEC TERT2: 39.2;WM-115: 33.2"					"Low region specificity"	"Detected in all"			HPA040092	Approved		Approved	"Golgi apparatus,Plasma membrane,Cytosol"		No	No			"Plasma membrane, Cytosol"	"Golgi apparatus"	"HPA040092: AB_10795374"	"prognostic favorable (9.18e-4)"	"unprognostic (1.67e-1)"	"prognostic unfavorable (4.96e-4)"	"unprognostic (2.68e-2)"	"unprognostic (3.86e-1)"	"unprognostic (4.40e-2)"	"prognostic unfavorable (5.55e-4)"	"unprognostic (2.75e-2)"	"unprognostic (1.42e-1)"	"unprognostic (2.34e-2)"	"unprognostic (1.10e-2)"	"unprognostic (4.43e-2)"	"prognostic unfavorable (2.75e-5)"	"unprognostic (5.10e-2)"	"unprognostic (7.93e-2)"	"unprognostic (3.58e-2)"	"prognostic favorable (2.72e-5)"	16.5	12.5	11.6	12.1	10.1	5.3	12.8	11.3	9.7	14.6	16.5	13.0	130.4	23.4	15.8	14.8	8.4	15.3	16.7	10.9	9.2	10.0	15.9	25.8	17.8	6.7	10.9	9.3	25.1	34.0	13.8	11.2	10.8	9.0	15.6	7.5	15.0	20.8	80.0	8.8	8.4	22.1	13.4	14.3	7.6	14.1	4.5	11.1	4.9	12.8	9.6	6.4	10.7	11.3	3.2	21.6	6.2	1.2	4.8	5.4	3.0	17.4	2.2	0.7	1.2	3.4	6.4	0.0	15.2	13.7	19.2	12.9	8.9	30.5	0.0	1.1	9.8	7.7	3.2	0.0	16.1	7.9	4.3	6.3	2.8	8.0	0.0	22.7	0.0	0.0	3.8	4.6	21.8	0.0	19.4	39.2	0.1	0.2	0.0	12.9	0.3	2.6	2.9	3.2	1.6	4.5	13.5	0.0	0.1	13.3	0.6	8.3	6.1	17.1	9.6	3.8	2.8	2.5	21.9	18.1	1.2	0.0	3.4	29.7	0.0	0.0	0.0	1.0	4.0	33.2	6.2	1.1	2.4	3.3	0.9	4.1	3.2	5.4	2.6	4.1	2.7	5.1	1.5	0.1	4.8	1.2	21.6	0.5	3.0	11.6	10.1	11.3	9.7	9.2	10.0	10.9	9.3	9.0	11.1	17.9	66.3	11.9	39.0	24.8	15.2	0.3	68.8	10.7	20.5	54.1	9.8	14.0	38.1	94.3	0.9	20.2	81.2	23.3	74.3	97.6	32.9	36.0	43.7	49.7	24.9	7.9	66.7	21.5	7.0	3.1	29.4	17.5	38.8	23.4	57.1	28.8	107.8	112.2	28.7	115.0	14.1	25.8	53.4	0.9	2.1	19.3	10.1	10.0	43.0	29.2
HYKK	"AGPHD1, LOC123688"	ENSG00000188266	"Hydroxylysine kinase"	A2RU49	15	78507564-78537372	"Enzymes, Predicted intracellular proteins"		"Kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"Distal tubular cells: 24.9;Late spermatids: 27.7;Proximal tubular cells: 33.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"naive CD4 T-cell: 7.1"	"Lineage enriched"	"Detected in single"	8	"T-cells: 7.1"	"Cell line enhanced"	"Detected in many"		"HEK 293: 17.5;U-266/84: 17.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA040706	Approved		Approved	Vesicles,Aggresome		NA	NA			Vesicles	Aggresome	"HPA040706: AB_10795528"	"unprognostic (9.26e-2)"	"unprognostic (1.98e-4)"	"unprognostic (7.84e-2)"	"unprognostic (3.16e-2)"	"unprognostic (3.64e-1)"	"unprognostic (2.72e-2)"	"unprognostic (1.14e-1)"	"unprognostic (8.00e-3)"	"unprognostic (2.73e-1)"	"unprognostic (5.16e-2)"	"unprognostic (6.24e-3)"	"unprognostic (6.37e-2)"	"unprognostic (3.44e-3)"	"unprognostic (2.19e-1)"	"unprognostic (1.04e-1)"	"unprognostic (3.11e-3)"	"unprognostic (3.90e-2)"	6.3	7.5	6.4	4.8	8.0	1.7	7.7	2.3	6.1	8.2	14.3	2.5	6.8	11.1	6.4	11.0	7.0	6.5	7.5	8.5	4.3	3.5	19.4	10.5	3.6	4.3	3.5	3.6	9.7	15.5	4.0	8.8	1.5	4.3	8.0	6.2	10.1	7.9	10.1	8.9	3.9	21.2	9.4	3.4	1.6	6.8	7.8	2.2	5.7	7.3	3.7	4.1	7.1	5.1	0.4	0.6	0.8	0.2	0.5	7.1	1.2	3.1	5.1	0.5	9.0	2.0	4.4	1.9	1.0	2.1	3.0	3.5	1.7	3.7	2.5	1.1	2.0	5.2	3.6	8.2	2.7	2.8	1.1	17.5	1.1	2.2	4.2	5.1	0.3	1.4	4.0	5.1	1.1	2.3	1.0	2.1	10.7	3.0	6.5	1.7	3.8	2.9	0.5	0.5	7.6	6.5	1.7	9.9	2.0	5.6	3.5	0.9	1.2	2.2	6.7	7.9	1.4	7.6	0.2	0.9	1.9	1.4	3.6	3.3	10.2	17.8	0.1	2.2	0.1	2.7	0.8	0.2	0.5	0.3	0.1	0.4	0.4	2.4	0.4	0.1	0.4	7.1	1.3	0.8	0.5	0.1	0.6	1.0	1.2	6.4	8.0	2.3	6.1	4.3	3.5	3.5	3.6	4.3	2.2	11.9	2.6	0.9	6.2	3.2	2.7	4.4	0.0	4.0	1.2	7.0	2.0	6.0	24.9	1.9	11.0	4.5	2.8	0.0	6.8	3.6	3.6	3.7	0.0	5.0	0.7	0.0	4.1	5.5	0.6	27.7	4.9	0.6	6.8	0.0	3.4	4.8	2.4	3.1	3.5	33.6	1.8	0.0	3.7	3.2	7.5	1.4	2.9	0.0	6.0	3.5
IARS	"IARS1, ILRS"	ENSG00000196305	"Isoleucyl-tRNA synthetase"	P41252	9	92210207-92293756	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Protein biosynthesis"	"Aminoacyl-tRNA synthetase, Ligase"	"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA029806	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"HPA029806: AB_10601818"	"unprognostic (1.32e-3)"	"unprognostic (2.94e-2)"	"unprognostic (2.27e-2)"	"unprognostic (8.23e-2)"	"unprognostic (1.33e-1)"	"unprognostic (1.26e-2)"	"prognostic unfavorable (4.98e-7)"	"unprognostic (2.00e-2)"	"unprognostic (3.80e-2)"	"unprognostic (1.10e-1)"	"unprognostic (4.96e-2)"	"unprognostic (3.67e-2)"	"unprognostic (1.40e-2)"	"unprognostic (2.88e-2)"	"unprognostic (4.71e-2)"	"unprognostic (2.21e-1)"	"unprognostic (7.76e-3)"	20.6	31.0	19.1	21.1	28.5	13.8	24.8	24.5	32.1	22.8	23.7	17.5	25.8	13.6	31.9	24.8	29.7	23.8	15.1	26.0	21.4	18.5	24.5	29.9	24.4	24.1	21.6	20.6	28.4	42.8	57.4	29.0	21.1	31.6	23.6	26.7	17.1	25.2	27.7	47.4	25.4	18.8	32.6	20.0	23.1	29.0	18.7	16.9	25.1	52.3	26.7	28.8	22.1	20.5	14.5	15.3	1.9	7.3	18.6	18.6	9.7	35.0	36.3	20.3	32.0	33.5	37.8	32.2	37.2	35.5	29.5	36.1	12.7	22.6	47.6	14.7	57.4	32.5	43.9	62.6	48.4	37.3	29.9	23.3	29.0	31.3	22.6	70.8	39.5	21.5	36.8	54.4	51.4	85.1	19.4	31.0	57.2	51.1	43.3	41.4	25.5	36.5	15.4	32.9	74.5	33.6	25.6	30.9	22.9	24.3	17.6	26.0	21.6	25.2	27.7	35.0	22.9	22.2	24.8	22.8	21.8	27.3	36.0	30.2	31.7	40.5	25.2	51.0	30.5	40.2	1.9	6.7	0.5	14.7	7.3	18.6	14.5	14.5	14.9	15.3	10.7	14.7	15.3	0.8	18.6	6.2	6.2	12.9	9.7	19.1	28.5	24.5	32.1	21.4	18.5	21.6	20.6	31.6	16.9	17.9	25.5	29.7	27.4	60.8	34.2	44.5	40.8	24.1	27.3	17.4	43.2	23.5	13.3	22.2	8.9	20.8	5.4	0.0	25.9	26.2	31.1	25.2	36.9	26.0	15.7	9.5	11.5	16.0	21.6	4.0	26.4	17.7	13.5	11.8	23.8	15.5	26.0	8.6	27.6	29.1	34.6	6.5	32.5	39.2	38.1	59.2	14.5	18.7	26.3	27.4
IARS2	FLJ10326	ENSG00000067704	"Isoleucyl-tRNA synthetase 2, mitochondrial"	Q9NSE4	1	220094102-220148041	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Protein biosynthesis"	"Aminoacyl-tRNA synthetase, Ligase"	"Cataract, Deafness, Disease mutation, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA024212, HPA024594, HPA024596"	Enhanced		Enhanced	Mitochondria		NA	NA		26000	Mitochondria		"HPA024212: AB_1851363, HPA024594: AB_1851368, HPA024596: AB_1851370"	"unprognostic (2.15e-2)"	"prognostic unfavorable (1.04e-4)"	"unprognostic (2.42e-3)"	"unprognostic (3.22e-2)"	"unprognostic (2.04e-1)"	"unprognostic (1.55e-1)"	"unprognostic (1.91e-1)"	"unprognostic (7.81e-2)"	"unprognostic (1.78e-1)"	"unprognostic (1.91e-1)"	"prognostic unfavorable (9.24e-5)"	"unprognostic (9.48e-2)"	"unprognostic (2.10e-2)"	"unprognostic (3.01e-1)"	"unprognostic (2.16e-1)"	"unprognostic (8.87e-2)"	"unprognostic (6.27e-3)"	25.9	39.3	18.0	17.9	16.9	6.7	31.9	15.1	20.8	16.9	26.2	14.8	24.3	18.9	21.5	16.8	23.8	18.8	16.5	40.0	17.5	12.6	29.5	37.3	16.8	25.9	15.6	16.0	20.5	20.5	42.5	15.3	26.2	17.4	18.5	24.9	15.0	22.4	22.3	57.8	22.2	23.4	17.7	15.7	16.1	18.5	15.7	13.7	19.5	17.8	25.9	20.1	24.9	18.7	16.8	20.0	17.2	19.0	18.5	22.6	16.8	38.3	36.0	20.7	20.3	31.3	31.6	49.9	23.4	25.2	25.9	21.0	34.6	40.1	35.5	31.7	28.9	20.1	37.3	28.7	29.2	30.0	24.5	34.6	17.6	29.4	38.8	19.5	27.9	19.1	22.8	29.8	28.0	29.0	25.1	25.2	23.1	43.4	20.6	33.9	21.3	22.0	20.2	26.9	30.0	23.9	19.5	41.3	56.8	37.3	25.8	11.2	31.5	35.4	55.0	36.4	24.8	63.6	31.7	25.7	25.6	21.4	34.3	39.1	17.7	27.1	25.8	27.1	22.0	28.3	17.2	16.7	15.1	16.8	19.0	22.6	16.8	18.4	22.0	20.0	13.6	20.8	19.0	3.3	18.5	14.5	7.3	19.7	16.8	18.0	16.9	15.1	20.8	17.5	12.6	15.6	16.0	17.4	13.7	32.8	33.1	24.4	24.3	17.9	26.7	126.1	15.3	58.9	45.5	27.9	23.6	68.4	10.0	37.8	12.3	43.0	33.8	0.0	56.4	44.9	24.9	20.4	18.5	88.4	40.3	19.1	34.8	38.6	46.6	2.0	34.5	26.7	18.6	25.2	50.3	28.6	54.2	28.8	40.0	28.3	31.0	45.3	22.6	32.5	40.2	23.2	60.0	22.7	61.0	20.5
ICK	"KIAA0936, LCK2, MGC46090, MRK"	ENSG00000112144	"Intestinal cell kinase"	Q9UPZ9	6	53001279-53061802	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Cilium biogenesis/degradation"	"Developmental protein, Kinase, Serine/threonine-protein kinase, Transferase"	"Disease mutation, Epilepsy"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000791, HPA001113"	Approved		Approved	"Nucleoli fibrillar center"		NA	NA			"Nucleoli fibrillar center"		"HPA000791: AB_2732392, HPA001113: AB_1851385"	"unprognostic (1.75e-2)"	"unprognostic (1.02e-1)"	"unprognostic (5.47e-2)"	"unprognostic (2.95e-1)"	"unprognostic (2.32e-1)"	"unprognostic (1.00e-2)"	"unprognostic (1.44e-1)"	"unprognostic (1.82e-2)"	"unprognostic (1.17e-3)"	"unprognostic (5.11e-2)"	"unprognostic (1.18e-1)"	"unprognostic (8.28e-2)"	"unprognostic (8.12e-3)"	"unprognostic (1.21e-1)"	"unprognostic (1.39e-1)"	"unprognostic (1.07e-1)"	"unprognostic (2.26e-1)"	9.8	28.2	10.1	6.5	10.7	2.8	13.4	14.3	12.7	11.5	12.3	20.1	6.6	11.3	10.6	6.8	10.4	9.2	8.3	9.6	10.8	7.7	5.4	9.6	8.2	5.5	13.3	8.1	11.8	8.2	9.0	5.3	44.3	12.3	12.2	13.0	9.7	20.7	12.7	5.9	10.1	14.2	13.7	16.8	6.2	15.0	5.6	12.6	14.8	7.6	7.0	7.9	10.6	9.1	4.5	4.1	6.2	3.1	3.2	5.0	2.1	5.1	1.9	10.1	6.9	6.3	10.0	11.7	4.6	8.5	7.5	8.6	2.7	1.6	3.7	2.8	14.1	2.4	3.4	12.0	4.8	9.9	13.0	4.7	2.8	2.3	14.8	3.2	3.4	3.7	8.8	5.3	3.2	3.7	5.4	6.9	8.2	5.3	15.5	17.0	4.4	3.6	4.2	3.8	18.0	4.2	5.8	4.5	5.0	3.1	3.7	16.3	7.3	4.5	11.2	6.4	10.3	6.5	7.3	5.7	12.0	5.6	4.4	11.4	4.3	3.1	1.5	2.4	3.3	5.8	6.2	3.1	5.6	5.0	2.3	4.8	3.7	3.6	4.1	2.9	4.5	4.2	3.6	1.7	3.2	2.5	4.1	4.8	2.1	10.1	10.7	14.3	12.7	10.8	7.7	13.3	8.1	12.3	12.6	17.9	16.8	7.1	4.3	6.9	30.5	8.7	7.6	17.4	26.1	3.5	35.3	17.7	11.6	8.9	1.8	8.7	9.5	0.0	21.0	27.3	8.2	14.5	19.7	12.3	5.2	25.4	8.6	8.0	10.4	1.1	13.3	6.0	3.3	5.4	25.7	20.1	16.6	2.9	26.9	3.8	41.7	6.5	14.4	6.4	2.7	7.3	48.6	7.5	12.3	8.0
ICMT	"HSTE14, PCCMT, PPMT"	ENSG00000116237	"Isoprenylcysteine carboxyl methyltransferase"	O60725	1	6221193-6235972	"Enzymes, Plasma proteins, Predicted membrane proteins"		"Methyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Region enriched"	"Detected in all"	5	"cerebellum: 126.5"	"Low region specificity"	"Detected in all"			"HPA032024, HPA032025"	Uncertain					NA	NA					"HPA032024: AB_2674115, HPA032025: AB_10601819"	"unprognostic (1.95e-3)"	"unprognostic (3.83e-2)"	"unprognostic (7.34e-2)"	"unprognostic (4.40e-2)"	"unprognostic (5.53e-2)"	"unprognostic (9.30e-2)"	"prognostic unfavorable (1.79e-4)"	"unprognostic (2.30e-2)"	"unprognostic (7.05e-2)"	"unprognostic (2.15e-1)"	"unprognostic (1.87e-1)"	"unprognostic (6.58e-2)"	"unprognostic (2.11e-2)"	"unprognostic (4.11e-1)"	"unprognostic (5.27e-1)"	"unprognostic (8.97e-2)"	"unprognostic (1.99e-3)"	19.0	20.9	11.2	11.4	22.6	3.2	37.4	20.1	19.8	19.8	16.6	12.9	13.3	17.3	18.0	19.7	19.0	15.1	17.7	28.5	11.5	10.3	23.5	14.5	17.2	13.9	13.9	8.4	8.7	20.2	26.2	24.0	20.3	12.7	16.2	16.0	21.5	15.4	18.2	41.3	16.9	22.8	19.8	11.1	11.3	13.5	9.1	7.8	13.0	18.1	30.3	17.2	15.4	13.6	4.1	6.2	4.1	5.1	4.6	7.4	3.9	12.7	11.9	16.4	16.0	50.4	20.1	7.0	30.8	20.8	18.4	14.0	12.7	10.4	14.0	11.9	24.4	15.8	17.4	18.7	13.1	19.6	27.9	18.1	9.6	17.5	9.7	9.8	15.1	13.7	12.8	8.8	19.2	7.3	12.3	14.2	11.7	9.3	11.1	20.7	8.0	15.1	10.5	11.0	23.2	16.6	12.7	23.1	8.1	22.1	9.4	22.3	10.9	15.1	36.0	13.2	19.1	9.4	12.8	17.6	21.0	8.2	24.5	22.1	10.3	20.1	11.3	10.3	35.0	10.8	4.1	4.2	3.6	7.4	5.1	6.5	2.7	6.0	7.3	3.9	4.1	5.4	4.5	1.8	4.6	4.0	6.2	3.4	3.9	11.2	22.6	20.1	19.8	11.5	10.3	13.9	8.4	12.7	7.8	20.8	8.9	6.0	9.0	5.6	15.7	32.2	20.4	24.1	19.4	27.9	29.5	48.9	11.6	19.2	3.3	13.5	31.1	0.0	19.1	66.8	18.8	11.7	4.7	21.7	25.0	46.1	21.9	21.5	8.6	2.9	19.2	7.9	6.8	10.8	18.3	15.1	21.2	7.0	24.8	31.9	55.6	12.9	15.5	13.4	29.6	9.2	26.8	10.0	19.9	12.3
IDE		ENSG00000119912	"Insulin degrading enzyme"	P14735	10	92451684-92574076	"Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction"	"Allosteric enzyme, Host cell receptor for virus entry, Hydrolase, Metalloprotease, Protease, Receptor"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Cone photoreceptor cells: 45.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA063478	Approved				"Intracellular and membrane"	NA	NA		140000			"HPA063478: AB_2685020"	"unprognostic (1.70e-1)"	"unprognostic (6.40e-2)"	"prognostic favorable (3.69e-4)"	"prognostic favorable (3.53e-4)"	"unprognostic (2.54e-1)"	"unprognostic (1.78e-1)"	"unprognostic (2.51e-1)"	"unprognostic (3.79e-1)"	"unprognostic (8.88e-2)"	"unprognostic (2.57e-1)"	"unprognostic (6.58e-2)"	"unprognostic (7.79e-2)"	"unprognostic (6.81e-2)"	"unprognostic (9.24e-3)"	"unprognostic (6.13e-2)"	"unprognostic (3.89e-2)"	"unprognostic (3.91e-1)"	9.8	13.1	6.9	11.7	8.8	6.0	19.8	8.6	9.4	10.5	9.9	6.5	17.5	7.4	10.2	15.9	13.0	8.4	9.6	13.6	5.8	5.3	13.3	21.3	7.9	9.2	8.9	5.1	7.7	15.7	19.4	11.1	9.4	7.6	11.6	10.0	10.5	11.0	17.2	31.1	45.2	10.7	14.3	8.8	9.9	10.3	18.1	7.5	13.5	12.0	13.9	10.7	11.5	9.8	7.4	11.3	3.8	13.7	7.7	10.6	5.5	12.3	18.4	14.4	29.4	14.0	11.8	7.9	11.0	26.1	11.6	9.9	18.7	14.8	17.5	16.3	16.0	10.9	16.0	18.9	12.1	7.6	21.0	11.6	8.7	15.4	16.4	12.3	26.6	13.8	8.3	11.8	13.6	19.7	16.4	19.5	7.4	16.2	12.5	13.1	8.3	8.8	10.5	11.4	13.8	7.3	12.3	13.4	11.2	17.1	23.3	6.7	9.3	14.8	10.6	9.7	15.6	15.2	7.5	18.1	7.5	8.5	7.8	14.2	11.4	14.3	18.8	10.9	21.3	5.2	2.3	8.2	3.8	6.7	11.4	5.9	7.4	7.9	6.5	11.3	5.3	6.0	6.4	0.5	7.7	13.7	4.4	10.6	5.5	6.9	8.8	8.6	9.4	5.8	5.3	8.9	5.1	7.6	7.5	8.9	10.2	2.2	5.3	4.6	14.0	39.2	7.6	24.1	6.8	7.0	45.2	9.9	1.7	11.7	31.2	8.0	10.7	0.0	17.4	4.7	5.5	10.9	1.1	22.4	10.4	6.4	10.4	14.7	18.1	7.7	6.1	8.6	8.5	1.8	11.4	7.5	14.5	5.8	9.6	8.8	26.3	6.5	7.5	18.0	10.8	14.3	3.2	4.3	8.3	7.8
IDH1		ENSG00000138413	"Isocitrate dehydrogenase (NADP(+)) 1, cytosolic"	O75874	2	208236227-208266074	"Cancer-related genes, Citric acid cycle related proteins, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Glyoxylate bypass, Tricarboxylic acid cycle"	Oxidoreductase	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Cytotrophoblasts: 277.8;Hepatocytes: 306.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"Hep G2: 107.6;RT4: 75.1"	"Low region specificity"	"Detected in all"							"CAB033218, HPA035248, HPA057936, CAB062556"	Enhanced		Approved	"Nuclear bodies,Cytosol"		NA	NA		16000000	"Nuclear bodies, Cytosol"		"CAB033218: AB_2123166, CAB062556: AB_2665593, HPA035248: AB_10600714, HPA057936: AB_2683559"	"unprognostic (2.79e-1)"	"unprognostic (1.00e-1)"	"unprognostic (1.02e-1)"	"unprognostic (2.47e-3)"	"unprognostic (1.93e-1)"	"unprognostic (2.39e-2)"	"prognostic unfavorable (6.93e-5)"	"unprognostic (3.32e-1)"	"unprognostic (2.20e-3)"	"unprognostic (8.03e-2)"	"unprognostic (5.54e-2)"	"unprognostic (4.18e-3)"	"prognostic unfavorable (2.45e-5)"	"unprognostic (2.09e-1)"	"unprognostic (1.77e-1)"	"unprognostic (1.13e-1)"	"unprognostic (2.69e-2)"	41.3	82.3	6.2	8.8	7.0	1.3	20.9	6.5	8.3	12.6	35.2	8.7	38.0	30.6	8.0	29.9	30.3	8.8	18.7	10.8	6.3	6.2	20.5	91.0	19.8	14.3	8.1	4.7	19.4	21.5	4.8	6.2	24.1	8.7	38.5	23.1	15.4	18.7	39.0	4.7	7.4	54.1	10.1	9.3	21.3	20.4	15.6	8.4	3.5	7.9	11.0	11.9	43.4	12.1	4.9	22.8	6.4	31.6	7.4	6.6	12.0	9.5	16.1	23.0	9.3	41.8	29.9	13.1	4.0	18.3	6.7	16.4	25.4	23.4	1.9	25.4	12.4	28.6	14.8	16.5	19.3	6.5	1.3	6.2	8.2	13.2	107.6	55.7	5.3	8.2	25.7	41.0	15.4	11.2	10.7	18.5	5.6	8.2	6.6	10.3	6.1	3.8	9.2	42.0	68.5	6.6	3.6	8.4	5.4	30.4	75.1	3.9	6.9	15.2	14.7	49.7	25.4	5.6	15.7	12.2	6.9	6.9	9.7	4.3	3.2	5.0	2.5	22.2	32.5	5.5	5.7	31.6	4.8	4.5	14.5	5.1	4.9	4.0	5.3	22.8	4.9	3.3	3.9	6.4	7.4	6.5	8.4	6.6	12.0	6.2	7.0	6.5	8.3	6.3	6.2	8.1	4.7	8.7	8.4	11.9	38.0	25.9	15.5	11.0	19.3	16.8	58.6	14.7	27.3	27.9	23.6	277.8	18.3	23.8	6.9	15.5	112.0	0.0	76.5	152.3	23.7	78.5	13.9	306.5	146.5	11.1	56.1	41.1	109.5	7.7	22.7	46.5	25.3	53.3	85.9	26.7	42.8	52.6	27.6	74.2	45.5	12.9	12.2	7.7	30.8	13.0	80.0	16.0	106.9	38.2
IDH2		ENSG00000182054	"Isocitrate dehydrogenase (NADP(+)) 2, mitochondrial"	P48735	15	90083045-90102504	"Cancer-related genes, Citric acid cycle related proteins, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"	"Glyoxylate bypass, Tricarboxylic acid cycle"	Oxidoreductase	"Cancer-related genes, Disease mutation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 126.2;skeletal muscle: 190.7"	"Cell type enhanced"	"Detected in many"	8	"Cytotrophoblasts: 682.3;Distal tubular cells: 989.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"MOLT-4: 69.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA007831	Enhanced		Supported	Mitochondria		NA	NA		53000000	Mitochondria		"HPA007831: AB_1851397"	"unprognostic (2.45e-2)"	"prognostic favorable (5.15e-5)"	"unprognostic (2.92e-1)"	"unprognostic (1.53e-1)"	"unprognostic (3.53e-1)"	"unprognostic (8.46e-2)"	"unprognostic (3.83e-2)"	"unprognostic (2.55e-3)"	"unprognostic (1.86e-2)"	"unprognostic (1.89e-2)"	"unprognostic (2.76e-1)"	"unprognostic (4.90e-2)"	"unprognostic (2.19e-3)"	"unprognostic (3.92e-3)"	"unprognostic (4.46e-1)"	"unprognostic (1.30e-2)"	"unprognostic (2.58e-2)"	5.4	2.0	14.9	10.1	16.6	22.6	8.8	4.9	19.1	6.4	16.2	13.8	12.4	16.1	5.9	15.3	23.7	6.0	9.4	126.2	10.2	9.3	25.0	93.2	6.9	15.8	14.4	12.0	3.0	25.1	8.4	3.3	15.1	11.9	13.3	14.5	6.0	28.0	21.9	190.7	11.0	13.9	15.8	11.0	7.5	27.9	1.2	7.6	28.2	3.4	69.0	13.6	11.0	8.6	16.8	32.8	17.2	56.3	22.2	29.5	31.2	10.3	5.9	30.6	30.3	4.3	5.2	26.0	13.0	19.8	12.3	13.2	2.8	9.0	12.3	3.7	10.7	11.7	3.6	4.4	3.9	5.8	24.2	2.9	21.0	2.2	20.6	5.2	14.4	21.3	11.0	2.2	2.9	2.3	14.9	25.1	43.6	3.1	10.6	9.4	30.2	69.1	22.4	9.1	14.2	2.4	58.6	21.9	36.7	18.9	12.5	44.1	22.4	16.1	64.4	5.2	17.8	51.9	44.5	6.0	21.9	3.2	2.8	6.0	17.5	3.2	1.4	7.0	30.3	12.6	9.0	26.4	17.2	26.1	48.0	12.4	16.8	18.7	29.5	32.8	9.8	10.2	18.2	5.1	22.2	56.3	17.8	15.9	31.2	14.9	16.6	4.9	19.1	10.2	9.3	14.4	12.0	11.9	7.6	6.0	21.8	67.0	66.5	35.4	5.3	402.1	104.4	56.2	21.6	71.5	9.8	682.3	989.8	188.2	4.7	25.3	53.5	23.3	255.6	386.0	36.6	189.5	30.1	240.4	229.9	9.5	59.3	41.1	60.4	2.5	13.0	70.5	55.6	96.4	122.1	17.5	127.7	132.1	33.2	128.5	5.1	12.9	38.3	0.5	4.5	58.6	479.2	123.2	268.2	90.1
IDH3A		ENSG00000166411	"Isocitrate dehydrogenase 3 (NAD(+)) alpha"	P50213	15	78131498-78171949	"Citric acid cycle related proteins, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"	"Tricarboxylic acid cycle"	Oxidoreductase	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"plasmacytoid DC: 47.2"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041465, HPA062971"	Supported		Enhanced	Mitochondria		No	No		2000000	Mitochondria		"HPA041465: AB_10794377, HPA062971: AB_2684913"	"unprognostic (2.33e-1)"	"unprognostic (1.21e-1)"	"unprognostic (5.76e-3)"	"unprognostic (2.26e-1)"	"unprognostic (1.02e-1)"	"unprognostic (4.01e-1)"	"unprognostic (2.29e-1)"	"unprognostic (6.47e-2)"	"unprognostic (1.69e-2)"	"unprognostic (2.30e-1)"	"unprognostic (3.05e-1)"	"unprognostic (1.42e-1)"	"prognostic favorable (6.49e-8)"	"unprognostic (1.40e-1)"	"unprognostic (3.08e-2)"	"unprognostic (4.49e-2)"	"unprognostic (3.39e-2)"	14.6	18.1	18.0	13.0	25.3	6.5	7.7	16.1	29.5	9.9	17.6	11.9	6.1	24.5	11.2	5.9	12.0	8.4	6.5	41.5	16.6	16.8	15.2	10.4	8.8	11.0	20.6	18.1	8.0	9.2	18.5	12.4	8.4	29.0	10.1	18.8	10.4	11.2	11.9	47.7	11.1	23.8	11.9	18.1	10.1	8.9	11.5	13.8	16.2	8.1	26.5	16.4	11.1	10.3	10.1	47.2	6.1	17.0	5.5	6.0	7.4	16.0	22.0	4.0	14.0	10.0	10.3	8.7	19.1	9.3	15.7	11.9	15.7	9.8	34.2	14.2	11.2	23.2	24.3	37.2	14.8	14.5	15.0	12.3	13.2	23.9	7.1	8.6	25.6	18.9	7.8	9.1	15.2	16.0	7.5	9.8	12.2	16.9	14.1	9.9	15.3	18.7	6.8	4.9	9.3	8.3	10.9	17.2	10.6	13.0	21.9	16.0	6.2	21.9	31.4	17.8	7.7	12.5	13.9	10.0	18.5	17.1	24.3	30.8	16.1	35.8	18.2	13.0	24.5	14.4	4.2	9.4	2.7	5.3	17.0	5.7	9.2	5.2	4.8	14.2	10.1	5.6	6.0	6.1	5.5	16.6	47.2	5.6	7.4	18.0	25.3	16.1	29.5	16.6	16.8	20.6	18.1	29.0	13.8	8.9	13.9	26.8	49.8	49.7	32.4	15.3	10.2	40.2	11.4	24.4	35.3	35.1	69.6	20.4	40.5	16.4	42.3	0.0	15.5	32.0	20.6	24.1	26.5	21.2	23.7	25.4	18.5	11.1	22.8	17.5	19.2	26.5	25.3	6.4	36.6	24.2	18.9	28.8	22.3	37.6	27.3	12.9	34.3	41.4	22.6	36.0	57.2	20.3	49.2	35.8
IDI1		ENSG00000067064	"Isopentenyl-diphosphate delta isomerase 1"	Q13907	10	1039152-1049170	"Enzymes, Predicted intracellular proteins"	"Cholesterol biosynthesis, Cholesterol metabolism, Isoprene biosynthesis, Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis, Steroid metabolism, Sterol biosynthesis, Sterol metabolism"	Isomerase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA039169	Approved					NA	NA					"HPA039169: AB_10674280"	"unprognostic (1.61e-2)"	"unprognostic (2.59e-2)"	"unprognostic (4.58e-2)"	"unprognostic (1.97e-1)"	"unprognostic (5.72e-3)"	"unprognostic (1.27e-1)"	"unprognostic (1.76e-2)"	"unprognostic (1.97e-1)"	"unprognostic (3.72e-2)"	"unprognostic (3.88e-2)"	"unprognostic (2.59e-1)"	"unprognostic (2.26e-1)"	"prognostic favorable (1.46e-4)"	"unprognostic (9.63e-2)"	"unprognostic (2.01e-2)"	"unprognostic (2.19e-3)"	"unprognostic (2.61e-2)"	13.6	30.4	23.1	15.2	28.3	47.8	68.8	16.4	39.2	8.8	16.1	22.5	8.0	27.9	7.7	12.6	19.2	6.5	9.9	9.7	23.0	29.2	15.3	67.6	15.6	15.5	21.7	25.3	13.4	13.7	12.3	20.6	10.0	55.9	22.3	15.0	16.9	9.9	7.1	35.1	13.7	17.6	8.3	30.6	17.5	12.9	10.2	14.4	8.5	9.8	16.8	16.3	12.5	11.1	16.1	8.9	36.4	19.6	14.5	18.4	14.8	25.5	9.6	51.3	12.5	21.5	46.9	7.5	10.8	12.2	12.5	26.6	25.2	40.3	23.2	7.1	11.7	29.9	22.3	28.4	51.0	11.4	8.0	26.9	22.6	14.5	28.7	25.1	8.7	11.2	29.6	21.5	34.9	4.6	5.3	9.7	21.6	15.4	32.7	21.0	20.0	16.6	14.3	20.7	20.8	5.7	19.4	24.5	25.8	54.3	22.7	8.0	9.6	13.7	28.3	28.3	16.5	29.4	29.3	9.8	6.9	3.9	20.1	7.7	19.0	17.9	43.7	8.6	25.9	6.2	36.4	9.4	21.9	18.2	17.1	18.4	16.1	14.2	15.2	8.6	14.9	10.7	15.8	25.1	14.5	19.6	8.9	14.9	14.8	23.1	28.3	16.4	39.2	23.0	29.2	21.7	25.3	55.9	14.4	68.5	123.1	100.7	66.5	79.6	74.8	59.3	50.9	54.9	45.5	38.4	35.3	59.8	127.6	39.4	221.4	48.6	87.1	0.0	90.3	44.8	52.3	86.3	97.1	52.9	70.4	60.4	101.5	63.8	60.6	68.2	24.5	54.0	126.5	66.7	65.1	108.3	56.5	59.6	28.0	48.2	63.2	25.8	71.4	47.2	43.8	126.5	156.5	103.8	41.3	93.4
IDI2	IPPI2	ENSG00000148377	"Isopentenyl-diphosphate delta isomerase 2"	Q9BXS1	10	1018907-1025859	"Enzymes, Predicted intracellular proteins"	"Cholesterol biosynthesis, Cholesterol metabolism, Isoprene biosynthesis, Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis, Steroid metabolism, Sterol biosynthesis, Sterol metabolism"	Isomerase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	125	"skeletal muscle: 141.6"	"Cell type enhanced"	"Detected in some"	13	"Club cells: 1.2;Horizontal cells: 1.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"MAIT T-cell: 1.0"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"HEL: 1.4;NB-4: 2.7;NTERA-2: 1.5;SK-MEL-30: 3.4"									HPA041254			Uncertain	Vesicles		NA	NA			Vesicles		"HPA041254: AB_10794270"									"unprognostic (6.69e-3)"	"unprognostic (4.05e-2)"				"unprognostic (1.64e-1)"				1.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.6	0.0	0.0	1.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	141.6	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.7	0.7	0.5	0.1	0.0	0.7	0.0	0.8	0.1	0.0	1.0	0.0	0.0	0.4	0.4	0.8	0.7	0.0	0.1	0.0	0.0	0.0	0.0	0.6	0.0	0.1	0.2	0.0	0.0	0.7	0.0	0.5	0.0	0.3	0.9	1.4	0.2	0.0	0.0	0.3	0.4	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.1	0.0	0.0	0.2	0.3	2.7	1.5	0.0	0.0	0.1	0.2	0.0	0.0	0.4	0.1	0.0	0.0	0.0	3.4	0.2	1.0	0.1	0.0	0.1	0.1	0.4	0.0	0.2	0.4	0.5	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.1	1.0	0.1	0.1	0.1	0.0	0.7	0.1	0.1	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.1	0.0	0.6	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1
IDNK	"bA522I20.2, C9orf103, hGntK"	ENSG00000148057	"IDNK, gluconokinase"	Q5T6J7	9	83623049-83644130	"Enzymes, Predicted intracellular proteins"		"Kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 35.9;liver: 39.1"	"Cell type enhanced"	"Detected in many"	12	"Distal tubular cells: 68.0;Proximal tubular cells: 149.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"MCF7: 19.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA020378, HPA058429"	Approved		Approved	Mitochondria,Cytosol		NA	NA			"Mitochondria, Cytosol"		"HPA020378: AB_1845794, HPA058429: AB_2683716"	"unprognostic (1.49e-3)"	"unprognostic (7.94e-2)"	"unprognostic (3.30e-1)"	"prognostic favorable (1.10e-6)"	"unprognostic (1.39e-1)"	"unprognostic (1.56e-1)"	"unprognostic (5.41e-3)"	"unprognostic (1.81e-2)"	"unprognostic (6.08e-2)"	"unprognostic (1.57e-1)"	"unprognostic (2.61e-2)"	"unprognostic (3.00e-1)"	"unprognostic (5.86e-3)"	"unprognostic (7.32e-2)"	"unprognostic (1.07e-1)"	"unprognostic (2.55e-1)"	"unprognostic (3.11e-2)"	4.3	6.1	9.4	2.9	20.3	2.2	4.5	12.3	8.3	2.3	11.3	7.0	3.1	14.2	2.5	7.4	4.1	6.8	4.5	2.8	7.6	8.6	27.2	39.1	3.7	4.7	7.3	6.3	3.2	6.6	3.6	5.2	1.8	6.2	4.2	4.7	5.2	4.6	5.0	1.2	3.3	20.2	3.5	7.0	4.2	4.3	2.0	6.8	14.5	7.0	1.2	4.3	2.8	2.1	17.5	9.6	35.9	20.5	15.0	23.0	11.4	3.4	8.2	1.1	1.3	3.7	5.4	6.0	2.3	6.9	2.6	2.1	2.1	3.0	4.3	4.0	3.7	2.5	5.7	0.9	1.6	2.8	9.5	1.0	1.6	3.2	9.4	16.4	1.0	2.0	3.7	2.2	5.7	5.4	3.9	5.9	10.3	1.3	4.6	3.8	19.0	2.6	1.0	0.9	13.8	3.7	3.2	3.1	2.5	6.9	4.0	5.3	6.8	5.5	4.3	5.8	1.6	4.3	5.8	6.0	1.1	0.8	10.7	4.4	6.6	7.6	0.6	5.9	1.8	2.1	35.9	6.1	8.6	14.7	10.6	12.3	17.5	12.7	12.1	8.5	11.4	10.2	13.8	1.1	15.0	20.5	9.6	23.0	11.4	9.4	20.3	12.3	8.3	7.6	8.6	7.3	6.3	6.2	6.8	11.9	5.4	5.9	2.6	6.1	7.5	8.7	15.3	22.7	9.1	5.2	0.0	6.3	68.0	10.1	0.3	6.0	10.8	0.0	14.3	3.8	8.4	5.2	19.7	37.2	10.0	9.5	7.0	3.1	9.5	1.1	4.0	7.7	11.8	27.9	10.6	17.7	5.2	11.5	3.9	149.6	3.1	0.0	9.5	1.1	1.5	5.1	2.5	17.5	7.8	2.7
IDO1	"IDO, INDO"	ENSG00000131203	"Indoleamine 2,3-dioxygenase 1"	P14902	8	39902275-39928444	"Cancer-related genes, Enzymes, Predicted intracellular proteins"	"Immunity, Tryptophan catabolism"	"Dioxygenase, Oxidoreductase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 77.7;placenta: 33.2"	"Cell type enriched"	"Detected in some"	552	"monocytes: 4555.6"	"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Cell type enriched"	"Detected in some"	17	"eosinophil: 77.7"	"Lineage enriched"	"Detected in many"	17	"granulocytes: 77.7"	"Cell line enriched"	"Detected in some"	7	"EFO-21: 36.6"	"Region enriched"	"Detected in single"	13	"basal ganglia: 30.5"	"Low region specificity"	"Detected in all"			"HPA023072, HPA023149, HPA027772, CAB072820"	Enhanced		Supported	Nucleoplasm,Vesicles,Mitochondria,Cytosol		NA	NA			Cytosol	"Nucleoplasm, Vesicles, Mitochondria"	"CAB072820: , HPA023072: AB_1846220, HPA023149: AB_1846221, HPA027772: AB_1846222"	"unprognostic (1.68e-2)"	"unprognostic (1.71e-2)"	"unprognostic (4.08e-3)"	"unprognostic (7.21e-3)"	"unprognostic (1.90e-1)"	"unprognostic (1.09e-2)"	"unprognostic (1.86e-1)"	"unprognostic (3.06e-2)"	"prognostic favorable (5.27e-4)"	"prognostic favorable (3.32e-4)"	"unprognostic (3.59e-2)"	"unprognostic (2.74e-1)"	"prognostic unfavorable (1.12e-7)"	"unprognostic (4.18e-2)"	"unprognostic (4.42e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.97e-2)"	8.7	0.2	0.9	11.2	0.9	0.0	1.4	0.9	0.9	4.0	1.5	0.9	0.9	2.6	2.6	0.9	1.2	0.6	1.3	1.0	0.9	0.0	0.9	0.9	16.8	14.1	0.9	0.9	0.9	0.9	0.0	0.9	33.2	0.9	1.6	2.1	1.9	0.9	0.9	2.5	0.3	5.9	0.9	2.0	6.2	2.2	0.9	0.9	0.9	7.2	0.9	8.9	2.3	0.9	0.0	4.6	77.7	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	4.5	2.6	0.1	0.3	0.0	36.6	0.0	1.9	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	1.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	5.2	0.0	0.1	0.0	0.1	0.0	4.5	0.1	77.7	0.0	0.2	0.0	0.0	0.0	0.0	4.6	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.1	0.9	0.9	0.9	0.9	0.9	0.0	0.9	0.9	0.9	0.9	0.0	0.3	0.0	0.0	0.3	0.0	0.2	0.0	0.0	3.4	0.0	0.0	0.0	0.0	2.5	2.6	0.9	0.0	0.0	6.7	0.0	0.2	0.4	0.0	0.0	0.8	0.0	0.0	0.0	8.2	1.3	0.0	6.0	0.0	4555.6	0.0	3.0	0.6	0.0	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	2.4
IDS	SIDS	ENSG00000010404	"Iduronate 2-sulfatase"	P22304	X	149476990-149521096	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		Hydrolase	"Disease mutation, Mucopolysaccharidosis"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 107.9"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											HPA078003	Approved				"Intracellular and membrane"	NA	NA		8900000			"HPA078003: "	"unprognostic (9.88e-2)"	"unprognostic (1.10e-2)"	"unprognostic (6.59e-2)"	"unprognostic (1.45e-3)"	"unprognostic (2.83e-2)"	"unprognostic (4.52e-3)"	"unprognostic (2.13e-1)"	"unprognostic (1.94e-1)"	"unprognostic (2.35e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.71e-2)"	"unprognostic (1.42e-1)"	"unprognostic (9.76e-3)"	"unprognostic (3.61e-2)"	"unprognostic (1.91e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.87e-1)"	11.6	20.4	92.9	12.1	81.5	16.0	12.0	30.4	107.9	13.1	9.3	15.0	8.1	9.1	17.8	29.5	11.3	14.8	12.3	16.2	83.6	42.7	10.5	7.0	17.9	12.5	36.7	51.8	22.6	10.6	19.5	17.8	7.4	33.0	14.0	10.7	7.7	9.1	19.5	8.9	12.9	11.6	14.1	21.0	14.1	10.6	3.8	14.7	1.9	13.2	4.9	14.7	11.4	8.6	8.7	11.7	63.4	16.6	8.5	18.2	13.3	14.3	16.3	7.2	4.2	7.9	14.1	3.0	8.3	21.8	7.7	14.8	3.3	10.8	34.4	22.2	12.3	16.2	8.3	6.9	13.0	10.0	12.3	5.9	3.7	5.3	1.9	6.1	5.9	33.2	7.7	7.0	16.7	11.0	32.6	12.2	6.5	1.7	25.2	11.3	18.3	5.9	3.1	5.6	9.2	11.1	3.9	6.5	6.6	9.9	3.6	9.6	22.1	3.2	7.3	10.2	11.7	2.3	2.6	14.3	10.2	10.3	16.5	22.3	17.6	13.9	25.1	45.9	14.2	7.2	23.9	13.8	39.6	18.2	14.9	13.5	8.7	11.2	13.6	11.7	6.6	7.5	11.3	63.4	8.5	16.6	8.8	16.9	13.3	92.9	81.5	30.4	90.7	83.6	42.7	36.7	51.8	33.0	14.7	92.3	66.3	80.1	47.2	29.5	173.4	41.9	7.6	78.9	62.6	78.5	43.2	23.8	18.3	43.2	1.1	38.4	37.1	0.0	64.9	19.5	73.6	58.5	220.6	30.0	43.2	209.7	161.6	51.0	68.1	1.7	67.3	78.5	49.0	118.2	26.2	42.9	66.6	45.6	84.1	19.0	58.2	58.2	64.9	2.9	5.1	38.1	119.6	113.6	17.9	87.2
IDUA	MPS1	ENSG00000127415	"Iduronidase, alpha-L-"	P35475	4	986997-1004506	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		"Glycosidase, Hydrolase"	"Disease mutation, Mucopolysaccharidosis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Leydig cells: 18.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"U-266/70: 32.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB025901, HPA046979, HPA054254"	Enhanced		Supported	Vesicles	"Intracellular and membrane"	NA	NA		130000	Vesicles		"CAB025901: , HPA046979: AB_2679888, HPA054254: AB_2682429"	"unprognostic (3.62e-2)"	"unprognostic (9.08e-2)"	"prognostic unfavorable (3.13e-4)"	"unprognostic (7.23e-2)"	"unprognostic (1.45e-1)"	"unprognostic (2.31e-2)"	"unprognostic (1.83e-1)"	"unprognostic (1.67e-1)"	"unprognostic (1.43e-2)"	"unprognostic (1.89e-3)"	"unprognostic (2.64e-2)"	"unprognostic (4.61e-3)"	"prognostic unfavorable (7.87e-5)"	"unprognostic (2.24e-1)"	"unprognostic (1.55e-1)"	"unprognostic (2.46e-2)"	"prognostic favorable (8.04e-5)"	11.0	15.0	14.7	12.0	15.3	10.8	12.9	36.5	15.7	12.4	9.2	10.9	16.9	17.1	13.0	13.4	7.7	12.1	15.9	8.9	13.4	6.5	13.4	10.7	12.8	11.2	11.6	10.0	14.6	22.6	13.0	15.2	4.0	12.8	14.5	6.0	14.1	20.2	15.8	6.2	16.8	11.8	7.3	9.0	15.3	21.3	4.7	12.6	7.6	14.0	3.4	10.0	10.4	11.2	0.8	4.1	0.0	3.8	3.1	4.5	1.1	3.1	5.8	0.0	2.4	13.4	4.8	8.8	8.4	7.4	2.9	1.7	2.0	9.9	1.3	9.5	5.7	2.9	1.9	0.3	1.1	0.6	8.4	0.4	5.0	6.0	0.7	5.6	4.0	13.5	9.2	4.2	2.3	0.0	4.2	2.0	3.2	2.5	0.1	2.8	3.4	2.8	4.2	1.9	9.7	5.5	7.6	0.0	1.4	4.7	6.2	0.1	3.8	0.9	0.0	4.8	1.3	6.8	3.4	8.8	15.7	1.7	8.8	2.3	32.6	3.7	1.6	7.6	5.5	3.8	0.0	3.5	0.0	3.3	2.7	4.5	0.6	2.7	2.6	4.1	0.8	3.4	2.0	0.0	3.1	3.8	2.5	1.3	1.1	14.7	15.3	36.5	15.7	13.4	6.5	11.6	10.0	12.8	12.6	6.0	5.3	0.5	8.6	3.2	1.9	2.4	0.0	0.0	1.2	7.0	3.9	0.4	0.0	1.6	0.7	3.7	4.2	0.0	2.1	1.4	5.1	7.4	2.3	2.4	5.8	0.0	10.3	6.2	4.6	0.2	18.1	3.5	5.0	0.0	3.6	1.9	1.6	6.0	9.9	1.3	2.2	0.0	3.9	1.4	1.5	1.6	0.3	5.0	3.5	5.8
IFIH1	"Hlcd, IDDM19, MDA-5, MDA5"	ENSG00000115267	"Interferon induced with helicase C domain 1"	Q9BYX4	2	162267079-162318703	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Antiviral defense, Host-virus interaction, Immunity, Innate immunity"	"Helicase, Hydrolase, RNA-binding"	"Aicardi-Goutieres syndrome, Diabetes mellitus, Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+ SV40 Large T+: 31.9;BJ hTERT+ SV40 Large T+ RasG12V: 39.7;Karpas-707: 18.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA002656	Approved					NA	NA					"HPA002656: AB_1079344"	"unprognostic (2.85e-1)"	"unprognostic (4.71e-2)"	"unprognostic (5.51e-2)"	"unprognostic (3.85e-3)"	"unprognostic (3.34e-1)"	"unprognostic (1.39e-1)"	"unprognostic (5.65e-2)"	"unprognostic (5.29e-2)"	"unprognostic (2.23e-1)"	"unprognostic (1.86e-2)"	"unprognostic (1.53e-2)"	"unprognostic (2.62e-1)"	"unprognostic (1.72e-1)"	"unprognostic (1.57e-1)"	"unprognostic (1.27e-1)"	"unprognostic (4.41e-2)"	"unprognostic (7.29e-2)"	17.2	11.3	5.8	23.1	5.8	26.9	10.5	2.8	6.4	10.3	12.5	4.9	9.5	12.3	7.3	11.0	9.9	8.3	10.8	6.3	6.1	4.7	10.4	11.8	19.7	17.2	6.1	3.2	11.2	11.5	11.6	14.0	15.6	7.0	12.3	7.8	5.9	15.7	17.2	4.7	6.4	18.0	5.8	7.4	25.3	9.0	4.3	4.2	20.5	15.9	8.3	12.9	9.1	10.4	12.3	10.5	14.5	11.6	3.6	9.4	7.1	3.0	0.3	0.1	0.0	4.0	3.1	1.2	0.5	8.5	31.9	39.7	0.5	7.6	6.2	4.6	0.5	16.1	3.3	0.5	4.2	3.4	14.7	1.8	3.7	0.5	1.8	3.6	4.0	2.7	2.4	2.7	3.9	0.8	3.9	2.4	3.1	0.1	18.9	0.5	6.4	4.2	4.1	0.0	2.8	1.5	3.1	0.0	8.8	3.6	3.9	0.1	0.0	1.9	10.4	18.2	0.1	2.7	3.2	1.9	0.9	0.8	0.4	1.2	7.3	11.9	0.9	1.7	3.2	2.8	4.2	11.0	4.0	6.5	11.6	9.3	11.4	8.3	7.2	10.5	12.3	6.9	7.1	14.5	3.6	11.0	1.5	9.4	7.1	5.8	5.8	2.8	6.4	6.1	4.7	6.1	3.2	7.0	4.2	29.8	8.1	10.0	9.3	6.1	0.0	4.9	15.3	24.1	12.5	7.0	0.0	4.7	5.0	15.8	36.2	17.3	9.8	0.0	16.4	14.4	6.6	9.4	12.7	5.0	13.2	0.0	15.1	15.4	12.3	36.7	12.7	10.4	5.0	18.0	10.3	7.3	10.9	9.5	12.4	4.3	0.0	0.0	2.7	1.6	1.5	5.1	2.9	8.6	6.5	10.3
IGF1R	"CD221, IGFIR, IGFR, JTK13, MGC18216"	ENSG00000140443	"Insulin like growth factor 1 receptor"	P08069	15	98648971-98964530	"Cancer-related genes, CD markers, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, RAS pathway related proteins"		"Kinase, Receptor, Transferase, Tyrosine-protein kinase"	"Cancer-related genes, Disease mutation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"neutrophil: 7.7"	"Group enriched"	"Detected in many"	5	"granulocytes: 7.7;T-cells: 2.9"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"							"CAB010268, HPA045563"	Approved					NA	NA		36000			"CAB010268: AB_671792, HPA045563: AB_2679368"	"unprognostic (1.30e-3)"	"unprognostic (5.81e-3)"	"unprognostic (1.53e-1)"	"unprognostic (3.34e-2)"	"unprognostic (2.65e-1)"	"unprognostic (2.05e-2)"	"unprognostic (1.29e-2)"	"unprognostic (6.87e-2)"	"unprognostic (2.64e-2)"	"unprognostic (2.87e-2)"	"unprognostic (8.56e-2)"	"unprognostic (1.62e-1)"	"prognostic favorable (3.75e-7)"	"unprognostic (1.57e-1)"	"unprognostic (3.59e-1)"	"unprognostic (1.41e-1)"	"unprognostic (1.06e-1)"	8.4	12.7	11.5	5.9	13.5	16.3	18.5	23.0	15.7	15.3	13.4	10.4	22.7	4.2	15.3	16.3	9.2	18.9	7.7	11.6	11.7	7.3	17.0	2.0	11.0	4.9	8.0	11.8	23.2	22.5	4.7	13.8	17.5	9.5	21.7	7.2	16.7	12.5	23.2	9.1	13.0	7.5	18.1	8.0	7.3	10.7	12.0	11.5	10.7	16.1	7.0	5.6	12.8	21.6	1.0	0.4	7.7	0.6	1.0	2.9	0.7	3.2	16.3	11.4	0.2	5.7	4.2	7.6	3.6	7.3	1.2	1.0	7.0	8.6	0.8	10.6	7.1	8.0	15.5	5.1	14.8	1.0	0.0	5.1	12.3	18.2	14.0	5.0	6.5	1.3	6.5	7.0	2.1	10.0	4.3	4.0	1.3	0.6	2.9	5.6	23.0	2.5	4.4	10.6	5.4	0.9	4.0	8.9	2.9	3.4	20.0	3.8	17.1	26.2	1.5	14.1	25.7	8.0	3.0	11.1	1.1	14.7	2.9	5.7	1.0	4.4	2.7	2.2	4.8	2.7	4.0	0.6	1.8	0.9	0.6	0.6	0.4	0.8	0.3	0.4	1.0	2.9	1.0	7.7	1.0	0.5	0.3	0.0	0.7	11.5	13.5	23.0	15.7	11.7	7.3	8.0	11.8	9.5	11.5	26.8	11.2	0.0	25.0	29.1	51.6	25.7	10.2	38.8	31.8	21.0	86.4	26.8	1.7	13.8	23.0	23.2	5.1	0.0	9.4	16.8	24.2	51.2	0.0	0.4	5.8	71.5	33.7	38.1	7.0	38.8	16.7	5.0	20.3	2.8	21.9	47.2	25.3	10.5	12.7	18.6	32.3	0.0	17.6	3.3	13.6	28.0	23.0	3.2	20.4	39.1
IGHMBP2	"CATF1, CMT2S, HCSA, HMN6, SMARD1, SMUBP2, ZFAND7"	ENSG00000132740	"Immunoglobulin mu binding protein 2"	P38935	11	68903842-68940602	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Activator, DNA-binding, Helicase, Hydrolase, Ribonucleoprotein, RNA-binding, tRNA-binding"	"Charcot-Marie-Tooth disease, Disease mutation, Neurodegeneration, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	10	"Early spermatids: 77.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004092, HPA060994"			Supported	"Nucleoplasm,Nuclear bodies"		NA	NA			Nucleoplasm	"Nuclear bodies"	"HPA004092: , HPA060994: AB_2684406"	"unprognostic (1.17e-1)"	"unprognostic (1.04e-1)"	"unprognostic (7.17e-2)"	"unprognostic (3.96e-1)"	"unprognostic (1.54e-1)"	"unprognostic (1.69e-1)"	"unprognostic (3.59e-3)"	"unprognostic (4.31e-2)"	"unprognostic (3.81e-1)"	"unprognostic (1.19e-1)"	"prognostic favorable (5.89e-4)"	"unprognostic (1.03e-1)"	"prognostic unfavorable (1.29e-8)"	"unprognostic (1.69e-1)"	"unprognostic (3.73e-2)"	"unprognostic (4.06e-2)"	"unprognostic (2.18e-2)"	7.2	6.0	6.9	8.1	11.0	13.8	9.4	17.7	14.9	8.1	14.6	8.3	14.3	9.7	12.0	5.4	8.8	8.5	7.8	7.7	6.6	5.3	6.7	8.7	7.3	7.9	4.6	7.0	9.4	9.6	7.7	6.0	6.5	6.6	9.0	6.1	7.9	12.7	10.0	12.2	11.7	9.4	8.1	4.1	8.9	9.1	36.9	5.7	10.0	7.3	5.9	8.8	8.8	8.3	5.0	3.3	4.7	12.1	2.7	5.1	2.7	8.0	9.3	5.6	8.9	4.5	3.5	8.4	8.1	5.1	10.0	6.6	18.8	8.1	7.0	11.4	4.1	8.1	12.9	9.3	5.1	4.2	8.3	7.8	10.0	10.9	6.1	5.2	7.6	9.5	2.6	6.1	10.6	5.4	5.0	5.1	12.4	11.7	9.0	3.4	6.3	11.9	13.6	4.9	11.0	9.8	10.0	8.4	8.6	4.7	7.3	8.9	6.5	9.6	8.2	19.1	3.8	12.7	5.7	6.9	8.6	7.6	11.5	8.3	10.1	7.7	8.1	6.1	7.4	7.8	0.0	3.9	2.2	5.1	3.3	4.7	5.0	3.4	4.0	3.3	3.3	2.4	3.3	4.7	2.7	12.1	2.5	4.0	2.7	6.9	11.0	17.7	14.9	6.6	5.3	4.6	7.0	6.6	5.7	6.0	10.6	2.9	3.6	5.0	9.1	4.3	5.1	2.7	6.8	1.8	19.6	3.9	1.7	4.8	77.4	5.8	3.5	0.0	4.3	3.8	5.0	6.2	6.9	4.7	5.0	11.1	2.9	2.5	3.2	25.6	7.2	5.2	1.7	8.2	3.4	6.6	4.9	5.8	6.7	2.0	9.6	0.0	6.6	20.9	6.5	5.8	5.6	5.1	4.3	4.8
IKBKB	"IKK-beta, IKK2, IKKB, NFKBIKB"	ENSG00000104365	"Inhibitor of nuclear factor kappa B kinase subunit beta"	O14920	8	42271302-42332653	"Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins"	"Host-virus interaction"	"Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes, Disease mutation, FDA approved drug targets, SCID"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	8	"Cone photoreceptor cells: 127.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001249, CAB004447"	Enhanced		Supported	Cytosol		NA	NA			Cytosol		"CAB004447: AB_627785, HPA001249: AB_1079126"	"unprognostic (1.04e-1)"	"unprognostic (2.30e-2)"	"unprognostic (1.31e-1)"	"unprognostic (1.73e-3)"	"unprognostic (1.26e-1)"	"unprognostic (1.27e-3)"	"unprognostic (1.95e-1)"	"unprognostic (1.25e-3)"	"unprognostic (1.75e-1)"	"unprognostic (1.55e-1)"	"unprognostic (3.27e-1)"	"unprognostic (1.73e-1)"	"unprognostic (1.20e-2)"	"unprognostic (1.89e-2)"	"unprognostic (9.20e-2)"	"unprognostic (3.02e-1)"	"prognostic favorable (1.46e-6)"	9.1	10.8	10.9	17.0	16.7	9.3	10.0	26.1	16.9	10.3	10.3	12.4	11.4	4.7	15.3	13.2	17.9	16.4	14.9	7.9	13.1	6.9	12.4	9.9	14.9	12.2	20.3	7.9	9.6	13.3	18.0	13.6	11.2	11.9	14.0	10.9	10.5	11.4	9.7	17.6	22.2	9.8	16.4	10.5	18.7	10.8	8.3	18.6	12.9	14.3	8.4	17.1	18.1	12.8	12.6	14.8	14.1	9.6	11.9	11.2	5.8	3.6	12.9	3.7	6.3	14.3	12.4	4.7	3.2	11.3	9.5	8.4	2.9	6.7	7.1	5.5	8.8	9.0	4.1	5.0	12.7	12.3	6.9	5.7	9.9	6.0	2.3	10.9	1.9	10.4	8.2	9.7	9.1	14.2	18.7	14.0	4.7	8.4	3.5	20.8	4.1	6.9	3.1	3.6	11.8	4.1	7.1	6.3	4.1	10.7	3.3	1.1	2.1	2.0	3.6	5.2	6.9	4.8	8.3	7.2	6.7	3.5	5.2	2.3	2.1	2.1	5.0	7.9	4.7	7.6	14.1	9.6	10.4	10.1	7.6	10.3	9.4	10.5	11.2	8.9	12.6	10.2	10.4	11.4	11.9	9.0	14.8	9.9	5.8	10.9	16.7	26.1	16.9	13.1	6.9	20.3	7.9	11.9	18.6	11.9	24.0	17.7	29.3	21.6	11.3	4.5	15.3	14.7	13.6	15.7	127.6	8.6	1.7	11.4	2.0	27.7	11.8	0.0	11.8	4.6	9.8	23.2	36.9	10.2	15.8	17.5	10.9	15.4	26.9	3.0	15.3	17.7	18.6	13.6	15.1	11.6	13.3	14.4	12.0	4.8	52.3	6.5	6.4	2.6	6.4	25.5	12.7	20.3	13.6	25.7
IKBKE	"IKK-i, IKKE, KIAA0151"	ENSG00000263528	"Inhibitor of nuclear factor kappa B kinase subunit epsilon"	Q14164	1	206470476-206496889	"Enzymes, Predicted intracellular proteins"	"DNA damage, Host-virus interaction"	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 24.8;lymphoid tissue: 19.5"	"Cell type enhanced"	"Detected in many"	5	"Paneth cells: 20.1"	"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"NB-4: 25.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA015788, CAB025983"	Approved		Supported	Cytosol		NA	NA			Cytosol		"CAB025983: , HPA015788: AB_1851566"	"unprognostic (6.43e-2)"	"unprognostic (3.04e-1)"	"unprognostic (1.48e-1)"	"unprognostic (5.76e-2)"	"unprognostic (7.78e-3)"	"unprognostic (7.37e-3)"	"unprognostic (1.99e-3)"	"unprognostic (2.82e-1)"	"unprognostic (5.09e-3)"	"unprognostic (1.30e-1)"	"unprognostic (1.50e-1)"	"unprognostic (1.27e-1)"	"prognostic unfavorable (5.34e-7)"	"unprognostic (1.48e-2)"	"unprognostic (5.77e-2)"	"unprognostic (2.84e-3)"	"unprognostic (2.84e-2)"	2.1	0.9	1.0	17.3	3.4	4.3	1.4	1.1	1.7	2.2	4.8	1.5	1.7	3.9	2.0	3.9	6.1	1.2	3.6	1.1	2.9		1.5	0.6	3.7	13.6	2.1	0.7	1.0	1.5	0.0	0.8	2.5	1.9	1.8	4.3	1.5	8.3	2.9	0.1	8.9	4.2	1.0	2.9	12.8	4.0	0.0	2.4	18.8	2.6	4.4	19.5	4.4	0.4	12.9	4.6	4.2	15.9	10.8	24.8	12.3	9.0	7.1	2.0	0.2	3.6	5.2	2.1	3.6	11.5	5.0	5.6	5.6	14.7	17.9	9.9	7.3	6.0	12.2	0.0	9.3	1.0	2.9	1.7	2.5	4.2	3.9	4.7	15.2	8.1	6.6	1.6	4.1	0.8	5.8	7.2	4.9	1.2	5.5	5.2	1.8	9.7	25.6	2.9	2.1	5.5	5.2	2.1	14.2	5.9	15.4	0.0	0.0	1.6	12.3	2.2	2.6	7.3	10.8	14.0	5.0	3.1	3.6	4.1	1.9	0.9	11.6	9.4	12.8	2.0	4.2	15.9	0.3	10.5	11.2	7.5	12.9	16.7	15.2	4.6	7.4	13.3	13.6	1.1	10.8	6.4	1.5	24.8	12.3											0.0	5.0	8.9	3.6	1.6	0.0	0.8	0.0	2.7	0.0	0.0	0.0	3.5	0.0	10.6	2.7	0.6	10.5	0.0	10.9	3.6	2.4	2.6	4.7	0.8	12.5	0.0	3.5	1.3	11.9	5.2	0.9	5.3	6.8	1.8	6.8	0.0	12.0	20.1	0.7	2.0	0.0	0.0	0.5	0.2	0.5	4.3	1.3	14.4	8.0	9.6
IL4I1	FIG1	ENSG00000104951	"Interleukin 4 induced 1"	Q96RQ9	19	49889654-49929539	"Enzymes, Predicted secreted proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 38.6;testis: 48.8"	"Cell type enriched"	"Detected in many"	12	"monocytes: 1188.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"MAIT T-cell: 38.6"	"Group enriched"	"Detected in many"	6	"monocytes: 13.0;T-cells: 38.6"	"Cell line enhanced"	"Detected in some"		"EFO-21: 18.0;HDLM-2: 31.2;Karpas-707: 25.3"	"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			HPA045598	Enhanced		Approved	Nucleoplasm,Cytosol	"Secreted to blood"	NA	NA			"Nucleoplasm, Cytosol"		"HPA045598: AB_10969138"	"unprognostic (6.23e-2)"	"unprognostic (1.32e-2)"	"unprognostic (8.39e-2)"	"unprognostic (1.50e-1)"	"prognostic unfavorable (1.33e-4)"	"unprognostic (5.61e-2)"	"unprognostic (3.74e-3)"	"unprognostic (7.03e-2)"	"unprognostic (2.52e-2)"	"unprognostic (3.84e-3)"	"unprognostic (1.49e-1)"	"unprognostic (1.18e-1)"	"prognostic unfavorable (1.23e-10)"	"unprognostic (2.10e-1)"	"unprognostic (1.01e-1)"	"unprognostic (6.44e-2)"	"unprognostic (2.11e-3)"	5.4	3.3	4.0	30.9	4.6	7.1	4.1	5.8	5.6	4.6	4.1	5.5	2.9	8.2	5.9	3.4	4.5	8.2	5.4	4.2	3.9	3.5	11.0	3.5	6.7	15.5	4.0	3.2	6.2	3.7	1.5	5.1	6.8	4.3	5.3	3.8	3.9	4.1	5.0	6.2	3.4	7.4	3.8	7.2	7.6	6.2	48.8	4.4	14.6	4.1	4.4	12.3	6.5	4.9	0.2	4.1	0.1	13.0	0.4	38.6	3.0	0.5	0.6	0.4	0.4	0.0	0.4	0.1	0.3	1.0	0.8	1.1	0.3	1.0	1.8	18.0	0.2	1.5	0.3	0.2	0.0	0.1	31.2	0.1	0.8	0.0	0.2	0.1	0.6	6.4	0.5	0.2	0.3	0.0	0.2	1.4	0.2	0.1	25.3	0.0	0.2	0.4	1.0	0.2	0.4	0.1	0.5	0.5	1.7	1.2	1.6	0.4	0.4	0.2	0.5	0.3	0.1	0.2	1.4	1.5	3.8	0.5	0.0	0.5	2.2	4.7	1.0	0.5	0.2	0.4	0.1	8.0	0.1	2.3	13.0	38.6	0.2	5.0	4.3	4.1	0.1	0.1	0.0	0.1	0.4	1.6	0.4	0.2	3.0	4.0	4.6	5.8	5.6	3.9	3.5	4.0	3.2	4.3	4.4	0.0	0.0	0.0	0.5	8.7	0.0	0.6	0.0	0.0	1.2	3.5	0.0	0.3	0.0	1.9	52.0	3.1	0.0	0.0	3.4	0.6	1.4	1.0	1.1	0.0	102.3	0.0	0.0	1.8	1.8	11.1	0.3	40.3	3.3	1188.5	0.0	0.1	0.5	0.0	0.4	1.6	0.2	0.0	2.1	11.9	2.5	7.2	0.7	5.0	0.1	1.4
ILK		ENSG00000166333	"Integrin linked kinase"	Q13418	11	6603708-6610874	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004041, HPA048437"	Enhanced		Supported	"Nucleoplasm,Plasma membrane,Focal adhesion sites"		NA	NA		130000000	"Plasma membrane, Focal adhesion sites"	Nucleoplasm	"CAB004041: AB_2127050, HPA048437: AB_2680391"	"unprognostic (1.78e-1)"	"unprognostic (2.26e-2)"	"unprognostic (5.26e-2)"	"unprognostic (2.12e-2)"	"unprognostic (7.57e-2)"	"unprognostic (1.01e-1)"	"unprognostic (6.19e-3)"	"unprognostic (5.25e-3)"	"unprognostic (1.49e-2)"	"unprognostic (9.65e-2)"	"unprognostic (2.64e-1)"	"unprognostic (8.12e-2)"	"prognostic favorable (2.44e-4)"	"unprognostic (4.01e-3)"	"unprognostic (9.27e-2)"	"unprognostic (2.42e-1)"	"unprognostic (6.36e-3)"	20.9	17.6	11.0	22.3	11.9	7.5	37.0	9.4	14.6	40.2	75.1	14.7	41.9	13.5	75.4	25.2	35.7	33.2	41.1	35.1	11.1	9.2	21.6	15.1	21.9	18.9	11.5	14.0	24.2	22.3	20.4	10.9	22.2	11.5	39.9	24.6	19.3	19.4	89.9	18.5	12.4	22.2	103.5	10.6	20.2	33.2	14.2	11.0	8.2	17.5	14.1	13.6	60.8	25.9	19.5	45.9	76.5	49.4	45.3	25.8	63.7	23.9	18.5	29.2	10.1	45.2	32.1	13.3	35.3	69.8	41.8	51.0	19.3	28.3	9.0	9.4	57.7	41.0	19.3	16.3	29.9	42.0	15.7	14.8	13.0	17.7	15.0	30.3	10.4	14.9	30.8	14.1	28.2	21.6	42.9	39.8	7.8	11.9	10.7	54.5	18.0	9.2	17.8	18.4	20.4	21.8	9.6	15.3	9.6	30.6	19.2	5.1	11.5	16.7	23.1	19.4	29.8	16.1	11.9	46.0	52.5	23.7	21.7	17.1	7.8	4.8	12.7	38.9	15.7	24.4	48.3	49.4	76.5	25.8	47.9	25.1	19.5	23.3	24.4	45.9	17.1	14.7	18.5	31.7	45.3	44.4	18.5	25.7	63.7	11.0	11.9	9.4	14.6	11.1	9.2	11.5	14.0	11.5	11.0	41.7	17.0	28.3	58.4	44.9	13.9	0.3	66.2	18.7	15.9	54.1	7.9	94.6	49.7	120.2	46.5	56.1	64.4	46.7	108.6	153.9	93.0	39.7	29.0	24.9	111.6	7.9	36.5	84.1	50.9	110.9	66.2	80.3	81.0	196.6	43.0	50.2	101.4	57.5	138.6	74.7	29.6	155.2	137.9	31.1	15.7	37.8	92.0	54.3	41.7	41.9
ILKAP	"DKFZP434J2031, FLJ10181, PPM1O"	ENSG00000132323	"ILK associated serine/threonine phosphatase"	Q9H0C8	2	238170401-238203729	"Enzymes, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004752, HPA056099"	Uncertain		Supported	Nucleoplasm		NA	NA			Nucleoplasm		"HPA004752: AB_1851753, HPA056099: AB_2797255"	"unprognostic (1.50e-1)"	"unprognostic (1.62e-1)"	"unprognostic (1.23e-1)"	"unprognostic (1.03e-1)"	"unprognostic (6.78e-2)"	"unprognostic (9.75e-2)"	"prognostic unfavorable (1.04e-4)"	"unprognostic (1.60e-1)"	"unprognostic (3.07e-2)"	"unprognostic (3.88e-2)"	"unprognostic (1.37e-3)"	"unprognostic (7.03e-2)"	"prognostic unfavorable (9.89e-6)"	"unprognostic (6.24e-2)"	"unprognostic (6.63e-2)"	"unprognostic (2.63e-2)"	"unprognostic (1.20e-1)"	17.0	17.1	19.4	31.3	22.2	34.6	24.2	34.1	23.4	18.7	23.4	29.5	22.0	20.5	23.0	22.7	19.4	19.0	21.8	20.9	20.6	19.8	17.8	20.8	27.1	25.7	23.9	21.4	22.1	24.1	17.5	24.7	18.1	22.7	21.5	18.9	20.2	19.0	24.9	32.8	19.4	19.0	26.5	19.8	22.2	18.1	21.2	25.5	23.9	22.6	19.0	24.8	18.1	26.1	18.9	20.7	24.1	18.1	17.4	23.8	16.2	17.9	11.7	17.3	16.9	13.5	9.0	17.7	19.0	12.9	19.3	16.8	10.8	9.6	11.5	4.9	13.7	23.1	15.4	22.3	15.8	19.6	20.5	22.2	29.8	11.6	23.7	20.8	19.0	23.6	9.4	10.9	20.5	20.7	9.5	14.4	15.7	22.9	7.5	16.4	21.6	19.1	25.9	16.1	17.0	11.3	23.4	35.4	10.6	14.2	8.6	25.5	12.6	12.8	13.8	30.4	13.8	10.8	19.8	12.9	18.8	17.2	25.2	20.2	13.4	13.4	20.7	15.4	21.4	15.9	24.1	15.1	19.6	22.5	18.1	20.1	18.9	20.0	21.0	20.7	18.5	23.8	18.6	5.3	17.4	15.1	15.8	22.4	16.2	19.4	22.2	34.1	23.4	20.6	19.8	23.9	21.4	22.7	25.5	11.9	22.4	26.5	25.9	24.0	27.2	20.9	5.1	17.4	13.6	24.4	27.5	31.9	36.5	21.9	7.1	20.3	20.0	23.3	24.8	34.9	21.1	24.0	33.4	14.1	30.1	36.5	18.3	17.2	12.7	9.1	26.2	19.1	28.7	35.1	21.4	23.4	21.2	17.5	27.6	24.2	27.2	32.3	28.0	48.7	60.2	25.1	33.8	27.1	22.5	19.3
IMMP1L	"FLJ25059, IMMP1"	ENSG00000148950	"Inner mitochondrial membrane peptidase subunit 1"	Q96LU5	11	31432401-31509645	"Enzymes, Predicted intracellular proteins"		"Hydrolase, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA038372, HPA058308"	Approved		Enhanced	Mitochondria		NA	NA			Mitochondria		"HPA038372: AB_10669643, HPA058308: AB_2732620"	"unprognostic (2.39e-1)"	"unprognostic (1.20e-2)"	"unprognostic (1.12e-1)"	"unprognostic (6.17e-2)"	"unprognostic (9.67e-2)"	"unprognostic (2.08e-2)"	"prognostic unfavorable (7.97e-4)"	"unprognostic (7.59e-2)"	"unprognostic (4.66e-3)"	"unprognostic (5.15e-3)"	"prognostic favorable (6.72e-4)"	"unprognostic (1.97e-1)"	"unprognostic (1.07e-2)"	"unprognostic (4.66e-1)"	"unprognostic (4.52e-2)"	"unprognostic (1.37e-2)"	"unprognostic (1.04e-3)"	9.1	16.6	25.4	11.6	27.8	8.8	15.4	28.4	18.5	10.0	11.3	11.7	12.8	12.1	9.6	25.6	8.4	7.7	5.1	20.4	21.7	17.4	16.2	11.9	10.7	11.2	16.1	12.1	14.0	23.8	7.2	18.2	8.7	11.4	11.2	8.3	17.4	13.6	12.0	39.8	10.1	10.3	9.3	13.2	7.6	10.8	13.8	12.6	17.6	10.0	13.3	10.8	6.8	7.5	16.4	20.0	14.8	1.7	16.9	21.7	7.8	10.2	15.0	39.6	11.7	5.3	3.6	7.4	13.6	3.0	5.7	4.4	11.4	7.9	10.7	9.5	5.8	16.5	11.9	13.6	10.3	8.6	14.4	28.8	12.6	22.4	14.5	5.7	16.5	12.2	3.0	9.2	3.3	7.4	15.9	6.1	21.7	20.2	12.9	5.4	12.7	20.7	23.7	8.0	42.7	13.2	16.3	34.2	10.4	19.4	12.7	10.9	12.5	15.8	7.9	13.5	26.8	18.0	16.9	2.9	13.4	13.3	10.4	21.7	11.8	24.4	18.6	17.6	11.3	13.1	9.0	1.7	14.8	15.6	1.6	14.5	16.4	14.0	15.5	4.0	15.0	17.7	21.7	0.3	16.9	1.6	20.0	16.6	7.8	25.4	27.8	28.4	18.5	21.7	17.4	16.1	12.1	11.4	12.6	32.8	10.5	28.2	25.1	16.3	29.6	46.2	20.4	24.1	9.1	57.6	31.4	31.7	101.2	15.6	27.8	14.6	14.3	23.3	21.0	26.9	15.5	23.7	20.9	35.9	18.2	41.3	54.3	17.8	9.5	7.0	12.4	11.6	8.5	10.8	27.6	51.1	14.4	21.0	19.4	81.2	35.9	32.3	15.3	62.7	19.8	23.8	19.8	28.7	31.9	22.3
IMMP2L	"IMMP2L-IT1, IMP2"	ENSG00000184903	"Inner mitochondrial membrane peptidase subunit 2"	Q96T52	7	110663051-111562517	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"		"Hydrolase, Protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"Distal tubular cells: 135.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"							HPA026711	Approved		Approved	Mitochondria		NA	NA			Mitochondria		"HPA026711: AB_1851760"	"unprognostic (2.55e-2)"	"unprognostic (1.40e-2)"	"unprognostic (4.29e-1)"	"unprognostic (1.04e-1)"	"unprognostic (3.76e-2)"	"prognostic unfavorable (1.89e-5)"	"unprognostic (5.64e-3)"	"unprognostic (1.00e-1)"	"unprognostic (4.17e-1)"	"unprognostic (5.68e-3)"	"unprognostic (1.12e-1)"	"unprognostic (1.09e-1)"	"unprognostic (2.89e-3)"	"unprognostic (1.32e-1)"	"unprognostic (6.65e-2)"	"unprognostic (1.79e-1)"	"unprognostic (2.71e-1)"	12.4	12.4	7.9	7.3	10.8	2.9	11.8	5.4	9.1	12.4	11.1	5.7	10.6	5.2	23.8	10.4	8.0	11.5	5.8	8.6	7.1	6.0	23.8	17.7	7.4	4.4	5.7	6.1	14.4	10.0	13.4	15.7	8.0	6.3	13.8	5.8	31.6	11.6	15.8	18.6	7.5	10.9	14.4	5.6	5.3	9.8	9.0	5.6	8.2	16.7	8.3	9.5	11.0	9.2	18.1	11.7	5.8	8.4	24.3	15.1	5.1	7.9	4.7	2.8	11.8	7.6	7.8	5.0	5.5	5.5	3.7	3.9	2.3	9.2	13.0	15.0	4.7	6.8	4.5	3.0	10.9	6.1	8.1	3.1	4.4	18.9	6.4	11.7	8.2	0.5	13.5	14.6	1.5	10.2	16.7	4.8	12.2	14.2	10.1	2.7	5.5	10.8	9.2	2.8	15.1	7.4	2.3	23.7	6.8	13.3	3.4	3.4	10.5	2.4	11.2	30.2	8.5	4.5	4.8	3.0	5.6	5.9	5.6	6.5	5.8	1.5	7.9	6.2	3.9	29.5	5.8	5.1	1.6	6.4	6.4	11.4	16.3	10.8	7.2	9.4	18.1	15.1	10.5	0.2	24.3	8.4	11.7	6.4	5.1	7.9	10.8	5.4	9.1	7.1	6.0	5.7	6.1	6.3	5.6	17.9	10.4	9.1	30.1	29.2	10.8	17.3	10.2	12.0	18.2	45.4	7.9	18.7	135.9	25.4	7.3	16.5	7.1	0.0	7.2	20.5	12.8	27.2	3.5	21.5	10.0	7.9	18.6	7.4	5.9	4.0	45.8	4.9	20.3	14.4	6.8	10.4	12.7	5.9	32.9	52.2	15.8	12.9	24.0	17.5	9.1	23.2	13.6	4.3	10.0	16.1
IMPA1	IMPA	ENSG00000133731	"Inositol monophosphatase 1"	P29218	8	81657961-81686693	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		Hydrolase	"Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA037489	Approved					NA	No		390000			"HPA037489: AB_10671757"	"unprognostic (1.78e-1)"	"unprognostic (3.59e-2)"	"unprognostic (6.95e-3)"	"unprognostic (2.15e-3)"	"unprognostic (1.31e-1)"	"unprognostic (6.27e-2)"	"unprognostic (3.80e-1)"	"unprognostic (2.46e-2)"	"unprognostic (1.06e-1)"	"unprognostic (4.68e-2)"	"unprognostic (7.78e-2)"	"unprognostic (6.26e-2)"	"unprognostic (2.52e-2)"	"unprognostic (5.87e-2)"	"unprognostic (1.84e-1)"	"unprognostic (2.42e-1)"	"unprognostic (5.41e-3)"	10.8	10.9	16.2	10.5	20.9	20.8	9.2	11.2	29.7	9.4	22.4	15.3	4.7	20.1	10.8	12.0	17.2	10.3	11.0	22.3	17.6	19.7	25.5	29.4	9.8	14.3	18.9	20.7	12.1	8.5	8.6	20.1	7.2	27.3	10.6	25.4	14.8	8.9	7.3	11.2	5.0	23.5	15.0	19.1	12.9	12.2	30.5	13.8	16.2	20.3	12.0	13.7	10.5	10.7	13.2	8.2	24.1	7.5	13.6	12.9	7.2	5.7	16.0	11.1	8.4	6.5	10.3	4.6	16.8	12.1	15.1	18.2	7.5	9.2	22.0	13.4	11.9	22.5	4.5	12.9	5.8	20.3	23.0	13.1	16.6	8.8	9.3	11.7	16.6	17.0	9.8	8.4	11.5	22.8	14.1	16.3	17.1	15.0	18.7	15.0	3.6	21.0	9.6	4.8	14.6	17.1	9.9	8.4	9.0	17.4	18.8	4.5	19.2	11.0	3.0	20.1	19.6	9.6	13.3	12.6	12.5	15.9	9.5	20.7	21.9	26.0	30.8	14.5	10.0	16.9	24.1	4.7	19.5	9.9	6.6	12.1	13.2	10.1	10.7	5.0	9.5	10.7	12.6	7.5	13.6	7.5	8.2	12.9	7.2	16.2	20.9	11.2	29.7	17.6	19.7	18.9	20.7	27.3	13.8	14.9	10.1	13.7	15.3	12.2	16.6	34.7	15.3	20.1	15.9	8.7	13.7	7.9	26.6	13.3	3.5	15.0	29.2	0.0	17.7	8.2	9.7	14.8	32.3	31.0	12.5	23.8	20.6	13.5	13.2	6.4	14.4	14.2	11.8	28.9	15.6	22.6	14.4	51.8	14.2	23.5	14.6	12.9	15.6	46.8	16.2	7.5	2.5	20.8	17.2	15.7
IMPA2		ENSG00000141401	"Inositol monophosphatase 2"	O14732	18	11981025-12030883	"Enzymes, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"pancreas: 90.1"	"Cell type enhanced"	"Detected in many"	8	"Distal tubular cells: 373.0;Extravillous trophoblasts: 196.1;Proximal tubular cells: 383.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"eosinophil: 14.4;neutrophil: 18.7"	"Group enriched"	"Detected in many"	14	"dendritic cells: 5.3;granulocytes: 18.7;monocytes: 6.8"	"Cell line enhanced"	"Detected in many"		"BEWO: 60.5;OE19: 67.8;RPTEC TERT1: 29.2;SiHa: 36.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA029561	Approved		Approved	Nucleoplasm,Mitochondria		Yes	No			Nucleoplasm	Mitochondria	"HPA029561: AB_10601932"	"unprognostic (1.16e-1)"	"unprognostic (1.28e-2)"	"unprognostic (4.76e-3)"	"unprognostic (2.50e-2)"	"unprognostic (4.25e-2)"	"unprognostic (3.25e-3)"	"unprognostic (4.26e-3)"	"unprognostic (4.08e-2)"	"unprognostic (1.87e-1)"	"unprognostic (1.96e-2)"	"unprognostic (4.56e-2)"	"unprognostic (4.24e-3)"	"prognostic favorable (0.00e+0)"	"unprognostic (1.95e-1)"	"unprognostic (1.19e-1)"	"unprognostic (2.08e-2)"	"unprognostic (3.35e-2)"	6.2	2.8	1.5	5.2	1.9	6.9	10.7	0.3	1.5	6.8	12.2	0.7	1.6	5.6	7.3	3.0	40.3	4.1	17.5	20.1	1.4	0.5	41.3	21.0	6.5	4.6	2.2	0.3	3.1	90.1	1.0	5.7	35.6	1.3	17.5	7.8	3.4	9.8	2.5	55.0	30.4	9.2	40.0	1.4	4.8	13.5	1.5	2.0	3.1	8.0	31.4	10.3	22.6	14.7	0.7	5.3	18.7	6.8	0.1	0.6	1.8	6.2	9.7	2.6	4.6	3.4	2.5	60.5	1.6	4.3	0.7	1.0	7.8	5.0	1.3	3.8	2.3	5.7	4.3	3.1	1.6	0.2	7.4	3.8	0.0	12.7	6.7	2.0	10.7	0.5	5.8	8.7	2.3	1.2	2.0	0.9	7.0	1.5	0.0	2.5	6.2	4.3	5.6	9.1	67.8	7.3	7.3	7.3	6.4	29.2	3.5	3.5	0.0	36.5	8.3	3.5	3.4	7.8	13.4	0.0	1.3	2.5	17.9	1.6	5.0	13.3	3.7	5.8	7.2	2.2	3.3	6.8	14.4	0.4	4.9	0.2	0.7	0.4	0.1	5.3	0.2	0.2	0.3	18.7	0.1	3.0	3.7	0.6	1.8	1.5	1.9	0.3	1.5	1.4	0.5	2.2	0.3	1.3	2.0	17.9	25.4	6.9	15.2	93.8	0.2	10.6	45.9	9.4	9.1	21.0	0.0	35.5	373.0	57.8	2.3	5.8	44.1	0.0	96.5	196.1	13.1	33.2	2.3	62.3	36.5	0.0	16.8	8.6	39.4	4.7	4.4	16.7	13.5	4.6	70.8	21.8	73.4	51.8	3.5	383.7	0.9	103.5	9.5	0.4	11.7	123.6	88.9	4.4	78.2	45.7
IMPAD1	"FLJ20421, gPAPP, IMPA3"	ENSG00000104331	"Inositol monophosphatase domain containing 1"	Q9NX62	8	56957933-56993844	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"		Hydrolase	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA009411	Supported		Supported	"Nucleoplasm,Golgi apparatus,Cytosol"		NA	NA		560000	"Golgi apparatus"	"Nucleoplasm, Cytosol"	"HPA009411: AB_1079138"	"unprognostic (1.62e-2)"	"unprognostic (7.89e-3)"	"unprognostic (6.58e-2)"	"unprognostic (6.42e-2)"	"unprognostic (2.00e-1)"	"unprognostic (8.59e-2)"	"unprognostic (1.88e-1)"	"unprognostic (1.67e-2)"	"unprognostic (2.09e-1)"	"unprognostic (4.53e-2)"	"unprognostic (4.24e-3)"	"unprognostic (1.41e-1)"	"unprognostic (1.43e-2)"	"unprognostic (1.68e-3)"	"unprognostic (2.89e-1)"	"unprognostic (1.68e-1)"	"unprognostic (1.05e-1)"	30.6	33.9	17.8	13.9	23.7	9.6	17.6	23.6	33.1	24.7	17.7	30.9	17.8	11.7	23.2	15.2	17.7	15.6	18.0	25.2	19.9	21.6	21.3	32.6	16.5	10.3	23.6	21.1	16.0	25.2	30.4	20.4	23.3	27.2	28.8	16.2	25.2	28.7	22.5	41.4	13.4	12.3	23.0	21.7	13.0	14.7	19.0	19.5	12.0	24.4	18.1	13.0	17.2	14.9	1.9	2.0	6.1	4.6	6.8	2.4	0.6	17.4	14.5	11.2	11.5	34.5	23.7	15.4	26.6	25.9	19.1	16.7	7.2	12.5	10.9	20.4	28.2	13.6	14.3	13.5	17.9	28.4	15.0	9.7	21.3	10.3	12.9	21.5	13.5	15.2	19.0	18.0	17.1	27.8	17.7	25.3	10.3	9.1	19.9	20.9	9.3	16.4	8.1	8.3	20.0	5.4	11.5	10.1	12.3	19.8	10.4	4.3	12.2	14.9	18.4	15.1	12.3	16.4	9.9	21.1	25.9	14.9	25.5	19.0	20.5	17.1	11.7	35.4	11.3	15.8	2.9	1.9	1.1	2.0	1.2	1.6	1.3	1.3	1.2	1.4	1.9	1.5	2.4	6.1	6.8	4.6	2.0	0.9	0.6	17.8	23.7	23.6	33.1	19.9	21.6	23.6	21.1	27.2	19.5	20.8	18.6	9.0	24.5	48.3	29.9	43.1	25.5	8.1	12.5	45.4	15.7	15.1	5.0	17.1	13.5	27.0	19.0	0.0	23.5	68.2	45.0	43.5	9.2	61.6	24.1	38.1	33.4	38.1	25.6	4.2	23.6	23.8	15.1	5.4	33.4	25.1	24.0	17.5	33.6	16.8	27.4	32.3	38.9	34.6	22.2	52.2	28.3	14.9	16.0	33.9
IMPDH1	"LCA11, RP10, sWSS2608"	ENSG00000106348	"Inosine monophosphate dehydrogenase 1"	P20839	7	128392277-128410252	"Disease related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins"	"GMP biosynthesis, Purine biosynthesis"	"DNA-binding, Oxidoreductase, RNA-binding"	"Disease mutation, FDA approved drug targets, Leber congenital amaurosis, Retinitis pigmentosa"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	8	"Bipolar cells: 172.4;Cone photoreceptor cells: 133.5;Horizontal cells: 114.4;Rod photoreceptor cells: 184.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"classical monocyte: 21.6;eosinophil: 20.2;intermediate monocyte: 26.2;myeloid DC: 15.1;neutrophil: 49.9;non-classical monocyte: 31.0"	"Group enriched"	"Detected in all"	5	"dendritic cells: 15.1;granulocytes: 49.9;monocytes: 31.0"	"Cell line enhanced"	"Detected in all"		"SK-BR-3: 89.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA001400	Approved		Supported	"Cytosol,Rods & Rings"		NA	NA			Cytosol	"Rods & Rings"	"HPA001400: AB_1079139"	"unprognostic (2.84e-1)"	"prognostic unfavorable (3.87e-4)"	"unprognostic (2.23e-2)"	"unprognostic (6.45e-2)"	"prognostic unfavorable (7.31e-5)"	"unprognostic (6.03e-2)"	"prognostic unfavorable (1.12e-7)"	"unprognostic (1.24e-1)"	"unprognostic (7.45e-3)"	"unprognostic (1.03e-2)"	"unprognostic (1.79e-1)"	"unprognostic (2.50e-1)"	"prognostic unfavorable (1.78e-12)"	"unprognostic (1.65e-1)"	"unprognostic (1.19e-1)"	"unprognostic (1.10e-1)"	"prognostic unfavorable (3.72e-5)"	26.0	7.4	7.5	20.7	8.5	24.5	37.1	7.7	10.2	11.3	10.9	3.6	12.4	5.2	8.5	6.5	14.6	9.1	7.6	12.6	7.6	5.0	7.5	3.5	14.8	31.2	5.1	5.8	10.7	20.3	5.2	12.0	7.2	9.9	12.1	6.3	19.5	20.6	11.4	3.5	11.9	8.8	12.3	6.4	25.1	20.6	7.1	5.6	3.9	5.5	11.2	9.7	14.2	9.9	4.1	15.1	49.9	31.0	2.8	6.4	11.7	25.5	22.0	3.3	24.5	13.9	10.1	9.4	17.5	11.1	15.0	9.8	16.0	8.2	16.3	6.0	26.0	15.6	19.6	18.5	24.6	7.5	5.9	20.7	10.7	16.3	11.3	12.7	14.1	5.1	12.0	11.8	15.2	15.2	7.1	17.7	9.9	10.6	12.3	5.0	17.5	9.9	38.0	18.6	20.3	25.8	11.9	6.1	33.7	6.6	8.2	13.2	13.3	11.3	89.8	15.8	2.1	10.2	27.4	16.2	25.3	9.2	13.2	12.4	9.2	8.5	20.9	12.9	31.3	15.3	2.3	21.6	20.2	5.9	26.2	6.4	4.1	4.7	5.1	15.1	2.4	2.8	3.4	49.9	2.8	31.0	1.5	5.2	11.7	7.5	8.5	7.7	10.2	7.6	5.0	5.1	5.8	9.9	5.6	0.0	12.8	13.7	7.5	7.8	172.4	4.5	0.0	6.7	6.8	5.2	133.5	2.2	5.0	6.6	0.5	14.0	1.7	0.0	15.6	18.1	11.6	17.1	20.7	0.4	41.4	114.4	9.2	12.9	59.2	1.3	4.4	34.4	15.1	56.9	8.9	17.6	11.7	0.0	6.3	1.3	184.8	0.0	13.3	3.1	18.8	6.5	1.9	14.9	11.9	8.5
IMPDH2		ENSG00000178035	"Inosine monophosphate dehydrogenase 2"	P12268	3	49024325-49029408	"Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"	"GMP biosynthesis, Purine biosynthesis"	"DNA-binding, Oxidoreductase, RNA-binding"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001400, CAB020717"	Approved		Supported	"Cytosol,Rods & Rings"		NA	NA		19000	Cytosol	"Rods & Rings"	"CAB020717: , HPA001400: AB_1079139"	"unprognostic (2.09e-2)"	"unprognostic (2.91e-1)"	"unprognostic (5.96e-2)"	"unprognostic (1.20e-1)"	"unprognostic (7.31e-3)"	"unprognostic (1.56e-1)"	"prognostic unfavorable (3.22e-4)"	"unprognostic (1.30e-1)"	"unprognostic (2.65e-1)"	"unprognostic (2.17e-1)"	"unprognostic (5.44e-2)"	"unprognostic (4.24e-2)"	"unprognostic (1.30e-1)"	"unprognostic (3.85e-1)"	"unprognostic (5.80e-2)"	"unprognostic (2.24e-1)"	"unprognostic (4.47e-2)"	25.0	21.5	16.1	25.7	15.4	23.9	47.0	9.7	21.1	34.7	24.9	15.1	19.1	18.9	29.5	19.8	40.1	51.9	33.3	29.3	13.0	11.2	21.4	29.4	19.9	52.5	18.1	13.0	89.0	88.8	19.1	16.6	23.2	15.6	33.2	31.7	10.8	22.1	22.2	61.4	40.7	17.8	34.1	15.2	23.7	22.2	15.3	15.4	31.2	29.8	51.3	33.4	30.3	32.1	31.6	18.8	6.2	16.8	21.6	34.8	16.0	40.1	23.2	32.2	33.3	48.2	88.1	31.3	27.9	45.2	67.3	57.4	40.3	36.3	73.4	20.0	33.6	19.1	28.0	66.5	56.6	59.0	19.2	22.2	54.4	34.3	36.9	41.4	57.5	22.4	78.2	62.4	64.3	116.9	51.6	47.2	52.0	32.5	41.6	54.1	32.7	48.7	40.1	41.8	38.4	46.9	21.2	33.9	72.0	38.3	26.0	20.9	20.6	30.3	34.3	50.4	27.9	42.4	25.7	23.7	29.5	54.8	71.6	71.5	40.3	29.1	35.2	34.1	64.3	28.8	6.2	10.1	4.0	17.0	16.8	31.7	31.6	23.3	19.6	18.8	31.1	34.8	28.6	4.4	21.6	13.9	14.5	15.5	16.0	16.1	15.4	9.7	21.1	13.0	11.2	18.1	13.0	15.6	15.4	59.6	51.7	94.7	205.9	180.0	15.2	31.5	58.6	44.2	79.6	34.9	13.7	273.1	68.0	75.3	1.3	60.9	35.9	0.0	160.1	214.5	119.3	96.3	66.7	22.1	86.0	14.3	58.3	51.0	42.7	4.7	114.2	60.0	84.4	76.7	112.2	22.9	107.0	31.6	66.8	71.0	14.2	38.8	124.9	26.3	53.7	171.0	262.6	46.8	265.0	109.1
INMT		ENSG00000241644	"Indolethylamine N-methyltransferase"	O95050	7	30697985-30757602	"Enzymes, Predicted intracellular proteins"	Detoxification	"Methyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lung: 73.5"	"Group enriched"	"Detected in many"	10	"Ito cells: 257.8;Leydig cells: 264.1;Peritubular cells: 428.2"	"Cancer enhanced"	"Detected in many"		"thyroid cancer: 22.2"	"Low region specificity"	"Detected in some"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Group enriched"	"Detected in some"	5	"CACO-2: 18.7;HHSteC: 8.0"									HPA061343			Approved	"Golgi apparatus,Vesicles"		NA	NA			"Golgi apparatus, Vesicles"		"HPA061343: AB_2684483"	"unprognostic (1.70e-1)"	"unprognostic (4.36e-2)"	"unprognostic (5.26e-2)"	"unprognostic (6.78e-3)"	"unprognostic (1.59e-1)"	"unprognostic (3.39e-4)"	"prognostic favorable (5.72e-4)"	"unprognostic (3.08e-2)"	"unprognostic (3.94e-2)"	"unprognostic (1.59e-1)"	"unprognostic (8.51e-2)"	"unprognostic (9.07e-2)"	"unprognostic (4.97e-2)"	"unprognostic (1.62e-2)"	"unprognostic (1.43e-2)"	"unprognostic (9.71e-2)"	"unprognostic (1.58e-2)"	19.7	18.0	0.3	3.0	0.7	0.0	5.9	0.3	0.6	4.9	3.7	1.3	14.0	0.8	9.8	18.9	12.4	16.3	14.7	24.6	0.6	0.4	11.8	24.3	73.5	12.1	1.1	0.8	20.2	4.0	0.7	3.2	12.9	2.5	10.1	1.6	13.0	6.1	19.9	4.7	1.5	3.9	11.3	1.3	6.5	5.0	28.2	0.2	0.5	9.4	3.8	2.8	9.6	6.4	1.7	1.1	4.2	1.0	2.2	1.0	0.6	0.0	0.1	0.1	0.1	1.8	2.6	0.4	0.2	2.4	0.0	0.0	18.7	0.1	0.0	0.1	0.6	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.2	8.0	0.1	0.3	0.9	0.0	0.0	0.1	0.0	0.4	0.2	0.1	0.3	0.3	0.1	0.0	0.4	0.9	0.0	0.0	0.1	0.1	0.2	0.0	0.2	0.2	0.6	0.1	0.8	0.0	0.8	0.2	0.1	1.1	0.1	0.8	0.3	0.1	0.8	0.3	0.1	0.2	0.1	0.3	4.2	1.0	0.8	0.7	0.4	0.7	1.2	0.7	0.6	0.4	1.7	1.0	0.8	3.0	2.2	0.4	1.1	0.6	0.6	0.3	0.7	0.3	0.6	0.6	0.4	1.1	0.8	2.5	0.2	0.0	5.1	0.0	0.2	1.9	0.0	7.8	2.5	1.4	4.5	0.0	0.0	0.5	0.0	0.0	1.3	9.7	0.0	0.0	0.0	0.2	21.8	0.2	0.0	3.0	0.7	0.0	1.2	257.8	19.4	8.5	264.1	0.5	3.3	0.0	0.0	0.0	0.0	0.0	428.2	0.0	0.0	32.3	16.0	1.4	1.4	1.9	1.5	0.0	0.0	0.3
INO80	"hINO80, Ino80, INO80A, INOC1, KIAA1259"	ENSG00000128908	"INO80 complex subunit"	Q9ULG1	15	40978880-41116354	"Enzymes, Predicted intracellular proteins"	"Cell cycle, Cell division, DNA damage, DNA recombination, DNA repair, Mitosis"	"Actin-binding, DNA-binding, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041484, HPA048601"			Supported	"Nucleoplasm,Nuclear bodies,Cytosol"		NA	NA			"Nucleoplasm, Nuclear bodies"	Cytosol	"HPA041484: AB_2677506, HPA048601: "	"unprognostic (5.39e-3)"	"unprognostic (2.25e-1)"	"unprognostic (2.73e-1)"	"unprognostic (1.02e-1)"	"unprognostic (1.51e-1)"	"unprognostic (3.92e-2)"	"unprognostic (4.24e-2)"	"unprognostic (1.84e-1)"	"unprognostic (1.93e-1)"	"unprognostic (6.30e-2)"	"unprognostic (1.18e-1)"	"unprognostic (6.69e-2)"	"prognostic favorable (6.30e-4)"	"unprognostic (1.77e-1)"	"unprognostic (1.76e-1)"	"unprognostic (7.72e-2)"	"unprognostic (1.47e-2)"	14.0	10.6	11.8	13.9	13.4	20.7	13.9	29.5	13.0	12.3	13.2	17.4	11.5	11.3	14.9	13.4	15.1	12.6	12.4	10.6	12.8	7.8	12.1	12.9	14.8	13.4	10.2	10.3	15.4	17.8	18.8	13.3	16.4	12.1	12.5	13.9	13.8	11.9	15.7	23.0	16.4	13.2	13.3	9.5	14.5	12.3	13.9	11.6	18.1	13.3	12.6	15.8	13.9	13.3	5.2	2.3	0.9	2.7	5.7	3.4	1.5	9.2	9.2	8.0	7.8	12.6	10.6	9.3	8.6	14.1	13.1	11.4	11.2	7.8	9.9	7.0	13.1	16.3	18.2	14.7	15.0	13.9	11.4	7.5	12.3	12.7	8.4	12.1	12.1	12.1	10.5	13.9	10.5	27.9	8.7	12.5	10.8	13.7	8.5	8.7	7.7	8.8	8.0	8.4	15.8	10.1	13.6	8.5	7.9	9.9	19.4	10.6	7.3	6.3	13.9	5.8	8.3	7.8	14.7	14.3	10.4	9.5	13.2	13.8	9.4	6.4	16.2	12.2	18.0	8.6	0.9	2.7	0.6	2.7	1.7	3.3	3.2	3.4	3.0	2.3	5.2	3.4	3.2	0.9	5.7	1.2	1.8	2.6	1.5	11.8	13.4	29.5	13.0	12.8	7.8	10.2	10.3	12.1	11.6	8.9	25.5	24.6	15.0	7.6	28.4	14.9	12.7	24.1	23.9	15.7	21.6	11.1	6.6	14.7	1.7	13.7	9.7	0.0	11.5	9.4	10.4	13.3	15.1	8.7	8.7	25.4	12.6	11.6	14.9	1.2	13.6	9.5	6.8	18.0	9.2	11.8	12.4	11.0	14.9	9.4	28.8	6.5	11.3	18.4	22.0	11.2	16.0	12.1	11.9	12.8
INPP1		ENSG00000151689	"Inositol polyphosphate-1-phosphatase"	P49441	2	190343470-190371665	"Enzymes, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	12	"Early spermatids: 658.4;Late spermatids: 591.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	5	"eosinophil: 36.6"	"Lineage enriched"	"Detected in all"	5	"granulocytes: 36.6"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036698, HPA036699"	Supported		Approved	"Centriolar satellite,Cytosol"		NA	NA		15000	"Centriolar satellite"	Cytosol	"HPA036698: AB_10672226, HPA036699: AB_2675260"	"unprognostic (1.08e-3)"	"unprognostic (4.50e-3)"	"unprognostic (3.87e-2)"	"unprognostic (2.70e-1)"	"unprognostic (7.85e-2)"	"unprognostic (3.67e-3)"	"unprognostic (4.44e-2)"	"unprognostic (1.17e-1)"	"unprognostic (1.75e-1)"	"unprognostic (2.96e-2)"	"unprognostic (7.28e-2)"	"unprognostic (2.41e-1)"	"unprognostic (2.54e-1)"	"unprognostic (3.74e-1)"	"unprognostic (1.55e-1)"	"prognostic favorable (1.12e-5)"	"prognostic favorable (5.70e-4)"	14.9	25.8	18.3	9.1	26.5	10.3	32.5	17.4	25.1	15.0	19.8	20.4	11.5	27.4	12.0	10.8	42.7	9.8	20.6	17.7	21.2	17.9	11.0	24.8	19.9	8.8	21.0	16.5	10.0	25.6	32.3	17.0	10.4	18.6	10.0	16.8	12.0	9.9	16.0	13.1	28.3	28.0	15.5	23.6	15.7	13.9	31.4	17.1	4.6	12.9	14.0	15.4	19.2	18.8	1.8	3.5	36.6	3.4	6.2	8.0	1.9	10.9	3.1	6.0	0.0	6.5	14.1	0.1	13.2	17.6	12.4	16.3	11.9	7.0	0.0	15.8	12.6	4.0	15.2	2.4	8.5	15.2	13.5	4.6	8.2	9.7	7.1	13.8	6.1	2.6	9.6	13.1	14.1	8.2	8.9	23.1	0.1	19.6	6.9	21.8	0.0	0.4	5.8	1.8	17.5	17.0	0.2	4.9	0.1	9.6	26.1	8.9	3.3	9.1	0.5	12.8	6.5	0.0	8.8	21.3	7.9	5.6	14.2	7.6	1.3	1.4	0.1	2.5	2.4	6.3	8.1	3.4	36.6	3.0	3.1	2.7	1.4	1.9	2.0	3.5	1.8	1.0	1.5	1.6	6.2	1.8	0.1	8.0	1.9	18.3	26.5	17.4	25.1	21.2	17.9	21.0	16.5	18.6	17.1	3.0	5.6	13.4	129.9	76.7	14.5	19.3	28.1	8.1	20.5	10.4	5.9	5.3	6.6	24.1	658.4	50.2	44.8	0.0	75.1	2.7	22.1	67.5	8.1	17.8	8.6	15.9	29.9	60.2	6.9	591.7	24.7	15.4	25.3	5.4	20.3	68.5	42.2	20.4	22.3	14.6	11.6	25.8	20.2	15.3	7.6	85.1	3.3	17.0	22.6	190.1
INPP4A	INPP4	ENSG00000040933	"Inositol polyphosphate-4-phosphatase type I A"	Q96PE3	2	98444854-98594390	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Bipolar cells: 46.8;Kupffer cells: 37.8;T-cells: 39.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in all"		"Karpas-707: 34.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA001628	Approved		Supported	"Nucleoplasm,Nuclear membrane"		NA	NA			"Nucleoplasm, Nuclear membrane"		"HPA001628: AB_10961254"	"unprognostic (3.45e-1)"	"unprognostic (2.39e-2)"	"unprognostic (1.74e-2)"	"prognostic unfavorable (3.70e-6)"	"unprognostic (1.58e-1)"	"unprognostic (3.10e-2)"	"unprognostic (1.15e-3)"	"unprognostic (9.44e-2)"	"unprognostic (1.37e-2)"	"unprognostic (1.23e-1)"	"unprognostic (9.65e-2)"	"unprognostic (3.70e-2)"	"unprognostic (2.90e-2)"	"unprognostic (4.89e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.08e-2)"	"unprognostic (1.97e-2)"	9.0	15.0	11.4	13.5	23.1	12.3	7.0	24.0	28.4	7.5	8.5	8.3	3.8	7.7	8.2	5.7	8.4	6.7	11.0	10.8	12.9	7.8	8.1	7.2	13.5	17.0	6.1	19.8	8.3	8.2	12.7	7.0	8.6	17.9	6.8	8.6	16.1	9.3	7.2	13.6	7.3	12.1	10.5	10.4	24.0	8.4	6.4	6.8	17.6	8.4	2.7	13.4	16.8	6.9	0.8	5.9	3.8	5.1	5.8	6.4	1.8	6.4	5.4	10.0	8.0	5.7	6.5	10.0	5.6	5.0	6.0	6.2	6.9	5.7	4.1	6.4	8.2	7.3	6.0	7.1	5.5	4.9	13.7	6.1	4.8	4.9	3.2	5.1	9.1	17.8	5.8	5.2	5.7	5.1	5.1	8.4	23.3	4.4	34.2	4.4	7.8	13.8	8.1	9.4	3.6	5.3	6.0	7.0	26.7	2.9	19.8	6.6	8.6	6.4	5.2	5.1	10.7	2.4	7.3	7.9	7.0	8.9	5.5	3.8	24.3	14.1	2.8	5.7	8.7	6.0	2.0	1.8	3.8	5.5	3.9	6.4	0.8	3.1	3.7	1.9	0.2	4.3	4.9	2.0	5.8	5.1	5.9	1.6	1.8	11.4	23.1	24.0	28.4	12.9	7.8	6.1	19.8	17.9	6.8	6.0	9.6	10.0	4.7	7.1	46.8	10.5	2.5	0.0	10.3	5.2	7.9	7.2	3.3	3.9	12.8	10.1	1.7	0.0	1.3	6.6	7.2	4.6	0.0	3.2	9.0	31.8	5.2	14.7	37.8	5.4	8.6	17.7	10.1	4.6	5.4	9.2	3.8	3.4	11.3	2.2	13.8	6.5	9.0	9.7	11.2	5.4	7.9	39.8	3.5	5.4
INPP4B		ENSG00000109452	"Inositol polyphosphate-4-phosphatase type II B"	O15327	4	142023160-142847432	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	11	"Early spermatids: 163.6;Late spermatids: 196.7;Sertoli cells: 84.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"memory CD4 T-cell: 19.2"	"Group enriched"	"Detected in many"	6	"NK-cells: 9.1;T-cells: 19.2"	"Cell line enhanced"	"Detected in many"		"CAPAN-2: 52.6;SK-MEL-30: 23.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037681, HPA037682"	Approved		Approved	Centrosome		NA	NA			Centrosome		"HPA037681: AB_10670389, HPA037682: AB_10671377"	"unprognostic (9.79e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.95e-1)"	"unprognostic (9.25e-2)"	"unprognostic (1.77e-1)"	"unprognostic (8.24e-2)"	"unprognostic (3.03e-3)"	"unprognostic (5.76e-3)"	"unprognostic (1.95e-2)"	"unprognostic (3.16e-1)"	"prognostic unfavorable (1.03e-4)"	"unprognostic (8.58e-2)"	"unprognostic (1.26e-2)"	"unprognostic (2.79e-2)"	"unprognostic (1.30e-1)"	"unprognostic (4.58e-1)"	"unprognostic (1.39e-2)"	15.4	4.7	8.4	8.5	12.5	2.2	21.2	5.1	10.3	28.1	7.1	1.8	5.6	5.0	19.7	18.4	9.1	9.2	8.7	18.4	5.9	6.1	6.1	2.0	9.9	10.8	5.5	8.9	15.4	4.0	2.3	3.8	6.2	4.6	8.3	5.8	1.7	4.9	6.8	10.8	4.7	7.3	10.2	3.1	7.0	7.0	19.6	2.4	8.2	6.5	4.9	7.4	15.8	14.6	0.0	0.0	2.2	0.1	9.1	19.2	3.7	9.3	3.9	2.6	1.2	2.0	1.2	0.5	11.3	13.3	2.9	5.5	1.0	52.6	0.2	3.2	10.1	4.5	14.3	0.0	13.2	6.9	0.0	0.4	2.2	1.5	0.0	0.6	0.4	1.8	2.1	1.8	2.0	7.0	8.8	1.6	0.0	0.0	0.5	6.3	16.7	0.3	0.0	0.1	5.7	2.8	0.1	8.7	0.4	4.0	17.4	0.2	0.2	1.3	4.0	23.4	1.6	12.0	1.6	1.0	6.7	8.2	9.9	0.1	0.1	0.0	0.0	1.5	10.3	17.4	2.2	0.1	0.0	3.3	0.0	6.5	0.0	19.2	8.5	0.0	0.0	13.2	5.7	0.2	9.1	0.0	0.0	9.8	3.7	8.4	12.5	5.1	10.3	5.9	6.1	5.5	8.9	4.6	2.4	0.0	1.1	0.0	9.8	6.0	7.3	36.2	7.6	17.4	9.1	8.7	0.0	1.4	5.0	12.2	163.6	10.8	8.4	0.0	26.9	3.9	4.1	13.4	5.8	0.0	6.2	6.4	8.5	3.7	4.4	196.7	12.7	1.9	69.2	0.0	3.4	0.8	47.4	0.0	6.0	0.8	0.6	84.1	43.7	3.1	2.0	2.3	1.6	16.6	3.4	41.0
INPP5A	5PTASE	ENSG00000068383	"Inositol polyphosphate-5-phosphatase A"	Q14642	10	132537820-132783480	"Enzymes, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	5	"basophil: 8.4"	"Lineage enriched"	"Detected in single"	21	"granulocytes: 8.4"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA012285	Enhanced		Approved	"Plasma membrane,Cytosol"	"Intracellular and membrane"	NA	NA			Cytosol	"Plasma membrane"	"HPA012285: AB_1851802"	"prognostic unfavorable (7.47e-4)"	"unprognostic (2.38e-1)"	"unprognostic (2.54e-1)"	"unprognostic (1.68e-3)"	"unprognostic (1.43e-1)"	"unprognostic (3.25e-2)"	"unprognostic (2.08e-1)"	"unprognostic (1.16e-1)"	"unprognostic (5.65e-2)"	"unprognostic (4.35e-1)"	"unprognostic (4.70e-2)"	"unprognostic (1.70e-2)"	"prognostic favorable (3.15e-4)"	"unprognostic (2.14e-1)"	"unprognostic (1.44e-1)"	"unprognostic (8.91e-3)"	"unprognostic (8.66e-2)"	13.6	11.8	10.3	11.3	49.8	5.8	10.3	40.7	20.8	17.4	24.0	10.1	11.5	12.9	25.8	13.9	20.3	15.2	13.6	48.8	9.5	8.5	9.4	7.2	13.8	6.0	9.2	10.4	13.1	11.6	8.9	9.4	19.0	9.1	17.1	11.7	17.1	8.5	16.9	43.7	11.5	14.8	27.9	10.6	8.9	14.8	14.9	16.6	4.2	9.5	12.1	7.8	19.4	22.4	0.3	0.1	8.4	0.2	0.0	0.3	0.6	18.7	7.5	12.6	12.1	19.3	13.6	10.3	19.9	15.3	13.0	8.7	17.7	7.7	1.7	7.7	21.1	8.5	10.7	13.6	8.3	15.7	5.7	7.9	2.7	9.4	24.0	14.0	6.8	6.6	9.2	8.3	8.3	15.9	10.5	9.0	3.6	3.9	10.1	6.9	15.2	1.9	21.9	5.7	11.3	13.4	4.0	8.3	3.0	10.8	10.7	3.0	10.3	9.9	14.7	12.0	12.0	9.5	16.5	7.5	8.4	9.7	11.2	11.6	2.0	9.3	5.8	8.1	4.7	3.6	8.4	0.2	1.1	0.0	0.0	0.0	0.3	0.0	0.1	0.1	0.2	0.0	0.0	1.5	0.0	0.2	0.0	0.3	0.6	10.3	49.8	40.7	20.8	9.5	8.5	9.2	10.4	9.1	16.6	8.9	22.4	1.4	3.6	4.7	10.7	9.0	5.1	2.7	9.1	7.0	0.0	3.3	0.0	5.7	9.4	6.4	18.4	0.0	7.9	3.3	6.2	6.4	8.1	16.0	2.6	7.9	5.8	19.0	6.3	11.2	6.6	3.1	1.7	0.0	9.3	7.8	9.9	11.5	11.0	3.8	4.9	6.5	20.0	5.5	6.6	5.1	2.1	1.9	10.9	5.0
INPP5B		ENSG00000204084	"Inositol polyphosphate-5-phosphatase B"	P32019	1	37860697-37947057	"Enzymes, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA028803	Approved		Supported	Cytosol		NA	NA			Cytosol		"HPA028803: AB_10612121"	"unprognostic (2.28e-2)"	"unprognostic (8.91e-3)"	"unprognostic (7.67e-2)"	"unprognostic (2.27e-1)"	"unprognostic (4.30e-2)"	"prognostic favorable (1.11e-4)"	"unprognostic (1.67e-2)"	"unprognostic (1.52e-2)"	"unprognostic (4.75e-2)"	"unprognostic (1.85e-1)"	"prognostic favorable (5.33e-4)"	"unprognostic (8.27e-2)"	"prognostic unfavorable (6.11e-5)"	"unprognostic (1.03e-1)"	"unprognostic (2.00e-1)"	"unprognostic (2.51e-1)"	"unprognostic (1.28e-1)"	14.5	10.2	11.7	15.9	18.2	22.3	12.8	25.4	16.1	15.3	18.3	21.0	9.4	9.3	19.5	13.7	9.9	15.0	13.7	14.3	12.2	9.0	11.7	16.2	18.7	21.1	23.2	11.4	28.7	11.4	13.1	14.4	14.3	15.9	12.0	13.7	18.9	9.4	16.0	9.7	12.0	13.9	17.5	18.5	19.0	14.7	8.6	21.8	17.4	13.8	4.7	22.3	17.4	13.2	6.7	5.3	19.1	4.7	5.3	9.1	3.8	3.7	2.8	6.7	10.7	8.4	10.8	11.8	4.7	8.3	6.0	8.6	4.4	5.7	14.0	2.2	8.6	3.0	5.2	8.8	3.4	7.8	9.0	3.8	21.3	9.2	2.9	12.2	11.3	31.1	12.6	2.1	6.2	4.0	6.2	7.1	9.4	7.3	18.3	8.1	3.2	9.1	12.0	9.4	5.7	2.2	11.1	13.2	6.6	3.5	3.5	2.6	4.5	5.0	2.4	12.2	9.9	3.0	10.0	7.1	6.0	5.6	5.6	4.3	14.9	7.2	11.3	7.1	10.6	5.1	19.1	2.5	13.2	6.3	2.0	9.1	6.5	4.5	6.1	5.3	6.7	5.8	5.3	3.4	5.3	4.7	4.8	5.6	3.8	11.7	18.2	25.4	16.1	12.2	9.0	23.2	11.4	15.9	21.8	26.8	22.9	10.2	5.0	1.9	15.6	2.4	0.0	5.3	9.1	1.8	23.6	3.4	0.0	1.9	8.1	4.3	3.1	0.0	3.7	12.1	4.3	3.5	8.1	6.4	4.3	22.3	3.4	6.2	6.5	12.4	7.8	6.7	6.8	10.0	4.1	4.5	2.4	3.7	8.5	2.2	20.1	6.5	5.3	4.1	7.5	2.9	3.9	10.7	4.3	3.4
INPP5D	"hp51CN, SHIP, SHIP1"	ENSG00000168918	"Inositol polyphosphate-5-phosphatase D"	Q92835	2	233059967-233207903	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Apoptosis, Immunity"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 40.9"	"Cell type enhanced"	"Detected in many"	9	"B-cells: 58.1;Kupffer cells: 48.3;T-cells: 51.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HBEC3-KT: 15.4;HEL: 31.9;HMC-1: 33.5;hTCEpi: 30.7;NB-4: 29.9;THP-1: 21.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"CAB016300, HPA070455"	Enhanced		Approved	Cytosol		No	No			Cytosol		"CAB016300: AB_628250, HPA070455: AB_2686267"	"unprognostic (5.29e-2)"	"unprognostic (2.05e-3)"	"unprognostic (1.99e-2)"	"unprognostic (6.71e-3)"	"unprognostic (1.10e-1)"	"prognostic favorable (2.03e-5)"	"unprognostic (1.57e-1)"	"unprognostic (1.08e-1)"	"unprognostic (2.29e-2)"	"unprognostic (3.74e-1)"	"unprognostic (2.56e-1)"	"unprognostic (1.23e-1)"	"unprognostic (1.14e-2)"	"unprognostic (1.66e-1)"	"unprognostic (4.82e-2)"	"unprognostic (6.58e-2)"	"unprognostic (6.54e-2)"	7.1	3.1	7.2	33.0	10.7	24.6	4.7	1.7	6.9	3.6	3.7	12.5	0.7	3.5	4.1	2.9	3.3	3.3	6.7	3.2	6.6	9.1	5.1	3.3	8.0	26.1	8.8	2.6	1.9	2.1	1.6	3.4	7.4	7.6	4.5	4.5	3.3	18.8	3.0	1.9	3.4	15.8	3.4	17.6	40.9	4.1	2.4	9.5	16.7	3.1	3.4	32.3	6.2	3.5	14.5	12.0	10.5	18.2	11.9	16.7	14.0	0.0	0.0	0.2	0.0	0.0	0.1	1.7	0.0	0.0	0.0	0.0	0.0	0.4	6.0	0.0	0.0	0.0	0.0	0.0	15.4	0.0	5.1	0.0	31.9	0.0	3.0	0.2	9.6	33.5	0.6	30.7	0.1	3.4	0.1	4.4	0.9	0.1	2.8	0.1	0.0	4.4	29.9	1.0	0.0	0.0	9.3	0.0	2.2	0.0	1.8	0.0	0.0	0.0	0.6	0.0	4.1	0.0	21.4	3.6	0.0	0.5	0.0	0.0	0.0	1.7	9.2	0.0	12.4	0.0	9.8	9.8	10.5	16.7	15.8	11.4	14.5	7.5	12.3	12.0	13.9	6.3	8.8	9.9	11.9	18.2	6.0	10.2	14.0	7.2	10.7	1.7	6.9	6.6	9.1	8.8	2.6	7.6	9.5	3.0	25.7	58.1	1.2	1.4	0.1	3.2	2.5	4.0	4.5	3.5	0.0	0.4	0.0	0.3	12.8	17.5	0.0	0.0	0.4	0.6	1.0	0.4	14.0	1.3	24.6	0.0	0.0	13.5	48.3	10.6	0.0	20.7	0.0	13.6	0.2	0.0	0.2	0.9	1.1	0.3	0.0	0.0	1.2	0.4	0.7	1.0	0.9	51.0	0.4	1.0
INPP5E	"CORS1, JBTS1, pharbin, PPI5PIV"	ENSG00000148384	"Inositol polyphosphate-5-phosphatase E"	Q9NRR6	9	136428619-136439823	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Lipid metabolism"	Hydrolase	"Ciliopathy, Disease mutation, Joubert syndrome, Mental retardation, Obesity"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA065758	Approved		Supported	"Nucleoplasm,Golgi apparatus,Focal adhesion sites"		NA	NA			"Golgi apparatus, Focal adhesion sites"	Nucleoplasm	"HPA065758: AB_2685554"	"unprognostic (1.99e-1)"	"unprognostic (8.68e-2)"	"unprognostic (1.87e-2)"	"unprognostic (1.23e-2)"	"unprognostic (4.00e-1)"	"unprognostic (6.92e-2)"	"unprognostic (9.60e-3)"	"unprognostic (3.21e-1)"	"unprognostic (5.81e-2)"	"unprognostic (2.65e-2)"	"prognostic favorable (1.82e-4)"	"unprognostic (2.03e-1)"	"unprognostic (3.04e-2)"	"unprognostic (3.76e-1)"	"unprognostic (5.48e-2)"	"unprognostic (4.64e-1)"	"unprognostic (2.66e-2)"	14.3	11.2	14.9	15.3	10.4	8.9	19.2	19.9	19.1	10.5	10.7	11.5	11.1	10.3	13.1	10.1	8.4	17.2	9.4	11.9	12.6	12.0	10.2	9.0	10.1	13.5	8.4	12.3	14.7	11.6	11.4	12.3	9.8	13.2	9.9	5.2	11.0	14.4	12.9	11.6	18.2	10.7	10.7	6.6	19.4	8.6	15.2	10.3	8.5	12.5	6.2	10.7	8.8	19.3	2.6	1.0	1.9	0.5	0.0	2.4	0.6	6.2	7.2	8.5	8.4	4.3	5.6	10.5	7.5	4.4	5.8	3.7	7.4	4.4	7.8	7.7	6.3	8.3	17.5	3.7	5.1	2.2	24.3	14.7	5.2	12.4	4.9	7.3	6.1	8.5	6.0	4.8	6.4	5.7	6.9	5.6	10.0	8.8	7.2	4.9	10.3	7.8	13.4	5.5	3.9	12.0	14.3	6.5	5.8	5.2	6.1	8.9	8.0	7.2	6.8	5.2	6.1	10.9	9.1	8.0	17.9	6.7	7.2	13.0	7.8	6.3	3.3	9.2	5.4	6.5	0.0	0.5	1.9	2.0	0.0	1.3	2.6	2.3	1.5	0.5	1.7	0.8	1.6	0.4	0.0	0.3	1.0	2.4	0.6	14.9	10.4	19.9	19.1	12.6	12.0	8.4	12.3	13.2	10.3	3.0	5.8	2.9	1.5	4.8	7.1	4.1	7.6	6.7	3.4	3.5	2.0	2.0	1.7	4.5	0.3	5.8	2.8	0.0	4.8	2.0	3.9	2.0	9.2	3.0	2.6	14.3	5.8	2.5	3.8	0.7	6.9	3.5	5.0	4.6	2.9	8.5	5.3	0.0	5.3	2.2	11.4	0.0	4.8	9.8	7.8	4.3	0.7	4.3	4.3	1.6
INPP5F	"hSac2, KIAA0966, SAC2"	ENSG00000198825	"Inositol polyphosphate-5-phosphatase F"	Q9Y2H2	10	119726097-119829278	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 69.7"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"AF22: 30.5;SH-SY5Y: 24.2;SK-MEL-30: 46.0;SuSa: 63.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042605			Supported	Vesicles		NA	NA			Vesicles		"HPA042605: AB_10793886"	"unprognostic (2.65e-2)"	"unprognostic (3.23e-1)"	"unprognostic (3.42e-2)"	"unprognostic (5.84e-2)"	"unprognostic (1.87e-2)"	"unprognostic (1.57e-3)"	"unprognostic (2.46e-3)"	"unprognostic (2.21e-1)"	"unprognostic (1.12e-1)"	"unprognostic (8.09e-2)"	"unprognostic (2.09e-1)"	"unprognostic (6.46e-2)"	"unprognostic (7.78e-2)"	"unprognostic (1.02e-1)"	"unprognostic (9.91e-2)"	"unprognostic (2.96e-2)"	"unprognostic (6.21e-2)"	4.6	12.3	17.5	5.9	50.4	3.2	5.7	37.0	52.9	10.9	5.0	5.5	2.2	3.1	11.8	18.0	4.5	4.2	5.5	4.1	24.6	53.1	7.3	2.0	4.2	7.6	23.7	29.1	9.8	4.6	8.9	34.0	8.2	69.7	8.3	6.1	3.4	7.1	8.4	7.5	10.4	3.8	10.8	19.2	4.1	3.8	10.1	7.3	1.4	8.4	1.4	9.3	5.3	4.5	12.2	7.4	1.5	4.5	3.8	6.7	2.2	3.9	2.7	30.5	4.4	3.3	3.4	2.7	5.5	3.0	2.6	2.6	4.0	5.0	2.5	2.1	6.9	3.6	4.4	3.3	3.2	4.0	1.6	3.0	1.7	1.4	4.1	4.6	1.1	5.6	4.1	3.0	5.2	5.2	5.4	8.8	2.0	1.5	4.1	6.2	2.2	1.5	4.6	2.9	3.6	3.5	2.1	5.4	0.6	4.4	2.0	2.2	24.2	6.1	1.9	46.0	63.8	1.3	1.2	5.8	2.6	3.4	3.4	5.3	4.6	2.0	1.1	3.3	3.9	10.7	1.1	4.0	1.5	1.3	3.5	1.6	8.1	2.8	1.9	7.4	12.2	3.2	1.4	1.0	3.8	4.5	1.8	6.7	2.2	17.5	50.4	37.0	50.5	24.6	53.1	23.7	29.1	69.7	7.3	6.0	4.5	10.0	9.8	8.0	24.8	5.3	0.0	2.7	5.7	12.2	15.7	7.7	10.0	3.1	28.7	7.4	6.4	0.0	3.9	7.2	6.7	8.4	2.3	2.8	8.6	39.7	1.2	4.9	5.7	18.7	4.9	11.5	18.6	21.6	5.8	18.8	5.5	5.5	3.5	16.7	21.0	6.5	7.5	10.3	40.3	9.2	11.1	4.3	6.0	10.2
INPP5J	"INPP5, PIB5PA, PIPP"	ENSG00000185133	"Inositol polyphosphate-5-phosphatase J"	Q15735	22	31122731-31134696	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"		Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"parathyroid gland: 65.2;thyroid gland: 71.2"	"Cell type enhanced"	"Detected in many"	11	"Collecting duct cells: 33.2;Enterocytes: 31.9;Muller glia cells: 20.3"	"Cancer enriched"	"Detected in many"	6	"thyroid cancer: 63.1"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"myeloid DC: 2.4"	"Lineage enriched"	"Detected in single"	5	"dendritic cells: 2.4"	"Cell line enhanced"	"Detected in many"		"HL-60: 12.3;SK-BR-3: 26.8;T-47d: 16.9;U-698: 11.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA034539			Approved	Nucleoli,Cytosol		NA	NA			Cytosol	Nucleoli	"HPA034539: AB_10670974"	"unprognostic (1.76e-1)"	"unprognostic (2.09e-1)"	"unprognostic (1.73e-1)"	"unprognostic (7.05e-2)"	"unprognostic (1.68e-1)"	"unprognostic (1.19e-2)"	"unprognostic (2.21e-3)"	"prognostic favorable (1.47e-5)"	"unprognostic (6.81e-2)"	"unprognostic (1.86e-2)"	"unprognostic (4.29e-4)"	"unprognostic (1.47e-1)"	"prognostic favorable (1.12e-7)"	"unprognostic (2.79e-3)"	"unprognostic (3.65e-2)"	"unprognostic (2.14e-1)"	"unprognostic (1.39e-2)"	0.8	0.9	4.6	0.8	6.3	0.5	3.7	27.4	13.4	1.5	6.4	0.8	16.7	7.9	1.3	0.8	1.0	1.0	1.0	9.5	7.4	2.0	9.5	0.5	1.5	0.7	2.3	4.6	0.8	5.3	65.2	3.7	0.5	5.5	3.5	2.2	5.6	15.5	19.2	1.6	1.7	21.7	1.2	0.9	0.6	3.8	1.6	1.1	0.0	71.2	0.0	0.7	1.1	0.9	0.3	2.4	0.0	0.4	0.0	0.0	0.2	1.3	1.3	0.8	1.5	0.2	0.2	0.7	0.5	0.5	2.7	2.6	0.8	0.8	0.0	0.6	0.2	0.3	1.6	1.6	0.7	1.1	0.0	4.3	0.0	5.6	0.2	0.5	12.3	0.1	0.1	0.8	2.2	0.2	1.8	0.1	0.0	1.1	1.9	0.0	4.1	0.1	0.0	1.5	1.7	0.2	0.0	0.3	2.9	1.1	1.6	6.5	4.9	1.0	26.8	0.3	0.7	16.9	1.0	0.0	0.1	4.9	0.5	0.3	0.0	2.1	11.6	0.4	0.0	2.0	0.0	0.4	0.0	0.0	0.3	0.0	0.3	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.4	0.9	0.0	0.2	4.6	6.3	27.4	13.4	7.4	2.0	2.3	4.6	5.5	1.1	0.0	2.6	0.0	2.3	0.8	7.9	4.8	0.0	0.0	1.2	33.2	0.0	0.0	10.0	1.2	0.3	0.0	31.9	0.0	1.9	0.1	0.2	3.7	0.0	0.0	0.1	4.8	0.0	0.0	0.0	0.0	0.0	0.2	0.0	1.0	5.0	20.3	1.0	10.5	0.0	0.6	2.3	0.0	0.3	1.7	0.9	1.1	0.1	0.0	6.8	0.9
INPP5K	SKIP	ENSG00000132376	"Inositol polyphosphate-5-phosphatase K"	Q9BT40	17	1494571-1516888	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		Hydrolase	"Cataract, Congenital muscular dystrophy, Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"retina: 114.9"	"Cell type enhanced"	"Detected in many"	11	"Late spermatids: 261.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA						"unprognostic (7.47e-2)"	"prognostic favorable (3.91e-4)"	"unprognostic (8.91e-2)"	"prognostic favorable (2.33e-5)"	"unprognostic (3.25e-1)"	"unprognostic (9.22e-2)"	"unprognostic (1.50e-1)"	"unprognostic (7.50e-2)"	"unprognostic (2.00e-1)"	"unprognostic (2.77e-2)"	"prognostic favorable (1.47e-6)"	"unprognostic (4.71e-2)"	"unprognostic (9.35e-3)"	"unprognostic (3.01e-2)"	"unprognostic (7.20e-2)"	"unprognostic (4.28e-3)"	"unprognostic (1.04e-1)"	27.9	10.5	12.7	13.8	13.5	25.9	37.0	14.9	17.7	13.4	13.4	14.9	9.8	9.1	12.8	12.2	12.0	10.4	12.9	17.5	12.8	12.6	11.6	10.5	20.8	14.3	12.8	12.0	14.3	18.9	12.0	10.8	15.9	21.2	13.5	11.4	114.9	12.9	12.2	26.4	22.3	13.9	10.9	10.7	16.2	12.8	20.8	11.3	22.1	27.3	13.8	16.4	12.5	14.1	12.1	16.5	36.4	27.0	17.0	30.8	24.6	9.5	13.2	5.4	10.4	14.1	7.9	8.1	8.0	13.5	9.1	11.6	8.2	5.7	8.5	15.4	12.2	7.5	12.5	13.0	5.2	9.3	22.0	21.8	5.3	10.1	3.2	17.9	5.0	10.3	9.3	13.8	9.1	9.0	5.8	14.4	14.5	5.7	15.3	6.0	6.8	15.1	4.1	2.3	14.3	9.0	11.6	4.3	8.0	7.3	5.9	4.3	10.9	6.3	12.3	14.3	8.4	10.4	4.1	10.2	8.0	8.2	11.5	10.3	8.1	13.5	4.5	9.0	5.2	10.0	36.4	19.9	31.9	22.2	18.7	18.2	12.1	20.7	22.4	16.5	11.3	17.7	18.9	33.3	17.0	27.0	11.9	30.8	24.6	12.7	13.5	14.9	17.7	12.8	12.6	12.8	12.0	21.2	11.3	29.8	13.1	9.5	13.9	26.7	7.5	31.5	5.1	5.3	7.9	22.7	2.0	11.5	11.6	15.2	90.2	27.4	20.9	0.0	21.2	13.3	15.4	14.1	19.6	8.9	10.7	19.1	16.7	21.5	19.1	261.4	10.6	16.0	30.4	48.7	17.0	20.3	21.3	21.0	7.1	9.0	7.6	19.4	16.4	31.6	16.7	26.5	26.0	36.3	11.0	14.4
INPPL1	SHIP2	ENSG00000165458	"Inositol polyphosphate phosphatase like 1"	O15357	11	72223701-72239105	"Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Cell adhesion, Immunity"	"Actin-binding, Hydrolase"	"Cancer-related genes, Diabetes mellitus, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA037601	Approved		Supported	"Golgi apparatus,Cytosol"		NA	NA			Cytosol	"Golgi apparatus"	"HPA037601: AB_10672281"	"unprognostic (2.68e-1)"	"unprognostic (2.69e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.12e-1)"	"unprognostic (3.68e-3)"	"unprognostic (1.58e-1)"	"prognostic unfavorable (7.37e-4)"	"unprognostic (2.49e-2)"	"unprognostic (3.54e-2)"	"unprognostic (1.51e-2)"	"unprognostic (1.64e-1)"	"unprognostic (4.34e-2)"	"unprognostic (3.66e-2)"	"unprognostic (2.33e-1)"	"unprognostic (2.88e-1)"	"unprognostic (1.99e-3)"	"unprognostic (2.07e-1)"	20.9	23.7	22.2	20.4	19.5	25.1	18.6	11.1	18.9	25.2	32.0	22.7	28.8	19.8	24.7	18.4	17.4	24.3	29.6	29.5	24.1	10.3	23.9	17.1	24.9	19.0	27.6	10.4	30.1	22.7	21.6	26.9	31.9	20.4	28.7	13.5	30.7	27.5	24.2	60.0	17.7	23.0	34.7	27.5	28.3	24.5	11.8	24.3	16.0	29.1	19.3	18.3	25.0	18.1	2.6	5.2	7.0	7.6	4.2	4.5	3.3	6.5	14.0	16.8	11.4	8.3	9.9	30.0	30.2	14.1	18.9	12.1	19.1	16.5	18.6	30.8	23.0	13.5	24.9	13.8	8.5	6.5	24.1	14.3	19.3	70.9	7.0	16.3	12.7	43.3	14.0	9.0	18.3	7.3	23.5	10.1	6.9	13.6	8.0	10.3	17.6	9.4	51.6	17.2	4.6	21.9	44.5	38.2	4.1	22.0	11.0	8.2	11.9	32.4	19.6	42.1	8.9	20.7	24.2	17.2	20.3	23.8	31.1	9.8	23.2	3.8	18.2	5.7	12.1	11.0	5.2	7.6	7.0	4.5	4.4	3.7	2.2	3.7	3.0	5.2	2.6	2.7	3.7	5.2	4.2	7.0	3.9	3.3	3.3	22.2	19.5	11.1	18.9	24.1	10.3	27.6	10.4	20.4	24.3	3.0	13.8	2.4	4.6	6.4	1.2	11.2	5.1	5.3	10.3	12.2	25.5	20.7	1.7	10.7	1.1	6.3	16.0	0.0	10.6	12.5	9.8	6.8	7.0	8.6	18.9	9.5	21.8	10.4	26.9	1.5	9.2	18.1	10.1	3.6	15.4	14.3	13.4	17.5	13.1	12.5	17.2	6.5	9.2	1.2	4.1	4.3	27.1	6.7	17.5	5.2
INSR	CD220	ENSG00000171105	"Insulin receptor"	P06213	19	7112255-7294034	"CD markers, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, RAS pathway related proteins"	"Carbohydrate metabolism"	"Kinase, Receptor, Transferase, Tyrosine-protein kinase"	"Diabetes mellitus, Disease mutation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"pancreas: 64.5"	"Cell type enhanced"	"Detected in many"	4	"Peritubular cells: 230.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	7	"dendritic cells: 8.8;granulocytes: 5.1;monocytes: 10.5"	"Cell line enhanced"	"Detected in many"		"Karpas-707: 31.3;U-266/70: 23.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036302, HPA036303"	Uncertain		Approved	"Vesicles,Plasma membrane"		NA	NA		72000	Vesicles	"Plasma membrane"	"HPA036302: AB_2675048, HPA036303: "	"unprognostic (4.64e-2)"	"unprognostic (2.42e-1)"	"unprognostic (9.65e-3)"	"unprognostic (9.70e-2)"	"unprognostic (1.44e-1)"	"unprognostic (1.15e-2)"	"unprognostic (2.58e-1)"	"unprognostic (5.09e-2)"	"unprognostic (1.97e-1)"	"unprognostic (3.05e-1)"	"unprognostic (9.29e-2)"	"unprognostic (1.86e-1)"	"unprognostic (6.33e-2)"	"unprognostic (3.45e-3)"	"unprognostic (2.43e-1)"	"unprognostic (2.75e-1)"	"unprognostic (8.82e-2)"	13.9	14.7	7.1	3.5	8.2	4.5	12.0	12.0	8.2	10.3	15.2	11.7	10.6	8.4	15.5	6.1	4.7	13.1	7.7	17.7	6.4	5.8	18.7	32.5	5.3	2.2	10.1	4.9	28.3	64.5	11.6	11.6	26.2	8.0	10.5	8.9	11.0	12.0	10.6	15.1	7.3	16.0	10.6	6.8	47.3	8.7	6.9	9.7	2.2	17.1	5.0	3.2	11.3	16.0	1.1	8.8	5.1	10.5	0.8	0.7	1.3	3.8	2.1	2.0	3.0	10.9	3.8	6.5	2.2	2.0	1.2	1.2	5.4	4.4	4.8	5.4	3.9	2.6	1.0	4.7	1.0	0.7	0.0	3.8	0.0	1.5	11.8	4.7	2.2	3.9	5.9	2.4	0.1	2.8	2.4	2.2	2.7	5.9	31.3	0.9	1.7	1.7	3.9	1.8	2.0	3.4	16.7	1.1	4.2	0.1	15.8	3.7	2.9	3.9	2.1	2.1	3.7	1.0	11.0	2.0	2.3	1.4	4.9	2.8	23.1	12.6	11.2	2.6	3.9	0.0	2.0	8.2	5.1	0.2	7.8	0.3	0.8	0.3	0.1	8.8	1.1	0.7	0.1	1.7	0.8	10.5	7.4	0.0	1.3	7.1	8.2	12.0	8.2	6.4	5.8	10.1	4.9	8.0	9.7	44.7	26.7	8.2	54.6	57.7	38.7	85.3	107.0	41.5	50.0	59.3	74.6	15.8	13.3	41.1	2.9	52.3	87.1	0.0	68.2	39.2	29.8	84.0	3.5	214.7	8.6	36.5	157.1	201.3	47.7	3.6	89.2	26.7	49.0	8.2	103.9	26.9	67.8	56.1	230.5	116.2	22.2	58.2	42.3	6.2	1.2	60.1	32.0	6.4	56.3	113.2
INSRR	IRR	ENSG00000027644	"Insulin receptor related receptor"	P14616	1	156840063-156859018	"Enzymes, Predicted membrane proteins"		"Kinase, Receptor, Transferase, Tyrosine-protein kinase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"adrenal gland: 5.5;brain: 5.9;kidney: 8.3"	"Group enriched"	"Detected in some"	6	"Bipolar cells: 1.3;Cardiomyocytes: 1.7;Early spermatids: 1.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	7	"SCLC-21H: 5.5;SH-SY5Y: 19.1"	"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			HPA025285	Uncertain					NA	NA					"HPA025285: AB_1851814"	"unprognostic (1.19e-1)"	"unprognostic (7.69e-2)"	"unprognostic (2.42e-2)"	"unprognostic (6.76e-4)"	"unprognostic (1.51e-1)"	"unprognostic (9.07e-3)"	"unprognostic (5.57e-2)"	"unprognostic (1.75e-1)"	"unprognostic (6.17e-2)"	"unprognostic (5.57e-2)"	"unprognostic (2.20e-2)"	"unprognostic (7.00e-2)"	"unprognostic (4.22e-5)"	"unprognostic (2.82e-1)"	"unprognostic (9.55e-2)"	"unprognostic (2.75e-3)"	"unprognostic (3.66e-2)"	0.9	5.5	0.0	0.3	5.9	0.1	0.8	1.9	1.4	1.9	0.1	0.0	0.0	0.1	2.7	0.1	0.1	0.6	0.3	1.9	0.5	1.3	8.3	0.1	0.1	0.4	0.8	0.6	0.3	0.9	0.1	1.7	0.4	5.6	2.7	0.1	2.1	0.6	0.5	0.4	0.1	0.2	0.3	0.0	0.2	3.0	4.2	0.4	0.3	0.3	0.0	0.8	0.2	0.5	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	5.5	19.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.9	1.9	1.4	0.5	1.3	0.8	0.6	5.6	0.4	0.0	0.0	0.0	0.0	0.0	1.3	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0
IP6K1	"IHPK1, KIAA0263"	ENSG00000176095	"Inositol hexakisphosphate kinase 1"	Q92551	3	49724294-49786542	"Enzymes, Predicted intracellular proteins"		"Kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	4	"Cone photoreceptor cells: 84.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA040825	Approved		Supported	"Nucleoplasm,Nucleoli fibrillar center,Cytosol"		NA	NA			"Nucleoli fibrillar center"	"Nucleoplasm, Cytosol"	"HPA040825: AB_10960426"	"unprognostic (6.18e-2)"	"unprognostic (1.33e-1)"	"unprognostic (3.58e-2)"	"unprognostic (4.71e-2)"	"unprognostic (1.99e-1)"	"prognostic favorable (2.08e-4)"	"unprognostic (9.97e-3)"	"unprognostic (8.45e-2)"	"unprognostic (1.16e-1)"	"unprognostic (2.11e-1)"	"prognostic favorable (6.85e-4)"	"unprognostic (1.29e-2)"	"prognostic favorable (5.77e-5)"	"unprognostic (8.75e-2)"	"unprognostic (1.67e-1)"	"unprognostic (9.24e-2)"	"unprognostic (1.64e-2)"	14.2	17.5	23.5	12.9	26.9	12.1	15.8	38.6	40.4	17.7	16.1	20.7	16.1	13.6	21.4	14.5	19.6	20.0	14.7	13.7	23.8	23.5	16.3	15.9	16.9	16.3	17.9	18.3	30.2	21.9	30.3	16.7	18.3	21.2	14.3	13.2	18.6	18.3	21.1	9.0	18.2	12.7	19.5	16.9	16.9	13.7	27.3	14.8	22.3	17.1	8.4	14.4	16.3	15.6	6.8	4.1	24.0	4.8	6.9	9.7	6.0	12.3	15.0	17.6	20.6	18.4	14.2	14.2	16.5	17.4	27.1	23.8	19.5	12.9	10.8	10.7	18.2	18.4	9.2	24.8	14.9	15.4	21.7	19.8	24.4	23.0	13.1	20.4	14.9	17.1	16.5	18.6	29.2	17.7	15.3	22.6	12.6	16.0	12.7	13.3	11.0	18.1	15.6	18.9	9.8	25.0	11.5	12.5	21.6	17.5	18.9	9.5	19.0	21.0	13.7	18.9	10.6	11.0	22.0	20.2	15.2	15.3	20.8	19.1	15.5	20.8	11.5	13.9	17.3	15.5	2.5	4.8	8.2	8.7	3.9	8.8	4.6	8.0	9.6	4.1	6.8	9.7	9.5	24.0	6.9	4.8	2.9	8.2	6.0	23.5	26.9	38.6	40.4	23.8	23.5	17.9	18.3	21.2	14.8	23.8	10.5	11.8	13.7	13.9	37.4	8.9	15.3	17.4	10.3	12.2	84.4	15.7	5.0	12.1	69.3	16.6	12.9	23.3	11.3	13.2	13.6	16.1	19.6	10.6	10.8	28.6	26.5	17.8	11.8	11.8	19.5	10.7	18.6	14.4	12.2	22.0	16.3	8.6	15.6	10.3	70.3	19.4	11.5	17.9	22.6	16.4	23.0	23.5	11.0	13.3
IP6K2	IHPK2	ENSG00000068745	"Inositol hexakisphosphate kinase 2"	Q9UHH9	3	48688003-48740353	"Enzymes, Predicted intracellular proteins"	"Lipid metabolism, Phospholipid metabolism"	"Kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007532, HPA070811"	Approved		Approved	"Nucleoplasm,Nucleoli fibrillar center,Cell Junctions"		NA	NA			"Nucleoplasm, Nucleoli fibrillar center"	"Cell Junctions"	"HPA007532: AB_1851542, HPA070811: AB_2732165"	"prognostic favorable (1.25e-4)"	"unprognostic (2.55e-2)"	"unprognostic (8.86e-2)"	"unprognostic (6.69e-3)"	"unprognostic (1.01e-1)"	"unprognostic (1.49e-2)"	"unprognostic (1.76e-3)"	"prognostic favorable (2.95e-4)"	"unprognostic (6.57e-3)"	"unprognostic (1.56e-1)"	"unprognostic (1.92e-3)"	"unprognostic (1.99e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.35e-1)"	"unprognostic (1.64e-1)"	"unprognostic (3.50e-2)"	"prognostic favorable (1.83e-4)"	18.3	31.1	40.4	20.0	55.9	51.7	28.2	74.1	37.3	29.5	32.5	23.7	34.0	36.9	34.6	56.1	30.0	28.1	24.0	19.0	30.7	19.2	32.4	24.3	18.4	22.5	35.4	27.6	33.9	28.1	23.5	42.3	20.7	29.4	34.9	41.9	22.2	28.3	32.1	19.1	50.0	31.6	21.1	28.3	25.5	27.6	26.0	37.4	31.7	35.7	21.6	19.5	24.1	34.0	27.3	22.8	50.7	25.7	27.9	35.1	19.0	8.5	16.7	34.7	24.4	19.6	24.5	25.1	16.3	18.3	18.7	21.7	13.8	22.9	15.1	13.4	15.2	23.5	22.3	17.3	24.4	17.5	17.8	15.2	17.3	51.7	29.6	15.9	16.4	16.9	23.2	35.6	25.4	21.0	24.9	25.9	49.1	12.9	19.0	21.7	19.0	35.0	22.5	26.6	16.7	31.0	14.7	11.5	16.5	25.4	41.0	21.7	32.8	35.3	24.0	17.3	28.8	23.2	27.7	18.4	20.4	20.3	12.8	16.1	17.6	20.8	21.3	18.5	19.2	17.8	50.7	22.5	38.5	29.7	21.6	26.5	27.3	25.8	27.7	21.7	25.7	24.2	24.9	35.3	27.9	25.7	22.8	35.1	19.0	40.4	55.9	74.1	37.3	30.7	19.2	35.4	27.6	29.4	37.4	65.5	38.7	24.2	78.6	73.7	63.9	10.1	33.1	69.6	69.4	94.2	37.3	101.3	64.6	51.7	30.9	42.0	85.6	0.0	41.6	64.1	64.4	60.2	53.1	20.7	35.7	19.1	105.7	35.0	15.3	14.2	75.1	31.2	25.3	34.3	96.2	28.0	50.1	90.2	64.3	55.6	50.0	51.8	35.7	56.7	54.0	72.5	103.7	47.2	78.7	75.6
IP6K3	"IHPK3, INSP6K3"	ENSG00000161896	"Inositol hexakisphosphate kinase 3"	Q96PC2	6	33721670-33746905	"Enzymes, Predicted intracellular proteins"		"Kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in many"	5	"brain: 22.5;skeletal muscle: 87.9"	"Cell type enhanced"	"Detected in some"	12	"Cardiomyocytes: 10.9;Hepatocytes: 5.8;Horizontal cells: 9.5;Proximal tubular cells: 3.6;Sertoli cells: 6.5"	"Low cancer specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"basal ganglia: 13.0;cerebral cortex: 6.2;midbrain: 22.5;pons and medulla: 7.7;thalamus: 15.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HHSteC: 16.2;HSkMC: 5.8;LHCN-M2: 25.7;RH-30: 11.3"	"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			"HPA053644, HPA062531"	Approved		Approved	Nucleoplasm,Cytosol		Yes	NA			Nucleoplasm	Cytosol	"HPA053644: AB_2682214, HPA062531: "	"unprognostic (3.23e-2)"	"unprognostic (2.87e-1)"	"unprognostic (2.07e-5)"	"unprognostic (1.07e-3)"	"unprognostic (2.20e-1)"	"unprognostic (5.10e-3)"	"unprognostic (1.38e-1)"	"unprognostic (1.75e-1)"	"unprognostic (2.45e-1)"	"unprognostic (2.47e-2)"	"unprognostic (1.24e-2)"	"unprognostic (2.94e-3)"	"prognostic unfavorable (6.09e-4)"	"unprognostic (1.63e-2)"	"unprognostic (2.01e-1)"	"unprognostic (2.66e-3)"	"unprognostic (1.33e-1)"	2.2	1.0	2.1	0.8	13.0	0.5	0.9	0.6	6.2	1.2	2.2	11.8	1.4	0.8	1.6	1.4	5.2	1.3	0.6	10.0	3.2	1.3	4.7	7.7	2.0	0.6	22.5	1.1	0.6	0.7	0.5	0.5	3.8	7.7	2.8	1.0	1.2	1.4	1.8	87.9	0.5	1.1	1.8	9.2	1.4	0.9	0.6	15.2	0.0	9.9	8.1	0.5	1.5	1.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	2.6	0.1	0.2	0.2	1.9	0.0	0.0	0.0	0.4	0.0	0.1	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.1	16.2	0.0	0.0	5.8	0.8	0.1	0.4	0.0	0.0	0.0	0.0	0.0	25.7	0.0	0.0	0.0	0.1	0.0	0.0	0.0	11.3	0.0	0.0	0.0	0.3	0.1	0.0	0.5	0.4	4.0	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	2.1	13.0	0.6	6.2	3.2	1.3	22.5	1.1	7.7	15.2	0.0	0.0	0.0	0.0	0.0	2.2	10.9	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.1	0.0	0.0	5.8	0.2	9.5	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	3.6	0.1	6.5	0.4	0.0	0.0	0.0	0.6	0.0	0.0	0.1
IPMK		ENSG00000151151	"Inositol polyphosphate multikinase"	Q8NFU5	10	58191517-58267934	"Enzymes, Predicted intracellular proteins"	"Lipid metabolism, Phospholipid metabolism"	"Kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Basal keratinocytes: 48.0;Suprabasal keratinocytes: 50.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"neutrophil: 6.4"	"Group enriched"	"Detected in many"	4	"granulocytes: 6.4;monocytes: 2.1"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037837, HPA057542"	Uncertain		Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"HPA037837: AB_10670166, HPA057542: AB_2683460"	"unprognostic (4.52e-2)"	"unprognostic (3.29e-2)"	"unprognostic (4.22e-3)"	"unprognostic (6.85e-2)"	"unprognostic (2.41e-2)"	"unprognostic (1.99e-1)"	"unprognostic (1.39e-3)"	"unprognostic (2.10e-1)"	"unprognostic (9.39e-2)"	"unprognostic (2.23e-1)"	"unprognostic (1.55e-1)"	"unprognostic (8.56e-2)"	"prognostic unfavorable (9.96e-7)"	"unprognostic (1.79e-1)"	"unprognostic (4.33e-1)"	"unprognostic (1.27e-3)"	"unprognostic (9.02e-3)"	12.2	4.1	5.4	6.8	5.6	2.8	6.7	8.7	5.6	5.9	19.4	3.5	2.1	9.5	3.2	5.6	10.8	3.8	8.6	7.4	5.2	5.5	5.3	21.3	11.0	13.8	4.9	3.3	4.8	6.0	22.5	6.1	13.8	4.3	4.4	7.5	4.8	6.4	4.4	9.8	9.0	28.1	4.9	6.0	14.1	4.4	2.9	3.8	11.7	5.9	4.9	5.9	10.4	12.3	0.7	1.0	6.4	2.1	0.4	0.9	0.4	14.7	3.8	5.6	5.4	5.5	6.5	4.9	3.9	8.4	3.4	6.8	7.6	9.5	11.8	8.0	4.6	3.2	4.6	4.7	5.2	10.8	5.4	3.6	2.9	3.8	7.2	3.3	4.6	6.7	7.1	4.7	5.7	11.5	3.8	7.2	3.5	1.9	6.1	5.9	3.7	6.2	8.9	3.5	6.0	3.6	0.4	12.1	5.5	6.2	3.8	3.9	6.8	5.1	13.6	3.9	9.6	11.3	5.6	6.2	3.7	7.1	7.7	4.9	13.1	7.7	9.4	6.9	4.9	1.4	2.3	1.5	3.3	0.4	1.6	0.4	0.7	0.4	0.2	1.0	0.4	0.9	0.3	6.4	0.4	2.1	0.4	0.1	0.4	5.4	5.6	8.7	5.6	5.2	5.5	4.9	3.3	4.3	3.8	6.0	3.4	9.7	9.1	48.0	9.1	2.4	5.1	17.4	7.9	1.8	5.9	8.5	3.3	3.2	1.9	3.2	22.2	0.0	4.2	17.8	16.0	7.8	6.9	11.4	9.0	12.7	8.1	8.6	27.1	1.0	2.6	17.3	25.3	1.0	11.7	3.7	6.2	16.4	1.8	7.3	5.4	6.5	12.2	9.8	4.3	50.7	7.9	4.3	9.0	14.3
IPPK	"C9orf12, FLJ13163, INSP5K2, IP5K, IPK1"	ENSG00000127080	"Inositol-pentakisphosphate 2-kinase"	Q9H8X2	9	92613184-92670265	"Enzymes, Predicted intracellular proteins"		"Kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Late spermatids: 26.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA020603	Uncertain		Approved	Cytosol		NA	NA			Cytosol		"HPA020603: AB_1851853"	"unprognostic (3.51e-2)"	"unprognostic (4.66e-2)"	"unprognostic (6.26e-2)"	"unprognostic (1.26e-1)"	"unprognostic (3.63e-2)"	"unprognostic (2.08e-1)"	"unprognostic (4.88e-2)"	"unprognostic (3.13e-2)"	"unprognostic (4.40e-2)"	"unprognostic (1.10e-1)"	"unprognostic (2.68e-1)"	"unprognostic (1.98e-1)"	"unprognostic (6.26e-9)"	"unprognostic (1.28e-2)"	"unprognostic (4.23e-2)"	"unprognostic (2.83e-1)"	"prognostic unfavorable (1.28e-4)"	5.0	7.5	7.6	5.2	12.3	8.3	7.5	13.4	14.1	7.9	4.7	9.7	6.8	3.7	6.0	5.9	29.7	6.4	5.3	8.1	7.9	5.9	5.2	5.8	4.9	6.0	7.1	5.7	6.5	4.2	11.3	11.0	7.1	10.0	5.1	5.3	6.0	10.8	4.3	6.9	31.5	4.6	6.3	6.4	5.8	4.8	12.0	7.7	5.7	5.5	17.8	16.1	4.9	13.7	4.2	3.9	5.8	3.2	1.4	7.5	3.1	11.9	6.4	5.9	5.1	7.3	5.5	19.7	8.6	5.3	8.8	5.0	4.0	4.7	7.5	4.3	11.9	7.8	17.2	10.4	11.9	7.4	9.2	6.7	6.1	13.6	6.1	5.2	10.3	7.2	5.4	11.8	10.5	8.2	8.0	6.5	6.2	8.2	9.1	8.6	16.3	5.9	4.8	10.1	13.2	9.5	5.2	6.4	3.0	5.2	7.3	12.4	7.3	6.9	28.7	5.0	6.1	6.8	2.6	12.6	6.5	7.4	18.3	8.9	8.4	9.7	4.2	8.5	4.7	6.3	0.0	2.3	5.8	6.4	3.1	7.3	4.1	5.6	5.7	3.6	4.2	4.4	4.8	3.6	1.4	3.2	3.9	7.5	3.1	7.6	12.3	13.4	14.1	7.9	5.9	7.1	5.7	10.0	7.7	3.0	4.3	1.5	5.2	22.6	8.3	0.3	0.0	0.0	3.4	1.8	5.9	7.8	5.0	5.2	8.3	5.8	3.3	0.0	6.9	11.0	4.3	5.0	0.0	2.6	4.4	14.3	6.4	10.4	5.9	26.7	2.8	3.9	3.3	1.8	3.4	4.5	6.5	0.0	2.8	3.1	4.1	6.5	2.7	15.7	16.8	25.7	19.1	4.4	3.3	9.0
IRAK1	"IRAK, pelle"	ENSG00000184216	"Interleukin 1 receptor associated kinase 1"	P51617	X	154010500-154019980	"Enzymes, Predicted intracellular proteins"	"Host-virus interaction, Immunity, Innate immunity"	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Exocrine glandular cells: 97.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004461, HPA054476"	Supported		Supported	Nucleoplasm,Cytosol		No	No			Cytosol	Nucleoplasm	"CAB004461: AB_2249106, HPA054476: AB_2682501"	"unprognostic (4.46e-3)"	"unprognostic (9.32e-2)"	"unprognostic (1.71e-2)"	"unprognostic (5.04e-3)"	"unprognostic (7.09e-3)"	"unprognostic (4.43e-3)"	"prognostic unfavorable (3.03e-4)"	"unprognostic (7.89e-3)"	"unprognostic (3.36e-2)"	"unprognostic (3.69e-2)"	"unprognostic (1.95e-1)"	"unprognostic (6.64e-2)"	"prognostic unfavorable (2.06e-4)"	"unprognostic (2.76e-3)"	"unprognostic (2.36e-1)"	"unprognostic (2.21e-3)"	"unprognostic (3.04e-1)"	22.3	23.7	12.1	25.0	11.4	48.3	38.5	7.7	14.8	11.1	24.8	10.8	13.4	29.9	13.2	12.4	25.5	12.2	23.1	14.1	9.9	12.3	23.7	46.9	18.5	37.5	12.6	7.9	15.1	34.6	8.1	15.2	14.3	11.9	18.0	11.0	10.1	31.9	15.9	32.6	15.9	34.6	11.5	12.7	34.0	19.3	14.3	9.8	17.0	12.6	20.4	26.7	17.2	15.3	10.0	13.0	6.7	10.6	6.3	6.7	3.4	77.0	30.0	4.3	34.6	8.5	6.8	18.5	11.5	10.9	17.8	16.5	23.7	34.2	32.9	64.8	12.3	27.3	21.1	9.8	18.8	6.9	25.8	29.3	12.0	27.0	14.1	19.5	28.3	20.6	9.4	16.5	16.9	18.7	9.2	10.6	6.7	21.1	38.1	12.4	28.4	11.6	25.3	10.5	24.6	59.8	30.2	21.5	55.2	11.8	14.6	23.8	17.2	13.7	15.3	22.7	1.7	5.9	30.2	14.5	21.6	34.2	49.3	71.3	48.0	30.6	60.3	31.5	34.1	22.3	1.3	8.7	6.7	6.7	10.6	5.9	7.5	5.3	5.3	5.4	10.0	3.1	6.1	5.9	6.3	8.1	13.0	2.5	3.4	12.1	11.4	7.7	14.8	9.9	12.3	12.6	7.9	11.9	9.8	0.0	14.1	25.2	11.0	11.8	8.1	8.2	20.4	6.7	19.4	10.4	5.9	9.6	6.6	45.8	0.6	13.7	36.0	0.0	97.4	17.8	12.1	24.0	12.7	32.6	52.7	15.9	19.7	10.4	45.4	1.8	16.7	26.5	13.5	11.8	24.2	14.0	61.0	24.6	20.1	13.3	5.0	0.0	14.5	1.7	6.3	11.4	10.3	14.0	28.8	23.4
IRAK2		ENSG00000134070	"Interleukin 1 receptor associated kinase 2"	O43187	3	10164865-10243743	"Enzymes, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 28.7"	"Cell type enhanced"	"Detected in many"	7	"Basal glandular cells: 18.1;Glandular cells: 20.2;Urothelial cells: 22.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BEWO: 16.2;BJ hTERT+: 16.9;CAPAN-2: 17.1;GAMG: 30.8;RT4: 23.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB013483, HPA050520"	Uncertain		Approved	Vesicles		NA	NA			Vesicles		"CAB013483: , HPA050520: AB_2681154"	"unprognostic (1.31e-1)"	"unprognostic (2.04e-2)"	"unprognostic (1.46e-2)"	"unprognostic (4.61e-3)"	"unprognostic (8.71e-2)"	"unprognostic (9.55e-2)"	"prognostic unfavorable (8.35e-4)"	"unprognostic (1.89e-2)"	"unprognostic (8.01e-2)"	"unprognostic (1.24e-1)"	"prognostic unfavorable (2.26e-4)"	"unprognostic (2.24e-1)"	"unprognostic (3.10e-2)"	"unprognostic (7.22e-2)"	"unprognostic (4.38e-2)"	"unprognostic (3.91e-2)"	"prognostic favorable (6.60e-5)"	12.1	5.8	3.6	8.6	5.9	28.7	5.4	4.5	7.0	3.3	4.0	12.2	2.3	3.3	3.5	2.6	8.4	2.4	6.8	2.7	3.6	5.2	4.3	15.4	12.7	5.3	10.4	3.7	1.9	3.2	2.4	1.8	3.5	7.8	6.4	3.1	2.1	4.8	3.4	19.6	6.2	6.7	3.4	6.1	5.9	5.2	1.7	8.6	3.9	4.1	2.7	16.7	14.3	7.2	5.0	1.3	2.5	1.2	8.4	7.9	2.5	1.2	3.7	0.1	0.5	4.0	3.4	16.2	1.3	16.9	2.3	2.2	1.7	17.1	0.0	0.4	2.0	30.8	0.4	0.4	4.3	3.1	1.0	1.2	0.3	0.8	4.7	2.0	0.0	0.5	2.1	0.7	8.5	11.0	6.1	4.7	0.1	0.8	5.2	2.7	0.0	0.0	0.8	0.1	2.0	3.6	0.8	0.0	0.2	5.1	23.4	0.2	0.1	1.6	0.0	0.1	0.4	0.4	0.8	4.8	5.3	0.4	3.2	3.3	1.7	5.1	1.0	11.3	2.2	0.9	0.2	1.2	0.1	7.5	0.7	7.9	5.0	2.2	4.1	1.3	4.5	1.6	3.9	2.5	8.4	0.2	0.1	0.9	2.5	3.6	5.9	4.5	7.0	3.6	5.2	10.4	3.7	7.8	8.6	0.0	5.5	0.9	18.1	7.1	0.6	1.6	0.0	0.0	2.3	0.0	0.0	0.1	0.0	8.5	3.3	2.1	1.1	0.0	3.5	0.4	1.0	20.2	0.0	4.7	2.9	0.0	0.0	1.3	2.5	1.1	0.9	4.3	5.0	2.8	0.1	1.7	10.4	0.0	0.0	1.0	0.0	0.0	3.1	0.4	0.4	6.5	0.8	1.5	0.4	22.1
IRAK3	IRAK-M	ENSG00000090376	"Interleukin 1 receptor associated kinase 3"	Q9Y616	12	66188879-66254622	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"	Asthma	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 58.0"	"Cell type enhanced"	"Detected in many"	14	"Ito cells: 36.2;Kupffer cells: 118.3;Macrophages: 66.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"basophil: 5.6;classical monocyte: 13.1;intermediate monocyte: 13.2;myeloid DC: 6.2;neutrophil: 7.2;non-classical monocyte: 20.6"	"Group enriched"	"Detected in many"	12	"dendritic cells: 6.2;granulocytes: 7.2;monocytes: 20.6"	"Cell line enhanced"	"Detected in some"		"ASC diff: 15.0;ASC TERT1: 12.4;HEL: 12.8;HL-60: 17.0;NB-4: 13.6;THP-1: 20.6;U-937: 14.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA043097	Approved		Approved	Vesicles	"Intracellular and membrane"	NA	NA			Vesicles		"HPA043097: AB_10795612"	"unprognostic (7.12e-2)"	"unprognostic (1.06e-1)"	"unprognostic (2.90e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.90e-1)"	"unprognostic (7.56e-3)"	"unprognostic (1.49e-1)"	"unprognostic (2.46e-1)"	"unprognostic (7.82e-2)"	"unprognostic (1.33e-1)"	"unprognostic (2.95e-2)"	"unprognostic (8.52e-2)"	"prognostic unfavorable (6.23e-4)"	"unprognostic (5.58e-2)"	"unprognostic (4.64e-2)"	"unprognostic (3.41e-2)"	"unprognostic (3.23e-2)"	21.8	3.7	2.1	10.6	3.6	58.0	13.4	1.0	2.4	8.7	6.5	2.3	5.5	1.7	6.2	8.6	4.9	7.0	7.6	16.0	2.9	2.1	3.6	2.9	22.1	25.6	4.6	0.3	5.9	2.7	1.3	17.9	6.1	3.7	7.0	3.0	5.5	6.0	5.5	5.5	3.3	4.9	6.4	5.9	25.3	6.2	5.1	2.8	1.0	4.9	4.5	5.4	9.5	11.4	0.4	6.2	7.2	20.6	0.9	0.3	3.6	0.0	0.0	0.2	0.0	15.0	12.4	0.0	1.6	0.0	0.9	1.3	0.0	1.2	0.0	0.8	3.0	0.0	0.0	1.8	0.0	0.7	0.0	0.0	12.8	0.7	0.0	7.8	17.0	2.4	7.8	0.0	0.7	0.0	0.0	4.4	0.0	0.0	0.0	0.5	0.0	0.0	13.6	0.7	0.0	0.0	0.0	3.7	0.0	0.1	1.9	0.1	0.0	6.7	0.0	0.7	0.0	0.0	20.6	4.7	0.0	0.0	0.0	0.0	0.5	0.1	1.2	0.0	14.9	0.0	5.6	13.1	2.2	0.0	13.2	0.0	0.0	0.0	0.0	6.2	0.4	0.0	0.0	7.2	0.9	20.6	0.0	0.3	3.6	2.1	3.6	1.0	2.4	2.9	2.1	4.6	0.3	3.7	2.8	8.9	20.8	0.8	4.1	1.3	0.3	2.2	0.0	6.7	20.5	3.5	0.0	0.2	0.0	0.6	3.6	29.3	0.0	0.0	1.0	0.1	17.3	1.4	26.5	0.0	8.9	0.0	0.0	36.2	118.3	3.0	6.6	66.9	5.0	2.8	1.0	0.2	2.8	0.0	10.6	0.2	0.0	0.0	7.2	0.7	0.9	1.1	0.2	2.5	0.2	2.2
IRAK4	NY-REN-64	ENSG00000198001	"Interleukin 1 receptor associated kinase 4"	Q9NWZ3	12	43758944-43789543	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Immunity, Innate immunity"	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"U-937: 32.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB016685, CAB022077"	Uncertain		Approved	Nucleoli,Microtubules,Cytosol		NA	NA			Microtubules	"Nucleoli, Cytosol"	"CAB016685: AB_1618505, CAB022077: "	"unprognostic (2.76e-2)"	"unprognostic (5.63e-2)"	"unprognostic (1.47e-2)"	"prognostic favorable (3.46e-5)"	"unprognostic (6.15e-2)"	"unprognostic (3.50e-3)"	"unprognostic (1.44e-2)"	"unprognostic (8.49e-2)"	"unprognostic (6.44e-3)"	"unprognostic (7.50e-2)"	"unprognostic (4.00e-3)"	"unprognostic (6.29e-2)"	"unprognostic (4.52e-2)"	"unprognostic (2.95e-1)"	"unprognostic (2.31e-1)"	"unprognostic (1.84e-1)"	"prognostic favorable (4.42e-5)"	18.0	9.4	5.1	15.0	10.4	10.3	11.3	3.7	6.0	10.3	12.2	9.1	12.5	10.2	13.0	14.1	15.0	9.4	10.8	7.6	6.7	5.2	13.3	11.8	12.0	24.0	13.2	3.9	9.3	20.1	9.1	16.1	14.0	9.8	10.5	10.0	11.9	11.9	15.1	4.1	15.2	15.0	11.8	13.0	25.0	12.3	7.1	11.7	30.3	17.0	7.7	18.9	11.1	10.7	5.1	5.8	16.9	6.0	8.8	7.7	4.7	5.3	4.0	2.8	3.7	10.2	17.2	4.0	7.6	5.4	6.0	5.5	3.4	5.2	9.2	7.5	6.3	4.0	4.4	3.1	4.9	8.7	13.2	2.9	8.8	3.1	2.1	5.8	12.1	10.8	9.1	7.8	7.6	4.5	10.6	8.9	9.0	8.1	6.9	16.6	2.9	10.5	6.8	1.0	0.0	4.7	7.0	3.4	4.8	4.7	5.1	2.0	2.0	3.7	4.7	3.6	4.0	5.9	10.8	7.9	7.4	1.4	9.1	5.2	8.4	10.9	8.0	7.7	32.7	4.1	16.9	4.6	9.4	7.4	5.4	7.7	4.0	6.1	6.3	4.5	5.1	5.5	5.9	9.3	8.8	6.0	5.8	7.5	4.7	5.1	10.4	3.7	6.0	6.7	5.2	13.2	3.9	9.8	11.7	17.9	17.0	15.7	9.4	9.6	5.7	4.1	22.9	6.7	10.3	31.4	19.6	12.5	18.3	10.9	12.6	12.4	13.8	0.0	15.4	7.3	9.3	8.1	20.9	7.3	15.2	7.9	3.5	12.9	29.8	16.3	11.5	22.9	10.1	18.0	9.3	9.1	12.5	5.8	10.6	11.3	25.0	6.5	8.6	27.0	12.6	10.3	23.3	41.5	7.8	11.2
IRF2BP1	"DKFZP434M154, IRF-2BP1"	ENSG00000170604	"Interferon regulatory factor 2 binding protein 1"	Q8IU81	19	45883607-45886170	"Enzymes, Predicted intracellular proteins"	"Transcription, Transcription regulation, Ubl conjugation pathway"	"Repressor, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"NB-4: 38.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042164, HPA049480"	Approved		Supported	Nucleoplasm		NA	NA			Nucleoplasm		"HPA042164: AB_2677882, HPA049480: AB_2680785"	"unprognostic (5.90e-2)"	"unprognostic (1.34e-1)"	"unprognostic (8.86e-2)"	"unprognostic (9.49e-2)"	"unprognostic (1.78e-1)"	"unprognostic (2.61e-2)"	"unprognostic (1.62e-1)"	"unprognostic (1.67e-1)"	"unprognostic (3.03e-1)"	"unprognostic (1.01e-1)"	"prognostic favorable (2.32e-4)"	"unprognostic (2.60e-1)"	"prognostic favorable (3.85e-5)"	"unprognostic (1.33e-2)"	"unprognostic (6.99e-2)"	"unprognostic (2.66e-1)"	"unprognostic (5.07e-3)"	14.2	11.9	12.2	9.0	14.1	6.7	8.7	23.1	26.2	12.7	11.2	12.6	10.6	14.4	15.3	8.1	8.2	12.4	12.6	10.8	11.8	11.7	12.0	14.8	10.0	9.5	13.2	12.8	20.3	18.5	12.4	15.6	8.6	12.5	13.5	4.8	12.6	19.6	15.2	33.4	13.4	12.4	9.3	8.7	15.6	16.4	8.0	12.8	17.4	13.7	8.0	8.6	12.0	8.7	2.7	2.0	1.4	1.7	2.4	3.6	1.6	8.3	12.8	3.2	7.0	2.7	1.7	5.2	6.2	3.6	5.0	4.4	4.8	4.0	6.8	4.7	3.1	2.9	7.9	2.2	2.3	1.4	8.5	22.3	6.8	3.6	6.0	5.5	7.0	6.4	2.4	3.2	2.6	1.9	3.1	3.0	8.5	10.7	5.4	1.9	6.5	14.2	38.4	5.9	3.1	11.4	16.4	3.7	5.8	3.5	4.7	9.5	16.2	6.5	8.6	7.8	1.2	7.1	13.1	4.3	4.3	8.7	3.3	8.7	14.8	16.3	4.0	5.8	6.7	6.2	0.0	1.2	0.4	2.8	1.7	2.8	2.7	2.5	2.3	1.1	2.3	3.6	2.2	1.4	2.4	0.7	2.0	2.3	1.6	12.2	14.1	23.1	26.2	11.8	11.7	13.2	12.8	12.5	12.8	0.0	1.4	10.4	5.2	9.5	13.2	0.9	5.1	1.4	0.0	10.4	0.0	9.7	11.6	6.7	1.3	4.7	7.9	0.0	8.1	6.2	7.3	7.0	0.0	7.6	4.2	9.5	9.2	5.5	2.6	1.0	17.3	3.9	8.5	2.8	9.8	12.0	6.1	10.5	10.3	10.1	6.4	19.4	7.3	3.6	1.9	9.8	7.3	4.8	8.0	2.6
ISG20	"CD25, HEM45"	ENSG00000172183	"Interferon stimulated exonuclease gene 20"	Q96AZ6	15	88636153-88656483	"Enzymes, Predicted intracellular proteins"	"Antiviral defense, Immunity, Innate immunity, rRNA processing"	"Exonuclease, Hydrolase, Nuclease, RNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 116.8;lymphoid tissue: 56.6"	"Cell type enhanced"	"Detected in many"	5	"B-cells: 305.7;monocytes: 313.8;Urothelial cells: 376.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Daudi: 36.6;Karpas-707: 21.7;SK-MEL-30: 121.9;U-698: 21.8"					"Not detected"	"Not detected"									NA	NA						"unprognostic (2.55e-3)"	"unprognostic (1.19e-3)"	"unprognostic (2.00e-2)"	"unprognostic (1.32e-1)"	"prognostic unfavorable (6.51e-5)"	"unprognostic (1.55e-2)"	"unprognostic (1.46e-1)"	"unprognostic (4.54e-2)"	"unprognostic (1.35e-3)"	"prognostic favorable (1.85e-5)"	"unprognostic (5.60e-2)"	"unprognostic (2.07e-1)"	"prognostic unfavorable (4.86e-8)"	"unprognostic (1.04e-1)"	"unprognostic (4.69e-2)"	"unprognostic (3.39e-1)"	"unprognostic (1.58e-2)"	8.4	2.4	2.2	39.6	3.6	12.1	7.3	0.8	3.1	4.1	18.3	1.9	8.3	25.9	2.7	8.2	9.9	3.9	36.6	4.9	2.4	2.6	6.1	9.9	26.0	56.6	3.2	1.8	6.8	6.4	0.2	10.1	4.6	3.2	6.0	3.0	2.2	13.2	8.1	4.1	3.4	39.4	1.2	3.6	53.8	21.9	2.5	1.8	29.1	14.5	6.1	41.4	10.7	4.2	99.2	12.3	116.8	5.1	31.0	104.4	29.7	1.6	2.5	0.0	0.0	0.0	0.0	0.4	0.0	1.1	7.5	10.4	0.8	3.6	36.6	1.9	0.1	3.5	0.5	0.1	0.8	0.2	11.5	0.1	0.1	1.2	1.5	5.0	0.0	0.0	0.7	1.4	2.6	1.7	0.1	1.2	2.6	0.1	21.7	0.0	2.6	0.1	0.2	0.3	5.8	5.5	1.4	0.1	6.8	0.6	0.3	0.1	0.1	0.3	14.5	121.9	0.0	0.4	0.8	1.5	0.2	0.8	0.0	0.5	15.4	4.1	21.8	0.3	0.5	1.5	8.4	3.0	6.2	27.7	5.1	36.6	94.6	47.9	39.7	2.6	99.2	35.5	37.2	116.8	31.0	3.8	12.3	104.4	29.7	2.2	3.6	0.8	3.1	2.4	2.6	3.2	1.8	3.2	1.8	44.7	47.2	305.7	100.8	158.8	0.0	1.2	50.9	65.6	50.0	3.5	0.0	1.5	1.7	54.2	12.1	28.6	92.1	116.8	133.1	66.9	47.5	249.9	7.0	10.4	8.0	0.0	36.0	14.1	25.6	3.3	2.0	43.4	214.2	313.8	83.6	0.0	202.6	80.7	1.8	5.5	0.1	25.8	27.8	0.9	2.1	250.9	43.5	278.6	6.2	376.0
ISPD	"hCG_1745121, IspD, Nip"	ENSG00000214960	"Isoprenoid synthase domain containing"	A4D126	7	16087527-16421322	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		"Nucleotidyltransferase, Transferase"	"Congenital muscular dystrophy, Disease mutation, Dystroglycanopathy, Limb-girdle muscular dystrophy, Lissencephaly"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	17	"basophil: 10.7"	"Lineage enriched"	"Detected in single"	22	"granulocytes: 10.7"	"Cell line enhanced"	"Detected in many"		"BEWO: 8.5;HEL: 11.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043810, HPA053554"	Approved		Approved	"Nucleoplasm,Nucleoli fibrillar center"		NA	NA			"Nucleoli fibrillar center"	Nucleoplasm	"HPA043810: AB_10964489, HPA053554: AB_2682185"	"unprognostic (4.65e-3)"	"unprognostic (5.92e-2)"	"unprognostic (2.61e-1)"	"unprognostic (9.41e-2)"	"unprognostic (1.49e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.19e-1)"	"unprognostic (7.07e-2)"	"unprognostic (3.47e-2)"	"unprognostic (3.39e-2)"	"unprognostic (6.01e-2)"	"unprognostic (2.07e-1)"	"prognostic favorable (1.38e-11)"	"unprognostic (4.01e-2)"	"unprognostic (1.78e-4)"	"unprognostic (6.26e-2)"	"unprognostic (2.79e-1)"	3.0	3.8	4.2	1.9	4.5	2.6	3.0	7.7	7.7	3.7	2.9	3.9	3.4	1.8	4.7	2.4	2.0	2.8	3.2	7.1	4.4	4.5	7.0	10.0	2.9	1.5	4.7	3.9	2.7	3.9	3.6	5.7	8.0	4.6	3.5	3.0	5.7	5.5	10.1	4.5	2.6	1.8	3.7	4.9	1.4	10.2	3.9	2.4	1.1	2.6	2.4	1.4	3.2	3.7	0.3	0.4	10.7	0.1	0.4	0.3	0.0	0.3	2.4	1.3	1.9	1.1	1.5	8.5	1.9	1.3	1.6	1.4	2.7	2.2	0.0	4.1	2.7	0.8	3.1	1.4	0.0	2.9	1.0	1.5	11.7	1.5	0.6	1.4	0.9	1.5	2.7	1.2	1.3	0.2	0.8	1.2	1.0	2.8	0.3	4.2	0.5	1.1	1.1	2.2	1.0	0.3	0.0	1.9	0.1	2.8	0.8	2.0	1.3	1.4	2.5	2.5	2.7	1.7	2.6	1.3	2.3	2.1	0.3	2.2	0.2	0.0	0.0	1.9	2.7	2.8	10.7	0.1	0.4	0.3	0.0	0.2	0.1	0.2	0.2	0.0	0.3	0.3	0.2	0.6	0.4	0.0	0.4	0.0	0.0	4.2	4.5	7.7	7.7	4.4	4.5	4.7	3.9	4.6	2.4	0.0	2.9	0.0	1.6	0.3	6.0	7.3	0.0	2.7	4.5	3.5	7.9	2.1	1.7	1.0	7.5	2.2	0.4	0.0	0.6	7.9	2.2	2.2	1.1	4.7	0.7	4.8	1.2	4.9	0.3	1.2	1.4	0.0	1.7	0.0	2.0	4.1	2.6	0.0	3.2	5.8	5.8	0.0	0.7	6.6	6.1	0.9	2.4	0.5	1.2	1.7
ISYNA1	"Ino1, INOS, IPS"	ENSG00000105655	"Inositol-3-phosphate synthase 1"	Q9NPH2	19	18434388-18438301	"Enzymes, Predicted intracellular proteins"	"Inositol biosynthesis, Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism"	Isomerase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 83.6"	"Cell type enhanced"	"Detected in many"	14	"Cytotrophoblasts: 829.0;Sertoli cells: 310.4;Syncytiotrophoblasts: 865.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"B-cells: 4.0;NK-cells: 11.9;T-cells: 8.5"	"Cell line enriched"	"Detected in many"	4	"BEWO: 103.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007931, HPA008232, CAB020720"	Enhanced		Approved	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"CAB020720: , HPA007931: AB_2667940, HPA008232: AB_2668018"	"unprognostic (1.87e-2)"	"unprognostic (1.86e-1)"	"unprognostic (2.98e-2)"	"unprognostic (3.16e-2)"	"unprognostic (3.88e-1)"	"unprognostic (1.81e-2)"	"unprognostic (2.49e-1)"	"unprognostic (3.12e-1)"	"unprognostic (1.74e-1)"	"unprognostic (2.28e-2)"	"unprognostic (2.73e-2)"	"unprognostic (5.08e-2)"	"prognostic unfavorable (9.23e-4)"	"unprognostic (2.23e-2)"	"unprognostic (9.26e-2)"	"unprognostic (1.19e-2)"	"unprognostic (1.50e-1)"	7.9	8.4	7.1	3.0	5.7	4.5	7.1	2.7	6.7	9.9	3.5	10.0	44.2	3.4	13.9	12.3	4.5	20.0	6.5	8.0	5.7	7.4	12.7	4.1	4.7	3.8	4.1	4.1	31.6	25.5	7.7	12.6	44.2	16.2	9.5	1.3	19.3	8.8	34.4	8.2	3.4	3.9	3.0	2.3	10.5	3.7	83.6	3.5	3.0	5.6	3.8	3.3	5.9	7.8	4.0	1.9	0.9	0.2	11.9	8.5	4.9	2.8	8.6	20.5	6.1	0.1	0.0	103.8	1.3	0.2	0.1	0.0	4.9	5.2	0.0	7.0	0.6	0.0	7.4	0.6	0.0	0.0	7.7	23.6	10.3	0.5	15.9	2.2	0.1	0.2	1.6	0.1	0.6	0.1	0.0	1.3	0.2	21.1	0.4	0.0	16.6	0.7	0.7	10.7	2.6	6.9	14.2	0.0	4.8	1.7	0.0	6.3	15.8	0.3	1.9	10.5	4.4	14.0	1.1	3.9	0.1	0.2	0.1	0.3	3.3	1.4	0.6	0.6	0.4	3.6	0.9	0.1	0.0	7.6	0.2	5.9	4.0	7.4	6.7	0.7	2.3	6.1	8.5	0.8	11.9	0.1	1.9	5.2	4.9	7.1	5.7	2.7	6.7	5.7	7.4	4.1	4.1	16.2	3.5	3.0	0.6	2.2	67.1	10.6	0.0	4.2	7.6	4.0	4.5	45.4	2.0	829.0	44.7	34.8	81.2	19.7	1.3	0.0	7.5	57.3	25.4	8.5	13.9	0.9	73.6	0.0	62.2	19.0	5.3	178.1	34.5	3.7	21.9	7.2	2.6	7.2	4.6	0.0	47.4	4.7	0.5	310.4	167.1	59.2	21.8	5.0	865.2	9.6	4.6	31.8
ITCH	AIP4	ENSG00000078747	"Itchy E3 ubiquitin protein ligase"	Q96J02	20	34363235-34511393	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Antiviral defense, Apoptosis, Host-virus interaction, Immunity, Innate immunity, Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Late spermatids: 102.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021126, HPA049032, CAB072824, CAB072825"	Supported		Enhanced	Nucleoplasm,Vesicles		No	No			Nucleoplasm	Vesicles	"CAB072824: , CAB072825: , HPA021126: AB_1851941, HPA049032: AB_2680607"	"unprognostic (2.51e-1)"	"unprognostic (6.95e-2)"	"unprognostic (1.25e-3)"	"unprognostic (3.22e-2)"	"unprognostic (1.77e-1)"	"unprognostic (1.13e-1)"	"unprognostic (2.78e-1)"	"unprognostic (9.29e-3)"	"unprognostic (1.94e-1)"	"unprognostic (3.89e-3)"	"unprognostic (1.28e-3)"	"unprognostic (1.42e-1)"	"unprognostic (1.84e-2)"	"unprognostic (1.30e-1)"	"unprognostic (2.24e-1)"	"unprognostic (3.23e-2)"	"unprognostic (2.21e-1)"	20.7	16.7	18.9	15.4	26.9	20.5	17.5	19.8	26.7	23.9	18.2	37.9	15.2	16.9	18.4	15.1	35.9	14.5	14.5	17.9	20.4	15.9	21.1	46.5	18.5	16.8	29.2	16.5	19.3	17.1	21.6	26.3	26.9	29.0	17.5	20.4	16.7	20.1	18.4	24.0	19.2	20.3	19.8	30.4	17.3	17.3	34.8	32.3	22.3	22.7	13.0	23.6	19.6	21.0	7.3	11.4	19.6	6.2	6.2	11.4	2.7	20.2	13.4	13.7	9.8	15.1	21.6	16.4	16.5	18.9	20.7	20.2	37.6	31.3	9.9	16.0	21.0	28.2	25.7	20.8	33.3	25.2	7.4	6.7	28.8	11.4	22.5	15.8	11.8	13.0	11.0	17.0	17.4	27.4	18.7	15.5	14.4	16.3	17.2	16.1	10.1	17.2	6.2	6.6	12.5	15.9	14.5	28.9	22.9	12.3	35.3	8.4	6.1	30.8	12.1	18.5	14.1	14.5	10.7	15.0	24.7	14.8	16.1	12.2	13.7	14.3	14.5	15.3	7.6	14.4	3.6	5.8	6.1	10.8	6.2	11.4	7.3	3.8	5.7	4.5	6.9	3.3	4.9	19.6	6.2	3.8	11.4	4.8	2.7	18.9	26.9	19.8	26.7	20.4	15.9	29.2	16.5	29.0	32.3	11.9	17.9	13.3	15.9	13.4	19.6	20.1	7.6	28.1	33.0	29.6	23.6	15.1	5.0	11.7	46.0	17.5	21.6	0.0	14.1	17.6	16.0	23.0	18.5	43.1	14.0	14.3	11.5	16.5	22.8	102.3	20.8	21.2	25.3	23.4	15.8	34.3	16.6	21.0	14.5	18.0	26.8	12.9	17.8	25.7	21.5	14.2	39.2	20.6	9.9	38.9
ITK	"EMT, LYK, PSCTK2"	ENSG00000113263	"IL2 inducible T cell kinase"	Q08881	5	157142933-157255191	"Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Adaptive immunity, Immunity"	"Kinase, Transferase, Tyrosine-protein kinase"	"Cancer-related genes, Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"blood: 28.0;lymphoid tissue: 60.5"	"Cell type enhanced"	"Detected in some"	20	"Alveolar cells type 2: 10.4;granulocytes: 32.2;T-cells: 47.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Group enriched"	"Detected in many"	28	"gdT-cell: 13.8;MAIT T-cell: 9.1;memory CD4 T-cell: 19.5;memory CD8 T-cell: 18.9;naive CD4 T-cell: 28.0;naive CD8 T-cell: 22.8;NK-cell: 9.2;T-reg: 23.1"	"Group enriched"	"Detected in many"	29	"NK-cells: 9.2;T-cells: 28.0"	"Group enriched"	"Detected in some"	9	"JURKAT: 36.5;MOLT-4: 13.3"	"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			HPA043670			Uncertain	"Plasma membrane,Cytosol"		NA	NA			"Plasma membrane, Cytosol"		"HPA043670: "	"unprognostic (2.08e-3)"	"unprognostic (6.57e-4)"	"unprognostic (5.06e-3)"	"unprognostic (4.96e-5)"	"unprognostic (1.52e-2)"	"unprognostic (1.12e-4)"	"unprognostic (8.45e-4)"	"unprognostic (1.56e-2)"	"unprognostic (1.87e-2)"	"unprognostic (5.99e-3)"	"unprognostic (1.76e-1)"	"unprognostic (2.52e-1)"	"unprognostic (4.52e-6)"	"unprognostic (3.64e-1)"	"unprognostic (4.42e-2)"	"unprognostic (1.46e-1)"	"unprognostic (3.26e-2)"	2.3	0.7	0.5	12.2	0.6	2.5	1.3	1.9	0.5	1.4	3.3	0.0	0.0	0.5	1.2	1.1	1.8	1.4	4.3	0.9	0.5	0.5	1.4	1.2	6.6	60.5	0.9	0.0	0.7	0.7	0.0	0.9	0.1	0.3	1.1	1.3	1.5	3.5	1.1	0.5	1.0	8.9	0.4	1.2	10.7	2.3	1.4	0.0	60.3	1.6	2.7	24.3	4.1	1.3	0.0	0.0	0.4	0.6	9.2	28.0	13.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	2.2	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	36.5	0.0	0.0	0.0	0.0	13.3	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	13.8	0.0	9.1	0.0	19.5	18.9	0.0	0.0	28.0	22.8	0.4	9.2	0.6	0.0	23.1	13.6	0.5	0.6	1.9	0.5	0.5	0.5	0.9	0.0	0.3	0.0	0.0	10.4	0.0	0.6	2.4	0.0	0.8	0.0	0.0	1.2	1.8	0.0	0.0	0.0	0.0	5.7	0.0	0.0	0.0	0.0	0.0	0.5	0.2	32.2	0.6	0.0	0.0	0.0	1.8	0.6	5.5	0.0	1.5	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	2.1	0.0	0.0	3.0	0.1	47.3	0.0	0.4
ITPA	"C20orf37, dJ794I6.3, HLC14-06-P"	ENSG00000125877	"Inosine triphosphatase"	Q9BY32	20	3208868-3223870	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Nucleotide metabolism"	Hydrolase	"Disease mutation, Epilepsy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA022824, HPA073963"	Approved		Supported	Nucleoplasm,Cytosol		NA	NA		69000	"Nucleoplasm, Cytosol"		"HPA022824: AB_1851960, HPA073963: "	"unprognostic (1.58e-2)"	"unprognostic (1.98e-1)"	"unprognostic (1.73e-1)"	"unprognostic (3.57e-1)"	"unprognostic (4.63e-2)"	"unprognostic (1.53e-2)"	"prognostic unfavorable (2.54e-5)"	"unprognostic (1.11e-2)"	"unprognostic (1.68e-1)"	"unprognostic (1.76e-1)"	"unprognostic (1.83e-1)"	"unprognostic (2.28e-1)"	"unprognostic (1.94e-2)"	"unprognostic (8.34e-2)"	"unprognostic (3.63e-1)"	"unprognostic (1.24e-1)"	"unprognostic (1.84e-1)"	17.7	27.5	18.6	24.7	21.2	20.4	17.7	10.2	22.7	21.3	21.4	18.3	20.6	22.9	18.1	17.3	31.0	26.6	19.6	25.9	18.1	13.5	22.9	20.3	22.7	30.6	20.5	24.1	16.5	43.8	17.6	10.2	17.0	16.2	14.6	16.8	13.2	19.9	21.5	19.5	23.4	19.0	16.3	16.3	20.6	19.3	16.7	19.5	15.2	24.9	29.0	24.1	14.6	17.7	19.3	30.7	11.3	31.0	24.7	24.1	18.2	32.7	25.9	12.8	13.3	8.5	12.6	8.5	14.9	20.7	19.6	17.2	20.7	30.5	14.1	13.6	13.6	19.2	28.5	17.6	22.3	13.7	9.2	26.3	35.3	10.7	31.4	16.1	15.1	12.0	12.0	17.1	18.4	11.5	8.1	14.9	11.4	24.2	9.7	17.5	15.0	17.8	43.9	21.4	37.0	26.2	17.1	17.8	37.0	26.8	10.4	19.4	22.9	11.7	41.1	27.3	5.9	17.1	25.2	10.4	22.0	12.3	14.4	31.4	14.5	18.2	26.7	10.2	28.0	23.9	11.3	25.7	8.8	20.7	31.0	18.0	19.3	18.9	21.8	30.7	17.8	14.2	17.2	1.4	24.7	21.9	28.3	24.1	18.2	18.6	21.2	10.2	22.7	18.1	13.5	20.5	24.1	16.2	19.5	20.8	43.1	32.8	43.8	35.6	18.3	8.0	40.8	26.8	37.5	41.8	13.7	62.7	49.7	88.7	2.3	18.6	41.6	0.0	90.9	108.9	44.0	43.6	41.5	32.1	103.0	4.8	26.4	29.4	43.0	2.3	28.7	50.7	38.8	123.6	48.5	17.1	82.5	52.6	20.8	63.4	20.3	19.4	36.4	14.6	19.4	43.0	47.0	46.3	66.6	52.1
ITPK1		ENSG00000100605	"Inositol-tetrakisphosphate 1-kinase"	Q13572	14	92936914-93116320	"Enzymes, Predicted intracellular proteins"		"Hydrolase, Isomerase, Kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Enterocytes: 79.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"neutrophil: 24.2"	"Group enriched"	"Detected in all"	5	"granulocytes: 24.2;monocytes: 13.0"	"Cell line enhanced"	"Detected in all"		"WM-115: 42.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA055230	Approved		Approved	Mitochondria		NA	NA			Mitochondria		"HPA055230: AB_2682748"	"unprognostic (1.93e-3)"	"unprognostic (2.50e-1)"	"unprognostic (2.15e-1)"	"prognostic favorable (8.56e-4)"	"unprognostic (4.27e-1)"	"unprognostic (2.04e-2)"	"unprognostic (6.97e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.24e-2)"	"unprognostic (2.86e-2)"	"unprognostic (8.14e-2)"	"unprognostic (2.27e-1)"	"unprognostic (1.37e-3)"	"unprognostic (2.39e-1)"	"unprognostic (2.02e-1)"	"unprognostic (4.20e-1)"	"unprognostic (7.25e-3)"	32.0	10.2	44.3	11.9	49.5	12.2	14.4	19.3	50.5	23.8	20.0	29.7	9.6	34.9	20.2	10.2	18.7	15.9	16.1	18.4	49.0	30.6	11.4	13.4	13.0	7.6	42.1	27.1	11.4	15.0	13.2	5.3	11.2	18.5	15.1	13.6	14.5	8.3	19.1	9.4	5.5	36.6	19.4	44.8	14.1	11.9	9.4	26.1	3.4	10.0	3.2	5.5	16.7	16.2	1.9	3.9	24.2	13.0	1.3	1.9	2.4	10.3	21.5	4.0	10.2	9.0	5.0	10.8	4.4	6.7	8.9	5.4	12.3	18.7	6.6	22.2	7.0	3.4	12.3	11.5	19.1	2.8	24.4	5.0	14.5	5.7	10.6	6.7	6.6	16.2	3.2	11.5	4.5	10.4	3.9	8.7	6.9	7.9	7.6	4.3	27.9	5.6	9.4	8.4	13.6	9.7	10.8	5.9	9.8	6.0	17.5	10.9	13.8	11.2	22.8	19.0	3.2	30.6	8.1	6.8	6.2	6.8	10.4	7.0	7.5	6.8	4.2	5.7	5.2	42.6	2.5	5.2	9.5	1.9	8.6	1.1	1.9	1.2	1.2	3.9	0.7	0.7	1.3	24.2	1.3	13.0	1.9	1.7	2.4	44.3	49.5	19.3	50.5	49.0	30.6	42.1	27.1	18.5	26.1	11.9	12.0	6.7	6.5	6.5	9.7	21.5	15.3	4.0	5.7	27.9	17.7	6.9	11.6	20.4	8.3	10.1	79.1	0.0	23.9	8.8	7.8	13.3	16.1	25.9	18.3	6.4	27.6	12.3	38.1	17.6	13.8	26.0	25.3	15.4	25.6	15.5	29.8	38.6	45.3	17.0	9.3	19.4	15.3	2.8	12.8	3.9	5.7	9.6	25.9	7.9
ITPKA	"IP3-3KA, IP3KA"	ENSG00000137825	"Inositol-trisphosphate 3-kinase A"	P23677	15	41493393-41503551	"Enzymes, Predicted intracellular proteins"		"Calmodulin-binding, Kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"brain: 28.8;intestine: 19.8;stomach 1: 10.7"	"Cell type enhanced"	"Detected in some"	23	"Early spermatids: 36.6;Enterocytes: 34.8;Late spermatids: 119.2"	"Low cancer specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"amygdala: 12.3;basal ganglia: 21.2;cerebral cortex: 28.8;hippocampal formation: 10.4;olfactory region: 8.2"	"Cell type enriched"	"Detected in single"	8	"MAIT T-cell: 4.7"	"Lineage enriched"	"Detected in single"	13	"T-cells: 4.7"	"Cell line enhanced"	"Detected in many"		"Hep G2: 22.7;OE19: 12.5"	"Group enriched"	"Detected in many"	13	"amygdala: 120.1;basal ganglia: 97.6;cerebellum: 62.9;cerebral cortex: 164.4;hippocampal formation: 162.9"	"Group enriched"	"Detected in many"	7	"amygdala: 12.1;basal ganglia: 40.8;cerebral cortex: 32.2;hippocampal formation: 28.6"	HPA040454	Enhanced	Approved	Approved	"Vesicles,Plasma membrane"		No	No			Vesicles	"Plasma membrane"	"HPA040454: AB_10672897"	"unprognostic (5.91e-2)"	"unprognostic (2.16e-3)"	"unprognostic (4.19e-1)"	"unprognostic (3.57e-3)"	"prognostic unfavorable (6.77e-4)"	"unprognostic (2.25e-2)"	"unprognostic (2.69e-2)"	"unprognostic (1.01e-1)"	"unprognostic (3.58e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.21e-1)"	"unprognostic (2.06e-1)"	"prognostic unfavorable (3.76e-9)"	"unprognostic (2.15e-1)"	"unprognostic (2.87e-1)"	"unprognostic (1.12e-3)"	"unprognostic (2.10e-2)"	0.4	3.0	12.3	1.1	21.2	0.8	0.4	3.0	28.8	0.6	8.5	0.3	0.0	19.8	0.6	0.5	0.4	0.6	0.6	0.7	10.4	0.9	0.4	0.8	0.4	0.4	1.6	8.2	0.6	2.5	1.7	0.0	0.7	0.3	0.8	3.4	0.0	2.1	0.8	1.4	0.4	19.7	0.7	0.2	0.4	10.7	3.5	0.6	0.0	0.4	0.0	0.4	0.4	0.2	0.0	0.0	0.0	0.0	0.3	4.7	0.0	4.7	1.3	0.2	5.6	0.0	1.8	10.2	3.0	2.4	2.0	2.1	11.2	0.2	0.0	2.5	0.2	4.5	0.5	2.4	0.2	0.1	4.5	3.0	6.8	3.0	22.7	9.2	2.3	0.3	0.1	0.1	1.9	0.6	1.1	0.1	0.9	8.6	1.3	0.7	3.1	0.2	4.4	0.6	12.5	4.0	1.1	1.0	0.4	0.2	0.3	0.5	1.1	2.2	0.0	0.2	0.0	0.6	3.4	0.2	4.9	5.1	5.4	8.1	0.7	7.1	0.0	9.1	9.0	1.6	0.0	0.0	0.0	0.3	0.0	4.7	0.0	0.3	0.5	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	12.3	21.2	3.0	28.8	10.4	0.9	1.6	8.2	0.3	0.6	0.0	0.0	0.0	0.4	0.1	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	36.6	0.0	34.8	0.0	0.6	0.4	0.2	0.2	0.0	0.0	0.2	0.0	0.0	0.6	0.0	119.2	2.3	0.0	0.0	0.0	12.0	7.3	0.4	19.3	1.4	0.0	0.1	6.5	0.7	1.9	3.0	0.0	0.1	0.0	14.4	0.1
ITPKB	"IP3-3KB, IP3KB"	ENSG00000143772	"Inositol-trisphosphate 3-kinase B"	P27987	1	226631690-226739323	"Cancer-related genes, Enzymes, Predicted intracellular proteins"		"Calmodulin-binding, Kinase, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 63.1"	"Cell type enhanced"	"Detected in many"	5	"Endothelial cells: 35.8;Ito cells: 27.0;Smooth muscle cells: 32.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"SK-MEL-30: 28.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030273, HPA072923"	Enhanced		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA030273: AB_10601127, HPA072923: AB_2686558"	"unprognostic (4.54e-2)"	"unprognostic (3.85e-2)"	"unprognostic (8.41e-3)"	"unprognostic (9.37e-3)"	"unprognostic (1.53e-1)"	"prognostic favorable (1.72e-5)"	"unprognostic (1.24e-1)"	"prognostic favorable (6.65e-4)"	"unprognostic (2.29e-1)"	"unprognostic (9.57e-2)"	"unprognostic (1.41e-2)"	"unprognostic (1.75e-2)"	"unprognostic (3.23e-3)"	"unprognostic (2.90e-2)"	"unprognostic (7.46e-2)"	"unprognostic (6.54e-3)"	"unprognostic (7.87e-2)"	23.8	4.2	34.7	13.0	35.1	14.8	15.2	11.1	33.6	14.3	19.7	32.4	8.5	6.0	27.1	15.6	12.6	15.3	8.9	7.8	27.9	24.8	9.7	3.2	13.4	22.7	50.4	16.3	8.8	4.8	10.1	4.2	13.5	40.0	13.1	6.3	20.8	24.9	21.3	9.8	10.5	12.5	32.6	63.1	19.0	12.4	3.2	34.0	20.0	5.9	4.3	17.1	19.6	8.5	3.1	0.9	7.7	3.5	3.0	7.9	2.6	2.8	3.0	4.9	5.7	3.9	2.5	1.3	0.8	3.4	1.6	3.7	0.5	3.6	13.1	4.7	0.7	0.3	4.2	6.3	2.5	0.8	1.8	4.3	5.8	3.4	0.0	1.5	5.4	10.3	2.8	3.7	1.7	1.6	4.4	10.7	6.7	0.0	1.8	0.2	2.7	9.9	7.3	10.9	2.1	4.9	3.8	8.9	2.9	11.5	4.6	2.9	3.8	2.3	1.7	28.6	5.1	7.3	6.1	7.4	2.1	1.6	1.8	4.6	0.1	4.6	16.0	0.5	4.9	7.5	1.2	1.4	7.7	4.4	2.1	3.9	1.9	5.3	4.5	0.9	3.1	7.9	5.7	5.4	3.0	3.5	0.8	3.0	2.6	34.7	35.1	11.1	27.9	27.9	24.8	50.4	16.3	40.0	34.0	0.0	6.1	11.1	3.8	10.9	0.3	5.6	0.0	2.7	5.7	7.0	0.0	0.5	3.3	2.0	2.0	35.8	1.3	0.0	2.0	1.1	8.5	6.5	9.3	0.9	16.4	0.0	4.1	27.0	17.7	16.5	6.6	8.6	18.6	2.8	2.6	1.4	2.3	3.2	8.9	0.5	0.0	0.0	32.0	0.9	2.3	8.8	0.3	22.3	2.9	2.1
ITPKC	"IP3-3KC, IP3KC"	ENSG00000086544	"Inositol-trisphosphate 3-kinase C"	Q96DU7	19	40717103-40740860	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		"Calmodulin-binding, Kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Alveolar cells type 1: 80.4;Basal glandular cells: 76.3;Glandular cells: 89.9;Urothelial cells: 88.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"hTCEpi: 24.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA050760, HPA053003"	Approved		Supported	"Nuclear speckles"		No	No			"Nuclear speckles"		"HPA050760: AB_2681227, HPA053003: AB_2682011"	"unprognostic (4.27e-2)"	"unprognostic (3.73e-2)"	"unprognostic (8.31e-2)"	"unprognostic (9.12e-3)"	"unprognostic (1.10e-2)"	"unprognostic (9.81e-2)"	"unprognostic (6.06e-2)"	"prognostic unfavorable (4.91e-4)"	"unprognostic (1.48e-1)"	"unprognostic (1.54e-3)"	"unprognostic (1.84e-3)"	"unprognostic (2.63e-1)"	"unprognostic (2.59e-1)"	"unprognostic (1.70e-1)"	"unprognostic (2.86e-2)"	"unprognostic (3.45e-2)"	"unprognostic (3.32e-1)"	26.0	8.2	6.6	9.8	10.9	2.4	13.4	4.4	7.7	14.2	9.3	3.7	7.6	8.5	8.8	5.2	46.8	11.0	17.1	10.8	13.2	3.7	7.3	7.7	18.4	6.9	4.4	2.7	6.8	16.4	6.4	9.9	10.8	23.8	12.1	5.2	6.0	15.4	8.4	8.1	21.6	9.8	11.9	17.8	6.5	11.4	3.8	5.2	3.2	7.8	31.4	28.0	10.6	17.1	3.3	2.3	3.9	3.2	0.9	3.5	1.7	6.6	6.3	3.9	6.1	17.7	15.4	6.2	3.9	8.3	4.1	3.6	8.9	6.9	1.8	4.6	5.0	3.1	7.0	3.8	17.1	1.7	3.4	4.0	1.4	2.2	6.3	17.5	1.5	1.9	21.3	24.9	3.8	14.3	5.5	10.0	2.6	5.3	3.2	4.0	8.1	2.2	2.3	2.0	15.2	2.9	2.4	1.9	2.5	6.4	11.2	2.8	3.4	4.0	16.3	3.7	4.7	7.5	3.9	6.4	2.6	4.0	1.8	2.6	1.8	0.4	1.9	4.1	1.6	2.8	3.9	3.2	1.7	3.5	1.6	1.4	1.4	2.7	1.9	1.5	3.3	1.9	2.2	1.6	0.9	2.2	2.3	2.6	1.7	6.6	10.9	4.4	7.7	13.2	3.7	4.4	2.7	23.8	5.2	80.4	35.7	2.2	76.3	53.7	8.9	3.8	10.2	16.0	28.4	3.5	0.0	6.0	1.7	12.8	2.0	14.2	35.9	0.0	10.8	4.4	10.8	89.9	3.5	4.9	2.4	4.8	16.0	26.4	7.5	1.9	10.9	7.0	18.6	3.6	9.4	3.1	18.0	17.5	7.1	3.3	4.4	0.0	9.4	1.2	1.7	46.7	14.1	5.4	8.0	88.5
IVD	ACAD2	ENSG00000128928	"Isovaleryl-CoA dehydrogenase"	P26440	15	40405795-40435947	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Fatty acid metabolism, Lipid metabolism"	Oxidoreductase	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Hepatocytes: 123.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041391, HPA044250"	Enhanced		Supported	Nucleoplasm,Mitochondria		NA	NA		66000	Mitochondria	Nucleoplasm	"HPA041391: AB_2677449, HPA044250: AB_2678875"	"unprognostic (9.30e-2)"	"unprognostic (3.31e-1)"	"unprognostic (1.36e-2)"	"unprognostic (4.24e-2)"	"unprognostic (7.53e-2)"	"unprognostic (1.74e-1)"	"prognostic favorable (1.95e-5)"	"unprognostic (1.50e-2)"	"unprognostic (2.53e-1)"	"unprognostic (2.84e-2)"	"unprognostic (4.08e-2)"	"unprognostic (2.31e-1)"	"prognostic favorable (2.91e-9)"	"unprognostic (1.40e-1)"	"unprognostic (3.40e-2)"	"unprognostic (1.14e-1)"	"unprognostic (5.46e-3)"	12.3	32.0	15.4	13.2	20.6	6.7	24.3	14.4	18.0	12.7	13.7	20.5	23.3	12.3	11.8	16.6	8.9	17.2	22.7	30.4	13.8	16.1	28.9	71.9	14.2	10.4	16.1	15.9	19.4	18.9	19.5	23.9	7.4	16.3	21.0	13.0	14.4	11.8	31.9	30.6	3.5	9.8	13.7	14.7	11.0	14.4	11.2	15.7	8.6	55.7	12.2	9.0	11.2	7.9	11.6	34.1	14.3	29.8	14.7	13.5	8.6	8.7	5.3	9.7	17.4	15.4	13.5	0.4	13.5	13.2	17.3	10.8	19.8	7.6	0.3	25.8	17.0	14.9	10.3	18.4	19.9	10.7	12.6	14.8	22.7	15.4	19.0	27.1	9.2	22.6	20.6	6.9	9.6	20.2	20.0	17.1	24.4	1.0	1.1	15.5	13.8	11.4	14.3	8.2	0.5	16.9	16.7	13.3	10.4	20.5	23.7	16.6	9.2	18.6	40.5	8.2	9.4	34.9	40.7	14.5	14.4	9.4	10.1	10.8	21.8	14.9	0.3	13.5	9.2	14.1	5.8	10.2	14.3	13.5	16.1	12.6	11.6	7.5	11.4	22.3	9.9	8.4	11.7	1.3	14.7	29.8	34.1	9.7	8.6	15.4	20.6	14.4	18.0	13.8	16.1	16.1	15.9	16.3	15.7	26.8	46.2	14.3	16.6	2.1	24.6	72.6	45.9	42.8	40.9	41.8	13.7	16.5	81.2	15.9	4.4	18.0	17.7	23.3	13.0	4.8	15.4	16.0	32.5	123.8	25.1	15.9	18.9	17.2	20.2	4.9	19.0	13.9	5.0	31.5	22.5	25.1	14.1	3.5	23.3	60.9	18.9	19.4	13.9	19.0	4.3	0.5	8.2	12.2	33.1	11.2
IYD	"C6orf71, DEHAL1, dJ422F24.1"	ENSG00000009765	"Iodotyrosine deiodinase"	Q6PHW0	6	150368892-150405969	"Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins"		Oxidoreductase	"Congenital hypothyroidism, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	16	"thyroid gland: 212.3"	"Group enriched"	"Detected in many"	5	"Alveolar cells type 2: 8.5;Cholangiocytes: 20.4;Club cells: 12.5;Enterocytes: 25.8;Hepatocytes: 18.3;Mucus-secreting cells: 15.4;Paneth cells: 17.3;Proximal tubular cells: 33.8;Undifferentiated cells: 10.3"	"Cancer enriched"	"Detected in many"	20	"thyroid cancer: 80.7"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in many"		"neutrophil: 5.9"	"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in some"	7	"CACO-2: 3.0;OE19: 6.8;SK-BR-3: 7.4"	"Group enriched"	"Detected in some"	13	"hippocampal formation: 8.1;thalamus: 2.6"	"Low region specificity"	"Detected in many"			HPA059627	Enhanced		Supported	"Plasma membrane"		NA	NA			"Plasma membrane"		"HPA059627: AB_2684086"	"unprognostic (3.73e-4)"	"unprognostic (2.93e-2)"	"unprognostic (5.97e-2)"	"unprognostic (1.95e-2)"	"unprognostic (1.55e-1)"	"unprognostic (2.98e-2)"	"prognostic favorable (6.22e-4)"	"unprognostic (1.11e-1)"	"unprognostic (3.80e-2)"	"unprognostic (1.17e-1)"	"unprognostic (7.41e-2)"	"unprognostic (1.02e-1)"	"unprognostic (3.07e-9)"	"unprognostic (9.79e-3)"	"unprognostic (2.04e-1)"	"unprognostic (2.03e-2)"	"unprognostic (2.18e-2)"	0.1	0.1	0.1	0.6	0.1	0.0	0.1	0.1	0.1	0.1	8.2	0.1	0.1	3.6	0.1	0.3	0.1	0.1	6.7	0.1	0.1	0.1	5.4	6.8	0.2	0.0	0.1	0.0	0.1	0.2	0.0	0.1	0.0	0.5	0.1	1.2	0.0	0.3	0.0	0.1	0.2	13.5	0.0	0.1	0.1	0.3	0.1	0.0	0.0	212.3	0.0	0.1	0.1	0.1	1.4	1.0	5.9	1.3	2.3	0.7	2.3	0.1	0.0	0.2	0.3	0.1	0.8	0.4	0.0	0.0	0.0	0.0	3.0	0.5	0.2	0.0	0.0	0.3	0.3	0.0	0.0	0.0	0.4	0.2	0.4	0.8	0.3	0.0	0.1	0.7	0.0	0.0	0.1	0.0	0.2	0.0	0.1	0.3	0.6	0.0	0.4	0.0	0.3	0.3	6.8	0.2	0.3	0.2	0.2	0.0	0.7	0.3	0.2	0.0	7.4	0.0	0.1	0.7	0.0	0.2	0.2	0.2	0.2	0.0	0.2	0.0	0.1	0.4	0.2	0.1	3.3	1.3	0.7	0.7	1.1	0.5	0.6	0.6	0.5	0.1	1.4	0.6	0.7	5.9	2.3	0.5	1.0	0.5	2.3	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.5	0.0	3.0	8.5	0.0	0.5	0.1	0.0	0.5	20.4	1.4	12.5	0.0	0.0	0.0	1.7	0.1	0.0	0.0	25.8	0.0	0.2	0.0	0.0	1.0	1.1	18.3	0.1	0.0	3.5	1.3	0.0	0.0	0.0	0.5	0.0	0.0	15.4	0.0	0.2	17.3	0.0	33.8	1.1	0.0	0.0	0.0	0.2	0.4	0.2	0.0	10.3	0.7
JADE2	"JADE-2, KIAA0239, PHF15"	ENSG00000043143	"Jade family PHD finger 2"	Q9NQC1	5	134524312-134583230	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA025959, HPA055789"	Uncertain		Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"HPA025959: AB_1855289, HPA055789: AB_2682922"	"unprognostic (8.98e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.10e-2)"	"unprognostic (1.29e-1)"	"unprognostic (3.46e-2)"	"unprognostic (2.14e-1)"	"unprognostic (7.69e-2)"	"unprognostic (5.56e-2)"	"unprognostic (8.25e-2)"	"prognostic unfavorable (4.42e-4)"	"unprognostic (1.58e-2)"	"unprognostic (3.49e-2)"	"prognostic favorable (5.36e-6)"	"unprognostic (3.73e-1)"	"unprognostic (1.76e-3)"	"unprognostic (2.68e-1)"	"unprognostic (2.87e-2)"	15.6	19.8	16.7	16.1	22.0	9.7	13.9	22.8	21.7	16.0	13.4	15.3	9.2	12.7	13.9	8.4	11.8	20.6	13.2	13.4	17.8	14.5	14.8	4.7	15.0	25.8	30.8	16.0	28.4	14.0	30.9	14.4	8.5	20.1	12.8	8.2	16.4	15.0	16.9	12.0	11.5	17.8	13.0	16.8	22.9	12.9	8.1	30.8	13.0	20.6	6.0	19.2	20.0	22.7	7.3	2.0	6.8	3.0	3.1	6.2	2.4	28.7	20.5	0.6	0.8	7.2	8.7	9.4	5.2	13.7	9.6	11.3	15.6	22.4	31.7	11.6	6.7	9.7	6.1	3.6	27.5	4.8	19.1	1.4	7.4	14.3	4.2	7.2	8.1	1.1	5.8	13.3	11.7	14.8	7.6	7.2	9.5	4.6	11.9	5.8	10.3	14.0	7.3	6.8	8.8	10.7	12.6	0.6	12.4	9.0	8.0	4.4	2.9	12.8	0.4	18.4	5.8	5.6	10.1	10.1	6.8	6.1	19.1	12.9	5.5	23.0	29.3	10.5	14.6	9.5	6.8	1.2	4.4	6.2	1.1	6.0	7.3	5.7	5.6	2.0	5.5	5.6	5.6	1.3	3.1	3.0	1.2	5.8	2.4	16.7	22.0	22.8	21.7	17.8	14.5	30.8	16.0	20.1	30.8	8.9	9.1	20.8	6.1	3.8	21.4	10.1	10.2	6.7	4.5	7.0	33.4	6.4	6.6	4.6	0.2	9.2	8.4	0.0	14.6	8.4	8.1	4.3	2.3	3.0	4.0	9.5	11.1	15.4	30.1	0.0	19.0	8.0	1.7	22.6	9.7	6.0	8.8	3.5	18.0	9.1	21.8	0.0	10.8	0.2	1.5	3.1	6.1	20.2	11.9	3.4
JAK1	"JAK1A, JAK1B, JTK3"	ENSG00000162434	"Janus kinase 1"	P23458	1	64833229-64966504	"Cancer-related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"		"Kinase, Transferase, Tyrosine-protein kinase"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"ASC diff: 70.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB013088	Approved					NA	NA					"CAB013088: "	"prognostic favorable (9.63e-4)"	"unprognostic (1.24e-1)"	"prognostic favorable (2.81e-4)"	"unprognostic (5.10e-2)"	"unprognostic (1.16e-1)"	"unprognostic (4.21e-2)"	"unprognostic (1.53e-1)"	"unprognostic (7.00e-3)"	"unprognostic (8.40e-2)"	"unprognostic (7.88e-3)"	"unprognostic (1.66e-2)"	"unprognostic (8.84e-2)"	"prognostic favorable (2.67e-4)"	"unprognostic (2.35e-1)"	"unprognostic (2.04e-1)"	"unprognostic (7.30e-2)"	"unprognostic (3.51e-1)"	46.7	20.4	15.5	31.1	16.5	21.2	56.6	24.3	20.4	27.3	27.1	16.3	16.5	13.8	28.2	22.0	27.0	20.7	27.7	27.3	15.3	16.5	31.4	38.3	36.5	61.4	15.6	14.1	33.3	29.1	28.3	39.8	22.9	25.1	26.0	22.2	18.1	19.8	21.3	45.1	29.7	29.3	30.7	16.3	52.7	20.9	17.3	15.0	62.7	29.0	17.9	42.5	37.2	29.3	20.2	15.4	34.9	17.1	68.1	27.5	25.8	11.2	14.6	6.1	0.6	70.7	40.1	7.9	17.5	25.9	14.6	17.2	4.8	6.2	17.1	13.6	31.1	27.2	6.3	4.1	13.5	20.8	22.5	6.6	23.1	7.7	10.4	26.1	8.8	16.1	35.1	18.8	22.0	23.0	17.4	45.4	8.5	8.4	18.3	16.1	6.4	4.8	5.9	4.2	12.9	8.8	6.9	17.6	6.3	37.6	19.8	4.3	12.9	24.0	11.3	10.3	12.7	24.0	5.5	41.2	17.5	7.8	39.6	9.3	11.5	5.2	13.5	16.3	11.7	7.9	31.2	10.9	31.5	22.8	15.2	27.5	20.2	22.0	25.7	15.4	16.1	24.3	20.7	34.9	68.1	17.1	10.5	26.5	25.8	15.5	16.5	24.3	20.4	15.3	16.5	15.6	14.1	25.1	15.0	47.6	79.3	120.3	114.0	103.6	35.7	98.8	79.0	41.5	63.7	106.4	21.6	5.5	36.5	152.3	100.2	130.9	49.5	23.3	184.7	94.8	76.6	173.3	55.4	77.3	52.1	20.6	63.8	178.0	138.0	72.8	88.9	109.3	47.2	252.5	54.9	54.4	180.7	49.2	79.5	61.6	35.1	161.7	144.2	30.5	50.9	145.2	10.2	159.2	38.1	188.3
JAK2	JTK10	ENSG00000096968	"Janus kinase 2"	O60674	9	4984390-5128183	"Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"	"Adaptive immunity, Immunity, Innate immunity"	"Chromatin regulator, Kinase, Transferase, Tyrosine-protein kinase"	"Cancer-related genes, Disease mutation, FDA approved drug targets, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Kupffer cells: 36.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"basophil: 40.8"	"Lineage enriched"	"Detected in all"	4	"granulocytes: 40.8"	"Group enriched"	"Detected in many"	5	"ASC diff: 19.4;HDLM-2: 27.4;HEL: 56.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB013089, HPA040820, HPA043870"	Approved		Supported	"Nucleoplasm,Plasma membrane,Focal adhesion sites"		No	No			Nucleoplasm	"Plasma membrane, Focal adhesion sites"	"CAB013089: AB_2533647, HPA040820: AB_2677151, HPA043870: AB_2678708"	"unprognostic (2.24e-3)"	"unprognostic (2.76e-2)"	"unprognostic (1.50e-2)"	"unprognostic (7.67e-2)"	"unprognostic (5.50e-2)"	"unprognostic (3.09e-2)"	"unprognostic (1.48e-1)"	"unprognostic (7.36e-2)"	"unprognostic (1.09e-1)"	"unprognostic (5.49e-3)"	"unprognostic (1.58e-1)"	"unprognostic (1.72e-2)"	"unprognostic (3.85e-1)"	"unprognostic (4.53e-2)"	"unprognostic (3.43e-2)"	"unprognostic (1.96e-1)"	"unprognostic (7.37e-3)"	19.8	8.8	11.5	19.0	10.5	19.0	17.7	14.7	14.4	17.8	10.6	7.0	10.3	7.2	14.8	13.6	12.4	13.4	14.6	27.6	10.3	6.7	7.7	5.6	16.1	19.4	7.0	10.5	15.9	6.7	10.1	7.5	12.0	10.0	12.0	7.4	9.4	7.2	7.4	14.4	19.0	12.3	10.4	11.7	21.5	14.1	10.1	9.0	13.6	8.6	6.5	13.5	13.9	15.6	2.1	9.6	40.8	7.5	3.4	2.1	2.5	2.5	1.5	1.5	2.5	19.4	5.0	0.4	3.5	3.0	2.7	1.8	0.1	0.8	0.1	0.8	2.1	2.2	0.9	1.6	2.1	2.0	27.4	0.5	56.1	3.0	0.7	4.0	3.8	2.9	4.1	0.9	1.1	1.8	3.3	2.5	2.0	4.0	6.5	4.8	0.9	0.9	5.4	1.3	1.3	1.7	1.9	2.8	0.8	2.0	1.3	1.7	0.9	1.0	1.5	1.1	1.6	0.8	6.7	5.1	4.1	1.4	4.2	2.4	1.2	2.3	0.5	5.3	1.9	2.0	40.8	7.5	13.4	2.1	7.3	1.7	2.1	1.6	1.2	9.6	1.9	0.9	1.1	7.1	3.4	5.8	3.6	1.6	2.5	11.5	10.5	14.7	14.4	10.3	6.7	7.0	10.5	10.0	9.0	14.9	6.4	6.9	2.8	8.7	7.4	22.0	0.0	5.3	7.9	7.0	7.9	1.8	1.7	3.0	7.4	8.7	3.9	23.3	3.4	0.8	7.0	1.7	13.9	1.6	11.9	7.9	2.9	4.9	36.0	5.3	21.9	27.7	5.0	16.2	4.2	12.2	5.4	14.4	31.5	2.5	11.1	0.0	5.0	14.9	5.7	7.3	2.9	5.0	3.3	4.1
JAK3	"JAK-3, JAK3_HUMAN, JAKL, L-JAK, LJAK"	ENSG00000105639	"Janus kinase 3"	P52333	19	17824780-17848071	"Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins"	"Adaptive immunity, Immunity, Innate immunity"	"Kinase, Transferase, Tyrosine-protein kinase"	"Cancer-related genes, Disease mutation, FDA approved drug targets, SCID"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"lymphoid tissue: 68.3"	"Cell type enhanced"	"Detected in many"	7	"B-cells: 18.2;Ito cells: 14.1;Peritubular cells: 13.8;T-cells: 24.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"HDLM-2: 20.6;HEL: 9.2;HMC-1: 9.4;Karpas-707: 24.0;U-266/70: 9.3;U-266/84: 13.8;U-937: 14.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA070314	Enhanced		Approved	"Plasma membrane,Cytosol"		NA	NA			"Plasma membrane, Cytosol"		"HPA070314: AB_2686251"	"unprognostic (5.59e-3)"	"prognostic favorable (6.42e-5)"	"unprognostic (5.71e-2)"	"unprognostic (2.34e-1)"	"unprognostic (6.13e-3)"	"unprognostic (1.11e-3)"	"unprognostic (4.21e-2)"	"unprognostic (2.60e-1)"	"unprognostic (2.38e-2)"	"unprognostic (2.36e-1)"	"unprognostic (3.58e-2)"	"unprognostic (1.94e-1)"	"prognostic unfavorable (2.89e-14)"	"unprognostic (2.28e-1)"	"unprognostic (2.21e-2)"	"unprognostic (4.43e-2)"	"unprognostic (7.61e-2)"	6.8	1.7	4.0	24.5	8.5	12.0	2.7	2.4	3.1	1.9	2.3	1.0	0.0	2.2	1.7	2.0	2.5	3.5	3.6	4.3	2.7	2.8	3.8	2.0	8.4	68.3	7.5	0.0	11.0	2.0	0.4	2.3	4.1	5.3	3.0	2.4	1.6	6.1	1.5	0.7	1.3	9.5	2.5	8.4	36.1	3.2	1.8	5.8	20.9	3.4	1.7	28.8	5.3	2.4	7.4	4.5	16.9	9.6	8.4	15.0	6.8	0.1	0.3	0.3	1.1	0.4	1.5	0.2	0.5	0.0	0.0	0.1	0.0	0.9	0.4	2.0	0.4	0.3	0.1	0.0	0.2	0.0	20.6	0.0	9.2	0.0	0.8	0.7	0.0	9.4	5.1	0.2	0.0	0.0	0.0	0.2	2.1	0.0	24.0	0.0	0.4	3.6	0.0	0.2	0.5	0.7	4.7	0.0	0.4	0.5	0.0	0.0	0.3	0.1	0.2	0.0	0.1	2.0	1.4	0.4	0.0	0.4	0.0	0.0	9.3	13.8	2.5	0.1	14.0	0.2	1.2	4.9	0.2	12.6	9.6	14.5	6.5	15.0	13.1	4.5	7.4	14.9	13.0	16.9	8.4	8.8	3.7	11.8	6.8	4.0	8.5	2.4	3.1	2.7	2.8	7.5	0.0	5.3	5.8	0.0	5.8	18.2	0.5	0.7	0.3	1.4	0.0	0.0	1.2	1.8	0.0	0.9	0.0	0.6	1.0	5.8	0.0	0.0	0.3	0.7	2.3	0.2	4.7	0.0	11.5	0.0	0.0	14.1	10.8	0.9	11.5	3.5	3.3	12.6	0.0	0.8	0.4	0.0	13.8	0.1	0.5	6.5	2.1	0.3	0.7	0.9	1.1	24.5	0.0	0.5
JOSD1	KIAA0063	ENSG00000100221	"Josephin domain containing 1"	Q15040	22	38685543-38701556	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	"Hydrolase, Protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA001168	Uncertain					NA	NA					"HPA001168: AB_1079162"	"unprognostic (6.50e-2)"	"unprognostic (1.06e-2)"	"unprognostic (3.42e-3)"	"unprognostic (5.67e-2)"	"unprognostic (1.57e-1)"	"unprognostic (1.08e-1)"	"prognostic unfavorable (4.50e-4)"	"unprognostic (1.65e-2)"	"unprognostic (5.10e-2)"	"unprognostic (1.39e-1)"	"unprognostic (3.23e-3)"	"unprognostic (2.46e-1)"	"unprognostic (1.83e-3)"	"unprognostic (1.06e-1)"	"unprognostic (4.41e-1)"	"unprognostic (2.88e-2)"	"unprognostic (4.41e-1)"	20.4	16.8	17.5	19.9	18.3	55.8	26.0	23.2	30.5	19.0	34.6	11.0	16.2	19.9	19.1	20.1	20.8	18.6	29.9	20.8	16.9	14.2	13.1	16.0	22.6	18.8	14.2	20.7	35.5	18.8	14.7	19.5	16.5	13.9	16.2	28.8	12.5	15.0	27.7	16.5	17.2	45.2	20.8	15.0	16.5	16.8	13.7	8.1	16.4	16.1	20.9	17.2	23.6	18.6	3.3	2.5	7.2	5.6	4.1	7.6	2.5	26.4	9.5	14.0	18.0	17.9	22.0	10.6	20.4	24.4	26.6	27.9	15.7	13.5	25.4	10.6	20.3	17.7	17.1	19.3	18.1	21.5	27.1	12.8	13.4	22.8	13.4	30.6	24.1	13.2	19.0	27.0	25.0	43.1	23.4	31.3	16.1	12.0	27.0	19.5	11.2	10.4	9.9	5.3	16.0	10.8	18.8	20.5	10.6	14.4	13.7	12.9	6.9	23.4	11.6	20.9	12.2	11.6	7.0	27.2	15.9	19.4	20.4	12.3	29.9	25.9	20.7	21.1	12.9	14.7	1.8	3.5	3.7	5.3	5.6	3.8	3.3	4.5	6.9	2.5	3.2	4.9	7.6	7.2	4.1	3.0	2.1	5.8	2.5	17.5	18.3	23.2	30.5	16.9	14.2	14.2	20.7	13.9	8.1	23.8	17.9	22.7	61.3	41.2	28.2	15.6	43.3	16.0	12.5	34.9	21.6	8.8	11.6	30.0	2.9	24.5	63.9	0.0	33.6	12.0	20.6	61.4	16.1	20.2	20.5	17.5	22.4	25.8	27.0	3.6	11.8	33.6	15.1	34.3	47.0	20.3	48.9	31.6	13.1	11.6	21.6	12.9	17.4	14.4	28.0	45.0	10.8	24.5	28.3	87.3
JOSD2	SBBI54	ENSG00000161677	"Josephin domain containing 2"	Q8TAC2	19	50505998-50511353	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	"Hydrolase, Protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA						"unprognostic (8.77e-2)"	"unprognostic (3.09e-2)"	"unprognostic (2.59e-1)"	"unprognostic (1.57e-2)"	"unprognostic (7.25e-2)"	"unprognostic (2.38e-1)"	"prognostic unfavorable (6.04e-5)"	"unprognostic (3.63e-2)"	"unprognostic (2.41e-1)"	"unprognostic (5.68e-2)"	"unprognostic (1.75e-2)"	"unprognostic (6.49e-2)"	"unprognostic (2.42e-3)"	"unprognostic (8.05e-2)"	"unprognostic (2.04e-1)"	"unprognostic (6.05e-2)"	"unprognostic (9.34e-2)"	20.7	14.1	18.0	14.6	19.6	16.8	21.7	7.5	18.6	11.2	16.0	18.9	11.5	24.0	13.0	12.3	15.4	11.0	15.5	19.1	19.3	14.4	12.4	25.4	13.1	21.6	22.6	11.6	11.0	13.6	8.8	9.8	12.5	19.5	10.4	5.1	7.5	21.6	15.0	28.3	21.0	20.8	8.9	30.4	14.7	24.8	8.8	16.7	9.8	23.7	15.5	6.7	11.6	16.4	8.7	26.2	33.6	36.9	10.5	18.7	16.5	15.6	28.1	0.1	8.3	9.4	11.2	5.1	19.2	7.4	5.6	5.8	4.7	12.2	4.6	11.7	7.4	6.9	10.7	0.8	9.0	1.5	21.2	11.3	4.7	5.2	2.3	12.0	1.3	16.9	12.1	8.0	3.7	2.8	7.2	5.1	5.3	5.8	12.3	5.8	12.0	5.4	6.1	1.9	10.6	27.2	1.5	12.8	8.9	5.4	15.1	4.7	12.2	5.6	14.6	15.9	0.7	11.5	8.3	11.0	9.5	11.3	12.0	10.9	12.9	10.2	1.5	27.0	5.9	18.3	16.5	36.9	33.6	17.5	33.8	14.7	8.7	16.8	17.8	26.2	8.6	12.3	13.5	6.2	10.5	23.7	18.9	18.7	16.5	18.0	19.6	7.5	18.6	19.3	14.4	22.6	11.6	19.5	16.7	6.0	1.7	14.9	35.9	27.5	9.8	2.5	40.8	8.1	0.0	31.4	0.0	34.8	56.3	77.8	10.1	24.8	134.0	0.0	76.1	82.0	46.3	25.7	5.7	58.7	84.4	15.9	16.1	46.6	72.5	27.7	82.6	63.3	74.2	108.2	55.0	26.4	101.5	105.2	91.9	66.9	9.3	51.8	45.7	23.2	18.1	40.1	34.6	33.0	42.0	48.9
KALRN	"ARHGEF24, DUET, duo, HAPIP, Hs.8004, Kalirin, TRAD"	ENSG00000160145	"Kalirin RhoGEF kinase"	O60229	3	124080023-124726325	"Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"		"Guanine-nucleotide releasing factor, Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 35.2;retina: 31.2"	"Cell type enhanced"	"Detected in many"	6	"Bipolar cells: 71.2;Early spermatids: 45.5;Ito cells: 50.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"T-reg: 4.3"	"Lineage enriched"	"Detected in single"	5	"T-cells: 4.3"	"Cell line enhanced"	"Detected in many"		"CACO-2: 32.4;HEL: 19.8;OE19: 11.2;SH-SY5Y: 9.3"	"Low region specificity"	"Detected in many"							"HPA011913, CAB026456"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA		110000	"Nucleoplasm, Cytosol"		"CAB026456: , HPA011913: AB_1850494"	"unprognostic (2.54e-2)"	"unprognostic (3.43e-1)"	"unprognostic (2.08e-1)"	"unprognostic (3.12e-4)"	"unprognostic (2.54e-1)"	"unprognostic (1.74e-1)"	"unprognostic (1.52e-1)"	"unprognostic (1.53e-1)"	"unprognostic (3.41e-2)"	"unprognostic (8.58e-2)"	"unprognostic (1.65e-1)"	"unprognostic (1.04e-1)"	"unprognostic (2.26e-3)"	"unprognostic (5.58e-2)"	"unprognostic (2.67e-1)"	"unprognostic (3.70e-2)"	"unprognostic (2.81e-3)"	5.5	4.3	12.7	2.4	14.1	0.6	4.2	1.8	35.2	4.0	3.8	3.7	0.5	2.7	5.6	2.3	9.6	4.2	3.1	12.1	17.6	3.9	2.6	7.3	2.9	1.1	4.1	15.8	2.3	11.9	2.5	14.4	6.8	9.4	3.1	2.1	31.2	2.2	5.4	23.5	1.5	7.2	6.4	3.6	8.0	11.5	2.2	2.4	0.0	5.3	6.7	3.1	2.9	4.1	0.1	0.0	0.9	0.0	0.1	4.3	1.2	0.3	0.6	3.6	0.7	0.5	0.1	4.7	1.4	0.9	1.4	0.6	32.4	2.5	0.1	0.4	3.6	2.2	0.2	0.8	0.0	1.1	0.0	0.3	19.8	0.3	4.9	0.0	0.0	0.0	0.2	0.0	0.3	0.0	1.5	1.6	0.0	4.5	0.1	0.4	2.4	0.0	0.0	2.0	11.2	3.2	1.0	1.6	0.0	0.1	0.3	1.2	9.3	0.4	0.3	0.3	3.6	0.7	0.1	8.2	4.1	1.6	0.6	0.6	0.0	0.3	0.0	0.5	0.0	1.8	0.1	0.0	0.0	0.1	0.0	0.0	0.1	1.8	0.3	0.0	0.0	2.4	0.7	0.9	0.1	0.0	0.0	4.3	1.2	12.7	14.1	1.8	35.2	17.6	3.9	4.1	15.8	9.4	2.4	3.0	3.8	0.0	1.4	1.4	71.2	33.4	17.8	8.1	0.0	15.7	5.9	7.3	1.7	4.7	45.5	26.9	30.6	0.0	7.2	0.7	4.8	2.8	3.5	17.4	0.8	0.0	9.2	50.3	2.6	34.6	3.4	0.7	3.3	0.0	12.2	5.4	3.9	20.4	31.1	2.4	2.7	19.4	14.6	1.9	1.7	1.0	11.9	0.7	10.0	1.4
KARS	"DFNB89, KARS1, KARS2"	ENSG00000065427	"Lysyl-tRNA synthetase"	Q15046	16	75627474-75648643	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Host-virus interaction, Protein biosynthesis"	"Aminoacyl-tRNA synthetase, Ligase, Transferase"	"Charcot-Marie-Tooth disease, Deafness, Disease mutation, Neurodegeneration, Neuropathy, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041345, HPA041550"	Enhanced		Supported	"Plasma membrane,Cytosol"	"Intracellular and membrane"	NA	NA			Cytosol	"Plasma membrane"	"HPA041345: AB_10795589, HPA041550: AB_10794520"	"unprognostic (1.56e-1)"	"unprognostic (7.93e-2)"	"unprognostic (3.36e-2)"	"unprognostic (1.02e-2)"	"unprognostic (5.39e-2)"	"prognostic unfavorable (8.84e-6)"	"unprognostic (6.24e-3)"	"unprognostic (8.97e-3)"	"unprognostic (1.18e-1)"	"unprognostic (9.11e-3)"	"unprognostic (8.71e-3)"	"unprognostic (8.46e-2)"	"unprognostic (7.86e-2)"	"unprognostic (1.56e-1)"	"unprognostic (1.03e-1)"	"unprognostic (3.07e-2)"	"unprognostic (2.13e-1)"	25.4	21.1	19.2	29.2	22.0	24.6	28.0	17.5	19.5	26.3	28.3	15.2	28.1	20.6	23.4	26.7	35.8	24.1	27.5	49.6	16.3	18.6	31.7	47.1	25.8	26.6	18.8	16.2	34.9	62.6	28.5	22.4	30.4	19.6	30.7	29.7	20.1	31.7	23.2	80.0	26.6	32.3	28.4	17.1	37.3	26.3	33.6	14.5	41.3	34.4	43.6	34.7	38.6	33.4	32.8	39.0	35.5	44.2	35.0	62.4	39.5	27.2	31.9	23.3	32.0	25.0	25.3	45.9	23.1	28.4	50.9	38.4	56.3	35.9	49.2	25.6	30.7	24.3	39.3	46.9	42.2	55.7	14.3	24.1	27.0	27.9	58.2	45.9	40.6	30.5	29.7	30.4	45.0	73.3	26.0	41.4	43.5	45.0	11.8	38.4	63.0	41.7	43.5	49.3	40.1	23.5	55.0	20.9	60.0	40.8	23.2	35.1	28.5	58.1	21.2	25.8	26.6	28.7	38.5	22.8	28.2	29.1	21.5	33.0	25.4	29.0	117.4	24.6	34.8	34.3	20.9	31.5	35.5	34.1	44.2	62.4	32.8	42.3	40.2	39.0	27.6	40.1	36.1	7.2	35.0	43.2	24.6	43.5	39.5	19.2	22.0	17.5	19.5	16.3	18.6	18.8	16.2	19.6	14.5	41.7	22.7	66.3	80.5	40.9	19.6	83.2	53.5	42.8	59.1	38.4	33.4	104.3	89.5	100.0	165.6	61.2	50.2	46.7	126.0	122.6	54.5	53.6	38.2	37.5	80.9	11.1	54.8	39.3	59.8	236.5	43.4	52.9	33.7	143.3	61.7	20.0	101.6	42.1	47.7	58.7	38.2	45.3	49.9	89.9	114.1	39.5	92.0	63.4	85.8	94.5
KAT2A	"GCN5, GCN5L2, PCAF-b"	ENSG00000108773	"Lysine acetyltransferase 2A"	Q92830	17	42113108-42121358	"Enzymes, Predicted intracellular proteins"	"Host-virus interaction, Transcription, Transcription regulation"	"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA048958	Uncertain					NA	NA					"HPA048958: AB_2680571"	"unprognostic (1.71e-1)"	"unprognostic (9.08e-2)"	"unprognostic (1.66e-1)"	"unprognostic (2.31e-1)"	"unprognostic (3.41e-1)"	"unprognostic (9.07e-2)"	"unprognostic (1.91e-3)"	"unprognostic (3.87e-2)"	"unprognostic (2.53e-1)"	"unprognostic (1.09e-1)"	"prognostic favorable (3.57e-4)"	"unprognostic (2.78e-2)"	"prognostic unfavorable (1.41e-8)"	"unprognostic (3.97e-2)"	"unprognostic (2.90e-1)"	"unprognostic (1.89e-1)"	"unprognostic (2.29e-3)"	16.9	15.9	30.2	13.6	28.6	8.6	14.0	24.0	42.0	11.2	11.9	10.9	13.1	14.9	13.9	8.9	11.4	14.2	11.8	7.6	27.8	11.5	10.0	11.8	7.2	11.2	27.6	18.0	23.5	16.5	14.8	11.9	10.7	26.0	12.9	9.6	6.0	17.3	14.5	20.1	19.9	13.4	9.7	13.9	15.6	13.0	7.8	29.7	5.3	11.7	6.4	10.4	11.2	21.7	2.0	1.6	0.1	0.4	0.6	2.7	0.8	10.8	21.0	3.1	11.6	4.4	3.6	13.7	7.1	3.8	15.8	7.8	14.2	8.9	21.4	17.9	5.4	11.9	16.3	12.7	11.3	5.6	11.9	26.4	5.3	12.9	12.8	4.6	14.2	14.3	4.3	9.6	8.8	5.6	4.3	6.2	5.4	13.3	4.1	4.2	11.7	33.8	10.4	6.6	27.2	0.0	8.1	6.1	14.1	4.2	11.0	15.0	6.6	7.6	16.7	5.7	2.4	12.3	6.8	4.8	8.0	8.1	11.6	12.6	11.0	10.5	11.9	5.8	12.2	4.4	0.0	0.4	0.0	0.8	0.0	1.7	2.0	1.9	2.4	1.6	1.6	2.7	0.7	0.1	0.6	0.1	0.4	0.3	0.8	30.2	28.6	24.0	42.0	27.8	11.5	27.6	18.0	26.0	29.7	11.9	11.5	13.1	11.2	10.9	14.2	4.7	20.4	4.0	5.7	17.4	9.8	20.4	3.3	7.9	1.0	17.1	3.8	0.0	6.8	15.3	10.1	8.2	11.5	13.7	10.6	9.5	15.1	19.0	8.5	1.3	30.2	7.2	6.8	6.4	8.6	5.8	6.5	5.8	27.3	2.5	7.4	12.9	10.0	4.7	19.6	12.2	9.4	6.4	16.9	7.3
KAT2B	"GCN5, GCN5L, P/CAF, PCAF"	ENSG00000114166	"Lysine acetyltransferase 2B"	Q92831	3	20040023-20154404	"Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Biological rhythms, Cell cycle, Host-virus interaction, Transcription, Transcription regulation"	"Activator, Acyltransferase, Transferase"	"Cancer-related genes, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Cardiomyocytes: 56.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002470, CAB004526, HPA055839, HPA073897"	Supported		Enhanced	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"CAB004526: AB_2128417, HPA002470: , HPA055839: AB_2682938, HPA073897: "	"unprognostic (2.91e-2)"	"unprognostic (6.85e-3)"	"unprognostic (9.05e-2)"	"unprognostic (2.25e-1)"	"unprognostic (2.66e-2)"	"unprognostic (3.01e-3)"	"unprognostic (2.44e-1)"	"unprognostic (3.83e-3)"	"unprognostic (2.44e-2)"	"unprognostic (1.03e-1)"	"unprognostic (5.23e-3)"	"unprognostic (7.13e-2)"	"unprognostic (7.03e-2)"	"unprognostic (2.26e-2)"	"unprognostic (1.59e-1)"	"unprognostic (5.16e-2)"	"unprognostic (4.63e-2)"	10.6	6.6	30.1	9.4	27.5	24.9	6.8	22.0	20.1	10.2	9.4	27.6	7.9	10.9	7.8	5.4	17.3	7.7	8.0	21.9	24.7	18.0	10.8	24.0	10.1	12.7	26.8	15.9	18.2	11.6	38.1	8.7	8.5	24.2	9.5	8.1	10.7	20.9	9.2	33.4	8.9	13.0	8.7	21.4	11.7	9.0	1.8	31.1	8.7	10.0	7.4	12.0	8.7	11.0	2.1	2.7	5.5	1.5	1.1	4.8	0.8	1.5	4.0	2.2	3.6	9.1	8.6	5.2	5.1	7.6	5.4	7.9	1.2	2.6	13.7	2.1	9.6	6.8	1.1	5.5	1.6	4.5	12.4	5.2	12.0	6.3	0.4	4.3	1.8	15.6	3.7	3.0	4.7	3.0	9.5	5.1	3.4	7.7	19.4	7.6	1.9	3.9	3.6	0.9	3.8	3.9	5.1	4.2	2.9	7.3	8.1	1.1	2.4	2.8	4.6	17.3	3.6	4.8	8.1	4.9	9.1	3.7	3.4	5.8	7.4	15.4	3.3	8.3	7.9	19.2	1.3	1.1	2.8	3.6	1.5	3.4	1.0	3.1	2.5	0.9	2.1	1.1	2.1	5.5	1.1	1.1	2.7	4.8	0.8	30.1	27.5	22.0	20.1	24.7	18.0	26.8	15.9	24.2	31.1	29.8	17.3	4.7	10.0	7.6	11.9	56.5	2.5	17.4	14.8	5.2	3.9	5.4	10.0	2.8	2.3	10.5	13.6	23.3	3.8	1.1	9.3	10.0	10.4	26.1	6.5	14.3	11.1	18.4	21.9	1.3	6.1	15.7	16.9	5.4	5.7	12.6	3.7	0.0	4.9	5.3	11.2	6.5	9.9	0.9	0.9	11.3	8.2	13.8	3.1	7.1
KAT5	"cPLA2, ESA1, HTATIP, HTATIP1, PLIP, TIP60, ZC2HC5"	ENSG00000172977	"Lysine acetyltransferase 5"	Q92993	11	65711996-65719604	"Enzymes, Predicted intracellular proteins, Transcription factors"	"Growth regulation, Host-virus interaction, Transcription, Transcription regulation"	"Activator, Acyltransferase, Chromatin regulator, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA016953	Approved		Supported	Nucleoplasm		NA	NA			Nucleoplasm		"HPA016953: AB_1851277"	"unprognostic (2.20e-1)"	"unprognostic (3.58e-1)"	"unprognostic (3.59e-2)"	"unprognostic (2.74e-1)"	"unprognostic (9.61e-2)"	"unprognostic (7.16e-2)"	"unprognostic (1.29e-3)"	"unprognostic (1.20e-1)"	"unprognostic (2.01e-1)"	"unprognostic (2.74e-1)"	"unprognostic (2.13e-1)"	"unprognostic (2.54e-1)"	"prognostic favorable (1.10e-13)"	"unprognostic (1.37e-1)"	"unprognostic (2.55e-1)"	"unprognostic (1.85e-1)"	"unprognostic (8.54e-2)"	18.5	19.5	21.2	16.0	27.4	34.3	21.6	29.4	37.1	22.1	24.1	28.2	22.3	16.5	30.1	24.8	21.2	32.9	24.5	21.1	18.3	19.2	22.6	16.1	20.8	18.3	19.0	25.7	29.5	23.2	38.8	22.0	32.7	24.6	21.2	19.4	29.3	23.6	27.5	24.6	27.6	19.2	25.2	20.1	22.0	21.9	30.7	22.8	26.9	26.5	19.1	22.1	24.4	22.0	25.0	24.0	40.4	23.6	24.8	28.6	23.3	19.1	23.4	21.3	16.2	16.9	17.9	22.4	13.9	22.7	23.3	20.3	17.0	22.9	17.6	19.9	24.3	25.7	16.2	26.5	23.3	14.1	22.9	17.0	25.8	19.3	20.1	24.3	28.1	31.0	19.0	26.1	15.3	31.5	18.0	14.6	20.7	26.6	27.6	22.0	34.9	23.8	32.9	18.6	13.7	15.1	19.6	14.1	32.2	21.3	29.1	19.9	21.0	13.2	25.0	26.5	11.6	24.5	18.2	18.7	18.9	16.7	14.9	14.9	21.2	21.8	25.9	16.3	13.8	15.4	23.4	23.6	40.4	25.7	22.3	22.1	21.1	22.5	25.5	24.0	25.0	28.6	23.3	26.1	24.8	23.3	14.5	21.5	23.3	21.2	27.4	29.4	37.1	18.3	19.2	19.0	25.7	24.6	22.8	11.9	13.7	18.8	38.6	18.8	41.0	0.6	17.8	24.1	14.8	27.9	29.5	43.8	29.9	35.7	7.2	16.8	22.2	0.0	44.9	35.8	24.2	20.6	33.4	9.3	32.0	36.5	29.1	16.5	14.9	9.4	25.9	18.3	40.5	53.3	18.0	36.1	31.7	25.9	36.4	25.6	34.3	45.3	33.0	35.4	22.7	18.6	85.7	25.5	24.7	24.6
KAT6A	"MOZ, MYST3, RUNXBP2, ZC2HC6A, ZNF220"	ENSG00000083168	"Lysine acetyltransferase 6A"	Q92794	8	41929479-42051990	"Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, Acyltransferase, Chromatin regulator, Repressor, Transferase"	"Cancer-related genes, Mental retardation, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB017023, HPA063266, HPA065052"	Supported		Approved	"Nucleoli,Nuclear speckles,Cytosol"		NA	NA			"Nuclear speckles"	"Nucleoli, Cytosol"	"CAB017023: , HPA063266: AB_2684973, HPA065052: AB_2685414"	"unprognostic (3.51e-2)"	"unprognostic (1.14e-1)"	"unprognostic (2.04e-1)"	"unprognostic (3.23e-2)"	"unprognostic (2.28e-1)"	"unprognostic (9.27e-3)"	"unprognostic (3.61e-1)"	"unprognostic (2.29e-1)"	"unprognostic (2.95e-1)"	"unprognostic (2.45e-2)"	"unprognostic (1.50e-1)"	"unprognostic (4.45e-2)"	"unprognostic (4.20e-3)"	"unprognostic (1.18e-1)"	"unprognostic (2.24e-1)"	"unprognostic (8.58e-2)"	"unprognostic (2.95e-2)"	20.8	10.9	15.3	19.8	20.3	36.8	22.6	29.9	18.7	19.7	14.6	19.4	14.4	10.7	20.6	12.1	16.9	16.5	14.3	13.0	15.5	11.5	12.3	13.6	26.9	28.2	23.2	10.3	27.2	13.1	26.8	22.3	20.9	15.7	14.1	12.0	12.8	15.1	17.0	21.0	25.5	18.0	25.0	22.9	20.4	14.0	14.1	21.7	30.4	17.9	14.3	20.1	16.9	24.2	4.7	1.8	10.9	1.6	3.1	3.9	1.4	13.1	10.8	17.8	11.3	10.0	11.4	6.0	8.8	11.5	10.9	8.5	6.8	6.3	19.5	8.9	8.7	10.6	8.5	13.8	8.4	13.0	10.0	8.1	28.1	6.7	5.1	7.5	14.8	12.9	9.5	9.6	10.1	12.6	8.0	10.5	17.3	23.5	12.4	10.0	5.8	30.0	4.7	6.8	9.9	4.3	24.0	19.9	6.2	5.4	15.1	11.1	9.5	10.3	6.9	7.1	8.4	15.9	6.5	12.2	13.5	9.6	12.0	9.4	10.1	16.4	21.2	7.3	6.7	11.6	3.5	1.6	2.8	3.5	1.2	3.9	2.4	2.6	3.3	1.0	4.7	3.6	2.9	10.9	3.1	1.2	1.8	3.5	1.4	15.3	20.3	29.9	18.7	15.5	11.5	23.2	10.3	15.7	21.7	32.8	30.4	27.2	23.8	44.8	44.6	22.6	25.5	21.4	30.7	12.2	51.1	12.1	3.3	11.8	1.8	50.4	18.7	46.7	10.4	13.1	28.5	21.6	33.6	22.2	14.6	55.6	23.7	43.0	37.4	3.5	26.2	31.3	21.9	8.2	25.7	32.4	13.2	17.5	21.5	9.3	45.4	19.4	33.9	41.9	36.2	53.4	17.6	45.8	18.9	26.1
KAT6B	"Morf, MOZ2, MYST4, qkf, querkopf, ZC2HC6B"	ENSG00000156650	"Lysine acetyltransferase 6B"	Q8WYB5	10	74825582-75032622	"Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, Acyltransferase, Chromatin regulator, Repressor, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"PC-3: 22.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA006104	Supported		Approved	"Nucleoplasm,Nuclear bodies"		NA	NA			"Nucleoplasm, Nuclear bodies"		"HPA006104: AB_1079445"	"unprognostic (4.17e-1)"	"unprognostic (1.98e-1)"	"unprognostic (1.82e-1)"	"unprognostic (2.32e-2)"	"unprognostic (7.83e-2)"	"unprognostic (2.85e-2)"	"unprognostic (3.56e-1)"	"unprognostic (2.62e-1)"	"unprognostic (2.54e-1)"	"unprognostic (1.09e-1)"	"unprognostic (9.47e-2)"	"unprognostic (8.78e-2)"	"prognostic favorable (4.82e-4)"	"unprognostic (2.52e-1)"	"unprognostic (3.70e-1)"	"unprognostic (2.59e-2)"	"unprognostic (3.15e-1)"	11.6	9.5	11.1	13.2	11.9	15.1	12.4	19.0	11.6	16.7	12.2	13.3	15.3	7.2	25.1	13.0	12.0	13.2	12.0	10.0	10.6	9.5	9.0	7.3	9.2	9.0	9.0	9.9	24.6	13.3	24.8	31.1	9.4	8.9	13.5	9.6	10.1	17.9	12.0	15.3	10.6	11.3	16.2	9.3	10.4	13.0	12.8	12.1	26.6	13.0	8.9	12.5	14.3	12.7	3.2	1.9	1.6	1.1	5.3	3.7	1.5	3.9	4.1	7.4	6.3	5.9	8.7	3.6	3.5	7.0	3.0	3.4	2.7	4.6	8.5	1.9	6.4	3.2	3.1	3.9	3.1	5.0	3.6	5.7	3.1	3.3	3.9	4.4	7.4	2.1	5.6	5.0	4.2	6.7	9.9	3.5	6.7	3.3	7.3	3.8	4.3	7.1	3.4	4.1	4.3	22.9	11.1	3.8	1.8	2.2	2.0	3.7	6.2	3.6	6.6	3.2	2.8	3.7	2.9	4.2	4.3	5.1	2.8	3.3	5.4	6.3	5.7	4.6	7.8	0.9	0.7	1.1	1.6	3.2	0.9	3.4	2.4	2.4	2.7	1.2	3.2	3.7	3.4	0.9	5.3	0.8	1.9	2.4	1.5	11.1	11.9	19.0	11.6	10.6	9.5	9.0	9.9	8.9	12.1	41.7	50.1	23.2	20.4	17.6	50.8	43.1	10.2	38.8	35.2	8.7	64.8	8.7	8.3	8.6	4.4	18.6	17.3	23.3	15.8	8.8	28.2	22.8	39.4	14.4	9.7	41.3	22.8	13.5	11.0	6.7	39.1	13.9	13.5	4.6	18.3	49.8	10.2	14.4	37.8	8.0	53.6	25.8	24.0	25.6	21.2	15.3	19.0	34.6	15.5	17.1
KAT7	"HBO1, HBOA, MYST2, ZC2HC7"	ENSG00000136504	"Lysine acetyltransferase 7"	O95251	17	49788555-49835030	"Enzymes, Predicted intracellular proteins, Transcription factors"	"DNA damage, DNA repair, DNA replication, Transcription, Transcription regulation"	"Acyltransferase, Chromatin regulator, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA044470, HPA071116"	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA044470: AB_10965785, HPA071116: "	"unprognostic (1.30e-1)"	"unprognostic (3.15e-2)"	"unprognostic (6.20e-3)"	"unprognostic (2.20e-2)"	"unprognostic (7.99e-2)"	"unprognostic (1.53e-1)"	"unprognostic (1.35e-2)"	"unprognostic (1.72e-2)"	"unprognostic (1.36e-1)"	"unprognostic (6.26e-2)"	"unprognostic (1.44e-2)"	"unprognostic (2.52e-1)"	"unprognostic (1.33e-3)"	"unprognostic (2.75e-1)"	"unprognostic (5.03e-2)"	"unprognostic (6.23e-2)"	"unprognostic (7.68e-2)"	15.8	14.3	16.9	16.2	25.9	44.4	17.5	37.0	35.0	19.5	17.3	23.8	17.9	13.1	27.3	18.6	18.8	19.5	14.6	25.3	16.8	21.8	18.7	11.3	13.9	15.3	17.0	23.6	21.9	13.6	44.4	19.8	19.8	21.9	20.4	14.9	20.8	18.9	23.3	31.7	22.7	14.7	21.8	17.9	15.8	15.5	63.7	19.1	25.9	28.6	14.5	20.6	22.7	17.4	13.0	12.7	15.2	11.4	20.6	20.7	14.2	13.0	18.3	17.8	12.4	8.4	11.1	21.5	11.3	13.2	20.4	14.6	28.3	9.3	14.9	18.4	12.0	17.8	11.4	16.9	11.8	24.1	16.2	16.7	17.7	13.3	11.7	12.5	18.1	14.8	10.6	11.9	18.3	22.9	11.8	15.0	16.6	19.6	14.9	19.1	19.8	25.7	13.0	44.1	27.9	16.0	16.2	28.4	12.9	9.5	14.7	19.3	16.4	11.6	6.9	10.6	28.1	25.5	16.0	9.0	25.9	14.0	11.3	14.7	21.8	23.8	17.5	11.7	10.9	16.1	15.2	11.0	15.1	16.9	8.9	20.7	13.0	16.3	17.1	12.7	12.2	20.6	16.2	13.1	20.6	11.4	6.6	14.3	14.2	16.9	25.9	37.0	35.0	16.8	21.8	17.0	23.6	21.9	19.1	23.8	17.6	14.7	9.0	14.9	30.8	23.6	20.4	24.1	20.5	26.2	29.5	18.8	8.3	9.4	17.4	18.6	10.4	0.0	6.5	13.0	11.4	13.2	23.1	9.0	11.5	42.9	24.1	12.3	16.1	11.0	15.5	11.1	13.5	12.6	12.1	15.3	8.2	8.6	17.3	8.7	25.3	38.8	13.9	69.0	33.2	17.6	28.3	20.2	11.4	7.2
KAT8	"FLJ14040, hMOF, MOF, MYST1, ZC2HC8"	ENSG00000103510	"Lysine acetyltransferase 8"	Q9H7Z6	16	31115754-31131393	"Enzymes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, Acyltransferase, Chromatin regulator, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	4	"Late spermatids: 102.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"eosinophil: 17.8;neutrophil: 17.4"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA066324			Supported	Nucleoplasm		NA	NA			Nucleoplasm		"HPA066324: AB_2685658"	"unprognostic (8.58e-2)"	"unprognostic (9.53e-2)"	"unprognostic (7.83e-2)"	"unprognostic (1.12e-2)"	"unprognostic (8.59e-2)"	"unprognostic (1.06e-1)"	"unprognostic (3.22e-1)"	"prognostic favorable (6.34e-4)"	"unprognostic (3.13e-2)"	"unprognostic (3.05e-1)"	"unprognostic (5.50e-2)"	"unprognostic (9.77e-2)"	"unprognostic (7.33e-2)"	"unprognostic (2.97e-1)"	"unprognostic (1.29e-1)"	"unprognostic (5.00e-1)"	"unprognostic (1.41e-1)"	18.4	21.7	22.7	29.4	23.6	26.6	29.7	48.9	30.8	28.0	24.8	18.3	27.5	15.7	29.8	48.3	16.7	35.0	28.2	32.7	23.0	21.2	20.8	18.9	26.3	29.0	20.2	21.0	52.8	31.4	38.0	22.2	31.5	16.8	21.2	17.7	22.1	35.1	26.2	39.8	22.1	19.7	25.9	20.5	27.4	18.6	27.3	18.4	30.2	31.7	22.6	22.2	20.2	26.6	2.1	4.1	17.8	4.6	1.7	2.9	1.9	7.7	12.0	15.0	4.5	17.8	13.4	15.4	6.9	13.3	11.2	12.3	6.0	17.0	18.3	11.0	8.6	10.2	9.3	23.9	11.6	11.1	15.3	16.2	7.9	8.8	19.0	16.0	13.1	14.4	12.6	23.4	8.3	24.2	14.7	10.6	19.4	21.1	15.1	5.7	22.6	20.2	24.8	16.9	18.8	7.3	32.6	12.3	21.5	9.0	4.6	15.8	16.1	4.2	11.7	5.8	9.6	12.7	21.8	6.3	4.7	10.1	5.3	5.0	14.4	14.5	10.4	7.2	17.5	7.1	3.9	4.4	17.8	1.9	2.4	2.4	2.1	2.2	2.6	4.1	1.8	2.9	2.1	17.4	1.7	4.6	1.4	1.3	1.9	22.7	23.6	48.9	30.8	23.0	21.2	20.2	21.0	16.8	18.4	17.9	15.6	17.9	35.9	18.4	17.8	15.2	12.7	4.0	14.8	8.7	13.7	25.5	18.3	19.6	99.8	18.5	18.6	23.3	23.2	17.7	24.7	25.4	27.6	11.1	26.6	30.2	23.6	16.5	29.2	102.1	49.8	22.4	23.6	22.6	19.7	36.9	14.8	17.5	50.9	12.4	23.7	25.8	17.5	30.4	18.8	13.7	38.0	20.0	20.7	22.1
KATNA1		ENSG00000186625	"Katanin catalytic subunit A1"	O75449	6	149594873-149648972	"Enzymes, Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"	Isomerase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	12	"Early spermatids: 312.3;Late spermatids: 142.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA036207	Approved		Supported	"Nucleoplasm,Centriolar satellite"		NA	NA			"Centriolar satellite"	Nucleoplasm	"HPA036207: AB_10672238"	"unprognostic (1.57e-1)"	"unprognostic (2.41e-2)"	"unprognostic (2.95e-2)"	"unprognostic (3.57e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.12e-1)"	"prognostic unfavorable (3.57e-7)"	"unprognostic (9.78e-2)"	"unprognostic (8.89e-2)"	"unprognostic (7.40e-2)"	"unprognostic (2.70e-2)"	"unprognostic (4.50e-2)"	"unprognostic (3.92e-2)"	"unprognostic (2.10e-1)"	"unprognostic (3.37e-1)"	"unprognostic (1.74e-3)"	"unprognostic (8.85e-2)"	12.5	7.8	9.3	11.9	9.8	14.2	11.7	13.0	9.5	13.8	12.1	15.0	6.0	7.6	15.3	10.3	12.5	10.9	10.1	11.3	9.1	6.7	13.7	8.4	10.8	11.8	10.4	7.9	18.7	9.6	5.7	12.1	11.0	15.0	12.7	9.5	17.5	10.1	10.5	21.2	12.0	10.8	12.4	8.9	12.2	10.4	36.7	12.0	22.5	13.9	10.3	14.0	15.1	12.7	19.6	19.4	23.5	20.8	12.7	24.2	14.9	11.5	4.1	9.5	20.7	11.5	18.4	14.7	14.5	12.3	15.3	20.3	9.9	6.1	16.1	8.4	14.4	11.1	9.1	18.6	9.5	20.0	14.7	15.7	21.4	8.9	13.7	15.9	29.9	8.1	11.6	11.3	17.5	13.9	14.2	14.0	21.7	22.1	11.8	13.5	16.0	20.5	19.5	9.3	12.9	7.0	14.1	17.3	7.8	10.9	6.5	7.7	10.9	26.4	7.6	10.1	13.9	7.8	29.2	12.0	8.0	12.2	21.0	16.7	11.0	10.1	22.1	10.5	21.3	13.0	23.5	15.2	21.0	19.9	20.8	17.5	19.6	20.2	20.0	19.4	14.2	17.2	17.3	7.0	12.7	18.0	16.7	24.2	14.9	9.3	9.8	13.0	9.5	9.1	6.7	10.4	7.9	15.0	12.0	14.9	9.9	13.7	31.3	26.1	8.6	15.9	10.2	24.1	13.6	14.0	27.5	18.4	14.9	16.5	312.3	15.5	9.7	23.3	10.9	15.9	23.8	16.3	19.7	6.6	15.3	12.7	5.8	10.4	11.8	142.0	19.5	18.0	10.1	22.6	8.4	10.9	12.0	10.5	15.6	16.6	34.9	6.5	18.9	100.5	54.7	25.1	21.4	17.5	8.9	15.2
KATNAL1	MGC2599	ENSG00000102781	"Katanin catalytic subunit A1 like 1"	Q9BW62	13	30202630-30307484	"Enzymes, Predicted intracellular proteins"		Isomerase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	10	"Early spermatids: 107.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"fHDF/TERT166: 30.6"					"Low region specificity"	"Detected in all"			HPA046205			Uncertain	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"HPA046205: AB_10965325"	"unprognostic (3.34e-1)"	"unprognostic (6.44e-3)"	"unprognostic (2.08e-2)"	"unprognostic (6.91e-2)"	"unprognostic (2.53e-1)"	"unprognostic (1.52e-1)"	"unprognostic (1.57e-2)"	"unprognostic (2.84e-2)"	"unprognostic (3.43e-1)"	"unprognostic (4.68e-3)"	"unprognostic (4.54e-2)"	"unprognostic (2.17e-2)"	"unprognostic (1.84e-3)"	"unprognostic (7.41e-2)"	"unprognostic (6.42e-2)"	"unprognostic (5.12e-2)"	"unprognostic (1.83e-3)"	11.0	5.7	12.2	6.4	12.5	7.6	12.0	11.0	14.4	14.1	11.4	10.4	4.6	2.2	12.7	4.2	8.1	6.6	5.4	22.6	8.5	9.8	5.9	5.4	6.7	8.2	10.3	14.9	6.3	2.9	3.2	11.9	4.2	11.9	6.7	5.9	4.1	3.5	8.5	7.1	3.8	4.2	19.7	10.8	4.5	4.7	25.1	7.8	12.0	4.4	3.3	9.1	7.7	7.9	5.2	6.9	3.4	1.0	9.5	7.1	1.4	5.5	4.6	8.1	4.3	6.2	13.2	0.2	23.0	7.4	12.3	9.7	0.9	5.6	8.9	2.7	30.6	15.5	1.5	5.7	5.9	18.8	7.7	2.1	6.4	5.7	2.1	3.3	3.1	4.3	5.1	3.0	13.8	3.4	11.6	12.9	5.0	3.4	3.9	15.0	1.1	7.0	2.9	3.5	0.1	3.0	7.9	9.6	0.9	4.4	0.4	3.4	7.1	6.1	1.2	4.3	7.1	2.0	1.9	11.7	10.9	16.6	5.9	9.2	2.1	3.8	12.3	4.3	3.1	15.6	1.9	0.9	3.4	5.8	0.5	2.9	2.6	4.6	5.8	2.3	5.2	1.1	2.6	0.3	9.5	1.0	6.9	7.1	1.4	12.2	12.5	11.0	14.4	8.5	9.8	10.3	14.9	11.9	7.8	8.9	2.6	1.9	3.5	5.3	9.0	35.3	2.5	16.0	2.3	5.2	25.5	0.2	3.3	5.4	107.1	6.4	0.0	0.0	1.3	0.7	9.4	1.6	9.3	9.0	2.8	20.6	9.8	6.7	2.1	42.6	8.3	3.4	16.9	35.1	0.5	8.5	4.5	0.0	4.9	5.7	17.6	6.5	11.2	41.6	21.5	5.0	0.2	7.5	0.6	1.3
KATNAL2	"DKFZP667C165, MGC33211"	ENSG00000167216	"Katanin catalytic subunit A1 like 2"	Q8IYT4	18	46917492-47102243	"Enzymes, Predicted intracellular proteins"		Isomerase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"parathyroid gland: 30.3;testis: 33.2"	"Group enriched"	"Detected in many"	4	"Ciliated cells: 46.8;Early spermatids: 59.9;Late spermatids: 47.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"Daudi: 19.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040712, HPA042029"	Approved		Approved	"Nucleoplasm,Intermediate filaments"		No	No			"Nucleoplasm, Intermediate filaments"		"HPA040712: AB_2677092, HPA042029: AB_2677807"	"unprognostic (3.40e-1)"	"unprognostic (7.75e-2)"	"unprognostic (9.00e-3)"	"unprognostic (9.28e-2)"	"unprognostic (1.74e-2)"	"unprognostic (6.55e-3)"	"unprognostic (6.97e-2)"	"unprognostic (1.28e-2)"	"unprognostic (3.90e-2)"	"unprognostic (5.36e-2)"	"unprognostic (9.52e-6)"	"unprognostic (1.28e-1)"	"prognostic favorable (1.24e-7)"	"unprognostic (1.64e-1)"	"unprognostic (7.14e-4)"	"unprognostic (1.06e-3)"	"unprognostic (1.61e-1)"	5.5	2.9	8.2	4.1	9.7	2.8	7.1	4.0	7.5	2.5	2.4	11.3	2.5	1.8	2.8	7.1	2.7	8.6	5.1	4.3	8.1	7.6	9.5	5.2	4.6	3.4	9.6	6.2	3.1	3.3	30.3	7.0	2.2	9.0	3.4	3.1	6.4	3.4	3.7	6.0	8.0	1.5	2.3	8.7	3.3	2.0	33.2	6.3	2.4	15.5	1.1	3.0	2.3	2.5	3.1	0.6	2.7	1.3	0.8	1.5	0.3	1.9	4.3	2.4	15.0	4.9	5.9	1.1	1.8	1.6	1.5	1.9	0.2	5.1	19.8	1.5	2.8	1.9	0.6	4.7	0.5	1.1	2.0	2.5	0.8	1.3	0.3	2.0	1.2	1.9	12.2	1.8	2.5	0.6	3.4	0.5	9.1	0.7	1.6	8.5	1.9	1.2	2.6	5.4	2.5	2.7	5.5	1.1	0.0	4.7	0.4	5.4	6.0	1.9	0.4	0.6	8.8	11.4	11.0	1.0	5.0	0.5	2.0	1.2	1.3	1.0	13.3	2.7	12.5	9.6	1.7	0.7	0.5	1.1	1.3	0.9	2.2	0.9	0.5	0.3	3.1	1.5	1.4	2.7	0.8	0.9	0.6	0.2	0.3	8.2	9.7	4.0	7.5	8.1	7.6	9.6	6.2	9.0	6.3	0.0	1.4	0.0	2.6	1.3	10.4	2.2	0.0	46.8	6.8	3.5	5.9	0.0	11.6	0.4	59.9	1.4	0.8	0.0	0.2	0.0	1.5	1.2	0.0	3.9	2.8	11.1	0.0	3.1	1.0	47.0	1.4	0.6	3.3	1.0	0.3	2.4	0.2	0.0	2.1	5.2	2.1	0.0	0.8	11.2	4.3	1.0	0.1	0.0	1.5	1.4
KCMF1	"DEBT91, DKFZP434L1021, PCMF, ZZZ1"	ENSG00000176407	"Potassium channel modulatory factor 1"	Q9P0J7	2	84971093-85059472	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030383, HPA030384"	Enhanced		Enhanced	Nucleoplasm,Cytosol		NA	NA			Cytosol	Nucleoplasm	"HPA030383: AB_10599977, HPA030384: AB_10601230"	"unprognostic (8.01e-2)"	"unprognostic (1.98e-2)"	"unprognostic (9.95e-2)"	"unprognostic (7.42e-3)"	"unprognostic (1.24e-2)"	"unprognostic (8.54e-2)"	"prognostic unfavorable (2.33e-7)"	"unprognostic (5.68e-3)"	"unprognostic (1.43e-1)"	"unprognostic (9.81e-2)"	"prognostic unfavorable (6.10e-5)"	"unprognostic (4.98e-2)"	"prognostic unfavorable (4.18e-6)"	"unprognostic (6.11e-2)"	"unprognostic (2.66e-1)"	"unprognostic (4.42e-1)"	"unprognostic (1.01e-1)"	19.2	13.3	17.9	20.2	16.0	23.6	26.1	13.4	18.6	15.0	20.2	10.7	20.3	15.4	16.3	18.8	28.5	12.8	17.9	30.4	16.5	12.0	14.8	20.7	16.4	18.8	13.7	11.1	17.2	48.6	14.7	18.7	20.5	14.4	17.5	21.4	14.0	19.4	15.7	67.2	17.6	20.6	25.7	10.3	16.7	16.8	29.0	11.5	19.7	18.7	21.8	22.5	23.9	34.0	4.0	4.2	8.1	3.4	2.8	8.8	1.5	27.6	21.7	19.4	14.9	20.5	19.9	33.1	29.6	27.5	28.4	19.0	26.5	29.9	30.1	29.8	40.1	28.4	18.4	15.1	28.6	37.6	22.5	10.5	19.2	16.4	27.0	40.2	21.1	18.3	20.5	45.3	27.8	77.2	25.4	21.4	16.3	19.0	24.0	28.4	25.5	20.3	11.7	21.2	35.2	18.3	14.7	27.3	18.8	25.7	24.3	18.7	14.0	17.2	22.0	28.7	23.3	10.2	13.5	18.2	29.1	28.3	27.1	30.7	27.4	33.8	30.5	21.9	15.6	21.7	5.0	2.6	8.1	4.5	2.2	3.6	3.5	3.2	3.4	2.2	4.0	2.8	3.1	7.5	2.8	3.4	4.2	8.8	1.5	17.9	16.0	13.4	18.6	16.5	12.0	13.7	11.1	14.4	11.5	29.8	28.2	27.9	82.6	63.0	31.1	41.6	20.4	10.7	25.0	12.2	13.7	22.2	21.6	33.1	65.6	24.8	41.1	23.3	45.9	22.3	26.3	94.5	17.3	29.8	18.4	68.3	18.5	25.8	25.1	87.4	23.9	22.8	25.3	23.4	27.6	31.3	46.8	35.9	27.3	28.6	27.5	25.8	36.8	31.0	29.4	69.1	34.1	19.1	28.1	106.5
KDM2A	"CXXC8, DKFZP434M1735, FBL11, FBL7, FBXL11, FLJ00115, JHDM1A, KIAA1004, LILINA"	ENSG00000173120	"Lysine demethylase 2A"	Q9Y2K7	11	67119269-67258087	"Enzymes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Biological rhythms, Transcription, Transcription regulation, Ubl conjugation pathway"	"Chromatin regulator, Dioxygenase, DNA-binding, Oxidoreductase, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Cone photoreceptor cells: 129.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB012272, HPA044251"	Supported		Supported	Nucleoplasm		NA	NA			Nucleoplasm		"CAB012272: , HPA044251: "	"unprognostic (7.43e-2)"	"unprognostic (1.84e-1)"	"unprognostic (4.09e-1)"	"unprognostic (8.66e-2)"	"unprognostic (1.67e-1)"	"unprognostic (2.30e-2)"	"unprognostic (6.05e-2)"	"unprognostic (2.84e-1)"	"unprognostic (4.46e-1)"	"unprognostic (2.04e-3)"	"unprognostic (3.27e-2)"	"unprognostic (5.08e-2)"	"unprognostic (2.67e-2)"	"unprognostic (3.30e-1)"	"unprognostic (1.05e-1)"	"unprognostic (5.61e-2)"	"unprognostic (9.45e-3)"	19.6	14.6	18.6	25.3	23.9	38.1	21.0	36.5	22.8	20.0	21.9	17.8	20.7	15.3	32.0	18.6	32.7	20.2	19.3	18.8	17.4	12.7	16.8	20.3	24.3	30.1	17.9	14.9	27.4	15.3	26.1	21.1	26.0	17.5	23.3	17.1	21.0	22.2	20.5	32.8	28.7	24.1	25.0	14.6	29.0	19.8	27.6	18.6	32.2	19.9	20.3	37.3	24.9	25.9	7.2	1.9	5.0	1.9	4.6	5.2	2.8	25.5	15.4	9.4	14.6	9.3	13.6	7.1	11.2	13.0	20.1	13.8	24.1	13.4	19.7	19.7	15.7	12.4	25.0	15.5	11.1	16.3	33.0	6.9	14.5	18.4	6.0	9.9	12.3	20.1	11.2	13.6	19.7	13.8	11.1	14.6	11.5	13.4	27.8	9.7	17.0	15.9	8.9	19.0	15.9	13.2	20.3	15.8	11.0	8.4	16.1	12.8	10.2	35.9	20.7	21.3	11.6	31.1	12.6	19.5	13.5	9.1	18.5	9.5	15.5	17.0	12.5	11.9	8.9	9.3	0.6	1.9	0.5	4.8	1.5	5.2	6.4	3.6	4.2	1.2	7.2	3.8	3.5	5.0	4.6	1.0	1.9	4.3	2.8	18.6	23.9	36.5	22.8	17.4	12.7	17.9	14.9	17.5	18.6	35.7	36.8	25.7	19.5	36.6	73.1	27.1	38.2	25.4	28.4	15.7	129.6	18.9	0.0	15.1	20.3	31.6	30.8	0.0	12.5	11.7	30.7	26.1	26.5	32.7	19.2	90.6	30.5	27.0	41.3	10.2	19.8	42.0	18.6	31.5	24.9	25.1	20.3	23.0	21.5	9.1	113.7	19.4	25.9	56.1	34.8	41.8	27.0	45.7	23.2	39.3
KDM2B	"CXXC2, Fbl10, FBXL10, JHDM1B, PCCX2"	ENSG00000089094	"Lysine demethylase 2B"	Q8NHM5	12	121429097-121581015	"Enzymes, Predicted intracellular proteins"	"Transcription, Transcription regulation, Ubl conjugation pathway"	"Chromatin regulator, Dioxygenase, DNA-binding, Oxidoreductase, Repressor, RNA-binding, rRNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"monocytes: 64.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA071257			Uncertain	Nucleoplasm		NA	NA			Nucleoplasm		"HPA071257: "	"unprognostic (7.67e-2)"	"unprognostic (3.72e-3)"	"unprognostic (2.15e-1)"	"unprognostic (1.69e-1)"	"unprognostic (1.37e-1)"	"prognostic favorable (6.74e-6)"	"unprognostic (1.16e-1)"	"unprognostic (5.45e-2)"	"unprognostic (1.01e-2)"	"unprognostic (1.95e-1)"	"prognostic favorable (8.64e-4)"	"unprognostic (1.77e-1)"	"unprognostic (4.44e-3)"	"unprognostic (1.44e-2)"	"unprognostic (3.90e-2)"	"unprognostic (7.07e-2)"	"unprognostic (4.82e-2)"	6.2	6.3	13.9	20.1	15.7	14.9	7.0	31.1	25.1	9.2	7.6	12.3	5.2	8.2	9.9	7.3	14.4	10.8	7.9	5.8	11.8	7.2	6.6	10.2	9.5	21.3	14.3	15.1	14.1	8.2	13.0	8.2	7.2	12.2	6.6	7.7	8.1	9.1	6.8	11.7	18.9	13.1	8.1	13.2	16.3	7.4	9.8	14.5	27.0	8.2	5.5	20.9	11.1	11.6	11.5	5.0	4.2	3.6	2.6	8.3	4.0	6.7	8.6	17.0	5.2	4.7	4.9	17.4	6.7	9.1	9.8	8.3	11.7	3.8	33.1	9.9	6.1	5.2	5.9	18.1	6.6	7.4	13.7	11.7	19.1	7.8	10.4	5.2	22.3	14.8	3.9	4.0	8.8	6.7	9.8	7.0	16.6	14.4	4.7	5.0	10.0	24.2	26.8	27.3	5.4	7.0	27.9	8.6	16.3	5.4	13.1	18.6	11.0	11.5	6.8	6.8	14.8	12.8	24.5	8.8	10.2	7.6	9.7	6.5	11.0	9.7	32.3	9.3	17.5	6.3	4.2	3.6	2.8	8.3	3.2	6.3	11.5	6.6	4.8	5.0	10.6	5.9	7.5	0.5	2.6	1.9	4.8	5.5	4.0	13.9	15.7	31.1	25.1	11.8	7.2	14.3	15.1	12.2	14.5	0.0	11.7	22.7	5.0	15.0	19.7	13.0	15.3	2.7	4.5	10.4	11.8	5.7	10.0	6.6	41.3	7.3	4.7	0.0	5.0	9.1	9.4	5.4	13.9	12.2	21.8	14.3	5.2	8.0	16.4	37.2	7.2	21.0	15.1	64.1	4.7	3.9	5.1	5.9	6.7	3.3	13.8	19.4	9.9	5.1	13.9	13.2	5.5	17.8	6.6	5.4
KDM8	"FLJ13798, JMJD5"	ENSG00000155666	"Lysine demethylase 8"	Q8N371	16	27203495-27221768	"Enzymes, Predicted intracellular proteins"	"Biological rhythms, Cell cycle, Transcription, Transcription regulation"	"Aminopeptidase, Chromatin regulator, Dioxygenase, Hydrolase, Oxidoreductase, Protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 44.9"	"Cell type enriched"	"Detected in many"	5	"Hepatocytes: 46.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA026545	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA026545: AB_1852015"	"unprognostic (1.39e-1)"	"unprognostic (1.37e-3)"	"unprognostic (2.80e-1)"	"unprognostic (2.16e-2)"	"unprognostic (3.21e-1)"	"unprognostic (1.22e-2)"	"unprognostic (2.41e-3)"	"unprognostic (1.33e-2)"	"unprognostic (7.95e-2)"	"unprognostic (3.41e-1)"	"prognostic favorable (1.75e-4)"	"unprognostic (1.22e-1)"	"unprognostic (2.75e-2)"	"unprognostic (5.33e-2)"	"unprognostic (2.71e-1)"	"unprognostic (2.04e-1)"	"unprognostic (3.92e-3)"	1.9	3.2	2.7	3.6	3.5	1.4	2.1	5.9	5.9	2.2	4.2	3.7	3.2	12.0	3.1	2.2	2.1	2.5	2.5	2.0	2.7	3.2	2.3	44.9	2.0	3.3	2.3	5.1	3.0	4.5	2.8	3.3	1.7	3.7	2.9	1.9	2.1	2.6	2.5	4.0	1.9	16.8	1.9	2.2	3.7	2.3	2.2	2.2	5.9	2.9	2.0	3.7	2.8	2.2	5.6	6.5	1.3	3.4	2.2	8.2	3.5	1.6	3.7	6.4	3.3	1.6	1.9	3.4	2.1	2.4	4.8	4.3	3.1	2.9	9.6	3.7	3.5	2.4	1.9	3.7	3.2	2.8	11.0	5.5	6.1	4.1	7.3	3.4	4.3	7.3	2.5	2.6	3.2	2.1	2.8	3.7	4.6	7.7	5.9	2.9	2.8	4.3	7.7	11.1	1.3	2.2	6.3	3.9	8.6	1.8	1.9	6.0	3.8	0.9	3.0	2.3	2.2	3.2	5.7	4.1	5.7	3.0	2.1	2.2	3.7	3.8	7.7	2.3	4.0	0.5	0.4	3.2	1.3	4.2	3.4	3.6	3.2	6.2	6.0	3.0	5.6	6.0	8.2	0.1	2.2	2.9	6.5	3.6	3.5	2.7	3.5	5.9	5.9	2.7	3.2	2.3	5.1	3.7	2.2	0.0	1.7	0.5	0.2	0.2	1.0	1.0	0.0	9.4	2.3	0.0	2.0	1.3	3.3	0.9	0.4	1.0	1.6	0.0	0.6	0.4	0.8	0.4	0.0	46.0	1.6	0.0	5.2	1.3	1.3	0.0	0.3	1.2	0.0	1.0	1.3	1.6	0.7	0.0	1.1	1.2	2.5	0.0	0.8	0.9	2.5	0.0	1.1	0.5	1.1	0.1
KDR	"CD309, FLK1, VEGFR, VEGFR2"	ENSG00000128052	"Kinase insert domain receptor"	P35968	4	55078259-55125595	"Cancer-related genes, CD markers, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted membrane proteins, RAS pathway related proteins"	"Angiogenesis, Differentiation, Host-virus interaction"	"Developmental protein, Kinase, Receptor, Transferase, Tyrosine-protein kinase"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in many"	6	"Endothelial cells: 100.3;Ito cells: 200.7;Muller glia cells: 229.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	9	"HUVEC TERT2: 32.5;TIME: 36.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			CAB004028	Enhanced		Supported	"Plasma membrane"	"Intracellular and membrane"	NA	NA		7400000	"Plasma membrane"		"CAB004028: AB_2212507"	"unprognostic (1.61e-1)"	"unprognostic (2.03e-1)"	"unprognostic (9.65e-2)"	"unprognostic (1.97e-1)"	"unprognostic (9.63e-2)"	"unprognostic (1.22e-2)"	"unprognostic (1.78e-3)"	"unprognostic (2.59e-2)"	"unprognostic (1.19e-2)"	"unprognostic (1.10e-1)"	"unprognostic (8.79e-3)"	"unprognostic (1.34e-1)"	"prognostic unfavorable (7.26e-4)"	"unprognostic (4.00e-2)"	"unprognostic (2.30e-1)"	"unprognostic (3.22e-1)"	"unprognostic (1.86e-1)"	19.7	6.2	1.8	4.4	3.1	0.4	20.5	1.1	2.2	11.4	6.0	1.8	11.5	2.3	28.8	10.2	5.2	9.5	6.2	12.1	2.3	1.7	7.8	10.4	13.2	14.1	3.1	2.9	6.0	8.1	8.0	6.8	34.5	3.9	9.5	1.4	27.6	7.1	10.3	5.3	3.0	3.8	7.7	2.6	4.4	4.2	5.3	1.2	0.5	20.0	5.3	3.0	4.4	12.0	0.1	0.1	0.7	0.0	0.2	0.2	0.1	0.0	0.0	1.7	0.0	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	3.0	0.0	0.0	3.8	0.0	0.0	0.3	0.0	0.0	0.2	0.2	32.5	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.8	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	36.7	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.4	0.0	0.1	0.1	0.0	0.7	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.1	0.0	0.2	0.0	0.1	0.0	0.1	1.8	3.1	1.1	2.2	2.3	1.7	3.1	2.9	3.9	1.2	0.0	8.2	7.5	0.4	2.3	7.4	4.8	0.0	6.7	30.7	0.0	0.0	0.1	0.0	0.5	0.8	100.3	0.0	0.0	0.0	0.1	1.9	0.4	2.3	1.3	0.4	0.0	0.0	200.7	14.5	0.6	0.0	1.0	6.8	0.0	0.0	229.2	0.3	0.0	0.4	0.0	6.0	0.0	1.4	0.2	0.2	2.4	0.1	0.0	0.0	0.4
KDSR	"DHSR, FVT1, SDR35C1"	ENSG00000119537	"3-ketodihydrosphingosine reductase"	Q06136	18	63327726-63367510	"Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Lipid metabolism, Sphingolipid metabolism"	Oxidoreductase	"Cancer-related genes, Disease mutation, Palmoplantar keratoderma, Proto-oncogene"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in all"		"U-266/70: 38.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB003673, HPA044884"	Approved					NA	NA					"CAB003673: AB_425440, HPA044884: AB_2679131"	"unprognostic (4.44e-2)"	"unprognostic (8.57e-2)"	"unprognostic (2.52e-2)"	"unprognostic (4.56e-2)"	"unprognostic (5.88e-3)"	"unprognostic (7.50e-3)"	"unprognostic (1.80e-2)"	"unprognostic (2.66e-1)"	"unprognostic (2.97e-1)"	"unprognostic (1.97e-1)"	"unprognostic (2.70e-2)"	"unprognostic (6.81e-2)"	"prognostic favorable (9.53e-6)"	"unprognostic (3.32e-2)"	"unprognostic (5.77e-2)"	"unprognostic (2.22e-1)"	"unprognostic (2.16e-3)"	21.1	19.4	19.0	11.1	22.4	6.4	29.7	12.5	17.2	18.2	17.3	23.9	14.2	10.0	19.4	30.0	17.8	14.3	17.7	15.8	19.7	16.9	21.3	52.6	15.3	11.5	32.1	14.6	29.1	14.3	19.6	10.5	24.9	19.5	18.0	11.0	15.9	16.1	17.4	12.4	28.8	13.1	18.9	39.0	9.1	11.8	10.4	23.3	8.8	21.2	12.3	9.9	19.9	22.8	4.0	5.6	0.9	5.6	9.8	19.5	3.7	5.9	2.7	2.8	3.1	22.4	16.8	5.5	19.8	12.2	4.4	5.9	1.1	4.1	6.1	8.5	7.7	7.3	26.5	3.5	11.1	5.4	11.4	5.9	4.7	3.6	1.3	17.1	8.5	3.3	16.0	21.2	7.0	20.1	8.1	4.3	4.1	3.7	8.7	11.6	2.4	9.4	3.9	3.3	1.5	10.0	6.4	8.3	8.6	12.1	3.9	3.6	6.9	9.6	4.7	8.5	3.8	2.5	4.9	10.1	18.6	4.5	6.2	8.6	38.2	17.4	3.5	14.0	5.3	5.5	0.0	3.7	0.3	4.8	5.6	19.5	4.0	10.2	7.6	5.6	3.6	7.3	4.6	0.9	9.8	2.6	2.8	12.9	3.7	19.0	22.4	12.5	15.9	19.7	16.9	32.1	14.6	19.5	23.3	32.8	41.4	40.4	112.3	140.9	36.2	21.8	68.8	46.8	48.9	36.6	25.5	53.1	13.3	45.0	0.7	35.9	29.0	0.0	32.1	57.8	53.6	62.1	25.4	77.0	31.7	38.1	19.7	44.8	25.0	3.6	65.9	36.3	54.0	30.7	30.6	57.7	41.5	46.0	66.4	36.6	40.8	32.3	42.2	0.9	5.3	125.1	76.4	20.3	40.8	94.6
KEL	"CD238, ECE3"	ENSG00000197993	"Kell blood group, metallo-endopeptidase"	P23276	7	142941114-142962681	"Blood group antigen proteins, Cancer-related genes, CD markers, Enzymes, Predicted intracellular proteins, Predicted membrane proteins"		"Blood group antigen, Hydrolase, Metalloprotease, Protease"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"bone marrow: 21.1;testis: 36.4"	"Cell type enriched"	"Detected in some"	14	"Erythroid cells: 46.7"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in some"			"Cell type enriched"	"Detected in single"	7	"intermediate monocyte: 1.4"	"Lineage enriched"	"Detected in single"	14	"monocytes: 1.4"	"Group enriched"	"Detected in some"	12	"HEL: 15.3;K-562: 12.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA064442			Supported	"Nucleoplasm,Plasma membrane"		NA	NA			"Plasma membrane"	Nucleoplasm	"HPA064442: "	"unprognostic (5.78e-3)"	"unprognostic (1.08e-5)"	"unprognostic (5.29e-3)"	"unprognostic (4.85e-3)"	"unprognostic (9.68e-2)"	"unprognostic (1.96e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.54e-2)"	"unprognostic (5.18e-2)"	"unprognostic (1.08e-2)"	"unprognostic (3.71e-2)"	"unprognostic (3.57e-2)"	"unprognostic (2.29e-3)"	"unprognostic (9.24e-2)"	"unprognostic (7.05e-2)"	"unprognostic (3.32e-2)"	"unprognostic (3.25e-3)"	0.2	0.0	0.9	2.5	1.1	21.1	0.2	0.2	0.4	0.4	0.2	0.3	0.2	0.0	0.2	0.2	0.6	0.1	0.2	0.2	1.4	0.7	0.4	0.2	1.4	5.0	2.0	0.2	0.2	0.2	0.0	0.2	1.1	0.3	0.2	0.0	0.3	2.5	0.2	0.2	0.0	0.5	0.2	4.4	3.8	0.0	36.4	0.3	0.4	0.2	0.2	3.7	0.2	0.2	0.0	0.0	0.0	1.4	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	12.4	0.1	0.0	0.0	0.5	0.3	0.3	0.0	0.0	0.1	0.0	0.1	0.0	1.2	0.0	0.1	0.2	0.0	0.5	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.9	1.1	0.2	0.4	1.4	0.7	2.0	0.2	0.3	0.3	0.0	0.0	0.0	0.8	0.0	0.0	0.3	0.0	0.0	2.3	3.5	0.0	0.0	1.7	0.2	1.9	0.0	0.0	46.7	0.0	0.2	0.0	0.2	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.4	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.1	0.0	0.0	1.0
KHK		ENSG00000138030	Ketohexokinase	P50053	2	27086747-27100772	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Carbohydrate metabolism"	"Kinase, Transferase"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"intestine: 60.2;kidney: 38.4;liver: 67.0"	"Group enriched"	"Detected in many"	6	"Hepatocytes: 359.6;Proximal tubular cells: 948.1"	"Group enriched"	"Detected in all"	7	"liver cancer: 62.2;renal cancer: 32.5"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HEL: 18.6;Hep G2: 27.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA007040	Enhanced		Approved	Cytosol		NA	NA		320000	Cytosol		"HPA007040: AB_1079185"	"unprognostic (8.44e-2)"	"unprognostic (1.49e-1)"	"unprognostic (1.70e-1)"	"prognostic unfavorable (7.62e-8)"	"unprognostic (2.25e-1)"	"unprognostic (1.21e-1)"	"unprognostic (3.08e-2)"	"unprognostic (3.13e-2)"	"unprognostic (1.67e-2)"	"unprognostic (2.50e-2)"	"unprognostic (3.01e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.68e-2)"	"unprognostic (2.56e-3)"	"unprognostic (2.32e-1)"	"unprognostic (2.44e-1)"	"unprognostic (1.02e-2)"	0.9	1.9	2.1	1.2	2.7	0.7	1.9	5.2	3.9	1.1	22.3	1.9	0.2	40.0	1.5	0.9	1.1	1.6	0.6	0.6	2.2	2.2	38.4	67.0	0.7	0.8	3.5	1.9	1.8	4.2	0.6	0.7	0.4	3.0	0.9	0.6	0.6	1.7	0.7	1.4	1.0	60.2	0.9	1.8	0.8	1.0	1.6	3.6	0.0	0.5	1.2	0.6	0.7	0.9	5.1	7.3	0.6	6.6	5.4	8.8	6.0	14.0	10.7	1.7	6.4	1.2	0.3	1.4	1.0	0.6	1.3	0.8	5.1	3.1	2.1	3.4	0.0	1.5	6.2	5.5	1.8	0.4	5.0	10.1	18.6	2.8	27.1	0.6	2.5	2.2	0.1	0.8	1.6	0.1	0.7	1.2	3.0	3.3	3.6	0.1	9.1	3.0	2.0	2.3	12.7	4.2	10.7	0.8	11.8	1.6	1.7	6.0	9.4	2.1	3.6	4.0	0.6	1.6	1.1	1.1	0.4	2.1	0.9	3.7	4.4	7.9	3.6	1.8	6.1	1.0	0.0	6.6	0.4	5.4	3.8	7.4	5.1	8.8	7.8	6.1	5.1	6.4	7.8	0.6	5.4	1.6	7.3	5.5	6.0	2.1	2.7	5.2	3.9	2.2	2.2	3.5	1.9	3.0	3.6	3.0	5.9	9.6	2.3	3.2	3.6	1.9	15.3	0.0	1.2	38.4	2.0	2.6	109.5	3.1	0.8	5.8	12.3	0.0	2.6	3.6	1.9	0.9	4.6	359.6	7.5	6.4	5.8	6.7	13.2	3.6	1.7	5.8	8.5	1.0	5.9	8.5	2.7	1.7	1.4	948.1	5.2	0.0	4.5	0.9	6.8	5.9	7.9	4.6	14.3	1.0
KIAA0391	"MRPP3, PRORP"	ENSG00000100890	KIAA0391	O15091	14	35121846-35277614	"Enzymes, Predicted intracellular proteins"	"tRNA processing"	"Hydrolase, Nuclease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											HPA020459	Approved		Supported	Nucleoplasm,Mitochondria		NA	NA			Mitochondria	Nucleoplasm	"HPA020459: AB_2670449"	"unprognostic (6.44e-3)"	"unprognostic (8.10e-2)"	"unprognostic (7.71e-3)"	"unprognostic (4.90e-2)"	"unprognostic (3.42e-2)"	"unprognostic (1.74e-1)"	"unprognostic (2.76e-2)"	"unprognostic (8.67e-2)"	"unprognostic (1.94e-2)"	"unprognostic (3.25e-4)"	"unprognostic (1.75e-1)"	"unprognostic (1.80e-1)"	"unprognostic (9.67e-5)"	"unprognostic (2.56e-1)"	"unprognostic (1.67e-1)"	"unprognostic (2.10e-2)"	"unprognostic (6.65e-2)"	13.9	26.1	18.8	17.6	20.1	12.5	17.5	23.1	21.9	17.4	22.4	20.6	15.6	16.6	13.0	19.4	26.1	14.7	13.2	16.7	17.6	16.3	31.1	29.5	20.9	29.5	20.2	17.7	10.8	16.5	29.8	27.4	13.4	19.2	14.1	24.9	15.8	18.0	21.8	22.2	23.0	16.5	15.0	23.0	18.7	15.8	17.1	20.9	31.2	18.9	21.3	24.8	18.2	16.0	10.0	9.7	10.9	5.4	12.1	25.5	12.4	22.8	18.3	12.7	16.8	13.9	16.5	11.2	15.4	13.8	19.7	17.1	17.3	14.2	25.1	20.1	14.6	5.6	17.8	23.3	26.6	22.3	19.7	7.2	11.3	14.1	36.9	14.4	13.9	12.4	17.6	20.5	18.6	17.2	17.0	28.5	21.6	18.2	7.3	24.0	25.9	21.0	15.3	13.6	19.8	18.1	20.2	21.1	14.5	27.7	23.4	11.8	13.4	19.9	22.1	12.8	17.1	32.2	11.5	21.6	15.2	13.7	11.7	13.2	8.0	18.6	26.3	7.7	15.1	15.9	10.9	5.4	3.4	15.4	5.2	22.4	10.0	23.8	16.6	7.2	7.0	21.2	15.6	6.3	12.1	4.3	9.7	25.5	12.4	18.8	20.1	23.1	21.9	17.6	16.3	20.2	17.7	19.2	20.9	3.0	1.3	1.3	0.5	0.0	1.3	1.5	0.0	1.4	2.3	0.0	0.0	0.8	1.7	1.0	0.0	1.0	1.4	0.0	0.8	0.5	0.8	1.0	2.3	1.6	1.0	0.0	0.0	1.8	0.8	0.0	0.6	0.8	0.0	0.0	0.9	1.2	1.5	0.0	0.4	1.4	1.5	0.0	0.3	0.5	1.1	0.0	0.6	0.0	1.6	0.9
KIT	"C-Kit, CD117, PBT, SCFR"	ENSG00000157404	"KIT proto-oncogene receptor tyrosine kinase"	P10721	4	54657918-54740715	"Cancer-related genes, CD markers, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted membrane proteins, RAS pathway related proteins"		"Kinase, Receptor, Transferase, Tyrosine-protein kinase"	"Cancer-related genes, Disease mutation, FDA approved drug targets, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"breast: 65.5"	"Group enriched"	"Detected in many"	10	"granulocytes: 496.5;Melanocytes: 200.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	6	"basophil: 12.7;eosinophil: 10.0;NK-cell: 9.7"	"Group enriched"	"Detected in many"	6	"granulocytes: 12.7;NK-cells: 9.7"	"Group enriched"	"Detected in some"	13	"HEL: 48.8;HMC-1: 102.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB003288, HPA004471, CAB068253, CAB072867, HPA073252"	Enhanced	Supported	Supported	"Plasma membrane"		NA	NA		48000000	"Plasma membrane"		"CAB003288: AB_2335702, CAB068253: AB_2665717, CAB072867: AB_2665718, HPA004471: AB_1078431, HPA073252: AB_2686589"	"unprognostic (1.55e-2)"	"unprognostic (1.91e-1)"	"unprognostic (4.04e-2)"	"unprognostic (8.19e-2)"	"unprognostic (3.96e-2)"	"unprognostic (2.18e-2)"	"unprognostic (2.33e-2)"	"unprognostic (1.97e-2)"	"unprognostic (3.60e-2)"	"unprognostic (1.64e-1)"	"unprognostic (2.20e-1)"	"unprognostic (1.92e-2)"	"prognostic favorable (5.63e-4)"	"unprognostic (1.34e-3)"	"unprognostic (1.87e-1)"	"unprognostic (1.29e-2)"	"unprognostic (2.30e-1)"	8.1	1.6	9.5	6.6	11.8	3.7	65.5	18.3	12.0	12.1	10.3	6.5	10.2	5.8	8.9	4.2	9.9	2.5	15.5	2.4	36.0	4.4	9.4	1.1	13.8	3.8	3.6	6.0	28.5	2.1	1.3	2.3	6.2	5.7	9.6	10.4	20.7	12.9	6.9	1.3	14.6	8.9	10.2	3.9	3.2	12.8	4.0	4.5	0.4	28.9	4.3	4.9	9.8	12.5	0.0	1.8	12.7	0.9	9.7	1.9	0.1	0.0	0.0	0.8	0.0	0.1	0.0	0.0	0.6	0.9	2.6	3.2	0.0	0.0	0.0	0.0	1.4	0.1	0.0	0.5	0.0	2.2	0.0	1.2	48.8	0.0	0.0	0.0	0.0	102.6	0.0	0.0	0.0	0.0	0.0	5.7	0.8	0.6	0.1	0.0	0.0	0.2	0.4	1.4	0.0	0.0	0.1	0.0	0.0	0.0	4.8	1.2	0.4	0.0	0.0	0.0	3.0	0.0	0.5	0.0	0.1	0.0	1.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	12.7	0.0	10.0	0.1	0.0	1.9	0.0	0.3	0.7	1.8	0.0	0.0	0.0	0.8	9.7	0.9	0.0	0.0	0.1	9.5	11.8	18.3	12.0	36.0	4.4	3.6	6.0	5.7	4.5	6.0	34.8	1.4	1.1	12.7	0.0	0.4	5.1	0.0	5.7	3.5	0.0	0.0	3.3	0.8	0.0	2.4	0.0	0.0	0.0	0.1	1.3	0.5	496.5	0.0	0.3	0.0	5.2	1.8	0.3	0.0	1.1	3.1	200.8	0.0	0.3	2.4	0.0	0.0	0.0	0.6	0.3	0.0	0.5	0.0	8.2	3.3	0.2	2.2	0.3	0.3
KL		ENSG00000133116	Klotho	Q9UEF7	13	33016433-33066145	"Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins, Predicted secreted proteins, Transporters"		"Glycosidase, Hormone, Hydrolase"	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"kidney: 64.3;parathyroid gland: 76.9;placenta: 25.5"	"Cell type enriched"	"Detected in some"	6	"Proximal tubular cells: 99.7"	"Group enriched"	"Detected in many"	6	"prostate cancer: 5.9;renal cancer: 17.8"	"Region enhanced"	"Detected in some"		"pons and medulla: 11.6"	"Cell type enhanced"	"Detected in single"		"classical monocyte: 1.0"	"Low lineage specificity"	"Detected in single"			"Group enriched"	"Detected in some"	5	"HMC-1: 5.1;SK-BR-3: 9.6"	"Low region specificity"	"Detected in many"												"Secreted to blood"	NA	NA	510000					"unprognostic (1.32e-1)"	"unprognostic (3.10e-1)"	"unprognostic (2.35e-1)"	"unprognostic (2.73e-3)"	"unprognostic (3.37e-1)"	"unprognostic (1.15e-4)"	"unprognostic (3.06e-2)"	"unprognostic (6.50e-2)"	"unprognostic (2.22e-2)"	"unprognostic (2.60e-1)"	"prognostic favorable (4.44e-4)"	"unprognostic (9.46e-2)"	"prognostic favorable (1.29e-9)"	"unprognostic (4.76e-3)"	"unprognostic (1.91e-1)"	"unprognostic (2.86e-2)"	"unprognostic (1.07e-1)"	4.8	0.6	0.8	0.9	4.3	0.1	7.4	0.0	0.8	0.7	2.1	3.3	0.2	1.0	1.0	3.2	0.8	0.7	0.9	0.9	2.4	0.8	64.3	0.2	10.4	0.9	0.5	0.3	0.4	1.6	76.9	0.3	25.5	11.6	3.3	0.4	0.3	0.7	1.0	0.9	0.4	3.2	0.7	0.4	3.1	1.9	0.6	0.3	0.0	1.4	1.3	0.3	1.5	1.1	0.0	0.0	0.0	1.0	0.3	0.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.1	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	9.6	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.8	4.3	0.0	0.8	2.4	0.8	0.5	0.3	11.6	0.3	0.0	0.3	0.0	0.1	0.1	0.0	0.8	0.0	1.4	1.2	12.2	0.0	0.1	5.0	0.0	1.7	1.8	0.9	0.0	0.0	0.1	0.7	4.4	0.0	0.0	2.1	0.0	15.6	0.0	0.8	0.0	0.3	0.7	0.0	1.0	0.0	0.0	0.0	0.0	0.4	99.7	0.0	0.0	0.3	0.5	0.2	0.1	0.1	0.0	0.6	0.1
KLK1	Klk6	ENSG00000167748	"Kallikrein 1"	P06870	19	50819148-50823787	"Enzymes, FDA approved drug targets, Predicted secreted proteins"		"Hydrolase, Protease, Serine protease"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	56	"pancreas: 742.6;salivary gland: 473.0"	"Cell type enhanced"	"Detected in many"	19	"Exocrine glandular cells: 663.7;Mucus-secreting cells: 890.7;Pancreatic endocrine cells: 205.3"	"Group enriched"	"Detected in many"	6	"colorectal cancer: 20.0;pancreatic cancer: 50.9;renal cancer: 84.1"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	10	"memory B-cell: 10.9;naive B-cell: 3.8"	"Lineage enriched"	"Detected in single"	14	"B-cells: 10.9"	"Cell line enriched"	"Detected in some"	4	"RPMI-8226: 29.2"														"Secreted to digestive system"	NA	NA		4300000				"unprognostic (1.51e-3)"	"unprognostic (1.23e-2)"	"unprognostic (4.20e-1)"	"unprognostic (1.73e-2)"	"unprognostic (1.10e-1)"	"unprognostic (8.72e-2)"	"unprognostic (1.92e-2)"	"unprognostic (7.47e-3)"	"unprognostic (1.66e-1)"	"unprognostic (2.49e-2)"	"unprognostic (8.06e-2)"	"unprognostic (2.12e-1)"	"unprognostic (1.42e-2)"	"unprognostic (2.55e-1)"	"unprognostic (6.49e-2)"	"unprognostic (2.10e-1)"	"unprognostic (6.23e-2)"	0.1	0.2	0.1	0.3	0.1	0.0	0.1	0.1	0.1	0.2	2.5	0.1	0.1	0.2	0.2	0.1	0.1	0.1	0.1	0.1	0.1	0.0	3.8	0.1	0.1	0.1	0.1	0.1	0.1	742.6	0.0	0.1	0.1	0.1	0.2	1.9	0.1	473.0	0.1	0.1	1.8	0.6	0.1	0.1	0.3	0.1	0.1	0.1	0.1	1.2	0.2	0.2	0.1	0.1	10.9	0.7	0.1	0.3	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.6	0.3	0.2	0.2	0.3	1.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.4	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	6.6	0.0	0.0	0.0	29.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.6	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.3	0.0	10.9	0.0	0.0	0.2	3.8	0.0	0.0	0.1	0.0	0.2	0.7	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	1.1	17.9	1.4	17.3	0.0	0.3	0.0	0.0	1.2	0.0	0.0	0.0	38.1	2.8	0.4	0.1	46.5	0.0	663.7	0.0	1.6	15.7	9.2	0.0	0.6	0.0	112.7	0.0	0.8	0.0	5.8	2.9	5.0	9.0	890.7	0.0	205.3	113.2	0.0	0.2	0.0	0.0	0.1	0.3	0.7	47.2	0.0	0.0	128.7	3.4
KLK10	"NES1, PRSSL1"	ENSG00000129451	"Kallikrein related peptidase 10"	O43240	19	51012739-51020175	"Cancer-related genes, Enzymes, Predicted secreted proteins"	"Cell cycle"	"Hydrolase, Protease, Serine protease"	"Cancer-related genes, Tumor suppressor"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 78.6;lymphoid tissue: 58.6;tongue: 136.3"	"Cell type enhanced"	"Detected in many"	13	"Alveolar cells type 1: 29.8;Club cells: 77.3;Glandular cells: 41.6;Pancreatic endocrine cells: 43.5"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"neutrophil: 2.1"	"Low lineage specificity"	"Detected in single"			"Group enriched"	"Detected in some"	5	"CAPAN-2: 50.7;HaCaT: 76.9;OE19: 49.9"	"Region enriched"	"Detected in single"	4	"hippocampal formation: 1.7"	"Not detected"	"Not detected"								"Secreted in other tissues"	NA	NA		670000				"prognostic favorable (8.32e-4)"	"unprognostic (6.06e-2)"	"unprognostic (1.73e-1)"	"unprognostic (4.26e-3)"	"unprognostic (3.81e-2)"	"unprognostic (1.80e-1)"	"unprognostic (1.51e-2)"	"unprognostic (2.10e-2)"	"unprognostic (3.94e-1)"	"unprognostic (3.38e-2)"	"prognostic unfavorable (6.46e-5)"	"unprognostic (2.71e-2)"	"unprognostic (2.46e-6)"	"unprognostic (9.34e-2)"	"unprognostic (7.81e-2)"	"unprognostic (2.66e-3)"	"unprognostic (1.52e-2)"	1.5	0.5	0.2	1.7	0.3	0.3	2.4	0.7	0.4	20.8	0.9	0.3	0.5	0.2	2.9	0.8	78.6	7.8	36.0	0.7	0.2	0.5	0.2	0.3	4.3	0.2	0.2	0.3	7.2	0.2	0.0	0.2	0.8	0.6	1.6	0.4	0.3	11.0	0.6	0.4	17.7	0.4	0.4	0.4	0.2	0.5	1.6	0.2	1.0	0.3	136.3	58.6	0.5	33.4	0.4	0.5	2.1	0.4	0.4	0.3	0.1	11.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	50.7	0.0	2.8	0.0	0.0	76.9	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	49.9	0.2	0.0	0.0	0.0	4.5	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.3	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.3	0.2	0.3	0.2	0.3	0.2	0.3	0.2	0.1	0.4	0.3	0.3	2.1	0.4	0.4	0.5	0.3	0.1	0.2	0.3	0.7	0.4	0.2	0.5	0.2	0.3	0.6	0.2	29.8	1.6	0.0	13.6	6.6	0.6	0.4	7.6	10.7	77.3	0.0	0.0	0.0	0.0	3.4	0.2	0.3	0.0	0.0	14.1	0.0	0.5	41.6	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.4	10.6	1.1	0.0	1.0	0.0	0.2	43.5	0.0	5.6	0.0	0.4	0.0	0.9	0.9	1.2	3.8	0.0	0.0	0.0	18.7
KLK11	"PRSS20, TLSP"	ENSG00000167757	"Kallikrein related peptidase 11"	Q9UBX7	19	51022216-51028039	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"		"Hydrolase, Protease, Serine protease"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 103.4;lymphoid tissue: 88.5;salivary gland: 96.5"	"Cell type enhanced"	"Detected in many"	8	"Basal glandular cells: 141.1;Glandular cells: 237.5;Late spermatids: 257.5;Suprabasal keratinocytes: 189.7;Urothelial cells: 143.9"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in single"	11	"pons and medulla: 10.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"EFO-21: 9.6;HaCaT: 29.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			CAB026340	Approved				"Secreted in other tissues"	NA	NA		320000			"CAB026340: "	"unprognostic (4.23e-2)"	"unprognostic (1.50e-2)"	"unprognostic (1.27e-1)"	"prognostic favorable (3.78e-4)"		"unprognostic (2.08e-2)"	"unprognostic (4.67e-1)"	"unprognostic (5.32e-2)"	"unprognostic (3.72e-1)"	"unprognostic (3.02e-1)"	"prognostic unfavorable (4.17e-4)"	"unprognostic (2.92e-2)"	"unprognostic (4.16e-6)"	"unprognostic (3.90e-2)"	"unprognostic (2.73e-1)"	"unprognostic (4.40e-2)"	"unprognostic (2.53e-1)"	5.5	0.0	0.2	1.1	0.2	0.0	4.9	0.2	0.6	24.5	1.7	2.0	0.4	0.0	5.1	2.7	103.4	9.7	61.8	0.4	0.9	0.0	0.2	0.6	12.3	0.2	0.2	0.2	2.3	25.0	0.0	2.1	0.4	10.7	18.8	0.0	5.1	96.5	1.6	0.3	49.8	0.6	0.3	0.2	0.2	18.7	7.7	0.2	0.9	0.2	65.2	88.5	0.7	33.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	4.6	0.0	9.6	0.0	0.0	29.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.1	3.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.2	0.6	0.9	0.0	0.2	0.2	10.7	0.2	80.4	7.2	0.0	141.1	94.9	0.0	0.4	63.7	26.8	108.1	0.0	0.0	0.0	0.0	2.9	105.3	2.2	0.0	0.0	118.6	0.0	8.9	237.5	1.1	0.0	0.3	0.0	19.4	0.0	0.0	257.5	2.6	2.6	8.5	0.0	2.8	0.0	49.0	0.0	0.4	0.0	1.4	0.0	0.3	2.1	2.5	189.7	0.0	0.0	0.3	143.9
KLK12	KLK-L5	ENSG00000186474	"Kallikrein related peptidase 12"	Q9UKR0	19	51029092-51035230	"Enzymes, Predicted secreted proteins"		"Hydrolase, Protease, Serine protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"cervix, uterine: 27.6;esophagus: 53.9;lymphoid tissue: 24.7;tongue: 33.3;vagina: 24.8"	"Cell type enhanced"	"Detected in some"	19	"Early spermatids: 22.9;Intestinal endocrine cells: 38.5;Late spermatids: 21.2;Mucus-secreting cells: 8.4"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 17.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"CACO-2: 1.2;HaCaT: 2.0;U-698: 1.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			CAB025473	Uncertain				"Secreted in other tissues"	NA	NA					"CAB025473: "	"unprognostic (2.84e-1)"	"unprognostic (1.41e-1)"	"unprognostic (1.08e-3)"	"unprognostic (1.15e-1)"		"unprognostic (5.80e-3)"		"unprognostic (4.99e-3)"	"unprognostic (3.18e-1)"	"unprognostic (1.41e-1)"	"unprognostic (4.64e-2)"	"unprognostic (1.51e-1)"		"unprognostic (1.56e-1)"		"prognostic favorable (8.01e-4)"	"unprognostic (8.50e-3)"	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	27.6	2.0	0.0	0.0	3.6	1.2	0.2	53.9	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.3	0.7	0.0	16.6	0.0	0.0	0.4	4.3	0.1	0.2	0.0	0.4	0.5	0.0	0.2	0.0	33.3	24.7	0.0	24.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.3	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.1	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.2	0.0	0.0	0.2	0.0	2.7	1.2	0.0	0.0	0.0	0.0	0.0	22.9	0.0	0.2	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	38.5	0.0	0.0	21.2	0.0	0.0	0.0	0.0	8.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.7	1.8
KLK13	KLK-L4	ENSG00000167759	"Kallikrein related peptidase 13"	Q9UKR3	19	51056206-51065114	"Cancer-related genes, Enzymes, Predicted secreted proteins"		"Hydrolase, Protease, Serine protease"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"esophagus: 100.5"	"Cell type enriched"	"Detected in some"	7	"Late spermatids: 184.3"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 42.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	11	"HaCaT: 20.8"	"Not detected"	"Not detected"							HPA062136	Enhanced				"Secreted in other tissues"	NA	NA					"HPA062136: AB_2684694"	"unprognostic (1.99e-3)"	"unprognostic (1.89e-1)"	"unprognostic (1.25e-1)"	"unprognostic (3.66e-2)"		"unprognostic (3.43e-1)"		"unprognostic (2.99e-2)"	"unprognostic (1.69e-1)"	"unprognostic (6.76e-2)"	"unprognostic (2.18e-2)"	"unprognostic (8.30e-2)"	"unprognostic (7.07e-6)"	"unprognostic (7.33e-2)"	"unprognostic (2.53e-1)"	"unprognostic (6.38e-2)"	"unprognostic (7.06e-2)"	0.1	0.1	0.1	0.1	0.1	0.0	0.3	0.1	0.2	15.7	0.4	0.2	0.1	0.2	0.3	0.1	100.5	0.2	0.9	0.1	0.1	0.0	0.1	0.1	0.2	0.1	0.1	0.1	0.4	1.7	0.0	0.5	0.1	0.2	0.1	0.0	0.3	12.4	0.1	1.2	2.1	0.4	0.1	0.1	0.1	0.2	6.1	0.1	0.1	0.1	17.9	12.8	0.1	19.4	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	20.8	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.3	0.0	0.0	0.0	0.0	0.0	0.2	1.9	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.4	1.1	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.2	0.1	0.0	0.1	0.1	0.2	0.1	0.0	0.0	0.0	0.6	1.8	0.0	0.4	0.0	0.0	6.8	0.0	0.0	0.0	0.0	0.0	27.9	0.1	0.0	0.0	1.2	0.0	0.0	0.7	0.0	0.0	0.0	0.0	1.7	0.0	0.0	184.3	0.3	0.0	1.7	0.0	0.0	0.0	0.3	0.0	0.4	0.0	0.0	0.0	0.0	0.7	0.7	1.1	0.0	0.0	0.0	2.0
KLK14	KLK-L6	ENSG00000129437	"Kallikrein related peptidase 14"	Q9P0G3	19	51077495-51084245	"Cancer-related genes, Enzymes, Plasma proteins, Predicted secreted proteins"		"Hydrolase, Protease, Serine protease"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"skin 1: 14.2"	"Group enriched"	"Detected in some"	29	"Ciliated cells: 1.4;Club cells: 4.5"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 26.8"					"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HaCaT: 14.0;HEK 293: 4.0;U-266/84: 7.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			CAB026228	Uncertain				"Secreted in other tissues"	NA	NA					"CAB026228: "	"unprognostic (2.08e-1)"	"unprognostic (1.22e-1)"	"unprognostic (2.44e-2)"	"unprognostic (2.60e-2)"	"unprognostic (1.23e-1)"	"unprognostic (6.12e-2)"	"unprognostic (4.91e-2)"	"unprognostic (5.79e-2)"	"unprognostic (7.84e-2)"	"unprognostic (1.38e-1)"	"unprognostic (7.60e-2)"	"unprognostic (8.87e-2)"	"unprognostic (2.04e-8)"	"unprognostic (1.93e-1)"	"unprognostic (3.74e-3)"	"unprognostic (1.94e-2)"	"unprognostic (8.08e-2)"	0.2	0.0	0.4	0.2	1.2	0.1	2.7	2.1	0.9	3.8	0.6			1.8	0.4	0.9	1.2	0.8	0.3	1.1	0.6	0.5	0.1	0.1	0.5	0.4	0.3		0.9	0.4	0.0	0.3	0.0		0.7	0.4		1.1	0.7	0.3	14.2	1.0	0.0	0.3	0.4	0.8	0.7			0.1		0.6	0.2	3.9	0.0	0.0	0.3	0.1	0.0	0.0	0.0	1.8	0.8	0.1	1.0	0.7	0.6	0.8	0.2	0.0	0.0	0.2	1.7	2.1	0.8	0.6	0.3	0.4	14.0	0.2	0.3	0.0	0.5	4.0	0.3	1.0	0.0	0.2	0.3	0.3	0.4	0.4	0.5	0.6	0.2	0.2	0.6	0.3	0.5	0.0	1.2	0.2	0.8	0.8	1.6	1.5	0.2	0.1	0.8	0.0	0.7	0.1	0.0	0.3	1.3	0.4	0.4	0.6	0.0	0.0	0.2	0.6	0.9	0.2	3.7	7.3	0.5	0.2	0.3	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	4.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
KLK15	"ACO, HSRNASPH, prostinogen"	ENSG00000174562	"Kallikrein related peptidase 15"	Q9H2R5	19	50825289-50837213	"Cancer-related genes, Enzymes, Predicted intracellular proteins, Predicted secreted proteins"		"Hydrolase, Protease, Serine protease"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"intestine: 5.7;salivary gland: 9.7"	"Cell type enhanced"	"Detected in some"	19	"Late spermatids: 6.7;Mucus-secreting cells: 21.9;Spermatocytes: 14.7;Spermatogonia: 7.0"	"Cancer enhanced"	"Detected in some"		"prostate cancer: 3.5"					"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	5	"RPMI-8226: 7.3"	"Not detected"	"Not detected"							HPA019802	Uncertain				"Secreted to blood"	NA	NA					"HPA019802: AB_1852601"		"unprognostic (6.06e-2)"	"unprognostic (2.85e-1)"	"unprognostic (8.13e-2)"		"unprognostic (2.90e-1)"				"unprognostic (2.29e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.17e-1)"		"unprognostic (1.55e-1)"	"unprognostic (2.52e-1)"	"unprognostic (2.72e-2)"		0.0	2.4	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	5.7			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0		0.0	0.2	0.0	0.0	0.0		1.4	2.1		9.7	0.0	0.0	0.3	0.2	0.0	0.0	0.0	0.0	2.1			1.7		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.6	0.0	0.0	0.0	7.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.5	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	1.7	0.0	0.0	6.7	0.9	0.0	0.0	0.0	21.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.7	7.0	0.0	0.0	0.0	0.6	0.0
KLK2		ENSG00000167751	"Kallikrein related peptidase 2"	P20151	19	50861568-50880567	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"		"Hydrolase, Protease, Serine protease"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	29	"prostate: 163.5"	"Cell type enriched"	"Detected in some"	36	"Glandular cells: 729.8"	"Cancer enriched"	"Detected in some"	1666	"prostate cancer: 989.9"	"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BEWO: 5.0;NB-4: 10.2"									HPA000764	Supported				"Secreted in male reproductive system"	NA	NA					"HPA000764: AB_1079700"	"unprognostic (3.05e-2)"	"unprognostic (2.40e-1)"	"unprognostic (1.69e-1)"	"unprognostic (8.53e-2)"		"unprognostic (1.15e-1)"		"unprognostic (8.97e-2)"	"unprognostic (3.22e-1)"	"unprognostic (6.44e-2)"	"unprognostic (8.06e-2)"	"unprognostic (3.61e-1)"	"unprognostic (2.11e-3)"	"unprognostic (7.56e-2)"	"unprognostic (8.10e-2)"	"unprognostic (1.68e-1)"	"unprognostic (2.04e-1)"	0.0	0.1	0.0	0.1	0.0	1.1	0.2	0.0	0.6	0.0	0.0	0.0	0.6	0.1	0.1	0.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	163.5	0.0	0.1	2.3	0.0	0.2	0.0	0.1	0.2	0.0	0.0	0.0	0.6	0.0	0.0	1.1	0.0	0.0	0.2	0.0	2.2	1.9	5.7	2.2	1.6	1.3	0.5	1.7	1.1	0.6	1.6	0.0	0.9	5.0	0.5	0.3	0.2	0.2	0.6	0.8	1.8	0.2	0.0	0.8	2.0	0.2	0.0	0.3	1.7	1.1	0.0	1.3	0.4	0.0	0.3	3.1	0.5	0.3	0.3	0.4	0.5	0.0	1.1	1.5	2.0	0.3	1.8	1.2	10.2	1.1	1.7	0.0	0.9	0.0	2.9	0.0	1.7	0.9	1.6	0.3	1.4	1.3	0.2	1.3	0.4	0.8	1.3	1.9	4.9	1.7	1.8	3.2	0.8	1.9	1.7	1.4	0.9	2.2	1.6	1.2	1.0	1.0	1.0	0.8	1.0	0.5	2.2	0.8	1.3	5.7	1.6	0.8	1.9	0.4	0.5	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	13.7	0.2	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.1	0.0	729.8	0.0	0.0	0.1	0.0	0.0	0.0	0.0	3.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	20.4	5.0	0.6	0.0	0.0	0.0	9.2
KLK3	"APS, PSA"	ENSG00000142515	"Kallikrein related peptidase 3"	P07288	19	50854915-50860764	"Cancer-related genes, Enzymes, Plasma proteins, Predicted secreted proteins"		"Hydrolase, Protease, Serine protease"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	115	"prostate: 447.4"	"Cell type enriched"	"Detected in some"	62	"Glandular cells: 3142.6"	"Cancer enriched"	"Detected in some"	3905	"prostate cancer: 4241.6"	"Region enriched"	"Detected in single"	8	"cerebral cortex: 1.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	138	"BEWO: 22.4;NB-4: 18.9;RPMI-8226: 12.5;SH-SY5Y: 7.4;U-2197: 7.6"									"CAB000070, HPA000764"	Enhanced				"Secreted in male reproductive system"	NA	NA					"CAB000070: , HPA000764: AB_1079700"	"unprognostic (5.06e-3)"	"unprognostic (5.60e-2)"	"unprognostic (9.93e-2)"	"unprognostic (3.90e-2)"		"unprognostic (1.09e-2)"				"unprognostic (1.26e-2)"	"unprognostic (1.88e-2)"	"unprognostic (1.54e-1)"	"unprognostic (5.13e-3)"	"unprognostic (1.94e-1)"	"unprognostic (4.64e-1)"	"unprognostic (3.15e-1)"		0.1	0.3	0.0	0.1	0.0	0.0	0.7	0.0	1.0	0.1	0.1	0.0	0.2	0.1	0.1	0.5	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	447.4	0.0	0.1	3.8	1.3	0.0	0.0	0.1	0.3	0.0	0.0	0.0	1.0	0.0	0.1	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	22.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	18.9	0.0	0.0	0.0	0.0	0.0	12.5	0.0	0.0	0.0	7.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	50.4	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	3142.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	5.7	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	32.4
KLK4	"EMSP, EMSP1, KLK-L1, PRSS17, PSTS"	ENSG00000167749	"Kallikrein related peptidase 4"	Q9Y5K2	19	50906352-50910738	"Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins"	Biomineralization	"Hydrolase, Protease, Serine protease"	"Amelogenesis imperfecta, Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in some"	9	"prostate: 79.3"	"Cell type enriched"	"Detected in some"	23	"Glandular cells: 120.1"	"Cancer enriched"	"Detected in many"	55	"prostate cancer: 463.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"CAPAN-2: 8.0;HaCaT: 9.8;OE19: 8.8;SK-BR-3: 6.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA051839	Enhanced				"Secreted in male reproductive system"	NA	NA					"HPA051839: AB_2681632"	"unprognostic (3.58e-2)"	"unprognostic (2.26e-1)"	"unprognostic (1.23e-3)"	"unprognostic (1.66e-3)"	"unprognostic (3.11e-2)"	"unprognostic (4.35e-1)"	"unprognostic (3.18e-1)"	"unprognostic (6.66e-2)"	"unprognostic (9.69e-2)"	"unprognostic (8.23e-3)"	"unprognostic (1.26e-1)"	"unprognostic (1.07e-1)"	"unprognostic (4.20e-3)"	"unprognostic (3.27e-3)"	"unprognostic (2.21e-2)"	"unprognostic (1.64e-2)"	"unprognostic (1.34e-1)"	0.2	0.8	0.1	0.3	0.1	0.1	0.7	0.2	0.5	2.0	1.2	0.0	3.8	1.8	1.5	7.7	0.4	0.2	0.1	0.1	0.3	0.2	0.2	0.1	0.2	0.0	0.2	0.0	0.1	0.1	0.0	0.1	0.1	0.5	79.3	0.8	0.2	3.2	2.1	0.7	2.4	1.2	0.6	0.1	0.1	0.3	0.6	0.1	0.0	8.7	0.0	0.0	0.2	0.2	0.1	0.4	0.6	0.1	0.0	0.3	0.0	4.9	2.0	0.2	0.3	0.0	0.0	4.4	0.1	0.0	0.0	0.0	4.5	8.0	0.5	0.4	0.1	0.2	9.8	0.0	5.3	0.0	1.3	1.3	1.5	3.6	1.7	0.0	1.6	2.2	0.0	2.5	0.0	0.0	0.3	0.0	0.4	0.9	4.1	0.0	1.2	0.1	2.4	0.1	8.8	0.4	0.3	0.5	1.1	0.0	3.2	0.0	0.6	0.3	6.3	0.0	0.2	5.1	0.4	1.1	0.3	0.3	1.3	0.3	2.6	1.0	0.5	0.1	0.3	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.4	0.0	0.0	0.1	0.1	0.2	0.5	0.3	0.2	0.2	0.0	0.5	0.1	0.0	0.0	0.0	2.9	0.2	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.2	0.0	0.0	120.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	2.2	0.0	0.0	0.0	5.3	0.0	0.0	0.0	0.0	0.0	0.2	0.5	0.0	0.0	0.6	1.7
KLK5	"KLK-L2, SCTE"	ENSG00000167754	"Kallikrein related peptidase 5"	Q9Y337	19	50943303-50953093	"Cancer-related genes, Enzymes, Predicted secreted proteins"		"Hydrolase, Protease, Serine protease"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"skin 1: 69.2;tongue: 67.3"	"Group enriched"	"Detected in some"	5	"Early spermatids: 88.7;Late spermatids: 144.1"	"Cancer enhanced"	"Detected in many"		"ovarian cancer: 112.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	40	"A-431: 87.4;HaCaT: 85.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA014343, CAB025503, CAB026341"	Enhanced				"Secreted in other tissues"	NA	NA					"CAB025503: , CAB026341: , HPA014343: AB_1852603"	"unprognostic (3.19e-2)"	"unprognostic (1.06e-1)"		"prognostic unfavorable (2.33e-4)"	"unprognostic (4.30e-4)"	"unprognostic (3.01e-1)"		"prognostic unfavorable (9.79e-4)"	"unprognostic (3.04e-1)"	"unprognostic (3.05e-1)"	"unprognostic (1.70e-3)"	"unprognostic (2.21e-1)"		"unprognostic (2.76e-1)"	"unprognostic (2.53e-1)"	"unprognostic (9.16e-3)"	"prognostic unfavorable (3.85e-6)"	1.1	0.0	0.7	0.4	0.2	0.0	12.1	0.2	0.5	3.8	0.3	0.2	0.2	0.1	1.4	0.9	6.5	0.2	0.3	0.2	0.2	0.1	0.6	0.2	2.5	0.2	0.2	0.2	0.2	0.2	0.0	0.2	0.2	0.4	0.2	0.0	0.3	7.0	0.2	0.4	69.2	0.2	0.2	0.2	0.2	0.0	3.3	0.2	0.4	0.3	67.3	4.4	0.2	3.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	87.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	85.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.2	0.2	0.5	0.2	0.1	0.2	0.2	0.4	0.2	14.9	0.0	0.0	1.9	23.8	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	88.7	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	144.1	1.1	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	1.4	0.5	9.5	0.0	0.0	0.0	0.0
KLK6	"Bssp, Klk7, neurosin, PRSS18, PRSS9"	ENSG00000167755	"Kallikrein related peptidase 6"	Q92876	19	50958631-50969673	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"		"Hydrolase, Protease, Serine protease"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 97.6;esophagus: 48.9"	"Cell type enhanced"	"Detected in some"	22	"Collecting duct cells: 10.4;Early spermatids: 2.0;Late spermatids: 2.1;Pancreatic endocrine cells: 4.6;Urothelial cells: 2.7"	"Cancer enhanced"	"Detected in many"		"ovarian cancer: 131.3"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	8	"A-431: 70.0;CAPAN-2: 167.5"	"Region enhanced"	"Detected in many"		"pons and medulla: 175.6"	"Group enriched"	"Detected in many"	8	"midbrain: 106.3;pons and medulla: 164.1;thalamus: 62.4"	HPA051837			Supported	"Nucleoplasm,Nuclear membrane,Cytokinetic bridge"	"Secreted in other tissues"	Yes	No		6800000	Nucleoplasm	"Nuclear membrane, Cytokinetic bridge"	"HPA051837: "	"unprognostic (7.30e-2)"	"unprognostic (3.32e-1)"	"unprognostic (6.58e-2)"	"prognostic unfavorable (1.38e-5)"	"unprognostic (1.10e-1)"	"unprognostic (2.31e-1)"		"prognostic unfavorable (8.85e-4)"	"unprognostic (3.02e-1)"	"unprognostic (2.46e-1)"	"prognostic unfavorable (7.82e-4)"	"unprognostic (4.45e-1)"	"unprognostic (2.72e-2)"	"unprognostic (1.31e-1)"	"unprognostic (2.46e-1)"	"unprognostic (9.07e-2)"	"prognostic unfavorable (1.27e-4)"	0.9	0.9	9.7	0.9	23.5	0.9	6.5	3.3	42.2	10.0	1.0	82.0	0.0	1.1	2.0	1.2	48.9	24.6	3.8	0.9	20.1	11.8	9.0	0.9	0.9	0.9	46.1	14.9	0.9	0.9	0.9	0.2	0.9	44.3	1.0	0.9	0.0	5.9	2.8	0.9	2.9	0.9	1.0	97.6	5.1	1.0	1.5	32.6	0.0	0.9	15.7	28.1	0.9	5.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	70.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	8.3	167.5	0.0	1.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	15.4	0.2	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.6	2.3	0.1	0.2	0.0	0.1	6.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.7	23.5	3.3	23.1	20.1	11.8	46.1	14.9	44.3	32.6	0.0	0.0	0.0	0.5	0.0	0.0	0.2	0.0	0.0	0.0	10.4	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	2.1	0.3	0.0	0.0	0.0	0.0	0.0	4.6	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.2	0.0	0.0	2.7
KLK7	"PRSS6, SCCE"	ENSG00000169035	"Kallikrein related peptidase 7"	P49862	19	50976482-50984099	"Cancer-related genes, Enzymes, Predicted intracellular proteins, Predicted secreted proteins"		"Hydrolase, Protease, Serine protease"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"esophagus: 29.1;skin 1: 77.5;tongue: 90.2"	"Cell type enhanced"	"Detected in some"	20	"Alveolar cells type 1: 6.0;Basal keratinocytes: 4.4;Suprabasal keratinocytes: 9.4"	"Cancer enhanced"	"Detected in many"		"ovarian cancer: 139.8"	"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in some"	6	"CAPAN-2: 6.7;HaCaT: 26.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA018994, CAB026342, HPA062126"	Enhanced		Supported	"Nuclear membrane,Plasma membrane"	"Secreted in other tissues"	NA	NA		960000	"Plasma membrane"	"Nuclear membrane"	"CAB026342: , HPA018994: AB_1852607, HPA062126: AB_2684691"	"unprognostic (1.88e-2)"	"unprognostic (6.41e-2)"	"unprognostic (8.57e-2)"	"prognostic unfavorable (8.06e-5)"	"unprognostic (4.33e-3)"	"unprognostic (2.28e-1)"		"unprognostic (4.44e-3)"	"unprognostic (2.99e-1)"	"unprognostic (1.31e-1)"	"prognostic unfavorable (1.16e-4)"	"unprognostic (2.10e-1)"	"unprognostic (2.82e-3)"	"unprognostic (3.25e-1)"	"unprognostic (4.47e-2)"	"unprognostic (1.12e-2)"	"unprognostic (5.60e-3)"	2.1	0.3	5.4	0.3	4.3	0.4	5.6	0.5	11.3	5.4	0.3	0.0	0.0	0.5	0.7	0.3	29.1	7.8	3.3	0.2	4.8	0.5	2.6	0.2	1.6	0.3	0.3	3.5	1.0	0.2	0.2	0.1	0.5	4.2	0.3	0.2	0.0	7.4	0.3	0.6	77.5	0.3	0.4	0.3	0.5	0.4	0.3	0.0	0.0	0.4	90.2	15.3	0.2	9.0	1.1	0.4	1.3	0.8	2.1	1.0	0.6	2.7	0.0	0.0	0.2	0.0	0.0	1.3	0.0	0.0	0.0	0.0	1.5	6.7	0.0	1.0	0.0	0.1	26.6	0.0	0.9	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.2	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.1	0.1	0.2	0.3	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.2	0.0	0.1	0.0	0.1	0.1	1.3	0.8	0.4	0.4	0.4	0.7	0.6	0.6	0.4	0.4	1.1	1.0	0.9	0.9	2.1	0.4	0.4	0.7	0.6	5.4	4.3	0.5	11.3	4.8	0.5	0.3	3.5	4.2	0.0	6.0	0.6	0.0	0.1	4.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	9.4	0.0	0.0	0.0	1.8
KLK8	"HNP, neuropsin, ovasin, PRSS19, TADG14"	ENSG00000129455	"Kallikrein related peptidase 8"	O60259	19	50996007-51002711	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"		"Hydrolase, Protease, Serine protease"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 43.6;skin 1: 40.4;tongue: 46.9"	"Group enriched"	"Detected in some"	13	"Basal keratinocytes: 58.6;Suprabasal keratinocytes: 157.5"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 29.9;ovarian cancer: 30.7"	"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	7	"A-431: 32.2;CAPAN-2: 42.3;HaCaT: 31.2"	"Region enriched"	"Detected in many"	5	"hippocampal formation: 39.6"					"CAB019393, HPA035761"	Enhanced		Approved	Vesicles	"Secreted in other tissues"	NA	NA		950000	Vesicles		"CAB019393: , HPA035761: AB_2674769"	"unprognostic (4.27e-3)"	"unprognostic (2.59e-1)"	"unprognostic (2.54e-1)"	"prognostic unfavorable (2.31e-4)"		"unprognostic (5.46e-2)"		"prognostic unfavorable (5.72e-4)"	"unprognostic (2.95e-1)"	"unprognostic (9.02e-2)"	"prognostic unfavorable (1.10e-4)"			"unprognostic (4.29e-2)"	"unprognostic (4.66e-2)"	"unprognostic (1.54e-1)"	"prognostic unfavorable (6.17e-4)"	1.6	0.0	0.1	0.4	0.1	0.0	4.5	1.0	0.3	8.1	0.7	0.1	0.1	0.0	1.1	0.7	43.6	6.7	0.3	0.1	0.1	0.0	0.2	0.1	0.1	0.1	0.1	0.1	1.1	0.1	0.0	0.1	0.4	0.6	0.3	0.0	0.3	6.0	0.1	0.3	40.4	0.1	0.1	0.6	0.3	0.0	0.7	0.1	0.5	0.3	46.9	11.1	0.3	13.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	32.2	0.0	0.0	0.2	0.0	0.0	4.7	0.0	0.0	0.0	0.0	0.6	42.3	0.0	0.8	0.0	0.0	31.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	3.8	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	1.0	0.3	0.1	0.0	0.1	0.1	0.6	0.1	0.0	0.0	0.0	0.0	58.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	3.4	1.7	0.0	8.5	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.6	3.4	157.5	0.0	0.0	0.0	0.1
KLK9	KLK-L3	ENSG00000213022	"Kallikrein related peptidase 9"	Q9UKQ9	19	51003111-51009634	"Cancer-related genes, Enzymes, Predicted secreted proteins"		"Hydrolase, Protease, Serine protease"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"tongue: 37.6"	"Not detected"	"Not detected"			"Cancer enriched"	"Detected in single"	6	"head and neck cancer: 0.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	28	"HaCaT: 1.2;HBEC3-KT: 4.2"									CAB025049	Enhanced				"Secreted to digestive system"	NA	NA					"CAB025049: "						"unprognostic (3.22e-2)"												0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	4.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	8.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	37.6	3.8	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	4.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
KLKB1	KLK3	ENSG00000164344	"Kallikrein B1"	P03952	4	186208979-186258471	"Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Blood coagulation, Fibrinolysis, Hemostasis, Inflammatory response"	"Hydrolase, Protease, Serine protease"	"Disease mutation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	76	"liver: 102.9"	"Cell type enriched"	"Detected in some"	11	"Hepatocytes: 203.0"	"Cancer enriched"	"Detected in some"	17	"liver cancer: 27.6"	"Low region specificity"	"Detected in single"			"Cell type enriched"	"Detected in single"	7	"gdT-cell: 1.3"	"Lineage enriched"	"Detected in single"	8	"T-cells: 1.3"	"Cell line enhanced"	"Detected in some"		"NTERA-2: 7.3;SCLC-21H: 5.0;SK-MEL-30: 2.2;U-937: 2.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"								"Secreted to blood"	NA	NA	28900000000	4900000000				"unprognostic (4.80e-2)"	"unprognostic (4.53e-3)"	"unprognostic (4.36e-2)"	"unprognostic (4.17e-2)"	"unprognostic (5.93e-2)"	"unprognostic (1.90e-2)"	"unprognostic (1.15e-2)"	"unprognostic (2.83e-1)"	"unprognostic (8.14e-2)"	"unprognostic (1.35e-1)"	"unprognostic (1.38e-2)"	"unprognostic (1.15e-1)"	"unprognostic (1.45e-2)"	"unprognostic (6.01e-2)"	"unprognostic (7.30e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.59e-2)"	0.3	0.3	0.8	0.3	1.2	0.0	0.3	0.7	0.5	0.3	0.4	0.3	0.3	0.7	0.4	0.4	0.3	0.2	0.7	0.5	0.6	0.5	1.3	102.9	0.3	0.3	0.5	0.5	0.3	1.3	0.5	1.0	0.4	0.4	0.3	0.3	0.5	0.3	0.3	0.5	0.1	0.6	0.3	0.3	0.5	0.0	0.3	0.3	0.4	0.3	0.3	0.4	0.3	0.3	0.1	0.1	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.2	0.8	0.2	0.0	0.0	0.0	0.2	0.0	0.4	0.3	0.3	0.0	0.2	0.2	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.2	0.0	0.0	0.0	0.1	0.0	0.6	0.0	0.2	0.0	0.0	0.4	0.0	7.3	0.1	0.0	0.1	0.0	0.2	1.3	0.0	5.0	0.4	0.2	0.0	2.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.1	0.0	0.0	0.0	1.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.8	1.2	0.7	0.5	0.6	0.5	0.5	0.5	0.4	0.3	0.0	0.0	0.0	0.0	0.0	4.2	3.9	17.8	1.4	0.0	1.8	15.7	0.0	0.0	1.1	2.2	0.4	0.2	0.0	0.5	0.0	0.0	0.0	0.0	203.0	0.2	0.0	2.9	5.5	3.2	0.8	0.6	0.0	0.0	0.0	0.3	14.6	0.7	0.3	0.0	0.9	3.6	0.0	0.2	1.4	0.9	0.0	0.0	0.0	0.4	0.0
KMO		ENSG00000117009	"Kynurenine 3-monooxygenase"	O15229	1	241532134-241595642	"Enzymes, Predicted membrane proteins"	"Pyridine nucleotide biosynthesis"	"Monooxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"blood: 20.3;liver: 58.6;placenta: 26.0"	"Cell type enhanced"	"Detected in many"	23	"Hepatocytes: 43.2;Proximal tubular cells: 45.1;Syncytiotrophoblasts: 150.6"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	79	"classical monocyte: 5.2;intermediate monocyte: 14.7;memory B-cell: 16.1;myeloid DC: 5.3;naive B-cell: 20.3;non-classical monocyte: 14.7;plasmacytoid DC: 11.1"	"Group enriched"	"Detected in many"	97	"B-cells: 20.3;dendritic cells: 11.1;monocytes: 14.7"	"Cell line enhanced"	"Detected in some"		"Daudi: 5.4;RPMI-8226: 7.8;RPTEC TERT1: 20.0;SK-BR-3: 10.4;U-698: 8.3"	"Region enriched"	"Detected in single"	4	"thalamus: 1.3"	"Not detected"	"Not detected"			"HPA031115, HPA056942"	Enhanced					NA	NA					"HPA031115: AB_10601924, HPA056942: AB_2683281"	"unprognostic (4.27e-2)"	"unprognostic (3.35e-2)"	"unprognostic (3.95e-2)"	"unprognostic (7.48e-3)"	"unprognostic (8.37e-3)"	"unprognostic (2.63e-1)"	"unprognostic (9.79e-2)"	"unprognostic (3.65e-1)"	"unprognostic (2.42e-1)"	"unprognostic (4.75e-3)"	"unprognostic (8.07e-2)"	"unprognostic (1.47e-1)"	"prognostic unfavorable (6.49e-8)"	"unprognostic (1.60e-2)"	"unprognostic (3.65e-2)"	"unprognostic (3.36e-2)"	"unprognostic (6.81e-2)"	3.7	0.6	0.5	3.3	0.6	0.3	2.4	0.2	0.9	0.3	0.4	0.2	0.0	0.0	2.7	0.1	0.3	0.4	0.5	0.4	0.8	0.4	14.2	58.6	6.5	3.2	0.3	0.3	0.4	0.3	0.0	0.4	26.0	0.3	0.4	0.3	0.3	0.5	0.0	0.2	0.3	1.0	0.1	0.5	8.0	0.4	0.6	0.1	0.7	0.4	0.1	4.5	1.4	0.3	20.3	11.1	0.1	14.7	0.0	0.0	2.8	0.1	1.6	0.1	0.0	0.0	0.2	0.2	0.1	0.1	0.2	0.4	0.0	0.2	5.4	0.4	0.0	0.1	2.2	0.0	0.2	0.0	0.9	0.0	0.0	0.1	0.1	0.0	0.5	0.2	0.2	0.7	0.1	0.1	0.5	0.0	0.4	0.1	0.8	0.0	0.2	0.0	2.3	0.9	0.8	0.4	1.4	0.1	7.8	20.0	4.1	0.3	0.1	0.0	10.4	0.0	2.1	4.0	1.7	0.0	0.0	0.1	0.1	1.4	0.3	0.5	8.3	0.2	2.0	1.6	0.0	5.2	0.1	0.0	14.7	0.0	16.1	0.0	0.0	5.3	20.3	0.0	0.0	0.1	0.0	14.7	11.1	0.0	2.8	0.5	0.6	0.2	0.9	0.8	0.4	0.3	0.3	0.3	0.1	0.0	0.3	22.3	0.0	0.9	0.0	0.4	2.5	0.0	0.0	0.0	0.0	3.0	5.0	2.2	3.5	0.0	0.0	0.0	0.2	1.6	0.5	0.3	0.0	43.2	7.1	0.0	0.0	1.3	17.4	0.4	0.0	18.4	0.0	3.6	0.0	0.0	2.5	0.0	0.0	45.1	0.0	0.0	0.0	0.5	0.1	1.3	150.6	0.0	0.0	0.0
KMT2A	"ALL-1, CXXC7, HRX, HTRX1, MLL, MLL1A, TRX1"	ENSG00000118058	"Lysine methyltransferase 2A"	Q03164	11	118436490-118526832	"Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transcription factors"	"Apoptosis, Biological rhythms, Transcription, Transcription regulation"	"Chromatin regulator, DNA-binding, Methyltransferase, Transferase"	"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB017794, CAB024270, HPA044910"	Enhanced		Supported	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"CAB017794: , CAB024270: , HPA044910: AB_2679141"	"unprognostic (6.80e-2)"	"unprognostic (8.93e-2)"	"unprognostic (1.83e-1)"	"unprognostic (4.56e-1)"	"unprognostic (4.96e-2)"	"unprognostic (1.72e-3)"	"unprognostic (4.52e-3)"	"unprognostic (6.07e-2)"	"unprognostic (1.61e-1)"	"unprognostic (8.46e-2)"	"unprognostic (3.21e-1)"	"unprognostic (1.16e-1)"	"unprognostic (5.91e-3)"	"unprognostic (7.90e-2)"	"unprognostic (3.73e-1)"	"unprognostic (1.67e-1)"	"unprognostic (1.02e-1)"	14.4	11.3	17.7	17.0	19.2	28.6	16.8	43.8	21.2	17.3	14.6	19.8	18.1	8.5	21.8	17.1	10.6	15.7	14.1	10.2	17.3	13.4	13.1	9.3	15.3	19.6	16.6	18.7	35.6	16.8	28.9	21.8	10.2	15.4	15.6	12.4	14.4	14.2	19.2	11.1	16.8	14.2	15.2	12.1	15.7	12.3	7.9	23.4	16.6	16.6	7.8	19.4	18.8	24.6	6.7	3.5	8.3	2.0	6.5	5.3	0.8	12.1	5.6	15.2	11.4	9.3	11.1	4.5	5.5	8.0	5.8	6.7	11.3	8.8	15.0	11.3	8.0	10.3	10.6	16.1	6.1	11.6	16.5	6.2	29.4	5.2	6.1	5.2	17.5	5.7	5.3	6.2	12.7	17.0	7.3	9.0	9.8	19.1	12.8	7.3	9.5	11.6	10.3	9.2	5.0	8.4	8.8	14.6	5.0	8.5	9.2	12.5	8.1	13.8	4.5	2.9	8.3	7.8	5.9	13.2	9.9	9.0	7.2	9.8	3.7	2.9	10.1	3.7	12.9	5.9	8.3	2.0	4.6	5.3	1.3	4.3	6.2	4.8	4.6	0.8	6.7	4.9	4.8	1.3	6.5	1.4	3.5	3.9	0.8	17.7	19.2	43.8	21.2	17.3	13.4	16.6	18.7	15.4	23.4	65.5	59.8	31.5	64.8	77.2	147.8	34.4	38.2	53.5	35.2	36.6	143.3	12.2	3.3	26.8	6.6	70.1	19.7	0.0	22.3	8.1	43.5	71.4	26.7	23.1	14.2	184.3	63.8	45.4	32.6	4.7	61.9	26.1	40.5	33.3	29.3	117.0	23.2	14.4	73.9	6.9	144.6	64.7	59.7	11.1	14.9	70.4	5.0	50.7	27.3	49.9
KMT2B	"CXXC10, HRX2, KIAA0304, MLL1B, MLL2, MLL4, TRX2, WBP7"	ENSG00000272333	"Lysine methyltransferase 2B"	Q9UMN6	19	35718019-35738878	"Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Chromatin regulator, DNA-binding, Methyltransferase, Transferase"	"Cancer-related genes, Disease mutation, Dystonia"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Bipolar cells: 61.2;Rod photoreceptor cells: 74.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"neutrophil: 3.2"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA006487			Approved	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA006487: AB_1080587"	"unprognostic (1.09e-2)"	"unprognostic (3.53e-2)"	"unprognostic (3.41e-2)"	"unprognostic (7.95e-2)"	"unprognostic (9.92e-2)"	"unprognostic (3.53e-3)"	"unprognostic (2.33e-2)"	"unprognostic (4.57e-2)"	"unprognostic (7.28e-2)"	"unprognostic (2.07e-2)"	"unprognostic (3.13e-3)"	"unprognostic (2.63e-3)"	"unprognostic (9.47e-3)"	"unprognostic (2.10e-1)"	"unprognostic (2.37e-1)"	"unprognostic (3.77e-2)"	"unprognostic (2.24e-2)"	10.2	9.3	11.4	14.2	13.1	18.4	10.4	23.9	11.4	10.0	12.0	14.2	12.9	13.8	13.0	7.1	11.4	11.6	12.6	7.5	11.0	5.3	9.9	8.9	10.6	14.7	14.7	6.8	15.3	19.6	10.8	13.3	9.3	11.2	12.1	5.6	13.8	14.7	10.0	13.3	19.9	12.3	12.2	12.4	15.8	12.1	21.5	14.9	14.1	14.9	7.0	14.2	12.4	14.2	0.4	0.7	3.2	0.7	2.1	0.7	0.2	11.5	19.5	9.0	9.9	4.7	4.6	9.4	5.6	4.1	5.7	4.4	13.0	5.9	10.3	8.8	4.6	6.1	7.6	8.1	4.8	2.5	15.2	9.0	18.5	9.1	6.5	4.6	11.2	21.2	6.2	6.5	5.8	6.4	5.1	5.5	10.7	15.4	12.9	3.7	11.8	9.5	9.7	8.3	10.0	6.9	15.0	5.9	5.6	3.1	10.3	10.2	8.2	8.5	13.8	5.9	5.0	8.4	12.0	7.7	11.4	12.4	7.6	11.8	17.8	10.9	8.2	6.2	10.4	7.9	1.0	0.7	0.6	0.7	0.4	0.4	0.3	0.2	0.3	0.2	0.4	0.3	0.4	3.2	2.1	0.3	0.7	0.2	0.2	11.4	13.1	23.9	11.4	11.0	5.3	14.7	6.8	11.2	14.9	8.9	19.1	13.3	8.5	11.3	61.2	7.7	10.2	4.0	5.7	8.7	49.1	5.2	0.0	5.5	2.1	11.7	14.0	0.0	6.7	4.9	8.1	13.1	4.7	9.7	7.3	33.4	19.4	11.6	8.7	4.1	7.5	6.4	5.0	6.4	10.4	27.2	7.1	11.4	11.7	4.2	74.2	0.0	8.2	28.1	36.4	11.3	7.9	10.2	11.3	12.8
KMT2C	"HALR, KIAA1506, MLL3"	ENSG00000055609	"Lysine methyltransferase 2C"	Q8NEZ4	7	152134922-152436005	"Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Activator, Acyltransferase, Chromatin regulator, DNA-binding, Methyltransferase, Transferase"	"Cancer-related genes, Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA074736			Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA074736: AB_2686709"	"unprognostic (7.75e-2)"	"unprognostic (3.10e-1)"	"unprognostic (2.83e-1)"	"unprognostic (1.33e-2)"	"unprognostic (1.31e-1)"	"unprognostic (5.23e-3)"	"unprognostic (1.09e-1)"	"unprognostic (1.59e-2)"	"unprognostic (1.01e-1)"	"unprognostic (1.17e-1)"	"unprognostic (3.45e-1)"	"unprognostic (1.06e-1)"	"prognostic favorable (8.01e-6)"	"unprognostic (1.78e-1)"	"unprognostic (3.83e-1)"	"unprognostic (3.04e-2)"	"unprognostic (2.64e-1)"	13.9	12.6	11.7	16.7	18.6	29.7	14.5	24.8	14.1	18.4	12.6	15.5	21.4	9.7	20.2	20.6	14.4	12.8	12.7	10.8	13.4	9.5	10.3	11.4	13.0	12.1	17.7	9.4	18.8	18.4	18.8	18.9	38.0	12.6	14.0	11.8	12.6	15.8	22.9	30.3	25.2	13.1	13.6	16.0	14.6	14.9	13.6	19.6	22.6	16.9	9.3	16.8	17.8	31.6	5.6	3.5	16.1	3.9	5.5	2.9	0.6	9.7	4.9	9.1	9.7	16.5	10.0	10.7	5.1	3.9	4.1	5.0	9.3	5.9	15.5	7.4	9.2	5.6	5.6	9.8	7.4	6.9	9.8	5.0	9.2	7.4	6.4	8.0	15.5	11.3	8.4	10.3	5.8	7.8	6.6	5.8	8.1	14.8	13.4	8.9	13.6	11.2	14.1	5.5	7.6	4.9	7.6	8.3	8.1	7.0	10.0	13.3	10.5	8.4	15.0	5.5	9.9	4.9	12.8	7.3	6.8	3.6	7.3	7.2	14.1	6.9	16.7	8.9	12.8	7.0	8.8	3.5	4.3	2.1	2.2	2.9	5.6	1.7	1.7	1.7	3.8	2.7	1.8	16.1	5.5	3.9	3.5	1.3	0.6	11.7	18.6	24.8	14.1	13.4	9.5	17.7	9.4	12.6	19.6	71.5	66.6	54.7	36.1	79.1	82.8	58.2	45.9	44.2	92.1	43.6	163.0	29.7	5.0	30.2	18.6	49.2	41.0	23.3	28.7	45.7	47.0	48.1	62.5	36.6	29.6	76.3	65.1	41.7	48.8	11.0	62.5	61.0	40.5	25.2	44.5	62.2	33.0	43.8	56.6	15.7	75.2	25.8	50.1	33.5	31.5	84.2	106.4	50.4	30.3	55.0
KMT2D	"ALR, CAGL114, MLL2, MLL4, TNRC21"	ENSG00000167548	"Lysine methyltransferase 2D"	O14686	12	49018975-49059774	"Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Chromatin regulator, Methyltransferase, Transferase"	"Cancer-related genes, Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Cone photoreceptor cells: 49.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"neutrophil: 5.9"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA035977	Approved		Approved	"Nucleoplasm,Plasma membrane,Cytosol"		Yes	No			"Plasma membrane, Cytosol"	Nucleoplasm	"HPA035977: AB_10670673"	"unprognostic (8.33e-2)"	"unprognostic (1.49e-1)"	"unprognostic (9.14e-2)"	"unprognostic (2.52e-1)"	"unprognostic (8.07e-2)"	"unprognostic (6.91e-3)"	"unprognostic (7.35e-2)"	"unprognostic (2.29e-1)"	"unprognostic (3.57e-1)"	"unprognostic (5.14e-2)"	"unprognostic (7.23e-2)"	"unprognostic (3.07e-1)"	"unprognostic (1.68e-2)"	"unprognostic (7.10e-2)"	"unprognostic (1.87e-1)"	"unprognostic (3.20e-2)"	"unprognostic (7.60e-2)"	12.1	7.6	4.9	6.7	10.8	26.1	6.8	11.7	10.5	9.5	6.5	5.8	13.0	5.5	15.7	7.4	8.8	8.9	5.8	9.1	6.1	3.5	6.2	6.5	22.9	9.6	6.7	3.3	9.7	11.6	13.3	9.2	12.9	13.7	6.7	6.6	9.8	7.6	8.0	16.1	13.6	9.4	7.1	9.1	13.6	8.3	7.3	5.7	6.2	11.0	6.1	7.6	7.0	6.3	2.0	2.2	5.9	0.5	1.5	0.8	0.6	17.1	16.3	16.5	13.3	17.1	11.5	17.7	9.1	9.5	11.8	6.3	28.6	7.3	17.8	11.8	12.7	8.5	11.6	21.7	10.0	9.8	10.4	17.4	22.6	17.1	15.3	11.7	26.8	22.7	9.7	14.4	16.5	17.1	14.1	17.5	18.5	28.3	9.9	13.3	18.9	13.3	25.0	15.6	23.7	14.1	20.0	10.2	6.4	9.9	19.0	13.8	11.7	14.0	13.8	9.5	15.0	13.7	23.5	23.3	9.3	16.6	8.1	15.2	14.1	9.1	17.3	10.7	13.9	6.9	0.6	0.5	3.0	0.8	0.2	0.4	0.3	0.3	0.5	0.3	2.0	0.3	0.8	5.9	1.5	0.1	2.2	0.0	0.6	4.9	10.8	11.7	10.5	6.1	3.5	6.7	3.3	13.7	5.7	8.9	18.4	11.1	6.5	12.5	25.2	4.7	12.7	5.3	9.1	17.4	49.1	6.6	1.7	5.8	2.5	12.6	11.1	0.0	5.2	4.6	8.5	8.3	8.1	12.3	8.3	20.6	12.6	17.2	19.7	1.1	8.9	9.6	10.1	4.6	10.5	5.2	7.2	8.6	10.3	4.3	38.9	6.5	3.3	3.7	3.2	15.4	9.5	10.4	10.1	8.4
KMT5A	"PR-Set7, SET07, SET8, SETD8"	ENSG00000183955	"Lysine methyltransferase 5A"	Q9NQR1	12	123383773-123409358	"Enzymes, Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis, Transcription, Transcription regulation"	"Chromatin regulator, Methyltransferase, Repressor, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA064495			Supported	Nucleoplasm,Cytosol		NA	Yes			Nucleoplasm	Cytosol	"HPA064495: AB_2685273"	"unprognostic (5.62e-2)"	"unprognostic (4.45e-2)"	"unprognostic (3.90e-1)"	"unprognostic (3.04e-1)"	"unprognostic (2.20e-2)"	"unprognostic (1.73e-1)"	"prognostic unfavorable (6.21e-7)"	"unprognostic (3.88e-3)"	"unprognostic (1.06e-2)"	"unprognostic (1.64e-2)"	"unprognostic (6.13e-2)"	"unprognostic (3.44e-1)"	"unprognostic (4.75e-3)"	"unprognostic (4.27e-2)"	"unprognostic (1.30e-1)"	"unprognostic (4.39e-2)"	"unprognostic (1.06e-1)"	7.6	5.4	8.9	14.0	7.5	20.2	7.9	9.8	14.1	13.9	9.1	9.9	21.4	7.3	15.7	9.5	22.3	12.3	8.3	10.9	8.1	5.5	6.7	7.4	8.7	8.4	7.8	10.6	7.2	13.1	6.8	7.4	9.9	12.8	18.6	9.1	7.9	19.3	12.5	13.6	15.6	9.1	11.0	10.3	13.3	9.0	5.2	8.6	42.2	17.2	8.9	19.7	12.3	14.2	3.5	3.8	7.8	3.8	4.1	5.4	0.6	12.4	7.9	9.5	14.6	6.1	10.9	13.0	18.6	8.9	10.8	9.5	9.0	7.3	28.7	10.8	12.3	4.0	11.6	13.6	6.8	11.6	12.1	14.1	24.1	8.3	4.5	9.1	18.7	6.1	4.6	8.6	11.7	10.9	10.4	8.8	12.3	43.6	13.4	8.8	9.0	18.9	27.9	4.4	11.3	9.0	22.5	8.1	7.8	7.5	15.2	13.0	10.2	18.5	9.4	8.5	8.8	13.1	23.9	11.2	12.2	8.9	14.5	13.3	7.5	7.8	26.3	8.4	9.8	10.2	4.1	2.5	7.8	2.8	3.8	5.4	3.5	3.3	4.3	2.0	2.3	1.8	2.3	3.4	4.1	3.6	3.8	2.7	0.6	8.9	7.5	9.8	14.1	8.1	5.5	7.8	10.6	12.8	8.6	11.9	12.6	0.0	14.2	0.0	19.6	0.0	5.1	21.4	12.5	26.2	5.9	10.7	6.6	8.0	7.4	11.3	8.5	0.0	8.1	13.9	8.7	20.1	2.3	13.4	15.1	3.2	4.7	28.8	17.1	2.1	15.0	10.3	0.0	1.0	28.5	22.4	11.3	10.5	40.3	8.3	16.8	6.5	0.0	8.9	11.7	0.0	11.9	8.2	12.4	19.3
KMT5B	"CGI-85, SUV420H1"	ENSG00000110066	"Lysine methyltransferase 5B"	Q4FZB7	11	68154863-68213828	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Myogenesis, Transcription, Transcription regulation"	"Chromatin regulator, Methyltransferase, Repressor, Transferase"	"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"SK-MEL-30: 52.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA063648			Supported	Nucleoplasm		NA	NA			Nucleoplasm		"HPA063648: AB_2685073"	"unprognostic (5.82e-2)"	"unprognostic (4.25e-2)"	"unprognostic (2.54e-1)"	"unprognostic (5.36e-3)"	"unprognostic (3.52e-1)"	"unprognostic (2.94e-1)"	"unprognostic (1.83e-2)"	"unprognostic (1.08e-1)"	"unprognostic (3.16e-2)"	"unprognostic (1.71e-1)"	"unprognostic (5.54e-2)"	"unprognostic (1.21e-1)"	"unprognostic (3.79e-3)"	"unprognostic (2.62e-1)"	"unprognostic (4.26e-2)"	"unprognostic (3.21e-2)"	"prognostic favorable (9.30e-4)"	17.6	19.1	20.9	23.4	22.5	23.7	27.3	38.8	26.7	22.4	21.2	19.9	32.3	21.8	26.2	22.7	19.7	20.4	18.2	15.1	23.8	15.3	19.1	21.5	17.4	16.9	18.6	22.2	27.4	24.0	27.4	28.1	26.6	17.0	24.9	21.5	15.4	25.2	30.4	18.8	20.8	24.0	23.4	18.4	19.6	19.7	19.1	23.6	38.0	30.9	17.5	19.1	20.5	22.5	4.5	5.5	16.0	5.2	8.9	5.9	2.7	10.3	7.8	16.0	10.3	3.7	9.4	17.3	7.5	5.2	9.3	5.5	24.6	16.6	8.5	13.0	10.1	9.2	5.4	11.0	8.6	13.6	9.5	6.4	8.0	9.2	10.1	13.6	11.2	11.0	9.3	17.8	11.2	11.8	8.6	9.2	8.5	11.8	9.9	7.9	21.3	7.9	11.8	17.1	20.7	5.9	13.1	12.5	22.6	6.9	10.0	14.0	16.7	11.5	11.6	52.3	9.1	14.9	7.4	9.6	12.6	16.8	9.6	7.5	12.7	5.5	17.9	7.9	7.1	13.4	7.8	3.7	16.0	4.7	5.2	3.3	3.4	5.1	5.7	3.6	4.5	5.9	5.2	11.3	8.9	4.8	5.5	4.0	2.7	20.9	22.5	38.8	26.7	23.8	15.3	18.6	22.2	17.0	23.6	56.6	48.3	13.8	31.8	0.0	45.8	0.0	22.9	58.9	46.6	24.4	11.8	24.2	18.3	24.2	13.7	24.8	22.7	0.0	28.3	24.3	18.6	34.9	20.9	32.7	15.6	60.4	24.6	25.2	31.0	17.2	25.9	18.9	0.0	34.3	38.9	26.9	30.1	24.6	29.7	19.2	39.1	32.3	0.0	34.9	59.5	0.0	43.3	17.5	31.2	40.1
KMT5C	"MGC2705, SUV420H2"	ENSG00000133247	"Lysine methyltransferase 5C"	Q86Y97	19	55339853-55348120	"Enzymes, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Chromatin regulator, Methyltransferase, Repressor, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Bipolar cells: 47.4;Cone photoreceptor cells: 47.1;Horizontal cells: 63.5;Rod photoreceptor cells: 46.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"HEK 293: 16.6;SCLC-21H: 16.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA052294	Uncertain		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA052294: AB_2681788"	"unprognostic (4.02e-2)"	"unprognostic (3.45e-2)"	"unprognostic (2.92e-3)"	"unprognostic (6.77e-3)"	"unprognostic (2.48e-1)"	"unprognostic (8.27e-2)"	"unprognostic (2.29e-2)"	"unprognostic (1.27e-1)"	"unprognostic (8.69e-2)"	"unprognostic (3.04e-1)"	"unprognostic (9.48e-3)"	"unprognostic (1.49e-2)"	"prognostic unfavorable (1.05e-8)"	"unprognostic (7.39e-2)"	"unprognostic (2.96e-1)"	"unprognostic (9.41e-2)"	"unprognostic (2.39e-2)"	5.0	5.6	8.5	7.3	15.7	13.4	5.4	20.0	10.7	5.1	7.5	11.2	4.9	11.9	7.0	5.4	4.6	11.0	7.4	4.2	11.2	4.5	5.1	4.4	5.5	4.6	17.1	5.3	6.1	8.5	6.2	11.7	6.5	9.6	6.6	3.8	6.3	7.7	6.3	6.6	13.5	8.5	3.6	6.2	6.2	9.8	7.0	14.7	10.1	5.1	2.3	3.5	6.3	4.6	0.3	0.8	0.9	0.6	1.1	0.8	0.3	5.0	3.5	3.3	2.8	0.7	0.9	9.3	1.4	0.6	0.5	1.3	2.2	4.3	5.0	1.8	1.1	0.2	2.8	2.1	1.8	0.6	4.5	16.6	4.0	2.5	2.2	1.2	2.3	4.8	0.8	2.5	1.7	0.9	0.7	1.1	5.5	9.8	2.8	0.6	5.8	6.6	5.2	6.0	3.0	5.2	9.8	3.9	4.9	0.8	1.3	16.2	6.9	0.7	3.7	2.0	1.9	4.2	2.9	1.2	1.6	4.0	0.5	1.0	8.3	4.1	3.2	0.8	5.6	2.2	0.3	0.6	0.3	0.7	0.4	0.0	0.1	0.5	0.7	0.6	0.3	0.3	0.8	0.9	1.1	0.0	0.8	0.2	0.3	8.5	15.7	20.0	10.7	11.2	4.5	17.1	5.3	9.6	14.7	6.0	5.5	1.9	11.9	0.0	47.4	0.0	10.2	6.7	5.7	3.5	47.1	25.7	1.7	5.8	1.6	2.2	8.4	23.3	2.6	16.4	3.1	9.2	2.3	1.0	8.3	63.5	7.0	4.9	3.1	1.5	6.9	4.9	0.0	1.0	14.9	28.9	6.1	15.3	6.0	2.1	46.0	6.5	0.0	8.4	11.1	0.0	16.6	9.6	13.3	9.8
KSR1	"KSR, RSU2"	ENSG00000141068	"Kinase suppressor of ras 1"	Q8IVT5	17	27456470-27626438	"Enzymes, Predicted intracellular proteins, RAS pathway related proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"pancreas: 57.7"	"Cell type enhanced"	"Detected in many"	8	"Cone photoreceptor cells: 68.7;Late spermatids: 33.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"eosinophil: 7.0"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 89.7;HEL: 32.2;HMC-1: 22.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009623, HPA011215"	Uncertain					NA	NA					"CAB009623: AB_2265455, HPA011215: AB_1852649"	"unprognostic (2.03e-2)"	"unprognostic (2.74e-1)"	"unprognostic (2.60e-1)"	"unprognostic (3.48e-3)"	"unprognostic (2.90e-1)"	"unprognostic (6.98e-2)"	"unprognostic (1.92e-5)"	"unprognostic (8.36e-3)"	"unprognostic (1.32e-1)"	"unprognostic (3.15e-2)"	"unprognostic (1.12e-3)"	"unprognostic (1.65e-1)"	"prognostic unfavorable (6.54e-4)"	"unprognostic (1.00e-1)"	"unprognostic (7.55e-2)"	"unprognostic (1.74e-2)"	"unprognostic (9.61e-2)"	10.5	9.3	15.3	12.5	16.0	9.5	7.7	20.5	18.5	15.5	6.1	20.5	7.0	5.4	17.9	7.0	15.5	9.3	21.2	7.0	17.5	7.0	12.4	3.8	12.4	8.6	18.3	12.5	14.4	57.7	7.3	8.9	29.4	16.2	7.9	5.9	19.8	4.7	13.4	17.5	13.8	7.6	13.7	12.0	12.2	5.1	11.5	19.9	5.2	16.3	3.3	9.4	8.9	13.5	0.9	1.1	7.0	4.1	1.5	1.1	0.7	1.0	4.2	2.6	1.3	2.2	1.6	15.4	0.9	2.1	1.4	1.7	12.7	0.1	1.0	2.2	1.8	9.8	0.6	2.6	0.5	0.9	89.7	2.8	32.2	4.1	5.2	3.9	0.4	22.2	1.9	0.9	4.2	0.1	6.1	8.1	1.4	16.8	0.1	0.8	1.0	0.4	1.2	1.9	0.9	0.7	2.0	14.6	0.7	6.0	0.7	4.1	2.7	5.2	1.2	1.4	7.3	0.1	1.7	7.6	0.4	2.0	1.2	0.7	0.1	0.0	0.0	0.4	1.8	2.4	0.0	1.9	7.0	0.7	4.1	0.7	0.9	0.3	0.4	1.1	0.4	0.2	0.2	2.2	1.5	2.0	0.1	1.1	0.7	15.3	16.0	20.5	18.5	17.5	7.0	18.3	12.5	16.2	19.9	6.0	4.3	1.4	3.5	2.7	12.4	1.1	0.0	17.4	14.8	14.0	68.7	15.9	3.3	1.4	26.8	7.0	4.9	0.0	4.5	17.5	9.9	1.2	0.0	1.0	5.7	9.5	6.3	12.3	6.5	33.8	1.4	5.3	8.5	5.4	1.3	7.1	2.4	3.5	2.1	2.5	28.7	0.0	3.4	2.1	5.3	5.3	16.2	5.7	0.6	7.1
KSR2	FLJ25965	ENSG00000171435	"Kinase suppressor of ras 2"	Q6VAB6	12	117453012-117968983	"Enzymes, Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"brain: 27.4;pituitary gland: 24.6"	"Cell type enhanced"	"Detected in many"	21	"Bipolar cells: 48.8;Collecting duct cells: 153.5;Cone photoreceptor cells: 37.3;Horizontal cells: 44.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HUVEC TERT2: 7.3;SCLC-21H: 5.4;TIME: 11.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA035536	Enhanced					NA	NA					"HPA035536: AB_10673485"	"unprognostic (1.74e-2)"	"unprognostic (4.21e-2)"	"unprognostic (2.38e-1)"	"unprognostic (2.29e-2)"	"unprognostic (9.11e-2)"	"unprognostic (8.42e-2)"	"unprognostic (6.91e-3)"	"unprognostic (1.10e-2)"	"unprognostic (5.78e-2)"	"unprognostic (5.80e-2)"	"unprognostic (2.05e-4)"	"unprognostic (1.19e-1)"	"unprognostic (9.28e-3)"	"unprognostic (5.02e-2)"	"unprognostic (5.68e-2)"	"unprognostic (8.14e-3)"	"unprognostic (5.74e-2)"	0.9	5.0	13.2	1.1	13.8	1.1	1.7	27.4	17.2	1.0	1.9	1.3	2.2	1.0	0.8	2.6	0.9	1.7	1.0	0.8	12.9	4.8	3.5	0.8	1.2	1.6	2.2	10.8	0.8	3.0	0.9	24.6	0.9	7.7	1.3	2.3	0.2	1.2	3.4	0.9	1.0	1.0	0.9	2.9	1.0	1.7	3.2	3.0	0.0	3.8	0.0	1.5	2.3	0.5	0.1	0.2	0.8	0.1	0.2	0.1	0.0	0.1	0.7	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.1	0.1	1.1	0.0	0.2	0.2	0.0	0.0	0.0	0.5	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.3	2.2	0.0	0.0	0.0	1.6	0.1	0.0	0.5	0.1	1.2	0.0	0.0	0.1	0.7	1.5	5.4	0.1	0.0	0.0	0.0	0.1	1.1	0.0	11.0	0.0	0.8	0.0	0.2	0.9	1.5	0.0	0.5	0.0	0.1	0.5	0.1	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.8	0.2	0.1	0.2	0.0	0.0	13.2	13.8	27.4	17.2	12.9	4.8	2.2	10.8	7.7	3.0	0.0	0.0	0.5	1.1	0.2	48.8	2.0	2.5	0.0	0.0	153.5	37.3	0.5	0.0	1.6	8.4	0.3	0.0	0.0	1.4	0.3	0.0	1.3	0.0	0.0	0.1	44.5	19.7	0.0	0.0	9.4	0.0	0.0	0.0	0.0	8.2	2.3	0.4	1.1	0.0	0.5	28.3	0.0	0.0	0.2	1.7	0.3	0.2	0.0	2.8	1.0
KYAT1	"CCBL1, GTK, KATI"	ENSG00000171097	"Kynurenine aminotransferase 1"	Q16773	9	128832942-128882494	"Enzymes, Predicted intracellular proteins"		"Aminotransferase, Lyase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"	11	"Ciliated cells: 5.3;Cytotrophoblasts: 3.4;Distal tubular cells: 3.3;Proximal tubular cells: 6.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021176, HPA021177, HPA027736"	Approved		Supported	Cytosol		NA	NA		21000	Cytosol		"HPA021176: AB_1846120, HPA021177: AB_1846119, HPA027736: AB_10611818"	"unprognostic (6.51e-2)"	"unprognostic (8.67e-3)"	"unprognostic (1.05e-2)"	"unprognostic (5.98e-3)"	"unprognostic (2.15e-2)"	"unprognostic (5.44e-2)"	"unprognostic (2.91e-2)"	"unprognostic (1.12e-2)"	"unprognostic (2.47e-1)"	"unprognostic (8.60e-3)"	"unprognostic (1.43e-1)"	"unprognostic (3.65e-2)"	"unprognostic (3.10e-2)"	"unprognostic (5.79e-2)"	"unprognostic (2.03e-1)"	"unprognostic (1.08e-1)"	"unprognostic (1.98e-1)"	4.4	5.2	12.2	5.1	18.9	3.9	7.0	17.8	17.6	4.7	3.8	14.2	5.5	4.1	5.5	5.4	4.6	8.5	4.8	13.5	12.1	9.3	8.1	12.0	4.1	7.3	18.4	12.1	7.1	5.0	8.9	8.1	4.5	12.2	8.9	2.7	5.8	7.0	8.4	17.0	12.2	4.8	5.8	10.2	5.8	4.0	6.9	17.2	3.7	7.5	2.8	7.4	8.1	8.1	12.1	7.6	3.5	5.1	4.6	9.6	4.9	3.8	8.7	8.0	7.9	7.2	9.1	4.1	5.2	6.1	5.2	7.8	4.8	7.1	7.3	2.6	3.9	6.5	12.4	11.8	10.2	6.7	8.2	8.2	4.8	21.2	8.7	6.5	4.6	2.0	4.0	6.5	6.8	6.5	17.5	9.1	18.5	7.3	6.4	6.8	2.5	10.6	3.1	14.0	15.0	6.8	12.7	6.9	13.7	7.1	1.6	8.5	7.3	8.4	2.1	4.8	10.3	5.1	1.7	6.0	3.9	6.8	5.9	4.6	11.9	10.1	9.1	7.5	7.2	3.1	0.1	3.1	3.3	7.8	2.2	6.2	12.1	8.1	8.1	7.6	5.8	8.6	9.6	3.5	4.6	5.1	4.8	8.7	4.9	12.2	18.9	17.8	17.6	12.1	9.3	18.4	12.1	12.2	17.2	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	5.3	1.2	0.0	0.0	3.4	3.3	1.5	0.0	0.0	0.0	0.0	0.2	2.1	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	6.2	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0
KYAT3	"CCBL2, KAT3, KATIII, RBM1, RP11-82K18.3"	ENSG00000137944	"Kynurenine aminotransferase 3"	Q6YP21	1	88935773-88992953	"Enzymes, Predicted intracellular proteins"		"Aminotransferase, Lyase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	8	"Cytotrophoblasts: 59.0;monocytes: 55.9;Syncytiotrophoblasts: 69.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA026538, HPA027168"	Enhanced		Approved	"Nucleoli,Cytokinetic bridge,Cytosol"		NA	NA			Cytosol	"Nucleoli, Cytokinetic bridge"	"HPA026538: AB_1852076, HPA027168: AB_1852078"	"prognostic favorable (3.19e-5)"	"unprognostic (3.36e-3)"	"unprognostic (1.88e-2)"	"unprognostic (1.62e-1)"	"unprognostic (2.01e-2)"	"prognostic favorable (1.86e-4)"	"unprognostic (2.61e-1)"	"unprognostic (3.61e-3)"	"unprognostic (2.11e-1)"	"prognostic favorable (2.80e-4)"	"unprognostic (1.04e-1)"	"unprognostic (3.17e-1)"	"prognostic favorable (5.02e-6)"	"unprognostic (1.17e-1)"	"unprognostic (1.06e-1)"	"unprognostic (2.51e-1)"	"unprognostic (2.78e-1)"	22.2	26.8	16.6	13.2	19.3	10.6	27.5	14.9	23.5	23.7	17.5	20.0	13.0	19.4	24.1	21.2	27.2	18.9	17.8	13.2	18.6	14.2	27.3	23.8	17.1	17.6	16.9	22.2	27.4	28.6	27.0	19.5	21.9	23.4	19.0	19.6	19.5	21.0	20.7	10.4	22.0	17.2	22.1	14.8	20.7	23.5	15.6	17.2	15.5	24.5	13.4	20.2	25.2	17.7	9.6	17.0	9.2	12.7	11.5	16.7	8.2	20.8	4.4	21.4	7.1	7.7	21.5	18.6	12.8	24.2	16.5	21.5	6.4	7.3	13.8	9.8	9.5	11.0	5.9	6.0	9.9	25.2	8.1	8.6	12.3	4.2	10.5	25.1	17.2	3.4	18.1	10.0	11.3	20.4	10.5	15.9	16.2	15.9	7.3	15.5	6.9	18.4	8.4	12.7	16.1	3.8	18.8	15.0	7.3	34.6	21.3	15.6	19.1	17.0	22.8	11.1	14.3	12.6	4.2	10.6	6.9	4.6	22.1	9.3	9.9	4.9	9.2	3.4	7.7	5.9	5.6	12.7	7.1	9.1	7.9	12.6	9.6	11.8	10.5	17.0	9.3	12.4	10.4	9.2	11.5	10.2	6.3	16.7	8.2	16.6	19.3	14.9	23.5	18.6	14.2	16.9	22.2	23.4	17.2	11.9	8.3	0.0	0.0	0.0	0.0	0.0	0.0	6.7	14.8	12.2	0.0	59.0	21.6	29.8	0.0	0.0	0.0	0.0	33.6	33.1	0.0	0.0	4.7	0.0	21.4	0.0	0.0	0.0	0.0	0.0	0.0	5.7	0.0	55.9	0.0	0.0	21.3	0.0	0.0	26.9	0.0	0.0	0.0	0.0	0.0	0.0	69.8	0.0	0.0	0.0
KYNU		ENSG00000115919	Kynureninase	Q16719	2	142877498-143055832	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Pyridine nucleotide biosynthesis"	Hydrolase	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 35.9;liver: 41.1;placenta: 34.3"	"Cell type enhanced"	"Detected in many"	18	"Macrophages: 94.5;monocytes: 360.7;Syncytiotrophoblasts: 87.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	18	"classical monocyte: 28.7;intermediate monocyte: 35.9;memory B-cell: 19.7;myeloid DC: 28.4;naive B-cell: 12.7;non-classical monocyte: 29.2;plasmacytoid DC: 19.9"	"Group enriched"	"Detected in many"	21	"B-cells: 19.7;dendritic cells: 28.4;monocytes: 35.9"	"Cell line enhanced"	"Detected in some"		"A549: 37.9;GAMG: 62.8;HeLa: 42.3;Hep G2: 25.7;hTEC/SVTERT24-B: 22.2;U-87 MG: 66.4"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			HPA031686	Enhanced		Supported	Nucleoplasm,Cytosol		NA	NA		360000	Cytosol	Nucleoplasm	"HPA031686: AB_2673995"	"unprognostic (2.58e-2)"	"unprognostic (3.39e-3)"	"unprognostic (1.21e-2)"	"unprognostic (5.94e-2)"	"unprognostic (1.65e-2)"	"unprognostic (9.04e-2)"	"unprognostic (5.36e-3)"	"unprognostic (3.58e-3)"	"unprognostic (4.88e-2)"	"unprognostic (3.35e-2)"	"unprognostic (2.87e-3)"	"unprognostic (1.51e-1)"	"unprognostic (1.40e-3)"	"unprognostic (3.33e-3)"	"unprognostic (3.65e-2)"	"unprognostic (5.24e-2)"	"unprognostic (1.64e-1)"	9.0	3.7	2.2	11.0	3.7	3.9	15.4	0.6	1.7	3.0	1.2	1.3	0.8	0.2	1.1	2.6	5.6	1.5	4.4	3.8	1.4	1.1	8.4	41.1	12.7	13.7	2.9	0.4	1.7	1.0	0.2	1.6	34.3	2.7	1.9	1.2	1.5	3.0	0.8	0.7	1.5	2.7	2.0	6.3	16.0	2.4	7.0	2.6	2.7	2.2	1.7	13.0	12.4	2.6	19.7	28.4	1.3	35.9	0.4	0.1	11.1	0.0	37.9	0.1	0.1	0.0	0.1	0.1	0.0	1.0	0.0	0.0	0.6	0.5	2.2	0.1	0.0	62.8	0.1	0.0	0.0	0.0	0.1	0.0	0.8	42.3	25.7	0.5	0.1	0.2	3.6	3.1	22.2	0.1	0.0	0.0	0.0	0.1	0.2	0.3	19.3	0.0	2.3	0.1	0.0	0.1	0.0	0.2	0.1	0.6	19.6	0.1	0.0	21.0	3.1	0.2	0.2	10.5	5.4	0.3	1.2	0.1	18.5	0.0	0.1	0.0	0.0	66.4	4.4	0.1	0.1	28.7	0.5	0.1	35.9	0.1	19.7	0.1	0.1	28.4	12.7	0.1	0.0	1.3	0.4	29.2	19.9	0.1	11.1	2.2	3.7	0.6	1.7	1.4	1.1	2.9	0.4	2.7	2.6	3.0	2.4	22.6	0.5	3.5	0.1	1.2	5.1	2.7	10.3	3.5	3.9	2.8	5.0	12.1	34.6	2.9	0.0	0.0	7.8	1.5	3.3	0.8	0.0	44.8	38.5	9.5	0.0	3.1	59.7	39.6	1.7	94.5	1.7	360.7	0.0	0.2	37.4	0.0	0.4	23.0	0.5	6.5	1.3	40.0	8.0	2.8	87.5	0.0	0.0	4.2
L2HGDH	"C14orf160, FLJ12618"	ENSG00000087299	"L-2-hydroxyglutarate dehydrogenase"	Q9H9P8	14	50237563-50312548	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		Oxidoreductase	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Alveolar cells type 1: 38.7;Cone photoreceptor cells: 53.0;Rod photoreceptor cells: 40.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"basophil: 10.5"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA065409, HPA069708"	Approved		Enhanced	Mitochondria		NA	NA			Mitochondria		"HPA065409: AB_2685485, HPA069708: AB_2686179"	"unprognostic (1.74e-1)"	"unprognostic (1.15e-2)"	"unprognostic (1.13e-2)"	"unprognostic (1.23e-3)"	"unprognostic (1.04e-2)"	"unprognostic (4.33e-2)"	"unprognostic (8.84e-2)"	"unprognostic (1.58e-2)"	"unprognostic (4.17e-2)"	"unprognostic (9.91e-2)"	"unprognostic (2.84e-1)"	"unprognostic (1.97e-1)"	"prognostic favorable (9.75e-10)"	"unprognostic (1.24e-2)"	"unprognostic (5.88e-2)"	"unprognostic (1.45e-1)"	"unprognostic (1.02e-2)"	5.4	5.1	6.9	3.6	8.4	3.5	5.1	12.7	10.9	3.5	5.6	4.9	4.8	6.2	3.4	4.3	9.0	4.4	3.2	7.7	6.1	4.7	25.5	16.0	2.5	3.3	7.7	4.7	4.2	5.4	7.1	5.8	2.6	5.7	4.6	6.8	7.7	5.0	5.6	17.7	7.0	5.0	4.7	5.3	2.3	5.6	6.0	6.0	3.7	6.5	6.2	5.2	4.6	4.4	1.4	1.5	10.5	0.6	2.4	3.3	0.8	14.0	9.9	4.1	3.9	2.0	1.3	11.5	4.7	2.6	7.4	8.8	15.8	6.5	11.0	5.5	1.9	5.9	10.3	12.3	4.9	8.3	8.8	7.0	23.9	6.8	2.2	1.9	8.4	8.3	1.2	3.1	4.9	4.3	1.8	3.2	11.5	8.3	7.0	1.9	16.9	9.5	3.8	5.9	12.0	10.5	9.0	13.3	8.6	6.9	16.5	8.4	6.0	13.8	10.5	6.0	5.7	13.8	2.3	2.9	4.7	13.2	5.4	6.2	6.4	14.5	15.6	2.6	4.3	5.2	10.5	0.6	1.4	1.5	0.3	3.3	1.4	1.7	1.6	0.9	1.2	2.1	2.6	0.9	2.4	0.3	1.5	2.4	0.8	6.9	8.4	12.7	10.9	6.1	4.7	7.7	4.7	5.7	6.0	38.7	16.3	4.4	2.3	3.3	15.6	12.6	0.0	32.1	35.2	12.2	53.0	4.7	13.3	3.5	21.5	2.1	4.7	0.0	3.8	5.8	2.1	2.4	17.4	13.9	1.9	11.1	7.5	3.1	1.5	5.6	2.3	1.4	1.7	2.8	5.3	6.1	2.4	2.9	4.2	18.5	40.7	0.0	2.1	11.6	10.6	5.5	4.1	3.3	6.8	1.8
L3HYPDH	"C14orf149, FLJ25436"	ENSG00000126790	"Trans-L-3-hydroxyproline dehydratase"	Q96EM0	14	59460363-59484430	"Enzymes, Predicted intracellular proteins"		Lyase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Ciliated cells: 26.8;Proximal tubular cells: 31.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA056694	Approved		Uncertain	Vesicles		NA	NA		16000	Vesicles		"HPA056694: AB_2683210"	"unprognostic (3.39e-2)"	"unprognostic (5.55e-3)"	"unprognostic (3.81e-2)"	"unprognostic (5.86e-2)"	"unprognostic (1.10e-1)"	"unprognostic (5.06e-2)"	"unprognostic (8.34e-2)"	"unprognostic (1.16e-1)"	"unprognostic (7.24e-2)"	"unprognostic (9.50e-2)"	"unprognostic (1.26e-3)"	"unprognostic (6.60e-2)"	"prognostic unfavorable (1.72e-9)"	"unprognostic (1.16e-1)"	"unprognostic (2.22e-1)"	"unprognostic (1.05e-1)"	"unprognostic (1.14e-1)"	17.9	15.4	13.5	13.5	17.1	4.9	22.8	10.4	16.5	12.6	9.9	18.5	10.9	12.3	17.6	10.3	9.8	16.3	13.2	15.9	13.6	7.2	20.2	17.4	11.5	18.5	22.7	9.6	20.1	12.8	23.1	22.5	11.9	18.2	15.5	12.0	12.9	13.6	15.5	8.7	11.0	13.7	14.0	18.4	14.3	11.0	18.9	17.4	6.6	17.9	9.9	15.0	12.7	18.7	2.3	7.9	0.8	7.0	7.0	5.1	2.5	6.0	16.6	3.6	8.5	7.8	20.7	5.0	16.5	13.2	9.6	9.4	3.3	11.1	2.1	7.0	9.1	17.0	16.6	5.8	8.9	9.5	3.5	7.5	5.7	14.5	12.0	8.8	5.0	4.0	14.9	6.1	9.6	14.9	15.0	11.7	5.9	7.4	9.7	9.9	7.3	1.9	8.3	5.8	2.4	15.0	2.8	5.8	8.4	15.3	3.5	3.7	5.3	15.6	6.5	5.9	3.1	6.8	3.3	16.3	11.2	13.7	8.7	19.3	2.5	1.1	2.0	19.3	4.3	21.9	0.0	5.0	0.8	5.1	7.0	3.4	2.3	2.5	3.0	7.9	2.2	3.9	1.4	0.0	7.0	3.2	4.3	1.1	2.5	13.5	17.1	10.4	16.5	13.6	7.2	22.7	9.6	18.2	17.4	3.0	6.7	3.2	5.1	4.6	3.0	7.5	5.1	26.8	5.7	3.5	2.0	10.8	6.6	6.2	6.8	6.7	2.0	0.0	2.1	9.5	9.7	2.6	13.9	13.1	7.1	1.6	2.9	11.1	3.5	6.8	17.8	3.0	3.3	0.0	3.6	4.0	4.2	0.0	11.3	31.2	2.1	12.9	9.2	13.4	5.1	3.0	4.1	3.9	3.1	0.9
LACTB	"FLJ14902, MRPL56"	ENSG00000103642	"Lactamase beta"	P83111	15	63121800-63142061	"Enzymes, Predicted intracellular proteins"	"Lipid metabolism"	"Hydrolase, Protease"	"Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"monocytes: 175.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036361, HPA036362"	Supported		Supported	Mitochondria	"Intracellular and membrane"	NA	NA			Mitochondria		"HPA036361: AB_10672244, HPA036362: AB_10670798"	"unprognostic (6.07e-2)"	"unprognostic (2.02e-1)"	"unprognostic (2.22e-2)"	"unprognostic (2.87e-1)"	"unprognostic (1.20e-2)"	"unprognostic (3.10e-2)"	"unprognostic (8.08e-2)"	"unprognostic (6.25e-2)"	"unprognostic (8.98e-2)"	"unprognostic (3.08e-1)"	"unprognostic (6.22e-3)"	"unprognostic (5.16e-3)"	"unprognostic (6.28e-2)"	"unprognostic (3.24e-1)"	"unprognostic (8.64e-2)"	"unprognostic (7.90e-2)"	"unprognostic (3.88e-3)"	26.5	22.7	9.2	13.1	12.2	31.5	9.3	7.3	9.1	6.8	11.4	6.3	4.0	12.5	7.0	6.9	9.8	5.7	9.2	24.9	7.9	6.1	20.5	38.3	18.8	12.9	8.5	6.1	7.2	9.3	6.7	10.4	7.4	9.5	7.6	10.4	5.8	9.3	4.7	37.3	10.1	19.6	8.1	8.0	21.6	8.3	13.2	9.8	8.3	8.4	11.1	9.0	11.5	12.8	3.3	10.4	5.8	8.9	2.3	3.1	2.0	21.5	13.6	3.9	2.7	19.6	10.6	3.3	9.5	14.6	16.3	30.4	3.4	13.9	2.9	11.7	13.7	17.7	6.1	13.1	6.1	20.5	19.8	3.2	5.6	4.6	8.5	18.3	5.0	9.7	14.3	13.1	16.7	13.8	24.4	16.7	17.0	5.3	8.2	27.5	8.2	3.8	6.0	5.8	13.2	4.2	2.8	10.0	6.6	8.8	33.9	3.5	1.6	6.8	7.7	20.4	14.2	5.8	8.3	29.9	22.0	17.2	9.8	11.9	8.6	7.6	0.7	16.8	14.2	10.0	3.6	8.8	4.6	1.3	8.9	2.0	3.3	1.1	1.0	10.4	2.9	1.0	1.6	5.8	2.3	7.6	0.9	3.1	2.0	9.2	12.2	7.3	9.1	7.9	6.1	8.5	6.1	9.5	9.8	23.8	19.9	13.7	23.6	51.7	5.9	40.8	17.8	9.4	7.9	12.2	11.8	13.0	21.6	45.5	42.5	22.5	20.6	0.0	37.1	32.4	22.4	24.9	64.7	50.3	87.0	7.9	7.0	9.2	54.2	26.0	13.3	86.6	25.3	175.9	24.0	5.8	61.1	20.1	15.2	52.5	10.6	6.5	32.5	93.3	10.6	52.4	15.1	15.8	15.3	33.8
LAP3	"LAP, LAPEP, PEPS"	ENSG00000002549	"Leucine aminopeptidase 3"	P28838	4	17577192-17607972	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Aminopeptidase, Hydrolase, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Hofbauer cells: 227.4;monocytes: 251.5;Proximal tubular cells: 217.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029606, HPA029607"	Enhanced		Supported	Nucleoplasm,Midbody,Cytosol		Yes	No		4100000	Cytosol	"Nucleoplasm, Midbody"	"HPA029606: AB_10599288, HPA029607: AB_10611381"	"unprognostic (2.10e-2)"	"unprognostic (1.01e-1)"	"unprognostic (6.95e-3)"	"unprognostic (1.46e-1)"	"unprognostic (1.26e-1)"	"unprognostic (2.87e-1)"	"unprognostic (2.16e-1)"	"unprognostic (1.55e-1)"	"unprognostic (5.33e-2)"	"unprognostic (1.44e-3)"	"unprognostic (2.61e-3)"	"unprognostic (1.17e-1)"	"unprognostic (4.29e-3)"	"unprognostic (1.73e-1)"	"unprognostic (3.28e-2)"	"unprognostic (3.06e-1)"	"unprognostic (8.79e-2)"	42.5	29.7	23.2	43.9	38.5	18.1	30.7	8.5	23.5	13.3	21.0	23.5	12.3	27.5	17.2	20.8	19.3	18.7	24.3	25.4	24.4	17.0	71.7	70.3	39.4	54.2	33.7	16.1	13.5	14.7	23.5	13.2	25.0	34.9	15.3	22.7	15.0	23.0	12.1	33.3	20.9	30.6	26.9	35.0	54.9	20.8	19.3	30.7	19.9	29.4	21.7	32.1	24.4	23.7	7.5	45.7	9.5	46.1	11.8	12.9	25.3	10.9	9.6	9.2	8.7	18.3	22.3	0.1	17.3	19.5	62.9	76.5	17.5	20.9	43.2	11.5	13.3	37.5	6.8	34.5	12.2	24.0	16.4	9.9	23.9	10.6	22.8	21.3	21.5	15.4	22.7	7.8	20.6	10.9	7.2	21.8	11.4	23.1	30.9	14.8	11.8	19.1	29.5	19.2	20.6	18.4	29.7	8.8	21.8	16.4	12.9	13.6	11.2	15.8	9.8	33.8	13.3	8.3	8.3	14.1	16.0	10.8	16.8	30.0	28.4	43.4	37.3	21.6	35.9	15.4	8.4	43.4	9.5	8.0	46.1	7.4	7.5	7.5	8.5	45.7	5.2	6.5	6.8	6.2	11.8	31.9	25.9	12.9	25.3	23.2	38.5	8.5	23.5	24.4	17.0	33.7	16.1	34.9	30.7	26.8	44.7	44.2	21.0	19.6	8.0	43.2	10.2	46.8	26.1	26.2	2.0	31.2	99.5	46.8	71.4	104.1	38.5	0.0	96.6	44.5	25.9	23.1	63.4	92.3	227.4	6.4	15.6	68.2	96.6	22.8	21.3	135.7	40.5	251.5	30.0	93.7	42.5	30.2	32.9	217.2	12.6	32.3	24.7	46.4	13.2	19.9	46.6	30.5	39.9	21.7
LARS	"FLJ10595, FLJ21788, HSPC192, LARS1, LEUS, RNTLS"	ENSG00000133706	"Leucyl-tRNA synthetase"	Q9P2J5	5	146113038-146182660	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Protein biosynthesis"	"Aminoacyl-tRNA synthetase, Ligase"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036424, HPA040881"	Supported		Approved	"Nuclear bodies,Cytosol"		NA	NA		14000	"Nuclear bodies, Cytosol"		"HPA036424: AB_10670102, HPA040881: AB_2677185"	"unprognostic (2.20e-2)"	"unprognostic (1.87e-1)"	"unprognostic (2.38e-3)"	"unprognostic (1.92e-1)"	"unprognostic (2.69e-1)"	"unprognostic (3.39e-1)"	"prognostic unfavorable (3.78e-5)"	"unprognostic (8.17e-2)"	"unprognostic (2.72e-1)"	"unprognostic (6.80e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.60e-1)"	"unprognostic (1.06e-1)"	"unprognostic (3.13e-1)"	"unprognostic (1.29e-1)"	"prognostic unfavorable (2.98e-4)"	"unprognostic (2.96e-2)"	32.2	30.1	27.0	25.8	31.2	17.8	38.6	31.8	33.7	25.5	25.3	30.1	23.9	16.8	35.8	31.3	28.5	26.8	16.4	29.0	24.2	22.2	26.5	18.4	20.0	24.8	27.3	26.1	32.0	40.8	35.0	43.0	20.6	31.6	26.3	29.9	19.5	39.9	24.8	55.5	24.1	21.5	32.5	30.9	25.2	24.9	20.5	30.5	25.6	30.8	22.8	28.9	30.9	29.2	21.3	28.0	5.8	18.3	19.0	21.8	11.2	20.5	24.3	28.2	46.2	23.4	30.5	43.9	24.1	17.8	24.4	35.3	25.4	22.5	31.3	14.9	31.6	30.9	17.6	47.6	39.6	42.7	26.9	28.0	35.7	30.8	14.7	32.4	50.7	23.7	23.9	39.9	39.9	69.3	22.0	33.2	46.5	39.7	58.7	26.1	17.0	39.1	31.1	43.7	16.6	27.0	30.3	35.5	31.2	18.6	18.6	27.8	35.1	26.2	28.9	60.8	28.0	32.8	43.8	32.5	28.5	19.0	25.8	36.0	30.5	45.0	51.2	31.0	53.6	33.2	2.5	13.5	5.8	14.8	18.3	19.8	21.1	16.4	13.6	18.6	21.3	21.8	18.0	1.2	19.0	13.6	28.0	14.8	11.2	27.0	31.2	31.8	33.7	24.2	22.2	27.3	26.1	31.6	30.5	26.8	57.1	43.4	48.5	24.6	46.8	120.8	22.9	81.7	77.3	45.4	39.3	32.4	43.1	59.7	27.5	55.0	26.5	0.0	47.0	33.7	27.8	49.5	77.6	28.0	32.9	20.6	30.6	29.4	40.0	22.8	58.1	39.7	21.9	59.5	33.8	40.2	49.7	28.1	56.6	52.5	48.0	32.3	59.7	106.6	46.2	31.0	27.6	32.0	43.8	38.2
LARS2	"KIAA0028, LEURS, MGC26121, mtLeuRS"	ENSG00000011376	"Leucyl-tRNA synthetase 2, mitochondrial"	Q15031	3	45388506-45549421	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Protein biosynthesis"	"Aminoacyl-tRNA synthetase, Ligase"	"Deafness, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035951, HPA045450, HPA066085"	Approved		Supported	Nucleoplasm,Mitochondria		NA	NA			Mitochondria	Nucleoplasm	"HPA035951: AB_10672997, HPA045450: AB_2679328, HPA066085: AB_2685612"	"unprognostic (3.89e-1)"	"unprognostic (3.89e-1)"	"prognostic favorable (1.71e-4)"	"unprognostic (3.02e-2)"	"unprognostic (3.77e-1)"	"unprognostic (1.45e-1)"	"unprognostic (2.21e-3)"	"unprognostic (9.19e-2)"	"unprognostic (6.13e-2)"	"unprognostic (2.86e-1)"	"unprognostic (4.98e-1)"	"unprognostic (4.37e-2)"	"prognostic favorable (1.32e-11)"	"unprognostic (2.81e-1)"	"unprognostic (5.74e-2)"	"unprognostic (9.90e-2)"	"unprognostic (9.07e-2)"	9.6	14.3	18.8	9.6	21.8	6.7	8.1	11.9	17.9	9.2	14.8	13.1	8.3	9.6	9.8	8.9	10.4	11.2	8.4	14.2	14.6	13.6	18.9	17.2	7.0	10.3	15.7	9.5	10.2	8.2	20.0	14.0	10.6	12.3	10.8	15.3	10.0	8.7	9.8	14.1	7.8	8.8	11.0	8.8	10.0	8.9	7.3	11.8	16.1	10.5	8.3	12.8	11.3	7.8	5.1	5.9	2.4	3.3	8.4	6.0	3.7	6.4	8.0	9.4	8.9	8.6	9.7	10.1	10.0	10.3	18.7	13.9	14.2	8.9	13.3	8.6	11.6	13.7	7.0	34.9	20.9	14.2	11.6	8.8	14.4	13.0	13.8	9.0	20.8	5.3	12.5	12.9	17.8	9.4	9.7	11.6	16.1	22.3	7.5	11.6	7.0	14.9	7.6	23.5	10.8	14.9	8.5	9.3	14.8	16.6	15.5	7.4	9.3	15.9	9.0	8.3	11.2	14.3	12.2	10.2	11.4	8.5	9.5	12.0	6.0	10.8	14.2	13.5	14.1	10.1	0.6	2.8	2.4	6.0	3.3	5.8	5.1	4.4	5.4	5.9	4.0	4.8	5.4	1.2	8.4	3.0	4.5	3.9	3.7	18.8	21.8	11.9	17.9	14.6	13.6	15.7	9.5	12.3	11.8	0.0	1.3	2.7	1.1	1.0	5.0	7.8	2.5	2.7	1.2	5.2	3.9	4.1	5.0	2.5	0.6	3.8	2.3	0.0	2.4	4.2	1.6	2.2	1.1	6.7	4.4	1.6	4.6	2.5	3.7	1.1	1.1	1.6	1.7	2.8	4.3	3.6	2.8	6.6	2.1	2.1	4.4	0.0	1.2	0.7	2.4	1.1	2.4	1.8	6.3	1.6
LATS1	WARTS	ENSG00000131023	"Large tumor suppressor kinase 1"	O95835	6	149658153-149718256	"Enzymes, Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"	"Kinase, Serine/threonine-protein kinase, Transferase"	"Tumor suppressor"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA031804	Approved					NA	NA					"HPA031804: AB_10601688"	"unprognostic (4.02e-3)"	"unprognostic (3.80e-3)"	"unprognostic (1.28e-2)"	"unprognostic (1.00e-1)"	"unprognostic (4.40e-2)"	"unprognostic (2.09e-1)"	"unprognostic (6.15e-3)"	"unprognostic (1.29e-2)"	"unprognostic (9.67e-2)"	"unprognostic (1.02e-2)"	"unprognostic (1.74e-1)"	"unprognostic (1.52e-1)"	"unprognostic (5.62e-2)"	"unprognostic (1.92e-1)"	"unprognostic (8.43e-2)"	"unprognostic (2.63e-1)"	"unprognostic (2.65e-1)"	15.4	12.9	17.6	12.5	17.6	19.4	14.7	38.4	16.9	15.9	13.6	17.4	9.5	10.1	17.7	11.8	12.2	14.6	11.1	11.7	15.1	8.8	11.5	11.1	12.7	12.6	18.2	8.8	23.6	12.2	22.3	21.8	17.2	15.5	16.3	12.5	14.1	13.8	11.9	12.4	12.8	14.7	15.8	13.0	13.5	11.6	10.6	19.6	20.5	12.9	6.5	12.8	14.7	14.7	7.4	4.6	9.5	11.4	4.2	8.9	2.9	6.1	4.9	10.3	14.6	9.8	12.8	7.9	8.2	8.3	8.9	8.9	7.9	5.4	10.0	8.4	11.5	7.0	8.7	13.5	8.8	14.1	9.3	10.8	20.3	6.2	7.1	9.1	19.0	14.8	8.5	14.2	10.1	17.3	9.0	11.0	8.8	24.9	10.3	8.7	7.4	9.8	7.8	6.1	5.7	4.8	9.6	12.4	4.7	8.2	8.8	6.9	11.0	11.6	8.5	6.1	7.2	8.7	16.4	13.6	7.1	11.2	8.4	13.2	8.6	9.5	11.6	6.5	10.7	10.4	9.5	4.2	6.6	8.9	7.7	8.0	5.8	7.0	7.4	4.6	7.4	6.0	7.8	2.9	4.2	11.4	4.1	6.7	2.9	17.6	17.6	38.4	16.9	15.1	8.8	18.2	8.8	15.5	19.6	11.9	17.6	9.0	9.7	14.4	19.3	8.9	17.8	13.4	13.6	7.0	17.7	8.2	1.7	7.3	18.1	13.1	11.6	0.0	5.7	9.8	11.4	13.8	13.9	12.2	9.5	12.7	16.1	20.9	12.6	5.2	12.7	11.0	13.5	5.4	12.3	10.4	8.1	11.5	24.4	5.0	21.0	19.4	10.5	7.1	8.7	15.7	11.0	13.6	11.1	11.2
LATS2		ENSG00000150457	"Large tumor suppressor kinase 2"	Q9NRM7	13	20973032-21061547	"Enzymes, Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"	"Kinase, Serine/threonine-protein kinase, Transferase"	"Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"Early spermatids: 94.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"							"Low region specificity"	"Detected in all"			"HPA039191, HPA049037"	Approved		Supported	"Centriolar satellite,Cytosol"		NA	NA			"Centriolar satellite, Cytosol"		"HPA039191: AB_2676385, HPA049037: AB_2680609"	"unprognostic (2.77e-1)"	"prognostic unfavorable (3.26e-4)"	"unprognostic (6.22e-3)"	"unprognostic (3.38e-2)"	"unprognostic (2.51e-2)"	"unprognostic (1.84e-2)"	"unprognostic (1.88e-1)"	"unprognostic (2.16e-3)"	"unprognostic (4.48e-1)"	"unprognostic (6.57e-3)"	"unprognostic (8.03e-2)"	"unprognostic (4.92e-2)"	"unprognostic (7.85e-2)"	"unprognostic (1.66e-2)"	"unprognostic (1.25e-1)"	"unprognostic (7.97e-2)"	"unprognostic (1.11e-2)"	22.9	13.0	3.0	8.6	5.7	12.8	33.0	7.9	3.7	16.6	14.0	6.8	9.3	2.9	21.2	12.7	15.1	11.0	20.6	14.1	5.4	2.6	12.4	11.0	19.8	10.9	5.2	2.4	17.4	10.2	5.0	3.5	18.3	6.3	13.7	4.5	16.7	8.0	11.1	23.0	9.3	7.4	34.6	7.5	15.2	10.4	27.8	5.2	1.4	17.2	13.8	7.0	20.3	28.0	0.1	1.5	3.3	1.9	1.3	3.1	0.5	3.4	3.8	8.5	5.1	10.0	13.2	7.8	11.4	11.9	12.0	10.3	10.8	5.2	0.0	5.6	17.4	4.7	5.0	5.0	5.2	17.8	1.9	1.3	6.3	4.8	8.1	15.5	1.7	2.2	19.5	9.6	7.9	5.3	6.0	16.7	1.4	1.1	0.2	15.1	5.9	0.2	5.9	2.0	3.5	1.8	1.5	15.1	0.0	8.5	1.6	0.1	0.0	9.0	6.0	11.9	7.7	5.1	3.2	21.0	12.8	8.5	9.3	7.2	1.5	0.8	0.0	3.0	1.9	9.7	0.4	1.9	1.8	1.6	1.5	3.1	0.1	0.2	0.5	1.5	0.0	0.1	0.3	3.3	1.3	0.6	0.1	0.0	0.5	3.0	5.7	7.9	3.7	5.4	2.6	5.2	2.4	6.3	5.2	38.7	6.9	2.4	13.7	29.2	0.0	20.6	15.3	12.0	11.4	5.2	0.0	18.7	3.3	8.7	94.1	30.9	3.2	0.0	6.4	7.9	22.8	18.0	4.7	14.5	9.0	0.0	0.0	43.0	13.7	6.2	23.6	16.6	16.9	0.0	1.6	4.5	14.9	1.7	32.5	6.4	0.7	6.5	25.9	6.7	13.7	22.1	40.2	4.4	1.0	9.4
LCAT		ENSG00000213398	"Lecithin-cholesterol acyltransferase"	P04180	16	67939750-67944131	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins"	"Cholesterol metabolism, Lipid metabolism, Steroid metabolism, Sterol metabolism"	"Acyltransferase, Hydrolase, Transferase"	"Corneal dystrophy, Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	11	"brain: 64.4;liver: 154.2"	"Cell type enriched"	"Detected in many"	16	"Hepatocytes: 204.0"	"Low cancer specificity"	"Detected in all"			"Region enriched"	"Detected in all"	7	"cerebellum: 64.4"	"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"BEWO: 35.6;Hep G2: 27.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044767			Approved	Nucleoplasm	"Secreted to blood"	NA	NA	6470000000	9500000000	Nucleoplasm		"HPA044767: AB_2756312"	"unprognostic (3.34e-2)"	"unprognostic (3.56e-2)"	"prognostic unfavorable (8.50e-4)"	"unprognostic (5.43e-3)"	"unprognostic (1.25e-2)"	"unprognostic (2.16e-1)"	"prognostic favorable (4.21e-8)"	"unprognostic (6.42e-2)"	"unprognostic (4.26e-1)"	"unprognostic (4.12e-1)"	"unprognostic (1.50e-2)"	"unprognostic (7.21e-2)"	"prognostic unfavorable (1.71e-4)"	"unprognostic (9.93e-2)"	"unprognostic (1.83e-1)"	"unprognostic (2.85e-1)"	"unprognostic (1.90e-3)"	4.4	3.6	6.3	2.2	3.7	0.9	4.3	64.4	9.6	4.5	4.4	7.3	1.4	1.3	5.3	3.0	1.8	3.5	3.5	4.5	8.4	1.8	3.9	154.2	5.6	1.9	5.5	6.3	4.7	2.5	5.9	2.7	5.5	9.2	6.4	1.3	1.8	2.4	6.2	3.4	9.9	2.4	3.8	7.5	3.9	2.3	2.2	6.1	1.4	7.6	1.6	1.4	2.6	4.5	1.8	0.8	5.0	1.1	1.3	1.4	0.1	2.5	4.0	6.0	6.8	5.2	7.4	35.6	9.9	4.3	6.7	4.7	13.3	3.1	1.3	1.9	14.3	2.4	8.8	1.4	13.6	4.2	0.6	3.6	1.7	8.9	27.7	7.2	0.3	4.7	12.8	12.9	13.9	4.8	9.1	4.9	4.0	3.8	0.6	4.7	4.1	1.6	4.2	3.9	0.4	2.2	1.7	6.5	1.4	1.9	4.3	0.2	3.1	15.0	0.7	1.7	12.9	8.5	2.7	9.3	8.7	13.6	9.5	3.5	8.2	2.2	3.7	4.1	1.1	7.5	2.4	1.1	5.0	0.9	0.1	1.3	1.2	0.7	0.8	0.2	1.8	1.4	0.4	2.8	1.3	0.5	0.8	0.0	0.1	6.3	3.7	64.4	9.6	8.4	1.8	5.5	6.3	9.2	6.1	8.9	4.5	0.0	4.1	8.4	0.2	4.2	7.6	2.7	3.4	3.5	2.0	6.0	0.0	1.6	0.0	4.3	0.0	0.0	0.9	2.7	7.1	2.9	1.1	204.0	2.1	0.0	1.2	12.3	3.2	0.5	8.1	1.6	6.8	2.8	0.0	7.5	1.4	0.0	8.1	0.0	0.5	12.9	7.1	1.0	1.5	2.3	10.2	0.0	0.0	1.4
LCK		ENSG00000182866	"LCK proto-oncogene, Src family tyrosine kinase"	P06239	1	32251239-32286165	"Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins"	"Host-virus interaction"	"Kinase, Transferase, Tyrosine-protein kinase"	"Cancer-related genes, Disease mutation, FDA approved drug targets, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	8	"blood: 112.2;lymphoid tissue: 153.0"	"Cell type enriched"	"Detected in many"	10	"T-cells: 207.5"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	14	"gdT-cell: 83.4;MAIT T-cell: 77.5;memory CD4 T-cell: 86.1;memory CD8 T-cell: 90.2;naive CD4 T-cell: 97.0;naive CD8 T-cell: 91.3;NK-cell: 42.8;T-reg: 112.2"	"Group enriched"	"Detected in many"	13	"NK-cells: 42.8;T-cells: 112.2"	"Group enriched"	"Detected in some"	6	"JURKAT: 66.9;MOLT-4: 93.9;U-698: 54.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA003494, CAB003816"	Enhanced		Approved	"Golgi apparatus"		NA	NA			"Golgi apparatus"		"CAB003816: AB_562158, HPA003494: AB_1852751"	"unprognostic (6.38e-3)"	"unprognostic (5.45e-3)"	"unprognostic (8.39e-2)"	"prognostic favorable (2.96e-6)"	"unprognostic (2.20e-2)"	"prognostic favorable (2.91e-4)"	"unprognostic (4.78e-3)"	"unprognostic (1.33e-2)"	"prognostic favorable (5.65e-5)"	"unprognostic (3.07e-2)"	"unprognostic (3.80e-2)"	"unprognostic (2.83e-1)"	"prognostic unfavorable (2.60e-5)"	"unprognostic (8.15e-2)"	"unprognostic (4.05e-2)"	"unprognostic (7.39e-2)"	"unprognostic (1.17e-2)"	2.6	0.7	0.4	28.2	0.5	3.8	1.3	0.3	0.5	1.7	3.9	0.5	0.9	2.2	1.1	4.5	2.3	1.6	3.8	1.0	0.4	0.4	3.0	2.3	6.6	34.9	0.9	0.5	1.2	0.8	0.0	0.8	0.7	0.6	2.2	1.9	1.3	8.4	1.3	0.9	1.0	16.5	0.7	1.0	28.9	3.5	0.7	0.5	153.0	2.9	1.5	27.1	5.8	2.1	6.1	0.5	2.5	0.3	42.8	112.2	109.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	11.4	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	66.9	0.0	0.0	0.0	0.0	93.9	0.0	1.0	0.8	0.0	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	54.1	0.0	0.0	0.0	0.6	0.3	0.4	83.4	0.3	77.5	4.0	86.1	90.2	0.3	6.1	97.0	91.3	2.5	42.8	0.3	0.5	112.2	109.3	0.4	0.5	0.3	0.5	0.4	0.4	0.9	0.5	0.6	0.5	0.0	16.0	20.4	0.9	4.0	0.0	1.1	2.5	2.7	2.3	3.5	0.0	0.2	0.0	0.3	0.1	1.6	0.0	0.0	0.4	0.1	2.0	0.8	4.7	1.0	0.3	0.0	2.4	3.7	4.9	0.0	0.0	0.6	3.3	0.0	0.0	0.0	2.7	0.0	0.4	1.1	0.0	0.0	0.9	3.7	1.9	2.8	0.3	207.5	0.4	1.0
LCLAT1	"AGPAT8, ALCAT1, FLJ37965, LYCAT"	ENSG00000172954	"Lysocardiolipin acyltransferase 1"	Q6UWP7	2	30447226-30644225	"Enzymes, Predicted membrane proteins"	"Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism"	"Acyltransferase, Developmental protein, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031880, HPA049217"	Uncertain		Supported	"Endoplasmic reticulum,Cytosol"		NA	NA			"Endoplasmic reticulum"	Cytosol	"HPA031880: AB_10610002, HPA049217: AB_2680678"	"unprognostic (6.60e-2)"	"unprognostic (2.47e-1)"	"unprognostic (1.12e-1)"	"unprognostic (9.52e-3)"	"unprognostic (4.10e-1)"	"prognostic unfavorable (9.67e-4)"	"prognostic unfavorable (8.72e-4)"	"unprognostic (2.03e-1)"	"unprognostic (1.33e-1)"	"unprognostic (3.88e-2)"	"unprognostic (7.11e-3)"	"unprognostic (2.85e-2)"	"unprognostic (4.14e-2)"	"unprognostic (1.07e-1)"	"unprognostic (1.63e-1)"	"unprognostic (3.93e-3)"	"unprognostic (1.10e-1)"	7.7	9.7	7.0	13.7	8.7	12.3	7.1	10.2	10.1	11.6	10.7	5.2	12.6	15.7	18.7	15.0	13.0	9.9	12.6	21.7	7.5	9.2	15.2	13.8	10.0	12.5	6.1	6.0	15.4	16.7	10.8	21.8	5.7	7.0	10.7	10.6	9.7	9.5	16.3	10.9	9.4	25.0	11.3	5.5	8.0	8.4	12.1	4.2	20.7	17.9	11.9	11.7	9.1	10.4	9.6	2.8	10.5	3.9	4.1	12.6	2.8	11.0	14.6	7.9	13.3	1.8	4.2	11.3	8.0	8.0	8.5	7.2	14.7	13.0	7.1	7.4	12.4	10.6	12.5	26.1	10.8	8.5	9.0	8.9	13.1	9.2	14.1	8.4	18.5	10.0	3.2	8.5	9.0	12.6	5.6	5.9	4.1	12.0	6.8	6.5	8.6	10.5	10.9	8.6	9.0	8.4	10.3	15.8	14.5	6.8	16.2	9.2	14.2	17.9	11.9	10.3	5.7	8.6	6.4	6.7	15.5	12.9	8.3	12.5	4.9	10.3	16.0	15.8	13.6	11.8	10.5	2.5	4.8	5.6	3.9	6.6	7.5	8.7	7.1	2.8	9.6	12.6	12.1	7.4	4.1	3.5	2.2	4.0	2.8	7.0	8.7	10.2	10.1	7.5	9.2	6.1	6.0	7.0	4.2	8.9	5.8	4.5	4.6	6.4	12.5	15.1	22.9	13.4	7.9	14.0	25.5	4.3	0.0	7.2	3.1	6.7	11.5	0.0	14.3	4.3	5.5	7.7	3.5	19.0	4.9	14.3	12.6	11.1	5.4	1.2	5.2	2.7	5.0	0.0	15.3	7.3	10.3	7.0	8.5	12.2	16.7	6.5	16.2	8.9	20.5	5.8	1.6	8.7	14.3	4.4
LCMT1	"CGI-68, PPMT1"	ENSG00000205629	"Leucine carboxyl methyltransferase 1"	Q9UIC8	16	25111729-25178231	"Enzymes, Predicted intracellular proteins"		"Methyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Cytotrophoblasts: 149.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA041559, HPA043530"	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"HPA041559: AB_2677548, HPA043530: AB_2678532"	"unprognostic (9.08e-2)"	"prognostic favorable (2.78e-4)"	"unprognostic (1.18e-1)"	"unprognostic (3.71e-1)"	"unprognostic (3.15e-1)"	"unprognostic (1.73e-1)"	"prognostic unfavorable (5.85e-4)"	"unprognostic (1.41e-2)"	"unprognostic (7.41e-2)"	"unprognostic (4.45e-2)"	"unprognostic (4.62e-2)"	"unprognostic (1.16e-1)"	"prognostic favorable (7.53e-6)"	"unprognostic (1.23e-1)"	"unprognostic (8.99e-2)"	"unprognostic (1.84e-3)"	"unprognostic (6.71e-2)"	9.8	18.0	27.9	11.6	30.6	13.9	18.1	27.5	36.4	15.4	17.1	15.5	17.5	13.1	16.2	26.7	13.4	16.8	14.1	25.3	22.8	27.5	17.8	7.5	10.8	11.9	21.7	26.7	23.8	31.4	25.3	20.5	18.9	24.8	15.7	17.2	15.0	14.4	18.3	31.6	16.5	12.7	15.1	18.9	10.1	12.6	29.8	14.4	16.9	15.5	14.3	15.3	11.7	12.1	19.7	17.6	21.6	18.9	15.8	38.9	19.5	17.0	16.1	15.0	20.8	13.5	19.8	15.4	10.7	17.7	15.6	20.6	20.3	15.7	10.4	15.3	16.2	19.9	8.8	15.5	14.7	21.2	10.6	23.7	5.6	16.4	32.9	30.9	13.4	9.3	22.4	16.3	17.8	18.6	23.0	14.2	23.7	8.9	13.7	17.2	43.6	16.0	25.8	22.9	10.8	16.7	19.0	13.8	20.2	17.7	12.1	24.5	15.2	12.8	19.9	24.4	18.4	20.1	6.2	8.4	15.6	10.9	10.1	10.5	17.9	18.1	11.0	19.1	11.8	11.4	12.7	18.9	21.6	20.6	16.7	22.6	19.7	25.6	22.3	17.6	14.3	23.1	21.1	7.4	15.8	17.5	9.1	38.9	19.5	27.9	30.6	27.5	36.4	22.8	27.5	21.7	26.7	24.8	14.4	14.9	13.7	23.2	24.4	21.4	25.3	30.5	15.3	22.7	7.9	31.4	2.0	149.0	41.4	46.1	60.5	21.8	58.0	0.0	58.2	63.7	29.6	28.2	9.2	9.0	41.1	22.3	49.3	17.8	33.7	98.3	24.2	25.1	32.1	33.3	47.4	20.7	45.5	40.3	22.6	69.2	18.9	25.8	18.4	50.2	46.6	27.9	137.0	33.1	48.4	31.3
LCMT2	"KIAA0547, MGC9534, PPM2, TYW4"	ENSG00000168806	"Leucine carboxyl methyltransferase 2"	O60294	15	43323649-43330605	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"tRNA processing"	"Methyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039401, HPA048176"	Approved		Approved	Nucleoplasm,Vesicles		NA	NA			Vesicles	Nucleoplasm	"HPA039401: AB_10805478, HPA048176: AB_2680299"	"unprognostic (4.32e-2)"	"unprognostic (1.44e-1)"	"unprognostic (1.55e-1)"	"unprognostic (4.11e-2)"	"unprognostic (1.99e-1)"	"unprognostic (2.27e-1)"	"unprognostic (9.08e-2)"	"unprognostic (5.14e-2)"	"unprognostic (3.52e-2)"	"unprognostic (2.20e-1)"	"unprognostic (3.33e-3)"	"unprognostic (9.57e-2)"	"prognostic favorable (5.69e-9)"	"unprognostic (2.28e-1)"	"unprognostic (3.21e-2)"	"unprognostic (1.62e-2)"	"unprognostic (1.57e-1)"	7.9	10.9	6.5	8.3	8.1	2.5	25.9	11.4	10.1	10.8	7.4	7.2	10.6	5.2	10.3	12.7	11.0	10.2	6.7	8.4	6.7	8.4	11.9	9.2	6.2	9.9	6.1	7.6	13.0	8.2	13.7	10.1	6.4	9.6	10.2	7.5	8.9	10.3	13.8	7.9	6.2	8.4	8.6	4.8	9.6	8.7	7.1	9.6	12.2	9.8	11.2	13.9	7.4	9.6	6.3	6.9	5.5	4.0	3.3	10.5	5.0	6.0	4.9	11.5	9.9	12.3	3.8	5.6	7.5	9.0	9.8	10.8	7.2	2.8	5.2	15.3	8.5	10.3	14.4	0.0	9.9	7.5	8.0	5.3	9.3	13.0	4.2	7.5	0.0	7.0	5.8	9.6	7.2	6.7	6.6	3.1	12.1	11.7	7.0	11.8	9.5	10.4	4.4	4.9	13.5	4.1	12.3	10.1	5.0	17.1	7.0	15.4	13.1	9.9	8.3	4.3	9.4	10.2	14.3	2.6	11.6	5.2	13.1	12.2	4.7	11.1	2.2	7.2	7.7	11.9	2.4	4.0	5.5	4.0	3.8	5.5	5.0	6.7	4.8	6.9	6.3	10.5	6.8	1.3	3.3	3.5	3.9	5.3	5.0	6.5	8.1	11.4	10.1	6.7	8.4	6.1	7.6	9.6	9.6	0.0	1.9	3.2	3.5	2.7	6.9	2.8	7.6	6.7	7.9	3.5	7.9	3.6	3.3	5.4	1.4	2.8	1.3	0.0	3.5	2.1	2.2	2.8	1.1	3.4	2.3	3.2	5.2	5.5	1.6	1.3	4.6	1.5	0.0	2.8	2.7	8.6	3.2	2.3	1.4	4.2	6.6	6.5	3.1	7.5	8.3	2.5	2.1	2.5	3.4	2.0
LCT		ENSG00000115850	Lactase	P09848	2	135787840-135837180	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted membrane proteins"		"Glycosidase, Hydrolase, Multifunctional enzyme"	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	133	"intestine: 255.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	19	"plasmacytoid DC: 1.9"	"Lineage enriched"	"Detected in single"	19	"dendritic cells: 1.9"	"Group enriched"	"Detected in some"	4	"JURKAT: 3.6;MOLT-4: 6.9;RPMI-8226: 13.7"	"Region enriched"	"Detected in single"	16	"hippocampal formation: 17.3"											NA	NA						"unprognostic (2.21e-2)"	"unprognostic (1.65e-4)"	"unprognostic (2.54e-1)"	"unprognostic (2.06e-1)"	"unprognostic (3.39e-2)"	"unprognostic (8.03e-4)"	"unprognostic (3.55e-3)"	"unprognostic (6.71e-3)"	"unprognostic (1.89e-1)"	"unprognostic (3.57e-1)"	"unprognostic (1.69e-1)"	"unprognostic (9.32e-2)"	"unprognostic (1.64e-4)"	"unprognostic (4.90e-2)"	"unprognostic (8.92e-2)"	"unprognostic (8.97e-2)"	"unprognostic (1.02e-1)"	0.1	0.1	0.2	0.0	0.1	0.0	0.1	0.2	0.1	0.1	209.8	0.0	0.0	67.7	0.1	0.0	0.1	0.1	0.0	0.1	0.3	0.2	0.1	0.1	0.1	0.0	0.1	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.1	255.5	0.0	0.1	0.1	0.1	0.4	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	1.9	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	3.6	0.0	0.7	0.0	0.0	6.9	1.1	0.0	0.0	0.0	1.6	0.0	13.7	0.0	0.0	0.7	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.2	0.1	0.2	0.1	0.3	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
LDHA		ENSG00000134333	"Lactate dehydrogenase A"	P00338	11	18394388-18408425	"Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"		Oxidoreductase	"Cancer-related genes, Disease mutation, FDA approved drug targets, Glycogen storage disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 249.1"	"Cell type enhanced"	"Detected in many"	4	"Basal keratinocytes: 1952.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"CAB015336, CAB069404"	Uncertain		Supported	Vesicles,Cytosol		NA	NA		300000000	Cytosol	Vesicles	"CAB015336: AB_2134947, CAB069404: "	"unprognostic (8.83e-2)"	"prognostic unfavorable (2.78e-5)"	"unprognostic (3.81e-2)"	"unprognostic (1.73e-1)"	"unprognostic (3.43e-3)"	"unprognostic (4.66e-3)"	"prognostic unfavorable (3.26e-8)"	"prognostic unfavorable (2.27e-6)"	"unprognostic (1.08e-1)"	"unprognostic (1.88e-2)"	"prognostic unfavorable (8.09e-6)"	"unprognostic (1.76e-2)"	"prognostic unfavorable (9.69e-9)"	"unprognostic (4.15e-2)"	"unprognostic (1.89e-1)"	"unprognostic (3.07e-1)"	"unprognostic (1.05e-2)"	84.2	56.4	24.5	52.6	32.5	64.0	56.0	22.3	40.2	38.1	53.5	13.5	9.1	60.5	24.9	36.2	77.7	29.0	31.6	59.4	24.4	33.0	100.1	249.1	37.1	59.4	29.7	25.7	49.7	34.1	10.5	16.4	49.7	44.3	33.3	51.2	45.9	46.3	37.0	199.6	70.2	128.3	50.7	35.5	45.0	31.2	25.9	23.9	45.0	56.4	90.6	60.1	81.9	44.8	27.6	76.5	29.1	61.2	32.8	52.2	72.1	131.7	82.0	3.1	46.2	72.2	49.3	44.0	127.5	135.5	112.0	166.7	36.6	21.7	99.7	41.9	128.8	80.8	106.6	82.0	195.4	242.9	34.0	48.5	34.5	74.9	62.8	17.8	85.1	25.9	49.2	90.1	44.0	44.1	189.0	66.1	31.6	48.6	48.0	131.1	34.9	70.0	53.9	19.8	43.8	102.6	45.4	32.7	83.5	178.0	30.6	24.6	30.4	69.1	57.0	23.6	50.2	26.8	20.3	59.5	140.3	50.9	122.1	1.5	38.2	55.9	95.9	200.8	44.1	47.2	28.9	53.1	29.1	38.1	61.2	42.6	27.6	50.2	40.1	76.5	19.2	32.8	33.3	18.1	32.8	59.5	25.8	52.2	72.1	24.5	32.5	22.3	40.2	24.4	33.0	29.7	25.7	44.3	23.9	68.5	191.6	171.4	331.5	1952.6	415.5	222.7	142.7	85.6	187.7	293.1	137.4	475.1	368.1	1059.9	147.3	475.2	671.1	0.0	1350.8	1780.5	725.6	281.3	256.4	438.3	607.6	486.3	43.8	182.3	215.4	106.3	266.3	427.9	1116.8	1462.6	176.8	316.6	1380.9	487.5	192.7	408.8	354.8	187.5	1239.9	102.9	38.5	1506.3	419.6	213.6	251.8	384.9
LDHAL6A	"LDH6A, MGC23940"	ENSG00000166800	"Lactate dehydrogenase A like 6A"	Q6ZMR3	11	18455824-18479600	"Enzymes, Plasma proteins, Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"testis: 18.9"	"Group enriched"	"Detected in some"	6	"Early spermatids: 7.5;Late spermatids: 5.6;Spermatocytes: 4.6;Spermatogonia: 3.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enriched"	"Detected in some"	6	"HL-60: 15.6"															NA	NA						"unprognostic (1.41e-1)"	"unprognostic (4.84e-2)"	"unprognostic (8.95e-2)"	"unprognostic (5.35e-2)"	"unprognostic (1.03e-1)"	"unprognostic (3.31e-2)"	"unprognostic (7.34e-2)"	"unprognostic (1.75e-1)"	"unprognostic (1.23e-1)"	"unprognostic (1.60e-1)"	"unprognostic (2.35e-2)"	"unprognostic (3.58e-1)"	"unprognostic (2.22e-2)"	"unprognostic (2.51e-1)"	"unprognostic (1.81e-1)"	"unprognostic (8.31e-3)"	"unprognostic (1.48e-1)"	0.2	0.7	0.6	0.4	0.6	1.4	0.2	2.4	1.9	0.1	0.2	0.4	0.0	0.9	0.2	0.4	0.4	0.2	0.3	1.1	0.4	0.5	0.4	0.2	0.2	0.6	0.3	0.7	0.7	0.4	0.0	0.4	0.2	2.2	0.2	0.1	1.9	0.3	0.3	0.2	1.5	0.8	0.0	0.3	0.4	0.4	18.9	0.0	0.1	0.8	0.0	0.1	0.2	0.2	1.3	0.7	3.5	0.5	1.6	1.9	0.2	0.2	0.4	1.0	0.8	0.0	0.0	0.6	0.4	0.0	0.0	0.0	0.5	0.5	0.9	0.3	0.0	0.2	0.6	0.1	0.3	0.4	0.7	1.0	0.6	0.9	0.5	0.0	15.6	0.7	0.1	0.3	0.0	0.2	0.2	0.0	1.0	0.4	1.2	0.1	0.3	0.4	1.1	0.4	0.2	0.7	0.8	0.4	1.5	0.1	1.1	0.6	0.5	0.5	0.3	0.2	0.5	0.4	2.2	0.8	0.6	0.2	1.0	0.3	2.7	0.6	0.2	0.3	0.6	0.3	2.1	0.4	0.4	1.9	0.3	0.3	0.9	0.5	0.5	0.7	1.3	1.1	1.0	3.5	1.6	0.5	0.5	1.3	0.2	0.6	0.6	2.4	1.9	0.4	0.5	0.3	0.7	2.2	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.4	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	7.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.6	0.9	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.4	0.0	0.6	0.0	0.0	4.6	3.6	0.0	0.2	0.0	0.0	0.0
LDHAL6B	"LDH6B, LDHAL6, LDHL"	ENSG00000171989	"Lactate dehydrogenase A like 6B"	Q9BYZ2	15	59206823-59208515	"Enzymes, Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	69	"testis: 56.6"	"Cell type enriched"	"Detected in some"	20	"Spermatocytes: 103.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A549: 1.2;CAPAN-2: 1.5;HaCaT: 1.6;HeLa: 4.4"	"Region enriched"	"Detected in single"	6	"olfactory region: 1.7"					HPA053962	Enhanced					NA	NA					"HPA053962: AB_2682324"	"unprognostic (1.59e-1)"	"unprognostic (9.41e-2)"	"unprognostic (2.37e-1)"	"unprognostic (4.46e-2)"	"unprognostic (6.59e-2)"	"unprognostic (2.23e-1)"	"unprognostic (1.34e-1)"	"unprognostic (1.58e-1)"	"unprognostic (2.29e-1)"	"unprognostic (1.66e-1)"	"unprognostic (5.13e-3)"	"unprognostic (1.64e-1)"	"unprognostic (3.12e-7)"	"unprognostic (3.47e-2)"	"unprognostic (1.49e-2)"	"unprognostic (8.53e-2)"	"unprognostic (7.80e-2)"	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.2	0.1	0.1	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	56.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.8	0.0	0.4	0.0	0.0	0.0	0.4	1.2	0.0	0.0	0.0	0.0	0.2	0.3	0.0	0.1	0.0	0.0	1.5	0.4	0.0	0.0	0.3	1.6	0.0	0.0	0.0	0.1	0.0	0.0	4.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.1	0.3	0.0	0.2	0.0	0.0	0.1	0.5	0.0	0.5	0.1	0.0	0.0	0.4	0.4	0.8	0.3	0.0	0.1	0.0	0.4	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	5.2	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	103.7	0.6	0.0	0.0	0.0	0.0	0.0
LDHB		ENSG00000111716	"Lactate dehydrogenase B"	P07195	12	21635342-21757857	"Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"		Oxidoreductase	"Disease mutation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 255.8;kidney: 233.1"	"Cell type enhanced"	"Detected in all"	7	"Cardiomyocytes: 2212.6;Distal tubular cells: 2801.9;Proximal tubular cells: 2766.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Lineage enriched"	"Detected in all"	4	"T-cells: 145.1"	"Cell line enhanced"	"Detected in many"		"RPTEC TERT1: 316.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004641, HPA019007"	Enhanced		Supported	Cytosol		No	No		780000000	Cytosol		"CAB004641: AB_425525, HPA019007: AB_2670008"	"unprognostic (2.93e-1)"	"unprognostic (9.20e-3)"	"unprognostic (6.10e-2)"	"unprognostic (1.11e-1)"	"unprognostic (5.39e-3)"	"unprognostic (1.36e-3)"	"unprognostic (1.61e-2)"	"unprognostic (1.72e-2)"	"unprognostic (5.34e-2)"	"unprognostic (8.40e-2)"	"unprognostic (2.91e-1)"	"unprognostic (6.41e-2)"	"prognostic favorable (2.51e-4)"	"unprognostic (1.31e-1)"	"unprognostic (1.71e-1)"	"unprognostic (2.55e-1)"	"unprognostic (9.32e-2)"	70.9	60.2	79.5	33.3	79.6	40.8	33.4	52.4	80.1	24.9	31.8	30.6	13.2	11.8	38.7	27.3	25.6	34.4	32.3	255.8	58.8	69.9	233.1	9.8	27.7	52.3	91.6	62.3	68.0	54.8	41.8	19.4	40.1	84.9	34.9	39.4	26.8	21.8	42.2	29.7	8.6	18.0	42.9	52.9	23.8	47.5	16.4	47.6	59.1	48.5	56.3	58.7	49.7	21.8	28.1	32.9	33.0	15.3	33.7	145.1	93.2	32.6	87.5	77.0	50.6	55.2	61.5	89.5	45.6	45.6	63.8	63.2	138.5	0.1	115.5	29.9	30.7	62.2	16.4	105.9	84.5	81.3	29.6	73.7	118.8	83.7	0.1	52.8	110.9	51.4	70.3	30.3	55.9	76.1	75.5	72.7	83.7	64.9	17.4	70.1	0.1	94.2	134.3	222.1	53.5	38.0	85.1	107.5	93.1	316.6	145.6	24.8	57.4	20.9	32.5	78.6	213.4	0.2	87.0	28.3	43.0	56.4	30.5	85.8	15.4	20.8	151.7	47.6	53.2	51.0	33.0	15.3	1.8	28.5	9.4	47.5	28.1	110.7	59.4	28.3	17.7	145.1	92.2	2.5	33.7	6.7	32.9	105.4	93.2	79.5	79.6	52.4	80.1	58.8	69.9	91.6	62.3	84.9	47.6	131.0	259.8	264.1	356.5	64.9	144.4	2212.6	252.3	329.2	235.4	450.1	64.8	1548.4	2801.9	8.8	8.2	201.1	10.6	163.5	278.5	675.2	313.9	183.2	261.1	6.8	514.5	133.5	88.8	124.0	155.9	19.6	254.3	185.3	170.4	154.1	114.8	173.5	149.2	14.4	390.3	2766.7	85.3	232.8	418.6	17.7	95.7	56.1	1371.1	274.1	316.8	307.0
LDHC	CT32	ENSG00000166796	"Lactate dehydrogenase C"	P07864	11	18412307-18452058	"Enzymes, Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	37	"testis: 143.9"	"Group enriched"	"Detected in some"	11	"Early spermatids: 838.5;Spermatocytes: 827.5"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"SK-BR-3: 3.5;U-2197: 8.7;U-266/70: 7.8;U-266/84: 6.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA045442	Enhanced					NA	NA					"HPA045442: AB_10966720"	"unprognostic (2.32e-2)"	"unprognostic (3.42e-3)"	"unprognostic (1.87e-1)"	"unprognostic (2.83e-2)"	"unprognostic (2.19e-1)"	"unprognostic (8.56e-4)"	"unprognostic (1.35e-1)"	"unprognostic (5.74e-2)"	"unprognostic (6.65e-2)"	"unprognostic (1.73e-1)"	"unprognostic (2.04e-1)"	"unprognostic (1.18e-2)"	"unprognostic (1.08e-1)"	"unprognostic (9.30e-2)"	"unprognostic (3.00e-1)"	"unprognostic (4.25e-1)"	"unprognostic (1.93e-1)"	0.1	0.1	0.7	0.0	0.9	0.1	0.1	0.6	0.4	0.0	0.1	0.0	0.0	0.0	0.0	1.1	0.1	0.1	0.0	0.5	0.2	0.1	0.1	0.4	0.0	0.1	0.3	0.0	0.1	0.4	0.0	0.3	0.0	0.4	0.1	0.0	0.2	0.1	0.0	0.2	0.1	0.3	0.0	0.3	0.0	0.0	143.9	0.3	0.0	0.2	0.1	0.2	0.0	0.0	2.4	2.7	3.6	1.1	0.2	3.8	1.2	0.0	0.0	0.3	2.0	1.5	1.6	2.0	0.1	0.1	0.1	0.1	0.2	0.3	0.2	0.1	0.4	0.1	0.2	0.0	0.0	0.1	0.2	2.8	0.2	1.1	0.0	0.0	0.2	0.3	0.0	0.4	0.1	0.1	0.2	1.0	0.2	0.1	0.6	0.0	0.4	0.2	0.5	0.0	0.1	0.5	0.1	0.0	0.1	0.0	0.0	1.9	0.0	2.2	3.5	0.5	0.1	0.2	0.1	0.9	0.4	2.8	8.7	0.1	7.8	6.8	0.3	0.1	0.0	0.1	1.3	0.7	1.0	0.6	1.0	2.3	0.8	1.8	2.2	0.0	2.4	3.8	2.6	3.6	0.2	1.1	2.7	1.7	1.2	0.7	0.9	0.6	0.4	0.2	0.1	0.3	0.0	0.4	0.3	0.0	0.0	0.0	0.9	0.1	0.0	0.6	0.0	1.4	1.2	1.8	0.0	0.0	3.3	0.3	838.5	0.6	0.0	0.0	5.5	0.1	0.2	0.4	0.0	0.0	0.2	0.0	0.0	0.6	0.0	78.1	21.6	0.0	0.0	0.0	0.0	1.0	1.2	0.0	17.0	2.9	0.6	19.4	0.0	827.5	26.0	0.5	0.0	0.0	0.0	0.1
LDHD		ENSG00000166816	"Lactate dehydrogenase D"	Q86WU2	16	75111860-75116771	"Enzymes, Predicted intracellular proteins"		Oxidoreductase	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 44.3;skeletal muscle: 39.7"	"Cell type enhanced"	"Detected in many"	10	"Cardiomyocytes: 33.6;Enterocytes: 38.8;Hepatocytes: 81.8;Proximal tubular cells: 75.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	6	"basophil: 8.9;classical monocyte: 2.7;intermediate monocyte: 4.6;non-classical monocyte: 5.7"	"Group enriched"	"Detected in many"	31	"granulocytes: 8.9;monocytes: 5.7"	"Cell line enhanced"	"Detected in many"		"Hep G2: 8.7;HMC-1: 12.0;T-47d: 23.5;U-266/70: 9.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041766, HPA048639, HPA066148"	Enhanced		Approved	Cytosol		No	NA			Cytosol		"HPA041766: AB_2677660, HPA048639: AB_2680473, HPA066148: AB_2685626"	"unprognostic (8.75e-2)"	"unprognostic (3.68e-3)"	"unprognostic (1.27e-1)"	"unprognostic (5.28e-2)"	"unprognostic (1.57e-1)"	"unprognostic (1.53e-1)"	"prognostic favorable (5.61e-4)"	"unprognostic (2.49e-3)"	"unprognostic (1.91e-1)"	"unprognostic (2.72e-1)"	"unprognostic (3.74e-1)"	"unprognostic (4.01e-1)"	"prognostic favorable (2.95e-14)"	"unprognostic (4.10e-3)"	"unprognostic (4.49e-2)"	"unprognostic (7.00e-2)"	"unprognostic (2.20e-1)"	15.3	5.5	6.8	1.6	6.7	0.8	3.7	4.9	11.7	4.1	12.5	7.6	4.5	6.1	1.5	3.0	3.8	2.1	3.6	25.3	6.6	5.8	21.5	44.3	2.8	0.9	8.1	9.7	7.9	7.7	8.5	4.4	2.1	9.9	4.4	6.8	5.1	14.2	4.5	39.7	1.8	2.5	1.2	4.5	0.7	11.2	1.0	4.0	0.0	4.3	14.4	2.7	1.1	1.2	0.0	0.2	8.9	5.7	0.1	0.1	0.9	0.6	1.6	0.0	0.3	1.3	1.1	5.1	0.1	0.1	0.1	0.2	2.1	2.2	0.0	1.8	0.7	0.8	0.2	0.0	0.0	0.0	0.0	0.2	0.1	0.5	8.7	2.1	0.0	12.0	1.6	0.3	0.0	0.0	0.4	0.1	0.3	0.6	1.9	0.0	4.0	0.0	0.6	1.1	2.1	1.0	0.0	0.0	6.0	1.1	0.1	0.0	0.0	0.0	4.1	0.3	0.6	23.5	2.6	0.0	0.0	0.2	0.0	0.0	9.3	0.5	0.0	1.6	0.0	0.0	8.9	2.7	0.8	0.0	4.6	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.1	5.7	0.0	0.0	0.9	6.8	6.7	4.9	11.7	6.6	5.8	8.1	9.7	9.9	4.0	0.0	7.9	2.2	2.1	0.6	0.0	33.6	10.2	1.4	1.2	10.4	0.0	1.6	31.5	1.3	0.3	0.6	38.8	0.0	5.5	1.1	0.5	1.6	10.3	81.8	6.2	1.6	2.9	4.3	5.3	0.2	0.0	1.6	5.0	1.0	9.4	11.0	3.7	19.9	0.0	75.5	1.0	0.0	0.4	0.0	0.3	0.3	2.6	1.3	11.0	1.7
LFNG	SCDO3	ENSG00000106003	"LFNG O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase"	Q8NES3	7	2512529-2529177	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		"Developmental protein, Glycosyltransferase, Transferase"	"Disease mutation, Dwarfism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"pancreas: 55.0"	"Cell type enhanced"	"Detected in many"	12	"Intestinal endocrine cells: 84.0;Kupffer cells: 31.7;Mucus-secreting cells: 36.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"CAPAN-2: 18.5;OE19: 22.3;RH-30: 23.0;U-2 OS: 25.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA069130	Approved				"Intracellular and membrane"	NA	NA		620000			"HPA069130: AB_2686091"	"unprognostic (4.58e-2)"	"unprognostic (1.17e-2)"	"unprognostic (2.52e-2)"	"prognostic favorable (6.36e-4)"	"unprognostic (1.85e-2)"	"unprognostic (8.34e-2)"	"unprognostic (4.15e-1)"	"unprognostic (7.86e-2)"	"unprognostic (1.91e-1)"	"unprognostic (2.25e-1)"	"unprognostic (8.55e-3)"	"unprognostic (1.89e-1)"	"unprognostic (5.16e-3)"	"unprognostic (5.40e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.97e-2)"	"unprognostic (2.28e-2)"	10.4	4.9	8.3	12.6	13.5	6.5	15.7	8.3	12.0	10.9	17.3	11.2	0.8	11.9	15.0	5.9	7.9	4.1	16.9	10.1	7.1	11.8	6.6	1.9	15.6	18.1	15.0	6.6	3.0	55.0	1.7	2.6	6.2	19.4	13.0	9.6	8.4	16.5	7.3	3.7	43.0	11.6	6.0	10.2	13.2	28.4	3.4	5.2	5.8	4.4	10.4	19.8	9.0	8.3	2.6	2.5	12.8	7.7	1.3	4.5	1.5	0.7	6.9	9.1	1.2	1.0	0.9	0.6	2.6	1.4	2.4	3.0	2.9	18.5	0.5	8.4	7.2	4.1	13.3	1.4	2.5	1.2	4.1	0.3	2.1	3.6	1.5	0.0	2.9	3.8	1.7	6.3	3.8	0.4	1.6	0.9	0.1	0.3	0.1	1.8	16.4	0.0	4.1	11.1	22.3	5.1	0.8	23.0	1.4	0.9	2.1	8.4	2.1	3.0	0.7	0.1	2.5	5.0	3.5	2.2	5.3	25.4	0.2	7.2	0.1	0.0	0.7	5.8	7.9	1.0	5.3	5.9	12.8	2.0	7.7	2.4	1.3	2.0	1.0	2.5	2.6	2.2	2.0	3.2	1.3	7.0	0.6	4.5	1.5	8.3	13.5	8.3	12.0	7.1	11.8	15.0	6.6	19.4	5.2	6.0	8.9	9.3	2.7	6.1	1.0	2.8	7.6	1.4	4.5	0.0	0.0	0.1	0.0	1.1	0.1	12.7	6.6	0.0	5.5	0.2	2.6	2.0	17.3	0.0	6.9	0.0	84.0	12.9	31.7	0.0	1.7	12.3	3.3	9.0	36.6	26.9	14.2	0.0	0.0	0.3	0.7	0.0	2.1	0.2	3.3	3.4	0.0	10.9	11.5	0.3
LGMN	"LGMN1, PRSC1"	ENSG00000100600	Legumain	Q99538	14	92703807-92748702	"Cancer-related genes, Enzymes, Predicted intracellular proteins"		"Hydrolase, Protease, Thiol protease"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	15	"Hofbauer cells: 1236.6;Ito cells: 365.8;Syncytiotrophoblasts: 348.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	11	"plasmacytoid DC: 54.2"	"Lineage enriched"	"Detected in many"	11	"dendritic cells: 54.2"	"Cell line enhanced"	"Detected in many"		"RPMI-8226: 129.9;U-266/70: 71.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA001426	Enhanced		Approved	Nucleoplasm,Vesicles	"Intracellular and membrane"	NA	NA		1200000	Vesicles	Nucleoplasm	"HPA001426: AB_1079247"	"unprognostic (1.19e-1)"	"unprognostic (1.16e-1)"	"unprognostic (2.37e-1)"	"unprognostic (1.52e-1)"	"unprognostic (1.99e-1)"	"unprognostic (3.29e-2)"	"unprognostic (4.52e-2)"	"unprognostic (1.31e-1)"	"unprognostic (5.03e-2)"	"unprognostic (3.50e-2)"	"unprognostic (4.70e-2)"	"unprognostic (2.47e-1)"	"prognostic favorable (4.70e-4)"	"unprognostic (8.06e-2)"	"unprognostic (3.64e-2)"	"unprognostic (7.18e-3)"	"unprognostic (7.24e-2)"	42.9	16.3	8.6	17.4	10.7	3.5	19.9	5.8	17.9	13.3	22.3	11.7	13.9	24.2	12.1	48.1	17.4	14.1	32.7	38.8	10.3	10.1	87.6	44.6	31.5	42.4	8.3	10.1	20.5	14.6	54.4	9.7	113.6	9.9	22.0	24.5	23.2	22.6	8.4	17.3	11.9	37.1	23.3	11.5	58.3	23.7	14.0	7.9	17.2	36.8	19.2	17.3	31.4	18.2	4.7	54.2	0.7	0.8	1.0	4.3	1.7	4.9	7.1	4.8	8.7	14.9	12.0	16.7	10.6	10.2	11.1	13.1	5.5	8.9	2.7	15.8	17.4	6.9	12.3	0.0	9.2	5.3	0.2	5.5	0.1	3.9	6.3	4.4	0.1	0.4	8.5	4.5	10.7	6.2	3.3	13.1	5.1	1.0	23.0	0.8	6.6	1.3	0.2	2.3	31.1	4.9	1.2	4.2	129.9	12.0	19.3	5.2	3.5	14.8	9.1	7.7	11.0	6.7	0.0	7.1	5.5	7.0	9.9	3.2	71.5	8.4	3.7	3.1	0.1	10.5	0.7	0.4	0.1	0.2	0.8	0.4	4.7	1.4	0.4	5.0	3.4	4.3	2.5	0.5	1.0	0.2	54.2	2.6	1.7	8.6	10.7	5.8	17.9	10.3	10.1	8.3	10.1	9.9	7.9	53.6	113.7	33.9	33.3	20.5	9.9	25.0	45.9	18.7	34.2	29.6	88.4	130.6	8.3	49.8	0.8	31.3	68.2	0.0	45.2	121.5	45.8	47.6	8.1	36.1	1236.6	12.7	35.1	365.8	242.3	2.3	28.1	82.0	45.5	62.3	31.1	25.8	41.2	52.6	54.5	101.8	15.3	19.4	64.6	22.3	17.7	15.3	348.2	8.5	40.4	39.9
LHPP	HDHD2B	ENSG00000107902	"Phospholysine phosphohistidine inorganic pyrophosphate phosphatase"	Q9H008	10	124461834-124617888	"Enzymes, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 106.0"	"Cell type enhanced"	"Detected in many"	7	"Early spermatids: 103.7;Late spermatids: 124.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA009163, HPA009269"	Enhanced		Supported	"Nuclear speckles,Cytosol"		NA	NA		880000	"Nuclear speckles, Cytosol"		"HPA009163: AB_1079250, HPA009269: AB_1079249"	"unprognostic (3.46e-2)"	"unprognostic (1.23e-2)"	"unprognostic (4.78e-2)"	"unprognostic (3.89e-1)"	"unprognostic (2.14e-1)"	"unprognostic (1.96e-1)"	"unprognostic (5.77e-3)"	"unprognostic (2.02e-2)"	"unprognostic (3.58e-1)"	"unprognostic (1.93e-1)"	"unprognostic (6.42e-2)"	"unprognostic (5.55e-2)"	"unprognostic (1.79e-3)"	"unprognostic (2.52e-1)"	"unprognostic (2.10e-1)"	"unprognostic (1.98e-1)"	"unprognostic (1.64e-1)"	9.6	14.2	37.3	6.0	34.0	6.9	7.9	11.9	34.2	12.3	13.6	29.7	8.2	17.9	7.5	11.0	12.7	8.1	8.3	9.8	43.0	31.5	18.6	33.8	6.6	8.2	62.7	19.3	5.5	12.2	6.6	5.6	7.2	20.5	6.9	6.7	6.7	13.3	10.6	6.5	8.9	15.7	8.1	106.0	8.2	12.4	14.2	19.5	7.1	20.5	3.6	11.2	8.7	5.7	24.7	20.0	13.3	16.1	3.9	17.2	12.9	14.8	7.4	3.0	7.6	11.7	9.6	8.0	5.5	11.2	3.5	6.4	1.3	13.8	14.7	12.8	8.2	3.8	16.2	0.9	2.9	3.6	3.3	10.6	10.8	2.4	6.8	12.0	2.1	17.5	7.1	12.6	3.4	8.3	10.2	5.5	13.3	5.3	5.9	4.3	14.7	7.1	6.9	5.3	6.3	4.2	7.6	3.3	18.8	7.5	1.9	1.7	9.1	3.8	14.1	5.0	4.3	10.7	0.3	2.6	5.4	8.0	4.5	1.4	4.9	1.5	4.7	4.9	4.2	1.2	4.6	16.1	13.3	9.5	13.5	12.4	23.7	11.1	10.1	20.0	24.7	13.7	9.6	2.7	3.9	14.9	7.5	17.2	12.9	37.3	34.0	11.9	25.0	43.0	31.5	62.7	19.3	20.5	19.5	3.0	15.0	15.6	9.1	6.5	6.2	12.0	15.3	18.7	12.5	7.0	0.0	44.1	28.2	4.0	103.7	1.6	23.3	0.0	2.1	20.7	9.3	7.6	10.4	53.3	22.8	11.1	9.1	7.4	13.2	124.0	5.5	9.2	16.9	14.4	17.3	6.9	3.5	25.9	9.9	58.6	6.4	12.9	5.1	28.8	10.2	4.6	20.3	7.2	19.6	11.1
LIAS	LAS	ENSG00000121897	"Lipoic acid synthetase"	O43766	4	39458587-39485109	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		Transferase	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Early spermatids: 82.3;Late spermatids: 80.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA018842, HPA019076"	Approved	Supported	Approved	Nucleoplasm,Mitochondria		Yes	No			"Nucleoplasm, Mitochondria"		"HPA018842: AB_1852864, HPA019076: AB_1852866"	"unprognostic (3.61e-1)"	"unprognostic (1.89e-1)"	"unprognostic (8.44e-2)"	"unprognostic (2.33e-1)"	"unprognostic (4.87e-2)"	"unprognostic (1.49e-1)"	"unprognostic (8.31e-2)"	"unprognostic (1.57e-1)"	"unprognostic (4.19e-2)"	"unprognostic (3.68e-2)"	"unprognostic (2.46e-3)"	"unprognostic (3.80e-2)"	"prognostic favorable (4.11e-7)"	"unprognostic (9.41e-3)"	"unprognostic (2.35e-1)"	"unprognostic (5.45e-2)"	"unprognostic (6.98e-2)"	9.8	12.9	9.9	7.0	12.7	10.2	11.3	10.2	13.3	7.0	10.7	12.9	8.1	10.4	9.1	10.7	11.6	11.9	7.4	14.0	10.6	10.6	15.7	15.5	5.7	9.0	12.3	10.5	19.2	12.4	10.0	11.5	6.8	15.7	8.2	12.4	9.0	7.8	7.0	42.7	8.8	9.9	13.6	12.4	8.9	9.9	20.1	13.2	8.7	8.8	13.5	8.3	10.0	7.9	9.6	5.8	3.7	7.1	6.9	16.7	4.3	4.0	3.1	4.0	3.8	8.4	8.2	3.4	4.6	2.6	4.3	2.9	5.0	5.5	14.6	5.3	1.7	10.9	3.6	11.3	6.3	5.8	1.6	2.8	6.1	1.6	5.0	7.7	13.2	4.0	7.9	10.5	5.1	16.2	9.6	4.9	9.1	14.4	3.6	5.2	2.5	7.4	17.0	5.3	10.6	10.1	6.5	10.8	8.8	5.1	2.1	4.4	3.8	2.7	3.6	14.9	5.8	4.0	6.1	1.8	3.5	7.7	4.5	10.7	7.1	10.8	10.2	5.4	15.4	3.0	2.0	6.2	3.7	6.1	7.1	12.6	9.6	8.3	8.0	5.8	8.5	16.7	11.5	3.3	6.9	5.1	5.4	5.2	4.3	9.9	12.7	10.2	13.3	10.6	10.6	12.3	10.5	15.7	13.2	8.9	9.3	13.4	11.9	8.7	24.0	16.5	10.2	20.1	13.6	17.4	9.8	21.5	18.3	10.7	82.3	7.1	13.1	0.0	5.5	12.9	8.0	5.2	17.3	17.0	15.4	9.5	17.4	5.5	11.7	80.7	9.5	10.9	1.7	17.2	12.1	15.2	9.0	10.5	11.7	23.2	23.3	0.0	9.5	47.0	20.9	8.2	8.0	12.9	18.1	8.4
LIG1		ENSG00000105486	"DNA ligase 1"	P18858	19	48115445-48170603	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, DNA damage, DNA recombination, DNA repair, DNA replication"	Ligase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB037015, HPA041431, HPA048071"	Approved		Supported	"Nucleoplasm,Golgi apparatus,Vesicles"		Yes	No			Nucleoplasm	"Golgi apparatus, Vesicles"	"CAB037015: , HPA041431: AB_2677476, HPA048071: AB_2680248"	"unprognostic (1.83e-1)"	"unprognostic (1.48e-3)"	"unprognostic (6.45e-2)"	"unprognostic (9.76e-2)"	"unprognostic (9.47e-2)"	"unprognostic (9.24e-3)"	"unprognostic (1.17e-3)"	"unprognostic (2.28e-1)"	"unprognostic (6.03e-3)"	"unprognostic (4.26e-1)"	"unprognostic (1.78e-2)"	"unprognostic (1.10e-3)"	"prognostic unfavorable (5.75e-5)"	"unprognostic (3.59e-2)"	"unprognostic (4.09e-2)"	"unprognostic (1.59e-2)"	"unprognostic (1.55e-2)"	4.1	5.6	8.1	25.2	10.4	37.8	6.4	17.2	10.6	6.5	9.2	6.5	8.7	12.0	6.8	6.1	11.0	7.8	6.9	2.6	6.3	5.3	6.0	6.2	5.9	18.6	7.7	7.4	10.8	10.3	9.1	9.7	11.7	8.1	7.5	6.0	4.6	7.2	7.9	6.1	12.5	12.8	3.6	7.1	11.2	6.7	15.1	11.5	34.7	10.7	12.1	16.9	6.6	8.6	10.4	1.3	2.0	5.6	10.9	11.5	4.8	15.8	20.4	21.9	14.1	0.9	1.1	15.8	9.2	6.8	14.8	16.4	11.5	15.6	28.7	5.7	3.9	4.1	10.7	9.0	9.0	6.4	15.4	15.5	17.7	14.4	14.9	0.3	22.0	14.7	2.0	0.7	7.9	1.2	1.9	7.9	17.5	15.0	10.8	7.5	12.7	35.1	32.7	12.4	17.1	4.7	30.3	17.1	14.1	4.6	24.2	13.8	13.8	11.1	13.0	3.1	5.2	8.4	16.9	7.8	11.8	20.0	9.9	14.3	10.7	16.8	29.2	4.8	12.4	13.1	0.0	1.4	2.0	7.6	5.6	6.8	10.3	8.4	7.6	1.3	10.4	11.5	8.0	1.1	10.9	2.7	1.2	8.9	4.8	8.1	10.4	17.2	10.6	6.3	5.3	7.7	7.4	8.1	11.5	3.0	9.9	14.6	6.7	7.3	17.6	3.9	2.5	25.4	12.5	3.5	9.8	16.2	6.6	5.1	17.7	5.5	4.5	0.0	4.5	29.3	5.0	2.8	5.8	3.9	13.9	7.9	0.0	4.3	5.2	6.4	2.0	5.8	3.3	10.8	6.8	11.9	3.5	5.8	1.8	3.7	11.6	12.9	4.9	9.8	28.5	8.0	8.4	11.4	8.1	5.5
LIG3	LIG2	ENSG00000005156	"DNA ligase 3"	P49916	17	34980494-35009743	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, DNA damage, DNA recombination, DNA repair, DNA replication"	Ligase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Late spermatids: 51.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA006723	Supported		Supported	Nucleoplasm		NA	NA			Nucleoplasm		"HPA006723: AB_1847781"	"unprognostic (6.05e-3)"	"unprognostic (2.98e-1)"	"unprognostic (1.24e-1)"	"unprognostic (2.83e-1)"	"unprognostic (1.57e-1)"	"unprognostic (8.76e-2)"	"unprognostic (2.40e-2)"	"unprognostic (2.78e-1)"	"unprognostic (2.25e-1)"	"unprognostic (1.02e-2)"	"unprognostic (8.77e-3)"	"unprognostic (1.31e-1)"	"unprognostic (6.67e-3)"	"unprognostic (3.39e-1)"	"unprognostic (3.28e-1)"	"unprognostic (3.29e-2)"	"unprognostic (4.71e-2)"	8.8	11.5	10.7	9.8	17.0	9.2	12.5	15.9	18.3	14.7	11.5	15.8	11.4	8.4	21.5	12.3	14.2	17.3	7.9	11.0	14.2	8.0	9.8	11.8	9.8	9.6	9.1	11.7	17.8	15.4	22.9	13.3	16.5	9.3	16.5	13.1	11.8	14.3	13.9	17.0	13.9	9.8	14.7	8.0	14.3	11.6	27.8	10.9	20.8	14.5	9.7	13.9	13.6	12.7	4.6	10.1	4.8	6.3	11.1	8.4	4.5	7.9	15.8	19.1	16.8	3.8	4.7	14.6	7.7	5.6	10.4	10.5	7.6	4.3	13.0	6.4	10.0	10.3	7.4	21.6	9.9	13.5	6.1	14.5	13.6	7.6	11.0	6.0	21.2	24.1	3.5	8.7	7.7	12.1	5.2	12.6	20.0	21.3	14.9	7.5	8.9	26.7	6.8	18.3	9.9	6.7	14.5	17.5	13.7	5.1	8.6	15.6	11.2	11.5	9.4	7.4	29.3	17.0	10.7	6.0	6.8	8.5	8.3	12.3	13.4	14.4	16.8	4.9	10.1	13.0	0.6	3.8	4.8	5.9	6.3	8.4	4.6	4.0	5.2	10.1	4.0	5.4	3.8	0.3	11.1	3.2	6.0	2.5	4.5	10.7	17.0	15.9	18.3	14.2	8.0	9.1	11.7	9.3	10.9	3.0	10.1	1.5	8.9	4.4	16.2	8.7	10.2	4.0	13.6	12.2	15.7	12.3	8.3	5.8	35.6	3.9	6.2	0.0	5.2	15.3	5.4	10.6	9.2	7.3	7.0	15.9	6.4	3.7	5.9	51.3	6.6	4.5	3.3	3.6	8.2	8.5	3.7	7.0	7.4	5.7	16.8	6.5	3.9	29.6	15.8	4.5	18.1	4.9	9.7	8.4
LIG4		ENSG00000174405	"DNA ligase 4"	P49917	13	108207439-108218368	"Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Cell cycle, Cell division, DNA damage, DNA recombination, DNA repair, DNA replication"	Ligase	"Cancer-related genes, Disease mutation, SCID"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Ciliated cells: 26.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001334, HPA057325"	Approved		Supported	"Nucleoplasm,Cytoplasmic bodies"		NA	NA			Nucleoplasm	"Cytoplasmic bodies"	"HPA001334: AB_1078689, HPA057325: AB_2732608"	"unprognostic (9.93e-2)"	"unprognostic (1.56e-1)"	"unprognostic (2.35e-1)"	"unprognostic (2.00e-2)"	"unprognostic (1.40e-1)"	"unprognostic (1.97e-1)"	"unprognostic (1.56e-1)"	"unprognostic (7.97e-2)"	"unprognostic (2.43e-1)"	"unprognostic (4.87e-1)"	"unprognostic (1.96e-2)"	"unprognostic (4.21e-3)"	"unprognostic (1.94e-2)"	"unprognostic (3.04e-1)"	"unprognostic (1.82e-1)"	"unprognostic (1.50e-2)"	"unprognostic (9.03e-3)"	8.8	12.4	11.6	10.4	15.9	4.3	9.1	14.2	20.6	5.4	7.1	10.2	7.8	8.9	5.8	11.4	8.1	5.9	8.7	8.8	15.6	14.4	11.2	16.7	8.7	12.7	15.5	10.6	7.9	8.3	17.0	20.3	8.3	19.6	7.5	8.7	3.8	6.7	7.1	9.5	6.6	8.6	8.4	14.4	12.6	9.7	11.7	13.6	18.6	10.0	5.4	10.2	8.1	5.3	3.3	2.1	6.8	10.7	2.7	2.7	1.5	8.9	3.4	9.2	6.1	7.7	8.3	3.3	8.8	6.7	6.7	8.1	4.0	4.0	15.2	7.2	5.8	8.3	3.7	6.1	5.9	11.8	8.9	5.8	7.1	7.8	2.1	9.2	9.5	7.6	7.5	9.9	6.5	5.9	6.5	8.0	28.1	2.5	2.8	10.4	4.8	15.8	7.0	2.3	7.3	2.1	14.5	3.6	2.4	8.9	5.7	5.8	6.0	1.9	5.4	6.6	7.5	4.6	14.8	11.9	4.0	4.4	4.5	7.9	7.5	4.9	24.7	15.5	5.5	9.1	0.8	2.3	6.8	1.8	3.8	2.5	2.6	2.0	1.9	2.1	3.3	2.0	2.7	3.2	2.7	10.7	1.4	2.7	1.5	11.6	15.9	14.2	20.6	15.6	14.4	15.5	10.6	19.6	13.6	8.9	7.4	2.4	2.3	2.4	9.6	10.1	0.0	26.8	11.4	1.8	7.9	1.9	8.3	4.6	9.5	3.6	4.1	0.0	6.5	1.0	2.3	3.0	3.5	7.8	5.0	17.5	9.2	4.3	7.3	3.6	2.6	5.0	1.7	8.2	4.6	6.9	6.8	5.3	5.6	5.6	12.6	12.9	2.5	16.4	2.7	5.0	1.5	2.5	2.8	2.0
LIMK1	LIMK	ENSG00000106683	"LIM domain kinase 1"	P53667	7	74082933-74122525	"Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes, Williams-Beuren syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 45.2"	"Cell type enhanced"	"Detected in many"	6	"B-cells: 22.9;Hofbauer cells: 25.0;Horizontal cells: 33.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"U-87 MG: 50.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028516, HPA073571"	Approved		Supported	"Nuclear speckles,Cytosol"		NA	NA			"Nuclear speckles, Cytosol"		"HPA028516: AB_10601751, HPA073571: "	"unprognostic (1.45e-2)"	"unprognostic (2.75e-1)"	"prognostic unfavorable (4.95e-5)"	"unprognostic (2.77e-2)"	"unprognostic (1.40e-3)"	"unprognostic (3.35e-2)"	"prognostic unfavorable (7.79e-6)"	"unprognostic (1.90e-2)"	"unprognostic (2.16e-1)"	"unprognostic (1.18e-1)"	"unprognostic (3.32e-2)"	"unprognostic (3.16e-2)"	"prognostic unfavorable (6.63e-8)"	"unprognostic (4.14e-2)"	"unprognostic (7.00e-2)"	"unprognostic (3.84e-2)"	"unprognostic (5.79e-2)"	8.8	8.6	31.6	18.2	18.6	6.3	7.4	14.3	44.1	11.5	6.6	7.1	6.6	6.9	7.3	5.3	6.4	6.0	10.8	6.3	26.8	32.9	5.2	2.6	12.5	22.0	33.4	22.2	12.1	8.1	4.0	7.2	8.0	45.2	6.1	4.7	4.8	18.1	9.6	10.9	6.8	7.2	7.6	10.8	18.4	7.8	10.4	6.5	4.3	7.5	3.7	18.1	14.1	7.2	4.6	8.6	3.8	7.7	6.9	2.4	3.1	17.0	13.3	10.2	16.9	13.5	18.3	7.4	10.6	10.2	8.6	9.6	7.7	16.9	10.6	4.8	13.0	28.9	10.3	3.8	6.5	3.3	18.3	6.7	7.8	4.5	8.8	15.5	5.9	28.7	18.1	5.9	6.9	3.6	26.0	12.8	7.7	5.2	3.4	10.7	14.9	5.1	10.7	19.3	6.0	8.4	7.4	15.8	6.6	9.6	3.7	4.0	9.3	6.8	16.4	8.5	11.7	5.2	5.4	15.2	13.7	12.8	35.4	17.0	3.8	4.3	19.4	50.9	4.3	9.3	0.1	6.5	3.8	2.4	7.7	1.8	4.6	0.6	1.5	8.6	2.4	0.2	0.7	0.7	6.9	4.7	0.8	0.4	3.1	31.6	18.6	14.3	44.1	26.8	32.9	33.4	22.2	45.2	6.5	3.0	2.4	22.9	4.6	2.6	5.6	2.7	7.6	2.7	3.4	1.8	2.0	2.2	0.0	6.6	0.6	3.0	0.9	0.0	5.6	5.4	7.5	5.1	5.7	1.1	25.0	33.4	2.4	2.5	10.7	1.5	6.6	14.1	3.3	10.0	2.1	3.1	10.2	2.9	5.6	1.5	3.1	0.0	2.1	1.9	12.4	2.8	3.1	10.1	2.5	6.2
LIMK2		ENSG00000182541	"LIM domain kinase 2"	P53671	22	31212239-31280080	"Enzymes, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Syncytiotrophoblasts: 96.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"eosinophil: 14.7;neutrophil: 37.2"	"Lineage enriched"	"Detected in all"	7	"granulocytes: 37.2"	"Cell line enhanced"	"Detected in all"		"BEWO: 37.6;hTCEpi: 69.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008183, CAB019313, HPA053882"	Approved		Supported	Nucleoplasm,Cytosol		NA	Yes			Nucleoplasm	Cytosol	"CAB019313: , HPA008183: AB_1079252, HPA053882: AB_2682291"	"unprognostic (1.79e-1)"	"unprognostic (1.95e-1)"	"unprognostic (1.04e-2)"	"unprognostic (2.59e-2)"	"unprognostic (1.39e-1)"	"unprognostic (2.42e-2)"	"unprognostic (4.02e-2)"	"unprognostic (5.99e-2)"	"unprognostic (1.21e-1)"	"unprognostic (2.95e-1)"	"unprognostic (3.96e-1)"	"unprognostic (1.43e-1)"	"prognostic unfavorable (4.57e-6)"	"unprognostic (4.48e-2)"	"unprognostic (1.48e-2)"	"unprognostic (5.72e-2)"	"unprognostic (1.37e-1)"	9.4	6.6	23.5	23.6	26.2	29.4	17.0	9.9	16.8	11.0	20.9	15.6	10.7	13.1	12.9	8.7	33.7	22.1	28.7	6.0	15.4	10.7	15.4	19.9	21.6	18.1	20.8	7.2	11.4	19.9	20.0	12.8	64.3	23.3	17.1	22.1	10.1	25.7	16.2	9.7	36.7	13.3	10.1	28.3	17.4	18.5	16.8	17.9	12.4	25.8	15.6	15.3	13.1	20.0	1.0	1.6	37.2	1.9	2.4	5.6	1.6	7.0	1.1	4.9	2.7	2.1	2.5	37.6	4.6	2.2	4.7	4.0	6.0	3.3	6.9	8.3	7.0	2.2	14.3	5.7	24.5	2.9	5.0	6.2	5.0	5.5	6.5	3.2	9.2	9.2	4.0	69.7	3.8	11.5	32.0	11.9	5.6	2.7	5.0	6.4	5.5	5.6	3.1	4.6	18.2	1.8	7.4	8.3	3.8	5.4	16.7	6.3	5.6	3.5	22.6	9.3	15.9	18.8	3.7	7.2	4.2	6.6	2.3	4.3	2.8	4.1	6.0	2.6	4.3	1.8	2.1	1.9	14.7	1.3	1.3	2.4	0.8	2.3	1.7	0.7	1.0	2.3	1.8	37.2	2.4	0.5	1.6	5.6	1.6	23.5	26.2	9.9	16.8	15.4	10.7	20.8	7.2	23.3	17.9	29.8	17.0	3.0	42.2	31.9	7.0	19.8	12.7	33.5	28.4	5.2	19.6	59.9	3.3	10.9	1.0	19.3	16.9	0.0	38.9	46.0	10.8	19.1	23.1	6.8	15.7	3.2	12.7	12.9	7.9	1.3	4.0	11.8	3.3	2.8	41.8	15.6	22.5	10.5	4.2	8.1	23.2	19.4	4.1	9.8	10.4	34.3	96.6	8.7	49.0	20.7
LIPA	"CESD, LAL"	ENSG00000107798	"Lipase A, lysosomal acid type"	P38571	10	89213569-89414557	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Lipid degradation, Lipid metabolism"	Hydrolase	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adipose tissue: 139.0"	"Group enriched"	"Detected in many"	7	"Hofbauer cells: 503.3;Kupffer cells: 514.1;Macrophages: 167.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"classical monocyte: 31.8;intermediate monocyte: 68.4;myeloid DC: 23.3;non-classical monocyte: 35.6"	"Group enriched"	"Detected in all"	5	"dendritic cells: 23.3;monocytes: 68.4"	"Cell line enhanced"	"Detected in many"		"AN3-CA: 61.6;ASC TERT1: 77.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB034892, HPA057052"	Enhanced		Supported	"Nucleoplasm,Nucleoli fibrillar center,Vesicles,Cytosol"	"Intracellular and membrane"	NA	NA		150000	"Vesicles, Cytosol"	"Nucleoplasm, Nucleoli fibrillar center"	"CAB034892: AB_784329, HPA057052: AB_2683322"	"unprognostic (1.27e-1)"	"unprognostic (3.23e-1)"	"unprognostic (1.17e-1)"	"unprognostic (1.07e-1)"	"unprognostic (1.61e-1)"	"unprognostic (2.55e-2)"	"unprognostic (7.14e-2)"	"unprognostic (1.66e-1)"	"unprognostic (1.19e-1)"	"unprognostic (4.28e-2)"	"unprognostic (1.08e-1)"	"unprognostic (7.30e-3)"	"unprognostic (1.39e-2)"	"unprognostic (1.40e-1)"	"unprognostic (4.42e-2)"	"unprognostic (3.42e-2)"	"unprognostic (5.71e-2)"	139.0	16.3	15.8	14.4	22.7	7.8	19.9	8.8	21.4	13.4	28.1	61.3	3.4	37.4	10.2	5.2	9.5	9.0	19.4	8.7	22.5	13.8	10.8	49.3	38.5	45.7	41.6	13.4	10.4	9.5	17.5	6.3	17.8	28.4	7.4	16.7	5.7	11.0	8.8	4.1	6.8	65.8	11.3	55.1	87.3	7.9	3.1	37.2	7.0	8.3	4.7	10.0	15.1	8.6	7.0	23.3	3.2	68.4	5.5	8.3	25.5	55.0	8.5	5.6	61.6	58.1	77.3	1.6	29.2	34.2	12.2	21.9	3.2	29.7	10.2	5.7	45.7	13.1	55.2	2.4	15.8	9.1	14.3	5.7	4.2	3.6	13.1	15.3	8.1	8.4	34.3	11.4	13.0	7.0	14.8	2.4	7.7	0.0	19.0	9.5	4.6	7.0	5.5	3.6	9.8	9.6	4.6	6.6	9.4	11.3	8.7	1.9	3.9	7.1	9.2	21.5	3.9	10.5	10.5	4.4	10.4	2.7	22.2	7.1	9.9	10.5	4.2	12.4	18.0	13.0	0.8	31.8	3.2	8.2	68.4	8.2	6.5	7.3	7.8	23.3	7.0	7.7	8.3	1.4	5.5	35.6	4.7	7.1	25.5	15.8	22.7	8.8	21.4	22.5	13.8	41.6	13.4	28.4	37.2	38.7	42.2	50.6	22.0	15.8	5.2	8.5	45.9	14.7	13.6	31.4	0.0	28.4	18.3	29.7	4.4	53.1	3.9	23.3	31.7	28.0	34.8	15.2	27.7	46.5	503.3	15.9	20.9	52.8	514.1	1.8	10.6	167.0	45.5	27.9	9.4	29.4	17.5	5.9	20.5	14.6	1.3	6.5	21.8	4.8	10.9	10.9	16.7	33.0	8.7	20.1
LIPC	"HL, HTGL"	ENSG00000166035	"Lipase C, hepatic type"	P11150	15	58410569-58569843	"Disease related genes, Enzymes, Potential drug targets, Predicted secreted proteins"	"Lipid degradation, Lipid metabolism"	"Heparin-binding, Hydrolase"	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	20	"liver: 91.7"	"Cell type enriched"	"Detected in some"	10	"Hepatocytes: 125.3"	"Group enriched"	"Detected in some"	14	"liver cancer: 20.4;renal cancer: 10.4"	"Low region specificity"	"Detected in some"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	8	"granulocytes: 3.7;NK-cells: 3.0;T-cells: 4.5"	"Cell line enhanced"	"Detected in some"		"CACO-2: 7.0;EFO-21: 5.3;Hep G2: 20.0;HMC-1: 5.9;MOLT-4: 4.5;U-2197: 15.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"								"Secreted to blood"	NA	NA		3200000				"unprognostic (1.76e-2)"	"unprognostic (9.15e-3)"	"unprognostic (7.89e-2)"	"unprognostic (7.15e-4)"	"unprognostic (1.40e-1)"	"unprognostic (1.33e-2)"	"unprognostic (9.93e-3)"	"unprognostic (6.25e-2)"	"unprognostic (3.79e-2)"	"unprognostic (1.10e-2)"	"unprognostic (3.06e-1)"	"unprognostic (2.31e-1)"	"unprognostic (2.82e-2)"	"unprognostic (1.41e-1)"	"unprognostic (2.87e-2)"	"unprognostic (1.80e-2)"	"unprognostic (2.27e-2)"	0.2	0.1	0.4	1.1	0.7	0.0	0.7	0.1	0.4	0.3	0.2	0.6	0.0	0.7	0.1	0.4	0.2	0.4	0.3	0.3	0.4	0.2	3.0	91.7	0.3	0.2	1.2	0.2	0.3	1.0	0.0	1.0	0.1	1.5	0.3	0.3	0.5	0.1	1.5	0.1	0.3	0.3	0.1	1.2	0.4	0.2	0.1	0.5	2.7	0.5	0.0	0.1	1.1	0.2	0.1	0.2	3.7	0.4	3.0	4.5	2.5	0.0	0.0	0.0	0.0	0.2	0.9	0.0	0.0	0.7	0.0	0.0	7.0	0.0	0.0	5.3	0.2	0.2	0.0	0.0	0.0	0.0	0.4	0.0	2.5	0.0	20.0	0.4	0.0	5.9	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.1	0.0	0.1	0.1	4.5	0.6	0.0	0.0	0.0	0.9	0.3	0.0	2.2	0.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.1	15.8	0.0	0.0	0.0	0.1	0.1	0.4	0.0	3.7	0.3	0.0	3.0	0.2	4.5	0.0	0.8	2.2	0.2	0.1	1.0	3.2	0.4	3.0	0.4	0.1	2.1	2.5	0.4	0.7	0.1	0.4	0.4	0.2	1.2	0.2	1.5	0.5	0.0	0.0	5.1	0.0	0.2	0.0	0.8	12.7	0.0	1.2	3.5	0.0	0.0	5.0	3.7	0.0	0.0	0.0	0.0	3.3	0.0	1.2	0.2	0.0	125.3	0.1	0.0	0.0	5.5	4.0	0.0	0.3	0.0	1.7	1.0	0.0	0.0	0.3	0.0	0.0	9.6	0.0	0.0	0.9	0.0	0.0	0.5	0.0	0.0	0.0	0.0
LIPE	HSL	ENSG00000079435	"Lipase E, hormone sensitive type"	Q05469	19	42401507-42427426	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Cholesterol metabolism, Lipid degradation, Lipid metabolism, Steroid metabolism, Sterol metabolism"	Hydrolase	"Diabetes mellitus, Obesity"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	7	"adipose tissue: 207.4;breast: 65.1"	"Group enriched"	"Detected in many"	6	"Early spermatids: 123.5;Late spermatids: 188.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enriched"	"Detected in many"	7	"ASC diff: 57.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA006567, CAB017700"	Enhanced		Supported	Cytosol		NA	NA			Cytosol		"CAB017700: AB_2135504, HPA006567: AB_2667618"	"unprognostic (4.24e-2)"	"unprognostic (2.46e-2)"	"unprognostic (8.99e-3)"	"unprognostic (3.74e-2)"	"unprognostic (1.77e-1)"	"unprognostic (3.38e-3)"	"unprognostic (5.68e-2)"	"unprognostic (2.84e-1)"	"unprognostic (3.11e-1)"	"unprognostic (9.44e-2)"	"prognostic favorable (1.15e-4)"	"unprognostic (1.52e-1)"	"unprognostic (3.63e-10)"	"unprognostic (1.47e-1)"	"unprognostic (1.83e-1)"	"unprognostic (3.76e-2)"	"unprognostic (2.34e-3)"	207.4	6.0	3.2	2.9	9.4	2.1	65.1	2.0	6.8	1.2	6.7	19.6	0.8	2.4	1.7	1.3	2.2	1.6	3.6	4.8	6.2	4.2	1.5	1.1	1.4	2.7	18.0	2.3	1.5	2.2	2.2	0.8	1.7	9.9	1.7	1.3	3.7	5.4	1.7	3.7	2.9	3.4	1.7	19.2	3.1	1.6	9.0	10.8	1.7	1.5	1.8	1.9	2.0	3.7	6.1	4.8	10.8	12.1	4.1	5.2	4.0	4.9	3.8	2.5	0.9	57.3	0.5	0.0	2.3	1.3	3.7	3.5	0.9	1.9	8.2	2.6	0.7	1.8	2.2	1.5	4.6	0.4	1.5	2.4	2.3	1.8	0.1	1.1	0.0	5.6	0.5	4.4	0.6	0.8	0.5	1.0	3.4	1.0	5.2	0.5	0.0	5.7	0.2	0.3	3.8	1.1	4.7	0.4	2.7	1.0	5.2	3.5	3.6	2.0	2.3	2.1	0.1	0.6	3.0	1.9	1.0	3.2	0.4	2.1	3.9	3.2	6.1	2.6	0.2	3.5	10.8	12.1	4.7	3.6	6.0	3.3	4.8	4.6	5.2	4.8	6.1	4.1	3.7	2.0	4.1	3.3	3.9	3.9	4.0	3.2	9.4	2.0	6.8	6.2	4.2	18.0	2.3	9.9	10.8	0.0	3.5	1.3	10.1	3.7	8.1	2.2	0.0	0.0	0.0	1.8	9.8	0.0	1.7	6.4	123.5	4.5	3.2	23.3	2.4	0.1	1.7	5.2	0.0	0.0	0.6	7.9	0.0	17.8	1.8	188.1	2.8	1.2	5.0	0.0	1.1	3.3	1.4	0.0	1.4	1.1	12.3	0.0	1.0	26.8	12.4	2.0	0.0	6.9	2.7	9.0
LIPF	"HGL, HLAL"	ENSG00000182333	"Lipase F, gastric type"	P07098	10	88664441-88678814	"Enzymes, FDA approved drug targets, Predicted secreted proteins"	"Lipid degradation, Lipid metabolism"	Hydrolase	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	24	"stomach 1: 762.9"	"Not detected"	"Not detected"			"Cancer enriched"	"Detected in some"	75	"stomach cancer: 278.5"	"Region enhanced"	"Detected in single"		"cerebral cortex: 1.9"	"Cell type enriched"	"Detected in single"	16	"eosinophil: 1.5"	"Lineage enriched"	"Detected in single"	16	"granulocytes: 1.5"	"Cell line enhanced"	"Detected in some"		"HMC-1: 6.4;MOLT-4: 5.0;NTERA-2: 5.3;REH: 3.1;THP-1: 10.0;U-2 OS: 3.6;U-266/70: 4.9"	"Region enriched"	"Detected in single"	51	"olfactory region: 9.9"					HPA045930	Enhanced				"Secreted to digestive system"	NA	NA					"HPA045930: AB_10959518"										"unprognostic (1.53e-1)"				"unprognostic (1.83e-1)"				0.1	0.0	0.1	0.1	0.5	0.0	0.1	0.1	1.9	0.1	0.2	28.2	0.1	8.2	0.1	0.1	31.6	0.1	0.6	0.1	0.1	0.0	0.3	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.3	0.1	0.1	0.1	0.0	0.1	9.9	0.1	0.1	0.0	0.1	0.1	0.1	0.1	762.9	0.1	0.1	0.2	0.1	1.1	0.1	0.1	0.1	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.0	0.1	5.3	0.0	0.0	3.1	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.0	0.0	0.0	3.6	0.0	0.0	4.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.5	0.1	1.9	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0
LIPG	EDL	ENSG00000101670	"Lipase G, endothelial type"	Q9Y5X9	18	49560699-49599182	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Lipid degradation, Lipid metabolism"	"Heparin-binding, Hydrolase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 37.0;placenta: 44.7;thyroid gland: 84.3"	"Cell type enhanced"	"Detected in many"	9	"Cone photoreceptor cells: 56.9;Extravillous trophoblasts: 60.0;Hepatocytes: 66.8"	"Cancer enriched"	"Detected in many"	7	"thyroid cancer: 20.9"	"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"AN3-CA: 31.4;HaCaT: 48.1;RPTEC TERT1: 32.0;TIME: 62.4"	"Group enriched"	"Detected in many"	5	"amygdala: 3.7;basal ganglia: 2.1;cerebral cortex: 2.9;hippocampal formation: 1.8;olfactory region: 1.9"	"Low region specificity"	"Detected in many"			HPA016966	Uncertain				"Secreted to blood"	NA	NA	657000000	170000			"HPA016966: AB_1852893"	"unprognostic (2.20e-2)"	"unprognostic (3.36e-3)"	"unprognostic (1.16e-1)"	"unprognostic (4.25e-3)"	"unprognostic (6.38e-2)"	"unprognostic (1.36e-1)"	"unprognostic (5.72e-2)"	"unprognostic (4.55e-3)"	"unprognostic (9.93e-2)"	"unprognostic (1.44e-1)"	"unprognostic (6.44e-2)"	"unprognostic (8.74e-2)"	"unprognostic (2.98e-1)"	"unprognostic (8.68e-2)"	"unprognostic (5.64e-2)"	"unprognostic (1.54e-1)"	"unprognostic (1.35e-1)"	1.5	0.4	0.8	4.7	0.7	0.1	0.8	2.0	0.7	0.4	5.6	3.9	15.0	1.9	0.4	3.1	1.0	0.5	4.3	1.2	1.1	0.9	5.2	37.0	4.4	0.7	1.1	0.1	0.5	1.0	0.0	0.6	44.7	1.4	1.0	2.2	8.3	0.6	24.6	2.6	1.1	7.6	2.2	1.4	0.4	1.4	5.8	0.4	0.3	84.3	2.1	0.5	2.0	0.6	1.2	0.6	2.1	0.6	1.7	0.8	0.1	0.5	0.0	13.8	31.4	0.1	0.0	0.2	0.1	1.4	0.0	0.0	13.6	4.9	0.0	7.6	0.0	9.6	48.1	2.0	9.8	0.0	0.1	0.0	0.0	0.0	0.0	2.1	0.0	0.2	1.4	11.1	4.9	9.6	0.1	7.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.3	0.1	0.0	0.0	0.7	32.0	3.7	0.2	0.0	0.2	0.3	0.0	1.8	0.0	0.0	62.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.6	0.4	0.7	0.4	0.4	0.8	0.5	0.5	0.2	1.2	0.8	0.7	2.1	1.7	0.4	0.6	0.4	0.1	0.8	0.7	2.0	0.5	1.1	0.9	1.1	0.1	1.4	0.4	0.0	1.4	0.0	4.8	1.5	0.8	1.7	25.5	0.0	3.4	14.0	56.9	4.7	0.0	3.2	8.0	1.4	9.5	0.0	1.2	60.0	1.0	8.4	0.0	66.8	1.6	0.0	13.3	4.9	1.9	6.0	0.3	0.0	1.7	1.0	3.4	1.0	7.7	2.9	0.0	1.0	2.4	0.0	0.7	1.0	0.8	2.3	16.2	0.7	6.2	9.9
LIPT2		ENSG00000175536	"Lipoyl(octanoyl) transferase 2"	A6NK58	11	74491712-74493733	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		"Acyltransferase, Ligase, Transferase"	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	12	"Early spermatids: 47.3;Late spermatids: 20.4;Spermatocytes: 28.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA040249	Approved					NA	NA					"HPA040249: AB_10795275"	"unprognostic (8.80e-2)"	"unprognostic (9.67e-2)"	"unprognostic (5.12e-3)"	"unprognostic (1.09e-1)"	"unprognostic (6.74e-3)"	"unprognostic (1.43e-1)"	"unprognostic (1.50e-2)"	"unprognostic (8.96e-2)"	"unprognostic (1.11e-2)"	"prognostic favorable (1.63e-4)"	"unprognostic (6.11e-2)"	"unprognostic (2.02e-1)"	"unprognostic (1.17e-2)"	"unprognostic (9.45e-2)"	"unprognostic (1.01e-1)"	"unprognostic (1.51e-2)"	"unprognostic (1.35e-1)"	2.0	4.1	2.6	2.6	3.0	2.1	5.8	2.3	4.3	3.1	4.0	3.4	6.5	5.8	3.4	6.5	3.6	5.8	8.8	2.9	3.3	2.6	8.1	5.3	4.0	8.4	3.5	1.0	6.2	10.8	6.2	4.3	8.3	2.9	4.6	3.6	3.8	5.9	6.9	11.3	2.4	6.3	3.1	2.9	4.2	5.6	19.0	0.8	8.7	6.4	5.5	4.3	4.6	3.8	11.2	7.2	6.6	4.9	8.1	14.8	5.4	2.3	3.0	6.6	3.2	2.7	0.5	9.4	0.9	1.6	4.2	2.6	9.9	3.3	14.7	5.7	0.6	8.4	3.5	3.0	2.3	1.6	3.4	3.1	4.2	2.7	2.7	3.1	4.9	5.9	1.5	2.4	2.0	2.7	2.1	0.2	13.4	3.3	4.2	1.3	3.7	6.5	7.5	5.9	12.4	3.9	5.3	7.3	4.1	2.8	8.3	6.7	4.3	6.2	1.9	8.9	6.6	6.0	3.7	1.1	1.0	2.4	1.4	2.1	6.9	6.1	10.0	0.8	2.9	3.3	0.0	4.9	6.6	5.9	3.0	8.8	11.2	7.9	7.2	5.3	11.0	14.8	11.2	1.1	8.1	3.7	7.2	3.7	5.4	2.6	3.0	2.3	4.3	3.3	2.6	3.5	1.0	2.9	0.8	0.0	0.0	1.7	0.7	0.7	0.7	0.8	5.1	0.0	0.0	3.5	0.0	10.8	5.0	2.2	47.3	0.4	1.4	0.0	4.0	11.2	0.8	0.9	0.0	3.2	4.5	3.2	0.0	1.3	0.0	20.4	1.7	0.5	1.7	0.0	2.0	9.1	2.7	0.0	1.1	11.3	0.9	0.0	0.5	28.6	7.6	0.5	6.8	1.3	3.4	0.3
LMLN	"Gp63, LMNL1, Msp"	ENSG00000185621	"Leishmanolysin like peptidase"	Q96KR4	3	197960200-198043720	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Cell cycle, Cell division, Mitosis"	"Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Ciliated cells: 32.1;Early spermatids: 29.2;Spermatocytes: 29.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA016481, HPA028844"	Uncertain		Supported	"Focal adhesion sites,Cytosol"		NA	NA			Cytosol	"Focal adhesion sites"	"HPA016481: AB_1852955, HPA028844: AB_10602347"	"unprognostic (2.54e-1)"	"unprognostic (3.15e-1)"	"unprognostic (7.63e-2)"	"prognostic favorable (6.77e-4)"	"unprognostic (1.14e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.30e-1)"	"unprognostic (4.07e-2)"	"unprognostic (1.94e-1)"	"unprognostic (2.31e-1)"	"unprognostic (6.36e-2)"	"unprognostic (2.98e-1)"	"unprognostic (4.82e-3)"	"unprognostic (8.78e-2)"	"unprognostic (7.65e-2)"	"unprognostic (1.01e-1)"	"unprognostic (1.63e-1)"	3.9	4.9	5.2	2.5	11.0	2.3	4.5	6.1	9.1	6.2	3.5	5.8	14.3	2.2	4.8	20.3	3.5	9.3	5.1	5.9	5.7	7.4	6.6	3.7	8.1	3.5	5.6	8.9	6.5	6.1	8.8	15.0	3.9	11.6	4.6	4.1	5.4	4.2	11.7	3.7	6.5	2.3	4.0	5.5	3.0	3.9	27.0	4.4	1.2	7.6	3.0	2.6	3.5	3.7	1.9	1.9	0.8	2.4	1.8	2.4	1.2	6.5	2.5	2.9	3.5	5.8	8.2	2.5	3.4	3.1	6.1	5.1	2.4	2.4	2.1	15.8	2.4	13.3	2.5	2.7	2.7	9.0	0.3	2.0	1.2	2.1	1.8	3.6	3.6	1.8	3.9	6.1	7.6	5.0	3.6	2.6	5.3	6.3	4.0	5.9	4.8	2.2	3.2	3.3	4.7	5.9	2.5	0.7	2.2	6.3	1.7	4.8	1.4	4.7	4.2	3.4	3.5	11.0	2.8	5.7	7.6	1.1	9.1	5.7	7.1	13.7	0.6	10.8	6.4	6.8	0.2	0.6	0.5	1.2	2.4	1.7	1.9	0.8	1.6	1.9	1.1	2.2	2.4	0.8	1.8	0.9	0.5	0.0	1.2	5.2	11.0	6.1	9.1	5.7	7.4	5.6	8.9	11.6	4.4	14.9	11.3	1.9	1.5	1.8	7.7	9.2	2.5	32.1	13.6	8.7	15.7	2.5	0.0	2.5	29.2	2.5	1.0	0.0	2.3	2.1	3.3	1.9	2.3	2.4	4.2	7.9	4.6	4.3	2.8	18.6	4.4	2.0	3.3	0.0	3.1	7.7	1.8	0.0	5.3	3.7	16.3	0.0	3.2	29.2	24.7	1.5	2.4	1.3	2.3	1.3
LMTK2	"AATYK2, BREK, cprk, KIAA1079, KPI-2, KPI2, LMR2, PPP1R100"	ENSG00000164715	"Lemur tyrosine kinase 2"	Q8IWU2	7	98106885-98209633	"Enzymes, Predicted membrane proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"neutrophil: 4.8"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA010657, HPA041836"	Uncertain		Approved	"Nuclear speckles,Plasma membrane,Centriolar satellite,Cytosol"		NA	NA			"Nuclear speckles, Centriolar satellite"	"Plasma membrane, Cytosol"	"HPA010657: AB_1079259, HPA041836: AB_2677698"	"unprognostic (7.36e-2)"	"unprognostic (3.16e-1)"	"unprognostic (1.59e-1)"	"unprognostic (2.60e-3)"	"unprognostic (2.47e-2)"	"unprognostic (2.45e-1)"	"unprognostic (2.35e-2)"	"unprognostic (1.23e-1)"	"unprognostic (4.96e-1)"	"prognostic unfavorable (8.03e-4)"	"unprognostic (1.23e-1)"	"unprognostic (4.65e-1)"	"prognostic favorable (1.12e-7)"	"unprognostic (1.88e-1)"	"unprognostic (3.92e-1)"	"unprognostic (2.16e-2)"	"unprognostic (6.38e-3)"	5.1	10.3	13.7	5.6	21.3	17.3	5.6	16.6	34.3	7.3	13.8	6.1	5.6	12.6	6.1	6.3	12.7	6.4	7.9	16.9	11.0	10.1	10.1	8.5	10.0	5.1	7.5	18.9	8.0	21.0	22.2	10.0	4.8	13.2	7.9	11.8	5.4	10.5	6.5	17.5	11.5	13.8	5.7	5.5	6.8	9.4	8.0	6.9	7.2	8.7	5.7	7.4	8.3	8.1	0.6	0.7	4.8	0.9	0.3	1.6	0.5	9.8	11.6	9.0	9.2	4.8	3.9	8.4	4.1	4.5	4.0	4.9	9.1	9.0	5.2	11.8	5.2	15.3	10.8	10.4	6.3	6.3	7.4	7.3	3.5	10.4	9.1	5.9	6.2	6.3	2.6	8.7	8.3	11.3	4.1	6.0	6.0	9.1	10.9	3.6	13.3	6.6	3.7	11.0	13.5	5.7	7.2	6.1	10.2	6.7	17.3	6.5	12.9	8.2	15.0	6.0	9.5	4.1	2.5	7.3	8.4	13.8	16.8	9.3	4.9	8.5	10.3	5.7	4.9	10.0	1.2	0.6	0.5	0.8	0.3	0.5	0.6	0.9	0.9	0.3	0.6	1.1	1.6	4.8	0.3	0.9	0.7	0.8	0.5	13.7	21.3	16.6	34.3	11.0	10.1	7.5	18.9	13.2	6.9	26.8	10.5	0.0	4.2	8.7	14.0	18.7	17.8	10.7	9.1	1.8	13.7	2.3	1.7	5.0	0.8	3.1	26.2	0.0	7.9	1.6	3.5	6.2	2.3	6.8	1.8	6.4	11.5	3.1	2.6	2.1	1.7	2.3	1.7	0.0	13.5	5.8	8.6	13.1	4.2	2.4	9.9	0.0	3.8	6.3	4.7	9.5	2.5	2.9	12.6	13.2
LMTK3	"KIAA1883, LMR3, PPP1R101, TYKLM3"	ENSG00000142235	"Lemur tyrosine kinase 3"	Q96Q04	19	48485271-48513189	"Enzymes, Predicted membrane proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"brain: 38.1"	"Cell type enhanced"	"Detected in many"	10	"Distal tubular cells: 21.6;Ductal cells: 19.4;Horizontal cells: 17.5;Urothelial cells: 44.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HMC-1: 8.6;SK-BR-3: 10.2;U-266/70: 9.5;U-266/84: 7.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040203, HPA077070"	Enhanced	Supported	Uncertain	"Nucleoplasm,Cell Junctions"		NA	NA			Nucleoplasm	"Cell Junctions"	"HPA040203: AB_10671690, HPA077070: AB_2732330"	"unprognostic (2.41e-1)"	"unprognostic (1.48e-1)"	"unprognostic (5.37e-2)"	"unprognostic (5.45e-2)"	"unprognostic (2.95e-1)"	"unprognostic (1.71e-2)"	"unprognostic (5.67e-2)"	"unprognostic (2.46e-1)"	"unprognostic (2.09e-1)"	"unprognostic (2.51e-3)"	"unprognostic (5.71e-2)"	"unprognostic (1.47e-1)"	"prognostic favorable (3.18e-8)"	"unprognostic (1.38e-1)"	"unprognostic (3.22e-2)"	"unprognostic (3.24e-1)"	"unprognostic (6.11e-2)"	1.3	4.4	19.8	2.3	28.6	2.0	2.0	20.0	38.1	2.0	1.5	6.0	0.2	6.2	1.4	1.5	2.3	1.6	1.9	1.7	17.2	11.1	2.5	1.3	3.2	2.2	6.5	23.8	1.3	2.1	8.5	6.1	2.1	12.5	3.5	1.2	1.6	5.2	3.1	1.2	2.4	4.0	1.2	6.6	1.8	2.9	1.5	10.3	0.0	2.3	0.0	2.2	1.6	1.2	0.0	0.0	0.0	0.2	0.0	0.4	0.1	4.6	3.1	0.4	0.0	0.0	0.0	4.5	0.0	0.3	0.0	0.1	2.2	3.7	1.7	1.3	0.0	1.2	2.2	0.3	1.6	0.0	0.0	1.2	0.2	0.3	0.7	0.0	0.0	8.6	0.2	0.9	0.0	0.0	2.0	0.1	2.8	1.4	2.9	0.0	3.1	0.6	0.8	1.1	2.4	0.9	3.9	0.0	1.3	1.1	0.8	0.7	2.9	0.1	10.2	0.0	0.6	3.9	0.2	0.1	0.0	0.8	0.1	0.0	9.5	7.7	0.4	0.2	3.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.1	19.8	28.6	20.0	38.1	17.2	11.1	6.5	23.8	12.5	10.3	3.0	1.7	0.8	9.2	0.5	16.4	2.2	2.5	4.0	4.5	7.0	0.0	4.3	21.6	19.4	0.1	0.0	0.7	0.0	0.4	2.5	0.9	15.7	0.0	0.0	1.0	17.5	0.0	1.3	0.3	0.0	0.6	0.3	3.3	0.0	1.0	7.3	10.7	0.0	0.0	0.6	1.9	0.0	0.7	2.4	1.3	1.6	5.7	0.0	0.6	44.3
LNPEP	"CAP, IRAP, P-LAP, PLAP"	ENSG00000113441	"Leucyl and cystinyl aminopeptidase"	Q9UIQ6	5	96935394-97037515	"Enzymes, Predicted membrane proteins"		"Aminopeptidase, Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	4	"placenta: 104.4"	"Cell type enhanced"	"Detected in many"	4	"Cone photoreceptor cells: 117.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA043642	Approved				"Intracellular and membrane"	NA	NA		390000			"HPA043642: AB_10964137"	"unprognostic (1.52e-1)"	"unprognostic (5.39e-2)"	"unprognostic (7.78e-2)"	"unprognostic (1.53e-2)"	"unprognostic (6.38e-2)"	"unprognostic (6.59e-3)"	"unprognostic (6.83e-2)"	"unprognostic (2.11e-1)"	"unprognostic (1.11e-1)"	"unprognostic (3.54e-3)"	"unprognostic (6.24e-2)"	"unprognostic (2.08e-1)"	"unprognostic (3.28e-1)"	"unprognostic (4.13e-3)"	"unprognostic (1.46e-1)"	"unprognostic (1.69e-1)"	"unprognostic (1.17e-1)"	9.8	4.7	5.6	12.0	7.3	13.2	7.7	23.3	12.9	6.3	7.6	6.9	7.8	4.2	8.2	4.4	10.2	6.6	4.3	10.1	5.2	5.6	7.6	4.3	6.9	15.9	7.7	8.8	8.2	5.9	13.8	9.7	104.4	9.1	7.9	6.8	3.9	7.8	7.7	13.2	14.0	9.0	6.6	7.5	10.0	8.5	3.3	7.7	23.6	7.2	2.9	15.8	8.9	7.7	4.1	3.5	5.0	12.8	11.2	7.9	4.3	5.3	6.2	2.8	2.9	17.1	8.2	3.3	5.5	7.3	6.5	9.9	5.2	8.7	26.5	10.4	7.4	18.3	7.1	3.6	10.4	6.8	9.4	2.0	6.6	4.5	3.6	4.4	7.6	9.1	6.3	6.4	9.4	6.9	7.0	6.8	5.9	2.8	17.6	7.4	4.7	9.0	5.3	0.6	1.7	3.3	6.5	10.6	4.0	23.2	11.1	5.5	1.4	6.7	5.9	3.3	2.8	18.1	10.0	13.5	9.5	5.3	7.5	8.3	3.8	8.8	24.2	8.4	7.2	4.3	5.0	3.3	4.4	7.9	5.5	6.8	3.1	5.9	6.1	3.5	4.1	5.9	6.4	4.1	11.2	12.8	3.3	5.1	4.3	5.6	7.3	23.3	12.9	5.2	5.6	7.7	8.8	9.1	7.7	32.8	42.4	53.7	16.7	52.8	57.3	58.2	17.8	22.7	20.5	34.9	117.8	9.5	5.0	14.0	2.4	31.5	15.8	0.0	12.3	21.8	30.1	24.6	24.4	14.1	14.7	22.3	24.6	33.7	46.5	3.8	30.5	38.3	20.3	12.6	27.8	43.8	15.9	14.0	43.9	9.1	35.8	25.8	24.7	21.4	23.1	41.3	22.9	70.5	21.5	19.9
LNX1	"LNX, MPDZ, PDZRN2"	ENSG00000072201	"Ligand of numb-protein X 1"	Q8TBB1	4	53459301-53701405	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	11	"Early spermatids: 114.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"OE19: 13.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002235, HPA071091"	Approved		Supported	"Cell Junctions,Cytosol"	"Intracellular and membrane"	NA	NA			"Cell Junctions"	Cytosol	"HPA002235: AB_1079261, HPA071091: AB_2686344"	"unprognostic (4.95e-2)"	"unprognostic (1.74e-2)"	"unprognostic (2.00e-2)"	"unprognostic (3.16e-2)"	"unprognostic (2.79e-1)"	"unprognostic (2.31e-1)"	"unprognostic (1.31e-1)"	"unprognostic (5.62e-2)"	"unprognostic (8.14e-2)"	"unprognostic (1.06e-1)"	"unprognostic (5.18e-2)"	"unprognostic (8.56e-2)"	"prognostic favorable (3.08e-7)"	"unprognostic (2.67e-1)"	"unprognostic (5.49e-2)"	"unprognostic (6.81e-2)"	"unprognostic (3.05e-2)"	16.9	2.5	11.8	1.7	24.6	0.8	13.2	4.4	33.3	5.9	7.2	1.5	11.2	8.3	4.5	3.2	21.7	5.6	4.8	6.9	6.1	5.5	10.0	3.7	2.5	1.8	3.8	11.6	2.1	12.9	10.8	5.0	21.6	4.8	5.1	5.6	2.0	22.1	10.0	5.1	10.0	8.2	2.8	1.3	0.9	8.0	4.1	2.0	0.7	15.0	5.7	7.8	5.8	7.7	1.4	1.1	1.5	1.9	3.8	1.6	0.6	1.5	0.5	1.8	0.9	3.3	6.9	8.7	1.4	0.7	0.0	0.0	2.5	7.9	1.9	1.1	3.9	0.5	1.5	0.0	0.2	0.0	0.5	4.4	2.8	1.6	1.5	1.4	2.6	0.8	5.1	0.2	0.4	0.0	2.1	2.7	0.9	1.6	0.9	6.2	4.4	2.2	1.7	4.5	13.4	0.9	1.4	0.7	0.8	6.0	8.3	2.2	2.4	0.7	9.2	1.0	9.8	4.9	1.3	7.6	9.9	2.9	3.2	1.7	3.7	0.5	1.3	9.1	2.2	1.7	1.5	0.5	0.3	1.0	0.5	1.5	1.4	1.5	1.5	0.8	0.9	1.6	1.2	0.4	3.8	1.9	1.1	1.3	0.6	11.8	24.6	4.4	33.3	6.1	5.5	3.8	11.6	4.8	2.0	0.0	3.8	0.8	15.3	7.2	5.9	1.3	7.6	17.4	7.9	7.0	5.9	25.0	16.6	10.0	114.3	7.1	13.2	0.0	10.3	17.0	4.1	9.4	2.3	4.4	2.2	39.7	13.3	2.5	0.3	33.7	4.0	0.6	5.0	0.0	12.2	2.0	9.9	21.0	8.1	2.6	5.0	0.0	1.7	0.9	1.5	10.5	12.5	0.0	12.3	13.6
LONP1	"hLON, LonHS, PIM1, PRSS15"	ENSG00000196365	"Lon peptidase 1, mitochondrial"	P36776	19	5691834-5720572	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		"DNA-binding, Hydrolase, Protease, Serine protease"	"Cataract, Deafness, Disease mutation, Dwarfism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adrenal gland: 78.3"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002034, HPA002192"	Supported		Enhanced	Nucleoplasm,Mitochondria		No	No			Mitochondria	Nucleoplasm	"HPA002034: AB_2756304, HPA002192: AB_1079695"	"unprognostic (6.52e-2)"	"unprognostic (1.12e-1)"	"unprognostic (2.43e-1)"	"unprognostic (2.43e-2)"	"unprognostic (2.84e-1)"	"unprognostic (2.38e-1)"	"unprognostic (1.66e-3)"	"unprognostic (5.56e-2)"	"unprognostic (2.71e-1)"	"unprognostic (7.57e-2)"	"unprognostic (4.04e-2)"	"unprognostic (1.26e-1)"	"unprognostic (1.76e-2)"	"unprognostic (1.09e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.11e-1)"	"unprognostic (2.11e-1)"	15.8	78.3	16.4	12.8	19.8	12.5	13.9	16.1	22.8	11.3	13.6	15.8	13.3	13.7	10.5	13.8	12.7	12.7	15.7	27.3	15.4	15.3	19.9	49.6	10.3	14.5	17.7	14.9	15.5	17.7	17.6	16.8	16.6	16.2	11.7	8.5	12.7	18.5	14.7	38.0	14.7	13.9	11.5	12.7	15.5	13.5	9.8	13.3	13.8	21.2	15.3	11.8	14.7	12.5	6.7	6.5	6.0	6.2	4.0	7.2	3.0	23.0	23.9	7.9	25.3	9.4	6.7	24.7	14.7	11.7	15.9	19.5	20.4	8.3	28.9	20.6	15.4	15.3	9.8	20.4	17.8	7.7	17.1	16.8	16.0	20.9	26.7	43.7	36.4	16.8	12.6	25.6	15.1	29.9	7.7	12.7	40.6	42.3	57.8	7.3	15.3	18.0	21.7	28.3	9.4	31.6	19.0	11.4	31.2	8.8	13.7	21.1	21.1	12.9	18.9	51.6	5.8	11.1	45.7	8.9	8.1	8.9	22.5	21.4	60.9	37.5	25.7	36.5	39.9	14.6	6.0	4.1	0.8	6.4	6.2	4.1	6.0	5.6	6.1	4.3	6.7	7.2	4.8	0.5	4.0	2.4	6.5	4.0	3.0	16.4	19.8	16.1	22.8	15.4	15.3	17.7	14.9	16.2	13.3	6.0	13.3	13.7	8.7	7.3	24.7	17.9	15.3	9.4	10.3	26.2	5.9	24.8	39.7	28.3	5.3	9.8	24.8	0.0	23.9	27.0	10.5	12.9	5.7	44.0	28.2	20.6	10.9	14.1	11.3	4.0	11.8	15.2	13.5	24.4	21.6	20.9	25.6	14.4	16.3	36.0	22.0	19.4	10.3	9.1	13.4	9.4	29.3	9.2	22.2	9.4
LONP2	"LONP, LONPL, MGC4840"	ENSG00000102910	"Lon peptidase 2, peroxisomal"	Q86WA8	16	48244296-48363122	"Enzymes, Predicted intracellular proteins"		"Hydrolase, Protease, Serine protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA008862	Uncertain					NA	NA					"HPA008862: AB_2137156"	"unprognostic (8.08e-3)"	"prognostic unfavorable (4.55e-4)"	"unprognostic (1.75e-2)"	"unprognostic (2.33e-2)"	"unprognostic (6.08e-2)"	"unprognostic (1.60e-2)"	"unprognostic (7.59e-3)"	"unprognostic (2.13e-1)"	"unprognostic (2.36e-1)"	"unprognostic (3.10e-2)"	"unprognostic (5.39e-2)"	"unprognostic (1.40e-1)"	"prognostic favorable (6.71e-7)"	"unprognostic (6.53e-2)"	"unprognostic (1.49e-1)"	"unprognostic (5.60e-2)"	"unprognostic (1.33e-1)"	15.8	17.0	16.0	13.9	22.2	9.4	36.1	18.9	20.7	16.1	17.4	16.3	15.3	15.2	15.8	20.6	14.5	17.6	19.0	16.7	15.0	15.0	15.9	69.2	11.3	12.8	15.2	15.8	22.1	20.7	40.0	23.3	11.1	17.2	23.1	14.8	30.9	15.0	18.1	18.0	13.5	14.8	16.3	14.1	12.5	14.9	7.0	13.7	14.9	24.9	11.6	13.2	16.7	13.7	13.3	13.1	8.7	13.7	9.0	15.9	11.0	13.9	19.4	9.8	15.0	25.9	21.4	18.5	17.9	13.7	16.9	7.7	10.1	7.1	6.4	17.7	17.9	8.0	17.4	19.8	19.8	23.6	10.3	12.5	9.3	12.4	21.9	15.9	15.6	12.5	19.8	22.1	15.7	14.9	20.4	12.5	11.8	15.6	6.9	17.4	12.5	15.0	7.7	8.2	12.8	19.4	19.6	19.9	20.1	19.1	9.4	17.1	10.2	20.3	22.8	18.0	14.4	9.5	11.9	16.6	17.4	10.3	15.1	13.7	13.9	12.6	10.5	20.3	10.5	12.6	6.8	13.7	8.7	13.3	13.6	14.0	12.8	15.9	13.5	13.1	13.3	15.0	13.8	5.3	9.0	13.6	9.6	11.8	11.0	16.0	22.2	18.9	20.7	15.0	15.0	15.2	15.8	17.2	13.7	53.6	63.0	42.5	37.4	31.0	101.1	54.8	68.8	61.6	62.6	26.2	80.5	31.9	11.6	27.4	20.1	29.1	31.6	0.0	26.8	24.3	34.0	48.5	29.0	162.5	26.1	81.0	47.7	43.0	49.7	8.7	54.7	33.7	37.1	36.1	34.2	84.0	28.2	34.5	51.2	24.5	148.4	38.8	29.2	18.2	15.6	32.1	53.5	32.8	38.2	39.1
LOX		ENSG00000113083	"Lysyl oxidase"	P28300	5	122063195-122078360	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted secreted proteins"		Oxidoreductase	"Aortic aneurysm, Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	13	"Early spermatids: 34.9;Fibroblasts: 69.8;Peritubular cells: 36.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BJ: 105.1;fHDF/TERT166: 160.3;HSkMC: 39.1;hTERT-RPE1: 42.3;U-138 MG: 53.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA043930			Approved	"Endoplasmic reticulum"	"Secreted to extracellular matrix"	NA	NA		290000	"Endoplasmic reticulum"		"HPA043930: AB_2678736"	"unprognostic (5.10e-2)"	"unprognostic (1.03e-2)"	"unprognostic (6.99e-3)"	"unprognostic (3.64e-2)"	"unprognostic (9.86e-3)"	"unprognostic (1.91e-1)"	"prognostic unfavorable (7.38e-4)"	"unprognostic (2.42e-3)"	"unprognostic (3.06e-3)"	"unprognostic (8.92e-2)"	"unprognostic (3.21e-3)"	"unprognostic (1.91e-1)"	"prognostic unfavorable (3.93e-8)"	"unprognostic (1.11e-3)"	"unprognostic (9.92e-2)"	"unprognostic (4.31e-2)"	"prognostic unfavorable (3.32e-4)"	33.8	1.8	1.0	7.2	1.2	0.0	37.4	0.9	0.9	16.1	11.7	0.1	4.1	3.8	6.3	20.1	11.1	7.6	12.8	21.4	1.2	1.3	6.5	2.4	20.6	4.3	0.9	1.1	15.7	6.0	0.8	1.5	14.8	1.6	11.2	3.0	3.2	3.4	3.5	12.7	11.3	4.5	9.5	1.5	7.7	4.0	10.6	0.1	0.7	10.8	4.2	2.7	36.9	10.4	0.0	0.1	0.0	0.0	0.0	0.7	0.9	0.1	0.0	0.3	0.1	18.3	21.6	0.0	105.1	22.1	8.1	28.7	0.1	0.0	0.0	2.5	160.3	0.4	0.0	0.4	0.2	17.4	0.0	0.3	0.0	2.1	0.8	23.1	0.0	0.0	39.1	0.4	13.5	0.6	42.3	10.1	0.0	0.0	0.0	9.5	0.0	0.0	0.0	0.7	0.0	0.3	0.0	0.8	0.0	0.4	0.0	0.0	0.5	7.4	0.0	0.7	3.4	0.0	0.0	0.8	53.3	3.6	31.5	1.4	0.0	0.0	0.0	22.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.9	1.0	1.2	0.9	0.9	1.2	1.3	0.9	1.1	1.6	0.1	8.9	0.6	0.0	1.6	6.9	0.6	1.2	0.0	4.0	1.2	0.0	0.0	0.7	0.0	7.1	34.9	3.3	0.0	0.0	0.5	17.3	69.8	1.8	0.0	0.4	1.9	1.6	0.0	14.1	1.5	2.4	13.0	0.3	5.0	1.0	0.0	0.0	1.4	0.0	36.7	0.0	1.1	19.4	8.2	0.5	0.0	9.4	4.0	0.0	0.0	0.7
LOXL2	"LOR, WS9-14"	ENSG00000134013	"Lysyl oxidase like 2"	Q9Y4K0	8	23297189-23425328	"Enzymes, Predicted intracellular proteins, Predicted secreted proteins"	"Transcription, Transcription regulation"	"Chromatin regulator, Oxidoreductase, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"Endothelial cells: 15.5;Extravillous trophoblasts: 20.1;Fibroblasts: 16.6;Ito cells: 23.4;Sertoli cells: 25.8;Smooth muscle cells: 22.6"	"Low cancer specificity"	"Detected in all"			"Region enriched"	"Detected in many"	8	"pons and medulla: 22.7"	"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"BJ: 109.9;BJ hTERT+ SV40 Large T+ RasG12V: 63.6;fHDF/TERT166: 71.2;TIME: 59.3;U-87 MG: 110.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"CAB025848, HPA036257, HPA056542"	Approved		Enhanced	Nucleoplasm	"Secreted to extracellular matrix"	NA	NA			Nucleoplasm		"CAB025848: , HPA036257: AB_2675025, HPA056542: AB_2683168"	"unprognostic (9.48e-2)"	"prognostic unfavorable (9.83e-6)"	"unprognostic (2.03e-1)"	"unprognostic (2.81e-2)"	"prognostic unfavorable (1.24e-4)"	"unprognostic (5.55e-2)"	"unprognostic (1.42e-2)"	"prognostic unfavorable (1.46e-7)"	"unprognostic (2.91e-2)"	"unprognostic (3.63e-3)"	"prognostic unfavorable (9.05e-4)"	"unprognostic (1.25e-1)"	"prognostic unfavorable (2.91e-7)"	"unprognostic (1.51e-2)"	"unprognostic (7.07e-2)"	"unprognostic (4.93e-2)"	"unprognostic (3.68e-3)"	37.8	2.7	1.2	14.5	1.6	0.6	22.4	2.9	1.6	16.9	18.4	1.0	12.2	5.8	11.8	9.1	11.5	4.1	5.4	7.2	1.2	1.3	4.3	4.1	6.2	7.5	1.9	0.7	15.6	4.4	1.3	2.2	38.0	22.7	8.4	3.8	1.6	5.6	9.7	6.2	4.3	10.7	27.3	10.9	8.3	7.7	4.1	0.7	1.6	4.3	8.0	8.6	19.1	6.4	1.9	1.3	3.0	0.7	2.1	2.8	0.7	6.3	17.0	5.1	4.1	14.0	23.1	2.2	109.9	35.6	50.4	63.6	0.1	0.4	1.2	0.8	71.2	23.4	5.3	0.2	9.4	26.7	0.2	0.9	0.0	2.3	0.1	28.3	0.0	0.4	20.4	0.4	18.8	2.5	33.6	42.1	0.2	0.0	0.2	16.6	3.4	0.0	0.1	3.3	0.0	2.6	0.2	4.2	0.0	14.6	0.0	0.1	1.4	13.7	0.7	1.0	16.8	0.1	0.1	59.3	46.9	12.4	19.1	14.4	0.4	0.0	3.3	110.2	0.1	48.8	1.9	0.7	3.0	1.6	0.3	0.8	1.9	0.6	1.3	0.5	0.9	0.8	2.8	1.6	2.1	0.6	1.3	0.2	0.7	1.2	1.6	2.9	1.0	1.2	1.3	1.9	0.7	22.7	0.7	0.0	4.0	0.5	0.4	2.3	1.7	1.7	0.0	1.4	0.0	0.0	0.0	2.0	0.0	1.5	0.5	15.5	0.0	0.0	1.3	20.1	16.6	0.5	0.0	0.0	1.1	1.6	0.0	23.4	0.3	0.0	0.9	0.5	3.3	0.0	0.0	0.8	3.4	0.0	0.4	0.0	3.1	25.8	22.6	0.9	0.9	2.8	0.8	0.0	0.0	0.1
LOXL3		ENSG00000115318	"Lysyl oxidase like 3"	P58215	2	74532414-74555690	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins"	"Inflammatory response"	Oxidoreductase	"Deafness, Stickler syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"	10	"Hofbauer cells: 15.6;Kupffer cells: 10.8;Muller glia cells: 13.0;Sertoli cells: 19.4"	"Cancer enhanced"	"Detected in many"		"melanoma: 15.4"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"intermediate monocyte: 11.1;non-classical monocyte: 8.7"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 27.3;HDLM-2: 20.2;U-138 MG: 48.1;WM-115: 103.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA035281	Approved				"Secreted to extracellular matrix"	NA	NA		15000			"HPA035281: AB_10601766"	"unprognostic (7.54e-2)"	"unprognostic (2.53e-2)"	"unprognostic (5.34e-3)"	"unprognostic (4.55e-3)"	"unprognostic (6.85e-2)"	"unprognostic (1.96e-1)"	"unprognostic (1.68e-3)"	"unprognostic (6.84e-2)"	"unprognostic (1.41e-1)"	"unprognostic (1.78e-1)"	"unprognostic (1.52e-1)"	"unprognostic (1.09e-1)"	"prognostic unfavorable (7.97e-8)"	"unprognostic (1.22e-2)"	"unprognostic (7.33e-3)"	"unprognostic (7.09e-2)"	"unprognostic (3.38e-2)"	7.9	7.1	6.3	8.5	5.0	15.9	9.7	2.9	6.5	6.6	8.4	13.1	2.2	5.1	10.2	7.5	4.1	5.8	8.0	10.8	4.5	5.0	3.2	2.0	6.8	8.0	5.7	6.7	4.2	3.3	2.3	3.9	18.8	7.4	4.4	4.8	7.8	3.6	5.5	1.6	2.1	4.9	10.2	9.7	12.3	3.7	3.5	4.8	0.6	3.0	3.4	2.9	6.1	6.0	0.1	3.4	2.7	11.1	0.0	0.0	2.5	0.2	0.0	3.9	0.7	3.2	4.2	0.7	13.4	27.3	6.5	6.3	4.5	0.2	0.0	0.1	13.7	0.3	0.1	0.5	0.3	3.8	20.2	0.0	3.1	0.2	0.0	1.0	0.1	3.2	4.3	0.0	17.3	0.7	2.2	0.1	0.1	0.1	0.3	1.1	0.6	0.0	1.1	2.2	0.1	0.1	0.3	0.4	0.0	0.0	0.2	1.8	2.4	0.0	0.1	2.8	0.5	0.3	0.2	0.0	48.1	1.6	0.2	0.1	0.1	0.1	0.0	18.1	1.2	103.3	0.1	5.6	0.3	0.0	11.1	0.0	0.1	0.0	0.0	3.4	0.1	0.0	0.0	2.7	0.0	8.7	0.3	0.0	2.5	6.3	5.0	2.9	6.5	4.5	5.0	5.7	6.7	7.4	4.8	0.0	0.3	0.0	0.1	0.8	0.8	0.3	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.8	0.0	0.5	0.0	0.0	0.0	1.1	3.7	0.2	1.1	0.0	15.6	1.6	0.0	0.6	10.8	0.4	4.6	6.8	0.0	3.6	0.0	13.0	0.2	0.0	4.2	0.0	0.9	19.4	2.1	0.5	0.9	0.1	0.7	0.0	0.0	0.1
LPA	"LP, Lp(a)"	ENSG00000198670	Lipoprotein(a)	P08519	6	160531483-160664259	"Candidate cardiovascular disease genes, Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Lipid transport, Transport"	"Hydrolase, Protease, Serine protease"	Atherosclerosis	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	71	"liver: 43.4"	"Cell type enriched"	"Detected in some"	32	"Hepatocytes: 79.7"	"Cancer enriched"	"Detected in single"	38	"liver cancer: 3.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	6	"RT4: 4.7"									"CAB016072, HPA060604"	Supported				"Secreted to blood"	NA	NA	78800000000	2900000000			"CAB016072: AB_2135240, HPA060604: AB_2684330"		"unprognostic (2.16e-1)"	"unprognostic (5.10e-1)"	"unprognostic (7.75e-3)"	"unprognostic (6.70e-2)"	"unprognostic (1.60e-1)"	"unprognostic (4.17e-3)"	"unprognostic (1.59e-1)"		"unprognostic (6.38e-3)"	"unprognostic (3.63e-2)"	"unprognostic (3.18e-1)"	"unprognostic (7.45e-3)"	"unprognostic (2.56e-1)"	"unprognostic (1.80e-1)"	"unprognostic (1.34e-1)"	"unprognostic (3.72e-2)"	0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.3	0.1	0.1	0.1	0.2	0.2	43.4	0.1	0.1	0.1	0.1	0.1	0.2	0.0	0.1	0.1	0.1	0.2	0.0	0.1	0.1	0.6	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.2	0.1	0.1	0.1	0.1	0.1	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.4	0.0	0.0	0.5	0.7	0.0	0.0	0.1	0.0	0.0	4.7	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.7	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.2	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.4	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	79.7	0.0	0.0	0.0	1.3	2.1	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.6	0.8	0.0	0.0	0.0	0.0	0.2
LPCAT1	"AGPAT10, AGPAT9, AYTL2, FLJ12443"	ENSG00000153395	"Lysophosphatidylcholine acyltransferase 1"	Q8NF37	5	1456480-1523977	"Enzymes, Predicted membrane proteins"	"Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism"	"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lung: 35.6"	"Cell type enhanced"	"Detected in many"	12	"Alveolar cells type 2: 286.5;Cone photoreceptor cells: 137.4;Rod photoreceptor cells: 124.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"BEWO: 34.9;EFO-21: 33.5;PC-3: 23.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA012501, HPA022268"	Enhanced		Supported	"Endoplasmic reticulum,Lipid droplets"		NA	NA			"Endoplasmic reticulum"	"Lipid droplets"	"HPA012501: AB_1845224, HPA022268: AB_1845225"	"unprognostic (5.33e-3)"	"prognostic unfavorable (7.11e-5)"	"unprognostic (3.11e-1)"	"prognostic unfavorable (3.67e-4)"	"unprognostic (3.13e-2)"	"unprognostic (1.26e-2)"	"prognostic unfavorable (1.88e-8)"	"unprognostic (5.90e-2)"	"unprognostic (6.37e-2)"	"unprognostic (2.08e-2)"	"prognostic favorable (4.90e-5)"	"unprognostic (4.89e-2)"	"prognostic unfavorable (2.64e-7)"	"unprognostic (2.60e-1)"	"unprognostic (3.13e-1)"	"unprognostic (1.52e-1)"	"unprognostic (4.03e-1)"	9.8	5.6	5.2	9.0	5.7	5.1	7.4	9.2	9.5	5.4	7.5	2.9	4.5	3.9	7.0	3.2	3.2	5.9	5.8	4.3	5.3	5.2	4.9	3.1	35.6	8.5	3.2	3.7	5.0	5.4	3.1	5.6	10.0	4.6	5.2	2.3	13.6	4.5	4.4	3.5	3.2	5.9	5.5	3.3	28.8	9.4	3.0	2.9	5.8	4.7	1.4	8.1	6.6	10.6	0.9	0.7	2.4	1.7	1.7	3.6	0.6	2.0	3.0	0.5	3.3	0.3	0.5	34.9	7.8	0.4	0.4	0.3	1.1	0.9	6.8	33.5	0.2	1.4	5.8	0.6	0.2	0.2	16.5	14.2	1.6	4.9	2.0	0.6	1.7	4.6	0.6	0.1	0.3	0.1	0.5	0.4	2.3	3.7	1.3	0.0	4.3	6.4	2.6	12.3	0.1	23.3	12.3	0.6	4.9	1.4	2.8	4.4	4.3	6.2	5.7	1.8	0.3	2.6	2.7	3.9	0.6	7.7	2.3	2.8	4.4	4.2	1.6	1.4	2.8	2.1	0.0	0.6	0.8	3.6	1.7	3.6	0.9	0.8	1.8	0.7	0.7	0.1	1.0	2.4	1.7	1.2	0.2	0.8	0.6	5.2	5.7	9.2	8.0	5.3	5.2	3.2	3.7	4.6	2.9	80.4	286.5	25.1	1.9	5.6	52.2	3.2	7.6	5.3	21.6	14.0	137.4	5.1	0.0	16.9	1.5	10.3	2.6	0.0	11.7	67.8	9.3	5.6	8.1	4.0	21.8	22.3	14.3	18.4	26.3	1.5	10.0	16.2	6.8	10.8	9.0	28.2	22.2	0.0	14.5	4.4	124.0	0.0	12.3	1.7	9.8	3.4	26.5	26.7	2.5	1.6
LPCAT2	"AGPAT11, AYTL1, FLJ20481, LysoPAFAT"	ENSG00000087253	"Lysophosphatidylcholine acyltransferase 2"	Q7L5N7	16	55508998-55586670	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism"	"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	10	"Collecting duct cells: 64.6;granulocytes: 165.5;Kupffer cells: 68.0;Macrophages: 64.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"basophil: 28.8;eosinophil: 49.4"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 49.4"	"Cell line enhanced"	"Detected in many"		"CAPAN-2: 32.0;HaCaT: 24.5;HL-60: 27.3;HMC-1: 45.6;hTERT-RPE1: 45.8;WM-115: 32.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007891, HPA008433"	Enhanced	Supported	Supported	"Endoplasmic reticulum,Lipid droplets"		NA	NA			"Endoplasmic reticulum"	"Lipid droplets"	"HPA007891: AB_1845223, HPA008433: "	"unprognostic (1.43e-1)"	"unprognostic (2.44e-2)"	"prognostic favorable (3.43e-4)"	"prognostic favorable (8.03e-6)"	"unprognostic (2.91e-1)"	"unprognostic (9.65e-3)"	"unprognostic (8.12e-3)"	"unprognostic (3.26e-3)"	"unprognostic (1.67e-1)"	"unprognostic (7.97e-2)"	"unprognostic (3.18e-3)"	"unprognostic (9.16e-2)"	"unprognostic (1.93e-1)"	"unprognostic (2.33e-1)"	"unprognostic (4.15e-2)"	"unprognostic (1.96e-1)"	"unprognostic (3.53e-2)"	10.5	7.5	10.5	8.0	16.2	43.5	9.9	1.7	7.5	11.0	5.2	18.2	36.5	4.3	17.0	21.5	7.2	8.5	6.2	5.7	9.6	6.3	6.7	2.4	7.4	10.3	18.6	3.1	11.0	3.8	12.7	1.9	9.0	16.1	8.2	5.5	5.1	7.7	33.2	3.0	10.2	5.4	8.9	30.7	8.9	5.3	4.6	14.9	0.9	49.0	5.2	2.6	8.5	8.5	0.0	5.4	49.4	9.3	0.0	0.0	1.4	8.9	1.1	0.9	0.0	3.1	1.2	1.6	3.8	3.7	1.9	1.9	2.0	32.0	0.0	13.2	5.4	1.5	24.5	0.6	5.3	3.1	2.4	2.6	9.2	2.9	4.6	1.1	27.3	45.6	0.6	5.3	2.1	1.7	45.8	14.7	0.5	0.4	0.1	3.2	0.5	0.0	11.0	1.4	2.5	0.1	2.8	1.0	1.3	1.8	3.5	0.6	7.1	7.4	3.0	5.3	4.6	1.3	6.9	16.5	0.3	0.0	1.9	2.6	0.1	0.0	0.0	0.7	13.3	32.5	28.8	4.5	49.4	0.0	6.9	0.0	0.0	0.0	0.0	5.4	0.0	0.0	0.0	12.1	0.0	9.3	0.1	0.0	1.4	10.5	16.2	1.7	7.5	9.6	6.3	18.6	3.1	16.1	14.9	6.0	31.3	1.7	29.9	13.7	1.6	1.6	5.1	2.7	23.9	64.6	9.8	0.7	1.7	7.2	1.3	22.7	4.1	0.0	8.5	6.9	13.8	6.0	165.5	1.7	33.6	0.0	1.2	4.3	68.0	1.7	15.3	64.1	16.9	7.2	11.9	26.1	20.5	31.6	12.0	4.4	5.2	0.0	2.4	11.6	3.8	13.4	1.6	1.3	9.8	15.9
LPCAT3	"C3F, MBOAT5, nessy, OACT5"	ENSG00000111684	"Lysophosphatidylcholine acyltransferase 3"	Q6P1A2	12	6976186-7018510	"Enzymes, Predicted membrane proteins"	"Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism"	"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"intestine: 85.5;liver: 78.2"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"RT4: 48.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA						"unprognostic (1.74e-1)"	"unprognostic (3.33e-2)"	"unprognostic (1.70e-1)"	"unprognostic (1.57e-1)"	"unprognostic (6.72e-2)"	"unprognostic (3.86e-1)"	"unprognostic (2.40e-2)"	"unprognostic (6.90e-2)"	"unprognostic (1.88e-1)"	"unprognostic (5.00e-3)"	"unprognostic (2.06e-1)"	"unprognostic (2.58e-2)"	"prognostic favorable (4.89e-5)"	"unprognostic (1.13e-1)"	"unprognostic (2.21e-1)"	"unprognostic (6.49e-3)"	"unprognostic (1.23e-1)"	16.4	24.4	4.2	8.8	5.0	8.1	15.1	15.7	5.4	7.9	37.5	6.1	8.1	43.4	8.2	7.8	13.6	9.1	11.3	20.2	4.1	2.7	37.3	78.2	20.3	17.9	5.2	5.3	13.9	38.7	4.6	9.4	29.0	4.8	13.7	17.2	8.3	22.2	8.2	19.4	13.3	85.5	12.4	4.9	11.3	22.8	7.6	4.0	14.1	14.6	10.3	13.7	15.7	8.5	5.3	13.9	32.3	33.7	11.5	10.8	12.4	6.2	11.6	5.0	14.1	35.4	16.7	10.8	3.6	15.5	10.0	17.1	24.7	32.7	6.8	2.1	5.8	21.4	15.8	6.0	13.4	7.8	16.7	7.3	13.7	10.3	22.1	7.6	7.0	14.7	26.3	7.8	9.6	4.8	6.4	9.3	10.5	7.3	4.9	6.5	9.5	8.6	8.7	16.8	22.4	6.8	9.1	7.1	7.0	12.3	48.9	4.4	4.2	21.9	33.9	2.4	16.5	3.4	9.9	3.8	6.2	9.3	10.9	2.6	6.2	4.4	10.0	7.7	7.4	5.4	13.9	20.8	32.3	8.6	30.0	10.0	5.0	9.0	9.7	13.9	5.3	8.5	8.7	20.0	11.5	33.7	7.9	10.8	12.4	4.2	5.0	15.7	5.4	4.1	2.7	5.2	5.3	4.8	4.0	65.5	29.7	4.5	32.1	20.9	5.2	0.4	15.3	13.4	23.9	19.2	0.0	71.1	10.0	25.0	1.5	9.8	66.7	0.0	29.4	45.9	18.4	22.1	13.9	52.5	36.0	11.1	41.5	14.1	18.0	1.2	17.0	13.7	6.8	16.2	22.8	12.3	18.9	24.6	6.0	34.4	3.9	19.4	9.4	14.6	30.6	19.4	55.5	13.8	32.4	25.1
LPCAT4	"AGPAT7, AYTL3, FLJ10257, LPAAT-eta, LPEAT2"	ENSG00000176454	"Lysophosphatidylcholine acyltransferase 4"	Q643R3	15	34358618-34367278	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism"	"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"Enterocytes: 63.9;Paneth cells: 83.4;Undifferentiated cells: 62.1;Urothelial cells: 107.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HaCaT: 41.5;OE19: 42.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA057321	Supported					NA	NA					"HPA057321: "	"unprognostic (2.79e-2)"	"unprognostic (8.34e-2)"	"unprognostic (1.08e-2)"	"unprognostic (4.64e-3)"	"unprognostic (1.29e-2)"	"unprognostic (2.15e-2)"	"prognostic unfavorable (9.99e-4)"	"unprognostic (7.47e-2)"	"unprognostic (1.13e-1)"	"unprognostic (2.90e-1)"	"unprognostic (1.23e-3)"	"unprognostic (1.33e-1)"	"unprognostic (9.95e-3)"	"unprognostic (1.52e-2)"	"unprognostic (1.37e-1)"	"unprognostic (1.69e-2)"	"unprognostic (3.44e-3)"	9.7	5.3	20.1	9.6	35.1	5.0	11.0	38.6	32.2	11.9	30.5	4.3	3.5	25.3	8.0	8.6	17.7	16.4	19.0	17.1	14.2	21.0	4.9	1.8	7.8	7.2	13.2	18.2	9.6	6.8	6.4	6.1	4.6	28.9	5.7	30.0	2.9	6.4	8.3	6.1	15.2	23.8	14.4	7.1	8.5	33.1	2.6	13.1	4.5	4.4	4.5	9.3	15.4	14.2	2.6	6.2	4.7	1.8	2.1	9.4	1.0	5.1	12.2	6.1	4.8	16.6	16.9	2.9	7.2	12.2	6.9	9.4	4.4	13.8	4.6	15.0	10.0	16.2	41.5	5.3	13.6	3.0	9.4	3.0	4.6	5.1	4.2	3.4	4.9	4.8	12.5	6.2	6.5	8.5	16.0	11.2	8.5	3.0	9.0	12.8	4.9	4.3	9.7	6.1	42.9	9.7	5.4	6.9	9.3	15.0	12.3	4.8	3.7	4.3	5.8	2.7	7.4	4.5	6.7	13.8	12.8	7.8	20.1	6.8	11.1	8.7	1.6	9.5	13.8	2.9	0.1	1.1	4.5	3.9	1.4	9.4	2.3	4.6	6.0	1.8	2.6	2.8	2.5	4.7	2.1	1.8	6.2	7.3	1.0	20.1	35.1	38.6	32.2	14.2	21.0	13.2	18.2	28.9	13.1	23.8	5.1	11.9	7.6	4.2	10.4	10.4	30.6	13.4	7.9	8.7	3.9	3.4	1.7	9.9	0.0	22.7	63.9	0.0	8.6	14.1	6.6	8.4	11.5	0.8	6.9	9.5	24.3	13.5	6.5	0.6	14.4	6.1	8.5	4.6	52.9	0.8	28.2	83.4	6.3	3.3	6.1	12.9	8.5	0.7	4.9	5.4	2.1	15.2	62.1	107.8
LPIN1	KIAA0188	ENSG00000134324	"Lipin 1"	Q14693	2	11677595-11827409	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Fatty acid metabolism, Lipid metabolism, Transcription, Transcription regulation"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 88.4"	"Cell type enriched"	"Detected in many"	4	"Late spermatids: 1310.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"U-266/70: 38.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA024591, HPA038021"	Approved		Approved	"Plasma membrane,Cytosol"		NA	NA			Cytosol	"Plasma membrane"	"HPA024591: , HPA038021: AB_10669514"	"unprognostic (1.97e-1)"	"unprognostic (2.47e-1)"	"unprognostic (1.32e-1)"	"unprognostic (1.87e-2)"	"unprognostic (9.17e-2)"	"unprognostic (2.69e-2)"	"unprognostic (8.20e-2)"	"unprognostic (5.28e-3)"	"unprognostic (1.09e-1)"	"unprognostic (1.07e-2)"	"unprognostic (2.45e-3)"	"unprognostic (2.55e-2)"	"unprognostic (1.06e-1)"	"unprognostic (5.58e-3)"	"unprognostic (1.25e-1)"	"unprognostic (9.60e-2)"	"unprognostic (4.02e-1)"	18.1	10.1	13.0	10.7	18.3	6.0	22.1	20.0	16.4	10.5	8.6	10.9	7.3	8.9	11.0	15.0	20.0	7.0	10.4	12.8	11.6	11.9	7.6	13.2	8.0	15.4	13.2	11.2	19.3	7.5	17.2	32.0	9.0	17.9	9.6	7.1	9.0	14.4	11.6	88.4	6.5	9.2	11.0	10.3	8.4	7.6	39.0	13.2	8.3	8.1	14.0	19.2	10.4	21.7	6.5	9.6	11.6	2.8	8.0	11.1	3.2	5.5	6.6	5.5	12.3	25.5	28.4	2.8	7.8	13.4	5.0	8.7	2.4	5.5	2.7	1.0	6.6	14.8	6.0	6.2	17.0	4.6	11.4	3.4	6.8	3.7	3.5	9.0	4.7	32.1	25.6	7.7	20.8	7.9	14.7	9.7	6.7	9.4	24.7	3.7	2.1	4.4	4.1	5.7	1.8	6.7	6.1	10.1	17.3	12.7	3.6	15.3	12.1	2.8	6.8	17.5	5.5	1.7	2.6	6.8	8.0	7.2	5.1	6.7	38.8	30.0	5.2	11.3	8.4	5.9	9.5	2.8	11.6	10.3	2.1	11.1	6.5	9.6	9.7	2.5	5.0	8.4	7.1	1.1	8.0	2.1	9.6	10.5	3.2	13.0	18.3	20.0	14.4	11.6	11.9	13.2	11.2	17.9	13.2	20.8	49.1	22.9	38.9	16.9	40.6	49.5	25.5	61.6	63.7	10.4	80.5	7.3	6.6	18.7	314.7	24.6	9.7	0.0	24.2	5.3	24.6	29.2	33.6	21.9	8.1	46.1	34.7	15.4	15.7	1310.7	110.1	27.2	16.9	7.2	23.9	16.4	25.5	11.6	169.0	3.4	47.2	32.3	20.6	18.4	17.8	10.5	10.3	57.5	13.6	26.8
LPIN2	KIAA0249	ENSG00000101577	"Lipin 2"	Q92539	18	2916994-3013315	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Fatty acid metabolism, Lipid metabolism, Transcription, Transcription regulation"	Hydrolase	"Congenital dyserythropoietic anemia, Disease mutation, Hereditary hemolytic anemia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 83.9"	"Cell type enhanced"	"Detected in all"	5	"Cholangiocytes: 140.1;Hepatocytes: 111.5;Horizontal cells: 109.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in all"	6	"granulocytes: 20.8;NK-cells: 10.1;T-cells: 9.5"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB015223, HPA017857, HPA030550"	Enhanced		Approved	"Plasma membrane,Actin filaments,Cytosol"		Yes	No			Cytosol	"Plasma membrane, Actin filaments"	"CAB015223: , HPA017857: AB_1852904, HPA030550: AB_2673519"	"unprognostic (7.03e-2)"	"unprognostic (1.05e-1)"	"unprognostic (2.88e-1)"	"unprognostic (1.51e-3)"	"unprognostic (1.20e-1)"	"prognostic favorable (8.01e-4)"	"unprognostic (9.85e-3)"	"unprognostic (1.89e-2)"	"unprognostic (1.03e-2)"	"unprognostic (3.44e-3)"	"unprognostic (3.19e-1)"	"unprognostic (1.94e-1)"	"unprognostic (3.15e-3)"	"unprognostic (4.66e-2)"	"unprognostic (2.21e-1)"	"unprognostic (2.49e-1)"	"unprognostic (7.11e-2)"	6.8	5.6	13.0	10.5	18.4	9.2	7.7	11.9	16.5	6.6	25.2	10.4	2.4	31.6	6.7	3.9	5.9	6.3	14.3	5.1	11.0	14.5	20.7	83.9	11.8	11.8	11.2	9.8	8.8	9.0	9.7	8.2	16.3	15.3	5.8	7.4	6.8	4.4	5.3	2.2	2.7	43.3	6.1	9.6	10.7	15.6	13.5	9.6	6.3	7.5	1.5	10.0	6.8	6.7	1.2	1.1	20.8	2.0	10.1	9.5	2.1	4.9	6.7	10.6	3.7	18.4	17.1	6.3	12.0	14.6	11.9	11.6	8.7	4.2	3.6	7.3	18.3	18.6	0.2	8.7	3.7	9.4	7.0	1.8	9.2	5.2	9.9	17.2	7.3	10.2	17.2	2.5	11.8	10.3	17.3	14.8	8.8	8.3	1.9	16.7	3.7	9.1	6.3	3.4	7.4	9.6	16.1	9.2	13.4	9.5	11.1	9.0	6.2	11.2	5.3	3.8	6.4	0.0	10.1	20.8	15.4	18.7	19.7	8.8	3.5	5.3	7.8	13.6	7.5	5.4	6.5	2.0	6.1	9.3	1.3	9.5	0.9	7.1	5.3	0.8	1.2	7.3	4.7	20.8	10.1	0.6	1.1	6.3	2.1	13.0	18.4	11.9	16.5	11.0	14.5	11.2	9.8	15.3	9.6	62.5	38.2	16.9	8.2	4.9	31.9	10.4	140.1	21.4	35.2	36.6	13.7	17.4	14.9	9.7	2.1	17.5	52.0	46.7	16.6	9.6	15.9	14.5	11.6	111.5	19.6	109.7	14.3	20.3	21.0	6.9	21.0	19.9	8.5	24.4	30.3	16.0	18.6	10.5	29.4	40.8	14.8	6.5	9.9	28.8	59.6	1.8	41.4	39.9	11.9	3.4
LPIN3	"LIPN3L, SMP2"	ENSG00000132793	"Lipin 3"	Q9BQK8	20	41340920-41360582	"Enzymes, Predicted intracellular proteins"	"Fatty acid metabolism, Lipid metabolism"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 49.1"	"Cell type enhanced"	"Detected in many"	9	"Enterocytes: 49.9;Late spermatids: 82.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"NK-cell: 6.3"	"Group enriched"	"Detected in many"	4	"granulocytes: 1.8;NK-cells: 6.3"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in some"			"HPA051466, HPA052667, HPA070640"	Approved		Supported	Cytosol		NA	NA			Cytosol		"HPA051466: , HPA052667: AB_2681908, HPA070640: AB_2686288"	"unprognostic (2.31e-1)"	"unprognostic (4.73e-2)"	"unprognostic (1.68e-1)"	"prognostic unfavorable (9.74e-4)"	"unprognostic (1.88e-1)"	"unprognostic (1.04e-1)"	"unprognostic (6.91e-3)"	"unprognostic (4.26e-2)"	"unprognostic (1.74e-1)"	"prognostic unfavorable (1.74e-4)"	"unprognostic (4.29e-2)"	"unprognostic (7.79e-2)"	"prognostic unfavorable (1.14e-5)"	"unprognostic (5.60e-3)"	"unprognostic (2.02e-1)"	"unprognostic (1.35e-1)"	"unprognostic (3.37e-3)"	11.6	3.7	3.0	8.1	5.2	0.1	23.4	1.5	3.0	10.9	29.2	2.8	13.5	26.8	12.8	21.6	16.3	7.5	11.2	8.8	3.6	0.7	28.2	14.4	4.5	1.6	2.8	3.7	7.9	7.4	8.1	6.7	4.4	4.2	10.1	8.8	8.7	11.0	15.1	1.8	26.1	49.1	5.5	2.4	2.7	7.4	2.5	1.5	1.2	14.2	10.6	9.0	8.0	12.5	0.9	0.7	1.8	0.9	6.3	0.8	0.2	6.9	6.8	0.4	4.1	11.2	17.5	5.3	4.3	6.0	5.3	7.2	12.7	6.2	0.3	5.4	9.4	5.6	17.7	2.1	11.2	3.3	0.1	4.0	0.3	9.6	6.4	1.8	0.0	4.8	12.6	14.3	8.9	3.5	6.2	1.3	0.1	1.8	0.2	6.6	14.9	0.0	0.1	0.6	4.3	7.1	0.0	0.1	0.5	18.4	8.8	0.5	0.1	5.7	7.4	3.6	3.5	8.6	3.5	0.4	0.3	1.7	5.9	0.0	3.4	1.8	0.0	0.1	0.1	0.3	1.8	0.5	0.7	0.5	0.5	0.8	0.6	0.7	0.4	0.3	0.9	0.7	0.6	1.8	6.3	0.9	0.7	0.5	0.2	3.0	5.2	1.5	3.0	3.6	0.7	2.8	3.7	4.2	1.5	6.0	10.5	0.8	8.2	12.8	0.0	0.6	10.2	1.4	4.5	10.4	0.0	2.3	5.0	7.4	10.4	2.1	49.9	0.0	3.3	2.2	7.7	3.5	1.1	33.7	2.7	0.0	14.3	4.3	1.3	82.8	2.8	1.5	10.1	0.0	16.6	7.5	5.5	21.6	2.5	5.9	0.3	32.3	6.4	0.9	2.1	11.0	2.2	1.3	16.2	3.9
LPL	LIPD	ENSG00000175445	"Lipoprotein lipase"	P06858	8	19901717-19967258	"Candidate cardiovascular disease genes, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Lipid degradation, Lipid metabolism"	"Heparin-binding, Hydrolase"	"Disease mutation, FDA approved drug targets, Hyperlipidemia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 178.6;breast: 146.2;heart muscle: 121.4"	"Cell type enhanced"	"Detected in many"	20	"Cardiomyocytes: 482.3;Hofbauer cells: 114.1;Horizontal cells: 195.5;Sertoli cells: 232.8"	"Cancer enhanced"	"Detected in all"		"glioma: 39.2"	"Region enhanced"	"Detected in many"		"basal ganglia: 16.3"	"Cell type enhanced"	"Detected in some"		"non-classical monocyte: 7.1"	"Lineage enriched"	"Detected in many"	5	"monocytes: 7.1"	"Cell line enriched"	"Detected in some"	5	"AF22: 91.4"	"Region enhanced"	"Detected in many"		"basal ganglia: 40.6"	"Region enriched"	"Detected in many"	4	"basal ganglia: 64.0"	HPA048749			Supported	Vesicles	"Secreted to blood"	NA	NA		880000	Vesicles		"HPA048749: AB_2680511"	"unprognostic (5.52e-2)"	"unprognostic (3.16e-1)"	"unprognostic (6.41e-2)"	"unprognostic (3.03e-1)"	"unprognostic (4.14e-2)"	"unprognostic (1.01e-2)"	"unprognostic (1.88e-4)"	"unprognostic (1.05e-1)"	"unprognostic (6.78e-2)"	"unprognostic (8.20e-2)"	"unprognostic (2.54e-2)"	"unprognostic (5.28e-1)"	"unprognostic (1.18e-1)"	"unprognostic (4.20e-3)"	"unprognostic (4.16e-3)"	"unprognostic (1.19e-1)"	"prognostic unfavorable (6.07e-4)"	178.6	4.3	2.0	11.4	16.3	0.6	146.2	3.9	8.0	1.0	16.9	0.3	27.3	0.8	1.3	1.1	1.1	0.7	8.2	121.4	2.8	2.3	4.8	0.6	20.7	7.0	4.5	0.7	2.7	1.8	32.6	0.9	7.1	1.7	0.9	1.8	8.4	9.2	85.1	53.8	1.8	3.1	1.3	2.8	0.8	1.8	0.7	3.4	0.0	2.7	9.7	1.0	3.2	6.1	0.0	0.7	1.3	7.1	0.0	0.1	0.4	0.0	0.0	91.4	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	18.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	2.2	0.0	0.0	0.0	0.0	14.5	0.0	0.0	1.8	0.0	0.0	0.0	0.0	3.5	0.0	0.4	0.0	0.0	1.8	0.0	0.7	0.0	0.0	0.0	0.0	0.0	7.4	0.0	1.6	1.3	0.0	2.8	0.0	0.0	0.1	0.0	0.7	0.0	0.0	0.0	0.0	0.0	7.1	0.0	0.0	0.4	2.0	16.3	3.9	2.3	2.8	2.3	4.5	0.7	1.7	3.4	11.9	93.6	0.0	0.1	1.3	1.0	482.3	0.0	5.3	1.2	0.0	2.0	0.3	13.3	0.0	0.6	5.4	0.0	0.0	0.0	0.6	3.1	0.3	5.8	0.0	114.1	195.5	0.0	4.3	13.4	1.0	1.1	23.8	13.5	2.8	0.0	1.7	0.0	0.0	0.0	0.0	2.2	232.8	19.1	0.3	0.2	0.5	0.3	0.0	0.0	0.1
LPO	SPO	ENSG00000167419	Lactoperoxidase	P22079	17	58218548-58268518	"Enzymes, Predicted intracellular proteins, Predicted secreted proteins"	"Hydrogen peroxide"	"Antimicrobial, Oxidoreductase, Peroxidase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	262	"salivary gland: 345.7"	"Group enriched"	"Detected in some"	5	"Early spermatids: 5.0;Late spermatids: 10.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enriched"	"Detected in some"	9	"THP-1: 14.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			HPA028688	Enhanced	Supported			"Secreted to digestive system"	NA	NA					"HPA028688: AB_10601909"	"unprognostic (2.74e-1)"	"unprognostic (5.12e-2)"	"unprognostic (4.14e-3)"	"unprognostic (1.56e-3)"	"unprognostic (2.41e-2)"	"unprognostic (9.71e-2)"	"unprognostic (2.06e-2)"	"unprognostic (1.53e-1)"	"unprognostic (2.40e-2)"	"unprognostic (6.27e-3)"	"unprognostic (6.32e-2)"	"unprognostic (2.56e-1)"	"unprognostic (0.00e+0)"	"unprognostic (3.41e-2)"	"unprognostic (3.15e-1)"	"unprognostic (2.72e-2)"	"unprognostic (1.22e-1)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.8	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	345.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.3	1.2	0.0	0.0	1.2	0.8	1.3	0.7	0.8	0.9	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.1	0.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	1.2	0.0	0.0	0.0	0.0	0.0	0.0	14.4	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.0	1.0	1.5	0.0	0.9	0.7	0.4	0.6	0.3	0.5	0.9	0.7	0.6	0.2	1.2	0.6	0.9	1.3	0.8	0.3	0.8	0.4	0.4	0.0	0.0	0.0	0.1	0.1	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.7	0.5	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	5.0	0.3	0.0	0.0	0.0	0.0	0.2	0.4	1.1	0.0	0.2	1.6	0.0	0.6	0.0	10.6	0.3	0.0	0.0	1.0	0.0	0.0	0.5	0.0	0.4	0.0	0.1	0.0	0.0	1.4	0.7	0.3	0.0	0.0	0.0	0.4
LRAT	LCA14	ENSG00000121207	"Lecithin retinol acyltransferase"	O95237	4	154626945-154753118	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Sensory transduction, Vision"	"Acyltransferase, Transferase"	"Disease mutation, Leber congenital amaurosis"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	7	"retina: 82.4"	"Cell type enhanced"	"Detected in many"	6	"Cholangiocytes: 7.6;Early spermatids: 7.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"classical monocyte: 4.5"	"Low lineage specificity"	"Detected in many"			"Cell line enriched"	"Detected in some"	8	"NTERA-2: 16.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA070726			Uncertain	"Endoplasmic reticulum,Golgi apparatus"		NA	NA			"Golgi apparatus"	"Endoplasmic reticulum"	"HPA070726: "	"unprognostic (3.64e-3)"	"unprognostic (1.07e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.34e-1)"	"unprognostic (4.75e-2)"	"unprognostic (2.01e-1)"	"unprognostic (3.38e-1)"	"unprognostic (9.15e-2)"	"unprognostic (2.48e-1)"	"unprognostic (2.24e-1)"	"unprognostic (2.65e-1)"	"unprognostic (9.25e-2)"	"unprognostic (1.03e-4)"	"unprognostic (4.49e-6)"	"unprognostic (6.11e-2)"	"unprognostic (1.05e-1)"	"unprognostic (3.98e-1)"	0.9	0.8	2.2	0.8	3.2	1.8	1.4	0.7	1.1	0.9	4.2	3.0	0.8	3.7	0.5	1.2	0.5	0.9	2.3	0.6	3.1	4.2	0.6	3.3	1.0	0.5	2.9	2.4	1.0	2.9	0.3	1.0	0.3	8.9	1.6	0.4	82.4	0.5	1.6	2.3	1.4	11.1	0.3	7.0	0.7	0.9	2.9	3.1	0.0	4.9	0.2	0.6	0.5	0.7	0.9	3.7	2.0	4.5	0.6	0.3	3.9	0.7	0.5	0.4	0.2	0.1	0.2	0.2	0.1	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.7	0.3	0.0	0.2	0.0	0.0	0.1	0.8	0.6	0.1	0.1	0.2	0.5	0.4	0.3	0.1	0.1	0.3	0.0	0.1	0.1	0.2	0.1	0.2	0.1	0.3	16.5	0.0	0.0	0.1	0.0	0.1	2.0	0.5	0.1	0.0	0.2	0.1	0.2	0.3	0.1	0.0	0.0	0.4	0.2	0.6	0.1	0.1	0.0	0.0	0.0	0.2	0.5	1.0	4.5	0.4	0.3	1.6	0.3	0.5	0.3	0.3	3.7	0.9	0.3	0.3	2.0	0.6	0.5	0.5	0.2	3.9	2.2	3.2	0.7	1.1	3.1	4.2	2.9	2.4	8.9	3.1	0.0	4.1	0.0	4.2	1.0	0.8	0.2	7.6	0.0	1.2	0.0	0.0	0.1	3.3	0.8	7.2	0.2	2.0	0.0	0.7	0.1	0.3	2.4	0.0	2.0	0.1	0.0	0.0	1.8	0.0	1.6	0.0	0.0	5.0	0.0	0.7	3.7	1.4	0.0	0.0	0.3	0.9	0.0	0.1	4.8	4.5	1.0	0.2	0.7	0.3	0.6
LRRK1	"FLJ23119, KIAA1790, RIPK6, Roco1"	ENSG00000154237	"Leucine rich repeat kinase 1"	Q38SD2	15	100919215-101078254	"Enzymes, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 26.3"	"Cell type enhanced"	"Detected in many"	5	"Leydig cells: 30.0;monocytes: 32.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"eosinophil: 3.2;plasmacytoid DC: 3.3"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"Daudi: 23.5;Karpas-707: 17.3;U-266/84: 15.6;U-698: 15.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA010537	Uncertain		Supported	Mitochondria,Cytosol		NA	NA			"Mitochondria, Cytosol"		"HPA010537: AB_1079283"	"unprognostic (3.74e-2)"	"unprognostic (1.41e-1)"	"unprognostic (2.82e-1)"	"unprognostic (3.72e-1)"	"unprognostic (6.68e-2)"	"unprognostic (6.35e-2)"	"unprognostic (1.94e-1)"	"unprognostic (4.75e-2)"	"unprognostic (3.43e-2)"	"unprognostic (3.34e-2)"	"unprognostic (2.95e-2)"	"unprognostic (8.50e-2)"	"prognostic unfavorable (5.71e-5)"	"unprognostic (2.92e-2)"	"unprognostic (1.82e-2)"	"unprognostic (3.13e-1)"	"unprognostic (5.25e-2)"	6.1	1.9	4.5	26.3	3.9	6.5	5.0	2.1	8.1	6.4	8.0	5.9	2.2	2.9	7.9	6.0	5.4	7.1	4.2	3.4	4.0	1.5	2.7	1.0	4.7	15.0	4.5	4.0	6.3	5.3	2.8	2.3	4.4	2.5	7.1	6.5	2.8	7.7	6.8	1.6	7.3	8.5	5.7	3.7	11.1	3.9	5.1	3.4	1.2	3.5	2.1	17.4	7.5	6.7	2.3	3.3	3.2	1.1	0.0	0.0	0.1	0.8	4.8	0.0	0.0	7.4	7.6	0.0	2.9	2.1	2.7	1.9	0.8	2.1	23.5	1.1	7.8	0.0	4.8	0.7	0.5	1.4	0.4	1.1	7.1	1.1	0.0	0.5	3.8	5.5	6.0	1.0	1.7	1.5	0.7	4.7	0.0	1.2	17.3	0.5	0.0	0.0	2.4	0.2	4.3	2.0	1.7	0.4	6.4	0.0	0.0	0.0	1.7	1.8	2.7	5.4	0.0	0.3	4.6	5.4	0.0	0.8	1.0	0.0	8.8	15.6	15.2	0.3	0.5	4.4	0.0	0.7	3.2	0.0	0.3	0.0	2.3	0.0	0.0	0.9	1.5	0.0	0.0	0.8	0.0	1.1	3.3	0.0	0.1	4.5	3.9	2.1	8.1	4.0	1.5	4.5	4.0	2.5	3.4	14.9	12.8	11.9	6.5	2.9	0.6	2.8	2.5	8.1	7.9	0.0	5.9	8.4	0.0	3.6	3.0	5.7	12.0	0.0	2.7	3.1	3.5	6.3	1.1	0.0	9.5	0.0	13.2	12.3	14.3	2.4	30.0	14.0	3.3	32.5	12.8	0.8	6.7	10.5	20.1	0.3	0.4	6.5	2.1	5.2	1.1	3.0	3.0	0.5	10.8	9.3
LRRK2	"DKFZp434H2111, FLJ45829, PARK8, RIPK7, ROCO2"	ENSG00000188906	"Leucine rich repeat kinase 2"	Q5S007	12	40196744-40369285	"Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Autophagy, Differentiation"	"GTPase activation, Hydrolase, Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes, Disease mutation, Neurodegeneration, Parkinson disease, Parkinsonism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	4	"blood: 40.4;lung: 50.4"	"Cell type enriched"	"Detected in many"	5	"Alveolar cells type 2: 391.0"	"Group enriched"	"Detected in many"	7	"lung cancer: 5.3;renal cancer: 17.1;thyroid cancer: 22.7"	"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	7	"neutrophil: 40.4"	"Lineage enriched"	"Detected in many"	7	"granulocytes: 40.4"	"Cell line enhanced"	"Detected in some"		"A549: 9.9;ASC TERT1: 10.2;BJ hTERT+: 5.7;RPTEC TERT1: 10.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA014293, CAB037160"	Approved		Supported	Vesicles		NA	NA			Vesicles		"CAB037160: AB_1840989, HPA014293: AB_1853353"	"unprognostic (2.67e-1)"	"unprognostic (1.75e-1)"	"unprognostic (6.45e-3)"	"unprognostic (1.06e-1)"	"unprognostic (3.00e-2)"	"unprognostic (6.10e-3)"	"unprognostic (2.71e-1)"	"unprognostic (3.14e-1)"	"unprognostic (2.25e-1)"	"unprognostic (9.07e-2)"	"unprognostic (2.76e-1)"	"unprognostic (1.23e-1)"	"prognostic favorable (3.02e-6)"	"unprognostic (2.55e-2)"	"unprognostic (3.43e-2)"	"unprognostic (2.01e-3)"	"unprognostic (5.21e-3)"	3.7	3.4	2.3	7.0	3.9	8.6	3.0	1.7	5.0	5.1	4.5	1.7	2.6	0.7	5.3	2.9	5.3	3.8	4.5	4.0	1.8	1.4	10.6	4.5	50.4	6.8	2.2	3.6	5.8	3.3	10.9	2.5	1.0	1.9	3.6	1.6	3.3	4.2	2.0	5.6	2.6	3.4	6.7	4.9	8.6	2.7	1.2	2.4	0.5	3.9	2.7	4.9	4.6	6.8	0.9	1.5	40.4	5.8	0.0	0.0	0.8	0.0	9.9	0.1	0.0	3.9	10.2	0.1	2.1	5.7	0.4	0.3	0.0	0.0	0.0	0.0	1.9	0.3	0.0	0.3	0.0	0.4	0.0	0.8	0.3	0.2	0.0	0.7	0.5	0.1	2.5	0.7	0.0	0.2	3.8	0.6	0.0	0.0	0.0	0.7	0.0	0.0	1.2	0.2	0.0	0.1	0.0	0.0	0.0	10.9	0.0	0.1	0.6	0.0	0.2	2.8	0.3	2.8	2.2	1.4	1.2	1.1	1.2	0.7	0.0	0.0	0.0	2.4	0.0	0.5	0.0	5.8	1.2	0.0	3.1	0.0	0.9	0.0	0.0	1.5	0.9	0.0	0.0	40.4	0.0	3.0	0.2	0.0	0.8	2.3	3.9	1.7	5.0	1.8	1.4	2.2	3.6	1.9	2.4	29.8	391.0	17.5	1.5	2.2	7.5	6.9	5.1	5.3	30.7	26.2	0.0	0.0	1.7	0.8	0.4	4.5	0.0	0.0	2.3	0.1	9.4	0.6	12.8	7.8	4.6	44.5	0.0	9.2	74.8	0.0	17.5	19.9	11.8	10.8	0.0	11.0	1.1	0.0	11.3	15.2	0.9	0.0	3.9	0.2	0.4	2.8	0.3	0.8	0.0	0.5
LRSAM1	"CMT2P, FLJ31641"	ENSG00000148356	"Leucine rich repeat and sterile alpha motif containing 1"	Q6UWE0	9	127451486-127503501	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Autophagy, Protein transport, Transport, Ubl conjugation pathway"	Transferase	"Charcot-Marie-Tooth disease, Disease mutation, Neurodegeneration, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021403, HPA021844, CAB037304"	Supported		Approved	Cytosol		NA	NA			Cytosol		"CAB037304: AB_2138198, HPA021403: AB_1853366, HPA021844: AB_1853368"	"unprognostic (8.83e-2)"	"unprognostic (3.13e-1)"	"unprognostic (7.48e-3)"	"unprognostic (4.15e-3)"	"unprognostic (9.42e-2)"	"unprognostic (2.05e-1)"	"unprognostic (1.64e-1)"	"unprognostic (5.00e-2)"	"unprognostic (1.66e-1)"	"unprognostic (2.72e-2)"	"prognostic favorable (6.78e-6)"	"unprognostic (1.27e-1)"	"prognostic favorable (5.72e-4)"	"unprognostic (1.94e-2)"	"unprognostic (3.26e-1)"	"unprognostic (9.07e-2)"	"unprognostic (3.33e-2)"	9.5	13.6	15.6	10.1	17.2	15.3	9.2	24.2	22.6	10.7	18.0	15.3	10.9	10.8	12.6	17.6	12.3	11.0	11.9	18.7	13.3	17.3	11.2	15.6	11.7	11.5	13.5	22.7	16.0	9.6	17.6	11.8	9.2	17.9	13.6	8.6	10.2	11.9	13.7	20.4	28.3	11.1	16.0	18.7	12.6	12.2	6.1	13.9	5.5	11.6	9.6	11.5	17.2	12.9	4.1	5.4	17.4	6.6	1.3	4.8	3.2	5.7	8.8	5.3	10.2	9.0	8.9	8.4	5.4	6.8	8.4	6.2	10.1	5.6	9.9	5.6	7.5	4.3	19.1	6.5	11.4	3.3	10.4	4.9	5.4	11.4	8.8	7.2	5.9	11.4	5.1	9.4	5.7	11.0	10.8	9.0	8.2	4.7	10.3	3.7	14.6	4.1	5.1	5.0	13.4	8.9	6.7	4.8	15.4	9.1	5.0	9.8	8.1	3.5	12.1	7.1	5.3	24.9	3.2	10.5	5.6	5.7	7.0	3.7	11.4	8.5	1.6	9.3	5.5	2.9	14.6	4.9	17.4	4.4	6.6	4.8	4.1	3.0	3.7	5.4	3.1	1.5	2.0	5.7	1.3	5.5	4.6	2.4	3.2	15.6	17.2	24.2	22.6	13.3	17.3	13.5	22.7	17.9	13.9	8.9	4.6	2.7	2.8	1.0	5.6	18.3	5.1	6.7	10.3	0.0	5.9	4.1	5.0	5.4	0.6	3.6	5.6	0.0	1.2	1.7	2.4	3.6	9.2	5.9	5.4	11.1	1.2	4.3	6.6	0.2	2.6	4.5	3.3	10.8	5.2	5.7	4.2	4.3	4.9	5.0	4.8	0.0	4.1	4.6	3.0	2.4	5.8	5.0	4.9	3.0
LRTOMT	"CFAP111, COMT2, DFNB63, LRRC51"	ENSG00000184154	"Leucine rich transmembrane and O-methyltransferase domain containing"	"Q8WZ04, Q96E66"	11	72080331-72110782	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Catecholamine metabolism, Hearing, Neurotransmitter degradation"	"Methyltransferase, Transferase"	"Deafness, Disease mutation, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"fallopian tube: 49.8;testis: 47.8"	"Group enriched"	"Detected in many"	10	"Early spermatids: 522.5;Late spermatids: 1781.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"T-47d: 27.7"									HPA039949	Approved		Uncertain	Microtubules		NA	NA			Microtubules		"HPA039949: AB_10960708"	"unprognostic (2.68e-1)"	"unprognostic (6.43e-2)"	"unprognostic (1.85e-2)"	"prognostic favorable (7.70e-4)"	"unprognostic (8.09e-2)"	"unprognostic (9.07e-2)"	"unprognostic (1.42e-1)"	"unprognostic (1.90e-1)"	"unprognostic (4.22e-2)"	"prognostic favorable (5.36e-4)"	"unprognostic (6.12e-2)"	"unprognostic (8.43e-2)"	"unprognostic (2.64e-2)"	"unprognostic (1.58e-1)"	"unprognostic (1.34e-1)"	"unprognostic (1.67e-1)"	"unprognostic (1.44e-1)"	3.5	3.7	10.6	2.0	11.1	2.1	7.1	3.7	8.9	7.1	4.2	14.0	6.1	3.2	6.0	13.6	3.5	49.8	5.3	2.6	8.8	7.6	9.0	6.2	6.2	2.6	7.7	8.5	8.5	7.0	7.1	8.9	4.4	10.6	7.5	6.2	7.3	4.3	4.7	5.2	4.5	2.5	4.8	7.7	3.2	3.6	47.8	8.9	3.1	9.3	2.4	3.5	3.5	2.6	4.3	4.2	9.2	2.9	10.1	6.2	2.0	2.6	9.8	6.2	5.0	5.4	4.8	1.5	3.1	2.5	2.8	2.5	4.7	14.3	3.4	4.7	5.3	6.9	5.3	4.4	7.4	3.2	6.4	4.3	2.5	4.5	3.3	0.9	2.0	2.7	2.1	3.8	4.3	3.3	4.6	1.0	7.2	2.7	5.3	4.1	9.3	6.0	4.0	3.1	15.4	2.6	7.3	6.3	5.2	11.0	3.2	5.8	4.5	6.1	14.0	7.5	4.5	27.7	2.4	4.6	3.0	4.2	8.0	2.1	5.7	6.2	3.9	2.9	1.7	3.3	2.3	2.9	5.0	3.1	2.8	3.2	4.2	3.3	2.6	1.7	4.3	3.0	3.0	9.2	10.1	1.8	4.2	6.2	2.0	10.6	11.1	3.7	8.9	8.8	7.6	7.7	8.5	10.6	8.9	0.0	1.0	6.1	6.6	2.1	3.7	1.7	5.1	115.1	9.1	3.5	11.8	11.0	10.0	6.1	522.5	4.5	3.1	0.0	2.1	6.7	4.1	11.4	0.0	5.6	2.7	6.4	1.2	3.1	1.0	1781.2	13.8	2.2	1.7	1.8	8.8	12.6	1.8	2.9	9.6	14.6	12.6	6.5	7.1	69.5	22.8	2.0	11.0	2.6	4.3	4.7
LSS	OSC	ENSG00000160285	"Lanosterol synthase"	P48449	21	46188141-46228824	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis"	Isomerase	"Cataract, Disease mutation, Hypotrichosis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"GAMG: 63.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA032060, HPA032062, CAB034116"	Supported		Approved	Cytosol		NA	NA			Cytosol		"CAB034116: AB_2138611, HPA032060: AB_10671085, HPA032062: AB_2674134"	"unprognostic (2.78e-3)"	"unprognostic (8.53e-3)"	"unprognostic (6.95e-2)"	"unprognostic (2.07e-1)"	"unprognostic (1.74e-2)"	"unprognostic (1.06e-1)"	"unprognostic (2.74e-2)"	"unprognostic (1.33e-2)"	"unprognostic (1.72e-1)"	"unprognostic (1.58e-2)"	"unprognostic (1.68e-2)"	"unprognostic (2.02e-2)"	"unprognostic (2.34e-2)"	"prognostic unfavorable (6.80e-4)"	"unprognostic (1.92e-1)"	"unprognostic (2.50e-1)"	"prognostic unfavorable (3.07e-4)"	21.1	22.9	17.9	9.9	38.8	5.0	14.7	22.5	33.9	11.2	16.9	37.7	5.8	26.4	16.6	12.5	23.4	11.0	12.1	17.8	19.0	17.3	8.4	33.8	19.7	8.3	49.5	14.9	25.7	15.8	10.4	22.7	10.3	42.7	24.0	10.7	13.2	11.0	13.2	24.5	26.2	10.3	12.2	33.3	7.1	14.1	13.8	46.9	6.0	7.5	9.8	8.3	12.3	11.8	4.8	8.0	5.2	3.3	2.7	8.3	5.0	18.1	5.9	19.2	8.2	26.1	25.1	5.4	7.0	49.9	8.7	17.1	19.4	14.5	3.9	6.0	13.6	63.9	8.6	16.9	29.4	3.5	3.8	9.1	9.7	9.7	12.5	23.8	3.5	6.8	24.7	11.2	16.2	7.0	6.0	7.2	19.3	9.4	23.5	7.4	6.1	7.6	5.0	31.2	2.9	5.3	9.0	5.9	23.7	22.6	10.0	11.2	9.9	8.3	6.4	7.2	8.6	10.2	8.8	10.7	10.3	8.4	9.1	5.4	8.6	7.3	7.9	10.8	15.6	4.4	5.2	3.3	3.5	6.9	3.0	4.7	4.8	5.0	8.3	3.8	3.0	4.2	6.2	0.0	2.7	2.5	8.0	2.3	5.0	17.9	38.8	22.5	33.9	19.0	17.3	49.5	14.9	42.7	46.9	11.9	33.7	11.5	3.8	32.7	12.9	13.4	12.7	8.1	7.9	10.4	3.9	3.4	0.0	9.7	4.2	9.8	5.3	23.3	15.0	5.1	25.7	14.9	3.5	23.8	8.1	22.3	18.9	9.8	7.8	5.3	19.5	5.0	20.3	19.0	10.0	8.7	10.9	0.0	12.7	3.8	15.2	0.0	10.0	13.6	9.4	47.2	5.3	5.0	10.0	4.1
LTA4H		ENSG00000111144	"Leukotriene A4 hydrolase"	P09960	12	96000828-96043520	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins"	"Leukotriene biosynthesis"	"Hydrolase, Metalloprotease, Protease"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Hofbauer cells: 215.6;Kupffer cells: 278.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008399, CAB015221, HPA017017"	Supported		Approved	Nucleoplasm,Cytosol		NA	NA		85000000	"Nucleoplasm, Cytosol"		"CAB015221: , HPA008399: AB_1852816, HPA017017: AB_1852818"	"prognostic favorable (9.79e-4)"	"unprognostic (6.62e-2)"	"unprognostic (6.04e-2)"	"unprognostic (1.87e-1)"	"unprognostic (1.38e-2)"	"unprognostic (2.59e-2)"	"unprognostic (4.25e-3)"	"prognostic favorable (8.96e-4)"	"unprognostic (1.72e-1)"	"unprognostic (1.75e-2)"	"unprognostic (3.38e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.73e-1)"	"unprognostic (1.74e-1)"	"unprognostic (1.04e-1)"	"unprognostic (3.50e-2)"	"unprognostic (1.34e-1)"	27.9	33.2	11.2	21.5	16.7	55.7	19.0	24.1	15.6	27.2	29.1	13.1	16.7	27.6	27.6	14.1	53.4	22.7	14.5	19.2	10.6	12.2	27.2	19.4	68.0	33.4	12.3	11.3	49.9	28.2	21.2	31.8	11.3	13.3	29.6	17.8	20.7	21.1	16.1	20.6	23.6	41.2	21.5	13.3	44.3	22.1	13.7	11.5	29.2	38.8	22.3	43.1	30.1	25.2	20.6	35.3	6.1	84.2	14.2	9.0	54.6	21.0	22.6	31.8	18.9	27.6	30.9	13.9	8.8	26.1	17.4	20.3	16.5	18.2	47.1	11.1	13.1	13.7	27.7	26.0	35.9	23.8	16.1	25.2	17.3	14.5	20.0	16.3	9.1	10.5	29.4	30.3	24.0	29.5	79.5	34.5	27.6	10.5	8.3	25.1	14.4	23.9	28.0	37.0	25.1	30.7	22.4	23.7	27.1	32.0	26.8	16.5	19.5	17.8	20.8	19.1	25.5	25.9	11.2	12.3	7.4	12.5	10.5	9.5	11.2	19.4	21.8	5.2	16.5	5.8	0.4	76.0	2.2	4.5	84.2	8.4	15.1	6.3	5.8	35.3	20.6	9.0	6.7	6.1	14.2	73.2	8.7	6.3	54.6	11.2	16.7	24.1	15.6	10.6	12.2	12.3	11.3	13.3	11.5	35.7	107.1	87.8	57.2	46.0	19.4	23.4	17.8	48.2	91.0	36.6	31.4	27.0	63.0	34.2	44.9	33.1	22.4	0.0	24.3	24.3	27.5	27.6	7.0	18.1	215.6	11.1	20.7	47.3	278.8	8.1	33.9	139.0	20.3	38.7	40.9	32.1	23.4	24.6	38.5	53.1	58.0	6.5	18.5	45.1	12.5	65.5	17.4	34.8	53.6	42.1
LTC4S	MGC33147	ENSG00000213316	"Leukotriene C4 synthase"	Q16873	5	179793980-179796647	"Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins"	"Leukotriene biosynthesis, Lipid biosynthesis, Lipid metabolism"	"Lyase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 31.3"	"Cell type enriched"	"Detected in many"	6	"granulocytes: 332.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"basophil: 8.5;eosinophil: 31.3"	"Lineage enriched"	"Detected in many"	7	"granulocytes: 31.3"	"Cell line enriched"	"Detected in some"	10	"HMC-1: 52.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA044688			Approved	"Nucleoplasm,Endoplasmic reticulum,Cytosol"		NA	NA			Nucleoplasm	"Endoplasmic reticulum, Cytosol"	"HPA044688: "	"unprognostic (8.94e-2)"	"unprognostic (2.40e-2)"			"unprognostic (9.35e-3)"		"unprognostic (3.57e-2)"	"unprognostic (1.24e-2)"		"unprognostic (9.40e-2)"	"unprognostic (4.53e-5)"	"unprognostic (2.27e-2)"	"unprognostic (1.06e-1)"	"unprognostic (9.99e-2)"	"unprognostic (2.65e-1)"	"unprognostic (1.98e-2)"	"unprognostic (4.62e-1)"	9.0	6.7	3.5	2.8	3.5	8.6	4.6	1.7	5.0	6.9	5.0	9.4	5.4	3.6	8.7	10.4	4.2	13.0	15.7	11.3	3.9	3.1	6.2	2.3	28.3	8.0	6.8	4.2	5.8	2.4	2.0	3.2	2.9	4.3	5.6	1.9	3.3	7.4	11.6	2.7	3.5	5.7	4.5	6.3	6.7	5.0	3.3	3.9	0.8	5.3	5.6	3.2	3.6	3.9	0.1	4.5	31.3	0.3	2.2	1.7	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.3	0.4	5.3	0.0	0.2	0.2	0.3	52.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.6	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.5	0.0	8.5	0.2	31.3	0.5	0.3	1.7	0.1	1.2	0.8	4.5	0.1	0.2	0.5	0.1	2.2	0.0	0.2	0.1	0.3	3.5	3.5	1.7	5.0	3.9	3.1	6.8	4.2	4.3	3.9	0.0	5.6	2.2	7.5	8.9	0.2	0.0	12.7	4.0	3.4	14.0	0.0	6.9	1.7	4.1	0.3	11.3	0.4	0.0	2.1	1.5	4.7	3.1	332.3	0.8	33.8	0.0	2.9	53.4	8.9	0.0	15.3	23.5	1.7	1.0	1.6	0.0	2.1	0.0	44.6	40.2	0.3	0.0	0.9	0.0	0.7	6.0	2.5	5.0	2.6	5.0
LTK	TYK1	ENSG00000062524	"Leukocyte receptor tyrosine kinase"	P29376	15	41503638-41513887	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"		"Kinase, Receptor, Transferase, Tyrosine-protein kinase"	"Systemic lupus erythematosus"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"lung: 15.1"	"Cell type enhanced"	"Detected in many"	11	"Enterocytes: 13.4;Ito cells: 14.7;Mucus-secreting cells: 7.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Group enriched"	"Detected in some"	5	"MAIT T-cell: 8.3;plasmacytoid DC: 7.0"	"Group enriched"	"Detected in many"	10	"dendritic cells: 7.0;T-cells: 8.3"	"Cell line enhanced"	"Detected in some"		"HEL: 5.4;NB-4: 10.5;RH-30: 5.1;THP-1: 16.1"	"Low region specificity"	"Detected in many"							HPA059545			Approved	Vesicles		NA	NA			Vesicles		"HPA059545: AB_2684057"	"unprognostic (9.47e-4)"	"unprognostic (5.52e-4)"	"unprognostic (1.51e-1)"	"unprognostic (2.49e-1)"	"unprognostic (4.12e-1)"	"unprognostic (5.65e-3)"	"unprognostic (1.74e-2)"	"unprognostic (7.22e-2)"	"unprognostic (2.89e-2)"	"unprognostic (2.81e-3)"	"unprognostic (9.36e-3)"	"unprognostic (5.36e-2)"	"unprognostic (4.68e-2)"	"unprognostic (5.78e-2)"	"unprognostic (1.52e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.90e-1)"	1.0	0.5	0.5	5.1	1.6	3.1	0.5	2.0	3.2	0.6	8.2	0.5	1.9	10.6	1.3	1.1	1.2	0.3	2.0	2.2	0.5	0.1	3.5	4.3	15.1	0.6	0.5	0.5	1.0	0.5	1.0	0.7	8.9	0.5	0.7	4.8	4.3	11.7	0.5	2.0	0.9	10.7	0.5	0.5	5.5	8.3	2.4	0.8	0.5	0.7	0.5	2.2	0.6	0.7	0.7	7.0	0.0	0.0	0.0	8.3	0.2	0.0	0.0	0.0	0.0	0.1	0.3	0.6	0.1	0.6	1.0	1.3	2.4	0.0	0.0	0.1	0.7	0.0	0.0	2.9	0.0	0.4	0.2	1.4	5.4	0.0	0.0	2.4	0.0	0.0	0.4	0.4	0.0	0.1	0.0	0.0	0.0	2.0	0.0	2.1	0.0	0.0	10.5	0.4	2.0	0.2	0.2	5.1	0.2	0.0	0.0	0.5	3.4	0.1	0.2	0.0	3.0	0.2	16.1	0.0	0.0	0.2	0.2	0.1	0.4	0.2	0.2	0.0	0.5	0.9	0.0	0.0	0.0	0.6	0.0	8.3	0.7	0.5	1.4	0.1	0.1	0.0	0.1	0.0	0.0	0.0	7.0	0.0	0.2	0.5	1.6	2.0	3.2	0.5	0.1	0.5	0.5	0.5	0.8	0.0	0.0	0.0	0.0	0.1	0.0	0.6	5.1	4.0	1.2	0.0	0.0	0.2	0.0	0.0	2.1	0.1	13.4	0.0	0.2	1.1	0.2	0.0	0.0	0.2	0.1	0.0	1.7	14.7	3.2	1.7	0.0	0.0	3.3	0.0	7.8	0.0	0.5	3.5	0.0	0.0	0.0	0.0	0.0	0.5	1.1	0.1	0.3	1.3	2.8	0.0
LTN1	"C21orf10, C21orf98, FLJ11053, KIAA0714, LISTERIN, RNF160, ZNF294"	ENSG00000198862	"Listerin E3 ubiquitin protein ligase 1"	O94822	21	28928144-28992956	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	5	"Early spermatids: 218.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029143, CAB034164, HPA055604"	Uncertain		Enhanced	Cytosol		NA	NA			Cytosol		"CAB034164: AB_2180094, HPA029143: AB_10671360, HPA055604: AB_2682859"	"unprognostic (3.67e-2)"	"unprognostic (7.07e-2)"	"unprognostic (7.78e-2)"	"unprognostic (3.99e-1)"	"unprognostic (1.42e-2)"	"unprognostic (3.66e-3)"	"unprognostic (5.38e-2)"	"unprognostic (5.40e-2)"	"unprognostic (9.98e-2)"	"unprognostic (4.45e-2)"	"unprognostic (2.85e-2)"	"unprognostic (1.13e-1)"	"unprognostic (9.87e-2)"	"unprognostic (1.72e-1)"	"unprognostic (8.22e-2)"	"unprognostic (4.57e-2)"	"unprognostic (1.52e-1)"	17.9	15.1	10.3	12.4	19.8	21.2	17.9	19.9	23.2	16.6	14.7	17.8	12.1	12.4	16.5	15.4	15.2	14.5	10.8	13.1	12.0	10.6	14.1	19.3	12.0	15.7	19.6	14.2	16.4	23.7	18.4	22.6	29.0	28.7	19.0	15.6	9.7	16.1	12.6	22.5	14.8	17.1	13.4	17.4	16.7	15.4	20.7	15.8	23.0	17.6	14.6	14.9	16.6	14.7	7.8	6.2	12.2	11.9	8.6	8.4	3.3	12.8	5.5	11.5	5.2	9.9	13.6	11.7	10.9	8.9	9.4	13.0	7.7	10.7	8.5	5.3	9.7	8.1	6.6	12.2	8.9	17.1	9.9	8.5	25.3	7.6	6.1	7.4	8.4	9.9	9.4	8.1	13.3	11.1	9.3	9.9	6.2	20.6	20.4	10.7	4.0	5.3	8.1	16.5	10.7	6.6	7.2	23.1	17.7	10.6	11.1	6.3	13.1	12.5	9.6	10.9	11.3	9.7	11.8	13.0	8.3	15.4	11.1	9.1	16.6	15.6	12.0	12.9	18.2	9.8	12.2	6.4	9.5	8.4	9.8	7.0	7.8	5.8	5.6	6.2	7.1	6.2	4.7	11.3	8.6	11.9	3.9	6.1	3.3	10.3	19.8	19.9	23.2	12.0	10.6	19.6	14.2	28.7	15.8	14.9	19.9	19.0	22.3	26.9	24.3	23.8	7.6	21.4	19.4	10.4	31.4	15.4	1.7	12.5	218.4	21.5	16.6	0.0	12.2	16.4	19.2	28.0	26.6	18.4	11.3	39.7	21.8	15.4	24.1	45.8	24.7	18.9	11.8	19.0	17.8	44.4	16.5	17.3	19.8	15.7	29.4	12.9	19.5	36.9	19.0	28.0	24.9	27.3	17.8	29.8
LVRN	"APQ, AQPEP, FLJ90650, TAQPEP"	ENSG00000172901	Laeverin	Q6Q4G3	5	115962454-116027619	"Enzymes, Predicted intracellular proteins"		"Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	7	"placenta: 75.1"	"Cell type enhanced"	"Detected in some"	20	"Early spermatids: 25.5;Extravillous trophoblasts: 21.0;Late spermatids: 42.0;Syncytiotrophoblasts: 8.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC diff: 2.4;ASC TERT1: 3.9;CAPAN-2: 1.8;SiHa: 1.5;U-266/70: 1.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA053254	Enhanced				"Intracellular and membrane"	NA	NA					"HPA053254: AB_2682092"	"unprognostic (1.47e-1)"	"unprognostic (3.38e-3)"	"unprognostic (5.81e-2)"	"unprognostic (2.97e-3)"	"unprognostic (5.38e-2)"	"unprognostic (1.32e-1)"	"unprognostic (2.59e-3)"	"unprognostic (1.88e-2)"	"unprognostic (2.23e-1)"	"unprognostic (2.23e-2)"	"unprognostic (3.83e-3)"	"unprognostic (1.22e-1)"	"unprognostic (1.67e-7)"	"unprognostic (1.05e-2)"	"unprognostic (5.94e-2)"	"unprognostic (6.53e-2)"	"unprognostic (3.31e-2)"	10.6	0.1	0.0	0.5	0.0	0.1	3.9	0.0	0.0	0.3	1.4	0.0	0.4	0.1	0.0	0.0	1.8	0.2	0.4	1.1	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.9	0.1	0.0	0.1	75.1	0.0	0.7	0.4	0.0	0.6	1.2	1.3	1.0	1.7	0.5	0.0	0.0	0.4	0.3	0.0	0.0	0.3	1.7	0.1	0.7	0.7	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.2	0.0	0.3	0.1	2.4	3.9	0.9	0.2	0.3	0.1	0.3	0.0	1.8	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.5	1.2	0.1	0.0	0.9	0.0	0.0	0.2	0.3	1.3	0.4	0.0	0.0	0.3	0.1	0.6	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.4	1.5	0.0	0.0	0.6	0.0	0.0	0.0	0.3	0.3	0.0	0.6	1.6	0.1	0.1	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.1	25.5	0.0	0.0	0.0	0.0	21.0	0.2	0.2	0.0	0.0	1.0	0.0	0.0	0.0	0.0	42.0	4.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.2	0.2	0.0	8.9	0.0	0.0	0.0
LYN	JTK8	ENSG00000254087	"LYN proto-oncogene, Src family tyrosine kinase"	P07948	8	55879813-56014168	"Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Adaptive immunity, Host-virus interaction, Immunity, Inflammatory response, Innate immunity"	"Kinase, Transferase, Tyrosine-protein kinase"	"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 70.9"	"Cell type enhanced"	"Detected in many"	6	"Hofbauer cells: 110.4;Kupffer cells: 161.3;Macrophages: 122.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"neutrophil: 36.8"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HEL: 57.7;HMC-1: 58.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001231, CAB004492"	Enhanced		Supported	"Golgi apparatus,Vesicles,Plasma membrane"		NA	NA		11000000	"Golgi apparatus, Plasma membrane"	Vesicles	"CAB004492: AB_627897, HPA001231: AB_1079286"	"unprognostic (7.87e-2)"	"unprognostic (4.89e-2)"	"unprognostic (9.04e-2)"	"unprognostic (3.74e-1)"	"unprognostic (8.12e-2)"	"unprognostic (2.17e-1)"	"unprognostic (5.70e-2)"	"unprognostic (1.11e-1)"	"unprognostic (2.79e-1)"	"unprognostic (8.80e-2)"	"unprognostic (3.68e-2)"	"unprognostic (7.15e-2)"	"prognostic unfavorable (3.43e-4)"	"unprognostic (2.13e-1)"	"unprognostic (2.72e-3)"	"unprognostic (1.21e-1)"	"unprognostic (7.39e-2)"	8.8	6.8	4.5	34.0	6.3	33.6	11.1	9.5	4.1	5.3	10.5	5.8	7.2	15.6	3.4	7.8	7.2	6.7	13.7	8.9	4.8	3.6	6.1	13.8	34.6	70.9	7.7	2.1	5.3	9.8	3.1	4.9	19.1	5.6	5.7	6.6	6.3	14.9	8.5	2.7	3.4	16.2	6.6	8.5	69.4	7.4	3.6	5.1	3.8	9.4	5.3	25.8	10.7	7.5	8.4	9.2	36.8	26.5	1.9	0.9	2.7	12.8	7.7	1.8	0.3	0.1	0.0	13.9	9.8	14.5	6.2	4.4	5.3	4.4	12.4	4.4	3.9	4.8	6.0	7.2	7.3	5.3	20.1	7.2	57.7	2.3	1.9	1.9	5.8	58.6	0.3	2.5	0.1	4.5	3.6	8.3	0.0	30.5	26.9	0.9	0.7	0.0	6.1	11.1	20.2	0.9	0.9	2.8	1.5	4.0	6.1	1.2	22.3	4.9	0.0	2.0	13.8	1.1	13.6	9.7	0.0	2.9	0.0	4.4	9.0	3.3	28.1	0.6	11.5	0.4	2.1	7.2	12.3	0.9	16.8	0.7	8.2	0.2	0.3	6.4	8.4	0.1	0.4	36.8	1.9	26.5	9.2	0.0	2.7	4.5	6.3	9.5	4.1	4.8	3.6	7.7	2.1	5.6	5.1	32.8	35.7	89.3	18.6	4.7	2.1	1.4	17.8	22.7	31.8	8.7	2.0	2.5	0.0	18.6	0.6	18.5	14.9	0.0	44.9	61.3	8.4	36.9	70.5	10.9	110.4	0.0	5.8	25.8	161.3	1.7	3.1	122.4	5.0	73.1	13.5	61.7	37.6	13.5	1.1	1.3	1.5	19.4	4.3	0.2	1.2	5.1	32.4	24.5	12.3	92.1
LYZ		ENSG00000090382	Lysozyme	P61626	12	69348341-69354234	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted secreted proteins"		"Antimicrobial, Bacteriolytic enzyme, Glycosidase, Hydrolase"	"Amyloidosis, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 490.0;salivary gland: 1017.8"	"Cell type enhanced"	"Detected in many"	16	"Kupffer cells: 3040.5;Macrophages: 4386.3;Pancreatic endocrine cells: 1930.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"classical monocyte: 490.0;myeloid DC: 308.1"	"Group enriched"	"Detected in all"	18	"dendritic cells: 308.1;monocytes: 490.0"	"Cell line enriched"	"Detected in some"	13	"OE19: 521.4"					"Not detected"	"Not detected"			"CAB000055, HPA048284, HPA066182"	Enhanced		Approved	"Nucleoplasm,Golgi apparatus,Actin filaments"	"Secreted to blood"	NA	NA	1500000000	2600000000	"Golgi apparatus, Actin filaments"	Nucleoplasm	"CAB000055: AB_2341230, HPA048284: AB_2680339, HPA066182: AB_2732741"	"unprognostic (8.52e-2)"	"unprognostic (6.12e-3)"	"unprognostic (2.83e-1)"	"unprognostic (7.29e-2)"	"unprognostic (7.91e-2)"	"prognostic favorable (7.45e-4)"	"unprognostic (1.21e-1)"	"unprognostic (7.40e-2)"	"unprognostic (1.41e-1)"	"unprognostic (2.08e-2)"	"unprognostic (1.44e-1)"	"unprognostic (3.13e-1)"	"unprognostic (2.50e-1)"	"unprognostic (2.37e-1)"	"unprognostic (3.65e-2)"	"unprognostic (5.78e-2)"	"unprognostic (3.62e-2)"	19.1	2.4	1.7	42.1	1.8	187.0	2.9	1.6	1.6	2.9	52.5	2.0	0.1	72.4	2.3	6.9	3.9	3.4	105.0	15.4	1.8	1.8	4.8	4.8	81.0	57.2	2.1	0.0	4.5	5.0	0.0	1.8	8.3	0.9	2.4	5.0	2.7	1017.8	2.8	1.8	2.1	95.0	1.8	2.5	34.2	212.1	1.6	0.5	24.5	2.4	207.7	75.7	6.6	2.4	1.6	308.1	21.9	490.0	2.3	1.1	407.9	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.4	0.2	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	39.8	0.0	4.6	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	4.5	0.1	521.4	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	20.5	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.0	22.3	0.0	7.5	490.0	5.9	0.7	102.3	1.1	1.6	0.4	0.5	308.1	0.4	0.4	0.4	21.9	2.3	17.6	6.5	0.6	407.9	1.7	1.8	1.6	1.6	1.8	1.8	2.1	0.0	0.9	0.5	80.4	424.7	79.8	2.3	50.8	0.1	0.0	815.3	52.2	87.6	26.2	0.0	4.1	0.0	46.7	1.4	10.8	19.6	0.0	484.8	7.4	19.7	4.1	113.9	7.3	924.7	0.0	12.0	37.4	3040.5	3.7	3.7	4386.3	50.6	757.4	61.5	0.0	1930.3	401.2	2.1	5.0	1.1	38.8	3.9	0.6	2.3	33.4	7.1	13.8	38.3	2.2
LYZL1	"LYC2, MGC33408"	ENSG00000120563	"Lysozyme like 1"	Q6UWQ5	10	29289061-29318328	"Enzymes, Predicted membrane proteins, Predicted secreted proteins"		"Glycosidase, Hydrolase"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in single"	371	"testis: 39.5"	"Group enriched"	"Detected in some"	48	"Early spermatids: 474.4;Late spermatids: 148.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A549: 1.0;SuSa: 2.9"														"Secreted in male reproductive system"	NA	NA												"unprognostic (1.88e-1)"						"unprognostic (8.40e-3)"					0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	39.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	474.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	148.3	4.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.0	6.5	0.0	4.2	1.9	0.0	0.0	0.0	0.0	0.0
LYZL2		ENSG00000151033	"Lysozyme like 2"	Q7Z4W2	10	30611779-30629762	"Enzymes, Predicted membrane proteins, Predicted secreted proteins"		"Glycosidase, Hydrolase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	84	"testis: 34.2"	"Group enriched"	"Detected in some"	53	"Early spermatids: 605.6;Late spermatids: 151.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	6	"SK-BR-3: 8.2"														"Secreted in male reproductive system"	NA	NA						"unprognostic (2.83e-4)"																	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	34.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	605.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	151.9	7.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.0	2.6	1.6	0.0	0.0	0.0	0.0	0.0
LYZL6	"LYC1, PRO1485, TKAL754"	ENSG00000275722	"Lysozyme like 6"	O75951	17	35934518-35943699	"Enzymes, Predicted intracellular proteins, Predicted secreted proteins"	Fertilization	"Antimicrobial, Bacteriolytic enzyme, Glycosidase, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	51	"testis: 33.2"	"Cell type enriched"	"Detected in some"	10	"Early spermatids: 287.4"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	5	"NB-4: 1.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA025734, HPA053073"	Enhanced				"Secreted in male reproductive system"	NA	NA					"HPA025734: AB_1853444, HPA053073: AB_2682034"																		0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0		0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	33.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	287.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	30.2	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	2.1	2.5	0.0	0.0	0.0	0.0	0.0
MAK	"dJ417M14.2, RP62"	ENSG00000111837	"Male germ cell associated kinase"	P20794	6	10762723-10838555	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Differentiation, Spermatogenesis, Transcription, Transcription regulation"	"Developmental protein, Kinase, Serine/threonine-protein kinase, Transferase"	"Disease mutation, Retinitis pigmentosa"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"retina: 38.1;testis: 19.3"	"Group enriched"	"Detected in many"	4	"Cone photoreceptor cells: 347.5;Early spermatids: 112.5;Rod photoreceptor cells: 298.8"	"Low cancer specificity"	"Detected in some"			"Region enriched"	"Detected in many"	7	"pons and medulla: 10.6"	"Cell type enriched"	"Detected in single"	13	"neutrophil: 11.7"	"Lineage enriched"	"Detected in single"	14	"granulocytes: 11.7"	"Cell line enhanced"	"Detected in some"		"HDLM-2: 4.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"									NA	NA						"unprognostic (1.23e-3)"	"unprognostic (8.77e-3)"	"unprognostic (2.44e-1)"	"unprognostic (3.81e-2)"	"unprognostic (6.62e-2)"	"unprognostic (1.35e-3)"	"unprognostic (1.97e-2)"	"unprognostic (2.53e-1)"	"unprognostic (3.21e-2)"	"unprognostic (2.42e-2)"	"unprognostic (1.13e-3)"	"unprognostic (6.73e-2)"	"unprognostic (6.59e-5)"	"unprognostic (1.55e-1)"	"unprognostic (8.40e-2)"	"unprognostic (7.71e-3)"	"unprognostic (4.59e-2)"	0.6	0.3	0.7	0.7	1.5	1.4	0.7	0.4	0.4	0.8	0.2	3.5	0.3	0.2	0.6	2.9	0.3	8.6	1.0	0.3	1.1	1.2	0.3	0.2	1.8	3.7	0.2	0.1	2.2	0.5	9.3	3.6	0.2	10.6	0.5	0.0	38.1	0.5	0.4	0.2	1.1	0.4	0.1	0.7	1.4	0.5	19.3	0.7	0.0	0.6	0.4	0.2	0.2	1.2	0.6	0.4	11.7	0.8	0.3	0.7	0.1	3.0	0.9	1.8	1.8	0.1	0.0	1.7	0.0	0.2	1.0	1.0	1.3	1.7	0.9	0.7	0.0	2.9	0.5	0.6	0.3	0.4	4.7	1.9	0.7	0.7	1.2	0.0	3.2	2.9	0.1	0.0	0.2	0.3	0.6	0.0	0.6	1.6	0.6	0.1	0.4	0.4	1.9	0.8	0.1	0.4	0.6	0.8	0.3	0.1	0.4	1.9	0.9	0.1	0.5	0.1	1.4	1.1	0.3	0.2	0.7	1.1	0.2	1.1	0.5	0.1	0.4	0.5	0.6	1.0	0.5	0.8	0.9	0.4	0.5	0.4	0.2	0.4	0.3	0.4	0.6	0.4	0.7	11.7	0.3	0.8	0.4	0.1	0.1	0.7	1.5	0.4	0.4	1.1	1.2	0.2	0.1	10.6	0.7	0.0	5.4	0.0	2.4	0.3	11.3	0.6	0.0	57.6	7.9	3.5	347.5	0.4	0.0	0.3	112.5	1.1	0.0	0.0	0.2	0.7	0.4	1.2	2.3	0.0	0.2	4.8	0.0	1.3	0.0	27.7	0.6	0.9	1.7	0.0	0.0	15.7	0.1	0.0	0.4	0.0	298.8	0.0	1.0	7.0	6.0	0.4	0.7	0.0	0.0	0.8
MALT1	"MLT, PCASP1"	ENSG00000172175	"MALT1 paracaspase"	Q9UDY8	18	58671386-58754477	"Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Ubl conjugation pathway"	"Hydrolase, Protease"	"Cancer-related genes, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Cone photoreceptor cells: 80.5;monocytes: 107.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"RPTEC TERT1: 51.8"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB004494, HPA048432"	Enhanced		Approved	"Nucleoli fibrillar center,Cytosol"		No	No			"Nucleoli fibrillar center"	Cytosol	"CAB004494: AB_627909, HPA048432: AB_2680389"	"unprognostic (3.25e-1)"	"unprognostic (2.31e-1)"	"unprognostic (3.64e-2)"	"unprognostic (3.25e-2)"	"unprognostic (1.65e-3)"	"unprognostic (4.67e-2)"	"unprognostic (6.46e-2)"	"unprognostic (4.50e-2)"	"unprognostic (3.33e-2)"	"unprognostic (4.16e-3)"	"unprognostic (3.74e-1)"	"unprognostic (2.07e-1)"	"unprognostic (2.53e-2)"	"unprognostic (2.34e-1)"	"unprognostic (2.97e-1)"	"unprognostic (1.03e-1)"	"unprognostic (6.00e-2)"	11.2	3.9	4.1	21.7	5.6	10.2	10.6	9.1	6.8	11.0	10.7	3.9	10.9	5.5	8.1	10.5	16.4	6.6	8.1	8.7	4.0	4.3	14.9	10.5	14.3	29.0	4.1	1.8	8.1	6.2	10.0	9.3	8.8	4.9	18.1	7.9	7.5	10.7	8.4	10.7	12.6	12.2	6.6	6.2	19.9	6.2	11.8	4.8	22.4	7.9	12.4	24.0	9.6	12.3	6.3	3.6	1.2	1.7	1.6	4.8	1.1	7.5	10.8	13.2	3.3	2.6	5.9	6.0	13.6	9.6	11.8	10.1	8.8	9.8	12.0	6.1	16.8	8.5	7.4	5.7	5.6	14.6	8.1	3.1	4.2	7.7	14.1	4.3	8.6	5.8	3.7	11.9	9.3	9.4	6.2	2.5	3.4	7.0	21.0	6.4	2.4	1.9	3.7	3.3	3.1	3.7	6.5	7.8	8.5	51.8	3.1	1.4	3.0	7.5	3.8	5.1	9.8	3.8	5.0	3.5	15.3	6.7	4.5	12.5	18.8	22.2	10.5	6.1	6.5	6.0	0.8	1.5	1.0	2.7	1.7	2.1	3.6	4.8	2.9	2.2	6.3	4.3	2.8	1.2	1.6	1.6	3.6	2.9	1.1	4.1	5.6	9.1	6.8	4.0	4.3	4.1	1.8	4.9	4.8	20.8	19.2	15.7	28.7	29.3	12.4	13.1	10.2	6.7	7.9	10.4	80.5	5.2	3.3	14.7	9.8	21.6	6.8	0.0	7.2	5.0	8.0	52.3	31.1	8.9	10.4	52.4	6.4	9.8	16.4	5.3	9.5	23.0	11.8	107.4	8.2	29.6	11.9	20.1	6.7	17.3	17.2	19.4	12.0	33.4	32.5	21.7	7.6	22.4	9.1	29.1
MAN1A1		ENSG00000111885	"Mannosidase alpha class 1A member 1"	P33908	6	119177209-119349761	"Enzymes, Plasma proteins, Predicted membrane proteins"		"Glycosidase, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 74.2"	"Cell type enhanced"	"Detected in many"	7	"Early spermatids: 149.9;Hepatocytes: 232.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"ASC diff: 60.3;Hep G2: 42.3;Karpas-707: 47.2;U-266/70: 63.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB037058, HPA053198, HPA063561"	Uncertain		Supported	"Golgi apparatus"		NA	NA		390000000	"Golgi apparatus"		"CAB037058: AB_477183, HPA053198: AB_2682078, HPA063561: AB_2685042"	"unprognostic (1.50e-1)"	"unprognostic (7.36e-3)"	"unprognostic (4.83e-2)"	"unprognostic (2.21e-2)"	"unprognostic (2.95e-2)"	"unprognostic (2.19e-1)"	"unprognostic (3.33e-3)"	"unprognostic (3.44e-2)"	"unprognostic (2.04e-1)"	"unprognostic (5.11e-2)"	"unprognostic (1.68e-3)"	"unprognostic (4.62e-1)"	"unprognostic (2.37e-2)"	"unprognostic (3.49e-2)"	"unprognostic (2.25e-1)"	"unprognostic (6.89e-2)"	"unprognostic (3.40e-1)"	41.8	19.8	5.8	10.5	17.4	8.1	32.2	1.5	7.9	12.3	23.3	3.2	3.6	17.4	11.3	12.0	10.6	9.5	22.0	10.4	5.0	3.3	23.4	74.2	16.4	16.8	2.8	5.7	10.3	22.0	3.4	6.4	26.1	3.7	14.7	9.9	10.5	41.0	5.3	7.1	9.6	36.3	19.7	3.5	20.9	10.0	8.7	3.7	8.8	15.2	10.3	9.1	21.2	36.4	1.4	5.5	6.0	1.1	1.9	4.7	0.6	0.0	0.0	0.7	0.0	60.3	26.7	1.4	1.4	8.8	1.1	2.7	4.1	0.5	9.0	0.0	5.5	14.2	0.1	1.6	0.0	1.4	13.3	4.1	7.5	0.8	42.3	6.0	0.0	3.8	18.2	1.1	9.0	5.5	4.8	0.7	2.6	26.0	47.2	8.5	1.2	0.3	0.0	0.5	4.1	2.1	2.5	0.9	13.6	2.9	7.4	3.0	4.5	0.0	0.1	0.0	1.9	2.2	1.0	5.2	3.7	3.4	6.9	3.3	63.8	9.0	17.8	10.9	0.1	2.2	6.0	0.6	2.0	2.4	1.1	4.7	1.4	1.3	1.3	0.6	0.9	0.8	1.9	3.8	1.9	0.9	5.5	1.4	0.6	5.8	17.4	1.5	7.9	5.0	3.3	2.8	5.7	3.7	3.7	8.9	36.6	18.6	5.7	28.2	18.6	3.9	45.9	8.1	11.4	101.2	0.0	4.7	5.0	5.1	149.9	42.5	42.8	23.3	32.8	8.0	90.1	5.0	3.5	232.5	81.6	0.0	46.1	103.7	76.4	24.4	24.5	57.9	27.0	6.4	55.5	1.3	20.9	14.4	3.9	32.2	4.7	6.5	18.1	2.1	3.9	24.3	5.1	26.1	11.5	7.6
MAN1A2	MAN1B	ENSG00000198162	"Mannosidase alpha class 1A member 2"	O60476	1	117367449-117528872	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"		"Glycosidase, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	4	"placenta: 122.4"	"Cell type enhanced"	"Detected in all"	7	"Extravillous trophoblasts: 201.3;Syncytiotrophoblasts: 318.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA034559, HPA057364"	Enhanced		Enhanced	"Golgi apparatus"		NA	NA		1100000	"Golgi apparatus"		"HPA034559: AB_10671229, HPA057364: AB_2683419"	"unprognostic (2.24e-1)"	"unprognostic (1.20e-1)"	"unprognostic (2.92e-3)"	"unprognostic (2.15e-1)"	"unprognostic (3.11e-2)"	"unprognostic (9.70e-2)"	"unprognostic (1.95e-2)"	"unprognostic (8.01e-2)"	"unprognostic (8.19e-3)"	"prognostic favorable (4.08e-4)"	"unprognostic (1.41e-1)"	"unprognostic (4.38e-2)"	"unprognostic (6.84e-2)"	"unprognostic (1.45e-1)"	"unprognostic (7.39e-2)"	"unprognostic (1.17e-1)"	"unprognostic (5.08e-2)"	11.1	9.7	13.9	9.1	15.8	3.8	9.7	11.9	15.2	14.4	10.7	8.5	9.4	8.1	15.8	10.7	11.5	12.2	9.2	11.0	11.2	9.2	11.8	16.4	8.1	9.9	12.0	13.9	11.2	27.4	21.7	9.6	122.4	11.3	11.2	9.5	8.3	11.1	10.5	10.5	7.5	9.0	13.7	10.4	10.4	10.3	10.1	14.4	16.1	19.4	6.9	9.8	13.6	9.8	3.7	4.4	4.0	2.7	6.0	9.8	2.4	14.4	6.3	10.8	9.3	14.2	17.1	34.6	12.0	18.8	5.4	5.1	4.8	8.3	10.8	22.3	15.4	5.1	8.6	5.0	10.2	12.2	13.5	7.6	6.4	8.9	5.3	8.6	10.0	14.8	11.5	11.0	8.3	7.3	10.0	16.1	7.6	10.3	16.7	11.3	28.1	6.1	3.2	5.5	7.3	6.6	5.5	23.5	7.4	7.5	19.7	5.9	8.6	11.9	12.8	9.4	14.7	6.3	6.4	15.3	12.2	10.1	8.6	12.2	11.4	7.7	7.3	16.2	8.0	29.0	1.3	2.7	4.0	5.2	2.1	6.2	3.3	4.3	4.3	2.3	3.7	3.6	5.2	2.1	6.0	1.7	4.4	9.8	2.4	13.9	15.8	11.9	15.2	11.2	9.2	12.0	13.9	11.3	14.4	35.7	30.2	42.7	29.6	27.5	59.3	85.6	35.7	42.8	40.9	41.8	21.6	40.9	14.9	26.4	27.9	33.3	25.6	23.3	52.0	201.3	31.7	37.6	15.1	78.0	25.6	41.3	20.8	34.4	30.7	15.9	49.8	22.8	38.8	12.6	32.4	40.2	36.9	21.0	61.5	21.5	39.0	38.8	29.1	63.9	52.5	30.2	318.2	30.5	26.4	37.2
MAN1B1	"ERManI, MANA-ER, MRT15"	ENSG00000177239	"Mannosidase alpha class 1B member 1"	Q9UKM7	9	137086927-137109187	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"		"Glycosidase, Hydrolase"	"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA051516	Approved		Uncertain	Vesicles		NA	NA		540000	Vesicles		"HPA051516: AB_2681518"	"unprognostic (1.21e-2)"	"unprognostic (4.66e-1)"	"unprognostic (1.25e-3)"	"unprognostic (4.67e-3)"	"unprognostic (2.27e-1)"	"unprognostic (3.70e-3)"	"prognostic unfavorable (1.45e-4)"	"unprognostic (1.59e-1)"	"unprognostic (6.67e-2)"	"unprognostic (1.79e-2)"	"unprognostic (5.93e-3)"	"unprognostic (1.75e-1)"	"unprognostic (3.55e-2)"	"unprognostic (2.28e-1)"	"unprognostic (5.85e-2)"	"unprognostic (2.37e-1)"	"unprognostic (1.44e-3)"	20.4	25.4	19.7	13.5	23.7	9.8	18.6	21.6	36.1	24.3	21.6	24.5	20.6	19.8	22.7	28.1	23.1	28.9	25.9	19.5	20.5	21.5	24.3	32.7	20.4	19.9	18.6	25.2	24.2	32.6	23.6	25.1	30.8	18.0	21.2	12.0	22.0	32.7	23.1	12.2	25.4	17.8	18.5	16.4	22.2	21.8	30.3	18.2	19.9	25.1	12.7	19.3	21.0	16.0	13.0	23.0	16.3	24.4	18.0	21.9	18.5	7.2	17.1	6.0	16.9	22.5	19.4	19.8	12.4	26.2	16.5	14.7	8.4	22.9	6.6	41.5	20.6	23.3	25.1	3.6	12.0	3.0	9.1	6.0	2.9	15.4	9.6	21.3	5.1	11.4	22.9	22.7	9.6	8.1	22.1	10.9	8.9	8.0	10.9	11.7	14.7	5.4	12.1	8.0	21.4	17.3	3.1	10.0	20.9	13.2	3.6	6.9	6.2	18.3	19.4	12.6	3.2	21.6	10.9	15.3	24.5	9.1	18.0	14.4	4.4	3.6	4.4	29.4	6.5	21.0	7.9	20.1	16.3	21.9	21.8	20.5	13.0	17.3	20.6	23.0	11.0	17.0	17.0	5.9	18.0	24.4	16.1	21.5	18.5	19.7	23.7	21.6	36.1	20.5	21.5	18.6	25.2	18.0	18.2	17.9	33.0	15.9	12.9	10.3	17.8	9.3	15.3	16.0	7.9	24.4	15.7	44.1	6.6	27.3	4.5	16.8	31.6	0.0	27.7	61.8	26.8	11.6	20.7	17.9	29.2	28.6	29.2	17.8	16.4	4.3	19.5	16.3	21.9	33.3	26.3	17.7	26.2	24.6	20.5	13.0	18.2	12.9	16.0	15.6	26.2	14.2	38.0	24.5	21.3	6.8
MAN1C1	HMIC	ENSG00000117643	"Mannosidase alpha class 1C member 1"	Q9NR34	1	25617468-25786207	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"		"Glycosidase, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	8	"Cone photoreceptor cells: 51.1;Ito cells: 82.9"	"Low cancer specificity"	"Detected in all"							"Cell type enhanced"	"Detected in many"		"naive CD4 T-cell: 8.3"	"Lineage enriched"	"Detected in many"	5	"T-cells: 8.3"	"Cell line enhanced"	"Detected in many"		"AF22: 12.7;HSkMC: 47.0;U-266/70: 14.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA048352	Uncertain		Uncertain	Nucleoplasm,Vesicles		NA	NA		1200000	"Nucleoplasm, Vesicles"		"HPA048352: AB_2680368"	"unprognostic (2.75e-1)"	"unprognostic (5.45e-3)"	"unprognostic (5.71e-3)"	"unprognostic (2.05e-2)"	"unprognostic (1.95e-1)"	"unprognostic (8.90e-3)"	"unprognostic (4.78e-2)"	"prognostic favorable (7.55e-4)"	"unprognostic (1.80e-1)"	"unprognostic (5.70e-2)"	"prognostic favorable (4.79e-4)"	"unprognostic (2.51e-1)"	"unprognostic (9.09e-3)"	"unprognostic (3.18e-2)"	"unprognostic (7.23e-2)"	"unprognostic (7.44e-2)"	"unprognostic (5.18e-2)"	4.6	4.5	4.2	3.0	3.8	0.0	2.2	9.9	8.8	8.6	3.6			1.2	6.6	2.5	2.4	3.9	7.3	3.4	5.2	3.2	10.3	12.1	3.2	4.0	4.2		7.1	0.7	4.4	7.8	8.3		7.2	1.2		1.8	7.5	0.9	2.7	1.9	8.0	6.0	7.0	3.1	1.0			10.7		3.2	4.3	4.0	1.0	0.6	1.1	1.6	0.8	8.3	1.1	0.0	0.1	12.7	2.7	9.5	7.4	3.7	0.1	2.4	0.6	0.2	0.2	0.0	0.1	0.1	0.9	1.7	0.1	1.2	0.1	0.2	4.0	0.5	0.2	0.2	0.0	1.1	2.1	5.3	47.0	0.2	0.2	0.0	0.2	0.0	0.5	0.0	0.5	0.0	0.6	0.0	2.3	3.3	0.0	0.1	0.2	7.8	0.2	0.1	0.2	7.5	0.2	0.3	2.0	0.6	2.4	1.0	1.5	0.0	0.0	0.7	8.6	0.3	14.0	0.0	0.0	1.9	4.5	0.6	0.4	1.6	0.7	0.6	1.0	0.8	0.4	3.6	1.6	0.6	1.0	8.3	4.8	1.1	0.8	1.3	0.4	0.8	1.1											3.0	2.7	1.9	2.9	6.0	19.1	6.4	5.1	2.7	7.9	21.0	51.1	8.3	8.3	0.5	0.3	11.1	0.0	0.0	3.4	1.0	9.9	2.6	2.3	37.6	19.1	20.6	2.9	82.9	16.5	0.9	25.0	3.6	1.7	0.0	0.0	20.6	2.2	0.0	20.8	12.8	4.5	6.5	3.1	0.2	2.0	4.5	35.7	5.3	0.0	1.3
MAN2A1	"GOLIM7, MANA2"	ENSG00000112893	"Mannosidase alpha class 2A member 1"	Q16706	5	109689366-109869625	"Enzymes, Plasma proteins, Predicted membrane proteins"		"Glycosidase, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 46.8"	"Cell type enhanced"	"Detected in many"	5	"Extravillous trophoblasts: 88.9;Hepatocytes: 113.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB022377, HPA026896"	Enhanced		Supported	"Golgi apparatus"		NA	NA		70000000	"Golgi apparatus"		"CAB022377: , HPA026896: AB_1853512"	"unprognostic (1.62e-2)"	"unprognostic (4.06e-2)"	"unprognostic (1.25e-2)"	"unprognostic (6.96e-2)"	"unprognostic (2.52e-1)"	"unprognostic (1.08e-1)"	"unprognostic (5.80e-2)"	"unprognostic (4.20e-2)"	"unprognostic (3.91e-1)"	"unprognostic (2.90e-2)"	"unprognostic (4.73e-2)"	"unprognostic (1.23e-1)"	"unprognostic (6.77e-3)"	"unprognostic (2.03e-2)"	"unprognostic (1.20e-2)"	"unprognostic (1.11e-3)"	"unprognostic (5.31e-3)"	7.6	17.5	10.9	7.7	21.8	5.7	7.4	1.9	13.2	8.4	11.2	46.8	2.4	17.2	9.2	1.8	7.7	6.2	10.6	4.2	11.7	4.8	9.5	20.7	8.5	7.8	29.9	10.4	7.5	16.7	20.1	3.4	8.7	19.8	4.7	11.9	5.6	9.0	6.0	8.7	7.0	14.4	11.2	23.1	6.9	8.9	7.5	30.6	15.0	9.0	1.8	7.8	10.9	6.2	3.3	2.7	5.8	6.7	0.9	5.5	1.6	7.3	6.8	8.5	3.6	16.4	14.5	32.0	16.4	27.1	9.3	16.9	8.0	11.9	5.3	10.6	21.3	6.5	8.7	4.5	17.0	20.5	5.7	3.5	10.8	5.1	7.3	9.2	4.9	5.9	12.3	7.0	14.9	19.9	11.5	18.4	5.4	2.9	31.1	22.0	3.6	9.1	1.3	6.1	4.9	2.5	3.6	13.3	23.5	7.5	11.7	1.2	1.1	7.7	6.9	4.6	9.6	6.8	4.3	19.6	18.5	8.2	10.0	10.6	16.6	21.5	4.5	14.2	6.3	10.2	5.8	2.9	0.9	3.0	3.8	1.9	3.3	4.5	4.9	2.7	2.9	5.5	4.8	2.1	0.9	6.7	2.5	4.1	1.6	10.9	21.8	1.9	13.2	11.7	4.8	29.9	10.4	19.8	30.6	6.0	6.7	28.2	9.3	15.9	0.2	5.9	40.8	9.4	7.9	29.6	0.0	16.0	1.7	21.5	7.3	22.4	45.5	23.3	30.1	88.9	21.8	26.3	14.0	113.4	16.8	0.0	23.7	41.7	62.5	4.9	9.2	22.8	25.3	25.2	37.1	7.5	30.3	28.1	6.3	21.4	0.3	19.4	16.0	5.5	19.1	20.7	19.8	15.8	41.2	17.8
MAN2A2	"HsT19662, MANA2X"	ENSG00000196547	"Mannosidase alpha class 2A member 2"	P49641	15	90902218-90922584	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"		"Glycosidase, Hydrolase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Rod photoreceptor cells: 69.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"basophil: 8.4;neutrophil: 10.0"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HEL: 40.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA077930			Approved	"Cytoplasmic bodies"		NA	NA		30000000	"Cytoplasmic bodies"		"HPA077930: AB_2732363"	"unprognostic (5.17e-2)"	"unprognostic (9.80e-2)"	"unprognostic (2.43e-2)"	"unprognostic (2.41e-1)"	"unprognostic (2.58e-1)"	"unprognostic (1.86e-2)"	"unprognostic (1.82e-1)"	"unprognostic (1.82e-1)"	"unprognostic (3.41e-1)"	"unprognostic (2.27e-1)"	"unprognostic (5.06e-3)"	"unprognostic (1.09e-2)"	"prognostic unfavorable (8.95e-4)"	"unprognostic (7.55e-3)"	"unprognostic (1.13e-1)"	"unprognostic (8.36e-2)"	"unprognostic (2.33e-2)"	17.8	12.1	15.9	11.5	24.3	58.1	17.3	33.7	31.2	7.2	9.9	52.4	6.3	12.0	8.9	9.8	7.6	8.0	9.4	22.7	17.8	14.0	8.1	16.7	13.3	12.4	31.6	19.7	9.7	24.0	13.0	15.2	12.4	31.0	9.2	9.0	17.2	20.6	12.6	41.8	14.8	13.0	7.6	33.1	19.1	12.4	12.7	28.3	3.8	13.8	2.7	9.1	7.5	10.7	1.5	2.1	10.0	3.2	0.1	1.4	1.5	5.8	6.1	4.3	10.2	13.0	3.5	8.4	4.3	3.9	4.5	3.5	4.9	4.4	0.8	10.6	5.0	4.1	6.7	4.5	2.5	2.8	14.5	10.6	40.0	9.2	3.3	4.3	5.8	21.7	2.5	4.7	5.4	4.4	9.0	5.9	10.7	15.0	5.3	2.0	7.9	3.8	11.6	1.4	9.7	1.9	5.2	4.1	6.1	5.6	14.1	10.4	6.0	5.9	11.1	8.4	4.5	5.2	19.1	5.0	3.7	4.0	4.5	5.6	8.1	24.9	2.1	4.3	8.5	6.2	8.4	1.6	0.6	1.4	1.1	0.9	1.0	0.6	0.8	0.3	1.5	0.4	0.4	10.0	0.1	3.2	2.1	1.3	1.5	15.9	24.3	33.7	31.2	17.8	14.0	31.6	19.7	31.0	28.3	11.9	23.5	5.6	2.9	5.4	24.8	12.6	7.6	5.3	10.3	8.7	25.5	7.3	0.0	3.9	5.9	7.9	8.1	23.3	5.6	1.8	6.4	5.8	15.1	19.2	5.4	23.8	4.1	7.4	12.2	5.2	6.4	13.5	28.7	10.0	7.2	18.0	4.1	5.7	4.6	3.0	69.2	12.9	8.5	8.8	6.1	4.1	6.3	8.7	7.9	3.0
MAN2B1	"LAMAN, MANB"	ENSG00000104774	"Mannosidase alpha class 2B member 1"	O00754	19	12646511-12666742	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		"Glycosidase, Hydrolase"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Erythroid cells: 23.3;Macrophages: 18.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"classical monocyte: 42.1;intermediate monocyte: 39.4;myeloid DC: 35.2;non-classical monocyte: 28.4;plasmacytoid DC: 41.9"	"Group enriched"	"Detected in all"	5	"dendritic cells: 41.9;monocytes: 42.1"	"Low cell line specificity"	"Detected in all"											"HPA041530, HPA053404"	Supported		Approved	Nucleoplasm,Vesicles	"Intracellular and membrane"	NA	NA		3400000	"Nucleoplasm, Vesicles"		"HPA041530: AB_10795639, HPA053404: "	"unprognostic (6.63e-2)"	"unprognostic (3.61e-1)"	"unprognostic (2.20e-2)"	"unprognostic (5.48e-2)"	"unprognostic (3.81e-1)"	"unprognostic (1.04e-1)"	"unprognostic (1.61e-1)"	"unprognostic (1.84e-2)"	"unprognostic (9.55e-2)"	"unprognostic (1.95e-1)"	"unprognostic (2.79e-2)"	"unprognostic (1.50e-1)"	"prognostic unfavorable (1.94e-5)"	"unprognostic (4.00e-1)"	"unprognostic (4.17e-2)"	"unprognostic (2.22e-1)"	"unprognostic (1.51e-1)"	25.2	15.6	7.9	26.7	11.0	33.4	24.4	4.4	7.0	10.5	15.0	14.0	8.6	14.2	15.3	16.5	12.2	13.4	16.4	19.4	6.4	4.4	13.6	16.3	30.2	68.6	10.0	4.7	12.2	21.7	9.1	7.2	15.8	8.6	13.7	10.6	12.0	22.0	8.1	7.7	18.0	20.0	10.2	11.7	51.3	19.5	6.3	8.2	22.1	11.3	7.8	30.0	18.7	11.2	7.7	41.9	6.5	42.1	2.7	8.4	26.0	16.5	8.5	8.7	10.2	29.0	19.5	24.6	12.3	26.0	11.0	10.8	6.8	7.0	18.2	15.0	9.7	3.1	13.0	4.4	8.2	5.3	9.0	13.5	6.3	4.2	11.0	14.8	41.5	43.3	23.2	16.2	6.1	7.8	11.9	10.4	6.9	8.0	13.8	5.8	12.9	5.6	23.4	7.2	8.3	10.8	13.0	11.9	9.0	13.0	19.2	2.7	8.5	12.2	10.5	20.0	5.5	16.2	25.7	13.6	15.0	6.2	14.5	11.5	18.4	20.2	9.0	10.1	40.9	16.7	2.2	42.1	6.2	7.5	39.4	8.4	7.7	6.9	6.7	35.2	6.5	3.8	3.8	6.5	2.7	28.4	41.9	6.8	26.0	7.9	11.0	4.4	7.0	6.4	4.4	10.0	4.7	8.6	8.2	6.0	6.9	14.4	1.6	3.2	2.6	0.7	2.5	5.3	1.2	1.8	0.0	2.0	1.7	1.6	2.0	1.0	2.5	23.3	2.0	2.3	2.8	2.2	1.1	0.8	7.9	0.0	1.7	2.5	10.2	8.1	3.4	18.6	1.7	5.4	0.9	1.3	1.0	2.9	4.2	1.1	3.0	12.9	1.2	0.5	1.5	2.9	2.3	5.4	1.7	1.6
MAN2B2	KIAA0935	ENSG00000013288	"Mannosidase alpha class 2B member 2"	Q9Y2E5	4	6575175-6623362	"Enzymes, Plasma proteins, Predicted secreted proteins"		"Glycosidase, Hydrolase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"								"Secreted to blood"	NA	NA		11000000				"unprognostic (1.30e-1)"	"unprognostic (3.32e-1)"	"unprognostic (1.28e-1)"	"prognostic favorable (7.59e-4)"	"unprognostic (1.09e-1)"	"unprognostic (2.07e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.57e-1)"	"unprognostic (5.78e-2)"	"unprognostic (3.02e-1)"	"unprognostic (2.38e-2)"	"unprognostic (2.72e-1)"	"unprognostic (6.53e-2)"	"unprognostic (2.55e-1)"	"unprognostic (1.13e-1)"	"unprognostic (2.66e-3)"	"unprognostic (2.18e-1)"	21.3	15.4	12.4	15.6	23.2	15.7	16.7	5.1	26.8	17.3	14.3	16.2	12.1	15.9	20.0	21.5	13.9	18.1	24.7	23.2	11.6	14.2	15.8	32.4	20.1	19.4	13.7	11.4	30.4	26.0	10.8	19.2	17.0	14.3	20.6	9.8	22.2	18.6	15.2	7.8	13.5	15.9	14.5	11.6	19.7	20.9	8.7	13.4	16.6	27.3	10.4	18.4	20.7	20.7	5.0	8.4	13.4	15.7	6.0	12.0	9.1	8.1	7.4	1.6	10.1	22.3	15.5	9.6	16.8	19.6	8.2	11.3	4.3	15.5	4.1	8.1	18.1	19.3	8.3	0.5	5.3	4.5	4.8	4.2	5.4	5.4	4.8	9.8	10.2	25.4	20.4	5.3	6.5	1.8	14.9	9.5	5.3	2.3	10.6	10.6	5.0	5.0	6.5	1.8	10.3	5.7	5.0	7.0	4.8	4.3	8.2	2.5	2.7	11.2	6.7	4.3	5.2	13.4	13.8	17.3	15.0	4.6	18.6	10.5	4.4	3.8	2.2	17.5	12.0	12.8	13.1	8.5	13.4	12.0	13.0	9.3	4.4	7.4	10.9	8.4	5.0	6.9	8.7	10.7	6.0	15.7	3.2	10.1	9.1	12.4	23.2	5.1	26.8	11.6	14.2	13.7	11.4	14.3	13.4	14.9	20.5	11.5	3.9	4.4	9.1	14.7	22.9	10.7	13.6	10.4	5.9	9.9	1.7	8.9	0.4	7.3	11.9	0.0	9.3	7.5	10.1	7.8	10.4	36.3	17.8	9.5	7.5	12.3	27.8	0.0	18.1	10.4	3.3	3.6	8.7	12.1	9.5	7.0	23.0	3.7	6.8	12.9	7.3	0.9	0.7	3.3	7.1	10.9	6.6	3.7
MAN2C1	"MANA, MANA1"	ENSG00000140400	"Mannosidase alpha class 2C member 1"	Q9NTJ4	15	75355207-75368630	"Enzymes, Predicted intracellular proteins"		"Glycosidase, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040627, HPA067407"	Uncertain		Enhanced	Nucleoplasm		NA	NA		9000	Nucleoplasm		"HPA040627: AB_10795490, HPA067407: AB_2685834"	"unprognostic (4.68e-2)"	"unprognostic (1.95e-1)"	"unprognostic (3.84e-3)"	"unprognostic (3.48e-2)"	"unprognostic (3.85e-1)"	"unprognostic (3.00e-2)"	"unprognostic (1.26e-2)"	"unprognostic (6.26e-2)"	"unprognostic (2.47e-1)"	"unprognostic (5.02e-2)"	"unprognostic (1.06e-2)"	"unprognostic (3.40e-2)"	"unprognostic (4.87e-3)"	"unprognostic (9.56e-2)"	"unprognostic (1.33e-1)"	"unprognostic (2.91e-1)"	"unprognostic (1.39e-3)"	29.9	28.8	22.6	20.4	26.0	30.0	24.6	27.5	25.5	25.1	25.1	26.8	23.8	22.9	27.8	27.5	20.2	24.2	23.3	28.2	18.3	12.9	22.9	21.4	25.2	17.0	23.0	28.3	32.8	22.3	28.2	30.6	22.4	18.3	24.9	14.2	30.8	25.6	20.2	37.9	30.9	27.7	20.0	15.0	28.1	23.0	28.8	19.9	21.0	34.7	15.3	19.5	21.1	21.3	2.3	15.7	2.6	16.2	3.9	7.3	8.5	5.5	13.3	11.1	8.0	12.7	11.0	13.8	12.9	12.2	6.8	5.7	9.2	19.1	2.7	7.6	9.4	6.2	17.2	6.1	8.7	4.4	15.2	13.4	17.5	25.2	9.1	18.8	11.2	2.8	13.1	8.8	6.4	8.1	14.4	15.8	8.0	10.0	14.4	5.5	10.8	5.5	12.7	4.7	6.6	5.6	7.8	5.6	16.6	8.9	25.9	6.6	12.0	8.2	12.5	5.8	8.3	12.4	13.1	30.9	14.3	10.0	9.9	12.7	14.4	3.5	4.4	9.2	12.9	14.2	2.6	13.3	2.0	7.2	16.2	6.8	2.3	5.3	5.2	15.7	2.0	7.3	5.1	1.4	3.9	12.4	6.4	7.0	8.5	22.6	26.0	27.5	25.5	18.3	12.9	23.0	28.3	18.3	19.9	20.8	52.5	12.9	13.4	11.9	32.1	2.0	5.1	16.0	18.2	8.7	51.1	14.5	3.3	9.4	8.2	17.2	21.3	0.0	7.7	8.8	15.0	13.8	31.1	21.5	17.5	27.0	32.8	33.2	37.8	10.6	21.6	24.1	15.1	19.8	21.0	18.6	9.2	14.4	11.7	12.3	52.0	25.8	10.4	18.6	10.9	7.4	17.7	12.7	20.7	11.9
MANBA		ENSG00000109323	"Mannosidase beta"	O00462	4	102630770-102760994	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		"Glycosidase, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"ASC diff: 37.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA053478	Approved		Supported	Vesicles	"Intracellular and membrane"	NA	NA		12000000	Vesicles		"HPA053478: AB_2682165"	"unprognostic (2.29e-2)"	"unprognostic (1.40e-1)"	"unprognostic (3.80e-1)"	"unprognostic (1.70e-1)"	"prognostic unfavorable (7.56e-5)"	"unprognostic (4.11e-2)"	"prognostic unfavorable (3.74e-6)"	"unprognostic (1.32e-1)"	"unprognostic (2.19e-1)"	"unprognostic (4.87e-2)"	"unprognostic (7.78e-2)"	"unprognostic (1.44e-2)"	"unprognostic (1.33e-1)"	"unprognostic (1.75e-2)"	"unprognostic (7.12e-2)"	"unprognostic (4.81e-2)"	"unprognostic (2.13e-1)"	12.7	23.5	8.5	12.2	11.9	8.6	17.1	13.4	8.4	12.1	9.9	12.9	11.7	8.1	11.6	13.6	9.3	11.0	15.5	12.1	8.7	8.6	11.8	10.3	17.7	20.2	15.1	6.2	16.7	18.1	25.1	18.4	25.0	10.8	12.0	10.8	12.4	27.4	11.4	5.4	7.8	14.0	14.2	15.3	21.3	14.4	4.6	13.5	9.4	19.2	3.6	12.8	17.9	12.6	3.9	9.5	25.2	11.6	3.6	3.1	3.9	7.0	3.9	1.9	1.9	37.5	17.4	4.9	4.9	9.7	2.1	4.2	5.1	8.2	7.6	6.6	6.8	6.8	3.3	5.0	10.8	1.7	5.3	2.1	4.3	4.5	7.8	11.4	8.0	19.6	14.8	18.5	9.1	7.6	27.8	3.9	3.3	7.2	7.8	7.7	3.2	1.9	7.7	2.7	8.7	3.2	3.9	4.5	2.1	6.1	8.3	1.2	0.9	5.8	10.1	7.6	20.0	14.4	5.5	3.0	5.8	2.8	13.0	2.6	4.2	8.7	0.7	10.5	3.6	4.2	6.2	11.5	25.2	1.8	10.6	1.4	3.8	3.1	2.0	9.5	3.9	3.0	2.0	10.1	3.6	11.6	2.3	1.6	3.9	8.5	11.9	13.4	8.4	8.7	8.6	15.1	6.2	10.8	13.5	29.8	35.2	25.3	8.3	5.3	5.4	10.4	12.7	4.0	12.5	8.7	5.9	32.0	1.7	5.7	1.9	7.2	4.6	0.0	2.4	6.3	10.6	7.4	33.5	15.8	38.4	6.4	1.7	9.2	46.4	1.1	8.3	42.8	0.0	29.7	10.9	4.3	5.7	21.0	18.7	7.6	7.1	0.0	8.3	0.2	1.1	4.0	18.9	10.9	10.5	8.3
MANEA	"FLJ12838, mandaselin"	ENSG00000172469	"Mannosidase endo-alpha"	Q5SRI9	6	95577543-95609457	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 44.9"	"Cell type enhanced"	"Detected in many"	7	"Hepatocytes: 53.1;Ito cells: 36.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA011046, HPA011069"	Enhanced		Supported	"Golgi apparatus"		NA	NA		87000	"Golgi apparatus"		"HPA011046: AB_1079303, HPA011069: AB_1079304"	"unprognostic (6.00e-2)"	"unprognostic (7.81e-2)"	"prognostic favorable (3.04e-4)"	"unprognostic (1.17e-2)"	"unprognostic (1.11e-1)"	"unprognostic (5.03e-2)"	"unprognostic (2.98e-3)"	"unprognostic (2.74e-1)"	"unprognostic (5.71e-2)"	"unprognostic (1.30e-1)"	"unprognostic (2.44e-1)"	"unprognostic (9.07e-2)"	"unprognostic (2.86e-3)"	"unprognostic (5.18e-2)"	"unprognostic (3.08e-1)"	"unprognostic (9.68e-2)"	"unprognostic (7.47e-2)"	18.0	8.1	6.0	6.7	6.9	2.4	14.4	8.3	6.0	9.6	9.5	5.0	5.8	7.7	7.5	8.2	11.5	7.2	7.1	9.3	6.5	6.2	14.6	44.9	9.8	12.3	8.9	6.7	10.4	8.0	10.9	13.5	7.4	7.8	9.2	8.0	4.5	8.1	7.6	3.8	5.9	9.5	6.0	11.6	13.2	10.7	7.1	6.9	17.9	11.7	5.9	9.7	11.2	7.5	6.6	3.4	8.5	5.7	3.8	10.4	3.3	3.8	3.3	12.5	10.1	20.8	24.5	4.8	10.8	9.9	6.3	9.5	3.7	9.7	7.4	13.5	7.0	9.5	6.4	8.6	7.2	14.5	12.7	7.7	10.0	3.1	6.0	7.2	13.1	8.9	24.2	8.4	7.5	5.3	9.1	14.7	7.7	15.4	17.2	13.4	2.7	7.6	5.6	1.8	10.2	3.3	9.2	12.5	11.0	9.6	6.7	10.1	5.4	6.1	4.4	3.8	9.3	7.0	12.3	13.3	6.3	4.5	11.3	10.6	12.9	7.5	9.2	11.3	11.5	14.3	8.5	3.3	1.9	4.8	5.7	6.8	6.6	5.9	5.5	3.4	3.3	6.9	4.6	0.7	3.8	4.9	1.3	10.4	3.3	6.0	6.9	8.3	6.0	6.5	6.2	8.9	6.7	7.8	6.9	11.9	6.7	4.5	4.6	6.5	8.3	3.2	7.6	10.7	7.9	12.2	3.9	4.5	5.0	3.3	12.0	6.3	2.5	0.0	6.2	4.6	5.2	3.2	2.3	53.1	9.2	11.1	1.7	36.8	9.1	10.0	5.5	6.9	8.5	2.8	4.7	9.1	3.3	3.5	14.9	8.6	4.8	12.9	5.3	6.8	12.5	6.0	1.1	6.4	5.2	3.0
MAOA		ENSG00000189221	"Monoamine oxidase A"	P21397	X	43654907-43746824	"Disease related genes, Enzymes, FDA approved drug targets, Predicted membrane proteins"	"Catecholamine metabolism, Neurotransmitter degradation"	Oxidoreductase	"Disease mutation, FDA approved drug targets, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	8	"Enterocytes: 358.2;Proximal tubular cells: 497.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"classical monocyte: 1.0;MAIT T-cell: 1.3"	"Group enriched"	"Detected in many"	10	"monocytes: 1.0;T-cells: 1.3"	"Cell line enhanced"	"Detected in many"		"ASC diff: 40.4;HHSteC: 75.9;HSkMC: 19.1;hTCEpi: 21.4;RT4: 31.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009437, HPA054807, HPA059299"	Enhanced		Enhanced	Mitochondria,Cytosol		No	No			Mitochondria	Cytosol	"CAB009437: AB_2137260, HPA054807: AB_2682607, HPA059299: AB_2683970"	"unprognostic (9.54e-3)"	"unprognostic (1.63e-1)"	"unprognostic (7.99e-2)"	"unprognostic (3.07e-1)"	"unprognostic (6.75e-2)"	"unprognostic (3.32e-1)"	"unprognostic (9.51e-2)"	"unprognostic (6.89e-3)"	"unprognostic (2.21e-1)"	"unprognostic (4.29e-2)"	"unprognostic (3.94e-1)"	"unprognostic (3.54e-1)"	"unprognostic (1.45e-3)"	"unprognostic (1.16e-2)"	"unprognostic (1.47e-1)"	"unprognostic (4.04e-2)"	"unprognostic (2.98e-3)"	72.3	11.0	8.2	10.2	7.8	0.3	35.2	3.3	6.1	12.4	85.7	2.8	10.7	53.6	12.5	6.2	36.6	12.0	14.7	37.8	6.7	8.3	77.8	45.9	34.4	5.2	11.1	6.1	14.2	24.4	9.6	1.5	79.8	8.7	26.2	39.9	6.2	49.1	12.9	12.5	11.2	90.1	23.6	3.4	2.1	19.3	5.5	4.7	0.0	68.6	9.7	3.9	35.3	35.1	0.0	0.0	0.1	1.0	0.0	1.3	0.1	0.0	0.8	0.1	2.4	40.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.1	4.1	1.5	5.4	0.0	0.0	0.6	1.6	0.1	4.3	75.9	0.0	4.1	19.1	21.4	0.0	11.2	0.0	4.8	0.0	0.0	0.1	1.4	0.6	0.0	0.1	0.4	4.9	1.2	0.0	0.0	0.1	5.5	31.3	0.7	1.9	0.0	0.0	0.0	0.1	0.1	0.0	2.1	0.0	2.0	0.1	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.0	1.0	0.0	0.0	0.0	1.3	0.0	0.1	0.3	0.0	0.0	0.1	0.6	0.1	0.0	0.0	0.0	0.0	0.1	8.2	7.8	3.3	6.1	6.7	8.3	11.1	6.1	8.7	4.7	65.5	115.2	10.9	141.7	9.7	4.4	90.1	91.7	34.8	50.0	57.6	21.6	9.7	102.8	29.5	19.6	35.3	358.2	0.0	12.0	17.7	14.2	55.4	5.7	169.3	6.2	3.2	36.6	36.8	14.9	22.5	5.2	4.0	10.1	29.7	119.4	23.2	31.4	140.8	0.0	497.3	21.7	6.5	15.1	1.1	0.4	12.5	173.1	3.1	215.1	89.9
MAOB		ENSG00000069535	"Monoamine oxidase B"	P27338	X	43766611-43882447	"Enzymes, FDA approved drug targets, Predicted membrane proteins"		Oxidoreductase	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 104.9"	"Cell type enhanced"	"Detected in many"	10	"Cardiomyocytes: 111.3;granulocytes: 138.1;Hepatocytes: 197.3;Peritubular cells: 89.5;Proximal tubular cells: 130.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	5	"naive CD8 T-cell: 1.0"	"Lineage enriched"	"Detected in single"	6	"T-cells: 1.0"	"Group enriched"	"Detected in some"	7	"Hep G2: 20.6;SiHa: 39.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002328, CAB037200"	Enhanced					NA	NA		3600000			"CAB037200: AB_1841012, HPA002328: AB_1854062"	"unprognostic (1.19e-2)"	"unprognostic (1.36e-1)"	"unprognostic (5.16e-2)"	"unprognostic (1.85e-2)"	"unprognostic (4.39e-2)"	"unprognostic (2.69e-2)"	"unprognostic (5.61e-2)"	"unprognostic (4.37e-2)"	"unprognostic (1.56e-1)"	"unprognostic (1.04e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.54e-2)"	"unprognostic (9.74e-2)"	"unprognostic (5.35e-3)"	"unprognostic (1.48e-2)"	"unprognostic (3.53e-1)"	"unprognostic (1.90e-3)"	25.0	18.2	24.8	3.9	34.8	0.5	16.5	5.5	24.5	12.0	18.9	20.3	15.6	24.9	38.0	20.0	11.4	34.9	15.4	32.4	21.2	46.9	41.8	104.9	10.9	2.3	24.4	19.9	56.0	4.1	15.6	8.9	9.4	26.8	30.1	6.3	3.0	38.0	55.9	34.8	3.0	30.5	35.9	39.1	1.3	8.4	5.2	21.3	0.2	1.8	8.2	2.8	12.1	8.5	0.0	0.0	0.0	0.1	0.0	1.0	1.2	0.0	0.5	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	2.7	2.4	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	4.5	20.6	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.5	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.1	1.8	0.0	0.0	0.0	0.0	0.2	2.1	0.0	0.0	0.6	39.9	0.0	0.3	0.3	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	1.2	24.8	34.8	5.5	24.5	21.2	46.9	24.4	19.9	26.8	21.3	0.0	5.5	0.0	0.4	4.8	1.0	111.3	38.2	21.4	3.4	5.2	3.9	0.3	53.0	15.6	0.1	11.3	8.0	0.0	2.5	0.7	11.2	0.6	138.1	197.3	1.4	14.3	0.0	4.9	4.7	0.4	42.6	1.3	6.8	0.0	2.9	25.5	4.7	8.0	89.5	130.3	0.7	12.9	15.6	0.0	0.1	3.4	0.3	4.3	3.9	0.3
MAP2K1	"MAPKK1, MEK1, PRKMK1"	ENSG00000169032	"Mitogen-activated protein kinase kinase 1"	Q02750	15	66386817-66492312	"Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins, RAS pathway related proteins"		"Kinase, Serine/threonine-protein kinase, Transferase, Tyrosine-protein kinase"	"Cancer-related genes, Cardiomyopathy, Disease mutation, Ectodermal dysplasia, FDA approved drug targets, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB003834, HPA026430"	Approved		Enhanced	"Plasma membrane,Cytosol"		NA	NA		62000	"Plasma membrane, Cytosol"		"CAB003834: AB_562310, HPA026430: AB_1853742"	"unprognostic (4.05e-2)"	"unprognostic (1.23e-2)"	"unprognostic (2.07e-1)"	"unprognostic (4.92e-2)"	"prognostic unfavorable (1.95e-4)"	"unprognostic (1.81e-3)"	"unprognostic (5.78e-2)"	"unprognostic (9.91e-3)"	"unprognostic (1.11e-1)"	"unprognostic (1.77e-1)"	"unprognostic (1.45e-1)"	"unprognostic (7.62e-3)"	"unprognostic (1.20e-1)"	"unprognostic (2.71e-1)"	"unprognostic (1.96e-1)"	"unprognostic (1.15e-1)"	"unprognostic (9.40e-3)"	28.6	16.9	33.9	19.1	54.1	29.0	23.6	32.5	48.4	12.5	12.1	8.4	10.2	10.0	11.8	16.5	22.0	10.6	14.4	19.1	49.2	26.4	15.3	53.1	16.4	23.3	17.6	31.2	13.5	11.7	23.4	12.0	15.4	17.2	14.4	12.9	9.1	13.2	12.4	39.5	12.3	10.9	16.9	17.4	14.5	10.8	7.8	12.6	12.6	12.3	9.7	27.9	13.6	18.7	4.6	16.2	5.5	8.2	8.4	7.9	2.7	33.6	15.9	31.9	13.3	19.3	14.5	18.5	24.4	20.9	26.5	23.7	23.8	27.7	30.9	30.3	20.1	20.2	30.0	29.8	35.7	31.3	24.9	17.8	9.9	16.6	12.9	15.6	13.0	14.8	11.2	22.1	19.2	28.5	28.3	20.7	15.8	17.5	39.6	38.7	13.0	10.5	17.1	16.3	31.2	13.9	11.9	19.7	27.5	25.7	14.5	19.7	11.0	19.8	15.5	20.5	26.9	14.0	11.2	28.5	34.6	21.2	24.4	36.2	24.5	43.6	19.7	36.5	23.1	16.1	3.2	8.2	5.5	7.4	8.2	6.7	3.0	6.6	6.9	8.3	4.6	7.9	4.9	3.9	8.4	7.3	16.2	4.9	2.7	33.9	54.1	32.5	46.9	49.2	26.4	17.6	31.2	17.2	12.6	26.8	21.9	30.2	40.5	73.6	8.5	16.9	38.2	6.7	13.6	24.4	13.7	40.9	39.7	65.3	10.2	19.0	20.0	46.7	20.4	39.4	31.3	59.4	9.2	116.5	44.9	9.5	20.8	17.2	91.3	18.3	20.8	67.7	50.6	88.4	17.0	33.9	70.1	21.0	20.5	28.5	5.6	6.5	53.6	16.3	44.5	58.8	43.3	40.5	16.8	65.5
MAP2K2	"MEK2, PRKMK2"	ENSG00000126934	"Mitogen-activated protein kinase kinase 2"	P36507	19	4090321-4124129	"Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins, RAS pathway related proteins"		"Kinase, Serine/threonine-protein kinase, Transferase, Tyrosine-protein kinase"	"Cancer-related genes, Cardiomyopathy, Disease mutation, Ectodermal dysplasia, FDA approved drug targets, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	9	"Late spermatids: 596.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"CAB003835, HPA051993"	Supported		Supported	Cytosol		NA	NA			Cytosol		"CAB003835: AB_562312, HPA051993: AB_2681685"	"unprognostic (4.39e-1)"	"prognostic favorable (3.72e-4)"	"unprognostic (4.24e-1)"	"unprognostic (1.26e-3)"	"unprognostic (2.58e-1)"	"prognostic favorable (7.98e-4)"	"unprognostic (2.08e-3)"	"unprognostic (2.11e-1)"	"unprognostic (2.65e-1)"	"unprognostic (1.06e-1)"	"unprognostic (7.45e-3)"	"unprognostic (4.95e-2)"	"unprognostic (1.32e-1)"	"prognostic favorable (5.43e-5)"	"unprognostic (2.91e-2)"	"unprognostic (2.25e-1)"	"unprognostic (4.90e-2)"	23.9	33.0	35.6	27.6	36.1	46.7	30.2	31.2	43.4	22.6	38.8	24.6	27.0	70.9	21.8	23.2	32.8	21.7	27.9	41.4	33.1	31.0	22.7	42.0	24.1	44.5	34.4	29.2	30.8	46.0	18.9	29.7	21.3	26.1	25.7	24.3	21.7	41.5	24.0	134.9	27.4	56.7	19.0	25.2	25.9	28.3	42.0	20.9	44.1	26.2	42.2	29.1	20.0	26.9	11.4	10.7	28.3	10.6	11.3	12.1	4.5	36.8	40.7	22.3	31.3	30.9	37.3	22.3	24.3	32.6	33.3	30.2	35.2	20.0	31.6	23.0	27.7	26.8	26.6	17.4	26.0	25.8	26.8	21.2	11.5	22.2	38.9	47.3	21.1	24.3	41.1	25.3	23.4	31.2	44.6	29.4	28.8	22.0	62.4	28.0	46.3	41.8	29.7	25.5	27.2	29.6	32.0	14.7	36.1	29.1	23.7	30.3	30.2	22.3	30.9	75.8	26.9	23.8	36.4	25.9	27.3	23.8	69.8	37.4	62.8	38.0	22.1	42.4	38.2	46.8	15.2	9.1	28.3	11.9	10.6	9.7	8.9	9.7	12.1	10.7	11.4	8.9	11.6	14.4	11.3	8.7	6.0	9.2	4.5	35.6	36.1	31.2	43.4	33.1	31.0	34.4	29.2	26.1	20.9	8.9	38.8	57.0	73.8	31.5	79.0	54.9	17.8	10.7	19.4	38.4	39.3	23.7	124.3	17.7	223.1	33.7	242.0	0.0	38.5	28.5	33.0	88.2	19.6	43.1	46.2	114.4	60.6	34.4	35.6	596.7	33.1	29.7	40.5	12.6	77.6	82.3	41.7	90.9	21.5	75.0	82.4	25.8	32.5	25.9	14.5	55.8	29.7	45.4	69.4	97.8
MAP2K3	"MAPKK3, MEK3, MKK3, PRKMK3"	ENSG00000034152	"Mitogen-activated protein kinase kinase 3"	P46734	17	21284672-21315240	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase, Tyrosine-protein kinase"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB018548	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"CAB018548: AB_631927"	"unprognostic (2.31e-1)"	"unprognostic (6.39e-2)"	"unprognostic (4.63e-2)"	"unprognostic (3.68e-1)"	"unprognostic (3.54e-3)"	"unprognostic (1.60e-1)"	"unprognostic (2.97e-2)"	"unprognostic (1.35e-2)"	"unprognostic (5.25e-3)"	"unprognostic (1.88e-2)"	"unprognostic (3.16e-2)"	"unprognostic (2.18e-2)"	"unprognostic (1.33e-1)"	"unprognostic (6.48e-2)"	"unprognostic (1.22e-2)"	"unprognostic (2.92e-1)"	"unprognostic (1.77e-1)"	16.1	12.1	5.5	14.8	7.3	66.9	29.0	12.4	8.9	10.2	12.4	6.3	10.3	18.1	7.6	11.1	24.2	11.6	25.1	26.8	5.6	5.3	15.8	37.1	25.5	34.0	7.4	3.9	10.1	26.3	9.6	15.8	26.7	9.5	12.2	9.3	12.7	18.5	9.2	46.4	20.9	23.8	18.1	7.6	26.7	16.3	5.3	4.1	16.4	11.5	45.0	21.4	16.0	17.3	13.2	17.3	49.2	33.3	5.4	16.2	10.0	21.4	21.7	2.9	13.2	17.6	11.3	11.0	33.2	36.1	26.5	24.4	24.1	13.8	19.4	13.6	52.0	22.4	21.3	9.2	29.5	18.9	20.1	16.8	11.2	12.5	21.8	5.5	14.7	23.1	8.7	8.4	36.1	10.9	8.3	11.8	11.4	2.1	9.7	22.1	21.3	7.4	14.0	8.3	38.6	12.5	15.3	18.7	14.3	15.0	22.6	7.9	2.8	12.3	13.3	23.1	30.1	6.6	5.0	10.8	25.2	20.6	26.9	21.4	12.1	6.1	25.0	24.3	12.7	13.0	14.5	16.0	25.2	14.6	24.0	12.6	13.2	12.1	13.6	17.3	10.6	7.8	10.1	49.2	5.4	33.3	12.7	16.2	10.0	5.5	7.3	12.4	8.9	5.6	5.3	7.4	3.9	9.5	4.1	35.7	59.6	38.8	149.8	229.1	5.9	17.0	45.9	29.4	45.5	21.0	3.9	51.1	63.0	81.6	1.1	21.1	72.0	210.2	69.2	75.4	38.0	143.0	94.4	63.8	45.6	17.5	115.4	21.5	64.9	0.7	11.2	56.1	82.7	15.4	50.2	16.4	93.5	56.1	15.6	27.9	6.9	0.0	70.0	0.9	4.4	190.7	56.1	56.1	31.9	222.1
MAP2K4	"JNKK1, MEK4, MKK4, PRKMK4, SERK1"	ENSG00000065559	"Mitogen-activated protein kinase kinase 4"	P45985	17	12020824-12143830	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins"	"Apoptosis, Stress response"	"Kinase, Serine/threonine-protein kinase, Transferase, Tyrosine-protein kinase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"neutrophil: 13.2"	"Low lineage specificity"	"Detected in all"			"Cell line enriched"	"Detected in all"	5	"SuSa: 67.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB007751, HPA060074"	Enhanced		Approved	"Nucleoplasm,Cell Junctions"		NA	NA			Nucleoplasm	"Cell Junctions"	"CAB007751: , HPA060074: AB_2684197"	"unprognostic (1.55e-1)"	"unprognostic (1.85e-1)"	"unprognostic (4.47e-2)"	"unprognostic (1.02e-2)"	"unprognostic (1.04e-1)"	"unprognostic (2.70e-1)"	"unprognostic (2.89e-1)"	"unprognostic (2.16e-1)"	"unprognostic (1.93e-3)"	"unprognostic (2.53e-1)"	"unprognostic (2.76e-3)"	"unprognostic (4.82e-2)"	"unprognostic (5.32e-3)"	"unprognostic (3.13e-1)"	"unprognostic (2.30e-1)"	"unprognostic (7.00e-2)"	"unprognostic (1.79e-1)"	10.7	13.2	23.7	9.4	21.0	3.1	14.4	25.0	42.7	12.5	11.5	7.9	8.5	9.6	12.1	17.8	18.5	11.5	10.7	14.9	31.7	29.3	15.8	20.6	11.4	14.6	24.5	27.1	13.0	11.1	19.6	16.7	15.1	23.4	14.5	13.1	6.5	9.8	13.2	20.6	14.4	9.9	13.5	16.3	10.7	10.7	10.3	9.8	10.3	16.5	11.6	13.4	11.1	11.2	2.8	1.8	13.2	4.3	3.5	3.3	2.3	10.6	9.2	12.1	6.2	6.7	8.7	7.7	7.3	9.6	8.3	8.0	5.4	3.7	4.4	5.9	11.3	5.4	7.1	10.5	10.1	12.5	7.8	12.3	4.9	5.4	10.2	7.9	4.7	7.4	7.2	10.0	9.7	10.2	8.6	7.5	6.3	5.2	2.6	10.4	3.9	5.6	4.4	7.0	11.5	4.5	7.0	13.6	3.0	11.4	6.9	2.4	7.2	8.4	4.5	7.0	67.1	5.7	3.4	6.8	4.1	6.3	5.6	8.6	5.1	5.7	3.5	7.7	3.7	5.9	0.6	2.7	2.0	3.0	1.5	2.7	2.8	2.4	2.4	1.8	2.7	2.0	3.3	13.2	3.5	4.3	1.8	2.6	2.3	23.7	21.0	25.0	42.7	31.7	29.3	24.5	27.1	23.4	9.8	8.9	14.2	10.8	26.3	36.9	14.2	21.2	10.2	2.7	21.6	14.0	7.9	10.7	21.6	11.2	6.3	8.7	11.8	0.0	12.4	8.6	12.9	32.3	1.1	16.3	10.2	17.5	11.5	10.4	17.7	5.8	10.9	11.7	11.8	19.0	13.8	10.3	14.7	11.5	12.0	17.7	9.7	12.9	12.0	7.9	8.1	34.4	21.2	9.5	10.6	40.3
MAP2K5	"HsT17454, MAPKK5, MEK5, PRKMK5"	ENSG00000137764	"Mitogen-activated protein kinase kinase 5"	Q13163	15	67542709-67807123	"Enzymes, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase, Tyrosine-protein kinase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	8	"Early spermatids: 115.1;Late spermatids: 149.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB022094, HPA027347, HPA027755"	Supported		Approved	Nucleoli,Microtubules		NA	NA			"Nucleoli, Microtubules"		"CAB022094: , HPA027347: AB_10599290, HPA027755: AB_10600883"	"unprognostic (4.54e-2)"	"unprognostic (1.87e-2)"	"unprognostic (4.16e-2)"	"unprognostic (9.06e-2)"	"unprognostic (1.77e-3)"	"unprognostic (1.06e-1)"	"unprognostic (1.96e-1)"	"unprognostic (3.73e-1)"	"unprognostic (2.41e-2)"	"unprognostic (2.83e-1)"	"unprognostic (1.47e-2)"	"unprognostic (5.41e-2)"	"prognostic favorable (8.03e-5)"	"unprognostic (1.68e-1)"	"unprognostic (2.74e-1)"	"unprognostic (3.99e-2)"	"unprognostic (2.73e-2)"	18.6	22.2	20.3	13.8	30.9	14.6	23.7	25.0	25.4	17.0	19.3	17.2	19.9	14.7	17.4	11.3	13.5	16.2	14.4	18.8	17.1	16.4	14.2	15.5	13.5	27.9	12.6	11.5	29.0	21.0	34.1	14.4	17.7	22.2	15.9	14.8	15.6	15.7	18.5	28.5	18.7	15.0	19.4	17.2	13.0	15.4	20.3	16.2	40.2	16.9	9.2	11.9	17.0	17.9	6.6	10.2	10.3	7.3	11.7	11.2	5.5	5.3	14.2	8.5	10.0	12.6	22.2	6.7	5.4	10.9	10.1	11.1	5.7	9.6	8.8	11.4	8.9	11.0	8.1	14.5	8.6	8.4	12.8	14.5	12.0	10.6	6.1	15.9	7.2	7.5	15.2	11.3	7.3	16.6	22.3	13.3	20.5	10.5	14.8	8.3	6.9	11.8	8.6	12.0	6.2	6.9	11.7	9.9	14.7	6.1	9.8	5.4	8.4	6.0	8.9	21.4	15.4	11.2	14.2	11.0	10.5	6.9	7.2	7.2	21.0	24.6	10.3	14.0	16.6	7.5	10.3	7.3	6.6	7.7	5.6	11.2	6.6	7.3	9.0	10.2	6.2	10.4	9.5	1.7	11.7	6.2	3.9	7.4	5.5	20.3	30.9	25.0	25.4	17.1	16.4	12.6	11.5	22.2	16.2	6.0	4.3	4.2	7.5	6.2	10.0	8.0	2.5	1.4	1.2	5.2	9.8	10.3	6.6	7.7	115.1	7.0	8.8	0.0	7.4	9.1	7.1	4.5	2.3	6.8	8.8	4.8	9.1	9.8	9.2	149.4	11.5	5.3	10.1	2.8	8.4	16.0	6.9	10.5	11.0	6.8	7.2	0.0	5.1	10.4	8.2	7.2	8.2	8.7	9.4	2.7
MAP2K6	"MAPKK6, MEK6, MKK6, PRKMK6, SAPKK3"	ENSG00000108984	"Mitogen-activated protein kinase kinase 6"	P52564	17	69414698-69553861	"Enzymes, Predicted intracellular proteins"	"Apoptosis, Stress response, Transcription, Transcription regulation"	"Kinase, Serine/threonine-protein kinase, Transferase, Tyrosine-protein kinase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 31.9;skeletal muscle: 55.6"	"Cell type enhanced"	"Detected in many"	7	"Intestinal endocrine cells: 43.8;Muller glia cells: 32.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	7	"classical monocyte: 9.3;neutrophil: 19.3;plasmacytoid DC: 31.9"	"Group enriched"	"Detected in all"	9	"dendritic cells: 31.9;granulocytes: 19.3;monocytes: 9.3"	"Cell line enhanced"	"Detected in many"		"A549: 24.4;AN3-CA: 13.3;HUVEC TERT2: 17.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB007744, HPA031134"	Enhanced		Supported	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"CAB007744: AB_562318, HPA031134: AB_10603016"	"prognostic favorable (2.27e-6)"	"unprognostic (2.24e-1)"	"unprognostic (8.46e-2)"	"unprognostic (4.10e-2)"	"unprognostic (3.75e-2)"	"unprognostic (1.23e-1)"	"unprognostic (7.61e-3)"	"unprognostic (9.52e-2)"	"unprognostic (3.67e-1)"	"unprognostic (4.09e-3)"	"prognostic favorable (7.52e-4)"	"unprognostic (3.61e-2)"	"unprognostic (2.29e-2)"	"unprognostic (7.48e-2)"	"unprognostic (9.43e-2)"	"unprognostic (1.39e-1)"	"unprognostic (2.03e-2)"	4.5	2.0	3.2	8.6	5.9	10.1	14.0	13.7	7.5	19.8	21.5	6.2	4.7	7.2	4.7	3.1	3.4	3.3	5.1	2.5	3.9	3.5	4.1	8.6	2.6	10.3	5.4	4.1	2.7	8.5	0.0	3.2	1.1	5.3	2.8	22.8	5.3	4.0	4.6	55.6	2.3	7.3	2.3	6.2	5.9	5.4	2.1	5.4	13.7	2.8	4.8	5.1	3.0	2.5	2.3	31.9	19.3	9.3	1.8	2.1	2.6	0.1	24.4	11.0	13.3	4.7	2.6	1.6	0.1	3.6	1.0	1.5	0.7	1.1	0.6	9.0	0.5	0.8	1.2	3.8	0.5	0.3	0.8	2.0	0.1	6.9	6.8	4.7	1.0	1.0	12.1	0.3	0.3	0.0	1.0	17.5	3.3	0.0	1.7	0.0	0.1	12.7	0.5	7.8	0.5	4.5	4.6	1.1	0.3	4.9	3.4	4.9	7.4	1.0	0.9	2.2	6.1	3.4	1.3	3.1	1.3	1.6	1.1	0.4	1.2	1.3	0.3	1.0	1.5	1.0	0.8	9.3	1.6	1.2	1.1	2.1	1.6	1.4	1.5	2.9	2.3	1.6	1.5	19.3	1.8	0.4	31.9	1.9	2.6	3.2	5.9	13.7	7.5	3.9	3.5	5.4	4.1	5.3	5.4	3.0	7.9	4.7	3.2	2.4	4.9	1.4	2.5	6.7	5.7	0.0	2.0	7.5	19.9	1.2	8.5	2.4	17.0	0.0	3.6	5.4	2.8	1.9	1.1	2.0	5.1	3.2	43.8	4.9	8.9	1.9	4.0	7.0	3.3	0.0	22.4	32.9	1.2	8.6	3.5	1.1	3.8	0.0	3.1	0.0	0.2	3.8	0.7	11.5	23.7	2.3
MAP2K7	"Jnkk2, MKK7, PRKMK7"	ENSG00000076984	"Mitogen-activated protein kinase kinase 7"	O14733	19	7903843-7914478	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Apoptosis, Stress response"	"Kinase, Serine/threonine-protein kinase, Transferase, Tyrosine-protein kinase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"HPA001633, CAB004262, HPA064711"	Supported		Approved	"Golgi apparatus,Plasma membrane,Cytosol"		NA	NA			"Plasma membrane, Cytosol"	"Golgi apparatus"	"CAB004262: AB_627925, HPA001633: AB_1079516, HPA064711: AB_2685331"	"unprognostic (1.77e-1)"	"unprognostic (5.04e-2)"	"unprognostic (1.06e-2)"	"unprognostic (2.16e-1)"	"unprognostic (4.24e-2)"	"prognostic favorable (8.54e-5)"	"unprognostic (1.80e-3)"	"unprognostic (2.55e-1)"	"unprognostic (2.69e-2)"	"unprognostic (1.69e-2)"	"unprognostic (1.27e-3)"	"unprognostic (1.56e-1)"	"unprognostic (3.54e-2)"	"unprognostic (3.71e-2)"	"unprognostic (6.05e-2)"	"unprognostic (1.73e-2)"	"prognostic favorable (1.56e-4)"	16.3	14.9	13.5	16.4	16.4	23.8	13.6	28.7	21.5	14.3	15.6	23.2	15.1	19.3	19.1	9.9	13.6	13.1	14.3	15.8	14.6	11.9	12.8	15.9	12.5	15.9	17.2	13.9	18.4	22.3	13.9	17.0	16.4	16.2	14.4	7.9	14.2	23.0	13.4	61.6	21.3	18.7	14.1	12.5	19.4	14.8	21.5	16.5	9.8	13.7	17.3	12.8	15.4	15.2	3.0	2.6	4.8	2.7	3.3	2.5	1.0	12.9	7.4	6.4	10.6	5.2	5.0	12.1	8.5	4.2	5.8	6.0	10.7	7.9	15.4	13.8	4.5	5.7	11.9	5.6	6.5	2.3	12.2	27.8	10.8	9.8	7.9	6.7	10.1	13.8	5.8	8.5	4.6	5.2	7.7	5.2	11.3	15.8	20.3	3.3	6.8	14.3	24.5	11.4	6.9	16.7	14.3	7.0	15.6	5.2	10.8	11.9	11.9	5.8	10.2	11.8	4.0	11.0	11.5	7.8	17.7	10.1	12.4	11.5	29.4	13.6	14.5	8.9	14.9	7.1	0.0	2.7	1.9	2.3	2.5	1.5	2.1	1.9	2.0	1.3	3.0	1.7	2.5	4.8	3.3	1.5	2.6	0.7	1.0	13.5	16.4	28.7	21.5	14.6	11.9	17.2	13.9	16.2	16.5	23.8	21.5	21.9	31.0	34.3	50.6	12.6	22.9	9.4	5.7	19.2	72.6	23.2	11.6	19.1	3.8	18.7	26.2	0.0	16.4	25.3	18.1	32.9	10.4	17.4	16.3	54.0	35.1	19.0	12.4	8.6	26.7	15.7	30.4	16.2	23.6	25.8	19.2	21.0	11.7	14.7	70.3	32.3	26.9	14.2	26.4	37.3	41.2	28.0	24.2	25.2
MAP3K1	"MAPKKK1, MEKK, MEKK1"	ENSG00000095015	"Mitogen-activated protein kinase kinase kinase 1"	Q13233	5	56815574-56896152	"Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Kupffer cells: 81.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"SH-SY5Y: 27.5;THP-1: 25.7"	"Region enriched"	"Detected in many"	6	"olfactory region: 22.5"	"Low region specificity"	"Detected in all"			"CAB004500, HPA046509"	Approved		Approved	Cytosol		NA	NA			Cytosol		"CAB004500: AB_627926, HPA046509: AB_2679678"	"unprognostic (1.77e-1)"	"unprognostic (1.71e-2)"	"unprognostic (4.09e-1)"	"unprognostic (2.18e-1)"	"unprognostic (3.48e-2)"	"unprognostic (5.39e-3)"	"unprognostic (5.20e-3)"	"unprognostic (2.52e-2)"	"unprognostic (1.35e-1)"	"unprognostic (1.41e-1)"	"unprognostic (1.05e-2)"	"unprognostic (6.73e-2)"	"unprognostic (1.97e-3)"	"unprognostic (2.18e-2)"	"unprognostic (1.58e-1)"	"unprognostic (9.92e-3)"	"unprognostic (1.11e-1)"	6.7	4.9	5.4	14.6	4.8	15.2	14.9	8.0	4.5	7.6	6.7	5.4	7.3	4.3	7.1	9.4	12.7	7.2	5.9	4.3	3.7	3.2	9.5	4.4	8.8	21.4	6.4	3.1	8.4	9.2	6.3	7.9	8.1	4.5	8.3	4.5	12.6	15.4	9.7	3.5	21.8	11.2	4.0	3.8	21.3	5.5	8.5	5.1	11.7	19.2	6.6	18.2	6.0	11.7	6.6	2.8	6.7	7.2	2.7	5.8	2.3	6.6	4.0	6.3	4.2	1.0	0.8	10.6	1.3	1.7	4.0	5.6	18.7	5.0	5.9	0.4	1.5	3.4	3.4	5.2	2.3	5.6	2.0	2.3	3.3	1.8	8.8	2.5	5.2	9.2	1.0	2.5	1.2	2.0	1.1	1.7	2.0	2.8	10.7	1.0	2.9	3.6	7.1	2.9	3.4	0.5	5.7	4.4	20.3	7.0	6.9	2.6	27.5	3.9	4.9	11.2	5.8	13.4	25.7	5.0	0.4	3.4	1.5	2.4	7.8	4.0	11.3	0.6	3.1	6.8	6.7	4.5	1.0	1.2	6.8	1.2	6.6	3.8	1.8	2.8	5.1	2.5	0.9	2.6	2.7	7.2	1.5	5.8	2.3	5.4	4.8	8.0	4.5	3.7	3.2	6.4	3.1	4.5	5.1	6.0	9.8	47.7	14.5	46.5	15.2	2.7	50.9	4.0	12.5	34.9	45.2	12.9	6.6	14.2	1.6	13.5	6.6	0.0	12.8	7.7	11.3	11.9	7.0	12.1	26.3	27.0	9.8	17.2	81.7	1.9	4.9	40.3	35.4	45.9	10.1	10.6	13.0	7.0	1.8	20.1	34.7	6.5	5.2	10.0	15.0	47.8	5.6	16.6	8.9	10.0
MAP3K10	"MEKK10, MLK2, MST"	ENSG00000130758	"Mitogen-activated protein kinase kinase kinase 10"	Q02779	19	40191744-40215575	"Enzymes, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 32.0"	"Cell type enhanced"	"Detected in many"	7	"Bipolar cells: 13.9;Horizontal cells: 22.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA007039	Approved		Approved	"Nucleoplasm,Actin filaments,Cytosol"		NA	NA			"Nucleoplasm, Actin filaments, Cytosol"		"HPA007039: AB_1079357"	"unprognostic (2.09e-1)"	"unprognostic (3.77e-2)"	"unprognostic (1.42e-3)"	"unprognostic (2.03e-2)"	"unprognostic (2.04e-1)"	"prognostic favorable (8.69e-4)"	"unprognostic (4.50e-3)"	"unprognostic (1.80e-1)"	"unprognostic (3.94e-2)"	"unprognostic (6.13e-2)"	"unprognostic (1.34e-3)"	"unprognostic (4.62e-3)"	"unprognostic (6.88e-2)"	"unprognostic (1.53e-2)"	"unprognostic (1.51e-2)"	"unprognostic (4.77e-3)"	"prognostic favorable (2.13e-4)"	7.7	7.0	29.6	4.7	22.8	3.7	2.2	14.3	32.0	3.3	3.4	5.3	1.8	4.4	4.5	1.8	3.7	3.1	4.0	8.2	28.2	11.2	4.7	2.1	4.2	4.6	11.5	9.4	4.3	8.1	4.7	5.2	3.7	9.0	4.6	2.0	2.4	6.9	4.8	22.9	5.6	5.0	4.0	5.3	6.7	6.2	6.6	7.1	2.3	3.3	2.6	2.4	3.8	5.4	0.8	0.0	0.0	0.2	0.0	0.9	0.0	6.3	7.6	2.4	5.6	2.2	1.3	6.5	4.4	2.2	2.0	2.1	1.7	1.8	5.8	4.6	1.5	5.1	2.1	0.9	2.3	0.3	11.0	7.2	1.5	3.2	1.7	4.2	1.3	3.7	1.2	5.5	2.2	1.5	2.3	1.9	8.2	5.5	9.9	0.6	3.8	4.8	2.3	2.8	2.1	5.0	5.9	2.5	3.4	1.8	4.0	7.9	11.4	5.1	1.9	10.4	1.5	2.5	2.3	3.1	5.4	5.2	7.8	8.5	13.1	7.5	2.6	6.2	2.4	7.8	0.0	0.1	0.0	0.4	0.2	0.0	0.8	0.2	0.9	0.0	0.1	0.1	0.5	0.0	0.0	0.1	0.0	0.0	0.0	29.6	22.8	14.3	28.7	28.2	11.2	11.5	9.4	9.0	7.1	0.0	0.0	2.2	1.5	1.3	13.9	2.4	0.0	0.0	0.0	7.0	7.9	0.6	0.0	2.3	2.6	2.3	2.6	0.0	3.6	0.7	1.9	2.0	0.0	2.6	2.2	22.3	4.1	3.7	2.2	6.5	2.8	1.1	1.7	1.0	1.9	5.2	3.4	1.9	4.6	3.7	7.3	6.5	2.6	2.6	1.7	2.4	1.1	1.9	2.1	1.7
MAP3K11	"MEKK11, MLK3, PTK1, SPRK"	ENSG00000173327	"Mitogen-activated protein kinase kinase kinase 11"	Q16584	11	65597755-65615382	"Enzymes, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"vagina: 75.8"	"Cell type enhanced"	"Detected in all"	4	"Enterocytes: 120.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB010165	Approved		Supported	"Centriolar satellite,Cytosol"		NA	NA			"Centriolar satellite, Cytosol"		"CAB010165: AB_631936"	"unprognostic (8.36e-2)"	"unprognostic (1.17e-2)"	"unprognostic (1.06e-1)"	"unprognostic (9.99e-2)"	"unprognostic (3.40e-1)"	"unprognostic (1.87e-1)"	"unprognostic (7.56e-3)"	"unprognostic (3.10e-2)"	"unprognostic (4.50e-2)"	"unprognostic (4.30e-1)"	"unprognostic (4.69e-2)"	"unprognostic (2.77e-2)"	"unprognostic (3.13e-2)"	"unprognostic (2.01e-2)"	"unprognostic (7.62e-2)"	"unprognostic (1.95e-1)"	"unprognostic (8.27e-3)"	23.2	10.8	11.4	23.7	21.2	14.2	27.4	7.9	13.8	8.6	15.8	29.8	6.1	31.9	11.0	8.1	14.7	11.6	12.0	11.6	13.3	8.1	16.1	31.2	21.1	14.4	30.9	8.2	8.4	12.5	8.3	10.3	14.7	16.7	13.4	8.2	15.4	13.5	9.5	11.9	13.7	31.9	8.6	17.7	28.8	16.9	8.6	19.0	8.9	13.6	7.6	12.7	8.9	75.8	2.3	7.6	13.8	12.0	1.8	3.5	5.6	16.7	14.8	8.0	8.5	2.6	3.2	8.2	6.5	4.6	7.8	5.3	14.8	16.3	6.3	24.1	5.1	11.4	14.7	4.8	7.0	2.9	13.9	6.1	17.8	10.1	17.7	7.1	10.2	26.9	5.1	6.8	5.8	5.3	8.3	21.8	7.3	7.7	12.7	4.1	20.8	11.9	19.2	8.8	11.2	19.0	19.8	5.2	12.8	7.4	14.6	7.3	8.2	7.7	22.2	38.1	4.2	17.7	16.6	24.4	12.0	13.0	17.5	11.5	8.1	9.2	5.6	14.0	11.8	27.8	4.3	7.7	9.2	2.4	12.0	2.4	2.0	2.6	3.5	7.6	2.3	2.0	1.5	13.8	1.8	11.7	2.3	1.4	5.6	11.4	21.2	7.9	13.8	13.3	8.1	30.9	8.2	16.7	19.0	20.8	19.7	19.7	21.8	18.7	22.9	9.6	17.8	5.3	6.8	10.4	23.6	21.6	16.6	18.8	9.8	69.5	120.7	23.3	23.8	13.7	11.6	23.2	25.4	45.6	44.4	17.5	40.3	49.7	42.7	44.8	8.9	39.8	20.3	37.9	41.8	14.5	24.8	77.2	6.0	21.1	53.6	32.3	11.2	11.4	13.6	26.2	28.7	21.2	36.5	30.8
MAP3K12	"DLK, MEKK12, MUK, ZPK, ZPKP1"	ENSG00000139625	"Mitogen-activated protein kinase kinase kinase 12"	Q12852	12	53479669-53500063	"Enzymes, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 40.3"	"Cell type enhanced"	"Detected in many"	10	"Cone photoreceptor cells: 35.3;Rod photoreceptor cells: 81.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"granulocytes: 3.4;monocytes: 1.7;T-cells: 2.8"	"Cell line enhanced"	"Detected in many"		"ASC diff: 26.4;HHSteC: 25.2;HSkMC: 25.1;hTERT-RPE1: 33.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039936, HPA071996"	Enhanced		Approved	"Nucleoplasm,Plasma membrane"		NA	NA			"Nucleoplasm, Plasma membrane"		"HPA039936: AB_10795239, HPA071996: AB_2686481"	"unprognostic (4.01e-1)"	"unprognostic (3.30e-1)"	"unprognostic (8.89e-3)"	"unprognostic (6.40e-3)"	"unprognostic (1.10e-1)"	"unprognostic (2.22e-1)"	"unprognostic (6.97e-2)"	"unprognostic (3.61e-2)"	"unprognostic (2.39e-1)"	"unprognostic (2.70e-1)"	"prognostic favorable (1.51e-4)"	"unprognostic (8.50e-3)"	"prognostic unfavorable (5.43e-10)"	"unprognostic (1.65e-2)"	"unprognostic (2.44e-1)"	"unprognostic (1.32e-1)"	"unprognostic (1.18e-1)"	8.0	8.7	12.3	5.8	16.0	3.0	5.1	40.3	20.6	14.1	6.1	7.0	7.8	3.6	15.1	5.8	4.6	11.5	16.1	4.2	9.4	7.7	4.5	1.4	8.8	4.5	6.4	14.7	13.7	1.8	3.0	12.7	7.3	10.8	5.9	4.6	9.5	2.4	13.5	1.2	4.5	4.1	16.9	5.3	5.3	3.9	6.5	7.4	2.7	4.3	1.4	3.2	11.3	6.4	0.3	0.6	3.4	1.7	0.6	2.8	0.5	0.2	7.0	4.4	6.8	26.4	14.1	0.5	4.7	8.9	5.2	5.3	0.1	0.8	1.5	2.7	5.1	4.2	0.0	2.0	3.1	2.1	2.3	2.4	1.7	3.6	0.0	25.2	0.0	1.7	25.1	2.3	7.1	3.7	33.3	8.1	3.5	0.0	7.5	4.9	3.0	1.7	0.3	1.5	0.0	2.6	2.4	2.9	0.4	2.6	0.0	4.4	6.0	2.5	3.2	6.7	1.0	2.2	4.4	5.9	5.0	5.4	2.3	1.2	3.0	3.4	0.0	8.1	3.0	4.9	0.0	1.7	0.0	1.5	1.3	2.8	0.3	2.1	2.3	0.6	0.0	0.9	1.2	3.4	0.6	0.4	0.3	0.4	0.5	12.3	16.0	40.3	20.6	9.4	7.7	6.4	14.7	10.8	7.4	6.0	13.4	5.6	1.9	0.7	26.7	0.7	10.2	8.1	11.4	1.8	35.3	1.6	8.3	5.4	1.2	3.7	4.6	0.0	1.6	1.8	3.8	2.7	12.7	7.7	3.6	28.6	3.4	7.4	12.7	1.4	7.5	5.9	0.0	7.2	2.5	17.4	4.5	2.6	7.8	7.0	81.9	6.5	4.9	2.3	1.9	0.9	1.8	7.5	3.5	2.0
MAP3K13	"LZK, MEKK13"	ENSG00000073803	"Mitogen-activated protein kinase kinase kinase 13"	O43283	3	185282941-185489097	"Cancer-related genes, Enzymes, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"monocytes: 456.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA016497, HPA036691, HPA036692"	Uncertain		Approved	"Nucleoplasm,Centriolar satellite,Cytosol"		NA	NA			"Centriolar satellite"	"Nucleoplasm, Cytosol"	"HPA016497: AB_10670027, HPA036691: AB_10673661, HPA036692: AB_10670845"	"unprognostic (8.95e-2)"	"unprognostic (6.72e-3)"	"unprognostic (9.46e-2)"	"prognostic unfavorable (1.28e-5)"	"unprognostic (5.16e-2)"	"unprognostic (2.81e-1)"	"unprognostic (2.61e-1)"	"unprognostic (1.23e-2)"	"unprognostic (9.04e-2)"	"prognostic favorable (1.11e-4)"	"prognostic unfavorable (7.27e-5)"	"unprognostic (2.70e-3)"	"unprognostic (1.54e-2)"	"unprognostic (2.94e-2)"	"unprognostic (2.82e-1)"	"unprognostic (6.64e-2)"	"unprognostic (9.31e-3)"	9.8	24.8	21.7	8.7	22.2	9.5	15.1	16.4	26.1	12.9	16.9	18.4	10.5	16.8	12.9	42.1	15.2	14.6	13.1	8.1	19.2	18.6	21.9	20.7	15.2	7.4	23.2	17.1	16.5	24.9	20.9	24.5	9.1	21.8	14.5	18.9	18.6	26.2	11.4	3.3	9.8	23.4	12.1	26.4	8.7	16.4	12.9	15.8	4.4	18.6	8.3	10.3	12.5	11.5	23.7	21.5	21.1	13.2	11.5	17.4	7.8	29.1	5.8	11.3	0.3	10.3	12.7	6.7	6.7	4.6	10.9	13.2	11.2	11.0	0.2	23.0	12.2	18.2	16.7	0.3	15.5	19.4	32.5	15.0	0.1	7.9	9.2	11.2	15.3	8.4	11.5	13.6	9.3	11.7	11.3	12.1	0.3	0.3	23.7	9.7	9.1	1.8	7.2	13.0	22.5	13.7	0.2	13.5	16.0	19.2	7.6	18.6	12.4	11.3	17.1	23.2	12.9	25.8	8.6	8.0	9.0	11.7	16.2	14.5	12.1	15.6	9.6	13.2	7.8	14.7	6.4	13.2	5.1	10.3	12.2	15.8	23.7	12.4	12.8	21.5	19.0	17.4	16.8	21.1	11.5	8.6	9.4	4.8	7.8	21.7	22.2	16.4	26.1	19.2	18.6	23.2	17.1	21.8	15.8	50.6	76.2	44.7	172.9	125.7	111.5	22.1	104.4	64.3	84.2	75.0	86.4	120.9	243.7	92.5	109.7	52.6	82.0	0.0	111.2	29.4	48.3	249.1	28.9	83.1	55.4	42.9	102.2	83.4	50.4	168.4	40.0	59.4	81.0	456.3	109.9	93.7	112.0	96.2	50.9	224.8	81.3	45.3	74.0	119.3	28.8	127.2	170.1	31.2	98.7	249.0
MAP3K14	"FTDCR1B, HS, HSNIK, NIK"	ENSG00000006062	"Mitogen-activated protein kinase kinase kinase 14"	Q99558	17	45263121-45317040	"Enzymes, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	9	"monocytes: 49.5"	"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"A549: 22.4;HDLM-2: 23.0;U-251 MG: 22.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA027269, HPA027270"	Approved		Supported	"Nucleoplasm,Nucleoli fibrillar center,Vesicles,Cytosol"		NA	NA			"Vesicles, Cytosol"	"Nucleoplasm, Nucleoli fibrillar center"	"HPA027269: AB_2732436, HPA027270: AB_2732437"	"unprognostic (1.05e-2)"	"prognostic favorable (5.27e-5)"	"unprognostic (2.71e-2)"	"unprognostic (9.42e-2)"	"unprognostic (5.31e-2)"	"unprognostic (2.61e-3)"	"unprognostic (2.70e-2)"	"unprognostic (1.72e-1)"	"unprognostic (3.40e-1)"	"unprognostic (3.45e-1)"	"unprognostic (1.07e-2)"	"unprognostic (1.78e-1)"	"prognostic unfavorable (2.78e-4)"	"unprognostic (8.82e-2)"	"unprognostic (3.49e-2)"	"unprognostic (1.03e-2)"	"unprognostic (2.28e-1)"	3.7	3.4	3.0	14.7	4.0	3.4	2.7	4.9	3.6	5.0	7.3	4.5	3.5	6.0	5.5	3.3	6.8	4.2	6.2	4.5	3.0		4.4	5.1	4.9	12.0	3.0	0.6	3.5	5.7	3.5	7.7	1.5	4.6	5.2	3.5	4.3	7.5	4.8	14.5	6.1	9.6	5.2	4.1	8.4	4.0	4.5	4.5	7.1	2.2	6.9	18.0	4.9	2.8	9.5	4.8	7.7	3.6	5.6	5.2	2.3	9.5	22.4	2.3	4.0	1.6	3.8	5.7	2.6	1.8	8.5	5.2	3.4	11.9	4.2	13.6	2.8	8.5	6.8	1.0	3.6	4.4	23.0	1.7	0.9	6.1	1.5	4.1	0.7	4.5	5.9	2.3	4.2	2.2	9.0	1.6	2.0	1.8	18.3	4.3	3.5	4.0	1.5	1.2	5.9	3.1	5.2	6.9	9.6	6.2	1.9	2.4	1.9	4.1	2.7	2.9	3.4	1.7	0.4	3.6	3.9	6.0	3.3	22.5	17.5	6.5	2.2	2.2	2.5	5.2	1.5	3.4	1.6	3.5	3.6	2.0	7.6	2.4	2.5	2.3	9.5	2.6	2.5	7.7	5.6	2.2	4.8	5.2	2.3											3.0	13.8	9.7	13.7	0.0	3.6	2.0	15.3	9.4	4.5	0.0	3.9	0.7	0.0	4.2	3.7	1.6	11.2	0.0	2.3	1.2	1.8	6.5	1.1	8.1	4.4	1.6	12.6	4.9	7.8	4.5	4.4	6.2	0.0	49.5	6.4	2.2	3.3	7.8	1.1	2.5	2.7	0.0	0.6	4.5	2.4	0.0	0.0	5.1	6.7	5.0
MAP3K15	"ASK3, bA723P2.3, FLJ16518"	ENSG00000180815	"Mitogen-activated protein kinase kinase kinase 15"	Q6ZN16	X	19360056-19515261	"Enzymes, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"adrenal gland: 17.3;brain: 13.2"	"Cell type enhanced"	"Detected in some"	12	"Alveolar cells type 2: 1.9;Cardiomyocytes: 2.5;Collecting duct cells: 5.2;Cone photoreceptor cells: 3.9;Distal tubular cells: 3.3"	"Low cancer specificity"	"Detected in single"			"Region enriched"	"Detected in some"	6	"pons and medulla: 13.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A549: 3.2;HAP1: 7.9;HEK 293: 6.7;JURKAT: 3.9;REH: 4.1;SuSa: 8.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			HPA004006			Approved	Vesicles		NA	NA			Vesicles		"HPA004006: AB_1079358"	"unprognostic (2.87e-1)"	"unprognostic (7.09e-2)"	"unprognostic (3.21e-2)"	"unprognostic (6.56e-8)"	"unprognostic (3.47e-2)"	"unprognostic (1.42e-2)"	"unprognostic (2.19e-3)"	"unprognostic (2.35e-2)"	"unprognostic (1.46e-1)"	"unprognostic (4.87e-2)"	"unprognostic (1.30e-2)"	"unprognostic (8.95e-2)"	"unprognostic (2.77e-3)"	"unprognostic (4.00e-1)"	"unprognostic (2.37e-1)"	"unprognostic (3.98e-2)"	"unprognostic (8.20e-2)"	0.1	17.3	0.5	0.4	0.3	0.5	0.1	2.3	0.1	0.1	0.1	5.0	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.1	0.4	0.5	3.6	0.1	0.5	0.0	0.1	0.0	1.3	4.1	0.4	5.7	0.0	13.2	0.1	0.0	4.1	0.1	0.0	0.1	0.1	0.1	0.0	0.1	2.6	0.1	2.1	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	3.2	0.1	0.3	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.3	0.0	0.4	0.0	7.9	0.0	0.0	1.3	6.7	2.7	0.0	0.7	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	3.9	0.5	0.0	0.0	0.2	0.0	2.1	2.0	0.0	0.8	4.1	0.0	0.0	0.5	0.0	0.1	0.1	0.0	0.0	0.0	8.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.5	0.3	2.3	0.1	0.4	0.5	0.1	0.0	13.2	0.0	0.0	1.9	0.0	0.6	0.1	0.6	2.5	0.0	0.0	0.0	5.2	3.9	0.0	3.3	0.0	0.3	0.0	0.0	0.0	0.0	0.2	0.1	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.3	0.1	0.0	1.1	0.0	0.6	0.0	0.0	0.2	1.2	0.0	0.1	0.0	0.0	0.0
MAP3K19	"FLJ23074, RCK, YSK4"	ENSG00000176601	"Mitogen-activated protein kinase kinase kinase 19"	Q56UN5	2	134964491-135047468	"Enzymes, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"brain: 18.3;fallopian tube: 23.9"	"Group enriched"	"Detected in some"	5	"Ciliated cells: 151.3;Early spermatids: 55.2;Late spermatids: 74.5"	"Cancer enhanced"	"Detected in some"		"endometrial cancer: 0.8"	"Region enhanced"	"Detected in many"		"pons and medulla: 18.3"	"Cell type enriched"	"Detected in single"	6	"plasmacytoid DC: 1.5"	"Lineage enriched"	"Detected in single"	6	"dendritic cells: 1.5"	"Group enriched"	"Detected in some"	4	"RPMI-8226: 4.1;U-266/70: 2.4"	"Low region specificity"	"Detected in all"			"Region enhanced"	"Detected in many"		"midbrain: 20.2"	HPA011388			Uncertain	Cytosol		NA	NA			Cytosol		"HPA011388: AB_1848822"	"unprognostic (7.12e-3)"	"unprognostic (6.55e-3)"	"unprognostic (6.96e-2)"	"unprognostic (3.90e-3)"	"unprognostic (3.63e-1)"	"unprognostic (2.21e-1)"	"unprognostic (1.96e-1)"	"unprognostic (9.38e-2)"	"unprognostic (1.09e-1)"	"unprognostic (4.33e-1)"	"unprognostic (2.02e-2)"	"unprognostic (1.32e-1)"	"unprognostic (4.04e-6)"	"unprognostic (1.50e-1)"	"unprognostic (4.13e-2)"	"unprognostic (1.54e-1)"	"unprognostic (2.83e-4)"	0.1	0.2	1.7	0.2	6.2	0.1	0.1	0.0	0.5	1.1	0.2	7.3	0.0	0.2	1.0	6.7	0.2	23.9	0.1	0.1	2.9	3.8	0.2	0.2	5.6	0.2	0.5	1.5	7.3	0.1	0.1	1.0	0.1	18.3	0.3	0.2	0.0	0.2	0.2	0.3	0.2	0.2	0.1	0.5	0.2	0.2	7.6	3.1	0.0	0.1	0.0	0.1	0.1	0.0	0.0	1.5	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.6	0.0	4.1	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.6	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.2	0.0	1.7	6.2	0.0	0.5	2.9	3.8	0.5	1.5	18.3	3.1	0.0	0.6	0.0	0.0	0.0	0.2	0.4	0.0	151.3	17.0	0.0	9.8	0.0	0.0	0.0	55.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	74.5	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.5	1.1	0.0	0.0	0.0	0.0	0.1
MAP3K2	"MEKK2, MEKK2B"	ENSG00000169967	"Mitogen-activated protein kinase kinase kinase 2"	Q9Y2U5	2	127298730-127388465	"Enzymes, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"neutrophil: 13.6"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA021540	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"HPA021540: AB_2670742"	"unprognostic (5.81e-2)"	"unprognostic (2.76e-1)"	"unprognostic (1.58e-1)"	"unprognostic (9.46e-2)"	"unprognostic (1.02e-1)"	"unprognostic (5.76e-2)"	"unprognostic (7.19e-2)"	"unprognostic (4.50e-1)"	"unprognostic (1.27e-1)"	"unprognostic (4.00e-1)"	"unprognostic (1.25e-1)"	"unprognostic (1.39e-1)"	"unprognostic (4.97e-3)"	"unprognostic (7.56e-2)"	"unprognostic (8.93e-2)"	"unprognostic (8.88e-2)"	"unprognostic (2.11e-1)"	18.5	14.5	13.7	20.1	14.5	41.0	22.6	20.1	16.3	16.6	19.6	12.7	18.9	18.8	19.8	18.0	13.4	15.9	18.6	13.3	12.5	10.2	15.5	27.6	20.0	28.5	17.9	13.0	20.3	15.4	23.8	21.2	13.9	12.3	13.6	13.1	12.2	18.1	25.5	24.5	19.4	22.5	18.1	14.9	17.0	18.0	14.9	14.3	25.8	22.5	13.7	16.8	17.1	20.3	3.1	5.1	13.6	2.9	2.3	2.1	1.1	16.4	7.0	5.6	5.7	7.9	10.5	9.4	10.3	11.2	10.2	8.3	8.4	7.3	10.9	17.8	14.7	9.4	14.0	9.0	6.9	11.5	27.3	7.0	10.1	12.8	7.3	9.2	10.1	21.9	9.4	7.6	12.3	15.2	9.0	4.7	8.2	4.7	21.8	10.0	6.0	11.9	7.2	5.8	4.6	9.2	7.8	10.6	8.1	4.1	15.5	11.2	6.0	15.0	9.2	9.3	4.8	6.0	7.8	10.7	20.0	18.8	9.2	13.9	22.7	16.3	11.2	9.6	6.7	8.6	4.0	2.9	2.0	1.7	1.8	2.1	3.1	1.6	1.7	2.4	2.6	1.9	2.0	13.6	2.3	2.2	5.1	1.4	1.1	13.7	14.5	20.1	16.3	12.5	10.2	17.9	13.0	12.3	14.3	77.4	39.5	24.5	32.1	64.0	51.3	27.5	38.2	57.6	46.6	27.9	100.1	16.2	11.6	17.3	3.2	38.8	49.0	23.3	29.5	16.3	51.8	41.5	60.0	61.1	46.1	68.3	43.6	22.1	61.3	3.8	39.1	76.0	54.0	23.4	36.2	25.5	35.7	24.6	48.8	27.2	56.9	19.4	48.6	31.4	55.2	68.6	22.0	30.5	24.4	35.7
MAP3K20	"MLK7, MLTK, MLTKalpha, MLTKbeta, MRK, ZAK"	ENSG00000091436	"Mitogen-activated protein kinase kinase kinase 20"	Q9NYL2	2	173075435-173268010	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Cell cycle"	"Kinase, Serine/threonine-protein kinase, Transferase"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skeletal muscle: 96.1"	"Cell type enhanced"	"Detected in many"	7	"Alveolar cells type 1: 35.7;Alveolar cells type 2: 51.9;Cytotrophoblasts: 48.5;Ductal cells: 34.2;Pancreatic endocrine cells: 31.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"myeloid DC: 13.7"	"Group enriched"	"Detected in many"	5	"dendritic cells: 13.7;monocytes: 8.0"	"Cell line enhanced"	"Detected in many"		"hTERT-HME1: 44.9;U-138 MG: 48.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA017205	Approved		Supported	Cytosol		NA	NA			Cytosol		"HPA017205: AB_1858933"	"unprognostic (2.90e-2)"	"unprognostic (9.99e-3)"	"unprognostic (4.63e-3)"	"unprognostic (1.98e-1)"	"unprognostic (7.63e-2)"	"unprognostic (5.02e-2)"	"unprognostic (2.34e-2)"	"unprognostic (3.89e-3)"	"unprognostic (2.83e-2)"	"unprognostic (9.27e-2)"	"unprognostic (4.54e-2)"	"unprognostic (1.74e-1)"	"prognostic unfavorable (3.41e-6)"	"unprognostic (2.34e-1)"	"unprognostic (1.86e-1)"	"unprognostic (2.23e-1)"	"unprognostic (1.19e-2)"	21.7	5.0	2.9	7.4	3.3	0.8	9.2	2.8	3.1	25.7	24.8	2.1	10.7	3.1	30.2	15.4	26.2	13.1	14.9	52.5	3.5	3.0	2.4	8.5	7.5	2.5	4.5	3.0	21.7	4.4	22.6	3.1	6.9	4.2	25.6	5.4	11.5	6.7	15.8	96.1	5.8	8.0	68.4	4.7	3.7	15.8	6.6	3.5	2.8	6.7	38.0	4.9	46.7	24.0	2.1	13.7	2.3	8.0	0.4	1.6	2.7	8.9	7.5	5.9	7.8	17.3	25.8	3.7	32.3	25.3	15.1	16.3	5.1	5.9	6.9	8.5	32.3	13.3	6.1	8.8	17.1	34.1	13.4	5.9	11.2	8.5	1.0	6.9	10.0	11.9	20.7	7.4	28.4	44.9	12.6	10.0	7.6	5.0	1.3	9.9	3.8	6.3	5.0	3.3	7.5	4.3	9.3	12.1	0.0	3.7	5.1	3.5	3.4	12.4	3.0	5.3	10.1	3.4	5.4	10.0	48.3	19.8	14.3	7.3	0.0	0.0	1.4	34.7	2.7	5.0	0.1	8.0	0.0	0.9	7.5	0.9	1.5	0.8	1.6	13.7	2.1	0.0	0.8	2.3	0.4	6.6	0.3	0.7	2.7	2.9	3.3	2.8	3.1	3.5	3.0	4.5	3.0	4.2	3.5	35.7	51.9	0.0	0.0	0.0	0.0	0.0	0.0	24.1	13.6	10.4	0.0	48.5	1.7	34.2	0.0	0.0	0.0	0.0	23.2	22.4	0.0	0.0	4.7	0.0	18.6	0.0	0.0	0.0	0.0	0.0	0.0	8.2	0.0	27.1	0.0	0.0	31.3	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	18.1	0.0	0.0	0.0
MAP3K21	"KIAA1804, MLK4"	ENSG00000143674	"Mitogen-activated protein kinase kinase kinase 21"	Q5TCX8	1	233327768-233385148	"Enzymes, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"pancreas: 28.9"	"Cell type enhanced"	"Detected in some"	18	"Alveolar cells type 1: 32.8;Alveolar cells type 2: 7.7;Collecting duct cells: 14.0;Ductal cells: 9.7;Exocrine glandular cells: 8.4;Pancreatic endocrine cells: 7.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in single"	6	"NK-cell: 5.0"	"Lineage enriched"	"Detected in single"	6	"NK-cells: 5.0"	"Cell line enhanced"	"Detected in many"		"HEK 293: 18.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA007636	Uncertain		Approved	"Plasma membrane,Cytosol"		NA	NA			"Plasma membrane, Cytosol"		"HPA007636: AB_1079392"	"unprognostic (3.29e-2)"	"unprognostic (5.10e-2)"	"unprognostic (2.00e-1)"	"unprognostic (2.42e-3)"	"unprognostic (4.30e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.82e-2)"	"unprognostic (1.84e-1)"	"unprognostic (1.51e-1)"	"unprognostic (1.25e-1)"	"unprognostic (2.09e-1)"	"unprognostic (8.21e-2)"	"unprognostic (3.76e-2)"	"unprognostic (2.23e-1)"	"unprognostic (1.71e-1)"	"unprognostic (9.22e-2)"	"unprognostic (4.84e-2)"	0.6	3.2	2.0	3.4	2.2	1.3	2.2	10.0	3.3	1.5	11.4	0.6	9.1	9.9	0.8	5.2	2.4	3.9	3.9	0.7	1.3	2.1	12.5	13.3	5.6	0.5	0.9	1.7	0.8	28.9	4.4	2.6	1.0	1.2	1.3	6.0	1.0	3.7	2.5	0.4	2.7	17.2	0.3	0.9	0.7	10.1	12.4	0.6	0.5	2.4	0.8	1.3	1.1	1.6	0.5	0.8	0.1	0.3	5.0	0.2	0.1	7.4	12.7	0.2	0.0	0.0	0.0	6.4	0.2	0.0	0.3	0.5	7.0	6.5	0.7	5.2	0.1	2.4	4.0	9.5	3.9	0.8	13.8	18.3	0.1	7.1	0.0	0.5	12.1	2.9	0.1	5.2	0.2	7.4	1.4	0.4	5.8	0.1	2.4	0.0	1.6	3.8	4.3	9.1	8.7	5.6	0.0	0.0	13.3	8.8	3.1	9.4	2.5	4.3	0.2	0.0	1.0	3.7	3.9	0.0	0.0	1.2	0.0	7.4	2.3	2.9	0.0	1.2	3.3	0.3	0.0	0.3	0.0	0.0	0.1	0.0	0.3	0.2	0.1	0.8	0.5	0.0	0.0	0.1	5.0	0.0	0.2	0.2	0.1	2.0	2.2	10.0	3.3	1.3	2.1	0.9	1.7	1.2	0.6	32.8	7.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	14.0	0.0	0.0	3.3	9.7	0.0	0.0	0.0	0.0	8.4	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	1.8	0.0	0.0	7.8	0.0	0.0	6.7	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0
MAP3K3	"MAPKKK3, MEKK3"	ENSG00000198909	"Mitogen-activated protein kinase kinase kinase 3"	Q99759	17	63622415-63696303	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB007764, HPA035410, HPA035411"	Uncertain		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"CAB007764: AB_562314, HPA035410: AB_2674614, HPA035411: AB_2674615"	"unprognostic (9.65e-3)"	"unprognostic (1.33e-1)"	"unprognostic (5.14e-2)"	"prognostic unfavorable (1.13e-4)"	"unprognostic (1.16e-1)"	"unprognostic (4.12e-2)"	"unprognostic (1.03e-2)"	"unprognostic (1.33e-1)"	"unprognostic (1.36e-1)"	"unprognostic (9.37e-2)"	"unprognostic (1.46e-3)"	"unprognostic (5.51e-2)"	"unprognostic (2.35e-1)"	"unprognostic (2.79e-2)"	"unprognostic (4.68e-2)"	"unprognostic (1.09e-1)"	"unprognostic (3.08e-2)"	23.9	11.8	10.5	20.5	15.0	24.8	19.1	26.8	14.9	22.2	21.8	15.0	14.0	8.0	24.5	13.2	16.6	18.3	20.6	37.4	11.3	8.4	17.1	12.4	23.1	21.4	14.4	9.6	21.6	11.4	16.9	12.3	21.0	11.9	18.4	8.3	21.7	12.8	18.5	19.6	15.4	14.7	20.4	13.2	30.4	16.4	26.5	12.3	12.9	15.5	12.8	15.4	19.0	26.8	1.9	3.5	18.3	8.5	1.1	2.6	2.3	10.2	7.7	9.8	9.6	18.9	15.2	4.5	10.2	11.2	12.7	10.3	3.5	2.1	11.1	7.2	19.9	9.3	3.8	6.4	7.2	8.1	9.7	14.1	9.0	10.5	5.0	9.9	6.9	9.7	10.9	5.0	15.8	8.3	8.1	30.8	8.2	5.5	14.7	10.1	7.3	12.4	7.3	6.1	2.1	8.3	6.6	25.2	7.2	4.6	4.7	5.0	12.1	6.9	8.3	8.5	12.9	8.3	6.9	27.7	32.5	8.6	17.6	12.3	14.7	14.8	4.1	7.0	5.6	8.4	8.8	8.5	10.4	2.2	8.3	2.3	1.5	2.6	2.1	3.5	1.9	2.5	2.5	18.3	1.1	8.2	1.3	1.9	2.3	10.5	15.0	26.8	14.9	11.3	8.4	14.4	9.6	11.9	12.3	17.9	12.6	8.8	5.9	6.9	13.9	9.9	2.5	4.0	5.7	15.7	13.7	2.7	8.3	3.7	7.1	33.7	2.1	0.0	6.9	2.9	7.4	8.9	3.5	8.3	13.8	17.5	4.1	39.3	38.3	4.4	13.8	15.3	21.9	8.2	3.3	7.5	4.9	0.0	12.4	2.1	15.0	19.4	11.4	18.0	6.1	9.8	1.1	8.7	4.4	3.7
MAP3K4	"KIAA0213, MAPKKK4, MEKK4, MTK1"	ENSG00000085511	"Mitogen-activated protein kinase kinase kinase 4"	Q9Y6R4	6	160991727-161117385	"Cancer-related genes, Enzymes, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA007625	Uncertain		Approved	Cytosol		NA	NA			Cytosol		"HPA007625: AB_1853770"	"unprognostic (3.05e-3)"	"unprognostic (2.19e-2)"	"unprognostic (1.36e-1)"	"unprognostic (1.44e-1)"	"unprognostic (2.06e-1)"	"unprognostic (7.65e-2)"	"unprognostic (1.35e-3)"	"unprognostic (6.38e-2)"	"unprognostic (2.09e-1)"	"unprognostic (3.81e-3)"	"unprognostic (2.09e-2)"	"unprognostic (2.61e-1)"	"unprognostic (1.16e-2)"	"unprognostic (5.86e-2)"	"unprognostic (3.45e-1)"	"unprognostic (1.93e-1)"	"unprognostic (6.84e-2)"	12.0	8.0	13.1	17.7	12.6	9.1	14.6	23.1	14.0	16.4	13.9	9.3	12.2	9.5	22.2	11.9	21.4	14.1	11.4	12.4	11.9	7.8	9.4	8.2	15.9	14.4	12.8	8.9	17.4	12.1	15.8	16.2	12.4	9.2	14.2	9.8	9.4	15.0	15.4	24.4	15.1	13.3	13.9	7.7	10.6	11.1	13.5	12.4	16.2	10.6	13.0	16.8	15.8	23.9	8.8	5.4	17.5	3.8	3.5	8.9	2.2	4.7	5.4	10.3	8.8	6.4	7.5	6.7	5.4	4.8	6.2	6.6	7.7	3.5	9.8	3.9	13.7	8.9	11.9	10.5	10.8	7.6	7.1	8.6	12.8	5.0	7.5	4.9	13.2	6.2	4.7	12.6	6.5	5.9	9.7	8.1	7.4	32.2	11.3	6.6	4.9	8.9	6.7	6.3	3.4	8.3	9.8	9.5	7.8	5.7	3.5	5.9	5.3	10.1	10.8	0.9	9.4	4.4	16.2	7.5	7.6	9.8	7.1	25.5	6.6	5.3	9.0	9.0	13.7	8.0	17.5	3.8	2.3	5.0	3.0	8.9	6.2	7.1	4.5	4.3	8.8	5.0	4.9	0.2	3.5	1.7	5.4	4.8	2.2	13.1	12.6	23.1	14.0	11.9	7.8	12.8	8.9	9.2	12.4	17.9	12.6	14.2	8.2	8.8	15.7	17.9	10.2	8.1	19.4	14.0	21.6	16.7	3.3	8.0	2.6	11.3	5.9	0.0	6.5	9.4	7.8	10.8	3.5	7.3	6.4	22.3	14.8	4.3	7.0	2.5	10.6	9.0	0.0	18.0	9.4	18.9	9.7	7.0	11.7	5.9	28.6	6.5	8.0	13.5	29.6	10.3	27.7	12.1	10.9	12.9
MAP3K5	"ASK1, MAPKKK5, MEKK5"	ENSG00000197442	"Mitogen-activated protein kinase kinase kinase 5"	Q99683	6	136557047-136792518	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Apoptosis, Host-virus interaction, Immunity, Innate immunity, Stress response"	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adrenal gland: 55.6"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 22.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB007824, HPA063245"	Supported		Supported	Cytosol		NA	NA			Cytosol		"CAB007824: AB_598175, HPA063245: AB_2684969"	"unprognostic (1.37e-1)"	"unprognostic (3.21e-2)"	"unprognostic (2.85e-2)"	"unprognostic (1.38e-1)"	"unprognostic (3.19e-1)"	"prognostic favorable (6.08e-4)"	"unprognostic (8.76e-2)"	"unprognostic (1.41e-2)"	"unprognostic (2.84e-1)"	"unprognostic (1.90e-2)"	"prognostic unfavorable (5.91e-4)"	"unprognostic (3.97e-1)"	"unprognostic (3.75e-2)"	"unprognostic (1.37e-1)"	"unprognostic (2.72e-1)"	"unprognostic (2.72e-2)"	"unprognostic (6.59e-3)"	7.7	55.6	13.0	7.5	17.6	7.6	5.5	12.9	12.7	4.0	5.4	6.9	3.6	4.6	7.2	5.1	6.4	6.1	4.9	7.3	11.8	6.8	6.8	5.5	7.7	8.8	8.2	6.4	32.4	28.2	1.5	9.9	3.4	7.9	11.6	6.2	5.8	4.2	4.9	3.7	5.0	4.6	4.3	7.5	9.8	8.7	7.3	8.6	2.0	10.0	3.4	9.0	10.8	18.9	2.5	2.5	8.5	3.0	4.1	7.0	1.4	2.9	1.8	0.0	0.0	4.2	11.3	1.0	4.2	22.7	2.2	2.1	0.1	3.0	1.7	6.2	5.8	1.6	4.0	7.2	2.1	5.7	2.3	5.7	15.0	4.0	0.0	20.1	6.9	0.0	14.8	2.8	3.4	9.8	8.4	7.3	2.1	3.7	16.8	15.3	5.6	0.1	5.9	0.7	5.7	2.4	3.9	4.8	6.8	8.8	18.6	5.3	3.5	3.5	3.4	0.9	0.8	0.7	6.2	6.3	3.6	1.1	0.2	3.9	13.7	9.1	0.0	2.8	9.8	3.2	5.7	3.0	3.3	2.7	2.3	4.9	2.0	4.3	3.7	2.5	2.5	0.4	1.4	8.5	4.1	2.1	2.4	7.0	1.4	13.0	17.6	12.9	9.4	11.8	6.8	8.2	6.4	7.9	8.6	6.0	22.4	10.4	17.9	4.4	17.5	21.8	2.5	16.0	34.2	10.4	5.9	0.7	3.3	2.1	4.9	3.8	7.7	0.0	19.7	0.9	5.1	22.3	5.7	9.6	7.1	0.0	33.5	9.8	22.1	2.3	21.9	18.4	0.0	1.0	12.1	42.4	18.9	5.8	13.4	6.8	2.5	12.9	8.0	1.4	15.0	8.8	2.3	6.9	10.0	19.3
MAP3K6	"ASK2, MAPKKK6, MEKK6"	ENSG00000142733	"Mitogen-activated protein kinase kinase kinase 6"	O95382	1	27355184-27366892	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skin 1: 63.9"	"Cell type enhanced"	"Detected in many"	4	"Ito cells: 28.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			HPA051192	Approved		Approved	"Nucleoplasm,Plasma membrane,Actin filaments,Cytosol"		NA	NA			Nucleoplasm	"Plasma membrane, Actin filaments, Cytosol"	"HPA051192: AB_2681380"	"unprognostic (1.19e-2)"	"unprognostic (2.77e-3)"	"unprognostic (2.62e-2)"	"unprognostic (1.97e-2)"	"prognostic unfavorable (2.13e-4)"	"prognostic favorable (7.26e-4)"	"prognostic unfavorable (8.76e-4)"	"unprognostic (9.10e-2)"	"unprognostic (2.79e-1)"	"unprognostic (6.91e-2)"	"unprognostic (6.56e-2)"	"unprognostic (1.25e-1)"	"unprognostic (4.65e-3)"	"unprognostic (4.95e-2)"	"unprognostic (2.79e-1)"	"unprognostic (7.07e-3)"	"unprognostic (1.50e-1)"	37.5	6.3	7.4	6.9	8.6	1.3	22.1	12.6	8.3	19.9	9.0	2.7	8.9	3.3	13.1	10.3	25.7	12.8	12.4	14.9	6.2	2.6	13.6	5.0	21.7	5.5	11.4	1.9	11.7	8.3	8.2	15.8	7.3	9.8	13.9	5.9	15.7	11.5	9.7	6.3	63.9	6.2	16.0	11.7	8.7	9.0	6.7	7.0	0.6	12.0	16.1	14.3	14.3	18.3	2.7	3.3	5.1	6.9	1.1	7.6	2.4	7.5	7.0	6.3	7.0	8.8	15.4	1.6	9.4	5.4	7.1	5.4	2.1	10.2	0.1	8.4	14.2	2.8	11.9	2.1	6.5	3.6	6.2	5.2	0.5	16.2	3.1	2.7	0.5	0.6	12.4	16.1	7.4	2.6	7.9	4.8	0.5	2.3	4.1	11.3	18.7	0.3	8.6	2.0	7.5	5.8	2.7	4.2	1.7	10.6	7.9	2.3	3.5	9.9	8.7	7.4	2.7	4.6	6.4	9.9	17.9	7.5	19.9	4.9	3.4	4.2	0.1	15.8	6.1	5.2	1.8	1.5	5.1	5.3	3.3	7.6	2.7	5.5	5.9	3.3	2.3	4.4	3.6	2.4	1.1	6.9	0.0	5.6	2.4	7.4	8.6	12.6	8.3	6.2	2.6	11.4	1.9	9.8	7.0	17.9	16.2	4.7	10.4	11.1	0.5	8.9	10.2	1.4	11.4	3.5	0.0	0.9	3.3	2.3	0.4	15.8	1.7	0.0	3.8	1.7	7.7	7.3	2.3	0.8	2.5	4.8	0.0	28.8	12.5	1.1	15.0	5.1	5.0	13.6	4.9	5.2	8.9	0.0	14.2	1.5	0.4	6.5	10.5	8.7	2.1	12.9	0.1	10.2	4.3	14.4
MAP3K7	"MEKK7, TAK1"	ENSG00000135341	"Mitogen-activated protein kinase kinase kinase 7"	O43318	6	90513573-90587045	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Apoptosis, Host-virus interaction, Stress response, Transcription, Transcription regulation"	"Kinase, Serine/threonine-protein kinase, Transferase"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007633, HPA075335"	Approved		Supported	"Nuclear speckles,Plasma membrane,Cytosol"		NA	NA			Cytosol	"Nuclear speckles, Plasma membrane"	"HPA007633: AB_1079359, HPA075335: "	"unprognostic (1.48e-1)"	"unprognostic (3.45e-2)"	"unprognostic (1.35e-1)"	"unprognostic (6.48e-2)"	"unprognostic (1.44e-1)"	"unprognostic (1.84e-1)"	"prognostic unfavorable (3.51e-4)"	"unprognostic (9.77e-2)"	"unprognostic (6.51e-2)"	"unprognostic (1.98e-2)"	"unprognostic (1.44e-1)"	"unprognostic (2.79e-1)"	"unprognostic (2.56e-3)"	"unprognostic (4.76e-2)"	"unprognostic (1.95e-1)"	"unprognostic (2.08e-1)"	"unprognostic (1.17e-1)"	15.5	17.6	19.6	17.3	26.3	10.3	21.6	27.5	27.3	21.1	16.4	15.7	15.8	12.5	23.1	23.6	15.2	15.5	17.6	22.2	20.5	17.5	15.9	15.5	20.0	22.2	22.9	16.4	25.0	13.5	25.8	25.6	23.6	20.7	21.2	15.3	12.4	17.0	23.3	24.3	18.7	14.7	19.4	23.0	23.3	14.7	13.8	21.7	28.2	20.3	10.8	21.9	17.2	18.9	14.2	15.9	19.4	17.7	18.2	22.1	13.6	7.9	7.0	20.5	17.6	15.0	20.1	14.5	16.0	18.5	14.4	18.2	9.0	7.6	17.7	10.2	17.2	12.8	8.5	12.9	12.4	24.6	9.0	13.7	15.8	9.7	11.9	15.8	17.5	12.2	16.6	15.3	14.0	17.2	16.6	13.5	15.6	31.5	14.5	20.6	9.7	8.1	14.8	16.8	12.4	8.9	14.0	36.9	8.6	12.1	8.9	10.4	14.8	11.1	7.7	12.0	16.8	7.7	31.1	12.9	11.7	7.4	10.7	14.8	12.9	11.5	7.7	18.0	19.2	17.2	15.5	12.7	19.4	15.1	17.4	16.8	14.2	14.5	14.4	15.9	10.5	16.5	16.0	12.5	18.2	17.7	9.8	22.1	13.6	19.6	26.3	27.5	27.3	20.5	17.5	22.9	16.4	20.7	21.7	14.9	24.0	20.7	17.4	32.3	22.8	28.8	12.7	16.0	10.3	15.7	25.5	27.6	6.6	16.6	2.6	20.3	9.3	0.0	18.3	26.6	23.5	24.4	12.8	17.9	21.1	27.0	11.6	30.7	26.3	2.2	24.7	25.3	20.3	27.9	15.6	18.9	15.5	7.0	38.5	13.1	21.1	19.4	19.1	24.6	24.0	32.5	40.5	25.5	15.1	23.0
MAP3K8	"c-COT, COT, EST, ESTF, MEKK8, Tpl-2"	ENSG00000107968	"Mitogen-activated protein kinase kinase kinase 8"	P41279	10	30433937-30461833	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Immunity"	"Kinase, Serine/threonine-protein kinase, Transferase"	Proto-oncogene	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 104.6"	"Cell type enhanced"	"Detected in many"	5	"Syncytiotrophoblasts: 133.3;Urothelial cells: 168.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HMC-1: 24.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB005120, HPA017962"	Supported		Supported	Cytosol		NA	NA			Cytosol		"CAB005120: AB_2140669, HPA017962: AB_1853776"	"unprognostic (1.91e-2)"	"unprognostic (2.94e-1)"	"unprognostic (3.07e-1)"	"unprognostic (9.29e-2)"	"unprognostic (6.73e-2)"	"unprognostic (1.00e-2)"	"unprognostic (1.44e-1)"	"unprognostic (3.36e-2)"	"unprognostic (1.41e-2)"	"unprognostic (8.04e-3)"	"unprognostic (8.23e-2)"	"unprognostic (2.96e-1)"	"prognostic unfavorable (8.76e-7)"	"unprognostic (1.88e-1)"	"unprognostic (1.49e-1)"	"unprognostic (1.63e-2)"	"unprognostic (5.98e-3)"	28.0	7.6	3.6	15.6	4.1	104.6	26.1	1.5	2.6	8.2	8.4	2.7	11.3	3.4	11.5	16.5	13.8	19.5	15.3	20.1	4.3	2.9	6.3	7.6	29.0	33.7	4.3	2.0	9.8	3.6	2.8	4.1	27.5	8.3	7.9	6.8	9.4	6.1	18.4	8.6	15.3	9.6	23.4	9.7	25.6	10.7	6.7	3.6	2.4	7.0	13.2	17.2	13.2	15.6	19.6	13.8	23.7	16.8	12.4	7.8	4.0	8.0	7.2	2.0	4.2	10.5	8.8	9.3	2.0	12.1	4.5	5.4	5.0	18.8	5.3	5.2	4.3	4.4	15.2	4.5	1.9	1.6	12.3	2.3	9.9	12.3	16.0	8.9	3.1	24.4	11.0	1.1	4.5	0.9	4.5	2.0	0.1	4.4	8.0	0.7	4.6	0.1	11.8	0.7	4.3	2.6	0.6	1.6	3.0	4.4	16.4	0.2	0.8	7.2	6.2	0.9	5.7	2.1	6.6	0.1	2.8	2.4	9.9	0.3	12.1	11.3	1.6	4.0	13.4	0.1	17.9	7.0	23.7	7.8	12.0	4.3	9.6	1.7	4.9	6.6	19.6	0.1	3.0	16.7	12.4	16.8	13.8	0.4	4.0	3.6	4.1	1.5	2.6	4.3	2.9	4.3	2.0	8.3	3.6	35.7	41.7	14.7	46.9	103.8	13.9	7.1	5.1	25.4	13.6	3.5	0.0	23.9	1.7	25.2	0.4	36.9	5.2	0.0	9.8	71.1	77.1	32.5	71.4	3.0	109.0	0.0	11.5	14.1	86.6	0.0	7.8	94.5	40.5	78.5	5.3	5.0	17.6	17.5	3.9	2.4	1.1	6.5	75.4	0.0	0.7	74.2	133.3	52.3	5.8	168.4
MAP3K9	"MEKK9, MLK1, PRKE1"	ENSG00000006432	"Mitogen-activated protein kinase kinase kinase 9"	P80192	14	70722526-70809534	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Apoptosis, Stress response, Transcription, Transcription regulation"	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 20.1"	"Cell type enhanced"	"Detected in many"	5	"Horizontal cells: 28.6;Urothelial cells: 25.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"A-431: 18.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA000942	Approved		Approved	Nucleoplasm,Nucleoli	"Intracellular and membrane"	NA	NA			"Nucleoplasm, Nucleoli"		"HPA000942: AB_1079360"	"unprognostic (1.20e-1)"	"unprognostic (3.75e-1)"	"unprognostic (4.01e-2)"	"unprognostic (1.43e-2)"	"unprognostic (3.16e-3)"	"unprognostic (2.45e-2)"	"unprognostic (3.75e-5)"	"unprognostic (2.58e-1)"	"unprognostic (4.20e-2)"	"unprognostic (4.38e-2)"	"unprognostic (1.53e-2)"	"unprognostic (2.48e-2)"	"unprognostic (4.23e-6)"	"unprognostic (5.71e-3)"	"unprognostic (6.86e-3)"	"unprognostic (1.79e-1)"	"unprognostic (2.35e-1)"	0.5	2.2	5.8	2.0	9.2	1.4	2.8	20.1	16.5	2.4	3.1	1.8	0.4	3.0	1.1	3.4	10.1	2.2	1.5	1.2	5.7	7.1	3.1	2.4	3.9	2.6	5.9	5.9	1.4	4.3	6.8	4.7	2.8	12.8	2.0	3.1	3.1	3.2	1.3	1.9	7.8	2.9	0.7	1.6	1.9	3.4	10.1	1.8	0.6	5.3	3.2	6.8	2.0	3.9	2.3	0.5	1.3	0.2	1.1	1.4	0.3	18.1	8.4	1.6	2.0	0.0	0.0	5.6	0.4	0.2	1.7	1.6	6.0	7.0	3.7	2.5	0.1	3.7	8.6	5.3	10.2	1.9	2.4	1.5	0.2	2.9	4.0	0.3	0.4	0.8	0.1	5.6	1.2	10.6	3.1	0.0	3.3	1.3	0.8	0.4	7.3	2.8	0.4	3.5	7.2	3.9	1.0	3.2	0.7	3.9	8.3	11.6	2.5	5.2	6.2	1.0	3.2	5.6	0.6	0.0	0.0	7.4	0.0	2.8	1.9	4.4	1.9	2.8	0.3	1.1	0.5	0.2	0.8	0.6	0.1	0.1	1.0	0.6	1.0	0.0	2.3	1.0	0.7	1.3	1.1	0.2	0.5	1.4	0.3	5.8	9.2	20.1	16.5	5.7	7.1	5.9	5.9	12.8	1.8	6.0	14.9	0.9	10.9	7.7	15.8	1.8	15.3	0.0	10.3	7.0	11.8	2.5	1.7	5.5	13.2	0.7	3.1	0.0	4.0	1.3	0.8	9.0	1.1	4.9	1.0	28.6	8.1	0.6	0.8	15.9	0.6	1.4	3.3	0.0	3.4	3.4	7.4	3.5	0.0	1.9	12.3	0.0	1.0	5.4	8.5	8.0	3.3	2.9	5.0	25.4
MAP4K1	HPK1	ENSG00000104814	"Mitogen-activated protein kinase kinase kinase kinase 1"	Q92918	19	38587641-38618882	"Enzymes, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 16.2;intestine: 16.9;lymphoid tissue: 39.2"	"Cell type enhanced"	"Detected in many"	14	"B-cells: 29.0;Rod photoreceptor cells: 58.2;T-cells: 33.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"Daudi: 20.8;HDLM-2: 20.6;Karpas-707: 21.4;REH: 11.4;RPMI-8226: 12.9;U-266/70: 16.9;U-266/84: 16.6;U-698: 26.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"HPA007419, CAB007754"	Enhanced		Approved	"Plasma membrane"		NA	NA			"Plasma membrane"		"CAB007754: AB_562299, HPA007419: AB_1853778"	"unprognostic (1.99e-3)"	"prognostic favorable (6.17e-5)"	"unprognostic (9.50e-3)"	"unprognostic (3.27e-1)"	"unprognostic (6.03e-2)"	"prognostic favorable (3.26e-4)"	"unprognostic (4.88e-3)"	"unprognostic (5.32e-3)"	"unprognostic (2.79e-1)"	"unprognostic (2.51e-1)"	"unprognostic (3.92e-2)"	"unprognostic (2.55e-1)"	"prognostic unfavorable (7.99e-10)"	"unprognostic (1.72e-1)"	"unprognostic (1.83e-1)"	"unprognostic (3.18e-2)"	"unprognostic (1.50e-2)"	1.6	0.9	1.2	31.4	2.3	6.3	1.1	1.0	1.2	1.0	3.1	1.7	0.1	2.1	0.9	1.4	2.6	1.2	2.9	0.9	1.1	1.4	2.2	1.6	3.9	23.0	2.3	0.7	0.8	1.2	0.2	1.2	1.4	2.1	1.6	1.9	2.0	4.4	0.8	0.5	1.2	16.9	0.7	3.4	34.4	2.3	0.9	1.3	19.1	1.9	1.4	39.2	3.1	1.3	16.2	15.9	1.3	6.2	3.7	14.6	7.3	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	20.8	0.3	0.0	0.0	0.0	0.0	0.0	0.0	20.6	0.1	4.4	0.0	0.0	0.0	1.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	10.6	0.1	21.4	0.0	0.1	4.9	5.2	0.6	0.1	0.0	11.4	0.0	12.9	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.1	0.1	4.7	0.0	0.0	0.1	0.0	0.0	16.9	16.6	26.2	0.0	5.9	0.0	1.3	3.2	1.2	13.4	6.2	12.4	16.2	11.2	14.0	15.9	10.7	6.2	8.7	0.3	3.7	3.4	14.0	14.6	7.3	1.2	2.3	1.0	1.2	1.1	1.4	2.3	0.7	2.1	1.3	3.0	8.2	29.0	0.1	2.1	6.1	0.6	0.0	0.0	1.2	0.0	11.8	0.2	0.0	0.0	0.0	1.4	0.0	0.0	0.2	0.2	1.0	0.3	15.1	0.0	2.5	1.6	0.0	1.3	7.1	0.0	0.0	11.7	3.3	2.8	0.0	6.7	0.0	0.0	0.0	0.2	58.2	0.0	0.4	0.6	4.3	0.9	0.1	33.2	0.2	0.1
MAP4K2	"BL44, GCK, RAB8IP"	ENSG00000168067	"Mitogen-activated protein kinase kinase kinase kinase 2"	Q12851	11	64784914-64803241	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Immunity, Innate immunity, Stress response"	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Early spermatids: 29.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA007330	Enhanced		Approved	Vesicles		NA	NA			Vesicles		"HPA007330: AB_1079361"	"unprognostic (1.66e-1)"	"unprognostic (2.83e-1)"	"unprognostic (3.07e-3)"	"unprognostic (4.37e-3)"	"unprognostic (2.67e-1)"	"unprognostic (9.23e-2)"	"prognostic unfavorable (3.10e-5)"	"unprognostic (4.51e-2)"	"unprognostic (3.65e-1)"	"unprognostic (5.28e-2)"	"unprognostic (1.24e-2)"	"unprognostic (1.41e-1)"	"unprognostic (2.47e-2)"	"unprognostic (2.97e-1)"	"unprognostic (1.57e-2)"	"unprognostic (1.82e-1)"	"unprognostic (1.95e-2)"	6.9	6.2	9.4	15.2	10.0	19.1	5.8	12.1	15.6	5.2	5.8	10.1	6.9	4.9	6.2	4.0	4.3	4.4	6.3	5.5	9.4	9.2	6.2	3.1	12.0	22.3	8.3	7.3	4.2	7.2	5.2	8.0	12.3	12.5	6.1	4.7	6.7	9.0	8.9	3.4	5.0	9.9	5.6	6.7	22.6	7.1	5.5	6.6	11.5	8.7	3.9	18.8	6.1	5.1	10.8	5.0	8.2	14.8	2.3	9.6	7.1	6.0	5.5	3.6	6.4	3.2	2.0	8.5	4.5	4.3	5.5	3.9	2.4	2.8	10.5	8.4	5.2	9.7	1.8	4.3	4.4	3.3	13.7	2.1	18.5	7.6	5.0	3.9	9.7	7.0	1.9	2.2	4.3	2.7	3.8	13.4	18.4	1.5	1.0	1.6	7.5	5.7	9.7	2.4	3.6	7.4	12.0	0.4	12.1	3.1	3.0	4.3	6.2	3.9	5.1	4.0	4.3	10.3	15.0	10.3	4.6	10.3	4.2	1.9	1.2	2.3	11.4	4.1	14.7	3.4	2.2	4.2	5.6	5.2	12.2	5.3	10.8	7.0	4.7	4.4	7.6	8.6	6.3	8.2	2.3	14.8	5.0	9.6	7.1	9.4	10.0	12.1	15.6	9.4	9.2	8.3	7.3	12.5	6.6	3.0	4.5	18.1	3.3	1.1	19.5	3.6	2.5	1.4	2.3	1.8	23.6	6.4	3.3	1.3	29.3	15.5	1.8	0.0	1.5	10.2	2.8	2.6	1.1	1.8	9.1	11.1	5.8	20.3	8.5	25.2	3.7	8.3	1.7	8.2	2.0	7.0	0.9	11.5	6.7	2.8	13.8	6.5	2.5	1.8	11.1	1.3	4.2	10.0	1.9	1.6
MAP4K3	"GLK, MAPKKKK3, RAB8IPL1"	ENSG00000011566	"Mitogen-activated protein kinase kinase kinase kinase 3"	Q8IVH8	2	39249266-39437312	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Late spermatids: 80.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"AF22: 41.6;RT4: 38.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA030380	Approved		Approved	"Nucleoplasm,Centriolar satellite"		NA	NA			"Centriolar satellite"	Nucleoplasm	"HPA030380: AB_10601132"	"unprognostic (4.82e-2)"	"unprognostic (7.22e-2)"	"unprognostic (5.87e-3)"	"unprognostic (7.34e-3)"	"unprognostic (6.77e-2)"	"unprognostic (2.57e-1)"	"unprognostic (1.05e-2)"	"unprognostic (6.73e-2)"	"unprognostic (1.66e-1)"	"unprognostic (6.73e-2)"	"unprognostic (4.33e-3)"	"unprognostic (4.26e-2)"	"unprognostic (2.12e-1)"	"unprognostic (3.08e-2)"	"unprognostic (3.30e-1)"	"unprognostic (2.43e-1)"	"unprognostic (5.08e-2)"	19.7	18.9	17.6	15.4	17.6	9.6	17.8	37.1	19.6	19.2	16.9	14.6	9.8	13.7	23.5	14.8	11.1	15.3	18.7	19.5	15.4	12.5	26.2	15.4	15.6	5.8	15.4	13.4	24.6	14.0	25.7	24.6	30.8	14.4	18.6	14.1	17.9	13.3	15.7	33.0	17.8	17.2	18.6	15.3	11.5	26.1	21.0	16.5	9.4	25.9	11.3	7.5	18.8	32.6	0.7	0.5	2.5	1.9	1.0	1.3	0.4	9.9	6.2	41.6	6.6	6.8	13.6	11.4	8.8	11.3	8.8	7.5	5.2	5.0	2.1	10.0	6.0	9.1	5.4	15.6	7.8	13.4	2.4	6.4	3.6	4.4	12.1	17.7	1.6	5.9	12.2	7.8	11.4	12.4	9.3	7.5	2.0	4.6	4.1	11.7	5.4	3.4	2.3	12.5	9.4	9.4	3.8	13.5	1.6	11.6	38.5	7.4	8.5	5.2	8.3	23.0	13.7	5.6	2.2	6.1	6.8	8.1	6.1	4.7	6.2	3.5	0.7	8.4	2.6	7.9	2.5	0.7	0.0	1.2	1.1	0.1	0.1	1.2	0.9	0.1	0.7	1.1	1.3	0.0	1.0	1.9	0.5	0.6	0.4	17.6	17.6	37.1	19.6	15.4	12.5	15.4	13.4	14.4	16.5	3.0	6.7	5.1	15.6	15.7	23.8	32.7	17.8	13.4	15.9	21.0	23.6	9.2	16.6	9.0	38.6	10.3	11.9	0.0	10.7	5.5	15.6	20.0	2.3	16.2	9.1	6.4	9.2	15.4	9.5	80.0	19.2	12.2	5.0	1.8	12.5	15.2	12.8	7.0	16.6	10.9	41.2	19.4	12.7	19.5	20.8	16.8	8.7	4.4	9.3	29.0
MAP4K4	"FLH21957, HGK, NIK"	ENSG00000071054	"Mitogen-activated protein kinase kinase kinase kinase 4"	O95819	2	101696850-101894689	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 81.2"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA008476	Uncertain					NA	NA					"HPA008476: AB_1079362"	"unprognostic (6.40e-2)"	"unprognostic (1.09e-2)"	"unprognostic (4.01e-1)"	"unprognostic (1.89e-1)"	"unprognostic (1.88e-1)"	"unprognostic (1.87e-2)"	"unprognostic (2.83e-2)"	"prognostic unfavorable (1.57e-4)"	"unprognostic (4.29e-2)"	"unprognostic (9.79e-2)"	"unprognostic (2.22e-3)"	"unprognostic (8.65e-2)"	"prognostic unfavorable (3.62e-6)"	"unprognostic (6.67e-3)"	"unprognostic (8.98e-2)"	"unprognostic (3.15e-1)"	"unprognostic (7.14e-3)"	27.0	5.0	68.3	21.1	56.3	32.1	35.2	14.5	50.4	13.2	7.8	47.5	2.1	5.4	14.6	6.7	18.5	8.6	18.0	22.2	70.5	40.5	6.3	16.8	13.2	25.8	65.3	21.5	12.6	8.3	9.5	4.3	25.1	40.2	7.6	9.6	6.1	7.7	5.7	16.1	8.7	6.5	14.8	81.2	11.7	11.0	20.3	49.1	13.2	8.3	6.6	29.6	13.5	16.3	4.6	6.3	14.4	3.4	1.1	3.7	1.5	19.1	14.6	31.2	14.9	29.6	53.1	39.2	24.4	20.1	21.8	18.0	24.0	25.5	27.9	21.2	36.4	6.4	7.9	9.8	21.5	21.9	37.4	6.7	20.9	11.0	62.8	25.0	9.9	0.9	47.6	9.8	53.8	24.1	21.9	56.7	15.8	13.5	0.0	57.3	10.4	23.1	6.2	15.8	7.3	23.2	28.0	21.3	0.1	14.5	6.7	12.2	20.4	16.8	0.0	18.2	30.1	3.9	18.1	71.2	43.4	18.6	12.5	29.0	0.0	0.0	17.0	28.0	12.7	31.7	6.9	3.3	0.0	2.4	3.4	1.8	3.5	3.3	1.7	1.1	4.6	2.5	2.7	14.4	1.1	3.0	6.3	3.7	1.5	68.3	56.3	14.5	38.9	70.5	40.5	65.3	21.5	40.2	49.1	17.9	22.9	29.6	34.7	26.7	120.4	66.8	25.5	14.7	36.4	17.4	47.1	11.0	0.0	53.8	23.8	54.9	6.3	0.0	45.6	16.9	45.6	49.1	22.1	38.2	32.1	33.4	16.7	59.5	23.4	28.3	50.9	37.5	18.6	87.4	12.9	60.6	85.8	13.1	16.3	4.4	7.3	51.8	51.5	20.6	82.8	21.5	6.5	25.3	12.4	35.8
MAPK1	"ERK, ERK2, MAPK2, p41mapk, PRKM1, PRKM2"	ENSG00000100030	"Mitogen-activated protein kinase 1"	P28482	22	21754500-21867680	"Cancer-related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins"	"Apoptosis, Cell cycle, Host-virus interaction, Transcription, Transcription regulation"	"DNA-binding, Kinase, Repressor, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 80.3"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"K-562: 81.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003995, CAB004229, HPA005700, HPA030069"	Approved					NA	NA		250000			"CAB004229: AB_627547, HPA003995: AB_1078751, HPA005700: AB_1078750, HPA030069: AB_10602035"	"unprognostic (9.41e-3)"	"unprognostic (2.68e-1)"	"unprognostic (2.50e-3)"	"unprognostic (4.17e-1)"	"unprognostic (4.44e-3)"	"unprognostic (1.72e-1)"	"prognostic unfavorable (4.95e-4)"	"unprognostic (2.29e-1)"	"unprognostic (1.67e-1)"	"unprognostic (1.58e-1)"	"unprognostic (8.43e-3)"	"unprognostic (1.04e-1)"	"unprognostic (1.35e-2)"	"unprognostic (2.08e-1)"	"unprognostic (1.94e-1)"	"unprognostic (1.41e-1)"	"unprognostic (6.49e-2)"	16.1	21.1	32.9	18.3	80.3	20.2	13.6	31.0	54.5	18.6	18.5	23.2	9.6	13.7	17.4	10.6	25.7	16.9	14.9	22.8	32.4	23.4	21.7	16.4	19.9	16.6	18.4	23.6	16.0	19.8	27.4	10.9	17.2	27.6	16.4	19.9	14.2	15.8	17.8	28.2	17.5	15.1	22.8	20.4	19.8	17.2	24.2	21.5	19.5	23.0	11.1	21.4	17.7	15.3	2.5	3.2	13.5	4.9	7.0	13.7	2.5	19.7	12.5	16.1	9.2	19.1	19.2	6.1	21.8	20.4	19.6	19.0	9.9	10.5	10.9	10.9	29.2	18.0	18.8	18.9	17.4	25.6	44.0	17.7	19.8	11.7	11.6	15.7	27.8	20.6	14.3	14.0	23.7	21.9	15.4	26.7	11.9	81.1	12.5	23.9	8.1	18.0	6.1	6.1	26.8	12.3	19.8	39.7	2.9	11.2	16.2	13.1	7.3	23.6	14.2	12.7	16.7	10.7	9.4	23.3	16.4	21.4	18.8	13.8	12.0	14.6	17.0	15.5	13.6	17.7	1.0	4.0	5.8	13.7	4.6	3.9	2.0	2.9	4.9	3.2	2.5	2.8	5.1	13.5	7.0	4.9	3.2	2.7	2.5	32.9	80.3	31.0	54.5	32.4	23.4	18.4	23.6	27.6	21.5	44.7	30.2	28.0	22.1	53.3	23.8	34.6	63.7	21.4	33.0	48.8	51.1	18.0	16.6	24.0	33.2	31.2	46.6	23.3	33.6	18.2	31.5	37.5	93.2	59.4	47.7	27.0	57.3	57.7	88.6	9.9	30.2	59.7	38.8	15.4	44.2	32.3	39.5	28.8	41.8	37.6	21.0	32.3	32.2	70.0	47.7	54.1	16.0	95.8	30.7	34.8
MAPK10	"JNK3, p493F12, p54bSAPK, PRKM10"	ENSG00000109339	"Mitogen-activated protein kinase 10"	P53779	4	85990007-86594625	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, RAS pathway related proteins"	"Biological rhythms"	"Kinase, Serine/threonine-protein kinase, Transferase"	"Epilepsy, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 58.3"	"Cell type enhanced"	"Detected in many"	16	"Ciliated cells: 92.3;Early spermatids: 179.3;Late spermatids: 303.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enriched"	"Detected in many"	6	"AF22: 60.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB022625	Approved					NA	NA					"CAB022625: "	"unprognostic (2.46e-2)"	"unprognostic (4.36e-2)"	"unprognostic (1.13e-1)"	"unprognostic (4.05e-2)"	"unprognostic (5.17e-2)"	"unprognostic (2.03e-1)"	"unprognostic (4.59e-2)"	"unprognostic (4.82e-2)"	"unprognostic (3.81e-2)"	"unprognostic (4.45e-2)"	"unprognostic (1.18e-3)"	"unprognostic (3.02e-2)"	"prognostic favorable (3.11e-4)"	"unprognostic (1.92e-2)"	"unprognostic (1.44e-1)"	"unprognostic (6.22e-3)"	"prognostic favorable (5.57e-4)"	17.2	11.9	31.6	3.7	34.5	9.7	6.2	26.1	58.3	11.4	4.0	12.6	8.1	3.2	11.0	14.2	7.4	11.9	10.4	5.1	36.0	28.6	15.0	2.7	6.5	3.9	31.5	36.4	11.3	5.6	10.9	31.5	3.4	37.9	16.6	4.3	5.4	3.4	18.9	2.0	3.5	3.9	11.4	23.1	5.3	4.3	18.2	15.8	0.0	15.3	0.4	3.6	11.1	10.2	3.7	3.0	6.9	1.8	3.3	3.6	2.3	1.1	2.0	60.3	1.9	1.7	1.4	2.3	1.2	1.1	1.0	0.5	1.1	1.8	2.6	2.0	0.7	1.5	3.7	0.6	1.6	1.7	3.8	1.6	2.2	2.4	1.9	1.4	1.0	1.2	1.6	0.8	1.4	1.9	2.1	1.3	1.8	1.9	9.9	0.7	1.6	1.7	1.1	3.5	0.3	1.2	1.9	1.5	0.9	4.3	6.4	3.6	3.3	1.2	4.9	0.8	2.0	3.5	1.3	2.8	2.6	2.7	1.1	1.0	3.2	1.9	1.7	3.8	1.3	1.4	6.9	1.8	3.3	2.3	1.6	2.4	3.7	1.9	2.5	1.6	3.3	2.7	3.6	6.2	3.3	1.5	3.0	2.7	2.3	31.6	34.5	26.1	58.3	36.0	28.6	31.5	36.4	37.9	15.8	20.8	26.0	0.0	12.6	0.7	19.8	0.8	12.7	92.3	15.9	21.0	5.9	0.3	10.0	2.1	179.3	1.1	0.0	0.0	0.0	0.5	1.5	10.1	2.3	0.0	0.2	36.5	2.4	1.8	0.3	303.7	24.5	2.5	1.7	0.0	0.0	16.4	1.7	0.0	51.6	16.2	10.2	6.5	2.0	8.8	2.2	0.9	0.1	0.0	0.0	17.9
MAPK11	"p38-2, p38Beta, PRKM11, SAPK2"	ENSG00000185386	"Mitogen-activated protein kinase 11"	Q15759	22	50263713-50270767	"Enzymes, FDA approved drug targets, Predicted intracellular proteins"	"Stress response, Transcription, Transcription regulation"	"Kinase, Serine/threonine-protein kinase, Transferase"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	7	"Endothelial cells: 13.2;Ito cells: 14.7;Rod photoreceptor cells: 10.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"memory B-cell: 1.1"	"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB012961, HPA045069"	Approved		Approved	Mitochondria		NA	NA			Mitochondria		"CAB012961: AB_2533144, HPA045069: AB_2679207"	"unprognostic (1.11e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.49e-2)"	"unprognostic (1.92e-1)"	"unprognostic (1.18e-2)"	"unprognostic (1.64e-3)"	"unprognostic (1.02e-1)"	"unprognostic (5.84e-2)"	"unprognostic (5.89e-2)"	"unprognostic (2.46e-1)"	"unprognostic (4.96e-3)"	"unprognostic (2.18e-1)"	"prognostic unfavorable (6.02e-6)"	"unprognostic (9.84e-2)"	"unprognostic (4.25e-2)"	"unprognostic (9.16e-2)"	"unprognostic (2.10e-2)"	20.4	5.7	14.2	7.5	17.3	0.8	8.2	22.0	23.7	6.6	2.7	2.8	1.0	1.9	8.2	6.2	5.3	7.0	8.8	8.8	11.7	9.1	5.0	1.5	8.5	8.5	7.2	19.9	5.3	3.1	6.4	10.9	8.4	6.6	7.2	2.7	4.1	5.7	8.0	5.0	6.4	2.6	9.8	5.5	7.3	4.6	3.1	4.1	0.9	4.5	5.3	6.1	6.0	4.4	1.1	0.0	0.0	0.3	0.0	0.9	0.0	1.7	4.2	4.7	17.6	6.2	9.4	0.1	6.6	4.7	4.4	1.7	1.7	3.2	0.0	5.9	6.1	7.3	4.3	3.1	2.6	0.3	9.1	2.1	6.2	5.6	0.4	7.1	1.5	9.7	13.0	7.8	1.2	0.5	4.9	9.6	6.7	5.0	17.0	4.3	7.5	0.3	5.7	0.4	5.2	4.9	17.0	0.1	6.0	6.6	0.0	4.4	11.8	5.6	2.3	4.6	0.6	7.7	4.9	15.0	13.2	11.0	0.9	2.4	0.7	2.0	7.2	6.7	1.8	11.0	0.0	0.0	0.0	0.0	0.3	0.0	1.1	0.4	0.2	0.0	0.5	0.0	0.6	0.0	0.0	0.0	0.0	0.9	0.0	14.2	17.3	22.0	23.7	11.7	9.1	7.2	19.9	6.6	4.1	0.0	1.4	1.3	1.1	1.6	2.6	2.8	0.0	0.0	0.0	0.0	5.9	0.0	1.7	0.8	3.7	13.2	0.0	0.0	0.2	0.3	1.7	3.3	0.0	1.0	0.2	0.0	0.0	14.7	2.6	5.7	2.8	0.0	5.0	0.0	0.0	5.6	0.7	0.0	2.1	1.4	10.9	0.0	1.0	1.2	2.1	1.1	0.0	1.0	0.0	0.9
MAPK12	"ERK6, p38gamma, PRKM12, SAPK-3, SAPK3"	ENSG00000188130	"Mitogen-activated protein kinase 12"	P53778	22	50245450-50261825	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Cell cycle, Stress response, Transcription, Transcription regulation"	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	10	"skeletal muscle: 104.2"	"Cell type enhanced"	"Detected in many"	8	"Ito cells: 22.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	31	"NK-cell: 3.0"	"Lineage enriched"	"Detected in single"	31	"NK-cells: 3.0"	"Low cell line specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"cerebellum: 35.4"	"Low region specificity"	"Detected in all"			"CAB025483, HPA054562"	Enhanced		Approved	"Nuclear speckles,Cytosol"		NA	NA			"Nuclear speckles"	Cytosol	"CAB025483: , HPA054562: AB_2682524"	"unprognostic (3.68e-2)"	"unprognostic (1.72e-1)"	"unprognostic (4.53e-3)"	"unprognostic (1.54e-1)"	"unprognostic (3.22e-2)"	"unprognostic (6.35e-3)"	"unprognostic (3.90e-3)"	"unprognostic (3.16e-2)"	"unprognostic (6.02e-2)"	"unprognostic (5.70e-2)"	"unprognostic (3.48e-2)"	"unprognostic (1.07e-1)"	"prognostic unfavorable (5.00e-6)"	"unprognostic (2.57e-1)"	"unprognostic (8.88e-2)"	"unprognostic (1.11e-2)"	"unprognostic (4.28e-3)"	3.0	1.6	4.5	2.1	4.5	1.0	1.8	9.0	7.0	2.1	1.4	2.1	1.6	2.0	5.4	5.1	3.3	2.9	2.4	5.1	3.9	3.6	2.5	1.0	2.1	2.0	3.5	5.7	3.0	1.4	1.2	7.0	2.3	2.6	2.9	1.1	2.2	1.4	3.7	104.2	0.9	1.5	4.2	2.6	1.6	1.5	1.6	2.4	0.0	1.3	10.8	1.1	2.4	1.9	0.0	0.0	0.0	0.0	3.0	0.0	0.0	10.4	6.4	2.5	7.5	5.7	6.3	3.5	8.0	6.9	13.4	8.5	9.3	3.3	19.6	10.9	8.8	8.0	7.0	11.1	1.6	2.6	5.6	15.6	12.8	19.5	11.5	18.1	12.0	25.4	13.5	2.9	3.0	0.0	7.3	15.2	1.8	11.3	18.2	6.2	5.7	0.0	16.0	7.5	3.5	10.5	18.3	6.7	19.9	7.9	1.4	8.6	2.9	6.2	0.2	9.9	1.9	3.4	14.0	7.9	13.9	12.5	3.0	5.0	4.2	3.2	10.5	3.5	11.3	5.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.0	0.0	0.0	0.0	0.0	4.5	4.5	9.0	7.0	3.9	3.6	3.5	5.7	2.6	2.4	0.0	5.6	1.3	0.4	0.7	5.1	7.8	2.5	1.4	0.0	0.0	0.0	0.3	1.7	0.4	0.3	9.5	0.0	0.0	0.0	1.8	2.8	3.0	10.4	1.0	4.9	1.6	1.7	22.1	2.8	1.3	6.1	0.8	0.0	1.0	0.0	5.1	0.6	0.0	3.5	6.5	1.7	6.5	2.4	0.2	9.7	0.5	0.3	1.0	0.2	0.0
MAPK13	"p38delta, PRKM13, SAPK4"	ENSG00000156711	"Mitogen-activated protein kinase 13"	O15264	6	36127809-36144524	"Enzymes, Predicted intracellular proteins"	"Cell cycle, Stress response, Transcription, Transcription regulation"	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	7	"Enterocytes: 143.1;Late spermatids: 214.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"B-cells: 16.5;T-cells: 27.8"	"Cell line enhanced"	"Detected in many"		"HBEC3-KT: 46.2;RPMI-8226: 27.9;RT4: 28.9"	"Region enhanced"	"Detected in some"		"cerebellum: 6.5"	"Region enriched"	"Detected in some"	15	"cerebellum: 59.9"	"HPA007667, CAB025854"	Enhanced		Approved	"Nucleoplasm,Nucleoli,Nucleoli rim,Cytosol"		NA	NA			"Nucleoplasm, Nucleoli, Nucleoli rim, Cytosol"		"CAB025854: , HPA007667: AB_1079867"	"unprognostic (6.36e-2)"	"unprognostic (6.88e-2)"	"unprognostic (2.93e-1)"	"unprognostic (6.64e-3)"	"unprognostic (1.13e-2)"	"unprognostic (4.80e-2)"	"unprognostic (4.30e-3)"	"unprognostic (5.28e-2)"	"unprognostic (1.77e-1)"	"unprognostic (2.14e-2)"	"unprognostic (1.57e-1)"	"unprognostic (7.21e-2)"	"prognostic favorable (9.00e-4)"	"unprognostic (3.12e-2)"	"unprognostic (1.70e-1)"	"unprognostic (2.21e-2)"	"unprognostic (1.41e-1)"	6.5	22.0	2.2	5.4	4.0	2.9	6.8	2.8	7.3	6.8	18.9	0.5	36.8	18.8	1.9	10.3	41.1	2.4	12.0	1.2	1.7	1.8	6.5	2.8	9.6	11.2	0.8	3.8	3.9	24.6	18.8	12.4	10.5	2.5	6.8	16.0	2.4	20.7	26.3	0.9	28.6	37.7	2.1	0.8	5.9	12.2	23.7	1.1	5.0	13.8	16.0	18.5	7.3	13.9	16.5	0.1	5.2	0.3	2.8	27.8	6.7	19.6	0.1	0.3	0.2	1.2	5.7	2.7	1.6	0.2	0.2	0.5	16.3	19.4	4.7	1.2	1.5	2.8	15.2	0.0	46.2	0.4	12.0	5.2	0.1	0.5	16.2	2.0	0.1	1.2	4.9	16.4	3.0	0.6	2.3	3.0	0.5	0.3	5.3	0.5	10.3	0.1	1.2	0.1	19.4	0.3	11.6	0.2	27.9	9.0	28.9	19.6	0.3	1.7	0.3	0.1	0.6	22.0	2.5	4.1	1.4	0.2	0.5	0.3	0.3	7.0	1.4	0.0	0.5	0.1	5.2	0.3	4.5	16.2	0.0	10.5	10.8	11.6	13.0	0.1	16.5	10.6	11.9	3.9	2.8	0.0	0.0	27.8	6.7	2.2	4.0	2.8	7.3	1.7	1.8	0.8	3.8	2.5	1.1	26.8	24.1	11.5	34.8	24.3	0.8	1.6	22.9	1.4	22.7	27.9	5.9	41.4	13.3	48.4	89.5	2.3	143.1	0.0	102.6	8.3	3.2	28.0	2.3	1.6	35.8	0.0	63.0	0.6	6.1	214.3	6.6	6.4	16.9	22.6	80.8	1.5	76.0	89.2	9.2	7.9	2.2	0.0	1.0	6.1	1.5	46.5	27.0	20.2	93.7	47.8
MAPK14	"CSBP1, CSBP2, CSPB1, Mxi2, p38, PRKM14, PRKM15"	ENSG00000112062	"Mitogen-activated protein kinase 14"	Q16539	6	36027677-36111236	"Cancer-related genes, Enzymes, Predicted intracellular proteins"	"Apoptosis, Stress response, Transcription, Transcription regulation"	"Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	5	"basophil: 32.1;neutrophil: 12.3"	"Lineage enriched"	"Detected in all"	7	"granulocytes: 32.1"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB010285, CAB040578, HPA051825"	Approved		Supported	"Nuclear speckles,Cytosol"		NA	NA		7100000	"Nuclear speckles"	Cytosol	"CAB010285: AB_632140, CAB040578: , HPA051825: "	"unprognostic (6.76e-3)"	"unprognostic (6.28e-2)"	"unprognostic (6.30e-3)"	"unprognostic (3.30e-3)"	"unprognostic (6.98e-2)"	"unprognostic (4.04e-2)"	"unprognostic (8.10e-2)"	"unprognostic (1.93e-1)"	"unprognostic (2.20e-3)"	"unprognostic (8.39e-2)"	"unprognostic (6.27e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.47e-2)"	"unprognostic (3.66e-3)"	"unprognostic (6.66e-2)"	"unprognostic (3.25e-1)"	"unprognostic (1.58e-1)"	21.5	20.6	11.7	18.4	15.5	49.9	20.7	26.5	18.1	22.0	20.5	12.5	11.9	16.9	38.8	12.1	24.0	18.9	16.0	16.4	9.3	9.5	16.0	29.8	21.5	29.0	12.0	11.3	17.7	18.5	15.0	27.2	27.3	10.2	23.4	18.3	17.0	16.7	16.5	21.2	25.6	22.5	26.0	10.6	35.5	18.2	11.1	10.3	34.1	20.9	17.6	20.8	25.0	30.0	2.3	4.0	32.1	4.9	3.0	2.8	2.1	18.5	10.2	11.0	17.7	25.1	25.0	24.2	19.4	25.3	23.0	24.0	24.9	9.6	15.0	19.3	21.3	11.0	13.3	18.1	16.8	24.1	16.9	14.5	34.7	14.5	20.8	13.8	21.9	21.0	17.6	16.4	16.6	16.5	19.2	26.1	26.0	19.2	18.9	15.7	8.8	22.4	26.3	6.7	11.4	10.2	26.7	17.9	13.9	16.2	25.6	8.3	7.0	17.5	13.1	20.3	14.1	15.4	40.9	18.3	20.7	12.0	13.0	17.7	9.3	21.2	15.1	9.4	43.2	16.9	32.1	4.9	3.0	2.4	3.5	2.8	1.5	2.2	2.6	4.0	2.3	2.5	2.4	12.3	3.0	4.7	1.9	2.6	2.1	11.7	15.5	26.5	18.1	9.3	9.5	12.0	11.3	10.2	10.3	29.8	11.5	18.2	10.6	14.2	19.3	23.5	7.6	16.0	19.4	17.4	29.5	38.2	1.7	12.1	2.6	20.2	25.7	0.0	9.9	14.8	20.9	9.0	20.7	39.4	22.3	11.1	16.1	21.5	58.1	3.7	22.7	30.0	10.1	19.8	22.5	12.2	17.6	20.3	25.1	14.0	24.3	12.9	11.5	6.3	7.7	16.7	20.0	23.5	15.6	8.8
MAPK15	"ERK7, ERK8"	ENSG00000181085	"Mitogen-activated protein kinase 15"	Q8TD08	8	143716259-143722458	"Enzymes, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 26.9;epididymis: 27.6;fallopian tube: 29.5"	"Cell type enriched"	"Detected in some"	6	"Ciliated cells: 85.6"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"pons and medulla: 26.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"CAPAN-2: 7.2;HaCaT: 5.4;HeLa: 14.3;MCF7: 13.9;T-47d: 12.5"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			HPA002704			Approved	"Nucleoplasm,Cell Junctions,Cytosol"		NA	NA			"Nucleoplasm, Cytosol"	"Cell Junctions"	"HPA002704: AB_1079307"	"unprognostic (9.11e-2)"	"unprognostic (1.38e-1)"	"unprognostic (8.04e-3)"	"unprognostic (2.94e-1)"	"unprognostic (2.54e-2)"	"unprognostic (1.14e-2)"	"unprognostic (1.22e-1)"	"unprognostic (6.09e-2)"	"unprognostic (2.59e-2)"	"unprognostic (1.48e-1)"	"unprognostic (3.88e-1)"	"unprognostic (9.51e-2)"	"unprognostic (2.64e-2)"	"unprognostic (1.54e-2)"	"unprognostic (5.78e-1)"	"unprognostic (6.35e-2)"	"unprognostic (1.62e-2)"	0.6	0.1	3.6	0.3	8.1	0.1	1.1	0.2	2.1	4.5	0.4	8.7	5.2	0.5	2.2	27.6	1.3	29.5	0.4	1.1	5.4	4.6	3.9	0.2	7.4	0.5	0.2	1.5	4.7	2.0	9.1	4.2	0.6	26.9	0.9	0.4	1.6	3.0	2.4	0.2	4.9	0.7	0.5	0.4	0.5	0.9	7.3	2.4	0.1	8.4	0.5	0.4	0.5	0.9	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.4	1.7	0.0	0.0	0.0	0.6	1.3	0.0	0.0	0.0	0.2	7.2	0.0	1.3	0.0	0.0	5.4	0.1	0.2	0.0	1.1	1.6	0.0	14.3	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	1.0	0.0	0.3	2.7	0.0	0.0	13.9	0.0	0.0	2.0	1.2	1.1	0.0	3.0	0.4	0.9	1.3	4.0	4.0	0.0	2.8	0.0	0.2	12.5	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.6	8.1	0.2	2.1	5.4	4.6	0.2	1.5	26.9	2.4	0.0	8.3	0.0	0.2	0.3	0.0	0.8	0.0	85.6	13.6	0.0	0.0	0.0	0.0	0.6	12.6	0.0	0.0	0.0	0.0	0.6	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	8.9	0.0	0.0	0.0	0.0	0.5	0.0	0.5	0.0	0.0	0.8	0.0	0.0	0.0	2.7	0.7	0.3	0.1	0.0	0.1	0.0
MAPK3	"ERK1, p44erk1, p44mapk, PRKM3"	ENSG00000102882	"Mitogen-activated protein kinase 3"	P27361	16	30114105-30123506	"Cancer-related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins, RAS pathway related proteins"	"Apoptosis, Cell cycle, Host-virus interaction"	"Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"Early spermatids: 255.2;Enterocytes: 275.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	6	"eosinophil: 25.1;neutrophil: 11.3"	"Lineage enriched"	"Detected in many"	8	"granulocytes: 25.1"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002683, HPA003995, HPA005700, HPA030069"	Approved		Supported	Nucleoplasm		NA	NA			Nucleoplasm		"CAB002683: , HPA003995: AB_1078751, HPA005700: AB_1078750, HPA030069: AB_10602035"	"unprognostic (5.03e-2)"	"unprognostic (4.62e-2)"	"unprognostic (3.46e-2)"	"unprognostic (1.60e-1)"	"unprognostic (4.70e-3)"	"unprognostic (2.75e-1)"	"prognostic unfavorable (1.11e-4)"	"unprognostic (2.09e-2)"	"unprognostic (3.59e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.55e-1)"	"unprognostic (3.51e-2)"	"unprognostic (8.78e-2)"	"unprognostic (1.45e-1)"	"unprognostic (3.01e-2)"	"unprognostic (2.38e-1)"	"unprognostic (1.19e-2)"	24.9	18.5	63.3	15.3	43.2	15.6	21.1	24.8	52.0	21.3	45.1	30.4	6.3	39.7	24.2	11.4	44.1	28.7	25.6	21.2	37.1	34.0	13.4	8.8	23.3	13.1	33.8	27.4	32.7	13.0	26.1	15.2	27.6	27.6	20.1	36.7	26.2	17.1	18.3	13.9	18.7	49.2	24.0	27.8	15.9	33.7	11.6	19.5	8.4	20.5	18.7	26.0	18.2	22.2	1.4	1.5	25.1	2.7	0.8	3.1	1.4	14.0	7.7	16.4	9.2	41.2	54.6	9.2	10.5	26.0	16.6	19.9	9.1	28.2	14.1	10.4	29.3	19.2	5.2	13.7	12.3	16.3	26.7	15.9	4.3	8.5	15.3	41.4	3.2	12.1	33.7	7.2	19.0	8.6	25.3	42.2	15.5	5.9	18.2	22.0	36.8	14.5	5.0	4.3	28.6	6.7	17.2	9.7	31.7	15.2	8.9	14.5	10.3	6.0	21.1	6.1	13.8	13.8	7.7	29.9	11.0	9.5	12.5	3.6	20.7	9.4	7.2	22.0	6.8	7.7	2.4	2.7	25.1	0.9	1.9	1.4	1.3	2.1	1.6	1.4	1.4	1.5	1.6	11.3	0.8	1.0	1.5	3.1	1.4	63.3	43.2	24.8	52.0	37.1	34.0	33.8	27.4	27.6	19.5	20.8	20.3	9.0	19.0	8.8	28.0	12.7	15.3	20.1	7.9	8.7	21.6	66.6	19.9	31.0	255.2	49.5	275.3	0.0	54.5	107.4	25.7	11.8	2.3	6.4	38.5	7.9	52.6	52.8	25.3	107.0	30.0	18.9	21.9	27.9	135.6	38.1	77.0	98.1	25.8	18.2	32.7	19.4	18.6	10.5	17.5	11.5	28.3	13.1	63.5	18.0
MAPK4	"Erk3-related, Erk4, PRKM4"	ENSG00000141639	"Mitogen-activated protein kinase 4"	P31152	18	50560078-50731824	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle"	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adrenal gland: 26.4;brain: 33.4;parathyroid gland: 43.5"	"Cell type enhanced"	"Detected in some"	15	"Cardiomyocytes: 20.1;Early spermatids: 20.2;Late spermatids: 42.4;Muller glia cells: 55.0"	"Group enriched"	"Detected in many"	5	"glioma: 15.2;melanoma: 3.5"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HAP1: 3.0;HeLa: 4.5;NTERA-2: 3.0;SCLC-21H: 15.7;SH-SY5Y: 3.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA007461			Approved	"Nucleoplasm,Golgi apparatus,Midbody"		NA	NA			"Nucleoplasm, Golgi apparatus"	Midbody	"HPA007461: AB_1079308"	"unprognostic (4.12e-2)"	"unprognostic (3.24e-2)"	"unprognostic (3.60e-1)"	"unprognostic (1.42e-3)"	"unprognostic (5.17e-2)"	"unprognostic (1.84e-2)"	"unprognostic (6.32e-2)"	"unprognostic (2.08e-2)"	"unprognostic (8.24e-2)"	"unprognostic (1.61e-1)"	"unprognostic (4.38e-3)"	"unprognostic (2.16e-1)"	"unprognostic (3.44e-7)"	"unprognostic (1.96e-4)"	"unprognostic (5.99e-4)"	"unprognostic (2.31e-2)"	"unprognostic (1.82e-1)"	1.9	26.4	16.9	1.1	33.4	0.9	1.8	15.9	23.9	1.4	2.6	9.5	3.8	1.6	1.8	4.5	3.5	1.5	3.0	16.9	13.0	14.3	4.5	7.0	3.5	0.9	17.1	9.1	4.2	2.5	43.5	8.3	3.7	20.5	5.3	1.8	4.1	1.8	12.4	1.7	1.0	1.9	5.2	11.8	1.1	1.3	3.5	12.4	1.7	7.8	0.0	0.9	2.2	0.8	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	1.3	0.8	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.0	0.0	0.0	0.0	1.5	1.4	4.5	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.2	0.3	0.0	0.0	0.9	0.1	0.0	3.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	15.7	3.8	0.1	1.1	2.6	0.9	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	16.9	33.4	15.9	14.5	13.0	14.3	17.1	9.1	20.5	12.4	8.9	0.0	0.0	0.1	0.0	11.0	20.1	2.5	0.0	0.0	0.0	0.0	3.6	5.0	1.0	20.2	0.0	0.0	0.0	0.0	0.3	0.4	0.8	0.0	0.8	0.3	4.8	0.0	0.0	0.0	42.4	0.9	0.0	0.0	0.0	0.0	55.0	0.5	0.0	1.4	0.0	0.6	0.0	1.0	0.6	0.6	0.0	1.5	0.0	0.0	0.0
MAPK6	"ERK3, HsT17250, p97MAPK, PRKM6"	ENSG00000069956	"Mitogen-activated protein kinase 6"	Q16659	15	51952106-52067372	"Enzymes, Predicted intracellular proteins"	"Cell cycle"	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"CAB005184, HPA030262, HPA047825"	Approved	Supported	Supported	Cytosol		NA	NA			Cytosol		"CAB005184: AB_2140298, HPA030262: AB_10601868, HPA047825: "	"unprognostic (6.61e-2)"	"unprognostic (1.75e-2)"	"unprognostic (5.05e-2)"	"unprognostic (3.40e-3)"	"unprognostic (2.72e-1)"	"unprognostic (5.52e-2)"	"unprognostic (6.13e-2)"	"unprognostic (2.32e-3)"	"unprognostic (3.99e-2)"	"unprognostic (8.54e-2)"	"unprognostic (3.68e-2)"	"unprognostic (3.90e-2)"	"unprognostic (3.27e-3)"	"unprognostic (2.03e-1)"	"unprognostic (1.72e-1)"	"unprognostic (3.07e-2)"	"unprognostic (2.31e-2)"	11.8	7.4	14.4	10.9	23.2	25.6	13.7	33.0	24.5	16.3	18.7	12.5	9.3	16.3	15.9	13.3	32.3	8.2	17.0	9.1	13.3	15.9	14.4	32.6	12.6	9.4	13.1	16.8	11.5	8.5	12.2	15.3	13.9	23.8	10.5	18.1	9.5	17.9	11.4	27.1	24.0	26.2	17.8	14.2	9.2	15.7	25.7	13.0	11.7	13.4	22.7	12.4	18.9	22.4	4.9	4.2	3.0	4.5	6.5	7.9	3.6	8.7	11.8	23.3	8.9	7.2	11.9	17.1	12.6	12.7	11.6	13.7	14.1	5.3	12.6	8.8	16.1	17.0	12.4	17.9	23.9	15.9	7.7	5.6	18.8	7.0	22.4	17.5	14.0	40.2	12.7	44.0	14.0	36.5	12.4	10.9	8.7	24.3	21.6	14.8	19.8	9.8	11.1	8.3	10.9	5.7	8.6	15.0	20.3	11.1	36.9	11.5	10.8	10.1	8.3	18.3	33.7	7.5	20.9	10.8	13.9	15.0	9.0	16.7	11.2	32.9	15.7	17.2	20.6	17.0	3.0	4.5	1.2	3.8	4.3	4.7	4.9	5.6	4.3	4.2	2.6	5.4	3.8	0.6	6.5	2.8	1.9	7.9	3.6	14.4	23.2	33.0	24.3	13.3	15.9	13.1	16.8	23.8	13.0	26.8	29.8	23.8	84.4	99.5	34.6	20.2	22.9	24.1	29.6	15.7	15.7	14.3	14.9	31.8	133.3	22.8	95.4	0.0	43.1	33.7	40.4	80.6	139.2	47.8	25.7	31.8	29.7	16.5	30.7	167.7	21.0	26.7	28.7	11.8	32.2	25.1	52.1	31.6	22.3	30.5	21.1	19.4	21.7	56.4	75.8	96.7	27.7	17.0	19.8	153.6
MAPK7	"BMK1, ERK5, PRKM7"	ENSG00000166484	"Mitogen-activated protein kinase 7"	Q13164	17	19377721-19383544	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Differentiation"	"Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Sertoli cells: 25.8;Spermatocytes: 31.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"ASC diff: 24.1;SuSa: 29.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB018561, HPA031031"	Uncertain		Enhanced	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"CAB018561: AB_2140544, HPA031031: AB_2673706"	"unprognostic (1.63e-1)"	"unprognostic (2.75e-2)"	"unprognostic (1.72e-1)"	"unprognostic (2.90e-2)"	"unprognostic (4.38e-2)"	"unprognostic (1.20e-3)"	"prognostic unfavorable (1.86e-4)"	"unprognostic (5.67e-3)"	"unprognostic (1.62e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.83e-2)"	"unprognostic (4.75e-2)"	"unprognostic (1.23e-2)"	"unprognostic (1.90e-1)"	"unprognostic (5.71e-1)"	"unprognostic (1.55e-1)"	"unprognostic (3.78e-2)"	11.5	15.0	6.4	7.3	7.6	9.2	11.8	12.5	7.9	13.4	15.3	7.2	6.0	9.2	13.1	14.1	17.3	9.4	11.8	8.2	5.9	4.7	10.8	4.8	9.9	9.2	8.2	5.2	25.4	5.7	7.3	7.5	12.5	6.7	14.0	6.9	10.5	7.8	12.3	7.5	13.1	11.2	13.8	7.1	13.2	8.0	13.3	7.5	4.5	8.6	11.3	10.6	12.7	15.9	2.2	2.6	11.5	7.4	5.5	4.7	3.0	3.6	5.8	4.8	3.7	24.1	10.1	5.6	5.0	4.6	6.9	6.4	6.7	0.6	2.2	4.0	8.6	5.1	4.1	5.6	4.6	4.3	3.8	4.3	1.0	4.1	2.9	10.4	0.9	3.7	10.6	3.2	10.5	3.7	6.0	5.1	4.3	1.9	0.8	6.9	2.4	7.4	3.9	5.5	3.7	3.8	4.0	7.0	1.5	2.3	2.0	2.2	6.4	5.1	0.5	2.5	29.6	3.1	1.2	2.8	7.4	5.5	8.2	3.4	1.4	2.1	0.6	8.6	0.9	4.5	1.0	3.6	11.5	4.7	7.4	2.5	2.2	2.2	4.1	2.6	1.4	2.1	2.6	1.3	5.5	6.5	1.7	1.0	3.0	6.4	7.6	12.5	7.9	5.9	4.7	8.2	5.2	6.7	7.5	6.0	3.5	6.2	5.5	4.8	2.0	1.7	0.0	1.4	2.3	5.2	2.0	4.8	5.0	7.1	6.3	7.1	9.0	0.0	5.3	6.9	8.3	5.5	2.3	1.3	6.7	0.0	10.3	6.7	6.7	5.9	10.6	6.3	3.3	2.8	5.7	14.5	6.2	13.5	11.0	3.0	2.0	25.8	8.6	31.4	10.6	3.8	4.2	4.4	6.1	5.2
MAPK8	"JNK, JNK1, PRKM8, SAPK1"	ENSG00000107643	"Mitogen-activated protein kinase 8"	P45983	10	48306639-48439360	"Cancer-related genes, Enzymes, Predicted intracellular proteins, RAS pathway related proteins"	"Biological rhythms"	"Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Early spermatids: 142.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004463, CAB069396"	Approved					NA	NA					"CAB004463: AB_675868, CAB069396: AB_1619977"	"unprognostic (7.49e-2)"	"unprognostic (1.47e-1)"	"unprognostic (2.74e-2)"	"unprognostic (1.46e-1)"	"unprognostic (3.07e-2)"	"unprognostic (1.60e-2)"	"prognostic unfavorable (8.66e-4)"	"unprognostic (4.23e-2)"	"unprognostic (5.98e-2)"	"unprognostic (4.31e-3)"	"unprognostic (2.33e-1)"	"unprognostic (6.06e-2)"	"prognostic favorable (8.66e-4)"	"unprognostic (1.58e-1)"	"unprognostic (9.95e-2)"	"unprognostic (1.85e-2)"	"unprognostic (1.01e-3)"	13.4	11.7	15.3	11.5	18.5	13.3	22.1	33.6	35.2	15.2	13.9	12.9	19.5	16.7	17.1	10.8	16.1	12.4	15.1	11.2	20.0	18.0	20.1	23.6	11.7	12.0	15.9	16.7	18.9	15.3	12.7	23.7	12.2	23.6	13.0	14.3	12.4	17.2	15.9	18.9	10.8	17.7	14.6	13.7	9.6	12.2	23.4	12.2	20.5	22.3	9.0	13.8	11.8	13.0	4.5	4.3	5.2	4.3	4.7	5.7	3.5	16.0	4.3	14.5	8.3	5.6	6.6	11.3	24.2	16.6	14.5	11.9	5.0	16.6	5.8	6.6	13.5	7.6	9.8	5.0	9.3	19.0	34.7	8.3	8.3	5.0	6.8	9.2	14.2	9.8	5.5	10.7	10.8	21.4	8.6	13.3	16.1	13.3	10.7	9.4	4.7	17.3	7.6	9.1	5.8	3.2	11.4	15.0	5.8	8.9	6.2	24.4	19.4	9.4	7.9	10.9	9.8	8.6	6.8	11.4	10.8	26.0	8.2	18.2	3.4	8.3	11.8	7.5	15.1	6.2	0.0	3.3	3.0	4.1	2.8	4.7	4.5	5.7	5.0	3.3	2.9	5.6	3.9	5.2	4.7	4.3	4.3	2.9	3.5	15.3	18.5	33.6	35.2	20.0	18.0	15.9	16.7	23.6	12.2	3.0	11.3	7.8	38.8	39.8	58.6	8.3	22.9	14.7	14.8	7.0	29.5	11.7	10.0	24.2	142.4	17.8	21.0	0.0	22.3	5.8	15.8	35.2	11.5	16.3	8.8	66.7	29.7	8.6	9.9	66.1	13.6	16.2	20.3	31.5	12.5	21.2	25.4	15.0	9.6	19.2	34.4	6.5	25.8	22.7	25.1	32.0	13.2	11.5	11.5	38.7
MAPK9	"JNK2, p54a, PRKM9, SAPK"	ENSG00000050748	"Mitogen-activated protein kinase 9"	P45984	5	180233143-180292099	"Enzymes, Predicted intracellular proteins, RAS pathway related proteins"	"Biological rhythms"	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 48.7"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	4	"basophil: 13.2"	"Lineage enriched"	"Detected in all"	4	"granulocytes: 13.2"	"Cell line enhanced"	"Detected in all"		"HDLM-2: 69.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB008910	Enhanced					NA	NA					"CAB008910: "	"unprognostic (5.04e-3)"	"unprognostic (2.06e-2)"	"prognostic favorable (1.11e-4)"	"unprognostic (8.53e-2)"	"unprognostic (1.75e-1)"	"unprognostic (5.06e-3)"	"unprognostic (6.83e-3)"	"unprognostic (3.16e-1)"	"unprognostic (4.93e-2)"	"unprognostic (3.76e-1)"	"unprognostic (5.97e-2)"	"unprognostic (1.36e-1)"	"unprognostic (1.50e-1)"	"unprognostic (2.13e-1)"	"unprognostic (2.29e-1)"	"unprognostic (9.38e-3)"	"unprognostic (2.40e-1)"	10.3	12.4	22.9	9.6	31.8	10.3	11.4	48.7	41.4	10.8	12.4	10.6	4.7	10.1	8.7	9.5	8.7	8.8	7.8	14.0	24.3	25.0	12.2	9.7	10.8	10.0	22.0	21.0	8.5	25.9	16.3	8.8	10.9	29.4	11.7	15.3	7.0	9.9	13.1	20.5	6.3	10.4	11.4	16.8	8.6	12.3	9.4	10.3	7.1	15.4	5.1	11.3	9.9	7.3	1.4	1.4	13.2	2.4	1.3	3.1	0.3	17.2	14.3	12.6	15.8	12.5	14.1	27.2	16.6	14.8	14.0	14.1	18.7	12.3	18.5	28.7	17.6	30.8	13.3	13.0	27.9	16.5	69.4	12.5	7.7	15.9	13.3	9.5	15.9	13.5	10.3	12.5	13.6	13.2	14.6	16.6	14.5	8.4	13.4	19.0	22.6	15.8	6.6	8.8	21.4	8.5	15.3	21.5	8.8	10.6	16.5	14.6	10.3	19.5	19.0	13.2	16.4	19.3	13.8	11.9	16.8	16.9	23.6	24.8	9.7	11.4	12.6	17.8	14.9	11.1	13.2	0.6	2.5	2.0	1.3	2.0	1.0	1.5	1.8	1.0	1.4	1.0	1.2	0.9	1.3	2.4	1.4	3.1	0.3	22.9	31.8	48.7	41.4	24.3	25.0	22.0	21.0	29.4	10.3	29.8	11.8	11.5	6.1	9.0	18.3	20.7	10.2	5.3	10.3	8.7	15.7	12.1	5.0	7.1	0.9	15.7	13.5	0.0	13.9	18.8	9.9	10.0	11.5	15.3	10.3	12.7	16.0	13.5	17.2	2.3	9.8	12.8	5.0	10.0	17.1	10.4	10.9	11.5	12.7	9.2	14.2	12.9	7.2	15.9	17.0	9.9	14.9	8.6	14.5	7.3
MAPKAPK2		ENSG00000162889	"Mitogen-activated protein kinase-activated protein kinase 2"	P49137	1	206684944-206734283	"Cancer-related genes, Enzymes, Predicted membrane proteins"	"DNA damage"	"Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	6	"plasmacytoid DC: 18.7"	"Lineage enriched"	"Detected in all"	6	"dendritic cells: 18.7"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB010297, HPA045556, HPA063708, HPA064435"	Approved		Supported	Nucleoplasm,Centrosome		NA	NA			Nucleoplasm	Centrosome	"CAB010297: AB_2250405, HPA045556: AB_2679367, HPA063708: AB_2685100, HPA064435: AB_2685263"	"unprognostic (7.93e-2)"	"unprognostic (1.83e-1)"	"unprognostic (5.27e-2)"	"unprognostic (5.12e-2)"	"unprognostic (1.80e-1)"	"unprognostic (1.32e-2)"	"prognostic unfavorable (1.93e-4)"	"unprognostic (9.85e-2)"	"unprognostic (1.68e-1)"	"unprognostic (2.00e-1)"	"unprognostic (1.01e-2)"	"unprognostic (1.35e-1)"	"prognostic unfavorable (4.58e-6)"	"unprognostic (2.12e-1)"	"unprognostic (1.37e-1)"	"unprognostic (6.96e-2)"	"unprognostic (3.29e-2)"	23.0	25.3	11.6	21.2	15.7	58.6	23.9	11.1	14.5	19.3	25.6	17.2	14.5	25.7	20.0	18.5	23.5	17.3	26.0	89.2	12.3	8.7	33.7	26.7	26.7	21.5	16.7	6.5	23.3	19.1	16.9	22.8	13.6	15.7	20.2	14.4	17.8	19.8	14.4	62.9	18.3	32.9	18.3	14.6	37.7	23.1	21.3	14.6	26.9	24.3	25.2	28.2	22.9	46.1	1.1	18.7	3.2	1.1	2.3	1.6	0.5	21.2	8.4	11.7	13.2	34.6	20.3	14.6	14.8	33.7	22.7	21.4	16.1	10.4	10.2	10.4	29.9	14.2	16.1	8.7	15.8	16.3	11.9	6.6	17.2	10.5	10.3	26.7	25.4	57.6	28.0	20.2	21.8	24.1	18.9	18.5	13.9	19.8	46.7	18.3	26.4	10.2	18.4	13.5	7.5	11.8	26.2	24.6	3.3	17.1	13.1	9.4	12.1	17.5	29.6	20.5	22.8	14.4	24.7	17.6	20.5	17.3	23.7	20.2	60.9	54.0	8.3	23.2	15.5	6.7	1.1	0.7	1.4	1.6	1.1	1.5	1.0	1.2	1.5	0.6	1.1	0.6	1.1	3.2	2.3	1.0	18.7	1.4	0.5	11.6	15.7	11.1	14.5	12.3	8.7	16.7	6.5	15.7	14.6	50.6	53.7	28.9	47.2	75.9	11.3	97.2	40.8	6.7	29.6	29.6	19.6	5.0	13.3	28.0	71.3	26.3	27.4	23.3	50.4	7.0	28.6	55.9	34.6	34.4	22.4	0.0	59.3	21.5	27.7	20.1	21.0	27.9	32.1	12.6	32.0	17.7	50.5	21.2	16.3	21.0	14.8	25.8	48.7	11.8	4.1	63.0	13.8	37.4	24.1	68.1
MAPKAPK3	"3pK, MAPKAP3"	ENSG00000114738	"Mitogen-activated protein kinase-activated protein kinase 3"	Q16644	3	50611520-50649297	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 86.7;skeletal muscle: 70.1"	"Cell type enhanced"	"Detected in many"	9	"Cardiomyocytes: 193.9;Hofbauer cells: 91.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"classical monocyte: 30.2;eosinophil: 23.0;intermediate monocyte: 50.0;myeloid DC: 27.1;neutrophil: 20.5;non-classical monocyte: 61.4;plasmacytoid DC: 16.9"	"Group enriched"	"Detected in all"	5	"dendritic cells: 27.1;granulocytes: 23.0;monocytes: 61.4"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA058275			Supported	Nucleoplasm		NA	NA			Nucleoplasm		"HPA058275: AB_2683663"	"unprognostic (6.46e-3)"	"unprognostic (1.84e-1)"	"prognostic favorable (8.08e-5)"	"unprognostic (1.17e-1)"	"unprognostic (1.93e-1)"	"unprognostic (9.96e-2)"	"unprognostic (8.77e-3)"	"unprognostic (7.68e-3)"	"unprognostic (1.11e-1)"	"unprognostic (5.87e-2)"	"unprognostic (2.19e-3)"	"unprognostic (1.01e-1)"	"prognostic favorable (1.90e-8)"	"unprognostic (2.15e-2)"	"unprognostic (1.22e-1)"	"unprognostic (1.86e-1)"	"unprognostic (1.69e-1)"	8.9	16.1	5.6	9.3	7.2	30.4	6.3	1.9	6.2	5.5	9.5	7.1	7.5	9.9	5.5	8.6	16.8	5.1	8.5	86.7	4.8	3.7	17.9	11.9	11.0	15.1	7.2	4.1	8.7	24.2	11.2	9.0	9.0	6.0	7.6	6.7	10.9	12.4	9.2	70.1	17.6	12.0	5.2	5.9	12.5	9.0	4.0	5.2	25.9	22.6	40.9	14.3	6.1	7.5	3.0	27.1	23.0	61.4	7.3	6.4	19.5	23.4	7.3	3.0	8.6	4.6	11.7	6.9	5.7	8.2	8.8	7.5	11.3	21.9	9.4	5.8	19.1	21.9	8.4	20.9	22.5	7.9	20.8	5.0	49.5	10.3	10.2	9.3	35.6	26.4	9.3	14.0	20.5	28.0	8.8	7.8	16.8	13.9	6.2	18.5	9.5	15.1	35.9	11.4	8.2	30.0	6.7	7.3	14.2	41.0	13.5	5.7	4.0	5.1	14.5	6.5	5.3	9.1	22.1	5.6	7.0	16.0	36.0	14.1	4.2	7.7	7.8	37.0	56.1	2.8	6.4	30.2	23.0	5.5	50.0	5.4	3.0	6.2	6.4	27.1	1.8	4.9	5.5	20.5	7.3	61.4	16.9	5.2	19.5	5.6	7.2	1.9	6.2	4.8	3.7	7.2	4.1	6.0	5.2	8.9	9.4	7.5	19.5	10.1	0.9	193.9	10.2	6.7	6.8	10.4	0.0	5.0	54.7	35.3	28.4	6.7	23.1	0.0	26.4	5.7	11.0	21.5	35.7	10.9	91.5	0.0	5.8	4.9	48.9	60.2	6.6	40.9	6.8	46.9	13.9	10.8	54.8	8.6	3.2	28.5	2.3	25.8	11.7	3.4	4.3	17.7	4.2	18.7	27.9	30.1
MAPKAPK5	PRAK	ENSG00000089022	"Mitogen-activated protein kinase-activated protein kinase 5"	Q8IW41	12	111841978-111902238	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"	"Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"CAB004546, HPA015515"	Supported		Supported	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"CAB004546: AB_627910, HPA015515: AB_1853569"	"unprognostic (6.45e-2)"	"unprognostic (7.29e-2)"	"unprognostic (1.27e-3)"	"unprognostic (1.09e-2)"	"unprognostic (5.52e-2)"	"unprognostic (3.76e-2)"	"prognostic unfavorable (2.98e-8)"	"unprognostic (1.88e-1)"	"unprognostic (3.09e-2)"	"unprognostic (1.22e-1)"	"unprognostic (1.75e-1)"	"unprognostic (1.25e-2)"	"unprognostic (3.20e-1)"	"unprognostic (6.03e-2)"	"unprognostic (3.39e-2)"	"unprognostic (9.41e-2)"	"unprognostic (3.25e-2)"	20.7	26.2	21.4	17.5	26.4	24.1	21.7	23.7	28.3	17.3	28.8	26.1	21.9	26.3	25.8	22.8	20.8	17.5	22.7	20.7	17.7	15.2	21.7	21.5	18.9	19.4	22.3	20.4	21.3	24.5	19.8	20.4	21.0	17.3	18.7	32.9	23.6	23.3	20.5	33.2	23.0	28.4	21.1	18.0	18.4	19.8	16.7	22.0	19.3	20.5	15.1	19.3	19.9	16.5	4.9	4.1	3.2	11.4	3.9	6.8	2.5	14.9	19.8	19.2	16.1	13.9	14.1	29.3	15.0	18.1	23.0	16.0	25.6	12.3	22.6	11.1	17.6	13.7	14.9	25.2	15.7	21.6	15.0	13.8	20.1	13.8	20.5	16.8	25.2	14.2	14.8	22.6	22.0	26.2	17.5	16.9	20.6	27.7	8.9	16.8	16.8	25.0	39.9	27.3	36.8	14.0	24.8	14.0	21.7	18.3	21.7	23.7	20.1	17.0	29.0	20.8	18.3	23.5	28.9	14.7	13.1	13.2	13.4	18.7	18.3	22.4	26.7	15.9	18.4	18.5	1.3	4.8	3.2	6.5	3.5	3.5	4.9	4.3	4.7	3.3	4.0	6.8	5.1	2.5	3.9	11.4	4.1	6.6	2.5	21.4	26.4	23.7	28.3	17.7	15.2	22.3	20.4	17.3	22.0	3.0	17.2	13.8	19.4	18.2	45.9	15.7	22.9	9.4	15.9	3.5	39.3	26.2	11.6	25.6	11.1	15.5	36.7	0.0	25.7	28.0	17.4	20.5	2.3	11.1	17.5	22.3	35.2	16.5	15.8	5.6	14.4	16.6	8.5	24.4	39.9	19.2	27.7	28.8	16.6	16.8	34.7	19.4	17.9	18.0	36.8	18.6	25.2	22.3	30.8	24.3
MARCH1	"FLJ20668, MARCH-I, RNF171"	ENSG00000145416	"Membrane associated ring-CH-type finger 1"	Q8TCQ1	4	163524298-164384050	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Immunity, Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 24.4;lymphoid tissue: 32.4"	"Cell type enhanced"	"Detected in many"	11	"B-cells: 128.6;Cone photoreceptor cells: 184.6;Kupffer cells: 192.5;Macrophages: 105.3;Rod photoreceptor cells: 172.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	95	"classical monocyte: 16.8;eosinophil: 9.9;intermediate monocyte: 17.0;memory B-cell: 18.5;myeloid DC: 18.1;naive B-cell: 15.7;non-classical monocyte: 17.2;plasmacytoid DC: 6.8"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"Daudi: 9.6;U-266/70: 9.8"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA014600	Uncertain					NA	NA					"HPA014600: AB_1853573"	"unprognostic (7.29e-2)"	"unprognostic (5.82e-2)"	"unprognostic (1.48e-1)"	"unprognostic (9.09e-2)"	"unprognostic (8.25e-2)"	"unprognostic (2.98e-2)"	"unprognostic (4.79e-3)"	"unprognostic (9.00e-2)"	"unprognostic (3.00e-2)"	"unprognostic (2.18e-1)"	"unprognostic (1.13e-1)"	"unprognostic (2.20e-1)"	"unprognostic (1.24e-1)"	"unprognostic (7.00e-2)"	"unprognostic (2.48e-2)"	"unprognostic (2.70e-1)"	"unprognostic (2.91e-2)"	7.7	4.2	11.6	20.5	19.7	3.9	4.0	3.1	14.5	3.7	3.9	8.5	0.1	4.4	3.9	4.6	3.6	4.2	5.9	2.6	12.6	10.1	3.0	4.5	8.3	28.5	17.3	6.3	4.2	4.1	1.5	4.1	10.2	13.5	3.5	5.1	2.4	4.6	1.8	1.6	4.9	9.0	6.5	24.4	32.4	4.1	2.3	17.9	2.6	3.2	1.4	24.6	9.0	4.2	18.5	18.1	9.9	17.2	0.1	0.0	6.6	0.8	0.7	2.9	1.7	0.0	0.0	1.9	1.2	0.1	0.0	0.0	1.6	3.3	9.6	3.6	0.0	0.4	1.4	0.0	0.0	0.0	1.0	1.0	6.8	3.7	0.6	0.0	4.1	2.2	0.0	0.0	0.0	0.2	4.0	0.0	1.9	2.5	5.0	3.3	1.0	2.3	2.6	3.6	0.3	1.3	2.7	0.5	0.7	0.1	1.6	1.5	1.3	0.9	1.5	0.5	2.2	4.0	0.7	3.1	1.1	2.0	0.7	2.3	9.8	3.3	2.7	1.4	2.1	1.5	0.0	16.8	9.9	0.0	17.0	0.0	18.5	0.0	0.0	18.1	15.7	0.0	0.0	0.1	0.1	17.2	6.8	0.0	6.6	11.6	19.7	3.1	12.5	12.6	10.1	17.3	6.3	13.5	17.9	0.0	2.7	128.6	0.0	1.5	24.7	2.4	0.0	1.4	4.5	3.5	184.6	0.3	0.0	0.0	4.6	1.1	0.0	0.0	0.0	0.2	0.8	0.0	0.0	0.9	43.0	11.1	0.0	3.1	192.5	1.7	0.0	105.3	0.0	0.0	0.0	5.1	0.0	0.0	0.0	0.1	172.3	12.9	0.0	0.6	1.5	0.9	0.7	0.8	0.0	0.0
MARCH10	"FLJ35757, MARCH-X, RNF190"	ENSG00000173838	"Membrane associated ring-CH-type finger 10"	Q8NA82	17	62701314-62808344	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	10	"testis: 80.2"	"Group enriched"	"Detected in some"	7	"Early spermatids: 371.3;Late spermatids: 1043.9"	"Low cancer specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"gdT-cell: 3.4"	"Lineage enriched"	"Detected in single"	5	"T-cells: 3.4"	"Cell line enhanced"	"Detected in some"		"BEWO: 3.9;EFO-21: 7.3;HSkMC: 3.2;SCLC-21H: 12.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			HPA023322	Enhanced		Approved	"Plasma membrane,Cytosol"		NA	NA			"Plasma membrane, Cytosol"		"HPA023322: AB_1856351"	"unprognostic (2.79e-2)"	"unprognostic (2.32e-1)"	"unprognostic (9.60e-3)"	"unprognostic (6.95e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.21e-1)"		"unprognostic (1.03e-2)"	"unprognostic (1.67e-1)"	"unprognostic (1.39e-1)"	"unprognostic (7.99e-4)"	"unprognostic (3.16e-1)"	"unprognostic (2.85e-3)"	"unprognostic (1.38e-1)"	"unprognostic (4.83e-2)"	"unprognostic (9.37e-3)"	"unprognostic (2.66e-1)"	0.2	0.1	0.7	0.2	1.6	0.0	0.1	0.1	0.3	0.5	0.1	1.9	0.6	0.0	0.3	4.8	0.1	7.9	0.1	0.1	1.0	1.0	0.6	0.1	1.4	0.1	0.2	0.5	1.0	0.1	0.3	4.5	0.1	1.8	0.1	0.0	0.2	0.2	0.1	0.1	0.1	0.1	0.1	0.2	0.1	0.0	80.2	0.3	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.7	0.0	0.0	0.6	3.4	0.3	0.1	0.0	0.2	0.0	0.0	0.2	3.9	1.7	0.2	1.2	0.3	0.0	0.1	0.0	7.3	0.5	0.1	0.0	0.0	0.4	1.4	0.0	0.0	1.3	0.7	0.0	1.5	0.0	0.0	3.2	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.9	1.5	0.1	0.1	0.3	0.0	0.2	0.0	0.0	0.2	1.1	0.0	12.7	0.0	0.0	0.7	0.1	0.5	0.2	0.0	0.0	0.0	0.7	0.1	1.4	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	3.4	0.0	1.5	0.0	0.7	0.3	0.7	0.1	0.6	1.8	0.0	0.6	0.0	0.0	0.7	0.3	0.7	1.6	0.1	0.3	1.0	1.0	0.2	0.5	1.8	0.3	3.0	1.0	0.0	0.0	0.1	0.0	0.3	0.0	105.7	15.9	3.5	0.0	0.1	44.7	0.0	371.3	0.0	0.0	0.0	0.0	0.2	0.0	0.0	1.1	0.0	0.1	0.0	0.0	0.6	0.0	1043.9	4.9	0.5	0.0	0.0	0.0	0.0	0.0	0.0	3.5	0.0	0.0	6.5	0.0	42.4	10.6	0.0	0.1	0.5	0.0	0.0
MARCH11	"MARCH-XI, RNF226"	ENSG00000183654	"Membrane associated ring-CH-type finger 11"	A6NNE9	5	16067139-16180762	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	6	"testis: 42.1"	"Group enriched"	"Detected in some"	7	"Early spermatids: 83.9;Spermatocytes: 30.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	11	"SH-SY5Y: 44.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"									NA	NA						"unprognostic (9.91e-3)"				"unprognostic (1.08e-1)"					"unprognostic (2.98e-1)"	"unprognostic (1.50e-1)"	"unprognostic (1.54e-1)"			"unprognostic (1.52e-1)"	"unprognostic (3.55e-2)"		0.4	1.1	1.8	0.3	3.4	0.3	0.4	3.7	3.7	0.3	0.4	0.0	0.0	0.3	0.4	0.3	0.3	0.3	0.3	2.2	2.0	3.2	0.5	0.5	0.4	0.3	1.5	2.0	0.5	1.0	0.3	6.8	0.4	2.1	0.6	0.4	0.6	1.4	0.3	0.3	0.3	0.4	0.3	0.5	0.3	0.4	42.1	0.0	0.0	0.3	0.0	0.3	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.1	44.3	0.0	0.0	0.0	4.1	0.0	0.0	0.0	0.8	0.1	0.0	0.0	0.5	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	1.8	3.4	3.7	3.7	2.0	3.2	1.5	2.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	5.8	5.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	83.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.9	0.0	0.0	0.0	5.9	2.3	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.7	0.0	2.4	6.5	0.0	30.3	1.4	0.0	0.0	0.0	0.0	0.0
MARCH2	"HSPC240, MARCH-II, RNF172"	ENSG00000099785	"Membrane associated ring-CH-type finger 2"	Q9P0N8	19	8413270-8439017	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Endocytosis, Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA014063	Approved		Supported	"Endoplasmic reticulum,Cytosol"		NA	NA			"Endoplasmic reticulum"	Cytosol	"HPA014063: AB_1853576"	"unprognostic (1.15e-2)"	"unprognostic (4.01e-3)"	"prognostic unfavorable (6.48e-4)"	"prognostic favorable (1.05e-5)"	"unprognostic (3.00e-1)"	"prognostic favorable (8.29e-4)"	"unprognostic (3.43e-2)"	"unprognostic (6.95e-2)"	"unprognostic (3.06e-3)"	"unprognostic (2.32e-1)"	"prognostic favorable (6.21e-4)"	"unprognostic (2.01e-1)"	"unprognostic (3.52e-1)"	"unprognostic (1.01e-1)"	"unprognostic (3.16e-1)"	"unprognostic (9.91e-2)"	"unprognostic (1.80e-2)"	37.7	12.4	30.7	13.5	28.3	17.5	23.9	8.6	39.1	9.8	29.8	20.7	9.7	11.2	12.5	39.0	19.3	10.0	11.4	38.9	23.5	21.9	11.0	17.9	18.2	15.0	30.8	19.8	8.2	10.0	10.5	11.3	13.9	20.2	16.0	10.3	12.7	13.4	21.8	46.9	12.7	11.7	28.5	27.8	18.9	13.3	8.6	13.3	8.4	21.3	14.1	10.0	20.4	9.7	3.6	26.5	20.4	14.6	3.7	7.3	10.1	5.6	7.2	3.2	15.1	19.9	6.5	5.5	6.1	7.5	4.9	5.1	3.5	2.6	2.2	18.0	13.1	6.5	4.0	4.2	8.6	3.8	11.1	9.9	17.0	3.3	7.8	10.8	2.5	25.7	7.8	9.9	4.7	4.2	7.1	19.2	9.0	2.4	12.5	3.8	10.7	3.4	8.1	6.8	6.8	17.4	5.4	1.0	5.6	11.3	6.7	1.6	9.1	0.4	6.6	11.5	11.6	5.0	5.4	19.3	6.9	4.2	22.8	5.1	11.2	13.3	2.5	11.2	5.1	5.2	20.4	10.0	15.4	5.7	14.6	5.9	3.6	5.9	4.6	6.7	3.5	4.0	5.4	12.5	3.7	12.8	26.5	7.3	10.1	30.7	28.3	8.6	39.1	23.5	21.9	30.8	19.8	20.2	13.3	3.0	10.9	4.5	0.0	6.6	10.7	38.1	7.6	2.7	3.4	19.2	2.0	6.6	33.2	0.0	8.1	27.0	13.6	23.3	0.0	9.3	10.5	0.0	12.7	24.6	57.4	22.3	11.6	47.9	48.6	36.4	8.6	19.4	23.6	0.0	5.5	17.5	0.0	7.4	11.0	43.4	7.7	12.9	20.6	5.4	8.5	11.3	4.8	18.1	4.6	0.0
MARCH3	"MARCH-III, MGC48332, RNF173"	ENSG00000173926	"Membrane associated ring-CH-type finger 3"	Q86UD3	5	126867714-127030808	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Endocytosis, Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	6	"Muller glia cells: 52.5;Spermatocytes: 61.1;Syncytiotrophoblasts: 82.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"memory B-cell: 8.8;naive B-cell: 13.1"	"Lineage enriched"	"Detected in many"	5	"B-cells: 13.1"	"Cell line enhanced"	"Detected in many"		"hTEC/SVTERT24-B: 25.1;HUVEC TERT2: 16.7;TIME: 20.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA043406	Uncertain		Supported	Vesicles		NA	NA			Vesicles		"HPA043406: AB_10793947"	"unprognostic (5.96e-3)"	"unprognostic (1.46e-2)"	"unprognostic (1.91e-2)"	"unprognostic (4.21e-2)"	"unprognostic (9.00e-3)"	"unprognostic (1.17e-2)"	"unprognostic (7.75e-3)"	"unprognostic (9.41e-2)"	"unprognostic (8.93e-2)"	"unprognostic (2.05e-3)"	"unprognostic (3.15e-2)"	"unprognostic (1.82e-1)"	"unprognostic (5.60e-6)"	"unprognostic (7.74e-2)"	"unprognostic (7.64e-2)"	"unprognostic (1.05e-1)"	"unprognostic (3.64e-1)"	11.3	6.0	5.6	11.0	9.4	6.6	6.2	5.3	4.8	2.0	10.8	8.2	0.5	2.4	3.7	3.6	3.4	3.2	10.4	15.2	7.8	6.8	2.0	1.9	5.2	5.2	9.5	2.3	4.0	5.0	1.7	10.8	4.0	12.3	2.9	11.8	9.7	11.2	1.1	11.9	11.5	5.2	6.5	16.0	3.7	5.5	14.2	7.6	2.1	3.6	3.4	5.8	6.5	6.7	13.1	0.7	2.5	0.4	1.9	2.6	0.7	0.3	1.2	2.4	1.3	2.1	2.1	0.8	8.5	3.6	6.9	10.2	1.1	0.5	2.3	0.8	1.3	1.5	0.7	3.0	1.5	9.8	0.5	2.7	7.2	2.0	1.1	3.5	2.9	1.8	1.5	0.5	25.1	3.0	1.6	16.7	0.3	3.0	0.4	5.7	0.8	0.3	1.3	2.0	1.8	2.8	0.9	9.6	0.6	0.5	1.2	0.7	0.5	2.0	0.3	1.0	1.2	1.7	3.0	20.3	1.3	1.1	7.9	0.9	1.1	1.3	1.3	5.1	2.3	1.2	0.0	0.2	2.5	0.5	0.4	0.1	8.8	0.6	0.3	0.1	13.1	2.4	0.5	0.8	1.9	0.3	0.7	2.6	0.7	5.6	9.4	5.3	4.8	7.8	6.8	9.5	2.3	12.3	7.6	3.0	3.4	18.2	0.0	5.4	18.3	12.9	17.8	1.4	3.4	0.0	2.0	33.6	0.0	0.0	33.1	6.0	15.5	23.3	0.0	3.1	6.7	0.0	24.3	0.8	7.7	35.0	14.3	11.6	3.5	9.8	0.3	2.0	3.3	0.0	23.4	52.5	0.0	44.4	1.8	0.2	25.6	0.0	0.9	61.1	12.7	7.8	82.5	5.1	21.9	0.0
MARCH4	"KIAA1399, MARCH-IV, RNF174"	ENSG00000144583	"Membrane associated ring-CH-type finger 4"	Q9P2E8	2	216257865-216372027	"Enzymes, Predicted membrane proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"brain: 16.6;pituitary gland: 13.1"	"Cell type enriched"	"Detected in some"	6	"Intestinal endocrine cells: 15.6"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BJ: 33.8;fHDF/TERT166: 21.5;TIME: 15.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA014348	Approved					NA	NA					"HPA014348: AB_1853578"	"unprognostic (4.84e-2)"	"unprognostic (1.02e-4)"	"unprognostic (1.63e-1)"	"unprognostic (5.42e-2)"	"unprognostic (3.31e-2)"	"unprognostic (1.88e-1)"	"unprognostic (1.38e-1)"	"unprognostic (1.26e-2)"	"unprognostic (1.24e-2)"	"unprognostic (6.49e-2)"	"unprognostic (5.55e-3)"	"unprognostic (1.07e-1)"	"unprognostic (6.81e-5)"	"unprognostic (4.82e-2)"	"unprognostic (2.06e-1)"	"unprognostic (1.23e-1)"	"unprognostic (1.09e-3)"	0.7	2.9	7.0	0.7	11.9	0.7	0.6	1.0	16.6	0.6	1.1	0.3	0.0	1.5	0.7	0.7	0.6	2.5	0.6	0.6	5.8	5.6	0.6	0.6	0.8	0.6	2.0	4.8	0.6	1.5	0.6	13.1	3.1	3.4	0.7	1.2	0.1	0.6	0.6	0.6	0.7	1.4	0.6	1.6	0.6	5.1	0.7	1.1	0.0	0.6	0.0	0.6	0.6	0.1	0.0	0.0	0.0	0.0	0.5	0.4	0.0	5.6	1.2	0.0	0.0	0.1	0.8	0.0	33.8	11.6	7.3	2.6	0.0	0.5	0.0	5.2	21.5	12.2	0.0	0.0	13.3	7.2	0.0	0.0	2.5	0.0	0.0	1.7	0.0	0.0	0.0	0.0	6.6	10.0	4.7	9.5	0.0	0.0	0.0	11.2	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.6	0.9	0.0	0.0	0.0	1.1	0.0	0.0	15.9	11.3	11.8	0.0	9.0	0.0	0.0	0.0	2.6	0.0	8.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	7.0	11.9	1.0	16.6	5.8	5.6	2.0	4.8	3.4	1.1	0.0	0.0	0.0	0.0	0.0	2.5	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
MARCH5	"FLJ20445, MARCH-V, MITOL, RNF153"	ENSG00000198060	"Membrane associated ring-CH-type finger 5"	Q9NX47	10	92291163-92353964	"Enzymes, Predicted membrane proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Early spermatids: 116.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA056596			Supported	Mitochondria		NA	NA			Mitochondria		"HPA056596: AB_2683181"	"unprognostic (4.00e-2)"	"unprognostic (5.15e-2)"	"unprognostic (1.25e-1)"	"unprognostic (4.10e-2)"	"unprognostic (5.47e-3)"	"unprognostic (2.33e-3)"	"unprognostic (4.43e-1)"	"unprognostic (1.63e-1)"	"unprognostic (1.24e-2)"	"unprognostic (9.77e-2)"	"unprognostic (5.50e-3)"	"unprognostic (4.02e-3)"	"unprognostic (6.14e-2)"	"unprognostic (2.87e-1)"	"unprognostic (1.62e-1)"	"unprognostic (4.53e-1)"	"unprognostic (2.85e-2)"	18.2	21.7	17.5	17.7	18.3	20.7	27.1	16.8	25.7	15.5	15.4	12.7	20.7	15.8	19.3	18.8	28.0	14.8	15.4	18.4	15.8	15.1	21.7	27.6	16.5	16.6	16.3	17.9	20.9	16.7	16.3	12.3	16.3	14.8	22.2	14.8	14.5	19.4	19.3	42.6	13.7	16.0	18.1	14.0	12.1	14.4	20.1	13.5	25.0	24.5	21.5	17.3	14.7	21.0	7.3	9.4	16.8	10.2	6.5	8.7	6.6	16.2	8.8	17.5	20.0	11.9	12.4	9.0	14.6	16.1	18.2	18.7	5.9	11.7	9.5	10.1	14.2	8.0	13.4	12.1	12.2	26.2	7.1	14.3	7.6	8.3	13.8	14.5	12.1	7.6	12.7	16.5	12.0	25.2	24.3	16.0	10.2	8.3	11.9	14.5	10.3	10.7	14.0	4.1	10.6	13.3	11.6	17.9	5.6	18.6	10.5	8.1	15.0	12.6	9.4	15.4	8.7	16.4	9.5	15.5	8.6	9.4	9.3	19.9	12.1	9.2	8.4	7.8	16.9	5.7	5.2	8.3	9.0	7.6	10.2	7.6	7.3	8.4	8.0	9.4	6.7	8.7	8.3	16.8	6.5	8.5	6.2	7.8	6.6	17.5	18.3	16.8	25.7	15.8	15.1	16.3	17.9	14.8	13.5	20.8	22.1	26.1	0.0	78.5	12.2	22.9	20.4	9.4	9.1	19.2	7.9	35.2	72.9	0.0	116.8	22.5	30.7	0.0	0.0	36.8	29.4	0.0	28.8	32.6	30.8	9.5	28.6	20.3	24.8	37.2	27.3	19.9	37.1	0.0	22.9	18.6	0.0	23.0	17.3	56.2	10.9	19.4	24.5	37.4	28.3	68.3	54.6	25.5	24.7	0.0
MARCH6	"MARCH-VI, RNF176, TEB4"	ENSG00000145495	"Membrane associated ring-CH-type finger 6"	O60337	5	10353703-10440388	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Ubl conjugation pathway"	Transferase	Epilepsy	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040841, HPA063246"	Approved		Supported	"Endoplasmic reticulum"		NA	NA			"Endoplasmic reticulum"		"HPA040841: AB_2677162, HPA063246: AB_2684970"	"unprognostic (3.31e-2)"	"unprognostic (2.04e-1)"	"unprognostic (2.85e-2)"	"unprognostic (3.80e-3)"	"unprognostic (4.00e-1)"	"unprognostic (2.26e-1)"	"unprognostic (3.06e-2)"	"unprognostic (9.52e-3)"	"unprognostic (1.53e-1)"	"unprognostic (1.05e-3)"	"unprognostic (3.94e-2)"	"unprognostic (5.58e-2)"	"unprognostic (5.08e-3)"	"unprognostic (1.61e-1)"	"unprognostic (2.88e-1)"	"unprognostic (3.57e-1)"	"unprognostic (8.50e-3)"	22.5	25.6	28.6	21.2	25.5	57.0	62.4	42.0	53.8	21.4	23.0	24.0	18.3	28.6	24.7	24.2	22.8	25.1	22.0	35.5	27.6	23.7	31.9	28.9	35.0	33.2	29.8	39.1	34.0	41.5	56.0	27.4	20.3	33.4	21.4	18.4	20.3	28.0	23.4	49.8	23.9	32.1	27.4	38.6	31.2	26.0	25.6	26.9	18.0	26.8	17.1	20.3	24.6	36.4	13.4	7.3	15.6	12.1	9.9	15.7	9.4	12.6	19.0	31.9	24.7	18.3	14.7	26.1	20.1	18.7	17.3	22.2	18.1	33.9	13.3	30.6	18.7	24.0	17.6	16.9	13.0	23.5	28.2	15.4	17.3	63.2	12.3	12.9	20.5	19.5	17.1	14.4	17.3	19.0	17.9	16.0	14.4	20.7	30.1	15.7	14.4	11.1	15.9	11.6	10.2	13.4	17.3	13.3	19.2	13.5	24.6	13.7	19.9	37.3	20.4	13.1	15.4	17.0	11.1	15.4	21.0	20.5	10.3	14.9	21.1	30.3	19.0	15.5	14.3	14.9	15.6	8.5	13.6	13.5	9.6	15.4	13.4	13.4	13.4	7.3	11.5	15.7	14.6	13.7	9.9	12.1	5.6	11.7	9.4	28.6	25.5	42.0	53.8	27.6	23.7	29.8	39.1	33.4	26.9	50.6	44.3	66.5	0.0	124.9	104.6	89.0	53.5	62.9	56.9	68.0	62.8	47.1	18.3	0.0	9.4	58.6	66.9	93.5	0.0	24.4	54.5	0.0	48.5	71.6	32.5	128.7	95.5	58.9	54.8	10.0	64.5	39.1	89.4	0.0	73.5	52.7	0.0	56.1	72.2	52.5	79.3	77.6	80.4	84.4	67.3	119.4	68.0	58.0	58.3	0.0
MARCH7	"AXOT, MARCH-VII, RNF177"	ENSG00000136536	"Membrane associated ring-CH-type finger 7"	Q9H992	2	159712457-159771027	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Early spermatids: 208.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA014275, HPA022152"	Enhanced		Supported	"Plasma membrane,Cytosol"		NA	NA			"Plasma membrane, Cytosol"		"HPA014275: AB_10599820, HPA022152: AB_10601107"	"unprognostic (2.42e-1)"	"unprognostic (2.24e-1)"	"unprognostic (1.02e-2)"	"unprognostic (1.92e-2)"	"unprognostic (1.62e-2)"	"unprognostic (2.10e-1)"	"prognostic unfavorable (2.41e-4)"	"unprognostic (2.46e-2)"	"unprognostic (6.42e-2)"	"unprognostic (3.44e-1)"	"unprognostic (3.17e-2)"	"unprognostic (3.53e-2)"	"prognostic unfavorable (1.84e-4)"	"unprognostic (1.41e-3)"	"unprognostic (1.38e-1)"	"unprognostic (2.57e-1)"	"unprognostic (1.61e-1)"	31.6	21.1	18.3	27.4	29.0	22.6	28.9	33.1	23.0	33.4	25.3	17.0	22.0	17.1	32.3	24.1	47.6	22.7	22.4	28.1	16.9	14.4	21.8	30.9	29.5	32.9	21.6	17.8	31.6	15.4	25.3	31.5	41.3	21.5	28.8	22.3	24.8	25.7	22.6	48.0	24.2	25.2	33.8	20.4	28.9	20.0	34.1	21.8	60.4	28.5	25.5	32.9	30.0	35.1	10.0	10.1	46.1	14.5	14.0	14.6	10.5	18.4	12.7	34.2	15.3	24.9	32.9	33.1	31.0	31.3	31.9	29.3	26.2	22.2	26.2	14.1	32.2	18.1	23.3	21.0	28.6	40.9	26.8	15.5	35.6	18.4	19.8	24.2	29.1	27.8	29.2	32.7	38.9	33.8	36.4	38.2	19.2	27.0	25.4	32.2	15.1	18.6	27.9	32.3	20.3	18.2	27.7	25.3	21.7	29.3	38.5	20.4	19.1	25.3	18.6	24.8	38.8	21.6	35.4	34.4	34.2	20.6	20.9	17.5	20.2	21.3	35.8	21.2	17.6	31.8	24.8	10.3	20.6	11.1	10.6	13.3	10.0	12.1	12.6	10.1	9.7	14.6	14.1	46.1	14.0	14.5	7.9	12.5	10.5	18.3	29.0	33.1	23.0	16.9	14.4	21.6	17.8	21.5	21.8	68.5	35.6	53.7	0.0	76.4	37.4	78.7	10.2	57.6	44.3	34.9	25.5	31.0	16.6	0.0	208.1	38.3	17.5	23.3	0.0	29.9	37.4	0.0	53.3	28.0	29.4	46.1	27.6	52.2	38.4	46.0	45.8	42.0	21.9	0.0	24.9	38.9	0.0	17.5	38.5	32.1	34.2	58.2	45.3	77.0	31.7	79.3	37.0	41.5	21.9	0.0
MARCH8	"c-MIR, CMIR, MARCH-VIII, MIR, RNF178"	ENSG00000165406	"Membrane associated ring-CH-type finger 8"	Q5T0T0	10	45454585-45594906	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Adaptive immunity, Immunity, Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	20	"Cone photoreceptor cells: 106.0;Early spermatids: 508.4;Late spermatids: 175.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			HPA014597	Approved					NA	NA					"HPA014597: AB_1853580"	"unprognostic (1.38e-1)"	"unprognostic (3.69e-2)"	"unprognostic (1.74e-1)"	"unprognostic (1.68e-3)"	"unprognostic (1.32e-1)"	"unprognostic (2.01e-2)"	"unprognostic (3.51e-1)"	"unprognostic (2.58e-1)"	"unprognostic (1.56e-2)"	"unprognostic (2.04e-1)"	"prognostic favorable (2.71e-4)"	"unprognostic (1.28e-1)"	"prognostic favorable (6.64e-4)"	"unprognostic (1.01e-1)"	"unprognostic (1.24e-1)"	"unprognostic (1.85e-1)"	"unprognostic (3.12e-2)"	10.0	17.6	13.5	11.4	16.0	28.8	12.1	37.5	12.2	10.3	14.6	24.5	8.5	9.7	14.3	8.2	7.5	11.1	9.9	14.1	12.7	11.8	11.0	16.7	10.3	13.5	19.0	9.3	14.2	18.2	15.1	18.1	13.2	14.5	8.8	12.9	12.9	11.5	11.4	9.0	8.9	18.8	12.4	18.2	14.3	9.7	43.2	14.9	10.5	11.5	8.5	13.6	11.0	8.0	5.3	1.7	13.6	1.8	7.3	4.7	2.4	9.3	9.4	8.0	7.1	11.7	14.6	6.0	4.3	20.1	7.9	8.7	2.4	9.7	13.4	7.4	12.4	7.2	1.7	8.7	7.3	7.4	20.3	9.6	5.2	4.3	5.6	8.1	6.2	23.0	11.9	9.5	4.0	10.7	7.9	12.9	12.9	14.5	13.2	6.1	3.3	6.3	4.0	2.6	1.3	3.0	7.1	8.0	3.9	6.0	5.4	7.1	9.9	8.4	2.0	8.0	8.2	12.4	2.9	8.8	6.3	8.1	9.1	6.7	23.3	18.6	5.9	12.3	8.7	1.6	9.7	1.1	10.0	3.1	1.8	4.7	3.5	3.4	3.3	1.6	5.3	2.7	3.3	13.6	7.3	0.9	1.7	3.1	2.4	13.5	16.0	37.5	12.2	12.7	11.8	19.0	9.3	14.5	14.9	8.9	7.5	13.4	0.0	3.1	6.6	21.0	10.2	6.7	12.5	10.4	106.0	1.7	5.0	0.0	508.4	8.7	20.2	70.0	0.0	1.1	5.6	0.0	17.3	22.5	5.4	11.1	39.0	12.9	15.9	175.4	7.8	7.0	5.0	0.0	11.9	6.3	0.0	10.4	8.5	9.9	23.0	6.5	2.8	21.5	13.4	3.3	1.4	8.3	11.2	0.0
MARCH9	"FLJ36578, RNF179"	ENSG00000139266	"Membrane associated ring-CH-type finger 9"	Q86YJ5	12	57755098-57760407	"Enzymes, Predicted membrane proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"Bipolar cells: 72.9;Cone photoreceptor cells: 119.8;Horizontal cells: 54.0;Muller glia cells: 63.3;Rod photoreceptor cells: 188.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enriched"	"Detected in many"	12	"RH-30: 110.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA						"unprognostic (2.96e-2)"	"unprognostic (6.78e-2)"	"unprognostic (1.90e-3)"	"prognostic favorable (3.07e-4)"	"unprognostic (2.16e-1)"	"unprognostic (6.85e-2)"	"unprognostic (8.15e-3)"	"prognostic favorable (1.54e-5)"	"unprognostic (7.76e-2)"	"prognostic favorable (1.59e-4)"	"unprognostic (1.08e-2)"	"unprognostic (1.06e-1)"	"prognostic favorable (2.98e-5)"	"unprognostic (2.44e-1)"	"unprognostic (2.86e-1)"	"unprognostic (2.45e-1)"	"unprognostic (1.34e-1)"	5.9	11.8	11.0	10.7	14.1	6.1	8.8	25.0	16.6	9.5	9.3	7.8	17.5	10.1	6.8	11.9	8.3	9.6	14.3	12.2	10.8	9.9	16.9	5.6	16.5	16.6	7.7	11.0	6.4	14.4	26.3	24.6	10.3	7.4	11.0	9.0	16.8	12.3	17.6	10.5	13.4	12.7	7.0	6.1	19.4	11.6	5.2	6.8	37.6	20.2	6.2	17.8	9.2	7.7	6.8	11.0	2.2	0.7	3.0	6.1	1.3	3.1	1.5	2.4	2.6	0.2	0.0	3.2	0.4	3.3	1.9	1.8	2.0	2.5	7.6	2.6	0.0	3.2	2.8	4.0	3.4	1.2	4.5	4.4	1.0	1.1	1.0	2.3	0.9	1.6	0.4	3.5	0.5	1.9	5.6	0.8	7.7	1.4	7.9	0.5	2.9	4.8	1.1	1.6	2.2	3.4	4.0	110.2	8.2	3.7	2.7	5.6	3.6	0.2	0.2	2.0	1.2	5.6	1.8	0.0	2.4	2.0	1.3	1.5	8.9	4.0	4.7	2.7	0.2	2.4	2.2	0.5	0.1	4.0	0.7	5.9	5.3	6.0	5.2	1.5	6.8	6.1	4.6	0.2	3.0	0.2	11.0	3.6	1.3	11.0	14.1	25.0	16.6	10.8	9.9	7.7	11.0	7.4	6.8	20.8	12.3	17.1	0.0	9.2	72.9	9.4	12.7	1.4	5.7	8.7	119.8	1.6	5.0	0.0	0.3	7.3	5.3	0.0	0.0	0.7	3.1	0.0	2.3	3.9	6.6	54.0	14.6	12.3	1.2	0.8	9.2	3.3	6.8	0.0	8.0	63.3	0.0	2.9	10.6	7.0	188.1	6.5	4.7	2.3	3.4	8.3	0.9	10.1	11.0	0.0
MARK1	"MARK, PAR-1C"	ENSG00000116141	"Microtubule affinity regulating kinase 1"	Q9P0L2	1	220528183-220664461	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Wnt signaling pathway"	"Kinase, Serine/threonine-protein kinase, Transferase"	"Autism, Autism spectrum disorder"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	7	"Bipolar cells: 23.6;Cardiomyocytes: 19.9;Cone photoreceptor cells: 29.5;Spermatocytes: 17.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"RT4: 35.7;SuSa: 11.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007421, HPA008061"	Uncertain					NA	NA					"HPA007421: AB_1079311, HPA008061: AB_1079310"	"unprognostic (1.51e-1)"	"unprognostic (6.27e-2)"	"unprognostic (6.72e-2)"	"unprognostic (3.63e-2)"	"unprognostic (2.23e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.54e-2)"	"unprognostic (3.48e-1)"	"prognostic unfavorable (2.63e-4)"	"unprognostic (4.59e-2)"	"prognostic favorable (2.23e-5)"	"unprognostic (6.62e-2)"	"unprognostic (4.27e-2)"	"unprognostic (9.56e-3)"	"unprognostic (3.35e-2)"	"unprognostic (1.72e-1)"	"unprognostic (3.74e-2)"	14.3	5.6	11.4	4.6	13.5	0.9	9.0	15.2	22.7	9.8	6.7	4.7	6.4	2.1	7.8	26.6	9.4	5.9	5.0	19.1	10.0	12.5	4.7	1.5	4.8	2.3	10.3	12.4	3.7	3.0	5.8	12.1	3.9	13.2	7.2	4.1	6.2	5.0	11.3	4.2	3.5	3.4	10.1	7.1	3.2	4.3	16.0	4.6	0.4	8.4	5.3	5.7	8.8	14.9	0.8	0.0	0.0	0.0	0.0	0.3	0.1	0.7	0.0	4.5	1.2	0.0	0.0	1.9	1.5	2.2	1.6	2.4	0.0	0.0	0.0	0.0	0.0	3.3	2.3	9.5	6.2	1.1	0.0	7.0	0.0	2.4	0.0	0.0	0.7	0.9	0.7	5.3	0.0	2.9	0.8	0.2	2.3	0.0	0.0	0.0	0.0	0.0	0.0	8.8	4.5	2.2	0.0	7.1	0.0	0.0	35.7	6.6	5.8	0.3	0.3	0.4	11.1	0.7	0.0	0.0	0.0	3.5	4.8	6.2	0.0	0.0	0.0	1.4	0.0	3.3	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	11.4	13.5	15.2	17.5	10.0	12.5	10.3	12.4	13.2	4.6	0.0	0.3	0.5	2.4	3.1	23.6	19.9	0.0	1.4	2.3	3.5	29.5	1.7	0.0	1.6	5.5	3.0	1.1	0.0	0.0	1.8	3.1	1.7	0.0	0.0	0.2	9.5	8.6	4.3	0.3	3.0	2.0	0.0	0.0	0.0	0.2	15.1	0.1	0.0	6.0	0.0	10.6	0.0	15.1	17.9	5.2	2.9	0.8	0.0	0.4	3.9
MARK2	"EMK1, PAR-1, PAR-1B, Par1b"	ENSG00000072518	"Microtubule affinity regulating kinase 2"	Q7KZI7	11	63838928-63911019	"Enzymes, Predicted intracellular proteins"	"Differentiation, Wnt signaling pathway"	"Developmental protein, Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038790, HPA074905"	Approved		Supported	"Nucleoplasm,Plasma membrane"		NA	NA			"Plasma membrane"	Nucleoplasm	"HPA038790: AB_10674840, HPA074905: AB_2686722"	"unprognostic (1.33e-2)"	"unprognostic (2.45e-2)"	"unprognostic (1.64e-1)"	"prognostic unfavorable (3.21e-4)"	"unprognostic (7.13e-2)"	"unprognostic (3.82e-2)"	"prognostic unfavorable (1.30e-4)"	"unprognostic (2.73e-3)"	"unprognostic (4.41e-1)"	"unprognostic (5.79e-2)"	"unprognostic (3.94e-3)"	"unprognostic (3.77e-1)"	"unprognostic (5.20e-3)"	"unprognostic (5.15e-3)"	"unprognostic (6.78e-2)"	"unprognostic (1.03e-1)"	"unprognostic (2.40e-1)"	9.7	11.6	16.5	16.3	21.4	18.5	13.8	24.7	26.1	15.2	20.5	20.0	11.1	21.3	13.6	7.5	48.4	13.6	14.4	14.7	17.0	10.1	11.9	12.4	15.4	16.3	18.1	13.7	11.0	17.3	21.8	22.4	21.1	15.0	14.9	19.8	10.6	20.7	14.3	15.7	35.8	26.9	13.3	13.3	21.6	16.8	9.8	18.7	22.9	15.9	13.6	23.5	14.8	21.3	2.9	1.9	9.8	1.9	3.3	4.5	1.2	22.7	15.2	12.5	13.1	6.9	9.0	17.3	9.3	8.9	13.4	10.4	16.3	24.1	16.8	16.4	9.7	14.5	29.5	12.0	14.5	11.6	11.6	9.4	18.5	12.0	10.6	7.7	20.1	24.5	4.9	19.8	12.3	10.7	6.3	11.0	15.9	15.7	19.4	8.8	28.0	21.0	14.3	14.2	18.4	11.1	17.4	9.3	18.6	10.0	18.8	17.2	11.6	16.0	41.1	10.7	14.0	29.9	12.0	10.4	14.2	8.9	18.3	10.3	11.8	12.2	16.5	9.7	10.6	11.3	2.7	1.7	4.4	2.9	1.5	4.5	2.3	3.2	3.1	1.9	2.9	2.6	2.4	9.8	3.3	1.9	1.7	1.5	1.2	16.5	21.4	24.7	26.1	17.0	10.1	18.1	13.7	15.0	18.7	6.0	5.0	13.9	16.2	22.3	26.0	10.9	35.7	6.7	6.8	19.2	7.9	19.2	1.7	18.5	0.4	11.9	59.3	0.0	18.5	16.8	10.6	28.8	17.3	12.1	15.7	19.1	28.7	13.5	19.5	0.7	11.8	11.3	3.3	8.2	35.1	19.1	20.0	35.9	10.3	6.9	17.8	19.4	9.2	8.4	21.8	30.1	54.3	23.6	28.2	30.9
MARK3	"CTAK1, KP78, PAR-1A"	ENSG00000075413	"Microtubule affinity regulating kinase 3"	P27448	14	103385392-103503831	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	14	"eosinophil: 42.2"	"Lineage enriched"	"Detected in many"	23	"granulocytes: 42.2"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA024652	Approved					NA	NA					"HPA024652: AB_1853582"	"unprognostic (6.86e-2)"	"unprognostic (2.93e-1)"	"unprognostic (7.70e-2)"	"unprognostic (3.48e-2)"	"unprognostic (8.41e-2)"	"unprognostic (1.50e-1)"	"unprognostic (2.31e-3)"	"unprognostic (2.21e-1)"	"prognostic unfavorable (1.14e-4)"	"unprognostic (2.29e-3)"	"unprognostic (3.66e-2)"	"unprognostic (1.55e-2)"	"unprognostic (1.13e-1)"	"unprognostic (4.71e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.33e-2)"	"unprognostic (1.60e-1)"	20.8	31.9	24.6	20.9	29.5	62.7	19.7	59.1	30.2	25.3	20.8	33.2	19.9	17.4	28.5	28.4	24.4	23.1	22.2	33.6	24.9	22.4	20.3	20.1	25.9	20.8	29.6	23.3	24.6	30.7	28.1	30.9	20.5	27.4	19.3	20.0	23.6	18.3	23.1	40.9	19.9	19.2	26.8	20.9	26.8	26.9	24.1	30.3	29.1	25.8	23.1	23.0	20.8	29.0	1.2	1.2	42.2	1.1	0.8	1.8	0.4	13.4	16.3	23.7	17.9	28.5	22.3	20.5	23.8	25.2	28.9	27.8	12.8	21.1	16.0	15.1	22.4	12.5	25.3	25.9	25.7	36.9	18.6	11.5	20.7	17.3	16.0	53.8	23.5	13.8	25.9	23.8	23.4	47.9	26.4	26.7	16.0	21.2	37.4	21.6	36.0	16.1	20.9	17.4	22.7	24.6	21.1	24.3	12.8	25.5	28.6	20.9	20.9	25.3	17.4	23.2	28.1	23.6	20.2	23.0	15.5	11.1	28.9	21.2	24.2	30.7	19.2	18.9	19.0	20.9	0.4	1.1	42.2	1.1	0.8	0.9	1.2	1.6	1.8	1.1	0.9	1.8	1.4	3.1	0.8	0.7	1.2	1.6	0.4	24.6	29.5	59.1	30.2	24.9	22.4	29.6	23.3	27.4	30.3	53.6	64.4	40.2	43.5	39.3	70.1	69.8	35.7	25.4	52.4	36.6	153.2	26.8	10.0	40.4	26.7	50.1	30.4	186.9	36.6	26.3	42.6	53.5	47.3	26.8	26.4	55.6	30.0	47.3	26.0	38.0	56.4	44.1	35.4	50.5	28.7	36.1	46.0	29.2	55.5	15.8	90.5	32.3	43.7	40.2	55.6	45.7	41.1	42.6	28.4	99.3
MARK4	"FLJ90097, KIAA1860, MARKL1, Nbla00650, PAR-1D"	ENSG00000007047	"Microtubule affinity regulating kinase 4"	Q96L34	19	45079288-45305283	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Cell cycle, Cell division, Cilium biogenesis/degradation, Mitosis"	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	5	"Horizontal cells: 112.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039186	Approved		Supported	Cytosol		NA	NA			Cytosol		"HPA039186: AB_10796223"	"unprognostic (1.64e-1)"	"unprognostic (1.95e-1)"	"unprognostic (1.57e-3)"	"prognostic unfavorable (8.31e-8)"	"unprognostic (2.02e-1)"	"prognostic unfavorable (3.05e-5)"	"unprognostic (1.90e-1)"	"unprognostic (2.16e-2)"	"unprognostic (6.26e-2)"	"unprognostic (5.64e-3)"	"unprognostic (1.24e-3)"	"unprognostic (7.50e-2)"	"unprognostic (3.80e-2)"	"unprognostic (6.89e-2)"	"unprognostic (7.23e-2)"	"unprognostic (4.65e-2)"	"unprognostic (3.02e-2)"	11.8	13.0	19.4	10.3	26.0	8.4	15.2	21.9	28.6	11.4	10.2	9.0	12.9	6.6	14.0	17.5	13.5	12.9	13.4	14.7	22.2	15.7	8.7	13.5	11.7	10.5	14.3	21.6	21.0	16.8	13.7	12.9	12.1	15.0	12.2	6.3	14.1	12.1	14.2	40.7	20.6	7.5	14.1	10.8	12.4	10.3	32.1	12.3	11.2	10.5	11.5	9.4	13.7	17.9	1.0	2.8	3.5	2.9	1.8	4.3	1.2	8.9	3.8	15.1	11.0	10.8	17.2	4.2	6.6	10.4	9.9	9.3	2.3	5.1	4.3	5.7	12.1	8.2	6.1	10.7	9.7	5.6	7.9	8.8	8.6	4.7	8.2	19.9	2.1	7.5	21.4	13.8	8.3	9.6	17.5	13.2	9.6	10.9	10.8	10.7	7.5	7.6	6.7	6.5	7.4	3.3	29.6	4.9	2.8	9.3	7.2	28.4	12.5	9.8	8.7	5.1	15.3	4.1	12.5	10.7	8.9	6.8	6.0	4.3	12.1	9.6	4.9	9.5	4.0	7.1	3.5	2.9	0.7	3.4	2.2	0.7	0.9	1.2	4.3	0.8	1.0	2.3	2.6	2.9	1.8	2.0	2.8	2.4	1.2	19.4	26.0	21.9	22.7	22.2	15.7	14.3	21.6	15.0	12.3	11.9	1.9	3.0	9.5	22.1	20.9	7.3	10.2	0.0	2.3	8.7	23.6	3.3	10.0	7.8	2.1	10.5	3.3	0.0	5.3	1.1	7.5	8.5	2.3	10.9	5.8	112.8	5.8	18.4	8.4	4.1	15.0	6.1	3.3	2.8	6.0	13.2	7.3	3.2	13.1	5.6	14.6	0.0	7.3	0.5	6.1	21.1	9.6	6.9	3.4	14.0
MARS	"CMT2U, MetRS, SPG70"	ENSG00000166986	"Methionyl-tRNA synthetase"	P56192	12	57475445-57517569	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Protein biosynthesis"	"Aminoacyl-tRNA synthetase, Ligase, RNA-binding, tRNA-binding"	"Charcot-Marie-Tooth disease, Disease mutation, Neurodegeneration, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"RH-30: 118.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004125, CAB017097"	Supported	Approved	Enhanced	Cytosol		NA	NA		21000	Cytosol		"CAB017097: , HPA004125: AB_1079312"	"prognostic unfavorable (1.73e-4)"	"unprognostic (2.21e-1)"	"unprognostic (1.56e-1)"	"unprognostic (1.09e-1)"	"unprognostic (1.57e-2)"	"unprognostic (4.90e-3)"	"prognostic unfavorable (4.55e-7)"	"unprognostic (8.47e-2)"	"unprognostic (1.73e-1)"	"unprognostic (4.03e-2)"	"unprognostic (2.85e-2)"	"unprognostic (3.77e-2)"	"prognostic unfavorable (1.59e-4)"	"unprognostic (1.13e-2)"	"unprognostic (1.96e-1)"	"unprognostic (1.13e-1)"	"unprognostic (2.06e-2)"	23.8	26.7	35.1	27.3	29.1	23.0	19.8	25.1	36.0	17.4	23.9	23.1	23.9	17.3	23.3	36.3	29.5	17.9	16.1	25.0	28.0	29.5	20.5	45.9	24.3	25.1	40.1	25.5	25.8	48.3	35.7	34.0	22.2	30.9	25.6	24.7	19.8	26.0	30.0	24.5	18.4	20.1	33.7	30.7	30.7	31.3	29.6	30.9	21.4	26.9	22.3	34.3	24.3	27.9	12.9	29.3	19.0	27.0	14.1	18.9	15.5	16.8	23.4	15.7	27.1	17.6	10.7	28.9	24.1	28.2	25.5	27.3	25.1	18.7	29.6	16.0	29.2	15.9	19.2	35.7	31.1	26.8	25.6	15.5	20.9	8.7	14.1	39.2	31.4	24.0	15.5	48.4	29.2	75.7	12.2	18.2	37.8	32.3	63.4	17.7	23.3	28.1	23.7	29.6	27.0	25.8	24.4	118.3	30.6	19.2	13.2	20.9	21.3	12.5	19.3	33.4	18.4	25.4	41.2	13.5	9.2	27.3	13.3	14.3	58.2	58.8	35.7	22.7	23.9	31.5	12.1	14.6	19.0	18.9	27.0	17.2	12.9	12.9	17.1	29.3	7.7	11.1	15.2	7.2	14.1	21.8	28.4	13.1	15.5	35.1	29.1	25.1	36.0	28.0	29.5	40.1	25.5	30.9	30.9	35.7	22.7	29.8	15.6	16.6	14.8	10.1	12.7	28.1	29.6	17.4	31.4	24.6	5.0	32.2	19.0	13.7	11.1	0.0	39.9	18.6	15.5	18.1	26.7	11.3	17.0	6.4	14.5	8.0	12.0	6.6	12.0	22.6	3.3	32.5	10.3	11.5	33.5	14.0	14.2	9.8	28.8	12.9	17.9	33.4	34.1	14.1	31.8	20.3	9.7	23.1
MARS2	"mtMetRS, SPAX3"	ENSG00000247626	"Methionyl-tRNA synthetase 2, mitochondrial"	Q96GW9	2	197705369-197708387	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Protein biosynthesis"	"Aminoacyl-tRNA synthetase, Ligase"	"Deafness, Disease mutation, Neurodegeneration, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"Basal keratinocytes: 15.1;Suprabasal keratinocytes: 16.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035589, HPA035590"	Uncertain					NA	NA					"HPA035589: AB_10601870, HPA035590: AB_2674693"	"unprognostic (2.12e-1)"	"unprognostic (3.48e-2)"	"unprognostic (1.24e-2)"	"prognostic unfavorable (3.50e-4)"	"prognostic favorable (1.12e-4)"	"unprognostic (2.99e-2)"	"unprognostic (2.35e-2)"	"unprognostic (1.53e-1)"	"unprognostic (7.61e-2)"	"unprognostic (1.04e-1)"	"unprognostic (9.54e-2)"	"unprognostic (1.86e-3)"	"prognostic favorable (6.14e-5)"	"unprognostic (1.26e-2)"	"unprognostic (3.11e-1)"	"unprognostic (1.47e-2)"	"unprognostic (8.74e-2)"	5.9	12.1	5.8	8.4	11.4	6.0	9.9	9.6	10.6	3.8	10.0	6.9	3.3	8.9	5.3	3.0	12.3	4.9	5.1	7.7	7.8	5.0	7.9	14.1	4.9	12.1	17.8	5.5	4.0	14.6	6.7	3.4	5.0	9.3	4.5	9.9	3.2	11.4	6.0	12.1	7.4	8.8	5.1	10.8	10.9	7.7	5.5	12.0	6.1	6.0	9.9	12.3	6.3	5.4	4.1	4.8	0.8	4.8	9.9	8.1	4.3	3.8	4.6	4.5	7.5	4.3	2.1	8.4	2.9	2.3	5.7	4.3	11.9	3.6	24.4	4.4	1.7	3.0	7.3	15.6	6.4	6.1	6.6	9.1	14.9	5.3	10.4	4.0	21.9	7.2	2.2	8.2	3.8	6.6	1.5	3.7	7.2	17.4	8.8	3.2	6.5	11.1	10.4	7.7	9.0	11.9	11.5	4.7	17.1	6.8	6.9	7.9	3.8	3.7	10.1	6.6	6.1	4.3	7.7	2.9	4.7	3.7	3.5	8.6	5.8	4.3	20.1	3.5	13.4	4.3	0.0	3.0	0.8	5.5	4.8	6.5	3.5	4.6	4.9	4.8	4.1	7.6	8.1	0.1	9.9	2.3	3.4	8.0	4.3	5.8	11.4	9.6	10.6	7.8	5.0	17.8	5.5	9.3	12.0	0.0	0.6	3.2	4.0	15.1	1.5	1.6	0.0	1.4	1.2	3.5	0.0	1.6	5.0	2.4	2.1	1.6	1.2	0.0	1.5	0.9	1.5	1.2	4.6	6.7	2.2	0.0	0.0	1.8	1.3	0.0	1.4	0.9	5.0	1.8	1.9	0.8	1.2	2.9	0.4	3.7	2.5	0.0	2.7	3.1	2.9	16.6	0.7	4.4	4.2	3.9
MASP1	"CRARF, MASP, PRSS5"	ENSG00000127241	"Mannan binding lectin serine peptidase 1"	P48740	3	187217285-187292022	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins"	"Complement activation lectin pathway, Immunity, Innate immunity"	"Hydrolase, Protease, Serine protease"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"cervix, uterine: 43.4;liver: 80.1"	"Cell type enhanced"	"Detected in some"	15	"Cardiomyocytes: 32.5;Cholangiocytes: 28.1;Hepatocytes: 57.1;Ito cells: 30.7"	"Group enriched"	"Detected in some"	9	"glioma: 6.8;liver cancer: 7.7;prostate cancer: 3.0;renal cancer: 3.9"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	8	"BJ: 27.1;BJ hTERT+: 103.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001617, HPA009641"	Supported		Enhanced	Nucleoplasm,Cytosol	"Secreted to blood"	No	NA	8670000000	1800000000	"Nucleoplasm, Cytosol"		"HPA001617: AB_1079314, HPA009641: AB_1079313"	"unprognostic (1.67e-1)"	"unprognostic (1.02e-2)"	"unprognostic (1.99e-1)"	"unprognostic (5.20e-2)"	"unprognostic (1.02e-2)"	"unprognostic (1.25e-6)"	"prognostic favorable (2.20e-4)"	"unprognostic (9.92e-2)"	"unprognostic (3.22e-1)"	"unprognostic (2.29e-1)"	"unprognostic (4.18e-1)"	"unprognostic (1.29e-1)"	"unprognostic (2.82e-3)"	"unprognostic (3.56e-3)"	"unprognostic (1.97e-1)"	"unprognostic (7.85e-2)"	"unprognostic (4.29e-1)"	2.1	1.4	3.6	1.2	3.8	0.1	1.2	1.9	10.2	43.4	19.1	14.8	2.4	0.8	34.9	7.1	4.1	6.7	3.3	39.6	6.1	2.5	1.6	80.1	2.2	0.4	6.4	3.0	1.7	0.2	0.2	0.5	3.2	13.0	17.4	2.1	0.1	0.9	19.4	12.2	2.5	2.6	17.1	21.8	0.4	0.6	1.5	6.7	0.0	1.3	6.3	3.5	4.4	24.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.3	3.7	0.0	27.1	103.4	0.4	0.1	0.0	0.0	0.0	0.0	8.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.4	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.6	3.8	1.9	3.5	6.1	2.5	6.4	3.0	13.0	6.7	0.0	2.6	0.0	0.1	2.6	0.0	32.5	28.1	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.6	0.7	0.0	0.0	0.0	0.2	11.0	0.0	0.0	57.1	0.4	0.0	0.0	30.7	2.4	3.8	2.3	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.7	2.2	0.0	0.0	5.9	0.0	0.0	1.5	0.1	0.5	0.0	0.1
MASP2	MASP1P1	ENSG00000009724	"Mannan binding lectin serine peptidase 2"	O00187	1	11026523-11047233	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted secreted proteins"	"Complement pathway, Immunity, Innate immunity"	"Hydrolase, Protease, Serine protease"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	98	"liver: 185.1"	"Cell type enriched"	"Detected in some"	68	"Hepatocytes: 541.9"	"Cancer enriched"	"Detected in some"	71	"liver cancer: 41.9"	"Region enriched"	"Detected in single"	4	"cerebellum: 1.7"	"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enriched"	"Detected in many"	7	"Hep G2: 20.5"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"HPA029313, HPA029314"	Uncertain		Supported	"Golgi apparatus"	"Secreted to blood"	NA	NA	340000000	880000000	"Golgi apparatus"		"HPA029313: AB_10669654, HPA029314: AB_10670029"	"unprognostic (7.00e-2)"	"unprognostic (8.37e-2)"	"unprognostic (2.75e-2)"	"unprognostic (2.89e-1)"	"unprognostic (1.86e-1)"	"unprognostic (3.26e-3)"	"prognostic favorable (1.60e-4)"	"unprognostic (2.92e-3)"	"unprognostic (3.13e-2)"	"unprognostic (4.04e-2)"	"unprognostic (6.90e-3)"	"unprognostic (8.30e-4)"	"unprognostic (7.14e-2)"	"unprognostic (3.91e-1)"	"unprognostic (2.62e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.09e-4)"	0.3	0.2	0.3	0.4	0.3	1.8	0.3	1.7	0.5	0.3	0.3	0.3	0.3	0.3	0.4	0.3	0.3	0.4	0.3	0.3	0.3	0.1	0.3	185.1	0.3	0.6	0.3	0.3	0.5	0.4	0.0	0.3	0.3	0.3	0.3	0.0	0.3	0.7	0.3	1.4	1.4	0.5	0.3	0.3	0.6	0.3	0.3	0.3	0.3	0.3	0.3	0.3	0.3	0.3	1.4	1.2	1.2	0.2	0.8	1.3	0.0	0.5	0.3	2.9	1.6	0.0	0.1	0.5	0.8	0.0	0.0	0.0	1.3	1.1	2.4	0.7	0.0	0.6	0.7	0.0	0.0	0.0	0.6	2.3	1.4	2.6	20.5	0.0	2.2	1.7	0.0	0.0	0.1	0.0	2.0	0.0	1.9	0.8	0.5	0.0	0.6	0.6	1.2	0.4	0.2	0.6	1.8	1.0	0.5	0.0	1.4	1.8	0.7	0.9	0.5	0.5	1.8	0.6	1.3	1.2	0.9	0.6	1.0	0.6	0.8	1.1	1.7	0.6	1.9	0.4	1.2	0.2	1.1	0.7	0.1	1.0	0.7	0.9	0.8	0.5	1.4	1.3	1.3	0.2	0.8	0.2	1.2	0.1	0.0	0.3	0.3	1.7	0.3	0.3	0.1	0.3	0.3	0.3	0.3	0.0	0.0	3.4	0.2	0.8	0.0	0.4	2.5	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	1.1	541.9	0.1	0.0	0.0	8.0	7.0	0.0	0.0	0.0	1.7	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.1
MAST1	"KIAA0973, SAST"	ENSG00000105613	"Microtubule associated serine/threonine kinase 1"	Q9Y2H9	19	12833951-12874951	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"	"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"brain: 51.0"	"Cell type enhanced"	"Detected in many"	13	"Bipolar cells: 22.6;Cone photoreceptor cells: 41.2;Early spermatids: 13.0;Horizontal cells: 14.3;Rod photoreceptor cells: 18.7"	"Cancer enhanced"	"Detected in many"		"glioma: 3.5"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	6	"MAIT T-cell: 3.6;T-reg: 2.0"	"Lineage enriched"	"Detected in single"	8	"T-cells: 3.6"	"Cell line enhanced"	"Detected in many"		"AN3-CA: 15.0;SCLC-21H: 26.5;SH-SY5Y: 13.2;U-266/70: 10.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028181, HPA073106"	Enhanced		Supported	Vesicles,Cytosol		NA	NA			Vesicles	Cytosol	"HPA028181: AB_10603872, HPA073106: AB_2732218"	"unprognostic (6.32e-2)"	"unprognostic (3.66e-2)"	"unprognostic (3.93e-2)"	"unprognostic (2.83e-5)"	"unprognostic (1.72e-1)"	"unprognostic (4.19e-2)"	"unprognostic (2.38e-1)"	"unprognostic (8.72e-2)"	"unprognostic (1.04e-1)"	"unprognostic (3.64e-1)"	"unprognostic (8.89e-3)"	"unprognostic (3.43e-2)"	"unprognostic (3.84e-3)"	"unprognostic (1.19e-1)"	"unprognostic (7.04e-2)"	"unprognostic (2.49e-2)"	"unprognostic (1.96e-1)"	1.2	5.2	20.4	1.7	13.6	1.6	1.5	51.0	40.1	1.1	1.5	1.4	0.0	1.7	1.3	1.2	1.3	1.2	1.6	1.3	16.1	16.3	1.2	1.3	1.2	1.3	8.8	19.5	1.5	1.6	1.2	10.4	1.2	19.9	1.2	1.3	1.6	1.3	1.2	1.2	4.1	1.6	1.3	4.2	1.2	1.5	3.9	2.7	0.0	1.2	0.0	1.3	1.2	0.2	0.4	0.0	0.0	0.2	0.0	3.6	0.1	2.2	1.0	1.0	15.0	0.0	0.0	1.2	0.1	0.1	0.2	0.6	0.5	0.9	3.6	1.7	0.0	2.5	0.0	4.4	0.0	0.0	2.5	2.9	0.3	3.6	1.6	0.0	0.8	0.8	0.3	0.0	0.5	0.5	0.8	0.0	9.8	3.1	1.9	0.0	0.5	1.5	0.4	4.5	0.4	4.6	9.9	3.0	5.1	0.2	0.1	26.5	13.2	0.5	0.9	2.7	0.8	2.4	1.3	0.0	1.8	2.8	2.0	0.5	10.8	8.6	2.1	3.3	2.0	0.1	0.0	0.2	0.0	0.0	0.2	3.6	0.1	0.0	0.2	0.0	0.4	0.0	0.4	0.0	0.0	0.1	0.0	2.0	0.1	20.4	13.6	51.0	34.3	16.1	16.3	8.8	19.5	19.9	2.7	0.0	3.7	0.0	1.9	0.8	22.6	0.8	0.0	1.4	0.0	0.0	41.2	0.4	0.0	0.1	13.0	1.0	0.7	0.0	0.4	0.4	0.7	0.9	1.1	0.8	0.2	14.3	0.0	0.6	1.2	6.5	0.6	1.0	5.0	0.0	0.0	3.6	0.3	2.9	1.1	0.1	18.7	0.0	0.8	2.8	4.1	1.3	0.2	1.0	0.4	0.6
MAST2	"KIAA0807, MAST205"	ENSG00000086015	"Microtubule associated serine/threonine kinase 2"	Q6P0Q8	1	45786987-46036124	"Cancer-related genes, Enzymes, Predicted membrane proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 83.3"	"Cell type enhanced"	"Detected in many"	5	"Cardiomyocytes: 43.3;Cone photoreceptor cells: 51.1;Enterocytes: 45.1;Late spermatids: 44.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"non-classical monocyte: 4.3"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039722, HPA040155"	Approved		Approved	Cytosol		NA	NA			Cytosol		"HPA039722: AB_10795294, HPA040155: AB_10793957"	"unprognostic (7.80e-2)"	"unprognostic (3.02e-2)"	"unprognostic (5.77e-2)"	"unprognostic (1.52e-1)"	"unprognostic (3.82e-1)"	"unprognostic (3.17e-2)"	"prognostic unfavorable (4.31e-8)"	"unprognostic (8.86e-2)"	"unprognostic (2.34e-2)"	"unprognostic (1.98e-1)"	"unprognostic (1.60e-1)"	"unprognostic (1.75e-1)"	"prognostic unfavorable (6.85e-13)"	"unprognostic (4.82e-3)"	"unprognostic (2.43e-1)"	"unprognostic (9.73e-2)"	"unprognostic (4.90e-1)"	8.9	4.3	7.0	9.9	8.1	3.7	7.1	7.1	11.8	13.6	15.2	8.4	6.6	11.2	16.7	7.7	8.8	9.5	9.9	25.5	5.0	7.6	4.8	6.1	5.9	4.4	8.9	7.3	19.8	3.6	9.1	10.5	5.5	10.1	13.9	13.9	7.2	8.3	8.6	83.3	5.5	21.3	14.9	5.8	2.5	9.0	24.8	4.8	3.5	5.7	27.4	7.5	16.3	10.6	0.5	1.9	1.4	4.3	1.4	1.4	0.5	14.9	12.1	12.3	9.4	16.1	23.1	13.6	16.0	11.6	14.8	16.5	13.9	4.9	23.4	7.5	19.5	30.0	7.4	14.8	9.1	15.7	11.2	8.0	10.6	13.7	12.7	14.0	5.6	13.6	17.7	11.8	24.8	19.8	18.6	13.8	6.1	8.1	7.2	17.6	10.2	8.2	5.8	10.1	10.1	13.9	12.2	20.6	4.4	7.7	8.1	17.1	10.1	18.8	24.6	8.0	14.1	11.2	5.6	13.4	28.7	18.5	14.9	15.8	9.7	8.7	8.5	19.1	7.7	11.8	0.0	1.1	1.4	1.4	0.6	1.4	0.2	0.7	1.4	1.9	0.5	0.5	1.0	0.0	1.4	4.3	0.1	0.0	0.5	7.0	8.1	7.1	11.8	5.0	7.6	8.9	7.3	10.1	4.8	0.0	1.3	0.0	4.2	3.8	14.9	43.3	2.5	1.4	7.9	3.5	51.1	4.4	1.7	4.2	27.6	5.3	45.1	0.0	5.4	4.0	6.6	7.8	0.0	5.6	5.5	4.8	11.6	3.1	1.6	44.9	8.3	6.4	6.8	1.0	18.3	3.0	6.7	26.6	9.6	4.2	12.7	6.5	6.1	28.4	11.7	2.4	4.6	1.9	18.1	6.0
MAST3	KIAA0561	ENSG00000099308	"Microtubule associated serine/threonine kinase 3"	O60307	19	18097793-18151692	"Enzymes, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 72.5"	"Cell type enhanced"	"Detected in many"	5	"Kupffer cells: 21.5;Late spermatids: 24.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035061, HPA035062"	Uncertain		Approved	"Nuclear speckles"		NA	NA			"Nuclear speckles"		"HPA035061: AB_10670585, HPA035062: AB_10671508"	"unprognostic (5.94e-3)"	"unprognostic (4.75e-2)"	"unprognostic (1.70e-1)"	"unprognostic (1.02e-1)"	"unprognostic (3.38e-1)"	"prognostic favorable (2.97e-4)"	"unprognostic (1.93e-1)"	"unprognostic (4.63e-2)"	"unprognostic (1.43e-1)"	"unprognostic (3.21e-1)"	"prognostic favorable (7.01e-4)"	"unprognostic (2.58e-1)"	"unprognostic (1.64e-3)"	"unprognostic (1.02e-2)"	"unprognostic (3.61e-1)"	"unprognostic (1.58e-3)"	"unprognostic (1.26e-3)"	4.6	3.5	20.7	8.3	36.1	12.3	1.8	1.1	72.5	3.8	5.3	19.0	0.2	9.1	3.6	4.9	2.2	4.9	3.1	2.1	19.7	9.3	3.6	6.4	4.6	9.9	13.0	33.6	4.6	14.3	7.1	7.7	2.6	13.0	2.7	4.4	0.7	4.6	4.2	2.6	6.9	8.8	3.0	7.9	11.4	3.9	2.1	12.5	1.8	2.4	0.3	9.4	3.3	2.4	4.4	10.3	23.2	9.7	5.8	8.4	3.1	3.3	5.0	2.3	10.1	6.8	5.5	5.5	3.4	2.2	2.4	3.5	5.0	4.7	8.7	5.2	3.4	2.6	1.8	3.3	1.9	1.7	7.4	4.1	4.0	5.2	7.9	5.8	2.1	13.3	6.3	5.7	3.6	1.4	3.3	1.1	6.0	4.0	5.7	2.7	6.0	4.4	7.0	2.4	7.4	6.2	12.1	2.0	6.4	1.8	1.5	3.8	6.2	4.8	2.8	2.0	1.7	3.2	4.9	4.0	3.1	3.3	13.0	1.4	6.2	8.4	8.0	6.8	11.2	2.8	0.1	4.5	9.4	8.4	5.6	6.2	4.1	4.7	3.3	2.1	4.4	3.7	6.4	23.2	5.8	9.7	10.3	5.0	3.1	20.7	36.1	1.1	72.5	19.7	9.3	13.0	33.6	13.0	12.5	6.0	10.3	7.8	0.7	0.5	3.2	1.1	7.6	0.0	3.4	8.7	2.0	0.5	3.3	2.8	9.1	1.6	20.0	0.0	9.2	1.2	2.2	0.8	2.3	12.5	6.9	0.0	2.4	7.4	21.5	24.6	3.7	7.9	5.0	6.4	6.9	0.8	6.1	8.6	6.3	8.7	0.6	0.0	1.8	0.6	2.8	1.9	0.3	9.6	8.6	0.6
MAST4	KIAA0303	ENSG00000069020	"Microtubule associated serine/threonine kinase family member 4"	O15021	5	66596361-67169595	"Enzymes, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	9	"Basal glandular cells: 428.6;Basal keratinocytes: 327.4;Glandular cells: 324.3;Suprabasal keratinocytes: 348.9;Urothelial cells: 641.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"basophil: 12.1"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HBEC3-KT: 17.8;HDLM-2: 22.6;HEL: 18.7;RT4: 22.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA000544	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"HPA000544: AB_1079315"	"unprognostic (1.77e-2)"	"unprognostic (6.24e-2)"	"unprognostic (1.80e-1)"	"unprognostic (4.99e-3)"	"unprognostic (2.83e-2)"	"prognostic favorable (5.18e-5)"	"unprognostic (9.01e-2)"	"unprognostic (1.00e-1)"	"unprognostic (2.79e-2)"	"unprognostic (9.47e-2)"	"unprognostic (5.03e-2)"	"unprognostic (3.01e-2)"	"unprognostic (1.01e-2)"	"unprognostic (1.37e-2)"	"unprognostic (2.63e-1)"	"unprognostic (2.63e-1)"	"unprognostic (3.08e-2)"	16.2	12.9	10.2	6.9	11.8	2.5	12.6	6.2	19.4	13.9	6.9	6.3	6.3	6.3	14.4	8.9	31.2	11.6	9.7	24.5	9.9	8.1	14.2	9.5	13.1	5.0	6.5	9.2	20.2	5.9	35.6	16.7	18.4	11.1	10.1	5.3	5.7	13.7	8.7	12.7	16.9	6.8	11.4	5.6	6.0	8.2	10.7	5.0	37.5	8.1	21.8	20.6	13.6	22.3	3.4	1.1	12.1	0.9	2.4	7.5	1.4	7.6	4.2	2.1	0.1	6.9	6.2	5.0	1.7	2.6	0.6	0.5	3.8	2.1	0.5	3.6	1.4	1.6	6.9	6.4	17.8	0.7	22.6	2.1	18.7	2.4	1.6	0.5	0.0	6.6	10.3	9.8	3.9	7.9	7.3	14.1	1.7	1.8	2.1	4.8	6.6	2.7	0.1	1.4	0.6	3.4	0.6	1.8	0.4	1.7	22.9	3.0	2.4	2.3	0.9	0.1	1.5	1.5	0.1	13.5	1.6	2.3	2.5	2.9	5.5	2.4	0.1	4.3	0.0	1.3	12.1	0.4	0.8	1.2	0.5	2.9	3.4	4.7	1.2	0.4	2.1	5.0	2.1	4.1	2.4	0.9	1.1	7.5	1.4	10.2	11.8	6.2	19.4	9.9	8.1	6.5	9.2	11.1	5.0	29.8	44.7	9.0	428.6	327.4	18.2	114.6	17.8	29.4	59.1	17.4	2.0	33.2	31.5	46.4	104.5	72.0	17.3	0.0	103.5	42.2	34.0	324.3	92.3	37.2	4.6	7.9	30.9	60.2	6.0	92.7	38.3	9.8	45.5	2.8	14.9	56.5	55.6	15.6	30.8	73.9	3.5	38.8	35.8	11.4	8.5	348.9	114.8	15.2	15.0	641.7
MASTL	"FLJ14813, Gwl, THC2"	ENSG00000120539	"Microtubule associated serine/threonine kinase like"	Q96GX5	10	27154824-27186924	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"	"Kinase, Serine/threonine-protein kinase, Transferase"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Extravillous trophoblasts: 20.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA027175, HPA054273"	Approved		Enhanced	Nucleoplasm		NA	Yes			Nucleoplasm		"HPA027175: AB_1853591, HPA054273: AB_2682433"	"unprognostic (4.10e-2)"	"unprognostic (6.89e-2)"	"unprognostic (1.22e-2)"	"unprognostic (3.14e-3)"	"unprognostic (3.67e-1)"	"unprognostic (1.97e-2)"	"prognostic unfavorable (2.52e-6)"	"unprognostic (2.19e-2)"	"unprognostic (4.00e-2)"	"unprognostic (4.05e-2)"	"prognostic unfavorable (4.81e-5)"	"unprognostic (3.78e-2)"	"prognostic unfavorable (1.71e-6)"	"unprognostic (1.55e-3)"	"unprognostic (2.27e-1)"	"unprognostic (2.66e-1)"	"unprognostic (1.79e-1)"	9.1	7.0	3.6	8.9	6.1	21.1	8.3	4.0	7.5	7.4	7.6	3.8	5.7	5.7	6.0	6.7	12.3	5.4	5.3	5.6	6.8	4.5	6.5	7.1	10.2	14.8	5.4	5.7	7.0	12.7	6.7	6.3	14.2	6.7	5.5	7.1	5.6	8.0	4.7	4.0	10.1	10.0	6.1	5.6	8.7	6.2	11.3	2.3	21.1	6.5	4.3	12.3	8.7	7.5	3.9	2.6	5.6	4.9	2.3	4.0	1.8	11.9	9.6	18.4	6.8	2.8	4.2	10.9	17.9	7.5	29.7	36.6	11.6	12.0	9.6	6.8	7.5	14.4	11.6	11.7	7.1	21.1	8.1	11.3	11.3	6.7	6.7	1.6	4.3	8.5	2.5	3.2	17.9	3.5	3.9	6.4	7.8	8.6	21.6	18.0	7.9	14.0	4.7	13.7	6.7	3.9	9.0	30.7	7.9	7.3	4.5	8.2	11.8	11.3	7.6	7.9	12.7	7.6	9.1	5.5	7.4	15.6	18.9	15.7	2.6	4.2	14.1	8.1	13.1	6.1	0.1	4.4	3.8	2.0	4.3	3.0	2.6	2.5	1.8	2.5	3.9	2.5	2.3	5.6	2.3	4.9	2.6	4.0	1.8	3.6	6.1	4.0	7.5	6.8	4.5	5.4	5.7	6.7	2.3	6.0	8.5	7.2	4.0	9.7	1.9	1.6	0.0	4.0	9.1	1.8	0.0	3.3	0.0	3.2	1.7	3.6	3.0	0.0	2.2	20.7	5.8	3.3	12.7	1.7	5.1	3.2	4.1	2.5	12.0	1.5	2.8	5.6	0.0	1.8	3.4	1.5	3.6	1.9	2.5	1.4	0.9	0.0	5.9	11.2	16.4	8.7	5.1	8.7	3.5	5.9
MAT1A	"MAT, MATA1, SAMS, SAMS1"	ENSG00000151224	"Methionine adenosyltransferase 1A"	Q00266	10	80271820-80289684	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"One-carbon metabolism"	Transferase	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	14	"liver: 178.8"	"Cell type enriched"	"Detected in many"	51	"Hepatocytes: 4835.7"	"Cancer enriched"	"Detected in many"	54	"liver cancer: 209.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	15	"Hep G2: 45.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA048627	Supported					NA	NA		530000			"HPA048627: AB_2680465"	"unprognostic (6.92e-2)"	"unprognostic (2.63e-1)"	"unprognostic (2.88e-2)"	"unprognostic (9.43e-2)"	"unprognostic (3.79e-2)"	"unprognostic (2.49e-2)"	"unprognostic (2.03e-3)"	"unprognostic (1.46e-1)"	"unprognostic (1.09e-1)"	"unprognostic (2.58e-2)"	"unprognostic (1.76e-1)"	"unprognostic (8.66e-2)"	"unprognostic (1.11e-16)"	"unprognostic (8.59e-3)"	"unprognostic (9.90e-2)"	"unprognostic (3.58e-1)"	"unprognostic (5.98e-2)"	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.2	0.0	0.0	12.5	0.1	0.2	0.2	0.1	0.0	0.0	0.3	178.8	0.1	0.1	0.1	0.0	0.7	9.9	0.0	0.6	0.0	0.2	0.0	0.0	0.3	0.0	0.2	0.0	0.7	0.0	0.0	0.4	0.2	0.0	0.6	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.1	0.0	1.6	0.0	0.0	0.0	0.0	0.1	0.2	0.7	0.0	45.9	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.5	0.1	0.0	0.2	0.0	0.0	0.1	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.3	14.0	0.0	1.8	0.0	0.5	76.5	8.1	1.2	1.8	0.0	0.0	1.7	0.0	22.5	0.0	0.0	46.7	3.8	0.0	0.0	0.0	0.0	4835.7	0.1	0.0	0.0	88.4	94.8	4.2	0.3	0.0	0.0	0.0	0.0	0.0	3.9	0.0	0.4	0.0	0.0	0.0	0.0	2.4	0.1	2.4	0.0	0.0	0.0	0.0
MAT2A	"MATA2, MATII, SAMS2"	ENSG00000168906	"Methionine adenosyltransferase 2A"	P31153	2	85539165-85545280	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"One-carbon metabolism"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"pancreas: 205.8"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009968, HPA043028"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA		950000	Nucleoplasm	Cytosol	"CAB009968: AB_675710, HPA043028: AB_10960707"	"unprognostic (1.38e-3)"	"unprognostic (2.58e-2)"	"unprognostic (3.96e-2)"	"prognostic unfavorable (5.29e-5)"	"unprognostic (9.89e-3)"	"unprognostic (5.90e-3)"	"prognostic unfavorable (4.87e-4)"	"prognostic favorable (8.94e-4)"	"prognostic unfavorable (5.94e-5)"	"unprognostic (4.07e-2)"	"unprognostic (2.02e-1)"	"unprognostic (2.59e-2)"	"unprognostic (9.63e-3)"	"unprognostic (1.04e-1)"	"unprognostic (2.02e-1)"	"unprognostic (4.39e-2)"	"unprognostic (1.77e-2)"	55.9	68.9	37.4	35.3	54.1	20.4	30.3	37.5	50.0	28.6	35.3	74.5	39.7	33.6	35.8	59.8	33.5	44.9	51.6	35.0	41.7	28.5	52.3	26.4	32.9	27.0	74.8	37.6	44.2	205.8	38.8	60.5	29.3	48.9	40.6	36.8	35.0	28.2	31.3	51.4	33.7	35.8	47.6	57.7	24.7	44.6	34.9	69.4	22.7	94.0	34.1	30.8	46.9	33.4	13.8	15.3	4.9	17.2	16.9	22.8	14.9	30.0	44.6	52.4	32.5	36.1	44.1	31.0	37.8	34.9	39.8	42.5	36.4	101.4	70.5	24.9	45.9	32.5	46.9	65.9	56.4	51.2	35.7	48.4	42.1	64.6	31.5	66.0	62.4	47.1	39.9	57.2	42.9	30.0	50.7	37.7	41.0	47.3	55.5	90.3	25.8	56.9	68.8	34.8	25.9	57.5	60.6	49.6	45.7	60.1	47.7	41.3	38.1	34.2	33.0	60.9	27.7	27.9	33.5	36.6	48.9	29.5	26.9	45.1	34.3	27.2	51.0	31.9	78.4	25.6	4.8	15.2	4.9	15.4	17.2	22.8	13.8	17.5	16.2	15.3	12.2	16.4	14.3	1.6	16.9	13.7	10.9	15.3	14.9	37.4	54.1	37.5	50.0	41.7	28.5	74.8	37.6	48.9	69.4	44.7	76.0	36.8	172.0	127.5	81.9	4.5	86.6	34.8	63.7	68.0	64.8	30.7	16.6	50.4	46.3	49.1	61.0	23.3	49.9	34.3	63.9	55.3	83.1	40.6	57.5	25.4	79.9	36.2	106.8	20.7	66.7	92.6	64.1	35.1	55.5	59.7	55.5	42.1	78.8	119.6	80.9	109.9	101.9	51.4	57.7	103.4	31.9	36.2	51.7	86.6
MATK	"CHK, CTK, DKFZp434N1212, HHYLTK, HYL, HYLTK, Lsk, MGC1708, MGC2101"	ENSG00000007264	"Megakaryocyte-associated tyrosine kinase"	P42679	19	3777970-3802129	"Cancer-related genes, Enzymes, Predicted intracellular proteins"		"Kinase, Transferase, Tyrosine-protein kinase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 29.3;bone marrow: 19.1;brain: 27.4"	"Group enriched"	"Detected in many"	6	"granulocytes: 44.9;Hofbauer cells: 58.6;T-cells: 105.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"gdT-cell: 19.4;NK-cell: 29.3"	"Group enriched"	"Detected in many"	54	"NK-cells: 29.3;T-cells: 19.4"	"Cell line enhanced"	"Detected in some"		"HL-60: 41.6;HMC-1: 12.8;K-562: 18.5;MCF7: 13.5;NB-4: 29.0;SCLC-21H: 12.7;THP-1: 10.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004847, HPA066547"	Approved		Approved	"Microtubules,Cytokinetic bridge,Mitotic spindle,Centriolar satellite,Cytosol"		NA	NA			Microtubules	"Cytokinetic bridge, Mitotic spindle, Centriolar satellite, Cytosol"	"HPA004847: AB_1079316, HPA066547: "	"prognostic favorable (5.27e-4)"	"unprognostic (1.28e-2)"	"unprognostic (1.84e-1)"	"unprognostic (3.54e-2)"	"unprognostic (3.36e-1)"	"unprognostic (3.39e-2)"	"unprognostic (9.50e-2)"	"unprognostic (1.23e-1)"	"unprognostic (7.91e-2)"	"unprognostic (3.19e-3)"	"unprognostic (2.07e-2)"	"unprognostic (4.51e-2)"	"unprognostic (1.16e-2)"	"unprognostic (7.59e-2)"	"unprognostic (1.66e-1)"	"unprognostic (2.26e-1)"	"unprognostic (2.33e-2)"	11.2	1.6	22.1	6.8	18.1	19.1	2.2	1.5	27.4	1.5	2.3	1.7	0.0	7.0	1.2	0.4	1.1	4.7	5.1	1.7	25.1	10.0	1.1	2.8	7.3	9.6	7.0	11.0	1.0	1.6	0.1	1.4	1.4	6.1	1.2	1.4	0.6	3.8	1.0	0.8	1.6	6.7	1.1	2.8	14.8	4.1	2.1	1.3	3.5	0.9	0.0	4.5	2.4	0.7	0.4	0.3	0.4	0.0	29.3	19.4	2.7	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.7	0.0	0.4	4.2	5.5	0.1	0.0	0.0	7.2	4.6	0.5	1.1	0.0	41.6	12.8	0.0	0.0	0.0	0.0	0.0	0.0	0.5	18.5	0.0	0.0	13.5	0.1	29.0	3.4	3.5	0.1	0.0	0.0	0.0	0.0	0.0	12.7	0.0	0.0	0.0	0.0	0.4	0.0	10.9	1.3	0.0	0.2	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	19.4	0.0	13.2	0.0	2.5	12.2	0.3	0.4	1.2	7.1	0.4	29.3	0.0	0.1	0.1	2.7	22.1	18.1	1.5	27.4	25.1	10.0	7.0	11.0	6.1	1.3	0.0	1.4	2.4	0.0	0.3	1.7	1.1	0.0	1.4	0.0	0.0	11.8	0.2	0.0	0.0	1.5	1.4	0.0	0.0	0.0	0.3	0.5	0.1	44.9	0.8	58.6	0.0	6.8	11.6	3.5	4.0	0.0	7.2	1.7	1.0	0.0	0.5	0.0	0.0	0.0	0.0	1.6	0.0	0.4	0.3	2.7	1.0	0.2	105.8	0.1	0.0
MBOAT1	"dJ434O11.1, LPEAT1, MGC44669, OACT1"	ENSG00000172197	"Membrane bound O-acyltransferase domain containing 1"	Q6ZNC8	6	20102145-20212399	"Enzymes, Predicted membrane proteins"	"Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism"	"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	10	"Basal keratinocytes: 9.7;Melanocytes: 8.5;Paneth cells: 8.6;Suprabasal keratinocytes: 13.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HaCaT: 30.3;HEL: 24.9;T-47d: 22.9"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"									NA	NA						"unprognostic (1.26e-2)"	"unprognostic (4.18e-2)"	"unprognostic (2.06e-2)"	"unprognostic (5.85e-3)"	"unprognostic (3.88e-2)"	"unprognostic (5.31e-2)"	"unprognostic (2.55e-2)"	"unprognostic (6.57e-3)"	"unprognostic (1.87e-1)"	"unprognostic (1.62e-3)"	"prognostic unfavorable (9.15e-4)"	"unprognostic (2.90e-2)"	"unprognostic (5.59e-2)"	"unprognostic (5.17e-2)"	"unprognostic (2.56e-1)"	"unprognostic (1.70e-1)"	"unprognostic (4.24e-2)"	9.9	3.3	1.4	16.5	2.1	6.2	16.5	1.5	1.8	22.5	17.3	6.4	7.1	9.7	18.8	9.9	9.6	18.1	18.8	8.4	1.7	1.7	4.4	4.0	14.0	7.6	6.5	0.7	10.5	4.4	4.7	2.7	3.2	6.2	9.3	15.4	7.2	6.5	9.4	2.2	4.3	21.1	17.2	10.0	4.6	10.6	2.6	3.2	3.9	6.6	6.5	11.1	10.4	12.8	0.3	2.8	6.4	6.8	0.5	4.1	0.9	3.3	3.5	6.6	4.5	0.7	2.2	0.3	5.3	1.5	3.7	4.1	1.9	12.9	0.0	11.1	5.1	2.7	30.3	6.4	2.7	5.2	8.3	3.1	24.9	5.7	0.0	4.1	7.9	8.7	0.9	2.4	1.6	6.7	1.8	2.0	5.2	4.0	4.7	0.8	3.0	4.4	4.7	1.4	2.8	1.8	1.6	7.6	17.5	3.7	6.6	0.2	4.1	1.1	5.3	5.7	12.2	22.9	2.7	1.9	4.4	3.0	2.5	2.2	6.9	15.4	0.0	0.3	5.5	5.3	6.4	4.4	6.0	0.7	4.7	4.1	0.2	1.2	1.7	2.6	0.3	0.3	0.3	5.7	0.5	6.8	2.8	1.3	0.9	1.4	2.1	1.5	1.8	1.7	1.7	6.5	0.7	6.2	3.2	3.0	0.3	0.0	0.6	9.7	0.0	0.3	0.0	4.0	0.0	0.0	0.0	0.1	1.7	1.9	0.0	0.2	3.6	0.0	1.0	0.1	0.8	0.6	0.0	0.0	1.2	0.0	0.0	0.0	1.5	0.0	0.3	2.1	8.5	0.0	0.9	2.0	1.3	8.6	0.0	0.0	0.0	0.0	0.8	0.0	0.1	13.6	0.2	0.0	2.0	1.3
MBOAT2	"FLJ14415, FLJ90298, OACT2"	ENSG00000143797	"Membrane bound O-acyltransferase domain containing 2"	Q6ZWT7	2	8852690-9003813	"Enzymes, Predicted membrane proteins"	"Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism"	"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"parathyroid gland: 34.7"	"Cell type enhanced"	"Detected in many"	8	"Horizontal cells: 133.5;Muller glia cells: 95.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	7	"basophil: 6.3;eosinophil: 2.8;neutrophil: 6.7"	"Lineage enriched"	"Detected in single"	8	"granulocytes: 6.7"	"Cell line enhanced"	"Detected in many"		"SK-BR-3: 25.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA014836	Uncertain		Approved	Vesicles		NA	NA			Vesicles		"HPA014836: AB_1854745"	"unprognostic (2.49e-1)"	"unprognostic (2.17e-2)"	"unprognostic (2.61e-1)"	"prognostic unfavorable (2.13e-9)"	"unprognostic (1.30e-1)"	"unprognostic (2.32e-2)"	"unprognostic (2.38e-1)"	"unprognostic (3.97e-3)"	"unprognostic (3.09e-1)"	"unprognostic (3.00e-1)"	"unprognostic (1.03e-3)"	"unprognostic (1.70e-1)"	"unprognostic (5.90e-2)"	"unprognostic (2.23e-1)"	"unprognostic (3.04e-2)"	"unprognostic (6.66e-2)"	"prognostic unfavorable (5.32e-4)"	2.3	2.9	12.8	2.9	18.0	24.2	10.1	10.1	20.2	6.0	8.2	16.6	1.2	3.1	5.3	3.5	14.2	3.7	4.3	5.1	14.7	12.4	8.0	1.3	10.9	2.9	23.3	10.3	6.8	2.1	34.7	5.5	3.8	16.2	16.1	9.3	6.4	5.6	4.1	1.2	12.3	4.3	4.6	18.5	2.5	6.9	2.7	17.8	1.9	5.3	16.1	10.3	4.4	7.5	0.0	0.8	6.7	0.7	0.0	0.2	0.3	8.4	2.6	7.9	3.4	3.6	8.0	4.6	4.1	1.5	5.3	3.5	0.7	13.5	2.4	4.9	9.7	4.2	6.5	7.0	8.2	8.0	7.5	12.1	10.1	3.7	0.0	4.4	0.0	3.2	5.8	4.9	5.0	3.5	11.7	2.8	3.5	8.6	1.9	4.6	2.2	3.0	0.2	3.1	3.8	10.0	4.5	12.5	0.1	7.8	1.2	4.7	14.5	4.2	25.5	4.0	4.1	4.8	2.9	1.5	9.4	5.0	7.2	11.6	0.7	0.2	2.7	14.7	1.4	3.1	6.3	0.7	2.8	0.0	0.2	0.0	0.0	0.2	0.1	0.8	0.0	0.2	0.1	6.7	0.0	0.2	0.1	0.0	0.3	12.8	18.0	10.1	15.8	14.7	12.4	23.3	10.3	16.2	17.8	17.9	10.1	4.5	2.9	3.0	18.3	10.6	5.1	16.0	19.4	38.4	7.9	2.5	5.0	4.5	7.3	8.8	10.3	46.7	1.4	1.3	9.8	21.0	8.1	0.0	1.7	133.5	36.0	4.3	2.1	7.8	4.9	4.3	13.5	44.1	49.8	95.3	52.2	20.4	7.1	8.4	7.2	6.5	12.0	10.7	23.7	4.4	1.6	2.1	11.9	29.8
MBOAT7	"BB1, hMBOA-7, LENG4, LPIAT"	ENSG00000125505	"Membrane bound O-acyltransferase domain containing 7"	Q96N66	19	54173412-54189882	"Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins"	"Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism"	"Acyltransferase, Transferase"	"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	9	"basophil: 15.7;eosinophil: 30.6;neutrophil: 30.0"	"Lineage enriched"	"Detected in many"	10	"granulocytes: 30.6"	"Cell line enhanced"	"Detected in many"		"HMC-1: 57.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA055967	Approved		Approved	Cytosol		NA	NA			Cytosol		"HPA055967: AB_2682990"	"unprognostic (1.89e-2)"	"unprognostic (2.60e-2)"	"unprognostic (2.60e-1)"	"unprognostic (3.31e-1)"	"unprognostic (3.54e-2)"	"unprognostic (5.95e-2)"	"prognostic unfavorable (5.55e-6)"	"prognostic unfavorable (5.13e-4)"	"unprognostic (5.36e-2)"	"unprognostic (2.31e-2)"	"unprognostic (1.08e-2)"	"unprognostic (2.81e-1)"	"prognostic unfavorable (6.62e-5)"	"unprognostic (1.31e-1)"	"unprognostic (4.75e-2)"	"unprognostic (3.95e-1)"	"prognostic favorable (4.31e-4)"	10.7	63.1	16.8	14.8	24.2	15.9	7.9	11.3	37.8	10.3	17.7	9.2	15.6	30.3	10.5	8.0	10.5	11.5	14.3	6.9	18.5	23.4	10.5	11.6	11.5	14.7	10.0	18.8	15.1	24.4	23.8	12.4	11.9	21.6	11.4	6.1	8.1	10.8	28.8	7.9	10.0	28.5	6.5	9.2	14.4	16.4	30.8	6.8	7.6	12.7	5.0	6.3	22.6	17.5	0.3	2.9	30.6	2.1	0.9	0.5	0.8	14.2	8.5	1.3	14.0	4.6	3.6	12.3	25.0	8.9	5.8	11.5	4.8	16.2	3.7	11.2	5.4	2.5	29.2	0.0	5.1	1.1	5.1	16.6	3.9	9.2	3.1	4.5	9.0	57.3	6.7	3.4	2.8	2.0	4.6	10.4	2.7	14.7	11.8	2.0	8.6	2.6	3.2	5.9	2.5	18.2	8.4	2.4	7.5	5.8	17.3	0.5	3.7	16.7	10.2	5.1	0.1	10.3	0.8	20.7	12.3	4.4	3.6	9.9	5.4	9.3	1.5	17.7	6.4	8.1	15.7	2.1	30.6	0.2	1.5	0.5	0.2	0.2	0.2	2.9	0.3	0.1	0.2	30.0	0.9	0.8	0.8	0.2	0.8	16.8	24.2	11.3	37.8	18.5	23.4	10.0	18.8	21.6	6.8	11.9	26.6	12.2	44.1	12.4	15.8	6.5	30.6	13.4	14.8	41.8	5.9	38.6	5.0	45.1	1.1	16.6	88.9	0.0	28.7	43.8	12.7	39.8	76.1	13.9	28.4	28.6	40.8	14.7	36.9	1.9	17.8	32.1	8.5	19.8	45.8	22.4	34.4	40.3	14.5	12.2	6.8	38.8	23.4	3.9	14.5	18.9	43.1	11.4	38.5	48.0
MBTPS1	"KIAA0091, PCSK8, S1P, SKI-1"	ENSG00000140943	"Membrane bound transcription factor peptidase, site 1"	Q14703	16	84053761-84116906	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Cholesterol metabolism, Lipid metabolism, Steroid metabolism, Sterol metabolism"	"Hydrolase, Protease, Serine protease"	"Disease mutation, Dwarfism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	8	"Cone photoreceptor cells: 157.1;Rod photoreceptor cells: 283.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA056109	Supported					NA	NA					"HPA056109: AB_2683040"	"unprognostic (1.50e-1)"	"unprognostic (9.73e-2)"	"unprognostic (1.58e-1)"	"unprognostic (3.10e-3)"	"unprognostic (1.20e-1)"	"unprognostic (1.20e-1)"	"unprognostic (2.50e-1)"	"unprognostic (2.02e-1)"	"unprognostic (1.47e-1)"	"unprognostic (1.59e-1)"	"unprognostic (1.00e-2)"	"unprognostic (2.19e-1)"	"prognostic favorable (2.21e-5)"	"unprognostic (2.62e-1)"	"unprognostic (2.92e-1)"	"unprognostic (6.63e-2)"	"unprognostic (6.88e-2)"	26.6	25.3	15.2	17.9	32.0	13.2	27.2	29.9	30.2	27.5	23.6	20.5	21.5	15.8	33.5	22.2	18.8	29.2	20.4	31.5	15.7	18.2	23.4	28.9	22.1	17.1	14.8	15.9	34.3	32.6	47.5	38.7	28.5	15.9	24.0	21.2	33.1	29.7	26.8	16.2	18.7	19.0	25.9	11.4	21.8	23.5	17.7	16.1	24.0	36.7	16.7	23.2	26.1	19.6	10.9	11.5	12.8	14.3	14.4	16.7	15.4	15.4	19.6	17.6	24.4	41.6	33.8	13.8	26.0	40.3	23.0	17.4	13.9	22.9	14.8	27.1	37.2	18.3	17.0	16.1	18.0	25.6	13.3	18.1	10.8	18.9	19.3	20.1	26.1	23.9	34.7	26.2	21.1	18.2	33.1	29.8	20.1	14.1	13.1	13.9	26.7	14.3	14.7	16.4	8.7	14.0	18.7	9.4	10.6	18.6	12.8	13.5	16.8	50.2	13.9	19.3	19.9	43.6	24.1	31.7	23.9	17.5	14.2	12.2	16.6	30.8	28.5	17.4	16.0	14.5	6.6	14.3	12.8	15.8	12.1	16.2	10.9	13.6	14.7	11.5	9.9	16.7	14.8	4.1	14.4	9.8	6.4	8.7	15.4	15.2	32.0	29.9	30.2	15.7	18.2	14.8	15.9	15.9	16.1	44.7	42.4	21.6	19.9	12.2	63.0	46.9	38.2	60.2	50.0	24.4	157.1	18.8	10.0	21.2	0.6	34.9	15.3	0.0	23.6	18.0	31.0	27.3	27.8	28.8	14.6	79.4	33.6	33.7	14.8	3.7	49.5	16.1	18.6	1.8	28.7	40.6	25.3	21.0	47.4	15.9	283.9	25.8	21.3	13.7	19.9	13.8	18.1	16.2	29.3	24.0
MBTPS2	"KFSD, S2P"	ENSG00000012174	"Membrane bound transcription factor peptidase, site 2"	O43462	X	21839636-21885424	"Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins"	"Cholesterol metabolism, Lipid metabolism, Steroid metabolism, Sterol metabolism"	"Hydrolase, Metalloprotease, Protease"	"Disease mutation, Ichthyosis, Osteogenesis imperfecta, Palmoplantar keratoderma"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Horizontal cells: 28.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA005494, CAB009486"	Approved		Approved	Nucleoplasm,Mitochondria,Cytosol		NA	NA			"Nucleoplasm, Mitochondria, Cytosol"		"CAB009486: AB_2140370, HPA005494: AB_1079329"	"unprognostic (7.97e-3)"	"unprognostic (9.12e-2)"	"unprognostic (5.38e-2)"	"unprognostic (1.18e-2)"	"unprognostic (2.65e-1)"	"unprognostic (1.50e-1)"	"unprognostic (1.85e-1)"	"unprognostic (7.22e-2)"	"unprognostic (3.32e-1)"	"unprognostic (9.30e-2)"	"unprognostic (1.99e-1)"	"unprognostic (1.77e-1)"	"unprognostic (8.38e-2)"	"unprognostic (7.76e-2)"	"unprognostic (1.07e-1)"	"unprognostic (3.61e-1)"	"unprognostic (3.05e-2)"	12.0	17.4	9.3	7.2	13.9	2.5	12.7	20.8	18.5	11.8	9.3	13.4	6.9	7.6	14.7	9.1	9.3	10.9	10.1	11.6	9.9	10.7	13.9	26.0	8.6	6.6	10.6	13.0	18.7	12.2	17.9	15.6	22.3	17.4	15.7	9.1	12.4	14.1	13.1	14.5	8.2	8.1	14.6	14.6	7.5	9.1	6.9	7.0	7.1	13.1	7.4	6.7	11.4	9.1	3.9	6.9	1.5	4.8	4.6	5.9	3.3	8.9	18.6	8.9	9.1	11.3	14.0	4.3	13.3	13.6	12.7	11.1	7.4	12.3	7.8	6.9	14.2	24.8	8.4	12.3	7.6	15.7	5.8	9.8	3.8	11.8	6.1	15.5	8.2	3.8	13.2	8.3	19.1	14.1	12.9	9.7	4.6	10.6	8.7	14.4	5.6	3.3	4.3	8.3	4.7	13.8	4.2	16.6	8.7	8.8	4.6	2.2	18.3	18.7	11.9	16.4	12.4	15.9	7.1	11.5	16.0	3.7	23.2	9.9	10.7	13.5	3.8	17.8	3.4	15.3	0.1	4.3	1.5	4.5	4.8	4.2	3.9	3.5	4.1	6.9	3.8	4.7	5.6	0.5	4.6	4.8	4.8	5.9	3.3	9.3	13.9	20.8	18.5	9.9	10.7	10.6	13.0	17.4	7.0	8.9	7.8	3.0	3.4	4.8	11.7	12.0	7.6	10.7	6.8	7.0	17.7	5.6	0.0	5.1	0.3	4.6	3.3	0.0	7.7	5.4	8.9	6.6	10.4	16.1	8.0	28.6	2.4	10.4	9.5	0.9	9.8	4.4	10.1	3.6	3.3	7.7	5.3	3.1	12.4	7.5	14.0	0.0	6.9	2.8	1.7	2.4	4.0	4.3	4.2	4.1
MCAT	"fabD, FASN2C, MCT, MCT1, MT, NET62"	ENSG00000100294	"Malonyl-CoA-acyl carrier protein transacylase"	Q8IVS2	22	43132206-43143394	"Enzymes, Predicted intracellular proteins"	"Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Proximal tubular cells: 67.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003122, HPA035471"	Approved		Supported	Mitochondria		NA	NA			Mitochondria		"HPA003122: AB_2666795, HPA035471: AB_10670590"	"unprognostic (1.05e-1)"	"unprognostic (1.57e-2)"	"unprognostic (1.39e-2)"	"prognostic favorable (5.53e-4)"	"unprognostic (3.52e-1)"	"unprognostic (1.34e-1)"	"unprognostic (1.36e-3)"	"unprognostic (4.71e-2)"	"unprognostic (5.13e-2)"	"unprognostic (2.94e-1)"	"unprognostic (1.32e-1)"	"unprognostic (9.86e-2)"	"prognostic favorable (2.18e-4)"	"prognostic favorable (3.89e-4)"	"unprognostic (3.67e-2)"	"unprognostic (1.76e-1)"	"unprognostic (3.08e-1)"	10.4	18.2	13.3	8.2	17.2	11.0	12.8	10.4	24.6	10.6	11.9	9.4	10.7	9.5	11.0	17.2	12.3	20.7	21.4	12.9	14.4	14.2	25.6	24.3	8.6	7.1	12.0	12.0	14.4	16.2	20.3	14.3	9.2	15.1	12.8	10.6	9.9	14.5	10.2	17.7	11.7	9.7	8.6	6.0	7.6	12.1	19.6	5.2	18.4	20.1	14.0	9.9	8.5	8.1	10.2	13.9	2.5	9.5	11.6	10.3	5.6	7.2	9.5	6.8	11.8	5.7	6.1	6.9	8.1	7.2	11.0	10.2	9.5	7.4	12.2	8.4	6.0	6.2	12.2	12.8	10.7	8.2	4.2	37.8	4.5	11.0	10.5	9.1	21.6	5.5	4.5	10.5	10.7	8.5	6.4	7.8	7.4	10.7	5.0	5.3	13.3	10.0	23.5	6.5	10.2	16.9	13.3	6.6	19.3	13.7	6.3	8.9	4.7	8.7	17.1	12.3	3.2	8.8	14.0	4.6	4.8	9.4	10.3	11.4	8.9	9.2	8.8	10.3	8.3	5.7	0.0	9.5	0.7	7.7	9.1	10.3	8.3	8.6	10.1	13.9	10.2	10.1	7.1	2.5	11.6	5.5	13.7	5.5	5.6	13.3	17.2	10.4	24.6	14.4	14.2	12.0	12.0	15.1	5.2	6.0	5.0	6.7	9.1	15.9	10.0	8.7	30.6	10.7	4.5	19.2	0.0	16.7	43.1	25.8	13.8	7.1	10.0	0.0	19.0	8.4	9.3	14.1	3.5	20.8	13.6	6.4	13.9	16.5	8.2	9.0	6.9	4.8	6.8	8.2	12.4	9.5	19.8	17.5	15.6	67.4	8.7	19.4	9.8	29.0	10.4	18.3	7.7	4.9	22.7	9.5
MCCC1	MCCA	ENSG00000078070	"Methylcrotonoyl-CoA carboxylase 1"	Q96RQ3	3	183015218-183116075	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		Ligase	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"T-47d: 53.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA008310	Approved		Supported	Mitochondria	"Intracellular and membrane"	NA	NA			Mitochondria		"HPA008310: AB_1853620"	"unprognostic (4.01e-2)"	"unprognostic (1.83e-3)"	"unprognostic (2.05e-2)"	"unprognostic (2.59e-3)"	"unprognostic (3.46e-2)"	"unprognostic (4.16e-2)"	"unprognostic (1.69e-1)"	"unprognostic (1.10e-3)"	"unprognostic (2.57e-3)"	"unprognostic (9.82e-2)"	"unprognostic (9.74e-2)"	"unprognostic (7.65e-2)"	"prognostic favorable (3.68e-4)"	"unprognostic (4.73e-1)"	"unprognostic (2.21e-1)"	"unprognostic (2.95e-1)"	"unprognostic (1.36e-1)"	25.1	26.0	14.1	10.4	16.4	9.0	24.6	23.1	20.6	9.0	12.6	15.1	10.1	12.6	11.0	11.4	15.8	9.5	11.6	24.4	12.2	10.1	42.4	41.1	13.8	8.0	17.0	14.4	12.8	32.3	10.2	15.8	5.5	13.4	11.4	13.7	9.9	14.2	15.6	19.4	11.5	10.1	11.3	10.5	8.3	17.7	8.9	16.4	8.9	14.0	8.5	13.2	23.2	9.5	13.1	19.4	17.1	11.3	18.9	11.6	7.6	14.2	5.4	3.4	3.6	15.1	6.9	7.0	6.6	9.2	7.2	8.2	7.5	5.7	15.8	10.7	5.8	12.6	7.4	5.2	4.3	9.3	5.3	5.8	13.4	6.2	7.9	10.0	8.9	7.7	7.8	5.0	3.4	7.8	4.9	9.7	13.9	7.4	8.3	8.1	11.7	8.7	4.5	3.9	22.4	6.0	7.2	7.8	20.2	10.6	22.7	7.7	5.6	25.2	34.7	7.1	3.7	53.1	12.7	4.7	5.6	4.5	4.4	9.7	8.5	15.5	16.0	6.1	12.9	5.2	8.5	9.7	17.1	8.3	11.3	9.4	13.1	10.8	9.0	19.4	11.1	11.6	10.4	1.6	18.9	11.2	12.7	6.8	7.6	14.1	16.4	23.1	20.6	12.2	10.1	17.0	14.4	13.4	16.4	8.9	42.2	11.0	15.2	6.3	10.8	27.0	33.1	25.4	13.6	26.2	9.8	24.8	28.2	16.0	4.4	5.2	9.2	0.0	14.9	3.5	6.7	11.8	7.0	30.1	14.2	7.9	5.8	5.5	9.7	4.1	8.1	11.7	6.8	10.0	11.7	12.1	18.1	19.5	9.9	36.0	11.4	6.5	8.1	6.4	3.2	5.1	23.7	10.1	22.9	19.4
MCCC2	MCCB	ENSG00000131844	"Methylcrotonoyl-CoA carboxylase 2"	Q9HCC0	5	71587288-71658704	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		Ligase	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 74.3"	"Cell type enhanced"	"Detected in many"	4	"Hepatocytes: 79.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038300, HPA038301, HPA061546"	Enhanced		Enhanced	Mitochondria		NA	NA			Mitochondria		"HPA038300: AB_2675941, HPA038301: AB_10670661, HPA061546: AB_2684557"	"unprognostic (2.39e-1)"	"unprognostic (6.89e-3)"	"prognostic favorable (3.62e-4)"	"unprognostic (1.79e-2)"	"unprognostic (1.89e-2)"	"unprognostic (8.07e-2)"	"prognostic favorable (1.70e-4)"	"unprognostic (1.01e-1)"	"unprognostic (3.37e-1)"	"unprognostic (5.39e-2)"	"unprognostic (2.90e-1)"	"unprognostic (2.38e-1)"	"prognostic favorable (6.43e-8)"	"unprognostic (1.27e-1)"	"unprognostic (1.29e-1)"	"unprognostic (5.15e-2)"	"unprognostic (3.47e-2)"	12.4	29.4	9.2	11.8	13.6	2.7	30.5	7.9	10.0	11.2	15.3	12.2	15.1	13.0	9.7	20.0	14.5	9.1	12.3	74.3	7.6	8.1	35.6	61.9	8.4	11.6	7.8	8.0	9.6	18.9	14.1	10.3	15.1	13.4	24.6	18.1	12.8	20.6	29.4	17.6	10.8	14.1	7.8	17.0	11.0	13.6	6.9	6.9	9.4	22.2	13.3	14.3	15.7	8.5	8.8	16.7	1.7	11.5	12.9	10.2	6.7	11.9	16.5	7.1	27.1	7.6	7.8	12.1	5.7	9.6	11.8	8.5	28.9	15.2	27.7	21.0	8.3	9.2	9.9	12.3	19.0	14.8	14.7	15.7	15.0	8.5	31.7	13.3	7.4	14.3	10.0	10.0	10.8	8.6	5.3	10.3	8.0	18.9	10.4	8.1	32.6	0.1	13.6	9.3	10.5	9.3	14.5	20.4	40.7	30.6	21.6	11.2	12.4	24.9	36.9	12.1	3.5	30.6	18.9	7.5	4.8	7.5	8.7	15.3	7.5	13.8	17.2	7.9	20.7	11.9	1.7	7.4	1.6	6.1	11.5	7.9	8.8	7.9	6.9	16.7	8.6	8.0	8.7	1.2	12.9	6.8	7.4	10.2	6.7	9.2	13.6	7.9	10.0	7.6	8.1	7.8	8.0	13.4	6.9	14.9	23.4	22.9	14.2	11.7	12.8	60.9	17.8	16.0	18.2	15.7	5.9	40.3	18.3	18.3	3.1	14.2	19.6	0.0	16.1	19.0	8.9	25.3	12.7	79.8	15.6	3.2	28.4	8.0	10.8	7.4	12.7	12.2	11.8	19.0	22.7	19.0	14.2	17.5	19.1	48.4	11.4	6.5	9.1	3.9	13.3	12.0	53.2	12.9	28.8	18.5
MCEE	GLOD2	ENSG00000124370	"Methylmalonyl-CoA epimerase"	Q96PE7	2	71109684-71130239	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		Isomerase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Cardiomyocytes: 76.7;Distal tubular cells: 77.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA035196			Approved	Nucleoli	"Intracellular and membrane"	No	No		16000	Nucleoli		"HPA035196: AB_10601871"	"unprognostic (7.65e-2)"	"unprognostic (8.20e-2)"	"unprognostic (3.01e-1)"	"unprognostic (2.25e-1)"	"unprognostic (1.35e-1)"	"prognostic favorable (4.76e-4)"	"prognostic favorable (5.78e-4)"	"unprognostic (4.86e-3)"	"unprognostic (6.48e-2)"	"unprognostic (1.08e-1)"	"unprognostic (7.43e-3)"	"unprognostic (8.59e-2)"	"unprognostic (9.40e-3)"	"unprognostic (4.90e-2)"	"unprognostic (3.55e-1)"	"unprognostic (6.51e-2)"	"unprognostic (5.38e-2)"	10.5	20.4	8.5	10.1	9.2	4.3	18.9	10.5	9.8	14.1	13.8	9.4	24.6	11.1	8.8	19.7	16.9	8.6	12.6	19.8	6.6	6.2	18.8	39.7	9.1	9.5	13.1	6.6	12.4	29.0	9.8	24.5	9.9	9.1	13.7	13.5	11.1	28.9	20.5	18.2	15.2	14.9	10.9	11.5	10.1	13.1	5.7	11.4	9.3	11.0	18.7	10.9	13.0	13.3	15.9	17.6	20.0	18.4	11.2	24.9	11.1	6.4	3.1	5.7	4.1	19.4	26.4	16.5	9.9	12.6	5.0	7.6	7.7	8.0	9.9	3.0	9.7	3.8	6.7	6.9	5.1	5.3	9.2	6.0	6.8	8.7	22.1	10.9	7.6	5.6	17.5	7.5	3.4	6.7	11.2	5.7	7.9	8.9	17.4	4.8	8.2	5.6	8.9	5.2	17.7	7.7	6.7	6.5	18.4	7.7	5.2	6.5	4.7	3.7	21.9	9.7	6.9	17.3	7.3	7.4	5.9	4.6	6.0	3.9	16.7	6.8	10.5	9.6	12.4	5.3	13.0	18.3	20.0	12.8	18.4	17.3	15.9	15.7	12.3	14.9	13.2	14.6	12.3	4.5	11.2	17.6	17.6	24.9	11.1	8.5	9.2	10.5	9.8	6.6	6.2	13.1	6.6	9.1	11.4	23.8	8.3	13.7	11.3	7.6	2.6	76.7	22.9	17.4	9.1	5.2	2.0	30.6	77.9	10.4	0.8	9.0	14.7	0.0	16.1	27.7	21.1	8.8	0.0	60.2	13.5	4.8	8.6	9.8	11.6	0.9	27.0	11.2	13.5	3.6	28.7	6.7	10.6	10.5	16.6	64.3	8.7	25.8	10.8	2.4	4.1	18.2	9.5	12.9	25.1	9.2
MCM2	"BM28, CCNL1, cdc19, CDCL1, D3S3194, DFNA70, KIAA0030"	ENSG00000073111	"Minichromosome maintenance complex component 2"	P49736	3	127598223-127622436	"Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Cell cycle, DNA replication"	"DNA-binding, Helicase, Hydrolase"	"Cancer-related genes, Deafness, Disease mutation, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 69.9"	"Cell type enhanced"	"Detected in many"	9	"Cytotrophoblasts: 45.7;Extravillous trophoblasts: 22.4;Spermatogonia: 27.1;Syncytiotrophoblasts: 28.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"CAB000303, HPA031450, HPA031495, HPA031496"	Enhanced		Enhanced	Nucleoplasm		Yes	Yes		8600	Nucleoplasm		"CAB000303: AB_322519, HPA031450: , HPA031495: AB_2673904, HPA031496: AB_2673905"	"unprognostic (2.43e-1)"	"prognostic favorable (4.66e-4)"	"unprognostic (4.44e-2)"	"unprognostic (3.12e-3)"	"unprognostic (1.68e-1)"	"unprognostic (2.25e-2)"	"prognostic unfavorable (1.51e-7)"	"unprognostic (8.43e-3)"	"unprognostic (1.92e-2)"	"unprognostic (1.79e-1)"	"unprognostic (1.41e-3)"	"unprognostic (1.21e-2)"	"unprognostic (1.16e-2)"	"unprognostic (8.16e-3)"	"unprognostic (1.56e-1)"	"unprognostic (3.29e-2)"	"unprognostic (2.82e-1)"	2.9	3.7	2.1	24.3	4.0	32.5	3.5	6.7	3.2	4.7	7.1	3.3	2.2	4.7	4.7	5.9	11.2	4.8	5.4	3.6	2.0	2.3	3.9	3.4	3.4	14.6	2.2	3.5	5.1	3.0	2.4	2.4	26.4	3.0	3.2	6.0	2.5	4.7	1.9	7.0	6.0	7.1	2.9	2.9	13.3	3.8	20.3	3.9	69.9	4.1	16.6	20.7	3.4	5.1	10.4	3.6	0.9	1.4	5.8	10.6	3.4	25.1	21.4	23.5	20.5	1.4	3.0	23.0	13.2	8.5	26.6	29.0	35.5	16.7	27.1	12.9	6.5	22.8	20.3	41.9	15.2	16.6	22.4	26.2	44.9	28.7	25.8	0.9	41.9	19.6	1.6	1.7	18.0	2.7	3.2	8.3	29.6	22.3	24.9	9.8	33.3	38.8	30.7	34.4	21.6	18.9	43.6	33.7	38.8	5.5	19.5	29.3	22.2	33.9	10.1	3.5	9.9	21.7	32.9	4.2	20.7	17.7	25.5	17.8	25.8	29.2	67.4	14.3	31.7	7.9	0.0	0.6	0.2	4.7	1.4	5.9	10.4	4.1	5.5	2.8	9.2	3.9	5.0	0.9	5.8	0.3	3.6	10.6	3.4	2.1	4.0	6.7	3.2	2.0	2.3	2.2	3.5	3.0	3.9	3.0	1.3	6.7	1.7	4.0	2.2	7.6	0.0	10.7	5.7	0.0	0.0	45.7	0.0	4.1	0.7	1.7	1.0	0.0	1.6	22.4	3.3	0.7	1.1	1.7	15.2	0.0	3.5	1.3	1.6	0.7	1.7	1.6	1.7	15.4	5.1	1.5	1.7	0.0	1.4	0.5	1.7	0.0	2.8	6.2	27.1	2.6	28.0	3.2	12.0	0.6
MCM3		ENSG00000112118	"Minichromosome maintenance complex component 3"	P25205	6	52264009-52284881	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, DNA replication"	"DNA-binding, Helicase, Hydrolase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 82.5"	"Cell type enhanced"	"Detected in many"	5	"Cytotrophoblasts: 85.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002162, HPA004789, HPA004790"	Supported		Supported	Nucleoplasm		NA	Yes		29000	Nucleoplasm		"CAB002162: AB_564115, HPA004789: AB_1079336, HPA004790: AB_1079335"	"unprognostic (9.14e-2)"	"prognostic favorable (1.89e-4)"	"unprognostic (2.37e-1)"	"unprognostic (1.53e-2)"	"unprognostic (2.14e-1)"	"unprognostic (5.48e-3)"	"prognostic unfavorable (1.40e-4)"	"unprognostic (1.36e-1)"	"prognostic unfavorable (4.40e-5)"	"unprognostic (1.01e-3)"	"unprognostic (2.96e-2)"	"unprognostic (1.15e-1)"	"unprognostic (8.35e-2)"	"unprognostic (1.16e-2)"	"unprognostic (1.00e-1)"	"prognostic favorable (3.13e-5)"	"unprognostic (1.34e-2)"	17.3	10.9	8.5	29.7	10.5	22.3	15.3	10.7	9.7	15.9	17.2	9.5	20.2	9.0	21.2	13.0	21.7	15.5	15.8	15.4	7.4	6.6	16.1	12.6	13.7	30.1	8.9	5.8	20.0	13.8	16.0	7.4	24.7	10.0	15.9	19.2	12.7	12.6	23.4	12.1	15.0	17.8	17.7	9.5	23.2	15.3	16.1	10.5	82.5	12.9	20.1	35.7	19.1	15.3	21.1	12.9	11.4	13.3	22.2	29.4	18.6	30.2	20.1	35.1	33.0	7.6	6.8	23.0	22.5	17.3	38.4	39.4	41.1	16.5	33.0	22.6	13.1	25.1	24.1	46.2	27.5	38.8	37.1	43.7	62.4	40.4	57.9	2.0	61.2	25.6	4.1	6.4	28.2	7.9	9.4	19.5	40.0	50.7	76.2	19.7	19.9	61.6	47.3	29.1	60.3	14.2	54.7	53.7	44.1	17.0	32.2	35.6	27.3	23.6	13.6	20.4	51.4	26.8	43.4	10.0	26.2	28.2	27.1	33.5	22.6	25.8	58.8	22.5	53.1	30.7	11.1	8.0	11.4	22.9	13.3	19.7	21.1	23.3	23.0	12.9	19.2	22.6	24.0	1.1	22.2	7.4	8.3	29.4	18.6	8.5	10.5	10.7	9.7	7.4	6.6	8.9	5.8	10.0	10.5	20.8	10.5	30.5	14.0	17.1	13.8	13.9	12.7	22.7	20.5	21.0	3.9	85.3	11.6	21.3	0.6	24.8	4.9	23.3	17.7	53.2	16.0	7.5	36.9	9.3	30.8	0.0	7.0	14.7	8.9	2.3	25.0	13.8	6.8	10.8	16.7	19.0	13.0	10.5	19.8	6.5	11.2	6.5	24.7	21.7	59.4	8.8	22.9	27.7	31.0	11.2
MCM4	"CDC21, CDC54, hCdc21, MGC33310, P1-Cdc21"	ENSG00000104738	"Minichromosome maintenance complex component 4"	P33991	8	47960185-47978160	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Cell cycle, DNA replication"	"DNA-binding, Helicase, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 56.6"	"Cell type enhanced"	"Detected in many"	9	"Early spermatids: 117.9;Late spermatids: 57.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004497, HPA004873, HPA031052"	Enhanced		Enhanced	Nucleoplasm		NA	Yes			Nucleoplasm		"CAB004497: AB_627916, HPA004873: AB_1079337, HPA031052: AB_2673712"	"unprognostic (4.55e-2)"	"unprognostic (3.16e-3)"	"prognostic favorable (2.19e-4)"	"prognostic unfavorable (2.84e-5)"	"unprognostic (7.71e-2)"	"unprognostic (1.05e-1)"	"prognostic unfavorable (1.23e-4)"	"unprognostic (1.12e-3)"	"prognostic unfavorable (1.15e-4)"	"unprognostic (2.65e-2)"	"prognostic unfavorable (2.38e-4)"	"unprognostic (5.16e-2)"	"prognostic unfavorable (2.61e-4)"	"unprognostic (3.53e-2)"	"unprognostic (2.90e-1)"	"unprognostic (1.70e-2)"	"unprognostic (1.40e-1)"	4.9	8.7	6.7	18.4	12.6	33.1	9.3	13.9	14.8	6.7	11.9	6.9	3.6	8.3	4.7	7.8	21.6	5.9	6.8	8.3	6.6	7.1	8.0	6.6	4.4	20.3	5.9	7.7	5.3	5.5	4.3	4.1	29.2	7.7	4.2	13.2	5.3	9.0	3.1	8.7	16.2	10.3	5.9	6.4	10.1	6.3	39.0	4.1	56.6	4.0	21.8	23.7	8.0	9.5	5.1	4.9	3.4	4.3	4.9	12.9	4.5	34.5	21.5	39.9	14.6	3.9	6.9	17.6	26.4	17.3	33.3	37.7	22.8	31.5	37.5	14.8	13.1	25.0	25.5	50.3	21.4	37.6	11.8	33.2	64.3	25.8	25.3	1.1	34.3	14.1	4.1	4.3	26.5	9.5	5.1	11.7	25.3	35.4	31.2	22.9	21.4	75.8	25.0	43.3	41.1	9.3	48.2	31.3	24.4	12.0	31.0	38.4	18.4	53.4	22.3	7.9	23.8	26.6	18.1	7.8	25.4	24.7	28.5	24.2	10.3	24.6	76.5	20.4	31.9	22.7	3.4	2.1	1.5	5.5	3.7	2.7	5.1	5.0	6.8	4.9	2.1	4.6	3.4	0.1	4.9	4.3	1.7	12.9	4.5	6.7	12.6	13.9	14.8	6.6	7.1	5.9	7.7	7.7	4.1	0.0	4.6	3.0	9.5	19.3	11.6	22.4	0.0	17.4	10.3	5.2	9.8	26.7	3.3	6.0	117.9	5.2	5.0	46.7	5.2	33.9	7.4	4.3	1.1	3.4	10.4	15.9	6.4	1.3	3.5	57.7	4.9	9.9	3.3	2.8	9.6	6.5	4.1	3.5	2.8	2.2	15.3	0.0	8.0	45.2	31.3	16.7	24.9	3.8	20.2	8.2
MCM5	CDC46	ENSG00000100297	"Minichromosome maintenance complex component 5"	P33992	22	35400063-35425430	"Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Cell cycle, DNA replication"	"DNA-binding, Helicase, Hydrolase"	"Cancer-related genes, Disease mutation, Dwarfism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 57.0;lymphoid tissue: 60.6"	"Cell type enhanced"	"Detected in many"	11	"Cytotrophoblasts: 115.2;monocytes: 225.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB000101, HPA000845, HPA052880"	Enhanced		Enhanced	Nucleoplasm		Yes	Yes			Nucleoplasm		"CAB000101: AB_2235163, HPA000845: AB_1079338, HPA052880: AB_2681979"	"unprognostic (6.71e-2)"	"prognostic favorable (2.81e-6)"	"unprognostic (5.29e-3)"	"unprognostic (7.94e-2)"	"unprognostic (1.83e-2)"	"unprognostic (1.46e-2)"	"prognostic unfavorable (1.78e-4)"	"prognostic unfavorable (3.95e-4)"	"unprognostic (1.29e-1)"	"unprognostic (3.34e-2)"	"unprognostic (1.37e-1)"	"unprognostic (8.07e-2)"	"prognostic unfavorable (3.58e-5)"	"unprognostic (3.26e-2)"	"unprognostic (1.01e-1)"	"unprognostic (1.77e-3)"	"unprognostic (1.53e-1)"	12.1	4.9	6.1	27.5	9.0	57.0	9.1	6.7	5.7	10.4	11.5	12.3	5.0	9.5	10.8	10.8	15.8	8.7	9.4	5.2	4.4	3.4	6.8	8.0	9.3	31.1	8.8	3.7	17.9	10.8	6.2	3.6	19.3	5.8	7.2	8.3	6.5	8.9	5.1	8.8	10.3	16.7	6.0	7.8	31.2	8.4	16.4	8.8	60.6	9.0	17.7	33.0	8.7	9.6	46.8	30.9	19.0	26.0	21.3	32.9	24.0	39.3	28.6	22.6	23.0	2.2	4.5	19.9	26.3	14.0	39.4	37.5	19.0	19.7	26.1	15.3	13.4	16.3	19.7	22.6	20.9	12.6	21.0	41.5	37.2	28.7	38.0	0.8	76.8	33.7	2.4	1.9	23.5	6.4	3.6	17.4	23.9	23.0	39.0	14.9	32.5	62.5	25.6	30.1	26.9	17.0	70.8	32.1	32.8	7.7	22.9	17.5	18.6	36.2	14.5	8.1	12.4	15.2	29.4	10.3	39.8	30.2	24.7	27.1	21.7	26.8	49.1	25.8	29.1	30.3	19.0	20.7	14.5	18.4	24.1	13.1	46.8	16.1	19.4	27.1	37.0	13.1	14.8	9.9	21.3	26.0	30.9	32.9	24.0	6.1	9.0	6.7	5.7	4.4	3.4	8.8	3.7	5.8	8.8	6.0	8.2	53.6	8.0	9.4	1.5	3.4	12.7	5.3	4.5	7.0	0.0	115.2	5.0	14.8	1.9	7.5	3.8	70.0	11.1	61.5	6.2	3.3	15.0	5.1	47.1	1.6	3.4	13.5	21.1	3.6	10.0	25.5	6.8	225.4	9.2	4.5	9.4	7.0	5.6	3.7	3.2	19.4	6.4	11.2	52.2	5.5	68.8	20.8	32.2	4.7
MCM6	Mis5	ENSG00000076003	"Minichromosome maintenance complex component 6"	Q14566	2	135839626-135876426	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, DNA replication"	"DNA-binding, Helicase, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 66.3"	"Cell type enhanced"	"Detected in many"	6	"Erythroid cells: 46.7;Spermatogonia: 41.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004818, CAB009577"	Enhanced		Enhanced	Nucleoplasm		NA	Yes			Nucleoplasm		"CAB009577: AB_2266309, HPA004818: AB_1079339"	"unprognostic (6.73e-2)"	"unprognostic (6.68e-3)"	"unprognostic (1.22e-3)"	"unprognostic (3.60e-3)"	"unprognostic (8.98e-2)"	"unprognostic (4.34e-2)"	"prognostic unfavorable (5.70e-7)"	"unprognostic (1.71e-2)"	"prognostic unfavorable (1.09e-5)"	"unprognostic (2.36e-2)"	"unprognostic (1.36e-2)"	"unprognostic (3.53e-2)"	"prognostic unfavorable (8.29e-12)"	"unprognostic (2.84e-1)"	"unprognostic (9.02e-2)"	"unprognostic (7.42e-2)"	"unprognostic (1.68e-1)"	11.3	6.3	7.2	17.7	8.4	23.1	9.5	12.3	9.4	9.1	11.9	5.1	2.9	8.7	10.4	8.8	12.6	8.7	7.6	6.0	5.0	5.5	6.8	7.0	8.5	23.9	4.9	8.0	10.9	4.3	6.2	3.4	10.9	5.9	8.6	12.2	6.2	6.9	6.7	8.2	8.9	16.7	10.4	7.2	14.1	8.0	13.2	3.7	66.3	5.1	11.4	27.5	10.8	9.8	5.5	9.4	5.3	4.0	7.0	13.9	5.6	23.3	14.3	31.3	19.9	6.7	8.8	12.3	17.0	12.9	19.8	22.1	29.3	17.9	40.8	12.5	12.3	8.7	13.9	31.6	15.5	21.2	20.9	21.8	40.5	21.3	9.2	3.1	48.5	18.1	5.2	2.0	14.4	4.4	4.0	13.4	32.2	28.9	34.5	14.5	23.8	59.2	35.7	28.2	20.6	14.4	29.4	37.5	37.3	9.9	20.6	19.7	16.8	22.4	10.7	10.7	23.4	12.3	30.6	6.6	13.8	11.5	14.8	12.8	20.7	33.7	53.7	19.3	37.2	16.4	5.3	1.4	0.9	7.6	4.0	7.1	5.5	10.5	9.2	4.6	3.2	9.6	11.8	0.8	7.0	3.6	9.4	13.9	5.6	7.2	8.4	12.3	9.4	5.0	5.5	4.9	8.0	5.9	3.7	0.0	2.4	2.2	3.8	6.0	2.2	3.2	2.5	4.0	6.8	3.5	0.0	26.1	0.0	4.4	2.1	7.1	1.3	46.7	5.8	20.9	11.3	1.5	9.2	3.0	20.4	3.2	2.4	9.8	4.0	1.6	8.6	5.8	5.0	3.6	9.2	2.3	2.8	3.5	15.9	1.0	0.5	0.0	4.2	15.6	41.4	3.6	8.9	17.5	9.7	1.0
MCM7	"CDC47, MCM2, PPP1R104"	ENSG00000166508	"Minichromosome maintenance complex component 7"	P33993	7	100092728-100101940	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, DNA replication"	"DNA-binding, Helicase, Hydrolase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002163, HPA003898, CAB016312"	Enhanced		Enhanced	Nucleoplasm		NA	Yes			Nucleoplasm		"CAB002163: AB_564113, CAB016312: AB_627235, HPA003898: AB_1853632"	"unprognostic (1.87e-1)"	"prognostic favorable (1.28e-4)"	"unprognostic (1.36e-1)"	"unprognostic (5.20e-2)"	"unprognostic (1.94e-1)"	"unprognostic (7.03e-2)"	"prognostic unfavorable (2.18e-4)"	"unprognostic (2.08e-2)"	"unprognostic (5.79e-3)"	"unprognostic (2.16e-2)"	"unprognostic (2.42e-1)"	"unprognostic (9.34e-3)"	"unprognostic (3.83e-2)"	"unprognostic (5.41e-2)"	"unprognostic (1.76e-1)"	"unprognostic (1.32e-2)"	"unprognostic (2.38e-1)"	8.6	5.2	17.5	13.6	21.7	37.3	11.2	20.0	20.6	8.2	14.2	19.2	15.0	10.4	16.0	6.3	10.7	8.6	9.9	5.1	18.1	12.4	5.5	8.5	7.4	22.4	23.7	9.5	12.6	13.1	7.5	10.3	10.7	15.5	10.0	15.7	7.2	9.2	9.2	11.5	10.1	10.3	11.7	23.5	10.7	7.8	14.9	22.3	7.5	9.4	4.1	28.2	10.3	10.0	7.3	5.7	1.9	5.7	7.6	9.0	6.0	24.9	28.8	31.8	24.0	3.1	4.1	16.3	15.2	18.4	42.5	45.3	22.0	26.4	42.3	14.5	10.8	27.1	19.8	46.7	22.1	35.9	21.6	39.9	26.9	16.2	15.2	1.7	45.7	17.5	2.8	4.2	31.1	18.7	5.4	16.1	24.4	51.5	34.7	21.5	53.3	77.6	18.7	27.9	23.2	20.9	41.8	46.7	51.6	8.2	15.1	20.8	31.7	24.0	22.3	7.5	18.6	10.2	19.2	6.8	16.0	29.1	31.4	30.1	14.5	24.8	76.1	11.1	36.7	28.6	1.8	2.5	1.9	8.1	4.1	6.2	5.3	5.7	7.9	5.5	7.3	5.9	5.7	1.6	7.6	5.7	5.7	9.0	6.0	17.5	21.7	20.0	20.6	18.1	12.4	23.7	9.5	15.5	22.3	8.9	17.0	23.7	20.7	41.4	8.7	7.9	15.3	24.1	9.1	3.5	13.7	90.8	8.3	17.6	40.0	14.5	15.8	70.0	22.4	78.1	17.3	11.3	24.2	10.4	34.4	6.4	16.7	8.0	10.8	22.7	19.5	16.5	18.6	17.2	34.7	10.1	16.0	20.1	14.5	9.1	11.9	12.9	22.7	83.2	67.3	30.9	60.2	28.7	60.9	12.3
MCM8	"C20orf154, dJ967N21.5, MGC119522, MGC119523, MGC12866, MGC4816, REC"	ENSG00000125885	"Minichromosome maintenance 8 homologous recombination repair factor"	Q9UJA3	20	5950652-5998977	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Cell cycle, DNA damage, DNA repair, DNA replication"	"DNA-binding, Helicase, Hydrolase"	"Disease mutation, Premature ovarian failure"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	8	"Spermatocytes: 43.2;Spermatogonia: 32.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA045141, HPA066433"			Supported	Nucleoplasm		NA	NA			Nucleoplasm		"HPA045141: AB_2679230, HPA066433: "	"unprognostic (6.55e-2)"	"unprognostic (2.46e-2)"	"unprognostic (4.43e-1)"	"unprognostic (2.22e-3)"	"unprognostic (1.90e-1)"	"unprognostic (5.78e-2)"	"prognostic unfavorable (9.30e-8)"	"unprognostic (5.21e-2)"	"unprognostic (5.14e-2)"	"unprognostic (2.50e-1)"	"prognostic unfavorable (7.50e-4)"	"unprognostic (6.74e-2)"	"unprognostic (1.11e-2)"	"unprognostic (5.53e-2)"	"unprognostic (2.76e-1)"	"unprognostic (2.66e-2)"	"unprognostic (3.47e-1)"	4.9	5.4	7.3	11.0	7.6	11.2	9.3	17.9	12.7	5.4	6.2	3.1	12.0	5.4	5.9	3.9	6.6	4.3	2.7	11.3	4.8	2.2	4.3	3.1	6.3	9.6	10.6	5.1	5.0	5.6	5.1	4.8	5.4	7.1	5.9	6.0	3.5	5.1	7.2	11.2	6.1	6.1	7.0	8.3	6.1	5.6	21.9	7.7	8.8	4.4	7.0	9.5	6.0	6.1	1.8	1.7	3.3	0.7	1.9	3.0	0.4	19.1	15.0	12.9	13.0	3.4	4.2	11.5	15.7	6.4	12.4	14.9	16.3	12.1	19.5	4.7	5.2	22.3	20.6	21.4	12.4	22.3	5.3	8.7	21.6	7.2	15.9	0.5	22.7	3.4	1.9	2.0	20.8	8.6	3.2	5.7	12.5	22.0	19.3	12.6	5.4	11.7	11.9	17.3	11.8	8.8	14.3	21.9	7.9	3.1	7.6	9.6	10.2	16.0	17.9	9.6	14.5	11.5	8.1	3.8	21.9	18.3	11.8	22.8	8.3	20.7	33.2	4.4	14.7	18.0	3.3	0.5	1.7	1.8	0.5	3.0	1.8	1.1	2.1	0.1	1.7	1.1	1.7	2.1	1.9	0.7	1.7	2.0	0.4	7.3	7.6	17.9	12.7	4.8	2.2	10.6	5.1	7.1	7.7	0.0	4.1	10.0	2.6	2.1	6.9	8.5	7.6	4.0	2.3	12.2	15.7	5.2	0.0	1.2	6.5	3.0	3.8	0.0	2.3	4.7	2.7	4.2	1.1	1.6	3.6	6.4	4.1	1.8	2.1	2.3	3.4	3.5	1.7	0.0	2.9	4.0	2.7	3.5	2.8	2.4	10.7	6.5	2.7	43.2	32.6	2.3	3.3	3.9	5.2	1.8
MCM9	"C6orf61, dJ329L24.3, FLJ20170, MCMDC1, MGC35304"	ENSG00000111877	"Minichromosome maintenance 9 homologous recombination repair factor"	Q9NXL9	6	118813442-118935162	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"DNA damage, DNA repair"	"DNA-binding, Helicase, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA031137	Approved		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA031137: AB_10602027"	"unprognostic (3.11e-2)"	"unprognostic (1.99e-1)"	"unprognostic (4.33e-3)"	"unprognostic (2.90e-1)"	"unprognostic (2.78e-2)"	"unprognostic (2.82e-1)"	"unprognostic (3.00e-2)"	"unprognostic (2.29e-1)"	"unprognostic (3.61e-2)"	"unprognostic (7.76e-2)"	"unprognostic (1.53e-1)"	"unprognostic (2.99e-1)"	"unprognostic (8.30e-2)"	"unprognostic (2.16e-1)"	"unprognostic (3.95e-1)"	"unprognostic (2.26e-1)"	"unprognostic (8.79e-2)"	8.6	7.2	5.9	11.9	8.4	14.5	17.7	5.2	6.9	9.4	11.2	8.2	9.8	7.3	9.0	16.0	10.2	8.6	8.2	6.6	5.9	4.0	9.3	7.6	15.6	12.1	11.5	4.7	8.7	12.2	11.9	11.2	13.8	6.3	10.5	8.4	7.0	11.8	8.7	4.2	9.8	12.6	10.9	5.7	10.2	7.3	7.9	8.1	27.0	13.1	7.1	9.9	9.6	10.5	3.1	5.2	8.0	5.3	10.2	6.4	3.9	4.6	7.4	11.9	12.8	5.4	5.3	9.1	4.4	7.9	6.5	8.3	6.1	8.4	14.1	5.5	7.6	4.3	14.0	8.3	4.8	9.2	8.3	11.4	11.2	8.8	5.9	3.2	12.0	7.6	5.8	5.7	6.7	7.7	4.1	6.2	8.8	13.5	6.5	4.3	9.8	10.6	9.7	5.8	7.7	3.4	8.4	7.5	3.7	6.6	9.3	10.3	7.4	7.8	5.7	4.1	3.2	8.5	17.0	6.3	5.2	4.6	3.7	6.5	8.7	7.2	16.7	6.6	9.8	6.0	7.2	4.5	8.0	4.9	5.3	3.8	3.1	3.0	5.0	5.2	3.0	3.6	3.5	5.4	10.2	3.2	3.7	6.4	3.9	5.9	8.4	5.2	6.9	5.9	4.0	11.5	4.7	6.3	8.1	6.0	4.1	4.4	3.1	2.6	3.5	3.9	2.5	12.0	4.5	7.0	9.8	9.1	3.3	2.3	1.5	4.4	5.1	0.0	2.5	2.9	2.8	3.4	6.9	2.4	3.0	1.6	6.9	3.7	5.3	1.9	3.4	4.5	0.0	2.8	5.9	2.1	2.1	5.8	3.9	2.9	5.4	0.0	2.1	4.8	2.7	1.8	6.1	5.3	4.1	4.1
MDH1		ENSG00000014641	"Malate dehydrogenase 1"	P40925	2	63588609-63607197	"Cancer-related genes, Citric acid cycle related proteins, Enzymes, Plasma proteins, Predicted intracellular proteins"	"Tricarboxylic acid cycle"	Oxidoreductase	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 155.8"	"Cell type enhanced"	"Detected in all"	12	"Cardiomyocytes: 1859.7;Proximal tubular cells: 683.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA027296, CAB047333, HPA054276"	Uncertain		Supported	Centrosome,Cytosol		NA	NA		63000000	"Centrosome, Cytosol"		"CAB047333: , HPA027296: AB_10611118, HPA054276: AB_2682434"	"unprognostic (1.01e-1)"	"unprognostic (6.52e-3)"	"unprognostic (1.61e-2)"	"prognostic unfavorable (7.13e-4)"	"unprognostic (1.83e-1)"	"unprognostic (8.84e-3)"	"unprognostic (5.81e-2)"	"unprognostic (2.79e-2)"	"unprognostic (9.52e-2)"	"unprognostic (2.05e-1)"	"unprognostic (3.26e-1)"	"unprognostic (8.80e-2)"	"prognostic favorable (9.95e-4)"	"unprognostic (6.37e-2)"	"unprognostic (1.75e-1)"	"unprognostic (5.97e-2)"	"unprognostic (3.05e-1)"	32.0	28.6	28.0	10.5	58.1	9.2	18.4	38.0	69.5	12.4	21.4	12.5	9.0	19.3	13.4	22.6	16.7	14.7	11.5	155.8	33.6	37.5	47.6	33.2	11.2	14.7	33.4	40.1	10.9	8.9	26.0	18.3	11.4	65.9	16.1	24.9	13.8	15.4	19.9	91.1	11.1	17.1	21.5	18.6	9.4	22.4	8.6	12.2	14.1	15.6	47.1	20.2	15.6	10.2	61.7	57.1	50.7	61.5	46.7	74.5	67.8	44.2	36.3	49.1	32.1	69.7	51.7	50.8	34.9	51.6	53.1	53.9	42.9	39.4	55.8	20.7	45.7	66.4	39.0	55.2	64.6	76.3	33.7	42.6	52.3	33.9	68.2	38.3	60.2	41.5	51.2	44.2	49.8	29.4	43.3	40.5	56.8	28.9	40.6	69.9	26.6	52.7	60.8	28.7	66.4	45.2	42.1	57.8	54.7	88.0	42.0	45.5	27.1	29.2	47.2	66.8	39.1	34.4	62.9	23.6	40.8	40.0	33.9	43.8	50.7	44.4	68.3	50.4	54.5	33.7	50.7	45.8	45.8	52.7	61.5	55.0	61.7	61.3	57.6	57.1	56.4	60.5	57.5	7.0	46.7	55.7	43.3	74.5	67.8	28.0	58.1	38.0	69.5	33.6	37.5	33.4	40.1	65.9	12.2	56.6	41.7	76.8	91.9	72.5	153.0	1859.7	86.6	136.5	79.6	127.4	66.8	222.4	533.9	152.0	8.3	50.1	143.7	70.0	94.8	211.6	90.4	54.0	78.5	143.3	336.7	116.0	60.3	41.1	68.1	11.1	92.6	78.1	168.7	212.0	97.2	112.7	85.3	103.5	102.6	683.5	120.0	58.2	87.6	48.3	49.0	73.4	125.1	76.2	138.8	88.5
MDH2		ENSG00000146701	"Malate dehydrogenase 2"	P40926	7	76048051-76067508	"Citric acid cycle related proteins, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"	"Tricarboxylic acid cycle"	Oxidoreductase	"Disease mutation, Epilepsy, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 175.8"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019714, HPA019716, HPA019848, HPA026720"	Enhanced		Enhanced	Mitochondria		No	No		47000000	Mitochondria		"HPA019714: AB_1853678, HPA019716: AB_1853680, HPA019848: AB_1853683, HPA026720: AB_1853685"	"unprognostic (3.20e-2)"	"unprognostic (2.85e-1)"	"unprognostic (1.11e-1)"	"unprognostic (1.43e-2)"	"unprognostic (5.55e-3)"	"unprognostic (8.94e-2)"	"unprognostic (6.45e-2)"	"unprognostic (3.77e-2)"	"unprognostic (3.60e-1)"	"unprognostic (2.02e-2)"	"unprognostic (1.40e-1)"	"unprognostic (9.70e-2)"	"prognostic favorable (1.49e-5)"	"unprognostic (8.57e-2)"	"unprognostic (9.64e-2)"	"unprognostic (5.68e-2)"	"unprognostic (2.66e-1)"	18.1	39.1	17.4	15.4	20.6	18.3	22.2	15.3	34.4	14.9	27.0	13.5	16.9	32.5	16.6	13.5	31.8	19.4	17.6	103.1	17.1	18.8	29.1	101.9	13.8	26.6	17.4	21.9	17.3	35.5	16.8	16.9	17.5	20.5	17.9	24.3	15.0	26.8	21.5	175.8	24.6	26.7	21.9	12.8	21.1	22.3	17.6	9.5	22.4	20.1	76.2	23.8	19.9	17.8	37.1	52.8	22.1	45.3	30.1	45.6	44.7	29.0	47.7	17.3	43.2	19.7	21.7	29.7	19.5	25.2	28.0	25.4	41.9	35.0	44.0	8.8	25.7	30.3	29.7	44.3	29.2	20.0	31.3	64.1	24.4	25.6	38.6	24.3	38.0	25.3	27.4	26.1	27.2	40.6	22.0	26.0	27.4	76.9	25.7	25.9	65.8	32.9	67.0	38.5	51.5	60.2	26.9	21.3	63.2	26.2	38.4	43.3	39.4	19.6	98.1	40.3	23.0	55.7	42.9	20.1	28.1	26.6	30.5	38.8	28.9	23.8	48.7	24.4	48.7	42.7	22.1	38.9	18.2	32.7	43.5	34.2	37.1	36.9	35.3	52.8	32.1	36.0	33.1	10.2	30.1	45.3	47.1	45.6	44.7	17.4	20.6	15.3	34.4	17.1	18.8	17.4	21.9	20.5	9.5	47.6	54.0	113.9	144.7	120.7	61.8	448.3	122.3	80.3	48.9	109.9	17.7	283.1	379.7	210.0	208.8	86.2	316.5	0.0	291.5	257.6	93.5	138.9	53.1	240.8	220.1	68.3	162.9	73.1	117.9	127.9	92.0	117.1	172.1	171.3	226.5	63.6	223.7	228.0	93.3	301.0	48.8	84.1	129.5	71.9	69.5	145.2	246.6	109.1	306.4	194.4
MDM2	"HDM2, MGC5370"	ENSG00000135679	"MDM2 proto-oncogene"	Q00987	12	68808176-68850686	"Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Host-virus interaction, Ubl conjugation pathway"	Transferase	"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HBEC3-KT: 95.6;U-698: 91.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB000086, CAB016303"	Supported		Supported	Nucleoplasm		NA	NA			Nucleoplasm		"CAB000086: AB_563872, CAB016303: AB_627920"	"unprognostic (1.16e-1)"	"prognostic favorable (3.23e-4)"	"unprognostic (6.16e-2)"	"prognostic favorable (4.51e-7)"	"unprognostic (7.25e-2)"	"unprognostic (6.91e-2)"	"unprognostic (3.77e-2)"	"unprognostic (1.72e-1)"	"unprognostic (2.45e-2)"	"unprognostic (3.23e-1)"	"unprognostic (1.80e-3)"	"unprognostic (2.36e-1)"	"unprognostic (4.22e-2)"	"unprognostic (4.59e-2)"	"unprognostic (1.81e-1)"	"unprognostic (2.68e-1)"	"unprognostic (8.95e-2)"	16.6	15.3	11.1	12.5	10.8	23.1	12.5	12.0	11.3	13.1	16.6	13.6	11.9	5.2	8.8	9.4	14.2	12.6	12.3	9.0	8.8	8.6	11.2	25.7	15.9	13.3	14.2	7.1	11.0	21.4	11.4	10.4	24.5	11.9	12.6	21.5	7.8	10.5	11.1	19.5	9.8	7.2	10.8	10.8	15.3	9.8	6.5	11.5	29.5	13.6	10.8	14.1	13.5	12.6	4.9	4.0	19.3	6.4	3.6	4.4	3.0	3.1	7.5	7.9	3.9	10.2	9.5	40.2	8.9	8.9	4.7	7.6	4.5	1.4	33.3	2.5	5.8	1.3	1.9	5.4	95.6	7.6	8.8	3.7	6.1	6.3	20.2	10.0	5.4	5.6	14.6	8.2	18.7	12.8	4.7	13.2	5.8	6.2	8.1	9.0	5.1	7.1	1.8	6.6	1.6	1.4	25.3	5.4	2.7	2.9	26.6	6.0	3.5	5.6	4.4	1.9	16.7	10.4	3.6	14.1	3.6	6.8	2.9	3.1	12.3	7.8	91.9	5.5	2.1	14.7	5.3	5.4	4.8	4.4	4.0	3.9	4.7	3.7	4.1	2.8	4.9	4.0	3.7	19.3	3.6	6.4	4.0	3.8	3.0	11.1	10.8	12.0	11.3	8.8	8.6	14.2	7.1	11.9	11.5	29.8	48.8	22.9	24.5	13.9	27.9	17.8	25.5	97.7	62.6	24.4	31.4	43.9	11.6	18.1	1.1	20.2	16.6	0.0	20.8	23.6	22.4	34.7	31.3	38.4	16.5	28.6	24.1	22.1	44.9	1.8	17.8	21.8	11.8	31.5	23.5	26.4	19.8	20.1	14.2	15.3	34.5	19.4	21.7	13.9	20.6	19.3	78.8	25.4	19.7	74.5
MDP1	"FN6Pase, MGC5987"	ENSG00000213920	"Magnesium dependent phosphatase 1"	Q86V88	14	24213937-24216070	"Enzymes, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"monocytes: 29.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"							"HPA003064, HPA070338"	Uncertain		Approved	Nucleoplasm		NA	NA		34000	Nucleoplasm		"HPA003064: AB_10602350, HPA070338: AB_2686256"	"unprognostic (2.70e-1)"	"unprognostic (3.68e-1)"	"unprognostic (2.51e-1)"	"unprognostic (2.11e-1)"	"unprognostic (3.09e-1)"	"unprognostic (5.46e-2)"	"unprognostic (5.48e-2)"	"unprognostic (1.12e-1)"	"unprognostic (6.27e-2)"	"unprognostic (8.02e-2)"	"unprognostic (2.00e-3)"	"unprognostic (1.02e-1)"	"prognostic favorable (5.96e-4)"	"unprognostic (6.39e-2)"	"unprognostic (1.32e-1)"	"unprognostic (3.82e-1)"	"unprognostic (3.19e-2)"	12.2	17.6	18.5	8.3	15.0	8.1	18.7	18.6	18.3	13.3	10.2	13.1	21.0	6.7	10.6	19.0	8.9	14.3	12.0	17.8	13.8	13.9	16.6	14.7	8.7	13.5	15.1	14.5	12.9	20.2	14.8	18.3	9.4	16.6	13.3	8.6	13.5	14.3	16.3	11.4	10.6	9.8	10.9	13.9	10.4	10.0	6.6	17.0	14.3	14.6	10.6	10.8	10.0	9.6	10.1	23.0	12.2	11.1	9.0	11.9	7.9	3.1	7.9	6.0	3.9	6.0	5.6	0.2	3.4	7.4	6.9	7.2	4.2	9.1	12.8	8.8	3.5	2.1	3.1	2.9	6.8	4.3	4.3	3.2	4.9	2.9	9.6	5.8	6.2	3.6	3.9	6.3	4.2	8.0	7.1	4.9	9.3	1.5	9.6	6.2	17.2	8.8	10.2	1.7	6.3	14.2	6.3	4.2	10.1	6.7	4.6	7.4	7.2	5.4	11.6	7.2	3.4	7.0	3.3	2.9	7.6	7.3	3.2	3.4	15.6	6.2	9.3	7.1	3.1	5.8	3.1	10.9	12.2	6.3	11.1	5.9	10.1	8.1	7.3	12.4	9.5	9.9	8.2	3.8	9.0	9.4	23.0	11.9	7.9	18.5	15.0	18.6	18.3	13.8	13.9	15.1	14.5	16.6	17.0	6.0	11.7	7.5	2.8	4.0	3.4	0.0	5.1	21.4	0.0	5.2	0.0	3.1	11.6	10.4	3.0	5.2	8.1	0.0	17.0	4.4	5.6	2.4	4.7	5.0	7.0	3.2	11.1	6.2	2.2	2.9	5.8	11.0	16.9	29.7	11.1	3.1	12.6	2.9	7.1	15.7	2.7	12.9	7.2	1.9	3.2	4.0	2.1	5.1	10.7	2.0
ME1		ENSG00000065833	"Malic enzyme 1"	P48163	6	83210389-83431071	"Enzymes, Plasma proteins, Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	10	"Kupffer cells: 57.7;Muller glia cells: 93.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	8	"MAIT T-cell: 15.6"	"Lineage enriched"	"Detected in many"	11	"T-cells: 15.6"	"Cell line enhanced"	"Detected in many"		"CACO-2: 42.9;OE19: 48.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA006493	Enhanced		Uncertain	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA		3800000	"Nucleoplasm, Plasma membrane"	Cytosol	"HPA006493: AB_1078272"	"unprognostic (7.21e-2)"	"unprognostic (3.99e-2)"	"unprognostic (2.24e-1)"	"unprognostic (3.12e-3)"	"prognostic unfavorable (7.73e-4)"	"unprognostic (7.98e-3)"	"prognostic unfavorable (4.57e-5)"	"unprognostic (3.24e-1)"	"unprognostic (4.44e-3)"	"unprognostic (1.41e-3)"	"unprognostic (7.10e-3)"	"unprognostic (2.43e-1)"	"prognostic unfavorable (1.81e-7)"	"unprognostic (4.07e-2)"	"unprognostic (2.49e-1)"	"unprognostic (1.85e-2)"	"unprognostic (4.51e-2)"	30.7	35.3	16.3	4.6	17.7	0.8	27.1	5.5	13.1	5.9	6.7	5.4	39.2	18.1	3.8	7.4	24.5	4.2	13.5	21.3	10.5	14.0	3.6	12.4	7.7	6.0	16.8	11.8	10.0	3.3	30.0	11.1	2.9	16.3	7.9	10.1	9.3	7.8	30.2	25.7	10.1	8.7	18.7	17.2	6.3	20.0	13.4	7.2	1.4	6.3	20.9	4.5	13.7	14.9	0.0	0.0	0.0	1.4	0.0	15.6	0.5	8.8	18.3	0.4	0.0	15.6	14.6	0.0	5.7	14.7	6.1	11.9	42.9	7.8	0.0	15.0	13.4	12.2	9.3	13.6	5.1	6.7	0.0	7.6	0.0	11.7	0.0	20.0	4.3	16.1	15.9	10.3	12.3	8.4	10.3	9.5	0.0	6.1	0.0	8.3	9.9	0.0	4.9	0.0	48.5	7.2	0.0	15.4	8.5	18.1	4.2	1.8	4.7	9.7	14.4	0.3	8.3	0.0	10.6	10.0	3.8	4.6	1.2	0.0	3.4	3.9	0.0	0.0	0.0	11.2	0.0	1.4	0.0	0.8	0.3	15.6	0.0	0.2	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.5	16.3	17.7	5.5	13.1	10.5	14.0	16.8	11.8	16.3	7.2	17.9	8.9	0.0	4.2	1.6	16.7	35.8	5.1	1.4	6.8	5.2	2.0	0.5	1.7	10.0	4.4	1.9	8.0	0.0	8.4	0.6	7.1	5.6	0.0	12.4	6.8	12.7	0.0	4.9	57.7	4.2	23.9	9.5	0.0	5.4	4.0	93.9	12.7	5.8	35.0	2.6	6.4	0.0	3.3	4.9	1.5	3.0	0.7	0.9	5.5	1.8
ME2		ENSG00000082212	"Malic enzyme 2"	P23368	18	50878734-50954257	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Allosteric enzyme, Oxidoreductase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Cardiomyocytes: 93.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008247, HPA008880"	Enhanced		Supported	Mitochondria		NA	NA		3400000	Mitochondria		"HPA008247: AB_1853704, HPA008880: AB_1853702"	"unprognostic (1.23e-1)"	"unprognostic (3.26e-1)"	"unprognostic (9.57e-3)"	"unprognostic (2.22e-1)"	"unprognostic (4.97e-2)"	"unprognostic (1.23e-1)"	"prognostic unfavorable (8.29e-8)"	"unprognostic (1.97e-1)"	"unprognostic (3.66e-2)"	"unprognostic (1.02e-1)"	"unprognostic (1.34e-2)"	"unprognostic (4.75e-2)"	"unprognostic (1.43e-2)"	"unprognostic (4.27e-3)"	"unprognostic (2.30e-1)"	"unprognostic (2.47e-1)"	"unprognostic (4.09e-1)"	12.6	18.1	17.1	18.4	16.2	11.6	10.7	13.2	16.0	9.4	26.4	14.3	16.8	30.2	10.5	7.7	10.6	9.3	10.5	34.6	15.8	17.8	12.1	12.1	10.3	24.1	18.7	14.0	11.1	16.7	20.6	20.2	10.5	47.7	11.8	26.6	9.4	8.8	23.1	29.5	7.1	44.8	16.9	18.9	36.6	20.3	15.3	8.7	24.3	9.0	7.8	17.3	14.2	15.7	4.9	9.6	14.3	17.4	6.7	6.0	4.5	13.0	13.1	17.5	20.4	8.0	8.9	8.1	10.9	8.2	14.3	12.1	6.0	7.2	46.7	4.3	9.7	13.1	10.9	26.1	11.1	16.5	19.3	4.0	11.9	8.3	7.0	23.6	39.6	14.3	5.5	13.6	18.0	29.3	9.4	18.3	27.8	12.6	11.4	9.7	2.7	28.6	3.9	11.7	9.4	5.4	18.8	8.7	13.5	15.6	2.8	21.7	11.5	10.2	6.3	10.9	11.0	4.8	19.3	11.3	10.2	11.4	5.3	14.5	21.3	8.6	22.9	10.3	28.3	10.8	5.0	11.6	14.3	5.0	13.1	4.1	4.9	3.3	6.0	9.6	4.9	2.9	3.5	13.3	6.7	17.4	3.2	3.1	4.5	17.1	16.2	13.2	16.0	15.8	17.8	18.7	14.0	47.7	8.7	8.9	11.0	34.0	15.3	13.5	17.4	93.2	7.6	5.3	26.1	14.0	13.7	14.6	33.2	28.0	13.4	14.8	44.5	0.0	34.2	14.5	10.8	15.2	15.1	7.4	87.2	7.9	11.5	30.7	83.1	4.7	10.6	39.2	11.8	27.9	24.3	13.0	27.5	20.1	15.6	14.0	55.9	6.5	15.4	50.9	20.4	9.4	7.2	26.1	35.2	14.8
ME3		ENSG00000151376	"Malic enzyme 3"	Q16798	11	86441108-86672636	"Enzymes, Plasma proteins, Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	8	"Cardiomyocytes: 48.7;Distal tubular cells: 36.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"myeloid DC: 5.0"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"CAPAN-2: 24.5;hTERT-RPE1: 29.4;HUVEC TERT2: 16.3;TIME: 18.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA038473	Approved					NA	NA					"HPA038473: AB_10672747"	"unprognostic (1.83e-3)"	"unprognostic (8.00e-2)"	"unprognostic (1.99e-1)"	"unprognostic (1.04e-1)"	"unprognostic (2.13e-1)"	"unprognostic (2.91e-1)"	"unprognostic (5.01e-2)"	"unprognostic (1.51e-1)"	"unprognostic (1.29e-1)"	"unprognostic (2.71e-1)"	"unprognostic (1.20e-1)"	"unprognostic (5.74e-2)"	"unprognostic (2.97e-1)"	"unprognostic (1.65e-1)"	"unprognostic (2.73e-1)"	"unprognostic (2.96e-2)"	"prognostic favorable (3.86e-4)"	17.2	15.9	16.0	6.3	27.7	5.8	13.1	15.7	26.1	19.3	14.3	4.8	7.3	7.8	15.8	7.6	5.0	9.0	12.9	21.9	12.2	13.1	12.6	3.9	8.1	4.3	12.5	18.1	22.1	16.7	28.5	15.4	5.4	20.2	13.0	15.0	11.5	13.6	10.3	21.2	3.0	7.1	15.6	5.5	7.3	20.8	8.8	8.4	2.8	8.2	6.3	2.9	10.3	10.2	0.0	5.0	0.0	0.9	2.2	3.1	1.0	0.0	8.2	2.3	0.0	3.7	7.8	0.0	2.8	4.3	5.8	7.4	6.2	24.5	0.0	2.5	2.6	14.7	0.1	0.0	0.0	2.6	4.3	0.0	4.2	6.8	0.0	5.5	0.5	0.0	5.4	1.2	4.7	0.0	29.4	16.3	0.0	0.0	0.0	3.8	0.8	1.1	0.0	0.5	0.7	3.4	3.6	0.0	0.3	5.2	9.5	2.8	0.0	1.7	0.0	0.0	1.0	0.4	0.6	18.1	0.7	0.5	12.2	0.4	0.0	1.5	0.0	0.6	7.6	0.7	0.0	0.9	0.0	1.9	0.1	0.0	0.0	1.9	3.1	5.0	0.0	2.3	2.7	0.0	2.2	0.3	0.6	0.0	1.0	16.0	27.7	15.7	26.1	12.2	13.1	12.5	18.1	20.2	8.4	3.0	3.5	0.8	4.4	2.1	15.2	48.7	5.1	17.4	4.5	3.5	0.0	0.1	36.5	6.9	0.5	8.3	11.0	0.0	6.9	0.3	3.9	5.3	0.0	0.5	6.9	19.1	8.6	11.1	1.8	1.3	5.8	2.5	1.7	1.8	11.2	1.7	8.3	9.3	6.0	5.5	2.3	12.9	3.7	0.3	0.2	1.4	0.0	1.3	9.3	6.0
MECR	"CGI-63, ETR1, FASN2B, NRBF1"	ENSG00000116353	"Mitochondrial trans-2-enoyl-CoA reductase"	Q9BV79	1	29192873-29230942	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism"	Oxidoreductase	"Disease mutation, Dystonia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Rod photoreceptor cells: 62.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA022018, HPA022030, HPA028740"	Enhanced		Supported	Mitochondria		NA	NA			Mitochondria		"HPA022018: AB_1853714, HPA022030: AB_1853716, HPA028740: AB_10601133"	"unprognostic (2.53e-1)"	"unprognostic (1.09e-2)"	"unprognostic (1.52e-1)"	"unprognostic (1.84e-1)"	"unprognostic (1.07e-1)"	"unprognostic (2.46e-1)"	"unprognostic (1.39e-1)"	"unprognostic (2.07e-1)"	"unprognostic (1.34e-1)"	"unprognostic (1.69e-1)"	"unprognostic (3.06e-2)"	"unprognostic (8.66e-2)"	"prognostic favorable (5.81e-6)"	"unprognostic (7.01e-3)"	"unprognostic (3.29e-2)"	"unprognostic (2.59e-1)"	"prognostic unfavorable (5.29e-4)"	16.4	11.9	16.0	6.6	17.0	6.0	12.3	7.8	17.7	13.0	9.7	8.6	7.1	7.8	10.5	8.4	9.4	10.9	8.5	24.8	15.7	11.5	11.0	13.7	8.3	10.0	14.7	16.3	11.7	14.3	8.1	10.0	10.8	12.8	7.5	8.9	10.8	12.6	10.0	45.5	11.3	5.9	10.2	10.7	5.4	8.1	8.2	10.5	4.4	8.3	12.8	7.6	8.0	7.2	8.3	14.7	0.3	11.5	11.6	13.1	6.5	10.2	9.8	4.8	22.2	4.9	8.7	17.6	7.8	8.8	10.2	9.9	7.4	21.0	13.5	15.6	7.6	3.2	12.8	6.0	15.8	6.3	9.2	12.4	11.7	6.3	9.4	15.2	12.9	6.0	8.6	14.1	5.4	19.9	8.5	11.2	17.3	10.0	14.0	12.7	11.5	10.9	7.1	12.9	19.5	12.5	6.7	8.1	23.7	10.8	5.9	7.3	11.3	11.5	16.4	14.4	9.8	6.0	12.5	11.3	7.4	8.0	11.5	11.4	13.4	5.5	10.0	20.0	17.2	14.0	0.1	7.0	0.0	8.3	11.5	13.1	8.3	7.8	6.7	14.7	7.4	8.4	8.5	0.3	11.6	7.0	8.6	6.3	6.5	16.0	17.0	7.8	17.7	15.7	11.5	14.7	16.3	12.8	10.5	11.9	3.8	8.2	13.8	4.9	12.0	17.1	15.3	2.7	11.4	19.2	9.8	41.0	34.9	18.9	31.2	8.0	7.8	0.0	17.2	32.6	12.7	8.1	5.7	18.3	18.3	7.9	7.5	4.9	4.9	60.9	12.7	6.0	15.1	12.6	9.8	10.9	14.2	7.0	10.3	32.7	62.2	12.9	8.9	6.7	15.0	6.5	23.3	4.9	19.9	15.6
MELK	KIAA0175	ENSG00000165304	"Maternal embryonic leucine zipper kinase"	Q14680	9	36572862-36677683	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Apoptosis, Cell cycle"	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 42.4"	"Cell type enhanced"	"Detected in many"	15	"Extravillous trophoblasts: 36.8;Spermatocytes: 10.2;Spermatogonia: 19.0"	"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Cell type enriched"	"Detected in some"	5	"T-reg: 4.8"	"Lineage enriched"	"Detected in many"	5	"T-cells: 4.8"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			HPA017214	Uncertain					NA	Yes					"HPA017214: AB_1853798"	"unprognostic (5.03e-2)"	"unprognostic (9.57e-2)"	"unprognostic (2.27e-2)"	"unprognostic (3.42e-3)"	"unprognostic (2.16e-1)"	"unprognostic (1.23e-1)"	"prognostic unfavorable (2.91e-7)"	"prognostic unfavorable (3.99e-4)"	"unprognostic (1.26e-2)"	"unprognostic (1.60e-2)"	"prognostic unfavorable (4.58e-4)"	"unprognostic (4.69e-2)"	"prognostic unfavorable (0.00e+0)"	"unprognostic (8.86e-3)"	"unprognostic (1.37e-1)"	"unprognostic (2.40e-1)"	"unprognostic (1.35e-1)"	1.5	1.1	0.3	11.4	0.6	7.7	2.6	0.2	0.8	2.1	5.9	0.3	0.1	4.5	1.2	1.5	12.2	0.4	1.6	1.3	0.5	0.4	1.2	1.3	2.0	8.3	0.4	0.1	0.7	0.8	0.0	0.3	6.3	0.5	0.7	7.8	0.4	2.3	0.1	0.9	2.8	4.6	1.9	1.0	5.2	2.9	11.3	0.4	42.4	0.5	7.2	12.6	1.5	3.3	0.1	0.6	1.0	0.1	0.4	4.8	0.5	35.6	18.4	24.8	14.6	3.4	5.9	14.4	26.5	18.7	37.2	45.9	14.0	14.1	11.9	8.5	13.0	32.5	12.3	21.6	16.6	41.1	32.5	8.6	9.4	21.8	14.0	1.3	14.5	11.9	2.1	3.0	28.6	16.3	4.8	18.7	18.6	11.9	19.1	30.4	11.9	18.0	6.8	19.8	16.1	14.4	16.7	16.7	7.6	11.4	12.0	16.8	12.5	14.1	13.6	8.6	14.4	11.4	6.9	9.2	20.1	25.4	16.9	24.1	3.8	13.6	17.9	12.7	10.8	27.2	0.0	0.0	1.0	0.2	0.0	0.0	0.1	0.8	1.0	0.0	0.0	0.0	0.6	0.0	0.4	0.1	0.6	4.8	0.5	0.3	0.6	0.2	0.8	0.5	0.4	0.4	0.1	0.5	0.4	0.0	0.0	0.0	0.4	4.0	0.0	0.3	0.0	1.4	2.3	0.0	0.0	4.2	0.0	0.8	1.8	0.0	1.2	0.0	1.0	36.8	2.1	0.2	0.0	0.2	8.4	0.0	0.0	1.3	0.6	1.8	1.1	2.3	0.0	5.4	1.3	0.0	1.1	2.9	0.0	0.0	0.0	0.0	0.9	10.2	19.0	1.5	7.4	0.0	3.7	1.4
MEP1A	PPHA	ENSG00000112818	"Meprin A subunit alpha"	Q16819	6	46793390-46839782	"Enzymes, Plasma proteins, Predicted membrane proteins"		"Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	52	"intestine: 243.0"	"Group enriched"	"Detected in some"	4	"Enterocytes: 391.5;Paneth cells: 129.6"	"Cancer enriched"	"Detected in many"	5	"colorectal cancer: 38.6"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"myeloid DC: 1.6"	"Lineage enriched"	"Detected in single"	8	"dendritic cells: 1.6"	"Cell line enhanced"	"Detected in some"		"BEWO: 3.1;CACO-2: 7.1;Hep G2: 1.9;NB-4: 3.1;RPMI-8226: 3.5;SH-SY5Y: 2.2;U-2197: 2.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"CAB025163, HPA029416"	Enhanced					NA	NA		990000			"CAB025163: , HPA029416: AB_10600823"	"unprognostic (1.83e-1)"	"unprognostic (2.81e-4)"	"unprognostic (2.03e-1)"	"unprognostic (8.53e-2)"	"unprognostic (8.73e-2)"	"unprognostic (1.13e-1)"	"unprognostic (2.43e-2)"	"unprognostic (5.27e-4)"	"unprognostic (2.05e-1)"	"unprognostic (2.35e-2)"	"unprognostic (1.42e-1)"	"unprognostic (2.11e-1)"	"unprognostic (1.11e-3)"	"unprognostic (1.45e-1)"	"unprognostic (1.91e-2)"	"unprognostic (4.70e-3)"	"unprognostic (1.68e-1)"	0.1	0.1	0.1	4.7	0.1	0.0	0.1	0.1	0.1	0.1	100.5	0.1	0.1	51.7	0.1	0.1	0.1	0.2	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.2	0.1	0.1	0.5	0.0	0.1	0.1	0.1	0.1	19.8	0.1	0.2	0.1	0.1	0.1	243.0	0.2	0.2	0.2	0.1	0.3	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	1.6	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.1	0.0	0.0	0.0	0.0	7.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.2	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.1	0.0	0.2	0.0	0.0	0.0	3.5	0.0	0.0	0.5	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.2	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.8	0.0	391.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	14.9	0.0	0.0	4.7	0.0	0.0	0.0	0.0	61.3	0.0	0.0	129.6	0.4	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	28.3	0.0
MEP1B		ENSG00000141434	"Meprin A subunit beta"	Q16820	18	32185069-32220404	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins, Transporters"	"Inflammatory response"	"Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	167	"intestine: 241.5"	"Group enriched"	"Detected in some"	6	"Early spermatids: 2.1;Enterocytes: 6.3"	"Group enriched"	"Detected in some"	5	"pancreatic cancer: 3.0;stomach cancer: 0.6"	"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"SCLC-21H: 10.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA029119	Enhanced				"Secreted to digestive system"	NA	NA		120000			"HPA029119: AB_2672913"	"unprognostic (1.33e-1)"	"unprognostic (6.72e-2)"	"unprognostic (2.79e-2)"	"unprognostic (1.00e-1)"	"unprognostic (3.50e-4)"	"unprognostic (1.27e-1)"	"unprognostic (1.74e-2)"	"unprognostic (4.30e-1)"	"unprognostic (1.73e-1)"	"unprognostic (1.24e-2)"	"unprognostic (1.55e-1)"	"unprognostic (8.31e-4)"	"unprognostic (4.74e-2)"	"unprognostic (3.39e-1)"	"unprognostic (2.71e-1)"	"unprognostic (3.39e-2)"	"unprognostic (3.75e-2)"	0.1	0.1	0.1	0.4	0.1	0.0	0.1	0.3	0.1	0.1	78.8	0.0	0.0	54.5	0.1	0.0	0.1	0.1	0.2	0.1	0.1	0.1	0.1	1.2	0.1	0.0	0.1	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.1	0.2	0.0	0.1	0.0	0.1	0.1	241.5	0.0	0.1	0.1	0.1	0.3	0.0	0.0	0.1	0.0	0.0	0.1	0.1	1.1	0.4	0.3	0.3	0.0	1.4	0.5	0.2	0.0	0.0	0.5	0.6	0.0	2.1	1.0	0.3	0.3	0.1	0.6	1.4	1.7	0.5	0.0	0.8	0.2	0.0	0.0	0.0	0.8	1.0	1.1	0.7	0.6	0.4	1.3	0.3	0.0	0.7	0.0	0.1	0.7	0.5	1.6	1.1	0.2	0.0	1.9	1.3	4.1	1.3	0.5	0.0	1.8	1.8	2.9	0.0	0.7	10.6	2.4	0.8	0.2	0.3	0.3	0.4	3.1	0.9	1.4	0.8	3.4	0.0	0.6	2.3	0.5	2.6	0.0	0.5	0.0	0.3	0.3	1.0	0.1	1.3	1.1	0.7	1.4	0.4	0.1	1.2	0.3	0.2	0.0	0.1	0.2	0.5	0.5	0.1	0.1	0.3	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	6.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.0
MERTK	"c-Eyk, mer, RP38, Tyro12"	ENSG00000153208	"MER proto-oncogene, tyrosine kinase"	Q12866	2	111898479-112029561	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"		"Kinase, Receptor, Transferase, Tyrosine-protein kinase"	"Disease mutation, Proto-oncogene, Retinitis pigmentosa"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	15	"Ito cells: 36.8;Kupffer cells: 92.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	10	"intermediate monocyte: 10.3;non-classical monocyte: 6.4"	"Lineage enriched"	"Detected in single"	48	"monocytes: 10.3"	"Cell line enhanced"	"Detected in many"		"CACO-2: 21.3;Hep G2: 22.1;HUVEC TERT2: 22.0;RT4: 13.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036196, HPA075622"	Enhanced		Approved	"Endoplasmic reticulum,Plasma membrane,Midbody,Cytosol"		NA	NA		29000000	"Plasma membrane"	"Endoplasmic reticulum, Midbody, Cytosol"	"HPA036196: AB_10670676, HPA075622: AB_2686759"	"unprognostic (2.17e-2)"	"unprognostic (8.10e-2)"	"unprognostic (4.85e-2)"	"unprognostic (2.68e-1)"	"unprognostic (2.44e-1)"	"unprognostic (1.77e-1)"	"unprognostic (1.07e-1)"	"prognostic favorable (4.74e-4)"	"unprognostic (6.84e-2)"	"unprognostic (1.25e-1)"	"unprognostic (6.22e-2)"	"unprognostic (3.72e-1)"	"prognostic favorable (4.43e-5)"	"unprognostic (5.13e-2)"	"unprognostic (2.11e-1)"	"unprognostic (5.86e-2)"	"unprognostic (2.05e-2)"	20.1	55.1	13.1	12.5	17.8	1.9	31.8	6.2	13.8	10.8	13.8	6.8	27.7	11.5	11.3	25.4	8.4	12.8	11.7	7.1	16.5	6.3	14.2	18.9	12.7	30.3	8.1	10.1	12.9	9.0	23.9	14.3	18.4	18.6	14.1	7.9	20.4	6.8	24.9	6.4	6.4	12.8	13.6	12.2	38.4	12.3	17.3	9.8	1.7	9.9	2.0	8.4	14.1	26.6	0.0	0.2	0.1	10.3	0.0	0.0	0.3	0.5	0.9	4.4	10.0	0.2	0.1	7.1	0.0	0.1	0.5	1.0	21.3	1.3	0.1	4.7	0.0	4.6	0.1	5.8	0.0	0.8	0.8	3.1	3.8	0.0	22.1	0.1	0.1	0.9	0.2	0.0	5.1	0.3	2.3	22.0	0.8	1.2	2.0	1.7	1.0	0.0	5.0	2.7	0.6	3.4	1.4	1.2	1.7	11.2	13.1	0.1	4.2	0.1	0.3	1.7	1.6	0.0	0.2	3.3	0.6	2.0	0.0	0.0	1.7	2.5	0.0	0.0	0.8	0.0	0.0	0.8	0.0	0.0	10.3	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	6.4	0.1	0.0	0.3	13.1	17.8	6.2	13.8	16.5	6.3	8.1	10.1	18.6	9.8	3.0	20.1	0.8	2.9	1.4	0.6	2.1	5.1	1.4	11.4	0.0	2.0	2.6	1.7	0.8	1.6	7.1	1.6	0.0	0.8	1.0	4.1	2.0	0.0	8.9	23.6	0.0	0.0	36.8	92.6	1.5	4.6	11.0	0.0	0.0	2.3	8.6	1.7	1.9	6.3	1.9	9.2	6.5	11.3	0.5	1.5	1.1	15.8	0.8	1.8	1.4
MET	"DFNB97, HGFR, RCCP2"	ENSG00000105976	"MET proto-oncogene, receptor tyrosine kinase"	P08581	7	116672390-116798386	"Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins, RAS pathway related proteins"		"Kinase, Receptor, Transferase, Tyrosine-protein kinase"	"Cancer-related genes, Deafness, Disease mutation, FDA approved drug targets, Non-syndromic deafness, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	6	"Alveolar cells type 2: 78.1;Club cells: 116.0;Urothelial cells: 88.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"A-431: 45.3;CAPAN-2: 49.5"	"Group enriched"	"Detected in many"	5	"amygdala: 3.5;basal ganglia: 9.9;cerebral cortex: 7.6;hippocampal formation: 8.0;olfactory region: 9.1"	"Low region specificity"	"Detected in many"			"CAB005282, CAB018577, HPA055607"	Approved		Approved	"Plasma membrane,Cytosol"	"Secreted to blood"	NA	NA	179000000	70000000	"Plasma membrane, Cytosol"		"CAB005282: AB_631940, CAB018577: AB_649068, HPA055607: AB_2682860"	"unprognostic (1.60e-2)"	"unprognostic (7.71e-2)"	"unprognostic (2.53e-2)"	"unprognostic (1.58e-1)"	"unprognostic (3.57e-3)"	"prognostic unfavorable (6.75e-4)"	"unprognostic (1.68e-1)"	"unprognostic (3.22e-2)"	"unprognostic (3.81e-2)"	"unprognostic (2.52e-2)"	"prognostic unfavorable (1.21e-7)"	"unprognostic (1.86e-1)"	"unprognostic (1.25e-1)"	"unprognostic (5.53e-2)"	"unprognostic (8.88e-2)"	"unprognostic (2.01e-2)"	"unprognostic (2.20e-1)"	16.2	1.1	1.8	4.5	2.3	4.3	11.2	0.9	15.2	9.9	6.5	2.4	2.4	4.4	7.5	5.2	5.1	4.6	12.3	5.4	5.7	1.8	20.1	30.2	15.6	1.4	3.6	2.1	2.0	9.3	0.7	8.1	24.4	2.6	8.0	6.6	34.1	12.2	8.4	12.8	7.2	8.6	4.0	2.3	5.7	10.6	2.7	2.4	0.5	21.4	7.0	2.1	10.1	15.0	0.2	0.3	1.2	0.2	0.3	0.4	0.0	45.3	26.1	0.0	0.1	2.0	2.0	1.8	25.9	10.5	14.0	11.8	5.4	49.5	2.0	43.2	16.2	37.7	12.0	4.4	24.7	28.6	0.1	5.6	0.0	27.1	4.7	0.3	0.0	0.0	2.6	9.8	9.1	30.0	25.3	9.6	0.0	0.9	0.2	25.9	1.0	0.0	0.0	3.9	7.2	26.6	0.0	22.0	0.0	24.5	5.2	3.8	0.0	10.6	3.4	10.1	4.7	0.0	0.2	17.6	20.9	7.4	11.0	20.0	0.5	4.0	0.2	22.9	0.0	2.9	1.1	0.2	0.4	0.4	0.1	0.2	0.2	0.2	0.2	0.1	0.2	0.2	0.2	1.2	0.3	0.1	0.3	0.1	0.0	1.8	2.3	0.9	15.2	5.7	1.8	3.6	2.1	2.6	2.4	26.8	78.1	2.4	56.1	34.7	0.9	10.0	15.3	22.7	116.0	29.6	0.0	57.9	0.0	28.0	0.0	11.7	11.2	0.0	39.8	5.0	4.0	55.8	0.0	26.0	6.1	0.0	6.9	1.3	1.0	0.0	0.6	2.0	3.3	1.8	19.7	7.4	69.4	7.0	0.0	13.5	0.3	0.0	2.3	0.0	0.6	15.6	18.2	0.0	12.7	88.5
METAP1	"KIAA0094, MAP1A, MetAP1A"	ENSG00000164024	"Methionyl aminopeptidase 1"	P53582	4	98995620-99062813	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Aminopeptidase, Hydrolase, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	14	"Early spermatids: 345.0;Late spermatids: 1171.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB025485, HPA037997, HPA037998"	Approved		Approved	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA		11000	Cytosol	"Nucleoplasm, Plasma membrane"	"CAB025485: , HPA037997: AB_2675777, HPA037998: AB_2675778"	"unprognostic (1.79e-1)"	"unprognostic (3.39e-1)"	"prognostic favorable (7.22e-4)"	"unprognostic (1.58e-2)"	"unprognostic (6.53e-2)"	"unprognostic (2.15e-1)"	"prognostic unfavorable (3.08e-5)"	"unprognostic (1.09e-1)"	"unprognostic (1.51e-3)"	"unprognostic (2.05e-1)"	"prognostic unfavorable (2.28e-5)"	"unprognostic (2.00e-1)"	"prognostic favorable (1.72e-4)"	"unprognostic (5.50e-2)"	"unprognostic (8.51e-2)"	"unprognostic (1.15e-3)"	"prognostic favorable (9.31e-4)"	12.1	8.3	10.0	16.0	10.1	11.8	18.6	9.2	13.8	16.0	17.9	7.0	22.9	13.4	24.1	25.9	37.2	14.0	12.3	27.9	9.5	7.1	14.3	13.7	10.7	12.6	7.9	9.8	11.3	13.0	7.8	14.4	9.2	9.9	19.1	19.3	7.5	19.0	21.5	27.2	16.4	15.2	27.8	10.1	13.9	11.6	46.8	8.1	27.0	10.8	21.8	19.1	36.6	22.6	12.7	11.7	10.4	11.1	12.5	19.2	10.8	21.7	21.5	18.9	20.3	15.0	24.1	21.0	31.2	20.1	26.7	25.5	24.1	32.5	32.3	12.5	25.2	16.0	21.9	33.1	31.2	37.1	22.5	15.8	28.8	15.7	25.9	16.3	38.9	24.2	17.3	22.8	22.7	24.1	20.8	21.9	18.3	22.5	19.5	28.5	16.6	34.1	18.6	23.2	37.1	17.5	22.4	29.5	17.2	42.9	28.2	25.9	15.3	10.4	32.4	12.3	22.1	12.4	14.9	17.8	21.6	27.5	19.8	27.2	14.2	19.9	25.5	18.6	20.0	21.4	10.4	9.4	4.2	14.9	11.1	19.2	12.7	15.4	14.5	11.7	10.1	15.1	13.5	2.3	12.5	10.7	5.8	13.4	10.8	10.0	10.1	9.2	13.8	9.5	7.1	7.9	9.8	9.9	8.1	38.7	10.5	13.7	44.1	37.7	4.6	49.8	20.4	18.7	17.0	14.0	2.0	22.0	11.6	26.9	345.0	13.5	29.0	0.0	25.4	55.9	12.3	21.8	3.5	16.4	15.6	3.2	7.5	16.5	19.6	1171.9	17.8	14.6	15.1	6.4	25.2	8.3	22.3	34.2	21.2	22.9	3.5	25.8	22.1	15.1	46.4	33.9	6.4	15.2	32.6	39.6
METAP1D	"MAP1D, Metap1l"	ENSG00000172878	"Methionyl aminopeptidase type 1D, mitochondrial"	Q6UB28	2	171999583-172082430	"Enzymes, Predicted intracellular proteins"		"Aminopeptidase, Hydrolase, Protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Leydig cells: 31.1;Peritubular cells: 24.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030298, HPA030299"	Uncertain		Uncertain	Vesicles		NA	NA			Vesicles		"HPA030298: AB_2673419, HPA030299: AB_10602421"	"unprognostic (5.31e-2)"	"unprognostic (1.07e-1)"	"unprognostic (1.88e-1)"	"unprognostic (5.83e-2)"	"unprognostic (2.54e-2)"	"unprognostic (7.90e-3)"	"unprognostic (1.92e-3)"	"unprognostic (1.07e-2)"	"unprognostic (4.55e-1)"	"unprognostic (7.07e-2)"	"unprognostic (2.64e-2)"	"unprognostic (8.19e-2)"	"unprognostic (2.53e-3)"	"unprognostic (3.44e-3)"	"unprognostic (3.06e-2)"	"unprognostic (5.48e-3)"	"unprognostic (2.92e-2)"	7.1	7.5	7.2	8.0	8.4	6.3	8.2	6.7	9.2	6.5	6.1	9.6	6.5	5.0	9.0	6.4	5.2	10.3	4.5	6.4	6.0	4.9	5.4	8.3	3.6	8.1	9.3	7.1	18.9	23.8	5.5	13.8	4.1	8.6	8.3	7.1	7.3	9.7	10.3	13.8	7.1	5.9	10.0	7.2	8.6	6.3	5.9	9.5	2.1	5.6	6.3	6.7	5.4	5.7	2.5	0.5	0.2	1.2	1.2	3.6	0.7	3.3	2.7	3.9	13.2	5.8	7.6	8.1	3.9	3.9	6.2	4.0	6.1	4.5	1.7	7.1	4.1	6.4	6.2	8.6	6.8	6.4	6.0	10.3	9.5	7.0	8.1	6.2	5.6	2.5	5.8	10.7	6.2	10.0	5.4	3.5	6.6	13.7	4.9	4.7	4.1	3.2	7.6	7.2	9.6	3.3	7.2	3.4	3.0	4.4	4.7	8.2	3.2	2.7	5.6	9.6	3.6	6.5	7.6	4.1	8.0	6.3	4.8	3.7	6.1	5.5	3.8	5.7	11.2	7.6	0.0	0.2	0.0	1.3	1.2	0.6	1.2	1.9	0.7	0.5	2.5	1.9	3.6	0.2	1.2	0.2	0.0	1.4	0.7	7.2	8.4	6.7	9.2	6.0	4.9	9.3	7.1	8.6	9.5	0.0	5.8	5.8	8.8	4.9	4.9	3.4	5.1	1.4	1.2	3.5	2.0	3.9	6.6	2.1	0.6	3.8	0.4	0.0	2.9	3.9	8.0	4.7	4.6	6.0	3.4	4.8	0.0	6.2	2.8	0.9	31.1	1.3	5.0	0.0	2.6	3.2	1.8	0.0	24.8	3.8	4.9	12.9	5.6	6.9	10.6	5.0	1.6	6.9	5.2	4.1
METAP2	"MAP2, MNPEP, p67"	ENSG00000111142	"Methionyl aminopeptidase 2"	P50579	12	95473520-95515839	"Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"		"Aminopeptidase, Hydrolase, Protease"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB013025, HPA019095"	Enhanced		Supported	"Plasma membrane,Cytosol"		NA	NA		22000	"Plasma membrane, Cytosol"		"CAB013025: AB_2533993, HPA019095: AB_1853823"	"unprognostic (1.91e-1)"	"unprognostic (1.02e-1)"	"unprognostic (5.92e-2)"	"unprognostic (2.44e-1)"	"unprognostic (3.27e-2)"	"unprognostic (2.57e-2)"	"prognostic unfavorable (4.51e-6)"	"unprognostic (1.25e-1)"	"unprognostic (2.28e-2)"	"unprognostic (1.40e-2)"	"unprognostic (8.53e-2)"	"unprognostic (1.66e-1)"	"unprognostic (1.49e-1)"	"unprognostic (2.51e-1)"	"unprognostic (1.07e-1)"	"unprognostic (2.95e-2)"	"unprognostic (1.03e-1)"	24.2	36.4	25.8	49.9	33.7	39.1	25.1	25.9	32.3	23.9	26.2	16.3	102.5	16.6	28.7	25.4	30.1	22.5	21.7	30.7	29.6	24.0	26.0	46.8	22.1	32.6	29.1	23.4	29.4	31.9	21.0	36.1	25.1	42.9	24.2	24.0	10.1	22.1	140.7	94.4	28.7	19.7	26.1	48.2	25.2	22.2	26.3	27.7	32.1	24.1	29.0	55.2	33.4	37.3	39.4	31.8	21.3	27.1	25.7	32.0	16.2	33.9	28.6	30.6	23.8	18.7	30.0	23.6	33.5	23.4	33.0	23.5	41.5	16.3	98.8	21.1	23.9	19.2	21.9	34.4	25.6	38.0	23.5	29.7	44.2	21.8	29.2	19.9	54.7	21.7	25.9	27.4	31.2	30.6	39.6	35.1	34.1	57.2	11.2	24.4	22.3	40.5	37.4	37.5	19.6	42.8	31.9	26.5	32.4	22.6	36.0	23.8	31.3	29.7	24.3	29.3	27.6	29.3	26.0	30.1	19.0	18.4	21.2	35.3	16.2	42.1	105.9	10.8	30.9	23.8	21.3	27.1	11.1	23.8	19.1	29.2	39.4	26.7	26.6	24.4	37.6	32.0	29.7	1.2	25.7	22.3	31.8	25.3	16.2	25.8	33.7	25.9	32.3	29.6	24.0	29.1	23.4	42.9	27.7	262.0	228.6	96.8	102.9	207.2	62.7	117.4	91.7	104.4	160.3	275.7	62.8	125.5	139.3	94.7	135.8	104.6	80.2	256.9	126.2	136.4	102.7	68.6	119.0	278.9	86.9	71.5	88.0	102.5	122.4	83.3	92.9	93.2	87.7	80.2	109.6	67.6	105.7	83.4	100.4	81.6	68.7	97.0	97.6	340.7	217.0	187.9	143.8	93.5	118.5	90.7
METTL1	"C12orf1, TRM8, TRMT8"	ENSG00000037897	"Methyltransferase like 1"	Q9UBP6	12	57768471-57772793	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"tRNA processing"	"Methyltransferase, RNA-binding, Transferase, tRNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Proximal tubular cells: 53.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enriched"	"Detected in all"	6	"RH-30: 78.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA020914, HPA050450"	Uncertain		Supported	Nucleoplasm		NA	NA			Nucleoplasm		"HPA020914: AB_1853830, HPA050450: AB_2681130"	"unprognostic (5.24e-2)"	"unprognostic (2.60e-1)"	"unprognostic (9.43e-2)"	"unprognostic (3.46e-1)"	"unprognostic (9.01e-2)"	"unprognostic (1.41e-2)"	"prognostic unfavorable (4.25e-6)"	"unprognostic (5.67e-2)"	"unprognostic (6.19e-2)"	"unprognostic (1.14e-3)"	"unprognostic (1.78e-1)"	"unprognostic (2.32e-1)"	"prognostic unfavorable (3.55e-6)"	"unprognostic (7.75e-2)"	"unprognostic (1.96e-1)"	"unprognostic (5.01e-2)"	"unprognostic (2.22e-1)"	12.2	16.6	6.7	13.8	8.8	8.4	12.3	2.2	6.9	7.6	7.6	4.5	10.8	3.3	9.4	21.2	10.3	9.0	10.7	8.1	5.8	5.0	20.9	15.3	7.7	8.8	7.4	4.6	17.6	34.9	10.9	10.6	8.3	6.5	11.0	10.3	5.3	17.9	17.2	20.4	8.5	5.7	10.5	5.0	8.2	7.3	11.4	5.4	4.5	15.1	15.6	9.8	8.8	7.8	6.1	12.6	0.7	6.7	7.3	18.6	5.1	6.1	11.2	4.7	4.3	6.4	4.4	6.4	6.6	6.0	11.1	6.0	7.8	8.6	7.4	12.3	8.0	6.3	7.3	7.2	10.2	10.8	4.4	8.4	8.6	4.3	9.5	4.5	9.3	4.5	3.9	9.3	12.4	8.7	5.4	5.9	4.8	7.9	7.4	5.6	11.9	6.5	11.1	11.1	8.2	11.3	5.8	78.7	10.9	9.7	7.7	5.0	4.5	6.9	7.6	6.1	4.9	10.0	8.8	4.4	4.5	5.0	7.9	8.7	3.4	2.5	9.0	6.4	6.7	9.3	0.0	4.7	0.0	5.3	6.7	18.6	4.7	6.9	6.5	10.3	6.1	9.5	9.2	0.7	7.3	1.1	12.6	3.3	5.1	6.7	8.8	2.2	6.9	5.8	5.0	7.4	4.6	6.5	5.4	8.9	3.5	8.9	11.4	9.3	2.9	3.6	2.5	1.4	17.0	5.2	0.0	15.0	21.6	15.2	11.3	7.1	1.3	0.0	20.6	19.6	12.0	7.7	12.7	9.0	22.2	3.2	6.3	4.3	1.0	8.6	10.3	9.0	6.8	27.1	5.6	1.6	12.8	0.0	4.6	53.6	5.5	0.0	14.7	4.8	14.7	9.2	8.1	4.3	9.1	10.5
METTL11B	"C1orf184, HOMT1B"	ENSG00000203740	"Methyltransferase like 11B"	Q5VVY1	1	170146001-170167790	"Enzymes, Predicted intracellular proteins"		"Methyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in some"	8	"heart muscle: 7.0;skeletal muscle: 3.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	7	"NTERA-2: 6.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA028049	Uncertain					NA	NA					"HPA028049: AB_10610139"	"unprognostic (1.12e-1)"	"unprognostic (2.57e-1)"	"unprognostic (5.62e-2)"		"unprognostic (7.59e-2)"	"unprognostic (7.25e-2)"		"unprognostic (1.19e-1)"	"unprognostic (8.68e-2)"	"unprognostic (5.24e-2)"	"unprognostic (2.76e-3)"			"unprognostic (5.43e-2)"	"unprognostic (4.56e-1)"		"unprognostic (5.79e-4)"	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.2	7.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.0	0.0	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.6			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	6.3	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.9	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0
METTL16	"METT10D, MGC3329"	ENSG00000127804	"Methyltransferase like 16"	Q86W50	17	2405562-2511891	"Enzymes, Predicted intracellular proteins"		"Methyltransferase, RNA-binding, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA020352, HPA059798"	Uncertain		Supported	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA020352: AB_1853828, HPA059798: AB_2684128"	"unprognostic (4.94e-3)"	"unprognostic (2.86e-2)"	"unprognostic (2.29e-2)"	"unprognostic (5.66e-3)"	"unprognostic (1.50e-1)"	"unprognostic (5.47e-2)"	"unprognostic (3.35e-2)"	"unprognostic (1.88e-1)"	"unprognostic (1.25e-1)"	"unprognostic (3.46e-1)"	"prognostic favorable (3.06e-4)"	"unprognostic (5.35e-2)"	"unprognostic (4.85e-3)"	"unprognostic (2.91e-2)"	"unprognostic (2.32e-1)"	"unprognostic (1.61e-1)"	"unprognostic (2.68e-2)"	12.7	14.0	13.1	11.0	15.2	13.1	14.1	22.5	14.4	14.9	13.1	19.8	11.2	8.6	21.6	10.6	11.0	16.5	9.6	12.4	12.6	9.7	11.5	6.9	12.2	13.1	18.3	9.7	22.5	13.5	19.7	22.8	7.5	13.6	13.5	10.4	18.3	12.1	13.1	14.2	14.7	10.4	16.5	14.6	11.1	11.2	11.0	17.5	15.7	16.5	8.8	17.5	15.3	12.7	5.7	3.1	2.3	3.2	2.0	8.1	2.0	6.1	16.4	9.3	8.9	7.0	8.9	8.7	7.8	6.8	8.9	7.4	21.8	4.0	19.3	8.5	7.1	9.5	8.9	21.4	10.7	12.2	7.3	13.6	9.9	13.5	9.9	7.6	9.1	8.0	7.5	10.2	12.3	18.2	6.1	9.2	11.3	12.9	10.4	6.0	6.7	13.0	5.4	10.6	7.6	6.9	21.7	9.8	8.7	6.5	5.6	4.9	7.7	11.7	6.4	6.9	10.0	8.1	5.8	6.7	8.2	5.3	11.6	11.3	6.1	7.5	13.8	11.1	7.6	11.1	2.3	3.2	1.2	5.7	2.1	7.2	5.7	5.6	5.5	2.2	5.0	8.1	5.9	0.1	2.0	1.5	3.1	3.5	2.0	13.1	15.2	22.5	14.4	12.6	9.7	18.3	9.7	13.6	17.5	11.9	31.0	7.0	19.7	10.2	26.4	14.0	15.3	34.8	36.4	7.0	43.2	7.3	11.6	8.4	12.4	12.9	15.8	0.0	9.2	7.9	8.9	15.5	24.3	7.3	8.9	25.4	19.5	19.6	9.2	5.4	13.8	8.2	8.5	9.0	12.7	25.1	8.0	3.5	12.0	7.0	38.8	6.5	13.2	11.4	17.4	11.2	5.0	20.8	14.0	13.5
METTL3	"M6A, MT-A70, Spo8"	ENSG00000165819	"Methyltransferase like 3"	Q86U44	14	21498133-21511375	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Biological rhythms, Differentiation, DNA damage, Immunity, Innate immunity, Spermatogenesis"	"Methyltransferase, RNA-binding, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enriched"	"Detected in all"	4	"Early spermatids: 132.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA						"unprognostic (1.62e-1)"	"unprognostic (1.65e-1)"	"unprognostic (5.75e-2)"	"unprognostic (1.70e-1)"	"unprognostic (1.22e-1)"	"unprognostic (1.01e-1)"	"prognostic unfavorable (2.19e-5)"	"unprognostic (1.02e-3)"	"unprognostic (1.85e-1)"	"prognostic favorable (2.78e-4)"	"prognostic favorable (2.72e-4)"	"unprognostic (4.52e-2)"	"unprognostic (4.64e-3)"	"unprognostic (2.98e-2)"	"unprognostic (7.14e-2)"	"unprognostic (5.36e-2)"	"unprognostic (1.22e-1)"	13.1	21.0	15.7	18.3	20.4	6.8	17.4	27.1	16.4	13.5	12.8	16.3	20.4	7.7	17.1	19.8	14.3	20.9	11.2	17.3	16.3	8.6	14.6	14.0	14.2	18.4	21.7	15.2	18.2	14.2	25.8	21.3	16.0	16.3	19.3	13.9	12.2	17.0	19.3	18.8	17.0	11.9	17.6	13.8	17.5	12.9	21.6	20.6	15.4	19.2	13.3	21.8	15.1	14.8	13.0	12.6	7.7	10.3	15.3	14.3	8.1	16.6	24.9	23.7	9.5	18.4	15.2	11.9	15.3	11.3	18.4	21.6	9.4	19.7	17.4	9.9	9.5	24.1	17.7	29.0	15.1	29.2	16.4	17.1	10.8	13.8	37.2	7.5	14.5	12.3	11.4	13.3	11.4	13.4	8.1	24.0	9.0	13.2	10.0	24.3	12.2	12.9	11.6	20.2	28.2	30.8	12.9	18.8	15.4	16.8	11.2	14.7	15.9	16.7	22.0	15.6	19.7	17.4	9.6	15.6	6.5	11.0	12.0	10.4	10.6	13.2	12.1	8.0	11.7	13.8	5.1	8.1	7.7	8.7	10.3	12.7	13.0	10.5	9.6	10.5	10.3	11.0	9.7	0.9	15.3	8.4	12.6	14.3	8.1	15.7	20.4	27.1	16.4	16.3	8.6	21.7	15.2	16.3	20.6	11.9	15.3	14.3	20.7	13.3	23.6	30.5	12.7	16.0	12.5	12.2	13.7	26.1	3.3	12.6	132.7	11.7	4.2	23.3	8.6	12.2	16.4	16.1	8.1	9.5	14.4	20.6	10.4	10.4	7.1	15.9	15.8	12.9	15.1	19.8	7.6	16.2	9.0	3.5	18.7	7.2	18.7	32.3	14.2	32.6	17.9	10.8	21.2	13.8	11.1	17.6
MEX3C	"FLJ38871, RKHD2, RNF194"	ENSG00000176624	"Mex-3 RNA binding family member C"	Q5U5Q3	18	51174550-51218304	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Ubl conjugation pathway"	"RNA-binding, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	11	"Early spermatids: 519.8;Late spermatids: 374.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA040603	Uncertain		Approved	Vesicles	"Intracellular and membrane"	NA	NA			Vesicles		"HPA040603: AB_10805714"	"unprognostic (1.09e-1)"	"unprognostic (2.90e-2)"	"unprognostic (8.88e-2)"	"unprognostic (8.88e-3)"	"unprognostic (2.04e-1)"	"unprognostic (7.30e-2)"	"prognostic unfavorable (8.49e-5)"	"unprognostic (4.34e-2)"	"unprognostic (4.43e-1)"	"unprognostic (1.05e-2)"	"unprognostic (1.03e-2)"	"unprognostic (6.75e-2)"	"unprognostic (7.99e-2)"	"unprognostic (1.82e-1)"	"unprognostic (1.48e-1)"	"unprognostic (8.01e-2)"	"unprognostic (3.17e-1)"	12.6	12.2	13.8	14.5	13.5	27.5	19.4	21.7	13.7	14.7	11.3	10.7	8.8	8.7	13.4	9.5	11.7	11.1	13.0	11.3	15.1	9.1	9.3	10.3	12.0	19.8	16.3	8.3	14.5	10.1	16.6	9.5	11.7	12.3	10.3	9.8	7.6	12.4	10.1	9.0	10.2	12.7	13.6	12.6	16.3	10.5	43.7	12.7	40.0	13.6	9.3	18.4	13.0	17.5	2.8	2.0	10.3	1.3	5.8	3.8	1.5	7.6	4.5	22.1	8.3	12.3	15.1	17.2	10.9	14.3	6.3	7.8	7.3	5.8	15.6	3.8	14.5	10.2	14.0	9.5	15.6	12.3	11.4	4.2	3.3	4.6	9.5	19.8	21.2	6.3	12.8	22.0	8.9	28.0	18.5	16.4	12.5	3.5	27.3	16.4	5.6	15.8	10.5	10.6	4.8	4.6	16.0	11.5	16.0	14.7	2.5	9.8	13.4	8.2	4.5	43.0	21.6	4.4	11.8	12.2	15.4	10.3	4.6	9.3	19.8	2.9	24.9	10.6	10.8	34.7	10.3	1.3	1.5	3.6	1.3	3.1	2.8	3.8	3.7	2.0	2.1	1.6	3.8	0.7	5.8	0.9	2.0	3.1	1.5	13.8	13.5	21.7	13.7	15.1	9.1	16.3	8.3	12.3	12.7	17.9	5.3	9.3	8.7	34.0	12.9	11.1	17.8	2.7	9.1	3.5	19.6	4.1	5.0	9.9	519.8	25.3	7.3	0.0	7.5	6.3	17.5	10.6	12.7	6.8	6.7	11.1	6.4	8.6	12.6	374.0	15.0	4.4	18.6	3.6	8.4	8.0	12.4	0.0	14.2	6.2	13.8	0.0	10.3	13.0	12.4	40.1	3.5	21.7	11.2	17.0
MFNG		ENSG00000100060	"MFNG O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase"	O00587	22	37469063-37486401	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Developmental protein, Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 72.7;lymphoid tissue: 42.1"	"Group enriched"	"Detected in many"	5	"B-cells: 44.1;Endothelial cells: 25.5;granulocytes: 30.1;Hofbauer cells: 28.8;Ito cells: 45.4;Kupffer cells: 36.8;Macrophages: 23.4;monocytes: 20.8;T-cells: 53.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Daudi: 32.8;HEL: 25.3;HL-60: 41.3;HMC-1: 54.8;HUVEC TERT2: 44.2;U-698: 31.7;U-937: 37.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA048936, HPA056479"	Approved		Approved	Vesicles	"Intracellular and membrane"	NA	NA		28000	Vesicles		"HPA048936: AB_2680564, HPA056479: "	"unprognostic (1.21e-1)"	"unprognostic (4.17e-3)"	"prognostic unfavorable (5.12e-4)"	"prognostic favorable (1.65e-4)"	"unprognostic (6.41e-3)"	"unprognostic (1.00e-2)"	"unprognostic (2.64e-1)"	"unprognostic (2.36e-2)"	"unprognostic (4.64e-2)"	"unprognostic (2.91e-2)"	"unprognostic (5.44e-2)"	"unprognostic (1.42e-1)"	"prognostic unfavorable (3.31e-5)"	"unprognostic (2.67e-1)"	"unprognostic (4.03e-2)"	"unprognostic (3.86e-2)"	"unprognostic (1.43e-1)"	10.0	4.5	2.6	16.6	5.1	14.4	13.4	1.0	3.3	6.0	6.5	3.0	2.0	3.7	6.5	3.5	4.4	7.1	6.3	6.7	2.8	2.6	6.1	5.6	14.9	42.1	5.6	1.2	3.6	3.7	0.8	2.2	14.0	8.3	5.6	3.7	4.4	5.7	2.5	3.4	3.0	14.1	5.1	4.4	37.6	4.1	2.6	3.6	33.9	6.3	4.5	19.3	8.8	4.2	24.1	40.5	72.7	40.8	40.9	53.3	53.2	1.2	0.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.3	0.6	32.8	0.1	0.0	0.1	2.3	9.6	1.9	0.0	12.9	0.2	25.3	0.1	0.3	0.1	41.3	54.8	0.0	0.5	0.3	0.7	0.2	44.2	11.4	0.1	15.7	0.0	0.1	4.7	0.5	0.1	1.2	0.1	12.1	0.4	24.7	0.1	0.0	19.8	0.2	0.1	0.0	0.0	0.2	0.3	2.8	24.6	0.0	1.2	4.9	0.1	0.0	0.1	31.7	0.2	37.2	0.5	36.8	40.1	72.7	41.3	38.8	45.1	21.8	48.0	43.3	40.5	24.1	52.9	45.5	25.5	40.9	40.8	10.1	53.3	53.2	2.6	5.1	1.0	3.3	2.8	2.6	5.6	1.2	8.3	3.6	0.0	6.7	44.1	0.2	3.3	0.6	1.4	5.1	0.0	5.7	0.0	0.0	0.3	0.0	3.0	0.1	25.5	1.1	0.0	0.8	0.2	1.1	0.4	30.1	1.0	28.8	0.0	1.2	45.4	36.8	0.0	0.0	23.4	3.3	20.8	2.2	0.0	2.1	0.6	0.0	0.3	0.3	0.0	1.0	0.0	0.5	2.0	0.6	53.8	0.6	0.3
MGAM	MGA	ENSG00000257335	Maltase-glucoamylase	O43451	7	141907813-142106747	"Enzymes, FDA approved drug targets, Plasma proteins, Predicted membrane proteins"		"Glycosidase, Hydrolase, Multifunctional enzyme"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	4	"intestine: 155.5"	"Cell type enhanced"	"Detected in some"	24	"Early spermatids: 50.7;Late spermatids: 90.5;Proximal tubular cells: 18.9"	"Cancer enriched"	"Detected in some"	7	"renal cancer: 4.9"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in some"	8	"neutrophil: 14.1"	"Lineage enriched"	"Detected in single"	104	"granulocytes: 14.1"	"Cell line enhanced"	"Detected in some"		"A549: 3.7;BJ hTERT+: 3.3;HL-60: 5.5;U-937: 8.7;WM-115: 2.1"	"Region enriched"	"Detected in single"	12	"olfactory region: 3.1"					HPA002270	Enhanced					NA	NA		68000			"HPA002270: AB_1079366"	"unprognostic (1.02e-2)"	"unprognostic (1.45e-1)"	"unprognostic (1.13e-1)"	"unprognostic (6.95e-3)"	"unprognostic (2.80e-1)"	"unprognostic (7.81e-2)"	"unprognostic (7.32e-3)"	"unprognostic (3.83e-2)"	"unprognostic (4.97e-1)"	"unprognostic (2.17e-2)"	"unprognostic (6.86e-2)"	"unprognostic (1.99e-1)"	"prognostic favorable (6.16e-5)"	"unprognostic (1.82e-1)"	"unprognostic (2.82e-1)"	"unprognostic (1.34e-3)"	"unprognostic (3.03e-1)"	0.9	0.2	0.3	0.8	0.2	6.9	0.3	0.2	0.2	0.2	59.4	0.1	7.6	25.2	0.2	36.0	0.2	1.0	0.1	0.3	0.2	0.2	8.7	0.4	2.1	0.1	0.3	0.1	0.2	0.2	0.0	0.2	0.1	0.1	0.6	0.0	0.1	0.2	3.2	0.2	0.1	155.5	0.1	0.3	8.3	0.7	4.3	0.1	0.1	0.2	0.1	0.1	0.2	0.2	0.0	0.0	14.1	0.1	0.0	0.0	0.0	0.0	3.7	0.2	0.1	0.0	0.0	0.5	0.1	3.3	0.3	0.2	0.1	0.0	0.0	0.1	0.0	0.3	0.1	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	5.5	0.0	0.0	0.0	0.0	0.6	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.5	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.3	0.3	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.3	1.0	0.4	0.1	0.3	0.0	0.1	0.0	8.7	2.1	0.0	0.1	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.1	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.2	0.2	0.2	0.2	0.3	0.1	0.1	0.1	0.0	4.5	0.0	0.0	0.0	0.0	1.1	0.0	2.7	2.3	12.2	0.0	0.0	1.7	0.0	50.7	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	1.2	0.0	0.0	90.5	0.6	1.8	0.0	0.0	0.4	0.5	0.2	0.0	0.4	18.9	0.0	0.0	0.0	1.6	1.2	0.0	0.0	0.0	0.2	0.2
MGAM2		ENSG00000257743	"Maltase-glucoamylase 2 (putative)"	Q2M2H8	7	142111749-142222324	"Enzymes, Predicted membrane proteins"		"Glycosidase, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"intestine: 61.2;pancreas: 15.6;salivary gland: 35.4"	"Group enriched"	"Detected in some"	10	"Early spermatids: 21.0;Late spermatids: 12.0"	"Group enriched"	"Detected in some"	11	"colorectal cancer: 3.5;pancreatic cancer: 2.5;stomach cancer: 9.8"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	12	"neutrophil: 1.1"	"Lineage enriched"	"Detected in single"	12	"granulocytes: 1.1"	"Group enriched"	"Detected in some"	8	"OE19: 5.5;RH-30: 4.0"					"Low region specificity"	"Detected in many"			HPA055697	Enhanced		Approved	Vesicles,Cytosol		NA	NA			Vesicles	Cytosol	"HPA055697: AB_2682890"	"unprognostic (1.79e-2)"	"unprognostic (1.00e-1)"	"unprognostic (1.26e-1)"	"unprognostic (5.27e-3)"	"unprognostic (5.65e-2)"	"unprognostic (2.19e-2)"	"unprognostic (1.89e-2)"	"unprognostic (1.01e-1)"	"unprognostic (1.50e-2)"	"unprognostic (5.93e-2)"	"unprognostic (2.43e-1)"	"unprognostic (2.05e-1)"	"unprognostic (5.50e-4)"	"unprognostic (7.11e-3)"	"unprognostic (1.66e-1)"	"unprognostic (6.71e-2)"	"unprognostic (9.33e-2)"	0.2	0.1	0.1	2.5	0.1	0.2	1.3	0.1	0.1	0.1	28.8	0.0	0.0	15.0	0.1	0.4	0.1	0.3	7.0	0.1	0.1	0.1	0.1	0.2	0.4	0.0	0.4	0.0	0.1	15.6	0.0	0.1	0.0	0.1	0.1	1.4	0.7	35.4	0.0	0.1	0.2	61.2	0.0	0.5	1.5	0.7	1.0	0.0	0.0	0.1	1.7	0.8	0.1	0.1	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	5.5	0.0	0.0	4.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	21.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
MGAT1	"GLCNAC-TI, GLYT1, GNT-1, GnTI, MGAT"	ENSG00000131446	"Mannosyl (alpha-1,3-)-glycoprotein beta-1,2-N-acetylglucosaminyltransferase"	P26572	5	180784782-180815652	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	5	"Extravillous trophoblasts: 254.2;Syncytiotrophoblasts: 321.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA017432	Approved					NA	NA		7200000			"HPA017432: AB_1853851"	"unprognostic (1.12e-1)"	"unprognostic (1.34e-2)"	"unprognostic (3.38e-2)"	"unprognostic (2.11e-1)"	"unprognostic (3.91e-2)"	"unprognostic (6.70e-2)"	"unprognostic (4.39e-2)"	"unprognostic (9.34e-2)"	"unprognostic (2.00e-1)"	"unprognostic (2.98e-1)"	"unprognostic (3.70e-3)"	"unprognostic (6.44e-2)"	"prognostic unfavorable (8.65e-4)"	"unprognostic (4.15e-2)"	"unprognostic (3.52e-2)"	"unprognostic (5.68e-2)"	"unprognostic (5.00e-2)"	67.7	20.9	14.9	30.8	20.1	25.5	53.3	15.6	19.3	22.3	29.0	14.6	22.4	24.8	26.1	26.8	31.2	26.4	19.8	26.4	16.1	10.6	20.8	55.6	42.7	50.5	25.6	10.3	27.2	37.1	8.5	20.8	84.9	17.7	26.6	15.3	24.1	28.4	21.8	18.5	22.9	35.1	20.7	31.1	45.7	24.5	19.2	21.9	27.0	32.1	16.9	29.8	38.2	39.1	13.2	40.8	37.7	54.9	16.5	24.9	47.2	14.3	14.4	7.9	17.0	42.0	19.2	27.8	34.2	42.1	21.5	26.9	20.6	11.8	12.3	19.3	33.0	20.8	17.2	4.2	51.0	12.7	66.0	11.9	10.8	8.3	15.9	20.4	9.8	35.4	22.2	24.5	17.3	17.3	14.1	18.6	8.5	6.2	22.1	19.2	20.3	9.2	14.1	7.7	9.4	18.6	11.3	11.7	16.1	8.2	17.1	6.8	8.2	14.3	14.8	28.2	7.3	11.4	17.6	19.9	26.2	11.7	11.2	15.4	41.8	34.5	10.8	21.3	20.0	13.2	19.5	54.9	25.3	22.4	45.9	24.9	13.2	16.4	18.7	40.8	12.1	14.4	16.0	37.7	16.5	35.1	38.9	18.8	47.2	14.9	20.1	15.6	19.3	16.1	10.6	25.6	10.3	17.7	21.9	44.7	30.3	44.7	32.3	54.4	15.3	16.2	33.1	10.7	10.3	27.9	53.0	78.1	31.5	43.2	24.8	80.8	40.7	46.7	68.5	254.2	87.6	52.3	30.0	71.9	181.6	60.4	47.8	132.0	151.5	31.6	58.1	136.4	77.6	84.8	43.1	15.3	50.1	31.6	71.5	17.0	77.1	32.3	55.2	18.4	19.0	55.8	321.9	60.9	34.7	55.2
MGAT2	GNT-II	ENSG00000168282	"Mannosyl (alpha-1,6-)-glycoprotein beta-1,2-N-acetylglucosaminyltransferase"	Q10469	14	49620795-49623481	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		"Glycosyltransferase, Transferase"	"Congenital disorder of glycosylation, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA043721, HPA056824"	Approved		Supported	"Golgi apparatus"		NA	NA		5000000	"Golgi apparatus"		"HPA043721: AB_2678636, HPA056824: AB_2683248"	"unprognostic (1.20e-2)"	"prognostic unfavorable (3.22e-4)"	"unprognostic (2.84e-1)"	"unprognostic (5.49e-2)"	"unprognostic (1.37e-1)"	"unprognostic (1.70e-1)"	"unprognostic (3.77e-1)"	"unprognostic (1.92e-2)"	"unprognostic (1.14e-1)"	"unprognostic (7.44e-2)"	"unprognostic (7.12e-2)"	"unprognostic (5.63e-2)"	"unprognostic (2.59e-3)"	"unprognostic (9.14e-2)"	"unprognostic (3.74e-2)"	"unprognostic (4.72e-2)"	"unprognostic (2.12e-2)"	14.0	17.0	7.4	14.0	7.1	5.0	12.3	7.3	8.4	11.7	16.5	7.8	16.5	13.9	12.9	14.1	11.7	11.4	16.8	10.1	6.2	6.6	13.2	34.4	10.3	20.5	6.1	7.2	15.3	27.9	4.8	8.2	14.1	5.8	9.4	13.7	10.7	34.9	19.1	5.1	6.3	29.1	9.7	7.1	20.9	12.3	27.7	5.8	18.2	9.0	7.2	14.8	11.6	9.1	15.5	28.2	22.1	22.8	12.0	24.7	23.2	18.9	9.4	7.2	12.2	17.2	16.8	4.7	21.1	21.0	19.6	17.7	11.4	14.5	19.3	18.0	19.2	11.3	15.2	10.2	12.2	21.2	19.6	9.0	12.3	7.0	11.2	13.6	28.1	28.8	12.8	9.8	11.6	16.5	14.4	23.4	9.7	9.4	53.3	20.6	7.2	9.7	18.0	7.4	6.7	15.2	11.0	21.1	16.6	15.3	11.1	7.5	8.1	15.1	4.0	11.9	7.3	12.2	19.3	24.2	17.8	19.3	12.9	15.0	57.7	27.6	17.2	8.6	14.1	11.9	21.7	22.8	22.1	23.0	20.0	24.7	15.5	21.3	20.7	23.6	10.4	12.6	17.3	6.8	12.0	21.6	28.2	18.2	23.2	7.4	7.1	7.3	8.4	6.2	6.6	6.1	7.2	5.8	5.8	11.9	10.4	19.4	21.6	14.0	13.0	0.0	30.6	6.7	5.7	10.4	3.9	22.7	8.3	27.1	6.0	17.8	21.0	0.0	30.2	35.1	27.8	21.6	16.2	45.1	33.0	17.5	11.6	23.9	33.8	4.6	16.1	22.6	20.3	37.9	18.9	14.9	29.0	23.0	20.8	12.2	14.8	6.5	16.7	40.5	12.8	12.3	4.5	33.7	19.6	25.3
MGAT3	GNT-III	ENSG00000128268	"Mannosyl (beta-1,4-)-glycoprotein beta-1,4-N-acetylglucosaminyltransferase"	Q09327	22	39457344-39492194	"Enzymes, Predicted intracellular proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 29.0;intestine: 27.1"	"Cell type enhanced"	"Detected in many"	10	"Alveolar cells type 1: 41.7;Bipolar cells: 30.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	5	"basophil: 3.5;eosinophil: 3.3;memory B-cell: 1.7;naive B-cell: 1.2"	"Group enriched"	"Detected in many"	9	"B-cells: 1.7;granulocytes: 3.5"	"Cell line enhanced"	"Detected in some"		"BEWO: 28.1;HMC-1: 24.3;OE19: 24.3;U-266/70: 31.6;U-266/84: 12.8;U-698: 13.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA017598	Approved				"Intracellular and membrane"	NA	NA		78000			"HPA017598: AB_1853853"	"unprognostic (1.41e-3)"	"unprognostic (5.98e-3)"	"unprognostic (4.79e-2)"	"unprognostic (2.96e-1)"	"unprognostic (2.76e-1)"	"unprognostic (5.71e-3)"	"unprognostic (8.92e-2)"	"unprognostic (2.17e-1)"	"unprognostic (4.35e-3)"	"unprognostic (6.77e-2)"	"unprognostic (8.12e-3)"	"unprognostic (8.74e-2)"	"prognostic unfavorable (5.04e-8)"	"unprognostic (6.73e-2)"	"unprognostic (1.46e-1)"	"unprognostic (5.89e-2)"	"unprognostic (4.92e-2)"	5.3	1.2	17.1	3.9	18.7	9.2	3.6	29.0	24.6	7.1	11.9	8.9	0.0	21.1	3.4	1.2	1.4	4.0	7.9	3.0	18.1	14.9	3.3	0.4	14.9	7.2	13.1	13.4	1.0	3.1	0.9	1.4	10.5	10.7	1.0	4.9	1.7	2.1	1.4	1.6	2.5	27.1	3.2	10.4	3.3	7.8	4.9	9.0	0.2	1.1	0.0	8.9	3.0	2.7	1.7	0.1	3.5	0.2	0.0	0.2	0.1	0.1	0.1	4.6	0.4	0.0	0.0	28.1	0.2	0.3	0.2	0.0	6.2	1.5	9.7	3.4	0.0	0.0	0.5	2.3	0.0	0.0	0.0	0.2	7.8	0.0	0.0	0.1	0.0	24.3	0.0	0.0	0.0	0.0	0.0	0.0	0.8	6.4	1.2	0.0	0.1	0.2	0.6	1.3	24.3	0.0	0.4	0.0	1.6	0.2	0.2	2.6	1.9	0.0	0.0	0.0	8.4	0.3	0.4	0.0	0.0	3.7	0.0	0.0	31.6	12.8	13.7	0.0	0.0	0.7	3.5	0.1	3.3	0.1	0.2	0.1	1.7	0.0	0.0	0.1	1.2	0.2	0.2	0.4	0.0	0.0	0.0	0.1	0.1	17.1	18.7	29.0	24.6	18.1	14.9	13.1	13.4	10.7	9.0	41.7	4.0	3.7	0.1	0.3	30.0	1.2	2.5	2.7	1.2	0.0	5.9	4.6	0.0	0.0	11.0	2.3	5.2	0.0	0.2	10.1	0.6	0.0	2.3	0.0	1.3	12.7	7.5	0.0	0.0	16.2	4.0	0.7	0.0	0.0	3.2	1.5	1.3	3.4	3.5	1.3	2.3	6.5	1.4	0.7	1.0	0.5	3.1	0.9	3.4	1.3
MGAT4A	"GnT-4a, GnT-Iva"	ENSG00000071073	"Mannosyl (alpha-1,3-)-glycoprotein beta-1,4-N-acetylglucosaminyltransferase, isozyme A"	Q9UM21	2	98619106-98731126	"Enzymes, Predicted intracellular proteins, Predicted secreted proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 49.2"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BEWO: 46.0;HUVEC TERT2: 17.2;JURKAT: 30.7;TIME: 27.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA007608	Enhanced		Approved	"Golgi apparatus"	"Secreted in other tissues"	NA	NA			"Golgi apparatus"		"HPA007608: AB_10602008"	"prognostic unfavorable (4.30e-4)"	"unprognostic (1.15e-1)"	"unprognostic (2.07e-1)"	"prognostic unfavorable (6.48e-8)"	"unprognostic (1.35e-1)"	"unprognostic (2.28e-2)"	"unprognostic (3.82e-3)"	"unprognostic (1.89e-1)"	"unprognostic (3.76e-1)"	"unprognostic (3.58e-1)"	"unprognostic (2.80e-2)"	"unprognostic (2.32e-2)"	"unprognostic (4.17e-2)"	"unprognostic (1.50e-1)"	"unprognostic (4.62e-2)"	"unprognostic (4.04e-2)"	"unprognostic (2.04e-1)"	8.1	5.1	11.3	11.9	15.6	49.2	8.2	28.5	14.3	6.1	14.6	8.3	6.8	17.6	5.2	4.1	4.1	6.2	8.0	5.1	11.3	10.4	17.1	6.0	13.7	16.7	9.9	8.3	2.9	26.7	33.3	14.1	11.9	10.4	6.6	15.8	5.6	14.5	4.4	3.3	3.4	38.5	7.2	16.1	7.0	8.4	3.9	14.3	20.3	6.4	3.1	11.6	8.3	5.0	2.0	9.3	7.6	2.9	7.7	19.7	7.4	3.0	0.6	1.2	2.6	0.0	0.0	46.0	0.0	0.0	0.3	0.0	7.3	3.7	0.0	6.9	0.0	0.9	0.1	2.5	0.3	0.0	3.6	2.8	0.1	0.0	12.7	0.0	6.1	2.3	0.0	1.7	0.0	0.2	0.1	17.2	30.7	0.5	3.3	0.0	5.9	13.3	10.7	0.4	2.6	0.5	3.3	0.0	3.6	8.9	6.2	3.7	1.2	0.8	11.5	1.6	3.4	2.7	8.3	27.8	0.0	1.4	0.0	0.9	1.1	2.5	0.7	0.0	9.2	0.2	3.3	2.9	6.6	12.3	0.5	15.9	2.0	14.9	13.7	2.0	1.1	19.7	16.1	7.6	7.7	1.1	9.3	8.4	7.4	11.3	15.6	28.5	14.3	11.3	10.4	9.9	8.3	10.4	14.3	50.6	31.3	18.2	18.4	8.9	20.9	11.7	10.2	5.3	13.6	21.0	3.9	3.9	18.3	15.5	10.0	32.8	84.5	0.0	25.8	66.5	5.4	17.8	12.7	8.5	53.2	46.1	50.8	20.3	30.7	13.9	2.3	33.8	10.1	10.0	34.5	13.6	22.1	48.9	2.1	25.6	4.8	6.5	5.1	2.8	3.4	9.3	12.5	74.0	30.1	20.1
MGAT4B	GnT-Ivb	ENSG00000161013	"Mannosyl (alpha-1,3-)-glycoprotein beta-1,4-N-acetylglucosaminyltransferase, isozyme B"	Q9UQ53	5	179797597-179806952	"Enzymes, Predicted intracellular proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"intestine: 125.6;liver: 100.0"	"Cell type enhanced"	"Detected in many"	8	"Enterocytes: 212.8;Paneth cells: 114.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	9	"eosinophil: 8.5"	"Lineage enriched"	"Detected in single"	9	"granulocytes: 8.5"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA012804, HPA052134"	Uncertain		Approved	"Nucleoplasm,Golgi apparatus,Vesicles,Cytosol"	"Intracellular and membrane"	NA	NA			Nucleoplasm	"Golgi apparatus, Vesicles, Cytosol"	"HPA012804: , HPA052134: AB_2681741"	"unprognostic (2.01e-2)"	"unprognostic (8.68e-3)"	"unprognostic (1.40e-1)"	"unprognostic (3.83e-2)"	"prognostic unfavorable (6.15e-5)"	"unprognostic (3.61e-3)"	"unprognostic (7.57e-3)"	"unprognostic (1.22e-2)"	"unprognostic (2.02e-1)"	"unprognostic (5.13e-2)"	"unprognostic (2.26e-2)"	"unprognostic (2.27e-2)"	"prognostic favorable (5.78e-4)"	"unprognostic (1.52e-1)"	"unprognostic (2.54e-1)"	"unprognostic (1.72e-2)"	"unprognostic (1.42e-1)"	13.2	22.8	9.1	19.5	8.2	9.5	18.7	15.3	13.5	8.7	77.3	5.9	10.1	61.7	9.2	10.4	16.8	10.7	26.0	20.6	9.5	5.4	31.9	100.0	17.1	15.6	6.3	5.2	9.1	13.4	10.3	8.3	14.4	6.3	8.8	30.9	10.1	19.2	8.2	8.4	12.1	125.6	7.5	4.9	12.5	22.3	11.2	5.6	7.0	16.6	14.6	10.0	9.5	13.7	0.9	0.6	8.5	0.7	0.0	0.6	0.2	20.8	21.1	10.4	24.1	32.0	17.2	18.1	12.4	24.9	11.3	8.9	23.1	58.2	3.5	31.9	28.6	50.4	15.8	15.2	27.9	8.6	29.2	8.1	10.7	19.2	20.1	22.6	13.5	3.3	18.6	19.6	11.5	14.3	44.4	23.2	4.2	6.9	9.6	19.0	23.3	2.0	11.2	6.4	31.9	8.5	5.2	8.3	9.9	33.9	40.6	17.2	10.1	18.6	19.3	33.4	9.2	13.2	13.7	28.3	28.6	12.7	16.0	19.8	8.2	9.4	8.8	34.3	17.0	20.6	0.0	0.7	8.5	0.3	0.1	0.1	0.0	0.5	0.2	0.6	0.9	0.4	0.6	0.3	0.0	0.5	0.5	0.0	0.2	9.1	8.2	15.3	13.5	9.5	5.4	6.3	5.2	6.3	5.6	11.9	8.6	8.5	16.0	11.1	15.5	21.6	25.5	0.0	5.7	26.2	3.9	6.8	3.3	60.0	0.5	14.3	212.8	0.0	46.0	9.9	10.4	29.2	4.7	75.0	15.1	28.6	22.0	31.9	17.0	1.6	14.1	11.7	10.1	18.0	64.6	23.5	79.0	114.3	15.9	20.7	10.4	12.9	8.6	1.6	4.8	10.5	11.7	5.0	102.6	39.7
MGAT4C	HGNT-IV-H	ENSG00000182050	"MGAT4 family member C"	Q9UBM8	12	85955666-86838904	"Enzymes, Predicted membrane proteins"		"Glycosyltransferase, Transferase"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Group enriched"	"Detected in many"	4	"brain: 12.8;epididymis: 10.9;pituitary gland: 25.9;testis: 7.8;thyroid gland: 18.0"	"Group enriched"	"Detected in some"	6	"Early spermatids: 99.1;Late spermatids: 74.0"	"Cancer enriched"	"Detected in single"	19	"thyroid cancer: 2.6"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	10	"NTERA-2: 11.0;SCLC-21H: 4.8;SuSa: 3.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA016418	Approved		Approved	"Vesicles,Plasma membrane,Centriolar satellite"		NA	NA			"Vesicles, Plasma membrane"	"Centriolar satellite"	"HPA016418: AB_2732416"	"unprognostic (5.23e-2)"	"unprognostic (2.33e-1)"	"unprognostic (1.84e-1)"	"unprognostic (3.32e-4)"	"unprognostic (1.07e-1)"	"unprognostic (9.64e-2)"	"unprognostic (5.94e-3)"	"unprognostic (1.88e-1)"	"unprognostic (8.05e-2)"	"unprognostic (1.89e-1)"	"unprognostic (6.32e-3)"	"unprognostic (3.51e-2)"	"unprognostic (6.85e-10)"	"unprognostic (3.15e-2)"	"unprognostic (1.77e-1)"	"unprognostic (1.97e-1)"	"unprognostic (4.74e-3)"	1.0	3.0	5.5	1.0	12.3	1.1	0.9	4.9	12.8	1.3	1.2	2.5	0.4	0.9	1.0	10.9	1.1	1.1	1.2	3.6	9.4	3.9	1.0	0.9	1.0	0.9	3.0	9.3	0.9	0.9	0.9	25.9	0.8	10.6	1.1	1.2	0.0	0.9	2.4	0.8	1.0	1.0	1.0	4.3	0.9	1.0	7.8	5.1	0.0	18.0	0.0	0.8	0.9	0.6	0.5	0.3	0.8	0.2	0.2	0.2	0.0	0.0	0.1	0.0	0.1	0.0	0.5	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.5	0.0	0.1	0.1	0.2	0.0	0.2	0.1	0.0	0.3	0.1	0.0	0.1	0.1	0.1	0.0	0.0	0.2	0.2	0.1	0.1	0.0	11.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	4.8	0.0	0.0	0.0	0.0	3.8	0.0	0.1	0.1	0.0	0.2	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.8	0.2	0.1	0.2	0.2	0.0	0.0	0.0	0.1	0.0	0.5	0.2	0.1	0.8	0.2	0.1	0.3	0.2	0.0	5.5	12.3	4.9	12.8	9.4	3.9	3.0	9.3	10.6	5.1	6.0	0.6	0.0	0.1	0.1	9.7	7.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	99.1	1.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	74.0	15.0	0.0	0.0	0.0	0.0	0.5	0.7	0.0	3.9	0.0	1.6	0.0	0.0	1.7	0.6	0.1	0.0	0.0	0.0	0.3
MGAT5	GNT-V	ENSG00000152127	"Mannosyl (alpha-1,6-)-glycoprotein beta-1,6-N-acetyl-glucosaminyltransferase"	Q09328	2	134119983-134454621	"Enzymes, Predicted membrane proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Cardiomyocytes: 52.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA010919	Approved					NA	NA		96000			"HPA010919: AB_10601864"	"unprognostic (1.19e-1)"	"unprognostic (2.16e-1)"	"unprognostic (5.39e-2)"	"unprognostic (6.21e-2)"	"unprognostic (3.65e-1)"	"unprognostic (3.76e-1)"	"unprognostic (4.45e-3)"	"unprognostic (3.41e-3)"	"unprognostic (5.68e-2)"	"unprognostic (8.63e-3)"	"unprognostic (1.59e-1)"	"unprognostic (2.64e-1)"	"unprognostic (5.97e-2)"	"unprognostic (1.81e-2)"	"unprognostic (9.27e-2)"	"unprognostic (2.17e-2)"	"unprognostic (1.91e-1)"	8.4	9.8	13.0	21.7	15.7	12.0	8.0	21.3	17.6	9.0	13.2	17.2	4.6	14.2	8.5	6.3	8.2	17.5	15.1	33.9	13.9	17.5	14.3	4.9	9.3	20.1	23.6	11.6	11.3	11.1	18.8	7.9	22.0	28.0	7.9	13.8	8.3	11.9	9.1	3.2	6.6	19.2	10.1	28.7	23.1	15.0	6.6	13.2	16.5	10.3	5.1	28.9	11.0	9.2	7.5	1.8	2.3	0.8	2.4	3.1	1.1	10.2	4.1	10.5	7.5	9.4	18.0	7.3	13.7	20.9	5.5	4.7	1.7	5.1	16.5	10.5	10.9	6.3	3.6	8.2	6.4	10.7	16.1	4.8	9.2	5.3	21.4	6.1	8.9	32.9	4.9	6.7	11.6	7.2	7.5	41.3	8.3	4.7	11.3	10.0	6.6	4.8	4.2	4.8	10.7	10.2	6.0	12.4	10.3	4.3	12.6	17.4	21.4	4.4	3.8	26.1	7.4	2.9	6.2	18.6	17.5	9.3	12.7	7.1	3.2	1.5	6.2	14.7	12.8	27.8	1.2	0.7	1.8	1.6	0.7	2.7	5.6	3.1	2.1	0.6	7.5	1.3	1.6	2.3	2.4	0.8	1.8	1.9	1.1	13.0	15.7	21.3	17.2	13.9	17.5	23.6	11.6	28.0	13.2	3.0	3.7	22.6	5.1	7.1	27.7	52.8	5.1	13.4	3.4	1.8	2.0	3.0	0.0	8.0	14.2	11.6	18.6	0.0	7.8	24.2	4.1	7.5	0.0	2.9	12.9	15.9	6.9	11.1	12.7	10.6	4.0	7.3	13.5	1.8	17.2	8.8	10.4	14.2	8.9	2.1	4.7	0.0	11.8	0.3	7.0	6.4	4.5	10.2	9.4	13.2
MGAT5B	"FLJ25132, GnT-IX, GnT-VB"	ENSG00000167889	"Mannosyl (alpha-1,6-)-glycoprotein beta-1,6-N-acetyl-glucosaminyltransferase, isozyme B"	Q3V5L5	17	76868456-76950393	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	12	"brain: 28.1"	"Cell type enhanced"	"Detected in some"	12	"Bipolar cells: 5.1;Early spermatids: 6.3;Extravillous trophoblasts: 2.8;Late spermatids: 6.8"	"Group enriched"	"Detected in many"	5	"glioma: 2.6;melanoma: 7.1;testis cancer: 2.4"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"A549: 21.8;SCLC-21H: 11.2;U-138 MG: 13.2;U-2 OS: 14.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA011082			Approved	"Nucleoplasm,Cytokinetic bridge,Mitotic spindle"		Yes	No			"Nucleoplasm, Mitotic spindle"	"Cytokinetic bridge"	"HPA011082: AB_2668423"	"unprognostic (6.37e-2)"	"unprognostic (9.16e-3)"	"unprognostic (8.51e-2)"	"unprognostic (1.43e-3)"	"unprognostic (5.68e-3)"	"unprognostic (1.33e-1)"	"unprognostic (2.28e-3)"	"unprognostic (1.52e-3)"	"unprognostic (5.30e-2)"	"unprognostic (3.89e-2)"	"unprognostic (1.68e-1)"	"unprognostic (5.67e-2)"	"unprognostic (1.46e-7)"	"unprognostic (1.66e-1)"	"unprognostic (8.09e-3)"	"unprognostic (1.04e-1)"	"unprognostic (3.01e-1)"	1.1	1.2	9.3	1.1	13.4	1.0	0.9	4.4	28.1	1.0	0.9	1.1	0.0	0.8	1.1	0.7	0.9	1.0	0.9	0.8	5.5	2.8	0.9	0.7	1.0	0.9	2.3	8.1	1.2	0.8	1.0	0.6	1.1	2.6	0.8	0.8	1.1	0.8	0.8	0.7	0.9	0.9	0.8	0.7	1.4	1.0	2.3	1.7	0.0	0.8	0.0	0.9	0.8	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	21.8	4.4	2.2	0.0	0.0	2.3	0.3	0.9	8.0	4.7	0.0	0.5	0.0	1.7	1.0	9.4	0.1	1.0	0.2	2.1	0.0	0.3	0.0	1.1	0.1	0.0	0.0	0.1	0.1	0.1	0.0	1.3	3.6	1.4	0.4	0.1	0.0	0.0	1.0	0.0	0.0	1.2	0.5	2.3	3.0	3.9	4.5	6.2	0.0	11.2	4.3	3.8	1.7	3.4	0.2	0.1	0.1	4.0	13.2	14.3	0.2	4.1	0.0	0.0	0.5	0.4	0.0	9.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.3	13.4	4.4	27.4	5.5	2.8	2.3	8.1	2.6	1.7	0.0	0.0	0.0	0.1	0.1	5.1	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.3	0.0	0.0	0.0	0.0	2.8	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.6	0.0	6.8	0.6	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.4	0.0	2.1	0.0	0.2	0.9	2.2	0.0	0.1	0.0	0.0	0.0
MGEA5	"MEA5, NCOAT, OGA"	ENSG00000198408	"Meningioma expressed antigen 5 (hyaluronidase)"	O60502	10	101784443-101818465	"Enzymes, Predicted intracellular proteins"	"Host-virus interaction"	"Glycosidase, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Cone photoreceptor cells: 265.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036141, HPA076501"	Approved		Supported	Cytosol		NA	NA			Cytosol		"HPA036141: AB_10672079, HPA076501: AB_2686802"	"unprognostic (4.34e-1)"	"unprognostic (1.57e-1)"	"prognostic unfavorable (8.69e-5)"	"unprognostic (4.63e-1)"	"unprognostic (2.06e-1)"	"unprognostic (2.57e-2)"	"unprognostic (2.65e-1)"	"unprognostic (1.79e-2)"	"unprognostic (2.44e-1)"	"unprognostic (1.21e-3)"	"unprognostic (6.00e-2)"	"unprognostic (7.81e-2)"	"unprognostic (1.68e-1)"	"unprognostic (3.01e-1)"	"unprognostic (3.21e-2)"	"unprognostic (1.90e-1)"	"unprognostic (9.23e-3)"	29.5	17.5	51.9	27.4	54.4	49.3	35.5	58.9	51.4	24.5	27.0	29.0	20.9	17.6	29.9	36.8	26.0	23.3	19.1	27.4	46.0	29.8	27.7	28.6	24.0	40.1	30.7	43.6	33.8	20.9	53.3	22.1	25.5	42.6	31.6	26.5	30.7	24.4	26.3	25.4	36.6	28.5	37.4	29.5	35.2	23.9	21.9	35.4	32.9	25.9	11.8	39.5	34.3	26.7	8.1	3.3	14.7	5.6	6.8	7.1	1.4	30.8	15.7	23.0	44.6	14.8	36.0	16.0	21.7	22.0	10.1	17.5	11.5	19.8	20.7	15.9	25.9	17.5	22.3	21.5	27.4	21.6	30.2	14.7	20.6	21.9	9.0	16.0	15.2	11.7	34.7	30.8	17.4	41.5	29.1	18.8	18.9	14.5	38.4	17.2	15.7	16.0	15.9	12.7	6.7	16.0	22.3	25.4	15.1	17.0	28.0	10.0	17.7	19.5	10.5	27.1	22.0	27.8	16.6	28.4	15.7	15.2	22.7	24.8	19.2	30.5	16.5	19.7	26.2	8.5	10.5	2.1	6.8	7.1	2.0	5.6	6.4	4.9	6.1	1.3	8.1	6.8	5.7	14.7	6.8	5.6	3.3	4.5	1.4	51.9	54.4	58.9	51.4	46.0	29.8	30.7	43.6	42.6	35.4	107.2	86.7	52.8	42.9	64.5	144.1	0.0	63.7	61.6	70.5	0.0	265.1	31.5	0.0	0.0	86.9	51.4	61.9	23.3	0.0	23.6	49.2	69.4	73.0	70.0	33.8	74.7	86.1	95.8	62.6	94.2	73.4	62.1	62.4	0.0	53.3	63.6	0.0	48.9	59.4	0.0	132.6	25.8	55.6	20.2	36.6	81.8	42.6	117.6	48.7	51.0
MGLL	"HU-K5, MGL"	ENSG00000074416	"Monoglyceride lipase"	Q99685	3	127689062-127823250	"Enzymes, Predicted intracellular proteins"	"Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid degradation, Lipid metabolism"	"Hydrolase, Serine esterase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"monocytes: 404.8;Pancreatic endocrine cells: 322.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"eosinophil: 11.6;intermediate monocyte: 28.5;non-classical monocyte: 18.3;plasmacytoid DC: 30.4"	"Group enriched"	"Detected in many"	13	"dendritic cells: 30.4;granulocytes: 11.6;monocytes: 28.5"	"Cell line enhanced"	"Detected in many"		"BJ: 46.5;BJ hTERT+: 53.6;LHCN-M2: 42.8;RPTEC TERT1: 38.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA011348, HPA011993, HPA011994"	Enhanced		Enhanced	Nucleoplasm		NA	NA		4300000	Nucleoplasm		"HPA011348: AB_2668490, HPA011993: AB_1853914, HPA011994: AB_1853916"	"unprognostic (1.84e-2)"	"unprognostic (1.80e-2)"	"unprognostic (2.14e-1)"	"unprognostic (8.19e-2)"	"unprognostic (1.15e-2)"	"unprognostic (1.69e-1)"	"unprognostic (5.83e-2)"	"unprognostic (3.61e-2)"	"unprognostic (1.45e-1)"	"unprognostic (8.83e-2)"	"prognostic unfavorable (6.41e-4)"	"unprognostic (7.63e-3)"	"unprognostic (1.44e-1)"	"unprognostic (1.68e-1)"	"unprognostic (1.90e-2)"	"unprognostic (2.51e-1)"	"unprognostic (2.11e-3)"	72.2	6.7	29.4	22.6	29.7	7.5	39.0	32.8	36.9	13.3	36.3	8.3	8.4	16.5	8.7	10.8	63.8	16.3	24.1	35.5	23.6	10.2	22.6	32.1	32.4	6.0	15.4	17.8	3.9	3.6	1.7	5.0	18.9	10.2	10.6	27.6	10.0	31.4	13.6	40.9	11.9	22.3	13.6	12.2	19.2	17.5	3.2	15.5	2.4	6.4	33.4	19.7	14.4	14.5	1.8	30.4	11.6	28.5	0.6	0.9	6.0	11.2	10.1	0.0	0.0	17.8	21.0	1.3	46.5	53.6	10.3	16.6	0.3	4.6	2.9	12.9	15.7	3.1	0.4	0.0	6.1	5.7	5.0	0.1	0.3	7.2	0.0	6.4	0.0	0.3	7.8	3.6	19.3	21.1	5.8	21.8	0.1	0.0	0.5	42.8	1.1	0.0	0.1	0.0	7.3	16.0	0.0	5.5	23.8	38.6	1.2	6.0	0.4	8.0	15.8	2.7	0.4	0.7	0.4	27.9	11.3	3.3	27.2	6.3	0.0	0.0	9.5	23.4	0.6	35.0	4.2	2.8	11.6	0.2	28.5	0.9	1.8	0.2	0.3	3.1	0.2	0.0	0.0	0.5	0.6	18.3	30.4	0.0	6.0	29.4	29.7	32.8	36.9	23.6	10.2	15.4	17.8	10.2	15.5	181.7	90.0	5.2	8.0	20.3	16.7	42.0	119.8	56.2	34.2	40.1	0.0	68.4	142.6	90.3	3.6	101.2	167.0	23.3	144.8	129.8	47.2	9.2	8.1	126.2	122.7	0.0	85.0	14.7	24.4	4.0	30.2	33.6	20.3	404.8	177.1	46.3	322.3	129.8	65.4	60.0	6.1	84.1	176.1	0.2	1.1	19.4	60.8	10.2	49.8	4.2
MGMT		ENSG00000170430	"O-6-methylguanine-DNA methyltransferase"	P16455	10	129467184-129768007	"Cancer-related genes, Enzymes, Predicted intracellular proteins"	"DNA damage, DNA repair"	"DNA-binding, Methyltransferase, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	7	"Hepatocytes: 419.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB002786, HPA032135, HPA032136, HPA069497, CAB069881"	Supported		Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"CAB002786: , CAB069881: AB_10002128, HPA032135: AB_2674171, HPA032136: AB_2674172, HPA069497: AB_2732134"	"unprognostic (1.10e-1)"	"prognostic favorable (9.42e-4)"	"unprognostic (1.48e-1)"	"unprognostic (5.81e-2)"	"unprognostic (7.84e-3)"	"unprognostic (1.67e-1)"	"prognostic favorable (1.54e-4)"	"unprognostic (6.54e-3)"	"unprognostic (4.71e-2)"	"unprognostic (2.03e-1)"	"unprognostic (1.26e-1)"	"unprognostic (6.32e-1)"	"unprognostic (4.89e-1)"	"unprognostic (2.75e-1)"	"unprognostic (1.95e-1)"	"unprognostic (1.66e-1)"	"unprognostic (1.08e-1)"	11.7	11.3	7.4	15.5	7.6	7.1	11.3	3.5	9.1	8.3	12.2	10.0	19.6	10.8	15.3	17.1	9.9	15.2	14.1	10.5	7.1	7.1	12.6	45.6	7.5	11.6	8.6	6.6	12.3	16.5	5.7	5.8	4.5	9.2	11.2	3.4	11.8	14.9	24.5	14.4	9.2	9.6	10.9	8.1	8.6	9.9	11.7	3.9	16.0	10.2	14.9	14.7	12.6	13.0	20.3	17.7	6.5	15.3	18.2	21.2	16.6	0.0	2.5	2.7	13.0	5.7	11.8	10.2	5.7	6.4	4.2	4.1	15.8	16.9	11.8	9.2	7.4	0.0	7.7	1.7	6.1	1.9	0.0	1.0	2.3	5.8	10.1	8.8	0.2	6.8	7.5	0.0	2.4	0.0	0.0	0.0	20.0	0.0	8.3	5.1	21.3	9.3	12.1	0.6	10.9	10.2	10.8	0.0	4.6	7.8	5.8	2.7	6.8	6.9	2.8	0.0	2.2	11.2	9.2	0.0	5.5	2.8	0.0	0.0	0.0	0.0	6.0	0.0	3.8	0.0	2.6	15.3	6.5	19.1	14.8	18.6	20.3	17.5	17.8	15.8	19.9	17.6	18.9	1.8	18.2	13.7	17.7	21.2	16.6	7.4	7.6	3.5	9.1	7.1	7.1	8.6	6.6	9.2	3.9	11.9	14.7	57.0	56.4	45.4	15.7	37.8	86.6	57.6	15.9	97.7	7.9	41.1	107.8	40.8	70.9	48.0	68.8	23.3	51.1	53.2	48.9	49.8	64.5	419.1	76.3	14.3	52.4	98.2	75.3	90.6	62.5	39.9	62.4	45.9	56.4	33.9	74.4	47.0	51.9	227.8	39.0	45.3	55.7	43.1	97.3	37.3	22.4	67.1	59.6	48.8
MGRN1	"KIAA0544, RNF156"	ENSG00000102858	"Mahogunin ring finger 1"	O60291	16	4616493-4690974	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"neutrophil: 16.6"	"Lineage enriched"	"Detected in all"	4	"granulocytes: 16.6"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007653, HPA008033"	Approved		Supported	"Endoplasmic reticulum,Vesicles"		NA	NA			Vesicles	"Endoplasmic reticulum"	"HPA007653: AB_1846304, HPA008033: "	"unprognostic (2.27e-1)"	"unprognostic (1.09e-1)"	"unprognostic (1.18e-1)"	"unprognostic (1.04e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.97e-2)"	"unprognostic (4.24e-1)"	"unprognostic (1.26e-2)"	"unprognostic (9.96e-2)"	"unprognostic (1.70e-1)"	"unprognostic (4.03e-2)"	"unprognostic (9.47e-2)"	"unprognostic (6.41e-2)"	"unprognostic (2.32e-1)"	"unprognostic (9.06e-2)"	"unprognostic (1.79e-1)"	"unprognostic (5.04e-2)"	18.7	23.1	22.9	24.0	24.3	29.7	19.9	43.1	37.6	16.3	16.6	28.7	16.8	28.9	23.7	13.8	14.7	20.9	20.2	20.7	24.3	18.6	15.9	30.4	21.6	22.2	27.9	21.5	21.3	34.9	19.7	21.5	18.8	18.6	19.0	11.6	20.7	23.8	22.9	29.9	13.5	28.6	20.0	17.2	26.2	25.2	11.5	24.5	12.9	19.7	10.4	11.0	18.7	14.2	1.7	4.1	16.6	3.9	1.4	3.3	2.9	5.3	25.4	13.2	13.4	7.9	7.7	17.9	11.4	8.1	9.6	8.2	16.7	12.8	15.7	14.8	13.8	7.2	8.5	10.4	9.4	2.9	21.8	11.6	8.6	17.7	23.0	14.5	12.4	21.4	14.3	6.1	13.4	5.7	6.9	9.2	10.4	12.5	11.5	6.6	23.3	12.9	16.6	19.4	7.5	11.1	23.7	6.9	21.1	8.5	15.6	21.1	17.5	19.0	20.5	11.4	6.6	12.4	12.3	16.2	18.0	10.0	50.5	9.8	18.3	14.2	10.6	7.6	12.5	12.9	4.5	3.5	3.4	2.7	3.9	2.5	1.4	1.5	2.3	2.3	1.7	3.3	2.0	16.6	1.4	2.4	4.1	1.7	2.9	22.9	24.3	43.1	37.6	24.3	18.6	27.9	21.5	18.6	24.5	23.8	30.6	16.0	25.4	8.1	26.6	8.9	20.4	5.3	6.8	17.4	41.2	19.1	5.0	16.7	16.3	14.6	24.5	0.0	19.7	14.0	16.1	20.3	13.9	27.7	25.8	23.8	35.5	14.1	21.9	20.6	24.7	20.4	20.3	31.5	18.9	21.5	25.2	18.6	23.3	11.0	28.4	0.0	13.7	9.6	11.8	14.3	28.6	21.3	18.7	22.0
MGST1	"GST12, MGST-I"	ENSG00000008394	"Microsomal glutathione S-transferase 1"	P10620	12	16347142-16609259	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"		Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 382.8"	"Cell type enhanced"	"Detected in many"	16	"Hepatocytes: 3471.1;Proximal tubular cells: 978.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"classical monocyte: 46.1;myeloid DC: 34.1"	"Group enriched"	"Detected in many"	15	"dendritic cells: 34.1;monocytes: 46.1"	"Cell line enhanced"	"Detected in many"		"ASC diff: 342.0;ASC TERT1: 132.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044840	Enhanced		Approved	"Endoplasmic reticulum,Mitochondria"		NA	NA			Mitochondria	"Endoplasmic reticulum"	"HPA044840: AB_10965550"	"unprognostic (4.57e-2)"	"unprognostic (4.80e-3)"	"unprognostic (5.82e-2)"	"unprognostic (2.92e-3)"	"unprognostic (3.97e-3)"	"unprognostic (1.03e-1)"	"unprognostic (8.19e-2)"	"unprognostic (1.03e-1)"	"unprognostic (4.82e-2)"	"unprognostic (3.42e-1)"	"unprognostic (1.37e-3)"	"unprognostic (2.20e-1)"	"prognostic unfavorable (7.45e-4)"	"unprognostic (9.90e-2)"	"unprognostic (4.61e-1)"	"prognostic favorable (1.97e-4)"	"unprognostic (4.19e-1)"	127.9	106.0	18.5	10.8	32.6	9.5	116.8	10.3	14.0	9.3	39.7	9.6	2.6	17.0	4.1	6.4	19.5	6.9	26.6	12.1	19.6	13.9	56.9	382.8	42.0	2.7	18.9	8.9	3.1	12.4	0.8	5.3	8.7	18.4	23.5	28.3	3.0	14.7	8.2	8.9	7.0	15.5	11.5	20.1	0.9	10.3	6.8	12.0	0.0	69.9	13.9	3.6	32.6	37.2	0.2	34.1	2.7	46.1	0.0	0.2	13.0	0.0	30.6	7.3	8.5	342.0	132.0	0.0	25.1	25.7	13.7	21.3	11.6	51.3	0.0	3.0	32.1	43.1	0.1	19.0	40.2	12.4	0.0	2.5	10.4	17.0	40.7	79.9	20.2	0.0	85.6	44.8	41.8	44.1	34.0	24.0	0.0	7.3	0.0	29.4	6.2	0.0	8.1	60.9	0.0	24.3	0.0	4.3	13.8	30.8	60.5	1.3	1.1	39.2	25.2	1.0	41.3	27.1	11.4	15.1	14.1	1.9	27.7	32.3	0.0	0.0	0.0	46.4	32.3	0.4	2.7	46.1	0.4	0.0	7.0	0.1	0.2	0.0	0.0	34.1	0.0	0.0	0.0	1.5	0.0	1.5	9.6	0.2	13.0	18.5	32.6	10.3	14.0	19.6	13.9	18.9	8.9	18.4	12.0	247.1	493.0	46.4	120.5	22.8	0.0	5.3	738.8	293.1	502.7	68.0	0.0	2.3	154.2	22.7	20.8	14.2	262.1	46.7	371.4	189.8	162.1	379.2	32.4	3471.1	168.6	0.0	43.8	78.5	223.7	10.9	30.8	51.0	37.1	187.6	224.9	0.0	374.3	135.3	106.4	978.0	1.0	0.0	12.2	0.5	2.2	15.4	6.6	37.4	362.2	564.6
MGST2	MGST-II	ENSG00000085871	"Microsomal glutathione S-transferase 2"	Q99735	4	139665768-139740745	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Leukotriene biosynthesis, Lipid metabolism"	"Lyase, Oxidoreductase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"plasmacytoid DC: 46.9"	"Group enriched"	"Detected in many"	4	"dendritic cells: 46.9;monocytes: 25.9"	"Cell line enhanced"	"Detected in many"		"CAPAN-2: 47.4;OE19: 91.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			HPA010707	Approved					NA	NA					"HPA010707: AB_1853922"	"unprognostic (9.35e-2)"	"unprognostic (6.13e-2)"	"unprognostic (4.33e-2)"	"prognostic favorable (5.26e-5)"	"unprognostic (1.58e-1)"	"unprognostic (8.26e-2)"	"unprognostic (1.02e-2)"	"unprognostic (1.18e-1)"	"unprognostic (4.38e-2)"	"unprognostic (2.77e-2)"	"unprognostic (8.78e-2)"	"unprognostic (6.41e-2)"	"prognostic favorable (3.22e-9)"	"unprognostic (4.10e-1)"	"unprognostic (9.91e-2)"	"unprognostic (1.77e-2)"	"unprognostic (1.01e-2)"	26.9	30.2	6.9	9.7	10.8	7.4	29.0	12.6	9.3	16.4	27.3	7.3	31.3	27.3	12.2	19.4	54.9	14.7	42.0	26.9	7.4	9.0	25.3	79.1	20.6	21.6	10.1	5.9	10.6	27.8	16.4	18.2	19.2	10.2	23.3	25.4	14.7	30.4	36.7	20.4	24.2	60.3	13.3	10.7	19.6	15.2	29.0	8.8	8.3	23.7	40.9	26.8	19.1	22.6	0.5	46.9	8.1	25.9	5.8	8.8	8.8	6.6	9.7	5.0	0.0	0.8	2.7	3.0	1.2	11.0	0.5	1.8	10.1	47.4	0.0	27.7	2.9	2.4	12.6	8.9	13.7	0.8	3.7	8.0	29.3	10.7	40.0	2.3	25.2	22.6	9.2	33.7	0.3	2.1	11.1	27.7	0.0	12.1	4.4	4.0	5.5	0.0	4.1	1.1	91.7	9.9	2.1	5.9	8.9	25.8	14.3	12.7	3.8	9.0	14.1	10.7	0.3	9.0	33.5	17.6	0.9	4.8	1.3	1.0	5.2	3.6	1.6	0.6	42.7	2.2	8.1	25.9	7.0	1.1	15.4	0.7	0.3	1.9	0.9	35.7	0.5	0.6	0.6	4.4	5.8	4.8	46.9	8.8	8.8	6.9	10.8	12.6	9.3	7.4	9.0	10.1	5.9	10.2	8.8	23.8	29.3	18.2	223.2	54.3	8.1	90.8	229.3	57.6	47.8	90.7	23.6	70.4	76.3	102.7	5.6	212.7	268.6	23.3	122.5	52.4	30.4	143.0	43.7	322.9	310.1	6.4	117.0	164.5	94.6	9.0	41.1	102.8	37.1	19.0	165.9	13.7	108.9	204.6	31.5	203.6	2.7	12.9	48.4	3.7	15.1	109.2	56.2	27.1	227.8	357.7
MGST3	GST-III	ENSG00000143198	"Microsomal glutathione S-transferase 3"	O14880	1	165630861-165661796	"Enzymes, Predicted membrane proteins"		"Lyase, Oxidoreductase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	5	"Cytotrophoblasts: 1846.4;Syncytiotrophoblasts: 1983.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BEWO: 88.9;HDLM-2: 94.3;OE19: 97.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA053311, HPA077929"	Enhanced		Approved	Nucleoplasm		NA	NA		40000	Nucleoplasm		"HPA053311: AB_2682108, HPA077929: "	"unprognostic (1.21e-1)"	"unprognostic (1.44e-1)"	"unprognostic (1.65e-2)"	"unprognostic (1.22e-2)"	"unprognostic (2.67e-1)"	"unprognostic (7.78e-2)"	"unprognostic (3.09e-1)"	"unprognostic (2.06e-2)"	"unprognostic (2.16e-1)"	"unprognostic (1.90e-1)"	"unprognostic (3.96e-1)"	"unprognostic (3.34e-2)"	"unprognostic (1.12e-2)"	"unprognostic (7.60e-2)"	"unprognostic (8.88e-2)"	"unprognostic (1.89e-1)"	"unprognostic (1.90e-1)"	42.8	30.8	52.5	9.7	30.5	19.0	51.2	17.9	56.0	18.4	39.7	18.4	19.1	65.2	19.5	101.8	19.7	20.6	26.5	133.6	38.1	33.9	45.2	29.5	20.8	11.0	44.2	37.6	22.7	17.7	11.1	18.3	30.9	39.6	21.2	40.4	20.3	29.8	20.6	87.2	15.6	53.4	24.7	38.7	12.4	29.8	19.4	23.3	2.7	25.7	41.8	8.2	19.9	17.3	21.3	35.1	20.7	47.0	15.7	38.0	40.7	22.2	16.3	17.7	13.9	62.1	37.3	88.9	18.6	30.0	14.5	25.3	17.0	29.0	1.4	14.7	22.7	14.3	27.2	4.3	18.2	14.7	94.3	11.1	3.4	12.8	7.7	17.5	5.3	7.5	31.8	14.7	20.0	7.7	28.6	23.6	6.1	8.3	8.5	27.1	4.9	5.9	12.3	38.7	97.4	21.0	5.6	7.6	2.8	76.5	20.9	13.7	16.8	18.7	24.3	37.0	37.1	18.5	26.2	21.4	18.0	10.7	12.4	13.4	6.3	4.3	0.7	33.4	14.1	11.6	10.4	45.7	20.7	30.1	37.0	30.3	21.3	38.0	33.5	35.1	19.9	24.4	26.7	9.8	15.7	47.0	15.1	32.3	40.7	52.5	30.5	17.9	56.0	38.1	33.9	44.2	37.6	39.6	23.3	95.3	125.6	83.1	202.5	202.9	129.1	591.8	331.2	242.2	134.2	528.7	251.3	1846.4	848.8	339.3	13.2	253.1	716.8	630.8	371.6	1154.8	298.4	174.8	89.0	248.3	760.5	123.9	146.8	184.8	114.8	21.3	359.3	238.2	492.6	405.8	197.9	162.7	335.4	599.7	375.8	841.2	122.6	498.0	374.9	15.6	33.3	203.4	1983.2	87.4	339.8	197.4
MIB1	"DIP-1, KIAA1323, MIB, ZZANK2, ZZZ6"	ENSG00000101752	"Mindbomb E3 ubiquitin protein ligase 1"	Q86YT6	18	21704957-21870957	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Notch signaling pathway, Ubl conjugation pathway"	Transferase	"Cardiomyopathy, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"REH: 52.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019100, CAB037044"	Approved		Supported	"Vesicles,Plasma membrane"		NA	NA			"Plasma membrane"	Vesicles	"CAB037044: AB_1841007, HPA019100: AB_1853934"	"unprognostic (1.38e-1)"	"unprognostic (6.92e-2)"	"unprognostic (7.29e-2)"	"unprognostic (6.99e-2)"	"unprognostic (5.66e-2)"	"unprognostic (3.23e-2)"	"unprognostic (8.45e-3)"	"unprognostic (2.70e-1)"	"unprognostic (5.42e-2)"	"unprognostic (4.69e-2)"	"unprognostic (3.78e-2)"	"unprognostic (4.70e-2)"	"unprognostic (8.33e-3)"	"unprognostic (4.91e-3)"	"unprognostic (1.73e-1)"	"unprognostic (4.86e-2)"	"unprognostic (1.85e-2)"	12.1	9.1	15.3	7.9	20.6	5.9	15.7	16.1	17.4	16.6	10.9	16.3	9.7	6.9	19.1	13.7	11.4	11.5	12.0	9.4	16.3	12.9	15.7	14.1	10.1	9.6	17.4	16.5	17.2	11.7	18.4	11.5	14.9	15.5	14.7	10.1	14.6	12.0	12.6	9.6	12.5	8.4	17.9	13.8	9.4	10.7	11.5	18.1	13.9	19.1	9.8	10.6	13.0	13.8	1.2	1.2	3.5	1.7	2.5	2.0	0.6	8.5	3.4	16.8	11.7	9.0	10.8	4.0	6.9	7.8	5.0	7.3	5.0	3.2	7.3	6.4	9.6	5.4	5.8	9.7	9.4	11.3	9.6	4.5	8.2	4.4	6.9	7.3	16.6	3.5	6.9	10.4	5.8	14.9	7.3	12.4	2.9	11.2	21.7	7.7	4.2	8.0	6.3	4.2	5.3	4.5	52.4	13.9	18.1	8.5	7.6	5.5	13.6	11.9	5.6	6.1	8.9	3.9	10.9	10.6	12.8	6.4	5.3	9.2	11.4	4.0	11.3	5.4	10.6	7.6	3.5	1.7	0.6	1.0	0.9	1.2	1.2	1.5	1.0	0.6	0.6	1.2	0.9	1.5	2.5	0.5	1.2	2.0	0.6	15.3	20.6	16.1	17.4	16.3	12.9	17.4	16.5	15.5	18.1	44.7	17.7	5.9	14.0	19.5	29.4	15.1	20.4	21.4	34.2	15.7	23.6	10.7	3.3	11.3	3.3	22.5	10.5	0.0	11.2	6.2	22.6	33.3	13.9	26.3	10.8	14.3	23.1	21.5	18.7	3.7	19.0	11.5	25.3	5.4	15.4	16.5	16.7	5.8	23.3	14.4	14.7	0.0	23.4	16.7	11.5	21.5	21.2	10.1	9.4	14.4
MIB2	"FLJ39787, skeletrophin, ZZANK1, ZZZ5"	ENSG00000197530	"Mindbomb E3 ubiquitin protein ligase 2"	Q96AX9	1	1615415-1630610	"Enzymes, Predicted intracellular proteins"	"Notch signaling pathway, Ubl conjugation pathway"	"Actin-binding, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	6	"skeletal muscle: 72.5"	"Cell type enhanced"	"Detected in many"	8	"Basal keratinocytes: 116.3;Late spermatids: 190.0;Suprabasal keratinocytes: 110.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HaCaT: 13.4;SCLC-21H: 14.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA068322	Enhanced					NA	NA					"HPA068322: AB_2685973"	"unprognostic (3.93e-2)"	"unprognostic (6.02e-2)"	"unprognostic (2.34e-2)"	"unprognostic (6.60e-2)"	"unprognostic (2.08e-1)"	"unprognostic (1.70e-2)"	"unprognostic (7.36e-3)"	"unprognostic (2.61e-1)"	"unprognostic (1.54e-1)"	"unprognostic (6.57e-2)"	"unprognostic (1.15e-3)"	"unprognostic (3.17e-2)"	"unprognostic (2.22e-3)"	"unprognostic (1.29e-1)"	"unprognostic (3.58e-2)"	"unprognostic (2.49e-1)"	"unprognostic (1.01e-2)"	6.4	3.9	8.7	6.4	10.0	4.5	4.7	8.8	11.5	4.8	6.9	7.1	4.7	5.3	5.1	5.4	11.4	4.1	3.7	6.1	9.1	7.9	5.5	6.2	5.1	3.7	5.3	7.1	5.8	7.0	3.7	9.4	4.0	5.7	4.7	3.7	6.6	5.4	6.5	72.5	9.6	4.6	5.4	3.4	9.0	8.5	5.2	5.8	7.4	5.9	9.7	4.1	4.5	4.1	2.9	9.2	1.9	0.1	7.3	4.7	1.0	6.6	0.9	0.4	1.5	1.8	0.6	9.3	3.1	1.4	1.0	2.3	1.3	1.7	0.7	4.5	0.9	0.4	13.4	0.5	2.1	0.0	3.5	5.7	0.5	1.9	1.3	2.4	0.8	2.2	1.4	1.4	0.6	0.2	0.6	0.5	3.1	2.7	1.2	0.3	1.0	3.6	8.4	1.2	1.7	10.6	6.2	1.9	9.1	0.1	0.8	14.3	5.2	5.3	0.8	5.1	0.3	1.0	3.3	0.6	1.0	2.2	5.2	0.9	6.9	2.0	1.8	2.4	2.7	1.1	0.0	0.1	1.9	4.3	0.1	4.3	2.6	3.3	4.7	0.0	2.9	3.9	2.9	0.5	7.3	0.0	9.2	2.3	1.0	8.7	10.0	8.8	11.5	9.1	7.9	5.3	7.1	5.7	5.8	0.0	9.6	13.2	14.2	116.3	32.0	9.8	12.7	4.0	7.9	22.7	11.8	8.6	8.3	6.8	52.0	10.0	36.6	0.0	1.1	7.0	10.3	10.7	20.7	9.2	5.8	25.4	14.5	13.5	6.2	190.0	19.5	6.4	16.9	3.6	25.0	25.0	5.9	42.1	14.9	18.1	35.7	0.0	16.8	22.9	43.2	110.2	12.6	52.2	28.9	15.9
MICAL1	"DKFZp434B1517, FLJ11937, FLJ21739, MICAL, NICAL"	ENSG00000135596	"Microtubule associated monooxygenase, calponin and LIM domain containing 1"	Q8TDZ2	6	109444062-109465968	"Enzymes, Predicted intracellular proteins"		"Actin-binding, Monooxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"THP-1: 53.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA030175, HPA030176, HPA030178"	Approved					NA	NA		32000			"HPA030175: AB_2673359, HPA030176: AB_2673360, HPA030178: AB_10600824"	"unprognostic (1.07e-2)"	"unprognostic (1.86e-1)"	"unprognostic (1.23e-1)"	"unprognostic (2.17e-1)"	"unprognostic (2.21e-1)"	"unprognostic (2.71e-3)"	"unprognostic (1.52e-2)"	"unprognostic (1.92e-2)"	"unprognostic (6.93e-2)"	"unprognostic (1.94e-1)"	"prognostic favorable (2.63e-7)"	"unprognostic (2.31e-1)"	"prognostic unfavorable (6.71e-7)"	"unprognostic (2.05e-1)"	"unprognostic (3.27e-1)"	"unprognostic (1.39e-1)"	"unprognostic (1.22e-1)"	10.5	4.2	17.6	20.4	13.5	45.9	9.0	18.1	18.6	18.9	13.3	9.2	10.5	28.9	16.6	7.3	10.1	14.5	11.5	5.0	16.1	9.6	9.2	3.0	17.8	22.6	10.7	12.8	7.4	4.6	10.1	9.9	12.1	10.8	16.2	9.0	6.7	6.5	17.0	3.1	9.8	29.5	22.8	9.1	29.8	12.5	9.3	10.5	12.6	6.9	4.6	16.2	30.3	23.3	5.0	13.5	11.7	12.5	4.5	8.4	5.3	1.4	1.7	5.8	0.1	21.4	16.7	3.9	11.0	8.0	2.4	4.1	2.6	1.7	8.1	2.5	12.1	7.2	1.9	3.5	4.4	1.1	7.1	1.4	3.4	3.8	3.9	8.5	2.2	0.1	9.6	2.2	5.8	4.8	9.5	7.3	5.0	0.9	14.1	14.9	1.7	2.8	12.3	3.7	2.0	1.9	7.7	3.7	1.1	5.5	3.5	1.9	10.2	1.1	1.0	17.7	3.9	1.7	53.0	7.7	6.1	2.1	3.5	4.3	10.8	3.3	7.3	5.0	7.5	4.4	10.1	6.4	11.7	6.3	12.4	3.9	3.4	6.3	5.0	11.8	5.0	4.4	3.0	8.4	4.5	12.5	13.5	8.4	5.3	17.6	13.5	18.1	18.6	16.1	9.6	10.7	12.8	10.8	10.5	41.7	15.6	8.8	1.1	5.5	3.0	2.8	0.0	14.7	6.8	1.8	3.9	1.0	1.7	6.8	11.2	3.5	32.0	0.0	5.8	10.2	8.0	1.7	14.0	0.0	28.6	0.0	30.8	4.9	26.3	14.4	19.2	34.7	15.1	41.5	28.8	2.0	10.6	31.6	35.3	4.2	16.7	0.0	30.8	5.1	9.8	4.3	4.0	12.8	9.7	1.0
MICAL2	KIAA0750	ENSG00000133816	"Microtubule associated monooxygenase, calponin and LIM domain containing 2"	"O94851, Q6ZW33"	11	12094008-12359144	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Differentiation, Spermatogenesis"	"Actin-binding, Developmental protein, Monooxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"brain: 138.4"	"Cell type enhanced"	"Detected in many"	8	"Early spermatids: 73.9;Late spermatids: 128.9;Peritubular cells: 106.1"	"Low cancer specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"cerebellum: 138.4;cerebral cortex: 39.8"	"Cell type enhanced"	"Detected in many"		"neutrophil: 12.2"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"U-138 MG: 40.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030437, HPA039895, HPA040438"	Approved		Uncertain	"Nucleoplasm,Golgi apparatus,Plasma membrane,Cytosol"		NA	NA			"Golgi apparatus, Cytosol"	"Nucleoplasm, Plasma membrane"	"HPA030437: AB_10601873, HPA039895: AB_2676731, HPA040438: AB_10672896"	"unprognostic (2.68e-2)"	"unprognostic (1.77e-2)"	"unprognostic (5.77e-2)"	"unprognostic (1.31e-1)"	"prognostic unfavorable (6.88e-4)"	"unprognostic (2.20e-2)"	"unprognostic (3.60e-2)"	"unprognostic (9.32e-2)"	"unprognostic (2.86e-1)"	"unprognostic (1.36e-1)"	"unprognostic (1.15e-2)"	"unprognostic (6.47e-2)"	"prognostic unfavorable (3.63e-5)"	"unprognostic (4.61e-2)"	"unprognostic (1.97e-1)"	"unprognostic (1.21e-1)"	"unprognostic (1.67e-1)"	4.1	3.3	15.4	7.3	15.1	6.8	2.9	138.4	39.8	6.6	14.7	2.7	2.9	7.2	14.7	7.7	11.5	5.4	11.1	24.8	22.0	6.9	2.9	3.9	12.8	2.3	5.6	17.9	3.9	4.4	0.7	2.4	5.0	5.5	3.3	15.1	2.8	2.9	8.4	14.6	9.3	10.8	22.7	7.6	2.6	5.9	24.6	0.6	0.0	4.5	1.9	2.2	7.8	3.2	0.2	5.5	12.2	6.7	3.7	3.5	2.1	11.8	6.3	0.3	1.4	1.6	3.0	7.5	18.9	21.4	7.4	11.6	13.2	8.5	0.3	4.1	13.2	21.2	8.4	2.3	30.4	18.4	13.7	1.5	11.2	1.2	0.9	14.2	2.1	1.4	5.3	5.4	32.6	31.9	13.8	16.9	0.8	19.5	0.5	11.9	0.7	0.1	1.0	0.4	8.4	5.9	0.1	7.5	7.9	1.5	14.9	6.1	0.5	6.2	17.3	1.2	4.7	1.7	0.6	30.1	40.3	15.2	6.6	16.4	0.4	0.9	0.4	24.5	3.0	0.8	0.1	6.7	0.5	2.8	1.7	3.5	0.2	1.7	1.7	5.5	0.2	0.2	0.9	12.2	3.7	0.5	1.0	2.1	2.1	15.4	15.1	138.4	39.8	22.0	6.9	5.6	17.9	5.5	0.6	38.7	29.6	4.2	6.7	9.0	2.8	28.1	7.6	5.3	11.4	3.5	0.0	2.1	0.0	9.6	73.9	7.1	31.5	23.3	12.4	9.5	4.5	7.0	1.1	17.8	3.0	0.0	21.7	11.1	11.1	128.9	19.5	8.9	5.0	8.2	10.0	0.2	29.0	14.1	106.1	0.6	1.6	12.9	27.6	0.9	0.9	8.3	1.9	9.2	9.9	9.7
MICAL3	KIAA0819	ENSG00000243156	"Microtubule associated monooxygenase, calponin and LIM domain containing 3"	Q7RTP6	22	17787649-18024559	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Cell cycle, Cell division, Exocytosis"	"Actin-binding, Monooxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Muller glia cells: 59.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	5	"basophil: 10.0;memory B-cell: 3.3;naive B-cell: 5.2"	"Group enriched"	"Detected in many"	6	"B-cells: 5.2;granulocytes: 10.0"	"Cell line enhanced"	"Detected in many"		"WM-115: 51.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000639, HPA003421, HPA034882"	Approved		Supported	"Nucleoplasm,Plasma membrane,Midbody ring,Cytosol"		Yes	No			"Nucleoplasm, Midbody ring"	"Plasma membrane, Cytosol"	"HPA000639: AB_10301319, HPA003421: AB_10601134, HPA034882: AB_2674371"	"unprognostic (1.65e-1)"	"unprognostic (1.02e-1)"	"unprognostic (3.67e-2)"	"unprognostic (2.00e-2)"	"unprognostic (7.68e-2)"	"unprognostic (2.06e-1)"	"unprognostic (4.71e-2)"	"unprognostic (3.07e-3)"	"unprognostic (3.41e-1)"	"unprognostic (1.01e-1)"	"unprognostic (4.58e-1)"	"unprognostic (3.82e-1)"	"unprognostic (8.86e-3)"	"unprognostic (1.36e-2)"	"unprognostic (1.23e-1)"	"unprognostic (2.03e-2)"	"unprognostic (6.64e-2)"	10.1	9.0	15.4	20.7	19.2	10.2	9.6	62.2	25.0	12.8	22.4	30.0	8.8	8.3	30.3	14.0	13.8	28.6	9.5	23.7	15.4	13.8	8.7	16.8	6.1	15.2	21.6	15.6	20.2	10.2	30.4	11.0	11.9	19.4	11.8	16.5	14.2	8.0	14.8	28.0	14.7	13.2	26.1	20.9	12.2	11.1	15.7	22.6	3.0	10.4	7.8	20.8	14.7	15.1	5.2	0.3	10.0	0.1	1.3	1.1	0.2	13.9	15.4	8.2	13.2	6.1	7.9	9.8	12.3	13.4	17.5	13.8	14.6	2.0	15.6	6.3	16.8	20.1	16.2	12.0	14.2	17.0	15.1	11.4	16.2	16.3	6.1	4.1	7.2	8.7	6.3	11.4	18.3	19.5	11.1	10.1	4.5	17.8	10.1	6.4	12.5	6.8	4.5	5.5	10.3	10.0	9.5	12.2	0.7	14.0	9.9	21.5	8.4	17.4	11.0	26.2	13.0	4.4	3.1	17.8	18.0	11.6	12.3	25.6	6.6	11.7	20.9	15.6	3.2	51.4	10.0	0.0	0.1	0.5	0.1	0.8	3.3	0.6	0.5	0.1	5.2	0.3	0.2	0.2	1.3	0.0	0.3	1.1	0.2	15.4	19.2	62.2	25.0	15.4	13.8	21.6	15.6	19.4	22.6	3.0	15.1	14.3	10.9	10.0	13.4	13.4	12.7	20.1	15.9	12.2	49.1	11.8	0.0	19.8	9.4	14.0	21.9	23.3	8.4	29.4	9.6	10.5	18.5	33.0	2.7	1.6	9.8	6.2	2.7	10.5	3.7	3.7	8.5	8.2	18.5	59.7	22.3	20.1	6.0	3.9	11.6	0.0	9.2	19.3	12.6	10.3	9.4	7.7	15.7	6.7
MID1	"FXY, OS, RNF59, TRIM18"	ENSG00000101871	"Midline 1"	O15344	X	10445310-10833654	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Ubl conjugation pathway"	Transferase	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	6	"Horizontal cells: 65.2;Ito cells: 85.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"eosinophil: 3.3"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"A549: 57.2;AF22: 43.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002878, HPA003715"	Approved		Approved	"Centriolar satellite"		NA	NA			"Centriolar satellite"		"HPA002878: , HPA003715: AB_1079384"	"unprognostic (1.99e-1)"	"unprognostic (2.81e-1)"	"unprognostic (4.66e-2)"	"unprognostic (2.79e-1)"	"unprognostic (2.78e-1)"	"unprognostic (2.61e-1)"	"prognostic unfavorable (3.06e-4)"	"unprognostic (1.19e-1)"	"unprognostic (3.61e-1)"	"unprognostic (2.09e-1)"	"unprognostic (2.87e-1)"	"unprognostic (9.43e-2)"	"unprognostic (1.25e-3)"	"unprognostic (9.89e-2)"	"unprognostic (1.49e-1)"	"unprognostic (1.12e-3)"	"unprognostic (5.88e-2)"	13.4	3.6	6.5	10.4	8.4	0.3	8.6	16.3	7.1	17.5	21.5	3.8	11.7	7.7	17.9	11.3	12.2	7.7	13.1	13.2	6.2	4.2	7.9	4.9	10.4	4.2	4.5	3.7	12.0	4.8	2.7	6.6	7.8	4.9	14.6	12.8	15.9	7.1	19.1	2.8	3.9	8.7	30.6	2.6	1.3	5.3	6.5	4.1	0.8	6.2	7.1	5.8	17.1	20.5	1.0	0.7	3.3	0.0	0.0	0.1	0.1	12.3	57.2	43.3	6.6	2.5	3.6	5.3	7.7	6.5	8.0	8.2	10.5	3.7	4.2	2.5	7.0	22.4	8.5	3.5	5.4	6.0	0.2	5.2	0.9	8.1	0.2	1.1	0.0	0.2	4.1	2.8	5.2	5.5	7.5	7.6	1.9	0.6	0.7	3.1	2.0	1.6	0.1	13.8	1.6	4.2	1.2	11.0	0.0	5.9	11.4	3.0	1.1	3.3	9.8	3.6	14.6	6.8	0.0	4.8	2.6	0.3	13.4	6.8	0.6	0.3	0.1	5.7	0.0	12.9	0.1	0.0	3.3	0.1	0.0	0.0	0.0	0.0	0.0	0.1	1.0	0.0	0.1	0.1	0.0	0.0	0.7	0.0	0.1	6.5	8.4	16.3	5.2	6.2	4.2	4.5	3.7	4.9	4.1	32.8	16.5	0.0	25.6	19.1	7.7	4.1	7.6	14.7	21.6	22.7	17.7	7.1	1.7	12.3	1.5	24.5	14.4	0.0	7.5	22.8	11.8	5.9	1.1	5.4	1.4	65.2	11.6	85.3	4.4	4.5	27.9	1.1	3.3	0.0	8.1	44.8	5.7	14.4	38.9	1.4	2.5	6.5	2.3	0.2	1.9	8.8	16.7	0.0	18.0	51.2
MID2	"FXY2, MRX101, RNF60, TRIM1"	ENSG00000080561	"Midline 2"	Q9UJV3	X	107825755-107927193	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase	"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	8	"Urothelial cells: 8.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"naive CD4 T-cell: 4.2"	"Lineage enriched"	"Detected in single"	5	"T-cells: 4.2"	"Cell line enhanced"	"Detected in many"		"HUVEC TERT2: 24.3;Karpas-707: 21.2;MCF7: 15.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA						"unprognostic (8.28e-2)"	"unprognostic (8.51e-2)"	"unprognostic (3.69e-4)"	"unprognostic (6.40e-3)"	"unprognostic (1.16e-1)"	"unprognostic (7.50e-2)"	"unprognostic (3.87e-1)"	"unprognostic (7.20e-2)"	"unprognostic (1.09e-2)"	"unprognostic (4.87e-2)"	"unprognostic (2.00e-1)"	"unprognostic (2.09e-1)"	"unprognostic (3.19e-2)"	"prognostic unfavorable (3.73e-4)"	"unprognostic (2.07e-1)"	"unprognostic (3.77e-1)"	"unprognostic (5.97e-3)"	12.7	11.3	3.6	4.8	11.4	0.4	13.0	9.3	8.0	10.8	9.0	5.1	9.4	2.0	12.6	9.7	15.1	10.0	8.6	4.4	4.0	5.2	6.6	6.2	9.0	6.2	4.3	5.8	11.5	10.2	16.0	11.1	4.7	7.1	12.9	4.0	12.4	12.7	10.9	16.6	14.5	4.6	17.2	5.4	5.8	7.7	4.7	4.7	0.5	14.5	8.3	6.6	16.7	11.9	0.7	0.0	0.0	0.0	0.0	4.2	1.1	4.8	4.2	0.1	6.7	5.4	7.7	0.1	3.5	8.8	3.0	2.2	0.3	0.8	0.0	4.6	6.6	5.0	3.1	2.4	7.0	0.7	0.0	3.2	0.0	2.6	0.0	8.0	0.0	0.0	4.8	8.0	0.1	8.9	5.3	24.3	0.3	0.0	21.2	3.3	15.4	0.0	0.0	0.7	0.2	7.8	0.0	1.9	0.0	3.6	4.4	0.4	0.0	7.4	0.3	11.1	2.4	2.7	0.2	5.0	0.0	1.3	6.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	3.3	0.1	1.8	3.5	0.0	0.7	4.2	2.3	0.0	0.0	0.0	0.0	0.3	1.1	3.6	11.4	9.3	8.0	4.0	5.2	4.3	5.8	7.1	4.7	3.0	0.0	0.0	2.5	2.7	2.0	0.6	2.5	1.4	0.0	0.0	0.0	0.0	1.7	1.3	1.1	1.6	0.1	0.0	1.3	0.0	0.9	4.0	0.0	1.8	0.1	0.0	0.0	1.8	0.0	1.3	0.0	0.0	3.3	0.0	0.0	0.7	1.2	0.0	0.7	0.7	3.7	0.0	1.4	0.2	0.2	3.1	0.0	0.0	0.1	8.9
MIF	"GIF, GLIF"	ENSG00000240972	"Macrophage migration inhibitory factor"	P14174	22	23894004-23895227	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Immunity, Inflammatory response, Innate immunity"	"Cytokine, Isomerase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Distal tubular cells: 1397.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HEK 293: 129.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003868, CAB005284"	Approved		Supported	Nucleoplasm,Cytosol	"Secreted to blood"	No	No	13800000	14000000	Cytosol	Nucleoplasm	"CAB005284: AB_648587, HPA003868: AB_1079290"	"unprognostic (1.68e-1)"	"unprognostic (7.79e-3)"	"unprognostic (2.49e-1)"	"unprognostic (1.46e-1)"	"unprognostic (1.33e-1)"	"unprognostic (1.36e-2)"	"unprognostic (9.48e-2)"	"unprognostic (1.22e-3)"	"unprognostic (2.17e-2)"	"unprognostic (1.78e-2)"	"unprognostic (1.52e-1)"	"unprognostic (2.28e-2)"	"unprognostic (2.19e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.55e-1)"	"unprognostic (2.56e-1)"	"unprognostic (1.02e-1)"	30.6	49.8	43.9	42.0	39.9	46.0	71.6	19.0	66.1	23.0	42.7	10.4	55.6	39.9	22.5	113.3	51.9	23.3	42.5	60.7	42.8	40.3	71.8	58.8	46.2	113.9	33.5	43.7	24.5	80.2	16.2	41.1	30.5	45.2	54.8	11.6	15.0	57.3	101.2	36.0	63.3	50.6	26.7	78.3	42.5	56.2	24.9	19.2	19.0	28.9	43.7	16.7	21.4	44.6	56.8	42.5	17.6	23.8	38.3	52.7	66.0	49.8	11.0	2.4	11.2	0.9	2.3	18.7	18.8	3.1	6.1	7.8	8.3	8.2	23.7	14.9	1.3	2.8	22.2	2.6	11.4	0.7	19.9	129.4	8.9	10.1	17.2	4.9	34.6	21.1	4.7	6.8	3.6	1.7	4.5	4.8	17.8	13.8	12.1	2.0	25.1	23.5	64.2	14.3	9.8	60.3	30.2	4.1	66.5	4.7	3.4	32.5	37.8	12.0	12.7	31.0	0.6	16.4	10.4	13.7	5.3	35.6	3.2	0.4	52.3	18.4	24.4	21.5	12.9	10.8	16.3	23.8	17.6	37.4	22.3	52.7	56.8	51.8	40.4	31.6	49.1	46.1	38.0	7.1	38.3	14.6	42.5	48.3	66.0	43.9	39.9	19.0	66.1	42.8	40.3	33.5	43.7	45.2	19.2	145.9	147.8	297.7	257.6	597.1	25.5	0.3	433.1	384.1	354.8	657.8	2.0	427.6	1397.6	643.7	166.1	220.2	275.4	0.0	324.9	742.0	370.2	224.8	172.4	900.8	252.9	20.6	335.5	293.4	221.5	97.3	311.3	223.0	733.9	288.6	378.1	30.6	687.0	340.1	284.6	1307.4	25.0	135.8	432.6	7.9	117.5	663.2	573.7	251.6	418.6	198.5
MINDY1	"FAM63A, FLJ11280, MINDY-1"	ENSG00000143409	"MINDY lysine 48 deubiquitinase 1"	Q8N5J2	1	150996086-151008375	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"	15	"Distal tubular cells: 33.2;Ductal cells: 11.3;Proximal tubular cells: 10.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	6	"basophil: 26.3;eosinophil: 19.1;neutrophil: 30.4"	"Lineage enriched"	"Detected in many"	7	"granulocytes: 30.4"	"Cell line enhanced"	"Detected in many"		"T-47d: 27.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028351, HPA028358, HPA061086"	Approved		Enhanced	Nucleoplasm		NA	NA		240000	Nucleoplasm		"HPA028351: AB_10611110, HPA028358: AB_10601102, HPA061086: AB_2684425"	"unprognostic (5.73e-2)"	"unprognostic (2.86e-1)"	"unprognostic (5.47e-2)"	"unprognostic (3.14e-1)"	"unprognostic (3.39e-2)"	"unprognostic (6.90e-2)"	"unprognostic (1.47e-2)"	"unprognostic (1.64e-1)"	"unprognostic (1.02e-1)"	"unprognostic (1.88e-1)"	"unprognostic (9.22e-3)"	"unprognostic (1.06e-1)"	"prognostic favorable (3.43e-8)"	"unprognostic (2.30e-1)"	"unprognostic (7.95e-2)"	"unprognostic (2.50e-2)"	"unprognostic (6.06e-2)"	9.2	9.7	14.0	6.7	31.1	5.6	13.0	18.4	21.2	13.1	13.5	53.8	14.8	14.0	14.7	6.5	24.1	14.4	11.8	24.5	17.6	10.1	26.6	12.2	10.9	5.2	37.5	13.5	19.3	37.3	26.2	12.3	5.9	25.0	11.7	14.8	16.9	25.3	21.0	11.9	17.1	12.1	13.7	34.1	10.7	15.9	14.7	35.7	0.9	39.9	7.9	10.3	12.3	13.0	0.6	4.0	30.4	3.2	1.5	2.2	3.4	6.1	4.0	4.3	6.1	7.8	6.5	3.6	2.0	5.1	2.8	4.5	8.6	14.7	0.4	4.8	2.6	0.9	3.1	3.4	3.7	1.3	4.6	5.1	6.0	7.4	7.3	1.7	1.8	2.4	5.3	3.4	5.1	1.4	9.6	7.2	2.1	3.7	15.5	2.9	9.5	0.3	4.0	2.0	1.9	1.4	4.5	0.8	18.9	13.4	12.2	7.5	5.5	3.8	7.0	4.2	2.1	27.9	6.1	6.7	2.4	3.2	1.2	1.7	5.7	5.2	20.6	5.8	4.0	11.4	26.3	3.2	19.1	0.1	1.5	0.1	0.3	1.3	0.3	4.0	0.6	2.2	0.7	30.4	1.5	0.9	0.6	1.6	3.4	14.0	31.1	18.4	21.2	17.6	10.1	37.5	13.5	25.0	35.7	8.9	4.3	0.0	0.0	0.0	0.0	0.0	0.0	4.0	6.8	3.5	0.0	3.4	33.2	11.3	0.0	0.0	0.0	0.0	6.1	0.6	0.0	0.0	3.5	0.0	3.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.4	0.0	0.0	7.3	0.0	0.0	10.5	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0
MINDY2	"FAM63B, KIAA1164"	ENSG00000128923	"MINDY lysine 48 deubiquitinase 2"	Q8NBR6	15	58771192-58861900	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	10	"Alveolar cells type 1: 137.0;Collecting duct cells: 78.5;Extravillous trophoblasts: 84.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"U-2197: 40.6"	"Low region specificity"	"Detected in all"							"HPA051103, HPA063669"	Approved		Enhanced	Nucleoplasm		No	No			Nucleoplasm		"HPA051103: AB_2681345, HPA063669: AB_2685082"	"unprognostic (4.71e-2)"	"unprognostic (8.92e-3)"	"unprognostic (4.63e-2)"	"unprognostic (4.13e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.06e-1)"	"unprognostic (2.14e-1)"	"unprognostic (8.60e-2)"	"unprognostic (7.23e-2)"	"unprognostic (7.09e-2)"	"unprognostic (2.36e-3)"	"unprognostic (4.74e-2)"	"prognostic favorable (3.00e-8)"	"unprognostic (2.53e-1)"	"unprognostic (3.59e-1)"	"unprognostic (6.76e-2)"	"unprognostic (4.77e-2)"	14.0	9.2	15.5	8.8	14.7	5.6	11.1	41.0	15.4	12.4	8.8	12.4	11.8	5.8	13.0	8.0	11.8	11.7	10.4	16.7	14.6	12.6	16.9	5.8	12.5	6.1	16.2	15.5	11.7	6.4	15.5	12.5	21.9	14.9	15.0	6.6	11.7	7.7	11.8	6.1	11.4	6.5	13.6	16.9	9.4	7.8	6.2	15.8	8.6	15.8	5.4	6.0	13.1	9.1	4.6	2.9	5.5	3.1	1.9	5.5	1.4	5.8	2.9	4.1	2.5	6.2	11.4	6.5	5.4	11.5	1.7	2.4	4.6	2.9	3.0	5.9	6.5	3.0	5.7	7.5	4.3	2.6	3.0	2.7	4.2	3.2	4.1	3.8	3.1	3.9	5.0	7.3	2.0	4.5	6.4	4.1	3.2	7.2	3.4	3.9	0.7	3.9	2.4	8.7	0.8	1.5	1.7	11.8	3.2	5.0	6.6	3.7	2.8	3.9	5.5	9.8	9.1	1.7	6.7	4.8	2.4	2.1	40.6	2.3	3.0	4.3	3.0	5.3	5.2	5.7	5.5	1.8	3.3	3.2	1.6	5.5	2.7	2.8	3.5	0.6	4.6	2.4	3.3	3.9	1.9	3.1	2.9	2.2	1.4	15.5	14.7	41.0	15.4	14.6	12.6	16.2	15.5	14.9	15.8	137.0	33.7	0.0	0.0	0.0	0.0	0.0	0.0	52.2	33.0	78.5	0.0	54.4	39.7	36.7	0.0	0.0	0.0	0.0	18.8	84.1	0.0	0.0	10.5	0.0	28.7	0.0	0.0	0.0	0.0	0.0	0.0	5.9	0.0	16.2	0.0	0.0	23.8	0.0	0.0	12.2	0.0	0.0	0.0	0.0	0.0	0.0	44.5	0.0	0.0	0.0
MINDY3	"C10orf97, CARP, DERP5, FAM188A, FLJ13397, my042"	ENSG00000148481	"MINDY lysine 48 deubiquitinase 3"	Q9H8M7	10	15778170-15860520	"Enzymes, Predicted intracellular proteins"	"Apoptosis, Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"Alveolar cells type 1: 20.8;Ciliated cells: 21.4;Hofbauer cells: 31.6;Syncytiotrophoblasts: 27.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038400, HPA038406"	Uncertain		Supported	"Nucleoplasm,Nuclear membrane"		NA	NA			"Nucleoplasm, Nuclear membrane"		"HPA038400: AB_10669724, HPA038406: AB_2676001"	"unprognostic (9.20e-2)"	"unprognostic (5.84e-2)"	"unprognostic (3.09e-1)"	"unprognostic (3.26e-1)"	"unprognostic (1.99e-2)"	"unprognostic (3.67e-1)"	"unprognostic (8.29e-2)"	"unprognostic (2.81e-2)"	"unprognostic (3.85e-2)"	"unprognostic (9.63e-2)"	"unprognostic (6.48e-3)"	"unprognostic (6.50e-2)"	"unprognostic (1.32e-1)"	"unprognostic (2.97e-1)"	"unprognostic (1.04e-2)"	"unprognostic (1.76e-1)"	"unprognostic (3.19e-1)"	14.6	22.0	17.9	10.0	22.2	15.2	18.4	22.0	32.0	19.1	13.7	19.7	11.4	8.2	18.6	20.0	13.4	15.3	13.3	8.9	20.1	18.8	16.0	15.8	15.5	11.9	22.9	14.0	18.1	12.8	16.3	14.4	20.1	25.8	18.9	18.0	13.5	11.8	16.5	4.1	15.3	11.4	16.7	32.0	11.8	14.6	18.8	16.1	10.5	17.2	7.7	12.6	17.8	14.1	3.4	4.2	5.7	8.0	3.4	6.2	2.9	6.6	6.2	12.1	12.8	18.0	17.1	10.0	21.3	10.8	16.3	19.1	5.4	10.5	5.0	4.1	23.0	11.3	6.2	10.3	12.7	14.6	15.3	14.4	16.3	8.8	5.8	22.6	3.3	13.7	12.9	11.1	14.5	10.3	16.0	12.8	12.2	9.9	4.2	16.1	7.2	7.1	4.0	4.4	10.8	11.9	3.5	7.1	3.5	18.2	5.1	10.0	11.1	10.4	10.1	8.5	11.3	11.3	8.1	13.4	10.6	8.2	17.8	6.2	23.1	9.8	8.6	12.2	7.4	8.4	5.7	3.6	3.1	4.9	7.1	4.1	3.1	3.4	5.2	4.0	3.4	2.3	4.4	3.1	3.4	8.0	4.2	6.2	2.9	17.9	22.2	22.0	32.0	20.1	18.8	22.9	14.0	25.8	16.1	20.8	11.8	0.0	0.0	0.0	0.0	0.0	0.0	21.4	6.8	14.0	0.0	16.7	16.6	10.4	0.0	0.0	0.0	0.0	7.3	13.3	0.0	0.0	1.1	0.0	31.6	0.0	0.0	0.0	0.0	0.0	0.0	3.7	0.0	2.8	0.0	0.0	7.1	0.0	0.0	13.3	0.0	0.0	0.0	0.0	0.0	0.0	27.3	0.0	0.0	0.0
MINDY4	"C7orf67, FAM188B, FLJ22374"	ENSG00000106125	"MINDY lysine 48 deubiquitinase 4"	Q4G0A6	7	30771417-30892387	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in some"	5	"Alveolar cells type 1: 8.9;Ciliated cells: 33.5;Collecting duct cells: 12.2"	"Low cancer specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"MAIT T-cell: 2.7"	"Group enriched"	"Detected in many"	5	"dendritic cells: 1.1;T-cells: 2.7"	"Cell line enhanced"	"Detected in many"		"K-562: 16.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA019475, HPA030129, HPA030130"	Approved		Supported	Vesicles,Cytosol		NA	NA			"Vesicles, Cytosol"		"HPA019475: AB_1848806, HPA030129: AB_10599621, HPA030130: AB_10601565"	"unprognostic (2.96e-1)"	"unprognostic (1.27e-1)"	"unprognostic (2.62e-1)"	"unprognostic (2.10e-2)"	"unprognostic (1.64e-1)"	"unprognostic (4.07e-1)"	"unprognostic (6.01e-3)"	"unprognostic (3.81e-2)"	"unprognostic (5.25e-3)"	"unprognostic (1.97e-1)"	"unprognostic (5.59e-3)"	"unprognostic (2.96e-2)"	"unprognostic (1.92e-1)"	"unprognostic (9.55e-2)"	"unprognostic (1.12e-2)"	"unprognostic (1.05e-1)"	"unprognostic (2.18e-1)"	9.3	6.7	9.3	2.6	15.2	4.1	7.0	3.4	15.1	10.8	6.6	5.4	16.6	2.9	15.6	16.2	5.7	20.7	10.0	7.5	8.4	5.1	9.4	3.8	14.2	2.4	4.3	9.5	14.8	5.6	9.6	16.1	6.2	9.0	9.4	4.3	7.8	5.3	15.9	3.7	5.1	3.7	10.8	3.6	2.3	5.8	20.1	5.0	1.5	12.5	3.6	2.2	6.4	6.3	0.0	1.1	0.0	0.3	0.0	2.7	0.7	2.1	5.3	2.8	8.5	2.5	9.6	4.1	3.1	5.4	2.4	2.0	0.0	4.0	0.0	3.6	2.0	3.3	2.3	1.9	1.7	2.3	0.0	3.1	1.7	2.8	0.0	3.1	2.3	1.2	4.9	2.8	7.0	1.4	0.2	3.4	1.6	16.4	1.0	2.0	0.0	1.3	0.7	8.0	7.4	1.2	0.4	0.0	0.5	6.4	1.0	5.2	7.1	2.1	11.3	1.2	3.4	5.7	1.7	2.0	0.1	1.3	2.4	1.3	2.3	3.0	0.0	4.5	0.1	10.0	0.0	0.1	0.0	0.6	0.0	2.7	0.0	0.8	0.2	1.1	0.0	0.3	0.5	0.0	0.0	0.3	0.0	0.5	0.7	9.3	15.2	3.4	15.1	8.4	5.1	4.3	9.5	9.0	5.0	8.9	3.8	0.0	0.0	0.0	0.0	0.0	0.0	33.5	3.4	12.2	0.0	2.1	3.3	2.3	0.0	0.0	0.0	0.0	1.2	3.5	0.0	0.0	2.3	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0
MINK1	"B55, MAP4K6, MINK, YSK2, ZC3"	ENSG00000141503	"Misshapen like kinase 1"	Q8N4C8	17	4833388-4898061	"Enzymes, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA056296	Approved					NA	NA					"HPA056296: AB_2683090"	"unprognostic (2.80e-1)"	"unprognostic (3.83e-2)"	"unprognostic (1.85e-1)"	"unprognostic (6.62e-2)"	"unprognostic (2.88e-1)"	"unprognostic (3.26e-3)"	"prognostic unfavorable (3.00e-4)"	"unprognostic (4.64e-3)"	"unprognostic (3.21e-1)"	"unprognostic (2.78e-2)"	"prognostic favorable (2.77e-4)"	"prognostic unfavorable (9.27e-4)"	"unprognostic (8.44e-3)"	"unprognostic (2.49e-2)"	"unprognostic (1.37e-1)"	"unprognostic (2.47e-2)"	"unprognostic (1.62e-1)"	12.7	14.8	31.4	18.2	46.8	14.9	14.2	30.8	43.5	15.2	26.0	32.6	8.8	33.1	12.4	7.7	40.0	14.3	15.6	9.0	28.4	12.8	13.8	10.0	23.3	17.1	28.6	27.3	27.5	21.5	16.5	15.4	17.4	29.0	14.3	20.7	14.5	21.1	11.3	8.3	47.3	31.1	11.4	24.8	20.0	22.3	14.5	30.9	9.0	12.7	14.6	16.8	14.9	24.1	2.6	1.2	6.4	1.6	0.3	3.0	2.3	18.8	34.5	8.0	13.1	12.8	9.3	23.2	15.0	13.8	12.0	10.1	13.1	13.1	13.4	17.4	15.8	11.9	38.2	6.0	27.1	5.9	19.3	16.8	9.6	21.9	10.2	8.4	3.5	18.8	9.9	20.3	11.3	10.5	10.2	13.0	4.5	10.3	11.7	8.8	11.2	5.7	8.1	6.3	12.3	11.2	7.2	6.7	8.1	18.4	19.3	8.4	6.7	15.6	13.0	9.8	9.2	11.7	4.9	18.7	12.8	5.8	21.7	14.3	6.7	5.4	2.7	11.5	7.7	8.6	0.0	1.6	6.4	2.7	1.6	3.0	2.6	2.8	2.1	1.2	1.5	2.0	0.8	1.3	0.3	0.8	0.8	2.8	2.3	31.4	46.8	30.8	43.5	28.4	12.8	28.6	27.3	29.0	30.9	0.0	1.3	1.9	12.1	36.5	6.4	1.4	12.7	1.4	3.4	5.2	37.3	15.1	5.0	7.8	2.6	8.8	31.0	0.0	9.0	10.5	7.3	11.7	8.1	8.1	17.6	12.7	18.0	13.5	12.1	5.4	15.0	8.8	15.1	45.1	29.6	6.5	11.9	42.1	13.8	7.5	15.5	12.9	4.4	5.0	9.4	52.9	16.4	6.9	27.3	18.7
MINPP1	MIPP	ENSG00000107789	"Multiple inositol-polyphosphate phosphatase 1"	Q9UNW1	10	87504875-87553460	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		Hydrolase	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Erythroid cells: 70.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA026859	Approved				"Intracellular and membrane"	NA	NA		320000000			"HPA026859: AB_1853961"	"unprognostic (9.15e-2)"	"unprognostic (8.76e-3)"	"unprognostic (2.08e-2)"	"unprognostic (2.97e-1)"	"unprognostic (1.35e-1)"	"unprognostic (5.20e-3)"	"unprognostic (3.47e-2)"	"unprognostic (1.74e-1)"	"unprognostic (4.55e-1)"	"unprognostic (2.07e-2)"	"unprognostic (6.54e-2)"	"unprognostic (6.50e-3)"	"prognostic unfavorable (6.98e-5)"	"unprognostic (2.43e-1)"	"unprognostic (2.09e-1)"	"unprognostic (2.07e-1)"	"unprognostic (7.01e-2)"	9.9	27.6	8.5	8.0	8.9	24.6	14.2	12.0	9.2	9.1	13.3	8.0	12.8	16.7	12.1	10.0	5.4	8.4	9.5	7.2	8.5	10.0	19.4	28.9	9.5	10.1	8.2	6.3	11.1	18.2	10.2	18.5	31.4	7.6	11.6	12.4	9.3	8.9	12.2	5.9	9.5	19.4	7.4	8.2	8.2	8.9	8.8	8.5	13.5	13.1	5.3	6.5	8.7	13.9	8.9	13.5	8.5	12.9	10.4	16.4	9.3	8.3	12.9	12.9	18.9	22.0	18.2	10.9	13.6	23.3	13.5	18.1	6.8	16.4	7.2	12.7	16.0	9.0	13.0	13.6	12.4	15.4	16.5	16.2	18.5	5.2	25.2	16.5	7.9	16.9	15.9	16.0	15.0	9.1	24.4	16.9	6.5	10.8	35.3	15.6	6.2	5.2	11.2	9.3	6.3	9.3	0.0	7.4	4.9	17.7	4.7	4.7	14.8	12.9	2.7	22.6	15.2	7.8	6.6	14.8	8.7	10.5	10.3	13.0	11.5	11.8	1.9	13.9	12.2	6.3	8.5	10.3	4.6	11.6	12.9	10.3	8.9	11.0	13.2	13.5	7.3	10.6	11.9	0.7	10.4	10.8	7.8	16.4	9.3	8.5	8.9	12.0	9.2	8.5	10.0	8.2	6.3	7.6	8.5	6.0	13.8	10.7	7.2	2.5	13.2	3.9	20.4	14.7	5.7	7.0	2.0	16.9	5.0	13.7	11.4	7.8	12.6	70.0	14.6	15.3	13.1	7.1	24.3	50.4	11.9	9.5	12.6	18.4	13.7	0.5	8.6	10.1	10.1	12.6	19.4	11.8	10.8	17.3	7.8	23.5	14.1	0.0	9.2	9.5	13.2	3.0	6.8	8.7	10.4	4.3
MIOX	ALDRL6	ENSG00000100253	"Myo-inositol oxygenase"	Q9UGB7	22	50486784-50490648	"Enzymes, Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	43	"kidney: 136.7"	"Cell type enriched"	"Detected in some"	5	"Proximal tubular cells: 1814.0"	"Cancer enriched"	"Detected in many"	16	"renal cancer: 56.0"	"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"HDLM-2: 21.8;Hep G2: 4.9;Karpas-707: 11.6;U-266/70: 7.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA039451, HPA039562"	Enhanced					NA	NA					"HPA039451: AB_2676513, HPA039562: AB_2676574"	"unprognostic (2.11e-1)"	"unprognostic (4.32e-2)"	"unprognostic (2.22e-2)"	"unprognostic (1.30e-2)"	"unprognostic (9.83e-2)"	"unprognostic (5.25e-2)"	"unprognostic (1.61e-2)"	"unprognostic (3.84e-3)"	"unprognostic (2.84e-1)"	"unprognostic (4.72e-2)"	"unprognostic (1.85e-2)"	"unprognostic (9.83e-2)"	"prognostic favorable (2.60e-6)"	"unprognostic (1.77e-1)"	"unprognostic (1.50e-1)"	"unprognostic (1.36e-2)"	"unprognostic (2.23e-2)"	0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.0	0.8	0.1	0.1	0.0	136.7	0.1	0.1	0.1	0.1	0.1	0.1	0.2	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.4	2.7	0.1	0.1	0.1	0.1	1.3	0.6	3.1	0.7	0.4	1.4	0.4	0.0	0.0	0.1	0.3	0.2	0.1	1.8	0.2	0.0	0.0	0.1	0.1	0.3	0.1	0.6	0.4	0.0	0.1	0.1	0.0	0.0	21.8	0.0	0.1	0.3	4.9	2.9	0.0	0.2	0.0	0.0	0.1	0.4	0.0	0.0	1.0	0.1	11.6	0.0	1.1	0.0	0.1	0.2	0.5	0.4	0.1	0.1	0.1	2.3	0.1	0.1	0.3	0.0	0.0	0.4	0.4	0.0	1.2	0.0	0.0	0.5	0.1	0.0	7.0	0.6	0.3	0.1	0.0	0.2	3.1	0.4	0.6	0.5	0.3	0.2	1.3	0.5	1.4	0.1	0.9	0.5	0.6	1.8	0.4	0.7	0.6	0.4	0.4	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	1.7	2.4	0.8	0.7	0.5	0.0	0.0	0.0	0.0	94.2	0.0	0.0	359.8	0.0	0.0	0.1	0.0	0.0	0.8	0.1	0.2	0.4	0.0	0.2	0.1	0.0	1.2	0.6	0.0	0.0	0.0	0.8	0.0	0.0	0.4	0.2	0.0	0.0	0.0	1814.0	0.2	0.0	0.2	0.1	0.4	0.1	0.2	0.9	0.0	0.6
MIPEP	MIP	ENSG00000027001	"Mitochondrial intermediate peptidase"	Q99797	13	23730189-23889419	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		"Hydrolase, Metalloprotease, Protease"	"Disease mutation, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	8	"Cardiomyocytes: 80.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"OE19: 35.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030676, HPA031669, HPA031670"	Approved		Enhanced	Mitochondria		NA	NA			Mitochondria		"HPA030676: AB_10598907, HPA031669: AB_10600986, HPA031670: AB_10602198"	"unprognostic (2.05e-1)"	"unprognostic (3.17e-2)"	"unprognostic (3.75e-3)"	"unprognostic (3.72e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.23e-1)"	"unprognostic (2.41e-1)"	"unprognostic (2.21e-1)"	"unprognostic (4.69e-2)"	"unprognostic (1.12e-1)"	"unprognostic (7.54e-2)"	"unprognostic (4.76e-1)"	"prognostic favorable (7.66e-12)"	"unprognostic (1.62e-2)"	"unprognostic (4.95e-2)"	"unprognostic (2.79e-1)"	"unprognostic (6.90e-3)"	7.3	14.9	6.2	7.1	12.2	4.4	11.0	4.7	10.3	8.1	12.2	12.9	12.1	8.4	9.6	20.4	14.4	17.1	11.7	16.9	8.8	5.3	24.7	12.0	8.2	8.4	5.1	8.0	8.5	14.7	8.1	15.4	5.3	9.1	10.9	13.1	9.1	12.9	10.1	16.2	22.0	8.9	11.5	4.4	6.5	9.8	13.9	4.9	8.9	10.9	15.7	11.1	11.2	8.6	9.2	6.5	1.2	10.6	9.7	10.0	3.9	7.8	8.9	4.4	10.3	10.1	13.7	9.4	5.7	8.9	8.6	7.3	11.8	15.7	9.3	5.8	4.6	7.6	19.9	10.1	12.0	10.7	5.4	6.4	4.0	4.2	10.1	8.3	9.4	2.2	6.7	15.0	8.9	7.9	7.3	10.7	7.1	7.7	1.5	13.4	5.8	6.7	5.3	6.1	35.4	9.0	7.5	11.9	8.0	19.2	5.2	10.3	3.4	6.1	10.0	12.0	5.8	10.3	5.3	5.9	5.2	4.4	8.6	6.1	1.5	2.1	5.0	9.1	4.8	6.5	0.0	3.0	1.2	7.9	3.7	10.0	9.2	7.7	7.1	6.5	7.7	7.4	7.3	0.0	9.7	10.6	5.6	5.1	3.9	6.2	12.2	4.7	10.3	8.8	5.3	5.1	8.0	9.1	4.9	14.9	7.5	0.8	5.9	35.4	3.2	80.7	15.3	36.1	10.3	8.7	5.9	8.4	24.9	20.8	6.6	3.7	5.5	0.0	9.4	7.7	4.5	5.6	2.3	5.6	8.7	14.3	5.8	2.5	2.7	5.9	6.4	4.1	5.0	3.6	6.4	5.2	8.0	8.6	8.1	18.1	10.7	0.0	5.2	9.5	19.0	36.9	4.2	2.9	12.4	3.8
MKNK1	MNK1	ENSG00000079277	"MAP kinase interacting serine/threonine kinase 1"	Q9BUB5	1	46557408-46616843	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Translation regulation"	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"pancreas: 72.3"	"Cell type enhanced"	"Detected in all"	6	"Hofbauer cells: 113.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB027355, CAB037310, HPA071293"	Approved		Supported	Nucleoplasm		NA	NA			Nucleoplasm		"CAB027355: AB_2266303, CAB037310: AB_1854049, HPA071293: AB_2686382"	"unprognostic (4.05e-3)"	"prognostic favorable (7.05e-4)"	"unprognostic (5.28e-2)"	"unprognostic (3.47e-2)"	"unprognostic (1.64e-1)"	"unprognostic (7.38e-2)"	"prognostic unfavorable (1.24e-5)"	"unprognostic (3.50e-2)"	"unprognostic (1.77e-1)"	"unprognostic (2.60e-1)"	"unprognostic (1.50e-1)"	"unprognostic (2.14e-2)"	"prognostic unfavorable (1.51e-5)"	"unprognostic (7.02e-2)"	"unprognostic (3.19e-2)"	"unprognostic (4.67e-1)"	"unprognostic (5.67e-3)"	17.6	12.0	10.7	16.2	10.5	16.8	12.1	13.7	12.3	9.2	12.6	11.0	9.6	9.7	11.9	13.3	12.2	11.1	11.4	12.3	10.8	7.0	9.4	10.8	16.1	16.3	9.9	9.8	10.7	72.3	8.6	11.3	15.4	11.0	9.9	13.3	11.9	10.6	7.7	12.8	10.2	12.7	13.3	8.1	25.6	11.7	7.6	8.7	12.5	8.8	15.8	10.9	10.9	14.5	4.9	6.0	33.3	12.1	5.0	22.0	6.1	19.5	13.2	8.8	9.7	7.9	11.7	11.7	9.9	9.9	12.0	16.4	15.3	8.0	12.9	12.2	9.9	13.5	23.7	14.7	16.2	12.9	22.2	13.0	27.3	15.2	13.0	12.3	14.6	22.2	15.4	11.2	15.6	8.6	6.5	14.0	15.9	14.2	9.5	6.5	12.8	10.4	13.0	6.0	11.3	15.7	9.6	18.4	12.9	12.9	20.5	6.2	5.5	19.1	17.3	16.0	18.3	11.7	16.3	11.4	4.4	0.9	13.6	11.0	8.1	13.5	11.0	8.5	18.8	8.0	3.9	12.1	14.3	7.5	11.5	22.0	4.6	6.6	6.8	6.0	4.9	4.8	7.0	33.3	5.0	8.1	4.4	4.4	6.1	10.7	10.5	13.7	12.3	10.8	7.0	9.9	9.8	11.0	8.7	11.9	22.1	17.5	15.7	12.4	17.9	15.5	15.3	10.7	18.2	21.0	2.0	19.4	6.6	16.1	13.0	14.3	23.5	23.3	32.1	29.7	19.5	15.8	11.5	20.2	113.5	17.5	16.1	18.4	71.2	17.5	19.8	58.2	10.1	16.2	11.9	6.5	28.0	14.0	34.3	10.2	4.6	6.5	14.4	16.8	15.5	9.7	15.4	24.9	14.7	19.5
MKNK2	"GPRK7, MNK2"	ENSG00000099875	"MAP kinase interacting serine/threonine kinase 2"	Q9HBH9	19	2037465-2051244	"Enzymes, Predicted intracellular proteins"	"Apoptosis, Translation regulation"	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 207.5"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HHSteC: 80.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021875, CAB037253, HPA070499"	Supported		Supported	"Nuclear bodies"		No	No			"Nuclear bodies"		"CAB037253: AB_1079401, HPA021875: AB_1854050, HPA070499: AB_2732157"	"unprognostic (8.76e-2)"	"unprognostic (1.71e-1)"	"unprognostic (1.64e-1)"	"prognostic favorable (4.86e-5)"	"unprognostic (3.08e-1)"	"unprognostic (1.59e-2)"	"unprognostic (6.42e-3)"	"unprognostic (1.35e-1)"	"unprognostic (4.32e-2)"	"unprognostic (7.52e-2)"	"unprognostic (1.08e-1)"	"unprognostic (6.56e-2)"	"unprognostic (4.07e-2)"	"prognostic favorable (4.01e-4)"	"unprognostic (1.63e-1)"	"unprognostic (1.60e-1)"	"unprognostic (1.59e-1)"	30.3	15.6	7.6	24.2	8.5	31.9	31.1	16.6	9.7	12.5	22.7	6.5	21.4	13.1	9.3	18.4	42.1	11.0	21.7	33.3	7.5	5.7	10.3	22.0	24.5	16.9	10.3	3.3	13.8	53.1	8.3	13.4	16.7	9.2	18.8	8.4	14.2	35.2	32.5	207.5	19.3	15.1	13.0	7.0	27.8	16.7	9.1	9.1	16.0	32.3	47.1	32.8	21.2	63.6	10.7	5.9	26.9	8.0	6.1	7.5	2.2	13.4	15.1	6.4	14.1	47.8	17.4	14.4	7.9	5.7	5.7	5.8	9.7	23.5	19.0	11.0	16.0	5.9	16.6	8.1	23.2	2.6	25.8	7.5	7.7	12.7	10.3	80.4	15.0	13.8	18.4	56.5	10.8	23.0	13.3	13.5	12.8	13.1	34.0	3.9	7.8	8.9	12.5	16.8	10.2	16.5	17.2	1.8	23.9	10.1	8.7	8.9	10.6	18.7	27.6	34.0	7.5	11.4	18.6	20.2	2.1	8.2	8.4	9.5	55.3	21.4	18.5	16.8	11.3	3.8	2.7	6.1	5.7	5.6	6.3	5.1	10.7	5.8	6.2	4.8	10.2	3.7	4.5	26.9	6.1	8.0	5.9	7.5	2.2	7.6	8.5	16.6	9.7	7.5	5.7	10.3	3.3	9.2	9.1	35.7	53.3	43.1	91.9	73.3	45.8	46.4	30.6	16.0	11.4	34.9	23.6	21.3	8.3	25.3	6.2	35.4	94.0	23.3	48.2	31.0	32.0	121.4	28.8	50.0	30.9	39.7	144.2	58.3	34.6	10.0	18.7	27.4	54.0	19.8	92.4	38.7	46.8	69.1	19.1	18.2	43.0	19.4	34.0	15.5	21.8	102.4	47.3	39.5	64.3	110.6
MKRN1	RNF61	ENSG00000133606	"Makorin ring finger protein 1"	Q9UHC7	7	140453040-140479569	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA000567			Approved	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"HPA000567: AB_1079299"	"unprognostic (9.97e-2)"	"unprognostic (1.50e-1)"	"unprognostic (1.27e-1)"	"unprognostic (7.60e-3)"	"unprognostic (1.65e-2)"	"unprognostic (2.41e-1)"	"unprognostic (4.87e-3)"	"unprognostic (1.24e-2)"	"unprognostic (8.02e-2)"	"unprognostic (2.97e-2)"	"unprognostic (2.52e-1)"	"unprognostic (1.35e-1)"	"unprognostic (2.89e-3)"	"unprognostic (5.76e-2)"	"unprognostic (2.42e-1)"	"unprognostic (1.22e-1)"	"unprognostic (1.22e-2)"	16.8	17.6	26.8	20.8	28.8	69.9	20.1	37.2	32.6	20.4	39.6	16.1	19.7	28.4	20.1	18.6	23.3	22.2	22.4	38.5	24.9	29.8	20.6	17.5	23.6	18.3	25.7	23.3	24.9	27.3	28.2	21.5	31.7	29.4	21.0	33.7	19.4	24.8	23.1	38.5	24.4	26.6	26.3	20.5	22.5	21.7	95.4	20.2	21.0	23.6	18.8	22.3	25.3	36.4	13.1	7.5	39.3	10.5	12.8	17.8	6.4	28.4	22.0	17.2	25.5	27.3	23.9	24.3	19.6	25.5	15.5	17.9	9.0	30.0	20.7	30.8	19.1	31.0	13.9	19.3	21.6	19.7	40.9	16.7	21.5	13.2	16.6	22.0	18.4	33.2	23.8	32.6	17.4	16.5	25.6	15.4	14.3	16.9	26.1	14.8	24.5	21.5	32.9	44.2	24.0	16.3	15.6	14.7	31.6	24.8	33.0	23.8	24.6	24.6	33.4	35.1	26.5	16.4	16.0	21.8	10.9	8.7	26.5	17.9	62.3	45.6	18.1	31.2	28.9	22.4	19.4	9.2	39.3	6.7	8.7	8.0	13.1	13.0	10.1	7.5	10.9	17.8	11.3	18.1	12.8	10.5	2.5	14.0	6.4	26.8	28.8	37.2	32.6	24.9	29.8	25.7	23.3	29.4	20.2	47.6	30.4	57.3	58.0	72.9	58.8	51.3	63.7	33.5	43.3	40.1	33.4	63.4	87.9	55.8	227.6	33.8	112.4	256.9	59.7	76.6	47.0	74.5	36.9	38.9	53.2	112.8	93.6	40.5	91.7	263.0	61.5	68.3	65.8	87.4	100.7	52.1	52.9	123.8	58.7	39.1	43.2	45.3	49.5	153.2	47.1	83.4	115.4	66.0	96.2	100.8
MKRN2	"HSPC070, RNF62"	ENSG00000075975	"Makorin ring finger protein 2"	Q9H000	3	12557014-12583713	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	10	"Early spermatids: 562.3;Late spermatids: 587.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037559, HPA037560"	Enhanced		Approved	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"HPA037559: AB_10672460, HPA037560: AB_10696936"	"unprognostic (4.17e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.59e-2)"	"unprognostic (5.99e-2)"	"unprognostic (3.89e-2)"	"unprognostic (1.47e-2)"	"prognostic unfavorable (1.58e-4)"	"unprognostic (4.38e-1)"	"unprognostic (8.49e-2)"	"unprognostic (2.86e-1)"	"unprognostic (1.42e-1)"	"unprognostic (2.56e-3)"	"prognostic favorable (6.04e-4)"	"unprognostic (3.26e-1)"	"unprognostic (2.22e-1)"	"unprognostic (1.33e-2)"	"unprognostic (3.32e-2)"	13.7	10.4	15.1	11.1	18.3	16.4	11.6	29.3	19.5	13.7	12.7	12.4	16.1	12.5	15.2	12.3	16.2	13.1	10.9	26.3	14.0	15.1	13.7	12.5	12.1	12.6	15.2	14.8	20.8	26.6	17.3	11.9	14.4	16.0	11.3	11.5	13.2	12.8	13.1	24.5	12.8	10.9	15.9	16.2	10.1	11.7	46.1	14.7	15.4	18.2	17.0	13.7	13.0	12.6	21.3	19.0	30.0	20.3	25.3	26.2	18.7	10.7	12.5	14.9	11.2	23.3	22.7	28.8	16.7	17.9	21.3	17.9	12.0	10.7	15.3	9.6	18.4	9.8	6.6	19.3	16.4	19.0	17.3	16.3	21.8	14.3	16.1	26.9	21.4	9.9	25.2	15.3	24.8	15.6	19.1	17.4	21.3	20.3	21.7	18.3	15.2	26.2	11.1	9.9	10.5	22.0	25.3	14.4	17.2	14.9	14.3	8.7	14.8	14.5	7.4	14.8	11.0	16.8	19.0	17.6	14.6	14.3	17.3	22.6	16.5	33.7	32.8	15.8	25.7	21.9	18.9	17.2	30.0	21.5	15.6	26.2	21.3	22.1	22.0	19.0	16.4	23.9	22.3	15.0	25.3	20.3	15.1	23.4	18.7	15.1	18.3	29.3	19.2	14.0	15.1	15.2	14.8	16.0	14.7	17.9	8.1	9.3	8.8	8.5	14.5	12.1	2.5	17.4	11.4	5.2	3.9	16.1	16.6	13.6	562.3	11.6	7.3	0.0	14.7	16.7	10.4	6.8	18.5	5.4	13.3	11.1	2.4	6.7	9.8	587.8	19.0	7.9	15.1	24.4	11.9	18.1	12.7	12.9	19.4	8.1	12.4	12.9	14.7	60.0	42.8	8.2	13.5	9.6	11.4	7.9
MKRN3	"D15S9, MGC88288, RNF63, ZFP127, ZNF127"	ENSG00000179455	"Makorin ring finger protein 3"	Q13064	15	23565678-23630075	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 14.4"	"Cell type enhanced"	"Detected in some"	19	"Bipolar cells: 12.6;Cone photoreceptor cells: 23.6;Horizontal cells: 6.4;Rod photoreceptor cells: 6.4"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"naive CD8 T-cell: 5.7"	"Lineage enriched"	"Detected in many"	4	"T-cells: 5.7"	"Cell line enhanced"	"Detected in many"		"JURKAT: 16.0;K-562: 17.1"	"Low region specificity"	"Detected in many"							HPA029494	Uncertain		Approved	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Plasma membrane, Cytosol"	Nucleoplasm	"HPA029494: AB_10603873"	"unprognostic (3.18e-1)"	"unprognostic (1.26e-1)"	"unprognostic (4.26e-1)"	"unprognostic (1.86e-3)"	"unprognostic (1.04e-3)"	"unprognostic (1.15e-2)"	"unprognostic (6.27e-4)"	"unprognostic (1.51e-1)"	"unprognostic (8.52e-2)"	"unprognostic (7.05e-2)"	"unprognostic (4.97e-3)"	"unprognostic (2.86e-1)"	"unprognostic (1.05e-4)"	"unprognostic (5.37e-2)"	"unprognostic (1.52e-1)"	"unprognostic (8.91e-2)"	"unprognostic (9.78e-2)"	1.0	0.7	5.1	1.2	10.4	4.0	1.2	1.0	11.1	0.5	1.1	8.4	0.0	1.3	1.3	3.2	5.6	0.9	0.8	0.8	6.4	3.4	1.1	0.7	1.0	1.9	14.4	3.0	1.2	1.7	0.5	3.8	8.5	5.1	1.2	0.8	3.1	5.2	1.0	1.4	1.2	1.9	0.8	8.2	1.5	0.9	5.7	13.3	5.0	0.9	1.1	1.7	0.7	0.6	1.0	0.9	1.3	0.5	0.4	5.7	0.7	4.6	3.3	3.0	3.1	0.0	0.0	7.0	0.3	0.0	2.8	1.9	8.3	0.0	0.2	0.1	0.0	6.2	8.0	1.3	0.0	0.7	0.0	0.3	6.7	8.9	0.3	0.1	7.8	6.0	0.1	0.0	5.8	0.0	1.2	0.0	16.0	17.1	7.3	0.8	0.0	8.2	3.4	0.0	4.4	10.1	5.9	1.1	4.1	0.0	0.1	0.7	2.4	0.0	3.4	0.0	0.2	2.6	2.3	0.0	7.8	6.6	0.4	5.5	9.2	11.3	5.5	4.5	0.1	0.1	1.3	0.5	0.4	1.8	0.2	1.0	1.0	0.6	1.4	0.2	0.9	2.0	5.7	1.3	0.4	0.3	0.9	0.4	0.7	5.1	10.4	1.0	6.8	6.4	3.4	14.4	3.0	5.1	13.3	0.0	0.0	0.0	1.1	0.5	12.6	0.4	0.0	0.0	0.0	0.0	23.6	0.6	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.9	0.3	0.0	0.0	0.0	6.4	0.0	0.0	0.0	0.0	0.0	0.1	1.7	0.0	0.0	3.4	0.0	0.0	0.4	0.0	6.4	0.0	1.2	2.4	1.0	0.0	0.5	0.0	0.0	0.4
MLKL	FLJ34389	ENSG00000168404	"Mixed lineage kinase domain like pseudokinase"	Q8NB16	16	74671855-74700960	"Enzymes, Predicted intracellular proteins, Transporters"	Necrosis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"vagina: 50.4"	"Cell type enhanced"	"Detected in many"	6	"granulocytes: 27.8;Macrophages: 24.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA078638			Supported	"Plasma membrane,Cell Junctions,Cytosol"		NA	NA			"Plasma membrane"	"Cell Junctions, Cytosol"	"HPA078638: "	"unprognostic (7.53e-2)"	"unprognostic (1.74e-2)"	"unprognostic (2.57e-1)"	"prognostic favorable (2.16e-4)"	"unprognostic (1.23e-1)"	"unprognostic (3.07e-1)"	"unprognostic (5.69e-2)"	"unprognostic (3.67e-3)"	"unprognostic (1.90e-1)"	"unprognostic (6.64e-3)"	"unprognostic (1.37e-1)"	"unprognostic (2.74e-1)"	"unprognostic (1.60e-3)"	"unprognostic (5.30e-2)"	"unprognostic (1.26e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.53e-3)"	18.5	4.7	5.2	15.1	8.9	21.6	13.2	2.9	7.9	6.4	8.0	3.2	5.3	8.5	7.5	3.8	11.5	5.2	9.1	6.8	6.4	3.5	7.4	6.7	17.3	14.8	10.5	1.8	2.8	8.2	1.6	3.0	7.1	8.1	6.3	9.2	6.5	12.6	4.3	2.3	3.6	10.0	6.0	11.2	26.2	8.2	1.9	8.4	4.3	6.5	4.9	10.4	9.2	50.4	4.2	9.2	25.2	17.7	1.7	8.1	7.1	6.5	12.2	0.1	0.1	3.2	6.7	0.1	8.5	7.4	8.0	11.9	7.0	13.2	0.1	9.8	7.2	6.9	10.5	2.2	12.2	3.0	4.1	0.3	9.2	9.1	8.0	2.3	6.0	9.6	4.5	1.2	8.5	3.0	4.7	19.3	10.7	1.3	1.3	6.2	10.9	3.4	12.0	1.1	14.3	15.0	6.7	0.9	11.7	11.4	4.8	0.5	0.4	6.7	4.5	3.7	0.0	3.2	6.3	21.0	4.0	2.4	3.6	5.8	5.7	19.2	1.6	7.3	21.2	1.9	8.3	17.7	21.7	5.8	10.6	7.9	4.2	6.5	6.0	9.2	2.8	3.6	5.5	25.2	1.7	10.2	0.5	8.1	7.1	5.2	8.9	2.9	7.9	6.4	3.5	10.5	1.8	8.1	8.4	3.0	15.4	8.1	4.8	3.1	0.0	1.6	2.5	2.7	7.9	1.8	0.0	0.2	1.7	4.0	2.6	17.9	5.8	0.0	4.6	0.5	3.8	2.0	27.8	0.9	14.2	1.6	1.2	14.7	15.5	3.8	0.9	24.1	6.8	1.0	5.6	0.0	4.1	9.1	0.4	0.3	0.4	0.0	3.3	0.0	0.2	2.5	0.2	10.0	6.4	5.1
MLYCD	"hMCD, MCD"	ENSG00000103150	"Malonyl-CoA decarboxylase"	O95822	16	83899126-83927026	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism"	"Decarboxylase, Lyase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 39.1"	"Cell type enhanced"	"Detected in many"	8	"Cardiomyocytes: 72.8;Cone photoreceptor cells: 117.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in many"											HPA031625	Enhanced					NA	NA					"HPA031625: AB_10602028"	"unprognostic (6.23e-2)"	"unprognostic (1.94e-1)"	"unprognostic (9.07e-2)"	"unprognostic (2.76e-2)"	"unprognostic (1.89e-1)"	"unprognostic (1.95e-1)"	"unprognostic (1.26e-1)"	"unprognostic (2.36e-2)"	"unprognostic (1.28e-1)"	"unprognostic (6.23e-2)"	"unprognostic (1.84e-4)"	"unprognostic (2.33e-1)"	"prognostic favorable (2.61e-7)"	"unprognostic (2.39e-1)"	"unprognostic (3.19e-1)"	"unprognostic (9.56e-2)"	"unprognostic (1.51e-3)"	6.6	10.1	3.3	3.7	4.2	2.3	4.6	2.4	5.4	4.1	6.9	6.3	6.2	4.6	4.4	4.4	5.1	4.9	7.0	39.1	3.7	3.3	6.7	17.4	4.1	3.6	6.9	3.1	6.2	21.5	6.9	5.1	3.1	4.6	5.6	4.4	8.0	6.4	4.1	31.0	4.0	5.1	5.8	3.3	3.8	6.7	7.1	5.7	3.3	5.6	5.7	4.6	6.4	5.4	0.7	0.7	2.3	0.8	0.1	0.9	0.2	0.5	2.3	1.6	2.7	5.0	2.4	3.7	1.2	1.8	1.1	0.5	2.3	1.7	0.4	2.8	2.1	2.1	2.5	2.8	0.8	1.0	1.9	2.1	1.7	0.9	1.4	2.8	1.5	3.2	3.0	2.8	0.7	1.1	1.9	1.2	2.3	2.1	0.8	1.3	4.4	1.5	4.5	2.0	2.2	1.0	3.5	1.4	2.2	3.0	2.7	2.5	2.3	4.5	0.7	2.1	2.5	4.3	1.9	1.6	1.8	0.4	1.4	0.5	2.7	2.6	3.2	1.8	2.1	1.9	0.8	0.7	2.3	0.5	0.5	0.3	0.7	0.8	0.7	0.7	0.3	0.8	0.9	0.3	0.1	0.8	0.3	0.0	0.2	3.3	4.2	2.4	5.4	3.7	3.3	6.9	3.1	4.6	5.7	6.0	5.3	15.6	6.1	1.8	25.1	72.8	20.4	0.0	7.9	22.7	117.8	16.1	26.6	5.6	3.6	6.7	14.8	0.0	4.7	8.7	5.6	8.5	5.7	35.5	10.9	15.9	9.8	9.2	5.6	4.7	13.6	6.9	3.3	1.8	15.8	17.7	5.9	10.5	18.4	18.0	48.9	6.5	7.2	10.5	12.4	1.8	6.9	9.2	16.6	6.8
MMAB	"cblB, CFAP23"	ENSG00000139428	"Methylmalonic aciduria (cobalamin deficiency) cblB type"	Q96EY8	12	109553737-109573874	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		Transferase	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Hepatocytes: 187.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039017	Approved		Approved	Mitochondria		NA	NA			Mitochondria		"HPA039017: AB_10673603"	"unprognostic (1.16e-1)"	"unprognostic (1.25e-2)"	"unprognostic (1.90e-1)"	"unprognostic (1.79e-1)"	"unprognostic (4.38e-2)"	"unprognostic (2.10e-1)"	"unprognostic (1.38e-1)"	"unprognostic (4.22e-1)"	"unprognostic (2.04e-2)"	"unprognostic (5.15e-2)"	"unprognostic (1.47e-3)"	"unprognostic (2.58e-1)"	"prognostic favorable (1.55e-4)"	"unprognostic (4.90e-2)"	"unprognostic (1.51e-1)"	"unprognostic (2.23e-1)"	"unprognostic (9.65e-2)"	7.3	26.1	12.7	7.2	12.2	5.2	13.0	7.2	17.2	7.0	12.2	12.6	9.4	12.7	7.7	21.9	14.8	9.8	11.8	18.1	11.6	11.5	13.6	47.9	11.8	13.0	12.4	8.2	14.2	20.2	9.1	11.7	5.3	14.0	15.7	8.3	11.2	15.1	10.6	16.5	8.9	8.5	8.7	15.7	6.7	10.7	7.8	14.8	4.3	16.6	15.7	7.5	6.0	7.5	14.1	9.4	3.8	8.1	8.5	13.9	9.2	13.4	9.1	9.5	7.5	3.9	8.0	4.9	3.0	6.9	4.4	4.7	10.6	12.6	8.6	8.7	3.4	8.4	14.1	6.2	23.3	2.0	3.4	25.6	3.5	6.8	17.4	13.9	7.5	3.1	10.6	14.6	9.6	4.2	5.4	4.1	6.9	11.2	6.6	3.1	31.1	6.8	12.1	11.7	1.4	13.1	5.7	3.6	22.4	19.5	12.7	14.8	6.4	6.7	12.6	5.2	2.7	26.2	21.2	2.3	3.8	1.6	2.7	4.3	5.2	3.8	9.7	8.3	9.2	10.3	3.8	5.9	0.8	13.5	8.1	10.8	11.1	9.9	10.7	9.4	14.1	13.9	13.1	1.7	8.5	8.0	7.7	4.7	9.2	12.7	12.2	7.2	17.2	11.6	11.5	12.4	8.2	14.0	14.8	32.8	66.2	26.6	23.6	9.2	31.3	44.8	66.2	65.6	43.3	40.1	27.5	51.9	127.6	40.5	30.4	16.2	42.1	0.0	62.2	27.8	17.9	25.9	16.1	187.6	29.6	98.5	31.8	24.5	19.7	56.0	37.4	16.3	25.3	35.1	43.5	29.1	27.3	31.6	28.7	102.6	27.3	12.9	16.0	30.5	15.1	17.2	51.7	21.7	53.3	20.1
MME	"CALLA, CD10, NEP"	ENSG00000196549	"Membrane metalloendopeptidase"	P08473	3	155024124-155183729	"Cancer-related genes, Candidate cardiovascular disease genes, CD markers, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"		"Hydrolase, Metalloprotease, Protease"	"Cancer-related genes, Charcot-Marie-Tooth disease, Disease mutation, FDA approved drug targets, Neurodegeneration, Neuropathy, Spinocerebellar ataxia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 61.1;intestine: 136.0;kidney: 64.9"	"Cell type enhanced"	"Detected in many"	8	"Basal glandular cells: 62.4;Cytotrophoblasts: 71.6;Proximal tubular cells: 101.6;Syncytiotrophoblasts: 105.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in single"	129	"neutrophil: 61.1"	"Lineage enriched"	"Detected in single"	129	"granulocytes: 61.1"	"Cell line enhanced"	"Detected in many"		"ASC TERT1: 97.1;BJ hTERT+: 146.1;HSkMC: 94.2"	"Low region specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"basal ganglia: 26.8"	"CAB000013, HPA052583, HPA056072"	Enhanced					NA	NA		99000			"CAB000013: AB_563478, HPA052583: AB_2681872, HPA056072: AB_2683027"	"unprognostic (1.36e-1)"	"unprognostic (1.02e-3)"	"unprognostic (8.52e-2)"	"unprognostic (2.95e-1)"	"unprognostic (2.78e-2)"	"unprognostic (6.52e-3)"	"unprognostic (1.20e-1)"	"unprognostic (1.67e-2)"	"unprognostic (8.67e-2)"	"unprognostic (1.96e-1)"	"unprognostic (7.30e-3)"	"unprognostic (1.31e-1)"	"unprognostic (2.71e-3)"	"unprognostic (1.50e-1)"	"unprognostic (7.29e-2)"	"unprognostic (1.06e-2)"	"unprognostic (1.37e-2)"	26.5	0.4	0.4	3.4	7.4	1.9	14.7	0.4	0.7	4.8	65.6	0.1	18.4	74.0	2.8	8.1	0.7	0.9	8.5	1.8	0.3	0.4	64.9	11.5	13.7	3.0	2.1	0.2	0.9	0.6	0.0	0.6	35.0	8.6	18.3	0.4	1.3	3.7	11.3	11.7	1.4	136.0	0.6	0.9	2.7	0.7	1.0	1.2	13.2	1.0	5.3	2.3	3.4	4.9	0.1	0.4	61.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	39.4	97.1	0.2	21.7	146.1	11.1	28.7	0.0	0.0	23.9	0.0	19.2	15.1	0.0	0.7	0.8	26.7	0.0	0.1	0.0	0.0	0.0	31.6	0.0	0.0	94.2	0.1	5.9	42.5	12.3	8.4	0.0	0.0	0.0	17.7	0.1	0.0	0.1	0.9	0.0	0.1	39.7	18.7	0.1	0.6	0.2	0.0	0.2	0.0	0.0	4.2	8.9	0.0	0.0	23.8	47.7	0.1	16.3	3.7	0.0	0.0	31.5	5.7	0.0	1.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	61.1	0.0	0.0	0.4	0.0	0.0	0.4	7.4	0.4	0.7	0.3	0.4	2.1	0.2	8.6	1.2	8.9	18.3	0.9	62.4	0.7	0.0	1.1	17.8	2.7	19.4	21.0	0.0	71.6	8.3	0.1	0.3	0.6	0.0	0.0	0.0	48.9	19.2	29.2	2.3	48.9	8.1	0.0	0.0	3.1	1.8	0.2	3.7	2.7	0.0	0.0	0.2	0.0	0.3	0.0	1.1	101.6	0.0	0.0	3.1	0.2	0.4	0.3	105.4	0.0	0.0	29.2
MMEL1	"MMEL2, NEPII, NL1, NL2, SEP"	ENSG00000142606	"Membrane metalloendopeptidase like 1"	Q495T6	1	2590639-2632990	"Enzymes, Predicted intracellular proteins"		"Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"testis: 30.2"	"Cell type enhanced"	"Detected in many"	14	"Cholangiocytes: 28.1;Early spermatids: 82.5;Late spermatids: 27.3;Paneth cells: 37.7"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"basal ganglia: 8.5"	"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enriched"	"Detected in some"	5	"SK-BR-3: 17.8"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA007876, HPA008205, CAB020786"	Uncertain				"Intracellular and membrane"	NA	NA					"CAB020786: , HPA007876: AB_1854012, HPA008205: AB_1854011"	"unprognostic (5.80e-2)"	"unprognostic (4.61e-2)"	"unprognostic (1.87e-1)"	"unprognostic (4.27e-2)"	"unprognostic (1.33e-1)"	"unprognostic (2.71e-2)"	"unprognostic (1.45e-1)"	"unprognostic (7.96e-2)"	"unprognostic (1.36e-2)"	"unprognostic (2.37e-1)"	"unprognostic (4.54e-3)"	"unprognostic (2.44e-2)"	"unprognostic (4.79e-2)"	"unprognostic (3.18e-1)"	"unprognostic (2.82e-1)"	"unprognostic (2.18e-3)"	"unprognostic (7.01e-4)"	1.5	0.5	0.8	1.8	8.5	0.6	1.8	0.4	0.6	4.3	4.2	0.4	1.9	3.2	0.8	10.3	3.0	3.0	9.6	1.3	1.0	2.6	1.4	0.4	1.4	1.4	1.7	0.4	1.1	7.3	0.3	0.4	0.7	0.5	4.2	1.4	0.4	2.0	2.0	0.4	0.3	2.6	0.9	0.7	1.4	7.9	30.2	0.9	0.8	1.1	0.8	0.8	3.7	1.6	0.6	1.1	6.6	5.1	2.3	6.1	2.2	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	3.0	0.0	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.2	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	2.9	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.5	0.0	0.6	0.0	0.5	0.0	17.8	0.0	0.1	1.7	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.4	1.5	6.6	0.5	3.9	0.3	0.6	1.7	0.7	1.1	0.0	4.5	2.2	1.0	2.3	5.1	0.2	6.1	2.2	0.8	8.5	0.4	0.6	1.0	2.6	1.7	0.4	0.5	0.9	0.0	0.0	0.0	4.6	0.0	0.0	0.8	28.1	10.7	2.3	17.4	0.0	0.0	0.0	7.1	82.5	0.6	15.7	0.0	3.1	0.0	0.3	12.4	0.0	0.0	1.3	0.0	1.2	0.6	1.5	27.3	1.7	0.5	0.0	0.0	14.9	0.5	2.7	37.7	1.1	0.0	0.0	0.0	0.4	0.5	0.9	0.0	0.0	0.0	9.7	10.9
MMP1	CLG	ENSG00000196611	"Matrix metallopeptidase 1"	P03956	11	102789920-102798160	"Cancer-related genes, Candidate cardiovascular disease genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted secreted proteins"	"Collagen degradation, Host-virus interaction"	"Hydrolase, Metalloprotease, Protease"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"gallbladder: 62.4;stomach 1: 27.2"	"Cell type enriched"	"Detected in some"	7	"Pancreatic endocrine cells: 1303.6"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 344.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BJ hTERT+: 90.2;HBF TERT88: 89.3;HUVEC TERT2: 234.8;WM-115: 115.7"									HPA004920			Approved	Vesicles	"Secreted to extracellular matrix"	NA	NA	7730000	430000	Vesicles		"HPA004920: AB_2667293"	"unprognostic (4.11e-3)"	"prognostic unfavorable (4.66e-4)"	"unprognostic (4.20e-3)"	"unprognostic (1.19e-3)"	"unprognostic (6.46e-2)"	"unprognostic (6.50e-2)"	"prognostic unfavorable (4.22e-6)"	"unprognostic (7.83e-3)"	"unprognostic (2.94e-2)"	"unprognostic (5.44e-2)"	"unprognostic (1.11e-3)"	"unprognostic (1.75e-1)"	"prognostic unfavorable (9.86e-10)"	"unprognostic (1.67e-2)"	"unprognostic (1.49e-1)"	"unprognostic (1.26e-2)"	"unprognostic (5.11e-2)"	0.2	0.1	0.3	12.3	0.3	0.0	0.9	0.3	0.3	0.3	2.7	0.3	0.2	3.2	4.8	0.2	3.3	0.1	62.4	0.4	0.2	0.1	0.7	1.3	4.7	0.2	0.2	0.2	0.2	1.6	0.0	0.2	8.6	0.5	0.7	3.0	0.3	2.0	0.2	0.2	0.3	8.8	0.2	0.4	1.8	27.2	2.2	0.2	0.4	0.3	1.3	0.9	11.0	0.2	0.0	0.0	0.6	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	40.8	90.2	36.9	9.6	0.7	0.0	0.0	0.4	21.6	14.2	0.3	0.0	12.6	89.3	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	37.9	3.2	0.0	234.8	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	14.7	1.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	12.1	30.6	0.0	1.3	0.1	0.0	0.0	0.0	0.7	0.0	115.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	1.9	0.3	0.3	0.3	0.3	0.2	0.1	0.2	0.2	0.5	0.2	3.0	1.6	0.0	14.4	2.1	0.0	0.0	35.7	0.0	23.9	3.5	0.0	0.0	0.0	3.5	0.0	0.1	0.0	0.0	184.0	0.0	0.2	5.4	0.0	0.0	0.3	0.0	0.0	0.0	1.9	0.0	0.0	0.2	0.0	7.2	0.0	0.0	1303.6	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.3	0.1	0.0	0.0	25.0
MMP10	STMY2	ENSG00000166670	"Matrix metallopeptidase 10"	P09238	11	102770503-102780628	"Cancer-related genes, Enzymes, FDA approved drug targets, Predicted secreted proteins"	"Collagen degradation"	"Hydrolase, Metalloprotease, Protease"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	4	"endometrium 1: 89.4"	"Cell type enhanced"	"Detected in some"	14	"Basal glandular cells: 38.9;Club cells: 70.5;Collecting duct cells: 27.9;Pancreatic endocrine cells: 62.0"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 102.2"	"Region enriched"	"Detected in single"	9	"pons and medulla: 2.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BJ: 12.6;HUVEC TERT2: 16.2;SCLC-21H: 5.2"	"Not detected"	"Not detected"							CAB002159	Uncertain		Approved	"Plasma membrane,Cytosol"	"Secreted to extracellular matrix"	NA	NA	765000		Cytosol	"Plasma membrane"	"CAB002159: AB_564103"	"unprognostic (8.76e-2)"	"unprognostic (3.38e-1)"	"unprognostic (1.98e-3)"	"unprognostic (2.72e-3)"	"unprognostic (7.17e-3)"	"unprognostic (1.52e-2)"	"unprognostic (5.67e-8)"	"unprognostic (2.08e-3)"	"unprognostic (2.20e-1)"	"unprognostic (1.75e-1)"	"unprognostic (1.67e-2)"	"unprognostic (2.67e-1)"	"unprognostic (6.99e-5)"	"unprognostic (2.66e-2)"	"unprognostic (7.98e-2)"	"unprognostic (5.46e-2)"	"prognostic favorable (7.12e-4)"	0.1	0.1	0.0	2.6	0.2	0.1	0.1	0.0	0.3	1.7	0.5	0.0	0.0	0.4	89.4	0.1	0.2	0.1	0.5	0.1	0.0	0.1	0.1	3.6	11.0	0.1	0.0	0.0	0.5	0.3	0.1	0.9	19.8	2.8	3.2	0.2	0.0	2.9	0.1	0.1	0.1	0.7	0.1	0.0	0.2	3.3	0.5	0.0	1.2	0.1	0.0	1.9	0.6	5.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.8	0.2	0.0	0.0	0.2	12.6	0.7	0.1	0.1	0.3	0.0	0.0	3.7	1.9	0.2	2.9	0.0	1.4	0.0	0.0	0.2	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.4	0.6	0.0	16.2	0.0	0.7	0.0	0.0	0.0	0.0	0.3	3.0	0.5	1.7	0.0	0.0	0.0	0.0	0.7	5.2	0.0	2.5	0.0	0.0	0.9	0.0	0.0	2.0	3.9	1.3	0.4	0.5	0.0	0.0	0.0	0.6	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.3	0.0	0.1	0.0	0.0	2.8	0.0	0.0	0.0	0.0	38.9	0.7	0.0	0.0	0.0	5.3	70.5	27.9	0.0	0.0	0.0	9.8	5.0	0.0	0.0	0.0	12.9	0.0	0.2	5.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	1.2	0.0	2.8	0.0	0.0	62.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.1	0.1	0.0	0.0	0.0	7.4
MMP11	STMY3	ENSG00000099953	"Matrix metallopeptidase 11"	P24347	22	23768226-23784316	"Cancer-related genes, Enzymes, FDA approved drug targets, Predicted secreted proteins"	"Collagen degradation"	"Hydrolase, Metalloprotease, Protease"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"endometrium 1: 44.1;placenta: 119.6"	"Cell type enhanced"	"Detected in many"	15	"Extravillous trophoblasts: 34.6;Syncytiotrophoblasts: 15.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"Cell type enhanced"	"Detected in some"		"plasmacytoid DC: 7.8"	"Group enriched"	"Detected in many"	5	"B-cells: 2.4;dendritic cells: 7.8"	"Cell line enhanced"	"Detected in some"		"AN3-CA: 18.7;hTERT-RPE1: 9.7;REH: 7.8"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB002593, HPA068864"	Approved				"Secreted to extracellular matrix"	NA	NA					"CAB002593: , HPA068864: AB_2686051"	"unprognostic (1.06e-1)"	"unprognostic (3.08e-1)"	"unprognostic (1.83e-1)"	"unprognostic (1.84e-3)"	"unprognostic (2.77e-2)"	"unprognostic (6.73e-2)"	"unprognostic (2.14e-2)"	"unprognostic (5.15e-1)"	"unprognostic (2.73e-2)"	"unprognostic (2.20e-1)"	"unprognostic (1.89e-3)"	"unprognostic (7.04e-2)"	"prognostic unfavorable (2.62e-4)"	"unprognostic (8.05e-2)"	"unprognostic (6.78e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.68e-2)"	1.7	0.6	0.2	1.0	0.6	0.1	1.6	1.0	0.5	13.4	1.8	0.4	0.4	1.9	44.1	1.1	0.8	2.2	2.0	3.1	0.5	0.0	1.7	0.5	0.7	1.8	0.4	0.2	7.7	1.1	0.2	0.3	119.6	0.5	1.4	1.0	0.8	2.5	0.4	0.5	2.0	4.0	2.7	0.3	0.9	0.7	3.4	0.2	2.6	0.5	0.6	0.9	1.6	2.1	2.4	7.8	0.0	0.0	0.0	1.0	0.1	0.1	0.0	2.3	18.7	2.8	4.2	0.0	0.2	5.0	0.6	0.4	0.0	0.6	0.6	3.5	1.3	0.9	0.1	1.0	0.0	0.2	0.0	0.3	0.0	0.0	1.0	2.1	0.0	0.0	2.7	0.4	0.5	0.0	9.7	2.9	0.2	0.3	0.0	0.6	0.1	0.0	0.0	0.6	0.5	0.1	7.8	0.0	0.2	0.3	0.0	2.9	5.0	1.9	0.3	0.0	3.0	1.7	0.0	1.3	0.3	0.0	0.7	0.0	0.1	0.0	2.5	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	2.4	1.0	0.3	0.0	0.0	0.0	7.8	0.0	0.1	0.2	0.6	1.0	0.5	0.5	0.0	0.4	0.2	0.5	0.2	0.0	4.5	0.8	0.8	0.9	0.4	4.3	2.5	1.4	0.0	0.0	0.0	0.3	1.7	5.9	6.6	0.2	0.0	0.0	0.6	34.6	5.7	0.4	1.1	0.0	0.7	0.0	1.7	1.3	0.0	8.0	0.6	0.0	1.7	0.0	0.8	0.5	1.6	0.0	0.4	2.2	0.6	0.0	2.0	1.1	2.7	0.5	15.6	0.0	0.8	0.3
MMP12	HME	ENSG00000262406	"Matrix metallopeptidase 12"	P39900	11	102862736-102875034	"Cancer-related genes, Enzymes, FDA approved drug targets, Predicted secreted proteins"		"Hydrolase, Metalloprotease, Protease"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"lymphoid tissue: 42.4;urinary bladder: 13.2"	"Cell type enriched"	"Detected in some"	5	"Extravillous trophoblasts: 80.4"	"Low cancer specificity"	"Detected in all"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	12	"BJ: 4.2;fHDF/TERT166: 14.6;hTEC/SVTERT24-B: 8.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"								"Secreted to extracellular matrix"	NA	NA						"unprognostic (7.33e-2)"	"unprognostic (3.20e-2)"	"unprognostic (1.00e-2)"	"unprognostic (1.03e-1)"	"unprognostic (2.74e-1)"	"unprognostic (1.67e-1)"	"prognostic unfavorable (1.42e-4)"	"unprognostic (1.69e-2)"	"unprognostic (7.31e-2)"	"unprognostic (1.52e-2)"	"unprognostic (1.52e-3)"	"unprognostic (5.45e-2)"	"unprognostic (3.05e-6)"	"unprognostic (1.08e-2)"	"unprognostic (4.66e-2)"	"unprognostic (1.73e-1)"	"unprognostic (6.92e-2)"	2.7	0.0	0.0	21.2	0.0	0.0	0.0	0.0	0.0	0.3	6.9	0.0	0.0	3.3	0.0	5.9	0.0	0.0	1.0	0.0	0.0		0.0	0.4	0.6	18.9	0.0	0.0	0.1	0.0	0.0	0.0	9.7	0.0	0.3	8.4	0.0	0.9	0.0	0.0	0.0	3.8	4.6	0.0	42.4	1.3	0.1	0.0	5.5	0.0	1.5	9.9	13.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.2	0.4	0.2	0.0	0.1	0.0	0.0	0.0	14.6	0.1	0.5	0.0	0.0	0.4	0.4	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.5	0.0	0.1	0.0	0.0	0.0	0.5	0.6	0.2	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	1.0	0.0	0.0	0.0	0.0	17.0	80.4	0.0	0.0	0.0	0.0	15.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.8	0.0	0.0	1.4
MMP13	CLG3	ENSG00000137745	"Matrix metallopeptidase 13"	P45452	11	102942995-102955734	"Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted secreted proteins"	"Collagen degradation"	"Hydrolase, Metalloprotease, Protease"	"Cancer-related genes, Disease mutation, Dwarfism, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"lung: 12.6;vagina: 10.8"	"Group enriched"	"Detected in some"	8	"Club cells: 30.7;Urothelial cells: 14.0"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 70.9"	"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in some"	5	"HaCaT: 19.5;PC-3: 7.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			CAB002742	Supported				"Secreted to extracellular matrix"	NA	NA					"CAB002742: "	"unprognostic (8.98e-3)"	"unprognostic (1.54e-1)"	"unprognostic (4.75e-2)"	"unprognostic (4.57e-2)"	"unprognostic (3.05e-2)"	"unprognostic (1.59e-3)"		"unprognostic (1.32e-1)"	"unprognostic (6.35e-3)"	"unprognostic (1.69e-1)"	"unprognostic (7.55e-3)"	"unprognostic (2.24e-1)"	"unprognostic (1.73e-8)"	"unprognostic (2.12e-2)"	"unprognostic (3.14e-1)"	"unprognostic (4.14e-2)"	"unprognostic (4.33e-2)"	0.5	0.1	0.0	0.8	0.0	1.3	0.4	0.0	0.2	1.3	0.1	0.0	0.0	0.6	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.2	0.1	12.6	0.1	0.0	0.0	0.1	0.0	0.0	3.1	0.1	0.1	1.2	0.0	0.0	0.6	0.0	0.0	1.0	0.5	0.0	0.0	0.1	0.1	1.9	0.0	1.4	0.0	0.0	0.1	4.6	10.8	1.0	0.7	2.7	0.5	1.9	1.3	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	19.5	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.6	0.1	0.0	0.0	0.0	7.4	0.0	0.0	0.1	0.0	1.9	0.0	0.1	0.1	2.3	0.0	0.0	0.0	0.0	0.0	2.8	1.5	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	2.7	0.5	0.6	1.3	0.4	1.0	0.5	0.7	0.8	0.3	1.0	0.6	1.1	1.9	1.9	0.3	0.7	0.4	0.5	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.1	0.0	2.7	30.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.0
MMP14	MT1-MMP	ENSG00000157227	"Matrix metallopeptidase 14"	P50281	14	22836557-22849027	"Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"		"Hydrolase, Metalloprotease, Protease"	"Cancer-related genes, Disease mutation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	8	"Extravillous trophoblasts: 216.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC diff: 96.4;HHSteC: 91.2;HSkMC: 92.7;hTERT-RPE1: 91.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009918, HPA051432"	Approved		Approved	"Intermediate filaments,Cytosol"		No	No		570000	Cytosol	"Intermediate filaments"	"CAB009918: AB_2250767, HPA051432: AB_2681484"	"unprognostic (1.34e-1)"	"unprognostic (1.37e-1)"	"unprognostic (1.11e-2)"	"unprognostic (2.81e-1)"	"unprognostic (4.28e-2)"	"unprognostic (1.12e-2)"	"unprognostic (3.05e-3)"	"unprognostic (5.91e-3)"	"unprognostic (1.95e-1)"	"prognostic unfavorable (9.48e-4)"	"unprognostic (3.82e-3)"	"unprognostic (7.31e-2)"	"prognostic unfavorable (1.34e-4)"	"unprognostic (5.02e-2)"	"unprognostic (6.69e-2)"	"unprognostic (1.00e-2)"	"unprognostic (3.41e-3)"	60.9	10.5	2.4	16.6	4.7	0.2	64.2	2.2	3.2	56.3	35.0	8.2	12.7	12.0	53.1	24.1	47.0	21.9	39.6	17.5	3.4	1.8	16.8	9.0	29.8	16.9	5.8	2.9	39.3	11.2	34.4	4.7	73.5	16.4	39.1	11.3	27.1	24.4	16.7	20.4	37.0	22.9	28.5	20.7	22.5	18.2	26.3	4.6	5.4	22.3	14.6	16.7	52.5	53.9	0.1	0.7	0.0	0.7	0.0	0.0	0.1	7.8	0.1	2.4	0.1	96.4	61.3	44.3	24.7	49.8	7.5	13.4	2.3	29.4	0.1	13.8	26.0	2.3	20.0	0.0	25.7	9.6	0.1	0.1	3.6	0.1	0.5	91.2	0.0	0.1	92.7	15.5	31.2	26.8	91.6	45.3	0.1	0.0	0.2	17.6	0.1	0.0	8.8	1.4	1.7	4.3	0.3	8.5	0.0	6.8	13.5	0.0	0.0	16.1	0.0	53.5	10.8	0.1	7.9	40.0	60.9	5.2	17.7	28.1	0.1	0.1	0.1	37.1	0.0	35.3	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	2.4	4.7	2.2	3.2	3.4	1.8	5.8	2.9	16.4	4.6	11.9	4.8	3.7	19.4	30.2	0.0	3.6	53.5	2.7	3.4	7.0	0.0	83.6	10.0	61.2	0.4	13.5	16.8	0.0	24.9	216.8	65.7	13.9	3.5	2.9	79.3	0.0	7.5	41.1	18.3	0.7	66.7	26.5	35.4	34.3	32.5	17.1	102.2	28.5	51.6	13.0	0.8	38.8	34.8	0.9	0.7	29.9	102.6	1.0	17.1	28.7
MMP15	"MT2-MMP, MTMMP2, SMCP-2"	ENSG00000102996	"Matrix metallopeptidase 15"	P51511	16	58025566-58046901	"Cancer-related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"		"Hydrolase, Metalloprotease, Protease"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 43.2"	"Cell type enhanced"	"Detected in many"	7	"Cholangiocytes: 56.0;Enterocytes: 81.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	30	"plasmacytoid DC: 2.9"	"Lineage enriched"	"Detected in single"	30	"dendritic cells: 2.9"	"Cell line enhanced"	"Detected in many"		"BEWO: 37.1;Hep G2: 19.3;SK-BR-3: 18.6;WM-115: 30.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002611, HPA040390"	Uncertain		Approved	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Plasma membrane, Cytosol"	Nucleoplasm	"CAB002611: , HPA040390: AB_2676956"	"unprognostic (1.76e-2)"	"unprognostic (7.32e-2)"	"unprognostic (2.69e-1)"	"unprognostic (6.85e-2)"	"unprognostic (3.09e-1)"	"unprognostic (1.68e-1)"	"unprognostic (6.88e-3)"	"unprognostic (1.40e-1)"	"unprognostic (3.02e-2)"	"unprognostic (1.24e-2)"	"unprognostic (4.81e-2)"	"unprognostic (1.81e-1)"	"prognostic favorable (8.54e-8)"	"unprognostic (3.63e-2)"	"unprognostic (1.36e-1)"	"unprognostic (1.28e-1)"	"prognostic favorable (3.08e-4)"	5.9	2.3	2.0	5.5	3.0	0.1	7.7	3.7	7.2	3.3	19.5	4.2	16.3	22.6	2.9	1.7	2.5	3.6	15.9	17.6	2.3	3.7	8.4	26.4	6.1	2.0	2.5	2.2	2.1	10.3	7.3	5.2	28.5	10.4	3.6	8.2	9.5	4.7	14.7	3.4	2.3	43.2	3.4	3.4	5.2	14.7	28.0	2.1	1.1	26.8	2.5	2.2	3.3	4.2	0.0	2.9	0.0	0.0	0.0	0.0	0.0	5.7	4.4	2.3	11.9	2.4	0.1	37.1	0.5	0.3	2.1	0.5	3.5	14.9	0.0	7.0	0.6	1.6	8.1	2.0	1.7	0.6	0.0	3.9	0.0	1.9	19.3	3.1	0.1	7.7	1.2	3.1	0.3	0.9	3.3	1.4	3.3	4.8	0.0	0.7	2.9	0.2	0.9	6.8	17.0	1.2	2.9	0.3	3.1	6.5	2.1	0.6	4.1	7.7	18.6	3.5	5.5	2.0	3.1	1.3	0.1	3.7	1.4	0.5	0.0	0.0	0.1	0.7	0.9	30.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.9	0.0	0.0	2.0	3.0	3.7	7.2	2.3	3.7	2.5	2.2	10.4	2.1	17.9	11.8	0.9	1.0	2.3	1.9	19.3	56.0	5.3	9.1	17.4	15.7	33.4	1.7	33.5	2.2	6.0	81.1	0.0	10.5	19.6	2.8	1.6	0.0	29.0	10.2	1.6	10.9	19.6	3.5	4.8	0.9	0.1	1.7	0.0	31.8	1.7	13.5	40.7	3.2	5.4	1.4	0.0	0.8	0.9	4.9	1.9	40.5	1.5	28.3	1.4
MMP16	"C8orf57, DKFZp761D112, MT3-MMP"	ENSG00000156103	"Matrix metallopeptidase 16"	P51512	8	88032009-88328025	"Cancer-related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"	"Collagen degradation"	"Hydrolase, Metalloprotease, Protease"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 15.9"	"Cell type enhanced"	"Detected in some"	11	"Bipolar cells: 3.9;Early spermatids: 4.9;Fibroblasts: 9.9;Late spermatids: 4.7"	"Cancer enhanced"	"Detected in many"		"glioma: 4.8"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AN3-CA: 20.4;HUVEC TERT2: 8.8;SH-SY5Y: 11.4;U-138 MG: 9.7;WM-115: 20.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA023693	Uncertain		Approved	Vesicles,Cytosol	"Secreted to extracellular matrix"	NA	NA			Cytosol	Vesicles	"HPA023693: AB_1854025"	"unprognostic (2.58e-1)"	"unprognostic (2.42e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.87e-1)"	"unprognostic (7.09e-2)"	"unprognostic (3.31e-2)"	"unprognostic (2.39e-3)"	"unprognostic (1.45e-3)"	"unprognostic (2.46e-1)"	"unprognostic (2.61e-1)"	"unprognostic (9.42e-2)"	"unprognostic (2.92e-1)"	"unprognostic (2.09e-8)"	"unprognostic (6.90e-3)"	"unprognostic (1.16e-1)"	"unprognostic (3.62e-1)"	"unprognostic (2.19e-3)"	2.4	1.3	11.0	1.4	6.8	0.5	4.9	8.3	15.9	5.3	2.2	2.9	0.7	0.8	4.9	2.1	1.7	2.1	7.3	2.7	8.7	6.9	0.8	0.9	1.0	1.0	5.5	9.1	3.3	2.1	1.5	1.7	3.0	6.3	3.2	1.7	0.6	1.2	2.4	0.7	1.1	1.3	4.0	4.6	1.5	1.4	1.5	5.5	0.0	3.2	0.7	1.0	2.6	3.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	5.5	20.4	0.7	1.4	0.0	7.5	1.1	2.1	1.3	0.0	0.0	0.0	0.0	3.3	1.2	0.0	4.0	0.0	2.6	0.0	2.4	0.0	0.0	0.0	1.7	0.0	0.3	1.0	0.0	3.1	0.9	3.8	8.8	0.0	0.0	0.7	1.1	0.0	0.0	0.0	1.2	0.0	2.0	0.2	0.4	0.0	0.4	0.0	0.1	11.4	0.0	0.0	0.1	1.6	0.8	0.0	4.9	9.7	5.5	0.1	2.8	0.0	0.0	0.0	3.9	0.0	20.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.0	6.8	8.3	14.1	8.7	6.9	5.5	9.1	6.3	5.5	0.0	0.0	0.0	0.0	1.0	3.9	0.6	0.0	0.0	0.0	0.0	2.0	0.0	1.7	0.0	4.9	2.9	0.0	0.0	0.0	0.0	9.9	0.0	0.0	0.0	0.3	1.6	0.0	0.6	0.0	4.7	0.9	0.6	1.7	0.0	0.0	3.2	0.2	0.0	1.1	0.0	0.3	0.0	1.3	0.0	0.9	0.1	0.0	0.0	0.0	0.0
MMP17	MT4-MMP	ENSG00000198598	"Matrix metallopeptidase 17"	Q9ULZ9	12	131828393-131851783	"Enzymes, FDA approved drug targets, Predicted intracellular proteins, Predicted secreted proteins"		"Hydrolase, Metalloprotease, Protease"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 23.3"	"Cell type enriched"	"Detected in some"	7	"Melanocytes: 27.0"	"Cancer enriched"	"Detected in many"	10	"melanoma: 29.9"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	9	"classical monocyte: 2.2;intermediate monocyte: 2.1;memory B-cell: 1.4;myeloid DC: 1.2;naive B-cell: 1.7;non-classical monocyte: 2.7"	"Group enriched"	"Detected in many"	9	"B-cells: 1.7;dendritic cells: 1.2;monocytes: 2.7"	"Group enriched"	"Detected in many"	4	"REH: 17.3;SK-MEL-30: 42.1;WM-115: 62.3"	"Group enriched"	"Detected in many"	5	"amygdala: 51.6;basal ganglia: 52.2;cerebral cortex: 70.8;hippocampal formation: 73.1;hypothalamus: 21.6"	"Low region specificity"	"Detected in all"								"Secreted to extracellular matrix"	NA	NA						"unprognostic (9.11e-2)"	"unprognostic (1.27e-2)"	"unprognostic (1.69e-2)"	"unprognostic (3.71e-3)"	"unprognostic (5.62e-2)"	"unprognostic (1.85e-2)"	"unprognostic (8.90e-3)"	"unprognostic (2.14e-2)"	"unprognostic (2.60e-1)"	"unprognostic (2.66e-4)"	"unprognostic (7.68e-2)"	"unprognostic (5.88e-2)"	"unprognostic (9.26e-10)"	"unprognostic (1.15e-2)"	"unprognostic (2.65e-1)"	"unprognostic (1.21e-3)"	"unprognostic (2.81e-2)"	4.6	2.0	12.6	3.0	23.3	6.2	2.5	1.4	21.5	5.6	3.0	3.1	0.0	1.4	4.2	0.9	2.1	2.1	7.0	1.1	22.5	10.1	0.5	0.5	1.8	5.5	3.7	7.6	9.0	5.0	3.1	0.7	1.1	2.2	1.6	0.8	1.6	8.5	2.5	1.6	9.7	1.9	1.7	1.6	4.8	1.4	2.9	3.5	0.0	0.8	1.5	1.6	2.8	2.8	1.7	1.2	0.2	2.7	0.1	0.0	1.1	0.1	5.3	0.2	0.5	4.3	1.7	0.1	2.7	6.7	2.6	2.7	0.0	1.5	0.0	2.2	4.2	1.6	2.3	2.2	2.5	0.5	0.0	0.3	0.9	1.9	0.0	5.3	0.0	3.8	2.6	0.7	3.7	0.9	1.0	3.5	0.0	1.0	0.1	3.3	4.7	0.1	4.0	2.4	1.6	3.2	17.3	0.0	2.0	0.0	0.0	2.3	0.7	0.3	0.9	42.1	0.7	4.9	10.0	2.7	0.7	0.7	3.8	0.3	0.0	0.0	0.0	1.4	0.5	62.3	0.1	2.2	0.0	0.0	2.1	0.0	1.4	0.0	0.0	1.2	1.7	0.0	0.0	0.2	0.1	2.7	0.0	0.0	1.1	12.6	23.3	1.4	17.9	22.5	10.1	3.7	7.6	2.2	3.5	0.0	0.0	0.0	0.1	2.3	0.5	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.2	0.1	1.0	0.2	0.0	0.0	0.6	3.2	0.0	1.3	4.0	0.0	0.9	0.4	27.0	0.0	0.0	0.2	0.0	0.0	1.8	0.3	0.0	0.0	1.0	0.5	0.4	1.0	0.0	0.0	0.0	0.1
MMP19	"MMP18, RASI-1"	ENSG00000123342	"Matrix metallopeptidase 19"	Q99542	12	55835433-55842966	"Disease related genes, Enzymes, FDA approved drug targets, Predicted secreted proteins"	"Angiogenesis, Collagen degradation, Differentiation"	"Developmental protein, Hydrolase, Metalloprotease, Protease"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 60.7"	"Cell type enhanced"	"Detected in many"	8	"Extravillous trophoblasts: 42.0;Hofbauer cells: 31.2;Kupffer cells: 30.5;Macrophages: 48.2;monocytes: 38.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"Group enriched"	"Detected in some"	16	"classical monocyte: 3.2;myeloid DC: 1.0"	"Group enriched"	"Detected in many"	16	"dendritic cells: 1.0;monocytes: 3.2"	"Cell line enriched"	"Detected in many"	6	"BEWO: 57.2"	"Region enriched"	"Detected in single"	6	"olfactory region: 8.8"	"Low region specificity"	"Detected in all"			HPA070804			Approved	"Endoplasmic reticulum,Vesicles"	"Secreted to extracellular matrix"	NA	NA		800000	"Endoplasmic reticulum, Vesicles"		"HPA070804: AB_2686315"	"unprognostic (2.61e-1)"	"unprognostic (6.56e-2)"	"unprognostic (2.28e-2)"	"unprognostic (2.42e-1)"	"unprognostic (4.77e-3)"	"unprognostic (4.77e-3)"	"unprognostic (2.01e-2)"	"unprognostic (4.03e-2)"	"unprognostic (2.85e-2)"	"unprognostic (4.30e-2)"	"unprognostic (2.37e-1)"	"unprognostic (2.09e-1)"	"prognostic unfavorable (8.56e-9)"	"unprognostic (5.06e-3)"	"unprognostic (1.28e-3)"	"unprognostic (2.73e-2)"	"unprognostic (4.00e-2)"	60.7	1.9	0.2	10.9	0.7	0.0	9.9	0.2	0.5	7.6	3.9	0.4	1.4	0.8	12.7	6.0	3.6	11.8	30.3	4.7	0.6	0.1	4.1	3.0	14.0	15.5	0.5	0.2	7.4	8.1	0.0	0.5	24.5	1.0	2.9	2.8	3.1	2.0	3.5	2.1	2.7	4.1	7.7	0.8	27.4	5.0	2.9	0.2	2.7	3.3	1.8	7.1	5.9	3.5	0.0	1.0	0.1	3.2	0.0	0.0	0.6	0.8	0.0	0.0	0.0	6.3	8.1	57.2	6.0	7.1	2.5	2.9	0.3	0.2	0.0	0.0	8.4	0.1	0.0	0.0	1.8	3.4	0.3	0.0	0.0	0.0	0.1	5.2	0.0	0.2	8.4	0.2	1.5	1.6	3.0	0.4	0.0	0.1	0.0	8.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	1.4	0.0	1.1	2.9	0.0	0.0	0.1	0.0	0.0	0.6	0.0	0.1	9.7	1.5	3.3	0.0	0.2	0.0	0.0	0.0	4.5	0.0	0.0	0.0	3.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.6	0.2	0.7	0.2	0.5	0.6	0.1	0.5	0.2	1.0	0.2	0.0	5.8	0.9	0.2	6.4	0.5	0.6	5.1	2.7	5.7	0.0	3.9	14.4	0.0	0.3	0.4	2.1	0.0	0.0	0.4	42.0	24.0	0.4	2.3	0.5	31.2	0.0	0.0	4.9	30.5	0.4	5.5	48.2	11.8	38.7	0.0	0.3	0.1	0.0	4.9	0.0	1.7	0.0	9.6	0.0	0.2	3.8	15.7	0.0	0.0	0.1
MMP2	"CLG4, CLG4A, TBE-1"	ENSG00000087245	"Matrix metallopeptidase 2"	P08253	16	55389700-55506691	"Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Angiogenesis, Collagen degradation"	"Hydrolase, Metalloprotease, Protease"	"Cancer-related genes, Disease mutation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	11	"Extravillous trophoblasts: 217.4;Fibroblasts: 249.9;Leydig cells: 315.0;Peritubular cells: 393.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC diff: 292.5;ASC TERT1: 85.2;hTERT-RPE1: 329.2;U-87 MG: 93.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA001939, CAB002788"	Approved		Approved	Vesicles	"Secreted to extracellular matrix"	NA	NA	1600000000	160000000	Vesicles		"CAB002788: , HPA001939: AB_1079395"	"unprognostic (7.26e-2)"	"unprognostic (1.36e-3)"	"unprognostic (1.66e-1)"	"unprognostic (2.14e-3)"	"unprognostic (5.03e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.74e-1)"	"unprognostic (9.36e-3)"	"unprognostic (4.81e-3)"	"unprognostic (3.79e-2)"	"unprognostic (4.59e-3)"	"unprognostic (6.12e-2)"	"unprognostic (1.28e-3)"	"unprognostic (1.59e-2)"	"unprognostic (8.00e-2)"	"unprognostic (8.98e-2)"	"unprognostic (4.63e-2)"	197.5	9.0	1.2	13.2	1.6	0.0	136.4	0.8	1.4	74.3	74.4	2.4	36.9	5.6	85.0	123.0	52.3	25.7	115.4	54.0	0.9	0.5	9.4	3.5	38.9	3.9	1.5	1.1	71.0	6.5	0.7	2.2	58.9	2.2	66.8	18.7	36.4	18.6	20.4	68.6	68.2	22.6	57.1	1.8	12.4	20.5	57.0	1.1	1.3	20.6	31.8	9.1	84.1	105.3	0.0	0.0	0.9	0.7	0.0	0.0	0.0	0.3	0.1	9.7	0.1	292.5	85.2	15.9	25.0	57.5	5.0	4.0	0.0	0.1	0.0	20.1	44.1	1.9	2.7	0.0	0.2	2.9	0.0	0.0	0.0	0.6	0.1	27.7	0.0	0.7	72.6	0.0	26.0	0.2	329.2	32.7	0.0	0.0	0.1	16.8	0.0	0.0	0.3	7.7	0.0	0.0	0.0	2.3	0.0	0.8	0.3	0.1	17.6	4.6	0.0	0.1	45.4	0.0	1.7	45.9	79.6	7.6	15.2	3.2	0.0	0.0	0.0	93.1	1.3	14.5	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.2	0.0	0.0	0.0	1.2	1.6	0.8	1.4	0.9	0.5	1.5	1.1	2.2	1.1	0.0	0.3	0.0	13.0	108.4	5.2	3.1	0.0	0.0	3.4	10.4	0.0	5.4	0.0	1.7	11.5	11.9	0.0	0.0	0.3	217.4	249.9	2.7	0.0	0.0	25.6	1.6	27.1	15.4	0.0	26.9	315.0	5.3	121.4	0.0	0.0	5.0	6.9	0.0	393.8	0.0	1.8	12.9	70.0	1.2	2.1	89.5	14.4	0.0	0.0	3.8
MMP20		ENSG00000137674	"Matrix metallopeptidase 20"	O60882	11	102576835-102625332	"Disease related genes, Enzymes, FDA approved drug targets, Predicted secreted proteins"		"Hydrolase, Metalloprotease, Protease"	"Amelogenesis imperfecta, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"lymphoid tissue: 1.0;testis: 3.5"	"Cell type enriched"	"Detected in some"	10	"Early spermatids: 66.1"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	7	"OE19: 7.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"								"Secreted to extracellular matrix"	NA	NA						"unprognostic (4.62e-3)"		"unprognostic (2.61e-2)"	"unprognostic (1.68e-3)"		"unprognostic (1.75e-1)"		"unprognostic (2.13e-1)"		"unprognostic (3.06e-1)"	"unprognostic (2.97e-2)"	"unprognostic (6.75e-2)"	"unprognostic (9.58e-5)"	"unprognostic (6.10e-2)"		"unprognostic (2.35e-1)"		0.0	0.0	0.0	0.3	0.0	0.0	0.8	0.0	0.0	0.0	0.0			0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.5	0.0	0.0	0.2	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.5			0.0		1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	1.1	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	66.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.6	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	6.5	0.0	0.0	0.3	0.0	0.5	0.0	0.0	0.5
MMP21		ENSG00000154485	"Matrix metallopeptidase 21"	Q8N119	10	125766453-125775821	"Disease related genes, Enzymes, FDA approved drug targets, Predicted secreted proteins"		"Hydrolase, Metalloprotease, Protease"	"FDA approved drug targets, Heterotaxy"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in some"	13	"epididymis: 37.6"	"Cell type enhanced"	"Detected in single"	32	"Distal tubular cells: 1.7"	"Not detected"	"Not detected"							"Cell type enhanced"	"Detected in single"		"naive B-cell: 1.1"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"BEWO: 1.1;NB-4: 1.2;U-266/70: 2.1;U-266/84: 1.8"	"Not detected"	"Not detected"												"Secreted to extracellular matrix"	NA	NA						"unprognostic (1.32e-2)"	"unprognostic (1.28e-1)"	"unprognostic (8.51e-2)"	"unprognostic (2.19e-2)"	"unprognostic (4.02e-2)"	"unprognostic (2.21e-2)"	"unprognostic (4.22e-3)"	"unprognostic (1.01e-1)"	"unprognostic (2.12e-1)"	"unprognostic (1.48e-1)"	"unprognostic (2.89e-2)"	"unprognostic (3.62e-2)"	"unprognostic (9.70e-8)"	"unprognostic (1.30e-2)"	"unprognostic (7.69e-2)"	"unprognostic (7.00e-2)"	"unprognostic (2.18e-1)"	0.2	0.1	0.1	0.1	0.4	0.1	0.3	0.7	0.0	0.1	0.2			0.1	0.1	37.6	0.1	0.4	0.2	0.9	0.0	0.4	0.1	1.0	0.1	0.1	0.0		2.8	0.8	0.0	0.3	0.0		0.6	0.1		0.5	0.1	0.0	0.1	0.5	0.1	0.0	0.7	0.2	0.1			0.6		0.1	0.2	0.0	1.1	0.0	0.0	0.1	0.5	0.6	0.0	0.1	0.0	0.0	0.8	0.3	0.0	1.1	0.2	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.7	0.7	0.5	0.0	0.0	0.2	0.2	0.1	0.0	0.3	0.0	0.0	0.2	0.0	0.1	0.0	0.1	0.0	0.0	0.0	1.2	0.1	0.0	0.0	0.1	0.0	0.5	0.0	0.0	0.1	0.1	0.2	0.3	0.0	0.1	0.0	0.1	0.0	0.0	0.3	0.7	0.0	2.1	1.8	0.0	0.2	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.6	0.0	0.0	1.1	0.0	0.4	0.0	0.5	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0
MMP23B	"MIFR, MIFR-1, MMP22"	ENSG00000189409	"Matrix metallopeptidase 23B"	O75900	1	1632095-1635263	"Enzymes, FDA approved drug targets, Predicted intracellular proteins"		"Hydrolase, Metalloprotease, Protease"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"ovary: 51.8"	"Group enriched"	"Detected in many"	6	"Fibroblasts: 124.0;Leydig cells: 90.9;Peritubular cells: 167.3"	"Cancer enhanced"	"Detected in single"		"ovarian cancer: 0.8"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in some"	5	"plasmacytoid DC: 12.3"	"Lineage enriched"	"Detected in many"	5	"dendritic cells: 12.3"	"Cell line enhanced"	"Detected in some"		"AN3-CA: 3.4;HHSteC: 8.3;NTERA-2: 3.6;PC-3: 3.6;U-266/70: 6.5"	"Region enriched"	"Detected in some"	5	"cerebellum: 8.7"	"Not detected"	"Not detected"									NA	NA						"unprognostic (2.19e-2)"	"unprognostic (6.31e-2)"	"unprognostic (6.70e-3)"	"unprognostic (1.29e-1)"	"unprognostic (3.99e-2)"	"unprognostic (9.31e-2)"	"unprognostic (6.94e-2)"	"unprognostic (1.20e-1)"	"unprognostic (8.06e-2)"	"unprognostic (8.37e-2)"	"unprognostic (2.22e-1)"	"unprognostic (2.33e-1)"	"unprognostic (2.26e-11)"	"unprognostic (1.60e-3)"	"unprognostic (1.36e-1)"	"unprognostic (2.44e-2)"	"unprognostic (6.66e-2)"	4.7	2.4	0.3	3.9	0.3	2.1	2.3	0.5	0.4	19.6	3.2	0.1	4.2	3.9	17.3	20.1	4.7	6.4	28.5	14.4	0.2	0.3	3.6	2.3	11.0	3.3	0.1	0.0	51.8	0.7	0.0	3.1	10.5	0.1	32.1	0.2	1.2	1.4	6.3	0.9	2.5	2.7	11.7	0.2	4.1	4.3	13.5	0.0	0.4	1.2	0.9	2.8	13.9	7.0	0.2	12.3	0.1	0.2	2.2	1.8	1.3	1.0	0.0	0.3	3.4	0.0	0.0	1.7	0.0	0.0	0.2	0.0	0.7	1.0	0.2	0.8	0.0	0.0	0.1	0.0	0.0	0.0	0.7	2.6	1.0	0.3	2.2	8.3	0.4	0.5	0.2	0.0	0.0	0.0	0.1	0.0	0.4	0.3	0.3	0.0	0.9	0.0	0.6	3.6	0.0	3.6	1.3	0.1	1.6	0.0	0.1	0.6	0.2	0.5	0.0	0.2	0.1	1.0	0.0	0.7	0.5	0.3	0.7	0.0	6.5	0.3	1.1	0.1	0.4	0.3	0.0	0.2	0.0	1.8	0.0	1.1	0.0	0.4	1.1	0.0	0.2	0.1	0.9	0.1	2.2	0.1	12.3	0.2	1.3	0.3	0.3	0.5	0.4	0.2	0.3	0.1	0.0	0.1	0.0	0.0	0.3	0.0	0.9	11.8	1.1	9.0	2.5	0.0	0.0	1.8	0.0	2.7	0.0	0.8	0.8	1.5	1.7	0.0	0.5	1.6	124.0	0.4	0.0	1.0	5.1	3.2	2.9	20.9	1.5	3.2	90.9	1.0	18.6	1.0	1.7	0.8	3.4	0.0	167.3	0.6	5.7	0.0	8.2	1.6	10.7	13.8	8.6	9.2	1.2	0.7
MMP24	MT5-MMP	ENSG00000125966	"Matrix metallopeptidase 24"	Q9Y5R2	20	35226654-35277000	"Enzymes, FDA approved drug targets, Predicted membrane proteins, Predicted secreted proteins"	"Cell adhesion"	"Hydrolase, Metalloprotease, Protease"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"brain: 38.5"	"Cell type enhanced"	"Detected in some"	10	"Alveolar cells type 1: 14.9;Cholangiocytes: 12.7;Ductal cells: 7.5;Horizontal cells: 14.3;Proximal tubular cells: 7.3"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in all"	5	"cerebellum: 38.5"	"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"A549: 20.1;CACO-2: 30.6;EFO-21: 9.0;RPTEC TERT1: 13.8;U-2 OS: 10.4"	"Low region specificity"	"Detected in all"			"Region enriched"	"Detected in all"	4	"cerebellum: 91.3"	"HPA049280, HPA078816"	Approved		Approved	"Nucleoli,Plasma membrane"	"Secreted to extracellular matrix"	Yes	No			"Nucleoli, Plasma membrane"		"HPA049280: , HPA078816: "	"unprognostic (1.52e-3)"	"unprognostic (1.36e-1)"	"unprognostic (1.18e-1)"	"unprognostic (4.51e-4)"	"unprognostic (2.47e-2)"	"unprognostic (7.61e-3)"	"unprognostic (1.22e-1)"	"unprognostic (4.59e-2)"	"unprognostic (2.32e-2)"	"unprognostic (8.82e-2)"	"unprognostic (9.20e-3)"	"unprognostic (7.12e-2)"	"prognostic favorable (8.17e-11)"	"unprognostic (3.32e-2)"	"unprognostic (5.63e-2)"	"unprognostic (1.69e-2)"	"unprognostic (9.90e-4)"	1.6	1.3	4.0	0.4	7.8	0.6	0.4	38.5	8.9	0.7	0.3	1.3	0.2	2.8	1.6	0.9	0.2	2.8	0.6	1.0	2.7	3.2	8.6	0.9	6.1	0.3	1.8	1.5	0.9	8.0	0.0	3.8	0.6	1.7	2.2	0.1	0.5	0.4	6.0	0.2	1.5	1.7	2.5	0.9	0.6	0.7	0.4	1.4	0.2	0.8	0.2	0.2	0.5	0.2	0.8	0.4	2.2	0.8	0.6	1.2	0.3	0.3	20.1	0.0	0.1	0.1	0.0	0.6	1.1	1.3	2.1	1.1	30.6	5.4	0.0	9.0	1.4	0.7	0.3	4.7	0.0	0.9	0.1	0.2	1.1	0.6	0.3	0.0	0.0	0.2	0.1	0.1	0.1	0.0	0.6	0.0	0.1	0.0	0.3	0.2	0.2	0.1	0.1	7.7	0.0	1.4	0.0	0.1	0.0	13.8	0.1	8.0	5.5	1.4	0.5	0.2	1.8	0.3	0.1	0.3	4.3	10.4	1.0	0.4	0.1	0.1	0.0	0.9	0.1	0.6	1.0	0.6	0.1	1.0	0.7	1.2	0.6	0.7	0.8	0.4	0.8	0.6	0.6	2.2	0.6	0.8	0.2	0.0	0.3	4.0	7.8	38.5	5.3	2.7	3.2	1.8	1.5	1.7	1.4	14.9	1.0	0.0	0.1	0.1	3.6	0.6	12.7	0.0	2.3	1.8	0.0	0.0	5.0	7.5	0.6	0.7	0.3	0.0	0.8	0.1	0.2	0.4	0.0	0.2	0.0	14.3	0.0	0.0	0.3	0.0	0.3	0.0	1.7	0.0	0.0	0.2	2.1	0.0	0.0	7.3	0.3	0.0	0.2	0.0	0.0	0.3	0.0	0.0	0.0	0.0
MMP25	"MMP20, MMPL1, MT6-MMP"	ENSG00000008516	"Matrix metallopeptidase 25"	Q9NPA2	16	3046681-3060726	"Enzymes, FDA approved drug targets, Predicted intracellular proteins, Predicted secreted proteins"		"Hydrolase, Metalloprotease, Protease"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 17.6;bone marrow: 25.6;lymphoid tissue: 54.1"	"Group enriched"	"Detected in some"	4	"Alveolar cells type 2: 10.7;Kupffer cells: 5.9;monocytes: 23.4"	"Cancer enhanced"	"Detected in many"		"testis cancer: 7.1"	"Low region specificity"	"Detected in some"			"Group enriched"	"Detected in some"	6	"basophil: 10.2;eosinophil: 6.0;neutrophil: 17.6"	"Lineage enriched"	"Detected in many"	10	"granulocytes: 17.6"	"Cell line enriched"	"Detected in some"	12	"HMC-1: 50.5"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"CAB025177, HPA055640"	Uncertain		Supported	"Plasma membrane"	"Secreted to blood"	NA	NA			"Plasma membrane"		"CAB025177: , HPA055640: "	"unprognostic (4.51e-3)"	"unprognostic (9.28e-3)"	"unprognostic (7.57e-2)"	"unprognostic (2.95e-3)"	"unprognostic (2.26e-1)"	"prognostic favorable (1.09e-5)"	"unprognostic (1.36e-1)"	"unprognostic (7.39e-3)"	"unprognostic (7.63e-3)"	"unprognostic (2.29e-2)"	"unprognostic (1.51e-1)"	"unprognostic (2.53e-2)"	"unprognostic (2.37e-3)"	"unprognostic (1.17e-2)"	"unprognostic (8.30e-2)"	"unprognostic (4.01e-1)"	"unprognostic (2.02e-1)"	4.0	0.3	0.6	12.3	0.4	25.6	0.8	0.5	0.6	0.8	1.1	0.2	0.0	1.0	0.4	0.5	0.8	3.8	1.1	2.8	0.5	0.4	0.7	2.5	10.7	54.1	1.8	0.0	0.6	0.8	0.0	0.5	2.0	1.1	0.6	1.0	1.0	0.9	0.0	2.4	0.6	1.8	0.5	0.4	43.9	1.1	0.7	0.5	4.1	0.7	0.9	4.2	1.5	2.5	0.0	0.3	17.6	0.2	1.7	0.5	0.1	0.2	0.1	0.7	1.5	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.3	0.3	0.2	0.0	0.3	0.6	0.3	0.0	0.0	4.0	0.8	0.1	0.1	0.0	0.0	0.1	50.5	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.1	0.3	0.0	0.5	0.2	3.0	1.4	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.1	0.3	3.6	0.1	0.1	0.4	0.1	0.0	1.2	0.1	0.1	0.0	1.0	0.1	10.2	0.2	6.0	0.3	0.0	0.5	0.0	0.2	0.2	0.0	0.0	0.3	0.2	17.6	1.7	0.0	0.3	0.3	0.1	0.6	0.4	0.5	0.6	0.5	0.4	1.8	0.0	1.1	0.5	3.0	10.7	0.0	0.2	0.3	0.6	0.4	0.0	0.0	1.2	1.8	0.0	0.0	0.0	0.4	0.0	0.0	0.3	0.0	0.5	0.1	0.2	0.5	1.1	0.0	0.1	0.0	0.0	0.0	5.9	0.0	0.0	2.0	0.0	23.4	0.0	0.1	1.1	0.0	0.7	0.0	0.0	0.0	0.4	0.0	0.1	0.3	0.0	3.1	0.1	0.1
MMP26	"endometase, MGC126590, MGC126592"	ENSG00000167346	"Matrix metallopeptidase 26"	Q9NRE1	11	4704927-4992429	"Enzymes, FDA approved drug targets, Predicted secreted proteins"	"Collagen degradation"	"Hydrolase, Metalloprotease, Protease"	"FDA approved drug targets"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in some"	13	"endometrium 1: 19.1"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	20	"endometrial cancer: 8.8;prostate cancer: 2.0"					"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"																"Secreted to extracellular matrix"	NA	NA									"unprognostic (4.21e-3)"								"unprognostic (2.63e-1)"						0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	19.1	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0		1.4	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
MMP27		ENSG00000137675	"Matrix metallopeptidase 27"	Q9H306	11	102691487-102705806	"Enzymes, FDA approved drug targets, Predicted intracellular proteins"	"Collagen degradation"	"Hydrolase, Metalloprotease, Protease"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"breast: 10.4;tongue: 10.0"	"Cell type enriched"	"Detected in single"	5	"Suprabasal keratinocytes: 1.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	7	"neutrophil: 1.0"	"Lineage enriched"	"Detected in single"	7	"granulocytes: 1.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA069097	Approved				"Intracellular and membrane"	NA	NA					"HPA069097: AB_2686085"	"unprognostic (3.99e-2)"	"unprognostic (2.37e-4)"				"unprognostic (1.25e-3)"			"unprognostic (1.63e-1)"					"unprognostic (4.60e-1)"				3.2	0.0	0.0	0.0	0.5	2.4	10.4	0.0	0.0	1.5	0.8	0.0	0.0	0.3	0.9	4.7	0.8	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.6	0.0	5.1	0.0	0.8	5.4	2.6	2.0	0.0	0.1	0.4	0.4	0.0	0.9	0.1	10.0	2.2	0.4	0.3	0.0	0.0	1.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.1	0.0	0.0	0.0	0.0
MMP28	"EPILYSIN, MM28, MMP-25, MMP-28"	ENSG00000271447	"Matrix metallopeptidase 28"	Q9H239	17	35756249-35795707	"Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"		"Hydrolase, Metalloprotease, Protease"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	6	"Basal keratinocytes: 34.2;Enterocytes: 39.1;Mucus-secreting cells: 31.9;Paneth cells: 47.6;Urothelial cells: 34.5"	"Low cancer specificity"	"Detected in many"							"Cell type enhanced"	"Detected in many"		"naive CD4 T-cell: 7.2;naive CD8 T-cell: 5.9"	"Lineage enriched"	"Detected in many"	5	"T-cells: 7.2"	"Cell line enriched"	"Detected in some"	7	"HaCaT: 28.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA057288, HPA057890"			Approved	"Nucleoplasm,Focal adhesion sites"	"Secreted to extracellular matrix"	NA	NA			Nucleoplasm	"Focal adhesion sites"	"HPA057288: , HPA057890: "	"unprognostic (7.99e-3)"	"unprognostic (3.27e-1)"	"unprognostic (2.20e-1)"	"unprognostic (1.01e-1)"	"unprognostic (7.52e-2)"	"unprognostic (1.63e-1)"	"unprognostic (6.90e-2)"	"unprognostic (1.09e-2)"	"unprognostic (1.51e-1)"	"unprognostic (1.99e-1)"	"prognostic unfavorable (6.28e-6)"	"unprognostic (9.37e-2)"	"unprognostic (1.31e-1)"	"unprognostic (8.87e-2)"	"unprognostic (1.74e-1)"	"unprognostic (1.76e-2)"	"unprognostic (3.27e-3)"	8.0	1.6	1.8	2.7	3.7	0.5	4.3	0.0	5.1	1.7	7.3	1.6	1.4	3.0	3.2	4.8	4.3	1.5	12.3	0.5	2.8		0.8	0.2	10.3	0.4	0.0	2.9	0.1	1.3	0.5	0.0	0.7	1.3	2.9	4.1	2.7	0.1	2.1	0.6	4.5	9.3	4.3	0.2	0.6	7.2	13.4	0.2	0.0	4.2	4.4	2.5	5.5	2.2	1.1	1.5	0.1	0.2	1.3	7.2	0.9	0.1	0.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	3.0	0.1	0.7	0.0	0.1	28.7	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	1.1	0.0	0.0	0.0	2.6	0.0	0.1	0.0	0.2	0.2	0.0	0.1	0.0	0.2	0.1	0.2	0.0	3.9	0.2	0.6	0.0	0.0	0.0	1.6	0.2	0.5	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.1	2.0	1.1	0.4	1.7	0.1	0.9	7.2	5.9	0.1	1.3	0.2	1.5	0.0	0.9											26.8	20.8	0.0	5.1	34.2	0.4	1.0	2.5	5.3	5.7	7.0	0.0	0.0	0.0	0.1	5.0	8.1	39.1	0.0	0.3	0.0	1.6	1.8	0.0	0.0	0.1	1.6	3.5	6.2	0.0	7.1	1.1	0.9	3.3	0.0	31.9	9.1	9.7	47.6	2.8	0.7	0.5	6.5	2.0	0.5	2.5	29.0	0.0	0.7	18.5	34.5
MMP3	"STMY, STMY1"	ENSG00000149968	"Matrix metallopeptidase 3"	P08254	11	102835801-102843803	"Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Collagen degradation"	"Hydrolase, Metalloprotease, Protease"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"epididymis: 177.5;salivary gland: 73.4"	"Cell type enhanced"	"Detected in some"	10	"Basal glandular cells: 11.5;Basal keratinocytes: 7.4;Club cells: 11.4;Early spermatids: 14.6"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 59.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	17	"BJ: 101.3;BJ hTERT+: 275.6;fHDF/TERT166: 119.3"					"Low region specificity"	"Detected in many"			HPA007875	Uncertain		Supported	Vesicles	"Secreted to extracellular matrix"	NA	NA	2540000	170000	Vesicles		"HPA007875: AB_1079396"	"unprognostic (2.27e-1)"	"prognostic unfavorable (9.73e-4)"	"unprognostic (1.63e-3)"	"unprognostic (5.11e-3)"	"unprognostic (3.78e-1)"	"unprognostic (5.11e-2)"	"unprognostic (5.26e-6)"	"unprognostic (3.46e-2)"	"unprognostic (7.14e-2)"	"unprognostic (2.87e-1)"	"prognostic unfavorable (4.09e-4)"	"unprognostic (3.26e-2)"	"unprognostic (1.22e-15)"	"unprognostic (3.17e-1)"	"unprognostic (1.55e-1)"	"unprognostic (3.43e-2)"	"unprognostic (2.34e-1)"	19.1	0.0	0.2	14.4	0.3	0.0	6.9	0.2	0.5	0.2	1.5	0.3	0.2	1.8	28.3	177.5	0.2	0.0	1.4	0.2	0.2	0.0	0.3	0.5	0.4	0.2	0.2	0.2	0.3	0.2	0.0	0.2	0.2	0.2	1.2	1.7	0.2	73.4	1.5	7.3	12.6	0.7	5.9	0.2	0.2	2.8	1.4	0.2	0.2	0.6	1.5	0.9	7.5	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	101.3	275.6	1.8	0.5	0.0	0.0	0.0	0.0	119.3	6.8	0.0	0.0	0.0	3.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	8.1	0.4	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	9.4	0.8	0.1	0.0	0.0	0.0	0.0	3.9	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.2	0.5	0.2	0.0	0.2	0.2	0.2	0.2	3.0	0.0	0.0	11.5	7.4	0.0	0.2	5.1	0.0	11.4	0.0	0.0	0.1	0.0	0.7	14.6	0.0	0.0	0.0	1.2	2.2	1.3	0.6	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	2.3	0.6	0.0	0.0	0.0	0.0	1.0	0.0	0.9	3.0	0.2	0.0	0.1	5.2
MMP7	"MPSL1, PUMP-1"	ENSG00000137673	"Matrix metallopeptidase 7"	P09237	11	102520508-102530753	"Cancer-related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted secreted proteins"	"Collagen degradation"	"Hydrolase, Metalloprotease, Protease"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"gallbladder: 93.0;kidney: 129.5;salivary gland: 79.3"	"Cell type enriched"	"Detected in many"	6	"Ductal cells: 5335.6"	"Cancer enhanced"	"Detected in all"		"pancreatic cancer: 352.1"	"Region enriched"	"Detected in single"	5	"pons and medulla: 1.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A549: 23.2;CAPAN-2: 129.5;EFO-21: 30.7;RPTEC TERT1: 56.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"CAB025869, HPA051358"	Supported		Approved	Nucleoplasm,Vesicles	"Secreted to extracellular matrix"	NA	NA	2810000		"Nucleoplasm, Vesicles"		"CAB025869: , HPA051358: AB_2681452"	"unprognostic (1.06e-3)"	"unprognostic (9.51e-2)"	"unprognostic (4.15e-2)"	"unprognostic (1.38e-1)"	"unprognostic (7.70e-3)"	"unprognostic (7.28e-2)"	"prognostic unfavorable (2.53e-4)"	"prognostic unfavorable (3.38e-4)"	"unprognostic (3.96e-2)"	"unprognostic (5.63e-2)"	"unprognostic (6.59e-3)"	"unprognostic (1.51e-1)"	"unprognostic (6.36e-3)"	"unprognostic (1.42e-2)"	"unprognostic (5.54e-2)"	"unprognostic (1.48e-1)"	"unprognostic (1.46e-1)"	6.8	0.2	0.2	1.2	0.2	0.0	28.8	0.2	0.2	5.2	0.2	0.2	2.1	0.0	17.2	12.3	3.3	16.4	93.0	0.2	0.2	0.2	129.5	1.4	5.0	0.9	0.2	0.2	3.9	23.5	0.0	0.7	2.7	1.3	42.0	0.0	0.2	79.3	6.7	0.2	7.8	0.3	0.5	0.2	0.2	0.9	9.4	0.2	1.2	0.3	1.4	4.5	19.9	0.8	0.8	0.0	0.0	0.0	0.0	0.0	0.1	0.0	23.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.3	129.5	0.0	30.7	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	56.0	0.1	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.1	0.4	0.0	0.2	0.0	0.0	0.0	0.1	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.2	1.3	0.2	80.4	30.5	0.0	310.5	0.9	0.0	0.6	119.8	113.8	646.0	964.8	0.0	0.3	0.0	5335.6	3.9	0.3	0.0	0.0	184.1	0.2	0.4	323.2	2.3	0.0	103.8	0.0	0.0	0.0	0.0	6.5	10.9	7.3	0.0	113.6	0.0	0.0	723.2	0.0	0.0	6.0	0.0	0.0	0.4	0.0	0.1	2.0	0.7	0.0	0.0	640.3
MMP8	CLG1	ENSG00000118113	"Matrix metallopeptidase 8"	P22894	11	102711795-102727050	"Cancer-related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Collagen degradation"	"Hydrolase, Metalloprotease, Protease"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	6	"bone marrow: 119.3"	"Cell type enriched"	"Detected in single"	32	"Hofbauer cells: 4.3"	"Cancer enriched"	"Detected in single"	17	"melanoma: 5.7"	"Region enhanced"	"Detected in single"		"cerebral cortex: 1.7"	"Group enriched"	"Detected in some"	32	"neutrophil: 1.4;non-classical monocyte: 4.9"	"Group enriched"	"Detected in many"	32	"granulocytes: 1.4;monocytes: 4.9"	"Cell line enriched"	"Detected in some"	8	"WM-115: 40.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA021221, HPA022935"	Enhanced				"Secreted to extracellular matrix"	NA	NA		83000			"HPA021221: AB_1854043, HPA022935: AB_1854044"	"unprognostic (3.03e-1)"	"unprognostic (8.49e-5)"	"unprognostic (1.08e-2)"	"unprognostic (3.95e-3)"	"unprognostic (1.80e-1)"	"unprognostic (1.01e-2)"		"unprognostic (7.68e-3)"	"unprognostic (1.27e-1)"	"unprognostic (4.92e-2)"	"unprognostic (6.64e-3)"		"unprognostic (2.45e-6)"	"unprognostic (2.33e-4)"	"unprognostic (1.33e-1)"	"unprognostic (4.97e-1)"	"unprognostic (2.30e-2)"	1.9	0.1	0.2	0.2	0.4	119.3	0.3	0.1	1.7	0.1	0.2	0.0	0.0	0.1	0.6	0.1	0.1	0.1	0.1	9.0	0.2	0.3	0.4	0.8	12.6	2.6	0.3	0.0	0.9	0.9	0.1	0.6	1.4	0.2	0.1	0.1	0.1	0.3	0.1	0.6	0.3	0.1	0.2	0.3	18.7	0.2	0.1	0.1	5.2	1.9	0.0	0.1	0.2	7.6	0.0	0.0	1.4	4.9	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.1	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	40.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	4.9	0.0	0.0	1.7	0.2	0.4	0.1	1.7	0.2	0.3	0.3	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
MMP9	CLG4B	ENSG00000100985	"Matrix metallopeptidase 9"	P14780	20	46008908-46016561	"Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted secreted proteins"	"Collagen degradation"	"Hydrolase, Metalloprotease, Protease"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"adipose tissue: 64.0;blood: 63.2;bone marrow: 89.4;lymphoid tissue: 80.1"	"Cell type enhanced"	"Detected in many"	25	"Hofbauer cells: 273.8;Macrophages: 115.1;Melanocytes: 54.0"	"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	141	"neutrophil: 63.2"	"Lineage enriched"	"Detected in single"	339	"granulocytes: 63.2"	"Cell line enriched"	"Detected in some"	12	"NB-4: 89.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"CAB000348, HPA001238, HPA063909, CAB068199, CAB068200, CAB068201"	Enhanced		Approved	Cytosol	"Secreted to blood"	NA	NA	43300000	57000000	Cytosol		"CAB000348: , CAB068199: AB_2665675, CAB068200: AB_2665676, CAB068201: AB_2665677, HPA001238: AB_1079398, HPA063909: AB_2685150"	"unprognostic (4.62e-2)"	"unprognostic (1.64e-1)"	"unprognostic (2.85e-2)"	"prognostic favorable (2.55e-4)"	"unprognostic (6.65e-3)"	"unprognostic (2.82e-1)"	"prognostic unfavorable (7.19e-4)"	"unprognostic (1.54e-1)"	"unprognostic (8.57e-2)"	"unprognostic (3.21e-2)"	"unprognostic (4.15e-2)"	"unprognostic (1.96e-1)"	"prognostic unfavorable (4.05e-5)"	"unprognostic (4.65e-1)"	"unprognostic (9.85e-3)"	"unprognostic (2.48e-2)"	"unprognostic (2.17e-3)"	64.0	0.5	0.6	38.6	0.7	89.4	4.3	0.4	0.6	0.8	1.2	0.1	0.0	2.8	0.6	0.2	0.9	1.5	0.6	4.0	0.5	0.6	1.4	2.0	13.3	80.1	0.6	0.0	2.7	1.4	0.0	0.8	2.6	0.5	0.6	0.8	0.5	12.5	0.0	1.3	1.3	4.2	0.3	0.5	53.7	2.5	2.7	0.0	23.6	1.3	2.3	44.5	4.5	2.9	0.0	0.0	63.2	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.8	0.0	7.5	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.9	0.0	89.4	0.2	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.0	1.0	0.0	0.3	0.0	2.7	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	63.2	0.0	0.0	0.0	0.0	0.0	0.6	0.7	0.4	0.6	0.5	0.6	0.6	0.0	0.5	0.0	0.0	8.5	0.0	0.0	30.5	1.6	0.4	0.0	0.0	0.0	0.0	7.9	0.9	0.0	0.8	0.6	0.5	0.0	0.0	1.5	2.0	1.7	0.1	1.1	0.0	273.8	3.2	0.0	0.0	1.9	0.0	0.0	115.1	54.0	3.6	0.0	0.5	1.6	0.0	0.0	0.3	4.3	0.0	12.3	5.4	5.5	24.6	1.6	0.0	0.0	0.0
MOCOS	"FLJ20733, HMCS, MOS"	ENSG00000075643	"Molybdenum cofactor sulfurase"	Q96EN8	18	36187519-36272157	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Molybdenum cofactor biosynthesis"	Transferase	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 33.0;liver: 36.6"	"Cell type enhanced"	"Detected in many"	10	"Hepatocytes: 30.1;monocytes: 20.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"hTCEpi: 20.8;hTERT-HME1: 25.6;SiHa: 27.4;SK-MEL-30: 19.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA039412, HPA047958"	Uncertain		Supported	Mitochondria,Cytosol		NA	NA			Mitochondria	Cytosol	"HPA039412: AB_2676496, HPA047958: AB_2680225"	"unprognostic (3.07e-3)"	"unprognostic (1.81e-1)"	"unprognostic (1.69e-2)"	"unprognostic (1.50e-1)"	"unprognostic (3.18e-3)"	"unprognostic (2.55e-1)"	"unprognostic (1.97e-1)"	"prognostic unfavorable (3.55e-4)"	"unprognostic (5.84e-2)"	"unprognostic (1.33e-1)"	"prognostic unfavorable (1.29e-4)"	"unprognostic (2.91e-2)"	"prognostic unfavorable (3.03e-12)"	"unprognostic (8.98e-2)"	"unprognostic (2.37e-1)"	"unprognostic (4.09e-1)"	"unprognostic (6.35e-2)"	3.7	12.7	0.6	1.6	0.5	0.2	6.4	0.4	0.4	1.4	10.4	0.7	8.0	6.7	1.3	4.6	4.8	1.9	5.8	1.3	0.4	0.5	1.7	36.6	1.8	0.2	0.4	0.1	17.2	3.2	1.1	9.4	11.2	2.2	2.8	1.8	2.1	2.5	7.2	1.3	2.6	33.0	1.0	0.4	0.7	1.7	1.3	0.2	0.0	1.2	2.9	3.5	2.6	1.7	0.4	0.3	1.9	0.3	1.1	0.3	0.1	6.9	2.4	0.1	0.0	2.2	2.9	1.5	4.1	2.3	2.0	5.1	1.5	2.2	0.0	1.3	6.6	0.5	4.3	1.5	6.5	2.8	1.2	1.2	0.1	6.9	5.7	7.6	0.0	2.0	4.5	20.8	7.7	25.6	0.2	0.3	0.0	2.3	0.0	3.2	1.8	0.0	0.0	0.4	1.6	2.0	0.0	0.0	0.0	2.8	9.1	0.0	0.6	27.4	1.7	19.1	0.4	1.3	0.1	1.3	1.6	1.9	3.4	0.7	0.0	0.0	0.0	4.0	0.0	0.7	1.7	0.3	0.3	0.3	0.2	0.2	0.3	0.2	0.3	0.1	0.4	0.2	0.3	1.9	1.1	0.2	0.3	0.1	0.1	0.6	0.5	0.4	0.4	0.4	0.5	0.4	0.1	2.2	0.2	11.9	5.3	3.4	1.2	0.6	0.2	0.4	0.0	2.7	6.8	0.0	2.0	0.4	0.0	2.7	5.7	0.9	2.6	0.0	10.9	3.3	1.5	1.2	0.0	30.1	0.5	0.0	2.9	0.0	0.6	1.7	1.7	1.4	3.3	20.8	2.3	7.6	4.3	2.8	8.5	0.0	0.3	0.0	0.5	0.1	0.2	1.1	1.9	0.0	2.8	2.2
MOCS1	MOCOD	ENSG00000124615	"Molybdenum cofactor synthesis 1"	Q9NZB8	6	39899578-39934551	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Molybdenum cofactor biosynthesis"	Lyase	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	14	"Cytotrophoblasts: 23.5;Hepatocytes: 33.6;Sertoli cells: 77.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"naive CD4 T-cell: 2.9;naive CD8 T-cell: 2.5"	"Group enriched"	"Detected in many"	9	"NK-cells: 1.5;T-cells: 2.9"	"Cell line enhanced"	"Detected in many"		"CACO-2: 23.6;JURKAT: 30.1"	"Low region specificity"	"Detected in all"							"HPA045783, HPA058177, HPA075505"	Uncertain		Enhanced	Cytosol		NA	NA			Cytosol		"HPA045783: AB_10960058, HPA058177: AB_2683629, HPA075505: AB_2686751"	"unprognostic (1.22e-1)"	"prognostic unfavorable (1.07e-5)"	"unprognostic (3.26e-2)"	"unprognostic (1.44e-1)"	"unprognostic (9.03e-2)"	"unprognostic (1.99e-1)"	"unprognostic (2.61e-2)"	"unprognostic (4.85e-2)"	"unprognostic (3.14e-2)"	"unprognostic (1.08e-1)"	"prognostic favorable (6.07e-5)"	"unprognostic (5.34e-3)"	"unprognostic (1.21e-1)"	"unprognostic (3.97e-3)"	"unprognostic (2.78e-1)"	"unprognostic (2.93e-1)"	"unprognostic (6.21e-2)"	26.6	9.6	4.6	5.3	7.9	0.2	27.1	5.9	8.7	6.4	17.5	10.5	5.0	15.4	10.1	8.7	6.9	7.9	8.0	18.0	6.2	2.3	17.5	34.9	19.6	9.2	9.5	6.2	9.0	10.9	4.5	6.3	30.2	7.0	6.7	5.2	11.2	5.9	7.6	19.9	7.1	13.1	8.9	7.1	3.5	6.5	4.0	7.6	0.2	15.4	5.9	3.1	9.7	7.7	0.0	0.1	0.0	0.2	1.5	2.9	0.8	0.0	1.2	4.4	7.1	12.1	4.6	9.0	4.9	8.9	7.0	6.4	23.6	0.1	0.0	5.1	4.8	4.5	0.3	5.3	5.9	5.4	0.0	4.9	0.0	0.0	7.5	7.7	0.0	1.9	8.1	2.2	4.9	2.6	4.3	6.0	30.1	4.8	0.4	7.1	3.0	9.2	0.0	4.1	0.0	2.6	0.0	3.4	0.7	4.3	4.6	3.6	4.7	0.0	2.9	4.1	3.7	3.1	0.8	9.3	7.0	6.1	4.6	2.5	0.0	0.9	0.0	0.8	0.0	2.5	0.0	0.1	0.0	1.2	0.0	0.0	0.0	0.6	0.5	0.1	0.0	2.9	2.5	0.0	1.5	0.2	0.0	0.0	0.8	4.6	7.9	5.9	8.7	6.2	2.3	9.5	6.2	7.0	7.6	6.0	1.0	0.0	0.5	0.6	0.8	10.1	7.6	0.0	0.0	8.7	11.8	23.5	5.0	3.4	0.6	2.8	6.4	0.0	3.7	1.2	2.9	0.2	1.1	33.6	2.5	3.2	0.0	2.5	2.8	0.6	3.4	0.0	1.7	0.0	2.9	4.2	1.1	4.8	2.8	12.2	2.2	77.6	15.6	1.4	1.5	1.0	5.1	0.0	4.1	0.3
MOCS2	MOCO1	ENSG00000164172	"Molybdenum cofactor synthesis 2"	"O96007, O96033"	5	53095679-53110063	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Molybdenum cofactor biosynthesis"	Transferase	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	11	"Distal tubular cells: 485.7;Proximal tubular cells: 194.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037679, HPA037680"	Approved		Supported	"Nucleoplasm,Nuclear speckles,Cytosol"		NA	NA			Cytosol	"Nucleoplasm, Nuclear speckles"	"HPA037679: AB_2675604, HPA037680: AB_10673635"	"unprognostic (3.27e-1)"	"unprognostic (3.11e-2)"	"unprognostic (2.82e-1)"	"unprognostic (8.37e-3)"	"unprognostic (2.12e-1)"	"unprognostic (3.48e-2)"	"unprognostic (1.60e-2)"	"unprognostic (1.33e-1)"	"unprognostic (6.66e-2)"	"unprognostic (7.59e-2)"	"unprognostic (2.41e-3)"	"unprognostic (1.85e-1)"	"prognostic favorable (3.68e-6)"	"unprognostic (1.04e-1)"	"unprognostic (1.04e-2)"	"unprognostic (2.04e-1)"	"unprognostic (5.86e-2)"	18.1	34.6	41.5	9.8	38.0	4.0	19.6	21.7	41.8	16.0	17.1	20.7	10.4	17.6	14.8	28.2	17.0	12.9	15.9	39.9	36.7	32.1	49.7	52.0	13.1	11.4	30.0	22.4	21.2	18.4	30.4	23.3	16.2	28.7	18.6	14.9	17.2	21.2	20.8	38.3	8.9	17.6	16.1	27.1	10.7	16.6	11.0	20.0	8.2	31.5	19.4	11.2	16.9	15.4	16.9	12.5	6.3	10.9	17.3	25.8	12.9	20.2	16.6	12.0	28.7	24.6	22.7	15.2	24.9	26.2	22.2	26.4	22.6	15.2	20.7	37.5	19.6	34.4	12.3	24.0	25.5	35.0	5.2	23.4	15.9	16.3	20.4	25.3	17.2	12.0	18.1	12.8	25.2	22.5	22.0	23.8	26.7	15.4	11.3	37.0	30.0	18.5	9.8	10.6	8.7	34.6	9.4	25.8	18.8	38.4	15.4	8.9	10.3	18.1	14.8	18.6	15.9	28.6	4.4	15.2	21.3	22.1	18.9	32.0	13.3	19.7	23.4	30.5	4.9	32.9	5.2	9.2	6.3	16.9	10.9	20.2	16.5	19.0	19.2	12.5	16.9	25.8	22.2	1.7	17.3	9.8	11.4	18.3	12.9	41.5	38.0	21.7	41.8	36.7	32.1	30.0	22.4	28.7	20.0	50.6	20.6	25.2	32.7	11.8	27.0	111.0	66.2	36.1	19.4	66.3	25.5	82.4	485.7	34.6	5.6	32.8	17.8	0.0	38.2	28.9	48.8	44.5	9.3	99.9	36.5	6.4	25.3	19.0	25.0	10.1	46.9	27.4	21.9	7.2	17.9	36.8	23.4	19.3	64.7	194.9	18.1	32.3	50.3	40.7	54.7	13.7	27.0	26.1	22.9	30.2
MOCS3	"dJ914P20.3, UBA4"	ENSG00000124217	"Molybdenum cofactor synthesis 3"	O95396	20	50958826-50963931	"Enzymes, Predicted intracellular proteins"	"Molybdenum cofactor biosynthesis, tRNA processing"	"Multifunctional enzyme, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	11	"Early spermatids: 60.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA027556	Uncertain					NA	NA					"HPA027556: AB_2672333"	"unprognostic (1.29e-1)"	"unprognostic (2.57e-1)"	"unprognostic (3.16e-1)"	"prognostic unfavorable (5.82e-4)"	"unprognostic (2.11e-1)"	"unprognostic (1.17e-1)"	"prognostic unfavorable (1.39e-4)"	"unprognostic (3.76e-1)"	"unprognostic (3.19e-1)"	"unprognostic (1.33e-2)"	"unprognostic (8.67e-3)"	"unprognostic (4.90e-2)"	"prognostic favorable (7.55e-4)"	"unprognostic (8.39e-2)"	"unprognostic (8.48e-2)"	"unprognostic (1.62e-1)"	"unprognostic (1.89e-1)"	5.3	9.2	5.4	6.4	9.0	3.4	6.6	5.6	13.7	7.4	6.7	7.0	8.8	7.1	9.0	9.9	9.8	9.3	8.7	7.2	5.3	6.6	6.9	9.8	5.3	10.5	4.7	6.3	10.2	7.9	6.2	7.7	11.0	6.1	7.6	5.8	7.2	7.7	6.8	10.3	8.4	8.1	6.0	3.7	9.5	7.3	19.4	3.3	12.1	9.7	8.8	8.8	8.3	5.7	8.9	8.6	6.7	9.7	7.5	11.2	6.5	3.4	5.9	3.7	5.1	5.2	4.3	6.8	4.1	4.4	10.3	4.4	12.6	5.1	5.2	5.4	3.6	6.7	10.0	3.8	10.1	6.6	1.9	4.0	4.1	4.9	7.2	5.4	4.1	4.4	4.8	8.6	4.2	4.2	3.4	3.5	4.7	5.9	3.1	3.8	5.6	6.7	4.9	5.4	5.3	10.2	2.7	5.7	4.5	4.1	5.4	5.4	6.2	6.3	20.6	6.6	4.3	8.5	7.8	4.2	7.9	4.5	4.2	4.4	7.8	7.0	2.2	7.0	2.5	3.3	4.9	7.5	6.7	6.4	6.8	8.1	8.9	6.6	7.0	8.6	7.0	11.2	8.7	4.1	7.5	9.7	4.8	10.0	6.5	5.4	9.0	5.6	13.7	5.3	6.6	4.7	6.3	6.1	3.3	0.0	1.0	0.9	4.3	1.5	4.9	1.6	2.5	4.0	3.4	0.0	3.9	8.9	1.7	7.1	60.9	1.5	3.5	0.0	7.0	5.5	2.2	2.5	0.0	6.4	4.3	0.0	2.4	7.4	4.1	19.9	4.6	3.0	3.3	3.6	3.3	6.7	5.8	3.4	2.8	4.9	5.0	12.9	1.4	17.0	8.9	3.3	9.7	2.5	4.0	4.1
MOGAT1	"DGAT2L, DGAT2L1, MGAT1"	ENSG00000124003	"Monoacylglycerol O-acyltransferase 1"	Q96PD6	2	222671786-222709930	"Enzymes, Predicted membrane proteins"	"Glycerol metabolism, Lipid biosynthesis, Lipid metabolism"	"Acyltransferase, Transferase"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in many"	5	"gallbladder: 40.9"	"Cell type enhanced"	"Detected in some"	13	"Cholangiocytes: 5.1;Exocrine glandular cells: 4.5;Hepatocytes: 2.1;Muller glia cells: 2.2"	"Cancer enhanced"	"Detected in some"		"pancreatic cancer: 0.9"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	7	"plasmacytoid DC: 3.4"	"Lineage enriched"	"Detected in single"	7	"dendritic cells: 3.4"	"Cell line enhanced"	"Detected in single"		"Hep G2: 1.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA049944	Uncertain					NA	NA					"HPA049944: AB_2680964"	"unprognostic (6.32e-2)"		"unprognostic (2.38e-1)"	"unprognostic (1.15e-1)"	"unprognostic (1.41e-1)"		"unprognostic (4.28e-3)"	"unprognostic (4.39e-2)"	"unprognostic (4.32e-2)"	"unprognostic (9.44e-2)"	"unprognostic (1.91e-1)"	"unprognostic (8.59e-2)"	"unprognostic (3.07e-3)"	"unprognostic (4.99e-2)"	"unprognostic (3.89e-1)"	"unprognostic (9.03e-3)"		2.3	0.1	0.6	0.1	0.5	0.1	1.3	0.2	0.9	0.3	0.6	0.5	0.2	0.0	1.0	1.1	0.5	0.1	40.9	0.8	0.5	0.2	5.7	7.6	1.1	0.3	0.2	0.9	0.1	1.5	2.3	0.4	0.0	0.9	0.2	0.1	0.0	1.4	2.6	0.5	1.6	0.2	0.1	0.3	0.1	1.0	0.3	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	3.4	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.9	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.3	0.0	0.5	0.0	0.6	0.0	0.0	0.0	0.5	0.0	0.7	0.0	0.0	1.5	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.3	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.2	0.9	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.2	0.0	0.7	0.0	0.0	0.3	0.2	0.0	0.0	0.3	0.0	0.5	0.3	0.2	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.4	0.0	0.0	0.6	0.5	0.2	0.9	0.5	0.2	0.2	0.9	0.9	0.0	0.0	0.3	0.0	0.0	0.0	0.4	0.4	5.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.7	0.0	0.0	0.0	4.5	0.0	0.0	0.0	0.0	2.1	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	1.0	0.0	2.2	0.5	0.0	0.0	0.3	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0
MOGAT2	"DGAT2L5, FLJ22644, MGAT2"	ENSG00000166391	"Monoacylglycerol O-acyltransferase 2"	Q3SYC2	11	75717819-75732958	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Glycerol metabolism, Lipid biosynthesis, Lipid metabolism"	"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	13	"intestine: 90.2;liver: 40.5"	"Cell type enhanced"	"Detected in some"	19	"Enterocytes: 91.9;Hepatocytes: 64.7;Mucus-secreting cells: 33.4;Undifferentiated cells: 25.8"	"Cancer enhanced"	"Detected in many"		"liver cancer: 6.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	7	"Hep G2: 8.6;RPMI-8226: 5.8"	"Not detected"	"Not detected"							HPA028834	Uncertain					NA	NA					"HPA028834: AB_10601865"	"unprognostic (5.63e-2)"	"unprognostic (2.71e-2)"	"unprognostic (6.37e-2)"	"unprognostic (6.88e-3)"	"unprognostic (1.15e-4)"	"unprognostic (2.66e-3)"	"unprognostic (1.28e-3)"	"unprognostic (1.09e-1)"	"unprognostic (1.42e-2)"	"unprognostic (1.12e-1)"	"unprognostic (4.21e-2)"	"unprognostic (3.02e-1)"	"unprognostic (1.24e-5)"	"unprognostic (2.13e-3)"	"unprognostic (1.84e-2)"	"unprognostic (2.13e-1)"	"unprognostic (2.83e-3)"	0.1	0.0	0.1	4.8	0.1	0.0	2.1	0.1	0.1	0.2	34.0	0.1	1.4	22.3	0.1	0.1	0.2	0.0	2.6	0.1	0.1	0.0	0.2	40.5	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.6	7.0	0.1	0.4	2.2	0.4	0.9	90.2	0.2	0.1	0.1	0.2	0.1	0.1	0.1	0.1	0.2	0.3	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	8.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.1	0.0	0.3	0.0	1.0	0.0	0.0	0.1	5.8	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	91.9	0.0	0.5	0.0	0.0	0.8	0.0	64.7	0.0	0.0	2.4	0.6	0.6	0.0	0.0	0.0	0.0	0.0	33.4	0.0	0.0	18.7	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	25.8	0.1
MOGAT3	"DC7, DGAT2L2, MGAT3"	ENSG00000106384	"Monoacylglycerol O-acyltransferase 3"	Q86VF5	7	101195007-101201021	"Enzymes, Predicted membrane proteins"	"Glycerol metabolism, Lipid biosynthesis, Lipid metabolism"	"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	7	"intestine: 61.6;liver: 16.0"	"Cell type enhanced"	"Detected in some"	22	"Enterocytes: 76.6;Paneth cells: 56.1;Undifferentiated cells: 21.5"	"Cancer enhanced"	"Detected in many"		"colorectal cancer: 11.0;liver cancer: 11.1"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in many"		"neutrophil: 5.3"	"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in some"	6	"CACO-2: 4.8;Hep G2: 16.2"									HPA011940	Approved		Approved	Centrosome		NA	NA			Centrosome		"HPA011940: AB_1854057"		"unprognostic (1.19e-1)"	"unprognostic (1.13e-1)"	"unprognostic (7.14e-2)"	"unprognostic (6.11e-2)"	"unprognostic (3.20e-1)"	"unprognostic (9.54e-3)"		"unprognostic (9.36e-2)"	"unprognostic (3.08e-1)"	"unprognostic (1.05e-3)"	"unprognostic (1.87e-1)"	"unprognostic (1.23e-1)"	"unprognostic (9.66e-2)"	"unprognostic (1.65e-1)"		"unprognostic (2.59e-2)"	0.2	0.1	0.2	2.6	0.2	0.4	0.2	0.2	0.2	0.2	17.3	0.2	0.2	19.7	0.2	0.5	0.2	0.1	0.2	0.2	0.2	0.1	0.9	16.0	0.2	0.2	0.2	0.2	0.2	0.2	0.0	0.2	0.2	0.2	0.2	7.1	0.2	0.2	0.2	0.2	0.1	61.6	0.4	0.2	0.2	0.1	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.2	1.7	1.2	5.3	0.9	1.9	1.2	0.3	0.6	0.2	0.2	0.5	0.0	0.2	0.4	0.6	0.0	0.0	0.0	4.8	1.1	0.4	0.6	0.1	0.6	0.4	0.2	0.1	0.1	0.1	0.2	0.6	0.6	16.2	0.2	0.5	0.6	0.1	0.1	0.0	0.1	0.4	0.1	0.3	0.2	0.7	0.1	0.3	0.3	0.5	0.2	0.5	0.6	0.3	0.1	0.4	0.7	0.6	0.3	0.3	0.3	0.6	0.1	0.8	0.3	0.3	0.8	0.9	0.2	1.0	0.5	0.4	0.2	0.1	1.7	0.6	1.4	2.2	0.9	1.1	1.0	0.7	0.7	1.0	0.8	0.7	0.5	1.7	0.9	1.2	5.3	1.9	0.6	1.2	0.5	0.3	0.2	0.2	0.2	0.2	0.2	0.1	0.2	0.2	0.2	0.2	0.0	0.3	0.0	0.5	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	76.6	0.0	0.0	0.0	0.2	0.2	0.0	5.5	0.0	0.0	1.7	1.3	0.0	0.0	0.0	0.0	0.0	0.0	13.9	0.0	0.1	56.1	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	21.5	0.4
MOGS	"CWH41, DER7, GCS1"	ENSG00000115275	"Mannosyl-oligosaccharide glucosidase"	Q13724	2	74461057-74465410	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"		"Glycosidase, Hydrolase"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	10	"Late spermatids: 186.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA011322, HPA011969"	Approved		Supported	"Endoplasmic reticulum"		NA	NA		88000000	"Endoplasmic reticulum"		"HPA011322: AB_2668483, HPA011969: AB_1849579"	"unprognostic (5.66e-2)"	"unprognostic (1.98e-2)"	"prognostic unfavorable (5.33e-4)"	"unprognostic (1.91e-2)"	"unprognostic (4.67e-2)"	"unprognostic (2.04e-1)"	"prognostic unfavorable (2.34e-6)"	"unprognostic (1.48e-2)"	"unprognostic (2.66e-2)"	"unprognostic (3.32e-2)"	"unprognostic (6.21e-2)"	"unprognostic (4.36e-1)"	"prognostic unfavorable (2.79e-8)"	"unprognostic (1.40e-2)"	"unprognostic (3.06e-2)"	"unprognostic (2.66e-1)"	"unprognostic (7.59e-3)"	15.8	12.8	8.7	15.2	10.6	8.5	13.1	11.3	12.1	13.9	19.4	10.8	24.9	36.5	14.2	15.8	15.5	13.4	16.4	11.2	7.7	6.1	14.8	40.5	17.2	15.6	9.2	7.9	14.2	30.6	20.4	15.7	35.8	8.3	15.9	11.2	11.7	24.5	25.3	14.1	17.4	35.8	9.8	7.1	22.4	22.3	11.9	8.1	17.6	18.9	11.4	19.5	14.1	12.9	3.9	3.4	2.3	4.4	12.7	5.1	2.5	22.2	19.8	13.1	12.6	27.1	19.2	40.3	18.2	26.5	27.7	26.7	36.2	23.8	24.1	16.3	18.4	20.8	22.4	19.8	20.6	17.2	20.8	19.2	11.3	12.8	27.7	22.4	26.4	22.7	11.2	33.0	19.6	19.2	30.9	31.0	14.3	19.6	23.4	12.2	27.7	14.3	20.3	17.3	28.2	11.0	16.4	29.3	31.2	15.1	13.8	10.8	14.2	8.7	36.3	23.7	13.0	17.5	14.2	22.1	12.8	22.3	18.5	24.1	36.2	14.9	10.7	20.1	21.6	17.3	2.3	4.0	1.1	5.0	2.5	5.1	2.5	4.2	4.5	3.4	3.9	3.7	2.4	0.7	12.7	4.4	3.2	3.8	2.5	8.7	10.6	11.3	12.1	7.7	6.1	9.2	7.9	8.3	8.1	6.0	15.7	9.0	17.4	14.1	14.2	5.8	15.3	9.4	12.5	22.7	17.7	32.9	5.0	19.7	52.1	10.9	21.0	23.3	22.8	34.8	8.7	19.5	4.6	22.1	17.5	6.4	13.4	17.8	7.9	186.6	14.1	16.0	10.1	27.1	24.4	8.3	19.0	20.3	6.7	8.4	12.7	12.9	7.6	8.6	3.2	15.2	43.5	14.0	17.9	17.3
MOK	"RAGE, RAGE1, STK30"	ENSG00000080823	"MOK protein kinase"	Q9UQ07	14	102224500-102305200	"Enzymes, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in all"		"testis: 45.0"	"Cell type enhanced"	"Detected in many"	13	"Ciliated cells: 214.2;Cone photoreceptor cells: 174.7;Early spermatids: 171.0;Rod photoreceptor cells: 441.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"NK-cell: 10.6"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HBF TERT88: 28.6;hTEC/SVTERT24-B: 72.8;NB-4: 90.6;U-138 MG: 38.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA027292			Supported	"Endoplasmic reticulum"		NA	NA			"Endoplasmic reticulum"		"HPA027292: AB_10600989"	"unprognostic (8.16e-2)"	"unprognostic (1.82e-1)"	"unprognostic (6.68e-2)"	"unprognostic (6.05e-3)"	"unprognostic (1.34e-2)"	"unprognostic (1.81e-2)"	"unprognostic (4.43e-2)"	"unprognostic (3.49e-4)"	"unprognostic (2.19e-1)"	"unprognostic (2.03e-2)"	"unprognostic (2.93e-1)"	"unprognostic (3.01e-3)"	"unprognostic (5.97e-2)"	"unprognostic (1.81e-1)"	"unprognostic (2.17e-1)"	"unprognostic (1.26e-2)"	"unprognostic (2.48e-1)"	5.9	6.8	12.9	2.7	17.3	3.7	7.8	9.7	15.9	7.6	3.6	8.7	6.2	4.7	7.6	10.2	3.9	26.4	6.4	8.3	13.5	10.2	7.7	3.6	6.1	2.5	6.0	13.7	12.4	8.6	9.4	22.1	3.6	16.6	5.1	3.0	15.2	6.1	5.4	1.9	8.6	4.1	5.9	6.2	3.8	11.7	45.0	6.2	0.4	11.7	2.3	2.2	6.2	3.9	0.7	3.9	0.9	1.1	10.6	2.4	1.3	3.4	3.0	0.4	1.7	0.7	2.5	0.7	7.0	2.0	10.1	12.2	0.2	8.4	2.6	0.5	1.3	2.2	0.7	0.6	3.6	28.6	2.9	2.6	0.6	0.4	2.3	3.1	0.3	3.4	2.1	0.9	72.8	6.7	7.9	0.3	0.5	0.6	0.1	6.6	2.3	0.2	90.6	0.1	1.5	7.4	0.4	0.2	0.0	4.1	0.1	1.1	0.7	1.2	0.4	19.6	0.1	2.1	0.2	0.2	38.5	1.9	1.4	2.2	0.2	0.4	0.2	7.7	0.2	17.4	0.0	1.1	0.0	0.7	0.7	1.2	0.0	0.5	1.9	3.9	0.7	1.1	2.4	0.9	10.6	0.1	0.0	0.0	1.3	12.9	17.3	9.7	15.9	13.5	10.2	6.0	13.7	16.6	6.2	17.9	17.4	0.5	6.5	9.5	36.2	12.2	10.2	214.2	43.3	12.2	174.7	1.0	5.0	7.0	171.0	6.7	3.8	0.0	14.2	2.1	7.6	3.6	3.5	1.7	2.0	15.9	4.6	7.4	1.8	130.3	28.1	4.2	75.9	0.0	2.0	58.0	5.6	0.0	15.2	8.1	441.5	25.8	12.1	81.9	27.2	5.1	1.0	6.7	3.8	3.0
MOS		ENSG00000172680	"MOS proto-oncogene, serine/threonine kinase"	P00540	8	56112942-56113982	"Enzymes, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"	Proto-oncogene	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	5	"testis: 3.5"	"Cell type enriched"	"Detected in single"	8	"Early spermatids: 5.0"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"HAP1: 1.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"									NA	NA																				"unprognostic (3.28e-1)"			0.0	0.0	0.6	0.0	0.5	0.0	0.0	0.0	0.3	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.1	0.0	0.0	0.0	0.0	0.2		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.5			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0
MOV10	"fSAP113, gb110, MGC2948"	ENSG00000155363	"Mov10 RISC complex RNA helicase"	Q9HCE1	1	112673141-112700746	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction, RNA-mediated gene silencing, Transcription, Transcription regulation"	"Helicase, Hydrolase, RNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA031627			Approved	Cytosol		NA	NA			Cytosol		"HPA031627: AB_2673966"	"unprognostic (1.44e-2)"	"unprognostic (1.83e-2)"	"unprognostic (1.53e-1)"	"unprognostic (6.82e-3)"	"unprognostic (1.91e-1)"	"unprognostic (1.16e-1)"	"prognostic unfavorable (3.44e-4)"	"unprognostic (9.89e-2)"	"unprognostic (1.54e-1)"	"unprognostic (1.58e-3)"	"unprognostic (2.85e-1)"	"unprognostic (1.54e-1)"	"prognostic unfavorable (1.48e-11)"	"unprognostic (4.01e-2)"	"unprognostic (3.61e-1)"	"unprognostic (1.46e-3)"	"unprognostic (1.21e-3)"	12.5	17.0	6.2	12.6	6.9	3.5	15.0	1.9	6.3	11.4	23.1	9.3	12.3	18.8	16.4	12.6	15.8	12.2	15.3	5.8	8.6	5.1	13.3	19.4	9.7	7.7	5.9	5.1	14.5	12.9	13.1	14.1	20.2	8.2	14.0	9.3	13.8	13.5	16.5	3.1	23.2	33.8	9.4	6.3	12.9	10.4	17.7	6.0	14.5	12.1	6.9	10.9	11.0	12.5	1.9	5.6	0.9	9.5	9.9	10.8	5.9	12.0	7.4	4.4	17.0	3.6	10.4	16.8	8.3	19.7	24.4	35.0	13.7	13.3	0.0	5.7	11.4	9.1	12.8	16.8	19.9	8.5	13.2	10.2	8.3	10.8	15.4	15.5	3.4	8.3	17.5	6.1	14.8	4.7	16.1	20.7	17.2	11.0	4.2	7.5	22.3	13.1	2.7	9.9	5.0	7.6	23.7	11.2	0.5	11.3	13.2	1.9	6.4	17.1	11.6	13.4	9.1	9.0	8.0	12.3	7.6	13.7	5.3	7.3	4.8	1.3	0.0	15.1	7.2	21.7	0.7	2.8	0.5	10.7	8.4	10.8	1.9	9.7	9.7	5.6	1.4	9.4	7.1	0.9	9.9	9.5	0.9	8.2	5.9	6.2	6.9	1.9	6.3	8.6	5.1	5.9	5.1	8.2	6.0	8.9	10.9	5.4	9.8	7.8	2.1	2.5	7.6	6.7	10.3	15.7	0.0	42.2	3.3	13.7	4.2	14.7	31.4	0.0	13.3	16.6	5.1	9.2	1.1	14.0	13.8	4.8	14.5	17.8	9.4	4.9	8.6	7.1	3.3	18.0	15.3	20.4	13.7	28.1	7.1	11.2	0.8	12.9	6.2	2.6	2.6	6.0	31.9	5.7	11.5	9.5
MOV10L1	"CHAMP, DJ402G11.8, DKFZp434B0717"	ENSG00000073146	"Mov10 RISC complex RNA helicase like 1"	Q9BXT6	22	50089879-50161690	"Enzymes, Predicted intracellular proteins"		"Developmental protein, Helicase, Hydrolase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	9	"testis: 27.7"	"Cell type enhanced"	"Detected in some"	24	"Early spermatids: 110.5;Late spermatids: 224.1;Spermatocytes: 68.2;Spermatogonia: 38.5"	"Low cancer specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HHSteC: 3.3;HUVEC TERT2: 16.1;TIME: 7.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA019034	Approved					NA	NA					"HPA019034: AB_1854070"	"unprognostic (1.39e-1)"	"unprognostic (2.30e-2)"	"unprognostic (1.88e-2)"	"unprognostic (7.91e-2)"	"unprognostic (4.29e-2)"	"unprognostic (4.05e-2)"	"unprognostic (1.21e-1)"	"unprognostic (2.69e-1)"	"unprognostic (9.43e-2)"	"unprognostic (7.51e-2)"	"unprognostic (6.26e-2)"	"unprognostic (2.03e-1)"	"unprognostic (8.02e-3)"	"unprognostic (1.47e-1)"	"unprognostic (1.66e-1)"	"unprognostic (1.19e-1)"	"unprognostic (1.37e-1)"	0.4	0.1	0.7	0.2	1.5	0.3	0.2	1.3	1.3	0.9	0.8	0.6	0.2	0.1	3.0	2.0	0.4	1.0	1.2	0.3	0.9	0.6	0.3	1.0	0.3	0.2	0.5	1.5	1.8	0.2	0.1	0.4	0.6	2.1	1.0	0.2	0.6	0.2	0.2	0.2	0.3	0.4	1.9	0.7	0.2	0.1	27.7	0.2	0.2	0.5	0.2	0.3	0.4	2.0	0.0	0.0	0.0	0.6	0.0	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	1.4	0.5	1.0	0.0	0.0	0.0	1.4	0.5	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.7	0.0	0.0	3.3	0.0	1.5	0.2	0.0	0.0	0.0	0.2	16.1	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.1	0.0	0.0	0.1	0.0	0.0	7.4	0.0	0.9	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.7	1.5	1.3	1.3	0.9	0.6	0.5	1.5	2.1	0.2	0.0	0.0	0.0	0.1	0.2	2.4	1.4	0.0	0.0	0.0	1.8	0.0	0.1	0.0	0.0	110.5	1.0	0.0	0.0	0.3	0.1	0.5	0.1	0.0	0.0	1.4	4.8	0.0	0.0	0.0	224.1	1.4	0.0	0.0	0.0	0.0	0.9	0.0	0.0	2.8	0.8	3.8	12.9	0.0	68.2	38.5	0.0	0.1	0.0	0.0	0.0
MPG	MDG	ENSG00000103152	"N-methylpurine DNA glycosylase"	P29372	16	77007-85853	"Enzymes, Predicted intracellular proteins"	"DNA damage, DNA repair"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA006531	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA006531: AB_1854075"	"unprognostic (1.78e-2)"	"unprognostic (8.48e-2)"	"unprognostic (9.99e-2)"	"prognostic favorable (2.82e-5)"	"unprognostic (8.54e-2)"	"unprognostic (3.27e-1)"	"unprognostic (2.75e-2)"	"unprognostic (1.63e-1)"	"unprognostic (2.14e-1)"	"unprognostic (1.44e-1)"	"unprognostic (1.85e-2)"	"unprognostic (1.83e-2)"	"unprognostic (1.39e-2)"	"unprognostic (1.86e-3)"	"unprognostic (3.88e-2)"	"unprognostic (1.86e-2)"	"unprognostic (3.26e-1)"	20.8	32.1	18.4	21.1	18.4	25.3	33.2	18.3	32.1	19.5	20.4	12.6	24.6	21.0	22.6	30.5	21.5	18.5	28.5	37.4	16.7	15.1	16.1	32.0	20.1	39.7	15.8	18.2	23.8	36.5	8.0	21.7	19.0	16.5	23.2	7.2	15.2	47.1	24.2	33.6	19.0	19.4	19.2	13.6	25.6	27.3	10.9	11.2	18.3	29.2	22.4	22.8	27.2	25.2	33.5	38.8	27.2	27.4	41.2	31.1	22.4	14.0	20.5	5.6	17.1	10.3	23.5	14.0	20.1	27.8	13.1	14.4	12.9	18.9	10.0	17.6	11.4	6.5	18.0	3.9	8.8	2.0	17.1	14.9	6.5	10.4	19.2	29.8	6.7	40.2	22.6	12.2	14.7	6.1	17.5	22.8	11.3	14.2	18.0	17.0	48.4	11.7	31.1	10.1	8.1	22.4	22.3	6.7	38.0	10.9	5.1	4.6	11.7	10.6	11.5	25.3	2.7	16.4	34.9	19.9	10.7	13.6	14.5	9.9	17.6	5.9	12.7	19.8	19.5	38.1	14.2	27.4	27.2	22.7	19.2	20.6	33.5	21.8	22.6	28.5	30.6	16.8	17.2	14.0	41.2	15.7	38.8	31.1	22.4	18.4	18.4	18.3	32.1	16.7	15.1	15.8	18.2	16.5	11.2	3.0	24.6	65.6	62.0	31.8	13.4	1.1	30.6	20.1	22.7	38.4	3.9	68.9	28.2	68.7	6.3	43.1	60.4	0.0	99.2	74.2	79.8	90.4	54.4	44.9	80.7	9.5	47.8	47.3	65.5	3.6	60.9	47.4	54.0	72.1	66.3	38.4	109.6	66.2	54.5	52.3	9.1	84.1	64.9	18.8	43.7	35.9	51.7	62.9	63.6	97.9
MPI		ENSG00000178802	"Mannose phosphate isomerase"	P34949	15	74890005-74902219	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		Isomerase	"Congenital disorder of glycosylation, Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA007200	Approved		Approved	"Plasma membrane,Cytosol"		NA	NA		170000	Cytosol	"Plasma membrane"	"HPA007200: AB_1854079"	"unprognostic (1.38e-1)"	"unprognostic (7.18e-2)"	"unprognostic (1.63e-1)"	"unprognostic (1.65e-3)"	"unprognostic (7.34e-2)"	"prognostic unfavorable (2.39e-4)"	"unprognostic (1.79e-1)"	"unprognostic (2.76e-1)"	"unprognostic (3.20e-1)"	"unprognostic (2.93e-2)"	"unprognostic (1.47e-1)"	"unprognostic (1.27e-1)"	"unprognostic (3.34e-2)"	"unprognostic (2.11e-1)"	"unprognostic (1.15e-1)"	"unprognostic (2.09e-1)"	"unprognostic (6.58e-2)"	13.6	33.3	24.2	11.2	26.2	7.4	14.7	19.2	33.7	16.7	22.6	26.1	15.3	32.6	15.7	26.8	17.1	20.7	13.4	28.8	22.7	22.2	22.5	30.2	10.6	16.2	28.1	28.3	23.2	34.2	24.7	15.0	11.4	37.4	20.6	23.1	18.3	18.6	17.9	33.3	11.7	27.4	16.4	21.7	14.7	14.3	23.5	17.7	16.4	17.1	15.0	16.6	15.6	11.7	12.8	10.2	2.4	7.4	17.7	27.1	12.9	10.6	14.7	12.2	13.8	28.0	13.6	10.7	9.2	15.0	15.8	22.1	14.5	14.1	15.1	20.0	13.4	12.6	26.6	24.2	26.7	15.0	11.5	30.3	27.1	14.0	15.6	19.9	12.5	8.0	18.1	6.9	14.8	26.7	24.0	21.4	18.2	9.0	12.4	20.3	9.1	13.3	5.5	6.7	16.1	12.6	13.7	11.5	37.0	18.5	12.1	22.9	10.0	10.7	19.4	11.5	18.7	26.5	8.6	9.6	9.5	8.1	7.0	8.9	30.8	18.2	9.9	19.8	18.1	6.9	0.7	7.2	2.4	13.5	7.4	17.5	12.8	18.3	15.4	10.2	12.5	27.1	19.7	1.1	17.7	6.3	8.5	22.7	12.9	24.2	26.2	19.2	33.7	22.7	22.2	28.1	28.3	37.4	17.7	6.0	15.9	13.7	6.7	1.6	21.7	47.5	10.2	5.3	7.9	14.0	3.9	26.1	13.3	15.5	13.7	8.7	34.2	0.0	7.5	9.1	12.2	5.4	15.0	15.8	20.6	33.4	10.4	6.2	5.3	24.3	10.3	5.6	3.3	11.8	18.1	18.3	14.3	17.3	8.1	25.8	16.8	6.5	6.6	23.8	10.1	2.4	13.6	6.9	11.8	4.7
MPND	FLJ14981	ENSG00000008382	"MPN domain containing"	Q8N594	19	4343527-4360086	"Enzymes, Predicted intracellular proteins"		"Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"Enterocytes: 65.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043274, HPA045475"	Approved		Approved	"Nucleoplasm,Nucleoli rim"		No	No			"Nucleoli rim"	Nucleoplasm	"HPA043274: AB_2678403, HPA045475: AB_2679339"	"unprognostic (3.16e-2)"	"prognostic favorable (2.99e-4)"	"unprognostic (4.85e-2)"	"prognostic favorable (6.12e-4)"	"unprognostic (8.60e-2)"	"unprognostic (5.37e-3)"	"unprognostic (3.16e-2)"	"prognostic favorable (1.55e-4)"	"unprognostic (1.23e-1)"	"unprognostic (2.87e-2)"	"unprognostic (3.94e-3)"	"unprognostic (5.18e-2)"	"prognostic favorable (7.04e-4)"	"unprognostic (2.22e-3)"	"unprognostic (3.22e-1)"	"unprognostic (5.44e-2)"	"unprognostic (9.04e-2)"	7.7	13.7	18.9	14.1	12.3	11.5	8.0	12.1	21.6	6.5	19.9	6.6	15.7	25.9	8.5	7.8	13.8	8.2	11.8	12.1	14.2	11.3	12.8	25.1	14.3	8.5	12.7	20.0	8.7	20.7	14.5	7.2	7.0	11.9	12.1	13.9	11.5	14.3	9.0	17.4	12.5	20.7	9.3	8.9	10.1	12.5	4.2	6.7	13.5	8.6	8.3	10.1	9.3	11.0	3.1	4.5	10.3	6.0	2.4	5.6	1.9	7.9	6.7	11.1	12.7	7.0	3.3	11.3	3.9	3.8	3.2	4.0	12.9	4.1	7.2	12.2	5.0	9.5	8.2	5.0	6.7	1.8	8.1	11.3	5.5	9.5	20.9	5.6	7.4	10.0	5.0	4.9	3.5	3.7	5.0	9.9	19.2	2.9	18.8	4.0	23.0	17.4	6.3	5.1	13.5	9.7	14.3	3.4	10.4	8.2	14.1	12.4	12.7	7.1	10.0	5.3	6.6	6.7	9.1	3.7	5.2	5.6	31.4	7.7	15.7	9.6	4.8	5.7	4.1	5.9	10.3	5.1	2.4	2.2	6.0	3.4	1.8	2.6	3.1	4.5	3.1	1.7	1.9	1.2	2.4	2.7	4.5	5.6	1.9	18.9	12.3	12.1	21.6	14.2	11.3	12.7	20.0	11.9	6.7	0.0	3.0	4.5	6.6	4.7	7.2	11.5	10.2	1.4	3.4	10.4	2.0	11.3	0.0	4.3	0.5	4.9	65.9	0.0	4.4	9.3	3.9	9.1	4.6	21.2	13.6	6.4	16.0	6.7	23.8	2.2	5.8	10.2	3.3	6.4	27.9	3.9	4.9	32.5	3.5	11.4	3.4	6.5	5.1	0.0	5.3	7.3	8.7	5.3	28.8	7.1
MPO		ENSG00000005381	Myeloperoxidase	P05164	17	58269856-58280935	"Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Hydrogen peroxide"	"Oxidoreductase, Peroxidase"	"Cancer-related genes, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	15	"bone marrow: 315.2"	"Cell type enhanced"	"Detected in some"	11	"Distal tubular cells: 1.7;Kupffer cells: 1.2"	"Cancer enhanced"	"Detected in single"		"stomach cancer: 1.1"	"Low region specificity"	"Detected in single"			"Group enriched"	"Detected in some"	5	"classical monocyte: 7.6;intermediate monocyte: 3.8;myeloid DC: 3.2;neutrophil: 2.0"	"Group enriched"	"Detected in many"	30	"dendritic cells: 3.2;granulocytes: 2.0;monocytes: 7.6"	"Group enriched"	"Detected in some"	93	"HL-60: 218.1;NB-4: 285.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"CAB000059, HPA021147, HPA061464"	Enhanced		Supported	Nucleoplasm,Vesicles	"Intracellular and membrane"	No	NA	576000000	15000000	Vesicles	Nucleoplasm	"CAB000059: AB_2335676, HPA021147: AB_1854083, HPA061464: AB_2684531"	"unprognostic (1.91e-1)"	"unprognostic (9.08e-2)"	"unprognostic (4.62e-2)"	"unprognostic (2.90e-2)"	"unprognostic (2.13e-3)"	"unprognostic (2.78e-1)"	"unprognostic (3.23e-1)"	"unprognostic (2.91e-1)"	"unprognostic (2.56e-1)"	"unprognostic (1.68e-1)"	"unprognostic (6.92e-2)"	"unprognostic (8.34e-3)"	"unprognostic (4.91e-2)"	"unprognostic (3.07e-3)"	"unprognostic (2.83e-1)"	"unprognostic (1.14e-2)"	"unprognostic (8.05e-2)"	0.2	0.1	0.5	0.1	0.8	315.2	0.1	0.4	1.0	0.1	0.1	1.4	0.0	0.1	0.2	0.2	0.1	0.1	0.1	21.5	0.6	0.8	0.1	1.4	6.9	0.8	0.6	0.0	0.6	0.1	0.1	1.0	2.9	0.4	0.2	0.1	0.2	6.3	0.1	0.7	0.5	0.1	0.1	0.4	17.8	0.1	0.4	0.2	19.7	0.6	0.0	0.5	0.1	0.0	0.0	3.2	2.0	7.6	0.0	0.1	7.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	218.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	285.8	0.0	0.0	0.0	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	7.6	0.0	0.0	3.8	0.0	0.0	0.0	0.1	3.2	0.0	0.0	0.0	2.0	0.0	0.8	0.0	0.1	7.2	0.5	0.8	0.4	1.0	0.6	0.8	0.6	0.0	0.4	0.2	0.0	0.3	0.0	0.0	0.0	0.4	0.3	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.4	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.6	1.2	0.9	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0
MPST	"MST, TST2, TUM1"	ENSG00000128309	"Mercaptopyruvate sulfurtransferase"	P25325	22	37019635-37029822	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 106.2"	"Cell type enhanced"	"Detected in many"	7	"Enterocytes: 780.2;Hepatocytes: 473.7;Paneth cells: 550.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA001240	Enhanced		Approved	Mitochondria,Cytosol		NA	NA		2800000	Mitochondria	Cytosol	"HPA001240: AB_1079408"	"unprognostic (7.18e-3)"	"unprognostic (4.45e-1)"	"unprognostic (1.80e-1)"	"unprognostic (1.30e-3)"	"unprognostic (1.73e-3)"	"unprognostic (1.43e-1)"	"unprognostic (7.07e-2)"	"unprognostic (2.15e-1)"	"unprognostic (2.22e-1)"	"unprognostic (1.35e-1)"	"unprognostic (2.25e-1)"	"unprognostic (1.58e-1)"	"unprognostic (3.15e-3)"	"unprognostic (3.98e-2)"	"unprognostic (3.51e-1)"	"unprognostic (2.52e-1)"	"prognostic favorable (5.89e-4)"	8.7	7.2	4.5	6.8	6.4	10.5	22.7	2.6	5.4	8.8	39.1	8.0	2.8	36.8	6.1	3.0	19.8	4.3	15.3	14.1	4.6	2.3	14.1	106.2	10.3	5.4	8.8	3.8	12.6	20.7	0.7	2.7	4.2	5.6	6.6	5.7	3.8	13.4	3.9	11.5	15.9	33.7	4.8	4.8	4.1	12.8	24.9	7.1	2.1	6.3	6.2	5.1	8.7	11.6	9.6	37.1	18.5	26.5	28.8	16.1	12.5	14.3	17.0	8.3	17.1	9.8	6.1	13.2	7.8	7.1	8.6	11.5	16.2	6.4	22.6	11.4	5.6	5.7	10.1	7.2	11.4	1.2	13.6	40.3	8.7	7.4	38.0	31.0	9.4	12.2	10.6	22.2	5.6	5.2	7.9	17.3	11.2	15.5	6.6	2.3	11.1	0.8	32.0	15.7	18.8	17.7	24.3	9.9	16.8	8.6	4.7	4.2	32.0	5.2	8.3	14.9	4.4	8.9	15.2	13.3	7.4	21.0	8.1	5.3	11.6	5.3	6.8	2.6	11.5	3.7	15.3	26.5	18.5	11.8	9.4	16.1	9.6	7.7	9.9	37.1	9.6	1.1	4.1	7.9	28.8	4.3	6.0	15.2	12.5	4.5	6.4	2.6	5.4	4.6	2.3	8.8	3.8	5.6	7.1	32.8	55.2	24.6	70.3	72.5	4.6	26.6	188.5	1.4	19.4	57.6	0.0	50.1	112.7	124.1	138.8	35.9	780.2	116.8	129.7	102.0	53.0	67.5	17.3	473.7	65.5	3.2	104.3	84.7	67.1	60.3	84.3	59.9	55.6	57.7	299.4	16.4	119.7	550.6	79.5	318.0	2.6	45.3	28.3	7.9	12.0	133.6	41.9	42.6	311.7	103.6
MRI1	"MGC3207, MRDI, mtnA, Ypr118w"	ENSG00000037757	"Methylthioribose-1-phosphate isomerase 1"	Q9BV20	19	13764532-13774282	"Enzymes, Predicted intracellular proteins"	"Amino-acid biosynthesis, Methionine biosynthesis"	Isomerase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042744, CAB045988"	Approved		Supported	"Nucleoplasm,Nucleoli fibrillar center,Cytosol"		No	No		2600000	"Nucleoplasm, Cytosol"	"Nucleoli fibrillar center"	"CAB045988: AB_2145566, HPA042744: AB_2678141"	"unprognostic (1.16e-1)"	"unprognostic (1.20e-1)"	"unprognostic (2.14e-1)"	"unprognostic (7.36e-2)"	"unprognostic (4.14e-2)"	"unprognostic (1.05e-1)"	"unprognostic (3.24e-1)"	"unprognostic (1.57e-2)"	"unprognostic (4.27e-3)"	"unprognostic (1.61e-1)"	"unprognostic (8.98e-2)"	"unprognostic (1.50e-3)"	"unprognostic (1.75e-2)"	"unprognostic (1.18e-2)"	"unprognostic (1.67e-1)"	"unprognostic (1.77e-1)"	"unprognostic (1.28e-1)"	14.5	18.5	12.5	21.8	18.3	16.6	16.8	24.5	21.8	21.5	17.2	23.6	23.5	19.0	24.2	21.3	20.7	19.9	17.6	13.5	14.6	12.1	24.4	20.1	15.4	19.5	16.5	14.3	24.0	20.5	21.3	17.3	24.2	17.2	17.8	13.4	18.5	23.4	21.6	13.0	28.6	18.5	13.3	16.6	22.0	19.8	5.0	16.7	20.0	21.8	10.5	18.2	18.1	20.6	5.7	8.9	6.9	5.8	5.0	6.6	3.6	10.7	8.0	4.0	9.6	4.4	8.2	9.8	12.8	7.4	11.6	10.6	8.4	8.6	5.8	5.1	4.7	5.5	18.1	18.6	13.2	7.1	10.1	32.2	4.6	12.7	9.0	3.9	13.9	10.8	8.2	7.3	5.9	4.7	10.5	10.7	5.7	8.8	0.3	5.0	15.8	15.4	8.9	6.6	3.9	22.9	14.5	5.4	13.1	5.9	8.4	8.0	7.2	4.6	10.5	10.0	5.6	8.2	5.1	6.5	6.0	5.5	21.2	6.2	7.9	8.3	1.7	5.1	16.1	7.1	6.9	5.5	1.9	6.2	5.8	6.0	5.0	5.3	6.6	4.7	5.7	4.3	3.3	4.1	5.0	3.2	8.9	4.8	3.6	12.5	18.3	24.5	21.8	14.6	12.1	16.5	14.3	17.2	16.7	8.9	16.6	10.8	9.0	9.8	3.1	0.8	5.1	20.1	14.8	15.7	7.9	10.1	5.0	8.2	0.6	6.0	9.1	0.0	11.0	7.7	8.5	6.0	12.7	9.0	6.3	1.6	8.7	12.3	8.9	1.4	16.1	8.5	1.7	6.4	9.4	3.3	5.8	11.0	14.2	8.1	6.3	25.8	5.5	0.4	3.9	9.9	4.5	14.4	9.1	8.0
MRPL58	"DS-1, ICT1"	ENSG00000167862	"Mitochondrial ribosomal protein L58"	Q14197	17	75012670-75021261	"Enzymes, Predicted intracellular proteins, Ribosomal proteins"	"Protein biosynthesis"	"Hydrolase, Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	9	"Cytotrophoblasts: 56.1;Distal tubular cells: 48.0;Exocrine glandular cells: 52.2;Proximal tubular cells: 104.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003634	Approved		Approved	Nucleoplasm,Mitochondria		NA	NA			"Nucleoplasm, Mitochondria"		"HPA003634: AB_1851388"	"unprognostic (2.04e-1)"	"unprognostic (1.57e-2)"	"unprognostic (1.94e-3)"	"unprognostic (7.12e-2)"	"unprognostic (3.16e-2)"	"unprognostic (4.35e-2)"	"unprognostic (1.38e-3)"	"unprognostic (1.52e-1)"	"unprognostic (2.57e-1)"	"unprognostic (3.79e-3)"	"unprognostic (4.98e-2)"	"unprognostic (2.43e-2)"	"prognostic unfavorable (2.09e-4)"	"unprognostic (1.10e-1)"	"unprognostic (1.12e-1)"	"unprognostic (2.66e-2)"	"unprognostic (1.71e-1)"	12.4	23.4	13.9	18.4	14.8	13.7	17.6	18.1	15.7	10.6	15.2	9.8	17.5	13.1	12.5	15.1	19.4	12.5	16.3	31.2	12.2	12.0	25.7	41.7	10.2	15.2	14.3	14.0	10.5	24.2	13.5	9.1	13.9	14.0	13.6	16.3	10.1	17.7	22.5	57.3	16.5	13.4	14.8	12.9	14.6	15.1	7.6	14.0	13.2	14.8	31.2	15.7	14.3	11.6	18.3	28.9	11.2	22.0	20.0	33.5	20.9	26.1	36.9	12.3	14.1	13.3	13.2	17.2	15.5	16.9	32.4	27.6	28.3	16.5	18.2	12.8	15.4	20.0	18.7	25.2	26.7	34.3	9.3	29.9	14.3	17.5	23.5	25.1	29.8	9.8	14.2	12.8	21.5	34.5	11.0	24.6	18.9	23.0	13.3	18.3	32.7	25.7	20.5	9.3	40.8	50.0	13.3	21.9	26.5	23.8	19.4	11.5	22.0	13.4	24.5	30.1	16.5	32.8	24.6	10.4	17.5	19.2	18.4	29.2	13.9	11.0	20.1	20.0	33.4	14.4	11.2	22.0	10.5	17.3	20.7	14.9	18.3	21.1	17.2	28.9	14.8	15.7	17.6	2.0	20.0	17.4	19.4	33.5	20.9	13.9	14.8	18.1	15.7	12.2	12.0	14.3	14.0	14.0	14.0	29.8	8.3	0.0	0.0	0.0	0.0	0.0	0.0	38.8	14.8	24.4	0.0	56.1	48.0	41.8	0.0	0.0	0.0	0.0	52.2	30.7	0.0	0.0	1.1	0.0	42.2	0.0	0.0	0.0	0.0	0.0	0.0	6.5	0.0	26.2	0.0	0.0	44.8	0.0	0.0	104.5	0.0	0.0	0.0	0.0	0.0	0.0	24.4	0.0	0.0	0.0
MSMO1	"DESP4, ERG25, SC4MOL"	ENSG00000052802	"Methylsterol monooxygenase 1"	Q15800	4	165327623-165343160	"Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins"	"Cholesterol biosynthesis, Cholesterol metabolism, Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis, Steroid metabolism, Sterol biosynthesis, Sterol metabolism"	Oxidoreductase	"Cataract, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 171.6"	"Cell type enhanced"	"Detected in many"	5	"Hepatocytes: 234.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"GAMG: 69.5;Karpas-707: 68.2;RPTEC TERT1: 65.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA056127	Enhanced					NA	NA					"HPA056127: AB_2683045"	"unprognostic (5.76e-2)"	"prognostic unfavorable (2.97e-4)"	"unprognostic (3.35e-2)"	"unprognostic (7.85e-2)"	"unprognostic (1.74e-1)"	"unprognostic (1.20e-2)"	"unprognostic (7.14e-2)"	"unprognostic (1.75e-2)"	"unprognostic (3.52e-2)"	"unprognostic (2.06e-1)"	"unprognostic (3.22e-3)"	"unprognostic (2.28e-1)"	"prognostic favorable (9.21e-4)"	"unprognostic (2.39e-1)"	"unprognostic (1.56e-2)"	"unprognostic (3.54e-1)"	"unprognostic (1.40e-1)"	5.0	26.5	17.1	6.7	23.7	3.5	21.5	7.7	29.6	15.6	12.6	22.8	4.0	22.6	6.1	31.5	44.9	7.1	7.4	5.8	18.8	20.8	16.3	171.6	30.0	6.4	13.1	18.6	18.0	7.5	10.9	7.0	7.4	41.1	19.1	10.8	12.1	10.6	4.7	2.2	22.5	20.7	5.7	33.5	4.3	10.3	15.8	12.5	4.3	7.5	17.6	12.9	8.6	17.7	21.2	10.1	6.2	9.8	12.1	20.8	15.8	14.0	3.4	33.1	6.0	16.4	52.8	6.2	5.7	25.9	7.4	20.5	6.6	60.4	7.0	3.4	6.9	69.5	11.6	16.6	59.9	8.2	5.9	10.2	3.1	3.6	20.3	33.1	5.6	4.4	32.6	39.4	27.1	16.8	10.1	9.5	9.1	5.5	68.2	12.1	7.2	5.0	9.2	19.0	7.4	3.4	2.6	3.6	21.0	65.8	16.5	6.6	4.9	8.9	12.7	5.3	21.2	5.9	7.1	10.9	3.4	6.1	3.0	3.9	12.6	13.2	9.2	7.3	5.7	4.6	6.2	4.6	4.5	19.0	5.9	14.2	21.2	18.3	17.6	7.8	18.9	20.0	20.8	3.4	12.1	9.8	10.1	15.8	15.8	17.1	23.7	7.7	29.6	18.8	20.8	13.1	18.6	41.1	12.5	47.6	144.4	35.8	51.9	32.1	27.2	5.8	45.9	68.3	60.3	66.3	25.5	47.4	29.9	52.5	2.8	17.5	70.9	0.0	62.6	72.4	27.9	84.9	48.3	234.0	24.0	33.4	58.1	29.4	29.7	4.5	23.0	15.0	30.4	36.1	42.1	22.3	58.7	24.6	17.7	36.0	46.7	19.4	20.2	7.4	14.4	100.6	102.9	22.4	21.1	123.4
MSRA		ENSG00000175806	"Methionine sulfoxide reductase A"	Q9UJ68	8	10054268-10428891	"Enzymes, Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 78.4"	"Cell type enriched"	"Detected in many"	6	"Proximal tubular cells: 597.4"	"Low cancer specificity"	"Detected in all"			"Region enriched"	"Detected in all"	6	"cerebellum: 78.4"	"Cell type enhanced"	"Detected in many"		"eosinophil: 9.0"	"Group enriched"	"Detected in many"	4	"dendritic cells: 2.3;granulocytes: 9.0;monocytes: 3.2"	"Cell line enhanced"	"Detected in many"		"HMC-1: 15.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023804, HPA075766"	Approved		Supported	"Nucleoplasm,Plasma membrane,Actin filaments,Cytosol"	"Intracellular and membrane"	No	No		25000	"Nucleoplasm, Plasma membrane, Cytosol"	"Actin filaments"	"HPA023804: AB_1853826, HPA075766: "	"unprognostic (1.55e-1)"	"unprognostic (4.30e-3)"	"unprognostic (1.45e-3)"	"unprognostic (1.00e-2)"	"unprognostic (4.21e-2)"	"unprognostic (1.62e-2)"	"unprognostic (1.49e-2)"	"unprognostic (6.40e-2)"	"unprognostic (9.69e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.80e-1)"	"unprognostic (4.58e-2)"	"unprognostic (1.07e-3)"	"unprognostic (6.43e-3)"	"unprognostic (4.02e-1)"	"unprognostic (6.36e-3)"	"unprognostic (3.07e-1)"	7.0	8.1	8.0	5.2	7.5	36.1	5.9	78.4	13.7	3.6	5.9	4.3	2.2	5.9	4.8	3.7	5.5	4.2	4.4	8.5	8.9	5.5	32.4	22.9	5.7	6.8	6.8	9.5	4.2	10.2	2.9	3.4	4.6	8.1	3.4	4.0	3.9	6.0	5.0	4.7	3.8	12.7	4.9	6.7	7.2	4.9	8.5	5.5	3.5	4.4	2.6	3.8	3.9	2.7	1.1	2.3	9.0	3.2	1.1	0.8	0.3	0.1	1.1	1.8	5.4	1.6	1.8	0.6	3.3	0.7	0.5	2.2	0.7	2.7	0.0	0.8	3.0	7.2	2.9	0.5	0.2	1.7	0.4	0.0	0.5	1.7	2.5	5.3	1.0	15.2	0.5	3.9	0.4	0.0	1.8	0.9	0.3	0.5	0.3	5.9	0.2	0.0	0.3	0.8	3.9	1.0	1.8	1.7	2.3	1.3	1.3	3.1	2.0	5.4	0.2	0.7	0.6	2.8	3.3	3.2	2.2	2.6	0.5	1.6	0.2	0.1	0.9	5.9	1.0	4.1	0.8	3.2	9.0	0.7	2.2	0.6	1.1	0.8	0.5	2.3	0.4	0.6	0.5	3.8	1.1	1.6	0.3	0.5	0.3	8.0	7.5	78.4	13.7	8.9	5.5	6.8	9.5	8.1	5.5	0.0	9.0	10.0	24.1	14.5	10.7	18.1	17.8	5.3	4.5	24.4	29.5	5.8	77.9	27.0	64.1	26.4	29.0	0.0	41.4	4.5	11.3	16.9	81.6	82.9	42.3	15.9	9.2	16.5	31.0	107.2	8.6	33.1	28.7	14.4	19.7	13.4	40.7	28.8	9.2	597.4	5.8	12.9	17.6	27.7	18.8	12.3	7.0	15.3	17.4	28.6
MSRB1	"SelR, SelX, SepR, SEPX1"	ENSG00000198736	"Methionine sulfoxide reductase B1"	Q9NZV6	16	1938210-1943326	"Enzymes, Predicted intracellular proteins"	"Immunity, Innate immunity"	Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	5	"blood: 195.6;liver: 94.8;pancreas: 107.2"	"Cell type enhanced"	"Detected in many"	6	"Hepatocytes: 236.4;monocytes: 165.9;Proximal tubular cells: 237.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	5	"eosinophil: 85.8;neutrophil: 195.6"	"Lineage enriched"	"Detected in all"	7	"granulocytes: 195.6"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB008650, HPA043463, HPA069557"	Enhanced		Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"CAB008650: AB_1619225, HPA043463: AB_2678489, HPA069557: AB_2686153"	"unprognostic (3.93e-2)"	"unprognostic (3.68e-1)"	"unprognostic (1.32e-1)"	"unprognostic (9.61e-2)"	"unprognostic (1.76e-2)"	"unprognostic (1.15e-1)"	"unprognostic (2.19e-1)"	"unprognostic (1.49e-1)"	"unprognostic (2.88e-2)"	"unprognostic (4.90e-2)"	"unprognostic (5.29e-2)"	"unprognostic (3.60e-1)"	"unprognostic (4.27e-2)"	"unprognostic (8.46e-2)"	"unprognostic (4.92e-2)"	"unprognostic (7.31e-2)"	"unprognostic (4.59e-3)"	7.9	4.0	5.2	9.0	6.3	27.3	5.1	3.2	6.1	5.2	13.1	5.6	7.5	8.7	7.9	13.5	16.9	9.6	13.5	13.7	4.7	4.1	24.9	94.8	9.6	15.6	5.5	4.1	7.3	107.2	2.9	3.9	11.6	4.1	11.0	5.1	6.2	4.7	9.4	20.5	8.0	17.0	14.3	4.3	18.2	9.6	8.1	3.6	3.7	5.5	19.8	4.5	14.8	4.8	1.7	10.9	195.6	26.2	2.4	2.8	12.2	6.8	17.3	6.4	15.2	12.0	5.3	11.0	8.4	10.6	12.3	10.7	27.7	7.5	6.6	27.5	9.7	10.8	11.2	10.7	7.4	3.8	37.0	12.2	5.1	6.4	44.1	11.0	14.4	12.2	9.8	6.5	8.9	1.7	3.9	12.3	8.6	8.0	3.7	6.5	37.5	8.1	23.6	8.8	12.3	9.9	11.8	8.9	31.0	19.2	11.4	6.2	8.2	9.5	10.6	5.1	4.3	11.5	25.5	7.3	3.7	10.4	7.4	4.9	9.8	15.5	12.6	3.9	13.6	6.5	26.0	26.2	85.8	2.2	12.0	2.1	1.7	1.8	1.8	10.9	1.7	1.4	1.6	195.6	2.4	10.7	4.6	2.8	12.2	5.2	6.3	3.2	6.1	4.7	4.1	5.5	4.1	4.1	3.6	8.9	14.9	11.5	10.5	5.8	6.0	32.4	38.2	20.1	3.4	31.4	3.9	30.0	79.6	56.2	3.3	12.0	75.5	23.3	97.0	102.6	13.1	12.7	4.6	236.4	55.0	7.9	57.8	19.0	79.6	10.4	8.6	26.2	15.1	165.9	31.9	17.1	66.7	63.3	21.5	237.9	3.0	0.0	19.8	35.7	9.1	8.3	32.3	20.3	27.8	18.7
MSRB2	"CBS-1, CBS1, CGI-131, MSRB, PILB"	ENSG00000148450	"Methionine sulfoxide reductase B2"	Q9Y3D2	10	23095506-23122013	"Enzymes, Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 72.3"	"Cell type enhanced"	"Detected in many"	6	"Cardiomyocytes: 249.2;Proximal tubular cells: 323.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"							HPA027933	Enhanced				"Intracellular and membrane"	NA	NA					"HPA027933: AB_10601867"	"unprognostic (4.89e-2)"	"unprognostic (2.76e-2)"	"unprognostic (7.14e-3)"	"unprognostic (3.47e-3)"	"unprognostic (4.51e-1)"	"unprognostic (9.26e-3)"	"unprognostic (1.62e-1)"	"unprognostic (1.09e-1)"	"unprognostic (1.80e-1)"	"unprognostic (6.07e-3)"	"unprognostic (3.47e-2)"	"unprognostic (1.08e-2)"	"unprognostic (2.03e-1)"	"unprognostic (1.82e-2)"	"unprognostic (6.74e-2)"	"unprognostic (1.11e-1)"	"unprognostic (2.01e-1)"	13.2	11.6	16.4	6.8	16.2	6.0	9.9	6.5	11.4	10.7	14.4	8.0	14.3	8.2	10.6	15.2	14.1	10.5	15.8	72.3	13.9	14.5	16.0	25.7	7.9	6.3	14.2	8.2	11.3	7.0	11.5	9.4	12.4	9.3	16.3	10.2	10.6	7.7	18.0	31.5	3.6	13.5	25.1	10.8	8.2	7.5	5.6	6.1	6.0	16.7	11.0	5.5	19.0	10.3	0.4	3.1	6.7	2.6	0.3	1.3	0.5	4.0	5.9	11.0	6.6	11.4	10.3	3.3	6.5	3.6	4.2	4.8	4.0	8.9	3.3	5.8	13.8	6.3	2.6	3.6	4.8	3.5	22.2	4.0	2.4	9.8	2.2	16.1	0.5	2.9	13.1	8.2	4.9	1.2	9.2	5.9	6.5	3.2	5.9	9.1	12.1	3.8	3.0	6.0	23.0	3.4	4.5	6.3	0.8	5.2	1.5	2.2	15.1	8.0	7.1	13.1	9.6	4.8	9.5	4.3	3.6	3.4	8.1	3.8	7.7	2.4	0.1	5.2	7.1	3.0	1.6	2.6	4.1	0.7	2.1	0.6	0.4	0.7	0.5	1.6	0.1	1.3	0.9	6.7	0.3	1.5	3.1	0.7	0.5	16.4	16.2	6.5	11.4	13.9	14.5	14.2	8.2	9.3	6.1	0.0	16.0	12.3	46.9	16.3	63.8	249.2	76.5	14.7	6.8	85.5	21.6	88.5	149.2	108.6	0.9	27.2	64.2	0.0	56.2	49.9	58.5	35.8	29.9	158.3	94.8	106.5	53.5	38.6	53.9	3.3	46.1	29.8	69.2	18.0	46.4	85.9	76.4	76.4	58.7	323.7	43.6	58.2	52.8	1.1	5.4	15.3	58.2	10.7	59.3	40.6
MSRB3	"DFNB74, DKFZp686C1178, FLJ36866"	ENSG00000174099	"Methionine sulfoxide reductase B3"	Q8IXL7	12	65278643-65491430	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		Oxidoreductase	"Deafness, Disease mutation, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"smooth muscle: 75.9"	"Cell type enriched"	"Detected in many"	16	"Cardiomyocytes: 2030.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"eosinophil: 23.4"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"fHDF/TERT166: 37.2;hTERT-RPE1: 33.8;U-937: 31.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA014432	Enhanced				"Intracellular and membrane"	NA	NA					"HPA014432: AB_1854146"	"unprognostic (1.40e-2)"	"prognostic unfavorable (3.84e-4)"	"unprognostic (2.86e-3)"	"unprognostic (1.94e-1)"	"unprognostic (2.74e-2)"	"unprognostic (1.74e-2)"	"unprognostic (2.63e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.84e-2)"	"unprognostic (5.33e-2)"	"unprognostic (8.28e-2)"	"unprognostic (2.10e-1)"	"prognostic unfavorable (8.85e-8)"	"unprognostic (3.29e-3)"	"unprognostic (7.80e-2)"	"unprognostic (2.08e-2)"	"prognostic unfavorable (2.17e-4)"	15.2	3.8	4.5	11.6	5.3	6.4	26.8	5.1	5.2	19.0	39.4	3.6	20.4	4.0	40.3	15.0	23.0	16.1	23.4	30.9	4.8	4.3	4.1	1.4	11.7	4.4	5.0	5.0	13.3	2.5	0.8	3.1	8.7	4.7	19.8	10.2	11.8	4.7	38.4	32.2	3.8	10.0	75.9	5.0	6.5	17.2	6.1	4.8	0.4	6.0	11.2	2.5	33.9	20.9	0.2	6.5	23.4	0.6	4.4	0.1	0.8	2.5	5.6	4.9	22.8	22.2	19.7	0.1	25.8	27.8	10.1	6.1	0.2	0.3	0.0	5.6	37.2	3.2	0.5	2.3	6.5	9.2	0.0	4.7	0.0	5.0	0.2	14.5	13.5	0.1	10.3	3.6	8.5	11.9	33.8	20.4	0.0	0.1	0.1	23.0	0.8	0.0	3.1	1.6	0.0	3.1	0.0	6.7	0.1	2.3	0.3	0.1	2.4	8.9	0.5	6.3	5.3	4.2	13.0	23.4	12.9	7.0	5.8	10.0	2.4	1.8	0.0	3.5	31.3	8.0	6.3	0.3	23.4	0.1	0.6	0.1	0.1	0.0	0.0	0.1	0.2	0.1	0.1	4.0	4.4	0.2	6.5	0.0	0.8	4.5	5.3	5.1	5.2	4.8	4.3	5.0	5.0	4.7	4.8	11.9	4.3	0.5	13.0	5.7	20.7	2030.9	7.6	10.7	1.2	3.5	0.0	0.4	0.0	8.7	4.5	40.9	0.0	0.0	0.8	0.3	27.9	2.8	2.3	0.0	0.5	20.6	0.0	23.4	0.0	1.3	11.5	3.9	10.1	1.0	0.0	36.4	1.5	0.0	109.6	0.3	10.3	103.5	126.0	4.1	1.4	4.0	0.6	0.0	0.0	2.6
MST1R	"CD136, CDw136, PTK8, RON"	ENSG00000164078	"Macrophage stimulating 1 receptor"	Q04912	3	49887002-49903873	"CD markers, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Immunity, Innate immunity"	"Kinase, Receptor, Transferase, Tyrosine-protein kinase"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"gallbladder: 27.7;intestine: 34.3;skin 1: 28.7"	"Cell type enhanced"	"Detected in many"	7	"Alveolar cells type 1: 23.8;Enterocytes: 29.1;Mucus-secreting cells: 21.5;Pancreatic endocrine cells: 19.7;Paneth cells: 20.4"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"MAIT T-cell: 2.1"	"Lineage enhanced"	"Detected in single"		"T-cells: 2.1"	"Cell line enhanced"	"Detected in some"		"CAPAN-2: 35.9;HaCaT: 19.8;HBEC3-KT: 21.6;hTCEpi: 30.3;RT4: 23.1"	"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			"HPA007657, HPA008180, CAB008972"	Enhanced		Approved	Cytosol		NA	NA			Cytosol		"CAB008972: , HPA007657: AB_1079292, HPA008180: AB_1079291"	"unprognostic (3.84e-3)"	"unprognostic (3.86e-1)"	"unprognostic (1.92e-1)"	"unprognostic (7.33e-3)"	"unprognostic (3.82e-2)"	"unprognostic (2.32e-1)"	"unprognostic (8.07e-3)"	"unprognostic (1.54e-2)"	"unprognostic (4.12e-2)"	"unprognostic (2.15e-1)"	"unprognostic (1.24e-3)"	"unprognostic (2.28e-1)"	"unprognostic (8.08e-3)"	"unprognostic (2.38e-1)"	"unprognostic (2.18e-1)"	"unprognostic (8.00e-3)"	"prognostic favorable (2.33e-5)"	1.7	0.1	0.4	7.5	0.6	0.0	2.4	0.5	0.7	1.8	20.5	0.7	2.0	11.2	1.2	1.3	6.1	0.6	27.7	0.9	0.5	0.1	1.4	0.4	5.0	1.1	0.4	0.6	0.5	4.1	0.0	1.3	0.8	0.9	1.7	9.7	2.5	2.1	0.4	0.5	28.7	34.3	0.7	0.4	0.6	19.1	1.9	0.4	7.7	1.3	6.0	4.5	4.3	3.5	0.2	0.0	0.0	0.0	0.6	2.1	0.0	12.9	5.0	0.0	0.2	0.0	0.0	0.8	0.1	0.0	0.0	0.0	1.2	35.9	0.5	3.1	0.2	0.0	19.8	0.0	21.6	0.0	0.3	0.3	0.0	8.5	0.3	0.3	0.0	0.4	0.1	30.3	0.1	4.3	0.1	0.0	0.0	0.2	0.1	0.0	1.8	0.0	0.0	0.1	11.6	10.5	0.9	0.0	0.3	13.3	23.1	0.3	0.0	3.6	8.4	0.0	0.0	6.6	0.3	0.1	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.6	0.0	0.0	0.9	0.0	0.4	0.6	0.5	0.7	0.5	0.1	0.4	0.6	0.9	0.4	23.8	10.1	0.0	2.2	7.8	0.0	1.2	0.0	2.7	9.1	0.0	0.0	0.1	0.0	5.2	13.7	0.0	29.1	0.0	8.7	0.4	0.4	1.7	0.0	0.0	0.1	0.0	4.1	0.0	0.0	7.9	0.3	0.0	0.0	1.0	21.5	0.0	19.7	20.4	0.0	0.0	0.0	0.0	0.4	1.6	0.8	4.1	0.0	0.0	12.4	4.6
MT-CO1	"COI, COX1, MTCO1"	ENSG00000198804	"Mitochondrially encoded cytochrome c oxidase I"	P00395	MT	5904-7445	"Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins, Transporters"	"Electron transport, Respiratory chain, Transport"	Translocase	"Deafness, Disease mutation, Leber hereditary optic neuropathy, Non-syndromic deafness, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 396.5;heart muscle: 345.0;skeletal muscle: 380.7"	"Cell type enhanced"	"Detected in many"	6	"Cardiomyocytes: 81405.0;Enterocytes: 59874.1"	"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HeLa: 872.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB016241, HPA069328"	Enhanced		Supported	Mitochondria		NA	NA			Mitochondria		"CAB016241: AB_2229888, HPA069328: AB_2686122"	"unprognostic (4.39e-1)"	"unprognostic (2.45e-1)"	"unprognostic (1.39e-1)"	"unprognostic (2.21e-1)"	"unprognostic (1.59e-1)"	"unprognostic (3.31e-1)"	"prognostic favorable (2.29e-4)"	"unprognostic (8.28e-2)"	"unprognostic (1.01e-1)"	"unprognostic (5.56e-3)"	"unprognostic (1.20e-2)"	"unprognostic (6.60e-2)"	"unprognostic (2.83e-2)"	"unprognostic (5.06e-3)"	"unprognostic (4.50e-2)"	"unprognostic (2.15e-2)"	"unprognostic (2.44e-2)"	57.6	82.5	184.1	22.2	164.2	26.4	37.4	40.6	117.1	31.5	80.8			78.1	25.7	42.7	43.5	24.8	32.4	345.0	161.8	111.7	151.0	150.5	20.9	22.6	126.3		23.7	42.5	62.3	10.1	29.0		35.8	84.4		65.6	54.2	380.7	68.9	60.0	38.2	61.2	28.1	65.5	27.8			23.8		21.9	31.6	15.3	292.2	232.9	177.4	396.5	182.8	192.4	130.5	114.5	173.2	235.7	256.3	540.3	247.5	249.9	261.4	87.1	66.0	110.6	208.4	373.6	302.7	125.7	198.6	65.0	435.2	26.9	231.6	94.6	143.0	165.0	181.7	872.7	389.9	74.8	104.9	230.2	288.6	241.1	65.3	145.0	306.7	79.4	172.7	115.3	217.3	195.5	277.4	85.7	469.5	59.9	156.0	141.8	112.3	70.4	181.6	334.7	303.0	112.7	150.2	90.6	351.3	163.0	296.6	201.5	352.9	316.5	264.7	180.2	259.8	131.1	103.0	98.6	68.6	130.7	276.7	128.6	177.4	396.5	169.3	156.6	236.0	176.4	255.6	154.9	171.8	163.0	292.2	159.7	192.4	93.5	182.8	260.1	232.9	138.6	130.5											2694.8	3022.9	23660.6	9171.4	8678.3	0.0	81405.0	28094.1	4463.5	5243.5	18590.0	0.0	0.0	3606.0	6482.3	1224.4	4243.1	59874.1	34807.7	4485.9	0.0	3116.3	8181.6	3594.1	45857.2	0.0	0.0	7240.0	18002.1	27410.8	6497.0	10830.0	8032.7	6539.1	13021.9	32338.6	0.0	5722.6	29051.7	7980.9	24852.9	0.0	13394.3	6634.5	9840.4	12887.5	10030.7	0.0	18830.6	25753.2	17251.8
MT-ND1	"MTND1, NAD1, ND1"	ENSG00000198888	"Mitochondrially encoded NADH:ubiquinone oxidoreductase core subunit 1"	P03886	MT	3307-4262	"Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins"	"Electron transport, Respiratory chain, Transport"	Translocase	"Alzheimer disease, Amyloidosis, Diabetes mellitus, Disease mutation, Epilepsy, Leber hereditary optic neuropathy, MELAS syndrome, Neurodegeneration, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 314.4;skeletal muscle: 398.2"	"Cell type enriched"	"Detected in many"	5	"Cardiomyocytes: 72531.4"	"Low cancer specificity"	"Detected in all"							"Cell type enhanced"	"Detected in all"		"basophil: 314.4"	"Lineage enriched"	"Detected in all"	5	"granulocytes: 314.4"	"Cell line enhanced"	"Detected in all"		"HeLa: 673.1"	"Low region specificity"	"Detected in all"							"CAB033779, HPA066847"	Approved					NA	NA					"CAB033779: AB_2149736, HPA066847: "	"prognostic favorable (3.63e-4)"	"unprognostic (3.55e-1)"	"unprognostic (3.77e-2)"	"unprognostic (3.65e-1)"	"unprognostic (3.50e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.95e-3)"	"unprognostic (5.84e-2)"	"unprognostic (1.06e-1)"	"unprognostic (5.05e-2)"	"prognostic favorable (3.26e-4)"	"unprognostic (8.67e-2)"	"unprognostic (8.66e-2)"	"unprognostic (3.24e-2)"	"unprognostic (1.42e-2)"	"unprognostic (3.99e-2)"	"unprognostic (2.85e-2)"	83.5	48.0	118.0	15.2	136.1	17.7	31.8	45.0	85.9	19.6	58.3			40.2	16.3	43.4	30.7	16.7	17.6	223.1	106.1	74.3	96.0	104.7	20.5	12.1	101.8		14.2	48.2	35.1	14.3	32.2		26.6	58.6		71.2	48.4	398.2	75.4	33.3	24.6	55.2	16.7	45.0	29.8			13.8		17.1	19.9	9.4	60.8	32.2	314.4	54.4	35.8	46.4	19.5	101.9	104.3	85.6	77.9	325.0	59.2	110.1	88.0	26.0	24.4	25.8	181.3	111.3	125.2	56.0	66.3	24.8	68.2	9.4	53.0	49.0	89.2	73.5	139.3	673.1	257.0	69.8	65.9	137.7	140.2	144.8	37.8	54.6	99.7	26.2	36.7	64.0	78.3	72.4	140.2	53.0	273.1	22.9	64.3	78.6	55.9	38.9	67.2	135.5	165.5	35.6	56.7	48.8	78.1	85.3	108.9	69.7	228.7	137.9	81.8	73.9	104.2	73.1	86.9	53.5	58.0	55.0	116.9	22.3	314.4	54.4	103.0	25.7	31.4	37.3	54.3	30.8	34.0	20.6	60.8	41.1	46.4	157.8	35.8	32.0	32.2	22.0	19.5											1256.6	1138.7	6703.3	2831.5	2012.7	0.0	72531.4	10000.0	1801.4	2082.6	4374.0	0.0	0.0	875.4	1190.4	925.4	1519.1	10706.5	9881.7	3135.3	0.0	1058.8	2565.3	1330.0	13675.3	0.0	0.0	3018.7	7368.9	9328.1	4287.1	6527.3	2029.2	1420.6	1887.4	12938.3	0.0	1718.0	6638.7	3334.2	5210.0	0.0	6305.8	2437.5	5090.3	4626.8	1812.2	0.0	3284.5	11055.0	4223.0
MT-ND2	"MTND2, NAD2, ND2"	ENSG00000198763	"Mitochondrially encoded NADH:ubiquinone oxidoreductase core subunit 2"	P03891	MT	4470-5511	"Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins"	"Electron transport, Respiratory chain, Transport"	Translocase	"Alzheimer disease, Amyloidosis, Disease mutation, Leber hereditary optic neuropathy, Neurodegeneration, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 432.3"	"Cell type enhanced"	"Detected in many"	9	"Cardiomyocytes: 49093.4"	"Low cancer specificity"	"Detected in all"							"Cell type enriched"	"Detected in all"	5	"basophil: 432.3"	"Lineage enriched"	"Detected in all"	7	"granulocytes: 432.3"	"Cell line enhanced"	"Detected in all"		"HeLa: 612.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA						"unprognostic (5.82e-3)"	"unprognostic (1.58e-2)"	"unprognostic (1.53e-2)"	"unprognostic (1.36e-1)"	"unprognostic (4.77e-1)"	"unprognostic (4.79e-2)"	"unprognostic (9.56e-3)"	"unprognostic (3.74e-2)"	"unprognostic (2.18e-1)"	"unprognostic (3.38e-3)"	"unprognostic (4.55e-3)"	"unprognostic (3.79e-2)"	"unprognostic (4.35e-2)"	"unprognostic (3.94e-2)"	"unprognostic (2.11e-1)"	"unprognostic (5.92e-2)"	"unprognostic (4.35e-2)"	93.0	57.2	116.0	16.9	169.9	15.6	33.9	40.1	73.5	22.6	53.7			50.1	21.5	59.8	29.0	22.1	19.3	262.4	112.2	85.2	125.9	128.9	20.9	14.7	113.0		25.1	62.0	24.3	20.3	37.0		28.1	59.0		85.3	41.0	263.4	72.7	39.2	24.6	72.4	15.2	49.2	27.3			18.2		17.7	23.8	13.1	66.1	43.5	432.3	54.8	43.0	57.9	21.8	94.6	104.2	93.3	157.4	337.2	60.2	88.3	88.4	22.1	23.6	29.9	131.2	128.0	135.9	84.1	63.4	38.9	170.0	14.6	110.5	51.2	118.3	75.9	156.8	612.6	211.5	69.1	152.0	182.5	99.4	202.0	58.1	57.6	84.5	34.7	75.0	114.3	133.2	56.7	111.9	86.3	246.1	46.8	99.5	68.3	75.8	52.3	113.9	175.1	146.5	58.4	70.0	38.2	117.4	140.8	155.7	180.7	175.9	109.6	88.9	110.1	125.0	111.9	87.1	74.6	114.4	57.7	131.3	39.7	432.3	54.8	93.1	34.1	39.7	54.7	58.6	39.5	42.5	23.0	66.1	48.5	57.9	88.6	43.0	45.7	43.5	25.9	21.8											854.6	571.9	9056.6	6978.7	2368.7	0.0	49093.4	9352.8	2568.3	1610.6	5912.8	0.0	0.0	1531.9	1483.8	1182.4	1676.0	12590.8	16329.3	3187.2	0.0	1222.0	4063.7	1766.1	15003.8	0.0	0.0	3057.2	8326.4	10199.3	4945.8	8393.1	2380.5	1572.4	3231.9	13237.7	0.0	2288.2	10285.9	4266.6	9047.2	0.0	7166.1	2550.6	5515.5	4332.8	2146.6	0.0	6221.6	10985.9	6668.6
MT-ND3	"MTND3, NAD3, ND3"	ENSG00000198840	"Mitochondrially encoded NADH:ubiquinone oxidoreductase core subunit 3"	P03897	MT	10059-10404	"Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins"	"Electron transport, Respiratory chain, Transport"	Translocase	"Disease mutation, Leigh syndrome, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 357.8"	"Cell type enhanced"	"Detected in many"	7	"Cardiomyocytes: 33020.6;Erythroid cells: 20674.5"	"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"ASC diff: 644.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA063296	Enhanced		Uncertain	Cytosol		NA	NA			Cytosol		"HPA063296: AB_2684978"	"unprognostic (1.71e-2)"	"unprognostic (1.05e-1)"	"unprognostic (8.10e-2)"	"unprognostic (3.07e-1)"	"unprognostic (2.48e-1)"	"unprognostic (1.36e-1)"	"prognostic favorable (4.63e-5)"	"unprognostic (2.45e-2)"	"unprognostic (7.13e-2)"	"unprognostic (8.85e-2)"	"unprognostic (1.76e-3)"	"unprognostic (1.74e-1)"	"unprognostic (7.63e-2)"	"unprognostic (2.51e-2)"	"unprognostic (1.19e-1)"	"unprognostic (2.07e-1)"	"unprognostic (5.65e-3)"	102.1	73.9	117.3	17.6	137.2	17.9	59.3	33.7	70.5	31.2	76.3			64.0	25.9	49.2	21.7	24.7	19.7	256.8	110.3	81.7	138.1	145.8	19.7	17.4	92.0		27.5	77.8	14.6	22.2	34.6		39.1	59.1		67.6	50.7	357.8	42.2	48.9	28.4	66.8	19.1	60.6	21.0			25.0		20.3	24.2	15.9	84.8	32.6	159.6	48.5	48.6	75.3	24.4	85.5	139.7	93.3	91.5	644.7	129.2	77.7	72.1	42.4	39.1	44.3	210.2	133.3	89.1	111.9	92.5	70.8	178.3	40.1	157.5	67.3	127.7	192.1	87.6	465.1	346.0	100.6	129.0	132.7	223.4	292.0	65.5	73.9	233.9	60.8	102.4	69.0	104.2	73.7	279.5	67.7	172.2	47.9	245.4	129.3	58.7	91.7	82.0	237.9	236.2	38.5	83.7	34.8	69.8	142.5	254.3	161.5	208.4	103.2	60.5	91.9	105.1	77.0	40.5	53.1	192.1	49.1	78.4	34.2	159.6	48.5	36.6	36.7	36.4	49.8	73.1	42.6	44.8	32.6	84.8	63.1	75.3	100.7	48.6	32.7	32.3	27.6	24.4											652.1	738.1	6543.7	1904.3	1765.5	0.0	33020.6	8848.3	2785.1	1856.3	4782.3	0.0	0.0	986.5	1173.3	880.9	872.1	11850.5	20674.5	2500.6	0.0	790.1	1401.0	1375.6	14769.6	0.0	0.0	2746.0	8921.3	11655.5	4356.4	8457.2	1642.1	1763.0	2463.5	12873.7	0.0	1918.1	9893.1	4573.5	7467.5	0.0	6887.9	1962.1	6063.0	3539.9	1651.0	0.0	4305.8	10869.3	1952.0
MT-ND4	"LHON, MTND4, NAD4, ND4"	ENSG00000198886	"Mitochondrially encoded NADH:ubiquinone oxidoreductase core subunit 4"	P03905	MT	10760-12137	"Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins"	"Electron transport, Respiratory chain, Transport"	Translocase	"Disease mutation, Dystonia, Leber hereditary optic neuropathy, MELAS syndrome, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 392.9"	"Cell type enriched"	"Detected in many"	4	"Cardiomyocytes: 130137.0"	"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HeLa: 821.0"	"Low region specificity"	"Detected in all"							HPA053928	Approved		Supported	Mitochondria		NA	NA			Mitochondria		"HPA053928: AB_2682313"	"unprognostic (8.39e-2)"	"unprognostic (1.83e-1)"	"unprognostic (7.29e-2)"	"unprognostic (9.54e-2)"	"unprognostic (5.41e-2)"	"unprognostic (3.78e-2)"	"unprognostic (2.50e-3)"	"unprognostic (8.16e-2)"	"unprognostic (1.45e-1)"	"prognostic favorable (1.76e-4)"	"unprognostic (1.01e-2)"	"unprognostic (7.23e-2)"	"unprognostic (2.79e-2)"	"unprognostic (1.53e-1)"	"unprognostic (1.43e-1)"	"unprognostic (3.14e-2)"	"unprognostic (4.24e-2)"	82.5	72.4	124.2	19.8	138.2	14.9	34.5	43.8	78.5	34.1	68.7			56.5	27.8	37.1	32.9	25.2	23.7	292.7	122.4	90.3	129.8	178.5	20.8	17.4	101.6		25.5	58.3	37.8	19.7	39.1		37.3	82.1		61.7	65.6	288.4	61.1	41.0	37.8	63.6	21.7	67.7	29.6			24.3		23.4	26.0	15.3	164.7	87.6	392.9	119.5	87.1	129.7	53.0	102.6	106.9	138.9	205.1	326.5	82.3	97.3	104.6	40.0	24.3	47.5	162.1	117.7	182.9	92.3	89.1	35.8	192.5	12.4	169.4	43.6	105.5	67.2	112.6	821.0	271.8	49.3	113.1	134.0	139.2	179.5	35.8	128.4	229.8	58.7	92.3	93.8	226.5	87.5	231.7	44.5	257.0	39.3	89.7	72.7	60.6	43.6	110.2	177.8	222.1	51.2	69.3	60.8	202.4	104.6	257.3	141.7	267.4	162.8	99.5	96.8	133.1	81.0	135.9	55.1	81.4	64.9	196.6	52.9	392.9	119.5	268.8	82.9	91.3	115.5	148.0	93.0	98.9	65.9	164.7	109.6	129.7	105.7	87.1	89.0	87.6	67.6	53.0											1179.2	1324.7	15760.8	7514.4	3912.5	0.0	130137.0	15452.1	2295.3	2103.1	12148.5	0.0	0.0	2064.1	2636.7	917.0	2449.9	17720.8	23127.3	3538.6	0.0	2017.3	5309.0	2067.8	31565.1	0.0	0.0	4902.7	11944.3	15339.0	4282.8	8180.5	3605.2	3603.6	4879.3	17860.7	0.0	3353.9	12846.0	5441.2	13683.6	0.0	6208.8	3859.5	7259.5	5529.7	4316.1	0.0	9799.9	18174.2	10097.1
MT-ND4L	"MTND4L, NAD4L, ND4L"	ENSG00000212907	"Mitochondrially encoded NADH:ubiquinone oxidoreductase core subunit 4L"	P03901	MT	10470-10766	"Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins"	"Electron transport, Respiratory chain, Transport"	Translocase	"Disease mutation, Leber hereditary optic neuropathy, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in all"		"blood: 434.4;skeletal muscle: 294.4"	"Group enriched"	"Detected in many"	4	"Cardiomyocytes: 16050.3;Hepatocytes: 4100.6"	"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HeLa: 885.9"	"Low region specificity"	"Detected in all"							HPA075648			Approved	Centrosome,Mitochondria		NA	NA			Mitochondria	Centrosome	"HPA075648: AB_2686760"	"unprognostic (5.81e-2)"	"unprognostic (3.46e-2)"	"unprognostic (2.76e-2)"	"unprognostic (7.91e-2)"	"unprognostic (5.64e-2)"	"unprognostic (1.05e-1)"	"prognostic favorable (4.47e-4)"	"unprognostic (1.97e-1)"	"unprognostic (4.04e-2)"	"unprognostic (4.63e-3)"	"unprognostic (6.61e-2)"	"unprognostic (7.38e-3)"	"unprognostic (1.39e-1)"	"unprognostic (3.09e-1)"	"unprognostic (3.73e-1)"	"unprognostic (2.97e-2)"	"unprognostic (5.68e-2)"	101.1	71.9	102.4	20.3	114.5	13.2	39.4	41.5	73.3	39.4	83.8			48.0	26.1	34.1	30.7	23.9	23.4	187.5	102.7	79.1	123.5	185.7	20.2	13.1	88.6		26.2	43.4	29.7	18.5	30.9		34.2	80.0		43.2	75.4	294.4	31.8	38.4	38.6	59.2	16.1	62.5	27.5			24.6		24.4	25.8	14.3	200.8	111.2	434.4	139.9	112.1	153.0	66.8	97.1	90.4	163.1	166.1	571.6	120.3	71.9	208.6	52.3	32.7	59.8	150.2	89.8	241.1	85.5	140.9	53.6	185.3	25.3	223.3	65.2	94.9	104.4	173.3	885.9	279.0	83.9	178.2	155.8	210.6	228.8	62.4	218.5	246.4	65.5	125.0	95.5	172.9	119.9	173.6	67.7	228.6	41.1	103.4	109.2	39.3	70.3	107.2	174.1	205.2	49.5	67.0	102.3	162.1	69.9	366.4	115.3	224.3	209.4	86.0	107.1	125.8	79.8	156.5	73.2	128.4	61.7	242.4	40.1	434.4	139.9	290.0	102.4	110.6	140.6	166.9	110.0	117.5	86.1	200.8	132.4	153.0	78.4	112.1	99.4	111.2	79.0	66.8											208.4	153.9	1221.6	193.7	203.1	0.0	16050.3	1630.6	940.9	684.7	307.1	0.0	0.0	76.3	127.4	46.0	141.8	949.6	2499.6	297.1	0.0	116.0	126.2	448.0	4100.6	0.0	0.0	246.6	1665.3	1966.8	217.5	386.3	249.3	243.0	242.5	657.8	0.0	237.0	573.3	217.1	415.7	0.0	342.8	211.1	226.8	167.2	211.8	0.0	631.2	458.3	137.0
MT-ND5	"MTND5, NAD5, ND5"	ENSG00000198786	"Mitochondrially encoded NADH:ubiquinone oxidoreductase core subunit 5"	P03915	MT	12337-14148	"Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins"	"Electron transport, Respiratory chain, Transport"	Translocase	"Disease mutation, Leber hereditary optic neuropathy, Leigh syndrome, MELAS syndrome, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 193.9;heart muscle: 190.3;skeletal muscle: 223.2"	"Cell type enhanced"	"Detected in many"	14	"Cardiomyocytes: 21708.1;Hepatocytes: 6052.2"	"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HeLa: 367.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA						"unprognostic (2.87e-1)"	"unprognostic (3.18e-2)"	"unprognostic (3.00e-1)"	"unprognostic (1.53e-1)"	"unprognostic (2.99e-1)"	"unprognostic (1.30e-1)"	"unprognostic (1.07e-3)"	"unprognostic (5.09e-3)"	"unprognostic (1.06e-2)"	"unprognostic (3.01e-1)"	"unprognostic (3.29e-3)"	"unprognostic (4.78e-2)"	"prognostic favorable (7.31e-5)"	"unprognostic (9.93e-3)"	"unprognostic (8.75e-2)"	"unprognostic (1.26e-2)"	"unprognostic (3.68e-2)"	47.2	30.4	71.2	14.8	94.5	11.3	16.5	23.2	45.8	13.6	30.3			38.9	16.6	24.9	26.2	21.4	19.1	190.3	65.0	52.8	56.3	66.6	19.3	9.4	56.1		18.6	22.9	23.1	7.9	15.1		27.5	28.0		25.7	21.5	223.2	63.9	29.5	25.3	37.9	12.6	41.4	14.6			12.8		13.2	24.9	8.0	124.1	89.3	193.9	123.4	79.6	99.3	33.7	70.0	74.7	91.4	88.3	276.3	72.4	49.3	144.0	22.1	16.2	27.1	109.7	92.4	170.5	73.1	67.2	18.2	150.6	8.5	75.6	27.0	95.4	58.2	124.9	367.2	185.3	31.9	87.3	130.0	108.0	60.5	18.3	44.0	89.3	32.6	55.4	45.4	81.7	55.2	132.9	32.7	107.8	18.0	40.1	41.0	62.8	42.9	73.1	98.0	139.7	27.3	41.8	67.1	120.3	40.1	144.3	87.4	131.2	227.9	93.3	65.1	109.9	55.7	31.2	53.9	47.5	49.9	79.8	40.5	193.9	123.4	79.9	81.3	100.2	99.3	99.4	79.3	87.3	73.4	124.1	78.5	86.6	45.3	79.6	95.9	89.3	62.1	33.7											583.6	431.9	2723.9	906.1	795.2	0.0	21708.1	2619.1	1640.9	1064.6	1097.4	0.0	0.0	240.4	680.7	99.3	666.5	2590.2	4134.9	811.9	0.0	364.3	748.8	814.8	6052.2	0.0	0.0	752.3	2617.9	3186.6	403.9	979.2	872.2	577.0	1484.2	1582.7	0.0	1038.2	1813.1	797.6	2081.7	0.0	685.6	570.5	650.3	492.1	851.0	0.0	1584.2	1461.9	1233.6
MT-ND6	"MTND6, NAD6, ND6"	ENSG00000198695	"Mitochondrially encoded NADH:ubiquinone oxidoreductase core subunit 6"	P03923	MT	14149-14673	"Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins"	"Electron transport, Respiratory chain, Transport"	Translocase	"Disease mutation, Dystonia, Leber hereditary optic neuropathy, Leigh syndrome, MELAS syndrome, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 395.3;skeletal muscle: 593.2"	"Cell type enriched"	"Detected in many"	16	"Cardiomyocytes: 10763.4"	"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HeLa: 524.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA						"unprognostic (1.96e-1)"	"unprognostic (3.27e-1)"	"unprognostic (2.28e-1)"	"unprognostic (1.13e-1)"	"unprognostic (2.21e-1)"	"unprognostic (1.22e-2)"	"unprognostic (1.03e-3)"	"unprognostic (6.02e-3)"	"unprognostic (1.68e-2)"	"unprognostic (1.48e-1)"	"unprognostic (6.06e-3)"	"unprognostic (2.91e-1)"	"prognostic favorable (8.91e-6)"	"unprognostic (3.64e-2)"	"unprognostic (1.42e-2)"	"unprognostic (1.15e-2)"	"unprognostic (2.92e-2)"	79.2	43.1	55.5	34.4	78.5	30.7	9.6	14.7	76.1	5.9	30.2			90.3	19.2	0.0	69.5	23.2	40.2	395.3	50.7	41.2	65.5	42.8	28.5	25.9	41.9		23.2	48.0	0.0	3.5	10.3		28.0	0.3		48.1	0.0	593.2	176.3	63.8	0.0	24.8	19.9	53.2	22.7			17.5		0.0	32.3	5.7	127.3	91.2	164.8	108.2	88.8	104.3	29.7	99.5	80.8	71.5	90.8	12.0	1.1	51.3	134.7	0.2	0.4	0.4	109.8	101.1	214.8	91.6	3.6	13.5	149.0	0.7	2.4	0.7	126.9	62.0	128.7	524.8	313.8	0.9	81.4	121.6	2.0	3.3	3.3	2.7	68.1	0.7	45.0	55.3	84.4	2.9	212.8	25.0	112.4	15.5	57.2	39.8	60.9	45.7	92.3	1.9	293.8	29.5	47.4	70.1	123.5	55.6	118.8	95.7	158.8	273.9	79.6	67.2	112.6	53.9	28.9	77.1	51.5	54.0	83.1	46.2	164.8	108.2	68.3	89.1	103.5	104.3	118.4	94.5	96.1	66.2	127.3	94.7	102.4	53.7	88.8	103.7	91.2	71.8	29.7											77.4	48.1	340.3	38.0	14.9	0.0	10763.4	298.1	156.6	138.8	122.1	0.0	0.0	14.9	22.5	5.1	82.2	98.6	584.0	30.5	0.0	11.3	44.8	92.7	656.7	0.0	0.0	29.0	406.4	492.6	24.4	57.8	31.8	32.1	42.3	60.4	0.0	23.3	63.7	42.5	111.6	0.0	58.2	27.7	25.6	53.0	17.9	0.0	156.7	77.0	76.6
MTAP	"c86fus, MSAP"	ENSG00000099810	"Methylthioadenosine phosphorylase"	Q13126	9	21802543-21937651	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Purine salvage"	"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA046915			Supported	Nucleoplasm,Cytosol		NA	NA		3100000	Cytosol	Nucleoplasm	"HPA046915: AB_2679862"	"unprognostic (1.40e-2)"	"unprognostic (1.83e-1)"	"unprognostic (2.21e-1)"	"unprognostic (2.58e-3)"	"unprognostic (2.78e-1)"	"unprognostic (6.16e-2)"	"prognostic unfavorable (4.68e-4)"	"unprognostic (9.47e-2)"	"unprognostic (2.03e-1)"	"unprognostic (8.63e-2)"	"unprognostic (4.76e-3)"	"unprognostic (4.27e-2)"	"unprognostic (6.28e-3)"	"unprognostic (2.18e-1)"	"unprognostic (1.29e-1)"	"unprognostic (1.18e-1)"	"unprognostic (1.85e-1)"	17.0	12.6	7.8	12.6	10.4	8.4	13.9	4.6	10.2	17.3	14.5	12.8	13.4	8.0	21.2	11.6	19.6	12.2	16.9	11.4	7.9	7.7	13.0	17.5	11.4	13.0	12.0	6.2	20.5	17.2	17.6	14.4	17.5	12.3	17.0	13.1	14.3	14.6	15.9	10.8	11.8	10.3	19.9	14.3	17.9	11.7	7.9	10.1	19.1	11.7	14.3	16.2	19.7	17.2	9.3	8.4	1.4	6.9	8.5	8.2	3.5	14.4	2.2	11.7	9.9	9.7	10.0	13.2	21.2	10.4	10.7	12.4	9.9	6.8	7.2	6.6	10.0	8.8	6.7	12.0	29.9	18.3	0.1	9.8	0.1	27.4	13.1	9.4	11.5	12.9	12.0	0.0	19.8	21.7	12.4	11.1	0.2	0.1	9.7	11.2	2.0	13.2	0.3	13.7	6.7	17.7	0.2	8.9	12.7	9.3	0.1	6.7	7.6	6.9	8.1	10.5	8.9	5.2	0.2	12.1	0.1	7.6	0.1	16.8	6.5	11.4	15.1	0.1	11.5	6.2	1.4	6.9	0.3	5.0	5.4	8.2	7.7	7.2	5.6	8.4	9.3	6.5	5.9	1.0	8.5	3.4	8.0	4.1	3.5	7.8	10.4	4.6	10.2	7.9	7.7	12.0	6.2	12.3	10.1	20.8	16.6	17.1	39.8	12.6	0.0	21.0	25.5	16.0	28.4	14.0	0.0	42.6	13.3	34.0	42.8	11.2	6.9	0.0	24.4	68.9	13.3	17.2	10.4	19.8	23.3	0.0	9.2	16.5	21.0	8.8	13.8	17.0	10.1	12.6	13.2	0.0	37.3	0.0	13.8	15.3	0.0	12.9	13.2	0.9	16.0	11.4	18.9	13.4	18.8	44.6
MTFMT	FMT1	ENSG00000103707	"Mitochondrial methionyl-tRNA formyltransferase"	Q96DP5	15	65001512-65029639	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Protein biosynthesis"	Transferase	"Disease mutation, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA040710	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA040710: AB_10794879"	"unprognostic (1.20e-1)"	"unprognostic (2.72e-2)"	"unprognostic (9.28e-3)"	"unprognostic (4.35e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.42e-2)"	"unprognostic (6.63e-2)"	"unprognostic (2.02e-1)"	"unprognostic (6.95e-2)"	"unprognostic (2.18e-2)"	"unprognostic (2.41e-2)"	"unprognostic (1.78e-1)"	"prognostic favorable (3.31e-8)"	"unprognostic (2.75e-2)"	"unprognostic (4.06e-2)"	"unprognostic (3.26e-1)"	"unprognostic (1.85e-2)"	8.7	10.2	7.9	10.0	11.5	11.6	7.5	13.5	12.7	9.5	12.7	6.8	8.0	9.7	11.8	10.6	9.5	10.9	9.7	13.8	8.0	7.8	12.8	13.4	8.4	8.6	6.8	9.4	14.0	5.9	7.3	9.3	7.5	10.3	10.8	10.8	12.2	8.7	9.8	13.3	11.6	13.9	12.0	5.7	9.2	8.7	7.2	5.2	9.2	11.7	4.6	8.8	12.0	9.1	5.0	9.6	16.9	3.6	4.6	5.9	1.9	2.5	3.5	3.4	6.0	4.9	3.4	3.0	2.4	4.2	3.1	3.0	2.2	3.0	9.0	3.2	4.3	5.1	7.6	6.4	4.2	3.0	3.4	4.7	3.8	3.4	2.5	5.7	5.2	1.2	4.9	5.3	1.7	3.7	4.4	2.8	8.0	4.0	4.3	4.7	3.5	4.1	5.5	4.7	7.3	6.1	3.8	5.0	4.1	5.1	3.0	3.5	3.6	5.7	5.3	4.3	4.7	3.3	3.7	5.2	3.7	3.8	4.3	4.7	3.7	5.3	3.5	3.3	8.4	3.8	3.1	3.6	2.4	4.9	2.9	4.9	4.7	4.9	5.2	5.6	5.0	5.5	5.9	16.9	4.6	2.0	9.6	4.9	1.9	7.9	11.5	13.5	12.7	8.0	7.8	6.8	9.4	10.3	5.2	3.0	8.9	11.5	12.6	3.0	0.0	15.0	7.6	5.3	9.1	3.5	0.0	9.0	21.6	10.4	1.6	6.5	11.9	0.0	8.5	10.3	10.0	11.7	8.1	9.5	14.2	0.0	7.5	10.4	10.8	1.4	14.4	11.1	8.5	2.8	9.0	0.0	9.2	16.4	14.5	15.3	0.0	0.0	10.3	10.9	21.6	4.0	7.4	9.6	15.3	13.2
MTHFD1	"MTHFC, MTHFD"	ENSG00000100714	"Methylenetetrahydrofolate dehydrogenase, cyclohydrolase and formyltetrahydrofolate synthetase 1"	P11586	14	64388031-64463457	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Amino-acid biosynthesis, Histidine biosynthesis, Methionine biosynthesis, One-carbon metabolism, Purine biosynthesis"	"Hydrolase, Ligase, Multifunctional enzyme, Oxidoreductase"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	5	"liver: 121.6"	"Cell type enhanced"	"Detected in many"	8	"Hepatocytes: 125.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000704, HPA001290, HPA015006, HPA050052"	Approved		Enhanced	Cytosol		NA	Yes		250000	Cytosol		"HPA000704: AB_1079424, HPA001290: AB_1854177, HPA015006: AB_1854178, HPA050052: AB_2680998"	"unprognostic (3.58e-2)"	"unprognostic (5.50e-3)"	"unprognostic (1.24e-1)"	"unprognostic (2.46e-2)"	"unprognostic (1.37e-1)"	"unprognostic (7.01e-2)"	"unprognostic (8.85e-3)"	"unprognostic (7.62e-3)"	"unprognostic (1.28e-1)"	"unprognostic (2.29e-2)"	"prognostic unfavorable (6.96e-4)"	"unprognostic (1.84e-1)"	"prognostic favorable (5.93e-5)"	"unprognostic (2.45e-2)"	"unprognostic (1.75e-1)"	"unprognostic (7.30e-2)"	"unprognostic (2.29e-2)"	18.9	9.0	8.1	8.4	18.1	9.7	12.2	5.7	15.9	7.1	9.3	9.0	4.0	7.5	8.5	6.9	12.0	6.7	6.4	10.6	8.4	6.5	20.5	121.6	6.8	9.2	8.0	10.4	10.1	13.4	13.1	5.6	5.6	10.0	5.5	11.4	9.3	11.6	5.6	26.5	7.6	7.3	8.8	6.9	8.3	7.9	2.3	7.4	15.6	8.6	14.0	12.5	8.7	7.3	21.1	12.8	0.5	13.2	12.8	14.9	8.4	72.5	41.3	15.7	34.2	16.9	13.8	25.5	28.5	19.6	37.0	36.7	40.1	33.4	30.5	13.5	16.9	18.6	35.7	48.4	28.3	43.3	30.3	31.9	37.8	41.4	30.4	12.5	29.0	20.6	10.7	9.2	33.0	17.9	15.3	23.0	30.9	28.1	25.1	28.0	60.2	46.7	17.0	28.7	46.2	43.8	37.3	54.6	27.6	27.8	42.5	34.0	13.2	47.6	25.9	14.3	15.3	40.3	14.7	14.1	27.9	48.4	25.7	34.1	16.8	20.6	53.8	25.6	33.5	31.6	0.2	8.2	0.1	8.1	13.2	10.9	21.1	9.0	9.9	12.8	11.6	7.6	10.1	0.5	12.8	10.3	3.2	14.9	8.4	8.1	18.1	5.7	15.9	8.4	6.5	8.0	10.4	10.0	7.4	17.9	26.3	11.5	9.9	12.2	0.0	38.1	17.8	12.0	20.5	15.7	0.0	20.0	34.9	15.4	0.9	9.9	5.2	0.0	9.0	24.2	10.6	8.3	49.7	125.3	21.6	0.0	2.9	7.4	11.3	0.9	12.0	10.9	13.5	14.4	11.9	0.0	10.8	2.9	12.4	49.9	0.0	19.4	18.6	0.9	7.5	9.4	8.2	20.0	21.3	9.9
MTHFD1L	"DKFZP586G1517, FLJ21145, FTHFSDC1"	ENSG00000120254	"Methylenetetrahydrofolate dehydrogenase (NADP+ dependent) 1 like"	Q6UB35	6	150865549-151101887	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"One-carbon metabolism"	Ligase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	11	"Extravillous trophoblasts: 107.1;Syncytiotrophoblasts: 61.6;Urothelial cells: 39.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA015006, HPA029040, HPA029041, HPA050052, HPA074911"	Approved		Enhanced	Mitochondria		NA	NA			Mitochondria		"HPA015006: AB_1854178, HPA029040: AB_2672879, HPA029041: AB_2672880, HPA050052: AB_2680998, HPA074911: AB_2686723"	"unprognostic (3.66e-2)"	"prognostic unfavorable (1.68e-5)"	"unprognostic (1.02e-1)"	"prognostic unfavorable (7.28e-4)"	"unprognostic (3.25e-1)"	"prognostic unfavorable (5.10e-4)"	"prognostic unfavorable (8.33e-5)"	"unprognostic (6.35e-3)"	"unprognostic (2.45e-1)"	"unprognostic (1.44e-1)"	"unprognostic (1.02e-1)"	"unprognostic (1.32e-1)"	"unprognostic (1.11e-2)"	"unprognostic (2.93e-2)"	"unprognostic (3.51e-1)"	"unprognostic (2.91e-1)"	"prognostic unfavorable (8.69e-5)"	10.4	10.6	8.0	12.1	8.1	12.2	7.1	32.4	10.5	6.5	6.2	7.8	10.2	3.4	8.5	7.2	6.4	8.0	7.3	10.7	7.5	7.9	9.5	6.9	17.1	11.0	12.3	7.6	22.2	13.7	7.1	9.1	15.5	8.5	5.0	9.1	12.7	3.4	10.5	2.5	5.7	4.7	10.9	10.2	8.7	5.6	13.6	6.6	6.7	12.2	5.0	11.4	8.7	5.1	1.1	3.0	0.2	0.8	1.0	5.0	0.6	12.0	10.5	13.7	33.7	3.6	12.6	33.5	19.0	20.8	19.1	23.6	21.1	11.3	44.5	12.7	29.0	11.3	12.9	21.9	18.5	23.8	18.3	19.9	18.5	18.7	19.3	22.6	33.8	3.0	14.9	23.7	18.5	33.8	17.2	31.9	24.9	43.9	23.3	19.6	25.4	16.5	7.0	14.0	12.1	9.7	19.8	10.2	19.8	12.9	5.9	13.7	10.2	25.1	11.1	15.5	13.0	3.5	23.7	24.2	12.8	28.1	28.4	26.9	19.4	18.0	46.4	21.3	31.6	16.5	0.2	0.7	0.0	0.8	0.8	1.3	0.8	1.9	2.1	3.0	1.1	1.8	1.9	0.0	1.0	0.8	1.5	5.0	0.6	8.0	8.1	32.4	9.5	7.5	7.9	12.3	7.6	8.5	6.6	0.0	1.7	10.7	5.1	5.8	0.0	2.4	2.5	4.0	2.3	14.0	0.0	18.7	6.6	10.4	19.2	7.1	0.9	0.0	15.4	107.1	15.4	4.1	0.0	1.0	21.7	0.0	1.2	3.7	2.4	3.4	0.6	10.1	33.7	1.0	2.5	0.0	15.0	0.8	7.4	12.2	0.0	0.0	6.1	0.5	6.4	3.0	61.6	3.2	3.5	39.1
MTHFD2		ENSG00000065911	"Methylenetetrahydrofolate dehydrogenase (NADP+ dependent) 2, methenyltetrahydrofolate cyclohydrolase"	P13995	2	74198562-74217565	"Enzymes, Predicted intracellular proteins"	"One-carbon metabolism"	"Hydrolase, Multifunctional enzyme, Oxidoreductase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"monocytes: 263.3;Smooth muscle cells: 264.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB003684, HPA049657"	Approved		Supported	Mitochondria	"Intracellular and membrane"	NA	NA			Mitochondria		"CAB003684: AB_425867, HPA049657: AB_2680842"	"unprognostic (1.82e-3)"	"unprognostic (4.60e-2)"	"unprognostic (8.12e-2)"	"prognostic unfavorable (2.07e-5)"	"prognostic favorable (1.01e-4)"	"unprognostic (3.10e-3)"	"unprognostic (2.24e-3)"	"unprognostic (4.75e-3)"	"unprognostic (2.64e-2)"	"unprognostic (3.96e-2)"	"unprognostic (3.76e-3)"	"unprognostic (3.57e-3)"	"prognostic unfavorable (1.11e-16)"	"unprognostic (3.66e-2)"	"unprognostic (6.52e-2)"	"unprognostic (9.07e-2)"	"unprognostic (2.34e-3)"	26.2	5.7	5.8	21.6	14.1	12.1	21.9	3.0	8.0	15.1	12.4	5.9	12.6	10.1	15.8	8.7	14.1	17.5	10.5	12.1	10.0	8.2	12.0	3.4	15.9	21.0	19.0	1.5	20.6	39.7	1.5	15.6	8.2	16.1	12.7	15.3	3.0	32.9	12.0	39.4	8.6	9.2	21.0	25.6	26.3	15.3	11.9	11.8	8.4	11.4	16.7	23.5	20.3	41.8	4.8	11.4	13.6	19.7	10.7	12.7	6.3	18.6	6.9	7.8	26.6	8.6	9.7	20.6	23.5	15.9	13.8	19.6	15.9	7.9	39.4	6.3	12.7	15.4	6.6	25.9	13.8	26.1	21.2	10.8	38.0	3.9	15.4	35.2	27.6	25.4	20.0	44.1	17.2	74.8	7.1	9.2	63.6	17.5	57.4	13.5	11.7	17.3	34.2	17.0	27.2	11.5	19.3	21.9	34.7	7.9	5.5	20.4	14.9	8.1	24.4	55.1	5.9	20.9	38.4	4.0	4.3	34.7	9.8	26.3	47.5	21.0	32.0	11.9	33.9	12.2	13.6	8.1	9.6	3.3	19.7	4.8	4.8	6.0	3.6	11.4	3.0	4.3	3.3	1.1	10.7	19.1	5.0	12.7	6.3	5.8	14.1	3.0	8.0	10.0	8.2	19.0	1.5	16.1	11.8	14.9	26.5	62.1	28.1	79.3	0.0	8.2	7.6	2.7	13.6	1.8	0.0	20.5	3.3	54.8	3.2	18.0	6.9	93.5	92.6	49.1	52.6	48.5	53.0	0.6	64.6	0.0	18.3	13.5	55.9	2.9	21.0	92.7	67.4	263.3	33.2	0.0	75.9	5.8	19.8	1.4	0.0	135.8	264.7	30.1	55.8	65.2	11.7	30.5	21.6	55.0
MTHFD2L	MGC72244	ENSG00000163738	"Methylenetetrahydrofolate dehydrogenase (NADP+ dependent) 2 like"	Q9H903	4	74114174-74303099	"Enzymes, Predicted intracellular proteins"	"Amino-acid biosynthesis, Histidine biosynthesis, Methionine biosynthesis, One-carbon metabolism, Purine biosynthesis"	"Hydrolase, Multifunctional enzyme, Oxidoreductase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Hepatocytes: 105.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA035434	Uncertain					NA	NA					"HPA035434: AB_10601038"	"unprognostic (2.01e-1)"	"unprognostic (2.19e-1)"	"unprognostic (2.03e-1)"	"unprognostic (2.32e-2)"	"unprognostic (1.52e-2)"	"unprognostic (4.09e-2)"	"unprognostic (2.67e-2)"	"unprognostic (7.73e-3)"	"unprognostic (1.42e-4)"	"unprognostic (3.45e-3)"	"unprognostic (4.23e-2)"	"unprognostic (5.07e-2)"	"unprognostic (1.44e-1)"	"unprognostic (3.16e-2)"	"unprognostic (1.19e-1)"	"unprognostic (3.00e-1)"	"unprognostic (1.81e-3)"	5.4	11.7	10.2	6.0	8.8	5.2	10.3	6.9	8.5	4.5	5.6	5.9	8.2	5.3	5.6	10.9	6.3	5.0	5.6	17.7	9.3	10.7	6.9	16.2	7.0	5.8	10.5	4.1	5.8	13.6	6.1	7.4	5.8	6.6	5.3	4.0	4.8	4.9	6.2	9.3	4.2	5.6	4.9	11.0	5.1	4.1	2.9	7.3	14.8	10.5	5.0	3.8	3.8	8.4	3.9	3.9	1.4	6.5	2.5	2.7	2.5	2.6	2.8	3.9	3.6	1.4	2.1	0.9	3.3	2.6	2.2	2.4	2.1	2.5	2.9	4.5	1.5	1.6	1.7	3.2	2.1	3.3	2.9	1.9	3.5	1.9	2.5	2.5	5.5	0.7	1.5	5.1	3.3	7.9	4.1	4.6	6.5	6.2	3.6	2.7	2.6	10.2	7.9	1.2	4.3	3.1	10.4	2.7	4.8	14.2	1.3	3.7	8.1	1.8	2.8	3.3	4.5	1.5	3.9	4.7	2.5	3.8	4.8	5.4	3.6	4.6	8.5	15.6	1.3	3.8	0.4	2.1	0.9	0.7	2.0	0.7	3.9	0.6	0.9	3.3	1.5	2.1	2.2	1.4	2.5	6.5	3.9	2.7	2.5	10.2	8.8	6.9	7.3	9.3	10.7	10.5	4.1	6.6	7.3	20.8	15.8	16.8	49.0	14.7	0.0	21.3	25.5	22.7	21.6	47.1	0.0	16.4	71.3	20.8	53.1	14.3	16.8	46.7	16.6	6.3	12.2	87.5	10.3	105.4	21.6	0.0	35.7	18.4	22.7	16.4	11.8	19.6	15.1	11.8	31.5	0.0	16.0	17.5	8.1	35.8	0.0	25.8	18.4	6.5	10.0	19.7	10.3	12.2	33.8	58.9
MTHFR		ENSG00000177000	"Methylenetetrahydrofolate reductase"	P42898	1	11785723-11806920	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		"Allosteric enzyme, Oxidoreductase"	"Disease mutation, Schizophrenia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"K-562: 27.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA063389, HPA076180, HPA077255"	Enhanced		Approved	"Cell Junctions"		NA	NA			"Cell Junctions"		"HPA063389: AB_2685001, HPA076180: , HPA077255: "	"unprognostic (3.25e-2)"	"unprognostic (8.19e-2)"	"unprognostic (4.48e-2)"	"unprognostic (2.11e-2)"	"unprognostic (1.34e-1)"	"prognostic favorable (3.97e-5)"	"prognostic unfavorable (1.19e-4)"	"unprognostic (1.75e-2)"	"unprognostic (2.85e-1)"	"unprognostic (8.69e-2)"	"prognostic favorable (4.81e-5)"	"unprognostic (3.10e-1)"	"prognostic favorable (2.12e-4)"	"unprognostic (2.35e-3)"	"unprognostic (2.94e-1)"	"unprognostic (4.14e-2)"	"unprognostic (1.80e-2)"	11.7	11.0	8.9	10.3	12.4	24.5	9.7	15.3	15.8	9.0	10.4	13.5	8.3	10.7	10.4	54.5	11.3	12.7	10.9	23.4	9.2	8.6	12.0	12.4	16.2	13.3	9.9	10.7	28.8	11.2	6.7	17.5	6.6	10.7	10.2	9.1	14.1	7.3	7.2	15.3	13.2	13.6	10.9	7.4	18.3	13.6	10.6	10.9	10.2	15.8	9.8	11.7	10.4	17.9	4.9	3.2	4.7	7.4	3.4	4.7	2.3	1.3	5.9	6.8	7.8	6.8	10.5	1.1	4.2	8.8	4.0	3.5	5.4	8.7	11.4	2.3	4.3	9.3	2.6	4.8	4.0	1.7	5.4	4.4	8.4	7.4	1.5	9.1	4.6	10.9	9.2	4.0	3.0	3.3	6.6	6.2	10.8	27.4	7.5	4.1	1.8	5.0	2.2	2.3	5.9	2.1	5.2	3.7	12.6	6.4	7.2	6.8	11.6	5.2	5.1	8.2	4.3	8.1	7.2	5.5	4.0	3.3	4.7	1.0	4.2	5.7	21.3	4.9	10.6	3.6	1.1	3.8	1.9	4.7	7.4	1.8	3.0	1.6	2.5	3.2	4.9	2.4	2.7	4.7	3.4	6.9	1.5	1.0	2.3	8.9	12.4	15.3	15.8	9.2	8.6	9.9	10.7	10.7	10.9	23.8	50.3	12.3	6.7	7.4	0.0	35.5	10.2	5.3	10.3	26.2	0.0	4.1	1.7	7.7	13.8	16.2	32.7	46.7	22.0	2.7	16.0	9.3	8.1	19.5	18.8	0.0	11.6	38.6	38.0	28.3	17.0	26.2	11.8	10.8	15.4	0.0	15.7	17.8	8.5	14.3	0.0	19.4	24.7	6.0	4.7	8.2	2.4	8.7	16.5	8.1
MTHFS	HsT19268	ENSG00000136371	"Methenyltetrahydrofolate synthetase"	P49914	15	79833585-79897379	"Enzymes, Predicted intracellular proteins"		Ligase	"Disease mutation, Epilepsy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 88.7;liver: 120.9"	"Cell type enhanced"	"Detected in many"	7	"Hepatocytes: 163.6;monocytes: 231.8;Proximal tubular cells: 140.3;Syncytiotrophoblasts: 212.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"neutrophil: 88.7"	"Group enriched"	"Detected in all"	5	"granulocytes: 88.7;monocytes: 25.4"	"Low cell line specificity"	"Detected in many"											"HPA008067, HPA054177"	Approved		Supported	Cytosol		NA	NA			Cytosol		"HPA008067: AB_1078882, HPA054177: AB_2682405"	"unprognostic (4.57e-2)"	"unprognostic (9.76e-2)"	"unprognostic (6.11e-2)"	"unprognostic (1.82e-1)"	"prognostic unfavorable (8.52e-4)"	"unprognostic (9.13e-3)"	"prognostic favorable (1.29e-6)"	"unprognostic (1.34e-2)"	"unprognostic (1.03e-1)"	"unprognostic (6.18e-3)"	"unprognostic (2.91e-2)"	"unprognostic (2.76e-1)"	"prognostic favorable (2.04e-4)"	"unprognostic (1.36e-1)"	"unprognostic (2.85e-1)"	"unprognostic (7.60e-2)"	"unprognostic (2.90e-1)"	10.0	6.6	4.5	7.6	4.4	2.5	5.7	3.9	2.8	4.4	12.4	3.7	6.8	8.3	4.3	6.2	4.5	4.0	7.9	5.2	4.1	5.0	27.9	120.9	6.4	5.4	5.5	1.7	3.3	18.8	11.4	9.4	13.9	3.9	8.6	3.7	6.5	10.6	7.6	6.0	1.9	18.3	4.4	6.1	7.6	6.3	5.9	3.3	5.3	12.0	3.1	5.7	4.0	9.9	9.7	9.3	88.7	25.4	12.4	12.6	13.8	10.9	27.7	2.5	1.4	9.8	8.3	11.2	7.7	10.1	13.5	10.3	21.5	21.6	13.8	23.4	9.5	12.1	17.7	23.6	7.5	10.3	14.3	15.7	11.8	16.1	25.5	17.0	5.5	0.4	12.5	22.1	5.6	14.1	12.6	5.0	12.2	26.1	11.3	10.7	23.6	8.5	23.0	11.8	34.2	10.4	9.3	13.6	20.9	24.6	20.6	6.8	3.2	21.4	12.8	28.2	12.5	16.4	10.2	3.3	5.2	11.0	2.4	5.1	5.7	18.4	13.9	2.6	21.8	4.0	9.8	16.6	43.5	7.7	19.0	9.9	9.7	10.8	9.0	9.3	8.7	12.6	9.7	88.7	12.4	25.4	7.0	11.2	13.8	4.5	4.4	3.9	2.8	4.1	5.0	5.5	1.7	3.9	3.3	17.9	35.3	18.8	8.6	9.5	0.0	0.6	40.8	25.4	18.2	21.0	0.0	57.2	54.7	50.9	1.1	8.4	11.9	0.0	65.9	31.6	13.1	11.4	8.1	163.6	41.2	0.0	16.9	16.5	21.5	1.7	12.7	29.7	20.3	231.8	22.7	0.0	65.8	29.8	14.9	140.3	0.0	12.9	5.1	7.5	7.3	7.0	212.2	35.2	30.5	7.4
MTM1		ENSG00000171100	"Myotubularin 1"	Q13496	X	150568619-150673322	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Lipid metabolism, Protein transport, Transport"	"Hydrolase, Protein phosphatase"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA010008, HPA010665"	Approved		Supported	"Plasma membrane"		NA	NA			"Plasma membrane"		"HPA010008: AB_1079426, HPA010665: AB_1079425"	"unprognostic (3.66e-3)"	"unprognostic (8.43e-3)"	"unprognostic (3.52e-3)"	"unprognostic (2.13e-1)"	"unprognostic (1.08e-1)"	"unprognostic (6.45e-2)"	"unprognostic (4.98e-2)"	"unprognostic (1.22e-1)"	"unprognostic (4.74e-1)"	"unprognostic (2.35e-2)"	"unprognostic (1.08e-1)"	"unprognostic (4.59e-2)"	"prognostic favorable (7.40e-7)"	"unprognostic (4.46e-2)"	"unprognostic (1.25e-1)"	"unprognostic (4.99e-2)"	"unprognostic (2.46e-1)"	10.7	17.9	15.0	10.2	16.4	11.1	9.2	10.6	10.8	9.1	21.5	12.5	12.7	12.8	10.9	10.9	11.1	11.1	8.0	9.0	14.3	12.0	17.9	19.9	12.2	12.4	17.3	9.3	13.8	7.5	21.4	11.9	21.5	12.9	9.5	21.6	8.3	10.2	12.9	11.2	10.2	21.0	8.0	17.2	15.3	8.6	12.1	16.4	14.5	12.7	8.3	13.9	8.5	9.1	6.9	7.9	18.4	7.2	10.1	7.7	4.6	8.5	3.9	5.5	2.0	5.1	5.0	3.5	4.1	5.6	4.7	5.2	3.0	4.8	13.8	7.3	5.2	14.8	6.1	4.0	7.9	5.8	3.7	3.5	3.7	3.7	9.1	3.8	15.3	12.6	3.0	9.5	3.8	8.1	4.7	6.1	6.0	2.4	12.8	5.7	2.9	4.2	15.9	2.8	8.5	5.1	5.1	3.1	2.7	8.1	4.8	1.4	1.5	3.5	7.4	5.2	8.1	2.6	22.3	5.3	3.2	1.9	8.1	4.2	2.6	5.9	13.1	4.0	9.4	5.1	17.6	6.3	18.4	1.5	7.2	4.9	5.5	6.8	5.2	7.9	6.9	6.5	3.9	8.5	10.1	6.2	5.1	7.7	4.6	15.0	16.4	10.6	10.8	14.3	12.0	17.3	9.3	12.9	16.4	8.9	18.3	3.7	5.8	13.5	0.0	12.3	2.5	9.4	5.7	3.5	0.0	1.9	1.7	2.8	27.7	7.8	12.8	0.0	3.8	2.2	4.2	4.9	8.1	10.5	7.2	0.0	9.2	17.2	13.4	15.8	5.8	11.0	5.0	6.4	18.9	0.0	3.6	7.0	12.0	10.8	0.0	0.0	2.7	4.4	2.5	16.7	6.1	7.5	10.3	8.1
MTMR1		ENSG00000063601	"Myotubularin related protein 1"	Q13613	X	150692971-150765103	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Lipid metabolism"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"U-698: 44.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002977, HPA018502"	Approved		Approved	Centrosome		NA	NA			Centrosome		"HPA002977: AB_2666735, HPA018502: AB_1854185"	"unprognostic (2.37e-2)"	"unprognostic (1.64e-3)"	"unprognostic (2.07e-1)"	"unprognostic (1.05e-2)"	"unprognostic (4.34e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.97e-1)"	"unprognostic (1.34e-1)"	"unprognostic (4.35e-2)"	"unprognostic (3.16e-1)"	"unprognostic (7.48e-2)"	"unprognostic (1.41e-2)"	"unprognostic (1.67e-2)"	"unprognostic (1.32e-2)"	"unprognostic (1.93e-1)"	"unprognostic (3.19e-1)"	"unprognostic (8.40e-2)"	6.9	6.8	20.4	14.0	17.9	9.9	11.8	14.5	15.6	8.3	8.6	8.7	7.2	8.3	9.4	9.2	19.7	9.3	9.0	12.0	17.8	13.4	8.1	10.2	9.7	18.7	12.1	11.5	7.4	11.7	16.3	10.2	37.9	8.8	10.8	9.1	7.9	12.1	13.0	22.2	19.8	10.9	8.3	8.2	18.0	9.7	11.0	9.3	32.6	9.6	10.7	23.1	10.4	7.7	3.3	7.8	7.4	1.5	6.2	4.8	1.8	13.2	8.5	9.2	7.5	2.1	2.5	12.4	11.8	15.2	12.0	17.1	8.2	10.5	29.0	17.5	9.5	11.6	12.1	18.5	17.1	18.8	11.7	11.2	1.8	13.2	3.5	6.4	8.5	6.3	6.8	11.9	13.2	0.2	11.5	7.2	9.7	5.6	7.5	8.6	11.4	12.4	2.2	4.2	14.8	12.9	6.6	14.6	12.8	9.4	15.2	13.7	8.5	4.5	10.1	3.7	7.6	12.9	4.9	9.1	7.9	6.3	1.0	17.5	9.6	9.8	44.2	1.6	5.5	6.1	0.0	0.9	7.4	3.5	1.5	2.6	2.7	3.9	3.2	2.2	3.3	3.5	4.7	2.4	6.2	1.3	7.8	4.8	1.8	20.4	17.9	14.5	15.6	17.8	13.4	12.1	11.5	8.8	9.3	14.9	6.2	3.4	9.6	10.0	0.0	7.9	2.5	1.4	5.7	5.2	0.0	8.8	0.0	5.1	0.0	3.6	2.8	0.0	5.7	6.0	4.3	6.1	1.1	8.1	4.0	0.0	9.2	3.1	8.2	0.4	5.2	5.2	3.3	1.0	7.6	0.0	8.1	6.5	4.9	2.9	0.0	6.5	2.7	1.2	2.3	14.6	8.7	6.9	5.2	10.8
MTMR2	"CMT4B, KIAA1073"	ENSG00000087053	"Myotubularin related protein 2"	Q13614	11	95832882-95925315	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Lipid metabolism"	Hydrolase	"Charcot-Marie-Tooth disease, Disease mutation, Neurodegeneration, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"Late spermatids: 87.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA049831	Approved		Supported	Vesicles		NA	NA			Vesicles		"HPA049831: AB_2680904"	"unprognostic (1.71e-2)"	"unprognostic (2.55e-3)"	"unprognostic (7.81e-3)"	"unprognostic (4.16e-1)"	"unprognostic (4.18e-3)"	"unprognostic (5.36e-2)"	"prognostic unfavorable (1.61e-8)"	"unprognostic (3.23e-3)"	"unprognostic (3.42e-2)"	"unprognostic (1.77e-2)"	"prognostic unfavorable (3.60e-4)"	"unprognostic (1.12e-1)"	"unprognostic (2.34e-2)"	"unprognostic (1.54e-1)"	"unprognostic (1.50e-1)"	"unprognostic (1.14e-1)"	"unprognostic (8.03e-3)"	16.4	10.4	14.2	12.1	19.9	5.3	15.4	14.9	23.3	14.1	13.5	22.6	4.9	8.0	14.1	7.5	15.5	13.3	15.4	13.8	18.1	13.9	16.9	4.5	14.3	13.6	27.5	13.6	14.5	11.0	15.9	8.2	25.1	21.3	17.6	14.5	19.6	18.8	12.3	6.8	9.7	9.5	18.2	30.0	10.5	13.6	29.0	21.8	12.2	11.3	7.7	11.7	13.4	14.3	5.4	6.6	9.7	4.9	11.8	14.2	6.6	9.4	10.1	23.3	16.9	8.2	12.7	19.5	17.7	15.8	17.6	15.9	23.9	19.2	6.8	21.2	18.6	14.9	13.1	19.0	19.3	15.9	12.4	9.2	14.1	25.3	13.4	18.8	23.9	11.7	10.6	12.9	23.1	23.2	18.0	26.5	15.3	17.4	6.5	16.5	7.0	11.9	11.1	18.9	22.8	14.3	10.0	13.6	6.4	18.1	50.8	14.9	17.4	17.5	14.8	7.9	15.3	11.7	10.2	27.1	20.6	18.9	15.0	16.3	6.1	16.8	6.2	8.6	6.6	20.8	9.7	3.3	1.4	11.4	3.9	12.3	5.4	7.7	14.2	6.6	4.8	4.1	11.0	0.9	11.8	4.9	3.4	6.9	6.6	14.2	19.9	14.9	23.3	18.1	13.9	27.5	13.6	21.3	21.8	3.0	7.5	5.1	13.3	9.2	0.0	14.0	0.0	9.4	12.5	8.7	0.0	8.0	8.3	15.9	48.9	19.5	7.3	0.0	14.6	26.0	14.0	13.2	18.5	0.9	11.0	0.0	15.5	10.4	9.1	87.8	10.3	7.5	3.3	9.0	9.1	0.0	14.2	2.9	11.3	20.7	0.0	32.3	20.0	34.6	16.4	5.3	7.6	7.9	8.4	13.2
MTMR3	"FYVE-DSP1, KIAA0371, ZFYVE10"	ENSG00000100330	"Myotubularin related protein 3"	Q13615	22	29883155-30030866	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Lipid metabolism"	"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA034515, HPA034516, HPA061399"	Uncertain		Supported	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA034515: AB_10669726, HPA034516: AB_10669727, HPA061399: "	"unprognostic (4.39e-3)"	"unprognostic (7.84e-2)"	"unprognostic (2.46e-2)"	"unprognostic (1.76e-2)"	"unprognostic (5.61e-2)"	"unprognostic (4.51e-3)"	"unprognostic (2.25e-2)"	"unprognostic (3.20e-2)"	"unprognostic (3.42e-1)"	"unprognostic (4.39e-1)"	"unprognostic (8.33e-4)"	"unprognostic (1.28e-1)"	"unprognostic (5.35e-4)"	"unprognostic (7.96e-2)"	"unprognostic (7.64e-2)"	"unprognostic (2.49e-1)"	"unprognostic (8.38e-2)"	15.8	17.2	15.7	12.6	20.6	66.7	16.0	24.2	18.0	13.7	12.6	18.9	14.8	10.6	18.8	13.5	20.1	16.7	13.0	14.4	13.0	11.7	12.4	9.9	18.3	12.6	14.7	11.4	20.3	15.8	22.1	20.6	20.6	15.8	15.1	12.9	18.1	15.9	14.7	30.7	22.5	13.1	16.0	17.0	20.7	14.1	23.7	14.6	14.0	16.6	11.9	14.9	14.0	19.3	2.6	3.9	16.5	6.6	3.9	4.1	3.5	8.5	6.7	11.7	12.4	11.8	8.6	8.6	7.6	11.6	10.5	12.2	6.3	5.2	6.5	5.1	14.7	8.4	10.6	12.3	9.7	10.6	12.9	10.2	11.8	6.8	6.7	10.9	10.0	30.2	9.1	16.1	10.2	18.6	10.3	10.5	7.1	7.3	11.8	6.5	10.7	6.7	7.3	4.3	9.2	5.0	8.0	15.8	6.6	9.9	16.0	12.9	8.9	14.7	13.3	7.9	10.3	7.4	10.1	11.1	17.2	11.7	3.5	5.4	10.2	6.9	6.1	7.5	5.0	7.9	6.4	6.6	10.0	3.1	4.6	4.1	2.2	2.5	3.4	3.9	2.6	3.1	2.7	16.5	3.9	4.7	1.5	2.7	3.5	15.7	20.6	24.2	18.0	13.0	11.7	14.7	11.4	15.8	14.6	3.0	11.3	4.3	8.7	14.8	0.0	2.8	10.2	6.7	14.8	12.2	0.0	10.4	1.7	9.3	11.6	8.9	12.4	0.0	7.6	5.5	9.4	14.8	7.0	8.5	9.8	0.0	12.0	13.5	24.0	12.1	12.7	12.9	13.5	2.8	11.1	0.0	9.9	8.6	10.6	5.7	0.0	6.5	5.0	20.9	24.0	12.0	11.4	7.0	9.3	11.6
MTMR4	"KIAA0647, ZFYVE11"	ENSG00000108389	"Myotubularin related protein 4"	Q9NYA4	17	58489529-58517905	"Enzymes, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Hepatocytes: 54.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA						"unprognostic (3.07e-1)"	"unprognostic (6.52e-2)"	"unprognostic (4.87e-3)"	"unprognostic (1.68e-2)"	"unprognostic (1.54e-1)"	"unprognostic (6.42e-2)"	"unprognostic (4.97e-2)"	"unprognostic (3.45e-3)"	"unprognostic (6.82e-2)"	"unprognostic (2.21e-1)"	"prognostic favorable (5.09e-4)"	"unprognostic (1.04e-1)"	"prognostic unfavorable (1.53e-5)"	"unprognostic (1.45e-1)"	"unprognostic (2.13e-1)"	"unprognostic (1.59e-2)"	"unprognostic (2.92e-2)"	8.7	9.9	16.6	10.3	18.7	14.4	11.6	32.7	22.7	8.3	11.4	18.3	6.7	17.7	10.3	16.2	9.5	10.1	6.7	8.3	15.8	14.4	14.6	32.0	8.0	13.4	16.5	15.4	13.3	10.4	16.2	11.2	29.8	36.9	10.9	14.8	11.1	8.7	9.1	6.1	11.8	17.3	9.4	10.9	13.3	9.4	15.2	17.3	15.5	13.9	3.4	18.2	9.7	8.2	8.4	6.3	9.9	7.9	3.3	5.8	3.8	9.5	10.5	16.0	15.5	9.9	10.1	12.4	5.8	10.0	15.4	14.3	10.2	6.3	20.1	8.3	6.0	12.2	5.7	17.2	10.0	16.6	20.7	11.9	13.7	8.4	13.5	11.1	14.2	12.5	10.4	8.1	10.5	16.9	10.1	11.1	13.6	11.7	14.6	7.6	14.4	28.0	9.5	3.9	18.3	10.7	18.0	12.0	9.9	7.2	20.3	25.5	24.6	5.7	6.8	7.9	8.6	13.2	9.9	5.9	24.1	15.5	6.8	7.0	12.1	13.3	15.1	38.7	10.8	7.2	4.7	5.4	9.9	4.3	6.8	3.9	8.3	5.2	4.7	6.3	8.4	5.6	5.8	6.6	3.3	7.9	3.7	4.9	3.8	16.6	18.7	32.7	22.7	15.8	14.4	16.5	15.4	36.9	17.3	8.9	6.1	17.6	11.6	6.8	0.0	8.1	15.3	0.0	10.3	3.5	0.0	10.3	0.0	8.0	4.3	8.8	40.4	0.0	5.7	15.3	8.3	13.3	5.8	54.3	11.8	0.0	16.6	12.3	13.2	4.5	13.3	9.9	11.8	36.1	15.8	0.0	7.8	20.7	16.3	9.0	0.0	0.0	8.2	4.6	5.3	7.2	41.6	14.6	14.6	7.3
MTOR	"FLJ44809, FRAP, FRAP1, FRAP2, RAFT1, RAPT1"	ENSG00000198793	"Mechanistic target of rapamycin kinase"	P42345	1	11106535-11262507	"Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"	"Biological rhythms"	"Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes, Disease mutation, Epilepsy, FDA approved drug targets, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Sertoli cells: 38.8;Spermatocytes: 48.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB069425, HPA071227"	Approved		Approved	Vesicles,Cytosol		NA	NA			"Vesicles, Cytosol"		"CAB069425: , HPA071227: AB_2686367"	"unprognostic (3.18e-1)"	"unprognostic (1.50e-1)"	"unprognostic (1.20e-1)"	"unprognostic (2.45e-3)"	"unprognostic (5.50e-2)"	"unprognostic (2.55e-2)"	"unprognostic (1.39e-1)"	"unprognostic (1.68e-1)"	"unprognostic (1.18e-1)"	"unprognostic (8.24e-3)"	"unprognostic (3.48e-2)"	"unprognostic (1.88e-1)"	"prognostic favorable (1.49e-5)"	"unprognostic (1.27e-1)"	"unprognostic (2.45e-1)"	"unprognostic (6.60e-2)"	"unprognostic (7.55e-2)"	11.3	13.9	18.7	13.0	22.5	12.3	14.9	25.2	25.2	11.3	14.5	18.2	10.4	11.2	13.8	23.6	13.1	10.5	15.7	14.2	14.5	13.6	15.8	19.4	10.8	14.3	14.0	14.4	10.7	16.6	26.5	16.0	12.5	15.5	15.2	17.1	14.4	14.2	15.2	24.6	16.5	13.6	15.2	10.4	15.4	13.1	38.6	13.1	16.6	13.2	9.9	15.7	11.7	10.2	3.9	4.0	3.0	6.4	2.6	5.6	2.3	15.2	13.9	18.7	14.2	22.7	10.8	9.4	12.9	12.4	17.3	17.0	14.2	14.1	17.0	11.1	15.2	10.7	18.2	25.3	19.8	22.4	13.5	18.5	22.6	28.7	17.9	14.2	21.9	16.8	13.8	15.1	24.7	25.1	8.2	21.8	16.4	25.2	14.6	12.0	17.4	15.1	16.8	14.2	16.0	13.1	15.2	22.1	11.4	15.3	13.9	18.9	13.9	27.6	15.0	16.9	21.5	12.2	13.0	23.3	15.1	13.7	11.5	17.3	14.4	13.4	33.4	10.9	23.8	15.9	0.7	2.9	3.0	5.2	6.4	4.3	3.9	3.0	2.7	4.0	3.4	3.6	3.1	2.0	2.6	3.3	3.1	5.6	2.3	18.7	22.5	25.2	25.2	14.5	13.6	14.0	14.4	15.5	13.1	14.9	10.2	5.2	4.5	3.1	0.0	25.7	2.5	2.7	10.3	8.7	0.0	6.5	1.7	6.3	31.2	7.8	7.9	0.0	5.4	5.9	5.1	7.5	12.7	13.0	6.1	0.0	9.9	5.5	7.3	29.3	7.2	6.0	8.5	5.4	6.8	0.0	8.6	3.5	7.8	4.3	0.0	38.8	6.9	48.4	31.3	5.0	8.2	6.5	9.5	5.5
MTPAP	"FLJ10486, mtPAP, PAPD1, SPAX4"	ENSG00000107951	"Mitochondrial poly(A) polymerase"	Q9NVV4	10	30309801-30374448	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"mRNA processing, Transcription"	"Nucleotidyltransferase, RNA-binding, Transferase"	"Disease mutation, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	9	"Early spermatids: 194.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038620, HPA058232"	Approved		Supported	Mitochondria		NA	NA			Mitochondria		"HPA038620: AB_10673015, HPA058232: AB_2683646"	"unprognostic (2.76e-2)"	"unprognostic (2.04e-1)"	"unprognostic (1.73e-1)"	"unprognostic (3.43e-3)"	"unprognostic (3.05e-2)"	"unprognostic (1.01e-1)"	"prognostic unfavorable (4.20e-6)"	"unprognostic (1.16e-1)"	"unprognostic (2.04e-1)"	"unprognostic (4.78e-2)"	"unprognostic (1.77e-1)"	"unprognostic (3.56e-2)"	"unprognostic (9.02e-2)"	"unprognostic (6.28e-3)"	"unprognostic (3.77e-1)"	"unprognostic (1.14e-2)"	"unprognostic (4.39e-2)"	10.9	12.7	9.9	10.2	12.4	32.8	11.1	12.4	16.1	9.6	9.9	7.3	6.5	11.0	10.4	7.0	12.6	9.5	7.6	11.5	7.8	7.2	10.6	11.1	9.4	10.5	11.9	13.0	11.4	18.9	9.5	7.2	10.0	11.4	8.0	12.0	8.2	10.7	10.2	22.3	13.1	10.0	14.3	9.0	9.3	9.7	10.6	8.3	6.7	11.0	12.4	10.5	11.7	9.1	15.6	22.9	18.4	24.4	16.9	17.1	8.3	14.2	14.3	9.1	13.1	9.0	8.5	11.8	10.0	3.5	10.2	10.7	15.1	20.1	20.4	7.1	6.5	9.4	16.9	17.5	11.6	12.5	10.3	13.7	20.7	13.5	15.2	9.4	13.5	16.3	8.3	10.8	11.4	6.8	5.7	11.0	19.2	22.3	16.1	7.6	11.9	16.2	12.0	6.1	10.8	7.7	16.4	16.1	19.0	9.4	9.5	15.0	12.1	9.0	9.4	13.9	8.9	9.1	8.7	10.6	10.8	13.9	15.0	11.0	3.6	8.7	27.9	9.2	24.8	3.8	16.4	18.5	18.4	16.2	24.4	17.1	15.6	15.4	15.6	22.9	13.1	16.7	16.8	3.0	16.9	18.1	12.0	15.5	8.3	9.9	12.4	12.4	16.1	7.8	7.2	11.9	13.0	11.4	8.3	8.9	6.1	9.7	10.8	22.3	0.0	15.3	5.1	10.7	11.4	3.5	0.0	12.2	16.6	7.7	194.2	12.0	7.8	0.0	7.9	9.8	11.5	8.6	4.7	12.1	12.7	0.0	4.1	10.4	12.3	17.1	11.2	11.5	8.5	10.8	13.7	0.0	8.4	0.0	15.6	11.0	0.0	12.9	11.4	21.9	17.2	21.8	9.6	9.6	16.6	14.0
MTR	cblG	ENSG00000116984	"5-methyltetrahydrofolate-homocysteine methyltransferase"	Q99707	1	236795281-236903981	"Disease related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins"	"Amino-acid biosynthesis, Methionine biosynthesis"	"Methyltransferase, Transferase"	"Disease mutation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Cardiomyocytes: 84.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA044474, HPA054915"	Approved		Supported	Cytosol		NA	NA			Cytosol		"HPA044474: AB_10966696, HPA054915: AB_2732589"	"unprognostic (2.12e-1)"	"unprognostic (1.03e-1)"	"unprognostic (6.96e-2)"	"unprognostic (1.99e-1)"	"unprognostic (1.35e-1)"	"unprognostic (1.76e-1)"	"unprognostic (4.87e-1)"	"unprognostic (1.02e-1)"	"unprognostic (2.48e-2)"	"unprognostic (3.34e-1)"	"unprognostic (5.73e-2)"	"unprognostic (1.63e-1)"	"unprognostic (1.67e-2)"	"unprognostic (8.84e-3)"	"unprognostic (1.88e-1)"	"prognostic unfavorable (5.75e-4)"	"unprognostic (8.10e-2)"	14.5	11.4	9.9	13.2	13.5	7.6	13.6	14.8	14.4	16.9	16.4	16.2	16.0	7.5	18.1	27.3	10.4	18.4	16.3	21.9	9.4	9.8	21.2	9.5	11.7	14.3	12.6	12.8	24.7	20.8	27.4	12.4	17.5	13.0	14.0	8.9	17.7	11.1	17.3	27.0	15.4	11.7	23.3	12.1	13.9	14.9	20.1	12.1	20.8	22.4	11.1	13.2	18.4	14.4	3.3	1.6	3.0	2.0	2.3	5.8	2.1	9.9	6.7	8.3	6.8	15.4	14.2	9.8	8.8	7.8	9.7	10.1	6.4	7.7	22.3	8.1	9.8	5.2	6.9	10.7	7.8	11.6	10.3	9.2	13.1	9.0	11.7	10.3	20.7	8.2	20.2	4.9	12.8	12.3	7.6	12.8	12.1	18.8	10.5	8.1	6.9	10.8	6.7	11.1	8.2	3.6	11.8	14.7	14.3	7.0	11.6	6.8	18.9	9.9	7.2	8.8	6.1	10.3	8.5	16.6	16.0	6.1	12.2	11.3	22.7	7.0	13.0	10.4	13.1	15.8	2.7	1.6	3.0	3.2	2.0	5.8	2.7	4.2	4.5	1.5	3.3	5.0	4.0	0.1	2.3	1.5	1.6	2.9	2.1	9.9	13.5	14.8	14.4	9.4	9.8	12.6	12.8	13.0	12.1	53.6	31.2	20.1	6.8	7.2	0.0	84.0	20.4	20.1	13.6	38.4	0.0	19.3	1.7	11.9	5.3	12.8	6.3	0.0	12.8	7.8	17.5	8.3	29.0	9.6	12.6	0.0	8.1	15.4	16.5	4.2	22.2	10.4	10.1	10.8	7.3	0.0	11.7	10.5	31.1	5.7	0.0	6.5	15.5	14.9	19.7	4.4	18.9	11.7	12.1	4.8
MTREX	"Dob1, fSAP118, KIAA0052, Mtr4, SKIV2L2"	ENSG00000039123	"Mtr4 exosome RNA helicase"	P42285	5	55307760-55425581	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing, rRNA processing"	"Helicase, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Alveolar cells type 2: 39.4;Ciliated cells: 48.2;Club cells: 39.8;Exocrine glandular cells: 35.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA037379	Supported		Supported	Nucleoplasm		NA	NA			Nucleoplasm		"HPA037379: AB_10601713"	"unprognostic (7.71e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.33e-3)"	"unprognostic (1.32e-1)"	"unprognostic (1.50e-1)"	"unprognostic (2.08e-1)"	"unprognostic (1.79e-2)"	"unprognostic (5.08e-1)"	"unprognostic (4.17e-2)"	"unprognostic (1.46e-2)"	"unprognostic (5.05e-2)"	"unprognostic (7.67e-2)"	"unprognostic (1.11e-2)"	"unprognostic (2.09e-1)"	"unprognostic (3.98e-1)"	"unprognostic (2.86e-1)"	"unprognostic (2.11e-1)"	23.6	23.6	26.1	24.9	24.0	18.7	24.1	40.6	31.2	22.0	19.3	15.2	28.8	27.6	26.2	17.8	23.3	20.0	22.4	24.3	22.0	16.0	21.2	22.7	19.7	24.7	21.1	21.5	25.9	25.8	35.8	45.0	19.0	26.6	25.6	21.7	10.4	21.8	28.7	71.3	23.8	24.3	20.9	37.5	20.9	20.6	22.3	21.5	29.7	29.3	19.2	21.7	24.4	23.4	9.8	10.9	5.8	10.3	5.9	10.4	4.0	14.2	20.0	14.6	15.5	12.4	13.1	19.6	13.1	10.0	14.8	18.9	21.4	18.7	27.7	15.5	11.5	19.6	9.9	28.4	18.0	22.2	4.9	23.5	18.9	18.9	16.3	11.4	11.1	12.6	10.3	12.3	15.6	19.1	11.6	12.8	10.4	22.3	16.0	14.3	13.0	11.9	14.7	13.2	5.9	19.4	14.6	16.3	12.2	16.0	20.9	18.0	11.1	14.9	8.5	12.8	14.6	20.4	16.1	11.5	3.8	9.7	10.7	22.0	11.8	12.4	23.9	9.7	25.5	14.7	4.9	6.6	5.8	10.4	6.1	10.0	8.8	7.7	9.7	7.9	9.8	8.1	8.3	1.9	5.9	10.3	10.9	7.5	4.0	26.1	24.0	40.6	31.2	22.0	16.0	21.1	21.5	26.6	21.5	29.8	39.4	0.0	0.0	0.0	0.0	0.0	0.0	48.2	39.8	19.2	0.0	21.8	10.0	23.4	0.0	0.0	0.0	0.0	35.5	18.3	0.0	0.0	23.3	0.0	13.2	0.0	0.0	0.0	0.0	0.0	0.0	8.2	0.0	24.4	0.0	0.0	29.8	0.0	0.0	17.0	0.0	0.0	0.0	0.0	0.0	0.0	29.2	0.0	0.0	0.0
MTRR	cblE	ENSG00000124275	"5-methyltetrahydrofolate-homocysteine methyltransferase reductase"	Q9UBK8	5	7851186-7906025	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Amino-acid biosynthesis, Methionine biosynthesis"	Oxidoreductase	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Alveolar cells type 2: 57.4;Late spermatids: 61.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA038113	Supported		Approved	"Nucleoplasm,Intermediate filaments,Cytosol"		NA	NA			"Nucleoplasm, Cytosol"	"Intermediate filaments"	"HPA038113: AB_10671520"	"unprognostic (1.06e-1)"	"unprognostic (1.08e-1)"	"unprognostic (5.32e-2)"	"unprognostic (1.17e-2)"	"unprognostic (1.63e-1)"	"unprognostic (2.43e-1)"	"prognostic unfavorable (6.60e-4)"	"unprognostic (2.56e-2)"	"unprognostic (5.82e-2)"	"unprognostic (7.43e-2)"	"unprognostic (1.29e-1)"	"unprognostic (9.11e-3)"	"unprognostic (3.44e-2)"	"unprognostic (1.30e-1)"	"unprognostic (2.60e-1)"	"unprognostic (1.56e-1)"	"unprognostic (1.12e-1)"	12.2	12.3	11.2	10.5	13.8	5.4	9.7	15.6	14.3	10.8	10.4	24.1	11.5	10.3	17.3	15.9	10.5	11.3	13.3	15.8	14.2	12.9	22.0	23.9	14.9	11.4	18.1	9.6	13.6	13.6	9.4	13.1	11.6	16.6	10.8	11.9	13.6	11.3	7.4	34.6	10.5	11.5	14.2	22.1	9.3	9.2	8.4	12.5	8.1	14.7	9.9	13.5	13.6	8.8	4.6	4.8	4.6	6.8	3.4	11.4	4.2	9.4	8.9	4.7	10.5	18.2	5.9	13.5	14.7	8.7	7.3	8.4	13.4	7.6	15.9	14.1	11.8	14.0	6.1	7.3	7.2	13.9	10.1	8.2	7.6	31.0	7.1	11.1	11.6	3.3	9.5	6.6	12.4	9.1	10.4	4.7	4.1	9.9	12.1	4.3	1.8	7.4	5.9	3.6	14.0	9.9	6.1	5.1	6.7	7.9	7.4	7.4	1.0	25.8	18.8	16.2	9.7	5.8	9.0	7.3	17.1	10.8	13.1	11.5	18.0	5.9	13.1	12.4	25.6	9.1	4.6	5.1	4.1	5.5	6.8	9.5	4.6	9.2	7.9	4.8	4.1	5.4	5.1	0.1	3.4	5.4	2.7	11.4	4.2	11.2	13.8	15.6	14.3	14.2	12.9	18.1	9.6	16.6	12.5	14.9	57.4	8.2	7.5	14.4	0.0	10.1	2.5	9.4	11.4	8.7	0.0	8.3	18.3	8.0	40.0	7.0	8.5	0.0	4.9	7.5	10.2	9.9	10.3	16.6	6.7	0.0	9.2	10.4	12.5	61.7	9.8	8.7	1.7	5.4	9.6	0.0	5.8	7.0	11.0	23.3	0.0	6.5	13.3	16.9	11.9	18.1	9.4	12.9	8.9	7.0
MUL1	"C1orf166, FLJ12875, GIDE, MAPL, MULAN, RNF218"	ENSG00000090432	"Mitochondrial E3 ubiquitin protein ligase 1"	Q969V5	1	20499448-20508161	"Enzymes, Predicted membrane proteins"	"Apoptosis, Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA026827			Approved	Nucleoplasm,Mitochondria,Cytosol		NA	NA			"Nucleoplasm, Mitochondria, Cytosol"		"HPA026827: AB_10601137"	"unprognostic (1.39e-1)"	"unprognostic (2.73e-2)"	"unprognostic (1.32e-2)"	"unprognostic (1.51e-1)"	"unprognostic (4.82e-3)"	"unprognostic (1.85e-3)"	"unprognostic (6.05e-3)"	"unprognostic (1.01e-1)"	"unprognostic (6.31e-2)"	"unprognostic (5.86e-3)"	"unprognostic (4.05e-1)"	"unprognostic (9.10e-2)"	"prognostic favorable (6.15e-14)"	"unprognostic (1.59e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.05e-2)"	"unprognostic (2.37e-1)"	13.3	15.9	10.3	12.9	12.3	20.6	20.4	9.2	22.2	13.1	15.8	19.0	8.0	11.6	18.2	10.7	17.2	17.0	18.5	26.2	11.7	12.5	20.5	20.1	16.3	12.1	16.8	9.5	17.5	26.8	21.9	13.0	21.6	17.6	13.9	13.3	14.3	15.3	18.1	26.7	17.4	19.5	17.0	11.7	13.6	15.2	14.1	11.6	18.5	15.1	14.6	14.0	16.3	13.6	23.2	26.0	31.9	30.4	25.2	32.1	27.5	17.1	16.6	9.6	19.8	20.8	11.7	10.4	17.0	20.4	21.2	20.5	10.2	28.5	12.9	19.1	24.0	16.1	26.1	17.2	24.6	15.5	12.8	13.6	9.9	11.2	14.8	24.5	13.5	17.0	19.1	32.5	21.7	22.6	12.5	13.8	11.7	12.9	15.8	23.0	8.7	8.1	9.1	9.8	14.3	15.9	8.0	12.1	16.7	25.0	9.6	9.8	14.5	15.3	16.4	20.9	8.1	11.5	13.0	15.6	20.7	11.9	18.0	15.2	18.5	16.1	13.9	16.2	18.4	19.1	26.3	26.5	31.9	30.9	30.4	32.1	23.2	23.6	31.4	26.0	21.5	27.1	26.3	24.0	25.2	25.4	20.1	32.1	27.5	10.3	12.3	9.2	22.2	11.7	12.5	16.8	9.5	17.6	11.6	20.8	9.3	11.7	7.8	4.6	12.5	14.6	12.7	9.4	6.8	17.4	5.9	33.7	10.0	21.4	1.6	9.7	12.0	0.0	20.3	20.8	12.1	8.1	3.5	11.9	19.7	12.7	8.2	10.4	11.4	2.8	12.0	7.7	18.6	21.6	11.8	15.6	19.7	11.5	14.5	8.7	10.5	19.4	8.5	10.6	13.4	6.1	31.5	10.8	10.1	9.0
MUSK		ENSG00000030304	"Muscle associated receptor tyrosine kinase"	O15146	9	110668771-110801620	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	Differentiation	"Developmental protein, Kinase, Muscle protein, Receptor, Transferase, Tyrosine-protein kinase"	"Congenital myasthenic syndrome, Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in many"	7	"skeletal muscle: 50.0"	"Cell type enhanced"	"Detected in some"	31	"Early spermatids: 2.7;Late spermatids: 3.3;Leydig cells: 4.9;Peritubular cells: 18.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	15	"LHCN-M2: 19.8;RH-30: 20.1"	"Region enhanced"	"Detected in some"		"basal ganglia: 4.5"	"Not detected"	"Not detected"									NA	NA						"unprognostic (6.12e-2)"	"unprognostic (9.01e-2)"	"unprognostic (5.39e-2)"	"unprognostic (3.66e-1)"	"unprognostic (3.14e-1)"	"unprognostic (1.20e-2)"		"unprognostic (1.50e-2)"		"unprognostic (2.46e-1)"	"unprognostic (3.13e-1)"	"unprognostic (7.58e-2)"	"unprognostic (6.03e-5)"	"unprognostic (4.58e-2)"	"unprognostic (1.62e-1)"	"unprognostic (9.67e-2)"	"unprognostic (5.11e-2)"	7.5	0.3	0.6	5.8	0.7	0.0	0.2	0.1	0.2	0.3	6.8	0.0	0.0	2.3	0.2	4.0	3.8	0.1	2.1	3.2	0.9	0.7	0.2	0.5	4.2	0.9	0.2	0.1	0.3	0.3	0.0	0.2	0.6	0.3	1.9	5.3	0.0	0.4	0.0	50.0	0.3	5.0	3.0	0.3	0.2	2.6	5.9	0.0	0.0	0.3	1.4	3.9	3.6	2.9	0.0	0.2	0.6	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	1.3	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	19.8	0.0	0.0	0.0	0.4	0.0	0.2	0.0	20.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.7	0.1	0.2	0.9	0.7	0.2	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.3	4.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	18.4	0.0	0.0	0.0	0.0	0.3	0.2	0.1	0.1	0.0	0.0	0.0
MUT		ENSG00000146085	"Methylmalonyl-CoA mutase"	P22033	6	49430360-49463191	"Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"		Isomerase	"Disease mutation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 96.5"	"Cell type enhanced"	"Detected in many"	6	"Hepatocytes: 117.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035971, HPA035972"	Enhanced		Approved	Mitochondria,Cytosol		NA	NA		110000	Cytosol	Mitochondria	"HPA035971: AB_10696648, HPA035972: AB_2674895"	"unprognostic (1.34e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.17e-2)"	"unprognostic (3.72e-2)"	"unprognostic (3.18e-3)"	"unprognostic (1.20e-1)"	"unprognostic (1.16e-2)"	"unprognostic (1.16e-2)"	"unprognostic (3.62e-2)"	"unprognostic (1.89e-2)"	"unprognostic (6.57e-2)"	"unprognostic (9.89e-2)"	"prognostic favorable (8.71e-13)"	"unprognostic (5.38e-2)"	"unprognostic (3.78e-1)"	"unprognostic (6.01e-3)"	"unprognostic (1.91e-1)"	10.7	14.3	10.9	5.7	13.4	4.1	9.7	10.0	12.1	8.9	12.7	8.6	9.0	13.6	8.7	8.6	13.2	8.4	7.5	16.6	10.1	10.0	25.5	96.5	7.8	5.7	11.8	9.5	13.1	15.7	15.8	13.5	7.5	12.0	11.2	11.2	8.0	9.3	9.2	13.7	9.0	14.7	11.8	9.7	6.4	10.9	9.1	9.9	8.2	11.2	9.1	5.8	12.8	8.1	9.4	8.9	14.0	15.2	14.2	12.0	6.7	13.4	4.8	14.5	16.9	28.9	27.5	8.0	12.1	16.0	12.8	19.0	5.5	7.0	12.5	9.7	12.9	19.4	7.7	16.1	8.6	18.1	10.6	11.7	6.6	11.0	14.4	21.1	8.5	6.4	16.6	12.8	13.0	15.2	11.5	12.3	13.6	12.0	15.0	15.0	8.4	9.9	8.4	6.2	14.2	3.5	8.9	18.2	17.2	14.8	12.9	13.5	9.4	13.3	9.6	20.0	15.9	8.3	13.6	8.8	11.9	8.8	16.1	16.3	5.9	6.7	10.7	16.8	10.0	10.4	14.0	7.5	12.5	7.9	9.9	9.9	9.4	9.5	9.9	8.9	8.3	12.0	9.0	4.3	14.2	15.2	6.3	11.9	6.7	10.9	13.4	10.0	12.1	10.1	10.0	11.8	9.5	12.0	9.9	17.9	17.4	10.4	16.2	17.7	16.5	60.2	22.9	18.7	21.6	31.4	2.0	21.2	24.9	14.4	5.7	10.0	27.4	0.0	12.8	11.2	13.8	13.3	10.4	117.7	10.8	19.1	50.0	14.1	10.0	2.1	22.2	9.4	8.5	2.8	23.1	28.2	10.5	23.0	26.2	34.2	15.2	32.3	12.2	18.6	14.3	17.6	27.9	7.9	21.2	11.5
MUTYH	MYH	ENSG00000132781	"MutY DNA glycosylase"	Q9UIF7	1	45329163-45340470	"Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"DNA damage, DNA repair"	"Glycosidase, Hydrolase"	"Cancer-related genes, Disease mutation, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Cytotrophoblasts: 33.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA008732	Uncertain		Supported	Nucleoplasm		NA	NA			Nucleoplasm		"HPA008732: AB_1854219"	"unprognostic (6.30e-3)"	"unprognostic (7.12e-2)"	"unprognostic (6.29e-2)"	"unprognostic (8.80e-2)"	"unprognostic (3.43e-1)"	"unprognostic (5.16e-3)"	"prognostic unfavorable (4.76e-8)"	"unprognostic (2.80e-2)"	"unprognostic (7.12e-3)"	"unprognostic (3.05e-2)"	"unprognostic (7.80e-2)"	"unprognostic (1.14e-1)"	"prognostic unfavorable (7.25e-5)"	"unprognostic (3.50e-3)"	"unprognostic (1.62e-1)"	"unprognostic (5.57e-2)"	"unprognostic (5.49e-3)"	7.7	8.4	10.3	12.7	14.8	11.1	8.3	31.6	12.4	10.5	10.1	15.1	11.0	11.1	11.5	9.8	8.3	11.0	10.0	6.1	10.9	7.3	9.7	9.0	7.2	14.0	13.6	10.1	12.9	8.4	7.5	12.5	12.5	11.6	9.1	11.0	12.6	9.5	11.7	8.5	11.1	9.8	7.5	12.6	12.8	11.8	4.9	16.6	14.1	11.9	7.4	12.0	9.3	9.2	7.2	6.5	1.9	8.9	6.6	15.4	6.3	4.9	4.3	10.1	6.9	7.2	5.4	17.6	3.4	4.7	7.4	6.1	9.1	7.0	13.9	6.1	2.3	5.9	7.6	5.3	6.3	3.4	11.5	4.0	6.8	6.9	6.5	6.7	5.8	5.0	3.6	6.5	9.9	16.6	1.9	5.3	18.3	10.5	5.4	3.1	8.0	15.9	5.5	25.5	11.7	5.3	21.6	7.8	7.5	3.8	9.3	9.2	7.2	7.4	5.8	11.5	13.6	4.6	6.7	3.3	6.5	4.0	5.0	5.4	8.2	9.4	8.5	5.6	8.8	4.9	1.5	5.6	1.9	9.8	8.9	15.4	7.2	10.2	9.9	6.5	7.2	11.3	11.0	0.9	6.6	6.8	5.5	10.3	6.3	10.3	14.8	31.6	12.4	10.9	7.3	13.6	10.1	11.6	16.6	0.0	6.4	7.0	10.7	6.2	14.7	3.1	0.0	9.4	6.8	7.0	2.0	33.3	3.3	5.7	0.8	5.2	13.7	0.0	4.6	11.1	7.0	7.0	10.4	3.9	8.7	4.8	7.5	6.7	6.4	0.6	10.0	6.9	6.8	9.0	12.3	11.8	3.3	14.0	11.3	7.0	18.5	12.9	7.1	7.1	11.1	4.6	18.5	12.9	12.5	6.4
MVD	MPD	ENSG00000167508	"Mevalonate diphosphate decarboxylase"	P53602	16	88651935-88663161	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Cholesterol biosynthesis, Cholesterol metabolism, Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis, Steroid metabolism, Sterol biosynthesis, Sterol metabolism"	Lyase	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041404, HPA048250"	Uncertain		Approved	"Cell Junctions,Cytosol"		NA	NA		30000	Cytosol	"Cell Junctions"	"HPA041404: AB_2677457, HPA048250: AB_2680329"	"unprognostic (1.67e-1)"	"unprognostic (3.05e-1)"	"unprognostic (2.42e-1)"	"prognostic favorable (2.17e-4)"	"unprognostic (1.89e-1)"	"unprognostic (9.56e-2)"	"unprognostic (9.26e-3)"	"unprognostic (8.33e-2)"	"unprognostic (6.68e-2)"	"unprognostic (5.47e-2)"	"unprognostic (2.51e-1)"	"unprognostic (6.22e-2)"	"unprognostic (1.19e-3)"	"unprognostic (4.12e-2)"	"unprognostic (1.69e-1)"	"unprognostic (2.11e-1)"	"unprognostic (5.00e-2)"	11.9	18.5	15.8	16.9	19.7	7.6	12.5	21.7	27.9	10.8	19.4	17.1	10.8	39.6	8.4	7.3	30.0	7.4	8.7	11.9	17.2	18.2	9.2	25.9	14.6	12.6	14.6	17.3	11.1	19.0	11.0	7.8	7.6	24.5	13.7	5.1	10.8	16.1	8.7	27.8	18.3	20.7	6.6	23.8	11.1	21.2	23.0	14.6	4.3	9.2	18.6	12.2	7.3	13.8	15.0	17.6	2.5	8.9	18.1	18.1	9.4	14.7	9.5	15.9	10.3	5.4	11.9	9.0	7.3	7.7	5.0	4.3	25.1	37.5	7.1	11.9	4.3	18.6	22.0	7.1	39.0	1.4	4.5	12.1	5.2	5.2	38.1	10.9	3.3	3.7	9.4	7.5	13.3	4.2	2.5	5.3	17.5	14.6	3.9	2.7	34.5	11.3	17.0	19.1	5.1	9.3	11.8	4.6	18.5	14.8	9.3	16.1	5.4	18.3	4.2	5.3	3.4	20.8	15.0	11.5	4.7	9.5	8.3	4.1	11.0	4.8	24.4	5.6	16.4	7.7	2.5	8.2	1.5	18.1	8.6	13.5	10.3	12.1	11.9	9.5	15.0	9.4	11.5	1.1	18.1	8.9	17.6	12.6	9.4	15.8	19.7	21.7	27.9	17.2	18.2	14.6	17.3	24.5	14.6	23.8	45.3	22.0	10.8	13.5	19.2	11.9	28.1	10.7	15.9	19.2	5.9	20.1	21.6	27.8	48.8	12.0	73.8	0.0	53.8	25.2	18.8	15.9	16.1	17.8	31.6	22.3	31.6	23.9	28.8	70.6	7.5	16.4	20.3	45.9	40.3	14.8	24.2	38.6	8.5	16.5	16.5	6.5	14.2	32.0	13.5	18.9	40.8	32.0	29.4	16.7
MVK	"LRBP, MK"	ENSG00000110921	"Mevalonate kinase"	Q03426	12	109573255-109598117	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Cholesterol biosynthesis, Cholesterol metabolism, Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis, Steroid metabolism, Sterol biosynthesis, Sterol metabolism"	"Kinase, Transferase"	"Cataract, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Early spermatids: 59.6;Horizontal cells: 58.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA016961, HPA044110"	Approved		Supported	Vesicles,Cytosol		NA	NA			"Vesicles, Cytosol"		"HPA016961: AB_1854220, HPA044110: "	"unprognostic (3.10e-1)"	"unprognostic (2.27e-2)"	"unprognostic (1.85e-1)"	"unprognostic (4.43e-2)"	"unprognostic (3.66e-2)"	"unprognostic (2.08e-2)"	"unprognostic (4.30e-2)"	"unprognostic (8.98e-2)"	"unprognostic (1.05e-1)"	"unprognostic (2.73e-2)"	"unprognostic (8.23e-2)"	"unprognostic (1.30e-1)"	"unprognostic (6.43e-2)"	"unprognostic (2.09e-1)"	"unprognostic (1.58e-1)"	"unprognostic (3.88e-1)"	"unprognostic (3.28e-1)"	4.7	14.3	6.8	5.9	11.7	6.8	11.2	6.3	13.1	7.1	7.8	16.7	5.1	11.5	4.2	9.5	23.0	5.1	5.3	6.7	7.8	9.0	16.5	33.1	8.7	4.9	12.5	8.3	8.5	9.3	7.0	6.5	5.5	22.5	9.0	6.3	6.4	8.1	5.8	6.3	19.5	6.9	3.7	18.0	3.8	6.1	17.5	10.5	2.8	11.9	8.5	8.8	5.5	9.9	11.5	7.4	3.4	5.9	8.3	12.2	5.4	12.4	10.5	12.8	6.3	4.1	10.1	6.8	4.5	8.4	11.9	13.0	15.0	15.1	8.7	3.5	4.5	19.3	15.1	13.5	21.3	5.8	8.6	9.6	4.7	7.1	22.5	12.7	4.9	6.0	11.0	18.0	21.5	5.8	5.1	8.0	8.5	8.0	8.3	5.3	15.7	5.1	15.8	10.7	5.8	16.2	4.6	9.8	17.1	27.4	18.4	11.8	10.3	8.9	25.2	6.3	5.3	23.2	8.7	7.1	5.5	7.1	5.2	5.8	7.0	9.2	12.9	6.5	12.8	7.4	0.7	5.9	3.4	12.2	5.8	9.9	8.4	7.4	11.6	7.4	11.5	11.7	8.3	1.7	8.3	3.7	6.2	6.2	5.4	6.8	11.7	6.3	13.1	7.8	9.0	12.5	8.3	22.5	10.5	11.9	11.3	13.4	4.5	4.1	10.2	4.4	15.3	9.4	10.3	14.0	17.7	28.9	18.3	11.3	59.6	5.6	12.5	0.0	15.7	10.9	4.7	4.6	1.1	18.5	13.2	58.8	8.6	6.2	4.1	29.2	7.5	3.3	6.8	17.2	7.2	10.0	9.4	2.9	6.7	32.6	11.5	6.5	4.7	19.9	19.0	7.4	40.0	7.5	9.8	4.5
MYCBP2	"FLJ10106, KIAA0916, PAM"	ENSG00000005810	"MYC binding protein 2, E3 ubiquitin protein ligase"	O75592	13	77044655-77327050	"Enzymes, Predicted intracellular proteins"	"Biological rhythms, Ubl conjugation pathway"	"Guanine-nucleotide releasing factor, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HL-60: 40.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA058807			Supported	Nucleoplasm,Vesicles		NA	NA			Nucleoplasm	Vesicles	"HPA058807: AB_2732627"	"unprognostic (1.79e-1)"	"unprognostic (1.25e-1)"	"unprognostic (1.60e-1)"	"unprognostic (1.06e-1)"	"unprognostic (1.75e-1)"	"unprognostic (2.03e-2)"	"unprognostic (8.36e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.09e-1)"	"unprognostic (1.80e-1)"	"unprognostic (1.48e-1)"	"unprognostic (6.42e-2)"	"prognostic favorable (5.01e-5)"	"unprognostic (2.63e-1)"	"unprognostic (9.84e-2)"	"unprognostic (4.04e-2)"	"unprognostic (1.00e-1)"	28.0	13.4	31.0	26.1	28.8	24.1	22.4	31.3	32.7	15.5	10.9	8.1	11.5	8.0	16.2	26.7	18.9	11.7	11.1	13.5	24.1	18.6	12.3	13.2	12.4	29.8	15.3	31.1	22.8	12.6	14.5	17.2	9.6	20.0	17.9	11.5	9.6	12.9	12.4	13.7	57.6	13.6	13.2	14.0	24.1	10.3	14.1	16.2	18.6	11.6	12.6	30.7	13.3	34.0	8.3	4.6	3.3	3.7	4.2	7.3	2.5	7.8	4.0	4.9	5.3	24.5	10.9	2.8	5.0	7.4	4.4	5.7	3.5	4.1	22.5	3.2	9.8	4.3	7.3	8.4	9.2	6.0	8.9	8.3	19.1	8.2	7.3	8.3	40.0	6.8	12.2	7.7	4.0	8.0	4.3	9.9	8.3	4.0	7.1	7.8	4.7	10.9	27.0	2.6	10.5	5.1	12.5	5.0	5.4	7.4	7.8	7.7	3.6	6.0	8.7	4.5	5.2	3.2	30.7	13.0	4.2	3.5	2.7	4.8	7.7	5.3	16.1	8.5	33.0	4.2	2.0	3.5	3.2	5.8	3.7	5.1	7.9	6.5	5.0	3.2	8.3	7.3	5.8	3.3	4.2	2.5	4.6	7.3	2.5	31.0	28.8	31.3	32.7	24.1	18.6	15.3	31.1	20.0	16.2	35.7	43.3	79.8	35.8	73.2	212.4	65.7	30.6	17.4	26.1	33.2	98.2	33.8	1.7	22.3	46.1	82.8	12.8	23.3	28.6	26.5	62.0	42.9	47.3	46.5	37.4	206.6	31.4	39.3	93.9	20.0	60.9	48.5	30.4	37.9	18.1	141.3	26.4	17.5	90.5	11.2	95.1	103.5	74.0	61.5	64.3	131.7	36.7	68.3	24.7	36.1
MYLIP	"IDOL, MIR"	ENSG00000007944	"Myosin regulatory light chain interacting protein"	Q8WY64	6	16129125-16148248	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"placenta: 84.0"	"Cell type enhanced"	"Detected in many"	7	"Syncytiotrophoblasts: 294.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"RPMI-8226: 33.8"	"Low region specificity"	"Detected in all"													NA	NA						"unprognostic (1.54e-1)"	"unprognostic (4.84e-3)"	"unprognostic (2.79e-1)"	"unprognostic (9.65e-3)"	"unprognostic (1.07e-1)"	"unprognostic (2.07e-2)"	"unprognostic (1.11e-2)"	"prognostic favorable (6.44e-6)"	"unprognostic (2.75e-2)"	"unprognostic (2.67e-2)"	"unprognostic (5.44e-3)"	"unprognostic (1.03e-2)"	"prognostic favorable (3.67e-4)"	"unprognostic (1.42e-2)"	"unprognostic (1.47e-1)"	"unprognostic (2.35e-1)"	"prognostic favorable (4.11e-5)"	23.4	12.5	7.3	10.3	10.6	44.2	19.5	5.4	11.4	28.5	14.4	18.9	16.4	7.5	31.8	16.1	12.1	22.2	19.1	9.0	8.6	6.1	13.1	3.5	19.0	19.4	12.9	8.8	22.3	10.5	9.8	6.1	84.0	7.4	20.1	9.7	20.2	16.2	20.9	20.6	16.7	15.7	18.0	7.0	23.5	14.8	15.2	12.2	8.8	39.1	10.9	15.7	19.0	33.7	4.9	1.4	14.2	2.3	3.2	8.4	1.5	2.0	4.1	1.7	2.0	17.3	4.6	4.5	1.4	3.4	3.5	7.6	11.5	2.1	9.2	7.4	2.2	2.4	5.1	8.1	2.5	3.0	3.3	8.4	6.2	4.3	2.1	2.5	4.2	6.1	7.4	3.3	1.8	1.4	1.7	8.0	2.0	17.8	10.9	1.3	7.7	0.1	20.8	4.9	4.9	3.7	2.1	7.9	33.8	3.7	24.6	8.6	3.7	1.8	18.8	9.5	14.8	3.5	10.4	2.3	1.6	4.0	1.2	3.6	10.1	4.4	4.9	1.0	12.3	5.5	8.5	2.3	11.1	8.4	2.2	7.3	4.9	5.3	5.9	1.4	4.9	5.9	5.4	14.2	3.2	2.0	0.7	3.2	1.5	7.3	10.6	5.4	11.4	8.6	6.1	12.9	8.8	7.4	12.2	20.8	36.3	30.2	28.3	87.0	7.3	74.2	35.7	21.4	18.2	21.0	0.0	113.9	8.3	14.9	36.7	33.1	32.6	0.0	16.2	65.2	75.2	27.4	35.7	1.0	27.7	11.1	80.9	34.4	42.6	12.5	35.6	21.9	75.9	26.2	35.2	15.3	8.1	32.3	58.0	18.8	6.6	135.8	92.6	59.7	17.5	73.4	294.6	88.3	34.8	26.9
MYLK	"MLCK, MLCK1, MYLK1, smMLCK"	ENSG00000065534	"Myosin light chain kinase"	Q15746	3	123610049-123884331	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"		"Actin-binding, Calmodulin-binding, Kinase, Serine/threonine-protein kinase, Transferase"	"Aortic aneurysm, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"smooth muscle: 191.1"	"Cell type enhanced"	"Detected in many"	16	"Peritubular cells: 649.2;Sertoli cells: 271.7;Smooth muscle cells: 829.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	10	"basophil: 3.6;classical monocyte: 1.3;myeloid DC: 2.8;neutrophil: 4.5;plasmacytoid DC: 2.7"	"Group enriched"	"Detected in many"	13	"dendritic cells: 2.8;granulocytes: 4.5;monocytes: 1.3"	"Cell line enhanced"	"Detected in many"		"BJ: 36.4;BJ hTERT+: 55.1;fHDF/TERT166: 45.0;HBF TERT88: 29.0;hTERT-RPE1: 38.5;RPTEC TERT1: 59.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"CAB020789, HPA031677, HPA048055"	Enhanced		Enhanced	"Plasma membrane,Actin filaments"		NA	NA		3000000	"Actin filaments"	"Plasma membrane"	"CAB020789: , HPA031677: AB_10794617, HPA048055: AB_2732543"	"unprognostic (2.80e-2)"	"unprognostic (5.05e-2)"	"unprognostic (5.55e-2)"	"unprognostic (2.85e-2)"	"unprognostic (1.69e-1)"	"unprognostic (1.41e-1)"	"unprognostic (4.86e-2)"	"unprognostic (8.55e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.40e-1)"	"unprognostic (8.21e-2)"	"unprognostic (1.58e-1)"	"prognostic unfavorable (2.04e-6)"	"unprognostic (5.26e-3)"	"unprognostic (9.60e-2)"	"unprognostic (3.00e-1)"	"prognostic unfavorable (4.46e-4)"	14.9	4.9	4.5	19.8	10.9	0.0	14.4	0.8	5.8	77.1	107.3	22.0	93.2	9.4	111.2	48.3	96.0	56.3	40.6	6.6	4.7	3.2	8.3	5.4	13.2	6.5	25.8	2.8	50.2	1.6	0.5	1.1	8.0	16.0	85.1	27.6	6.0	17.6	158.6	1.6	4.8	33.3	191.1	28.8	7.4	38.7	17.4	13.0	0.2	4.1	2.5	3.4	137.1	21.3	0.2	2.8	4.5	1.3	0.0	0.2	17.3	2.5	7.7	2.0	1.3	2.1	0.4	0.9	36.4	55.1	23.6	16.9	1.6	1.4	0.1	8.2	45.0	11.2	0.9	0.9	0.3	29.0	0.0	0.1	20.3	0.2	5.0	10.9	0.1	1.9	6.8	0.7	4.6	6.9	38.5	1.8	0.2	0.2	0.1	17.4	0.3	0.0	0.5	2.2	0.1	1.0	2.3	1.2	6.6	59.6	1.4	0.3	1.1	3.7	0.4	0.6	5.0	0.2	0.0	6.7	7.2	2.6	1.7	5.9	0.6	0.7	0.0	18.5	0.2	1.8	3.6	1.3	0.3	0.1	0.2	0.0	0.2	0.0	0.0	2.8	0.1	0.2	0.1	4.5	0.0	0.0	2.7	0.1	17.3	4.5	10.9	0.8	5.8	4.7	3.2	25.8	2.8	16.0	13.0	14.9	34.7	2.9	24.1	18.2	2.5	16.5	33.1	5.3	6.8	26.2	117.8	0.6	3.3	4.5	38.5	34.3	13.8	0.0	3.6	0.6	23.4	4.9	2.3	169.4	4.0	3.2	10.9	66.9	9.2	26.0	97.0	8.0	18.6	0.0	3.0	4.8	2.7	24.0	649.2	9.6	18.7	271.7	829.4	3.0	3.3	17.7	2.1	0.5	3.7	1.6
MYLK2	"KMLC, MLCK2, skMLCK"	ENSG00000101306	"Myosin light chain kinase 2"	Q9H1R3	20	31819308-31834689	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		"Calmodulin-binding, Kinase, Serine/threonine-protein kinase, Transferase"	"Cardiomyopathy, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	10	"skeletal muscle: 176.1"	"Cell type enhanced"	"Detected in single"	29	"Hofbauer cells: 1.4"	"Cancer enhanced"	"Detected in some"		"glioma: 1.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"Karpas-707: 5.3;RH-30: 13.5;RPMI-8226: 10.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA059704, HPA059890"	Enhanced		Supported	"Endoplasmic reticulum"		NA	NA			"Endoplasmic reticulum"		"HPA059704: AB_2684108, HPA059890: AB_2684153"	"unprognostic (1.74e-2)"	"unprognostic (1.87e-1)"	"unprognostic (8.84e-2)"	"unprognostic (5.27e-2)"	"prognostic favorable (4.00e-4)"	"unprognostic (5.58e-2)"	"unprognostic (1.38e-7)"	"unprognostic (2.29e-1)"	"unprognostic (2.60e-3)"	"unprognostic (1.99e-1)"	"unprognostic (1.20e-1)"	"unprognostic (4.73e-2)"	"unprognostic (7.25e-11)"	"unprognostic (2.01e-1)"	"unprognostic (3.15e-1)"	"unprognostic (2.60e-2)"	"unprognostic (2.70e-2)"	1.4	0.0	0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.9	1.4	0.0	0.0	0.3	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	4.4	0.0	0.0	0.0	0.0	0.2	0.0	0.0	1.4	0.3	176.1	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.0	1.1	18.2	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.9	0.8	0.0	0.0	0.5	0.1	0.0	0.4	0.1	0.3	0.3	0.6	0.4	0.0	0.2	0.1	0.1	0.0	0.2	0.2	0.2	0.7	0.3	0.0	0.0	0.6	0.1	0.0	0.0	0.4	0.0	1.7	1.0	0.7	0.2	5.3	0.1	0.8	0.7	0.4	0.7	0.0	0.4	0.8	13.5	10.9	0.1	0.1	0.7	0.6	3.4	0.1	0.0	0.1	0.1	0.1	2.7	0.3	1.0	0.6	3.0	0.1	1.0	0.2	0.2	3.2	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0
MYLK3	"caMLCK, MLCK"	ENSG00000140795	"Myosin light chain kinase 3"	Q32MK0	16	46703369-46790407	"Enzymes, Predicted membrane proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"heart muscle: 62.2;skeletal muscle: 20.8;tongue: 31.1"	"Cell type enriched"	"Detected in some"	10	"Cardiomyocytes: 162.4"	"Not detected"	"Not detected"			"Region enhanced"	"Detected in many"		"pons and medulla: 6.6"	"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"BEWO: 9.7;HEL: 29.1;K-562: 4.5;SK-BR-3: 6.1"	"Group enriched"	"Detected in some"	7	"cerebral cortex: 9.8;hippocampal formation: 5.7"	"Region enriched"	"Detected in single"	5	"hippocampal formation: 5.2"	HPA073447	Enhanced		Approved	Nucleoplasm,Vesicles		NA	NA			Nucleoplasm	Vesicles	"HPA073447: AB_2732225"	"unprognostic (6.01e-4)"	"unprognostic (2.19e-1)"	"unprognostic (2.64e-1)"	"unprognostic (1.77e-2)"	"unprognostic (1.84e-1)"	"unprognostic (2.94e-3)"	"unprognostic (2.60e-1)"	"unprognostic (4.73e-2)"	"unprognostic (3.33e-2)"	"unprognostic (2.41e-2)"	"unprognostic (6.58e-3)"	"unprognostic (1.83e-1)"	"unprognostic (4.16e-2)"	"unprognostic (2.57e-2)"	"unprognostic (2.52e-1)"	"unprognostic (1.08e-2)"	"unprognostic (2.97e-1)"	0.0	0.1	0.7	0.0	1.7	0.1	0.0	0.1	0.2	0.2	0.0	3.8	0.0	0.0	0.1	3.4	2.0	0.8	0.1	62.2	1.5	1.4	0.4	0.0	0.2	0.1	0.1	0.4	0.2	0.1	0.1	0.5	0.2	6.6	1.0	0.0	0.0	1.3	0.0	20.8	0.0	0.0	0.0	0.3	0.0	0.0	2.9	0.3	0.0	0.1	31.1	1.1	0.1	0.0	1.2	0.9	2.6	0.7	1.2	0.7	0.2	0.0	0.1	0.1	0.1	0.0	0.0	9.7	0.0	0.0	0.0	0.0	0.7	0.1	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	29.1	1.6	0.1	0.1	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.5	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.3	0.3	0.0	6.1	0.2	2.9	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.4	0.0	0.3	0.0	0.1	0.0	2.5	0.7	0.6	0.6	0.4	0.4	0.7	0.5	0.5	0.3	1.2	0.7	0.7	2.6	1.2	0.5	0.9	0.3	0.2	0.7	1.7	0.1	0.2	1.5	1.4	0.1	0.4	6.6	0.3	0.0	3.5	0.0	0.7	0.0	0.5	162.4	0.0	16.0	6.8	0.0	2.0	1.4	0.0	0.0	7.4	0.0	0.0	0.0	0.2	0.4	1.4	0.6	1.1	0.0	0.4	0.0	0.0	0.6	0.0	3.2	0.6	0.5	0.0	0.0	0.0	0.5	0.1	0.0	0.0	0.0	1.4	0.0	0.0	0.9	0.2	0.0	0.2	0.0	0.0	0.2
MYLK4	SgK085	ENSG00000145949	"Myosin light chain kinase family member 4"	Q86YV6	6	2663629-2750966	"Enzymes, Predicted membrane proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in some"	17	"skeletal muscle: 23.6;tongue: 63.6"	"Cell type enhanced"	"Detected in some"	6	"Alveolar cells type 1: 3.0;Cholangiocytes: 2.5;Proximal tubular cells: 2.9"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in single"			"Low cell type specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Cell line enriched"	"Detected in some"	6	"HEL: 12.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA015860	Uncertain		Approved	"Nucleoli,Golgi apparatus,Vesicles"		NA	NA			"Golgi apparatus"	"Nucleoli, Vesicles"	"HPA015860: AB_2147922"	"unprognostic (1.75e-1)"	"unprognostic (2.04e-1)"	"unprognostic (1.87e-1)"	"unprognostic (5.22e-3)"	"unprognostic (1.85e-1)"	"unprognostic (2.99e-2)"	"unprognostic (7.48e-2)"	"unprognostic (2.80e-1)"	"unprognostic (5.32e-2)"	"unprognostic (2.25e-1)"	"unprognostic (2.02e-2)"	"unprognostic (2.91e-1)"	"unprognostic (2.74e-3)"	"unprognostic (1.43e-1)"	"unprognostic (2.65e-1)"	"unprognostic (1.19e-2)"	"unprognostic (4.63e-2)"	0.5	0.3	0.3	0.3	0.4	0.4	0.8	1.4	0.7	0.3	0.3	0.3	0.3	0.1	0.3	0.5	1.0	0.2	0.3	1.0	0.5	0.5	2.6	0.3	0.5	0.3	0.4	0.3	0.3	1.1	0.7	0.7	0.4	0.4	0.4	0.1	0.4	2.4	0.4	23.6	0.8	0.3	0.3	0.3	0.3	0.3	0.3	0.3	0.3	1.0	63.6	1.5	0.5	0.3	0.1	0.8	0.3	0.3	0.9	1.4	0.1	0.3	0.2	0.6	1.2	1.0	1.2	0.6	0.7	1.6	0.5	0.4	0.5	1.1	1.1	1.6	0.8	0.2	1.9	0.2	0.5	0.7	0.2	0.6	12.7	0.6	0.1	0.3	0.3	0.6	1.5	0.5	0.1	1.2	0.6	0.5	0.2	0.1	0.1	0.3	0.5	0.1	1.4	0.2	0.4	0.0	0.9	0.0	0.0	0.9	0.3	1.0	0.6	0.3	0.2	0.5	1.1	0.4	0.8	0.7	0.5	0.1	0.2	0.4	0.4	0.2	0.1	0.2	0.3	1.3	0.1	0.1	0.1	0.5	0.0	0.3	0.1	0.2	1.4	0.2	0.1	0.6	0.1	0.3	0.9	0.3	0.8	0.1	0.1	0.3	0.4	1.4	0.7	0.5	0.5	0.4	0.3	0.4	0.3	3.0	0.6	0.0	0.1	0.1	0.8	1.2	2.5	0.0	1.2	0.0	0.0	0.3	0.0	0.1	0.4	0.5	0.0	0.0	0.2	0.0	0.4	0.1	0.0	0.0	0.2	1.6	1.2	0.0	0.3	0.0	0.3	1.0	0.0	1.8	0.0	0.2	0.0	0.0	1.4	2.9	0.2	0.0	0.0	0.0	0.1	0.6	0.2	0.0	0.0	0.1
MYO3A	DFNB30	ENSG00000095777	"Myosin IIIA"	Q8NEV4	10	25934071-26212536	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Hearing, Sensory transduction, Vision"	"Actin-binding, Kinase, Motor protein, Myosin, Serine/threonine-protein kinase, Transferase"	"Deafness, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"pituitary gland: 8.1;testis: 12.5"	"Cell type enhanced"	"Detected in some"	23	"Early spermatids: 127.9;Late spermatids: 34.5;Muller glia cells: 68.5"	"Low cancer specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"basal ganglia: 5.0;cerebral cortex: 1.9;hypothalamus: 1.3;pons and medulla: 5.4"	"Cell type enriched"	"Detected in single"	12	"naive B-cell: 1.1"	"Lineage enriched"	"Detected in single"	12	"B-cells: 1.1"	"Cell line enhanced"	"Detected in some"		"AF22: 2.3;CAPAN-2: 2.2;HEK 293: 2.7;SCLC-21H: 2.5;U-2 OS: 4.4;U-698: 11.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"HPA051893, HPA075413"	Enhanced		Supported	"Plasma membrane,Actin filaments,Cytoplasmic bodies"		No	No			"Actin filaments, Cytoplasmic bodies"	"Plasma membrane"	"HPA051893: , HPA075413: "	"unprognostic (5.00e-3)"	"unprognostic (3.36e-2)"	"unprognostic (1.53e-1)"	"unprognostic (3.20e-3)"	"unprognostic (2.96e-1)"	"unprognostic (4.37e-2)"		"unprognostic (5.29e-2)"	"unprognostic (2.74e-1)"	"unprognostic (4.31e-2)"	"unprognostic (1.03e-1)"	"unprognostic (5.66e-3)"	"unprognostic (7.96e-3)"	"unprognostic (6.34e-2)"	"unprognostic (1.46e-2)"	"unprognostic (6.62e-2)"	"unprognostic (9.69e-2)"	0.8	0.7	0.4	0.3	5.0	0.5	1.5	0.3	1.9	2.1	0.6	0.1	0.7	0.4	0.3	3.2	0.9	1.1	0.3	0.3	0.5	1.3	0.9	0.2	1.0	0.3	0.2	0.0	0.5	2.1	0.2	8.1	0.2	5.4	0.5	1.1	3.8	0.2	0.6	0.3	2.2	0.6	1.0	0.4	0.3	0.9	12.5	0.8	0.0	1.3	1.4	0.9	0.5	0.9	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	1.6	1.5	0.0	0.0	1.2	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	4.4	0.0	0.0	0.0	0.0	11.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	5.0	0.3	1.9	0.5	1.3	0.2	0.0	5.4	0.8	0.0	0.3	0.0	0.3	1.5	0.9	0.6	0.0	0.0	4.5	0.0	0.0	0.0	1.7	0.5	127.9	0.0	0.0	0.0	0.0	0.3	0.0	0.3	0.0	0.0	0.1	0.0	1.7	0.0	0.0	34.5	1.1	0.0	0.0	0.0	0.2	68.5	0.3	0.0	1.1	1.4	3.4	0.0	0.0	20.0	5.8	0.9	0.0	0.0	0.0	0.1
MYO3B		ENSG00000071909	"Myosin IIIB"	Q8WXR4	2	170178145-170655171	"Enzymes, Predicted intracellular proteins"	"Hearing, Sensory transduction, Vision"	"Actin-binding, Kinase, Motor protein, Myosin, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"epididymis: 20.0;parathyroid gland: 12.6;retina: 21.6"	"Cell type enhanced"	"Detected in some"	20	"Cone photoreceptor cells: 80.5;Early spermatids: 23.6;Late spermatids: 18.5;Rod photoreceptor cells: 57.8"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"gdT-cell: 1.4;naive CD8 T-cell: 1.1"	"Lineage enriched"	"Detected in single"	5	"T-cells: 1.4"	"Group enriched"	"Detected in some"	10	"HDLM-2: 11.3;HEL: 10.4;RT4: 11.7"	"Region enriched"	"Detected in single"	5	"basal ganglia: 4.7"	"Not detected"	"Not detected"			HPA045483	Approved					NA	NA					"HPA045483: AB_2679344"	"unprognostic (1.65e-1)"	"unprognostic (7.87e-2)"	"unprognostic (1.96e-2)"	"unprognostic (1.43e-2)"	"unprognostic (1.67e-1)"	"unprognostic (7.15e-3)"	"unprognostic (5.07e-2)"	"unprognostic (2.61e-2)"	"unprognostic (5.84e-3)"	"unprognostic (2.12e-1)"	"unprognostic (7.99e-3)"	"unprognostic (2.59e-1)"	"unprognostic (4.25e-5)"	"unprognostic (2.34e-1)"	"unprognostic (8.12e-3)"	"unprognostic (1.18e-1)"	"unprognostic (1.07e-1)"	0.2	0.2	0.3	0.0	0.3	0.0	0.2	0.2	0.3	0.6	0.2	0.0	4.6	0.0	0.3	20.0	0.3	0.5	0.0	0.3	0.3	0.5	8.5	0.2	0.3	0.5	0.3	0.3	0.4	2.2	12.6	1.0	0.0	0.3	0.3	0.0	21.6	1.4	1.1	0.2	0.5	0.2	0.5	0.2	0.3	0.2	4.2	0.0	0.0	2.2	0.0	0.8	4.4	0.3	0.1	0.3	0.0	0.0	0.0	1.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	11.3	0.0	10.4	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	1.0	11.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.5	0.3	0.1	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.3	0.2	0.3	0.3	0.5	0.3	0.3	0.3	0.0	0.0	0.3	0.0	0.3	0.6	2.9	0.4	0.0	0.0	0.0	3.5	80.5	0.0	11.6	0.3	23.6	0.3	0.0	0.0	0.0	0.0	0.3	0.2	0.0	0.0	0.0	0.0	1.7	0.0	0.3	18.5	0.3	0.2	0.0	0.0	0.2	1.6	0.1	0.0	0.4	0.1	57.8	0.0	0.1	0.9	0.2	0.4	0.1	0.0	0.0	0.1
MYSM1	KIAA1915	ENSG00000162601	"Myb like, SWIRM and MPN domains 1"	Q5VVJ2	1	58654739-58700092	"Enzymes, Predicted intracellular proteins"	"Transcription, Transcription regulation, Ubl conjugation pathway"	"Activator, Chromatin regulator, DNA-binding, Hydrolase, Metalloprotease, Protease"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA054291, HPA057306"	Approved		Supported	Nucleoplasm,Nucleoli		NA	NA			Nucleoplasm	Nucleoli	"HPA054291: AB_2682438, HPA057306: "	"unprognostic (2.95e-3)"	"unprognostic (3.64e-2)"	"unprognostic (3.20e-2)"	"unprognostic (8.68e-2)"	"unprognostic (2.08e-2)"	"prognostic favorable (5.09e-5)"	"unprognostic (8.12e-3)"	"unprognostic (9.63e-3)"	"unprognostic (5.72e-3)"	"unprognostic (3.74e-1)"	"unprognostic (2.25e-1)"	"unprognostic (4.56e-2)"	"unprognostic (2.38e-3)"	"unprognostic (4.22e-2)"	"unprognostic (1.83e-1)"	"unprognostic (8.45e-2)"	"unprognostic (1.44e-2)"	13.2	12.3	14.1	14.4	15.7	24.4	17.3	16.9	24.3	14.3	13.7	11.4	11.9	12.5	17.5	14.3	13.5	13.0	9.9	14.1	11.7	8.1	11.0	11.0	12.9	14.3	14.0	13.3	18.1	14.0	16.5	19.2	11.3	18.0	14.4	11.6	9.3	15.5	15.2	23.2	20.4	14.6	13.7	15.2	14.2	11.5	8.3	14.7	11.9	15.5	10.6	12.9	13.3	14.7	1.1	0.7	2.2	2.1	0.2	2.3	0.5	8.3	2.4	6.2	6.6	5.7	7.3	8.9	5.0	5.6	5.0	4.3	4.2	3.7	8.7	1.5	3.8	5.9	6.4	6.8	2.9	9.6	5.8	4.6	10.5	1.1	4.6	6.9	15.8	8.0	5.2	5.0	6.4	3.3	6.6	1.2	5.6	11.1	5.6	5.7	2.8	7.7	13.2	9.8	3.4	4.5	6.6	14.9	5.3	4.1	3.2	5.1	5.0	4.2	8.3	11.7	11.7	2.5	9.0	4.0	8.9	4.0	6.8	9.5	10.2	4.8	11.6	5.2	11.5	9.7	0.8	0.7	0.5	2.0	1.0	1.4	0.9	1.4	1.6	0.6	1.1	2.3	1.1	2.2	0.2	2.1	0.7	1.4	0.5	14.1	15.7	16.9	24.3	11.7	8.1	14.0	13.3	18.0	14.7	20.8	28.9	12.6	19.3	16.9	20.3	24.6	10.2	22.7	48.9	10.4	23.6	7.0	13.3	7.0	3.2	17.3	18.0	0.0	8.1	4.8	11.6	20.1	54.4	12.4	9.7	17.5	15.5	31.3	13.2	4.0	11.8	14.6	8.5	15.4	16.2	12.0	10.3	14.4	16.3	6.3	26.3	25.8	14.1	13.0	20.4	16.2	9.5	25.5	13.6	22.6
NAA10	"ARD1, ARD1A, DXS707, TE2"	ENSG00000102030	"N(alpha)-acetyltransferase 10, NatA catalytic subunit"	P41227	X	153929242-153935223	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		"Acyltransferase, Transferase"	"Disease mutation, Microphthalmia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB006269, HPA030711"	Supported		Supported	Nucleoli,Cytosol		No	No			Cytosol	Nucleoli	"CAB006269: AB_425759, HPA030711: AB_2673579"	"unprognostic (7.57e-2)"	"unprognostic (1.40e-2)"	"unprognostic (1.81e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.02e-2)"	"unprognostic (1.94e-2)"	"unprognostic (4.52e-3)"	"unprognostic (1.22e-1)"	"unprognostic (1.68e-1)"	"unprognostic (1.04e-1)"	"unprognostic (9.01e-2)"	"unprognostic (9.63e-2)"	"prognostic unfavorable (3.29e-8)"	"unprognostic (1.28e-1)"	"unprognostic (1.40e-1)"	"unprognostic (1.29e-2)"	"unprognostic (7.48e-3)"	18.9	21.2	17.7	20.3	14.0	12.5	31.8	15.5	20.8	12.4	15.3	8.1	19.2	16.7	17.2	17.6	19.7	16.5	17.6	26.4	15.0	14.2	16.3	18.6	20.7	30.0	15.0	18.0	14.1	33.3	12.3	12.0	13.7	17.5	13.6	11.7	9.3	19.0	17.9	57.8	14.1	14.7	21.7	14.7	14.9	17.7	7.1	11.8	11.4	12.2	25.3	16.3	17.1	22.1	33.7	34.8	35.0	31.9	27.6	44.8	29.0	32.1	33.9	6.4	20.8	9.1	9.6	18.1	11.3	6.6	15.5	13.6	22.0	10.2	24.5	37.7	9.3	20.1	15.4	13.4	13.6	6.0	10.2	62.5	8.8	23.7	22.1	12.5	17.1	19.5	7.3	15.3	14.4	15.0	7.8	17.5	9.6	17.6	10.4	10.2	42.2	27.3	25.5	10.7	30.4	47.1	21.7	16.5	26.8	11.3	14.8	13.7	16.5	4.4	17.9	26.7	6.3	9.6	14.2	10.1	6.5	22.3	22.5	34.3	22.0	24.5	46.0	8.8	22.1	18.9	12.0	24.2	35.0	29.0	28.0	38.0	33.7	31.2	31.7	31.6	32.6	18.7	28.0	22.6	27.6	31.9	34.8	44.8	29.0	17.7	14.0	15.5	20.8	15.0	14.2	15.0	18.0	17.5	11.8	8.9	27.5	83.3	53.7	62.3	28.9	38.0	53.5	29.4	26.1	36.6	11.8	113.1	81.2	114.3	2.1	90.5	71.7	46.7	129.7	161.7	59.9	66.0	66.9	63.8	109.5	35.0	55.8	64.4	62.9	8.3	43.1	71.4	113.1	75.7	61.8	26.2	121.2	58.3	43.9	155.0	22.4	64.7	78.5	5.8	39.4	79.2	91.0	68.3	80.9	64.7
NAA11	"ARD1B, ARD2, hARD2"	ENSG00000156269	"N(alpha)-acetyltransferase 11, NatA catalytic subunit"	Q9BSU3	4	79225694-79326050	"Enzymes, Predicted intracellular proteins"		"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	166	"placenta: 32.1;testis: 30.5"	"Group enriched"	"Detected in some"	11	"Cytotrophoblasts: 16.7;Early spermatids: 21.1;Extravillous trophoblasts: 13.6;Late spermatids: 20.7;Spermatocytes: 14.4;Spermatogonia: 15.0;Syncytiotrophoblasts: 11.1"	"Cancer enhanced"	"Detected in some"		"testis cancer: 2.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"GAMG: 14.7;K-562: 8.8;U-266/70: 25.1;U-266/84: 8.0"					"Not detected"	"Not detected"			HPA035922	Approved		Supported	"Nucleoplasm,Golgi apparatus,Centrosome,Cytosol"		NA	NA			Nucleoplasm	"Golgi apparatus, Centrosome, Cytosol"	"HPA035922: AB_10673490"					"unprognostic (7.37e-2)"							"unprognostic (7.58e-2)"		"unprognostic (1.36e-1)"	"unprognostic (1.20e-1)"		"unprognostic (4.67e-1)"	0.1	0.1	0.1	0.0	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.0	0.1	0.1	0.1	0.1	32.1	0.1	0.1	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	30.5	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	14.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	8.8	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	2.5	0.0	0.2	0.2	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.1	0.0	25.1	8.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	16.7	0.0	0.0	21.1	0.0	0.0	0.0	0.0	13.6	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	20.7	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	14.4	15.0	0.0	11.1	0.0	0.0	0.0
NAA20	"dJ1002M8.1, NAT3, NAT5"	ENSG00000173418	"N(alpha)-acetyltransferase 20, NatB catalytic subunit"	P61599	20	20017116-20033655	"Enzymes, Predicted intracellular proteins"		"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA063344			Supported	Cytosol		NA	NA			Cytosol		"HPA063344: AB_2684991"	"unprognostic (2.94e-2)"	"unprognostic (1.14e-1)"	"unprognostic (7.14e-2)"	"unprognostic (2.59e-1)"	"unprognostic (1.89e-1)"	"prognostic unfavorable (1.96e-4)"	"unprognostic (2.00e-2)"	"unprognostic (1.11e-2)"	"unprognostic (2.40e-1)"	"unprognostic (6.18e-2)"	"unprognostic (9.30e-2)"	"unprognostic (3.85e-1)"	"unprognostic (2.93e-1)"	"unprognostic (1.72e-1)"	"unprognostic (2.13e-1)"	"unprognostic (2.28e-1)"	"unprognostic (1.32e-1)"	15.9	20.0	14.2	10.0	21.4	17.4	23.2	15.5	34.1	17.3	12.7	12.0	22.7	9.7	20.5	17.7	58.4	15.8	12.3	24.1	14.7	14.1	24.6	25.0	15.7	19.0	13.1	18.3	12.9	43.2	24.8	20.0	18.5	19.4	14.4	12.2	11.2	22.0	20.6	35.2	15.6	11.0	17.3	13.1	11.0	14.5	43.7	10.2	9.5	23.6	37.5	22.1	14.0	23.7	18.6	28.3	20.4	27.5	17.7	25.8	26.4	40.5	24.6	8.9	13.9	18.8	19.8	13.4	30.0	20.5	27.0	25.3	12.6	29.4	22.0	16.3	20.2	21.8	32.2	15.2	48.1	22.0	9.9	16.5	16.5	6.5	18.8	27.0	17.4	12.2	22.5	31.7	27.4	27.7	15.6	23.2	15.8	26.7	22.8	23.5	31.7	24.5	18.2	6.9	28.1	40.3	13.5	35.1	29.2	26.6	9.4	16.9	11.5	18.1	51.2	25.0	6.1	31.6	28.1	25.2	22.5	13.2	27.0	27.5	24.8	30.9	23.8	13.6	15.3	16.0	8.0	27.5	20.4	17.6	27.5	25.8	18.6	20.5	20.2	28.3	16.5	19.9	22.0	3.6	17.7	23.2	22.9	20.8	26.4	14.2	21.4	15.5	34.1	14.7	14.1	13.1	18.3	19.4	10.2	62.5	35.6	41.7	83.1	96.6	54.1	70.6	71.4	99.0	55.7	99.5	23.6	98.0	195.6	180.5	209.7	76.7	31.4	0.0	145.5	94.1	66.4	74.5	49.7	69.9	213.0	65.2	39.6	52.2	51.1	27.3	64.7	64.9	67.4	121.8	44.4	78.6	191.0	35.1	70.4	177.4	48.7	38.8	66.9	234.3	53.9	103.8	71.5	45.7	56.2	118.5
NAA30	"C14orf35, FLJ35355, MAK3, Mak3p, NAT12"	ENSG00000139977	"N(alpha)-acetyltransferase 30, NatC catalytic subunit"	Q147X3	14	57390544-57415917	"Enzymes, Predicted intracellular proteins"		"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Early spermatids: 72.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA057824	Uncertain		Supported	Cytosol		NA	NA			Cytosol		"HPA057824: AB_2683539"	"unprognostic (5.13e-2)"	"unprognostic (7.59e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.52e-2)"	"unprognostic (5.22e-2)"	"unprognostic (6.31e-2)"	"unprognostic (1.84e-2)"	"unprognostic (5.44e-2)"	"unprognostic (2.59e-1)"	"unprognostic (1.12e-1)"	"unprognostic (1.67e-1)"	"unprognostic (5.21e-2)"	"prognostic favorable (1.25e-8)"	"unprognostic (1.77e-1)"	"unprognostic (1.67e-1)"	"unprognostic (5.75e-3)"	"unprognostic (1.63e-1)"	10.7	10.3	15.8	10.7	18.3	15.0	16.4	18.1	18.9	9.9	15.0	9.2	8.6	11.4	12.1	8.8	13.5	9.1	12.5	18.8	13.9	15.6	14.7	19.1	8.2	9.6	12.9	16.4	18.1	10.5	16.2	13.4	15.4	12.0	12.3	9.6	9.6	10.8	12.8	34.9	10.5	13.5	13.0	9.9	9.8	8.6	21.4	10.1	15.0	12.6	13.6	10.3	12.8	13.7	2.6	1.5	1.7	5.3	5.5	4.2	0.8	14.1	13.6	7.8	12.7	13.2	17.3	13.2	16.6	16.1	12.7	11.6	12.2	10.5	10.4	14.7	13.7	9.7	15.0	14.0	10.7	21.3	18.0	7.2	8.4	7.8	10.6	13.8	16.8	9.8	11.7	16.0	11.5	19.3	14.2	19.5	13.0	8.2	10.4	16.8	16.3	14.0	9.8	8.3	13.1	15.2	11.2	22.5	8.1	13.1	12.9	16.8	8.8	14.0	13.9	16.8	14.6	17.8	8.8	17.0	20.0	21.0	10.9	10.5	7.7	9.3	12.7	13.2	8.5	14.1	1.7	0.9	0.5	2.9	2.1	3.0	2.3	2.8	4.2	0.8	2.6	3.0	2.8	0.4	5.5	5.3	1.5	3.7	0.8	15.8	18.3	18.1	18.9	13.9	15.6	12.9	16.4	12.0	10.1	8.9	7.5	12.0	10.0	36.5	12.8	36.4	15.3	6.7	5.7	3.5	17.7	14.5	8.3	11.2	72.4	16.1	8.5	0.0	10.2	13.2	13.2	14.3	6.9	21.2	8.7	9.5	20.2	11.6	10.7	23.6	12.7	6.9	21.9	8.2	14.6	12.3	11.8	11.9	12.7	13.7	13.4	19.4	12.3	44.7	16.9	36.0	18.5	14.6	10.9	12.4
NAA40	"FLJ13848, NAT11"	ENSG00000110583	"N(alpha)-acetyltransferase 40, NatD catalytic subunit"	Q86UY6	11	63938959-63957328	"Enzymes, Predicted intracellular proteins"		"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	8	"Horizontal cells: 96.9;Late spermatids: 100.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037816, HPA056142"	Uncertain		Supported	"Nucleoplasm,Centriolar satellite,Cytosol"		NA	NA			Nucleoplasm	"Centriolar satellite, Cytosol"	"HPA037816: AB_10672289, HPA056142: "	"unprognostic (3.52e-1)"	"unprognostic (4.12e-1)"	"unprognostic (1.40e-1)"	"unprognostic (6.88e-3)"	"unprognostic (1.50e-1)"	"unprognostic (2.11e-1)"	"prognostic unfavorable (1.43e-7)"	"unprognostic (1.45e-1)"	"unprognostic (1.13e-2)"	"unprognostic (1.58e-1)"	"unprognostic (7.01e-3)"	"unprognostic (6.29e-3)"	"unprognostic (3.42e-2)"	"unprognostic (6.43e-3)"	"unprognostic (2.49e-1)"	"unprognostic (1.55e-1)"	"unprognostic (5.25e-2)"	4.9	12.4	9.8	10.0	11.6	4.1	7.6	16.7	13.5	7.1	7.3	12.2	10.8	9.2	5.0	7.7	9.2	11.2	7.6	13.8	9.8	10.0	10.0	5.1	6.1	10.7	8.3	8.6	4.2	8.9	28.0	22.7	10.5	8.9	6.0	7.9	12.2	9.7	11.3	7.5	4.5	9.8	5.4	7.6	12.5	6.3	19.2	8.9	10.1	10.1	4.1	11.7	8.1	4.9	4.1	5.0	3.5	0.8	6.7	10.1	2.8	10.7	12.6	15.7	8.4	4.4	4.3	10.0	8.0	8.6	19.9	14.0	10.4	13.7	6.6	10.0	7.2	13.9	9.7	13.1	5.8	14.8	8.7	8.1	9.1	8.0	11.7	5.9	14.3	7.8	4.5	5.3	12.3	3.4	7.8	12.8	11.6	15.3	5.0	9.2	8.1	15.2	11.3	14.6	10.0	8.5	15.1	14.2	8.4	13.3	8.3	20.9	11.1	12.5	11.0	6.5	11.9	18.0	6.4	8.2	11.1	13.5	6.4	6.5	6.0	3.8	11.7	6.6	6.2	8.5	3.3	0.8	3.5	10.1	0.6	3.6	4.1	2.7	4.8	3.6	3.9	1.7	4.1	0.3	6.7	0.3	5.0	0.8	2.8	9.8	11.6	16.7	13.5	9.8	10.0	8.3	8.6	8.9	8.9	3.0	3.7	5.1	1.9	2.5	27.2	12.8	7.6	22.7	12.5	17.4	31.4	8.4	0.0	5.2	38.5	7.1	10.5	0.0	4.7	10.2	4.6	1.9	1.1	4.5	7.8	96.9	16.8	10.4	9.4	100.4	4.4	8.4	1.7	3.6	6.5	9.4	4.8	3.5	6.7	3.0	24.2	0.0	3.1	19.1	16.8	2.5	3.4	8.2	6.8	1.0
NAA50	"FLJ13194, MAK3, NAT13, NAT5, San"	ENSG00000121579	"N(alpha)-acetyltransferase 50, NatE catalytic subunit"	Q9GZZ1	3	113716460-113746300	"Enzymes, Predicted intracellular proteins"		"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 86.5"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA074489	Approved					NA	NA					"HPA074489: "	"unprognostic (9.74e-2)"	"unprognostic (1.49e-1)"	"unprognostic (3.19e-2)"	"prognostic unfavorable (2.32e-4)"	"unprognostic (4.75e-2)"	"unprognostic (1.51e-1)"	"prognostic unfavorable (1.51e-5)"	"unprognostic (1.62e-3)"	"unprognostic (6.82e-2)"	"unprognostic (3.43e-1)"	"prognostic unfavorable (7.92e-5)"	"unprognostic (2.97e-3)"	"unprognostic (1.09e-1)"	"unprognostic (2.25e-2)"	"unprognostic (9.59e-2)"	"unprognostic (7.13e-3)"	"unprognostic (2.43e-1)"	23.4	23.6	15.9	18.0	19.8	19.7	25.6	17.1	16.5	14.7	16.2	9.3	12.9	12.7	18.4	13.3	32.6	14.7	13.6	17.0	14.1	10.8	17.6	31.8	17.3	20.7	13.8	13.7	17.8	20.7	18.4	14.1	14.9	15.6	14.5	14.7	10.7	21.6	13.8	86.5	17.7	14.0	16.1	15.7	17.7	16.9	19.0	12.9	22.5	18.3	37.0	23.2	19.9	19.8	32.3	24.7	28.7	22.6	17.4	27.3	26.2	90.0	39.4	21.7	25.2	29.5	24.0	45.3	48.5	27.3	30.0	34.6	56.5	32.5	62.4	30.1	25.7	23.7	37.3	37.7	33.2	55.1	13.0	19.3	67.2	29.7	34.0	27.1	70.0	21.9	20.4	26.3	33.5	48.5	19.8	26.7	26.4	42.2	25.2	30.9	42.7	46.2	15.2	48.5	35.3	58.0	47.6	33.3	49.3	22.8	68.8	33.4	19.3	35.2	26.2	35.3	19.6	36.3	23.3	24.6	41.5	41.2	17.5	36.5	28.0	46.4	115.8	32.5	39.5	25.4	8.5	22.5	11.9	27.3	22.6	24.3	32.3	20.6	25.5	24.7	20.5	18.2	24.0	28.7	17.4	19.8	14.4	21.9	26.2	15.9	19.8	17.1	16.5	14.1	10.8	13.8	13.7	15.6	12.9	44.7	29.9	65.7	72.5	149.5	21.5	41.9	22.9	25.4	42.1	34.9	7.9	37.5	66.3	50.5	52.7	36.5	37.5	0.0	47.8	76.9	38.8	84.6	46.2	63.8	57.0	38.1	19.1	26.4	50.8	39.9	28.4	52.5	59.1	42.3	31.3	30.1	51.1	34.9	29.4	56.1	16.9	19.4	85.8	52.4	57.5	155.5	52.3	62.5	39.8	140.8
NAA60	"FLJ14154, NAT15"	ENSG00000122390	"N(alpha)-acetyltransferase 60, NatF catalytic subunit"	Q9H7X0	16	3443611-3486963	"Enzymes, Predicted intracellular proteins"	"Chromosome partition"	"Acyltransferase, Chromatin regulator, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA040916	Approved		Uncertain	"Actin filaments,Cytosol"		NA	NA			"Actin filaments, Cytosol"		"HPA040916: AB_10794428"	"unprognostic (8.59e-2)"	"unprognostic (2.16e-3)"	"unprognostic (3.39e-1)"	"prognostic favorable (3.14e-4)"	"unprognostic (1.81e-1)"	"unprognostic (5.90e-2)"	"unprognostic (2.88e-2)"	"unprognostic (1.53e-2)"	"unprognostic (5.23e-2)"	"unprognostic (5.12e-2)"	"prognostic favorable (4.30e-4)"	"unprognostic (9.54e-2)"	"unprognostic (1.64e-1)"	"unprognostic (1.60e-2)"	"unprognostic (8.96e-2)"	"unprognostic (3.59e-1)"	"unprognostic (6.74e-3)"	18.5	28.7	24.2	17.9	30.8	26.6	16.2	38.1	40.2	17.1	29.4	29.1	34.0	36.8	24.3	18.6	21.3	21.7	23.7	26.2	25.6	21.3	35.8	40.3	23.6	19.4	21.6	17.7	21.2	41.8	46.4	29.0	27.0	24.4	23.7	21.4	29.1	20.7	31.6	38.9	16.9	42.2	19.9	25.7	28.1	34.8	25.3	19.0	22.8	21.8	21.8	24.1	21.7	22.1	8.5	11.2	34.8	13.2	11.6	13.4	10.0	8.2	32.5	23.0	24.2	18.4	12.6	20.6	15.8	16.9	16.4	14.8	22.2	17.8	17.2	16.1	18.0	11.7	19.3	22.7	18.4	16.0	25.8	15.3	20.9	20.5	26.0	19.9	26.7	27.7	15.4	14.3	11.2	21.7	20.2	26.2	15.4	22.0	24.5	11.5	37.8	16.8	19.7	28.0	21.9	9.5	21.1	17.4	26.0	16.9	17.4	12.2	26.4	23.5	26.2	12.5	23.0	23.4	18.9	19.3	21.1	18.1	6.8	14.6	20.5	19.0	16.7	6.7	16.6	16.1	19.8	10.5	34.8	11.8	12.3	12.5	8.0	10.8	11.5	11.2	8.5	9.3	10.8	13.2	11.6	13.2	7.8	13.4	10.0	24.2	30.8	38.1	40.2	25.6	21.3	21.6	17.7	24.4	19.0	8.9	16.5	13.7	11.2	0.1	21.2	12.6	35.7	6.7	10.3	12.2	5.9	22.8	36.5	27.5	41.1	18.6	61.4	0.0	36.4	33.1	15.4	16.7	30.0	42.3	27.8	11.1	25.9	27.6	28.5	44.0	10.6	14.5	0.0	26.2	34.4	20.8	29.9	45.6	14.9	32.7	14.2	25.8	11.2	14.9	20.2	0.3	27.6	21.0	31.9	22.0
NAALAD2	"GCPIII, NAALADASE2"	ENSG00000077616	"N-acetylated alpha-linked acidic dipeptidase 2"	Q9Y3Q0	11	90131515-90192894	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"		"Carboxypeptidase, Dipeptidase, Hydrolase, Metalloprotease, Multifunctional enzyme, Protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"pituitary gland: 44.1"	"Cell type enhanced"	"Detected in some"	17	"Bipolar cells: 15.8;Early spermatids: 37.5;Horizontal cells: 66.7"	"Cancer enhanced"	"Detected in some"		"testis cancer: 1.5"	"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	6	"non-classical monocyte: 2.4"	"Lineage enriched"	"Detected in single"	12	"monocytes: 2.4"	"Cell line enhanced"	"Detected in some"		"CACO-2: 20.0;SH-SY5Y: 6.7;SuSa: 4.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA060820, HPA065419"	Approved		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA060820: AB_2684373, HPA065419: AB_2685487"	"unprognostic (1.68e-1)"	"unprognostic (2.66e-3)"	"unprognostic (1.49e-1)"	"unprognostic (4.52e-3)"	"unprognostic (4.73e-3)"	"unprognostic (2.97e-1)"	"unprognostic (3.82e-3)"	"unprognostic (1.77e-2)"	"unprognostic (2.44e-1)"	"unprognostic (2.30e-1)"	"unprognostic (3.30e-2)"	"unprognostic (8.00e-2)"	"unprognostic (9.97e-4)"	"unprognostic (1.52e-2)"	"unprognostic (2.54e-1)"	"unprognostic (1.63e-2)"	"unprognostic (2.93e-1)"	7.7	13.0	5.3	1.8	9.9	1.1	3.1	2.1	9.8	7.8	2.1	3.7	2.8	1.3	10.3	5.4	1.8	4.7	3.7	2.5	5.5	7.4	2.7	1.7	2.8	1.6	6.5	5.0	12.9	2.5	0.9	44.1	8.8	11.9	5.2	2.2	5.8	1.9	3.7	2.1	1.5	2.1	3.5	6.2	4.4	1.8	16.6	7.4	0.0	1.7	1.7	1.2	1.8	3.8	0.0	0.1	0.0	2.4	0.0	0.1	0.1	0.1	0.2	1.9	0.1	0.6	0.1	2.4	0.1	0.1	0.1	0.0	20.0	0.7	0.3	0.2	0.0	0.3	0.3	1.4	0.0	0.0	0.0	0.4	1.9	0.4	1.8	0.2	0.1	0.1	2.3	0.0	0.0	0.0	0.6	0.4	0.2	0.1	0.0	0.0	0.0	0.3	0.3	1.9	0.5	0.2	0.3	0.0	0.2	0.0	0.0	0.2	6.7	0.0	0.2	0.0	4.9	0.2	0.4	2.6	0.1	1.6	0.4	0.3	1.1	0.3	0.3	0.7	0.3	1.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	2.4	0.1	0.1	0.1	5.3	9.9	2.1	9.8	5.5	7.4	6.5	5.0	11.9	7.4	0.0	0.0	0.0	0.1	0.2	15.8	0.8	2.5	0.0	1.2	0.0	0.0	0.8	0.0	0.0	37.5	0.7	0.0	0.0	0.0	0.5	3.4	0.2	0.0	0.0	0.3	66.7	0.0	1.3	5.4	13.2	10.3	0.2	0.0	0.0	0.0	10.1	0.0	0.0	13.8	0.0	2.3	0.0	4.7	0.3	4.4	0.0	0.7	0.0	0.0	0.0
NAALADL1		ENSG00000168060	"N-acetylated alpha-linked acidic dipeptidase like 1"	Q9UQQ1	11	65044818-65058549	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Aminopeptidase, Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	12	"blood: 49.5;intestine: 123.4"	"Cell type enhanced"	"Detected in many"	7	"Enterocytes: 39.3;monocytes: 22.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"basophil: 49.5"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"ASC TERT1: 5.4;fHDF/TERT166: 6.8;HHSteC: 19.0;HSkMC: 12.5;SCLC-21H: 9.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA047123	Enhanced		Uncertain	Cytosol		NA	NA			Cytosol		"HPA047123: AB_2679942"	"unprognostic (2.98e-2)"	"unprognostic (2.06e-1)"	"unprognostic (1.58e-1)"	"unprognostic (8.76e-2)"	"unprognostic (1.70e-1)"	"unprognostic (1.28e-3)"	"unprognostic (1.36e-1)"	"unprognostic (1.40e-1)"	"unprognostic (1.89e-2)"	"unprognostic (1.38e-1)"	"unprognostic (3.03e-1)"	"unprognostic (2.18e-1)"	"unprognostic (1.75e-4)"	"unprognostic (2.10e-3)"	"unprognostic (3.22e-2)"	"unprognostic (1.45e-1)"	"unprognostic (4.80e-2)"	4.1	0.9	1.4	3.3	1.6	7.0	4.1	1.9	1.4	6.0	54.3	1.2	2.6	7.8	7.2	1.8	2.7	4.4	3.4	3.5	1.3	0.6	2.3	1.2	3.4	5.2	1.5	1.5	6.2	1.0	0.9	2.0	1.5	1.6	4.6	2.6	3.1	2.3	4.8	2.0	1.6	123.4	4.3	1.4	5.0	2.8	1.8	1.2	1.8	1.8	2.3	2.9	3.1	5.4	8.8	4.9	49.5	6.3	22.2	12.9	7.0	0.0	0.0	0.1	0.2	0.5	5.4	0.9	2.0	0.0	2.5	1.1	0.0	0.0	0.1	0.0	6.8	0.0	0.0	0.0	0.1	0.0	0.8	0.3	0.0	0.1	3.1	19.0	0.0	0.0	12.5	0.0	2.5	0.0	0.0	3.2	0.1	0.0	0.2	0.0	0.2	0.2	0.6	0.0	0.0	0.1	0.1	0.0	0.8	0.2	0.0	9.8	0.4	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.1	0.7	0.0	0.1	0.1	49.5	6.3	10.3	9.5	4.3	4.9	8.0	7.6	4.8	4.9	8.8	8.8	4.9	1.1	22.2	2.5	0.2	12.9	7.0	1.4	1.6	1.9	1.4	1.3	0.6	1.5	1.5	1.6	1.2	0.0	0.0	8.2	3.2	3.2	1.1	1.1	2.5	0.0	0.0	0.0	0.0	0.1	3.3	0.0	0.6	9.0	39.3	0.0	0.7	0.2	5.7	0.5	19.6	0.0	2.8	9.5	1.2	16.5	7.6	1.7	10.9	6.4	15.1	22.6	0.7	10.8	0.3	14.4	17.0	0.0	0.9	0.0	13.7	1.6	2.6	2.9	0.3	11.7	0.4	0.3
NAALADL2		ENSG00000177694	"N-acetylated alpha-linked acidic dipeptidase like 2"	Q58DX5	3	174438573-175810552	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"seminal vesicle: 29.3"	"Cell type enhanced"	"Detected in many"	8	"Early spermatids: 60.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"plasmacytoid DC: 1.7"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"ASC TERT1: 11.7;BJ hTERT+: 4.2;fHDF/TERT166: 4.9;WM-115: 4.5"	"Low region specificity"	"Detected in many"							"HPA012413, HPA017425, CAB025586"	Approved		Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"CAB025586: , HPA012413: AB_1854274, HPA017425: AB_1854275"	"unprognostic (7.28e-3)"	"unprognostic (1.10e-1)"	"unprognostic (6.28e-2)"	"unprognostic (1.60e-1)"	"unprognostic (2.56e-1)"	"unprognostic (2.56e-1)"	"unprognostic (2.29e-4)"	"unprognostic (3.44e-3)"	"unprognostic (5.70e-2)"	"unprognostic (7.42e-2)"	"unprognostic (7.85e-3)"	"unprognostic (9.49e-2)"	"unprognostic (3.66e-6)"	"unprognostic (7.11e-2)"	"unprognostic (1.48e-1)"	"unprognostic (9.05e-2)"	"unprognostic (2.22e-2)"	4.9	2.3	2.2	4.6	3.7	0.8	7.0	1.9	2.7	8.3	8.3	5.4	23.8	2.4	9.7	10.5	2.3	5.0	8.9	5.4	2.5	1.8	7.0	3.7	3.3	1.3	2.3	2.0	5.4	3.9	20.6	3.0	6.4	4.0	9.6	3.3	4.4	17.0	29.3	1.8	3.2	6.6	6.0	3.6	2.6	4.5	1.9	2.9	4.9	3.5	2.6	1.7	8.7	5.0	0.1	1.7	0.2	0.1	0.1	0.8	0.0	0.0	0.0	0.2	0.0	3.5	11.7	0.1	2.3	4.2	0.6	0.7	0.2	1.3	0.0	0.5	4.9	0.1	0.0	0.0	0.0	1.8	0.0	0.0	0.2	0.0	0.0	0.6	0.0	0.0	3.2	0.6	0.1	0.0	3.0	0.4	0.0	0.0	0.1	2.3	0.4	0.2	0.0	0.0	1.6	0.0	0.0	0.2	0.1	1.7	0.2	0.0	0.0	0.2	0.2	0.9	0.3	3.1	0.1	0.5	2.3	0.1	0.1	0.5	0.0	0.0	0.0	1.5	0.0	4.5	0.2	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.8	0.1	0.0	0.1	0.0	1.7	0.0	0.0	2.2	3.7	1.9	2.7	2.5	1.8	2.3	2.0	4.0	2.9	0.0	11.5	0.0	7.2	2.1	7.6	2.8	10.2	18.7	6.8	12.2	11.8	16.3	6.6	6.8	60.1	2.1	11.1	0.0	2.3	1.5	7.8	18.3	4.6	2.4	1.6	0.0	8.6	3.1	0.3	28.0	14.1	0.7	3.3	0.0	1.1	7.7	2.5	3.5	11.3	1.7	6.6	0.0	2.3	3.2	1.9	1.6	10.3	0.0	14.9	13.7
NADK	FLJ13052	ENSG00000008130	"NAD kinase"	O95544	1	1751232-1780457	"Enzymes, Predicted intracellular proteins"		"Kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"neutrophil: 80.4"	"Group enriched"	"Detected in many"	7	"granulocytes: 80.4;monocytes: 24.7"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA048909, HPA053368"	Uncertain		Approved	Nucleoplasm,Vesicles		NA	NA			Nucleoplasm	Vesicles	"HPA048909: AB_2680553, HPA053368: AB_2682130"	"unprognostic (1.29e-1)"	"unprognostic (4.29e-1)"	"unprognostic (7.07e-2)"	"unprognostic (6.82e-2)"	"unprognostic (1.98e-1)"	"unprognostic (1.58e-2)"	"unprognostic (3.32e-1)"	"unprognostic (9.03e-2)"	"unprognostic (7.81e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.49e-1)"	"unprognostic (1.68e-1)"	"unprognostic (4.54e-3)"	"unprognostic (1.40e-1)"	"unprognostic (5.36e-2)"	"unprognostic (1.50e-2)"	"unprognostic (1.16e-1)"	24.7	34.3	11.1	19.0	11.9	49.0	25.5	9.9	12.6	12.4	18.2	10.8	14.1	20.3	13.9	14.5	12.5	14.3	17.1	11.9	9.9	7.9	12.7	52.3	17.5	27.0	15.8	8.6	16.9	32.2	8.3	11.9	22.5	10.3	13.7	14.1	13.9	21.4	14.5	10.6	11.7	19.4	14.4	8.3	39.4	22.1	17.3	9.6	10.8	14.0	12.0	19.2	13.7	28.3	1.8	7.2	80.4	24.7	0.5	1.4	10.4	15.1	14.6	13.1	19.2	18.7	13.6	16.9	15.3	13.4	17.5	15.6	15.6	27.9	20.1	11.7	11.3	5.6	12.9	14.0	12.1	7.8	19.5	22.3	16.4	22.9	26.9	18.1	23.0	27.6	15.9	11.0	10.8	15.5	9.5	16.9	16.0	20.1	28.8	13.0	17.3	17.3	20.0	8.9	25.5	16.5	22.0	11.2	41.1	15.1	12.6	17.7	13.5	17.1	37.7	15.7	8.1	12.9	16.1	16.3	12.8	9.2	13.1	13.7	25.7	11.6	45.0	12.6	25.5	6.6	11.8	21.1	49.5	1.2	24.7	1.4	1.8	0.7	0.9	7.2	1.7	0.5	0.7	80.4	0.5	23.8	5.9	1.0	10.4	11.1	11.9	9.9	12.6	9.9	7.9	15.8	8.6	10.3	9.6	11.9	30.7	29.2	12.9	8.8	7.3	5.6	28.1	9.4	18.2	14.0	15.7	22.0	13.3	18.5	13.2	18.0	35.4	23.3	25.3	21.4	15.7	25.2	2.3	80.8	33.4	6.4	21.9	14.7	54.6	20.0	34.8	30.2	8.5	40.5	34.0	5.1	24.7	33.1	32.5	18.2	15.9	12.9	17.0	10.8	20.5	11.2	35.8	13.8	26.2	19.2
NADK2	"C5orf33, FLJ30596, MNADK, NADKD1"	ENSG00000152620	"NAD kinase 2, mitochondrial"	Q4G0N4	5	36192592-36242279	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		"Kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	5	"liver: 128.6"	"Group enriched"	"Detected in many"	7	"Early spermatids: 231.1;Hepatocytes: 160.3;Late spermatids: 119.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038366, HPA038367, HPA061492"	Enhanced		Supported	Mitochondria		NA	NA		28000	Mitochondria		"HPA038366: AB_2675977, HPA038367: AB_10672743, HPA061492: AB_2684538"	"unprognostic (1.15e-2)"	"unprognostic (2.63e-2)"	"unprognostic (3.01e-2)"	"unprognostic (3.10e-3)"	"unprognostic (1.64e-1)"	"unprognostic (1.97e-2)"	"unprognostic (4.06e-3)"	"unprognostic (8.84e-2)"	"unprognostic (3.32e-2)"	"unprognostic (1.93e-3)"	"unprognostic (1.09e-1)"	"unprognostic (1.76e-1)"	"unprognostic (9.73e-2)"	"unprognostic (1.93e-1)"	"unprognostic (1.58e-1)"	"unprognostic (2.54e-2)"	"unprognostic (1.75e-2)"	5.7	10.2	13.7	4.1	12.5	4.4	6.8	6.7	13.4	6.6	6.0	13.3	5.9	7.0	5.9	4.1	4.9	6.0	5.5	8.3	14.3	8.5	10.0	128.6	4.0	4.2	11.6	12.0	8.8	12.2	4.8	3.1	7.2	11.6	9.5	6.2	3.9	5.6	7.7	11.1	3.3	5.5	24.8	20.3	3.8	7.6	7.3	11.4	2.5	7.6	3.5	5.1	15.2	5.9	5.1	3.3	9.1	4.2	9.5	3.2	1.7	9.1	6.0	9.2	10.5	14.1	12.0	12.6	8.6	5.7	7.9	5.9	16.8	11.5	32.9	6.4	9.8	9.8	6.4	8.6	6.3	11.1	9.1	7.6	8.8	17.8	9.8	10.4	19.1	3.5	13.2	9.7	8.7	13.2	9.8	8.3	12.8	23.2	11.8	7.9	3.6	17.8	7.3	5.1	7.4	8.7	17.3	22.8	7.0	10.1	7.8	4.1	9.3	44.4	14.1	4.6	7.6	10.0	16.8	6.2	15.4	8.4	11.6	10.2	10.8	13.0	9.7	6.5	24.9	6.0	9.1	2.0	1.9	2.1	2.0	2.7	2.2	3.2	2.5	3.3	5.1	2.7	2.2	0.1	9.5	4.2	1.5	2.9	1.7	13.7	12.5	6.7	11.4	14.3	8.5	11.6	12.0	11.6	11.4	3.0	5.8	6.7	5.9	6.1	5.5	25.5	22.9	8.1	7.9	5.2	7.9	6.8	21.6	3.9	231.1	6.8	5.2	0.0	8.0	6.9	11.2	12.7	1.1	160.3	7.5	3.2	6.9	13.5	8.9	119.7	18.4	4.9	13.5	2.8	11.7	15.3	8.4	7.0	21.5	19.6	5.0	0.0	13.0	16.7	10.5	5.0	6.1	5.7	12.3	8.1
NADSYN1	FLJ10631	ENSG00000172890	"NAD synthetase 1"	Q6IA69	11	71453109-71524107	"Enzymes, Predicted intracellular proteins"		Ligase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB017798, HPA038523, HPA038524"	Approved		Approved	"Golgi apparatus,Vesicles,Cytosol"		NA	NA			Vesicles	"Golgi apparatus, Cytosol"	"CAB017798: , HPA038523: AB_2676060, HPA038524: AB_2676061"	"unprognostic (1.45e-1)"	"unprognostic (1.29e-1)"	"unprognostic (7.30e-2)"	"unprognostic (2.63e-3)"	"unprognostic (1.75e-1)"	"unprognostic (1.60e-1)"	"prognostic unfavorable (5.17e-6)"	"unprognostic (1.19e-2)"	"unprognostic (4.38e-2)"	"unprognostic (1.41e-1)"	"unprognostic (9.41e-2)"	"unprognostic (1.99e-2)"	"prognostic unfavorable (8.72e-5)"	"unprognostic (4.12e-3)"	"unprognostic (1.38e-1)"	"unprognostic (1.54e-2)"	"prognostic favorable (5.10e-4)"	14.5	16.9	10.8	23.2	21.2	39.6	14.0	12.2	18.5	12.4	30.6	21.9	24.1	26.3	15.0	17.5	29.1	16.4	33.1	10.6	10.4	9.5	16.5	24.8	18.1	20.5	22.7	9.2	15.6	20.6	13.5	20.2	17.1	15.6	23.9	25.3	12.9	18.0	17.2	9.8	15.0	36.8	13.6	14.6	30.7	19.2	17.4	20.0	26.4	17.3	21.7	29.8	26.1	17.1	9.5	22.3	12.8	19.7	11.9	12.6	13.1	6.1	14.9	4.8	8.8	14.6	21.4	13.3	12.0	10.9	6.3	6.9	12.7	10.5	5.4	13.7	14.1	8.4	22.1	6.3	17.2	3.3	10.9	5.1	8.8	10.0	14.1	18.3	17.6	17.0	30.3	27.1	8.1	7.4	14.4	22.1	9.8	4.5	7.6	8.9	19.3	8.6	11.5	2.9	27.5	8.7	10.8	15.3	5.3	15.5	28.6	3.6	5.2	8.6	11.3	22.0	7.6	10.0	9.6	26.6	7.0	6.0	12.7	4.6	9.8	4.2	4.6	12.3	10.1	4.8	4.5	19.7	11.8	11.7	17.4	9.9	9.5	10.5	10.6	22.3	7.4	7.0	8.8	12.8	11.9	15.1	16.7	12.6	13.1	10.8	21.2	12.2	18.5	10.4	9.5	22.7	9.2	15.6	20.0	20.8	35.4	18.2	14.5	5.6	6.5	6.9	15.3	14.7	18.2	10.4	3.9	14.5	3.3	15.1	16.8	15.8	63.6	23.3	14.9	11.8	10.8	15.4	20.9	14.4	17.4	12.7	22.5	9.2	22.1	49.9	8.6	20.8	8.5	20.8	28.6	6.9	16.9	54.7	9.6	13.9	7.7	12.9	7.8	16.4	4.3	11.2	14.4	21.3	38.6	20.2
NAGA	D22S674	ENSG00000198951	Alpha-N-acetylgalactosaminidase	P17050	22	42058354-42070842	"Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		"Glycosidase, Hydrolase"	"Cancer-related genes, Disease mutation, Epilepsy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Hofbauer cells: 80.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	8	"classical monocyte: 38.5;intermediate monocyte: 47.6;myeloid DC: 37.9;non-classical monocyte: 46.1;plasmacytoid DC: 23.2"	"Group enriched"	"Detected in all"	9	"dendritic cells: 37.9;monocytes: 47.6"	"Cell line enhanced"	"Detected in all"		"HMC-1: 66.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA000649	Enhanced				"Intracellular and membrane"	NA	NA		2300000			"HPA000649: AB_1079448"	"unprognostic (3.74e-2)"	"unprognostic (1.19e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.45e-3)"	"unprognostic (1.55e-1)"	"unprognostic (1.28e-1)"	"unprognostic (3.02e-2)"	"unprognostic (4.27e-1)"	"unprognostic (1.32e-2)"	"unprognostic (1.50e-1)"	"unprognostic (2.53e-2)"	"unprognostic (1.93e-1)"	"unprognostic (3.64e-2)"	"unprognostic (3.68e-2)"	"unprognostic (1.92e-3)"	"unprognostic (8.95e-2)"	"unprognostic (2.53e-1)"	23.7	13.5	12.1	20.3	14.5	11.3	12.5	11.8	10.3	16.3	18.3	15.0	10.7	13.2	18.9	16.1	14.5	17.3	16.5	15.8	10.1	8.6	17.9	28.2	19.9	32.6	12.6	7.3	18.1	9.5	27.8	13.1	45.3	11.5	15.2	18.0	19.8	16.6	14.5	9.2	9.9	25.6	18.7	11.4	22.0	14.1	9.3	13.2	12.0	15.0	11.4	17.9	17.3	14.5	2.1	37.9	4.9	47.6	3.4	3.4	19.2	9.2	4.7	7.5	13.4	13.1	15.1	5.5	7.6	15.7	13.2	13.8	10.5	13.6	4.5	4.7	16.6	8.0	6.5	5.7	9.3	7.9	10.3	7.2	11.2	7.3	7.1	7.7	9.2	66.6	10.3	8.2	11.8	5.0	6.8	21.8	3.9	4.0	19.3	10.4	10.7	3.4	3.8	2.0	8.4	6.3	7.6	3.8	8.0	10.2	11.0	2.3	2.6	10.1	9.3	10.0	6.9	13.9	17.1	11.7	9.3	11.4	5.9	6.9	10.7	10.7	3.6	9.9	17.7	11.4	4.9	38.5	4.6	2.8	47.6	2.8	2.1	2.9	2.6	37.9	1.5	1.9	1.8	1.9	3.4	46.1	23.2	3.4	19.2	12.1	14.5	11.8	10.3	10.1	8.6	12.6	7.3	11.5	13.2	8.9	7.0	6.7	6.8	3.0	2.8	3.4	5.1	16.0	7.9	7.0	7.9	40.8	3.3	14.3	9.9	6.0	26.2	23.3	7.2	55.8	12.9	7.8	9.2	29.8	80.8	0.0	5.8	9.2	52.1	12.0	6.6	49.9	18.6	47.7	13.7	5.6	11.1	19.5	6.3	8.4	5.7	19.4	12.3	10.5	5.3	3.0	48.7	7.7	12.1	8.6
NAGK	GNK	ENSG00000124357	"N-acetylglucosamine kinase"	Q9UJ70	2	71064344-71079805	"Enzymes, Predicted intracellular proteins"		"Kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Hofbauer cells: 191.3;Syncytiotrophoblasts: 266.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035206, HPA035207"	Enhanced		Approved	Nucleoplasm,Cytosol		NA	NA		690000	Cytosol	Nucleoplasm	"HPA035206: AB_2674517, HPA035207: AB_10602031"	"unprognostic (6.15e-2)"	"unprognostic (4.23e-3)"	"unprognostic (2.97e-2)"	"prognostic unfavorable (6.88e-4)"	"unprognostic (2.44e-1)"	"prognostic favorable (5.87e-4)"	"unprognostic (4.65e-3)"	"unprognostic (2.18e-2)"	"unprognostic (2.31e-1)"	"unprognostic (9.99e-2)"	"unprognostic (4.32e-2)"	"unprognostic (1.59e-1)"	"prognostic unfavorable (4.35e-4)"	"unprognostic (8.60e-2)"	"unprognostic (1.45e-2)"	"unprognostic (5.50e-3)"	"unprognostic (2.13e-2)"	20.0	17.6	21.8	30.9	24.5	9.8	15.7	13.9	18.8	23.6	15.5	23.7	17.4	11.4	16.4	19.7	67.0	13.7	20.0	14.0	17.6	20.4	16.9	20.2	18.3	30.6	31.1	20.3	15.0	25.8	27.5	21.8	43.9	26.2	15.8	15.8	14.7	49.0	17.8	11.3	29.5	14.6	22.8	21.6	43.4	15.5	24.8	26.7	20.2	13.0	27.2	39.9	24.5	26.1	14.3	53.0	37.4	79.3	8.5	7.1	52.2	19.0	15.5	8.7	8.9	34.8	21.3	34.3	42.5	18.4	28.5	25.9	18.1	10.0	10.6	10.1	29.4	33.6	9.2	6.6	12.6	17.7	15.1	5.2	6.0	5.1	11.2	26.1	3.7	15.2	19.0	13.2	30.6	4.8	20.6	29.9	9.3	2.7	12.0	39.4	17.4	9.4	13.3	9.3	15.2	12.0	7.4	24.4	5.4	17.2	34.1	9.0	5.0	12.8	20.2	13.3	15.6	10.5	4.8	26.2	34.0	13.2	13.1	14.8	8.4	7.3	6.2	23.2	10.2	18.6	10.3	79.3	31.5	5.4	69.8	5.5	14.3	6.4	5.2	53.0	13.3	5.5	4.5	37.4	8.5	46.6	42.4	7.1	52.2	21.8	24.5	13.9	18.8	17.6	20.4	31.1	20.3	26.2	26.7	35.7	38.8	52.2	25.0	23.9	42.8	14.8	22.9	24.1	28.4	36.6	21.6	111.0	34.9	60.8	114.8	28.1	13.8	0.0	39.8	106.9	36.8	15.4	49.8	12.1	191.3	44.5	22.4	30.7	107.2	16.6	27.9	97.6	37.1	45.1	18.1	42.9	52.7	22.6	35.3	46.9	53.5	19.4	33.0	33.7	22.6	36.4	266.6	23.8	13.8	37.2
NAGLU	NAG	ENSG00000108784	N-acetyl-alpha-glucosaminidase	P54802	17	42536172-42544449	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		"Glycosidase, Hydrolase"	"Charcot-Marie-Tooth disease, Disease mutation, Mucopolysaccharidosis, Neurodegeneration, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA038815	Supported				"Intracellular and membrane"	NA	NA		300000000			"HPA038815: AB_10697398"	"unprognostic (1.53e-1)"	"unprognostic (1.19e-1)"	"unprognostic (6.48e-2)"	"prognostic favorable (4.17e-4)"	"prognostic unfavorable (6.59e-4)"	"unprognostic (1.46e-1)"	"unprognostic (1.75e-3)"	"unprognostic (3.09e-2)"	"unprognostic (2.20e-1)"	"unprognostic (6.68e-2)"	"prognostic favorable (6.90e-4)"	"unprognostic (8.07e-2)"	"prognostic favorable (2.58e-6)"	"unprognostic (2.25e-1)"	"unprognostic (8.74e-3)"	"unprognostic (2.15e-2)"	"unprognostic (1.62e-1)"	21.1	21.0	10.2	8.4	15.9	10.7	18.3	5.5	11.4	16.9	17.1	19.1	16.3	14.8	19.3	20.6	11.9	14.6	21.4	11.5	10.7	5.9	31.3	50.1	16.3	12.5	21.6	8.0	20.4	38.9	10.6	12.7	23.5	12.1	14.8	10.2	20.9	32.4	12.3	9.1	13.2	17.3	10.1	13.5	22.5	17.0	9.8	20.5	8.9	20.7	8.9	12.3	16.1	12.7	4.8	6.0	3.8	5.8	4.3	5.8	2.4	6.0	21.1	4.2	9.6	42.1	14.0	14.3	9.2	21.9	9.7	12.4	5.7	15.6	7.7	9.4	14.1	21.5	14.7	3.8	4.4	2.2	5.9	7.8	4.2	10.9	11.7	14.1	5.0	10.9	16.6	6.9	5.3	6.6	10.7	12.6	1.4	6.1	15.6	10.7	14.5	0.8	8.6	4.9	12.9	2.7	3.2	9.2	17.9	12.8	13.9	6.4	9.7	5.0	6.9	7.8	6.4	32.1	5.3	9.8	23.6	3.9	9.3	5.9	20.8	9.3	6.4	14.4	5.5	16.7	2.3	5.5	3.8	5.6	3.7	5.8	4.8	2.4	3.1	4.5	4.6	4.3	3.5	2.5	4.3	5.8	6.0	0.5	2.4	10.2	15.9	5.5	11.4	10.7	5.9	21.6	8.0	12.1	20.5	11.9	8.5	6.7	5.2	2.5	13.3	3.9	20.4	0.0	2.3	17.4	3.9	19.9	3.3	13.8	0.2	8.7	20.2	0.0	28.2	11.7	13.8	9.4	2.3	35.8	31.7	14.3	6.4	28.3	21.0	1.9	18.4	10.9	15.1	5.4	15.9	12.0	16.3	2.9	12.0	31.2	6.4	6.5	8.2	0.4	5.3	3.0	15.4	5.0	10.2	4.7
NAGPA	"APAA, UCE"	ENSG00000103174	"N-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase"	Q9UK23	16	5024844-5034141	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"		Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Hep G2: 32.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA064055	Approved					NA	NA		3600000			"HPA064055: AB_2685183"	"unprognostic (9.93e-2)"	"unprognostic (1.61e-2)"	"unprognostic (2.08e-2)"	"unprognostic (2.21e-2)"	"unprognostic (7.12e-3)"	"unprognostic (3.30e-3)"	"prognostic unfavorable (4.67e-4)"	"unprognostic (1.05e-2)"	"unprognostic (2.98e-2)"	"unprognostic (1.35e-1)"	"unprognostic (9.51e-3)"	"unprognostic (9.41e-2)"	"prognostic unfavorable (2.67e-5)"	"unprognostic (1.26e-1)"	"unprognostic (6.09e-2)"	"unprognostic (7.47e-2)"	"unprognostic (1.02e-1)"	8.3	6.3	9.9	9.0	20.1	8.7	4.7	4.7	25.0	6.8	8.5	4.6	5.8	11.4	6.2	4.7	6.1	4.8	5.6	5.0	15.3	5.3	7.2	7.6	7.6	9.1	5.0	9.5	4.2	7.3	7.6	4.9	6.8	6.6	4.9	5.1	4.0	6.0	6.2	6.7	8.5	9.2	5.5	4.4	10.9	12.4	2.7	5.5	4.3	5.1	2.6	5.6	6.0	4.4	9.5	26.5	5.1	20.9	5.1	9.9	9.7	1.5	6.0	1.0	6.5	2.6	3.4	6.8	4.5	8.0	5.9	7.4	5.0	12.5	0.6	5.7	6.1	10.2	4.6	2.7	5.0	1.8	7.3	8.4	2.2	3.9	32.2	8.3	5.3	9.5	5.1	5.2	3.9	1.7	7.4	9.1	5.6	6.9	8.9	3.6	6.8	2.4	14.4	3.2	3.8	6.4	6.5	2.4	11.8	3.8	2.4	2.6	3.5	3.6	8.9	9.1	1.0	6.1	6.6	6.7	6.5	4.7	15.1	3.3	4.9	3.8	1.4	3.0	8.2	5.4	1.2	20.9	5.1	9.9	18.2	7.9	9.5	9.8	8.8	26.5	8.3	8.1	7.4	0.6	5.1	11.7	6.8	8.7	9.7	9.9	20.1	4.7	25.0	15.3	5.3	5.0	9.5	6.6	5.5	0.0	2.4	13.7	4.8	2.6	13.3	1.5	7.6	4.0	3.4	5.2	29.5	11.3	1.7	10.2	0.2	6.7	17.1	0.0	7.5	12.5	3.2	3.7	1.1	7.3	25.0	15.9	1.2	8.6	17.2	0.9	7.5	19.1	3.3	25.2	9.9	5.4	8.5	14.4	6.0	7.4	12.5	0.0	3.1	4.4	8.1	2.0	7.9	13.8	10.6	2.1
NAGS	"AGAS, ARGA, NAT7"	ENSG00000161653	"N-acetylglutamate synthase"	Q8N159	17	44004546-44009063	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Urea cycle"	"Acyltransferase, Transferase"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"intestine: 16.4;liver: 30.2"	"Cell type enhanced"	"Detected in many"	6	"Collecting duct cells: 12.2;Hepatocytes: 18.8;Proximal tubular cells: 14.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"ASC TERT1: 6.4;HHSteC: 6.6;TIME: 8.1;U-87 MG: 12.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA027300			Supported	Mitochondria	"Intracellular and membrane"	NA	NA			Mitochondria		"HPA027300: AB_2672207"	"unprognostic (1.51e-3)"	"unprognostic (9.24e-2)"	"unprognostic (1.68e-1)"	"unprognostic (8.67e-2)"	"unprognostic (1.44e-2)"	"unprognostic (1.30e-3)"	"unprognostic (2.38e-2)"	"unprognostic (1.98e-1)"	"unprognostic (3.14e-2)"	"unprognostic (2.73e-2)"	"unprognostic (2.53e-3)"	"unprognostic (1.46e-1)"	"unprognostic (5.19e-2)"	"unprognostic (6.99e-2)"	"unprognostic (1.29e-2)"	"unprognostic (1.22e-1)"	"unprognostic (2.27e-1)"	0.6	0.6	0.5	0.4	2.4	0.0	1.0	0.7	1.5	0.3	7.2	0.5	5.6	16.4	0.5	2.6	0.9	0.3	0.3	0.9	0.7	1.5	4.4	30.2	2.5	0.2	1.8	0.6	0.5	0.3	3.6	0.4	0.4	1.2	0.8	0.4	0.1	0.9	6.5	0.1	0.6	13.4	0.3	2.0	0.5	0.3	0.4	1.1	0.2	2.9	0.0	0.1	0.8	0.8	1.5	2.0	2.3	2.7	1.0	3.5	1.3	3.4	0.2	0.0	0.5	0.0	6.4	0.1	0.6	0.0	0.2	0.0	2.2	0.8	0.0	1.4	0.0	0.1	1.5	0.0	1.2	0.1	0.3	0.8	0.1	0.2	2.7	6.6	0.0	0.0	2.8	0.1	0.2	0.0	0.6	1.2	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.4	1.7	2.7	0.1	0.2	0.0	0.0	0.0	2.6	0.0	1.2	0.0	0.0	0.1	0.2	0.1	8.1	3.0	0.8	0.2	0.7	0.2	0.2	0.2	12.1	0.1	0.4	1.8	1.4	2.3	3.5	1.5	2.8	1.2	2.2	2.9	2.0	1.5	1.1	1.7	0.8	1.0	2.7	0.3	1.7	1.3	0.5	2.4	0.7	1.5	0.7	1.5	1.8	0.6	1.2	1.1	3.0	3.4	0.5	0.8	1.3	0.4	2.4	5.1	1.4	4.5	12.2	0.0	0.9	6.6	1.6	4.4	0.9	10.4	0.0	3.6	1.6	0.6	0.4	0.0	18.8	1.0	0.0	6.9	1.3	2.6	2.2	1.4	4.2	0.0	9.0	2.6	0.9	3.7	3.2	0.7	14.6	0.5	0.0	1.0	5.5	1.5	0.6	0.3	1.5	3.3	0.6
NAMPT	"PBEF, PBEF1"	ENSG00000105835	"Nicotinamide phosphoribosyltransferase"	P43490	7	106248285-106286326	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Biological rhythms, Pyridine nucleotide biosynthesis"	"Cytokine, Glycosyltransferase, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Hepatocytes: 597.4;Macrophages: 479.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	18	"neutrophil: 143.5"	"Lineage enriched"	"Detected in many"	20	"granulocytes: 143.5"	"Cell line enhanced"	"Detected in all"		"U-87 MG: 110.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB034349, HPA047776, HPA057722"	Approved		Approved	"Nuclear speckles,Cell Junctions"	"Secreted to blood"	NA	NA	2140000	410000	"Nuclear speckles"	"Cell Junctions"	"CAB034349: AB_2251220, HPA047776: AB_2680151, HPA057722: "	"unprognostic (2.87e-1)"	"prognostic unfavorable (4.78e-4)"	"unprognostic (5.90e-3)"	"unprognostic (1.63e-2)"	"unprognostic (1.50e-2)"	"prognostic unfavorable (8.81e-4)"	"unprognostic (2.15e-1)"	"unprognostic (2.74e-2)"	"unprognostic (2.74e-1)"	"unprognostic (3.30e-1)"	"prognostic unfavorable (1.51e-4)"	"unprognostic (3.02e-1)"	"prognostic unfavorable (2.49e-6)"	"unprognostic (6.83e-2)"	"unprognostic (6.96e-2)"	"unprognostic (7.76e-2)"	"unprognostic (6.44e-3)"	67.3	22.2	8.1	113.6	18.1	110.4	52.6	7.8	12.9	11.6	18.2	2.9	9.5	9.3	9.9	13.5	53.4	27.8	28.1	84.4	13.4	6.3	13.5	92.9	48.9	117.5	10.3	5.2	27.3	18.3	5.5	10.0	23.9	29.2	17.4	10.5	8.2	32.9	14.3	41.0	12.9	14.1	44.9	59.1	41.1	26.4	11.9	7.1	6.2	13.5	40.7	13.2	48.8	26.4	0.8	2.0	143.5	7.3	1.0	1.5	1.3	19.2	12.9	4.6	7.8	19.7	23.0	7.6	6.1	34.6	12.4	21.9	7.6	11.7	16.1	14.7	6.8	37.2	15.2	8.6	18.4	27.2	9.5	9.2	6.5	5.5	5.9	73.7	12.6	12.1	21.9	21.1	22.2	26.0	18.6	39.5	8.0	13.6	62.0	14.8	10.1	12.6	5.3	9.0	12.2	10.4	6.0	6.6	35.5	11.8	18.2	9.5	5.2	8.6	18.8	21.8	13.4	6.0	3.6	33.6	18.5	14.3	26.5	11.2	42.7	24.2	23.3	110.0	14.3	27.4	8.1	2.3	3.5	0.4	5.6	0.7	0.8	0.5	0.6	2.0	0.7	0.8	0.4	143.5	1.0	7.3	0.8	1.5	1.3	8.1	18.1	7.8	12.9	13.4	6.3	10.3	5.2	29.2	7.1	122.1	246.8	48.1	258.1	184.4	22.1	87.9	163.1	104.4	177.5	40.1	11.8	23.8	39.7	250.8	6.3	173.0	92.2	0.0	120.5	44.2	117.9	276.9	178.5	597.4	98.8	38.1	24.1	141.8	340.8	4.5	37.4	479.6	153.5	65.9	46.4	19.5	161.8	35.1	29.4	36.0	28.4	25.8	234.9	14.9	57.9	181.7	21.2	41.5	63.9	273.8
NANP	"C20orf147, dJ694B14.3, HDHD4, MGC26833"	ENSG00000170191	"N-acetylneuraminic acid phosphatase"	Q8TBE9	20	25612935-25624175	"Enzymes, Predicted intracellular proteins"	"Carbohydrate metabolism"	Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			HPA050342	Uncertain		Approved	"Nuclear membrane"		NA	NA			"Nuclear membrane"		"HPA050342: AB_2681098"	"unprognostic (8.72e-2)"	"unprognostic (1.88e-1)"	"unprognostic (7.42e-3)"	"unprognostic (6.01e-2)"	"unprognostic (5.59e-2)"	"unprognostic (2.12e-1)"	"prognostic unfavorable (9.01e-6)"	"unprognostic (3.20e-1)"	"unprognostic (3.75e-2)"	"unprognostic (7.70e-3)"	"unprognostic (1.24e-1)"	"unprognostic (3.46e-1)"	"unprognostic (2.07e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.76e-1)"	"unprognostic (1.71e-2)"	"unprognostic (9.42e-2)"	10.0	14.0	6.3	6.0	7.4	6.9	7.2	13.3	8.2	6.3	6.4	4.1	4.3	7.1	6.9	5.7	9.5	6.2	6.2	6.8	4.3	4.8	11.6	12.5	6.7	4.4	4.2	3.3	12.0	7.4	8.0	8.6	6.0	6.5	5.6	6.2	7.1	7.8	6.1	9.2	4.9	7.6	6.9	5.6	7.1	6.2	6.6	3.7	18.2	9.0	6.0	6.8	7.4	6.8	1.7	6.4	1.7	4.5	4.9	4.2	2.3	11.1	6.5	5.3	7.7	8.6	9.2	7.8	5.7	11.2	7.6	9.8	5.9	7.7	4.0	6.5	10.8	9.0	7.1	8.1	8.2	14.8	1.4	4.8	10.0	3.1	15.7	7.2	7.6	3.0	8.0	4.1	8.5	10.9	4.2	6.4	13.8	8.4	7.2	9.2	6.1	15.0	3.8	3.9	9.7	10.2	7.5	11.2	4.9	4.4	6.0	10.2	4.2	6.3	10.2	6.7	5.6	4.4	6.5	5.4	12.1	9.0	11.1	8.0	3.8	3.5	10.0	3.4	17.7	7.2	0.4	4.5	1.7	2.8	4.5	4.2	1.4	2.0	2.1	6.4	1.7	1.8	3.1	0.3	4.9	2.4	1.4	1.7	2.3	6.3	7.4	13.3	8.2	4.3	4.8	4.2	3.3	6.5	3.7	3.0	1.0	1.5	3.4	5.3	4.6	3.1	5.1	0.0	2.3	7.0	0.0	3.4	11.6	4.4	0.3	4.5	1.3	0.0	3.7	1.6	4.6	2.4	5.7	4.9	3.9	6.4	2.9	4.3	2.5	0.0	2.8	3.7	5.0	1.0	2.6	5.6	4.4	2.0	2.5	7.1	6.8	0.0	3.9	2.6	10.7	4.4	1.6	1.5	2.5	2.3
NANS	SAS	ENSG00000095380	"N-acetylneuraminate synthase"	Q9NR45	9	98056739-98083075	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		Transferase	"Disease mutation, Dwarfism, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA019223	Approved		Enhanced	Nucleoplasm		No	No		200000	Nucleoplasm		"HPA019223: AB_1854298"	"unprognostic (2.95e-1)"	"unprognostic (5.10e-3)"	"unprognostic (2.24e-2)"	"prognostic favorable (1.71e-4)"	"unprognostic (7.31e-3)"	"unprognostic (1.23e-1)"	"prognostic unfavorable (6.42e-4)"	"unprognostic (2.08e-1)"	"unprognostic (7.98e-2)"	"unprognostic (2.28e-1)"	"unprognostic (1.54e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.31e-2)"	"unprognostic (1.64e-1)"	"unprognostic (7.36e-2)"	"unprognostic (3.62e-3)"	"unprognostic (1.79e-1)"	17.2	10.1	8.8	20.2	11.4	22.2	16.4	7.0	11.7	20.2	47.6	6.4	17.0	19.4	11.0	15.1	18.6	10.4	25.0	20.9	14.4	12.4	15.0	49.6	17.1	20.1	11.5	10.6	14.1	59.2	6.1	16.3	15.8	12.1	37.2	49.6	9.4	80.0	18.3	11.9	10.3	18.9	11.0	9.0	22.2	28.3	11.5	9.8	10.6	19.7	15.2	25.0	15.7	14.8	12.3	41.9	16.4	49.8	7.4	12.1	18.3	73.9	21.9	6.5	18.7	13.1	14.2	14.1	23.7	18.6	19.4	15.9	26.1	10.6	22.8	11.5	26.0	20.5	26.3	12.0	20.3	16.2	18.3	18.0	13.5	24.5	52.1	36.3	15.2	11.1	11.9	13.9	20.6	23.6	22.6	20.6	11.4	24.5	23.8	14.1	50.8	10.2	22.0	11.2	53.6	28.4	19.8	17.8	23.2	15.4	22.7	13.2	6.9	15.2	82.5	20.1	7.5	27.3	16.5	53.6	15.1	14.7	38.7	24.2	22.2	18.4	8.7	17.9	18.5	11.7	5.3	42.1	6.0	8.0	49.8	12.1	12.3	10.5	8.3	41.9	10.1	11.5	7.8	16.4	7.4	43.0	38.4	11.9	18.3	8.8	11.4	7.0	11.7	14.4	12.4	11.5	10.6	12.1	9.8	26.8	52.4	47.0	107.6	62.3	8.1	21.5	53.5	151.3	77.3	21.0	17.7	73.6	59.7	41.8	35.3	57.3	177.1	0.0	89.0	121.2	62.1	166.7	43.8	28.6	139.8	9.5	62.4	25.2	52.6	53.6	30.0	94.4	123.2	58.7	195.9	13.3	63.2	189.8	24.8	47.7	7.0	12.9	96.2	7.2	16.9	54.0	126.1	27.7	245.2	195.9
NAPEPLD	"C7orf18, FMP30, NAPE-PLD"	ENSG00000161048	"N-acyl phosphatidylethanolamine phospholipase D"	Q6IQ20	7	103099776-103149560	"Enzymes, Predicted intracellular proteins"	"Lipid degradation, Lipid metabolism, Phospholipid degradation, Phospholipid metabolism"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	7	"Bipolar cells: 74.1;Early spermatids: 112.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019832, HPA024338"	Approved		Approved	Cytosol		NA	NA			Cytosol		"HPA019832: AB_1844422, HPA024338: AB_2671533"	"unprognostic (3.62e-1)"	"unprognostic (1.86e-1)"	"unprognostic (2.37e-1)"	"unprognostic (2.57e-1)"	"unprognostic (7.58e-2)"	"unprognostic (1.05e-3)"	"unprognostic (1.02e-2)"	"unprognostic (6.39e-3)"	"unprognostic (2.70e-2)"	"unprognostic (1.20e-1)"	"unprognostic (2.81e-2)"	"unprognostic (3.21e-1)"	"prognostic favorable (7.32e-6)"	"unprognostic (8.83e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.42e-1)"	"unprognostic (2.41e-2)"	3.8	5.3	8.6	3.8	14.0	3.1	3.9	13.9	18.5	5.1	8.8	17.2	3.7	15.9	4.9	3.5	2.6	6.5	6.1	4.2	6.4	5.5	15.1	7.4	4.3	3.8	15.0	11.6	9.7	4.1	8.5	6.2	2.9	10.3	5.4	10.1	5.0	4.2	4.1	5.0	5.7	10.8	4.5	9.7	6.6	11.2	11.1	16.7	5.3	8.8	0.9	3.8	6.9	4.6	7.9	3.7	5.7	4.6	2.9	7.6	2.5	4.6	6.2	4.0	3.6	3.6	3.9	0.6	3.0	2.8	2.1	3.4	2.7	6.2	4.2	5.1	2.3	4.7	4.3	2.8	1.0	2.5	6.5	3.9	1.7	3.7	1.2	0.9	3.7	1.8	2.2	1.2	1.9	0.0	7.8	3.4	3.0	2.0	4.5	4.0	1.7	4.4	2.0	3.7	7.3	7.3	2.8	1.8	2.2	7.6	2.1	2.9	3.9	8.2	2.6	1.8	2.2	1.7	2.1	3.0	5.9	4.2	12.0	3.7	5.6	6.1	3.6	4.2	2.7	11.3	0.2	3.1	5.7	4.9	4.6	4.4	7.4	5.3	5.8	3.7	7.9	7.6	5.6	0.3	2.9	3.0	2.7	4.7	2.5	8.6	14.0	13.9	18.5	6.4	5.5	15.0	11.6	10.3	16.7	17.9	7.7	9.8	4.8	6.0	74.1	10.2	20.4	1.4	6.8	50.6	49.1	7.3	8.3	4.4	112.3	2.9	30.7	0.0	2.3	3.1	4.6	8.5	4.6	18.4	3.5	47.7	13.3	4.9	3.5	31.4	29.4	2.7	13.5	4.6	26.3	21.0	3.7	28.6	31.5	26.7	34.0	6.5	2.3	14.6	10.9	2.5	2.4	4.3	23.0	5.5
NAPRT	"NAPRT1, PP3856"	ENSG00000147813	"Nicotinate phosphoribosyltransferase"	Q6XQN6	8	143574785-143578649	"Enzymes, Predicted intracellular proteins"	"Pyridine nucleotide biosynthesis"	"Ligase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"CAPAN-2: 22.3;SK-BR-3: 23.9;U-937: 18.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023739, HPA024017, CAB068206, CAB068207"	Enhanced		Approved	"Nucleoplasm,Golgi apparatus,Cytosol"		NA	NA		2000000	"Golgi apparatus"	"Nucleoplasm, Cytosol"	"CAB068206: AB_2665644, CAB068207: AB_2665681, HPA023739: AB_1854308, HPA024017: AB_1854309"	"unprognostic (7.08e-2)"	"unprognostic (1.55e-1)"	"unprognostic (5.76e-3)"	"unprognostic (2.94e-2)"	"unprognostic (1.06e-1)"	"unprognostic (2.30e-1)"	"unprognostic (7.65e-2)"	"unprognostic (2.19e-1)"	"unprognostic (2.84e-1)"	"unprognostic (1.08e-2)"	"unprognostic (1.75e-1)"	"unprognostic (4.13e-2)"	"prognostic favorable (6.28e-4)"	"unprognostic (6.02e-2)"	"unprognostic (3.97e-1)"	"unprognostic (2.28e-2)"	"unprognostic (1.61e-2)"	9.7	6.4	4.9	9.7	6.2	21.1	13.2	10.7	5.4	6.7	25.2	2.3	9.9	33.0	4.7	4.7	16.4	4.8	15.5	4.9	3.9	2.1	10.7	28.3	8.3	12.1	3.7	0.1	5.9	6.5	2.4	2.8	8.6	4.1	6.9	3.8	5.2	12.8	3.8	7.1	12.4	34.4	5.2	2.2	9.8	11.8	5.5	4.0	3.0	6.8	8.9	9.5	7.6	8.1	0.8	4.7	4.6	8.4	0.5	1.6	2.4	3.4	4.0	0.4	0.8	0.3	1.2	2.6	0.8	0.4	1.3	0.8	3.3	22.3	0.9	6.3	0.2	0.0	7.7	0.2	6.3	0.0	4.1	6.4	5.3	10.5	0.9	2.8	1.3	2.8	0.1	2.2	0.1	0.0	0.0	1.4	4.4	4.9	4.1	0.1	4.3	2.6	2.7	1.0	4.7	2.5	4.6	0.1	11.0	0.9	1.3	1.8	0.4	10.0	23.9	3.0	0.1	0.9	3.1	4.2	0.7	6.4	4.7	1.7	0.5	0.2	1.1	1.1	18.5	3.3	0.0	4.4	4.6	1.6	8.4	0.5	0.8	0.7	1.5	4.7	0.2	0.8	0.7	2.7	0.5	8.4	1.5	0.2	2.4	4.9	6.2	10.7	5.4	3.9	2.1	3.7	0.1	4.1	4.0	32.8	29.7	8.2	53.6	0.0	11.6	7.8	50.9	2.7	17.0	71.5	17.7	41.1	58.0	56.8	30.9	28.6	149.9	23.3	48.4	46.0	12.4	35.0	7.0	99.2	70.9	15.9	10.5	37.4	86.2	46.4	29.7	44.6	0.0	92.0	73.3	27.1	82.3	117.4	20.5	160.6	12.5	12.9	11.5	15.6	17.6	0.0	47.0	17.5	111.6	67.7
NAPSA	"KAP, Kdap, NAP1, NAPA"	ENSG00000131400	"Napsin A aspartic peptidase"	O96009	19	50358477-50365830	"Enzymes, Plasma proteins, Predicted secreted proteins"		"Aspartyl protease, Hydrolase, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	10	"kidney: 47.5;lung: 153.3"	"Cell type enriched"	"Detected in many"	5	"Alveolar cells type 2: 2552.8"	"Cancer enriched"	"Detected in many"	18	"lung cancer: 249.9"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"plasmacytoid DC: 10.5"	"Group enriched"	"Detected in many"	9	"B-cells: 5.1;dendritic cells: 10.5"	"Cell line enriched"	"Detected in some"	24	"U-698: 29.8"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"CAB009591, HPA045280, HPA047236, HPA047744"	Enhanced				"Secreted in other tissues"	NA	NA		380000			"CAB009591: , HPA045280: AB_2679283, HPA047236: AB_2679993, HPA047744: AB_2680143"	"unprognostic (5.36e-2)"	"unprognostic (4.77e-2)"	"unprognostic (1.64e-3)"	"unprognostic (1.78e-1)"	"unprognostic (1.93e-1)"	"unprognostic (4.65e-2)"	"unprognostic (1.02e-1)"	"unprognostic (8.30e-3)"	"unprognostic (2.29e-1)"	"unprognostic (2.23e-2)"	"unprognostic (1.76e-3)"	"unprognostic (7.67e-3)"	"prognostic favorable (1.21e-4)"	"unprognostic (4.08e-4)"	"unprognostic (3.29e-1)"	"unprognostic (9.83e-3)"	"unprognostic (7.26e-5)"	0.1	0.1	0.1	0.2	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	5.0	0.1	0.1	0.1	0.1	0.1	0.0	47.5	0.1	153.3	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.5	0.3	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.2	0.1	0.1	0.1	0.1	0.2	0.1	0.1	0.3	0.1	0.1	0.1	0.1	5.1	10.5	0.5	0.9	0.5	0.6	1.1	0.2	0.4	0.0	0.2	0.2	0.2	0.1	0.1	0.0	0.0	0.1	0.1	0.4	0.2	0.2	0.1	0.0	0.5	0.1	0.0	0.0	0.2	0.6	0.0	0.0	0.0	0.2	0.0	0.2	0.3	1.2	0.1	0.0	0.1	0.0	0.0	0.3	0.1	0.0	0.6	0.1	0.3	0.2	0.3	0.3	0.6	0.0	0.1	0.9	0.0	0.0	0.1	0.3	0.0	0.1	0.1	0.1	0.3	0.1	0.0	0.1	0.8	0.0	0.2	0.4	29.8	0.0	0.1	0.0	0.0	0.4	0.0	0.1	0.9	0.0	5.1	0.2	0.4	3.0	1.9	0.6	0.5	0.5	0.5	0.9	10.5	0.0	1.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.3	0.1	485.3	2552.8	8.0	0.4	0.1	1.3	0.4	0.0	29.4	84.2	43.6	3.9	0.4	8.3	0.4	34.9	0.1	0.9	0.0	0.7	0.2	0.2	0.6	64.0	0.0	0.3	0.0	0.0	0.0	0.3	4.5	0.9	4.0	0.0	0.0	0.9	1.3	0.1	2.8	0.4	230.9	0.7	0.0	0.3	0.5	0.7	0.5	0.1	0.0	0.8	0.0
NARS	NARS1	ENSG00000134440	"Asparaginyl-tRNA synthetase"	O43776	18	57600656-57622213	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Protein biosynthesis"	"Aminoacyl-tRNA synthetase, Ligase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB034257, HPA040017"	Enhanced		Supported	Cytosol		NA	NA			Cytosol		"CAB034257: AB_2151043, HPA040017: AB_2676801"	"unprognostic (9.85e-2)"	"unprognostic (1.88e-1)"	"unprognostic (3.86e-3)"	"unprognostic (1.68e-1)"	"unprognostic (2.61e-1)"	"unprognostic (1.28e-1)"	"prognostic unfavorable (1.23e-7)"	"unprognostic (1.78e-1)"	"unprognostic (1.48e-1)"	"unprognostic (1.62e-2)"	"unprognostic (1.98e-1)"	"unprognostic (8.82e-2)"	"prognostic favorable (1.73e-7)"	"unprognostic (1.24e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.51e-1)"	30.9	36.9	35.0	28.8	42.6	19.5	31.6	47.1	51.4	28.1	49.7	24.8	31.1	42.5	30.8	31.6	40.2	27.4	26.8	40.6	40.5	36.5	66.0	41.9	26.0	23.0	39.5	39.2	29.4	29.4	52.0	35.7	25.6	49.5	33.1	46.1	18.5	33.7	30.9	76.6	26.9	35.2	29.9	40.6	25.7	36.0	14.9	36.3	25.0	44.5	31.9	29.2	34.6	35.3	20.0	26.6	15.6	40.8	15.8	23.4	23.7	36.6	24.2	22.8	33.3	29.3	22.5	35.6	51.3	26.8	30.3	37.5	17.4	17.2	46.2	24.6	35.5	30.5	41.8	35.8	31.7	44.4	22.4	12.4	35.3	18.6	27.4	49.6	73.2	36.5	23.9	55.5	41.5	39.7	23.8	25.1	28.4	43.3	34.5	34.0	13.6	28.3	17.8	33.5	23.3	19.5	22.5	26.9	39.0	56.6	41.3	25.1	27.5	24.9	32.1	53.8	25.1	17.9	40.7	27.4	33.8	22.6	14.2	37.9	77.5	95.9	44.9	31.1	48.1	39.3	15.6	40.8	14.2	16.4	35.1	20.2	20.0	17.3	17.4	26.6	18.8	23.4	21.2	12.7	15.8	26.6	25.1	17.2	23.7	35.0	42.6	47.1	51.4	40.5	36.5	39.5	39.2	49.5	36.3	71.5	60.9	52.8	56.5	68.6	83.3	195.9	79.0	170.0	72.8	66.3	33.4	91.5	286.8	103.2	11.5	56.6	105.3	93.5	78.8	68.1	57.5	71.7	91.6	94.8	102.8	90.6	60.9	38.1	67.5	12.5	65.3	70.5	74.2	75.7	75.6	85.4	101.4	49.1	73.2	181.5	68.2	71.1	59.4	41.1	41.9	66.1	132.6	49.0	92.8	67.0
NARS2	"DFNB94, FLJ23441, SLM5"	ENSG00000137513	"Asparaginyl-tRNA synthetase 2, mitochondrial"	Q96I59	11	78435961-78574874	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Protein biosynthesis"	"Aminoacyl-tRNA synthetase, Ligase"	"Deafness, Disease mutation, Leigh syndrome, Non-syndromic deafness, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA026793	Supported		Approved	Nucleoplasm,Mitochondria,Cytosol		No	No			"Nucleoplasm, Mitochondria"	Cytosol	"HPA026793: AB_1848833"	"unprognostic (1.80e-1)"	"unprognostic (1.95e-1)"	"unprognostic (5.73e-3)"	"unprognostic (1.79e-3)"	"unprognostic (1.40e-2)"	"unprognostic (2.05e-1)"	"unprognostic (1.28e-1)"	"unprognostic (5.62e-2)"	"unprognostic (4.62e-3)"	"prognostic favorable (1.39e-5)"	"unprognostic (1.96e-1)"	"unprognostic (1.56e-1)"	"prognostic favorable (1.22e-6)"	"unprognostic (8.57e-2)"	"unprognostic (1.45e-1)"	"unprognostic (2.93e-1)"	"unprognostic (1.60e-1)"	10.9	16.0	11.8	9.3	11.2	6.4	13.4	19.4	11.8	11.6	13.0	13.1	13.5	12.0	17.6	13.9	10.8	12.0	9.9	12.7	11.3	12.2	22.3	26.8	9.0	10.2	13.4	8.4	15.9	20.0	14.0	17.3	9.4	13.8	13.3	13.3	23.2	12.7	13.2	24.4	9.1	11.1	10.6	10.8	12.6	11.3	11.8	10.3	17.3	16.0	7.7	14.1	9.7	10.7	14.6	13.5	6.7	9.4	16.2	16.6	8.7	7.3	10.3	10.8	7.1	7.6	6.4	9.0	6.1	6.0	9.5	7.9	17.7	7.9	18.2	15.9	3.9	9.2	9.7	18.2	11.9	13.3	11.9	9.8	12.8	8.0	15.0	6.3	13.7	4.8	4.5	7.7	8.4	15.0	8.6	8.1	15.4	19.3	5.0	10.6	8.6	14.2	22.2	11.8	30.0	12.5	14.9	17.7	24.6	12.7	10.4	12.9	8.1	9.1	11.7	15.7	12.2	11.0	5.5	4.9	13.0	15.3	14.8	10.3	8.4	14.1	40.1	2.5	12.4	8.8	6.7	7.9	3.5	9.8	8.3	12.0	14.6	11.3	10.8	13.5	12.6	16.6	14.8	1.7	16.2	9.4	10.3	8.2	8.7	11.8	11.2	19.4	11.8	11.3	12.2	13.4	8.4	13.8	10.3	17.9	17.1	9.0	12.7	11.9	5.3	8.3	2.5	10.7	7.9	5.2	2.0	17.3	24.9	8.2	11.0	6.3	5.0	0.0	6.5	20.2	10.4	14.0	8.1	16.3	10.6	0.0	11.5	2.5	6.5	3.9	7.2	6.1	16.9	1.0	7.7	5.7	6.1	13.3	4.6	22.1	8.7	6.5	8.3	7.4	18.1	12.0	12.8	5.1	13.7	7.5
NAT1	AAC1	ENSG00000171428	"N-acetyltransferase 1"	P18440	8	18170477-18223689	"Enzymes, Predicted intracellular proteins"		"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"intestine: 23.4"	"Cell type enhanced"	"Detected in many"	7	"Ciliated cells: 34.8;Paneth cells: 25.9"	"Cancer enriched"	"Detected in all"	14	"breast cancer: 47.9"	"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"											"CAB017782, HPA043704"	Approved					NA	NA					"CAB017782: , HPA043704: AB_2678625"	"unprognostic (1.31e-1)"	"unprognostic (1.05e-1)"	"prognostic favorable (5.07e-4)"	"unprognostic (2.09e-1)"	"unprognostic (2.53e-2)"	"unprognostic (8.25e-2)"	"unprognostic (5.20e-2)"	"unprognostic (6.53e-2)"	"unprognostic (6.75e-2)"	"unprognostic (1.27e-1)"	"unprognostic (1.37e-2)"	"unprognostic (9.51e-2)"	"unprognostic (6.60e-2)"	"unprognostic (7.44e-2)"	"unprognostic (2.30e-1)"	"unprognostic (3.28e-2)"	"unprognostic (8.15e-2)"	3.7	3.2	1.5	8.5	1.5	1.9	7.9	1.3	1.5	5.4	15.6	1.0	5.1	9.3	4.4	13.0	4.8	3.5	5.9	2.9	1.7	1.0	8.6	14.3	6.2	6.6	2.5	1.0	3.3	4.2	1.1	4.6	6.0	3.1	7.4	10.3	4.5	3.6	5.4	2.0	1.6	23.4	2.6	2.3	9.8	4.8	4.1	0.5	10.8	2.6	4.3	6.2	3.1	3.0	6.3	8.1	12.3	7.1	8.6	8.5	3.9	18.5	2.3	2.1	2.8	5.6	5.6	4.5	6.8	7.1	7.6	8.7	3.1	4.0	9.0	5.4	4.3	7.0	2.9	3.8	4.4	7.7	8.4	2.0	6.1	2.6	2.3	5.4	2.7	8.4	4.6	5.7	5.1	0.4	1.9	6.6	8.0	5.3	2.5	8.3	3.3	8.0	8.6	2.0	14.6	2.9	4.0	2.0	3.8	8.0	10.7	1.1	1.4	0.3	8.0	4.6	4.7	6.5	8.1	6.6	4.5	2.7	6.9	1.1	1.7	3.2	7.8	4.0	6.2	2.0	5.3	6.4	12.3	4.8	7.1	3.5	6.3	5.0	4.8	8.1	5.4	4.8	5.8	11.2	8.6	6.8	4.7	8.5	3.9	1.5	1.5	1.3	1.5	1.7	1.0	2.5	1.0	3.1	0.5	0.0	2.2	3.0	0.6	0.3	0.0	1.1	0.0	34.8	5.7	5.2	0.0	5.2	1.7	5.3	3.9	1.5	12.6	0.0	6.1	6.9	2.1	1.8	2.3	11.9	6.4	0.0	3.5	2.5	8.4	1.6	3.7	4.6	3.3	2.8	8.8	2.4	4.3	25.9	5.3	10.6	0.0	0.0	4.1	1.4	0.5	0.5	9.2	4.9	7.8	1.2
NAT2	AAC2	ENSG00000156006	"N-acetyltransferase 2"	P11245	8	18391245-18401218	"Cancer-related genes, Enzymes, Predicted intracellular proteins"		"Acyltransferase, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	22	"intestine: 28.4;liver: 75.5"	"Cell type enhanced"	"Detected in some"	25	"Enterocytes: 16.0;Hepatocytes: 52.3;Paneth cells: 10.1"	"Cancer enhanced"	"Detected in some"		"colorectal cancer: 4.0;liver cancer: 4.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"RPTEC TERT1: 2.8;RT4: 4.2;SCLC-21H: 5.8;SK-BR-3: 3.6"									HPA043704	Uncertain					NA	NA					"HPA043704: AB_2678625"	"unprognostic (2.74e-3)"	"unprognostic (4.03e-1)"	"prognostic favorable (4.61e-5)"	"unprognostic (1.43e-2)"	"unprognostic (1.07e-1)"	"unprognostic (1.83e-1)"	"unprognostic (2.52e-2)"	"unprognostic (2.67e-2)"		"unprognostic (1.27e-1)"	"unprognostic (1.33e-2)"	"unprognostic (4.07e-1)"	"unprognostic (6.05e-3)"	"unprognostic (1.02e-1)"	"unprognostic (3.40e-1)"	"unprognostic (1.83e-1)"	"unprognostic (1.64e-1)"	0.2	0.1	0.2	2.3	0.3	0.0	0.3	0.1	0.2	0.3	14.0	0.1	0.1	13.0	0.4	0.4	0.1	0.2	0.3	0.4	0.1	0.1	0.6	75.5	0.2	0.1	0.2	0.2	0.2	0.1	0.0	0.2	0.2	0.3	0.3	5.1	0.1	0.1	0.1	0.1	0.1	28.4	0.4	0.2	0.6	0.1	0.3	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.5	0.1	0.0	0.2	0.0	0.0	0.3	0.0	1.8	0.0	0.2	0.0	1.4	0.0	0.0	0.3	0.3	0.1	0.5	0.1	0.5	0.1	0.7	0.0	0.0	0.0	0.6	0.0	0.3	0.0	0.1	0.0	0.1	0.1	0.0	0.6	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	1.0	0.0	0.0	0.1	1.0	0.9	0.0	0.0	0.9	0.0	2.8	4.2	5.8	0.1	0.1	3.6	0.0	0.5	1.0	0.6	1.5	1.0	0.5	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.3	0.1	0.2	0.1	0.1	0.2	0.2	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	5.0	0.0	0.1	0.0	16.0	0.0	0.0	0.8	0.0	0.1	0.0	52.3	0.2	0.0	0.0	0.6	0.6	0.0	0.6	0.0	0.0	0.0	7.5	0.0	0.1	10.1	2.5	0.3	0.0	0.0	0.0	0.2	0.0	0.0	3.7	0.0	4.2	0.0
NAT8	"ATase2, GLA, Hcml1, TSC501"	ENSG00000144035	"N-acetyltransferase 8 (putative)"	Q9UHE5	2	73640832-73642393	"Enzymes, Predicted membrane proteins"		"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	9	"kidney: 140.4"	"Cell type enriched"	"Detected in some"	12	"Proximal tubular cells: 1951.9"	"Cancer enriched"	"Detected in some"	5	"renal cancer: 242.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	15	"Hep G2: 16.9"					"Low region specificity"	"Detected in all"			"HPA067855, HPA074519"	Enhanced		Approved	"Endoplasmic reticulum"		NA	NA			"Endoplasmic reticulum"		"HPA067855: AB_2732774, HPA074519: AB_2686699"	"unprognostic (4.51e-2)"	"unprognostic (6.36e-2)"	"unprognostic (1.95e-1)"	"unprognostic (1.81e-1)"	"unprognostic (1.98e-1)"	"unprognostic (4.95e-3)"	"unprognostic (2.46e-1)"	"unprognostic (1.90e-2)"	"unprognostic (9.42e-2)"	"unprognostic (1.82e-1)"	"unprognostic (2.13e-2)"	"unprognostic (8.60e-2)"	"unprognostic (1.37e-3)"	"unprognostic (2.07e-2)"	"unprognostic (4.11e-3)"	"unprognostic (2.13e-2)"	"unprognostic (8.36e-5)"	0.2	0.0	0.2	0.2	0.2	0.0	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.7	0.2	0.2	0.2	0.0	0.2	0.2	0.2	0.0	140.4	15.8	0.2	0.2	0.2	0.2	0.3	0.2	0.0	0.2	0.2	0.2	0.2	0.0	0.2	0.2	0.2	0.2	0.0	1.2	0.2	0.2	0.2	0.0	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.9	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.1	0.0	0.1	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	16.9	0.0	0.1	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.1	0.0	0.1	0.0	0.2	0.0	0.3	0.2	0.1	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.2	0.2	0.2	0.2	0.2	0.0	0.2	0.2	0.2	0.2	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	34.9	0.0	0.0	159.2	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	40.4	0.0	0.0	0.0	22.7	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.9	0.0	1951.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
NAT8L	"FLJ37478, Hcml3"	ENSG00000185818	"N-acetyltransferase 8 like"	Q8N9F0	4	2059512-2069089	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"		"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"adipose tissue: 45.9;brain: 45.9;testis: 11.8"	"Group enriched"	"Detected in some"	5	"Horizontal cells: 76.3;Muller glia cells: 25.6"	"Group enriched"	"Detected in many"	6	"endometrial cancer: 6.2;glioma: 17.2;melanoma: 14.6;ovarian cancer: 8.0;thyroid cancer: 7.9"	"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	28	"plasmacytoid DC: 3.8"	"Lineage enriched"	"Detected in single"	28	"dendritic cells: 3.8"	"Cell line enhanced"	"Detected in many"		"NB-4: 14.7;SCLC-21H: 19.0;SK-MEL-30: 15.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA040677			Approved	Mitochondria		NA	NA			Mitochondria		"HPA040677: AB_2732486"	"unprognostic (1.32e-2)"	"unprognostic (8.62e-2)"	"unprognostic (3.02e-3)"	"prognostic unfavorable (1.01e-5)"	"unprognostic (2.56e-1)"	"unprognostic (2.63e-4)"	"unprognostic (6.58e-2)"	"unprognostic (1.79e-1)"	"unprognostic (2.90e-2)"	"unprognostic (4.54e-1)"	"unprognostic (3.70e-2)"	"unprognostic (7.06e-2)"	"unprognostic (1.78e-3)"	"unprognostic (7.24e-3)"	"unprognostic (1.14e-2)"	"unprognostic (2.10e-2)"	"unprognostic (1.35e-2)"	45.9	2.0	23.5	1.3	28.3	1.2	7.9	16.4	45.9	1.2	1.5	7.4	0.3	1.3	1.6	2.8	1.3	2.4	1.3	2.1	20.8	12.9	8.2	1.2	1.2	1.4	16.4	12.6	1.4	3.9	1.2	5.6	1.3	12.8	2.4	1.3	1.2	3.8	3.2	7.3	2.4	1.5	1.4	6.5	1.5	1.6	11.8	8.2	0.0	1.6	0.0	1.2	1.2	0.1	0.0	3.8	0.1	0.0	0.0	0.0	0.0	0.0	6.6	3.6	7.3	0.7	0.0	4.2	0.1	0.0	0.2	0.0	2.9	0.2	0.0	1.3	0.0	1.1	0.1	8.2	0.0	0.1	0.0	9.6	0.1	1.4	4.7	1.2	10.1	5.0	0.0	0.1	0.0	0.0	1.4	0.0	2.5	7.8	0.0	0.3	4.4	0.1	14.7	10.3	0.0	3.0	0.5	1.7	0.2	0.1	0.3	19.0	6.3	4.8	0.0	15.1	0.6	0.5	5.9	0.0	0.0	2.5	0.1	3.9	0.0	0.0	0.1	0.0	4.3	0.8	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.8	0.0	0.0	23.5	28.3	16.4	32.7	20.8	12.9	16.4	12.6	12.8	8.2	0.0	0.0	0.0	0.0	0.2	7.1	2.0	0.0	0.0	0.0	1.8	5.9	0.0	0.0	4.2	0.8	0.1	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.0	0.7	76.3	1.7	0.0	0.0	3.1	0.0	0.1	10.1	0.0	0.0	25.6	0.5	0.0	0.0	0.0	4.7	0.0	0.0	0.5	0.6	0.1	0.0	0.0	0.0	0.0
NAV2	"FLJ10633, FLJ11030, FLJ23707, HELAD1, KIAA1419, POMFIL2, RAINB1"	ENSG00000166833	"Neuron navigator 2"	Q8IVL1	11	19350724-20121598	"Enzymes, Predicted intracellular proteins"		"Helicase, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 64.6"	"Cell type enhanced"	"Detected in many"	5	"Alveolar cells type 1: 59.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"plasmacytoid DC: 1.9"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"hTERT-HME1: 34.8;SH-SY5Y: 31.8;TIME: 24.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA011755, HPA011891"	Approved		Supported	Nucleoplasm		NA	NA			Nucleoplasm		"HPA011755: AB_1854319, HPA011891: AB_1854318"	"unprognostic (7.71e-2)"	"unprognostic (2.37e-1)"	"unprognostic (1.29e-1)"	"unprognostic (1.02e-1)"	"unprognostic (3.01e-1)"	"unprognostic (1.76e-3)"	"unprognostic (3.01e-2)"	"unprognostic (3.86e-2)"	"unprognostic (1.54e-1)"	"unprognostic (1.00e-1)"	"unprognostic (3.53e-3)"	"unprognostic (1.84e-1)"	"unprognostic (2.83e-2)"	"unprognostic (3.85e-2)"	"unprognostic (1.08e-1)"	"unprognostic (6.43e-2)"	"unprognostic (3.28e-2)"	14.8	3.1	7.9	4.7	12.5	3.1	13.8	13.8	16.1	10.2	17.6	16.1	8.6	5.1	9.3	13.4	7.8	5.7	3.2	64.6	9.9	7.0	12.3	18.7	11.2	3.0	16.5	11.5	4.7	10.8	10.1	6.6	16.2	23.5	7.9	6.3	8.6	16.5	11.8	3.4	7.9	4.7	13.0	32.2	2.5	9.9	2.1	12.6	0.0	20.1	1.8	5.3	6.0	8.6	0.3	1.9	0.0	0.5	0.0	0.3	0.0	5.9	1.7	3.9	0.4	13.2	8.5	4.2	5.0	8.6	6.6	5.0	6.7	0.8	0.0	0.2	7.5	10.8	0.7	0.2	3.9	7.8	1.0	0.4	0.1	8.8	7.6	2.4	0.0	0.2	5.5	10.2	3.1	34.8	4.9	8.8	0.0	0.7	3.0	19.1	6.3	0.0	0.0	9.2	1.6	5.0	0.0	18.0	0.9	5.7	1.7	6.8	31.8	3.8	3.0	5.7	21.5	0.1	0.0	24.5	15.5	2.3	18.3	4.7	1.0	0.5	0.0	5.3	0.3	4.6	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.3	0.5	0.2	0.0	0.0	0.0	0.0	0.5	1.9	0.0	0.0	7.9	12.5	13.8	16.1	9.9	7.0	16.5	11.5	23.5	12.6	59.6	16.9	0.8	19.9	3.8	1.7	12.3	10.2	25.4	25.0	19.2	0.0	22.2	11.6	17.9	2.4	10.8	1.0	0.0	18.3	18.1	14.6	23.3	1.1	33.0	8.6	25.4	10.4	11.1	1.5	5.6	0.9	2.3	15.1	1.8	7.7	32.7	26.8	0.0	3.9	0.4	2.1	0.0	9.0	1.5	0.5	3.1	12.2	0.0	8.0	15.2
NAXD	"CARKD, FLJ10769, LP3298"	ENSG00000213995	"NAD(P)HX dehydratase"	Q8IW45	13	110615460-110639993	"Enzymes, Predicted intracellular proteins"		Lyase	"Disease mutation, Neurodegeneration"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Cytotrophoblasts: 28.5;Distal tubular cells: 33.2;Extravillous trophoblasts: 22.2;Syncytiotrophoblasts: 25.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA010551	Uncertain					NA	NA		230000			"HPA010551: AB_1848669"	"unprognostic (1.24e-1)"	"unprognostic (5.14e-2)"	"unprognostic (1.79e-2)"	"prognostic favorable (3.15e-4)"	"unprognostic (1.78e-1)"	"unprognostic (1.81e-1)"	"unprognostic (3.48e-2)"	"unprognostic (2.89e-1)"	"unprognostic (3.20e-1)"	"unprognostic (9.01e-2)"	"unprognostic (1.94e-2)"	"unprognostic (4.36e-3)"	"prognostic favorable (4.63e-5)"	"unprognostic (2.19e-2)"	"unprognostic (1.27e-1)"	"unprognostic (2.30e-1)"	"unprognostic (1.62e-2)"	9.1	22.8	17.3	10.9	20.5	4.6	12.5	20.4	25.0	11.5	17.2	19.0	18.0	11.6	13.9	15.3	16.3	14.0	13.6	14.7	20.9	12.0	14.3	30.4	12.1	11.7	15.0	19.4	28.8	24.8	12.7	15.2	14.7	14.8	16.5	12.4	12.7	12.7	21.2	15.1	20.8	12.6	13.7	13.8	13.2	16.7	17.9	17.0	9.2	15.5	10.5	9.9	12.7	11.8	7.3	7.6	0.7	6.9	6.2	8.5	6.1	10.9	5.0	8.3	6.4	10.8	6.6	14.3	8.5	8.0	9.3	9.6	17.1	11.3	2.0	9.3	6.6	8.0	9.1	4.7	8.9	4.5	8.3	10.5	7.1	15.7	9.5	10.5	9.4	6.7	9.3	16.5	5.9	6.6	10.6	9.8	9.1	6.0	0.1	7.3	11.9	6.9	17.9	7.5	19.6	6.1	2.3	3.2	2.5	9.9	9.4	14.5	8.6	4.9	26.3	5.9	5.7	12.0	15.7	5.7	6.3	5.2	0.1	6.7	7.7	5.2	0.1	10.1	2.1	8.2	0.0	5.9	0.5	8.5	6.9	5.4	7.3	7.7	7.6	7.4	6.5	8.3	8.2	0.7	6.2	4.5	7.6	8.4	6.1	17.3	20.5	20.4	25.0	20.9	12.0	15.0	19.4	14.8	17.0	17.9	10.1	0.0	0.0	0.0	0.0	0.0	0.0	16.0	18.2	21.0	0.0	28.5	33.2	12.7	0.0	0.0	0.0	0.0	10.3	22.2	0.0	0.0	1.1	0.0	9.6	0.0	0.0	0.0	0.0	0.0	0.0	3.4	0.0	18.0	0.0	0.0	10.0	0.0	0.0	19.5	0.0	0.0	0.0	0.0	0.0	0.0	25.9	0.0	0.0	0.0
NAXE	"AIBP, APOA1BP, MGC119143, MGC119144, MGC119145, YJEFN1"	ENSG00000163382	"NAD(P)HX epimerase"	Q8NCW5	1	156591762-156594299	"Disease related genes, Enzymes, Potential drug targets, Predicted secreted proteins"	"Lipid transport, Transport"	Isomerase	"Disease mutation, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	8	"Cytotrophoblasts: 120.4;Distal tubular cells: 170.8;Proximal tubular cells: 189.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043766, HPA048164"	Enhanced		Approved	Nucleoplasm,Vesicles,Cytosol	"Secreted to blood"	NA	NA		3300000	Nucleoplasm	"Vesicles, Cytosol"	"HPA043766: AB_2678660, HPA048164: AB_2680294"	"unprognostic (1.27e-1)"	"unprognostic (2.34e-2)"	"unprognostic (2.49e-1)"	"prognostic unfavorable (4.94e-4)"	"unprognostic (7.38e-2)"	"unprognostic (5.32e-2)"	"unprognostic (2.46e-3)"	"unprognostic (2.60e-1)"	"unprognostic (1.72e-1)"	"unprognostic (3.08e-3)"	"unprognostic (3.23e-2)"	"unprognostic (3.14e-2)"	"unprognostic (2.15e-2)"	"unprognostic (8.05e-2)"	"unprognostic (7.43e-2)"	"unprognostic (2.09e-1)"	"unprognostic (3.81e-1)"	19.1	29.9	31.6	14.4	28.5	12.1	22.6	17.6	42.5	23.0	30.0	31.0	17.4	28.4	28.5	57.9	23.4	29.4	25.8	46.3	28.5	25.0	41.6	41.0	17.2	16.9	33.2	29.3	29.3	37.3	36.3	29.0	21.8	28.8	27.9	26.6	23.0	29.5	36.3	30.9	20.2	25.9	25.0	29.1	17.4	25.0	29.5	22.2	17.7	32.4	19.5	20.4	20.8	18.3	52.4	53.8	12.4	26.5	31.6	32.5	40.6	31.6	42.0	13.4	24.0	17.9	12.3	16.0	10.9	16.7	18.7	19.8	34.9	21.3	21.5	33.2	13.9	16.2	30.9	13.4	26.1	13.3	22.7	29.3	17.8	24.0	23.1	20.5	22.3	18.3	12.3	33.8	23.8	22.2	15.0	25.4	29.0	18.1	19.6	19.1	56.3	24.5	27.2	16.6	43.8	32.8	24.7	12.6	56.8	25.3	26.3	32.5	31.0	26.2	50.1	38.5	19.8	48.6	32.9	14.8	13.5	21.1	19.1	23.8	50.8	30.7	20.5	18.6	13.3	20.8	4.9	24.1	12.4	31.6	26.5	31.3	52.4	29.2	32.2	21.7	41.7	32.5	30.9	2.9	31.6	20.6	53.8	25.5	40.6	31.6	28.5	17.6	42.5	28.5	25.0	33.2	29.3	28.8	22.2	38.7	23.3	0.0	0.0	0.0	0.0	0.0	0.0	21.4	43.3	64.6	0.0	120.4	170.8	89.3	0.0	0.0	0.0	0.0	87.1	28.1	0.0	0.0	4.7	0.0	80.7	0.0	0.0	0.0	0.0	0.0	0.0	13.0	0.0	71.3	0.0	0.0	83.0	0.0	0.0	189.4	0.0	0.0	0.0	0.0	0.0	0.0	68.0	0.0	0.0	0.0
NCOA1	"bHLHe74, F-SRC-1, KAT13A, NCoA-1, RIP160, SRC1"	ENSG00000084676	"Nuclear receptor coactivator 1"	Q15788	2	24491914-24770702	"Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, Acyltransferase, Transferase"	"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"RH-30: 41.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB019402, HPA070213, HPA070520"	Supported		Enhanced	"Nucleoplasm,Plasma membrane,Cytosol"		No	No			Nucleoplasm	"Plasma membrane, Cytosol"	"CAB019402: AB_2196189, HPA070213: AB_2686235, HPA070520: AB_2686276"	"unprognostic (2.73e-1)"	"unprognostic (5.82e-2)"	"unprognostic (2.46e-2)"	"unprognostic (9.89e-3)"	"unprognostic (7.60e-2)"	"unprognostic (2.36e-2)"	"unprognostic (7.06e-3)"	"unprognostic (1.45e-1)"	"unprognostic (1.43e-1)"	"unprognostic (1.72e-1)"	"unprognostic (2.93e-3)"	"unprognostic (1.16e-1)"	"unprognostic (2.10e-2)"	"unprognostic (7.15e-2)"	"unprognostic (3.08e-1)"	"unprognostic (1.29e-1)"	"unprognostic (2.92e-2)"	9.8	10.0	15.3	7.3	18.0	8.9	10.5	15.9	17.1	13.7	8.9	13.5	4.9	12.5	13.0	11.5	10.8	10.0	8.3	8.8	20.8	12.2	11.9	8.8	9.4	8.2	10.8	9.9	17.2	10.3	23.9	16.0	10.1	14.2	9.6	10.1	19.9	10.6	13.0	42.5	9.3	10.9	11.6	9.7	9.6	7.6	11.4	10.7	8.5	7.0	12.2	9.3	9.7	10.8	2.5	5.5	14.2	3.5	3.4	4.1	1.8	6.7	5.0	8.9	4.6	9.8	9.0	13.6	3.6	7.3	4.6	4.1	4.7	2.9	4.9	1.5	6.6	8.8	1.6	5.3	3.1	5.0	23.3	7.7	17.6	2.0	1.9	6.2	8.0	14.7	14.3	4.7	4.4	3.6	5.7	4.6	6.4	10.7	8.2	6.9	4.5	7.1	2.9	4.2	4.0	3.4	5.7	41.0	2.5	5.0	9.2	8.1	6.4	8.4	5.1	3.7	4.9	6.1	4.1	5.0	7.7	6.1	5.2	3.6	9.5	8.2	8.6	4.4	5.1	3.8	11.0	3.5	6.9	3.8	2.7	4.1	1.8	3.4	4.1	2.6	2.5	3.3	4.0	14.2	3.4	2.8	5.5	3.7	1.8	15.3	18.0	15.9	17.1	20.8	12.2	10.8	9.9	14.2	10.7	35.7	29.8	13.6	10.7	27.1	97.2	33.1	15.3	20.1	31.8	14.0	49.1	11.2	6.6	12.0	13.1	29.2	24.6	23.3	23.0	14.9	31.2	14.1	18.6	20.3	15.3	58.8	24.2	33.2	25.2	3.8	43.7	26.2	18.6	10.0	22.7	63.8	17.7	35.1	40.7	11.4	67.4	38.8	35.4	32.1	36.8	27.0	4.5	25.4	23.0	14.6
NCOA3	"ACTR, AIB1, bHLHe42, CAGH16, KAT13B, p/CIP, RAC3, SRC-3, SRC3, TNRC16, TRAM-1"	ENSG00000124151	"Nuclear receptor coactivator 3"	Q9Y6Q9	20	47501902-47656877	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, Acyltransferase, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"BEWO: 38.1;MCF7: 63.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009800, HPA024210"	Supported		Supported	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"CAB009800: AB_2251314, HPA024210: AB_10602011"	"unprognostic (7.26e-3)"	"unprognostic (1.00e-1)"	"unprognostic (2.69e-1)"	"unprognostic (3.23e-2)"	"unprognostic (5.78e-2)"	"unprognostic (4.33e-2)"	"prognostic unfavorable (8.09e-4)"	"unprognostic (2.83e-2)"	"unprognostic (1.47e-1)"	"unprognostic (5.22e-3)"	"unprognostic (2.09e-2)"	"unprognostic (2.10e-1)"	"unprognostic (2.05e-1)"	"unprognostic (1.95e-1)"	"unprognostic (2.04e-2)"	"unprognostic (4.18e-1)"	"unprognostic (1.63e-1)"	20.1	8.9	6.6	34.0	7.4	11.1	15.7	11.9	9.9	12.3	10.1	8.1	9.0	6.7	15.5	8.8	16.7	12.0	8.6	11.5	6.7	4.8	9.1	9.3	17.4	25.8	7.9	4.7	13.3	10.7	13.5	13.5	54.7	7.9	9.7	9.0	10.8	13.5	10.0	32.5	15.0	17.1	11.3	9.5	30.8	11.4	9.2	7.2	17.6	13.5	10.5	33.3	15.1	17.7	13.0	6.7	6.0	7.3	2.7	4.0	3.5	5.9	19.2	5.4	7.3	12.8	15.0	38.1	5.7	8.6	9.8	5.2	9.2	6.5	20.5	3.8	9.8	13.8	14.4	4.2	7.0	7.5	10.8	2.2	2.8	5.4	12.7	7.6	2.2	15.3	6.8	20.2	9.3	10.8	7.9	6.9	3.4	6.3	4.8	5.4	63.9	3.2	3.8	1.9	4.5	7.4	6.1	3.8	8.8	5.4	13.8	1.0	1.9	14.4	17.9	6.1	6.5	8.3	5.6	12.0	5.8	5.1	7.0	2.5	13.2	12.0	21.1	6.8	2.2	3.9	3.4	5.2	4.0	3.5	7.3	3.2	13.0	3.2	3.1	6.7	10.0	3.7	4.0	6.0	2.7	7.0	5.5	4.0	3.5	6.6	7.4	11.9	9.9	6.7	4.8	7.9	4.7	7.9	7.2	11.9	21.3	77.0	14.2	30.7	16.1	22.0	20.4	22.7	17.0	14.0	7.9	56.2	5.0	11.0	9.0	39.0	7.8	0.0	16.8	23.2	22.6	21.3	8.1	18.4	20.1	12.7	14.3	66.9	49.4	3.6	23.0	45.5	32.1	22.6	11.4	9.7	15.9	14.0	25.8	5.1	22.4	19.4	26.8	22.7	17.8	45.2	74.6	22.4	11.7	56.9
NDST1	"HSST, NST1"	ENSG00000070614	"N-deacetylase and N-sulfotransferase 1"	P52848	5	150485818-150558211	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Inflammatory response"	"Hydrolase, Multifunctional enzyme, Transferase"	"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Hepatocytes: 42.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	10	"dendritic cells: 5.5;granulocytes: 7.2;monocytes: 6.5"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA060532	Approved					NA	NA		1000000			"HPA060532: AB_2684310"	"unprognostic (1.36e-1)"	"unprognostic (5.54e-3)"	"unprognostic (1.48e-1)"	"prognostic unfavorable (6.99e-4)"	"unprognostic (1.77e-1)"	"unprognostic (3.37e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.47e-2)"	"unprognostic (2.73e-1)"	"prognostic unfavorable (5.13e-4)"	"unprognostic (4.97e-3)"	"unprognostic (6.92e-2)"	"unprognostic (7.45e-2)"	"unprognostic (2.46e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.26e-1)"	"unprognostic (6.08e-2)"	26.3	15.5	17.3	9.9	20.2	4.9	21.3	8.6	28.3	12.9	10.2	41.7	7.3	9.3	11.8	10.0	25.5	11.0	16.9	19.6	17.9	14.4	11.4	49.2	25.2	6.1	28.5	13.8	17.3	28.9	16.5	4.7	10.0	26.1	11.3	7.3	10.8	25.4	13.5	15.3	24.9	14.7	14.3	32.8	30.1	10.2	12.6	19.6	1.4	17.3	11.9	9.8	10.5	11.5	0.6	5.5	7.2	6.5	0.1	0.6	2.9	9.8	8.8	14.6	17.8	14.7	14.7	14.7	18.1	23.9	18.1	27.3	25.9	10.4	6.7	18.4	36.1	29.1	16.9	7.8	36.7	12.1	0.8	12.2	7.9	5.7	4.0	10.9	5.9	14.5	20.0	15.3	21.8	9.9	18.2	24.6	4.0	7.5	2.4	17.6	8.3	0.7	1.8	6.8	2.7	10.4	11.4	12.2	2.9	10.6	10.0	4.4	15.4	10.9	34.3	14.5	10.9	18.3	1.4	12.0	31.0	28.1	13.4	14.8	5.4	1.4	2.5	25.4	9.2	11.9	1.7	6.5	4.4	0.1	2.3	0.0	0.6	0.0	0.6	5.5	0.1	0.1	0.2	7.2	0.1	5.5	0.4	0.0	2.9	17.3	20.2	8.6	28.3	17.9	14.4	28.5	13.8	26.1	19.6	35.7	8.3	0.8	2.4	5.0	11.1	10.4	15.3	0.0	7.9	15.7	7.9	7.4	1.7	8.2	0.4	12.6	12.1	0.0	8.9	9.2	10.0	6.0	1.1	42.9	7.0	12.7	1.2	35.0	17.9	1.5	11.5	5.0	10.1	1.0	6.3	12.2	13.6	5.8	30.1	8.4	10.1	0.0	7.1	0.0	0.6	10.8	3.8	1.0	4.4	3.5
NDST2	"HSST2, NST2"	ENSG00000166507	"N-deacetylase and N-sulfotransferase 2"	P52849	10	73801911-73811798	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"		"Hydrolase, Multifunctional enzyme, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"granulocytes: 13.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HMC-1: 50.8"									HPA051515	Approved		Approved	Cytosol		NA	NA		72000	Cytosol		"HPA051515: AB_2681517"	"unprognostic (8.84e-2)"	"unprognostic (7.57e-2)"	"unprognostic (2.53e-2)"	"unprognostic (9.43e-3)"	"unprognostic (5.69e-1)"	"unprognostic (1.07e-2)"	"unprognostic (5.83e-3)"	"unprognostic (2.16e-2)"	"unprognostic (8.19e-2)"	"unprognostic (1.61e-2)"	"unprognostic (2.23e-5)"	"unprognostic (1.49e-2)"	"unprognostic (4.08e-7)"	"unprognostic (3.71e-2)"	"unprognostic (3.69e-2)"	"unprognostic (5.93e-2)"	"unprognostic (9.06e-2)"	12.6	14.6	7.9	19.2	11.3	37.5	11.8	30.2	12.2	16.6	10.7	13.8	13.4	8.9	18.4	14.8	14.4	12.8	15.5	9.3	9.6	8.4	11.0	9.4	14.7	21.9	7.3	8.8	15.1	12.3	17.3	26.5	14.1	9.2	13.6	10.5	14.7	20.1	17.2	16.4	15.1	14.4	13.4	7.5	31.8	11.8	13.5	9.2	35.3	12.2	8.2	19.3	12.3	13.3	3.1	6.8	5.8	5.3	2.2	7.1	3.2	4.3	3.6	7.5	11.5	9.3	10.8	3.9	5.1	10.9	5.9	6.1	1.9	5.3	3.9	3.1	9.7	6.0	5.0	3.7	5.4	4.8	10.4	3.6	3.9	2.7	3.0	16.4	5.0	50.8	10.2	6.6	10.2	10.5	18.4	7.7	7.9	3.7	15.1	7.4	3.3	5.8	5.5	2.1	2.7	15.3	3.6	3.7	2.4	5.0	3.0	2.5	4.2	4.5	10.7	3.5	5.2	8.2	7.7	12.3	3.0	3.5	3.9	3.6	7.5	3.3	5.2	3.5	7.7	2.3	1.4	5.3	2.1	5.5	3.7	6.5	2.5	4.7	4.8	4.0	3.1	5.6	7.1	5.8	2.2	3.5	6.8	3.1	3.2	7.9	11.3	30.2	12.2	9.6	8.4	7.3	8.8	9.2	9.2	0.0	4.8	3.7	0.3	1.1	0.6	1.4	0.0	4.0	2.3	0.0	0.0	1.2	0.0	4.4	5.7	0.5	3.5	0.0	8.4	1.4	1.0	1.5	13.9	3.8	4.5	1.6	2.4	0.0	6.7	6.8	0.0	3.5	1.7	4.6	2.3	0.7	5.5	2.6	0.0	5.6	0.7	0.0	1.0	2.4	1.4	1.4	5.1	3.2	1.7	2.1
NDST3	HSST3	ENSG00000164100	"N-deacetylase and N-sulfotransferase 3"	O95803	4	118033618-118258648	"Enzymes, Predicted intracellular proteins"		"Hydrolase, Multifunctional enzyme, Transferase"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"brain: 22.2;lymphoid tissue: 6.8;pituitary gland: 7.6"	"Cell type enhanced"	"Detected in some"	25	"Bipolar cells: 20.2;Horizontal cells: 6.4;Kupffer cells: 27.2"	"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	5	"basal ganglia: 17.0;cerebellum: 22.2;cerebral cortex: 5.7"	"Cell type enhanced"	"Detected in some"		"neutrophil: 1.3"	"Low lineage specificity"	"Detected in single"			"Cell line enriched"	"Detected in some"	10	"MOLT-4: 19.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA056189	Uncertain					NA	NA					"HPA056189: AB_2683061"	"unprognostic (1.95e-2)"	"unprognostic (7.58e-2)"	"unprognostic (4.34e-3)"	"unprognostic (2.55e-7)"	"unprognostic (4.05e-2)"	"unprognostic (2.18e-2)"	"unprognostic (2.86e-3)"	"unprognostic (2.32e-2)"	"unprognostic (1.87e-1)"	"unprognostic (1.46e-2)"	"unprognostic (7.43e-2)"	"unprognostic (1.99e-2)"	"unprognostic (1.09e-3)"	"unprognostic (1.37e-1)"	"unprognostic (4.39e-3)"	"unprognostic (6.83e-2)"	"unprognostic (8.85e-2)"	0.3	2.0	3.2	0.3	17.0	0.6	0.3	22.2	6.9	2.1	0.4	0.0	0.0	0.3	0.4	0.2	0.3	1.3	0.4	0.3	2.3	2.0	0.9	4.6	0.4	0.6	0.9	1.7	0.6	0.2	0.2	7.6	0.4	1.7	0.5	0.4	1.3	0.2	1.2	0.3	0.4	0.4	0.4	0.6	6.8	1.0	0.5	2.4	6.8	0.6	0.0	0.4	0.3	0.3	0.3	0.4	1.3	0.2	0.4	0.1	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	1.2	0.0	1.9	0.0	0.0	0.0	0.0	19.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.2	0.9	1.1	0.2	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.0	0.3	0.1	0.1	1.3	0.4	0.1	0.4	0.0	0.0	3.2	17.0	22.2	5.7	2.3	2.0	0.9	1.7	1.7	2.4	0.0	0.0	0.0	0.0	0.0	20.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	6.4	0.0	0.0	27.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0
NDST4		ENSG00000138653	"N-deacetylase and N-sulfotransferase 4"	Q9H3R1	4	114827763-115113876	"Enzymes, Predicted intracellular proteins"		"Hydrolase, Multifunctional enzyme, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	6	"brain: 34.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enriched"	"Detected in many"	17	"pons and medulla: 34.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	4	"RH-30: 18.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA011129	Uncertain					NA	NA					"HPA011129: AB_1079460"	"unprognostic (5.58e-2)"				"unprognostic (5.90e-2)"					"unprognostic (4.82e-1)"	"unprognostic (1.71e-2)"	"unprognostic (1.08e-1)"		"unprognostic (1.11e-1)"	"unprognostic (1.94e-1)"		"unprognostic (6.55e-2)"	0.1	0.0	1.3	0.0	1.7	0.0	0.1	0.2	3.4	1.4	0.3	0.3	0.3	0.1	1.5	0.0	0.1	0.1	0.3	0.1	0.7	1.9	0.1	0.0	0.1	0.0	1.3	1.4	5.7	0.1	0.0	0.6	0.0	34.6	1.5	0.1	0.0	0.5	0.6	0.1	0.2	0.1	1.6	1.0	2.5	1.1	0.7	0.0	0.0	0.1	0.1	0.0	0.8	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	18.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	4.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	1.7	0.2	1.7	0.7	1.9	1.3	1.4	34.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0
NDUFAF7	"C2orf56, MidA, PRO1853"	ENSG00000003509	"NADH:ubiquinone oxidoreductase complex assembly factor 7"	Q7L592	2	37231631-37253403	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		"Methyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 44.4"	"Group enriched"	"Detected in many"	4	"Early spermatids: 139.4;Late spermatids: 75.9;Spermatocytes: 47.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA045217	Uncertain					NA	NA					"HPA045217: AB_10960395"	"unprognostic (6.38e-2)"	"unprognostic (2.92e-2)"	"unprognostic (2.13e-1)"	"unprognostic (1.38e-2)"	"unprognostic (1.17e-1)"	"unprognostic (2.15e-1)"	"prognostic unfavorable (1.48e-4)"	"prognostic favorable (3.08e-4)"	"unprognostic (5.44e-2)"	"unprognostic (1.55e-2)"	"unprognostic (9.88e-2)"	"unprognostic (8.12e-3)"	"unprognostic (5.94e-2)"	"unprognostic (3.48e-2)"	"unprognostic (1.03e-1)"	"unprognostic (5.73e-2)"	"unprognostic (8.67e-3)"	7.1	14.3	10.1	7.5	15.9	7.3	8.3	24.1	17.0	9.3	12.6	7.7	6.1	6.4	10.0	11.0	6.7	6.4	8.1	18.3	9.4	9.7	12.2	13.5	6.6	8.3	9.4	10.5	8.8	7.6	9.4	15.2	7.9	14.5	7.7	8.1	7.8	7.0	7.9	21.0	5.8	7.3	9.8	7.2	7.8	7.1	44.4	10.5	8.2	6.4	6.5	7.5	7.8	7.2	8.9	9.9	5.3	8.1	6.9	8.3	4.1	15.8	8.5	10.7	9.6	6.9	14.8	6.0	5.1	8.5	9.1	11.7	18.1	6.8	13.5	6.7	4.9	15.5	11.9	13.2	6.7	10.8	9.2	9.7	9.9	10.6	16.4	8.6	9.7	5.1	11.5	11.3	7.6	4.7	9.8	14.2	5.0	12.1	9.1	5.3	5.9	9.8	10.7	14.2	12.4	7.3	8.9	8.4	11.3	12.8	6.0	11.3	9.1	6.7	11.4	11.3	16.0	6.9	4.0	2.8	7.7	10.3	9.4	9.6	8.0	4.6	15.2	11.2	13.5	6.5	4.6	8.1	4.5	8.3	7.0	3.8	8.9	7.4	7.1	9.9	7.8	7.4	6.4	5.3	6.9	4.9	8.1	8.3	4.1	10.1	15.9	24.1	17.0	9.4	9.7	9.4	10.5	14.5	10.5	8.9	7.7	11.5	8.2	4.2	17.7	12.0	2.5	13.4	6.8	10.4	21.6	12.3	14.9	9.1	139.4	7.1	4.5	0.0	5.6	8.6	8.0	5.2	7.0	5.9	8.4	11.1	2.4	8.0	8.6	75.9	12.4	11.2	3.3	10.8	5.0	8.1	7.9	0.0	15.6	11.1	20.9	6.5	8.9	47.1	14.2	3.4	9.6	10.0	6.4	5.3
NDUFS1	CI-75k	ENSG00000023228	"NADH:ubiquinone oxidoreductase core subunit S1"	P28331	2	206114817-206159603	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Electron transport, Respiratory chain, Transport"	"Oxidoreductase, Translocase"	"Disease mutation, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 99.5"	"Cell type enriched"	"Detected in many"	5	"Cardiomyocytes: 534.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA064605, CAB070844"	Enhanced		Supported	Mitochondria		NA	NA			Mitochondria		"CAB070844: , HPA064605: AB_2685297"	"prognostic unfavorable (3.85e-4)"	"unprognostic (1.76e-1)"	"unprognostic (9.22e-3)"	"unprognostic (5.01e-2)"	"unprognostic (8.63e-3)"	"unprognostic (3.75e-1)"	"unprognostic (3.72e-2)"	"unprognostic (6.18e-2)"	"unprognostic (2.30e-2)"	"unprognostic (3.28e-1)"	"unprognostic (2.00e-2)"	"unprognostic (1.28e-1)"	"prognostic favorable (1.47e-12)"	"unprognostic (1.17e-1)"	"unprognostic (1.29e-1)"	"unprognostic (4.76e-2)"	"unprognostic (4.73e-2)"	13.9	29.0	12.1	8.3	22.1	7.6	10.3	11.6	26.4	9.1	17.4	16.4	9.2	18.3	9.1	7.7	15.7	7.7	7.3	62.6	11.3	11.7	29.5	30.7	8.3	7.7	13.3	13.8	8.2	9.3	22.1	11.6	10.8	24.2	10.7	18.9	13.5	12.8	10.9	99.5	11.0	19.9	11.1	10.8	8.4	14.9	8.8	11.1	11.2	10.8	34.7	10.5	11.6	9.4	10.7	15.3	15.7	21.4	12.5	16.1	8.9	12.9	12.9	18.8	13.6	17.6	14.3	21.9	19.1	20.6	31.9	23.2	33.5	15.2	14.7	16.9	23.8	31.7	18.2	25.1	18.5	28.4	6.7	11.8	29.3	32.1	30.0	18.3	21.1	13.3	17.4	10.9	25.0	19.7	14.3	24.8	18.6	31.7	14.9	20.7	16.2	17.4	14.0	17.4	21.9	23.1	17.6	26.3	25.4	26.4	23.7	18.4	14.4	22.0	21.6	31.2	26.9	19.0	20.5	18.9	17.6	15.7	17.2	18.1	14.4	17.3	21.9	17.6	17.5	17.9	12.0	13.3	15.7	13.6	15.4	10.8	10.7	12.2	13.0	15.3	9.5	10.9	12.4	9.6	12.5	21.4	8.2	16.1	8.9	12.1	22.1	11.6	26.4	11.3	11.7	13.3	13.8	24.2	11.1	56.6	24.1	13.7	19.6	14.3	94.7	534.9	63.7	60.2	35.2	36.6	113.9	40.2	79.6	36.7	9.9	33.7	63.8	0.0	24.5	26.7	24.7	17.4	35.9	83.9	29.8	111.2	49.0	33.7	34.6	5.2	31.1	25.2	28.7	27.1	47.3	60.7	29.2	35.1	42.1	80.9	78.2	32.3	27.8	28.6	37.3	14.4	43.8	18.7	52.8	23.9
NDUFS2	CI-49	ENSG00000158864	"NADH:ubiquinone oxidoreductase core subunit S2"	O75306	1	161197104-161214395	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Electron transport, Respiratory chain, Transport"	"Oxidoreductase, Translocase"	"Disease mutation, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 104.9"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA055140, HPA061953"	Enhanced		Supported	Mitochondria		NA	NA		16000	Mitochondria		"HPA055140: AB_2682713, HPA061953: AB_2684646"	"unprognostic (2.13e-2)"	"unprognostic (2.24e-2)"	"unprognostic (8.47e-2)"	"unprognostic (7.78e-2)"	"unprognostic (9.81e-2)"	"unprognostic (2.70e-1)"	"unprognostic (1.10e-2)"	"unprognostic (1.51e-1)"	"unprognostic (3.10e-1)"	"unprognostic (1.57e-2)"	"unprognostic (3.17e-2)"	"unprognostic (1.11e-1)"	"prognostic favorable (2.32e-4)"	"unprognostic (2.35e-1)"	"unprognostic (2.80e-1)"	"unprognostic (1.13e-1)"	"unprognostic (1.82e-1)"	14.6	30.7	16.6	8.0	25.4	10.2	15.5	23.4	25.4	13.0	25.6	17.9	11.7	23.6	12.3	11.2	16.7	14.5	10.6	75.4	17.6	14.8	37.4	52.6	12.8	9.2	28.0	25.0	14.1	14.3	25.6	10.7	11.5	24.1	12.7	27.2	11.4	14.6	14.5	104.9	14.0	22.1	15.7	16.1	13.0	19.4	8.8	25.3	10.4	12.3	37.1	15.1	13.2	10.5	18.9	47.3	26.6	42.2	20.3	29.2	32.4	17.2	27.8	17.6	20.4	25.9	23.0	15.2	15.7	23.1	31.1	24.5	30.5	18.0	22.0	29.6	24.2	17.1	23.2	28.1	28.1	27.5	14.6	23.6	21.4	20.9	26.6	26.9	23.2	19.9	33.1	24.8	25.1	28.7	20.6	35.5	23.0	27.4	12.0	29.2	19.9	14.7	12.4	32.1	60.6	25.7	12.7	18.2	30.9	36.9	20.7	18.7	27.8	19.0	46.9	26.8	26.3	42.1	60.8	22.7	15.1	12.9	10.6	21.2	16.9	26.7	18.4	23.1	19.6	19.4	26.6	35.9	18.9	20.5	42.2	19.9	18.9	20.9	20.7	47.3	15.7	21.6	21.8	20.2	20.3	37.0	31.8	29.2	32.4	16.6	25.4	23.4	25.4	17.6	14.8	28.0	25.0	24.1	25.3	32.8	43.7	52.8	39.4	34.6	72.7	193.6	76.5	68.3	35.2	73.3	29.5	125.8	281.8	158.0	7.1	61.2	199.4	23.3	126.2	94.3	73.7	24.9	68.1	177.0	131.6	87.4	69.2	58.9	83.7	4.7	40.3	64.2	79.2	127.2	94.1	51.2	124.2	89.2	31.5	226.7	49.8	45.3	68.0	36.7	32.1	37.9	132.5	50.1	138.8	41.7
NDUFS3	CI-30	ENSG00000213619	"NADH:ubiquinone oxidoreductase core subunit S3"	O75489	11	47565336-47584562	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Electron transport, Respiratory chain, Transport"	"Oxidoreductase, Translocase"	"Disease mutation, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 100.9"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA004484, CAB034894"	Enhanced		Supported	"Nuclear bodies,Mitochondria"		NA	NA			Mitochondria	"Nuclear bodies"	"CAB034894: AB_2151118, HPA004484: AB_1079464"	"unprognostic (2.18e-1)"	"unprognostic (7.42e-3)"	"unprognostic (1.75e-1)"	"unprognostic (5.01e-2)"	"unprognostic (7.51e-2)"	"unprognostic (3.13e-2)"	"unprognostic (6.40e-2)"	"unprognostic (6.24e-2)"	"unprognostic (1.93e-1)"	"unprognostic (1.41e-2)"	"unprognostic (6.75e-3)"	"unprognostic (7.73e-2)"	"prognostic favorable (2.61e-6)"	"unprognostic (2.77e-2)"	"unprognostic (1.42e-1)"	"unprognostic (1.88e-2)"	"unprognostic (3.17e-3)"	13.4	22.9	29.7	13.2	46.3	25.5	18.1	23.9	35.0	16.6	28.4	16.5	16.1	31.4	12.7	16.0	19.1	17.3	16.3	45.8	26.0	24.8	34.1	32.0	12.0	13.9	29.4	24.9	12.2	23.0	21.4	17.0	12.0	26.0	13.9	30.9	14.4	20.1	17.4	100.9	15.1	28.9	15.9	17.1	14.2	18.9	15.1	15.4	20.5	16.1	51.6	18.8	14.5	11.7	25.0	36.1	18.7	31.2	16.4	23.8	31.5	11.5	22.0	18.6	19.4	16.1	16.7	15.9	11.0	18.8	27.2	25.9	32.3	20.4	25.8	11.0	15.7	19.3	21.4	26.3	19.8	22.2	13.8	42.5	15.6	30.9	31.2	16.6	38.1	20.3	16.3	14.3	10.3	17.0	11.6	17.1	21.3	22.7	17.8	17.6	35.4	26.1	49.4	26.4	32.0	31.2	31.8	26.9	21.2	23.3	18.1	20.9	15.1	14.1	24.2	24.9	11.6	27.0	36.4	11.9	16.3	18.3	18.9	24.8	20.5	27.1	28.5	16.5	29.3	16.1	12.2	28.6	18.7	18.7	31.2	19.8	25.0	19.7	20.3	33.7	23.1	18.8	20.1	7.5	16.4	25.0	36.1	23.8	31.5	29.7	46.3	23.9	35.0	26.0	24.8	29.4	24.9	26.0	15.4	50.6	35.2	47.4	60.2	58.3	41.3	154.2	96.8	75.0	45.5	66.3	39.3	103.3	343.2	99.0	93.6	59.9	204.6	23.3	97.2	97.6	64.9	43.1	56.6	108.3	166.7	57.2	81.3	52.8	54.3	46.0	62.5	73.9	113.1	83.8	120.8	100.0	80.5	103.7	65.0	231.7	51.0	103.5	79.3	76.9	75.2	66.4	74.5	62.9	167.5	58.5
NDUFS7	"CI-20, FLJ45860, FLJ46880, PSST"	ENSG00000115286	"NADH:ubiquinone oxidoreductase core subunit S7"	O75251	19	1383527-1395589	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Electron transport, Respiratory chain, Transport"	"Oxidoreductase, Translocase"	"Disease mutation, Leigh syndrome, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	5	"skeletal muscle: 198.0"	"Cell type enhanced"	"Detected in all"	4	"Distal tubular cells: 688.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"U-266/70: 42.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA						"unprognostic (7.36e-2)"	"prognostic favorable (2.03e-4)"	"unprognostic (5.30e-2)"	"unprognostic (3.81e-2)"	"unprognostic (1.12e-1)"	"unprognostic (5.28e-2)"	"unprognostic (2.41e-2)"	"unprognostic (5.85e-2)"	"unprognostic (4.88e-2)"	"unprognostic (2.29e-1)"	"unprognostic (1.99e-3)"	"unprognostic (8.12e-2)"	"prognostic favorable (4.90e-7)"	"unprognostic (2.95e-1)"	"unprognostic (2.82e-1)"	"unprognostic (1.57e-1)"	"unprognostic (2.34e-2)"	22.4	17.6	15.3	10.1	17.6	9.9	7.0	16.6	22.7	6.1	18.7	20.6	7.6	34.5	7.1	9.6	13.3	6.7	10.0	35.9	16.1	15.1	20.7	20.7	7.1	9.1	19.6	11.9	7.2	28.7	5.0	12.0	6.8	17.6	11.9	4.0	12.0	23.6	10.2	198.0	8.3	25.2	7.5	20.1	11.5	18.2	14.2	14.6	9.7	8.0	39.2	10.0	6.7	7.9	29.1	41.8	19.8	39.1	17.2	29.2	20.8	18.3	18.7	0.6	4.3	0.6	1.7	9.6	11.1	1.1	2.4	2.6	30.5	4.5	27.2	11.4	0.6	0.3	9.6	0.8	2.2	0.1	30.3	21.4	8.6	19.9	18.9	2.9	14.8	9.5	1.4	3.8	0.4	0.0	0.4	3.2	10.0	17.0	10.7	0.6	19.2	14.7	6.1	6.7	1.6	23.1	14.3	7.1	27.6	1.1	14.2	10.5	10.6	9.8	9.3	18.0	0.0	7.3	9.3	13.9	4.5	6.2	9.7	14.3	42.9	37.5	18.4	11.2	20.0	6.2	19.8	33.6	16.1	21.3	39.1	18.1	29.1	20.1	20.0	41.8	27.1	19.7	19.1	9.1	17.2	31.7	31.6	29.2	20.8	15.3	17.6	16.6	22.7	16.1	15.1	19.6	11.9	17.6	14.6	74.5	95.4	131.8	86.9	79.8	72.1	67.4	168.2	78.9	51.2	137.9	47.1	192.7	688.1	137.5	357.3	76.0	544.6	46.7	141.5	160.0	98.8	68.4	110.7	228.2	287.0	49.3	168.3	69.3	190.4	312.5	77.6	125.3	248.0	122.6	224.8	92.8	114.3	256.1	69.6	490.7	62.6	71.1	129.1	207.7	148.4	92.6	156.2	96.4	322.1	105.1
NDUFS8	"CI-23k, TYKY"	ENSG00000110717	"NADH:ubiquinone oxidoreductase core subunit S8"	O00217	11	68030617-68036644	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Electron transport, Respiratory chain, Transport"	"Oxidoreductase, Translocase"	"Disease mutation, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 156.6"	"Cell type enhanced"	"Detected in many"	4	"Distal tubular cells: 706.2;Proximal tubular cells: 686.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA018524, HPA067429"	Enhanced		Approved	Mitochondria	"Intracellular and membrane"	NA	NA			Mitochondria		"HPA018524: AB_1854355, HPA067429: "	"unprognostic (2.90e-1)"	"unprognostic (1.41e-3)"	"unprognostic (2.41e-1)"	"unprognostic (5.20e-2)"	"unprognostic (1.37e-1)"	"unprognostic (1.30e-3)"	"unprognostic (1.36e-1)"	"unprognostic (7.75e-2)"	"unprognostic (3.15e-1)"	"unprognostic (1.77e-2)"	"unprognostic (3.81e-2)"	"unprognostic (1.81e-1)"	"prognostic favorable (3.27e-8)"	"unprognostic (2.29e-1)"	"unprognostic (1.38e-1)"	"unprognostic (2.60e-2)"	"unprognostic (9.45e-2)"	26.0	62.0	29.9	16.9	40.5	21.0	19.1	18.4	50.1	18.6	24.7	19.7	24.3	34.7	18.2	15.1	28.3	19.0	22.7	82.4	26.5	27.5	50.3	47.6	16.3	19.1	28.3	22.4	20.8	41.3	25.4	26.7	18.0	25.9	22.9	18.3	30.1	41.3	32.2	156.6	17.3	26.7	19.8	18.2	20.3	25.0	21.1	15.7	29.6	29.2	53.9	24.2	19.1	14.8	37.3	66.6	23.6	46.1	59.0	39.6	42.6	26.4	65.7	18.2	24.7	13.6	12.2	23.9	18.8	16.3	29.1	22.7	61.1	28.3	20.5	34.3	16.3	26.2	32.7	20.8	22.8	10.5	24.5	48.0	18.6	41.9	32.1	32.5	17.4	20.5	15.4	23.7	21.4	24.5	16.1	19.5	28.9	19.1	22.2	19.0	62.7	38.3	37.3	22.3	70.4	55.7	26.7	17.7	66.2	36.6	21.5	22.9	18.6	13.7	31.7	66.4	13.6	43.5	19.1	15.1	28.3	24.9	40.9	25.9	30.5	32.0	17.4	45.5	21.0	19.7	15.8	46.1	23.6	39.6	45.1	37.0	37.3	34.2	36.0	63.3	30.2	33.0	36.7	4.4	59.0	24.9	66.6	39.6	42.6	29.9	40.5	18.4	50.1	26.5	27.5	28.3	22.4	25.9	15.7	83.4	69.0	76.7	81.4	75.9	80.5	251.3	155.4	84.3	69.4	202.4	51.1	253.0	706.2	176.2	170.4	79.8	264.8	0.0	174.1	132.3	109.2	89.4	94.6	216.5	241.0	47.7	197.0	64.4	119.9	632.4	93.2	101.9	155.3	202.8	173.3	94.1	168.6	178.9	101.5	686.8	98.3	58.2	128.2	84.2	59.4	101.6	144.2	120.4	242.9	99.3
NDUFV1	CI-51K	ENSG00000167792	"NADH:ubiquinone oxidoreductase core subunit V1"	P49821	11	67606852-67612535	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Electron transport, Respiratory chain, Transport"	"Oxidoreductase, Translocase"	"Disease mutation, Leigh syndrome, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 150.8"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA045211, HPA075051"	Enhanced		Supported	Mitochondria,Cytosol		No	No			Mitochondria	Cytosol	"HPA045211: AB_10962830, HPA075051: AB_2686732"	"unprognostic (4.57e-2)"	"unprognostic (2.17e-2)"	"unprognostic (2.84e-1)"	"unprognostic (7.07e-2)"	"unprognostic (1.54e-1)"	"unprognostic (4.54e-3)"	"unprognostic (1.19e-1)"	"unprognostic (3.31e-2)"	"unprognostic (2.19e-1)"	"unprognostic (4.95e-2)"	"unprognostic (4.02e-2)"	"unprognostic (3.03e-2)"	"prognostic favorable (7.49e-10)"	"unprognostic (1.12e-2)"	"unprognostic (1.80e-1)"	"unprognostic (2.12e-1)"	"unprognostic (1.16e-1)"	23.3	28.9	27.3	20.7	33.9	20.3	18.9	32.9	48.8	18.5	33.0	23.1	19.2	40.6	19.4	21.5	25.5	22.5	23.4	93.0	26.5	24.1	39.0	41.5	15.9	20.6	31.5	40.5	24.6	38.3	49.2	18.8	15.7	34.8	16.1	25.1	17.6	27.3	27.0	150.8	28.4	30.3	22.7	23.1	21.5	28.2	30.2	24.3	18.3	23.4	67.9	20.3	18.7	18.6	23.8	41.2	13.5	30.7	36.2	28.2	24.3	25.9	27.9	14.2	28.5	17.8	17.9	26.6	16.2	15.6	25.4	17.0	52.8	31.5	48.0	34.2	13.9	20.7	35.0	30.0	25.3	8.0	24.4	23.7	19.6	37.9	26.0	25.2	26.7	22.0	26.5	24.6	20.6	18.5	16.1	22.5	35.2	35.7	39.3	15.4	39.0	31.2	52.9	13.9	59.1	35.2	36.3	27.6	77.9	20.6	19.5	22.7	21.4	20.5	71.8	54.1	9.9	36.4	27.2	17.8	24.7	18.4	35.1	17.0	38.4	21.8	23.9	28.7	28.3	23.7	12.6	26.7	13.5	25.9	30.7	28.2	23.2	21.7	24.5	41.2	23.8	20.2	25.1	4.8	36.2	17.4	26.5	27.8	24.3	27.3	33.9	32.9	48.8	26.5	24.1	31.5	40.5	34.8	24.3	56.6	80.9	64.0	70.8	71.3	67.0	408.9	66.2	72.3	67.1	82.0	47.1	180.6	336.5	96.7	57.0	53.7	205.0	23.3	97.8	127.6	79.5	47.7	59.0	122.2	121.6	60.4	94.7	53.4	67.1	159.3	60.7	67.5	108.0	83.8	141.7	63.1	68.4	126.7	55.5	398.9	60.4	45.3	98.9	77.2	78.1	70.4	158.1	71.2	225.4	78.9
NDUFV2	CI-24k	ENSG00000178127	"NADH:ubiquinone oxidoreductase core subunit V2"	P19404	18	9102630-9134345	"Enzymes, Predicted intracellular proteins"	"Electron transport, Respiratory chain, Transport"	"Oxidoreductase, Translocase"	"Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA003404, HPA077896"	Supported		Supported	Nucleoplasm,Mitochondria,Cytosol		No	No			Mitochondria	"Nucleoplasm, Cytosol"	"HPA003404: AB_1079466, HPA077896: AB_2686866"	"unprognostic (1.18e-1)"	"unprognostic (3.89e-2)"	"unprognostic (2.89e-1)"	"unprognostic (8.22e-2)"	"unprognostic (1.32e-2)"	"unprognostic (6.72e-3)"	"unprognostic (1.36e-2)"	"unprognostic (1.18e-1)"	"unprognostic (6.72e-3)"	"unprognostic (1.32e-3)"	"unprognostic (2.39e-1)"	"unprognostic (6.84e-2)"	"unprognostic (1.70e-1)"	"unprognostic (5.51e-2)"	"unprognostic (1.31e-1)"	"unprognostic (6.56e-2)"	"unprognostic (1.95e-3)"	20.0	34.5	25.2	18.0	23.7	31.1	25.6	20.6	37.3	15.6	26.1	13.1	20.3	23.1	14.7	21.5	27.5	13.9	17.6	82.6	22.7	23.8	40.7	89.1	17.2	29.9	26.7	19.4	11.2	36.3	14.9	14.9	21.6	26.2	20.8	27.8	17.8	20.1	20.2	122.6	17.4	24.4	23.5	20.8	19.3	25.2	19.0	12.7	20.5	20.5	59.5	22.7	20.4	14.1	55.6	74.7	49.3	45.1	27.0	53.5	48.1	18.6	19.6	22.7	21.1	16.8	24.0	19.2	23.5	37.4	31.1	29.6	36.6	15.4	28.8	21.6	22.0	28.7	9.5	22.0	24.4	29.8	14.5	19.4	18.4	20.2	49.3	19.4	51.2	22.9	20.1	20.5	19.2	20.8	22.5	33.5	26.0	29.3	91.0	28.5	23.4	35.7	44.9	18.9	103.3	24.4	17.0	16.8	109.2	49.6	30.3	23.8	17.7	23.2	26.5	29.5	16.9	24.8	39.0	20.5	39.7	28.2	28.4	30.5	26.3	39.0	32.2	28.3	22.7	25.6	49.3	39.9	44.1	30.2	45.1	37.6	55.6	45.5	35.7	56.6	43.6	40.0	36.9	18.0	27.0	41.6	74.7	53.5	48.1	25.2	23.7	20.6	37.3	22.7	23.8	26.7	19.4	26.2	12.7	74.5	120.4	122.8	254.8	131.4	96.8	61.3	175.8	207.5	127.4	143.1	82.5	309.8	742.8	337.2	214.8	108.5	232.3	46.7	461.4	265.4	107.6	372.3	115.7	324.6	267.7	89.0	102.4	92.7	98.1	135.7	113.1	187.8	219.4	393.1	177.0	104.6	465.3	175.4	95.8	576.3	143.4	103.5	138.2	182.6	170.4	129.0	242.0	118.9	207.0	348.6
NEDD4	"KIAA0093, MGC176705, NEDD4-1, RPF1"	ENSG00000069869	"Neural precursor cell expressed, developmentally down-regulated 4, E3 ubiquitin protein ligase"	P46934	15	55826922-55993746	"Enzymes, Predicted intracellular proteins, Transporters"	"Host-virus interaction, Neurogenesis, Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 57.7"	"Group enriched"	"Detected in many"	4	"Alveolar cells type 1: 86.4;Alveolar cells type 2: 87.7;Ciliated cells: 135.1;Club cells: 79.6;granulocytes: 67.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB001991, HPA039883, CAB072833"	Approved		Approved	Cytosol		NA	NA			Cytosol		"CAB001991: , CAB072833: , HPA039883: AB_10795683"	"unprognostic (1.18e-1)"	"unprognostic (2.10e-2)"	"unprognostic (5.66e-3)"	"unprognostic (1.15e-1)"	"unprognostic (6.97e-2)"	"unprognostic (2.23e-1)"	"unprognostic (3.18e-3)"	"prognostic unfavorable (5.14e-4)"	"unprognostic (1.36e-2)"	"unprognostic (1.62e-1)"	"unprognostic (4.96e-2)"	"unprognostic (1.43e-2)"	"prognostic unfavorable (3.74e-6)"	"unprognostic (6.38e-3)"	"unprognostic (2.98e-1)"	"unprognostic (2.22e-1)"	"unprognostic (2.35e-2)"	14.1	4.1	2.5	3.1	3.3	4.5	8.7	1.5	2.7	9.9	9.4	2.8	3.4	3.4	10.1	4.1	8.2	3.8	4.5	4.1	2.9	2.4	8.6	21.5	7.2	2.1	3.5	1.3	6.6	2.8	6.5	6.7	20.1	3.5	8.4	3.4	5.4	4.0	6.4	57.7	7.1	15.2	10.9	6.0	5.9	4.4	2.6	3.1	9.4	5.7	9.0	3.3	11.9	8.9	0.1	1.6	1.2	2.8	1.2	2.9	0.9	7.3	11.5	3.1	3.0	4.1	6.8	5.1	14.1	22.3	10.5	10.5	5.1	2.2	1.8	3.7	5.4	25.5	12.2	3.4	9.3	17.2	4.1	2.1	9.1	2.7	2.6	21.9	4.0	0.9	11.6	23.1	12.5	21.1	5.1	8.6	5.4	3.9	0.0	30.6	3.8	5.3	0.0	0.8	3.9	1.7	3.9	24.8	1.0	4.3	14.6	0.3	2.0	6.3	4.5	5.6	5.9	5.6	3.0	29.6	23.3	7.7	4.9	22.9	1.2	2.7	4.8	15.7	8.6	5.5	0.6	1.0	0.0	1.3	2.8	2.9	0.1	1.5	1.2	0.8	0.0	1.4	1.6	1.2	1.2	1.9	1.6	1.3	0.9	2.5	3.3	1.5	2.7	2.9	2.4	3.5	1.3	3.5	3.1	86.4	87.7	2.0	3.3	10.8	0.3	4.8	7.6	135.1	79.6	0.0	21.6	16.5	1.7	3.2	1.3	16.8	6.9	0.0	4.8	6.4	6.3	3.4	67.4	17.9	4.0	0.0	0.0	15.4	1.8	1.0	5.2	3.8	1.7	0.0	4.2	8.4	3.3	0.0	6.7	10.8	6.0	0.0	8.2	1.2	5.9	9.2	11.6	2.2	2.9	1.6
NEDD4L	"KIAA0439, NEDD4-2, RSP5"	ENSG00000049759	"Neural precursor cell expressed, developmentally down-regulated 4-like, E3 ubiquitin protein ligase"	Q96PU5	18	58044367-58401540	"Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Differentiation, Host-virus interaction, Ubl conjugation pathway"	Transferase	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Alveolar cells type 1: 235.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"T-reg: 8.1"	"Group enriched"	"Detected in many"	4	"granulocytes: 4.7;T-cells: 8.1"	"Cell line enhanced"	"Detected in many"		"Hep G2: 51.3;SK-MEL-30: 40.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA024618	Approved					NA	NA					"HPA024618: AB_1854362"	"unprognostic (2.56e-1)"	"unprognostic (2.41e-2)"	"unprognostic (1.58e-2)"	"unprognostic (3.14e-1)"	"unprognostic (3.90e-2)"	"unprognostic (1.50e-1)"	"unprognostic (2.11e-3)"	"unprognostic (2.26e-2)"	"unprognostic (9.24e-3)"	"unprognostic (4.39e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.27e-1)"	"prognostic favorable (6.55e-15)"	"unprognostic (2.42e-1)"	"unprognostic (8.26e-2)"	"unprognostic (8.49e-3)"	"unprognostic (4.75e-2)"	5.9	6.8	9.1	5.4	38.8	13.2	15.8	21.4	24.7	5.0	22.6	3.2	18.2	11.1	3.6	6.1	7.0	6.0	7.6	12.7	9.8	7.1	29.9	10.1	26.9	2.5	7.2	14.9	3.0	33.2	9.2	16.5	13.0	4.1	30.6	25.2	12.2	16.5	23.2	38.3	5.9	26.8	8.2	3.2	3.1	26.0	4.6	8.8	0.8	9.1	5.5	5.1	14.9	9.3	1.4	0.4	4.7	0.7	0.9	8.1	0.5	18.8	6.8	4.0	6.0	1.4	0.5	13.9	5.4	24.2	13.7	21.0	7.9	10.2	4.0	16.4	2.1	14.4	13.7	5.3	23.6	28.4	9.4	4.7	2.8	4.2	51.3	0.7	0.1	1.7	3.6	15.4	18.5	22.4	10.8	1.0	3.6	4.9	1.8	5.6	4.6	0.2	0.2	3.4	7.0	10.4	3.9	5.4	4.6	13.6	24.7	5.0	1.4	4.4	1.4	40.0	8.1	8.0	1.6	8.1	37.0	11.2	2.1	22.8	2.3	4.0	2.5	7.5	2.9	3.0	4.7	0.6	1.7	0.4	0.7	1.0	1.4	1.3	0.3	0.3	0.6	0.8	0.6	0.3	0.9	0.1	0.4	8.1	0.5	9.1	38.8	21.4	24.7	9.8	7.1	7.2	14.9	4.1	8.8	235.2	122.6	2.7	142.5	100.2	4.9	50.9	56.0	92.3	166.1	59.3	163.0	7.6	41.4	32.0	18.9	9.0	128.1	116.8	42.3	4.2	11.0	173.0	3.5	32.7	6.3	58.8	43.5	9.8	5.4	5.6	3.1	11.5	13.5	8.2	189.6	31.3	41.1	77.0	16.6	59.9	7.5	0.0	5.3	0.2	3.0	46.3	66.9	4.6	64.4	150.4
NEIL1	"FLJ22402, FPG1, hFPG1, NEI1"	ENSG00000140398	"Nei like DNA glycosylase 1"	Q96FI4	15	75346955-75357114	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"DNA damage, DNA repair"	"DNA-binding, Glycosidase, Hydrolase, Lyase, Multifunctional enzyme"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"gdT-cell: 4.7;memory B-cell: 4.0;naive B-cell: 6.5;NK-cell: 14.1"	"Group enriched"	"Detected in many"	12	"B-cells: 6.5;NK-cells: 14.1;T-cells: 4.7"	"Cell line enhanced"	"Detected in many"		"Daudi: 11.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA054084	Approved		Supported	Nucleoplasm		NA	NA			Nucleoplasm		"HPA054084: AB_2682372"	"unprognostic (9.84e-3)"	"unprognostic (1.19e-1)"	"unprognostic (1.15e-2)"	"unprognostic (4.62e-3)"	"unprognostic (3.21e-2)"	"unprognostic (1.81e-2)"	"unprognostic (2.24e-2)"	"unprognostic (1.17e-3)"	"unprognostic (1.67e-1)"	"unprognostic (1.33e-1)"	"prognostic favorable (2.09e-4)"	"unprognostic (3.50e-3)"	"unprognostic (8.60e-2)"	"unprognostic (9.24e-2)"	"unprognostic (2.05e-1)"	"unprognostic (3.03e-1)"	"unprognostic (2.27e-3)"	7.1	14.8	12.9	28.2	14.5	6.8	9.3	24.4	15.4	10.8	8.3	4.9	23.2	10.1	8.4	11.6	6.4	10.0	10.2	5.3	12.8	5.7	7.9	9.1	9.3	9.8	6.0	9.8	11.0	10.8	9.1	9.0	4.6	8.0	10.4	2.4	7.1	25.0	24.2	13.6	11.7	9.5	4.3	5.9	6.8	9.9	3.8	7.0	15.4	8.2	5.2	13.3	7.5	8.5	6.5	0.2	0.7	0.5	14.1	4.7	1.0	2.2	3.7	2.4	1.5	0.7	0.8	4.6	1.3	0.0	0.5	0.1	0.6	4.0	11.6	2.2	0.2	1.1	6.4	1.4	0.4	0.0	5.6	9.5	1.9	10.0	1.8	1.0	2.2	2.7	0.3	1.8	0.6	0.0	6.0	1.5	1.1	1.2	3.4	0.4	2.9	0.4	6.3	2.1	0.4	0.9	2.2	1.5	0.5	2.2	2.4	1.4	2.8	2.3	1.0	3.2	1.3	4.3	3.3	6.3	1.3	2.5	1.9	1.1	5.4	5.2	9.4	1.2	9.4	1.2	0.0	0.5	0.0	4.7	0.1	1.3	4.0	0.8	1.0	0.2	6.5	1.4	1.4	0.7	14.1	0.1	0.2	0.2	1.0	12.9	14.5	24.4	15.4	12.8	5.7	6.0	9.8	8.0	7.0	20.8	19.2	9.3	14.9	5.7	20.2	2.5	2.5	38.8	23.9	14.0	9.8	8.7	1.7	7.2	21.8	13.4	15.5	0.0	7.4	3.1	7.8	12.0	10.5	10.5	2.8	9.5	20.7	24.5	6.9	1.1	17.5	5.8	8.5	0.0	18.2	21.4	6.1	14.7	12.7	5.8	5.9	6.5	4.1	1.4	0.7	5.1	4.0	13.1	11.3	5.8
NEIL2	"FLJ31644, MGC2832, MGC4505, NEH2"	ENSG00000154328	"Nei like DNA glycosylase 2"	Q969S2	8	11769639-11787346	"Enzymes, Predicted intracellular proteins"	"DNA damage, DNA repair"	"DNA-binding, Glycosidase, Hydrolase, Lyase, Multifunctional enzyme"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA073029, HPA073916"			Supported	Nucleoplasm,Vesicles		NA	NA			Nucleoplasm	Vesicles	"HPA073029: AB_2732216, HPA073916: AB_2732245"	"unprognostic (1.52e-2)"	"unprognostic (1.08e-2)"	"unprognostic (1.03e-1)"	"unprognostic (9.88e-2)"	"unprognostic (2.18e-2)"	"unprognostic (5.72e-2)"	"unprognostic (2.70e-1)"	"unprognostic (2.88e-2)"	"unprognostic (5.46e-2)"	"unprognostic (6.85e-2)"	"unprognostic (1.99e-3)"	"unprognostic (1.29e-1)"	"unprognostic (1.12e-2)"	"unprognostic (5.29e-2)"	"unprognostic (1.91e-1)"	"unprognostic (2.09e-1)"	"unprognostic (4.05e-1)"	10.2	21.8	18.7	6.8	17.7	2.7	10.3	11.8	20.9	11.3	5.6	9.0	7.0	3.6	9.9	15.4	6.5	17.9	6.9	14.2	15.4	20.0	9.3	11.0	7.7	8.4	18.4	16.1	12.6	10.9	7.8	13.2	7.6	20.3	10.5	6.1	9.7	11.5	10.3	24.7	18.1	4.6	10.2	12.3	9.5	5.1	26.8	13.3	1.8	15.5	7.1	7.9	7.4	15.8	14.7	5.5	0.8	2.5	9.1	13.6	4.7	4.9	14.0	8.8	17.2	4.2	7.9	3.9	7.9	6.6	7.7	5.3	4.3	5.5	1.9	3.1	9.5	16.6	4.4	8.4	8.7	10.6	5.8	4.2	6.8	3.3	8.4	3.4	2.9	5.1	6.9	12.9	6.7	6.2	7.5	7.2	2.3	9.6	6.7	9.1	5.2	0.5	3.1	7.9	20.5	7.5	8.7	11.3	5.3	9.0	7.5	13.6	10.7	6.2	3.3	11.3	7.4	5.2	0.5	8.8	8.8	12.7	2.3	11.1	6.3	13.1	3.5	23.2	10.2	17.8	0.4	1.5	0.1	9.1	2.5	12.1	14.7	9.3	10.8	3.0	11.4	13.6	12.0	0.8	9.1	1.1	5.5	5.8	4.7	18.7	17.7	11.8	19.8	15.4	20.0	18.4	16.1	20.3	13.3	0.0	4.3	12.6	14.3	7.6	25.6	17.8	17.8	5.3	6.8	7.0	15.7	15.6	28.2	17.4	0.8	9.3	0.9	0.0	20.5	13.6	10.8	15.1	2.3	21.2	12.1	7.9	9.7	7.4	4.7	2.1	13.0	6.6	13.5	10.0	4.5	27.9	14.2	0.0	23.0	24.7	13.2	6.5	13.2	14.2	45.1	11.2	4.5	7.2	5.0	9.1
NEIL3	"FLJ10858, FPG2, hFPG2, hNEI3, ZGRF3"	ENSG00000109674	"Nei like DNA glycosylase 3"	Q8TAT5	4	177309836-177362943	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"DNA damage, DNA repair"	"DNA-binding, Glycosidase, Hydrolase, Lyase, Multifunctional enzyme"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	8	"lymphoid tissue: 70.8"	"Cell type enhanced"	"Detected in some"	8	"Club cells: 2.3;Extravillous trophoblasts: 2.9;Kupffer cells: 2.2;Spermatocytes: 1.9;Spermatogonia: 3.0"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 26.6;HL-60: 29.0;Karpas-707: 38.1;MOLT-4: 29.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA065761			Enhanced	Nucleoplasm		NA	Yes			Nucleoplasm		"HPA065761: AB_2685555"	"unprognostic (6.03e-2)"	"unprognostic (5.79e-2)"	"unprognostic (1.42e-1)"	"prognostic unfavorable (5.45e-4)"	"unprognostic (4.91e-2)"	"unprognostic (2.05e-1)"	"unprognostic (3.64e-7)"	"prognostic unfavorable (1.16e-4)"	"unprognostic (6.09e-3)"	"unprognostic (7.67e-2)"	"unprognostic (6.51e-4)"	"unprognostic (2.82e-3)"	"unprognostic (0.00e+0)"	"unprognostic (3.25e-2)"	"unprognostic (8.13e-2)"	"unprognostic (2.03e-1)"	"unprognostic (1.04e-2)"	0.5	0.4	0.2	7.4	0.2	9.3	0.7	0.1	0.2	0.8	1.5	0.1	0.1	1.5	0.5	0.1	5.6	0.2	0.3	0.5	0.2	0.2	0.4	0.4	0.9	5.1	0.2	0.1	0.3	0.2	0.0	0.2	1.6	0.2	0.2	2.1	0.2	0.8	0.1	0.2	3.4	1.7	0.5	0.7	1.5	0.8	3.5	0.3	70.8	0.2	1.1	5.0	0.7	1.3	0.2	0.3	0.8	0.0	1.6	1.6	0.2	7.1	5.9	6.3	3.1	0.7	1.3	3.1	8.8	3.3	9.8	5.8	2.1	6.3	7.9	1.3	2.3	9.7	3.3	6.6	3.5	14.3	26.6	4.3	5.4	4.7	5.6	0.2	29.0	3.7	0.1	0.2	10.1	2.2	2.0	3.7	20.5	5.6	38.1	6.3	3.1	29.3	11.1	2.9	2.1	4.4	6.0	4.3	2.5	2.5	0.9	5.0	3.4	4.4	5.1	2.4	2.9	4.2	7.6	1.7	5.9	4.6	3.0	8.9	2.6	1.7	12.5	3.9	10.3	9.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	1.3	0.0	0.2	0.0	1.1	0.8	1.6	0.0	0.3	1.6	0.2	0.2	0.2	0.1	0.2	0.2	0.2	0.2	0.1	0.2	0.3	0.0	0.0	0.0	0.0	0.8	0.0	0.3	0.0	0.0	2.3	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.2	2.9	0.4	0.0	0.0	0.0	1.3	0.0	0.0	0.6	2.2	0.0	0.0	0.2	0.0	0.0	0.7	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	1.9	3.0	1.1	0.2	0.5	0.4	0.1
NEK1	"KIAA1901, NY-REN-55"	ENSG00000137601	"NIMA related kinase 1"	Q96PY6	4	169392857-169612629	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Cell cycle, Cell division, Cilium biogenesis/degradation, Mitosis"	"Kinase, Serine/threonine-protein kinase, Transferase, Tyrosine-protein kinase"	"Amyotrophic lateral sclerosis, Ciliopathy, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Ciliated cells: 85.6;Early spermatids: 83.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA020873, HPA040413"	Approved		Supported	"Nucleoplasm,Centriolar satellite,Cytosol"		NA	NA			Cytosol	"Nucleoplasm, Centriolar satellite"	"HPA020873: AB_10671583, HPA040413: AB_10671169"	"unprognostic (4.10e-2)"	"unprognostic (2.97e-1)"	"unprognostic (1.59e-2)"	"unprognostic (1.97e-1)"	"unprognostic (6.98e-2)"	"unprognostic (3.10e-1)"	"unprognostic (3.95e-1)"	"unprognostic (3.29e-1)"	"unprognostic (1.13e-1)"	"unprognostic (2.78e-1)"	"unprognostic (4.06e-3)"	"unprognostic (2.21e-1)"	"prognostic favorable (1.42e-4)"	"unprognostic (1.07e-1)"	"unprognostic (1.03e-1)"	"unprognostic (2.10e-2)"	"unprognostic (3.46e-1)"	9.6	10.5	13.5	9.2	15.8	6.0	8.7	20.7	14.5	13.6	8.4	12.5	7.1	5.4	12.4	9.1	7.9	15.7	10.2	11.4	13.7	13.2	10.2	6.9	7.7	8.0	15.9	11.3	16.3	6.6	15.3	16.5	7.2	16.0	11.6	7.7	8.9	6.4	10.6	7.1	4.7	5.7	11.1	18.2	8.0	8.1	18.3	14.8	14.7	13.3	6.4	7.4	10.0	8.2	4.5	3.3	6.7	3.3	2.2	5.3	1.3	4.2	1.8	7.8	8.4	12.1	13.5	2.5	8.9	8.0	7.2	6.8	2.4	5.0	11.3	1.7	7.8	6.9	1.4	7.3	7.6	8.2	12.4	5.0	7.6	7.7	2.9	7.1	7.6	6.1	10.8	4.3	7.3	12.8	14.7	7.0	10.9	13.4	21.5	9.2	2.7	9.8	3.4	2.5	2.7	4.5	6.1	5.1	3.6	7.6	5.0	8.5	9.7	6.5	3.2	6.0	6.2	4.0	3.4	8.4	4.6	4.2	4.7	6.0	8.7	13.3	8.6	7.6	3.8	8.0	6.7	2.1	1.8	4.4	3.3	4.8	4.4	3.4	2.7	1.5	4.5	5.1	5.3	1.1	2.2	1.6	3.3	3.2	1.3	13.5	15.8	20.7	12.9	13.7	13.2	15.9	11.3	16.0	14.8	11.9	13.1	13.3	12.5	8.5	20.5	31.9	0.0	85.6	22.7	17.4	27.5	17.5	14.9	8.5	83.6	9.0	5.4	23.3	5.5	6.7	16.2	7.0	17.4	6.6	9.1	17.5	6.9	8.6	6.9	39.7	21.9	8.9	5.0	2.8	5.0	23.4	6.9	4.2	29.7	8.1	24.4	12.9	18.6	59.1	27.4	5.5	24.7	8.6	6.8	9.5
NEK10	FLJ32685	ENSG00000163491	"NIMA related kinase 10"	Q6ZWH5	3	27110085-27369460	"Enzymes, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"testis: 31.4"	"Cell type enhanced"	"Detected in many"	12	"Ciliated cells: 97.7;Cone photoreceptor cells: 82.5;Early spermatids: 98.7;Late spermatids: 45.8"	"Cancer enriched"	"Detected in single"	5	"breast cancer: 1.8"	"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in single"		"neutrophil: 1.9"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"BJ: 7.7;LHCN-M2: 10.6;U-2 OS: 9.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA038941	Uncertain		Approved	Nucleoplasm,Vesicles		NA	NA			Vesicles	Nucleoplasm	"HPA038941: AB_10673600"	"prognostic favorable (4.20e-4)"	"unprognostic (2.17e-1)"	"unprognostic (8.78e-2)"	"unprognostic (2.15e-2)"	"unprognostic (3.37e-2)"	"unprognostic (3.02e-1)"	"unprognostic (1.12e-1)"	"unprognostic (1.83e-1)"	"unprognostic (1.26e-1)"	"unprognostic (1.93e-2)"	"unprognostic (2.20e-3)"	"unprognostic (1.37e-1)"	"unprognostic (7.67e-2)"	"unprognostic (1.33e-2)"	"unprognostic (1.38e-2)"	"unprognostic (1.57e-3)"	"unprognostic (2.14e-1)"	0.4	0.5	4.5	0.5	14.6	0.4	14.2	0.6	6.8	1.6	2.0	1.1	2.0	2.5	0.9	8.3	2.0	10.5	2.1	3.1	8.4	3.8	1.4	2.5	4.5	0.6	0.8	6.7	2.7	0.8	0.5	9.0	0.3	3.4	1.9	0.7	1.3	0.5	1.4	10.5	0.4	1.0	1.2	0.8	0.6	1.1	31.4	1.3	0.3	0.8	0.3	0.7	1.4	0.4	0.4	0.2	1.9	0.1	0.1	0.6	0.1	1.0	2.1	1.1	1.2	0.9	2.1	0.4	7.7	1.2	2.1	1.9	0.0	0.5	0.7	1.9	3.2	1.5	0.1	0.5	0.5	2.3	1.4	0.8	0.2	4.1	3.7	0.2	0.4	1.0	2.5	0.5	3.3	0.1	2.7	1.5	4.4	0.1	0.7	10.6	0.1	0.8	0.5	0.7	0.2	0.3	1.0	0.4	0.3	4.1	0.6	0.2	0.2	1.2	0.5	0.6	0.8	6.2	0.4	0.9	5.7	9.0	0.3	0.8	0.3	0.2	0.5	4.8	0.9	2.1	0.1	0.1	0.2	0.6	0.1	0.1	0.1	0.5	0.4	0.0	0.4	0.1	0.5	1.9	0.1	0.0	0.2	0.0	0.1	4.5	14.6	0.6	6.8	8.4	3.8	0.8	6.7	3.4	1.3	6.0	0.0	0.0	0.2	0.2	4.0	10.2	2.5	97.7	13.6	1.8	82.5	0.0	0.0	0.3	98.7	0.7	0.7	0.0	0.0	0.2	2.9	1.5	0.0	0.5	0.2	0.0	0.0	0.6	1.3	45.8	1.7	0.4	0.0	0.0	0.1	1.4	0.2	0.6	1.1	0.0	19.6	0.0	1.1	25.4	1.7	0.4	0.0	0.0	0.1	0.1
NEK11	FLJ23495	ENSG00000114670	"NIMA related kinase 11"	Q8NG66	3	131026850-131350465	"Enzymes, Predicted intracellular proteins"	"Cell cycle"	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"fallopian tube: 26.9"	"Cell type enhanced"	"Detected in many"	14	"Ciliated cells: 148.5;Early spermatids: 122.2;Late spermatids: 80.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA016908	Approved		Supported	Nucleoplasm		NA	NA			Nucleoplasm		"HPA016908: AB_1854364"	"unprognostic (9.15e-3)"	"prognostic favorable (7.10e-4)"	"unprognostic (1.05e-1)"	"unprognostic (1.08e-1)"	"unprognostic (9.96e-2)"	"unprognostic (4.85e-3)"	"unprognostic (2.48e-5)"	"unprognostic (5.38e-2)"	"unprognostic (1.86e-1)"	"unprognostic (1.18e-1)"	"unprognostic (2.27e-1)"	"unprognostic (1.79e-1)"	"prognostic favorable (5.92e-6)"	"unprognostic (2.46e-2)"	"unprognostic (1.60e-1)"	"unprognostic (2.72e-2)"	"unprognostic (1.58e-1)"	3.9	5.8	9.3	2.7	11.1	0.5	8.7	2.7	7.6	7.3	2.8	11.2	8.4	2.0	6.5	16.0	3.2	26.9	6.0	2.9	9.1	10.0	8.2	1.1	5.5	1.7	7.8	5.4	8.7	2.8	5.0	9.3	4.6	17.3	4.0	3.3	3.0	3.8	6.7	1.7	2.8	2.6	4.3	7.3	1.8	2.3	17.8	5.5	0.2	12.3	2.5	1.7	4.2	3.0	0.9	1.0	1.1	1.3	0.3	2.9	0.3	5.9	2.4	1.8	5.2	7.0	10.5	1.0	2.9	5.5	4.5	3.4	2.2	8.3	0.3	2.1	5.2	4.3	3.3	0.5	5.1	6.3	0.6	0.7	0.8	0.4	1.0	2.3	0.6	1.5	4.4	8.5	4.8	2.2	4.8	0.9	2.6	0.2	0.9	7.5	4.2	0.1	0.5	0.5	0.9	2.3	0.0	0.2	0.1	10.3	2.3	2.2	2.5	1.4	0.1	2.0	0.8	4.9	0.1	0.9	4.7	2.3	3.6	1.4	1.4	2.3	0.1	3.2	0.2	0.8	0.0	0.3	1.1	0.6	1.3	1.2	0.9	2.9	2.6	0.5	0.6	1.0	0.8	0.9	0.3	0.9	1.0	1.5	0.3	9.3	11.1	2.7	7.6	9.1	10.0	7.8	5.4	17.3	5.5	14.9	2.7	0.0	3.4	3.8	2.7	1.1	2.5	148.5	29.6	1.8	5.9	0.5	5.0	4.7	122.2	2.4	1.7	0.0	2.2	1.0	5.4	1.4	0.0	0.0	1.8	0.0	2.4	2.5	0.0	80.8	6.4	1.4	0.0	1.0	2.7	5.7	2.9	3.7	5.6	8.4	6.9	6.5	2.2	30.5	4.9	1.8	1.4	0.0	1.7	1.8
NEK2	"NEK2A, NLK1, PPP1R111, RP67"	ENSG00000117650	"NIMA related kinase 2"	P51955	1	211658657-211675630	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Cell cycle, Cell division, Chromosome partition, Meiosis, Mitosis"	"Kinase, Serine/threonine-protein kinase, Transferase"	"Retinitis pigmentosa"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 14.0;testis: 41.0"	"Cell type enhanced"	"Detected in many"	22	"Early spermatids: 44.4;Erythroid cells: 93.5;Spermatocytes: 191.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Region enhanced"	"Detected in some"		"cerebellum: 3.2"	"Not detected"	"Not detected"			"CAB017530, HPA064967"	Enhanced		Supported	Nucleoplasm,Centrosome		NA	Yes			"Nucleoplasm, Centrosome"		"CAB017530: AB_1126558, HPA064967: AB_2685393"	"unprognostic (1.28e-1)"	"unprognostic (2.33e-1)"	"unprognostic (1.02e-1)"	"unprognostic (8.51e-2)"	"unprognostic (1.83e-1)"	"unprognostic (1.35e-2)"	"prognostic unfavorable (9.47e-6)"	"prognostic unfavorable (9.11e-4)"	"unprognostic (1.95e-2)"	"unprognostic (2.00e-2)"	"unprognostic (1.09e-3)"	"unprognostic (8.49e-2)"	"unprognostic (0.00e+0)"	"unprognostic (8.21e-2)"	"unprognostic (4.11e-2)"	"unprognostic (1.25e-2)"	"unprognostic (2.71e-1)"	1.1	0.7	0.6	6.7	0.5	7.4	1.3	0.3	0.9	0.9	2.5	0.3	0.3	3.4	0.3	1.2	4.2	0.7	1.4	0.9	1.0	0.3	0.6	0.6	1.0	3.9	0.3	0.3	0.6	0.3	0.0	0.3	1.2	0.4	0.9	3.6	0.4	1.0	0.3	0.3	1.8	3.0	0.6	0.6	1.6	1.1	41.0	0.4	14.0	0.3	1.5	4.8	0.6	1.6	1.8	0.9	2.7	0.5	3.9	4.3	0.9	30.7	22.2	17.0	12.2	1.0	1.7	18.8	11.9	11.2	21.0	18.1	11.8	30.3	16.4	5.7	9.2	13.3	16.5	14.8	8.9	26.5	25.0	12.3	7.8	19.4	15.9	0.1	15.4	10.7	0.5	1.1	16.1	17.4	5.1	13.5	16.7	21.4	28.8	21.0	8.6	16.8	10.4	16.1	19.9	11.4	16.6	26.1	24.9	7.3	8.8	15.4	17.1	17.2	19.2	14.9	15.2	29.6	9.2	7.0	10.5	20.8	20.6	31.9	11.9	22.0	21.7	9.1	11.9	17.4	2.7	0.5	0.4	0.5	0.3	0.2	1.5	0.6	0.3	0.1	1.8	1.1	0.7	2.4	3.9	0.4	0.9	4.3	0.9	0.6	0.5	0.3	0.9	1.0	0.3	0.3	0.3	0.4	0.4	0.0	0.3	0.8	0.5	2.6	0.7	0.4	0.0	2.7	3.4	0.0	0.0	0.9	0.0	0.1	44.4	0.1	1.1	93.5	0.2	11.4	0.2	0.3	0.0	0.0	4.7	3.2	0.0	2.5	2.8	28.5	2.3	1.1	0.0	0.0	1.2	0.8	0.0	0.8	0.7	0.0	1.9	6.5	0.0	191.1	25.4	1.5	1.1	0.7	2.3	0.9
NEK3	"HSPK36, MGC29949"	ENSG00000136098	"NIMA related kinase 3"	P51956	13	52132639-52159861	"Enzymes, Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Spermatocytes: 40.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019062, HPA043230"	Enhanced		Approved	Microtubules		NA	NA			Microtubules		"HPA019062: AB_2670037, HPA043230: AB_2678374"	"unprognostic (8.97e-2)"	"unprognostic (2.54e-2)"	"unprognostic (8.12e-2)"	"unprognostic (1.84e-1)"	"unprognostic (2.01e-2)"	"unprognostic (2.05e-1)"	"unprognostic (2.71e-1)"	"unprognostic (2.31e-1)"	"unprognostic (1.31e-1)"	"unprognostic (4.30e-3)"	"unprognostic (1.16e-3)"	"unprognostic (1.70e-2)"	"unprognostic (1.17e-3)"	"unprognostic (1.22e-2)"	"unprognostic (4.66e-2)"	"unprognostic (4.15e-2)"	"unprognostic (5.34e-2)"	7.7	2.8	7.1	5.4	12.9	7.1	7.3	3.2	7.1	7.0	13.8	20.4	3.1	7.8	9.1	5.8	3.9	6.0	6.4	5.0	8.7	5.2	6.1	5.7	7.2	4.2	14.0	9.5	7.9	6.4	2.2	3.7	14.8	11.3	5.4	15.0	6.8	5.2	5.0	4.1	5.4	11.7	7.3	9.6	3.9	4.6	14.7	13.3	2.4	5.0	2.7	4.3	6.5	6.0	4.4	7.8	5.9	7.7	2.0	3.5	1.6	0.2	1.4	13.2	7.5	4.2	6.6	0.2	4.2	4.3	5.1	5.7	5.1	7.3	0.0	0.2	5.3	4.2	0.9	0.2	3.2	3.1	8.7	6.9	1.0	1.4	13.7	5.4	12.7	6.8	4.8	5.9	2.6	12.2	3.7	7.8	0.6	1.8	4.4	5.2	3.6	0.6	15.3	12.9	2.7	0.3	0.3	1.1	4.8	7.3	1.3	1.3	9.1	1.9	4.0	8.9	13.0	1.7	16.3	6.7	0.7	4.3	4.0	4.5	4.7	1.6	8.8	1.1	5.0	7.2	5.9	7.7	5.3	2.1	6.6	1.3	4.4	2.5	1.3	7.8	2.5	1.7	0.6	0.5	2.0	1.5	6.9	3.5	1.6	7.1	12.9	3.2	7.1	8.7	5.2	14.0	9.5	11.3	13.3	6.0	6.2	1.9	3.8	2.5	2.2	6.1	7.6	8.1	7.9	7.0	0.0	10.1	11.6	5.4	6.3	21.2	18.6	0.0	15.1	12.1	7.0	4.2	9.3	6.2	15.3	3.2	5.8	20.9	9.9	2.7	6.6	7.9	11.8	34.3	14.6	3.7	11.3	14.0	6.3	5.0	5.8	0.0	7.6	40.9	27.9	3.0	4.0	1.3	17.2	4.8
NEK4	"NRK2, pp12301, STK2"	ENSG00000114904	"NIMA related kinase 4"	P51957	3	52708449-52770949	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 47.7"	"Cell type enhanced"	"Detected in many"	6	"Spermatocytes: 58.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA015750, HPA058543"	Enhanced		Supported	Cytosol		NA	NA			Cytosol		"HPA015750: AB_1854367, HPA058543: AB_2732623"	"unprognostic (1.32e-1)"	"unprognostic (1.57e-1)"	"prognostic favorable (2.69e-5)"	"unprognostic (9.65e-3)"	"unprognostic (3.42e-1)"	"unprognostic (6.64e-2)"	"unprognostic (8.75e-3)"	"unprognostic (2.27e-1)"	"unprognostic (7.85e-2)"	"unprognostic (5.52e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.32e-1)"	"unprognostic (3.74e-3)"	"unprognostic (5.11e-2)"	"unprognostic (2.85e-1)"	"unprognostic (1.51e-2)"	"unprognostic (8.39e-2)"	7.2	10.7	15.5	9.1	15.7	7.3	11.0	20.2	16.1	10.6	8.4	10.6	9.6	7.6	10.3	10.7	8.1	15.8	7.5	7.4	12.5	14.2	11.6	12.4	7.7	8.8	12.7	8.6	15.8	10.2	13.4	17.6	8.7	11.9	9.4	9.7	9.1	8.5	11.3	10.8	5.3	6.6	9.5	10.7	7.9	11.0	47.7	12.4	11.1	15.5	5.0	10.4	9.3	10.7	5.1	6.4	12.4	11.8	4.6	5.2	5.5	12.9	10.1	13.9	10.9	12.7	9.2	15.1	9.2	12.5	17.3	17.5	8.8	9.7	13.3	4.3	9.0	19.1	6.1	16.9	10.9	23.2	13.3	7.1	10.4	12.3	11.2	7.9	25.4	10.5	5.6	10.1	22.1	14.8	9.2	6.4	11.7	12.9	10.9	10.9	11.1	13.7	9.3	12.0	13.7	10.0	12.0	12.1	9.8	9.8	18.7	10.3	6.1	19.4	11.9	9.1	11.2	11.1	15.3	5.9	11.6	11.8	18.5	17.0	12.2	17.7	13.1	13.3	12.0	12.5	12.4	11.8	5.8	4.6	7.3	5.2	3.6	4.0	4.8	6.4	5.1	4.9	4.2	1.8	4.6	4.8	3.2	3.1	5.5	15.5	15.7	20.2	16.1	12.5	14.2	12.7	8.6	11.9	12.4	11.9	5.1	9.5	4.6	3.7	12.7	3.5	0.0	21.4	15.9	5.2	11.8	6.1	8.3	6.4	16.2	5.3	5.1	0.0	8.4	6.8	4.6	6.5	7.0	13.4	7.2	6.4	4.6	4.9	14.9	16.1	13.6	7.0	1.7	5.4	9.6	16.2	7.8	0.0	11.7	14.6	17.4	6.5	5.9	58.3	31.9	3.6	5.6	5.3	8.2	4.1
NEK5		ENSG00000197168	"NIMA related kinase 5"	Q6P3R8	13	52033611-52129078	"Enzymes, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"brain: 11.8;fallopian tube: 12.7;testis: 15.7"	"Cell type enriched"	"Detected in many"	4	"Ciliated cells: 172.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"basophil: 2.5"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"JURKAT: 3.5;OE19: 6.4;T-47d: 3.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA035565, HPA041399"	Enhanced					NA	NA					"HPA035565: AB_10672095, HPA041399: AB_2677453"	"unprognostic (4.14e-2)"	"unprognostic (1.49e-1)"	"unprognostic (1.89e-1)"	"unprognostic (5.80e-3)"	"unprognostic (2.80e-2)"	"unprognostic (2.47e-1)"	"unprognostic (3.57e-2)"	"unprognostic (6.50e-2)"	"unprognostic (8.82e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.37e-2)"	"unprognostic (2.94e-1)"	"unprognostic (2.06e-3)"	"unprognostic (1.83e-3)"	"unprognostic (1.10e-1)"	"unprognostic (1.19e-3)"	"unprognostic (9.44e-3)"	0.6	0.3	3.2	1.4	3.2	0.7	0.9	0.4	2.6	0.9	0.4	5.4	0.3	0.5	2.5	3.0	0.4	12.7	0.5	1.3	3.2	1.6	0.9	0.3	4.9	0.5	0.7	1.3	2.8	0.5	0.9	5.3	0.8	11.8	1.5	0.4	0.3	0.5	0.3	0.6	0.5	0.4	0.5	0.9	0.4	0.3	15.7	2.1	0.0	0.7	0.0	0.3	0.4	0.4	0.9	1.1	2.5	0.5	0.6	0.4	0.0	0.4	0.5	0.3	1.7	0.2	1.1	2.2	0.0	0.0	0.0	0.2	0.1	1.1	0.5	0.2	0.0	0.1	0.4	0.2	0.4	0.0	0.1	0.3	0.6	0.6	0.4	0.3	1.1	1.3	0.3	0.8	0.1	0.6	0.4	0.2	3.5	1.2	0.8	0.0	1.3	0.6	0.8	0.5	6.4	0.6	0.2	0.1	0.0	1.9	0.5	0.6	0.8	0.4	0.0	1.0	1.0	3.3	1.3	0.4	0.2	0.2	0.2	0.2	0.3	0.2	0.3	0.1	0.2	0.3	2.5	0.5	0.1	0.3	0.3	0.4	0.5	0.2	0.2	0.1	0.9	0.3	0.3	0.9	0.6	0.1	1.1	0.2	0.0	3.2	3.2	0.4	2.6	3.2	1.6	0.7	1.3	11.8	2.1	0.0	1.3	2.2	1.7	0.0	8.0	1.6	2.5	172.6	21.6	7.0	13.7	2.2	1.7	1.1	43.0	1.7	0.8	0.0	2.6	1.5	1.1	3.2	2.3	0.9	1.0	12.7	1.7	0.6	0.0	24.4	2.0	0.8	0.0	1.0	0.3	2.4	0.7	0.0	2.1	1.0	11.4	6.5	0.3	21.1	12.0	0.1	1.6	0.0	1.0	0.8
NEK6	SID6-1512	ENSG00000119408	"NIMA related kinase 6"	Q9HC98	9	124257606-124353307	"Enzymes, Predicted intracellular proteins, Transporters"	"Apoptosis, Cell cycle, Cell division, Chromosome partition, Mitosis"	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Extravillous trophoblasts: 103.8;Hofbauer cells: 99.7;monocytes: 90.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HMC-1: 62.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB045993, HPA056828"	Approved		Supported	"Nucleoplasm,Centriolar satellite,Cytosol"		NA	NA			"Nucleoplasm, Cytosol"	"Centriolar satellite"	"CAB045993: AB_2150651, HPA056828: AB_2683250"	"unprognostic (6.27e-2)"	"unprognostic (1.02e-2)"	"unprognostic (4.15e-2)"	"unprognostic (1.65e-2)"	"unprognostic (5.22e-2)"	"unprognostic (2.47e-2)"	"unprognostic (3.13e-3)"	"unprognostic (2.13e-2)"	"unprognostic (2.38e-1)"	"unprognostic (3.30e-2)"	"unprognostic (1.38e-3)"	"unprognostic (6.53e-2)"	"unprognostic (5.03e-3)"	"unprognostic (1.97e-1)"	"prognostic unfavorable (7.66e-4)"	"unprognostic (5.27e-2)"	"unprognostic (4.77e-3)"	14.8	5.3	26.1	22.2	29.1	12.8	18.8	7.2	21.2	20.5	15.6	13.4	4.3	12.5	9.2	7.5	6.8	8.5	18.4	7.0	17.1	16.6	12.9	51.9	17.0	18.1	19.4	13.3	11.2	20.5	1.6	6.4	21.4	14.7	14.8	16.6	18.5	16.9	13.2	5.5	5.1	18.2	23.4	13.0	11.3	19.0	5.8	12.9	4.0	6.3	1.9	22.0	17.7	10.1	21.9	11.5	29.0	18.8	8.3	3.8	7.6	7.4	12.3	11.9	4.6	22.5	29.4	14.8	9.4	15.1	14.6	12.2	11.6	14.0	9.1	15.1	18.1	33.4	1.4	6.1	27.3	9.9	10.0	5.4	24.9	10.4	20.4	26.9	4.5	62.6	39.1	4.4	13.8	14.3	38.4	15.9	4.3	4.4	0.4	26.0	7.8	0.2	4.9	3.0	39.4	11.2	9.6	8.9	4.6	15.6	2.7	5.3	1.8	3.0	5.8	13.3	12.6	12.7	18.4	31.0	10.7	10.8	7.3	6.4	2.0	2.5	5.2	13.4	10.2	14.1	10.2	18.8	29.0	3.8	12.3	2.4	21.9	2.3	3.2	11.5	9.0	0.4	1.6	23.4	8.3	14.7	10.6	2.8	7.6	26.1	29.1	7.2	21.2	17.1	16.6	19.4	13.3	14.7	12.9	8.9	6.6	9.8	11.0	2.2	0.7	2.5	17.8	1.4	4.5	3.5	0.0	33.9	1.7	35.3	14.7	5.5	12.9	23.3	20.0	103.8	9.9	17.8	21.9	33.3	99.7	0.0	5.8	4.3	10.7	12.3	4.6	30.4	6.8	90.2	15.5	28.1	24.3	15.2	3.5	29.9	1.8	0.0	5.3	1.2	10.6	1.0	30.2	0.0	18.6	8.9
NEK7		ENSG00000151414	"NIMA related kinase 7"	Q8TDX7	1	198156963-198322420	"Enzymes, Predicted intracellular proteins, Transporters"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	6	"Cardiomyocytes: 150.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BJ: 85.5;fHDF/TERT166: 115.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA015520, HPA018193"	Approved		Supported	Nucleoplasm		Yes	No			Nucleoplasm		"HPA015520: AB_1854371, HPA018193: AB_1854372"	"unprognostic (2.08e-1)"	"unprognostic (2.98e-2)"	"unprognostic (1.65e-1)"	"unprognostic (5.38e-2)"	"unprognostic (4.26e-2)"	"unprognostic (3.00e-2)"	"unprognostic (2.14e-2)"	"unprognostic (5.47e-2)"	"unprognostic (4.77e-2)"	"unprognostic (3.21e-1)"	"unprognostic (1.46e-3)"	"unprognostic (2.82e-1)"	"unprognostic (1.13e-2)"	"unprognostic (1.26e-2)"	"unprognostic (1.74e-1)"	"unprognostic (2.05e-2)"	"unprognostic (1.56e-1)"	31.7	31.4	24.9	15.2	23.0	5.6	23.7	7.8	15.6	19.3	20.6	25.5	13.7	11.3	24.5	11.4	18.7	12.8	15.1	74.7	23.9	20.4	16.1	16.0	22.3	14.9	26.8	13.4	17.2	11.1	14.6	17.6	40.5	18.0	20.0	13.2	11.8	13.5	21.3	29.9	10.6	15.8	30.9	34.9	16.4	11.7	9.5	22.6	18.0	14.9	12.8	12.5	27.4	20.7	1.6	2.1	6.1	2.2	3.8	14.7	1.4	7.1	1.9	2.3	0.9	6.0	6.9	2.7	85.5	35.8	34.8	16.5	3.5	7.1	2.6	6.2	115.4	2.0	4.4	3.5	4.6	35.2	8.1	5.0	3.5	8.2	1.4	7.2	5.9	7.3	4.3	4.0	22.9	6.9	13.0	6.6	21.6	2.7	6.4	15.9	2.2	5.1	3.5	1.2	5.7	1.4	2.7	5.7	4.5	5.9	3.7	1.4	2.7	14.2	8.2	9.5	3.4	6.0	5.4	14.5	9.8	8.3	28.0	8.9	4.5	4.1	1.7	4.2	5.4	7.5	1.9	2.2	3.0	3.2	1.9	14.7	1.3	3.6	4.6	2.1	1.6	2.9	3.6	6.1	3.8	1.7	1.4	6.0	1.4	24.9	23.0	7.8	15.6	23.9	20.4	26.8	13.4	18.0	22.6	26.8	24.2	12.3	15.3	45.6	9.4	150.0	10.2	25.4	21.6	17.4	13.7	11.6	10.0	8.8	2.1	26.3	19.8	46.7	16.9	13.3	24.9	20.4	8.1	19.2	15.2	3.2	19.0	35.0	42.5	1.7	27.0	23.7	28.7	16.2	19.6	10.0	34.6	17.3	36.0	11.6	25.0	19.4	44.2	7.5	5.7	43.0	53.8	20.1	14.9	22.4
NEK8	NPHP9	ENSG00000160602	"NIMA related kinase 8"	Q86SG6	17	28725897-28743455	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"	"Ciliopathy, Disease mutation, Nephronophthisis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"plasmacytoid DC: 14.7"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040661, HPA040679"	Approved					NA	NA					"HPA040661: AB_10794065, HPA040679: AB_10796226"	"unprognostic (2.63e-1)"	"unprognostic (4.57e-2)"	"prognostic unfavorable (6.98e-4)"	"unprognostic (6.25e-2)"	"unprognostic (2.23e-2)"	"unprognostic (5.93e-3)"	"unprognostic (6.48e-2)"	"prognostic favorable (4.52e-4)"	"unprognostic (7.85e-2)"	"unprognostic (1.37e-1)"	"unprognostic (1.51e-3)"	"unprognostic (1.55e-1)"	"unprognostic (4.87e-3)"	"unprognostic (4.61e-2)"	"unprognostic (3.58e-1)"	"unprognostic (1.75e-1)"	"unprognostic (4.67e-3)"	3.5	4.6	2.9	11.9	4.5	2.0	4.3	1.7	4.9	5.3	4.0	4.7	1.4	4.2	2.1	5.0	4.8	5.9	4.4	1.6	2.9	1.9	10.4	6.9	5.7	7.8	2.3	2.1	4.4	6.4	8.5	9.7	8.7	5.6	5.6	3.2	5.2	5.3	4.1	0.9	4.4	6.5	1.7	3.0	8.4	4.9	4.9	1.4	4.8	10.7	3.5	15.6	4.5	3.0	4.7	14.7	3.2	1.0	1.3	1.1	0.8	2.2	3.5	3.8	3.0	2.1	2.3	11.6	1.0	2.2	1.4	1.8	5.6	5.2	13.5	3.8	2.9	2.6	3.9	5.5	5.0	1.4	3.5	6.8	3.0	5.7	10.2	3.6	1.9	4.0	5.2	1.9	2.6	6.2	2.0	1.0	2.0	4.4	1.4	1.5	4.8	1.8	3.5	3.5	3.8	1.1	4.9	2.4	6.0	7.5	5.9	6.8	1.6	3.2	6.6	1.6	5.2	9.9	2.5	0.9	1.3	2.5	1.7	1.0	1.6	1.8	9.1	2.2	1.7	3.2	3.2	0.9	1.2	0.8	0.4	0.9	3.0	0.7	0.7	0.1	4.7	0.8	1.1	0.5	1.3	1.0	14.7	0.5	0.8	2.9	4.5	1.7	4.9	2.9	1.9	2.3	2.1	5.6	1.4	8.9	17.1	11.5	7.4	2.5	2.6	1.6	5.1	10.7	13.6	24.4	7.9	14.3	6.6	4.7	7.6	2.1	10.7	0.0	5.3	8.0	4.1	6.9	25.5	4.9	3.3	1.6	9.9	4.3	3.3	1.5	3.1	4.0	3.3	3.6	10.2	1.7	3.7	13.3	2.5	3.0	1.6	0.0	1.2	4.8	5.1	1.4	9.3	4.6	12.4	3.4
NEK9	"DKFZp434D0935, MGC16714, Nek8, NERCC"	ENSG00000119638	"NIMA related kinase 9"	Q8TD19	14	75079353-75127344	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters"	"Cell cycle, Cell division, Mitosis"	"Kinase, Serine/threonine-protein kinase, Transferase"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA001405	Approved		Approved	Mitochondria		NA	NA		190000	Mitochondria		"HPA001405: AB_1079467"	"unprognostic (1.00e-1)"	"unprognostic (5.37e-2)"	"unprognostic (9.97e-3)"	"unprognostic (2.64e-2)"	"unprognostic (3.86e-1)"	"unprognostic (2.77e-1)"	"unprognostic (1.12e-1)"	"unprognostic (5.60e-3)"	"unprognostic (2.81e-1)"	"unprognostic (1.15e-1)"	"prognostic favorable (5.63e-4)"	"unprognostic (8.58e-2)"	"unprognostic (1.36e-2)"	"unprognostic (4.54e-2)"	"unprognostic (9.22e-2)"	"unprognostic (2.61e-1)"	"unprognostic (1.57e-2)"	17.0	20.4	12.7	17.7	17.4	7.3	15.1	15.4	13.3	18.6	18.7	18.3	23.5	14.0	25.0	13.8	15.6	20.0	15.9	23.5	11.4	8.7	14.0	13.3	12.9	16.2	20.2	10.6	25.6	15.7	24.7	23.6	14.3	13.0	15.3	8.1	15.4	12.4	18.9	36.2	10.6	15.3	24.7	14.5	14.7	14.8	16.6	18.2	21.5	17.0	14.1	14.4	23.6	18.7	6.0	6.4	7.5	5.4	5.5	6.2	3.1	10.1	12.0	15.2	17.0	19.6	26.9	17.4	16.5	11.7	8.1	7.9	10.1	8.9	17.5	0.1	11.3	6.7	14.0	11.6	6.4	9.0	14.2	6.7	8.5	12.0	7.3	12.8	5.1	11.4	18.3	7.6	8.4	6.4	21.5	10.1	12.1	9.6	11.3	9.7	1.1	10.8	5.2	9.0	12.9	6.1	17.5	19.4	9.0	6.1	12.5	7.4	18.7	13.3	6.4	12.8	16.7	15.9	14.8	15.3	12.3	5.2	14.3	6.4	18.3	19.5	17.6	9.0	8.7	8.3	7.5	5.4	5.8	4.2	5.0	5.9	2.8	4.8	3.9	6.4	6.0	6.2	5.9	5.5	5.5	3.5	1.8	2.6	3.1	12.7	17.4	15.4	13.3	11.4	8.7	20.2	10.6	13.0	18.2	11.9	33.3	10.4	7.4	7.8	16.5	47.6	5.1	14.7	19.4	10.4	33.4	13.4	6.6	5.0	9.2	14.3	10.6	0.0	4.3	13.7	11.8	6.1	15.1	28.4	12.0	12.7	5.2	17.8	18.7	6.4	23.0	12.6	3.3	6.4	10.5	12.1	5.0	9.0	24.8	7.8	22.6	0.0	12.3	23.8	12.8	8.9	11.7	10.0	10.6	4.8
NEU1	NEU	ENSG00000204386	"Neuraminidase 1"	Q99519	6	31857659-31862906	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Carbohydrate metabolism, Lipid degradation, Lipid metabolism"	"Glycosidase, Hydrolase"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"GAMG: 38.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA015634, HPA021506"	Approved		Supported	"Vesicles,Cell Junctions"		NA	NA		86000	Vesicles	"Cell Junctions"	"HPA015634: AB_1854386, HPA021506: AB_1854385"	"unprognostic (3.84e-2)"	"unprognostic (7.47e-2)"	"unprognostic (9.64e-2)"	"unprognostic (4.65e-2)"	"unprognostic (3.00e-1)"	"unprognostic (4.42e-3)"	"unprognostic (1.38e-3)"	"unprognostic (8.58e-3)"	"unprognostic (7.49e-2)"	"unprognostic (5.21e-2)"	"unprognostic (4.44e-3)"	"unprognostic (1.27e-1)"	"unprognostic (2.70e-2)"	"unprognostic (6.22e-2)"	"unprognostic (1.48e-1)"	"unprognostic (2.12e-1)"	"unprognostic (2.13e-3)"	10.5	30.2	8.6	9.4	11.1	5.2	10.5	15.5	14.6	13.4	14.1	7.4	16.1	14.1	9.8	13.9	9.0	8.3	16.1	9.8	8.0	9.5	29.7	24.2	16.1	7.2	9.4	6.6	12.7	20.6	13.6	16.5	19.8	10.3	15.1	9.1	14.7	18.1	13.8	10.0	9.1	23.5	9.8	4.7	13.4	12.7	6.5	10.0	5.8	22.7	7.0	9.6	13.6	9.5	4.2	7.7	15.2	13.4	3.0	5.1	7.4	2.4	2.4	2.4	5.6	8.2	3.1	4.8	2.2	7.5	6.5	9.6	14.1	2.6	0.8	5.7	2.9	38.4	1.3	5.1	2.0	2.5	2.0	3.4	1.2	1.4	16.5	14.7	1.5	6.9	5.1	3.8	7.9	4.1	3.9	5.8	1.6	2.6	5.8	3.3	4.3	1.2	2.3	1.9	4.3	1.9	1.7	1.3	8.5	10.8	5.2	1.8	1.1	2.4	3.3	5.8	3.2	6.2	7.1	2.4	4.3	2.5	6.0	3.9	7.2	11.5	1.7	3.1	3.9	3.0	6.4	13.4	8.7	5.1	10.3	4.2	3.9	3.9	4.1	7.7	4.2	4.0	3.9	15.2	3.0	9.2	4.3	4.8	7.4	8.6	11.1	15.5	14.6	8.0	9.5	9.4	6.6	10.3	10.0	23.8	47.7	44.6	42.4	30.5	24.5	18.7	38.2	10.7	17.0	45.4	23.6	52.4	8.3	82.1	0.8	27.6	80.5	0.0	51.5	49.0	63.2	112.7	66.9	21.3	139.8	9.5	108.9	26.4	42.3	0.7	25.6	53.4	67.4	25.2	37.4	48.4	45.4	80.7	21.9	55.3	29.8	25.8	42.2	5.0	7.5	36.4	164.8	28.7	38.6	31.8
NEU2	SIAL2	ENSG00000115488	"Neuraminidase 2"	Q9Y3R4	2	233032672-233035057	"Enzymes, Predicted intracellular proteins"	"Carbohydrate metabolism, Lipid degradation, Lipid metabolism"	"Glycosidase, Hydrolase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	16	"skin 1: 6.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"A-431: 1.1;BEWO: 1.6;PC-3: 3.1"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	5	"cerebral cortex: 2.2;hippocampal formation: 1.1"	CAB022336	Uncertain					NA	NA		9000			"CAB022336: "						"unprognostic (1.30e-1)"												0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0			0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.0	6.1	0.0	0.0	0.0	0.0	0.0	0.0			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	3.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
NEU3		ENSG00000162139	"Neuraminidase 3"	Q9UQ49	11	74988134-75018893	"Enzymes, Predicted intracellular proteins"	"Carbohydrate metabolism, Lipid degradation, Lipid metabolism"	"Glycosidase, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 44.6"	"Group enriched"	"Detected in many"	4	"Cone photoreceptor cells: 58.9;Spermatocytes: 32.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038729, HPA070381"	Approved		Supported	Nucleoplasm,Vesicles		NA	NA			Nucleoplasm	Vesicles	"HPA038729: AB_2676179, HPA070381: "	"unprognostic (1.67e-1)"	"unprognostic (2.10e-1)"	"unprognostic (2.55e-2)"	"unprognostic (1.13e-3)"	"unprognostic (2.95e-2)"	"unprognostic (5.42e-2)"	"unprognostic (1.63e-1)"	"unprognostic (5.11e-2)"	"unprognostic (3.91e-3)"	"unprognostic (8.50e-2)"	"prognostic favorable (5.98e-4)"	"unprognostic (3.57e-3)"	"unprognostic (3.80e-2)"	"unprognostic (3.79e-1)"	"unprognostic (2.38e-1)"	"unprognostic (3.73e-1)"	"unprognostic (1.84e-1)"	5.4	13.4	3.7	10.5	6.9	17.0	5.4	7.9	9.1	4.0	3.9	3.0	4.1	3.6	5.4	4.8	3.9	4.4	3.6	5.9	4.0	4.5	4.3	6.7	8.7	9.0	3.8	6.6	7.2	7.3	15.1	11.2	3.1	4.2	9.7	5.4	5.6	4.8	4.6	19.1	6.7	4.7	4.0	3.5	5.5	5.1	44.6	3.0	19.0	6.8	3.5	7.5	4.5	3.1	3.2	3.8	5.8	6.4	1.2	4.2	2.2	4.6	4.0	3.4	6.6	2.6	2.5	3.8	4.5	2.9	5.2	4.0	13.7	3.9	13.3	4.6	3.6	6.6	4.3	8.2	5.8	7.9	7.0	4.4	10.9	7.4	5.6	2.9	17.2	10.6	3.0	4.9	5.2	8.1	3.4	3.7	19.0	17.7	10.0	5.9	5.0	16.9	8.9	4.2	9.1	5.4	14.8	9.0	11.7	6.4	4.9	6.3	4.0	6.9	4.6	20.2	4.2	9.8	4.4	5.6	6.5	6.5	4.3	4.5	8.2	8.0	26.6	1.9	8.9	5.5	2.1	6.4	5.8	4.1	3.7	3.0	2.8	3.2	3.9	3.8	3.2	3.5	4.2	3.3	1.2	4.6	2.7	2.3	2.2	3.7	6.9	7.9	9.1	4.0	4.5	3.8	6.6	4.2	3.0	3.0	5.8	2.2	1.8	0.5	7.2	7.3	2.5	2.7	4.5	1.8	58.9	1.8	0.0	1.0	5.7	1.6	1.3	0.0	2.6	1.2	1.5	2.7	1.1	7.2	4.8	11.1	6.9	4.3	8.6	5.3	1.4	4.5	0.0	4.6	2.9	2.9	2.7	0.0	1.8	3.3	5.8	0.0	2.2	32.5	1.7	0.5	1.1	3.5	3.2	0.4
NEU4		ENSG00000204099	"Neuraminidase 4"	Q8WWR8	2	241808825-241817413	"Enzymes, Predicted intracellular proteins"	"Carbohydrate metabolism, Lipid degradation, Lipid metabolism"	"Glycosidase, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"intestine: 27.1;liver: 42.9"	"Cell type enhanced"	"Detected in some"	14	"Enterocytes: 65.6;Hepatocytes: 117.5;Intestinal endocrine cells: 33.1;Mucus-secreting cells: 40.3;Paneth cells: 66.2;Undifferentiated cells: 40.1"	"Group enriched"	"Detected in some"	7	"colorectal cancer: 2.3;glioma: 6.0;liver cancer: 6.7"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	21	"Hep G2: 22.5;HMC-1: 31.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA037394	Enhanced					NA	NA					"HPA037394: AB_2675455"	"unprognostic (1.50e-1)"	"unprognostic (2.39e-3)"	"unprognostic (1.85e-1)"	"unprognostic (3.68e-4)"	"unprognostic (3.76e-2)"	"unprognostic (1.57e-1)"	"unprognostic (8.70e-2)"	"unprognostic (8.62e-2)"	"unprognostic (1.74e-1)"	"unprognostic (4.41e-2)"	"unprognostic (1.52e-2)"	"unprognostic (2.92e-1)"	"unprognostic (8.11e-4)"	"unprognostic (2.00e-2)"	"unprognostic (3.82e-1)"	"unprognostic (6.64e-3)"	"unprognostic (1.55e-2)"	0.6	0.5	6.5	0.7	5.3	5.7	0.3	1.9	7.0	0.6	13.9	4.9	0.0	9.3	0.3	0.3	0.7	1.1	2.6	0.6	6.4	5.8	1.4	42.9	0.4	0.5	6.9	4.4	0.4	0.3	0.3	0.4	0.4	3.8	0.5	6.1	0.0	0.4	0.4	3.6	0.3	27.1	0.4	4.1	0.5	0.5	0.6	2.3	0.0	0.4	2.8	0.3	0.5	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	22.5	0.0	0.0	31.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	6.5	5.3	1.9	4.0	6.4	5.8	6.9	4.4	3.8	2.3	0.0	0.0	0.9	0.0	0.0	0.7	0.5	0.0	0.0	0.0	1.8	0.0	0.0	3.3	0.0	0.0	0.0	65.6	0.0	0.0	0.0	0.2	0.0	1.1	117.5	1.2	0.0	33.1	0.6	3.2	0.0	0.6	0.7	0.0	0.0	40.3	26.2	0.0	66.2	0.7	8.6	1.4	0.0	0.0	0.0	0.7	0.0	0.0	0.0	40.1	0.1
NEURL1	"h-neu, neu-1, NEURL, RNF67"	ENSG00000107954	"Neuralized E3 ubiquitin protein ligase 1"	O76050	10	103493979-103592552	"Enzymes, Predicted intracellular proteins"	"Notch signaling pathway, Translation regulation, Ubl conjugation pathway"	Transferase	"Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 37.1;skeletal muscle: 83.5"	"Cell type enhanced"	"Detected in many"	15	"Early spermatids: 105.4;Late spermatids: 383.1;Paneth cells: 157.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	12	"intermediate monocyte: 16.0;non-classical monocyte: 37.1"	"Lineage enriched"	"Detected in many"	17	"monocytes: 37.1"	"Cell line enhanced"	"Detected in some"		"BEWO: 13.0;HeLa: 7.7;HMC-1: 6.6;JURKAT: 6.9;SCLC-21H: 16.4;SiHa: 8.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044204	Enhanced					NA	NA					"HPA044204: AB_10959383"	"unprognostic (1.21e-2)"	"unprognostic (8.14e-2)"	"unprognostic (1.18e-3)"	"unprognostic (1.58e-4)"	"unprognostic (1.31e-2)"	"unprognostic (2.60e-1)"	"unprognostic (5.24e-2)"	"unprognostic (2.54e-1)"	"unprognostic (1.37e-1)"	"unprognostic (4.31e-2)"	"unprognostic (1.32e-3)"	"unprognostic (1.08e-1)"	"unprognostic (8.61e-3)"	"unprognostic (1.59e-1)"	"unprognostic (1.44e-1)"	"unprognostic (2.91e-4)"	"unprognostic (3.23e-1)"	1.1	3.9	18.5	3.0	17.5	2.0	1.0	28.2	27.2	6.1	8.6	0.6	1.2	7.7	13.2	11.0	3.6	2.1	2.0	1.1	12.0	7.6	1.3	1.1	1.3	1.3	4.5	18.9	2.1	12.8	2.9	6.5	13.3	6.1	2.8	7.3	7.8	1.5	1.7	83.5	1.9	11.7	11.7	1.2	2.0	4.4	7.5	2.1	0.0	1.2	8.5	1.1	9.2	1.7	0.4	2.1	1.0	37.1	0.2	0.4	1.2	0.8	0.2	1.3	0.0	0.4	0.1	13.0	0.5	0.8	0.2	0.1	0.3	0.3	0.4	0.7	0.1	0.9	0.7	0.4	0.2	0.1	0.3	0.7	0.2	7.7	0.6	0.0	0.3	6.6	0.2	0.5	0.1	0.6	0.2	0.0	6.9	2.1	0.4	0.2	1.1	1.3	0.8	0.0	0.5	3.9	0.2	0.6	1.4	0.0	0.5	16.4	5.6	8.2	0.0	0.4	2.5	0.7	1.5	0.0	0.1	0.9	0.2	0.2	0.9	0.2	0.3	0.5	0.0	0.3	0.2	1.0	0.2	0.3	16.0	0.4	0.4	0.4	0.4	2.1	0.3	0.4	0.3	1.0	0.2	37.1	1.7	0.1	1.2	18.5	17.5	28.2	27.2	12.0	7.6	4.5	18.9	6.1	2.1	0.0	1.1	1.4	1.3	0.5	42.1	1.2	0.0	0.0	0.0	0.0	88.4	3.4	0.0	9.1	105.4	1.0	6.9	0.0	0.6	10.0	1.9	0.5	0.0	0.0	4.2	3.2	75.1	0.0	4.1	383.1	5.2	2.0	0.0	0.0	92.0	6.4	0.9	157.0	4.9	0.0	83.3	6.5	0.6	47.6	28.8	1.6	94.9	3.9	7.8	0.5
NEURL1B	"DKFZP761M1511, Neur2, RNF67B"	ENSG00000214357	"Neuralized E3 ubiquitin protein ligase 1B"	A8MQ27	5	172641266-172691540	"Enzymes, Predicted intracellular proteins"	"Notch signaling pathway, Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	7	"Endothelial cells: 32.6;Enterocytes: 45.0;Ito cells: 36.2;Leydig cells: 50.6;Paneth cells: 33.1;Smooth muscle cells: 30.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"REH: 27.6;T-47d: 13.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA037612	Approved		Supported	"Actin filaments,Cytosol"		NA	Yes			Cytosol	"Actin filaments"	"HPA037612: AB_10795573"	"unprognostic (3.56e-2)"	"unprognostic (8.46e-2)"	"unprognostic (6.72e-3)"	"unprognostic (2.70e-1)"	"unprognostic (1.64e-1)"	"unprognostic (1.55e-1)"	"unprognostic (6.58e-2)"	"unprognostic (2.95e-1)"	"unprognostic (2.86e-1)"	"unprognostic (1.09e-1)"	"unprognostic (7.13e-3)"	"unprognostic (6.81e-2)"	"prognostic unfavorable (3.00e-6)"	"unprognostic (1.79e-1)"	"unprognostic (1.40e-1)"	"unprognostic (4.67e-2)"	"unprognostic (3.22e-3)"	26.6	11.8	7.5	10.3	3.2	1.5	23.9	0.6	7.0	21.4	17.5	5.6	31.2	5.7	26.7	24.7	14.0	15.8	23.0	19.2	10.7	4.2	7.6	4.4	10.5	7.8	3.1	3.2	20.9	4.8	4.1	6.0	5.1	2.7	20.7	11.6	6.1	4.9	28.4	12.3	14.7	12.1	29.1	1.5	0.6	5.9	6.6	2.8	3.6	7.2	13.9	5.4	16.0	30.8	0.0	0.6	0.0	0.2	0.0	0.2	0.0	4.5	2.4	1.3	5.8	0.4	0.2	0.1	5.1	2.3	2.7	4.0	8.7	2.1	0.0	1.4	3.3	3.3	1.3	0.5	2.3	1.8	8.3	0.3	6.2	8.3	0.0	0.4	0.0	1.9	0.0	9.9	0.6	2.7	0.8	0.4	0.9	0.0	2.0	5.8	5.0	1.4	0.1	0.8	2.0	0.2	27.6	6.1	0.9	0.1	1.0	1.0	5.9	4.9	7.8	0.2	2.4	13.0	0.9	0.8	2.0	12.2	1.4	3.2	0.8	0.2	0.0	5.9	0.1	1.8	0.0	0.1	0.0	0.2	0.2	0.0	0.0	0.1	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	7.5	3.2	0.6	7.0	10.7	4.2	3.1	3.2	2.7	2.8	0.0	3.4	0.0	0.6	4.2	0.1	7.8	0.0	8.1	4.5	0.0	0.0	0.2	0.0	0.3	1.9	32.6	45.0	0.0	0.6	0.2	3.5	1.8	0.0	0.5	0.2	0.0	13.4	36.2	2.4	4.1	50.6	1.8	6.8	1.0	12.5	0.7	3.5	33.1	11.7	0.8	0.3	25.8	30.8	2.1	1.5	4.6	0.1	0.0	15.7	0.9
NEURL3	"Lincr, LOC93082, RNF132"	ENSG00000163121	"Neuralized E3 ubiquitin protein ligase 3"	Q96EH8	2	96497643-96508109	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"pancreas: 26.3;salivary gland: 22.4;seminal vesicle: 10.8"	"Cell type enhanced"	"Detected in many"	21	"Ductal cells: 94.8;Exocrine glandular cells: 31.1;monocytes: 20.8;Pancreatic endocrine cells: 20.7"	"Low cancer specificity"	"Detected in many"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 4.1;CAPAN-2: 16.7;GAMG: 6.0;RPMI-8226: 10.5;RT4: 5.0"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"									NA	NA						"unprognostic (4.97e-2)"	"unprognostic (6.07e-2)"	"unprognostic (7.22e-2)"	"unprognostic (1.42e-2)"	"unprognostic (2.49e-2)"	"unprognostic (4.35e-2)"	"prognostic unfavorable (6.46e-4)"	"unprognostic (2.29e-1)"	"unprognostic (9.55e-2)"	"unprognostic (1.18e-2)"	"unprognostic (1.06e-1)"	"unprognostic (8.14e-3)"	"unprognostic (1.23e-2)"	"unprognostic (5.83e-2)"	"unprognostic (6.57e-2)"	"unprognostic (2.44e-1)"	"unprognostic (6.57e-4)"	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.6	0.0	0.1	0.0	0.9	0.9	0.0	0.1	0.0	0.0	1.3	0.0	0.0		5.3	0.6	1.8	0.0	0.0	0.1	0.0	26.3	0.0	0.0	0.0	0.2	1.4	0.1	0.0	22.4	10.8	0.4	0.0	1.2	0.0	0.2	0.0	0.1	0.2	0.0	6.4	0.0	0.5	0.1	0.4	0.0	0.3	0.2	0.7	0.1	0.1	0.1	3.0	1.0	0.5	0.0	0.3	0.0	0.0	4.1	0.0	0.4	0.3	0.2	2.4	16.7	0.0	1.3	0.0	6.0	2.5	0.2	0.0	0.0	0.6	0.0	0.1	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	1.0	0.4	0.0	0.0	10.5	2.2	5.0	0.0	0.0	0.0	2.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.2	0.0	0.1	0.0	0.5	0.3	0.1	0.1	0.1	0.0	0.0	0.2	0.1	0.0	0.2	0.3	0.1	0.0	0.7	0.1	0.0	0.0	0.1	3.0											0.0	1.0	1.3	10.0	0.0	0.0	0.4	2.5	0.0	1.2	8.7	0.0	0.1	3.3	94.8	0.0	0.0	7.9	0.0	31.1	0.0	0.0	13.5	0.0	0.0	1.1	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	20.8	0.5	0.7	20.7	2.3	0.0	3.6	0.0	0.0	0.3	0.4	1.1	0.0	0.0	0.0	0.6	4.3
NFS1	"IscS, NifS"	ENSG00000244005	"NFS1, cysteine desulfurase"	Q9Y697	20	35668055-35699359	"Enzymes, Predicted intracellular proteins"	"Molybdenum cofactor biosynthesis"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"CAB034314, HPA051801, HPA054755"	Enhanced		Supported	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"CAB034314: AB_2235980, HPA051801: AB_2681616, HPA054755: AB_2682594"	"unprognostic (1.72e-1)"	"unprognostic (2.96e-1)"	"unprognostic (1.27e-2)"	"unprognostic (5.88e-3)"	"unprognostic (1.05e-1)"	"unprognostic (4.33e-2)"	"unprognostic (1.14e-1)"	"unprognostic (2.02e-1)"	"unprognostic (9.00e-2)"	"unprognostic (1.73e-1)"	"unprognostic (6.52e-3)"	"unprognostic (3.93e-2)"	"prognostic favorable (4.72e-6)"	"unprognostic (2.33e-2)"	"unprognostic (1.97e-1)"	"unprognostic (1.64e-2)"	"unprognostic (5.54e-2)"	10.2	28.0	16.9	6.7	19.3	3.7	9.7	15.3	20.8	11.2	11.7	12.0	10.0	11.0	8.4	9.9	10.1	11.7	9.9	19.2	14.6	14.0	36.9	33.0	7.8	7.0	16.5	15.5	12.5	14.0	20.7	14.8	7.8	14.3	9.5	13.0	12.2	12.6	12.2	19.7	9.5	9.6	10.1	12.4	6.6	10.3	25.3	15.8	4.9	10.2	8.4	10.4	8.1	7.7	10.4	11.2	7.4	8.1	12.8	11.4	6.1	13.2	16.5	5.8	6.1	15.8	14.5	11.7	10.1	10.8	15.4	10.0	29.8	7.6	11.3	20.0	9.4	15.7	16.8	19.7	20.5	13.9	5.0	9.3	24.2	17.7	23.1	13.2	10.2	4.7	11.6	19.6	12.0	13.2	11.4	11.4	13.4	17.2	7.6	10.7	20.3	11.4	10.7	6.6	30.4	24.9	4.5	18.8	19.0	15.6	9.0	7.3	6.6	25.3	24.6	16.5	14.2	21.9	9.1	8.3	17.4	8.3	10.1	9.9	11.0	15.1	10.4	14.7	11.1	8.5	2.5	8.1	7.4	7.6	7.7	9.7	10.4	8.8	11.2	11.2	7.6	10.3	9.3	3.4	12.8	6.0	5.6	11.4	6.1	16.9	19.3	15.3	20.8	14.6	14.0	16.5	15.5	14.3	15.8	6.0	16.7	9.7	7.5	5.5	12.2	19.3	20.4	2.7	6.8	17.4	9.8	28.1	28.2	13.8	4.2	5.7	12.1	0.0	9.8	17.9	7.5	4.8	6.9	24.1	14.2	14.3	6.4	8.0	8.9	3.4	5.2	8.5	10.1	15.4	7.8	14.5	9.3	9.9	9.9	41.3	11.8	12.9	8.7	36.8	17.8	5.0	17.6	9.6	13.4	5.0
NGLY1	"FLJ11005, PNG1"	ENSG00000151092	"N-glycanase 1"	Q96IV0	3	25718944-25790039	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"		Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	8	"Early spermatids: 518.0;Late spermatids: 684.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA036825	Approved				"Intracellular and membrane"	NA	NA					"HPA036825: AB_10672231"	"unprognostic (3.65e-2)"	"unprognostic (8.65e-2)"	"prognostic favorable (1.17e-5)"	"unprognostic (2.96e-2)"	"unprognostic (1.72e-2)"	"unprognostic (1.59e-2)"	"prognostic unfavorable (1.96e-6)"	"unprognostic (2.20e-1)"	"unprognostic (2.34e-1)"	"unprognostic (3.73e-3)"	"unprognostic (2.55e-1)"	"unprognostic (4.23e-2)"	"unprognostic (4.92e-3)"	"unprognostic (1.07e-2)"	"unprognostic (2.47e-1)"	"unprognostic (9.08e-2)"	"unprognostic (1.89e-2)"	10.7	14.4	11.4	19.6	11.4	12.9	15.0	17.1	15.0	9.5	12.4	6.9	11.7	10.5	10.2	13.8	13.2	8.4	10.5	14.3	12.0	9.0	12.8	18.1	13.9	17.4	9.5	12.5	10.6	20.7	9.0	11.3	8.7	11.0	10.9	15.2	7.8	12.4	18.0	46.6	9.0	11.2	8.7	10.1	14.6	11.9	42.0	9.0	18.0	10.3	10.9	18.1	11.5	10.6	26.1	39.7	19.9	10.8	22.6	14.7	10.3	12.5	10.7	6.0	12.7	11.6	10.7	8.6	10.8	9.1	13.6	12.3	6.6	9.6	31.9	12.3	9.1	14.1	5.7	20.2	5.7	18.5	15.0	8.6	23.7	8.2	10.7	13.0	21.8	13.0	9.5	7.6	14.9	14.0	14.8	14.5	15.7	22.4	23.0	13.8	5.5	25.9	12.9	8.1	14.7	19.5	26.5	7.9	22.7	12.5	15.4	3.7	4.5	15.6	15.1	10.0	12.0	14.3	18.3	9.8	10.7	11.1	12.9	13.9	28.3	24.4	22.2	12.9	23.7	8.4	19.9	10.8	18.9	13.7	10.1	14.7	26.1	13.8	12.6	16.3	21.7	14.0	13.6	12.8	22.6	8.4	39.7	10.4	10.3	11.4	11.4	17.1	15.0	12.0	9.0	9.5	12.5	11.0	9.0	17.9	12.9	39.7	20.7	11.2	21.6	22.4	22.9	28.1	15.9	5.2	11.8	36.2	29.9	26.6	518.0	20.1	20.2	0.0	38.1	28.0	19.8	22.0	19.7	22.7	21.1	11.1	6.9	15.4	16.4	684.0	13.8	24.8	23.6	20.8	27.3	19.8	25.0	24.6	14.9	29.8	20.4	0.0	14.6	73.4	43.7	12.0	47.4	33.3	28.9	19.0
NHLRC1	"bA204B7.2, EPM2B"	ENSG00000187566	"NHL repeat containing E3 ubiquitin protein ligase 1"	Q6VVB1	6	18120440-18122687	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Autophagy, Ubl conjugation pathway"	Transferase	"Disease mutation, Epilepsy"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"	5	"Exocrine glandular cells: 3.2;Intestinal endocrine cells: 3.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"EFO-21: 9.2;K-562: 7.8;SCLC-21H: 8.2"	"Low region specificity"	"Detected in all"							HPA066030			Uncertain	Vesicles		NA	NA			Vesicles		"HPA066030: "	"unprognostic (1.61e-1)"	"unprognostic (1.39e-1)"	"unprognostic (7.95e-2)"	"prognostic unfavorable (9.01e-4)"	"unprognostic (6.95e-3)"	"unprognostic (2.45e-1)"	"unprognostic (1.09e-1)"	"unprognostic (3.69e-1)"	"unprognostic (2.39e-1)"	"unprognostic (7.17e-2)"	"unprognostic (5.07e-3)"	"unprognostic (1.28e-1)"	"unprognostic (2.32e-2)"	"unprognostic (3.19e-1)"	"unprognostic (2.33e-1)"	"unprognostic (2.77e-2)"	"prognostic favorable (5.30e-4)"	2.5	3.6	5.0	1.8	6.5	2.1	4.6	2.6	8.5	1.9	3.3	7.1	1.7	3.2	2.0	6.1	2.4	3.5	2.7	3.9	5.0	5.1	1.9	9.0	5.1	4.7	5.4	3.9	3.5	12.2	2.4	2.8	1.0	5.2	3.4	3.0	3.3	5.1	2.8	5.2	8.5	4.3	1.8	5.4	2.4	3.0	2.1	3.8	2.4	3.6	0.9	1.8	2.5	1.8	3.3	7.2	0.6	7.2	2.2	2.5	2.6	3.3	2.0	0.8	0.1	1.8	1.7	0.0	3.5	1.1	1.3	0.7	0.1	2.8	0.1	9.2	2.5	0.2	4.0	0.0	2.2	1.0	0.1	1.2	0.5	1.1	0.2	2.8	0.0	2.2	2.9	3.4	1.3	1.2	0.8	2.8	0.0	7.8	0.1	2.8	3.6	0.0	0.0	0.0	0.4	2.0	0.0	0.0	0.1	1.9	3.6	8.2	0.1	6.9	5.8	2.0	0.8	4.2	2.2	0.5	0.2	1.8	2.4	0.0	0.1	0.0	0.1	0.1	0.0	3.5	0.5	6.6	0.6	1.1	7.2	1.2	3.3	1.7	0.8	7.2	2.3	2.5	1.6	0.5	2.2	3.2	0.9	1.8	2.6	5.0	6.5	2.6	8.5	5.0	5.1	5.4	3.9	5.2	3.8	0.0	2.1	0.0	1.0	1.6	0.1	0.4	0.0	0.0	2.3	0.0	0.0	0.3	0.0	2.0	0.0	0.0	0.3	0.0	3.2	0.0	0.2	0.1	1.1	1.0	1.1	0.0	3.4	0.0	0.6	0.0	0.6	0.9	1.7	0.0	0.0	0.5	1.7	0.0	0.0	1.1	1.1	0.0	0.4	0.2	0.0	1.6	0.3	0.0	0.4	0.3
NIM1K	"MGC42105, NIM1"	ENSG00000177453	"NIM1 serine/threonine protein kinase"	Q8IY84	5	43192071-43280850	"Enzymes, Predicted membrane proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in many"	5	"brain: 23.7;pituitary gland: 9.7"	"Cell type enhanced"	"Detected in some"	16	"Bipolar cells: 7.1;Cone photoreceptor cells: 5.9;Horizontal cells: 17.5;Muller glia cells: 8.2;Rod photoreceptor cells: 6.1"	"Cancer enriched"	"Detected in some"	11	"glioma: 6.2"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"T-reg: 3.2"	"Group enriched"	"Detected in many"	10	"dendritic cells: 1.2;T-cells: 3.2"	"Cell line enhanced"	"Detected in some"		"BJ hTERT+ SV40 Large T+ RasG12V: 4.5;HDLM-2: 4.9;PC-3: 5.6;U-87 MG: 6.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA007695	Uncertain		Approved	Cytosol		NA	NA			Cytosol		"HPA007695: AB_2667897"	"unprognostic (7.97e-2)"	"unprognostic (9.79e-2)"	"unprognostic (8.74e-2)"	"unprognostic (2.10e-1)"	"unprognostic (1.67e-1)"	"unprognostic (2.17e-1)"	"unprognostic (2.40e-1)"	"unprognostic (4.35e-2)"	"unprognostic (1.35e-1)"	"unprognostic (4.28e-2)"	"unprognostic (8.84e-4)"	"unprognostic (1.25e-1)"	"unprognostic (1.55e-5)"	"unprognostic (2.18e-1)"	"unprognostic (2.66e-1)"	"unprognostic (6.46e-3)"	"unprognostic (4.98e-3)"	1.4	3.5	9.4	1.6	10.9	0.9	1.3	4.9	23.7	1.6	1.4	6.3	0.0	1.1	1.2	1.6	1.6	1.4	1.5	1.8	8.7	7.7	1.4	1.2	3.6	1.2	5.6	5.8	1.2	1.5	1.2	9.7	1.8	6.4	1.4	1.7	1.7	2.3	2.4	2.0	1.8	1.2	1.3	4.9	1.0	3.0	1.4	8.1	0.0	2.7	0.0	1.0	1.1	0.8	0.1	1.2	0.0	0.0	0.2	3.2	0.0	0.2	0.6	0.1	0.1	0.9	0.6	0.0	1.0	3.2	1.2	4.5	0.1	0.0	0.5	0.6	0.8	1.6	0.3	0.6	0.0	2.8	4.9	0.3	0.1	0.6	0.2	1.6	0.2	0.7	1.9	0.1	0.5	0.0	1.7	0.0	0.1	0.2	0.3	0.9	0.2	0.3	0.2	0.0	0.0	5.6	0.2	0.3	0.5	0.1	0.7	0.9	0.1	1.8	0.5	0.3	0.2	0.4	1.5	0.0	0.9	0.8	0.8	0.7	1.6	0.4	0.3	6.1	0.5	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.8	0.0	0.6	0.0	0.0	0.0	0.0	0.2	0.0	1.2	3.2	0.0	9.4	10.9	4.9	11.6	8.7	7.7	5.6	5.8	6.4	8.1	0.0	4.1	0.0	0.1	0.5	7.1	0.3	0.0	0.0	0.0	0.0	5.9	0.1	0.0	0.0	0.8	0.0	0.0	0.0	0.0	1.3	0.3	0.1	0.0	0.0	0.1	17.5	0.0	0.0	0.0	1.3	0.0	0.0	0.0	1.0	0.0	8.2	0.2	0.0	0.7	0.0	6.1	0.0	0.4	0.4	0.5	0.4	0.0	0.0	0.0	0.0
NIT2		ENSG00000114021	"Nitrilase family member 2"	Q9NQR4	3	100334701-100361635	"Enzymes, Plasma proteins, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 41.1"	"Cell type enhanced"	"Detected in many"	10	"Proximal tubular cells: 436.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036999, HPA041289"	Approved		Supported	Centrosome,Cytosol		NA	NA		960000	Cytosol	Centrosome	"HPA036999: AB_10672105, HPA041289: "	"unprognostic (3.27e-1)"	"unprognostic (1.29e-1)"	"unprognostic (7.06e-3)"	"prognostic unfavorable (4.62e-4)"	"unprognostic (6.28e-2)"	"unprognostic (2.10e-1)"	"unprognostic (4.56e-1)"	"unprognostic (1.12e-1)"	"unprognostic (6.60e-3)"	"unprognostic (2.21e-1)"	"unprognostic (6.68e-2)"	"unprognostic (7.92e-2)"	"unprognostic (1.37e-2)"	"unprognostic (4.48e-2)"	"unprognostic (1.29e-1)"	"unprognostic (8.26e-2)"	"unprognostic (1.47e-3)"	9.9	7.4	6.7	5.4	9.9	5.9	12.4	3.7	10.5	6.4	7.2	6.1	10.6	5.5	6.6	13.3	9.2	7.9	7.1	7.4	5.8	6.3	29.8	41.1	5.6	8.9	5.9	8.0	7.2	8.5	4.7	7.6	4.9	7.7	7.2	6.8	11.3	8.2	10.2	14.7	7.7	5.3	7.0	5.4	5.7	6.8	3.3	3.3	4.4	10.8	14.5	10.5	8.2	5.6	4.2	5.9	1.5	2.4	3.0	4.3	1.3	9.9	9.9	1.2	5.2	8.9	12.1	6.2	4.1	6.1	9.7	9.3	8.4	11.2	10.0	6.2	5.9	4.2	7.5	4.5	11.0	11.6	3.1	2.3	7.2	3.2	4.3	10.9	4.7	4.9	7.6	16.8	5.2	8.5	5.1	6.2	5.7	3.3	8.1	11.8	9.5	3.1	4.3	4.4	12.5	15.1	3.5	4.2	9.8	16.0	6.3	6.9	3.2	5.6	9.6	6.1	3.3	7.1	4.5	4.5	6.1	2.5	2.9	3.5	5.0	5.5	8.5	9.6	8.0	7.7	0.4	2.4	1.1	3.3	2.1	4.3	4.2	3.1	2.5	5.9	3.7	3.6	3.5	1.5	3.0	1.6	1.8	3.1	1.3	6.7	9.9	3.7	10.5	5.8	6.3	5.9	8.0	7.7	3.3	11.9	12.1	26.5	41.3	29.0	11.3	49.4	30.6	38.8	26.1	55.8	15.7	80.0	159.2	63.8	2.3	15.5	14.9	0.0	46.2	64.1	34.7	40.0	20.7	147.3	56.1	12.7	23.1	16.0	18.8	2.4	40.9	33.3	47.2	136.1	20.8	11.7	55.0	25.7	35.3	436.2	23.6	38.8	46.4	1.5	14.5	36.4	49.5	26.2	34.7	40.6
NKTR	p104	ENSG00000114857	"Natural killer cell triggering receptor"	P30414	3	42600614-42648741	"Enzymes, Predicted intracellular proteins"		"Isomerase, Rotamase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA022120, HPA051576"	Approved		Supported	"Nucleoplasm,Plasma membrane,Cytosol"		No	No			"Nucleoplasm, Plasma membrane, Cytosol"		"HPA022120: AB_1854513, HPA051576: AB_2681540"	"unprognostic (2.73e-3)"	"unprognostic (3.11e-1)"	"unprognostic (2.33e-1)"	"unprognostic (2.06e-1)"	"unprognostic (5.27e-3)"	"prognostic favorable (1.26e-4)"	"unprognostic (4.62e-2)"	"unprognostic (5.65e-2)"	"unprognostic (4.02e-2)"	"unprognostic (1.61e-1)"	"unprognostic (5.33e-2)"	"prognostic unfavorable (6.01e-4)"	"prognostic unfavorable (5.02e-4)"	"unprognostic (3.82e-1)"	"unprognostic (4.57e-1)"	"unprognostic (1.40e-1)"	"prognostic favorable (1.05e-5)"	12.9	14.4	9.8	18.8	22.2	16.3	15.9	42.0	12.3	18.8	10.4	18.5	15.4	11.8	27.2	17.4	11.0	12.0	13.1	11.2	10.9	10.5	9.5	9.7	14.6	15.5	14.5	11.3	22.7	18.4	19.2	26.9	11.1	14.1	12.9	11.1	20.4	13.2	19.5	12.0	20.0	13.3	19.4	15.0	18.5	10.1	17.8	13.8	20.6	14.9	10.9	19.4	12.9	13.9	9.3	8.5	11.7	10.0	11.1	10.2	3.6	8.9	5.2	17.2	7.0	10.3	12.6	9.7	14.6	3.7	6.1	8.3	9.0	7.2	14.2	7.0	4.4	6.0	7.9	10.1	3.7	12.5	7.1	8.5	18.2	16.3	14.6	4.4	14.0	12.0	5.1	7.2	12.0	4.6	11.1	10.7	3.4	18.3	11.0	11.5	3.7	9.5	13.7	14.8	4.8	7.6	10.1	7.7	5.8	8.5	6.9	6.1	3.6	15.7	6.5	2.4	8.0	9.6	10.2	17.1	10.9	8.0	11.9	14.0	9.5	13.3	9.9	5.8	17.2	6.7	9.2	6.2	11.7	10.2	7.7	9.4	8.9	9.8	8.5	4.7	9.3	10.0	8.7	9.1	11.1	10.0	8.5	8.3	3.6	9.8	22.2	42.0	12.3	10.9	10.5	14.5	11.3	14.1	13.8	101.3	122.0	67.1	53.1	52.4	190.3	63.1	50.9	45.5	75.1	83.7	231.7	56.8	14.9	39.7	13.6	120.9	75.7	23.3	34.0	42.2	62.5	58.7	92.6	44.7	39.4	125.5	69.0	103.2	49.9	13.7	155.3	72.2	49.0	62.3	51.5	160.2	38.7	44.6	126.2	9.7	283.7	90.5	58.5	210.1	183.7	50.1	26.2	126.8	54.0	42.1
NLK		ENSG00000087095	"Nemo like kinase"	Q9UBE8	17	28041737-28196381	"Enzymes, Predicted intracellular proteins"	"Transcription, Transcription regulation, Wnt signaling pathway"	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"Bipolar cells: 93.3;Cone photoreceptor cells: 145.3;Early spermatids: 243.8;Late spermatids: 250.1;Rod photoreceptor cells: 92.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	32	"basophil: 17.6"	"Lineage enriched"	"Detected in single"	32	"granulocytes: 17.6"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA018192, HPA056511"	Approved		Approved	"Nucleoplasm,Nucleoli,Cell Junctions"		NA	NA			Nucleoplasm	"Nucleoli, Cell Junctions"	"HPA018192: AB_1854525, HPA056511: AB_2683160"	"unprognostic (7.19e-2)"	"unprognostic (1.98e-1)"	"unprognostic (5.54e-2)"	"unprognostic (5.64e-3)"	"unprognostic (2.11e-1)"	"unprognostic (1.29e-1)"	"unprognostic (1.67e-2)"	"unprognostic (2.59e-3)"	"unprognostic (2.72e-2)"	"unprognostic (4.23e-3)"	"unprognostic (1.07e-2)"	"unprognostic (1.09e-2)"	"unprognostic (5.29e-2)"	"unprognostic (1.66e-1)"	"unprognostic (3.92e-1)"	"unprognostic (5.27e-2)"	"unprognostic (6.57e-2)"	6.4	30.5	19.4	10.9	14.1	7.4	7.5	7.5	38.2	6.2	6.7	8.3	14.4	8.3	5.7	8.8	4.5	5.1	8.2	8.5	18.2	12.0	13.0	8.2	7.1	11.7	15.2	23.6	4.6	11.5	20.8	9.4	9.1	7.0	6.7	7.1	12.7	5.8	17.4	4.9	4.5	8.3	4.6	15.3	10.1	7.0	17.4	7.5	10.9	13.2	3.7	11.0	7.2	4.4	0.5	0.3	17.6	0.3	0.1	0.5	0.2	4.6	5.4	13.0	4.5	2.8	3.6	5.8	4.7	4.8	7.8	6.0	27.1	4.2	6.3	7.1	3.8	9.9	4.4	9.2	8.5	9.0	14.6	5.8	24.8	5.0	4.6	4.7	5.2	25.6	4.7	5.3	5.1	6.2	7.6	9.1	18.0	9.5	7.7	7.1	5.5	13.4	6.0	5.0	9.1	2.7	11.2	8.4	4.6	14.2	5.7	9.5	3.6	7.1	6.8	29.1	16.4	10.6	8.3	9.3	5.6	7.6	4.6	9.4	9.0	8.6	6.1	5.5	5.7	6.1	17.6	0.2	0.2	0.3	0.3	0.1	0.5	0.4	0.4	0.2	0.3	0.2	0.5	0.1	0.1	0.3	0.3	0.4	0.2	19.4	14.1	7.5	38.2	18.2	12.0	15.2	23.6	7.0	7.5	20.8	5.9	4.7	3.5	4.7	93.3	23.0	10.2	6.7	4.5	31.4	145.3	2.5	1.7	3.3	243.8	10.6	5.9	0.0	5.5	3.0	3.7	5.4	24.2	8.9	7.2	35.0	27.1	10.4	14.2	250.1	5.2	5.0	15.1	4.6	9.4	9.4	5.7	7.0	2.5	6.3	92.4	12.9	3.9	25.8	9.5	4.3	5.4	5.1	8.3	5.8
NLN	"AGTBP, KIAA1226"	ENSG00000123213	Neurolysin	Q9BYT8	5	65722196-65871725	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	5	"classical monocyte: 4.7;intermediate monocyte: 5.9;myeloid DC: 4.1;non-classical monocyte: 4.1"	"Group enriched"	"Detected in many"	5	"dendritic cells: 4.1;monocytes: 5.9"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA031862	Approved		Approved	Mitochondria		Yes	No		53000	Mitochondria		"HPA031862: AB_10600827"	"unprognostic (5.91e-3)"	"unprognostic (4.52e-2)"	"unprognostic (1.34e-3)"	"unprognostic (4.37e-2)"	"unprognostic (3.85e-1)"	"unprognostic (1.45e-2)"	"unprognostic (7.29e-3)"	"unprognostic (3.24e-2)"	"unprognostic (3.19e-1)"	"unprognostic (3.58e-1)"	"prognostic unfavorable (7.51e-4)"	"unprognostic (1.27e-1)"	"prognostic favorable (5.58e-7)"	"unprognostic (1.52e-2)"	"unprognostic (1.98e-1)"	"unprognostic (1.29e-1)"	"unprognostic (6.18e-3)"	4.5	2.4	7.6	4.7	10.5	2.9	7.3	2.8	11.9	4.1	6.8	5.8	1.0	2.4	5.8	5.0	5.2	3.3	2.7	5.1	7.2	7.6	7.5	18.9	3.4	5.1	8.7	8.5	4.0	11.0	3.6	2.4	4.9	9.8	5.4	6.5	2.0	4.3	2.6	15.0	5.7	5.3	5.5	10.9	5.8	7.5	2.4	6.2	1.8	5.5	7.9	4.0	4.3	3.3	0.9	4.1	0.6	5.9	0.9	0.7	1.8	9.2	8.9	5.3	8.7	6.7	11.5	10.6	9.4	4.0	5.5	6.0	5.1	5.5	13.2	11.9	11.2	11.1	7.4	6.8	14.4	9.7	3.9	4.6	3.6	6.7	12.8	5.8	8.3	2.2	8.7	7.9	7.6	9.1	4.7	15.5	5.9	7.8	2.8	11.9	7.1	5.7	7.5	16.1	4.7	2.6	6.7	11.2	20.9	9.1	4.1	16.4	8.5	7.6	7.8	7.7	14.9	9.3	9.9	8.9	3.7	4.4	5.4	7.0	2.4	4.8	5.8	5.7	16.4	5.5	0.2	4.7	0.2	0.2	5.9	0.3	0.9	0.4	0.3	4.1	0.9	0.7	0.5	0.6	0.9	4.1	0.2	0.1	1.8	7.6	10.5	2.8	11.9	7.2	7.6	8.7	8.5	9.8	6.2	6.0	3.2	1.5	5.1	5.0	0.6	13.2	10.2	2.7	11.4	12.2	3.9	5.2	5.0	15.3	0.2	5.0	20.6	0.0	12.3	12.1	5.2	8.8	15.0	26.4	24.7	4.8	1.7	5.5	23.4	0.0	4.0	8.4	1.7	2.8	7.1	13.2	23.5	10.7	2.1	17.4	3.5	0.0	3.1	1.4	4.3	4.5	2.4	0.9	7.1	5.5
NME1	"NDPKA, NM23, NM23-H1"	ENSG00000239672	"NME/NM23 nucleoside diphosphate kinase 1"	P15531	17	51153536-51162428	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins"	"Differentiation, Endocytosis, Neurogenesis, Nucleotide metabolism"	"Kinase, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008467, CAB040571, HPA041113"	Supported		Supported	"Nucleoplasm,Plasma membrane,Cytosol"	"Intracellular and membrane"	NA	NA		28000000	Cytosol	"Nucleoplasm, Plasma membrane"	"CAB040571: , HPA008467: AB_1079492, HPA041113: AB_2677305"	"unprognostic (2.24e-1)"	"unprognostic (2.01e-1)"	"unprognostic (3.48e-3)"	"unprognostic (5.96e-2)"	"unprognostic (9.71e-2)"	"unprognostic (2.33e-3)"	"prognostic unfavorable (2.60e-5)"	"unprognostic (4.54e-2)"	"unprognostic (3.35e-1)"	"unprognostic (2.33e-3)"	"unprognostic (2.90e-2)"	"unprognostic (1.01e-1)"	"prognostic unfavorable (2.07e-9)"	"unprognostic (9.01e-2)"	"unprognostic (1.51e-1)"	"unprognostic (1.83e-1)"	"unprognostic (9.46e-2)"	25.0	29.5	38.0	28.1	30.1	27.9	29.0	19.6	41.9	16.4	25.4	13.1	10.1	15.1	17.3	22.5	30.1	22.2	13.4	14.1	41.7	39.4	19.6	56.0	14.2	28.5	34.2	34.2	15.6	43.6	13.7	17.3	16.9	38.9	14.5	36.8	14.9	34.3	14.7	14.8	22.4	12.4	29.6	20.5	22.4	13.4	11.6	11.3	19.0	18.8	32.7	41.4	22.8	15.2	24.9	36.2	0.6	19.5	17.2	20.3	18.4	46.6	93.2	32.2	44.9	13.5	21.6	54.1	36.4	25.3	75.5	57.3	73.3	28.3	82.1	38.0	33.6	30.0	25.1	61.5	61.9	64.6	39.8	82.8	53.8	72.4	101.8	27.4	59.0	24.7	20.5	39.0	56.8	53.2	13.3	45.5	26.4	79.4	27.3	44.7	79.0	70.1	67.8	38.6	103.3	85.0	43.0	63.6	75.6	57.9	32.6	44.7	51.5	19.1	52.3	33.9	28.8	54.4	39.9	28.6	48.7	44.2	30.3	74.7	35.2	81.2	96.7	29.5	50.1	37.0	0.2	15.2	0.6	13.4	19.5	20.3	24.9	14.4	14.6	36.2	17.3	16.4	17.8	0.4	17.2	11.5	20.7	12.1	18.4	38.0	30.1	19.6	41.9	41.7	39.4	34.2	34.2	38.9	11.3	29.8	22.5	33.5	67.6	117.7	287.4	27.7	63.7	36.1	59.1	68.0	269.0	166.3	127.6	180.3	23.8	58.6	14.6	46.7	172.7	210.0	82.7	60.4	46.0	102.6	183.6	38.1	86.1	27.0	26.9	65.0	56.7	62.9	123.2	55.9	70.8	61.6	165.1	38.6	55.2	140.8	268.7	12.9	66.0	19.8	83.3	116.3	74.0	40.6	110.8	81.0
NME2	"NDPKB, NM23-H2"	ENSG00000243678	"NME/NM23 nucleoside diphosphate kinase 2"	P22392	17	51165435-51171747	"Cancer-related genes, Enzymes, Predicted intracellular proteins"	"Nucleotide metabolism, Transcription, Transcription regulation"	"Activator, DNA-binding, Kinase, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"Ciliated cells: 115.1;Club cells: 150.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"CAB036213, CAB036214, CAB036215, HPA041113"	Approved		Supported	"Plasma membrane,Midbody ring,Cytosol"		NA	NA			Cytosol	"Plasma membrane, Midbody ring"	"CAB036213: , CAB036214: , CAB036215: , HPA041113: AB_2677305"	"unprognostic (7.21e-3)"	"prognostic unfavorable (4.74e-4)"	"unprognostic (4.85e-2)"	"unprognostic (1.15e-2)"	"unprognostic (8.86e-2)"	"unprognostic (1.42e-2)"	"prognostic unfavorable (7.09e-4)"	"unprognostic (6.62e-3)"	"unprognostic (5.68e-2)"	"unprognostic (2.31e-1)"	"unprognostic (1.38e-1)"	"unprognostic (6.41e-2)"	"prognostic unfavorable (1.55e-6)"	"unprognostic (2.82e-1)"	"unprognostic (9.09e-2)"	"unprognostic (8.87e-2)"	"unprognostic (3.19e-2)"	62.1	54.6	42.3	58.2	44.1	44.2	188.9	20.1	43.7	58.9	74.0	16.3	67.7	52.5	65.0	52.0	104.3	56.8	65.3	115.1	38.2	32.1	77.3	115.7	59.0	174.7	45.0	23.7	90.7	234.3	17.5	30.4	37.9	34.0	64.0	62.7	29.9	109.4	65.8	105.3	63.3	45.1	88.3	34.6	69.4	50.2	32.3	24.4	42.5	66.9	102.0	56.6	81.3	140.8	49.3	71.3	8.3	43.7	32.6	34.5	38.2	89.1	131.0	31.4	54.7	70.2	102.4	86.6	61.8	64.3	94.6	72.1	105.7	47.5	75.0	100.2	63.3	48.6	57.1	65.8	84.3	78.0	90.4	194.5	63.0	91.4	153.0	76.6	99.5	44.2	92.6	98.5	61.0	107.4	67.1	56.3	53.7	86.3	50.6	68.1	158.5	49.8	124.4	46.7	205.0	201.3	47.8	104.0	119.7	102.4	112.7	71.5	44.3	38.0	95.6	92.8	61.7	65.9	76.3	57.1	91.3	66.0	64.8	98.2	88.4	114.8	85.9	49.3	50.7	45.7	8.3	35.1	2.0	24.7	43.7	34.5	49.3	33.0	26.9	61.5	36.2	23.8	25.6	2.1	32.6	38.0	71.3	29.9	38.2	42.3	44.1	20.1	43.7	38.2	32.1	45.0	23.7	34.0	24.4	26.8	56.3	13.7	6.1	12.9	0.9	0.0	22.9	115.1	150.2	5.2	0.0	10.6	31.5	37.0	0.4	14.4	5.6	23.3	30.1	24.4	10.8	3.7	39.5	37.1	14.9	0.0	14.0	31.9	41.2	1.1	23.9	13.6	10.1	88.4	24.3	0.2	47.4	14.0	12.0	26.2	0.8	6.5	5.7	0.5	5.0	13.0	7.3	18.1	29.3	6.8
NME3	"DR-nm23, NDPKC, NM23-H3"	ENSG00000103024	"NME/NM23 nucleoside diphosphate kinase 3"	Q13232	16	1770286-1771730	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Apoptosis, Nucleotide metabolism"	"Kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HEK 293: 31.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041113, HPA052733"	Approved		Approved	Nucleoplasm,Cytosol	"Intracellular and membrane"	NA	NA		7900000	Nucleoplasm	Cytosol	"HPA041113: AB_2677305, HPA052733: AB_2681930"	"prognostic favorable (6.81e-5)"	"unprognostic (1.41e-1)"	"unprognostic (1.49e-1)"	"unprognostic (1.15e-3)"	"unprognostic (1.26e-1)"	"unprognostic (1.61e-1)"	"unprognostic (1.05e-1)"	"unprognostic (4.54e-2)"	"unprognostic (1.13e-1)"	"unprognostic (6.22e-3)"	"unprognostic (4.40e-2)"	"unprognostic (4.43e-2)"	"unprognostic (7.09e-3)"	"unprognostic (1.79e-1)"	"unprognostic (3.84e-1)"	"unprognostic (3.64e-1)"	"unprognostic (6.11e-3)"	20.6	45.6	18.0	12.9	19.8	6.6	20.0	21.9	18.2	16.6	18.0	11.0	31.6	25.7	14.4	19.1	12.9	14.3	21.5	11.8	17.5	16.1	17.7	11.2	17.3	11.3	18.4	15.9	22.1	26.8	15.1	24.1	9.7	14.4	26.9	6.4	13.8	34.3	41.4	15.2	9.2	24.6	14.6	14.1	20.4	17.5	7.2	14.6	5.1	24.1	11.7	8.8	11.5	17.9	19.3	34.1	15.5	25.6	20.1	24.4	20.0	0.7	11.7	0.2	9.6	2.7	1.4	1.1	6.8	2.0	1.2	0.9	0.0	14.0	0.1	19.2	0.9	1.2	10.0	0.6	3.8	0.1	13.7	31.3	0.0	5.5	5.5	5.2	2.3	4.4	6.4	3.5	1.2	0.7	2.3	2.5	0.1	4.7	1.9	1.2	17.0	0.2	4.6	12.5	2.3	9.5	6.5	0.1	18.3	2.0	0.5	13.7	10.6	20.7	15.6	1.7	0.5	14.9	5.6	8.7	2.6	9.7	8.3	4.6	5.0	1.5	1.0	3.5	0.4	5.8	4.9	25.6	15.5	17.5	22.9	17.1	19.3	24.4	16.4	22.0	16.3	21.4	16.8	5.3	20.1	24.5	34.1	21.8	20.0	18.0	19.8	21.9	18.2	17.5	16.1	18.4	15.9	14.4	14.6	32.8	63.8	51.1	124.1	64.5	115.4	25.8	76.5	58.9	55.7	120.4	56.9	65.8	51.4	53.1	16.8	69.7	85.0	0.0	33.3	35.7	82.8	109.1	50.7	52.9	65.1	62.0	130.1	72.4	57.8	13.2	138.4	78.5	77.6	175.9	94.2	102.4	38.5	89.7	119.9	123.2	117.3	116.4	86.4	1.4	41.7	57.3	38.6	61.8	96.6	69.8
NME4	"NDPKD, nm23-H4, NM23H4"	ENSG00000103202	"NME/NM23 nucleoside diphosphate kinase 4"	O00746	16	396725-410367	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Lipid transport, Nucleotide metabolism, Transport"	"Kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Distal tubular cells: 212.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB045997, HPA072588"	Approved		Supported	Mitochondria		Yes	No			Mitochondria		"CAB045997: AB_11126630, HPA072588: AB_2686538"	"unprognostic (3.27e-1)"	"prognostic unfavorable (6.53e-4)"	"unprognostic (3.70e-2)"	"unprognostic (7.16e-3)"	"unprognostic (1.32e-1)"	"unprognostic (2.00e-1)"	"unprognostic (4.40e-2)"	"unprognostic (4.46e-3)"	"unprognostic (1.98e-1)"	"unprognostic (3.12e-1)"	"unprognostic (3.74e-2)"	"unprognostic (7.79e-3)"	"prognostic unfavorable (1.61e-7)"	"unprognostic (3.78e-2)"	"unprognostic (2.16e-1)"	"unprognostic (6.04e-2)"	"unprognostic (3.08e-1)"	34.5	34.4	21.5	13.9	17.6	46.8	34.6	10.4	13.6	25.6	44.6	12.8	40.7	9.7	21.7	33.7	25.1	20.0	39.9	26.9	16.6	16.5	20.2	61.2	13.5	27.5	16.9	11.3	31.9	19.2	22.0	17.3	19.4	11.7	46.9	10.6	32.2	44.4	44.0	13.7	7.5	15.3	83.9	12.4	17.8	27.1	13.3	10.9	19.6	21.0	14.2	14.5	64.1	27.5	13.1	28.6	18.2	6.3	1.2	13.7	5.2	0.1	50.4	44.8	61.6	18.0	31.6	10.0	23.7	28.6	35.9	30.9	33.6	29.3	0.5	17.9	37.8	13.0	0.6	24.2	25.5	10.6	20.3	36.2	24.4	6.9	44.9	34.0	17.8	9.0	40.6	13.4	22.0	2.1	25.9	23.0	35.1	25.3	4.3	26.7	41.3	15.5	22.4	45.7	12.3	11.2	78.4	10.0	12.7	24.9	0.2	13.1	71.0	6.0	0.4	22.1	17.2	30.0	41.8	28.7	25.7	37.4	17.1	5.9	0.5	0.3	13.3	11.2	3.2	29.6	4.1	6.3	18.2	7.5	5.6	6.5	12.3	7.7	8.3	8.7	13.1	13.7	7.1	2.2	1.2	4.8	28.6	0.4	5.2	21.5	17.6	10.4	13.6	16.6	16.5	16.9	11.3	11.7	10.9	0.0	11.5	29.0	48.4	28.6	13.9	34.0	35.7	4.0	4.5	55.8	2.0	59.9	212.2	109.2	3.5	43.9	11.0	186.9	35.0	20.4	74.3	109.3	29.9	119.9	107.7	7.9	43.4	47.9	41.0	14.6	82.6	23.2	59.1	66.7	34.5	18.6	75.4	17.3	89.1	59.0	5.4	51.8	95.1	1.4	43.5	21.5	18.2	14.9	56.3	48.5
NME6	"IPIA-ALPHA, NM23-H6"	ENSG00000172113	"NME/NM23 nucleoside diphosphate kinase 6"	O75414	3	48290722-48301685	"Enzymes, Predicted intracellular proteins"	"Apoptosis, Nucleotide metabolism"	"Kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA017909	Approved		Approved	Vesicles		NA	NA			Vesicles		"HPA017909: AB_1854530"	"unprognostic (7.31e-3)"	"unprognostic (1.87e-1)"	"unprognostic (8.19e-3)"	"unprognostic (2.09e-2)"	"unprognostic (8.52e-2)"	"unprognostic (2.20e-1)"	"prognostic unfavorable (2.17e-7)"	"unprognostic (1.90e-1)"	"unprognostic (1.56e-1)"	"unprognostic (4.00e-3)"	"unprognostic (1.32e-1)"	"unprognostic (2.98e-1)"	"prognostic favorable (3.18e-5)"	"unprognostic (1.98e-2)"	"unprognostic (1.57e-2)"	"unprognostic (1.23e-1)"	"unprognostic (9.50e-2)"	11.7	12.2	7.0	14.4	11.0	7.7	13.5	9.2	10.9	12.2	12.0	11.9	14.6	13.5	16.1	13.2	16.1	16.3	8.8	13.7	9.9	6.8	18.0	17.5	11.1	12.9	9.2	10.3	14.5	20.6	12.1	13.3	22.1	8.8	13.2	12.7	13.5	20.8	17.6	20.1	10.3	13.4	13.3	7.1	14.2	13.4	9.0	8.2	12.6	17.5	14.3	15.1	13.9	15.7	26.4	23.5	43.3	22.7	23.0	25.8	14.3	17.9	11.2	15.3	11.1	12.5	16.8	13.7	17.6	13.6	25.9	19.7	18.7	15.8	18.1	9.2	13.7	24.3	6.3	13.7	19.4	15.4	21.6	13.3	11.8	15.0	15.2	16.7	14.9	12.7	13.7	21.3	23.0	27.4	12.4	13.9	13.7	19.7	14.0	9.7	8.5	12.5	6.4	12.9	12.7	14.7	7.4	13.4	15.2	13.0	15.5	4.7	8.1	12.0	13.2	15.7	12.4	14.8	13.9	12.4	5.1	20.4	12.7	25.0	16.6	22.4	16.3	9.7	19.8	11.3	22.0	20.1	43.3	25.8	20.7	23.6	26.4	24.2	21.9	23.5	24.4	18.7	17.7	22.5	23.0	22.7	21.1	19.4	14.3	7.0	11.0	9.2	10.9	9.9	6.8	9.2	10.3	8.8	8.2	26.8	20.2	17.6	7.9	4.4	12.2	9.2	20.4	44.2	21.6	8.7	13.7	42.3	33.2	22.4	1.9	8.3	11.2	0.0	26.1	34.3	7.8	7.3	9.3	8.3	29.6	9.5	4.1	6.7	6.7	1.5	10.9	12.4	15.1	29.7	8.8	14.6	25.4	7.0	6.7	12.8	12.2	12.9	7.4	9.1	13.2	3.6	16.5	13.8	12.8	5.9
NME7	"CFAP67, FLJ37194, NM23-H7"	ENSG00000143156	"NME/NM23 family member 7"	Q9Y5B8	1	169132531-169367967	"Enzymes, Predicted intracellular proteins"	"Nucleotide metabolism"	"Kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Ciliated cells: 72.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038014, HPA054289"	Approved		Approved	Mitochondria		NA	NA			Mitochondria		"HPA038014: AB_10673037, HPA054289: AB_2682437"	"unprognostic (1.28e-1)"	"unprognostic (8.52e-2)"	"unprognostic (6.21e-2)"	"unprognostic (6.30e-2)"	"unprognostic (1.11e-1)"	"unprognostic (7.44e-3)"	"prognostic unfavorable (3.24e-5)"	"unprognostic (1.42e-1)"	"unprognostic (1.96e-1)"	"unprognostic (2.90e-1)"	"unprognostic (1.05e-1)"	"unprognostic (2.00e-1)"	"unprognostic (6.63e-2)"	"unprognostic (2.67e-2)"	"unprognostic (1.12e-1)"	"unprognostic (7.75e-2)"	"unprognostic (2.74e-1)"	7.7	12.1	13.5	8.0	22.8	3.7	12.8	14.6	16.8	15.6	11.5	5.5	13.4	4.6	16.0	15.8	8.6	31.1	11.2	8.4	18.9	11.3	13.9	8.6	8.9	6.0	9.5	11.5	17.0	8.1	18.9	39.9	5.6	15.6	9.6	6.7	9.3	5.9	14.3	5.1	4.9	5.5	17.2	9.5	5.2	8.1	17.2	9.6	11.9	15.9	5.8	7.0	10.0	8.2	8.5	5.2	1.7	7.1	9.1	12.0	4.7	10.5	11.3	12.3	9.6	12.4	12.5	4.4	7.3	11.1	13.3	16.9	6.4	16.0	3.1	13.4	6.5	18.4	7.4	6.9	15.8	21.8	11.0	5.7	5.6	10.8	6.5	8.5	10.2	3.6	9.1	9.6	13.4	18.2	19.2	19.0	9.6	5.3	4.3	13.3	3.4	9.2	7.5	12.1	12.7	11.6	7.2	13.3	6.8	21.6	3.1	13.3	19.2	11.1	3.3	8.2	14.4	11.4	7.4	11.4	8.3	27.5	7.3	17.7	5.2	8.8	6.5	9.1	3.6	8.2	1.4	3.3	1.7	8.3	5.1	10.1	8.5	10.8	8.8	5.2	7.0	9.3	10.6	1.0	9.1	7.1	4.4	12.0	4.7	13.5	22.8	14.6	16.8	18.9	11.3	9.5	11.5	15.6	9.6	6.0	7.5	8.2	29.3	12.8	17.2	4.1	15.3	72.3	15.9	26.2	23.6	6.8	19.9	22.8	19.4	13.7	2.6	0.0	7.9	6.3	18.5	7.6	20.8	10.4	12.0	27.0	16.8	11.1	4.0	7.9	16.7	8.2	8.5	2.8	3.9	18.0	13.9	6.0	19.4	30.7	61.3	19.4	17.5	51.2	20.0	8.9	2.3	14.1	6.6	17.3
NMNAT1	"LCA9, NMNAT, PNAT1"	ENSG00000173614	"Nicotinamide nucleotide adenylyltransferase 1"	Q9HAN9	1	9943428-9985501	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Pyridine nucleotide biosynthesis"	"Nucleotidyltransferase, Transferase"	"Disease mutation, Leber congenital amaurosis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA059447	Approved		Supported	"Nucleoplasm,Nuclear bodies"		NA	NA			"Nucleoplasm, Nuclear bodies"		"HPA059447: AB_2684022"	"unprognostic (1.94e-1)"	"unprognostic (3.81e-3)"	"unprognostic (7.54e-3)"	"unprognostic (1.01e-1)"	"unprognostic (3.50e-1)"	"unprognostic (1.73e-1)"	"unprognostic (1.56e-1)"	"unprognostic (2.29e-1)"	"unprognostic (4.45e-3)"	"unprognostic (4.55e-2)"	"unprognostic (1.12e-1)"	"unprognostic (3.57e-1)"	"prognostic favorable (3.85e-14)"	"unprognostic (3.11e-3)"	"unprognostic (1.17e-1)"	"unprognostic (1.47e-3)"	"unprognostic (5.16e-2)"	7.2	13.2	8.1	7.2	9.0	4.0	8.8	4.1	8.1	8.8	12.8	9.3	11.9	8.9	10.1	8.8	8.7	7.4	7.3	13.9	7.6	6.8	11.5	12.6	5.3	5.6	10.3	8.3	5.1	14.1	10.3	9.3	5.6	13.0	7.0	13.6	10.1	17.7	8.4	29.1	8.1	9.2	8.3	9.0	8.6	7.1	10.7	8.3	6.8	10.8	11.5	6.8	6.2	10.4	5.3	4.3	12.8	4.9	3.1	2.7	2.3	3.8	4.7	6.6	6.3	12.6	11.4	1.6	7.5	6.2	8.8	5.7	2.0	6.5	4.1	4.9	11.4	3.7	3.9	8.0	10.8	10.6	8.4	4.1	6.7	2.9	6.2	10.0	5.5	6.6	12.1	12.1	10.6	15.3	8.3	9.2	9.0	7.8	2.7	9.7	6.5	3.1	3.5	0.8	8.6	8.5	3.6	4.0	2.1	10.2	2.1	4.7	2.5	9.9	8.5	8.5	3.6	3.2	5.9	8.6	3.7	3.2	7.4	3.5	3.9	3.7	4.0	6.2	11.6	7.4	6.6	4.9	3.9	2.4	3.3	1.1	5.3	2.3	2.7	4.2	3.6	2.1	2.5	12.8	3.1	4.5	4.3	1.9	2.3	8.1	9.0	4.1	8.1	7.6	6.8	10.3	8.3	13.0	8.3	3.0	4.1	1.7	5.2	2.1	7.7	11.8	5.1	8.1	3.4	7.0	5.9	8.3	19.9	7.9	5.8	6.8	17.0	0.0	6.0	4.2	3.7	4.5	4.6	7.3	11.2	9.5	2.9	6.7	6.9	3.2	6.1	8.6	5.0	11.8	7.7	8.5	6.4	3.5	6.0	11.3	6.3	6.5	4.2	11.1	8.3	1.6	7.6	2.9	12.8	4.1
NMNAT2	"C1orf15, KIAA0479, PNAT2"	ENSG00000157064	"Nicotinamide nucleotide adenylyltransferase 2"	Q9BZQ4	1	183248237-183418602	"Enzymes, Predicted intracellular proteins"	"Pyridine nucleotide biosynthesis"	"Nucleotidyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 53.9"	"Cell type enhanced"	"Detected in some"	14	"Cardiomyocytes: 30.1;Early spermatids: 50.3;Horizontal cells: 19.1;Late spermatids: 19.5;Sertoli cells: 19.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HSkMC: 12.9;SCLC-21H: 37.5;SuSa: 12.3;U-2197: 21.9;U-87 MG: 17.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA015708, HPA061714"	Enhanced		Approved	Cytosol		NA	NA			Cytosol		"HPA015708: , HPA061714: AB_2732669"	"unprognostic (3.70e-1)"	"unprognostic (7.98e-3)"	"unprognostic (8.83e-2)"	"unprognostic (4.16e-2)"	"unprognostic (8.95e-2)"	"unprognostic (9.96e-2)"	"unprognostic (1.81e-1)"	"unprognostic (1.35e-1)"	"unprognostic (7.92e-2)"	"unprognostic (8.09e-2)"	"unprognostic (1.33e-2)"	"unprognostic (3.20e-1)"	"unprognostic (2.73e-3)"	"unprognostic (2.90e-3)"	"unprognostic (1.87e-1)"	"unprognostic (7.51e-2)"	"unprognostic (1.02e-1)"	9.6	7.7	26.2	1.9	34.5	1.0	2.9	53.9	53.5	3.6	2.2	2.0	0.0	1.5	2.5	2.7	1.9	3.8	4.1	19.6	20.6	15.1	1.5	1.1	1.8	1.7	8.6	28.3	1.5	2.9	1.3	17.4	2.0	15.6	1.3	2.1	0.5	1.5	4.1	1.3	1.7	2.0	2.7	4.1	1.2	2.1	8.7	6.3	0.0	7.2	0.0	1.7	1.9	0.7	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.6	0.2	2.5	0.0	1.5	6.2	2.2	1.6	4.1	0.8	0.2	1.2	2.4	0.0	6.8	0.4	0.7	1.0	0.1	0.0	1.6	0.0	0.0	0.0	0.9	0.0	0.2	0.0	0.0	12.9	0.5	1.0	0.2	5.3	0.2	0.0	0.0	0.0	1.0	0.0	0.0	0.2	4.4	0.0	2.4	0.0	0.1	0.0	2.8	2.0	37.5	2.9	0.3	0.1	0.0	12.3	0.3	0.6	1.4	1.2	0.4	21.9	1.5	0.3	0.0	0.0	17.1	0.1	0.1	0.0	0.7	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	26.2	34.5	53.9	34.7	20.6	15.1	8.6	28.3	15.6	6.3	0.0	1.0	0.0	0.2	0.7	10.7	30.1	0.0	2.7	3.4	0.0	0.0	0.6	0.0	0.1	50.3	2.9	0.0	0.0	0.0	9.6	0.4	0.1	0.0	0.0	0.5	19.1	0.0	0.0	0.6	19.5	0.0	0.5	1.7	0.0	0.0	0.3	0.5	0.0	0.0	0.0	1.6	19.4	5.0	0.5	0.2	0.3	1.1	0.0	0.0	0.0
NMNAT3	PNAT3	ENSG00000163864	"Nicotinamide nucleotide adenylyltransferase 3"	Q96T66	3	139560180-139678017	"Enzymes, Predicted intracellular proteins"	"Pyridine nucleotide biosynthesis"	"Nucleotidyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	10	"Alveolar cells type 1: 527.0;Alveolar cells type 2: 437.0;Ciliated cells: 459.0;Club cells: 396.9;granulocytes: 256.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HEL: 22.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA039077, HPA057402"	Approved		Supported	Mitochondria		NA	NA			Mitochondria		"HPA039077: AB_2676336, HPA057402: AB_2683427"	"unprognostic (9.45e-3)"	"prognostic favorable (9.67e-4)"	"unprognostic (2.29e-1)"	"unprognostic (1.56e-3)"	"unprognostic (2.33e-2)"	"unprognostic (2.33e-1)"	"unprognostic (2.77e-3)"	"unprognostic (6.22e-2)"	"unprognostic (9.69e-2)"	"unprognostic (1.92e-1)"	"prognostic favorable (7.29e-5)"	"unprognostic (4.57e-2)"	"prognostic favorable (1.95e-5)"	"unprognostic (4.13e-2)"	"unprognostic (1.63e-1)"	"unprognostic (1.44e-1)"	"unprognostic (3.07e-1)"	6.2	6.3	9.9	7.0	9.8	14.1	10.8	7.7	9.8	7.4	7.4	6.8	2.7	7.8	7.9	7.3	6.5	11.6	7.9	12.6	11.9	8.1	7.9	6.2	4.7	3.6	7.7	14.0	17.9	10.0	6.2	6.6	1.8	6.7	7.6	6.4	12.7	7.5	4.8	21.9	14.9	6.5	7.3	7.0	4.2	4.8	16.8	8.4	2.4	8.3	9.0	4.8	6.3	6.8	7.2	4.2	11.9	5.0	6.1	5.1	2.1	6.8	3.0	3.3	3.7	0.8	0.7	4.4	2.9	0.4	0.5	0.4	3.9	5.2	4.8	8.8	0.6	3.3	3.5	2.3	1.0	0.7	4.4	3.9	22.3	6.3	5.0	1.8	4.2	4.3	1.2	5.8	0.9	1.4	7.0	0.5	2.9	3.9	10.6	0.5	4.7	4.0	3.7	7.5	12.0	2.9	3.5	3.7	3.2	1.0	5.2	7.2	4.4	6.9	3.8	2.5	6.5	9.5	11.2	3.9	4.7	10.4	5.6	4.3	17.6	8.3	3.4	3.2	6.7	4.3	11.9	5.0	3.0	4.1	4.5	3.0	3.6	3.6	3.4	3.6	7.2	5.1	5.1	10.8	6.1	4.4	4.2	2.2	2.1	9.9	9.8	7.7	9.8	11.9	8.1	7.7	14.0	6.7	8.4	527.0	437.0	3.0	5.2	3.7	2.5	7.5	2.5	459.0	396.9	8.7	3.9	0.3	10.0	2.6	101.2	2.3	2.0	0.0	2.7	0.3	4.7	3.7	256.9	2.1	1.9	1.6	6.4	3.1	2.6	164.7	7.2	4.0	6.8	0.0	5.5	7.8	0.7	3.5	6.0	12.0	18.2	6.5	1.2	39.2	2.6	8.4	0.1	0.0	11.4	3.8
NMRK1	"bA235O14.2, C9orf95, FLJ20559, NRK1"	ENSG00000106733	"Nicotinamide riboside kinase 1"	Q9NWW6	9	75060573-75088217	"Enzymes, Predicted intracellular proteins"	"Pyridine nucleotide biosynthesis"	"Kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"monocytes: 102.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 29.9;Karpas-707: 36.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA049795	Approved		Approved	Nucleoplasm,Centrosome,Cytosol		NA	NA			"Nucleoplasm, Cytosol"	Centrosome	"HPA049795: AB_2680886"	"unprognostic (1.12e-1)"	"unprognostic (4.13e-2)"	"unprognostic (3.58e-2)"	"prognostic favorable (3.70e-6)"	"unprognostic (3.56e-2)"	"unprognostic (2.35e-1)"	"unprognostic (5.20e-3)"	"unprognostic (2.21e-2)"	"unprognostic (3.27e-2)"	"unprognostic (2.43e-1)"	"unprognostic (2.06e-2)"	"unprognostic (1.78e-1)"	"prognostic favorable (5.60e-4)"	"unprognostic (9.25e-2)"	"unprognostic (1.76e-1)"	"unprognostic (5.28e-2)"	"unprognostic (5.64e-2)"	15.5	7.7	11.1	15.9	10.7	6.9	14.3	21.5	14.6	13.2	15.2	5.8	20.1	12.2	8.1	15.6	24.6	9.4	10.9	9.4	10.2	9.7	22.1	40.3	15.4	19.9	10.8	9.7	15.2	30.6	45.8	18.1	19.7	10.2	15.9	10.3	10.9	29.5	17.7	15.0	15.6	26.6	8.3	8.7	18.8	13.6	6.7	8.9	14.4	31.6	11.2	22.0	12.6	14.8	6.7	8.8	7.3	6.7	8.2	24.2	10.1	5.1	1.1	1.5	3.5	12.2	16.5	8.3	7.5	11.8	1.9	3.1	0.0	13.6	3.0	4.5	7.2	3.6	9.0	1.7	5.0	6.0	29.9	1.8	2.1	2.4	2.6	10.9	2.0	0.4	11.4	12.9	3.1	6.4	11.4	13.0	5.2	0.2	36.8	13.2	3.8	1.9	1.8	1.9	19.4	4.7	0.6	13.5	19.3	15.3	9.2	1.0	0.2	3.2	3.3	4.2	10.3	8.5	2.2	8.9	6.5	1.2	5.9	2.0	16.3	13.0	1.8	10.6	2.2	6.6	7.3	2.7	4.5	13.9	2.5	16.7	6.7	24.2	16.0	3.1	3.9	22.1	16.7	5.2	8.2	6.7	8.8	15.4	10.1	11.1	10.7	21.5	14.6	10.2	9.7	10.8	9.7	10.2	8.9	35.7	17.1	17.1	33.3	18.7	8.5	15.1	15.3	20.1	22.7	22.7	7.9	52.7	44.7	25.5	14.0	20.7	33.3	0.0	31.3	65.3	17.5	21.3	1.1	34.4	51.6	11.1	4.1	39.3	19.7	24.5	21.9	10.5	25.3	102.8	28.0	9.6	23.2	24.6	11.7	75.6	7.6	12.9	15.2	6.6	3.8	23.6	38.1	29.9	22.4	26.0
NMRK2	"ITGB1BP3, MIBP, NRK2"	ENSG00000077009	"Nicotinamide riboside kinase 2"	Q9NPI5	19	3933103-3942416	"Enzymes, Predicted intracellular proteins"	"Pyridine nucleotide biosynthesis"	"Kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	10	"heart muscle: 271.6;skeletal muscle: 103.2"	"Cell type enriched"	"Detected in single"	1346	"Cardiomyocytes: 751.9"	"Cancer enhanced"	"Detected in some"		"renal cancer: 32.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"BEWO: 22.8;NTERA-2: 18.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA049909, HPA054792, HPA072450"	Approved		Enhanced	Nucleoplasm,Vesicles		NA	NA			Nucleoplasm	Vesicles	"HPA049909: , HPA054792: AB_2682601, HPA072450: AB_2686522"				"unprognostic (3.61e-1)"	"unprognostic (5.92e-2)"	"unprognostic (1.18e-2)"		"unprognostic (2.54e-1)"	"unprognostic (1.03e-1)"	"unprognostic (7.61e-2)"		"unprognostic (3.30e-2)"	"prognostic favorable (1.19e-4)"	"unprognostic (1.72e-1)"	"unprognostic (3.29e-2)"	"unprognostic (5.38e-1)"		0.2	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.5	1.0	0.0	0.0	271.6	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.4	0.0	1.0	1.9	0.1	103.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.4	18.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	22.8	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	18.9	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	2.8	5.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	751.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0
NMT1	NMT	ENSG00000136448	"N-myristoyltransferase 1"	P30419	17	45051610-45109016	"Enzymes, Predicted intracellular proteins"		"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	6	"Hepatocytes: 304.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA022949, HPA022963"	Supported		Supported	"Plasma membrane,Cytosol"		NA	NA			Cytosol	"Plasma membrane"	"HPA022949: AB_1854534, HPA022963: AB_1854535"	"unprognostic (1.40e-1)"	"unprognostic (2.87e-1)"	"unprognostic (1.30e-2)"	"unprognostic (6.14e-2)"	"unprognostic (1.65e-1)"	"unprognostic (1.64e-1)"	"prognostic unfavorable (4.94e-4)"	"unprognostic (4.96e-3)"	"unprognostic (3.86e-1)"	"unprognostic (3.04e-2)"	"unprognostic (2.19e-1)"	"unprognostic (1.98e-1)"	"unprognostic (3.77e-3)"	"unprognostic (1.01e-2)"	"unprognostic (4.89e-2)"	"unprognostic (4.17e-3)"	"unprognostic (9.45e-2)"	28.8	32.6	44.9	28.2	37.3	12.0	26.1	34.5	64.3	23.7	24.4	17.2	22.9	23.4	27.3	29.3	26.6	30.9	17.3	26.8	37.7	29.6	28.8	36.6	26.7	27.2	27.7	43.6	29.3	21.8	41.6	23.7	32.7	38.1	23.7	23.1	18.1	34.9	30.1	75.5	28.8	24.8	30.1	36.6	28.2	23.4	26.1	34.0	20.7	29.4	18.6	30.9	25.1	43.3	10.2	18.2	7.6	9.3	7.4	10.0	3.3	17.0	22.6	19.5	17.2	35.3	22.8	20.5	19.0	25.2	37.1	30.6	25.2	14.7	20.5	27.6	26.1	26.6	16.1	33.5	26.6	34.4	52.1	23.4	20.4	15.1	24.8	23.2	26.3	24.6	28.7	24.2	27.5	21.9	19.9	24.8	21.0	32.3	10.4	20.6	14.6	31.9	17.9	18.2	31.4	23.6	21.9	29.1	15.6	29.3	15.8	16.3	14.7	12.0	11.0	17.2	34.8	23.7	20.9	19.9	22.7	17.4	18.2	25.3	16.2	23.0	20.5	24.3	14.8	23.9	6.5	8.1	7.6	7.9	9.3	7.2	10.2	7.8	9.3	6.6	7.6	10.0	7.6	5.3	7.4	6.9	18.2	7.5	3.3	44.9	37.3	34.5	64.3	37.7	29.6	27.7	43.6	38.1	34.0	35.7	35.1	55.6	14.2	12.4	85.1	38.9	94.3	16.0	27.3	66.3	110.0	63.6	66.3	62.0	17.1	41.3	50.2	116.8	61.6	49.6	39.9	11.1	22.0	304.8	40.7	122.3	48.9	77.3	77.9	6.8	50.9	41.1	10.1	108.2	32.8	38.5	58.3	45.6	48.1	45.3	119.2	58.2	14.4	60.6	32.8	12.3	68.4	41.5	52.5	15.0
NMT2		ENSG00000152465	"N-myristoyltransferase 2"	O60551	10	15102584-15168693	"Enzymes, Predicted intracellular proteins"		"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"granulocytes: 89.2;Hepatocytes: 122.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	6	"basophil: 8.7;eosinophil: 7.9;gdT-cell: 7.2;MAIT T-cell: 12.9;memory CD4 T-cell: 11.5;memory CD8 T-cell: 8.3;naive CD4 T-cell: 14.7;naive CD8 T-cell: 9.3;NK-cell: 12.9;T-reg: 17.5"	"Group enriched"	"Detected in many"	7	"granulocytes: 8.7;NK-cells: 12.9;T-cells: 17.5"	"Cell line enhanced"	"Detected in many"		"fHDF/TERT166: 33.8;TIME: 49.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA001303	Approved		Supported	"Golgi apparatus,Plasma membrane,Cytosol"		NA	NA			"Golgi apparatus, Plasma membrane, Cytosol"		"HPA001303: AB_1079494"	"unprognostic (1.08e-1)"	"unprognostic (7.65e-2)"	"unprognostic (8.78e-2)"	"unprognostic (1.15e-3)"	"unprognostic (6.97e-2)"	"unprognostic (2.24e-1)"	"unprognostic (7.11e-2)"	"unprognostic (5.13e-2)"	"unprognostic (3.20e-1)"	"unprognostic (4.01e-3)"	"unprognostic (3.31e-1)"	"unprognostic (2.00e-1)"	"unprognostic (7.06e-2)"	"unprognostic (3.79e-3)"	"unprognostic (2.00e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.16e-1)"	29.3	5.4	18.9	6.5	17.3	3.8	19.2	35.6	25.3	12.0	9.9	6.0	4.7	7.4	14.5	5.0	8.2	8.9	8.1	9.6	12.8	9.2	10.8	18.5	7.2	9.0	8.8	15.0	18.2	7.1	28.5	7.9	5.1	10.3	10.7	10.7	8.3	5.8	9.4	18.8	11.5	11.9	12.5	10.3	10.1	8.8	14.5	9.9	23.7	6.9	4.5	8.9	10.1	20.1	1.9	0.3	8.7	0.5	12.9	17.5	3.9	2.8	3.6	4.2	3.1	11.5	12.4	0.8	6.2	5.0	5.7	7.8	3.5	12.7	0.1	4.3	33.8	15.7	3.5	3.7	3.5	9.6	3.7	4.8	7.6	1.8	4.8	7.7	0.5	28.3	11.0	3.6	8.1	2.4	20.9	22.0	5.3	3.6	0.5	21.2	3.5	5.8	1.4	3.1	3.2	3.5	4.3	6.2	0.5	4.2	0.6	1.2	4.8	7.5	1.2	2.0	3.7	3.8	2.3	49.0	5.7	8.4	25.0	4.4	4.3	4.5	0.3	7.0	2.0	4.1	8.7	0.3	7.9	7.2	0.4	12.9	1.4	11.5	8.3	0.3	1.9	14.7	9.3	1.2	12.9	0.5	0.2	17.5	3.9	18.9	17.3	35.6	25.3	12.8	9.2	8.8	15.0	10.3	9.9	8.9	9.1	18.2	17.3	14.7	21.8	11.1	76.5	5.3	14.8	26.2	3.9	0.8	8.3	23.8	6.4	20.4	30.1	46.7	16.8	2.1	11.6	13.9	89.2	122.4	2.4	19.1	17.2	24.5	6.9	9.6	20.1	6.5	11.8	13.6	9.9	12.0	21.3	12.2	19.4	44.1	14.9	0.0	15.3	7.4	50.5	12.9	2.2	38.3	16.9	13.4
NNMT		ENSG00000166741	"Nicotinamide N-methyltransferase"	P40261	11	114257787-114313285	"Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"		"Methyltransferase, Transferase"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 97.7"	"Cell type enriched"	"Detected in many"	9	"Hepatocytes: 3284.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HSkMC: 68.8;LHCN-M2: 40.9;RPTEC TERT1: 105.9"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			HPA059180	Approved		Approved	"Golgi apparatus,Cytosol"		NA	NA		15000	"Golgi apparatus"	Cytosol	"HPA059180: AB_2683940"	"unprognostic (1.62e-1)"	"unprognostic (2.33e-2)"	"unprognostic (1.61e-2)"	"unprognostic (6.14e-2)"	"unprognostic (3.51e-1)"	"prognostic unfavorable (2.07e-4)"	"unprognostic (1.76e-1)"	"unprognostic (5.84e-2)"	"unprognostic (2.71e-2)"	"unprognostic (2.48e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.69e-2)"	"prognostic unfavorable (1.02e-6)"	"prognostic unfavorable (1.75e-4)"	"unprognostic (1.11e-1)"	"unprognostic (3.37e-3)"	"unprognostic (2.77e-2)"	23.7	1.4	0.6	8.8	0.9	0.1	14.6	0.6	1.7	13.1	8.5	0.7	4.9	0.5	15.8	8.7	12.0	8.3	15.3	8.2	1.6	0.0	4.7	97.7	10.0	3.4	1.1	0.6	11.2	2.0	0.6	2.6	8.6	3.3	9.6	3.3	1.6	3.6	6.7	18.3	8.2	4.3	12.4	1.5	5.8	5.1	7.3	0.6	1.3	5.3	2.2	3.1	10.9	35.3	0.6	0.1	0.7	0.2	0.0	0.9	0.0	0.0	4.8	0.0	4.3	24.8	32.2	0.0	6.1	16.3	9.8	19.5	0.0	6.6	0.0	21.8	12.5	1.3	0.0	0.0	2.2	9.9	0.0	0.0	0.0	7.6	0.0	33.8	0.0	0.0	68.8	23.8	6.9	10.3	8.2	13.5	0.0	0.0	0.0	40.9	0.0	0.0	0.0	0.0	0.0	0.1	0.0	27.4	0.0	105.9	0.0	0.0	0.0	30.7	0.0	0.0	1.5	0.0	0.0	9.5	5.6	22.6	8.7	1.0	0.0	0.0	0.0	1.7	0.0	0.4	0.0	0.2	0.0	0.2	0.1	0.9	0.2	0.0	0.2	0.1	0.6	0.0	0.2	0.7	0.0	0.0	0.1	0.0	0.0	0.6	0.9	0.6	1.7	1.6	0.0	1.1	0.6	3.3	0.6	41.7	380.8	30.2	10.6	92.0	0.5	4.0	76.5	18.7	20.5	76.8	0.0	0.9	8.3	207.6	0.2	191.1	0.0	163.5	133.3	1.9	375.3	11.6	12.8	3284.1	21.8	0.0	5.1	176.1	103.2	1.0	68.7	12.7	91.1	10.0	0.0	0.0	366.0	0.0	12.4	27.9	0.1	0.0	113.1	0.3	0.4	80.5	1.8	46.0	0.0	2.4
NNT		ENSG00000112992	"Nicotinamide nucleotide transhydrogenase"	Q13423	5	43602692-43707405	"Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"		Translocase	"Disease mutation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 100.0"	"Group enriched"	"Detected in many"	6	"Cardiomyocytes: 303.5;Hepatocytes: 274.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"							"Low region specificity"	"Detected in all"			"HPA004829, CAB004975"	Enhanced		Approved	Mitochondria,Cytosol		NA	NA		1100000	Mitochondria	Cytosol	"CAB004975: AB_425908, HPA004829: AB_1079495"	"unprognostic (1.51e-1)"	"unprognostic (1.07e-1)"	"unprognostic (3.33e-2)"	"unprognostic (4.81e-2)"	"unprognostic (5.02e-2)"	"unprognostic (1.81e-1)"	"unprognostic (4.04e-2)"	"unprognostic (1.96e-3)"	"unprognostic (2.20e-2)"	"unprognostic (3.98e-2)"	"unprognostic (1.65e-1)"	"unprognostic (8.33e-2)"	"prognostic favorable (1.22e-15)"	"unprognostic (8.24e-2)"	"unprognostic (1.11e-1)"	"unprognostic (2.76e-2)"	"unprognostic (2.58e-1)"	10.8	10.5	11.7	8.3	14.0	7.3	9.1	8.3	19.0	7.6	11.2	7.3	8.8	9.2	7.1	8.8	7.9	5.4	7.1	62.1	10.8	8.2	26.0	48.5	7.2	9.6	9.2	10.3	5.8	12.2	15.6	6.2	5.8	10.0	8.5	12.1	6.7	14.4	7.8	100.0	6.0	8.9	14.7	6.1	6.5	13.6	4.2	6.1	14.0	14.0	32.6	8.7	10.9	6.2	11.4	25.5	13.1	18.5	18.2	19.1	13.5	8.3	6.2	14.3	26.6	16.7	18.6	4.5	8.4	14.4	10.4	9.4	7.1	13.9	8.6	10.5	16.0	11.0	8.0	56.7	2.0	11.0	13.6	15.3	12.4	33.3	8.7	9.6	20.7	18.5	16.0	6.3	5.9	8.5	18.2	20.5	12.5	8.9	34.4	24.7	5.7	22.3	11.2	2.8	0.0	5.6	25.1	33.8	30.8	19.7	7.4	21.1	17.6	30.9	0.4	19.1	3.1	21.6	20.9	11.2	15.2	14.8	6.3	4.1	18.5	19.0	13.2	3.1	27.7	9.8	9.3	14.2	13.1	14.4	18.4	14.8	11.4	15.6	14.5	25.5	10.3	14.6	13.3	2.4	18.2	18.5	9.2	19.1	13.5	11.7	14.0	8.3	19.0	10.8	8.2	9.2	10.3	10.0	6.1	50.6	27.8	20.7	7.7	10.2	17.5	303.5	28.1	24.1	31.8	26.2	33.4	7.2	23.2	10.7	12.2	12.6	17.2	23.3	9.3	2.1	17.9	10.5	23.3	274.2	21.7	6.4	19.1	20.3	31.4	3.4	13.8	18.2	13.5	10.8	24.6	13.2	9.5	11.5	18.0	21.1	11.9	0.0	15.1	2.1	1.2	7.0	1.7	27.7	25.8	7.6
NOCT	"Ccr4c, CCR4L, CCRN4L, NOC"	ENSG00000151014	Nocturnin	Q9UK39	4	139015789-139045939	"Enzymes, Predicted intracellular proteins"	"Biological rhythms"	"Hydrolase, Repressor, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 38.7"	"Cell type enhanced"	"Detected in many"	8	"Alveolar cells type 1: 8.9;Cone photoreceptor cells: 13.7;Extravillous trophoblasts: 7.7;Syncytiotrophoblasts: 10.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA012287, HPA053714"	Uncertain		Supported	"Nucleoplasm,Nuclear bodies,Cytosol"		NA	NA			"Nuclear bodies"	"Nucleoplasm, Cytosol"	"HPA012287: AB_2668640, HPA053714: AB_2682238"	"unprognostic (2.16e-1)"	"unprognostic (2.16e-3)"	"unprognostic (1.47e-1)"	"unprognostic (2.29e-1)"	"unprognostic (3.36e-3)"	"unprognostic (2.00e-3)"	"unprognostic (3.24e-1)"	"prognostic unfavorable (5.28e-5)"	"unprognostic (1.86e-1)"	"unprognostic (5.64e-3)"	"unprognostic (4.63e-2)"	"unprognostic (1.01e-3)"	"prognostic unfavorable (1.05e-5)"	"unprognostic (2.54e-1)"	"unprognostic (1.14e-1)"	"unprognostic (3.52e-4)"	"prognostic unfavorable (6.23e-4)"	17.5	3.9	3.3	4.9	8.0	38.7	7.4	3.2	7.3	2.7	3.1	2.7	0.0	2.2	2.8	1.5	4.0	2.5	7.9	5.4	4.9	3.7	6.9	25.8	5.1	3.1	3.0	3.1	1.7	4.4	4.0	4.7	9.3	3.7	2.0	2.8	1.8	10.8	1.4	12.0	3.9	10.5	4.5	2.3	3.2	3.0	4.9	2.6	3.7	2.9	11.8	3.9	3.7	4.6	1.9	1.5	6.3	3.1	1.4	2.4	0.2	4.7	5.5	2.2	4.1	5.0	2.1	13.5	7.1	5.1	10.1	7.3	7.3	2.0	15.8	5.7	5.3	14.3	3.4	11.4	6.2	9.6	7.0	4.6	7.3	3.3	6.4	4.5	10.7	4.3	2.4	3.1	11.2	7.6	2.0	4.4	3.2	13.1	5.2	4.5	5.4	7.3	5.6	7.0	2.1	5.9	6.0	6.4	5.6	6.8	3.1	8.2	5.5	4.5	5.1	4.0	8.9	3.7	8.3	6.6	5.5	7.1	5.2	8.4	4.3	4.0	10.0	5.1	21.2	6.9	1.5	1.4	0.8	2.4	1.5	1.4	1.1	1.1	1.3	0.6	1.9	0.8	1.6	6.3	1.4	3.1	1.5	0.7	0.2	3.3	8.0	3.2	7.3	4.9	3.7	3.0	3.1	3.7	2.6	8.9	0.6	0.0	2.6	0.0	4.7	0.0	2.5	1.4	1.2	0.0	13.7	4.3	1.7	1.9	0.6	0.0	0.3	0.0	0.2	7.7	0.5	2.0	2.3	1.5	1.4	1.6	0.0	0.6	2.2	0.0	0.9	0.7	0.0	0.0	0.1	0.3	1.8	0.0	0.0	3.1	4.6	0.0	0.0	0.9	3.2	0.0	10.1	0.0	0.0	1.7
NOS1	"nNOS, NOS"	ENSG00000089250	"Nitric oxide synthase 1"	P29475	12	117208142-117452170	"Cancer-related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"		"Calmodulin-binding, Oxidoreductase"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"brain: 13.4;skeletal muscle: 36.3"	"Cell type enhanced"	"Detected in some"	12	"Basal glandular cells: 7.9;Basal keratinocytes: 3.4;Glandular cells: 2.8;Ito cells: 8.0"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"HaCaT: 6.3;RH-30: 13.1;RPTEC TERT1: 8.2;U-2 OS: 2.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002167, HPA058312, HPA069509"	Enhanced		Supported	"Nucleoplasm,Plasma membrane"		NA	NA			"Plasma membrane"	Nucleoplasm	"CAB002167: AB_564073, HPA058312: AB_2683676, HPA069509: "	"unprognostic (1.63e-1)"	"unprognostic (3.14e-2)"	"unprognostic (2.18e-2)"	"unprognostic (6.64e-3)"	"unprognostic (4.91e-2)"	"unprognostic (2.74e-1)"	"unprognostic (2.54e-1)"	"unprognostic (9.12e-3)"	"unprognostic (2.51e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.07e-1)"	"unprognostic (7.56e-2)"	"unprognostic (1.01e-1)"	"unprognostic (3.73e-2)"	"unprognostic (1.34e-1)"	"unprognostic (5.97e-4)"	"unprognostic (1.87e-1)"	0.5	0.6	3.8	3.5	13.4	0.7	0.6	4.4	4.8	0.7	2.0	1.1	0.0	0.5	0.6	0.7	1.3	0.8	0.5	0.5	2.8	4.4	1.9	0.5	1.4	0.6	2.4	1.6	0.5	1.9	0.4	0.8	0.4	5.9	1.6	0.9	0.6	3.8	0.6	36.3	2.2	0.6	0.8	1.2	0.5	0.5	0.9	3.0	0.0	0.6	0.0	0.5	0.9	0.6	0.9	0.6	2.1	0.5	0.8	0.5	0.0	0.0	0.4	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.3	0.0	0.0	6.3	0.0	0.0	0.0	0.1	0.0	0.1	0.2	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.2	0.0	1.5	0.0	13.1	0.1	8.2	0.1	0.3	1.3	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.1	2.5	0.0	0.0	0.1	0.0	0.1	0.4	0.1	0.0	2.1	0.5	0.5	0.5	0.4	0.4	0.7	0.4	0.3	0.2	0.9	0.5	0.5	1.9	0.8	0.5	0.6	0.3	0.0	3.8	13.4	4.4	4.8	2.8	4.4	2.4	1.6	5.9	3.0	0.0	0.0	0.0	7.9	3.4	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	1.9	0.4	0.0	0.0	0.0	0.0	0.1	2.8	0.0	0.0	0.0	0.0	0.0	8.0	0.0	0.2	0.3	0.2	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.9	0.5	0.0	0.0	0.0	1.0
NOS2	"HEP-NOS, iNOS, NOS, NOS2A"	ENSG00000007171	"Nitric oxide synthase 2"	P35228	17	27756766-27800499	"Cancer-related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"		"Calmodulin-binding, Oxidoreductase"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 20.8;lymphoid tissue: 15.6"	"Group enriched"	"Detected in some"	6	"Extravillous trophoblasts: 22.7;Undifferentiated cells: 6.6"	"Cancer enhanced"	"Detected in many"		"colorectal cancer: 16.0"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	8	"CACO-2: 17.0;SCLC-21H: 13.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			CAB002014	Enhanced					NA	NA					"CAB002014: "	"unprognostic (1.95e-3)"	"unprognostic (3.08e-3)"	"unprognostic (4.75e-3)"	"unprognostic (4.42e-3)"	"unprognostic (3.49e-1)"	"unprognostic (2.13e-2)"	"unprognostic (5.61e-2)"	"unprognostic (5.09e-2)"	"unprognostic (9.91e-3)"	"unprognostic (1.93e-1)"	"unprognostic (2.39e-2)"	"unprognostic (1.34e-1)"	"unprognostic (6.04e-2)"	"unprognostic (8.02e-2)"	"unprognostic (3.68e-1)"	"unprognostic (8.69e-2)"	"unprognostic (4.03e-2)"	1.0	0.7	1.6	15.6	1.6	0.0	0.5	1.5	7.3	0.4	6.8	0.0	0.0	11.8	0.4	0.0	1.0	0.5	0.4	0.7	1.3	1.1	1.7	0.2	3.8	1.8	1.0	2.2	1.0	0.3	0.1	2.1	3.4	0.4	0.9	9.0	1.2	0.2	0.2	0.7	0.4	20.8	1.7	0.8	0.2	0.3	0.4	0.2	0.2	0.5	5.3	1.7	5.4	0.3	0.4	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.1	0.1	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	17.0	0.0	0.0	0.0	0.0	0.1	0.0	0.6	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.1	0.0	0.0	0.0	0.0	0.0	0.0	13.9	1.0	0.0	0.1	0.1	0.8	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.6	0.0	0.0	0.4	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	1.6	1.5	7.3	1.3	1.1	1.0	2.2	0.4	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	1.3	0.0	0.0	22.7	0.0	0.6	0.0	0.0	0.5	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	1.4	0.4	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.5	0.0	6.6	0.3
NOS3	"ECNOS, eNOS"	ENSG00000164867	"Nitric oxide synthase 3"	P29474	7	150990995-151014588	"Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"		"Calmodulin-binding, Oxidoreductase"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 70.6"	"Cell type enhanced"	"Detected in many"	18	"Early spermatids: 62.0;Endothelial cells: 23.5;Ito cells: 30.1;Late spermatids: 21.4"	"Low cancer specificity"	"Detected in all"			"Group enriched"	"Detected in all"	5	"basal ganglia: 32.4;cerebral cortex: 12.4;hippocampal formation: 18.8;pons and medulla: 35.3"	"Low cell type specificity"	"Detected in many"			"Lineage enriched"	"Detected in many"	5	"T-cells: 5.3"	"Cell line enhanced"	"Detected in some"		"BEWO: 11.4;HUVEC TERT2: 22.1;K-562: 7.8;TIME: 40.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB002168	Enhanced					NA	NA					"CAB002168: AB_564072"	"unprognostic (6.53e-2)"	"unprognostic (3.36e-1)"	"unprognostic (1.63e-2)"	"unprognostic (8.46e-2)"	"unprognostic (2.96e-2)"	"unprognostic (1.47e-1)"	"unprognostic (1.35e-1)"	"unprognostic (1.36e-1)"	"unprognostic (6.97e-2)"	"unprognostic (2.56e-1)"	"unprognostic (9.40e-2)"	"unprognostic (2.36e-1)"	"prognostic unfavorable (3.63e-4)"	"unprognostic (1.25e-2)"	"unprognostic (6.63e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.01e-1)"	11.4	4.5	3.1	7.5	32.4	1.9	25.6	1.8	12.4	4.6	3.2	1.7	1.0	4.0	8.3	2.5	4.7	5.0	6.6	35.2	18.8	3.4	5.5	5.4	14.0	10.3	4.7	1.7	4.5	4.1	2.7	4.8	11.5	35.3	5.2	2.5	5.2	3.0	3.2	6.0	4.9	4.0	5.4	25.9	70.6	3.6	4.5	1.6	0.0	5.9	2.1	2.4	5.1	7.3	1.1	0.5	0.7	0.4	0.5	5.3	1.2	0.2	0.0	0.6	2.0	0.0	0.0	11.4	0.0	0.0	0.0	0.0	0.1	1.0	0.2	1.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.2	1.0	0.1	3.0	0.3	0.2	5.1	0.0	0.1	0.0	0.0	0.0	22.1	2.5	7.8	1.8	0.0	0.0	0.1	0.2	0.8	0.3	0.0	1.4	0.0	0.8	0.0	0.1	0.2	0.2	0.1	0.7	0.0	0.2	0.1	0.7	40.2	0.1	0.4	0.2	0.0	1.2	4.1	1.0	0.0	3.6	0.0	0.3	0.3	0.2	2.5	0.4	1.5	0.8	3.9	2.2	0.5	1.1	5.3	2.1	0.7	0.5	0.4	0.5	4.4	1.2	3.1	32.4	1.8	12.4	18.8	3.4	4.7	1.7	35.3	1.6	8.9	2.1	0.0	0.0	0.8	0.0	2.0	0.0	1.4	1.2	0.0	0.0	0.2	0.0	0.5	62.0	23.5	0.0	0.0	0.0	0.1	3.1	0.2	5.7	0.0	0.3	0.0	0.0	30.1	0.6	21.4	0.9	0.4	0.0	0.0	0.0	0.0	1.0	0.0	1.1	0.1	0.3	0.0	1.0	3.7	2.5	0.5	3.0	0.0	0.0	0.2
NOSIP	CGI-25	ENSG00000142546	"Nitric oxide synthase interacting protein"	Q9Y314	19	49555711-49590262	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	"Developmental protein, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 119.4"	"Cell type enhanced"	"Detected in all"	8	"Late spermatids: 645.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043464, HPA062132"	Approved		Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"HPA043464: AB_10794284, HPA062132: AB_2684693"	"unprognostic (2.27e-1)"	"unprognostic (4.69e-2)"	"unprognostic (1.39e-1)"	"unprognostic (4.17e-2)"	"unprognostic (1.59e-2)"	"unprognostic (9.46e-2)"	"unprognostic (1.47e-2)"	"unprognostic (9.42e-2)"	"unprognostic (3.79e-1)"	"unprognostic (1.25e-1)"	"unprognostic (2.27e-2)"	"unprognostic (9.73e-2)"	"unprognostic (3.97e-2)"	"unprognostic (2.15e-1)"	"unprognostic (9.76e-2)"	"unprognostic (1.02e-1)"	"unprognostic (2.95e-3)"	13.4	13.9	14.2	14.0	14.0	14.3	11.5	12.1	14.2	11.3	15.9	12.3	13.1	17.3	12.5	8.1	12.7	11.1	11.7	14.9	12.3	11.4	13.2	14.5	12.6	24.6	18.3	10.8	12.9	39.7	7.1	13.6	15.6	14.3	11.6	7.9	11.3	19.2	11.4	66.9	11.9	16.5	11.0	13.1	18.0	13.9	40.2	16.3	20.6	15.5	17.6	16.3	11.7	15.0	20.4	21.5	31.8	16.8	29.7	119.4	69.2	66.5	36.1	14.1	31.0	12.6	9.2	13.5	15.7	13.9	26.5	24.4	25.2	11.8	17.9	27.6	13.2	11.1	14.9	13.8	27.6	11.6	20.4	39.9	22.6	20.8	28.0	19.9	18.3	19.1	12.0	19.2	20.1	10.9	10.8	15.9	28.8	25.0	14.3	13.8	17.8	18.6	39.4	19.1	25.0	31.4	24.4	23.4	15.9	12.3	20.1	17.6	22.9	21.2	18.1	15.8	6.7	14.7	19.4	23.5	23.0	19.5	8.0	30.0	26.9	50.8	24.2	8.7	25.2	17.7	28.0	16.8	23.5	35.1	15.7	45.4	20.4	71.4	40.2	16.6	19.8	119.4	65.8	31.8	29.7	14.3	21.5	37.5	69.2	14.2	14.0	12.1	14.2	12.3	11.4	18.3	10.8	14.3	16.3	17.9	37.0	70.7	51.2	64.7	22.7	33.5	58.6	30.8	14.8	48.8	21.6	81.7	72.9	76.5	286.4	75.9	124.9	46.7	245.7	72.4	65.6	38.9	66.9	45.0	63.5	11.1	56.3	82.3	64.5	645.6	66.4	58.6	59.1	85.6	76.3	39.5	185.4	94.7	67.8	92.9	31.4	58.2	62.7	203.6	46.2	66.7	114.0	101.0	98.9	47.7
NOTUM		ENSG00000185269	"Notum, palmitoleoyl-protein carboxylesterase"	Q6P988	17	81952507-81961840	"Enzymes, Predicted intracellular proteins, Predicted secreted proteins"	"Wnt signaling pathway"	"Hydrolase, Serine esterase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	12	"placenta: 127.4"	"Cell type enriched"	"Detected in some"	47	"Extravillous trophoblasts: 865.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	6	"Hep G2: 96.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA022851			Approved	"Endoplasmic reticulum"	"Secreted in female reproductive system"	NA	NA		59000	"Endoplasmic reticulum"		"HPA022851: "	"unprognostic (1.49e-1)"	"unprognostic (1.55e-1)"	"unprognostic (1.23e-2)"	"unprognostic (4.80e-3)"	"unprognostic (1.97e-1)"	"unprognostic (9.02e-3)"	"unprognostic (3.01e-2)"	"unprognostic (1.01e-2)"	"unprognostic (6.49e-2)"	"unprognostic (8.72e-2)"	"unprognostic (1.40e-1)"	"unprognostic (2.01e-2)"	"unprognostic (4.48e-6)"	"unprognostic (1.76e-1)"	"unprognostic (9.88e-2)"	"unprognostic (1.22e-3)"	"unprognostic (1.00e-1)"	0.2	0.1	1.1	0.2	1.2	0.1	0.2	0.3	1.0	0.2	0.2	0.2	0.5	0.6	1.0	1.3	0.3	0.2	0.3	0.3	0.5	0.9	0.8	10.4	1.8	0.2	0.7	0.4	0.2	0.2	0.0	0.2	127.4	0.6	0.4	0.0	0.2	0.3	0.2	4.9	2.4	0.2	0.2	0.3	0.3	0.9	3.0	0.5	0.2	0.2	0.3	0.2	1.3	1.3	0.7	0.0	0.0	0.0	0.0	0.4	0.5	0.0	0.2	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	2.2	0.1	0.0	0.4	0.0	0.0	0.1	0.5	0.0	0.0	0.0	0.2	0.5	0.6	96.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	2.5	0.0	0.0	0.1	0.0	0.0	0.0	15.6	0.1	0.0	0.0	0.0	0.0	0.0	3.7	0.3	0.9	0.4	1.4	0.5	0.0	1.1	0.0	0.1	1.5	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.4	0.0	0.0	0.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.5	1.1	1.2	0.3	1.0	0.5	0.9	0.7	0.4	0.6	0.5	0.0	3.0	0.0	0.1	0.1	0.0	1.1	0.0	0.0	0.0	0.0	0.0	8.8	0.0	0.0	0.1	0.0	0.0	0.0	0.0	865.2	2.3	0.0	0.0	0.9	17.2	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	9.8	0.0	18.4	0.0	0.0	0.0
NPEPL1	"bA261P9.2, FLJ11583"	ENSG00000215440	"Aminopeptidase like 1"	Q8NDH3	20	58689131-58719238	"Enzymes, Predicted intracellular proteins"		"Aminopeptidase, Hydrolase, Protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"basophil: 12.2;classical monocyte: 13.4;eosinophil: 4.9;intermediate monocyte: 8.9;myeloid DC: 8.2;neutrophil: 9.6;non-classical monocyte: 11.9"	"Group enriched"	"Detected in all"	5	"dendritic cells: 8.2;granulocytes: 12.2;monocytes: 13.4"	"Cell line enhanced"	"Detected in many"		"MCF7: 43.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"CAB004986, CAB017025, HPA036356"	Approved		Approved	Nucleoplasm		NA	NA		16000	Nucleoplasm		"CAB004986: AB_426073, CAB017025: , HPA036356: AB_2675082"	"unprognostic (1.68e-1)"	"unprognostic (5.87e-3)"	"unprognostic (8.28e-2)"	"unprognostic (2.78e-1)"	"unprognostic (5.42e-2)"	"unprognostic (1.47e-3)"	"unprognostic (2.86e-3)"	"unprognostic (3.11e-2)"	"unprognostic (4.14e-1)"	"unprognostic (1.08e-2)"	"unprognostic (1.62e-3)"	"unprognostic (3.78e-2)"	"prognostic unfavorable (1.87e-9)"	"unprognostic (7.97e-2)"	"unprognostic (1.64e-1)"	"unprognostic (2.21e-1)"	"prognostic favorable (5.73e-4)"	17.2	10.3	9.9	9.7	15.3	15.8	25.0	24.2	10.1	9.6	14.9	10.2	17.2	14.4	11.9	23.5	17.9	12.5	24.5	19.4	10.1	8.6	16.7	11.9	14.5	12.6	12.9	7.2	12.5	15.6	13.6	11.4	11.2	13.1	15.0	4.5	15.7	19.1	17.2	51.8	15.2	13.7	25.8	10.0	16.5	12.8	13.0	9.0	5.6	16.5	20.4	11.8	15.3	20.4	1.0	8.2	12.2	13.4	2.0	2.3	4.1	9.3	13.1	2.4	1.9	5.3	9.8	0.7	3.4	0.3	11.8	6.6	7.5	7.1	0.4	19.6	6.7	0.1	10.1	3.2	4.4	1.1	8.2	2.9	3.1	10.0	3.3	13.4	3.3	5.6	9.6	14.0	4.1	0.0	4.3	9.9	2.6	0.4	1.5	4.6	43.7	1.3	8.8	3.5	5.5	13.7	2.7	1.1	5.1	4.8	6.0	4.4	1.4	9.5	2.6	17.6	1.4	10.2	6.5	10.4	3.0	2.4	5.9	1.8	4.5	1.6	0.3	4.3	6.4	1.2	12.2	13.4	4.9	1.9	8.9	2.3	1.0	1.1	1.3	8.2	0.7	0.7	1.3	9.6	2.0	11.9	0.4	2.3	4.1	9.9	15.3	24.2	10.1	10.1	8.6	12.9	7.2	13.1	9.0	8.9	14.1	0.8	7.2	8.1	14.8	13.3	7.6	14.7	12.5	26.2	23.6	11.6	11.6	13.1	1.3	12.2	10.9	0.0	8.0	6.9	9.0	5.9	2.3	7.3	10.0	7.9	11.5	14.7	15.1	6.4	20.4	9.9	6.8	8.2	9.9	20.9	8.6	15.3	13.8	17.3	8.6	19.4	11.8	2.1	3.3	9.8	7.4	10.1	12.0	4.7
NPEPPS	"MP100, PSA"	ENSG00000141279	"Aminopeptidase puromycin sensitive"	P55786	17	47522942-47623276	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Aminopeptidase, Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Cone photoreceptor cells: 253.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"T-47d: 81.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021453, HPA045649"	Uncertain		Supported	Cytosol		No	No		2100000	Cytosol		"HPA021453: AB_2670709, HPA045649: AB_2679406"	"unprognostic (1.63e-1)"	"unprognostic (3.15e-2)"	"prognostic favorable (3.39e-5)"	"unprognostic (2.66e-2)"	"unprognostic (1.53e-1)"	"unprognostic (5.92e-2)"	"prognostic unfavorable (3.67e-5)"	"unprognostic (3.84e-2)"	"unprognostic (1.22e-1)"	"unprognostic (1.77e-1)"	"unprognostic (3.85e-2)"	"unprognostic (3.63e-2)"	"unprognostic (1.93e-1)"	"unprognostic (8.55e-2)"	"unprognostic (1.52e-1)"	"unprognostic (1.23e-2)"	"unprognostic (1.07e-1)"	16.0	26.0	27.2	15.9	27.7	11.1	56.1	36.5	33.8	17.1	17.7	9.8	14.6	14.6	16.9	17.1	47.7	17.2	16.3	22.2	24.0	15.6	18.8	11.1	30.3	24.1	16.0	29.7	20.8	16.8	21.2	15.3	17.6	27.2	18.6	20.0	13.3	21.8	16.5	52.3	29.6	17.3	20.4	22.8	15.7	16.2	15.3	16.1	7.0	14.5	14.8	18.1	19.0	30.5	6.9	9.0	23.2	8.6	9.3	9.2	5.4	32.7	21.6	21.8	15.3	25.1	25.4	45.9	14.5	18.8	21.9	21.4	13.9	37.7	19.6	22.4	21.1	19.9	20.0	23.9	13.3	34.2	8.7	20.6	23.5	22.3	16.1	14.5	13.3	15.3	19.4	13.2	15.9	8.4	32.0	22.5	6.8	19.8	11.4	31.1	8.8	17.6	11.9	13.3	18.5	19.6	14.3	30.6	17.3	27.4	24.0	17.4	15.0	18.6	10.9	12.9	38.4	81.1	9.3	28.8	14.7	10.6	21.8	10.1	23.4	22.5	11.9	20.7	7.0	9.6	10.2	8.6	10.7	9.1	6.6	9.2	6.8	7.3	8.5	8.7	6.9	6.5	7.6	23.2	9.3	6.8	9.0	8.4	5.4	27.2	27.7	36.5	33.8	24.0	15.6	16.0	29.7	27.2	16.1	77.4	58.6	28.2	59.7	69.1	136.0	50.0	50.9	29.4	39.8	40.1	253.3	68.9	23.2	54.3	25.4	43.7	53.1	0.0	47.2	63.0	58.6	89.0	39.4	26.9	35.7	106.5	42.6	39.3	44.0	43.4	48.9	38.9	55.6	26.2	41.6	39.6	80.1	54.0	47.0	38.3	167.1	77.6	44.8	47.1	27.9	89.6	87.5	32.0	44.8	147.8
NPL	"C1orf13, DHDPS1, NPL1"	ENSG00000135838	"N-acetylneuraminate pyruvate lyase"	Q9BXD5	1	182789293-182830384	"Enzymes, Predicted intracellular proteins"	"Carbohydrate metabolism"	Lyase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 76.0"	"Cell type enhanced"	"Detected in many"	18	"Cytotrophoblasts: 103.5;Hofbauer cells: 387.9;Ito cells: 109.2;Kupffer cells: 121.2;Syncytiotrophoblasts: 89.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"neutrophil: 76.0"	"Group enriched"	"Detected in many"	36	"granulocytes: 76.0;monocytes: 23.6"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA028345, HPA075808"	Enhanced		Approved	"Vesicles,Plasma membrane"		NA	NA		190000	Vesicles	"Plasma membrane"	"HPA028345: AB_10610145, HPA075808: "	"unprognostic (2.43e-2)"	"unprognostic (5.71e-3)"	"unprognostic (1.72e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.57e-1)"	"unprognostic (3.06e-1)"	"prognostic unfavorable (8.05e-4)"	"unprognostic (4.41e-2)"	"unprognostic (6.54e-3)"	"unprognostic (1.45e-1)"	"unprognostic (1.49e-1)"	"unprognostic (6.18e-2)"	"prognostic unfavorable (6.63e-4)"	"unprognostic (2.11e-1)"	"unprognostic (2.93e-2)"	"unprognostic (2.35e-2)"	"unprognostic (7.44e-2)"	14.9	6.8	10.9	14.2	12.3	12.4	5.3	3.5	10.2	3.9	5.3	15.0	11.4	2.4	2.5	23.7	8.0	4.1	10.1	4.7	9.2	8.7	37.4	15.4	14.3	20.4	16.0	8.6	2.8	3.2	2.5	2.5	32.9	15.4	4.4	7.4	3.9	5.7	5.8	2.4	6.5	4.8	5.8	15.3	32.1	4.0	4.0	14.4	3.1	3.4	1.3	10.9	11.8	5.5	0.7	1.3	76.0	23.6	0.0	1.3	10.3	2.7	0.5	0.8	0.0	2.4	2.4	0.7	0.9	1.8	1.0	0.5	0.0	1.2	7.3	1.3	0.0	0.0	1.1	1.6	2.0	0.2	0.0	1.2	11.6	0.3	0.1	1.3	4.4	7.0	1.9	7.8	0.2	0.0	0.1	0.1	8.5	8.7	11.7	1.8	0.9	0.2	2.9	9.3	5.7	0.9	1.1	0.6	8.9	0.2	6.1	2.6	3.9	4.2	0.2	3.7	0.9	2.4	7.1	0.2	1.0	2.0	0.6	0.1	8.4	10.1	7.4	2.1	7.8	3.0	3.6	23.6	18.0	1.0	20.8	0.9	0.3	0.8	0.9	1.3	0.7	0.7	0.9	76.0	0.0	16.0	0.2	1.3	10.3	10.9	12.3	3.5	10.2	9.2	8.7	16.0	8.6	15.4	14.4	0.0	5.6	9.1	4.0	5.5	5.1	2.5	2.5	0.0	1.2	7.0	2.0	103.5	16.6	1.0	14.0	2.1	1.3	23.3	2.1	6.6	3.3	1.2	5.7	2.4	387.9	6.4	1.7	109.2	121.2	20.9	0.9	25.3	10.1	21.6	1.1	2.4	1.4	0.0	0.4	55.2	2.4	0.0	2.9	8.6	8.3	6.1	89.7	3.5	0.8	3.9
NPR1	"ANPa, ANPRA, GUCY2A, NPRA"	ENSG00000169418	"Natriuretic peptide receptor 1"	P16066	1	153678637-153693992	"Enzymes, FDA approved drug targets, Predicted membrane proteins"	"cGMP biosynthesis"	"Lyase, Receptor, Vasoactive"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"breast: 98.4"	"Cell type enriched"	"Detected in many"	10	"Ito cells: 136.2"	"Cancer enhanced"	"Detected in all"		"ovarian cancer: 39.2"	"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	6	"ASC diff: 60.5"	"Region enriched"	"Detected in many"	5	"olfactory region: 23.0"	"Region enhanced"	"Detected in single"		"olfactory region: 11.1"	HPA031087			Approved	"Nucleoplasm,Nucleoli,Plasma membrane"		NA	NA			Nucleoli	"Nucleoplasm, Plasma membrane"	"HPA031087: AB_10601975"	"unprognostic (2.54e-1)"	"unprognostic (3.03e-3)"	"unprognostic (6.31e-2)"	"prognostic unfavorable (3.97e-4)"	"unprognostic (1.55e-1)"	"unprognostic (6.60e-2)"	"unprognostic (1.54e-2)"	"unprognostic (2.03e-1)"	"unprognostic (2.46e-1)"	"unprognostic (3.27e-2)"	"prognostic favorable (2.49e-4)"	"unprognostic (1.27e-1)"	"unprognostic (6.69e-2)"	"unprognostic (1.16e-2)"	"unprognostic (1.09e-1)"	"unprognostic (4.06e-1)"	"unprognostic (1.74e-2)"	41.1	4.3	0.5	5.9	0.9	0.1	98.4	0.5	0.8	8.1	8.2	0.3	7.3	1.2	16.8	11.1	8.7	25.0	9.3	19.6	0.9	0.5	28.7	3.7	34.8	8.6	0.7	0.0	19.5	4.2	7.8	4.5	11.8	2.5	4.9	1.5	2.0	2.0	9.0	6.9	3.4	4.6	15.6	2.2	1.2	5.0	6.4	0.2	0.8	7.6	5.1	1.1	11.6	26.5	0.0	0.5	0.0	0.3	0.0	0.0	0.0	0.0	0.4	0.0	0.0	60.5	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	10.0	0.0	7.2	0.0	0.0	0.1	0.0	0.1	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	5.7	0.0	0.0	0.8	0.0	0.0	0.0	0.6	0.0	2.0	0.4	0.0	0.0	0.0	0.0	0.0	3.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.9	0.5	0.8	0.9	0.5	0.7	0.0	2.5	0.2	0.0	5.8	0.0	0.4	1.3	0.0	4.8	5.1	0.0	0.0	14.0	0.0	0.1	0.0	0.6	8.0	14.2	0.0	0.0	0.0	0.9	3.9	0.4	0.0	1.5	0.2	0.0	0.0	136.2	6.0	7.9	9.5	0.0	0.0	9.0	0.0	0.0	0.7	0.0	3.9	2.8	0.0	0.0	0.9	0.2	0.1	0.9	0.6	0.0	0.0	0.0
NPR2	"AMDM, ANPb, ANPRB, GUCY2B, NPRB"	ENSG00000159899	"Natriuretic peptide receptor 2"	P20594	9	35792154-35809732	"Disease related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"cGMP biosynthesis, Osteogenesis"	"Lyase, Receptor"	"Disease mutation, Dwarfism, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 32.7"	"Cell type enhanced"	"Detected in many"	5	"Leydig cells: 8.6;Muller glia cells: 8.2;Peritubular cells: 7.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"plasmacytoid DC: 3.1"	"Group enriched"	"Detected in many"	6	"dendritic cells: 3.1;T-cells: 2.1"	"Cell line enhanced"	"Detected in many"		"ASC diff: 27.6;ASC TERT1: 20.6;BJ hTERT+: 16.8;HSkMC: 20.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA						"unprognostic (2.93e-2)"	"unprognostic (8.22e-3)"	"unprognostic (9.25e-3)"	"unprognostic (3.59e-2)"	"unprognostic (6.13e-2)"	"unprognostic (2.63e-2)"	"unprognostic (1.41e-1)"	"unprognostic (1.56e-1)"	"unprognostic (1.56e-1)"	"unprognostic (2.40e-1)"	"unprognostic (3.06e-1)"	"unprognostic (1.49e-1)"	"unprognostic (3.99e-2)"	"unprognostic (6.99e-3)"	"unprognostic (7.10e-2)"	"unprognostic (3.24e-1)"	"unprognostic (7.86e-2)"	9.0	4.8	3.8	1.9	6.4	0.0	7.2	32.7	11.2	29.2	7.8	1.8	4.4	1.8	22.6	9.8	5.3	7.6	5.7	7.6	3.7	4.2	3.7	8.4	4.7	2.3	2.5	5.1	8.0	1.3	2.7	7.9	7.1	11.8	8.3	4.0	8.3	3.3	9.5	7.7	6.2	3.7	17.1	3.9	2.6	4.5	5.5	4.0	0.9	3.2	2.4	2.0	6.2	8.9	0.4	3.1	0.0	0.0	0.1	2.1	0.1	0.0	1.6	1.9	0.0	27.6	20.6	1.2	7.7	16.8	6.2	6.7	4.0	2.7	1.1	2.0	15.0	11.6	0.7	2.3	0.2	5.6	1.3	0.7	1.0	1.8	2.0	15.0	0.1	0.0	20.4	1.1	6.9	0.5	6.1	10.1	1.7	0.5	0.1	11.6	0.5	0.3	0.4	2.6	0.8	2.8	1.3	0.1	0.5	1.0	0.8	0.5	0.6	0.2	0.0	0.3	3.1	0.1	0.0	6.5	6.6	5.1	2.1	0.7	0.2	0.3	3.0	8.4	0.3	3.7	0.0	0.0	0.0	1.1	0.0	0.0	0.4	1.2	0.6	0.0	0.0	0.5	0.4	0.0	0.1	0.0	3.1	2.1	0.1	3.8	6.4	32.7	11.2	3.7	4.2	2.5	5.1	11.8	4.0	3.0	4.3	0.0	0.6	1.0	4.0	0.6	0.0	1.4	0.0	0.0	2.0	0.3	0.0	0.4	0.1	2.3	0.1	0.0	0.7	0.1	5.7	1.7	1.1	5.7	0.3	3.2	0.0	2.5	0.3	0.0	8.6	0.0	0.0	0.0	0.9	8.2	0.5	3.1	7.4	0.6	2.1	0.0	1.9	2.8	2.0	1.4	0.2	0.0	1.0	0.3
NQO1	"DHQU, DIA4, DTD, NMOR1, QR1"	ENSG00000181019	"NAD(P)H quinone dehydrogenase 1"	P15559	16	69706996-69726951	"Cancer-related genes, Enzymes, Predicted intracellular proteins"		Oxidoreductase	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"stomach 1: 142.1"	"Cell type enhanced"	"Detected in many"	8	"Cholangiocytes: 203.8;Ciliated cells: 259.6;monocytes: 222.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"A549: 149.4;OE19: 264.4;SiHa: 169.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007308, CAB012421"	Enhanced		Supported	Cytosol		NA	NA		310000	Cytosol		"CAB012421: , HPA007308: AB_1079501"	"unprognostic (1.04e-2)"	"unprognostic (1.95e-3)"	"unprognostic (3.14e-1)"	"unprognostic (3.76e-3)"	"unprognostic (9.03e-2)"	"prognostic unfavorable (1.45e-4)"	"unprognostic (1.05e-3)"	"unprognostic (1.97e-1)"	"unprognostic (5.07e-2)"	"unprognostic (1.24e-2)"	"unprognostic (1.49e-2)"	"unprognostic (2.25e-1)"	"unprognostic (2.41e-2)"	"unprognostic (6.36e-2)"	"unprognostic (1.45e-1)"	"unprognostic (1.98e-1)"	"unprognostic (3.27e-1)"	31.3	24.2	12.8	6.4	20.7	0.6	77.1	2.7	9.1	7.6	23.2	7.8	5.7	29.5	3.9	8.6	36.3	8.2	77.2	9.3	9.9	7.5	44.7	1.2	17.2	6.9	11.3	6.0	3.7	2.5	7.0	3.7	3.5	25.5	9.8	20.8	20.2	10.5	7.6	7.6	2.3	17.7	22.7	10.4	6.0	142.1	3.8	4.9	0.1	25.7	69.7	16.2	21.2	18.9	5.2	3.2	0.9	3.2	15.1	12.3	4.4	13.1	149.4	12.5	55.9	31.2	45.3	4.7	22.3	40.0	23.0	35.6	18.1	85.3	0.4	26.5	115.2	40.2	13.8	4.8	25.1	11.8	5.3	0.2	0.6	37.0	131.8	41.5	3.1	10.7	10.6	15.9	39.9	4.6	34.6	57.0	1.0	5.4	0.9	122.9	42.6	0.6	5.7	6.6	264.4	14.5	1.0	2.6	6.1	45.9	47.9	4.5	1.0	169.7	24.1	99.3	14.9	39.0	10.5	38.6	23.2	9.6	8.7	17.5	0.7	2.9	0.6	29.7	1.7	114.7	0.6	3.2	0.2	5.7	0.3	2.9	5.2	6.6	7.2	3.2	2.1	2.1	4.7	0.9	15.1	0.3	1.2	12.3	4.4	12.8	20.7	2.7	9.1	9.9	7.5	11.3	6.0	25.5	4.9	23.8	13.4	1.4	19.5	4.6	4.0	4.5	203.8	259.6	28.4	40.1	3.9	2.1	124.3	22.1	0.3	55.5	72.0	0.0	134.0	3.1	13.1	25.1	19.6	3.2	12.5	3.2	19.5	31.9	3.3	0.9	23.3	8.2	16.9	222.8	60.8	7.6	63.7	49.1	11.3	24.5	10.7	6.5	17.6	0.2	1.5	4.0	1.6	4.4	33.4	25.4
NQO2	"DHQV, DIA6, NMOR2, QR2"	ENSG00000124588	"N-ribosyldihydronicotinamide:quinone reductase 2"	P16083	6	2987987-3028869	"Enzymes, Plasma proteins, Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	14	"monocytes: 212.8;Proximal tubular cells: 716.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"neutrophil: 62.1"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021283, HPA021332"	Enhanced		Supported	Nucleoplasm,Cytosol		NA	NA		6500000	Cytosol	Nucleoplasm	"HPA021283: AB_1854600, HPA021332: AB_1854601"	"unprognostic (7.11e-3)"	"unprognostic (1.43e-3)"	"unprognostic (2.41e-1)"	"unprognostic (3.01e-2)"	"unprognostic (1.00e-2)"	"unprognostic (3.58e-1)"	"prognostic unfavorable (8.40e-4)"	"unprognostic (1.77e-1)"	"unprognostic (1.15e-1)"	"unprognostic (4.90e-2)"	"unprognostic (6.59e-2)"	"unprognostic (3.60e-2)"	"unprognostic (8.28e-2)"	"unprognostic (2.03e-1)"	"unprognostic (3.32e-2)"	"unprognostic (3.96e-1)"	"unprognostic (2.02e-1)"	24.7	45.6	18.2	11.0	17.6	27.2	21.9	44.3	28.1	12.9	11.5	8.9	8.8	15.6	10.4	15.4	12.1	11.2	12.8	38.2	16.0	13.3	82.9	47.0	11.7	17.5	17.0	23.5	13.5	18.4	12.1	9.3	12.1	24.5	12.7	9.0	18.0	24.5	13.5	41.3	20.2	15.5	10.7	11.8	15.3	12.8	7.7	12.5	7.0	11.9	13.9	7.9	10.4	11.0	3.2	16.6	62.1	25.2	7.3	9.3	13.1	12.7	21.6	13.2	29.0	23.3	13.8	14.2	12.4	15.9	11.5	12.9	22.7	4.9	11.2	45.3	21.3	26.9	9.8	13.5	8.6	9.0	26.1	11.5	6.9	26.5	22.7	19.0	6.9	22.1	8.5	10.3	13.9	13.0	16.5	11.1	14.6	39.2	6.7	9.5	28.4	7.9	12.8	17.9	26.9	18.0	14.7	15.7	32.7	17.3	6.8	2.8	5.1	18.8	8.0	39.4	24.7	11.0	4.8	19.1	10.8	4.2	14.4	5.4	14.6	33.1	3.4	12.7	21.0	21.3	5.6	25.2	13.5	9.2	15.7	6.6	3.2	8.3	8.3	16.6	2.1	5.0	5.7	62.1	7.3	13.9	1.7	9.3	13.1	18.2	17.6	44.3	28.1	16.0	13.3	17.0	23.5	24.5	12.5	8.9	17.3	8.1	35.0	31.3	32.4	60.5	50.9	22.7	10.3	24.4	9.8	36.3	137.6	19.8	39.2	32.9	25.6	23.3	55.3	41.3	45.4	32.3	12.8	167.7	66.5	39.7	4.6	20.3	34.6	38.3	33.1	71.3	64.1	212.8	19.0	47.3	40.8	17.3	38.5	716.7	18.8	25.8	46.2	7.0	10.1	36.0	26.1	17.3	20.9	42.3
NRBP1	"BCON3, MADM, MUDPNP, NRBP"	ENSG00000115216	"Nuclear receptor binding protein 1"	Q9UHY1	2	27427790-27442259	"Enzymes, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029527, CAB033078"	Supported		Supported	Cytosol		NA	NA		38000	Cytosol		"CAB033078: AB_2154375, HPA029527: AB_10601379"	"unprognostic (4.95e-3)"	"unprognostic (1.29e-1)"	"unprognostic (1.09e-1)"	"unprognostic (1.38e-1)"	"unprognostic (3.62e-2)"	"unprognostic (3.95e-1)"	"prognostic unfavorable (2.22e-5)"	"unprognostic (7.36e-2)"	"unprognostic (1.44e-1)"	"unprognostic (6.11e-2)"	"unprognostic (3.13e-1)"	"unprognostic (2.60e-1)"	"prognostic unfavorable (5.84e-5)"	"unprognostic (1.26e-1)"	"unprognostic (2.69e-1)"	"unprognostic (2.75e-2)"	"unprognostic (3.48e-3)"	30.8	27.6	20.9	30.8	25.9	49.8	29.1	31.6	38.4	36.3	35.2	21.3	27.5	27.3	40.6	34.2	52.2	28.7	29.9	27.7	18.0	26.0	24.6	38.8	27.1	25.6	21.5	26.2	36.6	28.2	23.0	27.0	58.7	33.9	30.3	25.4	30.6	31.6	34.7	62.2	36.6	31.5	40.7	18.3	29.1	28.9	46.9	20.6	24.4	25.4	39.4	37.6	34.2	37.7	20.6	29.1	57.9	37.2	27.5	33.7	32.9	30.2	30.4	25.2	33.4	39.1	39.0	30.6	28.9	36.4	41.3	32.2	30.7	12.4	8.8	21.7	45.8	41.1	20.9	25.0	26.0	26.7	17.2	15.6	17.4	12.4	40.3	32.8	9.7	23.5	31.8	32.8	42.2	28.3	27.0	45.4	9.8	9.8	14.0	36.2	45.6	12.8	23.5	31.7	26.9	19.2	9.9	53.8	9.8	29.3	21.1	6.8	19.2	34.2	24.7	18.0	29.4	13.6	10.9	35.8	36.5	36.3	21.8	23.3	29.4	29.3	10.5	28.6	17.0	18.2	53.6	28.5	57.9	33.2	37.2	29.2	20.6	28.6	29.9	29.1	18.1	26.3	27.0	38.2	27.5	33.3	18.6	33.7	32.9	20.9	25.9	31.6	38.4	18.0	26.0	21.5	26.2	33.9	20.6	6.0	18.4	41.7	48.8	50.8	34.3	23.0	17.8	34.8	28.4	33.2	33.4	135.2	26.6	78.8	200.9	40.3	55.7	0.0	84.0	190.6	54.2	36.0	19.7	33.7	70.8	27.0	26.9	44.8	33.9	22.9	42.6	38.2	28.7	87.4	34.7	43.5	81.5	38.6	57.0	40.7	51.1	32.3	51.5	50.5	89.7	45.8	169.9	34.6	27.6	51.7
NRBP2	DKFZp434P086	ENSG00000185189	"Nuclear receptor binding protein 2"	Q9NSY0	8	143833594-143840974	"Enzymes, Predicted intracellular proteins"	Neurogenesis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 54.1"	"Cell type enhanced"	"Detected in many"	5	"Alveolar cells type 1: 41.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"MAIT T-cell: 1.5"	"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in many"							"Low region specificity"	"Detected in all"			"CAB020944, HPA029051, HPA029052"	Approved		Approved	Cytosol		NA	NA			Cytosol		"CAB020944: , HPA029051: AB_2672886, HPA029052: AB_10602714"	"unprognostic (1.84e-1)"	"unprognostic (4.66e-2)"	"unprognostic (2.54e-2)"	"unprognostic (1.53e-3)"	"unprognostic (1.01e-1)"	"unprognostic (2.00e-2)"	"unprognostic (4.03e-1)"	"unprognostic (2.86e-1)"	"unprognostic (3.97e-1)"	"unprognostic (1.08e-1)"	"unprognostic (2.24e-1)"	"unprognostic (2.47e-2)"	"prognostic unfavorable (2.01e-5)"	"unprognostic (3.86e-2)"	"unprognostic (3.98e-1)"	"unprognostic (4.56e-2)"	"unprognostic (2.04e-1)"	18.5	10.7	21.6	6.8	21.1	1.9	10.0	17.5	32.6	7.6	13.3	47.5	8.7	8.8	11.2	10.0	9.9	14.6	11.3	15.2	23.5	14.9	14.0	18.9	14.9	4.9	30.9	23.6	10.7	10.4	8.4	8.8	6.1	30.2	17.8	6.9	10.1	22.1	15.5	7.6	23.0	9.3	12.3	54.1	7.5	10.1	6.1	27.5	1.0	9.0	3.6	3.8	8.2	7.8	0.5	0.0	0.0	0.4	0.0	1.5	0.3	5.9	7.4	6.7	8.3	10.5	16.2	1.5	12.1	5.3	4.4	6.4	1.7	5.5	0.6	3.2	14.4	3.3	9.5	3.9	4.2	1.7	7.1	2.9	1.1	19.6	3.0	10.8	0.0	2.8	20.7	10.0	2.3	2.2	14.9	6.1	2.1	3.7	7.8	9.3	2.5	0.5	0.3	2.5	6.0	4.1	2.0	6.2	2.7	6.0	2.0	2.4	4.9	15.5	7.9	6.0	4.5	11.3	0.4	14.0	2.6	8.0	12.5	3.9	4.3	0.2	0.1	13.9	2.4	3.5	0.0	0.4	0.0	0.2	0.2	1.5	0.0	0.2	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.3	21.6	21.1	17.5	21.4	23.5	14.9	30.9	23.6	30.2	27.5	41.7	10.7	0.8	6.0	8.1	14.2	8.1	28.1	5.3	13.6	10.4	13.7	0.7	0.0	4.0	0.3	7.1	5.1	0.0	3.6	0.9	5.8	9.0	0.0	32.1	2.4	15.9	8.6	7.4	4.1	0.0	26.7	3.2	10.1	4.6	8.4	23.2	4.7	3.5	20.1	2.8	10.6	12.9	10.3	1.1	2.3	8.0	0.7	2.9	4.5	3.7
NRDC	"hNRD1, hNRD2, NRD1"	ENSG00000078618	"Nardilysin convertase"	O43847	1	51789191-51878937	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 96.4"	"Group enriched"	"Detected in many"	8	"Early spermatids: 492.5;Late spermatids: 1318.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA053661			Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA053661: AB_2682221"	"unprognostic (1.22e-1)"	"unprognostic (6.52e-2)"	"unprognostic (2.14e-2)"	"unprognostic (5.62e-2)"	"unprognostic (2.61e-1)"	"unprognostic (3.25e-2)"	"prognostic unfavorable (5.49e-6)"	"unprognostic (1.42e-1)"	"unprognostic (4.17e-2)"	"unprognostic (1.67e-1)"	"unprognostic (5.86e-2)"	"unprognostic (1.00e-1)"	"prognostic unfavorable (2.12e-9)"	"unprognostic (2.75e-1)"	"unprognostic (2.35e-2)"	"unprognostic (9.54e-2)"	"unprognostic (5.53e-3)"	16.4	15.9	13.4	15.8	17.5	14.5	11.7	14.7	16.9	12.2	13.7	11.0	9.9	11.2	11.8	12.1	14.4	10.9	10.9	25.7	13.1	13.3	12.4	28.5	12.0	13.6	16.2	10.6	11.7	15.9	19.3	21.4	14.2	15.7	13.8	12.1	9.8	11.9	11.3	96.4	19.1	10.3	13.3	14.0	13.6	11.9	32.3	14.5	19.4	11.7	21.5	15.1	13.0	16.0	13.8	18.5	36.3	19.1	15.8	15.1	16.2	46.9	26.5	26.6	38.1	28.0	43.3	30.9	47.5	41.1	34.6	36.7	18.5	18.6	31.0	25.4	35.7	46.4	27.4	39.0	36.8	43.8	36.7	19.2	37.0	36.0	16.1	28.7	32.3	28.2	34.4	28.2	50.4	46.8	29.8	35.9	33.0	48.7	20.8	43.2	17.2	29.2	11.2	47.2	19.4	28.5	28.6	31.8	34.2	25.5	27.3	25.5	19.2	43.3	34.9	25.7	53.9	23.3	39.3	29.8	30.4	28.2	33.1	40.3	31.1	46.9	29.0	35.9	40.7	34.8	19.3	18.1	26.0	13.7	19.1	13.7	13.8	12.7	15.1	18.5	9.3	12.5	13.4	36.3	15.8	14.5	15.0	14.4	16.2	13.4	17.5	14.7	16.9	13.1	13.3	16.2	10.6	15.7	14.5	32.8	55.9	17.8	35.3	0.0	67.0	0.0	17.8	108.4	63.7	26.2	76.6	47.3	26.6	38.1	492.5	33.3	18.8	70.0	55.1	37.0	33.6	42.0	32.5	52.9	39.9	58.8	17.5	28.3	38.2	1318.0	61.2	53.3	0.0	60.5	26.4	53.0	45.7	14.0	55.5	15.1	68.3	58.2	0.0	37.6	20.9	0.0	69.0	40.6	27.9	33.4
NRK	DKFZp686A17109	ENSG00000123572	"Nik related kinase"	Q7Z2Y5	X	105822543-105958610	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"ovary: 42.2;placenta: 64.8"	"Group enriched"	"Detected in some"	4	"Cytotrophoblasts: 56.0;Leydig cells: 105.0;Syncytiotrophoblasts: 56.8"	"Cancer enriched"	"Detected in some"	8	"testis cancer: 6.1"	"Region enriched"	"Detected in single"	10	"cerebellum: 4.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"fHDF/TERT166: 30.7;HSkMC: 5.9;RH-30: 7.0;RPTEC TERT1: 18.9;SuSa: 23.1"	"Region enriched"	"Detected in single"	28	"cerebellum: 16.0"	"Low region specificity"	"Detected in many"			HPA017238	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"HPA017238: AB_1854645"	"unprognostic (2.64e-4)"	"unprognostic (9.82e-2)"	"unprognostic (5.98e-3)"	"unprognostic (5.52e-2)"		"unprognostic (3.87e-2)"	"unprognostic (2.29e-2)"	"unprognostic (1.12e-1)"	"unprognostic (2.86e-2)"	"unprognostic (1.35e-2)"	"unprognostic (6.08e-2)"	"unprognostic (3.24e-2)"	"unprognostic (5.28e-3)"	"unprognostic (1.47e-3)"	"unprognostic (1.14e-1)"	"unprognostic (4.28e-2)"	"unprognostic (6.80e-3)"	2.6	12.7	0.4	2.7	0.4	0.0	0.8	4.3	0.3	3.5	1.5	0.1	4.6	0.0	4.3	15.6	1.6	1.3	7.5	2.9	0.4	0.4	9.9	0.4	0.5	0.0	0.3	0.0	42.2	0.5	0.0	2.9	64.8	0.2	22.0	0.1	0.0	2.1	1.6	0.4	0.4	0.5	2.8	0.4	0.3	0.9	10.6	0.0	0.0	0.5	3.1	0.3	1.9	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	30.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	5.9	0.0	0.0	0.0	1.9	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	7.0	0.0	18.9	0.3	0.0	0.1	0.0	1.0	0.0	23.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.4	4.3	0.3	0.4	0.4	0.3	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.8	0.0	0.0	0.0	0.0	0.0	56.0	16.6	0.2	0.9	0.3	0.0	0.0	0.0	7.2	0.5	0.3	0.0	0.0	6.1	0.0	0.0	0.0	0.0	1.1	105.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.7	0.1	0.0	0.0	0.0	0.6	1.4	0.0	56.8	0.0	0.0	0.1
NSD1	"ARA267, FLJ22263, KMT3B, STO"	ENSG00000165671	"Nuclear receptor binding SET domain protein 1"	Q96L73	5	177133025-177300215	"Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Activator, Chromatin regulator, Methyltransferase, Repressor, Transferase"	"Cancer-related genes, Disease mutation, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Cone photoreceptor cells: 141.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA048431, HPA070333, HPA073705"	Supported		Supported	"Nucleoplasm,Plasma membrane"		NA	NA			"Nucleoplasm, Plasma membrane"		"HPA048431: AB_2680388, HPA070333: AB_2686255, HPA073705: AB_2732239"	"unprognostic (3.48e-2)"	"unprognostic (7.46e-2)"	"unprognostic (7.14e-3)"	"unprognostic (2.64e-3)"	"unprognostic (1.38e-1)"	"unprognostic (9.67e-2)"	"unprognostic (2.29e-2)"	"unprognostic (7.08e-2)"	"unprognostic (1.68e-3)"	"unprognostic (8.04e-2)"	"unprognostic (1.48e-1)"	"unprognostic (2.09e-1)"	"unprognostic (7.77e-3)"	"unprognostic (3.53e-2)"	"unprognostic (1.01e-1)"	"unprognostic (7.51e-2)"	"unprognostic (7.32e-2)"	11.8	13.2	11.9	25.4	15.7	23.9	14.0	28.9	16.7	15.6	14.2	18.5	17.0	10.6	19.0	13.9	17.8	13.6	15.8	11.7	12.8	11.5	14.4	10.5	12.3	19.4	12.9	11.7	16.6	27.1	24.6	19.3	16.0	13.4	14.2	14.3	13.8	13.5	18.7	20.6	16.1	14.5	15.6	13.2	16.1	13.1	28.1	16.1	27.3	20.1	10.6	22.7	13.4	20.2	10.2	8.9	18.7	10.8	10.9	7.8	2.9	9.9	12.8	13.3	11.5	6.6	8.5	0.4	9.0	9.0	12.7	11.8	2.8	8.3	20.5	10.2	12.4	11.7	8.5	21.2	20.0	15.4	34.7	12.8	9.1	14.5	0.1	10.9	19.6	10.8	8.0	12.1	15.0	14.1	9.0	18.4	13.0	12.4	7.2	12.7	20.8	13.6	6.3	14.5	6.7	11.3	15.1	1.7	6.3	8.2	12.1	16.3	11.2	23.4	10.2	7.0	12.9	10.2	16.3	13.5	8.8	12.9	5.6	11.1	8.5	7.4	14.7	5.1	9.6	9.4	10.7	9.1	9.4	7.5	6.1	6.3	8.5	6.3	5.0	6.7	10.2	7.8	6.3	18.7	10.9	10.8	8.9	5.7	2.9	11.9	15.7	28.9	16.7	12.8	11.5	12.9	11.7	13.4	16.1	20.8	26.1	42.4	26.2	15.0	91.7	37.5	33.1	13.4	36.4	52.4	141.4	34.8	14.9	22.8	25.5	31.5	21.9	0.0	18.5	20.4	23.3	24.0	39.4	16.3	24.2	84.2	40.3	31.3	29.2	33.9	47.2	39.1	15.1	50.5	19.4	35.7	20.1	24.6	31.1	13.9	100.0	51.8	19.6	63.2	47.7	18.1	29.6	51.1	21.5	23.5
NSD2	"KMT3G, MMSET, WHSC1"	ENSG00000109685	"Nuclear receptor binding SET domain protein 2"	O96028	4	1871424-1982207	"Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Chromatin regulator, DNA-binding, Methyltransferase, Transferase"	"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Alveolar cells type 1: 11.9;Alveolar cells type 2: 17.3;Ciliated cells: 13.4;Club cells: 14.8;Collecting duct cells: 12.2;Hofbauer cells: 11.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA015801, CAB068246, CAB068247"	Enhanced		Supported	Nucleoplasm		No	No			Nucleoplasm		"CAB068246: AB_2665690, CAB068247: AB_2665689, HPA015801: AB_1858830"	"unprognostic (3.70e-1)"	"unprognostic (9.80e-2)"	"unprognostic (3.33e-2)"	"unprognostic (1.77e-1)"	"unprognostic (4.01e-1)"	"unprognostic (1.31e-2)"	"prognostic unfavorable (2.61e-4)"	"unprognostic (3.24e-2)"	"unprognostic (6.22e-2)"	"unprognostic (7.66e-2)"	"unprognostic (2.09e-1)"	"unprognostic (9.25e-3)"	"prognostic unfavorable (7.19e-4)"	"unprognostic (3.89e-2)"	"unprognostic (2.95e-1)"	"unprognostic (1.31e-1)"	"unprognostic (6.15e-2)"	8.7	7.6	17.6	11.5	16.2	35.1	8.5	20.6	18.2	7.0	14.8	12.4	6.3	14.0	9.5	7.4	12.7	6.8	6.9	11.9	15.1	10.9	8.4	7.5	11.1	18.8	14.7	16.1	7.0	11.7	10.7	11.8	9.8	14.6	8.7	17.7	9.4	10.2	7.4	11.8	12.1	14.6	10.5	15.3	13.5	11.0	26.3	13.4	46.7	13.8	5.5	17.7	8.6	9.4	4.9	3.9	4.1	1.8	2.7	4.3	0.6	27.7	14.0	42.3	18.5	4.6	6.8	12.3	22.4	19.9	27.5	30.8	12.4	33.0	29.9	7.7	18.5	36.0	12.1	27.3	18.5	47.3	14.3	11.3	35.6	19.4	7.3	5.8	21.8	18.7	2.6	4.7	24.1	23.2	15.2	21.6	30.2	19.3	31.4	22.5	10.9	58.1	22.9	17.8	14.1	16.2	33.2	27.6	10.3	11.3	13.2	26.3	21.0	18.4	6.9	8.4	19.2	16.3	14.6	16.7	27.5	20.5	17.4	45.1	14.7	15.5	27.1	16.5	21.6	25.5	2.1	1.7	1.7	2.9	1.8	3.2	1.8	3.2	3.2	1.5	4.9	2.8	2.3	4.1	2.7	1.4	3.9	4.3	0.6	17.6	16.2	20.6	18.2	15.1	10.9	14.7	16.1	14.6	13.4	11.9	17.3	0.0	0.0	0.0	0.0	0.0	0.0	13.4	14.8	12.2	0.0	10.0	3.3	10.2	0.0	0.0	0.0	0.0	6.1	7.3	0.0	0.0	2.3	0.0	11.6	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	10.0	0.0	0.0	10.2	0.0	0.0	2.9	0.0	0.0	0.0	0.0	0.0	0.0	2.9	0.0	0.0	0.0
NSD3	"FLJ20353, KMT3F, WHISTLE, WHSC1L1"	ENSG00000147548	"Nuclear receptor binding SET domain protein 3"	Q9BZ95	8	38269697-38382272	"Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Chromatin regulator, Methyltransferase, Transferase"	"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"Cytotrophoblasts: 85.7;Extravillous trophoblasts: 142.9;monocytes: 86.6;Syncytiotrophoblasts: 109.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA005659, CAB013721, HPA018893"	Uncertain		Approved	Nucleoplasm,Mitochondria		NA	NA			Mitochondria	Nucleoplasm	"CAB013721: , HPA005659: AB_1080596, HPA018893: AB_1858833"	"unprognostic (6.21e-2)"	"unprognostic (3.73e-2)"	"unprognostic (2.18e-2)"	"unprognostic (4.12e-1)"	"unprognostic (2.25e-1)"	"unprognostic (1.53e-2)"	"unprognostic (4.35e-2)"	"unprognostic (1.97e-2)"	"unprognostic (2.49e-1)"	"unprognostic (5.72e-2)"	"prognostic unfavorable (7.48e-4)"	"unprognostic (5.06e-2)"	"unprognostic (5.60e-3)"	"unprognostic (6.69e-2)"	"unprognostic (4.04e-1)"	"unprognostic (1.05e-2)"	"unprognostic (1.60e-2)"	19.2	11.3	31.1	15.8	31.4	36.3	20.1	51.5	37.7	18.5	15.5	16.7	14.0	16.2	16.0	12.5	17.0	16.8	17.0	12.7	24.4	16.6	14.2	11.2	17.9	22.3	25.0	26.8	26.5	16.3	21.0	24.2	22.5	21.9	16.4	18.7	12.3	18.3	17.9	12.3	16.2	17.7	16.0	15.3	17.2	19.7	9.3	25.6	16.7	19.2	6.9	20.4	19.6	23.3	26.7	5.6	26.2	5.1	8.6	18.0	2.9	24.1	13.9	23.9	16.1	16.8	19.3	17.7	20.3	22.4	17.6	20.5	7.4	13.4	28.8	18.7	13.8	17.1	14.6	18.9	16.2	25.2	11.4	11.1	36.7	11.2	8.6	17.2	16.1	13.3	10.3	16.5	15.9	32.4	16.5	20.1	31.9	26.0	19.2	16.7	8.7	47.1	13.7	16.2	18.8	6.6	21.6	26.1	9.1	12.5	18.7	13.5	18.2	16.5	14.5	14.1	16.0	18.2	12.3	19.2	18.3	19.0	27.2	11.9	17.1	20.4	27.8	15.5	16.3	13.2	13.9	5.1	9.1	8.0	2.4	5.3	16.5	12.0	7.1	4.1	26.7	15.0	6.3	26.2	8.6	1.5	5.6	18.0	2.9	31.1	31.4	51.5	37.7	24.4	16.6	25.0	26.8	21.9	25.6	62.5	52.3	0.0	0.0	0.0	0.0	0.0	0.0	62.9	55.7	48.8	0.0	85.7	19.9	60.6	0.0	0.0	0.0	0.0	53.3	142.9	0.0	0.0	8.1	0.0	39.1	0.0	0.0	0.0	0.0	0.0	0.0	12.5	0.0	86.6	0.0	0.0	50.3	0.0	0.0	28.5	0.0	0.0	0.0	0.0	0.0	0.0	109.4	0.0	0.0	0.0
NSDHL	"H105e3, SDR31E1, XAP104"	ENSG00000147383	"NAD(P) dependent steroid dehydrogenase-like"	Q15738	X	152830967-152869729	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Cholesterol biosynthesis, Cholesterol metabolism, Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis, Steroid metabolism, Sterol biosynthesis, Sterol metabolism"	Oxidoreductase	"Disease mutation, Ichthyosis, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000248, HPA000571"	Enhanced		Enhanced	"Endoplasmic reticulum,Lipid droplets"		NA	NA			"Endoplasmic reticulum"	"Lipid droplets"	"HPA000248: AB_1079507, HPA000571: AB_1079506"	"unprognostic (1.84e-1)"	"prognostic favorable (5.65e-4)"	"unprognostic (2.66e-1)"	"unprognostic (1.81e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.33e-1)"	"prognostic unfavorable (5.04e-4)"	"unprognostic (1.03e-1)"	"unprognostic (5.70e-2)"	"unprognostic (4.32e-2)"	"unprognostic (5.62e-2)"	"unprognostic (2.63e-1)"	"prognostic favorable (6.09e-5)"	"unprognostic (3.53e-2)"	"unprognostic (1.36e-1)"	"unprognostic (3.91e-2)"	"unprognostic (4.79e-2)"	17.4	24.8	11.0	7.7	10.5	6.0	20.4	7.7	15.0	13.4	23.4	13.9	20.5	13.3	10.4	35.7	36.2	11.9	7.4	16.7	14.3	11.4	11.6	38.1	9.9	8.7	9.7	10.4	9.8	7.9	9.8	6.9	7.9	18.9	12.0	10.7	7.9	12.2	17.7	6.9	14.5	24.0	9.9	14.2	7.3	9.6	8.6	9.3	6.0	11.0	22.2	17.0	7.5	16.1	16.2	17.5	16.4	17.7	17.0	17.3	13.0	40.6	14.9	20.4	10.6	17.6	13.4	11.5	8.1	10.9	14.8	18.8	20.6	22.2	20.1	27.3	11.0	55.0	20.9	26.5	37.5	13.1	6.7	15.2	8.2	14.6	20.9	12.8	8.2	6.7	16.4	14.5	28.9	7.3	6.4	13.7	8.9	13.6	9.1	11.2	18.0	8.0	10.7	8.1	20.4	18.0	6.0	14.8	16.5	30.7	16.8	7.4	8.4	7.2	10.9	8.5	14.8	7.2	10.5	11.6	6.9	11.4	16.6	15.6	12.9	8.6	34.6	12.8	12.9	6.5	16.4	17.7	15.8	15.6	16.2	15.7	16.2	15.6	13.5	17.5	12.9	11.4	12.6	1.9	17.0	12.1	15.6	17.3	13.0	11.0	10.5	7.7	15.0	14.3	11.4	9.7	10.4	18.9	9.3	11.9	14.7	9.7	9.8	9.6	3.8	21.0	15.3	18.7	10.3	12.2	0.0	18.3	8.3	16.9	8.7	7.4	12.0	0.0	17.6	18.3	9.8	7.8	8.1	26.3	16.1	1.6	5.8	8.0	8.3	5.9	7.8	9.3	5.0	15.4	8.7	10.3	16.2	7.8	8.5	11.5	5.4	0.0	8.2	3.7	8.2	10.7	15.6	5.7	9.4	15.3
NSF	"SEC18, SKD2"	ENSG00000073969	"N-ethylmaleimide sensitive factor, vesicle fusing ATPase"	P46459	17	46590669-46757464	"Enzymes, Predicted intracellular proteins, Transporters"	"Protein transport, Transport"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 35.4"	"Cell type enhanced"	"Detected in many"	5	"Bipolar cells: 95.1;Cone photoreceptor cells: 82.5;Rod photoreceptor cells: 82.9"	"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003154, CAB009324, HPA071089"	Enhanced		Supported	"Golgi apparatus,Cytosol"		NA	NA		6900	Cytosol	"Golgi apparatus"	"CAB009324: AB_653479, HPA003154: AB_1079508, HPA071089: AB_2686343"	"unprognostic (5.70e-2)"	"unprognostic (1.50e-1)"	"unprognostic (1.07e-3)"	"unprognostic (1.98e-1)"	"unprognostic (1.52e-1)"	"unprognostic (2.04e-1)"	"unprognostic (2.30e-2)"	"unprognostic (1.09e-1)"	"unprognostic (3.95e-2)"	"unprognostic (5.48e-2)"	"unprognostic (2.37e-2)"	"unprognostic (3.25e-2)"	"unprognostic (1.19e-1)"	"unprognostic (2.07e-2)"	"unprognostic (3.09e-1)"	"unprognostic (1.65e-1)"	"unprognostic (1.74e-1)"	1.9	3.6	11.2	2.7	19.1	1.6	2.6	14.1	35.4	2.5	4.0			1.4	1.9	2.7	3.9	2.2	2.8	1.5	13.9	14.4	3.4	2.5	2.2	3.1	12.6		1.3	3.5	6.5	5.5	2.6		2.8	5.5		2.4	2.1	4.3	2.4	3.2	2.2	3.1	1.6	3.0	3.1			3.6		3.4	3.3	1.0	7.2	15.5	10.4	13.3	6.7	11.1	8.8	6.1	13.6	9.1	0.6	5.4	7.6	7.4	8.4	9.9	8.1	7.9	9.3	0.0	15.0	15.1	18.6	8.4	1.1	10.2	3.1	13.3	5.3	13.4	0.5	9.8	12.8	8.0	0.4	3.3	6.9	4.3	16.4	6.9	4.3	12.7	3.8	10.0	8.2	17.9	12.0	10.0	3.9	5.1	19.1	16.2	7.2	8.8	14.0	9.3	12.8	8.4	9.5	12.4	0.0	5.9	10.1	15.6	18.7	10.3	22.9	8.1	12.1	12.6	17.7	10.1	8.9	6.4	8.1	16.1	10.4	13.3	7.8	8.2	12.1	8.9	6.8	8.2	10.5	15.5	7.2	6.9	8.1	6.0	6.7	12.1	6.2	11.1	8.8											8.9	9.9	12.6	3.2	3.5	95.1	6.2	10.2	4.0	7.9	21.0	82.5	10.9	10.0	10.3	26.6	10.6	25.1	0.0	14.0	12.0	9.3	10.6	9.2	18.7	16.9	41.3	29.3	11.6	27.2	34.0	5.5	15.5	10.1	28.9	27.8	21.3	11.7	14.4	8.1	12.2	82.9	0.0	11.7	28.9	31.3	5.0	15.4	10.9	16.1	7.8
NSMCE1	NSE1	ENSG00000169189	"NSE1 homolog, SMC5-SMC6 complex component"	Q8WV22	16	27224991-27268794	"Enzymes, Predicted intracellular proteins"	"DNA damage, DNA recombination, DNA repair, Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"granulocytes: 274.2;Late spermatids: 281.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041567, HPA043091"	Supported		Supported	Nucleoplasm,Vesicles		NA	NA			"Nucleoplasm, Vesicles"		"HPA041567: AB_10964260, HPA043091: AB_10962722"	"unprognostic (6.27e-2)"	"unprognostic (8.17e-2)"	"unprognostic (2.52e-2)"	"unprognostic (2.48e-3)"	"unprognostic (4.17e-1)"	"unprognostic (4.52e-3)"	"unprognostic (1.59e-1)"	"unprognostic (1.06e-1)"	"unprognostic (1.79e-1)"	"unprognostic (1.22e-1)"	"unprognostic (1.93e-1)"	"unprognostic (9.91e-2)"	"unprognostic (1.40e-1)"	"unprognostic (5.45e-3)"	"unprognostic (3.58e-1)"	"unprognostic (1.46e-1)"	"unprognostic (1.29e-1)"	24.0	37.3	26.7	33.3	27.4	16.9	30.1	16.9	27.2	22.2	24.7	31.4	30.8	14.1	23.1	32.5	34.7	36.0	36.7	21.7	24.3	26.3	30.9	37.4	27.1	36.7	31.9	20.9	29.5	45.3	46.7	20.5	21.4	27.1	33.8	21.2	26.0	37.2	31.5	22.5	19.5	23.8	35.4	32.4	20.9	26.2	55.4	19.3	41.5	33.9	25.7	29.3	27.6	20.4	42.0	38.9	31.8	27.7	60.4	41.6	32.6	14.6	21.0	14.4	15.7	23.5	31.6	11.6	15.7	16.0	11.9	12.5	16.3	35.8	28.8	37.7	23.8	12.3	15.8	27.0	47.0	15.5	35.3	18.8	13.3	19.6	31.2	41.0	15.5	10.1	30.9	32.8	30.0	57.4	34.7	16.0	27.6	17.8	9.1	22.0	24.7	20.2	17.2	12.7	24.3	14.5	17.8	17.8	45.1	34.5	9.5	15.3	13.9	10.7	14.9	26.8	18.5	24.6	18.6	9.9	14.5	9.1	16.5	15.0	27.4	19.7	22.2	31.2	15.4	6.2	31.8	27.7	25.0	25.2	24.3	27.8	24.1	36.0	30.6	38.9	42.0	41.6	32.6	9.0	60.4	22.5	37.7	32.8	32.6	26.7	27.4	16.9	27.2	24.3	26.3	31.9	20.9	27.1	19.3	32.8	38.0	33.8	48.8	25.1	13.2	37.8	66.2	91.0	30.7	41.8	2.0	102.9	109.5	65.4	163.4	30.6	55.1	0.0	63.9	52.2	45.2	45.6	274.2	58.2	73.6	12.7	56.4	52.2	49.4	281.7	22.5	40.9	43.9	118.2	57.5	55.3	42.9	45.9	37.4	129.3	13.5	25.8	50.1	91.7	45.8	28.5	53.8	64.8	42.6	44.4
NSUN2	"FLJ20303, Misu, MRT5, TRM4"	ENSG00000037474	"NOP2/Sun RNA methyltransferase family member 2"	Q08J23	5	6599239-6633291	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Cell cycle, Cell division, Differentiation, Mitosis, Spermatogenesis, tRNA processing"	"Methyltransferase, RNA-binding, Transferase, tRNA-binding"	"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA037896	Supported		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA037896: AB_10670532"	"unprognostic (3.99e-2)"	"unprognostic (5.73e-2)"	"unprognostic (1.44e-1)"	"unprognostic (7.66e-3)"	"unprognostic (8.56e-2)"	"unprognostic (5.21e-2)"	"unprognostic (1.44e-3)"	"unprognostic (5.12e-2)"	"unprognostic (4.48e-2)"	"unprognostic (1.41e-1)"	"unprognostic (1.84e-1)"	"unprognostic (2.48e-2)"	"prognostic unfavorable (5.69e-5)"	"unprognostic (1.98e-1)"	"unprognostic (1.47e-1)"	"unprognostic (4.30e-3)"	"unprognostic (1.70e-2)"	19.0	19.1	11.3	20.4	17.4	16.7	28.1	13.4	16.0	17.4	17.9	20.2	18.2	15.4	21.5	20.6	27.0	19.3	17.1	20.1	12.7	9.7	15.0	34.9	15.0	22.5	13.6	16.5	17.2	18.7	19.5	22.3	18.2	16.1	15.5	21.2	14.3	20.0	15.8	42.3	22.9	20.9	19.1	15.9	23.7	19.9	15.8	13.2	26.7	14.3	17.1	29.5	19.2	17.1	18.1	16.7	15.6	17.3	17.6	22.7	12.7	27.2	23.7	13.9	12.3	8.9	9.9	32.9	21.4	13.0	22.8	19.8	30.8	20.5	47.1	21.9	17.1	28.7	21.0	28.8	24.9	31.0	32.1	23.3	28.0	56.2	17.9	12.8	48.3	22.7	11.3	18.4	25.8	22.6	9.2	16.1	19.8	36.1	17.3	21.1	19.1	26.4	20.9	23.1	18.4	31.0	34.4	14.6	14.5	16.0	30.3	13.3	18.9	52.8	26.8	20.6	18.8	23.4	21.6	18.8	18.2	24.0	18.8	31.8	14.3	26.8	45.2	14.6	38.5	20.9	9.7	14.6	15.6	17.5	17.3	22.7	18.1	18.4	20.7	16.7	16.5	20.4	20.6	2.9	17.6	15.2	16.5	13.0	12.7	11.3	17.4	13.4	16.0	12.7	9.7	13.6	16.5	16.1	13.2	17.9	14.5	12.9	11.7	33.5	5.3	16.1	17.8	17.4	39.8	17.4	13.7	17.1	8.3	18.8	2.2	12.1	10.5	0.0	13.1	17.7	12.1	13.9	19.7	28.4	12.9	3.2	14.3	9.8	22.4	2.2	12.0	14.6	15.1	19.0	15.5	6.8	19.7	14.1	13.4	8.4	6.8	6.5	13.0	13.5	18.7	26.7	19.3	14.1	17.8	12.8
NT5C1A	"CN-I, CN-IA, CN1, CN1A, MGC119199, MGC119201"	ENSG00000116981	"5'-nucleotidase, cytosolic IA"	Q9BXI3	1	39659121-39672038	"Enzymes, Predicted intracellular proteins"	"Nucleotide metabolism"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"skeletal muscle: 51.9;tongue: 13.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	13	"SH-SY5Y: 20.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA050283, HPA054158"	Supported					NA	NA					"HPA050283: AB_2681072, HPA054158: AB_2682402"	"unprognostic (7.85e-2)"				"unprognostic (1.60e-1)"	"unprognostic (6.19e-1)"		"unprognostic (1.51e-3)"	"unprognostic (7.19e-2)"		"unprognostic (2.87e-1)"	"unprognostic (3.34e-1)"	"unprognostic (1.32e-1)"	"unprognostic (3.29e-2)"		"unprognostic (1.81e-2)"		0.7	2.8	1.2	0.8	3.0	0.5	0.5	5.6	7.6	0.7	0.5	1.0	0.0	0.5	0.6	2.9	3.0	0.7	0.5	9.8	1.7	1.7	0.9	0.5	0.5	0.5	1.8	4.9	0.7	6.0	0.5	0.5	0.5	6.9	0.9	0.5	0.0	0.7	0.7	51.9	0.5	0.6	0.6	5.2	0.5	0.6	0.7	1.0	0.0	0.5	13.9	0.5	0.5	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	20.4	0.0	0.0	0.3	0.0	0.0	1.5	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	3.0	5.6	7.6	1.7	1.7	1.8	4.9	6.9	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
NT5C1B	"AIRP, CN-IB"	ENSG00000185013	"5'-nucleotidase, cytosolic IB"	Q96P26	2	18562872-18589572	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Nucleotide metabolism"	Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	14	"testis: 52.6"	"Group enriched"	"Detected in some"	90	"Early spermatids: 137.7;Late spermatids: 218.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"											HPA056683	Uncertain					NA	NA					"HPA056683: AB_2683207"	"unprognostic (4.18e-2)"	"unprognostic (1.20e-2)"	"unprognostic (7.67e-2)"	"unprognostic (1.31e-1)"	"unprognostic (1.02e-1)"	"unprognostic (4.97e-2)"	"unprognostic (4.96e-2)"	"unprognostic (4.84e-1)"	"unprognostic (8.49e-2)"	"unprognostic (4.42e-2)"	"unprognostic (2.91e-2)"	"unprognostic (2.35e-1)"	"unprognostic (1.61e-1)"	"unprognostic (6.96e-2)"	"unprognostic (2.50e-1)"	"unprognostic (1.15e-1)"	"unprognostic (3.77e-1)"	0.1	0.3	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.4	0.1	0.3	0.7	0.0	0.4	0.3	0.1	0.0	0.1	0.2	0.1	0.1	0.1	0.1	0.1	0.2	0.0	0.3	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.8	0.1	0.1	0.1	0.1	0.5	52.6	0.1	0.1	0.5	0.1	0.1	0.5	0.1	1.2	3.7	0.0	0.1	0.7	2.6	0.4	3.2	0.7	0.3	0.0	0.0	0.0	0.5	2.5	0.0	0.0	0.0	0.0	3.5	1.6	0.5	0.0	2.2	1.0	0.0	0.0	0.0	0.6	0.0	0.5	0.0	0.9	0.0	0.6	0.1	0.0	0.0	0.2	0.0	3.3	0.0	0.5	1.1	0.2	0.0	2.9	0.1	0.2	0.6	0.6	1.6	0.3	0.7	0.8	0.1	2.9	2.4	1.2	2.6	0.4	1.5	0.4	0.7	0.7	1.6	1.5	1.0	2.9	0.5	1.0	0.7	2.0	2.5	0.0	1.2	0.0	0.1	0.0	1.3	0.0	2.3	0.1	1.3	1.3	0.3	1.2	2.6	2.2	0.0	0.7	0.1	3.7	0.5	0.4	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	137.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	218.9	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	1.6	1.2	0.0	0.0	0.0	0.0	0.0
NT5C2	"cN-II, GMP, NT5B, PNT5, SPG65"	ENSG00000076685	"5'-nucleotidase, cytosolic II"	P49902	10	103088017-103193306	"Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Nucleotide metabolism"	"Allosteric enzyme, Hydrolase"	"Cancer-related genes, Disease mutation, Hereditary spastic paraplegia, Neurodegeneration"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003751	Approved					NA	NA					"HPA003751: AB_1854664"	"unprognostic (8.18e-2)"	"unprognostic (1.98e-1)"	"unprognostic (2.55e-2)"	"unprognostic (2.46e-1)"	"unprognostic (5.54e-2)"	"unprognostic (4.87e-3)"	"unprognostic (2.24e-2)"	"unprognostic (1.72e-1)"	"unprognostic (6.41e-2)"	"unprognostic (9.59e-2)"	"unprognostic (2.93e-3)"	"unprognostic (6.20e-2)"	"unprognostic (3.26e-2)"	"unprognostic (3.70e-2)"	"unprognostic (6.40e-2)"	"unprognostic (3.43e-1)"	"unprognostic (1.50e-1)"	15.0	17.0	17.6	18.2	21.2	31.6	19.7	22.5	19.6	17.5	20.7	25.4	24.5	10.9	24.6	19.6	38.6	14.8	17.0	16.5	16.7	20.7	19.6	15.5	18.8	16.8	21.8	17.3	24.8	19.4	18.7	29.5	16.9	29.1	22.9	17.0	26.2	67.2	21.6	41.6	11.7	13.9	20.4	19.1	20.5	15.9	21.7	14.5	29.7	39.2	16.3	31.5	21.1	31.1	6.7	9.7	23.8	14.5	10.5	8.7	7.1	50.7	20.7	14.4	32.3	12.7	14.1	8.3	25.5	24.8	12.4	12.9	15.0	40.7	24.3	19.8	17.6	10.8	26.0	9.5	13.1	14.6	14.6	8.9	17.5	8.8	14.5	22.7	25.3	8.7	21.7	14.6	10.8	17.5	30.2	11.4	11.8	11.3	17.0	21.5	30.0	22.6	32.8	13.6	15.5	25.6	36.9	12.4	7.0	17.8	29.0	4.3	10.8	13.4	10.6	20.0	20.4	16.1	19.7	11.6	9.9	10.0	14.1	18.6	14.9	24.7	32.6	10.0	29.3	2.8	19.8	11.7	23.8	8.1	11.9	8.7	6.7	7.0	6.5	9.7	4.2	6.0	6.2	21.4	10.5	14.5	7.3	6.5	7.1	17.6	21.2	22.5	18.0	16.7	20.7	21.8	17.3	29.1	14.5	77.4	27.5	10.4	26.3	6.5	19.9	2.4	20.4	32.1	67.1	26.2	43.2	16.3	10.0	27.7	82.0	15.7	21.6	0.0	22.4	10.0	11.0	32.1	8.1	14.9	17.8	44.5	11.1	12.3	30.0	49.8	23.0	20.7	25.3	13.6	16.7	78.8	41.7	14.2	12.7	13.9	53.0	32.3	12.6	23.0	21.5	6.6	29.3	16.6	13.3	73.2
NT5C3A	"cN-III, hUMP1, NT5C3, p36, P5'N-1, PN-I, POMP, PSN1, UMPH, UMPH1"	ENSG00000122643	"5'-nucleotidase, cytosolic IIIA"	Q9H0P0	7	33014113-33062797	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Nucleotide metabolism"	"Hydrolase, Transferase"	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA010630, HPA029058"	Uncertain				"Intracellular and membrane"	NA	NA					"HPA010630: AB_2668319, HPA029058: AB_10601380"	"unprognostic (7.50e-2)"	"unprognostic (3.10e-1)"	"unprognostic (1.14e-1)"	"unprognostic (2.69e-2)"	"unprognostic (1.22e-1)"	"unprognostic (5.56e-2)"	"prognostic unfavorable (2.42e-4)"	"unprognostic (3.25e-2)"	"unprognostic (3.12e-2)"	"unprognostic (2.82e-3)"	"unprognostic (2.08e-2)"	"unprognostic (1.98e-1)"	"prognostic unfavorable (1.70e-4)"	"unprognostic (9.37e-2)"	"unprognostic (2.05e-1)"	"unprognostic (2.12e-3)"	"unprognostic (3.43e-3)"	12.3	12.1	9.9	17.0	9.9	15.4	11.4	16.2	12.2	12.0	27.5	7.4	8.1	20.9	14.7	11.6	12.0	9.0	12.9	11.6	9.8	10.3	11.7	10.5	11.6	15.0	10.3	9.8	10.3	19.1	5.5	10.9	10.6	8.4	9.6	27.2	8.5	9.0	8.9	53.3	15.0	19.7	7.5	9.9	18.4	14.5	6.3	8.9	15.4	9.8	28.8	22.8	12.0	11.6	21.4	6.8	36.6	11.4	8.6	18.9	13.3	14.3	10.5	9.8	8.7	7.4	6.5	7.9	15.7	10.3	10.7	14.6	6.5	40.6	36.1	9.1	9.2	18.7	21.9	10.5	10.4	15.9	5.6	13.5	16.4	12.4	9.4	7.9	19.5	13.6	7.2	9.3	11.7	23.5	6.5	7.0	12.4	14.1	9.6	13.2	9.8	7.2	30.6	10.0	17.3	9.2	9.6	8.9	21.3	34.1	15.1	10.5	13.1	10.3	19.4	24.6	8.6	12.9	10.9	6.1	9.1	8.2	15.5	20.5	19.3	22.0	17.7	7.5	12.1	14.2	26.9	8.0	29.8	9.0	10.2	10.2	21.4	12.1	11.0	6.8	20.5	12.4	10.6	36.6	8.6	11.4	6.4	18.9	13.3	9.9	9.9	16.2	12.2	9.8	10.3	10.3	9.8	8.4	8.9	20.8	10.7	82.5	30.5	41.6	22.0	14.0	30.6	37.5	27.3	15.7	39.3	30.8	24.9	25.8	3.2	34.9	102.1	46.7	70.0	25.2	31.9	27.6	17.3	16.3	22.9	1.6	114.8	20.3	26.5	3.6	31.4	25.2	25.3	17.2	74.0	23.6	44.1	98.2	20.8	48.5	23.5	12.9	27.8	30.9	17.2	34.0	23.7	34.5	50.5	60.6
NT5C3B	"cN-IIIB, MGC20781, NT5C3L"	ENSG00000141698	"5'-nucleotidase, cytosolic IIIB"	Q969T7	17	41825181-41836263	"Enzymes, Predicted intracellular proteins"	"Nucleotide metabolism"	Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Spermatocytes: 135.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030786, HPA057095"	Approved					NA	NA					"HPA030786: AB_10602716, HPA057095: AB_2683333"	"unprognostic (3.90e-2)"	"unprognostic (5.75e-2)"	"unprognostic (8.87e-2)"	"unprognostic (1.46e-1)"	"unprognostic (2.25e-1)"	"unprognostic (1.21e-1)"	"prognostic unfavorable (8.11e-5)"	"unprognostic (3.40e-2)"	"unprognostic (6.05e-2)"	"unprognostic (2.31e-1)"	"prognostic favorable (2.67e-4)"	"unprognostic (3.07e-1)"	"unprognostic (7.17e-3)"	"unprognostic (2.36e-2)"	"unprognostic (4.80e-3)"	"unprognostic (7.14e-3)"	"unprognostic (1.42e-2)"	10.0	12.4	15.9	8.3	26.2	3.2	18.3	22.8	31.2	11.6	15.6	8.4	10.1	4.4	14.1	21.3	13.9	12.6	11.5	11.4	15.0	14.9	19.2	19.4	11.0	7.9	12.9	16.4	15.5	19.6	21.1	13.7	11.5	13.2	12.6	13.8	12.6	15.9	20.1	7.8	8.6	8.1	22.1	6.7	7.7	12.0	24.8	9.8	1.4	37.8	5.6	10.7	13.3	9.7	5.3	5.2	2.5	5.6	1.0	5.9	4.1	8.6	13.0	22.2	29.2	20.4	17.3	3.1	8.7	25.4	27.8	27.8	10.6	5.1	13.0	4.5	17.8	17.4	8.4	22.0	12.3	45.2	6.4	8.7	7.9	13.5	11.2	13.6	0.1	3.3	12.2	11.8	23.5	19.2	20.9	16.1	10.4	7.3	8.1	19.6	5.1	12.6	3.0	5.9	17.2	1.9	10.8	29.6	12.0	12.1	9.4	13.6	7.0	13.1	47.0	4.6	28.9	12.7	4.7	11.0	8.6	6.7	14.3	17.9	1.6	6.6	6.3	11.2	0.2	10.5	1.5	5.6	0.5	3.8	1.0	5.8	4.7	5.9	5.1	5.2	5.3	5.4	4.5	2.5	1.0	0.7	2.7	0.8	4.1	15.9	26.2	22.8	31.2	15.0	14.9	12.9	16.4	13.2	9.8	8.9	15.0	15.7	49.4	16.1	30.4	11.2	7.6	14.7	7.9	27.9	17.7	35.2	86.2	47.9	69.9	21.5	2.5	0.0	36.0	48.9	37.1	35.6	11.5	19.7	11.9	109.7	37.8	19.0	7.9	92.8	30.0	17.0	33.7	5.4	12.5	29.9	37.1	12.9	28.7	45.0	27.3	38.8	52.0	135.0	29.1	15.1	26.1	13.8	14.0	38.3
NT5E	"CALJA, CD73, eN, eNT, NT5"	ENSG00000135318	"5'-nucleotidase ecto"	P21589	6	85449584-85495791	"CD markers, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"		Hydrolase	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	7	"Ito cells: 45.4;Pancreatic endocrine cells: 72.9;Rod photoreceptor cells: 77.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"memory B-cell: 13.4;memory CD8 T-cell: 6.6;naive B-cell: 19.9;naive CD8 T-cell: 17.3"	"Group enriched"	"Detected in many"	47	"B-cells: 19.9;T-cells: 17.3"	"Cell line enhanced"	"Detected in many"		"hTERT-RPE1: 93.4;LHCN-M2: 105.7;TIME: 61.2;U-87 MG: 95.4"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			HPA017357	Approved		Supported	"Nucleoplasm,Plasma membrane,Cytosol"	"Intracellular and membrane"	NA	NA		1600000	"Plasma membrane"	"Nucleoplasm, Cytosol"	"HPA017357: AB_1846330"	"unprognostic (1.92e-2)"	"unprognostic (4.44e-3)"	"unprognostic (1.54e-1)"	"unprognostic (1.57e-3)"	"unprognostic (9.33e-2)"	"unprognostic (1.82e-3)"	"unprognostic (1.20e-2)"	"prognostic unfavorable (6.66e-4)"	"unprognostic (5.45e-2)"	"unprognostic (1.80e-1)"	"prognostic unfavorable (1.32e-5)"	"unprognostic (1.39e-1)"	"unprognostic (3.11e-2)"	"prognostic unfavorable (1.02e-4)"	"unprognostic (3.49e-2)"	"unprognostic (2.26e-1)"	"unprognostic (2.78e-1)"	12.2	3.2	9.3	7.7	11.6	0.5	16.6	1.1	6.9	58.8	13.9	3.6	8.1	18.6	33.3	14.8	7.6	12.2	15.4	6.1	5.7	5.5	8.8	26.0	3.4	6.8	6.3	6.6	25.4	1.4	1.6	9.3	42.2	5.3	16.4	15.6	15.3	4.6	17.8	5.7	4.5	14.9	35.3	6.3	7.0	6.0	12.4	4.2	1.6	26.5	7.3	7.1	16.6	20.2	19.9	0.0	0.2	0.0	0.4	17.3	3.9	5.3	2.8	4.9	0.1	11.2	35.7	0.0	34.5	37.8	17.0	32.0	0.0	53.0	0.0	12.4	30.1	43.8	2.7	0.0	34.7	40.6	0.0	0.0	0.0	0.8	0.6	5.6	0.0	0.0	9.1	0.4	34.7	22.1	93.4	14.1	0.0	0.0	0.1	105.7	0.9	0.0	0.0	0.1	0.9	3.8	0.1	1.1	0.1	36.8	2.4	0.0	0.6	0.4	2.1	11.7	0.2	0.0	0.9	61.2	13.9	0.1	17.5	56.1	2.6	1.6	0.0	95.4	0.0	43.5	0.0	0.0	0.2	2.0	0.0	3.5	13.4	2.3	6.6	0.0	19.9	2.4	17.3	0.2	0.4	0.0	0.0	0.8	3.9	9.3	11.6	1.1	6.9	5.7	5.5	6.3	6.6	5.3	4.2	0.0	4.3	15.6	1.0	4.6	4.6	0.8	20.4	6.7	6.8	1.8	9.8	0.4	3.3	3.7	0.5	13.5	10.3	0.0	3.7	1.5	16.9	0.9	0.0	29.0	1.3	0.0	0.0	45.4	5.3	0.9	12.0	2.5	6.8	0.0	33.2	5.6	72.9	31.7	24.1	20.6	77.4	0.0	8.0	0.0	0.2	4.3	12.7	2.2	13.8	5.9
NTHL1	"NTH1, OCTS3"	ENSG00000065057	"Nth like DNA glycosylase 1"	P78549	16	2039815-2047866	"Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"DNA damage, DNA repair"	"Glycosidase, Hydrolase, Lyase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	12	"Hepatocytes: 755.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB025152	Supported					NA	NA					"CAB025152: "	"unprognostic (1.06e-1)"	"unprognostic (9.71e-2)"	"unprognostic (1.23e-1)"	"unprognostic (2.54e-1)"	"unprognostic (7.89e-2)"	"unprognostic (1.77e-1)"	"unprognostic (2.86e-1)"	"unprognostic (2.46e-2)"	"unprognostic (4.98e-2)"	"unprognostic (1.11e-1)"	"unprognostic (2.77e-2)"	"unprognostic (6.78e-2)"	"unprognostic (6.53e-2)"	"unprognostic (2.27e-1)"	"unprognostic (1.34e-1)"	"unprognostic (5.08e-2)"	"unprognostic (1.62e-2)"	10.5	8.2	13.4	10.5	19.9	6.0	7.8	15.6	17.9	14.8	12.3	9.0	15.1	9.7	11.8	6.9	9.4	20.5	14.7	10.6	12.5	12.1	7.4	17.5	11.1	10.4	13.6	15.7	18.8	24.6	5.8	8.7	8.3	13.3	9.8	8.2	9.1	22.2	18.2	12.4	6.3	11.2	7.8	10.4	15.2	11.1	6.4	11.6	9.6	9.5	6.6	8.4	7.8	9.3	21.4	14.7	2.4	14.2	9.7	18.8	8.5	10.8	26.7	7.8	11.8	3.2	6.1	8.7	4.5	4.9	8.7	5.5	19.0	10.6	23.2	9.6	3.8	5.7	9.8	9.6	10.7	1.5	10.7	23.6	7.2	17.0	21.1	4.4	8.2	8.5	5.1	5.5	4.6	5.0	5.8	12.1	14.3	7.8	8.4	3.4	12.1	12.2	30.8	17.3	13.5	17.5	29.4	8.2	37.3	6.2	3.9	16.6	16.5	5.0	15.3	8.8	3.0	11.0	8.1	4.7	7.4	8.2	6.6	8.5	11.5	13.4	9.4	3.3	11.5	9.2	2.4	8.7	2.0	8.8	14.2	9.8	21.4	10.5	9.8	14.7	17.1	7.8	9.5	0.3	9.7	12.1	14.6	18.8	8.5	13.4	19.9	15.6	17.9	12.5	12.1	13.6	15.7	13.3	11.6	26.8	28.0	7.5	16.5	7.7	8.8	9.8	48.4	16.0	15.9	3.5	0.0	9.0	14.9	15.3	7.6	35.9	21.6	0.0	8.0	14.8	13.9	8.1	5.7	755.9	11.6	6.4	64.8	43.0	19.9	16.6	31.4	11.7	20.3	6.4	53.2	10.1	11.3	40.7	23.7	22.5	6.0	12.9	18.9	5.8	30.9	8.8	2.3	9.2	42.8	19.7
NTMT1	"AD-003, C9orf32, HOMT1A, METTL11A, NRMT, NRMT1"	ENSG00000148335	"N-terminal Xaa-Pro-Lys N-methyltransferase 1"	Q9BV86	9	129608884-129636131	"Enzymes, Predicted intracellular proteins"		"Methyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	10	"Early spermatids: 302.3;Late spermatids: 570.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA020092, HPA058420"	Uncertain		Enhanced	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA020092: AB_1853831, HPA058420: AB_2683713"	"unprognostic (4.74e-3)"	"unprognostic (1.77e-1)"	"unprognostic (2.44e-1)"	"unprognostic (1.48e-1)"	"unprognostic (1.17e-1)"	"unprognostic (1.24e-3)"	"unprognostic (4.17e-3)"	"unprognostic (4.92e-2)"	"unprognostic (1.24e-1)"	"unprognostic (8.57e-2)"	"unprognostic (3.63e-1)"	"unprognostic (4.35e-2)"	"unprognostic (1.00e-3)"	"unprognostic (1.11e-3)"	"unprognostic (1.75e-1)"	"unprognostic (5.58e-2)"	"unprognostic (3.50e-3)"	10.2	25.7	11.9	11.5	13.1	13.8	10.0	13.2	15.3	8.9	10.7	9.0	14.4	11.7	8.8	13.6	10.2	7.8	16.6	31.8	11.5	11.5	11.7	16.8	8.9	11.5	15.7	11.3	8.8	19.5	9.4	10.8	12.1	13.8	10.2	7.4	9.4	13.0	11.4	54.6	10.7	10.2	13.6	10.3	13.1	10.5	56.2	10.7	10.8	12.3	22.1	9.8	12.3	14.5	27.1	28.4	20.3	34.2	14.8	26.6	19.4	16.7	34.8	14.4	24.4	9.2	13.7	15.5	31.9	18.9	32.3	28.0	28.5	22.0	21.6	16.4	22.7	23.3	32.7	30.2	28.1	20.4	16.6	16.2	9.0	31.3	28.7	29.5	18.1	13.7	14.6	14.3	33.8	16.9	10.4	17.6	19.3	33.0	16.2	16.8	55.4	20.4	24.5	18.8	31.2	30.4	19.4	17.0	43.2	13.0	9.6	29.3	15.3	15.7	29.5	21.8	9.6	24.5	9.5	11.9	38.9	19.7	36.0	33.4	12.8	15.2	32.8	17.7	18.8	22.2	15.1	27.3	20.3	25.2	28.7	24.8	23.4	25.5	26.6	26.4	27.1	26.4	22.0	7.6	14.8	34.2	28.4	23.4	19.4	11.9	13.1	13.2	15.3	11.5	11.5	15.7	11.3	13.8	10.7	3.0	11.5	55.2	60.7	88.7	16.0	2.8	20.4	10.7	18.2	21.0	21.6	61.3	82.9	57.5	302.3	31.5	59.1	0.0	48.7	71.0	52.7	55.2	30.0	42.9	59.3	39.7	19.4	20.3	27.3	570.1	32.5	46.3	52.3	28.9	25.6	18.8	57.3	24.6	23.3	72.8	22.1	25.8	84.4	60.3	47.2	86.8	113.4	40.1	37.2	65.8
NTPCR	"C1orf57, HCR-NTPase, MGC13186"	ENSG00000135778	"Nucleoside-triphosphatase, cancer-related"	Q9BSD7	1	232950605-232983882	"Enzymes, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028125, HPA054304"	Uncertain		Approved	Cytosol		NA	NA			Cytosol		"HPA028125: AB_10601091, HPA054304: AB_2682443"	"unprognostic (2.67e-1)"	"unprognostic (2.28e-2)"	"unprognostic (1.63e-2)"	"unprognostic (7.59e-2)"	"unprognostic (5.85e-3)"	"unprognostic (1.04e-1)"	"unprognostic (8.70e-3)"	"unprognostic (2.12e-1)"	"unprognostic (6.00e-2)"	"unprognostic (5.03e-3)"	"unprognostic (4.78e-2)"	"unprognostic (1.08e-1)"	"unprognostic (2.66e-1)"	"unprognostic (2.74e-2)"	"unprognostic (1.73e-1)"	"unprognostic (1.08e-1)"	"unprognostic (6.37e-3)"	5.4	9.8	13.2	5.8	14.9	2.5	8.7	14.5	15.9	9.9	8.0	11.1	4.1	5.1	9.6	9.5	8.0	11.3	9.6	10.3	13.3	13.1	8.4	6.1	7.4	6.5	13.7	10.8	12.9	13.4	16.9	8.0	6.3	18.5	8.8	10.3	10.8	10.1	10.0	26.8	9.9	6.8	9.9	12.6	6.3	5.8	11.2	11.0	5.7	13.6	11.1	6.5	7.1	7.4	2.4	1.5	3.3	1.8	1.6	4.3	1.3	2.5	6.2	7.1	3.5	5.3	7.0	0.1	1.7	5.5	5.3	7.2	4.4	3.0	3.9	3.8	3.4	3.0	3.4	4.7	6.3	5.8	2.9	8.9	1.2	3.9	5.6	5.5	2.1	2.4	9.3	12.3	5.1	5.2	5.3	4.3	7.5	3.4	6.1	6.2	1.8	5.5	5.6	7.0	5.1	7.4	3.6	4.6	5.7	7.8	3.1	6.2	10.3	2.4	2.1	2.5	5.6	5.2	4.8	3.2	4.4	3.6	4.8	4.7	6.9	5.6	4.5	5.2	5.2	6.3	1.1	1.6	0.8	2.1	1.8	2.5	1.6	3.0	1.3	1.5	2.4	4.3	3.5	3.3	1.6	1.6	0.6	3.5	1.3	13.2	14.9	14.5	15.9	13.3	13.1	13.7	10.8	18.5	11.0	17.9	19.7	13.4	32.1	17.2	15.2	58.9	28.1	12.0	11.4	24.4	25.5	55.1	79.6	53.6	28.3	24.0	38.0	0.0	56.9	49.7	26.7	31.6	16.1	32.1	37.9	9.5	24.8	26.4	19.2	21.4	18.7	22.0	21.9	33.3	46.4	34.1	37.9	21.0	28.7	60.8	20.0	12.9	24.7	60.2	34.9	20.8	23.5	17.5	61.5	31.6
NTRK1	"MTC, TRK, TRKA"	ENSG00000198400	"Neurotrophic receptor tyrosine kinase 1"	P04629	1	156815640-156881850	"Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Predicted membrane proteins, RAS pathway related proteins"	"Differentiation, Neurogenesis"	"Developmental protein, Kinase, Receptor, Transferase, Tyrosine-protein kinase"	"Cancer-related genes, Disease mutation, FDA approved drug targets, Proto-oncogene"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	8	"adrenal gland: 15.8;blood: 32.3;brain: 28.3"	"Group enriched"	"Detected in some"	8	"granulocytes: 56.4;Horizontal cells: 54.0"	"Cancer enhanced"	"Detected in some"		"glioma: 1.3"	"Region enriched"	"Detected in many"	5	"pons and medulla: 28.3"	"Cell type enriched"	"Detected in single"	127	"basophil: 32.3"	"Lineage enriched"	"Detected in single"	323	"granulocytes: 32.3"	"Cell line enriched"	"Detected in some"	4	"HMC-1: 42.1"	"Region enhanced"	"Detected in some"		"basal ganglia: 8.2"	"Low region specificity"	"Detected in all"			"CAB004606, HPA035799, HPA076570"	Approved		Approved	Vesicles,Cytosol		NA	NA		140000	"Vesicles, Cytosol"		"CAB004606: AB_628397, HPA035799: AB_2674788, HPA076570: "	"unprognostic (5.89e-3)"	"unprognostic (7.56e-2)"	"unprognostic (2.74e-2)"	"unprognostic (5.99e-3)"	"unprognostic (7.26e-2)"	"unprognostic (1.43e-3)"	"unprognostic (1.56e-1)"	"unprognostic (7.42e-3)"	"unprognostic (7.63e-2)"	"unprognostic (1.35e-1)"	"unprognostic (6.73e-2)"	"unprognostic (2.29e-2)"	"unprognostic (3.18e-11)"	"unprognostic (2.18e-3)"	"unprognostic (3.79e-2)"	"unprognostic (1.07e-1)"	"unprognostic (4.89e-1)"	1.0	15.8	0.5	0.8	6.0	0.9	0.4	0.0	0.7	0.9	1.1	0.1	0.0	0.8	1.6	2.0	0.7	0.6	2.1	1.5	0.0	1.2	2.9	0.2	1.9	0.3	2.1	0.6	0.3	0.3	0.3	1.1	0.5	28.3	2.2	0.2	3.1	1.2	0.5	0.7	0.2	0.4	1.1	1.2	0.2	1.0	2.4	1.5	0.4	0.3	0.0	0.4	0.7	0.8	0.0	0.0	32.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	5.7	0.0	6.8	0.0	0.0	0.0	0.0	42.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.8	0.0	0.0	0.0	1.2	0.0	0.0	0.6	1.2	0.0	0.1	0.0	0.0	0.8	9.6	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.6	0.0	0.0	1.6	0.2	0.0	0.0	0.0	0.0	32.3	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	6.0	0.0	0.6	0.0	1.2	2.1	0.6	28.3	1.5	0.0	2.2	0.0	0.0	0.0	6.8	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	56.4	0.0	0.1	54.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.2	2.5	0.1	0.0	0.0	0.0	0.0
NTRK2	TRKB	ENSG00000148053	"Neurotrophic receptor tyrosine kinase 2"	Q16620	9	84668551-85027070	"Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted membrane proteins, RAS pathway related proteins"	"Differentiation, Neurogenesis"	"Developmental protein, Kinase, Receptor, Transferase, Tyrosine-protein kinase"	"Cancer-related genes, Disease mutation, Epilepsy, Obesity"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 133.8;thyroid gland: 63.4"	"Cell type enhanced"	"Detected in many"	12	"Horizontal cells: 228.8;Leydig cells: 96.4;Muller glia cells: 248.1;Sertoli cells: 122.9;Smooth muscle cells: 96.9"	"Group enriched"	"Detected in many"	5	"glioma: 31.6;head and neck cancer: 8.0;lung cancer: 9.8;thyroid cancer: 26.4"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"T-reg: 1.4"	"Lineage enriched"	"Detected in single"	14	"T-cells: 1.4"	"Cell line enhanced"	"Detected in some"		"AF22: 10.4;HaCaT: 3.7;RPTEC TERT1: 11.7;SH-SY5Y: 13.4;SuSa: 6.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007637, CAB010346, HPA074873"	Enhanced		Approved	Cytosol		NA	NA		13000000	Cytosol		"CAB010346: AB_2155274, HPA007637: AB_1080385, HPA074873: "	"unprognostic (2.75e-3)"	"unprognostic (3.48e-2)"	"unprognostic (1.82e-2)"	"unprognostic (3.26e-1)"	"unprognostic (9.26e-2)"	"unprognostic (2.56e-2)"	"unprognostic (1.29e-2)"	"unprognostic (9.16e-2)"	"unprognostic (6.13e-2)"	"unprognostic (1.05e-1)"	"unprognostic (4.25e-2)"	"unprognostic (2.18e-2)"	"unprognostic (2.66e-2)"	"unprognostic (1.20e-2)"	"unprognostic (1.21e-2)"	"unprognostic (1.31e-1)"	"unprognostic (1.39e-3)"	19.8	2.7	66.1	2.0	56.7	1.2	33.2	15.1	133.8	6.4	4.4	27.4	0.0	1.4	3.0	3.3	5.6	3.7	18.7	5.8	61.0	30.7	12.5	2.1	6.3	2.7	32.4	41.4	6.6	18.9	1.6	3.0	2.1	34.1	3.8	3.1	2.0	8.6	11.9	2.0	7.2	1.6	3.0	22.1	6.5	1.4	2.4	34.1	0.0	63.4	2.6	3.4	3.5	3.8	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	10.4	0.0	0.0	0.0	0.0	0.8	0.1	0.0	0.0	0.0	1.7	0.0	0.2	0.0	0.0	3.7	0.0	0.0	0.0	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	1.4	0.0	0.0	0.0	0.0	11.7	0.8	0.9	13.4	0.0	0.0	0.0	6.2	0.0	0.0	0.0	0.0	0.2	0.0	0.5	0.0	0.1	0.0	0.4	0.0	3.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	66.1	56.7	15.1	45.6	61.0	30.7	32.4	41.4	34.1	34.1	0.0	0.3	0.0	1.0	50.4	24.4	8.7	0.0	2.7	0.0	8.7	5.9	0.0	23.2	26.5	1.5	4.5	0.0	0.0	0.6	0.1	10.6	0.9	0.0	0.0	0.2	228.8	0.0	5.5	0.0	1.7	96.4	1.2	16.9	1.0	0.0	248.1	0.5	7.2	45.3	7.9	9.1	122.9	96.9	0.7	1.1	21.5	0.0	0.0	5.4	0.8
NTRK3	TRKC	ENSG00000140538	"Neurotrophic receptor tyrosine kinase 3"	Q16288	15	87859751-88256768	"Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Differentiation, Neurogenesis"	"Developmental protein, Kinase, Receptor, Transferase, Tyrosine-protein kinase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 41.8"	"Cell type enhanced"	"Detected in many"	13	"Bipolar cells: 58.9;Early spermatids: 85.5;Late spermatids: 103.3;Sertoli cells: 51.8;Smooth muscle cells: 37.7"	"Cancer enhanced"	"Detected in some"		"glioma: 2.5"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Cell line enriched"	"Detected in some"	8	"U-138 MG: 48.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009233, HPA027484, HPA048065"	Approved		Supported	"Nuclear membrane,Nucleoli,Nucleoli rim"		NA	NA		11000000	"Nucleoli, Nucleoli rim"	"Nuclear membrane"	"CAB009233: AB_632555, HPA027484: AB_2672297, HPA048065: AB_2680245"	"unprognostic (1.27e-3)"	"unprognostic (1.24e-2)"	"unprognostic (1.98e-2)"	"unprognostic (2.04e-2)"	"unprognostic (1.65e-1)"	"unprognostic (3.34e-1)"	"unprognostic (3.18e-2)"	"unprognostic (2.23e-2)"	"unprognostic (2.34e-1)"	"unprognostic (3.91e-1)"	"unprognostic (2.88e-1)"	"unprognostic (1.09e-1)"	"unprognostic (5.78e-3)"	"unprognostic (6.45e-3)"	"unprognostic (1.06e-2)"	"unprognostic (1.26e-2)"	"unprognostic (2.49e-3)"	20.8	7.4	22.0	2.5	28.1	1.5	6.2	30.4	41.8	7.0	4.0	8.4	1.3	2.0	12.4	6.7	3.4	9.5	3.9	5.5	22.0	11.1	5.1	2.0	5.7	3.1	11.2	18.7	5.1	2.9	1.6	7.9	2.8	14.7	6.8	4.7	8.0	11.5	8.7	1.9	2.9	2.5	7.7	13.7	4.1	3.0	13.8	13.7	0.0	2.5	0.7	4.3	7.1	4.8	0.7	0.4	1.3	0.5	0.5	0.8	0.0	0.0	6.1	1.3	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.5	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	48.6	0.9	0.0	0.6	0.0	0.0	0.0	1.4	0.0	0.1	1.2	0.5	0.4	0.3	0.1	0.2	0.4	0.3	0.3	0.1	0.7	0.4	0.4	1.3	0.5	0.1	0.4	0.8	0.0	22.0	28.1	30.4	28.9	22.0	11.1	11.2	18.7	14.7	13.7	0.0	0.0	0.0	5.9	0.5	58.9	5.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	85.5	0.7	0.0	0.0	0.0	0.0	1.7	0.6	0.0	0.0	0.9	1.6	0.0	1.8	0.0	103.3	3.1	0.2	0.0	0.0	0.0	8.9	0.0	0.0	25.8	0.0	2.7	51.8	37.7	8.8	1.9	0.1	0.1	0.0	0.0	0.1
NUAK1	"ARK5, KIAA0537, NuaK1"	ENSG00000074590	"NUAK family kinase 1"	O60285	12	106063340-106140033	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Cell adhesion, DNA damage"	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 24.3;parathyroid gland: 18.6"	"Cell type enhanced"	"Detected in many"	12	"Cardiomyocytes: 46.0;Endothelial cells: 46.6;Ito cells: 119.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"memory CD8 T-cell: 1.4;naive CD8 T-cell: 1.3"	"Lineage enriched"	"Detected in single"	14	"T-cells: 1.4"	"Cell line enhanced"	"Detected in many"		"AF22: 23.1;EFO-21: 23.1;RH-30: 33.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA057143			Approved	"Nucleoplasm,Nucleoli fibrillar center,Microtubules"		Yes	No			"Nucleoli fibrillar center"	"Nucleoplasm, Microtubules"	"HPA057143: AB_2683349"	"unprognostic (4.20e-2)"	"unprognostic (8.42e-2)"	"unprognostic (3.71e-2)"	"prognostic unfavorable (9.83e-4)"	"unprognostic (4.13e-2)"	"unprognostic (2.34e-1)"	"unprognostic (1.43e-1)"	"unprognostic (4.80e-2)"	"unprognostic (9.91e-2)"	"unprognostic (4.06e-3)"	"unprognostic (3.29e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.93e-3)"	"prognostic unfavorable (4.27e-4)"	"unprognostic (2.31e-1)"	"unprognostic (8.70e-2)"	"unprognostic (4.47e-2)"	8.2	1.8	4.2	2.0	13.0	0.0	5.5	9.9	20.1	4.6	1.7	24.3	1.1	1.0	5.8	1.6	1.9	3.6	2.7	11.3	5.1	3.3	2.5	2.4	4.9	1.5	8.7	8.4	3.2	1.2	18.6	1.9	2.5	7.6	3.6	2.2	2.3	1.8	3.7	9.4	11.6	1.5	6.3	5.5	1.1	1.5	1.3	9.3	1.1	1.8	1.1	1.4	3.4	3.7	0.0	0.0	0.0	0.0	0.0	1.4	0.0	5.0	3.4	23.1	0.2	9.3	1.0	10.7	5.7	3.9	4.4	3.3	1.7	0.8	0.0	23.1	10.4	1.9	4.8	4.8	4.6	2.1	0.0	1.3	0.0	3.7	1.8	1.9	0.0	0.0	4.8	3.1	2.5	0.8	7.6	8.4	0.0	0.0	16.8	3.1	0.5	0.1	0.2	4.5	0.0	1.4	0.0	33.2	4.0	2.5	5.9	2.7	0.1	2.6	0.8	0.2	15.9	1.2	0.1	6.2	3.8	12.9	1.4	6.8	0.0	0.0	0.3	1.1	0.0	3.8	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.3	1.4	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	4.2	13.0	9.9	17.5	5.1	3.3	8.7	8.4	7.6	9.3	0.0	3.7	0.0	32.0	11.9	30.8	46.0	2.5	0.0	5.7	7.0	0.0	0.4	3.3	5.0	0.3	46.6	0.0	23.3	8.3	4.1	9.2	4.4	0.0	10.5	6.1	38.1	0.0	119.1	9.7	1.7	3.7	1.3	10.1	1.0	2.0	1.7	11.7	0.0	2.8	1.4	2.6	0.0	14.4	0.7	5.5	13.9	0.2	0.9	0.9	3.7
NUAK2	"FLJ90349, SNARK"	ENSG00000163545	"NUAK family kinase 2"	Q9H093	1	205302059-205321791	"Enzymes, Predicted membrane proteins"	Apoptosis	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 42.4"	"Cell type enhanced"	"Detected in many"	6	"Collecting duct cells: 31.4;Ductal cells: 40.9;monocytes: 48.7;Mucus-secreting cells: 40.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in all"		"neutrophil: 42.4"	"Group enriched"	"Detected in all"	4	"B-cells: 15.3;granulocytes: 42.4;T-cells: 10.7"	"Cell line enhanced"	"Detected in many"		"BEWO: 22.8;RPMI-8226: 17.6;RPTEC TERT1: 20.9;SuSa: 24.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA008958	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"HPA008958: AB_1080040"	"unprognostic (2.24e-2)"	"unprognostic (6.33e-2)"	"unprognostic (1.17e-1)"	"prognostic unfavorable (3.01e-7)"	"unprognostic (8.24e-3)"	"unprognostic (1.58e-2)"	"unprognostic (3.00e-2)"	"unprognostic (1.08e-2)"	"unprognostic (1.74e-1)"	"unprognostic (9.19e-2)"	"prognostic favorable (7.94e-6)"	"unprognostic (3.71e-2)"	"unprognostic (3.17e-2)"	"unprognostic (4.90e-2)"	"unprognostic (5.80e-2)"	"unprognostic (4.54e-2)"	"unprognostic (1.61e-1)"	1.4	2.8	0.8	12.5	2.4	8.3	0.9	9.2	1.5	18.9	10.4	3.9	2.4	13.6	2.7	3.8	31.3	3.4	1.3	1.1	1.7	1.0	14.5	3.6	16.2	20.3	5.5	1.5	3.3	13.2	0.1	2.3	7.2	2.0	1.5	7.5	9.8	9.7	2.0	0.7	12.9	15.4	0.9	2.7	10.4	2.0	5.6	2.4	5.5	14.5	20.1	31.7	2.8	24.6	15.3	3.6	42.4	5.6	5.7	10.7	5.4	2.1	11.6	7.1	0.3	0.1	0.3	22.8	2.8	2.9	7.6	3.1	12.2	0.4	3.4	1.7	0.7	12.5	4.2	1.6	4.2	3.3	0.0	0.2	0.0	0.7	2.1	4.9	0.0	0.0	1.3	3.1	4.4	2.6	1.7	0.3	0.0	0.4	0.9	1.4	0.5	0.0	0.0	4.5	1.5	0.3	0.0	0.5	17.6	20.9	0.0	1.1	0.1	0.8	3.3	0.3	24.7	3.3	0.0	0.8	2.7	1.3	0.3	4.3	6.2	0.9	2.1	0.4	0.0	1.0	3.4	5.6	13.2	3.9	4.2	2.8	14.2	4.8	4.6	3.6	15.3	10.7	8.1	42.4	5.7	4.1	1.4	2.8	5.4	0.8	2.4	9.2	1.5	1.7	1.0	5.5	1.5	2.0	2.4	6.0	5.0	9.1	0.8	1.0	0.8	1.4	20.4	2.7	0.0	31.4	0.0	6.5	5.0	40.9	1.7	2.2	20.3	0.0	1.5	27.7	4.0	1.8	0.0	2.9	4.6	0.0	10.4	1.3	11.7	1.2	0.0	6.5	6.8	48.7	40.0	1.7	7.2	2.9	0.0	15.0	0.5	6.5	2.5	0.5	0.9	4.6	3.4	4.5	18.7	0.2
NUDT1	MTH1	ENSG00000106268	"Nudix hydrolase 1"	P36639	7	2242222-2251146	"Cancer-related genes, Enzymes, Predicted intracellular proteins"		"Hydrolase, RNA-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 59.5"	"Cell type enhanced"	"Detected in many"	7	"Erythroid cells: 233.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA012636	Approved		Supported	Cytosol		No	No			Cytosol		"HPA012636: AB_1854696"	"unprognostic (1.31e-1)"	"unprognostic (1.19e-2)"	"unprognostic (2.13e-2)"	"unprognostic (2.37e-1)"	"unprognostic (3.01e-3)"	"unprognostic (3.37e-1)"	"prognostic unfavorable (4.44e-4)"	"unprognostic (2.15e-2)"	"unprognostic (4.77e-1)"	"unprognostic (3.81e-2)"	"unprognostic (3.81e-2)"	"unprognostic (1.53e-1)"	"prognostic unfavorable (1.30e-7)"	"unprognostic (1.29e-1)"	"unprognostic (6.71e-2)"	"unprognostic (3.49e-2)"	"unprognostic (1.70e-1)"	8.8	3.9	7.4	12.6	13.4	37.1	10.8	5.0	10.8	5.9	9.0	8.7	2.2	9.1	8.2	9.2	13.1	6.0	8.1	11.3	8.7	4.7	4.1	2.9	7.2	18.9	8.2	7.0	4.8	4.0	0.7	1.8	5.8	7.2	7.2	6.3	4.0	5.5	4.2	12.0	18.8	9.3	10.5	11.9	11.1	5.5	26.7	5.3	30.7	4.1	14.4	17.2	6.8	8.1	18.3	59.5	11.9	21.3	10.1	20.4	13.0	21.7	35.1	19.3	25.5	7.1	9.8	14.2	9.6	8.4	13.2	15.4	18.9	16.5	23.0	7.8	10.5	26.9	26.6	14.6	14.6	7.7	10.2	25.0	17.9	29.6	16.0	1.7	13.9	18.1	6.4	3.8	19.0	6.8	4.3	7.1	33.5	14.2	25.7	14.7	55.5	25.9	54.2	41.4	10.8	21.7	36.3	28.6	19.2	7.2	12.3	19.4	26.9	9.9	29.2	4.4	14.6	19.2	37.0	6.5	12.7	48.5	29.3	22.8	19.9	15.0	23.8	12.8	34.7	45.6	9.0	17.5	11.9	12.9	21.3	10.2	18.3	15.1	13.6	26.6	18.0	15.1	13.1	4.6	10.1	17.4	59.5	20.4	13.0	7.4	13.4	5.0	10.8	8.7	4.7	8.2	7.0	7.2	5.3	6.0	6.9	41.2	21.9	35.6	10.2	15.1	12.7	8.1	7.9	10.4	3.9	30.9	16.6	20.1	42.6	10.8	14.4	233.6	32.2	67.3	28.8	13.6	61.0	5.3	76.9	0.0	7.5	4.3	37.3	78.4	20.4	69.4	43.9	36.9	26.8	18.6	17.6	17.3	17.7	11.7	6.1	32.3	28.5	80.4	63.8	32.4	19.8	39.2	33.8	16.0
NUDT10	"DIPP3a, hDIPP3alpha"	ENSG00000122824	"Nudix hydrolase 10"	Q8NFP7	X	51332231-51337525	"Enzymes, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"ductus deferens: 28.8;seminal vesicle: 36.3;testis: 27.2"	"Group enriched"	"Detected in some"	5	"Ito cells: 54.6;Peritubular cells: 27.3"	"Group enriched"	"Detected in many"	6	"glioma: 5.0;prostate cancer: 5.4;testis cancer: 7.7"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"NK-cell: 2.1"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"AF22: 6.2;HAP1: 11.6;HEK 293: 8.6;NTERA-2: 21.3;SH-SY5Y: 4.6;SuSa: 4.4;U-2 OS: 10.7"									"HPA047027, HPA057684"	Approved		Approved	Cytosol		NA	NA			Cytosol		"HPA047027: AB_2679907, HPA057684: AB_2683501"	"unprognostic (2.61e-2)"	"unprognostic (1.12e-2)"	"unprognostic (7.40e-3)"	"unprognostic (7.84e-2)"	"unprognostic (1.82e-1)"	"unprognostic (2.51e-2)"	"unprognostic (1.16e-1)"	"unprognostic (2.06e-1)"	"unprognostic (2.54e-2)"	"unprognostic (1.11e-1)"	"unprognostic (2.49e-2)"	"unprognostic (1.27e-1)"	"unprognostic (1.51e-3)"	"unprognostic (1.80e-3)"	"unprognostic (1.04e-2)"	"unprognostic (1.12e-2)"	"unprognostic (5.04e-5)"	1.0	2.3	9.3	1.4	10.7	1.8	1.4	6.0	13.1	4.4	2.0	0.9	28.8	1.1	5.5	18.3	1.7	3.4	2.0	0.9	4.9	13.6	3.1	1.9	0.7	0.9	5.3	8.0	19.2	0.6	0.5	4.5	0.5	6.2	17.9	1.3	0.8	1.0	36.3	0.5	1.0	1.2	4.9	1.9	3.1	1.1	27.2	1.2	0.0	0.8	0.0	0.9	2.8	2.9	0.8	0.1	0.0	0.7	2.1	1.0	0.3	0.0	0.0	6.2	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	1.0	0.0	11.6	0.5	0.0	0.0	8.6	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	21.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	4.6	0.0	0.0	0.0	4.4	0.0	0.0	0.0	0.0	10.7	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.7	0.0	0.1	0.1	0.0	0.8	1.0	0.0	0.1	0.3	0.0	0.6	0.0	2.1	0.5	0.0	0.0	0.3	9.3	10.7	6.0	11.7	4.9	13.6	5.3	8.0	6.2	1.2	0.0	2.2	0.0	4.6	0.9	0.0	0.2	0.0	0.0	1.2	0.0	0.0	0.1	0.0	0.0	1.2	0.6	0.0	0.0	0.0	0.4	0.4	2.1	0.0	0.0	0.2	0.0	0.0	54.6	3.4	4.0	5.5	0.0	1.7	0.0	0.0	1.8	0.0	0.0	27.3	0.0	0.4	0.0	1.9	2.4	7.9	0.1	0.3	0.0	0.0	0.0
NUDT11	"DIPP3b, FLJ10628, hDIPP3beta"	ENSG00000196368	"Nudix hydrolase 11"	Q96G61	X	51490011-51496596	"Enzymes, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 26.1;testis: 35.5"	"Cell type enhanced"	"Detected in many"	7	"Basal keratinocytes: 13.6;Peritubular cells: 19.4;Smooth muscle cells: 12.7;Spermatocytes: 13.4;Spermatogonia: 11.9"	"Cancer enhanced"	"Detected in many"		"testis cancer: 17.4"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"gdT-cell: 3.7;MAIT T-cell: 1.4;memory CD4 T-cell: 1.2;memory CD8 T-cell: 1.9;naive CD8 T-cell: 3.1;NK-cell: 1.9"	"Group enriched"	"Detected in many"	5	"NK-cells: 1.9;T-cells: 3.7"	"Cell line enhanced"	"Detected in many"		"HAP1: 33.6;NTERA-2: 21.0"									"HPA047027, HPA057684"	Approved		Approved	Cytosol		NA	NA			Cytosol		"HPA047027: AB_2679907, HPA057684: AB_2683501"	"unprognostic (2.01e-1)"	"unprognostic (2.57e-1)"	"unprognostic (8.21e-2)"	"unprognostic (1.93e-3)"	"unprognostic (6.61e-2)"	"unprognostic (1.13e-3)"	"unprognostic (5.52e-3)"	"unprognostic (1.25e-1)"	"unprognostic (2.25e-2)"	"unprognostic (2.18e-1)"	"unprognostic (8.41e-2)"	"unprognostic (1.33e-1)"	"unprognostic (7.80e-12)"	"unprognostic (4.34e-4)"	"unprognostic (1.17e-2)"	"unprognostic (2.78e-1)"	"unprognostic (3.94e-4)"	1.2	5.4	11.2	1.4	21.9	1.6	2.8	7.4	26.1	3.8	2.6	0.8	4.4	1.7	5.9	4.3	1.9	1.6	2.2	0.8	7.0	17.9	0.9	0.6	0.8	1.1	5.3	12.7	10.0	3.8	0.5	2.8	0.6	5.3	10.1	1.4	0.5	1.3	11.9	0.6	1.7	1.5	5.0	1.8	0.9	0.9	35.5	1.1	3.6	1.0	0.2	1.1	1.7	1.6	0.5	0.4	0.0	0.2	1.9	3.7	1.0	0.0	0.5	10.1	0.0	8.8	11.2	0.0	4.7	1.3	0.2	0.2	0.0	0.0	0.0	0.2	5.7	5.6	0.7	33.6	11.5	0.1	0.0	2.2	0.0	0.0	0.0	4.1	0.0	2.2	6.8	4.6	3.0	11.1	1.9	7.9	10.4	0.0	0.0	9.5	0.2	12.7	0.0	21.0	0.0	8.5	0.0	7.1	0.0	2.1	0.0	0.0	6.6	2.0	0.0	1.8	5.2	0.0	0.0	4.6	2.4	11.1	0.7	0.0	4.4	2.0	7.2	1.5	0.0	0.9	0.0	0.0	0.0	3.7	0.0	1.4	0.5	1.2	1.9	0.4	0.3	0.2	3.1	0.0	1.9	0.2	0.2	0.0	1.0	11.2	21.9	7.4	14.9	7.0	17.9	5.3	12.7	5.3	1.1	0.0	0.0	0.0	4.8	13.6	1.5	0.4	0.0	0.0	1.2	0.0	0.0	0.2	0.0	0.2	9.4	0.0	0.0	0.0	1.3	0.9	4.1	9.3	0.0	0.0	0.1	0.0	0.0	0.0	0.8	10.2	8.1	0.6	5.0	0.0	0.0	0.9	2.2	0.0	19.4	0.0	0.1	0.0	12.7	13.4	11.9	8.0	0.2	0.0	0.0	1.1
NUDT12	DKFZP761I172	ENSG00000112874	"Nudix hydrolase 12"	Q9BQG2	5	103548855-103562793	"Enzymes, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	6	"Distal tubular cells: 49.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA045449	Supported					NA	NA					"HPA045449: AB_2679327"	"unprognostic (1.94e-1)"	"unprognostic (1.94e-2)"	"unprognostic (3.27e-2)"	"unprognostic (1.44e-1)"	"unprognostic (7.53e-2)"	"unprognostic (1.10e-1)"	"unprognostic (2.61e-1)"	"unprognostic (8.79e-2)"	"unprognostic (9.16e-2)"	"unprognostic (1.31e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.92e-1)"	"prognostic favorable (2.86e-5)"	"unprognostic (1.13e-1)"	"unprognostic (4.23e-2)"	"unprognostic (2.67e-1)"	"unprognostic (5.92e-2)"	6.3	15.2	10.1	3.5	13.3	0.9	11.4	6.1	12.5	9.2	11.9	10.2	10.9	15.3	6.1	11.7	10.1	8.1	7.7	9.2	10.0	8.9	24.7	25.3	6.1	2.4	13.1	8.5	6.6	15.3	26.9	14.7	6.8	13.7	13.9	13.4	8.4	11.2	7.9	12.1	8.2	15.8	8.7	14.8	4.3	12.5	5.9	14.8	5.0	15.0	8.7	3.4	8.9	6.0	1.5	3.9	0.0	1.3	1.5	2.2	0.9	4.0	1.8	10.1	3.8	6.9	14.5	0.0	7.2	6.9	6.6	8.5	3.5	14.9	0.0	4.8	4.1	7.3	6.7	9.4	15.0	9.2	0.0	5.7	4.2	7.1	1.8	7.1	0.0	0.0	6.9	13.2	4.4	11.4	7.7	4.4	0.0	6.8	0.0	11.4	7.5	0.3	0.2	5.1	0.0	5.7	0.0	8.9	3.3	11.1	7.1	7.6	7.9	4.7	7.0	11.0	8.3	15.4	4.2	5.4	8.3	3.0	7.2	5.7	4.9	7.5	0.0	8.5	0.0	6.0	0.0	0.9	0.0	0.0	1.3	0.0	0.9	0.8	0.5	2.8	1.5	2.2	1.0	0.0	1.5	0.9	3.9	0.6	0.9	10.1	13.3	6.1	12.5	10.0	8.9	13.1	8.5	13.7	14.8	8.9	7.0	2.4	5.1	3.0	9.0	11.2	15.3	14.7	4.5	12.2	2.0	4.9	49.7	8.9	4.2	2.9	16.5	0.0	12.2	3.1	3.4	8.4	1.1	12.9	5.2	11.1	4.1	1.8	4.1	3.4	12.4	4.3	8.5	2.8	14.0	12.9	10.2	12.4	9.9	27.0	14.6	6.5	5.8	11.1	4.4	2.8	2.5	0.0	11.6	7.0
NUDT14	UGPP	ENSG00000183828	"Nudix hydrolase 14"	O95848	14	105172938-105181323	"Enzymes, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA046755, HPA058759"	Approved		Approved	Nucleoli,Microtubules		NA	NA			Microtubules	Nucleoli	"HPA046755: AB_10963433, HPA058759: AB_2683809"	"unprognostic (1.05e-2)"	"unprognostic (6.01e-2)"	"unprognostic (1.89e-1)"	"unprognostic (2.44e-1)"	"unprognostic (1.91e-1)"	"unprognostic (3.55e-1)"	"unprognostic (1.05e-3)"	"unprognostic (9.17e-3)"	"unprognostic (2.02e-1)"	"prognostic favorable (1.66e-4)"	"unprognostic (3.16e-3)"	"unprognostic (3.13e-1)"	"prognostic favorable (1.18e-5)"	"unprognostic (1.89e-1)"	"unprognostic (1.02e-1)"	"unprognostic (7.21e-3)"	"unprognostic (2.38e-1)"	18.2	12.6	22.4	5.0	16.0	3.1	14.3	2.5	23.4	6.5	11.0	7.9	5.9	16.7	4.7	11.7	7.1	12.6	9.8	20.9	15.4	13.5	16.7	11.2	12.6	9.4	16.1	14.8	4.0	26.0	4.7	27.6	4.8	11.2	10.5	4.6	14.7	16.7	9.9	28.7	6.2	13.8	3.1	13.2	6.3	12.7	8.9	7.8	3.1	17.9	9.2	5.7	4.9	4.7	5.8	15.1	1.7	27.3	6.1	5.8	8.9	8.2	11.3	1.0	4.4	1.3	1.6	18.1	2.3	3.1	3.8	5.5	8.0	8.8	0.6	11.6	1.2	8.5	10.4	0.5	6.3	0.3	4.3	8.3	1.8	4.9	5.5	9.7	2.2	22.3	2.3	8.0	0.9	0.7	1.6	7.5	4.1	2.8	1.4	1.3	24.0	0.2	0.0	5.9	19.5	15.8	4.3	10.4	4.8	4.1	23.8	15.7	2.3	4.1	0.1	9.6	1.9	8.9	10.7	17.6	6.3	2.8	4.5	2.3	0.7	0.4	1.0	9.3	2.5	2.3	1.7	18.5	0.5	5.8	17.4	3.6	5.8	4.6	3.8	15.1	4.0	4.5	5.2	0.6	6.1	27.3	7.3	2.5	8.9	22.4	16.0	2.5	23.4	15.4	13.5	16.1	14.8	11.2	7.8	11.9	22.0	13.7	80.0	34.6	11.8	47.7	35.7	34.8	5.7	33.2	17.7	39.7	149.2	84.7	2.5	43.4	95.9	0.0	26.5	19.7	19.5	39.7	39.1	21.8	112.1	33.4	35.8	22.7	24.1	8.2	10.6	28.5	43.9	36.9	61.8	28.1	58.1	126.7	3.5	138.7	12.3	0.0	9.5	10.0	28.9	16.7	31.9	15.2	80.1	65.1
NUDT15	"FLJ10956, MTH2"	ENSG00000136159	"Nudix hydrolase 15"	Q9NV35	13	48037567-48047222	"Enzymes, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Extravillous trophoblasts: 67.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA038968, HPA038969"	Approved		Supported	Nucleoplasm		Yes	No			Nucleoplasm		"HPA038968: AB_10697402, HPA038969: AB_2676295"	"unprognostic (9.48e-2)"	"unprognostic (5.91e-3)"	"unprognostic (2.64e-2)"	"unprognostic (9.00e-3)"	"unprognostic (4.99e-2)"	"unprognostic (2.50e-3)"	"unprognostic (2.29e-2)"	"unprognostic (7.47e-3)"	"prognostic unfavorable (1.25e-5)"	"unprognostic (1.04e-1)"	"unprognostic (8.50e-2)"	"unprognostic (3.69e-1)"	"unprognostic (4.63e-2)"	"unprognostic (1.84e-3)"	"unprognostic (3.35e-1)"	"unprognostic (9.58e-2)"	"unprognostic (8.93e-3)"	15.0	15.2	11.4	16.6	14.6	16.5	18.0	14.1	17.7	14.8	21.1	9.5	14.3	22.1	11.1	15.5	23.8	12.8	13.5	13.3	10.5	15.7	20.3	21.3	11.1	7.4	12.8	11.1	13.0	13.8	6.1	18.6	14.2	15.8	16.9	24.1	8.2	14.1	12.6	15.9	10.8	20.5	11.3	11.9	9.6	13.9	22.2	10.6	11.6	22.3	24.1	12.0	12.1	14.2	4.7	7.0	4.6	9.9	3.8	9.2	4.1	19.6	11.9	22.4	9.9	9.2	13.4	16.5	16.0	15.1	17.7	17.2	17.6	19.1	14.6	9.1	12.6	15.9	23.2	21.7	23.5	27.4	7.6	18.7	14.2	11.7	19.1	8.6	21.2	13.6	9.2	15.1	14.3	20.2	8.0	19.1	14.7	12.5	5.8	28.4	9.6	16.7	20.1	35.9	30.1	14.2	11.5	14.5	9.5	19.7	15.0	13.6	14.5	10.9	18.8	12.4	20.1	9.6	16.1	9.8	12.5	15.2	15.6	22.0	3.1	5.1	18.3	6.5	16.7	20.1	2.1	7.3	4.6	4.6	9.9	4.5	4.7	7.4	5.8	7.0	4.7	8.8	9.2	1.6	3.8	6.7	5.6	5.0	4.1	11.4	14.6	14.1	17.7	10.5	15.7	12.8	11.1	15.8	10.6	11.9	11.2	7.5	29.2	14.7	7.3	10.8	15.3	12.0	20.5	7.0	2.0	29.2	41.4	15.1	13.5	11.7	22.0	0.0	15.4	67.2	13.0	26.5	9.2	14.7	14.6	36.5	8.1	8.0	6.7	7.2	15.5	9.6	10.1	10.8	19.4	7.7	12.6	11.5	11.7	33.4	7.1	0.0	21.2	5.8	30.2	17.9	31.8	5.7	29.5	30.3
NUDT16	FLJ31265	ENSG00000198585	"Nudix hydrolase 16"	Q96DE0	3	131381671-131388830	"Enzymes, Predicted intracellular proteins"	"Nucleotide metabolism"	"Hydrolase, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	4	"Kupffer cells: 138.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"classical monocyte: 18.2;eosinophil: 18.8;intermediate monocyte: 21.9;myeloid DC: 13.6;neutrophil: 14.6;non-classical monocyte: 24.5"	"Group enriched"	"Detected in all"	4	"dendritic cells: 13.6;granulocytes: 18.8;monocytes: 24.5"	"Low cell line specificity"	"Detected in many"							"Low region specificity"	"Detected in all"			"HPA060452, HPA062492"	Uncertain		Supported	Nucleoplasm,Nucleoli		NA	NA			"Nucleoplasm, Nucleoli"		"HPA060452: AB_2684279, HPA062492: AB_2684781"	"unprognostic (4.85e-3)"	"prognostic favorable (9.39e-5)"	"unprognostic (3.19e-3)"	"unprognostic (9.21e-2)"	"unprognostic (2.49e-1)"	"unprognostic (1.22e-2)"	"unprognostic (9.96e-2)"	"unprognostic (1.15e-1)"	"unprognostic (5.16e-2)"	"unprognostic (1.94e-1)"	"unprognostic (1.77e-1)"	"unprognostic (5.88e-2)"	"prognostic favorable (1.05e-7)"	"unprognostic (3.29e-1)"	"unprognostic (1.62e-1)"	"unprognostic (2.00e-2)"	"unprognostic (9.44e-2)"	25.9	13.4	22.1	13.1	22.0	8.7	13.1	13.5	20.5	11.1	32.8	23.9	13.9	20.2	11.7	11.6	8.7	14.0	13.6	22.2	21.1	19.6	25.9	23.1	16.2	31.1	27.7	16.9	23.0	18.3	32.9	9.7	7.6	20.1	13.4	18.4	13.6	11.7	13.6	20.3	6.8	37.5	18.5	30.4	22.2	13.8	9.5	21.6	2.2	17.1	11.5	9.1	12.4	8.4	4.3	13.6	18.8	24.5	3.7	4.3	6.7	12.6	6.8	11.2	5.8	22.5	20.5	5.2	10.4	9.6	7.0	7.3	10.4	5.7	2.1	9.1	9.6	13.9	9.3	9.9	6.5	11.2	6.3	7.2	5.4	8.7	10.0	14.4	9.0	9.9	18.2	5.8	4.6	12.7	6.3	10.9	0.0	6.1	11.0	6.8	13.2	0.0	2.4	8.7	12.7	10.1	7.1	8.1	16.0	7.0	10.3	5.5	9.6	6.2	6.3	9.5	9.9	13.8	7.2	10.7	11.5	5.0	21.0	8.0	11.0	10.8	0.3	7.4	7.0	6.3	2.2	18.2	18.8	2.6	21.9	2.7	4.3	2.7	2.4	13.6	4.2	2.4	2.4	14.6	3.7	24.5	1.8	4.3	6.7	22.1	22.0	13.5	20.5	21.1	19.6	27.7	16.9	20.1	21.6	14.9	31.3	19.1	10.7	7.4	22.7	83.1	40.8	16.0	18.2	19.2	7.9	18.7	58.0	20.4	59.4	30.8	62.9	23.3	32.8	21.8	21.4	14.7	18.5	95.7	54.0	41.3	24.3	84.1	138.2	27.2	24.5	46.3	16.9	14.4	61.2	10.0	23.8	50.3	37.1	92.4	18.3	25.8	23.7	17.6	5.1	4.6	6.1	20.8	42.4	14.7
NUDT18	"FLJ22494, MTH3"	ENSG00000275074	"Nudix hydrolase 18"	Q6ZVK8	8	22106872-22109419	"Enzymes, Predicted intracellular proteins"	"Nucleotide metabolism"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028581, HPA030125"	Approved		Supported	"Nucleoplasm,Golgi apparatus"		NA	NA			Nucleoplasm	"Golgi apparatus"	"HPA028581: AB_10601381, HPA030125: AB_2673324"	"unprognostic (9.90e-3)"	"prognostic favorable (1.43e-4)"	"unprognostic (4.88e-3)"	"prognostic favorable (2.49e-6)"	"unprognostic (1.29e-2)"	"unprognostic (6.82e-3)"	"unprognostic (1.20e-1)"	"unprognostic (1.54e-2)"	"unprognostic (5.30e-2)"	"unprognostic (1.67e-1)"	"prognostic favorable (2.47e-4)"	"unprognostic (1.43e-1)"	"prognostic favorable (8.30e-4)"	"unprognostic (3.59e-3)"	"unprognostic (1.05e-1)"	"unprognostic (6.84e-2)"	"unprognostic (2.32e-1)"	3.6	2.7	2.9	4.4	6.4	2.9	3.6	5.3	6.8	2.0	6.1	4.3	5.4	5.3	1.6	11.9	3.7	4.3	3.8	2.5	1.7		2.9	2.9	4.5	6.3	3.2	3.3	1.2	8.6	2.1	5.2	1.8	3.7	3.6	3.8	3.8	5.6	11.0	1.0	3.6	5.4	2.7	2.5	6.0	5.6	2.8	3.4	7.1	5.0	2.3	5.8	3.2	0.0	3.6	3.6	5.0	3.2	7.8	4.7	1.5	6.8	14.5	0.5	3.2	11.5	4.3	8.0	4.0	11.1	5.5	6.2	3.4	5.4	5.1	6.6	4.9	13.8	12.0	2.1	6.7	1.8	6.3	2.0	4.3	4.1	3.3	7.6	1.3	13.5	7.9	6.4	2.2	5.7	7.1	6.9	11.3	3.1	8.6	5.1	7.2	5.7	3.9	0.8	4.2	3.5	2.6	1.3	5.5	7.9	6.0	1.6	2.4	2.9	3.5	3.5	3.6	8.2	7.2	5.5	3.5	1.9	4.7	2.1	3.8	0.4	1.6	6.2	3.9	8.6	0.1	2.9	5.0	4.7	3.2	4.3	2.6	3.7	2.7	2.0	3.6	4.0	2.2	0.7	7.8	2.3	3.6	1.4	1.5											3.0	2.1	5.2	3.9	1.8	3.0	1.6	12.7	2.7	1.2	5.2	0.0	5.5	5.0	6.8	10.6	3.0	15.0	0.0	11.8	8.3	3.9	3.7	0.0	2.5	12.8	3.2	2.9	4.9	19.5	10.0	2.8	3.0	5.0	12.6	7.0	3.7	8.6	11.5	3.2	8.8	1.3	0.0	2.8	2.6	2.0	1.6	2.6	8.5	6.3	2.2
NUDT2	APAH1	ENSG00000164978	"Nudix hydrolase 2"	P50583	9	34329506-34343713	"Enzymes, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004684, HPA044903, HPA058623, HPA067639"	Uncertain		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"CAB004684: AB_425306, HPA044903: AB_2679139, HPA058623: AB_2683780, HPA067639: AB_2685877"	"unprognostic (2.74e-3)"	"unprognostic (2.58e-2)"	"unprognostic (3.37e-1)"	"unprognostic (2.05e-3)"	"unprognostic (3.08e-1)"	"unprognostic (2.39e-1)"	"unprognostic (1.24e-1)"	"unprognostic (6.55e-2)"	"unprognostic (7.06e-2)"	"unprognostic (3.05e-3)"	"unprognostic (1.18e-2)"	"unprognostic (2.80e-1)"	"unprognostic (2.77e-2)"	"unprognostic (6.24e-2)"	"unprognostic (1.72e-1)"	"unprognostic (1.23e-1)"	"unprognostic (1.91e-1)"	12.0	18.0	21.6	9.6	21.9	10.2	20.6	14.0	25.5	14.9	14.9	26.0	15.4	12.8	15.7	30.2	14.5	20.5	12.3	16.0	17.3	18.6	10.7	17.5	11.2	12.2	19.5	19.0	28.3	20.9	12.0	19.0	14.1	20.5	16.5	15.3	15.7	16.1	13.0	30.8	13.9	10.1	14.7	20.7	11.3	13.0	8.6	19.1	18.6	3.8	13.2	13.8	14.4	12.1	16.6	15.8	14.3	12.2	14.3	22.2	11.2	23.8	9.8	12.8	4.5	8.8	16.3	9.2	11.5	26.1	13.3	14.0	6.7	11.3	6.6	9.6	14.3	5.1	10.5	11.5	28.4	13.6	24.8	10.3	14.3	18.5	12.6	25.6	11.0	5.9	16.5	18.4	17.2	32.4	18.2	27.5	23.2	4.0	27.1	19.5	14.8	11.4	10.3	7.9	10.6	28.3	14.8	8.0	16.7	13.1	7.8	2.6	10.4	18.7	7.1	10.8	12.0	5.7	11.9	17.7	11.5	10.4	7.5	11.9	6.1	9.9	11.7	14.4	10.6	14.3	14.3	12.2	9.7	11.7	10.3	16.7	16.6	19.2	15.2	15.8	15.0	22.2	19.6	4.5	14.3	10.7	14.7	19.7	11.2	21.6	21.9	14.0	25.5	17.3	18.6	19.5	19.0	20.5	19.1	3.0	5.5	15.9	17.8	25.0	13.1	18.6	43.3	17.4	11.4	15.7	5.9	33.9	74.6	22.6	9.7	21.5	18.6	0.0	34.7	35.6	23.1	17.1	12.7	31.0	32.5	7.9	21.4	30.1	38.4	21.8	25.3	23.9	21.9	32.5	29.1	16.2	26.1	26.9	18.0	39.6	12.8	25.8	23.6	35.8	17.5	27.6	15.8	25.3	31.4	15.7
NUDT22	MGC13045	ENSG00000149761	"Nudix hydrolase 22"	Q9BRQ3	11	64225941-64230686	"Enzymes, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039334, HPA053464"	Approved		Enhanced	Nucleoplasm		No	No			Nucleoplasm		"HPA039334: AB_10795174, HPA053464: AB_2682160"	"unprognostic (2.72e-1)"	"unprognostic (3.77e-1)"	"unprognostic (1.86e-2)"	"unprognostic (1.61e-1)"	"unprognostic (2.36e-2)"	"unprognostic (9.75e-2)"	"unprognostic (1.73e-3)"	"unprognostic (1.98e-1)"	"unprognostic (1.15e-1)"	"unprognostic (1.43e-1)"	"unprognostic (7.65e-2)"	"unprognostic (6.61e-2)"	"prognostic favorable (2.18e-6)"	"unprognostic (1.76e-2)"	"unprognostic (1.50e-1)"	"unprognostic (1.71e-1)"	"unprognostic (8.54e-2)"	9.2	16.8	8.1	16.0	9.2	14.3	9.8	7.3	12.8	9.2	24.2	9.1	30.9	29.6	9.1	16.9	17.8	9.0	16.7	23.4	8.3	7.0	21.1	30.1	10.2	15.9	10.5	8.4	7.9	26.4	13.8	12.2	14.7	8.6	12.3	8.5	9.0	28.6	35.2	24.9	12.9	23.7	11.4	7.8	20.5	18.5	7.8	7.7	19.5	15.4	15.7	19.6	13.5	9.4	30.0	49.1	20.0	33.9	19.2	25.0	20.1	14.7	9.4	2.4	9.9	3.6	4.4	9.0	6.2	6.5	4.5	4.2	6.1	12.6	7.0	16.5	6.2	6.8	15.5	1.4	9.9	0.6	9.0	4.0	9.4	6.9	6.3	10.8	6.0	15.7	6.8	7.4	4.8	5.1	3.4	7.3	8.4	4.6	7.7	5.3	22.1	8.4	11.2	3.7	9.1	19.9	10.4	4.0	26.0	7.8	8.2	5.5	8.8	5.5	20.9	24.8	0.9	21.3	6.9	6.7	7.6	7.2	23.8	5.3	28.9	11.4	4.4	26.1	7.1	8.8	13.8	28.7	20.0	23.0	33.9	20.5	25.3	20.3	22.4	29.1	30.0	18.0	19.6	17.3	19.2	31.8	49.1	25.0	20.1	8.1	9.2	7.3	12.8	8.3	7.0	10.5	8.4	8.6	7.7	3.0	13.4	41.3	23.3	10.6	12.3	3.1	61.1	4.0	6.8	38.4	11.8	92.1	139.3	53.1	12.7	17.7	92.0	0.0	76.6	42.4	24.2	26.6	14.0	47.8	50.9	28.6	35.7	27.0	50.0	6.5	18.7	38.1	32.1	73.9	66.5	25.6	56.4	92.1	18.4	113.9	16.8	12.9	20.6	4.9	8.3	15.3	56.4	39.2	56.2	28.8
NUDT3	DIPP	ENSG00000272325	"Nudix hydrolase 3"	O95989	6	34279679-34392674	"Enzymes, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA047027, HPA055953"	Uncertain		Approved	Cytosol		NA	NA		110000	Cytosol		"HPA047027: AB_2679907, HPA055953: AB_2682984"	"unprognostic (2.42e-1)"	"prognostic favorable (5.29e-4)"	"unprognostic (9.63e-3)"	"unprognostic (4.74e-3)"	"unprognostic (3.60e-2)"	"unprognostic (1.84e-1)"	"unprognostic (1.41e-3)"	"unprognostic (4.21e-2)"	"unprognostic (4.93e-3)"	"unprognostic (1.08e-1)"	"unprognostic (3.16e-1)"	"unprognostic (4.63e-1)"	"unprognostic (1.24e-2)"	"unprognostic (3.28e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.54e-1)"	"unprognostic (6.24e-2)"	10.5	11.4	38.8	9.3	28.6	8.8	12.6	33.4	40.0	15.4	11.4	16.8	10.3	7.7	11.4	25.9	10.8	15.2	8.5	16.9	33.8	30.0	15.3	10.1	11.2	10.5	29.4	25.6	17.4	9.1	27.9	9.3	8.9	26.1	11.4	9.7	11.2	9.4	15.6	50.7	11.2	8.0	11.2	20.3	13.0	8.4	7.3	21.3	5.4	21.3	8.7	12.1	8.6	9.9	4.5	6.4	12.4	5.9	2.1	3.9	2.6	5.4	4.0	10.8	21.1	7.2	12.2	4.7	4.0	6.7	4.1	3.0	4.8	3.8	19.6	5.4	7.1	2.7	4.6	6.1	10.8	7.7	7.3	7.8	21.6	5.6	10.4	7.2	20.3	11.3	11.0	10.0	5.0	9.4	5.3	11.8	10.2	21.4	7.1	6.6	5.7	14.0	23.8	6.9	16.1	4.0	12.3	8.9	20.4	9.4	11.4	15.2	17.0	8.8	12.5	15.9	3.4	12.5	14.6	12.9	8.3	3.0	7.2	8.6	6.1	14.1	14.4	5.0	20.8	12.9	1.9	5.8	12.4	3.4	5.9	3.9	3.4	3.4	3.2	6.4	4.5	3.2	3.7	4.1	2.1	5.8	3.2	2.4	2.6	38.8	28.6	33.4	40.0	33.8	30.0	29.4	25.6	26.1	21.3	14.9	22.4	43.5	59.4	53.1	115.6	43.3	63.7	46.8	14.8	40.1	111.9	28.0	11.6	15.4	3.0	55.9	18.4	0.0	24.5	26.3	42.3	39.4	12.8	52.1	67.2	160.5	47.2	84.7	91.0	4.0	34.8	58.5	50.6	22.6	24.7	115.6	20.8	19.8	59.4	19.2	125.0	58.2	46.4	44.7	78.0	52.7	16.4	20.1	25.2	59.3
NUDT4	"DIPP2, DIPP2alpha, DIPP2beta, HDCMB47P, KIAA0487"	ENSG00000173598	"Nudix hydrolase 4"	Q9NZJ9	12	93377883-93408146	"Enzymes, Predicted intracellular proteins"		"Hydrolase, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 140.7"	"Cell type enhanced"	"Detected in all"	5	"Muller glia cells: 411.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA017593, HPA047027, HPA057684"	Approved		Approved	Cytosol		NA	NA			Cytosol		"HPA017593: AB_1854703, HPA047027: AB_2679907, HPA057684: AB_2683501"	"unprognostic (1.44e-2)"	"unprognostic (2.15e-1)"	"unprognostic (4.40e-3)"	"unprognostic (4.25e-1)"	"unprognostic (3.08e-3)"	"unprognostic (1.42e-1)"	"unprognostic (8.12e-2)"	"unprognostic (9.09e-3)"	"unprognostic (1.88e-1)"	"unprognostic (1.51e-1)"	"unprognostic (2.60e-2)"	"unprognostic (1.96e-1)"	"prognostic favorable (1.27e-4)"	"unprognostic (1.75e-1)"	"unprognostic (2.87e-1)"	"unprognostic (5.01e-1)"	"unprognostic (8.32e-3)"	17.2	29.7	14.1	14.7	9.5	37.4	20.4	7.0	29.0	15.2	14.7	6.7	17.5	6.5	13.6	24.8	13.7	12.8	40.0	140.7	12.4	12.4	47.9	11.2	11.3	10.9	9.4	13.7	41.9	21.1	16.1	11.9	19.2	13.9	27.1	16.9	25.1	65.2	14.8	40.3	8.1	12.7	13.8	12.6	9.2	13.1	10.6	6.3	14.6	25.5	22.4	8.9	19.6	32.9	6.0	4.1	13.6	3.6	7.6	6.6	2.5	5.8	5.0	9.1	10.2	34.0	14.1	11.5	16.3	13.0	9.4	6.9	46.9	14.6	8.2	3.6	13.0	6.1	7.4	25.5	8.2	14.4	12.5	5.4	30.7	4.4	23.9	32.7	15.9	7.4	30.5	27.5	9.6	21.6	47.1	53.1	14.8	31.1	11.5	10.7	6.0	14.8	15.2	14.4	14.4	12.0	12.4	8.2	8.8	11.2	42.3	7.4	9.5	13.2	25.9	36.5	15.3	18.8	20.8	20.1	8.0	4.7	12.0	10.3	6.5	8.1	12.1	4.2	12.6	24.4	8.2	2.8	13.6	3.9	3.6	6.6	6.0	5.8	3.9	2.6	4.7	6.2	5.8	2.4	7.6	2.9	4.1	5.2	2.5	14.1	9.5	7.0	29.0	12.4	12.4	9.4	13.7	13.9	6.3	17.9	42.6	40.8	110.6	103.7	39.3	226.3	94.3	91.0	31.8	59.3	58.9	156.3	306.7	20.9	78.9	50.0	102.5	327.1	14.7	23.0	86.0	142.6	25.3	48.9	37.7	39.7	146.0	28.8	34.5	17.0	36.2	31.8	101.3	12.6	83.5	411.5	37.2	85.6	43.9	43.1	40.3	71.1	166.9	28.7	7.7	84.6	137.0	29.9	64.3	133.5
NUDT5	"hYSAH1, YSA1H"	ENSG00000165609	"Nudix hydrolase 5"	Q9UKK9	10	12165325-12196144	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Hydrolase, RNA-binding, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA019827	Approved		Approved	Nucleoplasm,Vesicles,Centrosome		NA	NA		660000	Vesicles	"Nucleoplasm, Centrosome"	"HPA019827: AB_1854704"	"unprognostic (2.08e-2)"	"unprognostic (2.10e-1)"	"unprognostic (1.61e-1)"	"unprognostic (2.09e-1)"	"unprognostic (3.77e-3)"	"unprognostic (4.91e-2)"	"unprognostic (2.54e-2)"	"unprognostic (4.60e-2)"	"unprognostic (1.32e-1)"	"unprognostic (6.39e-3)"	"unprognostic (2.06e-1)"	"unprognostic (9.97e-2)"	"prognostic unfavorable (7.14e-12)"	"unprognostic (1.61e-1)"	"unprognostic (1.33e-1)"	"unprognostic (3.12e-2)"	"unprognostic (3.68e-2)"	19.6	22.0	17.4	18.6	21.2	13.5	20.2	15.4	21.4	16.7	20.4	16.1	15.2	17.3	10.0	16.5	25.8	16.3	12.1	10.0	16.2	14.3	26.0	57.1	16.8	22.7	21.7	12.8	12.5	16.9	19.1	35.7	19.9	18.5	13.4	24.2	13.2	16.7	19.7	5.1	20.6	15.9	11.6	17.9	22.4	14.1	8.0	21.5	28.2	19.1	16.5	29.5	16.2	18.6	22.4	45.9	50.1	19.5	16.2	37.0	20.4	35.6	26.3	31.5	29.3	30.5	30.2	27.9	26.4	16.9	31.1	33.4	37.7	34.1	35.7	23.0	21.4	19.5	35.9	43.9	40.9	28.7	29.2	42.9	29.7	32.3	55.4	31.8	19.7	20.9	31.7	24.5	33.9	17.3	24.1	39.7	57.2	39.7	24.4	28.3	32.7	36.8	23.1	27.4	57.3	16.4	33.7	11.4	41.4	29.1	12.3	15.2	22.8	32.0	24.7	36.7	38.5	42.3	20.3	24.8	13.3	25.5	37.0	32.3	20.6	36.2	48.0	27.9	25.7	9.8	8.1	19.1	33.5	22.8	19.5	26.2	22.4	24.6	26.8	27.0	18.3	17.0	23.0	50.1	16.2	14.8	45.9	37.0	20.4	17.4	21.2	15.4	21.4	16.2	14.3	21.7	12.8	18.5	21.5	23.8	37.8	33.5	51.1	38.1	19.2	2.8	25.5	60.2	39.8	22.7	15.7	73.5	63.0	74.1	27.1	31.4	34.2	23.3	72.2	127.8	35.8	30.5	31.1	116.5	105.0	20.6	36.8	40.5	41.3	6.6	36.5	39.3	28.7	110.0	34.5	32.9	64.5	28.1	27.3	95.7	22.5	32.3	25.6	20.2	27.5	52.9	48.6	51.7	51.0	40.6
NUDT9	MGC3037	ENSG00000170502	"Nudix hydrolase 9"	Q9BW91	4	87422582-87459454	"Enzymes, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"RPTEC TERT1: 60.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036917, HPA044866, HPA078535"	Approved		Approved	"Nuclear membrane,Nuclear bodies,Cell Junctions,Mitochondria"	"Intracellular and membrane"	NA	NA		9000	"Nuclear bodies, Mitochondria"	"Nuclear membrane, Cell Junctions"	"HPA036917: AB_10696790, HPA044866: AB_2679120, HPA078535: AB_2686885"	"unprognostic (7.22e-2)"	"unprognostic (2.59e-2)"	"unprognostic (1.45e-2)"	"prognostic favorable (7.43e-5)"	"unprognostic (2.05e-2)"	"unprognostic (1.36e-1)"	"unprognostic (1.33e-1)"	"unprognostic (3.47e-2)"	"unprognostic (2.04e-1)"	"unprognostic (1.02e-1)"	"unprognostic (1.09e-2)"	"unprognostic (4.23e-1)"	"prognostic favorable (8.00e-11)"	"unprognostic (1.21e-1)"	"unprognostic (1.99e-1)"	"unprognostic (1.19e-1)"	"unprognostic (5.77e-3)"	14.2	25.6	19.5	10.0	22.7	4.0	31.1	22.5	22.3	17.9	19.6	11.8	18.0	27.0	17.3	24.5	12.8	16.2	11.4	18.0	21.8	19.4	28.1	30.9	15.8	12.2	22.9	16.5	18.4	64.1	35.4	33.1	17.5	20.0	22.5	18.3	11.3	20.2	18.7	23.8	10.2	30.0	16.0	17.0	9.9	14.1	14.1	22.6	7.6	22.7	16.0	9.7	13.6	35.9	13.9	13.8	3.7	13.9	9.3	18.3	10.6	10.6	11.6	12.9	6.5	25.6	16.2	10.4	20.7	13.5	8.0	8.0	8.1	18.5	15.7	21.2	16.7	14.6	7.4	11.9	14.5	12.8	11.7	9.1	5.1	13.5	14.3	16.1	9.4	8.5	15.5	19.3	9.5	9.0	16.5	15.9	5.1	14.4	10.6	15.0	14.1	13.1	10.2	10.4	25.1	4.7	15.4	11.5	9.2	60.2	9.9	15.7	10.7	13.3	23.6	10.5	17.5	13.5	13.6	16.3	12.9	12.5	9.4	10.1	8.1	6.3	12.8	18.5	8.9	16.3	0.9	11.7	3.7	13.4	13.8	12.4	13.9	13.4	13.2	13.8	12.0	15.9	18.3	1.3	9.3	13.9	13.0	12.3	10.6	19.5	22.7	22.5	22.3	21.8	19.4	22.9	16.5	20.0	22.6	62.5	31.4	15.2	36.7	8.9	13.8	35.3	43.3	45.5	60.3	22.7	25.5	27.4	34.9	42.5	19.0	27.0	24.4	0.0	31.7	28.2	26.6	34.7	19.7	42.0	28.9	6.4	16.1	17.8	11.6	7.6	23.6	17.1	10.1	22.6	15.4	21.8	28.5	25.8	25.1	47.3	15.3	25.8	26.7	29.8	21.7	8.3	31.5	7.2	22.2	26.3
NUS1	"C6orf68, MGC7199, NgBR, TANGO14"	ENSG00000153989	"NUS1 dehydrodolichyl diphosphate synthase subunit"	Q96E22	6	117675502-117710640	"Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins"	"Angiogenesis, Differentiation, Lipid metabolism"	"Developmental protein, Receptor, Transferase"	"Congenital disorder of glycosylation, Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA027504	Supported		Approved	"Vesicles,Plasma membrane"		NA	NA			Vesicles	"Plasma membrane"	"HPA027504: AB_10603124"	"unprognostic (1.21e-2)"	"prognostic unfavorable (6.99e-4)"	"unprognostic (1.09e-2)"	"unprognostic (2.31e-1)"	"unprognostic (1.21e-1)"	"unprognostic (8.26e-3)"	"unprognostic (1.42e-3)"	"unprognostic (2.42e-2)"	"unprognostic (8.62e-2)"	"unprognostic (2.99e-1)"	"unprognostic (2.62e-1)"	"unprognostic (8.35e-2)"	"unprognostic (1.00e-1)"	"unprognostic (2.27e-1)"	"unprognostic (3.22e-2)"	"unprognostic (1.56e-1)"	"unprognostic (7.97e-2)"	8.4	10.2	14.7	9.3	14.7	7.0	10.0	8.8	13.4	29.6	9.2	6.8	2.0	7.1	9.6	13.5	9.5	8.8	7.1	8.2	12.7	9.9	13.1	17.4	9.5	8.4	16.4	15.7	8.8	28.9	15.0	20.0	10.6	16.2	9.6	9.3	7.1	13.8	14.9	7.9	6.1	14.4	8.5	7.3	9.1	10.6	5.6	12.2	7.2	16.5	3.1	8.7	9.1	18.0	2.4	8.1	3.3	4.9	4.1	4.5	2.3	10.3	7.6	16.4	18.3	16.6	21.8	40.4	18.9	19.7	15.8	18.2	17.2	11.6	24.4	20.6	17.4	20.1	9.4	24.4	18.5	29.5	18.2	22.5	27.9	12.8	30.7	25.6	35.1	16.5	19.0	21.0	17.3	35.4	16.2	16.2	18.3	33.3	21.8	23.6	11.6	16.5	22.4	19.1	14.2	13.9	15.9	11.8	17.5	31.4	10.3	19.5	15.4	11.4	14.8	13.8	19.1	9.4	36.9	14.2	9.8	12.1	15.6	27.1	30.3	22.6	26.0	23.2	27.1	19.5	3.3	3.0	1.8	3.1	3.0	4.5	2.4	3.7	4.1	3.2	2.1	3.1	4.0	0.2	4.1	4.9	8.1	3.4	2.3	14.7	14.7	8.8	13.4	12.7	9.9	16.4	15.7	16.2	12.2	0.0	21.1	21.6	29.1	53.8	14.3	6.1	15.3	10.7	14.8	24.4	9.8	21.6	23.2	19.8	11.9	17.5	19.7	0.0	26.2	41.6	19.7	52.1	31.1	35.9	32.9	14.3	12.6	27.0	29.1	11.8	16.7	32.9	30.4	22.6	26.8	7.5	29.9	21.0	19.1	29.2	8.2	6.5	37.6	21.8	28.8	49.1	48.4	14.1	21.0	80.5
NXN	"FLJ12614, NRX"	ENSG00000167693	Nucleoredoxin	Q6DKJ4	17	799313-979770	"Enzymes, Predicted intracellular proteins"	"Differentiation, Wnt signaling pathway"	"Developmental protein, Oxidoreductase"	"Disease mutation, Dwarfism"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"Late spermatids: 74.7;Urothelial cells: 52.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HaCaT: 31.7;HHSteC: 35.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA023566	Approved		Approved	Cytosol		NA	NA			Cytosol		"HPA023566: AB_1854737"	"unprognostic (1.68e-2)"	"unprognostic (1.75e-1)"	"unprognostic (1.15e-2)"	"unprognostic (3.48e-2)"	"unprognostic (7.29e-2)"	"unprognostic (1.00e-1)"	"unprognostic (1.75e-2)"	"unprognostic (6.98e-2)"	"unprognostic (1.65e-3)"	"unprognostic (2.27e-2)"	"unprognostic (3.16e-2)"	"unprognostic (1.43e-1)"	"unprognostic (5.76e-2)"	"unprognostic (3.56e-2)"	"unprognostic (2.34e-1)"	"unprognostic (2.68e-2)"	"unprognostic (2.05e-3)"	11.9	4.9	5.8	11.5	5.9	1.0	12.8	5.0	5.0	21.7	27.1	4.7	16.9	4.0	21.5	19.2	14.0	13.8	14.5	7.6	6.0	4.2	5.1	3.8	15.8	7.2	3.9	3.1	13.9	23.1	1.1	3.2	10.0	5.6	18.9	3.6	12.3	10.9	19.0	48.9	10.6	8.1	25.8	4.4	2.9	13.0	6.4	4.3	6.0	5.7	17.4	11.8	20.8	26.3	0.9	1.2	1.5	0.2	1.8	1.6	0.3	4.4	6.6	26.1	16.8	1.7	0.3	1.4	14.0	9.3	14.9	23.8	15.6	4.6	0.1	27.0	17.9	3.4	31.7	16.8	26.2	11.8	0.2	9.8	0.0	4.1	13.7	35.0	0.1	0.7	10.6	24.3	1.9	11.7	3.0	13.3	3.6	2.2	0.0	3.9	1.8	0.8	0.3	12.5	13.1	0.4	1.9	0.6	0.1	10.5	6.4	6.7	4.4	6.6	0.0	0.3	16.9	4.7	4.0	0.0	0.3	6.3	0.1	3.9	2.4	1.5	0.1	0.1	0.5	0.2	0.8	0.2	0.1	0.2	0.1	0.1	0.9	0.4	0.2	1.2	0.3	1.6	0.2	1.5	1.8	0.1	1.2	1.4	0.3	5.8	5.9	5.0	5.0	6.0	4.2	3.9	3.1	5.6	4.3	29.8	13.2	0.8	42.2	15.5	1.8	6.3	0.0	10.7	11.4	3.5	31.4	0.4	0.0	3.1	20.4	29.2	0.0	0.0	21.1	0.6	18.8	21.1	1.1	6.7	4.8	4.8	1.7	11.6	0.3	74.7	14.4	3.8	6.8	1.0	0.0	9.6	8.6	0.0	6.7	0.3	16.7	12.9	19.8	10.6	9.1	10.8	0.3	0.0	0.0	52.9
OAS1	"IFI-4, OIAS, OIASI"	ENSG00000089127	"2'-5'-oligoadenylate synthetase 1"	P00973	12	112906777-112933222	"Enzymes, Predicted intracellular proteins"	"Antiviral defense, Immunity, Innate immunity"	"Nucleotidyltransferase, RNA-binding, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 83.9"	"Cell type enhanced"	"Detected in many"	9	"Hofbauer cells: 91.2;Urothelial cells: 142.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"non-classical monocyte: 83.9"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+ SV40 Large T+: 50.8;BJ hTERT+ SV40 Large T+ RasG12V: 73.0;OE19: 48.0;U-266/70: 71.6;U-266/84: 54.4"									"HPA003657, CAB021104"	Uncertain		Supported	Nucleoplasm,Cytosol	"Intracellular and membrane"	NA	NA			"Nucleoplasm, Cytosol"		"CAB021104: AB_10057722, HPA003657: AB_1854747"	"unprognostic (1.03e-1)"	"unprognostic (6.59e-2)"	"unprognostic (8.56e-3)"	"unprognostic (2.20e-3)"	"unprognostic (2.78e-1)"	"unprognostic (1.30e-1)"	"unprognostic (2.00e-2)"	"unprognostic (3.16e-2)"	"unprognostic (1.37e-1)"	"unprognostic (2.20e-2)"	"prognostic unfavorable (3.02e-4)"	"unprognostic (5.37e-2)"	"unprognostic (1.63e-2)"	"unprognostic (6.91e-2)"	"unprognostic (3.68e-2)"	"unprognostic (5.67e-2)"	"prognostic favorable (6.12e-6)"	31.2	7.3	6.1	16.6	7.1	5.7	8.4	2.1	6.0	16.4	25.4	11.0	2.6	23.6	5.8	21.0	39.1	5.1	10.7	5.1	4.2	5.7	18.3	23.3	20.7	17.3	5.9	5.3	7.4	3.2	4.3	6.1	18.8	8.6	11.5	20.5	11.7	31.8	4.2	2.9	6.3	27.2	7.6	9.4	30.1	22.7	4.2	6.2	21.6	9.4	13.5	27.3	20.9	13.0	18.2	24.4	4.1	83.9	4.5	16.8	29.0	1.0	5.8	0.0	0.0	2.0	1.5	0.4	0.0	7.5	50.8	73.0	3.3	6.2	7.9	2.2	0.0	27.5	2.6	0.0	0.7	0.7	5.8	0.0	0.2	10.4	1.2	0.6	0.1	0.4	0.1	2.2	1.9	0.0	0.8	2.7	0.2	0.0	3.5	0.0	0.1	0.2	3.6	0.3	48.0	5.0	1.6	0.0	3.3	2.5	16.4	0.1	0.3	0.8	1.0	19.4	0.0	0.2	1.3	10.0	0.0	0.1	0.7	0.1	71.6	54.4	5.5	0.6	2.3	0.4	1.0	40.9	0.5	4.9	63.6	4.6	18.2	6.5	6.1	24.4	13.6	2.5	3.3	4.1	4.5	83.9	22.1	16.8	29.0	6.1	7.1	2.1	6.0	4.2	5.7	5.9	5.3	8.6	6.2	3.0	2.1	16.4	10.9	3.1	0.2	1.2	15.3	12.0	7.9	5.2	0.0	11.1	5.0	15.7	0.2	16.3	40.3	23.3	10.7	32.3	5.9	6.4	4.7	9.4	91.2	0.0	4.1	12.3	28.2	0.9	6.6	27.7	5.0	10.0	56.5	14.1	14.1	45.6	9.9	19.4	0.4	6.5	1.4	0.0	0.2	1.9	4.8	7.5	10.4	142.9
OAS2		ENSG00000111335	"2'-5'-oligoadenylate synthetase 2"	P29728	12	112978395-113011723	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Antiviral defense, Immunity, Innate immunity"	"Nucleotidyltransferase, RNA-binding, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"B-cells: 14.9;Endothelial cells: 14.3;Hofbauer cells: 15.1;Kupffer cells: 16.2;Macrophages: 15.1;T-cells: 13.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+ SV40 Large T+: 72.2;BJ hTERT+ SV40 Large T+ RasG12V: 58.9;SK-MEL-30: 28.2;U-266/70: 26.3;U-266/84: 22.6"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"HPA003320, CAB024984"	Approved		Approved	Centrosome		NA	NA			Centrosome		"CAB024984: , HPA003320: "	"unprognostic (2.39e-1)"	"unprognostic (9.51e-2)"	"unprognostic (2.13e-2)"	"unprognostic (1.15e-2)"	"unprognostic (1.34e-1)"	"unprognostic (7.94e-2)"	"unprognostic (4.79e-2)"	"unprognostic (2.05e-2)"	"unprognostic (1.31e-1)"	"unprognostic (7.64e-3)"	"prognostic unfavorable (4.63e-4)"	"unprognostic (4.20e-1)"	"prognostic unfavorable (4.31e-6)"	"unprognostic (1.12e-1)"	"unprognostic (4.17e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.94e-2)"	37.9	3.8	4.0	13.9	5.1	9.0	7.2	1.8	4.9	8.5	4.3	7.5	1.2	4.6	9.0	6.9	13.2	3.9	9.6	6.9	3.8	4.4	8.8	9.9	15.6	24.1	5.0	3.7	3.9	1.9	1.2	2.9	22.2	7.3	6.6	4.7	6.9	32.9	1.8	2.2	2.9	8.8	6.4	7.1	36.6	9.7	2.2	3.0	32.4	9.8	8.2	27.4	13.7	5.4	12.0	12.7	2.0	26.8	15.1	17.4	13.2	0.7	0.1	0.0	0.0	0.4	2.6	0.0	0.1	8.2	72.2	58.9	0.1	1.2	18.2	1.8	1.5	16.2	0.8	0.1	0.2	2.5	4.5	0.0	0.0	0.1	0.1	0.5	0.0	0.0	0.2	1.3	4.1	0.0	0.0	1.1	0.9	0.0	9.5	0.0	0.3	0.5	1.0	0.0	0.1	2.6	3.9	0.0	2.7	0.0	6.5	0.0	0.0	0.7	0.2	28.2	0.0	0.6	1.1	1.8	0.1	0.0	0.3	0.0	26.3	22.6	2.8	0.6	0.9	0.7	2.0	15.9	1.2	13.4	26.8	16.8	12.0	15.4	15.2	12.7	8.9	15.2	11.2	1.8	15.1	26.0	5.3	17.4	13.2	4.0	5.1	1.8	4.9	3.8	4.4	5.0	3.7	7.3	3.0	3.0	8.9	14.9	1.5	1.8	0.0	1.4	0.0	8.1	3.4	1.8	0.0	0.1	0.0	1.0	0.6	14.3	0.3	0.0	1.0	2.1	2.1	2.4	1.1	1.8	15.1	0.0	0.0	11.1	16.2	0.7	0.6	15.1	5.0	3.6	3.1	0.5	2.3	0.2	3.2	0.0	0.1	0.0	1.0	0.0	0.1	1.0	0.1	13.8	0.1	7.7
OAS3		ENSG00000111331	"2'-5'-oligoadenylate synthetase 3"	Q9Y6K5	12	112938352-112973249	"Enzymes, Predicted intracellular proteins"	"Antiviral defense, Immunity, Innate immunity"	"Nucleotidyltransferase, RNA-binding, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Urothelial cells: 25.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+ SV40 Large T+: 64.2;BJ hTERT+ SV40 Large T+ RasG12V: 70.2;GAMG: 31.4"	"Not detected"	"Not detected"							"HPA041253, HPA041372"	Uncertain		Supported	"Nucleoplasm,Plasma membrane,Cytosol"		Yes	No		21000	"Nucleoplasm, Cytosol"	"Plasma membrane"	"HPA041253: AB_10794990, HPA041372: AB_10795590"	"unprognostic (8.47e-2)"	"unprognostic (9.13e-2)"	"unprognostic (1.27e-2)"	"unprognostic (4.39e-3)"	"unprognostic (2.59e-2)"	"unprognostic (1.45e-1)"	"unprognostic (4.14e-3)"	"unprognostic (8.06e-3)"	"unprognostic (3.19e-1)"	"unprognostic (1.73e-2)"	"unprognostic (2.29e-3)"	"unprognostic (2.48e-1)"	"prognostic unfavorable (2.23e-5)"	"unprognostic (4.25e-2)"	"unprognostic (1.37e-2)"	"unprognostic (3.29e-2)"	"unprognostic (2.93e-2)"	36.9	4.9	5.1	11.2	5.4	18.3	7.0	2.9	5.5	10.5	6.8	5.5	3.2	7.3	10.0	11.8	17.9	4.2	9.4	6.7	4.5	5.3	10.3	7.1	19.9	13.3	5.1	5.1	6.1	3.2	3.3	4.6	19.3	8.7	5.6	6.9	8.9	24.7	3.4	3.3	6.0	9.3	8.3	6.2	22.0	9.5	3.0	3.3	21.3	9.9	6.7	13.5	9.9	8.2	2.6	4.8	10.1	14.7	5.0	3.8	3.9	6.3	9.5	0.0	1.5	0.3	1.4	0.8	1.2	8.3	64.2	70.2	7.2	5.8	0.4	2.3	2.9	31.4	5.5	1.2	7.8	5.4	4.7	0.3	4.9	4.4	2.3	1.2	1.7	2.7	0.5	2.5	9.1	0.5	1.1	3.3	1.3	0.1	1.0	0.8	4.1	2.7	0.9	0.5	11.7	5.6	3.9	3.4	0.1	3.0	17.6	0.2	0.0	5.8	2.2	5.7	0.0	7.6	0.5	2.2	1.7	1.2	1.5	2.6	0.5	19.2	0.1	1.4	4.8	5.2	0.9	7.9	1.6	2.0	8.6	2.5	2.6	3.0	3.0	4.8	1.3	2.2	2.6	10.1	5.0	14.7	0.2	3.8	3.9	5.1	5.4	2.9	5.5	4.5	5.3	5.1	5.1	8.7	3.3	3.0	4.6	2.4	4.8	3.1	0.4	1.7	0.0	0.0	2.3	3.5	0.0	4.0	3.3	10.8	6.1	13.4	4.1	0.0	8.6	15.8	5.4	6.5	1.1	1.5	16.5	0.0	1.7	9.2	4.7	5.9	9.5	6.6	1.7	6.4	6.3	4.4	14.5	4.0	14.2	2.1	0.2	0.0	3.1	0.5	0.2	4.1	1.6	4.6	3.7	25.3
OAT	HOGA	ENSG00000065154	"Ornithine aminotransferase"	P04181	10	124397303-124418976	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		"Aminotransferase, Transferase"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"intestine: 208.5"	"Cell type enhanced"	"Detected in all"	5	"Erythroid cells: 303.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"							"CAB033576, HPA040098, HPA064742"	Enhanced		Supported	Nucleoplasm,Mitochondria		NA	NA			Mitochondria	Nucleoplasm	"CAB033576: AB_2298892, HPA040098: AB_10793955, HPA064742: AB_2685343"	"unprognostic (1.61e-2)"	"unprognostic (1.70e-2)"	"unprognostic (9.96e-2)"	"unprognostic (1.02e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.05e-1)"	"unprognostic (2.03e-1)"	"unprognostic (4.43e-3)"	"unprognostic (1.65e-1)"	"unprognostic (2.37e-2)"	"unprognostic (2.45e-1)"	"unprognostic (7.62e-2)"	"unprognostic (1.70e-2)"	"unprognostic (2.21e-1)"	"unprognostic (2.19e-1)"	"unprognostic (2.72e-2)"	"unprognostic (2.00e-2)"	13.5	37.1	25.9	9.1	26.7	20.3	33.8	17.2	39.8	24.7	71.9	22.8	33.9	164.0	21.6	15.5	26.1	14.9	16.0	12.7	25.6	29.8	25.6	36.8	11.6	9.3	27.9	30.1	21.8	12.3	12.1	18.0	14.8	37.8	17.9	15.8	13.3	55.2	29.1	13.7	16.3	208.5	22.5	25.5	8.4	17.3	14.6	19.4	4.9	15.9	23.1	15.2	15.5	18.2	10.2	26.5	23.0	23.6	9.6	20.1	16.3	42.0	7.6	5.0	17.9	51.0	49.3	17.1	25.5	52.1	22.8	25.0	19.5	5.5	0.0	18.6	43.0	21.7	44.8	22.8	47.7	24.8	7.4	31.6	47.1	5.3	14.5	26.3	0.0	31.1	32.2	24.6	20.5	24.0	37.8	26.5	8.7	81.0	9.1	31.8	10.9	12.4	2.6	10.0	12.9	10.8	11.6	19.1	11.4	21.8	0.7	10.5	11.2	16.0	42.8	35.9	30.1	14.2	11.6	20.4	13.0	12.2	21.5	15.8	7.8	8.1	11.4	18.0	12.7	6.2	18.6	23.6	20.7	18.5	20.7	20.1	9.6	15.6	19.4	26.5	10.2	19.6	19.1	23.0	9.6	20.8	5.7	14.4	16.3	25.9	26.7	17.2	39.8	25.6	29.8	27.9	30.1	37.8	19.4	17.9	38.8	36.2	123.3	134.4	27.8	14.0	22.9	44.2	75.1	33.2	25.5	97.9	76.3	32.5	16.9	35.8	49.1	303.7	12.0	67.3	125.7	58.3	43.8	69.3	56.5	41.3	41.3	35.6	32.6	9.0	96.4	49.4	81.0	20.8	48.6	32.0	11.7	36.8	112.8	114.0	21.3	77.6	123.8	32.5	27.0	110.2	40.3	40.6	67.9	76.5
OBSCN	"ARHGEF30, KIAA1556, KIAA1639, UNC89"	ENSG00000154358	"Obscurin, cytoskeletal calmodulin and titin-interacting RhoGEF"	Q5VST9	1	228208130-228378874	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	Differentiation	"Calmodulin-binding, Developmental protein, Kinase, Muscle protein, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"skeletal muscle: 180.2;tongue: 48.4"	"Cell type enriched"	"Detected in many"	14	"Cardiomyocytes: 136.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Cell type enhanced"	"Detected in some"		"naive CD4 T-cell: 3.2"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HeLa: 16.0"	"Low region specificity"	"Detected in single"							"HPA021186, HPA065801"	Enhanced		Approved	"Plasma membrane,Cytosol"		NA	NA			"Plasma membrane, Cytosol"		"HPA021186: AB_1854761, HPA065801: "	"unprognostic (8.47e-3)"	"unprognostic (1.56e-1)"	"unprognostic (9.99e-2)"	"prognostic unfavorable (1.64e-4)"	"unprognostic (5.30e-3)"	"unprognostic (6.36e-2)"	"unprognostic (4.54e-3)"	"unprognostic (1.82e-1)"	"unprognostic (8.81e-2)"	"unprognostic (1.93e-2)"	"unprognostic (3.38e-1)"	"unprognostic (1.45e-1)"	"unprognostic (1.57e-3)"	"unprognostic (1.34e-1)"	"unprognostic (1.77e-1)"	"unprognostic (3.53e-1)"	"unprognostic (1.16e-2)"	2.5	0.9	0.5	0.9	4.4	0.6	0.7	3.1	0.6	0.6	0.8	0.5	0.5	0.6	0.8	4.4	2.4	1.0	0.6	21.2	0.5	0.7	1.6	0.5	1.0	1.0	0.5	0.5	1.7	1.4	0.4	2.4	0.5	0.9	1.7	0.3	5.2	2.6	1.1	180.2	1.1	0.8	0.5	0.6	1.4	0.5	0.7	0.6	0.5	2.2	48.4	3.5	0.6	0.7	1.0	1.1	0.1	0.4	0.6	3.2	0.7	2.9	2.8	8.0	4.5	0.2	0.1	5.6	1.5	0.5	1.0	0.9	2.0	2.1	5.7	8.1	0.5	0.6	1.0	0.4	1.1	0.2	2.2	5.1	1.9	16.0	0.0	2.0	1.3	6.1	3.0	1.0	0.4	0.2	5.4	0.4	9.4	5.3	1.3	0.3	5.0	2.1	1.6	8.8	0.8	1.8	8.1	0.1	1.3	4.6	1.5	3.0	9.0	0.2	2.9	1.1	2.4	8.0	3.7	0.7	0.0	9.3	0.2	0.1	4.7	0.9	1.4	0.0	0.8	2.1	0.1	0.4	0.0	0.9	0.1	0.9	0.5	0.9	0.7	0.9	1.0	3.2	0.5	0.1	0.6	0.1	1.1	0.8	0.7	0.5	4.4	3.1	0.6	0.5	0.7	0.5	0.5	0.9	0.6	0.0	5.6	0.0	5.9	1.9	3.2	136.5	2.5	1.4	4.5	5.2	9.8	0.1	10.0	2.9	3.8	1.6	0.4	0.0	0.4	0.4	1.5	1.9	6.9	0.5	0.1	0.0	0.0	1.3	0.0	4.0	2.8	0.3	1.7	0.0	1.7	9.7	1.0	0.0	4.2	4.2	2.8	0.0	1.2	0.1	2.5	1.5	1.0	1.8	1.1	3.4
OCRL	OCRL1	ENSG00000122126	"OCRL, inositol polyphosphate-5-phosphatase"	Q01968	X	129539849-129592561	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Cilium biogenesis/degradation"	Hydrolase	"Cataract, Ciliopathy, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Peritubular cells: 32.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"non-classical monocyte: 6.6"	"Group enriched"	"Detected in many"	6	"dendritic cells: 2.4;monocytes: 6.6"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA012495	Approved		Approved	"Microtubules,Centriolar satellite,Cytosol"		NA	NA			Cytosol	"Microtubules, Centriolar satellite"	"HPA012495: AB_1851804"	"prognostic unfavorable (2.93e-5)"	"unprognostic (3.17e-2)"	"unprognostic (2.30e-1)"	"unprognostic (6.34e-3)"	"unprognostic (9.88e-2)"	"unprognostic (1.35e-1)"	"unprognostic (2.82e-2)"	"unprognostic (2.68e-1)"	"unprognostic (3.08e-3)"	"unprognostic (2.56e-2)"	"unprognostic (6.30e-3)"	"unprognostic (1.74e-1)"	"unprognostic (4.61e-3)"	"unprognostic (4.10e-1)"	"unprognostic (5.83e-2)"	"unprognostic (1.59e-1)"	"unprognostic (1.17e-1)"	12.1	20.5	10.7	6.0	18.2	5.3	10.8	13.4	23.1	12.7	13.4	10.1	28.8	9.1	15.8	19.7	13.3	12.8	13.8	8.6	13.0	20.5	10.9	11.3	8.6	6.0	12.9	15.1	33.0	12.4	37.3	20.3	13.2	17.8	21.7	14.1	15.3	8.5	27.7	11.4	9.6	9.8	21.5	8.0	6.3	11.4	23.2	6.4	4.3	19.0	5.6	4.1	18.0	9.2	0.4	2.4	0.3	6.6	0.0	0.7	0.7	9.7	11.2	9.3	10.5	16.4	13.7	9.1	14.9	11.9	15.5	14.4	7.5	7.1	0.8	25.7	12.6	18.2	6.1	17.1	11.4	16.1	0.0	11.5	3.0	10.1	7.5	12.2	3.0	0.3	11.4	15.0	15.2	15.1	15.4	11.5	4.5	4.0	7.4	16.0	12.7	2.2	4.2	3.3	12.9	16.7	2.2	9.6	5.8	8.8	10.1	11.3	14.3	7.1	10.1	7.8	12.4	7.2	5.3	9.6	12.6	5.8	13.1	14.8	2.1	1.6	2.0	8.9	11.1	9.9	0.0	2.1	0.0	0.2	2.4	0.7	0.3	0.1	0.1	2.4	0.4	0.6	0.2	0.3	0.0	6.6	0.9	0.1	0.7	10.7	18.2	13.4	23.1	13.0	20.5	12.9	15.1	17.8	6.4	3.0	8.5	0.8	3.1	4.1	9.9	7.9	5.1	4.0	10.3	17.4	5.9	5.1	3.3	4.9	19.5	5.3	13.7	0.0	3.1	4.7	5.1	5.7	0.0	10.9	4.3	12.7	16.8	7.4	10.4	5.9	21.3	4.4	8.5	2.8	11.7	8.6	6.7	10.7	32.2	3.9	6.0	0.0	5.7	6.4	14.0	6.5	4.8	0.0	9.7	6.0
ODC1	ODC	ENSG00000115758	"Ornithine decarboxylase 1"	P11926	2	10439968-10448504	"Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"	"Polyamine biosynthesis"	"Decarboxylase, Lyase"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	8	"Early spermatids: 459.5;Late spermatids: 626.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001536, CAB035996"	Approved		Approved	"Plasma membrane,Cytosol"		NA	NA			"Plasma membrane, Cytosol"		"CAB035996: , HPA001536: AB_1079521"	"unprognostic (2.33e-1)"	"unprognostic (3.41e-1)"	"unprognostic (7.25e-3)"	"unprognostic (5.21e-3)"	"unprognostic (4.22e-2)"	"unprognostic (2.70e-1)"	"prognostic unfavorable (3.07e-5)"	"unprognostic (3.06e-2)"	"unprognostic (4.18e-2)"	"unprognostic (6.27e-2)"	"unprognostic (3.04e-1)"	"unprognostic (6.65e-2)"	"unprognostic (1.67e-3)"	"unprognostic (1.18e-1)"	"unprognostic (1.05e-1)"	"unprognostic (2.26e-2)"	"unprognostic (5.86e-2)"	13.2	8.2	11.6	33.5	11.1	41.8	9.1	7.2	11.8	11.7	17.4	11.5	33.8	8.6	22.9	21.6	16.5	16.5	30.0	33.8	9.7	10.6	31.5	48.7	14.2	42.3	11.3	6.5	29.2	48.7	13.4	35.4	6.9	11.2	26.3	20.7	18.2	11.0	27.2	64.2	9.6	14.9	26.2	10.2	20.4	19.2	54.6	6.3	31.0	16.4	19.8	39.6	16.1	14.6	13.4	10.8	2.4	2.4	1.2	4.4	3.0	19.0	15.3	21.3	25.2	3.8	11.4	49.4	27.6	13.6	26.1	12.1	81.2	8.9	100.7	13.8	16.8	25.2	3.5	65.2	31.3	31.8	38.3	27.2	46.0	26.3	49.5	30.9	77.6	11.0	7.6	8.5	59.0	74.1	13.5	20.9	28.1	76.4	32.8	14.4	12.5	76.8	30.6	38.8	26.5	49.9	54.9	66.9	67.9	15.8	14.0	29.8	25.3	34.6	10.6	13.9	17.1	7.1	34.8	14.6	21.2	43.7	27.3	59.1	15.3	46.3	91.6	19.0	51.5	13.0	0.0	1.3	2.4	2.7	2.4	3.2	13.4	3.8	4.4	3.0	11.0	2.7	4.3	0.5	1.2	1.5	10.8	3.8	3.0	11.6	11.1	7.2	11.8	9.7	10.6	11.3	6.5	11.2	6.3	41.7	217.2	112.6	112.8	51.5	34.5	48.8	71.4	25.4	36.4	38.4	29.5	1.0	61.3	55.5	459.5	35.3	38.6	0.0	23.5	53.1	21.2	276.8	57.7	46.1	43.4	6.4	260.2	11.6	30.9	626.4	14.4	29.0	21.9	12.6	143.2	85.1	24.6	48.9	10.6	101.8	62.6	0.0	40.8	91.4	74.0	76.5	2.9	37.6	120.9	94.9
OGDH	E1k	ENSG00000105953	"Oxoglutarate dehydrogenase"	Q02218	7	44606572-44709066	"Citric acid cycle related proteins, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"	Glycolysis	Oxidoreductase	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 99.3"	"Cell type enhanced"	"Detected in many"	4	"Cardiomyocytes: 100.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019514, HPA020347"	Supported		Enhanced	Mitochondria		No	No		53000	Mitochondria		"HPA019514: AB_1854772, HPA020347: AB_1854773"	"unprognostic (1.96e-2)"	"unprognostic (1.40e-1)"	"unprognostic (4.39e-1)"	"unprognostic (5.64e-3)"	"unprognostic (3.02e-3)"	"unprognostic (1.20e-1)"	"unprognostic (3.45e-1)"	"unprognostic (7.58e-2)"	"unprognostic (1.74e-1)"	"unprognostic (1.52e-2)"	"unprognostic (3.38e-1)"	"unprognostic (3.30e-2)"	"prognostic favorable (2.22e-14)"	"unprognostic (1.53e-1)"	"unprognostic (1.62e-1)"	"unprognostic (2.23e-2)"	"unprognostic (5.88e-3)"	18.9	20.8	12.3	14.5	18.5	8.7	11.0	14.3	23.7	10.1	19.4	15.9	13.5	29.0	16.2	11.1	19.5	11.1	11.8	73.9	11.3	12.8	28.8	14.8	13.0	11.1	14.2	11.7	9.8	13.0	25.5	11.0	14.5	22.2	12.3	13.3	22.3	23.7	15.9	99.3	15.6	35.5	16.4	10.1	12.1	14.9	11.3	11.0	11.3	17.8	39.8	15.8	13.0	10.8	7.2	13.4	7.5	20.4	11.2	25.7	11.6	10.8	22.8	13.7	20.8	21.2	23.3	13.3	17.0	16.6	19.3	16.9	20.7	22.5	47.8	20.2	24.7	39.0	33.8	27.0	25.4	18.9	27.9	7.1	14.5	46.1	10.2	10.8	17.9	16.3	21.6	19.3	27.4	19.7	14.2	26.2	16.0	16.7	14.3	20.4	15.3	17.7	10.3	12.6	30.2	25.7	17.0	9.6	53.6	22.2	32.4	23.4	11.2	24.5	34.1	10.6	25.9	20.2	18.0	20.6	13.9	12.6	24.2	19.6	13.0	24.9	26.4	25.3	20.3	25.3	4.8	12.1	7.3	11.7	17.7	12.8	7.2	13.5	11.7	13.4	5.9	5.8	7.0	7.5	11.2	20.4	6.6	25.7	11.6	12.3	18.5	14.3	23.7	11.3	12.8	14.2	11.7	22.2	11.0	6.0	22.7	20.4	11.1	17.3	20.1	100.7	15.3	12.0	9.1	45.4	17.7	19.4	26.6	13.2	43.1	14.2	61.4	0.0	14.8	14.3	16.4	14.4	20.8	17.5	29.3	58.8	22.4	14.1	22.4	20.0	10.9	21.9	20.3	21.6	29.2	15.4	16.7	21.0	16.3	38.9	22.2	19.4	18.2	9.1	20.0	23.1	30.7	13.8	27.6	14.2
OGG1	"HMMH, HOGG1, MUTM, OGH1"	ENSG00000114026	"8-oxoguanine DNA glycosylase"	O15527	3	9749944-9788219	"Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"DNA damage, DNA repair"	"Glycosidase, Hydrolase, Lyase, Multifunctional enzyme"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Proximal tubular cells: 65.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027514, CAB047301"	Approved		Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"CAB047301: , HPA027514: AB_10602189"	"unprognostic (6.95e-2)"	"unprognostic (7.82e-3)"	"unprognostic (7.19e-2)"	"unprognostic (1.24e-3)"	"unprognostic (9.69e-2)"	"unprognostic (1.97e-2)"	"prognostic unfavorable (5.77e-5)"	"unprognostic (7.83e-2)"	"unprognostic (2.45e-2)"	"unprognostic (3.43e-3)"	"unprognostic (9.66e-3)"	"unprognostic (4.23e-2)"	"prognostic favorable (2.65e-4)"	"unprognostic (2.06e-2)"	"unprognostic (2.24e-1)"	"unprognostic (1.65e-1)"	"unprognostic (1.59e-1)"	10.4	12.9	15.4	28.5	16.2	12.7	11.5	22.0	17.7	16.7	18.8	16.2	10.5	22.0	16.2	13.1	10.0	14.7	12.1	10.7	14.7	10.8	30.1	17.8	9.9	28.5	12.3	14.1	22.5	12.0	5.8	10.2	10.3	15.3	14.4	10.2	14.6	14.3	13.2	7.4	11.5	28.2	12.1	13.6	14.1	10.8	7.3	15.6	19.8	12.2	6.3	25.5	12.2	13.3	12.2	11.9	15.4	8.5	19.4	15.4	8.3	5.7	10.8	10.9	6.8	10.7	12.3	20.2	7.5	7.8	11.6	13.9	10.3	5.7	35.2	5.0	9.5	18.5	5.6	6.4	8.2	4.9	12.5	9.2	17.5	17.4	14.8	11.3	6.8	11.2	12.2	10.6	20.0	8.5	9.4	14.3	5.0	5.5	5.7	11.0	10.8	5.4	6.7	5.8	5.2	15.5	4.0	7.4	11.4	6.5	2.9	4.9	8.6	9.7	7.9	5.8	5.9	12.4	11.6	9.2	11.8	12.4	9.2	12.3	5.7	8.2	18.1	9.5	19.6	7.2	11.3	8.5	15.4	15.1	6.6	14.6	10.4	13.0	12.3	7.6	12.2	10.2	9.6	2.1	19.4	5.3	11.9	15.4	8.3	15.4	16.2	22.0	17.7	14.7	10.8	12.3	14.1	15.3	15.6	0.0	4.3	24.5	8.6	4.8	19.3	2.0	7.6	4.0	2.3	8.7	33.4	5.4	10.0	7.2	0.6	8.3	10.4	23.3	5.9	8.2	9.7	5.0	2.3	8.5	15.7	7.9	17.2	6.7	6.7	0.9	13.3	8.2	6.8	12.6	7.6	10.3	7.1	10.1	12.7	65.4	29.4	25.8	9.0	8.3	15.3	4.0	3.3	13.8	12.2	4.3
OGT	"FLJ23071, HRNT1, MGC22921, O-GLCNAC, OGT1"	ENSG00000147162	"O-linked N-acetylglucosamine (GlcNAc) transferase"	O15294	X	71533083-71575897	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Apoptosis, Biological rhythms, Host-virus interaction, Ubl conjugation pathway"	"Chromatin regulator, Glycosyltransferase, Transferase"	"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030751, HPA030752, HPA030753, HPA030754, CAB034099"	Approved		Supported	"Nucleoplasm,Plasma membrane"		Yes	No			Nucleoplasm	"Plasma membrane"	"CAB034099: AB_2157067, HPA030751: AB_10600217, HPA030752: AB_10601445, HPA030753: AB_2673594, HPA030754: AB_2673595"	"unprognostic (1.37e-1)"	"unprognostic (2.20e-1)"	"unprognostic (2.32e-2)"	"prognostic unfavorable (8.33e-4)"	"unprognostic (3.40e-2)"	"prognostic favorable (1.97e-4)"	"unprognostic (9.56e-3)"	"unprognostic (1.96e-3)"	"unprognostic (5.58e-2)"	"unprognostic (2.29e-1)"	"unprognostic (1.06e-1)"	"unprognostic (9.74e-3)"	"prognostic unfavorable (2.36e-6)"	"unprognostic (2.99e-3)"	"unprognostic (2.28e-1)"	"unprognostic (8.03e-3)"	"prognostic favorable (6.85e-7)"	26.1	24.0	33.3	39.7	36.6	38.7	33.7	75.7	43.8	25.0	23.0	22.0	31.1	22.5	36.7	48.3	24.3	33.4	21.2	25.1	29.3	15.4	27.4	20.3	31.0	47.9	30.2	25.6	42.8	46.1	26.5	34.5	19.5	26.6	34.2	30.3	29.9	35.9	30.9	35.0	45.4	38.4	31.1	32.3	56.7	28.2	11.8	36.6	35.7	34.1	27.6	41.4	24.9	31.0	9.7	7.6	3.2	7.2	12.5	9.9	6.0	14.2	13.3	17.3	15.2	18.7	17.3	11.7	10.9	19.8	11.9	18.3	14.0	16.4	17.0	7.7	13.4	12.4	17.8	18.9	10.7	14.7	14.5	19.4	10.7	31.9	10.0	14.2	22.0	17.8	16.5	21.8	13.0	24.6	20.6	11.1	36.5	10.8	59.1	11.3	12.1	16.9	26.5	11.5	12.7	18.3	16.8	19.5	21.7	18.4	16.5	8.9	7.8	17.0	11.3	10.5	13.7	8.3	15.0	12.8	12.9	10.5	13.4	6.3	16.1	11.6	20.4	9.1	23.2	7.8	3.2	5.3	2.3	9.9	7.2	9.0	9.7	8.3	8.0	7.5	8.5	9.7	9.5	2.4	12.5	6.5	7.6	7.6	6.0	33.3	36.6	75.7	43.8	29.3	15.4	30.2	25.6	26.6	36.6	32.8	80.7	38.6	31.8	78.3	24.7	38.6	20.4	20.1	31.8	47.1	7.9	11.8	8.3	11.5	1.7	42.7	29.0	46.7	12.1	7.0	45.0	42.9	26.6	24.9	14.0	38.1	33.6	45.4	64.9	1.8	49.5	36.1	33.7	15.4	36.2	13.8	15.0	31.6	28.0	12.2	23.2	32.3	32.5	1.8	6.0	73.5	9.2	59.0	30.2	38.6
OLAH	"FLJ11106, SAST, THEDC1"	ENSG00000152463	"Oleoyl-ACP hydrolase"	Q9NV23	10	15032227-15073852	"Enzymes, Predicted intracellular proteins"	"Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"placenta: 61.3;testis: 24.0"	"Cell type enriched"	"Detected in some"	10	"Early spermatids: 347.4"	"Group enriched"	"Detected in some"	7	"testis cancer: 3.6;thyroid cancer: 0.8"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in some"	4	"neutrophil: 6.6"	"Lineage enriched"	"Detected in many"	6	"granulocytes: 6.6"	"Cell line enhanced"	"Detected in some"		"HSkMC: 5.8;hTCEpi: 7.4;LHCN-M2: 5.6;SK-BR-3: 8.8;SuSa: 4.8;U-266/70: 4.9"									"HPA037947, HPA037948"	Enhanced					NA	NA					"HPA037947: AB_10795028, HPA037948: AB_10805352"	"unprognostic (2.01e-1)"	"unprognostic (6.12e-2)"	"unprognostic (8.20e-3)"	"unprognostic (4.04e-3)"	"unprognostic (1.92e-1)"	"unprognostic (8.09e-2)"	"unprognostic (7.12e-2)"	"unprognostic (5.12e-2)"	"unprognostic (4.55e-1)"	"unprognostic (3.74e-2)"	"unprognostic (4.70e-1)"	"unprognostic (1.69e-1)"	"unprognostic (5.22e-10)"	"unprognostic (4.55e-2)"	"unprognostic (2.09e-1)"	"unprognostic (5.11e-2)"	"unprognostic (9.78e-2)"	1.0	1.1	0.2	0.2	0.7	1.2	5.2	0.3	0.7	0.8	0.5	0.3	0.1	0.0	0.2	0.4	2.7	1.4	1.1	0.8	0.2	0.2	0.8	0.4	1.9	4.3	0.9	0.1	0.2	0.1	0.1	1.5	61.3	0.4	0.1	0.0	0.3	3.0	0.1	0.5	0.4	0.3	0.1	0.5	8.0	0.2	24.0	0.3	0.2	1.2	0.1	0.3	0.3	1.1	0.5	1.1	6.6	0.4	1.0	0.6	0.1	0.2	0.6	0.7	0.5	0.3	1.1	2.2	0.4	0.4	0.2	0.1	0.4	0.0	0.2	0.0	0.0	0.6	0.2	0.0	0.2	0.7	0.4	0.2	0.3	0.4	0.0	0.9	0.0	0.6	5.8	7.4	0.9	0.1	0.1	0.7	0.2	0.5	0.3	5.6	0.0	0.5	0.7	0.7	0.2	0.4	0.7	1.3	1.8	0.0	0.0	0.0	0.4	0.3	8.8	0.1	4.8	0.2	0.5	1.0	0.1	2.9	1.3	0.1	4.9	1.6	0.4	2.7	0.5	0.0	1.4	0.4	0.4	0.4	0.2	0.3	0.2	0.6	0.2	0.2	0.5	0.3	0.3	6.6	1.0	0.2	1.1	0.4	0.1	0.2	0.7	0.3	0.3	0.2	0.2	0.9	0.1	0.4	0.3	3.0	1.1	0.0	0.2	0.2	0.0	0.3	0.0	1.4	0.0	0.0	0.0	0.3	0.0	0.9	347.4	0.0	0.0	0.0	0.0	1.4	0.5	0.3	0.0	0.0	0.1	0.0	0.0	0.0	2.2	35.4	4.0	0.6	0.0	0.0	0.0	0.0	0.3	0.0	7.8	0.0	0.7	6.5	0.4	1.7	1.7	0.3	9.5	0.5	0.0	0.1
OMA1	"FLJ33782, MPRP-1, YKR087C, ZMPOMA1"	ENSG00000162600	"OMA1 zinc metallopeptidase"	Q96E52	1	58415384-58546802	"Cancer-related genes, Enzymes, Predicted intracellular proteins, Predicted membrane proteins"		"Hydrolase, Metalloprotease, Protease"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Ciliated cells: 54.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA055120	Approved		Approved	Nucleoplasm,Mitochondria		NA	NA			"Nucleoplasm, Mitochondria"		"HPA055120: AB_2682702"	"prognostic favorable (1.63e-4)"	"unprognostic (2.67e-2)"	"prognostic favorable (7.70e-4)"	"unprognostic (1.60e-3)"	"unprognostic (1.61e-1)"	"unprognostic (9.57e-2)"	"unprognostic (3.94e-3)"	"prognostic favorable (8.52e-4)"	"unprognostic (8.22e-3)"	"unprognostic (6.91e-2)"	"unprognostic (4.10e-2)"	"unprognostic (1.40e-1)"	"unprognostic (9.54e-3)"	"unprognostic (2.52e-2)"	"unprognostic (3.93e-2)"	"unprognostic (1.74e-2)"	"unprognostic (5.24e-3)"	10.2	22.4	13.8	21.5	18.1	9.2	15.8	10.6	14.6	14.5	16.4	14.1	20.1	12.1	15.4	15.1	17.1	15.9	12.1	15.8	12.6	10.0	23.0	23.8	19.1	17.9	16.7	9.6	15.0	18.2	15.7	20.9	8.9	13.0	17.8	16.1	11.3	20.6	22.7	20.9	10.2	16.1	24.2	18.2	17.2	13.9	6.9	19.4	18.4	18.3	14.5	16.4	17.0	20.6	22.5	9.5	18.6	19.5	18.6	22.8	10.2	13.5	5.7	3.8	3.5	19.2	18.0	10.9	5.6	6.1	4.9	6.2	1.6	8.2	30.6	11.9	5.8	17.2	13.9	13.4	13.6	5.8	23.4	7.5	9.5	4.4	6.6	9.5	23.3	6.7	16.9	15.3	4.8	10.0	11.1	4.3	15.3	18.0	9.2	13.4	8.3	7.9	8.3	5.6	20.5	12.4	9.9	12.5	12.8	10.7	9.1	4.0	1.9	11.4	18.8	15.8	18.3	8.5	9.0	2.5	2.5	5.1	12.6	5.8	7.5	9.8	20.1	7.8	18.3	6.2	10.8	9.2	18.6	12.8	14.5	16.5	22.5	15.7	15.0	9.5	21.4	22.8	20.8	10.6	18.6	19.5	5.0	13.9	10.2	13.8	18.1	10.6	14.6	12.6	10.0	16.7	9.6	13.0	19.4	17.9	11.5	14.7	15.7	5.4	7.2	25.0	10.2	54.9	11.4	24.4	11.8	19.1	21.6	7.7	5.0	4.9	6.9	0.0	4.8	7.8	8.6	15.0	5.8	15.5	13.6	1.6	5.8	8.6	10.7	9.7	9.2	10.4	6.8	7.2	15.0	10.0	5.2	10.4	8.1	20.7	19.6	6.5	4.4	11.7	12.1	5.9	15.3	13.8	13.0	17.5
OPA1	"FLJ12460, KIAA0567, MGM1, NPG, NTG"	ENSG00000198836	"OPA1, mitochondrial dynamin like GTPase"	O60313	3	193593144-193697823	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters"	"Apoptosis, Sensory transduction, Vision"	Hydrolase	"Cardiomyopathy, Deafness, Disease mutation, Neurodegeneration, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	6	"Cardiomyocytes: 130.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036926, HPA036927"	Supported		Supported	Nucleoplasm,Mitochondria		NA	NA		13000	"Nucleoplasm, Mitochondria"		"HPA036926: AB_10671247, HPA036927: AB_2675388"	"unprognostic (2.10e-2)"	"unprognostic (9.23e-3)"	"unprognostic (7.98e-2)"	"prognostic unfavorable (8.61e-4)"	"unprognostic (1.62e-2)"	"unprognostic (4.59e-2)"	"unprognostic (2.24e-1)"	"unprognostic (1.86e-2)"	"unprognostic (1.57e-1)"	"unprognostic (1.08e-1)"	"prognostic unfavorable (8.44e-5)"	"unprognostic (3.48e-2)"	"prognostic favorable (1.84e-4)"	"unprognostic (2.92e-1)"	"unprognostic (4.75e-1)"	"unprognostic (4.50e-3)"	"unprognostic (3.21e-1)"	17.0	19.7	18.2	13.5	31.7	25.9	15.9	20.2	30.9	13.9	21.8	11.1	12.6	20.0	15.2	11.8	18.8	11.8	12.8	43.9	23.0	19.4	21.8	24.1	10.7	15.3	19.0	22.4	13.2	13.4	20.9	15.6	13.8	28.0	15.5	20.5	9.1	15.7	20.8	38.4	14.6	17.3	16.5	17.0	13.1	16.7	7.6	10.8	18.0	16.8	18.4	14.2	16.5	13.6	8.3	8.8	8.2	17.6	5.0	7.5	5.9	26.0	8.4	8.5	9.3	7.5	11.9	9.0	12.7	11.7	13.9	13.6	20.3	8.8	17.3	27.4	11.9	12.7	17.0	14.8	14.3	24.7	20.8	12.0	29.9	7.5	10.2	11.7	24.6	13.8	13.3	12.8	13.4	19.1	8.6	11.7	7.3	12.7	17.0	13.8	20.6	9.5	13.7	11.9	15.0	28.0	12.5	18.7	18.5	10.4	16.3	18.5	11.3	18.9	21.2	13.4	6.8	27.8	19.5	11.7	12.9	9.8	13.8	26.6	15.4	17.8	33.9	14.3	19.7	12.9	8.2	8.1	7.7	7.2	9.3	6.6	8.3	6.8	6.8	8.8	6.3	6.9	7.3	3.2	5.0	17.6	4.6	7.5	5.9	18.2	31.7	20.2	30.9	23.0	19.4	19.0	22.4	28.0	10.8	14.9	20.0	20.6	13.8	14.2	17.0	130.0	15.3	16.0	20.5	17.4	29.5	16.2	14.9	14.8	7.2	13.5	20.6	70.0	20.7	12.2	15.9	15.5	18.5	30.2	15.9	20.6	22.4	16.0	23.5	10.2	14.7	21.2	20.3	11.8	20.6	15.7	22.7	7.0	13.8	26.9	21.6	6.5	17.5	11.3	15.0	19.6	15.0	12.8	25.8	19.6
OPLAH	"5-Opase, OPLA"	ENSG00000178814	"5-oxoprolinase, ATP-hydrolysing"	O14841	8	144051266-144063965	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 49.3"	"Group enriched"	"Detected in many"	4	"Early spermatids: 97.1;Late spermatids: 174.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	5	"classical monocyte: 3.0;intermediate monocyte: 1.0;neutrophil: 3.8"	"Group enriched"	"Detected in many"	9	"granulocytes: 3.8;monocytes: 3.0"	"Cell line enhanced"	"Detected in many"		"AN3-CA: 22.7;BEWO: 14.2;Hep G2: 12.2;PC-3: 17.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA026562, HPA028260, HPA052429"	Uncertain		Approved	"Nucleoli fibrillar center"		NA	NA			"Nucleoli fibrillar center"		"HPA026562: AB_1854804, HPA028260: AB_10601383, HPA052429: AB_2681830"	"unprognostic (7.89e-2)"	"unprognostic (3.08e-2)"	"unprognostic (1.69e-1)"	"unprognostic (9.09e-2)"	"unprognostic (2.21e-2)"	"unprognostic (3.87e-3)"	"unprognostic (2.04e-2)"	"unprognostic (9.37e-2)"	"unprognostic (2.90e-1)"	"unprognostic (1.26e-1)"	"unprognostic (6.82e-2)"	"unprognostic (3.62e-1)"	"prognostic favorable (1.53e-6)"	"unprognostic (4.03e-3)"	"unprognostic (4.33e-1)"	"unprognostic (3.54e-2)"	"unprognostic (8.24e-2)"	5.6	5.6	3.3	1.7	3.9	2.3	3.1	4.9	5.3	1.9	7.0	7.0	4.5	11.8	1.6	1.9	5.9	1.3	5.2	16.2	2.5	1.7	10.8	17.2	2.9	2.0	4.5	4.2	2.0	6.0	5.8	1.2	1.3	5.5	3.5	2.0	4.8	9.4	5.6	25.6	5.5	10.4	1.2	4.4	3.7	7.2	49.3	4.9	0.3	1.9	5.4	1.8	2.1	3.3	0.0	0.3	3.8	3.0	0.0	0.1	0.8	2.7	2.7	0.3	22.7	1.0	2.2	14.2	1.3	0.9	0.8	0.5	5.2	5.1	0.0	4.6	2.5	0.0	3.6	0.7	2.0	0.0	0.7	0.0	0.9	4.1	12.2	7.3	0.1	0.0	3.0	9.4	0.9	0.0	0.0	0.1	3.9	3.2	0.0	0.0	3.1	0.2	2.1	1.9	4.2	17.5	0.3	0.0	3.5	2.4	3.3	0.8	0.1	0.0	0.9	0.0	0.3	5.9	3.0	0.1	0.0	3.8	0.0	0.9	0.8	0.9	0.7	0.3	0.7	0.0	0.0	3.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	3.8	0.0	0.4	0.0	0.0	0.8	3.3	3.9	4.9	5.3	2.5	1.7	4.5	4.2	5.5	4.9	3.0	2.7	0.8	1.7	1.8	1.0	2.6	5.1	1.4	3.4	8.7	0.0	1.4	10.0	3.5	97.1	0.7	32.0	0.0	2.4	2.2	1.1	1.6	0.0	20.2	2.1	0.0	1.2	3.1	6.0	174.0	2.3	1.7	0.0	1.0	6.3	5.2	3.8	11.2	3.5	11.0	0.0	0.0	1.0	3.5	2.3	1.6	2.1	1.3	10.9	2.0
OSGEP	"GCPL1, KAE1, OSGEP1, PRSMG1, TCS3"	ENSG00000092094	"O-sialoglycoprotein endopeptidase"	Q9NPF4	14	20446411-20455105	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"tRNA processing"	"Acyltransferase, Transferase"	"Disease mutation, Epilepsy, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039751	Uncertain		Supported	"Nucleoplasm,Plasma membrane"		NA	NA			Nucleoplasm	"Plasma membrane"	"HPA039751: AB_10794754"	"prognostic favorable (1.48e-4)"	"unprognostic (4.15e-3)"	"unprognostic (1.29e-1)"	"unprognostic (4.33e-3)"	"unprognostic (1.54e-2)"	"unprognostic (3.95e-2)"	"unprognostic (5.54e-3)"	"unprognostic (2.80e-3)"	"unprognostic (2.98e-1)"	"unprognostic (1.05e-1)"	"unprognostic (3.35e-3)"	"unprognostic (1.22e-1)"	"prognostic unfavorable (4.64e-6)"	"unprognostic (4.83e-2)"	"unprognostic (1.86e-2)"	"unprognostic (2.53e-2)"	"unprognostic (9.91e-2)"	11.2	14.2	13.2	13.1	14.5	10.7	14.4	21.3	18.3	14.3	15.6	18.6	11.6	8.8	16.0	19.2	12.9	13.1	13.6	15.8	13.4	10.2	12.3	22.2	12.4	16.9	13.4	12.5	12.4	12.4	10.6	20.8	13.6	15.5	10.8	14.0	14.5	12.4	18.6	19.6	9.9	12.4	16.8	12.3	18.8	13.6	5.7	15.2	16.2	15.7	9.6	18.7	16.6	11.0	24.5	28.8	23.4	19.1	13.0	14.2	15.7	6.3	10.2	3.3	10.0	5.9	4.0	10.4	5.0	6.5	12.7	12.3	14.0	7.5	13.2	6.5	6.3	5.5	5.5	10.2	10.0	8.0	10.4	13.0	8.3	8.6	18.0	4.3	14.3	11.9	3.1	3.0	15.2	8.1	2.7	8.3	12.0	8.0	7.6	9.9	11.8	14.0	6.2	5.1	18.3	20.3	22.3	6.3	7.4	7.2	7.2	13.2	2.6	8.8	9.3	6.7	2.0	6.2	13.6	3.8	5.3	13.0	6.7	5.9	2.3	12.3	18.0	3.3	22.3	6.4	5.1	19.1	23.4	13.7	17.6	11.9	20.5	14.2	12.0	28.8	24.5	11.3	12.9	8.7	13.0	13.6	12.4	12.9	15.7	13.2	14.5	21.3	18.3	13.4	10.2	13.4	12.5	15.5	15.2	32.8	30.4	31.8	18.6	10.2	35.1	14.5	17.8	25.4	31.8	22.7	35.3	58.5	29.9	21.8	2.7	18.3	27.1	0.0	25.9	38.4	17.9	13.7	24.4	16.6	56.2	9.5	25.8	22.7	27.5	2.5	17.8	30.6	20.3	17.2	21.1	28.4	19.2	31.5	20.1	30.7	52.1	12.9	23.0	5.1	15.6	10.0	38.6	22.5	29.5	13.6
OSGEPL1	"OSGEPL, Qri7"	ENSG00000128694	"O-sialoglycoprotein endopeptidase like 1"	Q9H4B0	2	189746660-189763227	"Enzymes, Predicted intracellular proteins"	"tRNA processing"	"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Sertoli cells: 25.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA030693	Uncertain		Supported	Mitochondria		NA	NA			Mitochondria		"HPA030693: AB_10601978"	"unprognostic (1.10e-1)"	"unprognostic (8.72e-2)"	"unprognostic (8.19e-2)"	"unprognostic (6.70e-2)"	"unprognostic (6.07e-2)"	"unprognostic (6.38e-2)"	"prognostic unfavorable (3.71e-4)"	"unprognostic (4.18e-3)"	"unprognostic (1.06e-3)"	"prognostic favorable (3.19e-4)"	"unprognostic (2.33e-1)"	"unprognostic (1.80e-2)"	"unprognostic (3.34e-2)"	"unprognostic (2.68e-1)"	"unprognostic (1.51e-2)"	"unprognostic (6.39e-2)"	"unprognostic (1.55e-3)"	6.6	17.0	8.6	6.5	12.1	2.6	11.1	12.9	10.9	7.3	5.6	14.8	2.9	5.0	11.8	9.1	7.0	8.1	4.8	13.0	8.4	7.3	13.0	11.6	5.8	11.2	18.9	9.3	13.8	6.1	7.5	9.8	6.1	11.6	6.9	6.1	9.0	9.7	6.1	16.6	9.2	6.5	8.1	13.4	9.6	5.8	9.4	15.4	10.6	8.2	7.3	9.2	8.0	5.8	9.3	6.0	2.1	2.6	6.6	11.5	3.0	5.6	3.1	13.9	10.6	11.0	6.1	8.3	8.8	6.2	12.5	13.5	3.7	5.9	3.8	9.9	3.7	7.0	8.3	12.4	10.4	14.3	9.7	9.5	12.3	7.7	4.8	5.8	6.9	6.4	6.7	8.9	9.4	4.7	8.6	9.3	9.7	4.4	6.0	8.2	3.2	5.4	8.0	6.7	7.7	14.5	5.9	11.2	6.5	8.1	3.2	8.5	9.4	5.9	10.8	19.2	18.1	8.4	7.6	3.9	8.2	7.2	11.9	5.4	6.1	5.1	6.1	10.8	8.9	8.9	0.2	2.6	2.1	7.3	2.4	10.5	7.4	7.7	8.4	3.5	9.3	11.5	10.2	0.4	6.6	2.1	6.0	5.9	3.0	8.6	12.1	12.9	10.9	8.4	7.3	18.9	9.3	11.6	15.4	6.0	2.2	1.3	2.3	1.6	8.0	8.1	2.5	8.1	1.2	0.0	11.8	8.6	6.6	2.4	0.6	2.3	0.9	0.0	2.0	6.1	3.8	1.2	3.5	3.0	3.8	9.5	0.0	4.3	1.0	0.0	10.3	2.3	1.7	0.0	1.1	12.4	1.5	0.0	7.8	8.4	10.0	25.8	3.1	10.7	12.6	1.8	1.8	5.0	2.3	0.5
OTC		ENSG00000036473	"Ornithine carbamoyltransferase"	P00480	X	38352545-38421450	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Amino-acid biosynthesis, Arginine biosynthesis, Urea cycle"	Transferase	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	14	"intestine: 59.1;liver: 90.3"	"Group enriched"	"Detected in some"	7	"Hepatocytes: 74.1;Ito cells: 20.3"	"Cancer enriched"	"Detected in some"	20	"liver cancer: 59.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"JURKAT: 1.7;NB-4: 1.7;RPMI-8226: 1.0;SH-SY5Y: 1.1;SiHa: 1.8"	"Not detected"	"Not detected"							"HPA000243, HPA000570"	Enhanced		Supported	Mitochondria		NA	NA		1800000	Mitochondria		"HPA000243: AB_1079535, HPA000570: AB_1079534"			"unprognostic (6.93e-2)"		"unprognostic (2.48e-1)"		"unprognostic (1.89e-3)"	"unprognostic (4.38e-2)"	"unprognostic (3.15e-1)"	"unprognostic (1.33e-1)"	"unprognostic (4.19e-2)"			"unprognostic (7.70e-3)"	"unprognostic (5.61e-2)"			0.4	0.1	0.1	0.4	0.2	0.0	0.2	0.1	0.1	0.8	16.5	0.0	0.2	26.9	1.1	0.2	0.2	0.3	5.3	0.2	0.1	0.2	0.1	90.3	0.7	2.3	0.2	0.0	0.2	0.8	0.0	0.1	0.0	0.0	0.4	0.5	0.0	0.1	0.0	0.1	0.1	59.1	0.8	0.3	0.1	0.4	0.2	0.0	0.0	0.3	0.0	0.0	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.9	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.2	1.7	0.0	0.1	0.0	0.1	0.0	1.0	0.0	0.0	0.6	1.1	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.1	0.1	0.1	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	5.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.6	0.3	1.7	0.0	0.2	0.0	0.0	0.0	0.0	74.1	0.0	0.0	1.2	20.3	1.9	2.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	2.9	0.0	0.0	0.0	0.0	0.0	0.1	0.9	0.0	0.0	0.0	1.5	0.0
OTUB1	"FLJ20113, FLJ40710"	ENSG00000167770	"OTU deubiquitinase, ubiquitin aldehyde binding 1"	Q96FW1	11	63985853-64001811	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Adaptive immunity, DNA damage, DNA repair, Immunity, Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039176, CAB072836"	Approved	Supported	Approved	Nucleoplasm,Cytosol		NA	NA		630000	"Nucleoplasm, Cytosol"		"CAB072836: , HPA039176: AB_10674980"	"unprognostic (2.50e-1)"	"unprognostic (5.70e-3)"	"unprognostic (3.93e-2)"	"unprognostic (1.63e-1)"	"unprognostic (2.78e-1)"	"prognostic unfavorable (3.05e-4)"	"unprognostic (1.85e-3)"	"unprognostic (1.34e-2)"	"unprognostic (2.45e-1)"	"unprognostic (1.27e-2)"	"unprognostic (3.04e-1)"	"unprognostic (1.34e-1)"	"unprognostic (1.33e-3)"	"unprognostic (6.76e-2)"	"unprognostic (1.42e-1)"	"unprognostic (4.84e-2)"	"unprognostic (1.82e-1)"	19.8	24.7	41.9	24.1	61.6	32.6	20.8	41.8	101.9	24.3	25.0	31.9	22.3	24.7	21.9	23.6	37.8	34.5	21.6	31.6	46.9	37.8	27.2	27.6	23.0	31.9	33.1	45.4	23.4	23.0	26.0	21.6	30.7	60.4	23.8	24.1	24.2	30.4	27.7	26.7	36.9	26.0	23.1	26.7	25.7	23.9	22.1	21.2	27.8	29.9	24.5	32.8	27.1	22.9	46.0	60.8	56.1	71.3	44.8	64.5	78.2	30.7	55.7	30.7	27.2	20.8	23.0	23.7	18.6	27.6	41.4	30.6	37.4	29.5	16.4	35.3	29.8	36.0	38.6	39.7	46.3	25.7	19.0	30.7	27.4	33.5	47.3	29.2	27.1	30.0	24.4	30.1	31.6	20.2	21.5	39.0	15.3	19.1	18.6	27.7	63.4	29.6	35.9	36.1	26.1	26.5	24.3	12.0	28.1	43.0	45.1	23.3	33.6	21.0	32.3	33.9	22.0	50.1	24.0	28.1	22.1	21.5	29.5	24.4	22.0	13.8	23.6	28.6	17.7	21.1	55.1	56.3	54.3	53.1	71.3	41.4	46.0	49.1	48.6	60.8	41.9	38.4	42.6	56.1	44.8	60.9	42.1	64.5	78.2	41.9	61.6	41.8	101.9	46.9	37.8	33.1	45.4	60.4	21.2	17.9	66.5	50.3	60.6	42.8	41.6	27.7	35.7	62.9	52.4	43.6	37.3	125.6	63.0	73.0	63.0	39.3	99.3	23.3	74.8	89.9	46.6	44.0	46.3	28.0	78.9	28.6	84.2	34.4	55.6	67.0	31.7	66.2	49.0	114.6	62.4	40.9	72.8	56.1	24.1	69.5	48.4	25.8	45.3	45.7	63.7	45.9	162.9	67.3	48.9	63.9
OTUB2	"C14orf137, FLJ21916, MGC3102"	ENSG00000089723	"OTU deubiquitinase, ubiquitin aldehyde binding 2"	Q96DC9	14	94026329-94048930	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"testis: 34.5"	"Group enriched"	"Detected in many"	9	"Early spermatids: 657.5;Late spermatids: 1026.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	5	"classical monocyte: 2.1;intermediate monocyte: 2.5;myeloid DC: 3.3;non-classical monocyte: 1.9"	"Group enriched"	"Detected in many"	5	"dendritic cells: 3.3;monocytes: 2.5"	"Cell line enhanced"	"Detected in many"		"GAMG: 14.5;Karpas-707: 15.7;OE19: 15.3;RPTEC TERT1: 9.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002329, HPA075090"	Enhanced					NA	NA					"HPA002329: AB_1079537, HPA075090: AB_2686734"	"unprognostic (6.80e-3)"	"unprognostic (1.39e-3)"	"unprognostic (3.68e-3)"	"unprognostic (4.82e-3)"	"unprognostic (1.66e-1)"	"unprognostic (2.20e-1)"	"unprognostic (2.30e-3)"	"unprognostic (1.18e-2)"	"unprognostic (2.55e-1)"	"unprognostic (3.09e-3)"	"unprognostic (2.80e-2)"	"unprognostic (1.16e-2)"	"unprognostic (6.25e-3)"	"unprognostic (1.15e-1)"	"unprognostic (2.06e-2)"	"unprognostic (1.02e-4)"	"unprognostic (3.16e-1)"	2.3	1.3	2.6	0.5	3.3	0.4	1.7	1.0	5.3	2.9	1.0	0.8	1.9	0.7	1.7	1.4	5.2	1.2	0.8	0.4	3.3	1.1	1.7	1.5	0.7	0.6	0.8	1.3	1.6	1.7	4.6	1.0	6.2	1.4	1.2	1.6	0.8	1.9	0.5	0.3	9.5	0.7	0.6	1.0	0.6	1.0	34.5	0.5	0.0	0.6	1.0	2.6	1.7	2.0	0.2	3.3	0.2	2.5	0.0	0.5	0.9	1.1	3.1	2.1	2.0	0.8	0.7	2.4	0.4	0.3	1.2	1.8	0.7	5.1	0.3	2.0	0.5	14.5	0.2	2.8	1.5	1.0	0.7	1.2	0.0	0.3	3.2	1.2	0.0	0.5	0.5	1.9	0.4	0.8	1.6	1.4	2.8	0.1	15.7	0.6	1.1	0.1	0.3	0.6	15.3	2.6	0.1	0.2	0.8	9.9	1.4	1.6	1.1	0.6	0.7	1.6	1.5	5.5	0.7	1.4	0.8	2.5	0.6	0.8	2.6	1.8	0.0	1.5	0.7	1.2	0.0	2.1	0.0	0.3	2.5	0.0	0.2	0.4	0.5	3.3	0.0	0.2	0.0	0.2	0.0	1.9	0.1	0.2	0.9	2.6	3.3	1.0	5.3	3.3	1.1	0.8	1.3	1.4	0.5	0.0	0.3	0.0	0.6	0.1	1.6	0.3	0.0	1.4	1.2	0.0	0.0	3.1	1.7	3.6	657.5	0.0	0.7	0.0	1.4	1.2	0.5	0.5	0.0	0.8	1.3	0.0	0.0	0.0	1.2	1026.7	6.4	2.8	0.0	0.0	0.6	0.8	3.5	0.6	3.2	1.1	1.2	6.5	0.1	6.6	4.0	1.9	98.3	0.0	0.6	2.0
OTUD1	"DUBA7, OTDC1"	ENSG00000165312	"OTU deubiquitinase 1"	Q5VV17	10	23439458-23442390	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 60.8;tongue: 61.1"	"Cell type enhanced"	"Detected in many"	7	"Cardiomyocytes: 124.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"CAPAN-2: 25.3;HaCaT: 23.8;SiHa: 15.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038503, HPA038504"	Approved		Approved	"Nucleoplasm,Nuclear bodies,Golgi apparatus"		NA	NA			Nucleoplasm	"Nuclear bodies, Golgi apparatus"	"HPA038503: AB_2676049, HPA038504: AB_10672712"	"unprognostic (1.84e-1)"	"unprognostic (2.80e-2)"	"unprognostic (1.96e-1)"	"prognostic unfavorable (4.59e-4)"	"unprognostic (1.56e-1)"	"unprognostic (1.29e-2)"	"unprognostic (3.18e-3)"	"unprognostic (2.41e-1)"	"unprognostic (7.77e-2)"	"unprognostic (4.10e-2)"	"unprognostic (1.80e-2)"	"unprognostic (1.32e-1)"	"prognostic favorable (6.61e-7)"	"unprognostic (1.62e-1)"	"unprognostic (3.50e-2)"	"unprognostic (3.66e-1)"	"unprognostic (1.43e-2)"	11.6	9.2	5.9	8.5	6.9	39.3	14.7	9.7	9.5	13.8	8.8	9.3	6.9	4.9	9.8	10.0	8.2	9.0	9.9	25.9	6.0	5.9	14.7	7.3	26.6	11.0	6.2	6.7	10.9	6.5	12.8	7.8	11.5	5.4	8.0	5.8	9.8	6.4	6.2	60.8	17.5	7.9	7.3	6.5	13.1	16.9	9.9	5.8	8.1	14.9	61.1	12.3	12.7	10.5	3.5	1.0	5.1	4.0	0.2	3.5	0.5	3.0	1.5	1.6	0.7	6.4	3.2	2.1	1.2	2.7	3.0	2.7	0.6	25.3	1.4	2.7	1.6	1.0	23.8	1.7	3.0	2.0	10.7	4.6	0.0	3.7	0.9	5.6	0.2	2.1	3.3	13.2	0.9	4.2	2.6	1.0	1.5	0.3	10.1	1.6	1.5	0.9	0.9	1.2	1.7	0.8	1.5	7.3	1.4	3.9	2.6	0.7	1.7	15.4	2.7	7.0	4.4	1.1	2.2	1.8	1.7	2.4	4.6	0.5	5.0	9.2	0.7	2.6	1.0	0.7	5.1	1.6	2.6	0.8	1.7	1.0	1.9	1.5	0.8	1.0	3.5	1.2	1.7	3.6	0.2	4.0	0.6	3.5	0.5	5.9	6.9	9.7	9.5	6.0	5.9	6.2	6.7	5.4	5.8	62.5	14.4	35.3	7.1	28.4	17.9	124.4	10.2	8.1	4.5	5.2	2.0	2.2	10.0	5.5	7.1	15.7	28.0	0.0	6.1	2.7	16.0	9.2	5.7	7.2	41.9	50.9	5.8	16.5	44.2	4.7	6.1	61.4	32.1	1.8	19.7	27.9	10.6	14.4	12.4	18.8	24.4	6.5	18.9	6.7	2.8	26.7	6.6	10.1	12.6	5.9
OTUD3	"DUBA4, KIAA0459"	ENSG00000169914	"OTU deubiquitinase 3"	Q5T2D3	1	19882513-19912945	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028543, HPA028544"	Approved		Approved	"Nucleoplasm,Intermediate filaments,Cytosol"		NA	NA			Cytosol	"Nucleoplasm, Intermediate filaments"	"HPA028543: AB_10599302, HPA028544: AB_10602277"	"unprognostic (6.45e-3)"	"unprognostic (9.26e-2)"	"unprognostic (3.77e-1)"	"unprognostic (1.95e-1)"	"unprognostic (1.41e-1)"	"unprognostic (3.16e-3)"	"unprognostic (1.70e-3)"	"unprognostic (3.15e-3)"	"unprognostic (4.99e-2)"	"unprognostic (1.09e-1)"	"unprognostic (8.81e-2)"	"unprognostic (4.68e-2)"	"unprognostic (1.08e-1)"	"unprognostic (9.83e-2)"	"unprognostic (1.94e-1)"	"unprognostic (7.28e-2)"	"unprognostic (2.21e-2)"	6.5	11.0	15.0	6.9	19.2	11.4	10.0	19.3	23.2	10.6	8.9	6.6	6.4	10.2	14.2	13.0	6.1	8.2	7.2	5.2	12.6	7.3	7.1	4.8	8.5	7.0	9.9	12.5	11.2	7.2	9.3	20.2	5.4	9.0	9.8	8.3	6.9	6.2	9.2	9.2	13.0	9.6	11.9	8.1	7.7	7.3	28.4	9.7	6.0	6.9	2.9	6.3	7.0	7.6	1.7	0.6	0.8	0.4	0.6	2.2	0.3	5.1	1.9	8.7	10.4	3.8	3.3	8.6	5.5	3.2	2.8	2.8	9.1	4.9	8.1	4.5	12.1	2.0	5.0	8.1	3.2	5.5	5.3	10.8	7.8	10.4	6.3	2.1	5.7	7.2	2.7	3.2	4.4	5.7	6.0	3.7	8.3	5.5	3.5	4.8	2.8	4.3	5.7	4.1	4.1	5.1	10.1	22.3	3.0	4.7	5.6	7.7	5.5	3.9	3.2	4.2	8.9	4.8	4.2	4.5	6.8	8.7	7.5	4.7	4.0	3.4	5.0	4.8	7.6	3.1	0.8	0.4	0.1	1.5	0.3	1.4	1.7	1.7	1.4	0.3	1.3	2.2	1.8	0.7	0.6	0.1	0.6	0.9	0.3	15.0	19.2	19.3	23.2	12.6	7.3	9.9	12.5	9.0	9.7	14.9	6.9	3.0	5.2	12.6	13.5	3.6	0.0	10.7	1.2	8.7	15.7	2.3	0.0	4.5	9.9	4.5	3.8	0.0	4.0	4.7	4.2	8.8	1.1	2.1	1.6	25.4	11.5	9.2	1.6	11.5	5.2	3.3	5.0	2.8	6.7	10.2	3.9	5.9	5.6	3.4	16.0	6.5	3.5	19.1	21.2	7.8	2.1	4.4	5.9	3.0
OTUD4	"DUBA6, HSHIN1, KIAA1046"	ENSG00000164164	"OTU deubiquitinase 4"	Q01804	4	145110838-145180161	"Enzymes, Predicted intracellular proteins"	"Immunity, Innate immunity, Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Early spermatids: 130.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA036623	Uncertain		Supported	Cytosol		NA	NA			Cytosol		"HPA036623: AB_10696780"	"unprognostic (1.67e-1)"	"unprognostic (4.18e-2)"	"unprognostic (3.41e-2)"	"unprognostic (1.95e-1)"	"unprognostic (2.80e-1)"	"unprognostic (4.06e-2)"	"unprognostic (3.42e-2)"	"unprognostic (2.66e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.74e-2)"	"unprognostic (5.21e-3)"	"unprognostic (2.03e-2)"	"unprognostic (1.74e-1)"	"unprognostic (1.35e-1)"	"unprognostic (1.90e-1)"	"unprognostic (3.01e-1)"	"unprognostic (2.62e-1)"	14.3	11.8	16.6	11.6	16.7	24.7	12.0	22.7	15.9	14.0	15.3	16.0	10.1	10.0	13.9	13.3	14.8	14.9	11.2	15.6	12.0	9.2	11.1	17.7	15.5	13.1	14.1	8.4	14.3	13.4	22.4	12.2	17.9	12.7	10.6	11.2	10.6	12.7	11.0	36.2	13.6	16.2	12.4	10.1	13.5	10.8	26.8	18.8	13.1	13.4	13.6	12.3	11.5	12.8	3.3	2.8	2.8	2.8	1.6	3.5	1.0	15.2	8.7	10.5	9.6	12.4	15.1	14.0	13.3	15.1	17.3	13.8	9.4	18.9	28.1	6.1	18.7	10.6	9.3	18.0	18.7	22.7	12.0	8.6	13.4	10.6	8.5	14.5	28.2	10.2	11.8	19.1	21.1	27.7	14.6	15.2	12.4	22.2	21.1	16.9	9.1	17.4	12.3	11.6	14.8	10.0	14.4	11.5	6.6	16.7	11.2	10.1	8.3	12.3	18.7	13.3	14.4	6.2	11.6	18.3	19.5	12.4	10.0	17.7	15.6	15.3	18.6	13.5	20.1	18.8	0.0	1.7	2.8	3.5	2.1	2.6	3.3	2.7	2.8	1.6	2.4	2.7	2.4	0.5	1.6	2.8	2.8	2.0	1.0	16.6	16.7	22.7	15.9	12.0	9.2	14.1	8.4	12.7	18.8	59.6	19.7	15.9	40.5	56.1	15.3	18.5	28.1	42.8	23.9	26.2	23.6	17.2	8.3	11.1	130.8	21.8	10.5	0.0	12.7	17.3	25.9	44.8	19.7	20.2	11.8	6.4	14.6	22.1	18.0	63.1	18.7	17.9	30.4	5.4	12.1	7.5	18.4	14.0	28.3	6.6	19.1	0.0	29.9	28.8	41.0	47.6	13.4	14.6	14.3	50.2
OTUD5	"DKFZp761A052, DUBA"	ENSG00000068308	"OTU deubiquitinase 5"	Q96G74	X	48922028-48958386	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enriched"	"Detected in all"	4	"U-266/70: 187.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA017375	Approved		Approved	"Nucleoplasm,Nucleoli fibrillar center,Cytosol"		NA	NA			Cytosol	"Nucleoplasm, Nucleoli fibrillar center"	"HPA017375: AB_1854844"	"unprognostic (9.73e-2)"	"prognostic favorable (9.57e-4)"	"unprognostic (2.67e-2)"	"unprognostic (7.25e-2)"	"unprognostic (1.08e-1)"	"unprognostic (6.65e-2)"	"unprognostic (2.33e-3)"	"prognostic favorable (1.48e-4)"	"unprognostic (1.11e-1)"	"unprognostic (1.14e-1)"	"prognostic favorable (8.20e-4)"	"unprognostic (1.32e-1)"	"unprognostic (3.60e-1)"	"unprognostic (1.19e-1)"	"unprognostic (1.10e-1)"	"unprognostic (4.88e-2)"	"unprognostic (5.05e-3)"	23.5	27.5	32.4	26.8	40.9	38.4	21.9	35.0	52.4	21.3	22.9	28.2	23.4	30.5	25.5	26.8	20.5	25.1	20.9	16.6	29.8	31.3	22.6	24.5	25.2	30.8	25.4	29.8	30.0	25.4	29.6	26.8	23.1	29.4	24.0	17.8	20.4	26.9	27.4	24.4	24.5	29.1	27.1	21.4	34.5	22.3	12.7	24.0	34.8	24.5	14.4	27.2	22.1	22.7	7.8	6.3	8.6	5.1	18.6	7.5	3.5	6.2	9.5	4.4	11.0	7.5	6.8	5.2	5.5	6.5	7.0	7.6	4.7	7.0	7.0	3.6	6.9	6.1	7.7	6.7	5.6	6.5	8.2	8.1	5.3	9.6	5.4	6.4	5.0	5.9	7.5	5.2	7.2	4.9	7.7	5.5	5.8	6.7	11.1	4.9	6.3	7.9	10.9	8.0	2.3	7.5	6.3	6.5	9.1	4.9	5.6	4.3	7.6	7.3	4.7	7.3	10.8	6.3	4.6	7.8	4.6	5.8	12.0	4.5	187.1	46.7	6.7	7.0	7.1	3.1	5.2	3.4	7.0	7.0	5.1	5.8	7.8	5.5	6.0	4.8	6.0	5.2	7.5	8.6	18.6	4.7	6.3	7.0	3.5	32.4	40.9	35.0	52.4	29.8	31.3	25.4	29.8	29.4	24.0	8.9	21.1	23.0	19.4	19.7	31.7	8.5	10.2	17.4	17.0	26.2	25.5	11.3	8.3	13.0	1.5	18.5	26.4	0.0	15.9	12.0	16.5	23.0	6.9	22.9	14.5	27.0	46.2	18.4	24.7	1.5	19.2	19.5	25.3	21.6	26.6	16.0	17.8	15.8	22.3	20.3	25.0	12.9	13.3	5.9	10.9	22.3	25.7	30.9	17.4	22.8
OTUD6A	"DUBA2, FLJ25831, HSHIN6"	ENSG00000189401	"OTU deubiquitinase 6A"	Q7L8S5	X	70062491-70064179	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	10	"blood: 3.8;testis: 13.6"	"Group enriched"	"Detected in some"	7	"Spermatocytes: 20.9;Spermatogonia: 6.6"	"Cancer enriched"	"Detected in single"	57	"testis cancer: 2.8"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"basophil: 3.8"	"Lineage enriched"	"Detected in single"	4	"granulocytes: 3.8"	"Cell line enhanced"	"Detected in some"		"MCF7: 2.0;U-2 OS: 1.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA053304	Enhanced		Approved	Vesicles,Cytosol		NA	NA			Cytosol	Vesicles	"HPA053304: AB_2682107"															"unprognostic (1.58e-1)"			0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.0	0.0	0.0	0.0	0.1	13.6	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.9	0.4	3.8	0.4	0.7	0.6	0.0	0.4	0.0	0.2	0.2	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.6	0.4	1.0	0.5	0.0	0.7	0.8	0.4	0.3	0.2	0.0	0.0	0.5	0.8	0.8	0.0	0.3	0.7	0.3	0.4	0.2	0.3	0.2	0.0	1.1	0.2	0.6	0.0	2.0	0.3	0.9	0.6	0.0	0.2	0.0	0.0	0.0	0.8	0.7	0.6	0.3	0.5	0.2	0.0	0.5	0.1	0.1	0.0	0.2	1.9	0.3	0.5	1.6	0.3	1.5	0.1	0.2	0.2	3.8	0.4	0.3	0.4	0.2	0.4	0.3	0.3	0.2	0.0	0.9	0.3	0.6	2.6	0.7	0.3	0.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.3	0.5	0.8	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.3	0.0	0.0	0.0	0.1	0.4	0.3	1.1	0.0	0.1	0.0	0.0	0.0	1.2	0.7	0.3	0.5	0.0	0.0	0.0	0.5	0.0	0.0	1.4	0.0	1.9	0.0	0.0	20.9	6.6	0.5	0.2	0.0	0.0	0.3
OTUD6B	"CGI-77, DUBA5"	ENSG00000155100	"OTU domain containing 6B"	Q8N6M0	8	91070196-91087095	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"	"Disease mutation, Epilepsy, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA024046, HPA024503, HPA024772"	Approved	Approved	Approved	"Nucleoplasm,Golgi apparatus,Cytosol"		NA	NA			"Nucleoplasm, Golgi apparatus, Cytosol"		"HPA024046: AB_10600925, HPA024503: AB_1854845, HPA024772: AB_1854846"	"prognostic unfavorable (7.50e-4)"	"unprognostic (1.28e-1)"	"unprognostic (1.45e-1)"	"unprognostic (4.78e-3)"	"unprognostic (4.91e-2)"	"unprognostic (1.49e-1)"	"unprognostic (1.52e-2)"	"unprognostic (1.16e-3)"	"unprognostic (2.17e-1)"	"unprognostic (5.51e-2)"	"unprognostic (1.27e-2)"	"unprognostic (8.61e-3)"	"unprognostic (1.87e-2)"	"unprognostic (1.96e-1)"	"unprognostic (4.53e-1)"	"unprognostic (8.78e-2)"	"unprognostic (5.71e-2)"	11.4	11.3	14.6	14.1	18.2	8.9	13.2	13.8	19.6	12.3	11.3	9.9	10.3	9.2	12.1	9.0	13.2	9.1	8.6	14.0	14.9	13.7	11.0	10.5	10.0	13.8	18.5	15.5	12.5	9.9	11.2	14.4	14.9	16.2	11.6	11.3	6.0	9.5	14.8	35.3	11.2	9.1	12.4	19.9	11.3	8.8	11.9	17.4	13.9	11.8	11.0	11.9	11.9	14.0	7.2	12.9	8.8	7.8	7.8	6.8	2.9	16.3	9.4	8.5	6.3	3.8	2.9	8.8	13.0	4.9	12.1	7.9	8.1	10.3	17.3	6.3	6.8	4.9	5.6	17.5	10.6	18.8	13.9	10.7	23.6	9.8	6.1	8.2	12.0	12.5	4.8	5.1	9.7	23.1	7.2	9.8	13.7	23.6	10.9	10.3	8.9	20.1	7.9	4.5	12.5	18.7	9.1	8.1	15.5	9.4	11.8	2.0	7.6	1.2	28.8	12.5	11.5	14.7	5.8	10.0	7.2	10.9	11.0	12.3	10.9	20.7	25.5	10.6	15.1	13.8	8.8	6.5	4.3	5.9	7.8	6.8	7.2	4.8	5.7	8.1	6.8	6.7	5.9	0.9	7.8	5.8	12.9	3.6	2.9	14.6	18.2	13.8	19.6	14.9	13.7	18.5	15.5	16.2	17.4	8.9	9.9	12.4	5.2	20.6	13.1	14.0	10.2	9.4	13.6	1.8	31.4	9.3	8.3	4.7	0.4	7.5	3.1	0.0	4.3	8.3	5.1	4.0	18.4	9.2	7.0	11.1	10.4	9.2	7.5	0.9	8.9	9.4	3.3	8.2	4.2	13.4	5.3	4.2	3.9	6.2	16.7	0.0	7.2	1.9	6.6	15.8	5.6	7.9	5.6	4.7
OTUD7A	"C15orf16, CEZANNE2, OTUD7"	ENSG00000169918	"OTU deubiquitinase 7A"	Q8TE49	15	31475398-31870789	"Cancer-related genes, Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 20.4"	"Group enriched"	"Detected in many"	4	"Bipolar cells: 20.5;Horizontal cells: 23.8;Spermatogonia: 6.1"	"Low cancer specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"plasmacytoid DC: 3.2"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044554	Uncertain		Approved	Nucleoli,Cytosol		NA	NA			"Nucleoli, Cytosol"		"HPA044554: AB_10794895"	"unprognostic (3.61e-2)"	"unprognostic (1.35e-3)"	"unprognostic (1.39e-1)"	"unprognostic (1.25e-3)"	"unprognostic (1.29e-1)"	"unprognostic (1.03e-4)"	"unprognostic (1.50e-1)"	"unprognostic (1.21e-1)"	"unprognostic (1.38e-1)"	"unprognostic (1.67e-1)"	"unprognostic (3.24e-3)"	"unprognostic (1.34e-1)"	"unprognostic (1.79e-11)"	"unprognostic (6.78e-2)"	"unprognostic (2.76e-1)"	"unprognostic (8.27e-2)"	"unprognostic (1.79e-1)"	2.6	2.0	12.4	1.7	13.9	5.9	1.5	13.2	17.0	1.8	3.4	16.0	0.0	1.5	1.9	1.9	1.9	2.0	2.3	2.1	10.0	4.6	2.3	1.0	1.5	3.5	20.4	7.1	2.0	2.5	4.6	1.7	0.9	10.5	1.2	3.1	0.7	1.6	2.0	1.8	3.2	2.1	2.9	9.1	2.2	2.3	8.2	17.4	0.0	2.3	0.0	2.4	1.9	1.3	0.1	3.2	0.3	1.4	0.1	0.7	0.4	3.7	4.1	4.5	6.1	0.4	1.3	3.2	2.5	1.3	3.9	2.0	2.5	3.2	2.9	2.2	0.9	2.2	4.6	4.9	2.1	3.2	5.9	6.6	3.7	8.3	2.0	0.3	4.1	5.8	0.0	0.2	3.9	4.3	1.1	3.5	6.4	6.0	5.5	1.8	2.9	3.1	3.9	2.1	4.8	2.0	5.7	3.1	1.4	1.6	3.9	11.0	6.0	3.4	3.0	1.0	2.3	2.5	4.3	2.3	5.4	5.3	3.0	6.3	3.4	2.4	3.0	2.9	5.8	4.5	0.0	0.4	0.3	0.6	0.5	0.3	0.0	0.3	0.7	0.2	0.1	0.2	0.2	0.0	0.1	1.4	3.2	0.0	0.4	12.4	13.9	13.2	13.8	10.0	4.6	20.4	7.1	10.5	17.4	3.0	0.0	0.0	0.6	0.3	20.5	2.2	0.0	0.0	1.2	1.8	2.0	0.0	0.0	0.4	1.0	1.0	0.9	0.0	0.8	0.0	0.7	1.3	0.0	0.8	0.2	23.8	3.5	1.3	0.0	1.1	0.9	0.0	1.7	0.0	1.0	3.7	0.4	0.0	2.5	1.2	2.9	0.0	1.0	4.1	6.1	0.4	0.1	0.0	1.0	0.8
OTUD7B	"CEZANNE, ZA20D1"	ENSG00000264522	"OTU deubiquitinase 7B"	Q6GQQ9	1	149937812-150010676	"Enzymes, Predicted intracellular proteins"	"Adaptive immunity, Immunity, Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	5	"Cone photoreceptor cells: 100.1"	"Low cancer specificity"	"Detected in all"							"Cell type enhanced"	"Detected in many"		"basophil: 4.7"	"Group enriched"	"Detected in many"	4	"granulocytes: 4.7;NK-cells: 1.4;T-cells: 2.3"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027045, HPA076357"	Supported		Uncertain	"Microtubules,Cytokinetic bridge,Mitotic spindle"		NA	NA			Microtubules	"Cytokinetic bridge, Mitotic spindle"	"HPA027045: AB_1854847, HPA076357: "	"unprognostic (2.17e-2)"	"unprognostic (2.93e-2)"	"unprognostic (1.90e-1)"	"prognostic favorable (7.47e-4)"	"unprognostic (1.51e-1)"	"unprognostic (1.05e-1)"	"unprognostic (1.23e-3)"	"unprognostic (1.46e-2)"	"prognostic favorable (5.09e-5)"	"unprognostic (4.90e-2)"	"unprognostic (7.72e-2)"	"unprognostic (8.94e-2)"	"unprognostic (3.37e-2)"	"unprognostic (1.67e-2)"	"unprognostic (1.18e-1)"	"unprognostic (4.52e-2)"	"unprognostic (1.58e-2)"	8.8	6.2	5.8	2.6	12.3	0.3	6.2	8.5	8.9	8.6	6.3	20.6	4.0	4.6	8.5	4.1	6.1	7.6	4.3	5.3	6.0		4.5	8.6	5.6	0.9	12.7	5.1	9.2	4.5	12.5	4.3	5.3	11.6	5.3	5.6	7.4	5.4	6.3	13.2	4.3	5.1	8.9	8.5	2.3	5.2	9.6	12.5	0.0	8.3	2.3	2.1	6.3	7.1	0.6	0.6	4.7	0.3	1.4	2.3	0.2	11.5	9.3	6.5	10.9	8.6	8.1	6.2	8.2	12.0	9.8	6.8	6.8	9.4	0.1	5.3	14.8	4.4	9.2	9.2	9.0	10.4	11.1	4.7	4.4	12.9	4.6	9.2	5.0	4.9	8.9	7.0	16.6	14.6	7.7	8.0	1.4	12.1	12.6	7.0	11.8	0.9	1.4	8.3	8.7	9.1	1.2	9.0	2.9	3.8	15.9	4.2	8.0	14.4	10.6	12.9	8.9	8.8	2.7	9.5	10.2	9.5	6.8	9.5	13.5	13.0	1.3	9.1	1.5	16.7	4.7	0.3	1.3	2.3	0.2	1.7	0.6	1.0	1.4	0.1	0.6	0.9	1.0	1.2	1.4	0.3	0.6	0.6	0.2											32.8	9.4	2.2	22.0	14.2	25.3	16.2	12.7	12.0	15.9	10.4	100.1	16.8	6.6	11.5	56.6	14.7	19.3	23.3	9.6	7.6	13.6	16.9	0.0	29.3	2.8	22.3	16.7	12.3	0.6	57.7	13.6	2.5	35.4	7.2	12.2	25.5	16.8	21.0	21.5	10.3	66.3	0.0	11.3	10.7	6.4	14.4	17.7	6.7	9.2	21.0
OTULIN	"FAM105B, FLJ34884"	ENSG00000154124	"OTU deubiquitinase with linear linkage specificity"	Q96BN8	5	14664664-14699711	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Angiogenesis, Immunity, Innate immunity, Ubl conjugation pathway, Wnt signaling pathway"	"Hydrolase, Protease, Thiol protease"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA051074	Uncertain		Approved	"Plasma membrane,Mitochondria"		NA	NA			Mitochondria	"Plasma membrane"	"HPA051074: AB_2681334"	"unprognostic (4.81e-3)"	"unprognostic (1.11e-1)"	"unprognostic (4.00e-2)"	"unprognostic (1.19e-2)"	"unprognostic (7.48e-2)"	"unprognostic (1.91e-2)"	"unprognostic (7.94e-3)"	"unprognostic (1.43e-1)"	"unprognostic (2.48e-2)"	"unprognostic (9.55e-2)"	"unprognostic (1.02e-1)"	"unprognostic (7.13e-2)"	"prognostic unfavorable (2.59e-7)"	"unprognostic (2.92e-2)"	"unprognostic (2.28e-2)"	"unprognostic (1.60e-1)"	"unprognostic (5.02e-2)"	10.0	7.4	5.9	22.6	7.8	32.3	8.4	7.2	6.6	8.2	9.3	8.3	8.9	10.7	9.5	7.7	13.8	6.1	10.8	15.5	6.7	4.9	8.5	19.5	11.1	16.0	9.6	2.8	9.1	12.2	7.5	9.8	11.8	7.0	11.1	7.0	7.7	10.6	10.8	16.5	18.1	11.7	8.1	10.5	12.5	7.1	11.5	7.4	15.0	7.8	9.7	19.3	8.5	15.8	3.4	2.9	3.1	3.0	1.0	4.6	0.9	6.4	7.5	7.5	8.5	7.0	7.3	8.3	6.5	4.6	9.3	7.0	10.1	4.8	11.6	12.8	4.2	13.4	7.4	9.3	8.5	6.4	20.0	7.7	8.3	23.9	5.4	6.0	7.9	14.3	4.1	10.5	7.6	6.5	5.1	7.8	9.8	8.2	18.6	6.6	4.0	7.8	6.9	4.6	6.8	8.0	12.1	6.8	4.6	6.0	6.7	3.4	5.6	23.1	5.2	5.0	9.6	5.7	9.1	7.2	12.1	13.7	9.0	8.5	8.4	12.7	13.2	6.9	15.1	6.2	0.4	2.0	3.1	1.0	2.2	3.0	0.9	2.5	3.4	2.9	3.4	1.8	3.9	2.2	1.0	3.0	2.5	4.6	0.9	5.9	7.8	7.2	6.6	6.7	4.9	9.6	2.8	7.0	7.4	3.0	8.6	13.4	20.2	0.0	10.9	13.4	15.3	9.4	7.9	5.2	13.7	13.2	6.6	4.2	7.3	8.7	13.9	0.0	5.0	8.6	4.9	19.7	10.3	32.7	12.3	7.9	9.1	8.0	11.8	2.5	9.8	10.6	0.0	13.6	11.6	13.0	7.1	8.4	6.0	8.9	32.3	0.0	6.2	23.8	30.4	0.0	11.9	15.0	8.9	19.3
OVCH1	OVCH	ENSG00000187950	"Ovochymase 1"	Q7RTY7	12	29412474-29497686	"Enzymes, Predicted intracellular proteins, Predicted secreted proteins"		"Hydrolase, Protease, Serine protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"lung: 9.5;testis: 4.6"	"Group enriched"	"Detected in some"	6	"Early spermatids: 2.4;Late spermatids: 1.7"	"Not detected"	"Not detected"							"Cell type enhanced"	"Detected in single"		"neutrophil: 1.3"	"Low lineage specificity"	"Detected in single"			"Cell line enriched"	"Detected in some"	5	"Daudi: 11.0"					"Low region specificity"	"Detected in many"								"Secreted in female reproductive system"	NA	NA						"unprognostic (3.32e-1)"	"unprognostic (2.20e-1)"	"unprognostic (2.03e-1)"	"unprognostic (1.56e-5)"	"unprognostic (1.68e-1)"	"unprognostic (1.58e-1)"	"unprognostic (4.41e-2)"	"unprognostic (1.83e-1)"	"unprognostic (2.25e-2)"	"unprognostic (5.46e-2)"	"unprognostic (1.36e-1)"	"unprognostic (5.48e-2)"	"unprognostic (5.59e-3)"	"unprognostic (1.04e-1)"	"unprognostic (2.14e-1)"	"unprognostic (3.52e-2)"	"unprognostic (2.06e-1)"	0.6	0.4	0.0	0.4	0.3	0.1	0.5	0.0	0.1	0.4	0.2			0.0	0.2	0.0	0.1	0.2	0.4	0.2	0.1	0.2	0.2	0.3	9.5	0.2	0.1		0.3	0.0	0.0	0.6	0.0		0.1	0.3		0.0	0.0	0.3	0.5	0.1	0.0	0.2	1.9	0.2	4.6			2.1		0.0	0.1	0.2	0.5	0.2	1.3	0.5	0.0	0.6	0.3	0.0	0.0	0.6	0.0	0.7	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	11.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.6	0.0	0.3	0.0	0.0	0.3	0.1	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.5	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.3	0.0	0.0	0.2	0.0	0.8	0.0	0.5	0.8	0.1	0.1	0.2	0.1	0.1	0.5	0.0	0.5	0.0	0.6	1.3	0.0	0.0	0.2	0.0	0.3											0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
OXCT1	"OXCT, SCOT"	ENSG00000083720	"3-oxoacid CoA-transferase 1"	P55809	5	41730065-41870519	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		Transferase	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 108.8"	"Group enriched"	"Detected in many"	5	"Cardiomyocytes: 212.2;Distal tubular cells: 159.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HeLa: 56.9;SiHa: 74.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA012047, HPA061425"	Enhanced		Enhanced	Mitochondria	"Intracellular and membrane"	NA	NA		1000000	Mitochondria		"HPA012047: AB_1854857, HPA061425: AB_2684515"	"unprognostic (4.26e-2)"	"unprognostic (2.10e-2)"	"unprognostic (2.89e-2)"	"unprognostic (1.51e-1)"	"unprognostic (5.51e-2)"	"unprognostic (1.82e-2)"	"prognostic unfavorable (1.03e-4)"	"unprognostic (7.42e-3)"	"unprognostic (1.74e-3)"	"unprognostic (1.67e-1)"	"unprognostic (2.80e-2)"	"unprognostic (3.62e-1)"	"prognostic favorable (1.86e-8)"	"unprognostic (2.66e-2)"	"unprognostic (9.99e-2)"	"unprognostic (5.86e-3)"	"unprognostic (2.28e-3)"	21.9	8.0	17.3	7.5	30.3	5.8	9.5	26.6	36.8	6.7	9.2	8.3	10.7	4.4	8.6	8.7	13.1	6.9	7.5	108.8	19.3	15.2	25.3	1.2	4.2	9.5	13.1	25.7	7.2	3.0	20.9	8.4	2.8	21.2	12.5	10.4	6.6	8.5	14.7	13.4	10.7	6.5	17.0	8.9	5.2	14.6	6.2	5.3	22.8	13.0	10.7	11.8	8.0	7.5	8.0	4.6	3.3	1.6	7.5	15.6	5.1	7.9	0.3	6.6	7.9	20.5	11.0	0.0	14.3	9.1	11.9	7.2	1.2	5.4	20.7	3.5	10.9	6.1	4.7	18.0	12.9	14.0	17.7	2.1	14.5	56.9	2.7	8.9	28.2	4.9	10.3	3.5	11.6	19.6	5.8	10.8	18.9	2.9	26.7	13.6	1.0	23.5	1.3	1.4	0.0	5.7	18.7	18.5	15.6	9.7	0.6	6.6	6.8	74.0	0.0	8.7	0.6	0.1	6.1	6.5	9.5	12.4	16.2	11.5	4.4	3.6	0.8	14.3	20.7	7.2	1.0	1.0	3.3	9.1	1.1	10.9	8.0	9.2	9.8	4.6	6.1	10.8	8.9	0.3	7.5	1.6	1.8	15.6	5.1	17.3	30.3	26.6	36.8	19.3	15.2	13.1	25.7	21.2	5.3	6.0	8.6	7.5	12.0	13.2	13.1	212.2	7.6	5.3	18.2	10.4	2.0	5.2	159.2	4.7	14.3	5.6	2.3	0.0	0.6	9.8	8.4	11.2	9.2	0.0	29.1	12.7	12.7	4.9	1.0	5.6	5.8	4.4	15.1	3.6	13.4	11.3	3.9	3.5	7.1	11.3	19.5	12.9	15.6	36.7	14.9	18.9	5.7	17.3	15.5	5.2
OXCT2	"FKSG25, FLJ00030, SCOT-T"	ENSG00000198754	"3-oxoacid CoA-transferase 2"	Q9BYC2	1	39769523-39771348	"Enzymes, Predicted intracellular proteins"		Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	8	"testis: 31.8"	"Group enriched"	"Detected in some"	89	"Early spermatids: 428.2;Late spermatids: 642.7"	"Not detected"	"Not detected"							"Group enriched"	"Detected in some"	9	"memory B-cell: 3.3;naive B-cell: 1.9;NK-cell: 1.4"	"Group enriched"	"Detected in many"	9	"B-cells: 3.3;NK-cells: 1.4"	"Cell line enhanced"	"Detected in many"		"Karpas-707: 9.9;THP-1: 10.6;U-266/70: 8.2"									HPA075423	Enhanced					NA	NA					"HPA075423: AB_2732292"	"unprognostic (2.42e-3)"	"unprognostic (2.11e-1)"	"unprognostic (6.50e-2)"	"unprognostic (7.16e-2)"	"unprognostic (9.68e-2)"	"unprognostic (1.13e-1)"	"unprognostic (1.32e-1)"	"unprognostic (1.93e-3)"	"unprognostic (2.74e-1)"	"unprognostic (3.16e-1)"	"unprognostic (2.57e-3)"	"unprognostic (4.18e-2)"	"unprognostic (5.39e-5)"	"unprognostic (3.24e-1)"	"unprognostic (4.59e-1)"	"unprognostic (1.70e-1)"	"unprognostic (1.85e-1)"	0.0	0.6	0.2	0.2	0.2	0.1	0.0	0.8	0.5	0.3	0.3			0.4	0.5	0.7	0.4	0.2	0.5	3.9	0.4	0.1	0.0	0.1	0.0	0.3	0.3		1.5	0.4	0.2	0.3	0.0		0.8	0.2		0.0	1.2	0.0	1.4	0.5	0.4	0.4	0.3	0.2	31.8			1.6		0.0	0.1	0.0	3.3	0.0	0.0	0.2	1.4	0.0	0.1	0.5	0.3	0.0	1.2	0.4	1.5	0.0	1.5	0.0	1.4	0.7	5.0	0.6	0.0	1.0	2.0	0.2	0.5	1.5	0.1	0.7	0.0	3.3	0.9	3.3	0.2	2.4	0.0	0.5	0.7	0.4	0.2	0.1	0.0	1.1	0.4	0.3	9.9	0.2	1.4	0.0	1.5	0.1	0.0	1.3	1.3	1.6	1.5	0.4	1.0	1.7	0.9	4.3	0.3	1.5	0.1	0.5	10.6	1.2	0.0	0.3	4.8	0.0	8.2	4.3	0.6	0.1	0.6	2.4	0.0	0.2	0.0	0.0	0.0	0.0	3.3	0.0	0.0	0.0	1.9	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.1											0.0	1.1	0.8	0.2	0.2	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	428.2	0.5	0.5	0.0	0.6	0.1	0.3	0.4	0.0	0.0	0.2	0.0	0.0	0.0	0.3	642.7	3.7	0.8	1.7	1.0	0.6	0.3	0.6	0.0	6.0	0.0	0.0	0.0	5.6	2.7	2.2	0.4	0.0	0.0	0.3	0.1
OXSM	"CEM1, FASN2D, FLJ20604, KS"	ENSG00000151093	"3-oxoacyl-ACP synthase, mitochondrial"	Q9NWU1	3	25782917-25794534	"Enzymes, Predicted intracellular proteins"	"Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism"	"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Early spermatids: 38.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021293, HPA021300, HPA021337"	Enhanced		Approved	Mitochondria,Cytosol		No	No			"Mitochondria, Cytosol"		"HPA021293: AB_1848772, HPA021300: AB_1848774, HPA021337: AB_1848776"	"unprognostic (2.20e-2)"	"unprognostic (3.28e-1)"	"prognostic favorable (1.35e-4)"	"prognostic favorable (5.51e-4)"	"unprognostic (1.01e-1)"	"unprognostic (8.17e-2)"	"unprognostic (2.15e-3)"	"unprognostic (1.41e-1)"	"unprognostic (1.76e-1)"	"unprognostic (2.83e-2)"	"unprognostic (3.06e-2)"	"unprognostic (1.20e-1)"	"prognostic favorable (4.18e-9)"	"unprognostic (1.79e-2)"	"unprognostic (2.42e-1)"	"unprognostic (3.10e-1)"	"unprognostic (1.73e-2)"	6.2	13.7	6.7	9.8	10.5	3.7	10.3	8.3	11.9	6.0	11.8	6.2	13.7	10.1	6.4	16.2	10.3	7.7	7.9	13.5	6.6	6.4	14.9	26.1	10.0	7.7	6.6	6.5	6.4	18.7	8.3	13.0	7.3	7.0	8.0	13.8	10.4	15.5	15.6	19.4	8.3	8.9	5.8	6.7	9.6	8.9	19.9	8.0	8.1	11.7	12.3	11.3	7.9	6.4	8.4	9.0	3.7	6.5	10.3	11.8	6.6	7.7	12.9	2.7	7.6	8.0	8.8	8.0	6.2	9.0	11.7	8.3	9.8	9.3	14.3	8.4	5.7	6.8	8.2	11.4	11.9	11.0	8.6	11.5	15.8	10.9	11.8	9.8	12.7	10.1	8.2	14.8	9.3	9.8	7.6	10.0	13.6	16.2	11.6	9.9	11.5	9.3	9.8	0.5	6.2	14.9	12.4	7.2	23.4	17.1	4.8	3.9	7.2	9.9	17.0	12.6	4.6	18.6	11.9	6.1	7.3	8.8	9.6	8.9	11.1	12.8	4.5	10.3	11.2	7.5	2.1	5.4	3.7	9.4	6.0	10.8	8.4	9.7	11.6	8.6	8.2	11.4	11.8	0.9	10.3	6.5	9.0	6.0	6.6	6.7	10.5	8.3	11.9	6.6	6.4	6.6	6.5	7.0	8.0	0.0	10.3	2.9	5.0	2.7	6.2	9.8	7.6	5.3	4.5	10.4	3.9	17.5	10.0	11.3	38.3	4.9	6.3	0.0	5.9	13.9	6.5	5.4	9.3	13.9	7.7	4.8	2.4	6.7	2.7	11.5	6.6	3.7	5.0	6.4	9.8	8.3	7.4	7.6	3.9	16.1	6.5	0.0	3.1	26.1	12.0	3.9	11.8	5.0	9.6	2.4
OXSR1	"KIAA1101, OSR1"	ENSG00000172939	"Oxidative stress responsive 1"	O95747	3	38165089-38255488	"Enzymes, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Urothelial cells: 110.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008237, CAB017181"	Supported		Enhanced	Cytosol		NA	NA		21000000	Cytosol		"CAB017181: , HPA008237: AB_1079540"	"unprognostic (2.16e-1)"	"unprognostic (2.36e-2)"	"unprognostic (1.79e-2)"	"unprognostic (4.55e-3)"	"unprognostic (9.89e-2)"	"unprognostic (1.97e-2)"	"unprognostic (3.53e-3)"	"unprognostic (4.05e-2)"	"unprognostic (4.44e-1)"	"unprognostic (6.06e-2)"	"unprognostic (3.95e-3)"	"unprognostic (1.88e-2)"	"unprognostic (1.87e-3)"	"unprognostic (1.56e-1)"	"unprognostic (3.14e-2)"	"unprognostic (1.71e-1)"	"unprognostic (6.99e-3)"	17.6	16.8	9.4	18.3	13.4	24.2	15.9	17.4	14.9	16.8	15.4	9.2	35.7	12.4	14.9	14.7	31.6	11.6	18.9	15.5	11.9	9.0	18.3	17.6	14.6	13.9	13.6	9.3	16.7	12.3	23.7	15.3	21.4	12.3	16.5	16.8	13.0	15.1	23.9	32.6	17.4	21.4	17.0	12.9	15.8	14.0	11.2	13.2	26.2	14.2	24.1	19.6	23.5	19.2	2.3	4.4	10.1	4.8	5.0	4.7	1.6	17.7	8.1	16.3	11.3	11.4	13.2	18.5	15.7	21.6	22.8	24.8	10.5	11.6	19.7	8.0	18.8	9.8	11.1	21.8	16.2	30.1	20.8	8.9	21.5	17.3	11.4	13.6	13.3	13.2	10.4	19.1	21.0	34.1	21.5	14.2	25.5	16.3	11.4	39.0	5.0	25.6	9.6	17.1	11.5	9.7	8.9	13.6	15.2	14.0	13.5	8.5	13.1	17.2	43.6	10.7	18.7	14.3	8.7	12.9	14.3	14.2	21.7	23.2	8.7	10.3	14.5	19.7	16.6	28.5	10.1	2.8	6.1	3.3	4.8	3.5	1.9	4.0	3.1	4.4	2.3	3.0	3.7	5.5	5.0	4.1	2.5	4.7	1.6	9.4	13.4	17.4	14.9	11.9	9.0	13.6	9.3	12.3	13.2	11.9	26.3	13.3	24.0	39.2	11.8	26.6	2.5	12.0	27.3	26.2	19.6	9.4	16.6	25.2	3.1	17.1	28.7	0.0	12.5	15.6	14.9	44.7	15.1	17.8	13.4	20.6	23.2	12.3	32.9	1.4	8.9	28.2	6.8	33.3	18.0	7.6	33.8	24.6	12.0	19.4	5.5	12.9	26.7	12.7	15.0	45.4	27.6	17.5	15.3	110.3
P3H1	"GROS1, LEPRE1, LEPRECAN, MGC117314"	ENSG00000117385	"Prolyl 3-hydroxylase 1"	Q32P28	1	42746335-42767084	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		"Dioxygenase, Oxidoreductase"	"Dwarfism, Osteogenesis imperfecta"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Cytotrophoblasts: 37.3;Extravillous trophoblasts: 47.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"fHDF/TERT166: 50.7"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"HPA012113, HPA016980"	Approved		Approved	Nucleoli,Vesicles	"Intracellular and membrane"	NA	NA		13000	Vesicles	Nucleoli	"HPA012113: AB_2668626, HPA016980: AB_2669498"	"unprognostic (3.24e-1)"	"unprognostic (1.04e-1)"	"unprognostic (9.37e-2)"	"unprognostic (4.57e-1)"	"unprognostic (2.03e-1)"	"unprognostic (1.19e-1)"	"prognostic unfavorable (4.95e-7)"	"unprognostic (5.41e-2)"	"unprognostic (2.70e-3)"	"unprognostic (9.16e-2)"	"unprognostic (2.21e-1)"	"unprognostic (1.21e-1)"	"prognostic unfavorable (0.00e+0)"	"unprognostic (1.41e-2)"	"unprognostic (1.23e-1)"	"unprognostic (2.67e-2)"	"unprognostic (1.60e-3)"	11.9	11.2	7.1	8.6	6.3	5.2	9.7	6.4	5.3	14.0	7.1	6.0	7.7	2.6	13.8	11.1	6.4	8.8	12.1	8.8	3.8	2.9	7.9	19.9	10.8	10.1	6.1	3.3	13.1	6.8	5.8	15.2	36.1	4.6	7.8	5.7	10.5	6.4	6.5	4.3	7.2	6.6	19.7	3.4	13.3	6.6	13.1	4.7	10.2	7.4	5.3	7.8	11.4	8.5	3.1	16.2	11.0	16.2	11.7	7.9	6.1	2.2	5.8	13.1	30.6	30.9	23.7	5.4	26.9	35.1	19.5	33.3	2.9	4.9	3.3	21.6	50.7	7.8	2.0	5.5	6.8	13.4	5.0	7.0	7.9	9.2	8.4	17.9	7.8	9.1	20.1	4.6	19.6	8.4	27.7	27.4	4.8	4.4	4.3	13.0	1.2	5.1	4.5	14.3	1.2	4.2	5.0	19.3	4.5	10.2	1.2	2.7	4.6	16.4	0.4	11.6	23.9	0.9	33.0	22.3	14.6	12.9	11.6	10.6	3.8	4.3	3.0	16.7	10.6	20.2	3.5	13.2	11.0	6.0	14.0	6.4	3.1	4.6	5.1	16.2	2.6	3.9	3.9	1.2	11.7	16.2	7.6	7.9	6.1	7.1	6.3	6.4	5.3	3.8	2.9	6.1	3.3	4.6	4.7	3.0	2.9	4.8	5.7	0.0	10.0	4.2	5.1	1.4	1.2	10.4	23.6	37.3	0.0	10.4	16.8	15.7	0.4	0.0	6.6	47.0	22.9	3.0	1.1	10.6	15.4	14.3	5.8	17.8	6.7	7.5	17.8	8.7	0.0	10.0	2.8	2.6	6.7	2.0	15.2	1.7	20.0	0.0	7.6	21.8	11.1	0.0	14.6	12.5	1.7	3.5
P3H2	"FLJ10718, LEPREL1, MLAT4"	ENSG00000090530	"Prolyl 3-hydroxylase 2"	Q8IVL5	3	189956728-190122437	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		"Dioxygenase, Oxidoreductase"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 74.5"	"Cell type enhanced"	"Detected in many"	7	"Alveolar cells type 1: 44.7;Alveolar cells type 2: 62.9;Collecting duct cells: 41.8;Ito cells: 44.8;Muller glia cells: 49.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in single"	22	"plasmacytoid DC: 20.3"	"Lineage enriched"	"Detected in single"	104	"dendritic cells: 20.3"	"Cell line enhanced"	"Detected in many"		"GAMG: 38.1;HaCaT: 34.0;RPTEC TERT1: 34.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA007890, HPA013355, HPA013611"	Approved		Supported	"Nucleoplasm,Golgi apparatus,Vesicles,Cytosol"	"Intracellular and membrane"	NA	NA			"Golgi apparatus"	"Nucleoplasm, Vesicles, Cytosol"	"HPA007890: AB_1852796, HPA013355: AB_1852798, HPA013611: "	"unprognostic (4.90e-2)"	"unprognostic (1.57e-1)"	"unprognostic (3.76e-1)"	"unprognostic (4.32e-3)"	"unprognostic (1.97e-2)"	"unprognostic (7.75e-2)"	"unprognostic (9.68e-2)"	"unprognostic (2.17e-1)"	"unprognostic (3.15e-1)"	"unprognostic (1.19e-1)"	"unprognostic (1.03e-3)"	"unprognostic (1.60e-1)"	"unprognostic (1.15e-2)"	"unprognostic (1.80e-2)"	"unprognostic (1.48e-1)"	"unprognostic (1.10e-1)"	"unprognostic (4.01e-2)"	2.4	22.6	2.9	4.0	3.9	0.2	3.1	0.7	2.2	14.3	11.8	6.2	11.5	1.2	15.0	13.5	8.9	4.6	8.4	3.8	2.8	2.1	74.5	3.5	22.5	3.6	8.1	1.0	11.2	3.9	1.4	6.1	11.0	5.6	19.9	5.3	10.3	2.7	14.3	0.6	8.6	3.6	16.3	7.6	33.7	12.0	2.8	5.3	2.0	1.7	6.3	2.7	5.7	9.8	0.0	20.3	0.1	0.1	0.0	0.0	0.1	14.0	5.6	11.0	0.0	0.2	0.4	13.3	15.0	5.9	2.4	4.0	4.5	5.5	0.0	8.5	2.6	38.1	34.0	0.0	20.1	5.1	0.1	1.9	0.0	3.8	0.0	11.4	0.0	0.1	5.4	6.8	4.8	1.7	23.3	0.4	0.0	0.0	0.1	3.8	0.3	0.0	0.1	3.4	9.4	1.1	0.0	2.2	0.8	34.7	23.7	0.8	0.1	20.4	1.1	8.9	16.9	0.0	0.2	7.5	14.6	5.5	0.1	2.7	1.0	0.0	0.1	3.3	0.0	18.6	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.1	0.0	0.0	20.3	0.0	0.1	2.9	3.9	0.7	2.2	2.8	2.1	8.1	1.0	5.6	5.3	44.7	62.9	1.9	7.4	0.0	2.2	1.0	5.1	0.0	5.7	41.8	3.9	30.9	5.0	3.8	14.3	4.5	0.0	0.0	0.7	11.7	2.0	13.7	1.1	0.6	9.1	9.5	0.0	44.8	4.6	11.4	4.4	4.7	0.0	1.0	0.2	49.8	18.0	0.0	0.0	24.5	0.8	0.0	2.7	0.5	0.4	0.0	32.3	0.0	0.0	2.8
P3H3	"GRCB, HSU47926, LEPREL2"	ENSG00000110811	"Prolyl 3-hydroxylase 3"	Q8IVL6	12	6828410-6839851	"Enzymes, Predicted intracellular proteins"		"Dioxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"Bipolar cells: 28.3;Cone photoreceptor cells: 94.2;Horizontal cells: 41.3;Leydig cells: 46.1;Peritubular cells: 36.0;Rod photoreceptor cells: 26.9"	"Low cancer specificity"	"Detected in all"							"Cell type enhanced"	"Detected in some"		"MAIT T-cell: 2.1;naive CD4 T-cell: 1.7"	"Lineage enriched"	"Detected in single"	21	"T-cells: 2.1"	"Cell line enhanced"	"Detected in many"		"BJ: 22.1;hTERT-RPE1: 15.7;NTERA-2: 15.7;U-251 MG: 15.3"	"Low region specificity"	"Detected in all"			"Region enriched"	"Detected in all"	4	"cerebellum: 17.6"	HPA043695	Approved		Approved	"Nucleoli,Plasma membrane,Cytosol"	"Intracellular and membrane"	NA	NA			"Plasma membrane, Cytosol"	Nucleoli	"HPA043695: AB_10797146"	"unprognostic (2.54e-1)"	"unprognostic (6.66e-2)"	"unprognostic (1.14e-1)"	"unprognostic (3.34e-2)"	"unprognostic (5.76e-2)"	"unprognostic (6.55e-2)"	"unprognostic (2.66e-1)"	"unprognostic (2.92e-1)"	"unprognostic (6.90e-2)"	"unprognostic (1.44e-1)"	"prognostic favorable (4.91e-4)"	"unprognostic (1.29e-1)"	"prognostic unfavorable (1.64e-4)"	"unprognostic (2.58e-2)"	"unprognostic (9.67e-2)"	"unprognostic (2.27e-1)"	"unprognostic (7.77e-3)"	3.7	3.1	1.2	2.2	2.6	0.3	3.0	10.7	2.5	12.1	2.7	0.0	7.6	1.1	11.0	8.5	2.5	2.1	5.6	4.4	1.2		1.1	0.4	1.6	1.9	0.0	2.2	9.3	3.6	12.1	7.4	2.5	0.8	5.6	0.5	8.1	5.9	6.5	0.5	1.8	1.7	8.8	0.5	1.0	2.8	2.1	0.1	0.0	3.5	1.2	1.4	5.9	4.7	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.8	4.2	7.9	4.9	6.0	0.1	22.1	12.7	7.0	7.7	0.3	0.0	0.0	0.3	8.3	0.2	0.0	2.5	0.2	1.6	0.0	10.6	0.5	2.3	1.0	3.4	0.5	0.0	6.5	0.2	3.4	1.9	15.7	7.4	0.7	2.0	0.0	3.3	0.0	0.0	0.2	15.7	0.0	0.6	0.0	3.9	0.1	0.3	0.0	1.6	6.0	0.0	0.0	2.4	2.1	0.1	0.1	12.9	6.9	10.3	10.6	15.3	0.0	0.1	0.2	5.9	0.0	2.7	0.0	0.0	0.0	0.3	0.0	2.1	0.0	0.0	0.9	0.0	0.0	1.7	0.3	0.0	0.0	0.0	0.0	0.1	0.0											0.0	0.0	0.0	3.8	0.0	28.3	9.0	2.5	2.7	3.4	5.2	94.2	0.3	1.7	1.6	0.7	2.3	0.0	0.0	2.3	0.4	7.4	4.6	0.0	0.0	1.2	41.3	1.2	3.7	0.0	1.3	46.1	0.0	0.0	1.8	2.5	4.8	1.9	0.0	36.0	0.3	26.9	6.5	9.2	0.7	0.9	0.0	0.8	0.0	0.4	1.4
P4HA1	"C-P4Halpha(I), P4HA"	ENSG00000122884	"Prolyl 4-hydroxylase subunit alpha 1"	P13674	10	73007217-73096974	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Dioxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"vagina: 105.7"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"hTERT-RPE1: 94.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007599, HPA026593"	Enhanced		Supported	"Endoplasmic reticulum,Vesicles,Mitochondria"	"Intracellular and membrane"	Yes	No			"Endoplasmic reticulum"	"Vesicles, Mitochondria"	"HPA007599: AB_1854891, HPA026593: AB_1854892"	"prognostic unfavorable (9.01e-4)"	"prognostic unfavorable (3.19e-5)"	"unprognostic (2.76e-3)"	"unprognostic (3.04e-1)"	"unprognostic (1.69e-2)"	"prognostic unfavorable (1.19e-5)"	"unprognostic (2.30e-1)"	"prognostic unfavorable (5.10e-4)"	"unprognostic (1.28e-1)"	"unprognostic (2.29e-1)"	"prognostic unfavorable (2.85e-4)"	"unprognostic (9.15e-2)"	"prognostic unfavorable (9.40e-9)"	"unprognostic (3.14e-1)"	"unprognostic (4.22e-2)"	"unprognostic (1.02e-2)"	"unprognostic (5.75e-2)"	16.8	14.4	16.5	10.4	20.2	7.0	47.6	9.9	18.2	18.5	10.9	11.3	7.4	5.6	14.8	12.2	11.6	22.4	14.1	23.9	17.0	10.9	19.0	39.9	18.1	7.5	33.5	4.9	22.3	13.1	11.1	8.6	33.5	25.4	17.9	9.4	8.6	8.5	10.4	63.5	10.3	7.8	15.1	45.8	9.7	11.1	9.7	30.9	4.1	19.4	7.5	7.3	34.4	105.7	6.9	14.8	10.2	17.3	3.4	7.3	6.1	15.2	3.9	11.4	22.1	35.2	27.1	9.5	44.7	40.5	17.3	41.6	6.5	11.9	5.2	17.1	44.2	10.5	17.3	7.1	16.3	37.9	6.6	2.7	4.4	3.7	7.7	14.7	8.1	3.1	16.4	9.5	14.7	19.5	94.8	8.1	4.4	6.8	2.7	14.9	4.0	3.2	7.8	4.1	7.1	17.3	2.9	7.6	9.3	9.7	6.6	1.0	6.4	9.1	27.0	10.6	26.9	4.1	7.6	7.7	21.2	8.7	5.9	10.4	15.6	5.6	2.5	38.0	11.8	10.3	0.8	13.5	10.2	5.2	16.4	6.7	6.0	6.2	6.0	14.8	6.9	4.6	4.7	7.4	3.4	17.3	11.8	7.3	6.1	16.5	20.2	9.9	18.2	17.0	10.9	33.5	4.9	25.4	30.9	6.0	27.9	18.6	25.1	32.3	12.9	37.9	2.5	56.2	31.8	22.7	25.5	25.0	0.0	26.6	10.0	23.3	10.7	0.0	17.0	76.6	76.1	22.0	39.3	25.1	39.6	11.1	9.9	19.0	44.8	4.7	48.1	41.1	42.2	36.1	7.6	33.4	37.2	18.2	44.2	22.8	17.6	38.8	31.1	35.7	35.8	20.8	27.8	13.8	6.5	17.3
P4HA2	C-P4Halpha(II)	ENSG00000072682	"Prolyl 4-hydroxylase subunit alpha 2"	O15460	5	132191838-132295315	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		"Dioxygenase, Oxidoreductase"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HHSteC: 62.2;U-87 MG: 60.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA016997, HPA027824, CAB062557"	Enhanced		Enhanced	"Endoplasmic reticulum,Vesicles"	"Intracellular and membrane"	No	No			"Endoplasmic reticulum, Vesicles"		"CAB062557: AB_2665641, HPA016997: AB_2669501, HPA027824: AB_2672402"	"unprognostic (1.30e-3)"	"prognostic unfavorable (1.24e-5)"	"unprognostic (2.56e-3)"	"unprognostic (1.28e-3)"	"unprognostic (2.08e-3)"	"unprognostic (1.62e-3)"	"unprognostic (1.16e-3)"	"unprognostic (1.93e-3)"	"unprognostic (2.83e-2)"	"unprognostic (1.92e-1)"	"unprognostic (8.98e-2)"	"unprognostic (1.91e-1)"	"prognostic unfavorable (2.77e-7)"	"unprognostic (2.50e-2)"	"unprognostic (1.61e-1)"	"unprognostic (2.23e-1)"	"prognostic unfavorable (3.12e-4)"	10.2	5.6	7.1	6.5	5.4	0.8	12.2	9.5	7.8	14.4	12.5	4.6	6.1	9.8	20.0	35.3	11.6	13.7	9.7	26.1	6.6	7.0	34.4	6.3	16.0	4.3	6.3	4.2	6.7	42.5	6.7	15.8	15.1	9.5	9.3	14.6	15.1	21.1	8.4	7.1	9.3	17.1	23.3	5.1	6.3	12.6	5.1	4.4	4.1	12.2	10.8	5.4	11.3	34.5	0.2	1.0	3.1	1.3	2.6	2.6	0.7	10.3	6.3	2.0	10.1	28.3	33.8	11.5	48.2	41.2	20.5	50.8	14.2	9.1	0.2	14.2	51.6	22.9	13.0	6.3	25.2	32.5	7.6	2.1	0.0	9.3	8.6	62.2	0.0	6.2	20.4	37.3	24.3	22.4	30.7	10.8	0.0	3.7	0.6	25.0	4.1	0.0	0.0	0.5	9.5	5.2	0.1	0.6	1.6	5.7	2.0	1.0	2.8	12.3	4.1	8.2	16.5	5.1	0.7	16.5	31.2	12.2	9.4	10.4	4.4	4.7	2.0	60.1	0.0	8.7	0.0	1.3	0.0	2.6	1.1	2.4	0.0	1.4	0.4	0.6	0.2	0.0	0.4	3.1	2.6	0.2	1.0	0.0	0.7	7.1	5.4	9.5	7.8	6.6	7.0	6.3	4.2	9.5	4.4	32.8	10.1	1.4	26.7	14.9	7.9	11.8	12.7	60.2	14.8	10.4	21.6	2.4	5.0	58.5	1.0	9.8	35.4	0.0	62.7	51.9	40.5	21.4	5.7	5.9	7.2	0.0	14.5	15.4	1.8	1.6	7.5	4.7	28.7	3.6	12.9	7.5	69.0	34.5	4.9	34.1	5.5	25.8	27.8	18.2	29.4	8.5	6.3	2.5	10.8	16.5
P4HA3	C-P4Halpha(III)	ENSG00000149380	"Prolyl 4-hydroxylase subunit alpha 3"	Q7Z4N8	11	74235801-74311657	"Enzymes, Predicted intracellular proteins"		"Dioxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"epididymis: 22.6"	"Cell type enhanced"	"Detected in some"	10	"Cone photoreceptor cells: 13.7;Early spermatids: 16.6;Erythroid cells: 23.3;Horizontal cells: 17.5;Rod photoreceptor cells: 14.5"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in some"		"cerebellum: 2.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BJ: 12.8;fHDF/TERT166: 6.2;HSkMC: 6.2;HUVEC TERT2: 25.4;TIME: 18.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA007897	Approved				"Intracellular and membrane"	NA	NA					"HPA007897: AB_2156427"	"unprognostic (2.74e-2)"	"unprognostic (1.37e-4)"	"unprognostic (1.31e-3)"	"unprognostic (3.19e-2)"	"unprognostic (2.54e-4)"	"unprognostic (9.65e-3)"	"unprognostic (4.34e-2)"	"unprognostic (3.89e-2)"	"unprognostic (2.02e-1)"	"unprognostic (4.21e-3)"	"unprognostic (1.38e-2)"	"unprognostic (8.31e-2)"	"prognostic unfavorable (3.34e-9)"	"unprognostic (1.96e-3)"	"unprognostic (9.29e-2)"	"unprognostic (1.05e-2)"	"prognostic unfavorable (7.83e-4)"	3.0	1.2	0.1	4.7	0.5	0.0	1.3	2.1	0.4	2.5	2.3	0.4	2.8	0.3	7.1	22.6	0.7	1.9	7.5	1.1	0.4	0.2	0.9	1.7	2.2	0.9	0.1	0.0	3.8	0.3	0.0	5.7	7.4	1.1	9.8	0.9	6.4	2.0	6.1	1.1	0.5	1.0	13.7	0.4	0.2	0.7	2.3	0.0	0.0	4.1	1.6	0.4	9.7	2.7	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.9	1.1	0.0	4.3	0.4	0.0	12.8	0.9	0.6	1.4	0.0	0.0	0.0	1.2	6.2	0.4	0.0	0.0	0.2	0.1	0.0	0.1	0.0	0.7	0.0	5.5	0.0	0.0	6.2	0.0	4.4	0.5	0.7	25.4	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.2	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	18.0	0.1	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.5	2.1	0.4	0.4	0.2	0.1	0.0	1.1	0.0	0.0	0.0	0.0	0.6	0.3	8.6	0.3	0.0	0.0	0.0	0.0	13.7	0.1	0.0	0.2	16.6	0.7	0.0	23.3	0.0	0.4	1.0	0.7	0.0	0.0	0.3	17.5	0.0	4.3	0.0	1.1	0.0	0.0	0.0	1.8	0.1	3.1	0.4	0.0	0.4	0.0	14.5	0.0	0.5	2.6	3.4	0.3	0.1	0.0	0.1	0.6
P4HB	"DSI, ERBA2L, GIT, P4Hbeta, PDI, PDIA1, PO4DB, PO4HB, PROHB"	ENSG00000185624	"Prolyl 4-hydroxylase subunit beta"	P07237	17	81843159-81860694	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins"		"Chaperone, Isomerase"	"Craniosynostosis, Disease mutation, Osteogenesis imperfecta"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 383.4;pancreas: 677.5"	"Cell type enhanced"	"Detected in many"	5	"Extravillous trophoblasts: 1160.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB012463, HPA018884"	Enhanced		Supported	"Endoplasmic reticulum"	"Secreted - unknown location"	No	No		140000000	"Endoplasmic reticulum"		"CAB012463: , HPA018884: AB_1854896"	"unprognostic (9.47e-3)"	"unprognostic (1.09e-2)"	"unprognostic (2.99e-2)"	"unprognostic (7.14e-3)"	"unprognostic (7.75e-3)"	"unprognostic (1.05e-2)"	"unprognostic (1.30e-1)"	"unprognostic (5.26e-2)"	"unprognostic (1.22e-1)"	"unprognostic (4.73e-3)"	"unprognostic (1.43e-1)"	"unprognostic (3.93e-2)"	"prognostic unfavorable (2.30e-11)"	"unprognostic (1.18e-1)"	"unprognostic (1.04e-2)"	"unprognostic (4.99e-3)"	"unprognostic (3.19e-3)"	18.0	34.7	6.3	15.4	8.4	35.0	16.1	6.1	6.5	22.1	40.5	9.0	45.0	42.6	14.7	29.1	40.3	12.8	42.3	20.7	6.3	5.9	27.2	383.4	20.9	29.1	7.9	4.5	14.3	677.5	6.4	23.4	58.5	7.2	22.5	8.5	12.3	251.9	42.5	31.0	24.3	112.8	11.0	5.2	36.7	31.6	9.1	7.2	10.5	29.7	50.7	46.4	16.5	20.5	21.6	71.3	45.8	60.8	38.8	55.9	70.8	58.4	50.9	18.9	60.8	51.0	60.1	44.7	114.3	73.7	49.8	67.5	37.4	51.3	23.6	50.3	73.4	30.1	41.5	20.7	44.7	28.9	15.2	35.1	35.3	53.6	152.0	67.1	111.5	58.5	45.3	30.4	39.9	42.3	64.5	82.1	16.9	25.0	102.0	35.5	53.4	31.9	88.6	14.8	62.0	46.4	26.1	33.8	46.8	38.7	70.7	22.7	25.1	57.0	164.5	59.3	32.6	74.4	131.4	63.7	93.6	46.9	53.1	55.7	73.4	53.1	22.3	123.0	43.0	71.3	45.8	60.8	38.3	53.5	38.7	55.9	21.6	36.4	42.8	43.4	18.7	21.2	31.5	20.0	38.8	27.6	71.3	25.7	70.8	6.3	8.4	6.1	6.5	6.3	5.9	7.9	4.5	7.2	7.2	95.3	135.6	82.0	139.4	106.7	53.8	19.6	234.4	58.9	83.0	106.4	31.4	682.3	34.9	562.2	31.8	104.1	635.2	0.0	930.3	1160.9	218.5	265.2	99.1	768.8	403.4	58.8	191.7	211.1	166.1	51.9	130.9	120.0	129.9	349.9	361.7	113.5	636.3	443.3	105.4	92.7	40.7	155.2	103.8	85.8	107.3	126.5	837.3	139.5	385.8	170.2
PA2G4		ENSG00000170515	"Proliferation-associated 2G4"	Q9UQ80	12	56104319-56113907	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"rRNA processing, Transcription, Transcription regulation, Translation regulation"	"Repressor, Ribonucleoprotein, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"CAB011711, CAB012428, HPA016484"	Supported		Approved	Cytosol		NA	NA		1200000	Cytosol		"CAB011711: AB_732060, CAB012428: , HPA016484: AB_1854912"	"unprognostic (5.53e-2)"	"unprognostic (1.06e-1)"	"unprognostic (2.35e-2)"	"unprognostic (2.34e-2)"	"unprognostic (3.87e-1)"	"unprognostic (6.03e-3)"	"prognostic unfavorable (6.31e-7)"	"unprognostic (4.25e-3)"	"unprognostic (2.77e-1)"	"unprognostic (3.79e-3)"	"unprognostic (2.29e-2)"	"unprognostic (1.30e-2)"	"prognostic unfavorable (4.59e-7)"	"unprognostic (1.17e-1)"	"unprognostic (2.01e-1)"	"unprognostic (1.32e-1)"	"unprognostic (4.67e-2)"	41.1	32.1	26.6	41.4	29.8	52.5	38.5	35.1	38.8	33.7	39.2	31.0	27.1	34.4	36.1	22.4	69.4	31.2	31.9	55.6	26.6	25.5	36.1	51.6	32.6	43.3	26.7	28.0	43.3	44.3	42.8	20.5	39.0	28.2	40.3	44.2	23.6	34.6	33.4	77.3	53.0	31.7	39.4	32.3	46.7	34.4	27.9	23.9	70.8	39.7	57.2	54.0	45.5	39.6	25.5	27.1	13.5	25.1	37.4	48.9	36.0	53.5	47.6	32.7	36.0	15.1	23.0	65.7	56.8	27.2	69.9	39.0	58.2	39.9	107.3	38.2	26.8	20.6	44.2	74.5	63.3	68.3	30.4	63.9	82.4	32.5	49.6	29.6	111.8	30.5	23.2	32.4	60.5	54.7	28.9	42.4	36.7	100.0	49.9	38.2	47.5	86.9	58.4	53.6	33.4	58.5	71.6	59.1	72.7	35.3	40.2	49.1	29.7	37.4	59.1	34.7	25.3	63.8	43.5	33.9	34.1	48.2	39.2	62.6	30.7	42.0	105.1	30.9	67.3	44.2	7.8	23.0	13.5	36.6	25.1	48.9	25.5	38.9	39.4	27.1	22.2	37.6	37.3	3.7	37.4	20.0	26.3	43.3	36.0	26.6	29.8	35.1	38.8	26.6	25.5	26.7	28.0	28.2	23.9	50.6	76.2	104.2	176.7	327.3	53.9	31.3	112.1	121.8	170.6	123.9	17.7	192.6	164.2	166.6	352.5	140.6	87.8	373.8	214.0	240.3	114.2	91.6	164.3	167.1	182.5	31.8	89.5	96.3	99.0	161.4	122.3	128.8	123.2	116.4	123.0	92.6	216.5	94.7	119.2	155.9	42.6	142.3	166.0	162.3	110.4	317.1	161.8	164.1	218.3	201.6
PADI1	"HPAD10, PAD1, PDI, PDI1"	ENSG00000142623	"Peptidyl arginine deiminase 1"	Q9ULC6	1	17205126-17246005	"Enzymes, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"esophagus: 48.7;lymphoid tissue: 60.2"	"Group enriched"	"Detected in some"	12	"Cardiomyocytes: 12.6;Extravillous trophoblasts: 10.0;Urothelial cells: 3.8"	"Cancer enhanced"	"Detected in many"		"pancreatic cancer: 13.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"CAPAN-2: 9.5;EFO-21: 4.6;HaCaT: 2.9;LHCN-M2: 3.6;RPTEC TERT1: 4.9"	"Region enhanced"	"Detected in single"		"olfactory region: 0.5"	"Not detected"	"Not detected"			HPA062294	Enhanced		Approved	Nucleoplasm,Cytosol		NA	NA			Cytosol	Nucleoplasm	"HPA062294: AB_2684741"	"unprognostic (9.30e-2)"	"unprognostic (2.44e-1)"	"unprognostic (6.15e-2)"	"unprognostic (1.40e-1)"	"unprognostic (5.22e-2)"	"unprognostic (7.27e-2)"	"unprognostic (3.84e-1)"	"unprognostic (3.37e-2)"	"unprognostic (1.41e-1)"	"unprognostic (7.75e-2)"	"unprognostic (1.01e-3)"	"unprognostic (3.64e-2)"	"prognostic unfavorable (8.34e-11)"	"unprognostic (2.00e-1)"	"unprognostic (3.12e-1)"	"unprognostic (1.07e-1)"	"unprognostic (1.15e-1)"	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	3.0	0.1	0.0	0.0	0.0	0.3	0.0	48.7	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.5	0.0	0.1	0.1	0.0	4.6	0.0	0.0	4.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	14.1	60.2	1.3	6.6	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.3	2.0	0.0	0.0	0.0	0.0	0.9	0.5	0.0	0.2	0.0	0.1	9.5	0.0	4.6	0.4	0.4	2.9	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.6	0.0	0.0	0.0	0.0	3.6	0.1	0.0	0.0	0.0	0.6	0.0	0.0	0.1	0.0	4.9	0.4	0.0	0.0	0.5	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.5	12.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.5	0.0	0.0	0.0	0.0	0.0	10.0	0.0	0.7	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.6	0.0	0.2	3.8
PADI2	"KIAA0994, PDI2"	ENSG00000117115	"Peptidyl arginine deiminase 2"	Q9Y2J8	1	17066761-17119435	"Enzymes, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 76.7;skeletal muscle: 126.4"	"Cell type enhanced"	"Detected in many"	9	"Cone photoreceptor cells: 90.3;monocytes: 42.3;Mucus-secreting cells: 71.1;Paneth cells: 95.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	5	"eosinophil: 15.1;neutrophil: 37.2"	"Lineage enriched"	"Detected in many"	7	"granulocytes: 37.2"	"Cell line enhanced"	"Detected in some"		"A549: 6.9;RPTEC TERT1: 20.3;SK-BR-3: 31.1;T-47d: 8.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA047735	Enhanced					NA	NA					"HPA047735: AB_2680139"	"unprognostic (2.61e-2)"	"unprognostic (3.60e-2)"	"unprognostic (8.94e-3)"	"unprognostic (1.57e-1)"	"unprognostic (2.33e-2)"	"unprognostic (2.44e-1)"	"unprognostic (1.49e-1)"	"unprognostic (3.74e-3)"	"unprognostic (2.78e-3)"	"unprognostic (3.28e-3)"	"unprognostic (1.29e-1)"	"unprognostic (3.07e-1)"	"unprognostic (2.87e-1)"	"unprognostic (3.64e-2)"	"unprognostic (3.15e-1)"	"unprognostic (2.27e-1)"	"unprognostic (5.91e-3)"	2.1	1.4	16.2	5.0	25.1	10.9	19.2	3.3	25.6	2.7	41.4	76.7	1.3	1.6	1.4	1.3	3.8	2.3	1.8	1.1	21.9	15.6	5.5	1.3	2.2	1.4	36.8	13.6	1.1	1.7	1.3	1.5	1.6	45.6	2.3	43.4	4.6	21.1	1.8	126.4	2.8	3.6	3.9	69.6	4.2	2.1	1.3	26.0	0.0	1.2	14.8	1.6	2.1	0.7	0.0	4.2	37.2	5.1	0.0	0.0	1.7	0.0	6.9	0.0	0.0	0.0	0.0	0.4	0.1	0.0	0.1	0.0	0.1	2.9	0.1	0.9	0.3	0.1	0.9	0.2	0.0	0.2	0.0	0.5	0.3	0.0	0.0	0.0	0.4	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.5	2.2	0.3	0.8	1.0	2.3	0.0	0.0	0.0	0.2	20.3	0.0	1.2	0.1	0.0	31.1	0.0	1.8	8.5	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	1.1	0.0	0.4	5.1	15.1	0.0	0.3	0.0	0.0	0.0	0.0	4.2	0.0	0.0	0.0	37.2	0.0	0.1	0.1	0.0	1.7	16.2	25.1	3.3	22.0	21.9	15.6	36.8	13.6	45.6	26.0	0.0	2.2	0.0	0.2	0.2	2.2	0.3	0.0	0.0	2.3	1.8	90.3	0.1	10.0	0.5	5.7	0.0	25.6	0.0	0.0	0.4	0.4	0.3	16.2	0.0	7.6	0.0	3.5	1.3	6.8	8.5	0.3	4.8	27.0	42.3	71.1	30.6	0.0	95.1	0.7	0.2	29.3	0.0	1.0	0.2	0.3	0.4	0.1	0.0	21.7	0.1
PADI3	PDI3	ENSG00000142619	"Peptidyl arginine deiminase 3"	Q9ULW8	1	17249098-17284233	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		Hydrolase	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"esophagus: 10.5;smooth muscle: 9.4;urinary bladder: 28.0"	"Group enriched"	"Detected in some"	5	"Collecting duct cells: 1.8;Urothelial cells: 6.4"	"Cancer enhanced"	"Detected in many"		"urothelial cancer: 48.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"EFO-21: 13.5;RT4: 16.2;T-47d: 12.2;U-87 MG: 3.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA043739	Uncertain		Approved	Nucleoplasm,Vesicles		NA	NA			Vesicles	Nucleoplasm	"HPA043739: AB_10959466"	"unprognostic (4.47e-2)"	"unprognostic (9.32e-2)"	"unprognostic (1.50e-1)"	"prognostic unfavorable (3.22e-4)"	"unprognostic (1.05e-3)"	"unprognostic (6.66e-2)"	"unprognostic (3.10e-3)"	"unprognostic (5.88e-2)"	"unprognostic (2.06e-4)"	"unprognostic (1.03e-1)"	"unprognostic (3.47e-4)"	"unprognostic (1.76e-1)"	"prognostic unfavorable (1.55e-11)"	"unprognostic (2.40e-2)"	"unprognostic (4.73e-3)"		"unprognostic (2.64e-2)"	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	5.1	0.0	0.0	3.2	10.5	0.0	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.4	0.0	0.0	0.6	6.4	0.0	2.3	0.0	9.4	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.7	28.0	5.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	13.5	0.0	1.3	0.2	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	1.6	0.0	0.0	0.0	0.0	0.1	0.5	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	16.2	0.0	0.0	0.0	2.4	0.1	0.1	12.2	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	3.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.2	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.4
PADI4	"PAD, PADI5, PDI4, PDI5"	ENSG00000159339	"Peptidyl arginine deiminase 4"	Q9UM07	1	17308195-17364004	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Immunity, Innate immunity, Transcription, Transcription regulation"	"Chromatin regulator, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"blood: 48.2;bone marrow: 54.8;lymphoid tissue: 24.2"	"Cell type enhanced"	"Detected in some"	21	"Alveolar cells type 2: 5.9;granulocytes: 11.6;Kupffer cells: 4.7;Spermatogonia: 2.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"Group enriched"	"Detected in many"	7	"basophil: 17.0;classical monocyte: 18.6;eosinophil: 24.6;neutrophil: 48.2"	"Group enriched"	"Detected in many"	9	"granulocytes: 48.2;monocytes: 18.6"	"Cell line enhanced"	"Detected in some"		"BEWO: 1.8;HEL: 4.2;NB-4: 1.7;RPMI-8226: 4.9"	"Not detected"	"Not detected"							"HPA017007, HPA042825"	Enhanced					NA	NA		12000			"HPA017007: AB_1854921, HPA042825: AB_2678189"	"unprognostic (1.70e-1)"	"unprognostic (2.25e-1)"	"unprognostic (2.23e-1)"	"unprognostic (2.98e-1)"	"unprognostic (1.27e-1)"	"unprognostic (1.13e-2)"	"unprognostic (1.47e-1)"	"unprognostic (4.91e-2)"	"unprognostic (8.49e-2)"	"unprognostic (5.22e-2)"	"unprognostic (8.55e-2)"	"unprognostic (1.81e-1)"	"unprognostic (1.66e-3)"	"unprognostic (1.50e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.56e-2)"	"unprognostic (1.80e-1)"	1.2	0.2	0.3	0.5	0.2	54.8	0.2	0.1	0.8	0.2	0.2	0.5	0.0	0.2	0.2	0.1	0.4	0.9	0.4	9.8	0.6	0.1	0.3	1.2	9.7	5.2	1.8	0.0	0.9	0.3	0.1	0.6	4.1	0.6	0.1	0.2	0.9	0.5	0.1	0.2	0.2	0.2	0.4	0.2	24.2	0.3	1.0	0.3	2.6	0.6	0.2	0.2	0.4	7.5	0.4	3.6	48.2	18.6	1.1	1.2	8.1	0.2	0.0	0.0	0.1	0.0	0.0	1.8	0.0	0.0	0.2	0.0	0.4	0.2	0.1	0.0	0.0	0.2	0.2	0.0	0.0	0.2	0.2	0.0	4.2	0.1	0.4	0.0	0.4	0.6	0.0	0.5	0.1	0.0	0.0	0.1	0.0	0.6	0.2	0.0	0.0	0.0	1.7	0.2	0.0	0.2	0.2	0.0	4.9	0.0	0.3	0.2	0.1	0.0	0.2	0.0	0.1	0.1	0.0	0.0	0.2	0.7	0.0	0.1	0.0	0.1	0.0	0.2	0.5	0.1	17.0	18.6	24.6	0.1	1.4	0.0	0.2	0.1	0.2	3.6	0.4	0.7	1.2	48.2	1.1	0.4	1.6	0.1	8.1	0.3	0.2	0.1	0.8	0.6	0.1	1.8	0.0	0.6	0.3	0.0	5.9	2.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	11.6	0.0	0.2	0.0	0.0	0.0	4.7	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	2.3	0.0	0.1	0.5	0.0	0.0
PADI6		ENSG00000276747	"Peptidyl arginine deiminase 6"	Q6TGC4	1	17372196-17401699	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		Hydrolase	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	4	"blood: 3.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Cell type enhanced"	"Detected in some"		"myeloid DC: 3.5"	"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Region enhanced"	"Detected in single"		"cerebral cortex: 1.0"	"Not detected"	"Not detected"									NA	NA						"unprognostic (1.19e-1)"					"unprognostic (4.36e-2)"			"unprognostic (3.02e-2)"				"unprognostic (6.56e-2)"		"unprognostic (1.23e-1)"			0.0	0.0		0.1		0.7	0.0		0.0	0.0	0.0			0.0	0.0	0.1	0.0	0.0	0.0	0.0			0.0	0.0	0.1	0.1			0.0	0.0	0.0		0.0		0.0	0.0		0.0	0.0	0.7	0.0	0.0	0.0		0.1	0.0	0.5			0.0		0.0	0.0		0.0	3.5	0.0	0.8	0.0	1.9	0.4	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.2	0.0	0.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.3	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.8	0.0	1.9	0.1	0.0	0.0	0.2	1.1	3.5	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.4											0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
PAFAH1B2		ENSG00000168092	"Platelet activating factor acetylhydrolase 1b catalytic subunit 2"	P68402	11	117144267-117176894	"Cancer-related genes, Enzymes, Predicted intracellular proteins"	"Lipid degradation, Lipid metabolism"	Hydrolase	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA051836	Approved		Supported	"Nucleoli,Plasma membrane,Cytosol"		NA	NA		1600000	Cytosol	"Nucleoli, Plasma membrane"	"HPA051836: AB_2681630"	"unprognostic (1.08e-2)"	"unprognostic (3.14e-2)"	"unprognostic (2.07e-2)"	"unprognostic (3.88e-2)"	"unprognostic (9.94e-2)"	"unprognostic (1.21e-3)"	"prognostic unfavorable (9.44e-4)"	"prognostic unfavorable (3.07e-4)"	"unprognostic (1.01e-1)"	"prognostic favorable (4.25e-4)"	"prognostic unfavorable (7.79e-5)"	"unprognostic (8.18e-2)"	"unprognostic (1.11e-2)"	"unprognostic (9.97e-2)"	"unprognostic (3.25e-1)"	"unprognostic (2.46e-1)"	"unprognostic (1.34e-1)"	21.5	34.1	30.6	19.2	29.7	33.5	32.3	43.5	41.3	21.6	20.2	33.3	12.7	21.1	23.4	22.8	23.3	20.8	19.3	26.2	31.9	36.8	24.6	22.5	20.5	17.7	39.3	31.6	23.6	23.0	23.1	24.2	26.9	39.6	22.2	19.6	17.3	19.3	17.4	14.1	20.8	18.0	19.9	51.6	18.3	21.4	29.9	26.3	15.1	30.9	10.8	20.4	25.9	20.3	26.8	21.6	36.8	35.7	18.9	31.4	26.9	15.0	17.2	19.9	28.7	22.2	15.6	15.5	25.3	22.1	14.1	12.9	31.4	33.2	16.2	36.3	30.3	14.1	24.1	28.9	32.7	18.6	14.5	11.1	41.8	15.7	20.1	19.9	14.4	16.0	17.2	25.9	28.1	35.5	15.4	23.0	9.1	22.1	12.4	21.5	9.6	13.9	21.2	18.2	20.9	13.6	15.6	22.5	17.8	21.5	23.5	22.2	29.4	29.2	22.1	9.6	17.6	24.6	12.4	36.8	25.8	17.1	12.6	17.9	3.9	6.0	21.8	10.4	27.7	21.6	32.1	30.8	26.7	24.2	33.3	28.2	26.8	28.0	25.3	21.6	25.4	29.3	31.4	36.8	18.9	35.7	15.8	19.5	26.9	30.6	29.7	43.5	37.8	31.9	36.8	39.3	31.6	39.6	26.3	26.8	33.3	41.0	38.7	108.6	36.9	31.1	68.8	17.4	26.1	62.8	45.2	36.3	39.7	52.6	7.3	54.4	31.6	0.0	34.5	77.2	42.9	53.9	18.5	39.2	38.5	44.5	79.3	57.7	59.6	8.9	42.0	55.7	47.2	49.5	37.2	33.5	72.8	46.7	32.2	44.8	33.5	12.9	46.4	45.1	75.6	101.4	45.7	38.5	39.1	38.8
PAFAH1B3		ENSG00000079462	"Platelet activating factor acetylhydrolase 1b catalytic subunit 3"	Q15102	19	42297033-42303546	"Enzymes, Predicted intracellular proteins"	"Lipid degradation, Lipid metabolism"	Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"Spermatogonia: 212.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA035639	Uncertain		Approved	"Intermediate filaments"		NA	NA		370000	"Intermediate filaments"		"HPA035639: AB_10670163"	"unprognostic (3.19e-1)"	"unprognostic (5.38e-3)"	"unprognostic (1.13e-1)"	"unprognostic (5.99e-2)"	"unprognostic (1.83e-1)"	"unprognostic (2.09e-2)"	"prognostic unfavorable (8.74e-4)"	"unprognostic (1.73e-1)"	"unprognostic (2.67e-1)"	"unprognostic (6.36e-2)"	"unprognostic (2.37e-1)"	"unprognostic (7.67e-2)"	"prognostic unfavorable (2.07e-4)"	"unprognostic (2.68e-1)"	"unprognostic (3.21e-2)"	"unprognostic (4.56e-2)"	"unprognostic (6.80e-3)"	4.5	12.8	23.8	10.4	23.2	20.7	12.2	36.4	24.9	17.2	14.6	7.8	8.0	10.9	10.1	11.9	15.5	13.5	9.6	4.6	15.4	25.7	11.7	5.6	5.8	13.6	13.9	13.1	15.4	11.9	8.3	11.8	5.8	12.4	10.3	10.7	11.2	9.8	6.1	10.8	10.6	11.2	6.6	11.7	9.5	11.3	16.3	11.3	37.4	7.8	13.8	15.4	14.6	10.9	19.6	24.6	8.7	13.6	7.8	27.4	10.5	29.3	53.8	33.6	35.9	0.7	1.8	10.4	7.4	10.2	24.3	25.2	17.9	24.7	18.1	9.7	8.9	16.9	10.0	15.2	19.4	10.1	27.4	20.8	21.9	14.4	24.0	5.2	13.9	24.4	5.3	9.0	14.9	7.0	13.5	10.8	39.7	15.4	21.6	17.7	42.9	31.0	10.9	18.6	34.8	0.0	23.0	12.9	16.2	19.7	31.0	38.7	30.3	11.8	23.4	12.3	11.1	29.2	15.9	5.8	20.2	27.4	1.8	19.9	10.3	21.3	15.4	11.3	22.5	17.7	8.7	13.6	7.2	12.1	10.7	16.1	19.6	17.3	13.9	24.6	18.4	23.0	16.0	1.8	7.8	5.4	13.6	27.4	10.5	23.8	23.2	36.4	24.9	15.4	25.7	13.9	13.1	12.4	11.3	14.9	9.1	22.3	37.0	25.0	24.5	1.2	28.1	30.8	15.9	31.4	13.7	30.1	68.0	88.9	12.7	17.1	21.2	23.3	48.0	33.8	21.6	29.7	27.6	7.2	52.3	11.1	56.6	9.2	23.0	16.4	12.7	23.2	43.9	10.8	47.4	24.0	78.6	24.6	8.5	40.4	17.2	0.0	6.2	4.3	212.2	15.6	11.3	17.5	63.6	43.4
PAFAH2	HSD-PLA2	ENSG00000158006	"Platelet activating factor acetylhydrolase 2"	Q99487	1	25959767-25998157	"Enzymes, Predicted intracellular proteins"	"Lipid degradation, Lipid metabolism"	Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HMC-1: 33.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA018157	Approved					NA	NA					"HPA018157: AB_1854928"	"unprognostic (9.89e-2)"	"unprognostic (2.60e-1)"	"unprognostic (3.63e-3)"	"prognostic favorable (3.28e-6)"	"unprognostic (5.19e-2)"	"unprognostic (2.12e-1)"	"unprognostic (1.05e-1)"	"unprognostic (1.78e-1)"	"unprognostic (2.43e-1)"	"unprognostic (1.04e-1)"	"unprognostic (4.46e-2)"	"unprognostic (2.62e-1)"	"prognostic favorable (0.00e+0)"	"unprognostic (8.15e-2)"	"unprognostic (8.17e-2)"	"unprognostic (1.59e-2)"	"unprognostic (7.27e-2)"	6.5	8.8	8.9	6.3	11.0	4.1	7.0	10.7	9.0	7.0	12.3	11.9	7.8	13.2	5.7	7.7	8.7	6.4	10.1	6.7	8.0	4.5	15.5	20.9	6.3	5.5	10.7	5.1	4.7	34.7	14.8	13.6	7.8	9.8	6.8	13.0	9.6	9.0	5.0	19.3	9.5	25.3	5.2	9.8	7.9	11.6	8.4	11.1	4.4	13.6	6.3	11.4	6.5	6.3	2.4	18.9	28.0	3.3	8.3	12.3	3.9	5.2	6.7	4.2	4.8	8.8	7.0	8.7	6.0	3.1	5.4	3.6	2.7	11.2	2.3	7.5	3.5	5.2	4.7	6.3	5.8	7.0	4.7	3.8	3.8	2.9	5.3	5.3	2.0	33.5	4.5	13.2	8.3	5.6	3.0	5.2	5.6	5.3	4.5	7.2	2.3	6.2	1.9	8.4	18.2	3.7	5.1	4.0	5.2	8.7	1.8	5.1	4.3	3.5	4.8	11.0	7.3	8.0	3.6	4.8	3.8	4.7	7.9	4.7	8.3	10.7	3.0	8.0	8.1	12.6	12.7	3.3	28.0	12.3	3.1	7.8	1.8	4.3	7.9	2.4	2.4	5.6	7.9	3.0	8.3	1.1	18.9	4.3	3.9	8.9	11.0	10.7	9.0	8.0	4.5	10.7	5.1	9.8	11.1	14.9	13.8	2.9	1.9	1.3	8.5	6.5	12.7	9.4	14.8	17.4	25.5	9.5	3.3	11.1	0.6	3.6	36.7	0.0	6.4	7.5	3.6	5.1	26.6	19.7	9.8	4.8	7.5	5.5	10.5	1.0	2.3	6.0	8.5	5.4	17.1	5.8	10.2	11.5	2.5	15.7	9.3	6.5	2.1	17.0	9.6	3.3	8.4	12.8	16.5	3.8
PAH	PH	ENSG00000171759	"Phenylalanine hydroxylase"	P00439	12	102836885-102958410	"Disease related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins"	"Phenylalanine catabolism"	"Allosteric enzyme, Monooxygenase, Oxidoreductase"	"Disease mutation, FDA approved drug targets, Phenylketonuria"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	7	"kidney: 65.1;liver: 220.0"	"Group enriched"	"Detected in some"	8	"Cholangiocytes: 226.7;Hepatocytes: 723.9;Proximal tubular cells: 215.9"	"Cancer enriched"	"Detected in some"	17	"liver cancer: 94.7"	"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	31	"Hep G2: 72.8"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in single"			"HPA028407, HPA031642"	Enhanced		Approved	"Endoplasmic reticulum,Vesicles"		No	NA			"Endoplasmic reticulum, Vesicles"		"HPA028407: AB_10601241, HPA031642: AB_2673974"	"unprognostic (1.16e-1)"	"unprognostic (1.52e-1)"	"unprognostic (4.47e-2)"	"unprognostic (9.13e-3)"	"unprognostic (5.19e-2)"	"unprognostic (5.99e-2)"	"prognostic favorable (4.30e-4)"	"unprognostic (1.27e-1)"	"unprognostic (6.60e-2)"	"unprognostic (4.45e-3)"	"unprognostic (1.94e-3)"	"unprognostic (1.83e-1)"	"unprognostic (1.10e-2)"	"unprognostic (3.51e-1)"	"unprognostic (1.64e-1)"	"unprognostic (3.96e-2)"	"unprognostic (1.68e-2)"	0.1	1.3	0.5	0.0	0.5	0.0	0.1	0.2	1.0	0.0	0.1	0.6	0.0	0.0	0.0	0.1	0.0	0.1	20.3	0.1	0.8	0.3	65.1	220.0	0.0	0.0	0.3	0.7	0.1	1.7	0.0	1.6	0.0	0.8	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.8	0.1	0.0	2.8	0.4	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	72.8	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.5	0.2	1.0	0.8	0.3	0.3	0.7	0.8	0.4	0.0	0.0	16.2	0.0	0.0	0.0	0.4	226.7	0.0	0.0	5.2	0.0	0.0	18.3	2.0	50.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	723.9	0.0	3.2	1.7	14.1	22.2	13.1	0.6	0.0	0.0	0.0	0.0	0.4	0.0	0.0	1.1	215.9	0.1	0.0	0.0	0.7	0.4	0.0	0.0	5.0	0.0	0.0
PAICS	"ADE2H1, AIRC, PAIS"	ENSG00000128050	"Phosphoribosylaminoimidazole carboxylase and phosphoribosylaminoimidazolesuccinocarboxamide synthase"	P22234	4	56435741-56464579	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Purine biosynthesis"	"Decarboxylase, Ligase, Lyase, Multifunctional enzyme"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Extravillous trophoblasts: 137.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035895, HPA041538"	Approved		Approved	Cytosol		Yes	No		340000	Cytosol		"HPA035895: AB_10669660, HPA041538: AB_2677540"	"unprognostic (2.59e-3)"	"unprognostic (7.90e-3)"	"unprognostic (3.84e-3)"	"unprognostic (2.88e-2)"	"unprognostic (9.85e-2)"	"unprognostic (2.82e-3)"	"prognostic unfavorable (1.50e-4)"	"unprognostic (8.07e-3)"	"unprognostic (1.23e-2)"	"prognostic favorable (8.44e-4)"	"unprognostic (1.48e-3)"	"unprognostic (2.05e-1)"	"prognostic unfavorable (5.85e-5)"	"unprognostic (7.11e-2)"	"unprognostic (1.67e-1)"	"prognostic unfavorable (2.41e-4)"	"unprognostic (2.16e-1)"	15.5	27.1	21.6	20.4	17.4	21.4	29.3	15.8	20.6	17.5	22.5	18.5	18.4	17.2	19.6	12.6	29.0	19.6	11.4	13.4	16.7	22.6	26.5	63.7	11.3	25.6	26.4	19.2	23.3	27.7	26.2	17.9	24.3	29.8	17.5	30.5	13.1	15.7	16.8	23.8	20.0	16.1	19.4	23.5	19.8	12.8	18.3	15.9	44.9	17.8	26.8	33.1	18.7	18.9	13.7	12.8	3.2	6.4	10.9	14.4	6.7	34.3	25.8	53.3	33.0	11.4	25.9	45.9	29.8	21.6	42.8	42.2	40.9	40.9	79.6	34.7	19.9	23.3	21.3	84.1	43.3	73.4	15.9	29.6	43.2	39.5	45.3	21.9	76.8	19.3	21.9	31.4	45.4	34.3	23.7	35.0	45.7	74.5	29.7	36.8	22.9	88.1	38.5	61.1	66.2	32.3	71.6	22.8	52.3	40.5	24.1	57.3	34.3	29.3	41.0	18.0	45.5	27.1	24.6	18.8	33.9	44.4	33.3	60.8	21.0	18.0	83.7	35.7	56.3	37.3	3.2	3.7	0.3	4.1	6.4	11.8	13.7	11.5	7.3	11.4	8.9	14.4	12.1	0.9	10.9	4.8	12.8	8.3	6.7	21.6	17.4	15.8	20.6	16.7	22.6	26.4	19.2	29.8	15.9	20.8	19.3	31.8	57.8	50.4	26.0	20.9	56.0	21.4	31.8	31.4	5.9	117.2	31.5	30.5	45.8	21.6	14.2	46.7	22.8	137.4	35.6	28.6	20.7	68.6	45.7	27.0	23.8	11.6	15.8	6.6	27.6	17.1	16.9	22.6	34.9	13.2	23.3	7.0	21.9	41.1	22.9	0.0	17.9	39.4	47.7	44.2	45.7	16.0	65.0	44.1
PAK1		ENSG00000149269	"P21 (RAC1) activated kinase 1"	Q13153	11	77321707-77474635	"Enzymes, Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins"	"Apoptosis, Exocytosis"	"Allosteric enzyme, Kinase, Serine/threonine-protein kinase, Transferase"	"Disease mutation, Epilepsy, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 70.0;brain: 71.4"	"Cell type enhanced"	"Detected in many"	4	"granulocytes: 126.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	9	"classical monocyte: 29.3;eosinophil: 45.0;intermediate monocyte: 28.7;myeloid DC: 42.3;neutrophil: 70.0;non-classical monocyte: 30.4"	"Group enriched"	"Detected in all"	11	"dendritic cells: 42.3;granulocytes: 70.0;monocytes: 30.4"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003565, CAB005312"	Enhanced	Supported	Supported	"Plasma membrane,Cytosol"		NA	NA		200000	"Plasma membrane, Cytosol"		"CAB005312: AB_2160720, HPA003565: AB_1854935"	"unprognostic (1.15e-2)"	"unprognostic (3.23e-2)"	"prognostic favorable (5.87e-4)"	"unprognostic (1.30e-1)"	"prognostic unfavorable (1.15e-4)"	"unprognostic (6.62e-2)"	"unprognostic (8.19e-3)"	"unprognostic (4.84e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.22e-3)"	"unprognostic (1.86e-2)"	"unprognostic (2.76e-1)"	"unprognostic (1.02e-1)"	"unprognostic (6.91e-2)"	"unprognostic (1.57e-1)"	"unprognostic (4.00e-3)"	"unprognostic (1.52e-2)"	5.4	6.0	30.5	13.8	39.5	22.9	7.8	49.1	71.4	9.8	18.2	8.4	2.3	18.2	9.1	13.3	9.9	9.8	13.2	5.3	19.0	16.9	11.3	6.0	6.9	7.5	12.8	40.6	10.4	9.2	11.8	10.8	11.9	39.2	12.2	20.2	5.4	10.4	8.8	34.0	6.7	18.9	11.6	7.8	11.7	17.1	11.1	6.6	7.6	17.7	3.9	9.4	10.5	10.4	2.7	42.3	70.0	30.4	4.3	2.4	12.2	11.4	7.7	16.8	7.6	6.8	11.5	13.4	13.1	9.4	12.4	14.7	11.0	15.3	10.2	4.8	11.3	16.2	5.9	11.7	13.8	19.7	11.8	9.4	10.8	5.2	0.7	4.5	18.2	16.0	8.5	8.4	14.6	21.7	11.0	2.9	12.0	7.1	18.0	22.6	0.8	11.6	8.4	24.7	47.4	6.6	17.8	21.7	0.4	3.1	9.5	7.2	7.1	7.0	3.0	5.5	17.3	13.4	8.3	0.2	8.3	14.4	44.3	10.9	49.6	25.5	6.8	6.9	12.2	8.9	0.3	29.3	45.0	1.9	28.7	1.5	2.7	1.4	1.8	42.3	1.9	1.3	2.4	70.0	4.3	30.4	3.6	1.1	12.2	30.5	39.5	49.1	71.4	19.0	16.9	12.8	40.6	39.2	6.6	3.0	21.5	16.1	27.9	10.5	48.2	3.1	33.1	41.5	33.0	24.4	7.9	23.0	38.1	26.3	31.5	3.0	46.3	0.0	49.4	46.4	13.1	25.6	126.2	10.9	45.2	1.6	36.2	3.1	43.9	20.0	13.3	71.3	28.7	94.6	47.0	14.0	41.8	55.2	12.4	28.6	6.7	12.9	18.2	25.6	42.1	9.2	79.4	12.2	47.1	27.2
PAK2	"PAK65, PAKgamma"	ENSG00000180370	"P21 (RAC1) activated kinase 2"	Q13177	3	196739857-196832647	"Enzymes, Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins"	"Apoptosis, Growth regulation, Host-virus interaction"	"Allosteric enzyme, Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB007794	Approved		Approved	Nucleoplasm,Vesicles		NA	NA		590000	"Nucleoplasm, Vesicles"		"CAB007794: AB_562363"	"unprognostic (1.03e-2)"	"unprognostic (6.34e-2)"	"unprognostic (2.52e-1)"	"unprognostic (2.50e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.80e-1)"	"unprognostic (5.18e-3)"	"unprognostic (1.85e-2)"	"unprognostic (7.97e-2)"	"unprognostic (1.09e-1)"	"prognostic unfavorable (3.36e-4)"	"prognostic unfavorable (9.58e-4)"	"unprognostic (1.30e-3)"	"unprognostic (4.57e-2)"	"unprognostic (1.25e-2)"	"unprognostic (1.70e-2)"	"unprognostic (3.39e-1)"	28.7	18.9	22.4	27.6	23.5	21.4	56.5	17.4	20.7	19.5	23.0	27.8	17.4	19.0	22.6	19.2	23.4	17.9	20.7	29.0	22.6	22.0	19.5	34.3	35.7	50.2	26.8	13.5	19.9	16.6	30.5	13.0	27.6	22.8	17.7	23.0	12.9	19.6	21.2	34.2	16.3	25.2	23.0	32.1	34.6	18.4	15.9	24.8	44.9	16.9	19.1	31.9	24.1	32.7	6.6	13.7	25.9	12.6	6.6	10.8	7.0	36.0	12.9	18.1	13.3	12.9	17.1	27.0	18.3	15.1	19.9	18.1	30.6	18.5	23.1	52.3	18.4	20.3	18.5	19.2	17.4	30.8	10.4	9.3	34.2	14.9	24.0	26.2	33.2	32.9	13.6	14.3	17.8	37.9	21.1	19.6	25.7	16.4	28.8	19.3	38.0	31.6	17.2	10.8	19.4	19.5	28.9	10.3	20.9	17.4	25.3	10.6	12.1	24.5	17.3	13.8	14.6	60.5	24.1	20.2	16.5	9.2	17.3	26.9	19.6	34.6	56.9	13.7	33.3	15.7	16.5	10.3	24.5	6.3	12.6	8.5	6.4	7.3	7.1	13.7	6.6	5.4	6.3	25.9	6.6	10.8	5.1	10.8	7.0	22.4	23.5	17.4	20.7	22.6	22.0	26.8	13.5	22.8	24.8	74.5	44.7	76.2	49.3	86.5	39.1	56.5	63.7	88.3	47.8	78.5	49.1	41.1	28.2	62.3	49.4	78.8	52.5	0.0	51.3	82.8	47.0	116.6	143.4	125.4	90.3	52.4	43.1	63.3	144.6	51.0	56.4	118.7	32.1	120.0	42.8	58.0	77.2	48.4	42.8	60.3	40.6	38.8	52.3	24.2	41.4	75.4	29.2	71.3	38.3	112.3
PAK3	"bPAK, hPAK3, MRX30, MRX47"	ENSG00000077264	"P21 (RAC1) activated kinase 3"	O75914	X	110944285-111227361	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, RAS pathway related proteins"		"Allosteric enzyme, Developmental protein, Kinase, Serine/threonine-protein kinase, Transferase"	"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"brain: 26.2;pancreas: 46.5;pituitary gland: 37.2"	"Cell type enhanced"	"Detected in many"	13	"Bipolar cells: 81.5;Leydig cells: 31.7;Peritubular cells: 76.4"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	6	"MAIT T-cell: 4.3"	"Lineage enriched"	"Detected in single"	7	"T-cells: 4.3"	"Cell line enhanced"	"Detected in some"		"EFO-21: 9.8;HAP1: 8.8;HDLM-2: 11.0;NTERA-2: 8.6;SCLC-21H: 11.2;SH-SY5Y: 7.0;U-2197: 6.8;U-251 MG: 11.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA044791, HPA060219"	Approved		Approved	Vesicles		NA	NA			Vesicles		"HPA044791: , HPA060219: AB_2684223"	"unprognostic (1.80e-2)"	"unprognostic (1.54e-1)"	"unprognostic (1.80e-2)"	"unprognostic (3.27e-4)"	"unprognostic (2.46e-1)"	"unprognostic (5.63e-3)"	"unprognostic (7.29e-2)"	"unprognostic (3.23e-2)"	"unprognostic (1.27e-2)"	"unprognostic (3.01e-1)"	"unprognostic (6.80e-3)"	"unprognostic (1.66e-1)"	"unprognostic (1.89e-4)"	"unprognostic (5.71e-3)"	"unprognostic (6.81e-2)"	"unprognostic (1.06e-1)"	"unprognostic (3.30e-2)"	2.0	6.8	17.6	2.5	17.5	1.0	6.4	1.8	24.6	3.7	1.6	0.9	9.1	1.0	6.8	7.6	1.7	3.7	2.6	1.2	26.2	20.8	1.6	1.1	1.8	2.5	7.9	21.9	7.9	46.5	0.9	37.2	1.6	12.9	4.8	1.7	1.4	3.0	7.1	2.4	2.0	1.4	6.1	5.8	2.9	3.0	3.6	1.9	0.0	7.7	0.0	1.7	2.0	1.5	0.1	0.1	0.6	0.1	0.2	4.3	0.0	0.0	0.6	1.3	0.0	0.0	0.0	0.0	0.2	0.3	0.9	0.0	0.0	0.0	0.0	9.8	1.0	1.4	0.0	8.8	0.5	1.2	11.0	0.3	0.0	1.0	0.0	0.0	0.0	0.4	0.2	0.0	0.1	2.0	5.2	0.0	0.1	0.0	0.4	0.0	0.0	0.1	0.1	8.6	0.0	1.9	0.1	4.0	0.0	0.8	0.0	11.2	7.0	0.0	0.4	0.0	6.2	0.0	0.0	0.0	0.6	4.3	6.8	11.7	0.0	0.1	0.1	1.2	0.0	0.1	0.6	0.1	0.1	0.1	0.0	4.3	0.0	0.7	0.4	0.0	0.1	0.1	0.1	0.5	0.2	0.1	0.1	0.3	0.0	17.6	17.5	1.8	18.5	26.2	20.8	7.9	21.9	12.9	1.9	3.0	1.4	0.0	14.1	0.2	81.5	0.8	12.7	0.0	1.2	0.0	0.0	0.3	0.0	3.0	3.4	2.4	0.0	0.0	11.6	0.3	5.8	1.3	1.1	0.0	0.2	6.4	3.5	0.6	0.3	4.7	31.7	2.0	0.0	1.0	0.0	19.0	7.3	0.0	76.4	0.5	5.5	0.0	0.4	1.1	0.6	1.0	5.6	2.2	0.0	0.9
PAK4		ENSG00000130669	"P21 (RAC1) activated kinase 4"	O96013	19	39125770-39182816	"Enzymes, Predicted intracellular proteins, RAS pathway related proteins"	"Apoptosis, Cell cycle"	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"A549: 45.4;MCF7: 50.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB025747, CAB044670, HPA070175, HPA072220"	Uncertain		Supported	"Plasma membrane,Cell Junctions"		NA	Yes			"Plasma membrane, Cell Junctions"		"CAB025747: , CAB044670: AB_1854940, HPA070175: AB_2686232, HPA072220: AB_2686497"	"unprognostic (1.71e-1)"	"unprognostic (2.84e-1)"	"unprognostic (5.86e-2)"	"unprognostic (2.84e-2)"	"unprognostic (1.93e-1)"	"unprognostic (8.51e-2)"	"unprognostic (3.56e-3)"	"unprognostic (1.13e-3)"	"unprognostic (3.90e-2)"	"unprognostic (4.04e-2)"	"unprognostic (7.29e-2)"	"prognostic unfavorable (9.85e-4)"	"prognostic favorable (5.29e-5)"	"unprognostic (2.39e-1)"	"unprognostic (7.05e-2)"	"unprognostic (2.02e-1)"	"unprognostic (4.85e-2)"	6.8	11.1	11.0	12.7	12.3	4.8	11.9	13.7	12.4	17.3	19.6	13.7	19.9	26.0	12.2	17.3	20.1	15.3	16.5	8.1	10.9	8.1	19.4	17.0	18.7	5.4	13.7	7.7	13.8	29.6	11.2	17.0	23.0	10.3	29.6	8.1	19.7	40.9	18.5	10.3	18.6	25.1	9.0	8.3	7.9	18.6	22.3	12.5	8.8	15.2	10.1	14.7	11.5	15.0	2.8	3.4	4.2	2.5	3.6	4.5	1.9	17.9	45.4	6.8	10.3	2.1	2.3	20.5	8.6	3.5	5.8	5.9	29.7	15.3	4.1	13.1	5.4	7.6	6.6	3.7	6.8	2.2	10.9	10.4	4.8	8.3	14.4	3.4	4.9	7.1	2.7	3.0	5.4	3.9	3.8	7.5	6.3	9.7	3.2	3.4	50.0	5.2	5.4	12.3	15.9	10.9	5.3	5.3	3.1	5.6	19.8	21.7	15.0	8.7	39.0	9.7	3.7	17.3	8.2	12.5	9.9	17.0	11.3	15.3	3.7	3.5	3.4	12.1	2.9	11.8	1.0	2.5	4.2	2.6	1.4	3.6	2.2	2.9	4.5	3.4	2.8	2.2	2.2	2.1	3.6	2.1	2.9	3.0	1.9	11.0	12.3	13.7	12.4	10.9	8.1	13.7	7.7	10.3	12.5	0.0	1.0	0.5	15.0	12.8	14.8	1.2	20.4	6.7	0.0	17.4	23.6	35.6	26.6	18.7	2.7	15.8	35.5	0.0	17.2	46.7	10.8	17.8	5.7	10.5	8.3	20.6	43.0	12.3	5.6	4.9	10.9	2.5	6.8	14.4	30.6	14.1	16.5	40.3	9.9	10.6	13.1	0.0	7.2	5.7	17.7	16.4	54.7	8.7	29.9	20.6
PAK5	"KIAA1264, PAK7"	ENSG00000101349	"P21 (RAC1) activated kinase 5"	Q9P286	20	9537389-9839041	"Enzymes, Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins"	Apoptosis	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"brain: 30.3"	"Not detected"	"Not detected"			"Low cancer specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	9	"SCLC-21H: 10.2;SH-SY5Y: 3.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA020444	Approved		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA020444: AB_1854947"	"unprognostic (5.14e-5)"			"unprognostic (3.35e-1)"	"unprognostic (1.05e-1)"	"unprognostic (8.63e-2)"		"unprognostic (3.21e-1)"		"unprognostic (3.04e-1)"	"unprognostic (2.25e-4)"	"unprognostic (3.76e-1)"	"unprognostic (2.56e-2)"	"unprognostic (3.83e-1)"	"unprognostic (3.35e-2)"	"unprognostic (6.04e-2)"	"unprognostic (4.58e-1)"	0.5	5.2	5.7	0.6	11.7	0.5	1.6	30.3	19.6	0.8	0.6	0.8	0.0	0.7	1.0	2.2	1.0	0.7	3.4	0.6	4.0	3.3	1.0	2.3	0.7	0.6	1.6	8.8	0.6	3.5	0.5	2.0	0.6	5.3	1.6	0.6	0.6	1.2	1.6	0.6	1.6	0.6	0.6	1.2	0.6	1.2	1.0	1.7	0.0	0.6	0.0	0.6	0.5	0.2	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.4	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.2	3.8	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.2	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.6	0.2	0.0	0.0	0.0	0.0	0.2	0.0	5.7	11.7	30.3	13.6	4.0	3.3	1.6	8.8	5.3	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
PAK6	PAK5	ENSG00000137843	"P21 (RAC1) activated kinase 6"	Q9NQU5	15	40238759-40277487	"Enzymes, Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skin 1: 22.2"	"Cell type enhanced"	"Detected in many"	11	"Cytotrophoblasts: 38.8;Suprabasal keratinocytes: 16.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"CACO-2: 14.8;HaCaT: 23.0;hTCEpi: 14.1;SK-BR-3: 7.8"									HPA031124	Approved		Approved	"Nucleoplasm,Nucleoli fibrillar center,Cell Junctions"		NA	NA			"Nucleoplasm, Nucleoli fibrillar center"	"Cell Junctions"	"HPA031124: AB_10601044"	"unprognostic (1.85e-3)"	"unprognostic (2.15e-1)"	"unprognostic (3.33e-3)"	"unprognostic (7.79e-3)"	"unprognostic (7.08e-3)"	"unprognostic (9.57e-2)"		"unprognostic (2.71e-1)"	"unprognostic (7.73e-2)"	"unprognostic (1.34e-2)"	"unprognostic (7.13e-3)"	"unprognostic (4.04e-2)"	"unprognostic (8.87e-3)"	"unprognostic (1.72e-1)"	"unprognostic (1.79e-1)"	"unprognostic (7.37e-3)"	"unprognostic (3.34e-2)"	0.3	5.3	14.7	0.8	18.4	0.8	2.3	11.3	20.1	3.0	1.3	1.6	2.5	1.4	1.0	1.1	15.8	4.3	1.4	7.9	11.6	5.2	3.4	0.4	2.6	1.0	3.0	10.9	0.6	7.4	12.9	6.4	8.1	2.1	3.6	1.2	0.3	3.4	7.5	3.5	22.2	1.4	0.8	1.2	1.0	3.6	12.8	2.2	0.0	7.4	8.5	5.1	3.0	5.1	1.4	0.7	2.9	0.7	2.0	5.5	1.2	2.7	0.0	0.2	0.1	0.0	0.0	4.4	0.0	0.1	0.6	0.4	14.8	2.0	0.1	2.4	0.0	0.9	23.0	3.3	4.9	0.2	0.1	0.7	0.0	1.9	0.1	0.0	0.1	0.3	0.0	14.1	0.2	3.3	0.2	0.0	3.9	1.1	0.2	0.0	3.2	0.0	0.3	0.4	2.7	2.0	0.2	0.1	1.8	1.1	6.0	5.4	1.3	1.9	7.8	0.2	1.3	0.9	7.2	0.0	0.2	0.4	0.0	0.1	0.0	0.2	0.0	0.5	0.4	0.1	2.1	0.7	2.9	5.5	0.3	2.1	1.4	0.5	4.2	0.7	0.5	0.3	1.2	1.3	2.0	0.2	0.5	0.1	1.2	14.7	18.4	11.3	20.1	11.6	5.2	3.0	10.9	2.1	2.2	0.0	3.4	0.0	6.8	8.8	3.9	0.0	7.6	4.0	4.5	5.2	0.0	38.8	11.6	4.0	5.9	0.0	0.0	0.0	3.7	1.2	0.6	4.0	0.0	0.0	3.5	0.0	4.7	0.0	0.3	4.5	1.7	0.3	1.7	0.0	0.8	1.4	2.7	0.0	1.8	0.0	0.0	0.0	0.1	1.6	1.5	16.7	7.6	1.3	1.9	6.8
PAM	"PAL, PHM"	ENSG00000145730	"Peptidylglycine alpha-amidating monooxygenase"	P19021	5	102753981-103031105	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"		"Lyase, Monooxygenase, Multifunctional enzyme, Oxidoreductase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 304.2"	"Group enriched"	"Detected in many"	6	"Cardiomyocytes: 852.6;Intestinal endocrine cells: 308.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"ASC diff: 75.3;fHDF/TERT166: 96.5;hTERT-RPE1: 78.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB026119, HPA042260"	Enhanced		Approved	"Golgi apparatus,Cytosol"	"Secreted in other tissues"	NA	NA		59000000	"Golgi apparatus, Cytosol"		"CAB026119: , HPA042260: AB_2677919"	"unprognostic (4.30e-3)"	"unprognostic (1.60e-2)"	"unprognostic (1.12e-1)"	"prognostic favorable (1.63e-4)"	"unprognostic (4.23e-2)"	"unprognostic (6.30e-2)"	"prognostic unfavorable (6.20e-4)"	"unprognostic (7.58e-2)"	"unprognostic (6.62e-2)"	"unprognostic (2.71e-1)"	"unprognostic (9.91e-2)"	"unprognostic (3.18e-1)"	"unprognostic (1.86e-2)"	"unprognostic (1.08e-1)"	"unprognostic (9.79e-2)"	"unprognostic (5.51e-2)"	"unprognostic (8.80e-3)"	16.5	24.5	8.2	6.5	16.4	0.8	17.3	6.6	16.5	74.9	14.0	5.4	9.5	5.8	21.3	83.8	11.7	10.6	11.5	304.2	8.8	23.5	13.7	2.1	13.2	5.8	10.0	7.6	17.0	16.4	49.5	18.3	26.3	15.5	13.4	9.5	8.7	53.8	29.4	22.0	8.5	8.5	18.5	4.8	8.9	17.2	7.2	4.6	1.8	21.7	13.2	7.3	15.8	15.3	0.5	2.0	10.1	5.3	16.2	14.1	6.3	14.7	2.2	27.1	12.0	75.3	45.1	10.8	41.8	62.6	12.4	37.8	7.1	19.5	0.0	9.0	96.5	17.5	5.0	1.5	18.4	34.3	1.8	6.1	3.0	8.8	2.3	11.4	0.9	3.3	24.6	7.9	9.1	6.9	78.8	25.5	1.2	0.1	2.0	35.1	3.0	0.0	0.4	4.8	2.6	8.1	1.1	15.1	8.1	47.8	1.7	12.8	8.9	17.8	1.1	10.9	16.6	4.6	0.9	19.6	39.4	10.2	18.4	12.4	4.6	1.1	0.0	45.2	4.1	33.9	1.9	5.3	0.1	14.1	0.9	10.0	0.5	8.5	10.4	2.0	0.3	2.9	4.8	10.1	16.2	1.9	1.1	12.1	6.3	8.2	16.4	6.6	16.5	8.8	23.5	10.0	7.6	15.5	4.6	50.6	28.7	3.7	10.4	25.0	10.9	852.6	0.0	10.7	27.3	57.6	2.0	0.7	6.6	11.6	5.0	54.1	6.8	0.0	18.6	37.1	102.7	20.4	9.2	2.4	5.5	7.9	308.8	70.0	12.0	4.7	55.8	6.7	35.4	5.4	12.6	13.0	34.7	2.9	55.2	41.6	2.8	19.4	47.4	1.6	2.1	20.7	5.6	15.3	6.6	13.1
PAMR1	"DKFZP586H2123, RAMP"	ENSG00000149090	"Peptidase domain containing associated with muscle regeneration 1"	Q6UXH9	11	35431823-35530300	"Enzymes, Predicted intracellular proteins, Predicted secreted proteins"		"Serine protease homolog"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"	24	"Basal keratinocytes: 16.9;Fibroblasts: 47.8;Suprabasal keratinocytes: 8.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC diff: 17.9;ASC TERT1: 74.1;BJ hTERT+: 72.1;fHDF/TERT166: 17.1;HSkMC: 25.5;U-87 MG: 17.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"								"Secreted - unknown location"	NA	NA		3300000				"unprognostic (3.38e-1)"	"unprognostic (1.07e-2)"	"unprognostic (1.67e-1)"	"unprognostic (1.00e-3)"	"unprognostic (6.50e-3)"	"unprognostic (1.01e-1)"	"unprognostic (2.07e-2)"	"unprognostic (6.92e-2)"	"unprognostic (3.32e-2)"	"unprognostic (4.07e-2)"	"unprognostic (1.91e-2)"	"unprognostic (1.36e-2)"	"prognostic unfavorable (5.08e-5)"	"prognostic unfavorable (6.29e-4)"	"unprognostic (2.08e-1)"	"unprognostic (9.98e-2)"	"unprognostic (8.25e-2)"	14.1	9.9	11.9	0.7	10.5	0.4	10.2	0.7	12.8	40.1	6.6	9.7	5.1	3.1	37.0	12.7	6.8	12.1	12.7	11.1	9.5	7.3	2.6	8.0	3.5	1.1	9.9	5.4	4.4	3.4	0.8	3.4	34.0	18.1	12.7	4.6	0.8	2.7	12.1	3.1	12.5	4.7	14.6	13.8	3.7	3.1	5.8	5.7	0.6	3.4	6.0	2.9	18.8	21.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	17.9	74.1	0.0	9.1	72.1	1.0	1.7	6.4	0.0	0.0	0.0	17.1	0.0	0.0	0.0	0.0	0.6	0.0	0.1	0.0	0.0	0.0	10.8	0.0	0.0	25.5	0.3	1.9	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	3.0	0.4	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	17.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.9	10.5	0.7	12.8	9.5	7.3	9.9	5.4	18.1	5.7	0.0	0.0	0.0	1.5	16.9	0.0	1.2	0.0	1.4	3.4	1.8	0.0	1.5	0.0	0.4	0.0	0.5	0.0	0.0	0.0	0.9	47.8	0.1	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.3	0.0	1.7	1.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	6.2	0.0	0.0	8.2	2.9	0.0	0.0	0.2
PAN2	"hPAN2, KIAA0710, USP52"	ENSG00000135473	"PAN2 poly(A) specific ribonuclease subunit"	Q504Q3	12	56316223-56334053	"Enzymes, Predicted intracellular proteins"	"mRNA processing"	"Exonuclease, Hydrolase, Nuclease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA						"unprognostic (2.43e-1)"	"unprognostic (3.78e-1)"	"unprognostic (1.21e-2)"	"unprognostic (2.55e-1)"	"unprognostic (1.67e-1)"	"unprognostic (9.10e-3)"	"unprognostic (1.03e-1)"	"unprognostic (7.28e-2)"	"unprognostic (7.35e-3)"	"unprognostic (3.80e-1)"	"unprognostic (1.74e-3)"	"unprognostic (4.23e-3)"	"prognostic unfavorable (2.77e-4)"	"unprognostic (4.19e-1)"	"unprognostic (3.87e-1)"	"unprognostic (2.10e-1)"	"unprognostic (2.68e-2)"	8.1	13.4	12.8	7.1	17.7	7.4	9.9	21.7	17.6	9.6	9.5	16.1	16.4	11.0	11.2	17.6	7.4	11.3	7.8	9.8	13.9	5.1	9.7	17.6	8.7	9.0	19.7	7.0	17.8	12.9	24.3	30.7	9.2	14.6	9.1	9.6	12.6	10.0	14.1	9.1	9.4	10.7	8.8	16.4	10.6	10.5	18.2	19.4	15.3	20.2	4.8	11.0	11.0	9.2	3.1	7.6	3.9	8.1	3.8	5.2	3.4	2.8	4.4	10.8	3.5	9.5	10.8	7.1	2.2	3.0	5.0	2.3	2.6	5.7	7.9	8.6	4.3	2.7	6.0	12.7	8.4	2.8	3.5	6.2	10.1	4.2	2.5	8.4	2.2	5.4	10.1	11.4	5.3	15.5	13.2	3.7	16.8	6.8	19.9	2.9	6.2	7.5	5.6	3.6	4.8	2.9	6.5	7.7	14.2	4.9	2.3	8.6	7.7	4.2	5.5	5.4	12.6	7.1	4.4	1.6	5.2	5.1	2.3	2.0	16.8	6.6	5.2	6.1	4.7	4.2	3.9	5.8	2.3	2.4	8.1	3.7	3.1	1.9	3.5	7.6	2.7	4.1	5.2	0.4	3.8	3.8	2.9	3.0	3.4	12.8	17.7	21.7	17.6	13.9	5.1	19.7	7.0	14.6	19.4	8.9	17.1	4.7	4.8	4.5	25.5	9.0	5.1	16.0	10.3	5.2	25.5	6.5	1.7	2.4	1.2	6.0	5.5	0.0	1.8	4.1	5.6	3.7	5.8	15.3	4.7	14.3	13.8	12.9	5.4	2.1	10.3	6.3	1.7	2.8	9.6	7.2	3.3	8.2	6.0	2.8	16.3	6.5	3.1	19.1	6.1	3.3	4.2	5.7	8.5	2.7
PAN3		ENSG00000152520	"PAN3 poly(A) specific ribonuclease subunit"	Q58A45	13	28138506-28295335	"Enzymes, Predicted intracellular proteins"	"mRNA processing"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA028817	Approved					NA	NA					"HPA028817: AB_10602016"	"unprognostic (3.25e-2)"	"unprognostic (2.10e-1)"	"unprognostic (3.55e-2)"	"unprognostic (1.43e-1)"	"unprognostic (1.20e-1)"	"unprognostic (7.39e-2)"	"unprognostic (8.17e-2)"	"unprognostic (1.52e-1)"	"unprognostic (4.26e-3)"	"unprognostic (5.78e-2)"	"unprognostic (6.56e-2)"	"unprognostic (2.29e-2)"	"unprognostic (4.22e-2)"	"unprognostic (2.76e-2)"	"unprognostic (1.21e-1)"	"unprognostic (8.54e-2)"	"unprognostic (2.42e-2)"	15.2	9.0	8.3	18.6	7.7	20.0	13.9	41.7	10.1	12.1	12.5	10.7	13.0	7.0	15.2	17.8	12.3	10.5	9.0	7.8	8.6	4.5	8.1	5.9	14.4	14.3	10.3	6.8	12.8	10.4	9.2	10.1	11.4	8.5	10.3	9.5	11.0	15.9	12.3	9.6	16.0	12.6	10.2	6.2	16.0	10.5	12.4	10.7	25.2	13.3	7.9	14.8	17.5	12.4	12.3	14.8	21.6	12.5	11.5	12.3	8.7	5.8	3.9	9.6	9.8	4.8	6.7	7.8	6.0	9.4	6.3	6.1	6.0	11.9	20.5	4.7	8.7	7.3	8.6	9.1	6.2	10.6	13.2	4.5	16.6	4.7	4.9	6.5	12.6	10.0	7.0	6.6	5.0	10.7	7.9	8.4	9.4	8.8	6.1	6.3	7.0	13.7	26.7	10.3	7.4	3.9	32.5	11.0	7.2	9.1	7.6	9.5	7.6	7.2	9.8	7.9	6.2	5.3	22.3	8.3	6.0	5.5	5.9	5.6	4.9	3.8	21.1	3.9	8.9	7.6	18.8	10.1	12.2	9.5	9.2	9.9	12.3	10.7	9.5	9.4	11.8	12.3	11.7	21.6	11.5	12.5	14.8	8.0	8.7	8.3	7.7	41.7	10.1	8.6	4.5	10.3	6.8	8.5	10.7	14.9	15.0	35.0	14.5	58.8	25.9	5.9	12.7	9.4	13.6	15.7	27.5	14.0	1.7	11.1	11.3	24.1	11.1	23.3	11.1	13.6	14.1	26.7	16.1	9.0	12.4	25.4	26.0	23.4	45.9	10.4	24.5	31.5	54.0	32.5	19.0	13.0	10.8	20.1	20.5	11.0	33.3	12.9	17.8	20.2	22.6	70.6	20.1	30.5	15.3	23.3
PANK1	"MGC24596, PANK, PANK1a, PANK1b"	ENSG00000152782	"Pantothenate kinase 1"	Q8TE04	10	89579497-89645572	"Enzymes, Predicted intracellular proteins"	"Coenzyme A biosynthesis"	"Kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 20.1;liver: 63.8"	"Cell type enhanced"	"Detected in many"	13	"Distal tubular cells: 59.7;Hepatocytes: 103.1;Proximal tubular cells: 48.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA						"unprognostic (1.00e-1)"	"unprognostic (2.19e-1)"	"unprognostic (2.02e-2)"	"unprognostic (1.09e-2)"	"unprognostic (6.71e-2)"	"unprognostic (6.97e-2)"	"prognostic favorable (1.50e-4)"	"unprognostic (1.59e-1)"	"unprognostic (1.38e-2)"	"unprognostic (1.61e-1)"	"unprognostic (4.55e-4)"	"unprognostic (4.61e-2)"	"prognostic favorable (1.55e-10)"	"unprognostic (3.49e-2)"	"unprognostic (4.69e-2)"	"unprognostic (5.34e-2)"	"unprognostic (6.64e-2)"	1.1	2.5	2.3	1.2	1.9	0.0	1.0	13.4	4.1	2.4	6.1	1.3	0.5	9.0	0.9	1.9	2.9	1.2	1.5	3.9	1.9	2.6	20.1	63.8	2.1	0.6	2.1	2.7	1.1	1.2	2.6	2.2	1.0	3.1	1.5	7.8	1.8	1.4	1.0	5.7	5.5	9.2	1.0	1.7	0.9	2.0	1.5	1.0	2.6	4.7	2.4	1.0	1.1	5.5	1.0	2.3	0.9	0.6	0.1	1.6	0.7	5.6	3.7	20.4	14.0	11.1	8.1	10.3	3.3	3.6	3.2	4.2	5.7	5.8	4.1	2.2	2.5	2.3	5.6	9.2	2.1	3.4	1.4	4.1	2.7	4.0	11.3	3.3	8.4	1.5	4.9	9.3	4.8	3.8	6.7	3.6	3.5	4.7	0.5	4.5	4.3	9.3	8.7	16.0	14.7	2.2	8.3	4.0	2.7	9.7	2.7	6.4	7.6	4.1	5.0	3.2	12.7	5.4	6.2	1.5	1.9	1.8	3.8	3.9	4.7	8.7	5.0	2.5	6.8	1.3	0.9	0.3	0.1	0.7	0.1	1.4	1.0	0.8	1.6	1.0	0.1	1.0	0.2	0.7	0.1	0.6	2.3	1.1	0.7	2.3	1.9	13.4	4.1	1.9	2.6	2.1	2.7	3.1	1.0	6.0	3.0	5.6	0.7	2.1	4.1	10.2	10.2	1.4	2.3	10.4	2.0	3.9	59.7	0.8	0.4	1.0	20.9	0.0	0.6	3.8	1.8	0.5	0.0	103.1	2.0	12.7	10.9	4.3	3.7	0.2	1.1	1.6	0.0	0.0	16.2	0.8	0.1	8.6	2.1	48.4	1.0	0.0	2.7	0.5	0.9	2.5	1.5	1.5	22.8	0.4
PANK2	"C20orf48, FLJ11729, HARP, HSS, NBIA1, PKAN"	ENSG00000125779	"Pantothenate kinase 2"	Q9BZ23	20	3888839-3929882	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Coenzyme A biosynthesis"	"Kinase, Transferase"	"Disease mutation, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA008440	Approved		Supported	Cytosol		NA	NA			Cytosol		"HPA008440: AB_1079559"	"unprognostic (4.50e-2)"	"unprognostic (7.96e-3)"	"unprognostic (2.26e-1)"	"unprognostic (1.39e-2)"	"unprognostic (1.68e-1)"	"unprognostic (6.00e-2)"	"prognostic unfavorable (1.20e-5)"	"unprognostic (2.75e-1)"	"unprognostic (3.39e-1)"	"unprognostic (2.52e-1)"	"unprognostic (3.02e-2)"	"unprognostic (1.65e-1)"	"unprognostic (6.01e-3)"	"unprognostic (1.73e-2)"	"unprognostic (2.18e-3)"	"unprognostic (2.63e-1)"	"unprognostic (1.81e-1)"	15.2	21.5	18.7	18.5	18.9	20.8	19.7	21.8	24.8	14.7	14.4	16.8	10.7	11.8	15.5	15.5	28.9	19.1	14.3	11.0	17.4	18.6	18.8	20.3	16.1	18.5	16.2	16.2	14.4	13.5	15.3	15.7	18.1	20.8	14.5	16.4	17.0	15.8	13.2	14.4	12.8	14.5	16.6	12.3	20.6	12.1	28.9	14.1	23.2	17.0	10.5	24.6	17.3	16.4	5.8	8.6	8.0	12.8	8.3	6.4	3.1	20.8	13.5	14.6	7.4	17.5	15.2	8.0	13.7	15.0	18.1	23.5	18.2	11.2	17.0	6.4	15.3	36.2	17.3	15.7	26.7	23.1	5.0	6.9	23.2	9.7	33.9	14.7	15.4	7.7	13.4	11.6	20.2	13.0	6.9	16.9	12.0	17.0	15.9	19.4	5.2	13.2	13.6	14.6	8.6	10.2	10.9	20.4	10.7	11.2	19.2	19.0	9.3	17.0	18.6	34.0	14.9	11.3	12.5	11.6	21.7	10.9	28.3	21.0	8.9	25.9	12.9	6.4	14.1	16.9	1.6	11.2	4.7	4.4	12.8	4.3	4.7	4.3	4.5	8.6	5.8	4.4	4.0	8.0	8.3	10.7	3.0	6.4	3.1	18.7	18.9	21.8	24.8	17.4	18.6	16.2	16.2	20.8	14.1	17.9	9.4	18.5	15.5	22.7	20.0	9.0	7.6	16.0	9.1	14.0	23.6	25.6	19.9	16.8	63.9	22.4	12.3	23.3	15.4	29.5	18.0	15.9	7.0	13.0	29.7	33.4	19.4	20.3	37.4	13.0	19.5	30.0	18.6	36.1	9.9	13.3	12.2	11.5	21.2	15.3	20.0	6.5	16.9	32.6	21.8	21.2	15.6	25.5	12.6	16.5
PANK3	FLJ12899	ENSG00000120137	"Pantothenate kinase 3"	Q9H999	5	168548495-168579600	"Enzymes, Predicted intracellular proteins"	"Coenzyme A biosynthesis"	"Kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"intestine: 63.0"	"Cell type enhanced"	"Detected in many"	4	"Enterocytes: 101.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA078669	Approved		Approved	"Golgi apparatus"		NA	NA			"Golgi apparatus"		"HPA078669: "	"unprognostic (1.24e-2)"	"unprognostic (5.71e-2)"	"prognostic favorable (3.94e-4)"	"unprognostic (7.65e-3)"	"unprognostic (2.47e-2)"	"unprognostic (2.42e-2)"	"unprognostic (1.20e-2)"	"unprognostic (8.43e-2)"	"unprognostic (1.29e-1)"	"unprognostic (2.22e-1)"	"unprognostic (9.48e-2)"	"unprognostic (2.30e-1)"	"unprognostic (3.71e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.43e-1)"	"unprognostic (1.97e-3)"	"unprognostic (2.01e-1)"	9.1	16.6	11.6	17.5	10.4	10.5	17.6	22.8	11.9	8.9	23.9	9.0	8.5	28.0	10.2	8.8	12.8	7.8	6.9	7.4	11.7	9.1	13.2	39.2	12.5	8.2	8.4	7.5	10.7	8.8	14.6	11.2	9.4	10.8	9.1	17.9	6.7	11.0	9.6	8.2	11.9	63.0	8.0	10.3	9.6	10.9	10.2	11.0	10.2	10.5	13.4	8.2	9.9	11.6	4.1	2.7	3.5	4.7	0.9	2.5	1.1	13.9	7.9	32.7	17.4	12.3	14.2	13.9	8.4	9.0	11.3	16.7	13.1	13.0	21.6	13.9	11.9	18.3	10.1	22.0	17.0	20.4	20.0	10.6	11.0	7.5	9.7	14.2	14.9	15.0	11.4	23.0	14.2	16.0	8.0	13.3	16.4	10.2	21.9	15.5	7.8	14.8	6.7	14.0	10.9	5.8	10.8	22.4	8.8	14.2	20.8	15.3	32.7	9.7	16.0	23.9	17.2	20.8	18.8	13.6	15.3	21.5	9.0	17.9	15.3	21.0	16.1	9.1	15.2	11.8	3.5	3.2	1.6	1.9	3.8	2.5	4.1	1.9	1.9	2.0	1.6	1.3	2.3	1.3	0.9	4.7	2.7	2.4	1.1	11.6	10.4	22.8	11.8	11.7	9.1	8.4	7.5	10.8	11.0	23.8	17.1	17.4	18.7	30.5	27.4	13.5	22.9	18.7	17.0	24.4	25.5	14.0	8.3	15.1	9.7	23.2	101.4	0.0	17.5	11.9	20.0	29.7	15.0	79.1	19.5	27.0	32.8	17.8	27.0	13.1	15.5	18.7	21.9	10.8	33.0	12.0	18.9	31.7	16.6	19.6	26.0	25.8	31.6	26.0	27.4	49.1	35.0	10.1	35.0	45.2
PANK4	FLJ10782	ENSG00000157881	"Pantothenate kinase 4"	Q9NVE7	1	2508533-2526628	"Enzymes, Predicted intracellular proteins"	"Coenzyme A biosynthesis"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 43.1"	"Cell type enhanced"	"Detected in many"	4	"Cardiomyocytes: 22.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BJ: 9.0;HDLM-2: 9.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA011723, HPA012036, HPA027961"	Uncertain		Approved	Cytosol		NA	NA			Cytosol		"HPA011723: AB_2668522, HPA012036: AB_1854952, HPA027961: AB_10602042"	"unprognostic (1.23e-1)"	"unprognostic (2.31e-1)"	"unprognostic (3.36e-1)"	"unprognostic (1.13e-1)"	"unprognostic (4.92e-3)"	"unprognostic (1.99e-1)"	"unprognostic (1.34e-1)"	"unprognostic (2.55e-1)"	"unprognostic (6.51e-2)"	"unprognostic (1.80e-1)"	"unprognostic (1.18e-2)"	"unprognostic (3.29e-2)"	"prognostic favorable (1.57e-5)"	"unprognostic (1.22e-1)"	"unprognostic (2.03e-1)"	"unprognostic (2.25e-1)"	"unprognostic (8.15e-2)"	5.3	14.4	10.7	17.8	12.6	4.2	5.4	14.9	12.4	5.5	7.1	6.8	4.9	4.2	7.0	4.2	9.8	5.6	9.2	11.8	8.0	5.2	7.2	7.0	6.7	12.5	9.0	6.8	5.7	5.8	4.2	8.3	6.7	7.4	5.8	6.1	8.9	5.6	5.3	43.1	19.0	7.6	9.1	4.4	8.1	6.3	11.0	9.7	9.4	6.8	6.8	7.2	7.2	5.7	4.5	4.8	11.7	6.9	11.4	8.9	5.3	2.5	6.7	2.3	0.0	0.0	2.7	1.6	9.0	0.0	8.2	7.7	0.0	0.0	1.1	3.1	2.5	0.0	3.9	1.9	0.0	1.8	9.4	5.7	0.0	3.9	5.6	2.6	0.0	4.7	0.0	0.0	0.0	0.0	1.2	1.9	1.3	2.5	0.0	2.2	0.0	1.3	0.3	0.0	0.8	2.8	0.0	0.0	1.8	0.0	0.0	2.0	0.0	5.1	1.9	0.0	0.9	0.0	3.4	0.0	0.0	1.9	4.7	2.2	1.3	4.6	6.1	3.0	0.9	0.0	11.7	4.9	4.5	6.2	6.6	5.1	4.5	3.9	6.4	4.8	3.0	7.4	8.0	6.4	11.4	6.9	0.9	8.9	5.3	10.7	12.6	14.9	12.4	8.0	5.2	9.0	6.8	7.4	9.7	6.0	3.2	5.6	4.9	3.7	7.2	22.5	2.5	0.0	2.3	3.5	9.8	6.5	6.6	5.2	1.1	5.2	4.9	0.0	6.0	4.2	7.0	3.2	1.1	7.6	4.6	3.2	2.9	3.7	5.9	0.4	5.5	5.9	5.0	8.2	4.0	4.5	4.7	7.0	8.5	3.6	13.0	19.4	5.9	4.8	5.2	3.9	8.1	8.5	5.0	3.1
PAOX	PAO	ENSG00000148832	"Polyamine oxidase"	Q6QHF9	10	133379234-133391694	"Enzymes, Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 36.7"	"Group enriched"	"Detected in many"	11	"Early spermatids: 115.5;Late spermatids: 346.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"naive B-cell: 4.3"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"A-431: 6.4;K-562: 5.0;U-266/70: 18.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA047782			Uncertain	Nucleoplasm,Centrosome		NA	NA			Centrosome	Nucleoplasm	"HPA047782: "	"unprognostic (3.67e-3)"	"prognostic favorable (6.07e-5)"	"unprognostic (2.49e-2)"	"unprognostic (1.28e-3)"	"unprognostic (1.96e-2)"	"prognostic favorable (1.38e-5)"	"unprognostic (7.39e-2)"	"unprognostic (1.99e-3)"	"unprognostic (2.20e-1)"	"unprognostic (4.48e-2)"	"unprognostic (1.11e-2)"	"unprognostic (2.99e-1)"	"prognostic favorable (9.49e-4)"	"unprognostic (3.56e-2)"	"unprognostic (2.86e-1)"	"unprognostic (7.61e-2)"	"unprognostic (8.29e-3)"	6.7	4.1	4.3	5.8	6.7	1.5	4.7	6.8	8.7	3.7	6.0	10.8	5.6	5.6	3.7	1.8	7.4	3.4	2.4	2.5	5.7	2.7	8.9	9.2	2.8	5.2	10.0	3.4	3.6	3.2	1.9	2.5	2.1	4.2	4.8	1.5	2.8	9.9	5.1	3.5	4.4	8.5	2.8	4.7	8.2	7.5	36.7	7.6	0.7	2.4	2.1	5.4	4.6	4.2	4.3	1.1	1.0	1.0	1.7	0.3	0.4	6.4	0.0	0.2	1.2	0.0	0.7	1.6	2.9	1.2	1.4	0.2	1.1	0.1	0.0	0.9	0.6	0.8	3.5	0.4	0.8	0.6	4.2	0.5	0.6	0.0	0.2	1.7	0.0	1.0	0.1	0.3	0.9	0.4	0.0	0.1	0.0	5.0	0.3	0.0	0.1	0.0	0.1	1.2	0.0	3.0	4.6	0.0	0.0	0.2	0.0	0.3	2.2	0.9	0.1	0.0	0.0	1.4	0.0	2.8	0.3	1.4	1.2	0.0	18.5	3.4	1.7	0.0	0.0	0.1	1.0	0.3	0.0	0.2	1.0	0.0	1.6	0.3	0.2	1.1	4.3	0.0	0.0	0.0	1.7	0.9	0.8	0.0	0.4	4.3	6.7	6.8	6.5	5.7	2.7	10.0	3.4	4.2	7.6	0.0	5.8	20.9	6.2	3.3	1.5	1.5	5.1	1.4	0.0	1.8	0.0	0.7	5.0	4.5	115.5	2.3	6.8	0.0	3.0	1.7	2.3	4.8	5.7	11.3	4.1	4.8	0.0	3.7	10.4	346.0	8.9	3.9	0.0	17.2	3.4	7.7	2.9	2.9	7.4	13.2	2.7	19.4	2.5	9.9	3.0	3.1	0.2	4.6	3.2	8.6
PAPD4	"FLJ38499, GLD2, TUT2"	ENSG00000164329	"Poly(A) RNA polymerase D4, non-canonical"	Q6PIY7	5	79612120-79686648	"Enzymes, Predicted intracellular proteins"	"mRNA processing"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA054468			Approved	Cytosol		No	No			Cytosol		"HPA054468: AB_2682497"	"unprognostic (1.52e-1)"	"unprognostic (2.17e-1)"	"unprognostic (6.25e-3)"	"unprognostic (1.91e-1)"	"unprognostic (8.03e-2)"	"unprognostic (2.80e-3)"	"unprognostic (2.10e-2)"	"unprognostic (1.10e-1)"	"unprognostic (6.80e-2)"	"unprognostic (1.57e-3)"	"unprognostic (9.37e-2)"	"unprognostic (2.21e-1)"	"unprognostic (7.71e-2)"	"unprognostic (2.38e-1)"	"unprognostic (8.43e-3)"	"unprognostic (5.84e-3)"	"unprognostic (2.67e-3)"	25.4	21.1	15.8	34.4	22.1	42.1	27.9	20.9	30.3	23.8	22.6	24.7	22.7	19.2	34.4	28.1	22.0	20.7	23.3	16.5	16.5	14.6	20.0	25.3	25.6	34.7	19.4	20.2	29.6	21.4	18.0	23.1	25.7	17.2	20.6	23.3	23.8	21.4	28.3	21.0	25.5	25.4	23.1	22.2	37.4	21.0	26.0	21.2	33.8	24.9	21.3	29.3	22.6	21.9	20.2	19.5	22.3	22.1	19.3	29.9	15.7	11.6	8.1	9.1	14.3	15.9	18.5	14.6	14.1	21.7	16.6	26.5	7.2	13.9	21.8	7.4	15.6	19.6	11.2	11.6	15.7	19.0	16.2	10.6	12.4	10.1	11.2	20.7	18.3	17.2	16.3	17.1	11.7	22.0	16.2	14.0	16.0	14.1	16.1	18.2	6.3	20.8	23.6	8.4	8.9	5.8	18.7	9.1	24.3	16.0	16.7	6.0	10.9	11.2	12.3	22.1	15.0	10.5	29.0	12.8	9.0	6.1	8.7	15.6	17.0	14.1	21.6	15.8	19.3	12.5	22.3	19.1	18.6	18.2	22.1	29.9	20.2	19.9	19.9	19.5	16.2	19.3	19.8	17.3	19.3	21.7	10.7	20.2	15.7	15.8	22.1	20.9	30.3	16.5	14.6	19.4	20.2	17.2	21.2	17.9	15.6	14.7	16.3	26.1	21.3	0.0	12.7	24.1	14.8	0.0	21.6	23.1	0.0	0.0	7.5	20.4	16.9	23.3	0.0	18.7	18.8	16.8	20.9	23.2	29.3	31.8	13.8	33.2	52.9	6.6	17.8	36.5	15.1	0.0	17.6	17.1	0.0	20.9	25.1	0.0	33.2	12.9	12.5	24.2	15.0	27.5	28.1	35.0	18.4	20.3
PAPD5	TRF4-2	ENSG00000121274	"Poly(A) RNA polymerase D5, non-canonical"	Q8NDF8	16	50152918-50235310	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis, mRNA processing, rRNA processing"	"DNA-binding, DNA-directed DNA polymerase, Nucleotidyltransferase, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042968, HPA048225"	Uncertain					NA	NA					"HPA042968: AB_2678244, HPA048225: AB_2680319"	"unprognostic (1.05e-2)"	"unprognostic (4.09e-2)"	"unprognostic (1.77e-2)"	"unprognostic (1.63e-1)"	"unprognostic (3.27e-1)"	"unprognostic (2.91e-2)"	"unprognostic (4.33e-2)"	"unprognostic (2.46e-1)"	"unprognostic (7.83e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.30e-1)"	"unprognostic (3.30e-2)"	"prognostic favorable (1.85e-4)"	"unprognostic (4.24e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.83e-1)"	"unprognostic (7.00e-2)"	9.4	9.9	5.9	8.8	8.6	19.2	12.6	14.9	10.8	15.9	10.0	4.5	8.8	11.1	13.1	6.3	7.4	10.8	6.3	8.0	7.7	6.9	10.0	11.9	8.5	11.2	6.4	8.0	10.5	7.9	18.5	13.4	9.2	7.5	10.0	6.4	6.7	7.6	9.8	9.9	8.1	9.4	9.7	6.1	6.0	8.0	12.3	8.0	6.8	7.5	6.0	6.6	13.1	30.8	3.5	4.9	4.6	2.9	7.2	5.6	1.2	11.4	8.8	7.2	12.8	11.3	9.6	9.2	10.3	10.5	12.4	5.8	12.1	8.2	13.8	12.3	12.5	5.8	8.7	13.5	7.7	16.4	8.1	8.8	8.2	4.7	15.7	12.8	6.9	12.8	5.8	9.5	10.3	13.0	10.7	8.6	7.6	8.5	4.8	11.5	5.0	9.6	10.3	9.3	6.0	9.6	12.9	14.3	18.1	3.5	4.3	9.2	5.4	10.5	13.5	7.1	7.6	4.5	5.0	7.4	11.5	10.1	10.0	5.8	9.7	7.5	18.3	6.9	6.4	8.2	4.6	2.6	1.3	4.0	2.9	3.5	2.9	4.3	4.8	2.0	3.5	4.8	5.6	4.0	7.2	2.1	4.9	3.7	1.2	5.9	8.6	14.9	10.8	7.7	6.9	6.4	8.0	7.5	8.0	6.0	26.1	7.2	8.0	37.1	35.2	0.0	15.3	6.7	15.9	0.0	17.7	15.3	0.0	0.0	44.0	12.2	22.6	0.0	0.0	9.1	16.9	14.2	7.0	25.5	13.4	28.6	9.2	15.4	25.7	25.1	17.5	21.0	16.9	0.0	9.5	10.6	0.0	14.0	21.2	0.0	13.6	19.4	30.3	39.9	21.0	33.0	15.3	23.5	18.8	10.3
PAPD7	"LAK-1, POLK, POLS, TRF4, TRF4-1"	ENSG00000112941	"Poly(A) RNA polymerase D7, non-canonical"	Q5XG87	5	6713007-6757048	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"mRNA processing"	"Nucleotidyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Cone photoreceptor cells: 35.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA045487, HPA046742"	Enhanced		Supported	"Nucleoplasm,Nuclear membrane,Golgi apparatus"		NA	NA			Nucleoplasm	"Nuclear membrane, Golgi apparatus"	"HPA045487: AB_2679346, HPA046742: AB_2679781"	"unprognostic (1.45e-1)"	"unprognostic (2.96e-1)"	"unprognostic (2.08e-2)"	"unprognostic (2.12e-3)"	"unprognostic (7.57e-2)"	"unprognostic (1.30e-2)"	"unprognostic (4.22e-2)"	"unprognostic (2.37e-1)"	"unprognostic (2.62e-1)"	"unprognostic (9.78e-2)"	"unprognostic (3.10e-3)"	"unprognostic (3.73e-2)"	"prognostic unfavorable (7.99e-5)"	"unprognostic (6.56e-2)"	"unprognostic (2.08e-1)"	"unprognostic (2.60e-2)"	"prognostic favorable (8.55e-4)"	13.5	7.9	9.6	13.9	11.1	25.8	16.3	22.7	12.3	15.1	16.6	10.6	14.8	9.5	13.2	8.0	12.2	11.3	11.4	8.6	10.7	7.3	9.7	19.9	13.2	14.1	14.8	5.8	18.5	13.3	13.2	12.2	10.0	9.0	11.6	8.3	10.2	17.0	10.6	10.4	16.7	13.1	13.9	7.9	14.8	10.1	11.1	11.7	25.4	11.3	11.3	11.6	12.5	34.9	1.9	3.8	0.7	0.7	0.5	2.3	0.8	16.5	11.2	13.8	17.0	10.0	9.0	19.9	11.3	14.1	14.1	16.0	11.6	9.3	12.1	8.7	13.8	15.8	12.3	11.3	8.7	13.0	13.6	7.2	6.2	35.5	6.3	6.2	9.3	9.4	6.1	7.6	15.7	10.1	10.4	8.2	9.1	8.3	16.1	11.4	9.1	12.6	12.2	7.5	5.1	8.8	11.5	11.8	3.1	5.6	9.5	13.8	10.5	26.9	13.1	7.7	7.8	7.9	5.1	7.2	16.9	17.8	14.7	15.7	15.4	6.3	10.7	11.0	8.7	10.4	0.0	0.7	0.7	2.1	0.4	2.3	1.9	1.7	1.6	1.2	1.5	1.9	1.7	0.4	0.5	0.6	3.8	1.8	0.8	9.6	11.1	22.7	12.3	10.7	7.3	14.8	5.8	9.0	11.7	6.0	20.8	6.7	8.4	29.1	16.5	0.0	7.6	4.0	9.1	0.0	35.3	4.5	0.0	0.0	9.6	8.2	7.3	0.0	0.0	3.5	14.1	9.6	4.7	13.2	5.8	14.3	4.7	16.0	5.7	2.8	6.1	7.6	3.3	0.0	8.1	7.8	0.0	6.2	8.5	0.0	24.9	0.0	14.7	6.3	4.9	22.6	4.7	6.9	7.6	8.7
PAPOLA	PAP	ENSG00000090060	"Poly(A) polymerase alpha"	P51003	14	96501433-96567111	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"mRNA processing"	"RNA-binding, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	5	"Syncytiotrophoblasts: 866.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA001788	Supported		Supported	Nucleoplasm		NA	NA			Nucleoplasm		"HPA001788: AB_1079564"	"unprognostic (3.18e-1)"	"unprognostic (1.30e-1)"	"unprognostic (9.69e-2)"	"unprognostic (7.26e-2)"	"unprognostic (9.10e-2)"	"unprognostic (5.10e-3)"	"prognostic unfavorable (2.41e-5)"	"unprognostic (2.12e-2)"	"unprognostic (2.82e-2)"	"unprognostic (1.38e-3)"	"unprognostic (3.13e-1)"	"unprognostic (1.22e-3)"	"unprognostic (3.37e-1)"	"unprognostic (1.65e-1)"	"unprognostic (1.77e-1)"	"unprognostic (1.08e-2)"	"unprognostic (4.05e-1)"	35.8	43.4	49.1	45.7	51.6	54.5	39.7	61.2	60.5	41.0	45.1	25.2	45.6	34.9	43.8	48.3	42.0	38.7	35.6	71.8	46.3	39.6	40.0	50.2	37.1	44.7	48.1	39.7	58.2	52.9	50.2	68.7	54.5	45.6	45.1	45.8	24.0	39.2	45.5	46.4	35.5	45.5	38.9	41.9	50.9	40.4	53.0	55.7	53.0	54.8	34.8	49.6	44.9	119.5	26.4	23.0	39.0	23.5	25.2	23.4	19.8	32.2	31.1	40.0	40.1	29.0	32.8	91.1	29.5	31.9	35.1	33.8	35.9	33.3	43.6	34.0	34.5	31.2	27.9	13.0	40.6	63.0	36.0	21.2	35.2	23.6	35.2	30.0	46.0	35.7	29.9	35.6	39.2	35.1	34.3	39.2	22.1	33.0	40.0	33.8	46.9	36.1	23.3	27.3	52.6	35.4	38.5	48.8	25.3	35.0	51.4	41.2	27.3	39.4	30.9	28.7	47.0	43.8	40.6	31.2	24.8	19.8	27.9	35.9	31.6	47.2	38.5	40.1	35.3	41.5	39.0	19.7	32.7	15.5	23.5	20.4	23.8	19.6	22.6	23.0	26.4	23.4	21.8	27.4	25.2	22.6	15.2	18.7	19.8	49.1	51.6	61.2	60.5	46.3	39.6	48.1	39.7	45.6	55.7	74.5	97.8	147.6	322.5	204.0	74.0	149.1	91.7	188.7	112.6	80.3	90.3	292.7	155.9	102.9	458.6	132.1	96.5	93.5	118.9	339.8	138.5	332.8	134.9	110.0	138.1	60.4	112.4	76.1	123.0	196.9	89.2	135.9	160.3	140.7	124.7	87.2	118.9	101.7	75.7	103.9	102.5	103.5	150.3	203.7	195.7	216.4	866.4	116.1	134.7	394.8
PAPOLB	PAPT	ENSG00000218823	"Poly(A) polymerase beta"	Q9NRJ5	7	4857733-4861994	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"mRNA processing"	"RNA-binding, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	63	"testis: 33.0"	"Group enriched"	"Detected in some"	4	"Early spermatids: 67.3;Late spermatids: 69.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"THP-1: 1.7"	"Not detected"	"Not detected"							HPA047285			Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA047285: "					"unprognostic (7.58e-2)"					"unprognostic (1.25e-1)"				"unprognostic (1.68e-2)"	"unprognostic (1.78e-1)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	33.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.2	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.4	0.0	0.1	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	1.7	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.2	0.0	0.5	0.1	0.0	0.0	0.0	0.3	0.3	1.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	67.3	0.3	0.0	0.0	0.0	0.0	0.6	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	69.0	2.3	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.4	0.0	0.7	0.0	0.5	16.1	2.3	0.6	0.2	0.0	0.0	0.3
PAPOLG	FLJ12972	ENSG00000115421	"Poly(A) polymerase gamma"	Q9BWT3	2	60756230-60802085	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"mRNA processing"	"RNA-binding, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB017795, HPA035349, HPA035350"	Approved		Enhanced	Nucleoplasm		No	No			Nucleoplasm		"CAB017795: , HPA035349: AB_2674583, HPA035350: AB_2674584"	"unprognostic (1.83e-1)"	"unprognostic (1.06e-1)"	"unprognostic (2.14e-1)"	"unprognostic (3.39e-2)"	"unprognostic (5.56e-2)"	"unprognostic (3.54e-1)"	"unprognostic (6.72e-4)"	"unprognostic (2.49e-1)"	"unprognostic (6.97e-3)"	"unprognostic (6.83e-2)"	"unprognostic (1.95e-1)"	"unprognostic (1.88e-1)"	"prognostic unfavorable (4.21e-4)"	"unprognostic (2.67e-1)"	"unprognostic (1.99e-2)"	"unprognostic (3.06e-2)"	"unprognostic (2.62e-2)"	12.3	9.5	11.6	11.6	11.9	5.8	9.9	19.4	15.3	10.2	8.2	9.8	7.8	6.8	12.1	6.2	10.1	9.0	10.2	8.5	15.1	10.1	8.6	6.9	9.4	14.8	10.9	11.3	17.1	9.9	13.3	18.9	11.8	12.5	9.6	9.2	7.7	11.1	8.7	13.1	11.7	9.7	9.9	21.0	15.0	9.1	14.2	11.0	23.1	27.5	6.6	14.3	10.9	11.1	6.1	3.7	13.2	6.9	9.4	9.7	4.1	5.2	4.9	9.2	7.4	11.8	8.9	8.8	5.8	5.7	5.0	5.3	8.3	4.5	7.5	6.1	4.4	6.6	8.9	13.0	5.5	9.4	13.0	6.9	9.6	4.7	5.8	7.1	10.0	6.6	6.7	6.5	6.0	12.7	7.6	8.0	7.8	9.4	7.2	5.6	4.2	11.5	6.9	14.5	7.7	4.5	9.4	16.3	6.8	5.4	5.0	5.4	7.5	9.3	5.8	5.2	10.7	3.8	6.1	7.5	6.4	7.7	4.8	5.4	7.1	4.2	18.3	5.2	11.4	4.6	13.2	4.1	8.7	6.7	4.3	8.3	5.9	7.2	6.0	3.7	6.1	7.9	7.3	10.6	9.4	6.9	3.3	9.7	4.1	11.6	11.9	19.4	15.3	15.1	10.1	10.9	11.3	12.5	11.0	11.9	9.8	4.5	13.0	11.1	5.7	6.3	5.1	8.1	10.3	8.7	23.6	5.3	3.3	3.9	4.3	9.2	4.3	0.0	3.7	3.5	8.2	12.6	12.7	4.0	6.5	4.8	2.4	10.4	11.6	3.3	6.9	12.4	11.8	7.2	5.1	5.1	3.6	5.8	8.1	2.4	10.1	25.8	8.2	23.3	14.7	13.9	7.3	15.8	3.2	12.0
PAPPA	"ASBABP2, DIPLA1, IGFBP-4ase, PAPA, PAPP-A, PAPPA1"	ENSG00000182752	"Pappalysin 1"	Q13219	9	116153804-116402322	"Cancer-related genes, Candidate cardiovascular disease genes, Enzymes, Plasma proteins, Predicted secreted proteins"		"Hydrolase, Metalloprotease, Protease"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	86	"placenta: 484.6"	"Group enriched"	"Detected in many"	6	"Collecting duct cells: 157.1;Proximal tubular cells: 39.6"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC diff: 19.3;ASC TERT1: 14.8;HSkMC: 53.2;U-138 MG: 13.9"	"Low region specificity"	"Detected in some"			"Group enriched"	"Detected in many"	5	"midbrain: 10.4;olfactory region: 4.1;pons and medulla: 8.3;thalamus: 4.8"	"HPA001667, CAB016724"	Enhanced				"Secreted in female reproductive system"	NA	NA		41000			"CAB016724: , HPA001667: AB_1854960"	"unprognostic (3.25e-1)"	"unprognostic (6.18e-6)"	"unprognostic (2.47e-1)"	"unprognostic (6.49e-2)"	"unprognostic (2.01e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.13e-1)"	"unprognostic (5.42e-3)"	"unprognostic (5.44e-2)"	"unprognostic (3.87e-2)"	"unprognostic (6.87e-3)"	"unprognostic (8.25e-2)"	"unprognostic (8.00e-3)"	"unprognostic (2.37e-3)"	"unprognostic (2.48e-1)"	"unprognostic (4.01e-1)"	"unprognostic (1.02e-3)"	4.8	2.3	0.5	1.0	0.5	0.0	0.8	0.4	0.6	3.6	2.4	0.6	1.0	0.1	3.5	1.0	3.6	2.0	1.1	3.7	0.4	0.0	4.3	0.5	2.4	0.7	0.4	0.4	1.4	0.7	5.6	0.7	484.6	0.7	1.4	0.9	0.9	0.5	1.2	0.5	1.1	0.9	2.4	0.6	0.6	1.0	0.8	0.5	0.4	1.3	1.0	1.0	2.3	3.4	0.2	0.0	0.2	0.0	0.0	0.1	0.0	0.0	5.5	8.4	0.0	19.3	14.8	0.0	4.5	8.0	1.2	2.1	0.0	0.0	0.0	0.0	3.1	0.4	0.6	0.0	0.0	6.0	0.0	0.0	0.9	4.6	0.0	9.4	0.0	0.0	53.2	0.0	6.2	0.7	10.3	0.0	0.0	0.2	0.0	1.4	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.4	0.6	0.0	0.0	2.7	0.0	0.0	10.7	13.9	0.7	0.4	0.5	0.0	0.0	0.0	9.9	0.0	4.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.5	0.5	0.4	0.6	0.4	0.0	0.4	0.4	0.7	0.5	0.0	1.0	0.0	0.2	2.6	5.0	2.2	0.0	0.0	2.3	157.1	11.8	0.3	8.3	5.8	14.3	0.7	0.0	0.0	0.8	7.4	16.4	0.6	1.1	0.0	0.4	0.0	0.0	5.5	0.0	12.7	13.3	0.3	1.7	0.0	0.0	2.3	0.5	0.0	8.1	39.6	2.7	0.0	8.2	1.7	0.4	1.0	11.7	0.0	0.0	0.1
PAPPA2	"PAPP-A2, PAPPE, PLAC3"	ENSG00000116183	"Pappalysin 2"	Q9BXP8	1	176463171-176845605	"Enzymes, Predicted membrane proteins, Predicted secreted proteins"		"Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	35	"placenta: 406.4"	"Group enriched"	"Detected in many"	7	"Intestinal endocrine cells: 135.4;Muller glia cells: 47.6;Syncytiotrophoblasts: 61.9"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	5	"U-87 MG: 21.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA018412, HPA018430"	Enhanced		Approved	"Endoplasmic reticulum,Vesicles"	"Secreted in female reproductive system"	NA	NA			"Endoplasmic reticulum, Vesicles"		"HPA018412: AB_1854962, HPA018430: AB_1854961"	"unprognostic (2.90e-1)"	"unprognostic (1.58e-1)"	"unprognostic (1.07e-1)"	"unprognostic (3.61e-2)"	"unprognostic (9.04e-2)"	"unprognostic (1.60e-3)"	"unprognostic (1.36e-1)"	"unprognostic (2.45e-1)"	"unprognostic (1.00e-2)"	"unprognostic (3.54e-2)"	"unprognostic (1.29e-2)"	"unprognostic (4.39e-2)"	"unprognostic (2.85e-2)"	"unprognostic (1.52e-4)"	"unprognostic (1.85e-1)"	"unprognostic (8.18e-4)"	"unprognostic (4.35e-2)"	0.6	0.0	0.6	0.2	0.2	0.0	3.0	0.8	0.3	5.0	0.6	0.2	0.2	0.0	0.3	0.2	0.2	0.2	1.1	0.2	0.2	0.1	11.6	0.7	0.2	0.2	0.2	0.2	0.2	1.5	0.0	1.2	406.4	0.3	0.2	0.2	0.2	0.2	0.3	0.2	0.0	0.2	0.3	0.5	0.2	1.0	0.3	0.2	0.2	0.5	0.2	0.2	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.7	0.0	0.1	0.3	0.0	0.5	0.0	0.0	0.0	0.1	0.8	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	1.3	4.6	2.2	3.8	0.9	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.2	0.0	0.4	0.0	0.0	0.0	0.8	0.5	0.5	0.2	0.0	0.0	0.1	0.8	0.0	0.0	0.3	1.7	1.4	0.1	0.6	0.3	0.4	0.0	21.2	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.2	0.8	0.3	0.2	0.1	0.2	0.2	0.3	0.2	0.0	0.0	0.0	0.0	0.0	2.7	0.6	0.0	0.0	0.0	5.2	0.0	0.8	10.0	0.0	1.9	0.0	0.0	0.0	0.2	11.6	0.6	0.0	0.0	0.2	1.2	0.0	135.4	0.0	0.0	1.3	10.6	0.0	0.0	0.0	0.2	47.6	1.2	0.0	10.3	0.3	1.1	6.5	0.5	1.2	1.9	0.0	61.9	0.0	0.0	0.0
PAPSS1	"ATPSK1, PAPSS"	ENSG00000138801	"3'-phosphoadenosine 5'-phosphosulfate synthase 1"	O43252	4	107590276-107720452	"Enzymes, Predicted intracellular proteins"		"Kinase, Multifunctional enzyme, Nucleotidyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Ciliated cells: 113.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	6	"basophil: 50.3;eosinophil: 62.2"	"Lineage enriched"	"Detected in all"	6	"granulocytes: 62.2"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA049781	Approved		Approved	"Nucleoplasm,Nucleoli rim,Mitotic chromosome"		Yes	No			"Nucleoli rim, Mitotic chromosome"	Nucleoplasm	"HPA049781: AB_2680879"	"unprognostic (1.36e-2)"	"unprognostic (5.03e-2)"	"prognostic favorable (9.14e-4)"	"prognostic favorable (8.58e-4)"	"unprognostic (1.63e-2)"	"unprognostic (1.08e-1)"	"prognostic unfavorable (2.70e-5)"	"unprognostic (1.58e-2)"	"unprognostic (1.05e-1)"	"unprognostic (8.92e-2)"	"unprognostic (1.42e-1)"	"unprognostic (5.76e-2)"	"unprognostic (6.23e-3)"	"unprognostic (1.29e-1)"	"unprognostic (1.72e-1)"	"unprognostic (1.61e-2)"	"unprognostic (1.38e-1)"	13.5	7.4	24.3	14.4	28.5	11.1	25.2	16.4	32.2	26.6	10.0	45.0	9.4	7.9	25.1	22.8	18.3	24.9	13.3	7.7	31.3	23.9	16.7	5.1	22.0	14.7	29.7	21.9	15.6	24.6	15.6	15.5	8.5	38.2	21.7	12.7	9.5	32.2	14.0	3.3	24.5	8.5	17.0	59.9	9.6	30.4	8.1	25.5	14.7	10.3	11.0	24.6	16.5	13.7	8.5	9.2	62.2	10.2	4.6	6.8	5.8	10.5	9.7	16.4	20.4	20.2	25.5	13.1	13.5	25.4	13.2	17.8	14.8	15.3	16.5	8.6	24.7	10.2	13.3	15.5	26.7	17.1	38.8	11.7	19.3	21.0	33.0	11.1	29.2	33.4	21.1	13.8	15.2	12.5	32.2	29.3	21.1	4.2	32.2	37.0	16.2	23.5	9.0	17.5	11.4	10.8	19.8	25.9	4.7	19.9	14.7	18.6	26.9	14.0	21.1	16.5	21.8	12.5	4.5	17.3	16.6	17.1	11.1	11.3	25.9	17.2	15.4	20.1	22.4	26.0	50.3	8.9	62.2	3.0	9.6	3.5	8.5	4.0	3.4	9.2	4.1	2.5	2.9	9.4	4.6	10.2	1.8	6.8	5.8	24.3	28.5	16.4	32.2	31.3	23.9	29.7	21.9	38.2	25.5	89.3	19.8	21.5	31.5	28.4	13.4	6.5	30.6	113.8	69.4	54.1	9.8	17.1	14.9	29.3	5.2	17.4	7.0	0.0	40.0	37.0	49.8	27.9	41.5	8.1	53.6	28.6	22.5	20.3	50.0	3.7	16.7	46.3	57.3	35.1	18.0	37.3	29.6	7.0	24.1	21.2	13.7	25.8	22.7	16.5	14.3	35.8	7.4	11.8	15.1	20.1
PAPSS2	ATPSK2	ENSG00000198682	"3'-phosphoadenosine 5'-phosphosulfate synthase 2"	O95340	10	87659613-87747705	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		"Kinase, Multifunctional enzyme, Nucleotidyltransferase, Transferase"	"Disease mutation, Dwarfism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adrenal gland: 59.2;liver: 49.0"	"Cell type enhanced"	"Detected in many"	12	"Alveolar cells type 1: 223.4;Enterocytes: 147.6;Hepatocytes: 93.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	4	"intermediate monocyte: 5.3;myeloid DC: 2.7;non-classical monocyte: 9.7"	"Group enriched"	"Detected in many"	7	"dendritic cells: 2.7;monocytes: 9.7"	"Cell line enhanced"	"Detected in many"		"BJ: 35.4;fHDF/TERT166: 89.6;HHSteC: 38.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA071224, HPA075267"	Enhanced		Approved	Mitochondria		No	No			Mitochondria		"HPA071224: AB_2686366, HPA075267: "	"unprognostic (3.98e-3)"	"unprognostic (7.06e-2)"	"unprognostic (4.95e-3)"	"unprognostic (1.02e-1)"	"unprognostic (2.67e-1)"	"unprognostic (1.61e-2)"	"unprognostic (4.96e-2)"	"unprognostic (1.15e-1)"	"prognostic unfavorable (1.33e-6)"	"unprognostic (3.50e-2)"	"prognostic favorable (6.58e-4)"	"unprognostic (1.14e-1)"	"unprognostic (4.90e-2)"	"unprognostic (6.72e-3)"	"unprognostic (1.73e-1)"	"prognostic unfavorable (3.21e-5)"	"unprognostic (3.46e-3)"	16.0	59.2	3.5	18.1	6.0	0.3	18.1	1.9	4.3	8.6	25.5	2.2	1.9	9.2	4.0	7.0	3.7	5.3	10.7	9.1	3.9	2.1	9.9	49.0	31.3	15.6	4.4	1.6	10.8	21.2	0.4	1.7	19.0	5.2	3.8	21.2	6.2	6.2	2.0	4.8	1.7	19.4	5.5	3.4	2.9	2.9	3.6	4.3	0.8	7.3	6.2	11.0	5.7	5.3	0.0	2.7	0.8	9.7	0.0	0.1	0.8	3.5	3.7	1.2	0.0	25.7	32.8	0.0	35.4	30.3	21.6	15.6	0.1	0.7	0.0	1.8	89.6	0.6	1.5	2.6	2.5	24.7	0.0	1.9	1.6	2.6	0.0	38.9	0.0	0.7	11.6	0.0	12.4	1.0	26.0	17.9	0.2	0.0	16.7	15.1	13.5	0.0	0.1	1.4	0.8	4.6	0.0	0.0	0.0	22.5	1.6	0.1	0.3	17.2	0.6	0.2	2.5	2.5	0.9	22.4	7.3	4.3	24.7	2.5	0.0	0.1	0.0	3.5	0.0	0.0	0.0	1.4	0.0	0.0	5.3	0.1	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.8	0.0	9.7	0.0	0.0	0.8	3.5	6.0	1.9	4.3	3.9	2.1	4.4	1.6	5.2	4.3	223.4	31.0	5.2	0.8	2.1	0.0	3.5	5.1	2.7	14.8	8.7	0.0	0.4	11.6	4.4	0.9	11.3	147.6	0.0	25.2	0.6	18.5	2.7	0.0	93.7	11.5	0.0	12.1	28.8	29.3	0.2	16.1	25.7	1.7	1.8	25.6	1.0	24.6	48.9	4.9	8.4	0.0	12.9	11.3	0.4	0.6	1.1	1.1	1.3	42.4	0.9
PARG		ENSG00000227345	"Poly(ADP-ribose) glycohydrolase"	Q86W56	10	49818279-49970203	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"DNA damage"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021819, HPA053007"	Enhanced		Supported	Nucleoplasm,Vesicles,Cytosol		NA	NA			Nucleoplasm	"Vesicles, Cytosol"	"HPA021819: AB_1854974, HPA053007: AB_2682014"	"unprognostic (5.77e-3)"	"unprognostic (6.74e-2)"	"unprognostic (3.06e-2)"	"unprognostic (9.90e-2)"	"unprognostic (1.22e-2)"	"unprognostic (1.33e-1)"	"prognostic unfavorable (5.57e-5)"	"unprognostic (1.21e-1)"	"unprognostic (3.97e-1)"	"unprognostic (8.34e-2)"	"unprognostic (1.47e-1)"	"unprognostic (4.06e-2)"	"unprognostic (5.20e-3)"	"unprognostic (1.14e-1)"	"unprognostic (1.77e-1)"	"unprognostic (8.54e-2)"	"unprognostic (1.13e-1)"	4.0	5.6	4.3	4.2	5.4	1.4	5.3	7.8	6.3	4.8	5.1			6.7	4.9	3.0	6.2	4.3	3.6	6.6	4.6	5.9	9.2	5.2	3.5	5.8	4.5		4.7	3.5	8.1	4.7	5.8		4.9	6.1		4.7	5.1	8.1	6.7	5.1	4.7	4.0	5.9	4.7	5.8			4.9		6.9	4.4	4.8	6.9	7.0	12.5	7.7	8.3	9.4	5.5	12.7	10.6	18.6	13.7	9.0	11.2	13.7	12.7	14.0	14.8	14.2	8.5	11.9	9.6	8.3	10.7	6.6	14.4	15.7	8.0	15.9	14.7	14.6	9.8	8.7	9.3	10.2	14.1	8.2	7.2	15.5	12.4	20.5	10.1	9.0	12.7	16.6	8.5	11.1	7.1	15.5	12.7	18.4	7.8	24.3	18.6	21.2	11.1	11.9	8.2	12.9	16.3	10.3	16.4	13.3	18.8	18.8	7.9	9.1	9.2	11.3	9.6	14.2	9.4	14.0	20.5	15.9	15.0	6.7	12.5	6.2	3.0	5.2	5.5	7.9	6.9	7.1	6.7	7.0	6.9	9.4	9.1	3.0	8.3	7.7	5.4	5.5	5.5											8.9	11.7	8.3	4.6	5.5	13.2	23.8	12.7	29.4	12.5	12.2	25.5	6.5	8.3	6.3	3.5	8.3	8.5	23.3	5.6	5.2	6.7	4.0	13.9	9.6	8.2	4.8	6.3	7.4	13.2	3.3	6.9	7.0	3.3	9.0	8.1	8.9	6.7	2.9	7.8	27.7	20.8	0.0	5.5	15.7	12.1	5.3	3.9	7.5	9.7	3.8
PARK7	"DJ-1, DJ1, GATD2"	ENSG00000116288	"Parkinsonism associated deglycase"	Q99497	1	7954291-7985505	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Autophagy, DNA damage, DNA repair, Fertilization, Inflammatory response, Stress response"	"Chaperone, Hydrolase, Protease, RNA-binding"	"Disease mutation, Neurodegeneration, Parkinson disease, Parkinsonism, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004190, CAB005870"	Supported		Supported	Nucleoplasm,Cytosol		NA	NA		69000000	"Nucleoplasm, Cytosol"		"CAB005870: AB_444361, HPA004190: AB_1079566"	"unprognostic (6.88e-3)"	"unprognostic (7.50e-2)"	"unprognostic (3.48e-2)"	"unprognostic (1.16e-2)"	"unprognostic (4.08e-2)"	"unprognostic (5.68e-2)"	"unprognostic (7.45e-2)"	"unprognostic (9.63e-2)"	"unprognostic (2.01e-1)"	"unprognostic (1.66e-2)"	"unprognostic (1.12e-1)"	"unprognostic (2.02e-1)"	"unprognostic (1.96e-3)"	"unprognostic (8.17e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.30e-1)"	"unprognostic (7.43e-2)"	44.6	67.9	69.3	38.1	64.9	33.7	45.4	57.2	62.7	34.0	36.4	33.4	43.2	27.3	35.8	56.6	40.9	39.0	41.6	71.7	56.9	57.2	60.5	77.1	28.6	46.1	61.6	57.2	45.9	60.4	66.6	48.4	44.6	41.2	44.7	39.5	38.6	46.5	39.4	128.7	19.8	27.5	48.1	52.5	37.5	37.2	38.2	32.2	38.8	71.6	43.3	46.5	41.3	43.4	49.5	141.8	38.8	61.0	52.8	87.2	90.6	68.3	61.6	61.4	70.6	66.1	63.6	30.1	63.7	59.8	62.8	50.7	56.2	75.0	84.8	72.1	68.4	44.1	49.2	66.2	85.2	81.6	75.5	71.6	91.2	92.1	83.3	57.1	87.0	56.2	59.9	36.4	63.9	76.9	49.2	65.7	44.7	88.5	63.2	87.0	64.1	60.5	110.6	50.1	84.9	63.7	46.6	82.5	116.3	98.4	35.2	71.9	60.4	63.7	98.5	99.5	53.8	54.9	64.8	62.3	57.9	46.2	53.4	69.8	61.4	98.5	120.8	76.4	133.2	82.0	22.7	61.0	38.8	52.6	55.4	49.7	49.5	52.7	62.2	73.9	38.6	45.6	52.4	21.0	52.8	44.1	141.8	87.2	90.6	69.3	64.9	57.2	62.7	56.9	57.2	61.6	57.2	41.2	32.2	122.1	136.9	226.3	328.5	185.6	175.5	422.7	221.7	227.5	176.3	235.5	74.6	504.6	721.2	419.3	26.4	207.3	136.6	46.7	416.0	502.3	279.0	413.5	199.9	332.4	385.8	176.4	228.6	156.5	174.9	43.1	331.6	265.8	340.8	806.1	224.5	530.4	359.6	213.9	356.1	742.4	177.0	271.7	346.0	212.8	299.8	125.7	392.7	243.9	261.6	388.0
PARL	"PRO2207, PSARL, PSARL1, RHBDS1"	ENSG00000175193	"Presenilin associated rhomboid like"	Q9H300	3	183829271-183884933	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins, Transporters"		"Hydrolase, Protease, Serine protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											HPA019545	Approved		Approved	Mitochondria		NA	NA			Mitochondria		"HPA019545: AB_1855796"	"unprognostic (2.10e-1)"	"unprognostic (1.53e-3)"	"unprognostic (5.88e-2)"	"unprognostic (1.17e-2)"	"unprognostic (5.76e-2)"	"unprognostic (9.55e-2)"	"unprognostic (3.17e-3)"	"unprognostic (8.97e-2)"	"unprognostic (1.81e-1)"	"unprognostic (3.62e-3)"	"unprognostic (1.52e-1)"	"unprognostic (2.13e-2)"	"unprognostic (4.28e-2)"	"unprognostic (5.49e-2)"	"unprognostic (2.58e-1)"	"unprognostic (1.73e-1)"	"prognostic favorable (9.11e-5)"	24.2	20.6	26.2	19.2	30.1	21.2	30.4	22.1	29.6	22.7	29.0	24.4	19.4	21.5	20.2	43.8	21.4	19.6	21.2	30.9	23.1	23.4	27.0	26.7	20.3	26.5	28.4	20.3	20.3	47.5	22.0	20.6	18.5	19.5	22.1	31.3	25.9	35.1	33.4	41.2	22.3	27.0	38.1	19.4	22.3	24.5	22.2	18.9	22.1	20.7	25.4	24.3	23.2	18.2	21.5	45.4	44.3	50.0	21.5	25.9	35.4	32.6	15.5	11.5	9.8	11.2	12.9	23.9	12.3	16.7	23.7	18.6	47.7	17.1	14.6	27.4	15.6	21.3	14.6	18.3	18.9	26.7	20.7	22.5	22.0	10.4	26.1	16.8	21.8	18.6	17.5	24.3	16.6	20.3	11.2	16.8	23.2	12.5	13.6	19.4	35.4	41.6	53.4	30.9	27.4	15.9	18.4	22.5	26.5	22.1	27.3	11.6	16.5	14.6	47.2	30.0	14.7	48.5	41.4	9.8	8.8	19.2	18.2	31.2	27.4	18.5	33.6	16.9	22.2	10.5	27.6	50.0	44.3	19.0	35.4	21.7	21.5	21.6	22.1	45.4	19.9	25.9	21.1	14.5	21.5	26.2	27.0	24.4	35.4	26.2	30.1	22.1	29.6	23.1	23.4	28.4	20.3	19.5	18.9	20.8	26.1	28.3	47.3	27.0	33.9	33.9	20.4	18.7	15.9	29.6	29.5	49.5	99.5	41.8	15.3	30.4	28.2	0.0	73.6	40.6	37.9	39.4	69.2	28.2	68.8	31.8	32.4	30.1	52.8	7.4	26.7	58.0	40.5	60.5	36.5	35.7	49.3	35.1	25.5	71.7	38.7	6.5	49.1	43.3	46.0	26.2	35.2	38.5	49.1	46.1
PARN	DAN	ENSG00000140694	"Poly(A)-specific ribonuclease"	O95453	16	14435701-14632728	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Nonsense-mediated mRNA decay"	"Exonuclease, Hydrolase, Nuclease, RNA-binding"	"Disease mutation, Dyskeratosis congenita"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Spermatogonia: 62.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006314, CAB011673, HPA012010"	Supported		Supported	"Nuclear speckles"		NA	NA			"Nuclear speckles"		"CAB011673: AB_778216, HPA006314: AB_1079567, HPA012010: AB_1854976"	"unprognostic (2.54e-1)"	"unprognostic (3.43e-2)"	"unprognostic (1.55e-1)"	"unprognostic (2.23e-1)"	"unprognostic (2.28e-1)"	"prognostic unfavorable (4.64e-4)"	"unprognostic (2.99e-3)"	"unprognostic (5.07e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.94e-1)"	"unprognostic (2.16e-3)"	"unprognostic (1.75e-1)"	"unprognostic (1.52e-1)"	"unprognostic (3.25e-2)"	"unprognostic (2.46e-1)"	"unprognostic (3.10e-3)"	"unprognostic (1.09e-2)"	19.4	25.9	14.9	23.5	19.1	12.5	19.8	16.8	23.5	21.3	21.0	22.7	23.3	14.4	24.6	29.0	19.0	19.4	22.5	18.4	15.4	19.0	17.9	18.9	26.7	31.6	22.2	17.9	21.8	22.7	37.4	26.0	21.9	21.0	21.4	21.8	21.0	18.9	31.0	19.2	21.0	18.8	28.7	18.3	20.1	19.6	25.4	19.6	29.4	27.8	14.0	26.8	25.6	19.3	16.1	15.6	13.3	14.8	15.0	17.8	11.0	11.9	14.1	7.4	9.4	12.4	14.3	8.6	10.2	14.3	12.7	12.2	7.8	11.1	21.4	25.9	11.7	9.6	13.0	17.1	11.5	17.6	18.1	10.1	14.7	9.8	17.4	13.0	17.4	14.6	12.9	14.4	11.4	16.3	9.6	8.5	11.9	12.5	12.1	12.3	14.8	17.5	11.3	10.1	9.4	8.5	23.2	16.8	21.5	8.6	8.4	9.3	6.7	20.8	11.3	14.1	10.8	11.9	10.1	7.8	12.4	6.5	6.7	10.4	12.3	13.1	26.1	13.6	12.8	13.6	11.9	11.1	13.3	13.5	14.8	13.9	16.1	13.1	15.5	15.6	13.9	17.8	17.8	7.2	15.0	14.3	10.8	14.7	11.0	14.9	19.1	16.8	23.5	15.4	19.0	22.2	17.9	21.0	19.6	29.8	30.8	16.1	7.2	6.4	12.1	17.3	10.2	29.4	14.8	10.4	7.9	25.3	10.0	12.5	8.9	13.5	10.5	0.0	11.2	19.3	10.4	6.8	2.3	9.9	12.9	7.9	14.3	12.3	13.1	5.8	19.5	11.7	10.1	28.9	14.8	10.0	12.3	12.2	16.6	8.4	9.1	19.4	9.2	30.7	62.8	7.2	18.8	11.3	12.5	3.9
PARP1	"ADPRT, PARP, PPOL"	ENSG00000143799	"Poly(ADP-ribose) polymerase 1"	P09874	1	226360691-226408079	"Cancer-related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"	"DNA damage, DNA repair, Transcription, Transcription regulation"	"DNA-binding, Glycosyltransferase, Transferase"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	5	"Cytotrophoblasts: 400.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB000147, CAB003839, CAB003840, HPA045168, CAB075726, CAB075727"	Supported	Supported	Enhanced	Nucleoplasm,Nucleoli		NA	NA		39000	Nucleoplasm	Nucleoli	"CAB000147: AB_430876, CAB003839: AB_365493, CAB003840: AB_562187, CAB075726: AB_2665732, CAB075727: AB_2665733, HPA045168: AB_2679240"	"unprognostic (2.02e-1)"	"unprognostic (9.40e-2)"	"unprognostic (7.44e-3)"	"unprognostic (1.32e-1)"	"unprognostic (4.29e-1)"	"unprognostic (9.22e-2)"	"prognostic unfavorable (3.40e-4)"	"unprognostic (2.20e-1)"	"unprognostic (3.62e-2)"	"unprognostic (1.39e-1)"	"unprognostic (2.13e-1)"	"unprognostic (1.66e-1)"	"prognostic unfavorable (1.35e-5)"	"unprognostic (2.38e-2)"	"unprognostic (1.82e-1)"	"unprognostic (3.14e-2)"	"unprognostic (2.64e-1)"	17.3	16.6	31.2	35.7	31.2	14.3	15.3	21.1	29.2	14.3	21.8	37.4	10.3	15.0	18.2	13.0	18.1	15.0	10.8	24.2	27.8	21.9	13.4	24.8	14.1	56.3	40.7	21.8	14.6	28.1	62.6	22.9	28.7	30.4	22.0	19.2	16.3	17.0	24.7	47.3	11.7	19.6	25.5	49.1	32.7	15.9	22.5	34.8	29.5	14.5	16.5	70.2	19.9	13.7	53.0	16.5	9.0	17.5	11.1	21.8	11.5	28.9	15.5	43.2	30.6	11.3	9.4	24.6	19.2	17.1	26.1	21.5	24.7	14.2	84.4	28.7	11.6	11.5	21.8	59.4	18.8	23.1	35.4	82.9	32.6	20.7	16.1	6.8	54.2	15.8	9.2	7.5	21.0	14.9	7.3	20.3	19.6	51.9	43.1	13.5	13.8	17.3	19.6	79.5	40.9	30.8	52.5	74.0	78.0	12.2	20.7	43.5	38.1	25.0	28.0	15.7	31.8	23.5	34.0	15.4	13.9	23.0	18.7	35.9	17.6	29.4	72.5	11.6	18.3	31.1	9.0	6.7	6.9	18.3	11.3	21.6	46.8	19.4	18.0	14.3	53.0	15.2	16.4	1.0	11.1	17.5	16.5	21.8	11.5	31.2	31.2	21.1	28.4	27.8	21.9	40.7	21.8	30.4	34.8	50.6	68.3	130.2	75.6	64.2	94.4	106.4	43.3	75.0	97.8	54.1	133.5	400.4	61.3	77.0	28.3	54.0	16.8	23.3	91.9	75.6	55.5	70.8	116.9	65.7	117.1	85.8	72.1	31.9	42.2	16.3	37.2	45.7	59.1	93.8	46.5	78.6	54.3	24.6	32.9	36.1	102.8	45.3	47.4	92.8	211.4	42.0	115.1	74.0	57.9	42.9
PARP10	FLJ14464	ENSG00000178685	"Poly(ADP-ribose) polymerase family member 10"	Q53GL7	8	143977153-144012772	"Enzymes, Predicted intracellular proteins"	"DNA damage, DNA repair"	"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"plasmacytoid DC: 16.4"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Not detected"	"Not detected"							"HPA028122, HPA052427"	Approved		Supported	"Nucleoli rim,Golgi apparatus,Cytosol"		No	No			"Nucleoli rim"	"Golgi apparatus, Cytosol"	"HPA028122: AB_10601979, HPA052427: AB_2681828"	"unprognostic (9.80e-3)"	"unprognostic (5.89e-2)"	"unprognostic (2.63e-3)"	"unprognostic (9.10e-2)"	"unprognostic (1.74e-2)"	"unprognostic (1.46e-2)"	"unprognostic (7.37e-2)"	"unprognostic (3.61e-1)"	"unprognostic (9.05e-2)"	"unprognostic (7.17e-2)"	"unprognostic (1.71e-1)"	"unprognostic (1.05e-1)"	"unprognostic (4.69e-3)"	"unprognostic (1.09e-3)"	"unprognostic (4.17e-2)"	"unprognostic (8.69e-2)"	"unprognostic (5.30e-3)"	14.2	18.8	8.8	27.4	9.5	15.7	18.6	5.3	8.7	14.4	16.5	9.3	20.7	20.5	20.3	18.3	15.8	18.0	21.8	6.4	8.9	4.1	20.5	19.1	21.4	23.6	10.4	6.8	22.4	15.3	9.3	14.2	10.4	9.2	17.7	3.8	12.7	27.7	14.9	12.5	14.3	21.8	9.6	8.9	31.1	13.1	15.8	9.8	27.8	15.4	10.4	21.6	8.8	12.9	2.4	16.4	3.2	2.8	1.9	4.6	2.4	8.4	0.8	0.6	1.5	4.2	3.8	4.6	1.4	1.8	9.5	10.7	0.4	14.8	10.5	20.1	4.5	10.9	3.2	0.2	5.0	0.4	23.6	0.0	11.6	4.9	5.3	4.1	4.5	14.0	2.4	5.0	4.7	1.9	1.0	1.4	15.1	0.2	8.4	1.8	10.3	15.7	7.9	0.5	0.1	6.8	14.7	1.7	14.1	3.9	10.7	0.5	0.5	9.8	1.0	18.6	0.2	11.0	6.8	6.5	4.9	7.4	8.2	5.2	14.3	8.4	2.4	7.1	15.3	2.6	0.0	1.9	3.2	4.6	2.8	3.0	1.2	2.2	3.7	2.3	2.4	1.6	2.3	1.1	1.9	2.7	16.4	1.6	2.4	8.8	9.5	5.3	8.7	8.9	4.1	10.4	6.8	9.2	9.8	3.0	6.9	15.7	7.9	6.8	5.9	2.0	7.6	1.4	1.2	8.7	13.7	1.9	1.7	7.6	4.3	7.1	15.1	0.0	4.9	3.0	6.7	4.0	19.5	19.5	10.9	0.0	18.4	11.1	13.9	5.9	14.7	9.2	6.8	30.7	13.6	11.1	6.5	11.2	10.6	20.3	20.2	6.5	8.9	10.0	1.3	4.1	1.1	20.8	12.7	3.3
PARP11	C12orf6	ENSG00000111224	"Poly(ADP-ribose) polymerase family member 11"	Q9NR21	12	3791047-3873448	"Enzymes, Predicted intracellular proteins"	"Differentiation, mRNA transport, Protein transport, Spermatogenesis, Translocation, Transport"	"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	9	"Early spermatids: 60.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA026895	Uncertain		Supported	"Nucleoplasm,Nuclear bodies,Cytosol"		NA	NA			"Nuclear bodies"	"Nucleoplasm, Cytosol"	"HPA026895: AB_1854980"	"unprognostic (9.58e-2)"	"unprognostic (1.77e-1)"	"unprognostic (1.37e-1)"	"unprognostic (1.80e-1)"	"unprognostic (1.88e-1)"	"unprognostic (4.12e-2)"	"unprognostic (6.14e-2)"	"unprognostic (1.49e-2)"	"unprognostic (2.53e-1)"	"unprognostic (2.61e-1)"	"unprognostic (3.58e-2)"	"unprognostic (2.32e-2)"	"unprognostic (2.50e-1)"	"unprognostic (2.11e-1)"	"unprognostic (7.52e-2)"	"unprognostic (3.81e-2)"	"unprognostic (2.87e-2)"	7.1	14.5	11.2	8.6	9.2	3.7	8.3	11.0	9.1	6.4	5.4	5.6	4.8	4.9	10.2	7.5	5.0	6.3	5.6	5.1	6.1	5.7	5.7	5.7	6.3	12.8	5.0	5.7	13.1	6.6	10.0	10.4	4.1	7.6	12.0	5.7	7.2	6.6	6.0	4.1	3.9	6.5	7.2	6.1	9.2	4.2	12.8	5.6	16.9	12.3	2.7	12.1	8.3	5.8	10.7	10.2	18.3	10.2	8.2	12.5	7.1	2.3	1.9	12.8	2.0	4.1	6.5	3.6	2.8	4.8	5.0	5.0	7.3	1.8	7.0	1.8	6.2	6.3	2.0	4.2	4.2	8.1	14.1	4.2	10.0	0.0	5.4	4.6	6.7	3.8	5.2	3.3	3.9	11.1	0.0	3.7	13.7	2.6	5.7	7.0	3.3	3.5	2.6	4.7	2.4	0.3	7.1	8.7	1.6	2.3	5.3	0.8	2.9	2.8	2.4	3.6	14.6	0.4	6.1	7.2	4.3	4.3	6.6	3.8	2.7	5.9	9.8	4.1	3.7	1.1	18.3	10.2	10.2	9.2	8.5	12.5	10.7	10.2	6.7	10.2	10.1	11.7	9.4	10.2	8.2	6.4	8.9	4.3	7.1	11.2	9.2	11.0	9.1	6.1	5.7	5.0	5.7	7.6	5.6	8.9	7.4	11.8	4.3	1.6	11.1	3.2	2.5	6.7	2.3	1.8	2.0	3.0	0.0	3.1	60.8	4.5	2.1	0.0	2.6	1.5	4.6	8.0	14.9	3.4	6.2	3.2	3.5	8.0	9.1	25.5	9.8	6.9	1.7	3.6	3.7	6.2	2.9	4.2	8.1	3.3	6.9	6.5	5.1	7.5	8.7	1.6	2.2	10.2	4.3	3.4
PARP12	"FLJ22693, PARP-12, ZC3H1, ZC3HDC1"	ENSG00000059378	"Poly(ADP-ribose) polymerase family member 12"	Q9H0J9	7	140023744-140063721	"Enzymes, Plasma proteins, Predicted intracellular proteins"		Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"NB-4: 12.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA003584, HPA063872"	Approved		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA003584: AB_1079568, HPA063872: AB_2685139"	"unprognostic (1.46e-3)"	"unprognostic (2.93e-2)"	"unprognostic (1.73e-1)"	"unprognostic (2.71e-2)"	"unprognostic (6.74e-2)"	"unprognostic (1.42e-1)"	"prognostic unfavorable (1.63e-4)"	"unprognostic (2.30e-2)"	"unprognostic (1.15e-2)"	"unprognostic (4.86e-3)"	"unprognostic (7.51e-3)"	"unprognostic (2.68e-1)"	"prognostic unfavorable (4.12e-7)"	"unprognostic (3.31e-2)"	"unprognostic (2.76e-1)"	"unprognostic (1.75e-2)"	"unprognostic (6.01e-2)"	3.1	1.8	1.0	3.7	0.9	6.1	2.5	0.1	0.7	2.1	2.2			4.2	2.8	4.2	2.1	2.5	3.1	1.7	1.0	1.0	3.1	3.0	5.2	3.8	1.0		3.2	2.7	2.5	3.3	3.4		2.8	3.9		4.3	1.4	0.9	8.6	4.4	1.5	1.3	6.0	2.3	5.7			3.2		2.7	1.9	3.1	1.0	1.3	3.4	2.0	2.3	3.3	2.4	3.7	2.3	0.0	0.4	1.1	0.5	3.9	0.6	0.5	4.7	8.0	2.7	3.5	1.7	2.8	1.1	4.8	3.8	1.5	4.4	1.3	4.7	4.7	1.4	1.4	1.8	2.1	0.4	1.4	1.6	2.6	2.0	4.3	3.3	5.0	2.7	4.1	2.3	0.0	2.9	4.5	12.1	0.2	1.8	7.0	2.0	0.0	0.0	2.1	2.3	1.4	0.0	2.4	1.1	3.5	0.6	0.6	0.9	9.6	1.5	2.2	0.5	3.5	0.1	0.1	0.4	0.9	6.0	0.8	0.7	2.0	2.2	2.9	1.7	1.1	0.3	1.9	2.9	1.3	1.0	0.6	1.9	3.4	2.3	1.9	0.7	3.3	2.4											6.0	11.7	6.0	6.5	5.8	3.0	4.2	10.2	5.3	5.7	10.4	2.0	4.5	1.7	10.9	0.6	11.7	32.5	0.0	22.8	16.4	5.3	10.8	19.6	9.6	21.5	0.0	23.1	6.2	10.2	0.4	6.6	13.9	6.8	12.6	13.2	2.6	27.2	25.9	6.7	5.6	2.2	0.0	5.9	28.7	11.9	8.7	1.7	8.7	8.0	9.2
PARP14	"KIAA1268, pART8"	ENSG00000173193	"Poly(ADP-ribose) polymerase family member 14"	Q460N5	3	122680618-122730840	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Immunity, Innate immunity, Transcription, Transcription regulation"	"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	8	"Alveolar cells type 1: 229.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+ SV40 Large T+: 29.6;BJ hTERT+ SV40 Large T+ RasG12V: 45.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA008846, HPA012063"	Supported		Supported	Cytosol		NA	NA			Cytosol		"HPA008846: AB_1854982, HPA012063: AB_1854981"	"unprognostic (4.38e-2)"	"unprognostic (1.07e-2)"	"unprognostic (1.25e-1)"	"unprognostic (1.95e-2)"	"unprognostic (2.56e-1)"	"unprognostic (2.50e-3)"	"unprognostic (1.87e-1)"	"unprognostic (1.33e-1)"	"unprognostic (1.44e-1)"	"unprognostic (4.20e-2)"	"unprognostic (1.74e-3)"	"unprognostic (1.62e-2)"	"prognostic unfavorable (1.79e-4)"	"unprognostic (7.87e-2)"	"unprognostic (3.82e-2)"	"unprognostic (1.58e-3)"	"unprognostic (1.71e-2)"	21.6	10.3	5.6	15.8	7.2	11.7	9.3	2.3	6.0	11.6	13.3	5.9	6.4	11.4	10.6	12.7	11.7	7.2	10.0	6.5	5.2	4.8	13.7	21.5	26.0	16.7	7.3	5.2	10.0	6.7	7.2	6.8	17.5	6.3	12.3	6.7	7.5	8.5	5.5	5.2	5.7	22.3	11.9	6.8	29.7	7.6	4.6	4.9	18.7	20.4	6.4	18.9	12.8	12.4	15.9	4.2	20.8	10.5	7.4	7.0	2.8	5.9	5.0	3.2	3.4	4.5	10.7	0.0	2.3	15.6	29.6	45.6	2.6	11.9	0.0	9.8	5.2	16.6	4.6	4.6	4.8	6.0	9.1	0.5	5.5	2.3	4.0	10.9	2.4	2.7	6.4	2.4	5.1	2.0	7.2	12.8	4.9	2.6	8.9	1.0	3.1	9.1	1.6	0.4	0.9	4.3	12.8	3.2	1.6	7.2	6.2	0.2	0.0	6.0	1.3	6.7	0.4	2.2	4.3	8.6	1.6	3.9	0.9	2.1	3.5	0.6	1.0	4.8	5.7	2.8	8.3	8.2	4.0	6.9	10.5	6.0	10.2	3.8	4.5	4.2	15.9	3.2	3.4	20.8	7.4	9.3	0.6	7.0	2.8	5.6	7.2	2.3	6.0	5.2	4.8	7.3	5.2	6.3	4.9	229.3	87.3	41.0	15.2	14.9	1.1	10.1	30.6	52.2	84.2	24.4	3.9	12.0	3.3	28.1	0.3	61.9	21.0	0.0	35.6	24.3	19.7	23.9	30.2	29.6	32.4	0.0	10.3	67.5	50.6	0.2	25.9	50.6	15.1	94.6	14.3	18.7	33.8	17.5	16.3	7.0	0.8	12.9	18.4	1.6	1.1	9.3	4.0	27.4	11.0	21.3
PARP15	"FLJ40597, pART7"	ENSG00000173200	"Poly(ADP-ribose) polymerase family member 15"	Q460N3	3	122577602-122639047	"Enzymes, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 22.9;lymphoid tissue: 40.4"	"Group enriched"	"Detected in some"	4	"Alveolar cells type 1: 17.9;Alveolar cells type 2: 12.8;B-cells: 22.9;Ciliated cells: 18.7;granulocytes: 18.5;Hofbauer cells: 6.6;monocytes: 6.4;T-cells: 12.9"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	5	"gdT-cell: 9.3;MAIT T-cell: 6.5;memory B-cell: 11.2;memory CD4 T-cell: 5.0;memory CD8 T-cell: 6.4;naive B-cell: 11.9;naive CD4 T-cell: 4.3;naive CD8 T-cell: 5.9;NK-cell: 5.2;T-reg: 4.5"	"Group enriched"	"Detected in many"	6	"B-cells: 11.9;NK-cells: 5.2;T-cells: 9.3"	"Cell line enhanced"	"Detected in some"		"HEL: 10.6;JURKAT: 6.6;REH: 4.9;THP-1: 5.1;TIME: 12.6"					"Not detected"	"Not detected"			HPA035757			Approved	Mitochondria	"Intracellular and membrane"	NA	NA			Mitochondria		"HPA035757: AB_10669656"	"unprognostic (8.19e-3)"	"unprognostic (2.88e-3)"	"unprognostic (1.12e-1)"	"unprognostic (1.18e-3)"	"unprognostic (1.22e-1)"	"unprognostic (9.01e-5)"	"unprognostic (4.79e-2)"	"unprognostic (1.83e-2)"	"unprognostic (3.91e-2)"	"unprognostic (5.40e-2)"	"unprognostic (1.61e-1)"	"unprognostic (9.63e-2)"	"unprognostic (9.24e-7)"	"unprognostic (9.03e-2)"	"unprognostic (2.07e-2)"	"unprognostic (1.52e-1)"	"unprognostic (1.22e-2)"	2.4	0.9	0.5	24.5	0.4	9.8	1.3	0.3	0.8	1.2	2.8	1.2	0.5	1.0	1.5	2.3	1.9	1.4	2.8	1.5	0.6	0.5	1.5	1.9	5.6	20.3	0.6	0.6	1.1	2.7	0.0	1.0	1.0	0.6	1.3	2.1	1.8	5.5	0.2	2.6	0.7	22.9	0.9	0.9	40.4	1.7	1.7	0.4	9.4	1.9	1.7	34.8	3.6	1.2	11.9	1.2	1.3	0.6	5.2	9.3	2.7	0.6	0.2	0.5	0.5	0.2	0.3	0.6	0.3	0.2	0.1	0.1	0.3	1.0	0.8	0.6	0.2	0.3	0.6	0.1	0.0	0.0	1.9	0.2	10.6	0.8	0.5	0.2	0.7	0.5	2.2	0.1	0.4	0.2	0.4	2.4	6.6	0.3	2.1	0.0	0.5	3.2	0.7	0.7	0.2	0.3	4.9	0.4	0.6	0.0	1.0	0.8	0.5	0.3	0.2	0.3	0.6	0.8	5.1	12.6	0.4	1.1	0.5	0.4	1.0	0.7	2.4	0.7	0.3	0.2	1.3	0.2	0.1	9.3	0.5	6.5	11.2	5.0	6.4	0.9	11.9	4.3	5.9	0.7	5.2	0.6	1.2	4.5	2.7	0.5	0.4	0.3	0.8	0.6	0.5	0.6	0.6	0.6	0.4	17.9	12.8	22.9	0.0	0.5	0.0	0.4	0.0	18.7	3.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	18.5	0.5	6.6	0.0	0.0	2.5	3.5	0.0	0.0	3.2	1.7	6.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.3	0.0	0.2	12.9	0.0	0.0
PARP16	"C15orf30, FLJ20509, FLJ25281, pART15"	ENSG00000138617	"Poly(ADP-ribose) polymerase family member 16"	Q8N5Y8	15	65234460-65300618	"Enzymes, Predicted membrane proteins"	"Unfolded protein response"	"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Rod photoreceptor cells: 31.3;Spermatogonia: 26.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA017081	Approved					NA	NA					"HPA017081: AB_10963218"	"unprognostic (1.17e-2)"	"unprognostic (6.51e-3)"	"unprognostic (2.82e-2)"	"unprognostic (6.37e-2)"	"unprognostic (7.38e-2)"	"unprognostic (2.88e-2)"	"unprognostic (3.05e-2)"	"unprognostic (6.82e-2)"	"unprognostic (2.18e-1)"	"unprognostic (2.70e-1)"	"unprognostic (1.00e-1)"	"unprognostic (1.78e-1)"	"unprognostic (3.41e-3)"	"unprognostic (1.11e-1)"	"unprognostic (2.71e-1)"	"unprognostic (1.01e-1)"	"unprognostic (9.61e-2)"	8.9	14.2	12.0	13.1	11.6	8.0	20.4	32.2	17.7	18.6	12.8	5.6	11.9	9.3	13.1	8.5	10.5	12.0	8.7	7.2	9.7	5.3	9.0	18.1	11.5	14.0	11.5	6.2	17.6	11.3	12.7	8.5	9.2	9.1	11.5	10.4	7.5	10.3	21.4	5.4	10.8	9.7	17.7	8.0	9.3	11.0	7.6	12.0	15.1	9.5	6.3	12.4	14.0	25.6	10.1	4.4	14.1	5.3	10.3	14.2	6.0	3.7	3.8	4.2	6.6	3.5	3.6	1.9	1.7	4.6	4.8	5.0	3.1	3.4	12.1	4.8	2.1	10.3	6.1	19.6	2.4	3.6	4.4	7.8	2.0	4.1	4.3	6.5	5.5	3.8	4.2	4.0	1.2	4.9	7.1	4.4	11.6	5.0	4.6	4.1	4.5	11.4	5.9	2.0	19.3	5.2	21.1	7.7	9.1	3.4	3.4	7.3	4.9	5.3	5.1	4.3	3.5	6.0	5.0	1.8	5.7	4.3	3.2	2.6	8.6	10.1	15.8	4.7	8.2	2.6	14.1	3.3	10.0	11.6	5.3	12.9	7.8	11.2	11.8	4.4	10.1	14.2	10.5	13.0	10.3	5.2	3.9	9.2	6.0	12.0	11.6	32.2	17.7	9.7	5.3	11.5	6.2	9.1	12.0	3.0	1.9	6.6	4.9	4.6	10.8	3.9	7.6	4.0	3.4	3.5	0.0	10.7	0.0	5.2	0.7	3.5	4.0	0.0	7.9	4.2	5.6	2.6	0.0	5.1	3.4	3.2	1.7	1.3	1.8	1.8	9.2	1.8	3.3	4.6	5.2	6.2	3.7	3.4	7.4	3.3	31.3	6.5	4.7	1.6	26.2	3.8	4.6	5.7	6.0	2.4
PARP2	ADPRTL2	ENSG00000129484	"Poly(ADP-ribose) polymerase 2"	Q9UGN5	14	20343582-20357905	"Enzymes, FDA approved drug targets, Predicted intracellular proteins"	"DNA damage, DNA repair"	"DNA-binding, Glycosyltransferase, Transferase"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA052003	Approved		Supported	Nucleoplasm,Nucleoli		NA	NA			Nucleoplasm	Nucleoli	"HPA052003: AB_2681689"	"unprognostic (3.93e-1)"	"unprognostic (7.92e-2)"	"unprognostic (4.12e-1)"	"unprognostic (1.24e-1)"	"unprognostic (3.40e-2)"	"unprognostic (7.30e-2)"	"prognostic unfavorable (6.48e-4)"	"unprognostic (1.97e-2)"	"unprognostic (4.43e-2)"	"unprognostic (9.35e-3)"	"unprognostic (1.44e-2)"	"unprognostic (1.42e-2)"	"unprognostic (3.37e-3)"	"unprognostic (2.83e-1)"	"unprognostic (9.19e-2)"	"unprognostic (1.91e-1)"	"unprognostic (2.89e-2)"	11.5	16.6	23.6	8.9	28.5	20.9	15.2	36.7	31.3	12.0	11.7	16.8	9.3	11.2	18.8	16.8	10.7	14.7	8.9	14.0	19.2	17.8	14.0	15.0	12.0	11.8	16.6	30.8	20.2	11.8	11.6	14.6	11.3	22.1	11.3	12.9	10.8	10.5	12.9	25.9	15.1	10.8	14.6	13.9	11.4	11.6	20.4	17.4	6.0	11.7	13.9	15.2	9.3	10.4	6.7	5.6	1.8	5.0	6.9	12.3	4.9	20.3	14.9	23.0	17.2	7.6	7.3	16.7	22.7	12.4	28.9	35.8	14.1	19.5	15.1	10.3	7.1	25.8	19.2	30.6	10.4	34.2	12.1	14.9	13.8	18.1	23.5	6.8	28.6	7.9	5.0	8.9	18.0	19.9	8.0	14.8	18.5	14.6	20.7	19.8	12.6	14.6	12.3	12.6	23.2	23.3	18.3	31.3	9.8	11.5	10.6	16.0	11.0	25.3	14.1	6.6	15.3	13.0	9.7	10.1	17.6	26.7	12.1	18.4	19.4	24.7	20.1	7.3	12.7	19.5	1.8	5.0	0.5	9.5	4.5	12.3	6.7	8.9	8.3	5.4	4.6	9.6	9.3	0.1	6.9	2.5	5.6	5.2	4.9	23.6	28.5	36.7	31.3	19.2	17.8	16.6	30.8	22.1	17.4	23.8	6.2	10.4	9.3	5.8	26.8	12.3	5.1	36.1	21.6	7.0	11.8	19.1	6.6	10.5	7.3	10.0	3.4	23.3	7.7	17.9	8.4	3.7	8.1	9.6	10.2	28.6	4.6	6.2	4.9	7.3	10.6	6.4	8.5	4.6	4.2	21.9	8.0	5.5	15.9	5.6	21.7	6.5	9.5	17.7	33.3	4.3	12.5	4.4	5.2	4.6
PARP3	"ADPRT3, ADPRTL3, hPARP-3, IRT1, pADPRT-3"	ENSG00000041880	"Poly(ADP-ribose) polymerase family member 3"	Q9Y6F1	3	51942345-51948867	"Enzymes, FDA approved drug targets, Predicted intracellular proteins"	"DNA damage, DNA repair"	"Glycosyltransferase, Transferase"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA020984, HPA067657"	Supported		Supported	"Nucleoplasm,Nuclear bodies"		Yes	No			"Nucleoplasm, Nuclear bodies"		"HPA020984: , HPA067657: AB_2685881"	"prognostic favorable (6.39e-5)"	"unprognostic (1.25e-1)"	"unprognostic (1.54e-2)"	"unprognostic (2.85e-2)"	"unprognostic (7.31e-2)"	"unprognostic (1.56e-1)"	"unprognostic (4.13e-1)"	"unprognostic (3.53e-2)"	"unprognostic (2.26e-1)"	"unprognostic (2.01e-1)"	"unprognostic (7.44e-3)"	"unprognostic (4.30e-1)"	"prognostic favorable (1.25e-8)"	"unprognostic (5.63e-2)"	"unprognostic (1.77e-1)"	"unprognostic (1.40e-2)"	"unprognostic (4.65e-3)"	15.2	29.2	11.2	14.6	17.1	2.8	13.6	5.7	18.8	7.5	17.3	10.6	14.3	26.9	10.3	14.1	10.8	12.1	16.2	12.4	11.6	12.3	17.3	22.3	13.3	9.7	12.0	14.2	8.2	3.9	34.2	9.8	6.2	12.2	12.1	10.7	13.2	14.0	18.1	14.6	6.1	26.3	18.9	8.7	12.8	15.8	4.5	10.2	2.9	17.0	9.6	10.3	15.1	8.9	9.0	2.9	1.7	4.1	6.6	4.9	2.3	5.9	3.3	0.9	9.0	8.7	16.5	2.5	9.8	15.8	12.1	13.6	1.9	15.8	8.1	2.6	16.1	7.0	0.9	2.5	8.8	5.9	19.9	0.6	4.1	6.7	6.3	9.4	2.5	5.7	13.0	5.5	7.7	5.2	18.6	6.0	5.1	1.7	7.7	9.3	1.5	2.2	6.3	1.2	2.0	9.5	3.5	1.5	7.0	7.4	6.5	1.0	3.4	9.9	2.8	5.2	0.7	3.4	2.8	13.6	24.4	5.1	3.6	5.9	11.8	14.3	3.5	15.7	7.4	7.6	0.0	2.6	1.7	3.6	4.1	3.4	9.0	4.2	2.8	2.9	4.3	4.9	4.9	0.1	6.6	2.0	1.2	4.3	2.3	11.2	17.1	5.7	18.8	11.6	12.3	12.0	14.2	12.2	10.2	6.0	10.6	10.1	10.0	2.4	1.7	5.9	12.7	9.4	7.9	0.0	0.0	0.4	6.6	8.8	5.9	3.0	15.8	0.0	5.7	0.3	4.5	3.4	4.6	8.5	3.4	0.0	2.9	1.8	2.2	8.4	4.4	2.9	6.8	6.4	11.0	4.0	7.9	3.5	1.4	16.1	2.1	6.5	6.2	3.2	1.8	1.3	0.5	5.3	11.2	6.4
PARP4	"ADPRTL1, p193, VAULT3, VPARP, VWA5C"	ENSG00000102699	"Poly(ADP-ribose) polymerase family member 4"	Q9UKK3	13	24420926-24512810	"Enzymes, Predicted intracellular proteins"		"Glycosyltransferase, Ribonucleoprotein, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Ciliated cells: 83.0;granulocytes: 92.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA011739	Approved		Supported	Cytosol		Yes	No			Cytosol		"HPA011739: AB_1854986"	"unprognostic (1.61e-1)"	"unprognostic (2.34e-2)"	"unprognostic (1.62e-2)"	"unprognostic (4.35e-2)"	"unprognostic (2.46e-1)"	"unprognostic (1.21e-1)"	"unprognostic (1.20e-1)"	"unprognostic (2.52e-1)"	"unprognostic (2.45e-1)"	"unprognostic (2.02e-2)"	"unprognostic (4.12e-3)"	"unprognostic (2.97e-2)"	"prognostic favorable (1.21e-5)"	"unprognostic (3.23e-2)"	"unprognostic (1.71e-1)"	"unprognostic (3.80e-2)"	"unprognostic (2.84e-3)"	25.3	24.7	6.6	16.7	12.9	11.6	14.6	2.3	7.0	17.8	39.4	16.7	21.6	22.9	19.1	11.2	22.2	14.9	23.8	11.3	7.9	5.6	28.8	17.3	17.8	16.5	14.6	4.4	15.9	15.5	11.2	12.6	14.8	12.5	16.1	24.1	14.0	17.7	30.9	6.5	10.2	49.9	15.5	20.5	28.4	20.4	7.0	12.1	28.8	18.2	11.3	26.2	23.3	13.2	9.0	16.4	26.1	18.6	11.8	12.9	10.6	14.6	13.1	6.4	11.6	17.8	25.4	5.4	17.1	22.4	15.0	13.4	5.3	38.2	11.0	17.1	15.5	16.6	17.1	9.6	17.3	12.3	25.1	6.7	15.7	12.2	12.3	10.2	20.1	15.6	14.6	5.8	12.4	6.6	29.4	24.6	8.6	4.4	4.9	17.7	6.8	12.6	9.7	7.3	34.7	16.2	12.0	12.1	15.4	27.9	30.2	5.9	7.5	12.5	5.0	11.8	8.8	2.5	16.6	34.8	6.8	7.1	8.7	17.4	5.6	6.4	14.5	12.4	10.6	14.8	25.2	12.4	26.1	12.9	15.3	12.9	9.0	10.8	12.8	16.4	5.1	8.1	9.6	14.3	11.8	18.6	6.2	12.7	10.6	6.6	12.9	2.3	7.0	7.9	5.6	14.6	4.4	12.5	12.1	47.6	43.8	12.3	5.6	2.5	6.0	15.5	20.4	83.0	64.8	24.4	2.0	4.6	5.0	20.5	3.5	18.8	54.7	0.0	19.4	7.7	6.9	8.6	92.8	12.9	15.7	1.6	4.7	36.2	23.1	3.1	10.9	25.1	8.5	31.5	26.9	7.0	25.8	48.9	7.8	15.6	6.9	6.5	6.2	2.8	7.2	3.3	1.6	15.2	26.0	14.8
PARP6	pART17	ENSG00000137817	"Poly(ADP-ribose) polymerase family member 6"	Q2NL67	15	72241181-72272999	"Enzymes, Predicted intracellular proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	10	"Late spermatids: 137.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA026991	Approved		Approved	"Plasma membrane"		Yes	No			"Plasma membrane"		"HPA026991: AB_1854989"	"unprognostic (3.88e-2)"	"prognostic favorable (3.17e-5)"	"prognostic unfavorable (3.37e-4)"	"unprognostic (3.36e-1)"	"unprognostic (7.13e-2)"	"unprognostic (3.05e-1)"	"unprognostic (2.37e-2)"	"unprognostic (1.33e-1)"	"unprognostic (2.00e-1)"	"unprognostic (2.64e-1)"	"unprognostic (8.55e-2)"	"unprognostic (6.92e-2)"	"prognostic unfavorable (8.02e-8)"	"unprognostic (6.81e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.45e-1)"	"unprognostic (4.42e-2)"	13.7	16.6	28.0	12.8	32.4	25.1	26.5	46.6	41.2	15.5	16.2	16.9	18.2	14.1	23.3	23.8	14.0	17.0	20.2	18.4	26.1	22.4	14.3	9.0	15.7	16.8	19.9	21.8	26.3	20.9	20.6	30.8	17.0	19.4	19.3	14.3	14.5	21.3	18.8	23.9	20.3	14.4	19.6	14.2	18.2	18.2	25.1	15.8	9.6	21.7	12.5	15.8	16.3	15.8	4.1	4.0	12.1	5.3	4.3	4.3	2.9	7.3	13.2	13.9	18.1	15.0	12.5	11.3	6.3	9.5	10.4	15.4	8.7	13.3	10.0	3.9	9.5	15.3	9.6	15.3	8.5	6.0	11.9	13.8	14.6	23.1	0.1	12.5	7.5	14.0	16.0	21.0	9.7	26.8	16.4	6.9	16.8	7.4	11.6	8.3	13.3	6.4	13.2	6.4	6.1	0.0	11.9	9.9	7.9	9.6	14.5	39.4	20.9	10.5	8.6	17.1	19.3	10.9	8.7	6.5	13.1	12.0	17.0	9.5	13.1	12.0	10.9	9.4	14.7	9.0	1.7	5.3	12.1	3.8	4.4	2.7	3.3	2.7	4.0	4.0	4.1	4.3	3.2	5.7	4.3	4.9	3.1	4.2	2.9	28.0	32.4	46.6	41.2	26.1	22.4	19.9	21.8	19.4	15.8	20.8	20.5	4.7	8.4	12.8	14.0	14.6	0.0	2.7	15.9	8.7	19.6	5.9	6.6	7.3	49.1	9.8	9.2	0.0	11.2	4.3	9.3	7.6	15.1	4.2	8.1	17.5	16.7	7.4	12.4	137.7	11.5	8.2	15.1	6.4	5.3	7.4	8.1	5.8	9.2	10.3	15.1	6.5	9.5	39.0	8.3	13.8	5.4	7.5	5.6	8.3
PARP8	"FLJ21308, pART16"	ENSG00000151883	"Poly(ADP-ribose) polymerase family member 8"	Q8N3A8	5	50665899-50846522	"Enzymes, Predicted intracellular proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	8	"T-cells: 90.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"THP-1: 42.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA049183	Approved		Approved	"Nucleoplasm,Midbody ring,Cytosol"		Yes	No			Nucleoplasm	"Midbody ring, Cytosol"	"HPA049183: AB_2680667"	"unprognostic (1.22e-2)"	"unprognostic (2.53e-1)"	"unprognostic (1.77e-1)"	"unprognostic (1.05e-1)"	"unprognostic (2.12e-1)"	"unprognostic (6.33e-2)"	"unprognostic (8.86e-3)"	"unprognostic (7.27e-2)"	"unprognostic (1.86e-2)"	"unprognostic (8.96e-2)"	"unprognostic (2.85e-1)"	"unprognostic (6.81e-2)"	"unprognostic (9.63e-2)"	"unprognostic (2.84e-2)"	"unprognostic (4.42e-2)"	"unprognostic (4.23e-2)"	"prognostic favorable (1.12e-4)"	6.2	7.8	8.8	17.1	9.5	33.5	5.3	2.4	18.7	5.6	5.5	3.3	0.6	6.8	5.2	5.4	5.2	7.4	12.3	3.6	12.8	8.0	5.8	4.2	10.9	18.2	4.9	11.0	5.9	7.1	9.8	14.4	5.6	5.4	6.1	4.3	4.1	7.6	4.2	1.7	4.2	14.2	5.4	7.0	20.1	10.2	6.4	2.8	9.9	21.9	1.1	12.3	8.8	7.0	7.1	3.9	13.1	5.9	15.5	32.0	9.5	11.6	0.0	5.4	8.6	1.5	2.6	8.6	1.9	7.0	1.9	5.5	0.3	15.4	6.9	8.2	0.2	19.8	5.8	0.9	5.8	4.5	9.7	7.4	5.1	4.7	0.4	2.8	11.9	0.1	3.3	4.9	3.8	2.7	11.6	0.1	10.9	0.7	4.2	2.6	3.8	14.2	15.0	5.8	0.2	2.8	7.2	11.4	7.9	3.5	5.8	6.0	9.3	6.2	10.2	1.6	8.3	0.4	42.0	0.0	0.4	7.3	0.5	5.7	3.1	0.1	13.4	6.5	3.3	7.9	10.3	5.9	13.1	20.6	1.6	32.0	6.0	16.1	23.0	3.9	7.1	10.0	16.7	12.3	15.5	1.1	1.8	9.5	9.5	8.8	9.5	2.4	18.7	12.8	8.0	4.9	11.0	5.4	2.8	29.8	22.6	12.3	4.8	7.1	13.4	4.5	12.7	21.4	21.6	21.0	0.0	17.5	6.6	11.2	19.7	4.5	6.9	0.0	8.8	5.9	9.1	8.6	13.9	3.6	12.9	6.4	14.5	8.6	28.5	11.4	1.1	17.1	8.5	13.6	3.6	0.5	14.3	7.6	2.8	3.7	2.1	6.5	6.9	5.1	5.5	3.4	20.7	90.6	6.5	13.5
PARP9	"BAL, BAL1"	ENSG00000138496	"Poly(ADP-ribose) polymerase family member 9"	Q8IXQ6	3	122527924-122564577	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Antiviral defense, DNA damage, DNA repair, Immunity, Innate immunity"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+ SV40 Large T+: 35.1;BJ hTERT+ SV40 Large T+ RasG12V: 41.9;SK-MEL-30: 32.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA066708			Supported	Nucleoplasm,Mitochondria,Cytosol		NA	NA			"Nucleoplasm, Cytosol"	Mitochondria	"HPA066708: AB_2685707"	"unprognostic (3.06e-2)"	"unprognostic (4.80e-2)"	"unprognostic (1.55e-3)"	"unprognostic (6.70e-3)"	"unprognostic (1.11e-1)"	"unprognostic (6.38e-2)"	"unprognostic (4.73e-3)"	"unprognostic (3.39e-3)"	"unprognostic (1.31e-1)"	"prognostic favorable (6.65e-4)"	"unprognostic (1.00e-3)"	"unprognostic (5.63e-3)"	"unprognostic (1.56e-3)"	"unprognostic (3.06e-2)"	"unprognostic (3.70e-2)"	"unprognostic (9.65e-3)"	"unprognostic (1.56e-2)"	27.1	20.2	8.7	17.2	12.4	9.1	13.8	2.9	13.9	13.1	13.1	9.9	7.4	10.4	23.3	10.1	15.6	12.3	14.9	8.5	7.4	6.0	17.8	38.6	18.9	17.5	8.5	6.0	12.1	14.4	16.0	20.3	11.9	10.3	15.1	10.1	11.5	19.1	6.6	8.6	5.7	21.2	14.8	16.3	27.3	11.1	5.4	10.3	21.8	17.5	9.0	19.1	13.7	9.8	7.3	11.9	38.2	18.0	13.0	10.6	9.1	8.0	2.7	1.0	0.7	6.3	13.0	0.9	2.7	14.7	35.1	41.9	4.2	8.9	1.8	6.0	5.4	22.1	8.9	2.3	4.8	7.3	14.0	1.6	8.7	2.8	2.2	6.7	2.8	5.8	10.6	4.7	5.0	1.2	7.0	7.5	5.6	0.8	7.5	1.4	3.5	8.9	3.5	0.4	1.6	7.6	9.5	9.9	0.6	13.4	4.6	0.6	2.4	7.2	1.2	32.4	0.5	3.8	3.1	4.5	1.5	4.4	0.3	1.6	4.7	2.4	3.3	5.2	3.1	2.7	14.4	12.7	15.3	9.2	17.7	8.6	7.3	9.8	10.3	11.9	5.0	7.5	9.1	38.2	13.0	18.0	1.4	10.6	9.1	8.7	12.4	2.9	13.9	7.4	6.0	8.5	6.0	10.3	10.3	38.7	36.9	16.7	9.4	6.4	0.8	5.2	10.2	61.6	44.3	19.2	0.0	4.3	1.7	24.9	1.3	19.0	15.3	0.0	34.9	16.2	11.4	10.4	9.3	43.1	36.1	0.0	10.3	21.5	31.3	2.6	17.0	29.4	6.8	32.5	9.7	14.7	28.4	7.2	22.6	18.9	0.8	19.4	9.6	1.0	0.9	5.8	1.4	12.7	6.6	15.5
PARS2	DKFZp727A071	ENSG00000162396	"Prolyl-tRNA synthetase 2, mitochondrial"	Q7L3T8	1	54756898-54764514	"Enzymes, Predicted intracellular proteins"	"Protein biosynthesis"	"Aminoacyl-tRNA synthetase, Ligase"	"Disease mutation, Epilepsy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	5	"Spermatogonia: 10.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028308, HPA028314, HPA028518"	Uncertain		Approved	"Nucleoli fibrillar center,Mitochondria"		No	No			"Nucleoli fibrillar center, Mitochondria"		"HPA028308: AB_2672553, HPA028314: AB_10603981, HPA028518: AB_2672653"	"unprognostic (1.95e-1)"	"unprognostic (1.10e-1)"	"prognostic favorable (1.26e-5)"	"unprognostic (1.93e-2)"	"unprognostic (1.19e-2)"	"unprognostic (1.79e-3)"	"prognostic unfavorable (2.34e-4)"	"unprognostic (6.48e-2)"	"unprognostic (2.72e-1)"	"unprognostic (1.14e-1)"	"unprognostic (9.42e-2)"	"unprognostic (1.10e-1)"	"prognostic favorable (1.24e-6)"	"unprognostic (2.72e-2)"	"unprognostic (9.77e-2)"	"unprognostic (1.73e-2)"	"unprognostic (9.64e-2)"	6.8	8.4	4.7	4.0	8.2	0.5	6.2	5.2	7.9	6.5	9.0	9.5	8.3	6.0	7.9	7.5	7.0	10.4	4.1	6.6	6.5	4.4	9.6	11.3	4.1	5.8	4.5	5.3	11.5	13.6	7.0	6.6	5.6	4.9	7.1	8.3	5.0	7.2	6.9	8.7	6.7	5.1	4.9	4.3	4.9	6.2	11.5	9.4	8.7	6.7	5.9	5.2	6.0	5.2	7.3	8.9	5.3	11.6	8.1	10.5	6.0	4.7	7.8	5.1	6.7	6.3	5.4	11.5	4.0	5.0	7.2	5.2	9.0	3.1	8.3	6.4	3.6	10.5	7.6	9.2	6.4	5.4	5.3	8.3	8.0	4.8	6.6	9.8	4.6	2.8	5.8	9.8	9.3	8.4	6.2	5.3	9.2	14.0	1.1	5.4	5.0	6.4	6.1	11.8	9.0	10.1	5.0	10.1	9.6	6.1	3.4	5.3	5.4	5.8	7.7	10.5	10.3	4.4	5.9	2.8	5.4	5.6	7.6	5.0	8.2	6.9	3.3	4.0	5.5	3.1	1.5	6.6	5.3	6.4	9.7	7.6	6.1	7.0	6.8	8.9	7.3	10.5	7.0	0.6	8.1	11.6	7.1	9.3	6.0	4.7	8.2	5.2	7.9	6.5	4.4	4.5	5.3	4.9	9.4	0.0	0.6	0.5	0.9	0.6	2.1	1.0	2.5	0.0	1.2	0.0	0.0	5.8	8.3	3.9	6.5	0.0	1.7	0.0	2.4	4.0	0.6	1.1	0.0	1.9	2.6	4.8	0.0	0.0	1.2	5.3	3.4	0.7	0.0	1.0	2.5	2.8	2.1	0.0	2.8	4.5	1.3	0.0	0.4	8.1	10.4	0.9	2.7	0.0	4.3	0.6
PASK	"KIAA0135, PASKIN, STK37"	ENSG00000115687	"PAS domain containing serine/threonine kinase"	Q96RG2	2	241106099-241150264	"Enzymes, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 24.1;testis: 22.0"	"Cell type enhanced"	"Detected in many"	6	"Ito cells: 27.0;Peritubular cells: 23.0;Rod photoreceptor cells: 17.7"	"Low cancer specificity"	"Detected in all"			"Region enhanced"	"Detected in all"		"basal ganglia: 24.1"	"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"HPA016450, HPA021079"	Uncertain		Supported	Cytosol		NA	NA			Cytosol		"HPA016450: AB_1854992, HPA021079: AB_1854993"	"unprognostic (1.76e-2)"	"unprognostic (1.29e-2)"	"unprognostic (2.84e-1)"	"unprognostic (1.41e-2)"	"unprognostic (1.14e-1)"	"unprognostic (8.99e-6)"	"unprognostic (1.80e-2)"	"unprognostic (1.48e-1)"	"unprognostic (1.60e-3)"	"unprognostic (1.58e-2)"	"unprognostic (1.02e-2)"	"unprognostic (6.35e-2)"	"unprognostic (7.12e-2)"	"unprognostic (1.52e-3)"	"unprognostic (1.68e-1)"	"unprognostic (6.44e-2)"	"unprognostic (4.38e-3)"	1.5	1.1	2.4	10.3	24.1	8.9	3.1	6.3	5.2	2.2	2.1	2.2	2.1	3.8	2.9	6.7	3.1	7.2	3.3	1.1	2.9	2.7	3.7	1.3	3.0	14.5	1.3	1.6	1.9	3.3	4.4	4.9	1.1	3.6	12.1	2.8	4.7	2.7	1.8	2.0	4.9	3.9	1.4	1.6	4.4	3.4	22.0	7.2	9.0	4.8	1.9	9.9	2.7	1.9	7.1	1.1	4.8	1.0	2.7	6.0	3.0	5.0	6.8	9.2	11.6	0.8	1.4	12.3	4.8	1.5	4.5	6.3	5.5	5.1	2.6	1.0	1.1	10.0	12.6	10.4	4.2	3.3	10.6	9.9	7.2	12.6	9.7	0.5	9.8	11.3	0.7	3.3	4.6	1.3	1.9	3.2	11.2	9.3	3.6	3.1	5.7	11.6	10.3	10.2	5.9	4.1	18.5	9.3	3.2	1.7	11.4	16.3	4.9	2.9	5.6	2.1	5.1	4.7	7.1	4.2	6.1	5.6	7.8	6.4	4.8	4.9	12.4	3.8	7.4	5.6	4.8	1.0	0.7	1.7	0.6	1.5	7.1	5.9	5.3	1.1	6.6	3.7	3.9	1.3	2.7	1.0	0.7	6.0	3.0	2.4	24.1	6.3	5.2	2.9	2.7	1.3	1.6	3.6	7.2	3.0	9.3	10.6	1.0	2.4	2.3	2.8	2.5	6.7	1.2	3.5	3.9	0.8	0.0	1.2	7.7	2.4	1.8	0.0	1.8	1.5	0.9	2.5	3.5	1.0	1.6	1.6	0.0	27.0	5.3	2.2	5.5	1.9	11.8	1.0	2.9	1.6	0.6	0.0	23.0	1.0	17.7	0.0	0.3	14.7	12.7	1.3	0.2	13.1	2.7	0.7
PBK	"CT84, FLJ14385, Nori-3, SPK, TOPK"	ENSG00000168078	"PDZ binding kinase"	Q96KB5	8	27809620-27838095	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	7	"lymphoid tissue: 19.4;testis: 67.9"	"Group enriched"	"Detected in many"	4	"Early spermatids: 218.2;Spermatocytes: 187.0"	"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"NK-cell: 2.1;T-reg: 1.6"	"Group enriched"	"Detected in many"	10	"NK-cells: 2.1;T-cells: 1.6"	"Cell line enhanced"	"Detected in many"		"A-431: 61.3"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"HPA005753, HPA050656"	Enhanced	Supported	Approved	Cytosol		NA	Yes			Cytosol		"HPA005753: AB_1855018, HPA050656: AB_2681205"	"unprognostic (7.17e-2)"	"unprognostic (7.21e-3)"	"unprognostic (1.04e-3)"	"unprognostic (2.77e-2)"	"unprognostic (1.50e-1)"	"unprognostic (1.27e-1)"	"prognostic unfavorable (8.29e-5)"	"unprognostic (3.65e-3)"	"unprognostic (7.38e-2)"	"unprognostic (2.88e-3)"	"prognostic unfavorable (6.56e-4)"	"unprognostic (1.20e-1)"	"prognostic unfavorable (1.18e-12)"	"unprognostic (9.61e-2)"	"unprognostic (1.86e-1)"	"unprognostic (8.30e-2)"	"unprognostic (8.68e-2)"	0.6	0.8	0.2	7.7	0.3	3.3	1.3	0.3	0.4	1.1	3.8	0.3	0.2	3.7	0.4	0.6	6.2	0.3	0.8	3.3	0.3	0.2	0.7	0.9	1.2	5.4	0.3	0.2	0.4	0.4	0.0	0.2	2.2	0.3	0.4	4.6	0.2	1.1	0.2	0.4	1.9	3.6	0.9	0.6	1.7	1.7	67.9	0.2	19.4	0.3	4.7	5.3	0.7	1.9	0.1	0.0	0.0	0.0	2.1	1.6	0.5	61.3	20.0	19.7	12.5	1.9	3.5	8.3	28.2	13.4	29.0	24.5	6.9	11.4	32.7	10.0	10.8	32.3	16.3	18.9	9.5	31.9	8.0	10.2	7.8	14.2	10.1	0.1	5.1	11.7	0.9	7.8	13.4	7.2	5.2	14.6	16.2	11.5	22.0	34.2	6.9	19.3	6.0	3.5	16.6	17.4	12.1	27.4	8.8	10.9	9.5	7.8	12.2	10.5	12.4	15.8	5.7	13.0	7.8	8.5	19.1	46.0	24.2	29.9	3.1	8.7	15.1	11.6	9.0	41.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	1.3	0.0	0.1	0.0	0.1	0.0	2.1	0.0	0.0	1.6	0.5	0.2	0.3	0.3	0.4	0.3	0.2	0.3	0.2	0.3	0.2	0.0	0.0	0.0	0.9	7.9	0.0	0.3	5.1	0.0	2.3	0.0	0.0	3.1	0.0	0.5	218.2	0.0	1.3	46.7	0.0	40.6	2.9	0.7	0.0	1.0	4.2	0.0	0.0	7.4	1.9	37.5	7.8	0.6	0.0	0.0	4.3	0.0	0.2	0.0	2.8	0.0	0.0	6.5	0.5	187.0	31.0	2.0	5.6	0.0	5.3	0.7
PC	PCB	ENSG00000173599	"Pyruvate carboxylase"	P11498	11	66848233-66958376	"Citric acid cycle related proteins, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Gluconeogenesis, Lipid biosynthesis, Lipid metabolism"	"Ligase, Multifunctional enzyme"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adipose tissue: 41.1;liver: 76.0"	"Cell type enriched"	"Detected in many"	5	"Hepatocytes: 192.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"dendritic cells: 2.6;monocytes: 3.8;T-cells: 2.9"	"Cell line enhanced"	"Detected in many"		"HeLa: 28.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB033742, HPA043922, HPA058765"	Enhanced		Enhanced	Mitochondria		Yes	No		96000	Mitochondria		"CAB033742: AB_2283532, HPA043922: AB_2678732, HPA058765: AB_2683812"	"unprognostic (2.10e-1)"	"unprognostic (1.51e-1)"	"unprognostic (1.36e-2)"	"unprognostic (8.24e-3)"	"unprognostic (3.67e-1)"	"unprognostic (3.18e-2)"	"unprognostic (2.97e-1)"	"unprognostic (3.00e-1)"	"unprognostic (3.63e-1)"	"prognostic unfavorable (7.86e-5)"	"unprognostic (1.54e-1)"	"unprognostic (1.17e-1)"	"prognostic favorable (8.22e-5)"	"unprognostic (8.58e-3)"	"unprognostic (5.67e-2)"	"unprognostic (9.15e-3)"	"unprognostic (1.05e-1)"	41.1	10.7	11.1	2.8	14.6	3.1	12.9	13.1	14.9	2.4	3.8	10.7	21.4	5.6	2.1	2.4	5.0	2.7	2.9	4.0	11.3	8.9	18.7	76.0	2.1	1.6	15.5	11.5	4.4	4.3	19.4	4.0	4.1	10.9	5.4	3.1	3.4	24.2	24.4	5.7	2.8	6.7	1.8	9.4	1.5	3.3	6.1	13.1	0.6	4.2	2.5	2.5	2.2	2.1	0.6	2.6	0.0	3.8	0.3	2.9	2.0	2.9	9.1	3.4	8.3	13.9	5.5	3.5	1.9	7.9	3.6	3.5	4.5	3.3	0.0	3.8	2.9	4.8	3.9	3.8	21.0	1.1	1.8	5.3	4.5	28.3	17.3	10.9	0.0	5.9	21.0	5.4	2.9	6.6	2.3	2.9	7.9	8.5	0.0	1.2	19.4	5.1	2.4	6.4	7.7	7.6	3.8	7.0	1.8	3.3	0.9	7.4	10.5	17.6	9.4	7.2	2.6	7.7	1.2	3.2	4.0	3.7	4.7	2.1	2.0	2.3	0.0	4.1	2.9	3.4	0.0	3.8	0.0	1.2	0.9	1.4	0.2	0.5	1.9	2.6	0.6	2.9	1.6	0.0	0.3	0.5	1.0	1.5	2.0	11.1	14.6	13.1	13.6	11.3	8.9	15.5	11.5	10.9	13.1	0.0	4.8	2.2	1.1	1.1	4.7	3.7	10.2	0.0	1.2	3.5	2.0	15.6	1.7	3.1	15.2	1.4	18.6	0.0	1.6	3.5	1.9	2.4	9.2	192.6	11.2	0.0	8.6	4.3	6.9	39.9	0.6	1.6	5.0	32.5	4.2	9.2	2.3	7.0	3.9	37.8	4.7	0.0	1.4	6.0	4.2	0.5	21.3	1.3	6.0	1.1
PCBD1	"DCOH, PCBD, PCD"	ENSG00000166228	"Pterin-4 alpha-carbinolamine dehydratase 1"	P61457	10	70882280-70888784	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Tetrahydrobiopterin biosynthesis, Transcription, Transcription regulation"	"Activator, Lyase"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 99.0"	"Cell type enhanced"	"Detected in all"	7	"Hepatocytes: 577.2;Proximal tubular cells: 733.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"CACO-2: 67.0;Hep G2: 65.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037575, HPA061723"	Enhanced		Enhanced	Nucleoplasm,Cytosol		NA	NA		210000	Nucleoplasm	Cytosol	"HPA037575: AB_10671761, HPA061723: AB_2684594"	"unprognostic (1.02e-1)"	"unprognostic (5.05e-2)"	"unprognostic (7.43e-2)"	"unprognostic (3.69e-1)"	"unprognostic (5.39e-2)"	"unprognostic (4.80e-3)"	"unprognostic (1.81e-1)"	"unprognostic (1.47e-1)"	"unprognostic (2.35e-1)"	"unprognostic (2.40e-2)"	"unprognostic (2.95e-1)"	"unprognostic (5.63e-2)"	"unprognostic (3.38e-2)"	"unprognostic (9.26e-2)"	"unprognostic (1.74e-1)"	"unprognostic (5.76e-2)"	"unprognostic (7.43e-3)"	18.3	25.5	18.1	9.6	15.6	4.3	19.7	13.2	14.8	13.9	18.4	7.8	24.3	12.6	13.9	21.4	26.5	25.6	22.9	32.5	10.8	23.7	38.7	99.0	14.0	7.8	16.7	12.3	18.5	73.0	15.8	15.5	11.7	16.4	26.9	20.3	16.3	16.2	20.7	23.1	5.8	17.2	18.1	14.5	10.2	19.2	7.0	8.7	4.3	36.8	16.2	12.3	22.4	31.8	11.8	20.9	3.5	19.4	8.0	16.9	7.5	20.2	48.2	2.9	29.9	10.9	10.2	3.9	6.6	10.9	10.2	8.2	67.0	36.0	4.1	19.1	7.2	7.9	13.5	18.2	10.5	7.0	10.9	32.8	3.6	7.7	65.8	11.5	3.6	13.5	10.0	11.5	10.1	4.8	15.5	27.4	2.6	7.1	0.3	7.1	33.9	0.4	12.1	4.0	54.9	45.1	1.9	4.0	13.3	42.9	21.0	12.6	21.4	5.4	37.3	14.2	8.4	10.8	7.0	11.3	1.7	14.3	2.5	16.0	0.1	0.8	0.1	9.3	11.8	2.6	0.0	10.7	3.5	8.8	19.4	6.9	11.8	11.6	12.6	20.9	4.1	3.8	7.9	0.6	8.0	13.3	15.3	16.9	7.5	18.1	15.6	13.2	14.8	10.8	23.7	16.7	12.3	16.4	8.7	38.7	59.6	41.0	140.4	44.3	32.7	140.4	142.7	72.3	73.9	177.9	5.9	105.7	384.7	161.2	1.3	33.8	116.6	23.3	147.5	63.7	71.1	169.6	31.1	577.2	160.3	33.4	169.3	32.5	54.4	5.8	62.5	71.4	74.2	90.2	228.3	70.5	157.8	147.3	89.8	733.2	28.5	84.1	57.7	4.9	7.9	40.0	64.9	33.8	199.7	158.3
PCBD2	"DCOH2, DCOHM"	ENSG00000132570	"Pterin-4 alpha-carbinolamine dehydratase 2"	Q9H0N5	5	134904906-135007959	"Enzymes, Predicted intracellular proteins"	"Tetrahydrobiopterin biosynthesis"	Lyase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 47.0"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA036428	Uncertain		Approved	"Plasma membrane"		NA	NA			"Plasma membrane"		"HPA036428: AB_10670103"	"unprognostic (3.70e-2)"	"unprognostic (3.53e-2)"	"unprognostic (3.54e-3)"	"unprognostic (1.36e-2)"	"unprognostic (2.92e-1)"	"unprognostic (1.98e-1)"	"unprognostic (4.22e-1)"	"unprognostic (6.43e-2)"	"unprognostic (4.49e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.22e-1)"	"unprognostic (5.18e-2)"	"unprognostic (1.87e-3)"	"unprognostic (4.57e-2)"	"unprognostic (6.34e-2)"	"unprognostic (9.32e-3)"	"unprognostic (1.50e-1)"	4.9	8.1	5.4	7.0	6.6	6.6	5.3	3.0	4.4	3.9	8.7	6.5	9.4	8.0	6.5	8.4	9.3	4.9	6.9	13.8	5.0	5.3	9.2	9.8	6.5	5.0	5.6	5.2	5.1	12.9	9.6	6.1	4.8	6.8	4.7	6.4	9.6	14.2	7.9	47.0	6.7	12.7	7.6	7.0	5.5	7.1	5.5	5.8	5.3	8.3	13.5	8.1	5.6	5.5	8.2	11.5	7.2	10.1	6.3	6.6	4.3	7.8	7.6	8.1	6.1	5.6	4.8	6.0	6.3	4.9	3.6	3.6	14.2	20.1	9.4	10.6	4.2	7.1	5.3	5.5	6.0	3.3	13.1	3.7	5.3	8.1	8.5	5.4	6.1	3.8	2.6	5.9	3.7	8.7	4.2	4.2	7.3	7.7	14.1	6.3	16.1	6.4	10.4	4.5	10.8	7.4	10.2	7.6	8.3	6.6	6.7	6.1	8.0	9.4	4.9	7.8	7.1	13.7	8.1	4.6	6.9	5.2	6.1	8.0	11.0	15.0	6.4	6.2	7.5	4.5	2.7	10.1	7.2	5.1	6.3	5.0	8.2	6.3	5.3	8.6	8.2	5.4	5.3	3.3	6.3	6.1	11.5	6.6	4.3	5.4	6.6	3.0	4.1	5.0	5.3	5.6	5.2	6.8	5.8	8.9	6.4	4.5	5.6	3.2	12.0	29.7	17.8	10.7	3.4	15.7	11.8	10.5	18.3	14.5	5.4	8.4	17.2	46.7	15.8	21.0	4.9	6.2	5.8	21.7	21.4	22.3	4.1	6.7	5.9	2.5	6.6	9.5	5.0	31.5	8.4	13.5	15.4	3.5	2.1	21.4	46.7	0.0	5.3	5.6	10.4	5.3	8.5	7.5	15.8	7.2
PCCA		ENSG00000175198	"Propionyl-CoA carboxylase alpha subunit"	P05165	13	100089015-100530437	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Lipid degradation, Lipid metabolism"	Ligase	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"epididymis: 106.7"	"Cell type enhanced"	"Detected in many"	6	"Distal tubular cells: 84.6;Proximal tubular cells: 63.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"RPTEC TERT1: 54.3;SCLC-21H: 30.1;U-937: 41.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041716, HPA047792"	Enhanced		Supported	Mitochondria		NA	NA		120000	Mitochondria		"HPA041716: AB_2677635, HPA047792: AB_2680156"	"unprognostic (1.18e-1)"	"unprognostic (2.13e-1)"	"unprognostic (1.97e-2)"	"unprognostic (4.71e-2)"	"unprognostic (1.11e-2)"	"unprognostic (1.71e-2)"	"unprognostic (1.55e-1)"	"unprognostic (5.90e-3)"	"unprognostic (2.41e-1)"	"unprognostic (1.55e-1)"	"unprognostic (6.14e-2)"	"unprognostic (1.42e-1)"	"prognostic favorable (0.00e+0)"	"unprognostic (7.08e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.18e-1)"	"unprognostic (9.32e-2)"	15.6	26.2	9.7	11.3	11.1	3.2	12.0	24.0	10.7	12.0	17.5	12.0	14.3	6.7	16.4	106.7	8.8	8.4	7.6	12.4	9.5	7.5	51.3	44.3	8.1	4.0	11.2	8.2	9.7	12.7	5.5	12.4	10.5	12.6	13.1	13.7	11.7	12.2	10.4	10.7	7.7	7.8	17.0	12.0	8.2	16.1	4.7	10.9	4.2	11.9	5.0	6.9	10.8	8.8	3.7	13.0	1.6	10.8	7.3	6.1	4.7	3.3	5.9	9.8	3.2	9.4	8.2	5.5	3.3	5.0	3.1	2.9	7.3	4.5	0.2	5.1	3.2	4.0	3.8	2.9	4.6	5.1	5.5	3.2	7.7	4.2	15.8	5.2	0.3	3.7	7.5	5.0	2.9	4.8	7.6	6.4	4.2	3.0	4.4	5.6	3.6	0.8	17.3	6.1	11.8	2.6	6.7	4.2	5.4	54.3	6.6	30.1	3.6	2.2	12.6	5.5	11.1	9.1	13.7	4.6	3.2	2.7	2.2	2.3	4.3	3.9	0.1	6.1	41.9	2.2	1.5	8.5	1.6	4.6	10.3	6.1	3.7	3.0	4.3	13.0	2.6	4.1	5.1	1.3	7.3	10.8	1.1	6.0	4.7	9.7	11.1	24.0	10.7	9.5	7.5	11.2	8.2	12.6	10.9	3.0	8.3	7.3	25.7	1.6	15.4	8.7	38.2	10.7	10.3	19.2	27.5	21.2	84.6	13.8	14.8	9.9	14.0	0.0	7.3	5.4	7.1	14.3	13.9	41.9	10.3	27.0	3.5	11.6	10.2	7.9	8.1	7.2	5.0	2.8	10.1	10.4	6.2	14.0	12.7	63.9	32.3	12.9	8.9	4.8	4.3	3.3	25.3	4.9	26.5	19.5
PCCB		ENSG00000114054	"Propionyl-CoA carboxylase beta subunit"	P05166	3	136250306-136337896	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		Ligase	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 80.2"	"Cell type enhanced"	"Detected in all"	12	"Early spermatids: 317.0;Late spermatids: 128.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036939, HPA036940"	Enhanced				"Intracellular and membrane"	NA	NA		79000			"HPA036939: AB_10671366, HPA036940: AB_10669779"	"unprognostic (2.74e-1)"	"unprognostic (7.88e-3)"	"unprognostic (3.99e-2)"	"unprognostic (2.89e-2)"	"unprognostic (2.75e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.05e-2)"	"unprognostic (1.50e-1)"	"unprognostic (2.31e-2)"	"unprognostic (2.47e-2)"	"unprognostic (1.74e-1)"	"unprognostic (1.05e-1)"	"prognostic favorable (6.47e-7)"	"unprognostic (2.43e-2)"	"unprognostic (2.64e-1)"	"unprognostic (3.50e-1)"	"unprognostic (4.13e-1)"	13.0	46.0	14.3	7.7	16.3	12.7	11.8	7.8	19.2	8.1	17.5	21.0	11.6	15.3	7.1	6.4	11.8	8.1	12.5	36.7	14.1	12.6	36.0	80.2	7.7	8.7	18.9	16.4	6.8	20.8	16.2	9.6	10.0	22.3	10.2	17.6	10.0	10.9	10.6	30.5	8.0	11.1	14.1	18.6	7.9	11.5	17.6	15.5	6.3	15.7	12.4	8.1	9.6	6.6	12.4	24.6	3.9	16.6	12.8	14.9	11.5	19.8	14.2	13.7	20.5	10.4	11.5	24.2	10.5	11.4	16.0	22.6	21.1	14.1	24.8	29.3	14.8	14.3	11.1	16.0	14.1	24.3	14.8	13.6	43.5	16.8	31.8	22.2	33.4	19.4	13.6	13.5	10.1	23.1	10.3	17.9	41.8	31.6	13.3	12.2	37.9	33.0	19.6	11.5	30.5	12.9	9.2	11.3	35.5	29.3	21.8	27.3	20.3	26.5	15.8	24.1	12.9	31.3	19.9	13.4	8.0	8.6	22.4	9.2	25.4	21.0	20.7	11.4	13.0	9.3	2.8	16.2	3.9	13.2	16.6	14.9	12.4	8.8	13.6	24.6	10.2	9.0	11.1	1.4	12.8	14.6	21.2	7.9	11.5	14.3	16.3	7.8	19.2	14.1	12.6	18.9	16.4	22.3	15.5	8.9	9.4	10.0	7.3	3.7	15.1	45.4	12.7	18.7	11.4	19.2	9.8	51.9	33.2	19.9	317.0	6.0	14.4	23.3	12.5	19.8	10.3	9.0	28.8	63.8	31.1	11.1	8.7	8.6	13.1	128.9	12.7	15.4	18.6	24.4	12.7	10.3	14.9	14.8	10.3	71.0	13.1	12.9	8.3	10.9	28.8	2.9	42.6	9.6	21.7	8.9
PCK1	PEPCK-C	ENSG00000124253	"Phosphoenolpyruvate carboxykinase 1"	P35558	20	57561080-57568112	"Citric acid cycle related proteins, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	Gluconeogenesis	"Decarboxylase, Kinase, Lyase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	6	"liver: 419.5"	"Cell type enhanced"	"Detected in many"	24	"Distal tubular cells: 499.0;Enterocytes: 868.1;Hepatocytes: 756.2;Proximal tubular cells: 2559.6"	"Cancer enriched"	"Detected in many"	5	"liver cancer: 99.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	10	"ASC diff: 22.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA006277, HPA006507, CAB017027"	Approved					NA	NA		380000			"CAB017027: , HPA006277: AB_1079579, HPA006507: AB_1079578"	"unprognostic (3.50e-2)"	"unprognostic (5.60e-2)"	"unprognostic (4.60e-2)"	"unprognostic (8.62e-3)"	"unprognostic (1.99e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.21e-2)"	"unprognostic (4.43e-2)"		"unprognostic (1.84e-1)"	"unprognostic (2.37e-1)"	"unprognostic (1.64e-1)"	"prognostic favorable (1.47e-5)"	"unprognostic (1.03e-1)"	"unprognostic (6.40e-2)"	"unprognostic (1.05e-3)"	"unprognostic (2.21e-1)"	10.0	0.1	0.4	2.2	0.4	0.0	11.1	0.2	0.6	0.1	52.0	0.2	0.1	19.2	0.1	0.7	0.2	0.1	5.6	0.4	0.3	0.2	72.0	419.5	0.2	0.3	0.2	0.2	0.4	0.2	0.0	5.0	0.1	0.5	0.2	14.0	0.2	0.2	0.1	0.3	0.1	58.5	0.4	0.1	0.1	0.1	0.2	0.2	0.1	0.4	0.4	0.3	0.4	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	22.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.4	0.3	0.0	0.0	0.1	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	2.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.4	0.2	0.6	0.3	0.2	0.2	0.2	0.5	0.2	0.0	0.0	9.5	0.0	0.1	0.2	0.3	30.6	0.0	1.2	85.5	0.0	0.0	499.0	0.3	0.0	0.1	868.1	0.0	0.0	0.0	0.2	0.0	9.2	756.2	0.0	3.2	51.8	23.4	17.7	0.0	0.0	0.0	0.0	0.0	182.0	8.0	0.1	241.9	0.0	2559.6	0.2	0.0	2.1	0.0	0.0	0.3	0.2	8.5	181.4	0.0
PCK2	"PEPCK, PEPCK2"	ENSG00000100889	"Phosphoenolpyruvate carboxykinase 2, mitochondrial"	Q16822	14	24094053-24110598	"Citric acid cycle related proteins, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	Gluconeogenesis	"Decarboxylase, Lyase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	5	"intestine: 156.3;liver: 115.1"	"Cell type enhanced"	"Detected in many"	11	"Enterocytes: 152.4;Hepatocytes: 291.7;Proximal tubular cells: 166.4"	"Cancer enhanced"	"Detected in all"		"liver cancer: 91.3"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HHSteC: 35.3;hTCEpi: 34.3;SK-MEL-30: 32.5"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"CAB018734, HPA051162, HPA053502"	Enhanced		Enhanced	Mitochondria		NA	NA		3300000	Mitochondria		"CAB018734: AB_2160168, HPA051162: AB_2681368, HPA053502: AB_2682171"	"unprognostic (3.38e-2)"	"unprognostic (1.13e-1)"	"unprognostic (1.50e-2)"	"unprognostic (4.07e-1)"	"unprognostic (3.11e-1)"	"unprognostic (2.10e-1)"	"prognostic favorable (2.81e-4)"	"unprognostic (3.91e-2)"	"unprognostic (1.04e-1)"	"unprognostic (2.18e-2)"	"unprognostic (1.26e-1)"	"unprognostic (3.67e-2)"	"unprognostic (1.33e-2)"	"unprognostic (2.81e-1)"	"unprognostic (3.71e-1)"	"unprognostic (2.82e-2)"	"unprognostic (1.17e-1)"	8.2	2.5	1.0	4.9	1.9	1.0	4.3	1.3	1.3	1.3	69.7	1.4	6.9	51.8	1.3	8.5	4.5	1.2	4.2	2.6	1.5	1.0	26.4	115.1	6.0	4.4	1.7	1.2	1.8	8.5	3.4	1.7	1.2	1.8	2.0	5.4	1.9	11.5	4.9	1.0	2.7	156.3	1.1	1.7	6.7	3.3	3.9	1.3	1.3	5.8	1.9	4.6	2.8	1.9	8.8	10.8	2.4	15.1	1.5	6.5	3.9	5.5	3.1	0.9	5.9	3.7	3.7	15.0	6.9	8.3	5.8	9.4	5.1	6.4	14.1	0.8	10.6	1.9	8.1	6.0	8.9	4.8	7.2	0.2	2.5	1.7	27.5	35.3	4.9	11.1	4.3	34.3	3.6	8.9	1.6	4.6	16.4	7.2	26.1	2.2	23.9	1.2	2.5	1.0	12.5	4.2	2.8	3.4	8.0	1.7	8.6	3.7	5.9	5.3	6.8	32.5	0.9	9.2	7.6	0.8	1.2	6.7	1.8	1.9	17.9	5.6	3.5	3.5	7.7	3.1	0.1	8.2	2.4	3.1	15.1	3.4	8.8	3.5	3.5	10.8	6.1	2.2	2.0	1.0	1.5	14.4	1.9	6.5	3.9	1.0	1.9	1.3	1.3	1.5	1.0	1.7	1.2	1.8	1.3	11.9	22.0	24.4	8.8	3.0	4.1	1.2	20.4	2.7	3.4	17.4	0.0	3.4	29.9	17.2	49.9	3.5	152.4	0.0	67.0	11.6	5.3	6.8	1.1	291.7	56.2	0.0	8.7	10.4	15.0	15.5	3.1	14.5	6.8	29.7	43.0	5.6	27.0	63.4	2.8	166.4	5.4	0.0	5.1	8.6	0.9	4.3	2.5	9.6	63.5	11.9
PCMT1		ENSG00000120265	"Protein-L-isoaspartate (D-aspartate) O-methyltransferase"	P22061	6	149749443-149811420	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"		"Methyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	9	"Early spermatids: 968.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003239	Approved		Supported	Cytosol		No	No		8200000	Cytosol		"HPA003239: AB_1079580"	"prognostic unfavorable (4.02e-7)"	"prognostic unfavorable (9.58e-4)"	"unprognostic (1.35e-2)"	"prognostic unfavorable (4.27e-4)"	"unprognostic (1.02e-1)"	"prognostic unfavorable (1.88e-4)"	"prognostic unfavorable (2.58e-4)"	"unprognostic (1.91e-2)"	"unprognostic (1.58e-2)"	"unprognostic (9.02e-2)"	"unprognostic (6.45e-2)"	"unprognostic (6.77e-2)"	"unprognostic (6.14e-2)"	"unprognostic (4.38e-1)"	"unprognostic (1.70e-1)"	"unprognostic (2.17e-2)"	"prognostic unfavorable (6.38e-4)"	19.1	18.4	35.7	13.0	43.0	28.5	19.3	33.5	58.3	20.2	16.9	19.2	12.4	14.7	16.0	22.2	17.9	15.8	11.0	43.9	35.0	38.8	21.3	29.5	15.1	14.6	35.1	46.0	16.2	14.6	16.4	15.5	17.2	57.4	22.1	18.1	11.6	17.2	21.4	69.5	14.7	13.6	19.6	28.6	12.0	12.7	29.1	19.2	18.1	19.3	15.9	17.9	14.4	13.7	31.6	53.0	51.2	58.0	30.0	37.4	51.6	21.8	17.3	17.7	22.1	38.1	31.5	19.7	35.9	20.5	28.5	36.1	50.2	16.7	27.6	30.5	30.3	33.9	27.2	30.4	35.8	41.2	19.2	44.0	42.2	32.5	49.0	25.5	50.2	51.9	15.7	26.5	32.5	35.2	20.6	26.9	23.4	60.3	27.1	34.0	65.0	24.3	38.3	14.4	21.5	19.4	20.2	23.0	19.9	27.7	16.1	33.8	13.0	27.2	43.5	23.3	22.7	26.3	35.8	20.0	16.8	21.4	31.9	38.9	17.1	26.6	28.2	26.5	33.6	33.4	40.0	58.0	51.2	30.2	53.6	30.1	31.6	30.6	32.7	53.0	24.2	28.5	32.5	30.8	30.0	52.2	23.9	37.4	51.6	35.7	43.0	33.5	58.3	35.0	38.8	35.1	46.0	57.4	19.2	50.6	33.8	61.0	64.4	155.6	73.9	150.1	58.6	62.9	33.0	75.0	35.3	145.0	66.3	107.5	968.1	68.2	50.9	46.7	96.6	180.3	97.5	60.4	104.1	112.2	107.3	62.0	53.0	50.3	78.3	318.9	66.4	94.5	131.6	139.7	62.0	111.0	87.2	56.9	69.3	69.4	50.7	109.9	107.2	205.7	85.4	137.8	124.0	71.9	52.4	51.7
PCSK1	"NEC1, PC1, PC3, SPC3"	ENSG00000175426	"Proprotein convertase subtilisin/kexin type 1"	P29120	5	96390415-96434143	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins"		"Hydrolase, Protease, Serine protease"	"Disease mutation, Obesity"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 36.6"	"Cell type enriched"	"Detected in some"	39	"Intestinal endocrine cells: 215.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in single"		"basophil: 1.8"	"Lineage enhanced"	"Detected in single"		"granulocytes: 1.8"	"Group enriched"	"Detected in some"	5	"SCLC-21H: 19.0;U-138 MG: 16.1;U-87 MG: 13.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA048564, HPA079656"	Approved				"Secreted in other tissues"	NA	NA					"HPA048564: AB_2680444, HPA079656: "	"unprognostic (1.86e-2)"	"unprognostic (2.13e-2)"	"unprognostic (4.66e-3)"	"unprognostic (8.20e-5)"	"prognostic unfavorable (9.13e-5)"	"unprognostic (8.47e-4)"	"unprognostic (1.46e-1)"	"unprognostic (5.84e-3)"	"unprognostic (4.71e-1)"	"unprognostic (3.07e-3)"	"unprognostic (1.89e-3)"	"unprognostic (1.01e-1)"	"unprognostic (7.90e-6)"	"unprognostic (5.25e-2)"	"unprognostic (9.96e-2)"	"unprognostic (1.33e-3)"	"unprognostic (9.37e-3)"	2.3	8.5	1.3	6.0	10.1	0.5	1.3	0.5	36.6	1.2	3.3	0.5	0.0	6.7	0.5	8.8	0.4	0.4	0.6	1.0	2.8	27.1	0.5	0.4	0.8	0.4	3.1	14.0	0.6	9.8	0.3	10.9	0.4	7.5	0.5	3.3	0.1	2.8	0.5	0.5	1.7	4.6	1.0	1.3	0.5	8.4	0.5	0.4	0.0	1.9	0.0	0.3	0.9	0.6	0.0	0.0	1.8	0.5	0.0	0.0	0.0	0.0	0.0	0.3	0.0	2.0	0.6	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.8	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.6	2.1	0.0	0.0	0.0	0.0	1.7	0.9	0.3	0.1	0.1	0.8	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	19.0	0.0	2.7	0.0	0.0	0.4	0.0	0.0	1.0	16.1	0.5	0.2	0.1	0.0	0.0	0.1	13.4	0.0	0.3	1.8	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	10.1	0.5	36.6	2.8	27.1	3.1	14.0	7.5	0.4	0.0	0.0	0.0	0.1	0.0	5.5	0.6	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	215.9	0.6	0.0	0.4	0.0	0.0	0.0	0.0	0.6	0.1	2.4	0.0	0.0	0.0	0.7	0.0	0.7	0.0	0.0	0.0	0.1	0.0	0.2	0.0
PCSK2	"NEC2, PC2, SPC2"	ENSG00000125851	"Proprotein convertase subtilisin/kexin type 2"	P16519	20	17226107-17484578	"Enzymes, Predicted intracellular proteins, Predicted secreted proteins"		"Hydrolase, Protease, Serine protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adrenal gland: 35.0;thyroid gland: 79.5"	"Cell type enhanced"	"Detected in many"	26	"Horizontal cells: 125.5;Melanocytes: 199.1;Muller glia cells: 518.9"	"Group enriched"	"Detected in many"	6	"pancreatic cancer: 14.6;thyroid cancer: 65.1"	"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	22	"basophil: 2.2"	"Lineage enriched"	"Detected in single"	22	"granulocytes: 2.2"	"Group enriched"	"Detected in some"	5	"AF22: 36.7;SCLC-21H: 9.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA049627	Approved		Approved	Vesicles	"Secreted in other tissues"	NA	NA			Vesicles		"HPA049627: AB_2680835"	"unprognostic (2.03e-3)"	"unprognostic (1.61e-1)"	"unprognostic (3.13e-1)"	"unprognostic (2.18e-1)"	"unprognostic (2.13e-1)"	"unprognostic (6.84e-2)"		"unprognostic (3.07e-3)"	"unprognostic (4.31e-1)"	"unprognostic (5.88e-2)"	"unprognostic (2.50e-3)"	"unprognostic (2.14e-1)"	"unprognostic (7.26e-5)"	"unprognostic (2.29e-1)"	"unprognostic (1.57e-1)"	"unprognostic (2.35e-1)"	"unprognostic (1.14e-1)"	1.6	35.0	16.3	1.7	20.5	1.3	1.3	7.7	27.8	2.9	4.2	1.6	0.0	6.2	0.9	1.2	2.1	2.0	1.4	3.1	18.0	11.1	1.1	1.0	2.2	0.8	4.1	16.2	11.6	23.7	0.9	1.7	1.5	9.0	1.3	2.8	16.6	2.7	2.3	1.0	16.6	3.3	1.3	5.4	0.9	11.9	4.7	3.8	0.0	79.5	0.0	0.9	1.9	1.8	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	36.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	4.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.7	0.1	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.1	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	16.3	20.5	7.7	27.8	18.0	11.1	4.1	16.2	9.0	3.8	0.0	5.3	0.0	0.0	7.2	27.6	0.9	0.0	0.0	1.2	0.0	5.9	0.0	0.0	0.0	76.9	0.6	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	125.5	0.0	8.0	0.0	2.7	2.6	0.2	199.1	0.0	0.0	518.9	4.6	0.0	0.0	0.0	11.5	0.0	1.0	0.5	0.2	1.3	0.0	0.0	0.0	0.1
PCSK4	"DKFZp434B217, MGC34749, PC4, SPC5"	ENSG00000115257	"Proprotein convertase subtilisin/kexin type 4"	Q6UW60	19	1481428-1490752	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"		"Hydrolase, Protease, Serine protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	12	"testis: 50.7"	"Group enriched"	"Detected in many"	5	"Early spermatids: 214.2;Late spermatids: 528.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"naive CD4 T-cell: 1.2;plasmacytoid DC: 1.7"	"Group enriched"	"Detected in many"	4	"dendritic cells: 1.7;T-cells: 1.2"	"Cell line enhanced"	"Detected in some"		"AN3-CA: 9.7;HMC-1: 5.2;JURKAT: 7.4;U-266/70: 10.7"	"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			HPA005572	Uncertain					NA	NA					"HPA005572: AB_1855087"	"unprognostic (1.00e-2)"	"unprognostic (9.12e-2)"	"unprognostic (2.36e-3)"	"prognostic favorable (9.45e-5)"	"unprognostic (5.23e-2)"	"unprognostic (6.14e-2)"	"unprognostic (1.78e-1)"	"unprognostic (6.34e-3)"	"unprognostic (2.94e-1)"	"unprognostic (8.29e-3)"	"unprognostic (1.93e-2)"	"unprognostic (7.44e-2)"	"unprognostic (6.56e-2)"	"unprognostic (3.82e-2)"	"unprognostic (1.71e-2)"	"unprognostic (3.57e-2)"	"unprognostic (7.03e-2)"	0.5	1.2	2.5	0.6	3.4	0.9	0.7	0.6	1.8	1.2	0.9	1.8	2.5	2.5	0.8	2.2	0.7	4.2	1.0	0.4	2.5	2.1	1.7	2.0	0.8	0.6	1.0	2.0	0.8	3.8	1.4	4.2	0.5	2.3	1.2	0.4	2.4	1.3	2.4	0.5	0.8	1.1	0.6	1.2	0.7	1.2	50.7	1.8	1.2	2.0	0.0	0.4	0.7	0.6	0.0	1.7	0.0	0.3	0.0	1.2	0.1	0.8	0.5	1.7	9.7	0.2	0.3	2.6	0.7	0.2	0.1	0.3	0.9	1.4	0.0	1.0	0.0	0.0	1.0	0.0	0.0	0.0	0.6	0.2	0.4	1.4	1.3	0.6	0.0	5.2	0.8	0.0	0.0	0.1	0.4	0.2	7.4	1.6	2.5	0.0	0.0	0.2	0.4	0.1	0.4	0.5	1.7	0.1	0.2	0.6	0.0	0.0	2.0	0.2	0.4	0.1	0.6	3.5	0.5	0.0	0.8	0.1	0.2	0.0	10.7	1.9	0.3	0.5	0.9	0.4	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.5	0.2	0.0	0.0	1.2	0.1	0.0	0.0	0.0	1.7	0.0	0.1	2.5	3.4	0.6	1.8	2.5	2.1	1.0	2.0	2.3	1.8	0.0	0.6	0.0	1.0	0.6	1.3	1.1	0.0	4.0	4.5	0.0	7.9	0.4	5.0	1.3	214.2	0.4	2.1	0.0	0.9	0.3	0.2	0.5	0.0	3.2	0.6	3.2	0.0	0.0	0.0	528.7	5.8	0.0	3.3	0.0	1.2	2.3	0.9	0.0	4.9	1.4	9.8	0.0	0.0	80.2	9.6	0.0	0.2	0.0	2.0	0.7
PCSK5	"PC5, PC6, SPC6"	ENSG00000099139	"Proprotein convertase subtilisin/kexin type 5"	Q92824	9	75890644-76362339	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"	Pregnancy	"Hydrolase, Protease, Serine protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	5	"blood: 157.6;intestine: 71.5"	"Cell type enhanced"	"Detected in many"	6	"Enterocytes: 67.7;Horizontal cells: 52.4;Muller glia cells: 43.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	7	"basophil: 157.6;neutrophil: 57.4"	"Lineage enriched"	"Detected in all"	12	"granulocytes: 157.6"	"Cell line enhanced"	"Detected in many"		"BEWO: 15.9;HaCaT: 22.2;RH-30: 14.7;RPTEC TERT1: 20.6;U-2 OS: 32.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA031072	Approved		Supported	"Golgi apparatus"	"Secreted to blood"	NA	NA			"Golgi apparatus"		"HPA031072: AB_10602190"	"unprognostic (3.28e-2)"	"unprognostic (1.44e-1)"	"unprognostic (4.13e-4)"	"unprognostic (4.08e-2)"	"unprognostic (7.43e-3)"	"unprognostic (3.17e-1)"	"unprognostic (2.07e-3)"	"unprognostic (9.39e-2)"	"unprognostic (1.15e-1)"	"unprognostic (5.92e-2)"	"unprognostic (2.81e-2)"	"unprognostic (6.80e-2)"	"prognostic unfavorable (9.61e-5)"	"unprognostic (2.99e-1)"	"unprognostic (3.21e-2)"	"unprognostic (3.22e-2)"	"unprognostic (1.77e-5)"	15.8	3.8	2.9	13.7	2.8	1.5	9.5	2.4	3.2	8.5	51.8	2.9	4.5	19.7	6.5	13.9	9.6	7.8	22.9	6.7	3.8	2.4	3.7	1.9	7.7	5.6	2.3	3.1	17.2	3.4	9.5	3.2	7.7	3.5	4.5	6.7	3.3	5.0	5.8	4.0	4.8	71.5	6.9	3.5	2.5	3.3	5.1	2.4	18.0	6.4	14.2	4.5	7.1	11.4	11.7	12.2	157.6	4.4	12.6	12.7	0.8	1.1	0.8	2.4	1.6	1.5	0.5	15.9	2.2	0.2	0.1	0.0	8.4	0.9	0.3	0.6	0.3	0.0	22.2	1.1	0.6	0.1	0.2	1.9	2.9	1.6	0.7	0.4	0.8	1.3	3.0	0.2	0.5	0.2	0.1	4.6	1.5	3.3	1.0	1.6	5.3	3.3	5.0	10.8	1.9	0.9	0.6	14.7	0.9	20.6	1.2	0.2	0.2	3.3	0.7	0.2	4.8	1.2	3.6	3.6	0.7	32.2	1.8	0.9	0.2	0.1	0.4	2.5	1.2	12.2	157.6	4.2	16.2	9.7	2.3	8.3	8.8	9.8	8.9	1.9	11.7	9.9	12.7	57.4	12.6	4.4	12.2	8.4	0.8	2.9	2.8	2.4	3.2	3.8	2.4	2.3	3.1	3.5	2.4	6.0	4.5	0.0	4.1	5.8	4.4	3.7	10.2	17.4	20.5	5.2	0.0	1.4	0.0	5.2	19.6	8.9	67.7	0.0	5.4	25.1	17.5	1.4	0.0	0.9	2.8	52.4	1.2	14.1	4.0	31.4	19.0	3.4	1.7	3.6	8.8	43.7	7.8	17.5	23.7	3.3	1.2	19.4	8.2	1.1	1.5	2.6	2.1	6.4	16.1	0.7
PCSK6	"PACE4, SPC4"	ENSG00000140479	"Proprotein convertase subtilisin/kexin type 6"	P29122	15	101297142-101525202	"Enzymes, Predicted intracellular proteins, Predicted secreted proteins"		"Hydrolase, Protease, Serine protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 69.3;liver: 76.0;lymphoid tissue: 37.4"	"Group enriched"	"Detected in many"	9	"Hepatocytes: 210.8;Horizontal cells: 185.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"NK-cell: 7.5"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"BEWO: 24.9;CACO-2: 17.4;HEK 293: 26.1;Hep G2: 23.3;OE19: 31.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA004774	Uncertain				"Secreted to extracellular matrix"	NA	NA		38000			"HPA004774: AB_1079583"	"prognostic favorable (9.99e-4)"	"unprognostic (1.09e-1)"	"unprognostic (4.37e-2)"	"unprognostic (2.46e-2)"	"unprognostic (9.83e-2)"	"unprognostic (8.14e-2)"	"unprognostic (2.20e-3)"	"unprognostic (8.56e-2)"	"unprognostic (2.16e-1)"	"unprognostic (2.39e-2)"	"unprognostic (3.85e-3)"	"unprognostic (2.01e-1)"	"prognostic unfavorable (7.06e-7)"	"unprognostic (2.02e-1)"	"unprognostic (1.87e-1)"	"unprognostic (1.15e-1)"	"unprognostic (1.03e-2)"	3.0	1.5	5.1	1.5	25.1	0.9	6.1	4.5	11.5	1.5	8.4	41.9	0.0	3.6	1.4	2.5	4.8	1.9	1.9	10.1	8.9	5.7	1.7	76.0	2.3	4.6	38.8	8.4	4.0	1.7	0.5	3.1	16.5	29.0	1.9	8.2	0.7	1.5	0.7	3.5	4.0	4.8	1.9	69.3	37.4	5.3	6.6	24.5	3.7	1.4	3.5	1.3	1.6	1.6	2.6	0.7	1.9	2.4	7.5	1.4	2.5	8.1	6.7	1.2	0.8	0.0	0.1	24.9	0.5	1.3	0.0	0.1	17.4	3.8	0.1	1.1	0.2	0.5	5.6	6.7	0.7	0.1	1.2	26.1	14.3	3.4	23.3	0.8	2.0	0.3	0.4	4.6	0.1	0.2	0.1	0.0	1.8	11.0	0.2	0.0	3.9	0.1	1.8	3.5	31.6	2.9	0.1	0.2	1.8	2.2	11.6	3.4	3.6	11.5	0.8	3.7	3.8	0.9	9.1	0.1	0.1	0.7	0.2	0.0	0.3	0.3	0.3	0.1	0.3	3.3	1.3	0.6	1.9	0.6	0.8	0.7	1.1	1.0	0.5	0.2	2.6	1.4	1.3	1.1	7.5	2.4	0.7	0.2	2.5	5.1	25.1	4.5	10.4	8.9	5.7	38.8	8.4	29.0	24.5	3.0	1.1	0.8	0.2	0.3	1.9	1.5	7.6	1.4	1.2	1.8	19.6	5.6	0.0	0.4	1.3	4.3	5.1	0.0	0.7	21.0	2.8	0.8	0.0	210.8	1.3	185.9	0.0	19.6	6.3	2.2	9.8	0.3	0.0	0.0	4.1	1.5	5.2	7.0	0.0	0.0	1.5	0.0	0.9	4.2	2.1	0.1	2.7	1.5	4.5	0.1
PCSK7	"LPC, PC7, PC8, SPC7"	ENSG00000160613	"Proprotein convertase subtilisin/kexin type 7"	Q16549	11	117204337-117232525	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"		"Hydrolase, Protease, Serine protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Cone photoreceptor cells: 231.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA						"unprognostic (7.11e-2)"	"unprognostic (2.90e-2)"	"unprognostic (8.33e-3)"	"unprognostic (4.24e-2)"	"unprognostic (1.32e-1)"	"unprognostic (2.77e-2)"	"unprognostic (1.56e-1)"	"unprognostic (2.60e-1)"	"unprognostic (1.96e-1)"	"unprognostic (2.41e-1)"	"unprognostic (8.80e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.02e-1)"	"unprognostic (1.51e-1)"	"unprognostic (1.06e-1)"	"unprognostic (1.00e-1)"	"unprognostic (3.03e-2)"	19.4	11.6	11.9	28.7	13.9	11.3	14.4	12.9	16.5	15.0	44.8	15.4	13.4	20.4	47.9	9.4	27.3	23.9	20.7	12.2	10.4	5.2	9.9	11.5	14.5	19.7	18.7	14.1	11.5	14.9	6.2	12.8	18.3	13.3	24.0	17.7	9.6	14.1	11.4	12.8	11.4	20.3	9.2	9.7	16.8	28.4	6.3	13.9	17.8	10.4	13.7	25.3	34.6	13.0	12.7	4.2	4.2	5.3	19.6	19.7	8.7	5.6	10.6	8.7	8.1	9.6	7.3	7.2	22.2	9.1	10.2	9.8	23.8	34.8	9.0	22.2	15.9	12.5	19.9	9.8	13.2	6.4	14.0	9.1	13.4	15.4	7.0	11.5	8.5	21.5	13.9	8.2	13.7	9.2	12.0	17.5	10.8	8.3	8.2	14.3	8.2	11.3	9.8	7.3	26.1	10.4	8.3	7.1	11.4	12.3	13.7	11.4	13.7	16.2	21.0	3.0	15.7	13.0	7.7	16.2	24.4	8.1	13.7	14.6	5.6	3.4	5.7	7.9	12.3	14.6	3.9	3.3	4.2	19.5	4.7	16.4	12.7	15.2	17.8	3.7	9.6	11.0	12.7	2.8	19.6	5.3	4.2	19.7	8.7	11.9	13.9	12.9	16.5	10.4	5.2	18.7	14.1	13.3	13.9	44.7	45.9	100.9	39.4	62.3	108.5	5.6	35.7	10.7	37.5	45.4	231.7	39.5	5.0	25.4	4.9	36.5	104.5	0.0	47.7	31.2	39.3	31.0	32.4	24.3	28.3	82.6	60.0	73.1	48.0	4.8	31.1	49.7	50.6	28.9	75.0	24.9	52.6	133.5	37.4	5.9	164.4	71.1	70.4	43.5	23.2	82.4	52.3	171.5	88.7	50.6
PCSK9	"FH3, HCHOLA3, NARC-1"	ENSG00000169174	"Proprotein convertase subtilisin/kexin type 9"	Q8NBP7	1	55039548-55064852	"Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted secreted proteins"	"Apoptosis, Cholesterol metabolism, Lipid metabolism, Steroid metabolism, Sterol metabolism"	"Hydrolase, Protease, Serine protease"	"Disease mutation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"liver: 47.1;lung: 14.6"	"Cell type enhanced"	"Detected in some"	13	"Alveolar cells type 1: 14.9;Alveolar cells type 2: 15.3;Hepatocytes: 17.0"	"Low cancer specificity"	"Detected in many"			"Group enriched"	"Detected in some"	9	"cerebellum: 6.9;pons and medulla: 2.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A-431: 29.1;CACO-2: 13.5;HaCaT: 38.9;HeLa: 33.9;RPTEC TERT1: 19.2"	"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"								"Secreted to blood"	NA	NA	143000000	300000000				"unprognostic (1.28e-3)"	"unprognostic (6.93e-2)"	"unprognostic (4.02e-1)"	"unprognostic (2.19e-2)"	"unprognostic (7.30e-2)"	"unprognostic (1.82e-1)"	"unprognostic (1.20e-3)"	"unprognostic (1.14e-2)"	"unprognostic (5.44e-3)"	"unprognostic (1.22e-2)"	"unprognostic (2.09e-3)"	"unprognostic (3.70e-2)"	"unprognostic (2.45e-4)"	"unprognostic (1.49e-1)"	"unprognostic (1.86e-1)"	"unprognostic (2.13e-1)"	"prognostic unfavorable (2.40e-4)"	0.2	0.1	0.0	6.1	0.5	0.4	0.0	6.9	0.2	0.6	4.4	0.0	0.0	3.9	0.2	0.7	5.2	0.4	2.6	0.0	0.0	0.0	0.1	47.1	14.6	0.0	0.1	0.0	0.1	11.0	0.0	0.0	0.0	2.6	0.0	1.9	0.1	0.3	0.3	0.0	0.8	5.1	0.8	0.1	0.2	1.0	0.4	0.0	0.0	0.0	6.1	0.9	0.6	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	29.1	6.5	0.9	0.0	2.1	1.5	0.1	0.0	0.0	0.0	0.0	13.5	4.6	0.0	5.3	2.5	0.1	38.9	1.1	11.8	0.0	0.0	0.0	0.0	33.9	9.4	0.7	0.0	0.0	2.3	8.8	8.5	6.2	0.0	0.0	0.0	3.7	0.0	0.0	0.0	0.0	0.0	5.5	0.5	0.7	0.0	0.0	0.3	19.2	0.0	0.5	0.0	3.8	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	6.9	0.2	0.0	0.0	0.1	0.0	2.6	0.0	14.9	15.3	0.0	0.0	0.5	0.0	0.6	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.3	0.2	0.0	0.5	0.0	1.3	0.0	0.4	0.1	0.0	17.0	0.1	0.0	4.1	1.8	1.6	0.2	0.0	0.0	1.7	0.0	2.2	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.6	0.5	0.0	0.0	2.9	0.2
PCYOX1	"KIAA0908, PCL1"	ENSG00000116005	"Prenylcysteine oxidase 1"	Q9UHG3	2	70257386-70281191	"Enzymes, Plasma proteins, Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	4	"Alveolar cells type 1: 556.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"ASC diff: 80.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA035193	Approved				"Intracellular and membrane"	NA	NA		480000000			"HPA035193: AB_10602017"	"unprognostic (1.09e-1)"	"unprognostic (1.72e-2)"	"unprognostic (7.91e-2)"	"unprognostic (1.15e-2)"	"unprognostic (1.44e-1)"	"unprognostic (2.05e-1)"	"unprognostic (6.87e-2)"	"unprognostic (6.28e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.80e-1)"	"unprognostic (1.61e-1)"	"unprognostic (4.38e-2)"	"prognostic favorable (1.89e-4)"	"unprognostic (3.26e-2)"	"unprognostic (1.55e-1)"	"unprognostic (1.13e-1)"	"unprognostic (1.54e-2)"	36.6	20.6	12.9	13.5	17.0	2.1	21.7	12.5	19.7	32.2	20.1	13.2	27.2	12.9	31.3	26.5	24.5	23.0	26.5	22.5	12.3	24.1	48.9	53.3	29.2	10.6	14.9	17.4	22.1	12.9	47.7	29.8	18.8	23.2	24.2	12.8	30.5	55.8	31.4	42.0	17.2	18.3	24.6	13.8	10.8	17.3	11.3	10.8	5.0	31.8	22.8	13.7	24.5	23.1	4.6	8.4	13.5	7.2	6.6	13.4	6.8	9.2	13.4	10.8	12.0	80.3	41.4	9.5	15.9	14.7	8.9	6.7	21.0	8.3	0.9	6.9	21.7	14.6	15.3	7.8	12.3	10.2	5.3	6.6	3.5	10.5	18.2	8.0	3.3	3.2	39.7	13.6	11.8	3.3	23.7	10.5	3.4	6.3	6.9	12.5	5.6	2.4	5.4	6.5	13.5	5.7	4.7	22.5	8.2	12.6	10.4	2.8	6.0	23.9	11.8	11.1	16.0	9.6	4.3	13.0	15.0	8.4	13.2	8.2	5.7	12.8	1.2	18.0	4.6	5.4	13.5	7.2	7.4	10.0	6.3	12.5	4.6	9.8	8.1	6.7	3.7	13.4	11.2	5.0	6.6	6.4	8.4	8.6	6.8	12.9	17.0	12.5	19.7	12.3	24.1	14.9	17.4	23.2	10.8	556.9	69.3	10.4	20.6	18.9	44.9	69.0	38.2	22.7	48.9	50.6	41.2	33.8	6.6	21.9	1.4	32.9	23.0	0.0	8.9	29.3	41.9	33.6	9.3	137.7	18.8	54.0	8.2	36.2	16.7	2.0	82.6	10.9	23.6	5.4	24.2	94.5	14.0	26.9	113.5	50.9	29.8	71.1	35.0	4.9	30.4	24.7	18.4	11.7	20.7	15.9
PCYT1A	"CT, CTPCT, PCYT1"	ENSG00000161217	"Phosphate cytidylyltransferase 1, choline, alpha"	P49585	3	196214222-196287957	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism"	"Nucleotidyltransferase, Transferase"	"Cone-rod dystrophy, Disease mutation, Dwarfism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"EFO-21: 73.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA035428	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA035428: AB_10602045"	"unprognostic (8.58e-3)"	"unprognostic (2.63e-1)"	"unprognostic (8.45e-2)"	"unprognostic (8.61e-3)"	"unprognostic (2.87e-1)"	"unprognostic (1.85e-1)"	"prognostic unfavorable (8.65e-5)"	"unprognostic (8.52e-2)"	"unprognostic (5.99e-2)"	"unprognostic (1.65e-2)"	"unprognostic (6.72e-3)"	"unprognostic (1.74e-2)"	"unprognostic (1.10e-1)"	"unprognostic (2.11e-1)"	"unprognostic (1.47e-2)"	"unprognostic (7.16e-3)"	"unprognostic (2.41e-2)"	24.8	22.2	15.3	19.9	18.7	25.8	18.0	14.2	17.8	13.6	25.3	23.0	21.1	41.1	18.2	18.7	25.2	15.0	19.8	36.0	14.8	13.8	20.2	17.8	18.7	15.6	16.6	14.1	15.6	13.9	16.0	12.1	14.2	20.5	13.3	16.5	14.4	17.1	19.2	45.8	32.8	37.2	19.5	18.3	23.4	18.1	19.4	18.6	13.2	14.8	28.0	19.0	17.6	16.7	7.8	8.7	20.5	9.8	7.9	13.5	4.6	28.7	11.6	8.1	11.9	16.7	18.6	12.3	22.0	15.7	18.9	16.7	28.3	10.5	7.4	73.8	25.2	19.9	22.5	12.9	16.9	16.2	13.4	9.0	21.2	12.2	12.0	15.0	10.2	18.2	15.7	13.0	18.3	13.1	12.2	20.2	6.9	11.8	16.5	18.8	24.3	6.4	5.4	7.0	18.1	17.3	10.6	10.4	11.9	11.6	16.2	8.0	5.9	14.9	25.7	14.3	11.8	37.7	12.8	30.2	15.1	8.4	20.5	29.7	15.3	29.1	13.6	23.1	14.3	18.9	7.5	8.7	9.2	9.6	9.2	8.0	7.8	7.2	10.2	8.7	5.7	4.6	6.8	20.5	7.9	9.8	5.6	13.5	4.6	15.3	18.7	14.2	17.8	14.8	13.8	16.6	14.1	20.5	18.6	14.9	18.8	17.9	8.2	12.9	14.3	58.5	17.8	33.5	15.9	14.0	23.6	10.4	11.6	21.4	63.4	19.5	43.0	0.0	19.9	14.2	13.7	9.7	19.7	31.7	32.6	7.9	21.2	25.2	28.9	52.1	18.4	30.0	18.6	33.3	20.4	11.8	20.8	14.8	26.5	19.4	12.4	25.8	13.7	30.0	10.6	18.7	15.6	22.7	20.5	11.0
PCYT1B	"CCT-beta, CTB"	ENSG00000102230	"Phosphate cytidylyltransferase 1, choline, beta"	Q9Y5K3	X	24558087-24672677	"Enzymes, Predicted intracellular proteins"	"Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism"	"Nucleotidyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 23.9;testis: 15.6"	"Group enriched"	"Detected in some"	6	"Early spermatids: 21.7;Late spermatids: 58.8;Muller glia cells: 30.2"	"Cancer enhanced"	"Detected in some"		"glioma: 4.4"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"basophil: 2.7;neutrophil: 2.2"	"Lineage enriched"	"Detected in single"	4	"granulocytes: 2.7"	"Cell line enhanced"	"Detected in some"		"AF22: 8.3;CACO-2: 17.8;HEL: 21.9;Hep G2: 9.1;NTERA-2: 9.4;SCLC-21H: 6.5;SuSa: 7.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA006367	Uncertain					NA	NA					"HPA006367: AB_1079585"	"unprognostic (4.49e-1)"	"unprognostic (2.20e-1)"	"unprognostic (1.16e-1)"	"unprognostic (7.39e-2)"	"unprognostic (9.88e-2)"	"unprognostic (6.83e-2)"	"unprognostic (5.05e-2)"	"unprognostic (2.92e-1)"	"unprognostic (1.61e-2)"	"unprognostic (1.67e-1)"	"unprognostic (1.65e-2)"	"unprognostic (5.64e-2)"	"unprognostic (2.63e-6)"	"unprognostic (2.62e-4)"	"unprognostic (4.56e-2)"	"unprognostic (1.75e-2)"	"unprognostic (1.96e-4)"	0.8	1.1	12.0	1.1	11.4	2.0	1.0	3.1	23.9	1.6	1.1	13.7	2.3	1.3	3.2	1.7	2.8	5.7	1.7	4.2	10.0	6.0	1.0	0.6	2.1	0.6	7.8	10.5	4.0	3.1	0.7	1.4	3.6	10.7	2.3	1.3	2.1	1.0	6.4	0.7	0.7	1.1	6.1	10.3	1.0	0.9	15.6	8.7	0.0	0.6	0.0	0.7	0.9	0.4	0.4	0.5	2.7	0.5	0.6	0.2	1.4	0.0	0.0	8.3	0.0	0.0	0.0	0.0	0.0	0.8	0.2	0.1	17.8	0.0	0.0	4.7	0.0	0.0	0.9	3.9	0.0	0.0	0.0	0.1	21.9	0.0	9.1	0.1	0.0	0.4	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	3.2	0.5	9.4	0.0	0.0	0.0	1.1	0.0	0.0	0.0	6.5	5.2	0.0	0.0	0.4	7.1	0.1	0.0	0.0	0.0	0.3	0.0	0.5	0.2	0.0	0.0	4.3	0.6	0.2	2.7	0.3	0.3	0.2	0.1	0.1	0.1	0.1	0.1	0.2	0.4	0.2	0.2	2.2	0.6	0.5	0.5	0.2	1.4	12.0	11.4	3.1	11.3	10.0	6.0	7.8	10.5	10.7	8.7	0.0	0.0	0.0	0.0	0.0	0.2	1.2	0.0	6.7	1.2	0.0	0.0	0.1	0.0	0.7	21.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	4.6	0.0	0.0	0.0	1.7	0.0	0.0	58.8	0.3	0.0	0.0	0.0	0.0	30.2	0.3	0.0	2.5	0.0	1.2	0.0	0.2	0.4	0.5	0.0	0.0	0.0	0.0	0.0
PCYT2	ET	ENSG00000185813	"Phosphate cytidylyltransferase 2, ethanolamine"	Q99447	17	81900965-81911464	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism"	"Nucleotidyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 70.8"	"Group enriched"	"Detected in many"	11	"Early spermatids: 615.4;Late spermatids: 2143.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"Hep G2: 61.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023033, HPA023034"	Enhanced		Approved	Nucleoplasm,Cytosol		NA	NA		7000	Cytosol	Nucleoplasm	"HPA023033: AB_1855094, HPA023034: AB_1855095"	"unprognostic (4.05e-3)"	"unprognostic (4.39e-3)"	"unprognostic (3.81e-1)"	"unprognostic (9.72e-2)"	"unprognostic (1.92e-1)"	"unprognostic (9.86e-2)"	"unprognostic (1.24e-2)"	"unprognostic (1.06e-1)"	"unprognostic (4.24e-1)"	"unprognostic (8.97e-3)"	"unprognostic (1.84e-1)"	"unprognostic (2.34e-1)"	"prognostic favorable (4.29e-6)"	"unprognostic (1.19e-1)"	"unprognostic (8.59e-2)"	"unprognostic (1.63e-1)"	"unprognostic (4.47e-2)"	13.6	5.5	13.3	5.7	12.7	5.3	10.4	12.2	17.0	6.5	16.2	13.4	6.4	30.7	5.8	8.6	7.6	12.2	8.0	17.7	14.0	11.8	21.7	46.5	7.2	6.3	13.4	16.0	7.8	11.5	8.2	4.6	6.0	15.9	10.1	8.5	5.8	10.8	6.6	13.5	4.5	26.5	5.0	14.3	4.1	11.5	70.8	11.0	5.6	6.7	6.8	5.8	7.5	4.4	7.3	6.6	2.1	3.5	4.7	8.4	4.0	11.8	6.8	5.5	15.5	27.6	14.5	8.1	8.5	18.4	12.0	14.3	26.7	12.4	4.1	4.7	8.9	22.3	9.8	8.3	15.9	7.0	1.2	6.8	9.0	9.4	61.2	29.5	9.0	7.6	11.9	9.2	10.8	8.4	4.3	11.1	12.7	16.7	8.6	8.9	10.0	10.7	11.1	4.4	41.7	7.3	7.1	5.9	14.7	14.4	22.5	7.0	6.4	6.4	35.5	8.3	11.3	9.8	21.4	7.4	8.9	5.8	6.6	7.0	5.6	2.3	4.0	9.2	12.1	8.7	2.1	3.5	1.2	7.1	3.4	4.6	6.0	8.4	7.2	6.6	7.3	7.0	7.2	1.0	4.7	3.0	6.5	5.0	4.0	13.3	12.7	12.2	17.0	14.0	11.8	13.4	16.0	15.9	11.0	0.0	15.9	13.0	6.8	4.7	11.8	14.9	56.0	10.7	4.5	24.4	0.0	67.4	101.2	15.9	615.4	7.1	65.6	23.3	16.0	30.7	6.8	9.0	9.2	125.6	20.2	15.9	13.4	20.3	10.0	2143.8	25.6	9.3	32.1	21.6	22.6	19.8	17.5	17.3	24.4	119.0	7.1	25.8	11.4	131.3	17.2	5.0	42.4	12.5	30.7	4.5
PDE10A		ENSG00000112541	"Phosphodiesterase 10A"	Q9Y233	6	165327287-165986603	"Disease related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins"		"Allosteric enzyme, Hydrolase"	"Disease mutation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 36.8"	"Cell type enhanced"	"Detected in many"	7	"Horizontal cells: 15.9;Muller glia cells: 21.0"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in all"		"basal ganglia: 36.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HeLa: 7.7;LHCN-M2: 14.0;RH-30: 8.2;RT4: 8.5;SH-SY5Y: 8.6;TIME: 14.5;U-2 OS: 7.9"	"Region enriched"	"Detected in many"	11	"basal ganglia: 307.0"	"Group enriched"	"Detected in all"	4	"basal ganglia: 155.2;cerebellum: 80.7"	"CAB045998, HPA047200"	Supported					NA	NA					"CAB045998: AB_2162589, HPA047200: AB_2679981"	"unprognostic (1.02e-1)"	"unprognostic (3.63e-2)"	"unprognostic (3.58e-2)"	"unprognostic (2.91e-1)"	"unprognostic (1.20e-1)"	"unprognostic (1.25e-1)"	"unprognostic (1.76e-1)"	"unprognostic (1.23e-1)"	"unprognostic (9.36e-2)"	"unprognostic (6.03e-2)"	"unprognostic (3.79e-2)"	"unprognostic (9.24e-2)"	"prognostic unfavorable (4.44e-7)"	"unprognostic (3.59e-3)"	"unprognostic (2.37e-2)"	"unprognostic (3.44e-2)"	"unprognostic (5.90e-3)"	3.1	1.9	1.7	1.0	36.8	0.0	3.4	4.5	6.9	2.2	1.0	1.1	4.3	0.8	2.9	7.5	0.7	3.1	3.2	3.6	2.6	2.1	8.8	0.9	4.3	1.4	2.7	1.1	3.4	0.8	1.2	2.5	5.3	1.7	2.6	0.5	0.6	0.7	4.9	0.9	0.6	0.8	4.3	1.1	2.5	1.2	8.7	16.0	0.0	12.2	1.0	0.8	7.3	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	6.8	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.3	0.8	0.0	0.0	0.0	5.0	0.0	2.8	0.0	0.0	0.0	3.4	0.0	7.7	0.0	0.5	0.0	0.0	0.1	0.0	0.6	0.0	0.0	7.5	0.0	0.0	0.0	14.0	0.1	1.1	0.0	1.5	0.0	5.6	1.7	8.2	0.0	7.4	8.5	2.2	8.6	0.0	0.0	0.4	0.6	0.0	0.0	14.5	0.0	7.9	0.0	0.0	0.0	0.0	0.0	0.1	0.0	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	36.8	4.5	6.9	2.6	2.1	2.7	1.1	1.7	16.0	0.0	0.0	0.0	2.8	0.3	8.8	6.9	0.0	1.4	1.2	5.2	2.0	6.0	3.3	1.7	8.9	10.3	0.0	0.0	0.0	5.2	2.0	11.7	1.1	0.0	0.7	15.9	0.0	9.8	0.0	11.8	0.0	0.0	1.7	0.0	0.0	21.0	0.2	0.0	0.4	6.5	0.6	0.0	2.1	6.6	0.5	0.3	2.4	0.0	0.0	2.2
PDE11A		ENSG00000128655	"Phosphodiesterase 11A"	Q9HCR9	2	177623252-178072755	"Disease related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins"		"Allosteric enzyme, Hydrolase"	"Cushing syndrome, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"prostate: 20.8"	"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in some"		"prostate cancer: 1.7"	"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"CAPAN-2: 3.8;fHDF/TERT166: 5.6;HAP1: 3.2;Hep G2: 6.4"									HPA034560	Approved				"Intracellular and membrane"	NA	NA					"HPA034560: AB_10602140"	"unprognostic (1.02e-1)"	"unprognostic (4.73e-2)"	"unprognostic (1.02e-1)"	"unprognostic (9.61e-3)"	"unprognostic (2.34e-2)"	"unprognostic (1.43e-2)"	"unprognostic (1.30e-1)"	"unprognostic (2.28e-2)"	"unprognostic (2.23e-1)"	"unprognostic (3.91e-1)"	"unprognostic (9.95e-2)"	"unprognostic (2.80e-2)"	"unprognostic (5.06e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.75e-1)"	"unprognostic (4.11e-4)"	"unprognostic (1.64e-3)"	2.9	0.5	1.3	0.7	1.0	0.2	2.5	0.2	0.8	4.2	3.1	0.1	0.0	1.2	1.9	1.5	0.3	0.4	5.4	2.6	1.6	2.0	4.0	11.8	0.5	0.0	3.3	0.0	0.5	7.8	9.8	13.6	0.0	1.2	20.8	0.5	5.6	8.5	1.2	7.5	0.3	7.6	1.7	5.6	0.1	0.4	3.8	0.0	0.1	13.2	0.7	0.1	0.6	0.3	1.0	0.8	2.2	0.9	0.9	0.7	0.2	0.1	1.0	0.5	0.2	0.2	0.0	0.2	2.5	0.4	0.1	0.9	0.5	3.8	0.1	1.6	5.6	0.6	0.2	3.2	0.1	0.1	0.0	2.0	2.4	0.2	6.4	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.3	0.0	2.1	0.1	0.4	0.6	0.9	0.3	1.3	0.1	0.7	0.5	0.1	0.5	0.0	1.1	0.1	0.7	1.7	0.0	0.2	0.4	0.5	0.3	0.0	0.0	0.3	0.6	0.2	0.3	0.5	0.0	0.0	1.0	0.1	0.2	1.6	0.7	1.1	0.7	0.6	0.5	0.7	0.6	0.7	0.4	1.0	0.6	0.7	2.2	0.9	0.9	0.8	0.7	0.2	1.3	1.0	0.2	0.7	1.6	2.0	3.3	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0
PDE12	"2'-PDE, 3635, DKFZp667B1218"	ENSG00000174840	"Phosphodiesterase 12"	Q6L8Q7	3	57556276-57566844	"Enzymes, Predicted intracellular proteins"	"mRNA processing"	"Exonuclease, Hydrolase, Nuclease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA043171	Approved					NA	NA					"HPA043171: AB_10794654"	"unprognostic (2.79e-1)"	"unprognostic (3.18e-1)"	"prognostic favorable (2.85e-5)"	"unprognostic (2.39e-1)"	"unprognostic (1.48e-1)"	"unprognostic (9.21e-2)"	"unprognostic (1.58e-2)"	"unprognostic (8.43e-3)"	"unprognostic (1.27e-1)"	"unprognostic (6.45e-2)"	"unprognostic (2.10e-1)"	"unprognostic (9.88e-3)"	"prognostic favorable (3.63e-8)"	"unprognostic (6.97e-3)"	"unprognostic (1.32e-1)"	"unprognostic (7.85e-2)"	"unprognostic (2.62e-1)"	14.2	22.1	10.0	13.7	15.7	21.1	11.2	18.0	18.4	10.7	12.4	16.9	10.6	15.7	14.9	8.5	19.8	10.9	12.7	11.2	11.0	10.8	16.8	22.1	11.4	14.3	15.5	10.6	15.7	17.0	18.2	15.5	12.7	13.6	11.8	12.2	13.2	14.6	12.4	19.1	11.4	13.8	12.2	12.4	12.6	13.8	9.9	14.2	21.7	13.0	11.7	16.4	14.1	11.6	10.4	10.1	16.6	12.6	14.5	13.4	9.5	12.9	12.8	8.0	14.9	10.4	7.4	14.6	11.0	10.6	12.4	11.2	16.9	8.9	21.3	4.4	9.9	16.6	8.6	17.0	11.5	10.3	9.7	8.9	16.0	11.2	12.9	11.9	20.7	16.6	10.1	7.9	15.0	13.3	6.5	10.7	11.2	13.2	15.7	11.2	10.0	18.5	6.8	12.4	10.2	22.1	7.0	6.5	15.8	10.0	15.1	7.1	11.5	11.9	14.0	11.9	6.8	10.6	12.0	13.1	10.4	9.9	19.7	17.8	15.4	22.3	18.8	12.2	16.3	15.3	16.6	9.1	8.2	11.6	12.6	12.9	7.2	10.9	11.9	10.1	10.4	13.4	13.4	2.6	14.5	12.5	5.4	12.9	9.5	10.0	15.7	18.0	18.4	11.0	10.8	15.5	10.6	13.6	14.2	23.8	18.7	12.8	16.2	32.6	18.3	9.7	17.8	2.7	13.6	29.6	11.8	16.3	5.0	8.9	1.0	11.8	13.4	23.3	8.4	9.0	11.5	15.3	19.6	24.1	12.9	25.4	12.0	18.4	14.0	1.1	9.8	12.5	11.8	8.2	9.9	17.8	7.8	12.9	11.7	13.5	24.8	6.5	10.3	13.4	8.7	34.6	17.2	13.8	14.9	16.5
PDE1A		ENSG00000115252	"Phosphodiesterase 1A"	P54750	2	182140036-182523192	"Enzymes, FDA approved drug targets, Predicted intracellular proteins"		"Calmodulin-binding, Hydrolase"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 66.0;kidney: 37.1"	"Group enriched"	"Detected in many"	6	"Distal tubular cells: 157.5;Early spermatids: 314.8;Late spermatids: 455.7"	"Cancer enhanced"	"Detected in many"		"thyroid cancer: 13.0"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"myeloid DC: 1.4"	"Low lineage specificity"	"Detected in single"			"Group enriched"	"Detected in some"	5	"ASC diff: 22.8;HHSteC: 13.5;HSkMC: 28.9"	"Group enriched"	"Detected in many"	6	"amygdala: 118.0;basal ganglia: 76.2;cerebral cortex: 161.5;hippocampal formation: 155.8;hypothalamus: 47.8"	"Low region specificity"	"Detected in all"			HPA022151	Approved		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA022151: AB_1855118"	"unprognostic (3.63e-1)"	"unprognostic (7.21e-2)"	"unprognostic (1.32e-1)"	"unprognostic (8.61e-2)"	"unprognostic (1.58e-1)"	"unprognostic (3.02e-1)"	"unprognostic (3.84e-1)"	"unprognostic (3.82e-1)"	"unprognostic (1.02e-1)"	"unprognostic (5.38e-2)"	"unprognostic (2.78e-1)"	"unprognostic (2.86e-1)"	"unprognostic (5.55e-3)"	"unprognostic (2.50e-3)"	"unprognostic (5.96e-2)"	"unprognostic (1.37e-1)"	"unprognostic (1.40e-3)"	7.6	3.9	13.8	3.6	11.5	0.5	4.1	66.0	25.3	11.5	8.8	6.2	1.7	2.6	7.3	6.7	4.7	7.4	18.2	11.8	12.6	4.1	37.1	3.2	3.1	1.8	7.1	15.7	9.2	2.0	1.3	2.3	1.3	6.9	3.8	5.6	3.0	1.8	4.8	2.4	2.1	4.6	11.8	10.1	2.6	4.6	24.6	9.0	0.0	35.1	2.6	1.1	8.3	9.0	0.0	1.4	0.8	0.2	0.0	0.0	0.0	0.0	0.1	2.3	0.0	22.8	1.9	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.0	3.2	0.0	13.5	0.0	0.0	28.9	0.0	0.0	0.0	0.3	0.0	0.0	0.0	4.4	0.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	2.2	0.0	3.2	0.0	0.0	0.1	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	13.8	11.5	66.0	25.3	12.6	4.1	7.1	15.7	6.9	9.0	0.0	1.6	0.0	2.2	1.1	12.6	3.6	0.0	0.0	2.3	26.2	0.0	0.1	157.5	0.3	314.8	5.8	0.0	0.0	0.3	0.0	1.9	2.0	0.0	0.0	0.1	0.0	0.0	8.0	0.0	455.7	13.8	0.2	0.0	0.0	0.6	0.2	0.2	0.0	7.8	1.4	1.1	51.8	47.4	4.4	3.9	1.1	0.0	0.0	0.0	0.7
PDE1B	PDES1B	ENSG00000123360	"Phosphodiesterase 1B"	Q01064	12	54549350-54579239	"Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"		"Calmodulin-binding, Hydrolase"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"brain: 52.6"	"Cell type enhanced"	"Detected in many"	11	"Erythroid cells: 23.3;Kupffer cells: 11.5;Sertoli cells: 12.9;Smooth muscle cells: 9.5"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in all"		"basal ganglia: 52.6"	"Cell type enriched"	"Detected in single"	4	"naive CD4 T-cell: 1.6"	"Lineage enriched"	"Detected in single"	4	"T-cells: 1.6"	"Cell line enhanced"	"Detected in some"		"HDLM-2: 11.5;HL-60: 6.4;HMC-1: 12.3;NB-4: 8.1;THP-1: 7.8;U-937: 6.5"	"Region enriched"	"Detected in all"	6	"basal ganglia: 895.2"	"Region enriched"	"Detected in all"	7	"basal ganglia: 253.8"	HPA018492	Enhanced					NA	NA					"HPA018492: AB_1855119"	"unprognostic (2.90e-1)"	"unprognostic (1.51e-1)"	"unprognostic (7.67e-4)"	"unprognostic (5.63e-3)"	"unprognostic (7.02e-2)"	"unprognostic (7.51e-2)"	"unprognostic (1.97e-1)"	"unprognostic (9.39e-2)"	"unprognostic (1.14e-1)"	"unprognostic (5.11e-2)"	"unprognostic (3.84e-3)"	"unprognostic (2.70e-2)"	"prognostic unfavorable (4.77e-6)"	"unprognostic (6.64e-4)"	"unprognostic (2.14e-1)"	"unprognostic (3.09e-1)"	"unprognostic (2.83e-2)"	12.3	1.4	9.9	4.6	52.6	5.6	2.7	3.1	19.4	2.6	3.7	1.4	0.0	1.2	3.9	2.5	1.7	2.4	2.9	1.9	3.7	3.8	1.3	1.6	2.9	1.6	3.0	9.3	12.5	0.6	11.0	0.5	0.5	5.8	1.0	1.7	0.5	1.3	2.1	0.7	1.0	2.6	4.9	1.2	4.8	2.5	1.1	7.7	0.0	2.7	0.0	1.1	2.8	1.1	0.2	0.3	0.1	0.3	0.1	1.6	0.4	0.0	0.0	0.5	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	3.1	0.1	0.0	0.0	0.0	1.8	0.0	0.0	11.5	0.3	4.7	0.0	0.0	0.0	6.4	12.3	0.7	0.0	0.0	0.0	0.0	0.0	4.6	0.0	1.9	0.0	0.0	0.7	8.1	3.4	0.0	0.0	2.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	7.8	0.0	0.0	0.2	0.0	0.0	0.0	0.1	2.4	0.0	6.5	1.3	0.0	0.3	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.3	0.2	1.6	0.0	0.1	0.1	0.0	0.0	0.0	0.4	9.9	52.6	3.1	19.4	3.7	3.8	3.0	9.3	5.8	7.7	0.0	0.6	0.0	0.2	0.9	0.1	3.1	0.0	0.0	1.2	3.5	0.0	0.0	0.0	0.0	4.8	0.3	0.0	23.3	0.0	0.0	0.4	0.3	0.0	0.0	7.3	4.8	1.7	0.0	11.5	3.4	2.0	5.2	0.0	1.8	0.0	0.0	0.0	0.0	2.8	0.0	0.1	12.9	9.5	0.9	0.5	0.4	0.2	1.5	0.0	0.1
PDE1C	Hcam3	ENSG00000154678	"Phosphodiesterase 1C"	Q14123	7	31751179-32299329	"Enzymes, FDA approved drug targets, Predicted intracellular proteins"		"Calmodulin-binding, Hydrolase"	"Deafness, Disease mutation, FDA approved drug targets, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"brain: 33.6;heart muscle: 56.2"	"Group enriched"	"Detected in some"	7	"Bipolar cells: 55.0;Cardiomyocytes: 112.6;Cone photoreceptor cells: 49.1;Early spermatids: 40.4;Late spermatids: 38.3"	"Cancer enhanced"	"Detected in some"		"glioma: 1.7"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BJ: 15.2;fHDF/TERT166: 49.0;hTERT-RPE1: 15.0;U-251 MG: 26.5;WM-115: 35.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA052375			Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA052375: AB_2681802"	"unprognostic (1.29e-2)"	"unprognostic (2.20e-5)"	"unprognostic (1.68e-2)"	"unprognostic (1.20e-3)"	"unprognostic (2.29e-1)"	"unprognostic (5.65e-2)"	"unprognostic (4.06e-3)"	"unprognostic (2.75e-1)"	"unprognostic (6.79e-3)"	"unprognostic (6.49e-2)"	"unprognostic (3.88e-5)"	"unprognostic (7.03e-2)"	"unprognostic (3.09e-3)"	"unprognostic (5.76e-2)"	"unprognostic (5.80e-2)"	"unprognostic (1.49e-1)"	"unprognostic (1.06e-3)"	2.9	2.7	10.6	3.2	27.7	0.9	5.1	2.4	17.1	1.2	2.7	30.1	0.0	2.3	3.1	6.8	7.4	8.4	2.4	56.2	14.8	7.5	4.0	1.0	5.0	1.4	31.1	12.0	4.9	2.7	1.3	1.3	4.0	16.3	2.9	2.7	7.9	2.6	4.2	1.4	0.9	2.8	10.4	17.1	1.4	3.8	4.2	33.6	0.0	3.9	0.2	1.0	7.6	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	5.2	0.0	0.2	0.1	0.0	15.2	6.2	7.2	5.9	0.0	0.0	0.0	0.0	49.0	0.0	0.4	0.0	0.0	9.3	0.0	0.0	0.4	0.4	0.0	0.0	0.0	10.9	0.6	0.0	1.5	0.1	15.0	2.1	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	4.1	0.0	0.0	0.0	7.4	0.0	2.3	0.0	0.0	0.0	0.0	0.4	0.0	0.1	0.0	8.1	3.0	0.1	26.5	0.0	0.0	0.0	0.7	0.1	35.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.6	27.7	2.4	17.1	14.8	7.5	31.1	12.0	16.3	33.6	0.0	0.0	0.0	0.8	0.0	55.0	112.6	0.0	4.0	1.2	1.8	49.1	0.0	0.0	5.6	40.4	2.9	0.0	0.0	0.4	0.0	0.0	0.2	8.1	0.0	0.1	3.2	0.0	0.0	0.0	38.3	0.3	0.0	0.0	0.0	0.0	0.9	0.2	0.0	0.4	0.0	4.4	0.0	2.1	1.1	0.7	0.0	0.0	0.0	0.0	0.0
PDE2A		ENSG00000186642	"Phosphodiesterase 2A"	O00408	11	72576141-72674591	"Enzymes, FDA approved drug targets, Predicted intracellular proteins"		Hydrolase	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 48.0;lymphoid tissue: 65.4"	"Group enriched"	"Detected in some"	6	"Endothelial cells: 33.1;Intestinal endocrine cells: 33.1;Ito cells: 118.4"	"Low cancer specificity"	"Detected in many"			"Group enriched"	"Detected in all"	4	"amygdala: 30.4;basal ganglia: 34.2;cerebral cortex: 48.0;hippocampal formation: 18.0;olfactory region: 27.0"	"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"B-cells: 3.7;T-cells: 9.6"	"Cell line enriched"	"Detected in some"	8	"HeLa: 107.5"					"Group enriched"	"Detected in all"	5	"amygdala: 111.5;basal ganglia: 166.3;cerebral cortex: 98.9;hippocampal formation: 120.9"	"CAB009752, HPA031192"	Enhanced		Supported	Cytosol		NA	NA			Cytosol		"CAB009752: AB_2268159, HPA031192: AB_2673781"	"unprognostic (1.92e-1)"	"unprognostic (1.52e-3)"	"unprognostic (4.58e-2)"	"unprognostic (1.49e-1)"	"unprognostic (1.26e-1)"	"unprognostic (2.50e-1)"	"prognostic favorable (1.76e-6)"	"unprognostic (3.06e-2)"	"unprognostic (1.35e-1)"	"unprognostic (3.01e-3)"	"unprognostic (3.13e-3)"	"unprognostic (1.50e-2)"	"unprognostic (1.77e-2)"	"unprognostic (2.85e-3)"	"unprognostic (6.31e-2)"	"unprognostic (7.72e-2)"	"unprognostic (7.96e-4)"	27.8	18.4	30.4	3.0	34.2	2.5	25.4	1.0	48.0	8.9	7.7	3.8	1.9	3.5	9.4	4.9	10.2	11.6	12.0	11.3	18.0	6.1	7.0	10.4	5.1	3.8	3.8	27.0	3.4	2.4	4.4	3.4	6.6	6.7	4.8	5.2	3.0	2.3	6.3	6.6	4.8	4.2	10.3	2.1	65.4	4.2	2.9	7.4	0.1	7.0	3.9	2.2	8.3	11.2	3.7	1.2	0.2	1.0	0.1	9.6	1.9	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.1	2.6	0.0	0.4	0.0	0.2	0.0	0.0	0.0	0.0	0.0	107.5	0.1	0.2	0.0	1.6	0.0	0.2	0.5	4.4	0.2	2.4	0.1	0.1	0.1	0.0	0.0	0.0	0.0	1.6	0.0	2.9	0.0	0.0	0.2	0.0	0.0	9.6	0.5	0.0	0.0	0.4	0.1	0.0	0.0	13.7	0.0	2.0	0.7	0.0	0.0	0.0	0.0	0.8	0.0	0.1	0.0	0.8	0.0	9.6	1.0	5.6	3.7	5.7	5.6	1.2	2.5	3.7	3.0	0.2	0.1	0.5	0.0	2.3	1.9	30.4	34.2	1.0	48.0	18.0	6.1	3.8	27.0	6.7	7.4	0.0	0.3	0.0	0.0	2.3	2.7	6.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	33.1	0.0	0.0	0.0	0.2	0.9	0.1	1.1	0.9	0.5	1.6	33.1	118.4	10.0	1.5	0.3	1.0	1.7	0.0	0.6	0.0	0.1	0.0	0.4	0.0	0.4	0.0	4.3	1.4	0.8	2.5	0.0	0.0	0.0	0.3
PDE3A	CGI-PDE	ENSG00000172572	"Phosphodiesterase 3A"	Q14432	12	20369245-20684381	"Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted membrane proteins"		Hydrolase	"Disease mutation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 62.2"	"Cell type enhanced"	"Detected in many"	15	"Bipolar cells: 41.0;Cardiomyocytes: 107.8;Horizontal cells: 49.3;Smooth muscle cells: 51.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 7.9;HEL: 14.6;HeLa: 39.5;HUVEC TERT2: 7.1;SH-SY5Y: 14.8;U-138 MG: 11.4"	"Low region specificity"	"Detected in some"			"Region enhanced"	"Detected in many"		"cerebellum: 35.4"	"HPA014492, HPA074258"	Approved		Approved	"Plasma membrane"		NA	NA		23000	"Plasma membrane"		"HPA014492: AB_1855120, HPA074258: "	"unprognostic (2.59e-2)"	"unprognostic (2.94e-2)"	"unprognostic (1.25e-1)"	"unprognostic (3.23e-1)"	"unprognostic (2.27e-1)"	"unprognostic (1.21e-1)"	"unprognostic (3.50e-2)"	"unprognostic (1.67e-2)"	"unprognostic (8.14e-2)"	"unprognostic (1.49e-1)"	"unprognostic (4.25e-1)"	"unprognostic (3.37e-1)"	"prognostic unfavorable (1.72e-6)"	"unprognostic (5.58e-2)"	"unprognostic (5.94e-2)"	"unprognostic (4.28e-2)"	"unprognostic (2.76e-4)"	7.1	1.0	1.7	4.7	2.0	0.0	3.8	3.5	1.4	7.8	15.9	1.0	2.0	2.1	7.8	3.5	9.1	4.9	5.5	62.2	1.6	1.4	3.7	1.8	3.9	3.3	1.9	1.1	7.1	6.5	1.0	2.8	13.8	2.7	6.3	9.0	12.0	7.8	4.2	2.0	1.4	21.4	6.0	1.8	2.1	5.5	2.3	0.7	0.0	2.8	1.9	0.9	4.0	3.7	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.2	7.9	0.0	1.8	1.3	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	14.6	39.5	0.2	0.6	0.0	0.0	1.8	0.0	0.4	0.1	0.1	7.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	1.1	0.0	0.0	0.0	2.2	0.0	0.1	14.8	0.0	0.0	0.0	3.5	0.0	0.0	0.2	11.4	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	1.7	2.0	3.5	1.4	1.6	1.4	1.9	1.1	2.7	0.7	0.0	0.0	0.0	0.1	0.2	41.0	107.8	5.1	0.0	1.2	0.0	0.0	0.0	0.0	3.7	0.2	2.2	24.6	0.0	0.4	0.0	3.5	0.5	16.2	0.0	0.5	49.3	4.1	0.6	0.0	0.0	1.4	0.0	1.7	0.0	7.4	2.5	0.5	24.6	0.7	2.6	2.2	6.5	51.8	0.2	0.4	0.3	0.0	0.0	13.9	0.2
PDE3B	HcGIP1	ENSG00000152270	"Phosphodiesterase 3B"	Q13370	11	14643723-14872044	"Enzymes, FDA approved drug targets, Predicted membrane proteins"	Angiogenesis	Hydrolase	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 42.6"	"Cell type enhanced"	"Detected in many"	7	"granulocytes: 34.7;Hepatocytes: 50.5;Spermatocytes: 45.1"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in many"	6	"cerebellum: 19.2"	"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	6	"granulocytes: 5.0;T-cells: 8.7"	"Cell line enhanced"	"Detected in many"		"HL-60: 13.6;Karpas-707: 15.7;THP-1: 16.7;U-266/70: 17.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA056111			Approved	"Endoplasmic reticulum"		NA	NA			"Endoplasmic reticulum"		"HPA056111: AB_2683041"	"unprognostic (1.05e-1)"	"unprognostic (2.86e-2)"	"unprognostic (4.12e-2)"	"unprognostic (2.76e-3)"	"unprognostic (4.25e-1)"	"unprognostic (1.84e-3)"	"unprognostic (3.40e-2)"	"unprognostic (3.24e-2)"	"unprognostic (5.39e-2)"	"unprognostic (1.20e-1)"	"prognostic favorable (7.91e-4)"	"unprognostic (1.77e-1)"	"unprognostic (2.33e-2)"	"unprognostic (1.39e-2)"	"unprognostic (3.42e-1)"	"unprognostic (2.47e-1)"	"unprognostic (9.03e-3)"	42.6	1.0	2.3	12.6	2.2	6.7	17.0	19.2	3.0	2.9	21.8	0.9	0.8	2.2	0.9	1.4	2.6	1.0	6.9	4.7	2.2	2.1	2.4	18.2	10.2	14.1	1.6	1.6	0.9	7.3	0.3	5.1	5.5	1.5	10.7	8.1	1.9	16.5	1.3	0.8	0.9	6.3	9.7	2.1	8.7	3.0	12.5	0.8	7.8	1.2	2.3	7.1	10.5	4.5	0.3	0.4	5.0	1.2	0.1	8.7	1.8	0.0	1.5	3.4	5.5	6.8	0.0	1.3	0.4	0.0	0.0	0.0	5.0	0.0	0.0	0.0	0.0	1.6	0.0	5.1	0.0	0.0	0.1	11.3	0.1	8.3	10.2	2.4	13.6	0.0	0.5	0.0	0.0	0.3	0.0	0.0	4.0	11.9	15.7	0.0	0.1	2.7	6.6	4.6	1.8	2.5	6.5	1.5	10.3	0.0	1.1	5.2	9.7	1.3	8.8	3.0	1.6	0.0	16.7	0.0	0.0	0.8	0.0	0.0	17.7	5.4	0.4	0.1	2.3	1.0	0.0	0.7	2.9	1.4	0.7	2.9	0.3	4.2	3.2	0.4	0.2	8.7	7.5	5.0	0.1	1.2	0.1	4.2	1.8	2.3	2.2	19.2	3.0	2.2	2.1	1.6	1.6	1.5	0.8	14.9	9.9	1.9	0.8	0.2	0.4	8.2	0.0	6.7	11.4	1.8	0.0	1.0	1.7	0.0	12.4	2.2	2.6	23.3	4.3	1.9	8.5	3.4	34.7	50.5	6.3	0.0	1.2	7.4	14.0	10.1	1.4	12.3	0.0	1.0	13.1	4.5	2.9	17.5	8.5	1.9	0.3	0.0	0.1	45.1	11.1	0.1	2.1	11.7	9.7	0.9
PDE4A	DPDE2	ENSG00000065989	"Phosphodiesterase 4A"	P27815	19	10416773-10469631	"Enzymes, FDA approved drug targets, Predicted intracellular proteins"		Hydrolase	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 38.5;testis: 31.8"	"Cell type enhanced"	"Detected in many"	13	"Late spermatids: 164.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HMC-1: 22.0;NB-4: 25.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB017632, HPA043310, HPA076091"	Uncertain		Supported	"Nucleoplasm,Plasma membrane"		NA	NA			"Plasma membrane"	Nucleoplasm	"CAB017632: AB_1127109, HPA043310: AB_2678419, HPA076091: AB_2686775"	"unprognostic (1.29e-2)"	"unprognostic (3.98e-2)"	"unprognostic (8.91e-2)"	"unprognostic (1.82e-1)"	"unprognostic (7.00e-2)"	"unprognostic (6.84e-2)"	"unprognostic (1.54e-2)"	"unprognostic (4.39e-2)"	"unprognostic (7.91e-2)"	"unprognostic (1.52e-2)"	"unprognostic (6.90e-2)"	"unprognostic (2.41e-1)"	"unprognostic (2.27e-2)"	"unprognostic (1.64e-2)"	"unprognostic (2.57e-2)"	"unprognostic (1.67e-1)"	"unprognostic (2.15e-1)"	6.4	2.5	9.0	4.2	13.9	3.4	6.3	15.0	38.5	8.4	4.3	3.2	0.4	2.0	4.4	1.1	3.1	4.8	5.0	4.1	12.4	6.9	2.8	1.9	7.7	2.0	5.3	19.4	1.7	9.8	17.3	2.3	4.9	34.7	3.7	3.0	3.1	7.1	4.0	26.1	2.2	2.7	4.7	3.6	4.1	6.1	31.8	4.5	0.0	5.4	1.0	1.9	4.6	3.5	0.2	3.3	5.9	4.4	5.3	2.0	1.3	0.0	1.4	0.3	3.9	11.6	6.9	2.2	3.3	6.6	0.4	1.1	3.5	3.2	1.5	9.7	8.5	0.2	0.3	2.3	0.4	0.2	3.8	3.3	13.6	4.7	3.8	7.5	2.2	22.0	5.1	0.4	3.7	0.0	0.4	3.1	1.2	10.7	3.3	2.3	1.0	1.3	25.3	1.8	3.9	2.8	8.9	2.2	11.7	0.6	0.8	2.5	0.9	0.2	0.1	3.6	0.6	0.5	4.5	6.6	5.0	6.5	3.4	2.1	6.5	0.5	7.2	2.1	0.1	4.0	5.9	2.6	5.1	1.5	4.4	0.8	0.2	0.5	2.0	3.3	0.1	0.1	0.7	0.2	5.3	4.4	0.2	1.2	1.3	9.0	13.9	15.0	38.5	12.4	6.9	5.3	19.4	34.7	4.5	3.0	15.2	8.0	2.7	9.0	23.9	5.8	12.7	10.7	7.9	8.7	0.0	0.3	0.0	2.8	44.2	10.9	1.3	0.0	11.1	4.3	13.4	3.1	32.2	0.8	9.8	52.4	0.0	11.6	18.3	164.4	16.1	37.2	13.5	14.4	6.2	1.3	10.6	0.0	17.0	0.0	2.6	6.5	8.1	7.7	7.8	7.0	0.3	16.0	6.8	1.4
PDE4B	DPDE4	ENSG00000184588	"Phosphodiesterase 4B"	Q07343	1	65792514-66374579	"Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"		Hydrolase	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 48.2"	"Cell type enhanced"	"Detected in many"	7	"Glandular cells: 81.5;Horizontal cells: 108.1;monocytes: 104.6"	"Cancer enhanced"	"Detected in all"		"glioma: 18.9"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"neutrophil: 36.6"	"Group enriched"	"Detected in all"	5	"B-cells: 16.1;granulocytes: 36.6;T-cells: 13.3"	"Cell line enhanced"	"Detected in many"		"AN3-CA: 24.4;HUVEC TERT2: 36.6;NTERA-2: 22.2;SK-MEL-30: 22.0;TIME: 20.4;U-266/84: 19.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003005	Uncertain		Approved	"Golgi apparatus,Cytosol"		NA	NA			"Golgi apparatus"	Cytosol	"HPA003005: AB_1079587"	"unprognostic (7.86e-2)"	"unprognostic (3.13e-1)"	"unprognostic (4.62e-2)"	"unprognostic (2.90e-1)"	"unprognostic (3.21e-1)"	"unprognostic (3.33e-3)"	"unprognostic (1.35e-1)"	"unprognostic (1.15e-3)"	"unprognostic (1.04e-2)"	"unprognostic (6.10e-2)"	"unprognostic (8.78e-2)"	"unprognostic (4.24e-2)"	"prognostic unfavorable (5.04e-4)"	"unprognostic (2.89e-2)"	"unprognostic (3.54e-1)"	"unprognostic (9.04e-3)"	"unprognostic (8.33e-3)"	14.9	2.9	21.5	28.4	29.0	48.2	15.0	12.7	31.9	6.4	6.6	39.2	0.7	3.9	6.7	2.1	3.9	3.5	8.1	16.1	20.7	18.8	3.7	8.7	10.0	15.9	36.3	14.2	2.0	1.7	1.7	3.4	13.1	32.2	18.3	8.6	6.6	15.9	10.3	28.2	6.2	8.5	9.5	37.4	18.5	4.2	3.2	36.9	2.3	5.5	5.5	14.7	16.1	3.9	16.1	2.6	36.6	2.8	4.4	13.3	3.7	0.1	7.0	13.8	24.4	0.7	0.7	0.0	4.5	5.3	4.2	5.6	0.0	0.0	2.0	0.1	8.4	0.1	0.0	0.1	0.0	4.2	5.9	0.0	0.1	2.0	0.0	0.5	4.9	0.0	1.4	0.2	2.1	0.1	0.6	36.6	0.0	0.0	1.3	1.8	0.1	0.0	2.8	22.2	0.0	0.3	1.0	2.4	1.3	3.4	0.0	0.1	10.6	0.0	1.2	22.0	1.2	0.1	1.7	20.4	3.3	0.8	1.8	0.7	0.6	19.1	7.5	3.4	5.1	1.4	2.7	2.8	8.4	4.4	2.4	8.4	15.4	8.3	6.2	2.4	16.1	9.4	6.5	36.6	4.4	2.1	2.6	13.3	3.7	21.5	29.0	12.7	24.6	20.7	18.8	36.3	14.2	32.2	36.9	8.9	16.4	50.2	24.5	18.0	35.4	29.1	0.0	2.7	12.5	5.2	0.0	5.2	0.0	0.5	7.9	23.2	0.0	0.0	0.8	1.6	9.3	81.5	14.0	1.6	12.6	108.1	4.1	12.3	25.8	5.6	0.3	42.5	49.0	104.6	1.2	12.2	0.1	0.0	2.5	1.6	3.3	0.0	10.3	0.1	0.7	7.0	4.7	36.2	1.1	5.7
PDE4C	DPDE1	ENSG00000105650	"Phosphodiesterase 4C"	Q08493	19	18208652-18248200	"Enzymes, FDA approved drug targets, Predicted intracellular proteins"		Hydrolase	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"tongue: 28.6"	"Cell type enhanced"	"Detected in many"	14	"Enterocytes: 141.8;Paneth cells: 179.9;Undifferentiated cells: 66.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"BEWO: 6.0;Hep G2: 4.0;U-87 MG: 9.0"									"HPA048975, HPA054218"	Approved		Approved	"Midbody ring,Centrosome,Cytosol"		NA	NA			"Centrosome, Cytosol"	"Midbody ring"	"HPA048975: AB_2680581, HPA054218: "	"unprognostic (4.20e-2)"	"unprognostic (4.02e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.27e-1)"	"unprognostic (5.22e-4)"	"unprognostic (1.44e-2)"	"unprognostic (7.70e-2)"	"unprognostic (1.15e-1)"	"unprognostic (4.01e-2)"	"unprognostic (5.69e-2)"	"unprognostic (2.50e-3)"	"unprognostic (2.21e-1)"	"unprognostic (7.25e-10)"	"unprognostic (2.73e-2)"	"unprognostic (2.65e-1)"	"unprognostic (9.21e-2)"	"unprognostic (2.45e-2)"	2.0	1.3	1.8	1.5	2.8	1.0	2.0	0.8	6.1	4.1	4.4	1.5	3.1	1.5	6.4	6.8	1.3	4.2	5.6	4.2	1.6	1.9	4.1	2.0	4.1	0.5	1.7	5.1	2.0	0.8	0.3	3.5	7.0	2.8	5.8	1.3	2.5	1.3	5.4	13.4	0.6	4.1	3.4	0.7	2.3	5.2	2.6	1.1	0.4	1.2	28.6	0.7	1.8	3.3	1.3	0.6	3.5	0.7	1.0	0.7	0.2	0.1	0.3	0.2	0.3	0.1	0.3	6.0	0.1	0.0	0.2	0.3	1.2	0.2	0.2	0.6	0.1	0.4	0.1	0.0	0.0	0.0	0.1	0.2	0.3	0.4	4.0	0.2	0.2	0.6	0.7	0.1	2.6	0.0	0.5	0.0	0.3	0.9	2.1	0.1	0.4	0.2	0.3	0.2	0.4	0.2	0.2	0.3	0.4	0.1	0.2	0.2	0.8	0.3	0.5	0.0	1.6	0.5	0.3	0.0	0.4	0.2	0.7	0.1	1.3	0.6	0.2	9.0	0.2	0.3	3.4	0.7	1.0	0.6	0.4	0.5	0.5	0.5	0.4	0.2	1.3	0.5	0.7	3.5	1.0	0.4	0.6	0.3	0.2	1.8	2.8	0.8	6.1	1.6	1.9	1.7	5.1	2.8	1.1	3.0	8.8	0.0	2.2	4.8	3.0	28.1	5.1	0.0	1.2	0.0	5.9	1.9	0.0	0.0	29.1	3.6	141.8	0.0	0.0	3.5	4.2	1.8	4.6	0.0	0.4	0.0	6.9	1.3	2.2	26.0	0.6	1.1	1.7	0.0	34.4	2.7	0.0	179.9	3.9	0.0	3.3	45.3	13.4	1.9	1.9	3.3	0.9	0.0	66.4	18.4
PDE4D	DPDE3	ENSG00000113448	"Phosphodiesterase 4D"	Q08499	5	58969038-60522120	"Disease related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins"		Hydrolase	"Disease mutation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 60.0"	"Cell type enhanced"	"Detected in many"	4	"Alveolar cells type 2: 76.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	5	"eosinophil: 28.1"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 28.1"	"Cell line enhanced"	"Detected in many"		"A549: 25.3;AN3-CA: 29.1;HeLa: 41.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA045895	Uncertain		Supported	"Plasma membrane,Cytosol"		NA	NA			"Plasma membrane"	Cytosol	"HPA045895: AB_10960275"	"unprognostic (1.14e-1)"	"unprognostic (8.73e-3)"	"unprognostic (4.35e-2)"	"unprognostic (7.87e-2)"	"unprognostic (5.97e-2)"	"unprognostic (2.03e-1)"	"unprognostic (8.10e-4)"	"unprognostic (1.17e-1)"	"unprognostic (6.59e-2)"	"unprognostic (1.84e-1)"	"unprognostic (2.71e-1)"	"unprognostic (2.65e-1)"	"prognostic favorable (4.00e-5)"	"unprognostic (1.51e-1)"	"unprognostic (8.20e-2)"	"unprognostic (1.77e-2)"	"unprognostic (2.56e-2)"	8.2	1.9	4.4	6.8	8.6	46.2	5.3	4.2	13.0	13.5	18.6	1.4	14.7	4.1	17.1	14.0	10.3	6.6	12.7	15.5	4.5	5.8	12.8	3.4	11.1	3.7	5.2	6.6	5.3	2.9	7.0	9.0	11.8	2.7	18.2	11.2	8.6	24.4	16.5	60.0	5.1	7.5	35.8	5.0	3.8	10.2	2.6	2.8	4.4	6.2	11.3	9.5	20.0	11.2	6.1	0.7	28.1	1.1	0.1	0.8	0.5	0.0	25.3	5.3	29.1	1.0	1.9	4.2	0.6	0.7	1.4	2.1	9.9	0.8	1.9	0.1	0.2	4.3	4.3	0.0	1.1	2.5	1.1	2.9	3.7	41.9	2.1	3.9	1.7	0.2	3.9	0.9	4.0	0.7	0.4	3.0	0.1	0.0	0.6	2.4	1.8	1.4	4.1	1.0	0.7	1.3	0.4	6.7	4.2	6.6	9.5	0.9	3.3	6.7	11.3	5.7	5.0	0.8	3.7	3.4	0.3	0.1	5.0	1.3	1.4	0.0	0.2	4.3	7.0	1.1	2.0	1.1	28.1	0.8	0.0	0.8	6.1	0.7	0.3	0.7	6.1	0.5	0.4	1.5	0.1	0.1	0.0	0.4	0.5	4.4	8.6	4.2	13.0	4.5	5.8	5.2	6.6	2.7	2.8	29.8	76.9	9.1	30.5	9.4	13.6	32.7	10.2	22.7	48.9	40.1	68.7	9.2	10.0	0.5	16.6	12.4	16.7	0.0	1.6	14.8	13.1	46.1	21.9	0.8	4.3	1.6	32.0	14.1	6.0	29.3	1.4	9.4	10.1	4.6	18.4	16.1	5.4	10.5	4.6	17.7	52.1	0.0	5.3	0.5	7.1	7.8	2.6	37.3	10.1	21.1
PDE5A		ENSG00000138735	"Phosphodiesterase 5A"	O76074	4	119494395-119628991	"Enzymes, FDA approved drug targets, Predicted intracellular proteins"		"Allosteric enzyme, Hydrolase"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	11	"Peritubular cells: 98.6;Smooth muscle cells: 79.9"	"Cancer enhanced"	"Detected in all"		"thyroid cancer: 27.3"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 24.6;HHSteC: 35.4;hTERT-RPE1: 12.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA004729, HPA012873"	Approved		Approved	Cytosol		NA	NA		3100000	Cytosol		"HPA004729: AB_1079588, HPA012873: AB_1855124"	"unprognostic (6.95e-2)"	"prognostic favorable (5.20e-4)"	"unprognostic (1.28e-1)"	"unprognostic (1.56e-1)"	"unprognostic (1.25e-1)"	"unprognostic (3.66e-2)"	"unprognostic (7.36e-2)"	"unprognostic (2.58e-2)"	"unprognostic (2.29e-2)"	"unprognostic (6.97e-2)"	"unprognostic (2.05e-2)"	"unprognostic (2.54e-1)"	"unprognostic (2.16e-2)"	"unprognostic (1.52e-2)"	"unprognostic (8.98e-2)"	"unprognostic (8.71e-3)"	"prognostic unfavorable (1.17e-4)"	12.3	4.9	2.0	28.2	2.3	0.4	8.1	3.0	2.3	21.3	28.0	1.7	20.1	6.5	17.3	21.4	30.7	10.7	13.3	5.3	2.0	2.8	3.8	1.2	11.4	4.1	2.4	3.4	10.0	7.8	5.1	3.4	8.9	4.4	31.8	11.7	20.2	8.5	23.7	6.8	4.2	15.6	45.6	2.0	2.1	9.1	7.6	1.2	0.9	9.1	8.1	2.2	25.9	15.9	1.5	0.5	1.4	0.4	0.6	2.1	4.2	8.1	0.4	5.7	0.6	2.0	3.0	1.0	5.5	24.6	0.2	0.5	0.5	0.7	0.8	0.2	6.8	1.5	3.0	1.8	0.8	0.7	0.2	3.7	9.1	1.4	0.4	35.4	1.9	0.9	3.3	1.7	0.6	0.0	12.9	0.7	1.9	1.0	1.5	0.8	0.4	2.4	0.3	1.2	0.9	1.4	0.3	2.9	2.1	2.1	2.5	2.2	4.6	6.3	8.0	0.6	4.4	1.4	1.0	1.2	3.2	2.8	1.7	0.7	2.1	1.0	0.7	3.1	0.5	0.4	0.0	0.3	0.0	0.6	0.1	2.1	1.5	1.3	0.4	0.2	1.0	0.6	0.9	1.4	0.6	0.4	0.5	0.4	4.2	2.0	2.3	3.0	2.3	2.0	2.8	2.4	3.4	4.4	1.2	6.0	4.6	0.0	2.3	3.1	8.1	3.5	12.7	1.4	5.7	1.8	13.7	0.2	0.0	12.0	25.6	3.3	6.3	0.0	2.5	0.2	3.8	2.4	1.1	1.0	0.2	4.8	2.4	1.3	0.0	9.4	19.2	0.7	5.0	0.0	10.1	28.4	4.2	9.1	98.6	0.5	5.9	19.4	79.9	2.9	5.5	2.0	0.2	0.0	8.6	1.6
PDE6A	"PDEA, RP43"	ENSG00000132915	"Phosphodiesterase 6A"	P16499	5	149857955-149944793	"Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"	"Sensory transduction, Vision"	Hydrolase	"Disease mutation, FDA approved drug targets, Retinitis pigmentosa"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	8	"retina: 153.4"	"Cell type enriched"	"Detected in many"	12	"Rod photoreceptor cells: 2864.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enriched"	"Detected in some"	4	"CACO-2: 7.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA016970, HPA074677"	Enhanced					NA	NA					"HPA016970: AB_1855125, HPA074677: AB_2732264"	"unprognostic (6.85e-2)"	"unprognostic (8.84e-2)"	"unprognostic (1.70e-2)"	"unprognostic (4.11e-2)"	"unprognostic (1.12e-2)"	"unprognostic (5.72e-2)"	"unprognostic (4.39e-3)"	"unprognostic (8.83e-2)"	"unprognostic (6.54e-2)"	"unprognostic (5.91e-3)"	"unprognostic (1.77e-2)"	"unprognostic (9.21e-2)"	"unprognostic (7.57e-5)"	"unprognostic (9.93e-2)"	"unprognostic (3.08e-1)"	"unprognostic (1.31e-1)"	"unprognostic (2.26e-2)"	0.2	2.3	0.2	0.2	0.2	0.9	0.2	0.3	0.2	0.2	1.8	0.2	0.3	0.2	0.2	20.1	2.4	0.1	0.2	0.2	0.2	0.0	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.2	4.6	0.2	0.2	0.2	1.0	153.4	1.4	0.2	0.2	1.6	0.2	0.2	0.2	0.2	0.1	3.1	0.2	0.2	0.4	0.3	0.5	0.2	0.2	1.5	0.8	3.3	0.8	1.2	0.8	0.1	0.4	0.8	0.6	0.6	0.3	0.3	0.6	0.3	0.1	0.4	0.1	7.6	0.8	0.9	1.4	0.2	1.4	0.7	0.2	0.4	0.5	0.6	0.3	1.0	1.1	0.6	0.2	0.8	0.6	0.3	1.1	0.9	0.6	0.6	0.2	0.4	0.3	1.4	1.5	0.4	0.5	0.9	0.5	0.2	0.5	0.3	0.8	0.7	0.5	1.0	0.8	1.1	0.0	0.7	0.2	0.6	1.0	0.5	1.4	0.8	1.7	0.8	0.5	0.6	0.4	0.5	0.8	0.8	0.6	3.3	0.8	0.5	0.6	0.4	0.5	0.7	0.6	0.5	0.2	1.5	0.7	0.8	2.8	1.2	0.5	0.8	0.4	0.1	0.2	0.2	0.3	0.2	0.2	0.0	0.2	0.2	0.2	0.2	0.0	7.2	0.0	0.5	1.0	117.9	3.6	0.0	5.3	4.5	0.0	229.7	0.9	0.0	0.0	7.0	0.6	3.9	0.0	0.2	1.9	0.6	0.3	3.5	0.8	0.3	71.5	0.0	2.5	0.3	4.0	1.1	0.5	0.0	1.0	0.2	162.2	0.1	2.9	0.4	0.0	2864.0	0.0	1.0	1.1	0.9	0.5	2.4	0.5	0.9	0.1
PDE6B	"CSNB3, CSNBAD2, PDEB, rd1, RP40"	ENSG00000133256	"Phosphodiesterase 6B"	P35913	4	625584-670782	"Disease related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins"	"Sensory transduction, Vision"	Hydrolase	"Congenital stationary night blindness, Disease mutation, FDA approved drug targets, Retinitis pigmentosa"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 30.2;retina: 64.2"	"Cell type enriched"	"Detected in many"	6	"Rod photoreceptor cells: 453.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"EFO-21: 8.0;JURKAT: 11.8;MOLT-4: 20.5;REH: 11.1;SCLC-21H: 14.0;SH-SY5Y: 8.2;U-266/84: 15.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA054148, HPA059929"	Enhanced		Approved	Cytosol		NA	NA			Cytosol		"HPA054148: AB_2682401, HPA059929: AB_2684166"	"unprognostic (2.43e-2)"	"unprognostic (1.33e-4)"	"unprognostic (2.45e-4)"	"unprognostic (7.18e-3)"	"unprognostic (1.88e-2)"	"unprognostic (5.04e-3)"	"unprognostic (7.32e-3)"	"prognostic favorable (5.34e-4)"	"unprognostic (9.70e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.37e-2)"	"unprognostic (2.33e-2)"	"unprognostic (4.09e-2)"	"unprognostic (1.67e-2)"	"unprognostic (2.26e-1)"	"unprognostic (2.41e-3)"	"unprognostic (1.85e-1)"	1.6	1.9	12.1	4.6	19.1	6.7	3.8	2.3	13.2	2.3	1.3	30.2	1.5	0.8	2.5	3.9	1.4	9.6	3.2	5.2	18.1	10.2	4.6	0.7	4.2	12.0	29.6	9.8	2.6	1.4	9.1	3.2	2.6	14.5	2.5	1.0	64.2	3.5	2.9	0.7	1.8	2.2	2.1	20.2	8.7	2.5	3.6	22.4	4.3	11.4	0.2	8.3	4.1	1.1	16.5	14.1	11.2	5.8	10.2	13.1	7.1	0.0	0.2	0.8	0.4	0.2	0.3	0.2	0.0	0.0	0.5	1.4	0.0	0.1	0.2	8.0	0.2	0.7	0.1	1.7	0.4	0.0	0.1	0.0	0.6	0.2	0.0	4.1	0.1	0.3	0.5	0.1	2.4	0.0	0.5	0.7	11.8	0.1	0.6	0.0	0.2	20.5	0.2	6.5	0.4	0.2	11.1	0.2	0.4	1.4	0.9	14.0	8.2	0.0	0.3	0.1	3.3	0.4	0.0	0.2	0.1	0.8	0.1	0.3	5.4	15.2	0.2	0.2	0.2	0.1	11.2	4.2	0.6	11.5	5.8	10.5	10.0	7.7	7.9	6.6	16.5	12.2	13.1	1.1	10.2	5.6	14.1	11.4	7.1	12.1	19.1	2.3	10.0	18.1	10.2	29.6	9.8	14.5	22.4	3.0	5.3	4.5	1.2	0.3	18.2	3.7	0.0	16.0	5.7	0.0	78.5	0.1	1.7	5.1	0.4	1.8	0.0	0.0	0.6	0.2	0.8	0.9	3.5	0.0	9.2	11.1	1.7	2.5	3.9	0.0	1.4	3.4	3.3	7.2	0.2	20.9	0.7	0.0	1.4	6.7	453.5	0.0	0.2	3.9	2.7	0.3	0.2	7.0	0.1	0.6
PDE6C	"ACHM5, COD4, PDEA2"	ENSG00000095464	"Phosphodiesterase 6C"	P51160	10	93612588-93666010	"Disease related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins"	"Sensory transduction, Vision"	Hydrolase	"Disease mutation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	4	"retina: 12.8"	"Cell type enriched"	"Detected in some"	18	"Cone photoreceptor cells: 53.0"	"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	7	"cerebellum: 3.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"Hep G2: 2.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"									NA	NA						"unprognostic (1.39e-3)"	"unprognostic (7.41e-3)"	"unprognostic (2.61e-2)"	"unprognostic (2.24e-1)"	"unprognostic (3.17e-2)"	"unprognostic (5.23e-3)"	"unprognostic (2.46e-3)"	"unprognostic (2.81e-3)"	"unprognostic (9.68e-2)"	"unprognostic (2.64e-1)"	"unprognostic (1.51e-2)"	"unprognostic (2.96e-3)"	"unprognostic (2.19e-7)"	"unprognostic (1.19e-1)"	"unprognostic (6.61e-2)"	"unprognostic (1.81e-1)"	"unprognostic (1.80e-3)"	0.4	0.6	0.3	0.4	0.4	1.3	0.4	3.0	0.7	0.8	0.3	0.3	0.3	0.4	0.5	0.3	0.3	0.5	0.3	0.3	0.3	0.2	0.3	0.5	0.5	1.0	0.3	0.3	1.0	0.3	0.0	0.8	0.3	0.3	0.7	0.0	12.8	0.8	0.3	3.1	3.1	0.7	0.3	0.3	0.9	0.6	0.7	0.3	0.3	0.6	0.3	0.3	0.4	0.7	0.2	0.1	0.2	0.2	0.3	0.6	0.0	0.2	0.7	0.4	1.4	0.0	0.1	1.0	0.8	0.0	0.0	0.0	0.8	1.0	0.6	0.2	0.0	0.1	0.4	0.0	0.0	0.0	0.1	0.6	0.5	1.4	2.4	0.1	0.5	0.3	0.0	0.0	0.0	0.0	0.3	0.0	0.7	0.3	0.8	0.0	0.2	1.0	1.6	0.8	0.1	0.4	0.6	0.0	0.1	0.0	0.2	1.2	0.1	0.2	0.0	0.1	0.5	0.5	0.3	0.2	0.0	0.4	0.0	0.2	0.7	0.6	0.6	0.6	0.4	0.2	0.0	0.2	0.0	0.5	0.0	0.0	0.1	0.2	0.1	0.1	0.2	0.6	0.5	0.2	0.3	0.2	0.1	0.0	0.0	0.3	0.4	3.0	0.3	0.3	0.2	0.3	0.3	0.3	0.3	0.0	0.0	0.0	0.0	0.0	0.7	0.3	0.0	0.0	0.0	0.0	53.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	3.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
PDE6G	"PDEG, RP57"	ENSG00000185527	"Phosphodiesterase 6G"	P18545	17	81650459-81663112	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Sensory transduction, Vision"	Hydrolase	"Retinitis pigmentosa"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"retina: 260.3"	"Cell type enriched"	"Detected in many"	6	"Rod photoreceptor cells: 2889.5"	"Cancer enhanced"	"Detected in many"		"testis cancer: 10.6"	"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	5	"basophil: 29.7;NK-cell: 57.8"	"Group enriched"	"Detected in all"	5	"granulocytes: 29.7;NK-cells: 57.8"	"Cell line enhanced"	"Detected in some"		"Hep G2: 6.3;NB-4: 6.7;NTERA-2: 11.6;REH: 13.5;SuSa: 8.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA045118	Supported		Uncertain	Vesicles		NA	NA			Vesicles		"HPA045118: AB_2732517"	"unprognostic (6.16e-2)"	"unprognostic (1.95e-2)"	"unprognostic (2.83e-2)"	"unprognostic (3.51e-3)"	"unprognostic (1.68e-1)"	"unprognostic (1.46e-2)"	"unprognostic (6.33e-2)"	"unprognostic (3.80e-2)"	"unprognostic (1.10e-2)"	"unprognostic (1.02e-1)"	"unprognostic (4.85e-2)"	"unprognostic (5.01e-2)"	"unprognostic (1.94e-2)"	"unprognostic (5.71e-2)"	"unprognostic (5.44e-2)"	"unprognostic (2.73e-1)"	"unprognostic (1.14e-1)"	0.9	1.3	0.4	2.9	0.5	4.7	0.7	0.5	0.6	0.4	0.8	0.5	0.4	0.0	0.4	0.5	0.6	0.3	1.6	0.5	0.5	0.7	3.8	2.6	2.0	13.8	0.6	0.5	0.5	0.4	0.0	0.5	8.6	0.5	0.5	0.5	260.3	0.5	0.4	0.6	0.8	2.8	0.4	0.8	17.9	0.7	2.2	0.5	2.5	0.6	0.4	4.6	2.1	0.4	1.3	8.6	29.7	7.7	57.8	2.4	3.7	0.2	0.3	0.5	0.0	0.3	0.0	0.0	0.3	1.1	1.2	1.3	0.1	0.8	0.6	0.2	0.7	0.6	0.1	0.2	0.2	2.8	0.2	0.0	0.9	0.1	6.3	0.9	0.1	0.2	0.0	0.2	1.2	0.0	2.4	3.3	0.4	0.1	0.3	1.3	0.8	0.1	6.7	11.6	0.0	0.4	13.5	0.1	2.0	0.0	0.0	0.1	0.3	0.0	0.3	0.5	8.6	0.1	0.8	1.3	0.4	0.1	0.2	0.3	0.1	0.6	1.0	1.6	2.7	0.2	29.7	5.1	8.6	1.2	7.7	0.4	0.8	0.3	0.6	8.6	1.3	0.7	2.4	0.7	57.8	4.2	0.8	0.0	3.7	0.4	0.5	0.5	0.6	0.5	0.7	0.6	0.5	0.5	0.5	0.0	1.1	1.4	0.0	0.8	338.0	0.0	0.0	0.0	0.0	5.2	486.9	0.2	1.7	0.4	0.6	0.0	0.0	0.0	0.2	0.3	0.2	0.1	24.1	0.0	18.8	247.9	0.0	3.1	3.8	1.6	0.0	3.2	3.3	19.8	0.0	402.2	0.3	0.0	0.0	0.3	2889.5	0.0	0.0	0.7	0.2	1.3	0.2	2.1	0.0	0.0
PDE6H		ENSG00000139053	"Phosphodiesterase 6H"	Q13956	12	14973022-14981865	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Sensory transduction, Vision"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in some"	7	"retina: 67.4"	"Cell type enriched"	"Detected in some"	6	"Cone photoreceptor cells: 783.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AN3-CA: 4.2;JURKAT: 1.0;MOLT-4: 2.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA045118	Supported		Uncertain	Vesicles		NA	NA			Vesicles		"HPA045118: AB_2732517"					"unprognostic (1.47e-3)"										"unprognostic (1.07e-2)"			0.1	1.3	1.2	0.2	1.5	9.4	0.1	0.1	4.2	0.2	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.0	0.2	0.1	1.0	2.1	0.1	0.1	0.2	0.2	2.2	0.1	0.1	0.1	0.0	0.1	2.5	0.7	0.1	0.1	67.4	0.1	0.1	0.1	0.0	0.1	0.1	0.5	0.8	0.0	0.1	0.1	0.2	0.1	0.1	0.2	0.3	0.1	0.0	0.0	0.6	0.7	0.0	0.0	1.4	0.2	0.0	0.8	4.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.6	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	1.0	0.0	0.0	0.0	0.0	2.9	0.0	0.0	0.0	0.0	0.8	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.8	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	1.4	1.2	1.5	0.1	4.2	1.0	2.1	2.2	0.1	0.7	0.1	0.0	0.0	0.0	0.0	0.0	47.5	0.0	0.0	0.0	0.0	0.0	783.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	17.5	0.0	0.0	0.0	0.0	1.0	22.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	55.0	0.0	0.0	0.0	0.0	141.6	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0
PDE7A	HCP1	ENSG00000205268	"Phosphodiesterase 7A"	Q13946	8	65717510-65842322	"Enzymes, FDA approved drug targets, Predicted intracellular proteins"		Hydrolase	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 87.5;skeletal muscle: 48.3"	"Cell type enhanced"	"Detected in many"	5	"B-cells: 80.1;Rod photoreceptor cells: 69.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"Karpas-707: 32.0;MOLT-4: 53.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB018770, HPA027340"	Approved					NA	NA					"CAB018770: AB_677329, HPA027340: AB_1855127"	"unprognostic (2.76e-1)"	"unprognostic (2.94e-2)"	"unprognostic (1.36e-1)"	"unprognostic (1.17e-2)"	"unprognostic (2.15e-1)"	"unprognostic (7.11e-2)"	"prognostic unfavorable (5.64e-4)"	"unprognostic (1.44e-2)"	"unprognostic (6.94e-2)"	"unprognostic (1.54e-1)"	"unprognostic (1.76e-2)"	"unprognostic (1.56e-1)"	"prognostic unfavorable (1.35e-4)"	"unprognostic (3.08e-2)"	"unprognostic (1.26e-1)"	"unprognostic (5.06e-2)"	"unprognostic (2.03e-2)"	6.9	1.4	4.4	22.7	4.6	12.3	10.0	7.3	4.3	7.1	4.1	5.8	5.9	5.6	3.6	8.2	3.6	3.8	6.1	21.0	4.3	3.6	13.4	2.7	10.1	27.7	4.3	2.7	3.4	9.2	1.4	7.5	4.0	4.6	7.3	5.0	3.3	11.7	12.6	48.3	4.3	13.6	4.0	3.4	16.3	6.2	4.8	5.5	87.5	13.0	25.4	22.4	5.4	4.7	7.7	2.2	5.3	0.7	2.1	12.6	1.8	4.0	3.6	15.8	7.4	2.3	2.0	6.7	3.0	2.6	3.8	3.7	4.4	2.7	11.4	0.7	1.9	3.4	4.5	5.8	6.4	4.1	13.3	3.0	8.2	5.7	3.1	1.1	6.5	3.3	2.9	10.8	2.5	7.6	3.3	3.8	27.9	6.1	32.0	2.6	2.3	53.3	8.2	16.8	3.2	1.6	19.9	2.4	2.9	2.6	8.1	7.9	9.0	3.2	1.6	1.6	11.4	8.7	17.1	2.4	5.4	6.7	3.8	2.4	15.6	6.7	19.8	5.5	13.9	2.9	0.2	0.7	5.3	3.7	0.6	6.0	6.7	5.7	3.7	1.5	7.7	12.6	9.6	2.6	2.1	0.1	2.2	4.5	1.8	4.4	4.6	7.3	4.3	4.3	3.6	4.3	2.7	4.6	5.5	17.9	17.7	80.1	11.5	16.1	26.4	35.0	17.8	26.8	25.0	3.5	53.0	11.4	0.0	6.7	20.3	9.0	4.2	0.0	4.6	7.2	18.3	16.5	9.2	3.9	9.2	17.5	9.2	8.0	14.5	10.3	6.9	15.6	15.1	10.0	6.4	11.4	5.1	5.8	7.1	15.4	69.6	0.0	10.3	10.0	11.5	16.4	7.2	50.7	6.0	8.1
PDE7B		ENSG00000171408	"Phosphodiesterase 7B"	Q9NP56	6	135851696-136195574	"Enzymes, FDA approved drug targets, Predicted intracellular proteins"		Hydrolase	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	10	"Collecting duct cells: 21.0;Endothelial cells: 18.2;Ito cells: 35.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"naive B-cell: 4.3"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"ASC diff: 7.3;ASC TERT1: 8.6;EFO-21: 13.4;HeLa: 7.8;HSkMC: 18.7;HUVEC TERT2: 8.7;U-2197: 9.3"	"Region enriched"	"Detected in all"	5	"basal ganglia: 112.3"	"Low region specificity"	"Detected in all"			HPA023967	Uncertain		Approved	Nucleoplasm		No	NA			Nucleoplasm		"HPA023967: AB_1855128"	"unprognostic (3.18e-1)"	"unprognostic (3.47e-1)"	"unprognostic (2.34e-1)"	"unprognostic (1.79e-3)"	"unprognostic (3.34e-1)"	"unprognostic (3.22e-4)"	"unprognostic (1.37e-2)"	"unprognostic (3.00e-1)"	"unprognostic (2.80e-1)"	"unprognostic (6.73e-3)"	"unprognostic (1.11e-2)"	"unprognostic (7.85e-2)"	"prognostic favorable (1.59e-4)"	"unprognostic (3.14e-3)"	"unprognostic (2.68e-2)"	"unprognostic (1.43e-1)"	"unprognostic (3.34e-2)"	5.8	4.3	7.3	4.0	21.9	0.8	3.6	1.6	12.8	6.2	4.0	2.3	25.2	3.6	14.2	4.9	2.8	4.2	6.1	7.9	5.1	7.4	9.6	6.4	3.3	2.8	6.4	4.2	22.7	1.6	3.7	8.7	2.2	5.9	6.8	5.0	5.4	5.0	28.5	7.2	1.5	3.7	13.5	5.3	2.3	5.2	2.9	7.1	7.7	8.3	6.1	1.9	10.6	5.1	4.3	2.6	0.6	0.9	0.7	1.8	0.3	0.0	4.5	0.1	0.0	7.3	8.6	0.0	0.4	2.3	1.7	0.9	0.0	0.0	0.0	13.4	2.9	0.0	0.0	0.0	0.0	0.6	0.0	0.1	0.0	7.8	0.0	3.1	0.1	0.0	18.7	0.0	3.4	0.0	0.7	8.7	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.1	3.0	0.5	3.2	3.0	0.1	0.1	0.0	0.0	1.5	0.0	1.9	0.0	9.3	0.0	0.1	0.0	0.0	0.5	0.0	0.7	0.2	0.9	0.6	0.2	0.2	0.1	1.5	0.4	0.2	2.6	4.3	1.8	1.0	0.3	0.7	0.1	0.2	0.2	0.3	7.3	21.9	1.6	12.8	5.1	7.4	6.4	4.2	5.9	7.1	0.0	0.3	3.0	0.2	0.3	2.3	8.5	2.5	0.0	0.0	21.0	0.0	0.1	0.0	0.1	0.4	18.2	0.0	0.0	1.5	0.0	3.3	0.3	10.3	4.7	0.3	6.4	7.0	35.0	1.5	0.0	11.2	0.5	0.0	0.0	0.0	13.8	0.1	0.0	7.4	1.2	0.7	12.9	3.1	0.1	0.2	1.3	0.0	0.0	0.0	0.1
PDE8A	HsT19550	ENSG00000073417	"Phosphodiesterase 8A"	O60658	15	84980440-85139145	"Enzymes, FDA approved drug targets, Predicted intracellular proteins"		Hydrolase	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in all"		"RT4: 40.2"	"Low region specificity"	"Detected in all"							HPA007722	Approved		Approved	"Golgi apparatus"		NA	NA			"Golgi apparatus"		"HPA007722: AB_1855130"	"unprognostic (1.68e-1)"	"unprognostic (2.83e-2)"	"unprognostic (4.81e-2)"	"unprognostic (4.97e-2)"	"unprognostic (6.25e-2)"	"unprognostic (3.47e-2)"	"unprognostic (2.97e-2)"	"unprognostic (3.94e-2)"	"unprognostic (1.03e-1)"	"unprognostic (2.45e-1)"	"unprognostic (8.99e-3)"	"unprognostic (2.75e-2)"	"unprognostic (3.42e-1)"	"unprognostic (3.72e-1)"	"unprognostic (4.26e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.94e-2)"	14.3	16.6	14.0	8.5	18.7	2.6	9.8	2.6	14.8	11.4	21.0	35.5	9.1	13.2	9.0	8.2	5.9	8.8	14.3	7.8	17.2	9.8	21.7	26.2	10.5	5.4	23.3	12.1	12.0	12.7	17.6	7.1	10.1	20.1	6.9	19.8	12.6	8.2	9.2	5.6	6.2	11.7	10.7	17.6	6.7	10.8	10.6	25.5	2.2	11.2	4.8	5.0	11.9	10.6	1.3	1.7	1.7	4.5	0.6	3.2	0.6	12.8	21.5	3.7	2.5	15.5	8.2	4.4	8.6	9.6	7.7	8.9	4.8	7.7	2.5	6.8	11.6	9.2	9.1	15.6	6.8	10.4	4.7	9.3	3.4	13.9	6.9	11.2	2.0	5.2	8.2	4.2	9.0	8.7	6.7	9.9	2.9	6.8	8.4	7.0	10.8	1.1	1.9	1.7	4.2	4.0	1.5	3.0	3.6	6.1	40.2	8.5	6.5	8.5	9.4	25.0	4.2	3.0	3.9	7.7	18.1	6.3	6.4	14.1	4.1	7.2	2.8	12.3	8.1	5.1	0.0	2.4	1.7	1.1	2.2	2.1	0.8	1.8	1.9	1.7	1.3	2.2	0.9	0.2	0.6	4.5	0.0	3.2	0.6	14.0	18.7	2.6	14.8	17.2	9.8	23.3	12.1	20.1	25.5	6.0	31.1	9.3	10.7	10.1	13.4	5.2	30.6	10.7	15.9	7.0	11.8	6.3	6.6	8.7	5.6	17.9	20.8	0.0	8.2	5.8	13.3	17.2	20.9	20.8	9.7	9.5	13.9	16.5	12.5	4.1	10.0	16.1	10.1	6.4	17.5	2.5	11.6	31.7	10.6	15.7	32.2	38.8	14.1	22.4	14.5	9.2	3.8	4.8	22.9	22.5
PDE8B		ENSG00000113231	"Phosphodiesterase 8B"	O95263	5	77210449-77429807	"Disease related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins"		Hydrolase	"Cushing syndrome, Disease mutation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"thyroid gland: 67.7"	"Group enriched"	"Detected in many"	4	"Cardiomyocytes: 26.4;Cone photoreceptor cells: 51.1;Glandular cells: 41.8;Horizontal cells: 65.2;Muller glia cells: 77.6"	"Cancer enriched"	"Detected in many"	6	"thyroid cancer: 35.7"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in some"	4	"BJ hTERT+: 12.4;HeLa: 28.4;SK-BR-3: 7.6"									"HPA036911, HPA036912"	Supported		Approved	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"HPA036911: AB_2675378, HPA036912: AB_10670377"	"unprognostic (1.30e-1)"	"unprognostic (7.95e-2)"	"unprognostic (3.35e-2)"	"unprognostic (7.61e-4)"	"unprognostic (1.59e-2)"	"unprognostic (1.41e-1)"	"unprognostic (2.66e-2)"	"unprognostic (4.48e-2)"	"unprognostic (1.71e-1)"	"unprognostic (3.26e-2)"	"unprognostic (3.98e-2)"	"unprognostic (2.44e-1)"	"unprognostic (9.04e-3)"	"unprognostic (3.40e-2)"	"unprognostic (3.76e-2)"	"unprognostic (1.98e-1)"	"unprognostic (3.19e-2)"	6.8	2.5	9.9	0.7	14.2	0.4	3.8	1.1	16.3	6.3	1.2	2.3	0.3	1.2	11.3	3.2	1.1	10.1	2.1	7.9	8.2	9.2	3.1	1.2	2.2	0.7	5.4	8.3	1.9	4.2	0.3	3.8	13.1	8.6	10.5	0.8	2.0	5.3	7.1	0.4	0.7	1.3	10.3	2.3	0.4	1.5	1.5	5.7	0.3	67.7	0.3	0.7	0.8	1.4	0.2	0.8	1.4	2.3	0.4	0.4	0.1	0.3	3.4	1.4	0.4	1.2	0.0	0.5	1.1	12.4	0.2	0.1	1.4	0.2	0.5	0.2	0.1	0.3	0.9	0.1	0.0	0.2	0.2	1.1	0.7	28.4	0.3	0.0	0.5	0.6	0.5	0.0	0.0	0.0	0.6	0.0	0.6	0.2	0.3	0.0	0.2	0.6	0.7	0.8	0.3	0.1	0.8	1.4	0.7	0.0	0.3	3.8	1.1	1.7	7.6	0.8	1.1	1.6	1.1	0.6	0.4	0.2	0.2	0.6	0.9	0.5	0.6	1.6	0.7	0.4	0.0	0.3	1.4	0.3	2.2	0.1	0.2	0.2	0.3	0.8	0.2	0.4	0.0	0.3	0.4	2.3	0.5	0.1	0.1	9.9	14.2	1.1	16.3	8.2	9.2	5.4	8.3	8.6	5.7	3.0	3.2	0.0	1.6	0.3	11.8	26.4	0.0	0.0	2.3	1.8	51.1	0.0	0.0	1.8	3.6	0.7	0.0	0.0	0.0	0.0	2.3	41.8	1.1	0.0	0.3	65.2	4.7	4.3	0.6	3.0	5.5	0.0	1.7	0.0	0.6	77.6	0.2	0.0	0.0	0.8	4.6	6.5	8.2	0.6	2.1	1.0	0.0	0.0	0.5	2.4
PDE9A		ENSG00000160191	"Phosphodiesterase 9A"	O76083	21	42653636-42775509	"Enzymes, FDA approved drug targets, Predicted intracellular proteins"		Hydrolase	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	15	"Enterocytes: 168.7;Paneth cells: 77.2"	"Cancer enhanced"	"Detected in all"		"prostate cancer: 31.5"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"naive CD4 T-cell: 6.8"	"Group enriched"	"Detected in many"	4	"NK-cells: 1.7;T-cells: 6.8"	"Cell line enhanced"	"Detected in many"		"AF22: 16.3;EFO-21: 16.5;MCF7: 12.2;NB-4: 18.2;NTERA-2: 22.5;SCLC-21H: 12.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA011380, HPA011978"	Enhanced		Supported	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			Cytosol	"Nucleoplasm, Plasma membrane"	"HPA011380: AB_1855132, HPA011978: "	"unprognostic (5.75e-2)"	"unprognostic (9.92e-3)"	"unprognostic (3.50e-1)"	"unprognostic (1.08e-1)"	"unprognostic (1.44e-1)"	"unprognostic (1.40e-1)"	"unprognostic (5.06e-2)"	"unprognostic (3.99e-2)"	"unprognostic (6.02e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.25e-2)"	"unprognostic (5.01e-2)"	"unprognostic (1.90e-2)"	"unprognostic (4.01e-3)"	"unprognostic (1.97e-1)"	"unprognostic (6.55e-2)"	"unprognostic (1.79e-1)"	6.1	6.6	9.9	6.8	15.2	0.8	9.4	13.7	9.0	3.7	37.1	11.9	14.0	3.0	5.7	18.8	6.1	10.3	7.7	3.5	6.2	7.7	13.2	2.5	4.7	4.6	10.0	4.9	4.1	4.0	4.7	6.0	9.6	6.9	33.2	15.8	9.7	8.8	15.9	2.3	3.8	26.1	22.3	8.0	15.9	8.4	1.5	8.9	4.9	5.2	2.1	4.1	12.6	4.0	0.5	0.9	1.0	0.1	1.7	6.8	0.5	0.0	1.5	16.3	2.0	0.0	0.6	0.3	0.0	0.0	0.0	0.0	1.8	9.8	0.0	16.5	0.0	1.1	0.0	1.4	5.3	0.0	0.0	5.6	0.0	0.0	3.3	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.2	0.0	0.0	12.2	0.8	18.2	22.5	8.0	0.0	0.0	0.0	0.6	11.2	4.5	12.5	7.4	2.8	0.0	0.2	4.0	0.1	10.1	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	6.5	0.1	0.0	0.0	0.0	0.8	0.1	0.0	0.0	2.1	0.6	0.2	0.5	6.8	1.7	1.0	1.7	0.1	0.9	2.2	0.5	9.9	15.2	13.7	6.7	6.2	7.7	10.0	4.9	6.9	8.9	3.0	5.3	0.0	8.5	0.9	21.0	1.4	5.1	1.4	0.0	17.4	0.0	0.0	24.9	6.2	0.3	6.7	168.7	0.0	2.1	0.1	3.1	27.6	1.1	0.8	5.6	33.4	12.6	3.7	0.6	1.7	10.9	1.0	27.0	1.8	19.3	9.4	5.1	77.2	5.6	7.6	2.7	12.9	5.9	0.4	0.7	0.5	0.3	2.1	22.2	13.1
PDF		ENSG00000258429	"Peptide deformylase, mitochondrial"	Q9HBH1	16	69328621-69330595	"Enzymes, Predicted intracellular proteins"	"Protein biosynthesis"	Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 30.2"	"Cell type enhanced"	"Detected in single"	21	"Alveolar cells type 1: 3.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"							HPA063409	Approved		Approved	Nucleoplasm,Mitochondria	"Intracellular and membrane"	No	No			Mitochondria	Nucleoplasm	"HPA063409: AB_2685007"	"unprognostic (4.28e-2)"	"prognostic unfavorable (4.63e-4)"	"unprognostic (1.37e-1)"	"unprognostic (1.47e-1)"	"unprognostic (2.85e-1)"	"prognostic unfavorable (2.73e-4)"	"unprognostic (2.98e-3)"	"prognostic unfavorable (7.35e-4)"	"unprognostic (5.84e-2)"	"unprognostic (4.35e-1)"	"unprognostic (1.02e-1)"	"unprognostic (1.00e-1)"	"prognostic favorable (6.11e-4)"	"unprognostic (4.78e-2)"	"unprognostic (1.05e-1)"	"unprognostic (5.98e-2)"	"unprognostic (1.22e-2)"	6.6	7.9	4.8	7.8	4.5	5.3	4.8	3.1	6.9	3.6	7.6	3.8	3.3	7.1	5.3	5.6	8.4	4.4	6.5	3.8	4.6	3.3	14.9	30.2	3.7	7.0	3.0	5.2	5.0	14.2	8.2	3.9	4.9	4.4	5.3	4.1	4.3	12.8	4.6	10.4	6.0	5.2	3.4	2.3	5.0	8.3	3.7	2.0	10.2	7.3	9.2	6.2	3.7	4.0	10.3	3.2	2.5	2.8	1.7	6.9	1.5	9.0	6.1	1.2	2.9	1.8	1.4	10.7	7.6	2.0	5.4	4.7	15.0	6.4	16.7	10.1	2.6	2.5	13.0	3.7	4.0	2.2	4.0	31.0	8.5	5.8	21.4	3.7	11.8	6.8	2.8	7.1	4.8	2.3	0.9	3.1	8.6	20.3	1.9	2.9	11.6	9.2	12.4	7.8	3.3	11.2	21.7	1.9	15.5	4.3	5.7	10.4	8.3	13.1	2.3	6.4	0.5	12.9	3.8	4.7	4.7	8.8	5.4	8.7	15.8	10.5	19.7	3.1	8.8	6.0	0.0	2.8	2.5	1.2	1.6	3.1	4.3	3.9	3.9	3.0	10.3	6.9	2.5	0.0	1.7	1.5	3.2	3.0	1.5	4.8	4.5	3.1	6.9	4.6	3.3	3.0	5.2	4.4	2.0	3.0	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.1	0.0	0.2	0.2	0.0	0.0	0.6	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.9	0.0	0.0	0.0	0.0	0.0	0.4	0.2	0.0	0.0	0.0
PDGFRA	"CD140a, GAS9, PDGFR2"	ENSG00000134853	"Platelet derived growth factor receptor alpha"	P16234	4	54229097-54298247	"Cancer-related genes, CD markers, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, RAS pathway related proteins"	"Chemotaxis, Host-virus interaction"	"Developmental protein, Kinase, Receptor, Transferase, Tyrosine-protein kinase"	"Cancer-related genes, Disease mutation, FDA approved drug targets, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"ovary: 81.5"	"Group enriched"	"Detected in many"	9	"Fibroblasts: 171.4;Leydig cells: 416.6;Peritubular cells: 384.4"	"Cancer enhanced"	"Detected in all"		"glioma: 30.8"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"ASC diff: 82.8;ASC TERT1: 38.8;BJ hTERT+: 48.0;fHDF/TERT166: 33.4;HHSteC: 28.0;HSkMC: 70.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004947, CAB018143"	Supported		Approved	"Nucleoplasm,Plasma membrane,Cell Junctions"	"Intracellular and membrane"	NA	NA		150000	"Nucleoplasm, Plasma membrane, Cell Junctions"		"CAB018143: AB_2162351, HPA004947: AB_2732399"	"unprognostic (1.67e-1)"	"unprognostic (9.35e-2)"	"unprognostic (4.59e-3)"	"unprognostic (1.60e-1)"	"unprognostic (8.92e-2)"	"prognostic favorable (9.33e-4)"	"unprognostic (1.24e-1)"	"unprognostic (2.00e-2)"	"unprognostic (1.46e-1)"	"unprognostic (2.18e-2)"	"unprognostic (2.18e-1)"	"unprognostic (7.01e-2)"	"prognostic unfavorable (9.79e-6)"	"unprognostic (9.58e-3)"	"unprognostic (9.87e-2)"	"unprognostic (2.16e-2)"	"unprognostic (1.72e-3)"	35.0	12.4	12.6	16.1	7.6	0.9	17.2	2.4	20.1	33.2	19.1	9.2	6.4	9.6	27.6	14.6	21.9	22.5	16.2	15.3	8.9	7.4	22.8	8.4	24.1	26.9	9.2	4.0	81.5	6.8	1.6	2.1	25.1	7.2	18.6	15.2	19.2	8.5	8.3	11.9	7.0	17.4	19.7	8.8	51.6	13.6	19.0	9.3	0.5	11.3	12.8	4.3	35.9	24.6	0.9	0.4	2.5	0.4	0.3	0.8	0.3	0.0	0.0	0.2	0.1	82.8	38.8	0.1	4.3	48.0	0.0	0.1	11.5	0.0	0.1	0.1	33.4	0.1	0.1	3.3	0.0	0.0	0.4	0.1	0.1	0.1	0.2	28.0	0.0	0.0	70.4	0.0	5.5	0.0	0.9	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.2	0.6	0.0	0.1	0.1	0.0	0.0	0.0	0.3	0.1	6.7	0.0	0.1	0.0	0.3	0.1	0.0	0.1	15.2	0.5	16.6	0.0	0.0	0.0	0.1	0.4	0.0	0.3	2.5	0.4	0.2	0.5	0.2	0.2	0.6	0.8	0.4	0.0	0.9	0.7	0.4	2.3	0.3	0.3	0.4	0.2	0.3	12.6	7.6	2.4	7.3	8.9	7.4	9.2	4.0	7.2	9.3	0.0	0.3	0.9	0.3	15.1	0.7	4.0	0.0	0.0	0.0	0.0	0.0	1.3	1.7	2.9	1.6	3.3	0.0	0.0	5.8	1.2	171.4	0.4	0.0	0.8	2.8	0.0	0.0	38.1	0.6	3.7	416.6	1.6	21.9	8.2	0.0	18.3	12.2	0.0	384.4	0.0	0.4	0.0	13.2	1.1	3.5	13.8	1.1	0.0	0.0	0.8
PDGFRB	"CD140b, JTK12, PDGFR, PDGFR1"	ENSG00000113721	"Platelet derived growth factor receptor beta"	P09619	5	150113837-150155872	"Cancer-related genes, CD markers, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, RAS pathway related proteins"	Chemotaxis	"Developmental protein, Kinase, Receptor, Transferase, Tyrosine-protein kinase"	"Cancer-related genes, Disease mutation, FDA approved drug targets, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enriched"	"Detected in many"	5	"Sertoli cells: 1267.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"gdT-cell: 2.9;non-classical monocyte: 4.1"	"Group enriched"	"Detected in many"	8	"monocytes: 4.1;T-cells: 2.9"	"Group enriched"	"Detected in some"	4	"ASC diff: 173.0;ASC TERT1: 59.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB003842, CAB018144, HPA028499"	Enhanced		Supported	"Golgi apparatus,Vesicles"		NA	NA		35000000	Vesicles	"Golgi apparatus"	"CAB003842: AB_562328, CAB018144: AB_2162497, HPA028499: AB_10602018"	"unprognostic (4.75e-2)"	"unprognostic (2.48e-1)"	"unprognostic (5.21e-2)"	"unprognostic (3.60e-2)"	"unprognostic (3.27e-1)"	"unprognostic (5.61e-2)"	"unprognostic (1.02e-1)"	"unprognostic (3.36e-2)"	"unprognostic (2.12e-2)"	"unprognostic (2.57e-3)"	"unprognostic (6.72e-2)"	"unprognostic (1.25e-1)"	"prognostic unfavorable (5.87e-8)"	"unprognostic (3.13e-3)"	"unprognostic (1.25e-2)"	"unprognostic (5.47e-2)"	"prognostic unfavorable (8.11e-4)"	61.8	10.4	8.3	11.0	9.1	0.5	66.1	4.6	10.4	73.1	15.7	6.7	6.9	5.1	44.3	17.3	21.7	26.1	51.7	24.2	8.2	3.9	17.0	4.6	28.9	21.5	7.9	8.1	46.5	7.5	10.4	7.7	46.4	7.7	24.2	6.3	22.9	11.2	19.3	29.8	20.3	11.2	29.8	5.0	19.6	9.2	21.5	6.7	1.4	21.4	16.0	7.3	23.6	35.1	0.4	0.1	0.0	4.1	0.0	2.9	0.6	0.0	0.0	1.0	0.0	173.0	59.9	0.4	6.0	25.1	4.2	7.1	0.6	0.0	0.0	0.8	17.3	2.4	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.4	0.4	24.5	0.0	0.0	27.0	0.0	5.8	0.0	13.5	0.0	0.0	0.0	0.6	0.6	0.0	0.0	0.0	1.1	0.0	0.0	0.4	0.3	0.0	0.0	0.0	0.0	3.2	0.0	0.0	0.0	5.0	0.0	0.0	0.0	6.8	2.2	2.9	0.3	0.0	0.0	0.0	4.2	0.0	0.1	0.0	0.0	0.0	2.9	0.6	0.0	0.4	0.1	0.8	0.1	0.1	0.0	1.3	0.0	0.0	4.1	0.0	0.0	0.6	8.3	9.1	4.6	10.4	8.2	3.9	7.9	8.1	7.7	6.7	0.0	0.6	0.0	0.5	21.3	5.0	13.4	0.0	1.4	0.0	1.8	3.9	0.6	0.0	0.0	0.8	16.2	0.0	0.0	0.0	1.0	68.8	0.6	0.0	1.5	1.4	0.0	0.0	6.7	0.0	4.7	153.1	2.2	23.6	1.0	0.0	74.9	0.1	0.0	191.6	0.0	1.1	1267.6	273.4	1.1	1.5	13.4	0.7	1.0	0.4	0.9
PDHA1	PDHA	ENSG00000131828	"Pyruvate dehydrogenase E1 alpha 1 subunit"	P08559	X	19343893-19361705	"Citric acid cycle related proteins, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Carbohydrate metabolism, Glucose metabolism, Tricarboxylic acid cycle"	Oxidoreductase	"Disease mutation, Leigh syndrome, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 107.3"	"Cell type enhanced"	"Detected in all"	7	"Cardiomyocytes: 422.4;Distal tubular cells: 300.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA047487, HPA047864, HPA063053"	Approved		Supported	Mitochondria	"Intracellular and membrane"	NA	NA		15000	Mitochondria		"HPA047487: AB_2680066, HPA047864: AB_2680190, HPA063053: AB_2684931"	"unprognostic (5.71e-3)"	"unprognostic (2.46e-3)"	"unprognostic (5.71e-2)"	"unprognostic (3.36e-3)"	"unprognostic (3.12e-2)"	"unprognostic (2.27e-2)"	"unprognostic (1.37e-2)"	"unprognostic (4.28e-1)"	"unprognostic (1.01e-1)"	"unprognostic (7.01e-3)"	"unprognostic (6.90e-2)"	"unprognostic (8.68e-2)"	"prognostic favorable (1.13e-7)"	"unprognostic (3.72e-2)"	"unprognostic (3.03e-1)"	"unprognostic (1.92e-2)"	"unprognostic (9.06e-2)"	22.5	16.1	14.7	11.7	24.3	20.4	14.7	18.6	25.0	12.3	28.6	13.0	27.7	22.7	13.0	21.6	17.2	12.4	11.8	89.3	15.5	12.2	36.6	26.6	10.5	8.9	14.8	19.9	12.2	28.7	25.0	11.6	14.9	19.0	10.8	28.2	12.7	41.8	18.3	107.3	12.7	21.1	21.2	12.7	11.5	24.9	6.3	12.0	11.3	15.0	44.9	14.9	13.1	12.4	39.4	45.1	34.8	46.1	35.5	36.6	31.9	25.6	31.9	23.1	24.3	22.4	17.2	28.4	17.7	15.8	36.7	28.4	45.4	16.5	43.8	13.2	21.3	49.1	33.5	70.9	30.7	38.7	14.5	39.5	21.7	54.9	39.9	23.8	34.7	17.8	22.1	28.6	33.8	33.6	18.6	22.3	27.4	19.1	18.6	25.6	33.9	28.9	35.6	23.5	47.1	55.8	29.9	38.8	53.6	63.2	26.2	12.8	13.6	28.2	35.8	32.0	52.0	37.7	24.4	13.8	19.0	17.1	51.6	22.4	15.8	16.2	29.0	17.9	24.3	16.4	34.8	35.0	24.2	30.3	46.1	36.6	39.4	29.4	32.8	45.1	29.3	29.0	30.6	6.1	35.5	39.1	29.8	31.1	31.9	14.7	24.3	18.6	25.0	15.5	12.2	14.8	19.9	19.0	12.0	41.7	37.7	36.5	48.9	26.6	58.2	422.4	79.0	26.8	50.0	144.8	31.4	91.3	300.1	74.7	2.0	28.6	76.1	23.3	52.1	102.6	45.2	31.9	42.6	65.5	65.3	23.8	40.3	16.0	21.0	2.9	32.8	35.5	54.0	51.3	52.9	37.8	43.3	57.5	38.2	164.1	60.9	32.3	48.4	17.4	13.0	29.2	111.6	30.9	97.8	51.0
PDHA2	PDHAL	ENSG00000163114	"Pyruvate dehydrogenase E1 alpha 2 subunit"	P29803	4	95840019-95841474	"Citric acid cycle related proteins, Enzymes, Predicted intracellular proteins"	"Carbohydrate metabolism, Glucose metabolism, Tricarboxylic acid cycle"	Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	146	"testis: 60.5"	"Group enriched"	"Detected in some"	6	"Early spermatids: 311.1;Late spermatids: 202.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"BEWO: 1.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA047487, HPA047864, HPA063053"	Approved		Supported	Mitochondria		NA	NA			Mitochondria		"HPA047487: AB_2680066, HPA047864: AB_2680190, HPA063053: AB_2684931"																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	60.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	311.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	202.7	4.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	45.9	1.6	0.0	0.0	0.0	0.0	0.0
PDHB	PDHE1B	ENSG00000168291	"Pyruvate dehydrogenase E1 beta subunit"	P11177	3	58427630-58433857	"Citric acid cycle related proteins, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Carbohydrate metabolism, Glucose metabolism, Tricarboxylic acid cycle"	Oxidoreductase	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	4	"Cardiomyocytes: 245.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB033794, HPA036744, HPA036745"	Enhanced		Supported	Nucleoplasm,Mitochondria		No	No		6500000	Mitochondria	Nucleoplasm	"CAB033794: AB_2162946, HPA036744: AB_10670921, HPA036745: AB_2675285"	"unprognostic (2.06e-2)"	"unprognostic (1.79e-1)"	"unprognostic (6.04e-3)"	"unprognostic (1.22e-1)"	"unprognostic (7.22e-2)"	"unprognostic (1.42e-1)"	"unprognostic (3.20e-2)"	"unprognostic (6.13e-2)"	"unprognostic (9.62e-2)"	"unprognostic (5.94e-2)"	"unprognostic (3.98e-1)"	"unprognostic (2.35e-1)"	"prognostic favorable (2.79e-8)"	"unprognostic (2.67e-1)"	"unprognostic (8.37e-2)"	"unprognostic (1.06e-2)"	"unprognostic (9.85e-2)"	21.8	34.3	22.5	19.5	28.4	8.6	17.1	15.1	26.2	18.0	21.6	18.4	19.2	16.2	17.2	18.2	22.8	15.0	16.5	64.2	24.1	20.8	38.7	41.8	13.9	18.2	23.7	23.3	11.0	17.2	26.0	20.0	21.6	26.4	19.5	23.9	16.1	17.6	22.1	92.2	14.3	17.3	24.5	22.8	23.2	21.4	21.8	17.5	20.9	16.1	33.8	20.6	17.9	14.4	37.0	50.1	33.6	39.8	43.4	38.6	38.3	19.0	26.7	27.7	20.8	28.2	34.7	33.3	24.1	30.2	35.7	36.8	48.2	18.5	40.8	13.6	30.5	33.1	11.1	33.7	22.1	27.3	23.6	24.8	36.4	50.5	36.3	28.6	29.5	20.5	30.3	20.5	28.7	16.9	41.9	30.7	34.1	18.7	18.4	38.7	18.2	27.9	31.0	38.2	20.2	30.4	13.3	21.6	39.3	56.3	26.2	19.3	21.2	22.3	32.2	24.0	41.8	47.6	31.7	22.5	19.1	25.5	20.0	27.2	25.8	36.6	28.7	29.3	35.1	18.0	16.4	35.4	33.6	31.5	39.8	33.2	37.0	31.2	30.0	50.1	33.3	35.1	31.4	7.0	43.4	35.9	33.7	38.6	38.3	22.5	28.4	15.1	26.2	24.1	20.8	23.7	23.3	26.4	17.5	56.6	28.0	47.4	32.8	24.7	30.0	245.7	48.4	69.6	48.9	33.2	23.6	144.4	195.6	84.1	43.2	62.9	34.8	23.3	63.6	85.4	31.9	17.8	38.1	61.1	74.4	54.0	55.7	43.6	38.0	10.4	55.8	41.0	54.0	89.2	44.3	51.8	51.0	41.3	48.1	105.9	44.7	64.7	61.8	85.0	80.3	26.1	131.5	46.0	47.8	28.8
PDIA2	"PDA2, PDI, PDIP, PDIR"	ENSG00000185615	"Protein disulfide isomerase family A member 2"	Q13087	16	283152-287215	"Enzymes, Predicted intracellular proteins"		"Chaperone, Isomerase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	19	"pancreas: 286.5"	"Cell type enriched"	"Detected in some"	6	"Exocrine glandular cells: 253.2"	"Cancer enriched"	"Detected in many"	5	"pancreatic cancer: 28.6"	"Region enhanced"	"Detected in many"		"cerebellum: 15.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HAP1: 5.2;HEK 293: 11.6;Hep G2: 8.6;Karpas-707: 4.0;MCF7: 6.1;SH-SY5Y: 5.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"HPA051692, HPA053492"	Enhanced				"Intracellular and membrane"	NA	NA					"HPA051692: AB_2681575, HPA053492: AB_2682169"	"unprognostic (3.46e-2)"	"unprognostic (7.98e-3)"	"unprognostic (3.01e-2)"	"unprognostic (1.30e-1)"	"unprognostic (2.21e-1)"	"unprognostic (2.17e-2)"	"unprognostic (6.27e-3)"	"unprognostic (1.11e-2)"	"unprognostic (3.98e-1)"	"unprognostic (1.76e-1)"	"unprognostic (4.42e-2)"	"unprognostic (2.90e-2)"	"unprognostic (1.58e-14)"	"unprognostic (3.06e-2)"	"unprognostic (1.66e-1)"	"unprognostic (8.75e-2)"	"unprognostic (2.87e-2)"	0.3	0.3	2.1	0.2	1.5	0.3	0.2	15.3	3.0	0.2	0.7	4.3	0.2	2.9	0.2	0.3	0.2	0.2	0.8	0.4	2.8	3.0	0.2	0.2	0.2	0.2	4.0	0.5	0.4	286.5	0.2	0.2	0.5	2.2	0.2	0.2	0.2	0.3	0.2	0.2	0.2	1.0	0.2	5.4	0.2	10.2	0.3	2.8	0.1	0.2	0.2	0.3	0.2	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	1.3	0.0	1.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.7	0.1	0.0	0.1	0.1	0.1	0.1	5.2	0.2	0.7	0.1	11.6	0.0	0.3	8.6	1.0	0.0	0.0	0.0	0.4	0.0	0.0	1.0	0.2	0.0	0.4	4.0	0.2	6.1	0.2	0.6	0.4	2.1	0.0	0.1	0.0	1.1	0.0	0.0	2.2	5.0	0.0	0.1	0.0	0.7	1.5	0.0	0.0	0.0	0.5	0.2	0.0	0.0	0.1	0.2	0.4	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	2.1	1.5	15.3	3.0	2.8	3.0	4.0	0.5	2.2	2.8	0.0	0.3	0.0	0.0	0.5	1.8	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.9	0.0	253.2	0.6	1.2	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	1.0	0.2	39.2	0.3	0.4	0.0	0.5	0.0	0.0	0.0	0.2	0.0	0.5	0.0	0.9	0.0
PDIA3	"ERp57, ERp60, ERp61, GRP57, GRP58, HsT17083, P58, PI-PLC"	ENSG00000167004	"Protein disulfide isomerase family A member 3"	P30101	15	43746392-43773279	"Enzymes, Plasma proteins, Predicted intracellular proteins"		Isomerase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	4	"Syncytiotrophoblasts: 877.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002645, HPA003230, CAB011199, CAB015181, CAB075744"	Enhanced		Enhanced	"Endoplasmic reticulum"	"Intracellular and membrane"	NA	NA		390000000	"Endoplasmic reticulum"		"CAB011199: AB_609902, CAB015181: AB_2160857, CAB075744: AB_2665750, HPA002645: AB_1079031, HPA003230: AB_1079030"	"unprognostic (9.20e-2)"	"unprognostic (1.21e-3)"	"unprognostic (1.34e-1)"	"prognostic favorable (2.05e-4)"	"unprognostic (2.40e-2)"	"prognostic unfavorable (8.95e-5)"	"unprognostic (1.67e-1)"	"unprognostic (8.60e-2)"	"unprognostic (2.65e-1)"	"unprognostic (2.24e-1)"	"unprognostic (1.84e-2)"	"unprognostic (1.10e-1)"	"prognostic unfavorable (2.11e-8)"	"unprognostic (1.82e-1)"	"unprognostic (1.73e-1)"	"unprognostic (1.19e-1)"	"unprognostic (6.63e-2)"	16.9	21.2	10.0	20.5	13.5	20.8	31.1	12.7	9.2	24.7	19.4	12.3	33.9	22.2	19.7	42.4	21.7	18.4	25.1	20.6	10.2	12.7	27.3	112.5	20.0	34.6	12.4	10.3	22.4	46.8	21.1	21.7	44.0	13.3	24.6	21.2	13.7	43.4	36.9	8.7	17.9	28.8	15.8	11.4	25.2	20.5	17.1	14.3	15.6	74.0	16.4	19.8	14.7	28.3	7.7	18.3	13.5	10.8	11.7	14.1	14.5	12.3	4.6	9.8	21.9	19.9	21.4	30.1	24.7	24.5	18.4	22.9	12.9	12.7	14.1	16.1	28.2	12.3	19.7	12.4	24.0	16.1	10.2	18.4	19.1	7.4	11.9	32.8	10.7	13.9	13.7	19.9	13.9	23.5	21.7	32.0	4.5	11.0	6.9	17.9	4.2	3.6	12.2	9.9	19.0	18.7	7.1	15.4	10.6	15.7	10.1	9.9	11.0	20.6	19.8	7.8	10.4	13.8	11.0	21.6	15.3	8.1	12.3	12.0	3.2	3.6	14.8	19.6	17.0	11.5	10.0	10.3	13.5	13.4	10.5	14.1	6.5	8.5	10.8	9.6	7.7	7.2	8.4	2.9	11.7	10.8	18.3	6.7	14.5	10.0	13.5	12.7	9.2	10.2	12.7	12.4	10.3	13.3	14.3	178.6	134.5	154.1	249.6	170.7	50.3	49.5	142.7	231.6	287.8	158.7	39.3	559.5	59.7	337.0	18.9	151.7	227.1	23.3	345.2	636.6	296.9	292.3	254.2	280.2	396.2	66.7	178.5	269.5	152.1	20.5	234.7	267.6	231.2	285.9	259.4	139.7	260.6	167.0	260.3	106.7	46.2	122.9	160.2	185.1	135.1	129.7	877.1	174.3	233.4	256.5
PDIA4	"ERP70, ERP72"	ENSG00000155660	"Protein disulfide isomerase family A member 4"	P13667	7	149003062-149028641	"Enzymes, Plasma proteins, Predicted intracellular proteins"		Isomerase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 164.3"	"Cell type enhanced"	"Detected in many"	7	"Hepatocytes: 542.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006139, HPA006140, CAB017368"	Supported		Supported	"Endoplasmic reticulum"	"Intracellular and membrane"	NA	NA		12000000	"Endoplasmic reticulum"		"CAB017368: AB_10621725, HPA006139: AB_1848256, HPA006140: AB_1848257"	"unprognostic (1.98e-1)"	"unprognostic (1.62e-2)"	"unprognostic (1.77e-1)"	"unprognostic (1.87e-2)"	"prognostic unfavorable (9.69e-4)"	"unprognostic (1.97e-2)"	"unprognostic (1.81e-1)"	"unprognostic (2.11e-2)"	"unprognostic (5.11e-2)"	"unprognostic (3.24e-3)"	"unprognostic (6.08e-3)"	"unprognostic (3.20e-2)"	"prognostic unfavorable (5.20e-9)"	"unprognostic (1.03e-1)"	"unprognostic (1.53e-1)"	"unprognostic (6.76e-2)"	"unprognostic (2.51e-1)"	17.6	13.0	7.7	25.6	11.9	7.4	27.4	5.1	7.9	25.5	20.9	12.1	28.8	18.2	19.4	46.3	15.2	20.8	28.1	16.9	7.3	8.0	27.7	164.3	19.1	29.1	11.6	6.2	19.4	76.3	7.0	19.1	24.7	12.0	18.0	21.9	7.8	36.4	26.5	5.8	10.1	21.3	17.8	13.9	27.9	23.7	11.5	11.3	19.2	89.8	11.9	24.3	17.4	22.6	26.6	63.3	16.2	21.2	21.5	35.9	34.5	32.4	30.9	33.6	93.9	30.7	21.9	48.7	45.7	30.6	26.2	42.8	25.6	87.8	23.4	102.6	37.5	72.2	21.3	22.6	43.3	23.1	16.6	13.3	11.2	8.9	56.1	41.2	25.5	31.7	21.5	19.4	28.7	23.1	34.2	53.2	12.0	18.3	63.8	23.0	35.5	24.3	29.1	50.1	66.4	18.0	16.0	26.1	56.6	30.6	25.5	10.7	28.2	41.5	29.9	15.9	41.9	17.0	19.7	29.0	20.7	11.7	50.1	32.1	48.6	21.8	16.4	48.3	30.2	70.3	16.2	20.1	12.1	34.3	21.2	35.9	26.6	22.6	26.7	19.4	15.1	21.5	22.7	2.7	21.5	21.0	63.3	16.6	34.5	7.7	11.9	5.1	7.9	7.3	8.0	11.6	6.2	12.0	11.3	26.8	33.4	29.0	71.4	30.8	3.3	20.4	96.8	65.6	44.3	40.1	3.9	152.3	13.3	102.2	2.7	35.1	89.5	46.7	79.9	277.0	90.5	103.6	57.6	542.5	131.4	0.0	59.1	95.8	80.7	3.2	54.7	53.4	82.7	48.7	104.5	19.3	96.2	87.1	40.3	54.4	6.1	32.3	34.2	53.4	71.9	25.0	192.7	54.6	97.0	59.2
PDIA5	"FLJ30401, PDIR"	ENSG00000065485	"Protein disulfide isomerase family A member 5"	Q14554	3	123067062-123225227	"Enzymes, Predicted intracellular proteins"		Isomerase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 66.0"	"Cell type enhanced"	"Detected in many"	8	"Extravillous trophoblasts: 119.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"plasmacytoid DC: 12.8"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA030353, HPA030355"	Enhanced		Supported	"Nucleoplasm,Nucleoli fibrillar center,Golgi apparatus"	"Intracellular and membrane"	NA	NA		2900000	"Nucleoplasm, Golgi apparatus"	"Nucleoli fibrillar center"	"HPA030353: AB_10599734, HPA030355: AB_10602200"	"unprognostic (8.81e-2)"	"unprognostic (2.25e-2)"	"unprognostic (8.93e-2)"	"prognostic favorable (4.55e-4)"	"unprognostic (4.34e-2)"	"unprognostic (2.10e-2)"	"unprognostic (7.38e-2)"	"unprognostic (2.41e-1)"	"unprognostic (3.21e-2)"	"unprognostic (4.02e-2)"	"unprognostic (1.55e-1)"	"unprognostic (2.26e-3)"	"prognostic unfavorable (8.09e-11)"	"unprognostic (1.57e-1)"	"unprognostic (1.92e-1)"	"unprognostic (1.06e-2)"	"unprognostic (4.06e-3)"	11.6	17.1	2.6	11.2	3.1	6.3	9.3	1.0	4.0	10.0	11.0	2.4	10.9	5.6	12.2	17.1	6.7	9.1	22.2	7.2	2.5	1.2	11.0	66.0	14.4	7.1	2.2	1.8	11.4	18.3	5.2	12.1	29.1	1.9	14.3	10.8	12.7	10.8	7.6	8.1	6.1	8.2	9.5	2.3	8.6	17.6	18.0	2.5	3.2	18.2	5.5	7.9	7.8	6.9	3.2	12.8	0.3	9.0	0.5	2.4	2.3	8.2	5.1	6.4	7.7	29.4	26.7	34.1	15.8	26.5	8.8	24.4	16.3	7.6	0.0	20.6	24.4	5.7	4.4	2.8	9.6	9.4	0.2	3.1	3.6	1.5	19.4	12.2	9.1	0.6	22.8	14.5	6.0	12.6	9.5	29.8	3.5	4.6	21.6	6.0	10.1	2.4	10.6	4.7	18.9	5.3	2.3	4.6	22.8	7.4	4.8	6.9	4.2	7.7	8.6	13.5	10.9	7.5	11.1	16.6	2.3	7.3	10.6	4.2	6.4	1.7	3.7	7.3	7.2	7.7	0.0	9.0	0.3	1.4	2.2	2.4	3.2	1.0	0.9	5.4	0.8	0.6	0.6	0.2	0.5	0.4	12.8	0.0	2.3	2.6	3.1	1.0	4.0	2.5	1.2	2.2	1.8	1.9	2.5	17.9	27.8	1.5	3.6	4.4	9.3	2.0	25.5	8.1	13.6	5.2	37.3	39.8	0.0	28.0	1.1	21.8	3.3	0.0	25.3	119.9	23.6	13.9	3.5	42.3	10.8	0.0	8.1	37.4	8.4	1.5	22.5	4.5	8.5	1.8	26.1	2.0	13.8	3.5	20.8	4.9	29.6	12.9	7.3	1.2	1.5	3.6	42.0	2.2	16.3	4.3
PDIA6	"ERp5, P5, TXNDC7"	ENSG00000143870	"Protein disulfide isomerase family A member 6"	Q15084	2	10783391-10837977	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"		"Chaperone, Isomerase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	6	"Extravillous trophoblasts: 955.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB034347, HPA034652, HPA034653"	Enhanced		Supported	"Endoplasmic reticulum,Cytosol"	"Intracellular and membrane"	NA	NA		53000000	"Endoplasmic reticulum, Cytosol"		"CAB034347: AB_2299360, HPA034652: AB_2674263, HPA034653: AB_10601982"	"unprognostic (8.16e-2)"	"prognostic unfavorable (1.80e-4)"	"unprognostic (1.03e-1)"	"unprognostic (1.24e-1)"	"unprognostic (1.31e-1)"	"prognostic unfavorable (1.20e-4)"	"prognostic unfavorable (3.63e-5)"	"unprognostic (3.17e-2)"	"unprognostic (1.02e-2)"	"unprognostic (5.25e-3)"	"unprognostic (6.03e-3)"	"unprognostic (1.68e-1)"	"prognostic unfavorable (2.51e-6)"	"unprognostic (6.59e-2)"	"unprognostic (2.34e-1)"	"unprognostic (1.38e-2)"	"unprognostic (3.69e-3)"	26.9	32.7	16.7	25.0	29.9	19.9	28.7	11.3	16.8	33.4	26.1	13.9	53.7	20.4	30.4	76.1	27.1	25.5	22.4	32.7	14.2	13.9	42.1	118.4	30.4	36.3	17.8	12.7	26.5	141.6	24.9	23.3	39.5	19.0	22.6	30.1	14.6	53.4	45.0	15.7	16.1	28.4	26.5	14.3	35.1	30.9	12.4	19.5	18.1	97.9	20.1	29.7	21.9	30.6	45.2	61.0	52.0	46.2	51.5	52.2	59.7	33.2	36.1	51.7	81.1	66.6	57.6	92.0	80.9	75.1	42.5	57.3	51.2	65.7	54.0	57.0	79.1	82.6	27.3	38.8	67.7	45.7	42.3	30.6	43.8	28.3	83.1	72.1	44.8	32.9	41.5	52.1	41.1	74.2	78.8	95.7	20.5	37.6	116.5	41.9	39.4	17.2	46.5	43.2	108.3	28.6	41.4	52.7	97.8	60.5	40.2	33.2	66.5	31.9	46.8	45.4	70.0	16.5	76.1	47.0	39.9	51.0	35.9	46.7	110.0	67.8	35.0	53.9	56.4	55.8	52.0	44.4	20.5	47.5	46.2	52.2	45.2	37.7	44.7	48.6	33.1	18.4	31.0	8.1	51.5	33.9	61.0	37.7	59.7	16.7	29.9	11.3	16.8	14.2	13.9	17.8	12.7	19.0	19.5	53.6	94.6	111.7	205.7	91.5	66.3	27.4	152.8	108.4	161.5	186.7	27.5	420.2	36.5	263.9	6.1	114.4	100.2	23.3	210.7	955.4	173.7	256.1	129.2	285.4	369.6	39.7	151.3	244.9	137.9	12.1	112.2	137.1	189.0	126.2	149.4	95.2	191.3	100.8	126.9	98.3	45.7	84.1	115.4	95.8	139.7	89.6	463.4	112.4	196.3	240.5
PDIK1L	CLIK1L	ENSG00000175087	"PDLIM1 interacting kinase 1 like"	Q8N165	1	26111165-26125543	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Horizontal cells: 22.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA064157			Supported	Nucleoplasm		NA	NA			Nucleoplasm		"HPA064157: "	"unprognostic (1.09e-1)"	"unprognostic (1.81e-3)"	"unprognostic (2.99e-3)"	"unprognostic (2.52e-2)"	"unprognostic (2.54e-1)"	"unprognostic (1.34e-3)"	"unprognostic (3.93e-2)"	"unprognostic (1.72e-3)"	"unprognostic (7.29e-3)"	"unprognostic (1.08e-1)"	"unprognostic (2.42e-2)"	"unprognostic (3.59e-1)"	"unprognostic (1.34e-2)"	"unprognostic (4.24e-3)"	"unprognostic (2.94e-1)"	"unprognostic (4.47e-1)"	"unprognostic (1.78e-2)"	7.0	6.0	8.6	6.2	12.3	19.9	11.5	17.8	15.9	8.6	8.9	7.1	7.6	9.5	7.8	6.4	11.4	7.5	5.8	4.8	8.5	10.6	8.5	11.3	6.7	8.0	9.3	9.9	10.2	15.3	10.7	9.9	5.6	11.5	6.8	10.6	6.1	10.2	8.9	7.7	9.4	9.7	6.5	8.3	8.3	10.2	7.8	9.3	19.1	22.2	6.7	8.8	8.8	8.0	6.7	9.3	11.0	6.1	5.6	10.4	5.2	5.5	2.1	5.9	7.4	2.3	3.1	1.9	1.4	2.0	3.8	2.5	1.4	8.0	11.7	4.3	2.1	3.0	4.1	7.8	2.9	3.6	4.2	5.2	10.4	3.3	1.5	3.4	10.9	6.3	1.6	4.2	3.4	6.7	2.6	3.4	11.4	12.3	11.7	1.3	3.1	15.8	4.9	2.7	6.8	3.2	8.4	5.4	14.0	2.5	4.4	9.4	8.0	5.6	7.1	7.2	1.6	4.1	3.7	3.1	4.1	3.6	5.2	4.6	17.5	17.2	8.9	4.3	13.6	3.9	11.0	5.0	4.2	6.7	4.6	6.2	6.7	9.4	7.4	9.3	5.6	10.0	8.0	0.5	5.6	6.1	3.5	10.4	5.2	8.6	12.3	17.8	15.9	8.5	10.6	9.3	9.9	11.5	9.3	8.9	3.4	4.5	1.8	2.9	17.8	1.6	10.2	9.4	7.9	1.8	0.0	3.2	0.0	2.7	0.9	3.5	3.9	0.0	3.5	0.4	2.6	3.1	6.9	9.7	3.4	22.3	12.6	3.1	6.5	0.0	2.3	4.2	3.3	0.0	9.1	10.1	3.0	0.0	2.8	6.0	9.8	0.0	1.4	8.1	4.3	6.5	1.4	4.9	10.0	2.4
PDK1		ENSG00000152256	"Pyruvate dehydrogenase kinase 1"	Q15118	2	172555373-172608669	"Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"	"Carbohydrate metabolism, Glucose metabolism"	"Kinase, Transferase"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"Early spermatids: 96.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in all"	5	"B-cells: 5.9;granulocytes: 16.0;T-cells: 15.8"	"Cell line enhanced"	"Detected in many"		"U-266/70: 32.0;U-87 MG: 32.7"	"Low region specificity"	"Detected in all"							"CAB017554, HPA027376"	Approved					NA	NA		22000			"CAB017554: AB_2161138, HPA027376: AB_1855139"	"unprognostic (2.14e-1)"	"prognostic unfavorable (7.30e-5)"	"unprognostic (1.21e-1)"	"unprognostic (3.94e-2)"	"unprognostic (6.47e-2)"	"unprognostic (1.58e-1)"	"unprognostic (1.02e-2)"	"unprognostic (1.45e-1)"	"unprognostic (9.69e-3)"	"unprognostic (6.44e-2)"	"unprognostic (5.44e-3)"	"unprognostic (1.55e-1)"	"prognostic unfavorable (1.10e-8)"	"unprognostic (1.82e-1)"	"unprognostic (1.94e-1)"	"unprognostic (2.56e-2)"	"unprognostic (5.34e-2)"	9.9	16.2	6.8	11.0	10.5	13.4	16.7	7.1	15.6	7.3	15.3	3.3	2.9	15.5	5.4	8.0	11.2	4.4	5.8	27.6	6.9	5.2	6.8	14.2	6.1	21.4	7.2	5.2	19.5	7.2	3.4	7.5	7.9	7.2	6.5	13.1	7.6	14.1	7.6	9.6	24.7	8.4	5.2	10.7	14.2	12.5	11.0	6.7	10.3	5.1	5.0	20.8	18.0	9.8	5.9	2.3	16.0	2.2	1.4	15.8	6.2	14.4	0.6	3.7	9.3	1.5	2.3	5.3	12.7	10.3	6.4	13.7	3.7	3.1	13.7	7.0	3.9	5.3	6.3	2.5	7.9	20.5	2.7	5.1	16.7	3.4	4.3	2.7	8.3	6.2	3.0	2.9	4.4	7.5	8.9	3.4	7.3	3.5	9.5	8.4	1.5	5.2	10.4	9.1	2.9	4.0	5.5	6.1	22.1	3.3	4.6	7.0	8.0	3.3	3.9	4.8	3.3	2.5	3.4	3.9	10.2	3.3	5.3	3.4	32.0	18.5	11.3	32.7	6.0	2.0	12.2	2.2	16.0	2.5	1.5	3.0	4.7	4.2	2.8	2.3	5.9	15.8	9.6	8.5	1.4	1.9	0.4	8.0	6.2	6.8	10.5	7.1	15.6	6.9	5.2	7.2	5.2	7.2	6.7	3.0	5.3	32.2	5.4	44.5	26.8	32.3	5.1	1.4	2.3	3.5	45.2	9.1	5.0	7.7	96.0	8.9	6.0	0.0	3.3	9.6	8.4	5.5	5.7	11.9	8.7	52.4	7.5	23.9	12.9	34.3	3.1	8.8	28.7	5.4	5.2	7.6	9.0	14.0	3.5	1.5	18.9	6.5	12.3	6.3	7.7	37.9	3.4	12.5	6.0	2.1
PDK2	PDHK2	ENSG00000005882	"Pyruvate dehydrogenase kinase 2"	Q15119	17	50094737-50112152	"Enzymes, Predicted intracellular proteins"	"Carbohydrate metabolism, Glucose metabolism"	"Kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 101.0"	"Cell type enhanced"	"Detected in many"	6	"Proximal tubular cells: 118.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA008287	Supported		Approved	Nucleoplasm,Mitochondria		NA	NA			"Nucleoplasm, Mitochondria"		"HPA008287: AB_1079589"	"unprognostic (2.74e-2)"	"prognostic favorable (5.87e-4)"	"unprognostic (1.16e-1)"	"unprognostic (2.43e-3)"	"unprognostic (1.22e-1)"	"unprognostic (9.63e-3)"	"unprognostic (9.80e-3)"	"unprognostic (8.39e-3)"	"unprognostic (3.19e-2)"	"unprognostic (1.25e-1)"	"unprognostic (1.17e-2)"	"unprognostic (2.21e-1)"	"prognostic favorable (9.59e-5)"	"unprognostic (3.81e-1)"	"unprognostic (2.54e-1)"	"unprognostic (5.33e-1)"	"unprognostic (1.55e-1)"	20.6	26.1	17.2	5.2	27.5	3.2	10.8	53.7	34.4	10.1	16.1	16.1	10.1	15.5	13.1	69.8	12.5	14.4	11.5	51.7	18.2	13.0	33.7	27.8	9.0	5.7	14.6	20.9	27.7	24.1	16.9	7.5	8.6	14.2	12.7	12.4	19.5	14.0	16.5	101.0	10.6	16.5	15.1	9.9	7.8	13.6	7.2	11.4	6.2	15.6	31.4	7.4	13.8	9.4	11.3	20.1	8.9	12.9	16.5	17.4	12.2	6.4	9.2	11.1	10.0	11.8	8.9	1.2	7.0	10.4	10.5	10.2	0.8	7.0	8.1	11.7	19.5	7.1	3.1	7.4	2.8	10.3	16.3	10.3	7.2	9.1	6.8	6.3	0.0	7.8	18.7	10.8	6.8	0.5	18.5	9.1	10.4	2.9	8.1	5.9	8.2	6.0	0.0	2.4	19.5	9.0	9.1	24.9	10.9	5.7	5.5	7.4	11.2	9.9	3.1	4.7	14.2	18.3	7.2	4.7	12.3	10.1	8.4	5.1	16.0	15.1	4.4	18.0	2.6	7.9	8.9	12.9	6.8	14.0	9.8	11.1	11.1	12.5	14.8	14.2	11.3	14.6	15.0	2.2	16.5	10.5	20.1	17.4	12.2	17.2	27.5	53.7	34.4	18.2	13.0	14.6	20.9	14.2	11.4	8.9	9.3	13.6	13.9	13.5	20.8	5.0	10.2	1.4	11.4	19.2	5.9	15.1	49.7	8.0	7.3	8.3	46.6	0.0	7.9	3.4	19.5	7.6	1.1	39.8	16.7	41.3	13.3	13.5	13.7	15.0	22.5	7.9	23.6	15.4	45.3	33.6	7.9	43.6	49.5	118.5	9.2	19.4	12.1	3.3	4.4	16.4	6.6	15.8	37.1	8.4
PDK3		ENSG00000067992	"Pyruvate dehydrogenase kinase 3"	Q15120	X	24465221-24539837	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Carbohydrate metabolism, Glucose metabolism"	"Kinase, Transferase"	"Charcot-Marie-Tooth disease, Disease mutation, Neurodegeneration, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	8	"Early spermatids: 53.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA046583, HPA072492"	Approved		Supported	Nucleoli,Mitochondria		NA	NA			Mitochondria	Nucleoli	"HPA046583: AB_2679707, HPA072492: AB_2686526"	"unprognostic (5.41e-3)"	"unprognostic (5.43e-3)"	"unprognostic (5.35e-3)"	"unprognostic (3.40e-1)"	"unprognostic (4.05e-3)"	"unprognostic (5.38e-2)"	"prognostic unfavorable (2.76e-4)"	"unprognostic (1.51e-1)"	"unprognostic (5.57e-2)"	"unprognostic (1.35e-1)"	"unprognostic (1.39e-2)"	"unprognostic (2.02e-1)"	"unprognostic (1.72e-1)"	"unprognostic (1.02e-1)"	"unprognostic (2.92e-1)"	"unprognostic (2.28e-2)"	"unprognostic (9.43e-3)"	9.6	5.6	5.7	9.8	17.3	16.3	12.8	3.3	23.6	8.0	14.7	5.5	5.6	13.6	7.3	15.7	9.5	13.2	7.0	16.9	12.5	6.8	13.7	11.1	11.2	13.4	6.2	13.7	11.0	7.3	12.8	14.1	7.7	14.9	8.3	10.1	9.9	19.3	5.2	3.9	14.2	15.6	8.6	6.1	17.9	12.7	23.1	4.8	12.5	6.2	4.1	14.9	10.3	9.2	4.5	7.2	36.4	10.9	7.1	11.0	6.7	9.0	4.6	3.9	6.6	0.1	0.0	4.1	2.7	2.4	3.7	6.5	0.4	11.1	9.2	1.9	0.7	10.5	2.1	11.3	6.9	10.0	7.8	5.4	4.9	5.3	2.6	1.3	4.2	4.8	0.7	3.1	0.9	0.9	0.4	5.5	9.6	0.9	14.0	0.5	17.0	7.8	5.4	7.0	9.7	5.4	4.0	7.0	13.5	3.2	17.7	2.5	3.2	14.7	6.0	4.6	6.2	8.3	1.6	0.2	2.6	3.8	4.8	3.2	9.0	6.9	11.0	7.1	6.4	5.4	9.4	8.9	21.3	7.6	10.9	11.0	4.5	6.2	6.2	7.2	4.1	4.9	5.7	36.4	7.1	10.4	2.3	5.1	6.7	5.7	17.3	3.3	23.6	12.5	6.8	6.2	13.7	14.9	4.8	3.0	1.3	2.9	8.6	4.0	3.4	6.3	0.0	1.4	2.3	1.8	0.0	4.0	3.3	3.6	53.4	2.8	4.5	0.0	4.5	26.4	3.2	5.2	5.7	4.2	13.2	7.9	4.1	4.3	18.9	22.4	3.4	9.6	15.1	8.2	2.4	3.2	2.8	0.0	5.3	11.3	3.9	0.0	9.2	6.4	6.3	3.9	14.9	14.9	3.3	7.1
PDK4		ENSG00000004799	"Pyruvate dehydrogenase kinase 4"	Q16654	7	95583499-95596491	"Enzymes, Predicted intracellular proteins"	"Carbohydrate metabolism, Glucose metabolism"	"Kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 351.0;skeletal muscle: 497.0"	"Cell type enhanced"	"Detected in many"	11	"Cardiomyocytes: 766.1;Collecting duct cells: 359.4;Kupffer cells: 351.0"	"Cancer enhanced"	"Detected in all"		"renal cancer: 107.8"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	11	"classical monocyte: 14.2;eosinophil: 15.6;intermediate monocyte: 26.1;myeloid DC: 7.1;non-classical monocyte: 15.6"	"Group enriched"	"Detected in many"	11	"dendritic cells: 7.1;granulocytes: 15.6;monocytes: 26.1"	"Cell line enriched"	"Detected in some"	7	"ASC diff: 107.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA056731	Approved					NA	NA					"HPA056731: AB_2683218"	"unprognostic (3.18e-3)"	"unprognostic (1.98e-1)"	"unprognostic (1.52e-1)"	"unprognostic (1.34e-1)"	"unprognostic (5.15e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.00e-3)"	"unprognostic (3.47e-1)"	"unprognostic (6.38e-2)"	"unprognostic (2.24e-3)"	"unprognostic (1.87e-2)"	"unprognostic (8.75e-2)"	"unprognostic (2.41e-2)"	"prognostic unfavorable (1.80e-4)"	"unprognostic (9.15e-2)"	"unprognostic (4.20e-2)"	"unprognostic (1.12e-1)"	90.7	41.9	6.9	5.9	14.6	0.4	49.1	2.5	9.1	12.3	30.9	9.0	150.6	13.6	10.7	13.7	29.0	14.7	15.6	351.0	9.2	3.7	27.7	39.5	14.1	6.1	18.2	2.4	46.6	102.9	0.8	8.1	19.4	26.1	29.3	8.4	4.4	8.4	150.6	497.0	10.2	46.2	20.7	13.9	19.0	21.2	10.8	17.4	1.0	13.4	12.3	2.5	23.8	46.4	0.7	7.1	15.6	26.1	1.4	0.0	4.7	0.0	8.0	0.3	2.0	107.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.0	1.1	0.3	0.3	0.0	0.0	0.0	0.0	0.0	0.2	0.0	14.7	0.0	1.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.5	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	5.1	0.5	0.1	0.6	0.0	0.6	1.6	0.5	0.2	0.2	0.0	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	14.2	15.6	0.0	26.1	0.0	0.1	0.0	0.0	7.1	0.7	0.0	0.0	1.0	1.4	15.6	0.2	0.0	4.7	6.9	14.6	2.5	9.1	9.2	3.7	18.2	2.4	26.1	17.4	29.8	13.6	12.6	245.0	9.3	0.0	766.1	28.1	96.4	52.4	359.4	0.0	2.7	11.6	4.3	10.2	89.9	112.9	0.0	4.7	0.7	44.7	113.9	4.7	93.7	42.3	0.0	53.1	160.8	351.0	2.5	124.3	29.1	86.0	1.8	47.0	11.6	8.2	42.1	42.1	35.5	0.3	161.7	181.3	0.2	0.5	8.2	9.2	5.7	27.3	131.1
PDP1	"PDH, PDP, PPM2A, PPM2C"	ENSG00000164951	"Pyruvate dehyrogenase phosphatase catalytic subunit 1"	Q9P0J1	8	93857807-93926066	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 62.2"	"Cell type enhanced"	"Detected in many"	7	"Cardiomyocytes: 71.4;Early spermatids: 99.2"	"Low cancer specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"basal ganglia: 38.9;cerebral cortex: 62.2;olfactory region: 32.5"	"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"GAMG: 39.5;hTERT-RPE1: 39.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA018483, HPA019081, HPA021152"	Uncertain		Approved	Nucleoplasm,Mitochondria,Cytosol		Yes	No			"Nucleoplasm, Mitochondria, Cytosol"		"HPA018483: AB_1855634, HPA019081: AB_1855633, HPA021152: AB_1855635"	"prognostic unfavorable (8.61e-5)"	"unprognostic (4.62e-1)"	"unprognostic (8.79e-2)"	"unprognostic (1.09e-1)"	"unprognostic (9.46e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.59e-1)"	"unprognostic (1.18e-2)"	"unprognostic (1.00e-1)"	"prognostic unfavorable (5.60e-4)"	"unprognostic (1.71e-2)"	"unprognostic (3.25e-1)"	"prognostic favorable (8.42e-9)"	"unprognostic (1.85e-1)"	"unprognostic (1.84e-1)"	"unprognostic (5.04e-2)"	"unprognostic (1.67e-1)"	5.1	32.3	11.0	4.6	38.9	5.9	7.9	7.5	62.2	7.5	4.3	4.7	1.6	3.3	7.7	8.6	8.0	6.1	9.6	22.9	10.1	8.0	6.3	2.2	6.0	5.6	5.1	32.5	9.7	9.3	20.6	4.2	6.6	4.4	5.2	6.2	4.4	6.6	4.7	31.8	3.2	5.5	5.5	3.4	5.8	5.5	12.9	4.8	4.1	9.3	7.0	5.8	7.7	5.1	11.0	12.7	7.8	21.5	2.8	19.5	8.8	7.9	3.9	8.6	3.6	7.1	13.1	2.8	6.3	7.0	7.4	8.7	4.1	29.6	4.4	21.2	10.0	39.5	17.7	3.6	5.3	11.0	0.4	1.8	2.1	4.9	1.4	8.2	1.0	3.0	8.4	10.5	12.6	20.2	39.3	16.7	4.0	0.7	7.3	9.0	1.9	6.2	3.2	3.9	8.6	5.1	1.5	5.1	0.8	5.1	5.5	0.8	3.7	4.1	0.4	19.3	7.3	1.3	1.2	29.6	9.0	5.8	21.0	7.4	4.1	1.7	3.7	11.5	3.7	7.9	3.1	15.4	7.8	5.6	14.3	5.3	9.3	9.1	7.2	12.7	11.0	5.5	4.8	1.8	2.8	21.5	2.1	19.5	8.8	11.0	38.9	7.5	62.2	10.1	8.0	5.1	32.5	4.4	4.8	11.9	5.6	13.4	11.2	11.6	34.7	71.4	22.9	22.7	17.0	15.7	7.9	3.5	5.0	24.3	99.2	14.7	6.0	0.0	11.9	3.2	11.6	13.3	5.8	2.5	5.7	9.5	9.8	14.1	20.8	22.0	10.6	16.2	10.1	2.8	5.2	19.0	22.2	7.0	12.7	8.6	10.6	6.5	12.7	7.2	9.7	9.5	3.7	10.1	8.9	17.0
PDP2	"KIAA1348, PPM2B, PPM2C2"	ENSG00000172840	"Pyruvate dehyrogenase phosphatase catalytic subunit 2"	Q9P2J9	16	66878589-66895754	"Enzymes, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019950, HPA062059"	Approved		Approved	Mitochondria		NA	NA			Mitochondria		"HPA019950: AB_1855156, HPA062059: AB_2684671"	"unprognostic (8.42e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.19e-2)"	"unprognostic (1.31e-1)"	"unprognostic (2.31e-2)"	"unprognostic (5.44e-2)"	"unprognostic (1.17e-1)"	"unprognostic (4.90e-3)"	"unprognostic (1.57e-1)"	"unprognostic (7.24e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.39e-1)"	"prognostic favorable (9.75e-7)"	"unprognostic (1.89e-1)"	"unprognostic (5.10e-1)"	"unprognostic (3.20e-1)"	"unprognostic (6.15e-2)"	10.7	7.2	7.4	3.7	10.5	3.2	8.7	11.5	16.5	4.9	7.5	10.1	5.7	10.4	7.9	7.2	8.9	7.2	6.0	4.8	7.4	7.1	18.1	16.5	8.6	5.0	9.0	9.4	14.9	13.8	12.0	7.0	7.7	16.0	7.8	8.4	8.5	7.1	6.9	6.3	4.7	6.2	4.6	6.3	4.0	6.7	8.6	8.9	4.6	18.0	4.0	5.9	6.3	5.5	3.3	1.3	1.8	0.4	6.1	6.3	2.0	7.2	8.9	5.5	10.8	14.9	7.7	6.9	3.8	14.8	8.9	13.4	18.1	5.2	10.2	5.5	5.3	8.5	9.3	16.0	8.6	8.6	2.4	8.1	5.1	4.5	11.8	8.1	6.5	9.0	5.8	6.5	12.6	13.1	9.7	3.8	11.5	9.8	7.3	7.9	4.8	12.6	4.7	6.5	4.9	11.3	12.5	7.7	16.0	4.7	7.8	11.1	6.3	12.3	5.0	4.6	4.5	6.7	3.2	3.5	5.4	7.4	3.3	5.6	13.0	12.0	10.1	7.5	5.2	5.4	1.3	0.4	1.8	6.3	0.3	5.2	1.8	3.1	5.1	1.3	3.3	4.5	5.0	1.3	6.1	0.2	0.8	0.9	2.0	7.4	10.5	11.5	16.5	7.4	7.1	9.0	9.4	16.0	8.9	8.9	18.5	5.9	4.3	4.6	7.9	4.5	7.6	1.4	4.5	8.7	13.7	9.1	6.6	2.7	0.1	1.8	5.1	0.0	2.5	1.6	4.2	6.7	5.8	11.5	2.1	4.8	3.5	6.7	0.6	1.9	2.8	0.8	3.3	0.0	4.0	8.4	2.8	5.8	4.2	8.1	6.3	0.0	3.1	4.4	1.3	2.0	3.0	1.9	5.8	7.0
PDPK1	PDK1	ENSG00000140992	"3-phosphoinositide dependent protein kinase 1"	O15530	16	2537964-2603188	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Activator, Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004272, HPA035199"	Supported		Supported	Cytosol		NA	NA			Cytosol		"CAB004272: AB_626657, HPA035199: AB_2674514"	"unprognostic (2.67e-2)"	"unprognostic (1.63e-1)"	"unprognostic (3.12e-3)"	"unprognostic (4.21e-2)"	"unprognostic (1.34e-1)"	"unprognostic (4.69e-3)"	"unprognostic (8.37e-2)"	"unprognostic (3.18e-2)"	"unprognostic (8.17e-2)"	"unprognostic (3.70e-2)"	"unprognostic (1.52e-2)"	"unprognostic (3.28e-2)"	"prognostic favorable (1.29e-14)"	"unprognostic (2.04e-2)"	"unprognostic (5.96e-2)"	"unprognostic (1.95e-1)"	"unprognostic (2.16e-1)"	11.1	14.9	21.0	11.6	31.9	14.2	14.2	29.6	26.4	10.5	15.6	14.5	10.4	17.2	13.0	14.0	13.8	15.3	10.8	14.8	17.2	13.5	17.6	12.6	13.4	13.5	11.3	20.6	14.8	28.2	34.5	13.9	17.1	16.7	13.6	15.3	12.8	16.5	13.2	18.2	14.1	19.1	12.9	10.9	13.7	13.4	14.2	10.1	14.1	16.1	10.6	13.9	12.3	13.3	5.1	9.1	14.7	9.4	5.4	6.0	4.5	8.5	11.0	13.8	9.1	14.2	11.9	14.6	14.3	9.2	12.8	10.8	11.0	10.3	14.1	9.8	13.8	10.9	13.6	16.4	10.3	12.2	25.1	11.1	7.5	14.5	18.2	12.4	12.3	19.7	10.8	19.0	13.8	9.2	12.4	11.7	12.9	13.9	11.5	15.0	18.1	12.4	8.7	8.7	16.0	9.8	25.4	13.7	12.8	12.4	7.7	21.7	11.2	18.5	21.3	7.7	9.2	19.7	15.5	14.3	14.0	13.9	13.6	12.3	15.3	14.6	22.1	6.7	8.6	12.1	3.9	7.9	9.0	5.1	9.3	4.8	5.1	4.7	6.0	6.7	4.5	5.3	4.9	14.7	5.4	9.4	9.1	2.3	4.5	21.0	31.9	29.6	26.4	17.2	13.5	11.3	20.6	16.7	10.1	14.9	18.4	17.1	18.3	23.7	56.0	28.1	43.3	21.4	14.8	10.4	51.1	38.1	11.6	20.5	12.0	15.5	32.9	0.0	20.5	24.1	22.4	24.3	7.0	38.5	22.9	69.9	20.7	23.9	46.7	21.8	29.4	21.5	20.3	30.7	31.7	39.4	25.3	17.5	41.8	34.2	41.5	45.3	18.6	36.7	40.5	29.7	87.5	17.5	27.9	19.6
PDSS1	"COQ1, TPRT, TPT"	ENSG00000148459	"Decaprenyl diphosphate synthase subunit 1"	Q5T2R2	10	26697659-26746798	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Isoprene biosynthesis, Ubiquinone biosynthesis"	Transferase	"Disease mutation, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"intestine: 22.4;lymphoid tissue: 31.8"	"Cell type enhanced"	"Detected in many"	5	"Undifferentiated cells: 23.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038032, HPA042741"	Uncertain		Approved	Cytosol		NA	NA			Cytosol		"HPA038032: AB_10670650, HPA042741: AB_2678139"	"unprognostic (1.41e-2)"	"unprognostic (3.92e-1)"	"unprognostic (8.92e-3)"	"prognostic unfavorable (1.66e-4)"	"unprognostic (6.79e-3)"	"unprognostic (5.43e-2)"	"prognostic unfavorable (1.25e-5)"	"unprognostic (2.47e-2)"	"unprognostic (9.43e-2)"	"unprognostic (2.33e-2)"	"unprognostic (2.20e-1)"	"unprognostic (4.11e-2)"	"unprognostic (2.99e-3)"	"unprognostic (2.93e-3)"	"unprognostic (8.85e-2)"	"unprognostic (9.83e-2)"	"unprognostic (6.36e-2)"	3.1	2.6	2.4	7.0	3.1	5.6	3.5	5.6	5.1	3.1	18.2	1.5	1.2	20.6	3.8	2.1	8.3	3.4	3.7	4.2	2.2	2.2	8.6	7.2	4.0	7.8	2.1	2.3	2.8	3.8	1.7	2.5	2.8	2.9	2.3	17.0	3.2	3.5	1.8	10.4	2.7	22.4	3.6	3.1	5.7	3.8	3.0	1.6	31.8	2.1	4.7	5.0	2.9	4.0	3.2	5.2	0.9	5.3	0.8	3.4	1.3	7.6	5.9	4.5	8.3	1.5	2.8	6.3	7.1	1.9	10.3	7.0	9.1	4.3	17.4	3.7	3.5	3.9	9.7	14.5	10.8	8.8	7.3	12.1	15.1	5.2	6.6	2.2	10.0	6.0	3.5	4.7	9.6	2.6	1.8	5.4	11.5	13.8	4.6	7.2	12.0	31.5	7.0	9.1	12.3	5.8	14.7	13.0	12.6	6.0	3.6	13.3	8.2	6.8	14.2	7.7	4.9	5.0	11.7	3.4	5.8	9.2	11.8	11.2	1.8	6.7	12.7	5.7	25.5	4.4	0.0	5.3	0.9	0.9	4.1	2.1	0.5	1.8	1.3	5.2	3.2	3.4	1.5	0.3	0.8	2.1	1.4	0.1	1.3	2.4	3.1	5.6	5.1	2.2	2.2	2.1	2.3	2.9	1.6	0.0	0.0	3.7	3.2	6.2	2.8	1.8	7.6	1.4	3.4	3.5	3.9	5.3	6.6	6.6	9.3	2.2	14.7	0.0	3.3	10.1	2.9	2.7	0.0	3.4	7.9	1.6	10.4	3.1	6.8	2.5	2.0	5.1	1.7	2.8	9.8	1.2	4.2	7.0	2.5	17.7	4.7	0.0	3.8	7.0	9.8	2.8	5.3	3.3	23.4	2.5
PDSS2	"bA59I9.3, C6orf210"	ENSG00000164494	"Decaprenyl diphosphate synthase subunit 2"	Q86YH6	6	107152557-107459564	"Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Isoprene biosynthesis, Ubiquinone biosynthesis"	Transferase	"Cancer-related genes, Disease mutation, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029685, HPA029686"	Approved		Supported	Cytosol		NA	NA			Cytosol		"HPA029685: AB_10600219, HPA029686: AB_10602309"	"prognostic unfavorable (1.34e-5)"	"unprognostic (1.44e-1)"	"prognostic favorable (5.74e-5)"	"unprognostic (5.76e-2)"	"unprognostic (1.42e-1)"	"unprognostic (3.30e-2)"	"unprognostic (3.26e-2)"	"unprognostic (1.42e-1)"	"unprognostic (1.15e-1)"	"unprognostic (1.18e-1)"	"unprognostic (9.38e-2)"	"unprognostic (2.19e-1)"	"prognostic favorable (3.75e-7)"	"unprognostic (2.25e-1)"	"unprognostic (2.86e-1)"	"unprognostic (1.29e-1)"	"unprognostic (2.11e-2)"	10.6	27.3	7.2	17.0	8.3	8.3	19.6	9.0	10.3	10.4	12.7	9.0	13.7	9.6	13.1	11.4	11.5	9.2	11.2	16.0	7.0	6.8	22.1	27.4	18.2	18.3	9.2	5.3	10.8	14.0	11.4	19.4	7.0	9.6	15.6	13.9	12.0	19.9	19.9	13.1	9.0	10.1	11.0	8.1	9.1	10.5	12.8	10.1	11.3	14.1	11.1	10.6	10.9	12.9	8.5	9.4	4.1	12.1	4.6	8.3	4.3	5.7	7.7	6.7	10.3	11.5	14.7	15.2	10.2	12.9	9.8	9.5	7.6	8.4	11.0	9.3	11.3	10.5	7.9	16.0	12.7	13.4	7.0	7.8	10.9	9.2	12.7	12.2	14.0	8.8	10.9	15.1	15.5	12.3	8.6	10.3	12.9	15.5	15.0	9.5	7.1	4.0	14.9	4.2	13.3	10.0	7.3	5.9	8.8	12.1	7.9	6.6	5.7	7.0	12.2	14.5	7.5	9.9	17.0	6.4	7.0	4.2	9.8	8.7	4.2	5.1	8.5	13.0	20.9	12.9	4.1	6.6	3.5	5.3	7.6	8.3	6.6	5.6	6.8	9.4	8.5	7.3	6.9	0.9	4.6	12.1	4.5	7.1	4.3	7.2	8.3	9.0	10.3	7.0	6.8	9.2	5.3	9.6	10.1	14.9	15.5	8.3	11.4	3.8	8.1	15.1	10.2	20.1	11.4	14.0	2.0	22.3	29.9	10.8	31.9	6.8	11.2	0.0	12.7	14.4	6.2	15.1	13.9	24.1	10.3	6.4	9.9	5.5	14.1	4.4	4.9	10.4	6.8	6.4	16.1	10.9	11.0	11.5	8.9	33.4	10.1	25.8	5.9	18.1	12.5	5.1	10.0	6.2	17.4	10.7
PDXK	"C21orf124, C21orf97, FLJ21324, FLJ31940, MGC15873, PKH, PNK, PRED79"	ENSG00000160209	"Pyridoxal kinase"	O00764	21	43719094-43762307	"Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"		"Kinase, Transferase"	"Charcot-Marie-Tooth disease, Disease mutation, FDA approved drug targets, Neurodegeneration, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 68.9"	"Group enriched"	"Detected in all"	7	"Early spermatids: 1421.5;Late spermatids: 3146.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030196, HPA030197, HPA030198, CAB033918"	Enhanced		Enhanced	Nucleoplasm		NA	NA		870000	Nucleoplasm		"CAB033918: AB_2162502, HPA030196: AB_10599735, HPA030197: AB_10601792, HPA030198: AB_10603570"	"unprognostic (1.01e-1)"	"unprognostic (1.99e-1)"	"unprognostic (5.88e-2)"	"unprognostic (1.87e-1)"	"unprognostic (8.29e-2)"	"unprognostic (4.31e-3)"	"unprognostic (3.64e-3)"	"unprognostic (1.32e-1)"	"unprognostic (8.66e-2)"	"unprognostic (9.34e-2)"	"unprognostic (2.10e-1)"	"unprognostic (3.54e-1)"	"unprognostic (3.70e-2)"	"unprognostic (1.31e-3)"	"unprognostic (1.10e-1)"	"unprognostic (4.78e-2)"	"unprognostic (1.51e-3)"	28.1	13.2	37.4	8.7	36.6	13.3	13.3	21.9	38.5	9.7	13.8	11.0	15.7	16.7	9.0	13.2	11.0	12.9	8.8	11.4	26.1	30.4	22.8	17.4	20.4	9.5	24.1	22.7	16.4	17.6	25.7	20.7	12.6	20.3	10.6	11.8	7.8	18.3	13.9	5.8	14.3	22.1	8.8	10.1	7.8	15.2	68.9	10.7	3.9	13.6	7.0	11.0	9.7	8.6	2.7	2.5	1.3	7.7	1.9	3.3	2.4	17.4	21.4	3.4	6.5	8.4	11.9	4.2	6.3	9.9	6.1	5.2	17.4	27.3	5.9	6.7	9.0	8.5	13.2	6.6	17.9	4.1	6.6	5.7	6.0	23.4	12.8	16.5	5.6	8.7	16.8	17.2	6.4	7.2	10.0	2.9	2.6	10.4	13.6	5.8	11.8	0.8	10.1	9.3	17.0	8.2	6.7	2.0	16.3	26.6	21.4	3.3	3.9	26.1	24.2	9.3	1.5	8.0	7.9	5.1	4.5	8.8	6.0	5.8	8.3	3.9	3.4	18.4	16.2	4.3	1.3	4.8	0.2	1.7	4.4	3.3	1.4	1.7	1.9	2.5	2.7	2.0	1.4	1.3	1.9	7.7	1.2	1.5	2.4	37.4	36.6	21.9	38.5	26.1	30.4	24.1	22.7	20.3	10.7	74.5	71.3	17.5	132.2	25.2	41.8	39.3	25.5	21.4	31.8	96.0	21.6	37.3	152.5	146.7	1421.5	25.3	96.0	46.7	174.9	62.9	26.6	143.6	32.2	46.0	193.8	49.3	28.9	18.4	44.0	3146.3	46.3	89.3	40.5	27.1	42.8	10.9	164.5	30.9	50.9	69.5	40.4	6.5	25.8	332.6	27.9	24.8	103.8	22.4	42.8	203.8
PDXP	"CIN, dJ37E16.5, FLJ32703"	ENSG00000241360	"Pyridoxal phosphatase"	Q96GD0	22	37658727-37666934	"Enzymes, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 55.4;liver: 34.7"	"Cell type enhanced"	"Detected in some"	13	"Alveolar cells type 2: 1.1;Enterocytes: 1.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	8	"plasmacytoid DC: 12.9"	"Lineage enriched"	"Detected in many"	8	"dendritic cells: 12.9"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA000531	Approved					NA	NA		17000			"HPA000531: AB_2666018"	"unprognostic (6.29e-2)"	"unprognostic (7.89e-3)"	"unprognostic (1.00e-1)"	"unprognostic (2.89e-1)"	"unprognostic (2.15e-2)"	"unprognostic (3.25e-2)"	"unprognostic (2.81e-1)"	"unprognostic (4.44e-2)"	"unprognostic (2.54e-1)"	"unprognostic (1.46e-1)"	"unprognostic (1.57e-3)"	"unprognostic (2.76e-2)"	"unprognostic (1.77e-1)"	"unprognostic (3.03e-3)"	"unprognostic (2.04e-1)"	"unprognostic (4.66e-2)"	"unprognostic (2.38e-1)"	2.4	14.8	43.5	1.7	32.0	3.0	2.5	24.9	55.4	1.7	8.3	5.3	0.8	15.4	3.7	4.1	1.0	3.4	2.7	12.9	38.1	27.7	10.2	34.7	1.3	3.9	16.4	15.8	3.5	8.4	6.1	7.9	1.0	13.6	3.3	7.6	3.8	7.1	4.2	5.7	0.9	15.8	4.8	9.1	2.6	3.3	10.4	4.6	4.2	3.4	1.0	5.4	2.2	0.7	1.5	12.9	0.5	0.4	0.8	0.9	0.1	2.8	6.8	14.1	12.4	4.5	1.1	1.7	6.6	3.1	12.1	9.5	2.6	0.3	18.4	6.8	3.3	10.4	1.4	19.1	0.1	10.4	5.6	37.9	3.1	9.7	13.8	2.9	12.6	15.5	0.4	1.2	5.9	8.7	4.7	5.6	21.8	11.2	11.1	10.8	2.4	25.7	21.0	7.2	4.2	16.7	20.0	10.2	13.5	5.3	0.3	33.0	20.8	6.4	5.4	11.7	6.4	1.3	10.0	3.3	10.5	13.1	11.1	13.3	11.5	14.6	19.6	9.9	4.0	13.2	0.0	0.3	0.5	0.9	0.4	0.1	1.5	0.3	0.6	0.6	1.4	0.3	0.1	0.4	0.8	0.2	12.9	0.3	0.1	43.5	32.0	24.9	50.6	38.1	27.7	16.4	15.8	13.6	4.6	0.0	1.1	0.0	0.0	0.0	0.6	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0
PDZRN3	"KIAA1095, LNX3, SEMACAP3"	ENSG00000121440	"PDZ domain containing ring finger 3"	Q9UPQ7	3	73382433-73624940	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	11	"Cardiomyocytes: 61.9;Fibroblasts: 24.4;Peritubular cells: 26.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	52	"plasmacytoid DC: 5.2"	"Lineage enriched"	"Detected in single"	52	"dendritic cells: 5.2"	"Cell line enhanced"	"Detected in many"		"AF22: 15.4;ASC diff: 28.1;ASC TERT1: 14.8;BJ hTERT+: 20.0;HSkMC: 20.5;U-87 MG: 14.8"	"Group enriched"	"Detected in many"	5	"amygdala: 12.4;basal ganglia: 7.4;cerebral cortex: 17.9;hippocampal formation: 14.5"	"Low region specificity"	"Detected in many"			"HPA038822, HPA061420"	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			Cytosol	Nucleoplasm	"HPA038822: AB_10675952, HPA061420: AB_2684512"	"unprognostic (3.22e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.00e-2)"	"prognostic favorable (3.35e-5)"	"unprognostic (1.09e-1)"	"unprognostic (5.54e-2)"	"unprognostic (8.47e-2)"	"unprognostic (3.67e-1)"	"unprognostic (1.60e-1)"	"unprognostic (7.51e-2)"	"prognostic favorable (4.93e-4)"	"unprognostic (8.38e-2)"	"prognostic favorable (3.65e-7)"	"unprognostic (8.63e-3)"	"unprognostic (1.63e-1)"	"unprognostic (3.72e-2)"	"unprognostic (2.86e-3)"	13.0	17.4	11.5	4.8	12.9	0.0	10.3	1.7	26.8	18.7	32.6	4.5	4.6	4.3	29.0	12.4	13.6	11.6	13.1	19.8	9.1	2.5	5.3	0.9	6.3	1.9	3.6	11.2	35.1	2.9	0.3	2.2	8.1	6.8	15.4	6.9	9.7	9.7	14.9	38.3	7.5	10.2	26.3	3.8	1.0	19.3	3.4	2.9	0.2	1.6	5.1	1.1	21.3	18.0	0.0	5.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.4	0.0	28.1	14.8	0.0	8.0	20.0	2.4	1.5	7.5	0.0	0.0	0.0	10.7	0.3	0.0	0.0	0.0	2.4	0.0	1.0	0.0	0.0	0.0	4.7	0.0	0.0	20.5	0.0	6.7	0.0	2.9	0.0	0.0	0.0	0.0	2.3	0.9	0.0	0.1	2.2	0.0	0.0	0.0	4.1	0.0	0.0	0.0	1.8	5.1	0.0	3.7	5.8	4.7	2.2	0.0	0.0	10.1	0.7	11.3	1.0	0.3	0.0	0.1	14.8	0.0	8.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.2	0.0	0.0	11.5	12.9	1.7	26.8	9.1	2.5	3.6	11.2	6.8	2.9	0.0	0.0	0.0	9.3	2.2	9.5	61.9	0.0	0.0	0.0	5.2	5.9	0.6	1.7	0.0	0.4	1.3	0.0	0.0	0.4	0.2	24.4	12.7	0.0	0.0	0.7	0.0	20.3	0.0	0.0	0.4	21.6	0.9	15.1	0.0	7.0	20.0	0.4	0.0	26.5	6.3	1.5	0.0	15.5	0.2	4.1	1.6	0.7	0.0	2.3	4.3
PEAK1	"KIAA2002, sgk269"	ENSG00000173517	"Pseudopodium enriched atypical kinase 1"	Q9H792	15	77100656-77420144	"Enzymes, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	8	"Alveolar cells type 1: 137.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"NK-cell: 5.5"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"TIME: 25.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA026313, HPA026517"	Approved					NA	NA					"HPA026313: AB_1856801, HPA026517: AB_1856802"	"unprognostic (1.15e-1)"	"unprognostic (2.89e-1)"	"unprognostic (1.05e-1)"	"unprognostic (4.20e-1)"	"unprognostic (6.26e-2)"	"unprognostic (8.82e-2)"	"unprognostic (6.63e-3)"	"unprognostic (1.90e-1)"	"unprognostic (2.42e-2)"	"unprognostic (6.00e-3)"	"unprognostic (1.06e-1)"	"unprognostic (9.75e-2)"	"unprognostic (2.25e-3)"	"unprognostic (5.73e-2)"	"unprognostic (2.09e-2)"	"unprognostic (3.33e-1)"	"unprognostic (5.65e-3)"	21.5	6.0	14.3	8.7	13.2	9.7	12.4	8.4	14.1	15.1	9.3	12.3	6.2	7.2	16.1	8.7	6.6	7.5	12.2	18.5	12.3	7.5	6.6	4.9	20.5	7.5	13.8	8.8	9.8	5.8	7.6	4.2	19.5	9.8	8.4	10.2	13.7	7.0	9.5	8.8	8.4	9.1	14.8	10.1	41.8	6.7	11.5	15.9	2.7	8.3	9.0	5.7	10.0	12.2	0.9	0.6	1.1	0.6	5.5	1.4	0.4	2.6	3.8	9.2	2.1	17.3	18.7	3.2	14.2	9.8	7.6	7.6	3.0	2.3	2.0	2.5	20.4	2.9	1.3	7.3	2.2	8.7	2.0	3.8	3.7	5.7	1.8	6.3	2.2	2.0	14.3	2.2	14.6	2.4	8.3	21.1	3.3	4.8	2.0	8.1	1.0	1.2	2.4	4.2	1.8	1.0	2.5	5.5	1.4	2.2	4.7	2.0	2.5	5.5	1.2	9.5	10.5	0.8	1.5	25.8	16.2	7.8	6.7	6.0	3.2	4.4	2.9	2.8	5.2	8.6	0.4	0.6	1.1	0.7	0.2	1.4	0.9	0.2	0.2	0.3	0.8	0.3	0.3	0.6	5.5	0.2	0.6	0.2	0.4	14.3	13.2	8.4	14.1	12.3	7.5	13.8	8.8	9.8	15.9	137.0	38.5	5.6	7.4	19.5	17.0	40.3	10.2	56.2	45.5	1.8	11.8	2.8	0.0	5.6	12.1	29.4	16.1	0.0	4.7	1.6	38.5	5.2	16.3	3.2	15.1	19.1	2.9	33.2	19.7	10.8	18.4	17.1	11.8	5.4	10.3	31.5	8.3	8.6	15.2	3.1	20.6	12.9	25.0	10.6	11.7	15.7	5.3	5.1	9.7	8.1
PECR	"HSA250303, SDR29C1, TERP"	ENSG00000115425	"Peroxisomal trans-2-enoyl-CoA reductase"	Q9BY49	2	215996329-216082955	"Enzymes, Predicted intracellular proteins"	"Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism"	Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 78.4"	"Cell type enhanced"	"Detected in many"	8	"Hepatocytes: 72.5;monocytes: 42.3;Proximal tubular cells: 49.9"	"Cancer enhanced"	"Detected in all"		"liver cancer: 30.4"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Hep G2: 24.6;RPTEC TERT1: 23.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021593, HPA022539"	Enhanced		Supported	Peroxisomes		NA	NA			Peroxisomes		"HPA021593: AB_1855177, HPA022539: AB_1855178"	"unprognostic (7.97e-2)"	"unprognostic (1.08e-1)"	"unprognostic (5.72e-2)"	"unprognostic (1.32e-3)"	"unprognostic (2.90e-1)"	"unprognostic (6.40e-2)"	"unprognostic (1.16e-3)"	"unprognostic (3.56e-2)"	"unprognostic (4.03e-2)"	"unprognostic (1.11e-1)"	"unprognostic (5.01e-3)"	"unprognostic (5.61e-2)"	"prognostic favorable (1.36e-5)"	"unprognostic (6.63e-2)"	"unprognostic (1.84e-2)"	"unprognostic (7.75e-2)"	"unprognostic (6.64e-2)"	14.2	4.4	3.2	6.5	3.3	3.5	7.0	6.7	3.7	2.8	11.5	4.4	2.7	13.2	2.0	6.6	2.4	4.5	7.2	2.7	3.3	3.1	17.4	78.4	3.6	3.8	4.4	2.9	3.2	3.1	3.8	5.4	0.9	3.5	3.1	4.2	6.2	3.5	3.5	3.4	3.3	20.9	3.2	5.1	2.8	2.6	0.9	3.6	2.4	8.5	2.0	3.5	2.2	4.1	5.1	1.4	4.1	3.9	8.8	14.7	4.1	3.8	4.3	1.7	0.1	10.6	3.9	2.1	0.9	2.1	2.5	4.2	4.9	11.2	0.1	8.0	2.3	6.2	0.9	4.7	5.7	4.4	6.1	5.1	5.0	2.5	24.6	10.7	1.3	3.5	3.3	4.0	2.6	3.7	3.8	2.4	3.0	2.1	5.7	5.4	2.8	1.5	1.4	3.2	0.0	3.2	3.4	3.3	0.5	23.8	0.6	2.4	3.5	2.3	4.9	9.7	4.4	5.8	4.2	0.0	1.6	1.7	4.0	2.8	6.7	5.6	2.0	3.6	1.8	3.7	0.8	3.9	1.3	6.4	1.5	7.3	4.2	8.6	7.3	1.4	5.1	9.2	6.0	4.1	8.8	2.0	0.2	14.7	4.1	3.2	3.3	6.7	3.7	3.3	3.1	4.4	2.9	3.5	3.6	6.0	9.9	3.7	3.8	3.3	10.0	3.1	35.7	9.4	2.3	27.9	13.7	3.5	11.6	10.3	0.1	3.3	12.7	0.0	3.4	6.4	3.5	1.9	1.1	72.5	8.0	3.2	6.9	7.4	2.8	0.0	5.2	5.9	10.1	42.3	6.5	7.8	4.3	17.5	7.8	49.9	6.4	0.0	4.2	0.0	1.8	2.5	1.4	8.7	13.3	1.4
PELI1		ENSG00000197329	"Pellino E3 ubiquitin protein ligase 1"	Q96FA3	2	64092652-64144454	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 105.7"	"Cell type enhanced"	"Detected in many"	7	"Basal keratinocytes: 199.1;Suprabasal keratinocytes: 190.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"neutrophil: 33.9"	"Group enriched"	"Detected in all"	4	"granulocytes: 33.9;monocytes: 9.2"	"Cell line enhanced"	"Detected in many"		"CACO-2: 21.8;U-698: 54.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA053182	Uncertain		Approved	"Nucleoplasm,Nucleoli,Intermediate filaments"		NA	NA			"Nucleoplasm, Nucleoli, Intermediate filaments"		"HPA053182: AB_2682072"	"unprognostic (3.33e-2)"	"unprognostic (3.43e-2)"	"unprognostic (1.79e-2)"	"prognostic unfavorable (5.33e-4)"	"unprognostic (1.91e-2)"	"unprognostic (3.12e-3)"	"unprognostic (6.73e-3)"	"unprognostic (8.01e-3)"	"unprognostic (4.16e-2)"	"unprognostic (3.52e-3)"	"unprognostic (5.99e-3)"	"unprognostic (3.33e-1)"	"prognostic unfavorable (5.67e-6)"	"unprognostic (6.72e-2)"	"unprognostic (6.22e-2)"	"unprognostic (8.88e-2)"	"unprognostic (1.03e-1)"	15.7	5.1	10.0	15.1	20.5	105.7	22.3	15.1	8.9	9.9	14.5	11.0	3.3	9.9	14.5	7.1	26.4	8.0	14.9	11.6	11.3	6.8	6.7	8.6	20.1	16.8	15.6	5.2	4.8	6.2	11.0	14.8	13.7	10.8	7.6	11.8	6.0	12.3	8.5	4.5	17.5	17.3	8.4	15.0	17.8	10.2	7.8	12.8	19.9	6.3	10.2	19.3	14.1	14.8	3.9	2.3	33.9	9.2	1.3	5.0	2.5	1.3	1.0	14.0	9.3	1.6	1.2	3.2	1.8	2.0	1.6	2.6	21.8	1.5	17.9	4.4	0.6	0.6	2.1	4.2	3.9	3.3	4.4	3.3	1.6	0.7	3.5	4.9	1.7	3.2	1.6	3.1	2.4	8.4	1.7	9.2	6.9	1.0	4.5	1.4	0.1	3.8	2.5	9.1	4.1	0.6	4.8	4.8	10.2	6.7	4.0	6.4	9.0	1.3	2.1	4.8	4.5	1.1	1.2	6.5	1.5	2.2	1.5	2.6	10.4	1.0	54.2	0.8	1.6	4.1	5.1	6.5	6.3	0.4	6.1	0.7	3.9	2.2	0.9	2.3	2.4	2.7	1.1	33.9	1.3	9.2	0.2	5.0	2.5	10.0	20.5	15.1	8.8	11.3	6.8	15.6	5.2	10.8	12.8	26.8	45.1	22.4	65.1	199.1	0.9	5.1	10.2	30.8	55.7	5.2	0.0	1.4	1.7	4.5	8.5	42.7	37.0	0.0	23.1	6.5	25.9	43.3	14.0	6.8	19.1	3.2	24.6	36.2	52.6	7.8	1.4	57.1	106.3	13.6	22.2	4.5	18.2	28.1	1.8	7.7	1.8	0.0	48.4	6.1	7.8	190.1	3.3	11.5	27.3	104.0
PELI2		ENSG00000139946	"Pellino E3 ubiquitin protein ligase family member 2"	Q9HAT8	14	56117814-56301526	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in all"	4	"cerebellum: 21.4"	"Cell type enhanced"	"Detected in many"		"neutrophil: 9.0"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HMC-1: 19.3;JURKAT: 24.9;MOLT-4: 21.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA053182	Uncertain		Approved	"Nucleoplasm,Nucleoli,Intermediate filaments"		NA	NA			"Nucleoplasm, Nucleoli, Intermediate filaments"		"HPA053182: AB_2682072"	"unprognostic (3.26e-1)"	"unprognostic (2.25e-1)"	"unprognostic (9.21e-2)"	"unprognostic (8.94e-3)"	"unprognostic (1.57e-1)"	"unprognostic (1.68e-1)"	"unprognostic (2.53e-2)"	"unprognostic (3.36e-3)"	"unprognostic (1.81e-1)"	"unprognostic (2.68e-2)"	"unprognostic (1.18e-1)"	"unprognostic (2.14e-1)"	"prognostic favorable (1.53e-6)"	"unprognostic (3.64e-1)"	"unprognostic (2.15e-1)"	"unprognostic (5.43e-2)"	"unprognostic (2.22e-1)"	12.3	3.3	5.2	5.6	4.6	16.5	8.7	21.4	6.5	7.5	9.4	5.4	9.7	11.1	9.3	7.1	4.7	5.9	11.5	3.4	4.6	4.5	9.7	3.1	7.3	4.8	5.2	3.9	16.0	38.9	1.7	5.5	3.3	4.4	8.2	4.2	9.2	7.6	12.4	3.8	6.5	12.6	17.7	5.8	6.6	14.1	10.0	4.2	38.2	4.9	3.4	2.6	13.3	14.9	0.9	2.0	9.0	3.0	0.5	0.8	1.1	0.0	1.8	5.1	0.0	2.8	4.2	0.1	0.7	2.4	0.5	0.0	0.1	0.4	0.1	2.4	1.4	0.0	0.5	3.9	0.0	0.2	1.2	1.4	4.4	7.9	0.0	2.4	0.6	19.3	2.7	0.2	0.0	0.0	2.8	0.9	24.9	3.2	0.0	0.5	0.0	21.6	0.2	8.3	0.0	0.7	10.6	0.3	0.9	2.1	8.7	10.2	0.0	0.4	0.0	5.7	3.3	0.0	3.5	0.3	1.5	2.6	0.4	2.5	0.4	0.0	0.5	2.7	3.0	1.5	1.4	3.0	3.5	0.5	1.6	0.8	0.2	0.6	0.3	2.0	0.9	0.4	0.3	9.0	0.5	1.2	0.5	0.0	1.1	5.2	4.6	21.4	4.4	4.6	4.5	5.2	3.9	4.4	4.2	0.0	7.7	2.7	11.0	12.7	30.0	1.9	7.6	14.7	10.3	12.2	27.5	0.0	3.3	4.4	2.3	10.9	8.4	0.0	12.2	0.1	5.6	7.0	5.7	0.8	1.1	20.6	6.9	11.1	16.5	4.1	15.8	11.1	16.9	2.8	7.4	10.0	8.6	3.7	17.0	8.8	18.5	12.9	22.1	1.4	27.2	15.9	0.1	3.5	3.0	9.7
PELI3	MGC35521	ENSG00000174516	"Pellino E3 ubiquitin protein ligase family member 3"	Q8N2H9	11	66466327-66477337	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"Horizontal cells: 20.6;Intestinal endocrine cells: 25.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB033750, HPA038875, HPA062281"	Uncertain		Approved	Nucleoplasm,Nucleoli,Vesicles		NA	NA			"Nucleoplasm, Vesicles"	Nucleoli	"CAB033750: AB_2161361, HPA038875: AB_2676249, HPA062281: AB_2684735"	"unprognostic (1.15e-1)"	"unprognostic (1.58e-1)"	"unprognostic (3.04e-1)"	"unprognostic (1.43e-1)"	"unprognostic (1.02e-2)"	"unprognostic (1.89e-2)"	"unprognostic (1.30e-2)"	"unprognostic (1.94e-1)"	"unprognostic (1.35e-1)"	"unprognostic (1.19e-1)"	"unprognostic (2.19e-3)"	"unprognostic (7.91e-3)"	"prognostic favorable (8.19e-4)"	"unprognostic (1.59e-1)"	"unprognostic (1.44e-1)"	"unprognostic (1.91e-1)"	"unprognostic (3.01e-2)"	6.7	9.5	14.5	3.8	17.0	1.8	7.4	19.6	33.1	7.4	8.3	6.7	6.4	4.8	10.3	9.1	10.6	8.2	10.1	7.7	17.4	13.5	4.6	3.2	7.1	4.3	13.0	12.5	15.3	9.9	21.5	8.3	3.8	15.8	11.5	2.9	6.4	10.4	22.3	10.8	11.2	4.7	11.3	6.2	5.0	5.8	6.2	7.8	0.3	8.5	2.7	3.4	9.0	11.8	3.3	3.3	1.3	6.8	1.2	3.1	1.4	15.5	6.6	5.4	4.2	8.6	3.4	4.3	5.0	6.5	4.8	4.1	9.6	3.5	3.9	5.0	5.4	8.6	8.4	3.5	6.3	2.0	7.6	3.1	1.0	5.4	2.8	5.4	0.8	7.6	3.2	7.1	4.9	1.7	7.0	1.0	5.2	1.8	6.1	2.0	9.5	3.2	2.4	3.4	8.2	6.8	10.8	3.9	4.1	2.6	5.0	6.5	3.6	2.5	7.2	17.0	2.4	8.4	4.2	2.7	4.2	6.5	18.3	4.1	5.6	3.2	2.1	8.9	2.5	3.5	1.3	2.5	0.4	2.5	1.8	2.0	2.8	2.1	3.1	3.3	3.3	2.2	1.8	0.1	1.2	6.8	1.0	2.4	1.4	14.5	17.0	19.6	33.1	17.4	13.5	13.0	12.5	15.8	7.8	6.0	1.3	0.0	3.4	1.4	12.1	6.2	2.5	0.0	0.0	0.0	9.8	1.9	1.7	2.7	3.7	2.5	0.0	0.0	2.1	1.7	3.1	2.0	0.0	2.4	2.9	20.6	25.4	1.8	0.6	5.6	6.9	3.2	0.0	2.8	0.5	5.5	1.9	0.8	9.2	2.2	8.5	6.5	4.8	1.9	3.2	0.3	0.2	0.0	0.6	1.6
PEMT	"PEMPT, PEMT2"	ENSG00000133027	"Phosphatidylethanolamine N-methyltransferase"	Q9UBM1	17	17505563-17591708	"Enzymes, Predicted membrane proteins"	"Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism"	"Methyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"epididymis: 95.7;liver: 103.5"	"Cell type enhanced"	"Detected in many"	12	"Hepatocytes: 168.4;Peritubular cells: 326.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042375, HPA073930"	Approved		Supported	"Endoplasmic reticulum,Vesicles,Mitochondria,Cytosol"		NA	NA			"Endoplasmic reticulum, Mitochondria"	"Vesicles, Cytosol"	"HPA042375: AB_10796905, HPA073930: "	"unprognostic (1.39e-2)"	"unprognostic (3.43e-1)"	"unprognostic (2.43e-2)"	"prognostic favorable (6.77e-6)"	"unprognostic (2.85e-1)"	"unprognostic (7.14e-2)"	"unprognostic (1.31e-1)"	"unprognostic (1.28e-1)"	"unprognostic (3.89e-1)"	"unprognostic (3.41e-2)"	"unprognostic (5.47e-3)"	"unprognostic (2.67e-1)"	"unprognostic (8.63e-3)"	"unprognostic (2.08e-1)"	"unprognostic (2.10e-1)"	"unprognostic (6.66e-2)"	"unprognostic (7.60e-2)"	21.8	7.5	5.6	2.8	6.2	4.2	26.5	2.9	8.1	16.1	6.1	6.4	13.2	7.4	8.7	95.7	5.6	10.5	4.7	5.3	5.3	6.1	8.5	103.5	5.5	6.7	6.3	4.8	7.7	11.4	4.4	5.7	7.1	6.2	7.3	2.2	7.3	12.7	12.9	7.4	7.3	5.8	4.0	6.4	2.8	4.6	19.1	3.2	3.8	9.9	6.3	5.4	3.9	5.2	12.8	17.0	1.6	23.4	15.1	14.4	11.6	14.2	27.3	7.2	18.8	15.4	10.8	10.8	9.1	8.2	12.5	9.9	15.9	9.7	12.5	16.6	9.3	9.4	17.0	10.6	5.5	3.2	9.2	37.0	6.2	14.9	22.8	17.0	5.5	9.3	11.0	11.5	8.3	12.7	4.2	6.7	17.6	5.9	5.3	5.5	27.2	9.8	9.9	10.1	27.3	22.4	9.2	11.6	11.4	10.3	5.3	7.2	17.2	6.5	4.4	16.3	14.5	6.7	2.1	5.8	12.3	12.4	20.5	7.9	7.3	4.9	2.2	11.4	7.7	10.1	1.0	23.4	1.1	10.1	20.8	14.4	12.6	13.2	12.7	17.0	12.8	10.6	11.9	1.6	15.1	14.2	15.5	12.0	11.6	5.6	6.2	2.9	8.1	5.3	6.1	6.3	4.8	6.2	3.2	14.9	13.7	17.0	16.7	16.3	4.4	12.5	12.7	16.0	26.1	26.2	0.0	16.2	14.9	26.3	2.2	18.3	14.6	0.0	33.6	18.8	27.5	23.7	12.7	168.4	21.4	4.8	66.0	9.2	11.1	6.8	87.8	10.8	20.3	1.0	24.8	26.7	26.0	10.5	326.0	21.4	4.8	6.5	30.9	11.1	18.5	15.8	12.2	7.0	22.8	16.6
PEPD		ENSG00000124299	"Peptidase D"	P12955	19	33386950-33521794	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Collagen degradation"	"Dipeptidase, Hydrolase, Metalloprotease, Protease"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"intestine: 92.9;kidney: 106.0"	"Cell type enriched"	"Detected in many"	5	"Proximal tubular cells: 1020.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA015599, HPA072045"	Enhanced		Approved	Nucleoplasm		NA	NA		1000000000	Nucleoplasm		"HPA015599: AB_1855192, HPA072045: AB_2732194"	"unprognostic (1.39e-1)"	"unprognostic (2.62e-2)"	"unprognostic (2.27e-1)"	"unprognostic (4.01e-2)"	"unprognostic (2.98e-1)"	"unprognostic (6.77e-2)"	"unprognostic (2.82e-1)"	"unprognostic (3.64e-2)"	"unprognostic (3.96e-1)"	"unprognostic (5.10e-2)"	"unprognostic (1.11e-2)"	"unprognostic (1.99e-1)"	"prognostic favorable (6.50e-9)"	"unprognostic (4.38e-2)"	"unprognostic (1.99e-1)"	"unprognostic (1.65e-1)"	"unprognostic (1.29e-1)"	23.5	17.2	9.8	8.9	10.4	4.1	21.8	7.6	14.9	9.8	60.1	18.7	6.9	58.1	14.3	11.5	14.9	9.6	13.6	8.0	10.8	9.1	106.0	48.6	11.1	10.6	16.0	7.7	12.6	9.0	9.6	12.5	10.4	13.0	9.2	6.6	13.3	9.6	9.0	9.7	11.4	92.9	10.4	17.4	13.4	9.3	8.4	11.5	8.4	15.0	9.7	10.6	11.9	11.9	17.1	32.3	27.5	39.1	16.8	25.8	32.6	13.3	36.3	10.7	17.3	45.7	17.6	24.8	11.9	24.4	15.2	17.3	31.6	11.8	5.4	17.8	29.8	11.7	3.5	15.4	9.7	12.5	15.4	15.2	34.7	7.4	32.1	31.3	10.1	42.1	21.7	9.2	13.8	8.6	11.2	20.3	10.7	6.6	15.8	16.5	16.3	7.7	3.4	14.7	26.6	14.8	15.2	14.6	15.0	13.1	35.3	13.2	33.8	22.2	11.0	17.9	9.4	7.6	11.0	16.9	14.7	15.9	19.0	13.7	14.5	21.5	4.8	15.7	14.6	20.9	27.5	36.1	2.5	25.8	39.1	22.6	17.1	25.7	23.8	32.3	16.3	16.9	19.6	1.9	16.8	27.2	9.9	23.6	32.6	9.8	10.4	7.6	14.9	10.8	9.1	16.0	7.7	13.0	11.5	20.8	24.3	20.2	26.1	17.2	33.9	11.7	43.3	26.8	11.4	69.8	3.9	19.3	167.5	63.4	7.6	44.9	37.6	0.0	38.3	59.7	34.6	21.4	55.5	161.7	189.6	58.8	16.6	35.0	46.9	8.9	45.8	63.2	64.1	131.7	14.5	69.3	37.3	28.5	57.0	1020.8	23.8	38.8	38.8	11.4	48.3	17.8	25.4	31.0	16.7	18.0
PFAS	"FGARAT, GATD8, KIAA0361, PURL"	ENSG00000178921	"Phosphoribosylformylglycinamidine synthase"	O15067	17	8247618-8270491	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Purine biosynthesis"	Ligase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"neutrophil: 28.2"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA022140, HPA022886"	Enhanced		Approved	Vesicles		NA	NA		350000	Vesicles		"HPA022140: AB_1855232, HPA022886: AB_1855233"	"unprognostic (1.90e-1)"	"unprognostic (9.21e-2)"	"unprognostic (2.12e-1)"	"unprognostic (5.19e-3)"	"unprognostic (2.59e-1)"	"unprognostic (6.40e-2)"	"prognostic unfavorable (9.19e-4)"	"unprognostic (3.19e-1)"	"unprognostic (1.42e-2)"	"unprognostic (1.91e-1)"	"unprognostic (5.47e-3)"	"unprognostic (1.08e-3)"	"unprognostic (9.51e-3)"	"unprognostic (3.63e-2)"	"unprognostic (6.57e-2)"	"unprognostic (2.88e-3)"	"unprognostic (3.85e-1)"	15.4	15.3	11.4	14.8	13.0	17.5	12.8	14.6	18.5	11.2	12.4	14.0	10.0	9.8	15.1	11.2	13.2	13.5	14.3	9.7	9.0	8.0	13.0	17.0	9.5	18.5	10.7	12.6	16.6	15.7	11.5	9.2	10.7	10.7	11.5	12.2	12.0	10.6	10.6	11.6	13.6	11.5	14.3	7.9	18.0	11.4	17.2	11.1	29.5	12.8	10.8	16.2	10.4	9.5	9.2	7.1	28.2	2.9	2.7	6.5	1.1	5.9	26.5	13.6	20.4	5.0	4.1	15.7	7.7	2.9	14.2	10.8	12.9	5.4	26.5	12.5	4.5	5.0	14.0	31.3	10.0	10.6	12.0	25.6	15.5	25.0	16.1	4.3	12.5	11.5	3.9	2.5	16.4	10.4	4.0	11.7	14.5	20.8	4.0	5.7	9.0	22.1	10.9	22.6	3.3	12.1	33.3	14.1	12.7	6.5	10.0	8.3	12.9	9.5	6.1	8.8	7.6	6.0	5.8	8.2	7.9	10.3	14.4	19.0	4.8	8.5	13.0	8.7	17.8	13.3	9.1	2.9	6.5	4.0	2.5	5.2	7.8	5.2	4.6	2.4	9.2	6.5	5.1	28.2	2.7	1.9	7.1	2.7	1.1	11.4	13.0	14.6	18.5	9.0	8.0	10.7	12.6	10.7	11.1	0.0	6.4	2.2	1.5	2.2	6.5	2.8	2.5	8.1	5.7	3.5	5.9	4.2	0.0	3.0	1.6	2.1	1.0	0.0	2.6	3.2	2.3	1.8	1.1	3.8	4.0	1.6	0.0	3.1	3.0	0.4	4.9	2.2	3.3	6.4	2.0	1.5	1.9	3.6	1.4	2.4	6.4	0.0	1.7	3.9	10.3	1.8	2.6	2.5	5.3	1.3
PFKFB1	PFRX	ENSG00000158571	"6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 1"	P16118	X	54932961-54998534	"Enzymes, Predicted intracellular proteins"		"Hydrolase, Kinase, Multifunctional enzyme, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"adipose tissue: 24.2;liver: 24.4;skeletal muscle: 48.3"	"Cell type enriched"	"Detected in some"	10	"Hepatocytes: 15.5"	"Cancer enriched"	"Detected in some"	11	"liver cancer: 7.9"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"MAIT T-cell: 2.1"	"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in some"	4	"ASC diff: 13.9;Hep G2: 5.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"									NA	NA						"unprognostic (2.51e-1)"	"unprognostic (2.39e-2)"	"unprognostic (1.17e-2)"	"unprognostic (4.38e-3)"	"unprognostic (1.64e-1)"	"unprognostic (6.12e-2)"	"unprognostic (1.18e-3)"	"unprognostic (1.51e-1)"	"unprognostic (2.50e-1)"	"unprognostic (3.33e-1)"	"unprognostic (3.26e-3)"	"unprognostic (2.88e-1)"	"unprognostic (5.36e-3)"	"unprognostic (5.06e-1)"	"unprognostic (4.87e-2)"	"unprognostic (1.16e-4)"	"unprognostic (1.96e-3)"	24.2	0.2	0.1	1.6	0.1	0.1	13.1	0.1	0.2	0.1	1.7	0.1	0.1	0.0	0.1	0.2	0.5	0.0	0.1	0.1	0.1	0.1	0.4	24.4	0.1	1.6	0.1	0.1	0.1	0.6	0.2	0.2	0.1	0.1	0.3	0.2	0.1	1.3	0.1	48.3	0.3	0.2	0.1	0.1	0.1	0.1	0.2	0.1	0.1	0.5	8.3	0.6	0.2	2.0	1.5	0.1	0.0	0.7	1.3	2.1	0.3	0.3	0.2	0.4	0.6	13.9	0.3	1.0	0.0	0.1	0.2	0.0	0.9	0.2	0.6	0.3	0.1	0.6	0.5	0.1	0.3	0.5	0.4	1.1	0.4	0.1	5.5	0.0	0.1	0.6	0.2	0.6	0.1	0.4	0.0	0.0	1.3	0.1	2.2	0.2	0.7	0.6	0.3	0.4	0.4	0.3	0.5	0.2	0.2	0.0	0.4	0.4	0.3	0.5	1.6	0.2	1.2	0.4	0.0	0.2	0.1	0.5	0.4	0.2	1.1	1.7	0.4	0.2	0.4	0.1	0.0	0.0	0.0	0.2	0.7	2.1	1.5	0.2	0.0	0.0	0.8	0.0	0.8	0.0	1.3	0.1	0.1	0.0	0.3	0.1	0.1	0.1	0.2	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	15.5	0.1	0.0	0.0	0.6	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0
PFKFB2		ENSG00000123836	"6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 2"	O60825	1	207034366-207081024	"Enzymes, Predicted intracellular proteins"		"Hydrolase, Kinase, Multifunctional enzyme, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	8	"Cardiomyocytes: 70.2;Late spermatids: 128.8;Rod photoreceptor cells: 111.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	6	"eosinophil: 13.9;plasmacytoid DC: 16.7"	"Group enriched"	"Detected in many"	8	"dendritic cells: 16.7;granulocytes: 13.9"	"Low cell line specificity"	"Detected in many"							"Low region specificity"	"Detected in all"			"HPA049975, HPA063575"	Uncertain		Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"HPA049975: AB_2680977, HPA063575: AB_2685046"	"unprognostic (1.30e-1)"	"unprognostic (6.66e-2)"	"unprognostic (1.48e-1)"	"unprognostic (1.75e-2)"	"unprognostic (2.27e-1)"	"unprognostic (3.76e-2)"	"unprognostic (9.96e-3)"	"unprognostic (9.74e-2)"	"unprognostic (7.27e-2)"	"unprognostic (2.27e-2)"	"unprognostic (6.01e-2)"	"unprognostic (1.30e-1)"	"prognostic favorable (3.23e-7)"	"unprognostic (1.54e-2)"	"unprognostic (1.27e-1)"	"prognostic unfavorable (8.63e-4)"	"unprognostic (1.86e-2)"	3.3	6.1	9.8	5.8	16.6	15.7	5.1	2.1	14.6	7.3	16.0	19.5	5.3	23.2	4.0	9.1	7.7	4.5	9.1	22.8	14.1	7.7	22.0	3.6	10.9	5.3	13.4	15.1	4.3	11.9	6.2	27.5	3.0	25.3	3.9	18.1	22.4	6.3	3.5	34.9	6.4	18.7	4.0	17.4	12.5	10.7	6.1	15.1	6.5	38.4	8.8	5.0	3.4	3.6	1.6	16.7	13.9	1.9	1.1	0.4	0.4	9.7	4.3	2.8	4.9	5.9	2.9	4.7	1.4	1.7	2.4	1.3	10.5	14.1	1.7	2.2	2.2	7.4	13.9	2.1	5.2	1.4	0.3	2.1	13.8	10.8	3.9	4.9	0.0	9.7	4.1	8.0	2.3	13.2	2.9	0.5	5.8	9.4	0.1	1.3	2.9	2.3	0.4	3.9	4.7	6.5	0.0	0.0	0.2	3.3	10.1	4.5	2.7	9.1	15.4	11.4	3.2	10.6	1.1	0.2	0.0	5.3	7.5	1.3	4.5	4.4	0.9	6.1	0.0	2.6	1.0	0.9	13.9	0.2	1.9	0.3	1.3	0.1	0.3	0.8	1.6	0.3	0.4	2.6	1.1	1.3	16.7	0.0	0.4	9.8	16.6	2.1	14.6	14.1	7.7	13.4	15.1	25.3	15.1	6.0	42.0	4.5	3.4	13.5	7.3	70.2	5.1	14.7	5.7	15.7	0.0	0.5	21.6	4.0	47.4	2.7	43.0	0.0	6.7	0.4	2.5	6.5	9.2	4.9	4.9	3.2	5.8	1.3	11.3	128.8	2.6	6.0	20.3	1.8	18.9	8.1	10.5	27.7	2.8	30.6	111.9	0.0	3.2	3.1	3.3	10.2	1.3	1.0	27.6	11.2
PFKFB3		ENSG00000170525	"6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 3"	Q16875	10	6144934-6254644	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Hydrolase, Kinase, Multifunctional enzyme, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adipose tissue: 105.6;skeletal muscle: 135.7"	"Cell type enhanced"	"Detected in many"	8	"Collecting duct cells: 184.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"neutrophil: 20.5"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"A549: 72.7;RPTEC TERT1: 45.9;T-47d: 47.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008266, CAB020795, HPA043889"	Uncertain		Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"CAB020795: , HPA008266: AB_1855239, HPA043889: AB_2678717"	"unprognostic (1.61e-1)"	"unprognostic (5.08e-3)"	"unprognostic (2.89e-2)"	"unprognostic (6.18e-2)"	"unprognostic (2.29e-1)"	"unprognostic (1.79e-1)"	"unprognostic (3.11e-3)"	"unprognostic (1.88e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.04e-1)"	"unprognostic (3.30e-2)"	"unprognostic (7.34e-2)"	"prognostic unfavorable (1.87e-7)"	"unprognostic (1.89e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.13e-1)"	"unprognostic (2.74e-1)"	105.6	9.0	16.4	25.7	17.9	77.0	43.4	8.5	29.4	6.6	8.8	29.1	10.6	7.4	9.4	6.3	13.0	14.4	22.4	5.7	16.6	13.2	22.1	11.2	15.1	12.1	19.2	12.9	8.0	8.1	4.0	10.2	7.5	20.7	5.4	3.8	19.3	9.1	20.0	135.7	11.8	6.9	6.5	36.0	12.4	6.7	4.6	16.8	3.3	2.9	4.7	10.3	10.3	10.1	1.5	3.6	20.5	7.1	0.8	4.7	2.9	5.2	72.7	5.8	4.7	21.9	2.7	3.0	7.7	5.5	5.8	9.0	3.4	19.3	9.0	5.1	3.3	4.5	17.0	6.2	12.3	6.7	10.7	4.3	5.3	3.7	1.2	1.8	5.1	8.1	1.9	4.1	9.9	2.4	14.8	11.1	6.3	3.9	3.4	4.6	8.6	3.6	4.8	5.6	7.5	5.1	8.2	2.8	3.5	45.9	2.7	5.5	2.2	5.6	6.2	11.0	10.4	47.8	6.1	14.0	6.1	5.6	0.7	9.3	7.0	2.4	8.1	16.7	6.0	9.2	2.2	5.6	5.5	1.8	7.1	4.7	1.5	3.4	2.3	3.6	1.4	2.5	2.4	20.5	0.8	4.1	2.2	3.2	2.9	16.4	17.9	8.5	16.9	16.6	13.2	19.2	12.9	20.7	16.8	71.5	75.9	13.7	14.3	91.1	7.8	17.3	15.3	13.4	42.1	184.9	49.1	0.2	0.0	42.7	5.1	29.2	7.4	0.0	22.5	4.6	29.8	4.3	41.7	11.6	19.4	6.4	8.2	9.2	79.2	6.1	2.6	37.7	43.9	23.4	5.2	0.4	46.2	5.8	6.7	2.4	1.6	0.0	21.1	0.7	1.6	55.8	0.8	21.3	5.4	9.9
PFKFB4		ENSG00000114268	"6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 4"	Q16877	3	48517684-48562015	"Enzymes, Predicted intracellular proteins"		"Hydrolase, Kinase, Multifunctional enzyme, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 26.0"	"Cell type enhanced"	"Detected in many"	13	"Extravillous trophoblasts: 36.2;Mucus-secreting cells: 11.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"classical monocyte: 6.5;eosinophil: 11.4;intermediate monocyte: 7.3;neutrophil: 21.6;non-classical monocyte: 12.2"	"Group enriched"	"Detected in many"	6	"granulocytes: 21.6;monocytes: 12.2"	"Cell line enhanced"	"Detected in many"		"hTERT-RPE1: 22.9;U-87 MG: 36.5;WM-115: 31.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA047719, HPA066058"	Uncertain		Approved	Nucleoli		NA	NA			Nucleoli		"HPA047719: AB_2680129, HPA066058: AB_2685606"	"unprognostic (7.60e-2)"	"prognostic unfavorable (3.04e-4)"	"unprognostic (1.01e-1)"	"unprognostic (1.19e-1)"	"unprognostic (3.90e-3)"	"unprognostic (7.96e-2)"	"unprognostic (1.72e-6)"	"unprognostic (1.65e-1)"	"unprognostic (3.75e-2)"	"unprognostic (6.78e-2)"	"unprognostic (3.78e-2)"	"unprognostic (7.13e-2)"	"prognostic unfavorable (3.91e-8)"	"unprognostic (2.04e-1)"	"unprognostic (6.28e-2)"	"unprognostic (2.43e-3)"	"unprognostic (3.35e-2)"	2.0	2.2	4.0	3.9	4.9	12.7	2.1	6.3	6.3	2.6	17.1	8.6	3.0	17.8	2.1	18.5	6.4	1.5	1.8	1.4	4.2	5.2	3.6	1.7	3.8	6.3	7.4	2.7	3.5	18.9	4.1	5.1	9.5	6.9	3.3	3.5	3.3	2.5	2.0	4.8	3.3	24.0	2.5	5.3	10.0	1.2	26.0	5.2	0.4	1.6	3.6	2.6	4.9	4.2	0.2	2.7	21.6	12.2	0.2	0.5	2.1	5.0	1.5	3.6	3.3	1.2	1.8	7.1	2.5	4.3	5.2	12.6	2.5	1.8	2.2	2.4	1.9	12.4	1.4	1.5	4.4	4.6	1.5	1.2	5.1	3.3	2.7	1.0	0.9	2.3	1.8	6.6	8.3	0.8	22.9	1.2	2.9	1.7	1.9	4.1	1.1	0.3	7.1	2.2	1.0	3.4	0.4	1.7	2.3	2.0	4.7	1.0	2.2	2.7	1.2	9.9	3.7	2.8	2.2	0.3	5.3	2.1	0.6	15.3	8.8	1.9	1.3	36.5	1.8	31.7	0.0	6.5	11.4	0.2	7.3	0.1	0.2	0.3	0.0	2.7	0.1	0.5	0.1	21.6	0.2	12.2	0.3	0.0	2.1	4.0	4.9	6.3	6.3	4.2	5.2	7.4	2.7	6.9	5.2	0.0	2.2	0.0	0.3	2.9	5.0	0.6	0.0	1.4	1.2	0.0	2.0	11.1	0.0	2.0	2.6	0.4	1.7	0.0	1.3	36.2	1.5	0.4	1.1	0.0	5.3	6.4	4.1	1.8	11.0	2.0	0.9	4.4	1.7	0.0	11.8	3.6	2.9	0.3	0.7	0.0	4.3	0.0	0.8	0.5	0.5	1.5	4.6	0.0	1.5	0.0
PFKL		ENSG00000141959	"Phosphofructokinase, liver type"	P17858	21	44300051-44327376	"Enzymes, Plasma proteins, Predicted intracellular proteins"	Glycolysis	"Allosteric enzyme, Kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Enterocytes: 285.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA030047	Approved		Uncertain	Nucleoli,Mitochondria		NA	NA		1800000	"Nucleoli, Mitochondria"		"HPA030047: AB_10602815"	"unprognostic (6.21e-3)"	"unprognostic (2.93e-1)"	"unprognostic (4.46e-2)"	"unprognostic (1.23e-2)"	"unprognostic (1.87e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.10e-1)"	"unprognostic (6.98e-2)"	"unprognostic (9.75e-2)"	"prognostic unfavorable (4.41e-4)"	"unprognostic (5.69e-2)"	"unprognostic (5.40e-2)"	"unprognostic (1.55e-1)"	"unprognostic (4.99e-1)"	"unprognostic (2.49e-1)"	"unprognostic (8.06e-2)"	"unprognostic (3.01e-2)"	32.0	16.7	28.0	26.0	29.5	26.4	23.1	21.3	46.0	28.3	38.7	40.9	30.1	65.5	21.3	33.5	33.5	22.8	37.5	18.4	28.8	23.4	40.3	31.3	21.0	25.2	32.4	33.0	19.5	27.1	12.3	17.1	31.9	29.1	20.2	17.2	36.3	28.8	28.5	8.3	31.1	59.3	20.5	36.1	28.1	42.7	24.0	29.1	16.4	20.4	15.4	26.0	27.2	23.9	20.3	26.9	5.2	38.0	7.7	25.2	22.8	32.6	14.3	10.2	29.4	16.1	12.0	45.0	24.6	16.0	14.3	14.1	19.2	7.2	19.4	29.3	16.4	13.7	17.8	8.1	22.3	3.3	16.3	18.4	39.2	12.5	31.3	12.4	29.5	25.0	15.7	13.6	14.6	7.2	21.7	21.0	14.2	24.1	22.2	9.7	41.5	12.7	23.0	16.0	29.3	16.1	31.5	9.7	52.6	6.5	36.2	18.0	13.5	35.8	30.4	15.7	4.3	24.1	26.1	30.4	21.7	14.0	14.2	9.4	43.2	11.7	7.9	36.1	23.5	17.3	5.1	22.2	5.2	12.9	37.9	10.8	14.4	17.0	11.8	26.9	20.3	10.2	7.9	4.5	7.7	38.0	17.0	25.2	22.8	28.0	29.5	21.3	46.0	28.8	23.4	32.4	33.0	29.1	29.1	20.8	27.5	37.6	33.4	31.7	71.1	12.6	17.8	21.4	28.4	87.2	62.8	106.3	84.6	68.0	1.8	43.0	285.1	0.0	45.0	147.2	44.6	37.8	41.5	60.1	95.6	28.6	44.5	41.1	58.5	5.2	36.2	60.1	65.8	177.7	107.9	59.6	51.1	112.2	52.3	108.3	44.6	25.8	42.9	1.4	8.7	31.6	134.4	31.9	139.6	44.5
PFKM	"PFK-1, PFKX, PPP1R122"	ENSG00000152556	"Phosphofructokinase, muscle"	P08237	12	48105139-48146404	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	Glycolysis	"Allosteric enzyme, Kinase, Transferase"	"Disease mutation, Glycogen storage disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	5	"skeletal muscle: 284.3"	"Cell type enhanced"	"Detected in many"	13	"Cardiomyocytes: 326.0;Horizontal cells: 114.4;Muller glia cells: 114.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA002117	Approved		Approved	"Endoplasmic reticulum"		NA	NA		1100000	"Endoplasmic reticulum"		"HPA002117: AB_1855245"	"unprognostic (4.60e-2)"	"unprognostic (2.56e-3)"	"unprognostic (2.56e-3)"	"prognostic unfavorable (5.85e-6)"	"unprognostic (4.97e-1)"	"prognostic unfavorable (7.91e-5)"	"unprognostic (5.93e-3)"	"unprognostic (1.63e-1)"	"unprognostic (2.80e-1)"	"unprognostic (1.86e-1)"	"unprognostic (2.29e-3)"	"unprognostic (6.73e-2)"	"prognostic favorable (2.28e-7)"	"unprognostic (1.07e-1)"	"unprognostic (1.53e-1)"	"unprognostic (5.72e-2)"	"unprognostic (1.30e-2)"	4.4	11.6	10.0	3.0	16.2	2.3	3.9	13.0	23.6	5.8	5.3	6.1	5.4	3.0	6.4	5.8	9.1	5.4	4.8	55.5	8.2	10.1	10.9	2.7	3.6	2.4	9.4	10.8	10.8	3.0	14.2	11.4	3.3	17.9	7.1	4.2	10.8	5.2	9.4	284.3	2.6	2.8	8.3	4.6	2.7	4.1	10.3	3.8	0.0	5.5	54.9	4.6	5.3	3.7	10.7	6.7	8.7	3.2	2.2	5.4	3.5	8.7	8.5	27.0	24.5	27.5	20.0	5.5	23.7	21.8	20.5	14.5	21.0	11.0	52.1	19.6	11.4	12.0	9.7	23.3	23.9	19.3	1.2	12.2	14.8	19.3	0.6	14.7	0.7	8.6	28.3	14.1	18.0	29.7	34.3	23.2	0.8	17.8	26.3	18.8	6.6	18.3	1.2	19.2	9.6	26.5	30.8	15.7	40.0	14.0	9.7	31.9	23.5	14.0	22.2	23.7	22.4	22.5	3.2	20.9	9.5	13.1	13.9	19.7	14.4	38.3	28.5	18.4	1.5	7.9	0.4	3.2	8.7	2.5	2.8	1.0	10.7	4.3	2.4	6.7	7.0	5.4	3.0	0.8	2.2	2.3	1.0	3.8	3.5	10.0	16.2	13.0	23.6	8.2	10.1	9.4	10.8	17.9	3.8	14.9	5.9	6.8	17.7	6.5	38.0	326.0	17.8	9.4	7.9	21.0	41.2	2.2	56.3	9.4	29.7	15.8	2.2	0.0	2.2	3.5	16.7	6.1	1.1	2.5	3.5	114.4	8.7	9.8	2.7	19.6	28.4	3.2	52.3	18.0	6.2	114.5	3.3	0.0	44.9	25.8	41.0	25.8	26.2	46.8	11.5	4.5	2.1	4.4	12.1	7.6
PFKP	"PFK-C, PFKF"	ENSG00000067057	"Phosphofructokinase, platelet"	Q01813	10	3066333-3137712	"Enzymes, Plasma proteins, Predicted intracellular proteins"	Glycolysis	"Allosteric enzyme, Kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	8	"Early spermatids: 368.5;Late spermatids: 396.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA018257, HPA056484"	Uncertain		Supported	Cytosol		No	No		4500000	Cytosol		"HPA018257: AB_10960391, HPA056484: AB_2683147"	"unprognostic (1.16e-1)"	"unprognostic (2.41e-3)"	"unprognostic (5.79e-2)"	"unprognostic (1.74e-1)"	"unprognostic (1.40e-1)"	"prognostic unfavorable (1.55e-4)"	"prognostic unfavorable (8.72e-6)"	"unprognostic (1.36e-3)"	"unprognostic (2.38e-1)"	"unprognostic (8.51e-2)"	"unprognostic (2.37e-2)"	"unprognostic (8.82e-2)"	"unprognostic (6.02e-3)"	"unprognostic (2.60e-2)"	"unprognostic (9.74e-2)"	"unprognostic (2.06e-1)"	"unprognostic (4.54e-3)"	14.6	7.9	29.6	22.0	28.9	9.2	8.1	34.2	61.4	9.7	20.5	11.5	7.9	26.8	19.2	11.0	36.0	12.8	19.8	62.0	29.3	32.9	20.0	2.8	9.2	18.2	22.2	29.8	9.3	8.8	1.5	16.8	8.8	21.3	20.3	19.4	14.7	13.4	36.5	24.4	16.5	31.1	34.3	21.1	11.3	20.7	71.8	14.8	9.6	19.3	11.7	13.3	26.9	15.6	8.9	12.5	16.2	4.7	14.3	20.4	8.9	47.8	67.3	4.5	0.1	4.5	9.5	58.8	29.8	10.7	30.2	36.4	70.9	50.9	5.7	23.8	21.4	28.0	38.9	23.0	46.5	31.8	16.1	17.7	20.7	32.4	3.8	10.7	8.3	34.8	4.4	10.5	31.7	15.8	45.8	58.1	24.3	5.7	0.2	33.4	37.4	28.3	9.0	7.4	21.0	23.6	22.2	7.5	23.1	32.7	18.8	12.4	10.7	21.1	18.0	26.4	56.5	14.8	13.1	69.9	20.6	11.1	62.1	32.4	32.7	29.5	20.5	52.9	16.0	12.6	16.2	4.7	1.6	15.9	2.3	12.6	8.2	15.9	14.8	8.0	8.9	6.0	9.5	0.7	14.3	0.9	12.5	20.4	8.9	29.6	28.9	34.2	51.7	29.3	32.9	22.2	29.8	21.3	14.8	3.0	6.5	16.7	44.9	25.4	38.3	113.1	10.2	21.4	27.3	61.1	51.1	2.1	36.5	101.2	368.5	28.8	46.6	0.0	9.2	171.9	17.4	35.9	56.4	0.8	28.5	39.7	35.7	14.1	12.6	396.4	6.9	16.2	18.6	21.6	19.5	104.9	80.1	28.1	6.3	2.1	105.7	12.9	30.8	39.9	3.2	19.7	22.2	27.3	24.5	48.7
PGA3		ENSG00000229859	"Pepsinogen 3, group I (pepsinogen A)"	P0DJD8	11	61203307-61213098	"Enzymes, Predicted intracellular proteins, Predicted secreted proteins"	Digestion	"Aspartyl protease, Hydrolase, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in some"	28	"stomach 1: 1048.8"	"Group enriched"	"Detected in some"	5	"Collecting duct cells: 1.8;Exocrine glandular cells: 5.8;Rod photoreceptor cells: 3.2"	"Cancer enriched"	"Detected in single"	498	"stomach cancer: 24.8"	"Region enriched"	"Detected in single"	15	"cerebral cortex: 4.8"	"Cell type enhanced"	"Detected in many"		"intermediate monocyte: 6.7"	"Lineage enriched"	"Detected in many"	4	"monocytes: 6.7"	"Group enriched"	"Detected in some"	5	"HMC-1: 13.7;THP-1: 4.5"									"CAB026358, HPA046875"	Enhanced				"Secreted to digestive system"	NA	NA					"CAB026358: , HPA046875: AB_2679851"										"unprognostic (6.39e-2)"				"unprognostic (1.11e-1)"				0.3	0.1	0.0	0.2	0.3	0.0	0.3	0.0	4.8	0.2	0.4	19.9	0.0	0.1	0.1	0.5	36.8	0.2	0.0	0.4	0.0	0.0	0.5	0.2	0.1	0.0	0.0	0.0	0.4	17.7	0.0	0.0	0.2	0.0	0.2	0.0	0.1	2.0	0.1	0.1	0.0	0.0	0.7	0.0	1.4	1048.8	0.1	0.0	0.0	0.1	3.8	0.0	0.1	0.0	0.3	0.3	1.1	6.7	0.5	1.5	3.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	1.8	0.0	0.0	0.0	0.1	0.0	1.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	13.7	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.8	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.5	0.0	0.0	1.3	0.4	0.0	0.9	0.0	0.1	0.0	0.0	0.0	0.5	4.3	0.2	1.5	6.7	0.9	0.2	0.5	1.4	0.3	0.3	0.2	1.4	1.1	0.5	1.7	0.2	0.1	3.0	0.0	0.3	0.0	4.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.8	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.8	0.0	0.2	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	3.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1
PGA4		ENSG00000229183	"Pepsinogen 4, group I (pepsinogen A)"	P0DJD7	11	61222216-61231927	"Enzymes, Predicted intracellular proteins, Predicted secreted proteins"	Digestion	"Aspartyl protease, Hydrolase, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in some"	120	"stomach 1: 924.0"	"Cell type enriched"	"Detected in single"	128	"Exocrine glandular cells: 100.1"	"Not detected"	"Not detected"							"Group enriched"	"Detected in some"	16	"classical monocyte: 7.6;intermediate monocyte: 5.9;non-classical monocyte: 2.1"	"Lineage enriched"	"Detected in single"	23	"monocytes: 7.6"	"Group enriched"	"Detected in some"	8	"BJ hTERT+: 17.6;THP-1: 8.9"									HPA046875	Supported				"Secreted to digestive system"	NA	NA					"HPA046875: AB_2679851"										"unprognostic (2.22e-1)"								0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.5	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	924.0	0.0			0.0		0.0	0.0	0.0	0.0	0.3	0.1	7.6	0.0	0.1	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	17.6	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	1.4	0.0	1.2	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.9	0.0	0.0	0.0	0.2	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	7.6	0.0	0.0	5.9	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.1	0.0	2.1	0.0	0.0	1.4											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	100.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
PGA5		ENSG00000256713	"Pepsinogen 5, group I (pepsinogen A)"	P0DJD9	11	61241042-61251448	"Enzymes, Predicted intracellular proteins, Predicted secreted proteins"	Digestion	"Aspartyl protease, Hydrolase, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in some"	38	"stomach 1: 296.9"	"Cell type enriched"	"Detected in some"	278	"Exocrine glandular cells: 4020.2"	"Cancer enriched"	"Detected in some"	12	"stomach cancer: 15.0"					"Group enriched"	"Detected in some"	50	"classical monocyte: 3.4;intermediate monocyte: 7.7;non-classical monocyte: 3.7"	"Lineage enriched"	"Detected in single"	77	"monocytes: 7.7"	"Cell line enriched"	"Detected in some"	14	"BJ hTERT+: 25.7"									HPA046875	Supported				"Secreted to digestive system"	NA	NA					"HPA046875: AB_2679851"				"unprognostic (1.36e-3)"	"unprognostic (2.98e-2)"		"unprognostic (5.83e-3)"			"unprognostic (2.11e-1)"	"unprognostic (4.22e-1)"		"unprognostic (4.36e-2)"	"unprognostic (2.16e-2)"	"unprognostic (1.05e-1)"	"unprognostic (7.10e-2)"		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0			0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	296.9	0.0			0.0		0.0	0.0	0.0	0.0	0.0	0.0	7.7	0.0	0.0	0.6	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	25.7	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.2	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	3.4	0.0	0.0	7.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.7	0.0	0.0	0.6											0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	4020.2	0.0	0.2	0.0	0.0	0.0	5.0	0.0	0.0	0.0	6.3	1.3	0.9	0.3	0.0	1.0	0.0	14.5	5.9	0.0	0.0	0.7	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
PGAM1	"PGAM-B, PGAMA"	ENSG00000171314	"Phosphoglycerate mutase 1"	P18669	10	97426160-97433441	"Candidate cardiovascular disease genes, Enzymes, Plasma proteins, Predicted intracellular proteins"	Glycolysis	"Hydrolase, Isomerase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	4	"Extravillous trophoblasts: 698.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042528, HPA060483"	Approved		Supported	Nucleoplasm		NA	NA		200000000	Nucleoplasm		"HPA042528: AB_2678039, HPA060483: AB_2684292"	"prognostic unfavorable (2.04e-4)"	"prognostic unfavorable (3.86e-4)"	"unprognostic (3.64e-1)"	"unprognostic (5.64e-2)"	"unprognostic (1.16e-1)"	"unprognostic (9.47e-3)"	"unprognostic (7.60e-3)"	"unprognostic (1.74e-3)"	"unprognostic (3.22e-1)"	"unprognostic (1.05e-1)"	"unprognostic (4.37e-3)"	"unprognostic (2.48e-2)"	"unprognostic (1.48e-1)"	"unprognostic (5.74e-2)"	"unprognostic (4.94e-2)"	"unprognostic (1.19e-1)"	"unprognostic (2.61e-3)"	26.5	46.1	42.8	28.9	50.3	30.2	19.0	32.6	90.0	26.5	27.6	24.9	14.2	29.8	24.3	20.6	63.5	17.7	21.2	54.1	47.4	44.9	32.7	35.7	18.5	29.5	45.7	61.1	22.9	14.3	27.8	23.2	30.8	72.4	21.9	29.2	30.4	24.5	33.7	8.4	30.0	27.4	35.6	25.7	21.7	20.3	26.1	21.0	26.6	17.4	27.0	43.7	31.0	31.9	22.5	49.7	88.0	65.3	22.8	41.2	72.8	119.7	57.0	39.4	75.1	37.3	34.4	53.7	76.8	100.5	90.3	126.0	61.8	35.8	63.5	52.7	65.2	36.3	75.2	68.4	111.7	109.5	58.7	65.4	41.0	44.7	69.1	27.6	58.7	54.9	33.6	45.8	60.0	44.8	122.3	65.3	47.7	26.8	36.0	94.7	49.5	52.4	72.5	60.3	34.7	68.4	39.9	36.1	50.3	69.7	45.5	8.6	40.3	41.3	24.7	39.4	64.5	67.2	49.5	49.1	48.4	42.6	42.7	88.1	54.3	59.8	57.9	112.5	98.2	22.3	30.4	65.3	88.0	37.0	57.2	32.7	22.5	31.8	36.6	49.7	18.8	20.7	28.9	50.3	22.8	62.8	17.6	41.2	72.8	42.8	50.3	32.6	90.0	47.4	44.9	45.7	61.1	72.4	21.0	41.7	37.7	99.1	98.5	166.1	402.1	21.4	81.5	34.8	53.4	101.2	72.6	433.1	303.4	278.9	11.6	112.3	222.3	46.7	180.1	698.3	148.4	67.2	102.6	165.4	366.0	365.5	46.3	103.7	173.5	17.6	138.4	127.2	124.9	317.4	104.7	280.3	240.1	115.6	220.3	200.3	232.1	200.5	123.6	31.0	121.7	178.9	311.6	142.2	136.4	230.0
PGAM2	PGAM-M	ENSG00000164708	"Phosphoglycerate mutase 2"	P15259	7	44062727-44065587	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	Glycolysis	"Hydrolase, Isomerase"	"Disease mutation, Glycogen storage disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	12	"heart muscle: 111.6;skeletal muscle: 379.1;tongue: 119.0"	"Group enriched"	"Detected in many"	13	"Early spermatids: 421.0;Late spermatids: 1332.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	4	"eosinophil: 1.2;neutrophil: 1.1;plasmacytoid DC: 1.3;T-reg: 1.7"	"Group enriched"	"Detected in many"	4	"dendritic cells: 1.3;granulocytes: 1.2;T-cells: 1.7"	"Cell line enriched"	"Detected in some"	9	"SCLC-21H: 39.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"HPA043801, HPA050314, HPA060173"	Enhanced		Approved	Nucleoplasm,Nucleoli,Cytosol		NA	NA		60000000	Nucleoplasm	"Nucleoli, Cytosol"	"HPA043801: , HPA050314: AB_2732558, HPA060173: AB_2684215"																		1.4	0.8	2.0	0.4	2.2	0.4	0.5	6.9	2.1	0.5	0.5	3.6	0.0	0.6	0.5	9.1	6.1	0.6	0.7	111.6	2.1	3.2	0.8	0.4	0.4	0.4	4.2	1.6	0.5	0.6	0.6	1.3	0.4	2.0	1.9	0.4	2.3	7.6	0.5	379.1	0.4	0.4	0.4	3.2	0.5	0.5	16.7	1.1	4.8	1.5	119.0	4.8	0.4	0.0	0.3	1.3	1.2	0.0	0.0	1.7	0.2	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.6	0.0	0.0	0.1	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	39.0	4.3	0.0	0.2	0.2	0.0	0.4	0.0	0.0	0.0	0.1	0.0	0.0	0.6	0.3	0.1	0.1	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	1.1	0.0	0.0	1.3	1.7	0.2	2.0	2.2	6.9	2.1	2.1	3.2	4.2	1.6	2.0	1.1	0.0	0.0	0.5	0.2	1.0	4.3	0.0	0.0	0.0	0.0	0.0	9.8	0.0	68.0	0.0	421.0	0.0	0.0	0.0	0.5	0.0	0.0	0.2	0.0	0.0	0.0	0.0	22.0	0.0	0.3	1332.7	7.2	0.4	1.7	0.0	0.0	3.8	0.2	0.2	5.6	1.9	4.2	25.8	3.1	30.5	5.6	0.5	0.0	0.0	0.2	0.4
PGAM4	"dJ1000K24.1, PGAM-B, PGAM1, PGAM3"	ENSG00000226784	"Phosphoglycerate mutase family member 4"	Q8N0Y7	X	77968874-77969638	"Enzymes, Predicted intracellular proteins"	Glycolysis	"Hydrolase, Isomerase"		"Evidence at protein level"	"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in some"	6	"Basal keratinocytes: 2.1;Melanocytes: 3.3;Suprabasal keratinocytes: 2.0"	"Low cancer specificity"	"Detected in single"							"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"A-431: 5.4"									"HPA042528, HPA060483"	Uncertain		Uncertain	Nucleoplasm		NA	NA			Nucleoplasm		"HPA042528: AB_2678039, HPA060483: AB_2684292"	"unprognostic (3.10e-2)"	"unprognostic (2.41e-2)"	"unprognostic (5.25e-2)"	"unprognostic (3.18e-2)"	"unprognostic (4.37e-2)"	"unprognostic (4.21e-2)"	"unprognostic (7.71e-2)"	"unprognostic (1.89e-2)"	"unprognostic (1.78e-1)"	"unprognostic (7.52e-3)"	"unprognostic (3.19e-2)"	"unprognostic (1.14e-1)"	"unprognostic (4.20e-2)"	"unprognostic (1.20e-1)"	"unprognostic (4.15e-2)"	"unprognostic (1.10e-1)"	"unprognostic (2.76e-3)"	0.9	2.1	0.9	2.6	1.5	3.0	0.4	0.8	2.1	1.9	0.6			2.4	1.4	0.7	2.9	1.3	0.0	1.3	1.0	1.5	0.9	1.2	0.4	1.2	1.5		1.0	0.1	0.7	0.7	0.7		0.5	0.7		0.6	0.2	1.1	0.8	2.0	1.3	0.4	1.0	1.3	0.5			0.3		0.7	1.6	1.2	0.7	1.9	3.7	2.4	0.8	1.6	3.5	5.4	3.1	0.3	0.9	0.4	0.0	2.7	0.5	0.1	0.6	0.8	0.0	0.5	0.8	1.5	0.3	0.0	2.3	0.2	0.0	0.8	0.6	0.3	0.0	1.1	0.7	0.0	1.6	0.9	0.4	0.2	0.2	0.0	0.1	0.5	0.3	0.0	0.6	0.8	1.0	2.7	3.9	1.1	0.3	0.8	0.8	1.0	2.0	0.0	0.7	0.1	2.7	0.3	0.0	1.3	0.3	1.0	0.6	0.0	1.0	1.8	1.6	3.1	2.8	1.4	0.7	3.7	1.6	0.5	0.6	2.4	3.7	1.4	2.2	1.1	0.7	1.1	1.3	1.9	0.7	0.6	0.9	1.5	0.8	2.1	0.5	1.6	3.5											0.0	0.0	0.0	0.0	2.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	2.0	0.1	0.0	0.0	0.0
PGAM5	"BXLBv68, MGC5352"	ENSG00000247077	"PGAM family member 5, mitochondrial serine/threonine protein phosphatase"	Q96HS1	12	132710819-132722734	"Enzymes, Predicted intracellular proteins"	Necrosis	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036978, HPA036979, CAB068215"	Enhanced		Supported	Mitochondria	"Intracellular and membrane"	NA	NA			Mitochondria		"CAB068215: AB_2665674, HPA036978: AB_10964347, HPA036979: AB_10960559"	"unprognostic (9.57e-2)"	"unprognostic (2.00e-2)"	"unprognostic (3.83e-2)"	"unprognostic (3.11e-2)"	"unprognostic (3.46e-1)"	"unprognostic (1.39e-1)"	"prognostic unfavorable (1.13e-6)"	"unprognostic (3.32e-2)"	"unprognostic (1.47e-1)"	"unprognostic (5.67e-2)"	"unprognostic (1.23e-1)"	"unprognostic (6.92e-2)"	"unprognostic (6.42e-3)"	"unprognostic (1.63e-2)"	"unprognostic (1.71e-1)"	"unprognostic (1.19e-1)"	"unprognostic (5.53e-2)"	12.2	16.5	11.7	14.3	14.0	12.5	18.6	14.6	22.1	8.4	13.9	8.3	9.9	13.6	10.4	9.9	22.0	11.5	13.4	22.6	14.2	12.1	13.9	26.3	8.5	17.6	9.9	11.8	11.9	30.2	8.1	9.6	10.3	10.4	10.1	10.4	8.5	16.0	11.4	27.4	15.2	12.0	10.2	7.5	13.0	11.7	13.6	5.1	17.6	16.3	17.4	14.5	11.6	12.9	4.0	6.7	7.7	3.1	3.3	3.7	1.4	19.2	37.1	7.9	22.3	5.6	4.5	18.6	9.9	6.2	16.7	9.4	46.2	11.2	24.9	18.4	8.6	8.6	16.9	37.2	18.7	6.9	12.2	29.3	29.9	17.4	24.1	12.7	28.3	17.5	5.6	13.8	19.5	21.1	5.5	12.2	20.4	37.4	10.3	6.5	34.9	38.3	28.3	30.1	16.9	26.3	29.4	8.8	19.9	10.8	26.8	29.1	16.4	17.2	24.2	10.7	6.6	30.6	15.7	10.5	8.5	18.6	17.1	24.1	21.6	31.7	35.8	11.1	23.2	14.2	7.7	2.4	0.7	2.5	2.5	3.7	3.6	2.9	2.8	2.0	4.0	2.9	3.6	2.0	3.3	3.1	6.7	2.0	1.4	11.7	14.0	14.6	22.1	14.2	12.1	9.9	11.8	10.4	5.1	3.0	6.7	6.7	10.3	10.2	9.2	12.6	20.4	4.0	0.0	5.2	13.7	5.6	5.0	4.0	12.9	5.3	6.3	0.0	6.7	12.5	3.3	9.0	0.0	21.9	6.4	6.4	12.6	4.3	6.9	15.9	5.5	4.8	3.3	2.8	8.9	3.9	6.9	5.8	6.3	9.0	12.2	6.5	5.5	9.8	9.4	15.2	5.1	4.4	14.0	11.6
PGC		ENSG00000096088	Progastricsin	P20142	6	41736711-41754109	"Cancer-related genes, Enzymes, Predicted intracellular proteins, Predicted secreted proteins, Transporters"	Digestion	"Aspartyl protease, Hydrolase, Protease"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"ductus deferens: 249.6;pancreas: 798.6;stomach 1: 963.7"	"Cell type enhanced"	"Detected in some"	28	"Alveolar cells type 2: 270.0;Cholangiocytes: 150.3;Pancreatic endocrine cells: 843.0"	"Cancer enhanced"	"Detected in many"		"stomach cancer: 1050.3"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	7	"intermediate monocyte: 1.9"	"Lineage enriched"	"Detected in single"	7	"monocytes: 1.9"	"Group enriched"	"Detected in some"	11	"Hep G2: 69.6;OE19: 42.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA031717, HPA031718"	Enhanced		Approved	Nucleoplasm	"Secreted to digestive system"	NA	NA			Nucleoplasm		"HPA031717: AB_10670130, HPA031718: AB_10610148"	"unprognostic (9.18e-2)"	"unprognostic (1.87e-1)"	"unprognostic (9.83e-2)"	"unprognostic (2.27e-1)"	"unprognostic (7.18e-2)"	"unprognostic (2.74e-1)"	"unprognostic (1.47e-1)"	"unprognostic (8.50e-2)"		"unprognostic (1.86e-1)"	"unprognostic (9.23e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.33e-2)"	"unprognostic (2.92e-1)"	"unprognostic (1.65e-1)"		"unprognostic (8.74e-2)"	0.1	0.2	0.1	0.0	0.1	0.0	0.2	0.1	0.1	0.3	0.1	3.0	249.6	41.7	0.1	0.0	3.3	0.3	16.8	0.1	0.1	0.1	0.1	0.3	139.4	0.0	0.1	0.0	0.1	798.6	0.0	0.1	0.0	0.1	2.3	0.0	0.0	0.1	35.9	0.1	0.1	0.1	0.0	0.1	0.1	963.7	0.1	0.0	0.0	0.1	0.0	0.0	0.4	0.2	0.0	0.0	0.0	1.9	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.5	0.0	0.0	0.0	0.0	5.1	0.0	0.0	0.1	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	69.6	0.0	0.1	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.2	1.6	42.3	0.0	0.8	0.0	1.6	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.7	0.0	0.0	1.1	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	1.9	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.0	23.8	270.0	0.0	3.1	0.3	0.0	0.2	150.3	5.3	9.1	0.0	0.0	0.9	0.0	0.0	0.0	0.1	0.0	0.0	117.5	1.0	0.1	95.4	9.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	3.6	0.0	0.0	843.0	2.3	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	3.4	0.0	0.0	2.6
PGD		ENSG00000142657	"Phosphogluconate dehydrogenase"	P52209	1	10398592-10420144	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Gluconate utilization, Pentose shunt"	Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 115.1;esophagus: 123.8"	"Cell type enhanced"	"Detected in many"	6	"Kupffer cells: 204.0;monocytes: 212.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"basophil: 98.6;classical monocyte: 32.0;eosinophil: 115.1;neutrophil: 38.4"	"Group enriched"	"Detected in all"	5	"granulocytes: 115.1;monocytes: 32.0"	"Cell line enhanced"	"Detected in all"		"A549: 181.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031314, HPA031315"	Enhanced	Supported	Approved	"Intermediate filaments,Cytosol"		No	No		59000000	"Intermediate filaments, Cytosol"		"HPA031314: AB_10610278, HPA031315: AB_2673825"	"unprognostic (4.65e-2)"	"unprognostic (2.58e-1)"	"unprognostic (8.65e-2)"	"unprognostic (9.80e-2)"	"unprognostic (1.31e-2)"	"unprognostic (2.28e-1)"	"prognostic unfavorable (3.98e-4)"	"unprognostic (1.90e-2)"	"unprognostic (2.83e-1)"	"unprognostic (1.40e-2)"	"unprognostic (4.92e-1)"	"unprognostic (1.36e-1)"	"unprognostic (1.37e-3)"	"unprognostic (1.43e-1)"	"unprognostic (1.49e-1)"	"unprognostic (2.43e-3)"	"unprognostic (1.14e-1)"	29.8	12.7	10.9	14.2	11.8	85.5	23.7	8.0	19.1	16.0	14.1	13.8	8.1	22.9	6.3	12.5	123.8	8.4	24.9	14.3	10.3	12.1	15.4	23.2	25.6	34.9	12.4	11.4	14.3	8.3	16.2	10.8	17.0	19.3	7.9	12.9	19.7	31.8	6.8	8.5	10.6	25.3	9.5	12.6	27.6	13.4	27.0	7.4	16.8	21.2	68.8	49.9	14.8	26.1	3.9	15.9	115.1	32.0	2.0	3.0	19.0	23.1	181.8	45.3	48.7	69.0	42.7	9.8	15.7	27.8	21.8	29.8	26.6	26.7	22.8	19.4	16.1	29.9	19.7	33.1	28.1	14.7	15.7	28.9	30.8	32.7	55.9	21.0	50.8	34.2	30.4	14.1	34.4	8.5	27.8	51.4	32.0	41.0	20.2	27.8	26.3	41.9	25.5	27.2	31.8	16.0	32.5	41.6	41.9	30.4	12.5	24.4	21.3	13.4	21.3	18.5	31.2	23.5	43.6	48.1	11.5	20.4	13.7	17.3	15.3	27.9	40.8	25.1	55.2	10.3	98.6	32.0	115.1	2.6	15.3	3.0	3.9	2.5	2.4	15.9	2.3	2.4	2.6	38.4	2.0	10.9	11.4	2.4	19.0	10.9	11.8	8.0	19.1	10.3	12.1	12.4	11.4	19.3	7.4	17.9	31.2	16.0	28.9	11.6	7.9	9.5	50.9	17.4	23.9	19.2	17.7	114.8	44.7	45.3	7.1	17.5	32.9	0.0	35.1	31.4	28.8	33.1	24.4	48.2	117.8	1.6	22.4	16.0	204.0	9.8	15.8	88.3	16.9	212.8	23.7	12.9	39.9	25.9	9.9	40.3	16.4	19.4	9.8	33.4	37.9	14.4	68.0	16.0	44.1	66.7
PGGHG	"ATHL1, FLJ22635"	ENSG00000142102	"Protein-glucosylgalactosylhydroxylysine glucosidase"	Q32M88	11	289135-296107	"Enzymes, Predicted intracellular proteins"		"Glycosidase, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	6	"pancreas: 148.7"	"Cell type enhanced"	"Detected in some"	19	"Alveolar cells type 1: 148.9;Alveolar cells type 2: 104.9;Club cells: 58.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"JURKAT: 54.5;U-266/70: 14.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"HPA039383, HPA058829"	Uncertain		Enhanced	Cytosol		NA	Yes			Cytosol		"HPA039383: AB_10796225, HPA058829: AB_2683830"	"unprognostic (1.40e-3)"	"unprognostic (2.18e-1)"	"unprognostic (4.22e-2)"	"unprognostic (2.37e-1)"	"unprognostic (1.36e-2)"	"unprognostic (5.83e-2)"	"unprognostic (7.95e-3)"	"unprognostic (2.77e-2)"	"unprognostic (2.16e-2)"	"unprognostic (2.14e-2)"	"unprognostic (2.71e-2)"	"unprognostic (3.45e-1)"	"unprognostic (1.92e-3)"	"unprognostic (2.85e-3)"	"unprognostic (1.09e-2)"	"unprognostic (1.22e-1)"	"prognostic favorable (5.12e-4)"	5.6	1.8	6.0	16.7	9.3	6.3	10.5	2.9	7.7	12.7	5.6	3.3	10.4	21.1	6.9	14.9	5.6	8.4	8.3	4.4	6.3	1.7	14.8	17.0	15.7	24.6	7.6	2.5	3.5	148.7	2.6	3.6	3.4	8.0	8.5	3.0	7.1	8.9	21.8	5.6	2.4	23.2	5.2	10.1	24.2	4.7	2.3	7.5	6.3	18.0	6.4	15.4	7.3	8.7	2.3	2.5	4.9	4.2	6.9	8.5	2.7	2.1	2.3	4.4	4.8	1.8	1.6	3.3	1.7	1.4	1.0	0.8	2.0	6.1	0.0	2.2	2.0	2.1	1.3	0.3	0.7	0.1	5.2	1.6	1.0	1.5	2.6	2.2	0.1	9.4	5.9	0.6	0.3	0.3	3.7	3.3	54.5	4.0	6.5	0.5	3.1	8.9	4.7	3.4	0.7	0.3	8.5	0.8	3.0	2.3	0.7	0.0	1.0	0.6	3.2	2.9	2.0	2.3	1.1	3.0	2.1	2.9	0.6	0.2	14.3	0.4	2.3	0.3	1.7	2.4	1.5	0.9	1.2	8.5	4.2	7.2	2.1	1.3	4.7	0.6	2.3	3.1	6.1	4.9	6.9	3.2	2.5	0.2	2.7	6.0	9.3	2.9	7.7	6.3	1.7	7.6	2.5	8.0	7.5	148.9	104.9	0.0	0.0	0.0	0.0	0.0	0.0	18.7	58.0	31.4	0.0	0.3	0.0	4.9	0.0	0.0	0.0	0.0	7.1	2.9	0.0	0.0	5.8	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	1.8	0.0	0.0	14.6	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0
PGGT1B	"BGGI, GGTI"	ENSG00000164219	"Protein geranylgeranyltransferase type I subunit beta"	P53609	5	115204012-115262872	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Prenyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Rod photoreceptor cells: 111.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA030646	Uncertain		Approved	"Nucleoplasm,Endoplasmic reticulum,Cytosol"		NA	NA			"Nucleoplasm, Endoplasmic reticulum"	Cytosol	"HPA030646: AB_10602019"	"unprognostic (2.73e-2)"	"unprognostic (1.67e-1)"	"unprognostic (3.92e-2)"	"unprognostic (7.34e-2)"	"unprognostic (5.57e-2)"	"unprognostic (7.56e-3)"	"unprognostic (1.34e-1)"	"unprognostic (1.75e-1)"	"unprognostic (3.25e-2)"	"unprognostic (1.33e-1)"	"unprognostic (2.17e-1)"	"unprognostic (2.48e-1)"	"unprognostic (4.38e-2)"	"unprognostic (1.58e-1)"	"unprognostic (3.75e-1)"	"unprognostic (5.93e-3)"	"unprognostic (1.15e-2)"	10.5	12.4	7.3	13.3	10.1	10.9	13.9	8.8	22.1	10.8	13.8	7.7	7.9	12.3	9.2	4.6	14.9	7.3	7.0	13.5	9.5	5.9	8.2	13.7	22.2	22.2	10.2	10.0	9.6	10.1	12.0	13.4	7.8	8.2	8.4	15.1	5.7	10.6	8.4	10.2	9.9	10.4	9.5	6.9	10.4	11.0	5.1	10.5	10.2	8.8	9.9	10.1	9.6	10.5	8.0	11.5	21.8	16.7	6.7	6.3	6.4	10.2	11.2	12.8	16.5	7.5	6.3	6.3	12.7	7.5	10.6	11.0	12.2	11.0	20.9	17.3	8.8	11.0	8.0	16.8	16.7	15.9	23.0	9.3	12.0	14.6	9.7	10.0	16.5	17.8	9.4	10.3	10.4	10.9	6.8	10.6	12.4	9.7	8.9	12.1	16.0	14.4	5.5	9.5	11.6	8.7	15.8	17.1	21.2	11.1	19.4	12.5	9.5	15.1	11.5	12.1	8.0	15.4	12.4	12.1	10.9	10.3	7.5	14.8	15.0	16.7	11.0	7.9	17.2	15.1	8.3	12.8	21.8	5.0	16.6	5.6	6.8	5.7	6.3	11.5	8.0	5.4	5.0	13.1	6.7	16.7	10.3	4.9	6.4	7.3	10.1	8.8	22.1	9.5	5.9	10.2	10.0	8.2	10.5	11.9	14.4	20.7	10.2	8.9	22.7	15.7	5.1	25.4	18.2	15.7	45.2	12.3	23.2	17.0	28.4	16.1	17.8	0.0	18.9	11.6	11.7	13.7	23.1	24.5	19.5	22.3	28.9	20.3	18.3	8.1	12.4	23.0	10.1	12.6	23.0	25.4	17.9	21.0	14.5	18.3	111.9	12.9	14.1	11.4	15.6	10.8	11.3	19.1	23.3	17.8
PGK1		ENSG00000102144	"Phosphoglycerate kinase 1"	P00558	X	77910739-78129296	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	Glycolysis	"Kinase, Transferase"	"Disease mutation, Hereditary hemolytic anemia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB010065, HPA045385, HPA073644, HPA073656"	Approved					NA	NA		290000000			"CAB010065: AB_628116, HPA045385: AB_2679306, HPA073644: AB_2732231, HPA073656: AB_2732235"	"prognostic unfavorable (7.05e-8)"	"prognostic unfavorable (2.69e-5)"	"unprognostic (1.21e-1)"	"unprognostic (8.30e-2)"	"unprognostic (1.10e-1)"	"prognostic unfavorable (2.65e-6)"	"prognostic unfavorable (2.74e-4)"	"unprognostic (1.13e-2)"	"unprognostic (1.27e-1)"	"unprognostic (6.66e-2)"	"prognostic unfavorable (8.34e-4)"	"unprognostic (5.66e-2)"	"unprognostic (2.99e-1)"	"unprognostic (8.99e-3)"	"unprognostic (3.58e-1)"	"unprognostic (2.90e-2)"	"unprognostic (6.57e-2)"	45.0	50.9	29.2	41.3	38.4	62.2	29.9	43.8	67.9	31.9	36.6	24.2	27.5	35.5	25.7	23.3	62.1	25.6	32.4	69.4	28.6	35.0	71.8	58.5	37.5	47.6	32.1	32.7	26.8	21.2	45.7	29.0	43.7	49.9	28.3	42.8	40.0	38.2	32.0	115.5	38.7	41.9	33.9	30.1	43.7	29.7	11.3	24.9	51.8	39.1	61.1	52.4	42.2	38.0	20.9	53.7	49.2	79.0	21.0	26.3	77.0	100.7	46.7	15.6	31.6	27.1	22.0	37.3	51.6	35.9	45.4	76.2	42.3	31.8	40.4	53.5	35.6	54.1	43.9	69.2	80.2	91.1	24.6	27.3	31.3	77.1	36.7	29.7	71.5	34.9	27.4	33.9	41.2	21.9	73.2	46.4	39.9	32.6	61.8	61.9	39.8	62.5	54.1	48.4	68.0	89.0	45.3	42.0	123.7	47.3	42.1	23.4	32.3	53.4	45.6	44.8	41.6	23.9	37.6	37.3	48.6	33.6	48.5	35.5	68.7	128.4	42.4	137.0	81.5	31.7	22.7	54.6	49.2	20.8	59.9	23.2	20.9	25.0	22.6	53.7	15.8	23.0	24.4	45.7	21.0	79.0	20.9	26.3	77.0	29.2	38.4	43.8	67.9	28.6	35.0	32.1	32.7	49.9	24.9	140.0	160.9	145.9	244.9	128.1	204.1	404.2	163.1	85.6	114.9	165.7	72.6	242.5	399.6	557.2	11.8	143.5	182.6	46.7	207.9	529.0	138.1	108.8	187.4	169.3	452.6	292.4	98.3	141.2	307.1	7.6	87.8	291.4	158.6	539.2	123.3	226.5	430.4	133.6	119.5	437.4	139.8	122.9	131.3	8.4	51.9	104.1	292.3	207.0	146.6	230.5
PGK2	"PGK-2, PGKPS"	ENSG00000170950	"Phosphoglycerate kinase 2"	P07205	6	49785651-49787307	"Enzymes, Plasma proteins, Predicted intracellular proteins"	Glycolysis	"Kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	55	"testis: 70.2"	"Group enriched"	"Detected in some"	48	"Early spermatids: 906.2;Late spermatids: 2050.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"RT4: 1.0;U-2197: 1.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA045385, HPA073644, HPA073656"	Supported					NA	NA					"HPA045385: AB_2679306, HPA073644: AB_2732231, HPA073656: AB_2732235"					"unprognostic (8.87e-3)"					"unprognostic (5.02e-1)"				"unprognostic (1.24e-1)"				0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	70.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.4	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.1	0.5	0.0	0.6	0.1	0.1	0.0	0.3	0.0	0.0	0.1	1.1	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	906.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2050.3	13.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.0	0.0	0.0	6.5	0.0	30.9	8.6	0.0	0.0	0.0	0.0	0.0
PGLS	6PGL	ENSG00000130313	6-phosphogluconolactonase	O95336	19	17511629-17521288	"Enzymes, Plasma proteins, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"PC-3: 71.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040744, HPA042032"	Approved		Supported	Nucleoplasm,Cytosol		NA	NA		10000000	Nucleoplasm	Cytosol	"HPA040744: AB_2677111, HPA042032: AB_2677809"	"unprognostic (3.68e-2)"	"unprognostic (8.98e-3)"	"unprognostic (1.25e-1)"	"unprognostic (9.64e-3)"	"unprognostic (1.35e-1)"	"unprognostic (1.04e-1)"	"unprognostic (3.55e-3)"	"unprognostic (2.95e-1)"	"unprognostic (1.44e-1)"	"unprognostic (7.55e-2)"	"unprognostic (2.16e-1)"	"unprognostic (1.30e-1)"	"unprognostic (4.75e-3)"	"unprognostic (2.39e-1)"	"unprognostic (1.99e-1)"	"unprognostic (5.05e-2)"	"unprognostic (9.26e-3)"	27.3	31.5	15.6	23.6	13.9	29.3	33.7	9.0	20.1	23.8	29.5	16.0	17.9	21.9	16.6	18.7	38.0	25.9	27.8	18.5	13.9	11.6	25.9	42.7	27.5	60.0	14.3	11.8	32.0	42.1	19.1	16.4	26.5	10.9	23.5	13.5	16.8	31.5	20.7	10.9	27.2	30.8	13.3	16.8	31.4	20.8	15.8	12.2	46.6	26.7	19.2	27.6	18.5	21.6	17.6	46.4	45.8	44.5	17.4	14.9	22.4	18.9	17.1	10.7	7.3	16.5	27.4	20.6	13.0	21.2	13.1	16.9	8.1	28.7	21.0	14.6	20.3	9.3	13.1	6.0	20.3	3.9	10.4	23.5	9.9	7.9	14.5	28.3	10.4	11.0	32.1	28.2	7.8	23.5	13.5	17.6	8.2	11.1	5.1	16.1	20.8	22.9	29.5	14.4	19.7	71.7	15.5	6.9	13.3	17.7	15.3	13.7	16.5	8.3	9.2	18.3	6.1	13.3	19.0	16.4	13.6	3.8	27.1	7.3	9.2	6.4	8.9	19.4	26.9	13.3	15.2	40.8	45.8	14.9	44.5	12.1	16.4	13.2	13.2	46.4	17.6	12.5	12.6	39.6	17.4	41.5	34.4	14.0	22.4	15.6	13.9	9.0	20.1	13.9	11.6	14.3	11.8	10.9	12.2	26.8	37.6	86.9	79.0	57.4	21.4	7.6	91.7	29.4	39.8	45.4	15.7	102.5	94.5	158.8	26.8	57.1	173.6	23.3	181.6	135.6	85.0	78.7	25.3	85.9	223.6	25.4	127.8	76.1	277.9	55.5	84.0	130.9	70.9	196.6	120.1	61.4	172.0	171.9	65.0	148.8	22.8	51.8	55.6	36.4	23.4	84.1	88.0	79.9	140.5	131.2
PGLYRP2	"PGLYRPL, PGRP-L, PGRPL, tagL, tagL-alpha, tagl-beta, TAGL-like"	ENSG00000161031	"Peptidoglycan recognition protein 2"	Q96PD5	19	15468645-15498956	"Enzymes, Plasma proteins, Predicted membrane proteins, Predicted secreted proteins"	Immunity	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	13	"liver: 95.8"	"Cell type enriched"	"Detected in some"	16	"Hepatocytes: 136.1"	"Cancer enriched"	"Detected in some"	16	"liver cancer: 42.9"	"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	7	"granulocytes: 3.6;monocytes: 7.1;T-cells: 3.7"	"Group enriched"	"Detected in some"	6	"MCF7: 10.9;T-47d: 10.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"CAB033468, HPA046311, HPA075237"	Supported		Approved	"Cell Junctions"	"Secreted to blood"	NA	NA		160000000000	"Cell Junctions"		"CAB033468: AB_1127187, HPA046311: AB_2679621, HPA075237: AB_2686739"	"unprognostic (7.39e-3)"	"unprognostic (1.52e-2)"	"unprognostic (5.22e-2)"	"unprognostic (8.79e-2)"	"unprognostic (3.97e-1)"	"unprognostic (4.88e-4)"	"unprognostic (5.93e-3)"	"unprognostic (6.48e-2)"	"unprognostic (1.99e-1)"	"unprognostic (1.18e-2)"	"unprognostic (3.15e-2)"	"unprognostic (2.40e-1)"	"unprognostic (6.66e-16)"	"unprognostic (6.35e-3)"	"unprognostic (2.80e-1)"	"unprognostic (2.45e-2)"	"unprognostic (2.81e-4)"	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	95.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.2	3.6	7.1	0.6	3.7	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	10.9	0.0	0.0	0.1	0.0	0.0	0.0	0.5	0.1	0.0	0.7	0.0	0.0	0.2	0.0	0.0	0.0	10.9	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.4	0.0	3.6	0.7	0.3	2.6	2.4	2.5	0.3	1.6	1.3	0.2	0.0	3.6	3.7	2.5	0.6	7.1	0.0	0.1	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.2	0.0	0.0	0.2	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	136.1	0.3	0.0	0.0	3.1	1.3	2.5	0.3	0.0	8.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.1	0.0	2.9	0.0	0.0
PGM1		ENSG00000079739	"Phosphoglucomutase 1"	P36871	1	63593276-63660245	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Carbohydrate metabolism, Glucose metabolism"	Isomerase	"Congenital disorder of glycosylation, Disease mutation, Glycogen storage disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	4	"skeletal muscle: 233.5"	"Cell type enhanced"	"Detected in many"	5	"Exocrine glandular cells: 209.3;Hepatocytes: 186.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004666, HPA024190, HPA024637, HPA046329"	Enhanced		Approved	Cytosol		NA	NA		20000000	Cytosol		"CAB004666: AB_425590, HPA024190: AB_1855266, HPA024637: AB_1855267, HPA046329: AB_2679625"	"unprognostic (2.50e-1)"	"unprognostic (2.26e-3)"	"unprognostic (1.74e-2)"	"unprognostic (5.90e-2)"	"unprognostic (1.65e-1)"	"unprognostic (1.63e-1)"	"unprognostic (1.28e-2)"	"unprognostic (1.86e-3)"	"unprognostic (2.42e-3)"	"unprognostic (2.20e-1)"	"prognostic unfavorable (8.74e-5)"	"unprognostic (7.07e-2)"	"unprognostic (1.55e-2)"	"unprognostic (6.58e-3)"	"unprognostic (1.37e-1)"	"unprognostic (2.46e-1)"	"unprognostic (9.74e-3)"	17.8	14.1	7.0	4.4	8.3	3.5	9.8	4.4	8.3	6.7	12.9	5.2	4.6	10.6	4.6	7.7	8.8	3.3	8.9	36.9	6.4	5.4	10.0	56.4	7.6	2.7	6.2	6.3	9.7	21.6	12.9	6.2	11.5	8.5	8.7	9.1	5.4	7.9	9.4	233.5	5.3	12.4	8.4	5.6	3.0	5.7	3.0	5.5	3.0	6.0	42.8	6.3	9.4	4.7	12.2	25.9	25.6	17.9	21.1	23.3	16.6	29.8	12.5	4.7	15.5	31.2	23.1	38.3	12.3	16.7	13.4	22.0	10.3	13.9	9.4	25.8	19.0	29.7	7.1	6.5	25.9	15.8	11.5	8.7	19.9	21.2	10.6	25.8	17.4	1.1	29.1	16.7	15.6	24.8	36.0	8.0	9.8	0.0	12.6	21.5	1.8	5.0	9.6	21.4	0.9	20.1	7.1	22.0	3.0	19.5	9.4	2.8	18.4	26.9	28.2	41.0	22.9	8.8	6.6	0.7	19.9	10.2	17.6	10.4	8.0	11.7	15.4	32.5	15.3	8.5	20.5	17.9	25.6	23.3	12.0	18.6	12.2	13.7	17.5	25.9	6.9	12.5	14.5	21.2	21.1	10.2	7.5	10.6	16.6	7.0	8.3	4.4	8.3	6.4	5.4	6.2	6.3	8.5	5.5	86.4	31.4	19.9	24.0	15.9	8.1	140.8	50.9	14.7	10.3	15.7	9.8	71.5	74.6	42.0	24.0	10.7	74.3	0.0	209.3	136.9	28.0	18.3	4.7	186.6	22.2	0.0	12.6	16.0	18.3	5.2	20.4	10.7	25.3	32.5	40.1	54.2	92.3	23.0	35.7	59.8	10.7	12.9	17.9	4.7	7.5	15.8	49.2	21.8	71.1	13.6
PGM2	FLJ10983	ENSG00000169299	"Phosphoglucomutase 2"	Q96G03	4	37826633-37862937	"Enzymes, Predicted intracellular proteins"	"Carbohydrate metabolism, Glucose metabolism"	Isomerase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	5	"Muller glia cells: 345.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA040676	Uncertain		Approved	"Intermediate filaments"		NA	NA		1900000	"Intermediate filaments"		"HPA040676: AB_2677076"	"unprognostic (3.11e-2)"	"unprognostic (1.01e-2)"	"prognostic favorable (2.14e-5)"	"unprognostic (2.29e-1)"	"unprognostic (3.94e-1)"	"unprognostic (5.44e-2)"	"unprognostic (1.70e-2)"	"unprognostic (2.09e-3)"	"unprognostic (5.32e-2)"	"unprognostic (7.02e-2)"	"unprognostic (5.37e-2)"	"unprognostic (2.22e-2)"	"unprognostic (6.72e-3)"	"unprognostic (3.21e-2)"	"unprognostic (1.88e-1)"	"unprognostic (9.97e-2)"	"unprognostic (1.02e-1)"	11.2	10.8	7.7	11.6	5.9	7.5	13.5	9.8	5.7	14.7	10.3	4.2	6.5	6.1	15.0	7.6	41.3	7.0	11.0	8.3	7.1	4.0	11.1	13.3	7.5	13.2	4.4	5.7	10.0	9.0	9.5	6.4	27.9	10.4	11.1	8.4	6.8	11.0	5.0	2.4	17.7	8.6	12.2	6.9	13.4	9.0	9.0	3.9	17.3	8.8	31.7	22.9	13.6	18.9	4.5	15.3	30.8	13.1	13.2	7.0	7.2	11.7	4.1	6.3	6.7	4.7	5.3	8.3	14.2	8.4	11.7	12.0	7.2	8.6	15.5	7.1	7.7	15.6	6.1	15.3	13.3	29.8	9.9	8.8	17.0	6.9	5.1	10.3	17.8	11.9	7.7	16.1	9.5	8.6	7.3	18.6	13.7	22.1	2.8	10.2	6.2	20.3	21.1	7.3	8.5	6.4	15.5	10.0	6.4	7.2	22.7	13.3	4.5	7.1	10.5	4.9	9.1	9.1	19.2	16.2	8.8	10.8	11.8	28.8	6.3	16.4	17.6	4.6	23.4	14.6	8.0	13.1	30.8	4.9	10.5	5.8	4.5	4.1	5.6	15.3	2.8	4.0	5.0	16.3	13.2	8.0	3.4	7.0	7.2	7.7	5.9	9.8	5.7	7.1	4.0	4.4	5.7	10.4	3.9	0.0	8.0	10.3	13.2	13.1	5.8	4.5	7.6	5.3	4.5	3.5	0.0	26.6	5.0	13.0	0.8	25.5	7.9	0.0	10.4	30.7	6.7	18.4	12.7	7.3	33.4	6.4	6.9	44.8	19.6	0.9	7.8	24.9	5.0	52.3	9.0	345.3	11.4	3.5	9.2	7.4	13.5	12.9	23.7	0.7	0.5	28.1	66.7	12.9	12.3	17.9
PGM2L1	"BM32A, FLJ32029"	ENSG00000165434	"Phosphoglucomutase 2 like 1"	Q6PCE3	11	74330318-74398473	"Enzymes, Predicted intracellular proteins"	"Carbohydrate metabolism, Glucose metabolism"	"Isomerase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	5	"brain: 48.6"	"Cell type enhanced"	"Detected in many"	6	"Ciliated cells: 76.3;Exocrine glandular cells: 109.6;Pancreatic endocrine cells: 102.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HUVEC TERT2: 13.4;LHCN-M2: 16.0;RH-30: 15.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA056995, HPA060948"	Enhanced		Approved	Mitochondria		No	No		64000	Mitochondria		"HPA056995: AB_2683305, HPA060948: AB_2684394"	"unprognostic (7.44e-3)"	"unprognostic (1.33e-1)"	"unprognostic (7.28e-3)"	"unprognostic (8.91e-2)"	"unprognostic (6.16e-2)"	"unprognostic (1.55e-1)"	"unprognostic (7.16e-6)"	"unprognostic (1.43e-1)"	"unprognostic (1.95e-1)"	"unprognostic (5.97e-3)"	"unprognostic (1.70e-2)"	"unprognostic (2.98e-1)"	"unprognostic (9.33e-3)"	"unprognostic (3.71e-1)"	"unprognostic (1.97e-1)"	"unprognostic (3.04e-1)"	"unprognostic (1.03e-2)"	3.0	4.0	30.6	4.9	19.8	4.0	3.2	6.3	48.6	6.1	4.5	1.3	1.0	2.3	6.1	1.9	2.1	4.7	4.8	1.6	30.1	15.1	2.5	2.1	2.7	4.0	9.7	20.4	1.7	4.4	1.4	4.5	2.1	11.7	3.8	5.1	2.9	3.2	2.5	7.1	1.7	2.6	5.6	2.6	2.5	3.4	2.3	0.3	10.0	4.1	1.3	4.0	5.2	2.6	2.4	1.7	2.5	0.6	3.0	7.5	1.1	2.1	3.0	11.8	2.1	3.6	1.6	0.3	2.8	2.1	2.4	2.7	1.1	5.5	0.2	7.0	1.8	4.3	1.0	2.3	0.5	2.3	0.8	1.2	1.6	1.6	0.9	0.4	1.9	2.6	0.8	0.5	5.5	1.0	2.7	13.4	4.0	2.1	1.5	16.0	0.3	7.6	1.7	2.3	1.6	2.7	2.4	15.4	0.1	6.4	0.4	0.5	2.3	4.5	1.0	2.0	3.4	0.2	0.3	11.1	5.5	5.1	2.2	2.9	2.0	2.9	0.2	0.5	2.7	1.3	2.5	0.6	1.1	2.1	0.6	2.8	2.4	3.5	2.3	0.5	1.8	3.3	1.9	0.7	3.0	0.3	1.7	7.5	1.1	30.6	19.8	6.3	24.4	30.1	15.1	9.7	20.4	11.7	0.3	6.0	5.4	13.7	35.5	6.8	10.1	6.1	12.7	76.3	30.7	8.7	15.7	0.6	5.0	31.7	9.2	20.2	5.3	70.0	109.6	4.7	15.4	55.2	8.1	0.9	4.8	7.9	11.3	20.3	20.4	2.3	2.3	14.4	15.1	3.6	15.9	5.0	102.3	7.0	3.5	3.3	9.9	25.8	11.3	17.6	14.5	4.5	0.1	17.0	18.7	42.9
PGM3	"AGM1, DKFZP434B187, PAGM"	ENSG00000013375	"Phosphoglucomutase 3"	O95394	6	83161150-83193936	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Carbohydrate metabolism"	Isomerase	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004998, HPA029759, HPA029760"	Enhanced		Approved	Nucleoplasm,Cytosol		NA	NA		73000	"Nucleoplasm, Cytosol"		"CAB004998: AB_425591, HPA029759: AB_10600305, HPA029760: AB_10601109"	"prognostic unfavorable (8.78e-4)"	"prognostic unfavorable (5.67e-4)"	"unprognostic (1.45e-2)"	"unprognostic (3.03e-2)"	"unprognostic (1.51e-2)"	"unprognostic (4.04e-2)"	"unprognostic (1.09e-3)"	"unprognostic (6.72e-3)"	"unprognostic (3.11e-1)"	"prognostic favorable (9.96e-4)"	"unprognostic (4.00e-1)"	"unprognostic (1.30e-1)"	"prognostic unfavorable (2.39e-7)"	"unprognostic (2.21e-1)"	"unprognostic (7.98e-2)"	"unprognostic (1.22e-1)"	"unprognostic (4.22e-3)"	15.5	16.7	11.2	10.4	13.7	4.8	12.3	19.1	13.3	15.4	10.1	9.0	30.7	8.9	10.6	26.2	10.3	8.8	14.2	12.2	11.0	8.6	12.2	44.9	13.4	6.3	13.5	9.9	15.5	36.3	9.3	36.2	27.6	18.1	30.9	13.7	7.4	29.2	23.4	5.5	7.5	11.6	11.1	9.7	8.1	14.4	16.8	11.3	4.0	14.9	7.6	8.7	11.1	10.0	8.2	7.4	11.1	6.5	5.3	8.7	3.9	10.1	6.8	13.1	15.6	21.3	22.8	15.2	34.8	25.3	16.9	26.6	17.5	4.8	5.4	7.4	34.8	17.2	6.5	11.9	14.6	32.4	4.0	11.6	6.9	13.3	29.2	24.2	6.7	3.4	14.4	12.1	29.7	37.7	17.1	19.9	3.7	22.5	5.9	18.2	10.6	1.1	4.4	5.8	9.1	9.3	4.7	29.3	3.1	13.1	10.1	5.2	8.2	10.0	9.0	7.0	20.5	7.8	7.5	28.9	11.6	6.4	23.3	18.7	11.5	4.4	3.8	9.1	5.4	18.2	11.1	6.4	3.8	5.0	6.0	6.7	8.2	5.2	6.2	5.5	5.0	8.7	8.2	2.7	5.3	6.5	7.4	3.6	3.9	11.2	13.7	19.1	13.3	11.0	8.6	13.5	9.9	18.1	11.3	26.8	20.1	3.7	21.9	14.1	16.1	5.2	20.4	12.0	28.4	10.4	9.8	27.6	6.6	29.3	40.4	10.8	14.0	23.3	43.3	56.1	40.5	76.0	4.7	30.5	15.6	7.9	15.4	16.5	4.7	15.6	31.1	8.3	10.1	12.6	25.8	25.2	36.6	17.5	17.3	18.1	20.4	6.5	18.6	54.3	31.1	13.7	53.9	7.5	15.5	17.9
PGP		ENSG00000184207	"Phosphoglycolate phosphatase"	A6NDG6	16	2211997-2214807	"Enzymes, Predicted intracellular proteins"	"Carbohydrate metabolism"	"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 40.7"	"Cell type enhanced"	"Detected in all"	13	"Cone photoreceptor cells: 380.9;Early spermatids: 399.7;Late spermatids: 977.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043096, HPA046739"	Approved		Approved	"Nuclear bodies"		NA	NA		46000	"Nuclear bodies"		"HPA043096: AB_2678311, HPA046739: AB_2679779"	"unprognostic (8.33e-2)"	"unprognostic (4.77e-3)"	"unprognostic (2.36e-2)"	"unprognostic (7.23e-2)"	"unprognostic (2.12e-3)"	"unprognostic (1.76e-1)"	"unprognostic (5.75e-3)"	"unprognostic (5.87e-2)"	"unprognostic (7.90e-2)"	"unprognostic (4.43e-3)"	"unprognostic (6.50e-2)"	"unprognostic (9.04e-2)"	"prognostic favorable (7.05e-4)"	"unprognostic (1.28e-1)"	"unprognostic (2.63e-1)"	"unprognostic (1.11e-1)"	"prognostic favorable (6.42e-4)"	5.7	7.2	10.9	7.3	12.5	9.2	3.6	31.4	21.4	3.9	6.7	4.8	7.3	7.9	4.7	6.5	3.6	3.7	4.4	15.6	11.4	9.8	6.1	5.5	6.2	7.5	9.6	12.8	2.5	6.6	8.7	6.1	6.9	17.8	5.3	5.3	4.7	6.2	6.8	40.7	5.6	7.5	4.9	6.0	8.0	6.7	23.0	7.4	5.9	8.8	7.9	5.0	4.2	2.6	1.8	1.9	6.1	3.4	0.3	2.2	0.4	9.2	15.2	10.8	10.3	4.5	3.5	20.8	10.9	5.2	10.1	10.4	23.6	11.8	7.1	10.8	5.0	8.2	15.6	7.6	9.3	4.5	9.6	21.1	7.0	23.1	10.6	3.0	12.5	11.7	4.2	4.2	9.4	3.5	3.6	6.5	11.7	12.8	7.5	5.5	25.3	14.1	20.5	14.3	5.7	14.4	23.1	9.4	15.9	8.3	5.9	14.5	8.8	9.7	18.3	7.5	8.1	13.6	14.6	6.4	10.4	13.7	9.3	10.8	17.8	7.7	10.0	3.5	11.1	8.0	0.0	2.3	6.1	2.2	3.4	0.3	0.7	1.3	1.6	1.6	1.8	0.8	1.4	1.4	0.3	3.1	1.9	1.3	0.4	10.9	12.5	31.4	21.4	11.4	9.8	9.6	12.8	17.8	7.4	6.0	8.5	13.4	7.0	20.7	194.2	37.5	12.7	1.4	5.7	38.4	380.9	102.8	49.7	8.0	399.7	21.1	46.4	23.3	12.2	86.7	22.8	21.1	10.3	30.7	50.8	136.7	28.6	19.0	30.8	977.0	23.9	41.2	33.7	8.2	22.2	54.1	10.8	24.6	26.5	28.7	225.9	38.8	21.2	167.9	61.0	27.9	45.5	23.5	34.6	14.4
PGPEP1	"Pcp, PGP, PGP-I, PGPI"	ENSG00000130517	"Pyroglutamyl-peptidase I"	Q9NXJ5	19	18340587-18369950	"Enzymes, Predicted intracellular proteins"		"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Proximal tubular cells: 73.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HMC-1: 33.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035368, HPA055277"	Approved		Approved	"Golgi apparatus"		NA	NA			"Golgi apparatus"		"HPA035368: AB_10601388, HPA055277: AB_2682770"	"unprognostic (9.52e-3)"	"unprognostic (1.37e-2)"	"unprognostic (6.95e-2)"	"unprognostic (5.74e-3)"	"unprognostic (5.29e-2)"	"unprognostic (6.60e-2)"	"unprognostic (1.96e-2)"	"unprognostic (2.11e-3)"	"prognostic favorable (6.80e-4)"	"unprognostic (2.79e-2)"	"prognostic favorable (1.71e-4)"	"unprognostic (4.81e-3)"	"prognostic favorable (3.71e-8)"	"unprognostic (1.12e-2)"	"unprognostic (1.66e-1)"	"unprognostic (1.51e-1)"	"unprognostic (1.20e-3)"	11.0	18.6	14.8	10.1	14.9	12.4	10.7	8.1	12.5	13.9	23.3	14.8	25.3	23.6	8.2	16.0	6.3	10.0	16.7	20.6	18.2	15.4	29.9	29.7	9.4	11.4	17.8	7.3	13.2	26.6	15.1	17.1	7.5	12.5	13.4	17.2	13.7	22.8	23.6	25.2	3.6	33.6	12.1	25.5	16.2	15.4	4.2	15.6	8.6	11.5	7.4	7.0	12.8	10.0	3.9	3.3	17.6	6.1	4.3	4.9	3.6	4.7	7.5	6.3	6.3	8.0	6.3	7.7	5.7	8.9	3.9	5.9	5.3	10.2	7.3	9.6	9.3	7.0	1.3	2.4	1.3	2.2	8.6	2.7	8.0	7.5	14.9	11.3	4.7	33.4	6.3	2.8	3.0	0.5	14.2	5.8	12.7	14.6	11.1	3.2	7.6	4.7	3.8	6.4	3.2	2.3	0.0	2.3	6.5	4.2	7.5	2.2	3.5	1.1	0.6	10.1	4.3	2.9	9.5	8.9	4.5	3.1	5.9	2.4	13.8	6.5	4.4	12.1	13.2	4.1	17.6	5.4	7.1	4.9	5.4	2.8	2.0	3.4	4.4	3.3	3.9	4.3	4.0	3.1	4.3	6.1	2.2	3.8	3.6	14.8	14.9	8.1	12.5	18.2	15.4	17.8	7.3	12.5	15.6	8.9	16.7	9.0	10.8	2.1	3.9	17.8	30.6	1.4	6.8	29.6	9.8	15.9	6.6	18.9	0.5	8.0	61.2	0.0	38.9	18.4	7.3	12.7	33.6	67.2	20.3	4.8	37.4	13.5	24.6	0.7	7.2	19.7	15.1	2.8	20.9	6.6	35.6	28.8	19.1	73.1	6.0	6.5	8.0	2.1	4.1	1.0	15.7	15.8	28.1	13.3
PGPEP1L		ENSG00000183571	"Pyroglutamyl-peptidase I-like"	A6NFU8	15	98968230-99007795	"Enzymes, Predicted intracellular proteins"		"Hydrolase, Protease, Thiol protease"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in some"	4	"skeletal muscle: 34.7"	"Cell type enhanced"	"Detected in some"	10	"Cardiomyocytes: 2.0;Distal tubular cells: 1.7;Early spermatids: 2.7;Spermatocytes: 2.8;Spermatogonia: 2.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"Group enriched"	"Detected in some"	6	"basophil: 2.0;neutrophil: 1.9"	"Lineage enriched"	"Detected in single"	6	"granulocytes: 2.0"	"Cell line enhanced"	"Detected in some"		"HeLa: 1.9;U-2 OS: 4.5"					"Not detected"	"Not detected"			HPA041781	Uncertain					NA	NA					"HPA041781: AB_10795642"	"unprognostic (2.48e-1)"	"unprognostic (2.82e-2)"		"unprognostic (8.26e-2)"	"unprognostic (2.43e-3)"	"unprognostic (7.18e-2)"		"unprognostic (3.99e-2)"	"unprognostic (1.69e-1)"	"unprognostic (5.44e-2)"	"unprognostic (9.78e-2)"	"unprognostic (1.58e-1)"	"unprognostic (4.53e-3)"	"unprognostic (1.86e-1)"	"unprognostic (2.62e-1)"	"unprognostic (2.00e-2)"	"unprognostic (1.65e-1)"	0.7	0.1	0.5	0.2	1.4	0.1	0.6	0.2	0.5	0.4	0.4	0.4	0.0	0.2	0.2	0.4	0.8	0.2	0.5	3.6	0.6	0.4	0.4	0.0	0.2	0.3	0.4	0.2	0.2	0.5	0.0	0.1	0.3	0.4	0.6	0.0	1.6	0.9	0.5	34.7	0.1	0.2	0.3	0.3	0.1	0.2	5.0	0.2	0.1	0.1	8.6	0.5	0.2	0.3	0.0	0.0	2.0	0.0	0.0	0.3	0.0	0.0	0.0	0.2	0.0	0.0	0.2	1.2	0.7	0.0	0.2	0.1	0.0	0.0	0.5	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.7	0.2	0.0	1.9	0.0	0.3	0.5	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.3	0.9	1.4	0.1	0.0	0.2	0.4	1.3	0.2	0.4	0.4	0.1	1.2	0.0	1.0	0.3	0.4	0.5	1.4	0.2	0.4	0.8	0.0	0.7	0.0	4.5	0.2	0.1	0.8	0.2	0.7	0.0	0.6	0.0	2.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.5	1.4	0.2	0.5	0.6	0.4	0.4	0.2	0.4	0.2	0.0	0.0	0.0	0.1	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.1	1.7	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.9	2.8	2.0	0.0	0.1	0.0	0.0	0.0
PGS1	DKFZP762M186	ENSG00000087157	"Phosphatidylglycerophosphate synthase 1"	Q32NB8	17	78378640-78425114	"Enzymes, Predicted intracellular proteins"	"Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA022526	Approved					NA	NA					"HPA022526: AB_1855271"	"unprognostic (1.19e-2)"	"unprognostic (1.12e-1)"	"unprognostic (3.48e-1)"	"unprognostic (1.86e-3)"	"unprognostic (1.35e-2)"	"unprognostic (1.71e-2)"	"prognostic unfavorable (1.37e-4)"	"unprognostic (5.76e-3)"	"unprognostic (3.17e-2)"	"unprognostic (8.46e-3)"	"prognostic favorable (7.33e-5)"	"prognostic unfavorable (9.94e-4)"	"prognostic unfavorable (1.16e-5)"	"unprognostic (9.94e-2)"	"unprognostic (5.60e-2)"	"unprognostic (1.33e-1)"	"unprognostic (2.72e-2)"	16.4	11.6	14.5	20.8	20.3	41.4	28.2	17.6	17.4	14.4	13.1	18.4	13.2	13.7	17.3	13.2	14.5	16.9	17.2	14.0	15.7	16.1	14.3	8.0	25.5	19.1	21.6	17.0	18.3	14.0	16.0	13.3	24.0	15.3	13.9	10.2	12.9	13.1	16.8	13.8	11.9	15.1	13.4	18.0	22.6	12.6	13.9	18.8	17.7	18.6	7.8	14.3	16.9	32.3	8.0	14.0	26.0	12.6	6.7	11.3	8.4	13.3	11.8	11.5	8.6	10.1	16.2	13.6	12.5	12.0	13.5	14.9	10.9	10.5	13.7	7.6	7.1	13.3	10.3	13.6	8.5	10.6	20.6	15.4	15.0	14.0	10.9	9.9	11.3	12.2	16.5	11.2	9.7	8.8	11.7	25.7	10.9	17.5	9.6	9.1	7.3	25.6	10.3	12.0	5.8	11.4	13.5	20.5	11.7	13.2	12.2	15.2	23.1	10.7	11.8	11.4	11.6	12.4	13.8	16.1	17.5	12.1	9.3	10.5	10.6	6.3	10.5	13.2	12.7	12.9	1.5	12.6	13.2	8.4	10.4	9.8	7.8	8.8	8.8	14.0	8.0	11.3	8.1	26.0	6.7	4.6	6.6	10.4	8.4	14.5	20.3	17.6	17.4	15.7	16.1	21.6	17.0	15.3	18.8	11.9	12.6	7.5	10.1	3.9	12.5	4.2	7.6	6.7	10.3	12.2	2.0	15.2	3.3	5.3	14.1	14.3	7.1	0.0	6.0	7.3	8.9	6.8	7.0	3.0	13.3	19.1	4.1	13.5	13.1	7.9	9.8	17.5	5.0	10.0	5.2	9.7	5.8	12.5	8.1	4.3	10.5	32.3	7.6	18.0	15.9	3.3	16.1	6.9	7.6	8.2
PHEX	"HPDR, HPDR1, HYP, HYP1, PEX, XLH"	ENSG00000102174	"Phosphate regulating endopeptidase homolog X-linked"	P78562	X	22032441-22251310	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted membrane proteins"	Biomineralization	"Hydrolase, Metalloprotease, Protease"	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 8.3;lung: 6.7"	"Cell type enhanced"	"Detected in some"	21	"Basal glandular cells: 5.2;Horizontal cells: 15.9"	"Cancer enhanced"	"Detected in some"		"thyroid cancer: 5.9"	"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in single"	37	"plasmacytoid DC: 8.3"	"Lineage enriched"	"Detected in single"	37	"dendritic cells: 8.3"	"Cell line enhanced"	"Detected in some"		"HBEC3-KT: 5.8;HUVEC TERT2: 4.4;PC-3: 4.8;TIME: 4.9;U-87 MG: 10.6;WM-115: 4.4"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"									NA	NA						"unprognostic (2.01e-2)"	"unprognostic (2.69e-1)"	"unprognostic (2.43e-1)"	"unprognostic (1.05e-3)"	"unprognostic (1.22e-1)"	"unprognostic (3.04e-2)"	"unprognostic (2.25e-3)"	"unprognostic (1.23e-1)"	"unprognostic (1.87e-1)"	"unprognostic (1.21e-2)"	"unprognostic (7.53e-2)"	"unprognostic (7.45e-2)"	"unprognostic (9.84e-8)"	"unprognostic (1.18e-1)"	"unprognostic (1.58e-1)"	"prognostic favorable (2.51e-4)"	"unprognostic (7.68e-2)"	0.3	0.0	1.8	1.9	1.1	0.0	1.7	0.9	1.1	0.8	0.9	0.8	0.3	1.2	5.0	0.3	0.4	0.1	2.0	0.3	1.5	1.8	0.3	0.3	6.7	3.4	2.0	0.3	3.9	0.3	0.0	0.3	0.3	5.0	1.3	0.0	0.3	2.8	0.9	0.3	0.1	1.4	3.9	3.8	3.4	0.0	0.3	0.3	1.3	4.8	0.3	4.3	0.5	0.6	0.1	8.3	0.0	0.0	0.0	0.2	0.0	0.3	0.8	0.2	0.1	0.1	0.4	0.0	0.0	0.1	0.1	0.3	1.3	0.1	0.1	1.3	0.1	0.2	0.1	0.0	5.8	0.3	0.0	0.1	0.1	0.5	0.0	0.1	0.1	0.2	2.2	1.1	1.1	3.4	0.2	4.4	0.4	0.0	0.5	0.5	0.0	0.0	0.2	0.0	0.0	4.8	0.0	1.0	0.0	0.6	0.2	0.1	0.2	0.4	2.5	0.8	0.6	2.9	0.0	4.9	1.0	0.2	0.6	0.8	0.0	0.1	0.0	10.6	0.0	4.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	8.3	0.0	0.0	1.8	1.1	0.9	1.1	1.5	1.8	2.0	0.3	5.0	0.3	0.0	0.0	0.0	5.2	0.0	0.4	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.8	0.4	0.2	1.7	0.0	1.0	0.1	0.5	1.6	0.0	0.0	0.0	15.9	0.0	0.0	0.0	0.0	1.7	0.0	1.7	0.0	0.0	0.8	0.7	0.0	0.0	0.5	0.5	0.0	0.4	0.0	0.0	0.1	0.7	0.0	0.0	2.7
PHF8	"JHDM1F, KDM7B, KIAA1111, ZNF422"	ENSG00000172943	"PHD finger protein 8"	Q9UPP1	X	53936676-54048958	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Cell cycle, Transcription, Transcription regulation"	"Activator, Chromatin regulator, Dioxygenase, Oxidoreductase"	"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Spermatogonia: 48.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038779, HPA062015"	Approved		Supported	Nucleoplasm		NA	NA			Nucleoplasm		"HPA038779: AB_10675950, HPA062015: AB_2684658"	"unprognostic (6.35e-2)"	"unprognostic (2.16e-2)"	"unprognostic (1.70e-2)"	"unprognostic (1.04e-1)"	"unprognostic (8.76e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.40e-1)"	"unprognostic (2.66e-3)"	"unprognostic (1.97e-3)"	"unprognostic (1.22e-1)"	"unprognostic (5.64e-2)"	"unprognostic (1.02e-1)"	"unprognostic (5.17e-2)"	"unprognostic (1.22e-1)"	"unprognostic (9.94e-2)"	"unprognostic (1.85e-2)"	"prognostic favorable (3.74e-5)"	8.8	6.8	8.2	11.5	9.4	10.7	11.1	12.5	9.2	10.3	8.2	12.9	27.4	7.9	12.2	54.0	10.7	11.1	9.8	7.8	7.2	5.4	8.8	21.7	10.5	11.2	11.3	7.0	16.8	14.1	10.6	14.6	9.8	9.4	12.8	7.5	10.3	10.3	14.7	8.4	9.6	11.1	8.9	8.5	11.8	9.7	30.6	10.4	19.6	11.1	8.1	13.0	12.8	16.1	6.2	5.1	10.7	7.9	5.4	9.5	5.1	8.8	7.7	11.7	11.3	7.3	5.7	19.2	6.7	5.9	7.5	6.7	8.7	7.2	13.0	4.0	6.1	8.1	9.3	29.1	5.8	8.0	20.3	13.9	7.8	10.0	8.8	5.7	12.2	14.7	6.4	8.2	8.6	11.8	5.7	6.9	13.8	10.3	19.1	4.3	8.9	16.6	9.4	21.3	6.2	11.6	16.4	13.0	12.7	5.1	10.8	17.2	8.5	17.9	12.0	5.9	19.0	11.8	8.5	8.0	6.0	8.6	11.0	5.5	14.5	13.4	15.8	7.1	15.5	6.4	10.7	4.5	7.2	6.2	7.9	9.5	4.3	6.2	7.1	5.1	6.2	4.6	5.0	7.7	5.4	5.2	4.0	9.2	5.1	8.2	9.4	12.5	9.2	7.2	5.4	11.3	7.0	9.4	10.4	8.9	9.3	9.3	8.2	7.9	12.4	6.6	10.2	17.4	2.3	8.7	11.8	10.6	0.0	4.1	34.1	10.8	6.8	0.0	4.0	3.9	5.3	10.8	13.9	34.6	5.8	7.9	5.2	8.6	12.4	22.6	8.6	9.1	3.3	2.8	8.3	8.6	3.9	9.0	6.0	2.9	15.1	6.5	8.1	22.6	48.0	8.5	10.2	7.5	7.1	11.5
PHGDH	"PDG, PGDH, SERA"	ENSG00000092621	"Phosphoglycerate dehydrogenase"	O43175	1	119648411-119744226	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Amino-acid biosynthesis, Serine biosynthesis"	Oxidoreductase	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"naive CD8 T-cell: 16.5"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"SK-MEL-30: 99.3"	"Low region specificity"	"Detected in all"							"CAB003681, HPA021241, HPA024031, CAB068216"	Enhanced		Enhanced	"Nucleoplasm,Plasma membrane,Cytosol"		No	No		9000000	"Plasma membrane, Cytosol"	Nucleoplasm	"CAB003681: AB_425928, CAB068216: AB_2665666, HPA021241: AB_1855299, HPA024031: AB_1855300"	"unprognostic (2.30e-1)"	"unprognostic (2.16e-1)"	"unprognostic (1.80e-2)"	"prognostic unfavorable (1.48e-4)"	"prognostic favorable (1.62e-4)"	"unprognostic (9.80e-2)"	"unprognostic (1.56e-2)"	"unprognostic (1.40e-1)"	"unprognostic (5.24e-2)"	"unprognostic (4.45e-3)"	"unprognostic (8.80e-3)"	"unprognostic (5.00e-2)"	"unprognostic (2.37e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.74e-1)"	"unprognostic (1.95e-1)"	"unprognostic (1.78e-3)"	18.8	1.9	33.3	4.4	32.1	4.4	13.8	7.8	27.2	11.9	5.8	49.7	9.4	4.2	6.1	41.0	16.7	24.5	3.9	5.3	26.7	20.5	14.0	53.2	4.3	5.7	42.0	20.7	17.3	58.2	67.5	5.7	6.4	23.3	24.5	4.7	8.7	62.9	16.4	1.7	35.9	3.0	8.1	28.3	1.9	9.0	8.6	38.1	9.9	15.8	7.3	7.3	7.9	14.1	6.7	3.2	2.9	0.7	1.2	16.5	3.2	13.6	5.6	14.6	35.0	8.4	11.0	27.2	12.3	22.3	17.7	29.3	28.8	2.4	0.0	5.4	33.0	1.9	18.4	27.0	25.7	12.5	0.1	24.6	4.3	19.6	19.9	17.3	27.5	0.1	15.8	43.0	16.9	20.0	9.9	12.7	48.8	7.9	32.6	7.8	53.5	18.4	8.4	36.4	10.6	42.5	16.2	25.3	2.3	1.2	16.2	15.7	14.4	9.0	6.1	99.3	13.9	12.3	47.0	0.1	2.9	15.3	17.9	13.8	26.9	6.7	27.5	35.8	38.5	22.7	2.9	0.7	0.2	2.9	0.2	0.2	6.7	1.8	4.9	3.2	2.7	9.1	16.5	2.0	1.2	0.2	1.8	2.4	3.2	33.3	32.1	7.8	27.2	26.7	20.5	42.0	20.7	23.3	38.1	3.0	9.3	9.7	92.1	46.0	0.8	2.0	84.1	21.4	7.9	19.2	2.0	32.1	114.4	48.9	40.9	3.3	0.2	0.0	120.7	43.3	25.5	86.4	5.7	90.0	8.0	0.0	1.7	2.5	1.3	81.6	62.7	4.8	54.0	19.0	1.1	79.1	39.9	2.5	120.2	80.4	2.9	12.9	16.0	5.2	3.4	67.4	21.2	5.0	1.5	39.9
PHKG1	PHKG	ENSG00000164776	"Phosphorylase kinase catalytic subunit gamma 1"	Q16816	7	56080283-56092996	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Carbohydrate metabolism, Glycogen metabolism"	"Calmodulin-binding, Kinase, Muscle protein, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"skeletal muscle: 105.6;tongue: 32.9"	"Cell type enhanced"	"Detected in many"	5	"Cholangiocytes: 50.9"	"Cancer enriched"	"Detected in many"	18	"glioma: 23.6"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"neutrophil: 3.3"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA012057	Enhanced					NA	NA					"HPA012057: AB_1855305"	"unprognostic (2.00e-3)"	"unprognostic (1.09e-1)"	"unprognostic (7.09e-3)"	"unprognostic (5.87e-3)"	"unprognostic (2.19e-1)"	"unprognostic (1.54e-2)"	"unprognostic (1.31e-1)"	"unprognostic (6.69e-3)"	"unprognostic (2.10e-1)"	"unprognostic (1.99e-1)"	"unprognostic (9.14e-4)"	"unprognostic (1.92e-1)"	"unprognostic (7.97e-9)"	"unprognostic (6.61e-3)"	"unprognostic (2.34e-1)"	"unprognostic (1.12e-2)"	"unprognostic (3.85e-2)"	2.0	1.5	4.9	0.8	6.1	1.1	1.5	6.0	5.8	0.7	2.6	6.5	0.0	1.0	0.9	1.5	3.2	0.9	1.1	11.8	4.1	2.9	0.6	0.7	0.9	0.8	3.5	3.9	1.0	0.8	1.2	0.6	0.6	6.8	1.4	0.8	0.0	1.6	0.8	105.6	1.6	0.9	1.1	3.6	0.8	0.8	0.7	4.8	0.0	0.6	32.9	1.2	1.8	0.3	1.3	0.6	3.3	0.7	0.3	1.9	0.2	2.9	2.1	0.5	1.8	3.2	5.4	1.4	0.4	0.6	1.0	0.8	0.7	1.3	0.8	0.5	1.0	1.2	1.6	1.2	0.2	0.8	0.8	2.1	0.8	3.0	0.7	0.8	1.5	3.3	3.4	2.3	1.6	0.7	0.8	0.3	2.1	2.2	4.0	0.1	1.3	2.2	5.6	1.0	0.9	1.3	1.2	0.3	1.0	0.6	1.9	1.5	1.6	0.3	2.2	0.1	0.5	1.2	1.9	0.8	0.5	1.7	4.5	1.1	1.8	0.7	2.2	1.2	1.4	1.0	0.4	0.5	0.0	0.8	0.2	1.9	0.3	1.2	0.3	0.2	1.3	0.6	0.6	3.3	0.3	0.7	0.6	0.5	0.2	4.9	6.1	6.0	5.8	4.1	2.9	3.5	3.9	6.8	4.8	11.9	3.4	25.1	6.4	1.1	4.0	1.4	50.9	4.0	6.8	26.2	0.0	6.6	1.7	13.2	2.2	1.4	11.4	23.3	10.9	11.6	6.1	9.6	8.1	41.4	11.0	11.1	16.0	20.9	30.5	5.6	16.7	6.0	1.7	8.2	10.9	4.8	12.7	10.5	15.2	9.0	4.3	12.9	1.0	7.6	9.4	0.9	6.1	8.7	14.4	7.0
PHKG2		ENSG00000156873	"Phosphorylase kinase catalytic subunit gamma 2"	P15735	16	30748270-30761176	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Carbohydrate metabolism, Glycogen metabolism"	"Calmodulin-binding, Kinase, Serine/threonine-protein kinase, Transferase"	"Disease mutation, Glycogen storage disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	4	"blood: 44.5;testis: 95.4"	"Group enriched"	"Detected in many"	6	"Early spermatids: 304.4;Late spermatids: 1171.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA065618, HPA068751"			Supported	Cytosol		NA	NA			Cytosol		"HPA065618: AB_2685520, HPA068751: AB_2686025"	"unprognostic (7.63e-3)"	"prognostic favorable (7.90e-4)"	"prognostic unfavorable (9.92e-4)"	"unprognostic (1.08e-1)"	"unprognostic (1.25e-1)"	"unprognostic (5.81e-2)"	"unprognostic (3.72e-2)"	"prognostic favorable (1.90e-4)"	"unprognostic (6.45e-2)"	"unprognostic (1.25e-2)"	"prognostic favorable (8.02e-4)"	"unprognostic (6.15e-2)"	"unprognostic (5.27e-2)"	"unprognostic (1.36e-2)"	"unprognostic (2.41e-1)"	"unprognostic (2.18e-2)"	"unprognostic (3.03e-2)"	4.3	8.3	8.7	6.9	8.0	15.9	5.8	9.1	12.0	4.7	7.9	7.3	9.0	6.8	5.6	7.8	5.3	6.8	7.2	6.4	9.0	9.3	8.2	11.0	5.8	6.8	8.6	9.2	4.7	5.1	17.3	8.5	6.3	11.8	7.7	7.6	6.4	7.0	9.9	6.4	8.4	7.3	6.3	5.8	6.9	7.2	95.4	7.3	5.5	8.6	5.5	7.7	5.2	4.7	8.8	21.2	44.5	22.7	23.5	16.8	17.6	13.7	9.0	7.6	9.3	7.1	5.8	17.1	9.6	14.4	13.2	15.1	7.8	6.9	11.9	11.4	9.9	6.7	13.2	7.9	12.2	10.6	6.4	21.9	6.5	15.0	21.8	11.0	10.0	9.3	7.8	6.6	12.6	5.9	6.3	13.4	8.5	8.8	6.9	9.5	31.5	11.8	14.8	10.5	9.9	10.5	16.0	11.9	15.8	15.1	15.5	10.2	7.0	7.8	21.8	9.2	7.2	17.1	8.7	7.9	8.1	9.0	10.1	8.8	13.9	7.5	8.1	16.1	19.6	6.5	14.0	22.7	44.5	16.2	22.4	13.3	8.8	11.6	16.4	21.2	8.5	10.4	12.1	18.2	23.5	15.9	18.2	16.8	17.6	8.7	8.0	9.1	12.0	9.0	9.3	8.6	9.2	11.8	7.3	11.9	23.7	12.6	12.5	18.7	8.9	10.6	2.5	25.4	29.6	17.4	9.8	26.7	23.2	11.4	304.4	9.9	23.2	0.0	21.4	32.3	12.9	24.0	12.7	19.5	25.4	19.1	15.6	9.2	22.4	1171.9	16.1	24.0	11.8	42.3	15.6	9.8	16.8	15.0	21.9	32.7	8.4	0.0	12.5	127.4	23.3	20.1	63.2	26.2	19.6	12.4
PHLPP1	"KIAA0606, PHLPP, PLEKHE1, PPM3A, SCOP"	ENSG00000081913	"PH domain and leucine rich repeat protein phosphatase 1"	O60346	18	62715450-62980433	"Enzymes, Predicted intracellular proteins"	Apoptosis	"Hydrolase, Protein phosphatase"	"Tumor suppressor"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 48.0"	"Cell type enhanced"	"Detected in many"	8	"Muller glia cells: 82.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	7	"neutrophil: 7.7;T-reg: 2.4"	"Group enriched"	"Detected in many"	7	"granulocytes: 7.7;T-cells: 2.4"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA020200	Uncertain				"Intracellular and membrane"	NA	NA					"HPA020200: AB_2670383"	"unprognostic (1.38e-1)"	"unprognostic (3.61e-2)"	"unprognostic (2.26e-1)"	"unprognostic (1.18e-1)"	"unprognostic (1.89e-1)"	"unprognostic (3.07e-2)"	"unprognostic (5.57e-2)"	"unprognostic (5.24e-1)"	"unprognostic (1.63e-1)"	"unprognostic (3.10e-1)"	"unprognostic (2.95e-1)"	"unprognostic (6.03e-2)"	"prognostic favorable (5.35e-8)"	"unprognostic (1.52e-1)"	"unprognostic (3.49e-2)"	"unprognostic (8.13e-2)"	"unprognostic (8.25e-2)"	5.8	10.6	22.1	2.3	34.1	7.4	7.4	8.3	29.6	4.3	6.0	48.0	0.9	6.2	4.4	2.5	6.1	4.0	4.9	3.0	22.4	12.3	4.0	18.5	3.4	3.0	44.4	13.8	5.5	8.0	9.6	5.6	6.3	20.6	5.0	6.7	4.4	11.2	4.5	3.9	9.1	5.5	4.0	18.6	2.0	5.6	11.5	44.8	2.3	5.6	1.6	4.1	5.6	3.2	0.6	0.7	7.7	0.2	0.6	2.4	0.1	9.0	3.4	14.0	4.6	2.4	2.0	10.9	2.7	2.5	5.4	5.6	7.4	5.5	6.1	1.7	4.1	2.1	11.1	7.2	4.3	7.0	18.8	6.0	2.0	3.7	13.7	3.4	3.1	1.0	2.1	2.9	5.8	5.3	4.4	3.8	3.3	5.2	12.3	5.2	2.0	2.3	2.7	5.6	1.8	3.3	21.7	7.9	7.3	3.1	11.8	6.5	2.6	3.0	6.8	5.6	8.5	3.0	8.9	4.8	4.5	2.1	2.6	6.3	1.4	0.7	7.2	2.6	3.6	3.4	0.0	0.2	0.1	0.7	0.0	0.0	0.6	0.1	0.0	0.7	0.2	0.4	0.1	7.7	0.6	0.2	0.3	2.4	0.1	22.1	34.1	8.3	21.1	22.4	12.3	44.4	13.8	20.6	44.8	3.0	1.0	0.0	3.7	14.9	14.8	3.3	15.3	8.1	5.7	0.0	27.5	10.8	1.7	2.5	26.9	5.8	5.6	0.0	3.6	4.7	6.0	6.4	2.3	16.3	2.1	25.4	11.6	6.2	2.8	24.6	5.5	4.6	23.6	3.6	7.9	82.5	3.7	5.8	3.5	1.8	16.7	0.0	4.4	5.0	16.9	16.3	21.9	0.0	11.5	7.4
PHLPP2	"KIAA0931, PHLPPL, PPM3B"	ENSG00000040199	"PH domain and leucine rich repeat protein phosphatase 2"	Q6ZVD8	16	71637835-71724701	"Enzymes, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"	"Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"intestine: 29.9"	"Cell type enhanced"	"Detected in many"	10	"Cone photoreceptor cells: 98.2;Enterocytes: 51.9;Rod photoreceptor cells: 60.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040761, HPA041837, HPA048598"	Approved		Supported	"Nucleoplasm,Cytokinetic bridge,Mitotic spindle,Cytosol"		NA	No			Cytosol	"Nucleoplasm, Cytokinetic bridge, Mitotic spindle"	"HPA040761: , HPA041837: , HPA048598: AB_2680459"	"unprognostic (5.67e-2)"	"unprognostic (2.00e-1)"	"unprognostic (2.29e-2)"	"unprognostic (2.44e-2)"	"unprognostic (1.76e-1)"	"unprognostic (1.59e-1)"	"unprognostic (1.17e-1)"	"unprognostic (3.27e-1)"	"unprognostic (1.22e-1)"	"unprognostic (3.43e-1)"	"unprognostic (1.97e-4)"	"unprognostic (3.08e-2)"	"unprognostic (8.85e-3)"	"unprognostic (6.41e-2)"	"unprognostic (4.92e-2)"	"unprognostic (8.46e-3)"	"unprognostic (8.27e-2)"	6.4	4.7	12.5	7.0	10.9	8.1	8.4	17.4	14.9	4.4	16.6	4.6	4.3	15.8	5.8	4.9	2.7	4.7	4.1	4.6	11.7	9.0	5.4	4.9	4.8	5.0	6.2	14.9	7.2	4.9	10.2	7.3	4.3	12.6	4.7	17.8	13.2	2.9	5.7	5.3	3.0	29.9	7.0	7.6	3.9	4.2	10.8	4.7	1.0	9.9	1.1	4.9	4.7	9.8	2.4	2.2	1.2	0.7	3.5	1.5	0.4	4.9	6.5	7.1	7.9	5.7	6.9	4.1	7.4	6.7	10.7	8.8	5.9	1.6	9.8	2.9	12.2	7.7	10.5	10.2	3.8	13.9	3.4	5.5	2.7	5.6	3.9	4.5	2.3	4.3	5.1	2.2	15.2	5.0	4.5	4.0	3.4	2.4	2.7	7.4	10.4	3.2	1.8	5.5	1.5	1.7	5.1	6.2	3.2	5.1	3.8	6.2	3.3	15.9	4.4	2.6	5.7	5.4	1.4	5.5	10.8	7.8	4.5	6.1	6.1	4.3	10.1	6.7	1.9	2.4	0.8	0.5	0.2	1.0	0.7	0.9	2.4	0.8	1.5	0.6	1.6	1.1	0.9	1.2	3.5	0.7	2.2	1.3	0.4	12.5	10.9	17.4	14.9	11.7	9.0	6.2	14.9	12.6	4.7	8.9	2.1	5.2	4.7	8.2	18.7	2.3	0.0	2.7	4.5	3.5	98.2	3.8	0.0	2.4	9.7	3.7	51.9	0.0	2.0	0.3	7.2	5.0	10.3	3.9	1.3	22.3	5.8	3.1	5.4	3.6	4.9	2.2	13.5	2.8	6.7	6.3	2.8	31.6	4.9	4.3	60.3	6.5	5.6	29.1	18.3	8.0	1.1	3.5	7.2	2.1
PHOSPHO1		ENSG00000173868	"Phosphoethanolamine/phosphocholine phosphatase"	Q8TCT1	17	49223362-49230766	"Enzymes, Predicted intracellular proteins"	"Mineral balance"	Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"blood: 80.0;testis: 52.3"	"Cell type enriched"	"Detected in some"	6	"Late spermatids: 1098.7"	"Low cancer specificity"	"Detected in some"			"Group enriched"	"Detected in many"	4	"cerebral cortex: 10.2;pons and medulla: 8.2"	"Group enriched"	"Detected in some"	171	"eosinophil: 30.6;neutrophil: 80.0"	"Lineage enriched"	"Detected in single"	248	"granulocytes: 80.0"	"Cell line enhanced"	"Detected in some"		"Daudi: 8.6;EFO-21: 5.8;HDLM-2: 6.1;SuSa: 8.9"	"Low region specificity"	"Detected in all"							HPA065025			Approved	"Plasma membrane,Actin filaments"		NA	NA			"Actin filaments"	"Plasma membrane"	"HPA065025: AB_2732727"	"unprognostic (1.37e-1)"	"unprognostic (3.01e-3)"	"unprognostic (7.53e-2)"	"unprognostic (4.41e-3)"	"unprognostic (1.57e-1)"	"unprognostic (4.70e-2)"	"unprognostic (1.44e-1)"	"unprognostic (1.39e-2)"	"unprognostic (2.04e-1)"	"unprognostic (6.88e-2)"	"unprognostic (1.02e-2)"	"unprognostic (2.88e-1)"	"unprognostic (2.03e-1)"	"unprognostic (1.45e-1)"	"unprognostic (1.62e-1)"	"unprognostic (1.08e-1)"	"unprognostic (1.87e-1)"	2.5	1.3	1.1	2.9	1.9	15.3	0.7	1.0	10.2	0.6	0.6	0.2	0.2	2.5	0.9	2.7	0.9	1.3	2.1	1.0	1.7	1.3	1.0	0.9	2.5	2.0	2.1	1.5	1.1	1.0	0.1	0.8	7.6	8.2	0.9	0.0	1.6	0.9	0.5	2.2	1.1	2.6	0.3	1.5	12.6	0.7	52.3	0.1	0.0	0.8	0.1	0.1	1.4	1.3	0.0	0.0	80.0	0.3	0.0	0.0	0.1	0.0	1.1	0.0	2.0	0.1	0.2	0.0	0.3	0.4	0.0	0.1	2.7	0.0	8.6	5.8	0.0	3.3	0.0	1.6	0.5	0.1	6.1	0.2	1.2	1.1	0.4	0.0	0.0	1.1	0.4	0.0	0.6	0.0	0.6	0.0	1.1	0.0	0.0	0.6	0.1	0.0	0.4	0.0	0.3	1.6	1.7	3.2	0.0	0.1	0.0	0.0	0.0	0.3	0.1	0.0	8.9	0.2	0.1	3.5	0.4	2.8	1.9	0.0	0.2	0.3	0.6	2.5	3.3	0.3	0.0	0.1	30.6	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	80.0	0.0	0.3	0.0	0.0	0.1	1.1	1.9	1.0	10.2	1.7	1.3	2.1	1.5	8.2	0.1	0.0	0.0	0.0	0.0	0.2	0.3	0.4	0.0	0.0	0.0	0.0	0.0	7.5	0.0	0.0	185.3	0.1	0.0	0.0	0.0	0.9	0.1	0.0	0.0	0.0	2.3	0.0	0.0	0.6	0.0	1098.7	7.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	5.6	0.0	0.4	0.0	0.0	8.2	3.8	0.0	198.7	0.0	0.0	0.0
PHOSPHO2	MGC22679	ENSG00000144362	"Phosphatase, orphan 2"	Q8TCD6	2	169694454-169701708	"Enzymes, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	12	"Early spermatids: 91.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA034726, HPA034727"	Uncertain		Approved	Nucleoplasm,Vesicles		NA	NA			Vesicles	Nucleoplasm	"HPA034726: AB_10602191, HPA034727: AB_2674302"	"unprognostic (1.98e-1)"	"unprognostic (1.22e-1)"	"unprognostic (7.56e-2)"	"unprognostic (1.39e-3)"	"unprognostic (1.30e-2)"	"unprognostic (2.26e-1)"	"prognostic unfavorable (3.82e-6)"	"unprognostic (4.31e-2)"	"unprognostic (2.11e-2)"	"unprognostic (5.19e-2)"	"unprognostic (1.40e-1)"	"unprognostic (2.31e-1)"	"prognostic favorable (9.53e-4)"	"unprognostic (4.10e-1)"	"unprognostic (2.60e-1)"	"unprognostic (6.12e-2)"	"unprognostic (7.53e-2)"	8.7	4.0	9.0	5.7	9.7	3.3	14.2	14.2	7.8	8.4	8.2	5.8	6.3	8.2	8.6	5.9	4.6	8.1	6.2	5.7	6.7	5.5	7.5	5.0	4.3	3.6	6.0	9.1	8.2	8.9	10.9	21.3	3.9	7.8	17.4	7.8	6.4	10.5	7.8	6.4	5.2	7.9	6.2	9.7	3.4	6.3	25.4	8.0	5.5	13.0	3.9	3.9	9.1	5.7	8.8	4.6	1.5	1.0	10.5	5.7	1.8	5.7	1.6	4.1	5.6	7.9	2.5	16.3	2.5	1.7	3.9	4.4	5.6	4.4	5.6	5.6	1.9	8.1	4.5	5.5	3.0	3.2	8.3	6.4	5.6	4.9	9.6	5.2	4.5	5.1	4.6	5.8	4.5	6.0	3.3	3.5	8.0	9.2	5.8	2.4	5.3	3.1	5.9	5.6	3.7	2.1	3.2	2.5	4.3	6.2	17.3	17.5	6.0	5.4	2.8	6.0	5.2	7.5	2.8	2.0	4.3	4.1	4.0	2.7	5.6	5.2	5.0	5.1	2.8	4.5	0.0	0.9	1.1	3.9	1.0	5.5	6.8	4.3	3.7	1.0	8.8	5.7	5.6	1.5	10.5	0.9	4.6	4.4	1.8	9.0	9.7	14.2	7.8	6.7	5.5	6.0	9.1	7.8	8.0	3.0	2.2	2.7	9.2	2.3	8.7	2.8	2.5	13.4	1.2	3.5	5.9	8.6	8.3	5.9	91.4	4.5	5.9	0.0	9.9	8.8	3.0	7.0	0.0	2.8	2.5	6.4	14.5	2.5	0.0	23.3	4.4	1.9	3.3	1.0	8.2	5.2	6.7	8.4	4.6	9.8	10.2	0.0	5.1	27.9	11.7	3.8	4.6	4.3	8.1	4.3
PHPT1	"bA216L13.10, CGI-202, DKFZp564M173, HSPC141, PHP14"	ENSG00000054148	"Phosphohistidine phosphatase 1"	Q9NRX4	9	136848724-136851027	"Enzymes, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB013584, HPA020952"	Approved		Approved	"Nucleoplasm,Nuclear bodies,Plasma membrane,Cytosol"		NA	NA		430000	Cytosol	"Nucleoplasm, Nuclear bodies, Plasma membrane"	"CAB013584: , HPA020952: AB_1855331"	"unprognostic (7.34e-2)"	"unprognostic (9.21e-2)"	"unprognostic (7.90e-2)"	"unprognostic (1.57e-2)"	"unprognostic (3.76e-2)"	"unprognostic (2.30e-1)"	"unprognostic (4.64e-2)"	"unprognostic (1.69e-2)"	"unprognostic (3.23e-2)"	"unprognostic (1.82e-1)"	"unprognostic (1.26e-3)"	"unprognostic (5.85e-2)"	"unprognostic (9.66e-3)"	"unprognostic (1.11e-2)"	"unprognostic (2.01e-1)"	"unprognostic (3.95e-2)"	"unprognostic (8.49e-2)"	15.8	26.4	31.5	12.1	28.0	11.7	15.3	14.7	27.2	19.2	15.7	18.5	13.7	14.7	11.2	21.7	13.7	21.1	14.2	59.1	22.7	19.3	18.4	12.6	12.1	12.7	27.0	21.0	13.7	46.5	15.6	21.2	14.7	20.8	20.2	11.6	14.1	30.5	22.6	86.0	9.2	16.3	16.9	24.3	10.3	13.4	13.8	18.6	7.5	20.7	19.8	10.4	12.0	9.8	24.9	48.8	3.3	35.4	20.0	24.3	32.1	7.1	52.0	29.7	18.9	19.2	34.9	43.7	16.6	21.2	20.3	18.1	18.9	16.3	15.2	20.2	20.5	24.3	18.9	6.4	37.5	6.4	13.6	13.2	4.8	34.2	41.5	23.9	9.5	19.5	43.5	30.9	11.6	14.0	18.4	26.6	11.9	11.5	14.1	31.4	40.6	13.8	20.0	23.5	47.6	22.4	11.5	13.0	25.1	32.1	11.9	14.6	13.8	17.9	21.0	8.6	14.8	15.9	26.4	21.6	42.5	13.2	11.7	15.3	9.4	9.1	9.3	24.0	6.9	25.4	2.9	35.4	3.3	24.3	34.2	20.9	24.9	21.1	21.9	37.5	16.5	15.0	21.3	1.7	20.0	24.0	48.8	22.9	32.1	31.5	28.0	14.7	27.2	22.7	19.3	27.0	21.0	20.8	18.6	89.3	132.7	80.4	156.2	133.5	37.9	336.8	191.1	136.5	125.1	205.9	21.6	300.5	633.3	164.3	214.6	110.1	411.5	70.0	220.3	372.9	227.8	244.3	120.2	179.9	249.5	63.5	254.7	94.5	103.8	640.4	189.8	148.3	317.2	367.9	241.4	126.9	202.0	354.2	210.0	509.4	53.8	84.1	248.0	93.6	149.9	141.4	220.8	93.5	262.8	160.3
PHYH	"PAHX, PHYH1, RD"	ENSG00000107537	"Phytanoyl-CoA 2-hydroxylase"	O14832	10	13277796-13302412	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		"Dioxygenase, Oxidoreductase"	"Cataract, Deafness, Disease mutation, Ichthyosis, Peroxisome biogenesis disorder, Retinitis pigmentosa"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 128.3;skeletal muscle: 83.8"	"Cell type enhanced"	"Detected in many"	5	"Cardiomyocytes: 202.2;Proximal tubular cells: 218.2"	"Cancer enhanced"	"Detected in all"		"liver cancer: 78.1"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"ASC diff: 42.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007598, HPA011796"	Enhanced					NA	NA					"HPA007598: AB_1855334, HPA011796: AB_1855335"	"unprognostic (5.78e-2)"	"unprognostic (3.83e-1)"	"unprognostic (6.98e-2)"	"unprognostic (3.62e-2)"	"unprognostic (5.52e-2)"	"unprognostic (1.61e-3)"	"unprognostic (1.16e-1)"	"unprognostic (1.95e-2)"	"unprognostic (7.09e-2)"	"unprognostic (6.15e-2)"	"unprognostic (1.59e-1)"	"unprognostic (3.24e-1)"	"prognostic favorable (7.28e-12)"	"unprognostic (2.07e-1)"	"unprognostic (1.06e-1)"	"unprognostic (1.07e-2)"	"unprognostic (2.19e-1)"	10.5	16.8	5.3	5.3	6.2	1.4	7.7	5.1	8.7	6.0	10.7	5.4	5.7	11.4	5.4	5.6	6.8	3.6	8.5	38.0	4.0	4.9	36.4	128.3	6.4	3.2	6.5	3.7	7.6	9.9	6.8	6.7	4.5	5.3	6.2	7.4	7.1	6.3	5.4	83.8	3.8	15.5	10.2	4.4	3.0	8.5	4.1	4.1	1.9	13.0	29.5	3.6	7.6	9.4	9.2	13.3	10.7	16.0	3.3	15.4	10.2	6.2	13.0	5.9	8.4	42.6	27.2	4.7	6.4	8.9	7.3	7.3	3.3	11.3	0.3	4.9	10.6	17.9	2.9	7.6	7.5	4.5	14.9	4.0	5.4	3.6	13.1	21.2	0.9	10.2	19.3	10.8	7.9	3.1	8.6	7.0	6.3	3.0	12.0	16.9	5.8	3.2	4.3	5.4	18.0	4.7	5.7	9.1	2.1	15.2	7.9	2.0	6.4	23.9	0.5	11.7	4.9	24.3	16.1	2.3	11.2	4.1	13.7	4.2	13.9	9.3	1.2	14.6	6.9	4.4	10.7	16.0	6.5	7.2	11.7	15.4	9.2	9.1	9.2	13.3	4.9	11.5	11.7	0.6	3.3	9.0	12.2	8.6	10.2	5.3	6.2	5.1	8.7	4.0	4.9	6.5	3.7	5.3	4.1	11.9	16.3	21.7	25.5	10.5	48.0	202.2	61.1	21.4	13.6	33.2	21.6	99.5	122.7	32.7	25.3	26.0	87.2	0.0	17.2	26.8	24.7	15.1	29.0	133.8	47.0	20.6	30.6	24.5	18.1	31.5	23.6	24.7	16.9	10.0	49.9	65.0	20.4	35.1	35.3	218.2	34.7	19.4	22.4	1.4	0.7	11.7	70.1	16.2	37.9	15.9
PHYKPL	"AGXT2L2, MGC15875"	ENSG00000175309	"5-phosphohydroxy-L-lysine phospho-lyase"	Q8IUZ5	5	178208497-178232791	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		Lyase	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA036461, HPA063608"	Approved		Approved	Mitochondria		Yes	No		190000	Mitochondria		"HPA036461: AB_10670717, HPA063608: AB_2685059"	"unprognostic (3.29e-3)"	"unprognostic (2.60e-1)"	"unprognostic (5.51e-2)"	"unprognostic (9.75e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.47e-1)"	"unprognostic (1.24e-1)"	"unprognostic (1.06e-2)"	"unprognostic (1.68e-2)"	"unprognostic (3.29e-1)"	"unprognostic (5.38e-2)"	"unprognostic (1.02e-3)"	"prognostic unfavorable (3.82e-5)"	"unprognostic (3.66e-2)"	"unprognostic (1.55e-1)"	"unprognostic (1.02e-1)"	"unprognostic (2.41e-3)"	18.7	13.1	10.5	25.0	10.8	9.8	15.5	8.3	10.9	13.9	24.3	13.4	14.4	15.1	13.5	14.9	10.7	13.6	17.5	15.5	8.9	4.9	18.1	44.4	14.7	16.8	13.7	9.3	13.2	18.0	11.9	11.9	11.8	10.2	12.4	23.9	12.1	12.3	13.7	20.2	7.6	29.8	14.1	10.7	20.2	15.3	16.4	11.7	16.3	16.6	10.5	17.4	14.0	11.8	13.9	32.8	16.7	21.7	10.7	14.0	14.3	5.8	2.4	5.8	2.3	14.7	11.7	8.8	3.7	4.1	4.9	7.9	6.2	7.5	7.6	11.2	11.2	6.2	3.8	5.0	9.4	5.7	15.6	5.0	9.7	9.8	4.4	23.9	5.5	6.3	13.3	9.9	6.2	15.1	10.1	16.3	11.4	7.1	17.7	7.4	8.5	7.7	2.9	1.2	7.3	8.0	5.1	2.8	15.3	8.9	5.3	3.6	3.3	5.8	3.4	6.1	7.1	3.7	4.5	6.6	5.1	4.6	3.3	3.9	11.3	3.1	4.6	1.5	5.9	3.4	6.3	19.5	16.7	10.0	21.7	10.1	13.9	11.3	11.4	25.2	12.6	14.0	11.3	4.4	10.7	21.3	32.8	12.9	14.3	10.5	10.8	8.3	10.9	8.9	4.9	13.7	9.3	10.2	11.7	17.9	14.7	36.2	35.3	9.5	20.4	15.7	33.1	12.0	9.1	22.7	23.6	14.0	16.6	17.9	16.8	22.4	97.5	0.0	16.2	15.1	23.7	24.7	12.7	27.6	27.2	14.3	18.5	22.7	23.8	45.2	39.4	30.7	23.6	63.1	33.9	26.4	14.7	54.6	23.7	31.0	26.5	12.9	16.5	28.6	23.7	9.2	18.4	34.6	33.9	31.3
PI4K2A	"DKFZP761G1923, PI4KII, PIK42A"	ENSG00000155252	"Phosphatidylinositol 4-kinase type 2 alpha"	Q9BTU6	10	97640686-97676434	"Enzymes, Predicted intracellular proteins"		"Kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Hofbauer cells: 32.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB030649, HPA076857"	Approved		Approved	"Plasma membrane"		NA	NA			"Plasma membrane"		"CAB030649: , HPA076857: AB_2686817"	"unprognostic (1.34e-1)"	"unprognostic (3.50e-2)"	"prognostic unfavorable (4.21e-5)"	"unprognostic (1.80e-2)"	"unprognostic (2.12e-1)"	"unprognostic (1.75e-2)"	"unprognostic (2.84e-3)"	"unprognostic (1.60e-2)"	"unprognostic (1.39e-3)"	"unprognostic (1.38e-2)"	"unprognostic (1.02e-2)"	"unprognostic (1.65e-1)"	"unprognostic (9.92e-2)"	"unprognostic (1.27e-1)"	"unprognostic (1.80e-1)"	"unprognostic (1.45e-1)"	"unprognostic (2.90e-1)"	17.2	23.0	13.8	10.7	21.2	22.8	9.5	16.8	33.8	12.0	9.1	16.8	9.5	10.9	12.8	15.5	18.3	8.9	16.1	15.2	14.5	17.9	14.7	17.1	15.0	11.0	15.9	15.7	10.6	9.5	23.2	15.5	19.9	30.7	10.3	10.2	23.8	10.1	12.7	11.3	15.3	9.9	15.0	9.9	14.4	8.8	14.9	7.5	8.2	12.0	8.8	11.8	13.6	11.2	4.1	3.7	1.1	3.4	1.9	4.0	1.6	12.1	9.2	7.6	13.5	16.3	11.8	6.1	12.2	27.0	19.3	20.5	8.3	12.1	4.4	7.2	15.4	14.2	11.8	8.4	24.3	16.1	5.3	7.2	3.9	6.5	7.5	15.7	3.5	5.6	12.4	20.8	20.2	36.0	21.2	9.8	8.7	6.1	7.3	13.3	6.2	7.7	2.7	4.9	6.3	8.7	3.6	7.9	4.3	13.2	11.4	2.6	8.4	10.3	2.6	15.2	11.2	7.2	5.6	10.8	9.2	6.9	10.9	9.4	6.5	7.6	7.2	17.1	2.1	3.0	0.0	3.4	0.0	4.0	2.3	2.8	4.1	1.7	3.4	3.7	1.9	1.4	2.6	1.1	1.9	1.6	1.7	3.1	1.6	13.8	21.2	16.8	33.8	14.5	17.9	15.9	15.7	30.7	7.5	3.0	4.8	4.7	4.1	11.8	12.9	9.8	10.2	1.4	2.3	5.2	11.8	11.6	3.3	4.0	1.9	5.0	8.3	0.0	4.2	5.3	9.4	4.3	1.1	9.3	32.1	11.1	2.9	3.1	11.0	1.7	4.0	17.5	10.1	22.6	2.5	6.9	5.7	0.0	8.5	6.2	14.2	6.5	5.9	9.1	5.6	12.5	22.7	7.0	2.5	7.1
PI4K2B	"FLJ11105, PI4KIIB, PIK42B"	ENSG00000038210	"Phosphatidylinositol 4-kinase type 2 beta"	Q8TCG2	4	25233975-25279092	"Enzymes, Predicted intracellular proteins"		"Kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"intestine: 49.3"	"Cell type enhanced"	"Detected in many"	4	"Hepatocytes: 36.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"											HPA004099	Approved		Supported	Cytosol		NA	NA			Cytosol		"HPA004099: AB_1855353"	"unprognostic (1.02e-1)"	"unprognostic (6.34e-3)"	"prognostic favorable (9.64e-5)"	"unprognostic (2.75e-2)"	"unprognostic (1.98e-2)"	"unprognostic (2.68e-2)"	"unprognostic (7.54e-2)"	"unprognostic (7.75e-2)"	"unprognostic (5.06e-1)"	"unprognostic (6.39e-3)"	"unprognostic (1.71e-1)"	"unprognostic (1.32e-1)"	"unprognostic (9.07e-2)"	"unprognostic (9.61e-2)"	"unprognostic (2.39e-2)"	"unprognostic (2.02e-2)"	"unprognostic (4.47e-2)"	9.2	7.1	3.4	13.6	2.9	3.9	8.0	3.2	2.3	8.7	48.4	4.1	11.3	19.4	7.4	8.0	13.5	4.9	9.5	4.2	3.1	2.7	12.9	38.6	14.3	9.4	3.5	2.3	6.9	10.5	4.2	5.7	7.7	2.9	6.4	9.8	3.3	22.6	12.0	4.4	8.6	49.3	6.9	4.5	13.8	11.3	8.0	2.7	18.6	16.2	12.9	14.1	7.8	10.3	1.4	1.8	1.5	1.0	0.4	4.1	0.4	11.5	2.1	4.9	5.2	6.6	12.3	11.9	17.4	16.4	15.2	19.5	3.7	12.4	29.9	4.0	13.1	10.6	4.8	11.1	8.7	15.1	9.1	3.9	9.5	5.2	9.2	6.3	19.2	7.5	8.2	7.9	5.7	6.0	4.6	10.3	8.5	6.3	25.1	14.8	4.4	18.5	17.2	8.5	13.8	4.7	11.2	19.2	17.4	13.4	8.2	10.2	2.2	8.8	7.0	3.6	5.5	9.9	11.1	10.5	10.8	2.8	6.6	11.2	28.8	13.8	22.8	12.7	16.3	11.0	1.5	0.4	0.0	1.3	1.0	0.9	1.4	1.5	1.2	0.3	1.0	1.4	1.3	0.2	0.4	0.9	1.8	4.1	0.4	3.4	2.9	3.2	2.3	3.1	2.7	3.5	2.3	2.9	2.7	6.0	14.4	14.1	11.2	13.4	1.9	0.0	7.6	2.7	12.5	8.7	0.0	18.1	5.0	5.1	0.6	6.4	14.2	23.3	6.2	10.1	8.3	11.3	0.0	36.0	9.1	1.6	8.1	6.7	12.4	0.9	4.0	7.0	5.0	12.6	12.8	1.1	5.0	8.6	4.2	15.6	3.0	0.0	7.2	8.0	12.7	13.7	11.3	5.0	12.7	11.9
PI4KA	"PI4K-ALPHA, pi4K230, PIK4CA"	ENSG00000241973	"Phosphatidylinositol 4-kinase alpha"	P42356	22	20707691-20859417	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"		"Kinase, Transferase"	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 48.0"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"K-562: 52.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009092, HPA075515"	Approved		Approved	"Nucleoplasm,Plasma membrane"		NA	NA		18000	Nucleoplasm	"Plasma membrane"	"CAB009092: AB_2164033, HPA075515: AB_2686753"	"unprognostic (8.06e-2)"	"unprognostic (1.53e-1)"	"unprognostic (1.20e-2)"	"unprognostic (4.45e-2)"	"unprognostic (1.21e-1)"	"unprognostic (5.01e-3)"	"unprognostic (3.19e-2)"	"prognostic favorable (5.24e-4)"	"unprognostic (2.08e-1)"	"unprognostic (4.21e-2)"	"unprognostic (1.88e-2)"	"unprognostic (1.29e-1)"	"prognostic favorable (7.22e-5)"	"unprognostic (1.37e-1)"	"unprognostic (1.33e-1)"	"unprognostic (2.35e-1)"	"unprognostic (1.50e-1)"	7.7	9.2	28.8	10.5	34.2	12.5	6.5	14.1	48.0	9.7	8.8	10.1	4.9	9.1	9.7	6.1	8.3	8.4	8.0	8.5	30.4	19.2	9.0	12.6	9.0	11.2	19.0	25.9	10.2	8.6	25.6	12.5	10.4	19.3	9.8	8.9	10.8	6.8	10.6	7.1	6.6	10.0	13.2	6.8	10.2	9.9	13.1	8.2	17.9	9.9	2.9	10.2	8.4	4.8	5.0	12.5	7.6	5.5	9.1	7.7	2.9	9.9	8.4	7.4	11.1	21.2	12.8	10.6	9.0	13.7	13.3	13.1	6.5	4.2	18.7	5.4	18.1	13.1	8.8	14.0	8.7	8.2	15.9	21.5	19.2	11.3	7.4	10.6	19.0	15.4	11.4	5.5	11.3	6.3	8.7	10.8	5.7	52.4	15.9	10.3	13.7	16.6	6.5	5.8	17.8	8.7	16.7	16.2	3.4	7.4	15.9	18.2	13.3	11.8	13.8	9.4	10.8	11.6	8.7	10.9	24.3	12.6	8.9	7.6	12.2	12.4	14.9	16.0	13.7	10.1	3.1	5.5	7.3	5.1	5.4	4.9	4.6	5.6	6.1	3.6	5.0	5.7	7.7	7.6	9.1	4.6	12.5	5.8	2.9	28.8	34.2	14.1	48.0	30.4	19.2	19.0	25.9	19.3	8.2	11.9	25.4	14.0	5.7	9.0	32.8	25.7	25.5	6.7	9.1	7.0	45.2	15.6	1.7	8.5	30.2	12.8	18.2	0.0	5.5	16.0	10.8	10.3	11.5	15.5	17.4	35.0	18.4	14.7	15.5	19.2	18.4	16.5	10.1	6.4	16.8	22.8	7.1	10.5	22.6	9.1	23.8	25.8	10.5	32.1	28.9	8.5	16.7	13.3	12.7	7.0
PI4KB	"PI4K-BETA, pi4K92, PIK4CB"	ENSG00000143393	"Phosphatidylinositol 4-kinase beta"	Q9UBF8	1	151291797-151327715	"Enzymes, Predicted intracellular proteins"	"Host-virus interaction"	"Kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006280, HPA006281, CAB022071"	Approved		Supported	"Golgi apparatus"		NA	NA			"Golgi apparatus"		"CAB022071: , HPA006280: AB_1079613, HPA006281: AB_1079614"	"unprognostic (1.17e-1)"	"unprognostic (1.57e-1)"	"unprognostic (5.42e-3)"	"unprognostic (5.23e-3)"	"unprognostic (7.32e-2)"	"unprognostic (1.36e-2)"	"prognostic unfavorable (2.97e-4)"	"unprognostic (1.87e-1)"	"unprognostic (3.94e-1)"	"unprognostic (1.58e-1)"	"prognostic favorable (1.25e-5)"	"unprognostic (8.51e-2)"	"prognostic unfavorable (3.23e-4)"	"unprognostic (2.53e-1)"	"unprognostic (2.16e-1)"	"prognostic unfavorable (6.78e-4)"	"unprognostic (7.08e-2)"	25.5	22.2	29.8	21.6	32.3	41.6	27.3	42.6	47.2	30.8	27.1	44.8	26.6	21.8	38.6	35.8	25.6	33.0	25.1	23.8	26.3	22.5	25.6	19.3	27.2	26.2	38.7	28.8	38.6	22.6	41.8	35.5	24.2	29.6	32.2	28.1	28.8	27.1	29.9	36.2	36.9	25.3	39.8	22.7	34.7	23.7	33.1	34.0	26.2	41.2	24.6	28.7	27.1	30.1	17.1	19.7	27.9	20.4	14.7	20.3	17.1	19.7	16.5	14.4	22.5	40.0	29.6	12.2	21.0	36.7	27.5	22.9	21.0	18.0	18.7	24.2	32.1	17.4	18.6	23.8	21.6	21.3	25.3	21.1	13.3	19.6	10.8	28.0	15.3	25.8	30.9	26.3	30.4	21.8	23.9	26.5	19.2	22.8	28.4	23.3	36.7	16.2	12.4	11.5	28.2	25.1	14.6	12.1	21.9	19.0	25.1	17.4	15.0	14.6	29.8	18.8	23.8	25.1	29.2	20.6	19.8	15.6	15.7	22.3	30.2	19.6	36.4	22.5	16.1	34.2	25.2	17.5	27.9	15.6	20.4	17.4	17.1	16.1	20.3	19.7	15.1	13.6	12.5	17.2	14.7	19.6	11.4	15.9	17.1	29.8	32.3	42.6	47.2	26.3	22.5	38.7	28.8	29.6	34.0	14.9	25.3	16.7	17.9	19.8	30.2	6.7	20.4	9.4	14.8	12.2	19.6	22.5	16.6	17.6	8.9	15.8	24.9	0.0	21.6	16.5	23.4	16.5	18.5	10.9	24.5	33.4	17.7	9.8	15.9	11.5	21.6	17.4	13.5	31.5	17.8	18.9	18.2	17.5	23.3	12.4	26.6	12.9	23.7	24.7	23.0	27.1	40.7	21.0	18.0	26.9
PIAS4	"FLJ12419, Piasg, PIASY, ZMIZ6"	ENSG00000105229	"Protein inhibitor of activated STAT 4"	Q8N2W9	19	4007646-4039386	"Enzymes, Predicted intracellular proteins"	"Transcription, Transcription regulation, Ubl conjugation pathway, Wnt signaling pathway"	"DNA-binding, Repressor, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	11	"Early spermatids: 73.5;Late spermatids: 189.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA010598, HPA076008"	Enhanced		Supported	Nucleoplasm,Centrosome		NA	NA			Nucleoplasm	Centrosome	"HPA010598: AB_1079616, HPA076008: "	"unprognostic (1.23e-1)"	"unprognostic (8.94e-3)"	"unprognostic (3.50e-2)"	"prognostic favorable (1.18e-5)"	"unprognostic (2.45e-1)"	"unprognostic (4.77e-3)"	"unprognostic (4.01e-3)"	"unprognostic (9.79e-2)"	"unprognostic (6.89e-2)"	"unprognostic (6.22e-2)"	"prognostic favorable (7.04e-4)"	"unprognostic (1.33e-2)"	"unprognostic (5.98e-2)"	"unprognostic (4.52e-3)"	"unprognostic (5.76e-2)"	"unprognostic (1.25e-1)"	"unprognostic (4.67e-3)"	11.0	9.2	12.4	11.1	16.8	8.6	7.6	22.5	15.7	8.8	11.9	16.7	8.1	13.0	9.5	9.2	9.1	8.4	9.7	6.9	9.7	7.1	7.3	12.4	7.8	10.2	18.2	9.3	11.2	16.0	7.1	9.3	12.9	12.6	9.9	5.4	6.5	14.7	8.7	15.2	12.2	11.2	8.0	12.3	12.0	13.9	38.1	15.9	11.0	6.6	6.3	8.3	8.8	9.8	17.9	11.8	20.2	19.1	16.3	17.3	11.3	10.6	7.7	7.2	6.8	3.5	3.2	11.5	6.5	3.6	6.9	6.3	12.0	5.0	8.1	5.9	3.5	7.5	11.2	7.4	5.2	3.0	13.0	11.6	5.8	5.5	9.2	7.3	8.4	10.3	3.7	5.7	6.2	3.8	3.8	8.1	8.5	10.8	11.2	3.3	10.9	15.3	9.9	15.9	5.2	7.1	13.7	7.3	10.6	4.5	6.0	13.2	14.7	9.3	9.1	7.1	5.6	8.4	7.8	5.9	6.9	9.9	14.3	10.1	21.1	15.7	10.3	5.7	10.4	8.4	10.5	14.9	20.2	17.3	16.0	12.2	17.9	12.6	15.9	11.8	15.9	11.1	12.5	16.6	16.3	19.1	11.8	13.4	11.3	12.4	16.8	22.5	15.7	9.7	7.1	18.2	9.3	12.6	15.9	3.0	12.9	7.5	7.0	16.4	17.6	3.0	5.1	13.4	7.9	8.7	11.8	19.8	6.6	16.0	73.5	9.8	12.3	0.0	15.5	13.7	7.1	11.8	6.9	9.3	12.6	25.4	21.2	10.4	9.8	189.7	13.0	8.3	6.8	11.8	14.3	10.4	13.0	5.8	17.3	10.2	21.3	6.5	7.2	35.8	35.3	13.6	30.4	7.5	10.8	7.4
PIF1	"C15orf20, FLJ22692"	ENSG00000140451	"PIF1 5'-to-3' DNA helicase"	Q9H611	15	64815632-64825668	"Enzymes, Predicted intracellular proteins"	"DNA damage, DNA recombination, DNA repair"	"DNA-binding, Helicase, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 14.3"	"Group enriched"	"Detected in many"	5	"Early spermatids: 22.3;Erythroid cells: 70.0"	"Cancer enhanced"	"Detected in many"		"testis cancer: 10.2"	"Low region specificity"	"Detected in some"			"Cell type enhanced"	"Detected in some"		"T-reg: 3.2"	"Lineage enriched"	"Detected in single"	5	"T-cells: 3.2"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			CAB018701	Supported		Supported	Nucleoplasm		NA	Yes			Nucleoplasm		"CAB018701: AB_2164654"	"unprognostic (1.99e-1)"	"unprognostic (6.11e-2)"	"unprognostic (1.34e-1)"	"unprognostic (3.12e-2)"	"unprognostic (1.62e-1)"	"unprognostic (8.33e-3)"	"unprognostic (8.66e-4)"	"unprognostic (1.47e-1)"	"prognostic unfavorable (5.22e-4)"	"unprognostic (6.68e-2)"	"unprognostic (2.38e-2)"	"unprognostic (3.27e-2)"	"unprognostic (0.00e+0)"	"unprognostic (2.96e-3)"	"unprognostic (1.78e-1)"	"unprognostic (9.61e-2)"	"unprognostic (5.95e-2)"	1.8	1.1	0.6	12.9	0.6	6.0	0.6	0.6	1.2	1.2	5.2	0.6	0.6	3.3	2.0	1.3	4.6	0.8	1.4	0.9	0.6	1.8	0.7	0.6	1.9	7.5	0.9	0.6	0.6	0.6	0.0	0.6	1.4	1.0	2.5	1.8	0.9	0.8	1.2	0.6	1.6	3.7	2.1	0.6	7.0	2.7	3.3	0.6	14.3	0.6	5.1	6.0	1.8	1.9	0.7	0.3	0.0	0.0	0.0	3.2	0.4	5.2	6.1	15.0	6.0	2.7	3.2	5.5	5.1	2.8	5.2	4.0	9.6	8.8	6.3	2.1	2.5	4.8	14.5	15.3	4.3	1.9	10.0	5.6	7.3	17.1	6.9	1.4	2.9	6.0	1.8	0.0	2.3	1.9	1.3	5.3	9.5	4.8	12.7	4.9	4.6	3.1	12.2	12.2	6.6	4.2	6.5	5.0	8.9	2.9	2.9	6.2	4.0	3.9	4.4	2.3	6.9	4.9	3.2	3.6	3.1	16.4	5.0	9.4	10.2	9.4	6.0	3.0	12.9	4.4	0.0	0.0	0.0	1.5	0.0	0.5	0.7	0.1	1.0	0.1	0.1	0.0	0.5	0.0	0.0	0.0	0.3	3.2	0.4	0.6	0.6	0.6	1.2	0.6	1.8	0.9	0.6	1.0	0.6	0.0	1.4	0.8	0.6	1.6	0.4	1.6	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	22.3	1.5	0.3	70.0	0.0	5.6	2.6	0.9	0.0	0.0	4.8	0.0	0.0	7.4	2.2	1.3	1.4	3.1	0.0	0.0	0.8	0.6	0.2	0.0	2.1	0.0	0.8	6.5	2.7	0.1	1.9	0.9	0.9	8.9	0.9	1.1
PIGA	GPI3	ENSG00000165195	"Phosphatidylinositol glycan anchor biosynthesis class A"	P37287	X	15319451-15335580	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"GPI-anchor biosynthesis"	"Glycosyltransferase, Transferase"	"Disease mutation, Epilepsy"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"Alveolar cells type 2: 84.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA001174	Approved					NA	NA					"HPA001174: AB_2666220"	"unprognostic (1.15e-1)"	"unprognostic (1.04e-1)"	"unprognostic (5.90e-2)"	"unprognostic (7.92e-2)"	"unprognostic (2.05e-1)"	"unprognostic (2.16e-1)"	"unprognostic (2.99e-3)"	"unprognostic (2.24e-2)"	"unprognostic (7.37e-3)"	"unprognostic (3.93e-3)"	"prognostic unfavorable (7.64e-4)"	"unprognostic (1.85e-3)"	"unprognostic (5.97e-3)"	"unprognostic (2.24e-1)"	"unprognostic (3.94e-1)"	"unprognostic (2.12e-2)"	"unprognostic (1.18e-2)"	6.9	6.1	6.8	5.0	8.6	16.1	7.0	7.6	10.0	6.0	6.8	9.6	5.8	3.5	6.2	7.5	9.9	5.6	7.8	6.2	8.0	5.4	7.5	11.0	14.4	5.9	9.6	6.4	7.0	9.9	8.5	5.2	10.8	16.7	5.9	7.5	7.0	11.5	9.1	4.2	10.9	4.8	5.2	10.2	5.7	7.2	5.3	9.4	4.7	8.6	8.5	8.7	11.6	6.6	2.9	3.9	16.7	7.6	1.5	4.4	2.4	12.5	7.8	8.1	4.1	2.4	2.5	6.7	3.3	5.2	7.3	7.0	8.5	5.5	5.9	2.7	2.6	8.5	5.0	13.4	11.0	11.9	5.3	9.2	5.0	9.6	5.0	4.2	7.1	2.6	3.4	7.4	9.4	14.9	2.2	4.6	4.7	5.4	6.3	4.4	7.9	8.0	2.6	4.2	4.7	8.6	2.8	11.7	9.3	5.2	8.5	5.6	8.7	6.6	5.9	12.7	8.3	6.0	6.3	3.8	5.4	2.2	12.0	6.6	4.8	6.2	9.1	8.4	5.1	6.9	16.7	3.6	3.9	2.7	6.0	3.8	2.9	4.4	2.7	3.9	2.2	4.0	3.1	5.2	1.5	7.6	2.5	3.8	2.4	6.8	8.6	7.6	10.0	8.0	5.4	9.6	6.4	16.7	9.4	17.9	84.7	1.9	34.4	26.3	3.4	6.7	2.5	17.4	22.7	3.5	0.0	4.8	10.0	6.3	3.5	4.5	5.4	23.3	5.1	8.2	10.6	28.9	32.4	4.3	7.5	3.2	10.3	2.5	6.9	3.2	2.8	13.8	27.0	1.8	3.7	3.7	7.9	4.5	2.8	4.7	2.5	12.9	19.6	1.6	3.9	48.1	23.5	6.4	4.1	49.8
PIGC		ENSG00000135845	"Phosphatidylinositol glycan anchor biosynthesis class C"	Q92535	1	172370189-172444086	"Enzymes, Predicted membrane proteins"	"GPI-anchor biosynthesis"	"Glycosyltransferase, Transferase"	"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA036663	Uncertain					NA	NA					"HPA036663: AB_10669912"	"unprognostic (3.35e-1)"	"unprognostic (3.01e-1)"	"unprognostic (2.14e-1)"	"unprognostic (1.01e-1)"	"unprognostic (2.65e-1)"	"unprognostic (3.72e-3)"	"prognostic unfavorable (4.49e-4)"	"unprognostic (7.25e-2)"	"unprognostic (2.20e-2)"	"unprognostic (4.69e-2)"	"unprognostic (3.08e-2)"	"unprognostic (1.24e-1)"	"prognostic unfavorable (1.43e-8)"	"unprognostic (1.09e-1)"	"unprognostic (1.77e-1)"	"unprognostic (6.04e-2)"	"unprognostic (1.90e-1)"	13.8	13.1	10.0	9.0	11.2	14.4	13.9	11.3	12.3	14.4	12.3	9.0	20.9	9.3	14.5	26.1	11.6	15.1	12.1	14.1	8.4	10.2	11.5	12.5	9.0	13.1	12.0	6.6	14.9	16.4	9.2	11.6	14.4	9.6	17.1	12.3	13.2	12.7	15.7	14.8	21.3	15.8	13.5	9.9	12.4	10.5	13.5	9.8	14.2	15.8	10.8	12.3	11.0	10.8	18.9	12.5	27.4	14.5	25.1	33.8	19.2	17.7	15.3	20.9	14.2	15.8	14.4	15.6	11.6	13.0	20.1	17.6	13.7	26.1	9.6	17.1	13.8	15.9	19.2	13.6	16.8	16.2	21.1	15.7	11.7	14.6	17.1	17.6	23.9	15.4	21.5	20.2	14.4	15.9	15.7	12.7	18.5	17.6	18.4	16.1	9.1	18.1	21.4	21.5	36.5	21.5	15.0	17.0	17.0	30.9	13.2	10.9	20.9	16.8	19.9	26.1	30.9	17.6	17.1	11.6	12.8	21.5	15.6	12.3	12.3	17.4	15.0	9.2	15.7	24.2	27.4	14.5	27.3	19.4	13.5	16.4	18.9	22.7	20.4	12.5	16.7	33.8	24.2	9.5	25.1	14.1	12.4	19.8	19.2	10.0	11.2	11.3	12.3	8.4	10.2	12.0	6.6	9.6	9.8	8.9	10.1	18.2	17.0	11.9	14.3	17.9	15.3	20.1	7.9	27.9	7.9	53.2	28.2	27.8	72.4	18.6	18.4	23.3	35.8	42.5	35.1	14.9	7.0	12.5	31.2	19.1	7.5	19.6	25.3	53.5	43.7	17.2	25.3	25.2	19.3	18.1	26.8	22.6	38.2	18.2	14.2	32.3	18.5	28.9	16.0	16.7	19.8	26.6	20.4	14.1
PIGH	GPI-H	ENSG00000100564	"Phosphatidylinositol glycan anchor biosynthesis class H"	Q14442	14	67581955-67600287	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"		"Glycosyltransferase, Transferase"	"Autism spectrum disorder, Disease mutation, Epilepsy"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Muller glia cells: 94.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA031624	Approved					NA	NA					"HPA031624: AB_10601046"	"unprognostic (1.59e-2)"	"unprognostic (3.07e-2)"	"unprognostic (1.08e-1)"	"unprognostic (5.80e-2)"	"unprognostic (3.47e-2)"	"unprognostic (8.25e-3)"	"unprognostic (8.69e-3)"	"unprognostic (3.26e-3)"	"unprognostic (1.19e-1)"	"unprognostic (2.73e-1)"	"unprognostic (6.17e-3)"	"unprognostic (1.39e-1)"	"prognostic favorable (2.68e-7)"	"unprognostic (7.42e-2)"	"unprognostic (1.42e-2)"	"unprognostic (7.00e-2)"	"unprognostic (3.73e-1)"	9.7	22.7	15.1	8.8	15.9	18.6	18.5	21.5	18.8	21.8	10.1	11.9	11.5	10.3	10.6	30.6	10.2	9.2	15.6	12.5	14.0	17.2	28.0	18.3	9.1	11.0	19.5	11.3	16.7	21.4	56.0	9.4	17.9	17.8	24.1	9.8	21.0	19.9	17.2	19.5	12.7	12.7	13.1	19.2	11.1	12.2	23.6	14.5	13.5	31.5	7.4	10.5	10.8	10.7	31.8	14.4	24.4	20.4	23.5	29.9	16.8	13.7	9.0	8.7	18.0	19.4	7.5	7.4	7.5	9.4	10.7	10.5	14.4	4.8	9.6	7.7	5.2	18.1	10.1	15.2	10.9	12.0	14.2	20.2	9.8	7.7	14.7	15.3	7.2	12.0	10.8	14.1	8.1	12.5	3.3	6.8	16.5	22.1	6.8	7.8	11.9	10.5	12.0	1.6	19.1	24.5	3.6	8.7	5.6	11.4	11.5	10.9	13.1	5.8	11.3	18.6	6.7	12.9	7.3	3.5	10.9	13.8	14.0	9.0	12.9	8.3	6.5	8.4	15.4	15.0	17.9	12.6	24.4	23.1	16.6	29.9	29.6	24.4	21.5	12.3	31.8	25.7	24.0	6.0	23.5	20.4	14.4	22.3	16.8	15.1	15.9	21.5	18.8	14.0	17.2	19.5	11.3	17.8	14.5	3.0	10.2	10.9	19.0	18.3	35.8	4.2	15.3	10.7	4.5	21.0	33.4	26.9	24.9	16.6	9.6	17.3	10.7	0.0	32.6	23.2	21.6	21.6	6.9	14.7	19.9	25.4	6.9	9.8	6.7	6.0	19.8	10.9	33.7	3.6	13.1	94.1	19.6	8.6	19.8	21.6	35.0	0.0	19.4	59.5	54.8	18.2	47.1	19.2	14.7	14.8
PIGK	"GPI8, hGPI8"	ENSG00000142892	"Phosphatidylinositol glycan anchor biosynthesis class K"	Q92643	1	77088990-77219430	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"GPI-anchor biosynthesis"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA056383, HPA057040"	Uncertain				"Intracellular and membrane"	NA	NA					"HPA056383: AB_2683109, HPA057040: AB_2683319"	"unprognostic (2.43e-2)"	"unprognostic (2.60e-1)"	"unprognostic (4.07e-2)"	"unprognostic (2.24e-2)"	"unprognostic (3.65e-1)"	"unprognostic (1.15e-1)"	"prognostic unfavorable (4.68e-4)"	"unprognostic (1.07e-1)"	"unprognostic (5.19e-1)"	"unprognostic (1.12e-1)"	"unprognostic (4.17e-2)"	"unprognostic (1.85e-2)"	"unprognostic (1.76e-2)"	"unprognostic (3.37e-1)"	"unprognostic (1.38e-1)"	"unprognostic (1.21e-1)"	"unprognostic (8.12e-3)"	14.5	17.4	13.8	8.0	20.4	10.2	17.1	14.8	22.9	14.2	11.4	17.4	9.6	9.2	14.6	13.8	10.7	13.0	13.6	20.0	15.4	17.7	25.4	19.0	12.3	10.6	17.7	11.7	13.7	14.1	24.9	23.1	11.2	23.8	15.9	12.9	11.2	11.9	12.9	11.9	7.6	11.6	14.5	19.9	14.7	11.6	9.6	17.2	14.6	22.3	8.1	9.8	12.9	9.4	5.2	7.6	7.6	4.4	8.9	12.8	6.3	5.7	6.8	5.6	7.1	32.4	24.4	9.1	11.7	16.1	12.3	17.7	5.6	5.9	5.0	12.1	20.7	14.7	5.2	7.1	10.0	22.5	10.4	7.3	6.8	7.3	5.2	7.2	15.1	6.1	14.7	5.4	13.1	11.4	14.8	18.1	6.3	8.3	17.4	18.9	3.9	4.7	6.1	5.0	6.5	11.3	5.6	16.5	6.4	15.7	4.2	4.8	4.5	11.1	10.1	12.7	9.7	4.8	8.7	10.3	19.9	7.8	10.7	11.9	7.9	11.0	5.1	14.8	19.2	7.8	6.9	4.1	7.6	8.3	4.4	8.4	5.2	8.5	7.0	7.6	4.1	10.7	9.5	2.0	8.9	4.2	5.2	12.8	6.3	13.8	20.4	14.8	22.9	15.4	17.7	17.7	11.7	23.8	17.2	8.9	7.8	11.5	13.1	8.5	13.1	18.9	22.9	20.1	9.1	38.4	2.0	16.1	3.3	18.9	1.5	17.3	6.5	0.0	18.7	28.7	19.2	13.7	17.3	24.6	18.1	7.9	10.4	16.5	14.3	2.2	18.1	11.1	18.6	8.2	11.9	15.7	11.7	7.0	25.8	18.8	7.2	51.8	21.2	56.1	20.2	10.5	12.7	18.1	11.2	10.8
PIGL		ENSG00000108474	"Phosphatidylinositol glycan anchor biosynthesis class L"	Q9Y2B2	17	16217191-16351797	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"GPI-anchor biosynthesis"	Hydrolase	"Deafness, Disease mutation, Ichthyosis, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"							HPA012739	Approved		Approved	Nucleoplasm,Cytosol	"Intracellular and membrane"	No	No			"Nucleoplasm, Cytosol"		"HPA012739: AB_1855367"	"unprognostic (3.07e-2)"	"unprognostic (2.65e-1)"	"unprognostic (2.15e-1)"	"unprognostic (1.30e-2)"	"unprognostic (7.70e-2)"	"unprognostic (6.14e-2)"	"unprognostic (9.39e-5)"	"unprognostic (1.11e-2)"	"unprognostic (1.15e-2)"	"unprognostic (1.63e-2)"	"unprognostic (6.37e-3)"	"prognostic unfavorable (2.57e-4)"	"prognostic unfavorable (1.47e-4)"	"unprognostic (3.19e-2)"	"unprognostic (2.13e-1)"	"unprognostic (3.38e-1)"	"unprognostic (2.75e-3)"	17.3	12.6	11.1	14.3	18.8	8.6	18.0	14.6	15.6	12.9	13.0	17.6	12.8	17.1	19.8	20.2	12.6	13.1	12.7	8.8	8.5	7.5	11.2	18.5	12.5	12.0	14.5	10.7	16.5	16.5	11.9	18.1	10.3	13.6	14.0	14.4	15.5	14.8	16.3	13.4	20.0	15.8	10.1	9.7	12.3	14.8	11.1	13.6	13.7	15.7	11.1	20.4	10.9	12.3	5.2	7.4	5.5	3.7	5.4	9.3	3.3	7.9	11.4	7.7	6.3	11.0	10.4	3.2	4.4	5.3	7.5	13.3	11.6	10.2	3.9	9.1	4.3	4.5	11.6	9.5	5.6	10.7	8.3	24.8	7.7	7.9	13.8	11.8	3.3	5.0	8.8	14.7	13.0	14.8	7.6	8.5	13.1	9.1	5.0	5.9	7.9	6.0	7.7	3.0	15.9	5.9	5.9	6.5	11.2	8.4	4.3	4.1	5.8	4.6	3.3	9.0	20.8	3.5	3.0	5.5	6.8	4.2	4.4	12.5	3.5	0.1	6.3	8.4	8.2	4.2	0.0	3.7	5.5	6.5	3.2	5.6	5.2	8.5	5.0	2.7	4.4	9.3	7.5	0.0	5.4	2.4	7.4	6.7	3.3	11.1	18.8	14.6	15.6	8.5	7.5	14.5	10.7	13.6	13.6	8.9	16.0	3.7	8.0	3.9	11.3	1.7	7.6	10.7	12.5	12.2	9.8	13.3	5.0	5.6	2.1	5.8	6.8	0.0	6.4	6.1	6.0	6.8	4.7	9.4	4.5	6.4	7.5	3.1	2.7	1.9	7.2	5.1	3.3	1.8	10.0	6.7	7.4	7.0	10.6	4.4	12.3	0.0	6.6	13.7	8.3	5.3	8.0	8.7	10.8	8.8
PIGP	"DCRC, DSCR5, DSRC"	ENSG00000185808	"Phosphatidylinositol glycan anchor biosynthesis class P"	P57054	21	37059170-37073170	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"GPI-anchor biosynthesis"	"Glycosyltransferase, Transferase"	"Disease mutation, Epilepsy"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Spermatocytes: 193.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA026921	Uncertain		Approved	Vesicles		Yes	No			Vesicles		"HPA026921: AB_1847874"	"unprognostic (4.47e-3)"	"unprognostic (9.45e-2)"	"unprognostic (3.03e-1)"	"unprognostic (2.40e-1)"	"unprognostic (2.85e-2)"	"unprognostic (1.92e-2)"	"unprognostic (1.92e-2)"	"unprognostic (5.54e-2)"	"unprognostic (1.55e-1)"	"unprognostic (1.22e-2)"	"unprognostic (4.21e-3)"	"unprognostic (1.12e-2)"	"unprognostic (1.96e-2)"	"unprognostic (1.93e-1)"	"unprognostic (5.48e-2)"	"unprognostic (1.02e-1)"	"unprognostic (6.55e-2)"	20.0	30.3	12.3	7.9	13.4	4.2	18.0	6.9	14.3	13.1	13.8	15.6	23.1	9.9	11.7	60.6	12.5	13.9	15.2	27.8	12.3	15.2	19.0	27.4	14.7	9.9	16.1	9.8	15.0	45.4	23.9	28.9	16.2	17.9	21.3	14.3	16.6	22.2	17.4	25.0	7.0	12.8	24.0	24.8	10.1	14.8	19.3	8.4	16.3	20.3	17.3	9.9	17.2	9.2	18.2	16.7	1.7	11.1	8.7	19.3	8.7	9.1	4.4	9.2	5.6	16.7	10.9	6.1	7.4	13.7	6.7	7.6	5.8	19.4	12.6	16.6	11.2	30.3	7.4	7.6	8.4	7.1	13.1	13.2	28.6	5.5	8.0	10.1	8.4	6.3	9.9	16.0	12.1	15.2	15.7	11.5	28.6	17.0	22.6	14.8	6.1	11.2	9.3	7.0	26.2	10.7	11.0	4.7	13.3	16.9	5.1	19.0	11.4	20.9	15.8	28.1	12.8	13.5	18.5	6.0	5.0	2.4	5.8	6.7	30.1	32.7	14.4	14.4	10.8	16.3	0.2	7.1	1.7	11.3	10.4	14.0	18.2	14.5	12.1	11.1	15.3	19.3	16.7	1.0	8.7	11.1	16.7	10.7	8.7	12.3	13.4	6.9	14.3	12.3	15.2	16.1	9.8	17.9	8.4	26.8	36.1	32.3	46.9	29.3	19.4	74.2	43.3	56.2	26.1	41.8	9.8	49.2	76.3	48.2	68.0	32.1	27.7	0.0	62.5	46.0	37.9	46.4	16.1	77.3	60.5	15.9	43.1	32.5	40.6	54.3	63.9	44.6	35.4	37.9	52.5	26.5	65.1	55.4	32.9	92.2	26.6	64.7	43.9	193.5	109.2	23.1	43.7	28.8	53.6	46.5
PIGQ	"GPI1, hGPI1"	ENSG00000007541	"Phosphatidylinositol glycan anchor biosynthesis class Q"	Q9BRB3	16	566995-584136	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"GPI-anchor biosynthesis"	"Glycosyltransferase, Transferase"	"Disease mutation, Epilepsy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039105, HPA039828, HPA061414"	Approved		Approved	"Nucleoplasm,Golgi apparatus,Vesicles"		NA	NA			"Golgi apparatus, Vesicles"	Nucleoplasm	"HPA039105: AB_10796221, HPA039828: AB_10795158, HPA061414: AB_2684508"	"unprognostic (1.23e-2)"	"unprognostic (6.12e-3)"	"unprognostic (2.81e-1)"	"unprognostic (2.65e-2)"	"unprognostic (1.09e-2)"	"unprognostic (2.42e-1)"	"unprognostic (9.58e-2)"	"unprognostic (8.05e-2)"	"unprognostic (2.12e-1)"	"unprognostic (2.02e-1)"	"unprognostic (3.02e-2)"	"unprognostic (8.98e-2)"	"prognostic favorable (2.53e-6)"	"unprognostic (2.73e-1)"	"unprognostic (2.60e-1)"	"unprognostic (2.55e-1)"	"unprognostic (2.80e-2)"	13.9	15.7	12.8	8.7	13.9	48.4	8.4	12.8	20.6	8.4	9.7	11.4	16.7	15.4	10.9	23.3	7.2	10.0	13.6	7.4	10.5	11.1	18.9	12.5	13.0	6.2	9.1	13.2	10.4	29.3	18.1	15.3	8.4	9.4	11.2	4.1	15.4	15.5	17.6	12.4	12.8	8.1	5.5	7.2	10.3	13.6	15.3	8.2	11.8	18.4	4.2	7.9	9.8	6.7	5.6	10.5	5.9	6.0	5.5	5.3	3.9	8.6	13.0	4.6	6.5	3.0	1.8	8.7	9.0	3.5	3.9	4.3	9.1	8.0	4.5	11.8	2.0	3.5	13.8	2.1	4.0	0.8	13.1	19.0	6.9	14.1	6.4	5.8	6.0	6.5	3.3	6.0	6.5	1.3	2.6	3.6	8.5	15.5	2.6	1.3	11.2	11.1	6.9	6.3	1.8	13.4	21.6	3.9	10.5	3.5	3.5	8.4	13.2	10.3	4.7	6.6	1.5	10.7	4.2	8.7	6.6	8.4	7.5	6.3	10.0	2.9	3.6	2.2	3.3	6.5	1.2	4.8	3.0	5.3	5.6	4.6	4.4	4.6	5.1	4.9	5.6	5.1	3.1	5.9	5.5	6.0	10.5	4.2	3.9	12.8	13.9	12.8	20.6	10.5	11.1	9.1	13.2	9.4	8.2	14.9	20.7	3.0	6.7	4.2	12.5	7.3	0.0	17.4	9.1	38.4	3.9	8.9	3.3	16.0	23.2	7.0	20.0	46.7	15.1	7.4	9.1	8.5	8.1	14.3	8.2	9.5	19.4	5.5	7.3	44.6	6.9	7.4	15.1	5.4	11.8	17.5	12.5	9.9	6.7	11.5	12.9	0.0	9.5	27.2	12.6	4.3	4.9	6.9	11.0	3.5
PIK3C2A	PI3K-C2alpha	ENSG00000011405	"Phosphatidylinositol-4-phosphate 3-kinase catalytic subunit type 2 alpha"	O00443	11	17077730-17207983	"Enzymes, Predicted intracellular proteins"	"Endocytosis, Exocytosis"	"Kinase, Transferase"	"Cataract, Disease mutation, Dwarfism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037641, HPA037642"	Uncertain		Supported	Nucleoplasm,Vesicles,Cytosol		NA	NA			Nucleoplasm	"Vesicles, Cytosol"	"HPA037641: AB_10671878, HPA037642: AB_10697081"	"unprognostic (2.35e-1)"	"unprognostic (2.16e-2)"	"unprognostic (3.71e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.63e-1)"	"unprognostic (6.63e-2)"	"unprognostic (2.47e-2)"	"unprognostic (1.39e-1)"	"unprognostic (2.29e-2)"	"unprognostic (1.86e-2)"	"unprognostic (4.74e-2)"	"unprognostic (1.84e-1)"	"prognostic favorable (1.66e-4)"	"unprognostic (3.20e-2)"	"unprognostic (1.51e-1)"	"unprognostic (1.18e-1)"	"unprognostic (1.37e-1)"	22.3	16.8	17.6	17.2	26.3	9.2	20.0	22.6	17.2	22.1	17.2	13.9	22.2	15.6	20.3	19.2	16.8	18.2	20.2	16.3	14.5	11.6	25.7	16.3	22.2	11.3	17.6	16.1	17.6	14.2	62.9	23.0	23.5	28.5	18.7	14.3	15.2	15.6	27.5	15.4	13.1	17.9	19.5	31.8	17.5	18.3	19.4	18.0	11.4	32.2	9.3	11.5	23.1	20.5	4.4	5.2	6.0	7.2	4.2	4.8	1.6	23.1	10.6	17.8	11.1	12.9	13.2	16.0	14.7	15.9	10.8	15.1	25.8	2.6	6.8	7.3	12.6	17.7	15.4	14.2	11.2	19.2	5.8	12.3	4.2	12.9	10.1	14.1	5.2	6.7	10.2	7.9	10.6	20.9	10.1	25.6	4.3	9.9	6.6	8.3	7.1	2.8	3.3	10.1	13.0	8.2	2.9	18.5	4.7	13.4	20.6	10.5	9.3	22.3	9.6	10.3	15.6	5.7	5.3	31.9	8.7	12.6	22.5	8.9	2.7	5.9	5.6	10.4	4.9	10.0	4.1	4.1	2.9	4.6	2.5	3.0	3.6	3.7	3.6	5.2	4.4	4.8	2.8	6.0	4.2	7.2	3.7	2.3	1.6	17.6	26.3	22.6	17.2	14.5	11.6	17.6	16.1	28.5	18.0	71.5	56.0	17.6	19.9	31.4	47.8	22.4	22.9	29.4	39.8	34.9	66.8	25.6	16.6	15.8	21.3	80.2	17.1	0.0	21.6	14.0	19.7	34.1	30.2	28.6	16.4	33.4	27.5	108.1	38.5	12.0	23.9	23.8	18.6	11.8	20.1	82.7	22.6	11.5	29.4	17.0	41.1	38.8	29.8	36.4	15.5	29.6	120.0	19.2	17.2	27.3
PIK3C2B	"C2-PI3K, PI3K-C2beta"	ENSG00000133056	"Phosphatidylinositol-4-phosphate 3-kinase catalytic subunit type 2 beta"	O00750	1	204422628-204494724	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"granulocytes: 32.3;Ito cells: 27.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"naive B-cell: 7.4"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"BEWO: 32.3;RT4: 33.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030515, HPA050360"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA030515: AB_10670043, HPA050360: AB_2681104"	"unprognostic (5.77e-2)"	"unprognostic (1.36e-1)"	"unprognostic (1.36e-1)"	"unprognostic (2.18e-2)"	"unprognostic (3.45e-1)"	"unprognostic (2.19e-3)"	"prognostic unfavorable (5.42e-4)"	"unprognostic (3.35e-3)"	"unprognostic (3.57e-3)"	"unprognostic (2.72e-2)"	"unprognostic (8.54e-2)"	"unprognostic (1.10e-1)"	"unprognostic (2.54e-1)"	"unprognostic (5.36e-2)"	"unprognostic (1.26e-1)"	"unprognostic (1.75e-1)"	"prognostic favorable (1.16e-4)"	12.9	4.5	11.0	16.0	19.3	5.3	11.0	9.1	17.5	7.4	17.0	36.0	9.6	15.5	10.5	5.8	14.6	7.7	14.7	10.7	14.4	9.1	7.6	5.8	18.0	23.9	24.2	11.2	3.9	6.1	4.7	4.3	20.4	14.5	7.3	14.5	6.3	8.0	14.1	20.0	22.6	15.7	11.2	16.2	14.2	20.7	2.4	23.0	31.8	9.8	8.1	23.1	13.1	11.8	7.4	0.3	0.5	0.2	1.6	2.0	0.4	3.2	6.6	5.9	5.4	3.5	0.3	32.3	0.4	1.3	1.3	0.9	3.9	8.7	5.6	1.2	0.7	1.1	8.2	3.5	2.3	0.5	3.4	0.9	0.1	13.1	1.4	0.2	1.9	4.3	0.4	2.5	0.3	0.2	0.5	8.6	5.7	2.0	3.8	0.1	7.3	6.7	5.6	5.4	12.9	4.2	7.3	1.5	1.0	1.6	33.8	6.5	3.6	11.7	16.4	3.8	2.2	7.3	1.0	0.3	0.2	2.1	0.6	0.1	4.1	1.1	7.3	0.2	3.0	0.8	0.1	0.2	0.0	1.2	0.0	1.0	2.9	1.3	0.8	0.3	7.4	0.7	0.6	0.5	1.6	0.0	0.1	2.0	0.4	11.0	19.3	9.1	17.5	14.4	9.1	24.2	11.2	14.5	23.0	0.0	12.6	11.1	1.9	3.4	16.6	6.4	0.0	2.7	4.5	3.5	0.0	3.8	0.0	1.1	0.6	20.0	14.8	0.0	3.0	3.4	4.1	2.2	32.3	3.9	3.3	14.3	9.2	27.0	2.2	0.0	1.1	2.3	3.3	2.8	23.7	2.5	3.3	10.5	7.1	1.9	1.0	0.0	3.1	0.0	1.5	6.9	1.8	2.5	13.2	6.3
PIK3C2G		ENSG00000139144	"Phosphatidylinositol-4-phosphate 3-kinase catalytic subunit type 2 gamma"	O75747	12	18247614-18648416	"Enzymes, Plasma proteins, Predicted intracellular proteins"	Chemotaxis	"Kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"ductus deferens: 54.2;epididymis: 30.7;seminal vesicle: 46.0"	"Cell type enhanced"	"Detected in many"	12	"Basal keratinocytes: 15.5;Cholangiocytes: 33.1;Collecting duct cells: 38.4;Hepatocytes: 21.5;Suprabasal keratinocytes: 18.7"	"Cancer enhanced"	"Detected in some"		"stomach cancer: 2.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"BEWO: 2.9;HaCaT: 4.7;hTERT-HME1: 8.7"	"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"									NA	NA						"unprognostic (1.29e-1)"	"unprognostic (1.61e-1)"		"unprognostic (6.21e-2)"	"unprognostic (1.47e-2)"	"unprognostic (9.46e-2)"	"unprognostic (8.27e-2)"	"unprognostic (2.85e-1)"	"unprognostic (6.52e-2)"	"unprognostic (1.81e-3)"	"prognostic unfavorable (3.50e-4)"	"unprognostic (6.05e-2)"	"unprognostic (1.81e-1)"	"unprognostic (2.74e-1)"	"unprognostic (1.98e-1)"		"unprognostic (2.37e-2)"	0.3	0.6	0.2	0.1	0.2	0.0	6.7	0.2	0.3	0.6	0.3	0.1	54.2	0.0	0.3	30.7	4.2	0.6	6.0	0.2	0.3	0.2	9.6	8.8	0.3	0.1	0.3	0.1	0.3	1.2	8.1	0.4	1.2	0.1	2.4	0.0	0.1	13.1	46.0	0.2	7.0	2.2	0.2	0.3	0.2	15.1	2.1	0.1	0.1	0.5	1.6	0.5	0.9	0.9	0.1	0.1	0.4	0.0	0.3	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.9	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	1.3	4.7	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	1.1	0.1	8.7	0.0	0.0	0.0	0.0	0.4	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.2	0.0	0.1	0.3	0.0	0.2	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.4	0.3	0.0	0.4	0.0	0.1	0.1	0.0	0.1	0.1	0.2	0.0	0.3	0.0	0.1	0.0	0.0	0.2	0.2	0.2	0.3	0.3	0.2	0.3	0.1	0.1	0.1	0.0	0.0	0.0	6.7	15.5	0.0	0.3	33.1	0.0	1.2	38.4	0.0	1.0	1.7	1.3	3.5	0.1	0.7	0.0	0.0	4.1	0.2	0.5	0.0	21.5	0.2	0.0	0.0	0.0	1.0	1.8	0.0	0.0	1.7	0.0	0.1	0.0	0.6	0.3	0.0	1.1	0.0	0.0	0.0	2.4	2.1	18.7	0.7	0.0	0.2	0.7
PIK3C3	Vps34	ENSG00000078142	"Phosphatidylinositol 3-kinase catalytic subunit type 3"	Q8NEB9	18	41955206-42087830	"Enzymes, Predicted intracellular proteins"	"Autophagy, Cell cycle, Cell division"	"Kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA040718	Approved					NA	NA					"HPA040718: AB_10793862"	"unprognostic (1.26e-1)"	"unprognostic (1.24e-1)"	"unprognostic (1.40e-2)"	"unprognostic (3.55e-3)"	"unprognostic (6.15e-2)"	"unprognostic (3.61e-2)"	"unprognostic (6.00e-3)"	"unprognostic (1.91e-1)"	"unprognostic (2.11e-1)"	"unprognostic (1.71e-2)"	"unprognostic (3.86e-2)"	"unprognostic (6.41e-2)"	"prognostic favorable (4.97e-4)"	"unprognostic (1.09e-1)"	"unprognostic (1.35e-2)"	"unprognostic (1.76e-1)"	"unprognostic (6.85e-3)"	19.3	24.1	24.0	14.8	28.3	18.5	21.8	48.2	29.6	18.9	15.3	18.2	17.9	11.4	21.1	23.1	18.8	16.8	16.2	17.0	22.9	12.8	21.9	18.2	16.7	16.7	22.6	22.1	23.9	15.1	23.1	33.7	22.2	30.7	17.7	18.3	12.3	21.2	17.7	21.2	20.7	14.6	18.4	27.4	18.5	16.2	22.2	28.0	24.0	20.3	13.0	20.0	18.0	17.8	10.8	9.4	19.2	10.7	11.1	15.7	7.4	7.5	5.3	13.5	10.3	15.8	17.1	8.3	15.0	19.2	12.1	16.4	2.5	3.8	4.7	8.6	15.1	9.5	12.5	10.5	8.3	16.8	7.6	7.4	9.7	8.2	10.3	13.2	14.2	10.6	18.6	12.7	11.3	14.8	18.6	12.4	9.5	9.4	6.0	16.7	2.4	6.3	9.3	9.9	2.8	3.9	38.3	10.0	12.1	14.0	8.2	11.9	13.8	4.7	3.6	10.5	15.8	5.2	11.9	16.0	16.4	4.8	3.6	6.8	16.2	19.0	5.3	13.6	19.5	8.7	14.5	9.4	19.2	9.3	10.3	10.3	10.8	9.4	11.4	9.4	9.2	12.3	9.1	18.3	11.1	10.7	5.6	15.7	7.4	24.0	28.3	48.2	29.6	22.9	12.8	22.6	22.1	30.7	28.0	20.8	37.5	14.2	10.2	10.2	25.0	20.7	2.5	24.1	34.2	14.0	19.6	17.3	6.6	11.9	13.3	18.0	9.9	0.0	9.0	11.2	12.7	12.5	16.2	11.5	13.4	52.4	4.7	16.0	17.6	8.7	13.6	13.4	6.8	13.6	12.5	24.3	12.6	10.1	22.6	10.0	21.5	19.4	13.4	20.9	17.9	9.9	22.9	18.3	9.3	14.4
PIK3CA	PI3K	ENSG00000121879	"Phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha"	P42336	3	179148114-179240093	"Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins, RAS pathway related proteins"	"Angiogenesis, Phagocytosis"	"Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes, Disease mutation, FDA approved drug targets, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA009985, CAB017804"	Approved		Supported	Mitochondria,Cytosol		NA	NA			Cytosol	Mitochondria	"CAB017804: , HPA009985: AB_1079610"	"unprognostic (1.81e-1)"	"unprognostic (2.77e-1)"	"unprognostic (2.18e-1)"	"unprognostic (2.69e-3)"	"unprognostic (6.49e-3)"	"unprognostic (1.43e-1)"	"unprognostic (2.65e-2)"	"unprognostic (1.00e-2)"	"unprognostic (1.03e-1)"	"unprognostic (2.37e-1)"	"unprognostic (2.57e-3)"	"unprognostic (5.21e-2)"	"unprognostic (4.50e-2)"	"unprognostic (1.16e-2)"	"unprognostic (2.48e-1)"	"unprognostic (9.74e-2)"	"unprognostic (3.82e-2)"	20.1	12.3	13.7	11.5	13.4	25.7	22.4	17.1	24.5	12.9	14.0	5.2	5.7	6.5	15.3	7.9	11.6	11.1	13.2	14.2	18.4	9.7	11.7	10.8	13.2	13.8	9.8	15.7	15.4	9.2	24.7	11.6	16.5	16.3	10.7	8.9	7.2	10.9	10.9	15.2	12.0	10.5	12.8	14.4	16.2	10.6	9.3	9.8	29.6	11.0	7.3	13.9	15.1	15.7	6.2	2.6	7.8	3.8	2.4	5.0	1.1	14.6	5.0	8.0	7.4	19.0	22.2	5.9	9.4	12.7	9.3	14.7	4.3	10.9	13.4	16.1	11.2	13.2	6.0	6.6	8.1	13.5	22.4	5.8	18.4	5.5	3.8	9.1	10.3	10.5	14.0	8.6	10.2	11.7	10.4	13.3	9.7	9.1	15.0	13.3	5.8	7.9	9.3	6.4	7.3	6.8	12.0	8.1	16.1	7.3	9.0	4.5	7.7	10.2	9.1	12.2	7.3	15.2	8.9	14.0	8.7	5.7	13.7	9.3	7.3	10.3	24.1	7.9	7.8	5.1	2.1	3.8	1.6	5.0	2.9	3.9	5.8	4.2	2.8	2.2	6.2	4.6	3.8	7.8	2.4	3.0	2.6	4.1	1.1	13.7	13.4	17.1	24.5	18.4	9.7	9.8	15.7	16.3	9.8	29.8	23.2	13.7	15.2	13.1	26.3	15.4	7.6	18.7	17.0	7.0	29.5	8.1	1.7	9.8	1.7	21.4	4.9	0.0	11.9	5.0	18.3	27.3	30.1	17.4	9.5	36.5	2.4	29.4	21.2	1.6	30.2	16.4	13.5	16.2	9.6	15.6	13.1	12.7	37.1	11.2	26.2	25.8	22.1	9.6	7.6	13.0	7.3	14.0	9.2	27.6
PIK3CB	PIK3C1	ENSG00000051382	"Phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta"	P42338	3	138652699-138834938	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins"	"Autophagy, Cell adhesion, Endocytosis"	"Kinase, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HEL: 42.0;HMC-1: 66.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB031938, HPA042288, HPA064207"	Approved		Supported	Nucleoplasm,Nucleoli,Vesicles,Midbody		Yes	No			Nucleoplasm	"Nucleoli, Vesicles, Midbody"	"CAB031938: AB_2165408, HPA042288: , HPA064207: AB_2685212"	"unprognostic (4.89e-2)"	"unprognostic (1.42e-2)"	"unprognostic (5.97e-2)"	"unprognostic (7.85e-2)"	"unprognostic (4.89e-2)"	"unprognostic (6.01e-2)"	"prognostic unfavorable (6.42e-4)"	"unprognostic (3.98e-2)"	"unprognostic (1.35e-1)"	"unprognostic (2.28e-1)"	"prognostic unfavorable (3.99e-5)"	"unprognostic (2.15e-1)"	"unprognostic (6.18e-3)"	"unprognostic (9.33e-2)"	"unprognostic (7.82e-2)"	"unprognostic (2.79e-1)"	"unprognostic (4.59e-2)"	12.5	9.9	10.6	9.7	20.6	17.4	11.5	29.9	25.0	12.4	14.6	11.9	11.7	13.7	9.6	6.9	15.2	10.9	8.7	12.7	12.2	14.2	22.6	9.3	9.5	9.1	11.9	15.2	8.8	20.3	20.2	10.9	18.1	24.1	13.4	15.7	12.2	14.9	15.9	33.4	19.6	16.4	8.3	12.5	9.9	11.0	6.4	10.7	14.4	37.4	7.1	11.9	13.4	11.0	4.6	9.1	11.3	7.8	1.3	6.5	2.6	23.0	10.0	4.3	3.6	3.9	5.3	29.3	5.4	5.2	5.5	5.9	10.7	8.8	9.3	14.8	5.3	10.6	9.9	5.6	8.6	9.9	11.8	6.3	42.0	6.8	6.4	4.0	10.2	66.6	4.5	6.6	3.8	7.8	9.8	8.3	4.5	16.0	6.9	6.9	10.6	5.9	7.2	6.2	17.0	9.4	4.3	4.5	6.6	8.5	12.8	3.7	2.7	15.0	6.5	19.3	13.2	16.3	24.4	8.7	3.5	4.5	7.7	7.6	11.7	7.6	8.5	8.6	9.9	4.9	7.0	7.8	11.3	4.0	4.5	2.7	4.6	5.2	3.0	9.1	4.1	6.5	4.4	10.0	1.3	4.3	1.4	2.2	2.6	10.6	20.6	29.9	25.0	12.2	14.2	11.9	15.2	24.1	10.7	8.9	14.7	4.7	12.9	16.9	15.4	30.2	12.7	14.7	21.6	17.4	23.6	29.1	5.0	9.4	0.9	8.5	21.3	0.0	16.5	46.3	6.5	23.0	13.9	15.8	13.4	20.6	15.6	11.6	28.8	1.1	3.4	19.7	6.8	14.4	14.9	8.2	15.2	21.8	6.3	18.9	17.9	6.5	6.1	10.7	14.9	20.5	40.0	6.1	12.7	15.3
PIK3CD	p110D	ENSG00000171608	"Phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta"	O00329	1	9651732-9729114	"Disease related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins, RAS pathway related proteins"	"Adaptive immunity, Chemotaxis, Differentiation, Immunity, Inflammatory response, Innate immunity"	"Kinase, Transferase"	"Disease mutation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 35.0;bone marrow: 32.8;lymphoid tissue: 40.3"	"Cell type enhanced"	"Detected in many"	7	"Alveolar cells type 2: 20.7;granulocytes: 24.3;Kupffer cells: 28.8;T-cells: 30.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 51.7;NB-4: 22.4;REH: 23.3;THP-1: 22.5;U-937: 26.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB015420, HPA044953"	Enhanced		Approved	"Vesicles,Cytokinetic bridge"		Yes	No			Vesicles	"Cytokinetic bridge"	"CAB015420: AB_831654, HPA044953: AB_2679153"	"unprognostic (5.73e-3)"	"unprognostic (2.75e-3)"	"unprognostic (8.93e-2)"	"unprognostic (4.05e-2)"	"unprognostic (4.71e-2)"	"unprognostic (1.40e-2)"	"unprognostic (2.13e-1)"	"unprognostic (7.42e-2)"	"unprognostic (2.78e-2)"	"unprognostic (1.54e-2)"	"unprognostic (3.46e-2)"	"unprognostic (6.75e-2)"	"unprognostic (8.65e-3)"	"unprognostic (2.09e-1)"	"unprognostic (1.34e-1)"	"unprognostic (2.04e-1)"	"unprognostic (6.78e-2)"	4.5	2.1	3.4	34.8	7.1	32.8	2.9	3.3	4.3	3.2	3.3	5.5	0.7	3.1	3.7	3.4	3.5	4.0	6.5	2.9	4.2	3.1	4.6	3.3	8.2	40.3	7.4	1.8	5.3	2.2	2.3	2.2	3.3	4.6	3.2	2.1	3.1	11.2	1.8	0.9	2.0	11.4	2.9	5.3	35.5	3.3	3.0	5.7	23.5	4.1	2.3	36.0	5.8	3.6	8.4	14.5	35.0	15.0	14.5	13.7	16.6	2.7	1.8	0.1	0.5	0.4	0.4	0.2	4.2	8.6	9.2	7.6	0.1	1.1	7.3	1.7	3.3	4.4	0.8	0.7	3.8	5.8	51.7	0.1	0.8	0.4	3.0	1.8	18.8	6.6	1.5	1.6	10.3	3.5	4.0	1.3	5.2	2.6	0.0	5.2	0.2	1.8	22.4	0.8	0.1	0.5	23.3	4.6	0.2	3.9	0.0	0.6	0.5	0.9	1.7	4.1	2.5	0.3	22.5	3.4	2.7	2.8	0.0	3.9	1.7	1.6	10.2	5.9	26.9	1.5	9.6	11.8	21.1	12.9	13.1	13.7	7.8	9.8	11.8	12.5	8.4	12.9	13.4	35.0	14.5	15.0	14.5	7.4	16.6	3.4	7.1	3.3	4.3	4.2	3.1	7.4	1.8	4.6	5.7	8.9	20.7	7.8	1.8	1.3	0.4	2.7	0.0	1.4	1.2	0.0	2.0	0.1	1.7	3.1	2.0	1.6	0.0	0.0	1.8	0.3	1.4	2.5	24.3	0.0	12.5	0.0	0.0	3.7	28.8	1.7	1.1	13.4	3.3	1.0	0.0	2.5	7.7	0.0	1.4	2.9	1.6	6.5	3.8	1.1	2.1	1.0	0.2	30.5	0.1	2.0
PIK3CG		ENSG00000105851	"Phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma"	P48736	7	106865278-106907145	"Cancer-related genes, Enzymes, Predicted intracellular proteins"	"Angiogenesis, Chemotaxis, Endocytosis, Immunity, Inflammatory response"	"Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"blood: 24.5;bone marrow: 27.8;lymphoid tissue: 40.8"	"Cell type enhanced"	"Detected in some"	8	"B-cells: 17.3;Early spermatids: 26.6;granulocytes: 19.7;monocytes: 24.4;T-cells: 17.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"Daudi: 12.4;HL-60: 12.1;HMC-1: 15.5;Karpas-707: 12.9;MOLT-4: 23.5;U-266/70: 31.5;U-937: 22.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA069976	Enhanced		Supported	"Plasma membrane,Cytosol"		NA	NA			"Plasma membrane"	Cytosol	"HPA069976: AB_2686224"	"unprognostic (8.34e-2)"	"unprognostic (2.01e-2)"	"unprognostic (1.44e-2)"	"unprognostic (1.71e-2)"	"unprognostic (3.20e-2)"	"unprognostic (3.82e-3)"	"unprognostic (3.02e-1)"	"unprognostic (6.77e-2)"	"unprognostic (1.16e-1)"	"unprognostic (7.06e-3)"	"unprognostic (1.15e-1)"	"unprognostic (1.97e-1)"	"unprognostic (1.77e-2)"	"unprognostic (9.08e-2)"	"unprognostic (1.23e-1)"	"unprognostic (5.38e-1)"	"unprognostic (5.24e-2)"	5.0	1.8	2.2	16.0	3.1	27.8	2.3	0.8	1.7	1.7	4.1	2.7	0.0	2.8	1.7	2.0	2.0	1.8	3.5	1.7	1.7	1.5	1.9	1.5	4.3	13.1	3.0	1.0	1.7	1.5	0.6	1.4	2.0	2.5	2.2	2.6	1.9	3.1	0.5	1.1	1.3	6.1	1.9	6.4	17.4	2.5	7.6	3.0	40.8	2.3	0.9	21.2	4.1	1.5	6.2	5.6	14.2	24.5	5.3	5.6	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.4	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	7.6	0.0	0.0	0.0	12.1	15.5	0.0	0.0	0.0	0.0	0.0	4.8	7.4	8.6	12.9	0.0	0.0	23.5	4.6	0.0	0.0	0.0	6.2	0.0	8.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.3	1.2	0.0	0.1	0.0	0.0	31.5	0.0	11.7	0.0	22.2	2.9	4.6	3.4	14.2	5.6	10.6	5.1	4.7	2.6	4.2	5.6	6.2	2.8	3.8	13.9	5.3	24.5	4.9	2.6	3.6	2.2	3.1	0.8	1.7	1.7	1.5	3.0	1.0	2.5	3.0	0.0	2.6	17.3	0.0	0.7	0.0	0.3	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	26.6	0.9	0.0	0.0	0.0	0.0	0.1	0.0	19.7	0.5	5.9	0.0	0.0	1.8	11.0	12.8	0.6	13.3	6.8	24.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.2	3.1	0.3	0.1	17.5	0.0	0.0
PIK3R4	"p150, VPS15"	ENSG00000196455	"Phosphoinositide-3-kinase regulatory subunit 4"	Q99570	3	130678935-130746829	"Enzymes, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036032, HPA036033"	Approved		Approved	Vesicles,Microtubules		NA	NA			Vesicles	Microtubules	"HPA036032: AB_10610281, HPA036033: AB_2674911"	"unprognostic (7.50e-2)"	"unprognostic (3.90e-3)"	"unprognostic (1.68e-1)"	"unprognostic (4.05e-3)"	"unprognostic (2.88e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.34e-1)"	"unprognostic (1.21e-1)"	"unprognostic (1.11e-1)"	"unprognostic (2.67e-1)"	"unprognostic (1.02e-3)"	"unprognostic (7.26e-2)"	"prognostic favorable (4.40e-6)"	"unprognostic (8.25e-2)"	"unprognostic (3.72e-1)"	"unprognostic (2.27e-1)"	"unprognostic (1.05e-1)"	15.5	16.2	11.6	11.6	15.9	10.6	14.9	14.7	17.2	16.5	13.1	14.9	9.5	10.3	18.8	12.0	12.9	15.6	12.0	12.2	9.7	10.0	14.9	28.2	13.7	12.4	12.0	11.4	17.8	12.0	40.7	20.6	14.4	17.3	14.1	11.6	14.1	14.0	15.4	14.8	16.0	13.4	14.6	12.1	18.5	13.3	14.9	11.8	29.7	18.1	10.2	13.6	16.5	13.9	8.4	9.6	12.0	8.5	11.5	13.7	7.0	14.3	9.1	13.4	9.7	19.9	15.9	9.3	10.7	12.9	14.8	17.2	11.8	12.2	16.9	13.5	10.8	11.8	20.6	22.0	16.6	23.3	10.2	8.2	13.8	10.5	8.2	9.1	20.9	6.9	10.9	12.0	15.8	10.0	9.3	13.7	9.9	16.0	8.6	13.0	12.6	17.1	6.4	16.9	13.0	9.0	12.0	15.6	15.2	9.7	11.8	12.4	9.1	15.4	9.7	10.8	16.5	13.4	9.2	10.8	11.4	9.9	12.8	8.5	10.1	9.1	22.3	12.5	8.0	10.5	12.0	7.2	9.2	9.4	8.4	13.7	8.4	8.6	6.9	9.6	5.7	10.1	9.0	6.0	11.5	8.5	3.4	9.3	7.0	11.6	15.9	14.7	17.2	9.7	10.0	12.0	11.4	17.3	11.8	6.0	5.4	0.0	3.4	3.4	8.2	7.5	15.3	14.7	11.4	10.4	13.7	4.6	1.7	4.1	3.4	6.7	5.3	0.0	5.1	3.1	3.5	3.7	9.2	15.6	5.1	4.8	2.9	8.0	6.7	2.7	8.9	3.8	5.0	5.4	6.2	8.0	5.3	5.8	11.0	4.9	12.0	6.5	3.2	10.8	12.7	3.9	3.5	4.6	5.8	2.5
PIKFYVE	"FAB1, KIAA0981, MGC40423, p235, PIKfyve, PIP5K, PIP5K3, ZFYVE29"	ENSG00000115020	"Phosphoinositide kinase, FYVE-type zinc finger containing"	Q9Y2I7	2	208266267-208358751	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		"Kinase, Transferase"	"Corneal dystrophy, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042558, HPA042604"	Uncertain		Supported	Vesicles		NA	NA			Vesicles		"HPA042558: , HPA042604: AB_10796580"	"unprognostic (1.00e-1)"	"unprognostic (1.67e-1)"	"unprognostic (1.88e-1)"	"unprognostic (3.03e-1)"	"unprognostic (2.04e-2)"	"prognostic favorable (6.81e-4)"	"unprognostic (6.82e-3)"	"unprognostic (6.45e-2)"	"unprognostic (1.85e-2)"	"unprognostic (3.81e-2)"	"unprognostic (1.77e-1)"	"unprognostic (2.10e-2)"	"unprognostic (1.32e-1)"	"unprognostic (2.14e-1)"	"unprognostic (3.29e-1)"	"unprognostic (1.06e-1)"	"unprognostic (7.05e-2)"	15.9	13.5	17.7	21.1	21.9	36.1	24.9	25.6	23.1	14.8	12.1	14.0	16.6	9.1	14.7	18.3	11.2	12.6	11.1	12.5	19.4	14.3	16.2	15.2	16.5	23.1	14.4	15.3	15.6	31.5	21.5	17.0	14.1	20.6	17.7	11.5	13.8	13.7	19.7	13.6	12.9	15.3	13.5	24.4	21.7	12.1	19.3	15.8	23.5	18.2	7.8	22.6	12.4	14.0	7.5	2.1	1.4	1.2	5.6	2.6	0.5	4.9	5.0	12.0	9.3	12.1	14.5	5.6	6.2	12.6	7.3	10.0	7.2	4.2	5.8	6.5	10.5	14.3	5.2	10.4	6.9	12.4	4.9	6.6	20.7	9.8	6.4	9.2	18.3	18.7	10.7	7.6	8.5	15.9	12.2	11.8	15.5	14.0	10.5	9.1	2.1	16.5	13.8	9.9	3.8	3.8	6.2	9.3	7.9	9.3	7.3	3.8	9.1	6.8	4.4	12.3	14.7	2.8	19.8	13.5	9.2	6.1	6.1	5.7	7.3	8.7	12.4	7.3	16.0	9.0	1.4	1.0	0.7	1.7	0.8	1.1	7.5	2.3	2.6	0.9	5.4	1.8	2.1	1.4	5.6	1.2	2.1	1.5	0.5	17.7	21.9	25.6	23.1	19.4	14.3	14.4	15.3	20.6	15.8	23.8	14.4	13.7	6.0	13.6	20.7	14.4	12.7	8.1	10.3	10.4	15.7	6.1	5.0	4.6	5.2	14.8	9.3	0.0	3.7	4.4	12.2	15.4	34.7	16.6	12.2	9.5	17.9	18.4	27.6	5.9	17.3	20.4	10.1	2.8	8.9	14.8	7.1	6.2	12.7	8.1	19.0	12.9	12.2	27.2	22.8	13.4	6.1	10.2	7.8	7.0
PIM1	PIM	ENSG00000137193	"Pim-1 proto-oncogene, serine/threonine kinase"	P11309	6	37170203-37175426	"Cancer-related genes, Enzymes, Predicted intracellular proteins"	"Apoptosis, Cell cycle"	"Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	9	"Suprabasal keratinocytes: 199.7;Urothelial cells: 399.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"basophil: 64.6"	"Group enriched"	"Detected in all"	5	"granulocytes: 64.6;T-cells: 19.0"	"Cell line enhanced"	"Detected in many"		"HEL: 35.7;HMC-1: 66.4;K-562: 30.6;U-698: 119.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003941, CAB017040"	Uncertain		Supported	Nucleoli,Cytosol		NA	NA			Cytosol	Nucleoli	"CAB017040: , HPA003941: AB_1079618"	"unprognostic (1.25e-2)"	"unprognostic (4.77e-1)"	"unprognostic (3.61e-2)"	"prognostic unfavorable (9.73e-4)"	"unprognostic (1.91e-2)"	"unprognostic (1.06e-1)"	"unprognostic (3.75e-1)"	"unprognostic (4.64e-2)"	"unprognostic (2.36e-1)"	"unprognostic (1.10e-1)"	"unprognostic (2.65e-2)"	"unprognostic (7.32e-2)"	"unprognostic (2.14e-3)"	"unprognostic (8.16e-3)"	"unprognostic (1.04e-1)"	"unprognostic (5.26e-3)"	"unprognostic (2.90e-1)"	39.3	5.4	7.4	18.5	8.9	80.9	20.1	8.1	9.9	23.0	17.9	4.7	4.2	17.9	15.4	9.8	56.3	21.6	24.7	20.8	8.2	3.7	7.5	24.5	14.5	35.7	7.4	2.2	20.0	9.6	2.0	5.6	28.7	12.7	15.6	8.8	6.9	12.8	4.5	26.5	31.3	26.1	31.6	10.7	21.4	12.1	6.8	7.6	15.0	7.2	20.1	28.8	32.6	31.2	1.7	1.4	64.6	1.7	8.4	19.0	8.5	3.0	1.3	2.0	1.1	4.7	2.5	24.0	1.1	3.4	2.3	3.6	4.6	4.3	6.2	1.7	1.3	5.1	3.6	2.1	3.3	2.1	28.1	1.4	35.7	1.3	5.9	4.8	0.6	66.4	8.5	4.1	2.1	1.4	2.5	0.6	1.5	30.6	10.0	0.3	0.8	1.9	3.2	3.8	5.7	2.0	4.8	3.7	7.3	0.6	18.8	10.0	2.0	2.4	0.3	0.6	4.9	0.5	1.0	1.2	1.3	4.0	6.0	1.3	4.7	2.5	119.4	0.5	9.0	1.3	64.6	1.7	24.4	14.7	1.6	19.0	1.7	13.1	12.9	1.4	1.3	11.9	9.0	14.1	8.4	0.9	0.4	9.4	8.5	7.4	8.9	8.1	9.9	8.2	3.7	7.4	2.2	12.7	7.6	20.8	23.1	27.2	134.9	113.6	4.2	17.3	12.7	4.0	22.7	8.7	0.0	27.3	5.0	30.7	3.8	14.3	33.2	46.7	15.5	92.9	73.9	69.5	46.4	27.1	44.8	14.3	35.6	9.2	40.0	10.4	7.5	45.8	42.2	101.0	11.9	4.3	37.7	17.5	2.8	13.0	0.9	0.0	57.5	3.3	34.5	199.7	67.5	126.4	6.6	399.5
PIM2		ENSG00000102096	"Pim-2 proto-oncogene, serine/threonine kinase"	Q9P1W9	X	48913182-48919024	"Cancer-related genes, Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Apoptosis, Cell cycle"	"Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 63.4;lymphoid tissue: 71.2"	"Group enriched"	"Detected in many"	4	"Alveolar cells type 2: 48.0;B-cells: 109.2;Melanocytes: 89.4;monocytes: 163.3;T-cells: 70.8"	"Cancer enriched"	"Detected in all"	6	"testis cancer: 171.3"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"HDLM-2: 60.3;Karpas-707: 74.7;RPMI-8226: 73.6;U-266/70: 136.0;U-266/84: 120.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA000285			Approved	Cytosol		NA	NA			Cytosol		"HPA000285: AB_1079619"	"unprognostic (2.34e-3)"	"prognostic favorable (4.05e-5)"	"unprognostic (8.04e-2)"	"unprognostic (7.30e-2)"	"unprognostic (6.41e-3)"	"unprognostic (2.74e-3)"	"unprognostic (2.84e-1)"	"unprognostic (5.23e-2)"	"unprognostic (2.47e-2)"	"unprognostic (4.01e-2)"	"unprognostic (1.33e-3)"	"unprognostic (2.73e-1)"	"prognostic unfavorable (1.17e-11)"	"unprognostic (3.36e-2)"	"unprognostic (1.96e-2)"	"unprognostic (1.27e-1)"	"unprognostic (4.38e-2)"	3.6	3.4	4.3	37.2	7.2	30.4	3.4	7.1	7.9	4.5	13.4	2.1	2.2	29.5	2.8	4.3	10.0	5.6	8.3	3.1	5.6	6.7	5.2	5.4	10.6	59.7	3.8	4.6	5.4	3.0	1.0	4.9	2.4	6.7	3.6	17.7	6.1	16.9	4.9	1.5	3.0	19.2	2.2	3.1	71.2	14.7	5.7	1.3	39.4	4.8	3.6	47.9	24.6	3.3	26.0	2.9	46.9	3.0	17.0	63.4	13.2	1.8	1.6	0.8	1.7	0.3	0.2	1.3	1.1	1.4	1.6	1.4	1.4	1.4	8.0	0.5	0.5	0.6	1.1	2.7	1.0	1.5	60.3	2.1	9.7	1.6	1.4	0.7	2.3	6.5	0.6	0.9	1.7	1.0	1.3	0.6	1.0	10.2	74.7	0.9	1.3	0.8	4.8	18.2	0.6	2.5	1.0	0.6	73.6	1.6	0.2	0.6	0.8	1.2	0.8	0.8	4.3	2.1	3.1	0.3	0.4	0.2	0.3	1.1	136.0	120.2	15.3	1.5	2.0	0.4	46.9	1.5	14.3	12.5	1.9	21.2	26.0	34.4	17.6	2.5	15.9	36.9	23.0	38.3	17.0	3.0	2.9	63.4	13.2	4.3	7.2	7.1	7.9	5.6	6.7	3.8	4.6	6.7	1.3	11.9	48.0	109.2	9.5	18.0	2.3	2.0	0.0	14.7	12.5	3.5	2.0	5.3	3.3	2.8	1.4	4.3	4.0	0.0	3.1	5.0	7.5	4.0	22.0	5.4	6.3	11.1	12.6	3.1	9.1	1.4	1.7	18.6	89.4	163.3	6.6	2.3	1.6	3.5	3.9	5.4	2.2	0.0	8.1	2.1	1.5	12.0	2.1	70.8	8.1	3.9
PIM3		ENSG00000198355	"Pim-3 proto-oncogene, serine/threonine kinase"	Q86V86	22	49960513-49964080	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins"	"Apoptosis, Cell cycle"	"Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Syncytiotrophoblasts: 326.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"neutrophil: 16.9"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"Karpas-707: 46.5;SK-BR-3: 41.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA068758			Supported	Cytosol		NA	Yes			Cytosol		"HPA068758: AB_2686026"	"unprognostic (3.67e-2)"	"unprognostic (7.69e-3)"	"unprognostic (1.07e-1)"	"unprognostic (1.11e-1)"	"unprognostic (3.67e-2)"	"unprognostic (5.83e-2)"	"unprognostic (1.48e-2)"	"unprognostic (1.13e-2)"	"unprognostic (2.71e-2)"	"prognostic unfavorable (9.68e-4)"	"unprognostic (2.00e-2)"	"unprognostic (1.00e-1)"	"prognostic favorable (8.09e-4)"	"unprognostic (5.59e-3)"	"unprognostic (1.71e-1)"	"unprognostic (3.92e-3)"	"unprognostic (7.27e-3)"	32.5	15.5	6.8	19.9	16.7	62.4	50.5	7.6	11.9	16.4	22.6	11.3	20.9	15.9	14.4	17.6	25.0	15.9	37.8	23.6	7.5	7.9	29.1	25.7	38.3	29.4	21.1	4.9	13.9	36.4	4.8	14.9	31.4	15.1	28.4	7.6	9.7	27.6	22.7	39.9	31.3	20.9	12.2	10.1	25.4	33.6	13.0	13.5	9.7	19.1	19.9	19.0	25.6	18.3	6.1	5.7	16.9	4.0	1.2	4.5	1.9	7.3	4.9	3.3	6.2	2.6	1.9	18.9	4.6	7.5	5.6	4.0	8.1	6.3	13.2	5.9	1.2	11.3	6.3	6.3	3.5	2.0	9.9	26.2	5.4	11.7	9.8	12.2	11.7	10.5	3.7	11.7	3.4	5.8	3.0	18.0	9.0	7.4	46.5	1.6	16.5	5.9	20.9	6.9	7.7	7.9	27.7	5.5	15.6	2.9	5.6	11.8	8.2	9.0	41.3	28.9	3.2	5.4	15.6	4.7	3.5	15.0	5.7	7.5	23.9	15.2	11.2	8.7	6.6	9.4	0.0	3.1	0.1	1.9	3.2	2.3	3.4	4.4	3.8	2.5	6.1	4.1	1.7	16.9	1.2	4.0	5.7	4.5	1.9	6.8	16.7	7.6	11.9	7.5	7.9	21.1	4.9	15.1	13.5	59.6	91.3	64.7	240.2	201.8	30.4	27.9	68.8	20.1	45.5	76.8	2.0	51.0	71.3	44.7	2.1	87.2	56.5	0.0	46.7	226.7	51.4	225.9	70.2	37.5	64.3	58.8	93.7	59.5	30.8	4.1	30.0	74.6	102.9	46.9	56.5	11.1	57.1	46.3	10.6	48.8	15.3	25.8	117.4	19.9	37.3	178.9	326.1	26.6	49.6	261.0
PIN1	dod	ENSG00000127445	"Peptidylprolyl cis/trans isomerase, NIMA-interacting 1"	Q13526	19	9835257-9849682	"Cancer-related genes, Enzymes, Predicted intracellular proteins"	"Cell cycle"	"Isomerase, Rotamase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 88.2"	"Cell type enhanced"	"Detected in all"	7	"Late spermatids: 571.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"CAB004528, CAB009326, HPA068650, HPA070887"	Enhanced		Enhanced	Nucleoplasm,Cytosol		NA	NA		30000	Nucleoplasm	Cytosol	"CAB004528: AB_628132, CAB009326: AB_2237080, HPA068650: AB_2686014, HPA070887: "	"unprognostic (2.54e-1)"	"unprognostic (6.14e-3)"	"unprognostic (6.50e-2)"	"unprognostic (4.36e-2)"	"unprognostic (1.71e-2)"	"unprognostic (6.50e-3)"	"unprognostic (1.90e-1)"	"unprognostic (2.86e-2)"	"unprognostic (2.67e-1)"	"unprognostic (7.23e-3)"	"prognostic favorable (3.25e-4)"	"unprognostic (9.43e-2)"	"prognostic favorable (7.80e-5)"	"unprognostic (2.20e-2)"	"unprognostic (2.56e-1)"	"unprognostic (3.13e-2)"	"unprognostic (1.21e-2)"	24.5	36.3	40.0	18.7	38.8	25.6	9.3	27.4	66.0	9.2	15.8	18.1	8.5	22.9	14.0	8.3	11.3	16.4	10.1	25.9	38.0	35.2	17.4	14.5	13.2	14.8	38.7	37.2	13.9	21.1	9.5	13.6	13.3	57.3	23.2	6.5	14.1	21.3	15.7	50.2	10.2	21.7	11.1	19.6	15.4	19.6	24.8	15.0	19.7	9.9	8.1	9.3	11.1	9.7	36.4	72.8	88.2	44.9	40.7	53.8	46.2	26.2	24.1	18.0	16.7	6.3	5.6	10.6	19.7	8.5	14.7	14.2	22.3	8.4	16.3	31.4	7.3	15.3	13.5	12.4	11.9	4.7	34.7	52.6	42.4	29.6	19.2	10.3	19.7	24.9	7.7	8.0	9.5	4.5	11.0	11.9	29.3	19.1	24.8	8.8	18.4	29.9	77.2	17.2	11.0	37.1	27.4	18.7	27.3	10.5	12.9	22.7	26.7	19.0	9.5	22.0	7.7	12.2	23.7	20.1	20.4	16.3	31.5	31.5	32.1	30.1	21.9	21.7	25.3	25.0	52.2	43.4	88.2	42.0	44.9	39.2	35.6	41.5	42.1	39.7	36.4	33.1	37.2	26.8	40.7	41.7	72.8	53.8	46.2	40.0	38.8	27.4	66.0	38.0	35.2	38.7	37.2	57.3	15.0	26.8	21.5	49.1	53.7	42.8	68.5	65.3	43.3	56.2	14.8	59.3	11.8	107.3	139.3	95.7	197.0	54.9	69.5	46.7	95.4	80.4	81.4	55.2	63.4	41.4	123.0	57.2	95.8	47.3	50.0	571.0	83.4	67.4	118.1	174.1	57.9	60.8	85.6	73.7	122.0	109.4	50.6	64.7	97.1	136.8	72.0	57.6	46.0	94.4	62.6	47.8
PIN4	"EPVH, PAR14, PAR17"	ENSG00000102309	"Peptidylprolyl cis/trans isomerase, NIMA-interacting 4"	Q9Y237	X	72181353-72302926	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"DNA-binding, Isomerase, Rotamase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 68.7"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA054483, HPA064504"	Approved		Supported	"Nucleoplasm,Nucleoli,Mitotic chromosome"		Yes	No			"Nucleoplasm, Nucleoli"	"Mitotic chromosome"	"HPA054483: AB_2682503, HPA064504: AB_2685274"	"unprognostic (2.47e-1)"	"unprognostic (6.97e-3)"	"unprognostic (1.65e-1)"	"unprognostic (3.77e-2)"	"unprognostic (8.42e-2)"	"unprognostic (1.30e-2)"	"unprognostic (1.14e-2)"	"prognostic favorable (6.37e-4)"	"unprognostic (1.56e-1)"	"unprognostic (2.13e-2)"	"unprognostic (2.49e-1)"	"unprognostic (9.54e-2)"	"unprognostic (2.09e-3)"	"unprognostic (1.92e-1)"	"prognostic favorable (2.58e-4)"	"unprognostic (3.34e-3)"	"prognostic favorable (2.66e-4)"	14.4	11.3	15.0	8.0	14.7	6.1	18.8	10.7	16.2	9.7	9.7	8.4	6.7	9.5	11.6	19.3	8.9	8.7	30.7	11.2	15.2	12.2	15.6	23.2	7.9	7.9	12.9	11.0	12.7	8.1	8.0	9.2	9.8	10.0	10.4	11.1	6.6	30.7	37.1	68.7	7.3	9.6	9.2	12.4	16.7	9.3	4.7	6.9	9.7	12.9	40.1	9.1	7.8	9.2	28.9	26.8	23.4	23.6	22.4	33.4	22.7	15.4	18.1	19.0	12.9	13.0	10.9	10.1	10.6	12.2	13.0	13.4	9.1	11.5	4.6	31.0	10.9	17.6	11.0	16.8	18.6	16.1	11.7	37.8	7.9	21.6	23.9	7.2	12.5	6.7	7.3	10.3	14.2	4.9	14.7	13.2	14.2	13.3	20.6	9.7	18.7	10.9	21.1	13.5	17.6	16.4	10.9	15.1	13.7	16.5	10.8	12.2	21.7	12.4	5.8	10.9	14.6	9.0	11.5	13.2	5.9	9.1	16.2	7.7	7.1	7.6	7.7	17.0	12.6	6.4	21.9	23.3	23.4	26.8	23.6	26.4	28.9	28.3	25.5	22.8	26.4	29.3	29.4	9.7	22.4	21.8	26.8	33.4	22.7	15.0	14.7	10.7	16.2	15.2	12.2	12.9	11.0	10.0	6.9	62.5	35.0	52.8	54.1	38.4	26.9	74.7	81.5	84.3	51.2	113.4	7.9	137.4	154.2	102.6	10.6	70.5	117.6	23.3	102.2	92.0	70.9	50.1	55.5	238.7	95.4	27.0	88.9	80.4	73.2	6.2	69.0	61.7	57.3	68.5	76.9	55.6	124.5	101.7	76.4	218.0	33.7	84.1	78.3	14.4	39.1	40.9	100.9	62.3	82.1	54.0
PINK1	PARK6	ENSG00000158828	"PTEN induced putative kinase 1"	Q9BXM7	1	20633455-20651511	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	Autophagy	"Kinase, Serine/threonine-protein kinase, Transferase"	"Disease mutation, Neurodegeneration, Parkinson disease, Parkinsonism, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 142.0"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"neutrophil: 10.7"	"Group enriched"	"Detected in many"	4	"granulocytes: 10.7;monocytes: 4.4"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001931, CAB026191"	Enhanced					NA	NA					"CAB026191: , HPA001931: AB_1079620"	"unprognostic (3.73e-3)"	"unprognostic (2.29e-2)"	"unprognostic (3.22e-1)"	"unprognostic (4.33e-2)"	"unprognostic (4.91e-2)"	"unprognostic (2.93e-2)"	"unprognostic (1.56e-2)"	"unprognostic (3.36e-2)"	"unprognostic (3.51e-2)"	"unprognostic (4.06e-3)"	"unprognostic (3.34e-2)"	"unprognostic (2.54e-1)"	"prognostic favorable (1.11e-16)"	"unprognostic (2.68e-1)"	"unprognostic (1.62e-1)"	"unprognostic (6.57e-2)"	"unprognostic (1.08e-1)"	17.9	35.9	38.9	6.7	38.0	6.0	10.1	16.8	45.0	9.8	13.0	17.8	10.0	15.2	9.3	9.8	20.7	10.7	11.4	51.4	31.0	28.7	20.2	26.1	10.0	5.1	39.5	27.1	11.6	24.3	16.3	7.1	13.9	31.0	12.4	7.7	10.6	23.9	15.4	142.0	10.8	12.7	10.8	30.2	8.3	10.5	27.2	16.8	3.3	16.0	21.5	4.6	12.7	9.5	1.2	1.4	10.7	4.4	0.7	1.7	0.8	17.7	8.1	3.8	11.0	13.3	12.6	4.0	25.1	25.2	12.2	21.3	2.8	14.5	4.2	19.9	25.5	28.4	8.2	5.5	13.3	6.1	5.0	21.0	2.1	22.7	4.3	10.3	2.2	6.7	11.8	14.4	15.2	5.3	13.7	7.9	3.9	5.1	5.4	8.7	7.5	3.2	5.0	1.7	4.6	26.8	2.8	6.7	3.3	7.6	4.2	14.2	5.5	27.3	9.0	7.6	4.8	3.0	7.8	11.9	11.0	5.7	18.4	3.5	6.3	1.2	1.9	23.9	6.4	5.1	4.8	2.2	4.7	1.1	1.4	1.4	0.3	1.0	1.5	0.7	1.2	0.8	1.1	10.7	0.7	4.4	1.4	1.7	0.8	38.9	38.0	16.8	45.0	31.0	28.7	39.5	27.1	31.0	16.8	20.8	16.3	7.5	31.9	14.0	40.7	0.8	28.1	1.4	6.8	41.8	35.3	21.6	68.0	22.2	58.2	29.5	63.2	23.3	24.0	29.3	21.6	60.4	0.0	92.6	20.3	27.0	19.3	46.6	19.9	102.1	32.8	20.6	20.3	4.6	26.4	52.6	41.8	45.6	53.4	91.3	57.1	84.1	37.3	110.5	24.5	21.0	28.6	13.1	18.0	30.8
PIP4K2A	"PIP5K2A, PIP5KIIA, PIP5KIIalpha"	ENSG00000150867	"Phosphatidylinositol-5-phosphate 4-kinase type 2 alpha"	P48426	10	22534849-22714555	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 92.0"	"Cell type enhanced"	"Detected in all"	7	"Erythroid cells: 93.5;Melanocytes: 99.5;T-cells: 152.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA065440, HPA068771"	Supported		Approved	"Golgi apparatus,Plasma membrane,Cytosol"		NA	NA		8800000	"Golgi apparatus"	"Plasma membrane, Cytosol"	"HPA065440: AB_2685490, HPA068771: AB_2686030"	"unprognostic (1.11e-1)"	"unprognostic (2.71e-3)"	"unprognostic (1.57e-3)"	"unprognostic (4.20e-3)"	"unprognostic (1.55e-1)"	"unprognostic (8.80e-3)"	"unprognostic (1.56e-3)"	"unprognostic (7.32e-2)"	"unprognostic (1.68e-1)"	"unprognostic (7.08e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.21e-1)"	"prognostic unfavorable (1.46e-4)"	"unprognostic (1.52e-3)"	"unprognostic (2.51e-1)"	"unprognostic (1.38e-1)"	"unprognostic (7.92e-3)"	13.0	7.3	43.8	20.3	63.8	17.3	6.9	6.6	41.4	13.2	7.8	75.5	1.0	5.9	9.9	5.6	9.2	7.2	15.1	5.9	56.0	31.7	7.6	8.3	11.5	33.4	65.7	22.9	4.3	4.9	29.5	4.2	10.5	36.5	4.4	9.0	5.7	3.9	6.3	2.6	4.0	8.1	14.4	92.0	26.6	8.4	5.4	59.8	10.1	5.9	1.0	38.5	11.5	5.8	14.7	12.0	26.3	16.6	38.4	46.7	39.3	8.9	8.8	10.3	3.3	16.5	22.5	7.8	16.6	17.7	9.0	11.1	8.2	14.3	18.7	6.0	33.3	19.8	3.1	8.9	4.6	9.1	41.4	9.3	35.2	6.4	18.1	29.3	6.7	27.6	11.2	4.2	12.2	11.9	13.9	13.3	25.3	19.5	36.6	16.6	3.7	26.9	6.0	4.2	4.3	6.3	10.9	14.7	25.4	13.3	1.7	1.8	4.3	5.3	2.7	26.4	12.2	2.3	11.7	16.0	7.0	10.2	12.8	10.1	23.3	13.1	13.6	18.9	20.5	5.3	16.1	8.8	26.3	34.5	15.6	46.7	14.7	27.5	40.0	11.6	8.6	18.6	34.9	10.9	38.4	16.6	12.0	19.6	39.3	43.8	63.8	6.6	30.3	56.0	31.7	65.7	22.9	36.5	59.8	3.0	7.9	43.2	3.6	15.7	4.1	6.8	15.3	1.4	7.9	17.4	2.0	6.7	10.0	8.7	15.7	24.8	2.6	93.5	9.3	4.0	17.1	5.4	22.0	6.4	27.8	12.7	4.7	68.2	77.2	23.8	15.5	49.0	99.5	85.6	2.8	4.0	16.5	3.5	9.6	9.8	8.1	19.4	21.1	4.1	2.3	14.8	10.4	152.2	2.3	5.5
PIP4K2B	"PIP5K2B, PIP5KIIB, PIP5KIIbeta"	ENSG00000276293	"Phosphatidylinositol-5-phosphate 4-kinase type 2 beta"	P78356	17	38765689-38800126	"Cancer-related genes, Enzymes, Predicted intracellular proteins"		"Kinase, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 23.6"	"Cell type enhanced"	"Detected in many"	5	"Horizontal cells: 41.3"	"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA062220			Supported	Nucleoplasm		NA	NA			Nucleoplasm		"HPA062220: AB_2684715"	"unprognostic (7.77e-2)"	"unprognostic (8.37e-2)"	"unprognostic (3.74e-2)"	"unprognostic (1.13e-1)"	"unprognostic (2.67e-1)"	"unprognostic (1.91e-1)"	"prognostic unfavorable (4.54e-4)"	"unprognostic (2.64e-1)"	"unprognostic (2.33e-1)"	"unprognostic (1.50e-2)"	"unprognostic (6.10e-3)"	"unprognostic (3.79e-1)"	"unprognostic (4.82e-3)"	"unprognostic (3.38e-2)"	"unprognostic (3.22e-1)"	"prognostic favorable (1.36e-4)"	"unprognostic (2.48e-1)"	5.1	6.5	12.4	3.3	12.9	1.1	5.0	8.8	17.4	6.8	2.7	7.0	4.2	2.2	7.2	5.9	3.5	7.4	3.6	7.1	9.6		4.1	2.2	5.0	4.2	5.4	13.3	13.3	3.0	5.1	2.7	5.4	7.5	5.1	3.2	4.1	3.8	6.5	23.6	5.8	2.3	7.3	4.7	5.1	2.5	2.8	6.5	2.0	4.7	2.2	4.5	3.7	5.9	3.3	3.1	2.4	2.4	3.4	5.0	3.7	5.7	12.7	21.2	22.0	18.5	14.7	4.3	10.8	12.0	13.6	11.2	8.6	5.7	14.8	6.8	18.4	11.9	12.4	14.0	8.9	13.1	10.2	9.0	12.8	8.2	12.6	8.4	14.6	7.9	12.9	10.9	10.6	7.9	19.2	11.3	15.4	11.2	7.0	14.6	4.3	13.4	10.7	11.8	6.4	5.9	14.6	20.9	8.1	10.0	7.2	11.8	17.1	10.9	4.4	11.0	23.1	14.0	13.8	11.9	11.5	7.6	9.9	9.3	9.2	11.5	6.7	13.7	11.6	10.4	1.6	2.4	0.8	4.8	2.2	5.0	3.1	4.1	4.6	3.1	3.3	4.7	4.2	2.4	3.4	1.8	3.0	3.9	3.7											17.9	10.7	3.7	3.7	5.5	33.8	18.9	7.6	4.0	9.1	5.2	9.8	6.3	1.7	4.7	8.7	14.6	3.9	0.0	4.2	4.1	8.5	4.5	1.1	9.8	7.5	41.3	11.1	20.3	8.3	13.7	14.1	5.7	1.7	1.8	6.9	12.9	5.4	3.5	15.6	6.7	13.4	6.5	7.2	4.6	8.1	3.9	2.1	7.2	7.3	1.8
PIP4K2C	"FLJ22055, PIP5K2C"	ENSG00000166908	"Phosphatidylinositol-5-phosphate 4-kinase type 2 gamma"	Q8TBX8	12	57591174-57603418	"Enzymes, Predicted intracellular proteins"		"Kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	8	"Cardiomyocytes: 112.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"RH-30: 49.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA028658	Approved		Supported	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			Cytosol	"Nucleoplasm, Plasma membrane"	"HPA028658: AB_10601245"	"unprognostic (7.84e-3)"	"unprognostic (1.51e-1)"	"unprognostic (2.42e-1)"	"unprognostic (2.77e-2)"	"unprognostic (2.49e-2)"	"unprognostic (3.37e-2)"	"prognostic unfavorable (7.98e-4)"	"unprognostic (3.17e-2)"	"unprognostic (6.00e-2)"	"unprognostic (5.51e-2)"	"unprognostic (1.75e-1)"	"unprognostic (1.88e-1)"	"prognostic favorable (2.06e-6)"	"unprognostic (1.87e-1)"	"unprognostic (2.16e-1)"	"unprognostic (3.27e-1)"	"unprognostic (3.42e-1)"	9.3	13.3	13.9	9.2	25.9	16.7	15.0	18.9	45.5	12.5	17.5	14.6	15.8	11.6	14.2	62.0	20.0	20.0	12.1	10.8	15.4	10.9	26.9	14.4	14.4	9.2	14.3	21.2	12.3	14.9	29.6	13.7	11.1	18.8	16.7	19.4	17.4	18.6	14.6	9.4	18.4	13.3	11.9	12.7	10.7	27.6	25.6	12.1	5.9	17.9	8.5	13.1	14.6	14.1	6.8	5.4	29.7	8.4	9.4	16.1	6.5	19.1	13.5	5.5	6.6	0.0	0.0	17.8	8.0	15.0	14.5	13.5	17.2	27.7	4.1	17.6	9.3	17.9	17.5	9.0	15.7	11.7	6.2	10.1	7.5	6.5	12.1	12.8	6.9	13.5	5.0	26.7	5.5	10.3	17.8	7.3	4.6	9.6	12.6	7.5	18.9	6.2	6.0	10.5	11.7	11.8	0.1	49.9	6.2	15.2	32.8	9.3	11.5	17.2	11.5	10.9	19.4	31.6	6.4	1.6	7.3	10.1	10.7	8.4	9.7	11.3	9.3	14.4	5.9	12.1	29.7	5.2	15.3	16.1	6.2	10.7	5.9	9.9	12.0	5.4	6.8	9.6	11.5	10.2	9.4	8.4	2.3	12.1	6.5	13.9	25.9	18.9	45.5	15.4	10.9	14.3	21.2	18.8	12.1	8.9	7.5	3.0	5.7	11.0	13.1	112.2	15.3	13.4	9.1	33.2	17.7	9.3	18.3	16.2	23.8	3.5	18.0	0.0	17.1	13.6	4.9	9.9	3.5	11.6	7.9	7.9	21.4	9.8	2.9	35.3	6.4	4.1	11.8	8.2	16.1	6.5	28.1	13.6	4.9	10.1	8.3	19.4	6.4	11.9	7.1	11.2	14.5	8.7	8.6	7.1
PIP4P1	"C14orf9, MGC26684, TMEM55B"	ENSG00000165782	"Phosphatidylinositol-4,5-bisphosphate 4-phosphatase 1"	Q86T03	14	20457719-20461612	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	14	"Cytotrophoblasts: 66.6;Hofbauer cells: 47.2;Syncytiotrophoblasts: 139.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA048528	Approved					NA	NA					"HPA048528: AB_2680427"	"unprognostic (1.84e-1)"	"unprognostic (6.23e-2)"	"unprognostic (1.81e-1)"	"unprognostic (7.07e-2)"	"unprognostic (2.04e-1)"	"unprognostic (8.51e-2)"	"unprognostic (1.71e-2)"	"unprognostic (3.37e-3)"	"unprognostic (4.94e-2)"	"unprognostic (1.33e-1)"	"unprognostic (7.78e-3)"	"unprognostic (1.85e-1)"	"prognostic favorable (1.01e-4)"	"unprognostic (4.80e-2)"	"unprognostic (1.47e-1)"	"unprognostic (7.53e-2)"	"unprognostic (1.96e-1)"	15.9	16.8	19.7	15.1	24.7	42.2	15.6	23.8	41.0	14.4	19.2	22.9	12.6	17.9	15.6	29.3	16.5	16.4	18.0	15.9	20.2	23.5	18.7	17.7	17.3	16.8	18.9	22.2	15.3	21.1	28.4	20.0	22.6	28.5	16.1	16.5	20.3	16.1	17.2	22.2	22.1	22.1	16.7	17.0	22.0	18.0	13.3	18.5	14.2	17.7	12.8	20.8	17.5	14.0	13.3	10.6	6.9	3.3	4.6	6.6	2.4	10.3	16.3	11.0	12.8	17.3	10.7	20.3	9.8	19.4	13.5	16.5	9.6	16.9	9.3	8.5	12.4	39.5	10.9	13.4	10.9	12.0	12.3	9.9	6.7	7.8	14.1	23.6	12.3	13.8	13.9	14.9	15.6	16.0	12.4	12.5	14.5	5.6	19.1	11.2	11.8	16.7	10.9	7.3	16.4	22.5	12.4	10.6	6.1	12.7	23.4	15.9	11.8	10.1	16.7	12.6	9.9	8.4	11.7	8.6	12.4	15.8	18.6	8.8	21.5	27.5	13.3	8.6	9.5	13.5	1.3	3.3	6.9	4.7	2.4	4.0	13.3	5.6	5.1	4.1	11.3	6.4	6.6	4.2	4.6	2.0	10.6	4.2	2.4	19.7	24.7	23.8	41.0	20.2	23.5	18.9	22.2	28.5	18.5	8.9	8.1	0.0	0.0	0.0	0.0	0.0	0.0	9.4	5.7	21.0	0.0	66.6	16.6	31.2	0.0	0.0	0.0	0.0	35.5	31.3	0.0	0.0	3.5	0.0	47.2	0.0	0.0	0.0	0.0	0.0	0.0	6.3	0.0	22.6	0.0	0.0	27.8	0.0	0.0	15.1	0.0	0.0	0.0	0.0	0.0	0.0	139.8	0.0	0.0	0.0
PIP4P2	"DKFZp762O076, TMEM55A"	ENSG00000155099	"Phosphatidylinositol-4,5-bisphosphate 4-phosphatase 2"	Q8N4L2	8	90993796-91041064	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"		Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	9	"Cytotrophoblasts: 27.7;Distal tubular cells: 41.4;Extravillous trophoblasts: 27.3;Hofbauer cells: 39.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	6	"neutrophil: 36.2"	"Lineage enriched"	"Detected in all"	6	"granulocytes: 36.2"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA014591	Approved					NA	NA		57000			"HPA014591: AB_1858124"	"unprognostic (6.09e-2)"	"prognostic unfavorable (1.01e-4)"	"unprognostic (8.45e-2)"	"unprognostic (1.23e-3)"	"unprognostic (1.19e-1)"	"prognostic unfavorable (1.54e-4)"	"prognostic unfavorable (3.76e-5)"	"unprognostic (3.76e-2)"	"unprognostic (1.08e-1)"	"unprognostic (7.58e-2)"	"unprognostic (4.42e-1)"	"unprognostic (6.95e-2)"	"unprognostic (7.25e-2)"	"prognostic unfavorable (8.01e-4)"	"unprognostic (1.59e-1)"	"unprognostic (9.05e-2)"	"unprognostic (7.99e-2)"	15.8	18.6	18.7	9.1	19.5	35.2	11.7	21.4	31.7	14.2	16.5	11.1	7.3	4.4	15.0	7.1	8.5	8.6	15.5	26.0	18.2	23.5	13.7	5.7	8.1	11.8	22.8	20.0	16.1	4.8	14.6	13.4	12.2	25.5	12.3	7.2	17.4	10.1	18.6	16.7	8.0	6.6	18.6	25.4	11.2	9.6	9.7	21.1	7.1	9.4	6.9	7.7	13.3	10.5	1.5	5.3	36.2	5.6	1.2	2.4	2.9	2.6	1.6	9.4	5.9	15.3	18.1	1.9	11.4	13.5	5.8	8.6	1.0	4.4	5.1	1.5	10.9	5.8	0.6	2.2	3.7	7.6	4.7	4.6	8.1	1.7	0.8	13.8	1.9	7.3	10.0	2.4	7.3	5.4	15.5	5.5	1.5	4.0	17.0	20.1	1.8	5.4	4.8	4.9	0.0	5.9	2.2	3.8	6.1	8.1	1.6	1.0	5.3	0.7	3.6	13.9	6.6	0.1	3.3	8.3	10.4	4.3	6.0	4.8	6.8	4.1	3.1	18.0	3.4	13.9	0.3	5.6	5.3	0.8	2.6	1.3	1.5	1.8	0.9	5.3	1.1	2.4	1.0	36.2	1.2	1.0	3.1	1.5	2.9	18.7	19.5	21.4	31.7	18.2	23.5	22.8	20.0	25.5	21.1	0.0	3.2	0.0	0.0	0.0	0.0	0.0	0.0	2.7	5.7	8.7	0.0	27.7	41.4	15.5	0.0	0.0	0.0	0.0	7.7	27.3	0.0	0.0	8.1	0.0	39.4	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	6.4	0.0	0.0	11.2	0.0	0.0	10.3	0.0	0.0	0.0	0.0	0.0	0.0	9.2	0.0	0.0	0.0
PIP5K1A		ENSG00000143398	"Phosphatidylinositol-4-phosphate 5-kinase type 1 alpha"	Q99755	1	151197949-151249536	"Cancer-related genes, Enzymes, Predicted intracellular proteins"		"Kinase, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Cone photoreceptor cells: 92.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA029366	Approved		Supported	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Plasma membrane, Cytosol"	Nucleoplasm	"HPA029366: AB_10602116"	"unprognostic (1.05e-1)"	"unprognostic (2.36e-2)"	"unprognostic (8.64e-2)"	"unprognostic (7.94e-3)"	"unprognostic (1.17e-1)"	"unprognostic (3.28e-2)"	"unprognostic (1.26e-2)"	"unprognostic (3.01e-1)"	"unprognostic (8.79e-2)"	"unprognostic (1.15e-1)"	"unprognostic (1.37e-1)"	"unprognostic (1.04e-1)"	"prognostic unfavorable (4.16e-7)"	"unprognostic (1.44e-1)"	"unprognostic (8.14e-2)"	"unprognostic (2.93e-1)"	"unprognostic (1.59e-1)"	18.1	19.5	15.7	15.4	21.0	9.6	20.2	22.6	27.6	19.8	18.0	20.3	14.7	16.4	24.8	22.6	20.7	19.4	20.7	18.9	17.3	13.4	17.8	18.3	21.7	17.1	12.7	17.5	20.4	16.6	21.8	25.3	44.6	14.6	17.3	15.6	29.5	17.8	15.2	26.1	20.4	20.4	27.2	16.1	20.1	16.8	42.1	14.0	19.3	20.1	13.9	22.3	16.2	17.7	9.1	8.7	11.7	6.2	4.7	5.9	6.3	17.7	13.8	21.4	24.7	14.1	15.0	21.1	23.5	33.0	43.9	39.4	25.1	17.2	16.2	25.0	25.0	19.8	15.1	27.7	16.1	38.5	24.3	19.8	12.8	18.3	12.0	26.7	22.9	16.2	19.9	15.0	27.3	34.6	19.4	17.8	25.8	12.5	13.8	22.0	24.9	22.8	11.4	31.7	13.6	21.5	22.1	18.7	12.0	22.5	10.3	14.4	19.0	31.7	24.4	20.6	37.4	25.6	21.7	17.1	17.5	24.4	16.1	28.2	19.3	32.1	36.5	17.0	6.7	20.8	0.1	5.5	7.3	5.3	6.2	4.1	9.1	5.0	5.9	8.4	4.6	5.4	4.2	11.7	4.7	4.8	8.7	3.9	6.3	15.7	21.0	22.6	27.6	17.3	13.4	12.7	17.5	14.6	14.0	29.8	13.5	19.0	21.3	58.7	33.2	17.3	12.7	12.0	11.4	29.6	92.3	21.0	8.3	11.8	2.8	13.2	15.9	0.0	7.5	24.0	19.1	15.9	11.5	11.6	11.1	25.4	5.8	17.8	10.1	3.6	12.4	11.5	11.8	10.0	8.4	13.8	13.3	8.4	10.3	7.9	43.5	12.9	19.6	46.5	22.4	43.7	53.1	8.7	9.5	32.5
PIP5K1B	"MSS4, STM7"	ENSG00000107242	"Phosphatidylinositol-4-phosphate 5-kinase type 1 beta"	O14986	9	68705414-69009176	"Enzymes, Predicted intracellular proteins"		"Kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	7	"Muller glia cells: 103.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	6	"eosinophil: 22.1"	"Lineage enriched"	"Detected in many"	6	"granulocytes: 22.1"	"Cell line enhanced"	"Detected in some"		"AF22: 23.8;HEL: 8.9;Hep G2: 7.3;OE19: 39.1;U-266/70: 9.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA009687	Uncertain		Approved	Nucleoplasm,Vesicles		NA	NA			Nucleoplasm	Vesicles	"HPA009687: AB_1855391"	"unprognostic (2.02e-3)"	"unprognostic (1.84e-2)"	"unprognostic (3.77e-2)"	"unprognostic (2.72e-1)"	"unprognostic (1.56e-1)"	"unprognostic (1.62e-1)"	"unprognostic (5.85e-3)"	"unprognostic (1.80e-2)"	"unprognostic (1.38e-2)"	"unprognostic (1.17e-1)"	"unprognostic (2.98e-2)"	"unprognostic (2.92e-2)"	"prognostic favorable (1.03e-9)"	"unprognostic (2.10e-2)"	"unprognostic (1.71e-1)"	"unprognostic (1.19e-1)"	"unprognostic (3.34e-1)"	4.0	9.5	9.4	8.4	6.5	10.2	4.2	33.4	14.6	5.6	26.9	4.1	10.8	26.1	6.1	2.0	1.2	5.0	7.6	24.6	8.1	11.7	6.1	0.8	12.6	2.1	10.4	6.4	1.4	6.7	21.3	8.5	16.8	32.8	3.3	23.1	28.7	11.6	13.6	3.0	2.4	39.7	2.6	3.7	3.1	19.9	17.6	1.5	0.0	1.6	1.9	3.3	3.5	2.9	3.9	0.9	22.1	0.3	0.0	1.0	0.2	0.0	0.0	23.8	0.0	0.0	0.0	4.6	0.0	0.0	0.0	0.0	2.5	0.0	1.7	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.4	8.9	0.2	7.3	0.0	0.5	2.2	0.0	1.0	0.0	0.0	0.0	0.0	0.2	0.4	5.1	0.1	0.6	0.0	0.1	1.2	39.1	0.7	0.7	0.0	0.1	0.1	1.8	0.4	0.0	0.0	0.0	0.3	0.6	0.1	0.0	0.0	0.0	0.2	0.0	0.0	9.2	1.7	1.1	0.0	1.6	0.0	3.1	0.3	22.1	0.0	0.0	0.0	3.3	0.2	0.0	0.1	3.9	0.5	0.0	1.2	0.0	0.1	0.9	1.0	0.2	9.4	6.5	33.4	14.6	8.1	11.7	10.4	6.4	32.8	1.5	32.8	27.2	5.2	3.0	0.6	4.6	51.2	5.1	4.0	2.3	5.2	2.0	16.1	23.2	1.3	54.3	3.0	49.9	46.7	12.3	0.7	1.0	2.3	5.7	0.0	3.2	0.0	35.5	1.8	1.3	32.7	2.3	2.2	5.0	0.0	26.7	103.2	5.6	33.1	1.4	0.7	3.1	25.8	46.7	1.2	1.7	0.3	7.3	1.3	23.7	4.3
PIP5K1C	"KIAA0589, LCCS3, PIP5Kgamma"	ENSG00000186111	"Phosphatidylinositol-4-phosphate 5-kinase type 1 gamma"	O60331	19	3630183-3700479	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Cell adhesion, Chemotaxis, Endocytosis, Exocytosis, Phagocytosis"	"Kinase, Transferase"	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"U-2197: 38.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA017168	Approved		Approved	Nucleoplasm,Cytosol		No	No			"Nucleoplasm, Cytosol"		"HPA017168: AB_1855395"	"unprognostic (1.20e-1)"	"prognostic favorable (1.79e-4)"	"unprognostic (1.36e-3)"	"prognostic favorable (7.28e-5)"	"unprognostic (7.03e-2)"	"unprognostic (4.02e-3)"	"unprognostic (5.80e-3)"	"unprognostic (8.50e-2)"	"unprognostic (1.31e-1)"	"unprognostic (2.57e-3)"	"prognostic favorable (2.32e-4)"	"unprognostic (1.51e-1)"	"prognostic favorable (3.00e-4)"	"unprognostic (2.25e-1)"	"unprognostic (1.84e-1)"	"unprognostic (2.30e-1)"	"unprognostic (2.70e-1)"	16.1	10.2	20.5	12.8	25.8	4.5	8.0	58.6	46.3	10.7	23.5	8.5	14.8	10.9	19.8	10.0	12.3	12.8	12.7	13.8	22.8	10.7	7.5	3.8	11.5	7.5	11.3	17.1	11.5	17.2	10.0	9.2	13.7	19.0	16.7	6.4	16.9	20.0	33.4	13.5	10.2	11.5	19.2	6.3	15.8	13.6	23.9	8.7	5.3	9.3	3.9	6.0	17.3	19.0	2.5	3.2	3.6	3.0	1.7	2.8	2.0	9.2	8.8	6.9	8.9	13.5	11.0	10.4	17.9	11.3	7.7	6.2	7.8	2.6	3.9	6.9	19.1	8.5	8.2	3.2	5.8	3.2	13.8	5.8	4.4	7.3	6.3	11.3	4.5	13.8	12.2	5.5	6.3	2.4	5.5	13.0	5.9	6.7	7.2	7.2	7.7	5.4	3.3	7.2	3.4	12.2	10.2	5.3	5.3	5.7	8.0	7.0	6.0	9.2	5.0	5.4	9.0	4.0	6.8	28.6	10.8	6.2	38.1	8.3	8.3	6.6	1.7	14.5	9.5	7.7	3.6	2.8	0.0	2.8	2.6	1.2	2.5	2.1	2.0	3.2	1.3	1.0	1.6	2.2	1.7	3.0	2.2	1.4	2.0	20.5	25.8	58.6	46.3	22.8	10.7	11.3	17.1	19.0	8.7	6.0	5.3	5.4	2.8	4.7	40.8	5.5	7.6	2.7	0.0	15.7	35.3	6.2	1.7	6.9	8.4	12.0	7.0	0.0	6.2	6.0	8.5	4.9	1.1	3.6	13.3	28.6	8.1	16.0	11.0	17.7	13.8	10.8	5.0	13.6	9.2	10.5	9.9	7.0	22.6	5.7	26.6	12.9	10.7	19.0	10.4	5.9	13.7	6.4	5.7	3.8
PIP5KL1	"bA203J24.5, MGC46424"	ENSG00000167103	"Phosphatidylinositol-4-phosphate 5-kinase like 1"	Q5T9C9	9	127920879-127930797	"Enzymes, Predicted intracellular proteins"		"Kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	10	"Alveolar cells type 2: 9.4;Ciliated cells: 9.4;Early spermatids: 20.0;Late spermatids: 14.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	6	"intermediate monocyte: 1.2;MAIT T-cell: 1.0;memory B-cell: 1.0;myeloid DC: 1.0;naive B-cell: 2.4;plasmacytoid DC: 1.3"	"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"Karpas-707: 29.6;RPMI-8226: 19.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA056240	Uncertain		Supported	Cytosol		NA	NA			Cytosol		"HPA056240: AB_2683075"	"unprognostic (2.15e-2)"	"unprognostic (3.06e-1)"	"unprognostic (1.23e-3)"	"unprognostic (8.51e-5)"	"unprognostic (1.44e-2)"	"unprognostic (4.62e-2)"	"unprognostic (1.19e-1)"	"unprognostic (6.29e-2)"	"unprognostic (5.20e-2)"	"unprognostic (5.50e-2)"	"unprognostic (2.49e-2)"	"unprognostic (1.57e-3)"	"unprognostic (9.95e-8)"	"unprognostic (1.87e-1)"	"unprognostic (7.21e-2)"	"unprognostic (6.05e-2)"	"unprognostic (1.59e-1)"	0.6	0.7	3.1	0.6	1.0	1.4	2.5	2.4	5.3	2.1	0.6	1.9	0.6	0.5	1.3	0.6	3.7	1.8	1.2	0.6	2.1	2.9	1.3	0.6	2.9	0.6	1.4	2.6	0.7	1.3	6.5	4.8	1.6	8.3	3.3	0.2	1.0	8.7	4.1	0.6	4.7	0.6	1.0	1.5	0.6	2.4	2.5	1.2	0.6	2.9	0.6	0.6	1.2	4.0	2.4	1.3	0.0	1.2	0.0	1.0	0.3	0.0	0.5	0.4	0.5	0.5	1.3	2.8	0.6	0.5	0.1	0.1	0.2	3.6	0.3	1.1	2.4	1.1	1.1	0.0	2.6	0.1	0.3	1.7	0.0	0.8	0.0	0.9	0.0	0.1	1.4	1.7	0.3	0.0	0.9	0.0	2.4	0.0	29.6	0.0	2.5	0.0	1.0	0.2	1.1	0.4	0.2	0.0	19.3	0.0	0.0	1.0	1.8	0.1	0.7	0.0	0.3	1.1	1.4	0.3	0.3	1.0	0.6	0.1	2.6	1.7	0.7	5.3	0.4	0.3	0.0	0.0	0.0	0.0	1.2	1.0	1.0	0.1	0.0	1.0	2.4	0.2	0.1	0.0	0.0	0.1	1.3	0.0	0.3	3.1	1.0	2.4	5.3	2.1	2.9	1.4	2.6	8.3	1.2	0.0	9.4	0.5	3.7	1.9	0.2	0.5	0.0	9.4	1.2	5.2	0.0	0.7	1.7	1.2	20.0	0.6	0.0	0.0	1.3	3.8	0.8	1.9	0.0	0.0	0.3	4.8	0.0	0.6	0.3	14.7	0.9	0.0	0.0	0.0	0.2	1.7	1.2	0.0	0.4	0.0	0.7	0.0	0.8	1.1	0.9	1.0	2.6	0.0	0.2	1.8
PIPOX	LPIPOX	ENSG00000179761	"Pipecolic acid and sarcosine oxidase"	Q9P0Z9	17	28950513-29057220	"Enzymes, Plasma proteins, Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	13	"kidney: 33.5;liver: 114.3"	"Group enriched"	"Detected in many"	6	"Hepatocytes: 183.0;Proximal tubular cells: 123.0"	"Group enriched"	"Detected in many"	13	"glioma: 15.5;liver cancer: 73.5"	"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in some"	6	"AF22: 12.5;Hep G2: 37.6;NTERA-2: 24.8;RH-30: 35.8"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"									NA	NA		390000				"unprognostic (8.02e-2)"	"unprognostic (3.50e-4)"	"unprognostic (3.03e-1)"	"unprognostic (6.25e-3)"	"unprognostic (1.52e-1)"	"unprognostic (5.01e-2)"	"unprognostic (1.95e-3)"	"unprognostic (1.15e-2)"	"unprognostic (2.17e-1)"	"unprognostic (3.45e-1)"	"prognostic favorable (1.49e-4)"	"unprognostic (2.39e-1)"	"unprognostic (3.13e-3)"	"unprognostic (2.58e-3)"	"unprognostic (2.01e-1)"	"unprognostic (2.79e-2)"	"unprognostic (1.22e-1)"	0.2	0.2	2.4	0.2	3.1	0.1	0.2	2.2	2.9	0.2	1.4	3.8	0.0	3.1	0.4	5.8	0.5	2.1	0.8	0.2	3.5	2.5	33.5	114.3	0.3	0.3	3.6	3.1	0.3	0.2	0.3	0.2	1.0	4.0	0.5	0.3	0.2	0.2	0.9	0.1	0.2	2.6	0.6	1.7	0.3	0.2	0.2	0.7	0.0	0.1	0.0	0.2	0.3	0.1	0.7	4.7	3.7	0.7	0.9	1.9	0.7	0.0	0.0	12.5	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.2	0.2	0.1	37.6	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.4	0.0	0.1	0.0	0.2	24.8	0.7	0.0	0.1	35.8	0.7	0.0	0.0	4.0	1.2	0.1	0.0	0.2	2.1	0.0	1.5	0.0	0.0	0.0	0.0	1.6	0.3	4.2	0.1	0.0	0.2	1.2	1.8	0.7	0.7	0.8	0.5	0.9	0.3	0.5	1.2	4.7	0.7	0.3	1.9	3.7	0.9	0.3	0.4	0.8	0.7	2.4	3.1	2.2	2.9	3.5	2.5	3.6	3.1	4.0	0.7	0.0	1.1	2.2	0.2	0.2	1.7	0.4	5.1	0.0	0.0	0.0	3.9	0.1	8.3	0.0	1.3	0.6	0.7	0.0	0.2	4.4	0.4	0.3	5.7	183.0	1.2	0.0	1.2	2.5	3.5	1.5	0.3	1.7	0.0	3.6	0.0	24.0	0.0	0.0	1.1	123.0	1.3	0.0	0.4	0.0	1.0	0.1	0.3	0.5	0.0	0.1
PIR		ENSG00000087842	Pirin	O00625	X	15384799-15493564	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Dioxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Cytotrophoblasts: 74.0;Syncytiotrophoblasts: 71.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"T-reg: 2.2"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"GAMG: 51.0;HUVEC TERT2: 117.2;SK-MEL-30: 44.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA000697	Approved		Supported	Cytosol		NA	NA			Cytosol		"HPA000697: AB_1079621"	"unprognostic (3.46e-3)"	"prognostic favorable (2.78e-4)"	"unprognostic (4.26e-2)"	"unprognostic (5.62e-3)"	"unprognostic (4.16e-3)"	"unprognostic (2.09e-2)"	"unprognostic (6.70e-3)"	"unprognostic (1.65e-1)"	"unprognostic (1.08e-1)"	"prognostic favorable (4.94e-4)"	"unprognostic (3.78e-2)"	"unprognostic (1.92e-1)"	"prognostic unfavorable (6.11e-7)"	"unprognostic (1.99e-2)"	"unprognostic (8.90e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.44e-1)"	20.9	16.1	14.1	5.9	16.8	5.7	26.5	8.5	13.5	8.1	7.5	14.0	21.8	7.7	11.2	18.8	20.7	16.2	13.4	14.0	11.7	12.1	13.9	23.7	18.6	8.6	20.8	9.8	13.0	2.6	5.4	9.1	12.1	15.6	12.1	8.3	25.0	7.5	18.0	9.8	13.7	6.9	24.6	26.0	15.5	13.8	7.2	14.4	1.3	12.1	19.9	9.1	26.5	11.7	0.0	0.5	1.0	0.5	0.0	2.2	0.3	2.3	12.9	7.8	11.4	4.6	5.2	2.5	0.7	4.5	1.9	4.3	3.6	20.3	0.0	25.7	2.0	51.0	16.5	9.0	3.6	0.7	0.0	1.9	1.4	14.6	10.5	5.9	0.7	5.2	1.4	12.5	7.2	2.5	3.3	117.2	0.0	1.0	3.3	1.6	4.9	0.5	0.6	8.3	10.4	8.2	0.0	1.5	6.4	3.8	22.9	3.0	8.3	6.2	3.5	44.1	14.0	7.3	4.4	7.3	1.0	1.9	4.9	1.4	1.5	6.4	0.0	5.0	2.6	10.2	0.0	0.5	1.0	0.0	0.0	0.0	0.0	0.6	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.2	2.2	0.3	14.1	16.8	8.5	13.5	11.7	12.1	20.8	9.8	15.6	14.4	0.0	2.6	1.9	20.5	7.7	2.5	5.1	10.2	24.1	4.5	1.8	0.0	74.0	8.3	3.8	0.4	25.9	4.0	0.0	2.2	8.6	8.9	8.4	0.0	21.3	18.4	19.1	10.9	17.2	6.4	0.2	34.8	2.9	38.8	20.8	2.4	26.6	4.6	1.4	26.9	7.7	4.5	12.9	8.6	0.5	2.4	11.0	71.6	0.9	3.3	43.0
PISD	"dJ858B16.2, PSDC"	ENSG00000241878	"Phosphatidylserine decarboxylase"	Q9UG56	22	31618491-31662432	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism"	"Decarboxylase, Lyase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	8	"Cytotrophoblasts: 177.5;Syncytiotrophoblasts: 204.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"MCF7: 39.6"					"Low region specificity"	"Detected in all"			"HPA031090, HPA031091"	Approved		Approved	"Golgi apparatus,Cytosol"		NA	NA			"Golgi apparatus, Cytosol"		"HPA031090: AB_10600114, HPA031091: AB_10600893"	"unprognostic (7.96e-2)"	"unprognostic (5.41e-3)"	"unprognostic (2.60e-1)"	"unprognostic (8.31e-2)"	"unprognostic (5.61e-2)"	"unprognostic (4.55e-3)"	"unprognostic (2.44e-3)"	"unprognostic (8.13e-3)"	"unprognostic (6.37e-3)"	"unprognostic (1.23e-1)"	"unprognostic (1.11e-3)"	"unprognostic (1.70e-2)"	"unprognostic (4.18e-3)"	"unprognostic (1.91e-2)"	"unprognostic (4.85e-2)"	"unprognostic (3.92e-2)"	"prognostic favorable (5.27e-5)"	38.3	12.3	9.5	15.1	10.9	20.9	18.5	34.5	12.3	5.9	7.3	6.2	7.4	11.4	9.6	14.4	7.0	10.0	9.5	6.9	6.4	6.9	11.9	8.4	12.9	14.6	8.3	10.1	7.5	10.9	6.0	11.7	38.1	8.6	8.2	3.3	7.7	7.9	7.9	6.4	10.2	8.0	6.2	5.8	16.5	9.7	17.8	7.7	4.2	10.6	5.3	9.8	6.2	7.0	6.9	11.0	28.6	12.9	5.7	6.8	7.9	10.5	9.8	3.0	2.9	9.0	3.5	6.8	8.7	6.9	6.1	6.6	14.1	3.3	6.4	9.3	4.4	8.1	12.0	4.0	7.7	1.0	7.0	8.5	6.7	5.9	11.6	18.8	13.9	17.5	6.5	4.4	10.8	4.7	2.5	5.3	4.5	19.3	3.8	3.4	39.6	6.0	6.0	2.9	7.0	4.1	8.5	3.3	6.4	3.9	9.4	7.3	4.3	5.0	16.3	5.6	2.5	13.4	7.6	10.4	7.7	9.2	4.9	8.0	4.5	6.3	7.9	7.3	9.4	6.1	9.9	12.9	9.3	6.8	9.5	6.5	6.9	4.9	5.7	11.0	6.3	6.7	5.5	28.6	5.7	5.0	5.4	4.7	7.9	9.5	10.9	34.5	12.3	6.4	6.9	8.3	10.1	8.6	7.7	14.9	14.1	13.5	30.6	22.8	22.8	39.5	12.7	4.0	27.3	40.1	19.6	177.5	10.0	26.6	41.3	19.1	11.7	0.0	14.6	14.4	14.5	37.7	17.4	6.6	31.6	17.5	20.1	9.2	32.2	61.8	8.9	19.4	3.3	13.6	11.8	11.0	14.6	8.6	6.7	11.6	25.8	19.4	11.3	16.3	18.1	18.6	204.9	8.7	11.8	36.8
PITRM1	"hMP1, KIAA1104, MP1, PreP"	ENSG00000107959	"Pitrilysin metallopeptidase 1"	Q5JRX3	10	3137728-3172841	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	8	"Early spermatids: 149.7;Late spermatids: 75.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006753, HPA006754"	Enhanced		Supported	Mitochondria		NA	NA			Mitochondria		"HPA006753: AB_1079624, HPA006754: AB_1079623"	"unprognostic (1.83e-3)"	"unprognostic (7.01e-3)"	"unprognostic (2.19e-1)"	"unprognostic (1.69e-1)"	"unprognostic (3.20e-2)"	"unprognostic (6.67e-2)"	"unprognostic (1.55e-1)"	"unprognostic (1.78e-1)"	"unprognostic (6.31e-2)"	"unprognostic (3.41e-1)"	"unprognostic (1.00e-2)"	"unprognostic (3.32e-1)"	"unprognostic (7.10e-2)"	"unprognostic (3.99e-1)"	"unprognostic (5.80e-2)"	"unprognostic (4.76e-3)"	"unprognostic (2.08e-2)"	26.7	39.4	22.7	20.4	34.4	31.0	21.5	29.7	47.8	21.6	23.4	29.8	19.1	19.1	27.6	27.2	25.0	21.3	23.7	41.0	22.1	19.3	28.8	47.1	23.6	21.2	22.9	25.6	35.3	25.7	31.2	26.0	17.8	38.8	27.2	22.4	29.2	25.1	23.8	62.0	28.0	25.3	26.3	19.1	18.9	21.6	41.6	20.4	48.6	28.7	33.0	26.8	26.0	22.4	11.5	13.7	6.0	13.9	12.4	13.9	9.1	25.7	20.9	8.3	11.2	23.6	25.6	9.5	38.2	17.9	30.6	16.7	18.8	15.8	13.0	13.3	23.9	11.8	19.9	13.3	29.5	23.1	22.4	18.9	18.3	17.1	14.1	13.4	7.1	21.9	21.1	22.0	33.4	19.1	20.9	31.7	20.2	18.5	17.1	40.3	22.3	17.8	7.3	5.7	33.1	25.4	8.8	11.5	18.4	24.3	19.8	10.6	6.5	29.0	21.2	16.1	12.2	24.7	8.5	39.0	24.2	6.8	59.1	18.3	13.7	14.4	13.4	36.9	13.0	11.8	6.0	9.4	4.9	13.1	12.0	12.9	11.5	11.3	12.2	13.7	6.8	12.1	13.9	1.4	12.4	13.9	7.6	13.8	9.1	22.7	34.4	29.7	47.8	22.1	19.3	22.9	25.6	38.8	20.4	26.8	22.3	6.5	17.3	6.1	13.1	36.4	10.2	22.7	29.6	3.5	19.6	10.5	6.6	14.9	149.7	11.3	11.1	0.0	25.0	16.4	10.8	18.9	13.9	13.0	12.9	6.4	17.3	7.4	9.4	75.9	15.8	9.4	18.6	13.6	10.9	5.8	26.9	8.6	13.8	7.5	19.1	6.5	14.2	25.1	19.3	5.0	11.3	8.7	12.4	15.7
PJA1	"FLJ11830, RNF70"	ENSG00000181191	"Praja ring finger ubiquitin ligase 1"	Q8NG27	X	69160851-69165793	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"epididymis: 98.7"	"Cell type enhanced"	"Detected in many"	7	"Early spermatids: 77.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HAP1: 38.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA000595	Approved		Approved	Nucleoplasm,Nucleoli		NA	NA			"Nucleoplasm, Nucleoli"		"HPA000595: AB_1079826"	"unprognostic (3.40e-2)"	"unprognostic (2.28e-1)"	"unprognostic (4.03e-2)"	"unprognostic (2.58e-3)"	"unprognostic (5.44e-2)"	"unprognostic (1.30e-2)"	"unprognostic (1.26e-3)"	"unprognostic (4.61e-2)"	"unprognostic (3.82e-3)"	"unprognostic (1.84e-2)"	"unprognostic (6.10e-2)"	"unprognostic (1.60e-1)"	"prognostic favorable (7.44e-5)"	"unprognostic (1.49e-1)"	"unprognostic (2.35e-1)"	"unprognostic (2.01e-1)"	"unprognostic (2.10e-1)"	12.6	9.9	21.6	5.5	35.7	2.6	7.9	13.4	23.7	12.2	5.8	8.9	19.3	4.7	9.2	98.7	5.7	10.2	7.1	7.5	18.4	23.4	7.5	4.4	7.4	5.9	14.9	16.7	16.2	6.0	27.1	12.5	10.7	11.7	9.9	5.3	7.2	6.4	20.3	4.7	7.1	4.4	9.8	12.0	5.9	6.5	13.7	9.5	3.0	13.8	2.9	7.4	7.8	7.9	11.2	4.3	2.7	4.5	14.8	17.8	9.0	10.4	8.0	25.1	17.6	8.8	9.3	7.6	7.0	8.4	6.6	8.9	6.5	9.9	1.6	10.9	11.1	15.6	9.1	38.6	13.7	8.3	7.8	13.7	3.1	6.6	4.3	11.0	1.8	6.0	9.7	9.1	11.3	6.7	6.4	7.4	5.3	2.9	1.1	6.7	5.6	0.8	3.6	17.1	8.9	13.2	7.5	11.2	2.5	10.6	8.8	18.7	12.1	11.2	1.9	8.5	20.9	3.1	2.6	6.7	5.7	9.2	16.9	3.2	0.0	0.1	3.8	6.2	5.1	7.6	2.7	3.3	1.0	15.5	4.5	17.8	8.7	13.7	14.2	3.6	11.2	14.4	16.6	1.1	14.8	2.9	4.3	8.3	9.0	21.6	35.7	13.4	23.7	18.4	23.4	14.9	16.7	11.7	9.5	14.9	4.5	5.1	14.7	36.5	16.4	6.3	5.1	2.7	11.4	3.5	7.9	30.0	13.3	20.5	77.4	5.1	0.7	0.0	10.2	12.8	18.9	7.8	4.6	1.7	6.7	4.8	5.2	5.5	3.8	22.6	25.0	4.1	5.0	1.8	2.8	28.6	13.9	1.4	18.4	4.4	5.9	6.5	17.0	0.9	1.0	25.7	17.4	7.9	2.3	17.6
PJA2	"KIAA0438, Neurodap1, RNF131"	ENSG00000198961	"Praja ring finger ubiquitin ligase 2"	O43164	5	109334709-109409994	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040347, HPA057636"	Supported		Enhanced	"Intermediate filaments"		No	No			"Intermediate filaments"		"HPA040347: AB_10795631, HPA057636: AB_2683485"	"unprognostic (5.78e-2)"	"unprognostic (1.25e-1)"	"unprognostic (5.48e-3)"	"unprognostic (1.17e-1)"	"unprognostic (2.99e-1)"	"unprognostic (7.83e-2)"	"unprognostic (2.83e-1)"	"unprognostic (4.33e-2)"	"unprognostic (4.84e-2)"	"prognostic unfavorable (8.02e-4)"	"unprognostic (4.46e-2)"	"unprognostic (6.03e-2)"	"unprognostic (5.64e-3)"	"unprognostic (1.47e-3)"	"unprognostic (5.94e-2)"	"unprognostic (7.59e-2)"	"unprognostic (1.00e-2)"	21.6	27.0	40.1	15.9	49.9	29.0	22.1	41.6	63.0	29.0	23.8	19.7	16.8	12.5	29.2	25.0	20.7	20.3	18.6	24.4	44.3	46.2	24.1	29.2	19.4	14.3	36.8	44.0	35.4	14.8	42.8	30.3	21.8	53.2	31.7	20.6	12.5	17.3	37.7	17.1	13.6	15.9	39.2	37.6	19.5	15.8	17.0	27.4	16.7	35.9	9.7	16.3	35.5	21.4	10.3	11.7	29.9	15.5	10.7	12.2	10.6	11.8	8.2	33.3	25.6	33.1	36.3	18.1	19.6	29.6	15.5	25.5	7.6	16.2	15.3	27.2	37.6	25.0	6.9	19.4	24.1	28.5	13.0	7.3	17.7	16.9	10.3	23.5	13.2	26.3	25.0	20.2	20.7	29.9	27.9	24.7	13.8	12.1	28.9	25.0	7.2	15.8	12.2	6.6	7.3	5.5	10.3	29.3	25.5	24.1	10.7	6.4	16.4	20.2	7.4	23.6	23.3	16.7	19.6	28.4	22.1	10.8	20.3	9.1	19.5	16.6	18.2	23.4	18.4	14.5	17.3	11.6	17.3	9.5	12.2	9.4	10.3	9.4	8.7	11.7	7.4	12.1	8.9	29.9	10.7	15.5	4.9	12.2	10.6	40.1	49.9	41.6	63.0	44.3	46.2	36.8	44.0	53.2	27.4	62.5	47.1	47.1	45.8	56.3	93.5	116.8	50.9	41.5	45.5	54.1	58.9	19.9	41.4	32.7	16.4	64.5	53.5	0.0	28.7	23.4	57.5	66.5	46.2	90.1	46.6	73.1	64.9	65.1	78.4	15.1	78.9	53.7	57.3	31.5	47.8	99.2	29.4	20.1	87.0	45.1	78.2	77.6	80.4	73.2	30.2	50.8	22.0	50.7	29.6	32.0
PKDCC	"SgK493, Vlk"	ENSG00000162878	"Protein kinase domain containing, cytoplasmic"	Q504Y2	2	42048020-42058528	"Enzymes, Predicted secreted proteins"	"Differentiation, Osteogenesis, Protein transport, Transport"	"Developmental protein, Kinase, Transferase, Tyrosine-protein kinase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"Intestinal endocrine cells: 69.1;Leydig cells: 127.4;Peritubular cells: 105.4;Rod photoreceptor cells: 93.6;Undifferentiated cells: 34.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AN3-CA: 31.2;ASC diff: 24.8;CACO-2: 36.9;HHSteC: 21.3;RH-30: 10.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA026427, HPA026442, HPA026526"	Approved				"Secreted to blood"	NA	NA		10000			"HPA026427: AB_10600773, HPA026442: AB_10601237, HPA026526: AB_10602416"	"unprognostic (6.77e-2)"	"unprognostic (3.35e-1)"	"unprognostic (1.04e-2)"	"unprognostic (3.59e-3)"	"unprognostic (8.31e-2)"	"unprognostic (1.11e-1)"	"unprognostic (2.18e-2)"	"unprognostic (5.79e-3)"	"unprognostic (1.04e-2)"	"unprognostic (1.32e-1)"	"unprognostic (3.20e-1)"	"unprognostic (6.09e-2)"	"unprognostic (2.14e-2)"	"unprognostic (9.08e-2)"	"unprognostic (2.62e-1)"	"unprognostic (4.73e-3)"	"unprognostic (2.58e-3)"	21.4	5.7	1.9	8.4	1.8	0.8	18.9	0.3	4.7	20.8	13.7	1.7	6.3	9.3	17.6	16.0	9.2	10.0	29.6	17.0	2.3	0.7	4.7	3.5	8.0	3.7	3.7	0.3	43.6	3.3	0.9	3.2	3.2	2.6	13.0	5.2	17.0	38.6	5.6	40.2	1.7	7.7	26.2	2.3	4.6	4.8	14.1	2.3	4.2	3.1	13.1	2.1	22.8	23.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	2.0	5.5	31.2	24.8	0.3	2.0	0.1	0.0	0.4	0.6	36.9	0.0	0.0	0.1	0.6	0.7	0.0	0.5	0.0	0.0	3.0	1.3	0.0	1.3	9.8	21.3	0.0	0.4	2.1	0.1	0.0	0.0	0.2	0.2	0.0	0.4	0.0	0.1	0.1	0.0	0.1	9.1	2.5	0.6	0.0	10.8	0.0	0.0	0.0	1.1	1.9	0.5	0.0	0.0	6.7	0.0	0.2	0.0	0.2	1.1	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	1.8	0.3	4.7	2.3	0.7	3.7	0.3	2.6	2.3	17.9	0.3	0.5	0.2	2.9	2.1	8.1	2.5	0.0	0.0	1.8	15.7	0.4	0.0	1.8	1.1	1.9	11.8	0.0	1.2	1.2	21.1	0.9	0.0	2.6	0.6	0.0	69.1	3.7	0.3	2.6	127.4	0.2	1.7	0.0	11.8	20.3	1.2	14.0	105.4	3.2	93.6	12.9	8.5	0.5	1.2	1.6	0.2	0.0	34.2	0.1
PKLR		ENSG00000143627	"Pyruvate kinase L/R"	P30613	1	155289293-155301434	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	Glycolysis	"Allosteric enzyme, Kinase, Transferase"	"Disease mutation, Hereditary hemolytic anemia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"intestine: 17.2;kidney: 12.4;liver: 47.8"	"Cell type enhanced"	"Detected in some"	25	"Early spermatids: 8.3;Hepatocytes: 15.1;Late spermatids: 16.6;Proximal tubular cells: 43.2"	"Cancer enriched"	"Detected in some"	9	"liver cancer: 56.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	9	"K-562: 48.5"	"Region enhanced"	"Detected in single"		"basal ganglia: 1.7"	"Not detected"	"Not detected"			"HPA006653, CAB034376, CAB034378"	Enhanced		Approved	"Golgi apparatus,Cytosol"		No	NA		2900000	"Golgi apparatus, Cytosol"		"CAB034376: AB_2163671, CAB034378: AB_2252321, HPA006653: AB_2667632"	"unprognostic (9.16e-2)"	"unprognostic (1.22e-1)"	"unprognostic (2.22e-1)"	"unprognostic (5.98e-2)"	"unprognostic (2.62e-1)"	"unprognostic (7.86e-4)"	"unprognostic (1.53e-2)"	"unprognostic (1.08e-1)"	"unprognostic (8.79e-2)"	"unprognostic (1.89e-1)"	"unprognostic (4.07e-1)"	"unprognostic (4.53e-2)"	"unprognostic (1.96e-2)"	"unprognostic (1.40e-1)"	"unprognostic (1.02e-1)"	"unprognostic (1.32e-1)"	"unprognostic (6.21e-3)"	0.1	0.0	0.1	0.3	0.1	7.2	0.1	0.9	0.2	0.1	4.9	0.1	0.1	5.8	0.1	1.3	0.1	0.0	0.7	0.1	0.1	0.4	12.4	47.8	0.5	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.2	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.6	17.2	0.1	0.1	0.1	0.0	0.5	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	5.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	48.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.9	0.2	0.1	0.4	0.1	0.1	0.1	0.1	0.0	0.0	0.9	0.0	0.0	0.0	0.3	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	8.3	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	15.1	0.2	0.0	0.0	0.0	0.0	16.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	43.2	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0
PKM	"OIP3, PK3, PKM2, THBP1"	ENSG00000067225	"Pyruvate kinase M1/2"	P14618	15	72199029-72231822	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins"	"Glycolysis, Translation regulation"	"Allosteric enzyme, Kinase, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	5	"skeletal muscle: 541.2"	"Cell type enhanced"	"Detected in all"	5	"monocytes: 1878.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB019421, HPA029501"	Uncertain		Enhanced	Cytosol		No	No		540000000	Cytosol		"CAB019421: AB_2252325, HPA029501: AB_10602118"	"unprognostic (8.73e-3)"	"unprognostic (4.63e-3)"	"unprognostic (1.68e-2)"	"unprognostic (3.09e-1)"	"unprognostic (6.51e-2)"	"prognostic unfavorable (1.30e-4)"	"prognostic unfavorable (2.74e-6)"	"prognostic unfavorable (2.85e-4)"	"unprognostic (9.51e-2)"	"unprognostic (1.17e-2)"	"prognostic unfavorable (5.17e-5)"	"unprognostic (3.16e-1)"	"unprognostic (3.22e-1)"	"unprognostic (7.85e-2)"	"unprognostic (3.17e-2)"	"unprognostic (1.44e-1)"	"unprognostic (1.25e-2)"	23.2	76.8	53.8	49.8	70.4	57.5	41.6	56.6	85.9	65.7	31.2	32.1	31.5	26.4	24.7	41.8	76.4	37.9	32.9	94.8	50.1	57.1	60.9	6.1	33.3	39.4	62.5	63.6	26.2	15.6	33.3	28.3	27.1	80.5	34.8	31.9	54.4	47.1	47.5	541.2	51.8	25.1	44.7	34.9	30.7	26.7	29.0	29.4	23.5	23.8	114.4	60.6	53.1	40.9	25.1	79.6	14.9	90.6	11.6	37.4	114.9	81.9	210.9	42.5	50.3	51.2	57.5	35.1	88.9	207.7	142.9	144.6	59.3	101.0	62.4	90.0	166.4	106.4	119.5	134.4	181.0	112.0	109.5	63.5	38.2	106.1	49.1	35.6	49.5	82.5	52.2	84.3	110.0	45.2	185.5	84.1	32.1	9.5	50.1	225.2	50.9	18.5	21.3	52.6	125.8	80.5	55.0	136.1	118.9	189.6	105.5	44.2	48.3	116.0	71.6	90.9	74.7	50.2	36.1	65.4	162.8	89.0	159.0	161.3	64.4	90.9	55.0	200.4	82.0	159.4	12.6	90.6	14.9	23.5	52.6	22.8	25.1	31.3	23.2	79.6	16.1	27.3	20.2	11.8	11.6	40.2	16.2	37.4	114.9	53.8	70.4	56.6	85.9	50.1	57.1	62.5	63.6	80.5	29.4	110.2	78.1	134.8	464.1	502.3	450.3	279.7	94.3	129.8	157.0	786.9	347.5	523.8	679.8	1147.1	307.8	224.6	361.4	70.0	528.2	1096.0	273.6	329.6	203.1	2.0	698.2	1005.9	270.8	71.2	307.3	1333.1	145.6	439.7	337.4	1878.3	130.3	624.4	887.7	231.5	252.1	165.5	510.0	122.9	245.6	32.6	84.3	340.0	481.5	163.0	247.6	730.1
PKMYT1	"MYT1, PPP1R126"	ENSG00000127564	"Protein kinase, membrane associated tyrosine/threonine 1"	Q99640	16	2968024-2980539	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Cell cycle"	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"bone marrow: 19.5;lymphoid tissue: 42.8;testis: 61.4"	"Group enriched"	"Detected in many"	6	"Extravillous trophoblasts: 39.8;Spermatocytes: 108.0;Spermatogonia: 40.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Cell type enriched"	"Detected in single"	5	"T-reg: 4.4"	"Lineage enriched"	"Detected in single"	5	"T-cells: 4.4"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA068860			Supported	"Nucleoplasm,Nucleoli,Golgi apparatus"		NA	Yes			"Golgi apparatus"	"Nucleoplasm, Nucleoli"	"HPA068860: AB_2686050"	"unprognostic (7.82e-2)"	"unprognostic (8.70e-2)"	"unprognostic (5.93e-2)"	"unprognostic (2.04e-2)"	"unprognostic (4.54e-2)"	"unprognostic (1.44e-1)"	"prognostic unfavorable (8.33e-4)"	"prognostic unfavorable (3.37e-4)"	"unprognostic (4.52e-2)"	"unprognostic (2.15e-1)"	"unprognostic (1.61e-2)"	"unprognostic (7.95e-3)"	"unprognostic (0.00e+0)"	"unprognostic (1.09e-3)"	"unprognostic (9.13e-2)"	"unprognostic (1.96e-1)"	"unprognostic (5.91e-2)"	0.9	0.7	0.7	9.4	0.6	19.5	1.3	2.6	0.8	1.3	2.9	0.3	0.5	1.9	0.8	1.5	7.2	0.2	1.5	1.4	0.7	0.7	0.8	1.0	1.3	6.2	0.8	0.2	0.3	1.3	0.0	0.7	4.3	0.4	0.6	0.8	0.3	1.3	0.2	1.6	3.4	3.2	0.6	1.0	4.4	2.7	61.4	0.2	42.8	0.3	9.2	12.7	0.7	2.0	0.8	0.4	0.3	0.5	0.4	4.4	1.0	24.9	17.5	6.8	9.8	0.1	0.3	18.6	19.4	4.6	12.3	11.8	13.6	14.8	15.6	8.7	2.1	7.3	32.1	4.8	6.2	2.2	20.0	15.7	7.9	15.8	11.9	0.0	8.8	22.5	0.2	0.5	7.3	2.0	1.5	2.5	17.3	22.7	27.7	4.0	37.4	24.6	24.5	11.2	11.7	9.3	26.9	15.3	30.2	2.3	5.5	13.0	13.8	9.4	24.5	7.3	3.9	14.0	17.6	2.3	16.6	21.0	24.2	20.3	21.0	15.6	26.8	6.3	11.8	19.2	0.0	0.4	0.3	0.3	0.3	0.0	0.8	0.5	0.5	0.4	0.0	0.0	0.0	0.1	0.4	0.5	0.1	4.4	1.0	0.7	0.6	2.6	0.8	0.7	0.7	0.8	0.2	0.4	0.2	0.0	1.4	0.0	0.8	2.3	0.1	0.4	2.5	0.0	2.3	1.8	5.9	3.0	0.0	1.1	11.2	0.3	0.2	0.0	0.5	39.8	0.4	0.5	0.0	0.2	10.2	0.0	1.7	0.0	1.3	7.5	0.3	1.3	0.0	1.0	1.2	0.3	0.3	0.0	0.4	0.0	6.7	0.0	0.0	108.0	40.5	0.5	6.2	0.7	3.5	0.4
PKN1	"DBK, MGC46204, PAK1, PKN, PRK1, PRKCL1"	ENSG00000123143	"Protein kinase N1"	Q16512	19	14433053-14471867	"Enzymes, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Chromatin regulator, Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003982, CAB010278"	Approved		Approved	"Plasma membrane,Focal adhesion sites,Cytokinetic bridge"		NA	NA			"Plasma membrane"	"Focal adhesion sites, Cytokinetic bridge"	"CAB010278: AB_2163965, HPA003982: AB_1855440"	"unprognostic (3.83e-2)"	"unprognostic (2.14e-1)"	"unprognostic (4.13e-2)"	"unprognostic (1.13e-2)"	"unprognostic (1.94e-1)"	"unprognostic (4.58e-1)"	"unprognostic (1.30e-2)"	"unprognostic (1.45e-1)"	"unprognostic (1.43e-1)"	"unprognostic (8.55e-3)"	"unprognostic (4.08e-3)"	"unprognostic (2.11e-1)"	"unprognostic (1.45e-2)"	"unprognostic (1.70e-1)"	"unprognostic (8.66e-2)"	"unprognostic (4.08e-1)"	"unprognostic (2.24e-2)"	28.8	19.5	19.1	27.6	26.7	39.6	25.3	21.9	19.2	19.2	26.0	20.9	16.5	10.0	25.4	19.7	16.6	22.2	22.5	38.3	17.1	17.6	17.9	16.3	27.9	42.2	19.5	16.3	21.7	32.3	15.8	18.7	22.7	19.2	22.6	6.9	21.5	22.6	22.7	43.2	7.6	16.9	22.5	19.4	39.7	24.2	21.5	18.9	39.2	17.8	13.8	24.0	22.1	30.5	11.5	17.0	24.1	30.6	13.5	20.7	15.2	37.7	22.5	8.4	17.4	13.6	16.1	13.8	13.6	16.3	14.4	13.8	8.8	21.7	36.1	35.2	23.3	18.0	8.8	13.4	6.0	5.6	29.2	17.4	43.2	14.4	18.6	45.1	17.0	27.1	11.5	4.4	8.7	13.7	16.4	33.4	19.2	19.1	25.1	10.6	15.5	25.5	15.7	15.2	13.7	25.8	34.3	11.5	25.9	7.1	6.2	30.6	43.4	8.4	10.8	22.0	4.2	9.7	29.6	49.9	28.6	12.3	34.6	20.6	33.0	30.0	19.7	18.8	34.1	22.4	15.4	17.3	24.1	20.7	24.2	15.7	10.7	14.0	14.2	17.0	11.5	13.1	14.3	21.3	13.5	30.6	11.1	15.9	15.2	19.1	26.7	21.9	17.3	17.1	17.6	19.5	16.3	19.2	18.9	3.0	2.1	24.5	5.5	3.3	36.7	3.5	25.5	1.4	1.2	33.2	15.7	1.9	1.7	23.7	4.1	29.5	2.6	0.0	25.6	12.9	16.0	10.2	2.3	9.6	49.5	46.1	38.6	51.0	56.2	6.7	18.4	27.1	16.9	29.7	12.0	47.4	49.8	9.5	21.5	12.7	25.3	25.8	16.5	6.3	26.6	2.4	3.1	48.4	6.6	3.2
PKN2	"Pak-2, PRK2, PRKCL2, STK7"	ENSG00000065243	"Protein kinase N2"	Q16513	1	88684222-88836255	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Apoptosis, Cell adhesion, Cell cycle, Cell division, Cilium biogenesis/degradation, Host-virus interaction, Transcription, Transcription regulation"	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in all"	5	"neutrophil: 35.7"	"Lineage enriched"	"Detected in all"	8	"granulocytes: 35.7"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA034861, HPA057913"	Approved		Supported	"Nucleoplasm,Nuclear bodies,Plasma membrane,Intermediate filaments,Centrosome,Cytosol"		Yes	No			"Nucleoplasm, Intermediate filaments"	"Nuclear bodies, Plasma membrane, Centrosome, Cytosol"	"HPA034861: AB_2674363, HPA057913: AB_2732617"	"unprognostic (7.52e-2)"	"unprognostic (1.46e-1)"	"prognostic favorable (5.67e-4)"	"unprognostic (5.95e-2)"	"unprognostic (3.39e-2)"	"unprognostic (2.51e-2)"	"unprognostic (4.64e-3)"	"unprognostic (1.38e-1)"	"unprognostic (4.43e-2)"	"unprognostic (1.27e-2)"	"unprognostic (2.90e-3)"	"unprognostic (1.23e-1)"	"unprognostic (1.51e-2)"	"unprognostic (5.98e-2)"	"unprognostic (2.38e-1)"	"unprognostic (1.01e-2)"	"unprognostic (1.99e-1)"	21.9	20.7	12.2	21.2	13.7	33.5	27.6	25.6	16.6	28.6	39.3	12.6	15.1	22.9	20.0	20.2	28.2	17.1	13.3	16.2	10.3	8.9	15.9	15.9	26.0	16.4	13.7	8.7	27.2	18.9	24.6	29.7	20.8	13.3	19.6	23.6	14.1	19.5	25.1	15.9	17.5	49.0	17.5	12.5	18.0	15.9	12.4	16.2	29.1	20.3	14.4	13.1	21.9	22.0	4.0	3.7	35.7	4.5	1.4	3.0	1.0	23.7	9.3	18.5	11.1	12.4	14.1	12.0	14.1	13.0	15.8	16.5	9.9	17.1	9.4	16.8	13.4	19.5	18.8	18.0	10.7	21.7	3.3	13.1	6.9	19.4	8.4	10.9	6.8	2.1	11.6	11.1	12.4	15.0	12.6	18.0	7.5	11.5	6.9	17.0	4.8	7.8	5.9	9.3	9.0	10.9	7.5	28.2	3.8	14.0	46.8	9.0	5.9	21.1	12.2	18.1	14.6	9.1	6.2	16.8	13.5	12.1	17.2	14.7	3.8	3.2	6.4	5.6	6.7	5.0	4.9	4.5	6.8	2.6	2.5	2.3	3.3	2.3	2.4	2.1	4.0	3.0	2.6	35.7	1.4	3.2	3.7	1.8	1.0	12.2	13.7	25.6	16.6	10.3	8.9	13.7	8.7	13.3	16.2	38.7	52.6	24.5	42.6	42.9	83.6	41.1	40.8	45.5	39.8	66.3	84.4	37.5	10.0	51.4	2.1	51.2	79.8	70.0	52.5	29.4	35.1	52.3	15.1	32.6	20.4	62.0	42.5	51.0	34.3	2.9	50.3	29.0	30.4	41.5	55.9	64.3	62.0	87.7	45.3	22.4	151.6	38.8	29.8	35.8	18.8	45.8	31.2	21.0	50.9	118.4
PKN3	"PKNbeta, UTDP4-1"	ENSG00000160447	"Protein kinase N3"	Q6P5Z2	9	128702523-128720918	"Enzymes, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	11	"Endothelial cells: 13.4;Extravillous trophoblasts: 5.1;Ito cells: 6.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HeLa: 33.4;REH: 20.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA045390, HPA058305"	Uncertain		Approved	Vesicles		NA	NA			Vesicles		"HPA045390: AB_2679308, HPA058305: AB_2683674"	"unprognostic (4.36e-2)"	"unprognostic (5.70e-2)"	"unprognostic (2.68e-2)"	"unprognostic (7.62e-2)"	"unprognostic (2.23e-1)"	"unprognostic (2.65e-2)"	"unprognostic (6.10e-2)"	"unprognostic (8.04e-2)"	"unprognostic (1.78e-1)"	"unprognostic (3.68e-1)"	"unprognostic (1.48e-1)"	"unprognostic (7.91e-2)"	"unprognostic (8.73e-3)"	"unprognostic (6.18e-3)"	"unprognostic (9.99e-2)"	"unprognostic (7.23e-2)"	"unprognostic (2.36e-1)"	11.4	1.8	1.5	6.8	3.8	3.7	10.5	10.1	3.9	4.3	5.8	3.7	4.8	7.7	9.7	2.2	7.1	5.3	10.9	7.3	2.3	1.7	5.0	6.4	8.9	9.1	3.9	1.2	4.0	4.2	3.3	1.4	5.6	4.5	4.2	1.6	4.1	12.9	3.7	7.4	6.7	5.4	4.9	4.4	7.8	7.4	4.3	1.7	9.3	8.1	6.1	5.9	4.4	5.0	0.4	1.0	2.3	0.7	1.0	1.8	0.3	1.4	6.9	5.6	8.5	0.0	0.1	13.9	4.3	1.3	6.3	6.5	0.0	5.0	0.0	4.2	2.3	1.3	9.3	6.8	1.0	1.4	4.3	12.8	8.2	33.4	9.7	1.0	1.0	1.5	0.3	0.3	3.4	0.9	1.3	12.4	2.5	18.6	0.9	1.1	12.8	1.2	4.4	5.2	6.3	2.0	20.3	10.6	1.8	2.6	0.8	0.9	4.2	3.2	1.7	3.2	3.2	6.1	6.6	10.7	0.0	5.3	9.9	3.2	3.1	1.3	2.7	0.8	1.0	3.9	0.0	0.1	1.4	0.9	0.7	1.8	0.2	0.6	0.8	1.0	0.4	0.8	0.1	2.3	1.0	0.2	0.2	1.0	0.3	1.5	3.8	10.1	3.9	2.3	1.7	3.9	1.2	4.5	1.7	0.0	1.3	0.0	1.4	0.9	0.0	1.5	0.0	0.0	2.3	0.0	0.0	1.2	0.0	1.6	0.3	13.4	1.1	0.0	2.3	5.1	0.9	0.9	0.0	0.2	1.5	0.0	0.0	6.2	0.3	0.4	1.4	0.2	0.0	1.8	1.0	0.5	2.6	0.8	0.7	0.3	0.2	0.0	0.8	1.0	3.4	0.9	1.1	1.0	1.4	1.6
PLA2G10	GXPLA2	ENSG00000069764	"Phospholipase A2 group X"	O15496	16	14672545-14694669	"Enzymes, Predicted secreted proteins, RAS pathway related proteins"	"Lipid metabolism, Phospholipid metabolism"	Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"intestine: 9.4;stomach 1: 13.0"	"Cell type enhanced"	"Detected in many"	10	"Enterocytes: 54.8;Exocrine glandular cells: 106.2;Extravillous trophoblasts: 45.9;Mucus-secreting cells: 110.3;Paneth cells: 80.4"	"Low cancer specificity"	"Detected in many"							"Cell type enhanced"	"Detected in single"		"neutrophil: 2.0"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"BEWO: 2.6;CAPAN-2: 4.2;OE19: 4.6;SK-BR-3: 2.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA041893	Uncertain				"Secreted in other tissues"	NA	NA					"HPA041893: AB_10794495"	"unprognostic (8.44e-3)"	"unprognostic (2.37e-1)"	"unprognostic (6.72e-2)"	"prognostic favorable (5.74e-5)"	"unprognostic (1.62e-2)"	"unprognostic (3.16e-2)"	"unprognostic (5.48e-2)"	"unprognostic (6.76e-2)"	"unprognostic (1.77e-2)"	"unprognostic (2.72e-1)"	"unprognostic (4.81e-2)"	"unprognostic (2.39e-1)"	"unprognostic (2.12e-1)"	"unprognostic (4.08e-2)"	"unprognostic (1.03e-1)"	"unprognostic (2.30e-2)"	"unprognostic (9.97e-3)"	0.0	0.0	0.0	0.6	0.4	0.0	0.0	0.0	0.0	0.3	9.4			2.4	0.0	0.0	0.0	1.1	0.9	0.0	0.0	0.0	0.0	0.0	4.0	0.0	0.0		0.0	4.2	0.0	0.0	0.0		0.2	7.2		0.0	0.0	0.0	0.0	4.6	0.0	0.0	0.0	13.0	2.1			0.0		0.0	2.8	0.0	0.9	0.5	2.0	0.5	0.1	0.4	0.1	0.1	0.9	0.1	0.1	0.0	0.1	2.6	0.1	0.0	0.0	0.0	0.6	4.2	0.3	0.4	0.0	0.1	2.0	0.0	0.0	0.0	0.1	0.1	0.3	0.4	0.0	0.1	0.8	0.8	0.0	0.1	0.0	0.1	0.0	0.0	0.4	0.2	0.7	0.0	1.9	0.3	0.2	0.4	4.6	0.1	0.8	0.3	0.2	0.0	0.3	0.6	0.5	1.0	2.6	0.3	0.3	0.4	0.4	0.8	0.0	0.3	0.1	0.0	0.7	2.1	0.7	0.6	0.1	0.1	0.1	0.5	0.5	0.3	0.4	0.3	0.1	0.2	0.4	0.5	0.9	0.3	0.3	2.0	0.1	0.3	0.3	0.1	0.1											32.8	17.2	0.0	0.7	0.0	0.0	0.0	10.2	32.1	9.1	1.8	0.0	0.4	0.0	0.3	0.3	0.0	54.8	0.0	106.2	45.9	0.0	1.9	0.0	0.0	0.8	0.0	12.2	0.0	0.0	0.7	0.0	0.0	0.0	0.0	110.3	0.0	15.5	80.4	0.0	0.0	0.0	0.0	0.0	0.7	0.5	0.0	0.5	0.0	23.8	12.6
PLA2G12A	PLA2G12	ENSG00000123739	"Phospholipase A2 group XIIA"	Q9BZM1	4	109709989-109730077	"Enzymes, Predicted secreted proteins, RAS pathway related proteins"	"Lipid degradation, Lipid metabolism"	Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035908, HPA035909"	Approved				"Secreted to blood"	NA	NA					"HPA035908: AB_2674856, HPA035909: AB_10672074"	"unprognostic (8.40e-2)"	"unprognostic (3.87e-1)"	"unprognostic (3.81e-3)"	"unprognostic (3.09e-2)"	"unprognostic (2.10e-1)"	"unprognostic (1.35e-1)"	"unprognostic (4.26e-2)"	"unprognostic (1.77e-1)"	"unprognostic (1.90e-1)"	"unprognostic (2.71e-3)"	"unprognostic (1.02e-1)"	"unprognostic (8.42e-2)"	"prognostic favorable (2.54e-9)"	"unprognostic (3.10e-1)"	"unprognostic (1.39e-1)"	"unprognostic (9.16e-3)"	"unprognostic (3.64e-2)"	9.8	9.9	13.1	4.4	16.2	5.6	12.9	14.5	14.3	9.6	12.2	13.4	7.3	11.9	8.9	8.2	12.6	9.2	9.2	21.0	13.0	11.4	15.3	20.6	7.8	4.9	16.8	11.7	11.9	38.8	22.8	19.0	10.4	12.7	16.4	12.0	10.7	12.1	8.3	21.1	9.8	16.3	8.1	20.3	5.5	10.0	5.7	12.4	4.9	19.0	9.2	6.2	7.5	7.7	4.9	8.7	3.6	4.6	4.9	10.2	13.8	9.6	3.6	2.8	4.2	9.0	9.0	5.5	8.9	7.1	5.0	5.3	8.9	17.0	13.8	6.7	6.5	8.4	5.4	8.6	11.5	7.7	5.1	13.4	4.9	10.4	5.3	8.9	10.6	3.5	9.1	13.4	5.1	12.6	9.1	5.0	13.0	27.0	6.4	8.5	17.0	8.6	4.8	5.0	22.0	14.0	5.2	8.5	10.9	9.4	14.3	18.1	6.0	7.8	20.7	6.7	7.6	12.4	2.3	5.9	7.3	6.1	7.5	6.1	10.9	19.6	10.2	8.2	6.2	9.1	3.6	4.6	2.7	7.2	2.9	6.6	4.2	9.0	6.9	8.7	4.9	10.2	9.2	2.2	4.9	4.4	7.6	8.7	13.8	13.1	16.2	14.5	14.3	13.0	11.4	16.8	11.7	12.7	12.4	23.8	17.9	15.2	28.9	32.5	46.8	53.4	30.6	10.7	13.6	21.0	47.1	33.9	23.2	12.4	18.0	12.7	27.4	23.3	22.2	44.9	23.9	62.2	13.9	86.9	17.1	25.4	103.4	18.4	19.4	7.1	30.8	8.9	28.7	1.8	52.7	39.7	13.5	35.1	32.5	14.6	39.5	19.4	19.1	55.2	41.1	37.3	28.8	13.8	59.3	35.7
PLA2G16	"AdPLA, H-REV107-1, HRASLS3, HREV107, HREV107-3, MGC118754."	ENSG00000176485	"Phospholipase A2 group XVI"	P53816	11	63573195-63616883	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins, RAS pathway related proteins"	"Host-virus interaction, Lipid degradation, Lipid metabolism"	"Hydrolase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adipose tissue: 113.6"	"Cell type enhanced"	"Detected in many"	9	"monocytes: 759.2;Proximal tubular cells: 471.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"plasmacytoid DC: 52.4"	"Group enriched"	"Detected in many"	5	"dendritic cells: 52.4;T-cells: 16.0"	"Cell line enhanced"	"Detected in many"		"A549: 32.7;ASC diff: 37.1;CAPAN-2: 59.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA011749, HPA058997"	Uncertain		Supported	Mitochondria		NA	NA			Mitochondria		"HPA011749: , HPA058997: AB_2683874"	"unprognostic (5.18e-2)"	"unprognostic (3.67e-2)"	"unprognostic (7.92e-2)"	"unprognostic (3.89e-2)"	"unprognostic (1.94e-1)"	"unprognostic (1.78e-1)"	"unprognostic (1.13e-1)"	"unprognostic (3.06e-2)"	"unprognostic (6.97e-2)"	"unprognostic (1.14e-1)"	"prognostic unfavorable (5.58e-6)"	"unprognostic (6.38e-2)"	"unprognostic (1.93e-3)"	"unprognostic (1.62e-1)"	"unprognostic (1.75e-1)"	"prognostic favorable (2.54e-5)"	"unprognostic (2.35e-1)"	113.6	15.2	32.0	4.4	39.4	1.6	33.9	4.8	30.2	6.1	7.2	46.6	6.1	4.0	5.0	11.5	5.9	13.9	12.9	39.0	37.6	25.2	24.7	28.9	13.5	4.5	58.4	22.2	30.9	13.2	15.1	8.1	16.2	30.5	5.9	3.7	8.8	10.1	13.2	37.8	2.4	7.5	8.0	70.4	6.4	10.2	17.8	48.9	0.1	17.1	11.1	2.3	8.0	4.7	2.1	52.4	0.4	6.2	5.3	16.0	6.4	20.6	32.7	0.9	0.0	37.1	6.4	6.0	0.7	6.6	5.5	2.7	7.4	59.7	0.0	13.8	1.6	18.0	1.0	30.9	1.6	4.2	25.5	1.2	0.3	7.8	1.2	22.1	0.0	0.3	3.8	0.1	13.6	0.5	22.0	8.6	0.0	0.3	2.3	5.8	3.6	0.0	0.1	2.6	13.0	10.6	0.0	0.0	2.0	17.3	2.9	0.4	2.4	4.4	12.5	6.8	14.0	27.1	1.0	12.6	2.4	0.1	8.3	1.8	9.8	6.4	0.0	9.9	0.0	0.2	0.0	6.2	0.0	16.0	2.4	8.8	2.1	3.7	11.6	1.7	0.3	1.2	9.4	0.4	5.3	0.1	52.4	2.4	6.4	32.0	39.4	4.8	21.9	37.6	25.2	58.4	22.2	30.5	48.9	95.3	77.4	17.6	17.3	10.3	10.6	128.7	96.8	113.8	45.5	109.9	3.9	112.1	96.2	54.1	56.9	116.5	22.2	0.0	99.5	300.4	35.3	29.0	56.6	210.7	56.9	38.1	3.4	165.7	48.0	16.0	28.7	51.4	25.3	759.2	4.5	120.3	123.3	14.4	20.5	471.4	17.2	12.9	42.8	135.2	4.9	8.2	243.0	69.8	1.7	59.6
PLA2G1B	"PLA2, PLA2A, PPLA2"	ENSG00000170890	"Phospholipase A2 group IB"	P04054	12	120322111-120327789	"Candidate cardiovascular disease genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins, Predicted secreted proteins, RAS pathway related proteins"	"Lipid metabolism, Phospholipid metabolism"	Hydrolase	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	933	"pancreas: 2360.6"	"Cell type enriched"	"Detected in many"	10	"Exocrine glandular cells: 17927.2"	"Cancer enriched"	"Detected in many"	185	"pancreatic cancer: 763.5"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"naive CD4 T-cell: 2.5"	"Group enriched"	"Detected in many"	19	"NK-cells: 1.3;T-cells: 2.5"	"Cell line enhanced"	"Detected in some"		"EFO-21: 2.2;Hep G2: 6.4;U-2 OS: 4.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA047822, HPA060803"	Enhanced				"Secreted to digestive system"	NA	NA		3900000			"HPA047822: AB_2680169, HPA060803: AB_2684369"	"unprognostic (1.28e-4)"	"unprognostic (6.02e-2)"	"unprognostic (1.84e-2)"	"unprognostic (2.86e-2)"	"unprognostic (2.74e-2)"	"unprognostic (2.41e-1)"	"unprognostic (1.05e-1)"	"unprognostic (1.13e-1)"	"unprognostic (2.63e-2)"	"unprognostic (3.61e-2)"	"unprognostic (1.27e-1)"	"unprognostic (1.03e-1)"	"unprognostic (2.80e-4)"	"unprognostic (2.15e-1)"	"unprognostic (1.97e-1)"	"unprognostic (3.60e-1)"	"unprognostic (8.61e-4)"	0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.2	0.1	0.0	0.1	0.1	1.1	0.1	0.1	0.1	1.1	2360.6	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.2	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.3	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	1.3	2.5	0.9	0.2	0.0	1.2	0.2	0.0	0.0	0.0	0.0	0.0	0.3	1.6	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.3	0.0	0.0	1.4	0.0	0.0	0.0	6.4	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	1.8	0.2	0.0	0.0	0.0	0.7	0.4	0.0	0.0	0.0	0.5	0.0	0.3	1.3	0.3	1.6	0.0	0.0	0.3	0.0	0.1	0.6	0.0	1.0	0.2	4.7	0.6	0.6	0.0	1.2	0.4	0.0	0.6	0.0	0.0	0.0	0.0	0.9	0.0	1.7	0.0	0.0	0.3	0.0	0.0	2.5	0.9	0.0	1.3	0.0	0.0	0.0	0.9	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	11.9	65.5	0.0	0.1	0.0	0.0	0.3	0.0	1.4	1.2	0.0	0.0	0.0	1.7	16.1	7.5	0.0	0.7	0.0	17927.2	0.0	0.0	0.2	0.0	1.6	0.0	0.0	1.2	0.0	0.0	27.8	2.8	0.3	0.0	76.7	1.0	0.0	1839.8	1.1	3.2	2.1	0.0	0.0	0.0	0.2	0.2	0.1	0.0	0.7	1.2	0.0
PLA2G2A	"PLA2B, PLA2L"	ENSG00000188257	"Phospholipase A2 group IIA"	P14555	1	19975431-19980416	"Enzymes, FDA approved drug targets, Predicted secreted proteins, RAS pathway related proteins"	"Inflammatory response, Lipid metabolism, Phospholipid metabolism"	"Antimicrobial, Bacteriolytic enzyme, Hydrolase"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 377.9"	"Cell type enhanced"	"Detected in many"	11	"Enterocytes: 366.3;Exocrine glandular cells: 945.9;Glandular cells: 937.5;Paneth cells: 354.3;Undifferentiated cells: 591.0"	"Cancer enhanced"	"Detected in all"		"prostate cancer: 875.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	23	"Hep G2: 23.4;OE19: 64.1;RT4: 21.5"					"Not detected"	"Not detected"			HPA015236	Enhanced				"Secreted to blood"	NA	NA	1000000	290000			"HPA015236: AB_10601047"	"unprognostic (2.33e-2)"	"unprognostic (1.28e-1)"	"unprognostic (2.79e-2)"	"unprognostic (7.85e-3)"	"unprognostic (8.71e-2)"	"unprognostic (9.27e-2)"	"unprognostic (2.02e-1)"	"unprognostic (1.80e-1)"	"prognostic favorable (1.49e-4)"	"unprognostic (1.68e-1)"	"unprognostic (1.06e-1)"	"unprognostic (1.58e-2)"	"unprognostic (3.77e-15)"	"unprognostic (2.72e-2)"	"unprognostic (9.14e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.51e-1)"	25.2	1.0	0.0	13.1	0.0	0.6	14.0	0.0	0.6	1.4	63.9	0.0	0.1	35.0	0.7	22.7	31.5	11.7	2.4	105.4	0.0	0.0	1.6	377.9	3.0	6.5	0.0	0.0	35.6	2.4	0.6	0.5	15.5	0.0	27.1	68.2	6.1	9.5	1.0	30.6	5.0	99.0	39.7	0.0	0.6	4.0	9.8	0.0	0.0	16.0	8.9	19.3	39.0	72.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	23.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	64.1	0.0	0.0	0.0	0.6	0.0	21.5	0.0	0.2	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.0	4.1	6.7	10.0	12.4	0.0	7.2	5.1	2.7	6.8	0.0	0.0	2.8	1.7	0.0	3.0	8.4	366.3	0.0	945.9	3.3	308.9	937.5	4.6	51.6	8.2	0.0	59.8	35.0	6.0	7.5	158.5	4.9	13.5	0.0	270.5	0.0	3.6	354.3	1.1	0.0	0.0	0.0	11.3	0.5	0.1	14.6	5.7	8.4	591.0	9.1
PLA2G2D	sPLA2S	ENSG00000117215	"Phospholipase A2 group IID"	Q9UNK4	1	20111939-20119566	"Enzymes, Predicted secreted proteins, RAS pathway related proteins"	"Lipid degradation, Lipid metabolism"	Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"lymphoid tissue: 39.9"	"Group enriched"	"Detected in some"	10	"Kupffer cells: 2.2;Melanocytes: 5.0"	"Cancer enriched"	"Detected in many"	6	"testis cancer: 25.6"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"memory B-cell: 6.6;naive B-cell: 5.6;plasmacytoid DC: 3.4"	"Group enriched"	"Detected in many"	5	"B-cells: 6.6;dendritic cells: 3.4"	"Cell line enriched"	"Detected in some"	6	"RPMI-8226: 13.7"	"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"								"Secreted - unknown location"	NA	NA						"prognostic favorable (4.35e-4)"	"prognostic favorable (8.15e-5)"	"unprognostic (3.88e-3)"	"prognostic favorable (9.74e-4)"	"unprognostic (1.78e-1)"	"unprognostic (2.56e-3)"	"unprognostic (1.98e-1)"	"unprognostic (1.60e-2)"	"unprognostic (1.82e-5)"	"unprognostic (7.51e-4)"	"unprognostic (2.50e-2)"	"unprognostic (1.22e-1)"	"unprognostic (4.64e-3)"	"unprognostic (1.05e-1)"	"unprognostic (2.85e-1)"	"unprognostic (8.08e-2)"	"unprognostic (2.60e-1)"	0.4	0.3	0.3	38.8	0.3	0.0	0.4	0.3	0.3	0.3	0.9	0.0	0.0	0.3	0.3	0.2	0.4	0.5	0.4	0.3	0.3	0.3	0.4	0.4	1.0	39.9	0.3	0.0	0.3	0.3	0.0	0.3	0.2	0.0	0.4	1.2	0.1	5.0	0.3	0.3	0.3	7.7	0.0	0.3	18.1	0.6	0.3	0.0	6.6	0.7	0.5	33.0	2.5	0.3	6.6	3.4	1.0	0.2	0.3	0.1	0.2	0.0	0.1	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.7	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.2	0.2	0.6	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	13.7	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.3	0.1	0.0	0.3	0.2	2.1	0.1	0.2	0.1	0.1	0.0	1.0	0.2	0.2	0.1	0.1	0.1	6.6	0.1	0.1	0.1	5.6	0.1	0.1	0.4	0.3	0.1	3.4	0.0	0.2	0.3	0.3	0.3	0.3	0.3	0.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.0	2.2	0.0	0.0	0.0	5.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1
PLA2G2E		ENSG00000188784	"Phospholipase A2 group IIE"	Q9NZK7	1	19920009-19923617	"Enzymes, Predicted secreted proteins, RAS pathway related proteins"	"Inflammatory response, Lipid metabolism, Phospholipid metabolism"	Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in some"	10	"lymphoid tissue: 7.7;skin 1: 3.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"CACO-2: 1.9;CAPAN-2: 1.2;OE19: 2.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA064085	Uncertain				"Secreted - unknown location"	NA	NA					"HPA064085: AB_2685188"														"unprognostic (9.56e-2)"		"unprognostic (3.71e-2)"		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.0	3.2	0.5	0.0	0.0	0.0	0.0	0.2			0.0		7.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.4	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
PLA2G2F		ENSG00000158786	"Phospholipase A2 group IIF"	Q9BZM2	1	20139326-20150386	"Enzymes, Predicted membrane proteins, RAS pathway related proteins"	"Immunity, Innate immunity, Lipid degradation, Lipid metabolism"	Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"lymphoid tissue: 11.1;skin 1: 13.7;urinary bladder: 19.5"	"Cell type enhanced"	"Detected in some"	13	"Cardiomyocytes: 1.0;Collecting duct cells: 1.8;Suprabasal keratinocytes: 1.5"	"Cancer enriched"	"Detected in some"	18	"urothelial cancer: 17.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	67	"RT4: 56.2"	"Region enriched"	"Detected in single"	4	"hippocampal formation: 3.3"	"Not detected"	"Not detected"								"Intracellular and membrane"	NA	NA						"unprognostic (1.95e-1)"	"unprognostic (1.18e-1)"	"unprognostic (2.64e-2)"	"unprognostic (1.79e-2)"		"unprognostic (5.11e-2)"		"unprognostic (4.63e-2)"	"unprognostic (4.83e-2)"	"unprognostic (1.51e-1)"	"unprognostic (1.61e-2)"	"unprognostic (3.36e-5)"		"unprognostic (7.06e-2)"	"unprognostic (1.84e-1)"	"unprognostic (4.69e-1)"	"prognostic favorable (3.86e-4)"	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.6	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	4.8	0.0	7.7	0.0	0.0	0.0	0.0	0.0	13.7	0.1	6.5	0.0	0.0	0.3	0.1	0.0	2.8	0.0	6.3	11.1	19.5	3.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	56.2	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.7	0.0	0.0	0.7
PLA2G3	GIII-SPLA2	ENSG00000100078	"Phospholipase A2 group III"	Q9NZ20	22	31134809-31140607	"Enzymes, Predicted secreted proteins, RAS pathway related proteins"	"Cilium biogenesis/degradation, Lipid metabolism, Mast cell degranulation, Phospholipid metabolism"	Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"esophagus: 13.1;skin 1: 14.1;tongue: 17.4"	"Cell type enriched"	"Detected in some"	7	"Suprabasal keratinocytes: 15.6"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in single"		"pons and medulla: 3.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"AF22: 14.2;AN3-CA: 14.3;NTERA-2: 7.3;SCLC-21H: 11.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA021016	Uncertain				"Secreted to blood"	NA	NA					"HPA021016: AB_1855443"	"unprognostic (1.80e-1)"	"unprognostic (4.63e-3)"	"unprognostic (1.07e-1)"	"unprognostic (1.49e-2)"	"unprognostic (9.72e-2)"	"prognostic favorable (4.47e-4)"		"unprognostic (1.74e-2)"	"unprognostic (2.30e-1)"	"unprognostic (4.25e-2)"	"unprognostic (9.55e-3)"	"unprognostic (4.41e-1)"		"unprognostic (3.67e-1)"	"unprognostic (3.29e-1)"	"unprognostic (9.49e-3)"	"unprognostic (3.72e-2)"	0.1	0.0	0.1	0.1	0.2	0.0	2.0	0.4	0.9	5.3	0.1	0.1	1.9	0.5	0.3	0.1	13.1	0.0	0.1	0.1	0.6	0.0	0.3	0.1	4.2	0.1	0.1	0.4	0.1	0.1	1.7	0.1	0.1	3.1	0.4	0.0	0.8	1.8	0.5	0.3	14.1	0.1	0.1	0.1	0.1	0.9	0.3	0.1	0.4	0.8	17.4	3.5	0.1	6.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.2	14.3	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.7	0.2	0.5	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.3	0.0	0.0	0.0	0.0	0.9	0.0	0.0	11.1	0.0	0.0	0.0	0.0	0.2	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.4	0.9	0.6	0.0	0.1	0.4	3.1	0.1	0.0	2.2	0.0	0.1	1.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	15.6	0.0	0.0	0.0	0.4
PLA2G4A	"cPLA2-alpha, PLA2G4"	ENSG00000116711	"Phospholipase A2 group IVA"	P47712	1	186828953-186988981	"Disease related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins, RAS pathway related proteins"	"Fatty acid biosynthesis, Fatty acid metabolism, Glycerol metabolism, Leukotriene biosynthesis, Lipid biosynthesis, Lipid degradation, Lipid metabolism, Phospholipid degradation, Phospholipid metabolism, Prostaglandin biosynthesis, Prostaglandin metabolism"	Hydrolase	"Disease mutation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"ductus deferens: 52.6;parathyroid gland: 63.5;seminal vesicle: 56.1"	"Cell type enhanced"	"Detected in many"	7	"Basal keratinocytes: 19.1;Peritubular cells: 13.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	6	"classical monocyte: 7.1;eosinophil: 7.7;intermediate monocyte: 8.4;myeloid DC: 7.8;non-classical monocyte: 3.9;plasmacytoid DC: 3.2"	"Group enriched"	"Detected in many"	7	"dendritic cells: 7.8;granulocytes: 7.7;monocytes: 8.4"	"Cell line enhanced"	"Detected in many"		"HeLa: 23.0;OE19: 33.2;RPMI-8226: 28.5;U-2197: 27.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"CAB010050, HPA050062, HPA054206"	Approved		Supported	Vesicles,Cytosol		NA	NA		78000	Cytosol	Vesicles	"CAB010050: AB_631312, HPA050062: AB_2681002, HPA054206: AB_2682417"	"prognostic favorable (9.07e-4)"	"unprognostic (1.18e-1)"	"unprognostic (2.03e-1)"	"prognostic favorable (2.85e-4)"	"unprognostic (5.55e-2)"	"unprognostic (1.51e-3)"	"unprognostic (2.67e-2)"	"unprognostic (2.43e-1)"	"unprognostic (2.63e-1)"	"unprognostic (7.14e-3)"	"unprognostic (1.50e-1)"	"unprognostic (1.68e-1)"	"unprognostic (2.96e-2)"	"unprognostic (8.07e-2)"	"unprognostic (1.58e-1)"	"unprognostic (1.90e-2)"	"unprognostic (4.26e-2)"	6.0	8.6	3.4	3.5	5.3	2.2	3.8	1.5	4.7	8.5	10.9	2.9	52.6	5.4	7.7	7.4	7.0	12.3	4.2	6.6	3.3	2.5	6.7	1.1	4.9	5.2	6.5	1.4	5.1	3.8	63.5	2.7	2.9	5.6	10.9	4.2	2.9	5.8	56.1	0.6	6.1	10.3	14.6	7.5	4.2	5.1	2.7	5.3	0.4	2.7	5.9	2.3	19.4	9.4	0.0	7.8	7.7	8.4	1.1	0.2	1.5	0.0	15.8	0.0	0.0	9.9	4.0	0.0	0.6	6.1	0.7	1.3	0.1	6.2	0.0	0.0	0.0	2.8	1.1	9.9	2.9	0.3	4.8	0.2	2.9	23.0	0.0	6.1	4.3	1.5	2.2	2.0	7.9	1.6	1.0	6.6	1.3	6.4	2.3	0.0	0.0	0.0	0.0	0.8	33.2	2.1	0.0	0.0	28.5	0.0	2.1	0.0	0.0	2.3	0.8	2.8	0.3	0.3	5.8	1.3	5.9	0.8	27.0	1.2	0.9	0.0	0.0	2.1	12.8	8.3	0.1	7.1	7.7	0.0	8.4	0.2	0.0	0.0	0.0	7.8	0.0	0.0	0.0	0.6	1.1	3.9	3.2	0.0	1.5	3.4	5.3	1.5	4.7	3.3	2.5	6.5	1.4	5.6	5.3	0.0	0.6	0.0	2.8	19.1	0.0	0.8	0.0	1.4	1.2	0.0	0.0	0.1	1.7	1.6	0.7	6.0	1.3	0.0	0.0	0.0	4.3	1.7	10.4	0.0	5.5	0.0	1.2	1.3	8.8	0.6	9.8	6.0	5.0	1.0	1.7	0.0	1.1	2.8	13.8	0.1	0.2	0.0	3.4	0.5	0.1	7.9	0.0	0.0	2.9	10.5
PLA2G4B	"cPLA2-beta, HsT16992"	ENSG00000243708	"Phospholipase A2 group IVB"	P0C869	15	41837775-41848147	"Enzymes, Predicted intracellular proteins, RAS pathway related proteins"	"Lipid degradation, Lipid metabolism"	Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 36.0;skin 1: 32.8;tongue: 56.0"	"Group enriched"	"Detected in some"	4	"Alveolar cells type 2: 1.9;Club cells: 2.3;Rod photoreceptor cells: 1.3"	"Not detected"	"Not detected"			"Region enriched"	"Detected in all"	4	"cerebellum: 10.8"	"Cell type enhanced"	"Detected in some"		"NK-cell: 3.9"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"RT4: 11.0;T-47d: 5.9"															NA	NA						"unprognostic (6.16e-2)"	"unprognostic (6.48e-3)"	"unprognostic (5.06e-3)"	"unprognostic (1.27e-4)"	"unprognostic (1.06e-1)"	"unprognostic (2.56e-3)"	"unprognostic (1.53e-1)"	"unprognostic (2.27e-2)"	"unprognostic (3.60e-2)"	"unprognostic (1.90e-2)"	"unprognostic (1.23e-2)"	"unprognostic (5.14e-3)"	"unprognostic (3.26e-5)"	"unprognostic (4.36e-1)"	"unprognostic (5.91e-2)"	"unprognostic (1.22e-1)"	"unprognostic (2.97e-2)"	1.8	1.2	1.8	1.8	2.2	3.4	3.6	10.8	2.1	6.1	1.8	1.8	1.8	1.9	2.7	2.3	19.3	2.0	1.9	1.8	1.8	2.5	2.5	2.6	2.2	3.3	1.8	1.8	4.2	3.5	1.4	3.2	1.8	1.8	4.8	1.1	1.8	7.0	2.7	1.8	32.8	2.4	1.8	1.8	3.0	1.8	1.8	1.8	2.2	4.8	56.0	36.0	2.0	5.9	3.0	0.5	0.2	0.8	3.9	1.5	0.1	1.3	0.7	0.0	0.0	0.1	0.0	3.7	0.4	1.2	1.3	0.1	0.3	0.7	0.3	0.1	0.7	0.1	4.4	1.5	0.5	0.3	0.0	2.5	1.1	1.4	3.4	1.7	0.2	1.4	0.9	4.9	0.2	1.3	0.1	0.6	1.9	1.7	0.2	0.4	2.1	1.0	4.1	1.0	5.5	1.2	0.0	1.2	0.9	1.0	11.0	0.2	1.1	0.0	2.0	1.0	0.9	5.9	1.8	0.0	0.0	1.0	1.0	0.1	3.4	0.0	0.9	0.3	5.0	0.0	0.0	0.8	0.0	1.5	0.5	0.9	0.1	0.4	0.8	0.5	3.0	0.9	0.8	0.2	3.9	0.2	0.5	1.2	0.1	1.8	2.2	10.8	2.1	1.8	2.5	1.8	1.8	1.8	1.8	0.0	1.9	0.0	0.2	0.0	0.4	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1
PLA2G4C	cPLA2-gamma	ENSG00000105499	"Phospholipase A2 group IVC"	Q9UP65	19	48047843-48110817	"Enzymes, Predicted intracellular proteins, RAS pathway related proteins"	"Host-virus interaction, Lipid metabolism, Phospholipid metabolism"	"Hydrolase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 31.8;skeletal muscle: 45.0"	"Cell type enhanced"	"Detected in many"	14	"Bipolar cells: 54.2;Cone photoreceptor cells: 62.8;Muller glia cells: 53.7;Rod photoreceptor cells: 133.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"intermediate monocyte: 7.9"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 8.2;HHSteC: 13.4;TIME: 18.6"	"Not detected"	"Not detected"							HPA043083	Approved		Approved	Cytosol		NA	NA			Cytosol		"HPA043083: AB_10795714"	"unprognostic (1.27e-1)"	"unprognostic (3.88e-2)"	"unprognostic (4.18e-2)"	"unprognostic (2.82e-2)"	"unprognostic (7.37e-2)"	"unprognostic (1.62e-2)"	"unprognostic (1.33e-1)"	"unprognostic (6.53e-2)"	"unprognostic (8.30e-2)"	"unprognostic (1.94e-1)"	"unprognostic (5.11e-3)"	"unprognostic (1.90e-1)"	"unprognostic (4.66e-2)"	"unprognostic (9.45e-2)"	"unprognostic (2.28e-3)"	"unprognostic (1.87e-1)"	"unprognostic (9.01e-2)"	4.0	11.7	8.9	4.2	23.2	0.4	3.0	12.9	14.5	3.4	3.5	23.4	2.0	5.1	6.8	5.2	3.6	4.3	4.6	18.5	10.0	10.0	4.4	3.8	5.9	7.2	31.8	8.5	2.0	4.1	14.8	4.6	4.1	16.9	5.7	2.9	5.4	3.1	6.7	45.0	4.9	6.7	8.1	18.6	8.1	2.4	2.4	17.1	0.7	3.3	7.5	4.3	4.9	2.1	5.4	2.0	0.0	7.9	1.5	0.8	2.0	0.7	1.1	0.0	0.3	5.2	3.0	0.1	1.3	8.2	1.2	3.5	0.0	2.1	0.0	1.8	3.2	2.6	0.2	0.0	0.2	2.0	0.8	0.1	0.0	0.3	1.2	13.4	0.0	1.8	0.6	0.3	0.5	5.4	2.5	5.1	0.0	0.0	7.4	2.0	2.0	0.0	0.1	0.1	0.9	0.1	0.1	1.8	0.7	2.5	0.4	0.8	0.1	1.5	2.6	6.3	4.2	0.7	1.8	18.6	2.3	0.7	2.5	0.9	0.5	1.4	0.2	1.6	0.0	4.4	0.0	3.2	0.0	0.2	7.9	0.6	5.4	0.8	0.0	2.0	1.6	0.0	0.0	0.0	1.5	2.0	1.4	0.2	2.0	8.9	23.2	12.9	14.5	10.0	10.0	31.8	8.5	16.9	17.1	3.0	1.7	0.5	0.8	2.5	54.2	30.9	10.2	0.0	0.0	0.0	62.8	0.1	1.7	7.7	0.2	16.9	1.6	0.0	2.5	0.2	3.8	1.7	0.0	1.0	5.0	31.8	0.0	3.1	0.3	0.0	0.6	2.8	6.8	4.6	1.5	53.7	4.1	0.3	7.4	3.4	133.4	12.9	11.8	0.3	0.5	2.6	0.1	0.0	0.0	0.1
PLA2G4D	cPLA2delta	ENSG00000159337	"Phospholipase A2 group IVD"	Q86XP0	15	42067009-42094554	"Enzymes, Predicted intracellular proteins, RAS pathway related proteins"	"Lipid degradation, Lipid metabolism"	Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	14	"cervix, uterine: 35.6;prostate: 22.4;skin 1: 13.9;tongue: 11.6;vagina: 17.1"	"Cell type enhanced"	"Detected in some"	15	"Cone photoreceptor cells: 2.0;Glandular cells: 2.2;Rod photoreceptor cells: 1.0;Suprabasal keratinocytes: 3.0"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	15	"RPMI-8226: 19.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"									NA	NA						"unprognostic (1.16e-1)"	"unprognostic (1.10e-2)"	"unprognostic (2.91e-2)"	"unprognostic (9.16e-3)"	"unprognostic (9.33e-3)"	"unprognostic (4.35e-2)"		"unprognostic (5.39e-2)"	"unprognostic (2.37e-1)"	"unprognostic (1.84e-1)"	"unprognostic (1.28e-2)"	"unprognostic (2.75e-1)"	"unprognostic (2.64e-7)"	"unprognostic (2.54e-2)"	"unprognostic (2.34e-1)"	"unprognostic (3.47e-2)"	"unprognostic (4.32e-2)"	0.1	0.1	0.1	0.1	0.1	0.0	0.3	0.1	0.1	35.6	0.1	0.1	0.1	0.0	1.4	0.3	1.2	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.5	0.1	0.1	0.1	0.1	0.1	0.0	0.5	0.1	0.1	22.4	0.0	0.1	0.6	0.1	0.1	13.9	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.4	0.1	11.6	1.2	0.6	17.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	19.8	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.3	0.8	0.0	0.3	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.5	3.0	0.0	0.0	0.0	0.3
PLA2G4E	FLJ45651	ENSG00000188089	"Phospholipase A2 group IVE"	Q3MJ16	15	41981582-42051190	"Enzymes, Predicted intracellular proteins, RAS pathway related proteins"	"Lipid degradation, Lipid metabolism"	"Hydrolase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	8	"skin 1: 19.9"	"Cell type enhanced"	"Detected in some"	27	"Alveolar cells type 2: 8.0;Basal keratinocytes: 16.1;Suprabasal keratinocytes: 39.3"	"Cancer enhanced"	"Detected in some"		"head and neck cancer: 11.2"					"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"CACO-2: 3.4;HaCaT: 2.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041105	Enhanced					NA	NA					"HPA041105: AB_2677300"	"unprognostic (2.98e-1)"	"unprognostic (5.52e-1)"	"unprognostic (2.60e-1)"	"unprognostic (5.99e-2)"		"unprognostic (5.12e-2)"	"unprognostic (1.54e-1)"	"unprognostic (1.99e-1)"	"unprognostic (2.77e-1)"	"unprognostic (4.22e-2)"	"unprognostic (2.43e-1)"	"unprognostic (1.22e-1)"	"unprognostic (1.83e-7)"	"unprognostic (1.81e-1)"	"unprognostic (2.68e-1)"	"unprognostic (7.48e-2)"	"unprognostic (4.67e-2)"	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.4	0.0			0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.6	0.0	0.0	19.9	0.0	0.0	0.0	0.0	0.0	0.0			0.0		2.3	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	3.4	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.7	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	8.0	0.0	0.2	16.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.9	0.0	0.0	3.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	39.3	0.0	0.0	0.0	0.5
PLA2G4F	PLA2G4F/Z	ENSG00000168907	"Phospholipase A2 group IVF"	Q68DD2	15	42139034-42156636	"Enzymes, Predicted intracellular proteins, RAS pathway related proteins"	"Lipid degradation, Lipid metabolism, Phospholipid degradation, Phospholipid metabolism"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lung: 30.4;skin 1: 48.1"	"Cell type enriched"	"Detected in many"	5	"Alveolar cells type 2: 54.9"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"OE19: 14.1;RT4: 10.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"HPA042713, HPA056752"	Enhanced		Approved	Nucleoplasm,Vesicles		NA	NA			Vesicles	Nucleoplasm	"HPA042713: AB_10793982, HPA056752: AB_2683226"	"unprognostic (1.99e-1)"	"unprognostic (6.21e-3)"	"unprognostic (1.59e-1)"	"prognostic unfavorable (2.00e-4)"		"unprognostic (1.06e-2)"	"unprognostic (2.32e-3)"	"unprognostic (1.48e-2)"	"unprognostic (5.85e-2)"	"unprognostic (2.25e-1)"	"unprognostic (4.79e-2)"	"unprognostic (6.65e-2)"	"unprognostic (1.21e-2)"	"unprognostic (9.32e-2)"	"unprognostic (1.11e-1)"	"unprognostic (4.55e-2)"	"unprognostic (1.63e-1)"	0.1	0.1	0.0	2.5	0.3	0.3	1.8	0.0	0.1	4.5	11.0	0.0	4.7	4.2	0.4	9.7	10.4	0.2	3.1	1.0	0.0	0.0	10.8	0.2	30.4	0.1	0.0	0.0	0.1	0.1	0.7	4.1	0.3	0.0	3.3	2.5	0.0	5.3	2.8	8.6	48.1	12.3	1.1	0.1	0.2	1.6	0.1	0.0	6.2	1.6	14.9	3.4	2.2	6.3	0.6	0.3	0.2	0.1	0.0	0.3	0.2	0.2	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	1.4	0.4	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.1	0.0	0.2	0.1	0.0	2.5	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	1.0	0.0	0.1	0.0	14.1	0.1	0.0	0.0	0.1	0.0	10.6	0.6	0.1	0.0	1.1	0.0	0.1	1.1	0.0	0.1	0.1	0.0	0.1	0.0	0.1	0.2	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.3	0.2	0.0	0.0	0.0	0.6	0.0	0.0	0.2	0.0	0.0	0.3	0.2	0.2	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.9	54.9	0.0	3.3	4.8	0.0	3.2	0.0	0.0	0.0	5.2	0.0	1.5	3.3	0.2	0.0	0.0	12.0	0.0	1.2	0.7	0.2	2.7	2.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.7	0.0	4.0	0.0	0.2	4.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.0	1.0	0.0	4.3	1.6
PLA2G5		ENSG00000127472	"Phospholipase A2 group V"	P39877	1	20028179-20091190	"Disease related genes, Enzymes, Potential drug targets, Predicted secreted proteins, RAS pathway related proteins"	"Fatty acid metabolism, Lipid degradation, Lipid metabolism, Phagocytosis, Phospholipid degradation, Phospholipid metabolism"	Hydrolase	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"heart muscle: 48.3;retina: 58.3"	"Cell type enhanced"	"Detected in some"	21	"Cardiomyocytes: 79.9;Cone photoreceptor cells: 66.8;Leydig cells: 75.4;Peritubular cells: 68.9;Sertoli cells: 258.7"	"Group enriched"	"Detected in many"	5	"glioma: 13.0;prostate cancer: 3.5"	"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	23	"plasmacytoid DC: 2.3"	"Lineage enriched"	"Detected in single"	23	"dendritic cells: 2.3"	"Cell line enhanced"	"Detected in some"		"EFO-21: 2.4;HaCaT: 1.1;hTEC/SVTERT24-B: 1.5;hTERT-RPE1: 1.4;U-138 MG: 3.1;U-2197: 6.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA053361	Approved				"Secreted - unknown location"	NA	NA					"HPA053361: AB_2682127"	"unprognostic (2.78e-2)"	"unprognostic (1.14e-2)"	"unprognostic (5.68e-3)"	"unprognostic (6.16e-2)"	"unprognostic (2.01e-2)"	"unprognostic (5.93e-2)"	"unprognostic (2.12e-2)"	"unprognostic (1.02e-1)"	"unprognostic (2.15e-2)"	"unprognostic (1.12e-1)"	"unprognostic (2.02e-1)"	"unprognostic (1.70e-3)"	"unprognostic (6.00e-5)"	"unprognostic (2.87e-2)"	"unprognostic (3.00e-1)"	"unprognostic (1.54e-1)"	"unprognostic (4.97e-3)"	2.6	0.5	2.8	2.0	6.7	0.2	1.9	1.9	5.2	0.3	10.5	2.1	2.5	1.2	0.5	2.1	5.7	1.9	3.0	48.3	2.6	2.4	0.2	1.8	3.2	1.0	6.1	2.0	17.3	1.2	0.2	0.1	8.3	6.8	6.9	3.2	58.3	1.0	10.3	0.4	0.4	1.0	19.3	1.0	0.8	2.3	3.3	1.3	0.0	0.7	0.0	1.7	7.3	2.2	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	1.5	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.4	3.1	0.0	6.7	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.0	2.8	6.7	1.9	5.2	2.6	2.4	6.1	2.0	6.8	1.3	0.0	0.3	0.0	0.0	0.3	9.3	79.9	0.0	0.0	0.0	0.0	66.8	0.1	0.0	0.0	0.7	1.0	0.0	0.0	0.0	0.1	2.1	1.5	0.0	0.0	0.2	0.0	0.0	8.6	0.8	3.6	75.4	0.0	0.0	0.0	0.0	25.1	0.0	0.0	68.9	0.0	27.8	258.7	2.4	0.5	0.6	0.4	0.2	0.0	0.0	0.0
PLA2G6	"iPLA2, iPLA2beta, NBIA2, PARK14, PNPLA9"	ENSG00000184381	"Phospholipase A2 group VI"	O60733	22	38111495-38205690	"Disease related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, RAS pathway related proteins"	"Chemotaxis, Lipid metabolism, Phospholipid metabolism"	"Calmodulin-binding, Hydrolase"	"Disease mutation, Dystonia, FDA approved drug targets, Neurodegeneration, Parkinson disease, Parkinsonism"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Spermatocytes: 23.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HEL: 31.8;HMC-1: 20.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA001171	Approved		Approved	"Centriolar satellite,Cytosol"		NA	NA			"Centriolar satellite, Cytosol"		"HPA001171: AB_1079145"	"unprognostic (5.26e-2)"	"prognostic favorable (7.29e-4)"	"unprognostic (8.74e-2)"	"unprognostic (6.27e-2)"	"unprognostic (3.83e-1)"	"unprognostic (3.70e-3)"	"unprognostic (8.67e-3)"	"unprognostic (9.55e-2)"	"unprognostic (3.48e-1)"	"unprognostic (1.91e-1)"	"unprognostic (2.37e-3)"	"unprognostic (4.95e-2)"	"unprognostic (1.94e-3)"	"unprognostic (1.01e-1)"	"unprognostic (3.00e-1)"	"unprognostic (1.48e-1)"	"prognostic favorable (1.55e-4)"	16.2	17.7	15.6	8.5	20.5	13.1	15.6	15.9	26.3	14.8	7.9	36.9	18.5	9.8	16.3	20.5	8.7	21.6	25.3	6.3	19.7	7.2	18.1	8.6	9.0	12.4	19.3	16.7	21.3	12.8	24.2	12.7	6.8	19.5	17.6	6.3	12.9	20.2	17.4	7.4	18.1	8.7	7.8	14.9	12.1	9.5	30.0	23.2	16.3	45.7	4.1	11.3	12.1	11.2	1.8	5.4	4.1	0.9	8.8	5.7	1.9	0.7	2.8	3.0	7.8	10.1	5.0	8.2	0.9	1.0	0.8	1.1	3.1	1.8	5.9	6.6	2.3	1.3	3.6	3.5	1.9	1.0	9.0	13.2	31.8	3.9	3.6	2.8	3.5	20.3	16.3	4.3	2.8	4.5	8.2	1.0	13.0	5.2	10.7	1.5	4.6	6.6	2.1	2.6	2.1	1.8	4.9	1.2	4.5	2.9	7.0	5.8	2.4	1.3	3.1	7.2	4.5	3.3	2.5	1.3	2.6	4.5	1.1	0.6	17.6	3.1	3.1	3.7	4.1	1.6	4.1	0.9	0.4	3.8	0.3	1.9	1.8	3.1	5.7	1.5	1.5	1.4	3.9	3.3	8.8	0.6	5.4	3.7	1.9	15.6	20.5	15.9	26.3	19.7	7.2	19.3	16.7	19.5	23.2	3.0	2.4	4.4	3.6	2.7	9.4	1.5	2.5	5.3	5.7	12.2	3.9	2.5	0.0	1.4	16.1	1.9	11.0	0.0	0.9	2.4	2.1	4.2	0.0	3.4	1.4	14.3	10.9	3.7	1.5	13.7	5.5	1.0	1.7	3.6	6.9	4.5	1.4	11.5	3.5	0.8	7.0	6.5	1.7	23.8	7.5	3.0	4.1	6.9	6.9	1.3
PLA2G7	"LDL-PLA2, PAFAH"	ENSG00000146070	"Phospholipase A2 group VII"	Q13093	6	46704201-46735693	"Candidate cardiovascular disease genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted secreted proteins"	"Lipid degradation, Lipid metabolism, Phospholipid degradation, Phospholipid metabolism"	Hydrolase	"Asthma, Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 57.0;lymphoid tissue: 32.9"	"Cell type enriched"	"Detected in some"	13	"Hofbauer cells: 332.5"	"Cancer enhanced"	"Detected in all"		"prostate cancer: 37.2"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"classical monocyte: 24.2"	"Group enriched"	"Detected in many"	56	"dendritic cells: 7.9;monocytes: 24.2"	"Cell line enhanced"	"Detected in some"		"GAMG: 2.2;NTERA-2: 3.9;PC-3: 7.9;RT4: 3.6;U-2 OS: 3.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"								"Secreted to blood"	NA	NA	7380000	170000000				"unprognostic (3.63e-3)"	"unprognostic (2.82e-3)"	"unprognostic (8.69e-2)"	"unprognostic (3.00e-1)"	"unprognostic (1.47e-1)"	"unprognostic (6.26e-2)"	"unprognostic (9.45e-2)"	"unprognostic (1.79e-1)"	"unprognostic (1.95e-1)"	"unprognostic (1.43e-1)"	"unprognostic (2.06e-2)"	"unprognostic (5.33e-2)"	"unprognostic (2.35e-2)"	"unprognostic (2.47e-1)"	"unprognostic (9.20e-2)"	"unprognostic (1.93e-1)"	"unprognostic (7.08e-2)"	57.0	2.1	2.8	14.0	5.8	1.1	2.9	2.0	2.7	1.5	4.4	2.0	0.4	2.3	2.9	1.6	0.8	1.4	3.6	2.0	2.1	1.7	1.0	4.3	19.0	22.2	3.2	1.8	4.0	0.9	0.1	3.1	15.8	2.3	8.5	6.6	2.8	2.5	1.6	0.9	2.3	3.7	1.5	7.1	32.9	1.4	0.7	2.0	6.4	13.1	0.6	6.0	7.2	0.8	0.1	7.9	0.2	24.2	0.0	0.2	6.1	0.0	0.5	0.3	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.5	0.0	2.2	1.6	0.0	0.1	0.0	0.2	2.0	0.0	1.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.3	3.9	0.0	7.9	0.0	0.0	0.1	0.0	3.6	0.1	0.5	0.0	0.0	0.0	1.1	1.0	1.0	0.0	0.0	3.7	0.1	0.9	0.1	0.0	0.0	0.0	0.2	1.3	0.0	24.2	0.1	0.0	5.0	0.2	0.1	0.0	0.0	7.9	0.0	0.0	0.0	0.2	0.0	0.2	0.1	0.0	6.1	2.8	5.8	2.0	2.7	2.1	1.7	3.2	1.8	2.3	2.0	0.0	2.2	0.0	3.6	0.7	0.0	0.2	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.4	0.0	0.0	0.0	0.0	0.0	2.8	0.9	8.7	0.0	0.0	332.5	1.6	3.4	0.0	19.0	0.0	0.0	25.7	10.1	22.6	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	2.6	0.0	0.0	3.3
PLAT		ENSG00000104368	"Plasminogen activator, tissue type"	P00750	8	42175233-42207724	"Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted secreted proteins"	"Plasminogen activation"	"Hydrolase, Protease, Serine protease"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"parathyroid gland: 132.2"	"Cell type enhanced"	"Detected in many"	22	"Basal glandular cells: 379.6;Glandular cells: 176.4;granulocytes: 158.4;Urothelial cells: 792.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"memory CD4 T-cell: 2.1;T-reg: 2.3"	"Group enriched"	"Detected in many"	7	"granulocytes: 1.6;T-cells: 2.3"	"Cell line enhanced"	"Detected in many"		"CAPAN-2: 85.9;HMC-1: 55.1;hTERT-RPE1: 61.0;LHCN-M2: 55.7;U-2197: 58.1;WM-115: 115.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003412, CAB009335"	Supported		Approved	"Actin filaments"	"Secreted to blood"	NA	NA	9900000	12000	"Actin filaments"		"CAB009335: AB_2237146, HPA003412: AB_1858205"	"prognostic favorable (7.57e-4)"	"unprognostic (2.23e-1)"	"unprognostic (4.08e-1)"	"unprognostic (3.39e-1)"	"unprognostic (4.88e-3)"	"unprognostic (9.39e-2)"	"unprognostic (4.65e-3)"	"unprognostic (5.78e-2)"	"unprognostic (1.55e-1)"	"unprognostic (1.75e-1)"	"unprognostic (2.98e-3)"	"unprognostic (2.46e-1)"	"prognostic unfavorable (4.95e-4)"	"unprognostic (8.72e-3)"	"unprognostic (1.37e-2)"	"unprognostic (2.63e-2)"	"unprognostic (6.09e-2)"	19.3	14.9	5.2	12.9	6.8	0.4	13.3	2.2	6.2	24.5	17.1	9.1	19.0	11.2	35.5	28.1	18.1	19.1	18.5	7.3	6.0	5.9	67.6	2.8	15.9	1.9	8.2	3.6	18.4	5.8	132.2	5.1	15.5	9.4	27.4	12.2	39.4	6.1	12.7	5.8	2.0	31.7	23.0	7.0	1.0	14.6	12.2	3.8	0.6	11.2	14.7	7.4	47.9	13.7	0.3	0.1	1.6	0.0	0.0	2.3	0.3	0.5	0.2	4.2	1.0	7.7	10.5	0.1	18.1	32.0	7.7	6.6	0.2	85.9	0.0	0.6	2.3	3.7	1.4	0.0	4.0	15.9	7.9	1.4	0.1	0.1	0.1	37.9	0.0	55.1	10.5	0.0	18.8	0.7	61.0	14.4	0.0	0.5	0.1	55.7	0.0	0.0	0.0	5.6	0.0	7.6	0.0	15.6	0.0	2.5	0.0	0.0	0.9	0.0	0.1	24.6	8.2	0.1	0.0	27.5	1.5	5.7	58.1	1.8	0.0	0.1	0.0	1.2	0.0	115.5	1.6	0.0	0.0	0.3	0.0	1.0	0.3	2.1	0.5	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	2.3	0.3	5.2	6.8	2.2	6.2	6.0	5.9	8.2	3.6	9.4	3.8	0.0	20.2	2.4	379.6	9.6	4.1	7.6	0.0	5.3	11.4	0.0	3.9	0.5	0.0	0.6	0.8	82.6	0.0	0.0	0.6	1.1	19.9	176.4	158.4	1.0	1.5	1.6	0.0	36.8	0.6	0.8	3.4	7.8	21.9	2.8	0.0	2.0	30.5	0.0	2.5	0.1	3.7	12.9	17.6	0.7	0.4	11.8	0.6	3.8	0.4	792.4
PLAU	"UPA, URK"	ENSG00000122861	"Plasminogen activator, urokinase"	P00749	10	73909177-73917497	"Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Blood coagulation, Fibrinolysis, Hemostasis, Plasminogen activation"	"Hydrolase, Protease, Serine protease"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"placenta: 48.4"	"Cell type enhanced"	"Detected in many"	17	"Basal glandular cells: 550.8;Pancreatic endocrine cells: 366.2;Urothelial cells: 779.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	9	"myeloid DC: 2.4;neutrophil: 4.5;plasmacytoid DC: 4.5"	"Group enriched"	"Detected in many"	11	"dendritic cells: 4.5;granulocytes: 4.5"	"Cell line enhanced"	"Detected in many"		"CAPAN-2: 70.3;LHCN-M2: 67.8;RPTEC TERT1: 257.8;U-251 MG: 69.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA070796	Supported				"Secreted to blood"	NA	NA	647000	58000			"HPA070796: "	"unprognostic (1.96e-2)"	"unprognostic (2.99e-2)"	"unprognostic (7.40e-2)"	"prognostic favorable (3.38e-4)"	"unprognostic (4.73e-2)"	"prognostic unfavorable (2.70e-4)"	"unprognostic (1.39e-2)"	"prognostic unfavorable (4.04e-4)"	"unprognostic (2.26e-1)"	"unprognostic (6.58e-2)"	"prognostic unfavorable (1.32e-4)"	"unprognostic (1.61e-1)"	"prognostic unfavorable (3.51e-4)"	"unprognostic (2.83e-1)"	"unprognostic (3.37e-2)"	"unprognostic (1.51e-2)"	"unprognostic (1.77e-2)"	26.7	2.4	1.0	15.5	2.1	11.3	9.7	1.6	1.5	6.9	5.8	2.9	4.9	3.8	10.7	21.2	9.1	6.5	10.7	14.3	1.3	1.0	23.3	2.3	23.4	5.5	1.6	1.5	6.8	3.7	3.6	1.8	48.4	3.1	7.5	6.7	4.5	10.6	5.0	12.2	9.0	8.1	8.4	2.5	23.8	7.8	5.8	1.3	4.8	10.9	11.6	8.2	16.3	9.3	0.1	4.5	4.5	0.4	0.0	0.0	0.3	13.3	7.1	3.0	0.1	0.2	5.1	0.1	8.1	37.9	3.3	5.2	0.1	70.3	0.0	15.0	1.1	35.0	9.2	0.0	13.5	3.8	0.7	0.0	0.0	0.3	0.1	6.2	1.2	2.6	13.5	1.6	22.6	8.7	37.6	9.4	0.0	0.0	0.0	67.8	0.0	0.0	1.7	0.8	0.0	18.7	0.0	9.2	0.0	257.8	10.5	0.0	0.0	0.0	0.3	0.2	2.2	0.0	1.8	23.8	0.2	1.7	1.7	69.2	0.0	0.1	0.1	18.2	2.0	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.1	0.0	0.0	2.4	0.0	0.0	0.0	4.5	0.0	0.0	4.5	0.0	0.3	1.0	2.1	1.6	1.5	1.3	1.0	1.6	1.5	3.1	1.3	3.0	5.8	0.5	550.8	33.2	0.0	2.4	0.0	1.4	10.3	27.9	0.0	17.1	58.0	65.4	0.5	11.7	0.0	0.0	18.1	16.5	18.1	169.7	31.1	0.0	38.5	0.0	3.4	6.2	3.9	0.0	2.3	31.5	6.8	41.5	0.0	0.0	366.2	0.0	0.0	0.7	0.0	6.5	25.9	0.0	0.1	25.7	14.6	0.5	0.9	779.6
PLB1	"FLJ30866, PLB"	ENSG00000163803	"Phospholipase B1"	Q6P1J6	2	28457145-28643788	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Lipid metabolism, Phospholipid metabolism"	Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	7	"intestine: 66.7"	"Group enriched"	"Detected in many"	7	"Early spermatids: 22.5;Extravillous trophoblasts: 20.1;granulocytes: 5.7;Hofbauer cells: 10.2;Kupffer cells: 12.3;Late spermatids: 11.8;Macrophages: 8.7;Syncytiotrophoblasts: 6.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Group enriched"	"Detected in many"	14	"classical monocyte: 3.1;eosinophil: 3.3;intermediate monocyte: 4.9;myeloid DC: 6.4;neutrophil: 9.9;non-classical monocyte: 5.2"	"Group enriched"	"Detected in many"	40	"dendritic cells: 6.4;granulocytes: 9.9;monocytes: 5.2"	"Cell line enhanced"	"Detected in some"		"BEWO: 5.8;OE19: 12.0;RT4: 4.3"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in some"									NA	NA						"unprognostic (2.18e-2)"	"unprognostic (2.49e-1)"	"unprognostic (6.58e-2)"	"unprognostic (1.42e-1)"	"unprognostic (2.94e-2)"	"unprognostic (1.25e-1)"	"unprognostic (4.91e-3)"	"unprognostic (4.74e-2)"	"unprognostic (4.48e-2)"	"unprognostic (2.03e-2)"	"unprognostic (1.53e-1)"	"unprognostic (2.17e-1)"	"unprognostic (2.61e-9)"	"unprognostic (2.48e-2)"	"unprognostic (2.19e-2)"	"unprognostic (4.99e-2)"	"unprognostic (8.03e-2)"	0.9	3.3	0.7	1.0	2.1	2.9	1.0	0.6	0.7	0.9	0.8	0.6	0.6	0.2	0.8	1.7	1.3	0.7	0.9	1.4	0.6	0.9	0.8	0.6	0.7	0.6	0.8	0.6	0.6	0.6	0.0	0.7	1.3	0.7	1.0	1.1	0.7	0.6	0.9	0.9	5.2	66.7	1.7	0.8	2.8	0.5	1.2	0.6	0.6	1.2	0.9	0.6	0.9	0.6	0.0	6.4	9.9	5.2	0.0	0.1	1.1	0.6	0.1	3.8	0.1	0.8	0.6	5.8	0.1	1.5	0.4	0.3	3.8	0.4	0.4	0.4	0.6	1.7	0.8	0.0	3.1	0.3	0.2	0.0	0.3	0.6	0.7	1.3	0.7	0.3	0.6	1.8	0.6	1.0	0.7	1.0	0.0	0.0	0.1	1.1	0.0	0.0	0.5	0.1	12.0	0.8	0.0	0.6	0.0	1.7	4.3	1.7	0.3	0.1	0.2	0.3	0.3	0.0	2.0	0.4	0.4	1.1	0.2	0.2	0.8	0.2	0.0	1.3	2.9	0.1	0.0	3.1	3.3	0.0	4.9	0.0	0.0	0.1	0.0	6.4	0.0	0.0	0.0	9.9	0.0	5.2	0.3	0.1	1.1	0.7	2.1	0.6	0.7	0.6	0.9	0.8	0.6	0.7	0.6	0.0	1.1	0.0	0.8	0.3	0.0	1.1	0.0	0.0	1.2	0.0	0.0	0.4	1.7	0.9	22.5	0.3	1.7	0.0	0.8	20.1	0.5	0.3	5.7	0.0	10.2	0.0	1.2	0.6	12.3	11.8	1.1	8.7	0.0	0.0	1.1	0.6	0.9	0.2	0.7	0.0	0.0	0.0	0.0	0.9	0.2	0.4	6.9	0.5	0.3	1.4
PLCB1	"KIAA0581, PLC-I, PLC154"	ENSG00000182621	"Phospholipase C beta 1"	Q9NQ66	20	8077251-8968360	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Lipid degradation, Lipid metabolism"	"Hydrolase, Transducer"	Epilepsy	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"parathyroid gland: 56.7"	"Cell type enhanced"	"Detected in many"	5	"Cardiomyocytes: 29.3;Distal tubular cells: 28.2;Endothelial cells: 30.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"CACO-2: 22.0;Hep G2: 33.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004275, CAB005334, HPA034743, HPA057910"	Enhanced		Approved	"Plasma membrane"		NA	NA		5400	"Plasma membrane"		"CAB004275: AB_628118, CAB005334: AB_632196, HPA034743: AB_2674311, HPA057910: AB_2683552"	"unprognostic (2.32e-1)"	"unprognostic (1.02e-1)"	"unprognostic (6.63e-2)"	"unprognostic (9.77e-2)"	"unprognostic (9.87e-2)"	"unprognostic (2.37e-1)"	"unprognostic (1.27e-4)"	"unprognostic (1.13e-1)"	"unprognostic (3.16e-2)"	"unprognostic (1.91e-1)"	"unprognostic (7.12e-3)"	"unprognostic (6.57e-2)"	"unprognostic (2.87e-3)"	"unprognostic (3.20e-2)"	"unprognostic (4.41e-2)"	"unprognostic (1.71e-2)"	"unprognostic (2.12e-1)"	5.6	7.0	13.8	4.4	27.7	3.4	5.9	7.5	31.1	6.5	9.9	2.1	20.6	5.5	8.0	10.3	4.5	7.4	6.6	8.6	15.7	9.1	10.0	3.1	4.0	1.6	9.3	14.5	3.2	10.8	56.7	4.6	14.2	5.5	10.4	3.6	1.3	19.7	22.2	9.8	2.3	4.5	12.3	4.0	2.9	5.5	2.6	8.0	4.1	3.1	1.9	1.1	8.6	6.3	0.5	0.8	2.8	3.3	2.4	5.2	0.4	0.0	0.6	2.3	0.1	4.3	8.3	3.2	9.8	6.5	2.6	1.6	22.0	2.4	1.0	4.1	1.9	0.1	0.0	1.8	0.0	1.9	0.0	2.1	0.4	1.6	33.1	1.1	0.5	0.3	0.5	0.4	3.5	0.0	3.3	5.2	6.3	3.3	12.9	0.0	2.9	0.5	1.6	7.4	5.1	3.6	7.0	0.0	5.8	2.0	8.1	8.5	3.6	0.0	2.0	0.4	8.9	9.8	3.2	0.9	8.5	3.8	0.6	6.1	9.7	11.2	16.6	4.3	6.1	14.5	0.8	3.3	2.8	3.6	0.7	5.2	0.2	1.0	1.3	0.4	0.5	0.5	1.1	2.1	2.4	0.4	0.8	0.2	0.4	13.8	27.7	7.5	30.8	15.7	9.1	9.3	14.5	5.5	8.0	0.0	4.3	0.8	17.4	1.6	0.8	29.3	5.1	16.0	3.4	15.7	0.0	1.9	28.2	0.9	7.6	30.5	0.3	0.0	11.3	1.9	7.9	21.8	1.1	2.1	0.7	1.6	0.0	21.5	4.6	3.1	3.1	2.5	6.8	1.0	1.9	16.3	2.4	0.0	3.5	7.9	3.7	0.0	13.0	3.1	4.3	1.5	1.5	5.1	1.2	16.2
PLCB2	FLJ38135	ENSG00000137841	"Phospholipase C beta 2"	Q00722	15	40278176-40307935	"Enzymes, Predicted intracellular proteins"	"Lipid degradation, Lipid metabolism"	"Hydrolase, Transducer"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 30.5;lymphoid tissue: 36.3"	"Group enriched"	"Detected in many"	4	"Alveolar cells type 2: 25.1;granulocytes: 25.5;Hofbauer cells: 26.0;Kupffer cells: 49.0;Macrophages: 28.1;T-cells: 15.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"HEL: 31.5;HMC-1: 39.3;THP-1: 11.4;U-937: 21.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"CAB009443, HPA041298, HPA068595, HPA069308"	Enhanced		Approved	"Plasma membrane,Cytosol"		NA	NA			"Plasma membrane, Cytosol"		"CAB009443: AB_632197, HPA041298: AB_2677395, HPA068595: , HPA069308: "	"unprognostic (5.52e-2)"	"unprognostic (4.96e-3)"	"unprognostic (6.09e-3)"	"unprognostic (1.88e-2)"	"unprognostic (1.31e-1)"	"prognostic favorable (3.00e-4)"	"unprognostic (1.66e-1)"	"unprognostic (3.08e-2)"	"unprognostic (1.28e-1)"	"unprognostic (2.34e-1)"	"unprognostic (1.42e-1)"	"unprognostic (2.75e-1)"	"prognostic unfavorable (7.20e-5)"	"unprognostic (9.89e-2)"	"unprognostic (2.06e-3)"	"unprognostic (5.81e-2)"	"unprognostic (1.13e-1)"	6.3	3.6	8.1	17.6	11.6	30.5	2.9	1.1	7.5	2.9	3.3	16.2	1.7	4.0	2.8	3.2	2.4	4.6	6.5	3.3	6.9	5.1	3.3	4.2	12.5	17.2	12.7	2.4	1.6	2.0	1.3	2.9	4.6	9.3	3.2	5.5	4.1	5.2	2.9	1.3	1.5	10.2	4.8	17.9	36.3	3.6	1.4	10.9	12.2	2.8	1.8	17.6	6.9	2.5	1.0	4.5	8.5	4.3	1.8	3.1	2.0	0.1	0.0	0.2	0.0	0.0	0.0	4.4	0.0	0.0	0.0	0.0	0.0	7.8	0.6	7.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	31.5	0.0	0.0	0.0	6.7	39.3	0.0	0.0	0.0	0.0	0.0	0.0	4.1	0.3	1.7	0.0	0.0	1.8	3.6	0.4	0.0	0.1	5.5	0.8	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	2.3	0.0	11.4	4.1	0.0	3.8	0.0	0.0	0.0	0.0	1.5	0.0	21.6	0.0	2.7	4.2	8.5	3.1	4.3	2.0	0.7	1.6	1.6	4.5	1.0	1.6	1.8	6.9	1.8	4.2	1.6	2.9	2.0	8.1	11.6	1.1	7.5	6.9	5.1	12.7	2.4	9.3	10.9	6.0	25.1	3.4	0.1	0.8	0.0	2.8	2.5	6.7	5.7	1.8	0.0	0.4	0.0	0.1	1.0	0.4	0.0	0.0	0.0	0.4	1.0	0.0	25.5	0.2	26.0	0.0	0.0	1.8	49.0	0.4	0.3	28.1	3.3	0.0	0.8	0.0	0.2	0.0	0.0	0.7	0.2	0.0	0.3	0.2	2.1	0.5	0.3	15.9	1.2	0.0
PLCB3		ENSG00000149782	"Phospholipase C beta 3"	Q01970	11	64251523-64269150	"Enzymes, Predicted intracellular proteins"	"Lipid degradation, Lipid metabolism"	"Hydrolase, Transducer"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	5	"intestine: 77.5"	"Cell type enhanced"	"Detected in many"	6	"Enterocytes: 54.0;Mucus-secreting cells: 41.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"plasmacytoid DC: 4.4"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009257, HPA039279, HPA043907"	Enhanced		Approved	"Nucleoplasm,Golgi apparatus"		NA	NA		94000	"Nucleoplasm, Golgi apparatus"		"CAB009257: AB_654079, HPA039279: AB_2676425, HPA043907: AB_2678726"	"unprognostic (1.30e-1)"	"unprognostic (1.21e-2)"	"unprognostic (2.86e-1)"	"unprognostic (2.35e-1)"	"unprognostic (9.35e-2)"	"unprognostic (6.23e-3)"	"prognostic unfavorable (1.39e-4)"	"unprognostic (2.44e-2)"	"unprognostic (6.61e-2)"	"unprognostic (1.26e-1)"	"unprognostic (8.07e-3)"	"unprognostic (1.00e-2)"	"prognostic unfavorable (4.31e-5)"	"unprognostic (5.04e-3)"	"unprognostic (1.52e-1)"	"unprognostic (1.20e-1)"	"unprognostic (3.88e-2)"	5.8	9.7	6.1	7.0	5.4	3.7	10.9	6.3	5.8	8.6	40.6	3.1	8.8	59.3	9.1	5.9	16.8	7.7	11.8	4.8	5.4	2.6	5.5	3.2	9.1	4.8	3.5	2.2	11.0	4.0	7.6	2.9	11.1	4.8	6.4	7.0	5.0	6.5	6.3	3.8	10.7	77.5	7.0	4.5	7.2	8.0	4.6	5.4	4.2	5.0	8.2	9.3	6.3	8.8	0.3	4.4	0.9	1.4	0.3	0.8	0.4	17.8	10.0	9.9	14.7	10.4	8.0	9.9	14.2	10.8	12.2	7.4	8.8	13.6	1.2	8.6	17.8	10.5	30.8	11.1	13.3	4.2	8.5	6.1	13.9	20.6	6.6	7.2	3.3	9.2	6.7	8.9	13.2	9.8	13.4	17.7	5.4	6.8	1.5	15.4	21.5	4.2	7.0	16.0	22.7	11.0	9.3	22.3	5.2	7.5	18.9	2.6	10.9	21.0	26.5	10.1	6.4	13.9	6.5	30.7	11.3	13.5	25.8	9.1	1.9	0.9	1.4	18.7	8.0	10.4	0.0	1.4	0.2	0.7	1.4	0.8	0.1	0.8	0.7	1.3	0.3	0.4	0.4	0.9	0.3	1.4	4.4	0.2	0.4	6.1	5.4	6.3	5.8	5.4	2.6	3.5	2.2	4.8	5.4	3.0	9.3	0.0	5.1	11.6	1.0	2.6	10.2	0.0	3.4	15.7	0.0	7.8	1.7	6.2	0.9	7.3	54.0	0.0	6.7	14.6	9.3	5.1	5.7	2.6	9.0	3.2	2.4	19.6	12.7	1.1	9.2	11.0	8.5	29.7	41.8	4.3	12.8	23.0	11.7	3.3	0.7	25.8	7.2	2.6	8.7	10.3	12.2	1.3	31.0	7.2
PLCB4		ENSG00000101333	"Phospholipase C beta 4"	Q15147	20	9068763-9481242	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Lipid degradation, Lipid metabolism"	"Hydrolase, Transducer"	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 44.9;retina: 40.2;salivary gland: 39.8"	"Cell type enhanced"	"Detected in many"	13	"Bipolar cells: 79.8;Cardiomyocytes: 57.6;Ciliated cells: 56.2;Horizontal cells: 155.7"	"Cancer enhanced"	"Detected in many"		"colorectal cancer: 23.5"	"Group enriched"	"Detected in all"	4	"cerebellum: 44.9;pons and medulla: 11.9"	"Cell type enriched"	"Detected in single"	20	"plasmacytoid DC: 6.6"	"Lineage enriched"	"Detected in single"	20	"dendritic cells: 6.6"	"Cell line enhanced"	"Detected in many"		"fHDF/TERT166: 38.2;hTERT-HME1: 18.7;LHCN-M2: 30.8;OE19: 17.8;RPTEC TERT1: 39.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA007951	Approved		Approved	Nucleoplasm,Microtubules		NA	NA			Microtubules	Nucleoplasm	"HPA007951: AB_2667944"	"unprognostic (3.88e-2)"	"unprognostic (3.62e-1)"	"unprognostic (1.19e-2)"	"prognostic favorable (2.11e-4)"	"unprognostic (1.44e-2)"	"unprognostic (9.72e-3)"	"unprognostic (3.32e-3)"	"unprognostic (2.57e-2)"	"unprognostic (7.75e-2)"	"unprognostic (4.23e-2)"	"unprognostic (5.21e-3)"	"unprognostic (1.35e-1)"	"unprognostic (4.64e-3)"	"unprognostic (7.12e-2)"	"unprognostic (1.37e-1)"	"unprognostic (2.22e-1)"	"unprognostic (4.45e-2)"	5.5	5.0	2.1	4.5	4.6	0.2	5.6	44.9	5.2	6.0	13.1	2.7	2.4	1.6	12.3	16.2	6.9	10.9	6.2	12.4	2.3	6.6	2.3	0.9	4.4	1.0	4.0	3.3	2.9	1.3	0.5	15.1	4.4	11.9	6.9	12.6	40.2	39.8	7.1	2.5	4.3	3.1	12.3	3.1	1.1	9.7	2.1	2.4	4.3	21.9	4.4	2.0	7.1	8.8	0.0	6.6	0.0	0.0	0.3	0.0	0.0	0.0	6.1	3.1	0.0	0.0	0.1	0.0	13.4	3.8	4.0	2.5	1.2	0.9	0.0	0.2	38.2	14.5	0.0	0.9	2.9	6.0	0.0	1.8	1.6	2.2	0.0	0.6	0.0	0.0	0.9	1.2	5.2	18.7	7.3	0.0	0.0	1.5	0.1	30.8	2.0	0.0	0.0	3.3	17.8	3.9	0.0	0.0	0.2	39.4	2.8	10.2	7.1	0.0	9.2	5.6	4.3	7.8	0.0	0.1	4.3	0.3	0.4	5.2	0.0	0.0	0.0	0.6	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	6.6	0.0	0.0	2.1	4.6	44.9	5.2	2.3	6.6	4.0	3.3	11.9	2.4	6.0	0.3	0.0	3.6	2.2	79.8	57.6	0.0	56.2	11.4	5.2	0.0	0.0	0.0	0.5	1.0	35.4	2.3	0.0	0.2	0.0	4.8	10.1	0.0	0.0	0.1	155.7	40.4	1.3	0.0	0.4	1.4	0.3	6.8	1.0	35.3	1.9	5.0	7.0	19.4	0.6	5.4	12.9	23.6	1.4	1.3	0.9	0.1	0.0	34.0	1.8
PLCD1		ENSG00000187091	"Phospholipase C delta 1"	P51178	3	38007496-38029762	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Lipid degradation, Lipid metabolism"	"Hydrolase, Transducer"	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"Enterocytes: 48.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"ASC diff: 16.0;ASC TERT1: 14.3;fHDF/TERT166: 15.8;hTCEpi: 19.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"CAB009913, HPA020107, HPA021677"	Approved		Approved	Microtubules		NA	NA			Microtubules		"CAB009913: AB_2163388, HPA020107: AB_1855318, HPA021677: AB_1855319"	"unprognostic (1.75e-3)"	"unprognostic (1.01e-2)"	"unprognostic (4.29e-2)"	"unprognostic (1.45e-2)"	"unprognostic (3.44e-1)"	"unprognostic (9.67e-3)"	"unprognostic (1.55e-1)"	"unprognostic (7.25e-3)"	"unprognostic (3.95e-1)"	"unprognostic (1.45e-1)"	"unprognostic (2.80e-1)"	"unprognostic (2.24e-1)"	"prognostic favorable (9.25e-11)"	"unprognostic (1.50e-1)"	"unprognostic (7.71e-2)"	"unprognostic (2.93e-1)"	"unprognostic (7.88e-2)"	10.9	11.3	11.2	5.6	12.1	5.1	8.0	6.0	11.2	11.6	19.3	15.2	7.3	6.6	9.1	7.6	21.9	8.6	8.5	8.0	13.0	6.9	7.8	5.8	9.4	9.3	10.5	11.4	12.8	6.2	4.7	7.3	6.9	15.9	10.6	12.7	8.3	10.9	12.6	4.5	17.0	6.5	12.3	15.5	6.3	6.5	37.3	8.7	7.7	6.6	21.2	12.2	14.6	23.1	1.0	2.6	8.6	2.4	3.7	13.2	5.4	0.6	1.7	5.7	1.6	16.0	14.3	1.8	1.7	6.9	2.7	4.1	0.6	1.4	0.4	0.9	15.8	1.7	9.1	3.0	1.8	0.8	2.5	0.7	0.2	0.9	2.9	9.4	0.0	1.0	11.6	19.6	7.9	1.1	5.9	5.0	1.4	9.6	0.8	5.9	0.7	1.3	0.6	1.5	3.3	1.7	0.5	0.8	2.2	3.1	3.1	0.0	1.6	0.5	7.7	1.9	1.9	1.6	0.7	2.9	1.6	4.1	4.2	0.0	3.5	1.4	0.3	4.1	0.0	0.9	8.6	1.9	0.1	10.2	2.4	11.6	1.0	13.2	9.8	2.6	0.5	7.8	6.1	6.9	3.7	1.4	1.5	11.8	5.4	11.2	12.1	6.0	10.7	13.0	6.9	10.5	11.4	15.9	8.7	3.0	6.9	1.4	11.2	2.5	1.0	3.8	10.2	0.0	4.5	8.7	2.0	1.5	3.3	9.2	1.4	7.4	48.4	0.0	2.6	3.8	6.6	12.4	4.6	3.8	3.5	3.2	4.7	19.6	3.5	2.5	11.8	5.1	1.7	3.6	23.8	14.2	3.3	15.9	13.4	5.0	1.4	6.5	9.1	2.6	3.2	5.1	0.7	8.2	9.4	15.0
PLCD3		ENSG00000161714	"Phospholipase C delta 3"	Q8N3E9	17	45108967-45133354	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Lipid degradation, Lipid metabolism"	"Hydrolase, Transducer"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 63.6"	"Cell type enhanced"	"Detected in many"	11	"Enterocytes: 138.0;Paneth cells: 62.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"OE19: 40.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA025711, HPA053665"	Approved		Approved	"Plasma membrane"		NA	NA			"Plasma membrane"		"HPA025711: AB_1855320, HPA053665: AB_2732580"	"unprognostic (3.58e-2)"	"unprognostic (1.66e-1)"	"unprognostic (2.77e-2)"	"unprognostic (1.27e-2)"	"unprognostic (2.66e-1)"	"unprognostic (4.14e-3)"	"unprognostic (8.13e-3)"	"prognostic unfavorable (2.89e-6)"	"unprognostic (2.96e-1)"	"unprognostic (9.53e-2)"	"unprognostic (1.34e-3)"	"unprognostic (6.21e-2)"	"unprognostic (3.18e-2)"	"unprognostic (2.07e-1)"	"unprognostic (1.62e-1)"	"prognostic favorable (4.28e-4)"	"unprognostic (3.34e-3)"	5.7	12.0	10.1	4.8	16.5	2.4	6.6	12.2	12.9	5.0	24.9	14.0	2.8	2.9	6.3	6.4	8.9	5.8	9.4	13.1	11.6	6.6	3.6	1.2	4.5	1.7	13.9	11.4	9.9	2.7	1.5	3.0	5.7	19.5	5.8	13.7	10.3	4.7	5.7	63.6	9.9	2.8	12.9	15.0	2.0	17.9	5.4	14.6	0.0	2.3	20.1	2.8	17.5	10.5	1.3	0.9	2.9	1.5	1.3	0.9	0.5	8.4	21.1	1.5	3.1	2.3	5.0	10.7	4.6	10.4	4.3	4.1	5.1	15.5	0.3	16.7	10.8	3.5	19.3	2.4	19.9	1.7	4.2	7.9	0.3	22.2	6.6	11.9	0.4	1.2	5.4	8.0	3.9	5.3	11.0	2.6	0.9	1.8	0.6	4.6	13.2	1.3	1.9	1.8	40.6	20.8	3.0	3.5	0.5	13.6	16.9	0.4	2.7	5.0	8.4	4.5	3.4	17.9	0.9	5.3	2.7	14.8	3.5	5.4	0.8	0.9	0.6	4.4	0.5	2.1	2.3	1.5	2.4	0.9	1.5	0.6	1.0	0.7	0.6	0.5	1.3	0.9	0.8	2.9	1.3	0.3	0.9	0.6	0.5	10.1	16.5	12.2	11.5	11.6	6.6	13.9	11.4	19.5	14.6	11.9	2.2	0.0	10.9	6.8	27.2	23.8	12.7	1.4	2.3	7.0	23.6	2.5	1.7	7.0	12.5	9.2	138.0	0.0	2.9	7.2	8.2	9.8	1.1	0.4	1.5	6.4	4.7	8.6	0.3	3.6	18.4	0.3	3.3	1.0	13.0	6.8	18.3	62.6	31.1	1.7	37.9	6.5	4.2	1.9	6.6	5.0	6.1	0.0	26.3	40.1
PLCD4		ENSG00000115556	"Phospholipase C delta 4"	Q9BRC7	2	218607765-218637184	"Enzymes, Predicted intracellular proteins"	"Lipid degradation, Lipid metabolism"	"Guanine-nucleotide releasing factor, Hydrolase, Transducer"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"retina: 23.0;skeletal muscle: 62.5;smooth muscle: 33.1"	"Group enriched"	"Detected in some"	8	"Bipolar cells: 81.4;Cone photoreceptor cells: 231.7;Rod photoreceptor cells: 181.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"SH-SY5Y: 21.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009914, HPA038139, HPA038140"	Enhanced		Supported	"Endoplasmic reticulum,Plasma membrane,Cytosol"		NA	NA			Cytosol	"Endoplasmic reticulum, Plasma membrane"	"CAB009914: AB_2252306, HPA038139: AB_2675855, HPA038140: AB_2675856"	"unprognostic (2.11e-1)"	"unprognostic (1.72e-1)"	"unprognostic (1.76e-2)"	"unprognostic (5.65e-5)"	"unprognostic (7.77e-2)"	"unprognostic (1.45e-2)"	"unprognostic (7.06e-3)"	"unprognostic (2.86e-2)"	"unprognostic (3.15e-1)"	"unprognostic (8.87e-3)"	"unprognostic (7.54e-5)"	"unprognostic (3.28e-2)"	"unprognostic (2.49e-1)"	"unprognostic (1.86e-1)"	"unprognostic (6.32e-2)"	"unprognostic (8.46e-3)"	"unprognostic (3.09e-1)"	1.1	2.5	1.5	1.0	1.6	0.5	1.0	0.9	2.4	0.6	6.4	0.3	3.8	0.9	0.8	1.1	3.7	0.6	0.9	0.9	1.0	1.5	3.9	0.5	0.7	0.7	1.6	1.0	0.7	0.4	1.4	4.7	0.6	2.6	6.4	1.5	23.0	1.4	0.6	62.5	0.8	1.4	33.1	1.1	0.5	3.5	3.9	0.5	0.0	1.4	6.8	0.5	9.6	5.3	0.9	1.2	0.3	0.4	0.9	0.9	1.0	0.6	1.6	2.2	0.4	0.2	1.4	1.2	1.2	2.6	0.4	1.4	2.4	0.3	1.4	1.8	0.4	1.0	1.0	0.0	1.5	0.3	0.5	1.8	1.2	3.6	1.9	0.2	1.2	0.6	3.0	0.1	2.0	0.5	4.8	2.8	0.8	1.0	1.1	2.3	1.8	0.4	1.2	0.7	0.2	3.4	0.9	0.8	0.5	4.4	3.0	2.3	21.5	1.0	0.8	0.3	1.3	2.6	0.5	6.1	1.6	1.2	0.7	0.7	0.5	0.8	0.9	4.7	0.3	1.6	0.0	0.4	0.0	0.5	0.0	0.1	0.0	0.3	0.9	0.3	0.9	0.7	0.8	0.3	0.9	0.0	1.2	0.7	1.0	1.5	1.6	0.9	2.4	1.0	1.5	1.6	1.0	2.6	0.5	0.0	1.4	0.0	0.2	0.5	81.4	0.8	0.0	0.0	0.0	0.0	231.7	0.1	0.0	0.2	14.2	1.1	0.0	0.0	0.0	12.6	0.6	0.0	0.0	0.0	0.5	7.9	0.0	0.0	0.0	22.0	0.3	0.0	0.0	0.0	0.0	8.8	0.4	0.0	0.0	1.4	181.4	0.0	1.4	2.2	0.8	0.1	0.7	0.0	0.0	0.1
PLCE1	"KIAA1516, NPHS3, PLCE"	ENSG00000138193	"Phospholipase C epsilon 1"	Q9P212	10	94030812-94332823	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, RAS pathway related proteins"	"Lipid degradation, Lipid metabolism"	"Guanine-nucleotide releasing factor, Hydrolase, Transducer"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"retina: 44.6"	"Cell type enhanced"	"Detected in many"	9	"Alveolar cells type 1: 65.5;Enterocytes: 45.9;Muller glia cells: 98.6;Paneth cells: 46.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"RT4: 18.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA015597, HPA015598"	Enhanced		Supported	Cytosol		NA	NA			Cytosol		"HPA015597: AB_1855321, HPA015598: AB_1855322"	"unprognostic (4.73e-2)"	"unprognostic (1.16e-1)"	"unprognostic (4.03e-2)"	"unprognostic (3.59e-3)"	"unprognostic (3.01e-1)"	"unprognostic (2.96e-1)"	"unprognostic (1.73e-2)"	"unprognostic (4.76e-3)"	"unprognostic (1.58e-1)"	"unprognostic (1.75e-1)"	"unprognostic (1.14e-1)"	"unprognostic (1.23e-1)"	"unprognostic (3.26e-3)"	"unprognostic (3.56e-1)"	"unprognostic (3.92e-2)"	"unprognostic (3.54e-2)"	"unprognostic (4.30e-2)"	3.2	2.4	4.1	9.1	5.5	0.0	2.2	1.8	7.9	9.2	13.8	3.1	1.6	5.0	11.4	4.6	4.5	4.2	3.8	12.8	4.1	2.6	6.3	0.7	7.2	0.4	2.4	6.8	3.2	12.8	0.1	5.2	3.1	6.4	3.3	12.6	44.6	2.1	7.7	4.3	0.7	4.6	5.8	2.4	5.8	8.7	1.7	2.3	0.0	15.1	7.3	1.1	7.9	5.4	3.2	1.2	0.8	0.9	1.1	2.3	0.5	5.8	8.1	1.7	0.9	0.9	5.7	2.3	3.6	1.0	0.8	1.1	5.2	1.4	0.6	1.8	2.9	2.9	2.5	4.1	1.0	1.3	0.3	2.0	0.4	4.4	0.4	0.1	0.7	0.3	2.3	0.0	2.2	0.0	9.7	0.0	0.3	0.4	0.3	7.0	0.2	0.6	0.8	0.6	11.0	8.4	0.1	5.5	0.2	0.2	18.2	0.8	1.4	4.2	5.8	0.5	7.9	4.9	0.5	0.5	3.7	10.9	2.3	4.7	0.5	0.2	0.3	3.0	1.0	3.3	0.4	0.5	0.1	1.5	0.9	1.3	2.6	1.6	1.1	0.6	3.2	2.3	1.8	0.8	1.1	0.8	1.2	0.6	0.5	4.1	5.5	1.8	7.9	4.1	2.6	2.4	6.8	6.4	2.3	65.5	4.8	9.3	7.4	7.2	11.5	32.3	0.0	10.7	13.6	0.0	0.0	3.2	1.7	1.3	15.0	7.4	45.9	0.0	5.7	2.0	7.3	2.9	0.0	1.1	0.6	6.4	1.7	6.2	0.6	3.4	11.2	1.4	6.8	1.0	6.4	98.6	3.2	46.7	21.9	2.1	19.4	6.5	19.4	3.5	7.8	6.5	1.6	4.3	28.0	6.0
PLCG1	"NCKAP3, PLC-II, PLC1, PLC148, PLCgamma1"	ENSG00000124181	"Phospholipase C gamma 1"	P19174	20	41136960-41196801	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins"	"Host-virus interaction, Lipid degradation, Lipid metabolism"	"Hydrolase, Transducer"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	7	"gdT-cell: 5.9;MAIT T-cell: 8.0;memory CD4 T-cell: 5.2;memory CD8 T-cell: 4.9;naive CD4 T-cell: 5.7;naive CD8 T-cell: 5.4;NK-cell: 4.0;T-reg: 4.4"	"Group enriched"	"Detected in many"	8	"NK-cells: 4.0;T-cells: 8.0"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004277, HPA036681, HPA036682"	Approved		Enhanced	Cytosol		NA	NA			Cytosol		"CAB004277: AB_628119, HPA036681: AB_2675245, HPA036682: AB_2675246"	"unprognostic (2.77e-1)"	"unprognostic (1.35e-1)"	"unprognostic (1.65e-1)"	"unprognostic (4.31e-2)"	"unprognostic (5.82e-2)"	"unprognostic (2.09e-2)"	"unprognostic (4.45e-3)"	"unprognostic (1.25e-2)"	"unprognostic (2.29e-2)"	"unprognostic (1.16e-1)"	"prognostic favorable (4.72e-4)"	"unprognostic (3.32e-1)"	"unprognostic (2.73e-3)"	"unprognostic (1.82e-1)"	"unprognostic (2.65e-1)"	"unprognostic (9.27e-2)"	"unprognostic (2.79e-2)"	20.2	15.1	25.1	20.9	22.1	8.3	34.9	52.6	26.8	19.9	13.9	23.4	12.5	16.5	27.6	13.9	13.5	17.0	18.7	20.9	25.4	13.6	15.3	6.8	19.3	30.7	18.5	20.5	28.7	9.1	16.9	14.2	22.2	18.7	18.4	13.2	20.0	13.2	20.6	13.4	22.3	17.1	22.2	15.4	20.1	12.4	19.9	23.9	48.1	28.5	11.9	21.9	17.1	21.1	0.7	0.0	0.0	0.0	4.0	8.0	3.3	5.4	6.9	33.2	24.3	13.3	9.3	10.6	8.9	11.5	18.0	15.3	16.6	1.8	12.1	11.0	9.7	18.9	10.1	14.4	16.0	10.5	3.4	7.7	0.8	11.5	19.5	10.1	4.7	3.3	11.9	9.0	13.3	10.4	16.3	20.0	26.0	9.0	8.0	16.2	40.4	29.2	3.7	12.3	7.0	12.7	23.3	24.2	5.9	9.9	10.0	11.8	22.5	16.0	7.5	16.0	19.4	8.7	5.6	21.6	43.1	14.0	13.7	10.8	8.9	3.9	10.0	10.2	5.2	17.8	0.0	0.0	0.0	5.9	0.0	8.0	0.3	5.2	4.9	0.0	0.7	5.7	5.4	0.0	4.0	0.0	0.0	4.4	3.3	25.1	22.1	52.6	26.8	25.4	13.6	18.5	20.5	18.7	23.9	14.9	6.5	0.8	1.8	4.9	3.7	9.2	0.0	1.4	3.4	3.5	9.8	1.3	0.0	2.7	5.1	15.8	6.4	0.0	1.4	1.6	6.1	1.9	1.1	2.5	3.2	3.2	1.7	13.5	2.2	5.3	14.1	1.7	3.3	1.0	9.8	7.2	2.8	3.7	17.3	2.4	4.6	12.9	5.1	11.6	11.5	6.0	0.7	6.9	5.1	0.9
PLCG2		ENSG00000197943	"Phospholipase C gamma 2"	P16885	16	81739097-81962693	"Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, RAS pathway related proteins"	"Lipid degradation, Lipid metabolism"	"Hydrolase, Transducer"	"Cancer-related genes, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 55.8"	"Cell type enhanced"	"Detected in many"	7	"Bipolar cells: 211.5;Muller glia cells: 142.4;Rod photoreceptor cells: 205.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"Daudi: 40.5;HMC-1: 19.4;REH: 16.5;U-698: 90.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"CAB004280, HPA020099, HPA020100"	Enhanced		Approved	Nucleoplasm,Vesicles,Cytosol		NA	NA		21000	"Vesicles, Cytosol"	Nucleoplasm	"CAB004280: AB_628120, HPA020099: AB_1855324, HPA020100: AB_1855325"	"unprognostic (2.86e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.09e-3)"	"unprognostic (1.10e-1)"	"unprognostic (1.58e-1)"	"prognostic favorable (6.71e-4)"	"unprognostic (6.23e-2)"	"unprognostic (5.01e-2)"	"unprognostic (2.22e-1)"	"unprognostic (4.58e-2)"	"unprognostic (4.66e-2)"	"unprognostic (1.71e-2)"	"prognostic favorable (4.88e-4)"	"unprognostic (1.52e-2)"	"unprognostic (1.21e-1)"	"unprognostic (2.89e-1)"	"unprognostic (3.40e-3)"	8.4	3.8	3.3	55.8	4.9	14.1	10.7	1.0	2.4	5.6	10.3	5.3	3.1	8.7	11.2	12.2	6.0	4.7	10.1	4.4	3.3	2.8	20.6	8.8	10.7	35.5	5.2	1.8	2.0	3.6	1.0	1.8	4.1	4.5	4.3	3.6	4.6	8.8	2.8	2.0	4.1	17.6	4.6	8.6	33.6	4.2	2.3	4.2	6.3	5.3	2.6	44.6	7.5	7.7	18.8	3.9	26.8	12.2	14.0	1.1	2.3	0.3	0.7	0.1	0.6	0.0	0.0	0.9	0.0	0.1	0.5	0.2	0.2	1.8	40.5	6.9	0.0	1.7	0.9	0.9	0.1	0.3	0.3	0.4	4.8	0.0	0.0	0.3	4.8	19.4	0.0	0.4	0.3	0.2	0.0	0.9	1.8	0.5	3.4	0.1	1.2	0.5	12.1	0.7	0.5	0.2	16.5	0.0	5.2	0.1	0.8	0.3	0.1	1.1	0.3	0.3	0.9	0.7	15.0	0.2	0.0	0.7	0.1	0.1	8.1	13.2	90.0	0.0	6.7	0.3	2.8	4.4	26.8	0.7	5.7	0.3	18.8	0.2	1.1	3.9	17.3	0.3	0.8	24.8	14.0	12.2	2.6	0.1	2.3	3.3	4.9	1.0	2.4	3.3	2.8	5.2	1.8	4.5	4.2	11.9	81.1	49.9	1.4	2.6	211.5	5.2	40.8	10.7	21.6	15.7	98.2	11.2	11.6	2.3	17.0	11.7	1.0	70.0	0.0	1.8	5.8	2.7	38.3	37.2	23.7	95.3	20.6	36.2	45.8	26.9	10.3	15.6	8.5	7.2	0.4	142.4	0.1	5.8	4.6	4.5	205.4	6.5	2.3	4.4	2.9	1.9	9.3	26.2	1.2	4.8
PLCH1	"DKFZp434C1372, KIAA1069, MGC117152, PLCeta1, PLCL3"	ENSG00000114805	"Phospholipase C eta 1"	Q4KWH8	3	155375580-155745067	"Enzymes, Predicted intracellular proteins"	"Lipid degradation, Lipid metabolism"	"Hydrolase, Transducer"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 14.7;testis: 15.8"	"Cell type enriched"	"Detected in many"	6	"Early spermatids: 148.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"MAIT T-cell: 1.2"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"A549: 8.4;AF22: 27.2;NTERA-2: 14.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA036176, HPA057978"	Uncertain		Enhanced	Vesicles		NA	NA			Vesicles		"HPA036176: AB_10671837, HPA057978: AB_2683569"	"unprognostic (1.08e-2)"	"unprognostic (3.68e-1)"	"unprognostic (2.17e-2)"	"unprognostic (1.55e-2)"	"unprognostic (3.50e-4)"	"unprognostic (6.41e-2)"	"unprognostic (2.94e-5)"	"unprognostic (5.04e-2)"	"unprognostic (2.41e-1)"	"unprognostic (2.24e-3)"	"unprognostic (4.84e-2)"	"unprognostic (1.76e-2)"	"prognostic favorable (3.03e-5)"	"unprognostic (3.28e-2)"	"unprognostic (1.62e-1)"	"unprognostic (1.47e-1)"	"unprognostic (1.37e-2)"	0.3	0.3	3.9	0.7	14.1	0.5	3.9	7.4	14.7	2.1	3.9	5.7	4.1	3.9	1.4	12.9	0.5	12.4	2.4	2.5	4.5	3.6	2.1	0.4	6.1	0.3	3.4	7.3	0.5	2.5	0.8	3.2	0.8	6.5	0.8	3.9	5.6	2.3	3.4	0.6	0.5	3.9	0.5	1.9	0.3	5.8	15.8	2.9	0.0	8.9	0.0	0.4	1.3	0.4	0.1	0.3	0.7	0.0	0.0	1.2	0.9	0.0	8.4	27.2	1.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	1.6	6.7	0.0	0.6	0.0	0.1	0.0	4.8	0.0	0.0	0.0	2.5	6.8	0.0	0.9	0.0	4.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	2.2	0.2	0.0	0.0	2.9	1.6	6.2	14.5	0.9	1.1	0.6	0.0	0.0	1.7	0.1	2.5	0.6	0.0	6.5	0.0	4.2	2.9	0.0	0.0	0.0	0.1	0.0	1.1	0.3	0.0	0.0	0.0	0.9	0.2	0.0	0.0	0.0	0.0	0.0	1.2	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.3	0.0	0.9	3.9	14.1	7.4	14.7	4.5	3.6	3.4	7.3	6.5	2.9	3.0	12.8	0.0	0.3	0.0	10.0	0.5	7.6	25.4	3.4	1.8	3.9	0.0	0.0	1.9	148.2	0.1	2.4	0.0	2.0	0.2	0.0	0.1	0.0	0.0	0.2	23.8	2.9	0.0	0.3	10.0	1.1	0.0	0.0	0.0	4.3	19.3	1.5	2.9	0.4	1.9	3.0	0.0	0.0	2.1	1.1	0.1	0.0	0.0	4.7	0.1
PLCH2	"KIAA0450, PLC-eta2, PLCeta2, PLCL4, RP3-395M20.1"	ENSG00000149527	"Phospholipase C eta 2"	O75038	1	2425980-2505530	"Enzymes, Predicted intracellular proteins"	"Lipid degradation, Lipid metabolism"	"Hydrolase, Transducer"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 32.0;retina: 28.6;skin 1: 36.6"	"Cell type enhanced"	"Detected in many"	18	"Bipolar cells: 76.1;Cone photoreceptor cells: 70.7;Rod photoreceptor cells: 155.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	9	"NK-cells: 2.9;T-cells: 2.4"	"Group enriched"	"Detected in some"	4	"HBEC3-KT: 50.7;hTCEpi: 23.9;hTERT-HME1: 14.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA072705	Enhanced					NA	NA					"HPA072705: AB_2732211"	"unprognostic (2.06e-3)"	"unprognostic (1.30e-2)"	"unprognostic (1.09e-3)"	"unprognostic (3.84e-3)"	"unprognostic (1.99e-1)"	"unprognostic (1.59e-2)"	"unprognostic (7.39e-2)"	"unprognostic (7.70e-2)"	"unprognostic (7.58e-2)"	"unprognostic (9.28e-2)"	"unprognostic (2.26e-1)"	"unprognostic (5.95e-2)"	"unprognostic (6.61e-3)"	"unprognostic (8.43e-2)"	"unprognostic (1.07e-1)"	"unprognostic (8.64e-2)"	"unprognostic (5.80e-2)"	0.5	1.2	6.4	2.9	9.1	1.4	3.1	32.0	25.1	3.2	0.9	1.6	0.5	1.6	0.3	1.7	9.7	2.5	2.4	0.3	20.2	2.7	0.8	0.8	1.2	4.0	2.6	8.4	0.2	1.7	0.1	3.0	0.4	2.6	6.7	0.7	28.6	8.6	4.9	0.2	36.6	2.0	0.2	6.4	4.0	1.7	0.8	2.0	0.2	1.2	0.2	4.9	8.3	6.4	0.3	0.1	0.0	0.0	2.9	2.4	0.9	0.1	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.1	0.0	0.0	7.0	0.0	50.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	23.9	0.0	14.3	0.0	0.0	0.0	0.0	1.2	0.1	0.4	0.0	0.0	0.0	0.7	0.9	0.0	0.0	0.0	0.1	2.8	5.7	1.5	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.9	0.3	1.5	1.4	0.0	0.3	1.1	0.7	0.0	2.9	0.0	0.1	2.1	0.9	6.4	9.1	32.0	25.1	20.2	2.7	2.6	8.4	2.6	2.0	0.0	1.7	2.0	13.5	13.7	76.1	3.2	5.1	1.4	4.5	0.0	70.7	0.0	1.7	0.0	0.0	0.3	1.1	0.0	0.0	0.0	0.5	4.9	0.0	0.0	0.1	25.4	1.2	0.0	0.0	0.0	0.0	0.0	3.3	0.0	1.4	12.3	0.2	0.0	0.0	16.6	155.3	0.0	0.9	0.1	0.2	12.8	0.0	6.9	0.4	6.7
PLCZ1	"NYD-SP27, PLCzeta"	ENSG00000139151	"Phospholipase C zeta 1"	Q86YW0	12	18683169-18738057	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Fertilization, Lipid degradation, Lipid metabolism"	"Developmental protein, Hydrolase, Transducer"	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	17	"testis: 29.5"	"Group enriched"	"Detected in some"	91	"Early spermatids: 451.0;Late spermatids: 242.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"hTEC/SVTERT24-B: 3.8;hTERT-HME1: 1.4;NTERA-2: 2.1;U-2 OS: 1.2;U-251 MG: 1.4"	"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"									NA	NA						"unprognostic (1.95e-1)"					"unprognostic (2.79e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.87e-2)"			"unprognostic (1.39e-2)"		"unprognostic (1.25e-2)"	"unprognostic (1.59e-1)"	"unprognostic (1.40e-1)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.2	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.3	29.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.8	1.4	0.4	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	2.1	0.0	0.7	0.0	0.1	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	451.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	242.6	2.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	1.4	0.0	0.0	0.0	0.0	3.8	1.3	0.0	0.0	0.0	0.0	0.0
PLD1		ENSG00000075651	"Phospholipase D1"	Q13393	3	171600405-171810950	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, RAS pathway related proteins"	"Lipid degradation, Lipid metabolism"	Hydrolase	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"gallbladder: 52.1"	"Cell type enhanced"	"Detected in many"	6	"Cholangiocytes: 50.9;Proximal tubular cells: 44.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"basophil: 10.2"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HUVEC TERT2: 30.3;SK-MEL-30: 16.9;TIME: 26.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"CAB004527, HPA042396"	Enhanced					NA	NA					"CAB004527: AB_677324, HPA042396: AB_2677977"	"unprognostic (3.23e-1)"	"unprognostic (3.27e-1)"	"unprognostic (5.82e-2)"	"unprognostic (5.13e-2)"	"unprognostic (4.58e-1)"	"unprognostic (4.76e-2)"	"unprognostic (9.03e-2)"	"unprognostic (1.46e-1)"	"unprognostic (6.23e-2)"	"unprognostic (8.02e-2)"	"unprognostic (2.06e-2)"	"unprognostic (2.95e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.29e-1)"	"unprognostic (1.16e-1)"	"unprognostic (1.19e-1)"	"prognostic unfavorable (4.76e-6)"	7.0	26.6	5.3	6.1	20.4	4.5	6.3	1.4	10.8	8.6	19.7	31.4	1.8	27.7	6.9	4.9	25.0	4.9	52.1	14.7	7.7	4.7	7.5	20.2	4.4	5.2	25.3	7.2	17.1	13.9	0.9	2.7	6.6	18.8	3.5	9.4	8.5	13.2	4.2	2.0	17.6	29.5	3.4	16.8	9.9	5.3	3.5	21.8	0.9	4.1	10.7	8.5	4.3	11.5	0.1	0.9	10.2	2.6	3.0	4.1	0.8	2.3	3.7	1.9	0.7	6.0	6.8	4.1	1.2	5.3	1.9	2.3	0.5	3.4	0.0	9.5	0.5	13.1	7.9	0.3	1.0	3.0	1.9	1.6	2.2	5.9	13.2	2.7	3.8	10.5	2.6	5.8	2.2	1.1	5.4	30.3	0.6	1.4	0.0	0.4	0.6	0.0	3.2	0.4	6.0	2.7	0.1	0.8	0.0	4.7	0.9	0.0	0.0	4.1	2.5	16.9	2.8	4.7	5.0	26.3	0.8	3.2	2.1	1.3	5.1	4.1	0.0	3.7	4.6	1.0	10.2	2.6	3.2	0.5	1.6	4.1	0.0	0.4	1.0	0.9	0.1	0.0	0.1	1.5	3.0	0.5	0.0	1.2	0.8	5.3	20.4	1.4	10.8	7.7	4.7	25.3	7.2	18.8	21.8	0.0	6.6	1.3	2.8	6.4	0.2	30.1	50.9	5.3	7.9	1.8	0.0	2.4	3.3	5.9	7.9	5.4	31.5	0.0	3.0	3.0	6.6	0.7	27.6	13.1	16.2	0.0	4.1	3.7	11.7	6.1	9.8	3.8	11.8	1.8	21.0	0.0	2.0	14.4	4.2	44.6	0.0	19.4	2.0	5.4	3.6	30.6	1.9	4.5	12.7	4.3
PLD2		ENSG00000129219	"Phospholipase D2"	O14939	17	4807096-4823434	"Enzymes, Predicted intracellular proteins, RAS pathway related proteins"	"Lipid degradation, Lipid metabolism"	Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"monocytes: 29.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA013397	Approved					NA	NA					"HPA013397: AB_1855328"	"unprognostic (1.87e-1)"	"unprognostic (3.27e-1)"	"unprognostic (2.30e-1)"	"unprognostic (1.82e-1)"	"unprognostic (1.97e-1)"	"unprognostic (2.90e-2)"	"unprognostic (3.85e-3)"	"unprognostic (3.64e-1)"	"unprognostic (6.15e-3)"	"unprognostic (2.58e-3)"	"unprognostic (1.25e-1)"	"unprognostic (8.10e-3)"	"unprognostic (1.08e-1)"	"unprognostic (2.95e-1)"	"unprognostic (1.91e-1)"	"unprognostic (1.85e-1)"	"unprognostic (5.48e-2)"	9.9	6.4	9.0	8.2	10.4	2.0	11.0	14.6	10.8	14.9	7.6	18.1	13.4	6.1	11.2	11.7	36.2	13.0	12.3	7.2	10.5	7.8	7.2	6.9	11.7	7.5	10.0	7.0	14.9	12.6	11.4	6.5	14.6	12.2	11.0	8.1	9.8	13.7	26.7	4.3	27.8	6.1	11.8	8.9	7.8	7.0	3.5	13.2	7.3	7.3	20.0	16.8	10.6	20.6	2.6	5.3	4.1	7.4	1.1	3.1	2.9	7.5	12.0	10.8	11.3	9.3	12.5	12.2	5.0	10.4	8.7	7.0	12.7	9.0	3.3	5.8	12.7	3.2	17.5	8.3	10.9	8.1	4.2	4.1	1.1	8.9	7.8	6.8	0.0	8.3	18.3	16.6	7.8	7.1	12.4	20.0	2.3	1.2	3.1	6.7	5.7	0.4	1.4	5.6	6.3	5.2	3.6	6.8	0.8	7.9	12.9	3.5	6.3	9.2	10.9	6.8	9.5	7.8	1.8	15.6	5.7	5.8	12.8	7.6	2.9	1.3	0.7	8.8	1.5	3.3	4.1	6.9	1.6	2.0	7.4	1.5	2.6	2.0	1.5	5.3	1.5	0.6	0.7	0.5	1.1	7.2	2.3	3.1	2.9	9.0	10.4	14.6	10.8	10.5	7.8	10.0	7.0	12.2	13.2	0.0	0.6	1.4	8.3	11.2	1.4	1.2	7.6	5.3	4.5	1.8	0.0	18.5	1.7	8.3	0.0	8.8	4.7	0.0	10.0	12.3	6.0	9.6	5.7	2.4	11.9	0.0	1.2	8.6	5.7	0.0	8.9	9.9	6.8	29.7	5.9	7.1	7.9	7.0	8.1	3.1	1.7	0.0	4.1	0.0	2.9	10.7	14.5	2.9	4.6	10.0
PLD3	HU-K4	ENSG00000105223	"Phospholipase D family member 3"	Q8IV08	19	40348456-40380439	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Immunity, Inflammatory response"	"Exonuclease, Hydrolase, Nuclease"	"Disease mutation, Neurodegeneration, Spinocerebellar ataxia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	9	"Hofbauer cells: 638.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in all"	4	"basophil: 149.2"	"Lineage enriched"	"Detected in all"	6	"granulocytes: 149.2"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA012800, CAB020812"	Approved		Approved	"Nucleoplasm,Endoplasmic reticulum,Cytosol"		NA	NA		490000	"Endoplasmic reticulum, Cytosol"	Nucleoplasm	"CAB020812: , HPA012800: AB_1855330"	"unprognostic (1.11e-1)"	"unprognostic (1.06e-1)"	"unprognostic (1.64e-3)"	"unprognostic (2.56e-3)"	"unprognostic (2.06e-3)"	"unprognostic (2.68e-1)"	"unprognostic (4.52e-2)"	"unprognostic (3.89e-2)"	"unprognostic (1.09e-1)"	"unprognostic (4.60e-2)"	"prognostic favorable (6.44e-4)"	"unprognostic (4.34e-2)"	"prognostic favorable (2.21e-4)"	"unprognostic (3.49e-2)"	"unprognostic (2.10e-1)"	"unprognostic (1.38e-2)"	"unprognostic (6.42e-2)"	45.7	57.5	44.6	23.1	79.0	12.8	21.9	35.5	126.1	31.2	23.5	25.4	17.1	22.6	26.3	35.0	18.3	30.0	30.8	33.0	46.4	73.4	22.1	25.6	49.7	25.2	44.7	53.9	44.8	42.5	32.9	122.1	38.9	62.2	29.6	16.1	31.6	35.3	37.2	27.4	24.2	23.5	25.6	28.6	48.9	23.0	17.0	19.3	11.9	20.6	11.2	12.9	27.3	20.7	3.6	23.0	149.2	24.6	9.7	7.8	16.8	14.1	43.7	28.3	44.5	78.9	37.6	21.6	35.1	35.8	25.5	29.2	8.3	16.0	6.1	36.9	30.5	8.3	6.6	6.8	13.8	11.2	22.9	24.9	6.6	15.0	10.4	53.9	2.7	75.9	71.5	28.9	19.4	13.4	42.8	21.4	10.1	23.3	24.9	18.3	18.5	4.8	13.1	18.5	23.2	9.0	6.1	21.6	25.2	13.1	10.6	20.3	33.8	16.8	10.4	18.8	30.9	14.3	47.6	37.6	21.5	10.3	18.2	7.8	26.0	27.7	6.3	34.6	11.0	13.3	149.2	24.6	35.3	7.8	12.8	6.4	3.6	6.2	6.9	23.0	3.1	6.5	6.5	2.5	9.7	5.7	3.3	6.1	16.8	44.6	79.0	35.5	126.1	46.4	73.4	44.7	53.9	62.2	19.3	29.8	62.9	34.4	70.6	31.5	98.5	18.5	25.5	12.0	28.4	54.1	31.4	137.8	18.3	50.7	5.8	46.8	52.7	0.0	51.3	94.8	142.4	49.1	59.9	35.8	638.2	114.4	69.9	90.9	219.8	8.6	140.4	84.2	87.7	44.1	36.8	99.5	49.7	41.2	135.1	30.0	39.3	19.4	53.1	13.9	57.5	29.2	163.8	35.4	34.5	52.0
PLD4	C14orf175	ENSG00000166428	"Phospholipase D family member 4"	Q96BZ4	14	104924816-104937790	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Immunity, Inflammatory response, Innate immunity"	"Exonuclease, Hydrolase, Nuclease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	10	"blood: 229.9"	"Group enriched"	"Detected in some"	4	"B-cells: 25.7;Hofbauer cells: 28.1;Macrophages: 25.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	5	"plasmacytoid DC: 229.9"	"Lineage enriched"	"Detected in many"	5	"dendritic cells: 229.9"	"Group enriched"	"Detected in some"	5	"HMC-1: 34.9;RPMI-8226: 25.0;THP-1: 63.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA051512	Uncertain					NA	NA		2000000			"HPA051512: AB_2681515"	"unprognostic (4.50e-3)"	"unprognostic (1.78e-4)"	"unprognostic (7.12e-2)"	"unprognostic (5.30e-3)"	"unprognostic (5.54e-2)"	"unprognostic (2.91e-3)"	"unprognostic (2.56e-1)"	"unprognostic (4.76e-3)"	"unprognostic (1.45e-3)"	"unprognostic (1.19e-3)"	"unprognostic (3.45e-3)"	"unprognostic (3.89e-1)"	"unprognostic (6.90e-3)"	"unprognostic (8.94e-2)"	"unprognostic (2.83e-1)"	"unprognostic (1.28e-2)"	"unprognostic (2.41e-1)"	0.7	1.6	8.9	6.7	8.8	15.0	1.9	5.7	10.0	1.5	1.3	23.1	0.1	5.6	1.5	0.5	1.1	2.8	3.5	0.8	8.7	8.4	1.2	0.9	2.6	14.4	14.5	3.4	0.9	1.6	1.0	2.8	1.2	9.0	2.1	0.8	1.5	4.6	2.3	0.5	0.9	5.5	0.9	19.0	11.6	3.5	0.8	9.2	2.7	1.0	0.0	11.2	3.9	0.9	14.7	229.9	43.4	17.7	1.7	0.1	4.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	34.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	3.0	0.0	0.0	0.0	8.8	0.0	25.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	63.3	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.0	0.2	2.8	43.4	0.0	11.9	0.1	14.7	0.0	0.0	35.1	12.3	0.1	0.0	0.6	1.7	17.7	229.9	0.0	4.4	8.9	8.8	5.7	9.6	8.7	8.4	14.5	3.4	9.0	9.2	0.0	0.0	25.7	0.1	0.3	0.3	1.4	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.4	0.3	0.0	0.0	0.0	0.3	0.4	0.1	3.5	0.0	28.1	1.6	0.0	0.0	1.3	2.5	0.0	25.2	5.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	6.5	0.4	0.7	0.1	0.4	0.2	0.0	0.0	0.0
PLG		ENSG00000122194	Plasminogen	P00747	6	160702238-160753315	"Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted secreted proteins"	"Blood coagulation, Fibrinolysis, Hemostasis, Tissue remodeling"	"Hydrolase, Protease, Serine protease"	"Cancer-related genes, Disease mutation, FDA approved drug targets, Thrombophilia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	11	"liver: 269.9"	"Cell type enriched"	"Detected in some"	7	"Hepatocytes: 1391.0"	"Cancer enriched"	"Detected in some"	84	"liver cancer: 180.7"					"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HEL: 1.2;HL-60: 3.6;RH-30: 4.0;U-698: 2.0;U-937: 1.6"									"CAB000668, CAB016678, HPA021602, HPA048823"	Supported				"Secreted to blood"	NA	NA	140000000000	41000000000			"CAB000668: , CAB016678: AB_1621208, HPA021602: AB_1855453, HPA048823: AB_2680532"		"unprognostic (1.70e-1)"		"unprognostic (2.16e-3)"	"unprognostic (2.44e-1)"		"unprognostic (8.54e-3)"	"unprognostic (1.41e-1)"		"unprognostic (1.76e-3)"	"unprognostic (6.28e-2)"	"unprognostic (7.25e-2)"	"prognostic favorable (4.22e-4)"	"unprognostic (3.97e-3)"	"unprognostic (5.21e-2)"		"unprognostic (2.33e-2)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	24.0	269.9	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0		0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.5	0.0	3.6	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.4	0.0	0.0	0.3	0.2	0.9	0.0	0.0	0.4	4.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.1	0.0	0.0	1.0	0.0	2.0	0.0	1.6	0.0	0.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	2.2	0.0	0.0	0.0	0.6	28.1	2.7	0.0	1.8	0.0	0.0	16.6	0.0	0.1	0.0	0.0	23.3	0.0	0.0	0.0	0.0	1.1	1391.0	0.1	0.0	0.0	26.4	26.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	203.6	0.0	0.0	0.0	0.4	0.0	0.0	0.0	4.9	0.0	0.0
PLK1	PLK	ENSG00000166851	"Polo like kinase 1"	P53350	16	23677656-23690367	"Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"	"Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 83.9;testis: 32.4"	"Cell type enhanced"	"Detected in many"	18	"Early spermatids: 86.9;Erythroid cells: 23.3;Extravillous trophoblasts: 48.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in some"	5	"T-reg: 9.0"	"Lineage enriched"	"Detected in many"	5	"T-cells: 9.0"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			"HPA051638, HPA053229"	Approved					NA	Yes					"HPA051638: AB_2681561, HPA053229: AB_2682084"	"unprognostic (7.21e-3)"	"unprognostic (1.77e-1)"	"unprognostic (1.98e-3)"	"unprognostic (4.97e-3)"	"unprognostic (9.56e-2)"	"unprognostic (5.12e-2)"	"prognostic unfavorable (2.70e-7)"	"prognostic unfavorable (2.28e-5)"	"unprognostic (2.55e-2)"	"unprognostic (1.89e-1)"	"prognostic unfavorable (4.12e-4)"	"unprognostic (1.24e-2)"	"prognostic unfavorable (0.00e+0)"	"unprognostic (1.33e-1)"	"unprognostic (8.10e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.26e-2)"	2.9	1.1	1.1	14.2	1.5	15.9	1.7	2.1	1.1	1.5	7.1	0.7	0.5	6.0	1.1	0.9	10.4	0.7	1.5	1.0	1.0	0.8	1.3	1.2	2.6	15.2	0.8	0.6	1.2	0.7	0.0	0.8	6.8	0.7	0.9	5.9	0.5	1.7	0.8	0.8	2.9	5.9	2.0	0.7	8.3	3.6	32.4	0.5	83.9	0.6	6.6	20.4	2.1	2.6	1.9	0.5	0.7	0.1	1.3	9.0	2.3	43.5	45.5	37.6	20.4	1.1	2.6	21.1	24.9	16.5	39.1	29.1	39.7	28.8	21.8	13.0	16.8	20.6	25.1	51.2	20.5	47.1	31.0	28.9	27.7	35.9	54.2	0.3	31.9	30.4	1.0	1.1	27.7	28.6	4.9	28.5	28.6	43.0	30.1	30.1	39.8	30.1	31.9	42.9	17.9	23.2	46.9	25.5	34.6	11.1	9.5	21.2	14.7	28.5	20.0	12.9	22.4	25.4	19.7	14.4	18.6	23.8	18.2	42.5	21.5	33.3	37.8	15.8	27.8	30.4	0.0	0.1	0.0	0.0	0.0	0.0	1.9	1.4	0.5	0.5	0.0	0.0	0.0	0.7	1.3	0.0	0.0	9.0	2.3	1.1	1.5	2.1	1.1	1.0	0.8	0.8	0.6	0.7	0.5	3.0	0.0	0.8	1.0	1.1	1.3	0.6	0.0	0.0	0.0	0.0	3.9	4.5	0.0	0.6	86.9	0.5	1.5	23.3	0.7	48.0	0.7	1.0	1.1	0.9	17.0	0.0	0.0	3.1	3.7	4.8	1.1	2.6	0.0	0.0	2.9	1.1	0.8	0.0	0.7	0.0	1.1	0.0	0.3	3.2	5.0	1.6	3.2	1.3	3.9	1.8
PLK2	SNK	ENSG00000145632	"Polo like kinase 2"	Q9NYY3	5	58453982-58460260	"Enzymes, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"	"Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Extravillous trophoblasts: 180.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"NK-cell: 10.4"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"hTERT-RPE1: 147.8;T-47d: 51.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"CAB009624, HPA069329"	Approved		Approved	Nucleoplasm,Mitochondria,Cytosol		NA	NA			"Nucleoplasm, Mitochondria, Cytosol"		"CAB009624: AB_2167745, HPA069329: "	"unprognostic (4.82e-2)"	"unprognostic (1.08e-2)"	"unprognostic (2.38e-1)"	"unprognostic (6.51e-2)"	"prognostic unfavorable (7.75e-4)"	"unprognostic (1.22e-1)"	"unprognostic (2.55e-2)"	"unprognostic (1.03e-2)"	"unprognostic (2.44e-2)"	"unprognostic (1.06e-2)"	"unprognostic (1.01e-1)"	"unprognostic (3.11e-1)"	"prognostic unfavorable (2.08e-4)"	"unprognostic (6.56e-2)"	"unprognostic (1.43e-1)"	"unprognostic (3.46e-1)"	"unprognostic (1.95e-3)"	11.4	3.7	19.6	4.0	40.2	4.4	23.4	1.3	39.4	20.6	5.7	3.7	5.0	5.1	19.2	7.1	17.7	9.5	18.2	28.1	18.8	5.1	6.9	17.6	17.7	3.8	4.2	20.6	11.8	12.6	3.8	3.3	25.9	8.7	8.7	8.7	12.6	22.1	6.2	8.7	20.9	6.1	15.4	2.7	54.7	4.7	19.8	7.4	1.0	8.9	16.6	7.5	14.2	15.5	1.2	2.9	3.0	1.6	10.4	1.2	0.6	16.4	14.9	5.2	0.4	2.7	4.5	2.0	3.5	5.9	11.7	6.8	1.1	14.6	0.0	23.2	12.6	28.5	20.7	0.2	8.1	10.7	0.0	0.4	0.0	6.7	1.2	14.8	0.0	0.4	2.6	11.3	4.5	12.7	147.8	23.5	0.0	0.0	0.5	23.1	6.0	0.0	0.0	0.9	1.6	2.4	0.8	14.3	0.0	30.8	3.3	0.3	0.7	10.8	2.1	9.5	9.7	51.9	0.2	30.0	3.2	8.7	1.4	28.1	0.0	0.0	0.0	2.5	0.0	14.4	3.0	0.7	2.3	0.1	1.6	0.0	1.2	0.7	0.0	2.9	0.9	1.2	0.6	1.9	10.4	0.6	2.0	0.5	0.6	19.6	40.2	1.3	39.4	18.8	5.1	4.2	20.6	8.7	7.4	17.9	18.6	2.7	128.0	125.8	2.8	105.2	22.9	18.7	68.2	17.4	3.9	55.6	8.3	96.4	5.7	109.7	37.3	0.0	69.2	180.6	32.4	45.1	9.2	6.0	13.5	0.0	80.9	51.5	8.9	2.3	11.8	11.2	23.6	5.4	25.3	3.5	71.6	40.7	10.3	2.5	2.7	0.0	79.3	72.4	10.4	90.5	108.6	6.4	24.3	54.0
PLK3	"CNK, FNK, PRK"	ENSG00000173846	"Polo like kinase 3"	Q9H4B4	1	44800225-44805990	"Enzymes, Predicted intracellular proteins"	"Apoptosis, Cell cycle, DNA damage"	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA060318	Enhanced					NA	NA					"HPA060318: AB_2684252"	"unprognostic (1.06e-1)"	"unprognostic (8.71e-2)"	"unprognostic (3.69e-2)"	"unprognostic (3.51e-3)"	"unprognostic (3.09e-2)"	"unprognostic (4.72e-2)"	"unprognostic (1.02e-1)"	"unprognostic (1.59e-1)"	"unprognostic (5.12e-3)"	"unprognostic (6.78e-2)"	"unprognostic (7.67e-3)"	"unprognostic (2.79e-2)"	"prognostic unfavorable (1.75e-4)"	"unprognostic (2.04e-1)"	"unprognostic (1.43e-1)"	"unprognostic (5.06e-2)"	"unprognostic (1.35e-1)"	14.8	7.6	4.4	16.3	18.8	8.6	10.0	2.4	6.4	8.6	5.3	13.9	3.2	4.0	9.9	5.8	23.9	8.5	21.6	6.8	10.5	6.0	6.7	9.0	14.9	10.0	9.9	2.5	7.8	10.7	15.6	9.0	29.6	14.8	6.4	4.0	7.6	8.2	6.8	7.0	16.6	7.0	6.0	15.2	9.1	6.1	4.5	5.6	4.6	8.4	25.0	18.2	9.9	9.5	1.3	4.2	2.8	5.1	0.6	11.0	3.5	4.1	2.7	4.2	1.9	3.1	10.1	7.8	9.7	13.7	3.7	3.7	1.6	5.8	5.0	4.1	7.9	12.0	3.7	2.3	13.2	2.1	8.1	0.7	5.6	1.5	3.6	15.2	1.8	7.2	7.9	8.0	11.0	10.8	12.9	11.6	1.8	2.8	2.1	8.3	2.7	3.7	1.6	2.8	2.5	3.3	4.4	2.8	7.3	13.2	1.5	3.2	2.0	2.6	4.5	10.7	6.7	0.4	1.7	14.8	2.3	5.7	4.5	5.7	5.8	2.7	1.3	4.9	2.9	4.5	0.0	2.9	0.8	1.7	5.0	2.1	1.3	9.9	4.2	4.2	1.1	11.0	4.9	2.8	0.6	5.1	1.8	10.5	3.5	4.4	18.8	2.4	6.4	10.5	6.0	9.9	2.5	14.8	5.6	11.9	41.5	19.3	51.6	39.2	5.3	2.2	12.7	9.4	12.5	5.2	2.0	13.1	0.0	17.7	0.6	29.7	73.5	0.0	11.3	19.2	25.9	18.8	78.3	5.4	35.4	6.4	50.8	24.5	18.9	0.4	9.2	52.8	11.8	10.8	21.9	5.4	18.2	66.6	4.9	2.3	9.6	25.8	26.8	1.7	4.9	29.4	49.5	24.5	28.1	55.0
PLK4	"Sak, STK18"	ENSG00000142731	"Polo like kinase 4"	O00444	4	127880861-127899195	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"	Dwarfism	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 16.5;lymphoid tissue: 21.7;testis: 21.7"	"Cell type enhanced"	"Detected in many"	14	"Early spermatids: 48.9;Erythroid cells: 23.3;Late spermatids: 60.1;Spermatocytes: 27.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"							"HPA017327, HPA035026, HPA043198"	Approved		Supported	Centrosome,Cytosol		NA	NA			"Centrosome, Cytosol"		"HPA017327: AB_2669584, HPA035026: AB_10602080, HPA043198: AB_2732504"	"unprognostic (2.44e-1)"	"unprognostic (4.24e-2)"	"prognostic favorable (7.46e-5)"	"unprognostic (2.18e-1)"	"unprognostic (3.79e-1)"	"unprognostic (9.20e-2)"	"unprognostic (1.06e-5)"	"prognostic unfavorable (5.13e-4)"	"unprognostic (1.44e-3)"	"unprognostic (5.66e-2)"	"prognostic unfavorable (5.14e-4)"	"unprognostic (1.27e-1)"	"unprognostic (2.22e-11)"	"unprognostic (2.29e-2)"	"unprognostic (3.58e-1)"	"unprognostic (4.75e-2)"	"unprognostic (7.93e-2)"	1.4	1.3	1.5	4.7	2.4	16.5	2.2	0.5	2.2	2.0	3.2	0.3	0.6	2.3	1.3	1.3	5.4	1.1	1.2	2.0	1.2	1.3	1.5	0.9	1.5	5.9	1.2	1.4	1.5	0.9	0.3	0.6	5.0	2.6	1.4	3.7	0.8	1.7	0.7	0.4	2.7	3.2	1.9	1.8	2.7	1.6	21.7	1.0	21.7	1.0	2.1	6.0	1.5	2.2	0.7	0.7	1.5	0.8	1.4	4.0	0.8	11.8	5.6	21.1	10.8	0.7	2.1	9.6	11.6	8.2	15.5	16.0	7.8	12.2	16.0	4.3	6.4	12.6	7.8	14.8	9.3	23.9	12.4	6.1	14.5	9.0	7.3	0.2	20.4	17.1	0.6	0.9	14.1	6.5	2.8	11.9	12.3	16.8	21.4	13.0	8.2	31.4	9.1	9.8	12.1	6.4	16.4	14.7	5.5	5.1	7.6	11.6	9.6	7.3	6.7	3.5	9.3	5.4	8.8	5.1	12.2	11.8	8.3	14.4	11.0	12.1	22.8	6.2	15.5	13.5	0.0	0.4	1.5	1.6	0.8	1.1	0.3	1.8	1.7	0.7	0.7	0.6	2.3	0.0	1.4	0.3	0.4	4.0	0.8	1.5	2.4	0.5	2.2	1.2	1.3	1.2	1.4	2.6	1.0	0.0	1.1	0.8	0.6	1.4	2.1	0.5	0.0	2.7	0.0	1.8	0.0	3.6	0.0	0.6	48.9	0.4	0.0	23.3	0.3	10.4	0.7	0.4	1.1	0.2	3.1	0.0	2.4	0.6	1.0	60.1	2.6	1.6	0.0	1.8	1.9	1.1	0.1	0.0	0.4	0.3	0.7	0.0	0.3	27.0	12.1	0.6	3.2	1.8	2.1	0.9
PLK5	"PLK5P, SgK384ps"	ENSG00000185988	"Polo like kinase 5"	Q496M5	19	1524074-1536046	"Enzymes, Predicted intracellular proteins"	"Cell cycle, Cell division, Differentiation, Mitosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in many"	6	"brain: 50.1"	"Group enriched"	"Detected in some"	5	"Leydig cells: 33.6;Peritubular cells: 63.6"	"Low cancer specificity"	"Detected in single"			"Region enriched"	"Detected in all"	6	"cerebellum: 50.1"	"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"Daudi: 5.0"									HPA035024	Enhanced					NA	NA					"HPA035024: AB_2674418"	"unprognostic (4.32e-2)"	"unprognostic (1.22e-2)"	"unprognostic (1.35e-1)"	"unprognostic (7.69e-2)"	"unprognostic (1.11e-2)"	"unprognostic (1.33e-1)"	"unprognostic (2.69e-1)"	"unprognostic (8.38e-2)"	"unprognostic (4.06e-2)"	"unprognostic (1.74e-1)"	"unprognostic (3.36e-2)"	"unprognostic (9.94e-3)"	"unprognostic (2.18e-3)"	"unprognostic (3.21e-1)"	"unprognostic (7.49e-2)"	"unprognostic (3.54e-2)"	"unprognostic (4.01e-4)"	0.4	0.7	8.3	0.4	4.8	1.7	0.8	50.1	7.9	5.9	0.4	1.6	0.3	0.5	6.4	6.2	1.6	2.7	0.4	0.3	3.2	1.7	0.3	0.3	0.3	0.4	1.1	1.9	0.8	0.6	0.5	0.5	0.3	2.9	0.9	0.4	8.4	0.6	3.2	0.5	1.0	0.7	2.8	0.8	0.4	0.2	7.4	1.8	0.0	0.4	0.0	0.3	0.2	2.9	1.2	1.2	4.4	0.9	1.0	1.1	0.1	0.2	0.9	0.8	1.2	0.4	0.9	1.0	0.2	0.5	0.5	0.4	0.5	1.0	5.0	0.3	0.5	0.3	1.2	0.8	0.5	0.2	0.5	0.7	1.0	1.3	0.8	0.1	0.2	1.1	1.0	0.3	0.8	0.2	2.0	0.3	0.7	0.8	1.7	0.8	1.0	0.4	1.0	1.4	0.3	0.9	1.0	0.3	0.4	0.6	0.1	0.5	0.7	0.7	0.4	0.3	0.6	1.5	0.7	0.0	0.9	1.0	1.3	0.2	1.5	0.4	0.6	0.4	0.7	0.5	1.6	0.9	2.2	0.8	0.5	0.5	0.7	0.8	0.5	0.2	1.2	1.1	0.6	4.4	1.0	0.6	1.2	1.0	0.1	8.3	4.8	50.1	7.9	3.2	1.7	1.1	1.9	2.9	1.8	0.0	0.0	0.0	0.1	0.1	2.4	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	33.6	0.0	1.7	0.0	0.0	10.1	0.0	0.0	63.6	0.0	0.6	0.0	0.0	0.0	2.1	0.1	0.1	0.0	0.0	0.1
PLOD1	"LH1, LLH, PLOD"	ENSG00000083444	"Procollagen-lysine,2-oxoglutarate 5-dioxygenase 1"	Q02809	1	11934205-11975538	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		"Dioxygenase, Oxidoreductase"	"Disease mutation, Ehlers-Danlos syndrome"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	11	"Extravillous trophoblasts: 215.9;Sertoli cells: 103.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA049137, HPA055799"	Uncertain		Uncertain	Nucleoplasm,Vesicles	"Intracellular and membrane"	NA	NA		2700000	Vesicles	Nucleoplasm	"HPA049137: AB_2680649, HPA055799: AB_2682924"	"unprognostic (1.00e-1)"	"unprognostic (2.69e-3)"	"unprognostic (9.21e-3)"	"unprognostic (5.43e-2)"	"unprognostic (7.53e-3)"	"unprognostic (1.12e-2)"	"prognostic unfavorable (2.79e-4)"	"unprognostic (1.13e-3)"	"unprognostic (1.23e-1)"	"unprognostic (1.79e-1)"	"unprognostic (4.15e-3)"	"unprognostic (2.32e-1)"	"prognostic unfavorable (1.91e-12)"	"unprognostic (2.79e-1)"	"unprognostic (7.12e-2)"	"unprognostic (5.92e-2)"	"prognostic unfavorable (2.43e-4)"	29.0	19.5	14.9	16.8	24.0	7.1	32.1	12.1	17.6	35.8	21.7	17.0	17.7	19.1	34.2	21.1	16.5	24.7	21.3	31.2	17.6	14.8	27.5	51.3	22.2	19.7	24.5	9.9	31.8	30.3	18.2	16.3	41.5	20.8	21.1	12.0	25.1	39.3	22.0	18.3	13.3	20.8	39.0	13.2	21.1	18.6	10.0	22.4	1.7	34.8	11.1	8.2	19.5	69.7	1.6	16.3	17.7	19.4	2.6	9.1	9.3	16.9	14.5	8.0	37.4	54.7	30.6	6.4	50.4	67.0	26.6	45.3	16.5	11.1	9.8	53.4	55.7	19.8	14.3	11.6	17.6	18.3	10.2	12.4	5.3	23.3	20.9	33.9	3.3	25.8	37.1	9.3	32.1	12.9	90.3	47.1	2.2	14.8	4.8	27.7	11.0	0.8	8.9	3.5	17.3	21.6	3.9	16.3	21.3	15.3	3.8	3.0	12.7	22.0	15.1	25.4	13.1	7.6	8.5	46.5	30.4	22.8	38.0	24.7	11.3	18.3	5.8	67.4	11.6	49.6	0.0	19.4	0.9	9.1	17.2	1.6	1.0	1.6	4.4	16.3	1.6	0.6	3.4	17.7	2.6	15.0	2.4	1.0	9.3	14.9	24.0	12.1	17.6	17.6	14.8	24.5	9.9	20.8	22.4	0.0	9.3	3.7	7.6	6.3	4.2	16.2	10.2	4.0	5.7	10.4	2.0	34.8	3.3	30.5	1.1	20.4	18.7	0.0	8.4	215.9	28.4	9.2	0.0	29.9	41.8	6.4	8.1	46.6	21.6	1.7	41.1	15.6	10.1	18.0	9.8	10.1	24.0	12.9	23.0	13.7	2.7	103.5	26.2	0.5	3.6	4.4	28.1	4.4	11.0	3.8
PLOD2	LH2	ENSG00000152952	"Procollagen-lysine,2-oxoglutarate 5-dioxygenase 2"	O00469	3	146069440-146163653	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"		"Dioxygenase, Oxidoreductase"	"Disease mutation, Osteogenesis imperfecta"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 73.1"	"Cell type enhanced"	"Detected in many"	5	"Extravillous trophoblasts: 109.4;Pancreatic endocrine cells: 83.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"neutrophil: 1.5"	"Lineage enriched"	"Detected in single"	5	"granulocytes: 1.5"	"Cell line enhanced"	"Detected in many"		"HBF TERT88: 82.6;hTERT-RPE1: 93.9;U-87 MG: 73.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB025898, HPA069126"	Approved		Uncertain	Nucleoli,Cytosol	"Intracellular and membrane"	NA	NA			"Nucleoli, Cytosol"		"CAB025898: , HPA069126: "	"unprognostic (8.68e-2)"	"prognostic unfavorable (1.97e-4)"	"unprognostic (2.23e-1)"	"unprognostic (2.15e-1)"	"unprognostic (1.34e-2)"	"unprognostic (1.29e-3)"	"prognostic unfavorable (7.64e-10)"	"prognostic unfavorable (1.42e-4)"	"unprognostic (2.97e-2)"	"unprognostic (3.36e-2)"	"unprognostic (6.27e-3)"	"unprognostic (2.24e-1)"	"prognostic unfavorable (4.99e-11)"	"prognostic unfavorable (2.83e-4)"	"unprognostic (6.07e-2)"	"unprognostic (4.06e-2)"	"unprognostic (4.41e-3)"	36.7	14.1	11.2	18.0	12.1	0.7	28.5	7.9	13.5	8.8	25.2	5.1	8.3	21.6	14.8	7.5	12.0	8.0	22.3	16.6	12.5	8.2	16.4	73.1	9.3	3.0	10.7	4.8	17.7	14.4	13.9	7.8	41.0	13.0	11.1	16.1	7.2	7.7	11.3	4.8	3.2	24.7	24.2	19.4	3.2	13.6	6.3	10.9	6.1	47.6	3.5	3.0	21.8	28.7	0.0	0.0	1.5	0.3	0.0	0.0	1.9	16.4	11.8	3.7	1.2	13.5	14.5	9.4	58.5	17.9	31.9	60.2	0.9	1.7	0.0	11.4	9.9	14.6	3.5	4.3	50.3	82.6	0.0	6.8	4.1	11.5	8.2	34.7	0.0	0.0	25.4	7.2	27.6	13.5	93.9	44.0	0.0	5.4	0.2	56.3	6.0	0.0	0.0	2.3	0.0	5.1	0.0	2.4	0.0	13.4	0.8	1.8	0.0	46.6	5.0	4.9	18.1	13.6	0.5	55.2	39.5	12.0	12.5	34.9	17.9	2.5	0.0	73.6	0.0	7.0	0.8	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	1.9	11.2	12.1	7.9	13.5	12.5	8.2	10.7	4.8	13.0	10.9	14.9	10.7	0.5	5.9	6.3	14.5	10.6	61.1	12.0	13.6	26.2	33.4	6.8	8.3	62.8	0.4	21.2	46.1	0.0	45.9	109.4	34.5	8.1	0.0	50.8	4.7	0.0	19.0	18.4	1.5	1.3	12.0	2.7	13.5	1.0	18.3	65.1	83.0	31.5	4.6	6.9	22.4	19.4	38.1	8.0	16.3	4.8	15.7	0.7	21.3	5.4
PLOD3	LH3	ENSG00000106397	"Procollagen-lysine,2-oxoglutarate 5-dioxygenase 3"	O60568	7	101205977-101218420	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins"		"Dioxygenase, Glycosyltransferase, Multifunctional enzyme, Oxidoreductase, Transferase"	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in all"	4	"dendritic cells: 13.4;monocytes: 14.3;T-cells: 9.2"	"Cell line enhanced"	"Detected in many"		"Karpas-707: 105.8;WM-115: 102.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA001236	Uncertain				"Secreted - unknown location"	NA	NA		370000			"HPA001236: AB_1855474"	"unprognostic (1.15e-1)"	"prognostic unfavorable (1.91e-5)"	"prognostic unfavorable (3.26e-4)"	"unprognostic (1.39e-1)"	"unprognostic (2.76e-3)"	"unprognostic (1.04e-2)"	"unprognostic (6.26e-3)"	"unprognostic (1.11e-3)"	"unprognostic (8.00e-3)"	"unprognostic (1.18e-2)"	"unprognostic (4.18e-2)"	"unprognostic (1.66e-1)"	"unprognostic (1.21e-3)"	"unprognostic (1.68e-1)"	"unprognostic (1.54e-1)"	"unprognostic (8.52e-3)"	"unprognostic (9.87e-2)"	23.9	16.1	11.9	19.5	24.0	14.6	35.4	7.2	19.2	17.8	20.0	31.2	16.6	22.7	22.9	15.1	11.0	17.4	16.7	22.1	14.8	11.6	20.2	54.1	21.0	18.2	36.3	8.9	16.1	23.2	18.5	16.5	33.1	22.4	14.4	14.2	11.1	11.3	19.6	8.8	14.0	23.2	23.2	29.0	20.4	16.7	10.1	30.6	5.1	16.8	6.0	6.9	17.3	42.6	2.6	13.4	2.8	14.3	2.5	9.2	5.3	10.1	9.2	3.8	25.8	18.4	13.3	7.9	18.7	21.0	19.2	13.9	14.8	13.2	0.8	21.1	32.3	14.8	12.4	7.7	11.0	4.9	5.5	3.5	1.0	11.1	14.4	25.4	4.6	8.7	14.3	10.5	11.2	8.9	18.2	17.0	0.7	9.8	105.8	12.9	29.0	0.4	10.9	8.1	17.5	14.0	3.2	5.2	15.7	6.5	3.0	2.9	17.5	11.6	17.0	41.7	10.7	3.2	15.9	14.8	29.1	14.2	35.2	22.9	5.9	10.8	0.6	17.2	11.1	102.0	0.0	10.8	2.8	9.2	14.3	8.1	2.6	6.8	6.1	10.4	1.8	3.2	3.4	1.0	2.5	14.3	13.4	4.3	5.3	11.9	24.0	7.2	19.2	14.8	11.6	36.3	8.9	22.4	30.6	20.8	8.3	9.0	8.8	7.9	5.1	12.3	17.8	12.0	7.9	24.4	13.7	16.7	1.7	35.7	0.4	23.6	35.9	0.0	27.6	62.3	31.0	7.5	19.6	16.6	45.4	7.9	15.5	27.0	21.6	1.5	24.2	16.4	59.1	20.8	16.2	10.8	29.4	28.1	13.8	10.5	5.9	19.4	17.6	7.2	12.6	4.3	15.8	8.6	21.1	4.2
PLPP1	"LPP1, PAP-2a, PPAP2A"	ENSG00000067113	"Phospholipid phosphatase 1"	O14494	5	55424854-55535050	"Enzymes, Predicted membrane proteins"	"Lipid metabolism"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	9	"Ito cells: 254.8;Leydig cells: 203.1"	"Cancer enhanced"	"Detected in all"		"prostate cancer: 200.4"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"ASC diff: 93.3;fHDF/TERT166: 28.4;HMC-1: 48.9;HSkMC: 35.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB033331, HPA047815"	Enhanced		Supported	"Plasma membrane"		NA	NA			"Plasma membrane"		"CAB033331: AB_2168044, HPA047815: AB_2680164"	"unprognostic (1.22e-1)"	"unprognostic (1.54e-1)"	"unprognostic (1.74e-1)"	"unprognostic (1.55e-2)"	"unprognostic (2.52e-1)"	"unprognostic (1.36e-1)"	"prognostic favorable (6.06e-4)"	"unprognostic (2.81e-1)"	"unprognostic (2.20e-1)"	"unprognostic (4.05e-3)"	"unprognostic (2.43e-2)"	"unprognostic (1.05e-1)"	"unprognostic (4.37e-3)"	"prognostic unfavorable (5.77e-4)"	"unprognostic (3.94e-2)"	"unprognostic (1.66e-1)"	"unprognostic (3.11e-2)"	56.3	26.7	12.5	14.8	14.6	0.6	57.9	10.6	18.5	34.5	30.9	26.1	18.0	17.3	36.8	26.0	18.4	20.4	61.0	33.7	13.4	10.8	34.5	42.0	15.9	17.3	20.8	10.1	16.5	17.6	16.9	10.1	22.4	21.4	82.0	24.7	29.8	9.8	24.0	18.4	16.6	25.4	39.6	28.2	10.2	21.7	18.1	14.5	4.4	32.7	9.6	10.0	43.1	18.1	5.4	13.6	3.3	0.7	2.7	9.5	1.6	2.0	4.9	1.4	2.9	93.3	10.9	2.0	4.4	12.4	2.4	5.8	3.4	3.6	2.0	4.2	28.4	6.7	1.3	5.1	2.5	2.8	1.3	4.0	0.2	2.1	4.2	14.7	0.5	48.9	35.8	5.3	3.6	2.2	4.9	4.0	1.9	0.0	5.7	4.9	1.2	1.3	1.0	3.3	0.2	4.0	0.4	2.4	0.1	9.3	15.9	1.8	1.2	4.4	0.9	2.6	6.4	3.2	0.3	4.9	0.8	1.5	3.7	3.1	3.5	1.4	2.4	3.3	0.2	4.0	0.0	0.4	3.3	1.5	0.4	1.6	5.4	5.2	3.2	1.9	3.4	9.5	7.5	0.3	2.7	0.7	13.6	2.2	1.6	12.5	14.6	10.6	18.5	13.4	10.8	20.8	10.1	21.4	14.5	6.0	10.3	3.9	48.9	0.0	5.2	0.0	15.3	4.0	10.3	27.9	2.0	2.2	5.0	22.3	30.3	45.0	26.9	0.0	24.7	9.6	32.8	109.6	25.6	50.5	11.0	1.6	1.2	254.8	14.9	19.1	203.1	3.6	0.0	7.2	23.2	14.3	28.1	29.4	83.1	24.5	4.8	58.2	0.0	47.0	18.1	0.0	4.1	4.3	14.9	41.0
PLPP2	"LPP2, PAP-2c, PPAP2C"	ENSG00000141934	"Phospholipid phosphatase 2"	O43688	19	281040-291504	"Enzymes, Predicted membrane proteins"	"Lipid metabolism"	Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	8	"Cholangiocytes: 188.5;Ciliated cells: 167.3;Ductal cells: 295.2;Rod photoreceptor cells: 190.0;Urothelial cells: 167.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"gdT-cell: 4.4;MAIT T-cell: 9.4"	"Lineage enriched"	"Detected in single"	52	"T-cells: 9.4"	"Cell line enhanced"	"Detected in many"		"A549: 34.1;CAPAN-2: 37.1;OE19: 63.6"	"Low region specificity"	"Detected in many"							HPA055540	Uncertain		Approved	Mitochondria		NA	NA			Mitochondria		"HPA055540: AB_2682839"	"prognostic unfavorable (4.55e-4)"	"unprognostic (8.91e-3)"	"unprognostic (1.06e-1)"	"prognostic favorable (3.21e-8)"	"unprognostic (2.95e-1)"	"unprognostic (1.36e-1)"	"unprognostic (3.83e-3)"	"unprognostic (5.48e-2)"	"unprognostic (1.59e-1)"	"unprognostic (5.67e-2)"	"unprognostic (1.18e-3)"	"unprognostic (3.85e-1)"	"unprognostic (3.53e-3)"	"unprognostic (1.06e-2)"	"unprognostic (1.71e-1)"	"unprognostic (1.30e-3)"	"unprognostic (1.36e-3)"	1.4	4.7	8.3	5.3	20.9	0.2	17.5	2.0	11.1	30.4	18.2	28.1	13.4	27.5	7.7	4.1	9.1	38.1	31.2	1.5	13.6	7.1	4.7	1.1	3.7	0.8	37.1	6.5	2.4	19.8	0.6	4.1	1.8	16.6	10.7	15.3	6.7	45.8	19.0	0.3	19.0	21.9	3.3	26.0	1.4	22.2	2.2	25.8	0.7	2.2	5.9	5.0	12.1	5.7	0.0	0.1	0.1	0.0	0.0	9.4	0.3	20.0	34.1	0.5	0.0	0.0	0.1	0.0	2.0	0.0	6.3	4.9	9.8	37.1	0.0	21.9	2.9	0.0	11.1	0.0	4.4	2.9	0.2	0.6	0.0	13.7	0.0	7.6	0.0	1.3	1.3	1.9	3.2	4.3	13.9	1.0	0.0	0.1	0.0	0.0	22.8	0.1	0.0	15.2	63.6	0.0	0.0	0.0	0.5	16.0	3.2	4.3	10.2	5.6	9.4	14.7	1.5	12.3	0.6	1.1	13.9	9.2	0.1	14.8	0.1	23.3	16.5	3.9	0.0	11.4	0.0	0.0	0.0	4.4	0.0	9.4	0.0	2.0	2.2	0.1	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.1	0.3	8.3	20.9	2.0	11.1	13.6	7.1	37.1	6.5	16.6	25.8	6.0	6.9	0.0	113.1	0.0	17.7	0.0	188.5	167.3	64.8	21.0	9.8	0.2	3.3	295.2	0.2	3.3	108.1	0.0	125.6	5.1	0.0	71.8	1.1	0.4	0.9	15.9	8.2	0.0	1.3	1.4	0.0	1.3	0.0	4.6	39.9	12.1	100.4	109.1	0.0	1.0	190.0	0.0	0.0	0.3	28.1	0.0	0.7	0.0	113.0	167.4
PLPP3	"LPP3, PAP-2b, PPAP2B"	ENSG00000162407	"Phospholipid phosphatase 3"	O14495	1	56494747-56645301	"Enzymes, Plasma proteins, Predicted membrane proteins"	"Lipid metabolism"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"Ito cells: 854.4;Leydig cells: 1011.7;Peritubular cells: 374.8"	"Cancer enhanced"	"Detected in all"		"thyroid cancer: 168.2"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	6	"memory B-cell: 5.4;naive B-cell: 4.5"	"Lineage enriched"	"Detected in single"	7	"B-cells: 5.4"	"Cell line enhanced"	"Detected in many"		"ASC diff: 105.3;ASC TERT1: 52.6;HSkMC: 65.0;U-2197: 95.5"									"HPA028892, HPA072751"	Uncertain		Supported	"Golgi apparatus"		NA	Yes			"Golgi apparatus"		"HPA028892: AB_10602149, HPA072751: AB_2686555"	"unprognostic (2.50e-2)"	"unprognostic (3.94e-1)"	"unprognostic (1.81e-1)"	"unprognostic (1.65e-1)"	"unprognostic (2.71e-1)"	"unprognostic (2.22e-3)"	"unprognostic (5.86e-3)"	"unprognostic (7.25e-2)"	"unprognostic (1.59e-1)"	"unprognostic (3.75e-2)"	"unprognostic (3.91e-2)"	"unprognostic (3.08e-1)"	"prognostic favorable (4.59e-4)"	"unprognostic (3.16e-2)"	"unprognostic (1.74e-1)"	"unprognostic (3.54e-2)"	"unprognostic (2.09e-1)"	46.4	17.2	29.0	10.8	30.7	4.2	39.1	13.5	27.5	102.7	15.5	33.8	22.1	8.1	32.7	36.9	20.8	36.7	24.0	23.3	39.9	13.5	30.2	57.7	24.3	6.7	19.2	30.1	27.9	12.2	30.7	7.2	70.9	20.0	37.7	14.4	34.7	22.4	58.7	16.6	24.4	12.5	32.9	16.5	7.9	18.7	23.4	29.7	5.2	107.1	19.4	6.7	35.8	44.0	5.4	0.0	0.8	0.3	0.0	0.0	0.2	0.4	1.5	2.0	0.2	105.3	52.6	5.0	5.5	5.6	5.1	2.5	4.4	0.8	0.7	0.6	8.3	5.7	0.8	0.3	0.1	1.0	0.0	1.3	0.1	0.6	6.1	2.5	0.0	0.0	65.0	0.4	4.9	4.1	3.6	4.8	0.0	0.4	0.0	5.5	0.4	0.0	0.0	6.2	1.2	6.1	0.0	0.0	0.2	0.8	4.6	0.0	4.1	1.7	2.3	0.5	6.4	0.7	0.0	3.0	25.8	2.1	95.5	0.2	0.0	0.0	0.0	4.5	0.2	1.8	0.0	0.3	0.0	0.0	0.0	0.0	5.4	0.0	0.0	0.0	4.5	0.0	0.0	0.8	0.0	0.3	0.0	0.0	0.2	29.0	30.7	13.5	27.5	39.9	13.5	19.2	30.1	20.0	29.7	23.8	20.5	11.5	20.0	0.0	3.2	0.0	56.0	8.1	23.9	21.0	0.0	102.0	18.3	16.0	5.7	50.7	10.7	23.3	7.9	10.3	54.5	13.7	3.5	84.4	36.2	0.0	2.4	854.4	45.1	12.0	1011.7	10.2	0.0	1.0	10.3	146.0	8.7	7.0	374.8	18.2	2.5	135.8	0.0	4.3	2.5	0.0	179.8	4.3	7.8	16.5
PLPP4	"DPPL2, PPAPDC1, PPAPDC1A"	ENSG00000203805	"Phospholipid phosphatase 4"	Q5VZY2	10	120456954-120589855	"Enzymes, Predicted membrane proteins"	"Lipid metabolism"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"brain: 26.5;kidney: 12.6"	"Cell type enhanced"	"Detected in some"	11	"Cholangiocytes: 12.7;Distal tubular cells: 6.6;Early spermatids: 7.1;Late spermatids: 7.9;Leydig cells: 17.8;Peritubular cells: 7.4;Proximal tubular cells: 7.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	22	"eosinophil: 2.2"	"Lineage enriched"	"Detected in single"	22	"granulocytes: 2.2"	"Group enriched"	"Detected in some"	4	"hTERT-RPE1: 62.8;U-251 MG: 34.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA045188	Approved		Approved	"Nucleoplasm,Nucleoli,Nucleoli rim"		NA	NA			"Nucleoli, Nucleoli rim"	Nucleoplasm	"HPA045188: AB_2679246"	"unprognostic (8.19e-2)"	"unprognostic (2.94e-2)"	"unprognostic (8.86e-2)"	"unprognostic (1.90e-3)"	"unprognostic (3.45e-1)"	"unprognostic (2.92e-2)"	"unprognostic (2.69e-1)"	"unprognostic (2.26e-3)"	"unprognostic (1.55e-1)"	"unprognostic (8.62e-3)"	"unprognostic (2.70e-3)"	"unprognostic (1.89e-1)"	"unprognostic (2.40e-3)"	"unprognostic (3.49e-2)"	"unprognostic (3.75e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.21e-3)"	0.6	1.7	11.4	1.2	13.6	4.9	3.1	11.6	18.2	3.4	1.2	12.1	1.0	0.7	1.7	2.7	0.9	1.2	11.3	0.7	15.9	17.4	12.6	2.8	0.5	0.6	15.5	6.0	0.6	0.6	0.4	0.5	0.6	26.5	3.0	0.8	0.0	2.0	6.1	0.4	1.7	0.8	1.5	19.1	0.5	1.2	11.1	12.5	0.0	1.5	0.0	0.5	0.8	0.7	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.3	0.8	1.7	1.0	0.0	1.0	0.0	0.0	8.0	6.3	0.1	0.7	0.1	0.9	1.0	0.8	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.8	0.0	62.8	6.5	0.0	0.7	1.6	0.7	0.0	0.0	0.0	0.7	0.0	2.0	0.0	0.0	0.0	3.3	0.0	0.6	0.1	0.5	0.0	0.5	3.5	1.4	0.0	9.0	7.2	4.0	0.3	34.8	0.0	0.0	0.0	6.6	0.0	1.9	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.4	13.6	11.6	10.0	15.9	17.4	15.5	6.0	26.5	12.5	0.0	0.0	0.0	0.6	0.0	0.0	0.0	12.7	0.0	0.0	3.5	0.0	0.0	6.6	0.0	7.1	0.0	0.0	0.0	0.2	0.0	0.0	0.4	0.0	0.0	1.9	0.0	0.0	2.5	0.0	7.9	17.8	0.0	0.0	0.0	0.0	0.0	1.5	0.0	7.4	7.6	0.0	0.0	0.0	0.2	1.1	0.0	0.0	0.0	0.0	0.3
PLPP5	"DPPL1, HTPAP, PPAPDC1B"	ENSG00000147535	"Phospholipid phosphatase 5"	Q8NEB5	8	38263130-38269243	"Enzymes, Predicted membrane proteins"	"Lipid metabolism"	Hydrolase	"Tumor suppressor"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"pancreas: 77.8"	"Cell type enhanced"	"Detected in many"	4	"Glandular cells: 138.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"memory B-cell: 37.2;naive B-cell: 65.4"	"Lineage enriched"	"Detected in all"	5	"B-cells: 65.4"	"Cell line enhanced"	"Detected in many"		"RPMI-8226: 51.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA055777			Approved	Vesicles		NA	NA			Vesicles		"HPA055777: AB_2682915"	"unprognostic (4.54e-2)"	"unprognostic (2.51e-3)"	"unprognostic (3.66e-2)"	"prognostic favorable (1.48e-5)"	"unprognostic (1.80e-2)"	"unprognostic (1.27e-2)"	"unprognostic (5.58e-2)"	"prognostic favorable (8.72e-5)"	"unprognostic (9.79e-2)"	"prognostic favorable (2.42e-5)"	"unprognostic (1.50e-1)"	"unprognostic (5.08e-2)"	"prognostic unfavorable (8.33e-10)"	"unprognostic (3.82e-2)"	"unprognostic (1.58e-1)"	"unprognostic (1.59e-3)"	"unprognostic (1.57e-2)"	5.5	9.3	6.9	11.9	7.9	4.8	8.8	7.5	6.7	11.2	11.5	3.9	33.9	14.4	5.7	30.9	6.6	10.2	21.0	4.6	6.1	6.1	9.6	20.3	7.5	12.0	4.5	5.1	8.4	77.8	4.2	29.9	8.3	6.7	27.9	12.8	16.2	52.0	36.5	2.3	4.7	18.4	5.2	3.5	12.8	16.1	4.6	4.4	3.8	11.9	5.0	14.8	8.0	6.7	65.4	5.3	13.3	3.6	4.3	5.0	3.7	5.5	11.1	6.6	13.5	13.0	12.7	9.1	15.8	19.9	8.1	10.6	5.1	8.5	0.4	13.5	16.3	11.7	6.2	5.4	11.5	6.9	3.5	3.5	9.8	4.7	14.8	22.1	2.8	11.8	9.9	12.0	11.2	14.8	14.3	13.1	13.1	0.4	25.5	9.8	11.4	6.3	4.7	10.0	22.5	3.8	6.9	4.9	51.3	20.2	7.2	5.2	8.0	6.5	10.1	9.2	6.1	21.6	5.5	7.8	5.7	5.0	9.6	4.1	15.8	10.4	1.6	15.8	7.5	9.8	13.3	2.7	4.5	3.0	2.7	5.0	37.2	3.9	3.8	2.5	65.4	2.0	1.9	1.6	4.3	3.6	5.3	3.4	3.7	6.9	7.9	7.5	6.7	6.1	6.1	4.5	5.1	6.7	4.4	8.9	44.0	74.7	61.1	0.0	5.3	0.0	38.2	101.7	39.8	71.5	15.7	39.2	36.5	59.1	22.7	13.5	17.2	0.0	78.1	37.8	35.3	138.3	29.1	20.7	32.8	58.8	43.3	16.5	9.1	6.2	16.4	24.8	0.0	10.0	73.6	37.6	56.5	36.8	8.9	20.3	3.5	12.9	0.0	24.7	4.3	0.0	73.7	17.0	51.4	46.1
PLPPR2	"LPPR2, PRG-4"	ENSG00000105520	"Phospholipid phosphatase related 2"	Q96GM1	19	11355386-11365698	"Enzymes, Predicted membrane proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	4	"neutrophil: 32.3"	"Lineage enriched"	"Detected in many"	4	"granulocytes: 32.3"	"Cell line enhanced"	"Detected in many"		"U-2197: 37.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA048973	Uncertain		Uncertain	Nucleoplasm		NA	NA			Nucleoplasm		"HPA048973: AB_2680580"	"unprognostic (1.29e-2)"	"unprognostic (1.69e-1)"	"prognostic unfavorable (6.45e-4)"	"unprognostic (2.90e-1)"	"unprognostic (1.43e-1)"	"unprognostic (1.70e-2)"	"unprognostic (7.10e-2)"	"unprognostic (1.37e-1)"	"unprognostic (9.60e-2)"	"unprognostic (1.72e-1)"	"prognostic favorable (6.82e-4)"	"unprognostic (2.23e-1)"	"prognostic unfavorable (7.46e-11)"	"unprognostic (1.99e-2)"	"unprognostic (1.46e-1)"	"unprognostic (4.37e-2)"	"unprognostic (1.17e-1)"	12.0	17.1	32.5	10.5	39.9	14.1	6.6	17.7	51.2	14.0	11.1	10.8	5.1	6.0	12.7	8.4	8.4	9.7	13.7	10.4	37.0	22.3	5.5	18.0	10.0	5.4	11.8	17.9	15.2	12.4	11.7	22.7	11.5	12.3	18.5	5.1	11.8	13.1	15.1	23.1	16.2	5.7	16.8	10.5	10.6	9.3	7.6	9.4	0.5	7.7	4.4	3.3	9.8	8.1	0.0	2.9	32.3	7.2	0.0	0.3	2.3	8.8	5.5	3.0	12.6	12.8	12.3	0.8	15.8	14.7	9.8	10.1	1.0	1.6	1.7	9.4	20.1	2.0	1.6	1.7	4.7	5.3	4.6	3.2	0.5	3.8	1.0	6.7	0.5	18.0	11.0	8.6	8.4	1.6	14.2	6.6	2.8	8.5	14.1	8.2	13.1	0.2	2.4	3.3	3.0	30.7	0.2	0.4	4.8	4.6	4.2	3.3	10.9	6.6	5.7	3.3	1.0	8.2	11.3	7.6	22.2	4.7	37.5	8.3	8.8	5.4	0.6	21.6	8.1	8.7	0.8	7.2	3.7	0.3	6.7	0.0	0.0	0.1	0.0	2.9	0.0	0.1	0.0	32.3	0.0	4.4	0.1	0.3	2.3	32.5	39.9	17.7	51.2	37.0	22.3	11.8	17.9	12.3	9.4	6.0	8.8	0.5	5.5	0.0	5.1	0.0	7.6	2.7	2.3	3.5	11.8	0.5	1.7	6.2	11.0	6.9	0.0	0.0	7.6	2.1	2.1	16.2	2.3	6.7	4.0	7.9	16.4	8.0	9.7	8.2	13.3	3.9	0.0	0.0	2.5	15.3	7.5	0.0	15.6	1.3	6.3	6.5	0.0	1.8	4.9	0.0	2.4	0.0	0.8	4.1
PLPPR3	"FLJ11535, LPPR3, PRG-2, PRG2"	ENSG00000129951	"Phospholipid phosphatase related 3"	Q6T4P5	19	812488-821977	"Enzymes, Predicted membrane proteins"		Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	7	"bone marrow: 18.2;brain: 30.0;fallopian tube: 12.6"	"Cell type enhanced"	"Detected in single"	21	"Horizontal cells: 1.6"	"Cancer enhanced"	"Detected in many"		"testis cancer: 4.4"	"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in single"	8	"eosinophil: 1.6"	"Lineage enriched"	"Detected in single"	8	"granulocytes: 1.6"	"Group enriched"	"Detected in some"	6	"NB-4: 24.1;THP-1: 51.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA052293, HPA057034"	Uncertain		Approved	"Nucleoplasm,Golgi apparatus,Cytosol"		NA	NA			"Golgi apparatus"	"Nucleoplasm, Cytosol"	"HPA052293: AB_2681787, HPA057034: AB_2683316"	"unprognostic (7.65e-2)"	"unprognostic (1.39e-2)"	"unprognostic (1.33e-2)"	"unprognostic (3.66e-3)"	"unprognostic (1.00e-1)"	"unprognostic (1.59e-2)"	"unprognostic (2.62e-2)"	"unprognostic (1.47e-1)"	"unprognostic (4.32e-1)"	"unprognostic (4.51e-4)"	"unprognostic (8.06e-3)"	"unprognostic (1.07e-1)"	"unprognostic (1.72e-12)"	"unprognostic (1.21e-2)"	"unprognostic (6.82e-2)"	"unprognostic (8.50e-2)"	"unprognostic (2.91e-1)"	0.7	0.7	20.5	1.2	30.0	18.2	2.1	0.1	21.3	0.9	0.7	0.7	0.0	0.7	1.3	0.7	0.7	12.6	1.1	0.7	14.4	13.1	0.7	0.7	2.6	0.9	3.9	14.9	1.0	0.7	0.7	0.1	0.8	4.7	0.9	0.7	0.1	0.7	0.8	0.9	0.8	1.0	0.7	1.1	0.9	0.9	3.0	3.1	0.0	0.7	0.0	0.7	0.8	0.0	0.1	0.0	1.6	0.0	0.0	0.1	0.0	0.1	0.6	5.0	0.0	0.0	0.0	2.8	0.1	0.0	0.0	0.0	0.3	0.0	0.0	3.5	0.0	0.0	0.1	0.9	0.0	0.0	0.0	2.1	0.0	0.6	0.0	0.2	1.7	0.1	0.6	0.0	0.0	0.0	0.0	0.0	0.0	4.7	0.1	0.0	0.4	0.0	24.1	3.9	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	6.4	0.1	0.0	0.0	2.7	2.2	51.0	0.0	0.0	0.1	0.1	0.0	0.1	0.2	0.0	0.0	3.9	0.0	0.0	0.0	1.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	20.5	30.0	0.1	21.3	14.4	13.1	3.9	14.9	4.7	3.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.1	1.6	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.0	0.2	0.0	0.0	0.0
PLPPR4	"KIAA0455, LPPR4, PHP1, PRG-1"	ENSG00000117600	"Phospholipid phosphatase related 4"	Q7Z2D5	1	99263953-99309590	"Enzymes, Predicted membrane proteins"		Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"brain: 55.3"	"Group enriched"	"Detected in some"	5	"Horizontal cells: 28.6;Muller glia cells: 25.5"	"Cancer enhanced"	"Detected in many"		"glioma: 7.2"	"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	22	"non-classical monocyte: 2.1"	"Lineage enriched"	"Detected in single"	22	"monocytes: 2.1"	"Cell line enhanced"	"Detected in some"		"BJ hTERT+: 20.3;BJ hTERT+ SV40 Large T+ RasG12V: 7.9;fHDF/TERT166: 6.8;SH-SY5Y: 15.3;U-138 MG: 7.6;U-87 MG: 12.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA						"unprognostic (4.32e-2)"	"unprognostic (4.92e-2)"	"unprognostic (2.74e-1)"	"unprognostic (1.67e-2)"	"unprognostic (1.67e-2)"	"unprognostic (2.95e-2)"	"unprognostic (1.00e-2)"	"unprognostic (1.17e-2)"	"unprognostic (9.09e-2)"	"unprognostic (9.70e-3)"	"unprognostic (3.36e-2)"	"unprognostic (2.21e-1)"	"unprognostic (7.25e-12)"	"unprognostic (1.67e-5)"	"unprognostic (3.47e-1)"	"unprognostic (1.34e-2)"	"unprognostic (1.16e-3)"	3.0	1.7	25.1	1.2	25.8	0.8	1.8	2.0	55.3	4.6	1.5	2.6	0.0	1.2	1.7	1.7	3.2	1.3	6.0	1.4	39.2	10.8	1.4	0.8	3.5	1.5	5.2	16.7	0.8	1.5	1.7	9.0	1.9	6.1	1.1	1.9	0.6	1.4	1.3	1.2	4.6	1.5	2.1	2.2	1.3	1.1	5.2	2.7	0.0	1.5	0.4	1.7	7.0	1.4	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.3	0.0	0.0	3.9	20.3	4.5	7.9	0.0	0.0	0.0	0.0	6.8	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	15.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.6	0.1	0.0	0.1	0.0	0.0	0.0	12.9	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	25.1	25.8	2.0	33.8	39.2	10.8	5.2	16.7	6.1	2.7	0.0	1.1	0.0	0.0	0.0	3.2	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	28.6	0.0	0.0	0.0	0.0	4.9	0.0	0.0	0.0	0.0	25.5	0.0	0.0	1.4	0.6	4.3	0.0	0.0	1.2	0.2	0.0	0.0	0.0	0.0	0.0
PM20D1	"Cps1, FLJ32569"	ENSG00000162877	"Peptidase M20 domain containing 1"	Q6GTS8	1	205828022-205850132	"Enzymes, Predicted secreted proteins"		"Hydrolase, Lyase, Protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	7	"pancreas: 103.5"	"Group enriched"	"Detected in some"	6	"Exocrine glandular cells: 18.7;Proximal tubular cells: 5.8"	"Cancer enriched"	"Detected in some"	32	"urothelial cancer: 30.2"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"T-reg: 4.5"	"Lineage enriched"	"Detected in single"	5	"T-cells: 4.5"	"Cell line enriched"	"Detected in single"	9	"Karpas-707: 6.6"	"Low region specificity"	"Detected in all"												"Secreted to digestive system"	NA	NA		3000000				"unprognostic (1.16e-1)"	"unprognostic (1.95e-1)"	"unprognostic (1.30e-1)"	"unprognostic (4.07e-2)"	"unprognostic (4.83e-1)"	"unprognostic (4.08e-3)"	"unprognostic (1.17e-3)"	"unprognostic (3.11e-1)"	"unprognostic (1.20e-1)"	"unprognostic (5.50e-2)"	"unprognostic (5.81e-2)"	"unprognostic (4.57e-2)"	"unprognostic (7.79e-3)"	"unprognostic (9.77e-2)"	"unprognostic (1.45e-1)"	"unprognostic (2.48e-1)"	"unprognostic (1.68e-2)"	0.5	0.0	0.0	0.5	0.2	0.0	0.6	0.1	0.4	0.0	0.2	0.6	0.4	0.0	0.2	0.3	0.0	0.1	0.0	0.3	0.3	0.0	3.2	0.1	0.2	0.5	0.2	0.0	0.3	103.5	0.0	0.0	0.1	0.4	0.8	0.0	0.3	0.2	0.4	0.0	14.3	0.1	0.1	0.1	0.4	1.2	0.2	0.1	0.1	0.1	0.1	0.4	1.5	0.3	0.3	0.0	0.8	0.2	0.0	4.5	1.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.6	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.2	0.0	0.8	0.7	0.0	1.3	0.3	0.9	2.4	0.0	0.2	0.3	0.9	0.0	0.0	0.2	0.0	4.5	1.0	0.0	0.2	0.1	0.4	0.3	0.0	0.2	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.2	1.2	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	18.7	0.2	0.0	0.1	0.0	0.0	0.1	0.0	0.0	1.3	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	5.8	0.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0
PM20D2	"ACY1L2, bA63L7.3"	ENSG00000146281	"Peptidase M20 domain containing 2"	Q8IYS1	6	89146050-89165565	"Enzymes, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Daudi: 34.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030325, HPA030326, HPA030327"	Approved		Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"HPA030325: , HPA030326: AB_2673429, HPA030327: AB_10603129"	"unprognostic (3.60e-2)"	"unprognostic (1.40e-1)"	"unprognostic (6.36e-2)"	"unprognostic (3.18e-3)"	"unprognostic (3.22e-2)"	"unprognostic (2.73e-1)"	"unprognostic (1.13e-3)"	"unprognostic (8.60e-2)"	"unprognostic (1.04e-1)"	"unprognostic (5.86e-2)"	"unprognostic (2.27e-2)"	"unprognostic (1.04e-1)"	"unprognostic (9.99e-2)"	"unprognostic (6.84e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.32e-1)"	"unprognostic (1.31e-1)"	6.8	5.0	4.8	11.4	6.9	6.5	7.6	11.2	4.9	11.9	13.4	4.4	9.3	7.0	11.3	7.1	14.2	11.0	9.1	16.9	5.1	5.5	9.6	9.7	6.2	8.3	3.7	3.1	21.0	11.3	12.5	23.8	6.9	8.6	23.5	8.5	17.6	8.6	8.7	38.5	10.2	8.0	27.7	4.8	5.2	7.6	4.0	2.9	16.6	23.0	10.6	12.1	19.5	8.5	4.1	2.4	3.0	1.0	4.8	4.0	1.5	11.9	5.3	4.8	7.4	1.6	1.0	0.3	6.0	6.0	9.0	11.6	6.2	5.9	34.9	7.4	1.3	7.7	4.6	9.8	4.8	20.6	10.8	12.5	7.0	3.2	5.8	1.8	20.2	5.7	1.6	3.6	3.4	7.3	7.4	2.1	10.5	2.7	18.7	2.8	1.8	12.7	16.0	1.9	10.4	5.3	21.2	23.8	25.3	10.1	2.3	13.5	9.4	3.6	5.8	5.9	6.5	0.0	17.9	3.5	0.2	5.5	1.9	12.6	10.0	14.6	7.4	2.5	17.5	0.8	1.9	1.0	2.9	2.2	0.6	3.5	4.1	2.7	3.7	1.6	3.1	4.0	3.5	3.0	4.8	0.6	2.4	0.5	1.5	4.8	6.9	11.2	3.9	5.1	5.5	3.7	3.1	8.6	2.9	8.9	9.3	11.5	19.6	26.9	19.1	18.2	28.1	10.7	14.8	15.7	29.5	2.0	5.0	11.3	4.3	10.5	4.9	0.0	9.0	1.9	14.7	40.0	5.8	7.3	3.0	7.9	10.4	7.4	8.2	7.0	22.7	3.2	16.9	19.8	16.1	10.3	16.0	3.5	18.0	13.2	21.1	6.5	17.6	4.5	6.1	27.7	1.0	10.0	24.9	14.4
PMM1	Sec53	ENSG00000100417	"Phosphomannomutase 1"	Q92871	22	41576894-41589890	"Enzymes, Predicted intracellular proteins"		Isomerase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030712, HPA074950"	Uncertain		Supported	Cytosol		NA	NA			Cytosol		"HPA030712: AB_10669600, HPA074950: "	"unprognostic (2.66e-1)"	"prognostic favorable (5.92e-4)"	"unprognostic (3.25e-2)"	"prognostic favorable (6.09e-6)"	"unprognostic (1.25e-1)"	"unprognostic (2.85e-2)"	"unprognostic (1.01e-2)"	"unprognostic (1.95e-2)"	"unprognostic (2.24e-3)"	"unprognostic (1.78e-1)"	"prognostic favorable (2.05e-4)"	"unprognostic (6.56e-3)"	"unprognostic (5.76e-3)"	"unprognostic (2.78e-2)"	"unprognostic (1.72e-1)"	"unprognostic (1.40e-2)"	"unprognostic (2.70e-1)"	20.8	25.1	24.3	15.2	28.8	15.3	15.0	15.5	27.9	24.7	29.5	12.6	14.1	25.3	12.1	20.1	36.5	24.8	14.7	17.7	19.6	20.6	32.8	32.2	21.7	10.8	20.3	25.5	34.8	30.5	7.7	8.7	9.7	17.8	13.7	13.9	11.8	13.0	17.3	6.6	13.6	22.0	14.3	15.2	6.0	24.5	27.6	13.2	8.8	8.9	12.7	14.7	15.2	13.2	10.6	13.2	24.5	12.7	6.8	27.1	10.3	5.3	9.8	6.7	14.4	19.4	30.2	7.8	21.1	24.1	19.5	21.5	7.8	5.1	5.0	7.1	25.1	14.0	8.0	8.8	13.6	11.0	10.3	13.5	1.2	12.3	16.4	30.8	7.4	8.1	25.1	13.2	20.1	8.5	21.7	3.1	8.1	5.5	17.8	26.4	14.0	5.6	10.7	2.1	25.2	13.2	4.3	7.2	10.3	8.2	5.7	1.9	3.8	17.2	6.2	25.2	5.5	7.0	8.2	2.4	22.0	12.1	20.5	10.8	11.2	10.8	7.9	24.6	6.2	13.2	9.6	12.7	24.5	16.3	10.2	13.8	10.4	16.8	13.8	13.2	10.6	18.3	12.9	16.6	6.8	12.0	5.0	27.1	10.3	24.3	28.8	15.5	27.9	19.6	20.6	20.3	25.5	17.8	13.2	32.8	81.3	24.1	11.2	13.2	18.0	10.2	61.1	46.8	36.4	33.2	5.9	49.2	91.2	22.6	11.4	5.8	103.9	23.3	9.6	78.2	28.7	9.3	3.5	75.7	29.4	27.0	46.8	10.4	11.3	10.8	25.9	14.0	42.2	25.2	41.2	49.6	15.1	112.2	28.7	109.0	19.6	38.8	39.8	45.9	10.4	12.3	54.6	20.3	47.6	5.5
PMM2	"CDG1, CDG1a, CDGS, PMI, PMI1"	ENSG00000140650	"Phosphomannomutase 2"	O15305	16	8788823-8849331	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		Isomerase	"Congenital disorder of glycosylation, Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Club cells: 46.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	7	"basophil: 52.2"	"Lineage enriched"	"Detected in all"	10	"granulocytes: 52.2"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA040852, HPA063649"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA040852: AB_10794069, HPA063649: AB_2685074"	"unprognostic (8.62e-3)"	"unprognostic (8.00e-3)"	"prognostic favorable (1.04e-4)"	"unprognostic (3.58e-2)"	"unprognostic (1.79e-1)"	"unprognostic (1.98e-2)"	"unprognostic (6.09e-2)"	"unprognostic (1.01e-1)"	"unprognostic (1.47e-1)"	"unprognostic (2.09e-1)"	"unprognostic (5.14e-3)"	"unprognostic (2.62e-1)"	"prognostic unfavorable (8.97e-6)"	"unprognostic (1.22e-1)"	"unprognostic (2.50e-2)"	"unprognostic (6.89e-2)"	"unprognostic (5.02e-2)"	14.8	13.1	6.8	15.4	9.0	4.3	13.6	8.2	8.2	11.4	19.4	7.0	11.6	18.9	9.7	13.1	22.7	10.0	13.9	10.7	4.7	2.9	14.6	43.3	11.8	11.2	6.6	4.3	7.8	40.4	7.8	28.3	19.9	6.6	12.0	20.4	8.8	21.2	13.5	12.5	13.2	19.6	9.5	5.7	12.0	15.2	9.7	7.8	7.6	10.0	12.0	22.0	10.5	12.2	2.9	3.5	52.2	4.9	1.6	3.6	3.0	10.8	24.3	5.4	14.1	9.6	15.2	12.0	17.0	20.6	17.1	18.5	18.2	13.5	17.4	7.2	29.7	9.0	15.1	11.0	20.8	17.5	12.9	12.9	5.7	14.7	31.0	18.3	15.2	13.8	22.7	14.8	18.2	16.8	7.9	17.4	10.8	7.8	17.0	11.3	28.5	15.6	14.0	22.9	25.4	15.8	19.8	12.0	34.6	19.0	19.3	10.3	19.3	14.0	30.9	10.2	9.0	20.1	13.4	20.1	12.3	13.9	33.2	16.6	21.0	17.6	21.9	10.3	19.2	16.3	52.2	4.9	0.9	2.5	3.7	3.6	2.9	2.2	3.2	3.5	2.4	2.5	2.4	7.8	1.6	2.3	3.2	1.6	3.0	6.8	9.0	8.2	8.2	4.7	2.9	6.6	4.3	6.6	7.8	14.9	17.9	9.8	6.8	3.4	4.8	2.4	5.1	26.8	46.6	0.0	13.7	7.4	8.3	10.9	0.2	4.5	10.2	23.3	24.6	9.5	5.4	9.5	22.0	11.3	5.1	1.6	7.5	3.7	6.0	0.6	5.8	6.3	1.7	8.2	11.5	2.3	17.8	10.2	2.1	10.0	8.9	0.0	5.2	1.6	3.1	3.6	8.9	5.1	9.2	11.3
PMPCA	"Alpha-MPP, INPP5E, KIAA0123"	ENSG00000165688	"Peptidase, mitochondrial processing alpha subunit"	Q10713	9	136410570-136423761	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"			"Disease mutation, Mental retardation, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021648, HPA063735"	Supported		Enhanced	Mitochondria		NA	NA		6500	Mitochondria		"HPA021648: AB_1855491, HPA063735: AB_2685108"	"unprognostic (9.80e-2)"	"unprognostic (1.96e-2)"	"unprognostic (4.03e-1)"	"unprognostic (1.69e-2)"	"unprognostic (4.01e-2)"	"unprognostic (8.19e-2)"	"unprognostic (6.09e-2)"	"unprognostic (1.19e-2)"	"unprognostic (1.97e-1)"	"unprognostic (3.32e-2)"	"prognostic favorable (8.00e-5)"	"unprognostic (9.47e-3)"	"prognostic favorable (2.14e-6)"	"unprognostic (4.27e-3)"	"unprognostic (1.57e-2)"	"unprognostic (2.40e-1)"	"unprognostic (3.54e-2)"	15.2	27.3	19.8	14.6	23.8	20.1	13.2	20.3	24.3	12.3	15.1	13.0	10.4	18.6	14.2	14.1	16.5	13.6	14.9	37.0	15.6	14.8	17.0	48.3	12.3	18.4	15.2	21.9	15.5	18.2	14.7	19.5	15.6	16.8	15.2	11.9	12.8	20.3	17.1	56.7	17.5	17.0	13.8	14.1	18.9	16.3	23.2	12.5	14.0	15.0	19.8	15.3	13.1	13.4	25.5	30.1	17.0	25.1	32.1	30.8	28.2	14.4	27.2	13.0	26.2	9.9	14.5	20.0	15.1	12.2	21.2	15.4	31.0	17.3	20.3	15.9	15.3	11.3	33.9	24.0	22.1	9.4	29.1	29.0	16.3	35.0	37.4	17.4	21.2	14.2	21.2	15.3	16.5	8.5	12.0	17.9	18.9	41.3	13.4	13.1	40.1	20.0	27.3	26.5	25.9	25.7	24.9	18.4	44.9	14.5	10.4	26.7	17.6	20.3	29.0	17.6	9.3	39.5	28.9	14.7	15.1	16.2	12.4	19.2	8.3	10.9	21.8	19.9	18.5	13.5	15.4	25.1	17.0	27.2	24.4	26.4	25.5	25.7	29.3	30.1	23.7	30.8	26.9	5.9	32.1	23.2	15.3	24.3	28.2	19.8	23.8	20.3	24.3	15.6	14.8	15.2	21.9	16.8	12.5	14.9	25.3	23.9	29.5	24.5	22.5	31.3	10.2	13.4	18.2	21.0	21.6	90.0	41.4	28.9	19.7	20.2	19.7	0.0	26.4	41.5	17.6	17.8	24.3	54.0	33.8	17.5	20.0	20.3	17.4	12.4	17.5	14.1	15.1	21.6	22.3	19.3	25.1	17.3	21.2	37.9	25.3	38.8	16.9	32.8	39.5	23.5	86.8	23.0	30.4	23.5
PMPCB	"MPPB, MPPP52"	ENSG00000105819	"Peptidase, mitochondrial processing beta subunit"	O75439	7	103297422-103329511	"Enzymes, Predicted intracellular proteins"		"Hydrolase, Metalloprotease, Protease"	"Disease mutation, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040674, HPA074168"	Approved		Enhanced	Mitochondria		No	No		57000	Mitochondria		"HPA040674: AB_10961998, HPA074168: AB_2686671"	"prognostic favorable (2.79e-4)"	"unprognostic (3.11e-1)"	"unprognostic (7.18e-3)"	"unprognostic (3.03e-1)"	"unprognostic (3.65e-2)"	"unprognostic (1.72e-1)"	"unprognostic (1.06e-1)"	"unprognostic (7.67e-2)"	"unprognostic (7.74e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.38e-1)"	"unprognostic (1.42e-3)"	"prognostic favorable (2.95e-8)"	"unprognostic (2.59e-2)"	"unprognostic (9.79e-2)"	"unprognostic (2.40e-1)"	"unprognostic (4.39e-2)"	29.1	41.8	31.8	23.0	34.3	41.5	31.6	41.1	38.4	29.0	26.9	21.6	28.2	35.1	32.0	25.9	27.9	26.9	23.5	41.4	27.7	20.1	45.9	47.2	21.9	31.3	32.6	35.0	36.8	40.6	41.1	33.9	24.8	34.2	31.6	31.5	20.8	30.6	31.0	31.5	31.6	31.0	25.7	27.8	27.9	33.6	31.3	35.9	37.2	33.2	24.2	30.0	30.7	27.9	19.5	18.4	9.7	16.1	12.9	21.9	15.7	12.4	18.0	21.2	28.6	12.9	26.2	16.0	11.6	20.0	23.5	28.0	19.2	14.3	32.0	18.6	19.7	25.1	16.2	25.5	18.7	22.4	11.2	30.4	11.1	30.9	25.6	15.7	15.2	13.1	23.9	17.4	18.3	17.7	22.5	12.4	24.1	21.4	32.6	21.4	28.9	25.1	35.8	26.0	24.8	22.6	17.6	14.9	32.5	22.0	22.3	26.7	32.6	15.6	46.2	22.8	22.4	18.9	20.4	10.2	20.7	24.9	36.9	21.5	25.0	31.9	24.6	15.4	24.5	16.3	9.7	14.1	9.3	14.7	16.1	16.1	19.5	17.1	14.7	18.4	14.3	21.5	17.4	4.4	12.9	13.6	9.4	21.9	15.7	31.8	34.3	41.1	38.4	27.7	20.1	32.6	35.0	34.2	35.9	29.8	31.7	53.2	52.9	32.5	29.3	64.2	28.1	49.5	40.9	26.2	21.6	104.2	61.3	64.5	72.7	34.3	36.7	0.0	64.0	49.3	41.1	31.6	58.9	46.5	48.7	22.3	26.0	24.5	42.2	18.6	48.1	38.4	25.3	93.8	43.0	33.6	54.8	42.1	46.7	96.5	33.4	64.7	42.9	84.6	53.0	32.9	104.5	57.5	55.1	47.7
PMVK	"HUMPMKI, PMK, PMKA"	ENSG00000163344	"Phosphomevalonate kinase"	Q15126	1	154924734-154936991	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Cholesterol biosynthesis, Cholesterol metabolism, Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis, Steroid metabolism, Sterol biosynthesis, Sterol metabolism"	"Kinase, Transferase"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA029900	Approved					NA	NA					"HPA029900: AB_10601390"	"unprognostic (2.52e-1)"	"unprognostic (3.68e-2)"	"unprognostic (1.25e-2)"	"unprognostic (1.32e-1)"	"unprognostic (2.31e-1)"	"unprognostic (1.81e-2)"	"unprognostic (8.13e-2)"	"unprognostic (5.47e-2)"	"unprognostic (8.22e-2)"	"prognostic favorable (9.70e-4)"	"unprognostic (1.41e-1)"	"unprognostic (8.76e-2)"	"prognostic favorable (4.96e-4)"	"unprognostic (2.07e-1)"	"unprognostic (1.67e-1)"	"unprognostic (1.78e-1)"	"unprognostic (2.10e-1)"	21.0	28.3	31.3	15.9	34.0	7.2	19.4	13.9	31.7	17.0	18.9	25.3	10.2	26.4	12.1	14.7	30.1	20.2	15.7	24.7	23.9	23.9	26.9	39.3	16.2	18.7	29.6	29.3	18.8	22.2	26.8	26.1	13.8	22.4	17.0	12.0	22.2	18.8	15.9	39.8	26.1	25.2	16.7	23.9	20.5	21.8	15.9	22.8	9.9	17.8	25.3	18.9	12.2	22.8	29.1	22.9	20.4	47.3	13.4	30.4	17.7	11.7	16.6	10.7	16.8	9.9	7.1	11.4	9.5	6.4	8.7	8.3	6.7	23.3	16.7	18.2	10.7	9.5	11.5	14.5	14.1	4.0	23.4	6.6	7.6	22.4	6.2	9.2	11.6	7.0	8.4	13.1	15.8	11.2	4.4	8.7	15.1	8.1	51.9	9.0	23.5	9.1	11.2	9.7	27.1	21.3	13.9	7.0	38.5	14.6	8.6	9.0	21.5	10.2	17.8	11.6	8.4	34.0	20.6	7.4	8.5	7.0	20.1	14.1	42.2	33.7	29.5	14.1	18.7	10.9	4.6	19.8	20.4	17.5	46.9	27.9	29.1	24.0	17.8	22.1	23.9	15.7	15.7	1.7	13.4	47.3	22.9	30.4	17.7	31.3	34.0	13.9	31.7	23.9	23.9	29.6	29.3	22.4	22.8	53.6	29.1	50.4	97.4	62.0	37.2	44.8	76.5	12.0	20.5	50.6	7.9	202.5	225.5	58.9	6.4	26.7	90.5	0.0	62.5	77.8	60.1	55.3	21.9	125.4	120.4	35.0	63.8	33.7	65.6	10.4	39.4	42.6	62.4	49.5	62.3	77.7	52.4	54.7	44.9	190.8	21.7	32.3	55.9	42.4	43.2	79.2	190.4	59.5	69.9	62.7
PNCK	"CaMK1b, MGC45419"	ENSG00000130822	"Pregnancy up-regulated nonubiquitous CaM kinase"	Q6P2M8	X	153669730-153689010	"Enzymes, Predicted intracellular proteins"		"Calmodulin-binding, Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 35.4;seminal vesicle: 38.5"	"Cell type enhanced"	"Detected in some"	13	"Bipolar cells: 16.5;Cone photoreceptor cells: 21.6;Extravillous trophoblasts: 44.0;Rod photoreceptor cells: 19.4;Syncytiotrophoblasts: 41.4"	"Cancer enhanced"	"Detected in many"		"renal cancer: 15.3"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	8	"AN3-CA: 27.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA007458	Approved		Approved	"Golgi apparatus,Plasma membrane,Cytosol"		NA	NA			"Plasma membrane"	"Golgi apparatus, Cytosol"	"HPA007458: AB_1079644"	"unprognostic (1.56e-1)"	"unprognostic (2.56e-1)"	"unprognostic (1.16e-2)"	"unprognostic (5.95e-3)"	"unprognostic (1.83e-2)"	"unprognostic (3.98e-2)"	"unprognostic (2.15e-4)"	"unprognostic (1.72e-1)"	"unprognostic (1.08e-1)"	"unprognostic (1.46e-2)"	"unprognostic (3.60e-1)"	"unprognostic (1.27e-1)"	"prognostic unfavorable (1.04e-6)"	"unprognostic (2.86e-3)"	"unprognostic (1.43e-1)"	"unprognostic (2.66e-1)"	"unprognostic (6.26e-3)"	1.6	1.8	21.4	2.2	35.4	0.6	0.9	3.7	24.9	0.9	21.9	0.9	6.9	3.8	4.2	3.1	14.5	2.9	2.9	3.8	19.5	17.0	1.0	0.5	0.7	0.6	6.1	15.5	0.7	0.5	1.4	0.3	2.4	3.8	12.6	4.2	0.4	0.7	38.5	2.2	1.4	5.2	15.3	2.6	0.7	5.5	4.7	1.7	0.0	0.5	0.0	0.7	10.4	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.4	27.1	0.0	0.0	2.9	0.3	0.3	0.0	0.0	0.0	0.1	0.0	0.8	0.0	0.2	0.3	0.4	0.0	0.0	0.0	3.3	0.0	0.0	0.4	0.1	0.0	0.1	0.0	0.0	0.0	0.0	1.2	0.0	0.2	0.3	0.2	0.1	0.5	0.0	0.0	0.7	0.3	0.0	0.0	0.0	0.0	0.1	0.1	0.2	3.2	0.0	0.1	2.2	0.8	0.3	0.3	0.0	0.2	1.1	0.0	0.2	0.2	0.0	0.2	0.4	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	21.4	35.4	3.7	23.2	19.5	17.0	6.1	15.5	3.8	1.7	0.0	0.0	0.0	0.4	0.6	16.5	2.8	0.0	0.0	0.0	0.0	21.6	8.3	0.0	0.2	0.2	0.3	2.0	0.0	0.3	44.0	0.2	0.2	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	1.7	0.0	0.4	2.7	4.8	0.0	0.4	0.1	19.4	0.0	0.4	0.5	0.6	0.5	41.4	0.0	0.0	0.9
PNKP	PNK	ENSG00000039650	"Polynucleotide kinase 3'-phosphatase"	Q96T60	19	49859882-49878351	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"DNA damage, DNA repair"	"Hydrolase, Kinase, Multifunctional enzyme, Transferase"	"Disease mutation, Epilepsy, Mental retardation, Neurodegeneration, Primary microcephaly"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA006782	Supported		Supported	Nucleoplasm,Nucleoli		NA	NA			"Nucleoplasm, Nucleoli"		"HPA006782: AB_1855496"	"prognostic favorable (9.18e-4)"	"unprognostic (1.87e-1)"	"unprognostic (4.31e-2)"	"unprognostic (4.23e-1)"	"unprognostic (1.00e-1)"	"unprognostic (4.40e-2)"	"unprognostic (1.08e-2)"	"unprognostic (1.24e-1)"	"unprognostic (3.36e-1)"	"unprognostic (1.58e-1)"	"unprognostic (3.71e-2)"	"unprognostic (1.70e-1)"	"unprognostic (4.55e-2)"	"unprognostic (3.00e-2)"	"unprognostic (2.82e-1)"	"unprognostic (7.24e-2)"	"unprognostic (3.68e-3)"	13.1	32.4	11.2	22.0	11.8	24.3	15.0	18.0	13.8	14.0	17.4	17.0	26.4	15.6	16.7	25.3	13.6	18.1	18.2	16.8	12.3	9.5	20.1	16.8	15.9	21.0	13.9	14.2	17.1	22.5	19.7	26.8	17.1	12.9	18.7	15.0	19.6	20.3	22.4	12.8	15.3	15.7	13.2	10.1	30.7	17.9	17.2	13.9	22.3	23.0	17.0	20.6	14.6	12.4	7.9	7.5	19.3	12.7	2.7	7.7	3.8	13.0	8.8	8.9	14.0	8.5	6.6	14.5	21.1	10.8	9.8	8.6	7.0	17.2	8.5	6.7	6.4	5.7	10.7	3.2	11.9	5.8	10.9	13.5	14.4	16.6	6.1	6.4	13.6	19.3	6.2	6.3	8.9	5.8	8.7	12.8	10.7	7.0	17.1	12.7	8.3	13.7	10.8	8.3	13.5	18.0	11.7	8.2	17.1	10.0	27.9	10.6	17.1	9.2	27.8	4.7	8.1	4.8	8.4	18.1	19.1	11.7	4.6	17.4	18.9	7.6	6.9	17.3	6.1	15.2	1.4	8.8	12.2	7.7	8.5	6.4	6.5	6.6	5.8	7.5	7.9	4.9	4.4	19.3	2.7	12.7	4.3	6.8	3.8	11.2	11.8	18.0	13.8	12.3	9.5	13.9	14.2	12.9	13.9	14.9	23.4	40.2	28.5	11.8	40.7	8.9	15.3	24.1	9.1	19.2	76.6	37.9	19.9	36.3	12.0	20.2	24.9	0.0	34.6	29.2	14.8	28.4	27.8	18.7	34.1	31.8	29.3	31.9	22.4	20.0	55.0	24.9	13.5	42.3	23.1	20.6	38.1	20.1	42.1	26.9	76.0	19.4	14.4	18.2	29.6	11.4	41.2	42.4	27.4	25.2
PNLDC1	"dJ195P10.2, FLJ40240"	ENSG00000146453	"PARN like, ribonuclease domain containing 1"	Q8NA58	6	159800249-159820704	"Enzymes, Predicted membrane proteins"	"Nonsense-mediated mRNA decay"	"Exonuclease, Hydrolase, Nuclease, RNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"testis: 26.7"	"Cell type enhanced"	"Detected in some"	11	"Cholangiocytes: 7.6;Early spermatids: 13.6;Late spermatids: 10.3;Spermatocytes: 11.1;Spermatogonia: 9.0"	"Low cancer specificity"	"Detected in many"			"Group enriched"	"Detected in some"	6	"basal ganglia: 5.7;cerebral cortex: 3.9"	"Cell type enhanced"	"Detected in some"		"intermediate monocyte: 1.8;plasmacytoid DC: 1.7"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"AN3-CA: 1.8;HAP1: 2.3;hTCEpi: 3.8;RPMI-8226: 2.1;SuSa: 1.8"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			HPA052026	Uncertain					NA	NA					"HPA052026: AB_2681699"	"unprognostic (1.58e-1)"	"unprognostic (3.88e-2)"	"unprognostic (1.01e-2)"	"unprognostic (2.39e-3)"	"unprognostic (8.47e-3)"	"unprognostic (3.55e-2)"	"unprognostic (2.04e-1)"	"unprognostic (4.24e-1)"	"unprognostic (1.01e-1)"	"unprognostic (5.37e-2)"	"unprognostic (4.19e-1)"	"unprognostic (9.98e-2)"	"unprognostic (2.69e-9)"	"unprognostic (1.14e-2)"	"unprognostic (2.25e-1)"	"unprognostic (1.69e-1)"	"unprognostic (2.24e-1)"	0.6	0.5	0.6	0.5	5.7	0.4	1.4	0.2	3.9	0.3	0.3	0.3	0.0	0.2	0.3	1.3	0.2	3.6	0.3	0.2	0.7	0.2	0.8	0.8	0.5	0.4	0.4	0.7	0.8	2.3	0.3	0.3	0.3	0.3	0.4	0.3	0.0	1.2	0.4	0.5	1.4	0.3	0.3	0.4	0.5	0.3	26.7	0.3	0.5	0.4	0.3	0.7	0.2	0.0	0.1	1.7	0.0	1.8	0.4	1.0	0.4	0.0	0.4	0.2	1.8	1.0	0.0	1.1	0.0	0.0	0.1	0.0	1.3	0.0	0.1	0.2	0.3	0.1	0.1	2.3	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.7	0.0	3.8	0.0	0.1	0.2	0.0	1.0	0.1	0.8	0.2	0.1	0.8	0.1	0.9	0.3	0.8	0.1	0.0	2.1	0.3	0.0	0.2	0.0	0.0	0.0	0.0	1.8	0.0	0.9	0.0	0.1	0.2	0.3	0.0	0.3	0.7	0.1	0.0	0.6	0.1	0.0	0.2	0.0	0.1	1.8	0.0	0.0	0.2	0.0	0.7	0.1	1.0	0.1	0.0	0.4	0.0	1.7	0.5	0.4	0.6	5.7	0.2	3.9	0.7	0.2	0.4	0.7	0.3	0.3	0.0	0.0	0.0	0.0	0.2	0.0	0.3	7.6	0.0	0.0	0.0	0.0	0.0	0.0	2.4	13.6	0.0	0.0	0.0	0.8	0.0	0.2	0.1	4.6	0.0	0.1	0.0	0.0	0.0	0.0	10.3	0.3	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	11.1	9.0	0.0	0.0	0.0	0.0	0.1
PNLIP	PL	ENSG00000175535	"Pancreatic lipase"	P16233	10	116545931-116567855	"Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted secreted proteins"	"Lipid degradation, Lipid metabolism"	Hydrolase	"Disease mutation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	1895	"pancreas: 3207.8"	"Cell type enriched"	"Detected in some"	4	"Exocrine glandular cells: 3478.1"	"Cancer enriched"	"Detected in some"	4854	"pancreatic cancer: 2731.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"EFO-21: 3.1;HDLM-2: 2.8;U-2 OS: 4.6;U-251 MG: 1.1;U-266/84: 1.5"	"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			"HPA062430, HPA062494"	Enhanced				"Secreted to digestive system"	NA	NA		13000000			"HPA062430: AB_2684761, HPA062494: AB_2684782"											"unprognostic (2.05e-2)"	"unprognostic (4.46e-2)"						0.2	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.3	0.2	0.1	0.1	0.0	0.1	0.4	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	1.6	3207.8	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.4	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.5	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.1	0.0	0.0	0.0	0.1	0.0	0.0	2.8	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.6	0.0	1.1	0.0	1.5	0.7	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.2	0.5	0.0	0.0	0.0	3478.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	25.2	0.0	0.0	826.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
PNLIPRP3		ENSG00000203837	"Pancreatic lipase related protein 3"	Q17RR3	10	116427867-116477957	"Enzymes, Predicted secreted proteins"	"Lipid degradation, Lipid metabolism"	Hydrolase		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"adipose tissue: 8.5;breast: 15.9;esophagus: 12.0;skin 1: 15.5"	"Cell type enhanced"	"Detected in some"	13	"Basal keratinocytes: 1.0;Late spermatids: 1.6;Melanocytes: 1.7"	"Cancer enhanced"	"Detected in some"		"head and neck cancer: 4.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	18	"hTCEpi: 86.9"					"Not detected"	"Not detected"			"HPA046202, HPA052009"	Uncertain				"Secreted - unknown location"	NA	NA					"HPA046202: AB_10959739, HPA052009: AB_2681692"					"unprognostic (2.62e-4)"	"unprognostic (1.60e-1)"			"unprognostic (6.97e-2)"									8.5	0.1	0.0	0.0	0.2	0.0	15.9	0.0	0.0	1.6	0.2	0.0	0.0	0.1	0.0	0.4	12.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	4.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.0	0.0	0.0	15.5	0.1	0.0	0.0	0.0	0.3	0.2	0.0	0.3	0.0	8.1	1.9	0.7	3.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	86.9	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	1.7	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.0
PNMT	PENT	ENSG00000141744	"Phenylethanolamine N-methyltransferase"	P11086	17	39667981-39670475	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins"	"Catecholamine biosynthesis"	"Methyltransferase, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"adrenal gland: 94.6;ductus deferens: 53.7;seminal vesicle: 40.7"	"Cell type enhanced"	"Detected in some"	12	"Cardiomyocytes: 12.2;Collecting duct cells: 5.2;Ito cells: 11.6"	"Cancer enhanced"	"Detected in many"		"cervical cancer: 27.0"	"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"gdT-cell: 2.5"	"Group enriched"	"Detected in many"	5	"B-cells: 1.0;T-cells: 2.5"	"Cell line enhanced"	"Detected in some"		"HEL: 4.9;K-562: 10.4;NB-4: 20.7;NTERA-2: 4.0;SCLC-21H: 5.6;SH-SY5Y: 5.2"	"Region enhanced"	"Detected in some"		"basal ganglia: 1.3"	"Not detected"	"Not detected"			"CAB017029, HPA043412, HPA051005"	Enhanced					NA	NA					"CAB017029: , HPA043412: AB_2630373, HPA051005: AB_2681306"	"unprognostic (1.50e-1)"	"unprognostic (3.74e-2)"	"unprognostic (1.08e-1)"	"prognostic unfavorable (3.95e-5)"	"unprognostic (4.27e-2)"	"unprognostic (3.02e-1)"	"unprognostic (2.98e-2)"	"unprognostic (5.75e-2)"	"unprognostic (5.29e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.51e-1)"	"unprognostic (1.33e-1)"	"unprognostic (1.52e-4)"	"unprognostic (1.58e-1)"	"unprognostic (1.97e-1)"	"unprognostic (4.72e-2)"	"unprognostic (1.87e-2)"	2.3	94.6	3.9	0.8	13.8	1.6	5.4	0.9	3.0	1.3	1.9	1.5	53.7	0.9	1.0	2.7	0.9	1.9	0.8	4.9	1.7	5.4	1.0	0.7	1.6	0.8	9.1	1.5	0.9	0.7	2.4	12.9	2.4	3.6	4.3	0.7	0.9	0.7	40.7	10.5	0.8	1.0	0.8	0.7	0.9	0.9	1.3	2.7	0.0	0.7	0.8	0.7	1.3	1.7	1.0	0.0	0.3	0.3	0.0	2.5	0.3	0.0	0.0	0.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.2	0.5	0.2	0.0	0.0	0.1	0.1	0.0	0.0	0.0	1.4	4.9	0.1	0.4	2.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	10.4	0.0	0.0	0.0	0.0	20.7	4.0	0.4	0.0	0.1	0.0	0.3	0.0	0.0	5.6	5.2	0.0	2.2	0.1	0.1	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	2.5	0.0	0.4	1.0	0.4	1.5	0.0	0.4	0.0	0.7	0.3	0.0	0.3	0.0	0.0	0.3	3.9	13.8	0.9	3.0	1.7	5.4	9.1	1.5	3.6	2.7	0.0	0.0	0.0	0.6	0.5	0.4	12.2	2.5	0.0	0.0	5.2	0.0	0.0	1.7	0.0	0.6	2.8	0.0	0.0	0.0	0.6	0.0	0.2	0.0	0.0	0.1	0.0	2.9	11.6	0.0	0.9	2.0	0.0	0.0	0.0	0.1	2.8	0.1	0.0	0.4	0.0	0.4	0.0	0.3	0.3	2.1	0.4	0.0	0.0	0.2	1.6
PNP	"NP, PUNP"	ENSG00000198805	"Purine nucleoside phosphorylase"	P00491	14	20468954-20477094	"Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"		"Glycosyltransferase, Transferase"	"Disease mutation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"epididymis: 153.1"	"Group enriched"	"Detected in many"	4	"Cytotrophoblasts: 276.6;Syncytiotrophoblasts: 540.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HL-60: 82.7;U-937: 94.3"					"Low region specificity"	"Detected in all"			HPA001625	Enhanced		Supported	Cytosol		NA	NA		100000000	Cytosol		"HPA001625: AB_1854577"	"unprognostic (1.20e-3)"	"unprognostic (2.68e-2)"	"unprognostic (1.04e-2)"	"unprognostic (1.70e-1)"	"unprognostic (3.10e-1)"	"unprognostic (7.06e-2)"	"prognostic unfavorable (4.43e-4)"	"unprognostic (4.94e-3)"	"unprognostic (3.87e-2)"	"unprognostic (7.45e-2)"	"unprognostic (1.85e-2)"	"unprognostic (2.21e-1)"	"prognostic favorable (2.24e-4)"	"unprognostic (1.69e-1)"	"unprognostic (7.54e-2)"	"unprognostic (2.46e-1)"	"unprognostic (1.64e-3)"	24.7	7.6	9.5	15.0	14.0	69.4	15.7	13.9	11.8	9.5	19.1	6.2	25.2	29.4	5.9	153.1	34.0	7.8	15.7	12.1	11.5	8.4	49.7	24.2	18.3	13.2	13.5	3.4	3.6	11.0	8.7	8.4	45.3	17.7	6.0	16.1	3.8	9.2	7.9	3.3	10.6	32.0	9.8	16.3	18.0	17.0	4.5	12.5	7.0	7.1	21.7	19.1	7.5	14.7	13.1	20.7	4.1	12.4	15.7	33.7	12.1	13.4	18.2	3.8	8.7	4.4	3.5	11.9	13.8	6.5	11.3	11.1	10.5	12.3	36.0	16.0	7.3	13.3	14.6	20.4	26.0	15.0	11.6	17.9	30.1	15.5	17.3	4.1	82.7	15.7	2.4	9.4	34.0	15.1	6.2	48.1	22.3	14.8	22.5	14.1	12.5	24.3	48.8	11.0	34.4	30.4	20.6	5.8	14.0	40.1	12.8	16.9	3.7	26.5	33.7	2.1	5.6	12.4	14.7	38.5	7.7	10.3	17.3	23.4	10.3	17.2	40.7	6.6	94.3	0.7	4.0	12.4	4.1	18.1	11.5	33.7	11.2	20.3	20.0	20.7	13.1	12.9	16.3	1.6	15.7	10.6	11.7	6.9	12.1	9.5	14.0	13.9	11.8	11.5	8.4	13.5	3.4	17.7	12.5	0.0	26.3	18.6	51.4	75.2	4.8	3.1	28.1	8.1	17.0	78.5	13.7	276.6	33.2	38.4	1.0	60.2	56.3	93.5	44.5	26.6	19.4	21.8	56.6	23.1	63.4	15.9	44.5	19.6	22.4	0.0	0.3	46.2	28.7	1.0	31.7	70.2	85.7	56.1	0.7	91.5	17.0	0.0	33.8	0.2	0.6	55.8	540.4	19.3	34.8	70.5
PNPLA2	"ATGL, desnutrin, FP17548, iPLA2zeta, TTS-2.2"	ENSG00000177666	"Patatin like phospholipase domain containing 2"	Q96AD5	11	818902-825573	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Lipid degradation, Lipid metabolism"	Hydrolase	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	4	"adipose tissue: 158.1;breast: 155.2"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"ASC diff: 65.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA055173, HPA062602, HPA075175"	Approved		Enhanced	"Nucleoplasm,Lipid droplets"		NA	NA			"Lipid droplets"	Nucleoplasm	"HPA055173: AB_2682725, HPA062602: AB_2684804, HPA075175: "	"unprognostic (2.11e-2)"	"unprognostic (3.37e-2)"	"unprognostic (5.87e-3)"	"unprognostic (2.51e-2)"	"unprognostic (8.97e-3)"	"unprognostic (1.68e-2)"	"unprognostic (6.39e-2)"	"unprognostic (3.28e-2)"	"unprognostic (3.00e-1)"	"unprognostic (5.61e-2)"	"unprognostic (7.93e-2)"	"unprognostic (2.09e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.68e-1)"	"unprognostic (5.46e-1)"	"unprognostic (4.09e-1)"	"unprognostic (2.07e-2)"	158.1	7.2	1.6	9.4	1.8	11.2	155.2	2.7	2.3	4.1	35.9	1.5	3.8	5.6	4.5	7.8	8.6	4.3	7.2	12.6	1.7	1.1	15.6	7.4	11.3	4.5	1.6	1.6	4.9	11.8	2.5	4.2	11.6	1.8	5.2	1.5	1.9	8.1	8.1	25.0	6.1	23.1	3.0	2.1	4.9	8.2	4.0	1.5	1.5	11.3	4.8	5.1	13.0	18.6	4.2	6.5	18.7	8.5	3.6	5.3	3.6	10.5	8.3	1.7	4.5	65.2	5.8	11.2	11.3	9.1	7.1	6.3	7.1	10.7	6.3	6.7	8.5	4.4	9.5	2.6	4.7	2.2	8.1	23.1	8.7	3.7	11.3	21.4	6.0	11.0	11.4	6.1	4.7	5.5	7.3	5.8	4.7	7.4	6.4	6.3	6.2	8.0	13.1	5.0	10.8	17.9	7.7	3.8	14.1	7.0	2.4	6.4	8.5	21.0	17.9	6.5	1.1	7.7	6.9	10.4	6.4	5.0	4.1	5.1	24.7	15.2	5.3	16.1	8.5	4.4	9.3	8.5	18.7	3.6	5.5	3.5	4.2	4.6	5.2	5.7	3.6	5.3	4.3	7.7	3.6	6.0	6.5	3.9	3.6	1.6	1.8	2.7	1.9	1.7	1.1	1.6	1.6	1.8	1.5	6.0	16.9	27.0	63.2	39.3	8.8	42.3	63.7	5.3	13.6	48.8	7.9	56.2	28.2	55.9	14.2	38.0	114.0	23.3	57.3	27.0	25.2	72.1	11.5	41.9	27.6	11.1	49.4	84.1	28.5	4.2	44.8	24.9	40.5	27.9	80.0	34.7	98.9	112.2	36.7	37.9	7.5	64.7	32.2	42.2	28.2	36.0	141.7	36.2	41.4	167.2
PNPLA3	"adiponutrin, ADPN, C22orf20, dJ796I17.1, FLJ22012, iPLA2epsilon"	ENSG00000100344	"Patatin like phospholipase domain containing 3"	Q9NST1	22	43923739-43964488	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism"	"Acyltransferase, Hydrolase, Transferase"	"Disease mutation, Obesity"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	7	"liver: 31.1;retina: 39.3"	"Group enriched"	"Detected in some"	6	"Bipolar cells: 37.1;Cholangiocytes: 15.3;Cone photoreceptor cells: 17.7;Hepatocytes: 42.7;Rod photoreceptor cells: 34.3"	"Cancer enhanced"	"Detected in many"		"liver cancer: 4.9"	"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"AF22: 13.5;LHCN-M2: 15.3"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			HPA058058	Approved		Approved	Nucleoli,Mitochondria,Cytosol		NA	NA			Nucleoli	"Mitochondria, Cytosol"	"HPA058058: AB_2683590"	"unprognostic (4.74e-3)"	"unprognostic (4.52e-2)"	"unprognostic (1.76e-1)"	"unprognostic (2.31e-1)"	"unprognostic (1.36e-2)"	"unprognostic (1.89e-1)"	"unprognostic (8.93e-2)"	"unprognostic (1.02e-1)"	"unprognostic (2.63e-1)"	"unprognostic (2.93e-1)"	"unprognostic (2.33e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.39e-3)"	"unprognostic (2.52e-3)"	"unprognostic (5.91e-2)"	"unprognostic (2.02e-2)"	"unprognostic (1.01e-1)"	2.8	0.4	0.5	0.7	1.0	0.3	4.0	0.3	2.4	0.8	1.3	0.4	0.0	1.0	0.5	1.9	0.4	1.1	0.5	0.9	0.8	0.6	4.6	31.1	1.4	0.4	0.3	1.8	0.5	0.2	0.6	0.2	0.4	2.2	0.2	0.2	39.3	0.9	0.2	2.2	5.3	0.6	0.2	0.5	0.6	0.3	0.5	0.3	0.0	0.2	0.0	0.3	0.2	0.4	1.2	0.7	1.8	0.6	0.9	0.8	0.0	3.9	1.3	13.5	5.5	3.8	4.3	0.4	2.4	1.4	3.3	7.2	3.9	7.1	0.0	2.1	4.0	1.9	3.4	8.4	3.9	2.8	0.0	0.7	0.2	3.2	7.2	6.2	0.0	0.2	4.9	3.1	10.6	0.5	5.7	0.4	0.1	0.0	0.0	15.3	0.6	0.2	0.0	9.2	0.4	0.0	0.0	7.3	0.1	1.5	0.2	1.2	0.1	2.7	1.1	3.8	2.4	4.2	4.6	0.4	1.3	4.1	0.1	0.1	0.0	0.0	0.0	11.6	0.0	4.8	1.5	0.6	0.4	0.5	0.4	0.3	0.7	0.4	0.3	0.2	1.2	0.6	0.8	1.8	0.9	0.3	0.7	0.2	0.0	0.5	1.0	0.3	2.4	0.8	0.6	0.3	1.8	2.2	0.3	0.0	0.0	0.0	0.5	0.3	37.1	1.1	15.3	0.0	0.0	0.0	17.7	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.1	0.4	0.4	0.0	42.7	0.6	0.0	1.7	0.6	2.6	0.0	0.3	0.0	1.7	0.0	0.5	1.3	1.5	0.0	0.7	5.0	34.3	0.0	0.0	0.4	0.7	0.1	0.0	0.0	0.0	0.4
PNPLA4	"DXS1283E, GS2, iPLA2eta"	ENSG00000006757	"Patatin like phospholipase domain containing 4"	P41247	X	7898247-7927739	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Lipid degradation, Lipid metabolism"	Hydrolase	"Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Distal tubular cells: 81.2;Proximal tubular cells: 97.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"											HPA003656	Approved				"Intracellular and membrane"	NA	NA					"HPA003656: AB_1079033"	"unprognostic (2.97e-1)"	"unprognostic (2.45e-1)"	"unprognostic (4.17e-3)"	"unprognostic (3.08e-2)"	"prognostic unfavorable (5.29e-4)"	"prognostic unfavorable (5.37e-4)"	"unprognostic (3.15e-1)"	"unprognostic (2.05e-1)"	"unprognostic (9.42e-2)"	"unprognostic (6.30e-2)"	"unprognostic (7.83e-2)"	"unprognostic (2.27e-1)"	"prognostic favorable (2.23e-12)"	"unprognostic (5.23e-2)"	"unprognostic (6.71e-3)"	"unprognostic (6.30e-2)"	"unprognostic (2.12e-1)"	11.3	18.1	12.6	6.0	18.8	4.7	13.9	5.0	11.5	8.9	8.9	8.5	13.3	11.2	9.2	11.4	13.2	15.0	6.2	24.0	10.9	11.9	26.5	39.8	5.8	6.3	12.0	8.7	14.0	21.0	13.3	17.0	4.7	12.2	8.0	7.5	13.1	18.9	10.7	40.9	10.8	10.5	7.4	11.2	5.4	11.5	7.8	10.6	7.2	23.6	21.1	8.9	6.6	9.5	13.2	18.3	7.6	10.4	9.0	10.3	8.4	18.4	7.6	1.2	19.0	0.4	0.2	5.1	5.7	0.6	10.0	6.2	7.6	6.8	5.8	0.0	1.8	0.1	10.9	0.0	19.3	17.1	0.2	13.5	4.1	14.7	15.9	12.7	7.2	6.1	13.0	19.8	5.1	11.9	2.4	6.9	0.2	16.2	0.2	0.1	4.8	0.1	7.2	20.1	12.8	16.1	0.1	0.1	6.4	13.2	8.4	11.0	5.5	17.4	7.2	9.8	22.6	11.2	5.4	3.9	0.1	5.0	15.3	0.1	8.8	0.1	11.0	0.1	0.0	1.6	5.2	9.8	7.6	5.4	10.4	6.2	12.3	7.8	5.9	18.3	13.2	10.3	9.8	0.7	9.0	9.7	13.5	4.8	8.4	12.6	18.8	5.0	11.5	10.9	11.9	12.0	8.7	12.2	10.6	8.9	12.2	10.2	12.9	10.5	11.3	43.9	22.9	26.8	9.1	19.2	0.0	24.2	81.2	29.5	2.3	11.6	26.5	0.0	42.6	18.0	10.3	13.5	8.1	58.6	26.3	9.5	19.0	13.5	7.2	2.2	15.3	11.0	16.9	17.2	30.1	29.0	29.8	28.1	19.1	97.0	12.8	6.5	11.3	15.9	21.3	14.6	11.7	5.2	34.5	13.7
PNPLA6	"iPLA2delta, NTE, SPG39, sws"	ENSG00000032444	"Patatin like phospholipase domain containing 6"	Q8IY17	19	7534004-7561764	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Lipid degradation, Lipid metabolism"	Hydrolase	"Disease mutation, Dwarfism, Hereditary spastic paraplegia, Hypogonadotropic hypogonadism, Mental retardation, Neurodegeneration, Retinitis pigmentosa"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Late spermatids: 82.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007522, HPA064773"	Uncertain		Approved	"Endoplasmic reticulum,Cytosol"		NA	NA			"Endoplasmic reticulum, Cytosol"		"HPA007522: AB_1079649, HPA064773: "	"unprognostic (2.73e-1)"	"unprognostic (1.02e-1)"	"unprognostic (1.52e-1)"	"unprognostic (3.23e-2)"	"unprognostic (2.78e-1)"	"prognostic favorable (5.25e-4)"	"unprognostic (3.53e-3)"	"unprognostic (1.50e-1)"	"unprognostic (2.07e-2)"	"unprognostic (1.62e-1)"	"prognostic favorable (3.51e-5)"	"unprognostic (3.36e-1)"	"prognostic favorable (7.53e-4)"	"unprognostic (3.10e-3)"	"unprognostic (3.50e-1)"	"unprognostic (3.25e-1)"	"unprognostic (2.17e-1)"	12.9	19.7	25.9	25.0	29.3	22.3	17.8	22.1	35.8	10.2	15.9	26.1	10.0	26.3	13.7	6.3	16.4	12.6	14.0	12.0	22.6	19.1	17.1	13.7	30.4	17.6	36.3	19.2	12.5	14.2	15.6	21.6	13.9	29.2	13.4	8.9	15.8	13.7	14.3	27.0	15.3	28.7	14.5	23.5	28.3	12.2	31.3	33.0	7.1	14.7	6.1	8.8	15.9	14.7	3.8	7.3	21.8	19.0	5.0	3.9	4.1	13.2	31.9	6.3	15.2	11.0	16.0	14.5	17.2	17.7	13.4	12.4	7.4	18.3	10.9	29.3	22.2	8.3	17.0	5.3	16.2	6.9	26.6	12.3	7.2	17.0	5.6	12.7	8.0	22.5	13.8	9.4	17.2	10.0	21.3	26.4	13.0	5.9	15.1	11.9	6.2	8.8	10.5	6.9	6.2	29.3	7.1	3.8	12.8	11.9	12.6	8.0	13.9	14.6	6.6	18.7	8.9	5.9	11.5	27.9	16.3	9.6	22.3	18.0	17.9	11.5	4.8	27.4	9.5	15.2	7.9	6.1	21.8	3.5	12.1	3.5	3.8	2.5	3.8	7.3	2.8	2.2	2.9	1.9	5.0	19.0	2.4	3.9	4.1	25.9	29.3	22.1	35.8	22.6	19.1	36.3	19.2	29.2	33.0	6.0	11.8	6.5	2.7	4.2	10.9	8.6	17.8	8.1	6.8	31.4	25.5	14.9	1.7	13.7	60.0	10.8	52.1	0.0	6.1	12.2	4.1	4.5	11.5	19.2	24.9	20.6	16.7	10.4	55.8	82.5	8.9	23.8	8.5	10.0	13.4	10.6	8.4	12.9	7.1	17.0	16.2	0.0	6.2	58.2	10.0	4.8	10.4	10.0	14.0	3.1
PNPLA8	"IPLA2-2, IPLA2G, iPLA2gamma"	ENSG00000135241	"Patatin like phospholipase domain containing 8"	Q9NP80	7	108470422-108569666	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Lipid degradation, Lipid metabolism"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA020083	Approved		Approved	"Nucleoplasm,Golgi apparatus,Cytosol"		NA	NA			"Nucleoplasm, Cytosol"	"Golgi apparatus"	"HPA020083: AB_1851849"	"unprognostic (4.48e-2)"	"unprognostic (3.37e-1)"	"unprognostic (5.73e-2)"	"unprognostic (2.75e-1)"	"unprognostic (4.61e-1)"	"unprognostic (2.73e-2)"	"unprognostic (3.48e-2)"	"unprognostic (3.32e-1)"	"unprognostic (2.80e-2)"	"unprognostic (1.03e-1)"	"unprognostic (2.48e-1)"	"unprognostic (2.49e-1)"	"prognostic favorable (1.86e-6)"	"unprognostic (3.16e-2)"	"unprognostic (3.64e-1)"	"unprognostic (4.28e-3)"	"unprognostic (1.24e-1)"	21.5	35.7	29.3	12.4	28.9	51.5	15.0	15.6	27.2	15.4	13.4	9.5	9.3	8.6	13.4	13.7	18.3	9.7	15.9	17.9	23.0	22.1	23.1	24.6	16.7	12.0	20.7	17.5	15.6	10.1	20.7	33.4	25.2	23.2	14.4	11.4	6.0	11.4	13.9	29.8	11.4	10.8	15.3	20.3	19.5	11.1	10.8	21.1	16.1	22.6	13.0	15.3	22.5	12.8	20.0	19.3	16.7	26.8	14.6	12.5	13.7	14.1	6.4	11.3	10.1	25.2	17.4	16.7	13.5	23.8	11.1	18.6	6.1	8.1	7.9	17.1	13.2	22.4	5.4	19.1	8.6	16.9	11.8	5.3	5.4	10.5	4.5	18.4	3.7	11.2	15.7	16.3	14.9	13.8	12.2	15.0	8.9	6.3	22.7	13.8	9.3	8.7	8.9	5.0	8.9	9.1	3.2	11.9	16.7	13.3	18.0	9.4	13.2	12.9	14.0	16.2	14.9	5.9	6.4	12.1	18.3	8.2	27.2	7.4	19.3	19.5	11.7	17.4	5.7	11.8	14.1	19.7	16.7	10.5	21.8	12.5	20.0	10.3	10.3	19.3	18.7	11.2	10.7	16.5	14.6	26.8	7.6	12.5	13.7	29.3	28.9	15.6	27.2	23.0	22.1	20.7	17.5	23.2	21.1	38.7	43.0	28.7	103.5	82.5	61.7	43.5	10.2	81.7	58.0	22.7	17.7	46.4	79.6	26.9	49.7	39.4	25.7	0.0	33.2	30.6	50.6	71.1	70.4	40.3	28.4	30.2	54.7	19.6	49.4	40.1	29.7	48.1	52.3	17.2	16.2	37.9	25.2	14.1	37.1	33.7	29.7	19.4	38.2	17.7	27.4	118.6	108.9	23.5	13.6	109.8
PNPO	PDXPO	ENSG00000108439	"Pyridoxamine 5'-phosphate oxidase"	Q9NVS9	17	47941506-47949308	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Pyridoxine biosynthesis"	Oxidoreductase	"Disease mutation, Epilepsy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 64.7"	"Cell type enhanced"	"Detected in many"	8	"Distal tubular cells: 53.0;Hepatocytes: 47.2;Proximal tubular cells: 75.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023204, HPA027776"	Enhanced		Approved	Nucleoplasm,Cytosol		NA	NA		150000	"Nucleoplasm, Cytosol"		"HPA023204: AB_1855506, HPA027776: AB_10601246"	"unprognostic (1.88e-2)"	"unprognostic (1.17e-1)"	"unprognostic (1.17e-1)"	"unprognostic (1.07e-1)"	"unprognostic (9.25e-2)"	"unprognostic (2.39e-2)"	"unprognostic (1.23e-2)"	"unprognostic (1.41e-1)"	"unprognostic (2.62e-1)"	"unprognostic (1.97e-2)"	"unprognostic (6.65e-2)"	"unprognostic (8.34e-2)"	"unprognostic (2.02e-3)"	"unprognostic (7.47e-3)"	"unprognostic (8.75e-2)"	"unprognostic (3.34e-2)"	"unprognostic (2.74e-1)"	6.0	13.1	9.9	5.1	13.0	2.9	8.6	8.3	16.5	6.2	7.0	8.6	6.9	8.5	4.2	9.6	8.1	8.4	10.1	10.2	8.7	12.0	26.0	64.7	5.3	7.7	11.2	9.9	8.0	13.7	17.3	7.4	5.8	11.1	6.9	7.4	8.4	8.3	7.1	14.7	5.5	9.6	5.2	7.1	6.8	6.7	6.4	6.0	5.2	14.4	8.2	6.1	5.4	5.2	6.8	12.2	2.4	16.4	7.7	8.2	8.7	17.6	14.6	1.1	2.7	7.5	5.8	0.0	6.0	3.9	6.7	5.8	23.9	13.0	16.8	28.6	5.9	2.7	10.6	9.1	16.3	9.7	20.4	7.8	11.8	6.8	24.8	8.0	10.5	8.2	7.6	12.7	12.4	15.5	6.2	8.7	12.6	11.1	5.8	7.8	13.1	10.6	3.4	2.1	17.5	18.1	9.0	5.1	12.2	18.6	9.1	5.9	4.9	5.5	8.9	5.0	4.3	15.7	3.8	9.1	10.8	6.4	10.8	12.4	13.9	15.3	8.9	8.8	9.1	5.5	2.1	11.0	2.4	6.8	16.4	8.0	6.8	6.2	7.4	12.2	5.7	8.2	7.9	1.1	7.7	10.4	8.9	6.4	8.7	9.9	13.0	8.3	16.5	8.7	12.0	11.2	9.9	11.1	6.0	11.9	15.2	1.5	5.9	1.3	0.7	1.7	22.9	5.3	7.9	12.2	3.9	7.5	53.0	15.3	0.4	3.6	11.0	0.0	13.5	2.0	3.1	7.8	12.7	47.2	15.2	3.2	3.5	4.9	7.0	0.4	9.2	8.5	1.7	8.2	9.9	6.7	13.1	10.5	5.6	75.4	1.7	0.0	1.7	0.7	1.3	1.9	5.3	1.0	13.6	4.8
PNPT1	"DFNB70, old-35, OLD35, PNPase"	ENSG00000138035	"Polyribonucleotide nucleotidyltransferase 1"	Q8TCS8	2	55634265-55693910	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"mRNA processing, Transport"	"Exonuclease, Hydrolase, Nuclease, Nucleotidyltransferase, RNA-binding, Transferase"	"Deafness, Disease mutation, Non-syndromic deafness, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB033424, HPA034602, HPA034603"	Supported		Supported	Mitochondria,Cytosol		NA	NA			Mitochondria	Cytosol	"CAB033424: AB_2299801, HPA034602: AB_2674243, HPA034603: AB_10603130"	"unprognostic (9.09e-2)"	"unprognostic (7.40e-2)"	"unprognostic (2.30e-1)"	"prognostic unfavorable (5.57e-4)"	"unprognostic (3.40e-2)"	"unprognostic (1.03e-2)"	"prognostic unfavorable (1.95e-7)"	"unprognostic (1.88e-1)"	"unprognostic (5.93e-3)"	"unprognostic (5.23e-2)"	"prognostic unfavorable (5.44e-5)"	"unprognostic (2.19e-2)"	"unprognostic (2.11e-2)"	"unprognostic (6.92e-2)"	"unprognostic (1.94e-1)"	"unprognostic (2.41e-1)"	"unprognostic (1.21e-1)"	11.1	11.7	13.3	6.5	21.7	11.7	10.8	13.3	18.8	5.7	8.2	12.8	5.4	5.7	8.3	8.8	9.5	7.9	5.8	11.0	12.4	10.9	9.8	11.4	9.1	7.1	24.1	7.4	6.9	9.1	7.4	14.3	5.1	15.2	7.7	10.1	4.2	9.0	6.3	23.5	10.1	7.0	7.9	17.6	10.4	7.6	13.5	22.5	9.6	10.0	7.8	5.9	5.3	7.4	9.8	7.4	6.1	6.5	3.8	8.6	4.7	6.8	3.7	5.1	2.3	3.6	6.4	6.8	10.2	6.2	16.2	10.9	10.7	3.2	14.3	4.3	4.7	5.2	5.5	6.5	7.9	7.5	5.1	14.4	8.3	4.7	5.4	9.7	18.6	5.6	7.1	5.5	6.7	5.8	3.9	4.9	6.0	8.7	3.2	6.4	3.9	11.3	13.1	12.3	7.2	6.2	11.3	8.5	12.6	6.8	4.3	12.4	7.4	3.6	11.3	12.4	4.7	3.0	8.3	5.1	3.8	3.2	3.4	10.4	14.5	1.1	3.1	7.4	16.3	6.5	4.2	6.5	6.1	8.1	5.7	4.8	5.4	3.7	8.6	2.8	9.8	6.9	7.9	6.1	3.8	5.1	7.4	2.4	4.7	13.3	21.7	13.3	18.8	12.4	10.9	24.1	7.4	15.2	22.5	44.7	72.6	7.5	15.0	21.5	40.4	23.8	12.7	46.8	69.4	19.2	55.0	17.7	8.3	14.2	15.0	19.3	7.4	0.0	13.8	18.9	14.2	10.3	54.6	14.7	13.8	28.6	9.8	12.9	11.1	1.9	16.1	15.2	15.1	9.0	12.3	27.5	11.7	14.1	17.3	16.7	61.4	25.8	18.4	39.0	20.0	17.7	10.3	17.3	16.4	14.2
POFUT1	"FUT12, KIAA0180, O-Fuc-T, O-FUT"	ENSG00000101346	"Protein O-fucosyltransferase 1"	Q9H488	20	32207880-32238667	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Carbohydrate metabolism, Fucose metabolism, Notch signaling pathway"	"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Hepatocytes: 32.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Lineage enriched"	"Detected in all"	4	"monocytes: 16.4"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA054519, HPA059935"	Approved		Approved	Centrosome	"Intracellular and membrane"	NA	NA		140000	Centrosome		"HPA054519: AB_2682515, HPA059935: AB_2684171"	"unprognostic (6.61e-2)"	"unprognostic (4.10e-3)"	"unprognostic (8.83e-2)"	"unprognostic (5.51e-3)"	"unprognostic (6.90e-2)"	"unprognostic (1.62e-1)"	"unprognostic (4.65e-1)"	"unprognostic (8.51e-2)"	"unprognostic (1.84e-1)"	"unprognostic (5.57e-2)"	"unprognostic (3.01e-1)"	"unprognostic (2.19e-1)"	"unprognostic (6.76e-2)"	"unprognostic (6.15e-2)"	"unprognostic (3.13e-1)"	"unprognostic (1.03e-2)"	"unprognostic (5.86e-3)"	15.9	13.5	8.2	15.5	8.9	7.4	19.4	6.6	11.3	15.5	20.2	13.1	10.4	16.4	18.1	19.6	13.9	17.4	23.6	20.1	7.5	6.3	18.8	44.6	14.8	22.2	8.8	6.6	18.3	24.6	19.2	11.3	22.4	7.8	16.0	16.0	16.9	13.3	16.0	13.5	13.3	27.5	20.8	7.7	12.4	12.5	16.5	7.0	12.7	20.1	13.9	13.0	15.7	12.6	2.8	3.9	3.3	16.4	1.7	3.3	3.2	15.1	12.2	10.6	11.6	18.3	17.9	19.9	15.8	18.7	26.6	17.5	36.5	20.6	10.3	23.8	17.5	29.6	16.9	10.1	19.5	23.2	5.3	6.4	15.3	11.2	16.5	14.2	13.1	9.8	15.7	15.4	20.1	13.2	11.4	14.8	9.9	11.5	5.9	18.5	7.4	9.0	10.1	5.4	14.7	19.8	7.5	28.2	9.5	8.1	10.1	7.0	8.9	36.1	10.1	13.4	8.5	14.9	15.8	12.8	38.7	14.4	24.1	26.7	7.2	9.2	9.5	23.4	45.7	24.4	3.3	4.4	2.1	2.9	12.8	3.3	2.8	2.6	2.7	3.9	2.4	3.3	2.4	0.9	1.7	16.4	2.9	2.7	3.2	8.2	8.9	6.6	11.3	7.5	6.3	8.8	6.6	7.8	7.0	8.9	7.4	2.2	3.6	2.6	3.3	11.7	10.2	6.7	6.8	7.0	2.0	12.9	1.7	8.7	0.7	6.0	18.8	0.0	8.9	23.4	9.6	5.3	4.7	32.6	9.2	7.9	11.5	14.1	3.3	0.9	9.8	4.3	5.0	4.6	15.0	5.2	7.5	7.0	13.4	4.5	4.1	12.9	5.1	2.3	7.2	1.5	6.4	4.3	17.5	3.5
POFUT2	"C21orf80, FUT13, KIAA0958"	ENSG00000186866	"Protein O-fucosyltransferase 2"	Q9Y2G5	21	45263928-45287898	"Enzymes, Predicted intracellular proteins"	"Carbohydrate metabolism, Fucose metabolism"	"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044297	Uncertain				"Intracellular and membrane"	NA	NA					"HPA044297: AB_10965176"	"unprognostic (1.32e-2)"	"unprognostic (1.65e-3)"	"prognostic unfavorable (4.55e-7)"	"unprognostic (1.49e-2)"	"unprognostic (4.09e-3)"	"unprognostic (5.03e-2)"	"prognostic unfavorable (2.78e-4)"	"unprognostic (2.62e-1)"	"unprognostic (2.15e-1)"	"unprognostic (4.16e-2)"	"unprognostic (4.20e-3)"	"unprognostic (1.48e-2)"	"prognostic unfavorable (8.66e-12)"	"unprognostic (1.56e-2)"	"unprognostic (2.53e-1)"	"unprognostic (3.91e-3)"	"unprognostic (5.25e-2)"	12.9	15.3	11.3	13.1	12.4	14.8	16.1	8.7	11.9	15.2	12.8	14.5	12.0	11.6	19.7	23.2	7.0	16.3	15.5	13.7	12.1	11.7	13.7	14.5	16.1	8.7	13.5	7.3	24.6	17.3	12.7	28.1	20.6	12.2	15.3	8.0	16.6	17.1	15.7	6.3	8.3	11.7	15.0	8.5	12.8	13.3	24.2	10.0	7.7	19.4	8.9	8.6	12.0	12.9	1.5	2.0	3.8	1.9	1.6	2.6	1.5	4.0	4.5	9.0	10.0	16.5	15.4	4.2	22.9	18.6	11.0	16.2	9.7	6.9	2.8	17.4	38.1	24.2	4.1	5.3	9.2	11.9	4.7	6.3	5.6	6.4	7.7	19.0	4.1	7.5	10.8	6.2	13.5	7.3	35.1	10.7	3.8	5.2	4.6	11.0	4.1	2.0	6.9	12.0	6.9	6.6	4.2	2.7	3.6	5.8	3.7	3.9	5.9	13.5	8.2	8.3	10.8	6.0	6.0	11.3	8.0	7.9	12.6	10.2	11.4	5.9	2.2	16.9	5.2	12.8	1.7	1.7	3.8	1.7	1.9	2.6	1.1	1.9	1.5	0.5	1.5	2.2	2.2	2.5	1.6	1.5	2.0	1.7	1.5	11.3	12.4	8.7	11.9	12.1	11.7	13.5	7.3	12.2	10.0	6.0	8.1	11.5	6.2	6.0	6.8	7.3	7.6	25.4	3.4	12.2	9.8	7.4	3.3	6.8	27.0	7.7	5.3	0.0	5.4	12.1	15.5	8.1	6.9	7.8	6.3	4.8	9.7	10.4	4.7	32.7	13.6	6.7	8.5	9.0	13.3	11.5	7.4	8.0	13.1	3.3	13.8	0.0	8.9	20.6	4.3	3.4	11.3	8.5	6.8	4.8
POGLUT1	"9630046K23Rik, C3orf9, hCLP46, KDELCL1, KTELC1, MDS010, MDSRP, MGC32995, Rumi"	ENSG00000163389	"Protein O-glucosyltransferase 1"	Q8NBL1	3	119468938-119494708	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	Gastrulation	"Developmental protein, Glycosyltransferase, Transferase"	"Disease mutation, Limb-girdle muscular dystrophy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	13	"monocytes: 247.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037855, HPA037856"	Approved		Supported	"Endoplasmic reticulum"	"Intracellular and membrane"	NA	NA			"Endoplasmic reticulum"		"HPA037855: AB_10672728, HPA037856: AB_2732477"	"unprognostic (2.43e-1)"	"unprognostic (5.94e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.83e-2)"	"unprognostic (5.62e-2)"	"unprognostic (2.00e-2)"	"unprognostic (3.38e-1)"	"unprognostic (2.81e-2)"	"unprognostic (1.84e-2)"	"unprognostic (1.03e-1)"	"unprognostic (6.52e-3)"	"unprognostic (1.31e-2)"	"prognostic unfavorable (7.02e-7)"	"unprognostic (3.08e-2)"	"unprognostic (1.89e-1)"	"unprognostic (1.23e-3)"	"prognostic favorable (2.23e-4)"	11.9	12.1	7.6	10.7	12.0	3.9	10.9	13.9	10.6	10.1	9.5	9.8	27.4	5.9	13.7	11.7	9.3	10.1	6.9	8.3	7.3	8.9	8.3	10.3	9.1	14.3	15.0	5.6	10.5	29.2	12.1	14.5	11.5	10.9	9.4	10.9	8.7	7.8	25.7	5.1	14.0	12.1	15.2	14.0	14.9	8.2	4.7	8.9	11.7	8.6	4.1	15.6	10.6	10.2	9.9	14.3	9.4	11.5	19.8	16.0	10.3	7.5	5.1	8.8	9.8	22.3	12.8	6.3	12.1	12.4	9.9	13.5	8.3	4.9	11.7	16.4	15.2	7.9	9.0	11.8	12.0	15.7	10.1	7.7	13.7	8.0	8.9	14.6	15.0	16.2	13.2	7.9	9.7	13.7	11.5	11.2	7.9	7.5	14.3	10.0	7.6	8.6	14.6	9.1	13.3	9.3	8.5	9.0	17.2	8.6	9.8	9.7	14.8	5.8	3.6	9.4	9.0	9.7	12.6	14.1	9.7	6.0	2.8	6.2	19.7	17.1	15.9	8.4	15.3	13.6	1.9	11.5	9.4	12.0	10.8	13.8	9.9	13.6	12.5	14.3	7.0	16.0	15.2	0.9	19.8	7.0	8.0	14.7	10.3	7.6	12.0	13.9	10.6	7.3	8.9	15.0	5.6	10.9	8.9	0.0	3.8	8.8	5.8	14.9	14.7	3.4	15.3	6.7	7.9	19.2	5.9	9.2	0.0	6.3	0.5	13.9	6.5	0.0	4.5	12.3	10.1	5.0	17.3	9.8	7.5	4.8	9.1	11.1	13.0	0.0	8.1	16.5	11.8	247.1	11.4	12.1	5.1	7.0	15.9	5.5	12.5	12.9	9.9	1.4	0.9	13.0	5.5	14.6	12.1	5.8
POLA1	"NSX, p180, POLA"	ENSG00000101868	"DNA polymerase alpha 1, catalytic subunit"	P09884	X	24693919-24996986	"Disease related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins"	"DNA replication, Host-virus interaction"	"DNA-binding, DNA-directed DNA polymerase, Nucleotidyltransferase, Transferase"	"Disease mutation, Dwarfism, FDA approved drug targets, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	4	"Erythroid cells: 46.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002947, CAB012274"	Supported		Supported	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"CAB012274: , HPA002947: AB_1079652"	"unprognostic (6.92e-2)"	"unprognostic (4.43e-3)"	"unprognostic (3.27e-3)"	"unprognostic (1.53e-2)"	"unprognostic (2.53e-1)"	"unprognostic (1.49e-1)"	"prognostic unfavorable (4.80e-5)"	"unprognostic (1.87e-1)"	"unprognostic (9.25e-3)"	"unprognostic (2.48e-2)"	"unprognostic (8.41e-2)"	"unprognostic (7.42e-2)"	"unprognostic (2.09e-1)"	"unprognostic (1.44e-1)"	"unprognostic (3.66e-2)"	"unprognostic (3.48e-2)"	"unprognostic (3.08e-1)"	10.5	5.5	8.0	15.0	10.2	14.3	10.9	12.0	9.6	10.1	9.7	11.8	5.8	5.7	11.2	7.7	10.2	8.9	5.5	9.3	7.8	6.6	6.1	4.9	7.2	12.7	10.3	4.5	12.9	7.3	8.5	8.5	10.7	8.7	7.3	11.0	7.5	7.9	9.3	22.4	9.3	7.5	9.7	13.1	9.0	7.9	5.7	10.0	30.1	7.0	8.5	14.7	9.9	10.6	4.6	2.5	1.2	4.6	2.7	3.8	1.7	14.3	10.7	14.1	11.4	2.6	3.2	3.1	10.7	5.8	11.5	13.2	8.8	7.5	18.3	3.6	4.5	10.3	11.8	26.8	8.6	15.6	9.5	11.4	13.6	20.9	6.6	1.1	17.8	7.3	2.0	1.8	14.3	4.1	2.9	5.9	9.5	12.5	9.3	8.0	9.9	19.3	5.9	13.7	9.6	9.0	17.3	37.0	13.8	4.2	9.4	12.8	7.9	12.6	6.0	5.7	16.3	11.8	5.9	4.6	10.2	7.0	19.4	10.2	5.6	8.1	14.7	5.9	8.5	11.3	0.0	2.0	1.2	3.0	4.6	2.9	4.6	3.4	3.8	2.5	3.2	2.4	2.4	0.6	2.7	1.3	1.6	3.6	1.7	8.0	10.2	12.0	9.6	7.8	6.6	10.3	4.5	8.7	10.0	8.9	6.2	2.2	3.8	2.5	2.9	9.3	0.0	9.4	11.4	1.8	2.0	4.3	3.3	2.8	0.3	3.6	1.5	46.7	2.6	4.3	2.4	2.0	9.2	2.8	3.9	1.6	4.1	3.7	4.3	0.4	5.8	2.4	0.0	1.8	3.7	4.5	1.3	0.0	3.2	1.2	7.2	6.5	3.8	3.4	4.2	1.9	1.9	2.9	4.3	2.2
POLB		ENSG00000070501	"DNA polymerase beta"	P06746	8	42338454-42371808	"Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"	"DNA damage, DNA repair, DNA replication, DNA synthesis"	"DNA-binding, DNA-directed DNA polymerase, Lyase, Nucleotidyltransferase, Transferase"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 73.6"	"Group enriched"	"Detected in many"	5	"Early spermatids: 173.0;Late spermatids: 102.4"	"Low cancer specificity"	"Detected in all"			"Region enriched"	"Detected in all"	4	"cerebellum: 73.6"	"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HMC-1: 81.2"	"Low region specificity"	"Detected in all"							"CAB011616, HPA049104"	Enhanced		Uncertain	Vesicles		NA	NA			Vesicles		"CAB011616: AB_731977, HPA049104: AB_2680632"	"unprognostic (1.67e-1)"	"unprognostic (2.68e-3)"	"unprognostic (2.43e-1)"	"prognostic unfavorable (1.46e-4)"	"unprognostic (8.49e-2)"	"unprognostic (2.64e-2)"	"unprognostic (4.24e-2)"	"unprognostic (1.02e-1)"	"unprognostic (2.31e-2)"	"unprognostic (1.99e-1)"	"unprognostic (4.57e-2)"	"unprognostic (4.77e-1)"	"prognostic unfavorable (2.15e-5)"	"unprognostic (1.06e-2)"	"unprognostic (1.40e-1)"	"unprognostic (4.22e-2)"	"prognostic favorable (5.65e-4)"	5.5	8.6	10.1	9.5	10.7	21.9	13.5	73.6	16.6	7.0	5.5	5.8	6.0	4.9	6.2	11.2	12.4	6.3	11.3	16.3	9.8	9.6	7.2	15.8	9.1	11.8	8.4	10.3	10.3	7.7	10.3	11.6	5.0	10.9	11.4	6.3	6.8	22.1	6.9	36.6	10.8	4.9	6.6	10.0	8.1	6.4	29.5	5.4	9.7	7.7	17.2	10.1	11.5	9.2	4.9	33.8	25.1	9.4	7.9	7.2	4.2	11.0	6.6	11.5	23.0	6.4	6.1	9.7	7.1	8.2	11.7	10.8	9.3	13.0	10.0	9.0	4.5	12.4	5.7	9.6	8.2	14.5	6.5	10.4	7.3	5.5	12.5	9.9	5.1	81.2	5.4	9.8	8.6	10.2	14.9	8.9	21.6	15.8	6.4	11.3	6.6	21.2	14.5	15.5	13.2	7.6	12.1	11.6	8.6	22.0	8.9	6.6	11.9	8.4	5.6	21.3	12.4	14.9	8.8	4.9	5.6	7.8	14.0	6.8	9.3	15.6	14.1	5.6	10.9	14.6	12.5	5.9	17.3	4.9	7.2	5.5	4.9	5.2	5.3	6.1	4.5	5.8	5.4	25.1	7.9	9.4	33.8	7.2	4.2	10.1	10.7	73.6	16.6	9.8	9.6	8.4	10.3	10.9	5.4	3.0	12.8	13.8	19.3	14.9	3.3	19.1	7.6	22.7	28.4	7.0	7.9	6.3	5.0	11.3	173.0	10.3	3.6	0.0	8.4	5.6	5.6	27.3	22.0	11.9	6.5	6.4	5.8	6.2	5.6	102.4	6.6	8.9	6.8	4.6	4.7	6.0	22.7	5.9	3.5	5.6	4.3	0.0	5.8	19.1	12.9	17.6	9.3	10.5	6.1	25.5
POLD1	"CDC2, POLD"	ENSG00000062822	"DNA polymerase delta 1, catalytic subunit"	P28340	19	50384204-50418016	"Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"DNA damage, DNA excision, DNA repair, DNA replication"	"DNA-binding, DNA-directed DNA polymerase, Exonuclease, Hydrolase, Nuclease, Nucleotidyltransferase, Transferase"	"Cancer-related genes, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	8	"Paneth cells: 38.7;Spermatogonia: 26.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004375, HPA046524"	Supported		Supported	Nucleoplasm		NA	NA			Nucleoplasm		"CAB004375: AB_675487, HPA046524: AB_2679684"	"unprognostic (2.45e-1)"	"unprognostic (7.02e-3)"	"unprognostic (1.59e-1)"	"unprognostic (4.35e-2)"	"unprognostic (2.55e-1)"	"unprognostic (1.85e-2)"	"prognostic unfavorable (2.87e-6)"	"unprognostic (4.12e-2)"	"unprognostic (1.16e-2)"	"unprognostic (2.83e-1)"	"unprognostic (5.08e-1)"	"unprognostic (3.92e-3)"	"unprognostic (4.01e-3)"	"unprognostic (1.28e-2)"	"unprognostic (1.61e-1)"	"unprognostic (2.89e-1)"	"unprognostic (3.70e-2)"	7.9	5.7	5.4	18.3	9.9	31.6	6.6	9.4	5.4	8.2	10.0	6.1	5.9	6.8	9.5	7.2	11.3	6.9	5.2	5.5	4.4	3.2	7.6	9.3	10.9	15.7	7.0	3.6	8.2	8.4	5.2	5.1	10.9	6.7	6.3	5.2	4.9	8.1	5.4	7.2	13.1	9.9	6.2	7.7	14.1	6.5	13.2	6.5	27.4	12.1	8.1	14.2	5.9	7.8	9.3	10.5	2.1	8.5	5.4	7.3	5.6	18.2	25.2	13.8	7.9	1.8	1.5	14.2	11.4	5.0	14.1	17.9	13.7	14.5	26.2	6.4	3.4	6.3	15.0	16.3	12.4	4.8	22.1	43.8	22.8	24.4	18.0	1.6	21.7	20.1	2.9	3.8	12.7	3.8	3.0	7.2	22.0	24.5	20.4	5.8	12.3	33.5	33.9	16.3	11.8	18.3	33.3	23.2	23.0	4.5	17.5	14.4	13.0	11.3	13.9	2.6	5.2	7.6	20.6	5.6	7.1	23.2	7.7	20.0	19.2	31.6	28.0	7.8	24.5	7.0	1.6	6.2	2.1	7.3	7.8	6.2	7.8	6.5	5.9	5.7	9.3	6.5	5.9	1.1	5.4	8.5	10.5	4.5	5.6	5.4	9.9	9.4	5.4	4.4	3.2	7.0	3.6	6.7	6.5	3.0	3.8	3.7	1.7	5.7	3.3	2.8	2.5	2.7	3.4	3.5	5.9	12.2	0.0	4.4	1.7	2.6	4.6	0.0	3.4	11.7	4.1	1.3	0.0	2.1	13.6	0.0	6.9	1.8	6.3	1.1	2.8	5.0	5.0	3.6	5.3	1.2	3.9	38.7	4.9	2.2	4.1	0.0	2.1	10.9	26.7	4.5	6.4	4.3	10.0	0.6
POLE	POLE1	ENSG00000177084	"DNA polymerase epsilon, catalytic subunit"	Q07864	12	132623753-132687365	"Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"	"DNA damage, DNA repair, DNA replication"	"DNA-binding, DNA-directed DNA polymerase, Hydrolase, Nucleotidyltransferase, Transferase"	"Cancer-related genes, Disease mutation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Sertoli cells: 25.8;Spermatocytes: 25.4"	"Low cancer specificity"	"Detected in all"			"Region enhanced"	"Detected in all"		"cerebellum: 34.8"	"Cell type enhanced"	"Detected in some"		"NK-cell: 4.8"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"HPA058210, HPA067385"			Supported	"Nucleoplasm,Plasma membrane"		NA	NA			Nucleoplasm	"Plasma membrane"	"HPA058210: AB_2683639, HPA067385: AB_2685830"	"unprognostic (1.60e-1)"	"unprognostic (1.77e-3)"	"unprognostic (2.00e-1)"	"unprognostic (9.17e-2)"	"unprognostic (1.68e-1)"	"unprognostic (2.01e-2)"	"unprognostic (3.96e-3)"	"unprognostic (2.23e-1)"	"prognostic unfavorable (1.44e-4)"	"unprognostic (7.12e-2)"	"unprognostic (2.21e-1)"	"unprognostic (1.67e-1)"	"prognostic unfavorable (3.19e-8)"	"unprognostic (8.60e-2)"	"unprognostic (3.18e-1)"	"unprognostic (1.28e-1)"	"unprognostic (9.95e-2)"	6.1	3.4	6.7	10.2	4.4	29.3	6.2	34.8	14.4	7.0	6.6	2.0	7.6	7.3	6.1	4.4	7.5	6.2	6.5	4.7	5.6	1.6	3.8	8.6	5.4	8.2	3.3	4.3	8.7	6.8	3.6	3.1	6.5	5.1	6.8	7.7	4.3	8.7	7.4	8.9	17.9	8.5	6.8	3.7	16.7	7.8	25.6	4.4	29.8	5.1	6.0	10.3	6.7	8.7	0.5	1.7	0.8	0.8	4.8	0.7	0.5	11.2	15.0	22.3	10.6	4.7	3.7	19.9	11.5	5.2	13.8	10.1	18.2	6.7	12.9	4.9	6.2	5.3	15.7	15.5	7.8	8.4	6.0	19.6	20.4	19.4	8.9	0.9	15.9	11.7	2.8	3.1	14.4	4.7	3.8	4.8	16.6	22.8	7.3	6.8	18.2	26.1	29.2	17.3	5.3	9.0	21.7	12.6	5.8	4.4	18.4	18.6	10.7	13.4	11.0	2.5	11.2	16.2	9.9	4.4	12.6	12.9	9.5	11.6	9.7	6.5	20.3	6.9	22.0	8.9	0.0	0.3	0.8	0.5	0.1	0.7	0.5	0.3	0.4	0.7	0.3	0.5	0.3	0.1	4.8	0.8	1.7	0.6	0.5	6.7	4.4	34.8	14.4	5.6	1.6	3.3	4.3	5.1	4.4	0.0	7.9	4.5	3.5	5.0	8.1	5.6	0.0	2.7	0.0	1.8	0.0	6.2	0.0	2.1	6.5	3.0	4.7	0.0	2.7	9.0	4.7	3.7	2.3	8.9	10.4	0.0	6.9	12.9	7.9	7.0	6.4	3.2	5.0	1.0	6.7	3.7	2.4	5.8	3.2	0.8	5.0	25.8	3.3	25.4	7.9	6.8	3.3	5.7	9.8	2.5
POLE2	DPE2	ENSG00000100479	"DNA polymerase epsilon 2, accessory subunit"	P56282	14	49643555-49688422	"Enzymes, FDA approved drug targets, Predicted intracellular proteins"	"DNA replication"	DNA-binding	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 17.6;lymphoid tissue: 17.6"	"Cell type enhanced"	"Detected in many"	9	"Erythroid cells: 23.3;Spermatogonia: 22.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"							"Low region specificity"	"Detected in all"			HPA027555	Uncertain		Supported	"Nucleoplasm,Nuclear bodies,Vesicles"		No	No			"Nucleoplasm, Nuclear bodies"	Vesicles	"HPA027555: AB_10610282"	"unprognostic (1.42e-1)"	"unprognostic (6.57e-3)"	"unprognostic (3.53e-2)"	"unprognostic (7.44e-2)"	"unprognostic (2.04e-2)"	"unprognostic (4.99e-3)"	"unprognostic (7.60e-3)"	"unprognostic (2.32e-3)"	"unprognostic (1.10e-3)"	"unprognostic (2.69e-2)"	"unprognostic (1.88e-2)"	"unprognostic (1.37e-3)"	"unprognostic (5.13e-11)"	"unprognostic (9.97e-2)"	"unprognostic (1.66e-1)"	"unprognostic (1.27e-1)"	"unprognostic (1.50e-3)"	3.3	2.2	1.5	11.6	2.8	17.6	3.4	1.7	1.6	4.4	4.2	1.1	1.5	2.6	2.8	3.5	9.0	2.4	2.3	1.6	1.0	1.2	2.5	5.1	2.2	5.3	1.1	0.3	2.7	5.0	1.4	2.5	4.1	1.4	2.1	5.2	2.6	2.6	0.7	1.1	3.7	7.7	2.9	2.7	5.4	3.0	5.3	2.4	17.6	1.6	10.3	8.4	2.1	4.2	1.2	0.9	0.7	0.0	3.2	2.7	0.5	17.3	8.9	16.9	7.8	0.8	5.0	8.6	9.9	5.0	15.8	18.3	8.9	13.6	10.8	5.6	5.5	8.5	10.7	16.9	6.1	18.7	12.6	9.3	16.1	9.8	11.0	0.4	19.2	7.0	1.4	0.4	8.6	1.4	2.0	9.1	14.5	14.1	6.9	15.8	15.2	19.5	12.5	9.9	14.2	20.8	16.6	15.5	9.8	5.7	9.8	12.2	7.0	10.0	5.9	3.1	8.5	11.8	6.8	3.2	2.5	18.8	10.5	7.8	5.1	10.3	25.0	4.8	14.2	10.2	0.0	0.0	0.7	0.9	0.0	0.7	1.2	0.9	1.7	0.6	1.2	0.1	0.8	0.0	3.2	0.0	0.9	2.7	0.5	1.5	2.8	1.7	1.6	1.0	1.2	1.1	0.3	1.4	2.4	3.0	0.3	0.8	1.6	4.2	0.8	0.8	0.0	1.4	1.2	0.0	0.0	5.3	0.0	1.2	0.9	0.8	0.8	23.3	1.3	8.5	2.6	1.2	0.0	3.2	4.7	0.0	1.2	6.7	3.7	0.2	1.4	1.2	1.7	1.0	2.0	2.1	0.6	0.0	2.8	0.8	3.3	0.0	1.9	3.0	22.2	3.1	2.9	0.9	2.9	0.8
POLE3	"CHARAC17, CHRAC17, p17, Ybl1"	ENSG00000148229	"DNA polymerase epsilon 3, accessory subunit"	Q9NRF9	9	113407235-113410672	"Enzymes, FDA approved drug targets, Predicted intracellular proteins"		DNA-binding	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA047945	Uncertain		Approved	Nucleoplasm,Nucleoli		NA	NA			"Nucleoplasm, Nucleoli"		"HPA047945: AB_2680218"	"unprognostic (9.55e-2)"	"unprognostic (3.39e-3)"	"unprognostic (1.56e-1)"	"unprognostic (1.67e-1)"	"unprognostic (6.52e-2)"	"unprognostic (1.86e-2)"	"prognostic unfavorable (8.35e-4)"	"unprognostic (1.04e-2)"	"unprognostic (1.60e-2)"	"unprognostic (1.10e-1)"	"unprognostic (4.59e-3)"	"unprognostic (2.31e-3)"	"unprognostic (1.75e-2)"	"unprognostic (1.56e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.18e-1)"	16.9	23.9	18.2	22.0	18.5	56.3	19.3	36.0	25.0	17.0	17.6	15.8	12.5	15.1	18.2	16.5	27.8	17.6	17.0	17.9	16.1	14.8	14.3	29.5	15.8	29.0	15.1	18.5	15.4	20.8	13.1	8.4	21.2	20.0	15.9	20.3	12.4	17.9	16.3	48.3	24.7	17.3	16.9	16.9	26.8	17.2	29.9	15.9	35.0	16.3	27.3	32.4	18.8	16.7	34.9	33.5	34.3	34.4	28.0	44.0	47.7	15.9	19.9	14.0	21.0	8.0	7.2	12.3	21.3	10.9	24.2	19.1	18.4	14.5	58.1	13.3	12.4	14.7	27.4	27.3	23.4	22.4	11.0	16.5	30.1	20.7	18.8	8.6	62.4	18.2	8.1	16.2	21.0	27.0	8.8	16.7	29.6	41.9	32.5	16.7	40.6	42.8	33.6	18.1	34.3	36.1	43.9	58.5	32.6	10.5	15.3	30.5	17.6	31.0	19.6	16.7	8.9	29.3	28.1	13.7	17.9	24.3	22.7	36.4	17.0	55.5	78.3	16.4	36.9	21.4	25.4	34.0	34.3	35.5	34.4	44.0	34.9	34.0	33.7	33.2	33.5	36.9	34.3	7.2	28.0	26.6	33.5	39.0	47.7	18.2	18.5	36.0	25.0	16.1	14.8	15.1	18.5	20.0	15.9	35.7	27.5	46.8	23.7	83.3	13.9	39.7	22.9	46.8	44.3	29.6	5.9	49.3	36.5	26.8	4.0	34.3	14.2	0.0	39.2	47.2	34.7	19.7	54.5	37.2	44.5	12.7	23.6	23.4	27.8	11.5	33.1	54.6	38.8	53.3	31.4	30.3	28.9	10.5	40.0	22.0	17.1	12.9	47.2	27.9	98.5	82.9	29.2	63.4	39.3	18.2
POLE4	p12	ENSG00000115350	"DNA polymerase epsilon 4, accessory subunit"	Q9NR33	2	74958492-74970128	"Enzymes, FDA approved drug targets, Predicted intracellular proteins"		DNA-binding	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"NB-4: 35.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA054979, HPA071815"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA054979: AB_2682661, HPA071815: AB_2686453"	"unprognostic (2.56e-2)"	"unprognostic (4.27e-2)"	"unprognostic (1.17e-1)"	"unprognostic (4.19e-2)"	"unprognostic (4.85e-2)"	"unprognostic (1.59e-2)"	"prognostic unfavorable (6.49e-4)"	"unprognostic (3.09e-1)"	"unprognostic (1.99e-1)"	"unprognostic (2.95e-1)"	"unprognostic (1.39e-2)"	"unprognostic (4.44e-2)"	"unprognostic (8.64e-3)"	"unprognostic (6.61e-2)"	"unprognostic (3.73e-1)"	"unprognostic (3.47e-2)"	"unprognostic (1.95e-1)"	19.2	14.5	23.6	15.2	17.3	27.1	21.4	4.4	15.5	18.4	13.4	8.6	7.0	9.0	10.4	9.0	10.0	9.7	13.1	18.1	15.9	10.6	11.6	18.8	10.7	17.0	13.9	12.6	12.8	12.5	2.8	3.9	9.6	12.2	12.0	8.8	13.9	16.2	11.2	28.1	8.1	12.4	14.1	11.7	12.2	12.5	11.0	10.0	5.5	13.1	15.1	10.4	13.9	31.9	14.7	14.7	8.0	22.2	4.4	9.9	12.3	11.8	11.3	1.0	1.0	3.9	8.6	0.0	8.0	10.0	12.9	11.0	15.0	5.3	11.6	6.8	9.1	3.2	5.4	5.4	6.7	15.1	5.3	14.5	9.0	6.5	14.8	14.0	12.7	14.2	8.7	13.1	5.4	11.9	4.0	5.6	1.6	11.0	6.8	9.8	11.5	3.7	35.8	7.9	6.9	21.2	4.5	9.7	9.3	10.7	0.3	3.6	5.4	11.0	4.6	6.4	0.6	3.4	4.1	6.2	2.9	3.3	2.0	7.7	2.4	1.6	4.3	10.5	19.1	14.2	2.3	22.2	8.0	6.3	13.2	7.0	14.7	8.9	7.8	12.9	13.7	9.9	6.9	1.6	4.4	12.4	14.7	8.5	12.3	23.6	17.3	4.4	15.5	15.9	10.6	13.9	12.6	12.2	10.0	23.8	36.0	84.1	81.2	75.1	21.9	40.6	58.6	34.8	21.6	69.8	41.2	124.8	126.0	43.1	10.2	56.2	119.0	23.3	70.2	125.8	83.2	82.4	61.1	123.4	106.6	17.5	11.7	68.7	111.2	19.3	62.2	91.0	92.8	30.7	80.6	78.1	62.4	147.3	51.2	125.5	104.8	77.6	87.3	41.3	86.7	85.4	78.6	69.3	78.6	82.9
POLG	"POLG1, POLGA"	ENSG00000140521	"DNA polymerase gamma, catalytic subunit"	P54098	15	89305198-89334861	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"DNA replication"	"DNA-binding, DNA-directed DNA polymerase, Nucleotidyltransferase, Transferase"	"Disease mutation, Epilepsy, Leigh syndrome, Neurodegeneration, Neuropathy, Primary mitochondrial disease, Progressive external ophthalmoplegia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA056821, HPA078482"	Approved		Supported	Mitochondria		NA	NA			Mitochondria		"HPA056821: AB_2683247, HPA078482: "	"unprognostic (1.87e-1)"	"unprognostic (4.71e-2)"	"unprognostic (2.61e-2)"	"unprognostic (3.64e-1)"	"unprognostic (1.62e-1)"	"unprognostic (3.19e-1)"	"unprognostic (2.22e-1)"	"unprognostic (1.13e-1)"	"unprognostic (8.41e-2)"	"unprognostic (2.63e-1)"	"unprognostic (1.41e-1)"	"prognostic unfavorable (5.73e-4)"	"unprognostic (2.65e-3)"	"unprognostic (1.58e-2)"	"unprognostic (4.29e-2)"	"unprognostic (2.07e-1)"	"unprognostic (3.45e-1)"	17.8	15.2	19.8	19.0	19.2	16.8	24.6	23.2	20.9	14.1	16.0	14.6	13.6	20.0	17.6	9.0	20.7	14.3	14.0	17.4	16.7	8.8	14.9	19.5	17.8	21.8	17.3	15.3	16.6	17.9	17.7	12.9	16.2	16.0	15.4	13.2	10.5	15.9	12.0	35.9	19.8	18.5	14.1	12.7	22.9	16.2	12.4	17.3	29.0	15.4	12.1	19.2	16.5	18.9	6.0	9.0	9.0	6.5	9.2	10.9	6.7	6.7	12.8	8.8	11.5	14.4	9.2	11.2	13.4	7.2	13.8	10.9	18.6	16.8	10.6	20.7	10.5	16.5	14.6	23.5	11.4	4.7	22.8	20.2	16.0	13.4	6.7	12.2	14.9	26.5	8.3	16.7	9.5	8.2	12.3	16.4	30.2	14.1	11.9	11.1	11.8	16.9	15.2	8.0	13.4	5.7	17.4	10.8	15.0	7.9	16.5	19.6	7.2	19.1	14.0	15.6	10.9	11.6	16.7	12.3	18.7	12.9	27.4	12.8	12.8	7.5	14.7	12.0	17.1	14.9	4.9	6.3	9.0	9.2	6.5	8.0	3.3	7.6	10.9	9.0	6.0	6.6	6.9	2.3	9.2	5.2	6.0	4.3	6.7	19.8	19.2	23.2	20.9	16.7	8.8	17.3	15.3	16.0	17.3	11.9	11.0	15.5	9.7	10.9	6.8	15.7	10.2	1.4	6.8	10.4	2.0	12.0	8.3	9.0	0.9	12.1	12.3	0.0	9.3	13.6	11.4	12.5	8.1	14.0	11.4	3.2	5.2	17.2	19.0	1.1	13.3	12.7	18.6	20.8	23.4	6.0	10.2	17.0	9.9	6.2	6.2	6.5	15.1	7.4	12.9	10.5	18.2	16.6	15.7	12.0
POLG2	"HP55, MTPOLB"	ENSG00000256525	"DNA polymerase gamma 2, accessory subunit"	Q9UHN1	17	64477785-64497036	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"DNA replication"	DNA-binding	"Disease mutation, Primary mitochondrial disease, Progressive external ophthalmoplegia"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Spermatocytes: 52.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"CAB017030, HPA023202"	Approved		Approved	"Nuclear bodies,Mitochondria"		NA	NA			"Nuclear bodies"	Mitochondria	"CAB017030: , HPA023202: AB_1855523"	"unprognostic (1.76e-1)"	"unprognostic (2.20e-1)"	"unprognostic (1.59e-1)"	"unprognostic (7.02e-2)"	"unprognostic (6.01e-2)"	"unprognostic (2.91e-2)"	"prognostic unfavorable (1.39e-6)"	"unprognostic (4.38e-2)"	"unprognostic (8.46e-2)"	"unprognostic (3.14e-1)"	"unprognostic (5.17e-3)"	"prognostic unfavorable (6.59e-4)"	"prognostic unfavorable (1.17e-5)"	"unprognostic (5.17e-2)"	"unprognostic (1.58e-1)"	"unprognostic (2.88e-2)"	"unprognostic (4.82e-2)"	6.7	9.3	5.4	17.5	10.0	8.1	8.2	10.9	8.7	7.7	7.8	7.0	11.1	7.9	10.2	6.8	6.4	7.5	7.9	7.3	5.6	4.4	7.8	7.8	10.4	12.2	10.8	5.2	13.0	9.4	5.0	9.9	6.9	8.7	8.0	5.7	5.8	8.6	11.9	10.7	10.5	8.4	9.3	5.6	11.5	6.9	24.2	7.9	9.8	9.6	5.4	13.3	6.6	11.5	12.2	10.5	6.5	8.2	6.0	12.2	4.4	6.9	8.5	6.1	7.5	5.8	4.7	7.4	4.1	3.9	6.3	5.4	8.8	5.5	12.7	5.0	2.2	6.5	5.7	8.3	3.9	7.9	3.5	9.7	8.6	10.3	8.7	6.5	12.1	9.6	4.7	4.5	5.0	7.5	8.7	4.5	7.7	15.1	4.9	6.1	9.2	12.9	16.1	6.4	7.6	9.5	12.0	20.1	13.4	5.7	2.0	8.6	9.6	3.3	7.4	7.6	9.9	7.3	10.2	5.0	6.8	9.0	5.8	10.7	8.7	5.9	9.6	5.3	11.4	4.7	6.5	5.9	6.5	7.9	3.5	7.5	12.2	8.8	7.6	10.5	12.1	12.2	11.6	1.2	6.0	8.2	4.8	8.4	4.4	5.4	10.0	10.9	8.7	5.6	4.4	10.8	5.2	8.7	7.9	11.9	23.4	11.1	7.7	7.2	4.0	15.7	17.8	5.3	14.8	3.5	0.0	10.9	0.0	4.3	9.2	12.4	11.2	0.0	3.2	12.2	9.9	9.7	12.7	3.8	8.2	6.4	10.5	18.4	7.8	5.0	6.1	6.9	6.8	3.6	13.9	3.0	2.7	16.7	2.8	4.3	8.4	6.5	8.6	52.0	8.2	7.5	3.3	10.2	18.2	4.7
POLH	"RAD30A, XP-V"	ENSG00000170734	"DNA polymerase eta"	Q9Y253	6	43576150-43615660	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"DNA damage, DNA repair, DNA replication, DNA synthesis"	"DNA-binding, DNA-directed DNA polymerase, Mutator protein, Nucleotidyltransferase, Transferase"	"Disease mutation, Xeroderma pigmentosum"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Erythroid cells: 23.3;Spermatocytes: 17.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"U-698: 41.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006721, HPA026762"	Approved		Enhanced	Nucleoplasm		NA	Yes			Nucleoplasm		"HPA006721: AB_1847785, HPA026762: AB_10601248"	"unprognostic (1.79e-1)"	"unprognostic (7.29e-2)"	"unprognostic (2.25e-1)"	"unprognostic (7.28e-2)"	"unprognostic (3.61e-1)"	"unprognostic (5.11e-3)"	"unprognostic (9.68e-2)"	"unprognostic (1.40e-1)"	"unprognostic (3.18e-1)"	"unprognostic (7.75e-2)"	"unprognostic (4.11e-3)"	"unprognostic (2.24e-1)"	"unprognostic (9.50e-2)"	"unprognostic (6.73e-2)"	"unprognostic (8.77e-2)"	"unprognostic (7.91e-2)"	"unprognostic (6.02e-2)"	7.4	9.4	7.5	9.7	10.4	4.6	7.2	10.5	10.5	8.5	8.4	12.7	8.0	5.7	9.6	7.1	11.4	7.8	6.2	6.7	5.3	4.4	7.2	7.5	9.8	16.3	8.9	8.1	7.4	13.0	7.1	9.7	5.1	7.9	6.9	10.1	8.9	8.6	5.6	9.5	11.7	7.9	11.8	6.9	9.2	7.6	24.7	6.8	22.1	9.9	6.2	18.3	8.6	8.4	8.6	4.3	4.5	2.6	6.8	7.2	3.2	20.5	4.7	6.4	9.3	9.1	15.1	15.2	22.0	6.9	12.9	14.8	5.4	3.6	22.8	5.5	8.9	3.7	5.2	6.4	13.8	16.1	11.5	4.9	6.7	13.3	15.6	6.8	11.4	9.0	10.1	17.0	10.5	5.7	5.2	12.1	7.0	10.5	13.7	16.2	6.8	10.3	3.0	1.9	15.7	3.6	11.3	6.6	5.7	4.9	15.4	7.2	2.5	7.0	5.8	3.5	7.4	8.3	5.1	16.4	11.9	11.6	5.6	11.1	12.9	8.9	41.2	5.7	6.7	12.9	4.5	2.6	4.1	7.2	2.5	6.4	7.8	6.0	5.2	2.1	8.6	5.0	5.2	2.0	6.8	1.9	4.3	7.0	3.2	7.5	10.4	10.5	10.5	5.3	4.4	8.9	8.1	7.9	6.8	11.9	5.1	4.9	2.6	4.1	6.3	2.4	2.5	5.3	7.9	3.5	9.8	1.7	5.0	2.0	7.6	2.1	2.6	23.3	0.7	2.4	2.6	2.1	0.0	2.1	1.5	0.0	5.2	0.6	1.5	6.0	3.1	1.7	1.7	2.8	2.2	2.3	1.6	2.9	2.8	1.4	8.5	0.0	3.1	17.9	5.9	2.6	1.6	2.9	3.1	2.5
POLI	"RAD30B, RAD3OB"	ENSG00000101751	"DNA polymerase iota"	Q9UNA4	18	54269404-54321266	"Enzymes, Predicted intracellular proteins"	"DNA damage, DNA repair, DNA replication, DNA synthesis"	"DNA-binding, DNA-directed DNA polymerase, Mutator protein, Nucleotidyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Early spermatids: 68.1;Spermatocytes: 70.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA012000, HPA064696"	Enhanced		Supported	"Nuclear speckles,Cytoplasmic bodies"		NA	NA			"Nuclear speckles"	"Cytoplasmic bodies"	"HPA012000: AB_1847786, HPA064696: AB_2685325"	"unprognostic (1.64e-1)"	"unprognostic (5.79e-3)"	"unprognostic (9.72e-3)"	"unprognostic (4.92e-2)"	"unprognostic (3.04e-1)"	"unprognostic (4.46e-2)"	"unprognostic (1.31e-1)"	"unprognostic (1.05e-2)"	"unprognostic (4.04e-3)"	"unprognostic (2.22e-2)"	"unprognostic (2.07e-3)"	"unprognostic (1.30e-3)"	"unprognostic (1.55e-1)"	"unprognostic (4.05e-2)"	"unprognostic (1.26e-1)"	"unprognostic (1.52e-2)"	"unprognostic (6.99e-2)"	16.5	11.1	10.2	9.5	14.0	5.2	15.8	9.6	14.7	12.9	9.9	13.4	13.7	6.6	13.2	13.1	6.6	10.3	8.3	9.1	8.7	7.6	12.9	6.4	9.0	7.4	10.9	9.0	16.4	11.8	17.6	21.3	17.4	15.3	12.7	7.7	9.6	11.3	14.7	7.2	8.2	7.6	10.9	12.0	8.2	9.0	30.5	10.9	17.3	27.3	1.5	7.0	12.7	10.5	9.9	10.3	10.9	10.7	7.9	12.7	7.1	7.6	2.8	21.0	12.7	7.1	13.9	6.8	6.3	13.6	7.3	12.2	2.1	7.3	3.6	2.1	9.2	7.4	6.3	4.9	7.3	8.2	8.7	2.4	4.5	3.1	5.3	11.6	7.2	3.8	15.1	11.1	6.3	13.3	16.6	15.4	6.0	3.1	10.3	12.2	6.0	5.1	6.4	7.2	2.0	3.1	3.3	4.3	9.0	8.3	10.2	9.9	10.1	4.5	4.0	6.7	14.2	14.7	3.3	7.4	13.8	3.8	2.0	5.2	8.4	1.9	5.2	9.8	6.5	10.0	5.4	10.7	10.9	8.3	5.7	7.7	8.6	8.8	8.6	10.3	9.9	12.7	7.6	6.7	7.9	5.8	8.1	9.8	7.1	10.2	14.0	9.6	14.7	8.7	7.6	10.9	9.0	15.3	10.9	23.8	16.0	4.5	7.9	2.3	15.1	9.5	2.5	24.1	10.3	5.2	9.8	26.3	8.3	7.9	68.1	6.0	2.0	0.0	5.4	14.9	7.1	3.8	12.7	5.8	7.9	3.2	5.8	10.4	8.4	12.8	18.4	6.1	6.8	6.4	4.7	18.8	5.6	2.9	17.0	12.5	20.8	32.3	8.0	70.7	28.2	2.3	23.3	4.4	3.9	2.4
POLK	"DINB1, DINP, POLQ"	ENSG00000122008	"DNA polymerase kappa"	Q9UBT6	5	75511756-75601144	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"DNA damage, DNA repair, DNA replication, DNA synthesis"	"DNA-binding, DNA-directed DNA polymerase, Mutator protein, Nucleotidyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	6	"Early spermatids: 167.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA012035, HPA057303, HPA068117, HPA069375"			Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"HPA012035: AB_2668606, HPA057303: AB_2683406, HPA068117: AB_2685957, HPA069375: AB_2686131"	"unprognostic (9.66e-2)"	"unprognostic (5.29e-2)"	"unprognostic (5.37e-2)"	"unprognostic (2.70e-1)"	"unprognostic (1.86e-1)"	"unprognostic (1.66e-1)"	"unprognostic (1.73e-2)"	"unprognostic (7.76e-2)"	"unprognostic (1.65e-2)"	"unprognostic (6.29e-3)"	"unprognostic (2.42e-1)"	"unprognostic (5.93e-2)"	"unprognostic (1.80e-2)"	"unprognostic (9.96e-3)"	"unprognostic (1.58e-1)"	"unprognostic (9.64e-2)"	"unprognostic (2.02e-1)"	14.7	12.7	10.1	8.6	12.9	6.3	13.4	17.0	13.4	18.1	10.7	8.8	13.6	6.3	21.3	12.1	11.7	10.5	9.5	11.4	14.1	10.5	12.6	12.3	12.2	9.2	14.1	12.9	15.5	11.1	18.5	23.9	15.2	17.2	13.9	8.1	6.5	10.2	10.5	15.2	10.3	9.2	15.4	16.9	13.1	9.0	9.8	12.4	12.1	18.8	9.3	8.9	12.7	10.2	7.0	7.5	6.0	13.3	4.6	4.5	2.5	6.4	6.6	4.1	5.3	5.5	10.9	3.5	12.3	8.8	9.6	10.0	4.2	5.2	6.6	10.2	8.1	6.3	2.5	3.8	4.2	11.6	7.3	4.5	6.0	5.8	2.0	10.4	3.9	5.0	5.1	5.3	7.7	5.3	7.7	8.0	4.4	5.3	3.9	9.1	0.5	7.5	3.1	1.5	0.7	3.9	3.2	10.6	4.6	5.8	2.2	4.2	4.6	9.3	2.5	3.3	2.9	3.6	3.7	10.1	7.1	3.6	3.3	7.0	4.6	4.1	6.0	4.7	6.1	12.1	5.7	7.1	3.4	3.3	7.9	2.9	7.0	3.7	4.0	6.1	5.4	4.5	3.0	6.0	4.6	13.3	7.5	4.1	2.5	10.1	12.9	17.0	13.4	14.1	10.5	14.1	12.9	17.2	12.4	29.8	39.4	38.7	18.4	13.1	33.6	17.1	30.6	18.7	29.6	27.9	19.6	14.0	19.9	16.1	167.0	32.1	9.2	23.3	13.7	11.0	21.7	14.6	49.8	20.9	18.7	62.0	14.3	49.7	37.8	38.8	34.8	32.2	21.9	27.9	12.4	23.5	16.5	11.5	36.0	17.0	40.7	6.5	16.5	43.4	16.6	11.3	5.6	18.5	10.6	10.5
POLL		ENSG00000166169	"DNA polymerase lambda"	Q9UGP5	10	101578882-101588270	"Enzymes, Predicted intracellular proteins"	"DNA damage, DNA repair, DNA replication, DNA synthesis"	"DNA-binding, DNA-directed DNA polymerase, Lyase, Nucleotidyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Cone photoreceptor cells: 45.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA076828			Supported	Nucleoplasm	"Intracellular and membrane"	NA	NA			Nucleoplasm		"HPA076828: "	"unprognostic (3.71e-3)"	"unprognostic (6.93e-3)"	"unprognostic (1.73e-2)"	"unprognostic (2.47e-2)"	"unprognostic (9.52e-2)"	"unprognostic (1.80e-2)"	"unprognostic (2.11e-2)"	"unprognostic (1.24e-1)"	"unprognostic (8.11e-2)"	"unprognostic (1.71e-2)"	"unprognostic (1.12e-2)"	"unprognostic (7.19e-2)"	"unprognostic (4.74e-2)"	"unprognostic (1.06e-2)"	"unprognostic (1.94e-1)"	"unprognostic (3.86e-1)"	"unprognostic (1.64e-3)"	11.0	15.1	14.4	16.0	17.1	9.2	13.4	11.2	22.1	13.7	12.6	16.4	15.6	14.3	15.1	22.1	15.4	18.1	17.7	12.3	11.1	10.4	16.4	16.5	11.8	13.0	9.6	13.0	20.9	30.7	21.7	23.7	11.7	12.7	17.2	15.0	19.5	17.8	14.7	26.1	12.8	11.9	12.7	9.4	15.6	16.7	53.2	11.2	4.6	18.3	10.2	14.2	14.8	11.6	8.5	10.7	1.1	8.5	8.4	11.9	7.1	11.7	10.7	8.5	11.8	8.6	16.0	11.9	7.8	13.5	11.9	12.6	7.8	14.2	2.9	12.3	7.0	6.7	14.8	9.3	11.5	9.7	10.3	12.7	9.2	10.1	8.9	15.9	9.5	8.4	14.6	15.7	13.2	27.4	33.6	12.8	5.7	10.2	10.2	7.5	9.3	0.0	10.4	4.5	6.5	6.4	0.0	7.5	4.8	10.0	7.1	5.9	8.7	4.8	8.1	13.3	13.0	24.5	5.6	6.8	4.3	8.7	4.9	8.5	14.7	7.4	4.4	9.3	8.3	3.2	0.5	8.5	1.1	6.7	5.9	10.6	8.5	7.4	6.8	10.7	7.1	11.9	7.9	0.9	8.4	5.7	0.2	8.9	7.1	14.4	17.1	11.2	22.1	11.1	10.4	9.6	13.0	12.7	11.2	6.0	11.7	10.2	7.5	3.3	15.9	6.7	12.7	4.0	5.7	7.0	45.2	14.0	5.0	8.6	16.4	5.6	10.5	0.0	18.3	7.2	6.9	5.2	13.9	8.1	10.0	20.6	12.6	4.9	12.3	39.9	13.0	8.8	10.1	15.4	12.0	9.9	11.4	7.0	10.6	8.4	22.0	12.9	5.7	23.8	9.1	1.8	9.6	9.6	12.8	5.2
POLM	Tdt-N	ENSG00000122678	"DNA polymerase mu"	Q9NP87	7	44072247-44082540	"Enzymes, Predicted intracellular proteins"	"DNA damage, DNA recombination, DNA repair"	"DNA-directed DNA polymerase, Nucleotidyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"neutrophil: 31.6"	"Lineage enriched"	"Detected in all"	5	"granulocytes: 31.6"	"Cell line enhanced"	"Detected in many"		"HBEC3-KT: 38.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA058900, HPA066007"			Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA058900: AB_2683848, HPA066007: AB_2685595"	"unprognostic (2.44e-2)"	"unprognostic (8.18e-2)"	"unprognostic (2.21e-3)"	"unprognostic (3.93e-2)"	"unprognostic (5.40e-2)"	"unprognostic (1.83e-1)"	"unprognostic (2.75e-1)"	"unprognostic (1.22e-1)"	"unprognostic (5.12e-2)"	"unprognostic (3.91e-1)"	"unprognostic (9.36e-2)"	"unprognostic (8.26e-2)"	"unprognostic (2.46e-3)"	"unprognostic (6.31e-2)"	"unprognostic (1.47e-1)"	"unprognostic (2.87e-1)"	"unprognostic (3.87e-3)"	10.7	8.7	7.0	18.0	7.1	7.6	12.2	11.9	8.8	13.8	11.2	11.1	11.7	12.2	10.1	12.0	11.7	11.8	11.8	10.8	6.8	4.4	13.0	12.5	10.1	20.9	9.9	7.0	13.8	12.3	10.0	9.0	8.1	8.2	11.8	7.1	12.4	13.5	14.3	11.2	12.0	12.6	8.9	9.0	18.7	12.0	6.8	8.1	30.1	15.4	8.3	17.6	12.4	10.7	5.9	4.8	31.6	2.1	3.5	4.2	1.3	1.1	1.5	1.5	3.5	2.2	2.6	5.0	3.5	4.0	2.7	1.6	1.9	2.6	11.3	3.6	3.0	3.4	3.4	1.6	38.3	1.6	3.9	3.6	1.3	1.6	0.7	3.1	3.5	5.1	4.0	3.7	2.3	2.8	5.6	4.9	11.3	1.6	5.5	2.3	2.6	7.1	3.1	3.3	3.4	8.2	5.7	0.9	4.4	3.0	1.8	1.6	3.0	1.7	7.3	3.7	2.7	4.6	6.0	3.4	1.9	2.8	1.9	5.1	9.0	4.5	8.8	3.5	3.2	4.6	8.6	1.8	5.1	3.3	2.1	3.3	4.0	2.9	3.0	1.6	5.9	4.2	3.4	31.6	3.5	1.6	4.8	2.7	1.3	7.0	7.1	11.9	8.8	6.8	4.4	9.9	7.0	8.2	8.1	3.0	8.5	24.9	9.9	3.9	18.3	5.5	15.3	4.0	9.1	12.2	27.5	10.7	1.7	6.4	0.4	6.4	12.3	0.0	8.2	8.5	5.0	11.9	24.2	8.9	9.0	17.5	5.2	12.9	10.8	0.4	13.0	9.1	10.1	10.0	7.3	7.2	6.9	15.6	9.6	3.8	38.8	0.0	13.0	10.8	11.5	4.4	8.1	14.4	10.1	10.7
POLN		ENSG00000130997	"DNA polymerase nu"	Q7Z5Q5	4	2071918-2242121	"Enzymes, Predicted intracellular proteins"	"DNA damage, DNA repair, DNA replication"	"DNA-binding, DNA-directed DNA polymerase, Nucleotidyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	9	"Late spermatids: 9.2;Spermatocytes: 17.6;Spermatogonia: 10.0"	"Low cancer specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"eosinophil: 2.4"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"ASC diff: 5.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA035939, HPA035940"			Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"HPA035939: AB_2674875, HPA035940: AB_2674876"	"unprognostic (8.52e-3)"	"unprognostic (1.55e-1)"	"unprognostic (4.87e-2)"	"unprognostic (1.32e-1)"	"unprognostic (2.53e-1)"	"unprognostic (1.45e-2)"	"unprognostic (3.46e-1)"	"unprognostic (2.70e-1)"	"unprognostic (5.83e-2)"	"unprognostic (2.23e-1)"	"unprognostic (2.02e-3)"	"unprognostic (1.25e-1)"	"unprognostic (1.49e-3)"	"unprognostic (9.14e-2)"	"unprognostic (2.67e-1)"	"unprognostic (2.66e-1)"	"unprognostic (1.82e-2)"	13.6	3.9	6.1	2.5	5.7	1.8	5.2	11.1	5.5	2.8	2.9	3.5	2.9	2.7	4.0	5.8	2.6	3.6	3.3	2.8	4.4	2.9	3.6	3.4	3.0	2.7	4.3	4.0	2.8	3.1	2.4	7.6	2.3	3.8	4.6	1.8	1.7	4.7	3.5	2.7	2.7	2.4	3.3	5.6	3.5	2.9	12.3	5.2	8.5	2.4	0.9	2.6	2.5	2.6	0.2	0.1	2.4	0.0	0.0	0.9	0.1	0.3	2.7	0.5	2.0	5.7	2.2	0.0	2.0	1.0	1.1	1.6	0.1	0.2	1.2	0.6	1.7	1.0	0.4	2.2	0.8	1.6	0.3	2.9	0.1	2.0	0.0	0.7	0.2	2.6	3.1	0.8	1.7	1.4	2.6	0.6	0.5	0.2	2.3	3.1	0.3	0.2	0.2	0.2	0.1	0.6	0.0	3.8	0.9	0.8	0.5	2.5	0.0	0.2	0.0	0.2	1.0	0.1	0.7	0.3	0.1	1.9	1.1	0.6	0.6	0.7	0.0	0.6	1.9	1.1	0.0	0.0	2.4	0.2	0.0	0.9	0.2	0.2	0.6	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.4	0.1	6.1	5.7	11.1	5.5	4.4	2.9	4.3	4.0	3.8	5.2	0.0	0.0	0.0	1.0	0.8	3.2	1.6	2.5	1.4	2.3	0.0	0.0	0.2	3.3	0.4	6.8	0.8	0.0	0.0	0.9	0.2	1.7	1.1	0.0	0.6	0.5	3.2	4.6	4.9	1.0	9.2	4.0	1.4	0.0	0.0	0.0	2.6	0.4	0.0	3.5	0.5	3.6	0.0	1.3	17.6	10.0	1.4	0.0	0.7	0.2	1.3
POLQ	POLH	ENSG00000051341	"DNA polymerase theta"	O75417	3	121431427-121546641	"Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"DNA damage, DNA repair"	"DNA-directed DNA polymerase, Nucleotidyltransferase, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 9.5;lymphoid tissue: 21.4"	"Cell type enhanced"	"Detected in some"	10	"Club cells: 3.4;Extravillous trophoblasts: 2.8;Spermatocytes: 7.0;Spermatogonia: 3.3"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"basophil: 1.6"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Not detected"	"Not detected"			"Region enhanced"	"Detected in many"		"cerebellum: 5.2"	HPA053359			Supported	"Nucleoplasm,Golgi apparatus,Cytosol"		NA	Yes			Nucleoplasm	"Golgi apparatus, Cytosol"	"HPA053359: "	"unprognostic (1.59e-1)"	"unprognostic (4.18e-2)"	"unprognostic (2.66e-2)"	"prognostic unfavorable (5.46e-5)"	"unprognostic (2.70e-1)"	"unprognostic (6.23e-3)"	"unprognostic (3.09e-5)"	"unprognostic (8.55e-3)"	"unprognostic (1.09e-4)"	"unprognostic (2.86e-1)"	"unprognostic (5.59e-5)"	"unprognostic (2.06e-3)"	"unprognostic (0.00e+0)"	"prognostic favorable (1.04e-4)"	"unprognostic (1.76e-1)"	"unprognostic (6.01e-2)"	"unprognostic (5.76e-2)"	0.5	0.8	0.2	8.2	0.7	9.5	0.6	0.6	0.4	0.9	3.5	0.2	0.8	2.0	0.9	0.6	6.0	0.3	0.4	0.8	0.3	0.2	0.4	0.6	0.9	4.7	0.3	0.0	0.4	0.4	0.0	0.2	2.8	0.3	0.4	3.7	0.1	1.1	0.8	1.2	2.4	3.9	0.5	0.4	2.6	1.1	5.8	0.6	21.4	0.3	5.6	7.5	0.6	1.7	0.5	1.1	1.6	0.4	0.0	0.4	0.0	13.5	9.2	7.9	5.6	0.7	0.9	7.2	6.4	2.5	7.6	10.2	7.3	5.0	16.1	2.9	3.5	9.2	10.7	9.3	4.1	12.9	4.7	5.1	10.3	5.7	4.5	0.0	11.1	9.5	0.1	0.3	6.9	4.3	1.3	3.7	6.0	6.8	12.3	7.9	5.2	10.0	6.5	7.5	4.1	4.5	8.5	9.5	5.7	2.4	7.8	4.3	3.9	7.4	4.0	2.6	7.2	3.7	11.1	2.9	6.7	8.8	2.6	8.3	6.2	5.0	16.7	3.2	8.3	4.9	1.6	0.2	0.0	0.3	0.2	0.0	0.3	0.4	0.3	0.4	0.5	0.0	0.2	0.0	0.0	0.4	1.1	0.1	0.0	0.2	0.7	0.6	0.4	0.3	0.2	0.3	0.0	0.3	0.6	0.0	0.3	0.0	0.4	0.8	0.3	1.4	0.0	1.4	3.4	0.0	0.0	0.9	0.0	0.1	0.3	0.0	0.4	0.0	0.0	2.8	0.7	0.3	0.0	0.0	1.9	0.0	0.0	0.0	0.6	0.2	0.3	1.5	0.0	1.0	0.4	0.5	0.3	0.3	0.0	0.1	0.1	0.0	0.5	7.0	3.3	0.1	0.2	0.9	0.9	0.9
POLR1A	"DKFZP586M0122, FLJ21915, RPA1, RPO1-4"	ENSG00000068654	"RNA polymerase I subunit A"	O95602	2	86020216-86106155	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, RNA polymerase related proteins"	Transcription	"Nucleotidyltransferase, Transferase"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB010145, HPA031513, HPA049700"	Supported		Enhanced	"Nucleoplasm,Nucleoli fibrillar center,Intermediate filaments"		No	No			"Nucleoli fibrillar center"	"Nucleoplasm, Intermediate filaments"	"CAB010145: AB_675814, HPA031513: AB_2673916, HPA049700: AB_2680856"	"unprognostic (1.22e-1)"	"unprognostic (1.82e-2)"	"unprognostic (1.55e-1)"	"unprognostic (2.46e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.93e-1)"	"prognostic unfavorable (3.70e-9)"	"unprognostic (1.06e-2)"	"unprognostic (1.35e-1)"	"prognostic unfavorable (3.37e-4)"	"unprognostic (4.31e-2)"	"unprognostic (4.56e-2)"	"unprognostic (3.27e-1)"	"unprognostic (2.20e-3)"	"unprognostic (1.94e-1)"	"prognostic unfavorable (8.41e-4)"	"unprognostic (7.20e-2)"	14.3	12.9	10.1	12.4	16.5	9.7	10.3	12.2	20.3	11.1	11.0	17.4	8.3	9.4	19.5	7.4	13.5	12.3	11.7	12.7	9.0	9.2	11.5	15.1	9.4	9.6	9.0	9.4	12.6	14.3	18.2	15.9	11.4	13.8	10.7	11.8	13.9	11.2	12.5	22.5	12.3	8.6	16.0	8.0	11.2	10.4	14.9	10.9	14.0	10.3	11.4	14.2	10.9	9.6	2.6	2.6	1.8	2.5	2.0	3.8	1.2	9.4	21.6	9.6	18.5	9.5	7.6	14.0	8.7	5.8	12.6	7.8	27.0	7.5	21.7	9.3	8.9	12.2	11.0	24.7	12.9	11.2	9.0	12.8	18.7	9.2	18.1	6.7	17.7	10.1	5.8	8.1	18.6	14.5	4.8	9.7	10.1	24.7	5.5	8.6	8.4	13.1	7.5	17.5	12.7	14.3	15.8	21.1	10.2	5.6	15.5	15.0	7.8	9.6	12.8	6.9	6.9	7.5	6.2	15.4	15.3	12.1	13.0	17.5	7.8	7.5	19.0	7.9	15.3	13.4	1.8	1.5	0.2	3.0	2.5	3.8	2.0	1.5	2.5	1.8	2.6	1.4	1.8	0.7	2.0	1.9	2.6	0.7	1.2	10.1	16.5	12.2	20.3	9.0	9.2	9.0	9.4	13.8	10.9	3.0	7.8	6.1	2.9	3.8	11.5	7.8	15.3	6.7	3.4	8.7	15.7	5.7	3.3	5.9	2.4	5.7	4.2	0.0	4.0	4.4	3.8	4.3	5.8	7.2	10.2	11.1	9.2	4.9	2.8	1.5	5.8	3.1	5.0	1.8	6.1	2.9	5.0	0.0	4.9	3.0	10.1	0.0	4.7	4.2	7.5	2.4	3.2	4.4	9.0	3.7
POLR1B	"FLJ10816, FLJ21921, RPA2, Rpo1-2"	ENSG00000125630	"RNA polymerase I subunit B"	Q9H9Y6	2	112541915-112577150	"Enzymes, Plasma proteins, Predicted intracellular proteins, RNA polymerase related proteins"	Transcription	"Nucleotidyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	5	"Early spermatids: 133.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA037528			Supported	Nucleoli,Cytosol		NA	NA			Nucleoli	Cytosol	"HPA037528: AB_10671627"	"unprognostic (1.66e-1)"	"unprognostic (3.17e-2)"	"unprognostic (2.55e-1)"	"prognostic unfavorable (2.71e-5)"	"unprognostic (2.07e-1)"	"unprognostic (1.16e-2)"	"unprognostic (1.98e-3)"	"unprognostic (1.98e-1)"	"unprognostic (2.05e-1)"	"unprognostic (1.13e-1)"	"prognostic unfavorable (5.52e-4)"	"unprognostic (6.12e-2)"	"unprognostic (1.29e-2)"	"unprognostic (1.18e-1)"	"unprognostic (2.19e-1)"	"unprognostic (1.08e-1)"	"unprognostic (3.56e-2)"	8.8	11.0	6.4	10.6	6.8	4.9	15.7	8.0	8.2	7.6	7.0	7.7	8.6	5.8	9.3	7.4	12.8	9.2	9.2	6.1	5.7	6.1	11.3	20.5	8.0	11.3	6.8	3.7	11.3	25.2	20.7	11.5	7.2	5.2	7.7	8.5	7.3	10.0	8.3	14.7	9.2	8.0	7.9	4.8	11.4	8.1	15.7	5.0	9.6	15.7	11.5	14.6	8.9	11.8	9.4	11.0	2.5	6.3	10.2	17.1	7.3	9.5	10.0	6.3	13.1	6.9	6.6	11.9	7.2	5.5	12.2	10.6	22.4	5.7	22.9	10.7	4.7	9.5	13.5	26.7	14.6	14.1	10.3	13.5	13.2	9.9	16.9	7.3	21.1	9.2	6.3	10.6	12.6	19.5	5.1	9.4	4.8	23.9	8.3	6.3	8.4	9.5	13.7	30.9	14.1	19.8	14.3	10.5	24.3	8.4	9.1	16.1	14.9	6.6	16.6	9.0	7.1	7.7	7.5	8.5	7.5	11.0	6.8	10.5	11.2	18.4	19.8	5.7	13.6	6.2	0.2	6.0	2.5	8.3	6.3	17.1	9.4	8.4	8.9	11.0	9.3	10.3	10.4	0.4	10.2	4.8	2.6	11.3	7.3	6.4	6.8	8.0	8.2	5.7	6.1	6.8	3.7	5.2	5.0	14.9	5.1	8.2	2.2	13.4	3.4	5.7	10.2	2.7	7.9	8.7	2.0	2.9	5.0	4.0	133.9	5.6	1.2	0.0	3.9	2.3	2.8	2.2	4.7	8.5	3.3	1.6	3.5	1.8	2.5	29.4	2.8	2.9	1.7	1.8	4.4	3.8	2.9	6.0	2.8	4.1	2.9	0.0	2.8	9.5	7.5	15.1	0.5	6.4	4.5	3.4
POLR2A	"POLR2, POLRA, RPB1"	ENSG00000181222	"RNA polymerase II subunit A"	P24928	17	7484366-7514616	"Enzymes, Predicted intracellular proteins"	"Host-virus interaction, Transcription"	"DNA-binding, Nucleotidyltransferase, RNA-directed RNA polymerase, Transferase"	"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"neutrophil: 4.9"	"Lineage enriched"	"Detected in many"	4	"granulocytes: 4.9"	"Cell line enhanced"	"Detected in some"		"HEK 293: 3.0;HL-60: 2.7;HMC-1: 4.0"									"CAB012226, CAB016388, CAB022311"	Enhanced		Supported	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"CAB012226: AB_304749, CAB016388: AB_677353, CAB022311: "	"unprognostic (2.03e-1)"	"unprognostic (1.32e-1)"	"unprognostic (1.58e-1)"	"unprognostic (2.40e-1)"	"unprognostic (1.71e-1)"	"unprognostic (5.43e-2)"	"unprognostic (8.77e-3)"	"unprognostic (1.48e-1)"	"unprognostic (5.19e-3)"	"unprognostic (1.81e-1)"	"unprognostic (1.52e-1)"	"unprognostic (3.70e-2)"	"unprognostic (1.01e-3)"	"unprognostic (1.25e-1)"	"unprognostic (2.30e-2)"	"unprognostic (1.49e-1)"	"unprognostic (4.70e-2)"	5.0	5.9	4.5	5.7	7.4	26.4	8.5	5.8	7.8	7.2	4.3	4.8	4.5	4.3	5.5	5.4	7.0	4.6	4.2	4.5	6.0	3.5	4.6	4.4	6.4	11.5	4.7	4.2	5.2	5.8	5.4	4.8	4.2	5.4	4.3	4.9	6.3	5.5	8.1	6.6	6.6	6.0	4.5	6.1	6.2	5.3	13.2	2.9	15.0	5.6	4.1	5.0	5.3	4.6	0.7	0.7	4.9	1.0	0.0	1.2	0.0	0.3	0.0	0.3	0.0	0.4	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.4	0.4	0.1	0.6	0.2	0.0	0.2	0.0	0.2	0.4	3.0	0.7	1.2	0.2	0.0	2.7	4.0	0.4	0.0	0.3	0.0	0.4	0.2	0.7	0.3	0.0	0.5	0.0	0.1	0.8	0.5	0.0	0.9	1.2	0.0	0.0	0.0	1.4	0.3	0.9	1.0	0.0	0.0	0.6	0.6	0.0	0.0	0.0	0.3	0.5	0.8	0.4	0.2	0.4	0.0	0.6	0.3	3.0	0.5	0.6	1.2	0.4	0.3	0.3	0.5	0.4	0.1	0.7	0.6	0.5	4.9	0.0	1.0	0.7	0.5	0.0	4.5	7.4	5.8	7.8	6.0	3.5	4.7	4.2	5.4	2.9	20.8	47.7	32.5	35.2	38.0	86.4	20.7	38.2	29.4	23.9	22.7	104.1	31.3	3.3	23.3	19.9	38.6	39.3	0.0	26.5	23.6	28.9	29.0	41.5	22.9	39.8	52.4	73.6	38.6	32.1	7.2	34.2	31.4	35.4	35.1	39.1	29.5	28.0	30.0	39.3	10.6	80.9	6.5	33.7	53.7	121.1	36.0	45.0	39.2	30.5	29.3
POLR2B	RPB2	ENSG00000047315	"RNA polymerase II subunit B"	P30876	4	56977722-57031168	"Enzymes, Plasma proteins, Predicted intracellular proteins, RNA polymerase related proteins"	Transcription	"Nucleotidyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA037506	Approved		Supported	Nucleoplasm		NA	NA			Nucleoplasm		"HPA037506: AB_10672597"	"unprognostic (9.88e-3)"	"unprognostic (4.38e-2)"	"unprognostic (1.83e-3)"	"unprognostic (7.51e-2)"	"unprognostic (2.30e-2)"	"unprognostic (4.21e-3)"	"unprognostic (1.24e-3)"	"unprognostic (3.51e-1)"	"unprognostic (6.39e-2)"	"unprognostic (1.22e-1)"	"unprognostic (1.23e-1)"	"unprognostic (1.95e-1)"	"prognostic favorable (7.17e-4)"	"unprognostic (1.91e-1)"	"unprognostic (1.51e-1)"	"unprognostic (3.43e-1)"	"unprognostic (7.35e-2)"	24.5	34.3	31.1	34.6	31.0	21.4	24.8	43.8	33.3	25.9	26.0	18.8	24.9	22.5	35.1	21.4	27.4	28.3	21.2	32.9	29.3	21.7	26.2	21.4	21.2	32.4	28.0	30.2	26.4	28.1	40.7	37.3	25.4	28.3	24.8	26.5	18.4	30.5	28.2	61.8	24.4	27.3	27.6	26.4	27.1	28.8	26.6	26.8	33.4	27.0	34.7	35.1	31.5	22.4	19.8	15.2	27.8	13.9	18.0	23.8	12.7	25.3	21.1	38.2	32.3	31.6	28.5	20.5	33.7	34.3	33.8	31.7	26.9	25.5	39.5	32.0	31.2	24.3	18.0	45.9	25.6	48.4	18.7	20.6	29.7	23.6	23.4	36.6	51.0	34.3	30.7	25.8	38.6	23.5	28.1	40.2	31.8	44.0	33.7	38.9	18.5	48.0	19.7	31.4	32.8	24.8	35.1	25.2	21.7	23.1	28.9	31.9	35.7	21.0	39.9	29.0	32.0	21.4	28.4	29.3	24.6	33.1	25.7	44.2	27.2	25.9	57.5	28.1	27.5	30.4	27.8	12.2	16.8	20.7	12.4	22.0	19.8	20.3	21.4	15.2	14.4	19.9	23.8	11.3	18.0	13.9	12.9	20.9	12.7	31.1	31.0	43.8	33.3	29.3	21.7	28.0	30.2	28.3	26.8	26.8	41.7	44.7	39.5	36.7	45.8	30.9	38.2	57.6	45.5	34.9	41.2	41.3	16.6	52.1	4.5	31.4	29.1	0.0	47.4	25.1	30.5	50.4	55.6	27.2	25.9	42.9	28.7	35.6	42.2	5.4	53.2	38.7	42.2	44.1	31.2	30.4	47.4	30.2	35.7	26.9	48.2	71.1	26.2	79.4	64.2	34.9	34.3	61.0	31.7	71.1
POLR3A	"hRPC155, RPC1, RPC155"	ENSG00000148606	"RNA polymerase III subunit A"	O14802	10	77969251-78029545	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, RNA polymerase related proteins"	"Antiviral defense, Immunity, Innate immunity, Transcription"	"Nucleotidyltransferase, Transferase"	"Disease mutation, Leukodystrophy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"Cone photoreceptor cells: 60.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"PC-3: 40.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA037926	Uncertain		Supported	Nucleoplasm		NA	NA			Nucleoplasm		"HPA037926: AB_10672400"	"unprognostic (6.83e-2)"	"unprognostic (3.41e-2)"	"unprognostic (4.54e-2)"	"unprognostic (2.76e-2)"	"unprognostic (6.41e-2)"	"unprognostic (1.75e-1)"	"prognostic unfavorable (3.64e-6)"	"unprognostic (3.25e-1)"	"unprognostic (1.07e-1)"	"unprognostic (1.73e-1)"	"unprognostic (6.64e-2)"	"unprognostic (2.09e-2)"	"unprognostic (1.51e-2)"	"unprognostic (1.34e-1)"	"unprognostic (3.19e-1)"	"unprognostic (1.30e-1)"	"unprognostic (4.11e-2)"	7.1	10.2	10.3	8.3	21.7	5.9	10.6	22.2	29.7	9.2	8.1	12.8	7.4	8.6	9.4	13.3	8.6	8.5	7.4	7.4	9.4	9.6	9.3	9.3	6.8	8.7	8.1	11.0	11.5	10.7	13.8	17.3	10.1	20.4	10.2	10.7	10.4	8.6	8.2	17.6	11.2	7.8	9.7	6.6	8.9	8.2	11.7	9.8	12.6	9.6	4.4	13.4	7.9	8.0	7.5	5.4	8.0	6.4	6.5	8.8	3.6	7.4	8.9	9.5	15.7	6.3	8.0	6.3	8.6	11.2	11.1	11.0	11.7	5.4	9.3	5.3	7.4	6.3	8.8	16.4	9.4	13.6	6.8	12.0	7.5	7.1	14.4	5.9	12.8	6.3	6.8	6.8	19.7	18.3	10.7	9.7	7.6	13.8	5.8	10.7	5.6	9.6	8.1	10.3	6.1	40.8	9.2	6.0	6.0	5.6	4.9	8.7	11.0	8.2	15.4	8.8	8.9	11.4	6.7	10.6	7.2	7.0	7.7	17.0	9.0	9.5	11.3	12.8	13.5	3.5	8.0	5.2	2.9	7.8	6.4	7.6	5.6	6.0	7.2	4.8	7.5	5.7	6.6	3.3	6.5	5.4	5.4	8.8	3.6	10.3	21.7	22.2	29.7	9.4	9.6	8.1	11.0	20.4	9.8	0.0	7.8	6.1	4.6	8.9	27.0	10.4	7.6	14.7	12.5	0.0	60.9	6.7	1.7	5.4	1.2	7.3	6.3	0.0	5.3	5.6	5.7	3.5	5.8	9.2	4.8	14.3	6.9	6.2	5.7	0.0	12.0	4.5	1.7	3.6	9.8	15.5	7.1	7.0	7.8	3.8	32.8	6.5	6.6	10.9	17.0	8.0	3.4	4.9	8.6	3.2
POLR3B	"FLJ10388, RPC2"	ENSG00000013503	"RNA polymerase III subunit B"	Q9NW08	12	106357658-106510198	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, RNA polymerase related proteins"	"Antiviral defense, Immunity, Innate immunity, Transcription"	"Nucleotidyltransferase, Transferase"	"Disease mutation, Leukodystrophy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA036466	Supported		Approved	"Nuclear speckles"		NA	NA			"Nuclear speckles"		"HPA036466: AB_10671842"	"unprognostic (1.17e-1)"	"unprognostic (1.52e-1)"	"unprognostic (4.80e-2)"	"unprognostic (1.37e-2)"	"unprognostic (1.13e-1)"	"unprognostic (2.73e-1)"	"unprognostic (4.21e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.33e-1)"	"unprognostic (3.36e-2)"	"unprognostic (6.11e-2)"	"unprognostic (5.09e-2)"	"prognostic favorable (1.21e-4)"	"unprognostic (1.54e-1)"	"unprognostic (1.46e-1)"	"unprognostic (8.73e-2)"	"unprognostic (9.24e-2)"	6.4	14.0	7.1	7.9	14.6	6.5	6.9	8.6	13.6	8.6	7.2	8.2	5.7	6.0	10.1	7.2	14.8	7.7	5.8	8.2	8.9	7.1	9.9	17.5	7.1	11.4	6.2	10.4	11.3	11.9	22.5	17.0	22.9	12.3	8.0	8.3	6.2	8.6	9.9	12.1	15.3	5.7	7.8	6.0	6.4	7.5	9.9	4.7	10.3	8.5	10.2	10.0	7.3	10.1	4.3	4.9	9.8	4.1	3.7	6.3	3.1	11.2	5.3	11.9	5.7	10.6	9.7	16.6	15.9	9.5	11.0	8.5	9.8	3.1	14.4	5.7	9.8	4.1	10.5	13.8	13.5	13.7	11.6	9.2	11.5	7.1	8.3	6.8	18.1	12.4	8.6	9.7	11.0	12.8	7.8	8.1	7.0	16.8	4.7	8.4	8.3	13.1	6.0	12.9	8.2	20.1	8.0	7.1	9.4	6.2	15.4	12.9	7.0	9.7	13.0	9.3	8.3	12.2	5.4	7.8	6.1	7.1	9.8	9.1	5.9	15.0	21.4	3.0	11.2	6.5	9.8	3.9	2.6	4.1	4.1	5.5	4.3	4.5	4.3	4.9	2.6	6.3	3.9	2.6	3.7	4.0	1.8	4.7	3.1	7.1	14.6	8.6	13.6	8.9	7.1	6.2	10.4	12.3	4.7	0.0	8.6	0.0	1.6	1.5	5.6	8.7	2.5	9.4	9.1	5.2	5.9	8.2	1.7	4.3	5.3	2.9	2.7	0.0	4.0	7.9	3.1	1.0	4.7	10.2	2.7	3.2	4.1	3.1	1.2	3.1	3.4	1.7	3.3	0.0	5.7	2.5	3.6	0.0	4.6	2.7	6.8	6.5	2.1	6.7	9.8	2.6	6.2	1.7	4.9	0.8
POLRMT	"APOLMT, h-mtRPOL, MTRNAP, MTRPOL"	ENSG00000099821	"RNA polymerase mitochondrial"	O00411	19	617224-633604	"Enzymes, Predicted intracellular proteins"	Transcription	"Nucleotidyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Late spermatids: 63.9;Spermatogonia: 84.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA006366	Uncertain		Supported	Mitochondria		NA	NA			Mitochondria		"HPA006366: AB_1079654"	"unprognostic (3.24e-1)"	"unprognostic (4.31e-2)"	"unprognostic (7.96e-2)"	"prognostic favorable (4.50e-4)"	"unprognostic (9.46e-2)"	"unprognostic (2.94e-2)"	"unprognostic (3.04e-2)"	"unprognostic (9.41e-2)"	"unprognostic (1.45e-1)"	"unprognostic (3.48e-1)"	"unprognostic (7.64e-3)"	"unprognostic (1.81e-2)"	"unprognostic (1.62e-1)"	"unprognostic (1.28e-3)"	"unprognostic (1.66e-1)"	"unprognostic (2.92e-1)"	"unprognostic (1.01e-1)"	10.2	10.7	10.1	16.3	11.9	6.9	8.1	12.1	20.7	9.5	11.6	12.3	4.4	16.7	9.8	12.2	14.4	8.7	12.7	24.7	11.5	8.9	12.9	21.4	7.3	11.8	9.4	15.1	10.1	15.9	9.5	10.7	6.2	9.7	10.2	8.8	8.5	9.6	11.7	42.2	16.7	12.8	10.8	8.4	12.8	11.2	32.1	6.3	11.6	11.1	8.6	10.4	10.1	7.8	8.2	7.3	3.1	5.5	7.5	9.0	5.3	10.5	19.1	4.4	19.2	9.2	5.2	16.1	4.9	5.9	7.4	6.7	19.2	7.3	10.8	10.1	4.5	3.7	10.9	16.2	9.4	5.5	12.1	38.5	8.4	11.9	24.6	9.6	14.2	16.1	5.0	13.3	7.5	9.1	5.3	10.3	15.2	15.8	10.9	6.7	14.9	18.8	19.5	17.4	13.8	13.4	18.2	6.0	18.5	9.7	9.0	14.0	10.0	4.5	12.2	12.3	4.9	6.9	13.0	6.1	8.0	10.2	12.5	14.5	25.9	21.3	16.5	17.1	11.9	9.7	0.0	3.7	3.1	9.0	5.2	7.1	7.8	6.7	6.6	7.3	8.2	5.7	6.3	0.6	7.5	5.5	7.2	4.1	5.3	10.1	11.9	12.1	20.7	11.5	8.9	9.4	15.1	9.7	6.3	11.9	14.4	8.8	5.0	7.1	17.9	15.6	10.2	4.0	9.1	15.7	17.7	13.3	6.6	5.3	31.3	7.1	22.6	0.0	6.7	7.0	6.0	5.1	12.7	22.5	9.2	11.1	12.5	8.6	7.9	63.9	11.5	9.2	10.1	3.6	12.0	7.8	5.6	11.5	12.4	14.6	15.8	6.5	9.9	30.7	84.7	6.4	6.4	8.7	19.1	5.4
POMGNT2	"AGO61, C3orf39, FLJ14566, GTDC2"	ENSG00000144647	"Protein O-linked mannose N-acetylglucosaminyltransferase 2 (beta 1,4-)"	Q8NAT1	3	43079232-43106076	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		"Glycosyltransferase, Transferase"	"Congenital muscular dystrophy, Disease mutation, Dystroglycanopathy, Limb-girdle muscular dystrophy, Lissencephaly"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Peritubular cells: 27.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA034870, HPA040989"	Uncertain				"Intracellular and membrane"	NA	NA					"HPA034870: AB_10602701, HPA040989: AB_2677238"	"unprognostic (2.37e-3)"	"unprognostic (8.22e-2)"	"prognostic favorable (8.13e-5)"	"unprognostic (2.57e-2)"	"unprognostic (4.17e-2)"	"unprognostic (1.96e-1)"	"prognostic unfavorable (1.26e-5)"	"unprognostic (8.71e-2)"	"unprognostic (1.73e-2)"	"unprognostic (7.43e-2)"	"unprognostic (1.95e-2)"	"unprognostic (4.01e-1)"	"prognostic favorable (4.00e-7)"	"unprognostic (4.98e-2)"	"unprognostic (1.55e-1)"	"unprognostic (3.26e-1)"	"unprognostic (2.57e-1)"	8.4	12.7	13.9	4.1	20.2	16.6	6.8	28.4	32.7	14.2	7.1	13.1	6.2	3.8	28.2	12.0	7.9	21.7	10.3	15.6	12.5	13.2	7.8	6.8	7.3	2.9	10.6	12.3	21.1	14.7	14.0	10.6	5.6	13.5	10.6	3.2	11.1	13.5	15.8	15.0	7.2	4.1	20.1	7.3	4.4	7.4	9.1	8.8	4.4	10.6	3.4	3.4	7.6	7.6	2.9	1.2	1.0	0.9	1.6	5.7	1.8	11.4	8.7	5.1	15.5	19.6	5.1	8.1	3.3	5.9	11.8	13.8	10.6	8.1	0.0	12.5	5.9	14.2	0.2	8.3	9.6	5.1	0.0	23.2	8.0	6.9	10.0	7.5	5.6	9.6	5.8	7.1	7.9	4.6	4.6	4.5	17.5	6.6	0.0	4.5	6.7	10.2	1.4	11.2	7.2	16.5	4.0	3.6	7.1	6.9	8.4	8.0	7.3	6.9	5.6	6.2	3.6	10.6	4.9	2.1	9.5	13.4	14.0	13.4	8.7	12.9	0.1	12.2	11.4	10.0	0.0	0.9	1.0	5.7	0.8	5.1	2.9	3.8	3.8	1.1	1.9	4.9	3.8	0.0	1.6	0.8	1.2	2.9	1.8	13.9	20.2	28.4	32.7	12.5	13.2	10.6	12.3	13.5	8.8	3.0	1.3	0.8	2.6	7.1	14.0	13.2	12.7	6.7	2.3	14.0	7.9	2.9	5.0	8.7	8.2	2.8	1.6	0.0	9.5	4.8	10.3	3.4	0.0	5.6	5.3	9.5	5.8	6.2	3.1	19.8	18.4	2.2	5.0	0.0	1.8	8.7	5.0	2.0	27.6	5.3	4.3	12.9	7.5	7.1	18.3	10.2	1.5	2.5	2.3	1.8
POMK	"FLJ23356, SgK196"	ENSG00000185900	"Protein-O-mannose kinase"	Q9H5K3	8	43093506-43123434	"Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins"		"Kinase, Transferase"	"Congenital muscular dystrophy, Disease mutation, Dystroglycanopathy, Limb-girdle muscular dystrophy, Lissencephaly"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"	8	"Bipolar cells: 1.4;Club cells: 2.3;Melanocytes: 1.7;monocytes: 1.8;Spermatogonia: 1.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA013321	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA013321: AB_2668809"	"unprognostic (1.66e-2)"	"unprognostic (1.12e-2)"	"unprognostic (1.27e-1)"	"unprognostic (4.37e-2)"	"unprognostic (1.29e-1)"	"unprognostic (4.62e-2)"	"unprognostic (5.56e-2)"	"unprognostic (2.42e-1)"	"unprognostic (2.50e-1)"	"unprognostic (8.10e-2)"	"unprognostic (1.23e-3)"	"unprognostic (1.03e-1)"	"unprognostic (2.32e-1)"	"unprognostic (7.09e-2)"	"unprognostic (1.06e-1)"	"unprognostic (3.71e-3)"	"unprognostic (2.10e-2)"	4.7	5.5	9.8	5.6	14.3	12.5	5.1	12.3	18.6	6.9	4.8	8.3	2.2	4.5	6.9	4.4	7.1	6.2	4.8	3.8	7.7	7.0	3.4	4.5	5.5	6.0	4.8	11.1	5.8	9.3	6.3	7.4	6.1	10.5	5.6	5.9	6.1	6.8	4.0	6.2	7.1	5.6	6.4	6.7	7.6	6.8	7.1	7.2	7.5	7.4	3.2	7.4	4.6	5.0	2.6	2.6	6.7	2.9	1.0	3.3	1.3	3.5	7.6	5.8	15.2	2.8	3.5	5.5	2.1	3.2	5.5	4.1	5.5	9.2	5.0	4.7	3.8	2.3	5.9	8.3	6.4	5.4	1.9	1.4	14.0	5.6	2.5	2.0	4.7	7.9	3.8	2.7	7.4	5.3	1.7	5.4	7.1	3.3	14.9	3.7	1.6	10.0	2.0	11.9	2.1	1.0	6.8	6.8	2.9	1.5	9.9	5.6	4.2	9.1	3.2	3.0	4.4	9.8	3.3	7.5	8.4	8.5	8.7	4.2	4.9	8.6	9.4	3.6	3.2	10.0	0.8	2.9	1.9	2.3	2.4	3.3	1.8	1.3	1.3	2.6	2.6	1.8	2.3	6.7	1.0	1.5	2.5	1.1	1.3	9.8	14.3	12.3	18.6	7.7	7.0	4.8	11.1	10.5	7.2	0.0	0.3	0.0	0.1	0.3	1.4	0.3	0.0	0.0	2.3	0.0	0.0	0.3	0.0	0.2	0.0	0.0	0.4	0.0	0.0	0.7	0.3	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.6	0.0	1.7	1.8	0.0	0.5	0.3	0.0	0.0	0.0	0.8	0.0	0.1	0.4	1.4	0.1	0.5	0.0	0.2	0.1
POMT1	LGMD2K	ENSG00000130714	"Protein O-mannosyltransferase 1"	Q9Y6A1	9	131502902-131523806	"Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins"		"Glycosyltransferase, Transferase"	"Congenital muscular dystrophy, Disease mutation, Dystroglycanopathy, Limb-girdle muscular dystrophy, Lissencephaly"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Early spermatids: 49.7;Spermatocytes: 57.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA065252			Uncertain	"Golgi apparatus"		NA	NA			"Golgi apparatus"		"HPA065252: AB_2685445"	"unprognostic (2.00e-3)"	"unprognostic (2.02e-1)"	"unprognostic (1.60e-1)"	"unprognostic (5.09e-3)"	"unprognostic (1.67e-1)"	"unprognostic (7.97e-2)"	"unprognostic (5.35e-3)"	"unprognostic (1.14e-1)"	"unprognostic (9.76e-3)"	"unprognostic (2.84e-1)"	"prognostic favorable (3.90e-5)"	"unprognostic (8.36e-2)"	"prognostic favorable (4.68e-5)"	"unprognostic (2.41e-2)"	"unprognostic (1.61e-1)"	"unprognostic (4.72e-2)"	"unprognostic (2.12e-1)"	9.5	12.3	21.6	10.6	18.8	10.2	10.2	34.2	22.4	10.0	12.1	16.9	14.6	11.2	15.0	14.6	8.8	14.6	13.0	15.2	25.8	17.9	13.8	12.8	10.6	13.2	15.0	16.5	17.2	16.9	17.1	18.0	12.9	15.2	16.0	11.6	13.3	19.5	17.1	28.2	16.6	11.9	12.1	13.4	12.3	10.7	49.9	13.4	8.7	11.6	5.5	11.0	7.8	9.5	2.8	5.1	3.4	3.8	3.8	10.8	4.9	6.7	10.8	9.9	16.6	12.7	10.3	17.8	7.8	9.7	12.5	8.6	11.4	9.5	2.1	9.5	18.0	5.7	15.3	12.1	8.5	6.6	11.1	17.2	3.9	25.5	7.9	15.0	10.0	8.7	7.2	7.7	8.3	2.8	14.8	10.8	13.8	6.8	11.5	12.5	18.0	9.4	22.9	5.7	5.6	13.6	10.9	9.3	16.1	11.0	2.0	11.2	9.9	13.3	15.5	7.8	6.7	22.7	10.1	11.7	9.9	2.1	17.9	6.6	7.2	6.2	3.5	5.9	18.8	8.1	0.0	3.8	3.4	7.4	3.6	10.8	2.8	7.2	7.4	5.1	2.7	6.7	5.5	0.5	3.8	3.3	3.1	7.6	4.9	21.6	18.8	34.2	22.4	25.8	17.9	15.0	16.5	15.2	13.4	8.9	20.2	7.3	4.8	3.9	11.9	8.5	10.2	4.0	6.8	12.2	7.9	18.5	1.7	9.9	49.7	7.1	12.3	0.0	5.8	10.1	7.1	5.3	2.3	9.7	9.1	20.6	7.5	6.7	5.3	24.3	8.1	5.7	5.0	10.0	8.2	14.1	7.3	3.5	9.6	9.0	16.9	6.5	6.0	57.0	7.9	2.6	14.6	6.9	8.0	2.0
POMT2	LGMD2N	ENSG00000009830	"Protein O-mannosyltransferase 2"	Q9UKY4	14	77274956-77320884	"Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins"		"Glycosyltransferase, Transferase"	"Congenital muscular dystrophy, Dystroglycanopathy, Limb-girdle muscular dystrophy, Lissencephaly"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003663	Uncertain		Approved	Nucleoplasm,Nucleoli,Cytosol		NA	NA			Nucleoplasm	"Nucleoli, Cytosol"	"HPA003663: AB_1079655"	"unprognostic (2.15e-1)"	"unprognostic (1.07e-2)"	"unprognostic (7.92e-2)"	"unprognostic (3.37e-2)"	"unprognostic (1.48e-1)"	"unprognostic (1.31e-1)"	"prognostic unfavorable (2.40e-4)"	"unprognostic (7.10e-3)"	"unprognostic (1.17e-1)"	"unprognostic (1.68e-1)"	"unprognostic (6.89e-3)"	"unprognostic (1.94e-3)"	"unprognostic (8.50e-3)"	"unprognostic (1.37e-1)"	"unprognostic (2.44e-1)"	"unprognostic (6.75e-3)"	"unprognostic (3.46e-2)"	6.7	10.8	10.4	6.8	11.4	3.8	7.7	12.5	13.3	6.8	6.3	18.0	9.8	4.6	6.9	17.1	5.7	8.7	6.9	7.7	9.3	7.7	8.1	8.3	6.2	3.0	11.7	6.2	7.6	10.6	14.7	16.1	11.4	9.7	7.3	5.8	8.2	10.1	12.3	17.0	4.3	4.6	7.8	8.4	5.2	5.6	30.9	14.4	2.5	11.5	4.9	3.8	5.7	5.0	1.4	1.9	0.8	1.9	0.0	1.7	0.4	10.4	13.4	13.0	14.7	9.3	7.5	10.4	9.2	7.6	13.8	11.8	6.6	9.4	3.1	7.5	8.6	19.1	11.7	6.1	9.2	9.6	4.6	8.3	1.9	6.6	5.4	11.4	2.1	6.3	7.6	9.8	12.9	12.6	9.6	8.0	3.1	4.9	7.3	9.0	20.6	3.6	10.1	3.7	14.5	11.3	3.5	12.7	2.8	14.3	7.7	11.0	10.8	6.0	10.2	7.7	8.9	10.5	4.4	6.6	10.4	16.4	12.0	8.0	4.8	9.4	1.4	5.3	3.2	9.1	0.0	0.4	0.0	1.7	1.9	0.4	1.4	0.0	0.3	0.9	0.2	0.1	0.0	0.8	0.0	0.8	1.9	0.0	0.4	10.4	11.4	12.5	13.3	9.3	7.7	11.7	6.2	9.7	14.4	6.0	3.2	2.2	2.3	2.7	6.5	4.0	5.1	0.0	0.0	1.8	15.7	5.0	0.0	6.6	8.0	2.8	3.9	0.0	6.4	8.6	6.0	3.5	2.3	4.4	4.8	7.9	17.2	3.1	2.4	12.1	1.7	2.2	1.7	3.6	3.0	8.2	5.8	1.9	3.9	3.0	15.0	0.0	3.9	9.8	8.5	1.6	4.8	0.0	2.6	1.4
PON1	"ESA, PON"	ENSG00000005421	"Paraoxonase 1"	P27169	7	95297676-95324707	"Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted secreted proteins, Transporters"		Hydrolase	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	23	"liver: 144.1"	"Cell type enriched"	"Detected in some"	47	"Hepatocytes: 399.2"	"Cancer enriched"	"Detected in some"	78	"liver cancer: 97.8"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"NK-cell: 1.0"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"A549: 1.5;HeLa: 1.0;RH-30: 1.0;U-266/70: 1.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			HPA001610	Approved				"Secreted to blood"	NA	NA	96000000000	24000000000			"HPA001610: AB_1079656"	"unprognostic (2.02e-2)"	"unprognostic (2.41e-2)"	"unprognostic (3.04e-1)"	"unprognostic (3.54e-2)"	"unprognostic (2.70e-1)"		"prognostic favorable (7.24e-7)"	"unprognostic (2.24e-1)"	"unprognostic (1.95e-1)"	"unprognostic (9.02e-3)"	"unprognostic (1.76e-3)"	"unprognostic (3.97e-2)"	"unprognostic (6.74e-9)"	"unprognostic (1.09e-3)"	"unprognostic (2.29e-2)"	"unprognostic (2.07e-1)"	"unprognostic (5.54e-3)"	0.0	1.7	0.2	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.1	0.0	144.1	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.3	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	6.1	0.0	0.0	0.0	0.0	0.0	0.1	0.5	0.6	0.0	1.0	0.1	0.0	0.0	1.5	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.6	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	1.0	0.6	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.4	0.4	0.0	0.2	0.0	1.0	0.0	0.0	0.3	0.6	0.1	0.0	0.3	0.0	0.2	0.4	0.0	0.5	0.0	0.1	0.0	0.2	1.0	0.3	0.0	0.0	0.2	0.3	0.6	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	1.0	0.0	0.5	0.0	0.0	0.2	0.1	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.4	7.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.1	0.6	0.0	399.2	0.0	0.0	2.9	8.0	8.6	0.0	0.6	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.4	0.0	0.1	0.0	0.0	0.0	0.0
PON2		ENSG00000105854	"Paraoxonase 2"	Q15165	7	95404863-95435329	"Candidate cardiovascular disease genes, Enzymes, Predicted intracellular proteins, Predicted secreted proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 81.0"	"Cell type enhanced"	"Detected in many"	5	"Extravillous trophoblasts: 257.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	4	"myeloid DC: 22.1"	"Lineage enriched"	"Detected in many"	4	"dendritic cells: 22.1"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB025430, HPA029193"	Enhanced				"Secreted to blood"	NA	NA		350000000			"CAB025430: , HPA029193: AB_10602148"	"unprognostic (1.43e-1)"	"prognostic unfavorable (1.43e-5)"	"unprognostic (3.80e-1)"	"unprognostic (4.14e-1)"	"unprognostic (3.89e-2)"	"unprognostic (3.77e-3)"	"unprognostic (1.19e-3)"	"unprognostic (9.87e-3)"	"unprognostic (9.54e-2)"	"unprognostic (2.53e-1)"	"unprognostic (1.58e-2)"	"unprognostic (2.80e-1)"	"prognostic unfavorable (4.30e-8)"	"unprognostic (1.40e-1)"	"unprognostic (6.43e-2)"	"unprognostic (7.99e-3)"	"unprognostic (2.56e-1)"	17.0	42.2	54.1	7.5	59.1	3.3	23.1	25.4	52.2	16.5	24.0	29.7	7.4	28.2	16.6	22.7	10.2	15.0	18.9	13.1	57.2	31.4	23.9	81.0	33.1	4.5	41.4	31.0	10.6	7.2	10.9	15.0	34.3	34.8	14.7	31.1	9.9	8.5	17.2	4.3	19.4	19.1	18.4	44.2	7.3	8.8	9.6	40.1	1.8	13.6	5.1	11.2	13.7	8.1	0.9	22.1	0.5	5.2	5.0	3.5	3.0	9.6	60.7	49.4	26.7	6.9	15.3	13.9	19.8	23.2	15.4	16.8	13.7	22.2	0.0	27.8	19.5	29.6	6.5	9.0	15.2	17.6	0.1	11.8	4.9	36.5	45.2	11.0	0.0	6.8	22.1	17.6	8.3	11.3	31.6	31.9	0.0	3.2	0.2	45.4	8.8	0.0	5.4	9.7	25.9	14.1	0.0	23.3	2.3	47.7	7.6	3.4	10.6	28.2	31.5	19.0	29.8	9.3	3.2	34.7	23.2	16.9	7.8	19.0	5.2	6.0	0.0	21.7	4.5	30.2	0.0	5.2	0.5	3.5	2.6	3.1	0.9	1.3	3.2	22.1	0.4	1.9	2.4	0.0	5.0	1.2	5.3	0.6	3.0	54.1	59.1	25.4	34.3	57.2	31.4	41.4	31.0	34.8	40.1	119.1	85.8	10.2	37.2	14.9	3.9	25.4	71.4	37.5	67.1	80.3	0.0	66.3	8.3	132.9	1.4	51.7	71.3	70.0	44.3	257.9	23.1	23.4	13.9	127.1	35.6	36.5	12.1	36.8	21.8	2.0	15.0	30.4	106.3	20.8	37.6	174.2	71.8	87.7	20.5	39.6	7.9	19.4	40.1	1.9	5.5	14.1	42.1	9.2	65.6	18.4
PON3		ENSG00000105852	"Paraoxonase 3"	Q15166	7	95359944-95396368	"Candidate cardiovascular disease genes, Enzymes, Plasma proteins, Predicted secreted proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	7	"liver: 148.0"	"Cell type enriched"	"Detected in many"	14	"Hepatocytes: 460.4"	"Group enriched"	"Detected in many"	9	"liver cancer: 30.8;lung cancer: 7.8"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	12	"NK-cell: 1.1"	"Lineage enriched"	"Detected in single"	12	"NK-cells: 1.1"	"Cell line enhanced"	"Detected in some"		"A549: 20.2;CACO-2: 6.5;CAPAN-2: 4.9;Hep G2: 22.4;T-47d: 12.6"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"HPA014848, CAB025250"	Enhanced				"Secreted to blood"	NA	NA	1760000000	350000000			"CAB025250: , HPA014848: AB_1855540"	"unprognostic (2.67e-1)"	"unprognostic (1.03e-1)"	"unprognostic (6.28e-3)"	"unprognostic (5.52e-3)"	"unprognostic (1.36e-1)"	"unprognostic (4.87e-1)"	"unprognostic (1.44e-3)"	"unprognostic (6.32e-2)"	"unprognostic (1.11e-1)"	"unprognostic (6.44e-3)"	"unprognostic (9.14e-2)"	"unprognostic (7.18e-3)"	"unprognostic (8.30e-9)"	"unprognostic (1.66e-1)"	"unprognostic (1.04e-2)"	"unprognostic (8.29e-2)"	"unprognostic (5.12e-2)"	0.4	0.7	0.3	0.1	0.6	0.0	6.9	0.2	0.5	0.9	1.0	0.3	2.3	1.5	0.2	1.2	0.2	0.4	0.7	0.4	0.7	0.3	0.7	148.0	4.0	0.0	0.4	0.2	2.4	7.1	0.0	15.5	0.2	0.5	0.2	0.4	0.8	21.4	5.5	0.1	1.8	1.7	0.1	0.3	0.2	0.5	3.6	0.4	0.4	1.5	0.0	1.1	0.5	0.3	0.0	0.0	0.0	0.0	1.1	0.0	0.0	2.2	20.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.5	4.9	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	22.4	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	3.9	0.0	0.0	12.6	0.0	0.0	0.0	0.1	0.0	0.0	1.3	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.3	0.6	0.2	0.5	0.7	0.3	0.4	0.2	0.5	0.4	6.0	32.1	1.4	0.7	0.8	0.0	0.3	25.5	8.1	14.8	3.5	0.0	1.5	1.7	0.2	9.0	0.5	4.0	0.0	1.8	1.9	2.6	2.2	0.0	460.4	0.2	0.0	0.0	8.6	7.0	3.6	7.5	0.0	13.5	0.0	2.3	3.0	1.5	0.0	2.8	5.2	0.0	0.0	0.1	17.7	13.6	1.1	1.1	0.5	2.3	0.3
POP1		ENSG00000104356	"POP1 homolog, ribonuclease P/MRP subunit"	Q99575	8	98117297-98159834	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"tRNA processing"	"Hydrolase, RNA-binding"	"Disease mutation, Dwarfism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Spermatogonia: 15.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA066194			Supported	Nucleoli		NA	NA			Nucleoli		"HPA066194: AB_2732742"	"prognostic unfavorable (2.54e-4)"	"unprognostic (9.42e-2)"	"unprognostic (5.96e-3)"	"unprognostic (3.31e-2)"	"unprognostic (1.46e-1)"	"unprognostic (7.46e-2)"	"prognostic unfavorable (1.26e-6)"	"prognostic unfavorable (9.88e-4)"	"unprognostic (4.85e-1)"	"unprognostic (1.47e-1)"	"unprognostic (3.79e-1)"	"unprognostic (1.39e-2)"	"prognostic unfavorable (5.97e-4)"	"unprognostic (1.81e-2)"	"unprognostic (1.25e-1)"	"unprognostic (1.34e-1)"	"unprognostic (2.96e-1)"	6.1	5.5	7.8	9.0	9.7	3.7	5.8	14.3	10.2	4.3	5.4	5.2	2.7	4.3	6.0	4.2	9.1	6.6	3.9	5.0	5.7	4.7	10.5	6.4	5.2	9.1	4.1	7.6	8.4	5.8	7.6	11.1	3.5	7.4	5.0	13.8	6.2	5.1	4.2	5.7	8.2	5.1	5.2	4.0	8.8	5.7	11.8	6.2	8.8	5.0	5.6	11.3	4.3	5.0	10.5	7.7	10.9	7.4	4.1	9.8	2.5	12.7	7.7	8.4	7.7	2.9	2.1	5.6	10.9	9.2	11.4	8.5	7.9	8.3	9.0	15.8	7.9	5.5	8.5	24.2	10.8	12.3	6.5	10.2	17.8	6.1	5.3	1.3	9.4	11.3	1.8	2.0	12.6	5.0	3.5	8.9	4.3	9.7	8.1	10.7	10.1	13.6	4.8	6.3	14.9	10.6	11.3	4.9	6.5	8.3	6.8	20.0	4.7	5.0	8.6	3.8	5.0	11.6	3.5	12.0	10.0	7.2	12.6	21.6	8.1	7.6	19.3	7.9	10.2	8.8	10.9	6.7	4.6	9.8	7.4	7.8	6.2	7.1	6.5	6.2	10.5	9.3	8.6	0.9	4.1	3.4	7.7	5.9	2.5	7.8	9.7	14.3	10.2	5.7	4.7	4.1	7.6	7.4	6.2	3.0	3.8	5.1	4.8	3.3	7.8	2.8	0.0	2.7	4.5	5.2	0.0	3.2	5.0	9.5	9.8	2.9	1.3	0.0	5.0	2.8	2.7	3.5	1.1	5.5	3.0	1.6	0.0	3.1	1.6	1.8	4.9	3.2	0.0	9.0	1.6	3.1	6.4	0.0	4.2	7.8	9.6	6.5	2.7	3.9	15.7	2.0	2.5	1.9	2.7	3.9
POP4	RPP29	ENSG00000105171	"POP4 homolog, ribonuclease P/MRP subunit"	O95707	19	29604017-29617237	"Enzymes, Predicted intracellular proteins"	"tRNA processing"	"Hydrolase, RNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042748	Approved					NA	NA					"HPA042748: AB_10964774"	"unprognostic (5.88e-2)"	"unprognostic (2.78e-2)"	"unprognostic (7.21e-2)"	"unprognostic (4.00e-3)"	"unprognostic (4.50e-2)"	"unprognostic (5.73e-2)"	"prognostic unfavorable (3.31e-4)"	"unprognostic (8.35e-2)"	"unprognostic (2.37e-2)"	"unprognostic (1.26e-1)"	"unprognostic (2.20e-2)"	"unprognostic (9.47e-2)"	"unprognostic (5.84e-2)"	"unprognostic (4.21e-1)"	"unprognostic (1.77e-2)"	"unprognostic (5.23e-3)"	"unprognostic (8.08e-3)"	23.7	17.1	14.6	14.5	15.8	13.6	11.1	14.1	18.9	8.9	19.4	14.0	10.5	13.8	15.5	11.8	15.1	12.1	9.5	17.7	13.8	12.8	21.0	22.9	10.4	12.7	14.7	14.4	11.0	15.7	10.6	10.0	15.2	14.7	12.8	7.7	13.6	17.3	10.6	29.1	12.2	17.1	11.0	15.1	15.7	15.3	17.2	8.0	17.8	18.0	16.2	16.3	11.6	10.0	28.9	27.0	35.3	34.2	23.3	35.2	26.9	17.2	30.5	3.0	2.4	4.0	2.1	11.7	16.3	2.1	4.9	5.0	13.6	4.4	14.8	28.7	3.4	4.3	8.1	4.5	5.2	1.9	32.8	28.3	17.3	9.9	8.4	4.2	19.7	9.1	2.3	3.4	3.7	2.0	2.3	3.9	8.0	15.0	4.2	3.7	18.0	11.7	3.9	4.9	6.6	16.2	7.9	20.3	7.5	2.6	7.9	7.1	7.0	16.9	7.8	8.1	2.3	6.9	5.7	11.6	6.2	18.7	9.5	14.2	14.1	26.4	18.2	7.4	11.0	5.8	35.3	27.0	26.4	26.7	34.2	19.0	28.9	25.5	28.4	27.0	23.6	20.9	25.3	16.4	23.3	26.7	22.0	35.2	26.9	14.6	15.8	14.1	18.9	13.8	12.8	14.7	14.4	14.7	8.0	20.8	18.3	33.5	16.7	11.2	15.2	22.6	33.1	28.1	7.9	31.4	7.9	47.6	68.0	46.6	8.6	26.7	32.3	0.0	68.2	37.5	18.2	17.1	25.4	36.5	54.8	11.1	16.7	26.4	26.4	11.8	15.3	28.4	23.6	67.7	24.3	32.5	51.0	24.6	26.5	49.6	9.3	25.8	18.6	37.7	13.7	14.1	39.6	21.9	25.3	15.2
POP5		ENSG00000167272	"POP5 homolog, ribonuclease P/MRP subunit"	Q969H6	12	120578764-120581398	"Enzymes, Predicted intracellular proteins"	"rRNA processing, tRNA processing"	"Hydrolase, RNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA047598, HPA069204"	Approved		Approved	Nucleoplasm,Nucleoli		NA	NA			Nucleoplasm	Nucleoli	"HPA047598: AB_2680096, HPA069204: "	"unprognostic (1.50e-2)"	"prognostic favorable (2.68e-5)"	"unprognostic (1.55e-1)"	"unprognostic (3.61e-3)"	"unprognostic (3.81e-1)"	"unprognostic (1.50e-1)"	"unprognostic (4.80e-3)"	"unprognostic (1.28e-1)"	"unprognostic (7.34e-2)"	"unprognostic (5.75e-2)"	"unprognostic (4.13e-2)"	"unprognostic (1.33e-1)"	"prognostic unfavorable (4.85e-4)"	"unprognostic (3.07e-1)"	"unprognostic (6.21e-2)"	"unprognostic (2.68e-1)"	"unprognostic (5.68e-2)"	16.3	33.8	16.2	25.6	14.4	14.1	23.9	8.7	16.7	18.6	17.5	13.6	24.2	11.8	14.5	27.1	15.9	14.6	19.5	25.8	18.1	13.9	24.1	24.1	18.3	19.7	16.9	15.9	11.7	18.9	25.0	17.5	8.2	14.2	15.6	18.0	15.1	20.9	22.6	13.3	12.7	15.1	19.5	14.4	20.3	15.2	9.0	12.1	24.2	19.8	18.9	19.6	13.7	19.2	32.0	33.5	3.6	19.7	18.2	28.2	22.8	20.1	34.6	12.3	15.0	23.4	12.6	19.6	17.0	11.0	20.8	16.0	29.8	9.3	11.9	25.9	13.6	10.9	21.4	20.6	32.4	18.7	28.1	31.2	14.5	22.6	33.7	16.5	20.4	15.2	15.9	18.7	24.0	11.0	11.7	17.3	28.4	17.7	7.7	20.6	44.4	16.6	18.4	14.7	29.3	29.9	19.5	15.1	32.5	29.1	20.8	9.6	10.6	28.8	8.5	21.9	14.6	39.4	19.7	12.5	10.9	16.3	17.3	18.5	19.9	33.5	21.0	21.2	24.9	17.3	3.6	16.2	3.5	24.7	19.7	22.6	32.0	22.6	23.0	19.0	22.4	28.2	26.8	1.1	18.2	16.7	33.5	21.4	22.8	16.2	14.4	8.7	16.7	18.1	13.9	16.9	15.9	14.2	12.1	11.9	25.1	40.9	40.5	17.4	19.6	53.8	40.8	25.4	37.5	73.3	13.7	49.9	131.0	34.2	1.3	26.7	23.2	23.3	38.8	36.9	22.4	23.7	54.2	46.1	46.0	17.5	21.2	23.9	18.3	2.7	33.4	31.2	47.2	27.1	27.7	54.1	31.5	24.6	35.3	99.7	28.3	19.4	28.8	19.1	33.4	21.7	14.8	37.4	37.5	25.7
POP7	"RPP2, RPP20"	ENSG00000172336	"POP7 homolog, ribonuclease P/MRP subunit"	O75817	7	100706053-100707495	"Enzymes, Predicted intracellular proteins"	"rRNA processing, tRNA processing"	"Hydrolase, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA021007	Uncertain		Supported	Nucleoli,Vesicles		NA	NA			"Nucleoli, Vesicles"		"HPA021007: AB_10963575"	"unprognostic (3.19e-1)"	"unprognostic (2.45e-2)"	"unprognostic (2.72e-2)"	"unprognostic (1.80e-3)"	"unprognostic (6.47e-2)"	"unprognostic (1.04e-1)"	"prognostic unfavorable (4.99e-5)"	"unprognostic (2.98e-2)"	"unprognostic (2.28e-1)"	"unprognostic (3.12e-2)"	"unprognostic (9.50e-2)"	"unprognostic (3.88e-1)"	"prognostic unfavorable (6.02e-4)"	"unprognostic (1.05e-2)"	"unprognostic (1.44e-1)"	"unprognostic (6.21e-2)"	"unprognostic (6.73e-2)"	12.3	16.6	20.5	15.1	21.0	25.3	16.1	25.1	33.2	11.3	14.7	8.7	14.0	17.5	13.9	12.5	20.4	13.4	13.9	19.6	18.3	18.1	13.1	31.4	11.7	18.2	16.8	22.0	13.2	21.2	6.6	11.5	18.1	13.3	16.0	8.1	10.0	24.2	15.8	46.4	22.6	17.6	12.3	12.9	12.3	15.5	7.0	9.4	11.0	11.6	20.5	11.8	11.5	12.5	32.1	30.4	46.4	35.6	42.1	37.0	32.0	24.6	24.6	9.9	17.5	5.3	5.1	19.5	14.0	6.6	15.6	15.5	35.9	16.0	20.0	23.6	6.1	17.2	15.7	14.5	16.5	7.7	18.2	43.9	9.0	16.0	34.4	9.0	13.8	11.1	5.9	6.2	15.9	15.7	4.4	8.6	14.3	31.9	17.9	8.1	70.0	34.6	47.3	30.5	15.7	34.0	26.2	10.5	34.0	9.3	13.6	20.0	20.3	11.3	34.9	16.6	9.3	11.5	14.0	8.4	21.6	26.0	42.4	27.5	7.6	20.6	35.9	13.6	23.9	23.4	46.4	35.6	38.2	32.4	34.1	29.4	32.1	32.5	31.6	30.4	26.4	29.9	31.1	21.9	42.1	35.3	27.9	37.0	32.0	20.5	21.0	25.1	33.2	18.3	18.1	16.8	22.0	13.3	9.4	17.9	14.2	18.6	25.5	93.3	23.7	23.0	33.1	25.4	10.3	33.2	5.9	127.6	79.6	64.3	1.9	39.5	51.5	70.0	76.1	144.7	43.7	49.5	17.3	88.3	57.5	30.2	38.6	28.8	23.7	5.6	38.9	27.4	54.0	41.5	44.2	33.8	71.6	45.0	35.0	66.2	18.4	45.3	39.1	7.5	43.1	104.3	116.5	27.4	49.7	41.7
POR	"CYPOR, FLJ26468"	ENSG00000127948	"Cytochrome p450 oxidoreductase"	P16435	7	75899200-75986855	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"		Oxidoreductase	"Congenital adrenal hyperplasia, Craniosynostosis, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 78.4"	"Cell type enhanced"	"Detected in many"	9	"Hepatocytes: 443.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"SK-BR-3: 74.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004372, HPA010136"	Enhanced		Approved	Nucleoplasm,Vesicles,Cytosol		NA	NA			"Nucleoplasm, Vesicles"	Cytosol	"CAB004372: AB_627391, HPA010136: AB_1079657"	"unprognostic (1.89e-1)"	"unprognostic (1.53e-1)"	"unprognostic (2.81e-3)"	"unprognostic (8.67e-2)"	"prognostic unfavorable (8.54e-4)"	"unprognostic (1.65e-1)"	"unprognostic (1.17e-2)"	"unprognostic (4.32e-2)"	"unprognostic (1.69e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.22e-1)"	"unprognostic (2.58e-1)"	"unprognostic (1.11e-1)"	"unprognostic (9.31e-2)"	"unprognostic (1.71e-1)"	"unprognostic (3.94e-2)"	"unprognostic (9.89e-2)"	12.8	48.2	7.4	7.5	10.8	3.6	15.0	5.3	16.4	11.0	20.8	9.6	32.1	24.9	9.0	8.2	13.4	12.8	9.9	8.4	7.1	7.2	12.0	78.4	13.7	9.9	5.2	10.1	14.4	12.8	12.1	18.5	18.6	7.1	9.3	5.3	10.8	7.8	58.7	13.1	10.0	24.3	7.0	5.2	11.7	9.8	22.4	5.0	8.2	33.3	9.9	8.6	9.8	10.2	5.7	20.6	26.7	18.4	11.2	9.9	13.9	12.8	28.2	12.9	24.0	48.9	18.6	21.6	5.4	17.7	10.2	14.3	21.1	57.3	12.3	5.0	11.7	34.8	6.3	16.9	8.5	4.4	10.5	12.5	5.7	8.3	39.0	34.0	5.7	10.2	38.1	10.7	13.4	9.8	8.2	9.4	6.1	17.0	5.3	9.1	18.9	6.1	10.2	16.1	20.2	16.0	8.8	8.5	13.2	11.5	15.6	13.5	12.9	14.5	74.1	19.5	7.6	21.2	9.6	8.5	9.6	10.6	14.4	10.6	5.2	8.0	8.4	13.6	8.7	12.3	26.7	18.4	25.3	9.9	17.7	8.3	5.4	8.4	9.2	20.6	5.7	8.4	7.1	24.3	11.2	13.0	5.8	8.7	13.9	7.4	10.8	5.3	16.4	7.1	7.2	5.2	10.1	7.1	5.0	35.7	31.2	12.6	24.7	15.1	30.1	9.3	56.0	78.9	37.5	69.8	11.8	88.1	1.7	55.5	13.2	25.3	144.8	0.0	25.7	71.6	24.8	20.8	24.3	443.8	58.9	14.3	19.0	27.6	38.6	6.1	70.2	40.5	11.8	16.2	29.0	33.2	24.3	119.3	105.7	27.5	21.8	64.7	30.9	14.7	32.6	12.8	161.6	20.0	36.8	40.7
PPA1	"IOPPP, PP, PP1, Ppase, SID6-8061"	ENSG00000180817	"Pyrophosphatase (inorganic) 1"	Q15181	10	70202830-70233911	"Enzymes, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	5	"monocytes: 942.2;Muller glia cells: 982.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019878, HPA020096"	Supported		Supported	Vesicles		NA	NA		110000	Vesicles		"HPA019878: AB_1855601, HPA020096: AB_1855600"	"unprognostic (1.50e-1)"	"unprognostic (2.85e-1)"	"unprognostic (4.71e-2)"	"unprognostic (2.85e-1)"	"unprognostic (1.42e-1)"	"unprognostic (4.47e-2)"	"unprognostic (2.86e-2)"	"unprognostic (9.43e-2)"	"unprognostic (3.34e-1)"	"unprognostic (1.62e-1)"	"unprognostic (2.13e-2)"	"unprognostic (3.60e-2)"	"unprognostic (1.82e-3)"	"unprognostic (5.36e-2)"	"unprognostic (2.37e-1)"	"unprognostic (3.53e-2)"	"unprognostic (2.74e-1)"	46.6	55.5	41.3	36.8	56.0	24.2	88.7	66.8	62.2	34.8	45.7	25.2	43.7	33.2	30.4	59.6	48.6	38.1	31.5	30.0	46.7	54.2	40.7	59.0	39.1	54.6	74.3	47.5	17.9	72.6	23.3	29.5	34.6	60.7	24.4	53.4	26.1	36.8	42.1	37.0	24.6	41.0	32.8	72.7	22.4	32.5	25.1	47.2	20.4	52.0	35.8	44.4	32.7	40.2	21.5	48.9	1.0	17.7	15.5	35.6	25.3	58.1	24.1	21.6	63.7	58.8	51.9	20.3	21.8	41.1	34.2	36.1	73.5	30.9	84.3	19.9	21.7	22.3	47.1	63.2	42.5	35.0	79.2	60.1	23.0	24.4	41.9	37.2	56.7	14.6	34.0	50.9	27.4	73.1	37.6	41.4	42.8	53.7	45.5	32.2	34.1	54.8	53.2	22.5	80.7	67.0	33.6	24.8	49.3	71.4	36.6	65.0	21.9	24.0	94.1	18.6	15.8	23.5	25.5	18.7	9.5	36.2	31.2	41.3	15.0	32.8	61.8	14.7	79.6	8.3	0.0	17.7	0.4	13.3	13.8	35.6	21.5	30.8	23.1	48.9	13.8	34.2	28.9	1.0	15.5	14.5	11.3	30.1	25.3	41.3	56.0	66.8	62.2	46.7	54.2	74.3	47.5	60.7	47.2	208.4	123.3	139.4	261.1	238.0	182.7	75.4	170.7	77.6	178.6	102.9	163.0	265.6	170.8	481.5	21.2	172.8	203.5	23.3	678.8	222.3	156.3	255.5	36.8	132.9	92.5	81.0	156.1	38.1	69.1	22.2	101.5	81.2	172.1	942.2	201.5	982.7	518.3	210.2	110.3	442.0	227.9	64.7	156.5	149.9	174.8	224.7	205.5	113.0	280.4	496.2
PPA2	FLJ20459	ENSG00000138777	"Pyrophosphatase (inorganic) 2"	Q9H2U2	4	105369077-105474081	"Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		Hydrolase	"Cancer-related genes, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030888, HPA031671, HPA031672"	Supported		Approved	Mitochondria		NA	NA		8300	Mitochondria		"HPA030888: AB_2673646, HPA031671: AB_10603986, HPA031672: AB_2673988"	"prognostic unfavorable (2.98e-4)"	"unprognostic (5.64e-2)"	"prognostic favorable (6.60e-4)"	"unprognostic (9.26e-3)"	"unprognostic (2.93e-2)"	"unprognostic (5.10e-2)"	"unprognostic (1.15e-1)"	"unprognostic (2.44e-1)"	"unprognostic (1.50e-1)"	"unprognostic (1.20e-1)"	"unprognostic (7.05e-2)"	"unprognostic (9.54e-2)"	"prognostic favorable (1.27e-11)"	"unprognostic (3.69e-1)"	"unprognostic (1.94e-1)"	"unprognostic (2.00e-1)"	"unprognostic (1.10e-1)"	9.2	18.0	18.4	17.2	15.4	24.0	20.6	12.3	17.6	10.2	19.8	9.3	20.3	18.1	13.3	20.7	14.8	10.7	18.7	42.5	15.6	15.3	23.7	21.2	23.1	34.8	17.2	12.1	9.5	25.0	10.4	15.0	9.3	15.4	16.1	16.7	12.6	21.4	26.8	29.6	15.0	16.8	22.8	12.4	12.1	15.0	9.7	10.7	9.4	14.3	28.2	10.6	12.2	9.5	20.0	35.3	14.7	20.8	22.0	17.0	14.6	11.4	5.4	10.6	18.0	6.8	5.4	7.7	6.5	8.5	8.0	5.7	12.1	16.8	9.4	8.6	5.2	6.4	5.7	21.2	10.3	9.4	13.3	7.6	8.4	8.8	11.0	5.3	19.9	8.2	5.2	10.6	5.5	4.3	9.1	7.6	16.5	14.0	13.0	7.2	14.5	17.0	14.4	7.7	22.3	18.5	15.1	6.5	9.3	26.3	8.8	11.0	6.5	4.4	26.6	9.4	6.5	13.9	16.3	4.0	5.7	11.2	6.2	11.2	11.5	14.5	9.8	10.1	10.8	7.7	14.7	15.0	9.7	15.3	20.8	13.3	20.0	16.0	16.2	35.3	16.6	15.5	17.0	6.4	22.0	16.2	17.7	15.9	14.6	18.4	15.4	12.3	17.6	15.6	15.3	17.2	12.1	15.4	10.7	8.9	50.5	30.0	71.8	44.4	30.3	55.7	53.5	57.6	43.3	31.4	15.7	106.7	223.8	100.3	91.0	35.1	73.1	23.3	104.8	78.8	31.9	70.3	43.9	59.7	73.9	20.6	63.1	23.4	36.7	95.8	25.6	65.5	72.6	46.9	86.9	28.4	66.2	97.6	30.4	222.1	16.9	38.8	49.5	16.1	9.4	50.4	70.8	45.8	109.9	75.5
PPAT	"GPAT, PRAT"	ENSG00000128059	"Phosphoribosyl pyrophosphate amidotransferase"	Q06203	4	56393362-56435615	"Enzymes, Predicted intracellular proteins"	"Purine biosynthesis"	"Allosteric enzyme, Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Horizontal cells: 36.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036091, HPA036092"	Approved		Approved	"Midbody ring"		Yes	No			"Midbody ring"		"HPA036091: AB_2674936, HPA036092: AB_10603132"	"unprognostic (5.11e-2)"	"unprognostic (5.13e-2)"	"unprognostic (1.39e-2)"	"prognostic unfavorable (5.15e-5)"	"unprognostic (1.38e-1)"	"unprognostic (4.37e-3)"	"prognostic unfavorable (1.14e-8)"	"unprognostic (6.74e-3)"	"unprognostic (2.95e-2)"	"unprognostic (3.79e-2)"	"unprognostic (2.88e-3)"	"unprognostic (1.51e-1)"	"prognostic unfavorable (8.34e-4)"	"unprognostic (1.41e-1)"	"unprognostic (3.01e-1)"	"prognostic unfavorable (1.95e-4)"	"unprognostic (1.09e-1)"	5.6	10.1	10.8	9.5	11.7	7.3	11.1	11.7	13.7	7.3	6.0	6.9	7.6	6.1	7.4	5.6	8.1	7.1	5.3	4.4	8.9	9.7	9.7	10.3	3.9	12.0	9.7	12.1	12.5	10.8	5.6	6.8	10.3	9.5	6.2	7.7	3.8	9.2	7.6	7.0	6.7	5.1	5.6	9.7	6.3	5.5	13.0	8.9	15.2	9.4	6.4	12.0	7.0	6.6	8.2	3.7	3.3	3.9	11.2	9.5	4.3	8.7	7.3	15.1	7.3	4.9	6.4	12.3	9.8	4.3	8.1	8.7	14.6	10.7	30.8	13.3	4.6	7.5	6.5	29.0	9.8	16.3	8.0	12.9	12.4	9.2	16.1	7.5	24.4	7.8	5.5	7.7	11.5	13.0	5.0	8.5	12.7	31.2	17.1	9.1	7.9	30.1	18.6	20.0	19.9	8.8	25.5	9.9	21.6	13.6	6.2	25.5	12.4	7.8	14.3	8.8	14.8	9.6	5.2	5.9	8.5	14.7	8.5	17.2	12.8	12.8	32.0	9.5	15.6	7.9	3.3	2.0	1.0	4.6	3.1	6.9	8.2	6.3	6.2	2.8	6.3	9.5	8.6	0.5	11.2	3.9	3.7	4.7	4.3	10.8	11.7	11.7	13.7	8.9	9.7	9.7	12.1	9.5	8.9	0.0	5.6	6.7	8.0	27.5	8.3	3.6	5.1	8.1	11.4	3.5	2.0	24.8	8.3	3.7	2.1	7.1	0.5	0.0	2.3	21.1	10.4	5.9	6.9	6.6	6.9	36.5	4.1	8.0	1.8	2.0	7.2	3.4	8.5	1.0	3.7	4.9	2.7	0.0	5.3	9.5	4.5	0.0	10.4	7.7	28.6	27.9	6.4	9.6	8.9	5.3
PPCDC	"FLJ14585, MDS018"	ENSG00000138621	"Phosphopantothenoylcysteine decarboxylase"	Q96CD2	15	75023555-75117462	"Enzymes, Predicted intracellular proteins"	"Coenzyme A biosynthesis"	"Decarboxylase, Lyase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Group enriched"	"Detected in all"	5	"dendritic cells: 19.9;granulocytes: 40.4;monocytes: 18.1"	"Cell line enhanced"	"Detected in all"		"Karpas-707: 54.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA045667	Approved		Approved	Cytosol		NA	NA			Cytosol		"HPA045667: AB_2679412"	"unprognostic (8.66e-2)"	"unprognostic (1.07e-3)"	"unprognostic (6.03e-2)"	"unprognostic (2.57e-2)"	"unprognostic (2.95e-2)"	"unprognostic (6.53e-2)"	"unprognostic (1.76e-2)"	"unprognostic (8.40e-2)"	"unprognostic (1.72e-1)"	"unprognostic (1.53e-1)"	"unprognostic (1.48e-1)"	"unprognostic (1.48e-1)"	"unprognostic (1.60e-2)"	"unprognostic (7.67e-2)"	"unprognostic (1.73e-1)"	"unprognostic (3.43e-1)"	"unprognostic (2.13e-3)"	10.4	18.5	7.7	11.1	9.3	16.7	14.5	10.8	10.2	8.4	10.8	16.0	15.1	9.4	16.3	13.3	17.5	10.9	12.1	7.8	7.3	7.9	12.5	12.0	13.9	14.0	16.8	5.9	9.2	22.1	14.4	11.3	8.9	11.0	12.0	9.3	15.6	17.5	8.0	10.5	8.3	11.6	6.1	13.6	18.0	10.7	9.7	11.3	7.4	11.0	11.5	16.5	14.2	9.4	4.2	19.9	40.4	18.1	4.5	5.6	4.2	6.0	11.4	4.7	3.7	2.9	2.7	4.1	6.1	2.7	8.3	6.5	6.7	16.5	6.9	11.0	3.0	5.1	6.3	7.7	10.2	4.2	24.3	9.4	12.1	7.1	7.1	8.3	7.0	15.8	3.6	6.8	8.5	13.1	3.3	6.5	10.3	8.1	54.0	5.9	11.7	4.2	10.9	7.6	12.9	5.3	7.1	9.3	14.8	6.2	8.7	11.5	3.3	9.0	12.6	13.2	5.7	15.6	9.1	3.7	8.5	5.9	4.2	10.8	16.5	10.8	11.4	5.2	17.9	9.5	10.9	6.5	40.4	3.4	17.5	5.6	4.2	3.1	3.8	4.9	2.3	3.6	4.3	39.3	4.5	18.1	19.9	3.3	4.2	7.7	9.3	10.8	10.2	7.3	7.9	16.8	5.9	11.0	11.3	14.9	6.9	2.2	6.1	3.4	2.6	3.4	5.1	12.0	3.4	8.7	0.0	14.7	21.6	15.1	0.7	9.8	11.1	0.0	13.4	11.5	7.2	5.7	11.5	4.2	16.7	7.9	4.1	4.9	12.5	2.9	4.0	15.4	13.5	21.6	8.5	3.5	16.2	31.7	4.9	14.9	8.4	6.5	8.2	6.5	16.4	3.4	9.2	13.1	10.0	11.9
PPCS	FLJ11838	ENSG00000127125	"Phosphopantothenoylcysteine synthetase"	Q9HAB8	1	42456117-42473385	"Enzymes, Predicted intracellular proteins"		Ligase	"Cardiomyopathy, Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Distal tubular cells: 336.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA031361, HPA031363"	Approved		Approved	Mitochondria		NA	NA		16000	Mitochondria		"HPA031361: AB_10602150, HPA031363: AB_2673844"	"unprognostic (1.49e-1)"	"unprognostic (6.71e-2)"	"unprognostic (8.15e-2)"	"unprognostic (1.55e-1)"	"unprognostic (3.84e-3)"	"unprognostic (1.68e-2)"	"prognostic unfavorable (5.96e-5)"	"unprognostic (2.71e-1)"	"unprognostic (7.79e-3)"	"unprognostic (9.13e-3)"	"unprognostic (3.24e-2)"	"unprognostic (2.44e-1)"	"unprognostic (2.41e-2)"	"unprognostic (6.45e-2)"	"unprognostic (2.32e-1)"	"unprognostic (2.80e-1)"	"unprognostic (4.30e-2)"	23.4	36.3	18.9	20.5	21.9	10.7	30.7	12.0	26.0	23.2	32.0	12.4	27.3	25.5	18.2	34.4	31.6	14.5	30.9	22.1	17.8	16.4	41.4	43.9	26.5	28.1	19.3	14.9	19.6	47.0	22.8	16.1	37.6	17.2	27.2	27.3	19.6	36.6	35.0	19.6	21.9	41.0	27.6	18.9	24.4	27.2	13.5	13.4	22.6	31.3	26.0	20.5	24.0	19.4	41.9	44.4	76.1	55.7	42.0	41.0	52.0	22.9	9.6	5.6	8.7	17.4	18.1	20.9	11.6	13.4	15.7	13.9	8.1	28.1	6.9	22.9	14.7	9.1	13.5	3.7	17.6	13.2	18.3	11.1	11.6	10.6	9.6	23.9	11.9	20.6	15.9	31.9	11.0	20.4	19.3	14.5	8.6	4.7	5.0	16.0	13.7	5.8	11.8	6.4	21.2	14.9	6.6	5.7	12.3	34.3	21.7	6.6	7.3	14.2	34.8	36.0	17.0	16.4	52.7	9.1	8.6	11.5	13.1	13.2	16.5	10.3	5.0	3.6	13.8	17.6	58.1	55.7	76.1	30.7	55.1	35.7	41.9	37.0	33.0	44.4	39.9	41.0	34.9	41.2	42.0	51.8	33.2	36.4	52.0	18.9	21.9	12.0	26.0	17.8	16.4	19.3	14.9	17.2	13.4	53.6	69.7	61.9	43.1	20.7	9.2	94.6	86.6	54.9	59.1	61.1	5.9	137.5	336.5	81.6	2.8	50.7	119.1	0.0	120.2	108.8	45.6	37.4	54.4	103.6	97.2	11.1	30.1	43.0	68.9	3.4	56.1	87.5	77.6	111.0	116.6	40.7	82.5	122.6	59.8	254.9	21.8	25.8	44.7	8.4	19.2	31.7	112.6	52.4	93.7	42.7
PPEF1	"PPEF, PPP7CA"	ENSG00000086717	"Protein phosphatase with EF-hand domain 1"	O14829	X	18675909-18827921	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 10.6;testis: 20.2"	"Group enriched"	"Detected in some"	11	"Early spermatids: 51.1;Late spermatids: 94.3"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in single"		"myeloid DC: 1.3"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"A549: 3.6;HAP1: 1.3;HeLa: 5.3;SH-SY5Y: 2.9;SK-MEL-30: 1.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA034577			Uncertain	"Plasma membrane,Cytokinetic bridge"		Yes	NA			"Plasma membrane"	"Cytokinetic bridge"	"HPA034577: AB_10602817"	"unprognostic (4.13e-2)"	"unprognostic (1.30e-1)"	"unprognostic (9.06e-2)"	"unprognostic (9.85e-2)"	"unprognostic (3.84e-2)"	"unprognostic (5.00e-2)"	"unprognostic (2.38e-1)"	"unprognostic (3.43e-2)"	"unprognostic (4.96e-3)"	"unprognostic (9.29e-2)"	"unprognostic (1.70e-1)"	"unprognostic (2.89e-1)"	"unprognostic (1.10e-11)"	"unprognostic (5.41e-3)"	"unprognostic (2.75e-1)"	"unprognostic (2.97e-2)"	"unprognostic (1.19e-2)"	0.1	0.5	3.1	0.2	6.4	1.4	3.9	0.2	10.6	0.2	0.2	0.1	0.0	0.1	0.3	0.9	0.2	0.2	0.3	0.3	1.9	1.0	0.3	0.1	0.4	0.3	1.7	6.9	0.2	0.2	0.1	0.7	1.0	0.2	0.5	0.1	0.0	0.3	0.6	0.1	0.7	0.1	0.2	10.5	0.3	0.1	20.2	0.0	0.1	0.4	0.0	0.3	0.4	0.1	0.2	1.3	0.0	0.9	0.0	0.0	0.2	0.0	3.6	0.1	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.3	0.0	0.0	0.3	1.2	0.0	5.3	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.4	0.0	0.0	0.8	0.0	0.6	0.0	0.0	0.0	0.0	0.1	0.0	0.7	0.0	0.0	0.0	0.0	0.2	0.3	2.9	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.6	0.0	0.2	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	3.1	6.4	0.2	10.6	1.9	1.0	1.7	6.9	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	51.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	6.4	0.0	0.0	0.0	94.3	0.6	0.0	3.3	0.0	0.0	0.5	0.0	0.0	0.7	0.1	0.5	0.0	0.0	0.7	0.7	0.1	0.0	0.0	0.0	0.0
PPEF2	PPP7CB	ENSG00000156194	"Protein phosphatase with EF-hand domain 2"	O14830	4	75859864-75902571	"Enzymes, Predicted intracellular proteins"	"Sensory transduction, Vision"	"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	24	"retina: 75.7"	"Group enriched"	"Detected in some"	22	"Cone photoreceptor cells: 157.1;Rod photoreceptor cells: 518.4"	"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	7	"cerebellum: 3.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"hTCEpi: 1.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"									NA	NA						"unprognostic (3.19e-2)"	"unprognostic (2.92e-1)"		"unprognostic (2.50e-1)"	"unprognostic (4.73e-2)"			"unprognostic (1.53e-1)"		"unprognostic (9.02e-2)"	"unprognostic (3.32e-4)"	"unprognostic (2.74e-2)"	"unprognostic (4.54e-8)"	"unprognostic (2.89e-1)"	"unprognostic (5.98e-2)"	"unprognostic (5.16e-1)"	"unprognostic (3.66e-3)"	0.1	0.0	0.0	0.2	0.4	0.2	0.3	3.1	0.2	0.4	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.1	0.1	0.2	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.3	75.7	0.0	0.0	0.3	0.4	0.1	0.1	0.1	0.3	0.1	2.5	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.5	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.3	0.0	0.3	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.4	3.1	0.2	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.1	0.3	0.0	0.0	0.0	0.0	157.1	0.0	0.0	0.0	4.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.5	0.0	0.0	0.0	0.0	0.0	15.3	0.0	0.0	0.0	0.2	518.4	0.0	0.0	0.6	0.1	0.0	0.0	0.0	0.0	0.0
PPIA	CYPA	ENSG00000196262	"Peptidylprolyl isomerase A"	P62937	7	44796680-44824564	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Host-virus interaction"	"Isomerase, Rotamase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"CAB004655, HPA058345"	Uncertain				"Secreted to blood"	NA	NA		420000000			"CAB004655: AB_425607, HPA058345: AB_2683685"	"unprognostic (3.10e-1)"	"unprognostic (2.28e-1)"	"unprognostic (1.27e-1)"	"unprognostic (7.86e-2)"	"unprognostic (9.27e-2)"	"unprognostic (2.19e-2)"	"prognostic unfavorable (2.27e-6)"	"unprognostic (1.12e-3)"	"unprognostic (3.30e-2)"	"unprognostic (3.92e-2)"	"unprognostic (8.68e-3)"	"unprognostic (2.52e-1)"	"unprognostic (6.35e-3)"	"unprognostic (2.77e-1)"	"unprognostic (1.24e-1)"	"unprognostic (7.84e-2)"	"unprognostic (1.16e-1)"	92.0	90.3	147.0	80.4	124.3	105.9	169.0	88.9	148.0	111.3	143.5	81.6	52.9	73.9	74.8	125.1	176.5	76.3	80.4	60.2	132.0	121.9	149.2	214.3	95.4	137.1	123.2	88.3	74.2	103.2	93.1	58.3	96.2	142.5	83.0	149.1	68.1	84.7	102.3	68.4	114.7	105.1	113.9	120.8	137.0	73.1	62.4	59.8	228.2	130.2	123.4	191.2	94.3	93.1	129.8	158.5	35.0	83.1	76.0	117.7	180.3	85.4	114.8	145.8	105.8	122.2	185.9	48.1	125.3	196.9	240.8	236.3	127.3	131.1	193.3	64.6	159.6	265.6	116.9	187.4	240.0	222.2	110.5	136.7	78.1	132.3	121.2	99.2	158.2	81.5	136.0	164.8	170.6	187.5	123.7	244.4	134.0	160.4	156.3	247.6	121.7	173.3	280.1	166.4	289.1	158.3	124.5	88.3	245.9	326.5	120.9	109.2	90.5	105.6	303.0	82.3	181.0	162.4	216.0	108.6	124.1	119.7	83.0	164.2	114.1	225.3	326.2	108.2	180.1	187.2	23.4	74.5	35.0	94.9	83.1	102.0	129.8	97.0	97.1	134.8	103.9	80.3	88.2	9.2	76.0	77.7	158.5	117.7	180.3	147.0	124.3	88.9	148.0	132.0	121.9	123.2	88.3	142.5	59.8	738.4	649.6	630.7	788.0	769.8	81.7	43.6	573.3	655.8	728.0	572.3	17.7	772.4	1198.7	1053.9	61.2	614.7	668.4	210.2	1054.9	1359.4	612.8	450.0	590.8	641.5	1374.9	104.9	508.7	685.7	1073.8	53.8	539.0	844.5	656.3	1506.8	976.8	169.9	1130.2	533.1	576.3	1183.4	66.5	388.1	545.9	364.4	288.3	865.6	509.5	657.9	1124.8	784.3
PPIAL4A	"COAS2, PPIAL4, PPIAL4B"	ENSG00000263353	"Peptidylprolyl isomerase A like 4A"	Q9Y536	1	120889746-120890405	"Enzymes, Predicted intracellular proteins"		"Isomerase, Rotamase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"blood: 3.5;intestine: 1.6"	"Cell type enriched"	"Detected in single"	10	"Distal tubular cells: 1.7"	"Not detected"	"Not detected"							"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"Karpas-707: 3.8;NB-4: 4.6;SK-BR-3: 4.7"									HPA058345	Uncertain					NA	NA					"HPA058345: AB_2683685"	"unprognostic (3.49e-3)"	"unprognostic (2.78e-2)"	"unprognostic (1.45e-1)"	"unprognostic (1.42e-1)"	"unprognostic (4.17e-1)"	"unprognostic (1.77e-1)"	"unprognostic (2.09e-1)"	"unprognostic (1.42e-2)"	"unprognostic (7.94e-3)"	"unprognostic (1.72e-2)"	"unprognostic (1.91e-1)"	"unprognostic (7.11e-2)"	"unprognostic (5.32e-2)"	"unprognostic (3.66e-2)"	"unprognostic (1.55e-1)"	"unprognostic (1.83e-2)"	"unprognostic (1.74e-1)"	0.3	0.8		1.0		1.4	0.2		1.2	0.0	0.0			1.6	0.0	0.0	0.0	0.0	0.0	0.1			0.2	1.2	0.0	0.5			0.1	0.0	0.0		0.4		0.0	0.0		0.0	0.0	0.0	0.2	1.0	0.0		0.4	0.4	0.0			0.0		0.0	0.0		3.0	3.2	0.6	1.6	2.2	2.4	3.5	0.9	0.0	0.1	1.4	0.0	0.0	0.7	0.0	0.0	0.2	0.0	0.0	1.0	0.7	0.2	0.0	0.3	1.8	0.2	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.8	1.0	0.0	0.8	0.0	0.0	0.0	0.3	0.0	0.2	3.8	0.3	0.6	1.7	4.6	2.5	0.0	0.0	0.8	1.5	1.9	0.0	0.0	1.0	0.3	0.3	4.7	0.4	0.1	3.1	2.5	0.7	3.0	1.2	2.9	1.7	1.4	0.9	2.5	2.6	1.6	3.2	0.2	1.6	0.6	1.4	1.2	1.4	3.0	2.3	2.4	3.1	2.2	1.5	2.4	0.0	2.2	1.2	3.2	2.4	3.5											0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
PPIAL4C		ENSG00000263464	"Peptidylprolyl isomerase A like 4C"	A0A0B4J2A2	1	149583865-149584464	"Enzymes, Predicted intracellular proteins"		"Isomerase, Rotamase"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"blood: 10.9;intestine: 5.5"	"Cell type enriched"	"Detected in single"	16	"Cardiomyocytes: 1.6"	"Not detected"	"Not detected"							"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"NB-4: 14.4;THP-1: 16.9"									HPA058345	Uncertain					NA	NA					"HPA058345: AB_2683685"	"unprognostic (3.16e-1)"	"unprognostic (2.83e-2)"			"unprognostic (1.50e-2)"	"unprognostic (7.93e-2)"		"unprognostic (5.98e-2)"	"unprognostic (1.37e-1)"	"unprognostic (1.79e-1)"				"unprognostic (6.61e-2)"			"unprognostic (2.25e-1)"	0.0	3.3		2.7		0.1	0.0		1.5	0.0	0.8			5.5	0.8	0.0	0.0	0.0	0.0	0.0			1.0	0.0	1.0	2.9			0.2	0.0	0.9		0.7		0.3	0.0		0.0	0.0	0.2	0.5	2.9	0.0		1.4	0.9	0.0			0.0		0.3	0.0		9.1	9.7	1.9	6.0	4.6	7.8	10.9	3.6	0.3	0.4	3.1	0.1	0.3	2.0	0.6	0.4	1.0	0.7	0.0	4.8	1.3	2.1	0.0	2.5	3.9	0.0	0.2	0.6	3.5	0.0	0.5	0.0	0.0	0.1	2.0	1.9	0.1	0.5	0.6	0.3	0.0	0.0	0.5	0.9	5.4	0.7	0.4	5.3	14.4	6.2	1.0	0.1	5.3	0.0	9.0	0.2	0.0	4.0	5.5	1.1	11.3	6.2	0.3	5.3	16.9	1.3	3.6	5.6	3.3	8.2	4.2	5.6	9.2	3.9	4.6	7.8	0.9	4.3	1.9	5.4	6.0	6.0	9.1	6.1	5.7	9.4	7.2	5.0	5.9	0.0	4.6	5.3	9.7	7.8	10.9											0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
PPIAL4D		ENSG00000256374	"Peptidylprolyl isomerase A like 4D"	F5H284	1	145241630-145242124	"Enzymes, Predicted intracellular proteins"		"Isomerase, Rotamase"		"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"No human protein/transcript evidence"		"Group enriched"	"Detected in some"	4	"blood: 5.4;brain: 3.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"CACO-2: 2.1;NB-4: 1.9;RPMI-8226: 1.0;SK-MEL-30: 1.8;THP-1: 1.5"									HPA058345	Uncertain					NA	NA					"HPA058345: AB_2683685"					"unprognostic (9.32e-2)"					"unprognostic (1.33e-1)"				"unprognostic (3.05e-2)"				0.0	0.0	0.5	0.0	0.7	0.0	0.0	3.9	0.5	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.0	0.6	0.2	0.7	0.0		0.0	0.0	0.0	0.0	0.7		0.0	0.5		0.0	0.0	0.0	0.5	0.1	0.0	0.2	1.0	0.0	0.0			0.2		0.0	0.0	0.0	4.5	3.8	0.7	3.7	1.8	4.1	5.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.5	0.0	1.0	0.0	0.9	0.4	0.0	0.0	0.0	1.8	0.0	0.6	1.5	0.0	0.6	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.9	0.0	0.7	1.4	0.3	1.2	3.7	1.4	4.5	2.7	1.7	3.6	3.1	2.8	3.5	0.0	1.8	1.8	3.8	4.1	5.4											0.0	0.0	0.0	0.0	0.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0
PPIAL4E		ENSG00000271567	"Peptidylprolyl isomerase A like 4E"	A0A075B759	1	144372875-144373659	"Enzymes, Predicted intracellular proteins"		"Isomerase, Rotamase"		"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"No human protein/transcript evidence"		"Tissue enhanced"	"Detected in some"		"blood: 3.4;bone marrow: 2.7;skeletal muscle: 1.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"BJ hTERT+ SV40 Large T+ RasG12V: 1.1;HL-60: 1.2;hTERT-RPE1: 1.9;NB-4: 1.4;SK-BR-3: 2.0;TIME: 1.9"									HPA058345	Uncertain					NA	NA					"HPA058345: AB_2683685"					"unprognostic (6.97e-2)"					"unprognostic (5.22e-2)"				"unprognostic (2.28e-1)"				0.0	0.4		0.0		2.7	0.0		0.0	0.0	0.0			0.6	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.1	0.0			0.0	0.7	0.0		0.0		0.0	0.0		0.0	0.0	1.8	1.1	0.4	0.0		0.0	0.0	0.0			0.0		0.0	0.0		1.7	0.6	1.9	2.0	3.4	2.9	0.6	0.6	0.5	0.4	0.1	0.0	0.0	0.4	0.2	0.5	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.3	0.0	0.0	0.0	0.0	1.4	0.0	0.9	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	2.0	0.3	1.0	0.0	0.0	1.9	0.1	0.5	0.3	0.0	0.6	0.4	0.2	0.0	0.2	0.0	0.0	2.0	1.0	2.9	0.5	1.9	1.3	1.6	1.3	0.5	1.7	0.5	0.5	1.9	3.4	1.5	0.6	0.8	0.6											0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
PPIAL4F		ENSG00000279782	"Peptidylprolyl isomerase A like 4F"	P0DN26	1	144592868-144593527	"Enzymes, Predicted intracellular proteins"		"Isomerase, Rotamase"		"No human protein/transcript evidence"	"No human protein/transcript evidence"	"No human protein/transcript evidence"	"No human protein/transcript evidence"		"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA058345	Uncertain					NA	NA					"HPA058345: AB_2683685"					"unprognostic (1.08e-1)"					"unprognostic (2.22e-2)"				"unprognostic (2.02e-1)"				0.0	0.0		0.0		0.0	0.6		0.0	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.2	0.0			0.0	0.0	0.0		0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0			0.0		0.9	0.0		0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
PPIAL4G		ENSG00000236334	"Peptidylprolyl isomerase A like 4G"	P0DN37	1	148479824-148483679	"Enzymes, Predicted intracellular proteins"		"Isomerase, Rotamase"		"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"No human protein/transcript evidence"		"Tissue enhanced"	"Detected in some"		"brain: 6.9;skeletal muscle: 6.8"	"Group enriched"	"Detected in some"	5	"Basal keratinocytes: 6.1;Suprabasal keratinocytes: 10.9;T-cells: 6.7"	"Not detected"	"Not detected"							"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"											HPA058345	Uncertain					NA	NA					"HPA058345: AB_2683685"		"unprognostic (2.17e-3)"			"unprognostic (3.63e-1)"	"unprognostic (4.83e-1)"		"unprognostic (2.26e-1)"	"unprognostic (2.37e-1)"	"unprognostic (2.11e-1)"		"unprognostic (3.95e-1)"	"unprognostic (2.67e-2)"	"unprognostic (1.79e-1)"				0.2	0.1	1.3	0.7	1.8	1.3	0.3	6.9	1.2	0.1	0.2			0.5	0.4	1.0	0.3	0.1	0.3	0.2	0.9	1.1	0.1	0.2	0.2	1.1	0.5		0.4	0.0	0.1	0.3	0.1		0.2	0.3		0.4	0.0	6.8	0.8	0.7	0.0	0.4	2.7	0.5	0.5			0.4		0.3	0.0	0.0	2.2	0.6	2.4	0.8	2.4	3.2	0.2	0.8	1.1	0.5	1.7	0.2	0.3	1.3	0.3	0.3	0.1	0.1	1.3	0.9	1.2	0.8	0.3	0.2	1.0	0.1	0.2	0.2	0.5	0.7	1.2	2.4	1.0	0.1	1.5	1.2	0.2	1.8	0.1	0.3	0.3	0.2	1.0	0.7	1.8	0.0	0.9	0.8	2.5	1.1	0.1	0.3	0.6	0.3	0.8	0.3	1.3	0.7	1.0	1.0	0.7	0.4	0.9	1.2	1.4	0.8	0.9	0.9	1.4	0.7	1.4	1.2	1.0	0.7	1.0	0.9	2.2	0.4	1.0	3.2	0.4	2.4	0.9	1.5	1.7	0.3	2.2	1.6	2.8	2.4	2.4	0.8	0.6	0.5	0.2											0.0	1.1	0.0	0.4	6.1	1.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.3	0.5	1.1	0.4	0.2	1.6	0.0	0.6	0.3	0.0	0.0	0.0	1.7	0.0	0.0	0.3	0.0	0.0	0.0	0.0	1.1	0.0	0.3	0.0	0.0	10.9	0.1	6.7	0.0	0.1
PPIB	"CYPB, OI9"	ENSG00000166794	"Peptidylprolyl isomerase B"	P23284	15	64155812-64163205	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted secreted proteins"		"Isomerase, Rotamase"	"Disease mutation, Dwarfism, Osteogenesis imperfecta"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB011487, HPA012720"	Enhanced		Supported	"Nucleoplasm,Endoplasmic reticulum"	"Secreted to blood"	No	No		120000000	"Endoplasmic reticulum"	Nucleoplasm	"CAB011487: AB_443295, HPA012720: AB_1847399"	"unprognostic (3.00e-3)"	"unprognostic (5.65e-3)"	"unprognostic (2.81e-1)"	"prognostic favorable (1.56e-5)"	"unprognostic (1.65e-1)"	"unprognostic (1.07e-3)"	"unprognostic (3.69e-2)"	"unprognostic (1.27e-2)"	"unprognostic (7.19e-2)"	"unprognostic (8.80e-3)"	"unprognostic (2.87e-1)"	"unprognostic (2.79e-2)"	"prognostic unfavorable (2.02e-11)"	"unprognostic (7.05e-2)"	"unprognostic (3.77e-2)"	"unprognostic (1.82e-1)"	"unprognostic (3.90e-2)"	56.9	64.3	23.9	49.3	26.9	54.9	48.1	15.1	32.1	75.3	44.1	35.4	102.8	42.0	64.2	106.9	48.0	54.8	58.1	44.5	23.8	27.3	89.5	285.9	57.2	63.8	29.7	19.6	67.5	193.7	26.7	71.8	120.2	27.5	51.0	47.7	36.2	123.3	95.4	19.5	33.1	57.5	54.3	30.7	78.0	47.7	27.2	29.5	53.7	154.3	45.7	69.1	49.2	51.7	63.5	191.6	41.0	51.1	44.9	71.6	87.1	39.7	50.0	45.2	102.6	158.3	91.9	39.8	94.9	124.7	75.2	89.4	71.9	73.8	38.0	77.2	147.0	76.4	64.9	82.5	63.8	38.8	24.1	31.1	53.6	55.2	94.1	166.0	53.4	48.5	84.6	68.8	43.8	106.9	93.2	90.8	18.2	37.3	132.4	56.9	63.5	16.3	82.0	39.4	110.7	32.2	31.2	48.0	193.7	78.0	62.0	25.6	40.3	43.5	74.8	69.1	69.6	44.7	163.5	55.8	75.2	62.3	42.0	64.0	71.9	69.6	39.9	70.2	86.1	75.0	41.0	51.1	33.9	71.6	39.2	71.5	63.5	50.5	58.1	67.4	38.0	33.0	44.2	25.5	44.9	25.2	191.6	40.1	87.1	23.9	26.9	15.1	32.1	23.8	27.3	29.7	19.6	27.5	29.5	116.1	168.3	153.4	361.8	142.3	26.7	0.7	280.2	128.5	194.5	258.2	29.5	546.5	76.3	534.3	16.2	209.5	301.3	70.0	495.6	1107.3	581.4	486.2	176.7	431.7	566.9	42.9	284.9	371.4	213.7	20.8	422.5	284.2	266.6	285.9	313.7	126.6	471.5	326.7	369.5	231.9	33.9	226.4	234.9	37.1	72.8	126.6	935.7	261.7	353.5	357.9
PPIC	CYPC	ENSG00000168938	"Peptidylprolyl isomerase C"	P45877	5	123023250-123036741	"Enzymes, Predicted intracellular proteins"		"Isomerase, Rotamase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	5	"Fibroblasts: 273.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"myeloid DC: 1.1"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"ASC diff: 58.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039163	Approved				"Intracellular and membrane"	NA	NA		5700000			"HPA039163: AB_2676374"	"unprognostic (7.81e-2)"	"unprognostic (1.44e-1)"	"unprognostic (3.28e-2)"	"unprognostic (7.44e-2)"	"unprognostic (2.03e-1)"	"unprognostic (7.49e-2)"	"prognostic unfavorable (4.78e-4)"	"unprognostic (1.39e-1)"	"unprognostic (1.37e-2)"	"unprognostic (3.88e-3)"	"unprognostic (1.67e-1)"	"unprognostic (1.31e-1)"	"unprognostic (3.37e-1)"	"unprognostic (1.70e-1)"	"unprognostic (2.38e-1)"	"unprognostic (4.27e-2)"	"unprognostic (2.43e-2)"	22.5	13.7	3.3	10.8	3.6	0.0	29.9	1.6	4.2	24.3	30.0	3.6	26.6	15.7	20.4	32.7	35.5	9.0	25.8	43.7	4.0	2.7	27.4	24.0	16.3	9.0	3.7	2.1	13.3	24.3	8.7	5.8	28.3	10.0	17.8	22.0	5.3	25.9	18.0	18.4	12.0	35.2	37.9	5.4	8.9	13.5	8.0	3.2	2.5	42.7	29.6	12.9	31.5	21.5	0.0	1.1	0.0	0.1	0.0	0.3	0.0	4.7	4.1	1.6	33.9	58.9	27.1	6.7	13.4	10.5	7.0	14.4	6.8	31.8	0.0	23.8	35.9	21.0	5.3	4.6	16.8	5.6	0.0	8.2	6.7	15.4	7.8	15.1	0.0	3.7	16.9	12.9	8.1	8.6	12.6	14.4	0.0	1.8	0.0	5.0	27.9	0.0	0.0	2.9	29.2	7.2	0.0	3.6	0.0	22.0	16.3	2.1	3.7	26.2	12.7	2.8	20.5	17.9	15.0	15.9	13.4	8.4	4.6	5.7	0.0	0.0	0.0	11.6	0.0	9.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.2	0.0	0.0	0.0	0.1	0.1	0.3	0.0	3.3	3.6	1.6	4.2	4.0	2.7	3.7	2.1	10.0	3.2	29.8	13.9	0.9	43.9	42.1	13.9	38.9	53.5	25.4	14.8	69.8	3.9	50.1	24.9	171.5	1.0	100.3	130.1	0.0	111.8	45.8	273.0	38.3	1.1	48.9	36.5	0.0	12.2	66.9	4.8	3.5	104.2	7.7	30.4	5.4	148.2	1.8	98.5	178.9	94.0	64.2	3.8	38.8	61.4	26.6	14.1	43.2	20.9	2.2	72.5	66.5
PPID	CYP-40	ENSG00000171497	"Peptidylprolyl isomerase D"	Q08752	4	158709134-158723396	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Apoptosis, Host-virus interaction, Protein transport, Transport"	"Chaperone, Isomerase, Rotamase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019520, HPA019692"	Approved		Supported	"Nucleoplasm,Nucleoli,Nucleoli rim,Cytosol"		NA	NA			Cytosol	"Nucleoplasm, Nucleoli, Nucleoli rim"	"HPA019520: AB_1847400, HPA019692: AB_1847401"	"unprognostic (4.26e-2)"	"unprognostic (2.03e-2)"	"unprognostic (8.91e-3)"	"unprognostic (8.17e-3)"	"unprognostic (1.50e-1)"	"unprognostic (2.04e-3)"	"unprognostic (4.72e-2)"	"unprognostic (1.62e-2)"	"unprognostic (4.72e-2)"	"unprognostic (5.92e-2)"	"unprognostic (4.54e-2)"	"unprognostic (1.46e-2)"	"unprognostic (2.66e-3)"	"unprognostic (8.78e-2)"	"unprognostic (1.74e-1)"	"unprognostic (1.64e-1)"	"unprognostic (1.09e-1)"	16.8	25.8	20.1	15.5	21.4	14.9	22.3	26.7	26.8	12.6	16.8	14.4	18.2	33.4	14.6	13.6	16.5	15.4	13.0	28.8	19.4	22.1	21.5	45.3	11.0	17.4	22.6	18.9	14.6	17.5	11.3	30.3	14.5	26.0	16.1	14.2	9.1	15.4	13.7	53.3	24.0	29.2	13.1	22.7	16.5	15.5	16.9	23.4	22.7	21.7	16.0	16.8	15.4	55.0	15.6	17.2	33.4	22.2	23.9	24.4	17.1	15.5	14.5	14.6	20.0	21.7	16.3	22.1	15.4	8.4	14.2	10.8	18.8	10.7	16.5	6.9	14.3	22.3	12.0	44.2	17.7	17.3	54.5	15.4	29.5	13.1	25.8	16.8	18.4	22.2	10.3	14.4	12.1	18.2	18.4	15.4	28.2	36.7	29.4	15.8	14.9	26.4	16.7	20.1	25.5	19.4	12.0	7.2	14.1	15.6	7.8	24.7	16.6	11.5	24.0	21.9	22.1	11.0	17.7	14.9	14.2	16.0	15.6	20.3	16.9	35.0	21.0	18.1	20.0	14.2	33.4	15.3	33.2	21.2	22.2	24.4	14.6	20.7	19.6	16.7	15.6	21.5	22.0	20.9	23.9	22.0	17.2	22.4	17.1	20.1	21.4	26.7	26.8	19.4	22.1	22.6	18.9	26.0	23.4	6.0	12.0	18.8	25.3	9.0	24.6	50.0	28.1	76.3	33.0	26.2	21.6	33.4	31.5	34.8	23.6	25.6	19.0	0.0	20.1	39.2	21.3	25.8	31.2	16.1	36.7	71.5	18.8	18.4	11.0	15.7	19.0	21.8	13.5	63.1	22.9	21.7	26.7	21.6	21.2	24.9	25.3	6.5	30.2	78.8	76.3	10.3	39.8	27.4	24.2	17.2
PPIE	"CyP-33, MGC111222, MGC3736"	ENSG00000084072	"Peptidylprolyl isomerase E"	Q9UNP9	1	39692182-39763914	"Enzymes, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	"Isomerase, RNA-binding, Rotamase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA019357, HPA020131"	Approved		Supported	"Nuclear speckles"		NA	NA			"Nuclear speckles"		"HPA019357: AB_2670131, HPA020131: AB_1847405"	"unprognostic (2.94e-1)"	"unprognostic (4.32e-2)"	"unprognostic (6.34e-2)"	"unprognostic (6.97e-2)"	"unprognostic (5.99e-2)"	"unprognostic (8.41e-2)"	"prognostic unfavorable (1.76e-4)"	"unprognostic (3.52e-2)"	"unprognostic (2.69e-1)"	"unprognostic (3.88e-3)"	"unprognostic (1.25e-1)"	"unprognostic (9.29e-2)"	"prognostic unfavorable (5.05e-5)"	"unprognostic (5.86e-2)"	"unprognostic (3.95e-1)"	"unprognostic (9.06e-2)"	"unprognostic (1.00e-1)"	19.3	23.8	23.7	24.3	22.5	18.6	25.7	25.9	36.1	25.5	28.1	35.6	22.2	19.7	30.6	26.5	26.0	34.7	21.1	27.1	22.3	22.1	25.2	29.8	20.6	25.9	26.3	20.5	35.5	42.1	27.4	23.6	21.9	24.9	26.1	22.7	26.9	30.7	28.9	29.6	21.7	23.2	34.2	25.6	25.7	23.9	38.8	20.2	22.8	33.7	21.9	33.9	31.5	22.6	43.3	31.6	14.1	27.2	49.0	46.9	44.2	9.8	17.1	15.7	12.6	17.5	15.6	8.3	17.0	17.1	26.0	24.5	21.3	29.2	28.0	24.1	19.0	16.7	15.1	21.5	25.2	24.8	18.1	23.2	30.9	19.8	6.4	24.0	27.8	16.9	14.1	23.1	24.4	9.0	18.9	23.3	25.0	31.3	19.6	18.9	17.7	12.8	22.6	18.8	23.3	19.1	19.0	11.8	15.9	19.6	18.4	22.4	17.9	17.8	14.5	12.3	19.4	18.2	73.1	15.1	16.3	18.1	20.2	26.0	26.9	26.9	19.4	11.3	35.9	25.6	11.6	27.1	14.1	38.3	27.0	37.0	43.3	39.7	38.2	31.6	39.8	46.9	38.9	2.2	49.0	27.2	28.5	40.0	44.2	23.7	22.5	25.9	36.1	22.3	22.1	26.3	20.5	24.9	20.2	29.8	27.1	41.2	35.7	22.0	24.9	29.6	17.8	64.3	56.9	31.4	13.7	54.2	56.3	49.6	25.8	24.5	23.9	0.0	42.1	51.6	34.0	28.9	54.3	27.6	48.7	22.3	27.6	25.8	36.1	47.7	27.6	34.0	37.1	53.3	28.0	35.4	38.6	28.1	42.5	54.9	25.9	58.2	41.0	62.7	44.8	23.1	29.1	40.6	33.0	29.5
PPIF	"Cyp-D, hCyP3"	ENSG00000108179	"Peptidylprolyl isomerase F"	P30405	10	79347469-79355337	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Apoptosis, Necrosis"	"Isomerase, Rotamase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"neutrophil: 32.8"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA077416			Supported	Mitochondria		NA	NA		27000000	Mitochondria		"HPA077416: AB_2686840"	"unprognostic (2.21e-1)"	"unprognostic (5.48e-2)"	"unprognostic (1.68e-1)"	"unprognostic (1.72e-3)"	"unprognostic (1.69e-1)"	"unprognostic (3.16e-3)"	"unprognostic (3.45e-1)"	"unprognostic (4.33e-3)"	"unprognostic (1.66e-1)"	"unprognostic (1.97e-1)"	"unprognostic (2.82e-1)"	"unprognostic (9.37e-3)"	"unprognostic (1.02e-3)"	"unprognostic (1.23e-1)"	"unprognostic (1.66e-1)"	"unprognostic (1.69e-3)"	"unprognostic (4.88e-2)"	16.5	76.2	12.1	15.7	18.8	52.0	16.9	7.1	21.3	8.3	18.1	27.1	13.2	13.3	5.2	7.6	21.0	8.8	10.0	36.5	13.0	14.5	21.0	73.1	9.4	19.4	23.3	16.6	7.2	42.0	12.0	6.2	11.3	25.2	6.6	19.9	7.5	12.7	21.9	44.4	22.5	11.1	9.9	28.0	19.6	34.0	20.8	18.0	8.8	10.0	73.9	19.8	12.5	11.0	8.0	18.6	32.8	14.9	3.6	5.0	6.5	35.6	15.2	10.7	21.0	10.0	13.0	13.7	20.8	27.3	45.8	43.4	35.5	17.3	37.1	11.6	14.6	32.6	21.4	33.1	19.4	71.5	11.7	31.2	58.1	14.9	62.4	17.0	40.0	13.8	30.4	13.9	45.4	45.5	14.9	8.0	14.6	56.5	45.8	15.5	18.3	10.3	33.5	9.0	16.4	84.5	17.8	16.5	19.0	17.8	33.3	21.3	15.8	10.7	43.3	16.0	7.3	18.9	30.9	7.2	20.1	18.3	23.6	40.0	21.3	21.6	30.0	19.9	52.1	5.4	5.1	14.9	7.3	4.7	11.4	5.0	8.0	4.2	4.3	18.6	3.9	3.8	3.7	32.8	3.6	4.1	2.3	4.2	6.5	12.1	18.8	7.1	21.3	13.0	14.5	23.3	16.6	25.2	18.0	6.0	5.0	34.4	26.4	37.8	4.4	106.2	15.3	12.0	9.1	12.2	5.9	70.1	77.9	37.7	11.0	13.8	22.2	46.7	24.2	113.4	24.0	17.4	13.8	70.1	83.0	7.9	20.7	8.6	32.4	11.1	5.8	60.2	33.7	33.3	62.3	9.9	40.0	17.5	5.6	31.1	4.9	19.4	24.1	7.0	22.2	33.0	119.0	17.5	63.7	28.5
PPIG	"CARS-Cyp, SCAF10, SRCyp"	ENSG00000138398	"Peptidylprolyl isomerase G"	Q13427	2	169584340-169641406	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Isomerase, Rotamase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021788, HPA057469"	Supported		Supported	"Nuclear speckles,Cytosol"		NA	NA			"Nuclear speckles"	Cytosol	"HPA021788: AB_1847408, HPA057469: AB_2683445"	"unprognostic (2.70e-1)"	"unprognostic (2.17e-1)"	"unprognostic (2.40e-1)"	"unprognostic (2.04e-3)"	"unprognostic (4.17e-2)"	"unprognostic (3.49e-2)"	"unprognostic (1.55e-3)"	"unprognostic (3.66e-2)"	"unprognostic (2.15e-3)"	"unprognostic (3.15e-3)"	"unprognostic (2.47e-2)"	"unprognostic (2.28e-1)"	"prognostic unfavorable (4.56e-4)"	"unprognostic (5.23e-2)"	"unprognostic (3.29e-1)"	"unprognostic (3.41e-2)"	"unprognostic (3.39e-2)"	26.2	25.3	28.5	23.8	45.3	39.2	26.7	45.0	40.7	33.1	27.1	14.6	26.0	25.3	27.1	28.1	29.4	24.3	21.2	24.2	30.0	20.3	26.0	41.1	25.5	30.4	27.7	35.9	29.5	22.8	39.4	56.7	26.0	38.0	29.3	23.9	13.8	28.6	28.8	27.8	24.5	30.8	31.9	39.7	29.7	24.1	19.8	33.7	24.1	28.4	22.6	29.9	37.4	27.6	36.4	23.7	41.7	24.7	18.7	29.6	13.3	19.5	9.3	26.3	14.4	14.6	17.9	24.8	22.4	16.8	16.5	17.1	25.4	22.6	33.7	20.6	16.1	20.7	18.8	20.6	18.3	24.5	23.4	16.6	50.7	13.9	30.9	14.1	47.7	22.6	15.0	20.7	22.4	25.2	15.7	18.1	20.6	48.9	28.2	18.8	15.8	35.2	29.3	37.7	15.9	9.5	32.4	26.3	32.9	20.4	29.4	23.0	15.2	24.0	17.9	24.3	21.1	16.7	27.6	20.8	21.6	16.5	14.4	18.3	16.4	23.6	47.1	15.9	25.6	19.7	20.7	20.0	29.9	20.3	20.1	23.2	27.6	27.0	23.8	14.9	36.4	29.6	23.7	41.7	18.7	24.7	23.7	22.9	13.3	28.5	45.3	45.0	40.7	30.0	20.3	27.7	35.9	38.0	33.7	205.4	160.5	152.0	169.4	134.5	178.8	130.1	61.1	132.5	155.8	89.0	51.1	146.0	68.0	90.9	6.8	121.2	97.1	70.0	90.5	147.9	117.4	133.0	172.3	157.2	134.3	208.2	100.6	106.2	118.2	8.4	131.5	135.1	104.6	124.4	115.6	123.1	82.2	108.7	137.9	99.6	103.2	161.7	154.6	225.0	148.0	150.9	171.9	152.4	132.6	136.1
PPIH	"CYP-20, CYPH, MGC5016, SnuCyp-20, USA-CYP"	ENSG00000171960	"Peptidylprolyl isomerase H"	O43447	1	42658425-42676758	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	"Chaperone, Isomerase, Rotamase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			HPA059019	Approved					NA	NA					"HPA059019: AB_2683885"	"unprognostic (7.93e-3)"	"unprognostic (5.49e-3)"	"unprognostic (2.53e-2)"	"unprognostic (6.42e-2)"	"unprognostic (3.79e-2)"	"unprognostic (1.95e-2)"	"prognostic unfavorable (1.55e-5)"	"unprognostic (1.09e-1)"	"unprognostic (2.37e-2)"	"unprognostic (1.82e-2)"	"unprognostic (2.84e-2)"	"unprognostic (3.40e-2)"	"prognostic unfavorable (1.78e-9)"	"unprognostic (6.59e-3)"	"unprognostic (4.93e-1)"	"unprognostic (2.41e-1)"	"unprognostic (1.52e-1)"	17.5	19.7	20.4	35.7	19.6	40.7	21.4	23.9	23.3	19.5	24.0	20.9	14.7	18.0	29.8	24.2	29.6	19.2	14.4	21.2	18.0	16.1	17.5	13.6	17.8	31.0	15.8	19.9	22.0	17.7	7.0	15.2	24.6	17.2	17.1	26.5	19.2	24.4	18.8	18.4	20.9	20.7	20.8	15.0	27.2	18.0	21.1	18.6	39.7	26.9	28.1	36.8	15.3	20.3	20.0	14.9	16.8	12.3	18.5	26.3	14.0	19.3	12.5	15.8	22.1	5.2	9.9	21.3	13.2	9.3	24.7	22.6	19.7	22.1	32.0	16.6	9.7	12.0	15.7	28.7	20.2	26.0	26.9	23.2	30.4	23.0	18.2	4.5	58.2	17.8	6.4	10.7	23.0	18.0	9.6	11.5	31.0	37.6	18.2	12.1	16.2	45.1	82.0	38.8	18.6	15.0	25.3	29.4	28.4	11.8	12.6	12.4	22.5	11.6	19.3	14.5	20.5	10.6	85.3	9.5	10.9	27.9	14.9	31.5	11.8	27.5	58.2	12.2	54.5	17.8	12.6	8.8	16.8	21.0	12.3	19.8	20.0	21.7	23.9	11.7	19.2	22.3	26.3	1.8	18.5	11.2	14.9	20.2	14.0	20.4	19.6	23.9	23.3	18.0	16.1	15.8	19.9	17.2	18.6	17.9	20.2	42.4	37.9	25.6	8.9	12.2	15.3	16.0	14.8	21.0	3.9	53.8	38.1	23.6	19.6	18.3	12.3	0.0	23.0	87.1	17.1	22.2	30.1	9.6	45.9	4.8	20.6	18.4	15.3	7.6	27.0	26.9	15.1	27.9	25.8	14.3	22.0	17.5	20.1	25.0	11.8	19.4	16.9	16.3	29.6	18.7	31.7	41.5	31.9	30.1
PPIL1	CYPL1	ENSG00000137168	"Peptidylprolyl isomerase like 1"	Q9Y3C6	6	36854827-36875024	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	"Isomerase, Rotamase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Extravillous trophoblasts: 54.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA062916			Supported	Nucleoli		NA	NA			Nucleoli		"HPA062916: AB_2684904"	"unprognostic (3.51e-2)"	"unprognostic (2.33e-1)"	"unprognostic (2.64e-3)"	"unprognostic (1.11e-2)"	"unprognostic (1.87e-1)"	"unprognostic (1.81e-2)"	"prognostic unfavorable (1.28e-5)"	"unprognostic (2.01e-1)"	"unprognostic (3.37e-2)"	"prognostic favorable (4.90e-4)"	"unprognostic (6.58e-2)"	"unprognostic (5.49e-2)"	"unprognostic (8.99e-2)"	"unprognostic (1.30e-1)"	"unprognostic (2.30e-1)"	"unprognostic (3.39e-2)"	"unprognostic (2.15e-2)"	9.0	17.2	15.9	11.1	23.1	7.3	12.3	16.6	18.7	11.1	10.2	13.0	5.7	8.7	13.7	11.7	13.1	17.5	7.5	29.7	13.2	19.8	17.6	34.3	7.5	13.4	15.0	15.5	13.2	36.7	10.6	19.4	16.0	15.3	11.2	13.2	11.0	12.0	12.5	11.7	5.6	8.2	17.4	15.8	10.3	8.5	14.0	11.0	10.2	23.5	13.4	17.4	12.2	8.1	7.7	6.6	1.1	4.4	5.0	15.0	6.9	14.3	11.3	29.9	19.9	4.0	8.5	16.2	14.5	9.7	22.0	18.3	19.8	9.5	22.0	18.4	10.2	29.0	11.6	35.3	24.2	25.2	18.3	29.5	26.0	7.4	26.1	13.4	22.2	10.9	6.3	11.5	16.9	31.6	8.1	19.6	21.3	48.8	10.7	15.8	13.6	26.4	10.2	19.8	27.5	15.3	21.3	26.2	19.7	13.0	10.1	31.8	16.8	9.7	10.4	19.1	23.0	15.2	18.9	11.9	17.0	15.7	12.9	24.2	11.8	30.6	40.1	5.4	41.2	32.3	1.1	3.2	0.8	11.2	4.4	15.0	7.7	9.3	10.7	6.6	6.2	10.5	12.3	0.9	5.0	2.1	5.6	6.8	6.9	15.9	23.1	16.6	18.7	13.2	19.8	15.0	15.5	15.3	11.0	6.0	6.9	6.7	16.2	2.7	14.1	40.3	7.6	20.1	7.9	5.2	3.9	50.9	19.9	22.9	21.9	9.2	2.6	0.0	17.8	54.4	8.4	9.5	10.4	6.8	25.9	15.9	3.5	3.7	2.8	8.5	6.4	9.5	6.8	11.8	8.5	25.1	18.1	7.0	11.7	10.2	10.5	6.5	8.9	14.4	49.0	4.0	21.2	7.5	10.3	8.6
PPIL2	"CYC4, Cyp-60, UBOX7"	ENSG00000100023	"Peptidylprolyl isomerase like 2"	Q13356	22	21666009-21700015	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Late spermatids: 67.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enriched"	"Detected in all"	4	"K-562: 71.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035344, HPA055637"	Supported		Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"HPA035344: AB_10672863, HPA055637: AB_2682869"	"unprognostic (1.97e-3)"	"unprognostic (3.61e-2)"	"unprognostic (2.70e-2)"	"unprognostic (4.31e-2)"	"unprognostic (2.27e-1)"	"unprognostic (2.90e-3)"	"unprognostic (5.16e-3)"	"unprognostic (3.77e-2)"	"unprognostic (9.46e-2)"	"unprognostic (1.54e-1)"	"unprognostic (2.33e-2)"	"unprognostic (1.89e-2)"	"unprognostic (2.45e-3)"	"unprognostic (5.46e-2)"	"unprognostic (5.39e-2)"	"unprognostic (5.39e-2)"	"unprognostic (1.54e-3)"	15.0	21.5	19.4	20.9	24.6	16.6	13.5	24.1	30.9	17.7	17.4	25.3	19.1	18.6	21.8	17.0	22.3	15.7	16.5	20.0	17.2	17.1	21.2	20.3	14.6	23.7	15.6	20.9	16.6	31.4	23.6	30.2	31.4	19.0	19.5	17.6	23.6	22.0	16.5	25.5	17.5	19.1	15.2	15.0	21.3	19.5	18.4	17.6	32.8	27.0	13.6	33.5	17.4	16.2	8.7	11.7	4.8	17.3	12.8	13.2	9.1	6.6	6.9	8.1	8.5	8.3	7.1	7.3	8.7	6.2	10.7	9.2	7.0	4.4	11.5	5.3	9.7	5.4	9.8	10.8	7.5	6.4	7.1	11.1	10.7	6.9	8.3	6.0	16.9	10.1	7.7	6.8	7.6	5.8	6.5	9.2	7.3	71.2	8.3	7.6	10.4	7.6	4.6	7.8	12.4	4.3	9.8	12.0	2.3	5.4	6.7	12.7	6.9	7.9	12.7	2.9	5.0	9.1	5.7	11.1	6.7	11.0	7.9	5.5	9.6	7.0	8.7	7.6	6.4	8.1	1.0	8.6	4.7	9.5	13.9	11.4	7.0	11.1	12.0	11.7	8.7	9.8	8.9	4.8	12.8	17.3	11.1	13.2	9.1	19.4	24.6	24.1	30.9	17.2	17.1	15.6	20.9	19.0	17.6	8.9	25.6	20.6	7.3	2.9	22.7	4.0	30.6	6.7	17.0	14.0	31.4	13.2	11.6	10.6	57.9	5.4	16.9	0.0	14.6	12.4	5.7	12.9	16.2	16.6	13.2	17.5	10.9	11.1	24.4	67.5	11.2	14.4	1.7	10.0	20.5	12.3	15.0	17.3	12.7	7.0	29.8	0.0	4.4	18.6	16.3	5.0	18.5	15.9	18.4	10.3
PPIL3	CyPJ	ENSG00000240344	"Peptidylprolyl isomerase like 3"	Q9H2H8	2	200870907-200889303	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"mRNA processing, mRNA splicing"	"Isomerase, Rotamase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040765, HPA062187"	Approved		Approved	Nucleoplasm,Nucleoli		NA	NA		35000	Nucleoplasm	Nucleoli	"HPA040765: AB_2677125, HPA062187: AB_2684706"	"unprognostic (8.96e-3)"	"unprognostic (6.07e-2)"	"unprognostic (5.34e-2)"	"unprognostic (8.16e-2)"	"unprognostic (2.69e-2)"	"unprognostic (9.61e-2)"	"unprognostic (8.31e-2)"	"unprognostic (8.05e-2)"	"unprognostic (1.40e-2)"	"prognostic favorable (1.19e-4)"	"unprognostic (5.23e-2)"	"unprognostic (6.60e-2)"	"prognostic unfavorable (5.16e-4)"	"unprognostic (1.14e-1)"	"unprognostic (5.96e-2)"	"unprognostic (2.21e-2)"	"unprognostic (4.87e-2)"	12.4	17.9	18.1	15.5	19.2	24.2	21.1	20.1	20.2	19.4	16.4	18.4	21.1	12.7	17.2	24.3	25.4	19.1	15.9	17.6	17.5	21.8	15.9	19.4	15.9	23.7	20.0	11.8	31.4	16.7	11.9	17.4	15.5	23.0	19.5	16.6	16.3	13.8	15.8	13.4	14.7	15.7	16.8	23.2	20.2	15.7	18.2	13.0	26.3	23.7	19.4	25.5	28.6	13.6	23.4	21.7	18.7	14.1	20.6	20.6	10.7	8.0	7.1	22.1	9.6	17.3	37.2	7.2	12.8	13.9	14.8	15.0	5.2	15.2	7.7	13.6	13.8	17.4	10.6	7.7	15.6	13.3	16.3	18.5	32.5	19.9	35.1	8.9	31.1	16.5	13.5	15.3	12.1	19.1	25.0	9.8	15.3	25.7	18.9	18.8	12.8	23.9	24.8	13.5	8.1	11.5	9.1	12.4	12.1	19.4	12.4	9.2	8.5	12.9	12.3	20.6	27.1	10.2	14.2	13.4	21.3	12.1	12.6	10.5	20.7	19.6	36.3	16.3	13.9	13.5	18.7	12.7	12.7	12.7	10.8	18.5	23.4	15.6	13.7	21.7	18.9	19.1	20.6	3.0	20.6	14.1	17.9	20.1	10.7	18.1	19.2	20.1	20.2	17.5	21.8	20.0	11.8	23.0	13.0	0.0	11.5	24.3	38.6	28.2	12.5	17.8	17.8	21.4	11.4	15.7	9.8	45.1	48.0	20.2	14.8	15.7	12.9	0.0	14.0	44.2	34.2	17.7	25.4	15.7	41.6	3.2	9.1	16.0	41.1	2.7	33.9	45.8	27.0	23.4	25.0	17.1	18.9	24.6	26.5	45.3	10.5	19.4	29.4	36.5	22.3	40.5	25.7	32.6	29.2	23.7
PPIL4		ENSG00000131013	"Peptidylprolyl isomerase like 4"	Q8WUA2	6	149504733-149546038	"Enzymes, Predicted intracellular proteins"		"Isomerase, RNA-binding, Rotamase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031599, HPA031600"	Approved		Enhanced	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA031599: AB_2673950, HPA031600: AB_10600928"	"unprognostic (6.12e-2)"	"unprognostic (4.90e-2)"	"unprognostic (3.85e-2)"	"unprognostic (8.42e-2)"	"unprognostic (7.53e-2)"	"unprognostic (6.36e-3)"	"unprognostic (2.91e-3)"	"unprognostic (2.22e-1)"	"unprognostic (4.22e-2)"	"unprognostic (1.09e-1)"	"unprognostic (2.38e-1)"	"unprognostic (4.62e-2)"	"unprognostic (3.88e-2)"	"unprognostic (2.11e-1)"	"unprognostic (1.59e-1)"	"unprognostic (8.50e-2)"	"unprognostic (7.94e-2)"	20.0	20.1	20.6	15.0	35.5	30.6	21.2	35.1	27.8	24.0	15.3	19.7	10.1	14.1	21.1	27.2	15.7	18.0	19.8	18.3	21.3	15.6	18.8	23.0	17.9	15.7	20.9	18.0	32.9	16.0	20.8	36.6	22.6	23.9	20.5	16.8	15.7	18.2	16.7	14.8	15.4	16.0	20.0	22.7	17.6	16.0	15.9	19.4	27.0	26.8	8.2	16.8	22.0	19.2	21.4	16.6	24.9	17.8	28.7	24.6	14.8	11.1	6.0	21.0	17.3	12.5	16.4	19.6	22.0	21.0	24.1	25.7	12.6	11.4	11.8	15.2	16.9	14.4	10.1	16.0	8.4	38.3	17.1	15.1	13.0	13.2	21.6	19.7	23.6	11.1	12.8	14.4	24.6	20.6	13.5	13.1	8.6	28.3	7.1	18.7	11.9	13.4	20.3	16.6	11.2	9.5	18.2	19.4	5.9	18.3	8.5	12.4	9.5	26.2	11.5	15.0	15.2	13.5	17.2	15.3	16.0	12.5	28.3	20.9	9.4	4.8	18.5	13.5	19.0	23.0	24.9	16.1	18.1	14.7	17.8	20.4	21.4	19.5	16.9	16.6	16.6	24.6	18.7	13.4	28.7	16.1	16.2	20.7	14.8	20.6	35.5	35.1	27.8	21.3	15.6	20.9	18.0	23.9	19.4	62.5	64.3	22.6	54.3	43.4	44.2	33.3	17.8	80.3	61.4	43.6	7.9	43.1	36.5	34.7	17.2	37.3	15.2	0.0	23.1	37.9	55.5	27.1	73.0	18.7	31.8	27.0	22.3	30.7	21.3	9.6	57.2	29.9	38.8	47.7	19.7	40.0	26.4	22.9	52.6	27.5	35.5	51.8	68.4	58.2	53.4	39.5	54.6	41.5	20.0	32.7
PPIL6	"bA425D10.6, dJ919F19.1, MGC41939, RSPH12"	ENSG00000185250	"Peptidylprolyl isomerase like 6"	Q8IXY8	6	109390215-109441171	"Enzymes, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"fallopian tube: 36.5"	"Group enriched"	"Detected in many"	4	"Ciliated cells: 187.4;Early spermatids: 262.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"AN3-CA: 6.5;ASC diff: 10.4;ASC TERT1: 12.9;hTERT-RPE1: 9.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA036717, HPA058165"	Approved		Approved	"Nucleoplasm,Golgi apparatus,Cytosol"		NA	NA			"Nucleoplasm, Cytosol"	"Golgi apparatus"	"HPA036717: AB_10671969, HPA058165: "	"unprognostic (1.24e-1)"	"unprognostic (2.40e-1)"	"unprognostic (5.68e-2)"	"unprognostic (2.68e-2)"	"unprognostic (3.12e-1)"	"unprognostic (3.61e-2)"	"unprognostic (1.26e-1)"	"unprognostic (5.53e-2)"	"unprognostic (3.14e-1)"	"unprognostic (8.03e-2)"	"unprognostic (1.42e-3)"	"unprognostic (2.51e-2)"	"unprognostic (4.71e-2)"	"unprognostic (1.95e-1)"	"unprognostic (3.29e-2)"	"unprognostic (5.86e-2)"	"unprognostic (2.32e-1)"	1.5	1.4	5.5	1.1	8.6	0.7	3.6	5.0	4.8	4.6	1.7	7.2	7.4	1.9	3.8	12.7	2.0	36.5	1.7	2.6	6.0	5.4	4.9	1.2	8.9	1.1	3.4	3.2	6.3	4.3	6.6	7.6	1.6	18.3	1.8	1.6	2.6	2.8	5.0	3.9	1.7	1.1	5.4	3.2	1.3	2.3	20.4	5.3	0.0	17.2	1.4	1.1	2.9	2.0	5.1	1.7	2.0	1.3	1.7	1.3	1.1	1.8	1.0	1.2	6.5	10.4	12.9	1.1	0.0	2.3	0.5	0.2	0.1	1.8	0.0	0.5	0.6	0.9	1.2	1.0	0.0	0.3	0.5	0.9	0.5	0.1	0.0	5.2	0.6	0.3	2.7	6.2	0.2	3.9	9.3	0.8	1.4	0.9	0.3	0.4	0.6	0.1	0.6	0.2	4.2	1.3	0.8	0.0	0.6	5.0	0.1	1.5	2.5	0.2	0.3	4.3	0.3	0.5	1.0	0.4	0.1	0.2	1.1	0.2	0.3	0.1	0.1	2.1	0.1	0.4	2.0	1.2	1.2	0.9	1.3	0.9	5.1	1.2	1.1	1.7	3.2	1.1	1.0	1.6	1.7	1.1	1.7	1.3	1.1	5.5	8.6	5.0	4.8	6.0	5.4	3.4	3.2	18.3	5.3	6.0	5.8	0.0	3.5	1.9	2.1	3.3	5.1	187.4	22.7	3.5	2.0	0.5	21.6	1.6	262.5	1.5	0.7	0.0	1.0	0.7	1.7	2.9	0.0	0.0	0.3	1.6	2.9	0.6	0.0	40.8	4.9	0.5	3.3	1.0	1.8	4.9	0.7	0.0	4.9	8.0	11.5	0.0	1.2	52.6	22.0	2.6	0.6	0.5	1.7	1.1
PPIP5K1	"HISPPD2A, IPS1, KIAA0377, VIP1"	ENSG00000168781	"Diphosphoinositol pentakisphosphate kinase 1"	Q6PFW1	15	43533462-43590253	"Enzymes, Predicted intracellular proteins"		"Kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 28.4"	"Cell type enhanced"	"Detected in many"	9	"Cone photoreceptor cells: 39.3;Rod photoreceptor cells: 42.3"	"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039380	Approved		Supported	"Plasma membrane,Cytosol"		NA	NA			"Plasma membrane, Cytosol"		"HPA039380: AB_10673528"	"unprognostic (8.72e-2)"	"unprognostic (6.49e-2)"	"unprognostic (1.90e-2)"	"unprognostic (1.12e-1)"	"unprognostic (2.38e-1)"	"unprognostic (2.78e-1)"	"unprognostic (8.18e-2)"	"unprognostic (5.78e-2)"	"unprognostic (2.59e-3)"	"prognostic unfavorable (8.57e-4)"	"unprognostic (6.67e-2)"	"unprognostic (2.85e-3)"	"prognostic favorable (7.14e-8)"	"unprognostic (2.67e-2)"	"unprognostic (3.35e-2)"	"unprognostic (5.92e-3)"	"unprognostic (7.95e-3)"	1.7	5.2	3.4	1.8	6.4	1.1	3.4	28.4	7.0	2.8	6.1			9.1	2.2	5.6	3.7	3.1	2.5	2.1	3.6	5.0	2.5	1.4	1.4	2.0	3.3		3.0	2.9	13.4	7.6	0.9		3.4	6.5		4.7	2.7	6.3	7.2	8.8	2.3	2.8	2.3	5.3	4.5			5.0		3.0	3.3	2.7	5.3	3.2	4.3	2.8	3.5	3.8	3.0	8.4	5.6	4.9	9.1	3.0	1.9	8.4	4.2	5.4	6.1	9.0	6.4	8.1	7.9	6.4	5.8	9.1	23.1	9.5	18.4	6.2	7.8	7.5	11.9	16.9	3.4	6.8	13.6	12.4	3.4	16.2	7.4	11.4	8.3	6.4	18.6	8.6	11.8	4.5	6.6	4.5	7.7	2.4	15.9	6.0	9.7	5.0	4.0	6.6	15.3	14.8	4.6	10.9	10.4	4.1	7.3	19.2	11.4	2.8	5.3	6.4	6.7	10.2	2.6	3.2	9.8	10.0	15.6	5.1	4.3	1.4	0.0	2.7	2.8	3.8	5.3	3.3	3.6	3.2	3.6	2.7	2.5	1.0	3.5	2.1	2.4	0.8	3.0											0.0	2.1	0.0	1.5	3.5	15.3	4.0	5.1	0.0	2.3	7.0	39.3	2.7	0.0	2.1	1.7	2.4	8.8	0.0	1.3	0.8	0.8	1.3	0.0	1.1	1.6	9.5	2.4	4.3	2.7	1.6	1.7	1.6	0.0	1.0	5.0	4.3	1.8	3.5	6.7	1.4	42.3	6.5	1.0	6.6	1.3	2.9	1.8	2.1	7.6	3.2
PPIP5K2	"CFAP160, HISPPD1, KIAA0433, VIP2"	ENSG00000145725	"Diphosphoinositol pentakisphosphate kinase 2"	O43314	5	103120149-103212799	"Enzymes, Predicted intracellular proteins"	Hearing	"Kinase, Transferase"	"Deafness, Disease mutation, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037895, HPA038442"	Approved		Approved	Vesicles		NA	NA			Vesicles		"HPA037895: AB_2675724, HPA038442: AB_10673173"	"unprognostic (2.18e-1)"	"unprognostic (1.04e-1)"	"unprognostic (2.36e-2)"	"unprognostic (1.93e-1)"	"unprognostic (8.83e-2)"	"unprognostic (1.60e-3)"	"unprognostic (1.13e-1)"	"unprognostic (2.43e-1)"	"unprognostic (1.60e-2)"	"unprognostic (8.59e-3)"	"unprognostic (1.39e-1)"	"unprognostic (2.12e-1)"	"unprognostic (4.32e-2)"	"unprognostic (1.29e-1)"	"unprognostic (4.06e-1)"	"prognostic unfavorable (1.12e-4)"	"unprognostic (8.80e-2)"	21.6	20.5	12.6	18.2	18.4	37.9	22.3	30.7	24.2	26.1	23.8	9.7	16.0	14.3	22.6	20.3	17.0	18.5	17.7	16.4	13.2	17.6	21.9	22.6	14.8	20.6	19.5	18.7	26.8	25.5	22.3	40.3	21.6	37.2	18.4	22.1	10.5	17.4	21.7	5.7	16.4	20.2	16.0	19.8	27.7	18.6	13.5	16.2	38.5	20.0	12.9	20.3	16.9	18.2	12.1	15.7	24.3	18.2	10.0	11.2	6.7	9.7	9.5	18.5	21.4	15.0	19.5	16.7	20.2	14.1	12.7	17.5	8.0	16.5	22.9	19.8	20.2	17.9	6.0	16.0	12.1	20.8	18.1	8.4	29.1	17.9	12.7	11.1	25.0	26.4	13.0	9.1	17.9	16.5	11.4	14.1	15.1	30.1	21.1	18.8	8.2	21.6	17.6	20.1	4.3	22.3	20.6	16.5	31.4	13.6	11.2	10.4	13.6	13.9	14.6	13.6	13.6	11.5	17.0	14.1	18.2	8.2	20.2	15.1	13.4	30.4	31.1	10.6	39.8	17.0	23.0	13.4	24.3	8.7	13.8	10.7	12.1	8.4	9.0	15.7	11.3	11.1	11.2	13.0	10.0	18.2	9.3	7.3	6.7	12.6	18.4	30.7	24.2	13.2	17.6	19.5	18.7	37.2	16.2	44.7	17.2	18.1	11.4	12.0	34.2	42.3	20.4	29.4	37.5	15.7	43.2	10.7	5.0	9.7	3.7	21.5	17.0	0.0	14.8	16.5	16.2	12.8	41.7	17.9	26.3	15.9	15.6	14.7	40.6	4.5	27.3	34.8	11.8	16.2	21.5	15.6	13.5	21.0	22.3	17.5	25.9	6.5	14.6	28.9	11.1	13.8	21.7	17.0	25.4	11.4
PPM1A	"MGC9201, PP2CA, PP2Calpha"	ENSG00000100614	"Protein phosphatase, Mg2+/Mn2+ dependent 1A"	P35813	14	60245752-60299087	"Enzymes, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"Early spermatids: 362.9;Late spermatids: 423.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA029209	Approved		Supported	"Plasma membrane,Cytosol"		NA	NA		850000	Cytosol	"Plasma membrane"	"HPA029209: AB_2672951"	"unprognostic (3.14e-1)"	"unprognostic (2.14e-1)"	"unprognostic (5.64e-2)"	"unprognostic (1.85e-1)"	"unprognostic (4.00e-2)"	"unprognostic (2.30e-2)"	"unprognostic (4.50e-2)"	"unprognostic (1.11e-1)"	"unprognostic (3.43e-1)"	"unprognostic (2.89e-2)"	"unprognostic (7.96e-2)"	"unprognostic (1.29e-1)"	"prognostic favorable (1.57e-9)"	"unprognostic (1.58e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.57e-2)"	"unprognostic (1.37e-1)"	16.2	11.7	13.8	15.0	18.3	64.0	15.1	20.5	28.6	15.5	32.4	13.3	9.4	19.1	17.4	12.7	15.2	10.7	10.8	37.1	13.5	16.1	22.8	26.7	14.6	11.8	15.6	19.1	12.1	13.3	18.2	12.2	15.8	24.3	16.5	19.4	12.3	18.7	13.5	56.1	16.7	25.2	15.0	13.8	11.6	14.9	29.7	12.7	23.4	13.3	11.6	13.4	15.2	16.5	4.0	2.7	8.0	2.1	4.7	4.5	1.9	48.6	11.0	9.6	8.1	14.7	13.6	12.2	13.4	15.7	10.0	9.5	6.2	14.4	29.3	12.8	15.1	7.4	10.8	9.9	13.8	17.5	26.3	5.6	18.0	7.8	9.6	12.3	20.4	12.9	11.5	16.6	11.7	16.0	11.7	9.7	15.0	9.9	23.3	12.1	21.3	26.5	4.8	9.0	9.7	9.3	9.5	22.2	9.4	12.0	23.4	16.3	12.2	13.9	16.3	11.3	9.1	16.4	8.9	13.4	20.8	20.8	9.1	9.5	18.2	10.3	34.3	9.5	8.1	10.5	6.7	1.8	5.1	3.5	1.8	3.8	1.7	2.8	3.1	2.7	4.0	2.2	2.1	8.0	4.7	2.1	1.6	4.5	1.9	13.8	18.3	20.5	28.6	13.5	16.1	15.6	19.1	24.3	12.7	14.9	23.5	24.8	36.4	68.7	40.5	85.1	38.2	9.4	15.9	36.6	60.9	27.7	28.2	22.7	362.9	29.7	97.1	70.0	21.2	20.1	41.4	73.1	26.5	65.2	24.8	55.6	58.3	21.5	27.7	423.8	39.1	33.5	57.3	16.2	52.8	37.7	29.2	66.2	49.1	73.2	62.7	38.8	44.2	46.9	24.8	72.0	61.4	35.5	36.5	38.6
PPM1B	"PP2CB, PP2CBETA, PPC2BETAX"	ENSG00000138032	"Protein phosphatase, Mg2+/Mn2+ dependent 1B"	O75688	2	44167969-44244384	"Enzymes, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA016745	Approved		Approved	Nucleoli,Cytosol		NA	NA			"Nucleoli, Cytosol"		"HPA016745: AB_1855622"	"unprognostic (5.49e-2)"	"unprognostic (2.67e-2)"	"unprognostic (1.11e-2)"	"unprognostic (2.96e-3)"	"unprognostic (1.92e-2)"	"unprognostic (1.48e-1)"	"unprognostic (1.04e-1)"	"unprognostic (1.50e-2)"	"unprognostic (1.58e-1)"	"unprognostic (1.94e-1)"	"unprognostic (2.25e-1)"	"unprognostic (6.71e-2)"	"unprognostic (1.70e-2)"	"unprognostic (3.81e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.34e-1)"	"unprognostic (1.75e-2)"	23.7	13.8	31.2	12.2	33.8	24.7	15.2	32.6	25.2	16.3	18.2	26.0	13.6	13.2	15.7	20.4	14.9	12.7	14.3	21.1	29.6	24.6	19.4	27.7	13.4	16.6	34.6	22.4	15.8	20.9	34.6	17.9	12.1	22.9	20.7	19.0	24.3	16.4	16.4	72.0	12.5	14.3	21.1	27.3	16.1	14.8	13.3	34.1	19.1	15.0	13.1	16.8	18.2	15.9	6.5	5.5	11.1	5.0	4.7	9.5	1.6	17.0	15.3	20.4	14.8	25.4	11.9	23.1	13.2	15.3	13.8	12.2	20.5	11.1	18.8	20.8	15.3	11.2	9.3	22.7	8.7	20.4	18.9	8.8	19.8	9.1	14.1	20.6	17.7	16.6	11.4	15.2	10.9	18.6	10.8	11.2	8.8	14.4	20.0	12.3	14.2	17.5	28.5	25.1	15.8	5.2	18.6	22.7	12.6	32.1	17.3	16.4	20.7	11.9	17.9	15.3	31.7	9.7	12.4	10.2	12.1	17.4	10.0	12.7	17.5	11.4	17.6	6.4	29.5	8.7	8.3	3.3	11.1	7.2	4.5	6.2	5.8	6.9	6.1	5.5	6.5	9.5	6.4	9.2	4.7	5.0	5.3	6.2	1.6	31.2	33.8	32.6	24.9	29.6	24.6	34.6	22.4	22.9	34.1	17.9	17.3	29.6	37.1	53.8	47.2	45.6	28.1	5.3	20.5	38.4	60.9	27.6	39.7	35.0	59.2	17.3	39.4	0.0	41.1	24.4	27.3	58.6	26.5	49.9	23.3	101.7	38.6	16.5	48.5	32.9	33.1	41.2	54.0	37.9	27.4	54.4	35.2	40.3	31.8	30.8	128.5	25.8	38.7	33.8	26.0	54.5	54.0	54.2	32.8	45.7
PPM1D	"PP2C-DELTA, Wip1"	ENSG00000170836	"Protein phosphatase, Mg2+/Mn2+ dependent 1D"	O15297	17	60600183-60666280	"Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Cell cycle"	"Hydrolase, Protein phosphatase"	"Autism spectrum disorder, Cancer-related genes, Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Early spermatids: 51.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"MCF7: 26.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA022277, HPA061848"	Approved		Supported	Nucleoplasm,Nucleoli		NA	NA			Nucleoplasm	Nucleoli	"HPA022277: AB_1858839, HPA061848: "	"unprognostic (1.48e-1)"	"unprognostic (1.36e-2)"	"prognostic favorable (3.52e-4)"	"unprognostic (1.76e-1)"	"unprognostic (1.02e-1)"	"unprognostic (5.12e-2)"	"prognostic unfavorable (4.27e-4)"	"unprognostic (5.50e-2)"	"unprognostic (1.70e-2)"	"unprognostic (6.07e-2)"	"unprognostic (2.52e-3)"	"unprognostic (3.46e-2)"	"unprognostic (1.95e-3)"	"unprognostic (7.33e-2)"	"unprognostic (1.58e-1)"	"unprognostic (1.71e-2)"	"unprognostic (1.98e-1)"	12.2	7.0	6.1	5.7	9.2	13.6	11.9	30.8	6.6	11.1	10.0	10.6	7.8	7.6	12.0	8.3	8.6	11.1	8.3	5.8	7.7	4.4	7.4	7.4	9.2	7.9	10.3	4.6	17.3	12.3	8.1	8.9	18.5	8.8	9.3	9.4	8.2	8.1	6.8	9.7	8.1	8.1	8.2	7.3	9.2	7.3	16.2	12.5	15.5	8.7	6.9	7.0	7.8	11.3	7.3	13.1	20.5	13.2	6.8	8.3	6.8	2.7	5.5	6.2	5.3	4.2	2.6	8.0	4.3	2.9	2.8	4.0	5.6	1.6	7.9	3.6	3.0	1.1	3.0	4.0	1.8	3.8	1.4	8.8	5.7	5.4	6.5	3.5	2.3	4.4	2.3	2.9	4.2	2.5	2.3	6.4	3.4	4.1	3.3	3.0	26.9	6.2	3.4	2.7	2.6	4.3	7.6	7.9	4.7	2.5	3.4	8.5	6.2	5.7	1.9	1.3	6.9	2.3	3.1	4.7	3.7	10.1	2.8	2.3	5.4	5.7	6.0	1.5	2.3	2.8	8.2	13.2	14.1	6.7	10.2	5.9	7.3	5.6	6.1	13.1	5.9	6.1	6.2	20.5	6.8	6.1	5.8	8.3	6.8	6.1	9.2	30.8	6.6	7.7	4.4	10.3	4.6	8.8	12.5	29.8	7.7	13.7	4.0	18.7	12.0	5.6	5.1	2.7	4.5	5.2	3.9	13.6	3.3	6.0	51.4	15.8	10.1	0.0	6.0	5.1	11.2	6.9	1.1	2.8	7.5	3.2	13.8	20.3	23.0	8.1	12.7	9.8	3.3	6.4	9.0	6.4	5.1	8.6	7.1	4.2	10.1	0.0	12.0	24.5	13.9	15.7	32.3	7.5	10.5	5.5
PPM1E	"CaMKP-N, KIAA1072, POPX1, PP2CH"	ENSG00000175175	"Protein phosphatase, Mg2+/Mn2+ dependent 1E"	Q8WY54	17	58755869-58985176	"Enzymes, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"adrenal gland: 10.7;brain: 36.5;testis: 13.1"	"Cell type enhanced"	"Detected in some"	19	"Bipolar cells: 16.0;Cone photoreceptor cells: 29.5;Early spermatids: 22.1;Horizontal cells: 73.1"	"Cancer enhanced"	"Detected in some"		"prostate cancer: 3.0"	"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	25	"basophil: 2.5"	"Lineage enriched"	"Detected in single"	25	"granulocytes: 2.5"	"Cell line enhanced"	"Detected in many"		"AF22: 10.2;HAP1: 16.5;MOLT-4: 7.8;SCLC-21H: 7.6;SH-SY5Y: 15.8;THP-1: 7.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA018462, HPA019263"	Approved		Approved	Nucleoplasm,Nucleoli		Yes	No			Nucleoli	Nucleoplasm	"HPA018462: AB_1855623, HPA019263: AB_1855624"	"unprognostic (2.50e-2)"	"unprognostic (5.75e-2)"	"unprognostic (8.12e-2)"	"unprognostic (2.99e-2)"	"unprognostic (5.30e-1)"	"unprognostic (8.19e-2)"	"unprognostic (3.96e-1)"	"unprognostic (1.52e-1)"	"unprognostic (3.22e-2)"	"unprognostic (5.24e-2)"	"unprognostic (8.80e-5)"	"unprognostic (4.97e-2)"	"unprognostic (1.23e-7)"	"unprognostic (1.05e-4)"	"unprognostic (1.64e-2)"	"unprognostic (1.27e-1)"	"unprognostic (9.12e-2)"	0.7	10.7	15.0	0.8	7.5	0.7	0.7	11.9	23.3	1.0	0.7	3.6	0.0	0.8	1.1	2.2	0.7	3.3	0.8	2.3	36.5	5.4	1.9	2.4	1.0	0.9	3.2	9.2	1.0	1.7	0.8	3.4	0.6	10.5	3.2	0.7	3.5	0.8	0.7	0.6	0.7	1.0	1.3	2.7	0.8	1.4	13.1	2.0	0.0	0.8	0.0	1.0	0.6	0.6	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	10.2	0.5	0.0	0.0	0.8	0.0	0.0	0.8	1.2	0.0	0.0	6.5	0.1	0.1	2.3	0.0	16.5	0.0	0.4	0.1	4.9	0.0	0.1	0.0	1.2	0.5	2.1	0.3	1.3	0.1	0.0	0.5	0.0	4.1	1.6	0.0	0.0	2.9	7.8	0.0	2.9	0.0	0.8	0.0	1.3	0.0	0.0	0.0	7.6	15.8	0.2	0.0	1.0	0.1	0.0	7.0	0.0	0.0	1.9	0.0	2.4	0.0	0.1	4.4	0.3	0.0	2.4	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.0	7.5	11.9	14.0	36.5	5.4	3.2	9.2	10.5	2.0	0.0	0.0	0.0	0.0	0.0	16.0	1.6	0.0	0.0	3.4	0.0	29.5	0.0	0.0	0.0	22.1	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.8	0.1	73.1	2.9	0.0	0.3	14.6	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.4	0.0	11.7	0.0	0.0	9.3	2.5	0.0	0.0	0.0	0.0	0.0
PPM1F	"CAMKP, CaMKPase, FEM-2, KIAA0015, POPX2"	ENSG00000100034	"Protein phosphatase, Mg2+/Mn2+ dependent 1F"	P49593	22	21919420-21952837	"Enzymes, Plasma proteins, Predicted intracellular proteins"	Apoptosis	"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	8	"Ito cells: 61.4;Kupffer cells: 32.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"neutrophil: 17.7"	"Group enriched"	"Detected in many"	7	"dendritic cells: 5.5;granulocytes: 17.7;monocytes: 13.9"	"Cell line enhanced"	"Detected in all"		"HUVEC TERT2: 36.5;K-562: 55.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030989, HPA030990"	Approved		Approved	"Nucleoplasm,Plasma membrane"		NA	NA		780000	Nucleoplasm	"Plasma membrane"	"HPA030989: AB_10669549, HPA030990: AB_10601249"	"unprognostic (6.26e-2)"	"unprognostic (2.50e-1)"	"unprognostic (1.82e-1)"	"unprognostic (2.11e-1)"	"unprognostic (2.51e-1)"	"unprognostic (4.77e-3)"	"unprognostic (4.88e-3)"	"unprognostic (1.94e-1)"	"unprognostic (1.70e-1)"	"unprognostic (1.65e-2)"	"unprognostic (1.45e-2)"	"unprognostic (4.81e-2)"	"prognostic unfavorable (6.03e-5)"	"unprognostic (6.44e-2)"	"unprognostic (3.02e-2)"	"unprognostic (3.30e-1)"	"unprognostic (4.11e-2)"	25.0	15.6	14.0	21.8	14.3	24.3	18.4	16.9	16.3	18.1	13.2	7.6	12.5	9.6	17.6	9.7	23.6	12.3	13.1	17.0	13.9	14.9	13.2	8.5	21.6	15.1	11.6	10.1	14.4	10.7	8.3	7.7	28.1	14.5	15.6	4.9	11.2	11.2	16.5	15.8	15.5	11.1	15.4	15.5	31.4	10.5	6.7	10.9	6.2	10.9	15.1	10.2	15.8	37.6	0.7	5.5	17.7	13.9	1.7	1.4	2.8	9.2	9.9	6.4	6.2	3.5	6.3	8.1	10.6	6.3	9.4	6.5	4.5	3.7	5.6	13.3	7.4	4.0	11.2	2.8	6.6	3.3	8.0	9.0	21.7	4.6	4.3	5.9	8.0	5.9	5.9	2.0	9.1	4.3	6.7	36.5	5.6	55.2	2.4	12.0	8.6	4.7	6.2	2.7	2.9	10.9	7.1	16.5	1.6	3.2	3.9	2.6	10.0	10.0	3.3	8.6	2.6	4.1	5.6	30.7	11.3	11.5	10.3	10.1	4.7	3.7	6.2	11.4	15.3	21.6	0.0	7.7	3.3	1.0	12.9	0.7	0.7	0.7	0.6	5.5	0.6	0.7	0.8	17.7	1.7	13.9	1.4	1.4	2.8	14.0	14.3	16.9	16.3	13.9	14.9	11.6	10.1	14.5	10.9	6.0	5.9	5.1	4.4	7.2	7.0	13.1	15.3	4.0	3.4	1.8	2.0	13.3	3.3	4.9	1.1	31.9	2.0	0.0	4.3	7.2	7.7	3.9	3.5	5.5	17.5	7.9	5.8	61.4	32.9	1.1	6.6	18.0	6.8	8.2	3.9	3.8	5.6	0.0	6.3	3.4	6.5	6.5	5.7	7.4	10.5	5.0	2.5	5.7	3.8	5.4
PPM1G	"PP2CG, PP2Cgamma"	ENSG00000115241	"Protein phosphatase, Mg2+/Mn2+ dependent 1G"	O15355	2	27381194-27409687	"Enzymes, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 93.3"	"Cell type enhanced"	"Detected in all"	17	"Early spermatids: 1236.5;Late spermatids: 2467.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035530, HPA035531"	Enhanced		Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"HPA035530: AB_10670021, HPA035531: AB_10610283"	"unprognostic (7.50e-2)"	"unprognostic (8.89e-2)"	"unprognostic (1.53e-1)"	"unprognostic (1.02e-1)"	"unprognostic (2.27e-1)"	"unprognostic (4.15e-2)"	"prognostic unfavorable (3.14e-7)"	"unprognostic (9.36e-3)"	"unprognostic (7.73e-2)"	"prognostic favorable (6.08e-5)"	"unprognostic (3.74e-2)"	"unprognostic (1.23e-1)"	"unprognostic (7.46e-3)"	"unprognostic (1.06e-2)"	"unprognostic (5.33e-2)"	"unprognostic (1.78e-1)"	"unprognostic (7.83e-2)"	12.7	17.0	9.9	19.9	9.2	19.4	30.2	10.9	19.3	17.9	14.6	9.1	16.9	12.1	26.8	12.5	19.4	19.2	17.7	13.6	8.8	7.6	12.6	18.6	14.7	20.2	9.4	8.0	13.4	18.6	13.8	13.2	11.4	8.7	10.2	16.4	9.1	16.4	18.7	24.1	10.9	12.2	14.9	6.7	14.7	14.1	93.3	8.4	25.8	14.1	19.1	22.5	25.2	17.3	20.2	40.3	24.5	29.1	22.7	38.3	19.0	50.9	42.1	30.9	23.7	19.7	16.1	28.5	31.8	20.9	38.2	30.7	64.8	27.0	60.2	23.4	22.5	32.5	27.9	51.9	35.7	34.4	25.1	42.2	58.6	30.7	68.4	17.8	57.8	24.8	17.4	20.7	38.9	31.4	18.2	36.5	29.9	49.0	18.7	28.9	45.6	42.9	62.8	44.9	35.4	30.4	44.4	64.8	31.6	25.8	35.6	41.6	47.1	28.5	31.6	22.8	25.6	17.5	19.0	29.3	28.6	34.6	25.0	48.2	40.8	45.7	95.2	22.4	47.4	21.4	22.1	17.8	24.5	26.9	22.3	26.5	20.2	28.7	27.9	28.5	18.0	21.7	22.4	9.1	22.7	29.1	40.3	38.3	19.0	9.9	9.2	10.9	19.3	8.8	7.6	9.4	8.0	8.7	8.4	59.6	43.5	61.1	65.0	72.0	42.0	33.6	50.9	61.6	66.0	66.3	27.5	71.4	28.2	97.8	1236.5	66.3	54.6	23.3	120.2	139.9	42.7	66.0	58.8	37.8	76.1	46.1	77.4	35.6	49.4	2467.5	65.0	65.1	23.6	147.9	59.6	64.9	122.3	42.1	66.8	48.3	34.6	45.3	45.8	594.3	323.3	70.4	44.4	79.7	83.2	121.2
PPM1H	"ARHCL1, FLJ13253, KIAA1157, NERPP-2C"	ENSG00000111110	"Protein phosphatase, Mg2+/Mn2+ dependent 1H"	Q9ULR3	12	62643982-62935037	"Enzymes, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 37.1;parathyroid gland: 36.6"	"Cell type enhanced"	"Detected in many"	5	"Cone photoreceptor cells: 25.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"basophil: 5.3"	"Group enriched"	"Detected in many"	11	"dendritic cells: 2.3;granulocytes: 5.3;monocytes: 1.7"	"Cell line enhanced"	"Detected in many"		"CACO-2: 35.9;HMC-1: 29.0;SK-BR-3: 16.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB020694, HPA044244, HPA058777"	Approved		Supported	Nucleoplasm		NA	NA			Nucleoplasm		"CAB020694: , HPA044244: AB_2678871, HPA058777: AB_2683816"	"unprognostic (3.41e-2)"	"unprognostic (1.94e-1)"	"unprognostic (9.51e-2)"	"unprognostic (8.61e-3)"	"unprognostic (1.44e-1)"	"unprognostic (1.23e-1)"	"unprognostic (1.86e-2)"	"unprognostic (5.85e-2)"	"unprognostic (3.17e-1)"	"unprognostic (1.78e-2)"	"unprognostic (5.53e-3)"	"unprognostic (2.19e-1)"	"prognostic favorable (2.72e-5)"	"unprognostic (3.90e-2)"	"unprognostic (1.73e-1)"	"unprognostic (8.04e-3)"	"unprognostic (1.14e-1)"	2.6	2.1	10.6	1.6	12.4	3.1	5.7	37.1	16.3	8.5	2.8	14.0	12.4	3.6	6.9	7.7	1.1	7.5	9.1	2.2	13.0	12.2	11.7	3.9	3.2	1.5	14.3	9.0	9.4	4.9	36.6	13.3	7.1	8.5	15.0	3.6	7.7	10.2	11.6	1.5	1.2	2.1	2.2	8.9	1.3	6.2	1.4	15.0	0.5	3.8	0.1	2.1	3.4	1.2	0.0	2.3	5.3	1.7	0.2	0.0	0.3	0.5	5.6	1.0	0.0	0.2	0.0	12.2	1.3	1.3	0.8	0.2	35.9	2.6	0.0	1.2	0.6	0.8	0.7	3.9	0.1	0.5	0.1	1.9	6.7	1.0	8.1	0.0	2.0	29.0	0.0	0.1	0.0	0.3	0.8	0.1	1.2	1.7	0.0	0.6	4.1	0.6	0.9	7.3	1.8	2.7	0.9	2.5	10.0	8.3	12.7	3.2	0.0	2.2	16.4	5.3	4.1	8.9	1.2	0.1	0.2	0.7	0.1	0.4	1.5	9.2	1.8	0.1	0.0	0.5	5.3	1.7	3.0	0.0	1.4	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.0	1.2	0.2	1.4	0.0	0.0	0.3	10.6	12.4	37.1	16.3	13.0	12.2	14.3	9.0	8.5	15.0	6.0	6.6	0.0	0.1	0.1	7.9	1.4	15.3	5.3	1.2	15.7	25.5	18.6	3.3	4.1	8.8	1.4	0.1	0.0	5.5	1.3	1.1	4.6	13.9	4.9	5.4	11.1	8.6	12.3	3.0	8.0	0.9	0.7	3.3	1.8	2.2	6.0	4.6	2.5	1.4	5.7	10.6	0.0	0.0	0.0	0.1	0.1	5.7	0.0	2.4	0.4
PPM1J	"DKFZp434P1514, FLJ35951, MGC19531, PP2Czeta, PPP2CZ"	ENSG00000155367	"Protein phosphatase, Mg2+/Mn2+ dependent 1J"	Q5JR12	1	112709994-112715477	"Enzymes, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 30.9;skeletal muscle: 45.1;testis: 31.9"	"Group enriched"	"Detected in many"	8	"Early spermatids: 105.4;Late spermatids: 189.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in some"	9	"plasmacytoid DC: 30.9"	"Lineage enriched"	"Detected in many"	17	"dendritic cells: 30.9"	"Cell line enhanced"	"Detected in many"		"T-47d: 20.4"	"Region enriched"	"Detected in some"	8	"olfactory region: 33.6"	"Low region specificity"	"Detected in all"			HPA046045	Uncertain		Approved	Vesicles		NA	NA			Vesicles		"HPA046045: AB_2679516"	"unprognostic (8.68e-2)"	"unprognostic (5.65e-2)"	"unprognostic (3.29e-2)"	"unprognostic (2.59e-1)"	"unprognostic (2.93e-3)"	"unprognostic (2.34e-2)"	"unprognostic (3.55e-2)"	"unprognostic (3.74e-2)"	"unprognostic (2.55e-1)"	"unprognostic (9.30e-3)"	"unprognostic (3.36e-2)"	"unprognostic (7.22e-2)"	"unprognostic (1.80e-2)"	"unprognostic (1.27e-2)"	"unprognostic (1.46e-1)"	"unprognostic (2.28e-2)"	"unprognostic (9.96e-4)"	0.8	2.3	6.4	0.9	4.8	0.8	1.9	7.8	6.8	0.9	0.7	2.1	1.6	0.7	1.4	14.8	3.0	2.4	1.3	5.4	4.3	4.8	1.2	0.7	0.7	2.4	3.7	4.4	1.3	3.8	2.4	1.1	0.8	3.9	1.4	0.7	1.5	2.3	2.3	45.1	13.3	0.6	1.3	1.6	1.3	0.7	31.9	0.7	1.4	1.6	5.3	1.9	1.6	1.5	0.4	30.9	0.0	1.7	0.0	0.0	0.3	2.7	0.1	1.6	1.7	0.8	1.6	1.2	0.3	0.8	0.3	1.0	1.2	0.8	0.4	0.5	0.8	0.9	5.1	1.1	4.8	0.4	0.0	2.8	0.8	0.2	0.2	1.0	0.0	0.2	1.8	3.2	0.9	4.9	1.1	2.2	0.2	1.0	0.0	1.2	2.9	0.0	0.0	1.7	1.5	2.4	0.1	0.2	0.0	2.9	0.1	0.8	0.2	0.6	4.6	1.4	2.4	20.4	0.0	1.2	0.3	3.0	0.0	0.2	0.1	0.0	0.0	2.5	0.6	2.7	0.0	0.1	0.0	0.0	0.6	0.0	0.3	0.0	0.0	3.2	0.4	0.0	0.0	0.0	0.0	1.7	30.9	0.0	0.3	6.4	4.8	7.8	6.8	4.3	4.8	3.7	4.4	3.9	0.7	0.0	0.3	0.0	3.5	1.9	3.1	4.8	0.0	0.0	1.2	1.8	9.8	0.9	8.3	2.0	105.4	2.2	0.5	0.0	3.7	1.1	1.3	3.3	0.0	0.0	0.6	0.0	0.0	0.6	0.8	189.5	2.8	1.8	0.0	1.0	0.7	19.0	1.6	3.2	2.5	0.6	8.4	6.5	2.7	2.3	11.5	2.5	0.5	0.0	0.6	2.3
PPM1K	"BDP, DKFZp761G058, hPTMP, PP2Ckappa, PP2Cm"	ENSG00000163644	"Protein phosphatase, Mg2+/Mn2+ dependent 1K"	Q8N3J5	4	88257620-88284769	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 59.1"	"Cell type enhanced"	"Detected in all"	12	"Cardiomyocytes: 417.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Daudi: 27.5;Karpas-707: 24.0;U-698: 23.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA020066, HPA020862, HPA023891"	Approved		Supported	Mitochondria		No	No			Mitochondria		"HPA020066: AB_1855628, HPA020862: AB_1855629, HPA023891: AB_1855630"	"unprognostic (2.38e-2)"	"unprognostic (5.86e-2)"	"unprognostic (7.42e-3)"	"unprognostic (6.70e-3)"	"unprognostic (1.18e-1)"	"unprognostic (1.17e-3)"	"unprognostic (1.87e-1)"	"unprognostic (5.88e-2)"	"unprognostic (5.50e-2)"	"unprognostic (1.41e-2)"	"unprognostic (9.25e-3)"	"unprognostic (6.56e-2)"	"unprognostic (9.82e-2)"	"unprognostic (5.57e-2)"	"unprognostic (1.34e-1)"	"unprognostic (2.11e-1)"	"unprognostic (2.28e-1)"	3.6	6.1	19.2	8.8	17.2	5.9	9.3	21.1	26.8	12.9	3.8	12.5	2.5	3.0	21.8	5.5	7.6	14.1	6.0	59.1	23.1	14.6	11.8	5.1	6.5	14.5	21.6	15.9	22.0	7.3	10.4	8.4	6.4	17.0	11.1	4.3	4.7	7.1	5.3	8.3	1.9	6.7	18.2	15.0	10.9	5.4	12.3	19.4	7.3	5.4	1.9	15.8	6.5	8.1	31.8	38.8	5.5	3.4	7.9	16.1	7.1	2.2	0.7	2.8	5.0	4.3	5.6	1.1	3.5	6.4	11.8	14.0	5.7	0.5	27.5	3.9	2.2	5.7	0.2	8.4	2.7	4.7	21.2	3.5	4.9	2.2	5.1	3.3	6.7	2.6	3.7	1.3	7.2	6.3	2.4	1.9	11.9	7.3	24.0	3.4	3.1	8.8	3.7	1.7	1.6	1.1	5.0	4.7	10.5	4.1	0.9	2.2	1.9	2.2	0.2	2.6	4.9	11.4	1.9	0.4	4.1	2.1	1.3	2.0	7.6	6.9	23.0	4.5	5.5	6.8	5.5	2.9	2.3	12.4	3.4	16.1	30.4	11.8	12.4	5.5	31.8	11.7	14.1	0.9	7.9	0.9	38.8	13.3	7.1	19.2	17.2	21.1	26.8	23.1	14.6	21.6	15.9	17.0	19.4	44.7	11.3	104.3	16.5	8.8	97.4	417.4	7.6	24.1	17.0	47.1	17.7	9.4	132.6	5.9	6.1	17.6	2.0	46.7	5.4	2.6	28.3	31.2	18.5	22.1	23.1	81.0	9.2	20.3	11.1	6.2	22.2	13.9	20.3	111.0	15.6	19.2	6.3	4.9	29.7	39.1	14.1	25.8	38.7	35.6	21.3	4.6	2.4	54.8	2.9	5.7
PPM1L	PP2CE	ENSG00000163590	"Protein phosphatase, Mg2+/Mn2+ dependent 1L"	Q5SGD2	3	160755602-161078907	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	8	"Bipolar cells: 59.9;Cardiomyocytes: 33.6;Cone photoreceptor cells: 33.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"non-classical monocyte: 7.6"	"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"HDLM-2: 35.6;U-266/70: 35.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019891, HPA019953"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			Cytosol	Nucleoplasm	"HPA019891: AB_1855631, HPA019953: AB_2170360"	"prognostic unfavorable (4.90e-4)"	"unprognostic (7.29e-3)"	"unprognostic (2.01e-1)"	"unprognostic (2.59e-2)"	"unprognostic (8.03e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.91e-1)"	"unprognostic (1.63e-2)"	"unprognostic (2.49e-2)"	"unprognostic (1.92e-1)"	"unprognostic (4.51e-2)"	"unprognostic (7.51e-2)"	"unprognostic (2.69e-3)"	"unprognostic (1.81e-1)"	"unprognostic (2.39e-1)"	"unprognostic (9.13e-3)"	"unprognostic (2.07e-1)"	7.7	8.5	7.4	3.5	11.5	3.3	6.3	15.8	23.2	11.3	7.0	5.5	1.1	3.0	6.2	3.7	8.7	6.1	12.6	9.9	6.3	7.8	8.4	6.0	4.6	1.9	8.0	10.1	3.7	5.4	33.6	26.3	11.5	13.8	9.6	5.9	5.6	18.9	3.7	25.7	7.6	3.6	16.4	4.6	3.4	8.4	2.8	3.7	5.6	14.4	9.6	3.5	16.6	10.8	0.7	1.3	4.9	7.6	1.1	2.6	2.0	1.2	0.8	4.1	2.1	2.4	0.0	2.5	0.2	0.1	0.4	0.1	0.2	0.2	0.2	0.4	0.1	0.9	3.7	3.4	0.2	0.1	35.6	3.6	3.5	3.3	0.4	0.1	2.1	4.1	0.4	1.6	0.1	0.2	0.3	0.2	1.7	0.1	5.6	0.0	1.9	0.8	0.2	2.3	6.5	0.8	4.2	0.7	0.8	0.1	3.8	4.9	4.2	2.0	2.4	0.1	1.4	2.7	2.1	0.2	0.4	0.4	0.3	1.3	35.6	0.1	2.0	0.6	1.8	0.8	0.7	2.3	4.9	2.6	5.5	0.2	0.2	0.6	1.7	1.3	0.7	1.0	1.8	0.2	1.1	7.6	0.8	0.0	2.0	7.4	11.5	15.8	17.9	6.3	7.8	8.0	10.1	13.8	3.7	6.0	2.4	0.0	5.2	7.7	59.9	33.6	10.2	13.4	5.7	1.8	33.4	2.4	0.0	1.5	1.1	2.4	3.8	0.0	3.7	1.6	7.0	6.0	0.0	14.9	5.9	6.4	13.3	0.6	12.4	0.4	4.6	7.2	3.3	2.8	7.6	9.3	1.7	7.0	4.9	3.3	10.1	0.0	11.2	1.5	3.1	7.5	2.2	2.9	4.9	18.0
PPM1M	"FLJ32332, PP2Ceta"	ENSG00000164088	"Protein phosphatase, Mg2+/Mn2+ dependent 1M"	Q96MI6	3	52245793-52250597	"Enzymes, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Hofbauer cells: 38.2;Kupffer cells: 40.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"U-266/70: 26.2"									"HPA036905, HPA062291"	Uncertain		Approved	"Nuclear bodies"		NA	NA			"Nuclear bodies"		"HPA036905: AB_10602818, HPA062291: AB_2684740"	"unprognostic (4.26e-3)"	"prognostic favorable (7.73e-4)"	"unprognostic (2.55e-2)"	"unprognostic (4.85e-3)"	"unprognostic (5.64e-2)"	"unprognostic (4.88e-3)"	"unprognostic (1.70e-2)"	"prognostic favorable (6.69e-4)"	"unprognostic (4.63e-2)"	"unprognostic (1.69e-1)"	"unprognostic (1.50e-1)"	"unprognostic (1.19e-1)"	"prognostic unfavorable (1.61e-5)"	"unprognostic (1.49e-1)"	"unprognostic (4.14e-2)"	"unprognostic (9.27e-2)"	"unprognostic (4.37e-2)"	14.3	7.2	13.9	22.7	14.8	16.5	26.3	3.6	9.2	16.9	12.5	4.6	7.8	4.4	13.6	12.0	10.8	11.7	19.4	14.5	8.7	8.5	8.7	4.9	30.1	38.0	5.4	12.3	14.9	5.9	6.9	7.5	8.6	4.9	15.1	6.7	11.0	10.8	12.4	3.1	7.5	8.8	18.1	6.8	22.5	8.3	6.2	5.9	20.5	11.3	9.9	20.5	11.3	13.5	5.0	9.6	19.6	18.6	7.4	15.0	10.1	0.4	2.5	1.5	3.7	22.8	22.8	2.4	5.8	12.5	8.2	6.4	1.4	2.0	4.2	1.7	15.1	4.6	0.7	5.1	1.1	3.3	5.0	1.2	9.6	6.7	1.5	16.7	1.4	9.1	18.8	2.5	9.2	5.8	13.3	10.6	19.5	1.6	7.0	9.6	1.0	6.2	0.4	2.0	1.9	7.0	1.4	0.7	9.2	3.5	1.1	1.1	4.5	4.2	1.0	5.2	3.4	3.6	3.7	7.3	3.1	5.3	1.8	0.7	26.2	4.8	4.5	6.2	2.5	3.8	1.2	15.7	8.5	15.0	12.4	11.7	5.0	11.8	13.8	9.6	3.8	11.1	13.8	19.6	7.4	18.6	5.8	13.2	10.1	13.9	14.8	3.6	9.2	8.7	8.5	5.4	12.3	4.9	5.9	0.0	4.8	11.5	3.9	4.5	1.0	2.0	5.1	1.4	3.4	1.8	0.0	3.0	3.3	1.7	9.9	6.9	0.7	0.0	1.0	5.3	8.2	2.7	5.7	2.4	38.2	1.6	1.2	10.4	40.0	14.2	11.8	24.5	5.0	10.0	0.2	5.1	1.6	1.9	9.2	2.2	0.4	19.4	6.1	0.4	3.6	3.3	1.6	22.0	0.7	1.8
PPM1N	FLJ40125	ENSG00000213889	"Protein phosphatase, Mg2+/Mn2+ dependent 1N (putative)"	Q8N819	19	45488777-45502510	"Enzymes, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"blood: 43.7;skeletal muscle: 81.9"	"Cell type enhanced"	"Detected in many"	10	"Cone photoreceptor cells: 29.5;Extravillous trophoblasts: 60.2;Rod photoreceptor cells: 73.0"	"Cancer enhanced"	"Detected in many"		"testis cancer: 11.3"	"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in many"	6	"non-classical monocyte: 43.7"	"Lineage enriched"	"Detected in all"	10	"monocytes: 43.7"	"Cell line enhanced"	"Detected in many"		"OE19: 16.9;RT4: 21.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA043577			Supported	Vesicles		NA	NA			Vesicles		"HPA043577: "	"unprognostic (2.38e-2)"	"unprognostic (1.11e-2)"	"unprognostic (8.53e-2)"	"unprognostic (6.59e-2)"	"unprognostic (4.71e-1)"	"unprognostic (2.64e-2)"	"unprognostic (1.98e-3)"	"unprognostic (1.02e-1)"	"unprognostic (1.25e-1)"	"unprognostic (4.45e-2)"	"unprognostic (9.27e-2)"	"unprognostic (2.48e-2)"	"unprognostic (1.11e-16)"	"unprognostic (3.42e-2)"	"unprognostic (1.79e-1)"	"unprognostic (3.92e-2)"	"unprognostic (1.86e-3)"	1.7	0.9	5.4	1.2	4.5	1.3	1.9	0.7	4.1	1.3	1.7	0.1	0.7	0.6	1.5	1.0	2.2	0.8	1.0	0.9	3.3	2.3	1.2	1.5	1.5	1.6	2.6	2.2	0.8	0.5	1.3	1.4	2.4	2.7	2.3	1.0	10.6	1.5	1.4	81.9	2.4	1.4	2.6	3.4	15.7	1.7	2.9	3.5	2.5	0.9	0.0	2.4	4.0	1.9	1.9	4.3	2.3	43.7	1.1	2.9	1.9	1.9	5.0	0.9	3.8	4.4	5.9	11.0	1.4	2.2	0.4	1.7	1.2	11.7	7.9	2.4	1.3	3.0	5.5	2.2	1.6	0.7	7.7	3.2	6.3	2.0	1.4	1.1	0.5	13.4	2.5	2.5	2.2	1.3	2.9	0.7	3.1	7.1	7.2	0.8	1.3	2.2	3.4	3.0	16.9	1.1	1.4	1.1	2.2	2.4	21.3	4.3	5.1	0.7	8.1	6.2	6.8	2.8	1.9	1.0	6.2	3.8	3.0	1.0	1.2	3.1	1.6	4.5	1.6	5.4	1.7	1.6	1.0	2.2	7.2	2.0	1.9	1.4	2.2	4.3	1.3	1.6	2.9	2.3	1.1	43.7	0.8	1.5	1.9	5.4	4.5	0.7	4.1	3.3	2.3	2.6	2.2	2.7	3.5	0.0	2.4	10.4	8.5	3.1	9.5	1.6	2.5	0.0	1.2	3.5	29.5	2.7	0.0	2.5	12.0	1.8	5.2	0.0	1.6	60.2	3.8	5.0	6.9	0.8	16.7	1.6	2.9	4.9	10.1	4.5	0.9	14.1	1.7	1.8	3.1	8.1	3.2	2.5	0.7	0.3	73.0	0.0	0.9	1.0	9.8	3.6	7.1	6.9	2.5	7.6
PPME1	PME-1	ENSG00000214517	"Protein phosphatase methylesterase 1"	Q9Y570	11	74171099-74254703	"Enzymes, Predicted intracellular proteins"		"Hydrolase, Serine esterase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"parathyroid gland: 69.0"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"RH-30: 92.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004541, HPA043900, HPA064396"	Enhanced		Supported	"Nucleoplasm,Nuclear bodies"		NA	NA		16000	Nucleoplasm	"Nuclear bodies"	"CAB004541: AB_628161, HPA043900: AB_2678722, HPA064396: AB_2685254"	"unprognostic (2.99e-2)"	"unprognostic (1.27e-2)"	"unprognostic (2.28e-1)"	"unprognostic (1.98e-1)"	"unprognostic (9.26e-2)"	"unprognostic (5.77e-3)"	"prognostic unfavorable (4.45e-6)"	"unprognostic (2.31e-2)"	"unprognostic (7.92e-2)"	"unprognostic (9.76e-2)"	"unprognostic (1.57e-1)"	"unprognostic (2.06e-1)"	"prognostic unfavorable (2.76e-4)"	"unprognostic (1.84e-1)"	"unprognostic (1.54e-1)"	"unprognostic (4.14e-3)"	"unprognostic (1.33e-3)"	9.4	16.1	13.3	6.2	27.6	8.4	9.3	27.4	38.5	11.4	9.2	13.5	9.4	7.1	13.1	16.5	13.5	15.2	8.9	12.8	14.6	18.3	12.3	6.5	8.2	5.5	13.6	18.6	12.4	10.4	69.0	13.6	15.5	22.4	15.1	9.8	9.6	11.9	15.9	21.0	16.2	7.4	13.4	12.7	5.0	8.3	22.9	9.3	8.6	14.9	7.9	8.5	11.4	10.2	7.5	11.3	10.9	9.6	12.2	14.0	8.4	10.1	13.3	9.1	9.6	9.6	7.9	9.0	15.0	9.9	28.4	22.5	29.3	6.8	5.4	10.5	11.1	15.8	17.0	13.5	10.2	26.7	7.6	5.2	8.1	14.5	12.5	19.0	5.9	7.2	7.6	8.4	15.0	6.6	11.1	8.2	7.8	18.8	4.6	49.5	6.7	6.9	6.3	7.2	12.5	10.6	8.2	92.7	8.2	10.7	7.1	12.4	10.7	17.9	8.2	21.0	9.9	15.0	6.1	5.0	11.4	13.6	10.9	11.4	8.7	11.0	9.6	8.4	5.3	9.2	1.3	8.6	10.9	10.8	9.6	13.3	6.9	13.8	12.7	10.8	7.5	14.0	11.2	5.0	12.2	8.5	11.3	9.7	8.4	13.3	27.6	27.4	38.5	14.6	18.3	13.6	18.6	22.4	9.3	26.8	10.9	9.0	17.3	18.0	29.2	15.3	7.6	36.1	30.7	33.2	35.3	10.9	14.9	14.1	36.8	11.4	10.9	70.0	11.8	27.4	13.1	16.6	8.1	7.4	11.8	31.8	24.6	8.0	5.7	10.9	12.7	13.2	3.3	13.6	11.9	15.0	12.8	10.8	23.7	10.1	18.2	6.5	17.0	60.5	41.0	21.8	12.9	10.4	10.7	15.4
PPOX	"PPO, VP"	ENSG00000143224	"Protoporphyrinogen oxidase"	P50336	1	161166410-161178013	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Heme biosynthesis, Porphyrin biosynthesis"	Oxidoreductase	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Ciliated cells: 62.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA030123	Uncertain		Approved	Vesicles,Mitochondria,Cytosol		NA	NA			Mitochondria	"Vesicles, Cytosol"	"HPA030123: AB_10603987"	"unprognostic (1.17e-1)"	"unprognostic (4.73e-2)"	"unprognostic (9.88e-2)"	"unprognostic (2.13e-2)"	"unprognostic (3.24e-1)"	"unprognostic (1.64e-2)"	"unprognostic (9.58e-3)"	"unprognostic (1.79e-2)"	"unprognostic (9.17e-2)"	"unprognostic (1.17e-1)"	"unprognostic (2.18e-3)"	"unprognostic (7.12e-3)"	"prognostic unfavorable (9.89e-4)"	"unprognostic (6.12e-2)"	"unprognostic (2.23e-1)"	"unprognostic (3.27e-1)"	"unprognostic (1.80e-2)"	7.3	14.8	11.6	9.1	12.1	31.7	10.2	23.5	16.5	11.0	9.9	13.2	8.5	6.0	11.7	13.5	7.5	33.2	9.5	9.5	11.5	12.5	12.0	9.1	10.2	11.2	14.2	16.1	13.0	13.1	10.5	12.3	10.1	12.1	11.0	6.7	14.4	11.3	14.6	8.5	15.9	7.1	10.0	10.6	12.0	8.2	6.9	13.7	9.2	11.0	6.1	8.7	8.7	8.2	9.8	11.5	6.9	7.7	12.3	16.7	8.9	7.1	6.6	9.9	6.4	7.5	8.0	3.3	4.9	5.7	6.1	8.1	7.7	6.9	5.6	11.9	3.4	3.1	4.9	7.6	7.9	5.5	3.9	15.0	6.7	14.8	17.6	8.0	2.2	3.7	6.4	8.0	5.9	8.4	9.2	11.5	5.2	19.9	8.7	4.4	6.7	8.9	7.1	7.1	9.0	14.1	10.9	6.8	13.2	11.6	3.1	7.8	12.7	6.0	8.7	9.9	12.5	15.8	10.5	4.0	5.6	6.2	4.9	6.3	15.5	11.3	8.6	5.7	4.9	4.3	6.9	7.7	5.5	12.7	7.7	8.4	9.8	9.8	8.8	11.5	8.6	8.6	8.8	1.6	12.3	5.3	7.2	16.7	8.9	11.6	12.1	23.5	16.5	11.5	12.5	14.2	16.1	12.1	13.7	3.0	13.6	4.5	7.2	10.6	16.2	7.7	7.6	62.9	13.6	7.0	21.6	17.7	18.3	8.8	8.4	9.1	4.9	0.0	4.9	8.3	10.3	3.6	5.8	5.8	8.0	14.3	5.8	8.0	4.3	10.0	9.5	7.9	1.7	10.0	6.5	9.6	6.4	3.6	6.3	14.8	17.3	6.5	6.7	9.6	6.1	13.0	8.7	13.1	7.6	4.7
PPP1CA	"PP-1A, PP1A, PP1alpha, PPP1A"	ENSG00000172531	"Protein phosphatase 1 catalytic subunit alpha"	P62136	11	67398183-67421183	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Carbohydrate metabolism, Cell cycle, Cell division, Glycogen metabolism, Host-virus interaction"	"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 177.2"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004545, HPA046833"	Enhanced		Supported	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA		8100000	"Nucleoplasm, Plasma membrane, Cytosol"		"CAB004545: AB_628177, HPA046833: AB_2679829"	"unprognostic (1.03e-1)"	"unprognostic (5.82e-3)"	"unprognostic (1.10e-1)"	"unprognostic (2.67e-1)"	"unprognostic (2.09e-1)"	"unprognostic (1.51e-2)"	"unprognostic (3.15e-3)"	"unprognostic (3.93e-2)"	"unprognostic (2.07e-1)"	"unprognostic (3.89e-2)"	"unprognostic (5.05e-3)"	"unprognostic (8.00e-2)"	"unprognostic (1.66e-1)"	"unprognostic (9.96e-2)"	"unprognostic (7.69e-2)"	"prognostic favorable (1.17e-4)"	"unprognostic (7.60e-2)"	28.4	35.4	24.2	42.0	32.3	42.1	25.1	19.6	33.4	23.9	39.6	22.1	29.9	33.9	19.6	25.8	59.7	22.8	28.6	33.0	21.8	17.1	43.7	55.0	27.6	49.3	19.9	19.9	20.1	53.3	23.1	21.6	44.0	19.3	27.2	33.2	23.2	49.7	31.1	39.0	34.4	47.3	20.5	21.3	53.7	35.1	15.7	19.4	77.7	38.5	40.5	63.9	25.5	25.7	78.8	76.6	126.2	118.0	68.2	113.9	177.2	45.3	52.4	31.1	45.8	15.5	19.0	31.7	22.5	26.4	45.4	34.5	74.9	54.8	39.1	38.4	34.1	33.8	39.8	35.9	46.8	27.9	41.1	24.4	37.5	24.7	39.2	33.9	47.6	48.5	21.4	31.0	38.6	22.8	21.6	45.5	38.3	34.8	32.4	36.7	103.5	60.3	93.6	51.6	86.5	41.5	42.9	43.0	33.8	44.6	37.6	24.3	40.4	26.1	46.9	69.4	24.3	56.1	33.0	32.4	35.1	35.9	41.3	29.1	32.5	30.1	44.4	42.0	32.7	36.9	81.4	80.1	126.2	88.6	100.5	69.3	78.8	79.8	90.5	76.6	77.0	49.1	69.2	93.3	68.2	118.0	54.4	113.9	177.2	24.2	32.3	19.6	33.4	21.8	17.1	19.9	19.9	19.3	19.4	71.5	93.0	166.0	108.0	88.8	35.0	7.9	117.2	41.5	46.6	82.0	9.8	320.7	180.8	238.7	1.8	77.3	292.4	23.3	272.4	398.0	69.2	127.9	107.3	102.4	338.5	41.3	93.0	87.2	194.1	5.3	45.5	157.2	129.9	390.5	160.1	42.9	250.4	210.5	26.9	236.5	23.6	97.0	60.9	13.0	106.5	106.3	357.3	222.6	164.6	168.4
PPP1CB	"PP-1B, PP1B, PP1beta"	ENSG00000213639	"Protein phosphatase 1 catalytic subunit beta"	P62140	2	28751640-28802940	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Biological rhythms, Carbohydrate metabolism, Cell cycle, Cell division, Glycogen metabolism"	"Hydrolase, Protein phosphatase"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB022558, HPA065425, CAB069426"	Supported		Supported	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA		7700000	"Nucleoplasm, Cytosol"	"Plasma membrane"	"CAB022558: , CAB069426: , HPA065425: AB_2685489"	"unprognostic (2.90e-1)"	"unprognostic (5.03e-2)"	"unprognostic (5.49e-2)"	"unprognostic (2.00e-1)"	"unprognostic (7.08e-2)"	"unprognostic (1.39e-1)"	"prognostic unfavorable (6.52e-6)"	"unprognostic (3.47e-2)"	"unprognostic (2.44e-1)"	"unprognostic (3.15e-2)"	"unprognostic (1.54e-3)"	"unprognostic (3.95e-1)"	"unprognostic (1.68e-1)"	"unprognostic (3.66e-1)"	"unprognostic (1.89e-1)"	"unprognostic (4.56e-1)"	"unprognostic (2.26e-2)"	28.5	22.6	30.0	20.5	37.6	29.5	32.4	19.1	29.8	51.1	39.3	21.1	30.7	24.4	58.0	31.8	86.0	37.0	33.3	67.1	27.8	27.9	32.0	20.0	35.3	22.3	27.4	24.4	39.7	21.9	48.9	28.7	42.3	22.0	46.4	27.7	25.2	36.5	38.6	99.6	25.1	30.0	100.8	27.5	25.2	31.4	25.5	21.4	28.1	27.5	32.9	25.3	82.1	50.5	15.6	25.4	41.5	42.7	23.5	28.3	17.9	37.1	23.4	81.7	25.2	28.0	26.1	47.6	20.0	22.8	19.5	19.3	20.7	22.0	29.7	25.1	20.6	21.6	23.0	23.2	26.7	23.2	47.1	12.0	22.5	28.8	22.4	61.0	25.4	10.6	20.0	38.0	21.0	44.0	20.5	23.5	15.8	20.4	29.5	25.5	18.6	26.9	22.0	26.8	28.6	18.6	26.4	72.4	22.6	63.3	44.9	22.4	27.7	31.0	34.6	27.1	24.4	16.7	14.2	28.1	26.1	28.7	18.6	24.0	21.1	33.1	60.9	27.7	27.4	19.3	22.5	24.8	32.1	16.8	37.8	21.3	15.6	25.5	19.6	25.4	13.4	22.7	25.5	41.5	23.5	42.7	19.6	28.3	17.9	30.0	37.6	19.1	29.8	27.8	27.9	27.4	24.4	22.0	21.4	86.4	80.7	105.5	134.5	437.2	53.8	298.4	104.4	129.8	72.8	294.8	25.5	104.9	207.2	242.7	375.6	106.2	128.9	163.5	183.3	167.5	182.4	291.0	146.3	81.8	104.3	154.1	271.6	108.6	144.9	304.1	182.1	233.4	318.9	92.8	133.9	100.9	238.2	181.4	283.9	113.6	53.2	620.9	265.8	57.5	61.8	400.4	328.6	110.8	99.3	394.6
PPP1CC	"PP1C, PP1gamma"	ENSG00000186298	"Protein phosphatase 1 catalytic subunit gamma"	P36873	12	110719680-110742939	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Biological rhythms, Carbohydrate metabolism, Cell cycle, Cell division, Glycogen metabolism"	"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	6	"Early spermatids: 486.0;Late spermatids: 696.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB022645	Uncertain					NA	NA		7600000			"CAB022645: "	"unprognostic (1.51e-1)"	"prognostic favorable (7.44e-4)"	"unprognostic (4.00e-2)"	"unprognostic (2.11e-1)"	"unprognostic (1.29e-2)"	"unprognostic (7.26e-2)"	"prognostic unfavorable (2.75e-6)"	"unprognostic (6.55e-2)"	"unprognostic (4.11e-2)"	"unprognostic (6.91e-2)"	"unprognostic (4.96e-3)"	"unprognostic (5.72e-2)"	"unprognostic (2.92e-3)"	"unprognostic (1.66e-2)"	"unprognostic (1.71e-1)"	"unprognostic (8.96e-2)"	"unprognostic (1.18e-1)"	23.3	29.4	27.4	23.4	29.8	28.8	24.1	31.9	32.3	25.2	63.3	22.2	15.4	63.0	25.9	19.8	31.3	22.9	21.5	66.5	29.4	21.0	19.8	20.6	19.6	41.4	32.0	21.9	31.7	38.8	19.6	25.8	17.0	25.9	26.1	36.4	28.7	26.9	19.4	63.4	24.0	73.3	46.3	25.9	27.1	25.2	43.7	28.3	42.3	25.9	18.3	41.3	37.9	23.2	17.8	19.1	30.8	19.1	8.5	14.9	12.5	45.8	27.7	47.4	34.6	28.8	39.8	36.3	26.5	39.5	44.1	35.3	47.3	23.4	71.8	20.1	28.4	27.6	26.2	63.5	34.8	61.7	41.7	42.8	46.4	20.8	48.2	23.5	59.0	40.4	25.1	28.5	33.3	29.8	46.9	50.9	40.8	46.2	19.5	40.3	19.1	47.7	66.2	74.6	30.3	41.0	47.0	32.7	45.4	28.2	34.9	38.3	30.8	29.2	35.2	51.0	43.6	55.1	46.2	22.6	22.5	37.3	30.3	33.2	30.7	31.9	61.5	21.2	43.0	34.2	18.7	19.1	30.8	8.2	14.9	8.0	17.8	14.9	11.7	19.1	15.4	12.4	10.2	16.3	8.5	18.8	7.4	13.7	12.5	27.4	29.8	31.9	32.3	29.4	21.0	32.0	21.9	25.9	28.3	32.8	25.1	131.3	108.1	185.8	159.6	121.9	61.1	12.0	21.6	34.9	64.8	118.3	79.6	59.1	486.0	77.6	126.9	70.0	109.1	164.3	97.7	101.2	58.7	34.2	118.8	96.9	81.6	50.3	154.1	696.0	83.1	84.6	121.4	49.5	90.9	76.2	74.1	147.3	130.4	66.8	93.8	109.9	130.8	168.8	41.4	183.6	110.5	92.7	142.6	110.4
PPP1R11	"CFAP255, HCG-V, HCGV, TCTE5, Tctex5"	ENSG00000204619	"Protein phosphatase 1 regulatory inhibitor subunit 11"	O60927	6	30066709-30070333	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	"Protein phosphatase inhibitor, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"epididymis: 93.3"	"Cell type enhanced"	"Detected in many"	9	"Late spermatids: 578.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"A-431: 18.8;AN3-CA: 25.1;HBEC3-KT: 15.7;HEL: 15.1;JURKAT: 29.4;RPTEC TERT1: 17.5;U-266/84: 16.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043266, HPA060174"	Approved		Approved	Vesicles		NA	NA			Vesicles		"HPA043266: AB_2678400, HPA060174: AB_2684216"	"unprognostic (2.00e-2)"	"unprognostic (1.10e-1)"	"unprognostic (8.88e-2)"	"unprognostic (4.24e-2)"	"unprognostic (3.45e-1)"	"unprognostic (1.05e-1)"	"unprognostic (1.77e-2)"	"unprognostic (1.18e-1)"	"unprognostic (2.81e-1)"	"unprognostic (1.74e-3)"	"unprognostic (3.33e-2)"	"unprognostic (2.68e-1)"	"unprognostic (8.36e-3)"	"unprognostic (1.74e-1)"	"unprognostic (3.31e-1)"	"unprognostic (2.21e-1)"	"unprognostic (4.69e-3)"	36.0	18.2	18.5	8.3	21.6	4.4	12.9	9.8	31.7	11.0	27.0	17.3	7.9	33.2	16.0	93.3	26.8	33.7	23.9	16.8	16.6	17.6	18.2	22.6	12.9	13.2	15.5	14.5	26.2	33.1	5.9	8.8	21.1	14.6	13.6	4.6	14.0	20.4	8.8	39.0	37.0	28.6	9.4	13.4	16.0	27.2	18.1	11.4	16.9	20.6	10.9	29.6	15.8	12.4	2.6	2.7	4.4	3.5	0.8	3.2	1.8	18.8	0.0	0.0	25.1	11.1	10.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.0	12.1	0.0	0.0	15.7	0.0	0.0	12.9	15.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	29.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	17.5	8.2	0.0	0.0	0.0	8.5	0.2	9.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.7	16.7	7.3	0.0	0.0	0.0	2.9	2.6	4.4	1.7	3.5	2.0	2.1	1.9	3.1	1.3	2.6	2.7	2.1	2.9	0.8	2.9	2.7	3.2	1.8	18.5	21.6	9.8	31.7	16.6	17.6	15.5	14.5	14.6	11.4	17.9	19.8	58.2	65.2	46.9	29.4	15.0	43.3	24.1	19.4	38.4	5.9	51.3	81.2	116.6	185.3	36.0	115.4	0.0	120.0	106.5	33.8	60.5	77.3	26.0	59.8	12.7	51.5	36.8	38.6	578.9	30.0	49.9	59.1	73.1	76.9	44.8	105.0	77.2	37.8	70.2	30.1	38.8	48.4	51.5	22.6	58.2	62.9	66.0	52.1	78.8
PPP2CA	"PP2AC, PP2Calpha"	ENSG00000113575	"Protein phosphatase 2 catalytic subunit alpha"	P67775	5	134194334-134226142	"Enzymes, Predicted intracellular proteins"	Meiosis	"Hydrolase, Protein phosphatase"	"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB003848, HPA043236"	Approved					NA	NA					"CAB003848: AB_562203, HPA043236: AB_2678379"	"unprognostic (1.44e-1)"	"unprognostic (1.02e-1)"	"unprognostic (1.60e-2)"	"unprognostic (3.35e-3)"	"unprognostic (1.26e-1)"	"unprognostic (3.21e-2)"	"prognostic unfavorable (7.33e-5)"	"unprognostic (1.59e-3)"	"unprognostic (1.57e-1)"	"unprognostic (2.02e-1)"	"unprognostic (1.34e-2)"	"unprognostic (1.31e-1)"	"unprognostic (5.24e-2)"	"unprognostic (2.43e-1)"	"unprognostic (1.43e-1)"	"unprognostic (6.14e-2)"	"unprognostic (1.57e-1)"	26.0	30.5	37.6	22.0	41.0	57.9	26.0	54.2	56.6	23.0	27.3	29.6	15.6	24.8	29.8	20.4	39.6	21.9	24.7	47.9	39.8	38.1	31.7	33.2	22.7	29.1	35.0	35.8	23.4	23.9	44.5	20.6	44.0	47.5	22.3	26.4	18.4	23.6	23.7	43.1	32.6	26.5	31.6	32.8	30.4	21.8	18.8	24.1	45.6	33.2	30.5	39.9	26.9	24.5	29.2	41.1	39.0	33.4	38.9	37.5	43.8	37.9	32.0	45.7	24.6	23.9	25.7	32.1	35.9	30.8	54.7	55.3	61.3	29.8	33.3	33.8	33.1	62.0	19.8	43.9	51.8	64.1	30.1	25.1	23.6	37.4	38.1	35.4	23.3	21.4	23.8	35.9	42.8	42.7	27.3	38.3	33.7	23.2	25.0	41.4	27.3	36.9	22.7	25.0	30.2	19.3	33.1	45.5	32.3	32.9	42.8	36.5	25.4	37.0	13.8	40.2	47.8	28.2	27.6	26.9	31.6	17.8	25.3	50.5	22.5	40.2	52.6	21.3	30.9	32.6	20.3	33.4	39.0	26.7	33.0	34.1	29.2	30.7	35.6	41.1	28.6	35.7	32.7	38.7	38.9	33.3	22.0	37.5	43.8	37.6	41.0	54.2	56.6	39.8	38.1	35.0	35.8	47.5	24.1	47.6	47.1	62.7	174.1	212.2	43.8	101.7	71.4	50.9	51.2	54.1	21.6	139.8	91.2	89.5	23.5	75.5	59.4	70.0	77.0	143.4	86.8	121.4	62.2	58.2	98.2	47.7	83.5	49.7	91.0	21.8	35.6	80.0	99.5	125.4	51.7	61.5	82.5	50.1	42.8	83.6	24.4	19.4	109.5	69.9	85.0	204.9	259.0	79.8	56.2	157.9
PPP2CB	PP2Abeta	ENSG00000104695	"Protein phosphatase 2 catalytic subunit beta"	P62714	8	30774457-30814314	"Enzymes, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Peritubular cells: 248.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB018600, HPA043236"	Approved		Supported	Nucleoplasm		NA	NA			Nucleoplasm		"CAB018600: AB_675841, HPA043236: AB_2678379"	"unprognostic (9.77e-2)"	"unprognostic (1.30e-1)"	"unprognostic (2.51e-2)"	"unprognostic (3.82e-1)"	"unprognostic (6.70e-2)"	"unprognostic (7.79e-2)"	"unprognostic (1.13e-2)"	"unprognostic (3.51e-1)"	"unprognostic (2.28e-1)"	"unprognostic (2.86e-2)"	"unprognostic (4.50e-2)"	"unprognostic (1.89e-2)"	"prognostic favorable (5.82e-7)"	"unprognostic (9.24e-2)"	"unprognostic (2.04e-1)"	"unprognostic (1.39e-1)"	"unprognostic (2.65e-3)"	26.7	21.0	61.3	11.9	54.9	2.6	28.7	32.0	46.2	28.8	24.1	30.7	19.4	21.7	34.5	37.5	29.7	28.2	23.1	27.2	57.3	43.7	41.0	35.7	27.7	8.4	52.6	39.8	48.0	22.9	33.7	14.8	27.4	47.7	23.7	24.5	12.5	19.5	29.1	27.4	18.0	31.2	39.0	49.7	15.0	18.9	18.8	48.2	6.3	44.5	14.0	14.0	17.7	34.3	5.8	7.9	5.1	6.5	7.3	4.8	1.7	22.1	19.4	33.9	12.9	33.9	30.9	18.9	29.7	27.8	30.8	32.3	20.3	16.3	10.8	29.2	39.5	29.5	13.4	20.2	34.1	41.6	6.7	10.6	14.4	13.2	20.4	38.9	6.4	8.2	27.2	39.0	26.0	29.2	31.3	36.9	18.1	22.3	11.5	51.9	10.9	17.5	8.2	24.7	33.5	11.2	12.3	13.6	8.0	41.2	18.0	32.6	13.5	13.7	14.6	28.6	39.5	8.0	11.0	38.7	26.6	20.0	8.7	24.5	5.9	7.7	12.8	22.8	6.0	34.0	4.8	5.0	3.3	4.2	6.5	4.8	5.8	3.8	4.2	3.5	2.7	3.8	4.6	5.1	7.3	3.0	7.9	2.8	1.7	61.3	54.9	32.0	46.2	57.3	43.7	52.6	39.8	47.7	48.2	65.5	53.8	13.8	81.2	92.5	34.5	71.2	40.8	34.8	50.0	82.0	29.5	36.8	39.7	34.2	13.3	49.6	112.3	0.0	42.0	43.1	62.0	108.1	17.3	81.5	48.8	44.5	31.0	101.3	52.3	13.4	67.9	30.8	38.8	16.2	51.0	105.4	64.5	41.8	248.2	63.4	21.1	45.3	59.7	30.2	35.8	83.6	59.0	14.0	32.4	132.7
PPP3CA	"CALN, CALNA, CNA1, PPP2B"	ENSG00000138814	"Protein phosphatase 3 catalytic subunit alpha"	Q08209	4	101023409-101348278	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		"Calmodulin-binding, Hydrolase, Protein phosphatase"	"Craniosynostosis, Disease mutation, Dwarfism, Epilepsy, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 71.8"	"Low cell type specificity"	"Detected in many"			"Cancer enriched"	"Detected in all"	7	"prostate cancer: 98.1"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA012778, CAB018581"	Enhanced		Enhanced	Nucleoplasm,Cytosol		NA	NA		35000	Nucleoplasm	Cytosol	"CAB018581: AB_2168324, HPA012778: AB_1855660"	"unprognostic (6.66e-2)"	"unprognostic (1.96e-1)"	"unprognostic (3.40e-1)"	"unprognostic (1.36e-1)"	"unprognostic (1.56e-1)"	"unprognostic (7.81e-2)"	"unprognostic (1.77e-2)"	"unprognostic (1.08e-1)"	"unprognostic (7.87e-2)"	"unprognostic (3.49e-3)"	"prognostic unfavorable (3.82e-4)"	"unprognostic (3.38e-2)"	"unprognostic (2.51e-2)"	"unprognostic (5.12e-2)"	"unprognostic (1.98e-1)"	"unprognostic (1.84e-2)"	"unprognostic (5.74e-2)"	12.2	9.2	22.7	7.4	71.8	7.7	10.6	42.1	52.4	9.4	9.5	4.8	9.8	5.8	6.2	6.9	7.4	7.2	6.8	4.3	36.0	13.5	5.8	8.4	10.0	6.7	10.1	22.1	9.6	4.7	7.0	4.2	6.6	11.9	34.6	8.4	2.6	10.4	21.1	23.7	11.4	6.4	7.9	7.5	6.9	11.0	5.3	13.0	3.8	6.8	6.8	8.9	8.4	6.8	27.7	18.3	44.3	14.9	22.3	15.5	6.6	19.4	13.8	3.8	7.5	21.6	16.4	7.4	21.5	19.8	8.7	9.2	8.0	24.4	9.3	9.0	19.4	10.8	9.8	13.9	28.6	14.8	22.7	6.4	14.7	19.8	10.2	15.9	23.6	7.5	17.0	15.0	19.0	21.8	16.6	16.3	6.0	5.7	25.6	13.9	23.4	4.9	17.7	6.4	22.5	9.0	9.0	35.0	10.7	8.4	15.4	30.4	11.5	17.7	15.2	10.3	5.5	13.6	13.5	19.0	20.6	23.5	18.8	14.2	12.0	12.2	16.4	11.4	13.4	5.5	24.6	11.8	24.8	13.6	11.4	15.5	27.7	12.9	13.1	9.9	23.4	6.2	12.3	44.3	22.3	14.9	18.3	8.6	6.6	22.7	71.8	42.1	51.5	36.0	13.5	10.1	22.1	11.9	13.0	71.5	48.8	59.1	33.3	149.9	74.7	24.1	33.1	32.1	20.5	29.6	37.3	28.9	28.2	18.2	1.8	105.6	33.9	0.0	27.3	76.5	53.9	157.6	33.6	37.0	32.1	17.5	122.2	43.6	52.2	4.7	60.1	49.5	87.7	44.1	39.6	19.3	41.1	107.8	57.3	31.7	81.9	12.9	39.4	7.2	22.1	150.4	23.0	55.4	39.9	32.0
PPP3CB	"CALNA2, CALNB, CNA2, PP2Bbeta"	ENSG00000107758	"Protein phosphatase 3 catalytic subunit beta"	P16298	10	73436428-73496024	"Enzymes, Predicted intracellular proteins"		"Calmodulin-binding, Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 133.0"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008233, HPA008823"	Uncertain		Approved	Mitochondria		NA	NA			Mitochondria		"HPA008233: AB_1855661, HPA008823: AB_2668148"	"unprognostic (3.05e-1)"	"unprognostic (2.54e-1)"	"unprognostic (1.50e-1)"	"unprognostic (4.93e-2)"	"unprognostic (8.93e-2)"	"unprognostic (4.28e-2)"	"prognostic unfavorable (9.59e-4)"	"unprognostic (1.14e-1)"	"unprognostic (1.34e-1)"	"unprognostic (2.12e-2)"	"prognostic favorable (6.96e-5)"	"unprognostic (4.73e-2)"	"unprognostic (1.51e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.45e-1)"	"unprognostic (2.66e-1)"	"unprognostic (1.68e-2)"	17.3	16.1	40.0	11.7	36.3	7.6	22.5	44.5	42.7	13.4	16.1	7.9	9.5	10.1	17.0	15.0	14.0	12.3	12.0	16.7	39.7	20.5	11.9	9.1	9.8	13.1	18.2	40.7	17.2	10.5	19.3	16.8	10.6	21.1	16.8	12.8	9.5	10.4	17.6	133.0	10.9	9.4	23.0	18.1	10.0	10.7	11.6	11.9	8.4	10.1	10.0	14.3	14.1	14.4	4.2	5.7	4.8	3.8	4.5	10.6	2.7	19.1	10.6	19.0	19.6	27.3	37.9	9.1	17.6	24.2	17.3	17.2	6.7	9.8	17.0	5.7	25.4	8.2	10.3	15.3	13.5	24.4	23.8	12.5	7.2	9.6	12.7	16.3	16.0	15.1	26.8	16.3	16.3	21.9	31.9	11.9	14.9	9.0	20.0	34.8	6.0	14.3	14.8	7.7	8.4	31.0	9.6	10.3	8.0	16.8	9.3	10.2	11.8	10.3	25.8	12.9	16.5	19.4	15.5	13.0	13.8	12.7	11.0	23.8	13.4	36.5	11.9	17.1	23.1	7.8	3.2	2.9	4.8	6.2	3.8	7.3	4.2	6.7	6.6	3.0	3.0	5.3	7.9	1.7	4.5	2.3	5.7	10.6	2.7	40.0	36.3	44.5	42.7	39.7	20.5	18.2	40.7	21.1	11.9	3.0	11.0	18.2	26.7	22.8	52.0	42.6	10.2	13.4	11.4	17.4	19.6	17.9	53.0	15.6	5.9	18.3	10.2	0.0	16.6	13.6	21.4	23.8	20.7	12.3	17.9	36.5	40.9	17.2	30.2	7.6	31.1	18.8	25.3	27.1	12.3	32.9	15.6	14.4	27.3	25.6	28.0	6.5	37.1	38.5	44.0	27.6	18.5	15.7	14.4	19.3
PPP3CC	"CALNA3, PP2Bgamma"	ENSG00000120910	"Protein phosphatase 3 catalytic subunit gamma"	P48454	8	22440819-22541142	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Calmodulin-binding, Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Early spermatids: 88.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023396, CAB024950"	Approved		Approved	Vesicles		NA	NA			Vesicles		"CAB024950: , HPA023396: AB_1855663"	"unprognostic (7.66e-3)"	"unprognostic (1.61e-2)"	"unprognostic (1.55e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.38e-1)"	"unprognostic (2.21e-2)"	"unprognostic (7.71e-2)"	"prognostic favorable (6.80e-5)"	"unprognostic (9.25e-2)"	"unprognostic (1.97e-1)"	"unprognostic (8.84e-2)"	"unprognostic (4.05e-2)"	"unprognostic (7.16e-2)"	"unprognostic (2.35e-2)"	"unprognostic (4.00e-1)"	"unprognostic (2.78e-2)"	"unprognostic (1.64e-2)"	18.0	8.3	6.9	13.7	8.1	15.2	21.1	11.9	12.0	10.3	10.2	10.9	3.7	6.1	13.4	7.8	11.6	9.0	10.7	27.5	7.6	7.3	8.9	8.2	16.5	22.3	7.7	4.9	10.1	9.9	13.7	15.1	12.7	9.9	11.1	7.1	20.7	15.5	6.0	52.4	9.1	9.8	13.5	7.9	14.1	9.5	41.6	6.9	6.8	11.5	13.2	20.0	14.7	11.0	15.5	4.0	6.6	2.9	11.9	16.0	3.9	5.5	4.1	3.6	4.4	9.7	12.1	5.3	7.7	13.6	11.5	12.8	2.3	3.5	21.0	9.5	11.9	19.2	3.9	8.4	7.7	14.7	12.0	4.5	4.5	4.7	6.7	13.1	3.2	7.4	7.3	10.7	7.7	7.9	12.3	9.9	10.3	8.8	28.0	12.8	2.6	7.5	5.3	2.6	5.7	5.6	24.7	8.6	6.9	10.7	5.2	2.6	6.1	5.8	3.4	7.9	7.2	2.3	5.4	10.6	17.9	3.8	27.1	5.9	14.0	16.9	22.0	9.5	4.3	11.8	3.4	1.6	6.6	11.4	2.0	8.7	15.5	12.9	16.0	3.2	13.9	12.4	10.1	0.4	11.9	2.9	4.0	10.1	3.9	6.9	8.1	11.9	12.0	7.6	7.3	7.7	4.9	9.9	6.9	6.0	3.2	39.8	18.1	14.7	9.7	7.0	12.7	2.7	3.4	7.0	45.2	15.0	6.6	12.0	88.7	24.7	7.2	0.0	18.7	19.5	22.6	23.7	3.5	6.8	11.9	3.2	9.9	23.9	11.3	9.4	20.8	18.5	27.0	43.3	3.1	12.3	15.5	9.9	20.1	10.4	50.5	32.3	26.2	71.2	27.9	9.9	11.8	43.6	6.0	23.0
PPP4C	"PP4, PPX"	ENSG00000149923	"Protein phosphatase 4 catalytic subunit"	P60510	16	30075978-30085377	"Enzymes, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA043837	Supported		Supported	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			Nucleoplasm	"Plasma membrane, Cytosol"	"HPA043837: AB_2678695"	"unprognostic (1.20e-1)"	"unprognostic (1.33e-2)"	"unprognostic (2.68e-1)"	"unprognostic (4.74e-2)"	"unprognostic (2.16e-1)"	"unprognostic (5.79e-3)"	"unprognostic (3.28e-3)"	"unprognostic (2.60e-3)"	"unprognostic (3.82e-1)"	"unprognostic (1.29e-1)"	"unprognostic (2.52e-1)"	"unprognostic (3.17e-2)"	"unprognostic (1.98e-2)"	"unprognostic (3.78e-2)"	"unprognostic (9.36e-2)"	"unprognostic (9.96e-2)"	"unprognostic (1.88e-1)"	24.7	26.6	13.5	26.1	14.1	26.7	18.6	16.0	15.9	19.2	28.4	14.5	20.5	22.5	19.2	28.4	39.1	17.7	31.9	28.5	12.6	12.1	28.9	52.3	27.4	25.3	12.5	12.8	22.5	26.3	23.9	16.2	51.6	11.9	18.3	17.4	18.8	22.0	14.9	26.0	26.1	38.8	15.9	11.9	36.2	22.6	39.0	9.5	59.7	27.1	26.5	37.9	22.2	21.1	19.5	30.3	57.3	28.2	12.4	23.6	12.0	30.8	34.6	23.1	32.2	21.9	18.5	36.0	27.5	30.7	36.2	40.2	30.4	40.3	24.0	35.4	32.4	23.6	25.2	28.6	34.1	21.4	30.1	51.2	16.3	21.5	67.2	33.3	22.9	30.9	26.8	30.2	33.0	21.0	21.7	42.0	31.3	31.8	22.0	27.6	88.9	39.9	41.8	44.0	24.5	18.4	44.7	24.0	41.8	34.2	31.8	22.5	33.3	13.5	40.8	23.5	20.2	37.6	39.0	26.7	21.2	22.3	17.1	21.1	37.8	41.5	28.1	30.2	29.6	25.6	21.4	26.9	57.3	18.3	28.2	13.1	17.0	19.2	20.6	30.3	19.5	17.2	15.2	56.9	12.4	24.5	23.5	23.6	12.0	13.5	14.1	16.0	15.9	12.6	12.1	12.5	12.8	11.9	9.5	47.6	33.1	81.7	96.8	130.7	20.0	9.3	89.2	54.9	23.9	73.3	27.5	268.8	134.3	208.0	127.6	84.2	174.4	0.0	169.7	278.1	71.4	111.6	69.1	85.6	210.3	33.4	120.5	58.9	91.3	98.3	58.1	124.3	75.9	252.5	114.3	41.8	254.7	168.4	49.1	156.3	25.7	71.1	65.1	231.9	141.6	150.8	352.1	111.4	129.3	192.9
PPP5C	"PP5, PPP5"	ENSG00000011485	"Protein phosphatase 5 catalytic subunit"	P53041	19	46346994-46392981	"Enzymes, Predicted intracellular proteins"	"DNA damage, DNA repair"	"Hydrolase, Protein phosphatase"	"Alzheimer disease, Amyloidosis, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB022641, HPA029065, HPA056933"	Approved		Supported	Vesicles,Cytosol		NA	NA		47000	"Vesicles, Cytosol"		"CAB022641: , HPA029065: AB_10610284, HPA056933: AB_2683278"	"unprognostic (8.25e-2)"	"unprognostic (7.90e-2)"	"unprognostic (1.44e-1)"	"unprognostic (6.30e-2)"	"unprognostic (5.92e-2)"	"unprognostic (2.62e-2)"	"prognostic unfavorable (3.45e-6)"	"unprognostic (1.29e-1)"	"unprognostic (1.04e-2)"	"unprognostic (8.25e-2)"	"unprognostic (5.56e-2)"	"unprognostic (2.20e-2)"	"unprognostic (3.24e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.35e-1)"	"unprognostic (5.92e-3)"	"unprognostic (1.37e-1)"	18.9	24.7	23.0	18.1	28.8	13.4	15.9	25.2	50.8	20.4	21.1	19.4	15.2	18.0	23.0	15.2	20.1	27.8	20.5	48.2	20.8	23.9	22.6	22.1	17.4	19.3	21.9	29.8	16.7	21.5	26.3	23.9	17.3	34.5	19.5	17.5	19.7	21.0	21.4	40.8	16.4	15.3	23.5	16.2	21.7	20.6	19.0	15.3	15.6	18.1	20.5	16.1	17.1	18.1	10.6	11.1	1.9	14.1	14.0	19.8	8.9	19.5	36.8	22.0	16.6	16.6	17.8	10.2	24.4	19.8	29.6	26.7	26.4	15.6	30.1	13.3	17.7	16.2	16.1	28.9	28.8	8.9	20.8	39.3	25.0	27.0	18.7	18.6	33.8	17.5	16.2	13.6	20.8	15.5	11.4	25.4	25.7	24.0	15.5	16.8	21.2	18.9	63.4	16.6	35.1	20.1	28.2	19.0	24.1	17.7	26.8	31.3	23.0	20.4	26.0	8.7	10.4	16.3	21.6	21.1	13.0	21.6	9.6	25.5	12.5	28.7	36.0	13.9	28.4	21.6	0.0	6.8	1.9	19.8	12.1	12.7	10.6	9.2	15.3	11.1	8.7	8.9	12.0	0.1	14.0	14.1	7.9	9.3	8.9	23.0	28.8	25.2	50.8	20.8	23.9	21.9	29.8	34.5	15.3	6.0	12.2	13.4	14.5	8.4	19.1	4.7	50.9	9.4	10.3	15.7	15.7	20.7	28.2	26.1	1.0	13.4	17.7	0.0	16.8	30.9	14.6	11.3	4.6	22.8	19.0	15.9	14.3	30.7	10.8	1.7	16.1	7.6	15.1	14.4	15.1	19.1	22.4	11.5	17.3	17.3	16.9	38.8	20.6	14.6	39.2	11.5	21.5	17.0	21.3	8.4
PPP6C	PP6	ENSG00000119414	"Protein phosphatase 6 catalytic subunit"	O00743	9	125146573-125189939	"Cancer-related genes, Enzymes, Predicted intracellular proteins"	"Cell cycle, Immunity, Innate immunity"	"Hydrolase, Protein phosphatase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA050940	Uncertain					NA	NA					"HPA050940: AB_2681283"	"unprognostic (6.45e-2)"	"unprognostic (4.01e-3)"	"unprognostic (7.12e-2)"	"unprognostic (5.36e-2)"	"unprognostic (2.78e-2)"	"unprognostic (2.92e-2)"	"unprognostic (2.57e-3)"	"unprognostic (1.53e-1)"	"unprognostic (2.14e-1)"	"unprognostic (2.44e-1)"	"unprognostic (1.71e-2)"	"unprognostic (2.28e-2)"	"prognostic favorable (4.50e-6)"	"unprognostic (1.54e-2)"	"unprognostic (3.51e-1)"	"unprognostic (1.12e-2)"	"unprognostic (1.12e-1)"	21.7	20.1	20.1	15.7	24.5	24.8	21.2	20.8	26.2	17.0	19.1	25.9	15.1	13.9	15.6	17.2	21.2	14.0	12.9	15.3	19.8	16.6	22.8	17.8	16.3	21.5	20.1	16.1	17.5	27.7	21.3	17.3	17.6	17.8	14.5	21.8	16.8	26.9	14.6	50.5	19.3	17.3	16.3	22.6	19.4	16.5	22.8	23.7	34.1	22.2	20.5	24.0	13.8	15.6	17.3	14.8	32.2	19.5	13.9	23.3	13.8	14.1	10.3	18.8	17.8	20.2	16.9	19.0	15.0	16.3	22.2	18.6	16.5	15.0	20.4	11.7	20.1	18.9	28.9	25.4	16.3	25.8	18.2	12.3	16.7	16.2	14.6	16.6	29.1	23.2	13.9	22.4	18.2	17.4	17.1	20.7	23.4	19.5	23.7	23.9	21.0	27.4	18.4	17.5	39.6	19.2	22.4	28.5	27.2	18.8	14.3	19.5	19.3	26.8	21.6	17.4	16.7	33.4	18.4	20.0	13.7	13.1	26.5	19.9	26.2	47.2	27.0	18.4	19.1	22.2	27.2	13.2	21.4	14.7	17.4	18.0	17.3	18.9	16.6	14.8	13.3	18.9	17.5	32.2	13.9	19.5	10.7	23.3	13.8	20.1	24.5	20.8	26.2	19.8	16.6	20.1	16.1	17.8	23.7	38.7	27.8	41.7	45.6	68.7	15.2	30.8	35.7	21.4	23.9	26.2	7.9	40.2	48.0	40.6	102.7	41.4	34.6	23.3	47.6	45.3	30.1	41.0	43.9	36.1	46.7	14.3	46.0	46.6	52.3	56.7	27.6	48.9	42.2	46.9	41.6	28.7	41.6	38.6	33.9	54.9	12.9	51.8	44.8	93.3	43.0	76.5	72.9	49.0	37.9	48.2
PPT1	"CLN1, INCL, PPT"	ENSG00000131238	"Palmitoyl-protein thioesterase 1"	P50897	1	40071461-40097727	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Sensory transduction, Vision"	Hydrolase	"Disease mutation, Neurodegeneration, Neuronal ceroid lipofuscinosis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	6	"Hofbauer cells: 247.2;Kupffer cells: 246.8;Macrophages: 282.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"SK-BR-3: 88.0;THP-1: 163.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA021546	Supported		Supported	"Golgi apparatus,Vesicles"	"Intracellular and membrane"	NA	NA		130000	"Golgi apparatus, Vesicles"		"HPA021546: AB_1855667"	"unprognostic (5.02e-2)"	"unprognostic (2.73e-1)"	"unprognostic (1.64e-1)"	"unprognostic (2.06e-3)"	"unprognostic (6.68e-2)"	"unprognostic (2.83e-2)"	"prognostic unfavorable (6.98e-8)"	"unprognostic (1.39e-1)"	"unprognostic (1.78e-1)"	"unprognostic (1.23e-1)"	"unprognostic (8.16e-2)"	"unprognostic (2.39e-1)"	"unprognostic (5.20e-3)"	"unprognostic (1.75e-1)"	"unprognostic (2.30e-1)"	"unprognostic (2.93e-2)"	"unprognostic (2.08e-2)"	33.3	27.1	37.6	31.0	41.5	33.3	39.7	35.2	41.0	30.3	21.0	31.5	17.2	12.9	31.3	19.4	18.5	20.7	23.2	18.1	32.7	35.8	29.4	18.4	47.3	48.5	35.3	29.1	24.7	17.4	30.4	21.2	25.9	34.6	28.0	26.0	26.3	22.1	23.6	8.3	13.8	16.6	36.5	33.6	61.3	17.9	13.8	29.1	19.8	18.7	14.4	30.0	23.0	19.8	9.3	77.4	59.9	90.0	7.2	19.1	91.6	10.3	7.0	11.3	6.3	13.6	11.6	22.1	5.8	10.4	13.9	17.2	40.1	17.3	11.8	11.3	6.0	11.5	18.1	17.5	10.3	19.1	14.8	18.0	6.2	17.2	19.8	15.4	13.8	14.9	10.9	11.3	11.1	10.3	7.8	18.7	10.1	14.3	17.1	7.8	20.6	7.9	10.3	21.2	15.8	10.8	8.9	15.2	20.5	9.7	18.4	9.0	9.6	11.3	88.0	35.0	11.1	12.7	163.5	6.6	6.8	14.6	6.3	17.1	15.4	32.3	11.3	8.7	33.8	12.3	6.2	90.0	48.2	9.9	77.6	11.8	9.3	14.7	11.5	77.4	9.2	19.1	14.7	59.9	7.2	58.3	7.6	16.8	91.6	37.6	41.5	35.2	41.0	32.7	35.8	35.3	29.1	34.6	29.1	26.8	50.8	34.5	72.3	35.1	45.4	13.0	38.2	38.8	47.8	36.6	15.7	48.8	5.0	52.1	40.9	45.0	3.0	23.3	36.9	52.5	46.0	47.6	82.1	8.3	247.2	23.8	19.1	48.5	246.8	54.3	29.1	282.7	64.1	155.1	8.2	108.8	23.0	7.0	37.1	15.4	24.1	19.4	53.3	13.7	37.9	23.8	34.4	40.8	10.3	29.4
PPTC7	TA-PP2C	ENSG00000196850	"PTC7 protein phosphatase homolog"	Q8NI37	12	110533245-110583320	"Enzymes, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 53.8"	"Cell type enhanced"	"Detected in all"	4	"Cardiomyocytes: 96.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039335, HPA040614"	Approved		Approved	"Plasma membrane,Cytosol"		NA	NA			"Plasma membrane, Cytosol"		"HPA039335: AB_10805474, HPA040614: AB_10795526"	"unprognostic (2.44e-1)"	"unprognostic (2.38e-2)"	"unprognostic (1.11e-1)"	"unprognostic (9.44e-2)"	"unprognostic (2.38e-1)"	"unprognostic (3.46e-2)"	"unprognostic (2.14e-1)"	"unprognostic (3.51e-2)"	"unprognostic (1.47e-2)"	"prognostic unfavorable (1.43e-5)"	"prognostic unfavorable (6.76e-4)"	"unprognostic (1.09e-1)"	"prognostic favorable (4.48e-5)"	"unprognostic (5.34e-2)"	"unprognostic (2.83e-1)"	"unprognostic (5.01e-3)"	"unprognostic (1.83e-1)"	10.4	15.3	6.5	10.3	9.6	26.2	10.3	8.3	12.9	9.7	11.8	5.7	4.9	7.5	9.3	4.6	12.6	7.8	8.8	35.3	9.0	9.0	12.6	11.9	13.1	10.9	10.4	6.8	8.9	7.5	13.0	12.7	6.9	15.3	7.7	9.8	8.0	12.9	8.2	53.8	13.4	11.7	13.1	7.4	9.4	8.4	8.2	6.5	16.1	8.0	15.5	13.1	12.4	12.4	2.1	1.4	6.1	1.7	1.7	2.4	0.6	12.2	7.0	6.0	6.3	15.0	13.2	8.6	5.6	7.5	6.2	6.2	7.9	4.8	21.5	5.9	5.5	8.9	11.9	12.0	13.1	12.6	15.6	10.0	19.0	7.5	8.5	14.3	21.0	15.7	11.4	21.6	8.8	25.9	9.3	11.7	15.0	14.1	6.1	10.0	3.1	18.5	18.0	8.5	6.6	13.1	15.5	8.1	13.1	25.7	13.7	9.7	7.6	10.7	14.8	12.4	6.1	7.0	11.3	13.4	5.7	6.1	17.3	9.5	17.8	19.7	24.0	9.6	11.6	11.2	0.1	1.7	1.3	2.3	1.5	2.4	1.3	1.9	1.8	1.3	2.1	2.2	1.9	6.1	1.7	1.1	1.4	1.3	0.6	6.5	9.6	8.3	12.9	9.0	9.0	10.4	6.8	15.3	6.5	20.8	21.2	21.7	47.9	81.6	8.5	96.6	15.3	25.4	22.7	8.7	13.7	6.3	14.9	6.8	29.6	22.2	18.4	23.3	7.1	7.0	37.6	42.4	23.1	24.9	15.0	12.7	16.1	14.7	25.1	17.5	10.6	19.9	32.1	10.0	14.2	3.9	11.1	14.4	9.2	10.5	24.1	12.9	39.1	12.5	22.5	91.1	5.6	20.8	13.8	64.3
PPWD1	KIAA0073	ENSG00000113593	"Peptidylprolyl isomerase domain and WD repeat containing 1"	Q96BP3	5	65563236-65587549	"Enzymes, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	"Isomerase, Rotamase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	5	"Early spermatids: 68.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019353, HPA019360"	Enhanced		Supported	"Nuclear bodies"		NA	NA			"Nuclear bodies"		"HPA019353: AB_1855668, HPA019360: AB_1855669"	"unprognostic (3.31e-2)"	"unprognostic (2.07e-2)"	"unprognostic (6.78e-2)"	"unprognostic (2.85e-1)"	"unprognostic (9.61e-2)"	"unprognostic (1.22e-2)"	"prognostic unfavorable (2.19e-4)"	"unprognostic (1.37e-1)"	"unprognostic (4.97e-2)"	"unprognostic (1.09e-1)"	"unprognostic (7.84e-3)"	"unprognostic (5.72e-2)"	"prognostic unfavorable (6.72e-4)"	"unprognostic (2.40e-1)"	"unprognostic (1.18e-1)"	"unprognostic (2.15e-1)"	"unprognostic (1.30e-2)"	17.5	15.8	24.3	23.5	26.1	26.0	18.9	28.3	29.7	21.3	16.5	17.9	16.8	15.0	22.0	20.9	17.3	20.4	17.1	14.9	20.0	12.6	14.2	17.3	16.3	28.7	20.9	18.3	26.0	18.6	22.7	26.9	20.9	20.9	18.7	21.5	13.1	16.6	17.7	18.0	23.7	21.2	16.9	19.3	28.9	17.8	19.1	21.1	32.4	19.5	15.2	26.7	16.7	23.7	15.6	13.5	18.1	12.3	15.4	23.3	14.5	19.5	12.9	19.4	18.8	17.1	21.2	20.7	19.0	13.6	20.5	25.7	19.5	19.4	22.2	15.1	13.6	26.9	17.4	21.0	19.5	27.9	18.5	18.3	13.7	20.3	17.1	14.9	12.7	14.5	16.8	8.0	19.7	14.0	14.2	17.6	17.0	18.7	15.6	16.2	19.7	19.6	16.1	13.6	7.6	7.7	18.3	25.9	18.7	12.0	16.5	9.9	7.9	18.7	8.1	16.9	15.7	11.9	16.8	13.4	11.3	15.8	12.1	27.8	8.9	13.3	23.2	12.4	18.8	12.0	18.1	10.1	16.7	17.2	11.1	20.7	15.6	18.9	18.7	13.5	12.3	23.3	20.4	8.2	15.4	12.3	7.8	20.7	14.5	24.3	26.1	28.3	29.7	20.0	12.6	20.9	18.3	20.9	21.1	26.8	15.3	15.7	13.4	11.0	15.8	15.9	2.5	20.1	27.3	10.4	7.9	23.5	8.3	7.4	68.1	14.3	6.6	23.3	6.6	11.2	13.4	6.0	10.5	4.2	10.2	6.4	9.2	16.5	14.2	27.5	18.7	10.8	13.5	19.0	14.2	14.9	7.6	14.0	17.7	6.5	20.4	6.5	11.0	20.2	31.1	10.3	21.1	20.0	10.3	7.2
PRAG1	"DKFZp761P0423, NACK, PEAK2, PRAGMIN, SgK223"	ENSG00000275342	"PEAK1 related, kinase-activating pseudokinase 1"	Q86YV5	8	8317736-8386498	"Enzymes, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 30.4"	"Cell type enhanced"	"Detected in some"	11	"Alveolar cells type 1: 8.9;Alveolar cells type 2: 6.2;Cytotrophoblasts: 6.4;Ductal cells: 6.6;Extravillous trophoblasts: 5.5;Hofbauer cells: 14.8;Pancreatic endocrine cells: 5.5"	"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"A549: 27.5;NTERA-2: 17.8;SuSa: 19.0"	"Low region specificity"	"Detected in all"							"HPA011776, HPA012066"	Uncertain		Uncertain	"Nucleoli,Focal adhesion sites"		NA	NA			Nucleoli	"Focal adhesion sites"	"HPA011776: , HPA012066: AB_1847706"	"unprognostic (7.04e-3)"	"unprognostic (7.90e-2)"	"unprognostic (2.32e-1)"	"unprognostic (2.95e-2)"	"unprognostic (1.60e-1)"	"unprognostic (2.92e-1)"	"unprognostic (1.05e-1)"	"unprognostic (4.78e-3)"	"unprognostic (2.64e-3)"	"unprognostic (5.19e-2)"	"unprognostic (4.95e-2)"	"unprognostic (1.78e-1)"	"prognostic favorable (4.81e-4)"	"unprognostic (5.27e-2)"	"unprognostic (1.23e-1)"	"unprognostic (5.04e-2)"	"unprognostic (5.22e-3)"	7.6	0.2	6.4	8.8	4.9	0.1	5.4	30.4	7.0	2.4	5.7	1.8	3.2	9.8	0.8	1.7	2.6	5.0	4.0	1.8	2.1		1.3	0.9	4.3	9.1	0.0	1.4	1.7	1.0	2.2	0.0	5.4	1.2	1.5	3.4	0.0	1.7	5.7	5.6	2.8	9.4	0.9	1.4	5.7	3.9	0.7	1.2	1.8	15.4	4.7	6.2	1.5	0.2	3.1	4.6	2.2	1.6	1.3	3.9	0.4	3.3	27.5	3.1	0.4	0.0	0.2	7.8	7.0	1.5	2.8	1.1	13.6	8.0	5.5	4.8	3.3	7.6	12.0	0.5	8.4	0.6	0.2	0.8	0.0	3.3	7.6	3.0	0.8	8.7	0.7	5.5	0.4	1.2	1.6	5.7	0.8	0.0	0.0	2.1	4.6	0.7	2.6	17.8	10.5	7.1	3.5	3.3	1.3	4.1	9.5	1.5	1.0	2.7	7.7	2.7	19.0	6.0	3.4	7.5	0.2	7.4	0.0	1.7	0.4	0.6	7.5	1.7	1.8	4.1	0.0	0.5	2.2	1.2	0.1	0.9	3.1	1.5	0.4	0.7	2.6	3.9	3.2	0.0	1.3	1.6	4.6	0.2	0.4											8.9	6.2	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.0	6.4	0.0	6.6	0.0	0.0	0.0	0.0	2.7	5.5	0.0	0.0	2.3	0.0	14.8	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	1.8	0.0	0.0	5.5	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0
PRCP	"HUMPCP, PCP"	ENSG00000137509	Prolylcarboxypeptidase	P42785	11	82823502-82970584	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Carboxypeptidase, Hydrolase, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	9	"Ito cells: 392.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"ASC diff: 99.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA017065, HPA071115"	Approved		Supported	Vesicles	"Intracellular and membrane"	NA	NA		34000000	Vesicles		"HPA017065: AB_1855676, HPA071115: "	"unprognostic (3.24e-1)"	"unprognostic (2.25e-1)"	"unprognostic (1.76e-1)"	"unprognostic (1.51e-1)"	"unprognostic (2.54e-1)"	"unprognostic (1.33e-2)"	"unprognostic (9.22e-2)"	"unprognostic (1.42e-1)"	"unprognostic (7.97e-2)"	"unprognostic (2.61e-1)"	"unprognostic (2.70e-1)"	"unprognostic (1.88e-2)"	"prognostic favorable (2.65e-6)"	"unprognostic (7.16e-2)"	"unprognostic (1.73e-2)"	"unprognostic (3.49e-1)"	"unprognostic (4.07e-1)"	32.6	45.9	25.0	21.5	22.2	13.1	69.5	19.4	23.8	38.8	17.9	17.9	27.6	11.0	30.7	35.5	32.2	24.6	25.6	66.3	25.8	18.9	52.4	52.5	38.1	95.1	27.0	14.8	27.8	23.4	30.6	19.3	59.8	34.9	25.1	18.4	25.1	38.1	34.5	10.3	26.2	15.7	32.8	45.0	25.1	16.8	17.4	17.7	9.8	27.9	24.2	31.7	39.4	30.1	13.1	50.0	31.2	27.9	12.1	6.2	14.7	7.5	8.3	12.8	25.7	99.0	36.4	15.0	16.2	28.9	15.5	22.8	20.5	15.7	10.9	23.7	23.5	17.6	12.0	11.6	10.7	18.2	9.7	8.4	7.8	11.6	12.7	18.5	7.0	28.6	26.5	8.3	16.2	15.3	38.1	51.4	6.0	8.3	15.4	15.9	3.4	1.0	25.0	7.4	18.5	7.7	5.7	22.2	13.0	21.7	14.0	5.3	11.6	22.2	12.8	9.1	19.7	15.4	9.6	13.3	18.3	18.4	15.8	7.9	14.5	24.6	9.8	7.5	8.5	9.4	15.5	26.4	17.4	5.3	27.9	6.1	9.9	5.3	5.8	50.0	13.1	4.4	6.2	31.2	12.1	21.2	8.9	5.0	14.7	25.0	22.2	19.4	23.8	25.8	18.9	27.0	14.8	34.9	17.7	17.9	14.6	43.2	35.5	27.8	10.0	19.8	43.3	5.3	12.5	59.3	2.0	49.3	24.9	28.4	24.0	120.7	4.9	0.0	10.6	99.1	49.9	26.3	12.7	56.8	72.6	15.9	18.9	392.8	149.3	39.4	40.9	76.3	67.4	54.1	18.6	57.0	10.0	7.0	43.5	76.8	4.3	64.7	26.8	23.6	5.7	30.6	44.3	25.4	19.9	33.8
PRDM2	"HUMHOXY1, KMT8, KMT8A, MTB-ZF, RIZ, RIZ1, RIZ2"	ENSG00000116731	"PR/SET domain 2"	Q13029	1	13700198-13825079	"Enzymes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding, Methyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA005809	Approved		Approved	"Nucleoplasm,Golgi apparatus"		NA	NA			"Nucleoplasm, Golgi apparatus"		"HPA005809: AB_1079673"	"unprognostic (2.22e-1)"	"unprognostic (3.28e-1)"	"unprognostic (5.34e-2)"	"unprognostic (1.28e-2)"	"unprognostic (6.70e-2)"	"unprognostic (2.72e-3)"	"unprognostic (1.94e-2)"	"unprognostic (1.12e-2)"	"unprognostic (3.20e-2)"	"unprognostic (2.53e-2)"	"unprognostic (2.30e-1)"	"unprognostic (1.35e-1)"	"unprognostic (9.63e-3)"	"unprognostic (3.81e-1)"	"unprognostic (2.45e-1)"	"unprognostic (1.85e-1)"	"unprognostic (5.85e-3)"	15.2	14.5	26.0	17.2	28.1	64.1	17.2	32.3	44.9	16.2	18.1	19.8	12.6	12.4	18.8	16.4	19.6	14.4	16.4	14.3	19.8	14.5	10.8	9.3	15.6	23.4	18.9	27.8	30.7	12.8	16.0	26.7	15.7	18.0	17.7	13.6	10.3	15.8	18.9	45.2	21.6	16.8	16.8	21.6	16.9	14.2	17.1	17.8	14.4	23.3	11.7	22.7	19.8	19.3	16.0	5.4	9.7	5.1	5.7	5.7	2.5	6.9	4.0	14.4	5.5	11.4	8.8	6.9	9.0	5.5	6.2	7.0	6.2	7.9	21.2	8.0	8.7	5.2	8.6	10.7	5.3	6.9	13.1	7.6	14.2	4.6	2.9	6.3	4.7	12.3	9.3	9.4	6.5	5.5	5.9	6.1	8.4	12.6	24.6	7.7	3.5	7.6	7.5	4.3	5.5	5.3	10.6	7.8	6.3	3.5	7.8	12.5	8.1	7.2	4.6	9.9	9.0	6.5	7.7	10.8	7.9	8.7	7.2	4.9	36.1	24.4	30.4	7.1	11.1	10.2	3.9	4.8	6.8	5.7	3.1	3.8	16.0	4.5	5.2	2.9	12.5	5.2	4.5	9.7	5.7	5.1	5.4	4.1	2.5	26.0	28.1	32.3	44.9	19.8	14.5	18.9	27.8	18.0	17.8	35.7	37.8	66.5	49.3	55.2	46.9	34.7	25.5	53.5	40.9	22.7	43.2	19.3	14.9	15.3	8.6	29.3	23.6	46.7	11.9	11.9	42.7	46.2	39.3	16.4	14.7	66.7	36.4	25.2	38.9	11.6	40.9	37.0	28.7	28.9	18.8	23.0	13.7	14.4	42.5	6.6	36.8	25.8	27.0	41.2	51.7	45.7	15.3	50.4	15.2	52.5
PRDM6	"KMT8C, PRISM"	ENSG00000061455	"PR/SET domain 6"	Q9NQX0	5	123089121-123194266	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Chromatin regulator, Methyltransferase, Repressor, Transferase"	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"gallbladder: 19.7;smooth muscle: 29.7;urinary bladder: 18.4;vagina: 18.7"	"Cell type enhanced"	"Detected in some"	8	"Early spermatids: 2.9;Fibroblasts: 6.0;Late spermatids: 4.1;Melanocytes: 3.3"	"Low cancer specificity"	"Detected in some"			"Region enriched"	"Detected in single"	6	"pons and medulla: 3.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 7.0;HEK 293: 9.8"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			HPA030324	Uncertain		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA030324: AB_10670032"	"unprognostic (2.33e-1)"	"unprognostic (1.39e-1)"	"unprognostic (2.18e-1)"	"unprognostic (2.32e-3)"	"unprognostic (3.12e-1)"	"unprognostic (5.44e-2)"	"unprognostic (2.22e-1)"	"unprognostic (1.54e-2)"	"unprognostic (4.66e-2)"	"unprognostic (7.66e-3)"	"unprognostic (1.23e-1)"	"unprognostic (1.92e-2)"	"unprognostic (1.02e-7)"	"unprognostic (9.30e-4)"	"unprognostic (1.10e-1)"	"unprognostic (3.43e-4)"	"unprognostic (1.27e-1)"	1.3	0.3	0.3	0.6	0.3	0.0	1.4	0.4	0.5	1.6	6.7	0.4	0.3	0.4	1.8	0.6	1.2	0.6	19.7	0.9	0.4	0.3	0.6	0.3	10.6	0.0	0.5	0.4	3.8	0.5	0.3	0.5	8.1	3.6	14.1	1.9	0.0	0.3	0.8	0.2	0.4	1.0	29.7	0.8	0.1	1.1	0.5	0.0	0.0	1.4	0.2	0.6	18.4	18.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.8	0.6	0.9	7.0	0.1	0.0	0.0	0.1	0.1	0.3	0.1	0.2	0.5	0.2	0.0	1.4	0.0	0.0	0.3	9.8	2.1	0.9	0.0	2.0	0.0	0.3	0.1	0.1	0.2	0.1	0.3	0.0	0.1	0.0	0.2	0.0	1.0	0.0	0.1	0.0	0.1	0.0	0.0	0.2	0.0	0.2	1.1	0.4	0.1	1.5	0.0	0.0	0.5	0.6	0.0	0.1	0.2	0.0	0.0	0.4	0.1	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.4	0.5	0.4	0.3	0.5	0.4	3.6	0.0	0.0	0.0	0.0	0.1	1.6	0.8	1.1	0.0	0.0	0.0	0.0	2.0	0.3	0.0	0.1	2.9	0.5	0.0	0.0	0.2	0.2	6.0	0.1	0.0	0.5	0.7	0.0	0.0	0.0	0.3	4.1	2.0	0.7	3.3	0.0	0.0	0.2	0.1	0.0	1.1	0.3	0.8	0.0	1.4	1.9	1.9	1.1	0.3	0.0	0.0	0.0
PRDM7	ZNF910	ENSG00000126856	"PR/SET domain 7"	Q9NQW5	16	90056566-90092072	"Enzymes, Predicted intracellular proteins"		"Chromatin regulator, Methyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in single"	27	"testis: 4.8"	"Group enriched"	"Detected in some"	7	"Alveolar cells type 2: 1.4;Cardiomyocytes: 5.0;Ciliated cells: 2.7"	"Cancer enriched"	"Detected in single"	30	"melanoma: 3.1"					"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	20	"REH: 9.1;SK-MEL-30: 6.7"									HPA059944	Approved		Uncertain	"Nuclear speckles"		NA	NA			"Nuclear speckles"		"HPA059944: AB_2684174"	"unprognostic (3.98e-1)"	"unprognostic (8.89e-2)"		"unprognostic (8.02e-3)"	"unprognostic (8.26e-2)"		"unprognostic (9.01e-2)"	"unprognostic (5.61e-3)"	"unprognostic (1.05e-2)"	"unprognostic (1.46e-1)"		"unprognostic (5.73e-1)"	"unprognostic (5.52e-4)"	"unprognostic (1.36e-1)"	"unprognostic (1.61e-1)"	"unprognostic (4.03e-3)"		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.8			0.0		0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	9.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	6.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0											0.0	1.4	0.0	0.0	0.0	0.0	5.0	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.0	0.0
PRDM9	"KMT8B, MSBP3, PFM6, ZNF899"	ENSG00000164256	"PR/SET domain 9"	Q9NQV7	5	23443586-23528597	"Enzymes, Predicted intracellular proteins, Transcription factors"	"Meiosis, Transcription, Transcription regulation"	"Activator, Chromatin regulator, DNA-binding, Methyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"blood: 4.1;epididymis: 3.3;testis: 8.3"	"Cell type enhanced"	"Detected in some"	18	"Early spermatids: 2.1;Late spermatids: 1.8;Spermatocytes: 3.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enriched"	"Detected in some"	11	"U-266/70: 12.4"	"Low region specificity"	"Detected in some"							HPA059555	Uncertain					NA	NA					"HPA059555: AB_2684061"							"unprognostic (1.23e-4)"			"unprognostic (8.64e-2)"				"unprognostic (2.18e-2)"	"unprognostic (8.34e-2)"		"unprognostic (4.11e-1)"	0.1	0.0	0.1	0.1	0.1	1.7	0.1	0.1	0.2	0.1	0.1	0.1	0.1	0.0	0.1	3.3	0.1	0.2	0.1	0.1	0.1	0.0	0.2	0.1	0.1	0.1	0.1	0.1	0.1	0.9	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.4	0.1	0.1	0.1	0.2	0.0	8.3	0.1	0.1	0.1	0.1	0.1	0.1	0.1	1.5	0.5	4.1	0.7	2.3	1.0	0.1	0.0	0.5	0.4	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.4	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.6	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.1	0.8	0.0	0.0	0.0	0.7	0.2	0.0	0.0	0.5	0.0	0.4	0.0	0.0	1.1	0.0	0.0	0.0	0.1	0.4	0.1	0.0	0.2	0.2	0.9	0.0	0.0	12.4	0.2	0.1	0.1	0.2	0.1	2.9	0.7	0.3	0.7	0.3	0.8	0.9	0.8	0.6	0.3	1.5	0.8	1.0	4.1	2.3	0.5	0.5	0.5	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	3.4	1.0	0.0	0.0	0.0	0.0	0.0
PRDX1	"NKEFA, PAGA"	ENSG00000117450	"Peroxiredoxin 1"	Q06830	1	45511036-45523047	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Antioxidant, Oxidoreductase, Peroxidase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"CAB004682, HPA007730"	Approved		Approved	Mitochondria		NA	NA		110000000	Mitochondria		"CAB004682: AB_437046, HPA007730: AB_1855204"	"unprognostic (1.28e-2)"	"unprognostic (4.64e-1)"	"unprognostic (2.22e-2)"	"unprognostic (3.65e-1)"	"unprognostic (2.38e-1)"	"unprognostic (3.95e-2)"	"prognostic unfavorable (1.17e-5)"	"unprognostic (2.47e-1)"	"unprognostic (1.31e-1)"	"unprognostic (4.68e-2)"	"unprognostic (3.05e-2)"	"unprognostic (2.90e-1)"	"unprognostic (2.39e-2)"	"unprognostic (5.99e-2)"	"unprognostic (2.88e-1)"	"unprognostic (1.24e-1)"	"prognostic unfavorable (2.89e-4)"	43.3	58.2	71.0	43.8	57.4	12.0	75.5	31.6	60.0	46.9	51.1	72.2	42.6	78.5	40.8	75.7	136.1	49.7	46.9	84.2	56.5	73.0	121.7	136.5	52.9	51.0	99.1	51.2	43.0	20.4	34.1	34.3	58.3	87.8	42.2	53.0	48.8	53.5	52.2	78.9	46.9	77.6	52.4	98.3	46.5	52.5	25.7	72.6	29.7	130.1	114.3	91.0	49.1	56.3	44.7	50.3	64.4	64.5	20.4	72.3	58.7	64.7	119.4	49.2	62.6	55.9	47.8	105.4	73.7	76.7	80.1	66.6	59.4	28.1	57.2	77.8	79.1	97.3	67.2	106.9	71.3	79.2	44.0	82.6	43.3	168.6	166.0	24.3	50.0	56.7	41.0	53.3	79.4	18.8	44.0	91.7	68.2	79.1	19.8	79.4	52.0	67.1	48.9	154.3	144.4	125.2	118.3	62.1	75.4	143.8	55.9	65.5	32.9	67.6	183.7	4.7	150.5	49.9	40.5	77.9	32.0	72.4	68.4	98.1	13.8	77.4	109.1	52.9	34.8	18.7	64.4	55.6	18.4	28.5	60.6	37.5	44.7	45.5	37.9	50.3	36.2	28.3	31.0	2.4	20.4	64.5	33.5	72.3	58.7	71.0	57.4	31.6	60.0	56.5	73.0	99.1	51.2	87.8	72.6	485.3	206.7	314.1	835.1	539.4	156.1	25.5	438.2	477.8	340.1	586.2	98.2	1056.6	802.4	878.0	14.3	395.3	667.0	116.8	386.1	1465.8	343.6	670.3	319.6	809.1	1307.1	195.5	167.4	307.6	343.8	26.3	461.7	625.9	551.7	763.8	204.7	292.0	608.7	403.3	386.1	1911.4	290.8	304.0	372.5	90.5	393.1	462.1	932.4	124.6	344.7	1354.4
PRDX2	"MGC4104, NKEFB, PRP, PRX2, PRXII, TDPX1, TSA"	ENSG00000167815	"Peroxiredoxin 2"	P32119	19	12796820-12801859	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins"		"Antioxidant, Oxidoreductase, Peroxidase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	9	"Distal tubular cells: 1115.8;Erythroid cells: 2453.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"											CAB008713	Approved					NA	NA		1100000000			"CAB008713: AB_1620974"	"unprognostic (1.12e-1)"	"unprognostic (1.98e-3)"	"unprognostic (8.58e-2)"	"unprognostic (4.40e-2)"	"unprognostic (4.56e-2)"	"unprognostic (1.92e-2)"	"unprognostic (2.44e-1)"	"unprognostic (2.59e-2)"	"unprognostic (1.01e-1)"	"unprognostic (1.47e-1)"	"unprognostic (3.26e-2)"	"unprognostic (9.18e-2)"	"prognostic favorable (5.66e-11)"	"unprognostic (7.01e-3)"	"unprognostic (2.15e-1)"	"unprognostic (3.51e-2)"	"unprognostic (1.41e-1)"	39.8	95.1	54.7	17.9	55.6	119.1	27.7	52.1	80.8	22.5	39.9	27.8	42.2	53.6	28.1	33.8	49.9	31.5	36.4	142.0	49.2	54.4	44.5	79.4	15.9	22.7	62.2	41.6	40.0	43.0	32.8	49.4	20.9	70.9	30.6	30.8	35.9	42.3	41.5	136.8	44.3	44.9	27.6	27.5	18.1	31.5	13.7	23.5	38.9	36.8	69.9	29.5	31.5	24.6	42.1	24.6	9.5	20.6	23.3	76.8	72.3	45.4	0.1	62.9	81.2	9.1	6.3	46.3	21.1	21.0	28.7	16.4	47.8	11.5	13.4	49.3	20.3	3.4	43.5	39.6	34.2	8.3	57.2	62.7	24.3	64.5	71.3	24.6	0.0	0.1	27.0	15.8	21.6	10.6	37.4	26.6	28.5	51.7	21.1	10.9	82.5	53.5	20.6	46.3	31.6	88.0	53.0	0.0	64.5	38.2	49.3	77.8	61.5	50.0	51.3	16.6	12.0	45.9	34.9	11.7	21.6	18.2	59.8	45.6	25.9	25.2	61.4	20.5	8.1	4.9	2.8	20.6	9.5	53.6	14.3	56.2	42.1	73.5	54.8	24.6	29.2	74.9	58.5	2.7	23.3	15.4	14.4	76.8	72.3	54.7	55.6	52.1	80.8	49.2	54.4	62.2	41.6	70.9	23.5	20.8	27.1	84.8	205.3	196.6	303.0	31.1	249.7	42.8	58.0	265.2	94.2	660.9	1115.8	292.4	2.4	139.3	489.0	2453.0	145.5	433.0	202.0	181.2	47.2	378.1	188.3	203.4	320.3	124.6	63.9	7.6	272.1	62.1	266.6	79.4	252.2	346.8	197.7	212.5	301.9	721.8	254.6	155.2	177.8	4.1	7.0	200.6	425.2	113.3	409.3	193.6
PRDX3	"AOP-1, AOP1, MER5, SP-22"	ENSG00000165672	"Peroxiredoxin 3"	P30048	10	119167703-119178833	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Antioxidant, Oxidoreductase, Peroxidase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	7	"Distal tubular cells: 898.6;Proximal tubular cells: 684.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB008656, HPA041488, CAB079909"	Enhanced		Supported	Mitochondria		NA	NA		14000000	Mitochondria		"CAB008656: AB_1620979, CAB079909: AB_2809998, HPA041488: AB_2677508"	"unprognostic (8.29e-2)"	"unprognostic (1.02e-1)"	"unprognostic (1.26e-2)"	"unprognostic (1.68e-1)"	"unprognostic (1.17e-1)"	"unprognostic (1.72e-3)"	"unprognostic (4.62e-3)"	"unprognostic (2.40e-1)"	"unprognostic (2.06e-1)"	"unprognostic (3.65e-2)"	"unprognostic (1.29e-2)"	"unprognostic (9.48e-2)"	"unprognostic (6.03e-3)"	"unprognostic (2.77e-1)"	"unprognostic (2.77e-1)"	"unprognostic (2.27e-1)"	"unprognostic (1.21e-1)"	34.0	100.7	28.8	18.8	28.3	14.4	29.1	16.1	28.9	23.0	27.1	20.7	25.1	28.1	25.5	26.3	30.6	24.8	21.8	55.8	26.7	28.2	78.8	114.8	16.3	20.0	29.9	23.2	19.2	34.1	25.2	24.6	29.9	33.6	27.4	29.6	21.2	40.5	29.3	80.9	10.3	34.6	26.8	24.1	27.4	24.6	14.0	24.6	24.3	48.9	46.1	20.5	25.9	17.9	30.9	65.7	41.4	74.9	20.9	34.2	73.0	54.1	62.1	37.9	43.0	40.1	43.5	23.7	38.9	66.4	59.4	62.5	47.6	54.3	63.6	34.1	45.8	28.3	24.8	62.6	47.0	67.1	62.2	65.9	28.6	27.0	84.2	42.0	53.5	34.7	50.9	30.3	47.4	44.2	42.7	42.9	39.1	35.1	13.3	54.3	21.7	40.4	45.3	35.4	41.3	36.8	43.0	55.1	43.9	100.3	26.0	16.7	24.3	41.3	55.8	51.0	34.2	28.9	64.5	30.2	19.4	29.3	27.7	50.4	20.8	30.3	51.0	30.5	79.5	17.2	19.5	74.9	40.8	20.3	61.8	25.9	30.9	27.1	24.5	65.7	24.3	28.3	25.2	41.4	20.9	53.2	36.8	34.2	73.0	28.8	28.3	16.1	28.9	26.7	28.2	29.9	23.2	33.6	24.6	44.7	64.4	72.5	95.3	62.0	25.6	212.3	122.3	104.4	39.8	139.6	9.8	296.9	898.6	109.2	4.2	70.9	99.7	70.0	65.9	187.6	95.6	106.7	51.9	340.4	218.6	38.1	106.5	71.2	159.0	8.6	71.7	113.7	126.5	146.1	117.2	58.7	65.7	98.2	95.1	684.3	19.1	71.1	104.2	10.0	22.8	45.9	129.6	54.3	181.8	109.3
PRDX4	AOE37-2	ENSG00000123131	"Peroxiredoxin 4"	Q13162	X	23664262-23686399	"Cancer-related genes, Enzymes, Predicted intracellular proteins"		"Antioxidant, Oxidoreductase, Peroxidase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	6	"liver: 127.6;pancreas: 320.8"	"Cell type enhanced"	"Detected in all"	5	"Late spermatids: 604.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB008659, CAB027389, CAB047362, HPA067039"	Enhanced		Supported	"Endoplasmic reticulum,Cytosol"	"Intracellular and membrane"	NA	NA		11000000	"Endoplasmic reticulum, Cytosol"		"CAB008659: AB_1620984, CAB027389: , CAB047362: , HPA067039: "	"unprognostic (3.82e-2)"	"unprognostic (6.05e-2)"	"unprognostic (1.09e-1)"	"unprognostic (6.06e-3)"	"unprognostic (1.64e-1)"	"unprognostic (1.65e-2)"	"unprognostic (1.29e-3)"	"unprognostic (1.08e-1)"	"unprognostic (8.32e-2)"	"unprognostic (3.75e-2)"	"unprognostic (2.97e-1)"	"unprognostic (1.79e-1)"	"prognostic unfavorable (1.33e-6)"	"unprognostic (7.44e-2)"	"unprognostic (1.29e-1)"	"unprognostic (3.56e-1)"	"unprognostic (4.10e-2)"	11.6	14.8	3.8	7.0	6.4	3.9	11.2	3.3	5.4	13.2	10.7	6.5	17.4	8.9	11.5	10.5	13.1	9.6	12.9	17.6	3.8	4.0	11.8	127.6	8.9	16.9	7.2	4.0	14.6	320.8	6.1	15.8	21.9	7.4	9.3	11.4	8.0	25.4	14.1	7.8	7.2	10.6	8.8	8.1	12.6	12.8	25.2	6.1	4.7	12.0	10.0	15.0	10.8	8.7	27.9	31.4	2.0	39.3	24.1	22.7	21.3	23.9	33.1	14.0	27.1	76.5	39.1	19.7	32.3	35.2	29.4	42.8	34.6	30.2	20.6	15.2	41.8	34.1	29.1	40.3	20.0	28.1	12.6	77.5	14.6	29.2	43.8	31.9	18.8	13.9	41.4	26.0	28.5	28.7	32.0	36.7	6.9	28.2	76.2	27.1	35.7	9.6	29.5	48.4	47.1	48.6	13.3	35.1	116.3	26.2	8.4	20.6	17.5	29.8	35.3	23.8	80.2	37.3	24.0	24.2	21.0	13.8	54.0	24.2	25.0	30.2	22.1	37.5	24.4	29.8	1.7	20.6	2.0	17.8	32.2	21.8	27.9	22.7	18.6	31.4	16.2	16.4	16.7	1.5	24.1	39.3	22.0	22.1	21.3	3.8	6.4	3.3	5.4	3.8	4.0	7.2	4.0	7.4	6.1	53.6	69.3	34.3	72.4	53.0	14.1	33.1	117.2	62.9	56.9	47.1	7.9	283.9	8.3	219.7	305.3	87.4	33.6	23.3	310.3	449.8	156.0	130.0	41.6	497.8	155.7	11.1	56.3	100.1	55.2	604.6	233.8	49.6	189.0	103.6	79.9	51.0	268.1	31.6	135.4	36.5	17.9	142.3	69.0	183.9	270.0	45.7	216.3	25.4	110.8	64.0
PRDX5	"ACR1, AOEB166, B166, MGC117264, MGC142283, MGC142285, PLP, PMP20, PRDX6, PRXV, SBBI10"	ENSG00000126432	"Peroxiredoxin 5"	P30044	11	64318088-64321811	"Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"		"Antioxidant, Oxidoreductase, Peroxidase"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB008661, HPA037915, HPA037916"	Enhanced		Supported	Mitochondria		NA	NA		19000000	Mitochondria		"CAB008661: AB_1620988, HPA037915: AB_2675735, HPA037916: AB_2675736"	"unprognostic (2.75e-1)"	"unprognostic (4.08e-1)"	"unprognostic (1.33e-1)"	"unprognostic (1.46e-1)"	"unprognostic (9.43e-2)"	"unprognostic (6.71e-3)"	"unprognostic (1.08e-3)"	"unprognostic (3.11e-1)"	"unprognostic (9.30e-2)"	"unprognostic (1.07e-3)"	"unprognostic (1.57e-2)"	"unprognostic (2.20e-1)"	"prognostic favorable (1.24e-5)"	"unprognostic (8.19e-2)"	"unprognostic (2.30e-1)"	"unprognostic (9.63e-2)"	"unprognostic (5.03e-2)"	28.7	69.7	70.3	38.6	60.3	57.0	35.5	69.3	73.9	47.2	79.3	31.9	49.0	49.5	26.6	54.8	69.6	94.9	44.8	102.4	56.7	74.2	57.3	54.2	50.3	25.0	68.6	70.2	42.2	72.0	36.0	53.7	49.1	71.4	30.7	71.2	33.9	77.5	62.6	104.7	27.0	51.2	30.9	44.1	27.3	64.5	35.0	29.3	25.1	82.0	64.8	33.5	34.4	50.4	55.2	69.2	115.0	66.9	48.4	40.5	75.3	26.3	53.8	32.6	53.9	35.1	52.9	37.7	33.0	52.9	24.3	30.3	39.1	54.1	38.6	57.8	52.7	87.4	60.3	30.4	70.1	15.4	53.6	24.0	39.0	84.6	44.5	72.1	14.7	33.3	53.6	91.6	40.7	41.3	47.5	36.8	45.9	21.9	91.9	34.1	66.8	25.7	64.1	49.3	41.7	68.8	24.8	33.5	136.5	90.8	52.3	27.6	52.6	27.6	61.3	94.1	32.6	44.9	33.6	35.5	34.7	32.3	40.1	14.5	47.0	56.0	45.5	42.0	29.8	27.0	79.8	66.9	85.4	37.7	59.6	32.7	53.8	35.0	30.8	52.4	55.2	34.8	35.0	115.0	48.4	52.5	69.2	40.5	75.3	70.3	60.3	69.3	73.9	56.7	74.2	68.6	70.2	71.4	29.3	247.1	407.2	232.2	603.5	290.1	156.4	523.8	356.7	1310.3	342.4	427.5	66.8	1002.3	1366.1	644.2	57.6	187.4	757.5	163.5	919.1	972.3	308.0	330.5	103.7	331.1	418.0	87.4	770.7	194.0	207.8	207.7	258.3	234.8	413.3	423.8	875.2	180.0	1093.8	547.1	213.2	1094.9	109.1	194.1	199.4	113.7	345.0	225.2	818.7	191.8	959.8	988.5
PRDX6	"1-Cys, aiPLA2, AOP2, KIAA0106, MGC46173, NSGPx, p29, PRX"	ENSG00000117592	"Peroxiredoxin 6"	P30041	1	173477266-173488807	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Lipid degradation, Lipid metabolism"	"Antioxidant, Hydrolase, Multifunctional enzyme, Oxidoreductase, Peroxidase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"HPA006983, CAB008663"	Supported		Supported	"Plasma membrane,Cytosol"		NA	NA		180000000	"Plasma membrane, Cytosol"		"CAB008663: AB_1620994, HPA006983: AB_1079595"	"unprognostic (9.92e-2)"	"unprognostic (1.50e-1)"	"unprognostic (3.67e-1)"	"unprognostic (2.99e-3)"	"unprognostic (1.96e-1)"	"prognostic unfavorable (1.23e-5)"	"unprognostic (5.71e-3)"	"unprognostic (2.80e-2)"	"unprognostic (5.27e-3)"	"unprognostic (3.96e-3)"	"unprognostic (3.19e-3)"	"unprognostic (1.59e-1)"	"prognostic unfavorable (9.51e-4)"	"unprognostic (2.50e-1)"	"unprognostic (7.12e-2)"	"unprognostic (1.15e-1)"	"unprognostic (4.73e-3)"	80.0	42.1	32.8	30.8	38.9	21.8	106.3	19.8	32.8	27.2	46.7	37.4	35.8	12.1	30.8	54.1	39.9	40.2	22.3	70.5	29.0	23.9	45.9	116.1	29.2	37.5	34.0	28.2	31.5	39.3	63.9	19.1	36.9	30.3	40.0	56.0	21.3	22.6	35.4	128.0	25.7	20.2	40.5	19.7	23.1	33.2	44.9	24.1	17.4	46.9	68.6	25.7	36.5	46.2	17.2	37.9	14.3	23.9	12.0	25.0	30.6	52.1	16.0	26.6	29.5	103.2	50.5	22.5	106.5	36.3	44.5	31.6	30.2	35.1	33.9	34.1	87.2	16.4	30.5	34.8	34.3	36.2	29.8	32.1	22.5	27.4	34.1	58.2	23.5	7.4	41.8	34.8	24.4	34.2	28.0	43.6	14.2	50.0	7.0	50.5	10.7	15.9	31.0	58.5	28.7	99.6	19.1	30.8	34.6	66.6	11.9	12.4	23.0	36.7	43.2	24.4	40.0	36.5	33.2	29.3	17.3	19.9	26.2	28.9	10.6	15.7	27.9	20.8	20.5	15.8	13.9	23.9	12.9	17.0	20.6	18.9	17.2	17.6	21.1	29.3	13.6	23.2	25.0	14.3	12.0	17.5	37.9	20.4	30.6	32.8	38.9	19.8	32.8	29.0	23.9	34.0	28.2	30.3	24.1	163.8	131.5	140.0	350.9	209.2	31.5	477.5	249.7	195.4	161.5	263.5	27.5	589.1	729.5	163.2	193.0	183.6	264.7	256.9	175.5	640.5	290.3	337.6	341.6	875.0	302.1	42.9	136.4	174.3	152.8	441.3	315.2	140.2	173.7	230.0	253.4	390.8	159.2	306.9	391.7	634.8	41.0	181.1	254.2	113.1	58.3	231.0	805.7	161.9	278.6	280.8
PREP		ENSG00000085377	"Prolyl endopeptidase"	P48147	6	105277565-105403084	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Hydrolase, Protease, Serine protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Syncytiotrophoblasts: 56.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB025414, HPA031388, HPA031389, HPA031390"	Supported		Supported	Cytosol		NA	NA		1400000	Cytosol		"CAB025414: , HPA031388: AB_2673855, HPA031389: AB_2673856, HPA031390: AB_2673857"	"unprognostic (3.05e-2)"	"unprognostic (9.09e-3)"	"unprognostic (2.85e-2)"	"unprognostic (5.46e-2)"	"unprognostic (3.36e-1)"	"prognostic unfavorable (3.33e-4)"	"unprognostic (2.63e-3)"	"unprognostic (2.39e-1)"	"unprognostic (6.78e-2)"	"unprognostic (5.81e-2)"	"unprognostic (2.66e-2)"	"unprognostic (1.15e-1)"	"unprognostic (4.47e-3)"	"unprognostic (2.74e-2)"	"unprognostic (8.98e-2)"	"unprognostic (6.59e-2)"	"unprognostic (2.33e-1)"	13.0	14.2	10.1	22.2	10.1	10.4	36.2	10.9	24.9	11.9	27.2	5.2	11.2	20.2	13.2	10.9	16.4	10.5	15.0	19.0	8.8	7.1	8.9	14.6	23.9	31.4	8.3	15.4	13.6	18.8	16.1	11.1	15.4	9.7	9.4	33.0	8.9	14.9	11.5	58.0	24.2	19.0	15.3	8.5	11.9	14.0	20.1	8.8	17.4	10.2	18.5	13.3	18.2	21.0	8.3	15.3	7.1	18.7	16.6	16.3	11.2	11.0	13.5	14.5	16.2	34.3	20.3	14.3	14.9	14.0	19.7	20.9	17.2	7.0	14.2	14.7	17.5	18.2	17.2	21.3	43.6	22.4	21.4	20.8	19.0	11.4	19.6	13.2	19.2	13.9	18.8	26.6	14.1	36.5	14.9	18.3	25.1	32.4	25.4	23.8	18.0	12.8	19.5	14.0	21.4	13.6	19.8	24.9	9.2	14.7	26.4	19.0	27.1	13.1	21.9	10.4	19.2	9.4	30.8	18.4	9.0	12.6	11.3	18.3	7.4	4.9	18.6	16.0	20.9	28.1	4.8	13.6	7.1	16.0	15.4	15.6	8.3	13.7	16.3	15.3	6.8	12.9	15.2	0.7	16.6	18.7	6.5	12.0	11.2	10.1	10.1	10.9	24.9	8.8	7.1	8.3	15.4	9.7	8.8	3.0	7.0	6.1	5.7	9.6	5.3	13.2	5.1	1.4	7.9	7.0	13.7	16.0	5.0	9.1	0.9	9.0	15.7	0.0	10.2	27.4	9.0	4.3	13.8	13.9	13.4	12.7	18.6	9.2	15.8	2.4	10.0	10.0	5.0	18.0	33.1	3.3	12.9	17.3	8.5	6.7	9.5	0.0	12.3	2.1	17.9	7.4	56.8	11.3	34.9	7.6
PREPL	KIAA0436	ENSG00000138078	"Prolyl endopeptidase like"	Q4J6C6	2	44316281-44361862	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		"Hydrolase, Protease, Serine protease"	"Congenital myasthenic syndrome, Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 78.4"	"Cell type enhanced"	"Detected in many"	5	"Horizontal cells: 136.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA063238	Approved					NA	NA					"HPA063238: AB_2684967"	"unprognostic (5.60e-3)"	"unprognostic (9.81e-2)"	"unprognostic (4.51e-2)"	"unprognostic (4.65e-3)"	"unprognostic (2.22e-1)"	"unprognostic (8.53e-2)"	"unprognostic (5.98e-3)"	"unprognostic (4.38e-3)"	"unprognostic (2.27e-1)"	"unprognostic (2.72e-2)"	"unprognostic (1.52e-2)"	"unprognostic (4.67e-2)"	"unprognostic (2.33e-2)"	"unprognostic (3.79e-1)"	"unprognostic (1.87e-1)"	"unprognostic (1.76e-1)"	"unprognostic (1.75e-1)"	11.5	24.5	32.6	8.2	78.4	2.5	15.0	57.3	75.8	18.1	11.3	18.7	6.0	12.0	22.1	34.2	10.9	16.4	13.4	28.2	51.8	50.2	30.4	9.9	11.4	7.6	28.5	44.0	24.3	11.6	34.9	33.2	9.9	69.4	18.1	14.1	13.0	11.7	16.5	13.7	10.2	12.6	16.3	31.3	10.5	12.1	12.6	21.5	5.2	28.9	7.1	8.2	10.7	10.3	8.8	6.3	4.7	4.8	11.1	12.5	5.8	18.4	14.2	16.4	20.8	26.5	27.9	12.6	20.7	15.8	14.9	12.9	15.3	13.0	23.7	28.8	21.5	17.1	15.9	23.5	15.0	28.8	21.6	16.6	16.5	11.3	11.6	19.3	15.6	15.3	17.9	30.1	28.8	23.4	29.4	14.3	11.1	20.2	34.5	20.0	9.8	17.2	7.6	15.7	23.7	16.2	13.6	20.0	16.9	28.6	10.8	28.2	21.8	13.5	14.3	30.0	16.6	19.1	12.4	15.1	26.6	15.1	20.7	14.0	19.0	12.5	15.5	31.1	18.6	19.5	4.7	4.5	3.4	8.5	4.8	12.2	8.8	8.1	9.2	6.3	7.4	12.5	9.7	1.3	11.1	4.1	3.1	8.7	5.8	32.6	78.4	57.3	75.8	51.8	50.2	28.5	44.0	69.4	21.5	29.8	32.0	11.7	12.7	11.6	79.2	75.5	43.3	26.8	18.2	61.1	45.2	7.0	33.2	13.9	7.2	19.7	12.3	0.0	20.5	4.1	18.2	21.3	12.7	29.7	10.1	136.7	31.7	16.5	15.7	7.2	32.8	7.8	16.9	1.8	24.5	38.9	14.6	17.6	31.1	30.6	56.8	19.4	17.0	23.0	23.0	12.9	7.3	15.2	15.7	8.3
PRKAA1	AMPKa1	ENSG00000132356	"Protein kinase AMP-activated catalytic subunit alpha 1"	Q13131	5	40759379-40798374	"Enzymes, FDA approved drug targets, Predicted intracellular proteins"	"Autophagy, Biological rhythms, Cholesterol biosynthesis, Cholesterol metabolism, Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis, Steroid metabolism, Sterol biosynthesis, Sterol metabolism, Transcription, Transcription regulation, Wnt signaling pathway"	"Chromatin regulator, Kinase, Serine/threonine-protein kinase, Transferase"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	9	"Early spermatids: 230.0;Late spermatids: 337.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB005050, HPA035409, HPA064946"	Supported		Supported	"Nuclear speckles,Cytosol"		NA	NA			"Nuclear speckles"	Cytosol	"CAB005050: AB_562037, HPA035409: AB_2674613, HPA064946: AB_2685390"	"unprognostic (2.07e-1)"	"unprognostic (1.41e-2)"	"unprognostic (2.51e-2)"	"unprognostic (3.57e-2)"	"unprognostic (3.97e-1)"	"unprognostic (1.05e-1)"	"unprognostic (3.51e-2)"	"unprognostic (7.53e-2)"	"unprognostic (1.66e-2)"	"unprognostic (2.88e-1)"	"unprognostic (3.34e-3)"	"unprognostic (2.63e-1)"	"unprognostic (2.82e-2)"	"unprognostic (1.35e-1)"	"unprognostic (1.60e-1)"	"unprognostic (1.27e-2)"	"unprognostic (1.10e-2)"	40.6	15.7	9.4	15.9	16.1	29.0	26.2	14.3	17.7	30.2	24.0	19.9	18.9	21.7	23.5	20.9	22.5	20.4	21.3	15.0	10.5	11.7	35.9	40.7	24.8	16.7	12.2	8.5	28.8	20.6	25.3	20.0	16.8	35.7	26.1	22.3	20.0	23.2	17.9	18.5	16.6	32.6	20.7	14.1	25.1	22.1	29.3	11.4	21.4	28.0	20.5	22.9	32.5	17.9	8.4	6.5	15.9	8.9	10.8	12.6	6.5	11.4	11.9	9.6	12.7	23.7	24.8	9.1	19.6	20.0	14.7	13.2	11.2	14.9	6.7	9.1	20.0	19.2	9.3	8.8	17.8	27.7	19.8	8.0	13.4	27.6	8.9	19.6	12.7	14.2	22.8	8.7	19.6	20.3	16.3	21.6	8.7	6.3	19.6	21.9	5.5	11.8	10.0	4.2	11.7	14.4	9.9	20.5	9.9	22.5	19.5	8.3	8.4	34.3	22.8	11.6	5.4	12.0	10.6	23.1	26.5	14.3	15.2	15.9	7.8	6.1	8.1	16.6	27.7	14.1	14.1	6.6	12.7	10.0	8.1	12.6	8.4	9.4	9.4	6.5	7.7	11.5	10.0	15.9	10.8	8.9	2.0	11.3	6.5	9.4	16.1	14.3	17.7	10.5	11.7	12.2	8.5	35.7	11.4	38.7	27.4	25.1	20.8	21.4	19.2	15.3	43.3	22.7	28.4	45.4	33.4	10.9	6.6	24.4	230.0	32.8	33.8	0.0	39.5	11.7	23.6	34.6	17.4	73.6	17.7	14.3	20.3	36.2	21.5	337.0	28.1	24.1	33.7	36.1	27.4	15.4	29.5	31.7	24.4	26.4	25.7	0.0	33.0	20.4	16.8	28.5	15.6	28.8	30.2	28.0
PRKAA2	"AMPK, AMPKa2, PRKAA"	ENSG00000162409	"Protein kinase AMP-activated catalytic subunit alpha 2"	P54646	1	56645322-56715335	"Enzymes, Predicted membrane proteins, Transporters"	"Autophagy, Biological rhythms, Cholesterol biosynthesis, Cholesterol metabolism, Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis, Steroid metabolism, Sterol biosynthesis, Sterol metabolism, Transcription, Transcription regulation, Wnt signaling pathway"	"Chromatin regulator, Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 39.1;skeletal muscle: 40.2"	"Cell type enhanced"	"Detected in many"	16	"Cardiomyocytes: 309.5;Rod photoreceptor cells: 106.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in single"		"neutrophil: 1.0"	"Lineage enriched"	"Detected in single"	5	"granulocytes: 1.0"	"Cell line enhanced"	"Detected in many"		"RPTEC TERT1: 13.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044540	Approved		Supported	"Nuclear speckles,Golgi apparatus"		NA	NA			"Nuclear speckles"	"Golgi apparatus"	"HPA044540: AB_2678977"	"unprognostic (4.17e-3)"	"unprognostic (1.62e-2)"	"unprognostic (4.17e-1)"	"prognostic unfavorable (4.80e-4)"	"unprognostic (9.35e-2)"	"unprognostic (1.92e-3)"	"prognostic unfavorable (5.30e-4)"	"unprognostic (7.30e-2)"	"unprognostic (3.94e-1)"	"unprognostic (1.82e-1)"	"unprognostic (1.97e-1)"	"unprognostic (8.64e-2)"	"prognostic favorable (4.95e-5)"	"unprognostic (1.30e-2)"	"unprognostic (4.52e-2)"	"unprognostic (1.57e-2)"	"unprognostic (1.85e-1)"	2.4	2.1	3.7	1.2	6.3	0.7	4.1	7.2	8.1	2.2	5.5	1.2	2.4	1.2	3.0	3.2	6.3	3.5	2.6	39.1	4.2	2.9	14.5	1.4	2.0	0.8	2.4	6.2	2.5	2.6	10.4	2.6	1.2	5.0	4.6	2.2	6.0	4.5	3.5	40.2	1.4	2.1	7.2	1.9	1.9	3.2	1.7	0.8	0.0	4.0	12.3	0.8	4.4	2.1	0.2	0.0	1.0	0.1	0.1	0.1	0.0	0.0	3.7	2.0	0.0	0.7	0.5	2.3	1.8	1.4	2.4	4.2	3.7	4.7	0.0	0.6	0.6	7.4	0.0	7.7	0.0	7.1	0.0	8.5	0.0	6.9	5.2	0.0	0.0	0.1	0.6	0.0	3.5	0.3	5.7	0.8	1.9	0.0	0.0	1.0	0.1	0.0	0.0	5.5	0.0	5.4	0.0	0.0	0.0	13.9	1.2	2.0	5.4	5.7	0.1	0.0	6.2	3.2	0.0	0.0	1.5	2.3	2.7	6.2	0.0	0.0	0.0	4.5	0.0	1.1	0.5	0.0	0.1	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.1	1.0	0.1	0.0	0.0	0.0	0.0	3.7	6.3	7.2	8.1	4.2	2.9	2.4	6.2	5.0	0.8	8.9	3.7	0.0	5.9	0.8	39.3	309.5	22.9	10.7	15.9	47.1	47.1	0.8	46.4	9.1	2.3	11.7	1.0	0.0	4.1	0.3	3.5	15.6	2.3	6.4	0.1	25.4	13.8	3.7	0.0	1.9	6.4	0.9	5.0	0.0	7.7	16.8	6.7	0.0	27.6	74.2	106.6	6.5	21.2	7.2	2.8	0.4	0.3	0.0	5.2	11.2
PRKACA	PKACa	ENSG00000072062	"Protein kinase cAMP-activated catalytic subunit alpha"	P17612	19	14091688-14118084	"Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, RAS pathway related proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes, Cushing syndrome, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Cardiomyocytes: 110.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB010361, HPA071185"	Approved		Approved	"Cytokinetic bridge,Cytosol"		NA	NA		1300000	Cytosol	"Cytokinetic bridge"	"CAB010361: AB_2268772, HPA071185: AB_2686356"	"unprognostic (1.08e-1)"	"prognostic favorable (6.28e-6)"	"unprognostic (2.09e-2)"	"prognostic unfavorable (6.26e-5)"	"unprognostic (1.38e-2)"	"unprognostic (2.95e-1)"	"unprognostic (1.64e-1)"	"unprognostic (9.36e-3)"	"unprognostic (7.01e-2)"	"unprognostic (3.41e-1)"	"prognostic favorable (6.47e-4)"	"unprognostic (2.86e-1)"	"unprognostic (1.17e-1)"	"unprognostic (4.68e-2)"	"unprognostic (1.87e-1)"	"unprognostic (3.66e-2)"	"unprognostic (6.14e-3)"	25.6	43.4	19.6	17.8	22.7	9.1	34.1	29.1	39.6	20.6	17.5	16.0	16.2	13.4	19.8	15.6	20.9	18.8	16.4	91.6	20.7	29.4	14.7	34.5	16.5	28.2	21.6	27.5	47.0	15.6	20.8	24.6	15.4	26.9	16.6	16.2	18.4	15.5	24.9	92.4	13.4	14.4	29.0	16.2	28.1	13.9	24.4	11.1	15.2	15.7	26.2	14.8	21.1	17.3	1.7	2.4	8.6	5.3	0.7	1.7	1.2	26.2	15.3	34.7	41.3	30.7	32.7	6.3	28.0	25.9	39.8	36.5	18.6	9.4	11.4	22.7	44.3	19.4	17.2	24.4	26.5	37.8	20.7	12.3	20.9	28.9	18.0	26.3	12.9	22.2	31.1	12.8	31.6	11.0	24.6	33.5	18.7	19.6	29.8	40.6	38.9	29.0	9.7	12.4	26.6	34.1	26.2	32.0	26.3	19.4	16.7	27.4	17.5	25.3	15.5	11.5	17.5	22.1	12.5	25.9	47.0	13.1	62.9	26.1	20.6	21.1	16.8	31.5	19.6	17.6	0.3	3.4	0.4	1.7	5.3	0.8	1.7	0.9	1.1	2.4	1.3	1.2	1.7	8.6	0.7	4.6	1.6	0.8	1.2	19.6	22.7	29.1	39.6	20.7	29.4	21.6	27.5	26.9	11.1	6.0	4.3	11.5	6.1	7.8	40.4	110.4	28.1	4.0	2.3	14.0	25.5	5.8	6.6	10.7	25.7	21.6	16.0	0.0	16.2	4.8	14.3	7.3	0.0	30.1	29.0	3.2	16.8	31.9	44.8	12.8	45.5	32.4	13.5	7.2	14.3	24.1	13.5	7.0	48.8	9.6	23.0	19.4	17.3	25.7	6.4	9.8	6.8	7.2	11.4	6.4
PRKACB	PKACb	ENSG00000142875	"Protein kinase cAMP-activated catalytic subunit beta"	P22694	1	84078062-84238498	"Enzymes, Predicted intracellular proteins, RAS pathway related proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 85.5"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB010363, HPA029754, HPA071185"	Approved		Approved	"Cytokinetic bridge,Cytosol"		NA	NA		1500000	Cytosol	"Cytokinetic bridge"	"CAB010363: AB_2170182, HPA029754: AB_10601491, HPA071185: AB_2686356"	"unprognostic (9.38e-2)"	"unprognostic (1.18e-1)"	"unprognostic (6.37e-2)"	"unprognostic (1.39e-1)"	"unprognostic (1.58e-1)"	"unprognostic (1.98e-1)"	"prognostic unfavorable (9.49e-4)"	"unprognostic (1.28e-1)"	"unprognostic (3.28e-2)"	"unprognostic (1.92e-1)"	"unprognostic (2.31e-1)"	"unprognostic (4.62e-2)"	"prognostic favorable (1.89e-6)"	"unprognostic (1.22e-1)"	"unprognostic (3.28e-1)"	"unprognostic (1.12e-2)"	"unprognostic (2.48e-1)"	7.0	21.5	40.0	10.5	57.0	6.2	8.0	54.7	85.5	9.4	23.6	16.9	3.9	4.8	8.7	17.6	8.1	5.2	11.5	10.1	43.1	52.1	10.6	9.0	6.9	16.2	38.3	33.5	8.3	11.9	12.2	18.3	5.1	35.5	13.8	22.6	4.9	32.9	12.7	3.2	2.6	6.3	12.6	47.7	14.6	14.2	3.6	25.9	25.5	11.1	1.8	15.3	13.5	4.6	13.5	7.1	17.1	5.4	25.9	27.6	22.0	3.1	6.3	10.1	12.1	11.7	10.3	4.7	15.6	11.9	8.0	7.5	0.1	2.8	16.6	10.8	12.2	14.6	2.2	4.7	5.1	8.5	16.1	2.6	36.5	8.6	1.2	11.5	14.4	0.8	6.1	2.3	7.7	4.3	11.6	36.6	6.2	1.1	9.6	12.9	0.6	18.7	7.6	9.9	0.0	4.4	14.5	15.7	10.0	19.4	11.2	3.3	12.9	8.6	3.3	9.5	7.9	3.0	3.0	32.4	11.1	8.6	11.2	11.8	7.1	8.5	16.7	5.3	15.4	13.8	17.1	2.7	5.8	23.3	3.6	18.7	13.5	17.3	20.6	7.1	10.2	26.4	27.6	1.5	25.9	5.4	4.1	15.9	22.0	40.0	57.0	54.7	58.2	43.1	52.1	38.3	33.5	35.5	25.9	0.0	1.0	20.3	6.7	4.5	44.0	38.9	15.3	4.0	5.7	14.0	33.4	1.4	28.2	6.9	2.4	8.4	61.7	0.0	10.3	1.0	11.0	15.2	57.7	14.8	23.2	44.5	20.8	26.4	52.7	2.6	13.8	32.7	15.1	1.0	61.1	36.9	13.3	28.8	20.5	15.6	30.0	12.9	13.7	5.9	6.9	2.5	0.6	69.2	52.4	6.5
PRKACG	PKACg	ENSG00000165059	"Protein kinase cAMP-activated catalytic subunit gamma"	P22612	9	69012529-69014113	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, RAS pathway related proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	31	"testis: 27.4"	"Group enriched"	"Detected in some"	8	"Early spermatids: 55.1;Late spermatids: 73.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"CACO-2: 1.3"									"CAB004530, HPA071185"	Supported		Uncertain	"Cytokinetic bridge,Cytosol"		NA	NA			Cytosol	"Cytokinetic bridge"	"CAB004530: AB_628137, HPA071185: AB_2686356"					"unprognostic (2.74e-1)"									"unprognostic (3.61e-2)"	"unprognostic (7.22e-2)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	27.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.3	0.0	0.6	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	55.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	73.9	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.3	1.5	0.0	0.0	0.0	0.0	0.0
PRKCA	PKCA	ENSG00000154229	"Protein kinase C alpha"	P17252	17	66302636-66810743	"Cancer-related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins"	"Angiogenesis, Apoptosis, Cell adhesion"	"Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes, FDA approved drug targets, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Rod photoreceptor cells: 77.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	17	"dendritic cells: 1.4;monocytes: 2.7;T-cells: 4.0"	"Cell line enhanced"	"Detected in many"		"U-87 MG: 53.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB003844, HPA006563, HPA006564, CAB016290"	Enhanced	Approved	Enhanced	"Plasma membrane,Cytosol"		NA	NA		1900000	Cytosol	"Plasma membrane"	"CAB003844: AB_562331, CAB016290: AB_628141, HPA006563: AB_1079626, HPA006564: AB_1079625"	"unprognostic (3.06e-1)"	"unprognostic (3.56e-2)"	"unprognostic (1.38e-2)"	"unprognostic (1.01e-1)"	"unprognostic (1.53e-1)"	"unprognostic (7.41e-3)"	"unprognostic (7.43e-2)"	"unprognostic (6.86e-3)"	"unprognostic (4.93e-2)"	"unprognostic (1.50e-1)"	"unprognostic (2.09e-1)"	"unprognostic (2.24e-2)"	"unprognostic (5.50e-2)"	"unprognostic (2.46e-1)"	"unprognostic (1.83e-1)"	"unprognostic (1.35e-3)"	"unprognostic (8.77e-2)"	4.0	19.6	26.5	9.0	22.8	2.5	3.0	10.8	33.9	7.0	13.8	19.0	3.5	14.6	14.8	6.7	4.7	6.1	10.8	5.8	31.6	15.6	16.7	6.5	6.0	8.4	18.7	15.6	20.4	5.5	1.7	6.0	6.5	17.6	17.2	11.2	7.0	3.1	22.3	6.6	3.8	12.7	13.7	15.0	7.9	7.9	3.7	14.4	0.4	4.5	1.3	5.9	9.5	9.5	0.0	1.4	0.1	2.7	0.1	4.0	1.0	2.3	12.5	2.6	2.6	6.3	16.1	0.3	13.4	8.8	9.7	8.3	1.4	1.5	3.1	3.6	21.7	16.3	0.3	1.3	1.6	21.2	5.2	3.0	0.0	7.4	6.5	8.6	3.9	21.1	7.0	0.6	12.1	10.4	14.2	8.3	15.1	8.1	0.0	15.0	0.7	7.8	2.4	1.0	6.1	6.7	1.4	19.1	0.0	3.4	2.1	1.5	8.6	4.4	2.6	0.1	2.8	0.3	5.5	24.8	16.9	9.8	10.5	8.4	0.0	0.0	0.3	53.7	0.0	8.3	0.1	0.6	0.0	0.5	0.8	1.5	0.0	2.5	1.2	1.1	0.0	4.0	2.3	0.0	0.1	2.7	1.4	0.5	1.0	26.5	22.8	10.8	28.2	31.6	15.6	18.7	15.6	17.6	14.4	0.0	9.6	3.9	15.4	9.4	33.9	7.9	40.8	5.3	4.5	38.4	2.0	3.3	6.6	11.3	2.5	3.0	24.2	0.0	5.9	2.8	11.0	12.4	20.7	11.9	19.7	9.5	8.1	36.8	8.2	1.3	49.5	7.7	10.1	1.8	32.8	43.1	7.2	20.1	45.6	16.8	77.1	25.8	17.0	1.1	1.7	9.2	12.7	24.1	21.3	12.3
PRKCB	"PKCB, PRKCB1, PRKCB2"	ENSG00000166501	"Protein kinase C beta"	P05771	16	23835946-24220611	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins"	"Adaptive immunity, Apoptosis, Immunity, Transcription, Transcription regulation"	"Chromatin regulator, Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 57.2;lymphoid tissue: 31.2"	"Cell type enhanced"	"Detected in many"	11	"B-cells: 149.8;Bipolar cells: 172.0;Horizontal cells: 74.7;Kupffer cells: 192.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"HEL: 41.7;HMC-1: 41.8;K-562: 59.4;THP-1: 18.8;U-937: 16.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB003843, HPA048321, HPA054203"	Approved		Supported	Nucleoplasm,Cytosol		NA	NA		3400000	Nucleoplasm	Cytosol	"CAB003843: AB_562197, HPA048321: AB_2680357, HPA054203: AB_2682416"	"unprognostic (1.53e-3)"	"unprognostic (4.53e-4)"	"unprognostic (2.52e-3)"	"unprognostic (3.07e-2)"	"unprognostic (1.72e-1)"	"unprognostic (7.13e-3)"	"unprognostic (2.06e-1)"	"unprognostic (1.67e-3)"	"unprognostic (3.19e-2)"	"unprognostic (1.79e-1)"	"unprognostic (7.38e-2)"	"unprognostic (1.06e-1)"	"unprognostic (3.17e-3)"	"unprognostic (2.08e-1)"	"unprognostic (2.12e-2)"	"unprognostic (3.28e-1)"	"unprognostic (4.95e-2)"	4.0	1.9	13.9	20.8	55.6	20.4	1.8	14.1	57.2	4.1	4.7	4.4	0.6	4.9	3.5	1.2	3.2	2.6	3.9	1.5	23.4	7.8	1.8	3.7	5.4	31.0	11.0	20.4	1.2	1.4	0.9	1.4	2.5	8.3	6.2	4.4	3.5	1.9	8.4	1.2	4.6	9.1	5.8	7.3	31.2	3.8	6.4	6.4	24.1	3.9	0.0	27.7	7.6	1.7	23.6	18.5	21.8	14.6	20.1	19.0	7.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.9	0.2	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.8	41.7	2.0	0.0	0.0	6.0	41.8	0.0	0.2	0.0	0.0	0.0	0.0	7.2	59.4	0.1	0.0	0.0	13.1	13.2	0.4	0.0	0.0	12.5	0.1	2.4	0.1	3.6	7.3	0.0	0.0	0.0	0.6	0.2	0.0	18.8	0.3	0.0	0.0	0.0	0.0	1.1	0.0	0.3	0.0	16.8	0.0	17.5	7.6	14.4	14.5	10.7	6.7	23.6	9.5	17.2	6.2	22.1	7.8	19.0	21.8	20.1	14.6	18.5	6.7	7.5	13.9	55.6	14.1	57.2	23.4	7.8	11.0	20.4	8.3	6.4	3.0	8.2	149.8	3.5	5.4	172.0	1.7	5.1	2.7	1.2	1.8	2.0	0.1	0.0	0.0	16.3	1.4	1.7	0.0	0.2	0.2	1.3	0.7	69.4	1.6	41.0	74.7	0.0	16.5	192.8	10.0	0.0	22.7	3.3	6.4	0.7	9.9	0.0	9.5	0.4	0.1	7.3	0.0	2.2	3.6	3.7	12.5	0.7	57.5	1.2	4.3
PRKCD		ENSG00000163932	"Protein kinase C delta"	Q05655	3	53156009-53192717	"Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Apoptosis, Cell cycle"	"Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	6	"basophil: 17.7;classical monocyte: 22.9;eosinophil: 17.0;intermediate monocyte: 22.2;myeloid DC: 17.6;neutrophil: 20.7;non-classical monocyte: 15.3;plasmacytoid DC: 8.5"	"Group enriched"	"Detected in all"	7	"dendritic cells: 17.6;granulocytes: 20.7;monocytes: 22.9"	"Cell line enhanced"	"Detected in all"		"SK-BR-3: 64.7;THP-1: 46.1"	"Group enriched"	"Detected in many"	5	"basal ganglia: 124.2;thalamus: 366.1"	"Low region specificity"	"Detected in all"			"HPA001863, HPA001890, CAB010469, CAB013225"	Enhanced		Enhanced	"Endoplasmic reticulum,Golgi apparatus,Cytosol"		NA	NA		300000	Cytosol	"Endoplasmic reticulum, Golgi apparatus"	"CAB010469: AB_632229, CAB013225: , HPA001863: AB_1079627, HPA001890: AB_1079628"	"unprognostic (3.59e-1)"	"unprognostic (4.85e-2)"	"unprognostic (2.66e-2)"	"unprognostic (1.90e-1)"	"unprognostic (1.17e-1)"	"unprognostic (6.97e-2)"	"prognostic unfavorable (2.24e-4)"	"prognostic favorable (9.01e-4)"	"unprognostic (1.95e-2)"	"unprognostic (1.42e-1)"	"unprognostic (1.79e-1)"	"unprognostic (2.89e-1)"	"unprognostic (2.05e-1)"	"unprognostic (1.73e-1)"	"unprognostic (2.48e-2)"	"unprognostic (2.06e-3)"	"unprognostic (2.95e-3)"	27.8	33.4	9.4	29.7	11.5	30.3	17.6	5.7	10.7	10.3	27.8	10.1	43.7	21.4	5.5	21.3	18.3	16.1	33.7	11.9	8.3	3.7	16.5	4.5	29.2	24.5	10.2	5.6	8.1	13.4	6.1	5.1	7.5	7.1	17.9	16.1	10.3	14.1	40.7	3.9	17.1	42.9	17.4	10.2	32.1	24.8	9.6	8.0	10.5	26.9	13.4	26.3	22.9	12.7	3.1	17.6	20.7	22.9	2.4	1.5	6.4	7.9	3.0	1.2	2.1	9.2	5.3	11.4	4.8	6.1	5.9	5.8	7.4	7.8	20.4	2.1	10.4	10.3	3.6	8.1	11.8	4.9	17.8	6.1	11.3	4.2	7.9	5.9	14.9	25.7	4.1	8.6	6.1	5.6	5.3	5.1	2.2	2.2	2.9	8.5	19.5	1.6	25.5	3.2	11.9	5.6	1.7	3.1	4.9	6.4	17.0	2.0	1.4	3.6	64.7	9.9	6.3	5.4	46.1	7.4	2.9	3.6	3.8	4.5	4.5	6.9	10.5	6.8	25.8	5.5	17.7	22.9	17.0	1.5	22.2	1.0	3.1	1.1	1.2	17.6	2.9	0.8	0.7	20.7	2.4	15.3	8.5	1.1	6.4	9.4	11.5	5.7	10.7	8.3	3.7	10.2	5.6	7.1	8.0	3.0	19.7	17.6	21.2	26.0	0.0	4.5	12.7	16.0	17.0	14.0	0.0	2.5	3.3	7.6	26.7	1.8	56.8	0.0	9.6	13.5	8.7	14.8	5.7	1.7	38.4	1.6	25.5	3.7	43.0	59.4	8.3	35.2	10.1	21.6	29.0	1.8	10.3	49.1	6.3	10.9	0.0	6.5	9.4	5.2	1.9	24.3	7.3	7.5	20.6	28.8
PRKCE		ENSG00000171132	"Protein kinase C epsilon"	Q02156	2	45651345-46187990	"Cancer-related genes, Enzymes, Predicted intracellular proteins"	"Cell adhesion, Cell cycle, Cell division, Immunity"	"Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 36.5"	"Group enriched"	"Detected in many"	5	"Early spermatids: 209.3;Late spermatids: 297.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"naive B-cell: 5.5"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"REH: 19.4;TIME: 19.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB001948, HPA008236, HPA044496"	Enhanced	Supported	Supported	"Vesicles,Plasma membrane,Intermediate filaments,Cytosol"		NA	NA			"Intermediate filaments, Cytosol"	"Vesicles, Plasma membrane"	"CAB001948: , HPA008236: , HPA044496: AB_2678959"	"unprognostic (1.10e-1)"	"unprognostic (1.78e-1)"	"unprognostic (2.27e-1)"	"prognostic unfavorable (2.42e-4)"	"unprognostic (9.61e-2)"	"unprognostic (5.70e-2)"	"unprognostic (1.51e-1)"	"prognostic favorable (9.62e-4)"	"unprognostic (3.05e-1)"	"unprognostic (6.72e-2)"	"unprognostic (7.49e-3)"	"unprognostic (9.99e-2)"	"prognostic favorable (2.63e-7)"	"unprognostic (1.21e-1)"	"unprognostic (7.11e-2)"	"unprognostic (6.43e-3)"	"unprognostic (2.23e-2)"	5.5	7.4	15.3	7.2	14.2	9.3	8.1	28.8	36.5	6.6	5.5	3.8	5.9	3.6	5.6	4.6	4.7	7.6	4.7	7.7	22.5	10.0	12.8	15.5	17.5	6.9	6.0	15.0	4.1	4.2	16.3	6.0	10.4	9.1	3.6	4.7	3.7	3.6	8.6	7.2	3.0	3.7	6.2	4.4	4.9	4.4	7.2	3.7	1.5	6.5	1.2	5.4	5.0	6.5	5.5	2.2	1.7	1.4	0.9	1.3	0.6	5.4	2.0	2.9	2.9	4.4	5.2	2.3	3.8	7.0	3.2	3.5	0.5	5.4	8.2	3.6	4.0	4.6	1.3	1.8	2.0	4.6	4.9	3.5	0.0	1.4	1.1	5.0	0.6	2.9	4.6	2.3	4.8	3.5	2.7	11.8	1.8	1.1	2.0	3.7	2.8	2.6	0.3	1.0	3.0	1.0	19.4	13.8	8.8	2.9	3.7	2.0	4.4	1.7	5.8	12.5	1.1	4.7	1.9	19.5	6.3	6.6	4.6	3.8	0.0	0.0	6.9	5.2	4.6	6.3	0.0	1.2	1.7	1.0	0.4	1.1	3.6	0.7	0.7	2.2	5.5	1.3	0.4	0.4	0.9	1.4	0.9	0.0	0.6	15.3	14.2	28.8	33.2	22.5	10.0	6.0	15.0	9.1	3.7	6.0	8.6	20.1	6.3	4.4	47.5	9.3	12.7	22.7	27.3	10.4	13.7	0.3	3.3	3.0	209.3	9.9	4.5	0.0	3.3	6.9	8.0	5.7	6.9	7.3	2.6	11.1	7.5	12.3	17.0	297.3	4.9	11.1	13.5	7.2	5.3	7.0	3.0	3.5	5.6	21.3	6.7	12.9	6.6	2.7	2.2	4.3	2.4	4.3	6.2	7.1
PRKCG	"MGC57564, PKCC, PKCG, SCA14"	ENSG00000126583	"Protein kinase C gamma"	P05129	19	53879190-53907652	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, RAS pathway related proteins"	"Biological rhythms"	"Kinase, Serine/threonine-protein kinase, Transferase"	"Disease mutation, Neurodegeneration, Spinocerebellar ataxia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	11	"brain: 49.9"	"Cell type enhanced"	"Detected in some"	15	"Early spermatids: 3.7;Horizontal cells: 4.8;Spermatocytes: 2.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A549: 4.8;OE19: 8.5;SH-SY5Y: 3.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA054560	Enhanced					NA	NA					"HPA054560: AB_2682523"	"unprognostic (7.14e-2)"	"unprognostic (5.42e-2)"	"unprognostic (1.85e-1)"	"unprognostic (3.86e-2)"	"unprognostic (1.41e-1)"	"unprognostic (5.38e-2)"	"unprognostic (5.96e-2)"	"unprognostic (4.46e-2)"	"unprognostic (2.09e-1)"	"unprognostic (2.64e-2)"	"unprognostic (7.48e-3)"	"unprognostic (2.68e-1)"	"unprognostic (2.22e-7)"	"unprognostic (2.41e-2)"	"unprognostic (2.61e-1)"	"unprognostic (1.06e-1)"	"unprognostic (1.83e-1)"	1.0	0.9	28.0	1.1	49.9	2.2	0.9	12.1	39.2	0.9	1.3	1.6	0.0	1.5	1.0	0.9	1.0	1.4	1.0	0.9	49.7	4.4	0.9	0.9	1.0	0.9	2.9	20.8	0.9	3.5	2.1	0.2	0.9	0.7	0.9	1.2	0.0	0.9	1.0	1.0	0.9	1.3	1.1	1.4	0.9	1.8	4.4	2.1	1.3	0.9	0.0	0.9	0.9	0.0	0.0	0.0	0.0	0.3	0.0	0.2	0.0	0.2	4.8	1.0	0.0	0.0	0.2	0.1	0.6	0.3	0.0	0.0	1.2	1.3	0.2	1.4	0.0	0.5	0.4	2.3	0.0	0.0	0.0	0.9	0.0	0.1	0.0	0.1	0.0	2.0	0.0	0.0	0.5	0.0	0.9	0.0	1.2	0.0	0.1	0.0	0.5	0.4	0.1	0.8	8.5	0.4	0.8	0.5	0.0	0.9	0.0	0.0	3.3	1.3	0.1	0.0	1.7	1.6	0.0	0.8	0.0	1.6	0.0	0.0	1.4	0.3	0.1	0.0	0.0	0.2	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	28.0	49.9	12.1	28.5	49.7	4.4	2.9	20.8	0.7	2.1	0.0	0.0	0.0	0.1	0.1	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.7	0.0	0.0	0.0	0.0	0.1	0.4	0.1	0.0	0.0	0.1	4.8	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	1.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	2.3	1.0	0.0	0.0	0.0	0.2	0.1
PRKCH	"PKC-L, PKCL, PRKCL"	ENSG00000027075	"Protein kinase C eta"	P24723	14	61187559-61550976	"Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	Differentiation	"Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	10	"Endothelial cells: 56.0;Erythroid cells: 70.0;Ito cells: 55.9;T-cells: 137.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	12	"gdT-cell: 30.0;MAIT T-cell: 23.9;memory CD4 T-cell: 23.0;memory CD8 T-cell: 35.3;naive CD4 T-cell: 28.5;naive CD8 T-cell: 27.6;NK-cell: 27.3;T-reg: 18.6"	"Group enriched"	"Detected in many"	14	"NK-cells: 27.3;T-cells: 35.3"	"Cell line enhanced"	"Detected in many"		"BEWO: 30.4;HUVEC TERT2: 39.9;MOLT-4: 26.5;RT4: 16.8;TIME: 26.1"	"Group enriched"	"Detected in many"	6	"basal ganglia: 25.0;thalamus: 19.5"	"Low region specificity"	"Detected in many"			"HPA026294, HPA053709"	Approved		Approved	"Plasma membrane,Cytosol"		NA	NA			Cytosol	"Plasma membrane"	"HPA026294: AB_10603988, HPA053709: AB_2682237"	"unprognostic (1.42e-1)"	"unprognostic (3.89e-3)"	"unprognostic (1.78e-1)"	"unprognostic (1.96e-3)"	"unprognostic (1.04e-1)"	"prognostic favorable (8.55e-6)"	"unprognostic (1.14e-2)"	"unprognostic (2.97e-2)"	"unprognostic (4.14e-1)"	"unprognostic (1.94e-1)"	"unprognostic (7.96e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.52e-3)"	"unprognostic (1.13e-1)"	"unprognostic (4.14e-2)"	"unprognostic (6.98e-2)"	"unprognostic (4.73e-3)"	17.5	5.4	5.0	21.6	22.0	11.2	14.7	2.8	6.1	13.6	10.3	6.2	6.9	5.1	19.1	7.0	20.1	8.6	12.7	10.1	6.8	4.4	8.1	5.5	24.1	27.6	5.9	2.5	7.1	5.9	8.8	15.5	22.7	7.2	9.8	5.0	9.1	24.7	10.8	9.1	15.9	16.0	10.5	5.7	25.9	6.0	4.3	6.4	54.6	15.1	10.6	34.6	13.2	14.4	0.4	2.2	1.5	0.7	27.3	35.3	17.9	6.4	2.2	0.3	1.7	1.0	0.2	30.4	0.1	0.5	0.3	0.3	0.7	3.8	0.1	4.6	0.0	0.6	4.4	0.2	4.9	0.5	0.8	2.9	0.0	0.7	0.2	0.4	0.0	0.9	0.8	5.1	0.2	3.5	0.4	39.9	12.9	0.0	0.1	2.3	11.7	26.5	0.2	0.5	4.6	3.1	2.2	1.1	0.0	0.0	16.8	1.1	1.9	0.7	5.9	3.6	5.6	5.8	0.5	26.1	0.7	5.2	0.8	0.3	0.5	0.1	0.2	1.1	0.4	1.3	0.1	0.7	0.5	30.0	0.4	23.9	0.4	23.0	35.3	2.2	0.3	28.5	27.6	1.5	27.3	0.2	0.7	18.6	17.9	5.0	22.0	2.8	6.1	6.8	4.4	5.9	2.5	7.2	6.4	6.0	10.7	4.6	15.8	16.7	0.2	3.9	10.2	10.7	18.2	0.0	0.0	23.4	3.3	4.6	25.5	56.0	1.7	70.0	5.9	16.9	3.7	13.1	1.1	1.0	5.6	0.0	11.3	55.9	11.1	3.6	1.7	9.0	15.1	5.4	2.6	9.3	4.4	2.9	6.3	0.8	0.3	0.0	4.1	0.0	2.1	23.3	40.4	137.1	0.7	24.4
PRKCI	"DXS1179E, PKCI"	ENSG00000163558	"Protein kinase C iota"	P41743	3	170222365-170305981	"Cancer-related genes, Enzymes, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes, Proto-oncogene, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA026574, HPA038635"	Approved		Supported	"Microtubules,Cytokinetic bridge,Cytosol"		Yes	No			Cytosol	"Microtubules, Cytokinetic bridge"	"HPA026574: AB_1855428, HPA038635: AB_2676124"	"unprognostic (2.26e-1)"	"unprognostic (6.75e-2)"	"unprognostic (4.57e-2)"	"prognostic unfavorable (3.93e-6)"	"unprognostic (1.59e-1)"	"unprognostic (1.84e-2)"	"prognostic unfavorable (3.02e-4)"	"unprognostic (2.52e-1)"	"unprognostic (7.10e-2)"	"unprognostic (1.73e-2)"	"prognostic unfavorable (1.22e-4)"	"unprognostic (5.32e-3)"	"prognostic favorable (3.10e-4)"	"unprognostic (1.16e-1)"	"unprognostic (2.65e-1)"	"unprognostic (1.06e-1)"	"unprognostic (9.73e-2)"	10.3	7.5	11.4	5.9	15.5	2.1	9.5	14.8	16.6	12.5	11.1	7.0	6.0	10.4	13.1	8.4	20.6	15.1	10.5	10.1	9.5	7.7	13.0	6.7	14.8	3.9	5.6	9.4	15.2	7.7	12.4	14.7	9.8	11.0	16.3	12.2	7.3	25.8	12.6	12.7	11.0	11.6	12.5	6.8	6.1	30.2	15.0	5.3	12.6	23.1	8.4	9.9	16.3	13.0	1.9	1.8	1.0	1.3	5.8	4.8	1.4	34.3	8.7	8.8	9.4	7.8	10.9	14.2	8.8	13.0	11.7	12.7	12.7	16.8	10.5	29.1	12.3	16.1	16.1	16.5	17.3	20.1	7.6	10.2	9.7	11.0	7.0	12.4	8.7	4.4	9.8	12.1	10.0	15.7	19.0	9.1	5.8	10.7	8.7	11.7	11.8	12.6	3.4	18.4	36.7	9.7	9.2	13.5	17.3	18.4	10.5	14.0	11.4	19.0	25.0	8.6	13.6	27.5	6.0	9.6	12.2	9.4	11.4	14.5	15.0	14.4	15.0	8.8	6.9	4.7	0.1	1.3	1.0	2.6	1.2	4.0	1.8	3.6	4.8	1.8	1.9	3.9	2.2	0.7	5.8	1.1	1.8	2.3	1.4	11.4	15.5	14.8	16.6	9.5	7.7	5.6	9.4	11.0	5.3	68.5	56.0	2.2	46.0	50.7	15.9	14.9	25.5	22.7	46.6	47.1	13.7	23.8	21.6	13.9	5.5	18.0	21.2	0.0	19.5	22.1	25.6	78.7	8.1	17.8	8.9	14.3	28.2	16.5	20.8	3.6	21.6	10.0	16.9	6.4	28.1	8.1	36.5	17.5	26.9	15.1	9.3	19.4	11.4	12.9	15.1	55.7	17.3	5.7	27.7	69.1
PRKCQ		ENSG00000065675	"Protein kinase C theta"	Q04759	10	6427143-6580301	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins"	"Immunity, Inflammatory response"	"Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"blood: 19.7;lymphoid tissue: 32.1;skeletal muscle: 63.4"	"Cell type enhanced"	"Detected in many"	19	"Alveolar cells type 2: 6.5;Distal tubular cells: 6.6;T-cells: 25.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	10	"gdT-cell: 12.7;MAIT T-cell: 9.8;memory CD4 T-cell: 13.5;memory CD8 T-cell: 13.2;naive CD4 T-cell: 10.7;naive CD8 T-cell: 10.0;NK-cell: 6.5;T-reg: 19.7"	"Group enriched"	"Detected in many"	11	"NK-cells: 6.5;T-cells: 19.7"	"Cell line enhanced"	"Detected in some"		"HEL: 29.8;JURKAT: 21.2;MOLT-4: 22.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA065279, HPA073098"			Enhanced	"Centriolar satellite"		NA	NA		200000	"Centriolar satellite"		"HPA065279: AB_2685453, HPA073098: AB_2686571"	"unprognostic (6.61e-3)"	"unprognostic (2.12e-1)"	"unprognostic (1.87e-1)"	"unprognostic (1.48e-1)"	"unprognostic (1.50e-1)"	"unprognostic (2.24e-1)"	"unprognostic (2.69e-3)"	"unprognostic (2.46e-1)"	"unprognostic (8.40e-2)"	"unprognostic (2.66e-1)"	"unprognostic (1.17e-1)"	"unprognostic (3.22e-1)"	"unprognostic (5.26e-2)"	"unprognostic (7.74e-2)"	"unprognostic (2.79e-1)"	"prognostic unfavorable (5.27e-4)"	"unprognostic (3.51e-2)"	0.9	0.7	3.6	9.4	4.3	3.1	0.8	0.9	5.2	1.3	1.1	7.4	0.1	1.2	1.8	5.4	1.6	2.6	1.3	0.5	4.4	4.0	4.6	0.9	3.3	6.6	4.0	2.2	1.1	7.7	0.3	1.0	0.4	2.7	1.4	1.3	5.4	2.8	1.0	63.4	0.6	2.5	0.8	3.6	3.4	1.4	0.9	4.5	32.1	9.1	7.5	6.8	1.9	0.8	0.0	0.1	1.1	0.2	6.5	19.7	5.2	0.0	2.8	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.1	0.1	0.2	1.8	0.2	0.0	0.0	0.0	0.0	1.8	3.1	0.0	0.0	2.0	29.8	0.0	0.2	0.3	1.4	0.3	0.1	1.9	0.1	0.1	0.0	0.2	21.2	6.5	0.0	0.0	0.0	22.3	4.2	3.1	0.2	0.0	4.3	0.7	0.0	6.3	1.5	0.2	1.1	0.0	0.0	0.0	1.9	0.0	3.0	0.0	0.0	3.1	0.0	0.0	0.0	0.0	0.0	0.0	3.7	0.0	1.1	0.1	0.1	12.7	0.2	9.8	0.0	13.5	13.2	0.1	0.0	10.7	10.0	0.8	6.5	0.0	0.0	19.7	5.2	3.6	4.3	0.9	5.2	4.4	4.0	4.0	2.2	2.7	4.5	3.0	6.5	0.0	0.1	0.0	1.6	0.3	0.0	1.4	1.2	1.8	0.0	0.0	6.6	0.2	1.8	0.0	0.0	0.0	0.7	0.1	0.3	0.0	1.1	0.0	0.4	0.0	1.7	1.3	1.5	4.5	0.0	0.5	0.0	0.0	0.3	1.5	0.2	0.0	0.0	0.1	0.3	0.0	0.0	0.9	2.0	0.0	0.0	25.4	0.3	0.1
PRKCZ	PKC2	ENSG00000067606	"Protein kinase C zeta"	Q05513	1	2050470-2185395	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Inflammatory response"	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 43.6;placenta: 93.0"	"Group enriched"	"Detected in many"	4	"Late spermatids: 539.8;Syncytiotrophoblasts: 926.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	6	"eosinophil: 15.0"	"Lineage enriched"	"Detected in many"	6	"granulocytes: 15.0"	"Cell line enhanced"	"Detected in many"		"BEWO: 23.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA021851	Enhanced		Supported	"Plasma membrane,Cytosol"		NA	NA			Cytosol	"Plasma membrane"	"HPA021851: AB_1855433"	"unprognostic (1.25e-2)"	"unprognostic (2.61e-1)"	"unprognostic (5.10e-2)"	"unprognostic (1.14e-2)"	"unprognostic (2.08e-1)"	"unprognostic (3.61e-2)"	"unprognostic (1.73e-2)"	"unprognostic (5.13e-2)"	"unprognostic (1.18e-1)"	"unprognostic (3.10e-1)"	"unprognostic (1.12e-1)"	"unprognostic (2.86e-1)"	"prognostic favorable (1.64e-9)"	"unprognostic (3.57e-2)"	"unprognostic (3.27e-2)"	"unprognostic (1.39e-1)"	"unprognostic (7.85e-2)"	1.2	7.8	15.9	3.0	31.8	1.4	3.9	39.8	43.6	3.2	8.6	17.1	2.3	20.0	1.7	5.5	10.1	6.5	3.1	6.4	15.5	6.4	11.3	6.8	22.3	5.0	12.2	23.6	1.9	8.5	9.8	12.0	93.0	27.3	5.8	7.5	2.6	7.0	3.0	0.4	8.8	18.4	1.2	8.4	6.9	6.1	17.5	13.5	0.6	14.1	0.9	5.0	4.0	4.6	0.4	0.3	15.0	0.3	0.8	2.6	0.3	7.3	4.7	1.7	8.7	0.0	0.0	23.0	0.5	0.2	5.5	0.3	11.9	16.0	0.0	14.6	1.8	4.8	12.9	9.9	12.3	3.9	0.5	11.0	0.0	7.6	15.8	1.6	0.0	5.7	0.3	7.4	0.0	4.2	0.0	0.0	1.9	3.2	0.1	0.1	9.0	0.4	0.0	3.3	20.2	11.4	0.0	0.0	2.5	9.4	7.8	12.0	9.7	6.0	13.4	2.5	14.9	9.4	2.0	0.0	0.0	6.9	0.0	0.0	3.5	0.6	0.1	0.6	0.1	8.3	0.3	0.0	15.0	0.6	0.3	2.6	0.3	1.0	0.6	0.0	0.4	0.8	0.4	1.2	0.8	0.0	0.3	0.8	0.3	15.9	31.8	39.8	43.6	15.5	6.4	12.2	23.6	27.3	13.5	113.2	71.1	0.8	10.2	11.6	22.8	1.2	2.5	21.4	26.1	7.0	3.9	84.1	6.6	10.9	181.6	6.0	56.7	0.0	9.3	48.8	3.1	16.4	8.1	12.5	12.7	58.8	9.8	6.7	1.0	539.8	8.9	3.3	6.8	5.4	22.1	15.6	12.2	31.6	8.1	19.0	21.6	0.0	2.2	15.8	26.8	11.7	926.6	7.7	25.3	11.9
PRKD1	"PKC-mu, PKCM, PKD, PRKCM"	ENSG00000184304	"Protein kinase D1"	Q15139	14	29576479-30191898	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Angiogenesis, Apoptosis, Differentiation, Immunity, Inflammatory response, Innate immunity, Neurogenesis"	"Kinase, Serine/threonine-protein kinase, Transferase"	"Disease mutation, Ectodermal dysplasia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	6	"Distal tubular cells: 24.9;Early spermatids: 31.1;Erythroid cells: 23.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"plasmacytoid DC: 1.4"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"ASC diff: 18.2;fHDF/TERT166: 19.3;HSkMC: 18.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB018367, HPA029834"	Uncertain		Supported	"Plasma membrane,Cytosol"	"Intracellular and membrane"	NA	NA			"Plasma membrane"	Cytosol	"CAB018367: AB_2253119, HPA029834: AB_10602821"	"unprognostic (5.35e-2)"	"unprognostic (3.20e-1)"	"unprognostic (2.27e-2)"	"unprognostic (6.70e-2)"	"unprognostic (2.37e-1)"	"unprognostic (1.92e-1)"	"unprognostic (1.08e-3)"	"unprognostic (8.88e-2)"	"unprognostic (2.37e-2)"	"unprognostic (5.29e-2)"	"unprognostic (7.08e-2)"	"unprognostic (1.56e-1)"	"prognostic favorable (2.44e-5)"	"unprognostic (9.45e-4)"	"unprognostic (1.99e-1)"	"prognostic unfavorable (2.91e-4)"	"unprognostic (3.89e-1)"	7.4	10.6	8.0	5.3	9.7	0.7	19.0	4.9	8.9	5.1	8.7	5.1	24.1	3.1	8.3	9.0	3.5	6.8	9.0	6.3	9.8	5.9	15.1	2.3	14.9	1.6	5.6	6.6	15.7	7.3	35.7	9.2	4.5	10.8	20.1	3.5	4.9	3.5	24.4	3.1	2.7	3.5	19.7	16.4	2.4	4.8	16.1	8.6	0.5	8.2	2.9	1.8	14.1	12.2	0.7	1.4	0.0	0.0	0.0	0.0	0.0	0.0	2.7	3.6	4.1	18.2	17.0	0.1	12.3	9.5	12.6	6.8	0.0	0.5	0.0	1.2	19.3	4.3	0.1	6.0	1.4	6.9	0.0	4.2	0.0	0.1	0.4	9.2	0.0	0.1	18.0	0.6	0.9	1.5	6.5	2.5	0.0	1.2	0.4	11.8	1.4	0.0	0.0	2.5	0.0	6.4	0.0	7.1	3.2	13.5	5.7	3.6	7.2	2.1	0.0	4.7	4.9	0.0	0.1	6.4	12.0	4.9	1.0	3.5	0.0	0.0	0.0	3.0	0.0	13.6	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	8.0	9.7	4.9	8.9	9.8	5.9	5.6	6.6	10.8	8.6	0.0	6.1	0.0	3.8	0.5	1.2	1.4	7.6	0.0	0.0	12.2	5.9	0.0	24.9	1.5	31.1	4.5	0.0	23.3	3.6	0.1	3.8	16.3	0.0	1.5	0.2	1.6	2.9	12.3	2.6	12.4	6.9	0.3	6.8	0.0	0.2	16.1	3.2	0.0	12.0	3.7	2.8	0.0	4.7	3.4	4.9	0.6	0.2	0.0	0.0	0.9
PRKD2	"DKFZP586E0820, HSPC187, PKD2"	ENSG00000105287	"Protein kinase D2"	Q9BZL6	19	46674275-46717127	"Enzymes, Predicted intracellular proteins"	"Adaptive immunity, Angiogenesis, Cell adhesion, Immunity"	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in all"		"U-266/84: 58.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA021490, HPA056727"	Enhanced		Supported	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA021490: AB_1855708, HPA056727: AB_2683217"	"unprognostic (3.01e-2)"	"unprognostic (1.22e-2)"	"unprognostic (1.23e-3)"	"unprognostic (7.06e-2)"	"unprognostic (8.91e-2)"	"unprognostic (1.99e-2)"	"unprognostic (8.79e-3)"	"unprognostic (2.61e-1)"	"unprognostic (6.22e-2)"	"unprognostic (4.21e-3)"	"unprognostic (8.89e-2)"	"unprognostic (2.74e-1)"	"unprognostic (3.45e-3)"	"unprognostic (1.04e-2)"	"unprognostic (7.19e-2)"	"unprognostic (4.34e-2)"	"prognostic favorable (9.15e-4)"	17.1	7.6	7.0	25.8	6.5	18.1	18.0	2.5	6.8	16.8	13.7	5.8	18.7	13.7	14.8	16.5	23.4	15.6	17.4	7.4	6.3	3.1	13.2	9.1	21.3	24.8	7.5	2.7	17.0	12.5	10.3	17.2	20.1	6.6	14.8	7.7	11.9	15.6	21.5	7.5	26.8	19.8	11.7	6.8	34.8	15.2	6.6	7.2	41.5	18.7	10.5	33.0	17.4	37.5	6.6	0.4	7.3	1.0	2.9	6.1	1.9	8.8	13.7	5.4	6.6	4.5	3.6	7.0	4.6	7.3	9.6	10.6	7.6	8.6	10.3	8.1	6.1	5.2	13.2	4.8	12.3	3.0	8.7	7.1	10.8	4.2	3.9	6.0	7.9	16.1	4.4	6.0	5.5	4.7	7.2	16.9	9.7	6.9	14.9	3.9	9.3	15.1	25.6	4.6	12.8	7.0	9.9	2.6	16.7	5.9	13.2	3.5	11.0	8.6	7.2	1.8	5.9	5.7	3.1	8.0	4.1	8.2	3.4	3.7	14.6	58.2	5.1	4.3	6.5	4.3	0.9	1.0	3.4	5.6	0.9	4.9	6.1	5.7	6.1	0.4	6.6	5.1	4.9	7.3	2.9	0.7	0.0	4.0	1.9	7.0	6.5	2.5	6.8	6.3	3.1	7.5	2.7	6.6	7.2	8.9	13.5	45.5	26.8	19.6	5.8	11.5	17.8	4.0	10.3	8.7	0.0	11.1	6.6	16.0	0.9	29.2	30.9	23.3	24.3	11.4	10.0	21.5	13.9	7.3	7.7	1.6	20.7	36.2	12.7	2.4	10.9	7.2	11.8	5.4	17.7	6.1	22.1	24.6	6.3	7.1	4.5	12.9	5.9	2.8	15.8	23.3	24.8	23.0	11.2	24.6
PRKD3	"EPK2, PRKCN"	ENSG00000115825	"Protein kinase D3"	O94806	2	37250502-37324808	"Enzymes, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Rod photoreceptor cells: 110.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA029529	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"HPA029529: AB_10602082"	"unprognostic (1.39e-1)"	"unprognostic (7.34e-2)"	"prognostic favorable (4.84e-4)"	"unprognostic (1.23e-2)"	"unprognostic (5.61e-2)"	"unprognostic (2.08e-1)"	"prognostic unfavorable (3.47e-4)"	"unprognostic (1.10e-1)"	"unprognostic (1.16e-1)"	"unprognostic (2.52e-2)"	"unprognostic (2.93e-1)"	"unprognostic (1.81e-1)"	"unprognostic (7.62e-3)"	"unprognostic (2.49e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.36e-1)"	"unprognostic (1.35e-1)"	16.1	22.1	9.5	20.7	10.7	5.3	35.1	4.8	9.2	17.2	18.0	7.2	7.2	6.0	19.2	16.0	9.8	11.3	10.0	11.6	12.7	6.1	9.9	8.4	20.4	22.3	11.4	3.7	15.0	7.6	12.9	20.7	11.1	10.3	14.4	8.3	27.8	11.1	13.3	19.1	11.5	12.1	16.5	15.4	22.0	10.5	16.8	10.8	16.2	11.8	9.3	21.2	12.4	17.7	16.4	8.2	5.7	8.3	6.3	11.5	3.4	12.8	5.4	14.5	11.9	11.1	18.6	10.6	8.3	15.5	9.4	9.6	8.7	4.5	18.8	7.0	12.4	14.1	5.1	9.8	10.2	12.7	24.3	14.4	12.4	8.4	5.8	4.5	8.8	7.6	8.8	5.2	14.9	9.8	8.7	16.7	6.3	10.4	23.2	10.9	2.1	3.8	6.9	15.3	0.1	5.3	13.0	22.9	16.1	6.2	14.4	10.9	28.3	8.0	4.6	48.8	7.8	4.9	8.1	16.1	27.0	14.0	10.7	9.3	26.5	49.1	22.0	9.4	3.7	16.2	5.7	8.3	5.5	10.5	6.6	9.1	12.4	8.8	8.4	7.8	16.4	10.4	11.5	1.5	6.3	3.3	8.2	4.1	3.4	9.5	10.7	4.8	9.2	12.7	6.1	11.4	3.7	10.3	10.8	38.7	16.2	38.3	20.7	33.7	29.6	7.1	15.3	5.3	13.6	17.4	64.8	9.1	3.3	10.9	42.2	44.7	5.4	0.0	9.0	28.2	34.8	27.0	77.1	11.3	11.1	41.3	18.1	38.1	28.4	78.9	31.1	24.5	47.2	12.6	6.1	16.0	12.3	3.5	29.0	7.1	110.0	25.8	26.9	56.0	44.5	20.8	8.1	27.4	11.0	32.3
PRKDC	"DNA-PKcs, DNAPK, DNPK1, HYRC, HYRC1, p350, XRCC7"	ENSG00000253729	"Protein kinase, DNA-activated, catalytic polypeptide"	P78527	8	47773108-47960183	"Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Biological rhythms, DNA damage, DNA recombination, DNA repair, Immunity, Innate immunity, Ribosome biogenesis"	"DNA-binding, Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes, Disease mutation, SCID"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB005167, HPA035174"	Supported		Enhanced	Nucleoplasm		NA	NA		1100000	Nucleoplasm		"CAB005167: AB_2172845, HPA035174: AB_2674504"	"unprognostic (3.14e-2)"	"unprognostic (3.02e-3)"	"unprognostic (1.56e-2)"	"prognostic unfavorable (1.03e-4)"	"unprognostic (8.95e-2)"	"unprognostic (1.34e-1)"	"unprognostic (7.70e-3)"	"unprognostic (5.74e-2)"	"unprognostic (1.12e-2)"	"unprognostic (1.60e-2)"	"unprognostic (7.76e-3)"	"unprognostic (7.77e-2)"	"unprognostic (2.84e-2)"	"unprognostic (2.32e-1)"	"unprognostic (2.20e-1)"	"unprognostic (6.76e-3)"	"unprognostic (2.15e-2)"	21.3	20.5	16.0	22.3	22.0	27.4	30.2	16.5	23.1	19.6	20.6	17.3	18.1	12.0	26.2	14.5	27.4	24.4	13.0	21.1	20.8	15.2	16.7	18.4	17.0	33.6	16.6	18.2	24.6	23.8	33.4	29.4	20.5	17.3	17.9	20.3	17.8	17.9	17.8	34.0	23.9	18.4	27.0	20.3	24.4	19.1	20.5	15.9	44.4	20.8	15.9	27.9	21.3	19.1	17.0	13.9	7.1	11.5	11.5	11.3	2.3	32.9	28.2	27.5	26.1	17.1	18.2	11.6	14.0	13.8	19.8	19.5	18.4	10.9	31.5	12.2	17.2	14.7	18.8	36.3	19.2	31.0	6.9	22.5	61.8	25.4	22.5	7.4	23.5	12.9	13.1	6.3	31.1	32.7	7.6	20.3	21.9	41.1	13.3	21.8	15.5	33.1	19.4	30.2	23.1	8.6	16.2	21.6	11.1	9.9	28.4	13.8	17.5	43.3	14.1	13.6	17.7	20.2	16.2	23.5	25.9	22.0	20.4	28.1	11.6	14.8	45.3	14.6	26.7	20.9	6.7	8.1	3.5	8.7	6.3	10.9	12.6	10.8	8.8	5.9	17.0	11.3	10.3	7.1	11.5	11.5	13.9	7.4	2.3	16.0	22.0	16.5	23.1	20.8	15.2	16.6	18.2	17.3	15.9	35.7	26.0	39.5	30.4	34.1	100.6	65.8	25.5	52.2	39.8	40.1	117.8	48.3	14.9	34.6	26.1	40.5	10.5	0.0	30.9	53.5	37.0	37.2	43.9	39.8	32.1	98.5	24.8	33.7	41.6	10.8	52.6	32.7	18.6	29.7	26.8	69.1	30.3	14.0	65.4	18.7	102.0	51.8	28.8	106.0	117.5	35.5	27.6	38.3	45.0	27.8
PRKG1	"PGK, PKG, PRKG1B, PRKGR1B"	ENSG00000185532	"Protein kinase, cGMP-dependent, type I"	Q13976	10	50990891-52298350	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		"Allosteric enzyme, Kinase, Serine/threonine-protein kinase, Transferase"	"Aortic aneurysm, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	6	"Early spermatids: 43.8;Late spermatids: 40.9;Peritubular cells: 37.1;Sertoli cells: 38.8;Smooth muscle cells: 47.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	21	"basophil: 8.0"	"Lineage enriched"	"Detected in single"	24	"granulocytes: 8.0"	"Cell line enhanced"	"Detected in many"		"AN3-CA: 11.6;BJ hTERT+: 15.9;fHDF/TERT166: 13.1;U-138 MG: 9.7;U-87 MG: 8.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007699, CAB009629"	Enhanced		Approved	Vesicles,Cytosol		NA	NA		33000	"Vesicles, Cytosol"		"CAB009629: AB_2170663, HPA007699: AB_1079677"	"unprognostic (3.94e-2)"	"unprognostic (2.60e-1)"	"unprognostic (1.44e-2)"	"unprognostic (5.36e-2)"	"unprognostic (1.25e-1)"	"unprognostic (1.86e-1)"	"unprognostic (5.54e-1)"	"unprognostic (2.23e-1)"	"unprognostic (4.94e-1)"	"unprognostic (2.05e-2)"	"unprognostic (1.22e-2)"	"unprognostic (3.40e-1)"	"unprognostic (9.26e-2)"	"unprognostic (5.50e-3)"	"unprognostic (4.24e-2)"	"unprognostic (1.11e-1)"	"unprognostic (3.78e-4)"	8.0	10.9	5.2	6.6	7.3	0.8	6.9	2.8	5.4	19.2	14.4	2.1	6.8	2.9	22.8	10.7	6.0	9.9	12.6	14.8	7.0	4.9	4.4	2.1	19.5	2.6	3.1	4.8	8.9	2.6	13.7	8.4	11.0	4.6	9.5	6.2	6.2	6.4	9.4	24.9	2.8	5.3	28.2	2.7	2.7	5.9	5.0	3.1	0.2	9.2	12.7	1.2	13.4	15.8	0.1	0.1	8.0	0.1	0.3	0.0	0.1	0.0	0.1	1.5	11.6	5.6	5.3	0.0	5.0	15.9	1.6	2.4	0.1	0.8	0.2	0.0	13.1	1.7	0.1	0.0	0.0	1.5	0.0	4.3	0.8	0.3	0.0	4.8	0.0	0.0	6.8	0.0	4.2	0.1	0.4	0.0	0.0	0.0	0.1	4.4	0.1	0.0	0.0	3.3	0.0	2.0	0.0	3.1	0.0	0.0	0.0	0.0	5.8	0.0	0.0	0.1	1.6	0.1	0.0	0.0	9.7	1.7	4.9	2.9	1.2	0.6	0.0	8.6	0.0	2.0	8.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.3	0.1	0.1	0.0	0.1	5.2	7.3	2.8	5.4	7.0	4.9	3.1	4.8	4.6	3.1	14.9	9.6	0.0	1.4	0.8	6.8	29.7	0.0	1.4	0.0	3.5	0.0	0.8	0.0	1.8	43.8	3.7	2.6	0.0	3.3	0.9	13.0	0.4	4.6	0.0	0.3	0.0	0.0	4.3	0.0	40.9	30.2	0.3	3.3	0.0	4.3	23.0	3.5	11.4	37.1	0.0	1.3	38.8	47.0	0.7	0.6	0.5	1.8	0.0	3.2	0.7
PRKG2	"cGKII, PRKGR2"	ENSG00000138669	"Protein kinase, cGMP-dependent, type II"	Q13237	4	81087370-81215117	"Enzymes, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 34.3"	"Cell type enhanced"	"Detected in some"	22	"Alveolar cells type 1: 32.8;Enterocytes: 13.8;Paneth cells: 8.6"	"Cancer enhanced"	"Detected in some"		"melanoma: 4.1"	"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"basophil: 2.0;MAIT T-cell: 2.2"	"Group enriched"	"Detected in many"	4	"granulocytes: 2.0;T-cells: 2.2"	"Cell line enhanced"	"Detected in some"		"ASC diff: 5.2;ASC TERT1: 4.0;HEL: 20.8;hTCEpi: 4.1;SCLC-21H: 6.4"	"Low region specificity"	"Detected in many"							"HPA007386, CAB018739"	Approved					NA	NA					"CAB018739: AB_2284387, HPA007386: AB_1079678"	"unprognostic (6.14e-2)"	"unprognostic (2.77e-1)"	"unprognostic (2.14e-1)"	"unprognostic (5.01e-4)"	"unprognostic (4.33e-2)"	"unprognostic (6.85e-2)"	"unprognostic (1.13e-1)"	"unprognostic (5.57e-2)"	"unprognostic (2.05e-1)"	"unprognostic (1.86e-1)"	"unprognostic (4.70e-2)"	"unprognostic (1.48e-1)"	"unprognostic (8.27e-2)"	"unprognostic (2.33e-1)"	"unprognostic (1.58e-1)"	"unprognostic (4.00e-3)"	"unprognostic (1.06e-1)"	4.7	0.4	5.2	0.4	2.9	0.6	2.2	0.8	5.3	1.4	7.7	1.2	0.7	12.2	0.6	0.6	3.8	0.6	0.4	6.3	2.9	3.3	0.7	0.3	4.3	0.3	2.5	1.9	0.3	1.8	0.0	12.1	0.2	9.3	12.7	3.8	1.4	0.8	4.6	0.3	2.1	34.3	0.7	1.3	0.3	1.3	1.7	2.4	0.0	1.3	0.0	0.6	1.2	1.3	0.4	0.0	2.0	0.0	0.4	2.2	0.4	0.1	0.3	0.1	0.0	5.2	4.0	0.0	0.3	0.0	0.0	0.0	0.4	2.4	0.0	0.2	0.9	0.0	0.1	0.3	1.6	0.0	0.4	0.0	20.8	0.6	0.0	0.0	0.0	0.0	0.6	4.1	0.0	0.0	1.1	0.0	0.6	0.0	0.6	0.0	0.0	0.0	0.1	0.9	0.6	0.4	0.0	0.0	0.1	0.0	0.9	6.4	0.0	0.0	0.2	0.0	0.3	0.5	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	2.0	0.0	0.0	0.2	0.0	2.2	0.2	0.5	0.3	0.0	0.4	0.8	0.9	0.0	0.4	0.0	0.0	0.0	0.4	5.2	2.9	0.8	5.3	2.9	3.3	2.5	1.9	9.3	2.4	32.8	1.6	0.0	0.6	0.0	0.0	2.6	0.0	1.4	3.4	0.0	0.0	0.0	0.0	0.1	5.3	0.0	13.8	0.0	0.0	0.1	0.0	0.7	1.1	0.0	0.1	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	1.3	0.0	0.6	8.6	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.1	0.0	0.0	0.4	0.2
PRKN	"AR-JP, PARK2, parkin, PDJ"	ENSG00000185345	"Parkin RBR E3 ubiquitin protein ligase"	O60260	6	161347420-162727771	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Autophagy, Transcription, Transcription regulation, Ubl conjugation pathway"	Transferase	"Disease mutation, Neurodegeneration, Parkinson disease, Parkinsonism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 41.8"	"Cell type enhanced"	"Detected in some"	16	"Alveolar cells type 1: 8.9;Alveolar cells type 2: 7.4;Distal tubular cells: 16.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"AN3-CA: 3.7;HEL: 9.2;Karpas-707: 5.9;RPMI-8226: 5.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB016257, HPA036012"	Enhanced		Supported	"Nuclear speckles,Cytosol"		NA	NA			"Nuclear speckles"	Cytosol	"CAB016257: AB_628104, HPA036012: AB_2732471"	"unprognostic (9.23e-2)"	"unprognostic (3.29e-2)"	"unprognostic (6.48e-2)"	"unprognostic (2.69e-3)"	"unprognostic (9.85e-2)"	"unprognostic (5.85e-2)"	"unprognostic (7.07e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.39e-1)"	"unprognostic (2.68e-2)"	"unprognostic (1.03e-3)"	"unprognostic (8.16e-2)"	"prognostic favorable (6.75e-12)"	"unprognostic (9.93e-2)"	"unprognostic (1.51e-1)"	"unprognostic (5.24e-2)"	"unprognostic (2.50e-1)"	6.8	7.1	7.9	2.3	12.2	1.5	4.2	7.2	13.4	5.3	4.3	6.3	4.6	2.8	7.8	4.4	6.1	3.4	4.3	17.7	9.2	6.2	17.4	3.6	2.6	3.0	5.8	5.2	6.4	3.0	5.6	8.6	2.0	5.5	4.0	2.4	8.3	3.5	4.8	41.8	4.0	3.3	6.6	5.9	2.7	3.5	10.3	6.8	0.6	3.8	4.7	2.7	4.9	2.1	4.6	1.2	4.2	0.8	1.8	4.6	1.3	0.1	0.3	1.3	3.7	0.9	0.3	0.6	0.0	0.0	0.0	0.0	0.0	0.3	0.4	1.2	0.0	0.9	0.0	0.2	0.2	0.0	0.4	0.6	9.2	0.2	0.0	0.9	0.2	0.1	3.2	0.1	0.0	0.5	0.6	0.0	0.4	0.4	5.9	1.0	0.5	0.1	0.1	0.2	0.6	0.9	0.0	0.0	5.9	0.7	0.1	1.0	2.5	0.0	0.0	0.3	1.2	0.0	0.6	0.0	0.1	0.3	0.1	0.3	0.8	0.1	0.0	0.1	0.2	2.2	2.8	0.8	4.2	2.1	0.5	3.5	1.5	2.0	2.2	1.2	4.6	4.4	4.6	1.5	1.8	0.4	0.3	0.2	1.3	7.9	12.2	7.2	11.7	9.2	6.2	5.8	5.2	5.5	6.8	8.9	7.4	0.0	0.0	0.0	0.0	0.0	0.0	2.7	3.4	1.8	0.0	0.4	16.6	0.8	0.0	0.0	0.0	0.0	1.8	0.1	0.0	0.0	2.3	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	4.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0
PRKX	PKX1	ENSG00000183943	"Protein kinase, X-linked"	P51817	X	3604370-3713608	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Angiogenesis, Differentiation"	"Developmental protein, Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"granulocytes: 85.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HMC-1: 38.8"	"Low region specificity"	"Detected in all"							HPA015324	Supported		Supported	Nucleoplasm		No	No			Nucleoplasm		"HPA015324: AB_1855715"	"unprognostic (1.07e-1)"	"unprognostic (1.23e-2)"	"unprognostic (1.57e-1)"	"unprognostic (3.63e-1)"	"unprognostic (2.45e-1)"	"unprognostic (3.33e-2)"	"unprognostic (1.47e-1)"	"unprognostic (1.33e-2)"	"unprognostic (4.14e-1)"	"unprognostic (1.68e-1)"	"unprognostic (2.68e-1)"	"unprognostic (2.92e-1)"	"unprognostic (1.07e-3)"	"unprognostic (2.15e-2)"	"unprognostic (9.91e-2)"	"unprognostic (2.52e-1)"	"unprognostic (1.70e-2)"	4.3	1.3	12.3	7.5	15.8	5.4	11.2	4.4	12.3	6.9	5.2	5.4	11.5	4.1	7.3	8.4	13.6	16.5	3.9	4.0	14.0	7.4	14.2	2.0	8.4	9.5	27.9	5.6	4.8	4.1	3.2	2.3	6.6	22.7	3.7	5.2	3.1	6.5	5.3	1.6	9.9	6.0	3.0	17.6	10.0	3.1	6.1	22.7	6.1	28.8	3.2	8.0	3.7	11.2	2.5	2.8	12.2	4.1	3.3	3.8	1.7	4.5	4.2	11.6	8.6	2.2	3.0	10.6	2.7	1.0	1.3	1.8	6.2	3.1	0.4	2.7	2.1	2.8	3.1	10.7	8.1	2.3	5.0	7.5	5.0	3.2	0.1	2.3	6.4	38.8	2.0	8.7	1.4	5.3	3.7	13.1	6.3	5.8	6.5	4.4	3.9	7.3	5.7	7.7	3.5	4.8	13.7	11.1	8.5	10.7	3.8	7.8	5.0	2.8	1.8	2.7	19.0	1.4	5.1	7.1	1.2	2.0	1.9	1.8	0.1	0.3	5.8	0.7	5.8	3.0	12.2	3.1	1.8	3.5	3.3	3.8	2.5	3.7	3.3	2.3	2.4	3.1	3.3	0.8	3.3	4.1	2.8	2.5	1.7	12.3	15.8	4.4	12.3	14.0	7.4	27.9	5.6	22.7	22.7	3.0	13.1	6.5	16.9	19.1	0.6	1.4	25.5	17.4	9.1	5.2	0.0	17.4	11.6	10.4	7.2	17.0	7.7	0.0	2.7	3.8	9.7	9.1	85.2	1.7	15.1	1.6	4.6	11.1	19.0	34.3	18.4	20.8	5.0	6.4	11.4	2.1	4.7	10.5	20.5	5.1	0.7	32.3	22.0	1.6	21.7	23.5	6.5	25.5	22.2	16.5
PRMT1	"ANM1, HCP1, HRMT1L2"	ENSG00000126457	"Protein arginine methyltransferase 1"	Q99873	19	49675786-49689029	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Methyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB022550, HPA069769, HPA072136"	Supported		Supported	Nucleoplasm		NA	NA			Nucleoplasm		"CAB022550: , HPA069769: AB_2686193, HPA072136: AB_2686490"	"unprognostic (1.88e-2)"	"unprognostic (1.28e-2)"	"unprognostic (3.00e-2)"	"unprognostic (3.84e-1)"	"unprognostic (4.13e-2)"	"unprognostic (3.33e-2)"	"prognostic unfavorable (8.04e-5)"	"unprognostic (3.43e-2)"	"unprognostic (1.82e-1)"	"unprognostic (1.77e-1)"	"unprognostic (3.59e-2)"	"unprognostic (1.05e-1)"	"unprognostic (7.19e-3)"	"unprognostic (2.21e-1)"	"unprognostic (3.66e-2)"	"unprognostic (4.73e-2)"	"unprognostic (1.10e-2)"	21.3	31.5	27.4	28.1	29.7	21.8	22.0	29.4	35.9	31.8	25.5	26.9	27.8	21.4	36.0	22.5	28.9	45.4	24.5	56.4	25.2	28.6	23.4	20.8	22.0	34.9	32.0	23.8	43.4	35.0	20.0	31.7	27.9	25.6	33.3	18.4	34.1	20.9	31.5	83.8	21.9	19.8	38.3	20.9	33.3	20.3	24.9	28.0	25.0	32.9	31.3	32.0	29.8	23.8	51.9	41.2	9.2	23.6	38.7	35.5	31.8	38.2	87.7	60.8	73.3	16.5	18.8	32.0	24.6	43.0	71.2	61.3	65.3	30.6	63.0	18.4	28.8	28.0	28.3	51.2	52.0	31.2	48.9	87.9	45.9	24.1	70.8	40.5	55.2	33.0	26.2	25.9	39.8	57.3	24.0	42.1	51.1	48.3	44.8	27.6	57.9	71.3	68.4	64.1	48.1	57.1	50.7	49.1	57.5	40.1	80.8	67.8	52.8	28.4	29.5	15.1	20.5	22.3	32.6	26.1	41.9	40.8	19.2	58.6	43.1	64.9	62.2	25.7	40.0	43.9	5.8	20.2	9.2	28.6	23.6	35.5	51.9	26.6	30.5	34.2	41.9	29.9	29.1	3.9	38.7	17.1	41.2	24.2	31.8	27.4	29.7	29.4	35.9	25.2	28.6	32.0	23.8	25.6	28.0	3.0	15.9	80.4	187.9	183.9	238.6	13.0	28.1	1.4	7.9	41.8	100.1	170.7	107.8	159.3	3.5	104.4	27.5	0.0	117.3	137.0	110.0	82.0	55.2	18.3	92.0	122.3	110.5	96.3	30.9	13.2	96.4	65.7	106.3	237.2	61.8	106.4	105.3	52.0	83.8	63.8	130.7	90.5	132.8	70.0	132.2	138.9	196.7	52.4	83.7	157.1
PRMT2	"HRMT1L1, MGC111373"	ENSG00000160310	"Protein arginine methyltransferase 2"	P55345	21	46635167-46665124	"Enzymes, Predicted intracellular proteins"		"Methyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA018976, HPA029591"	Uncertain		Supported	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"HPA018976: AB_1855719, HPA029591: AB_10601250"	"unprognostic (1.82e-1)"	"unprognostic (2.96e-1)"	"unprognostic (8.61e-3)"	"unprognostic (1.74e-1)"	"unprognostic (1.08e-1)"	"unprognostic (1.58e-2)"	"unprognostic (1.29e-3)"	"unprognostic (1.34e-1)"	"unprognostic (2.23e-1)"	"unprognostic (6.78e-2)"	"unprognostic (4.34e-3)"	"unprognostic (1.72e-1)"	"unprognostic (4.62e-3)"	"unprognostic (8.76e-3)"	"unprognostic (2.86e-2)"	"unprognostic (1.91e-3)"	"unprognostic (2.23e-1)"	19.9	14.7	37.1	21.8	43.6	18.7	28.4	21.4	37.2	25.5	25.2	35.4	12.0	14.7	24.5	15.9	30.7	27.1	23.4	29.4	37.4	53.1	19.9	8.5	21.7	28.7	44.8	32.2	48.5	15.1	19.9	20.1	26.2	44.9	22.0	17.1	20.6	21.0	28.0	9.5	28.1	20.0	28.5	69.6	25.6	17.4	10.1	40.3	13.8	20.1	7.4	28.3	23.1	26.0	18.9	27.6	64.2	26.1	50.8	60.2	41.6	22.7	19.5	39.5	14.7	28.9	28.2	9.7	21.5	24.2	24.4	22.4	27.4	18.6	13.4	27.4	38.3	33.3	6.7	18.4	27.1	14.2	33.4	17.7	34.7	16.5	20.4	14.0	10.3	16.5	17.4	27.0	29.6	21.2	27.4	35.3	19.2	22.0	25.2	37.3	25.5	14.8	19.4	21.7	14.5	23.1	19.1	10.0	8.8	19.0	19.5	28.6	17.8	22.7	10.4	41.1	6.1	14.0	10.7	31.8	23.9	16.4	12.7	14.1	6.7	6.1	8.5	21.9	28.1	34.5	44.2	19.6	64.2	60.2	26.0	43.6	18.9	40.5	51.0	27.6	16.7	49.9	56.9	26.3	50.8	26.1	23.8	29.0	41.6	37.1	43.6	21.4	37.2	37.4	53.1	44.8	32.2	44.9	40.3	86.4	33.4	59.7	59.7	41.0	46.0	58.2	71.4	75.0	52.4	71.5	27.5	55.8	76.3	68.8	2.4	76.8	42.4	23.3	45.8	37.4	57.5	64.0	111.2	26.7	91.9	35.0	34.3	129.5	113.7	5.6	51.5	104.6	82.7	214.6	26.3	44.1	63.8	35.4	58.4	73.2	53.9	64.7	66.1	20.2	31.9	39.4	57.9	132.0	32.2	56.9
PRMT5	"HRMT1L5, SKB1, SKB1Hs"	ENSG00000100462	"Protein arginine methyltransferase 5"	O14744	14	22920511-22929585	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Biological rhythms, Transcription, Transcription regulation"	"Chromatin regulator, Methyltransferase, Repressor, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA005525, CAB012459, HPA064708"	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"CAB012459: , HPA005525: AB_1079679, HPA064708: AB_2685330"	"unprognostic (8.34e-2)"	"unprognostic (5.14e-3)"	"unprognostic (1.19e-2)"	"unprognostic (2.19e-1)"	"unprognostic (4.56e-3)"	"prognostic unfavorable (1.82e-4)"	"prognostic unfavorable (4.77e-5)"	"unprognostic (3.64e-2)"	"unprognostic (6.80e-2)"	"unprognostic (1.48e-1)"	"prognostic unfavorable (2.61e-4)"	"unprognostic (4.69e-2)"	"unprognostic (1.99e-3)"	"unprognostic (1.21e-1)"	"unprognostic (7.04e-2)"	"unprognostic (6.28e-2)"	"prognostic unfavorable (1.04e-4)"	17.0	21.6	18.3	17.8	22.8	12.0	21.2	18.4	24.9	20.3	25.0	18.1	24.9	16.1	24.9	19.6	33.1	28.0	16.6	22.3	15.3	13.2	25.7	22.2	15.8	15.6	17.2	15.2	30.2	30.9	30.8	17.4	24.3	15.9	21.1	22.6	16.9	19.0	21.7	42.0	21.7	14.5	22.2	13.4	17.9	19.5	22.1	17.3	22.7	30.9	19.6	22.1	20.8	22.0	17.6	23.8	4.3	17.6	9.8	15.6	15.5	40.7	39.4	28.5	28.2	13.6	15.5	31.1	28.1	20.9	43.6	37.0	36.0	37.9	39.8	23.0	20.7	25.9	32.6	56.4	47.2	50.5	25.5	27.2	24.7	26.6	55.3	26.1	51.8	21.6	15.2	25.2	33.7	61.6	17.8	20.6	31.8	35.0	21.8	22.5	36.8	37.1	23.2	25.5	35.5	49.8	43.8	34.5	28.9	21.2	28.0	30.7	20.1	30.7	32.9	14.3	25.5	22.2	19.6	19.3	18.5	26.4	26.3	35.8	29.9	63.7	52.9	11.7	25.2	28.9	1.7	16.8	0.2	8.2	17.6	13.4	17.6	11.3	13.5	23.8	15.5	15.6	12.5	4.3	9.8	13.2	14.1	9.4	15.5	18.3	22.8	18.4	24.9	15.3	13.2	17.2	15.2	15.9	17.3	17.9	10.8	4.5	23.8	23.6	9.5	0.8	28.1	26.8	11.4	7.0	7.9	33.6	19.9	25.6	1.9	11.2	6.3	0.0	23.3	26.7	18.6	11.3	6.9	15.5	17.4	15.9	5.8	11.1	4.9	2.7	15.3	10.4	25.3	11.8	15.7	19.1	60.5	8.6	19.8	18.4	7.5	6.5	27.8	34.9	54.7	24.3	27.9	10.1	19.0	16.8
PRMT6	"FLJ10559, HRMT1L6"	ENSG00000198890	"Protein arginine methyltransferase 6"	Q96LA8	1	107056679-107059294	"Enzymes, Predicted intracellular proteins"	"DNA damage, DNA repair, Host-virus interaction, Transcription, Transcription regulation"	"Chromatin regulator, Methyltransferase, Repressor, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enriched"	"Detected in many"	5	"MCF7: 83.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA059424	Approved		Supported	Nucleoplasm,Nucleoli		NA	NA			"Nucleoplasm, Nucleoli"		"HPA059424: AB_2684012"	"unprognostic (5.17e-3)"	"unprognostic (1.48e-1)"	"unprognostic (1.47e-2)"	"prognostic unfavorable (3.05e-4)"	"unprognostic (2.68e-1)"	"unprognostic (2.55e-1)"	"unprognostic (1.36e-3)"	"unprognostic (2.13e-2)"	"unprognostic (9.72e-2)"	"unprognostic (2.53e-2)"	"unprognostic (1.42e-1)"	"unprognostic (2.63e-1)"	"unprognostic (3.15e-2)"	"unprognostic (1.03e-1)"	"unprognostic (8.34e-2)"	"unprognostic (1.01e-1)"	"unprognostic (1.73e-3)"	6.6	16.1	14.4	10.5	13.4	4.6	10.8	12.6	13.9	8.9	10.3	11.5	10.4	8.1	9.7	11.3	10.9	12.2	9.8	5.0	11.8	16.2	16.7	16.3	5.9	11.5	12.2	14.1	12.3	16.8	15.0	13.8	9.6	13.2	11.8	9.7	12.6	8.3	11.4	2.1	7.6	9.3	8.0	13.6	11.5	9.5	9.4	10.6	18.2	9.5	3.4	11.1	10.1	7.3	9.7	14.7	1.8	10.1	14.6	10.9	7.6	3.6	0.0	7.3	3.2	4.8	5.4	2.0	4.9	3.7	4.8	4.9	4.7	2.5	9.0	6.8	4.5	2.6	5.2	6.6	7.2	3.8	0.0	7.1	5.4	10.2	6.7	4.8	11.2	3.4	5.0	4.0	4.3	4.4	3.2	4.1	5.2	7.2	1.4	4.3	83.6	6.5	3.9	3.1	2.9	6.9	8.3	15.9	3.4	11.5	7.4	13.6	16.6	6.7	9.7	3.2	4.6	6.7	8.4	4.7	3.5	7.3	7.4	7.3	1.5	1.0	1.5	5.3	5.3	2.8	1.8	8.9	1.6	7.5	10.1	8.4	6.9	7.6	6.8	11.9	9.7	10.9	10.9	0.5	14.6	9.2	14.7	7.8	7.6	14.4	13.4	12.6	13.9	11.8	16.2	12.2	14.1	13.2	10.6	0.0	4.1	8.2	6.2	3.9	12.5	2.2	0.0	8.1	2.3	14.0	0.0	16.1	23.2	9.0	0.9	4.2	3.5	0.0	6.5	11.9	3.9	3.6	1.1	0.0	8.5	14.3	16.8	4.9	7.0	2.3	8.1	3.6	1.7	1.8	8.7	6.9	4.9	7.0	8.5	15.2	4.3	12.9	8.4	8.4	8.8	5.4	5.9	5.4	9.5	5.8
PRMT7	"FLJ10640, KIAA1933"	ENSG00000132600	"Protein arginine methyltransferase 7"	Q9NVM4	16	68310974-68358563	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Differentiation, Transcription, Transcription regulation"	"Chromatin regulator, Methyltransferase, Transferase"	"Disease mutation, Dwarfism, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Cone photoreceptor cells: 51.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044241	Supported		Enhanced	"Nucleoplasm,Nucleoli fibrillar center"		No	No			Nucleoplasm	"Nucleoli fibrillar center"	"HPA044241: AB_2678869"	"unprognostic (9.33e-2)"	"unprognostic (5.33e-2)"	"unprognostic (1.52e-1)"	"prognostic favorable (2.31e-5)"	"unprognostic (2.92e-2)"	"unprognostic (1.95e-1)"	"unprognostic (4.12e-2)"	"unprognostic (1.22e-1)"	"unprognostic (3.74e-1)"	"unprognostic (1.19e-1)"	"unprognostic (4.74e-3)"	"unprognostic (3.09e-2)"	"unprognostic (7.72e-2)"	"unprognostic (1.75e-1)"	"unprognostic (9.23e-2)"	"unprognostic (3.57e-1)"	"unprognostic (1.31e-1)"	14.8	14.4	15.6	12.7	22.0	11.1	12.9	29.4	20.5	11.4	11.7	20.2	13.9	7.0	18.9	11.9	12.7	18.1	9.3	23.1	14.4	13.1	9.5	12.2	9.7	17.0	11.2	18.7	21.9	14.8	12.0	14.0	11.4	13.3	12.8	7.6	20.8	17.3	16.2	34.0	16.9	9.9	18.5	11.6	12.4	9.9	17.0	13.1	24.4	11.1	12.0	14.9	13.3	10.4	10.8	26.2	9.9	8.5	18.6	18.1	11.5	10.2	16.7	8.0	20.0	7.6	7.2	26.7	10.3	5.6	13.1	10.9	42.3	10.3	21.9	17.4	8.7	4.8	13.4	11.3	10.4	7.3	7.8	16.9	6.5	18.8	19.1	5.5	11.9	10.2	8.0	4.5	10.8	10.2	8.1	7.8	11.4	15.4	1.2	7.1	17.2	14.7	18.5	13.1	10.3	11.4	19.8	11.7	14.8	6.1	9.4	10.9	8.5	34.5	8.7	7.0	6.8	14.5	11.9	9.3	9.3	8.3	11.1	9.2	6.7	12.4	22.5	11.8	12.8	9.6	9.9	7.0	5.9	15.8	8.5	18.1	10.1	10.6	13.9	10.2	10.8	16.1	14.1	0.8	18.6	7.7	26.2	11.7	11.5	15.6	22.0	29.4	20.5	14.4	13.1	11.2	18.7	13.3	13.1	17.9	11.7	10.4	7.4	6.2	20.5	11.8	15.3	14.7	9.1	8.7	51.1	21.8	5.0	11.0	3.4	6.8	24.9	0.0	14.4	6.5	8.0	6.2	6.9	7.5	10.2	28.6	12.7	6.7	5.9	3.2	10.9	8.3	8.5	4.6	27.0	9.4	15.1	26.9	12.4	6.8	16.4	12.9	5.7	6.3	20.0	5.3	9.7	15.2	23.3	9.3
PRMT9	"FLJ46629, PRMT10"	ENSG00000164169	"Protein arginine methyltransferase 9"	Q6P2P2	4	147637785-147684230	"Enzymes, Predicted intracellular proteins"		"Methyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Cone photoreceptor cells: 106.0;Rod photoreceptor cells: 79.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036844, HPA042537"	Uncertain		Approved	Nucleoplasm,Microtubules,Cytosol		NA	NA			Microtubules	"Nucleoplasm, Cytosol"	"HPA036844: AB_10672341, HPA042537: AB_2678043"	"unprognostic (2.17e-1)"	"unprognostic (1.46e-2)"	"unprognostic (4.65e-3)"	"unprognostic (2.35e-1)"	"unprognostic (8.46e-3)"	"unprognostic (1.10e-1)"	"unprognostic (1.35e-1)"	"unprognostic (1.55e-2)"	"unprognostic (4.14e-2)"	"unprognostic (7.29e-2)"	"unprognostic (2.11e-2)"	"unprognostic (2.33e-1)"	"prognostic favorable (3.58e-7)"	"unprognostic (1.72e-1)"	"unprognostic (4.52e-2)"	"unprognostic (1.54e-2)"	"unprognostic (1.30e-2)"	6.0	17.2	6.0	5.2	8.6	12.4	6.9	8.0	8.9	5.6	4.5	4.2	7.9	2.5	8.6	7.6	5.0	7.5	8.4	6.5	5.6	5.0	7.5	5.8	7.6	5.3	5.8	5.3	22.6	7.2	16.3	10.0	5.0	7.1	6.0	4.5	9.8	5.8	11.3	6.7	5.6	4.3	6.1	4.6	4.5	5.9	11.2	3.9	11.6	15.8	2.8	5.4	5.5	5.2	9.6	6.0	10.8	6.1	5.1	10.4	2.7	3.5	2.3	5.7	4.3	4.4	7.6	5.0	3.9	6.3	6.0	6.4	1.8	4.0	12.3	1.8	3.4	3.1	2.5	6.7	3.4	8.3	4.4	3.9	6.8	4.5	3.0	3.3	9.8	3.8	5.2	3.5	3.7	3.3	4.9	5.0	6.2	6.7	7.2	5.1	2.0	8.3	3.9	2.9	3.4	4.3	5.6	4.8	4.5	4.9	2.8	3.5	5.4	6.3	5.0	3.2	3.9	2.1	2.2	4.2	3.9	3.1	4.3	4.3	8.2	6.5	8.1	4.3	6.1	2.8	7.4	6.0	10.8	6.7	6.1	6.5	9.5	8.1	8.2	4.0	9.6	10.4	9.0	4.2	5.1	4.4	6.0	6.8	2.7	6.0	8.6	8.0	8.9	5.6	5.0	5.8	5.3	7.1	3.9	0.0	7.7	61.1	2.9	0.0	54.5	5.5	7.6	2.7	1.2	33.2	106.0	12.1	5.0	5.9	58.8	4.3	5.9	0.0	5.8	8.6	8.5	4.1	34.5	5.7	15.3	47.7	16.7	12.3	31.0	9.5	16.7	14.9	0.0	9.0	4.8	26.9	5.9	3.6	15.9	3.3	79.2	12.9	4.6	29.1	14.0	0.0	12.7	30.5	4.7	1.4
PROC		ENSG00000115718	"Protein C, inactivator of coagulation factors Va and VIIIa"	P04070	2	127418427-127429246	"Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Blood coagulation, Hemostasis"	"Hydrolase, Protease, Serine protease"	"Cancer-related genes, Disease mutation, FDA approved drug targets, Thrombophilia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"liver: 137.5"	"Cell type enriched"	"Detected in many"	4	"Hepatocytes: 348.7"	"Cancer enriched"	"Detected in many"	22	"liver cancer: 118.3"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in some"	9	"plasmacytoid DC: 29.2"	"Lineage enriched"	"Detected in many"	9	"dendritic cells: 29.2"	"Cell line enriched"	"Detected in some"	16	"Hep G2: 58.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA005550, CAB016721, CAB016792"	Supported				"Secreted to blood"	NA	NA		6400000000			"CAB016721: , CAB016792: , HPA005550: AB_1079687"	"unprognostic (2.46e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.38e-1)"	"unprognostic (1.58e-1)"	"unprognostic (6.64e-2)"	"unprognostic (3.13e-2)"	"unprognostic (4.90e-3)"	"unprognostic (2.63e-1)"	"unprognostic (1.67e-1)"	"unprognostic (3.29e-1)"	"unprognostic (3.74e-3)"	"unprognostic (2.56e-2)"	"unprognostic (8.12e-3)"	"unprognostic (2.01e-2)"	"unprognostic (1.71e-1)"	"unprognostic (4.60e-3)"	"unprognostic (8.06e-2)"	0.0	0.0	0.4	0.1	0.1	0.2	0.0	0.1	0.2	0.1	0.2	0.0	0.1	0.2	0.0	0.1	0.0	0.0	0.6	0.0	0.4	0.2	4.2	137.5	0.2	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.4	0.1	0.1	0.0	0.0	0.1	0.0	0.1	0.5	0.0	0.1	0.0	0.6	0.0	0.0	0.7	0.0	0.0	0.1	0.1	0.0	0.4	29.2	3.1	0.0	0.0	0.0	0.1	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	1.6	0.0	0.3	0.0	0.1	3.7	0.0	0.1	0.0	0.0	0.0	0.0	2.8	58.9	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.6	0.1	0.9	0.2	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.0	3.1	0.0	0.0	29.2	0.0	0.1	0.4	0.1	0.1	0.2	0.4	0.2	0.1	0.1	0.4	0.0	0.0	0.0	4.3	0.6	0.7	0.0	0.3	40.8	1.4	0.0	0.0	0.0	0.0	5.0	0.4	0.0	0.0	2.6	0.0	0.2	0.0	0.2	0.0	0.0	348.7	3.9	0.0	9.9	9.8	4.5	0.0	0.0	1.7	0.0	0.0	8.1	0.0	1.2	8.7	0.0	78.1	0.0	0.0	0.0	0.0	0.1	0.1	0.1	2.5	1.5	0.1
PRODH	"HSPOX2, PIG6, PRODH1, PRODH2, TP53I6"	ENSG00000100033	"Proline dehydrogenase 1"	O43272	22	18912777-18936553	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Proline metabolism"	Oxidoreductase	"Disease mutation, Schizophrenia"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 48.9"	"Group enriched"	"Detected in some"	4	"Alveolar cells type 1: 14.9;Alveolar cells type 2: 24.6;Melanocytes: 20.3;Suprabasal keratinocytes: 13.2"	"Cancer enhanced"	"Detected in many"		"testis cancer: 11.0"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"NK-cell: 1.0"	"Low lineage specificity"	"Detected in single"			"Group enriched"	"Detected in some"	10	"OE19: 39.9;RPTEC TERT1: 19.8"									HPA020361	Approved		Approved	Nucleoplasm,Vesicles,Mitochondria		NA	NA			Mitochondria	"Nucleoplasm, Vesicles"	"HPA020361: AB_10963116"	"unprognostic (2.46e-2)"	"prognostic favorable (1.54e-4)"	"unprognostic (1.40e-1)"	"unprognostic (3.70e-2)"	"unprognostic (3.80e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.78e-2)"	"unprognostic (1.07e-2)"	"unprognostic (2.49e-2)"	"unprognostic (6.56e-2)"	"unprognostic (3.12e-2)"	"unprognostic (1.61e-2)"	"unprognostic (7.44e-2)"	"unprognostic (1.07e-1)"	"unprognostic (1.21e-1)"	"unprognostic (5.34e-2)"	"unprognostic (3.94e-2)"	3.8	2.3	20.8	2.8	19.3	2.0	3.3	9.8	21.3	2.0	3.5	16.2	0.1	13.8	2.3	2.2	8.8	2.4	2.2	4.6	22.2	10.8	9.9	6.6	8.6	2.3	14.9	21.8	2.4	2.2	1.9	1.5	2.4	13.5	2.6	2.6	7.4	2.1	2.4	15.5	13.0	48.9	1.9	12.6	2.2	2.1	3.5	9.8	0.1	4.3	4.1	3.7	2.1	2.3	0.4	0.4	0.0	0.0	1.0	0.3	0.0	0.0	0.4	0.0	0.1	0.5	0.0	0.1	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.2	0.0	0.0	1.4	2.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.0	1.5	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	2.4	39.9	0.0	0.0	0.0	0.2	19.8	0.4	0.0	0.1	0.4	0.6	0.1	2.9	0.7	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.4	0.4	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	20.8	19.3	9.8	21.3	22.2	10.8	14.9	21.8	13.5	9.8	14.9	24.6	0.0	0.2	4.5	0.0	1.6	0.0	1.4	1.2	0.0	0.0	0.0	0.0	0.0	0.4	0.0	3.9	0.0	0.0	0.0	0.4	0.0	0.0	0.5	0.0	0.0	3.4	0.0	0.0	0.0	0.0	0.0	20.3	0.0	0.0	0.5	0.0	2.9	0.0	0.0	0.0	0.0	0.7	0.0	0.3	13.2	0.0	0.0	0.4	0.1
PRODH2	HSPOX1	ENSG00000250799	"Proline dehydrogenase 2"	Q9UF12	19	35799988-35813299	"Enzymes, Predicted intracellular proteins"	"Proline metabolism"	Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	29	"kidney: 51.2;liver: 49.3"	"Group enriched"	"Detected in some"	8	"Hepatocytes: 140.6;Proximal tubular cells: 216.9"	"Group enriched"	"Detected in some"	50	"liver cancer: 28.1;renal cancer: 5.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	18	"Hep G2: 26.5"	"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			HPA051287	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA051287: AB_2681420"							"unprognostic (2.58e-1)"				"unprognostic (3.41e-3)"		"unprognostic (2.75e-2)"	"unprognostic (7.03e-2)"	"unprognostic (1.73e-1)"			0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.2	0.1	0.1	0.1	0.1	1.7	0.1	0.0	0.3	0.1	0.1	0.0	51.2	49.3	0.1	0.1	0.1	0.1	0.1	1.2	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.2	0.1	0.1	0.2	0.1	0.1	0.1	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	26.5	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.0	3.4	0.0	0.1	0.3	0.3	0.0	0.0	0.0	12.2	0.0	0.0	23.2	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	140.6	0.1	0.0	0.0	1.3	4.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	216.9	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0
PROZ	PZ	ENSG00000126231	"Protein Z, vitamin K dependent plasma glycoprotein"	P22891	13	113158654-113172383	"Candidate cardiovascular disease genes, Enzymes, Plasma proteins, Predicted secreted proteins"	"Blood coagulation, Hemostasis"	"Serine protease homolog"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"liver: 45.0"	"Cell type enriched"	"Detected in some"	6	"Hepatocytes: 56.9"	"Cancer enriched"	"Detected in single"	27	"liver cancer: 12.1"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"intermediate monocyte: 2.7;T-reg: 1.5"	"Group enriched"	"Detected in many"	12	"monocytes: 2.7;T-cells: 1.5"	"Cell line enhanced"	"Detected in many"		"HaCaT: 4.9;Hep G2: 7.7"	"Not detected"	"Not detected"							HPA052006	Supported				"Secreted to blood"	NA	NA	1720000000	510000000			"HPA052006: AB_2681691"	"unprognostic (5.03e-2)"	"unprognostic (4.05e-2)"	"unprognostic (1.11e-1)"	"unprognostic (2.36e-1)"	"unprognostic (6.48e-2)"	"unprognostic (1.39e-1)"	"prognostic favorable (3.46e-4)"	"unprognostic (4.10e-1)"	"unprognostic (2.21e-1)"	"unprognostic (2.50e-1)"	"unprognostic (5.20e-2)"	"unprognostic (2.87e-1)"	"unprognostic (9.83e-2)"	"unprognostic (5.63e-2)"	"unprognostic (1.41e-1)"	"unprognostic (9.99e-2)"	"unprognostic (2.51e-4)"	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.2	0.1	0.1	0.3	0.1	0.1	0.1	0.1	0.5	0.1	0.0	0.1	0.1	0.1	0.0	9.3	45.0	0.1	0.1	0.1	0.1	0.1	0.2	0.0	0.5	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.3	0.1	0.1	0.1	0.1	0.1	0.6	0.1	0.1	0.2	0.1	0.1	0.1	0.1	0.0	0.1	0.0	2.7	0.0	1.5	0.2	0.9	1.5	0.7	1.0	0.0	0.0	0.6	1.5	0.0	0.0	0.0	3.0	1.8	0.8	0.0	0.0	0.3	4.9	0.0	0.0	0.0	0.8	2.4	1.0	2.9	7.7	0.1	0.8	0.4	0.0	0.0	0.0	0.0	0.2	0.0	2.5	1.1	0.6	0.0	1.0	0.6	0.8	1.8	3.1	0.4	1.3	0.2	0.3	0.0	1.1	2.9	0.2	0.0	0.3	1.3	1.7	0.0	1.0	0.7	0.8	0.1	0.8	0.3	1.6	0.9	0.8	1.6	0.9	0.7	0.0	0.0	0.0	0.3	2.7	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.6	0.1	1.5	0.2	0.1	0.1	0.2	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	56.9	0.0	0.0	0.0	0.6	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.8	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0
PRPF19	"hPSO4, NMP200, PRP19, PSO4, SNEV, UBOX4"	ENSG00000110107	"Pre-mRNA processing factor 19"	Q9UMS4	11	60890730-60906588	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"DNA damage, DNA repair, mRNA processing, mRNA splicing, Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB012448, HPA038051, HPA059070"	Supported		Enhanced	"Nuclear speckles"		NA	NA			"Nuclear speckles"		"CAB012448: AB_2170868, HPA038051: AB_2675807, HPA059070: AB_2683896"	"unprognostic (5.73e-2)"	"unprognostic (2.11e-1)"	"unprognostic (2.49e-1)"	"unprognostic (2.68e-1)"	"unprognostic (4.51e-2)"	"unprognostic (1.18e-2)"	"prognostic unfavorable (4.11e-8)"	"unprognostic (1.03e-1)"	"unprognostic (2.13e-1)"	"unprognostic (9.37e-3)"	"unprognostic (9.53e-2)"	"unprognostic (1.54e-1)"	"unprognostic (6.70e-2)"	"unprognostic (9.62e-2)"	"unprognostic (7.12e-2)"	"unprognostic (9.04e-2)"	"unprognostic (3.41e-3)"	20.5	32.2	33.6	27.0	37.9	32.0	28.9	49.6	61.8	30.4	30.6	21.3	24.5	24.2	27.1	21.4	36.7	34.9	20.1	18.0	32.8	46.3	21.5	39.4	18.0	33.1	35.0	50.0	41.3	31.3	45.7	37.6	24.9	46.2	37.7	31.5	21.5	28.8	30.9	31.9	39.0	24.6	28.8	23.7	28.3	23.7	15.2	24.4	46.3	25.3	24.4	41.7	24.8	24.8	3.1	5.3	4.4	11.8	2.4	3.3	1.2	43.7	34.2	38.4	27.4	22.6	19.8	34.9	23.8	32.4	47.9	36.0	37.5	33.0	63.4	32.1	22.8	28.7	40.1	54.0	42.9	37.3	43.2	34.5	52.7	27.1	40.3	32.7	69.6	37.6	21.0	32.7	36.8	41.5	14.0	37.1	38.9	52.3	36.7	23.4	61.6	70.3	52.4	67.9	34.5	46.1	62.5	39.3	49.6	24.2	28.7	32.8	39.5	29.5	49.1	39.7	18.3	51.3	38.6	23.2	21.2	34.2	36.9	38.4	32.8	45.9	63.8	26.4	47.8	31.9	4.4	11.8	2.6	3.2	5.4	2.6	1.3	2.6	2.3	4.8	3.1	3.3	3.0	0.7	2.4	2.9	5.3	2.2	1.2	33.6	37.9	49.6	61.8	32.8	46.3	35.0	50.0	46.2	24.4	17.9	21.3	32.2	30.9	37.4	31.5	14.9	17.8	18.7	26.1	26.2	9.8	75.0	23.2	33.3	15.9	20.3	20.2	23.3	44.7	70.4	22.6	29.5	22.0	40.0	40.5	58.8	37.5	16.5	27.1	2.7	34.2	21.5	25.3	47.7	32.9	24.1	30.9	24.6	36.4	22.4	22.1	45.3	22.3	18.4	35.8	36.4	34.0	23.8	47.8	26.8
PRPF4B	"KIAA0536, PR4H, Prp4"	ENSG00000112739	"Pre-mRNA processing factor 4B"	Q13523	6	4021267-4064983	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA020638	Approved		Supported	"Nuclear speckles"		NA	NA			"Nuclear speckles"		"HPA020638: AB_1855774"	"unprognostic (1.03e-1)"	"unprognostic (2.66e-1)"	"unprognostic (4.95e-2)"	"unprognostic (2.20e-1)"	"unprognostic (3.59e-3)"	"unprognostic (1.21e-2)"	"prognostic unfavorable (2.27e-4)"	"unprognostic (8.68e-3)"	"unprognostic (3.41e-2)"	"unprognostic (4.45e-3)"	"unprognostic (2.17e-1)"	"unprognostic (1.07e-1)"	"unprognostic (9.50e-3)"	"unprognostic (8.90e-2)"	"unprognostic (2.34e-1)"	"unprognostic (7.63e-3)"	"prognostic favorable (6.82e-5)"	23.2	21.6	19.6	24.0	20.5	8.5	21.4	35.6	26.8	18.3	19.3	6.0	14.7	12.0	22.2	14.2	23.6	14.7	13.6	16.3	16.5	11.7	15.0	14.5	13.0	15.4	14.5	14.1	19.1	14.4	20.9	30.9	17.1	21.0	14.9	15.7	5.3	22.7	20.4	45.7	16.3	16.4	14.9	23.7	19.0	13.6	11.6	20.2	21.8	21.1	11.3	17.4	21.4	22.2	9.7	13.6	7.5	11.9	11.8	9.1	3.9	14.7	12.8	20.2	13.8	11.5	10.7	9.8	14.3	15.7	15.6	15.8	12.2	7.5	24.1	18.0	16.1	12.8	13.2	25.4	12.4	22.5	11.3	18.6	27.1	14.7	10.9	8.8	29.9	14.8	9.7	8.2	11.1	6.9	7.6	15.5	11.8	37.1	8.9	15.3	8.6	21.9	10.0	12.1	12.9	11.9	24.9	19.5	23.4	10.0	16.6	15.7	10.3	16.6	10.4	12.6	16.8	16.2	15.0	16.6	15.4	8.9	10.1	13.8	10.1	15.8	28.1	8.4	13.7	18.7	7.5	11.9	3.6	7.6	9.9	9.1	9.7	8.6	9.0	10.2	9.3	8.0	8.0	6.1	11.8	8.7	13.6	6.3	3.9	19.6	20.5	35.6	26.8	16.5	11.7	14.5	14.1	21.0	20.2	101.3	91.8	89.2	53.8	74.1	81.8	69.0	61.1	89.7	101.2	92.5	84.4	51.4	61.3	56.7	8.7	82.4	58.2	46.7	49.5	40.6	50.2	53.8	86.8	76.7	36.1	100.1	72.3	68.2	59.0	11.9	91.5	57.7	33.7	71.3	57.5	80.9	52.5	57.5	83.8	50.1	181.0	58.2	43.9	67.7	79.4	79.8	53.2	69.3	57.5	63.7
PRPS1	"CMTX5, DFN2, DFNX1"	ENSG00000147224	"Phosphoribosyl pyrophosphate synthetase 1"	P60891	X	107628424-107651026	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Nucleotide biosynthesis"	"Kinase, Transferase"	"Charcot-Marie-Tooth disease, Deafness, Disease mutation, Gout, Mental retardation, Neurodegeneration, Neuropathy, Non-syndromic deafness, Retinitis pigmentosa"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA043760, HPA051269"	Uncertain		Approved	Vesicles		NA	NA		140000	Vesicles		"HPA043760: AB_2678656, HPA051269: "	"unprognostic (4.47e-2)"	"unprognostic (6.18e-2)"	"unprognostic (2.57e-2)"	"unprognostic (4.19e-3)"	"unprognostic (2.30e-3)"	"unprognostic (2.56e-3)"	"unprognostic (3.24e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.46e-1)"	"unprognostic (9.73e-2)"	"unprognostic (1.91e-2)"	"unprognostic (4.11e-2)"	"unprognostic (2.85e-2)"	"unprognostic (4.57e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.25e-2)"	"unprognostic (5.25e-2)"	16.8	19.0	18.8	18.7	22.4	33.5	13.0	27.0	30.3	13.5	12.1	20.5	7.0	7.3	16.6	10.4	11.8	17.6	9.6	19.9	19.0	26.5	18.5	45.1	14.9	25.4	21.8	17.5	21.4	17.8	20.0	18.2	10.0	26.9	14.9	12.4	15.0	11.2	12.4	31.2	8.4	10.8	20.0	19.3	19.4	10.8	11.3	13.6	32.3	29.9	11.3	28.6	16.9	10.7	18.2	8.5	12.6	8.7	14.4	22.1	11.6	20.7	30.8	13.7	15.8	7.6	6.0	4.7	61.1	12.7	34.7	29.4	13.3	8.9	34.2	26.4	22.2	24.9	8.5	40.8	12.6	35.7	16.9	25.4	18.2	30.7	17.3	7.0	33.7	13.6	6.8	7.4	21.0	13.8	23.3	11.9	24.7	29.0	41.5	16.0	11.1	22.8	18.2	49.6	17.5	26.7	26.6	22.0	27.5	13.6	11.9	22.6	12.1	30.3	18.3	12.3	26.8	8.4	14.1	7.1	22.6	10.6	24.7	24.2	14.2	23.1	37.4	11.7	36.6	14.1	4.8	5.2	12.6	15.7	8.2	17.6	17.0	19.7	19.3	6.2	18.2	22.1	18.7	3.1	14.4	8.7	8.5	20.1	11.6	18.8	22.4	27.0	30.3	19.0	26.5	21.8	17.5	26.9	13.6	6.0	10.6	39.3	13.5	27.6	29.0	9.5	12.7	30.8	12.5	15.7	3.9	8.6	21.6	12.6	0.6	12.2	1.6	0.0	17.6	10.9	22.4	16.3	25.5	52.0	30.0	14.3	15.5	10.4	11.7	2.6	13.0	19.1	25.3	34.3	5.4	18.6	15.4	3.5	15.9	23.1	12.2	0.0	40.6	3.1	9.7	19.4	1.5	49.0	6.4	8.4
PRPS1L1	"PRPS3, PRPSL"	ENSG00000229937	"Phosphoribosyl pyrophosphate synthetase 1-like 1"	P21108	7	18026774-18027863	"Enzymes, Predicted intracellular proteins"	"Nucleotide biosynthesis"	"Kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	33	"testis: 38.4"	"Group enriched"	"Detected in some"	8	"Early spermatids: 39.0;Spermatocytes: 72.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"BEWO: 1.3;K-562: 2.1"									HPA051269			Uncertain	Vesicles		NA	NA			Vesicles		"HPA051269: "					"unprognostic (2.39e-2)"									"unprognostic (3.18e-2)"	"unprognostic (1.11e-2)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	38.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.4	0.7	0.3	0.6	1.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.7	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.7	0.4	0.3	0.6	0.8	0.9	0.5	0.1	0.4	1.1	0.7	0.1	0.6	0.1	0.4	0.7	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	39.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.7	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	6.5	0.0	72.2	1.3	0.0	0.0	0.0	0.0	0.0
PRPS2		ENSG00000101911	"Phosphoribosyl pyrophosphate synthetase 2"	P11908	X	12791355-12824222	"Enzymes, Predicted intracellular proteins"	"Nucleotide biosynthesis"	"Kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"seminal vesicle: 138.1;testis: 109.7"	"Group enriched"	"Detected in many"	21	"Leydig cells: 1325.5;Peritubular cells: 1875.4;Sertoli cells: 614.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA051269, HPA067599, CAB070417"	Enhanced		Approved	"Nuclear speckles,Vesicles"		NA	NA			Vesicles	"Nuclear speckles"	"CAB070417: AB_11152035, HPA051269: , HPA067599: AB_2685869"	"unprognostic (7.50e-2)"	"prognostic favorable (1.90e-4)"	"unprognostic (2.09e-3)"	"unprognostic (1.03e-1)"	"unprognostic (1.16e-2)"	"unprognostic (1.10e-1)"	"unprognostic (7.63e-2)"	"unprognostic (4.75e-2)"	"unprognostic (6.98e-2)"	"unprognostic (2.64e-3)"	"unprognostic (4.44e-3)"	"unprognostic (1.81e-1)"	"unprognostic (7.83e-2)"	"unprognostic (2.20e-1)"	"unprognostic (1.50e-1)"	"unprognostic (1.35e-1)"	"unprognostic (2.04e-1)"	5.4	20.8	4.0	10.2	8.7	6.1	6.1	3.7	11.5	18.7	13.3	5.7	44.4	4.1	17.0	21.7	9.6	9.6	13.2	3.3	4.0	3.5	10.8	9.0	5.4	10.7	2.7	7.7	75.3	19.9	20.1	2.4	3.2	2.9	14.9	10.2	4.4	11.1	138.1	1.5	10.3	6.3	12.2	3.9	7.6	14.3	109.7	3.1	26.2	7.8	5.5	10.9	15.1	10.2	21.9	17.7	10.5	12.5	15.0	22.7	16.7	31.3	20.8	7.2	13.1	8.9	10.6	4.1	15.6	8.6	17.3	16.9	14.7	25.2	9.2	7.1	7.5	14.8	23.8	14.0	17.1	20.4	24.7	30.1	11.3	17.1	13.6	8.3	22.3	11.7	10.2	11.5	12.9	17.1	8.9	7.0	26.8	8.3	12.9	14.6	21.6	34.0	10.3	15.4	25.5	28.1	18.2	31.1	23.5	10.4	26.1	14.0	9.4	18.9	0.7	11.8	10.4	18.8	10.1	6.5	13.7	9.9	49.9	16.6	30.3	11.1	21.9	14.3	11.3	21.4	10.5	12.5	5.6	11.7	12.4	13.6	18.0	17.0	11.1	17.7	21.9	22.7	15.3	5.5	15.0	7.7	12.6	14.0	16.7	4.0	8.7	3.7	11.5	4.0	3.5	2.7	7.7	2.9	3.1	3.0	5.4	25.1	40.7	56.8	0.6	1.6	5.1	21.4	5.7	52.4	0.0	0.6	61.3	17.7	9.4	10.8	8.4	23.3	33.8	5.7	24.8	42.5	27.6	13.9	22.0	0.0	20.9	11.6	18.7	23.3	1325.5	24.5	38.8	20.8	26.7	0.3	28.8	5.8	1875.4	8.7	0.0	614.4	21.7	4.9	5.8	38.1	0.3	29.3	48.2	31.1
PRSS1	TRY1	ENSG00000204983	"Serine protease 1"	P07477	7	142749468-142753076	"Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	Digestion	"Hydrolase, Protease, Serine protease"	"Cancer-related genes, Disease mutation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	1708	"pancreas: 3057.4"	"Cell type enriched"	"Detected in some"	17	"Exocrine glandular cells: 49265.4"	"Cancer enriched"	"Detected in many"	224	"pancreatic cancer: 1920.3"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"basophil: 1.7"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"EFO-21: 2.7;OE19: 10.1;RPMI-8226: 5.4;U-2 OS: 3.2;U-266/84: 1.9"									"CAB025487, CAB025538, HPA062452, HPA063471"	Enhanced		Approved	"Endoplasmic reticulum,Vesicles"	"Secreted to digestive system"	NA	NA		26000000000	Vesicles	"Endoplasmic reticulum"	"CAB025487: , CAB025538: , HPA062452: AB_2684768, HPA063471: AB_2685017"	"unprognostic (6.55e-5)"	"unprognostic (5.28e-1)"	"unprognostic (7.58e-2)"	"prognostic unfavorable (6.41e-6)"				"unprognostic (8.26e-2)"		"prognostic favorable (7.05e-4)"	"unprognostic (1.35e-1)"			"unprognostic (3.93e-2)"	"unprognostic (1.96e-1)"	"prognostic favorable (4.91e-4)"	"unprognostic (3.12e-1)"	0.4	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.2	0.1	0.1	0.2	0.2	0.2	0.2	0.1	0.1	0.0	0.1	0.4	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	1.6	3057.4	0.0	0.1	0.1	0.1	0.2	0.0	0.1	0.4	0.2	0.1	0.0	0.4	0.1	0.1	0.1	0.5	0.2	0.1	0.1	0.1	0.1	0.1	0.1	0.1	1.0	0.0	1.7	0.0	0.0	0.9	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	10.1	0.0	0.0	0.0	5.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.2	0.0	1.1	0.0	1.9	0.4	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	1.0	0.9	0.0	0.0	0.8	0.3	0.0	0.0	0.0	0.0	0.0	0.6	0.1	0.1	0.1	0.1	0.2	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	58.1	0.0	0.0	0.0	0.0	49265.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	208.2	0.0	0.5	2827.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.1
PRSS12	"BSSP-3, MRT1"	ENSG00000164099	"Serine protease 12"	P56730	4	118280038-118353003	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted secreted proteins"		"Hydrolase, Protease, Serine protease"	"Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"gallbladder: 27.5;testis: 31.3"	"Group enriched"	"Detected in many"	4	"Ciliated cells: 84.3;Club cells: 46.6;Cytotrophoblasts: 36.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"fHDF/TERT166: 20.8;SH-SY5Y: 66.0;THP-1: 29.5"	"Group enriched"	"Detected in many"	5	"amygdala: 11.6;basal ganglia: 8.7;cerebral cortex: 26.5;hippocampal formation: 15.3;olfactory region: 11.0"	"Low region specificity"	"Detected in all"			HPA035054	Uncertain		Approved	"Nucleoplasm,Actin filaments"	"Secreted - unknown location"	NA	NA			"Actin filaments"	Nucleoplasm	"HPA035054: AB_10603990"	"unprognostic (4.30e-2)"	"unprognostic (1.04e-2)"	"unprognostic (2.55e-1)"	"unprognostic (4.41e-2)"	"prognostic favorable (2.66e-4)"	"prognostic favorable (1.03e-4)"	"unprognostic (4.21e-1)"	"unprognostic (3.48e-2)"	"unprognostic (7.83e-2)"	"unprognostic (6.38e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.27e-1)"	"unprognostic (2.41e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.85e-1)"	"unprognostic (9.55e-2)"	"unprognostic (1.09e-1)"	0.9	0.5	2.1	4.1	1.4	0.0	1.9	0.5	2.8	16.5	6.0	2.0	1.3	2.2	3.0	2.7	3.6	9.8	27.5	0.3	2.2	0.9	1.1	0.8	8.0	0.0	0.7	2.4	1.9	9.8	0.0	0.9	20.4	4.1	2.0	5.8	20.0	3.1	3.2	0.3	5.9	8.6	1.0	0.5	0.3	8.1	31.3	0.2	0.3	0.6	7.7	7.7	3.1	16.2	0.3	0.4	0.0	0.1	0.0	0.7	0.0	1.5	0.0	0.5	0.0	0.0	4.2	0.0	13.7	12.5	2.9	4.9	0.0	5.6	0.0	0.0	20.8	1.5	0.2	9.3	2.8	3.9	0.0	2.1	0.0	1.1	0.0	0.4	0.0	0.0	1.3	5.3	1.0	3.0	9.6	0.0	0.1	0.0	0.0	2.4	0.0	0.1	2.8	0.6	10.7	0.9	0.0	11.8	0.0	0.0	2.0	1.5	66.0	0.0	0.0	0.8	9.9	0.0	29.5	0.0	5.9	0.8	3.7	2.7	0.3	0.0	0.0	0.3	0.9	3.4	0.0	0.1	0.0	0.0	0.1	0.7	0.3	0.0	0.0	0.4	0.3	0.4	0.2	0.0	0.0	0.0	0.2	0.0	0.0	2.1	1.4	0.5	2.8	2.2	0.9	0.7	2.4	4.1	0.2	6.0	2.9	0.0	0.8	7.4	0.4	1.2	12.7	84.3	46.6	1.8	0.0	36.7	0.0	0.4	7.1	0.7	9.7	0.0	8.8	2.7	5.6	0.3	6.9	0.0	3.2	0.0	5.1	0.0	0.0	11.8	0.0	1.1	5.0	0.0	2.2	0.0	6.5	8.0	0.0	0.3	0.2	0.0	2.1	8.0	13.8	3.8	10.0	0.0	4.2	4.2
PRSS16	TSSP	ENSG00000112812	"Serine protease 16"	Q9NQE7	6	27247701-27256624	"Enzymes, Predicted intracellular proteins, Predicted secreted proteins"		"Hydrolase, Protease, Serine protease"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in many"	14	"lymphoid tissue: 242.8"	"Cell type enhanced"	"Detected in many"	6	"Cytotrophoblasts: 36.3;Syncytiotrophoblasts: 26.5"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"memory B-cell: 5.4"	"Group enriched"	"Detected in many"	39	"B-cells: 5.4;T-cells: 2.3"	"Cell line enhanced"	"Detected in many"		"hTCEpi: 19.9;RPMI-8226: 10.7"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"								"Secreted in other tissues"	NA	NA						"unprognostic (1.50e-1)"	"unprognostic (6.95e-2)"	"unprognostic (1.91e-2)"	"unprognostic (1.51e-1)"	"unprognostic (2.21e-2)"	"unprognostic (1.74e-2)"	"unprognostic (9.21e-3)"	"unprognostic (1.57e-1)"	"unprognostic (7.89e-2)"	"prognostic favorable (6.46e-5)"	"unprognostic (1.57e-1)"	"unprognostic (3.49e-2)"	"unprognostic (5.42e-2)"	"unprognostic (1.95e-1)"	"unprognostic (5.49e-2)"	"unprognostic (2.10e-1)"	"unprognostic (1.62e-2)"	0.9	0.5	0.9	0.9	0.9	0.0	3.6	0.9	0.9	2.0	3.3	0.9	0.9	2.3	0.9	9.3	3.6	3.3	2.1	0.9	0.9	0.0	1.4	0.9	2.4	0.9	0.9	0.9	1.2	17.1	6.4	1.8	2.1	0.9	1.8	4.1	0.9	4.3	2.5	0.9	2.9	2.8	0.9	0.9	0.9	3.9	0.9	0.9	242.8	8.7	0.9	0.9	2.0	1.1	5.4	0.0	0.0	0.0	0.0	2.3	0.4	3.0	0.2	0.0	0.0	0.0	0.0	4.1	0.0	0.0	0.0	0.1	3.4	4.6	0.0	0.7	0.0	0.0	1.5	2.5	3.1	0.0	0.1	0.5	0.0	0.0	0.0	0.0	2.0	0.5	0.0	19.9	0.0	4.0	0.5	0.0	1.6	2.3	1.9	0.0	1.2	0.4	0.0	0.7	1.9	0.5	0.0	0.0	10.7	2.3	3.4	0.0	0.0	1.3	3.0	0.0	4.6	1.9	0.8	0.0	0.0	0.8	0.0	0.0	0.7	1.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	1.8	0.0	2.0	5.4	2.3	1.0	0.0	0.5	0.0	0.2	0.0	0.0	0.0	0.0	0.5	0.4	0.9	0.9	0.9	0.9	0.9	0.0	0.9	0.9	0.9	0.9	8.9	7.7	0.8	9.8	5.7	0.0	0.4	7.6	2.7	3.4	14.0	0.0	36.3	1.7	6.8	0.5	0.3	16.0	0.0	15.6	21.7	0.4	6.6	5.7	0.0	3.4	0.0	4.1	0.0	0.3	0.0	0.6	0.0	5.0	0.0	17.5	1.0	10.5	19.8	0.0	0.2	0.0	0.0	0.7	1.0	5.3	5.6	26.5	0.0	14.5	7.4
PRSS2	TRY2	ENSG00000275896	"Serine protease 2"	P07478	7	142760398-142774564	"Enzymes, Plasma proteins, Predicted secreted proteins"	Digestion	"Hydrolase, Protease, Serine protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	708	"pancreas: 6267.9"	"Cell type enriched"	"Detected in some"	6	"Exocrine glandular cells: 92348.3"	"Cancer enriched"	"Detected in many"	72	"pancreatic cancer: 3463.4"					"Group enriched"	"Detected in some"	6	"basophil: 5.6;T-reg: 5.1"	"Group enriched"	"Detected in many"	6	"granulocytes: 5.6;T-cells: 5.1"	"Cell line enhanced"	"Detected in some"		"OE19: 11.6;RPMI-8226: 37.4;U-2 OS: 8.1"									"HPA062452, HPA063471"	Supported		Approved	"Endoplasmic reticulum,Vesicles"	"Secreted to digestive system"	NA	NA		27000000000	Vesicles	"Endoplasmic reticulum"	"HPA062452: AB_2684768, HPA063471: AB_2685017"	"prognostic favorable (2.32e-4)"	"unprognostic (3.80e-1)"	"unprognostic (2.46e-1)"	"unprognostic (3.30e-3)"		"unprognostic (1.99e-2)"	"unprognostic (3.06e-2)"	"unprognostic (1.36e-1)"		"unprognostic (4.62e-3)"	"unprognostic (1.48e-1)"	"unprognostic (4.65e-2)"	"unprognostic (1.55e-3)"	"unprognostic (1.58e-2)"	"unprognostic (3.50e-1)"	"unprognostic (5.36e-3)"	"unprognostic (1.18e-1)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	4.1	0.0	0.0	3.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.6	6267.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.8	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	5.6	0.0	0.7	5.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.2	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	1.4	2.4	0.2	0.0	0.0	0.0	1.1	0.0	11.6	0.0	0.0	0.0	37.4	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.1	0.5	2.1	0.0	1.6	0.2	0.0	0.0	0.0	5.6	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	5.1	0.3											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	307.0	0.0	0.0	0.0	0.0	92348.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	608.7	0.0	0.0	14696.4	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
PRSS21	"ESP-1, TEST1"	ENSG00000007038	"Serine protease 21"	Q9Y6M0	16	2817180-2826304	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Hydrolase, Protease, Serine protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"blood: 21.0;salivary gland: 20.9;testis: 37.5"	"Cell type enhanced"	"Detected in many"	17	"Late spermatids: 257.7;Spermatocytes: 426.2;Spermatogonia: 234.2"	"Cancer enhanced"	"Detected in many"		"ovarian cancer: 23.9"	"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	5	"basophil: 10.5;eosinophil: 21.0"	"Lineage enriched"	"Detected in many"	6	"granulocytes: 21.0"	"Cell line enhanced"	"Detected in some"		"CAPAN-2: 10.4;HEL: 11.6;HeLa: 29.8;K-562: 13.7;U-698: 42.2"	"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	27	"basal ganglia: 6.7"	HPA008477	Enhanced		Approved	Cytosol	"Intracellular and membrane"	NA	NA			Cytosol		"HPA008477: AB_1079697"	"unprognostic (4.35e-2)"	"unprognostic (3.46e-2)"	"unprognostic (7.06e-2)"	"unprognostic (4.28e-3)"	"unprognostic (1.19e-3)"	"unprognostic (7.02e-2)"	"unprognostic (1.22e-1)"	"unprognostic (2.61e-2)"	"unprognostic (2.33e-1)"	"unprognostic (5.21e-2)"	"unprognostic (8.83e-3)"	"unprognostic (1.52e-3)"	"unprognostic (2.97e-2)"	"unprognostic (1.14e-2)"	"unprognostic (5.07e-2)"	"unprognostic (7.79e-2)"	"unprognostic (2.99e-1)"	0.8	0.0	0.2	0.2	0.2	5.5	1.0	0.4	0.4	1.4	0.4	0.2	1.4	0.2	0.3	0.2	0.8	2.2	2.1	0.2	0.2	0.0	0.2	0.2	2.1	3.3	0.2	0.2	0.3	0.9	1.7	0.2	0.3	0.4	1.8	0.2	0.2	20.9	0.2	0.5	0.4	0.4	0.2	0.2	0.9	0.4	37.5	0.2	0.9	0.2	1.2	1.1	0.3	0.6	0.8	1.4	21.0	2.3	1.0	3.3	1.3	4.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	10.4	0.0	0.0	0.3	0.0	0.4	0.0	0.0	0.0	0.0	0.0	11.6	29.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.7	0.0	0.0	0.0	0.0	5.5	0.0	4.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	42.2	0.0	0.0	0.0	10.5	2.3	21.0	2.2	1.6	3.3	0.8	1.1	1.8	0.6	0.6	1.5	2.2	0.2	1.0	0.3	1.4	0.5	1.3	0.2	0.2	0.4	0.4	0.2	0.0	0.2	0.2	0.4	0.2	0.0	0.0	10.2	29.2	1.0	0.0	81.1	0.0	0.0	1.2	0.0	0.0	0.2	0.0	1.1	94.4	0.0	0.2	0.0	0.3	6.3	0.2	21.6	0.0	0.0	11.5	0.0	0.0	0.0	0.0	257.7	6.1	1.8	0.0	0.0	0.9	0.0	0.8	0.0	3.5	0.0	0.0	45.3	1.1	426.2	234.2	0.5	0.1	2.5	1.6	11.1
PRSS22	"BSSP-4, hBSSP-4, SP001LA"	ENSG00000005001	"Serine protease 22"	Q9GZN4	16	2852727-2858170	"Enzymes, Predicted secreted proteins"		"Hydrolase, Protease, Serine protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 40.4;lymphoid tissue: 40.1;tongue: 36.5"	"Cell type enhanced"	"Detected in many"	18	"Basal glandular cells: 187.4;Pancreatic endocrine cells: 242.0;Urothelial cells: 517.3"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in single"	16	"cerebellum: 1.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"CAPAN-2: 2.6;MCF7: 12.7;RT4: 5.9;SK-BR-3: 13.4"	"Region enhanced"	"Detected in single"		"cerebral cortex: 2.6"	"Low region specificity"	"Detected in all"			HPA049161	Approved		Approved	Nucleoplasm	"Secreted in other tissues"	NA	NA			Nucleoplasm		"HPA049161: AB_2680660"	"unprognostic (1.45e-1)"	"unprognostic (9.80e-2)"	"unprognostic (3.50e-2)"	"unprognostic (4.48e-1)"	"unprognostic (2.29e-4)"	"unprognostic (2.58e-1)"	"unprognostic (4.42e-2)"	"unprognostic (1.52e-2)"	"unprognostic (5.06e-1)"	"unprognostic (7.52e-2)"	"unprognostic (3.74e-3)"	"unprognostic (4.12e-1)"	"unprognostic (2.32e-4)"	"unprognostic (1.04e-2)"	"unprognostic (1.58e-1)"	"unprognostic (1.62e-1)"	"unprognostic (2.75e-1)"	0.4	0.7	0.0	0.4	0.0	0.6	1.3	1.5	0.4	9.9	1.0	0.0	8.6	1.5	3.0	0.6	40.4	3.0	6.8	0.4	0.0	0.0	2.4	0.7	3.0	0.4	0.0	0.0	0.4	7.5	0.4	1.1	4.3	0.0	5.1	0.6	0.0	13.4	10.6	2.3	1.3	0.4	0.7	0.0	0.4	3.5	0.4	0.0	0.0	1.5	36.5	40.1	5.2	9.6	0.0	0.0	0.0	0.0	0.0	0.5	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	12.7	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	5.9	0.0	0.0	0.0	13.4	0.0	0.0	1.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.0	3.4	0.0	187.4	20.6	0.0	0.2	33.1	8.1	23.9	15.7	0.0	30.9	1.7	101.8	0.0	0.0	4.2	0.0	86.5	19.4	0.8	63.4	0.0	0.0	2.0	0.0	3.5	0.0	0.0	0.0	0.0	0.9	6.8	1.8	5.3	0.0	242.0	10.5	0.0	0.0	0.0	0.0	1.0	0.0	0.1	24.1	8.8	0.0	5.2	517.3
PRSS23	"SIG13, SPUVE"	ENSG00000150687	"Serine protease 23"	O95084	11	86791059-86952910	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"		"Hydrolase, Protease, Serine protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	11	"Ductal cells: 178.1;Endothelial cells: 254.7;Ito cells: 438.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"gdT-cell: 36.4"	"Group enriched"	"Detected in many"	30	"NK-cells: 10.2;T-cells: 36.4"	"Cell line enhanced"	"Detected in many"		"GAMG: 114.9;hTERT-RPE1: 136.8;TIME: 116.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA030591	Uncertain				"Secreted to blood"	NA	NA		290000			"HPA030591: AB_10602067"	"unprognostic (2.68e-2)"	"unprognostic (1.20e-2)"	"unprognostic (1.90e-1)"	"unprognostic (2.04e-1)"	"unprognostic (2.40e-3)"	"prognostic unfavorable (2.12e-4)"	"unprognostic (1.89e-2)"	"unprognostic (4.30e-2)"	"unprognostic (2.08e-1)"	"unprognostic (2.09e-1)"	"prognostic unfavorable (5.56e-4)"	"unprognostic (5.35e-2)"	"prognostic unfavorable (3.06e-4)"	"unprognostic (5.13e-3)"	"unprognostic (9.44e-2)"	"unprognostic (1.99e-3)"	"unprognostic (8.01e-2)"	19.5	8.7	2.3	10.8	4.1	0.4	40.7	1.2	2.6	89.0	33.8	2.1	37.2	5.1	44.9	27.4	14.5	9.6	45.6	17.2	5.0	3.0	17.5	10.4	36.2	15.9	3.7	4.4	16.2	14.3	9.6	6.3	30.2	12.5	36.7	14.4	15.2	17.6	37.3	19.1	7.2	12.4	100.2	4.9	7.3	22.0	19.5	1.4	3.8	15.3	10.5	5.8	68.6	31.1	0.0	0.0	0.5	0.7	10.2	36.4	10.9	6.2	15.6	16.8	0.1	7.5	18.5	0.0	27.5	25.2	30.7	24.6	36.2	49.8	0.0	21.9	42.1	114.9	12.9	0.2	20.9	7.4	0.0	1.3	2.1	8.0	0.1	3.8	0.0	0.1	14.7	2.8	14.9	17.1	136.8	62.2	0.0	0.1	0.0	23.0	8.5	0.0	0.0	1.0	21.2	1.7	0.0	0.0	0.0	11.5	8.3	0.1	0.1	6.1	0.4	1.8	43.6	0.6	0.0	116.0	18.4	0.2	36.6	15.5	0.1	0.1	0.0	13.1	0.0	18.1	0.0	0.0	0.0	36.4	0.0	0.0	0.0	6.6	20.5	0.0	0.0	1.8	18.5	0.5	10.2	0.7	0.0	0.0	10.9	2.3	4.1	1.2	2.6	5.0	3.0	3.7	4.4	12.5	1.4	26.8	22.1	5.2	74.7	13.7	0.6	3.7	33.1	52.2	75.1	50.6	2.0	6.2	6.6	178.1	2.4	254.7	6.2	0.0	73.0	14.9	79.1	74.7	2.3	5.9	4.5	0.0	13.3	438.3	42.1	5.2	13.3	6.4	69.2	1.8	24.0	0.8	162.9	73.7	7.1	3.5	0.7	38.8	37.9	1.4	6.6	8.5	3.8	17.5	9.1	44.4
PRSS27	"CAPH2, MPN"	ENSG00000172382	"Serine protease 27"	Q9BQR3	16	2712418-2720551	"Enzymes, Predicted secreted proteins"		"Hydrolase, Protease, Serine protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"esophagus: 94.1;lymphoid tissue: 97.2;tongue: 64.5"	"Cell type enhanced"	"Detected in many"	5	"Alveolar cells type 1: 8.9;Horizontal cells: 11.1;Urothelial cells: 9.7"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 5.4"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"memory CD4 T-cell: 1.4;myeloid DC: 1.7"	"Group enriched"	"Detected in many"	5	"dendritic cells: 1.7;T-cells: 1.4"	"Cell line enhanced"	"Detected in some"		"BEWO: 5.6;SK-BR-3: 22.3;T-47d: 13.1;U-266/70: 4.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"CAB024920, HPA028848"	Approved		Approved	Vesicles	"Secreted to digestive system"	NA	NA			Vesicles		"CAB024920: , HPA028848: "	"unprognostic (2.10e-2)"	"unprognostic (2.15e-1)"	"unprognostic (3.46e-3)"	"unprognostic (5.35e-2)"	"unprognostic (5.25e-2)"	"unprognostic (2.48e-2)"	"unprognostic (2.56e-1)"	"unprognostic (3.12e-1)"	"unprognostic (4.66e-1)"	"unprognostic (1.08e-1)"	"unprognostic (3.79e-2)"	"unprognostic (4.40e-3)"	"unprognostic (4.03e-3)"	"unprognostic (2.40e-1)"	"unprognostic (2.26e-1)"	"unprognostic (2.04e-2)"	"unprognostic (1.28e-2)"	0.2	0.3	0.1	0.2	0.5	0.2	0.4	0.7	0.4	15.3	0.2	0.1	0.1	0.1	1.2	0.1	94.1	0.3	0.2	0.2	0.1	0.4	0.2	0.2	0.2	0.2	0.1	0.1	0.2	0.1	0.5	0.1	0.2	0.1	0.2	0.1	0.1	10.0	0.3	0.2	1.2	0.1	0.2	0.1	0.2	0.1	0.5	0.1	0.3	0.2	64.5	97.2	0.5	24.0	0.1	1.7	0.2	0.0	0.2	1.4	1.2	0.0	0.2	0.5	1.8	0.3	0.6	5.6	0.0	0.2	0.2	0.1	0.0	0.4	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.5	0.1	0.1	0.0	0.9	0.0	0.2	1.1	0.0	0.0	0.0	0.4	0.0	0.1	0.1	0.5	0.0	1.7	0.0	0.9	1.3	0.1	0.0	0.8	0.2	0.1	0.1	0.3	0.6	2.7	0.0	22.3	0.5	0.1	13.1	1.5	0.0	0.4	0.0	0.0	0.0	4.6	3.2	0.4	0.0	0.1	0.8	0.0	0.0	0.0	0.1	0.0	0.0	0.1	1.4	0.0	1.7	0.0	0.3	0.7	0.2	0.2	0.0	0.0	0.0	1.2	0.1	0.5	0.7	0.1	0.1	0.4	0.1	0.1	0.1	0.1	8.9	8.0	0.0	2.4	1.5	5.2	1.1	0.0	5.3	5.7	1.8	3.9	0.5	0.0	1.2	1.5	1.0	0.4	0.0	1.2	0.3	1.1	1.6	3.5	0.8	0.3	11.1	0.0	0.6	0.0	0.4	0.3	1.3	1.7	1.0	0.0	3.2	0.9	0.2	0.0	0.5	4.7	0.0	1.5	2.1	3.8	2.0	2.7	0.0	0.6	9.7
PRSS3	"PRSS4, TRY3, TRY4"	ENSG00000010438	"Serine protease 3"	P35030	9	33750466-33799231	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	Digestion	"Hydrolase, Protease, Serine protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	25	"pancreas: 984.9"	"Cell type enhanced"	"Detected in many"	19	"Enterocytes: 998.3;Exocrine glandular cells: 1691.4;Pancreatic endocrine cells: 545.2;Paneth cells: 388.3"	"Group enriched"	"Detected in many"	7	"colorectal cancer: 72.8;pancreatic cancer: 104.4;stomach cancer: 43.8"	"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in single"	82	"basophil: 39.0"	"Lineage enriched"	"Detected in single"	82	"granulocytes: 39.0"	"Group enriched"	"Detected in some"	5	"OE19: 46.2;PC-3: 121.2"									"HPA062452, HPA063471"	Supported		Approved	"Endoplasmic reticulum,Vesicles"	"Secreted to digestive system"	NA	NA		490000000	Vesicles	"Endoplasmic reticulum"	"HPA062452: AB_2684768, HPA063471: AB_2685017"	"unprognostic (6.90e-2)"	"unprognostic (2.26e-1)"	"unprognostic (1.69e-2)"	"prognostic unfavorable (4.30e-4)"	"unprognostic (3.18e-1)"	"unprognostic (1.64e-1)"	"unprognostic (3.29e-2)"	"unprognostic (5.89e-3)"	"unprognostic (1.38e-1)"	"unprognostic (2.06e-3)"	"unprognostic (1.10e-2)"	"unprognostic (8.94e-2)"	"unprognostic (7.75e-4)"	"unprognostic (5.46e-3)"	"unprognostic (2.13e-1)"	"unprognostic (8.79e-2)"	"unprognostic (4.96e-1)"	0.3	0.3	1.6	1.7	1.5	0.2	0.2	2.8	4.2	0.9	8.2	0.0	0.0	2.8	0.2	0.2	2.9	0.2	4.8	0.4	1.2	0.7	0.3	0.4	0.2	0.2	0.3	1.6	0.7	984.9	0.2	0.1	0.2	2.3	0.2	2.3	0.0	0.6	0.2	0.2	2.0	23.9	0.3	0.2	0.2	0.8	0.3	0.0	0.0	0.2	6.6	3.5	0.2	1.3	0.0	0.1	39.0	0.4	0.1	0.3	0.1	1.7	1.9	0.1	0.0	0.0	0.9	0.0	4.8	1.1	0.5	0.2	4.7	0.4	0.0	0.0	2.1	0.0	2.1	0.0	4.4	1.4	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.0	1.5	15.8	0.0	9.8	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	46.2	121.2	0.0	0.0	0.0	0.0	0.2	0.0	12.2	0.0	0.0	0.0	0.1	0.0	0.0	10.7	0.0	0.0	2.0	0.0	0.0	0.0	0.0	2.6	0.0	0.0	39.0	0.0	0.0	0.0	0.4	0.3	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.4	0.0	0.0	0.1	1.6	1.5	2.8	4.2	1.2	0.7	0.3	1.6	2.3	0.0	0.0	0.0	2.2	0.2	50.7	0.2	0.9	48.4	0.0	0.0	1.8	0.0	0.0	3.3	13.8	29.4	1.1	998.3	0.0	1691.4	0.0	0.4	7.0	9.2	1.0	0.0	0.0	184.8	1.3	0.3	56.5	1.4	1.2	6.8	10.0	156.0	0.0	545.2	388.3	0.7	6.7	0.0	0.0	3.1	0.5	0.4	117.2	0.1	0.0	282.9	19.5
PRSS33	EOS	ENSG00000103355	"Serine protease 33"	Q8NF86	16	2783953-2787948	"Enzymes, Predicted secreted proteins"		"Hydrolase, Protease, Serine protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	6	"blood: 132.7"	"Group enriched"	"Detected in some"	6	"Collecting duct cells: 1.8;Melanocytes: 1.7"	"Cancer enhanced"	"Detected in many"		"ovarian cancer: 8.0"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in some"	78	"eosinophil: 132.7"	"Lineage enriched"	"Detected in single"	422	"granulocytes: 132.7"	"Cell line enhanced"	"Detected in some"		"HMC-1: 4.7;hTERT-RPE1: 8.5;SK-MEL-30: 9.5;U-2 OS: 3.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"								"Secreted to blood"	NA	NA						"unprognostic (4.78e-1)"	"unprognostic (1.22e-1)"	"unprognostic (8.99e-2)"	"unprognostic (3.38e-2)"	"unprognostic (3.10e-1)"	"unprognostic (2.86e-2)"		"unprognostic (1.16e-1)"	"unprognostic (4.13e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.42e-2)"			"unprognostic (2.28e-1)"	"unprognostic (1.91e-1)"		"unprognostic (2.70e-2)"	0.0	0.0	0.3	1.1	0.3	0.1	0.1	0.2	0.4	0.2	0.2	0.2	0.0	0.8	0.1	0.0	0.1	10.2	3.6	0.0	0.1	0.1	0.3	0.0	0.2	1.1	0.1	0.0	0.4	0.0	0.0	1.0	0.0	0.0	0.0	0.2	22.5	1.9	0.0	0.0	0.0	1.8	0.8	0.0	0.7	1.1	0.9	0.2	0.2	0.2	1.0	0.2	1.0	0.0	0.0	0.0	132.7	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.7	0.0	0.0	0.0	0.0	8.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.6	0.0	0.0	0.1	0.1	0.0	0.0	9.5	0.0	0.0	0.0	0.0	0.0	3.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	132.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.0	0.0	0.0	0.0	0.3	0.3	0.2	0.4	0.1	0.1	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0
PRSS35	"C6orf158, dJ223E3.1, MGC46520"	ENSG00000146250	"Serine protease 35"	Q8N3Z0	6	83512538-83525704	"Enzymes, Predicted secreted proteins"		"Serine protease homolog"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 17.1;ovary: 16.3"	"Cell type enriched"	"Detected in some"	55	"Muller glia cells: 458.8"	"Cancer enhanced"	"Detected in some"		"testis cancer: 4.7"	"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in some"	9	"MAIT T-cell: 17.1"	"Lineage enriched"	"Detected in single"	172	"T-cells: 17.1"	"Cell line enhanced"	"Detected in some"		"BJ hTERT+: 5.2;CACO-2: 42.7;HAP1: 6.4;RPTEC TERT1: 12.6;SuSa: 9.6"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"amygdala: 4.2;cerebellum: 7.0;cerebral cortex: 7.5;hippocampal formation: 6.8;olfactory region: 5.7"	"HPA038787, HPA038788"	Uncertain				"Secreted in female reproductive system"	NA	NA					"HPA038787: AB_10675951, HPA038788: AB_2676208"	"unprognostic (6.17e-2)"	"unprognostic (8.75e-2)"	"unprognostic (1.19e-2)"	"unprognostic (2.63e-2)"	"unprognostic (1.16e-1)"	"unprognostic (4.03e-2)"	"unprognostic (3.70e-4)"	"unprognostic (6.08e-2)"	"unprognostic (1.18e-3)"	"unprognostic (2.33e-2)"	"unprognostic (7.01e-2)"	"unprognostic (9.07e-2)"	"unprognostic (3.88e-6)"	"unprognostic (7.15e-3)"	"unprognostic (5.81e-2)"	"unprognostic (2.82e-2)"	"unprognostic (3.54e-4)"	2.0	3.8	7.7	1.3	11.3	0.0	0.6	0.2	9.3	4.8	0.4	2.5	0.3	0.5	2.2	2.1	0.6	2.2	6.2	5.6	4.8	1.1	4.9	0.7	2.0	3.0	1.1	5.4	16.3	0.6	0.9	1.5	5.2	2.7	2.7	0.6	11.1	0.4	0.7	0.4	0.5	0.4	2.2	1.4	1.1	0.6	4.6	1.3	0.0	0.7	0.4	0.2	2.0	0.9	0.0	0.0	0.0	0.0	0.0	17.1	0.1	0.0	0.2	0.9	0.0	0.0	0.0	0.0	0.2	5.2	0.5	1.0	42.7	0.0	0.0	0.0	0.2	0.0	0.0	6.4	0.0	0.3	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	1.6	0.0	0.6	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.8	0.2	4.1	0.0	0.0	0.0	12.6	0.0	0.0	0.5	0.0	0.0	0.0	9.6	0.0	0.0	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.0	0.0	17.1	0.0	0.3	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	7.7	11.3	0.2	7.1	4.8	1.1	1.1	5.4	2.7	1.3	3.0	0.3	0.0	0.0	0.0	2.3	1.2	0.0	0.0	0.0	1.8	0.0	0.1	8.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	3.1	0.0	0.0	0.0	0.3	6.4	1.7	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	458.8	0.0	0.0	8.1	0.0	7.1	6.5	1.2	0.0	0.2	0.0	0.1	0.0	0.0	0.0
PRSS36	FLJ90661	ENSG00000178226	"Serine protease 36"	Q5K4E3	16	31138925-31150094	"Enzymes, Predicted secreted proteins"		"Hydrolase, Protease, Serine protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	10	"Enterocytes: 22.2;Hofbauer cells: 15.2;Paneth cells: 17.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Cell type enhanced"	"Detected in some"		"eosinophil: 4.3"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"HEL: 2.2;HeLa: 6.5;HMC-1: 2.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA036079	Uncertain				"Secreted - unknown location"	NA	NA					"HPA036079: AB_10602290"	"unprognostic (3.74e-2)"	"prognostic favorable (2.97e-7)"	"unprognostic (1.43e-1)"	"unprognostic (1.20e-2)"	"unprognostic (4.26e-3)"	"unprognostic (1.31e-5)"	"unprognostic (4.18e-2)"	"unprognostic (5.05e-2)"	"unprognostic (2.65e-2)"	"unprognostic (8.03e-2)"	"unprognostic (2.08e-1)"	"unprognostic (1.23e-1)"	"unprognostic (1.32e-3)"	"unprognostic (2.39e-1)"	"unprognostic (9.86e-2)"	"unprognostic (1.23e-1)"	"unprognostic (3.13e-1)"	3.0	2.0	0.4	1.0	1.2	1.1	6.2	0.4	1.8	1.6	1.8	0.4	0.4	3.2	0.4	1.8	1.2	0.5	0.4	2.1	0.4	0.5	0.5	0.7	2.3	0.4	0.4	0.4	1.7	0.4	0.4	6.5	2.5	0.4	1.0	0.9	0.4	3.5	0.4	1.3	3.4	2.1	1.2	0.4	0.4	1.0	0.7	0.4	0.4	0.6	0.4	1.0	2.0	0.4	0.0	2.1	4.3	0.8	0.2	0.4	0.1	0.2	0.2	0.1	0.1	0.1	0.1	0.3	0.3	0.3	0.2	0.1	0.4	1.4	0.0	0.9	0.4	0.4	1.4	0.1	0.2	0.0	0.2	0.6	2.2	6.5	1.2	0.1	0.3	2.9	0.2	0.1	0.2	0.2	0.2	0.2	0.4	0.1	0.0	0.2	0.5	0.0	0.3	0.4	0.8	0.1	0.5	0.1	0.0	0.0	0.2	0.3	0.0	0.6	0.7	0.0	0.0	0.1	1.2	0.2	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.8	4.3	0.2	0.1	0.1	0.0	0.0	0.0	2.1	0.0	0.1	0.4	2.6	0.2	0.0	0.6	0.1	0.1	0.4	1.2	0.4	1.8	0.4	0.5	0.4	0.4	0.4	0.4	0.0	1.4	0.0	2.5	1.6	0.0	1.1	0.0	0.0	1.2	0.0	0.0	0.6	0.0	1.4	1.3	0.6	22.2	0.0	2.5	1.0	0.4	2.1	0.0	2.6	15.2	0.0	0.0	1.3	4.1	0.4	2.6	2.3	0.0	7.2	2.0	0.5	1.3	17.5	2.5	1.1	0.0	0.0	0.3	0.7	2.5	2.3	0.5	0.0	2.3	1.7
PRSS37		ENSG00000165076	"Serine protease 37"	A4D1T9	7	141836286-141841487	"Disease related genes, Enzymes, Potential drug targets, Predicted secreted proteins"	Fertilization			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in single"	127	"testis: 39.1"	"Group enriched"	"Detected in some"	164	"Early spermatids: 641.3;Late spermatids: 239.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HL-60: 2.3;U-937: 1.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA020541	Enhanced				"Secreted in male reproductive system"	NA	NA					"HPA020541: AB_1853004"	"unprognostic (4.70e-2)"	"unprognostic (5.56e-2)"	"unprognostic (2.69e-1)"		"unprognostic (2.41e-1)"			"unprognostic (3.21e-2)"		"unprognostic (1.30e-1)"	"unprognostic (2.74e-2)"	"unprognostic (1.23e-2)"	"unprognostic (8.30e-7)"	"unprognostic (1.42e-1)"	"unprognostic (2.06e-1)"	"unprognostic (2.72e-2)"		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	39.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	2.3	0.0	0.0	0.6	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.3	0.0	0.2	0.0	0.0	0.3	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	641.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	239.1	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	2.7	1.0	0.0	0.0	0.0	0.0	0.0
PRSS38	MPN2	ENSG00000185888	"Serine protease 38"	A1L453	1	227815693-227846470	"Enzymes, Predicted secreted proteins"		"Hydrolase, Protease, Serine protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	19	"blood: 2.2;testis: 8.4"	"Group enriched"	"Detected in some"	10	"Spermatocytes: 9.6;Spermatogonia: 8.5"	"Not detected"	"Not detected"							"Group enriched"	"Detected in some"	18	"gdT-cell: 1.4;NK-cell: 2.2"	"Group enriched"	"Detected in many"	18	"NK-cells: 2.2;T-cells: 1.4"	"Cell line enriched"	"Detected in single"	20	"U-266/84: 5.2"	"Not detected"	"Not detected"							"HPA028003, HPA055809"	Enhanced				"Secreted in male reproductive system"	NA	NA					"HPA028003: AB_1853572, HPA055809: AB_2682931"										"unprognostic (9.54e-3)"					"unprognostic (3.61e-3)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	8.4			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	5.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.6	8.5	0.0	0.0	0.0	0.0	0.0
PRSS41	TESSP1	ENSG00000215148	"Serine protease 41"	Q7RTY9	16	2798485-2805302	"Enzymes, Predicted intracellular proteins"		"Hydrolase, Protease, Serine protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"blood: 11.6;testis: 4.0"	"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in some"		"testis cancer: 1.8"					"Cell type enriched"	"Detected in single"	116	"eosinophil: 11.6"	"Lineage enriched"	"Detected in single"	116	"granulocytes: 11.6"	"Cell line enriched"	"Detected in single"	11	"BEWO: 6.5"															NA	NA								"unprognostic (1.58e-1)"	"unprognostic (3.65e-1)"		"unprognostic (3.04e-3)"				"unprognostic (1.03e-1)"	"unprognostic (1.71e-2)"			"unprognostic (1.69e-1)"	"unprognostic (1.98e-1)"		"unprognostic (1.24e-2)"	0.0	0.0		0.1		0.0	0.1		0.0	0.0	0.1			0.0	0.0	0.0	0.0	0.3	0.0	0.0			0.0	0.0	0.0	0.0			0.0	0.0	0.0		0.0		0.0	0.0		1.7	0.0	0.0	0.0	0.1	0.0		0.0	1.2	4.0			0.0		0.0	0.0		0.0	0.0	11.6	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	6.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	11.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
PRSS42	TESSP2	ENSG00000178055	"Serine protease 42"	Q7Z5A4	3	46829542-46834095	"Enzymes, Predicted secreted proteins"	"Differentiation, Spermatogenesis"	"Hydrolase, Protease, Serine protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at transcript level"		"Group enriched"	"Detected in some"	5	"heart muscle: 12.9;skeletal muscle: 19.2"	"Cell type enriched"	"Detected in single"	4	"Cardiomyocytes: 2.5"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"CAPAN-2: 2.3;Daudi: 4.0;Karpas-707: 2.5;NTERA-2: 3.7"									HPA046925	Uncertain				"Secreted - unknown location"	NA	NA					"HPA046925: AB_10961401"	"unprognostic (6.53e-2)"	"unprognostic (2.72e-2)"	"unprognostic (3.57e-3)"	"unprognostic (9.14e-2)"	"unprognostic (3.26e-1)"		"unprognostic (2.37e-2)"	"unprognostic (1.85e-1)"	"unprognostic (6.54e-2)"	"unprognostic (4.26e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.12e-1)"	"unprognostic (1.45e-1)"	"unprognostic (1.09e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.62e-1)"	"unprognostic (7.98e-2)"	0.2	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.6	0.2			0.0	0.2	3.4	0.0	0.2	0.0	12.9	0.0	0.0	1.3	0.5	0.2	0.0	0.0		0.2	0.2	1.6	0.0	0.1		0.4	0.0		0.3	0.2	19.2	0.0	0.0	0.0	0.0	0.4	0.0	0.7			0.8		0.0	0.0	0.6	0.4	0.0	0.0	0.1	0.0	0.6	0.0	0.0	0.0	0.1	0.0	0.8	0.2	1.6	0.0	0.0	0.0	0.7	0.2	2.3	4.0	0.4	0.0	0.1	0.0	0.0	0.2	1.4	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	2.5	0.0	0.0	0.0	0.4	3.7	0.5	0.0	1.3	0.0	0.0	0.1	0.0	0.6	0.5	0.5	0.0	0.3	1.2	0.0	0.5	0.0	1.0	0.7	0.0	0.0	0.0	0.3	0.9	0.1	0.0	0.3	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.6	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.2	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.1
PRSS45	TESSP5	ENSG00000188086	"Serine protease 45"	Q7RTY3	3	46742092-46744755	"Enzymes, Predicted intracellular proteins"		"Hydrolase, Protease, Serine protease"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"epididymis: 7.6;skeletal muscle: 6.7"	"Cell type enhanced"	"Detected in some"	14	"Late spermatids: 1.1;Melanocytes: 1.7;Spermatocytes: 1.9;Spermatogonia: 1.2"	"Low cancer specificity"	"Detected in single"							"Cell type enriched"	"Detected in single"	19	"naive B-cell: 1.9"	"Lineage enriched"	"Detected in single"	19	"B-cells: 1.9"	"Cell line enhanced"	"Detected in some"		"Daudi: 1.1;HHSteC: 2.4;OE19: 1.7;SuSa: 1.1"									HPA060284	Uncertain					NA	NA					"HPA060284: AB_2684242"	"unprognostic (4.55e-3)"	"unprognostic (3.49e-2)"	"unprognostic (1.07e-2)"	"unprognostic (2.50e-1)"	"unprognostic (6.07e-2)"	"unprognostic (1.28e-2)"	"unprognostic (1.06e-1)"	"unprognostic (6.20e-2)"	"unprognostic (1.54e-1)"	"unprognostic (1.30e-1)"	"unprognostic (3.83e-4)"	"unprognostic (2.33e-2)"	"unprognostic (6.60e-3)"	"unprognostic (1.27e-2)"	"unprognostic (1.57e-2)"	"unprognostic (2.15e-1)"	"unprognostic (5.97e-3)"	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	1.5	0.2			0.1	0.2	7.6	0.1	0.8	0.0	0.2	0.0	0.0	0.9	0.7	0.2	0.1	0.0		0.3	1.3	2.0	0.5	0.1		0.5	0.0		0.5	0.3	6.7	0.3	0.0	0.0	0.0	0.0	0.2	1.6			3.2		0.0	0.4	0.4	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.6	0.3	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.6	0.4	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	1.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.2	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.1	0.0	0.0	1.7	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	1.2	0.0	0.0	0.0	0.0	0.0
PRSS48	ESSPL	ENSG00000189099	"Serine protease 48"	Q7RTY5	4	151277171-151291453	"Enzymes, Predicted membrane proteins, Predicted secreted proteins"		"Hydrolase, Protease, Serine protease"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Group enriched"	"Detected in some"	5	"brain: 1.0;skin 1: 1.9;testis: 4.1"	"Cell type enriched"	"Detected in some"	6	"Sertoli cells: 6.5"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HHSteC: 1.4;LHCN-M2: 1.4;PC-3: 1.5;RT4: 1.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA053801	Uncertain				"Secreted in male reproductive system"	NA	NA					"HPA053801: AB_2682267"			"unprognostic (9.68e-2)"		"unprognostic (1.35e-2)"			"unprognostic (2.15e-1)"		"unprognostic (2.18e-2)"				"unprognostic (3.76e-2)"	"unprognostic (4.10e-2)"			0.0	0.0	0.5	0.0	1.0	0.0	0.0	0.0	0.9	0.0	0.1			0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.7	0.1	0.0	0.0	0.1	0.0	0.2		0.0	0.0	0.0	0.0	0.1		0.0	0.0		0.0	0.3	0.0	1.9	0.0	0.0	0.5	0.0	0.0	4.1			0.0		0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	1.4	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.6	0.0	1.5	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.3	6.5	0.0	1.1	1.1	0.0	0.0	0.0	0.0	0.0
PRSS50	"CT20, TSP50"	ENSG00000206549	"Serine protease 50"	Q9UI38	3	46712115-46812574	"Enzymes, Predicted intracellular proteins"		"Hydrolase, Protease, Threonine protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"testis: 22.3"	"Not detected"	"Not detected"			"Low cancer specificity"	"Detected in many"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"NTERA-2: 2.4;SuSa: 1.8"									HPA040768	Supported					NA	NA					"HPA040768: AB_2677126"	"unprognostic (1.19e-2)"	"unprognostic (1.63e-1)"	"unprognostic (1.63e-2)"	"unprognostic (7.59e-3)"	"unprognostic (4.32e-1)"	"unprognostic (7.45e-2)"	"unprognostic (9.24e-2)"	"unprognostic (1.37e-1)"	"unprognostic (6.77e-2)"	"unprognostic (2.23e-1)"	"unprognostic (8.91e-4)"	"unprognostic (1.08e-1)"	"unprognostic (1.46e-3)"	"unprognostic (2.68e-2)"	"unprognostic (1.79e-2)"	"unprognostic (9.36e-2)"	"unprognostic (3.66e-3)"	0.1	0.7	0.0	0.0	0.0	0.0	0.6	0.4	0.3	1.3	0.2			0.1	0.7	6.2	0.1	0.5	0.0	0.9	0.0	0.6	1.8	0.7	0.2	0.0	0.0		0.7	1.7	4.7	8.2	0.0		1.6	0.0		1.7	1.7	7.7	0.0	0.0	0.2	0.0	0.0	0.2	22.3			7.9		0.0	0.2	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.1	0.0	0.3	0.5	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.2	0.0	0.0	0.2	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	2.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.5	0.3	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
PRSS50	"CT20, TSP50"	ENSG00000283706	"Serine protease 50"	Q9UI38	3	46712115-46717907	"Enzymes, Predicted intracellular proteins"		"Hydrolase, Protease, Threonine protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	11	"testis: 33.4"	"Group enriched"	"Detected in some"	5	"Spermatocytes: 155.2;Spermatogonia: 236.5"									"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"EFO-21: 2.1;HMC-1: 5.4;NTERA-2: 2.1"									HPA040768	Supported				"Intracellular and membrane"	NA	NA					"HPA040768: AB_2677126"																		0.1	0.8	0.1	0.1	0.1	0.0	0.2	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	2.9	0.1	0.2	0.1	0.1	0.1		0.2	0.1	0.1	0.1	0.3	0.1	0.3	0.9	1.7	1.1	0.1	0.1	0.2	0.0	0.1	1.6	1.8	0.1	0.0	0.1	0.1	0.1	0.1	0.0	33.4	0.1	0.4	1.6	0.1	0.2	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.7	0.1	0.1	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	2.1	0.2	0.1	0.0	0.0	0.0	0.3	0.9	0.4	0.0	0.0	0.0	0.4	0.0	5.4	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.1	0.0	0.0	0.0	0.0	2.1	0.2	0.0	0.2	0.1	0.0	0.0	0.1	0.3	0.5	0.0	0.2	0.2	0.9	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1											0.0	0.0	0.0	0.5	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	18.3	2.8	0.0	0.0	0.0	0.0	0.8	0.0	0.0	1.4	0.0	0.0	38.8	0.0	155.2	236.5	0.0	0.0	0.0	0.0	0.3
PRSS51		ENSG00000253649	"Serine protease 51"	A0A1B0GVH4	8	10482878-10547585	"Enzymes, Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"No human protein/transcript evidence"		"Group enriched"	"Detected in some"	5	"brain: 1.4;breast: 3.4;liver: 1.5;testis: 2.3"	"Group enriched"	"Detected in some"	27	"Early spermatids: 3.2;Late spermatids: 2.1"	"Low cancer specificity"	"Detected in many"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AN3-CA: 1.7;CAPAN-2: 1.6;OE19: 1.7;T-47d: 1.9;U-2 OS: 5.1"														"Secreted - unknown location"	NA	NA						"unprognostic (2.52e-1)"	"unprognostic (3.00e-1)"	"unprognostic (3.10e-1)"	"unprognostic (1.90e-1)"	"unprognostic (1.06e-1)"	"unprognostic (2.22e-2)"	"unprognostic (2.72e-1)"	"unprognostic (7.48e-2)"	"unprognostic (1.64e-1)"	"unprognostic (7.94e-2)"	"unprognostic (1.02e-1)"	"unprognostic (6.33e-3)"	"unprognostic (2.71e-3)"	"unprognostic (7.47e-2)"	"unprognostic (3.42e-1)"	"unprognostic (1.08e-1)"	"unprognostic (1.06e-1)"	0.0	0.0		0.0		0.4	3.4		1.4	0.0	0.0			0.4	0.0	0.0	0.0	0.0	0.0	0.0			0.0	1.5	0.0	0.0			0.0	0.0	0.0		0.0		0.0	0.0		0.0	0.0	0.0	0.2	0.0	0.0		0.1	0.0	2.3			0.0		0.0	0.0		0.0	0.0	0.3	0.0	0.0	0.1	0.2	0.0	0.0	0.3	1.7	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	1.6	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.3	1.7	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.6	0.0	0.0	5.1	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.3	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.2											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
PRSS53	POL3S	ENSG00000151006	"Serine protease 53"	Q2L4Q9	16	31083425-31089628	"Enzymes, Predicted secreted proteins"		"Hydrolase, Protease, Serine protease"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"liver: 10.9"	"Cell type enhanced"	"Detected in some"	10	"Leydig cells: 1.7;Peritubular cells: 1.1;Suprabasal keratinocytes: 1.3"	"Low cancer specificity"	"Detected in some"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"SCLC-21H: 10.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA034955, HPA034956"	Uncertain				"Secreted - unknown location"	NA	NA					"HPA034955: AB_2674380, HPA034956: AB_10696365"	"unprognostic (3.13e-1)"	"unprognostic (4.15e-1)"	"unprognostic (3.88e-3)"	"unprognostic (1.62e-1)"	"unprognostic (1.20e-1)"	"unprognostic (1.63e-2)"	"unprognostic (1.84e-1)"	"unprognostic (2.63e-2)"	"unprognostic (1.04e-2)"	"unprognostic (2.87e-2)"	"unprognostic (2.72e-2)"	"unprognostic (1.63e-4)"	"unprognostic (2.53e-12)"	"unprognostic (1.02e-1)"	"unprognostic (2.01e-1)"	"unprognostic (1.37e-1)"	"unprognostic (1.16e-1)"	0.3	0.0	0.0	0.5	0.3	0.0	0.1	2.9	0.4	0.2	0.3			1.4	1.0	0.0	0.1	0.3	0.6	0.2	0.1	0.3	0.6	10.9	0.5	0.9	0.1		0.3	2.2	0.0	0.8	0.2		1.2	0.0		0.0	0.8	0.0	3.9	0.5	0.4	0.2	1.0	1.3	0.0			0.3		0.0	0.5	0.3	0.3	0.0	0.0	0.0	0.0	0.4	0.8	0.3	0.0	0.3	0.0	0.0	0.0	1.0	0.5	1.2	1.0	0.0	0.2	0.0	0.3	0.7	0.0	0.0	1.3	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.3	0.0	0.8	0.5	0.0	0.0	0.0	0.0	1.7	0.1	0.3	0.1	1.3	0.3	1.6	0.8	0.0	2.0	1.6	0.0	0.0	0.0	0.0	10.0	0.8	0.9	0.0	1.0	0.0	0.8	0.1	0.7	1.0	0.7	2.5	0.2	1.4	0.1	0.3	2.5	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.8											0.0	0.0	0.0	0.2	0.3	0.2	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.8	0.1	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.2	0.3	0.0	1.1	0.0	0.3	0.0	0.3	0.0	0.0	1.3	0.0	0.7	0.1	0.3
PRSS54	"CT67, FLJ25339, KLKBL4"	ENSG00000103023	"Serine protease 54"	Q6PEW0	16	58279997-58295047	"Enzymes, Predicted intracellular proteins, Predicted secreted proteins"		"Serine protease homolog"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	95	"testis: 35.1"	"Group enriched"	"Detected in some"	63	"Early spermatids: 433.8;Late spermatids: 185.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"BEWO: 1.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			HPA041549	Enhanced				"Secreted in male reproductive system"	NA	NA					"HPA041549: AB_10795640"	"unprognostic (1.13e-1)"			"unprognostic (3.24e-2)"	"unprognostic (3.09e-2)"				"unprognostic (3.08e-1)"	"unprognostic (4.88e-2)"			"unprognostic (1.23e-1)"					0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	35.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.2	0.0	0.0	0.8	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.1	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	433.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	185.3	4.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.9	0.0	0.0	0.0	0.0	2.6	2.2	0.0	0.0	0.0	0.0	0.0
PRSS55	"CT153, T-SP1, UNQ9391"	ENSG00000184647	"Serine protease 55"	Q6UWB4	8	10525546-10554166	"Enzymes, Predicted intracellular proteins"		"Hydrolase, Protease, Serine protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	67	"testis: 25.5"	"Cell type enriched"	"Detected in some"	5	"Early spermatids: 179.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"								"Intracellular and membrane"	NA	NA									"unprognostic (3.64e-1)"	"unprognostic (8.44e-3)"					"unprognostic (6.10e-2)"	"unprognostic (7.40e-2)"		"unprognostic (6.23e-5)"	"unprognostic (6.62e-2)"				0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	25.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	179.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	37.4	1.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.1	0.0	0.0	0.0	0.0	1.5	1.2	0.0	0.0	0.0	0.0	0.0
PRSS56		ENSG00000237412	"Serine protease 56"	P0CW18	2	232520463-232525716	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		"Hydrolase, Protease, Serine protease"	"Disease mutation, Microphthalmia"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 4.4;retina: 8.6;skeletal muscle: 16.2"	"Group enriched"	"Detected in some"	22	"Early spermatids: 30.4;Muller glia cells: 49.6"	"Cancer enhanced"	"Detected in many"		"urothelial cancer: 4.7"	"Region enhanced"	"Detected in many"		"hypothalamus: 4.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	5	"Daudi: 4.8"	"Group enriched"	"Detected in some"	10	"basal ganglia: 1.6;olfactory region: 5.2"	"Region enhanced"	"Detected in many"		"olfactory region: 32.6"							NA	NA								"unprognostic (3.26e-1)"	"unprognostic (1.98e-2)"	"unprognostic (1.31e-1)"	"unprognostic (3.73e-3)"			"unprognostic (2.28e-1)"	"unprognostic (7.15e-2)"				"unprognostic (4.64e-2)"	"unprognostic (1.20e-1)"			0.1	0.1	0.3	0.1	1.8	0.1	0.1	0.1	1.0	0.1	0.1	0.1	0.1	0.1	0.1	1.1	0.1	0.1	0.1	0.1	0.2	4.4	0.1	0.1	0.1	0.1	2.2	0.1	0.6	0.1	0.1	0.1	0.1	0.1	0.2	0.1	8.6	0.1	0.1	16.2	0.1	0.1	0.1	0.8	0.2	0.1	2.6	0.1	1.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	4.8	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.8	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	1.8	0.1	1.0	0.2	4.4	2.2	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.2	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	30.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	49.6	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0
PRSS57	"PRSSL1, UNQ782"	ENSG00000185198	"Serine protease 57"	Q6UWY2	19	685546-695498	"Enzymes, Predicted secreted proteins"		"Heparin-binding, Hydrolase, Protease, Serine protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	7	"bone marrow: 61.8"	"Not detected"	"Not detected"			"Cancer enriched"	"Detected in single"	10	"pancreatic cancer: 2.2"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in many"		"basophil: 8.7"	"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in some"	13	"NB-4: 87.1;THP-1: 43.7"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"								"Secreted to blood"	NA	NA						"unprognostic (2.89e-1)"	"unprognostic (1.43e-1)"		"unprognostic (2.10e-1)"		"unprognostic (3.99e-4)"	"unprognostic (3.07e-1)"	"unprognostic (1.33e-2)"	"unprognostic (3.50e-2)"	"unprognostic (4.04e-2)"	"unprognostic (7.70e-2)"	"unprognostic (3.80e-1)"	"unprognostic (1.11e-1)"	"unprognostic (3.46e-2)"	"unprognostic (8.16e-2)"	"unprognostic (2.56e-2)"		0.3	0.2	0.0	0.0	0.0	61.8	0.2	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.4	0.6	0.0	3.9	0.0	0.1	0.2	0.8	4.0	0.1	0.1	0.0	0.9	0.0	0.0	0.1	0.4	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	5.1	0.0	0.2	0.0	9.3	0.3	0.0	0.9	0.0	0.2	0.0	2.2	8.7	1.6	3.1	4.5	4.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.2	0.0	0.0	0.0	1.8	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	87.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	43.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	8.7	1.6	0.0	0.6	0.3	0.0	0.0	0.0	4.5	2.2	0.0	0.0	0.8	1.0	3.1	0.0	0.1	0.0	4.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
PRSS58	TRYX3	ENSG00000258223	"Serine protease 58"	Q8IYP2	7	142252143-142258058	"Enzymes, Predicted secreted proteins"		"Hydrolase, Protease, Serine protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	85	"testis: 27.2"	"Group enriched"	"Detected in some"	128	"Early spermatids: 636.2;Late spermatids: 161.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	22	"RH-30: 2.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"								"Secreted in male reproductive system"	NA	NA																							0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	27.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	636.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	161.5	3.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	2.5	1.4	0.0	0.0	0.0	0.0	0.0
PRSS8		ENSG00000052344	"Serine protease 8"	Q16651	16	31131433-31135762	"Enzymes, Predicted membrane proteins, Predicted secreted proteins"		"Hydrolase, Protease, Serine protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 123.2;salivary gland: 143.7"	"Cell type enhanced"	"Detected in many"	8	"Enterocytes: 330.0;Extravillous trophoblasts: 497.6;Syncytiotrophoblasts: 376.9"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in single"	4	"pons and medulla: 3.4"	"Cell type enhanced"	"Detected in single"		"neutrophil: 1.0"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"BEWO: 58.3;CACO-2: 38.3;CAPAN-2: 26.3;hTCEpi: 37.6;SK-BR-3: 44.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA030436	Uncertain				"Secreted - unknown location"	NA	NA		3500000			"HPA030436: AB_10602291"	"unprognostic (1.88e-1)"	"unprognostic (2.97e-1)"	"unprognostic (9.34e-2)"	"unprognostic (4.08e-1)"	"unprognostic (6.83e-2)"	"unprognostic (5.07e-3)"	"unprognostic (5.78e-2)"	"unprognostic (2.05e-1)"	"unprognostic (2.26e-1)"	"unprognostic (4.51e-2)"	"unprognostic (8.74e-3)"	"unprognostic (1.58e-1)"	"prognostic favorable (2.05e-10)"	"unprognostic (1.89e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.31e-1)"	"unprognostic (3.63e-3)"	0.3	0.2	0.3	11.5	0.3	0.0	7.6	0.7	0.4	8.0	72.6	0.6	12.8	31.6	3.4	46.7	37.2	2.8	45.3	0.3	0.4	0.3	48.0	20.3	30.0	0.3	0.3	0.3	1.3	46.3	2.7	2.6	93.1	3.4	11.4	14.7	1.1	143.7	7.4	0.3	29.7	123.2	0.5	0.3	0.3	37.0	1.8	0.3	11.3	33.4	18.4	26.7	2.6	13.4	0.2	0.0	1.0	0.3	0.0	0.2	0.0	14.4	0.0	0.0	0.0	0.0	0.0	58.3	0.0	0.0	0.0	0.0	38.3	26.3	0.0	0.3	0.0	0.0	17.3	0.0	16.2	0.0	0.0	0.1	0.0	0.0	1.4	0.0	0.0	0.0	0.0	37.6	0.0	0.5	0.0	0.0	0.0	0.4	0.0	0.0	15.5	0.1	0.3	4.8	18.3	0.0	0.1	0.0	0.2	1.8	3.0	0.2	0.1	0.0	44.2	0.0	4.7	10.1	0.2	0.0	0.0	0.4	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.7	0.4	0.4	0.3	0.3	0.3	3.4	0.3	92.3	62.1	0.9	60.6	33.7	0.6	0.3	53.5	9.4	53.4	40.1	0.0	127.8	24.9	145.8	0.0	0.7	330.0	23.3	197.1	497.6	3.6	80.0	6.9	12.8	20.5	0.0	9.2	0.0	0.3	0.0	0.6	2.5	3.3	7.2	109.4	0.3	182.1	150.8	0.0	24.9	0.0	0.0	3.1	0.0	0.1	47.2	376.9	1.3	110.4	79.5
PRTN3	"ACPA, AGP7, C-ANCA, MBT, P29, PR-3"	ENSG00000196415	"Proteinase 3"	P24158	19	840960-848175	"Candidate cardiovascular disease genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins"	"Collagen degradation"	"Hydrolase, Protease, Serine protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"bone marrow: 167.3"	"Cell type enhanced"	"Detected in some"	23	"Cholangiocytes: 2.5;Kupffer cells: 1.2"	"Cancer enhanced"	"Detected in single"		"stomach cancer: 1.0"	"Low region specificity"	"Detected in some"			"Cell type enriched"	"Detected in single"	8	"neutrophil: 1.9"	"Lineage enriched"	"Detected in single"	8	"granulocytes: 1.9"	"Cell line enriched"	"Detected in some"	5	"THP-1: 151.5"	"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			"HPA005938, CAB017558"	Enhanced		Approved	Vesicles,Cytosol	"Secreted to blood"	NA	NA		120000	Cytosol	Vesicles	"CAB017558: AB_2172317, HPA005938: AB_1855764"	"unprognostic (2.81e-2)"			"unprognostic (2.10e-1)"	"unprognostic (3.83e-3)"		"unprognostic (4.20e-1)"	"unprognostic (3.31e-2)"		"unprognostic (3.34e-1)"	"unprognostic (9.98e-3)"	"unprognostic (3.67e-2)"	"unprognostic (8.62e-6)"	"unprognostic (5.31e-2)"	"unprognostic (2.00e-1)"	"unprognostic (5.14e-2)"		0.3	0.2	0.9	0.2	1.0	167.3	0.2	0.0	2.3	0.2	0.2	0.7	0.0	0.2	0.2	0.2	0.2	0.2	0.2	31.0	0.3	0.6	0.2	1.7	8.1	3.5	0.1	0.1	0.4	0.2	0.2	0.8	4.2	0.8	0.2	0.2	0.3	0.3	0.2	0.5	0.3	0.2	0.2	0.0	25.5	0.2	0.2	0.1	35.0	0.9	0.0	0.2	0.2	0.0	0.0	0.0	1.9	0.1	0.0	0.2	6.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	28.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	151.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	6.8	0.9	1.0	0.0	2.3	0.3	0.6	0.1	0.1	0.8	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.2	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
PRUNE1	"DRES-17, H-PRUNE, HTCD37, PRUNE"	ENSG00000143363	"Prune exopolyphosphatase 1"	Q86TP1	1	151008420-151035713	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		Hydrolase	"Disease mutation, Mental retardation, Neurodegeneration, Primary microcephaly"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"	7	"Alveolar cells type 2: 8.8;Collecting duct cells: 10.4;Proximal tubular cells: 6.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"U-698: 62.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA028411	Uncertain		Supported	Cytosol		NA	NA		210000	Cytosol		"HPA028411: AB_10603229"	"unprognostic (6.24e-2)"	"unprognostic (2.24e-1)"	"unprognostic (4.17e-2)"	"prognostic unfavorable (3.86e-4)"	"unprognostic (6.91e-2)"	"unprognostic (2.02e-1)"	"unprognostic (2.12e-3)"	"unprognostic (7.05e-2)"	"unprognostic (4.08e-2)"	"unprognostic (5.92e-2)"	"unprognostic (1.73e-1)"	"unprognostic (2.65e-1)"	"prognostic unfavorable (3.48e-4)"	"unprognostic (2.18e-1)"	"unprognostic (3.21e-2)"	"unprognostic (2.42e-2)"	"unprognostic (1.36e-1)"	9.3	9.7	9.3	8.8	11.6	3.7	16.0	15.7	16.4	15.0	12.5	10.9	16.2	11.7	17.9	15.7	11.5	15.6	12.8	31.3	10.5	10.3	18.0	12.8	10.1	11.8	11.9	9.2	17.1	16.2	16.5	16.2	7.2	8.8	12.2	14.0	12.7	13.3	18.2	24.4	10.5	11.8	14.7	7.9	11.0	10.5	16.3	8.6	15.0	41.6	8.5	12.9	13.8	13.6	12.1	9.5	14.7	8.9	14.3	19.0	18.3	3.9	4.2	7.5	7.2	9.4	2.6	4.2	1.9	4.1	7.0	6.1	5.1	4.7	8.1	8.2	2.5	2.0	5.7	7.3	4.9	5.6	8.7	8.3	9.5	4.4	7.4	5.1	6.2	4.8	3.2	9.3	3.7	3.6	5.8	3.3	10.7	7.4	6.8	3.3	9.4	9.5	5.1	7.0	14.3	5.5	8.7	4.8	7.7	5.0	5.4	10.9	8.9	6.3	8.8	5.8	11.1	12.1	9.4	2.3	2.5	3.0	2.7	2.9	16.6	14.0	62.0	2.4	4.7	6.2	12.5	6.4	13.4	14.0	6.0	16.9	12.1	15.5	15.7	9.5	11.6	19.0	15.0	14.7	14.3	8.9	5.1	14.5	18.3	9.3	11.6	15.7	16.4	10.5	10.3	11.9	9.2	8.8	8.6	6.0	8.8	0.0	0.0	0.0	0.0	0.0	0.0	5.3	5.7	10.4	0.0	3.6	0.0	4.9	0.0	0.0	0.0	0.0	4.9	3.8	0.0	0.0	0.0	0.0	4.4	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.0	2.8	0.0	0.0	5.1	0.0	0.0	6.5	0.0	0.0	0.0	0.0	0.0	0.0	4.2	0.0	0.0	0.0
PSAT1	PSA	ENSG00000135069	"Phosphoserine aminotransferase 1"	Q9Y617	9	78297143-78330093	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Amino-acid biosynthesis, Serine biosynthesis"	"Aminotransferase, Transferase"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 56.0;liver: 112.2"	"Cell type enhanced"	"Detected in many"	15	"Hepatocytes: 129.9;Proximal tubular cells: 244.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"T-reg: 13.3"	"Lineage enriched"	"Detected in many"	4	"T-cells: 13.3"	"Cell line enhanced"	"Detected in many"		"hTCEpi: 147.9;SK-MEL-30: 90.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB014882, CAB040567, HPA042924"	Enhanced		Enhanced	Cytosol		NA	NA		1700000	Cytosol		"CAB014882: , CAB040567: , HPA042924: AB_2678223"	"unprognostic (8.26e-3)"	"unprognostic (4.69e-2)"	"unprognostic (1.46e-1)"	"prognostic unfavorable (5.62e-5)"	"unprognostic (4.05e-3)"	"unprognostic (1.41e-1)"	"unprognostic (2.21e-3)"	"unprognostic (1.86e-1)"	"unprognostic (9.85e-2)"	"unprognostic (2.25e-2)"	"unprognostic (4.53e-2)"	"unprognostic (1.07e-1)"	"prognostic unfavorable (6.00e-7)"	"unprognostic (3.87e-3)"	"unprognostic (1.21e-1)"	"unprognostic (8.07e-3)"	"unprognostic (1.71e-1)"	3.1	25.0	44.6	3.8	33.4	1.7	3.0	8.5	50.5	2.4	3.3	44.8	0.9	3.2	2.7	28.4	9.3	16.0	1.6	1.4	33.9	22.3	56.0	112.2	1.6	4.5	42.2	24.6	3.7	54.6	4.8	2.1	2.2	21.9	5.3	3.3	8.1	26.2	2.8	1.1	24.7	2.8	2.3	29.8	2.4	7.0	5.1	35.0	2.2	13.7	4.9	5.9	4.2	2.6	3.0	0.2	0.2	0.1	0.0	13.3	3.1	26.7	18.0	15.2	26.9	4.5	5.3	35.9	22.7	16.2	11.6	21.7	4.6	5.2	17.4	10.1	51.1	10.5	26.6	25.9	25.1	17.4	17.0	9.2	5.9	8.3	35.4	41.6	33.1	10.7	16.9	147.9	15.3	41.1	2.8	10.5	68.0	6.3	44.8	9.6	10.0	11.3	5.3	34.8	50.3	19.7	5.6	9.8	20.4	15.8	6.2	6.9	16.0	6.3	10.9	90.5	10.0	5.2	41.8	2.4	2.9	9.5	10.8	18.4	30.5	28.1	0.1	34.2	26.2	13.9	0.0	0.0	0.0	4.9	0.0	5.7	3.0	4.8	6.5	0.2	1.0	7.9	7.3	0.2	0.0	0.1	0.0	13.3	3.1	44.6	33.4	8.5	24.9	33.9	22.3	42.2	24.6	21.9	35.0	0.0	0.0	16.4	6.8	37.3	0.8	0.5	0.0	2.7	0.0	10.4	0.0	25.8	53.0	14.1	1.3	2.1	0.7	46.7	41.7	10.5	2.4	14.9	0.0	129.9	4.4	4.8	3.5	3.7	3.2	1.7	4.6	1.8	18.6	6.4	2.0	22.2	28.4	0.0	1.8	244.0	1.3	0.0	1.0	1.4	2.8	44.4	7.8	4.4	3.0	11.2
PSEN1	"AD3, FAD, PS1, S182"	ENSG00000080815	"Presenilin 1"	P49768	14	73136418-73223691	"Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Apoptosis, Cell adhesion, Notch signaling pathway"	"Hydrolase, Protease"	"Alzheimer disease, Amyloidosis, Cancer-related genes, Cardiomyopathy, Disease mutation, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB006844, HPA030760, HPA067496"	Approved		Supported	"Nucleoplasm,Golgi apparatus,Cell Junctions"		Yes	No			"Golgi apparatus"	"Nucleoplasm, Cell Junctions"	"CAB006844: , HPA030760: AB_10696211, HPA067496: AB_2685853"	"unprognostic (1.67e-1)"	"unprognostic (4.79e-2)"	"unprognostic (7.39e-2)"	"unprognostic (8.68e-3)"	"unprognostic (3.84e-1)"	"unprognostic (5.48e-3)"	"prognostic unfavorable (1.99e-5)"	"unprognostic (1.65e-1)"	"unprognostic (8.99e-2)"	"unprognostic (8.45e-2)"	"unprognostic (1.76e-3)"	"unprognostic (2.74e-1)"	"prognostic favorable (1.52e-8)"	"unprognostic (2.29e-1)"	"unprognostic (2.32e-1)"	"unprognostic (7.12e-3)"	"unprognostic (1.85e-1)"	16.3	15.3	21.0	13.4	34.9	19.2	15.7	15.5	24.7	16.5	26.2	66.1	9.5	26.6	14.2	15.4	19.0	12.6	17.1	9.9	28.6	18.2	19.7	16.9	16.9	10.8	42.1	20.7	13.5	15.0	21.8	9.2	22.7	31.8	13.6	25.6	15.0	16.8	13.4	13.0	24.7	27.9	14.6	61.9	14.6	16.3	16.8	39.7	15.4	19.7	8.7	15.9	17.2	13.5	9.0	24.4	38.1	34.0	11.7	10.5	17.1	14.4	22.2	20.8	8.3	29.1	20.8	18.9	21.3	24.5	21.9	27.6	27.6	36.2	9.4	14.1	20.2	17.9	38.5	17.5	16.1	23.9	21.5	10.8	10.8	15.1	13.4	26.9	10.8	21.1	21.3	29.4	18.1	22.4	20.0	17.5	10.6	12.0	19.2	20.4	28.7	8.2	14.1	9.0	25.7	16.5	10.5	17.7	12.0	30.4	30.7	11.6	15.5	23.2	21.8	18.9	19.7	27.0	24.3	18.5	22.3	18.4	18.1	10.0	12.6	18.4	9.6	18.7	13.2	13.5	29.2	27.1	27.1	7.2	30.8	7.0	7.2	7.0	5.9	24.4	9.0	6.6	6.4	38.1	11.7	34.0	12.8	10.5	17.1	21.0	34.9	15.5	24.7	28.6	18.2	42.1	20.7	31.8	39.7	26.8	35.7	14.6	21.9	25.3	16.5	10.1	20.4	22.7	26.1	22.7	37.3	22.8	5.0	24.3	8.6	20.3	63.6	0.0	23.2	24.7	22.1	24.7	17.4	18.6	27.3	12.7	15.5	13.5	47.8	10.0	15.3	43.2	15.1	33.3	34.1	13.6	29.5	51.8	14.5	13.3	27.4	25.8	18.4	21.6	13.7	28.9	41.8	20.3	36.6	44.4
PSEN2	"AD3L, AD4, PS2, STM2"	ENSG00000143801	"Presenilin 2"	P49810	1	226870184-226896105	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Notch signaling pathway"	"Hydrolase, Protease"	"Alzheimer disease, Amyloidosis, Cardiomyopathy, Disease mutation, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Syncytiotrophoblasts: 38.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB013634, HPA038005"			Supported	Nucleoplasm		NA	NA			Nucleoplasm		"CAB013634: , HPA038005: "	"unprognostic (3.40e-2)"	"unprognostic (4.73e-3)"	"unprognostic (2.94e-1)"	"unprognostic (3.86e-2)"	"unprognostic (6.54e-2)"	"unprognostic (1.64e-3)"	"unprognostic (4.72e-2)"	"unprognostic (1.31e-1)"	"unprognostic (9.98e-2)"	"unprognostic (2.73e-2)"	"unprognostic (8.25e-3)"	"unprognostic (8.53e-3)"	"unprognostic (8.45e-2)"	"unprognostic (1.17e-1)"	"unprognostic (8.36e-2)"	"unprognostic (1.68e-1)"	"unprognostic (1.06e-1)"	8.9	13.2	9.5	5.9	7.9	1.2	8.1	16.6	10.7	9.2	9.2	5.9	7.3	9.4	16.4	9.0	9.4	8.7	12.0	9.7	6.5	10.8	7.8	7.7	9.0	11.6	8.1	9.3	13.1	31.6	14.0	15.2	7.6	14.8	12.8	6.9	15.9	9.6	13.4	22.1	6.8	12.2	17.0	4.9	10.6	7.1	21.8	5.3	1.4	6.0	7.2	7.0	9.0	7.2	5.1	7.7	19.4	18.7	12.3	3.4	3.1	9.0	13.6	4.0	12.6	5.5	1.8	6.7	7.7	15.1	9.6	7.4	10.6	11.7	0.1	10.4	9.8	6.6	4.6	7.1	7.3	3.9	9.7	13.1	6.1	9.6	6.9	9.3	4.8	10.1	5.4	8.2	11.5	6.3	6.8	4.4	0.0	10.5	4.1	5.6	7.6	0.1	5.5	12.4	11.3	11.2	0.1	14.8	14.5	8.5	7.7	7.1	11.8	6.2	17.1	30.5	11.8	14.7	6.1	4.8	6.8	5.8	6.2	9.6	16.6	24.4	0.4	12.2	1.5	9.0	19.4	5.7	12.1	3.2	6.5	3.4	5.1	1.1	2.9	7.7	2.6	0.6	1.7	1.2	12.3	18.7	0.6	1.4	3.1	9.5	7.9	16.6	10.7	6.5	10.8	8.1	9.3	14.8	5.3	14.9	13.3	3.0	4.2	1.4	6.0	7.5	12.7	2.7	3.4	5.2	0.0	12.2	1.7	11.0	1.9	7.7	6.7	0.0	15.7	4.3	7.6	4.8	13.9	6.8	16.3	15.9	5.8	23.4	5.3	0.9	6.6	8.3	32.1	30.7	4.3	20.0	11.9	5.8	12.4	6.0	5.4	6.5	4.7	0.7	4.5	1.6	38.3	2.5	4.1	3.9
PSKH1		ENSG00000159792	"Protein serine kinase H1"	P11801	16	67893272-67929678	"Enzymes, Predicted membrane proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA053927, HPA062763"	Approved		Supported	"Nuclear speckles,Cytosol"		NA	NA			"Nuclear speckles"	Cytosol	"HPA053927: AB_2682312, HPA062763: "	"unprognostic (2.57e-2)"	"unprognostic (8.91e-3)"	"unprognostic (1.88e-1)"	"unprognostic (5.79e-2)"	"unprognostic (3.26e-1)"	"unprognostic (3.89e-1)"	"unprognostic (1.64e-1)"	"unprognostic (1.29e-2)"	"unprognostic (3.03e-1)"	"unprognostic (1.66e-2)"	"unprognostic (9.85e-3)"	"unprognostic (8.32e-2)"	"prognostic favorable (4.28e-10)"	"unprognostic (1.46e-1)"	"unprognostic (1.99e-1)"	"unprognostic (4.15e-2)"	"unprognostic (3.90e-3)"	14.3	18.3	13.6	14.0	16.6	4.8	15.1	13.3	13.3	11.0	14.7	17.7	24.0	14.0	19.2	14.6	17.7	20.2	19.3	17.8	12.2	8.4	18.8	15.1	13.1	10.4	16.2	12.7	21.2	35.3	33.2	13.0	9.8	16.1	14.3	11.4	16.2	19.0	14.8	19.9	14.0	15.2	16.3	11.3	12.8	19.1	31.7	15.0	12.5	14.9	12.9	8.6	14.8	18.7	4.0	5.2	4.5	5.8	5.2	5.6	3.5	7.4	13.3	15.2	16.7	23.6	12.0	9.8	9.0	13.7	9.6	8.5	10.0	10.8	7.0	13.7	15.1	7.6	11.3	8.7	9.2	3.2	2.7	9.8	8.0	9.9	12.7	16.2	7.6	4.8	22.0	16.1	11.3	11.9	12.9	13.9	13.3	12.2	3.0	9.9	16.6	10.3	4.9	14.5	8.1	8.3	15.9	5.8	14.5	11.2	9.3	13.2	15.7	27.9	7.6	9.1	6.3	14.0	13.9	12.2	10.8	3.8	9.0	4.5	9.2	4.9	15.2	13.0	5.1	11.8	0.0	4.3	4.5	5.6	5.8	3.8	4.0	3.9	5.3	5.2	3.5	3.4	4.3	2.7	5.2	3.6	3.8	2.3	3.5	13.6	16.6	13.3	13.3	12.2	8.4	16.2	12.7	16.1	15.0	0.0	2.2	5.1	2.5	1.0	10.7	1.7	7.6	4.0	2.3	5.2	5.9	5.2	10.0	5.5	10.8	2.9	8.1	0.0	6.5	4.0	3.9	3.5	5.8	7.7	4.1	6.4	10.4	4.3	5.6	16.9	4.4	1.2	5.0	3.6	6.3	8.2	6.9	3.5	7.4	6.3	6.7	12.9	4.7	3.5	5.7	1.4	4.9	3.1	6.3	1.4
PSKH2		ENSG00000147613	"Protein serine kinase H2"	Q96QS6	8	86048373-86088621	"Enzymes, Predicted membrane proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Group enriched"	"Detected in some"	5	"kidney: 1.9;placenta: 1.2;testis: 2.0"	"Cell type enhanced"	"Detected in single"	35	"Rod photoreceptor cells: 1.3"	"Cancer enhanced"	"Detected in single"		"testis cancer: 0.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	18	"HEL: 14.3"									"HPA015095, HPA056839"	Approved		Approved	"Nucleoplasm,Nuclear bodies,Cytosol"		NA	NA			Nucleoplasm	"Nuclear bodies, Cytosol"	"HPA015095: AB_1855815, HPA056839: "															"unprognostic (1.77e-2)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
PSMA1	"HC2, MGC14542, MGC14575, MGC14751, MGC1667, MGC21459, MGC22853, MGC23915, NU, PROS30"	ENSG00000129084	"Proteasome subunit alpha 1"	P25786	11	14504874-14643635	"Enzymes, Predicted intracellular proteins"	Immunity	"Hydrolase, Protease, Threonine protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"CAB033765, HPA037646, HPA043891"	Supported		Enhanced	Nucleoplasm		NA	NA		27000000	Nucleoplasm		"CAB033765: AB_2253026, HPA037646: AB_10670386, HPA043891: AB_2678718"	"unprognostic (1.72e-2)"	"unprognostic (4.97e-2)"	"unprognostic (7.33e-2)"	"unprognostic (4.74e-2)"	"unprognostic (7.52e-2)"	"unprognostic (6.66e-3)"	"prognostic unfavorable (3.79e-5)"	"unprognostic (3.28e-3)"	"unprognostic (7.44e-2)"	"unprognostic (3.43e-3)"	"unprognostic (8.27e-3)"	"unprognostic (8.77e-2)"	"prognostic unfavorable (4.03e-11)"	"unprognostic (1.93e-1)"	"unprognostic (1.69e-1)"	"unprognostic (4.66e-2)"	"unprognostic (1.23e-2)"	46.6	46.3	33.7	36.0	40.2	45.7	39.0	28.3	42.7	33.4	35.5	23.1	37.4	37.3	42.1	43.1	43.7	33.0	32.2	55.4	31.7	34.1	47.8	61.0	38.8	42.3	32.0	32.4	34.0	35.6	28.2	39.4	55.2	36.9	35.6	42.4	32.9	34.9	37.1	86.6	35.3	42.7	39.0	26.7	45.8	37.3	31.6	25.9	53.0	45.5	62.8	42.2	41.5	31.7	24.2	55.4	20.9	42.3	30.5	35.7	45.2	67.4	47.7	40.0	47.9	39.9	40.2	33.4	39.9	52.5	60.9	50.1	41.3	85.2	59.0	44.2	42.1	55.8	50.9	45.6	49.5	57.7	57.3	67.7	36.8	31.7	48.7	52.4	61.0	48.1	38.9	29.5	33.0	69.2	44.5	59.5	47.6	69.0	49.8	54.1	44.7	55.5	45.9	33.4	57.6	71.2	37.6	59.3	36.7	52.9	47.9	33.0	20.8	42.5	47.7	35.6	43.1	28.4	37.3	47.0	39.9	37.5	69.8	48.7	21.8	58.3	52.8	59.0	48.6	50.9	20.9	42.3	11.0	24.3	31.1	32.3	24.2	28.3	27.2	55.4	20.6	25.7	25.0	9.4	30.5	29.4	31.3	35.7	45.2	33.7	40.2	28.3	42.7	31.7	34.1	32.0	32.4	36.9	25.9	77.4	91.8	78.9	188.2	127.0	44.8	0.0	73.9	65.6	95.5	83.7	17.7	398.7	217.2	193.4	40.4	121.2	89.1	70.0	203.0	301.8	137.7	149.4	72.1	111.7	261.1	54.0	38.6	87.8	164.2	23.5	107.9	156.0	136.7	273.3	81.1	94.3	195.2	111.4	119.9	182.7	40.0	84.1	135.9	126.7	65.4	132.7	524.5	142.0	111.1	217.3
PSMA2	"HC3, MU, PMSA2"	ENSG00000106588	"Proteasome subunit alpha 2"	P25787	7	42916857-42932223	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Hydrolase, Protease, Threonine protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"monocytes: 569.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											HPA008188	Uncertain					NA	NA		80000000			"HPA008188: AB_1855819"	"unprognostic (9.40e-3)"	"unprognostic (2.08e-2)"	"unprognostic (8.21e-2)"	"unprognostic (2.23e-2)"	"unprognostic (4.13e-2)"	"unprognostic (1.90e-1)"	"prognostic unfavorable (1.29e-4)"	"unprognostic (2.01e-2)"	"unprognostic (9.25e-2)"	"prognostic favorable (6.73e-5)"	"unprognostic (1.77e-1)"	"unprognostic (3.42e-1)"	"unprognostic (1.62e-3)"	"unprognostic (1.79e-1)"	"unprognostic (1.06e-1)"	"unprognostic (6.38e-2)"	"unprognostic (4.24e-2)"	24.7	32.2	25.3	24.6	29.5	29.7	29.4	19.6	22.0	19.2	25.6	13.4	26.0	29.8	22.6	26.2	31.1	19.4	20.5	35.8	22.3	16.6	33.3	90.9	23.2	27.4	27.2	17.6	20.8	28.8	12.0	18.8	33.7	29.2	24.5	26.0	10.1	21.7	19.6	57.2	22.4	33.1	22.0	21.4	26.6	27.8	18.6	23.5	42.2	29.9	44.6	29.9	22.8	20.2	46.2	54.1	81.7	47.4	36.7	56.7	75.0	32.1	34.6	40.6	49.1	21.7	24.4	30.3	28.5	33.4	46.1	49.4	51.5	53.0	59.9	50.9	25.2	72.2	45.1	41.9	39.5	53.2	43.2	33.3	30.5	46.9	54.3	23.2	51.7	33.1	22.4	28.9	35.5	21.2	33.0	43.3	36.9	61.4	36.8	36.8	37.8	46.1	101.8	80.4	53.2	43.0	45.1	39.5	58.8	44.3	44.5	33.0	33.6	31.0	71.3	31.1	57.6	51.8	60.6	30.9	27.4	49.9	29.2	56.1	48.0	72.7	98.0	46.5	65.8	77.2	59.0	45.7	81.7	35.2	45.2	40.4	46.2	43.4	40.5	48.5	40.7	39.0	41.3	23.3	36.7	47.4	54.1	56.7	75.0	25.3	29.5	19.6	22.0	22.3	16.6	27.2	17.6	29.2	23.5	83.4	79.1	145.3	58.9	0.1	28.0	0.0	124.9	107.1	122.8	90.7	21.6	258.4	144.2	278.9	15.8	73.3	147.1	70.0	330.5	246.8	63.2	74.2	161.7	195.1	170.9	27.0	148.7	112.3	163.6	12.0	73.4	114.0	0.0	569.9	160.7	54.7	284.0	133.3	79.5	175.7	38.7	129.4	0.0	98.4	110.0	0.0	233.4	138.4	230.0	89.8
PSMA3	HC8	ENSG00000100567	"Proteasome subunit alpha 3"	P25788	14	58244831-58272012	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction"	"Hydrolase, Protease, Threonine protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA000905	Approved					NA	NA		13000000			"HPA000905: AB_1079702"	"unprognostic (3.60e-1)"	"unprognostic (4.81e-3)"	"unprognostic (1.17e-1)"	"unprognostic (2.19e-2)"	"unprognostic (4.91e-1)"	"unprognostic (5.79e-2)"	"unprognostic (1.97e-3)"	"unprognostic (1.27e-1)"	"unprognostic (7.92e-2)"	"unprognostic (7.36e-3)"	"unprognostic (1.65e-2)"	"unprognostic (7.57e-2)"	"unprognostic (1.83e-3)"	"unprognostic (2.33e-2)"	"unprognostic (6.47e-2)"	"prognostic favorable (2.91e-4)"	"unprognostic (2.16e-1)"	26.6	41.5	21.3	27.7	25.0	24.3	28.7	16.2	25.1	23.3	26.5	17.5	34.3	27.7	25.4	46.3	33.5	23.4	21.1	55.8	24.2	22.6	51.2	59.6	28.0	31.9	23.2	20.3	23.5	25.1	20.0	30.8	50.6	28.3	24.7	28.9	17.5	25.0	27.7	68.6	18.1	34.4	27.0	22.4	33.9	26.9	15.9	15.8	32.5	37.6	50.6	31.2	32.0	20.5	36.1	50.7	31.2	40.3	38.0	45.9	36.1	67.7	42.3	42.0	34.5	33.1	31.0	54.1	35.9	40.2	50.3	50.6	62.4	56.4	57.0	66.6	32.4	40.6	46.7	47.9	38.3	59.1	50.0	29.4	39.1	32.0	70.3	62.8	62.9	33.6	26.4	27.7	34.9	33.3	30.5	59.0	46.4	36.9	33.8	40.3	77.1	54.9	60.9	28.5	55.2	64.1	46.6	54.5	42.2	72.4	67.1	39.7	19.8	31.8	50.7	34.9	41.9	52.8	47.2	37.7	29.4	57.4	33.0	47.8	13.7	25.4	58.9	42.4	49.4	35.4	31.2	34.3	20.6	32.4	40.3	40.6	36.1	39.7	38.1	37.9	25.6	32.4	37.2	20.1	38.0	33.7	50.7	45.9	36.1	21.3	25.0	16.2	25.1	24.2	22.6	23.2	20.3	28.3	15.8	110.2	101.7	83.4	140.0	105.3	37.2	101.5	73.9	100.4	96.7	83.7	33.4	328.8	140.9	209.6	19.7	104.1	81.8	46.7	200.7	212.5	105.9	111.5	93.5	140.1	163.4	39.7	61.7	64.4	52.6	19.2	101.2	107.2	102.9	276.9	57.4	65.3	175.7	61.9	99.7	236.8	67.1	97.0	101.3	102.6	54.3	92.6	337.4	83.0	79.8	145.5
PSMA4	"HC9, HsT17706"	ENSG00000041357	"Proteasome subunit alpha 4"	P25789	15	78540405-78552419	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction"	"Hydrolase, Protease, Threonine protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004973, HPA055466, HPA060613"	Supported		Supported	Nucleoplasm,Vesicles,Cytosol		No	No		12000000	"Nucleoplasm, Cytosol"	Vesicles	"CAB004973: AB_425627, HPA055466: AB_2682824, HPA060613: AB_2684332"	"unprognostic (1.80e-1)"	"unprognostic (7.08e-3)"	"unprognostic (1.31e-1)"	"unprognostic (1.62e-1)"	"unprognostic (4.71e-2)"	"unprognostic (5.35e-2)"	"unprognostic (6.26e-3)"	"unprognostic (1.09e-1)"	"unprognostic (3.28e-2)"	"unprognostic (2.08e-3)"	"unprognostic (2.75e-3)"	"unprognostic (1.26e-1)"	"prognostic unfavorable (6.74e-10)"	"unprognostic (1.68e-1)"	"unprognostic (1.56e-1)"	"unprognostic (3.78e-3)"	"unprognostic (6.32e-3)"	41.2	38.8	24.9	36.7	25.8	33.4	33.0	25.3	37.5	32.4	38.0	17.9	23.7	39.4	35.3	32.5	49.9	27.1	24.4	37.7	29.8	27.6	55.7	76.3	37.4	45.1	25.5	26.9	31.2	24.4	20.2	25.9	55.4	33.8	35.3	41.3	19.1	26.0	25.0	60.3	26.3	49.1	36.6	28.1	45.5	31.5	36.5	21.4	61.6	42.6	75.0	44.8	41.3	28.3	29.4	61.9	31.4	75.6	37.7	40.0	61.4	40.8	59.2	51.2	45.1	32.4	30.6	40.2	38.4	30.9	47.4	50.8	61.4	59.6	89.1	56.8	35.3	53.1	55.9	103.3	41.6	45.8	36.5	72.0	74.8	44.3	49.5	52.5	76.0	46.2	24.7	26.1	39.8	39.7	29.2	51.0	49.1	80.2	35.0	38.6	58.7	51.2	71.4	48.2	47.5	34.8	44.6	67.8	29.8	47.9	71.5	45.2	33.0	61.6	45.0	46.8	66.1	41.6	62.6	40.6	35.4	47.2	38.9	65.3	32.0	75.4	84.0	33.2	114.3	39.0	18.8	47.4	31.4	27.8	75.6	28.5	29.4	29.2	29.0	61.9	22.9	23.3	28.3	21.7	37.7	69.7	35.3	40.0	61.4	24.9	25.8	25.3	37.5	29.8	27.6	25.5	26.9	33.8	21.4	119.1	93.9	158.5	221.9	205.7	52.1	151.9	114.7	164.6	121.7	115.1	9.8	396.5	263.6	267.2	515.0	152.3	149.0	93.5	255.0	368.3	172.3	213.0	169.8	170.4	287.4	68.3	140.2	108.6	138.2	238.7	139.8	214.9	126.5	342.7	139.0	49.5	230.5	135.3	138.6	288.5	32.6	148.8	177.5	257.9	168.3	185.9	373.9	156.9	171.4	236.4
PSMA5	ZETA	ENSG00000143106	"Proteasome subunit alpha 5"	P28066	1	109399031-109426427	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Hydrolase, Protease, Threonine protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"MOLT-4: 31.2"	"Low region specificity"	"Detected in all"							"HPA028392, HPA028398, HPA028441"	Approved		Supported	Cytosol		NA	NA		22000000	Cytosol		"HPA028392: AB_10600115, HPA028398: AB_10602310, HPA028441: AB_10602003"	"unprognostic (3.82e-2)"	"unprognostic (3.09e-3)"	"prognostic favorable (1.45e-5)"	"unprognostic (1.57e-1)"	"unprognostic (2.71e-1)"	"unprognostic (1.52e-2)"	"prognostic unfavorable (2.28e-4)"	"unprognostic (5.95e-2)"	"unprognostic (1.71e-2)"	"unprognostic (1.13e-3)"	"unprognostic (4.20e-3)"	"unprognostic (3.05e-1)"	"unprognostic (1.07e-3)"	"unprognostic (3.99e-2)"	"unprognostic (2.34e-1)"	"unprognostic (8.81e-3)"	"unprognostic (1.05e-1)"	12.1	23.7	13.2	17.3	15.0	7.7	16.2	8.2	40.5	13.3	16.1	9.8	16.7	15.1	15.8	23.0	21.5	17.6	16.7	20.8	13.8	13.5	27.5	41.9	17.1	24.2	13.4	14.9	13.6	21.4	12.6	11.5	20.9	12.8	12.3	14.9	10.2	16.8	14.2	31.6	15.8	21.8	14.4	12.9	18.5	15.2	16.3	10.3	31.5	27.9	23.4	19.8	14.0	11.7	2.1	1.2	7.3	2.2	2.8	7.1	1.6	1.2	1.0	1.7	1.2	3.9	4.2	1.4	0.9	9.3	6.1	3.6	1.3	1.1	5.3	1.2	4.1	0.4	1.7	2.4	3.1	3.8	1.1	1.5	2.3	0.9	1.6	2.9	3.0	1.2	1.9	3.1	1.8	3.0	1.5	2.3	1.6	1.8	1.4	2.5	1.6	31.2	1.3	1.4	1.3	1.5	0.8	3.1	0.9	4.9	1.6	1.4	1.2	1.6	5.5	2.0	1.4	1.2	2.7	1.5	1.0	0.8	2.1	1.2	0.9	1.8	6.7	6.8	6.7	1.1	7.3	1.0	0.7	4.0	2.2	4.8	1.8	5.8	4.9	1.2	2.1	7.1	6.5	0.3	2.8	2.0	0.8	5.3	1.6	13.2	15.0	8.2	17.5	13.8	13.5	13.4	14.9	12.8	10.3	38.7	52.0	75.2	57.4	56.4	28.9	80.5	71.4	113.8	56.9	40.1	5.9	188.1	119.3	151.2	42.4	54.0	101.9	93.5	159.8	154.0	44.1	63.2	80.8	125.2	151.4	12.7	54.1	53.4	54.0	13.6	62.7	72.3	55.6	215.6	84.3	42.7	167.1	91.2	58.4	151.0	27.9	45.3	54.2	105.7	86.6	57.6	201.7	98.3	114.8	81.6
PSMA6	"IOTA, MGC22756, MGC2333, MGC23846, p27K, PROS27"	ENSG00000100902	"Proteasome subunit alpha 6"	P60900	14	35278633-35317493	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Hydrolase, Protease, Threonine protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	12	"Late spermatids: 395.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003049	Approved		Supported	Nucleoplasm		NA	NA		19000000	Nucleoplasm		"HPA003049: AB_1079703"	"unprognostic (9.68e-3)"	"unprognostic (5.91e-2)"	"unprognostic (1.90e-2)"	"unprognostic (8.07e-2)"	"unprognostic (3.42e-2)"	"unprognostic (4.11e-3)"	"unprognostic (7.48e-2)"	"unprognostic (1.25e-1)"	"unprognostic (1.16e-1)"	"prognostic favorable (3.27e-4)"	"unprognostic (1.29e-3)"	"unprognostic (2.63e-1)"	"unprognostic (1.52e-2)"	"unprognostic (2.05e-1)"	"unprognostic (5.45e-2)"	"unprognostic (3.49e-1)"	"unprognostic (5.08e-2)"	33.8	42.7	26.7	31.4	38.8	37.1	38.7	24.2	35.0	28.0	35.8	19.4	24.5	32.2	31.0	30.2	37.9	24.7	20.3	54.2	30.5	27.6	47.3	49.0	37.3	36.4	30.1	36.8	31.1	36.7	14.2	35.8	61.2	31.8	22.5	38.6	18.1	27.3	25.5	94.6	31.8	39.5	27.3	25.2	35.7	28.9	67.5	26.5	86.2	26.0	37.2	38.1	28.8	24.5	37.9	68.5	41.4	65.1	49.9	54.8	104.8	59.7	44.2	33.1	33.6	27.3	29.2	66.2	31.3	38.3	47.4	43.1	41.1	43.3	40.0	60.3	30.4	28.5	42.8	38.6	35.7	56.8	40.2	21.1	31.4	32.2	122.9	31.0	65.3	29.4	22.2	29.7	33.1	42.2	23.6	40.0	68.7	33.5	28.0	38.2	63.3	99.9	55.8	31.6	49.2	50.4	148.9	33.6	32.0	40.5	76.8	35.2	29.8	34.9	51.5	32.9	29.2	61.6	43.3	33.3	30.5	30.2	31.0	34.6	29.9	65.4	73.1	24.8	41.4	34.4	32.8	65.1	41.4	46.3	59.4	46.2	37.9	44.8	47.1	66.8	29.9	35.9	43.0	23.5	49.9	56.6	68.5	54.8	104.8	26.7	38.8	24.2	35.0	30.5	27.6	30.1	36.8	31.8	26.5	41.7	28.9	14.5	10.6	29.7	14.3	1.2	15.3	83.0	59.1	14.0	23.6	27.2	18.3	26.4	121.5	28.7	25.7	23.3	31.8	22.0	14.4	12.4	53.1	20.3	20.7	23.8	17.2	30.7	36.5	395.6	21.0	54.6	23.6	27.1	17.6	8.7	26.5	21.0	16.3	18.9	17.8	12.9	22.1	22.9	17.9	29.0	34.6	29.4	22.2	15.3
PSMA7	"C6, HSPC, RC6-1, XAPC7"	ENSG00000101182	"Proteasome subunit alpha 7"	O14818	20	62136735-62143440	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction"	"Hydrolase, Protease, Threonine protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB046007, CAB046008, HPA047266"	Approved					NA	NA		26000000			"CAB046007: AB_11128404, CAB046008: AB_2171861, HPA047266: AB_2680006"	"unprognostic (1.49e-2)"	"unprognostic (4.44e-2)"	"unprognostic (1.78e-2)"	"unprognostic (2.79e-2)"	"unprognostic (6.36e-1)"	"unprognostic (6.57e-3)"	"prognostic unfavorable (2.54e-5)"	"unprognostic (8.82e-2)"	"unprognostic (1.87e-2)"	"unprognostic (5.06e-3)"	"unprognostic (1.16e-1)"	"unprognostic (7.30e-2)"	"unprognostic (7.04e-2)"	"unprognostic (2.31e-1)"	"unprognostic (2.21e-2)"	"unprognostic (6.31e-2)"	"unprognostic (1.98e-2)"	45.1	40.2	26.5	35.0	28.0	56.1	53.1	23.8	30.7	23.2	34.2	21.1	25.4	32.1	33.3	26.6	36.6	26.4	27.3	64.7	26.3	25.7	36.0	63.6	32.8	36.0	28.4	27.0	28.0	48.0	17.1	21.5	27.9	25.0	27.7	27.6	20.7	25.7	27.7	130.5	26.2	33.1	36.9	24.7	34.8	29.7	16.1	22.6	37.2	33.0	53.4	36.8	36.1	44.0	92.3	112.0	124.4	111.2	64.3	114.6	153.5	56.9	70.6	43.6	45.3	40.2	31.0	40.2	44.7	36.6	110.1	46.5	185.0	53.6	47.3	104.2	44.8	71.2	68.4	40.7	79.2	54.9	29.7	31.4	106.1	71.3	93.3	49.9	45.1	62.3	33.0	64.8	56.8	50.6	27.7	54.4	46.3	46.5	45.3	47.7	58.3	72.2	72.1	36.6	63.3	102.3	50.5	82.2	51.3	42.0	53.7	58.7	36.1	67.3	83.6	71.9	29.3	50.1	68.4	44.3	98.0	80.7	51.4	66.4	32.4	49.9	55.7	68.3	34.6	56.9	98.4	111.2	124.4	93.3	109.7	79.2	92.3	93.7	92.0	102.8	83.7	74.7	77.5	94.4	64.3	109.7	112.0	114.6	153.5	26.5	28.0	23.8	30.7	26.3	25.7	28.4	27.0	25.0	22.6	196.5	155.3	252.3	303.7	332.6	126.5	267.8	364.3	245.0	226.3	244.3	68.7	587.8	422.7	492.7	257.1	315.9	330.8	350.4	630.8	671.4	333.0	338.3	242.8	717.4	718.5	77.9	222.6	352.9	445.3	113.3	309.8	460.9	349.2	628.4	200.1	169.6	555.7	259.6	276.2	527.8	96.0	226.4	368.4	74.4	147.9	270.4	713.1	268.8	302.8	319.1
PSMA8	"MGC26605, PSMA7L"	ENSG00000154611	"Proteasome subunit alpha 8"	Q8TAA3	18	26133852-26193355	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Differentiation, Spermatogenesis"	"Hydrolase, Protease, Threonine protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	6	"testis: 36.5"	"Cell type enriched"	"Detected in some"	26	"Spermatocytes: 183.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in some"	80	"Daudi: 23.7;JURKAT: 6.8;U-266/70: 14.7;U-266/84: 15.4"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"									NA	NA						"unprognostic (5.39e-3)"	"unprognostic (7.45e-5)"			"unprognostic (2.94e-1)"	"unprognostic (3.04e-2)"		"unprognostic (1.59e-1)"	"unprognostic (2.72e-1)"	"unprognostic (1.99e-1)"	"unprognostic (8.30e-2)"		"unprognostic (7.54e-4)"	"unprognostic (4.80e-2)"	"unprognostic (1.15e-1)"	"unprognostic (2.56e-1)"		0.1	0.1	0.1	1.2	0.1	0.0	0.1	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.0	1.6	0.1	0.0	0.1	0.0	0.0	0.1	0.2	0.7	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.2	0.0	0.1	1.1	0.0	36.5	0.2	0.7	0.1	0.0	2.2	0.1	0.0	4.0	1.9	0.2	0.1	1.2	5.8	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	23.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.7	15.4	0.1	0.0	0.0	0.0	0.0	0.1	0.0	2.0	0.1	2.2	4.0	2.1	3.9	0.3	3.1	2.4	5.8	0.2	1.2	0.1	1.9	4.3	1.4	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.7	0.2	0.0	0.0	1.5	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	6.3	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.6	0.0	3.6	1.1	0.0	1.7	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	6.5	0.0	183.4	7.0	0.0	0.8	0.0	0.0	0.0
PSMB1	"HC5, PMSB1"	ENSG00000008018	"Proteasome subunit beta 1"	P20618	6	170535117-170553341	"Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction"	"Hydrolase, Protease, Threonine protease"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029635, HPA029637, CAB033911"	Enhanced		Supported	Nucleoplasm		NA	NA		14000000	Nucleoplasm		"CAB033911: AB_2268890, HPA029635: AB_10599738, HPA029637: AB_10601793"	"unprognostic (2.78e-2)"	"unprognostic (3.10e-2)"	"unprognostic (6.73e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.20e-1)"	"unprognostic (5.41e-3)"	"unprognostic (2.36e-2)"	"unprognostic (3.32e-2)"	"unprognostic (8.39e-2)"	"unprognostic (4.28e-2)"	"unprognostic (3.07e-1)"	"unprognostic (1.09e-1)"	"prognostic unfavorable (3.76e-6)"	"unprognostic (3.63e-1)"	"unprognostic (7.50e-2)"	"unprognostic (1.45e-3)"	"unprognostic (9.62e-2)"	60.8	59.3	38.5	40.4	53.7	53.2	55.0	31.4	46.4	40.5	48.6	37.9	49.9	45.1	56.8	90.6	51.7	49.8	43.1	71.9	40.9	40.1	56.4	93.2	46.9	66.7	40.8	41.1	43.7	67.3	35.4	48.4	80.6	48.4	40.6	52.7	43.8	43.6	50.0	109.3	56.1	46.0	59.7	44.9	51.4	46.9	47.1	38.1	47.1	47.9	75.2	60.4	50.1	42.0	71.0	98.1	51.9	81.9	71.6	79.3	104.1	43.1	40.6	57.9	74.7	51.8	40.7	61.7	41.3	60.8	69.0	70.5	88.7	37.3	63.2	54.0	55.3	63.5	43.7	64.1	65.7	72.0	64.2	72.2	54.0	41.2	111.2	60.8	63.2	48.1	46.4	40.4	66.5	43.2	47.5	58.8	40.0	106.5	54.3	62.8	116.2	47.3	88.3	52.8	78.8	55.9	45.9	45.9	80.1	71.5	26.0	57.9	47.3	39.7	61.8	31.6	53.9	42.2	91.6	44.7	28.1	45.1	68.3	76.3	46.5	61.4	78.4	65.6	71.7	60.2	40.1	81.9	51.9	53.2	75.8	62.1	71.0	62.2	57.7	98.1	53.4	59.2	57.2	47.5	71.6	67.6	55.8	79.3	104.1	38.5	53.7	31.4	46.4	40.9	40.1	40.8	41.1	48.4	38.1	104.2	145.5	160.9	308.1	192.9	104.7	211.7	249.7	199.4	117.2	134.3	39.3	748.5	339.8	368.1	245.5	214.1	220.2	116.8	565.6	684.7	208.1	230.0	184.8	268.0	350.5	112.8	158.7	149.8	159.1	57.7	237.3	212.8	219.4	422.0	169.6	196.7	419.2	227.4	221.7	419.5	99.6	187.5	291.5	198.6	166.3	188.6	1001.7	194.1	216.2	303.9
PSMB10	"beta2i, LMP10, MECL1, MGC1665"	ENSG00000205220	"Proteasome subunit beta 10"	P40306	16	67934502-67937087	"Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction"	"Hydrolase, Protease, Threonine protease"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 117.3"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"REH: 36.6;U-266/70: 41.0"									"HPA030224, HPA030225, CAB034384"	Enhanced		Approved	Vesicles,Cytosol		NA	NA		1400000	Cytosol	Vesicles	"CAB034384: AB_2171876, HPA030224: AB_2673382, HPA030225: AB_10603231"	"unprognostic (1.18e-2)"	"unprognostic (1.90e-3)"	"unprognostic (2.00e-1)"	"unprognostic (2.53e-3)"	"unprognostic (2.00e-1)"	"unprognostic (1.85e-2)"	"unprognostic (7.22e-2)"	"unprognostic (3.35e-2)"	"unprognostic (1.07e-1)"	"unprognostic (2.60e-1)"	"unprognostic (8.22e-2)"	"unprognostic (1.79e-1)"	"unprognostic (1.32e-2)"	"unprognostic (2.97e-2)"	"unprognostic (1.98e-1)"	"unprognostic (1.32e-2)"	"prognostic favorable (5.44e-4)"	11.5	13.0	9.1	24.9	11.8	23.9	11.4	4.0	7.8	8.0	21.6	5.6	8.5	42.4	9.3	9.5	10.6	12.4	16.6	12.0	6.9	4.9	16.9	17.2	19.5	38.3	9.5	5.6	8.7	61.5	0.9	6.9	11.2	8.5	13.5	6.3	5.8	27.9	11.6	6.9	7.0	35.6	7.7	6.5	49.7	23.8	2.5	7.8	39.2	13.1	10.4	20.5	13.2	8.4	50.8	75.2	100.0	98.1	69.1	68.8	117.3	6.0	5.3	0.4	0.8	0.4	3.5	21.3	2.0	8.7	7.0	9.9	2.8	29.5	22.0	3.8	2.7	2.1	8.9	0.1	2.0	0.5	9.7	0.5	7.8	1.8	3.1	12.2	14.5	24.0	5.4	1.2	3.1	0.0	2.2	4.0	5.3	0.7	8.4	2.0	7.5	28.5	14.9	0.3	0.2	2.0	36.6	2.2	30.0	4.8	10.5	0.3	0.4	6.8	12.0	2.6	0.4	2.4	31.5	6.8	4.5	1.2	1.9	2.3	41.0	7.4	14.6	11.1	19.0	9.6	57.1	89.4	67.1	68.8	98.1	50.2	50.8	54.0	57.3	74.6	49.1	45.3	50.1	100.0	69.1	71.4	75.2	60.8	117.3	9.1	11.8	4.0	7.8	6.9	4.9	9.5	5.6	8.5	7.8	20.8	23.2	54.7	11.4	15.2	0.6	1.4	38.2	73.6	15.9	17.4	0.0	24.0	19.9	48.2	11.5	22.9	90.1	23.3	91.6	28.8	24.3	10.7	49.8	10.0	80.6	0.0	15.6	31.3	88.4	25.3	27.9	74.2	45.5	124.4	58.4	1.3	49.6	106.6	19.8	53.7	1.0	19.4	23.4	16.6	6.8	8.7	18.9	122.2	72.8	19.2
PSMB11	beta5t	ENSG00000222028	"Proteasome subunit beta 11"	A5LHX3	14	23042167-23044276	"Enzymes, Predicted intracellular proteins"		"Hydrolase, Protease, Threonine protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"		"Tissue enriched"	"Detected in some"	13	"lymphoid tissue: 32.7"	"Group enriched"	"Detected in some"	7	"Early spermatids: 1.3;Late spermatids: 1.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	6	"naive CD4 T-cell: 2.1"	"Lineage enriched"	"Detected in single"	21	"T-cells: 2.1"	"Cell line enriched"	"Detected in single"	4	"PC-3: 1.8"	"Region enriched"	"Detected in single"	7	"olfactory region: 2.3"	"Not detected"	"Not detected"			"HPA028967, HPA056970"	Enhanced					NA	NA					"HPA028967: AB_2732444, HPA056970: AB_2683293"				"unprognostic (7.96e-2)"	"unprognostic (2.77e-1)"													0.0	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.1	0.0	0.1	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	2.4	0.0	32.7	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.2	0.1	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	2.1	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.2	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
PSMB2	HC7-I	ENSG00000126067	"Proteasome subunit beta 2"	P49721	1	35599544-35641844	"Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction"	"Hydrolase, Protease, Threonine protease"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA026322, HPA026324"	Approved		Enhanced	Nucleoplasm		NA	NA		15000000	Nucleoplasm		"HPA026322: AB_1855821, HPA026324: AB_1855822"	"unprognostic (3.54e-2)"	"unprognostic (8.53e-2)"	"unprognostic (1.63e-3)"	"unprognostic (6.93e-2)"	"unprognostic (6.41e-2)"	"unprognostic (1.37e-1)"	"prognostic unfavorable (3.49e-7)"	"unprognostic (2.81e-2)"	"unprognostic (5.23e-2)"	"unprognostic (3.34e-3)"	"unprognostic (7.87e-2)"	"unprognostic (4.45e-1)"	"prognostic unfavorable (2.80e-6)"	"unprognostic (1.65e-1)"	"unprognostic (2.83e-1)"	"unprognostic (3.77e-2)"	"unprognostic (2.93e-2)"	26.5	30.5	29.4	28.0	35.1	37.2	25.3	20.1	50.9	23.2	26.1	35.9	15.4	27.5	27.8	25.0	30.4	26.5	20.7	23.8	30.6	33.4	27.9	63.8	24.6	30.4	30.6	24.8	22.7	24.6	22.0	21.8	37.5	32.6	23.1	27.8	22.8	23.0	24.9	54.7	28.2	27.0	28.7	32.5	29.3	22.8	23.5	21.5	42.8	22.7	29.1	34.0	23.9	22.4	24.6	30.2	19.4	35.3	25.1	28.1	25.4	40.9	25.7	28.1	19.1	14.9	17.9	35.5	19.4	22.9	40.1	32.7	30.4	49.3	40.9	45.7	22.9	24.5	25.5	36.1	32.2	33.8	33.3	33.5	37.1	28.1	29.7	26.9	38.9	21.9	19.5	20.4	47.9	23.2	16.4	31.5	33.9	44.2	23.4	25.8	18.8	50.6	29.1	37.5	18.2	27.4	31.4	28.6	28.8	27.8	22.2	24.9	18.3	22.3	21.1	30.1	33.5	15.5	17.7	21.6	20.1	23.7	18.9	45.9	20.2	32.4	41.5	29.7	41.0	34.8	17.4	27.0	19.4	23.1	33.0	23.4	24.6	23.1	24.2	29.7	19.3	16.7	20.9	9.7	25.1	35.3	30.2	28.1	25.4	29.4	35.1	20.1	50.9	30.6	33.4	30.6	24.8	32.6	21.5	59.6	61.8	70.7	120.5	98.8	48.7	51.8	71.4	68.3	47.8	62.8	15.7	342.2	122.7	240.6	77.0	88.7	69.5	23.3	197.3	290.1	75.1	97.6	33.6	136.0	195.7	55.6	94.4	84.7	99.4	12.8	93.2	93.1	72.6	231.8	76.2	58.8	222.8	74.6	85.9	183.0	36.4	90.5	72.1	168.5	124.8	97.5	369.7	82.8	96.1	159.8
PSMB3	"HC10-II, MGC4147"	ENSG00000277791	"Proteasome subunit beta 3"	P49720	17	38752736-38764231	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction"	"Hydrolase, Protease, Threonine protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 99.0"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"HPA042775, HPA048147"	Approved					NA	NA		28000000			"HPA042775: AB_2678158, HPA048147: AB_2680285"	"unprognostic (1.86e-1)"	"unprognostic (4.84e-3)"	"unprognostic (1.44e-1)"	"unprognostic (4.80e-2)"	"unprognostic (6.68e-2)"	"unprognostic (1.14e-3)"	"unprognostic (5.46e-2)"	"unprognostic (2.46e-2)"	"unprognostic (2.02e-1)"	"unprognostic (1.75e-2)"	"unprognostic (3.65e-1)"	"unprognostic (1.13e-1)"	"prognostic unfavorable (1.71e-6)"	"unprognostic (4.44e-1)"	"unprognostic (1.28e-1)"	"unprognostic (2.42e-3)"	"unprognostic (6.03e-2)"	13.3	9.6	5.2	9.9	8.6	13.3	10.3	3.0	13.9	8.5	11.8	7.5	6.4	9.2	5.6	15.3	14.7	10.3	9.8	15.6	4.4		21.6	36.8	11.6	13.0	8.4	7.1	9.6	11.3	7.3	5.7	17.2	8.5	10.8	12.0	9.1	8.5	10.0	22.2	10.0	14.1	11.0	4.7	17.5	7.2	8.5	7.0	23.3	16.7	12.2	15.6	10.2	5.6	32.7	55.0	99.0	56.5	29.1	43.1	63.7	28.1	52.9	22.0	33.9	24.4	19.2	28.1	18.5	31.5	65.2	57.5	63.2	36.6	32.3	33.5	27.7	46.2	48.5	36.3	35.9	40.4	42.2	63.6	20.8	30.7	65.6	12.1	33.2	32.0	20.1	22.1	49.0	16.6	16.8	35.2	38.2	33.4	36.8	31.4	36.8	51.7	51.8	29.7	33.8	39.5	29.2	44.5	50.6	38.0	28.7	27.1	17.9	23.8	18.1	23.0	32.1	41.5	38.7	18.5	17.1	31.6	36.3	47.3	24.1	40.8	41.9	33.9	32.9	30.0	41.1	56.5	47.4	30.3	49.7	27.9	32.7	28.5	27.6	55.0	28.1	23.0	24.8	99.0	29.1	39.9	53.2	43.1	63.7											71.5	124.7	150.3	148.2	177.2	62.4	281.8	122.3	170.0	120.6	167.5	23.6	383.7	344.8	286.9	26.5	168.4	172.3	93.5	430.9	364.8	178.3	175.3	150.1	236.3	368.1	28.6	128.1	114.8	177.4	35.0	138.4	256.1	190.6	331.0	131.4	145.3	327.0	210.5	137.2	493.2	50.1	122.9	183.6	147.5	74.1	176.0	421.6	159.6	160.1	208.1
PSMB4	"HN3, PROS26"	ENSG00000159377	"Proteasome subunit beta 4"	P28070	1	151399534-151401944	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction"	"Hydrolase, Protease, Threonine protease"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006700, HPA073499"	Approved		Supported	Nucleoplasm,Mitochondria		NA	NA		15000000	Nucleoplasm	Mitochondria	"HPA006700: AB_1079704, HPA073499: "	"unprognostic (1.11e-1)"	"unprognostic (1.44e-1)"	"unprognostic (2.69e-1)"	"unprognostic (2.52e-1)"	"unprognostic (1.63e-1)"	"unprognostic (5.74e-2)"	"prognostic unfavorable (7.45e-4)"	"unprognostic (2.27e-1)"	"unprognostic (1.69e-1)"	"unprognostic (4.37e-3)"	"unprognostic (3.73e-1)"	"unprognostic (3.77e-1)"	"prognostic unfavorable (2.90e-10)"	"unprognostic (5.33e-2)"	"unprognostic (2.46e-2)"	"unprognostic (3.82e-2)"	"unprognostic (5.85e-2)"	45.7	64.5	47.4	40.4	49.5	40.2	56.3	39.6	84.0	44.4	44.3	28.5	58.8	41.2	53.5	65.3	55.7	51.2	37.8	66.6	47.0	50.7	57.3	71.9	43.6	81.1	49.2	61.0	52.4	87.0	40.0	45.4	50.9	48.4	42.6	47.5	37.8	46.7	56.1	68.7	45.7	39.7	66.4	55.1	46.6	43.4	31.8	36.3	51.1	46.8	63.3	62.2	58.6	37.7	68.5	106.5	58.6	81.4	72.5	89.0	78.3	52.1	54.7	46.6	55.8	52.8	50.4	64.1	30.8	67.2	89.9	63.1	73.2	70.5	47.5	93.4	51.5	47.8	52.4	47.3	57.9	51.3	66.2	47.8	32.8	41.0	54.7	57.1	45.7	45.2	55.0	55.4	84.4	34.7	45.8	62.7	51.3	53.0	93.0	63.3	139.7	54.8	53.9	119.2	77.4	71.0	52.6	34.1	83.8	73.4	42.7	51.8	61.5	35.8	78.3	103.0	60.3	70.7	72.5	39.7	39.5	42.1	41.9	67.6	92.7	106.1	91.6	58.3	40.7	83.0	54.6	81.4	49.5	63.9	75.2	75.9	68.5	74.9	72.5	96.4	60.8	65.8	68.0	58.6	72.5	56.9	106.5	89.0	78.3	47.4	49.5	39.6	84.0	47.0	50.7	49.2	61.0	48.4	36.3	142.9	125.8	60.3	65.1	68.1	51.9	108.2	81.5	179.3	134.2	68.0	15.7	176.7	87.9	106.1	12.6	85.2	80.0	46.7	168.6	123.7	82.9	62.0	103.4	133.7	108.0	46.1	63.8	90.9	107.2	13.4	96.7	88.1	91.1	226.4	73.7	84.2	122.6	66.6	99.0	122.6	44.8	64.7	80.2	38.6	45.3	66.4	223.6	74.3	80.9	77.2
PSMB5	"MB1, X"	ENSG00000100804	"Proteasome subunit beta 5"	P28074	14	23016543-23035230	"Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction"	"Hydrolase, Protease, Threonine protease"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA049518, HPA061796"	Approved		Supported	Nucleoplasm,Centrosome		NA	NA		8200000	"Nucleoplasm, Centrosome"		"HPA049518: AB_2680802, HPA061796: AB_2684612"	"unprognostic (3.03e-1)"	"unprognostic (1.99e-2)"	"unprognostic (8.35e-2)"	"unprognostic (6.13e-2)"	"unprognostic (1.24e-1)"	"prognostic unfavorable (2.85e-4)"	"prognostic unfavorable (2.90e-5)"	"unprognostic (2.55e-2)"	"unprognostic (9.95e-2)"	"prognostic favorable (1.08e-4)"	"unprognostic (2.06e-1)"	"unprognostic (1.19e-1)"	"unprognostic (5.30e-2)"	"unprognostic (1.75e-1)"	"unprognostic (1.95e-1)"	"unprognostic (4.95e-2)"	"prognostic unfavorable (4.73e-4)"	28.1	38.8	33.6	19.3	35.5	9.6	29.0	19.4	42.9	24.7	28.3	26.8	25.4	21.0	24.2	49.2	31.6	31.6	22.0	37.7	32.9	33.3	35.3	45.4	20.6	18.3	37.5	35.4	22.2	36.6	35.4	26.6	32.5	33.9	27.2	32.2	21.1	28.4	28.7	101.2	22.3	17.2	34.9	32.5	16.7	25.1	27.6	27.3	15.7	29.0	47.3	22.7	20.6	25.2	32.3	53.4	24.6	39.9	19.4	46.8	39.5	22.5	48.1	34.4	32.6	46.4	40.1	34.0	32.2	38.4	56.9	48.4	40.5	36.0	28.0	30.1	43.8	39.5	30.8	54.9	40.2	55.0	17.2	37.9	17.8	35.1	142.5	36.6	21.6	21.4	44.7	37.7	42.2	35.2	37.8	58.8	24.7	26.7	16.0	46.5	66.5	12.3	29.6	38.2	43.6	78.0	16.6	26.0	18.7	44.2	32.7	43.9	34.2	22.7	46.1	31.0	47.0	22.2	28.1	31.6	27.9	28.4	25.8	31.6	13.8	27.3	21.0	21.8	17.4	34.5	24.6	39.9	17.3	29.3	39.0	34.2	32.3	35.1	28.1	42.6	30.1	46.8	35.6	15.5	19.4	27.9	53.4	28.7	39.5	33.6	35.5	19.4	42.9	32.9	33.3	37.5	35.4	33.9	27.3	71.5	50.9	58.0	134.8	124.6	57.4	134.8	129.9	149.9	80.8	90.7	27.5	350.9	233.8	261.5	57.3	106.7	63.2	0.0	201.1	383.6	136.2	130.9	30.1	134.4	190.5	66.7	148.5	90.9	54.9	77.1	109.9	70.7	109.6	199.2	94.1	137.0	244.2	80.7	114.9	331.7	53.8	97.0	134.4	207.4	76.8	137.3	359.7	49.8	123.0	163.4
PSMB6	"DELTA, Y"	ENSG00000142507	"Proteasome subunit beta 6"	P28072	17	4796144-4798503	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction"	"Hydrolase, Protease, Threonine protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023312, HPA063656"	Supported		Supported	Nucleoplasm,Cytosol		NA	NA		2800000	Nucleoplasm	Cytosol	"HPA023312: AB_1855828, HPA063656: AB_2685078"	"unprognostic (2.71e-1)"	"unprognostic (1.86e-2)"	"unprognostic (2.75e-1)"	"unprognostic (3.32e-3)"	"unprognostic (8.80e-2)"	"unprognostic (1.44e-1)"	"unprognostic (2.73e-1)"	"unprognostic (2.22e-2)"	"unprognostic (2.37e-1)"	"unprognostic (2.64e-2)"	"unprognostic (1.98e-2)"	"unprognostic (7.47e-2)"	"prognostic unfavorable (5.93e-4)"	"unprognostic (1.81e-1)"	"unprognostic (2.34e-1)"	"unprognostic (5.27e-2)"	"unprognostic (5.66e-2)"	28.6	35.0	33.7	23.2	36.4	31.7	34.0	24.2	41.5	29.6	31.7	26.7	26.8	22.6	33.4	47.1	41.9	30.3	24.2	72.0	30.4	30.5	41.4	67.1	25.7	35.3	33.4	34.0	25.3	41.8	40.8	26.6	49.6	35.9	26.4	36.1	23.5	30.6	36.6	97.4	33.6	23.2	40.5	29.7	29.0	31.2	27.0	28.0	35.8	34.6	53.8	39.6	27.9	26.0	93.9	96.3	51.1	95.3	60.4	81.2	107.9	46.8	82.1	44.3	37.8	37.8	34.0	51.1	24.9	52.1	76.0	59.7	61.0	38.3	36.5	49.4	59.5	43.8	47.6	67.3	69.6	74.2	47.4	71.0	21.6	54.0	70.8	43.6	22.3	34.5	32.0	53.5	66.4	63.2	42.9	73.8	58.3	33.0	55.5	58.2	55.8	39.4	37.3	37.5	60.6	57.0	44.2	31.5	48.3	57.1	31.6	25.9	31.8	35.7	27.9	25.6	48.4	34.0	25.1	35.2	37.5	28.4	50.4	60.1	23.2	30.9	22.2	53.7	40.8	45.1	51.1	95.3	50.5	57.1	87.5	57.8	93.9	62.3	62.6	96.3	79.8	53.7	56.1	32.9	60.4	78.0	89.7	81.2	107.9	33.7	36.4	24.2	41.5	30.4	30.5	33.4	34.0	35.9	28.0	125.0	90.0	86.3	149.5	203.5	62.3	388.1	150.3	148.5	136.5	127.4	15.7	501.8	303.4	283.2	179.9	152.8	127.2	46.7	303.5	339.8	176.1	166.1	102.7	181.7	306.8	30.2	142.4	94.5	116.6	27.7	101.5	205.7	224.4	422.0	103.5	128.7	291.3	143.8	115.6	455.7	57.6	109.9	242.8	120.2	84.7	242.3	555.7	109.0	129.8	191.2
PSMB7		ENSG00000136930	"Proteasome subunit beta 7"	Q99436	9	124353466-124415444	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction"	"Hydrolase, Protease, Threonine protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA052408, HPA054902"	Supported		Enhanced	"Nucleoplasm,Nuclear bodies,Cytosol"		No	No		2700000	Nucleoplasm	"Nuclear bodies, Cytosol"	"HPA052408: AB_2681820, HPA054902: AB_2682635"	"unprognostic (7.75e-2)"	"unprognostic (1.83e-2)"	"unprognostic (1.27e-1)"	"unprognostic (3.64e-3)"	"unprognostic (2.83e-1)"	"unprognostic (1.25e-1)"	"unprognostic (2.02e-2)"	"unprognostic (2.24e-3)"	"unprognostic (9.03e-2)"	"unprognostic (3.60e-1)"	"unprognostic (2.99e-1)"	"unprognostic (1.78e-1)"	"unprognostic (1.26e-2)"	"unprognostic (1.67e-1)"	"unprognostic (3.45e-1)"	"unprognostic (1.93e-3)"	"unprognostic (3.98e-2)"	36.9	56.9	51.0	32.8	55.1	53.4	41.9	33.7	52.7	26.6	33.3	34.0	27.9	32.5	33.6	52.1	41.9	32.6	29.2	59.6	44.5	41.3	53.7	87.1	27.0	33.6	43.6	46.9	32.7	67.1	38.5	24.1	53.2	47.3	28.8	37.1	31.1	48.2	26.9	76.7	48.7	32.2	31.4	39.9	28.6	33.1	50.3	36.5	48.2	32.7	67.7	39.5	32.3	30.8	53.4	67.9	45.2	62.7	53.6	66.2	69.0	52.6	64.4	44.1	53.3	31.2	37.2	63.6	51.3	70.8	74.4	51.4	84.6	51.6	60.1	41.5	48.0	73.5	75.4	54.9	54.3	68.4	57.8	47.4	37.7	102.4	70.2	70.5	74.7	37.6	44.5	48.0	77.5	77.7	57.5	62.4	54.6	76.8	42.8	57.4	91.7	53.5	50.2	65.2	80.2	92.2	47.4	65.8	70.2	52.6	34.5	52.1	42.3	48.8	62.5	76.0	45.2	72.1	32.9	49.4	48.2	38.9	61.4	76.8	46.5	130.1	60.7	80.6	46.1	67.6	40.4	61.7	45.2	41.8	62.7	45.0	53.4	48.1	46.1	67.9	47.5	46.3	44.9	27.3	53.6	58.4	57.8	66.2	69.0	51.0	55.1	33.7	52.7	44.5	41.3	43.6	46.9	47.3	36.5	71.5	73.0	111.6	140.8	172.4	37.7	121.6	112.1	101.7	62.6	66.3	21.6	382.0	280.2	281.6	279.3	121.5	147.6	46.7	340.4	299.5	140.7	127.9	102.7	222.4	205.6	31.8	135.5	87.8	123.1	322.3	128.9	128.4	189.0	172.3	121.7	86.0	308.8	129.0	117.8	341.8	43.4	84.1	126.0	246.2	184.2	191.3	408.7	106.6	146.6	177.4
PSMB8	"beta5i, D6S216E, LMP7, PSMB5i, RING10"	ENSG00000204264	"Proteasome subunit beta 8"	P28062	6	32840717-32844703	"Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"	"Differentiation, Host-virus interaction, Immunity"	"Hydrolase, Protease, Threonine protease"	"Disease mutation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Daudi: 25.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA046995, HPA050327"	Enhanced		Approved	"Vesicles,Cytokinetic bridge"		No	No		3300000	Vesicles	"Cytokinetic bridge"	"HPA046995: AB_2679896, HPA050327: AB_2681088"	"prognostic favorable (5.08e-4)"	"unprognostic (4.22e-2)"	"unprognostic (2.39e-2)"	"prognostic favorable (7.16e-4)"	"unprognostic (1.92e-1)"	"unprognostic (1.68e-1)"	"unprognostic (7.78e-2)"	"unprognostic (1.09e-1)"	"unprognostic (5.71e-2)"	"unprognostic (1.17e-2)"	"unprognostic (2.79e-2)"	"unprognostic (1.47e-1)"	"unprognostic (4.14e-2)"	"unprognostic (1.24e-1)"	"unprognostic (4.35e-2)"	"unprognostic (1.97e-3)"	"unprognostic (7.11e-3)"	17.0	21.9	7.9	34.8	11.7	14.0	14.9	3.6	7.5	10.0	20.8	5.1	8.8	20.1	12.5	15.3	16.6	13.2	23.8	10.6	6.6	5.7	20.9	30.0	29.0	46.3	9.9	5.1	11.3	12.7	3.6	8.2	9.7	8.8	13.5	24.4	9.2	14.6	11.2	5.1	14.7	37.3	11.5	9.0	42.8	19.4	3.9	9.0	32.2	18.7	18.7	29.0	13.9	12.5	28.9	27.4	37.6	33.2	23.3	29.9	52.2	6.4	2.0	0.1	0.0	2.7	7.1	4.4	1.5	10.2	12.5	18.1	0.0	11.4	25.1	4.8	4.1	9.8	4.5	1.4	6.1	3.4	10.3	0.0	11.1	1.3	0.4	15.0	0.2	4.2	8.0	2.8	7.0	2.4	0.4	8.4	5.4	0.3	5.3	3.1	0.0	5.8	6.1	0.0	0.0	1.6	15.6	0.8	12.4	10.2	1.8	0.1	0.1	2.2	5.4	3.4	0.0	2.4	20.5	2.5	3.7	2.0	3.5	0.2	8.9	8.4	5.6	1.3	14.5	4.7	19.4	29.0	37.4	25.5	33.2	22.1	28.9	21.7	26.4	27.4	26.3	15.1	21.6	37.6	23.3	28.6	23.3	29.9	52.2	7.9	11.7	3.6	7.5	6.6	5.7	9.9	5.1	8.8	9.0	35.7	58.8	174.3	61.0	75.0	1.6	6.1	79.0	62.9	45.5	59.3	0.0	1.7	72.9	173.5	0.5	121.7	242.4	0.0	217.6	10.1	57.2	72.3	49.7	67.1	157.1	6.4	63.1	92.1	135.9	0.6	36.2	111.9	54.0	193.0	164.1	32.8	163.9	247.6	28.7	51.6	2.7	38.8	45.7	0.2	1.2	69.5	2.3	193.7	184.0	98.2
PSMB9	"beta1i, LMP2, PSMB6i, RING12"	ENSG00000240065	"Proteasome subunit beta 9"	P28065	6	32844136-32859585	"Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction, Immunity"	"Hydrolase, Protease, Threonine protease"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 69.1;lymphoid tissue: 54.9"	"Cell type enhanced"	"Detected in many"	6	"monocytes: 319.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Daudi: 29.5;REH: 21.8"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB015180, HPA042818, HPA053280"	Enhanced		Supported	Cytosol		NA	NA		420000	Cytosol		"CAB015180: AB_2172368, HPA042818: AB_2678186, HPA053280: AB_2682098"	"unprognostic (1.09e-2)"	"unprognostic (1.68e-2)"	"unprognostic (1.26e-2)"	"unprognostic (2.18e-3)"	"unprognostic (7.84e-2)"	"unprognostic (1.89e-1)"	"unprognostic (5.68e-2)"	"unprognostic (6.67e-2)"	"unprognostic (1.56e-2)"	"unprognostic (6.50e-3)"	"unprognostic (1.87e-3)"	"unprognostic (1.84e-1)"	"prognostic unfavorable (1.33e-4)"	"unprognostic (2.65e-1)"	"unprognostic (1.09e-1)"	"unprognostic (4.96e-3)"	"unprognostic (5.99e-2)"	13.3	9.7	5.0	30.0	7.9	10.7	11.6	1.6	5.3	7.6	16.5	6.0	3.4	15.7	8.8	7.1	10.8	7.4	10.8	8.9	5.1	4.7	12.2	12.2	17.7	32.7	7.3	3.7	9.2	5.4	1.2	4.5	5.5	6.3	12.5	5.8	7.7	9.0	3.5	6.2	7.6	36.1	5.7	9.8	54.9	11.2	3.0	6.7	35.4	14.4	9.3	35.2	15.9	8.8	31.8	17.2	69.1	30.5	23.4	31.1	45.7	0.0	1.4	0.0	0.1	1.2	3.0	2.0	0.2	3.3	4.2	9.9	0.0	9.2	29.5	0.4	2.7	10.8	6.0	0.4	6.3	0.6	16.6	0.0	18.0	0.5	1.1	15.9	3.1	1.3	1.4	0.2	2.7	0.4	2.3	1.5	8.5	0.7	5.5	1.4	0.5	13.6	4.2	0.0	0.0	0.9	21.8	0.0	7.0	2.8	0.5	0.0	0.0	2.7	1.8	2.0	0.0	2.4	6.6	1.5	4.6	0.4	8.6	2.6	10.2	15.5	9.4	4.7	11.9	3.8	21.9	22.4	39.3	28.7	30.5	23.8	31.8	23.3	27.5	17.2	23.4	17.5	22.9	69.1	23.4	29.4	12.7	31.1	45.7	5.0	7.9	1.6	5.3	5.1	4.7	7.3	3.7	6.3	6.7	38.7	64.6	199.7	29.6	64.5	1.9	5.3	73.9	30.8	34.2	24.4	0.0	0.9	16.6	87.6	1.0	123.4	127.8	46.7	101.9	4.2	38.3	33.2	76.1	23.2	118.3	0.0	32.1	108.1	113.4	0.7	27.0	117.7	33.7	319.2	103.0	19.5	69.2	118.1	14.9	33.5	1.1	32.3	41.0	1.4	6.5	51.3	1.1	214.2	55.9	33.0
PSMD14	"pad1, POH1, Rpn11"	ENSG00000115233	"Proteasome 26S subunit, non-ATPase 14"	O00487	2	161308038-161411717	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"DNA damage, DNA repair, Ubl conjugation pathway"	"Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002114, HPA003828"	Approved		Supported	Nucleoplasm		NA	NA		9400	Nucleoplasm		"HPA002114: AB_1855850, HPA003828: AB_2667057"	"unprognostic (3.50e-3)"	"unprognostic (1.48e-1)"	"unprognostic (9.61e-2)"	"unprognostic (6.63e-2)"	"unprognostic (2.57e-1)"	"unprognostic (7.61e-3)"	"prognostic unfavorable (2.66e-8)"	"unprognostic (3.11e-2)"	"unprognostic (4.04e-2)"	"unprognostic (3.90e-3)"	"unprognostic (9.84e-3)"	"unprognostic (3.02e-1)"	"prognostic unfavorable (3.10e-6)"	"unprognostic (2.86e-2)"	"unprognostic (4.70e-2)"	"unprognostic (3.54e-1)"	"unprognostic (1.66e-1)"	18.2	26.3	24.8	19.9	25.0	16.8	19.8	21.0	36.9	14.7	17.9	13.5	11.0	15.0	15.6	16.3	23.7	14.4	12.2	22.3	24.8	26.1	23.5	33.7	16.2	24.9	26.2	16.1	11.8	15.0	18.6	24.3	21.5	27.9	16.8	21.9	13.0	15.1	16.7	60.8	16.7	14.3	20.6	26.0	20.2	13.6	19.0	15.3	22.1	18.2	21.6	25.6	15.2	13.1	22.9	27.2	13.1	24.6	23.6	29.6	24.7	35.5	30.9	34.8	30.5	25.4	21.7	42.6	37.4	36.0	53.6	43.7	45.4	30.3	42.2	57.1	27.2	31.8	27.4	37.9	39.6	53.6	43.9	28.5	42.1	25.0	50.9	31.2	40.8	25.1	16.5	30.0	60.5	56.6	20.8	39.8	25.3	45.6	30.4	44.5	33.9	30.1	30.8	48.3	26.2	46.9	26.0	33.8	41.2	47.2	30.5	30.3	22.3	25.4	28.7	34.6	30.2	19.5	26.2	31.4	36.0	33.8	24.4	40.8	18.2	49.2	39.6	38.6	27.2	39.4	13.1	17.9	8.8	25.3	24.6	26.5	22.9	27.4	27.0	27.2	19.1	22.2	26.5	1.9	23.6	19.1	26.7	29.6	24.7	24.8	25.0	21.0	36.9	24.8	26.1	26.2	16.1	27.9	15.3	47.6	33.9	44.7	39.4	44.0	40.0	76.7	63.7	42.8	47.8	22.7	17.7	140.9	76.3	104.7	52.8	33.7	43.3	116.8	102.6	127.3	45.3	47.7	48.7	107.7	92.8	44.5	50.4	38.6	35.5	24.8	25.6	45.0	45.5	84.8	42.0	72.5	114.5	46.3	32.2	81.6	54.2	32.3	39.1	93.8	67.0	48.9	184.2	43.6	58.4	43.1
PSMD7	"MOV34, P40, Rpn8, S12"	ENSG00000103035	"Proteasome 26S subunit, non-ATPase 7"	P51665	16	74296775-74306288	"Enzymes, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	5	"Syncytiotrophoblasts: 498.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB019379, HPA049824, HPA056069"	Enhanced		Enhanced	Nucleoplasm		NA	NA		340000	Nucleoplasm		"CAB019379: , HPA049824: AB_2680899, HPA056069: AB_2683025"	"unprognostic (4.75e-3)"	"unprognostic (1.30e-1)"	"unprognostic (2.84e-2)"	"unprognostic (6.95e-2)"	"unprognostic (7.62e-2)"	"prognostic unfavorable (6.64e-5)"	"prognostic unfavorable (7.71e-6)"	"unprognostic (1.97e-2)"	"unprognostic (6.51e-2)"	"unprognostic (1.91e-2)"	"unprognostic (9.34e-3)"	"unprognostic (1.34e-2)"	"unprognostic (2.52e-2)"	"unprognostic (5.06e-3)"	"unprognostic (7.04e-2)"	"unprognostic (2.12e-1)"	"unprognostic (1.86e-2)"	26.5	30.3	23.6	20.8	32.8	45.7	21.7	21.7	34.4	17.7	26.6	22.4	17.0	19.8	24.3	26.1	31.5	16.9	17.6	59.0	22.0	21.7	25.0	47.8	20.3	23.5	24.9	22.9	17.1	18.8	23.2	17.4	44.1	36.1	30.3	28.3	16.7	22.8	27.1	88.8	30.6	22.3	26.4	25.1	27.1	21.8	20.3	22.4	30.7	18.2	34.4	28.4	34.6	22.3	50.3	71.0	64.7	60.8	44.6	56.5	58.1	27.2	45.4	33.7	17.2	24.4	25.3	42.6	38.4	32.4	47.3	43.9	60.1	38.0	37.4	42.7	31.1	20.9	35.4	26.9	34.8	42.3	22.1	29.6	28.9	35.3	45.8	32.2	46.7	49.3	23.2	35.1	42.6	42.8	21.1	41.4	23.7	42.7	16.6	30.1	67.6	26.8	44.2	36.6	27.9	22.8	38.8	21.8	49.7	25.0	41.2	21.5	24.3	37.3	14.0	22.0	26.9	29.7	32.2	37.5	28.4	23.8	30.9	28.7	35.6	45.7	109.0	38.7	34.2	29.3	45.6	58.4	64.7	49.8	60.8	48.5	50.3	49.7	52.0	71.0	36.1	48.7	49.9	34.8	44.6	60.2	59.6	56.5	58.1	23.6	32.8	21.7	34.4	22.0	21.7	24.9	22.9	36.1	22.4	62.5	54.4	81.1	136.0	92.7	50.9	45.6	63.7	85.6	83.0	43.6	7.9	286.0	68.0	118.6	92.9	69.2	93.5	70.0	165.2	180.6	80.2	157.1	101.6	127.1	167.8	54.0	82.1	71.8	72.2	15.2	52.3	110.5	94.5	141.5	71.9	64.7	136.6	87.7	61.5	80.1	48.3	90.5	77.3	113.4	94.9	113.0	498.5	82.8	82.9	180.5
PSPH	PSP	ENSG00000146733	"Phosphoserine phosphatase"	P78330	7	56011051-56051604	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Amino-acid biosynthesis, Serine biosynthesis"	Hydrolase	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	10	"Distal tubular cells: 91.2;Early spermatids: 131.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA020376, HPA029515"	Approved		Approved	Cytosol		NA	NA			Cytosol		"HPA020376: AB_1855867, HPA029515: AB_10601492"	"prognostic unfavorable (2.30e-4)"	"unprognostic (7.80e-2)"	"unprognostic (1.55e-1)"	"unprognostic (2.03e-1)"	"unprognostic (1.07e-1)"	"unprognostic (7.66e-3)"	"prognostic unfavorable (2.75e-5)"	"unprognostic (1.74e-1)"	"unprognostic (2.13e-1)"	"unprognostic (4.45e-2)"	"prognostic favorable (3.77e-4)"	"unprognostic (3.78e-2)"	"unprognostic (5.74e-2)"	"unprognostic (2.64e-1)"	"unprognostic (3.01e-2)"	"unprognostic (1.90e-3)"	"unprognostic (9.05e-3)"	7.5	13.4	14.1	5.9	16.6	5.1	11.0	10.1	14.6	5.4	8.0	13.2	11.4	6.9	7.0	9.0	11.0	26.3	10.6	12.8	13.2	12.5	14.7	9.8	5.4	7.4	14.8	10.0	13.9	15.9	7.8	17.1	6.4	11.1	10.6	6.9	6.9	6.8	11.5	6.8	6.4	6.2	8.5	15.2	5.7	8.5	9.1	13.3	10.2	12.2	6.9	8.5	7.1	16.0	7.8	11.9	6.8	8.5	5.3	6.2	5.8	46.9	14.4	8.8	32.9	7.4	10.0	6.1	11.9	7.0	6.6	11.8	12.9	8.2	23.2	8.0	11.0	16.7	9.8	19.5	10.1	6.9	17.6	10.9	6.5	3.9	21.7	15.9	6.5	10.0	12.5	19.0	10.5	12.2	9.4	6.5	22.0	15.5	15.0	10.0	6.3	9.9	15.5	14.1	16.8	20.2	13.0	5.3	13.3	6.3	2.4	16.1	18.6	8.6	5.3	23.8	7.5	15.9	13.7	5.5	5.8	9.2	17.9	10.8	10.4	18.0	26.3	8.3	14.3	18.2	2.2	7.7	6.8	4.2	5.3	3.0	7.2	4.0	5.1	11.9	7.8	6.2	5.5	3.6	5.3	8.5	11.3	5.1	5.8	14.1	16.6	10.1	14.6	13.2	12.5	14.8	10.0	11.1	13.3	3.0	1.0	9.7	8.3	6.1	4.4	9.4	17.8	34.8	9.1	5.2	2.0	11.9	91.2	7.9	131.4	3.6	1.3	0.0	6.8	6.3	5.3	5.3	1.1	7.3	7.9	1.6	4.6	6.7	6.5	38.2	7.8	4.8	6.8	4.6	3.9	41.4	7.8	3.5	5.6	39.1	2.8	12.9	5.7	23.6	26.0	7.4	3.9	5.0	7.5	4.7
PSTK	"C10orf89, MGC35392"	ENSG00000179988	"Phosphoseryl-tRNA kinase"	Q8IV42	10	122954381-122997513	"Enzymes, Predicted intracellular proteins"	"Protein biosynthesis"	"Kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037780, HPA037781"	Approved		Approved	"Nucleoli,Nuclear bodies,Actin filaments"		No	No			"Actin filaments"	"Nucleoli, Nuclear bodies"	"HPA037780: AB_2675662, HPA037781: AB_10670530"	"unprognostic (8.95e-3)"	"unprognostic (5.51e-3)"	"unprognostic (1.37e-1)"	"unprognostic (7.39e-4)"	"unprognostic (5.21e-2)"	"unprognostic (4.08e-3)"	"unprognostic (1.60e-2)"	"unprognostic (5.92e-4)"	"unprognostic (3.55e-2)"	"unprognostic (1.16e-1)"	"unprognostic (6.22e-3)"	"unprognostic (7.10e-3)"	"unprognostic (2.39e-1)"	"unprognostic (4.50e-2)"	"unprognostic (4.92e-2)"	"unprognostic (3.02e-2)"	"unprognostic (5.55e-4)"	2.8	5.6	7.0	2.5	8.8	12.5	8.8	4.3	10.4	5.8	4.3	10.5	4.7	4.6	5.4	11.4	3.7	5.6	3.5	4.7	7.5	7.3	5.5	10.6	2.8	4.0	8.8	8.7	3.8	5.4	4.2	7.2	3.7	9.3	5.6	4.3	3.8	4.3	3.6	6.8	3.8	3.8	5.4	8.7	2.9	3.0	11.1	8.6	2.9	6.8	1.4	3.6	4.8	3.2	6.5	7.4	6.3	5.5	6.6	10.0	6.0	5.4	3.9	2.1	1.0	2.5	4.7	2.6	2.1	5.2	4.6	5.6	5.6	4.9	5.5	5.1	3.8	2.9	3.0	1.0	4.7	5.4	3.0	10.4	3.8	0.9	4.4	6.0	7.7	4.6	5.3	8.1	4.2	8.1	4.3	3.2	5.0	5.2	8.6	6.8	8.2	2.7	4.8	4.7	2.3	5.6	5.5	3.6	5.1	6.9	3.4	2.2	2.4	4.6	5.3	7.7	2.4	2.5	0.6	3.8	3.6	3.4	1.4	5.2	3.2	1.7	7.6	3.3	5.3	1.4	0.0	5.5	6.3	8.9	3.3	10.0	6.5	6.9	8.4	7.4	5.8	9.2	9.4	0.6	6.6	3.9	7.0	4.2	6.0	7.0	8.8	4.3	10.4	7.5	7.3	8.8	8.7	9.3	8.6	8.9	8.2	3.4	4.6	3.9	8.1	4.4	12.7	8.1	4.5	5.2	7.9	6.8	8.3	3.9	20.0	3.1	1.7	0.0	5.6	2.2	4.1	3.4	2.3	5.1	4.2	4.8	4.1	4.3	1.3	2.6	4.9	3.0	5.0	5.4	2.3	8.5	3.4	3.4	5.3	6.4	9.6	0.0	4.7	16.8	13.8	4.1	8.0	5.7	3.8	2.6
PTDSS1	"KIAA0024, PSS1, PSSA"	ENSG00000156471	"Phosphatidylserine synthase 1"	P48651	8	96261715-96336995	"Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins"	"Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism"	Transferase	"Disease mutation, Dwarfism, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA016852	Uncertain		Approved	"Nucleoplasm,Endoplasmic reticulum"		NA	NA			"Endoplasmic reticulum"	Nucleoplasm	"HPA016852: AB_1855878"	"unprognostic (1.44e-1)"	"unprognostic (1.71e-1)"	"unprognostic (1.08e-1)"	"unprognostic (7.89e-3)"	"unprognostic (7.48e-2)"	"unprognostic (5.68e-3)"	"prognostic unfavorable (1.08e-5)"	"prognostic unfavorable (9.83e-4)"	"unprognostic (2.79e-1)"	"unprognostic (1.71e-2)"	"unprognostic (2.36e-2)"	"unprognostic (1.19e-1)"	"unprognostic (2.29e-3)"	"unprognostic (4.78e-2)"	"unprognostic (1.79e-1)"	"unprognostic (4.08e-2)"	"unprognostic (3.55e-2)"	8.2	7.9	8.0	8.1	14.7	10.2	10.4	10.2	15.0	9.7	8.3	5.1	22.5	10.6	8.4	7.8	9.6	7.0	7.9	20.1	8.6	9.9	9.5	12.8	7.8	21.8	7.1	8.0	9.6	12.1	23.2	4.9	10.8	9.6	5.7	7.4	5.2	8.8	29.8	10.1	10.4	8.3	9.0	6.0	11.8	8.1	5.1	3.6	20.7	11.0	7.7	11.8	9.3	6.8	3.6	6.1	9.4	3.7	5.0	4.6	7.8	10.4	8.1	1.4	3.9	2.9	6.1	2.4	7.6	10.5	7.3	5.1	3.0	3.0	17.2	7.0	7.1	1.5	4.3	9.9	7.6	11.4	8.8	7.1	16.9	15.7	1.6	3.0	12.4	5.9	5.1	7.3	10.2	7.2	1.8	4.7	5.3	8.4	8.9	6.6	3.0	9.6	1.9	2.2	3.4	7.6	7.7	7.3	13.0	4.1	8.9	6.1	2.5	2.8	2.5	1.1	1.7	5.9	4.2	8.3	6.6	4.1	4.6	8.7	1.8	9.3	8.4	4.1	13.1	5.4	9.4	3.7	2.1	2.8	2.5	4.0	2.6	4.6	3.4	6.1	3.6	4.0	2.9	1.3	5.0	2.4	1.8	2.6	7.8	8.0	14.7	10.2	15.0	8.6	9.9	7.1	8.0	9.6	3.6	17.9	10.8	40.8	14.5	28.0	8.9	88.9	22.9	2.7	14.8	10.4	9.8	67.1	1.7	16.6	53.9	21.0	13.3	23.3	38.8	47.5	19.7	14.5	32.3	28.4	42.1	4.8	5.2	19.0	42.5	34.9	21.6	30.4	18.6	17.2	15.0	4.8	21.4	5.8	24.4	15.9	4.3	0.0	17.6	10.3	16.6	29.4	67.6	35.2	29.4	13.6
PTDSS2	PSS2	ENSG00000174915	"Phosphatidylserine synthase 2"	Q9BVG9	11	448268-491399	"Enzymes, Predicted membrane proteins"	"Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"Early spermatids: 114.3;Late spermatids: 274.1;Spermatocytes: 83.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HEK 293: 36.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038928, HPA038929"	Approved					NA	NA					"HPA038928: AB_10672832, HPA038929: AB_2676274"	"unprognostic (3.41e-1)"	"unprognostic (2.52e-1)"	"unprognostic (2.07e-1)"	"unprognostic (5.75e-3)"	"unprognostic (3.19e-2)"	"unprognostic (1.44e-1)"	"prognostic unfavorable (5.12e-9)"	"unprognostic (6.18e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.89e-2)"	"unprognostic (1.41e-3)"	"unprognostic (6.41e-2)"	"unprognostic (1.11e-2)"	"unprognostic (3.39e-2)"	"unprognostic (2.48e-1)"	"unprognostic (2.25e-1)"	"unprognostic (1.09e-1)"	14.6	15.5	14.8	8.0	15.3	6.2	14.9	20.0	19.9	12.2	10.1	19.3	13.6	5.2	11.9	12.0	9.3	14.2	10.8	15.9	15.4	13.1	19.8	11.2	10.4	7.8	15.6	12.0	17.6	17.6	35.2	10.4	14.9	13.7	11.9	7.1	13.5	12.2	14.6	18.6	8.3	7.2	13.1	17.3	9.1	11.7	32.0	15.1	10.6	16.5	8.3	6.6	12.7	10.2	0.1	1.2	0.0	1.3	0.8	1.8	0.0	8.5	7.9	7.1	10.6	6.3	10.4	9.2	7.4	8.8	9.3	8.5	2.1	5.9	4.6	6.3	9.1	8.5	14.0	8.6	11.5	4.6	7.7	36.2	5.7	5.7	4.4	12.1	7.7	5.0	11.8	8.8	3.3	5.8	8.4	7.3	5.3	16.7	1.5	7.2	0.8	7.4	7.1	10.5	6.7	19.2	7.8	8.1	2.1	6.7	1.4	11.0	6.0	10.3	6.6	8.0	8.2	2.4	4.3	9.2	4.5	3.0	2.3	4.7	5.9	2.4	2.0	7.8	3.6	3.1	0.0	0.5	0.0	1.1	1.3	0.3	0.0	0.1	0.2	0.5	0.1	0.7	1.8	0.0	0.8	0.2	1.2	0.3	0.0	14.8	15.3	20.0	19.0	15.4	13.1	15.6	12.0	13.7	15.1	0.0	6.7	6.7	7.0	4.2	36.0	12.3	2.5	1.4	5.7	7.0	27.5	16.5	5.0	11.5	114.3	6.7	9.1	0.0	11.0	19.1	10.1	9.3	0.0	5.0	14.0	20.6	15.4	8.0	4.6	274.1	15.8	5.6	5.0	6.4	7.6	26.9	11.2	5.8	14.5	14.9	26.2	6.5	9.2	83.2	19.8	4.4	14.5	3.9	6.9	5.6
PTEN	"BZS, MHAM, MMAC1, PTEN1, TEP1"	ENSG00000171862	"Phosphatase and tensin homolog"	P60484	10	87863113-87971930	"Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins"	"Apoptosis, Lipid metabolism, Neurogenesis"	"Hydrolase, Protein phosphatase"	"Autism spectrum disorder, Cancer-related genes, Disease mutation, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"neutrophil: 29.6"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"							"CAB004076, HPA031335"	Approved		Supported	Nucleoplasm,Cytosol	"Secreted - unknown location"	NA	NA			Nucleoplasm	Cytosol	"CAB004076: AB_390810, HPA031335: AB_2797221"	"unprognostic (8.72e-2)"	"unprognostic (2.45e-1)"	"unprognostic (5.43e-1)"	"unprognostic (1.50e-2)"	"unprognostic (3.71e-2)"	"unprognostic (1.30e-1)"	"unprognostic (2.18e-1)"	"unprognostic (2.08e-1)"	"unprognostic (2.07e-1)"	"unprognostic (6.87e-2)"	"unprognostic (9.77e-2)"	"unprognostic (2.71e-1)"	"prognostic unfavorable (7.35e-4)"	"unprognostic (1.57e-1)"	"unprognostic (2.73e-1)"	"unprognostic (6.54e-3)"	"unprognostic (2.41e-1)"	42.4	24.1	17.7	20.9	17.7	13.5	32.8	39.9	19.7	43.1	26.7	9.9	19.0	15.1	29.8	22.8	26.8	30.3	21.0	19.1	16.0	17.4	19.6	32.4	27.2	30.4	15.7	19.5	29.1	21.3	16.4	23.6	36.4	14.2	35.3	17.7	21.6	16.8	20.8	16.8	20.4	25.4	26.0	11.7	40.9	17.8	18.7	12.5	49.7	25.2	13.3	18.6	29.6	30.9	4.3	5.1	29.6	11.0	4.3	4.7	2.0	10.2	4.8	5.5	5.0	12.8	8.8	5.0	5.5	12.2	6.5	9.1	4.9	12.6	12.1	3.7	9.0	3.8	6.2	7.4	6.3	10.3	6.0	2.1	4.0	12.5	6.0	13.7	13.5	6.9	6.0	17.6	8.2	10.6	27.6	9.1	7.7	3.0	32.9	5.9	7.8	7.6	24.6	2.0	8.9	0.0	11.8	2.9	8.9	10.1	5.8	2.0	9.0	7.3	3.5	9.2	4.6	9.7	19.6	7.9	21.4	5.0	8.3	4.4	10.8	14.0	13.8	6.6	12.8	1.2	8.3	7.9	12.2	3.6	11.0	3.9	4.3	4.0	3.5	5.1	3.7	4.7	4.5	29.6	4.3	7.2	4.2	3.5	2.0	17.7	17.7	39.9	19.7	16.0	17.4	15.7	19.5	14.2	12.5	32.8	55.3	40.2	50.0	49.8	113.3	39.2	40.8	25.4	28.4	27.9	37.3	22.6	28.2	23.2	57.0	44.4	33.9	0.0	25.8	44.5	52.3	36.9	25.3	58.6	31.3	42.9	30.0	47.9	167.4	70.7	52.6	69.1	59.1	27.9	44.1	54.1	30.2	24.6	51.2	30.8	55.8	90.5	118.8	24.9	24.0	52.6	47.9	35.7	39.2	51.2
PTGDS	"L-PGDS, PGDS"	ENSG00000107317	"Prostaglandin D2 synthase"	P41222	9	136975092-136981742	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism, Mast cell degranulation, Prostaglandin biosynthesis, Prostaglandin metabolism, Transport"	Isomerase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 286.6;retina: 331.2"	"Group enriched"	"Detected in many"	11	"Leydig cells: 35232.9;Peritubular cells: 61248.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	27	"plasmacytoid DC: 140.9"	"Lineage enriched"	"Detected in many"	27	"dendritic cells: 140.9"	"Group enriched"	"Detected in some"	6	"HHSteC: 106.3;HSkMC: 51.8"									"HPA004938, CAB009916"	Approved				"Secreted to blood"	NA	NA		4300000000			"CAB009916: AB_2174617, HPA004938: AB_1855745"	"unprognostic (2.79e-2)"	"unprognostic (3.96e-3)"	"unprognostic (9.70e-2)"	"unprognostic (5.71e-3)"	"unprognostic (6.50e-2)"	"unprognostic (1.43e-3)"	"unprognostic (2.85e-1)"	"unprognostic (2.01e-2)"	"unprognostic (6.50e-2)"	"unprognostic (1.31e-2)"	"unprognostic (1.95e-1)"	"unprognostic (1.08e-1)"	"prognostic unfavorable (1.19e-7)"	"unprognostic (8.49e-3)"	"unprognostic (1.18e-1)"	"unprognostic (2.44e-1)"	"unprognostic (3.21e-2)"	34.1	27.9	138.1	37.5	159.8	2.5	11.3	61.5	154.6	260.4	10.5	192.5	23.0	6.4	22.5	130.0	26.0	72.4	65.8	286.6	121.0	85.2	22.3	6.0	39.7	114.8	170.8	130.6	7.0	20.0	1.8	20.6	38.5	118.8	78.5	4.2	331.2	18.8	149.8	17.0	19.7	11.2	18.6	188.0	50.1	13.5	218.5	103.2	3.3	3.4	4.3	51.1	49.5	75.8	0.0	140.9	0.2	0.1	0.3	5.2	1.0	0.0	0.0	0.0	0.0	1.0	3.3	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.8	4.7	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	106.3	0.0	0.2	51.8	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.2	0.0	0.0	0.0	1.2	0.1	1.4	0.0	0.0	0.0	0.3	0.0	0.0	0.3	0.4	0.0	0.1	0.0	0.0	0.1	13.5	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.8	0.0	0.1	0.0	0.0	0.0	5.2	0.1	0.3	0.0	0.4	0.6	0.1	0.0	0.1	1.1	0.2	0.3	0.0	140.9	0.1	1.0	138.1	159.8	61.5	154.6	121.0	85.2	170.8	130.6	118.8	103.2	0.0	1.1	0.0	3.5	62.5	41.8	283.2	0.0	0.0	0.0	130.9	49.1	12.3	58.0	0.3	163.9	98.7	0.0	0.0	0.0	31.2	935.4	19.2	1.1	1.6	48.0	20.6	0.0	51.5	2.8	458.6	35232.9	41.1	199.1	1.8	0.0	4317.3	1.2	0.0	61248.9	0.6	110.6	161.7	44.3	116.5	105.1	70.0	29.6	37.4	0.0	14.4
PTGES	"MGST-IV, MGST1-L1, MGST1L1, PIG12, TP53I12"	ENSG00000148344	"Prostaglandin E synthase"	O14684	9	129738331-129753047	"Enzymes, Predicted membrane proteins"	"Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism, Prostaglandin biosynthesis, Prostaglandin metabolism"	Isomerase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"ductus deferens: 59.8;placenta: 51.7;seminal vesicle: 182.9"	"Group enriched"	"Detected in many"	4	"Cytotrophoblasts: 118.4;Extravillous trophoblasts: 226.1;Fibroblasts: 92.9;Syncytiotrophoblasts: 231.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in some"	5	"basophil: 16.8"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 16.8"	"Cell line enhanced"	"Detected in many"		"ASC diff: 30.0;BEWO: 31.9;GAMG: 57.8;HaCaT: 41.7;SK-BR-3: 30.6;U-2197: 79.1"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			HPA045064	Enhanced		Supported	"Endoplasmic reticulum"		NA	NA			"Endoplasmic reticulum"		"HPA045064: AB_10795889"	"unprognostic (2.92e-3)"	"unprognostic (1.09e-1)"	"prognostic unfavorable (2.32e-4)"	"unprognostic (2.54e-2)"	"unprognostic (1.94e-3)"	"unprognostic (1.25e-1)"	"unprognostic (5.38e-3)"	"unprognostic (1.24e-3)"	"unprognostic (2.92e-1)"	"unprognostic (1.61e-1)"	"prognostic unfavorable (7.97e-5)"	"unprognostic (2.22e-1)"	"unprognostic (4.66e-2)"	"unprognostic (9.78e-3)"	"unprognostic (3.19e-2)"	"unprognostic (1.30e-1)"	"unprognostic (5.20e-2)"	17.0	0.6	1.1	6.2	1.7	3.0	16.7	1.1	1.8	11.9	4.2	0.8	59.8	1.2	2.0	9.1	8.7	2.7	4.1	4.2	2.1	3.5	3.9	0.4	3.5	3.1	1.3	0.7	2.7	0.6	6.3	0.7	51.7	2.1	11.2	2.0	2.9	16.3	182.9	2.5	19.8	3.7	4.8	1.4	1.3	3.4	9.9	0.6	2.3	1.7	6.6	14.1	14.5	15.0	0.0	0.1	16.8	3.2	0.0	0.0	0.1	0.2	18.7	0.0	8.9	30.0	10.4	31.9	1.4	12.3	0.2	0.3	0.9	13.7	0.0	0.5	3.4	57.8	41.7	0.1	1.4	0.1	0.0	0.1	0.0	13.3	0.0	0.7	0.0	0.0	6.1	9.7	0.1	0.0	0.2	0.0	0.1	0.0	0.0	0.1	0.3	0.0	0.0	0.2	8.9	1.6	0.0	0.0	0.0	1.0	19.9	0.1	0.7	16.7	30.6	0.1	1.3	16.0	0.0	0.0	0.0	0.0	79.1	0.0	0.0	0.0	0.0	15.7	0.0	0.1	16.8	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.4	0.0	3.2	0.0	0.0	0.1	1.1	1.7	1.1	1.8	2.1	3.5	1.3	0.7	2.1	0.6	0.0	0.0	0.0	8.2	15.9	0.0	0.0	0.0	0.0	4.5	3.5	0.0	118.4	1.7	10.6	0.4	0.3	0.0	0.0	1.0	226.1	92.9	6.9	1.1	0.0	15.4	0.0	7.0	0.0	0.0	0.0	0.3	3.8	13.5	12.6	6.4	0.0	5.7	0.0	0.0	0.5	0.0	0.0	11.2	0.3	0.0	37.6	231.0	0.0	0.3	38.2
PTGES2	"C9orf15, FLJ14038"	ENSG00000148334	"Prostaglandin E synthase 2"	Q9H7Z7	9	128120693-128128462	"Enzymes, Predicted intracellular proteins"	"Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism, Prostaglandin biosynthesis, Prostaglandin metabolism"	Isomerase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 73.5"	"Cell type enhanced"	"Detected in many"	13	"Cardiomyocytes: 606.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA020631, HPA020733"	Approved		Approved	Mitochondria		No	No			Mitochondria		"HPA020631: AB_1855887, HPA020733: AB_2670508"	"unprognostic (1.23e-1)"	"unprognostic (1.86e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.95e-2)"	"unprognostic (1.55e-1)"	"unprognostic (1.68e-2)"	"unprognostic (5.13e-3)"	"unprognostic (2.56e-1)"	"unprognostic (1.57e-1)"	"unprognostic (7.10e-2)"	"unprognostic (2.81e-2)"	"unprognostic (4.33e-2)"	"prognostic favorable (5.83e-7)"	"unprognostic (2.10e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.05e-1)"	9.3	17.0	16.5	9.2	17.8	4.4	7.4	15.3	24.1	7.1	14.8	9.9	7.6	17.7	8.1	9.0	12.6	8.4	10.0	36.4	17.4	14.0	13.2	13.0	5.8	10.2	14.2	11.6	9.2	18.3	11.7	14.3	10.7	10.5	8.0	7.0	13.2	16.2	12.0	73.5	9.3	13.2	5.9	7.0	9.5	14.3	5.8	9.8	9.3	10.5	16.2	13.3	8.5	7.3	5.2	8.2	1.2	6.3	3.7	6.5	2.9	12.7	35.8	4.0	14.8	3.6	3.7	12.2	9.8	5.5	12.4	6.6	26.7	20.0	11.3	15.7	3.9	9.7	33.2	5.8	12.1	1.7	8.1	15.6	5.8	27.1	24.9	11.1	11.7	11.6	5.0	8.8	10.0	6.9	3.8	8.5	12.0	12.8	7.0	4.1	39.5	14.0	22.4	12.8	15.4	29.0	10.6	7.9	28.8	8.4	9.6	20.0	12.0	14.2	22.6	9.5	2.0	20.2	6.3	11.1	12.8	15.8	17.2	17.8	16.2	7.9	11.0	9.7	9.1	11.8	1.2	6.0	1.0	5.6	6.3	6.5	5.2	3.7	5.9	6.7	4.5	4.3	5.1	1.1	3.7	2.8	8.2	4.2	2.9	16.5	17.8	15.3	24.1	17.4	14.0	14.2	11.6	10.5	9.8	14.9	5.4	25.3	29.8	20.4	34.7	606.9	35.7	0.0	6.8	22.7	19.6	69.1	124.3	64.1	1.9	21.1	88.3	0.0	44.8	49.4	20.3	34.0	14.9	33.3	50.6	35.0	43.4	15.4	22.9	3.2	28.4	33.8	54.0	154.1	52.3	18.2	52.2	51.8	20.5	79.0	38.1	19.4	28.3	2.3	56.6	21.5	55.7	21.7	83.1	40.8
PTGES3	"cPGES, p23, TEBP"	ENSG00000110958	"Prostaglandin E synthase 3"	Q15185	12	56663341-56688408	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism, Prostaglandin biosynthesis, Prostaglandin metabolism"	"Chaperone, Isomerase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"vagina: 358.9"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB034319, HPA038672, HPA038673"	Enhanced		Approved	Nucleoplasm,Cytosol		NA	NA		580000	Cytosol	Nucleoplasm	"CAB034319: AB_2175206, HPA038672: AB_10697395, HPA038673: AB_10670786"	"prognostic unfavorable (2.15e-5)"	"unprognostic (2.60e-1)"	"unprognostic (8.67e-3)"	"unprognostic (7.07e-2)"	"unprognostic (2.24e-1)"	"unprognostic (2.96e-3)"	"prognostic unfavorable (4.44e-6)"	"unprognostic (4.33e-3)"	"unprognostic (3.64e-2)"	"prognostic favorable (4.36e-4)"	"unprognostic (2.73e-2)"	"unprognostic (2.31e-2)"	"unprognostic (3.05e-3)"	"unprognostic (1.01e-1)"	"unprognostic (2.17e-1)"	"unprognostic (2.28e-1)"	"unprognostic (2.07e-1)"	44.7	41.4	56.0	41.2	55.7	39.6	175.0	44.2	51.7	49.0	51.9	38.1	49.5	46.4	57.7	52.0	52.6	69.8	36.0	46.0	54.6	57.2	52.1	67.1	46.4	62.0	67.0	41.4	82.3	55.1	43.2	49.2	50.3	57.0	60.7	55.3	24.0	36.6	49.4	64.2	37.0	46.7	64.7	72.5	42.7	36.6	39.7	65.1	53.5	72.5	36.7	55.1	72.7	358.9	40.6	36.9	27.3	74.8	29.2	42.5	60.5	81.4	71.0	57.7	34.3	42.5	38.6	87.9	53.4	40.8	68.8	51.4	60.1	85.9	90.3	81.1	45.5	46.3	52.5	108.0	69.7	87.2	66.3	71.9	70.5	44.9	69.5	31.1	83.7	51.2	27.9	51.0	51.9	63.1	65.5	70.7	58.1	113.0	86.5	67.1	50.8	83.1	79.6	98.5	71.9	83.0	72.7	54.4	121.2	60.5	63.8	74.8	43.7	54.5	78.6	46.2	79.6	90.5	70.3	42.3	41.3	48.1	49.5	73.7	36.5	100.4	72.6	45.0	69.1	74.3	27.3	37.5	23.2	32.0	59.0	42.0	40.6	42.5	38.1	36.9	28.5	42.3	36.4	14.8	29.2	74.8	31.3	42.5	60.5	56.0	55.7	44.2	51.7	54.6	57.2	67.0	41.4	57.0	65.1	166.7	121.6	178.4	623.1	343.3	128.5	151.7	150.3	313.2	146.7	179.7	72.6	370.5	316.7	252.0	38.5	189.7	176.9	116.8	186.9	545.4	268.2	456.4	232.8	165.2	311.0	106.5	250.8	168.1	180.7	81.6	221.2	245.7	268.2	312.0	185.6	201.5	190.6	194.6	200.5	268.7	99.7	142.3	307.9	546.1	341.1	330.1	473.4	233.5	241.8	443.4
PTGIS	"CYP8A1, PGIS"	ENSG00000124212	"Prostaglandin I2 synthase"	Q16647	20	49503874-49568146	"Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted membrane proteins"	"Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism, Prostaglandin biosynthesis, Prostaglandin metabolism"	"Isomerase, Lyase"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"smooth muscle: 88.2"	"Group enriched"	"Detected in many"	8	"Ito cells: 78.5;Leydig cells: 24.7;Peritubular cells: 98.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in some"	4	"ASC diff: 17.8;ASC TERT1: 17.9;U-2197: 55.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"CAB009517, HPA014193, HPA052244"	Enhanced		Approved	"Endoplasmic reticulum"		NA	NA			"Endoplasmic reticulum"		"CAB009517: AB_2173209, HPA014193: AB_1855746, HPA052244: AB_2732574"	"unprognostic (7.68e-2)"	"unprognostic (1.90e-1)"	"unprognostic (5.09e-3)"	"unprognostic (1.38e-2)"	"unprognostic (1.80e-2)"	"unprognostic (1.74e-1)"	"unprognostic (1.21e-2)"	"unprognostic (1.29e-2)"	"unprognostic (1.25e-1)"	"unprognostic (4.02e-2)"	"unprognostic (2.45e-2)"	"unprognostic (5.22e-2)"	"prognostic unfavorable (4.74e-8)"	"unprognostic (2.29e-2)"	"unprognostic (7.61e-2)"	"unprognostic (4.89e-3)"	"prognostic unfavorable (9.99e-5)"	18.2	2.5	0.6	8.0	1.3	0.1	28.3	0.2	1.6	23.3	14.6	0.5	6.5	1.7	36.5	21.7	13.2	32.0	36.3	23.8	0.3	0.5	3.0	3.8	7.5	1.6	0.5	0.9	51.2	1.3	0.2	0.5	1.0	1.0	27.2	3.7	3.2	3.7	4.6	7.0	3.2	4.4	88.2	1.4	0.3	8.7	16.2	0.3	0.0	6.7	5.6	1.7	64.2	36.1	1.0	0.8	2.7	0.6	0.8	0.5	0.1	0.0	0.0	0.7	0.0	17.8	17.9	0.2	0.3	2.1	0.0	0.0	0.0	0.0	0.0	7.1	5.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	1.3	0.0	0.2	0.0	5.8	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	3.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	3.3	0.0	0.0	0.0	0.3	0.9	55.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.6	0.4	0.4	0.4	0.3	0.4	0.3	0.3	0.1	1.0	0.4	0.5	2.7	0.8	0.3	0.8	0.2	0.1	0.6	1.3	0.2	1.6	0.3	0.5	0.5	0.9	1.0	0.3	3.0	2.4	0.0	0.6	3.3	0.8	3.4	0.0	4.0	3.4	3.5	0.0	0.3	0.0	0.4	1.7	3.8	0.0	0.0	0.0	0.1	8.3	0.3	0.0	0.6	0.3	0.0	0.0	78.5	1.5	2.2	24.7	0.7	1.7	0.0	0.0	0.3	0.7	0.0	98.6	0.0	4.6	0.0	2.5	0.7	1.1	4.3	0.2	0.5	0.0	0.6
PTGR1	"LTB4DH, ZADH3"	ENSG00000106853	"Prostaglandin reductase 1"	Q14914	9	111549722-111599855	"Enzymes, Plasma proteins, Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 117.6;liver: 113.8"	"Cell type enhanced"	"Detected in many"	11	"Cholangiocytes: 377.0;Hepatocytes: 710.5;Proximal tubular cells: 445.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	6	"plasmacytoid DC: 8.9"	"Lineage enriched"	"Detected in single"	9	"dendritic cells: 8.9"	"Cell line enhanced"	"Detected in many"		"OE19: 135.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA036724	Enhanced					NA	NA		940000			"HPA036724: AB_10670239"	"unprognostic (1.54e-1)"	"unprognostic (2.23e-1)"	"unprognostic (1.10e-2)"	"unprognostic (3.02e-3)"	"unprognostic (8.46e-2)"	"unprognostic (1.02e-3)"	"unprognostic (1.91e-2)"	"unprognostic (1.37e-1)"	"unprognostic (1.30e-1)"	"unprognostic (1.27e-1)"	"unprognostic (1.28e-2)"	"unprognostic (3.48e-1)"	"prognostic favorable (5.53e-4)"	"unprognostic (2.25e-1)"	"unprognostic (2.24e-1)"	"unprognostic (1.31e-2)"	"unprognostic (5.22e-2)"	9.9	23.7	6.7	3.4	8.1	0.4	8.0	9.7	10.0	8.0	116.3	2.2	3.0	45.2	8.0	7.8	27.4	14.3	15.2	7.7	7.0	4.2	47.3	113.8	5.2	2.6	3.3	6.6	5.9	4.3	6.2	9.0	3.2	6.4	12.3	6.7	6.8	11.4	6.4	3.3	6.7	117.6	8.7	2.5	2.2	21.2	3.3	3.4	1.1	9.0	36.4	12.5	21.9	23.6	0.3	8.9	0.2	0.9	0.0	0.2	0.5	7.7	32.9	9.6	0.1	35.3	35.7	7.5	12.6	19.2	12.0	12.6	8.9	10.6	0.0	3.6	12.0	23.8	9.5	7.7	13.3	14.9	0.0	2.3	1.9	20.4	43.3	8.1	1.1	4.0	25.4	20.1	16.5	8.4	14.2	30.4	0.0	1.3	0.0	23.3	2.3	0.0	0.2	3.9	135.6	8.1	0.0	2.7	0.2	14.1	25.3	10.8	0.5	15.5	4.7	4.6	10.1	14.5	5.2	24.5	2.3	4.9	26.9	2.2	0.0	0.0	0.0	11.5	0.0	2.9	0.0	0.9	0.0	0.0	0.1	0.2	0.3	0.0	0.0	1.5	0.0	0.0	0.0	0.2	0.0	0.0	8.9	0.0	0.5	6.7	8.1	9.7	10.0	7.0	4.2	3.3	6.6	6.4	3.4	17.9	24.1	7.4	46.4	34.3	15.0	31.9	377.0	41.5	26.1	134.3	23.6	41.2	127.6	59.9	2.6	22.5	52.9	0.0	153.0	26.9	30.9	61.7	1.1	710.5	45.6	0.0	25.5	47.3	25.0	2.2	30.8	19.7	33.7	37.9	29.6	37.3	177.9	43.2	37.1	445.1	42.8	12.9	54.5	8.7	4.5	26.7	17.2	5.1	43.5	89.4
PTGR2	"FLJ39091, ZADH1"	ENSG00000140043	"Prostaglandin reductase 2"	Q8N8N7	14	73851844-73886827	"Enzymes, Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Ciliated cells: 41.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"T-47d: 29.0"									HPA001125	Approved		Approved	Vesicles		NA	NA		1000000	Vesicles		"HPA001125: AB_2666207"	"unprognostic (3.82e-2)"	"unprognostic (2.79e-2)"	"unprognostic (6.05e-2)"	"unprognostic (3.26e-1)"	"unprognostic (2.28e-1)"	"unprognostic (1.40e-1)"	"unprognostic (1.39e-1)"	"unprognostic (1.96e-2)"	"unprognostic (2.80e-1)"	"unprognostic (8.10e-3)"	"unprognostic (6.99e-3)"	"unprognostic (5.96e-1)"	"prognostic favorable (4.55e-12)"	"unprognostic (4.42e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.33e-1)"	"unprognostic (7.24e-2)"	7.4	14.4	16.0	3.4	17.2	1.6	10.9	8.0	13.3	6.2	8.3	15.3	11.9	13.7	5.8	20.3	6.2	13.9	6.4	29.0	15.0	12.2	22.1	20.9	6.6	3.7	15.2	12.6	9.1	6.4	13.8	12.8	3.2	20.4	10.9	6.9	10.1	7.7	8.9	32.4	8.1	9.9	4.9	16.0	4.1	7.0	11.5	17.2	2.0	14.6	9.1	3.4	5.5	7.0	2.2	3.2	8.4	2.4	2.3	4.0	2.3	5.9	8.1	6.7	3.3	5.4	11.8	5.3	2.0	2.8	2.5	3.9	4.6	14.6	0.6	4.8	2.0	5.9	6.0	6.0	4.4	4.7	4.5	2.8	4.1	3.8	2.0	2.7	1.5	1.5	5.5	10.6	3.8	3.1	5.5	1.2	4.2	5.5	1.2	5.6	8.5	4.0	3.9	7.4	8.0	8.1	5.1	2.6	1.0	13.7	5.8	8.9	7.7	5.3	5.7	6.6	6.7	29.0	2.5	1.8	3.8	7.1	2.7	4.4	7.1	3.1	1.9	5.8	3.7	5.0	8.4	2.4	1.8	1.6	0.9	1.2	2.1	2.3	1.2	2.6	2.2	4.0	3.2	2.0	2.3	2.2	3.2	2.1	2.3	16.0	17.2	8.0	13.3	15.0	12.2	15.2	12.6	20.4	17.2	17.9	8.8	0.5	9.0	6.1	9.4	39.0	5.1	41.5	10.3	17.4	13.7	5.6	21.6	10.0	1.9	2.8	10.5	0.0	7.8	1.9	4.1	9.0	3.5	12.5	6.3	31.8	4.6	3.7	5.7	1.5	6.6	4.7	8.5	4.6	11.3	20.3	6.4	13.1	6.3	12.8	20.5	6.5	4.2	29.8	10.9	5.8	3.3	3.3	10.8	5.4
PTGS1	"COX1, PGHS-1, PTGHS"	ENSG00000095303	"Prostaglandin-endoperoxide synthase 1"	P23219	9	122370530-122395703	"Cancer-related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins"	"Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism, Prostaglandin biosynthesis, Prostaglandin metabolism"	"Dioxygenase, Oxidoreductase, Peroxidase"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"smooth muscle: 211.4;urinary bladder: 163.9"	"Cell type enriched"	"Detected in many"	4	"granulocytes: 205.3"	"Cancer enhanced"	"Detected in all"		"ovarian cancer: 53.4"	"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"dendritic cells: 13.0;granulocytes: 14.4;monocytes: 8.5"	"Cell line enhanced"	"Detected in some"		"ASC diff: 28.8;ASC TERT1: 22.8;BJ: 27.9;BJ hTERT+: 38.1;HEL: 17.5;HMC-1: 74.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002834, CAB020315"	Enhanced		Supported	"Golgi apparatus,Vesicles"	"Intracellular and membrane"	NA	NA		25000000	"Golgi apparatus"	Vesicles	"CAB020315: , HPA002834: AB_1079711"	"unprognostic (4.20e-1)"	"unprognostic (6.23e-2)"	"unprognostic (1.08e-2)"	"unprognostic (2.27e-2)"	"unprognostic (5.88e-2)"	"unprognostic (2.00e-2)"	"unprognostic (1.22e-3)"	"unprognostic (3.32e-1)"	"unprognostic (2.24e-1)"	"unprognostic (3.16e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.46e-1)"	"prognostic unfavorable (8.68e-4)"	"unprognostic (4.03e-2)"	"unprognostic (1.78e-2)"	"unprognostic (2.08e-1)"	"prognostic unfavorable (9.35e-4)"	4.5	1.1	1.8	9.1	3.1	2.6	2.5	0.5	2.7	2.6	35.3	4.6	3.0	3.9	2.5	1.6	25.7	16.7	9.4	4.9	1.9	1.6	3.9	1.8	4.0	1.4	3.5	0.7	3.6	1.0	0.7	2.4	0.8	2.5	60.9	9.3	1.5	1.9	2.3	0.7	55.9	6.5	211.4	4.9	3.6	7.8	1.0	3.1	0.4	1.5	5.3	4.2	163.9	19.5	2.5	13.0	14.4	8.5	1.9	0.1	13.7	0.0	0.1	0.1	0.0	28.8	22.8	0.0	27.9	38.1	0.2	0.2	0.0	0.0	1.0	1.3	4.7	0.0	1.7	0.1	2.5	0.2	0.0	0.0	17.5	0.1	0.0	8.3	1.2	74.3	11.6	0.3	1.4	0.0	0.0	10.3	0.0	0.0	0.0	0.5	0.0	0.0	1.5	0.4	0.0	0.1	0.0	0.3	2.0	3.6	0.0	0.1	0.1	0.1	2.3	0.0	0.1	0.0	2.0	0.2	0.1	0.1	0.4	0.0	0.0	0.0	0.0	0.1	7.6	0.0	12.0	7.6	14.4	0.0	8.5	0.0	1.7	0.0	0.0	13.0	2.5	0.0	0.0	3.5	1.9	6.1	0.9	0.1	13.7	1.8	3.1	0.5	2.7	1.9	1.6	3.5	0.7	2.5	3.1	0.0	10.0	0.9	2.4	8.9	0.0	1.1	0.0	1.4	2.3	40.1	0.0	0.1	0.0	0.5	0.0	6.0	0.0	0.0	0.4	0.2	4.7	1.9	205.3	0.0	25.3	0.0	1.7	36.8	10.7	0.0	1.4	22.9	3.3	4.6	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.0	51.3	0.3	0.7	0.5	0.6
PTGS2	COX2	ENSG00000073756	"Prostaglandin-endoperoxide synthase 2"	P35354	1	186671791-186680427	"Cancer-related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins"	"Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism, Prostaglandin biosynthesis, Prostaglandin metabolism"	"Dioxygenase, Oxidoreductase, Peroxidase"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	11	"ductus deferens: 324.6;seminal vesicle: 377.9"	"Cell type enhanced"	"Detected in many"	11	"Alveolar cells type 1: 318.6;Glandular cells: 122.9;granulocytes: 329.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in single"	16	"neutrophil: 12.8"	"Lineage enriched"	"Detected in single"	16	"granulocytes: 12.8"	"Cell line enriched"	"Detected in some"	4	"BJ hTERT+: 95.4"	"Region enhanced"	"Detected in many"		"hippocampal formation: 16.5"	"Low region specificity"	"Detected in all"			"CAB000113, HPA001335"	Enhanced		Supported	"Endoplasmic reticulum"	"Intracellular and membrane"	NA	NA			"Endoplasmic reticulum"		"CAB000113: , HPA001335: AB_1079712"	"unprognostic (1.36e-3)"	"unprognostic (9.97e-3)"	"unprognostic (3.97e-2)"	"unprognostic (3.31e-2)"	"unprognostic (1.55e-1)"	"unprognostic (1.11e-1)"	"unprognostic (5.96e-2)"	"unprognostic (9.50e-2)"	"unprognostic (9.03e-3)"	"unprognostic (2.81e-1)"	"unprognostic (3.24e-2)"	"unprognostic (3.07e-2)"	"prognostic unfavorable (9.79e-4)"	"unprognostic (8.04e-3)"	"unprognostic (4.38e-2)"	"unprognostic (8.89e-2)"	"unprognostic (3.74e-2)"	5.7	2.1	1.2	3.7	1.1	32.6	1.5	0.8	1.9	21.1	11.4	1.1	324.6	0.4	2.3	1.8	1.7	4.0	9.5	9.1	1.1	1.0	3.3	2.7	22.1	2.3	1.3	0.8	1.6	0.4	3.1	2.2	2.5	1.9	9.2	2.7	3.9	0.9	377.9	1.0	1.1	2.4	7.7	4.7	0.9	11.4	1.0	0.9	0.6	1.5	3.4	1.3	17.3	1.9	0.0	0.5	12.8	0.8	0.0	0.0	0.0	0.0	5.0	0.0	0.0	0.6	0.5	0.0	21.8	95.4	0.1	0.8	3.4	4.0	0.0	0.0	0.1	0.6	2.9	0.0	1.7	0.3	0.0	0.0	0.2	0.5	0.0	3.2	0.0	0.1	0.2	0.6	2.7	6.9	0.2	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	1.2	0.3	0.0	0.2	0.0	0.2	0.6	0.0	0.1	0.3	4.6	0.1	3.2	0.1	0.0	0.0	0.0	6.7	0.1	0.5	0.0	0.4	0.3	0.0	0.8	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	12.8	0.0	0.4	0.0	0.0	0.0	1.2	1.1	0.8	1.9	1.1	1.0	1.3	0.8	1.9	0.9	318.6	102.3	0.5	47.5	105.6	0.0	1.9	0.0	8.1	53.4	0.0	0.0	0.1	0.0	0.8	0.2	14.3	0.0	0.0	0.2	0.2	36.1	122.9	329.1	0.0	11.5	0.0	1.2	6.7	16.5	0.0	0.0	112.3	33.7	0.0	0.5	0.0	3.2	0.0	0.0	0.0	0.2	0.0	21.7	0.1	0.4	24.8	0.5	0.0	1.3	107.5
PTK2	"FADK, FAK, FAK1, PPP1R71"	ENSG00000169398	"Protein tyrosine kinase 2"	Q05397	8	140657900-141002216	"Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	Angiogenesis	"Developmental protein, Kinase, Transferase, Tyrosine-protein kinase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001842, CAB004036, HPA029671"	Approved		Supported	"Vesicles,Focal adhesion sites,Cytosol"		NA	NA		32000	"Focal adhesion sites"	"Vesicles, Cytosol"	"CAB004036: AB_2269034, HPA001842: AB_1855891, HPA029671: AB_10610288"	"prognostic unfavorable (3.21e-4)"	"unprognostic (3.86e-2)"	"unprognostic (1.95e-1)"	"prognostic unfavorable (9.11e-4)"	"unprognostic (1.93e-1)"	"unprognostic (2.28e-1)"	"unprognostic (3.02e-2)"	"unprognostic (1.27e-1)"	"unprognostic (1.97e-1)"	"unprognostic (2.96e-2)"	"unprognostic (1.06e-2)"	"unprognostic (2.38e-1)"	"unprognostic (2.80e-2)"	"unprognostic (2.94e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.53e-1)"	"unprognostic (2.90e-2)"	22.6	20.4	36.0	14.4	42.3	3.1	19.3	20.5	40.8	24.9	17.9	55.7	23.5	14.5	20.2	29.9	14.6	18.7	18.4	20.0	43.5	23.9	22.3	17.0	21.5	13.0	41.4	31.4	19.4	18.2	33.1	13.0	42.1	30.0	19.2	20.7	11.0	21.9	25.5	17.9	13.5	16.3	21.9	38.0	12.2	17.5	21.2	46.1	2.8	22.5	10.2	14.0	22.2	17.8	8.6	7.2	1.8	3.9	5.2	5.7	4.1	14.5	23.1	32.1	11.5	13.5	14.5	20.7	14.4	20.0	13.4	13.2	10.1	12.0	8.8	32.6	18.3	18.9	17.1	18.8	32.8	20.4	0.1	8.8	19.5	12.8	13.9	18.5	0.0	9.2	9.8	16.2	16.8	23.7	35.4	39.6	12.5	19.6	0.2	17.9	25.2	0.2	0.1	12.4	31.5	25.8	12.9	17.6	0.4	28.4	33.1	12.7	15.9	22.4	7.2	14.5	29.6	17.0	0.3	23.9	13.3	25.0	15.6	16.1	0.0	0.1	0.9	17.2	0.1	17.9	1.8	3.9	0.0	0.3	1.6	0.0	6.8	0.8	0.1	5.3	8.6	5.7	2.0	1.7	5.2	0.9	7.2	0.2	4.1	36.0	42.3	20.5	40.8	43.5	23.9	41.4	31.4	30.0	46.1	29.8	24.9	2.7	51.7	29.7	51.6	26.2	33.1	25.4	20.5	52.4	56.9	27.2	19.9	23.3	34.0	35.8	21.0	0.0	20.0	45.5	28.2	67.2	9.2	14.7	6.8	63.5	24.8	33.7	11.7	33.3	22.2	7.9	23.6	1.0	23.1	41.5	33.4	21.0	20.5	22.6	56.8	97.0	121.7	43.2	62.8	22.6	27.8	1.8	21.0	67.4
PTK2B	"CADTK, CAKB, FAK2, PTK, PYK2, RAFTK"	ENSG00000120899	"Protein tyrosine kinase 2 beta"	Q14289	8	27311482-27459391	"Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"	"Adaptive immunity, Angiogenesis, Immunity"	"Kinase, Transferase, Tyrosine-protein kinase"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 46.7;brain: 65.2"	"Cell type enhanced"	"Detected in many"	5	"Kupffer cells: 73.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Daudi: 37.7;REH: 41.9"	"Group enriched"	"Detected in many"	4	"amygdala: 202.9;basal ganglia: 236.9;cerebral cortex: 189.7;hippocampal formation: 443.3;olfactory region: 185.5"	"Low region specificity"	"Detected in all"			"CAB003850, HPA026091, HPA026276"	Approved		Supported	"Plasma membrane,Cytosol"		NA	NA		84000	"Plasma membrane, Cytosol"		"CAB003850: AB_562205, HPA026091: AB_10599739, HPA026276: AB_10601234"	"unprognostic (2.36e-2)"	"prognostic favorable (3.32e-4)"	"unprognostic (1.06e-1)"	"unprognostic (7.36e-3)"	"unprognostic (3.72e-2)"	"unprognostic (3.11e-2)"	"unprognostic (2.70e-2)"	"unprognostic (2.13e-2)"	"unprognostic (3.23e-1)"	"unprognostic (1.45e-1)"	"unprognostic (5.74e-2)"	"unprognostic (3.32e-1)"	"unprognostic (2.40e-3)"	"unprognostic (1.44e-1)"	"unprognostic (1.38e-1)"	"prognostic favorable (5.11e-4)"	"unprognostic (3.33e-3)"	7.2	4.7	20.4	24.3	30.0	46.7	4.9	65.2	48.3	5.4	14.5	7.8	5.0	16.6	4.3	4.7	7.9	6.8	6.4	4.7	30.5	7.0	6.8	5.0	11.5	35.6	4.3	25.4	2.4	5.4	5.2	5.3	4.1	3.9	10.1	11.9	8.3	12.6	6.7	2.2	15.1	18.4	5.5	4.8	32.0	10.8	4.3	3.7	37.8	5.6	2.9	35.4	13.0	6.0	26.9	18.7	24.0	25.8	14.7	19.0	21.5	11.1	3.1	0.8	0.9	24.0	1.7	6.5	0.9	0.6	0.6	0.8	2.9	6.5	37.7	1.2	1.7	0.9	10.3	0.3	9.4	0.3	2.5	0.2	7.8	3.0	0.6	4.9	8.3	14.0	13.0	14.0	0.8	5.4	4.0	0.3	10.9	9.1	26.3	0.6	1.1	14.3	16.8	0.6	9.7	0.8	41.9	0.2	25.8	2.6	8.8	6.0	1.1	4.0	2.8	1.5	2.1	3.3	21.6	5.3	0.4	0.8	0.7	0.3	21.1	9.1	20.4	1.6	18.1	0.7	22.3	23.7	18.0	19.0	22.4	12.5	25.5	9.6	13.3	18.7	26.9	12.1	14.2	24.0	14.7	25.8	6.2	9.5	21.5	20.4	30.0	65.2	48.3	30.5	7.0	4.3	25.4	3.9	3.7	3.0	30.9	54.0	32.1	33.5	4.1	3.1	12.7	13.4	13.6	14.0	0.0	2.4	0.0	6.4	1.1	7.5	48.3	0.0	7.0	23.9	3.8	16.5	27.7	21.8	20.9	7.9	7.5	3.1	73.4	0.8	1.4	42.5	8.5	34.3	18.6	3.4	9.4	35.1	0.7	14.7	4.0	0.0	1.6	4.2	5.5	26.3	1.6	39.9	14.9	14.8
PTK6	BRK	ENSG00000101213	"Protein tyrosine kinase 6"	Q13882	20	63528001-63537370	"Cancer-related genes, Enzymes, Predicted intracellular proteins"		"Kinase, Transferase, Tyrosine-protein kinase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 44.0;intestine: 24.2;skin 1: 24.2"	"Cell type enhanced"	"Detected in many"	12	"Alveolar cells type 2: 34.1;Enterocytes: 90.1;Mucus-secreting cells: 39.1;Paneth cells: 65.1"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"A-431: 10.6;CAPAN-2: 20.4;HaCaT: 16.6;hTCEpi: 22.5;OE19: 27.4;RT4: 13.0;T-47d: 12.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"CAB032952, HPA036070, HPA036071"	Approved		Supported	"Nucleoplasm,Nuclear bodies,Plasma membrane,Cytosol"		NA	NA			Nucleoplasm	"Nuclear bodies, Plasma membrane, Cytosol"	"CAB032952: AB_634461, HPA036070: AB_10602292, HPA036071: AB_10669982"	"unprognostic (2.32e-2)"	"unprognostic (1.36e-1)"	"unprognostic (1.05e-1)"	"unprognostic (2.42e-2)"	"unprognostic (1.41e-1)"	"unprognostic (1.35e-1)"	"unprognostic (1.04e-1)"	"unprognostic (2.29e-1)"	"unprognostic (3.03e-1)"	"unprognostic (3.72e-2)"	"prognostic unfavorable (1.96e-4)"	"unprognostic (1.28e-1)"	"prognostic unfavorable (1.26e-9)"	"unprognostic (4.19e-2)"	"unprognostic (1.74e-1)"	"unprognostic (1.73e-1)"	"unprognostic (4.24e-2)"	0.7	0.0	0.4	5.3	0.4	0.0	1.7	0.4	0.4	7.6	18.1	0.5	0.8	13.6	0.6	0.5	44.0	0.0	11.7	0.4	0.4	0.0	0.8	1.7	1.1	0.4	0.4	0.4	0.4	1.4	0.0	0.4	0.6	0.4	2.2	7.4	0.4	7.6	0.4	0.4	24.2	24.2	0.9	0.4	0.4	12.5	0.4	0.4	0.4	0.4	18.9	17.2	6.5	15.0	1.3	4.5	1.2	2.4	0.3	1.9	0.9	10.6	1.2	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	20.4	0.0	3.6	0.0	0.0	16.6	0.0	0.0	0.0	2.6	0.2	0.0	4.3	0.0	0.0	0.0	3.4	0.0	22.5	0.0	0.1	0.1	0.0	0.0	0.1	1.2	0.1	5.9	0.0	0.1	0.1	27.4	7.7	0.0	0.6	0.2	0.0	13.0	0.1	1.1	1.2	4.0	0.0	0.0	12.5	0.8	0.1	0.1	0.2	0.4	0.1	0.2	0.0	0.0	0.2	0.2	0.5	1.2	2.4	0.4	0.5	1.7	1.9	1.2	0.4	0.1	4.5	1.3	0.4	0.6	1.2	0.3	1.3	0.3	0.5	0.9	0.4	0.4	0.4	0.4	0.4	0.0	0.4	0.4	0.4	0.4	11.9	34.1	0.0	2.8	5.3	2.0	0.4	12.7	9.4	17.0	0.0	2.0	0.2	0.0	1.4	0.0	0.3	90.1	0.0	1.4	0.1	0.4	1.3	9.2	1.5	0.7	0.0	5.2	0.6	4.1	0.0	0.3	2.8	0.0	0.0	39.1	2.4	10.3	65.1	0.0	0.1	3.9	0.0	0.4	0.2	0.2	13.6	0.1	0.0	18.8	13.8
PTK7	CCK4	ENSG00000112655	"Protein tyrosine kinase 7 (inactive)"	Q13308	6	43076268-43161719	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"	"Cell adhesion, Wnt signaling pathway"	Receptor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enriched"	"Detected in many"	6	"Early spermatids: 314.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	9	"plasmacytoid DC: 13.8"	"Lineage enriched"	"Detected in many"	9	"dendritic cells: 13.8"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003222	Approved				"Secreted to blood"	NA	NA		10000000			"HPA003222: AB_1079713"	"unprognostic (1.80e-1)"	"unprognostic (7.49e-3)"	"unprognostic (6.22e-2)"	"unprognostic (2.03e-1)"	"unprognostic (1.65e-1)"	"unprognostic (1.15e-2)"	"unprognostic (5.85e-3)"	"unprognostic (9.81e-3)"	"unprognostic (1.47e-3)"	"unprognostic (7.15e-2)"	"unprognostic (5.11e-3)"	"unprognostic (8.17e-2)"	"unprognostic (3.37e-2)"	"unprognostic (1.73e-1)"	"unprognostic (3.61e-1)"	"unprognostic (9.12e-2)"	"unprognostic (5.70e-3)"	5.4	1.8	1.4	3.5	3.4	0.8	12.2	3.5	4.9	30.9	4.8	3.4	8.9	2.1	37.7	36.9	11.7	14.3	14.5	3.5	2.2	3.9	10.1	0.8	18.7	4.3	1.3	2.7	42.6	16.3	9.0	9.0	20.9	4.2	18.2	3.3	13.9	15.0	10.9	0.4	13.6	3.4	16.4	3.2	12.4	4.6	14.9	1.4	28.7	19.3	8.1	6.2	9.5	17.6	0.0	13.8	0.3	0.0	0.7	1.5	0.8	2.1	0.6	21.1	35.0	22.7	23.3	30.0	22.6	36.5	19.8	25.4	19.0	7.6	0.0	17.9	26.3	14.4	24.5	9.4	21.5	12.6	0.1	11.7	2.0	4.3	25.5	34.5	0.0	0.1	33.3	19.5	26.1	8.3	34.6	2.5	8.5	1.3	0.0	9.0	1.6	7.6	3.0	9.8	0.2	1.7	7.7	30.0	0.0	15.3	10.5	12.1	23.0	3.6	0.3	11.7	23.2	12.9	4.6	1.6	21.2	13.4	0.1	12.2	0.1	0.2	0.7	4.9	0.0	3.5	0.3	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.4	0.0	0.1	1.5	0.2	0.7	0.0	13.8	0.0	0.8	1.4	3.4	3.5	4.9	2.2	3.9	1.3	2.7	4.2	1.4	14.9	12.5	0.0	16.8	15.3	1.4	1.6	2.5	2.7	6.8	12.2	53.0	18.9	1.7	19.2	314.6	1.0	0.2	0.0	6.2	1.9	31.6	10.9	1.1	0.0	3.1	0.0	20.7	1.8	0.0	38.8	17.0	1.1	15.1	1.0	1.2	19.8	8.6	3.5	17.3	0.5	1.7	12.9	9.5	2.4	18.5	9.2	6.9	0.7	2.6	9.7
PTP4A1	"PRL-1, PRL1, PTPCAAX1"	ENSG00000112245	"Protein tyrosine phosphatase type IVA, member 1"	Q93096	6	63521748-63583587	"Enzymes, Predicted intracellular proteins"	"Cell cycle"	"Developmental protein, Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 135.1;skeletal muscle: 111.2"	"Cell type enhanced"	"Detected in many"	14	"Late spermatids: 2420.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003281	Approved					NA	NA					"HPA003281: AB_1855903"	"unprognostic (8.63e-2)"	"prognostic unfavorable (5.53e-4)"	"unprognostic (9.05e-2)"	"unprognostic (7.96e-2)"	"unprognostic (2.79e-2)"	"unprognostic (2.71e-2)"	"unprognostic (6.12e-2)"	"unprognostic (1.96e-1)"	"unprognostic (5.28e-2)"	"unprognostic (2.33e-2)"	"unprognostic (6.62e-3)"	"unprognostic (1.23e-2)"	"unprognostic (1.07e-2)"	"unprognostic (6.64e-2)"	"unprognostic (1.28e-1)"	"unprognostic (2.10e-2)"	"unprognostic (1.11e-2)"	13.9	42.3	11.3	10.5	14.0	54.3	10.8	7.1	17.0	17.5	30.2	18.9	8.0	17.9	13.1	13.5	16.1	12.3	16.7	10.0	12.0	14.8	14.2	135.1	25.0	9.0	16.1	13.8	24.1	87.4	5.0	12.8	19.8	16.3	17.7	31.2	13.6	20.1	10.0	111.2	17.2	18.3	35.7	24.2	7.1	15.5	19.8	13.3	6.4	11.4	19.9	9.3	31.0	12.6	14.6	18.2	46.9	20.6	15.8	20.1	14.4	19.3	24.0	30.3	29.2	20.7	19.2	60.6	34.1	22.8	12.4	17.4	20.2	11.4	16.5	14.8	20.1	25.8	9.6	20.6	42.8	20.0	17.8	13.9	10.3	67.2	91.7	41.0	31.6	16.9	23.4	83.1	26.9	71.9	15.2	19.2	15.7	23.5	32.1	34.5	26.2	15.1	14.2	12.5	21.7	13.1	20.2	12.6	13.1	27.7	23.0	11.4	21.1	74.4	16.3	33.6	36.3	15.7	28.1	19.1	31.3	34.4	24.7	33.5	26.9	23.0	30.5	16.7	16.9	36.7	34.6	19.8	15.2	13.7	20.6	20.1	14.6	15.0	14.6	18.2	12.4	14.8	14.2	46.9	15.8	14.2	9.1	18.1	14.4	11.3	14.0	7.1	17.0	12.0	14.8	16.1	13.8	16.3	13.3	20.8	83.0	74.7	257.9	605.1	22.1	73.9	163.1	38.8	51.2	71.5	15.7	216.2	68.0	128.0	616.2	31.2	259.4	0.0	168.0	175.7	85.2	143.0	64.4	416.3	88.4	11.1	124.3	41.1	65.9	2420.5	26.4	64.7	161.9	36.1	129.4	17.8	159.8	140.8	22.6	85.2	23.2	6.5	110.2	32.8	21.3	560.3	384.3	37.0	97.1	110.7
PTP4A2	"HU-PP-1, OV-1, PRL-2, PRL2, ptp-IV1a, PTP4A, PTPCAAX2"	ENSG00000184007	"Protein tyrosine phosphatase type IVA, member 2"	Q12974	1	31906421-31944856	"Enzymes, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	6	"Urothelial cells: 819.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003281, CAB011204"	Uncertain					NA	NA		440000			"CAB011204: AB_532271, HPA003281: AB_1855903"	"unprognostic (2.67e-2)"	"unprognostic (6.36e-2)"	"unprognostic (3.15e-3)"	"unprognostic (3.73e-2)"	"unprognostic (2.70e-2)"	"unprognostic (6.20e-2)"	"prognostic unfavorable (2.62e-5)"	"unprognostic (6.90e-2)"	"unprognostic (4.63e-2)"	"unprognostic (5.12e-2)"	"unprognostic (1.99e-2)"	"unprognostic (1.03e-1)"	"prognostic unfavorable (5.10e-11)"	"unprognostic (1.16e-2)"	"unprognostic (3.81e-1)"	"unprognostic (2.89e-1)"	"prognostic favorable (2.72e-5)"	51.6	22.4	41.1	39.6	57.3	74.6	48.8	12.0	34.6	26.3	37.1	68.9	24.9	31.9	23.4	20.8	25.3	23.9	31.6	64.8	50.6	31.4	26.7	36.3	34.6	44.0	56.3	29.5	34.6	28.5	17.1	19.2	25.8	40.9	28.6	36.9	21.1	28.0	27.5	82.8	16.5	29.1	32.7	58.5	40.9	31.3	44.6	48.7	110.5	48.0	20.0	47.2	49.0	40.3	14.7	14.8	50.0	44.6	18.2	29.0	18.2	42.3	24.7	24.2	45.2	48.6	52.1	16.6	41.6	58.1	34.2	35.6	21.7	61.4	75.3	32.8	56.5	38.5	17.3	24.7	24.2	63.5	67.7	14.0	52.3	43.8	22.5	52.2	42.4	53.0	47.8	20.2	48.2	47.6	34.2	34.6	60.6	67.2	30.9	43.8	20.6	135.8	20.8	32.4	32.5	36.1	23.6	40.7	31.3	22.9	78.4	23.8	17.1	44.3	28.9	47.1	44.1	82.5	23.5	35.7	40.3	34.0	60.0	45.8	32.2	50.2	38.4	39.0	34.8	39.1	50.0	17.2	27.4	25.4	32.6	20.3	14.7	22.6	29.0	14.8	11.3	14.5	24.9	18.0	18.2	44.6	10.7	17.8	18.2	41.1	57.3	12.0	34.6	50.6	31.4	56.3	29.5	40.9	48.7	113.2	107.0	105.7	413.0	172.4	53.2	156.4	145.2	36.1	85.3	191.9	56.9	42.6	162.5	131.4	33.4	86.3	153.7	46.7	159.0	99.5	130.0	535.6	85.4	139.5	112.1	93.8	123.2	81.0	165.5	29.0	163.7	193.7	109.6	162.3	177.6	142.6	155.3	178.2	164.8	128.3	51.1	129.4	116.1	95.6	88.0	171.8	133.9	143.0	162.7	819.0
PTP4A3	"PRL-3, PRL-R, PRL3"	ENSG00000184489	"Protein tyrosine phosphatase type IVA, member 3"	O75365	8	141391993-141432454	"Enzymes, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 166.4"	"Cell type enhanced"	"Detected in many"	10	"Cardiomyocytes: 234.6;Cone photoreceptor cells: 115.8;Rod photoreceptor cells: 210.7;Smooth muscle cells: 93.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"neutrophil: 30.3;non-classical monocyte: 27.8"	"Group enriched"	"Detected in many"	7	"granulocytes: 30.3;monocytes: 27.8"	"Cell line enhanced"	"Detected in some"		"HDLM-2: 70.2;Karpas-707: 21.4;REH: 12.0;RPMI-8226: 22.0;U-266/84: 23.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA003281	Uncertain					NA	NA					"HPA003281: AB_1855903"	"unprognostic (1.09e-1)"	"unprognostic (3.70e-1)"	"unprognostic (2.55e-2)"	"unprognostic (1.10e-3)"	"unprognostic (2.08e-1)"	"unprognostic (6.18e-2)"	"unprognostic (3.61e-2)"	"unprognostic (2.27e-2)"	"unprognostic (1.08e-1)"	"unprognostic (2.50e-1)"	"unprognostic (5.73e-3)"	"unprognostic (2.33e-2)"	"prognostic unfavorable (1.81e-5)"	"unprognostic (2.25e-1)"	"unprognostic (1.12e-2)"	"unprognostic (2.28e-2)"	"unprognostic (1.77e-1)"	5.9	2.4	2.8	3.9	6.5	1.7	4.1	3.9	10.9	5.5	6.2	2.6	2.5	3.4	7.6	5.4	5.5	6.1	3.0	48.0	2.7	3.0	5.1	1.7	5.5	7.9	2.8	5.0	4.8	13.6	2.4	22.0	4.1	4.6	7.2	2.0	15.7	8.2	3.8	166.4	3.4	3.3	7.6	1.5	5.6	9.9	3.5	0.6	1.7	3.3	15.9	5.1	5.5	3.3	2.8	4.3	30.3	27.8	0.8	3.5	2.5	0.1	0.5	0.8	0.4	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.1	2.0	0.0	6.5	0.1	0.0	0.0	0.1	0.0	0.0	70.2	0.5	5.0	0.0	1.1	0.5	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.1	0.6	2.7	21.4	0.0	5.4	0.6	0.1	1.3	0.5	0.3	12.0	0.0	22.0	0.0	0.1	9.0	2.1	0.4	0.0	1.8	0.6	1.0	0.3	0.1	0.0	1.3	0.0	0.0	6.7	23.3	0.2	0.0	2.0	0.2	0.4	1.6	6.6	1.6	14.8	1.1	2.8	3.5	1.6	1.2	0.8	3.4	1.9	30.3	0.8	27.8	4.3	2.5	2.5	2.8	6.5	3.9	10.9	2.7	3.0	2.8	5.0	4.6	0.6	3.0	45.2	18.2	3.6	8.9	90.4	234.6	5.1	0.0	5.7	7.0	115.8	0.2	8.3	6.5	9.8	29.7	0.0	0.0	53.0	0.2	11.8	9.7	1.1	0.2	3.2	14.3	9.8	9.2	2.8	3.6	3.4	6.0	20.3	10.8	2.4	25.7	16.3	0.0	1.8	4.2	210.7	32.3	93.8	1.8	22.8	8.9	0.2	8.7	2.3	2.5
PTPA	"PPP2R4, PR53"	ENSG00000119383	"Protein phosphatase 2 phosphatase activator"	Q15257	9	129110950-129148946	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Isomerase, Rotamase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Collecting duct cells: 50.6;Cytotrophoblasts: 42.8;Distal tubular cells: 46.4;Ductal cells: 58.5;Exocrine glandular cells: 54.1;Hofbauer cells: 45.3;Pancreatic endocrine cells: 49.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA005695, CAB022068, CAB035999"	Approved		Enhanced	Nucleoplasm,Cytosol		NA	NA		4800000	Nucleoplasm	Cytosol	"CAB022068: , CAB035999: , HPA005695: AB_1855658"	"unprognostic (4.97e-2)"	"unprognostic (1.70e-2)"	"unprognostic (1.13e-2)"	"prognostic favorable (6.50e-5)"	"unprognostic (1.56e-2)"	"unprognostic (1.15e-1)"	"unprognostic (6.65e-2)"	"unprognostic (6.44e-3)"	"unprognostic (2.22e-1)"	"unprognostic (1.15e-2)"	"unprognostic (3.20e-2)"	"unprognostic (1.37e-1)"	"unprognostic (1.01e-2)"	"unprognostic (1.92e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.48e-1)"	"unprognostic (1.69e-1)"	16.5	35.1	41.6	19.8	41.2	18.1	23.9	32.0	74.2	27.5	27.4	27.2	30.1	18.3	26.7	26.0	31.8	30.1	28.7	42.1	38.0	32.4	32.6	41.0	22.1	19.8	30.8	35.5	23.2	22.4	55.0	22.5	21.4	37.0	33.4	21.7	20.8	36.0	41.5	110.7	27.2	18.8	35.3	21.9	24.4	23.8	62.4	17.6	23.7	27.2	37.0	21.3	22.1	23.9	12.6	19.2	7.8	15.5	17.7	18.4	14.9	24.3	43.2	26.6	49.3	18.0	22.1	26.6	25.5	28.9	35.0	24.5	23.1	30.1	25.4	19.3	43.2	39.8	39.7	27.8	31.4	30.2	45.0	15.2	15.7	45.7	21.9	53.6	27.0	34.1	26.5	31.0	25.6	24.4	53.1	35.6	26.6	23.2	28.2	29.4	63.2	24.6	16.7	41.9	66.2	43.0	24.6	24.6	46.6	36.7	30.6	28.9	20.4	51.6	53.3	31.9	26.4	56.5	11.8	26.1	29.1	26.3	30.0	35.9	25.8	65.9	22.9	35.8	17.7	40.1	5.8	15.5	7.8	18.4	15.5	17.6	9.6	14.0	16.4	19.2	12.6	13.1	13.1	5.4	17.7	14.4	13.8	14.0	14.9	41.6	41.2	32.0	74.2	38.0	32.4	30.8	35.5	37.0	17.6	3.0	8.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.7	50.6	0.0	42.8	46.4	58.5	0.0	0.0	0.0	0.0	54.1	37.3	0.0	0.0	8.1	0.0	45.3	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.0	37.9	0.0	0.0	49.9	0.0	0.0	32.9	0.0	0.0	0.0	0.0	0.0	0.0	31.7	0.0	0.0	0.0
PTPMT1	"DUSP23, MOSP, PLIP"	ENSG00000110536	"Protein tyrosine phosphatase, mitochondrial 1"	Q8WUK0	11	47565430-47573461	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism"	"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	11	"Late spermatids: 522.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"HPA043932, HPA060060"	Approved		Enhanced	Mitochondria		NA	NA			Mitochondria		"HPA043932: AB_2678738, HPA060060: "	"unprognostic (6.61e-2)"	"unprognostic (2.09e-1)"	"unprognostic (1.28e-1)"	"unprognostic (2.37e-3)"	"unprognostic (1.02e-1)"	"unprognostic (1.26e-2)"	"prognostic unfavorable (3.04e-5)"	"unprognostic (3.29e-2)"	"unprognostic (2.77e-2)"	"unprognostic (1.93e-3)"	"unprognostic (6.76e-2)"	"unprognostic (1.72e-1)"	"unprognostic (2.68e-3)"	"unprognostic (1.21e-1)"	"unprognostic (5.39e-1)"	"unprognostic (2.17e-2)"	"unprognostic (1.75e-1)"	24.0	24.5	22.3	13.1	23.2	19.8	23.3	16.5	25.2	15.7	14.8	18.5	17.5	14.6	14.7	21.4	14.3	16.9	17.9	17.1	18.5	21.9	20.1	21.8	25.1	16.7	23.1	16.2	15.7	39.3	18.3	18.7	21.8	14.4	15.8	11.5	20.1	26.4	19.5	23.4	11.2	13.1	12.7	17.6	14.7	16.9	44.6	10.3	10.8	19.9	15.7	15.0	11.0	11.5	20.4	40.8	22.1	24.4	15.4	17.5	16.8	22.2	12.6	1.5	10.1	11.7	9.0	4.3	13.1	12.4	13.1	12.5	20.9	11.9	16.0	14.5	9.8	12.2	19.1	10.4	13.6	14.0	19.5	31.3	7.4	25.8	26.3	17.2	14.3	9.8	8.9	15.5	6.1	18.8	10.1	9.3	15.9	18.8	12.3	9.6	42.0	12.2	18.5	9.4	3.8	23.4	22.4	8.5	13.7	15.8	14.3	9.4	11.5	19.9	7.3	11.8	6.6	33.8	15.4	10.0	9.7	15.0	15.7	19.7	18.7	12.5	10.9	7.6	12.4	5.9	6.0	24.4	22.1	16.0	20.9	15.4	20.4	15.2	17.3	27.7	18.0	15.2	14.4	1.9	15.4	19.4	40.8	17.5	16.8	22.3	23.2	16.5	25.2	18.5	21.9	23.1	16.2	14.4	10.3	20.8	25.4	25.3	13.5	15.9	13.5	5.3	48.4	41.5	22.7	38.4	3.9	63.4	61.3	87.9	188.7	19.1	21.4	0.0	74.6	54.2	24.4	20.5	16.2	36.5	56.1	4.8	30.1	30.1	29.8	522.3	43.1	32.4	43.9	60.5	41.0	48.4	92.6	28.1	43.9	62.0	11.6	19.4	21.2	109.7	21.3	15.2	64.2	24.9	61.2	18.6
PTPN1	PTP1B	ENSG00000196396	"Protein tyrosine phosphatase, non-receptor type 1"	P18031	20	50510321-50585241	"Enzymes, Predicted membrane proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	8	"Alveolar cells type 1: 211.4;monocytes: 327.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009329, HPA012542, CAB015217"	Approved		Enhanced	"Endoplasmic reticulum"		NA	NA		11000	"Endoplasmic reticulum"		"CAB009329: AB_2174944, CAB015217: , HPA012542: AB_1855915"	"unprognostic (1.67e-1)"	"unprognostic (7.78e-2)"	"unprognostic (1.48e-1)"	"unprognostic (1.05e-2)"	"unprognostic (1.14e-1)"	"unprognostic (3.44e-2)"	"unprognostic (2.98e-3)"	"unprognostic (3.95e-2)"	"unprognostic (2.40e-2)"	"unprognostic (6.47e-3)"	"unprognostic (5.87e-2)"	"unprognostic (1.67e-1)"	"unprognostic (1.66e-2)"	"unprognostic (6.70e-2)"	"unprognostic (2.99e-2)"	"unprognostic (1.49e-1)"	"unprognostic (2.58e-2)"	22.1	22.2	12.1	31.9	16.0	35.3	17.9	12.9	16.6	18.2	17.8	18.8	14.2	10.5	20.0	16.6	23.2	17.1	18.0	20.5	15.8	9.0	43.8	16.7	42.7	36.1	14.1	14.1	21.8	12.2	31.2	18.8	28.3	18.7	20.0	14.8	21.0	16.3	15.0	41.0	18.6	21.9	16.9	15.8	45.3	17.5	23.5	13.3	26.9	15.7	13.9	42.8	20.0	18.4	15.9	9.4	18.8	16.4	3.9	10.7	6.4	21.1	10.7	12.9	8.9	8.5	11.7	18.4	14.2	13.6	41.9	15.3	31.3	44.6	10.5	25.3	13.1	16.5	18.8	10.2	40.9	26.7	15.5	9.1	14.8	10.4	16.5	16.9	15.4	20.4	13.6	28.7	18.9	23.3	18.4	24.0	12.8	25.8	9.7	22.7	11.8	16.5	12.2	6.8	11.7	14.7	14.7	15.0	10.0	24.1	15.9	10.4	11.9	20.4	26.0	23.0	11.3	16.8	16.5	35.6	36.6	14.7	16.4	17.6	10.6	8.5	12.8	22.9	10.5	13.5	12.0	5.6	18.8	10.7	9.5	7.9	15.9	9.0	8.2	5.5	13.7	7.7	8.3	12.2	3.9	16.4	9.4	7.1	6.4	12.1	16.0	12.9	16.6	15.8	9.0	14.1	14.1	18.7	13.3	211.4	72.3	67.9	44.4	76.4	23.0	27.2	10.2	32.1	47.8	34.9	45.2	41.8	19.9	20.5	47.2	26.1	20.4	0.0	16.9	17.3	21.4	26.7	67.2	18.6	32.9	41.3	17.9	37.4	28.2	22.4	13.0	52.2	35.4	327.4	13.7	13.8	28.9	11.5	11.3	59.6	25.9	19.4	34.0	20.7	24.3	41.3	45.4	43.7	15.5	55.1
PTPN11	"BPTP3, NS1, PTP2C, SH-PTP2, SHP-2, SHP2"	ENSG00000179295	"Protein tyrosine phosphatase, non-receptor type 11"	Q06124	12	112418351-112509913	"Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, RAS pathway related proteins"		"Hydrolase, Protein phosphatase"	"Cancer-related genes, Deafness, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Cardiomyocytes: 136.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB005377	Approved		Supported	"Nucleoplasm,Nucleoli rim,Actin filaments,Cytosol"		NA	NA		160000	"Nucleoli rim"	"Nucleoplasm, Actin filaments, Cytosol"	"CAB005377: AB_632401"	"unprognostic (2.18e-3)"	"unprognostic (1.73e-3)"	"unprognostic (5.62e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.63e-2)"	"unprognostic (2.27e-1)"	"unprognostic (6.05e-2)"	"unprognostic (4.25e-2)"	"unprognostic (3.55e-2)"	"unprognostic (1.88e-1)"	"unprognostic (2.22e-2)"	"unprognostic (8.85e-2)"	"unprognostic (3.75e-3)"	"unprognostic (1.66e-1)"	"unprognostic (2.46e-1)"	"unprognostic (3.62e-2)"	"unprognostic (1.80e-2)"	25.4	16.8	38.6	14.4	39.0	17.7	30.8	17.5	39.5	18.3	14.7	26.9	9.9	11.9	19.1	13.3	17.6	11.1	13.1	30.1	38.0	32.2	18.0	23.1	15.1	14.5	45.3	22.5	13.1	14.0	29.3	12.9	16.6	26.2	16.2	13.9	9.4	12.0	20.0	34.0	14.1	11.1	28.0	45.7	10.9	12.8	7.6	32.1	10.9	21.2	8.2	13.7	17.4	15.4	17.3	17.1	22.0	11.8	11.3	15.4	6.3	35.4	33.8	24.7	23.4	36.0	35.2	29.2	43.1	47.0	34.0	25.6	33.7	13.7	37.5	22.5	39.8	21.5	21.2	31.7	38.2	56.5	28.4	26.1	54.5	31.5	18.4	35.9	43.7	34.8	28.4	38.5	36.5	51.9	32.8	28.0	29.0	41.4	13.2	32.8	25.6	30.7	21.3	29.9	34.7	22.2	31.6	36.4	21.5	31.3	39.9	17.2	21.1	41.5	31.8	26.5	26.1	36.6	30.3	34.1	40.0	35.9	23.7	37.6	25.6	42.2	37.5	33.3	30.7	37.3	22.0	11.0	15.0	14.8	9.5	14.1	15.5	13.4	12.1	12.6	17.3	15.4	11.8	10.3	11.3	11.8	17.1	9.8	6.3	38.6	39.0	17.5	39.5	38.0	32.2	45.3	22.5	26.2	32.1	56.6	53.2	13.4	22.8	22.8	27.6	136.3	30.6	20.1	50.0	34.9	15.7	20.0	28.2	34.0	65.9	35.8	17.2	0.0	36.7	21.0	25.9	57.9	26.7	93.6	22.8	12.7	12.6	27.0	32.4	19.0	47.8	23.7	13.5	16.2	19.6	59.0	45.4	20.4	75.0	29.8	21.4	32.3	31.9	7.7	5.3	24.0	29.4	19.8	18.7	65.6
PTPN12	"PTP-PEST, PTPG1"	ENSG00000127947	"Protein tyrosine phosphatase, non-receptor type 12"	Q05209	7	77537275-77640071	"Enzymes, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA007097	Approved		Approved	"Plasma membrane,Cytosol"		NA	NA		1100000	"Plasma membrane, Cytosol"		"HPA007097: AB_1079689"	"unprognostic (2.28e-1)"	"prognostic unfavorable (1.15e-4)"	"unprognostic (1.35e-1)"	"unprognostic (3.35e-2)"	"unprognostic (1.40e-3)"	"unprognostic (4.48e-3)"	"prognostic unfavorable (8.78e-4)"	"unprognostic (1.29e-1)"	"unprognostic (5.83e-2)"	"unprognostic (2.64e-1)"	"prognostic unfavorable (2.01e-4)"	"unprognostic (1.09e-1)"	"prognostic unfavorable (7.27e-6)"	"unprognostic (4.99e-2)"	"unprognostic (2.97e-1)"	"unprognostic (1.81e-1)"	"unprognostic (3.21e-1)"	29.6	15.1	14.3	20.5	19.6	29.7	25.1	15.7	22.7	20.0	28.9	8.1	13.8	8.8	20.7	9.6	22.0	18.1	19.8	45.6	17.3	12.6	16.9	14.8	34.7	17.4	15.3	13.4	19.0	10.7	12.4	19.8	36.0	18.6	14.1	13.8	9.9	12.8	17.1	17.6	17.6	14.6	23.0	24.0	25.0	14.4	13.9	17.7	9.7	16.7	11.9	12.9	23.2	61.2	2.5	3.9	9.9	4.9	12.8	3.8	2.8	17.2	10.6	25.2	12.8	17.7	18.5	13.5	18.0	23.0	14.2	20.3	5.2	27.0	2.0	5.8	21.0	31.1	12.3	8.4	18.0	28.7	5.0	4.7	10.8	10.7	21.2	17.4	6.1	7.2	15.1	20.1	30.9	39.9	25.5	30.0	0.5	12.9	3.0	45.2	11.8	0.8	17.1	20.3	23.5	12.2	3.6	20.2	1.0	24.4	9.3	3.1	16.7	22.1	20.3	17.5	45.3	9.8	22.5	21.8	30.8	18.6	11.2	33.9	3.1	1.7	5.3	18.1	15.9	53.3	3.7	4.2	6.6	3.6	2.9	1.4	2.5	1.2	2.7	3.9	1.1	0.6	3.8	9.9	12.8	4.9	0.3	1.5	2.8	14.3	19.6	15.7	22.7	17.3	12.6	15.3	13.4	18.6	17.7	65.5	54.6	13.7	41.5	61.1	15.5	35.1	22.9	16.0	46.6	19.2	7.9	34.1	3.3	38.7	2.6	99.1	17.1	0.0	34.2	48.2	53.7	44.4	13.9	19.2	45.4	33.4	11.6	98.8	74.4	5.4	43.1	86.9	33.7	25.2	19.9	63.0	55.1	20.1	44.2	15.8	14.3	64.7	55.6	14.7	57.8	88.7	60.3	26.2	18.0	78.6
PTPN13	"PTP-BAS, PTP-BL, PTP1E, PTPL1"	ENSG00000163629	"Protein tyrosine phosphatase, non-receptor type 13"	Q12923	4	86594315-86815171	"Cancer-related genes, Enzymes, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	7	"Alveolar cells type 2: 152.9;Basal keratinocytes: 97.1;Rod photoreceptor cells: 171.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	6	"intermediate monocyte: 3.0;MAIT T-cell: 2.3;memory CD4 T-cell: 2.2;non-classical monocyte: 4.9"	"Group enriched"	"Detected in many"	7	"monocytes: 4.9;T-cells: 2.3"	"Cell line enhanced"	"Detected in many"		"AF22: 45.2;RT4: 21.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002213, HPA063119"	Approved		Supported	"Nucleoplasm,Nucleoli fibrillar center,Cytosol"		NA	NA			Nucleoplasm	"Nucleoli fibrillar center, Cytosol"	"CAB002213: AB_564089, HPA063119: "	"unprognostic (5.36e-2)"	"unprognostic (4.46e-1)"	"unprognostic (1.11e-1)"	"unprognostic (2.54e-3)"	"unprognostic (4.02e-1)"	"unprognostic (9.03e-3)"	"unprognostic (4.43e-2)"	"unprognostic (4.38e-2)"	"unprognostic (2.46e-1)"	"unprognostic (7.05e-2)"	"unprognostic (3.69e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.28e-3)"	"unprognostic (3.95e-3)"	"unprognostic (2.26e-1)"	"unprognostic (2.66e-1)"	"unprognostic (2.85e-2)"	10.3	5.9	10.8	2.7	16.9	0.7	9.9	5.7	11.6	15.9	4.1	13.0	7.6	1.2	10.8	21.2	18.7	11.4	6.5	5.3	10.4	5.7	22.1	1.6	18.0	4.3	16.9	7.9	24.1	4.3	26.6	38.3	3.0	14.2	12.0	2.4	39.0	5.9	9.4	1.0	43.0	2.3	8.7	10.3	3.5	3.6	12.2	17.6	1.9	16.9	12.4	11.8	15.7	17.6	0.0	0.5	0.1	4.9	0.1	2.3	0.1	5.1	2.6	45.2	4.4	19.1	16.7	0.0	9.5	19.4	3.6	4.6	0.0	2.6	0.0	2.1	10.5	1.3	17.0	7.8	14.3	7.0	0.1	5.8	4.3	5.6	0.0	2.3	7.5	0.0	10.7	4.6	2.6	8.7	7.6	0.0	0.0	0.0	7.4	0.0	2.3	0.6	2.7	10.3	0.0	1.9	1.5	0.0	0.0	13.8	21.5	2.6	3.8	2.8	6.3	5.2	7.6	3.7	0.2	0.0	3.5	2.7	0.0	1.2	7.7	0.0	0.0	3.7	0.0	1.5	0.0	0.2	0.0	0.2	3.0	2.3	0.0	2.2	0.3	0.5	0.0	0.0	0.0	0.1	0.1	4.9	0.0	0.1	0.1	10.8	16.9	5.7	11.6	10.4	5.7	16.9	7.9	14.2	17.6	44.7	152.9	0.0	21.0	97.1	9.8	1.7	10.2	32.1	75.1	45.4	86.4	0.2	3.3	4.3	20.2	2.2	0.0	0.0	3.0	0.1	20.2	12.1	4.7	0.0	0.2	1.6	4.6	1.8	2.2	14.8	42.3	5.7	18.6	0.0	0.5	14.1	4.3	3.5	30.8	9.2	171.6	12.9	12.5	24.4	21.6	86.9	0.2	4.4	0.2	45.5
PTPN14	PEZ	ENSG00000152104	"Protein tyrosine phosphatase, non-receptor type 14"	Q15678	1	214348696-214552449	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	5	"Alveolar cells type 1: 68.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB011469, HPA053864, CAB069441"	Uncertain		Supported	Nucleoplasm		NA	NA			Nucleoplasm		"CAB011469: AB_299202, CAB069441: , HPA053864: AB_2682281"	"unprognostic (1.54e-1)"	"unprognostic (8.19e-2)"	"unprognostic (5.42e-5)"	"unprognostic (1.42e-1)"	"unprognostic (2.91e-1)"	"unprognostic (5.97e-2)"	"unprognostic (1.26e-1)"	"unprognostic (1.58e-1)"	"unprognostic (2.84e-1)"	"unprognostic (1.31e-1)"	"prognostic unfavorable (2.29e-4)"	"unprognostic (7.43e-2)"	"unprognostic (8.34e-3)"	"prognostic unfavorable (5.16e-4)"	"unprognostic (1.16e-1)"	"unprognostic (2.21e-1)"	"unprognostic (4.81e-3)"	13.6	10.0	3.0	6.5	2.4	0.2	15.0	0.8	3.7	13.6	8.5	2.6	11.0	1.0	15.4	8.0	8.6	9.2	9.7	7.0	3.5	1.9	11.2	2.0	12.2	6.6	2.4	1.3	11.8	5.0	6.3	4.0	13.2	4.9	10.6	2.9	7.2	9.2	23.4	21.6	18.8	3.5	9.4	4.3	5.3	5.7	8.3	2.4	1.4	8.1	6.9	3.7	12.4	17.7	1.0	0.5	1.9	0.4	1.0	0.6	0.1	8.8	3.9	3.2	4.7	5.6	9.6	9.5	10.1	9.4	7.7	6.5	7.9	4.6	0.0	11.2	23.4	4.4	7.9	4.4	11.2	13.2	0.1	3.3	0.8	11.3	1.5	10.2	0.1	0.4	7.1	11.8	13.4	21.6	12.7	14.9	0.3	0.0	0.1	18.6	0.9	0.1	0.1	7.0	1.6	4.3	0.1	16.2	0.0	13.9	4.5	0.0	0.7	12.5	8.2	5.1	11.9	8.1	0.3	26.5	18.1	7.1	6.4	14.2	0.5	0.0	0.0	9.7	0.1	15.0	1.3	0.4	0.3	0.5	0.3	0.6	0.5	0.5	0.4	0.1	1.0	0.5	0.6	1.9	1.0	0.4	0.5	0.6	0.1	3.0	2.4	0.8	3.7	3.5	1.9	2.4	1.3	4.9	2.4	68.5	15.9	0.5	27.7	50.3	0.4	17.5	2.5	21.4	44.3	27.9	0.0	30.2	6.6	12.0	8.1	42.7	0.4	0.0	9.4	11.6	27.8	19.5	1.1	0.8	4.0	0.0	3.4	36.8	1.2	4.0	24.2	2.5	10.1	0.0	5.0	3.3	20.7	0.0	27.6	12.5	1.3	19.4	20.6	0.7	7.2	31.6	20.3	1.8	2.9	24.0
PTPN18	BDP1	ENSG00000072135	"Protein tyrosine phosphatase, non-receptor type 18"	Q99952	2	130356007-130375409	"Enzymes, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB012174, HPA053367"	Uncertain		Approved	"Intermediate filaments"		NA	NA		550000	"Intermediate filaments"		"CAB012174: AB_2173224, HPA053367: AB_2732579"	"unprognostic (3.11e-3)"	"unprognostic (2.89e-3)"	"unprognostic (1.67e-3)"	"unprognostic (1.73e-3)"	"unprognostic (5.81e-3)"	"unprognostic (3.08e-3)"	"unprognostic (2.49e-2)"	"unprognostic (1.28e-2)"	"unprognostic (4.65e-1)"	"unprognostic (2.10e-2)"	"unprognostic (7.33e-2)"	"unprognostic (5.65e-2)"	"unprognostic (4.52e-2)"	"unprognostic (1.00e-2)"	"unprognostic (3.60e-1)"	"unprognostic (1.05e-1)"	"unprognostic (5.85e-3)"	12.8	7.1	11.0	16.7	13.5	18.9	22.3	26.8	13.7	15.3	22.8	6.6	25.7	16.6	9.3	11.0	11.3	13.3	21.3	7.5	9.8	8.5	13.9	19.2	16.9	29.2	8.4	9.5	7.8	28.9	6.4	11.0	9.4	6.9	17.8	19.3	7.9	18.5	24.0	11.0	6.9	28.8	10.5	9.1	37.7	16.0	3.3	9.1	1.6	13.0	7.1	35.5	11.0	10.7	7.6	7.4	6.2	17.1	2.8	6.6	10.2	5.8	3.9	1.6	7.9	9.9	6.8	16.4	3.0	2.7	3.9	4.4	7.8	9.0	21.9	3.0	7.3	1.8	6.7	6.9	6.8	3.8	9.9	3.8	7.9	4.7	9.2	5.1	7.7	21.5	8.0	5.6	4.3	5.9	0.8	7.4	4.9	7.4	16.7	7.4	11.4	1.4	13.4	1.6	12.6	4.3	13.3	4.6	29.6	7.7	3.6	10.1	2.6	5.3	19.0	8.7	1.6	6.6	11.4	6.9	5.6	6.3	3.0	2.8	2.6	0.7	21.1	8.5	7.0	6.0	6.2	7.8	6.1	6.6	10.8	4.1	7.6	4.4	6.3	6.7	4.5	2.7	5.4	4.9	2.8	17.1	7.4	5.6	10.2	11.0	13.5	26.8	13.7	9.8	8.5	8.4	9.5	6.9	9.1	26.8	22.9	49.5	26.1	5.8	13.5	8.1	20.4	18.7	12.5	34.9	3.9	12.1	46.4	16.6	0.7	21.5	49.1	0.0	39.9	25.3	13.3	43.8	35.7	18.1	76.6	9.5	46.7	17.2	79.3	0.9	17.5	52.8	32.1	16.2	50.4	12.4	23.4	56.1	10.6	25.1	10.0	19.4	19.8	3.0	4.1	5.1	9.6	39.8	38.3	27.6
PTPN2	"PTPT, TC-PTP, TCELLPTP, TCPTP"	ENSG00000175354	"Protein tyrosine phosphatase, non-receptor type 2"	P17706	18	12785478-12929643	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA015004, HPA046176"	Enhanced		Supported	Nucleoplasm		NA	NA			Nucleoplasm		"HPA015004: AB_2669131, HPA046176: AB_2679569"	"unprognostic (5.83e-3)"	"unprognostic (8.50e-2)"	"unprognostic (5.85e-2)"	"unprognostic (7.21e-3)"	"unprognostic (8.94e-3)"	"unprognostic (2.31e-1)"	"unprognostic (1.12e-1)"	"unprognostic (1.68e-1)"	"unprognostic (2.37e-3)"	"prognostic favorable (1.37e-4)"	"unprognostic (1.06e-2)"	"unprognostic (1.75e-2)"	"prognostic unfavorable (1.20e-8)"	"unprognostic (3.19e-1)"	"unprognostic (6.84e-3)"	"unprognostic (2.17e-1)"	"unprognostic (4.61e-3)"	16.7	12.5	12.6	27.0	14.3	33.7	19.9	32.6	19.2	14.7	15.0	7.8	17.8	12.9	12.2	14.9	17.0	13.7	15.7	12.8	13.1	6.8	13.6	20.5	21.6	30.3	15.3	10.3	22.1	28.2	10.4	27.2	13.3	13.8	14.4	17.1	7.9	26.3	16.0	13.1	16.0	15.3	11.8	24.7	24.2	13.1	9.4	15.9	61.3	14.7	11.7	28.9	16.5	15.8	29.1	32.8	19.9	28.0	31.7	29.2	19.6	12.0	7.4	8.6	2.8	9.9	17.8	8.4	8.1	18.0	17.4	15.6	16.0	17.5	19.0	13.7	8.3	19.5	7.3	14.0	22.2	22.9	7.3	8.4	13.4	6.4	16.6	13.6	31.5	12.8	14.9	21.1	15.8	31.4	10.7	8.8	20.8	13.0	25.9	13.9	13.8	31.4	26.0	10.3	49.8	8.6	10.6	13.6	21.5	14.6	19.4	15.5	8.0	16.4	9.7	14.0	9.6	8.1	18.1	6.7	22.1	21.3	16.4	17.4	8.3	8.3	27.5	10.4	17.3	9.2	11.5	28.0	19.9	21.0	24.6	28.2	29.1	24.8	23.1	32.8	20.3	18.3	20.0	10.2	31.7	22.8	28.0	29.2	19.6	12.6	14.3	32.6	19.2	13.1	6.8	15.3	10.3	13.8	15.9	32.8	62.4	68.6	84.1	53.1	42.4	13.2	38.2	33.5	60.3	14.0	98.2	46.3	11.6	47.9	16.6	28.1	29.6	23.3	59.5	44.8	31.3	89.2	55.4	27.0	47.0	14.3	31.0	16.5	81.8	19.2	27.0	82.9	21.9	111.8	30.9	14.8	39.1	38.6	24.1	17.3	84.6	19.4	21.1	15.4	50.3	43.8	67.9	68.2	36.2	140.6
PTPN20	"bA142I17.1, bA42B19.1, CT126, DKFZP566K0524, PTPN20A, PTPN20B"	ENSG00000204179	"Protein tyrosine phosphatase, non-receptor type 20"	Q4JDL3	10	46911396-47002488	"Enzymes, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"testis: 13.2"	"Cell type enhanced"	"Detected in many"	10	"Distal tubular cells: 18.3;Early spermatids: 42.1;Late spermatids: 22.4;Spermatocytes: 17.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enriched"	"Detected in some"	5	"HDLM-2: 32.7"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"HPA043337, HPA046896, HPA048310, HPA069148"	Enhanced		Supported	"Centriolar satellite"		NA	NA			"Centriolar satellite"		"HPA043337: AB_2678436, HPA046896: , HPA048310: AB_2680350, HPA069148: "	"unprognostic (1.08e-1)"	"unprognostic (1.30e-1)"	"unprognostic (3.04e-2)"	"unprognostic (2.82e-3)"	"unprognostic (6.78e-2)"	"unprognostic (1.85e-1)"	"unprognostic (8.44e-2)"	"unprognostic (1.92e-1)"	"unprognostic (1.53e-1)"	"unprognostic (2.22e-2)"	"unprognostic (2.83e-1)"	"unprognostic (1.24e-1)"	"unprognostic (1.06e-1)"	"unprognostic (1.62e-1)"	"unprognostic (1.48e-2)"	"unprognostic (1.75e-1)"	"unprognostic (8.34e-2)"	1.2	9.7	1.0	1.9	3.1	0.0	3.4	3.4	5.4	0.8	1.3	1.0	5.0	1.1	1.4	0.4	3.4	1.0	0.5	8.8	1.4	3.4	4.3	0.6	0.6	0.2	2.4	0.8	1.6	3.9	0.0	2.3	0.3	11.7	1.1	1.5	1.2	7.8	3.2	11.0	5.6	1.0	0.6	1.2	1.0	1.0	13.2	0.0	0.2	1.9	1.7	0.5	1.0	1.0	2.8	2.2	0.0	0.0	2.3	3.1	0.7	0.0	4.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.4	0.0	0.0	1.9	0.0	2.5	0.0	0.0	0.0	32.7	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.7	0.0	1.5	0.9	6.0	3.7	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	2.0	4.6	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.3	0.0	0.1	2.8	1.7	0.4	1.1	0.6	2.2	3.1	0.0	2.3	0.0	2.2	1.3	0.7	1.0	3.1	3.4	5.4	1.4	3.4	2.4	0.8	11.7	0.0	0.0	1.0	0.0	1.7	0.0	5.8	12.1	0.0	6.7	4.5	8.7	5.9	0.0	18.3	1.3	42.1	0.0	0.0	0.0	0.8	0.1	1.0	0.6	0.0	0.5	0.4	11.1	1.2	1.8	0.0	22.4	0.0	0.0	0.0	1.0	0.1	5.4	2.4	0.0	6.7	12.9	2.7	0.0	0.3	17.9	10.9	0.0	0.1	0.0	0.6	0.9
PTPN21	"PTPD1, PTPRL10"	ENSG00000070778	"Protein tyrosine phosphatase, non-receptor type 21"	Q16825	14	88465778-88554733	"Enzymes, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	9	"Alveolar cells type 1: 53.6;Syncytiotrophoblasts: 85.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"RH-30: 23.1"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"CAB011468, HPA073999"	Approved		Approved	"Nucleoplasm,Golgi apparatus,Plasma membrane,Centriolar satellite,Cytosol"		NA	NA			"Plasma membrane, Cytosol"	"Nucleoplasm, Golgi apparatus, Centriolar satellite"	"CAB011468: AB_442979, HPA073999: AB_2732247"	"unprognostic (2.18e-1)"	"unprognostic (4.21e-2)"	"unprognostic (7.60e-2)"	"unprognostic (3.09e-2)"	"unprognostic (4.60e-2)"	"unprognostic (5.71e-2)"	"unprognostic (6.55e-2)"	"unprognostic (5.19e-3)"	"unprognostic (6.62e-2)"	"unprognostic (1.02e-2)"	"unprognostic (8.71e-3)"	"unprognostic (3.04e-3)"	"prognostic favorable (3.16e-9)"	"unprognostic (6.52e-2)"	"unprognostic (2.69e-1)"	"unprognostic (2.56e-1)"	"unprognostic (7.67e-2)"	10.5	4.7	5.3	8.6	7.3	0.0	13.2	4.4	5.8	10.7	8.7	10.7	7.4	4.9	10.6	10.7	8.9	8.3	12.7	17.4	7.4	4.2	8.1	6.0	15.3	1.6	6.6	4.2	15.8	7.8	10.6	3.9	15.6	6.4	11.9	6.5	12.6	6.5	10.5	8.8	24.2	10.5	15.7	7.3	3.7	7.4	15.2	6.5	0.8	16.0	8.4	3.1	12.0	26.1	0.8	0.0	0.0	0.1	0.0	0.1	0.0	3.6	2.9	7.7	3.0	8.2	7.2	8.0	9.8	7.5	5.8	8.1	5.2	6.6	0.0	2.4	12.4	5.2	3.4	1.1	3.4	8.5	0.2	1.7	0.0	3.2	2.1	9.2	0.0	0.1	4.7	6.8	4.8	5.8	7.5	4.7	0.0	1.1	0.1	14.8	3.0	0.0	0.1	2.2	3.9	5.6	0.0	23.1	0.0	5.0	2.6	0.5	9.0	5.6	14.1	3.2	6.8	6.9	1.5	9.2	10.8	8.5	4.4	6.7	0.3	1.2	0.0	4.0	0.1	4.3	0.0	0.1	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	5.3	7.3	4.4	5.8	7.4	4.2	6.6	4.2	6.4	6.5	53.6	5.9	0.0	4.0	9.3	7.3	31.1	5.1	9.4	7.9	7.0	33.4	7.6	0.0	4.4	12.7	4.5	9.3	0.0	7.2	4.4	9.3	7.8	2.3	9.0	1.6	1.6	4.6	7.4	1.2	3.5	15.8	0.7	0.0	0.0	14.6	4.9	8.2	5.8	25.5	3.3	9.0	0.0	8.5	12.1	6.1	10.5	85.2	0.0	4.6	4.7
PTPN22	"Lyp, Lyp1, Lyp2, PTPN8"	ENSG00000134242	"Protein tyrosine phosphatase, non-receptor type 22"	Q9Y2R2	1	113813811-113871759	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Autophagy, Immunity"	"Hydrolase, Protein phosphatase"	"Diabetes mellitus, Disease mutation, Systemic lupus erythematosus"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 23.6;lymphoid tissue: 46.0"	"Cell type enhanced"	"Detected in many"	15	"B-cells: 29.6;granulocytes: 26.6;Kupffer cells: 19.2;Macrophages: 20.5;T-cells: 65.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Daudi: 33.5;HL-60: 13.3;U-266/70: 14.4;U-698: 18.0;U-937: 13.6"	"Region enriched"	"Detected in single"	10	"cerebellum: 5.9"	"Not detected"	"Not detected"			"HPA004912, CAB012209, HPA013350"	Approved		Uncertain	"Nucleoplasm,Vesicles,Plasma membrane"		NA	NA			Nucleoplasm	"Vesicles, Plasma membrane"	"CAB012209: , HPA004912: AB_10602069, HPA013350: AB_10601570"	"unprognostic (2.25e-2)"	"unprognostic (5.31e-3)"	"unprognostic (3.48e-1)"	"unprognostic (3.33e-4)"	"unprognostic (9.14e-2)"	"unprognostic (2.47e-3)"	"unprognostic (9.60e-2)"	"unprognostic (8.14e-2)"	"unprognostic (3.71e-1)"	"unprognostic (1.82e-1)"	"unprognostic (1.62e-1)"	"unprognostic (3.02e-1)"	"unprognostic (2.75e-6)"	"unprognostic (3.19e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.61e-1)"	"unprognostic (3.22e-2)"	4.2	1.4	0.5	17.1	0.8	23.6	1.9	1.0	0.5	2.4	3.3	0.3	1.0	4.1	2.0	2.2	2.0	1.7	3.2	2.5	0.6	0.7	3.4	1.8	9.0	14.9	0.7	0.4	1.5	2.4	0.0	0.9	0.9	1.0	1.7	2.8	1.3	2.7	3.0	0.6	1.0	9.9	0.9	2.1	19.0	3.1	1.1	0.4	46.0	1.5	2.4	12.8	4.8	1.7	7.2	6.2	17.2	3.5	7.5	14.9	4.6	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.4	0.2	0.0	0.3	0.0	0.2	33.5	0.0	0.1	0.0	0.0	0.0	0.0	0.2	3.1	0.0	4.7	0.0	0.0	0.1	13.3	10.5	3.0	0.0	1.4	0.1	2.7	5.2	8.4	0.0	7.7	5.1	0.1	9.4	7.5	0.0	0.0	0.0	0.5	3.3	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	4.8	2.4	8.0	0.1	0.1	0.2	14.4	3.0	18.0	5.5	13.6	0.0	10.2	3.5	17.2	12.8	0.9	14.9	7.2	6.5	10.1	6.2	4.7	3.9	9.4	1.7	7.5	0.4	3.7	10.0	4.6	0.5	0.8	1.0	0.5	0.6	0.7	0.7	0.4	1.0	0.4	0.0	9.2	29.6	0.2	2.3	0.4	0.5	0.0	4.0	0.0	1.8	2.0	0.0	0.0	0.0	0.3	0.0	2.3	0.0	0.5	0.2	0.9	0.2	26.6	0.6	7.1	0.0	0.0	0.6	19.2	0.6	0.0	20.5	3.3	1.8	1.0	0.0	0.6	0.0	0.0	0.0	0.4	12.9	0.9	0.3	0.2	2.4	0.1	65.4	1.7	0.2
PTPN23	"DKFZP564F0923, HD-PTP, KIAA1471"	ENSG00000076201	"Protein tyrosine phosphatase, non-receptor type 23"	Q9H3S7	3	47381011-47413441	"Enzymes, Predicted intracellular proteins"	"Cilium biogenesis/degradation, Protein transport, Transport"	"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA016845	Approved		Supported	"Nucleoplasm,Nuclear bodies,Vesicles"		Yes	No			"Nucleoplasm, Nuclear bodies"	Vesicles	"HPA016845: AB_1855926"	"unprognostic (1.17e-3)"	"unprognostic (8.68e-2)"	"unprognostic (2.56e-1)"	"unprognostic (1.26e-1)"	"unprognostic (1.63e-1)"	"unprognostic (6.24e-2)"	"unprognostic (1.07e-3)"	"unprognostic (2.07e-2)"	"unprognostic (9.55e-2)"	"unprognostic (7.12e-2)"	"unprognostic (5.67e-2)"	"unprognostic (4.34e-2)"	"prognostic favorable (1.82e-4)"	"unprognostic (3.05e-2)"	"unprognostic (4.40e-1)"	"unprognostic (9.53e-2)"	"unprognostic (4.68e-2)"	15.9	18.5	23.1	17.4	22.3	19.2	21.6	22.8	25.0	18.1	12.5	21.4	14.6	20.7	20.0	15.1	17.2	17.2	12.8	13.2	17.9	11.7	16.4	13.0	16.8	17.8	24.6	23.7	23.4	19.4	53.4	29.9	17.1	20.5	16.9	10.4	15.2	20.8	19.0	25.7	25.9	16.0	16.0	20.3	19.2	17.9	17.8	22.7	9.7	24.8	9.7	11.1	17.7	18.1	1.4	1.1	3.7	1.2	0.9	1.5	0.8	13.0	18.6	10.4	13.4	13.6	10.5	10.0	11.9	11.9	11.2	9.5	15.7	12.9	9.3	11.0	13.5	19.9	11.7	8.9	12.9	5.4	8.6	9.6	12.8	13.6	14.6	15.0	7.5	17.4	13.9	13.3	14.5	14.9	7.9	13.7	7.9	9.5	12.8	11.9	18.3	7.1	6.3	11.1	9.1	13.1	4.4	5.0	11.2	8.4	25.3	5.5	13.0	10.5	22.4	8.7	6.6	12.8	7.2	13.7	17.1	14.5	23.7	16.8	18.4	12.0	5.4	18.6	7.1	12.1	3.7	1.2	0.0	0.8	0.5	0.6	1.4	0.6	1.3	0.4	0.7	0.6	0.8	1.4	0.9	0.5	1.1	1.5	0.8	23.1	22.3	22.8	25.0	17.9	11.7	24.6	23.7	20.5	22.7	8.9	6.5	1.5	4.4	7.1	11.3	6.2	10.2	10.7	7.9	5.2	13.7	8.5	1.7	9.1	1.4	11.1	14.2	0.0	7.6	6.5	6.1	7.9	2.3	9.6	11.6	15.9	7.0	12.3	11.1	2.1	17.8	7.8	11.8	9.0	15.6	9.2	11.8	8.6	12.7	8.2	13.8	6.5	6.2	7.4	10.9	9.5	7.8	4.3	11.5	6.3
PTPN3	PTPH1	ENSG00000070159	"Protein tyrosine phosphatase, non-receptor type 3"	P26045	9	109375466-109498313	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skeletal muscle: 38.1"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in single"		"neutrophil: 2.8"	"Lineage enriched"	"Detected in single"	4	"granulocytes: 2.8"	"Cell line enhanced"	"Detected in many"		"OE19: 16.9;RPTEC TERT1: 20.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038343, HPA046728"	Approved					NA	NA					"HPA038343: AB_10671741, HPA046728: AB_2679776"	"prognostic unfavorable (6.71e-4)"	"unprognostic (3.48e-1)"	"unprognostic (3.64e-2)"	"prognostic favorable (1.52e-4)"	"unprognostic (2.32e-2)"	"unprognostic (1.27e-1)"	"unprognostic (2.34e-1)"	"unprognostic (4.86e-2)"	"unprognostic (3.71e-2)"	"unprognostic (5.38e-2)"	"unprognostic (6.37e-2)"	"unprognostic (3.57e-2)"	"prognostic favorable (1.22e-15)"	"unprognostic (1.64e-2)"	"unprognostic (2.64e-1)"	"unprognostic (1.11e-1)"	"unprognostic (8.21e-2)"	2.7	1.9	3.4	4.8	5.0	0.0	4.8	2.1	11.1	4.4	9.4	2.0	10.7	7.6	3.2	13.4	10.3	6.4	6.3	12.1	3.1	2.8	28.8	21.1	4.9	0.5	1.2	3.9	1.5	17.0	10.6	4.9	14.5	4.5	4.7	6.5	3.8	13.1	13.6	38.1	18.8	18.8	0.8	0.9	0.9	5.9	2.1	0.0	1.1	9.4	7.2	9.5	4.1	5.5	0.6	0.3	2.8	0.6	0.3	0.3	0.1	6.3	7.9	0.3	2.1	0.0	0.0	12.6	1.4	0.0	1.7	1.9	4.2	10.4	0.0	1.4	0.1	4.4	15.2	2.2	8.9	1.8	3.5	4.8	0.0	3.8	4.3	0.0	0.0	0.1	0.1	9.6	2.2	4.6	0.7	0.0	2.7	0.0	0.1	0.1	8.0	10.9	1.9	1.0	16.9	5.9	0.0	2.6	0.1	20.6	12.3	5.2	1.1	3.5	13.0	0.0	4.5	7.4	1.0	0.0	0.6	5.0	0.8	0.0	6.3	10.2	0.0	6.8	0.0	4.5	0.4	0.6	0.8	0.2	0.4	0.2	0.4	0.2	0.2	0.3	0.6	0.3	0.3	2.8	0.3	0.6	0.3	0.1	0.1	3.4	5.0	2.1	11.1	3.1	2.8	1.2	3.9	4.5	0.0	14.9	25.0	0.0	20.1	10.5	9.6	46.0	20.4	24.1	19.4	29.6	0.0	19.8	14.9	13.1	20.8	2.2	25.4	0.0	16.7	20.5	3.6	23.7	1.1	32.7	2.2	0.0	12.6	4.3	0.0	12.7	1.1	1.9	3.3	1.0	16.5	0.3	22.0	23.5	1.8	16.1	2.1	6.5	6.2	0.9	11.7	18.1	9.0	0.8	17.3	26.2
PTPN4	PTPMEG	ENSG00000088179	"Protein tyrosine phosphatase, non-receptor type 4"	P29074	2	119759631-119983818	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"Bipolar cells: 53.9;Cone photoreceptor cells: 98.2;Horizontal cells: 152.6;Rod photoreceptor cells: 80.5;T-cells: 90.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	16	"NK-cells: 12.2;T-cells: 19.3"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA019351	Uncertain		Approved	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			Nucleoplasm	"Plasma membrane, Cytosol"	"HPA019351: AB_1855928"	"unprognostic (1.45e-1)"	"unprognostic (1.22e-1)"	"unprognostic (1.07e-1)"	"unprognostic (7.63e-2)"	"unprognostic (9.00e-2)"	"unprognostic (9.57e-2)"	"unprognostic (2.34e-1)"	"prognostic favorable (5.16e-4)"	"unprognostic (3.31e-2)"	"unprognostic (3.34e-3)"	"unprognostic (3.13e-1)"	"unprognostic (1.10e-1)"	"unprognostic (3.34e-2)"	"unprognostic (1.74e-1)"	"unprognostic (1.87e-1)"	"unprognostic (4.08e-2)"	"unprognostic (1.81e-1)"	6.8	6.9	10.0	5.9	12.2	7.3	7.2	37.4	16.9	9.6	5.5	7.2	5.2	8.1	7.2	6.6	6.9	8.9	6.3	8.9	10.2	8.4	12.0	6.6	8.0	7.9	7.3	13.1	8.9	6.3	11.6	16.3	4.1	8.3	6.2	4.0	7.1	7.9	6.6	11.2	5.8	5.5	4.7	7.3	9.2	8.9	7.7	6.5	18.9	22.5	6.8	6.5	5.3	5.8	0.5	0.3	0.9	0.4	12.2	19.3	4.7	7.4	4.4	5.8	7.7	5.2	5.4	9.9	3.4	9.6	1.9	5.3	6.6	11.6	5.4	8.2	3.8	5.8	6.6	4.5	5.3	5.2	12.6	3.8	3.7	4.2	6.2	3.5	3.8	2.8	4.9	10.0	9.0	4.1	6.6	8.5	5.5	6.4	5.5	5.1	5.7	5.2	4.4	7.6	4.2	7.2	3.6	10.0	7.6	7.0	10.2	7.6	9.4	4.7	6.0	3.9	5.1	2.9	2.4	10.6	0.3	6.7	2.3	4.1	9.5	13.2	6.8	5.1	0.2	3.2	0.2	0.2	0.9	19.3	0.3	15.6	0.5	9.6	15.1	0.3	0.5	3.2	11.0	0.7	12.2	0.4	0.3	5.6	4.7	10.0	12.2	37.4	16.9	10.2	8.4	7.3	13.1	8.3	6.5	3.0	10.5	14.0	12.8	7.2	53.9	13.9	10.2	6.7	6.8	15.7	98.2	8.5	6.6	6.1	3.8	12.8	8.1	0.0	6.3	9.0	7.6	8.7	11.5	9.0	3.6	152.6	8.7	13.5	5.6	7.1	16.1	5.3	8.5	7.2	7.8	23.6	5.5	10.1	13.4	10.4	80.5	0.0	5.0	21.2	20.6	5.8	3.1	90.0	10.6	7.8
PTPN5	"PTPSTEP, STEP, STEP61"	ENSG00000110786	"Protein tyrosine phosphatase, non-receptor type 5"	P54829	11	18727928-18792721	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	16	"brain: 70.0"	"Cell type enhanced"	"Detected in some"	15	"Cardiomyocytes: 2.4;Distal tubular cells: 1.7;Endothelial cells: 2.4"	"Group enriched"	"Detected in some"	6	"glioma: 1.6;testis cancer: 2.0"	"Region enhanced"	"Detected in many"		"basal ganglia: 70.0"	"Cell type enriched"	"Detected in single"	9	"basophil: 1.5"	"Lineage enriched"	"Detected in single"	9	"granulocytes: 1.5"	"Cell line enhanced"	"Detected in some"		"Daudi: 1.6;HMC-1: 3.7;NTERA-2: 5.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031014, HPA072091"	Supported		Approved	"Endoplasmic reticulum"		NA	NA			"Endoplasmic reticulum"		"HPA031014: AB_10669550, HPA072091: AB_2686487"	"unprognostic (1.23e-1)"	"unprognostic (2.91e-2)"	"unprognostic (8.93e-3)"	"unprognostic (1.09e-2)"	"unprognostic (3.27e-2)"	"unprognostic (2.13e-2)"	"unprognostic (5.83e-3)"	"unprognostic (3.59e-1)"	"unprognostic (4.91e-2)"	"unprognostic (2.59e-1)"	"unprognostic (2.00e-1)"	"unprognostic (3.58e-1)"	"unprognostic (8.44e-4)"	"unprognostic (4.21e-3)"	"unprognostic (3.90e-2)"	"unprognostic (9.39e-2)"	"unprognostic (8.49e-2)"	2.5	1.6	16.3	1.1	70.0	1.1	1.2	0.9	47.5	1.5	1.1	0.4	0.0	1.1	1.2	1.0	1.3	1.7	1.4	4.3	9.1	8.6	1.1	0.9	2.7	1.1	3.5	16.0	2.5	1.2	1.5	0.5	0.9	6.1	1.6	1.4	0.0	1.3	1.7	1.8	1.0	1.4	1.4	2.1	1.3	1.3	3.4	9.3	0.0	1.2	0.0	1.0	1.5	0.3	0.1	0.0	1.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	1.6	0.3	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	1.1	0.0	3.7	0.0	0.0	0.1	0.1	0.0	0.0	0.3	0.0	0.3	0.0	0.0	0.1	0.0	5.8	0.0	0.3	0.0	0.1	0.1	0.0	0.1	0.4	0.8	0.0	0.0	0.0	0.5	0.3	0.0	0.0	0.2	0.7	0.0	0.0	0.0	0.3	0.1	0.2	0.0	0.4	1.5	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	16.3	70.0	0.9	25.1	9.1	8.6	3.5	16.0	6.1	9.3	0.0	0.0	0.0	0.0	0.1	0.2	2.4	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0
PTPN6	"HCP, HCPH, PTP-1C, SHP-1, SHP1"	ENSG00000111679	"Protein tyrosine phosphatase, non-receptor type 6"	P29350	12	6946468-6961316	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 107.1;lymphoid tissue: 69.0"	"Group enriched"	"Detected in many"	5	"B-cells: 106.2;Early spermatids: 45.6;granulocytes: 130.8;Hofbauer cells: 168.2;Kupffer cells: 145.1;Macrophages: 118.2;T-cells: 105.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HEL: 28.7;HL-60: 25.5;HMC-1: 112.6;THP-1: 43.8"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA001466, CAB004572, CAB072845"	Enhanced		Supported	Nucleoplasm,Nucleoli		NA	NA		7400000	Nucleoplasm	Nucleoli	"CAB004572: AB_628251, CAB072845: , HPA001466: AB_1855930"	"unprognostic (4.28e-3)"	"prognostic favorable (1.87e-4)"	"prognostic unfavorable (5.42e-4)"	"prognostic favorable (6.65e-4)"	"unprognostic (6.54e-2)"	"unprognostic (7.92e-2)"	"unprognostic (2.36e-1)"	"unprognostic (1.44e-2)"	"unprognostic (6.93e-3)"	"unprognostic (3.57e-1)"	"unprognostic (1.41e-2)"	"unprognostic (2.61e-1)"	"unprognostic (1.60e-3)"	"unprognostic (1.98e-3)"	"unprognostic (2.60e-2)"	"unprognostic (5.91e-2)"	"prognostic favorable (2.64e-8)"	6.6	8.8	2.4	42.9	4.4	27.7	4.6	1.2	2.7	2.8	7.0	5.1	4.7	7.5	3.7	8.8	7.0	5.0	9.8	2.9	3.1	2.3	7.0	6.8	25.4	58.1	5.2	1.8	2.3	6.7	2.7	5.6	7.7	3.9	5.6	5.2	3.6	10.6	7.0	1.3	6.1	21.0	2.6	4.9	69.0	6.6	1.5	3.3	31.4	6.3	4.1	50.7	8.5	4.2	63.9	38.0	107.1	103.2	22.2	28.2	63.2	2.9	5.6	0.0	0.0	0.0	0.0	5.3	0.0	0.0	0.0	0.0	3.0	6.6	2.0	1.5	0.0	0.0	3.4	0.0	3.9	0.0	1.2	1.2	28.7	0.6	2.4	0.0	25.5	112.6	0.0	2.8	0.0	1.2	0.0	0.0	10.3	0.0	0.2	0.0	6.1	9.2	14.9	1.5	6.8	0.9	8.4	0.0	14.5	3.1	5.5	0.5	0.0	0.9	4.6	0.0	4.1	1.4	43.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	11.2	0.1	54.4	35.9	107.1	28.2	71.3	18.2	62.3	13.7	21.0	38.0	63.9	15.8	19.9	66.7	22.2	103.2	10.0	14.4	63.2	2.4	4.4	1.2	2.7	3.1	2.3	5.2	1.8	3.9	3.3	6.0	18.1	106.2	8.1	8.0	0.0	1.6	12.7	12.0	11.4	5.2	0.0	21.7	13.3	12.3	45.6	4.1	15.8	23.3	13.5	15.5	3.5	4.1	130.8	10.2	168.2	0.0	23.7	9.8	145.1	8.7	0.9	118.2	13.5	6.4	12.0	0.4	11.8	17.3	0.0	10.5	0.6	6.5	2.3	0.3	1.1	7.5	15.4	105.5	15.6	5.6
PTPN7	"HEPTP, LC-PTP"	ENSG00000143851	"Protein tyrosine phosphatase, non-receptor type 7"	P35236	1	202147013-202161588	"Enzymes, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 24.5;lymphoid tissue: 63.7"	"Group enriched"	"Detected in many"	5	"B-cells: 40.6;granulocytes: 137.4;T-cells: 156.8"	"Low cancer specificity"	"Detected in all"			"Group enriched"	"Detected in some"	5	"basal ganglia: 9.4;thalamus: 2.9"	"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in all"	5	"granulocytes: 17.0;NK-cells: 9.9;T-cells: 10.6"	"Cell line enhanced"	"Detected in some"		"HEL: 16.7;HL-60: 36.3;HMC-1: 48.9;NB-4: 15.8;THP-1: 16.7;U-937: 26.2"	"Region enriched"	"Detected in single"	10	"basal ganglia: 5.5"	"Region enriched"	"Detected in all"	4	"basal ganglia: 10.9"	"CAB009530, HPA019118"	Approved		Supported	"Microtubules,Mitotic spindle,Cytosol"		NA	NA			Cytosol	"Microtubules, Mitotic spindle"	"CAB009530: AB_2173845, HPA019118: AB_1855755"	"unprognostic (4.19e-3)"	"unprognostic (1.08e-3)"	"unprognostic (3.09e-2)"	"prognostic favorable (1.52e-4)"	"unprognostic (2.91e-2)"	"prognostic favorable (1.84e-4)"	"unprognostic (3.01e-2)"	"unprognostic (3.16e-2)"	"unprognostic (1.43e-2)"	"unprognostic (4.84e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.45e-1)"	"prognostic unfavorable (2.42e-8)"	"unprognostic (1.46e-1)"	"unprognostic (4.51e-2)"	"unprognostic (2.70e-1)"	"unprognostic (2.39e-2)"	2.6	3.1	0.5	27.1	9.4	24.5	0.6	0.4	0.5	0.6	2.3	0.6	0.0	3.0	0.7	0.6	1.7	0.8	2.9	0.5	0.6	0.8	1.1	0.9	3.2	16.5	1.2	0.2	0.6	0.6	0.0	0.7	0.4	0.8	1.3	1.9	0.7	5.3	0.3	0.4	0.6	3.7	0.9	1.6	15.4	1.4	12.7	2.9	63.7	0.9	0.6	24.8	2.9	0.8	2.6	2.6	17.0	1.1	9.9	10.6	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.9	0.0	16.7	0.0	0.0	0.0	36.3	48.9	0.0	0.0	0.0	0.0	0.0	0.0	12.7	0.7	1.5	0.0	0.0	4.9	15.8	0.0	0.0	0.0	0.7	0.0	12.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	16.7	0.0	0.0	0.1	0.0	0.0	7.4	1.8	10.5	0.0	26.2	0.0	11.5	1.1	17.0	10.6	1.1	9.5	1.9	7.1	10.5	2.0	2.6	5.3	6.4	7.1	9.9	0.4	2.6	9.0	2.8	0.5	9.4	0.4	0.5	0.6	0.8	1.2	0.2	0.8	2.9	3.0	9.0	40.6	1.0	2.1	2.4	0.7	0.0	0.0	1.2	0.0	0.0	0.4	0.0	0.2	0.4	2.9	0.0	0.0	0.0	0.1	1.7	0.5	137.4	0.5	15.6	0.0	0.0	4.9	6.2	1.3	4.9	23.4	8.5	9.0	0.0	5.6	0.1	0.0	2.1	0.6	4.4	0.0	0.9	0.9	0.4	2.0	0.7	156.8	0.0	0.5
PTPN9	MEG2	ENSG00000169410	"Protein tyrosine phosphatase, non-receptor type 9"	P43378	15	75463251-75579289	"Enzymes, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041922	Approved		Approved	Vesicles		NA	NA			Vesicles		"HPA041922: AB_10795269"	"unprognostic (9.58e-2)"	"unprognostic (1.87e-1)"	"unprognostic (1.28e-1)"	"unprognostic (2.42e-1)"	"unprognostic (1.54e-2)"	"unprognostic (6.80e-2)"	"unprognostic (7.38e-2)"	"unprognostic (5.95e-2)"	"unprognostic (3.93e-1)"	"unprognostic (3.14e-1)"	"unprognostic (9.25e-3)"	"unprognostic (6.35e-2)"	"prognostic favorable (2.49e-6)"	"unprognostic (2.26e-1)"	"unprognostic (1.05e-1)"	"unprognostic (2.71e-1)"	"unprognostic (2.39e-1)"	16.8	12.8	15.0	11.8	17.7	9.2	15.7	11.1	20.0	17.4	22.4	10.5	12.0	17.0	18.9	16.4	10.9	16.4	13.5	12.2	13.1	14.6	17.9	14.0	16.0	12.6	11.6	12.4	16.0	12.3	16.6	12.5	18.9	13.2	16.9	19.5	18.4	14.6	21.9	6.8	11.8	30.6	17.6	15.6	15.6	13.4	8.7	7.5	16.3	34.4	8.0	13.9	14.7	15.3	3.3	5.9	4.6	5.7	6.7	7.2	2.9	9.2	11.2	17.5	11.6	13.1	14.5	5.7	14.0	21.7	17.7	16.1	6.7	14.1	15.0	11.3	23.7	14.2	14.1	37.6	16.0	17.9	18.6	9.5	8.4	8.0	7.1	19.7	12.8	13.0	18.7	16.8	14.1	22.2	18.1	14.8	10.0	5.6	5.5	19.9	6.1	9.0	12.0	16.0	8.4	5.7	17.8	8.7	4.1	22.3	15.1	6.9	14.3	19.8	11.0	21.4	17.5	5.7	22.0	17.0	17.0	5.5	11.1	14.8	8.1	8.4	14.0	9.9	19.4	16.6	4.6	4.3	4.2	7.2	5.7	5.7	3.3	5.0	6.1	5.9	2.3	2.1	3.9	0.7	6.7	5.4	3.9	3.1	2.9	15.0	17.7	11.1	20.0	13.1	14.6	11.6	12.4	13.2	7.5	6.0	12.0	13.4	6.8	3.0	11.0	3.1	10.2	8.1	9.1	10.4	7.9	13.9	13.3	9.2	2.4	8.0	20.3	0.0	8.6	3.5	11.9	8.9	15.0	9.9	16.4	3.2	6.9	22.1	18.1	3.5	11.5	20.8	6.8	16.2	12.2	5.4	14.2	10.5	25.8	8.4	17.5	12.9	8.6	5.2	7.0	2.9	8.5	12.9	12.1	12.7
PTPRA	"HLPR, HPTPA, LRP, PTPA, PTPRL2, RPTPA"	ENSG00000132670	"Protein tyrosine phosphatase, receptor type A"	P18433	20	2864184-3039076	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029412, CAB034366, HPA069480"	Approved		Approved	Nucleoplasm,Vesicles		NA	NA		21000	Vesicles	Nucleoplasm	"CAB034366: AB_2269058, HPA029412: AB_10602293, HPA069480: AB_2686141"	"unprognostic (1.39e-1)"	"unprognostic (2.05e-1)"	"unprognostic (4.58e-2)"	"unprognostic (2.39e-3)"	"unprognostic (1.15e-1)"	"unprognostic (1.62e-1)"	"unprognostic (5.43e-3)"	"unprognostic (5.34e-2)"	"unprognostic (1.55e-1)"	"unprognostic (3.24e-1)"	"unprognostic (7.33e-2)"	"unprognostic (1.16e-1)"	"prognostic favorable (3.29e-6)"	"unprognostic (1.25e-1)"	"unprognostic (4.02e-1)"	"unprognostic (1.60e-2)"	"unprognostic (4.19e-1)"	21.9	18.5	55.6	14.3	48.6	16.4	23.3	44.5	56.0	29.7	19.7	37.5	9.4	14.7	26.3	18.7	22.7	26.5	21.3	14.0	45.9	41.1	22.1	13.5	21.6	16.9	38.0	46.7	28.6	14.9	41.5	23.4	29.0	52.5	23.5	20.0	18.5	16.7	21.8	8.2	21.0	15.3	25.7	52.6	17.9	16.3	27.4	30.4	20.6	32.4	8.5	20.4	22.9	19.2	7.7	5.7	7.9	6.7	6.2	11.0	3.7	21.0	12.9	37.2	11.4	41.2	75.1	7.9	15.8	31.0	19.6	24.1	15.3	29.2	13.8	12.5	21.2	19.8	22.6	15.0	22.6	22.2	21.3	9.6	19.6	5.4	19.4	14.7	19.7	9.3	33.5	23.5	16.2	17.1	24.2	27.1	19.9	19.7	17.7	19.4	8.6	22.7	22.3	14.3	18.9	10.3	17.4	18.0	17.2	16.7	16.3	20.6	19.7	15.3	26.1	23.5	16.9	16.3	16.9	19.4	17.6	8.7	19.5	13.9	13.0	18.0	18.2	8.1	18.7	16.4	7.9	4.8	7.5	11.0	4.8	9.0	7.7	7.4	7.9	3.7	5.1	7.4	9.0	6.0	6.2	6.7	5.7	8.1	3.7	55.6	48.6	44.5	56.0	45.9	41.1	38.0	46.7	52.5	30.4	20.8	16.3	29.4	29.9	14.1	87.6	6.5	45.9	17.4	27.3	43.6	29.5	25.3	23.2	13.3	11.8	26.9	31.5	23.3	13.4	35.4	36.1	29.8	23.0	28.0	33.5	66.7	42.6	43.6	35.2	12.5	55.8	21.8	35.4	10.8	27.0	77.3	13.8	25.8	46.0	19.2	55.1	38.8	26.4	51.2	75.4	15.1	27.3	39.5	26.2	27.6
PTPRB	PTPB	ENSG00000127329	"Protein tyrosine phosphatase, receptor type B"	P23467	12	70515866-70637440	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	Angiogenesis	"Hydrolase, Protein phosphatase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in many"	6	"Endothelial cells: 113.4;Ito cells: 448.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	7	"memory B-cell: 3.5"	"Lineage enriched"	"Detected in single"	7	"B-cells: 3.5"	"Cell line enhanced"	"Detected in some"		"EFO-21: 11.3;hTERT-RPE1: 9.1;HUVEC TERT2: 28.0;TIME: 40.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004782, HPA067868"	Uncertain		Approved	"Vesicles,Plasma membrane,Cell Junctions"		NA	NA		6700000	"Plasma membrane"	"Vesicles, Cell Junctions"	"CAB004782: , HPA067868: AB_2685911"	"unprognostic (3.18e-1)"	"unprognostic (2.99e-6)"	"unprognostic (1.56e-1)"	"unprognostic (1.80e-1)"	"unprognostic (3.55e-2)"	"unprognostic (1.77e-2)"	"prognostic favorable (6.05e-4)"	"unprognostic (4.59e-1)"	"unprognostic (2.22e-2)"	"unprognostic (1.85e-1)"	"unprognostic (2.28e-2)"	"unprognostic (1.40e-1)"	"prognostic favorable (1.02e-4)"	"unprognostic (2.91e-2)"	"unprognostic (7.18e-2)"	"unprognostic (1.31e-1)"	"unprognostic (1.38e-1)"	23.5	7.0	4.5	5.5	7.0	0.1	22.9	3.6	6.1	11.3	8.0	4.3	7.1	5.3	17.1	8.5	5.8	8.2	11.4	17.6	6.2	5.1	18.7	12.0	39.9	3.3	6.9	4.6	5.5	4.4	4.9	5.7	23.3	7.8	6.1	8.2	16.0	3.6	7.1	11.8	4.7	7.4	13.3	7.3	22.9	5.2	3.7	4.3	0.7	14.0	12.2	2.6	6.5	14.7	3.5	0.1	0.2	0.0	0.4	0.3	0.2	1.9	0.1	0.8	0.1	0.0	0.0	0.4	0.4	1.9	1.0	2.4	0.0	1.5	0.7	11.3	0.3	0.1	6.9	0.1	0.3	3.6	0.6	0.3	0.1	0.8	0.5	0.1	0.3	0.0	0.0	0.3	2.8	0.0	9.1	28.0	0.0	1.5	0.5	0.6	0.0	0.0	0.0	1.0	1.9	0.4	0.0	0.7	0.4	5.2	0.8	0.0	0.4	0.7	0.0	1.6	0.2	0.0	0.6	40.9	0.4	0.4	0.1	2.4	0.5	0.4	0.3	0.2	0.5	0.0	0.2	0.0	0.0	0.2	0.0	0.0	3.5	0.0	0.3	0.0	0.3	0.1	0.0	0.1	0.4	0.0	0.1	0.0	0.2	4.5	7.0	3.6	6.1	6.2	5.1	6.9	4.6	7.8	4.3	0.0	19.9	13.7	0.8	3.3	5.4	9.2	17.8	0.0	1.2	3.5	0.0	0.0	0.0	1.4	4.3	113.4	4.3	46.7	0.8	0.0	1.9	0.6	23.3	2.0	0.3	4.8	0.0	448.7	26.3	2.5	1.1	2.0	5.0	0.0	4.8	0.3	7.2	14.4	0.0	0.0	0.8	0.0	0.9	0.7	0.5	1.4	0.0	1.7	5.2	0.6
PTPRD	"HPTP, PTPD"	ENSG00000153707	"Protein tyrosine phosphatase, receptor type D"	P23468	9	8314246-10612723	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"		"Hydrolase, Protein phosphatase, Receptor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 32.1;parathyroid gland: 37.5"	"Cell type enhanced"	"Detected in many"	15	"Bipolar cells: 110.1;Intestinal endocrine cells: 34.0;Muller glia cells: 44.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 23.5;HAP1: 5.1;HSkMC: 8.0;NTERA-2: 5.7;RH-30: 8.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA054829	Uncertain		Approved	Nucleoplasm,Vesicles	"Intracellular and membrane"	NA	NA		2500000	Vesicles	Nucleoplasm	"HPA054829: AB_2682618"	"unprognostic (4.74e-1)"	"unprognostic (4.79e-2)"	"unprognostic (1.44e-2)"	"unprognostic (7.86e-2)"	"unprognostic (2.34e-1)"	"unprognostic (9.90e-2)"	"unprognostic (1.85e-1)"	"unprognostic (1.66e-1)"	"unprognostic (1.91e-2)"	"unprognostic (2.13e-2)"	"unprognostic (7.52e-3)"	"unprognostic (2.62e-1)"	"prognostic favorable (7.45e-6)"	"unprognostic (3.56e-4)"	"unprognostic (7.59e-2)"	"unprognostic (4.84e-2)"	"unprognostic (3.08e-3)"	2.6	1.7	19.7	1.5	19.2	1.1	1.1	27.9	32.1	5.6	5.4	21.7	0.2	4.0	3.6	1.8	1.5	3.6	2.6	3.0	18.0	13.5	11.4	4.2	3.4	0.9	17.9	22.3	12.7	1.7	37.5	4.4	9.4	15.1	3.3	5.3	1.9	1.1	2.0	1.0	1.2	4.6	2.8	29.7	1.4	1.7	2.5	18.5	0.0	3.2	0.0	1.0	2.7	1.9	0.0	0.0	0.0	0.3	0.0	0.0	0.2	0.0	0.1	23.5	0.0	0.3	1.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.1	0.0	0.0	0.0	2.6	4.8	0.6	0.0	0.0	0.0	0.2	8.0	0.1	0.0	0.1	0.0	0.6	0.0	0.0	0.0	0.0	0.0	2.7	0.0	5.7	0.0	1.5	2.9	8.7	0.0	2.1	0.0	4.0	0.3	0.0	0.0	0.0	3.9	0.0	0.0	0.0	1.8	0.3	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.4	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	19.7	19.2	27.9	32.1	18.0	13.5	17.9	22.3	15.1	18.5	0.0	2.7	0.0	0.2	0.5	110.1	4.6	25.5	0.0	2.3	5.2	15.7	0.3	0.0	2.5	13.0	0.4	10.1	0.0	0.0	0.1	7.6	1.7	0.0	12.8	1.0	4.8	34.0	1.3	0.6	3.7	14.7	0.0	0.0	0.0	14.3	44.7	0.3	3.5	0.0	22.3	7.4	0.0	3.7	1.1	1.1	0.6	0.2	0.0	5.2	0.0
PTPRE	PTPE	ENSG00000132334	"Protein tyrosine phosphatase, receptor type E"	P23469	10	127907061-128085855	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 91.0"	"Cell type enhanced"	"Detected in many"	10	"Kupffer cells: 141.1;Macrophages: 249.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"neutrophil: 91.0;plasmacytoid DC: 65.7"	"Group enriched"	"Detected in all"	11	"dendritic cells: 65.7;granulocytes: 91.0;monocytes: 25.5"	"Cell line enhanced"	"Detected in many"		"hTERT-RPE1: 18.8;HUVEC TERT2: 19.8;NB-4: 14.9;TIME: 37.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA015870, HPA021872"	Supported		Approved	"Intermediate filaments"		NA	NA			"Intermediate filaments"		"HPA015870: AB_1855759, HPA021872: AB_1855760"	"unprognostic (5.23e-2)"	"unprognostic (1.37e-1)"	"unprognostic (1.99e-1)"	"unprognostic (7.11e-2)"	"unprognostic (3.19e-1)"	"unprognostic (9.67e-2)"	"unprognostic (6.50e-2)"	"unprognostic (4.49e-2)"	"unprognostic (2.11e-1)"	"unprognostic (2.56e-2)"	"unprognostic (8.71e-3)"	"unprognostic (2.00e-1)"	"prognostic unfavorable (4.08e-5)"	"unprognostic (1.52e-1)"	"unprognostic (6.71e-3)"	"unprognostic (2.49e-2)"	"unprognostic (5.59e-2)"	16.8	18.5	12.5	24.0	12.5	39.5	11.0	7.4	15.3	4.8	9.2	14.5	1.6	9.6	5.1	8.1	8.8	6.2	10.7	12.3	15.0	12.2	4.4	4.8	22.5	20.0	12.5	6.5	4.3	3.1	3.4	6.5	8.0	9.8	4.5	9.8	4.8	7.0	3.1	1.9	4.9	12.7	7.7	14.3	26.4	7.7	4.3	10.9	11.4	6.6	6.1	12.2	10.0	5.0	1.2	65.7	91.0	25.5	4.0	5.4	4.9	1.9	0.4	0.2	0.0	1.2	0.2	3.6	0.0	0.0	0.8	1.7	0.8	12.0	1.5	1.3	1.0	2.6	1.1	1.0	5.7	0.3	1.8	0.9	0.1	0.7	0.0	2.0	7.4	5.6	0.4	3.3	2.9	5.9	18.8	19.8	4.9	0.0	0.9	1.2	1.8	2.2	14.9	0.1	2.1	0.7	8.8	1.2	2.9	3.3	8.5	0.0	1.2	3.4	0.6	0.1	0.9	0.3	9.4	37.4	0.8	0.8	3.7	4.1	0.4	0.6	2.1	5.5	5.8	0.0	17.4	25.5	19.3	5.4	9.0	3.2	0.9	2.4	3.6	13.3	1.2	1.7	2.9	91.0	4.0	6.8	65.7	3.5	4.9	12.5	12.5	7.4	12.7	15.0	12.2	12.5	6.5	9.8	10.9	77.4	67.6	24.7	47.2	52.9	2.6	15.1	5.1	9.4	33.0	3.5	0.0	33.6	0.0	4.3	1.6	49.4	12.3	0.0	4.0	40.5	9.9	8.3	30.1	1.3	53.6	0.0	6.4	46.1	141.1	1.7	0.6	249.1	23.6	4.6	14.4	0.0	28.7	11.5	0.4	1.9	0.8	0.0	8.1	0.5	1.4	56.6	14.2	52.4	10.2	34.4
PTPRF	LAR	ENSG00000142949	"Protein tyrosine phosphatase, receptor type F"	P10586	1	43525187-43623666	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion"	"Heparin-binding, Hydrolase, Protein phosphatase, Receptor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	5	"Extravillous trophoblasts: 261.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BEWO: 54.6;SK-BR-3: 62.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA012710	Uncertain		Approved	"Golgi apparatus"	"Intracellular and membrane"	NA	NA		95000000	"Golgi apparatus"		"HPA012710: AB_1855933"	"unprognostic (8.20e-2)"	"unprognostic (2.41e-2)"	"unprognostic (3.01e-2)"	"unprognostic (9.17e-2)"	"unprognostic (8.34e-2)"	"unprognostic (1.11e-1)"	"prognostic unfavorable (3.47e-4)"	"unprognostic (4.59e-1)"	"unprognostic (1.51e-1)"	"unprognostic (4.97e-2)"	"unprognostic (4.68e-2)"	"unprognostic (7.07e-2)"	"unprognostic (1.99e-2)"	"prognostic favorable (7.03e-4)"	"unprognostic (2.33e-1)"	"unprognostic (3.19e-2)"	"unprognostic (2.58e-1)"	37.1	5.5	22.4	10.4	18.1	0.9	30.7	6.8	19.5	14.2	34.3	16.8	34.4	30.7	12.3	33.4	41.4	32.2	20.0	6.3	17.2	15.0	12.0	45.6	15.7	5.8	17.2	18.5	10.4	25.3	17.5	10.3	38.1	16.1	30.9	23.1	5.9	41.9	23.6	2.9	46.8	35.5	16.8	11.2	2.0	21.8	4.3	15.8	4.6	12.5	11.7	14.9	21.4	21.3	0.9	0.0	0.2	0.0	0.0	0.0	0.7	31.0	14.9	9.7	11.5	2.2	0.1	54.6	17.8	7.1	14.7	12.6	15.8	42.3	0.0	5.0	7.8	11.9	24.3	11.3	39.2	17.9	0.3	14.1	0.1	10.2	14.3	6.9	0.2	0.2	2.3	22.6	21.2	35.2	18.6	21.9	1.5	4.7	1.4	5.4	17.9	0.2	0.2	14.8	17.2	4.1	10.8	17.3	0.7	5.7	46.9	14.6	5.4	17.7	62.4	2.3	26.9	18.1	3.3	17.1	0.3	23.6	1.5	23.7	0.6	0.5	0.0	1.4	0.7	46.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.7	22.4	18.1	6.8	19.5	17.2	15.0	17.2	18.5	16.1	15.8	145.9	89.7	2.2	43.9	55.8	11.0	4.0	152.8	81.7	63.7	82.0	41.2	48.4	0.0	138.1	4.0	7.0	185.3	0.0	104.8	261.2	17.9	82.4	4.7	141.8	12.4	174.8	96.9	9.2	4.3	6.9	6.4	5.4	11.8	4.6	152.5	28.3	148.7	95.1	6.7	13.9	28.0	0.0	11.0	8.0	34.8	79.8	55.4	2.2	124.5	65.3
PTPRG	"PTPG, RPTPG"	ENSG00000144724	"Protein tyrosine phosphatase, receptor type G"	P23470	3	61561569-62297613	"Enzymes, Plasma proteins, Predicted membrane proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	8	"Bipolar cells: 91.5;Horizontal cells: 146.2;Ito cells: 89.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"memory B-cell: 1.3"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"ASC diff: 36.2;HSkMC: 26.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000546, HPA064237"	Uncertain		Approved	"Plasma membrane"		NA	NA		520000000	"Plasma membrane"		"HPA000546: , HPA064237: AB_2685221"	"unprognostic (1.47e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.31e-2)"	"unprognostic (1.93e-1)"	"unprognostic (8.73e-2)"	"unprognostic (3.26e-1)"	"unprognostic (5.38e-2)"	"unprognostic (1.18e-2)"	"unprognostic (5.84e-2)"	"unprognostic (2.28e-1)"	"unprognostic (2.86e-1)"	"unprognostic (1.14e-1)"	"prognostic favorable (3.10e-6)"	"unprognostic (9.91e-2)"	"unprognostic (3.25e-1)"	"unprognostic (1.19e-1)"	"unprognostic (2.63e-2)"	22.2	18.0	12.9	10.1	10.7	1.2	26.1	8.1	16.4	17.2	13.9	5.2	12.0	5.6	15.8	19.0	6.4	13.1	15.7	12.4	24.5	9.9	20.2	8.2	38.9	10.2	8.3	10.5	16.6	6.0	58.6	11.9	13.1	15.1	11.3	8.9	23.3	7.9	17.2	19.2	6.6	8.4	17.4	12.7	9.2	8.7	11.4	5.0	0.1	21.7	7.0	3.2	10.0	14.6	1.3	0.9	0.0	0.0	0.0	0.0	0.0	0.0	2.1	11.7	0.0	36.2	18.5	5.7	7.2	11.8	7.7	10.4	5.4	0.2	0.2	4.2	8.5	6.1	0.1	5.6	5.6	12.2	0.6	3.2	0.5	0.0	6.2	12.2	3.0	0.0	26.8	2.3	10.9	13.2	2.5	8.3	0.8	0.0	7.2	6.9	3.1	0.0	0.0	7.2	0.0	0.0	4.7	3.6	0.2	7.9	3.3	0.9	1.9	1.7	0.0	2.8	5.0	0.0	0.1	18.9	10.8	10.3	17.2	6.0	2.3	2.6	0.0	8.2	1.3	13.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	12.9	10.7	8.1	16.4	24.5	9.9	8.3	10.5	15.1	5.0	11.9	25.9	0.8	5.2	8.1	91.5	10.4	7.6	2.7	5.7	21.0	5.9	7.6	5.0	7.9	2.9	41.3	11.0	0.0	1.6	0.6	33.6	7.0	0.0	26.0	15.0	146.2	23.6	89.0	2.2	2.5	61.5	1.8	16.9	1.0	7.6	38.3	4.5	7.0	53.4	13.3	4.8	71.1	52.3	1.0	6.1	4.3	10.5	0.9	11.0	2.2
PTPRH	SAP-1	ENSG00000080031	"Protein tyrosine phosphatase, receptor type H"	Q9HD43	19	55181248-55209506	"Enzymes, Predicted membrane proteins"	Apoptosis	"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"gallbladder: 29.6;intestine: 84.3;lymphoid tissue: 21.2"	"Cell type enhanced"	"Detected in many"	18	"Enterocytes: 106.7;Paneth cells: 38.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Cell type enhanced"	"Detected in single"		"non-classical monocyte: 1.5"	"Lineage enhanced"	"Detected in single"		"monocytes: 1.5"	"Cell line enhanced"	"Detected in many"		"HHSteC: 9.1;K-562: 10.6;OE19: 22.4;SK-MEL-30: 15.9"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in some"			HPA042300			Approved	Mitochondria		NA	NA			Mitochondria		"HPA042300: AB_10796900"	"unprognostic (1.87e-1)"	"unprognostic (1.10e-1)"	"unprognostic (2.59e-1)"	"unprognostic (7.57e-3)"	"unprognostic (5.01e-3)"	"unprognostic (8.14e-2)"	"unprognostic (1.15e-1)"	"unprognostic (1.96e-3)"	"unprognostic (1.60e-2)"	"unprognostic (1.06e-1)"	"unprognostic (9.96e-2)"	"unprognostic (6.16e-2)"	"unprognostic (1.47e-11)"	"unprognostic (4.08e-3)"	"unprognostic (2.47e-1)"	"unprognostic (1.52e-2)"	"unprognostic (1.57e-1)"	0.5	8.9	0.5	5.2	0.7	0.0	0.5	0.5	1.0	0.7	39.9	0.6	0.5	30.1	0.5	0.5	0.6	0.0	29.6	0.5	1.3	1.6	0.6	7.8	0.6	0.5	3.0	0.5	0.6	2.8	0.0	3.0	0.6	0.5	1.0	9.6	0.6	0.5	0.5	0.5	0.0	84.3	0.7	6.9	21.2	10.2	0.5	0.5	0.5	0.5	1.0	0.8	1.1	2.4	0.0	0.7	0.0	1.5	0.0	0.0	0.0	4.9	3.0	0.0	1.2	1.0	2.7	0.0	0.1	2.7	0.5	1.1	1.3	7.0	0.0	0.2	0.5	6.2	0.0	0.0	0.0	0.6	0.0	0.1	0.4	0.1	3.5	9.1	0.0	3.6	0.7	2.2	1.7	2.7	0.3	0.1	0.0	10.6	0.5	0.0	0.0	0.0	0.2	0.0	22.4	7.2	0.0	0.0	0.3	0.0	0.0	0.3	0.7	0.0	3.1	15.9	0.0	0.0	1.4	0.0	0.7	1.1	0.3	0.0	0.0	2.6	0.0	0.8	0.1	2.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.5	0.7	0.5	0.5	1.3	1.6	3.0	0.5	0.5	0.5	0.0	0.0	0.0	2.4	1.5	0.0	0.6	20.4	0.0	0.0	1.8	0.0	0.0	0.0	11.7	0.0	0.2	106.7	0.0	22.9	0.0	0.2	3.1	0.0	5.1	0.2	15.9	4.6	1.3	0.0	0.0	0.0	0.8	0.0	1.0	14.0	0.2	20.1	38.6	0.0	0.0	0.3	0.0	0.4	0.0	0.2	1.0	0.1	0.0	15.6	17.9
PTPRJ	"CD148, DEP1, HPTPeta"	ENSG00000149177	"Protein tyrosine phosphatase, receptor type J"	Q12913	11	47980558-48170841	"CD markers, Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	7	"Kupffer cells: 67.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"neutrophil: 12.2"	"Group enriched"	"Detected in all"	4	"granulocytes: 12.2;monocytes: 5.3"	"Cell line enhanced"	"Detected in many"		"EFO-21: 25.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA006026	Approved				"Intracellular and membrane"	NA	NA		840000000			"HPA006026: AB_1078446"	"unprognostic (1.46e-1)"	"unprognostic (2.21e-1)"	"unprognostic (1.55e-1)"	"unprognostic (3.83e-2)"	"unprognostic (3.20e-2)"	"unprognostic (2.99e-2)"	"unprognostic (6.58e-2)"	"unprognostic (2.15e-1)"	"unprognostic (9.64e-3)"	"unprognostic (3.79e-3)"	"unprognostic (5.16e-2)"	"unprognostic (1.89e-1)"	"prognostic favorable (1.13e-5)"	"unprognostic (1.09e-2)"	"unprognostic (7.98e-2)"	"unprognostic (9.18e-2)"	"unprognostic (2.00e-1)"	5.6	3.7	10.4	17.7	13.9	22.6	5.6	4.9	9.5	6.1	9.0	8.8	12.3	8.4	3.9	7.6	2.9	5.0	6.7	5.2	9.5	9.2	13.3	12.2	12.2	22.6	10.8	9.4	3.0	9.1	21.1	14.5	20.3	8.3	7.8	8.1	12.9	12.9	9.0	4.6	4.3	13.4	5.5	6.7	33.0	13.8	3.1	9.9	6.7	18.8	0.9	9.7	6.0	3.9	1.0	1.8	12.2	5.3	1.2	2.1	0.9	3.5	13.5	5.9	3.2	0.9	2.1	2.0	3.6	2.7	6.4	4.8	0.8	20.0	3.3	25.5	9.2	9.6	2.7	9.3	0.9	7.8	21.9	2.5	0.9	16.7	1.2	5.8	1.2	20.8	1.5	0.3	1.7	0.5	15.3	3.9	0.2	1.2	2.2	2.2	7.7	0.0	7.5	4.6	11.5	2.1	0.8	0.7	1.7	24.8	5.3	4.0	1.2	10.1	5.7	9.1	4.5	6.4	9.2	12.5	5.0	5.3	10.0	11.0	0.5	0.7	5.5	5.8	3.8	18.3	0.9	1.5	3.4	2.1	2.5	1.4	1.0	1.2	1.5	1.0	0.7	1.0	1.3	12.2	1.2	5.3	1.8	1.1	0.9	10.4	13.9	4.9	9.4	9.5	9.2	10.8	9.4	8.3	9.9	8.9	21.3	8.0	8.8	0.2	11.1	3.1	17.8	8.1	22.7	36.6	5.9	1.5	0.0	6.5	4.2	2.2	28.4	0.0	4.3	0.6	3.0	20.5	12.8	14.0	26.2	9.5	12.1	2.5	67.6	4.0	0.3	20.6	1.7	10.8	8.5	11.5	8.7	28.1	0.4	10.9	1.0	0.0	3.9	0.2	3.2	0.3	1.6	13.8	5.7	5.4
PTPRK	R-PTP-kappa	ENSG00000152894	"Protein tyrosine phosphatase, receptor type K"	Q15262	6	127968779-128520674	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"		"Hydrolase, Protein phosphatase, Receptor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	6	"memory B-cell: 2.3;naive B-cell: 4.8;naive CD8 T-cell: 1.6"	"Group enriched"	"Detected in many"	7	"B-cells: 4.8;T-cells: 1.6"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA054056, HPA054822"	Uncertain		Supported	"Vesicles,Plasma membrane,Cell Junctions"		NA	NA		13000000	"Cell Junctions"	"Vesicles, Plasma membrane"	"HPA054056: AB_2682359, HPA054822: AB_2682614"	"unprognostic (3.15e-2)"	"unprognostic (1.07e-2)"	"unprognostic (5.79e-3)"	"unprognostic (4.95e-3)"	"unprognostic (1.89e-2)"	"unprognostic (7.26e-2)"	"unprognostic (3.27e-1)"	"unprognostic (6.06e-2)"	"unprognostic (2.04e-1)"	"unprognostic (1.08e-1)"	"prognostic unfavorable (1.99e-4)"	"unprognostic (1.46e-1)"	"prognostic favorable (9.33e-5)"	"unprognostic (2.10e-1)"	"unprognostic (1.55e-1)"	"unprognostic (2.59e-1)"	"unprognostic (9.32e-2)"	12.0	5.2	18.6	10.7	20.3	1.2	20.9	4.7	24.4	12.2	21.9	25.6	11.2	25.7	12.1	10.3	9.1	13.2	29.6	11.4	17.2	12.6	13.3	23.6	17.4	5.7	20.5	19.3	15.6	25.7	11.4	12.2	17.4	14.9	16.3	23.4	3.9	18.3	17.5	9.1	13.5	27.4	14.6	17.1	6.4	24.6	2.7	23.7	15.3	10.1	6.5	7.6	18.4	15.1	4.8	0.0	0.0	0.0	0.4	1.6	0.2	4.5	4.9	2.9	0.2	6.2	8.3	3.0	12.3	23.8	5.1	4.6	8.1	3.8	0.0	3.7	11.3	14.8	12.9	3.1	9.7	7.2	13.6	4.9	0.1	7.5	11.2	7.6	0.0	0.4	6.1	9.0	10.6	14.5	13.3	13.8	4.4	0.0	0.2	12.4	9.1	6.9	0.0	3.1	8.3	6.3	24.8	6.3	0.8	12.6	9.3	15.5	0.0	12.7	14.2	0.7	3.5	3.9	0.3	23.4	8.0	5.6	15.5	11.1	0.1	1.6	0.0	10.2	0.0	8.4	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.1	0.1	0.0	4.8	0.4	1.6	0.0	0.4	0.0	0.0	0.1	0.2	18.6	20.3	4.7	24.4	17.2	12.6	20.5	19.3	14.9	23.7	23.8	27.4	9.7	78.6	56.3	3.1	19.3	76.5	18.7	33.0	17.4	3.9	21.8	0.0	51.8	3.4	46.7	63.1	0.0	53.2	4.5	30.5	99.0	1.1	36.5	5.1	9.5	42.2	8.0	1.0	2.1	15.8	1.8	16.9	2.8	41.3	7.0	84.8	57.5	17.0	11.2	0.6	58.2	35.8	3.6	5.8	33.2	22.4	1.0	48.9	100.5
PTPRM	"hR-PTPu, PTPRL1, RPTPU"	ENSG00000173482	"Protein tyrosine phosphatase, receptor type M"	P28827	18	7566782-8406861	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion"	"Hydrolase, Protein phosphatase, Receptor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	4	"Endothelial cells: 47.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"memory CD8 T-cell: 7.2"	"Group enriched"	"Detected in many"	50	"dendritic cells: 2.7;T-cells: 7.2"	"Cell line enhanced"	"Detected in many"		"ASC diff: 35.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003891, CAB022442, CAB022443"	Supported		Approved	"Plasma membrane"		NA	NA		76000000	"Plasma membrane"		"CAB022442: , CAB022443: , HPA003891: AB_2667073"	"unprognostic (2.59e-1)"	"prognostic unfavorable (8.65e-5)"	"unprognostic (4.89e-2)"	"unprognostic (1.00e-1)"	"unprognostic (1.13e-1)"	"unprognostic (1.46e-1)"	"unprognostic (1.80e-1)"	"unprognostic (3.41e-2)"	"unprognostic (7.62e-2)"	"unprognostic (2.74e-2)"	"unprognostic (1.56e-2)"	"unprognostic (9.64e-2)"	"unprognostic (5.63e-2)"	"unprognostic (3.11e-3)"	"unprognostic (9.41e-2)"	"unprognostic (2.63e-2)"	"prognostic favorable (1.07e-4)"	31.4	14.1	9.5	6.3	22.2	0.6	23.6	10.4	17.2	11.0	13.6	6.2	28.1	4.7	15.4	10.9	8.1	13.6	18.1	33.5	10.5	15.0	16.9	6.5	22.0	7.8	8.5	12.0	15.7	7.6	16.3	21.9	18.3	23.2	10.6	6.6	18.3	7.4	21.8	26.0	7.3	8.7	14.1	9.3	12.1	11.0	12.2	9.1	2.9	31.1	7.3	6.3	18.6	25.3	0.0	2.7	0.0	0.0	0.0	7.2	1.4	1.5	11.4	5.5	0.0	35.1	24.4	13.3	14.0	12.3	9.4	14.0	10.4	2.4	0.0	13.8	16.7	0.2	0.1	0.0	4.9	13.1	0.1	2.5	0.0	7.6	5.0	10.0	0.0	0.1	27.6	10.3	5.2	14.9	18.1	9.4	0.0	0.0	4.8	7.5	0.2	4.5	0.1	0.9	3.3	2.5	0.1	4.7	21.1	23.1	19.6	0.5	3.0	0.4	0.0	11.7	9.1	0.0	0.0	9.7	19.4	12.2	9.2	2.4	0.4	0.1	0.0	16.6	0.0	3.6	0.0	0.0	0.0	4.5	0.0	1.8	0.0	6.0	7.2	0.1	0.0	1.7	3.1	0.0	0.0	0.0	2.7	1.0	1.4	9.5	22.2	10.4	17.2	10.5	15.0	8.5	12.0	23.2	9.1	41.7	29.0	0.9	6.8	5.4	24.2	24.1	17.8	22.7	9.1	5.2	2.0	10.4	1.7	15.5	24.0	47.4	0.5	0.0	7.1	2.7	10.2	7.0	2.3	20.2	8.2	0.0	1.7	38.1	8.0	34.9	2.6	5.2	28.7	1.0	1.3	2.8	12.6	0.3	4.9	11.3	1.9	6.5	8.0	3.6	9.8	2.5	10.5	2.5	0.8	5.4
PTPRN2	"IA-2beta, ICAAR, KIAA0387, phogrin"	ENSG00000155093	"Protein tyrosine phosphatase, receptor type N2"	Q92932	7	157539056-158587788	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Lipid metabolism, Phospholipid metabolism"	"Hydrolase, Protein phosphatase, Receptor"	"Diabetes mellitus"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 40.6;pancreas: 51.3"	"Cell type enhanced"	"Detected in many"	7	"Ciliated cells: 84.3;Intestinal endocrine cells: 126.1"	"Cancer enhanced"	"Detected in all"		"prostate cancer: 40.8"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"neutrophil: 14.8"	"Lineage enriched"	"Detected in all"	4	"granulocytes: 14.8"	"Cell line enhanced"	"Detected in some"		"AF22: 15.6;HDLM-2: 22.0;NB-4: 22.6;SCLC-21H: 12.5;SH-SY5Y: 12.7;THP-1: 11.1;U-87 MG: 15.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006900, HPA007255, HPA026656"	Enhanced		Approved	Vesicles		NA	NA			Vesicles		"HPA006900: AB_1079715, HPA007255: , HPA026656: AB_1855912"	"unprognostic (2.42e-1)"	"unprognostic (4.17e-2)"	"unprognostic (7.82e-2)"	"unprognostic (2.69e-2)"	"prognostic unfavorable (9.37e-5)"	"unprognostic (7.12e-3)"	"unprognostic (1.04e-1)"	"unprognostic (4.55e-2)"	"unprognostic (4.27e-2)"	"unprognostic (1.64e-1)"	"unprognostic (1.20e-2)"	"unprognostic (1.39e-1)"	"prognostic favorable (8.68e-4)"	"unprognostic (2.60e-2)"	"unprognostic (1.48e-1)"	"unprognostic (1.43e-3)"	"unprognostic (6.16e-2)"	2.1	10.5	20.1	1.7	33.9	1.0	1.1	6.2	40.6	1.7	4.6	2.9	0.0	5.1	2.0	2.9	1.5	6.9	4.7	1.9	18.2	21.3	2.0	1.2	3.1	2.1	11.3	22.3	5.8	51.3	0.5	20.0	1.5	10.3	10.2	3.7	1.5	3.4	2.6	0.8	0.7	4.2	1.6	5.3	7.7	24.2	2.2	5.2	0.0	5.6	0.3	1.7	2.8	0.6	3.4	1.3	14.8	1.1	1.5	3.5	1.1	0.0	0.2	15.6	1.2	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.9	0.0	0.6	0.2	3.7	0.0	0.4	0.0	0.0	22.0	0.2	0.0	0.0	2.5	0.6	0.0	0.0	1.1	0.2	0.0	0.1	0.1	0.0	1.1	0.0	0.1	0.0	0.2	6.5	22.6	3.1	5.5	0.8	0.0	0.7	0.1	0.0	0.0	12.5	12.7	0.0	0.0	0.0	0.0	0.0	11.1	3.3	5.1	1.9	0.0	0.4	0.1	0.0	0.0	15.4	9.2	3.7	8.7	1.1	1.6	0.9	0.1	0.3	2.3	1.5	1.1	1.3	3.4	1.4	0.9	14.8	1.5	0.0	0.2	3.5	1.1	20.1	33.9	6.2	40.6	18.2	21.3	11.3	22.3	10.3	5.2	3.0	11.7	10.4	12.5	2.1	31.6	2.2	7.6	84.3	13.6	38.4	9.8	0.4	29.9	15.8	35.1	23.3	4.5	0.0	11.7	0.4	3.9	21.1	18.5	0.8	34.3	11.1	126.1	41.1	11.0	13.1	11.5	6.0	11.8	3.6	39.6	40.1	6.1	5.8	18.4	3.5	6.3	25.8	5.1	41.6	11.7	1.3	0.6	10.0	7.2	22.5
PTPRO	"GLEPP1, NPHS6, PTP-oc, PTP-U2, PTPU2"	ENSG00000151490	"Protein tyrosine phosphatase, receptor type O"	Q16827	12	15322397-15597399	"Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"		"Hydrolase, Protein phosphatase, Receptor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 26.1;intestine: 28.5;kidney: 21.6"	"Cell type enhanced"	"Detected in some"	7	"Bipolar cells: 16.3;Collecting duct cells: 15.7;Hofbauer cells: 22.6;Horizontal cells: 23.8;Kupffer cells: 17.2;monocytes: 19.0"	"Cancer enhanced"	"Detected in many"		"colorectal cancer: 8.7"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"classical monocyte: 5.2;intermediate monocyte: 10.5;memory B-cell: 8.3;myeloid DC: 7.4;naive B-cell: 7.0;naive CD4 T-cell: 2.9;non-classical monocyte: 10.5;plasmacytoid DC: 9.5"	"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in some"	4	"GAMG: 13.0;NTERA-2: 8.2;SCLC-21H: 5.0;SH-SY5Y: 9.9;THP-1: 4.1"	"Region enhanced"	"Detected in many"		"olfactory region: 215.3"	"Low region specificity"	"Detected in all"			HPA034525	Enhanced				"Intracellular and membrane"	NA	NA					"HPA034525: AB_10669785"	"unprognostic (3.68e-2)"	"unprognostic (3.49e-1)"	"unprognostic (9.64e-2)"	"unprognostic (1.25e-2)"	"unprognostic (7.87e-2)"	"unprognostic (2.08e-1)"	"unprognostic (5.93e-3)"	"unprognostic (5.37e-2)"	"unprognostic (2.03e-1)"	"unprognostic (3.72e-2)"	"unprognostic (2.00e-1)"	"unprognostic (5.43e-2)"	"unprognostic (4.89e-2)"	"unprognostic (2.12e-1)"	"unprognostic (1.99e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.44e-1)"	3.3	1.2	16.2	3.1	26.1	0.6	1.1	1.0	15.3	1.7	10.4	1.5	0.0	2.0	4.5	2.1	0.8	1.2	1.6	0.7	11.3	10.6	21.6	1.6	6.7	3.2	4.8	8.8	0.7	0.6	0.6	3.8	4.4	4.0	0.7	28.5	1.1	0.8	1.1	0.5	0.7	1.9	7.1	2.6	3.6	1.0	0.9	3.5	0.0	0.5	0.0	3.5	1.7	0.5	8.3	9.5	0.0	10.5	0.1	2.9	2.7	0.0	0.1	0.5	0.3	0.5	0.1	0.2	0.0	0.0	0.8	2.0	0.0	0.0	0.3	0.1	0.0	13.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.7	0.0	0.3	0.1	0.2	0.8	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.6	8.2	1.7	0.0	0.0	0.0	0.0	0.1	0.2	5.0	9.9	1.2	0.0	0.1	0.1	0.1	4.1	0.0	0.1	0.3	0.0	0.3	1.2	0.0	0.4	0.1	0.3	1.5	0.0	5.2	0.0	0.0	10.5	0.0	8.3	1.7	0.4	7.4	7.0	2.9	1.3	0.0	0.1	10.5	9.5	1.3	2.7	16.2	26.1	1.0	15.3	11.3	10.6	4.8	8.8	4.0	3.5	0.0	0.3	4.5	0.8	0.2	16.3	0.6	0.0	0.0	3.4	15.7	0.0	0.2	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.0	0.0	0.0	22.6	23.8	3.5	1.8	17.2	0.0	0.6	9.2	0.0	19.0	2.6	0.3	0.1	3.5	0.4	0.0	4.6	0.0	0.4	0.3	1.0	0.4	0.2	0.0	11.2	0.7
PTPRR	"EC-PTP, PCPTP1, PTP-SL, PTPBR7, PTPRQ"	ENSG00000153233	"Protein tyrosine phosphatase, receptor type R"	Q15256	12	70638073-70920843	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"		"Hydrolase, Protein phosphatase, Receptor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"brain: 56.1"	"Group enriched"	"Detected in some"	4	"Bipolar cells: 11.2;Club cells: 5.7;Enterocytes: 7.3;Horizontal cells: 15.9;Paneth cells: 11.4"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in all"		"cerebellum: 56.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"HDLM-2: 14.3;RT4: 27.4"	"Region enriched"	"Detected in all"	5	"cerebellum: 100.5"	"Low region specificity"	"Detected in all"			"CAB011461, HPA011851, HPA071067"	Uncertain		Supported	"Plasma membrane,Cell Junctions,Cytosol"		NA	NA			"Plasma membrane, Cell Junctions, Cytosol"		"CAB011461: AB_298890, HPA011851: AB_1855939, HPA071067: AB_2686340"	"unprognostic (4.98e-2)"	"unprognostic (1.91e-2)"	"unprognostic (1.55e-1)"	"unprognostic (2.04e-1)"	"unprognostic (3.63e-3)"	"unprognostic (3.48e-5)"	"unprognostic (5.44e-3)"	"unprognostic (1.77e-3)"	"unprognostic (1.13e-1)"	"unprognostic (9.01e-2)"	"unprognostic (1.37e-3)"	"unprognostic (8.06e-2)"	"unprognostic (1.10e-2)"	"unprognostic (1.92e-2)"	"unprognostic (4.78e-2)"	"unprognostic (2.72e-1)"	"prognostic favorable (1.40e-5)"	0.4	3.8	18.8	1.6	11.3	0.3	0.4	56.1	20.9	0.5	11.2	0.1	0.0	5.1	8.4	0.3	0.4	0.5	1.9	0.4	8.6	4.9	0.4	0.4	0.4	0.4	1.3	13.2	0.4	0.6	0.3	0.9	0.7	3.3	0.5	7.8	0.8	0.4	2.1	0.4	0.4	11.3	4.9	3.1	0.4	4.4	0.4	1.4	0.0	0.4	0.0	0.3	4.8	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	1.4	0.0	0.3	0.0	0.0	0.5	0.0	0.0	0.0	14.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.2	27.4	0.1	4.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	18.8	11.3	56.1	20.9	8.6	4.9	1.3	13.2	3.3	1.4	0.0	0.0	0.0	0.1	0.5	11.2	2.5	0.0	0.0	5.7	0.0	0.0	0.0	0.0	2.1	1.7	1.5	7.3	0.0	0.2	0.1	0.0	0.1	0.0	0.0	0.0	15.9	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.3	1.9	11.4	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.1	0.7	0.0	0.4	0.3
PTPRS		ENSG00000105426	"Protein tyrosine phosphatase, receptor type S"	Q13332	19	5158495-5340803	"Enzymes, Plasma proteins, Predicted membrane proteins, Predicted secreted proteins"	"Cell adhesion"	"Heparin-binding, Hydrolase, Protein phosphatase, Receptor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Basal keratinocytes: 54.1;Melanocytes: 75.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	82	"plasmacytoid DC: 13.4"	"Lineage enriched"	"Detected in single"	82	"dendritic cells: 13.4"	"Cell line enhanced"	"Detected in many"		"AN3-CA: 41.4;HaCaT: 42.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA054747			Approved	"Plasma membrane,Cytosol"	"Secreted - unknown location"	NA	NA		92000000	"Plasma membrane, Cytosol"		"HPA054747: AB_2682591"	"unprognostic (8.14e-2)"	"unprognostic (4.59e-3)"	"unprognostic (2.57e-2)"	"unprognostic (9.20e-2)"	"unprognostic (2.15e-1)"	"unprognostic (6.96e-3)"	"unprognostic (6.85e-2)"	"unprognostic (2.36e-1)"	"unprognostic (3.12e-3)"	"unprognostic (1.86e-1)"	"prognostic favorable (1.07e-4)"	"unprognostic (1.25e-1)"	"prognostic unfavorable (1.70e-4)"	"unprognostic (2.80e-1)"	"unprognostic (1.45e-1)"	"unprognostic (4.05e-1)"	"unprognostic (3.46e-2)"	59.1	17.3	14.4	9.4	14.8	3.1	32.0	27.6	53.3	28.7	11.4	29.6	14.4	4.6	21.4	15.4	13.3	24.0	22.2	18.6	15.9	15.1	10.7	6.9	13.9	8.6	20.5	12.1	29.2	38.4	10.5	16.6	4.3	12.0	23.1	3.6	28.9	21.5	20.1	11.9	23.8	6.5	17.5	13.8	8.3	12.7	10.8	18.7	4.4	21.1	7.2	7.5	19.1	22.7	0.0	13.4	0.0	0.0	0.0	0.1	0.0	3.7	21.3	19.2	41.4	8.8	7.2	2.5	6.4	7.7	7.8	6.4	0.2	2.0	0.0	15.3	10.8	6.2	42.1	5.1	0.0	3.5	0.4	8.2	0.0	8.7	13.2	4.0	0.0	4.8	7.6	1.8	1.6	0.3	10.2	0.2	2.6	5.9	0.0	3.1	15.7	1.6	4.0	10.8	0.1	9.1	0.0	4.2	0.0	1.6	7.5	14.8	20.3	6.1	1.1	11.7	3.9	7.4	1.6	0.9	7.0	12.1	16.0	7.8	2.1	0.0	12.2	3.6	0.0	15.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.4	0.0	0.0	14.4	14.8	27.6	17.6	15.9	15.1	20.5	12.1	12.0	18.7	6.0	0.6	3.2	32.4	54.1	33.8	10.9	12.7	1.4	2.3	12.2	2.0	0.5	8.3	1.4	2.3	10.2	0.0	0.0	0.8	23.7	30.9	35.7	0.0	18.3	1.5	11.1	2.9	28.3	0.3	2.9	43.1	1.4	75.9	0.0	0.0	37.3	0.5	0.0	33.9	2.4	7.7	12.9	39.2	7.2	5.3	32.0	0.8	0.0	0.0	21.1
PTPRT	"KIAA0283, RPTPrho"	ENSG00000196090	"Protein tyrosine phosphatase, receptor type T"	O14522	20	42072752-43189970	"Cancer-related genes, Enzymes, Predicted intracellular proteins, Predicted membrane proteins"		"Hydrolase, Protein phosphatase, Receptor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"brain: 23.5;fallopian tube: 17.0"	"Cell type enhanced"	"Detected in some"	17	"Bipolar cells: 40.8;Ciliated cells: 33.5;Early spermatids: 10.0;Late spermatids: 9.9"	"Cancer enhanced"	"Detected in many"		"breast cancer: 5.1"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 4.6;RPMI-8226: 1.2;SCLC-21H: 2.9;U-266/70: 1.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA017336, CAB069423"	Approved					NA	NA					"CAB069423: AB_1622602, HPA017336: AB_1855943"	"unprognostic (7.17e-3)"	"unprognostic (1.02e-1)"	"unprognostic (5.61e-3)"	"unprognostic (1.08e-2)"	"unprognostic (5.95e-2)"	"unprognostic (3.71e-2)"	"unprognostic (1.97e-1)"	"unprognostic (1.31e-2)"	"unprognostic (6.93e-2)"	"unprognostic (2.00e-1)"	"unprognostic (1.37e-6)"	"unprognostic (3.16e-1)"	"unprognostic (1.13e-2)"	"unprognostic (1.81e-1)"	"unprognostic (3.17e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.17e-1)"	0.6	0.8	5.0	0.6	11.1	0.5	4.6	1.6	23.5	1.6	0.7	0.9	0.0	1.2	0.5	1.8	0.5	17.0	0.7	0.8	4.7	6.5	0.6	0.9	2.1	1.0	2.2	12.6	0.5	0.9	0.5	4.1	4.6	5.1	0.8	0.6	0.5	2.0	4.6	0.5	0.8	1.0	0.5	1.4	0.7	1.8	2.8	0.9	4.9	0.5	0.0	1.1	0.5	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.4	0.0	0.0	0.3	0.0	0.0	0.0	0.0	1.2	0.0	0.0	2.9	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.0	11.1	1.6	22.6	4.7	6.5	2.2	12.6	5.1	0.9	0.0	0.6	0.0	0.0	0.8	40.8	1.1	0.0	33.5	1.2	0.0	0.0	0.0	0.0	0.0	10.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.2	4.8	0.0	7.4	0.3	9.9	0.0	0.0	0.0	0.0	0.0	9.1	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.1
PTPRU	"FMI, hPTP-J, PCP-2, PTP, PTPRO"	ENSG00000060656	"Protein tyrosine phosphatase, receptor type U"	Q92729	1	29236516-29326813	"Enzymes, Plasma proteins, Predicted membrane proteins"	"Cell adhesion, Differentiation"	"Hydrolase, Protein phosphatase, Receptor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	8	"Rod photoreceptor cells: 40.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BEWO: 40.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"CAB011476, HPA039832"	Approved					NA	NA					"CAB011476: AB_442989, HPA039832: AB_10793923"	"unprognostic (7.81e-2)"	"unprognostic (1.70e-1)"	"unprognostic (2.15e-3)"	"unprognostic (6.13e-2)"	"prognostic unfavorable (7.92e-4)"	"prognostic unfavorable (8.32e-4)"	"unprognostic (3.17e-1)"	"unprognostic (1.83e-2)"	"unprognostic (1.13e-1)"	"unprognostic (4.55e-3)"	"unprognostic (3.39e-3)"	"unprognostic (6.83e-2)"	"unprognostic (1.19e-2)"	"unprognostic (6.82e-2)"	"unprognostic (4.92e-2)"	"unprognostic (3.34e-1)"	"unprognostic (2.05e-1)"	6.0	3.2	3.1	1.7	5.8	0.6	16.0	6.7	12.7	24.8	3.7	2.6	6.1	1.3	9.5	4.7	3.9	14.5	7.0	8.9	4.5	5.1	3.9	7.0	11.4	1.2	5.2	5.3	12.2	12.0	12.1	8.1	14.3	21.4	11.0	2.3	18.7	11.3	17.9	14.7	7.3	1.7	6.5	6.6	2.4	4.5	4.4	0.9	0.3	4.9	2.1	2.0	12.2	17.6	0.4	0.0	0.0	0.5	0.0	0.2	0.0	3.2	4.4	0.2	0.6	12.4	0.4	40.5	3.4	3.1	0.1	0.2	3.8	14.4	0.5	6.9	0.6	0.4	17.5	16.1	11.2	0.0	0.2	8.1	0.6	5.0	16.0	5.2	0.0	0.7	5.7	6.1	0.0	1.0	4.8	0.1	2.0	0.1	0.5	3.2	5.3	0.2	0.1	6.6	6.4	2.0	0.0	4.7	0.2	5.0	16.2	13.7	17.8	3.5	11.0	2.4	2.9	6.5	0.7	2.9	0.6	4.0	1.1	0.4	0.3	0.4	0.0	8.0	0.7	0.8	0.0	0.2	0.0	0.2	0.3	0.0	0.2	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	3.1	5.8	6.7	12.7	4.5	5.1	5.2	5.3	21.4	0.9	8.9	12.8	0.0	6.2	1.3	3.6	3.4	0.0	6.7	11.4	5.2	11.8	16.4	0.0	5.6	0.5	0.7	0.0	0.0	2.3	9.3	5.1	5.4	1.1	4.5	2.1	0.0	0.0	1.8	1.2	1.1	4.4	0.3	8.5	0.0	0.0	17.4	5.3	0.0	6.7	0.2	40.7	6.5	3.8	1.2	6.1	0.5	7.6	0.0	0.0	8.6
PTPRZ1	"phosphacan, PTP18, PTPRZ, PTPZ, RPTPB"	ENSG00000106278	"Protein tyrosine phosphatase, receptor type Z1"	P23471	7	121873089-122062036	"Enzymes, Plasma proteins, Predicted membrane proteins, Predicted secreted proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"brain: 118.1"	"Cell type enhanced"	"Detected in some"	17	"Club cells: 27.3;Horizontal cells: 62.0;Muller glia cells: 107.0"	"Cancer enriched"	"Detected in many"	14	"glioma: 175.5"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	9	"AF22: 94.3;NTERA-2: 26.3;WM-115: 41.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA015103	Enhanced		Approved	Vesicles,Cytosol	"Secreted in brain"	NA	NA		950000	Cytosol	Vesicles	"HPA015103: AB_1855946"	"unprognostic (8.49e-4)"	"unprognostic (3.96e-3)"	"unprognostic (4.11e-2)"	"unprognostic (1.37e-1)"	"unprognostic (9.18e-2)"	"unprognostic (2.41e-2)"	"unprognostic (8.30e-3)"	"unprognostic (3.78e-2)"	"unprognostic (1.57e-1)"	"unprognostic (2.53e-1)"	"unprognostic (9.17e-4)"	"unprognostic (1.83e-1)"	"unprognostic (8.72e-6)"	"unprognostic (2.00e-1)"	"unprognostic (2.16e-1)"	"unprognostic (8.77e-2)"	"prognostic unfavorable (9.36e-4)"	2.0	2.5	33.1	2.3	44.1	1.5	4.0	15.4	118.1	2.4	2.2	19.3	0.0	1.9	1.6	2.0	7.0	1.7	1.9	2.0	39.6	15.9	1.6	1.6	2.1	1.5	18.6	17.8	2.0	3.3	1.5	1.6	1.6	67.6	2.1	2.3	0.8	2.4	2.0	1.5	19.3	1.9	2.4	76.6	2.1	9.8	1.7	23.6	0.0	1.5	1.8	3.0	2.2	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	94.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	5.9	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	26.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.0	3.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	2.4	1.1	0.0	0.1	0.0	41.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	33.1	44.1	15.4	39.6	39.6	15.9	18.6	17.8	67.6	23.6	0.0	1.0	0.0	5.6	22.3	14.1	0.8	0.0	17.4	27.3	0.0	3.9	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.6	0.1	1.1	1.1	0.0	0.0	0.1	62.0	0.0	0.0	0.0	0.4	0.3	0.0	18.6	0.0	0.0	107.0	0.6	0.0	0.0	0.0	6.2	0.0	0.4	0.0	0.2	18.7	0.2	0.0	0.0	7.4
PTRH1	"C9orf115, PTH1"	ENSG00000187024	"Peptidyl-tRNA hydrolase 1 homolog"	Q86Y79	9	127690348-127724873	"Enzymes, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"PC-3: 32.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA021223	Uncertain					NA	NA					"HPA021223: AB_1845798"	"unprognostic (6.58e-2)"	"unprognostic (7.01e-3)"	"unprognostic (3.46e-3)"	"unprognostic (2.53e-2)"	"unprognostic (7.05e-2)"	"unprognostic (1.30e-1)"	"unprognostic (2.44e-1)"	"unprognostic (3.90e-2)"	"unprognostic (1.74e-1)"	"unprognostic (6.58e-3)"	"unprognostic (8.67e-2)"	"unprognostic (4.08e-2)"	"unprognostic (5.98e-3)"	"unprognostic (5.74e-4)"	"unprognostic (1.38e-2)"	"unprognostic (1.91e-1)"	"unprognostic (1.72e-2)"	14.9	15.0	12.5	8.3	11.9	7.1	9.1	3.9	13.7	9.4	7.8	10.7	12.9	7.7	7.8	16.1	7.8	9.9	12.6	13.1	10.7	9.4	14.5	19.3	7.5	14.7	11.6	8.5	6.2	24.7	8.8	11.0	7.2	8.9	9.9	4.0	8.3	9.3	9.9	13.0	15.1	5.8	6.4	6.2	9.4	12.4	16.1	6.2	7.1	18.8	9.1	5.7	9.4	5.6	8.7	11.4	5.6	14.4	10.5	29.4	12.8	15.9	7.1	1.6	4.4	2.3	3.0	12.5	10.6	2.9	4.1	2.2	3.7	6.0	6.0	14.3	4.4	5.5	17.6	1.3	7.7	1.2	8.7	2.4	2.6	8.9	7.1	6.9	3.9	7.2	2.5	8.0	4.9	5.1	2.2	8.1	8.4	6.8	4.8	4.6	14.7	7.0	5.8	2.2	14.6	32.3	6.1	3.5	13.6	7.4	3.5	7.1	6.5	11.4	13.7	8.0	1.5	12.3	2.5	9.6	5.9	8.2	20.9	6.6	14.4	7.7	3.9	7.9	3.0	7.1	2.5	13.2	5.6	29.3	14.4	29.3	8.7	15.1	29.4	11.4	7.2	11.1	25.5	1.7	10.5	7.5	10.4	14.2	12.8	12.5	11.9	3.9	13.7	10.7	9.4	11.6	8.5	8.9	6.2	3.0	7.8	12.4	33.6	15.0	22.3	0.3	25.5	46.8	6.8	45.4	43.2	11.0	56.3	56.3	53.7	19.7	8.1	0.0	29.3	19.6	18.8	39.9	17.3	25.2	41.1	15.9	28.9	19.0	9.1	11.4	20.4	13.7	15.1	17.2	19.3	20.7	39.4	10.4	88.4	101.3	60.3	0.0	21.5	27.4	7.9	18.4	15.7	20.3	16.6	30.8
PTRH2	"BIT1, CFAP37, CGI-147, PTH2"	ENSG00000141378	"Peptidyl-tRNA hydrolase 2"	Q9Y3E5	17	59674636-59707626	"Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins"	Apoptosis	Hydrolase	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA012897	Supported		Supported	Mitochondria		NA	NA			Mitochondria		"HPA012897: AB_1855949"	"unprognostic (2.26e-1)"	"unprognostic (2.80e-2)"	"unprognostic (1.02e-2)"	"unprognostic (3.89e-2)"	"unprognostic (1.31e-2)"	"unprognostic (3.38e-2)"	"prognostic unfavorable (1.50e-4)"	"unprognostic (6.38e-2)"	"unprognostic (2.02e-1)"	"unprognostic (9.59e-3)"	"unprognostic (2.72e-1)"	"unprognostic (1.40e-1)"	"prognostic unfavorable (1.01e-8)"	"unprognostic (5.43e-3)"	"unprognostic (6.82e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.49e-2)"	15.9	22.9	17.1	12.4	17.1	9.9	20.7	12.5	22.1	15.6	17.2	11.8	16.3	11.6	14.3	36.7	16.4	13.8	13.1	12.6	19.3	17.8	14.8	34.7	12.1	12.5	16.7	15.2	14.2	19.9	10.3	18.3	13.6	21.0	15.9	20.7	8.1	13.7	18.7	23.3	11.4	11.0	16.8	17.1	15.5	14.3	15.7	18.1	9.0	11.8	13.5	16.9	13.0	10.5	15.6	21.6	12.6	29.3	13.1	15.5	13.0	18.9	36.2	11.7	10.6	22.2	19.1	12.5	18.3	16.1	15.7	23.0	23.4	14.9	13.8	27.8	15.3	26.9	18.9	25.1	23.6	22.9	26.5	34.1	24.6	18.8	42.8	34.3	21.7	14.0	21.5	30.7	24.3	28.3	11.2	26.1	9.7	27.4	15.4	23.3	45.8	18.5	17.7	10.0	49.3	28.7	10.1	19.6	20.1	26.1	27.3	15.1	19.6	9.4	10.3	22.4	14.0	24.1	15.5	17.1	20.5	20.7	12.2	19.8	20.0	22.2	20.4	13.5	13.6	15.6	1.9	25.8	1.1	9.2	24.4	12.4	15.6	10.8	10.4	18.5	13.1	15.5	11.1	12.6	13.1	29.3	21.6	12.3	13.0	17.1	17.1	12.5	22.1	19.3	17.8	16.7	15.2	21.0	18.1	14.9	12.8	13.4	31.9	32.5	3.3	14.8	7.6	30.8	50.0	10.4	3.9	22.1	10.0	25.9	17.7	18.3	9.1	0.0	22.0	20.6	19.7	23.3	22.0	27.3	15.2	7.9	6.4	11.6	7.3	7.9	16.1	18.7	13.5	10.0	9.7	6.6	25.9	13.9	9.2	13.2	3.2	12.9	21.7	16.7	11.4	31.1	26.5	8.3	13.2	31.5
PTRHD1	"C2orf79, LOC391356"	ENSG00000184924	"Peptidyl-tRNA hydrolase domain containing 1"	Q6GMV3	2	24789734-24793382	"Enzymes, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA019951	Approved		Approved	Nucleoplasm		NA	NA		55000	Nucleoplasm		"HPA019951: AB_1853109"	"unprognostic (1.28e-2)"	"unprognostic (5.79e-2)"	"unprognostic (6.34e-2)"	"unprognostic (1.34e-2)"	"unprognostic (2.61e-2)"	"unprognostic (3.99e-1)"	"unprognostic (8.84e-3)"	"unprognostic (1.26e-1)"	"unprognostic (3.69e-1)"	"unprognostic (8.31e-3)"	"unprognostic (1.58e-1)"	"unprognostic (2.12e-1)"	"prognostic unfavorable (2.31e-4)"	"unprognostic (2.93e-1)"	"unprognostic (1.55e-1)"	"unprognostic (1.51e-1)"	"unprognostic (5.76e-2)"	8.2	20.0	19.4	10.8	16.2	20.4	13.3	4.6	13.0	6.7	13.6	8.5	7.8	16.1	5.6	11.9	12.7	8.2	10.2	15.8	15.6	14.4	11.3	16.0	9.2	17.6	16.9	8.8	8.5	28.1	2.7	8.4	12.2	10.4	11.0	9.4	7.6	25.9	7.5	30.1	10.3	15.0	5.6	15.5	10.4	11.7	25.2	6.9	17.5	15.6	19.9	12.9	8.3	8.4	29.1	44.1	8.2	27.9	14.5	23.7	26.1	8.2	19.7	6.4	2.8	3.6	8.1	11.0	6.0	5.7	7.9	5.1	19.4	7.8	6.9	2.5	6.4	4.9	5.5	5.3	5.6	2.6	9.3	35.5	12.4	9.5	21.1	7.5	10.1	11.7	7.7	4.6	3.7	4.1	6.3	7.3	6.3	12.4	5.5	5.8	17.9	8.3	18.9	13.4	5.0	11.9	6.8	19.5	11.4	9.2	15.4	10.0	15.4	6.6	8.9	7.7	3.1	8.6	7.8	12.0	6.7	10.5	3.2	5.0	4.3	13.3	7.4	6.3	6.4	4.5	8.2	27.9	5.9	16.6	19.0	8.5	29.1	16.4	14.5	42.9	22.1	15.3	17.8	3.2	14.5	13.7	44.1	23.7	26.1	19.4	16.2	4.6	13.0	15.6	14.4	16.9	8.8	10.4	6.9	47.6	55.7	79.8	66.2	106.5	9.2	71.1	66.2	88.3	51.2	62.8	5.9	158.8	97.8	80.3	89.5	45.2	101.8	0.0	123.7	124.1	73.0	66.7	40.4	82.2	114.7	1.6	84.6	51.0	98.7	121.2	43.7	98.5	64.1	162.3	129.2	35.2	108.6	131.0	37.4	119.9	11.8	71.1	48.3	75.3	38.1	124.0	140.3	64.8	148.8	111.1
PTS	PTPS	ENSG00000150787	"6-pyruvoyltetrahydropterin synthase"	Q03393	11	112226365-112269955	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Tetrahydrobiopterin biosynthesis"	Lyase	"Disease mutation, Phenylketonuria"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA001481	Uncertain		Approved	Cytosol		NA	NA			Cytosol		"HPA001481: AB_1079716"	"unprognostic (2.08e-2)"	"unprognostic (1.91e-1)"	"unprognostic (9.66e-3)"	"unprognostic (8.38e-3)"	"unprognostic (4.58e-1)"	"unprognostic (3.28e-3)"	"unprognostic (2.38e-2)"	"unprognostic (1.81e-2)"	"unprognostic (2.05e-2)"	"unprognostic (8.74e-2)"	"unprognostic (2.59e-1)"	"unprognostic (7.07e-2)"	"unprognostic (3.81e-2)"	"unprognostic (1.20e-2)"	"unprognostic (2.97e-1)"	"unprognostic (1.52e-3)"	"unprognostic (1.65e-1)"	6.7	37.1	13.9	6.3	16.6	12.2	13.9	8.9	16.5	10.4	12.7	10.2	6.1	10.7	9.3	20.3	17.9	8.2	14.7	11.6	11.8	28.9	21.9	40.7	5.6	10.4	23.5	14.3	6.7	11.9	12.1	21.5	12.1	18.8	14.9	14.4	9.9	10.9	11.4	11.7	11.5	10.9	12.4	16.8	5.1	18.8	6.7	9.8	3.6	16.3	13.2	7.7	9.3	16.1	6.3	6.8	1.9	5.5	3.4	5.9	2.9	10.4	11.0	12.0	5.1	8.6	10.3	15.9	31.1	14.2	17.1	18.1	24.8	10.5	11.1	23.8	18.2	22.9	15.1	17.0	20.0	18.5	9.0	14.3	2.8	17.0	20.2	27.2	6.8	1.5	17.9	28.3	16.3	19.3	13.2	12.8	9.5	10.6	6.0	10.7	11.5	5.2	9.0	9.0	19.4	21.7	3.5	2.4	15.9	36.6	15.0	13.6	13.7	17.5	17.1	9.7	40.8	12.8	6.1	16.1	16.8	18.3	20.0	24.4	4.2	8.3	26.5	11.6	7.2	17.4	0.9	2.1	1.9	3.8	2.3	3.8	5.5	5.0	4.7	3.6	6.3	3.5	4.5	1.0	3.4	5.5	6.8	5.9	2.9	13.9	16.6	8.9	16.5	11.8	28.9	23.5	14.3	18.8	9.8	17.9	24.5	24.0	66.3	109.0	14.8	83.9	56.0	54.9	21.6	52.4	0.0	48.3	179.1	80.8	4.1	41.9	57.6	23.3	68.2	99.5	46.6	67.1	19.7	115.0	33.0	9.5	76.7	34.4	17.3	6.9	13.6	30.6	25.3	34.3	50.0	26.2	90.3	66.6	24.4	114.8	16.5	25.8	69.5	15.8	93.0	114.6	58.8	33.1	39.6	98.4
PUDP	"DXF68S1E, FAM16AX, GS1, HDHD1, HDHD1A"	ENSG00000130021	"Pseudouridine 5'-phosphatase"	Q08623	X	7048920-7148190	"Enzymes, Predicted intracellular proteins"	"Nucleotide metabolism"	Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Cytotrophoblasts: 36.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Not detected"	"Not detected"							HPA072672	Approved					NA	NA		14000			"HPA072672: AB_2732208"	"unprognostic (1.84e-1)"	"unprognostic (4.93e-2)"	"unprognostic (5.15e-3)"	"unprognostic (1.92e-1)"	"unprognostic (3.47e-1)"	"unprognostic (5.63e-3)"	"unprognostic (1.00e-3)"	"unprognostic (3.22e-2)"	"unprognostic (4.86e-2)"	"unprognostic (4.85e-2)"	"prognostic unfavorable (7.27e-4)"	"unprognostic (2.24e-1)"	"unprognostic (3.06e-2)"	"unprognostic (2.23e-1)"	"unprognostic (2.92e-2)"	"prognostic favorable (4.80e-4)"	"unprognostic (3.42e-2)"	10.8	9.3	10.2	10.3	12.5	2.6	7.5	7.8	10.5	9.1	15.0	9.7	9.1	15.2	8.6	6.3	9.9	17.0	7.1	17.1	8.1	10.6	19.8	10.1	10.3	13.1	12.5	7.1	9.6	8.9	7.3	11.2	42.4	10.0	7.4	10.5	8.3	9.8	6.9	31.8	5.0	15.1	9.8	10.6	11.2	15.8	7.7	11.4	13.3	10.4	8.9	13.1	10.2	8.9	7.0	11.1	2.1	14.9	5.1	9.6	7.5	19.5	18.4	29.1	12.1	14.9	14.7	5.0	7.0	6.7	7.7	7.9	26.1	12.1	9.0	14.5	6.9	26.5	6.0	13.2	15.6	12.0	8.0	25.5	9.5	6.9	14.3	7.1	8.3	10.8	7.7	6.1	21.0	9.8	5.4	23.1	11.5	18.2	8.2	12.2	9.1	9.3	12.3	15.4	8.1	9.1	7.0	11.3	24.3	11.2	7.4	7.0	7.3	5.5	10.4	10.4	26.4	11.6	7.8	8.9	4.8	2.9	19.9	5.9	26.2	0.1	14.6	6.8	4.8	9.3	2.1	14.4	1.6	6.4	14.9	6.4	7.0	6.8	6.0	11.1	5.2	5.2	5.8	1.5	5.1	14.0	3.6	9.6	7.5	10.2	12.5	7.8	10.5	8.1	10.6	12.5	7.1	10.0	11.4	11.9	2.9	10.4	3.2	0.0	3.6	0.0	22.9	9.4	6.8	17.4	3.9	36.7	8.3	18.0	0.4	3.6	8.4	0.0	15.2	25.6	2.0	5.5	1.1	9.0	19.6	4.8	0.0	4.3	19.2	1.0	5.8	6.8	0.0	7.2	15.3	12.6	14.7	28.1	4.6	19.5	4.3	6.5	0.0	5.1	17.0	0.0	23.6	0.0	15.5	5.5
PUS1		ENSG00000177192	"Pseudouridylate synthase 1"	Q9Y606	12	131929200-131945896	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"tRNA processing"	Isomerase	"Disease mutation, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA051636, HPA057593"	Approved		Supported	Nucleoplasm,Mitochondria		NA	NA			"Nucleoplasm, Mitochondria"		"HPA051636: AB_2681560, HPA057593: AB_2683479"	"unprognostic (2.72e-1)"	"unprognostic (9.13e-2)"	"unprognostic (1.81e-1)"	"unprognostic (2.69e-2)"	"unprognostic (8.12e-3)"	"unprognostic (8.07e-2)"	"unprognostic (4.57e-3)"	"unprognostic (7.34e-2)"	"unprognostic (1.01e-1)"	"unprognostic (3.34e-1)"	"unprognostic (2.06e-1)"	"unprognostic (5.30e-2)"	"prognostic unfavorable (3.49e-8)"	"unprognostic (1.80e-3)"	"unprognostic (8.06e-2)"	"unprognostic (8.59e-2)"	"unprognostic (1.56e-2)"	12.7	15.8	18.8	19.5	23.3	26.2	11.2	8.8	16.9	8.7	11.9	9.4	11.0	12.4	13.6	18.7	16.5	12.9	25.1	8.6	15.6	8.3	10.7	22.8	11.0	21.4	11.7	15.8	10.1	19.8	7.2	9.5	8.3	11.7	11.7	10.5	7.6	11.4	15.7	13.5	15.4	13.9	9.7	6.2	17.4	13.6	11.9	16.4	11.6	10.3	11.6	15.8	10.8	12.8	5.9	4.6	1.9	2.0	9.1	4.0	1.3	15.4	20.2	4.8	8.5	4.6	7.9	29.5	11.9	5.0	9.1	5.9	22.3	10.1	18.4	13.8	6.5	7.1	19.6	15.8	11.3	5.9	8.1	31.9	18.5	9.8	19.4	12.5	31.7	17.1	8.0	9.2	10.4	8.9	4.4	8.9	12.9	22.9	5.7	5.2	26.8	20.8	28.5	25.3	12.6	30.8	19.9	6.8	19.1	7.4	21.5	13.4	7.5	10.0	13.7	11.0	4.9	15.0	34.3	7.7	7.3	15.6	15.4	17.2	15.6	11.7	21.9	7.5	25.4	10.0	1.2	2.0	0.4	3.2	1.4	2.2	5.9	2.7	3.3	1.6	5.5	4.0	2.1	1.9	9.1	1.3	4.6	2.4	1.3	18.8	23.3	8.8	16.9	15.6	8.3	11.7	15.8	11.7	16.4	0.0	6.7	10.0	16.1	26.3	5.2	4.5	12.7	4.0	3.4	5.2	21.6	12.0	5.0	9.3	0.6	9.0	4.5	0.0	8.2	14.4	9.6	13.4	16.1	11.3	13.6	0.0	13.8	8.0	7.3	2.0	7.2	8.9	6.8	8.2	17.2	4.6	12.7	7.0	8.9	10.4	9.6	6.5	11.8	16.5	22.1	19.8	7.2	7.5	15.5	13.7
PUS10	"CCDC139, FLJ32312"	ENSG00000162927	"Pseudouridylate synthase 10"	Q3MIT2	2	60940222-61018259	"Enzymes, Predicted intracellular proteins"	"tRNA processing"	Isomerase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA044736, HPA049582"	Approved		Approved	"Nucleoplasm,Nuclear bodies,Mitochondria"		No	No			"Nucleoplasm, Nuclear bodies, Mitochondria"		"HPA044736: AB_2679066, HPA049582: AB_2680824"	"unprognostic (1.90e-3)"	"unprognostic (1.35e-1)"	"unprognostic (3.49e-2)"	"unprognostic (2.44e-4)"	"unprognostic (1.77e-1)"	"unprognostic (1.86e-2)"	"unprognostic (1.25e-1)"	"unprognostic (1.72e-2)"	"unprognostic (2.90e-2)"	"unprognostic (8.21e-2)"	"unprognostic (3.68e-2)"	"unprognostic (1.45e-1)"	"unprognostic (1.16e-4)"	"unprognostic (1.07e-1)"	"unprognostic (6.60e-2)"	"unprognostic (9.45e-2)"	"unprognostic (1.15e-3)"	7.0	8.7	7.4	5.0	7.3	3.9	7.3	6.8	7.9	4.8	10.0	5.1	3.0	9.2	7.7	9.1	5.0	5.4	6.4	4.6	6.5	6.9	8.5	17.6	6.3	6.5	8.5	4.6	6.8	7.2	6.3	10.3	4.2	5.9	6.6	6.0	6.7	6.2	3.9	6.7	4.3	19.8	3.6	7.1	5.9	4.2	7.8	8.0	9.1	10.4	4.1	8.3	4.4	4.4	5.2	4.9	9.8	6.9	4.8	4.3	1.8	2.7	1.6	4.5	7.7	4.0	4.4	5.2	5.7	5.3	5.6	5.3	4.3	3.9	8.7	5.9	3.2	5.2	3.0	5.1	4.6	6.8	8.8	2.5	7.9	2.1	13.4	7.1	8.7	5.0	5.2	5.4	3.9	9.5	6.9	7.0	8.7	8.1	6.1	3.8	2.5	6.9	7.0	4.1	2.1	3.0	6.8	6.0	4.4	3.2	5.3	2.6	3.6	4.5	8.0	9.1	3.2	3.1	5.6	5.3	5.4	4.2	3.5	4.1	7.4	3.2	18.6	4.6	5.2	6.0	9.8	1.9	2.0	3.9	2.2	4.3	5.2	2.5	2.6	1.6	3.2	3.0	3.4	4.1	4.8	6.9	4.9	1.5	1.8	7.4	7.3	6.8	7.9	6.5	6.9	8.5	4.6	5.9	8.0	0.0	11.0	1.9	2.2	2.2	6.8	4.2	0.0	10.7	3.4	3.5	0.0	5.2	6.6	2.6	1.5	3.9	16.5	0.0	4.4	3.8	2.8	2.9	0.0	11.6	5.3	1.6	1.2	6.2	5.1	1.1	2.8	3.2	1.7	10.8	2.0	6.5	4.3	2.9	1.4	5.1	6.3	6.5	2.1	7.1	10.9	1.9	10.4	5.7	3.3	4.3
PUS3	FKSG32	ENSG00000110060	"Pseudouridylate synthase 3"	Q9BZE2	11	125893485-125903221	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"tRNA processing"	Isomerase	"Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038040, HPA063802"	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA038040: AB_10697092, HPA063802: AB_2685126"	"unprognostic (5.89e-2)"	"unprognostic (7.24e-2)"	"unprognostic (1.29e-1)"	"unprognostic (4.37e-3)"	"unprognostic (4.59e-2)"	"prognostic unfavorable (8.10e-4)"	"unprognostic (7.67e-2)"	"unprognostic (1.77e-1)"	"unprognostic (8.92e-3)"	"unprognostic (4.47e-3)"	"unprognostic (3.37e-2)"	"unprognostic (1.06e-1)"	"unprognostic (2.08e-3)"	"unprognostic (9.95e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.13e-1)"	"unprognostic (2.44e-1)"	8.6	8.8	5.9	7.4	7.7	2.3	8.7	9.0	8.4	7.4	9.2	3.6	4.6	9.9	8.4	8.6	8.1	6.4	5.9	7.6	8.0	6.4	9.6	36.6	6.1	11.0	8.7	7.2	7.7	17.9	8.2	21.1	7.6	7.7	10.4	7.4	5.4	10.6	5.1	15.2	8.2	11.5	13.9	9.7	8.9	9.3	5.3	7.3	9.6	12.4	10.6	9.2	11.1	7.3	13.0	8.8	9.9	12.3	13.0	16.5	7.1	3.5	4.3	13.2	14.7	13.5	17.2	6.3	11.7	9.8	6.7	7.5	13.9	13.3	17.9	19.4	5.2	9.8	12.2	21.3	10.9	6.8	15.2	10.3	18.4	5.4	10.0	14.3	11.5	5.4	13.6	13.1	8.0	17.1	9.9	12.3	13.5	18.7	9.3	7.2	2.1	12.8	12.3	11.4	26.3	8.4	2.5	12.0	10.1	11.0	5.6	15.3	13.6	8.0	11.2	6.4	9.9	24.0	7.5	8.3	14.2	5.8	6.7	9.6	7.0	10.5	18.8	3.8	18.6	9.7	9.9	9.7	7.8	13.0	9.4	15.2	13.0	12.8	12.5	8.8	12.2	16.5	15.6	3.7	13.0	12.3	7.8	12.9	7.1	5.9	7.7	9.0	8.4	8.0	6.4	8.7	7.2	7.7	7.3	8.9	8.6	9.0	9.4	11.4	9.1	5.2	15.3	8.1	14.8	5.2	27.5	7.4	5.0	12.3	5.9	7.7	4.2	23.3	23.5	10.6	5.6	7.1	12.7	28.8	7.2	4.8	4.6	7.4	3.2	4.3	7.2	5.4	1.7	3.6	3.9	8.9	13.5	3.5	7.4	14.6	10.4	6.5	11.0	4.6	6.9	10.3	11.7	7.5	6.0	9.3
PXDN	"D2S448, D2S448E, KIAA0230, MG50, PRG2, PXN"	ENSG00000130508	Peroxidasin	Q92626	2	1631887-1744852	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins"	"Hydrogen peroxide"	"Oxidoreductase, Peroxidase"	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"breast: 60.8"	"Cell type enhanced"	"Detected in many"	10	"Endothelial cells: 40.8;Ito cells: 86.5;Sertoli cells: 45.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"plasmacytoid DC: 2.0"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"EFO-21: 57.3"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			HPA012375	Approved				"Secreted to extracellular matrix"	NA	NA		4000000			"HPA012375: AB_1855965"	"unprognostic (4.37e-2)"	"prognostic unfavorable (6.28e-4)"	"unprognostic (2.08e-1)"	"prognostic unfavorable (2.75e-4)"	"unprognostic (8.16e-3)"	"unprognostic (1.91e-1)"	"unprognostic (1.92e-2)"	"unprognostic (3.15e-3)"	"unprognostic (6.50e-3)"	"unprognostic (1.34e-2)"	"unprognostic (6.78e-2)"	"unprognostic (2.23e-1)"	"unprognostic (6.13e-3)"	"prognostic unfavorable (6.73e-4)"	"unprognostic (1.18e-1)"	"unprognostic (7.33e-3)"	"unprognostic (5.54e-3)"	36.4	3.2	2.6	13.1	2.0	0.5	60.8	0.3	3.7	15.5	17.7	2.7	5.1	4.3	20.4	8.9	7.4	9.7	12.9	16.2	2.0	2.6	5.8	6.9	14.3	8.5	1.8	1.4	19.2	2.1	1.5	6.5	18.3	3.6	15.2	5.0	7.6	7.3	6.8	8.4	3.7	8.4	41.0	2.6	13.7	7.8	5.8	1.2	4.3	5.9	4.8	3.4	26.3	20.1	0.5	2.0	0.0	0.0	0.0	1.1	0.1	6.6	2.3	12.6	0.0	35.7	32.8	9.6	39.9	31.7	17.5	19.2	0.0	0.1	0.0	57.3	39.4	0.8	1.4	0.0	24.5	22.3	0.1	0.4	0.0	24.9	0.0	35.4	0.1	0.0	36.1	7.2	19.7	14.9	53.1	42.9	6.2	0.0	0.0	24.7	3.9	1.1	1.3	10.2	0.0	9.1	2.2	44.1	0.1	20.5	0.0	0.0	23.3	0.0	12.9	0.0	26.4	4.7	0.1	41.6	28.9	14.3	1.0	30.7	0.0	33.6	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.4	0.5	0.0	0.0	0.0	0.0	1.1	0.5	0.0	0.0	0.0	2.0	0.0	0.1	2.6	2.0	0.3	2.7	2.0	2.6	1.8	1.4	3.6	1.2	6.0	2.9	0.0	2.3	2.6	1.4	5.3	7.6	2.7	0.0	1.8	0.0	0.6	0.0	7.9	33.3	40.8	0.0	0.0	0.0	7.7	15.2	12.9	1.1	0.8	1.6	0.0	1.7	86.5	9.7	24.5	24.7	1.1	6.8	1.0	0.8	11.2	0.8	0.0	14.2	0.0	0.7	45.3	26.2	1.8	10.1	2.5	1.1	0.0	0.0	1.0
PXDNL	"FLJ25471, PMR1"	ENSG00000147485	"Peroxidasin like"	A1KZ92	8	51319578-51809445	"Enzymes, Predicted intracellular proteins"	"Hydrogen peroxide"	"Endonuclease, Hydrolase, Nuclease, Oxidoreductase, Peroxidase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in some"	7	"heart muscle: 59.1"	"Group enriched"	"Detected in some"	9	"Cardiomyocytes: 29.9;Early spermatids: 34.8;Muller glia cells: 18.8"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	4	"memory B-cell: 1.5"	"Lineage enriched"	"Detected in single"	4	"B-cells: 1.5"	"Group enriched"	"Detected in some"	7	"AF22: 11.1;Daudi: 8.3;SH-SY5Y: 8.9"									HPA007919			Approved	Nucleoplasm,Cytosol	"Intracellular and membrane"	NA	NA			"Nucleoplasm, Cytosol"		"HPA007919: AB_1855966"	"prognostic unfavorable (3.27e-5)"	"unprognostic (4.59e-4)"	"unprognostic (5.57e-3)"	"unprognostic (2.83e-3)"	"unprognostic (2.71e-1)"	"unprognostic (5.14e-2)"	"unprognostic (1.18e-1)"	"unprognostic (7.18e-3)"	"unprognostic (1.85e-1)"	"unprognostic (1.15e-1)"	"unprognostic (7.07e-2)"	"unprognostic (1.07e-1)"	"unprognostic (2.60e-4)"	"unprognostic (2.28e-2)"	"unprognostic (3.35e-2)"	"unprognostic (2.42e-2)"	"unprognostic (2.97e-4)"	1.1	0.1	0.3	0.1	0.2	0.0	0.2	0.1	0.9	0.1	0.1	0.0	0.2	0.0	0.3	7.9	0.4	0.1	0.7	59.1	0.2	0.3	1.0	0.1	0.2	0.3	0.3	0.3	0.1	0.1	0.0	0.1	0.0	0.3	0.1	0.0	1.8	1.1	0.3	0.9	0.2	0.2	0.1	0.2	0.3	0.1	5.2	0.0	0.1	0.2	2.5	0.3	0.2	0.1	1.5	0.3	0.3	0.0	0.0	0.1	0.0	0.7	0.0	11.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.1	8.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.1	8.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.7	0.5	0.0	0.0	0.2	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	1.5	0.0	0.0	0.0	0.1	0.1	0.1	0.3	0.0	0.0	0.3	0.1	0.0	0.3	0.2	0.1	0.9	0.2	0.3	0.3	0.3	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.7	29.9	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	34.8	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	3.1	0.0	0.0	0.0	0.0	0.0	18.8	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.4	0.6	0.1	0.0	0.0	0.0	0.0
PXK	"FLJ20335, Slob"	ENSG00000168297	"PX domain containing serine/threonine kinase like"	Q7Z7A4	3	58332880-58426126	"Enzymes, Predicted intracellular proteins"		Actin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 81.1"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"U-937: 48.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA024068	Approved		Supported	"Plasma membrane,Centriolar satellite,Cytosol"		NA	NA			Cytosol	"Plasma membrane, Centriolar satellite"	"HPA024068: AB_1855967"	"unprognostic (2.98e-2)"	"unprognostic (3.29e-1)"	"unprognostic (2.71e-3)"	"unprognostic (1.61e-1)"	"unprognostic (2.40e-1)"	"unprognostic (6.62e-3)"	"unprognostic (5.03e-3)"	"prognostic favorable (5.68e-4)"	"unprognostic (3.90e-1)"	"unprognostic (8.09e-2)"	"unprognostic (3.48e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.38e-3)"	"unprognostic (2.14e-1)"	"unprognostic (1.06e-1)"	"unprognostic (1.03e-1)"	"unprognostic (2.86e-2)"	9.3	9.4	20.7	17.0	51.4	33.6	7.6	22.6	31.4	28.9	8.9	81.1	2.4	6.3	14.2	5.3	6.6	8.0	9.6	7.5	33.7	19.9	10.4	5.7	8.2	23.8	68.6	23.4	11.1	8.5	13.7	6.1	17.5	43.9	6.0	6.4	4.4	8.8	7.7	7.6	7.5	7.7	11.8	55.9	13.5	8.3	6.7	56.6	3.7	40.3	2.5	26.1	9.8	13.1	31.3	18.8	31.8	22.5	8.7	11.2	13.4	4.3	2.5	1.9	3.5	26.9	23.9	5.7	6.9	14.7	6.7	9.4	1.2	0.9	22.8	1.6	11.7	9.7	1.3	6.0	4.4	7.1	5.7	3.8	3.9	3.1	1.7	31.4	33.9	6.9	20.4	10.6	8.4	14.6	23.6	5.9	14.6	4.8	7.5	12.0	1.6	7.4	35.0	2.3	1.3	6.3	12.8	3.3	4.1	4.2	2.4	1.7	1.2	4.7	3.4	5.5	3.6	11.5	35.1	6.0	8.4	3.5	15.9	7.3	5.9	5.8	22.7	12.1	48.2	3.5	14.6	20.1	29.4	11.2	16.2	9.9	29.0	8.1	9.4	18.8	31.3	7.1	8.4	31.8	8.7	22.5	13.5	8.7	13.4	20.7	51.4	22.6	31.4	33.7	19.9	68.6	23.4	43.9	56.6	8.9	4.6	34.0	4.9	12.6	29.2	11.8	7.6	8.1	6.8	22.7	19.6	13.3	28.2	5.9	60.8	14.3	6.3	23.3	5.0	6.5	30.9	6.4	19.6	6.8	12.0	19.1	7.5	18.4	24.8	27.6	28.4	16.3	16.9	8.2	5.2	29.3	3.5	3.5	23.7	9.1	20.8	19.4	15.5	14.0	19.4	11.4	29.4	15.9	4.4	3.2
PYCR1	P5C	ENSG00000183010	"Pyrroline-5-carboxylate reductase 1"	P32322	17	81932384-81942412	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Amino-acid biosynthesis, Proline biosynthesis, Stress response"	Oxidoreductase	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"pancreas: 56.1;salivary gland: 53.3;stomach 1: 16.6"	"Cell type enhanced"	"Detected in many"	6	"Exocrine glandular cells: 55.5;Extravillous trophoblasts: 46.4;Mucus-secreting cells: 41.0;Pancreatic endocrine cells: 48.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"memory B-cell: 7.7"	"Group enriched"	"Detected in many"	7	"B-cells: 7.7;dendritic cells: 3.3;T-cells: 3.0"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			HPA047660	Approved					NA	NA					"HPA047660: AB_2680115"	"unprognostic (1.12e-2)"	"unprognostic (2.13e-2)"	"unprognostic (7.04e-2)"	"unprognostic (7.27e-2)"	"unprognostic (9.86e-2)"	"unprognostic (1.60e-1)"	"prognostic unfavorable (2.33e-4)"	"unprognostic (2.80e-1)"	"unprognostic (9.36e-3)"	"unprognostic (6.65e-2)"	"unprognostic (3.02e-3)"	"unprognostic (7.12e-2)"	"prognostic unfavorable (7.33e-12)"	"unprognostic (7.98e-2)"	"unprognostic (1.56e-1)"	"unprognostic (1.12e-2)"	"unprognostic (5.92e-2)"	2.1	1.3	4.3	5.0	5.0	4.0	6.9	2.1	4.3	10.4	9.1	2.3	10.1	5.6	4.2	2.2	6.4	3.5	5.7	3.5	3.5	3.6	2.4	3.1	4.9	2.3	6.0	2.0	7.6	56.1	0.0	7.6	8.3	6.4	10.4	5.6	1.5	53.3	4.7	3.4	1.8	4.8	4.6	2.9	2.4	16.6	8.7	4.0	1.7	3.3	4.5	6.4	4.9	4.0	7.7	3.3	0.0	0.4	0.6	3.0	2.2	19.1	20.5	11.7	43.3	6.9	13.3	22.4	32.2	15.9	10.4	14.0	23.4	21.6	29.4	7.2	34.4	6.2	8.4	27.5	12.2	6.2	7.6	3.4	17.3	10.6	63.2	41.5	11.4	13.4	11.3	24.5	12.7	33.6	12.2	17.6	24.0	55.6	27.4	6.5	67.8	12.1	9.2	9.8	53.1	31.8	0.1	19.7	37.0	9.3	7.0	45.0	31.7	6.7	38.0	41.0	9.1	39.1	21.3	12.9	10.1	38.9	17.0	11.9	34.6	24.0	27.3	10.8	0.1	33.2	0.0	0.3	0.0	0.5	0.4	0.7	7.7	1.3	0.4	2.3	3.5	3.0	2.3	0.0	0.6	0.0	3.3	0.5	2.2	4.3	5.0	2.1	3.6	3.5	3.6	6.0	2.0	6.4	4.0	0.0	3.8	3.7	8.2	6.3	0.2	0.6	0.0	1.4	3.4	3.5	0.0	1.7	0.0	14.6	10.8	3.5	4.1	0.0	55.5	46.4	23.5	32.3	4.6	1.7	4.3	3.2	10.4	4.3	0.0	25.5	6.9	0.0	8.5	1.0	41.0	0.1	48.3	20.1	3.5	1.3	0.0	0.0	3.1	24.5	15.2	5.3	3.2	1.0	37.6	7.4
PYCR2	P5CR2	ENSG00000143811	"Pyrroline-5-carboxylate reductase 2"	Q96C36	1	225919877-225924340	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Amino-acid biosynthesis, Proline biosynthesis"	Oxidoreductase	"Disease mutation, Leukodystrophy"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											HPA056873	Approved		Approved	Mitochondria		NA	NA			Mitochondria		"HPA056873: AB_2683263"	"unprognostic (1.11e-1)"	"unprognostic (8.08e-2)"	"prognostic unfavorable (5.02e-5)"	"unprognostic (2.91e-2)"	"unprognostic (1.76e-1)"	"unprognostic (1.03e-1)"	"unprognostic (4.20e-3)"	"unprognostic (1.56e-2)"	"unprognostic (6.89e-2)"	"unprognostic (1.12e-1)"	"unprognostic (9.07e-3)"	"unprognostic (1.56e-1)"	"prognostic unfavorable (1.42e-6)"	"unprognostic (9.69e-2)"	"unprognostic (2.61e-1)"	"unprognostic (6.44e-2)"	"unprognostic (1.16e-3)"	21.4	37.2	25.7	24.0	28.2	29.5	17.2	14.3	38.2	21.8	17.4	40.0	25.8	16.1	25.3	20.0	17.7	33.2	24.6	38.0	27.9	28.3	23.4	35.0	22.0	30.3	34.0	30.8	34.5	29.0	26.6	29.8	22.2	29.5	22.4	13.7	21.5	26.3	32.1	36.0	15.3	16.7	22.3	38.4	25.9	20.1	17.6	24.7	35.0	19.2	20.0	23.5	24.6	16.2	19.3	25.9	16.4	12.7	28.3	36.1	18.1	16.9	14.0	8.6	14.4	9.7	10.1	18.1	17.9	11.2	12.2	10.9	18.3	14.1	29.8	38.5	13.1	9.6	19.6	12.3	14.1	7.0	35.8	25.6	28.5	14.6	18.3	15.1	25.0	46.8	9.7	17.8	13.8	15.9	10.9	11.6	25.0	41.1	20.0	12.3	13.9	31.4	28.4	47.9	26.7	19.5	28.2	19.2	61.8	15.8	13.5	10.8	14.0	14.9	11.9	37.4	7.2	15.3	47.9	9.7	9.6	11.5	20.3	24.6	32.0	35.1	29.5	15.1	19.1	26.5	15.1	8.7	16.4	21.1	12.7	22.2	15.9	20.6	19.5	13.6	19.3	36.1	29.2	6.0	28.3	10.8	25.9	18.6	18.1	25.7	28.2	14.3	38.2	27.9	28.3	34.0	30.8	29.5	24.7	17.9	21.4	27.4	51.9	13.2	13.0	38.6	15.3	60.2	17.0	33.2	13.7	79.6	41.4	44.2	5.9	22.9	13.5	46.7	30.3	34.9	22.5	33.6	38.1	16.3	35.3	12.7	25.4	19.0	20.8	5.6	35.4	21.2	32.1	65.9	14.1	38.4	25.0	13.9	35.3	24.0	36.1	25.8	18.9	33.6	40.3	11.2	34.9	45.7	13.6	34.4
PYCR3	"FLJ13852, PYCRL"	ENSG00000104524	"Pyrroline-5-carboxylate reductase 3"	Q53H96	8	143603913-143609773	"Enzymes, Predicted intracellular proteins"	"Amino-acid biosynthesis, Proline biosynthesis"	Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"	8	"Ciliated cells: 8.1;Collecting duct cells: 14.0;Ductal cells: 7.1;Exocrine glandular cells: 7.9;Extravillous trophoblasts: 10.5;Proximal tubular cells: 10.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA053776, HPA063416, HPA069706"	Uncertain		Supported	"Cytokinetic bridge,Mitotic spindle,Cytosol"		NA	NA			Cytosol	"Cytokinetic bridge, Mitotic spindle"	"HPA053776: , HPA063416: AB_2685010, HPA069706: AB_2686178"	"unprognostic (2.12e-2)"	"unprognostic (3.16e-2)"	"unprognostic (2.74e-1)"	"unprognostic (2.44e-1)"	"unprognostic (1.06e-2)"	"unprognostic (2.30e-1)"	"unprognostic (7.68e-3)"	"unprognostic (1.79e-1)"	"unprognostic (1.96e-1)"	"unprognostic (2.26e-2)"	"unprognostic (5.85e-2)"	"unprognostic (5.44e-2)"	"unprognostic (1.82e-2)"	"unprognostic (3.64e-2)"	"unprognostic (2.96e-1)"	"unprognostic (3.54e-2)"	"unprognostic (2.54e-1)"	6.1	8.1	11.5	6.7	9.7	4.8	5.6	5.3	13.4	6.9	5.4	6.1	10.8	4.4	4.7	5.2	6.1	10.1	6.3	4.4	12.2	8.5	7.7	20.5	5.9	6.7	7.6	12.1	6.7	10.6	4.3	9.1	3.5	9.7	7.5	4.0	4.5	13.7	9.1	4.8	4.7	4.9	4.0	4.4	5.9	7.0	8.6	4.5	3.8	9.5	6.3	6.1	3.6	3.1	11.1	5.4	0.4	1.4	3.2	3.2	2.1	5.9	11.1	2.0	4.3	1.9	1.2	4.2	5.3	2.2	4.3	2.4	4.9	5.8	7.8	7.1	3.8	1.6	5.0	1.9	6.2	0.8	5.3	6.8	3.8	4.2	3.2	1.9	1.7	1.2	2.1	1.6	4.9	2.8	1.4	2.4	5.0	5.9	2.4	2.0	18.2	7.4	1.3	1.8	5.5	18.0	5.2	1.9	11.7	3.9	3.8	7.2	2.4	8.5	10.9	2.0	0.8	13.4	2.2	2.1	3.8	8.0	5.9	4.9	4.2	1.0	4.9	4.5	2.4	3.5	0.3	1.4	0.2	3.2	1.1	3.1	5.8	2.1	2.6	2.1	11.1	3.0	3.0	0.4	3.2	1.0	5.4	1.8	2.1	11.5	9.7	5.3	13.4	12.2	8.5	7.6	12.1	9.7	4.5	3.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	8.1	1.2	14.0	0.0	4.9	3.3	7.1	0.0	0.0	0.0	0.0	7.9	10.5	0.0	0.0	0.0	0.0	4.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.0	6.1	0.0	0.0	10.6	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0
PYGB		ENSG00000100994	"Glycogen phosphorylase B"	P11216	20	25248069-25298014	"Candidate cardiovascular disease genes, Enzymes, Plasma proteins, Predicted intracellular proteins"	"Carbohydrate metabolism, Glycogen metabolism"	"Allosteric enzyme, Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"smooth muscle: 101.9"	"Cell type enhanced"	"Detected in many"	5	"Cardiomyocytes: 93.8;Enterocytes: 83.8;Peritubular cells: 81.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"PC-3: 71.7;SK-MEL-30: 89.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA031067	Approved		Approved	Cytosol		NA	NA		16000000	Cytosol		"HPA031067: AB_2673722"	"unprognostic (6.13e-2)"	"unprognostic (5.98e-2)"	"unprognostic (1.21e-1)"	"unprognostic (2.22e-1)"	"unprognostic (1.21e-1)"	"unprognostic (1.05e-1)"	"prognostic unfavorable (4.37e-4)"	"prognostic unfavorable (1.10e-4)"	"unprognostic (1.23e-3)"	"unprognostic (8.39e-3)"	"unprognostic (1.58e-3)"	"unprognostic (1.98e-1)"	"unprognostic (1.22e-2)"	"unprognostic (3.41e-2)"	"unprognostic (1.69e-1)"	"unprognostic (1.40e-1)"	"prognostic unfavorable (1.43e-4)"	19.0	11.3	24.2	12.1	22.9	6.1	28.4	38.3	34.8	14.3	47.0	21.5	19.0	12.5	15.9	13.8	49.6	14.1	21.1	72.5	21.1	21.3	13.5	4.4	14.8	8.1	22.9	24.7	11.9	9.7	8.0	18.2	6.2	28.0	42.2	33.8	11.0	58.4	52.0	5.0	23.9	13.1	101.9	17.8	8.2	24.1	14.5	17.4	9.5	21.1	8.4	10.3	56.7	14.8	4.5	11.2	5.2	16.8	8.1	10.6	16.0	5.3	38.3	6.9	6.7	17.7	33.4	5.1	10.8	14.2	9.1	7.7	8.6	6.6	6.3	12.8	14.4	17.1	21.5	7.8	28.8	5.0	3.5	4.8	5.1	3.1	14.7	21.0	7.5	7.1	19.4	27.0	23.1	34.3	11.3	11.6	4.0	2.7	16.1	12.7	14.8	7.5	5.8	6.2	6.5	71.7	5.7	12.6	8.4	49.9	9.8	10.4	6.5	7.4	13.0	89.9	5.7	9.1	4.8	25.5	10.8	6.6	11.5	22.0	6.2	9.6	2.4	12.1	5.9	58.7	2.6	10.2	5.2	8.5	15.5	8.3	4.5	6.8	7.5	11.2	4.2	8.8	10.6	2.5	8.1	16.8	5.5	7.5	16.0	24.2	22.9	38.3	34.8	21.1	21.3	22.9	24.7	28.0	17.4	8.9	28.8	2.2	18.7	10.5	23.6	93.8	15.3	9.4	9.1	24.4	35.3	5.9	10.0	15.4	2.4	10.8	83.8	0.0	14.5	5.7	9.1	20.1	5.8	5.9	10.0	17.5	27.1	8.6	15.2	6.8	25.3	11.0	33.7	18.0	47.4	20.4	19.1	57.9	81.3	9.9	9.4	0.0	17.6	1.7	4.9	8.8	3.7	12.8	52.1	7.1
PYGL		ENSG00000100504	"Glycogen phosphorylase L"	P06737	14	50857891-50944736	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Carbohydrate metabolism, Glycogen metabolism"	"Allosteric enzyme, Glycosyltransferase, Transferase"	"Disease mutation, Glycogen storage disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	13	"Extravillous trophoblasts: 117.8;Hofbauer cells: 137.9;Muller glia cells: 253.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"eosinophil: 36.0;neutrophil: 41.4"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HaCaT: 57.0;HMC-1: 63.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA000962, HPA004119"	Enhanced		Supported	"Plasma membrane,Cytosol"		NA	NA		17000000	"Plasma membrane, Cytosol"		"HPA000962: AB_1079722, HPA004119: AB_1079723"	"unprognostic (2.70e-2)"	"unprognostic (8.64e-3)"	"unprognostic (1.46e-2)"	"unprognostic (8.55e-2)"	"unprognostic (9.41e-2)"	"prognostic unfavorable (5.97e-4)"	"unprognostic (1.66e-1)"	"unprognostic (1.34e-2)"	"unprognostic (3.34e-1)"	"unprognostic (1.94e-2)"	"prognostic unfavorable (2.63e-4)"	"unprognostic (4.45e-3)"	"unprognostic (3.15e-3)"	"unprognostic (1.95e-2)"	"unprognostic (1.76e-1)"	"unprognostic (9.72e-2)"	"unprognostic (1.12e-3)"	47.6	9.9	4.9	9.7	6.8	40.0	28.1	1.3	3.9	17.2	10.1	3.0	23.7	1.7	10.9	7.3	24.8	7.8	5.5	15.0	3.9	3.4	6.8	58.8	19.6	25.6	6.5	1.6	15.4	4.1	12.5	3.7	23.3	5.3	11.4	10.3	17.8	11.8	55.2	7.1	15.3	3.5	11.2	8.7	38.8	4.5	6.8	5.4	2.4	7.1	9.1	7.3	18.4	24.3	0.0	7.3	41.4	13.8	0.1	0.0	5.5	28.7	8.1	2.1	13.4	10.0	12.0	23.4	5.8	4.9	16.0	24.4	21.4	3.7	0.0	11.3	34.4	19.0	57.0	21.7	29.2	27.8	0.1	9.2	5.5	13.0	16.6	17.9	20.9	63.0	25.5	11.9	21.6	9.1	15.9	14.1	0.1	2.2	0.1	11.3	28.7	0.0	28.9	8.1	2.6	30.2	0.5	7.5	1.1	22.1	19.3	0.9	0.9	26.3	9.1	0.3	8.5	4.3	41.1	0.6	6.2	10.4	11.5	18.6	0.2	0.0	0.0	5.7	21.7	3.3	11.3	13.8	36.0	0.0	6.3	0.0	0.0	0.0	0.0	7.3	0.0	0.0	0.0	41.4	0.1	3.9	0.3	0.0	5.5	4.9	6.8	1.3	3.9	3.9	3.4	6.5	1.6	5.3	5.4	20.8	7.5	2.7	8.9	27.2	4.1	2.0	7.6	10.7	15.9	7.0	0.0	29.4	3.3	9.4	0.4	6.0	3.4	0.0	1.8	117.8	14.4	8.6	5.8	53.3	137.9	1.6	1.2	6.7	43.8	0.7	13.3	29.1	18.6	15.4	6.9	253.1	7.2	0.0	20.5	3.4	9.1	6.5	7.1	0.7	0.6	19.4	17.6	2.9	11.5	7.4
PYGM		ENSG00000068976	"Glycogen phosphorylase, muscle associated"	P11217	11	64746389-64760297	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Carbohydrate metabolism, Glycogen metabolism"	"Allosteric enzyme, Glycosyltransferase, Transferase"	"Disease mutation, Glycogen storage disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	37	"skeletal muscle: 572.6;tongue: 172.6"	"Cell type enhanced"	"Detected in many"	12	"Cardiomyocytes: 46.7;Late spermatids: 32.1;Peritubular cells: 41.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	5	"basophil: 9.9"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 9.9"	"Cell line enhanced"	"Detected in some"		"HSkMC: 8.3;NB-4: 4.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA056003	Enhanced					NA	NA		12000000			"HPA056003: AB_2683006"	"unprognostic (3.33e-1)"	"unprognostic (6.03e-3)"	"unprognostic (3.87e-4)"	"unprognostic (1.95e-3)"	"unprognostic (8.71e-2)"	"unprognostic (1.09e-2)"	"unprognostic (1.25e-3)"	"unprognostic (2.92e-1)"	"unprognostic (3.88e-1)"	"unprognostic (3.08e-2)"	"unprognostic (1.12e-1)"	"unprognostic (2.64e-1)"	"unprognostic (6.33e-6)"	"unprognostic (3.37e-3)"	"unprognostic (1.81e-1)"	"unprognostic (1.62e-2)"	"unprognostic (5.68e-2)"	6.4	0.8	2.2	0.7	3.0	0.7	0.8	1.1	3.1	0.9	2.1	1.8	0.7	0.7	1.1	4.6	7.1	1.5	0.9	5.5	2.9	1.0	0.7	0.6	0.7	0.7	1.5	1.1	0.7	0.7	0.6	0.3	0.7	6.6	2.5	0.9	1.6	7.9	2.8	572.6	0.6	0.8	2.5	4.1	0.7	0.8	0.9	1.8	0.0	1.2	172.6	6.4	1.5	0.6	1.9	0.3	9.9	0.0	1.6	0.3	0.2	0.2	0.1	1.7	0.2	1.2	1.7	0.3	0.2	0.1	0.3	0.0	0.7	0.7	1.3	0.5	0.0	0.3	0.4	0.5	0.1	0.1	1.4	0.3	0.8	0.3	0.0	0.8	0.8	0.3	8.3	0.6	0.6	0.2	0.1	0.0	2.4	1.5	1.5	0.0	2.2	1.5	4.8	1.7	0.2	0.2	0.9	1.5	0.3	0.0	0.2	0.5	0.1	0.6	0.7	0.9	1.1	0.7	0.9	0.6	0.0	0.9	0.4	0.1	2.4	2.8	1.0	0.0	0.2	0.0	9.9	0.0	0.0	0.3	0.0	0.0	1.4	0.0	0.2	0.0	1.9	0.0	0.1	0.2	1.6	0.0	0.3	0.3	0.2	2.2	3.0	1.1	3.1	2.9	1.0	1.5	1.1	6.6	1.8	0.0	2.9	0.0	0.6	0.7	3.6	46.7	0.0	0.0	1.2	0.0	3.9	0.5	0.0	0.1	11.7	1.0	0.7	0.0	0.0	0.2	2.1	0.4	0.0	0.0	0.4	0.0	0.0	1.8	1.2	32.1	15.3	0.9	0.0	0.0	0.7	9.1	0.2	0.0	41.4	0.0	1.2	6.5	15.3	1.0	0.9	0.5	0.1	1.3	0.8	0.3
QARS		ENSG00000172053	"Glutaminyl-tRNA synthetase"	P47897	3	49095932-49105135	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Protein biosynthesis"	"Aminoacyl-tRNA synthetase, Ligase"	"Disease mutation, Epilepsy, Primary microcephaly"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	6	"Late spermatids: 438.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036986, HPA036987"	Enhanced		Enhanced	Cytosol		No	No		21000	Cytosol		"HPA036986: AB_10672344, HPA036987: AB_2675418"	"prognostic favorable (1.43e-4)"	"unprognostic (1.96e-1)"	"unprognostic (7.31e-2)"	"unprognostic (1.10e-2)"	"unprognostic (5.13e-3)"	"unprognostic (6.62e-3)"	"unprognostic (6.53e-3)"	"unprognostic (1.52e-2)"	"unprognostic (1.17e-1)"	"unprognostic (2.51e-1)"	"unprognostic (4.33e-1)"	"unprognostic (9.14e-2)"	"prognostic favorable (5.60e-6)"	"unprognostic (2.73e-3)"	"unprognostic (1.65e-1)"	"unprognostic (2.74e-2)"	"unprognostic (3.11e-1)"	20.9	16.3	9.7	19.3	10.2	18.4	22.7	15.8	13.2	17.6	27.3	13.1	27.7	17.2	12.3	19.8	35.1	16.4	20.0	22.0	9.8	9.6	27.1	26.0	15.0	33.9	12.4	7.2	21.6	33.8	20.3	13.7	25.7	9.6	16.2	29.9	15.2	31.7	28.7	33.3	26.7	31.8	16.7	11.2	21.1	16.9	30.1	11.3	36.8	16.5	34.8	33.3	19.4	18.5	20.4	40.0	8.9	32.3	21.8	24.0	19.6	18.8	19.2	32.1	45.9	41.3	44.9	33.1	21.0	48.1	41.7	41.0	24.3	24.5	58.4	13.5	34.8	23.4	24.0	45.5	34.6	30.0	16.6	36.3	46.0	30.8	42.3	21.8	37.4	28.4	47.3	30.3	32.1	27.3	44.8	45.5	34.2	20.5	26.0	30.5	10.1	26.9	33.6	27.5	38.6	30.0	17.8	27.0	43.0	28.0	28.1	11.8	32.8	18.6	47.3	28.9	33.0	39.2	43.7	26.2	19.0	27.0	31.3	23.4	22.4	38.1	32.8	19.5	33.7	12.0	8.9	23.1	8.7	13.5	32.3	18.1	20.4	16.8	14.9	40.0	15.2	15.5	15.4	2.6	21.8	26.1	16.9	24.0	19.6	9.7	10.2	15.8	13.2	9.8	9.6	12.4	7.2	9.6	11.3	20.8	57.3	55.9	52.1	59.8	10.1	50.4	40.8	22.7	35.2	38.4	9.8	160.6	58.0	67.5	150.2	50.3	110.2	23.3	94.9	127.6	48.0	47.5	38.1	41.8	85.6	19.1	62.3	50.3	98.5	438.0	54.4	55.2	45.5	120.0	127.2	20.6	67.1	71.9	34.3	63.0	13.0	45.3	43.4	18.4	46.6	75.3	156.4	69.2	176.8	57.2
QDPR	"DHPR, PKU2, SDR33C1"	ENSG00000151552	"Quinoid dihydropteridine reductase"	P09417	4	17460261-17512234	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Tetrahydrobiopterin biosynthesis"	Oxidoreductase	"Disease mutation, Phenylketonuria"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 114.1;liver: 64.8"	"Cell type enhanced"	"Detected in many"	7	"Hepatocytes: 298.8;Muller glia cells: 301.8;Proximal tubular cells: 369.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA058951, HPA065649"	Enhanced		Approved	Mitochondria		NA	NA		1800000	Mitochondria		"HPA058951: AB_2683861, HPA065649: AB_2685526"	"unprognostic (1.30e-2)"	"unprognostic (4.29e-1)"	"unprognostic (8.27e-2)"	"unprognostic (2.52e-1)"	"unprognostic (1.21e-1)"	"unprognostic (1.20e-1)"	"unprognostic (3.29e-3)"	"unprognostic (3.80e-3)"	"unprognostic (1.19e-1)"	"unprognostic (1.45e-1)"	"unprognostic (6.82e-3)"	"unprognostic (2.07e-1)"	"prognostic favorable (7.84e-6)"	"unprognostic (1.58e-1)"	"unprognostic (2.60e-1)"	"unprognostic (9.01e-2)"	"unprognostic (3.19e-1)"	22.5	25.9	67.8	3.4	111.9	4.4	7.4	16.0	54.1	5.7	7.5	56.3	2.6	9.1	5.5	12.5	5.2	6.4	6.3	15.0	80.7	58.2	36.1	64.8	8.0	3.7	114.1	36.7	6.7	10.3	13.7	6.2	4.1	82.5	10.3	5.9	2.6	12.4	7.5	34.2	4.6	8.1	6.4	93.6	4.8	9.1	4.1	94.7	0.7	7.7	2.8	4.4	4.5	2.6	7.5	42.5	1.0	21.9	9.9	15.0	12.3	11.6	22.8	9.0	12.5	21.9	11.1	15.9	16.6	7.0	15.5	13.6	18.2	15.4	4.3	10.7	9.2	17.3	6.6	12.8	18.8	9.7	13.1	2.6	11.8	11.8	43.0	13.2	15.3	1.1	13.7	11.9	9.7	13.4	8.3	7.8	11.0	12.6	9.9	16.6	6.0	22.8	24.6	15.3	11.0	15.4	9.5	6.9	17.2	16.0	6.4	17.1	21.8	11.0	1.8	47.2	10.3	5.0	5.9	13.5	9.0	16.1	8.9	13.2	15.4	24.0	30.2	18.0	13.5	14.9	0.0	14.4	1.0	12.3	21.9	11.1	7.5	13.3	12.8	18.0	6.2	15.0	12.9	0.4	9.9	16.3	42.5	6.9	12.3	67.8	111.9	16.0	54.1	80.7	58.2	114.1	36.7	82.5	94.7	26.8	26.9	18.2	16.6	17.7	34.9	59.2	38.2	4.0	14.8	36.6	7.9	65.3	92.9	37.2	0.8	17.8	14.2	0.0	20.5	28.8	26.3	26.4	25.3	298.8	69.8	77.9	167.4	25.8	34.9	3.3	21.0	26.9	145.1	20.8	22.6	301.8	17.0	7.0	35.7	369.1	26.6	25.8	26.4	3.3	60.7	14.1	15.3	16.7	36.6	11.1
QPCT	"GCT, QC"	ENSG00000115828	"Glutaminyl-peptide cyclotransferase"	Q16769	2	37344574-37373322	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"		"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adrenal gland: 77.6;blood: 137.6"	"Group enriched"	"Detected in many"	6	"Intestinal endocrine cells: 208.4;Melanocytes: 501.0"	"Cancer enhanced"	"Detected in all"		"melanoma: 97.4"	"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in some"	5	"neutrophil: 137.6"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 137.6"	"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 17.9;SCLC-21H: 24.3;SK-MEL-30: 81.6;U-266/84: 63.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA008406	Enhanced		Approved	Cytosol	"Secreted to blood"	NA	NA			Cytosol		"HPA008406: AB_1855981"	"unprognostic (6.25e-3)"	"unprognostic (6.69e-2)"	"unprognostic (4.95e-2)"	"unprognostic (1.44e-1)"	"unprognostic (1.44e-2)"	"unprognostic (9.32e-2)"	"unprognostic (1.13e-3)"	"unprognostic (9.73e-2)"	"unprognostic (2.71e-3)"	"unprognostic (7.86e-2)"	"unprognostic (3.67e-2)"	"unprognostic (1.17e-1)"	"unprognostic (6.78e-2)"	"unprognostic (7.76e-3)"	"unprognostic (1.21e-1)"	"unprognostic (9.48e-3)"	"unprognostic (3.62e-3)"	3.2	77.6	4.3	5.4	5.8	17.0	6.4	1.2	11.6	9.2	11.3	2.2	1.5	2.2	6.2	43.7	2.4	1.9	5.5	2.9	6.7	17.9	12.4	1.3	6.1	7.4	3.9	5.0	1.4	5.5	9.6	31.6	7.8	5.9	3.5	4.2	21.2	14.7	2.8	4.0	14.2	2.3	3.4	3.0	8.5	3.4	2.6	0.5	2.3	1.8	4.4	4.8	7.0	2.9	0.2	10.7	137.6	29.7	0.0	0.0	12.1	0.1	8.0	0.0	0.0	1.1	2.7	0.0	1.1	17.9	1.3	2.1	0.5	1.4	0.0	0.6	6.0	15.2	0.0	0.5	0.0	2.1	0.1	15.6	3.6	0.0	1.5	0.1	0.5	0.0	1.5	0.0	9.9	0.0	0.0	5.3	0.0	0.0	0.0	0.0	0.8	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.1	8.8	2.2	24.3	0.0	1.3	0.0	81.6	1.6	0.1	0.6	3.8	0.0	0.0	0.0	0.1	3.1	63.8	0.0	5.5	0.0	0.0	0.6	29.7	0.2	0.0	3.4	0.0	0.2	0.0	0.0	10.7	0.1	0.0	0.0	137.6	0.0	0.3	0.2	0.0	12.1	4.3	5.8	1.2	11.6	6.7	17.9	3.9	5.0	5.9	0.5	3.0	2.9	8.2	9.7	34.7	10.9	1.1	2.5	1.4	0.0	21.0	2.0	0.5	1.7	45.4	0.4	7.3	2.0	0.0	2.1	4.3	11.0	9.5	55.3	0.2	21.3	41.3	208.4	22.7	29.2	2.2	2.8	35.6	501.0	10.8	5.8	1.2	25.4	1.9	22.3	4.7	2.9	12.9	15.5	2.1	0.6	12.7	3.9	1.9	6.9	5.5
QPCTL	FLJ20084	ENSG00000011478	"Glutaminyl-peptide cyclotransferase like"	Q9NXS2	19	45692483-45703989	"Enzymes, Predicted intracellular proteins"		"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"	7	"Ciliated cells: 4.0;Early spermatids: 4.4;granulocytes: 5.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA040797	Approved		Supported	"Golgi apparatus"		NA	NA			"Golgi apparatus"		"HPA040797: AB_10794148"	"unprognostic (6.50e-2)"	"unprognostic (4.14e-2)"	"unprognostic (2.09e-1)"	"unprognostic (7.50e-2)"	"unprognostic (1.90e-1)"	"unprognostic (2.26e-1)"	"unprognostic (8.41e-3)"	"unprognostic (2.30e-2)"	"unprognostic (9.46e-2)"	"unprognostic (1.69e-1)"	"unprognostic (3.14e-2)"	"unprognostic (6.05e-2)"	"prognostic unfavorable (2.15e-8)"	"unprognostic (1.07e-1)"	"unprognostic (1.75e-1)"	"unprognostic (4.02e-2)"	"unprognostic (5.71e-2)"	6.3	10.2	8.2	9.6	10.2	13.3	7.8	10.3	13.5	9.6	11.6	6.3	9.6	11.2	7.6	10.2	11.4	8.6	15.9	5.0	8.9	10.8	7.9	18.2	11.8	10.7	7.3	8.0	11.2	10.7	9.5	10.8	9.6	10.8	10.8	9.5	7.7	13.5	10.8	3.2	12.4	7.9	6.1	6.4	12.9	9.5	5.9	5.0	9.7	17.1	7.5	13.2	11.9	6.4	3.1	3.6	5.1	2.1	4.1	4.3	1.2	10.2	7.0	5.6	23.0	5.6	2.7	4.2	6.7	9.7	9.5	15.8	7.4	7.7	12.7	7.3	7.3	10.0	6.5	6.9	7.4	5.9	3.5	8.8	4.6	9.0	14.8	9.4	4.7	8.2	4.9	9.1	7.9	11.6	7.0	8.4	7.6	6.2	22.1	5.9	8.2	4.3	5.6	4.0	8.6	4.0	5.2	4.1	10.1	10.9	4.9	5.3	3.3	6.8	5.6	11.4	2.6	4.3	7.3	5.4	4.9	8.1	5.1	6.4	20.7	12.3	11.9	16.9	10.8	3.8	3.1	2.0	0.9	4.3	2.1	3.0	3.1	2.1	1.4	2.4	2.8	2.1	2.8	5.1	4.1	1.3	3.6	1.4	1.2	8.2	10.2	10.3	13.5	8.9	10.8	7.3	8.0	10.8	5.0	0.0	1.0	0.0	1.0	1.1	1.1	0.8	0.0	4.0	1.2	0.0	0.0	0.6	0.0	0.3	4.4	0.1	0.7	0.0	0.3	1.0	0.7	1.1	5.7	1.0	0.8	1.6	0.0	0.0	0.3	0.6	0.0	1.3	1.7	1.0	0.2	0.5	0.5	0.0	0.0	0.1	2.5	0.0	0.8	1.1	0.2	1.0	0.7	1.3	0.6	0.4
QPRT	QPRTase	ENSG00000103485	"Quinolinate phosphoribosyltransferase"	Q15274	16	29679008-29698699	"Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"	"Pyridine nucleotide biosynthesis"	"Glycosyltransferase, Transferase"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 61.2"	"Cell type enhanced"	"Detected in many"	8	"Cytotrophoblasts: 349.5;Extravillous trophoblasts: 260.2;Hepatocytes: 304.1;Proximal tubular cells: 417.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"non-classical monocyte: 7.7"	"Group enriched"	"Detected in many"	4	"dendritic cells: 4.6;monocytes: 7.7"	"Cell line enhanced"	"Detected in many"		"EFO-21: 98.7;Hep G2: 41.2"									"HPA011887, HPA076010"	Enhanced		Approved	Vesicles	"Intracellular and membrane"	NA	NA		230000	Vesicles		"HPA011887: AB_2668555, HPA076010: "	"prognostic unfavorable (5.10e-5)"	"unprognostic (2.00e-1)"	"unprognostic (9.48e-2)"	"unprognostic (2.88e-1)"	"prognostic unfavorable (9.31e-4)"	"unprognostic (1.44e-2)"	"unprognostic (8.75e-2)"	"unprognostic (1.22e-1)"	"unprognostic (8.16e-2)"	"unprognostic (1.01e-2)"	"unprognostic (2.39e-1)"	"unprognostic (6.81e-2)"	"unprognostic (3.37e-2)"	"unprognostic (1.33e-2)"	"unprognostic (2.65e-1)"	"unprognostic (1.63e-1)"	"unprognostic (1.58e-2)"	3.2	36.4	6.1	3.0	5.2	1.1	2.4	1.6	5.8	17.9	10.8	4.4	43.3	20.0	12.7	44.3	1.3	14.9	4.9	11.3	4.9	7.5	40.1	61.2	4.7	2.9	7.9	7.5	15.3	22.9	6.1	2.6	24.3	10.0	4.4	5.2	12.6	15.0	19.4	1.5	1.6	24.1	4.7	6.4	5.3	2.7	3.1	2.6	3.7	2.2	0.3	2.1	5.9	5.1	0.1	4.6	1.2	7.7	0.5	1.4	2.2	0.1	0.2	9.4	10.3	1.6	3.9	23.1	0.9	0.9	1.5	1.9	23.6	16.8	0.4	98.7	1.8	1.5	0.1	3.2	0.1	0.8	0.1	2.1	4.8	0.3	41.2	9.0	0.7	2.0	12.3	0.2	0.8	0.0	2.3	0.0	4.6	12.1	0.5	0.0	22.9	3.0	16.8	28.7	0.5	0.0	13.3	2.8	9.3	8.6	0.7	7.6	15.4	0.0	26.8	19.8	16.1	20.0	21.5	0.1	0.4	3.9	0.1	0.0	0.3	0.7	3.1	0.7	1.7	1.5	0.0	3.7	0.4	1.3	4.7	1.4	0.1	0.9	1.0	4.6	0.1	0.1	0.7	1.2	0.5	7.7	2.6	0.8	2.2	6.1	5.2	1.6	5.8	4.9	7.5	7.9	7.5	10.0	2.6	8.9	22.7	18.6	9.6	3.2	1.5	34.8	7.6	0.0	0.0	61.1	0.0	349.5	43.1	0.9	0.0	2.8	125.5	0.0	48.0	260.2	17.5	2.9	4.7	304.1	118.1	6.4	27.2	11.1	13.0	0.0	27.0	12.3	40.5	5.4	45.2	20.3	17.4	77.2	25.5	417.3	3.5	6.5	11.3	0.5	2.5	1.8	180.3	6.4	95.6	6.4
QRSL1	"DKFZP564C1278, FLJ10989, FLJ12189, FLJ13447, GatA"	ENSG00000130348	"Glutaminyl-tRNA synthase (glutamine-hydrolyzing)-like 1"	Q9H0R6	6	106629578-106668417	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Protein biosynthesis"	Ligase	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"B-cells: 62.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	7	"memory B-cell: 32.6;naive B-cell: 26.1"	"Lineage enriched"	"Detected in all"	7	"B-cells: 32.6"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029585, HPA029587"	Approved		Approved	Vesicles,Centrosome		NA	NA			Vesicles	Centrosome	"HPA029585: AB_10599823, HPA029587: AB_10602311"	"unprognostic (1.86e-3)"	"unprognostic (5.58e-2)"	"unprognostic (6.19e-3)"	"unprognostic (3.45e-1)"	"unprognostic (2.11e-3)"	"unprognostic (1.31e-2)"	"prognostic unfavorable (7.97e-5)"	"unprognostic (8.36e-2)"	"unprognostic (1.70e-1)"	"unprognostic (1.06e-1)"	"unprognostic (4.03e-2)"	"unprognostic (1.66e-1)"	"prognostic favorable (3.83e-4)"	"unprognostic (2.06e-1)"	"unprognostic (2.09e-1)"	"unprognostic (2.04e-1)"	"unprognostic (3.46e-1)"	9.8	10.8	12.4	17.0	14.7	8.5	15.6	10.1	15.6	7.6	11.7	10.1	11.9	11.3	9.5	10.8	10.3	8.5	8.3	13.9	10.4	9.1	15.5	12.5	7.7	21.0	15.8	8.3	10.2	10.8	10.9	11.9	8.7	9.9	8.3	13.7	7.5	10.6	12.5	35.7	8.8	14.8	8.8	11.9	16.7	11.0	10.6	13.7	13.8	13.7	14.6	21.3	8.9	8.6	32.6	4.0	1.6	4.5	2.6	3.1	2.2	6.2	6.5	9.0	13.0	5.8	7.3	12.7	7.1	7.4	9.6	9.6	7.5	5.2	20.9	6.6	7.9	9.9	11.1	13.3	8.6	12.1	9.9	10.2	10.1	6.9	7.8	9.1	22.9	9.1	7.2	13.5	10.2	15.1	7.3	6.8	13.2	18.4	6.8	7.9	7.0	7.3	11.2	9.3	10.9	7.6	20.1	11.5	5.3	10.4	7.2	7.8	8.0	5.7	13.4	10.5	8.2	8.7	17.8	6.6	6.8	5.6	7.2	11.0	4.0	5.6	12.2	9.3	15.6	10.0	1.6	2.4	0.4	2.6	3.6	2.5	32.6	2.9	2.2	4.0	26.1	2.7	2.6	0.7	2.6	4.5	3.2	3.1	2.2	12.4	14.7	10.1	15.6	10.4	9.1	15.8	8.3	9.9	13.7	17.9	8.4	62.4	6.4	3.5	14.2	24.6	10.2	26.8	7.9	10.4	15.7	18.2	14.9	13.3	10.4	10.4	10.5	0.0	15.9	19.4	7.2	6.4	17.4	13.0	11.3	3.2	16.7	8.0	13.2	4.5	7.8	9.0	8.5	14.4	10.5	9.4	12.8	7.0	8.5	14.6	18.7	0.0	6.6	20.7	12.0	4.6	10.3	11.4	19.0	8.4
QSOX1	QSCN6	ENSG00000116260	"Quiescin sulfhydryl oxidase 1"	O00391	1	180154834-180204030	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"placenta: 172.2"	"Cell type enriched"	"Detected in many"	8	"Extravillous trophoblasts: 1528.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HHSteC: 197.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA056243			Supported	"Golgi apparatus,Vesicles"	"Secreted to extracellular matrix"	NA	NA		3200000000	"Golgi apparatus"	Vesicles	"HPA056243: AB_2683077"	"unprognostic (1.13e-1)"	"unprognostic (2.62e-3)"	"unprognostic (2.46e-1)"	"unprognostic (2.49e-2)"	"unprognostic (2.00e-2)"	"unprognostic (2.73e-1)"	"unprognostic (5.47e-2)"	"unprognostic (2.22e-1)"	"unprognostic (3.94e-1)"	"unprognostic (3.12e-2)"	"unprognostic (5.07e-2)"	"unprognostic (2.80e-3)"	"prognostic unfavorable (1.86e-5)"	"unprognostic (3.25e-1)"	"unprognostic (2.14e-1)"	"unprognostic (3.53e-2)"	"unprognostic (1.40e-1)"	15.9	18.7	8.0	14.5	9.5	30.1	12.6	7.3	13.6	23.5	25.3	13.8	24.9	19.8	17.8	44.9	36.8	18.9	91.9	54.4	10.1	9.0	15.4	23.1	42.3	19.5	8.5	9.1	46.5	59.8	6.2	13.5	172.2	13.4	28.0	24.5	12.1	20.6	19.4	18.4	12.3	19.0	33.9	15.5	13.4	52.8	50.3	9.1	6.7	7.8	18.2	18.3	35.8	26.1	2.9	19.2	20.4	25.5	8.0	7.1	11.4	42.1	6.0	1.4	18.0	18.4	38.1	71.7	44.9	45.4	38.4	27.1	0.7	13.6	0.6	27.9	35.9	5.3	9.2	1.7	12.1	18.8	2.5	2.7	1.3	3.5	1.8	197.7	4.6	13.0	20.3	5.5	40.9	49.1	50.6	56.5	3.1	1.9	6.6	25.2	7.3	0.9	8.6	4.9	29.2	17.3	1.8	3.3	1.1	6.3	12.0	5.2	5.3	13.1	17.9	8.7	3.4	3.2	21.9	66.5	48.1	18.9	32.2	37.9	4.8	7.9	1.1	18.3	14.8	14.4	5.8	25.5	9.5	7.1	14.7	5.3	2.9	4.8	5.0	19.2	1.8	4.4	4.3	20.4	8.0	13.1	3.9	5.5	11.4	8.0	9.5	7.3	13.6	10.1	9.0	8.5	9.1	13.4	9.1	53.6	87.2	7.8	26.2	12.2	9.8	43.7	68.8	14.7	43.3	68.0	23.6	13.2	0.0	189.3	48.3	38.6	47.7	0.0	114.6	1528.4	54.2	30.1	25.3	1.5	63.8	6.4	44.4	101.9	45.4	16.5	164.5	43.6	42.2	44.1	163.8	43.9	172.2	143.8	66.8	9.5	6.5	32.3	17.5	20.9	25.4	8.7	129.1	15.0	96.4	58.0
QSOX2	"DKFZp762A2013, QSCN6L1, SOXN"	ENSG00000165661	"Quiescin sulfhydryl oxidase 2"	Q6ZRP7	9	136206333-136245841	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Spermatogonia: 26.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"naive B-cell: 3.4"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA012716, HPA017280"	Uncertain		Enhanced	"Nucleoplasm,Golgi apparatus"	"Intracellular and membrane"	NA	NA		5700000	"Golgi apparatus"	Nucleoplasm	"HPA012716: AB_2173315, HPA017280: AB_2669565"	"unprognostic (7.29e-2)"	"unprognostic (7.35e-3)"	"unprognostic (6.23e-2)"	"unprognostic (5.28e-2)"	"unprognostic (1.49e-1)"	"unprognostic (4.46e-3)"	"unprognostic (1.10e-3)"	"unprognostic (4.48e-2)"	"unprognostic (1.20e-1)"	"unprognostic (4.06e-3)"	"unprognostic (5.96e-2)"	"unprognostic (2.56e-2)"	"prognostic unfavorable (9.64e-6)"	"unprognostic (1.23e-2)"	"unprognostic (1.22e-1)"	"unprognostic (1.75e-2)"	"unprognostic (1.10e-2)"	7.2	8.0	8.4	15.9	14.1	16.0	7.3	30.3	10.6	5.8	5.8	9.4	8.9	6.0	8.1	13.2	5.6	8.1	5.5	7.0	7.6	7.1	7.0	9.2	6.5	19.1	11.0	6.7	9.4	21.7	12.1	29.2	5.8	9.6	6.1	6.7	7.9	6.5	4.9	5.1	12.4	10.3	8.1	7.1	14.6	7.6	11.7	10.1	8.3	12.1	6.0	16.7	5.4	6.4	3.4	0.8	1.6	0.3	0.4	0.8	0.2	7.0	17.1	14.2	18.8	8.0	9.8	17.9	8.9	10.0	17.5	16.1	12.7	15.3	10.8	14.8	12.0	32.2	22.8	16.8	12.9	14.2	15.9	8.4	5.8	28.3	14.0	11.4	17.2	8.9	7.8	13.2	17.3	21.1	7.7	12.8	11.4	14.0	29.3	9.2	11.9	6.3	11.5	16.8	21.2	10.9	11.8	18.5	17.7	6.0	6.3	15.2	11.5	14.1	11.2	7.5	9.7	8.0	10.1	7.3	21.3	15.4	17.4	20.3	10.4	13.8	23.8	14.2	9.1	19.8	1.6	0.3	0.7	0.5	0.0	0.8	1.9	0.6	0.2	0.1	3.4	0.2	0.4	0.1	0.4	0.0	0.8	0.3	0.2	8.4	14.1	30.3	10.6	7.6	7.1	11.0	6.7	9.6	10.1	8.9	6.4	6.9	2.5	5.0	16.1	3.1	0.0	8.1	5.7	5.2	17.7	1.2	1.7	3.3	4.9	7.0	1.1	0.0	3.4	2.5	4.7	4.8	1.1	3.4	2.0	4.8	15.6	2.5	4.8	4.7	5.5	2.7	0.0	1.0	4.9	2.8	3.5	0.0	6.7	1.9	8.2	6.5	5.7	16.8	26.4	10.0	0.8	3.1	3.4	3.3
QTRT1	TGT	ENSG00000213339	"Queuine tRNA-ribosyltransferase catalytic subunit 1"	Q9BXR0	19	10701430-10713437	"Enzymes, Predicted intracellular proteins"	"tRNA processing"	"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Mucus-secreting cells: 232.5;Paneth cells: 244.4;Undifferentiated cells: 247.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042695, HPA048651, HPA049440"	Approved		Approved	Mitochondria		NA	NA			Mitochondria		"HPA042695: AB_2678119, HPA048651: AB_2680477, HPA049440: AB_2680767"	"unprognostic (6.19e-2)"	"prognostic favorable (7.63e-5)"	"unprognostic (2.90e-2)"	"unprognostic (3.05e-1)"	"unprognostic (4.90e-2)"	"prognostic favorable (4.90e-4)"	"unprognostic (2.52e-1)"	"unprognostic (8.76e-3)"	"unprognostic (3.88e-1)"	"unprognostic (4.81e-3)"	"prognostic favorable (2.13e-4)"	"unprognostic (1.14e-2)"	"prognostic unfavorable (1.13e-6)"	"unprognostic (2.04e-2)"	"unprognostic (1.66e-1)"	"unprognostic (3.13e-1)"	"unprognostic (1.01e-3)"	14.0	18.4	20.6	13.4	29.1	14.2	11.5	18.0	21.3	11.3	14.5	13.3	19.4	12.8	15.3	11.6	14.6	15.8	13.5	19.5	19.7	13.1	11.8	18.9	8.4	13.5	22.9	19.3	22.1	33.9	5.8	12.0	9.8	19.9	13.7	6.6	10.5	26.6	12.7	20.5	12.6	14.2	13.3	12.7	11.5	12.5	5.0	22.2	5.3	19.0	11.9	10.3	12.0	10.3	19.6	19.1	0.9	14.4	18.5	18.8	10.4	17.2	13.9	6.6	19.3	7.0	8.4	8.7	8.8	7.9	10.3	10.2	11.1	6.6	19.5	21.7	5.0	6.2	11.6	6.0	10.6	3.4	11.5	8.4	12.8	5.6	23.3	12.1	19.0	11.3	12.4	9.1	6.7	9.9	4.7	10.5	10.8	14.1	22.4	5.1	26.9	16.3	23.7	17.5	10.8	21.5	17.2	8.8	30.1	8.4	11.1	21.5	9.3	13.5	14.8	11.5	2.9	9.5	8.0	8.1	15.9	8.9	25.4	20.5	24.7	19.0	9.5	8.6	23.1	19.2	0.9	8.3	0.2	15.1	14.4	18.8	19.6	16.3	13.1	16.4	19.0	17.5	13.9	0.6	18.5	7.3	19.1	17.7	10.4	20.6	29.1	18.0	21.3	19.7	13.1	22.9	19.3	19.9	22.2	0.0	5.0	26.7	54.7	56.6	36.4	5.6	28.1	12.0	5.7	54.1	47.1	41.0	54.7	20.6	1.3	27.0	191.9	70.0	23.8	30.6	33.2	38.0	16.1	26.7	26.1	85.8	185.1	16.5	20.2	1.1	46.9	9.6	47.2	7.2	232.5	24.4	15.1	244.4	35.3	58.5	54.3	19.4	30.3	12.1	28.9	36.6	23.5	26.2	247.9	33.9
RABGGTA	PTAR3	ENSG00000100949	"Rab geranylgeranyltransferase alpha subunit"	Q92696	14	24265538-24271739	"Enzymes, Predicted intracellular proteins"		"Prenyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA043488	Approved		Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"HPA043488: AB_10794887"	"unprognostic (2.00e-1)"	"unprognostic (8.37e-2)"	"unprognostic (2.61e-3)"	"unprognostic (1.13e-1)"	"unprognostic (8.34e-2)"	"unprognostic (1.39e-1)"	"unprognostic (2.78e-1)"	"unprognostic (5.78e-2)"	"unprognostic (3.89e-2)"	"unprognostic (7.11e-2)"	"unprognostic (3.12e-2)"	"unprognostic (1.12e-1)"	"prognostic favorable (5.44e-4)"	"unprognostic (1.77e-1)"	"unprognostic (1.84e-1)"	"prognostic favorable (1.51e-4)"	"unprognostic (2.01e-1)"	6.9	9.9	8.6	7.1	9.4	8.7	7.5	9.4	16.2	8.2	9.8	8.4	13.6	7.2	6.4	11.6	37.2	12.3	8.1	10.9	6.9	8.0	12.5	15.0	10.6	10.7	7.7	8.5	8.0	16.4	15.7	10.2	14.1	10.6	8.0	8.0	7.2	12.8	9.2	11.1	13.3	12.1	6.9	6.1	11.5	9.4	11.3	7.0	7.3	9.4	20.3	18.2	8.4	11.4	6.5	12.7	6.7	16.8	6.9	6.3	6.3	3.5	6.0	2.3	3.2	3.8	7.0	12.8	5.4	5.2	8.8	7.6	6.1	5.3	5.5	4.0	6.6	3.5	7.1	2.9	12.5	3.5	7.0	7.3	3.2	5.1	21.0	7.2	6.7	12.2	7.4	14.3	4.3	5.8	5.0	7.3	6.1	2.8	4.3	6.8	15.6	3.6	5.0	1.4	5.2	8.8	3.1	2.2	3.8	8.0	6.9	6.3	3.7	4.1	8.4	4.4	3.6	4.2	4.8	5.3	4.1	3.1	1.9	2.9	5.8	4.4	3.5	2.9	4.3	6.4	3.1	10.0	6.7	5.9	16.8	5.1	6.5	5.7	5.1	12.7	4.2	5.0	4.4	2.6	6.9	12.4	4.0	6.3	6.3	8.6	9.4	9.4	16.2	6.9	8.0	7.7	8.5	10.6	7.0	8.9	12.3	17.9	17.1	15.8	6.9	10.1	25.5	12.0	9.1	5.2	5.9	32.5	13.3	22.0	2.6	7.4	21.7	0.0	23.8	25.8	10.7	12.8	35.7	5.9	24.6	11.1	12.6	7.4	15.6	5.6	8.3	17.3	15.1	18.0	13.1	8.2	28.8	21.0	6.7	18.0	4.1	6.5	12.8	3.0	24.9	10.8	47.9	18.7	15.8	17.4
RABGGTB		ENSG00000137955	"Rab geranylgeranyltransferase beta subunit"	P53611	1	75786197-75795079	"Enzymes, Predicted intracellular proteins"		"Prenyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA026585, HPA027167, HPA030793"	Approved	Supported	Approved	Vesicles		NA	NA			Vesicles		"HPA026585: AB_1856026, HPA027167: AB_1856027, HPA030793: "	"unprognostic (4.83e-2)"	"unprognostic (3.04e-1)"	"unprognostic (2.09e-2)"	"unprognostic (2.45e-2)"	"unprognostic (9.02e-2)"	"unprognostic (3.52e-2)"	"prognostic unfavorable (9.80e-5)"	"unprognostic (9.62e-3)"	"unprognostic (2.93e-1)"	"unprognostic (1.93e-1)"	"unprognostic (2.23e-1)"	"unprognostic (6.95e-2)"	"prognostic unfavorable (1.12e-5)"	"unprognostic (6.05e-2)"	"unprognostic (1.56e-1)"	"unprognostic (6.77e-2)"	"unprognostic (3.89e-1)"	19.4	31.8	20.2	25.3	20.1	8.7	23.5	25.8	24.2	19.4	18.8	16.8	14.8	18.6	20.9	14.1	15.7	15.6	12.0	27.2	19.1	20.4	40.7	35.8	17.4	13.1	26.3	14.8	18.5	33.2	12.3	26.4	17.3	20.5	15.6	16.2	13.7	25.0	15.8	33.5	9.5	14.5	13.1	29.4	19.0	14.3	11.9	18.0	21.3	17.3	21.6	34.4	12.4	13.3	10.6	12.8	7.6	11.5	6.3	10.7	4.4	17.1	9.8	17.8	6.9	22.3	25.7	10.3	23.4	17.4	22.5	18.0	22.1	4.2	14.4	23.9	12.9	38.2	10.6	43.3	18.8	31.7	14.9	11.6	12.4	16.4	37.3	27.7	16.6	7.6	17.1	42.6	20.0	23.2	33.3	18.3	15.4	20.7	15.0	25.1	7.4	14.0	19.8	14.1	12.9	16.8	11.5	26.2	6.6	17.1	9.4	9.6	9.3	5.3	30.2	54.2	15.8	5.9	17.1	17.6	14.2	16.1	33.3	44.7	10.1	29.5	10.3	16.4	13.5	6.2	7.6	7.7	4.5	8.8	11.5	10.3	10.6	8.9	8.1	12.8	7.1	10.5	10.7	1.3	6.3	8.0	12.0	8.0	4.4	20.2	20.1	25.8	24.2	19.1	20.4	26.3	14.8	20.5	18.0	32.8	40.6	61.9	46.8	113.4	22.5	59.6	66.2	22.7	33.0	26.2	19.6	39.2	87.9	38.3	1.3	35.0	39.3	0.0	44.7	50.2	57.6	54.1	71.3	68.3	56.4	30.2	86.2	29.4	47.6	3.6	30.0	61.3	55.6	48.7	49.0	26.6	40.5	35.1	31.5	127.1	22.2	6.5	65.0	15.4	14.3	125.0	44.7	48.9	56.6	68.1
RAD1	"HRAD1, REC1"	ENSG00000113456	"RAD1 checkpoint DNA exonuclease"	O60671	5	34905264-34918989	"Enzymes, Predicted intracellular proteins"	"DNA damage, DNA repair"	"Exonuclease, Hydrolase, Nuclease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA006692	Approved		Approved	Nucleoplasm,Vesicles		NA	NA			"Nucleoplasm, Vesicles"		"HPA006692: AB_2667645"	"prognostic unfavorable (6.30e-4)"	"unprognostic (1.85e-2)"	"unprognostic (9.40e-2)"	"unprognostic (1.98e-3)"	"unprognostic (2.00e-1)"	"unprognostic (2.38e-2)"	"prognostic unfavorable (1.06e-5)"	"unprognostic (1.22e-2)"	"unprognostic (2.25e-3)"	"unprognostic (1.61e-3)"	"unprognostic (2.57e-1)"	"unprognostic (2.57e-1)"	"unprognostic (2.22e-2)"	"unprognostic (1.36e-1)"	"unprognostic (1.72e-1)"	"unprognostic (2.11e-1)"	"unprognostic (3.12e-3)"	3.1	6.5	3.4	3.2	4.9	4.8	4.4	5.2	4.7	5.4	3.2			2.9	4.6	3.8	3.7	3.5	3.3	6.6	3.5	4.4	3.7	3.5	5.6	6.1	2.9		4.0	3.3	3.0	3.4	6.0		5.3	3.1		4.3	3.7	7.4	4.5	3.6	3.3	2.6	3.1	3.7	5.8			5.2		4.7	3.8	4.7	9.4	7.6	7.2	3.1	4.8	9.3	2.6	5.8	6.8	7.3	14.0	5.1	6.0	10.4	9.2	9.0	9.7	8.0	6.4	8.0	15.2	3.3	8.2	11.7	5.4	8.0	5.6	10.9	6.8	6.8	8.1	20.7	4.4	8.8	11.1	7.5	5.3	4.8	10.6	7.1	3.6	4.7	6.6	14.4	9.1	8.2	7.3	11.3	7.9	9.5	3.8	10.3	10.4	15.2	5.3	4.7	6.2	7.5	7.9	19.0	13.0	8.5	5.3	8.0	9.3	4.2	12.7	9.7	6.5	9.6	5.0	9.1	13.4	6.6	16.8	8.8	7.2	3.0	6.8	5.9	3.1	7.7	8.7	6.5	8.0	2.9	9.4	9.3	8.0	2.3	4.8	2.9	7.6	5.3	2.6											20.8	39.2	16.0	18.1	26.0	22.1	20.7	15.3	9.4	13.6	19.2	25.5	69.8	16.6	14.1	15.1	14.1	9.5	23.3	19.5	44.4	23.7	18.0	20.8	12.1	20.7	22.3	12.6	9.2	13.2	11.8	23.3	15.3	16.9	10.0	11.0	18.9	14.2	10.5	20.5	13.2	33.2	12.9	19.1	59.4	59.0	25.0	67.4	26.3	11.2	19.7
RAD18	RNF73	ENSG00000070950	"RAD18, E3 ubiquitin protein ligase"	Q9NS91	3	8775402-8963773	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"DNA damage, DNA repair, Ubl conjugation pathway"	"DNA-binding, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006716, HPA006724, HPA008752"	Supported	Approved	Enhanced	"Nucleoplasm,Nuclear bodies"		NA	NA			"Nucleoplasm, Nuclear bodies"		"HPA006716: AB_2667650, HPA006724: AB_2667655, HPA008752: AB_2668129"	"unprognostic (1.26e-1)"	"unprognostic (1.07e-1)"	"unprognostic (4.45e-2)"	"unprognostic (1.25e-3)"	"unprognostic (2.73e-2)"	"unprognostic (6.15e-2)"	"prognostic unfavorable (1.12e-4)"	"unprognostic (2.01e-1)"	"unprognostic (9.76e-2)"	"unprognostic (1.17e-1)"	"unprognostic (2.02e-2)"	"prognostic unfavorable (3.73e-4)"	"prognostic unfavorable (3.65e-5)"	"unprognostic (1.97e-2)"	"unprognostic (1.51e-1)"	"unprognostic (7.92e-2)"	"unprognostic (1.89e-2)"	6.2	5.7	7.4	5.6	12.7	7.9	9.5	16.4	11.4	5.5	6.6	3.9	5.4	17.7	6.5	3.7	7.6	4.9	5.6	4.4	4.7	3.3	4.3	5.7	5.9	7.6	8.4	6.9	7.1	4.2	3.4	6.9	6.9	5.7	7.4	9.0	3.5	7.5	3.5	3.7	8.5	10.5	6.0	7.8	8.5	5.1	9.5	9.8	16.6	6.7	4.7	7.5	6.1	6.8	3.7	6.3	8.7	3.0	4.3	5.5	1.5	9.9	9.4	7.9	4.7	2.0	4.2	9.7	15.8	5.4	15.2	10.5	8.6	6.4	12.3	3.0	8.9	8.9	3.5	8.3	8.2	15.6	7.6	10.5	10.4	9.5	5.1	1.2	13.7	9.0	1.6	3.0	15.0	10.2	4.1	4.9	10.5	11.1	12.2	13.3	11.5	13.9	9.8	11.0	7.9	17.4	11.1	8.8	9.7	4.4	7.7	3.3	7.5	7.0	6.8	5.1	6.5	7.0	6.1	4.0	12.7	6.9	10.7	13.5	6.2	9.4	26.7	9.3	15.3	9.3	7.4	2.7	8.7	3.0	3.0	5.5	3.7	4.0	5.2	3.4	3.7	4.3	3.2	1.2	4.3	1.8	6.3	5.0	1.5	7.4	12.7	16.4	11.4	4.7	3.3	8.4	6.9	5.7	9.8	14.9	9.8	8.2	5.8	9.8	5.1	2.0	5.1	4.0	9.1	3.5	2.0	6.6	1.7	6.5	3.3	4.2	3.8	0.0	7.1	10.7	4.3	7.0	12.8	2.9	5.9	3.2	1.7	4.9	3.7	2.1	3.7	4.6	3.3	7.2	5.0	2.8	7.9	5.8	2.5	2.4	2.2	6.5	4.7	15.5	13.6	10.3	5.6	4.6	5.2	2.7
RAD54L2	"ARIP4, KIAA0809, SRISNF2L"	ENSG00000164080	"RAD54 like 2"	Q9Y4B4	3	51541144-51668667	"Enzymes, Predicted intracellular proteins"		"DNA-binding, Helicase, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035004, HPA039992, HPA077351"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA035004: AB_10671930, HPA039992: AB_2676789, HPA077351: "	"unprognostic (1.46e-2)"	"unprognostic (3.67e-2)"	"unprognostic (2.61e-1)"	"unprognostic (5.01e-2)"	"unprognostic (1.15e-1)"	"unprognostic (4.38e-2)"	"unprognostic (1.63e-1)"	"unprognostic (1.45e-2)"	"unprognostic (9.24e-2)"	"unprognostic (2.76e-1)"	"unprognostic (1.59e-1)"	"unprognostic (1.51e-1)"	"prognostic favorable (1.71e-5)"	"unprognostic (3.72e-2)"	"unprognostic (3.19e-1)"	"unprognostic (3.30e-2)"	"unprognostic (6.63e-2)"	4.4	4.1	3.3	3.5	4.3	5.2	4.1	7.8	4.3	3.6	4.4			2.2	5.3	4.6	3.6	3.9	2.5	3.1	3.4	3.5	3.4	8.8	4.2	3.8	3.4		5.6	5.0	5.3	3.9	4.9		3.8	3.5		3.7	4.2	7.3	4.6	4.1	4.3	4.1	4.7	4.4	4.7			4.2		5.2	3.8	3.5	6.9	5.2	6.5	7.1	6.3	8.3	4.0	5.6	4.4	11.4	11.2	6.4	4.6	6.0	4.8	6.8	6.6	6.3	7.8	3.3	14.8	1.4	8.4	6.9	4.4	17.9	6.0	8.2	7.8	4.0	12.7	9.5	5.1	5.8	14.1	7.6	5.2	4.8	10.1	9.8	4.2	7.3	12.9	8.3	8.1	5.2	4.3	12.6	6.4	9.0	2.8	4.8	5.8	8.8	2.0	3.3	7.3	4.7	8.9	7.6	7.3	4.9	7.2	4.7	8.5	9.5	7.0	8.0	7.1	9.3	8.7	8.8	15.0	7.5	8.0	8.8	6.5	4.8	4.7	8.1	6.0	8.3	4.3	7.1	6.6	5.2	6.9	4.7	5.4	2.2	6.3	7.1	5.2	6.3	4.0											8.9	11.8	9.0	6.6	8.1	33.3	9.7	10.2	10.7	7.9	8.7	29.5	13.5	1.7	8.3	6.1	11.1	4.2	0.0	9.0	7.3	8.0	8.9	17.4	20.7	7.7	44.5	15.6	11.1	11.4	1.9	14.1	6.8	13.5	4.6	6.8	10.4	10.2	6.2	15.9	3.4	31.5	12.9	9.2	37.2	39.4	7.9	24.8	9.6	7.0	9.8
RAD9A	RAD9	ENSG00000172613	"RAD9 checkpoint clamp component A"	Q99638	11	67317871-67398410	"Enzymes, Predicted intracellular proteins"	"DNA damage"	"Exonuclease, Hydrolase, Nuclease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006725, HPA048155"	Enhanced		Supported	Nucleoplasm		NA	NA			Nucleoplasm		"HPA006725: AB_1856041, HPA048155: AB_2680290"	"unprognostic (7.64e-2)"	"prognostic favorable (6.95e-4)"	"unprognostic (8.83e-3)"	"unprognostic (1.13e-1)"	"unprognostic (2.68e-1)"	"unprognostic (2.12e-3)"	"unprognostic (9.64e-3)"	"unprognostic (1.05e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.97e-1)"	"unprognostic (9.19e-2)"	"unprognostic (2.50e-2)"	"prognostic unfavorable (2.82e-5)"	"unprognostic (6.16e-2)"	"unprognostic (3.72e-3)"	"unprognostic (2.19e-1)"	"prognostic favorable (7.52e-6)"	5.4	5.2	7.0	10.6	8.4	10.8	6.1	7.7	6.3	6.7	11.8	8.5	5.1	14.2	7.1	4.1	8.2	12.1	6.3	6.1	3.8	3.5	6.9	9.4	9.5	9.0	7.8	2.5	6.8	20.1	3.7	7.2	10.2	5.5	8.6	3.3	4.9	12.8	8.1	7.8	12.8	17.5	5.5	4.1	10.7	11.3	7.2	6.0	18.2	11.7	7.2	16.8	6.2	7.1	6.7	5.1	8.9	3.9	4.7	9.0	3.2	6.7	11.0	5.8	8.3	1.7	0.8	7.8	4.3	2.9	5.0	4.3	13.1	12.9	8.1	8.1	0.9	7.9	11.4	3.4	3.3	0.7	7.7	9.5	10.9	5.9	6.5	2.4	7.1	14.4	2.1	3.3	4.3	1.8	3.1	3.3	15.3	8.8	9.0	1.0	20.9	13.8	13.8	8.8	9.4	8.3	11.5	7.9	9.2	1.3	5.4	6.7	7.2	6.0	16.4	13.6	1.3	11.6	6.8	2.5	7.2	9.4	14.6	5.1	9.6	8.9	7.0	4.8	7.0	5.9	8.0	3.2	8.9	9.0	3.6	6.4	6.7	7.2	7.3	2.1	5.3	4.9	5.7	4.7	4.7	3.9	5.1	3.9	3.2	7.0	8.4	7.7	6.3	3.8	3.5	7.8	2.5	5.5	6.0	20.8	17.9	32.3	16.6	15.1	18.1	0.8	12.7	29.4	23.9	19.2	66.8	21.0	11.6	10.1	18.0	13.7	57.3	0.0	11.5	18.5	14.7	20.0	19.7	5.9	13.4	20.6	13.7	8.6	7.1	9.4	9.8	22.6	18.6	4.6	18.9	14.0	9.0	24.6	11.7	6.9	31.2	12.9	9.7	27.6	15.0	15.2	34.0	41.5	24.0	11.9
RAF1	"c-Raf, CRAF, Raf-1"	ENSG00000132155	"Raf-1 proto-oncogene, serine/threonine kinase"	P04049	3	12583601-12664226	"Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins, RAS pathway related proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes, Cardiomyopathy, Deafness, Disease mutation, FDA approved drug targets, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"neutrophil: 53.9"	"Lineage enriched"	"Detected in all"	5	"granulocytes: 53.9"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002640, CAB019291"	Approved		Approved	"Nuclear speckles"		NA	NA			"Nuclear speckles"		"CAB019291: , HPA002640: AB_1856047"	"unprognostic (6.33e-2)"	"unprognostic (1.29e-1)"	"unprognostic (5.92e-2)"	"unprognostic (2.17e-3)"	"unprognostic (6.51e-3)"	"unprognostic (7.66e-3)"	"unprognostic (2.66e-3)"	"unprognostic (1.53e-2)"	"unprognostic (2.72e-1)"	"unprognostic (7.66e-2)"	"unprognostic (2.92e-2)"	"unprognostic (1.29e-2)"	"unprognostic (2.79e-2)"	"unprognostic (1.79e-1)"	"unprognostic (1.27e-1)"	"unprognostic (2.64e-2)"	"unprognostic (2.36e-2)"	19.5	15.6	15.1	14.7	17.1	32.2	17.5	35.2	18.9	19.9	20.3	21.1	19.6	18.4	24.9	15.7	24.6	18.6	20.2	39.3	15.3	11.0	21.7	36.2	19.7	15.7	16.0	13.4	24.9	31.3	30.7	16.9	24.8	14.3	18.8	19.2	25.0	18.3	18.4	79.7	23.9	29.6	23.7	13.8	22.1	23.7	16.7	17.8	27.7	26.9	27.9	26.1	20.5	20.4	6.6	9.3	53.9	9.9	8.5	8.6	7.7	15.4	17.8	27.1	21.0	23.6	19.1	54.6	23.6	40.0	31.3	35.5	13.9	12.8	16.2	11.3	36.5	16.9	9.9	28.5	20.9	32.6	28.3	22.4	21.8	21.4	12.9	23.9	21.2	20.7	17.6	21.2	32.2	26.1	21.6	22.4	24.9	15.8	42.6	30.1	26.4	27.2	15.7	27.6	19.3	24.2	22.0	23.8	20.4	18.7	23.4	8.5	17.8	19.3	18.7	12.5	22.0	31.0	28.1	16.0	21.5	20.5	18.0	26.2	33.2	52.9	34.9	18.5	24.8	22.8	11.3	9.7	18.4	7.4	9.9	7.5	6.6	7.3	7.2	9.3	6.3	7.5	7.6	53.9	8.5	9.6	4.2	8.6	7.7	15.1	17.1	35.2	18.9	15.3	11.0	16.0	13.4	14.3	17.8	20.8	36.5	39.7	31.1	30.6	51.6	25.8	28.1	25.4	21.6	26.2	62.8	34.3	11.6	22.9	7.1	29.1	32.5	0.0	32.0	39.8	32.9	38.2	33.5	36.5	25.2	41.3	28.2	31.3	36.8	3.4	36.2	34.2	25.3	29.7	29.6	32.1	28.8	34.8	38.9	15.7	84.2	32.3	33.0	17.7	27.4	38.0	52.1	38.3	29.5	36.9
RAG1	"MGC43321, RNF74"	ENSG00000166349	"Recombination activating 1"	P15918	11	36510709-36593156	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"DNA recombination, Ubl conjugation pathway"	"Chromatin regulator, DNA-binding, Endonuclease, Hydrolase, Multifunctional enzyme, Nuclease, Transferase"	"Disease mutation, SCID"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	62	"lymphoid tissue: 462.4"	"Cell type enhanced"	"Detected in some"	12	"Distal tubular cells: 3.3;Ito cells: 9.2"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"MAIT T-cell: 1.1"	"Low lineage specificity"	"Detected in single"			"Group enriched"	"Detected in some"	5	"MOLT-4: 67.2;REH: 64.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA043939			Supported	Nucleoplasm		NA	NA			Nucleoplasm		"HPA043939: AB_2732512"	"unprognostic (7.35e-2)"	"unprognostic (1.57e-3)"	"unprognostic (8.75e-2)"	"unprognostic (3.44e-1)"	"unprognostic (2.14e-1)"	"unprognostic (1.46e-2)"	"unprognostic (2.30e-1)"	"unprognostic (1.70e-2)"	"unprognostic (1.43e-1)"	"unprognostic (1.54e-2)"	"unprognostic (5.98e-3)"	"unprognostic (1.28e-1)"	"unprognostic (1.16e-9)"	"unprognostic (2.16e-2)"	"unprognostic (1.04e-1)"	"unprognostic (2.53e-4)"	"unprognostic (1.53e-1)"	0.7	2.3	0.5	0.5	0.5	7.4	0.7	0.5	0.5	0.5	0.6	0.5	0.5	1.2	0.5	1.3	0.5	0.6	0.5	0.6	0.5	0.2	2.4	1.2	0.8	0.5	0.5	0.5	0.6	1.1	1.9	0.5	0.8	0.5	0.5	0.4	0.5	1.5	0.5	0.5	0.2	1.5	0.5	0.5	4.4	0.8	0.9	0.5	462.4	4.5	0.5	0.8	0.7	0.5	0.2	0.3	0.0	0.0	0.2	1.1	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.1	13.4	0.0	0.0	0.1	0.0	67.2	0.0	0.5	0.0	0.0	64.2	0.0	0.3	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.5	0.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	1.1	0.0	0.0	0.8	0.0	0.2	0.1	0.1	0.0	0.2	0.0	0.3	0.0	0.0	0.5	0.5	0.5	0.5	0.5	0.2	0.5	0.5	0.5	0.5	0.0	0.0	0.0	1.0	0.1	1.2	0.8	0.0	0.0	0.0	1.8	0.0	0.2	3.3	0.4	1.7	1.5	1.4	0.0	0.4	0.1	0.2	0.3	0.0	1.7	0.3	0.0	0.0	9.2	1.6	1.3	0.0	0.0	0.0	1.8	0.6	0.1	0.7	0.0	0.0	2.1	0.8	0.0	0.4	1.2	0.7	0.4	0.3	0.0	0.4	0.5
RARS	DALRD1	ENSG00000113643	"Arginyl-tRNA synthetase"	P54136	5	168486445-168519299	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Protein biosynthesis"	"Aminoacyl-tRNA synthetase, Ligase"	"Disease mutation, Leukodystrophy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003979, HPA004130"	Approved		Enhanced	Nucleoplasm,Cytosol		NA	NA			Cytosol	Nucleoplasm	"HPA003979: AB_1856083, HPA004130: AB_1856084"	"unprognostic (1.06e-2)"	"unprognostic (1.92e-2)"	"unprognostic (2.74e-3)"	"unprognostic (2.82e-2)"	"unprognostic (2.50e-1)"	"prognostic unfavorable (7.59e-5)"	"prognostic unfavorable (1.10e-8)"	"unprognostic (3.26e-3)"	"unprognostic (5.16e-1)"	"unprognostic (4.22e-2)"	"unprognostic (2.92e-2)"	"unprognostic (4.27e-2)"	"unprognostic (5.43e-2)"	"unprognostic (6.43e-2)"	"unprognostic (2.35e-1)"	"unprognostic (2.39e-1)"	"unprognostic (1.33e-2)"	21.8	26.3	16.0	18.3	15.3	6.2	22.6	17.1	18.4	21.2	29.4	9.1	20.4	33.3	22.9	21.4	34.7	19.5	14.4	21.7	19.8	12.3	29.8	33.5	18.7	18.6	13.9	15.2	21.3	33.0	19.9	34.5	30.3	15.8	18.9	27.4	15.5	34.0	15.4	27.8	27.9	48.7	21.5	14.5	22.1	24.4	17.2	11.8	20.5	21.5	32.3	23.7	22.4	22.6	11.1	21.8	5.2	17.7	16.8	16.3	11.7	27.2	32.4	24.0	26.6	33.2	38.1	41.3	40.2	34.6	41.9	49.0	55.0	29.8	29.0	33.0	38.2	43.1	26.5	31.4	54.1	54.7	30.1	21.6	19.5	29.5	34.5	28.8	46.0	20.8	29.2	28.9	45.6	21.9	25.8	33.5	15.9	29.1	14.7	44.8	25.2	19.1	18.3	39.4	24.0	22.1	8.4	35.0	27.6	37.3	31.1	22.9	28.2	30.7	35.5	41.5	30.5	32.3	19.3	33.2	30.4	27.9	23.4	46.8	14.7	26.9	29.8	33.1	32.9	28.8	3.4	14.4	5.2	12.5	17.7	14.3	11.1	12.6	13.3	21.8	6.6	15.6	16.3	4.0	16.8	16.4	10.3	12.8	11.7	16.0	15.3	17.1	18.4	19.8	12.3	13.9	15.2	15.8	11.8	53.6	32.3	25.1	37.6	26.3	25.0	43.6	35.7	46.8	39.8	24.4	25.5	88.8	14.9	80.1	16.6	27.5	40.6	23.3	83.1	79.2	34.8	24.5	26.6	31.4	51.1	12.7	12.6	33.2	24.6	11.6	23.0	35.0	27.0	72.1	36.7	22.7	61.2	38.7	23.0	36.0	22.7	19.4	28.9	27.7	42.2	31.1	70.5	20.1	44.8	35.2
RARS2	"DALRD2, dJ382I10.6, MGC14993, MGC23778, PRO1992, RARSL"	ENSG00000146282	"Arginyl-tRNA synthetase 2, mitochondrial"	Q5T160	6	87514378-87590003	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Protein biosynthesis"	"Aminoacyl-tRNA synthetase, Ligase"	"Neurodegeneration, Pontocerebellar hypoplasia"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039987, HPA042645"	Uncertain		Approved	Mitochondria		NA	NA			Mitochondria		"HPA039987: AB_2676786, HPA042645: AB_2678097"	"unprognostic (1.49e-2)"	"unprognostic (1.08e-1)"	"unprognostic (5.03e-2)"	"unprognostic (6.98e-2)"	"unprognostic (9.27e-2)"	"unprognostic (5.41e-2)"	"unprognostic (6.61e-2)"	"unprognostic (4.30e-2)"	"unprognostic (1.88e-1)"	"unprognostic (1.08e-3)"	"unprognostic (8.28e-2)"	"unprognostic (2.20e-1)"	"unprognostic (7.56e-3)"	"unprognostic (1.62e-1)"	"unprognostic (1.89e-2)"	"unprognostic (5.73e-2)"	"unprognostic (7.16e-3)"	27.0	44.1	13.3	21.1	15.9	16.0	22.9	24.0	17.3	25.1	21.4	18.6	25.2	17.5	35.5	25.5	20.4	21.1	19.2	21.5	14.4	12.8	23.7	32.1	20.5	24.4	17.3	14.2	22.2	30.1	20.5	36.9	28.3	17.2	20.7	23.1	24.0	23.5	27.7	23.0	20.4	30.5	24.7	16.8	21.1	20.5	23.9	13.6	28.0	21.2	20.5	27.3	24.3	20.2	16.7	18.9	22.8	20.2	18.1	28.8	16.2	10.1	10.1	24.3	26.4	24.7	27.0	17.3	24.4	29.2	16.9	21.5	19.4	11.4	12.9	14.5	25.0	17.1	14.2	20.4	14.0	24.0	9.5	19.3	13.3	12.8	30.8	31.1	15.7	11.5	26.9	13.6	14.2	18.1	23.7	22.2	13.6	30.7	12.8	24.9	18.7	5.1	16.7	15.8	21.8	10.9	10.3	24.5	11.3	20.8	21.4	22.0	29.7	12.8	6.4	17.1	21.4	11.9	24.0	15.1	11.2	9.0	12.3	20.1	13.6	22.8	10.7	17.6	16.6	19.4	15.9	19.1	22.8	18.1	19.3	21.3	16.7	23.4	17.0	16.7	16.2	23.0	19.1	11.6	18.1	20.2	18.9	28.8	16.2	13.3	15.9	24.0	17.3	14.4	12.8	17.3	14.2	17.2	13.6	17.9	14.1	14.5	30.7	15.3	13.2	19.7	7.6	20.1	26.1	10.4	19.6	27.0	38.1	25.7	69.3	24.2	16.2	0.0	41.3	37.9	29.7	24.9	17.4	13.2	18.2	6.4	8.6	22.7	14.8	27.7	23.6	14.2	18.6	22.6	23.2	12.1	29.9	21.8	22.6	23.7	15.6	25.8	24.7	38.7	31.1	15.7	33.1	21.8	24.1	29.1
RBBP6	"P2P-R, PACT, SNAMA"	ENSG00000122257	"RB binding protein 6, ubiquitin ligase"	Q7Z6E9	16	24537693-24572863	"Enzymes, Predicted intracellular proteins"	"DNA damage, DNA replication, Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB032866, HPA041725, HPA043544"	Approved		Enhanced	"Nuclear speckles"		NA	NA			"Nuclear speckles"		"CAB032866: AB_2177791, HPA041725: AB_2677639, HPA043544: AB_2678543"	"unprognostic (1.04e-1)"	"unprognostic (5.08e-2)"	"unprognostic (3.35e-1)"	"unprognostic (3.85e-2)"	"unprognostic (1.97e-2)"	"unprognostic (2.15e-2)"	"unprognostic (1.08e-2)"	"unprognostic (6.60e-2)"	"unprognostic (2.70e-3)"	"unprognostic (1.29e-2)"	"unprognostic (1.77e-1)"	"unprognostic (2.01e-2)"	"unprognostic (1.21e-2)"	"unprognostic (1.44e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.22e-1)"	"unprognostic (2.83e-2)"	15.1	17.6	17.2	14.0	16.4	81.4	17.9	33.0	15.7	17.8	18.8	16.3	19.8	10.2	23.2	18.7	15.3	21.2	17.6	14.7	15.0	13.2	13.1	15.8	15.7	18.1	18.7	12.2	27.2	14.4	20.7	23.1	73.9	15.4	18.2	14.4	18.4	13.7	14.7	19.2	19.2	16.4	18.4	19.2	18.6	16.4	25.1	18.7	24.3	18.6	11.8	15.5	17.9	17.9	3.8	6.9	8.5	3.7	6.5	4.2	1.0	17.7	9.3	21.9	22.8	16.8	17.6	23.8	14.4	13.3	13.2	14.3	10.3	14.4	24.7	10.9	12.2	15.1	17.2	23.5	12.5	21.9	13.5	18.2	21.3	26.7	29.3	13.1	28.2	12.7	15.2	17.5	17.2	20.3	14.9	18.9	21.7	26.7	22.6	15.2	18.3	22.7	25.5	25.2	12.0	8.8	31.4	22.3	21.7	12.7	15.9	17.6	15.4	20.3	18.2	25.5	25.5	14.2	25.1	16.3	16.4	12.1	14.1	15.4	20.1	20.0	31.2	13.2	18.8	13.5	8.5	2.3	3.7	4.0	3.7	4.2	3.8	4.1	2.8	1.6	3.8	3.5	4.0	5.0	6.5	2.1	6.9	3.1	1.0	17.2	16.4	33.0	15.7	15.0	13.2	18.7	12.2	15.4	18.7	80.4	103.7	61.9	93.7	89.4	65.1	127.0	28.1	61.6	67.1	26.2	94.2	37.6	21.6	42.4	225.8	76.4	57.3	46.7	41.4	46.4	91.5	72.4	49.7	50.4	33.6	58.8	78.7	66.3	46.7	20.2	67.0	54.3	59.1	55.1	59.4	50.8	43.9	28.1	55.2	17.7	56.2	51.8	113.1	66.6	47.7	89.0	84.9	56.5	56.8	89.7
RBCK1	"C20orf18, HOIL1, RBCK2, RNF54, UBCE7IP3, XAP4, ZRANB4"	ENSG00000125826	"RANBP2-type and C3HC4-type zinc finger containing 1"	Q9BYM8	20	407498-430966	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Host-virus interaction, Ubl conjugation pathway"	Transferase	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"hTCEpi: 64.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA						"unprognostic (1.94e-2)"	"unprognostic (2.50e-1)"	"unprognostic (1.62e-2)"	"unprognostic (2.07e-2)"	"unprognostic (2.61e-1)"	"unprognostic (1.92e-1)"	"unprognostic (1.54e-3)"	"unprognostic (1.15e-2)"	"unprognostic (7.89e-2)"	"unprognostic (3.44e-1)"	"unprognostic (1.22e-1)"	"unprognostic (2.63e-2)"	"prognostic unfavorable (7.41e-9)"	"unprognostic (5.87e-2)"	"unprognostic (3.64e-2)"	"unprognostic (3.33e-2)"	"unprognostic (2.39e-3)"	24.6	36.4	18.8	30.7	23.9	24.2	26.0	40.2	18.8	21.4	34.0	25.4	22.5	31.9	25.7	29.7	27.6	23.5	31.4	23.2	18.6	15.1	28.1	53.0	31.3	29.8	27.2	19.1	28.9	28.7	22.9	28.9	30.5	19.1	28.0	17.5	18.2	39.7	30.4	21.7	27.1	43.3	20.9	20.9	34.6	25.0	18.2	24.3	44.4	26.2	18.5	19.4	23.4	23.3	17.5	26.6	50.3	30.1	18.5	23.2	18.4	18.5	22.3	5.5	9.6	10.1	13.4	14.7	11.7	13.8	14.3	18.8	13.0	18.6	9.3	15.0	16.8	26.8	16.7	6.6	37.4	4.9	6.8	9.4	8.2	5.1	35.4	46.2	8.1	6.1	19.9	64.3	10.3	44.7	16.6	13.7	31.1	7.9	14.2	9.4	8.4	15.2	21.7	5.4	18.8	22.7	11.6	7.1	10.5	18.4	13.9	11.3	11.5	8.4	30.0	36.4	6.7	17.4	16.2	9.4	13.2	7.7	9.1	13.1	12.8	15.6	10.0	7.2	16.1	9.7	17.3	18.9	30.1	23.2	24.8	16.8	17.5	18.3	23.1	16.3	16.0	15.2	17.6	50.3	18.5	30.1	26.6	19.5	18.4	18.8	23.9	40.2	18.8	18.6	15.1	27.2	19.1	19.1	24.3	29.8	35.7	52.5	67.0	39.5	14.8	17.8	76.5	25.4	17.0	54.1	15.7	75.1	53.0	98.6	46.1	55.4	110.5	0.0	100.3	81.8	51.2	75.5	43.8	107.5	59.0	15.9	59.2	58.9	64.9	123.1	60.9	53.8	40.5	63.1	107.7	31.1	92.7	77.0	44.9	53.2	28.5	45.3	46.7	33.7	23.2	35.1	79.2	69.2	68.2	102.3
RBKS	"DKFZp686G13268, RBSK"	ENSG00000171174	Ribokinase	Q9H477	2	27781364-27891098	"Enzymes, Predicted intracellular proteins"	"Carbohydrate metabolism"	"Kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	9	"Ciliated cells: 57.6;Proximal tubular cells: 88.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"EFO-21: 10.5;RPTEC TERT1: 22.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019725, HPA028285"	Enhanced		Approved	Nucleoplasm,Cytosol		No	No			Cytosol	Nucleoplasm	"HPA019725: AB_1856105, HPA028285: AB_10601480"	"unprognostic (1.25e-1)"	"unprognostic (2.16e-1)"	"unprognostic (2.51e-2)"	"unprognostic (5.54e-3)"	"unprognostic (4.15e-3)"	"unprognostic (2.44e-1)"	"unprognostic (1.43e-2)"	"unprognostic (4.77e-2)"	"unprognostic (2.45e-1)"	"unprognostic (5.35e-2)"	"unprognostic (1.46e-1)"	"unprognostic (3.98e-1)"	"unprognostic (1.20e-1)"	"unprognostic (1.19e-1)"	"unprognostic (1.72e-1)"	"unprognostic (1.74e-1)"	"unprognostic (9.27e-2)"	14.4	22.2	2.5	2.4	5.2	4.1	2.2	2.1	4.1	2.6	3.0	1.7	4.9	12.4	4.7	4.7	3.1	7.4	10.7	3.5	3.7	4.3	15.1	22.6	10.4	0.8	3.0	2.4	24.2	2.4	3.5	10.3	6.2	12.3	6.9	2.4	2.2	1.4	16.8	7.6	1.0	11.8	3.8	4.7	1.7	1.6	4.8	1.4	0.3	4.5	2.8	1.1	4.8	12.0	5.8	5.1	5.6	3.8	4.9	6.5	3.4	3.1	2.1	0.3	0.4	0.4	0.7	2.1	0.8	0.6	0.4	0.6	4.8	1.5	1.1	10.5	1.7	1.5	1.3	0.2	1.0	0.8	0.4	0.2	0.1	0.5	4.1	1.6	0.9	0.2	1.0	1.7	2.7	3.7	0.7	0.6	1.9	0.1	1.3	2.0	4.1	0.7	2.3	0.0	2.1	1.7	0.9	0.2	0.7	22.1	0.2	0.9	1.2	2.9	4.0	1.7	1.1	1.8	4.6	0.2	0.7	0.5	1.9	1.2	6.7	7.9	2.1	1.9	3.1	0.1	5.6	3.8	1.9	3.0	1.6	6.1	5.8	4.0	6.5	5.1	4.6	4.2	3.6	5.6	4.9	0.8	0.8	5.8	3.4	2.5	5.2	2.1	4.1	3.7	4.3	3.0	2.4	12.3	1.4	6.0	5.3	1.9	2.8	1.8	10.3	6.4	2.5	57.6	7.9	17.4	3.9	3.3	39.7	9.3	26.8	4.1	18.8	0.0	11.1	1.1	1.9	1.1	2.3	25.3	5.5	7.9	3.5	1.8	1.8	21.9	1.4	7.2	1.7	2.8	3.2	12.1	7.7	7.0	2.5	88.0	18.7	0.0	2.1	15.4	14.5	1.4	1.3	5.0	6.4	1.7
RBP3	"D10S64, D10S65, D10S66, RP66"	ENSG00000265203	"Retinol binding protein 3"	P10745	10	47348371-47357875	"Disease related genes, Enzymes, Potential drug targets, Predicted secreted proteins"	Transport		"Disease mutation, Retinitis pigmentosa"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	45	"retina: 135.2"	"Group enriched"	"Detected in some"	12	"Cone photoreceptor cells: 1949.7;Rod photoreceptor cells: 1076.2"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"HaCaT: 2.7;HDLM-2: 2.5;SH-SY5Y: 2.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA041301, HPA044239"	Enhanced				"Secreted in other tissues"	NA	NA					"HPA041301: AB_2677398, HPA044239: AB_2678868"	"unprognostic (3.48e-2)"	"unprognostic (4.78e-3)"	"unprognostic (1.36e-2)"		"unprognostic (4.02e-2)"	"unprognostic (1.40e-1)"		"unprognostic (1.58e-2)"		"unprognostic (5.09e-2)"	"unprognostic (5.14e-3)"			"unprognostic (7.44e-2)"	"unprognostic (1.23e-1)"		"unprognostic (4.68e-3)"	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	3.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.0	0.0	135.2	0.0	0.0	0.0	0.5	1.9	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	2.1	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	125.3	0.3	0.0	0.0	0.0	0.0	1949.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	41.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	104.8	0.0	0.0	0.0	0.0	1076.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
RBX1	"BA554C12.1, RNF75, ROC1"	ENSG00000100387	"Ring-box 1"	P62877	22	40951347-40973309	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"DNA damage, DNA repair, Host-virus interaction, Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003038			Supported	Nucleoplasm		NA	NA			Nucleoplasm		"HPA003038: AB_1079827"	"unprognostic (2.34e-1)"	"unprognostic (1.54e-2)"	"unprognostic (1.31e-1)"	"unprognostic (1.60e-3)"	"unprognostic (2.30e-1)"	"unprognostic (2.92e-2)"	"unprognostic (1.82e-3)"	"unprognostic (1.74e-1)"	"unprognostic (6.61e-2)"	"prognostic favorable (6.63e-4)"	"unprognostic (5.01e-3)"	"unprognostic (2.19e-1)"	"unprognostic (4.99e-3)"	"unprognostic (2.22e-2)"	"unprognostic (1.34e-1)"	"unprognostic (4.57e-2)"	"unprognostic (3.05e-2)"	24.1	27.9	41.6	22.2	35.3	37.6	32.9	28.0	35.7	23.0	22.7	27.4	15.8	18.4	19.4	43.7	27.6	21.2	16.6	39.2	38.3	37.4	34.2	28.3	23.6	28.1	40.4	22.3	18.5	15.6	12.3	19.5	54.1	32.4	20.3	23.9	22.1	21.3	20.8	46.5	21.8	23.0	23.2	45.2	26.4	21.4	16.4	24.8	31.7	31.1	37.4	34.4	19.5	19.4	33.4	60.7	32.2	41.5	23.9	38.5	62.6	31.4	18.0	34.0	16.9	24.2	29.0	19.2	25.4	23.3	38.3	33.9	29.1	15.2	27.6	17.2	24.9	15.4	18.0	32.3	29.0	40.5	32.1	51.5	17.1	26.4	35.5	20.8	41.7	22.2	24.0	23.5	27.7	20.1	21.9	32.4	16.9	20.2	28.1	33.7	38.6	25.0	48.1	18.7	62.3	19.0	32.9	23.6	34.7	43.7	20.4	16.1	10.4	22.3	22.4	22.7	19.9	19.3	28.7	21.5	23.3	24.1	19.5	24.1	23.9	21.9	40.9	29.3	21.3	25.9	32.2	37.2	29.9	24.7	37.0	23.1	33.4	30.9	26.0	37.6	29.4	27.0	29.2	12.6	23.9	41.5	60.7	38.5	62.6	41.6	35.3	28.0	35.7	38.3	37.4	40.4	22.3	32.4	24.8	214.4	129.3	179.4	176.3	267.3	89.0	482.7	183.4	214.2	152.4	212.9	23.6	426.2	431.0	299.7	34.9	245.1	200.1	537.3	290.2	543.9	259.5	193.3	126.0	227.4	379.6	84.2	155.8	166.3	230.6	64.7	172.0	279.5	323.9	596.9	175.3	142.8	316.2	192.9	166.6	432.2	119.9	116.4	233.8	222.2	235.9	324.0	565.2	152.3	178.9	211.6
RC3H2	"FLJ20301, FLJ20713, MNAB, RNF164"	ENSG00000056586	"Ring finger and CCCH-type domains 2"	Q9HBD1	9	122844556-122905341	"Enzymes, Predicted intracellular proteins, Transcription factors"	"Ubl conjugation pathway"	"Repressor, RNA-binding, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042863, HPA062144"	Approved		Enhanced	Vesicles		NA	NA			Vesicles		"HPA042863: AB_2678204, HPA062144: AB_2732677"	"unprognostic (6.05e-2)"	"unprognostic (7.87e-2)"	"unprognostic (7.24e-2)"	"unprognostic (1.66e-1)"	"unprognostic (4.08e-3)"	"unprognostic (2.37e-1)"	"unprognostic (2.43e-2)"	"unprognostic (3.92e-2)"	"unprognostic (1.99e-1)"	"unprognostic (1.57e-1)"	"unprognostic (1.80e-1)"	"unprognostic (1.21e-1)"	"prognostic favorable (5.50e-4)"	"unprognostic (1.36e-1)"	"unprognostic (1.68e-1)"	"unprognostic (2.16e-1)"	"unprognostic (1.26e-1)"	16.4	10.7	25.4	14.1	28.8	30.6	14.1	18.7	27.6	17.1	13.0	10.5	14.4	11.0	14.6	9.7	16.5	12.2	12.6	15.7	18.1	11.2	15.0	14.8	16.2	19.2	12.3	25.3	14.7	9.7	19.0	16.2	16.3	12.6	11.5	13.1	9.4	13.2	13.9	16.1	13.8	13.0	16.3	14.4	15.2	12.8	12.8	13.2	18.9	15.0	11.5	18.8	14.1	13.7	8.6	9.6	12.4	10.4	4.9	8.9	3.7	10.0	14.7	19.5	10.5	10.4	12.4	10.9	12.8	14.1	15.2	13.3	17.7	10.7	16.8	10.5	17.1	17.8	23.6	20.9	15.1	16.7	7.7	8.3	9.6	26.4	11.7	13.7	11.4	15.4	11.9	14.7	14.8	21.0	12.6	20.8	14.6	13.5	12.4	19.2	13.5	11.1	8.0	9.7	13.6	13.6	11.2	32.3	10.8	14.8	8.0	23.0	16.0	22.8	14.1	11.6	14.1	16.9	9.6	20.6	11.7	9.9	15.9	22.9	8.7	14.1	18.4	13.4	10.1	13.2	12.4	6.6	8.5	8.9	10.4	7.3	6.5	7.3	8.9	5.8	8.6	7.0	6.8	11.8	4.9	9.3	9.6	7.1	3.7	25.4	28.8	18.7	27.6	18.1	11.2	12.3	25.3	12.6	13.2	38.7	32.8	12.8	10.7	9.7	18.4	31.3	12.7	12.0	11.4	8.7	35.3	12.6	3.3	10.7	4.0	26.6	12.3	0.0	10.0	12.7	13.4	18.1	16.2	12.4	8.5	27.0	22.3	31.9	20.4	6.4	12.4	15.0	13.5	15.4	22.4	15.8	18.0	3.5	17.0	11.0	17.8	19.4	15.6	25.0	12.6	12.9	19.2	30.2	13.2	22.7
RCE1	"FACE-2, FACE2, hRCE1, RCE1A, RCE1B"	ENSG00000173653	"Ras converting CAAX endopeptidase 1"	Q9Y256	11	66842835-66846546	"Enzymes, Predicted membrane proteins"		"Hydrolase, Protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA074124	Approved					NA	NA					"HPA074124: "	"unprognostic (1.11e-1)"	"unprognostic (7.23e-2)"	"unprognostic (1.15e-1)"	"unprognostic (8.16e-3)"	"unprognostic (3.11e-1)"	"unprognostic (6.40e-3)"	"unprognostic (1.98e-3)"	"unprognostic (7.69e-3)"	"unprognostic (1.39e-1)"	"unprognostic (9.14e-3)"	"unprognostic (2.35e-3)"	"unprognostic (5.31e-3)"	"unprognostic (1.06e-1)"	"unprognostic (4.48e-3)"	"unprognostic (2.17e-2)"	"unprognostic (1.04e-1)"	"unprognostic (4.28e-2)"	12.3	9.0	7.6	11.9	9.4	19.5	15.9	27.5	9.4	10.8	13.0	9.2	9.3	11.3	10.9	11.8	15.9	9.6	9.7	5.9	6.6	9.4	13.7	7.4	9.7	17.6	8.9	5.1	13.2	23.9	10.2	12.6	20.8	5.6	13.7	9.5	11.2	14.9	13.9	5.6	22.1	13.0	6.7	5.0	12.0	10.2	17.1	5.4	14.8	14.3	10.5	13.6	9.9	9.9	11.4	22.0	12.2	17.9	10.0	17.1	12.4	10.7	12.1	7.4	6.9	4.6	4.1	16.2	5.7	5.6	8.9	8.1	22.6	23.3	8.1	10.8	5.4	15.0	19.4	8.6	8.6	5.3	9.7	9.6	7.3	8.5	8.7	16.5	9.2	11.0	6.5	16.6	10.1	9.0	7.0	7.3	11.6	10.0	12.9	4.5	20.7	13.3	18.3	21.6	21.1	12.4	10.7	5.3	15.9	9.8	5.9	9.2	8.3	8.0	11.2	35.3	7.7	13.1	7.9	4.3	12.4	9.3	13.3	8.8	6.9	7.0	9.0	8.3	9.8	8.9	12.2	15.6	10.7	13.7	17.9	12.5	11.4	11.5	17.1	14.4	9.0	9.4	14.3	5.1	10.0	15.3	22.0	4.8	12.4	7.6	9.4	27.5	9.4	6.6	9.4	8.9	5.1	5.6	5.4	0.0	4.5	16.1	22.5	27.7	8.9	1.4	10.2	2.7	4.5	15.7	27.5	46.9	3.3	23.0	7.7	10.5	12.3	0.0	23.8	50.4	13.2	13.3	8.1	2.4	20.4	3.2	10.3	8.0	9.1	17.1	6.4	11.8	13.5	14.4	12.8	5.7	23.5	19.5	6.0	7.1	17.4	12.9	11.3	10.3	26.6	21.8	49.0	14.9	15.0	21.6
RCHY1	"ARNIP, CHIMP, DKFZp586C1620, PIRH2, PRO1996, RNF199, ZCHY, ZNF363"	ENSG00000163743	"Ring finger and CHY zinc finger domain containing 1"	Q96PM5	4	75479037-75514764	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030338, HPA030339"	Approved		Supported	Nucleoplasm,Vesicles,Cytosol		NA	NA			Cytosol	"Nucleoplasm, Vesicles"	"HPA030338: , HPA030339: AB_10603232"	"unprognostic (1.53e-1)"	"unprognostic (1.57e-1)"	"prognostic favorable (9.09e-4)"	"unprognostic (1.90e-1)"	"unprognostic (3.45e-3)"	"unprognostic (1.19e-2)"	"unprognostic (7.87e-3)"	"unprognostic (5.82e-2)"	"unprognostic (1.96e-1)"	"unprognostic (1.98e-1)"	"unprognostic (7.45e-3)"	"unprognostic (4.60e-2)"	"prognostic favorable (3.62e-5)"	"unprognostic (1.69e-1)"	"unprognostic (2.07e-1)"	"unprognostic (1.83e-1)"	"prognostic favorable (7.89e-5)"	8.8	12.1	15.7	9.9	20.1	15.6	17.8	20.7	16.8	10.2	12.7	9.8	8.7	9.0	11.0	7.5	8.4	12.9	7.2	17.6	14.1	16.2	17.1	12.5	10.4	12.2	15.9	15.7	16.2	10.6	14.9	13.0	10.5	17.1	12.0	14.2	7.7	12.3	11.3	29.7	5.9	9.2	12.4	16.7	12.2	10.3	13.4	15.4	14.9	20.3	8.0	12.7	9.7	12.1	4.4	7.4	18.9	8.8	4.6	7.4	4.3	6.1	3.2	9.5	8.9	10.0	8.8	5.4	4.1	9.7	8.6	10.2	8.7	7.6	10.2	7.9	5.9	8.5	3.7	24.1	7.3	13.1	8.3	7.9	13.2	6.0	11.1	8.6	17.8	7.3	8.1	9.2	9.9	9.3	10.4	17.3	13.3	12.2	10.4	20.0	9.9	16.3	7.2	15.8	16.8	5.6	8.8	22.4	8.7	13.4	10.5	14.7	8.1	6.8	16.0	17.7	10.9	9.0	8.1	6.8	5.7	5.6	5.0	6.9	11.1	7.9	14.5	6.9	12.7	8.9	18.9	8.8	8.5	4.3	5.2	7.4	4.4	5.3	5.0	7.4	2.2	3.9	5.5	3.7	4.6	4.7	3.8	5.2	4.3	15.7	20.1	20.7	16.8	14.1	16.2	15.9	15.7	17.1	15.4	17.9	6.4	18.7	28.1	36.1	36.0	49.4	12.7	6.7	7.9	22.7	19.6	28.8	58.0	26.3	26.2	18.6	15.4	0.0	19.8	19.5	23.5	31.2	4.7	21.3	16.6	22.3	13.3	23.9	33.0	39.2	20.8	22.4	27.0	14.4	23.7	22.1	21.3	24.6	23.7	44.0	19.0	32.3	22.7	60.0	42.9	27.0	28.3	34.8	27.1	23.7
RDH10	SDR16C4	ENSG00000121039	"Retinol dehydrogenase 10"	Q8IZV5	8	73294612-73325281	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"retina: 134.3"	"Group enriched"	"Detected in many"	5	"Collecting duct cells: 193.7;Muller glia cells: 296.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"basophil: 4.4"	"Group enriched"	"Detected in many"	5	"granulocytes: 4.4;T-cells: 2.3"	"Cell line enhanced"	"Detected in many"		"ASC diff: 46.8;BJ: 33.5;CACO-2: 29.9;HDLM-2: 33.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA049199			Supported	"Lipid droplets"		NA	NA			"Lipid droplets"		"HPA049199: AB_2680673"	"unprognostic (1.78e-1)"	"unprognostic (1.23e-1)"	"unprognostic (8.86e-2)"	"unprognostic (2.52e-1)"	"unprognostic (2.45e-2)"	"unprognostic (1.13e-2)"	"unprognostic (1.14e-1)"	"unprognostic (2.80e-2)"	"unprognostic (7.87e-2)"	"unprognostic (7.98e-2)"	"unprognostic (1.18e-3)"	"unprognostic (8.88e-3)"	"unprognostic (1.13e-2)"	"unprognostic (4.38e-2)"	"unprognostic (1.67e-1)"	"unprognostic (2.98e-3)"	"unprognostic (6.23e-2)"	18.3	3.2	2.7	9.5	3.3	0.7	11.8	1.7	2.8	8.2	18.7	2.9	10.0	13.6	5.9	5.8	9.4	4.4	21.9	9.6	2.3	2.4	19.6	37.5	8.7	4.8	4.1	1.7	4.9	14.8	3.7	17.9	20.9	8.7	12.4	6.4	134.3	22.6	5.7	3.4	4.4	34.1	14.0	6.9	5.6	15.3	8.0	2.1	2.0	3.5	7.3	6.5	12.8	6.5	0.6	0.7	4.4	0.6	0.2	2.3	0.5	4.2	12.2	1.3	5.6	46.8	3.4	12.4	33.5	5.4	1.3	2.2	29.9	12.1	2.9	4.4	18.7	2.0	11.1	6.1	4.8	2.7	33.6	15.4	5.2	12.0	9.2	1.8	2.4	5.7	2.0	6.2	5.2	4.9	5.9	4.9	2.9	5.9	4.3	2.2	1.8	2.5	1.0	1.6	25.8	6.0	2.2	1.4	1.7	9.1	6.0	0.8	1.0	2.8	20.9	1.7	1.8	4.1	1.3	7.4	2.0	3.4	9.2	2.5	2.8	2.9	2.4	1.6	2.2	4.6	4.4	0.6	1.1	1.2	0.3	0.7	0.6	1.3	1.4	0.7	0.1	2.3	1.2	0.8	0.2	0.5	0.2	0.7	0.5	2.7	3.3	1.7	1.8	2.3	2.4	4.1	1.7	8.7	2.1	11.9	28.0	0.0	8.6	11.9	3.0	8.1	30.6	20.1	18.2	193.7	21.6	15.7	3.3	12.8	53.9	10.3	25.7	0.0	15.2	16.8	18.4	19.0	2.3	35.0	16.7	3.2	4.1	1.8	4.0	5.2	2.6	6.0	16.9	0.0	13.1	296.7	39.0	25.9	3.5	18.6	10.4	0.0	8.2	9.3	5.3	12.2	35.1	2.2	14.1	16.0
RDH11	"ARSDR1, MDT1, SDR7C1"	ENSG00000072042	"Retinol dehydrogenase 11 (all-trans/9-cis/11-cis)"	Q8TC12	14	67676801-67695814	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		Oxidoreductase	"Cataract, Dwarfism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"prostate: 204.2"	"Cell type enhanced"	"Detected in all"	7	"Glandular cells: 335.2;Muller glia cells: 352.2"	"Cancer enriched"	"Detected in all"	13	"prostate cancer: 286.6"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB046011	Enhanced				"Intracellular and membrane"	NA	NA		9100000			"CAB046011: AB_11129613"	"unprognostic (1.38e-1)"	"unprognostic (6.86e-3)"	"unprognostic (1.77e-1)"	"prognostic favorable (2.62e-4)"	"unprognostic (6.06e-2)"	"prognostic unfavorable (2.89e-5)"	"unprognostic (9.29e-2)"	"unprognostic (1.98e-1)"	"unprognostic (1.05e-1)"	"unprognostic (3.58e-2)"	"unprognostic (2.91e-2)"	"unprognostic (1.27e-1)"	"prognostic favorable (1.30e-7)"	"unprognostic (1.65e-1)"	"unprognostic (1.68e-1)"	"unprognostic (2.18e-1)"	"unprognostic (4.74e-2)"	8.8	24.9	18.3	8.9	19.0	5.1	10.8	15.7	25.3	13.0	10.8	24.3	16.1	12.3	13.0	31.4	13.6	9.3	15.6	7.2	18.5	19.9	40.7	51.6	12.6	7.2	21.8	16.6	11.4	15.3	28.7	13.1	8.3	31.1	204.2	12.0	40.4	16.2	13.5	3.6	11.2	10.2	15.8	32.5	10.8	11.6	10.3	15.8	12.5	24.2	8.1	9.5	14.8	11.4	11.5	17.0	62.4	19.7	14.4	20.8	28.2	47.8	21.8	19.4	22.0	31.0	28.2	16.2	18.2	36.1	22.9	41.6	18.1	58.3	8.3	14.1	17.1	28.6	38.4	27.9	40.2	31.3	16.7	11.3	17.2	11.6	17.9	29.9	6.3	12.6	26.3	26.7	29.8	25.3	17.5	26.1	23.1	13.4	27.5	20.8	25.4	18.5	9.9	10.9	13.0	25.1	14.1	24.0	11.9	52.4	24.7	20.2	16.9	19.2	24.3	25.4	16.5	27.2	10.0	20.1	24.7	28.2	10.5	13.0	13.0	10.3	10.8	32.1	17.7	20.0	62.4	19.7	28.2	18.7	16.1	20.4	11.3	20.5	18.5	14.5	11.5	20.8	20.1	3.3	14.4	16.9	17.0	17.6	28.2	18.3	19.0	15.7	25.3	18.5	19.9	21.8	16.6	31.1	15.8	23.8	57.7	45.5	30.5	10.2	50.0	15.5	73.9	22.7	28.4	45.4	47.1	23.0	6.6	75.7	1.9	38.4	22.6	46.7	73.5	33.5	32.0	335.2	28.8	124.8	32.2	74.7	41.6	54.0	39.8	5.1	40.0	33.9	33.7	38.7	21.8	352.2	48.1	34.5	52.6	56.8	94.6	45.3	30.9	19.1	14.3	16.8	53.1	30.8	15.7	29.3
RDH5	"HSD17B9, RDH1, SDR9C5"	ENSG00000135437	"Retinol dehydrogenase 5"	Q92781	12	55720367-55724705	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Lipid metabolism, Sensory transduction, Steroid metabolism, Vision"	Oxidoreductase	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 39.4;retina: 127.9"	"Cell type enhanced"	"Detected in many"	8	"Cone photoreceptor cells: 58.9;Rod photoreceptor cells: 68.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"ASC diff: 19.0;ASC TERT1: 16.4;hTEC/SVTERT24-B: 9.9;hTERT-RPE1: 16.2;LHCN-M2: 9.9;U-87 MG: 17.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA063345			Uncertain	Vesicles	"Intracellular and membrane"	NA	NA			Vesicles		"HPA063345: AB_2684992"	"unprognostic (1.04e-2)"	"unprognostic (6.45e-2)"	"unprognostic (1.80e-1)"	"unprognostic (2.67e-1)"	"unprognostic (3.66e-2)"	"unprognostic (1.48e-2)"	"unprognostic (1.88e-2)"	"unprognostic (1.54e-1)"	"unprognostic (5.35e-2)"	"unprognostic (4.04e-2)"	"unprognostic (4.05e-1)"	"unprognostic (1.26e-3)"	"unprognostic (7.63e-2)"	"unprognostic (8.79e-2)"	"unprognostic (3.46e-2)"	"unprognostic (2.12e-3)"	"unprognostic (3.27e-2)"	39.4	0.7	0.6	2.8	0.8	0.2	14.9	0.5	0.8	1.0	7.6	1.0	1.5	8.6	1.9	4.5	2.4	2.2	4.8	3.9	1.0	0.5	3.7	27.2	0.7	1.6	0.8	0.8	1.4	1.5	0.0	0.6	0.4	1.5	1.8	1.9	127.9	3.2	1.0	3.1	1.0	9.4	8.8	1.1	0.9	2.7	0.9	1.0	0.3	1.1	2.6	0.7	2.0	2.5	0.4	2.3	2.1	0.9	1.5	2.6	0.4	0.4	0.9	0.5	0.3	19.0	16.4	0.3	2.4	2.7	0.5	0.9	0.3	5.1	0.6	0.4	1.3	0.1	0.2	0.2	0.0	0.4	0.6	0.8	0.1	1.0	1.3	0.5	0.0	0.2	7.0	0.6	9.9	0.0	16.2	0.2	0.3	0.1	0.8	9.9	0.4	0.2	0.1	0.2	2.3	1.4	0.3	0.3	0.3	0.1	0.5	0.1	0.7	0.1	0.3	2.2	0.1	0.4	0.3	0.3	1.0	1.0	0.7	0.6	0.7	0.3	0.1	17.7	0.2	0.2	0.3	0.6	2.1	0.4	0.9	0.2	0.4	1.2	2.6	1.2	0.3	1.0	0.4	0.9	1.5	0.9	2.3	0.2	0.4	0.6	0.8	0.5	0.8	1.0	0.5	0.8	0.8	1.5	1.0	8.9	2.1	6.7	4.2	1.6	22.6	2.1	5.1	5.3	1.2	1.8	58.9	1.6	1.7	1.6	0.6	4.2	28.4	0.0	2.3	1.0	3.3	2.8	0.0	17.9	0.5	15.9	11.1	1.8	2.2	1.8	12.4	4.0	5.0	4.6	8.7	10.9	2.8	17.6	6.3	8.4	68.6	12.9	4.7	3.5	6.3	1.5	1.3	10.0	11.8	2.7
RECQL	"RecQ1, RecQL1"	ENSG00000004700	"RecQ like helicase"	P46063	12	21468911-21501669	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"DNA-binding, Helicase, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009743, HPA030960, HPA064259"	Enhanced		Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"CAB009743: AB_655306, HPA030960: AB_10794912, HPA064259: AB_2685230"	"unprognostic (9.70e-3)"	"unprognostic (2.55e-2)"	"unprognostic (1.86e-2)"	"unprognostic (6.25e-3)"	"unprognostic (2.47e-1)"	"unprognostic (1.39e-1)"	"unprognostic (8.97e-3)"	"unprognostic (1.89e-3)"	"unprognostic (8.74e-2)"	"prognostic unfavorable (3.15e-4)"	"unprognostic (3.77e-3)"	"unprognostic (3.78e-2)"	"unprognostic (2.85e-1)"	"unprognostic (1.27e-1)"	"unprognostic (1.09e-1)"	"unprognostic (2.99e-1)"	"unprognostic (3.69e-2)"	32.7	15.8	10.0	22.0	12.7	10.8	18.2	10.9	11.2	18.0	16.3	9.4	11.0	7.5	19.8	14.4	18.7	14.6	14.1	17.9	11.2	7.2	19.6	18.0	19.5	25.7	15.3	7.6	16.0	11.9	8.0	14.8	17.1	12.0	14.0	12.7	6.7	13.1	12.4	15.0	12.4	15.5	20.5	19.5	34.0	12.9	10.8	13.0	27.4	17.4	14.3	25.0	22.6	13.0	19.3	15.2	11.3	20.7	23.1	28.0	13.8	17.2	17.5	13.3	9.8	26.9	33.8	15.4	33.3	28.2	21.5	25.2	19.1	14.4	20.7	12.9	22.7	27.3	12.6	14.2	16.6	30.7	34.6	9.4	25.3	19.4	8.1	10.4	17.5	19.1	18.8	8.6	30.5	22.4	19.8	24.1	14.6	8.8	10.1	28.3	8.4	19.1	20.4	22.1	5.3	11.9	15.8	53.9	16.0	8.3	11.9	3.6	10.6	24.9	6.7	17.5	48.0	17.0	11.2	32.5	30.3	19.7	26.5	30.9	4.1	12.2	45.4	25.6	10.3	22.2	9.3	11.8	11.3	21.9	20.7	21.3	19.3	20.5	21.0	15.2	16.0	13.6	18.8	5.5	23.1	18.8	11.6	28.0	13.8	10.0	12.7	10.9	11.2	11.2	7.2	15.3	7.6	12.0	13.0	20.8	19.7	38.7	12.7	20.9	10.9	7.3	12.7	30.8	25.0	14.0	13.7	9.7	8.3	16.8	0.5	36.0	3.2	0.0	21.6	23.8	30.7	7.0	50.8	11.9	25.0	14.3	9.4	28.3	30.7	2.0	20.4	35.9	28.7	49.5	6.0	17.7	24.4	5.5	35.3	9.5	10.9	12.9	25.8	6.0	8.1	37.5	3.0	41.7	6.9	8.2
RECQL5	"FLJ90603, RecQ5"	ENSG00000108469	"RecQ like helicase 5"	O94762	17	75626845-75667189	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, DNA damage, DNA repair, DNA replication"	"Helicase, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Collecting duct cells: 26.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA029971			Supported	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA029971: AB_10611389"	"unprognostic (2.19e-1)"	"unprognostic (6.16e-3)"	"unprognostic (2.26e-2)"	"prognostic unfavorable (1.73e-6)"	"unprognostic (8.39e-2)"	"unprognostic (2.34e-2)"	"unprognostic (3.57e-3)"	"unprognostic (5.83e-2)"	"unprognostic (3.15e-1)"	"unprognostic (5.84e-2)"	"prognostic favorable (4.34e-4)"	"unprognostic (4.07e-2)"	"unprognostic (7.01e-2)"	"unprognostic (6.37e-2)"	"unprognostic (1.42e-1)"	"unprognostic (4.78e-1)"	"unprognostic (1.81e-2)"	7.4	12.9	12.6	11.7	16.0	10.0	9.8	11.4	17.7	9.4	10.6	24.4	17.4	22.9	10.5	13.2	20.4	11.8	12.4	6.7	12.9	8.6	14.9	15.8	8.4	16.8	14.5	11.0	14.3	10.8	17.6	21.9	32.3	14.3	12.2	9.8	13.2	15.6	14.0	6.8	21.1	23.2	9.6	13.2	16.6	23.8	21.0	17.0	12.1	21.4	6.2	16.0	12.1	12.8	5.2	16.4	6.0	3.9	3.8	4.2	3.2	11.2	20.9	8.5	12.0	11.8	7.9	19.6	8.3	7.0	10.9	9.7	9.2	12.0	13.4	9.1	7.3	14.5	10.8	8.8	10.0	10.4	7.2	16.4	24.4	25.3	13.2	11.9	7.9	12.2	11.2	12.3	10.8	13.1	12.5	14.2	14.9	12.3	11.9	8.0	10.0	16.1	10.7	5.5	10.8	16.2	13.1	19.8	13.5	9.2	13.4	10.2	9.9	9.1	16.4	11.2	12.2	29.5	6.3	7.2	14.1	16.2	7.7	8.6	17.0	9.7	12.9	11.6	7.9	10.1	6.0	3.1	4.4	4.2	3.9	2.7	3.6	2.7	3.1	3.8	5.2	4.1	2.9	2.1	3.8	1.9	16.4	2.2	3.2	12.6	16.0	11.4	17.7	12.9	8.6	14.5	11.0	14.3	17.0	0.0	9.9	5.4	2.9	0.9	7.9	6.1	5.1	14.7	2.3	26.2	17.7	6.8	5.0	4.6	3.7	3.6	11.1	0.0	2.9	4.2	3.1	2.9	1.1	6.0	4.4	9.5	4.6	8.0	5.9	1.5	3.7	3.9	3.3	1.8	8.5	7.4	5.3	8.2	2.5	3.7	12.8	0.0	1.0	10.9	10.5	1.8	9.7	4.4	6.3	8.9
REN		ENSG00000143839	Renin	P00797	1	204154819-204190324	"Candidate cardiovascular disease genes, Disease related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins, Predicted secreted proteins"		"Aspartyl protease, Hydrolase, Protease"	"Disease mutation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	4	"kidney: 63.6"	"Group enriched"	"Detected in some"	5	"Early spermatids: 6.1;Late spermatids: 19.3"	"Cancer enriched"	"Detected in many"	8	"renal cancer: 39.4"	"Region enriched"	"Detected in single"	12	"basal ganglia: 1.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A-431: 2.4;BJ: 4.9;HMC-1: 6.5;RT4: 1.8;SK-BR-3: 4.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA005131	Approved				"Secreted to blood"	NA	NA	692000				"HPA005131: AB_1079174"	"unprognostic (4.45e-2)"	"unprognostic (3.35e-1)"	"unprognostic (1.62e-1)"	"unprognostic (8.58e-2)"		"unprognostic (2.89e-1)"	"unprognostic (1.23e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.13e-1)"	"unprognostic (7.20e-3)"	"unprognostic (1.37e-1)"	"unprognostic (1.57e-1)"	"prognostic unfavorable (6.45e-5)"	"unprognostic (1.22e-1)"	"unprognostic (1.70e-1)"	"unprognostic (4.98e-2)"	"unprognostic (6.49e-2)"	0.4	0.3	0.0	0.0	1.2	0.0	0.5	0.0	0.0	3.1	0.2	0.0	0.8	0.1	4.4	13.5	0.1	0.3	0.0	0.6	0.0	0.0	63.6	0.4	0.3	0.0	0.0	0.0	11.6	0.0	0.0	0.4	14.4	0.0	0.3	0.1	0.4	0.3	0.5	0.0	0.0	0.1	1.0	0.0	0.0	0.0	2.0	0.0	0.0	1.1	0.0	0.2	4.4	0.1	0.0	0.0	0.0	0.0	0.0	0.6	0.0	2.4	0.0	0.0	0.0	0.3	0.0	0.0	4.9	1.0	0.0	0.0	0.1	0.6	0.0	0.3	0.0	0.0	0.4	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.1	0.3	0.0	6.5	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.4	0.0	0.2	0.6	0.0	0.0	0.0	0.3	0.7	0.0	0.0	0.0	0.0	1.8	0.2	0.1	0.0	4.6	0.2	0.0	0.5	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.8	0.0	0.2	0.0	0.0	0.0	0.0	1.8	0.0	0.1	0.0	1.2	6.1	0.0	0.0	0.0	1.0	0.2	0.1	0.7	0.0	0.0	0.4	0.0	0.0	0.0	0.0	19.3	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.3	0.4	0.0	0.1	0.0	0.0	0.2	0.2	0.0	0.9	0.0	0.0	2.7
RENBP	"RBP, RNBP"	ENSG00000102032	"Renin binding protein"	P51606	X	153935263-153944691	"Enzymes, Predicted intracellular proteins"		Isomerase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"kidney: 32.7;lymphoid tissue: 36.5"	"Cell type enhanced"	"Detected in many"	10	"granulocytes: 128.8;Hofbauer cells: 156.0;Ito cells: 72.4;Proximal tubular cells: 157.3"	"Cancer enhanced"	"Detected in all"		"melanoma: 57.5"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"EFO-21: 13.2;HMC-1: 44.8;SK-MEL-30: 29.7;U-266/84: 25.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA000428, HPA000522"	Enhanced					NA	NA		42000			"HPA000428: AB_1079799, HPA000522: AB_1079798"	"unprognostic (3.08e-1)"	"prognostic favorable (3.95e-4)"	"unprognostic (1.12e-2)"	"unprognostic (3.29e-1)"	"unprognostic (8.83e-3)"	"unprognostic (1.85e-1)"	"unprognostic (5.22e-2)"	"unprognostic (1.02e-2)"	"unprognostic (2.18e-2)"	"unprognostic (1.15e-1)"	"unprognostic (6.47e-3)"	"unprognostic (1.99e-1)"	"prognostic favorable (3.08e-5)"	"unprognostic (2.39e-2)"	"unprognostic (6.57e-2)"	"unprognostic (4.25e-2)"	"unprognostic (8.51e-2)"	12.7	11.1	7.8	11.2	16.8	8.6	8.4	2.3	11.5	4.2	6.2	11.3	1.1	7.4	2.1	6.0	3.0	2.5	5.7	8.7	9.4	9.1	32.7	4.6	12.8	12.1	16.9	7.4	1.2	1.6	1.8	3.4	8.1	11.6	3.6	3.0	9.6	3.4	2.0	1.4	5.2	7.5	4.5	12.7	36.5	4.4	1.4	13.5	3.0	2.9	1.1	4.4	5.7	2.9	1.1	0.6	5.3	3.1	0.3	0.9	0.7	0.0	0.0	1.1	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	13.2	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.5	10.0	0.0	0.9	7.7	0.0	44.8	0.3	0.0	0.0	0.0	0.0	0.0	0.3	2.8	3.5	0.0	0.2	2.0	0.1	0.1	0.1	0.0	4.7	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	29.7	1.1	0.0	3.5	0.4	0.0	0.3	0.0	0.0	4.5	25.7	1.8	0.9	4.7	3.5	2.9	2.0	5.3	0.3	1.4	0.3	1.1	0.1	0.1	0.2	0.6	0.9	0.4	4.5	0.3	3.1	0.6	0.0	0.7	7.8	16.8	2.3	11.5	9.4	9.1	16.9	7.4	11.6	13.5	0.0	2.1	9.7	1.1	4.1	1.6	0.8	5.1	0.0	0.0	8.7	0.0	1.0	31.5	1.0	0.0	4.3	1.3	0.0	0.3	4.4	2.3	1.3	128.8	0.8	156.0	14.3	1.7	72.4	62.0	0.0	0.3	37.4	27.0	35.1	0.5	12.6	0.5	0.9	0.4	157.3	0.7	12.9	3.9	0.0	1.2	1.8	2.4	7.9	0.5	0.4
RET	"CDHF12, CDHR16, HSCR1, MEN2A, MEN2B, MTC1, PTC, RET51"	ENSG00000165731	"Ret proto-oncogene"	P07949	10	43077027-43130351	"Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion"	"Kinase, Transferase, Tyrosine-protein kinase"	"Cancer-related genes, Disease mutation, FDA approved drug targets, Hirschsprung disease, Proto-oncogene"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"parathyroid gland: 63.9"	"Cell type enriched"	"Detected in some"	44	"Horizontal cells: 74.7"	"Cancer enhanced"	"Detected in many"		"breast cancer: 11.0"	"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"non-classical monocyte: 6.7"	"Group enriched"	"Detected in many"	13	"dendritic cells: 2.1;monocytes: 6.7"	"Cell line enhanced"	"Detected in some"		"MCF7: 18.0;NB-4: 11.8;SH-SY5Y: 91.8;THP-1: 27.4"	"Low region specificity"	"Detected in many"			"Region enriched"	"Detected in all"	6	"midbrain: 95.5"	"CAB002581, HPA008356, HPA008495"	Approved	Supported	Approved	"Golgi apparatus,Plasma membrane,Cytosol"		No	NA		260000	"Golgi apparatus, Cytosol"	"Plasma membrane"	"CAB002581: AB_563673, HPA008356: AB_1847232, HPA008495: "	"unprognostic (7.94e-2)"	"unprognostic (3.68e-2)"	"unprognostic (4.49e-1)"	"prognostic unfavorable (5.02e-4)"	"unprognostic (1.15e-1)"	"unprognostic (9.13e-4)"	"unprognostic (1.27e-2)"	"unprognostic (3.62e-2)"	"unprognostic (2.86e-1)"	"unprognostic (2.01e-1)"	"unprognostic (1.54e-3)"	"unprognostic (4.43e-1)"	"unprognostic (9.35e-5)"	"unprognostic (1.64e-3)"	"unprognostic (8.28e-2)"	"unprognostic (3.67e-3)"	"unprognostic (2.02e-2)"	1.8	15.2	1.1	1.8	1.3	0.7	1.2	4.1	9.0	1.9	3.1	0.9	1.1	1.5	0.9	0.6	1.2	0.7	1.0	1.2	1.5	5.8	1.0	11.7	0.7	0.8	17.5	1.2	0.8	1.3	63.9	6.3	0.8	16.8	2.2	1.5	2.8	13.6	2.0	4.5	1.1	2.6	1.1	2.8	0.6	2.1	2.0	0.0	0.1	0.8	5.1	0.6	1.9	1.4	0.2	2.1	0.0	6.7	0.0	0.3	0.4	0.0	0.1	0.0	0.5	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	18.0	0.0	11.8	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	91.8	0.0	0.0	0.0	0.1	1.3	27.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.8	0.0	0.2	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	6.7	2.1	0.3	0.4	1.1	1.3	4.1	9.0	1.5	5.8	17.5	1.2	16.8	0.0	0.0	0.3	0.0	0.5	0.2	0.1	1.6	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.1	0.0	0.0	0.2	1.7	1.0	1.2	1.1	0.8	0.1	74.7	0.0	0.0	0.0	1.4	0.3	0.0	0.0	0.0	0.8	0.3	0.0	0.0	0.0	0.0	0.4	0.0	1.4	0.4	1.1	0.5	0.0	0.0	0.0	0.1
RETSAT	FLJ20296	ENSG00000042445	"Retinol saturase"	Q6NUM9	2	85342088-85354620	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 86.1"	"Cell type enhanced"	"Detected in many"	11	"Enterocytes: 209.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"ASC diff: 65.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007961, HPA046513"	Uncertain		Uncertain	Nucleoli		NA	NA			Nucleoli		"HPA007961: AB_1079802, HPA046513: AB_2679680"	"unprognostic (6.17e-2)"	"unprognostic (1.02e-1)"	"unprognostic (1.29e-1)"	"unprognostic (5.84e-3)"	"unprognostic (1.14e-1)"	"unprognostic (1.31e-1)"	"prognostic favorable (4.23e-4)"	"unprognostic (1.89e-1)"	"unprognostic (2.16e-1)"	"unprognostic (3.59e-2)"	"unprognostic (1.77e-2)"	"unprognostic (1.59e-1)"	"prognostic favorable (1.95e-10)"	"unprognostic (2.73e-2)"	"unprognostic (5.34e-1)"	"unprognostic (8.24e-3)"	"unprognostic (9.90e-2)"	65.7	24.8	7.7	9.8	9.1	0.9	35.6	5.6	9.3	7.4	46.5	12.4	12.7	49.0	6.8	12.3	16.7	5.0	17.7	7.3	7.4	5.7	20.6	51.9	7.2	5.1	10.2	7.7	5.5	11.5	13.1	3.5	5.7	8.9	10.1	22.6	10.0	12.5	7.6	24.3	14.3	86.1	7.0	12.7	4.0	18.2	9.2	10.1	3.5	27.2	13.9	9.3	9.9	9.0	3.8	5.6	5.3	10.0	6.5	9.2	4.1	16.2	9.4	5.5	12.7	65.6	12.3	7.1	11.9	14.7	7.2	10.2	6.5	11.4	5.7	9.8	9.4	5.8	13.6	7.3	20.7	7.1	7.0	5.0	2.8	7.8	15.9	15.8	5.4	6.3	16.1	28.4	9.3	12.4	16.8	12.0	5.0	2.9	13.7	13.5	3.4	3.9	2.8	1.7	16.4	11.6	2.5	10.8	7.4	12.8	9.5	2.6	4.4	10.0	19.1	32.3	3.8	9.0	0.9	9.4	8.2	4.5	7.6	6.2	7.4	6.9	2.3	10.0	6.5	5.6	0.0	5.1	2.4	7.0	5.5	9.2	3.8	5.6	8.8	5.6	2.5	3.8	4.0	5.3	6.5	10.0	4.0	5.8	4.1	7.7	9.1	5.6	9.3	7.4	5.7	10.2	7.7	8.9	10.1	26.8	23.5	2.2	8.5	10.1	3.5	18.5	20.4	9.4	10.3	12.2	17.7	9.6	0.0	19.1	27.2	9.2	209.6	0.0	31.4	5.6	6.6	11.3	10.4	39.3	8.7	11.1	10.4	8.0	9.9	41.4	13.6	7.5	28.7	9.0	43.9	8.2	29.0	59.4	11.7	15.6	4.3	0.0	7.8	2.6	3.0	13.0	7.1	8.9	33.1	8.4
REV3L	"POLZ, REV3"	ENSG00000009413	"REV3 like, DNA directed polymerase zeta catalytic subunit"	O60673	6	111299028-111483715	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"DNA damage, DNA repair, DNA replication"	"DNA-binding, DNA-directed DNA polymerase, Nucleotidyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"ASC diff: 40.2;ASC TERT1: 30.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA064853, HPA069382"	Uncertain		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA064853: AB_2685369, HPA069382: AB_2686134"	"unprognostic (5.54e-2)"	"unprognostic (2.06e-1)"	"unprognostic (5.09e-2)"	"unprognostic (1.71e-1)"	"unprognostic (1.59e-1)"	"unprognostic (8.59e-3)"	"unprognostic (4.42e-2)"	"unprognostic (1.56e-2)"	"unprognostic (8.09e-2)"	"unprognostic (1.17e-1)"	"unprognostic (6.87e-3)"	"unprognostic (1.27e-1)"	"unprognostic (4.34e-2)"	"unprognostic (2.80e-1)"	"unprognostic (1.67e-1)"	"unprognostic (1.67e-1)"	"unprognostic (1.03e-3)"	21.0	7.1	7.8	8.8	7.3	7.3	15.1	26.0	7.6	31.7	11.0	5.8	14.1	5.4	34.5	18.5	7.6	12.2	7.4	7.1	6.5	6.1	6.5	6.4	10.8	6.3	5.4	5.8	11.3	8.1	7.8	15.1	10.2	6.8	11.4	7.4	8.3	6.9	16.3	17.1	8.2	7.0	18.0	6.9	7.1	8.6	10.3	6.7	10.2	9.2	7.2	5.5	18.3	16.2	5.1	2.8	6.0	2.9	1.7	4.6	1.0	4.7	3.0	5.8	8.8	40.2	30.6	6.4	6.7	11.1	3.7	6.1	5.3	2.9	10.4	4.9	9.7	5.8	4.9	8.5	3.7	6.3	6.1	4.7	6.9	7.6	7.1	5.6	7.2	4.2	19.5	3.4	6.8	10.7	6.4	6.8	5.4	8.8	6.6	7.1	4.4	8.5	1.5	2.0	2.4	5.0	5.5	6.4	3.4	2.8	5.9	7.7	6.1	8.4	3.1	7.2	4.7	3.8	7.8	7.8	5.6	5.2	26.0	7.6	7.0	8.1	9.3	5.4	5.6	7.3	1.9	1.7	3.3	3.3	1.3	4.6	2.8	2.5	3.0	1.7	5.1	1.6	2.8	6.0	1.7	2.9	2.8	1.9	1.0	7.8	7.3	26.0	7.2	6.5	6.1	5.4	5.8	6.8	6.7	44.7	73.8	34.3	19.1	27.1	106.3	31.0	12.7	56.2	45.5	19.2	53.0	18.3	3.3	13.5	30.3	42.0	13.4	0.0	9.9	10.9	62.7	15.8	45.1	12.5	10.9	33.4	57.4	19.0	18.3	11.9	46.6	44.7	20.3	15.4	14.8	74.6	10.1	13.5	36.7	9.2	58.5	38.8	60.6	40.2	68.7	23.5	27.6	22.4	17.7	6.7
RFFL	"CARP-2, CARP2, fring, rififylin, RNF189, RNF34L"	ENSG00000092871	"Ring finger and FYVE like domain containing E3 ubiquitin protein ligase"	Q8WZ73	17	35005990-35089319	"Enzymes, Predicted intracellular proteins"	"Apoptosis, Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 56.8"	"Cell type enhanced"	"Detected in many"	5	"Late spermatids: 81.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HDLM-2: 41.3;Karpas-707: 38.5"									"CAB008096, HPA017910, HPA019492"	Approved		Approved	Vesicles		NA	NA			Vesicles		"CAB008096: AB_2178607, HPA017910: AB_1856189, HPA019492: AB_1856190"	"unprognostic (2.59e-1)"	"unprognostic (2.87e-1)"	"prognostic favorable (4.92e-4)"	"unprognostic (1.24e-1)"	"unprognostic (1.44e-1)"	"unprognostic (1.79e-1)"	"unprognostic (5.73e-3)"	"unprognostic (4.34e-3)"	"unprognostic (2.31e-1)"	"unprognostic (9.26e-3)"	"unprognostic (2.39e-1)"	"unprognostic (2.63e-1)"	"prognostic unfavorable (2.43e-5)"	"unprognostic (1.44e-1)"	"unprognostic (1.97e-1)"	"unprognostic (8.68e-2)"	"unprognostic (1.36e-1)"	5.8	6.1	11.1	9.9	22.9	22.1	6.7	4.4	15.7	6.7	14.6	56.8	5.9	14.8	6.9	5.3	21.6	5.4	11.5	5.8	14.4	10.5	15.4	25.0	6.8	8.9	32.1	7.3	5.2	10.1	8.3	4.9	6.5	30.7	10.7	12.6	4.5	9.6	7.0	12.2	5.2	11.9	7.3	32.1	9.9	13.4	15.7	27.5	13.1	23.0	5.4	15.0	10.2	9.2	4.2	5.2	26.8	7.6	6.7	14.5	7.1	7.9	15.0	4.0	5.6	6.6	9.4	2.1	5.2	8.5	5.4	6.5	5.1	15.8	2.3	6.6	6.6	11.5	11.2	6.2	10.1	7.5	41.3	4.3	12.4	4.0	12.5	5.6	8.0	7.4	6.3	6.0	8.1	14.3	7.2	5.2	7.2	5.8	38.5	4.8	2.5	1.8	7.1	4.7	15.6	9.0	5.5	6.4	13.9	8.0	15.9	4.4	5.5	3.3	3.5	3.2	8.9	5.3	8.8	10.3	3.2	5.6	3.1	8.4	14.4	12.1	3.7	12.3	5.6	2.8	11.3	7.6	16.3	8.8	4.6	10.6	4.2	9.9	8.3	5.2	4.1	8.5	7.5	26.8	6.7	4.1	0.6	14.5	7.1	11.1	22.9	4.4	15.7	14.4	10.5	32.1	7.3	30.7	27.5	38.7	30.1	16.1	9.1	5.4	10.1	1.0	17.8	10.7	23.9	0.0	13.7	7.5	1.7	6.4	36.4	5.8	22.2	0.0	13.0	1.3	8.0	22.0	24.3	26.6	6.5	6.4	14.5	11.6	15.7	81.0	2.8	14.9	1.7	16.2	20.7	19.9	13.9	17.3	4.2	16.8	31.7	6.5	5.1	11.8	9.1	5.4	4.2	20.1	16.1	33.9
RFK	"FLJ11149, RIFK"	ENSG00000135002	"Riboflavin kinase"	Q969G6	9	76385517-76394517	"Enzymes, FDA approved drug targets, Predicted intracellular proteins"		"Kinase, Transferase"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Extravillous trophoblasts: 297.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023259, CAB033887, HPA057163"	Approved		Approved	"Golgi apparatus"		NA	NA			"Golgi apparatus"		"CAB033887: AB_2178617, HPA023259: AB_2671127, HPA057163: AB_2683357"	"unprognostic (1.79e-1)"	"unprognostic (3.98e-2)"	"unprognostic (1.83e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.34e-1)"	"unprognostic (1.76e-3)"	"unprognostic (8.61e-3)"	"unprognostic (3.11e-1)"	"unprognostic (1.39e-1)"	"unprognostic (2.88e-1)"	"unprognostic (1.02e-1)"	"unprognostic (4.61e-2)"	"unprognostic (1.22e-3)"	"unprognostic (3.22e-2)"	"unprognostic (1.83e-1)"	"unprognostic (2.70e-1)"	"unprognostic (3.88e-2)"	8.1	15.4	24.8	9.8	31.0	15.2	8.7	15.3	27.7	8.9	22.1	5.7	6.2	23.9	9.5	14.3	9.4	10.0	14.5	11.4	33.0	33.5	19.4	23.6	8.8	7.4	22.8	13.2	10.8	11.9	10.3	16.5	26.0	28.3	9.6	16.8	13.3	9.1	7.6	10.3	3.8	39.3	8.5	10.2	8.2	20.3	12.2	8.0	8.1	14.4	5.7	11.6	9.2	7.3	4.9	9.6	3.8	16.3	6.8	6.7	7.8	9.8	10.6	6.5	8.4	9.7	9.7	19.6	11.5	8.5	8.3	6.5	3.7	6.1	16.1	13.7	8.2	15.2	10.7	8.8	7.4	16.6	4.8	8.6	5.1	14.8	12.0	17.6	16.8	12.2	6.5	13.6	9.9	10.9	9.3	26.7	13.9	13.5	13.4	16.5	9.2	21.6	6.2	8.4	22.9	11.3	12.1	8.6	4.1	38.0	4.9	16.6	6.1	12.3	17.3	10.1	8.8	4.4	9.3	16.7	8.8	15.9	18.9	16.1	14.6	14.5	5.6	14.5	15.1	12.0	3.8	8.1	2.8	4.4	16.0	6.7	4.9	6.5	5.2	9.6	4.0	6.3	6.0	1.2	6.8	16.3	3.6	6.1	7.8	24.8	31.0	15.3	27.7	33.0	33.5	22.8	13.2	28.3	8.0	14.9	8.6	15.2	14.2	40.3	49.7	29.9	28.1	26.8	19.4	40.1	19.6	37.4	51.4	55.2	161.1	40.7	67.5	70.0	168.8	297.5	21.6	23.6	11.5	32.1	30.7	11.1	27.1	62.6	51.2	78.7	20.4	25.3	28.7	12.6	24.6	39.5	147.1	66.6	61.2	98.3	23.1	0.0	23.6	85.0	58.5	35.4	103.3	20.8	29.9	24.0
RFNG		ENSG00000169733	"RFNG O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase"	Q9Y644	17	82047902-82051831	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Differentiation, Neurogenesis"	"Developmental protein, Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HHSteC: 35.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA011564, HPA031673"	Uncertain		Approved	Nucleoplasm		No	No		450000	Nucleoplasm		"HPA011564: AB_1079803, HPA031673: AB_2673989"	"unprognostic (4.17e-3)"	"unprognostic (7.60e-3)"	"unprognostic (2.87e-3)"	"unprognostic (2.49e-1)"	"unprognostic (2.05e-1)"	"unprognostic (2.65e-2)"	"unprognostic (1.62e-1)"	"unprognostic (9.86e-2)"	"unprognostic (1.02e-1)"	"unprognostic (1.53e-1)"	"prognostic favorable (4.81e-4)"	"unprognostic (1.20e-1)"	"unprognostic (6.96e-3)"	"unprognostic (1.77e-1)"	"unprognostic (2.16e-1)"	"unprognostic (6.93e-2)"	"unprognostic (4.14e-2)"	19.5	13.0	13.8	9.3	13.3	11.7	43.8	14.3	13.8	11.4	11.8	9.0	22.7	14.9	13.5	20.9	13.4	16.3	17.0	12.2	11.6	8.7	12.5	34.5	16.7	10.1	11.2	8.0	19.7	26.6	4.1	10.7	8.2	9.9	11.8	4.8	10.6	27.3	20.4	32.6	13.3	12.7	12.9	8.5	8.9	13.2	12.8	10.6	5.7	12.6	10.5	7.6	12.4	12.8	3.4	3.4	4.3	5.0	0.4	6.3	1.5	9.5	9.5	2.8	9.6	7.2	6.3	12.3	8.9	5.2	4.3	3.4	5.8	6.8	2.2	6.4	14.1	8.8	5.3	1.9	7.7	0.9	2.9	10.0	3.2	2.3	23.6	35.5	1.2	7.1	11.5	5.2	7.3	12.5	8.4	8.0	7.5	4.0	8.4	3.4	11.7	7.1	3.3	2.8	6.4	10.0	5.0	3.4	5.0	4.8	5.8	5.0	12.4	3.4	5.8	26.3	3.2	16.1	6.8	3.0	6.8	9.2	6.4	4.8	11.3	2.1	2.3	8.5	2.0	5.8	2.3	5.0	4.3	4.1	1.4	1.5	2.5	2.8	4.3	3.4	3.4	2.8	1.9	2.0	0.4	1.5	2.7	6.3	1.5	13.8	13.3	14.3	13.8	11.6	8.7	11.2	8.0	9.9	10.6	6.0	11.3	5.2	11.2	8.7	28.3	10.0	7.6	4.0	3.4	22.7	23.6	4.8	6.6	7.0	2.9	9.2	17.1	0.0	12.8	2.8	17.9	13.2	1.1	42.9	8.3	11.1	10.9	17.8	9.7	8.5	20.1	6.1	10.1	2.8	13.3	30.4	11.9	17.3	18.7	28.9	24.4	0.0	7.0	17.9	3.1	8.9	3.1	7.5	11.1	7.0
RFWD3	"FANCW, FLJ10520, RNF201"	ENSG00000168411	"Ring finger and WD repeat domain 3"	Q6PCD5	16	74621394-74666881	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"DNA damage, DNA repair, Ubl conjugation pathway"	Transferase	"Disease mutation, Fanconi anemia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Spermatocytes: 46.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA048258, HPA075649"	Approved		Enhanced	Nucleoplasm,Cytosol		No	No			Nucleoplasm	Cytosol	"HPA048258: AB_2680332, HPA075649: AB_2686761"	"unprognostic (4.79e-2)"	"unprognostic (6.45e-3)"	"unprognostic (6.35e-2)"	"unprognostic (6.61e-2)"	"unprognostic (2.73e-1)"	"unprognostic (1.97e-1)"	"unprognostic (1.11e-3)"	"unprognostic (5.04e-2)"	"unprognostic (3.64e-2)"	"unprognostic (1.01e-1)"	"unprognostic (4.03e-3)"	"unprognostic (2.53e-3)"	"unprognostic (1.73e-3)"	"unprognostic (2.84e-1)"	"unprognostic (4.31e-1)"	"unprognostic (5.74e-2)"	"unprognostic (3.29e-1)"	7.3	5.2	4.2	12.2	6.1	33.9	7.8	7.8	5.6	7.4	6.7	8.4	8.4	5.5	9.7	10.0	12.8	6.3	5.5	5.4	3.9	3.7	6.5	5.6	6.5	12.0	6.1	4.8	7.7	9.6	8.5	7.5	11.5	5.3	6.5	8.1	7.2	8.0	8.4	4.5	11.6	7.8	5.6	4.8	9.7	6.2	35.1	7.2	40.5	7.0	7.5	18.0	7.2	8.6	9.3	7.1	13.8	10.9	9.1	11.7	6.5	14.1	18.2	13.8	10.0	2.9	4.0	15.5	12.8	9.9	20.5	17.9	23.7	14.9	19.8	10.5	10.0	10.3	17.1	22.4	13.3	25.2	6.2	13.4	17.5	14.8	13.3	2.5	17.6	18.3	2.8	4.2	25.8	16.0	5.3	8.7	16.9	26.4	8.9	15.4	22.6	25.6	16.1	27.1	8.3	8.8	39.9	9.3	17.4	7.3	15.1	10.2	10.9	20.6	7.3	9.1	13.0	13.4	15.0	8.4	15.0	14.4	8.4	16.1	12.1	22.4	59.4	10.7	13.6	18.2	13.8	6.8	9.9	9.3	6.3	10.2	7.8	7.7	8.6	7.1	9.3	11.7	8.1	7.7	9.1	10.9	5.5	10.9	6.5	4.2	6.1	7.8	5.6	3.9	3.7	6.1	4.8	5.3	7.2	0.0	5.1	11.2	5.0	9.6	5.8	2.4	2.5	2.7	5.7	1.8	9.8	9.1	10.0	5.6	4.2	5.2	4.2	23.3	6.6	6.6	4.8	9.2	4.6	6.4	7.6	3.2	9.1	10.4	13.7	5.4	3.4	6.1	15.1	3.6	8.3	3.5	8.2	0.0	3.9	3.4	6.8	6.5	5.6	46.5	30.6	8.2	6.3	7.5	7.3	12.0
RGN	"RC, SMP30"	ENSG00000130988	Regucalcin	Q15493	X	47078355-47093314	"Enzymes, Plasma proteins, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"adrenal gland: 51.0;liver: 118.8"	"Cell type enhanced"	"Detected in many"	13	"Distal tubular cells: 49.7;Hepatocytes: 141.5;Muller glia cells: 48.0;Peritubular cells: 65.4;Proximal tubular cells: 86.9"	"Cancer enriched"	"Detected in many"	6	"liver cancer: 47.8"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"CACO-2: 16.5;fHDF/TERT166: 5.3;Hep G2: 24.6"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"HPA029102, HPA029103, HPA029104"	Enhanced		Approved	Cytosol		NA	NA		47000	Cytosol		"HPA029102: AB_10599846, HPA029103: AB_10602097, HPA029104: "	"unprognostic (1.80e-1)"	"unprognostic (1.25e-1)"	"unprognostic (1.39e-1)"	"unprognostic (5.56e-3)"	"unprognostic (8.22e-3)"	"unprognostic (1.32e-2)"	"prognostic favorable (7.55e-4)"	"unprognostic (2.60e-3)"	"unprognostic (2.23e-2)"	"unprognostic (8.38e-2)"	"unprognostic (3.37e-2)"	"unprognostic (1.14e-2)"	"prognostic favorable (5.10e-10)"	"unprognostic (1.69e-2)"	"unprognostic (2.43e-1)"	"unprognostic (7.82e-2)"	"unprognostic (5.22e-2)"	2.6	51.0	6.7	0.6	6.5	0.4	1.5	8.4	6.2	2.8	1.9	6.2	2.5	4.5	2.3	6.1	1.5	1.7	2.0	4.5	6.1	4.2	17.6	118.8	4.9	0.7	5.9	4.5	7.5	12.7	6.2	2.5	4.2	5.0	4.8	1.1	8.4	7.5	6.3	3.8	0.6	4.6	4.9	4.4	1.1	2.9	1.5	5.2	0.0	6.5	1.6	0.6	2.1	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.1	0.0	0.0	0.2	0.4	0.3	0.6	0.0	0.0	16.5	0.0	0.0	0.9	5.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	24.6	0.8	0.1	0.0	1.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.6	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	6.7	6.5	8.4	6.2	6.1	4.2	5.9	4.5	5.0	5.2	6.0	2.2	0.0	2.9	0.5	10.2	25.8	7.6	2.7	1.2	14.0	0.0	0.1	49.7	8.4	0.4	1.8	0.0	0.0	7.9	0.1	7.5	0.9	0.0	141.5	0.1	4.8	4.6	6.2	4.0	0.6	23.0	0.0	1.7	0.0	0.0	48.0	7.8	0.0	65.4	86.9	1.9	12.9	8.0	0.2	0.2	0.3	0.2	0.0	0.3	1.1
RHBDD1	DKFZp547E052	ENSG00000144468	"Rhomboid domain containing 1"	Q8TEB9	2	226835581-226999215	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Apoptosis, Differentiation, Spermatogenesis"	"Hydrolase, Protease, Serine protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"U-698: 35.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA013972, HPA057125"	Approved		Supported	"Endoplasmic reticulum"		NA	NA			"Endoplasmic reticulum"		"HPA013972: AB_2178629, HPA057125: AB_2683343"	"unprognostic (1.42e-1)"	"unprognostic (5.37e-2)"	"unprognostic (3.26e-1)"	"unprognostic (5.23e-2)"	"unprognostic (2.57e-1)"	"unprognostic (2.91e-1)"	"unprognostic (1.17e-2)"	"unprognostic (2.07e-2)"	"unprognostic (1.18e-1)"	"unprognostic (9.40e-2)"	"unprognostic (4.74e-3)"	"unprognostic (4.97e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.79e-1)"	"unprognostic (1.09e-1)"	"unprognostic (9.77e-2)"	"unprognostic (3.04e-2)"	12.7	14.8	10.8	16.7	16.0	11.0	13.6	8.3	13.0	13.8	14.3	21.2	9.4	11.0	20.6	16.3	13.6	15.4	12.4	14.5	11.4	9.0	13.6	16.9	12.6	17.7	17.6	11.0	18.8	20.4	18.6	17.1	10.5	13.0	15.7	12.4	13.1	14.3	15.5	13.9	13.0	17.5	15.6	16.5	17.3	13.2	25.6	14.7	56.6	17.3	8.8	18.9	18.7	15.4	19.9	16.6	9.8	15.5	8.8	12.5	8.5	5.2	4.5	4.8	7.4	14.6	14.6	0.0	12.5	10.0	6.2	7.1	3.9	9.1	4.9	10.4	12.6	9.0	6.1	0.0	13.0	11.8	12.5	5.0	7.2	2.9	3.4	15.7	7.6	4.2	13.6	19.0	11.8	25.7	7.2	4.7	13.0	19.3	12.9	6.4	10.0	12.9	3.9	0.0	6.1	4.8	5.6	0.0	7.1	5.0	6.3	4.7	3.6	6.8	2.4	9.2	9.5	6.9	8.8	6.2	2.8	6.3	10.7	3.5	14.4	6.7	35.4	9.1	9.3	8.2	8.1	11.1	9.8	6.1	15.5	9.7	17.3	9.6	7.5	13.7	19.9	10.8	8.9	2.5	8.8	10.3	16.6	12.5	8.5	10.8	16.0	8.3	13.0	11.4	9.0	17.6	11.0	13.0	14.7	11.9	5.4	22.9	7.2	4.6	6.3	14.0	2.5	4.0	7.9	10.4	15.7	6.0	3.3	6.1	12.7	5.8	5.0	0.0	8.0	3.3	5.2	9.4	8.1	11.3	4.6	11.1	1.7	3.1	9.2	13.7	5.2	5.0	11.8	1.8	7.1	9.3	7.2	0.0	6.3	2.9	5.9	0.0	7.2	12.9	7.1	4.8	4.7	6.5	3.7	7.7
RHBDD2	"NPD007, RHBDL7"	ENSG00000005486	"Rhomboid domain containing 2"	Q6NTF9	7	75842602-75888926	"Enzymes, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Late spermatids: 233.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA045074, HPA051960"	Uncertain		Enhanced	"Golgi apparatus"		NA	NA			"Golgi apparatus"		"HPA045074: AB_10965705, HPA051960: AB_2681673"	"unprognostic (2.75e-1)"	"unprognostic (3.89e-2)"	"prognostic unfavorable (3.31e-5)"	"unprognostic (9.79e-2)"	"prognostic unfavorable (1.81e-4)"	"unprognostic (2.05e-2)"	"unprognostic (1.18e-2)"	"unprognostic (2.37e-3)"	"unprognostic (1.55e-1)"	"unprognostic (2.75e-1)"	"unprognostic (5.11e-2)"	"unprognostic (1.87e-2)"	"prognostic favorable (8.68e-6)"	"unprognostic (3.73e-1)"	"unprognostic (6.53e-2)"	"unprognostic (1.89e-1)"	"unprognostic (1.03e-1)"	12.3	50.9	44.3	9.2	64.6	12.1	12.1	14.4	68.3	17.9	11.9	18.5	43.8	18.2	8.5	31.8	14.2	22.6	12.5	14.1	48.5	69.1	18.5	21.7	22.1	8.9	33.6	29.9	12.3	23.6	81.3	56.5	10.6	37.1	15.8	9.1	23.0	22.8	57.3	6.0	14.4	12.5	7.0	16.2	9.5	15.3	15.5	10.7	9.5	34.3	4.2	7.6	10.0	9.6	11.1	13.5	76.4	14.0	13.2	27.4	12.2	7.5	25.0	11.2	22.7	6.6	4.3	4.7	4.6	18.1	10.5	8.9	13.5	20.9	2.9	4.1	8.7	22.9	12.3	7.4	5.4	3.2	8.6	14.7	2.5	15.8	12.9	18.2	4.3	23.6	9.4	13.3	11.7	5.3	16.2	6.7	19.4	5.8	18.6	8.9	50.4	8.1	24.1	11.0	14.9	14.3	6.0	7.8	21.7	17.2	13.6	14.9	29.7	17.1	36.3	17.4	9.0	23.7	8.2	6.2	16.4	13.7	10.8	9.4	15.4	5.3	4.5	16.4	6.8	20.0	76.4	14.0	17.6	18.9	13.9	16.6	11.1	21.3	16.7	13.5	10.8	18.0	15.3	24.0	13.2	7.9	11.1	27.4	12.2	44.3	64.6	14.4	68.3	48.5	69.1	33.6	29.9	37.1	10.7	38.7	29.3	20.0	41.3	20.6	34.2	7.7	53.5	46.8	39.8	82.0	31.4	45.1	16.6	79.5	128.0	23.5	40.6	0.0	89.9	35.2	36.2	52.9	189.3	34.5	39.0	17.5	86.2	65.7	29.1	233.4	39.4	32.1	57.3	21.6	32.4	62.9	61.3	31.6	49.5	44.0	27.9	6.5	24.7	38.5	29.7	20.7	43.5	43.7	23.9	42.0
RHBDF1	"C16orf8, Dist1, EGFR-RS, FLJ2235, iRhom1"	ENSG00000007384	"Rhomboid 5 homolog 1"	Q96CC6	16	58059-76355	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Protein transport, Transport"	"Growth factor binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	7	"Cone photoreceptor cells: 62.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"intermediate monocyte: 1.7"	"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA077399			Uncertain	Vesicles		NA	NA			Vesicles		"HPA077399: "	"unprognostic (2.62e-1)"	"unprognostic (2.86e-2)"	"unprognostic (4.76e-2)"	"unprognostic (4.04e-2)"	"unprognostic (1.51e-2)"	"unprognostic (3.69e-2)"	"unprognostic (5.60e-3)"	"unprognostic (4.54e-3)"	"unprognostic (4.51e-2)"	"unprognostic (1.02e-1)"	"unprognostic (7.81e-3)"	"unprognostic (2.09e-1)"	"prognostic unfavorable (2.49e-5)"	"unprognostic (4.81e-2)"	"unprognostic (1.87e-1)"	"unprognostic (8.36e-2)"	"unprognostic (4.22e-2)"	12.7	3.7	6.2	11.5	9.3	0.3	17.7	3.5	6.2	21.8	10.8	6.1	6.7	5.6	13.0	10.4	17.5	10.6	17.2	15.9	7.0	2.8	8.2	3.8	17.8	4.1	6.9	4.9	18.8	9.6	9.8	4.3	26.5	7.3	19.6	5.5	15.9	20.1	13.5	13.4	22.4	7.5	14.6	5.8	6.1	9.2	7.1	3.1	1.2	11.2	15.7	10.1	16.0	19.4	0.0	0.5	0.0	1.7	0.0	0.4	0.0	4.3	7.0	4.0	9.3	15.9	19.7	13.3	11.9	22.5	8.4	8.1	9.5	15.2	0.2	5.0	12.7	4.3	13.8	2.0	8.0	1.4	0.1	2.2	0.1	7.0	2.6	17.8	0.1	7.7	16.4	8.5	21.8	3.6	15.0	12.8	0.0	1.6	0.2	13.3	24.2	0.0	1.4	3.6	9.1	6.0	0.1	4.8	0.3	9.4	4.4	0.1	1.0	3.4	13.2	7.4	5.2	20.4	1.5	13.3	13.4	9.4	10.3	3.2	0.1	0.2	0.1	9.3	0.2	20.9	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	6.2	9.3	3.5	6.2	7.0	2.8	6.9	4.9	7.3	3.1	17.9	3.8	0.0	8.9	6.1	0.9	8.1	20.4	1.4	6.8	8.7	62.8	14.0	0.0	19.1	0.5	9.5	5.3	0.0	6.9	14.1	18.2	19.2	0.0	2.6	1.9	0.0	0.0	6.2	0.3	0.9	18.1	0.3	15.1	0.0	8.3	5.7	19.4	7.2	13.1	2.1	4.3	12.9	12.9	0.2	2.5	4.8	25.6	0.5	2.9	9.4
RHBDF2	"FLJ22341, iRhom2, RHBDL5, RHBDL6, TOC, TOCG"	ENSG00000129667	"Rhomboid 5 homolog 2"	Q6PJF5	17	76470891-76501790	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Protein transport, Transport"	"Growth factor binding"	"Disease mutation, Palmoplantar keratoderma"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"B-cells: 44.0;Kupffer cells: 43.5;monocytes: 46.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"RPMI-8226: 35.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			HPA018080	Uncertain					NA	NA					"HPA018080: AB_2178634"	"unprognostic (1.19e-1)"	"unprognostic (8.71e-2)"	"unprognostic (1.59e-2)"	"unprognostic (5.11e-3)"	"unprognostic (4.33e-2)"	"unprognostic (1.63e-1)"	"unprognostic (2.63e-3)"	"unprognostic (9.79e-3)"	"unprognostic (2.55e-1)"	"unprognostic (1.72e-1)"	"unprognostic (4.49e-2)"	"unprognostic (1.38e-1)"	"prognostic unfavorable (3.96e-11)"	"unprognostic (5.24e-2)"	"unprognostic (2.14e-2)"	"unprognostic (1.61e-2)"	"unprognostic (1.14e-1)"	18.7	7.6	11.6	29.1	17.5	25.9	11.2	3.2	11.5	6.7	6.8	16.4	1.8	6.3	5.4	5.0	16.7	7.5	11.0	6.0	12.8	7.1	9.5	5.2	17.1	24.5	18.2	3.8	6.3	18.9	4.7	4.4	9.9	15.3	6.6	4.6	7.0	9.4	4.7	8.9	19.4	18.2	6.0	23.4	31.6	8.5	4.0	15.3	3.5	8.9	8.1	26.8	10.7	10.0	12.5	9.3	10.7	12.2	4.5	8.2	6.5	16.6	19.0	0.6	5.4	0.1	0.5	14.0	4.3	13.0	3.8	4.6	5.5	22.4	17.8	14.4	4.9	19.1	14.1	3.1	19.5	3.0	3.2	5.8	1.2	1.3	9.1	13.0	0.7	2.7	2.5	10.2	8.6	9.9	7.3	9.5	2.8	2.2	8.6	2.3	13.5	1.9	2.0	3.2	10.8	11.1	4.6	0.1	35.1	8.5	6.0	4.2	6.1	4.2	14.4	18.8	3.9	11.9	5.1	14.5	0.3	7.2	0.3	4.9	21.5	10.1	15.0	11.8	5.5	12.9	3.9	11.6	3.7	8.2	12.2	5.7	12.5	2.3	5.8	5.9	7.7	1.4	3.4	10.7	4.5	10.4	9.3	1.2	6.5	11.6	17.5	3.2	11.5	12.8	7.1	18.2	3.8	15.3	15.3	6.0	8.6	44.0	11.5	15.7	3.2	2.8	20.4	1.4	2.3	3.5	2.0	0.8	0.0	18.3	0.4	11.3	1.3	0.0	8.4	1.7	5.4	7.1	0.0	2.5	32.4	0.0	1.7	9.8	43.5	0.4	0.9	35.6	10.1	46.9	3.4	1.6	13.0	3.5	0.4	1.5	0.9	6.5	3.4	0.4	5.3	25.6	1.4	14.9	6.9	15.8
RHBDL1	"RHBDL, RRP"	ENSG00000103269	"Rhomboid like 1"	O75783	16	675666-678268	"Enzymes, Predicted membrane proteins"		"Hydrolase, Protease, Serine protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 21.3"	"Cell type enhanced"	"Detected in many"	13	"Bipolar cells: 12.0;Cone photoreceptor cells: 11.8;Horizontal cells: 14.3;Rod photoreceptor cells: 35.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"memory CD4 T-cell: 3.4"	"Group enriched"	"Detected in many"	20	"B-cells: 2.2;NK-cells: 1.3;T-cells: 3.4"	"Cell line enhanced"	"Detected in many"		"HeLa: 9.3;MCF7: 9.8;U-266/70: 11.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030359, HPA030360, HPA046593"	Uncertain		Approved	Nucleoplasm		No	No			Nucleoplasm		"HPA030359: AB_2673445, HPA030360: AB_2673446, HPA046593: AB_2679711"	"prognostic favorable (8.12e-4)"	"unprognostic (1.70e-1)"	"unprognostic (7.38e-2)"	"unprognostic (4.45e-1)"	"unprognostic (2.07e-1)"	"unprognostic (1.58e-2)"	"unprognostic (3.27e-2)"	"unprognostic (1.94e-1)"	"unprognostic (2.78e-1)"	"unprognostic (6.60e-3)"	"unprognostic (2.74e-2)"	"unprognostic (3.97e-2)"	"unprognostic (5.63e-3)"	"unprognostic (5.89e-2)"	"unprognostic (1.27e-1)"	"unprognostic (8.30e-3)"	"unprognostic (1.49e-2)"	1.7	6.3	10.0	1.1	8.3	2.3	0.7	21.3	14.5	1.3	2.2	1.3	2.2	5.8	1.3	1.7	1.1	1.0	1.2	2.4	8.4	9.9	3.9	1.2	0.8	1.1	5.5	7.2	0.9	6.2	2.2	4.4	1.1	4.6	1.5	1.1	1.5	6.1	2.6	0.8	3.1	5.9	0.7	2.2	0.6	4.5	2.2	1.9	0.7	0.6	0.6	0.5	0.8	0.5	2.2	0.1	0.0	0.0	1.3	3.4	0.7	1.8	2.3	1.3	2.0	1.0	2.7	6.9	0.8	1.3	0.4	0.1	4.8	1.3	0.7	1.6	0.5	0.2	1.2	0.1	0.4	0.0	1.7	8.7	1.0	9.3	1.9	1.0	1.7	1.3	1.8	3.3	0.3	0.0	1.0	0.1	3.1	1.3	1.3	0.1	9.8	0.4	4.7	1.3	2.5	0.7	8.3	1.2	1.8	0.1	1.6	1.7	2.3	1.0	0.5	2.2	0.9	3.6	4.9	0.5	2.8	2.6	0.9	0.6	11.9	1.6	2.3	1.0	3.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	2.2	3.4	0.3	0.0	0.5	0.5	0.2	0.0	1.3	0.0	0.1	1.2	0.7	10.0	8.3	21.3	14.5	8.4	9.9	5.5	7.2	4.6	1.9	0.0	0.0	0.0	4.2	1.9	12.0	0.8	0.0	8.1	1.2	0.0	11.8	0.2	0.0	0.7	2.0	0.0	3.9	0.0	0.5	0.2	0.9	1.4	0.0	0.8	0.3	14.3	2.4	0.6	1.2	1.1	1.4	0.0	0.0	0.0	4.5	2.0	1.0	3.6	2.5	7.4	35.2	0.0	0.5	0.7	2.1	1.6	0.2	0.0	4.7	1.6
RHBDL2	FLJ20435	ENSG00000158315	"Rhomboid like 2"	Q9NX52	1	38885807-38941799	"Enzymes, Predicted membrane proteins"		"Hydrolase, Protease, Serine protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 18.9"	"Cell type enhanced"	"Detected in many"	6	"Enterocytes: 26.3;Pancreatic endocrine cells: 31.9;Suprabasal keratinocytes: 24.8;Undifferentiated cells: 31.4;Urothelial cells: 36.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"A-431: 8.2;CAPAN-2: 26.6;HaCaT: 13.8;RT4: 26.8"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			HPA043807	Approved					NA	NA					"HPA043807: AB_10961118"	"unprognostic (3.34e-2)"	"unprognostic (2.96e-1)"	"unprognostic (4.57e-2)"	"unprognostic (2.56e-1)"	"unprognostic (7.26e-3)"	"unprognostic (2.19e-2)"	"unprognostic (1.04e-3)"	"unprognostic (5.81e-2)"	"unprognostic (2.36e-1)"	"unprognostic (2.87e-1)"	"unprognostic (4.07e-3)"	"unprognostic (1.23e-1)"	"unprognostic (7.47e-9)"	"unprognostic (1.11e-2)"	"unprognostic (2.46e-1)"	"unprognostic (4.12e-2)"	"unprognostic (4.20e-2)"	1.4	0.0	2.9	6.7	2.7	0.0	1.5	0.4	4.0	5.5	14.9	1.7	0.4	0.7	1.9	0.7	18.9	0.7	6.9	4.9	4.2	2.1	0.5	0.4	2.1	1.5	4.9	0.7	1.2	2.4	0.0	0.4	1.0	1.6	3.1	14.7	0.8	8.2	0.4	0.4	13.4	0.9	0.9	7.9	0.6	12.3	8.4	0.4	1.3	0.4	12.2	16.4	6.9	8.2	1.7	2.1	5.3	1.7	0.9	0.9	0.7	8.2	3.3	0.2	0.1	0.1	1.0	0.9	0.4	0.1	0.6	0.1	0.5	26.6	0.2	1.9	3.8	2.4	13.8	0.0	4.9	0.3	0.1	0.1	0.1	2.0	1.8	0.5	0.0	0.3	0.6	0.6	4.0	0.0	2.5	0.8	0.2	0.0	0.2	0.5	0.0	0.0	0.1	0.2	0.9	0.7	0.1	0.1	0.0	0.0	26.8	0.2	0.1	2.8	6.8	0.2	0.3	3.5	0.2	0.5	3.0	0.3	0.2	0.2	0.2	0.3	0.3	2.6	0.4	0.1	3.6	1.7	1.1	0.8	1.1	0.4	1.7	0.6	0.5	1.9	1.1	0.7	0.7	5.3	0.9	0.7	2.1	0.9	0.7	2.9	2.7	0.4	1.5	4.2	2.1	4.9	0.7	1.6	0.4	0.0	0.3	0.0	6.7	15.8	2.4	0.4	2.5	9.4	6.8	3.5	0.0	0.4	0.0	11.2	2.8	1.1	26.3	0.0	14.2	0.2	2.3	11.4	4.6	0.0	0.2	1.6	2.4	1.3	0.0	0.4	0.6	0.0	1.7	1.0	21.0	1.5	31.9	23.0	0.0	0.0	1.6	6.5	2.0	0.0	0.0	24.8	0.6	0.0	31.4	36.7
RHBDL3	"RHBDL4, VRHO"	ENSG00000141314	"Rhomboid like 3"	P58872	17	32266176-32324661	"Enzymes, Predicted membrane proteins"		"Hydrolase, Protease, Serine protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 23.7"	"Group enriched"	"Detected in some"	9	"Horizontal cells: 96.9;Rod photoreceptor cells: 33.8"	"Cancer enhanced"	"Detected in some"		"glioma: 4.3"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A549: 5.9;AF22: 5.9;GAMG: 6.8;HDLM-2: 8.0;NTERA-2: 8.7;U-2 OS: 6.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA059607	Uncertain					NA	NA					"HPA059607: AB_2684081"	"unprognostic (7.70e-2)"	"unprognostic (3.71e-2)"	"unprognostic (2.36e-2)"	"unprognostic (6.95e-2)"	"unprognostic (2.91e-1)"	"unprognostic (2.83e-2)"	"unprognostic (2.22e-1)"	"unprognostic (1.93e-1)"	"unprognostic (1.85e-3)"	"unprognostic (1.13e-1)"	"unprognostic (1.82e-3)"	"unprognostic (1.75e-2)"	"unprognostic (4.19e-2)"	"unprognostic (2.18e-3)"	"unprognostic (2.11e-1)"	"unprognostic (1.23e-1)"	"unprognostic (8.87e-2)"	1.0	8.2	6.8	1.2	7.4	0.7	1.1	11.3	23.7	1.4	1.2	2.9	3.3	0.9	2.0	1.9	1.3	4.4	0.9	9.7	10.1	6.6	0.8	0.6	0.7	0.7	9.1	4.6	3.4	1.1	0.6	1.9	1.0	6.7	2.1	1.4	3.9	1.0	5.6	0.6	0.9	0.9	1.8	3.6	0.6	0.9	2.5	4.0	0.0	0.6	0.0	0.8	1.9	1.1	0.8	0.0	0.0	0.0	0.0	0.3	0.3	0.0	5.9	5.9	4.6	0.9	0.0	0.1	0.3	0.6	1.9	1.9	0.1	0.0	0.0	0.4	0.7	6.8	0.1	1.6	0.0	0.5	8.0	2.3	1.0	4.0	0.3	0.0	0.0	0.1	0.0	0.0	1.4	0.0	0.3	0.0	0.3	0.5	0.0	0.5	0.1	0.2	0.0	8.7	0.0	0.0	1.0	0.0	0.0	0.0	3.2	0.1	1.5	0.8	0.1	0.1	2.2	0.4	0.1	0.0	0.0	6.1	0.2	2.9	0.0	0.0	0.0	0.3	0.9	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.3	6.8	7.4	11.3	15.6	10.1	6.6	9.1	4.6	6.7	4.0	0.0	0.0	0.0	0.6	0.3	6.0	4.3	0.0	0.0	0.0	0.0	5.9	1.3	0.0	0.0	2.6	0.1	0.0	0.0	0.0	0.0	0.5	0.3	0.0	0.0	0.4	96.9	0.0	0.6	0.8	1.5	0.9	0.0	0.0	0.0	0.1	7.3	0.0	0.0	0.0	0.0	33.8	0.0	1.0	0.0	0.9	0.1	0.5	0.0	0.0	0.5
RIDA	"HRSP12, P14.5, PSP, UK114"	ENSG00000132541	"Reactive intermediate imine deaminase A homolog"	P52758	8	98102344-98117241	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Hydrolase, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	9	"kidney: 81.4;liver: 248.6"	"Cell type enriched"	"Detected in many"	5	"Proximal tubular cells: 1135.9"	"Cancer enhanced"	"Detected in all"		"liver cancer: 162.2"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"OE19: 61.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA022856, HPA023489"	Enhanced					NA	NA		5700000			"HPA022856: AB_1858253, HPA023489: AB_1858252"	"unprognostic (1.67e-2)"	"unprognostic (3.73e-1)"	"unprognostic (1.29e-1)"	"unprognostic (1.10e-1)"	"unprognostic (4.16e-1)"	"unprognostic (2.20e-2)"	"prognostic favorable (9.61e-6)"	"unprognostic (6.08e-2)"	"unprognostic (1.13e-1)"	"unprognostic (3.15e-1)"	"unprognostic (2.81e-1)"	"unprognostic (4.46e-1)"	"unprognostic (1.55e-1)"	"unprognostic (1.73e-1)"	"unprognostic (2.04e-1)"	"unprognostic (2.08e-2)"	"unprognostic (1.51e-2)"	8.3	9.4	16.8	2.5	18.8	1.6	4.2	5.6	11.6	2.6	4.7	4.5	2.7	5.8	2.1	4.8	2.8	2.2	4.3	5.2	11.7	12.5	81.4	248.6	2.2	2.1	19.1	9.5	4.6	5.2	3.5	1.8	2.4	11.8	4.0	4.8	2.3	3.2	2.7	6.8	2.3	4.2	2.5	7.9	1.8	4.6	3.3	9.5	0.6	3.2	3.5	2.6	3.2	1.8	12.1	10.0	5.0	8.3	8.4	12.8	7.1	13.9	12.1	9.8	11.9	22.2	17.3	10.7	12.9	9.1	8.6	10.4	16.4	9.4	19.8	16.6	9.4	11.5	9.9	21.4	18.3	17.5	6.9	9.2	14.4	8.2	17.5	10.1	5.3	2.3	14.9	6.3	12.1	13.3	10.9	11.1	21.4	25.6	4.3	11.5	18.1	11.2	14.4	15.5	61.2	22.1	13.0	7.1	5.7	20.8	10.0	10.6	5.3	8.2	5.7	8.9	13.0	14.5	7.0	6.7	6.7	4.2	11.3	5.1	10.3	14.1	9.7	11.7	11.2	4.3	0.1	8.3	5.0	6.5	7.0	8.3	12.1	9.4	9.5	10.0	9.5	12.2	12.8	1.5	8.4	7.0	7.6	12.3	7.1	16.8	18.8	5.6	11.6	11.7	12.5	19.1	9.5	11.8	9.5	23.8	15.3	0.0	0.0	0.0	0.0	0.0	0.0	10.7	3.4	45.4	0.0	25.5	242.1	13.4	0.0	0.0	0.0	0.0	7.5	23.7	0.0	0.0	2.3	0.0	21.3	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	10.0	0.0	0.0	14.6	0.0	0.0	1135.9	0.0	0.0	0.0	0.0	0.0	0.0	12.0	0.0	0.0	0.0
RIMKLA	"FAM80A, MGC47816, NAAGS-II, RP11-157D18.1"	ENSG00000177181	"Ribosomal modification protein rimK like family member A"	Q8IXN7	1	42380795-42422578	"Enzymes, Predicted intracellular proteins"		Ligase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 20.1"	"Cell type enhanced"	"Detected in many"	8	"Cone photoreceptor cells: 41.2;Horizontal cells: 33.4;Rod photoreceptor cells: 23.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"AN3-CA: 7.8;JURKAT: 6.3;Karpas-707: 9.1;SCLC-21H: 11.9;U-266/70: 8.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA027826	Uncertain		Uncertain	"Nucleoli fibrillar center"		NA	NA			"Nucleoli fibrillar center"		"HPA027826: AB_10603992"	"unprognostic (4.04e-2)"	"unprognostic (1.61e-1)"	"unprognostic (3.68e-3)"	"unprognostic (9.84e-2)"	"unprognostic (2.49e-2)"	"unprognostic (1.06e-1)"	"unprognostic (2.63e-3)"	"prognostic favorable (1.43e-4)"	"unprognostic (8.89e-2)"	"unprognostic (3.76e-1)"	"unprognostic (9.34e-2)"	"unprognostic (1.63e-1)"	"unprognostic (1.22e-3)"	"unprognostic (3.99e-2)"	"unprognostic (7.07e-2)"	"unprognostic (1.63e-2)"	"unprognostic (3.44e-1)"	0.9	1.2	6.2	1.5	10.4	0.8	1.3	7.8	18.4	1.0	7.9	1.7	0.0	1.4	1.0	0.8	1.0	0.9	1.8	8.5	7.5	5.9	2.5	0.7	5.4	0.8	7.9	8.5	0.7	2.5	6.6	2.0	1.3	20.1	2.2	9.0	3.3	1.1	1.2	1.4	1.1	1.3	2.4	3.6	1.1	2.1	2.3	1.2	0.0	2.2	0.0	0.8	1.1	0.4	0.3	1.6	1.3	0.2	0.4	2.0	0.1	0.0	0.8	0.1	7.8	0.1	0.0	1.5	0.0	0.0	0.2	0.5	0.4	0.2	0.0	1.6	0.0	1.3	0.0	4.6	0.0	0.4	4.1	3.1	0.3	0.1	1.3	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	6.3	0.0	9.1	0.0	0.3	2.1	0.0	4.0	0.6	5.5	0.0	0.3	0.4	0.7	2.1	11.9	5.1	0.4	0.3	0.1	0.9	0.4	2.0	0.0	0.0	0.4	0.0	0.8	8.3	4.7	5.5	0.1	0.0	0.0	1.1	0.2	1.3	0.2	0.2	2.0	0.2	0.1	1.0	0.0	0.3	0.1	0.2	1.0	0.4	0.1	1.6	0.1	0.1	6.2	10.4	7.8	18.4	7.5	5.9	7.9	8.5	20.1	1.2	14.9	4.6	0.0	0.8	0.6	13.2	13.0	0.0	0.0	1.2	1.8	41.2	1.0	1.7	3.2	4.7	0.9	7.8	0.0	4.2	11.6	0.3	2.9	0.0	0.0	0.8	33.4	10.9	1.3	0.0	6.4	0.3	0.8	5.0	0.0	7.5	4.5	6.8	5.9	0.0	2.4	23.9	0.0	0.5	1.0	2.5	0.1	1.4	0.0	5.5	0.7
RIMKLB	"FAM80B, KIAA1238, NAAGS, NAAGS-I"	ENSG00000166532	"Ribosomal modification protein rimK like family member B"	Q9ULI2	12	8681600-8783095	"Enzymes, Predicted intracellular proteins"		Ligase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	9	"Early spermatids: 171.4;Late spermatids: 230.6;Syncytiotrophoblasts: 114.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"SuSa: 31.2;U-698: 52.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA059552			Approved	"Nucleoplasm,Centriolar satellite"		NA	NA			"Nucleoplasm, Centriolar satellite"		"HPA059552: "	"unprognostic (5.29e-3)"	"unprognostic (2.26e-2)"	"unprognostic (1.89e-5)"	"unprognostic (2.40e-2)"	"unprognostic (2.30e-1)"	"unprognostic (3.35e-2)"	"unprognostic (6.56e-2)"	"unprognostic (8.52e-2)"	"unprognostic (8.67e-3)"	"unprognostic (1.76e-1)"	"unprognostic (3.25e-1)"	"unprognostic (2.15e-1)"	"unprognostic (2.01e-1)"	"unprognostic (2.16e-2)"	"unprognostic (3.02e-1)"	"unprognostic (3.74e-1)"	"unprognostic (3.99e-1)"	22.5	10.7	15.9	10.7	19.2	15.8	20.1	23.3	21.2	18.1	17.6	16.4	11.2	5.1	35.9	18.2	10.4	25.4	12.5	10.7	17.6	12.8	9.2	3.2	13.9	7.6	10.2	19.0	22.7	7.3	36.2	10.1	21.2	19.9	11.7	6.5	18.0	9.0	13.5	9.5	8.8	8.7	25.5	14.0	11.5	7.7	27.8	12.1	13.6	15.6	4.8	6.4	11.8	18.4	4.0	1.3	5.3	2.9	2.8	3.9	2.5	1.2	7.1	16.5	17.5	2.2	2.0	23.5	6.9	3.3	5.8	4.0	0.6	7.5	10.3	6.5	4.5	6.5	2.6	8.3	9.2	6.5	0.1	5.1	4.8	20.1	0.0	2.6	1.4	4.9	4.3	4.1	5.5	9.6	4.0	7.5	8.7	6.6	0.0	3.6	4.3	9.5	0.6	19.4	0.0	0.4	14.9	22.5	0.0	8.9	3.6	0.5	10.8	7.6	9.8	6.7	31.2	2.1	4.7	14.1	6.1	20.4	3.2	2.2	0.1	0.0	52.5	5.3	0.9	4.2	5.3	2.9	1.2	2.4	1.1	3.0	2.2	2.4	3.5	1.2	4.0	3.9	1.5	0.7	2.8	1.4	1.3	0.1	2.5	15.9	19.2	23.3	19.5	17.6	12.8	10.2	19.0	19.9	12.1	26.8	40.5	5.0	21.6	13.5	20.8	13.7	10.2	41.5	35.2	12.2	0.0	49.9	13.3	12.1	171.4	30.3	2.0	23.3	2.6	14.1	23.7	15.5	11.5	0.0	16.2	12.7	8.6	20.3	7.5	230.6	21.6	7.7	32.1	1.0	2.5	35.5	5.6	2.9	29.0	7.9	3.1	12.9	22.8	49.1	26.8	11.7	114.2	5.1	1.0	15.0
RING1	RNF1	ENSG00000204227	"Ring finger protein 1"	Q06587	6	33208495-33212722	"Enzymes, Predicted intracellular proteins"	"Transcription, Transcription regulation, Ubl conjugation pathway"	"Chromatin regulator, Repressor, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA008701	Supported		Approved	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA008701: AB_1079814"	"unprognostic (2.12e-3)"	"unprognostic (7.98e-2)"	"unprognostic (3.77e-2)"	"unprognostic (1.37e-1)"	"unprognostic (3.91e-2)"	"unprognostic (3.21e-1)"	"unprognostic (1.53e-1)"	"unprognostic (4.75e-2)"	"unprognostic (7.76e-2)"	"unprognostic (1.26e-2)"	"unprognostic (3.70e-2)"	"unprognostic (1.62e-2)"	"unprognostic (2.22e-1)"	"unprognostic (1.04e-1)"	"unprognostic (1.55e-1)"	"unprognostic (2.13e-1)"	"unprognostic (9.88e-2)"	26.7	22.6	17.8	15.9	21.3	12.0	14.6	27.6	24.2	22.2	17.6	22.0	21.0	18.2	31.9	17.3	14.5	18.8	21.4	14.4	17.3	18.2	19.3	21.6	16.8	14.5	24.0	15.4	25.0	18.3	24.0	34.0	14.9	17.0	21.8	7.6	20.0	19.0	20.5	18.0	21.7	19.5	22.9	18.5	23.2	24.1	16.9	20.8	25.5	29.3	13.1	14.3	13.9	17.1	1.2	2.2	0.8	1.5	0.2	2.2	0.2	4.2	3.6	4.2	4.1	4.3	1.4	9.8	11.2	6.8	4.6	4.7	3.8	3.2	7.0	4.7	4.5	5.8	7.7	3.6	3.4	3.2	8.6	2.9	8.4	5.9	7.2	9.7	4.8	6.9	0.0	3.4	4.1	7.6	3.6	1.7	3.8	12.1	5.4	4.8	0.0	0.3	3.7	1.9	3.1	4.6	4.5	7.0	7.7	5.0	3.7	8.4	5.2	4.0	4.3	11.6	1.1	5.0	8.4	2.3	5.1	3.8	0.0	9.2	6.1	6.2	6.7	3.8	4.4	3.1	0.0	1.5	0.8	2.2	0.4	0.4	1.1	0.7	1.0	0.7	1.2	1.7	0.9	0.3	0.2	0.5	2.2	0.4	0.2	17.8	21.3	27.6	24.2	17.3	18.2	24.0	15.4	17.0	20.8	0.0	22.7	20.1	35.5	24.5	30.5	21.4	17.8	17.4	14.8	21.0	15.7	36.0	13.3	28.6	21.1	23.2	23.3	0.0	30.3	27.6	28.0	27.3	19.6	30.5	26.3	23.8	29.4	30.7	29.6	13.2	37.2	20.0	16.9	20.8	19.8	38.3	26.5	21.0	28.0	26.9	18.0	25.8	22.7	32.9	18.8	26.7	52.7	25.4	21.0	24.7
RIOK1	"AD034, bA288G3.1, FLJ30006, RRP10"	ENSG00000124784	"RIO kinase 1"	Q9BRS2	6	7389496-7418037	"Enzymes, Predicted intracellular proteins"	"Ribosome biogenesis"	"Hydrolase, Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Spermatogonia: 78.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA017866, HPA051446"	Enhanced		Supported	Cytosol		NA	NA			Cytosol		"HPA017866: AB_2669670, HPA051446: AB_2681488"	"unprognostic (2.33e-2)"	"unprognostic (1.24e-1)"	"unprognostic (2.38e-1)"	"unprognostic (1.03e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.51e-1)"	"prognostic unfavorable (3.41e-5)"	"unprognostic (2.23e-1)"	"prognostic unfavorable (4.43e-4)"	"unprognostic (3.45e-2)"	"unprognostic (1.47e-1)"	"unprognostic (1.87e-1)"	"prognostic unfavorable (5.85e-5)"	"unprognostic (2.33e-1)"	"unprognostic (2.09e-1)"	"unprognostic (6.12e-3)"	"unprognostic (2.59e-2)"	13.8	10.6	7.7	13.2	13.0	17.5	13.1	12.2	13.5	12.7	11.6	7.3	4.0	7.3	15.4	6.0	15.6	12.3	8.5	11.8	8.0	8.1	8.7	11.7	10.1	14.2	11.6	9.4	13.8	15.3	7.7	17.8	13.9	13.3	10.7	9.6	7.2	10.2	10.3	18.8	12.5	9.9	15.5	9.4	14.4	10.3	21.3	9.2	19.2	10.1	14.7	16.8	10.9	12.6	15.4	14.9	7.7	11.1	18.6	15.0	8.2	7.6	4.4	7.2	16.8	11.2	9.2	11.0	9.6	6.5	9.0	7.4	12.9	3.9	19.9	17.1	7.8	7.8	7.8	18.1	7.7	11.5	13.1	19.5	10.6	7.1	13.8	9.5	30.5	13.9	6.8	10.7	9.7	20.0	4.3	7.9	15.0	27.0	4.7	8.4	10.0	20.7	14.5	15.4	14.2	10.5	15.9	9.4	21.6	5.0	7.4	24.0	11.8	8.1	4.9	14.0	19.4	7.4	10.1	7.9	9.8	7.4	6.5	14.5	6.4	12.2	29.6	3.0	15.7	15.0	7.7	8.5	5.9	11.5	11.1	13.8	15.2	11.9	12.1	14.9	15.4	13.7	15.0	1.7	18.6	9.7	12.4	11.3	8.2	7.7	13.0	12.2	13.5	8.0	8.1	11.6	9.4	13.3	9.2	6.0	26.6	22.4	26.7	46.9	9.2	20.4	2.5	25.4	45.5	7.0	9.8	29.8	3.3	13.2	34.2	23.9	5.8	0.0	10.2	28.8	22.0	11.9	32.4	8.9	20.4	4.8	6.9	17.2	6.5	6.5	18.4	16.7	16.9	11.8	10.4	5.5	10.9	5.8	18.7	9.0	10.4	19.4	26.4	55.6	78.8	56.7	23.3	22.0	15.3	20.6
RIOK2	FLJ11159	ENSG00000058729	"RIO kinase 2"	Q9BVS4	5	97160867-97183260	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Ribosome biogenesis"	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											HPA005681	Uncertain		Approved	"Plasma membrane,Cytosol"		NA	NA			Cytosol	"Plasma membrane"	"HPA005681: AB_1856286"	"unprognostic (6.36e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.13e-2)"	"unprognostic (8.04e-2)"	"unprognostic (1.38e-1)"	"unprognostic (4.51e-2)"	"unprognostic (2.71e-3)"	"unprognostic (3.08e-1)"	"unprognostic (3.90e-2)"	"unprognostic (1.11e-1)"	"unprognostic (8.76e-2)"	"unprognostic (6.63e-2)"	"unprognostic (1.26e-3)"	"unprognostic (3.60e-1)"	"unprognostic (9.98e-2)"	"unprognostic (1.43e-2)"	"unprognostic (1.39e-2)"	22.2	20.1	14.8	17.1	17.5	24.4	19.7	26.3	18.6	19.1	17.0	8.9	14.0	17.3	17.5	17.1	17.0	15.0	10.7	19.6	15.7	13.4	21.0	23.6	13.3	17.6	20.0	11.1	20.7	21.5	15.1	37.5	15.8	19.7	19.5	17.3	10.3	18.7	16.6	24.9	13.3	20.2	16.3	20.7	22.5	16.4	14.8	18.6	25.8	21.7	20.7	17.4	20.7	21.0	15.2	17.8	9.4	18.7	17.8	24.1	13.5	8.8	10.4	9.7	18.8	12.8	14.0	15.5	22.3	13.8	15.8	21.0	14.2	15.6	19.6	25.4	10.0	24.9	10.5	16.5	13.0	21.7	13.8	9.1	9.8	20.1	19.8	11.5	18.6	13.8	9.2	10.2	19.3	19.6	12.1	12.8	14.6	14.8	12.7	18.1	14.8	21.8	22.3	11.5	5.3	11.2	24.5	18.9	28.8	12.4	8.1	12.1	9.0	13.5	14.1	15.4	15.1	14.7	17.8	13.7	20.3	14.1	16.1	24.3	12.5	16.2	44.0	12.1	19.1	18.5	7.0	16.0	9.4	16.3	18.7	22.3	15.2	20.7	17.8	17.8	11.0	22.5	24.1	3.2	17.8	13.4	17.8	18.5	13.5	14.8	17.5	26.3	18.6	15.7	13.4	20.0	11.1	19.7	18.6	8.9	10.9	13.0	14.3	23.5	16.4	15.9	12.7	10.7	11.4	7.0	11.8	16.7	14.9	14.2	1.1	14.0	7.0	0.0	13.1	19.4	15.8	9.9	27.6	7.8	15.9	12.7	9.2	6.2	11.0	1.8	12.4	11.5	5.0	13.6	11.2	12.3	10.5	10.5	15.2	12.2	17.2	6.5	21.7	20.7	20.2	16.6	14.5	14.4	12.1	11.4
RIOK3	SUDD	ENSG00000101782	"RIO kinase 3"	O14730	18	23452823-23486603	"Enzymes, Predicted intracellular proteins"	"Antiviral defense, Immunity, Innate immunity, Ribosome biogenesis"	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001620, HPA024184"	Approved		Approved	"Golgi apparatus,Plasma membrane,Centriolar satellite,Cytosol"		NA	NA			"Plasma membrane, Cytosol"	"Golgi apparatus, Centriolar satellite"	"HPA001620: AB_1079815, HPA024184: AB_1856289"	"unprognostic (7.99e-2)"	"unprognostic (1.71e-2)"	"unprognostic (2.39e-1)"	"unprognostic (3.03e-2)"	"unprognostic (1.05e-1)"	"unprognostic (7.48e-2)"	"unprognostic (8.98e-3)"	"unprognostic (1.01e-1)"	"unprognostic (5.10e-2)"	"unprognostic (4.20e-1)"	"prognostic unfavorable (4.10e-4)"	"prognostic unfavorable (5.80e-4)"	"unprognostic (3.90e-2)"	"unprognostic (1.46e-1)"	"unprognostic (5.44e-2)"	"unprognostic (1.39e-1)"	"unprognostic (2.71e-2)"	10.1	8.7	6.9	11.7	7.7	52.4	10.9	8.9	10.1	14.7	21.4	8.5	5.9	15.6	8.8	9.3	41.0	7.8	10.7	11.5	6.1	5.5	10.5	19.9	10.1	10.7	9.1	6.2	7.6	10.7	7.5	11.6	21.4	11.6	6.8	14.7	6.0	14.9	7.0	40.0	13.3	36.5	15.2	10.5	8.9	12.9	22.7	7.6	11.1	7.3	16.0	16.5	13.7	21.5	11.7	11.0	21.7	21.5	8.3	11.2	10.0	14.8	5.8	6.1	7.9	11.1	12.4	11.0	14.9	11.0	10.6	10.2	6.7	16.1	10.3	19.6	16.6	10.8	19.5	10.3	17.0	16.4	10.2	4.3	9.6	10.9	8.4	27.8	27.0	8.4	14.8	32.4	18.8	26.0	12.1	14.7	6.5	13.9	13.0	15.9	7.9	9.3	4.4	5.6	21.7	11.7	10.5	12.7	12.5	12.1	19.5	14.2	10.2	19.1	8.7	10.9	15.9	7.7	14.6	23.1	17.5	4.4	7.7	9.6	23.5	19.7	15.3	10.3	12.5	13.1	21.7	13.5	8.0	9.1	19.6	6.9	8.2	7.6	7.9	11.0	11.7	6.1	6.9	9.3	8.3	21.5	5.1	11.2	10.0	6.9	7.7	8.9	10.1	6.1	5.5	9.1	6.2	11.6	7.6	74.5	51.9	21.7	78.2	107.0	43.0	61.7	43.3	56.2	67.1	24.4	53.0	38.5	21.6	40.3	191.3	39.6	193.3	116.8	45.8	56.7	46.6	92.4	61.2	72.5	37.1	27.0	60.3	33.7	55.0	227.3	20.8	49.5	40.5	47.7	85.9	17.1	98.8	75.8	28.3	40.3	43.8	6.5	38.7	23.6	9.5	125.6	73.9	34.1	42.3	194.9
RIOX1	"C14orf169, FLJ21802, JMJD9, MAPJD, NO66"	ENSG00000170468	"Ribosomal oxygenase 1"	Q9H6W3	14	73490964-73493392	"Enzymes, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Chromatin regulator, Dioxygenase, Oxidoreductase, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"	8	"Cytotrophoblasts: 8.0;Extravillous trophoblasts: 6.2;Hofbauer cells: 7.3;monocytes: 12.6;Proximal tubular cells: 6.6"	"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003730			Supported	"Nucleoli rim"		NA	NA			"Nucleoli rim"		"HPA003730: AB_2667040"	"unprognostic (4.70e-3)"	"unprognostic (1.94e-2)"	"unprognostic (2.45e-1)"	"unprognostic (2.32e-1)"	"unprognostic (1.84e-3)"	"unprognostic (1.73e-1)"	"unprognostic (2.27e-2)"	"unprognostic (1.48e-1)"	"unprognostic (6.51e-2)"	"unprognostic (5.36e-2)"	"unprognostic (1.35e-3)"	"unprognostic (4.55e-2)"	"unprognostic (2.84e-3)"	"unprognostic (1.05e-1)"	"unprognostic (1.67e-1)"	"unprognostic (7.97e-3)"	"unprognostic (8.62e-2)"	3.9	2.4	4.3	5.2	5.6	8.0	4.0	7.6	8.0	5.3	4.1	6.7	3.6	4.1	4.5	5.7	3.9	4.7	3.3	5.3	3.4		4.1	5.1	4.1	8.4	5.8	4.9	4.5	6.1	5.2	3.2	2.8	4.6	4.0	4.1	4.7	5.0	5.0	2.8	4.0	3.4	4.8	2.1	5.0	3.9	10.5	5.2	17.3	4.5	3.6	7.5	3.7	4.4	3.5	5.2	5.1	3.8	4.9	7.4	1.3	10.5	9.6	6.2	9.6	8.1	4.6	12.0	7.2	5.3	7.5	6.7	8.2	5.4	18.0	5.3	6.2	6.3	12.5	11.9	7.2	6.3	11.4	13.1	11.3	5.7	5.4	4.5	0.0	15.2	4.9	6.7	7.2	3.3	4.8	6.7	10.6	8.2	6.7	6.6	16.6	19.6	12.8	6.8	9.2	16.2	15.7	9.7	5.4	7.4	7.9	12.9	9.4	12.0	21.6	7.6	6.5	21.5	11.3	9.6	0.0	12.4	6.4	0.0	9.2	9.9	6.3	3.3	9.3	7.3	0.2	2.2	5.1	6.4	3.8	7.4	3.5	6.5	5.1	3.0	2.7	6.0	4.4	0.9	4.9	2.3	5.2	2.8	1.3											3.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.7	5.2	0.0	8.0	5.0	3.3	0.0	0.0	0.0	0.0	4.9	6.2	0.0	0.0	2.3	0.0	7.3	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	12.6	0.0	0.0	3.7	0.0	0.0	6.6	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0
RIPK1	RIP	ENSG00000137275	"Receptor interacting serine/threonine kinase 1"	Q13546	6	3063991-3115187	"Enzymes, Predicted intracellular proteins"	"Apoptosis, Host-virus interaction, Inflammatory response, Necrosis"	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB010302, HPA015257"	Supported		Supported	"Plasma membrane,Cytosol"		NA	NA			"Plasma membrane, Cytosol"		"CAB010302: AB_2178118, HPA015257: AB_1856294"	"unprognostic (1.24e-1)"	"unprognostic (6.83e-2)"	"unprognostic (1.87e-1)"	"unprognostic (7.75e-2)"	"unprognostic (6.08e-2)"	"unprognostic (1.01e-2)"	"unprognostic (1.26e-2)"	"unprognostic (1.96e-1)"	"unprognostic (9.46e-2)"	"unprognostic (1.46e-1)"	"unprognostic (5.00e-2)"	"unprognostic (3.29e-1)"	"unprognostic (9.65e-3)"	"unprognostic (3.44e-1)"	"unprognostic (9.01e-2)"	"unprognostic (1.38e-2)"	"prognostic favorable (6.71e-4)"	24.5	12.0	6.9	15.7	12.4	10.5	28.0	11.9	11.0	16.4	18.9	9.6	22.9	14.5	16.8	17.7	17.1	13.5	17.9	12.3	7.5	6.8	18.5	36.7	16.7	19.8	11.8	6.6	13.2	19.9	14.4	17.9	24.4	10.2	17.8	16.6	10.9	21.1	18.7	11.4	18.9	24.8	21.3	6.9	19.4	15.8	9.0	9.4	18.6	18.5	15.2	19.2	15.0	20.4	4.1	3.2	6.6	3.9	6.6	7.6	2.1	9.5	6.8	10.3	10.6	22.0	14.1	5.7	15.0	20.4	15.9	18.3	9.2	6.6	8.9	14.5	21.5	16.7	11.0	12.8	12.3	17.4	18.4	6.9	11.5	4.5	6.7	12.4	9.9	14.7	19.0	11.0	14.7	10.7	13.0	13.7	5.5	12.9	5.1	15.3	12.3	6.8	10.8	6.5	11.5	8.5	8.3	7.6	10.0	14.2	19.1	8.9	8.8	9.9	6.2	16.6	21.9	11.4	7.1	16.6	17.4	9.3	6.6	11.1	7.9	10.2	9.5	7.3	5.5	19.2	1.1	3.0	6.4	6.1	3.7	4.9	2.0	4.9	7.6	3.2	4.1	4.1	5.4	6.6	6.6	3.9	2.9	5.7	2.1	6.9	12.4	11.9	11.0	7.5	6.8	11.8	6.6	10.2	9.4	6.0	8.1	8.8	8.6	9.7	3.4	6.9	12.7	21.4	20.5	8.7	11.8	7.3	5.0	8.1	1.6	15.8	13.6	0.0	11.3	5.6	9.8	8.2	10.4	12.3	10.1	4.8	6.3	11.6	5.1	0.4	6.4	11.1	3.3	17.2	15.4	7.2	10.3	10.1	5.6	8.2	21.0	19.4	15.1	0.9	2.5	8.7	10.0	12.5	9.3	12.2
RIPK2	"CARD3, CARDIAK, RICK, RIP2"	ENSG00000104312	"Receptor interacting serine/threonine kinase 2"	O43353	8	89757747-89791063	"Enzymes, Predicted intracellular proteins"	"Adaptive immunity, Apoptosis, Immunity, Innate immunity"	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"hTERT-HME1: 28.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA015273, HPA016499"	Approved		Enhanced	Cytosol		NA	NA			Cytosol		"HPA015273: AB_1856299, HPA016499: AB_1856300"	"unprognostic (1.20e-1)"	"unprognostic (1.02e-2)"	"unprognostic (2.35e-1)"	"unprognostic (3.82e-2)"	"unprognostic (1.67e-1)"	"unprognostic (6.20e-2)"	"unprognostic (1.43e-3)"	"prognostic unfavorable (6.33e-5)"	"unprognostic (2.06e-1)"	"unprognostic (7.80e-2)"	"prognostic unfavorable (5.00e-6)"	"unprognostic (6.39e-2)"	"prognostic unfavorable (0.00e+0)"	"unprognostic (1.84e-2)"	"unprognostic (5.08e-2)"	"unprognostic (1.05e-2)"	"prognostic favorable (8.05e-4)"	12.0	5.5	9.3	11.2	7.9	13.6	10.0	3.0	9.3	9.7	7.9	10.6	5.2	3.5	10.9	7.8	8.3	7.0	17.3	11.6	9.2	8.6	7.7	10.4	18.7	10.9	11.8	5.8	8.9	13.2	14.7	7.3	20.8	9.1	10.7	5.6	4.6	10.2	5.8	3.1	10.4	6.9	10.4	16.5	14.2	8.3	5.6	11.5	5.1	8.5	4.9	11.8	15.0	7.6	7.5	6.9	19.4	11.2	3.8	5.5	4.3	10.3	3.6	1.8	2.6	4.5	6.3	3.4	11.5	19.6	6.1	7.9	3.1	5.4	8.0	17.9	6.4	4.9	2.5	4.9	3.8	11.3	5.7	4.9	6.7	1.7	3.1	12.7	2.4	3.3	5.0	3.1	8.7	28.1	6.5	6.4	0.0	3.2	2.6	5.6	2.1	0.0	5.1	1.0	4.7	8.5	1.7	2.6	3.9	14.3	4.6	0.3	2.0	2.7	7.2	5.4	2.5	7.0	3.0	5.7	3.7	3.5	6.3	5.3	5.3	2.4	4.8	9.1	0.2	2.4	8.8	5.7	19.4	3.6	10.6	4.1	7.5	5.5	4.7	6.9	4.3	5.2	5.5	4.5	3.8	11.2	2.3	1.2	4.3	9.3	7.9	3.0	7.4	9.2	8.6	11.8	5.8	9.1	11.5	32.8	17.8	13.4	31.1	51.2	2.4	2.8	5.1	10.7	22.7	3.5	0.0	10.6	5.0	66.4	5.0	9.5	2.3	0.0	53.1	35.2	38.5	46.3	42.7	2.6	39.0	3.2	0.0	5.5	25.3	1.6	7.2	48.6	18.6	50.5	5.2	10.0	41.2	0.0	5.6	6.7	0.1	12.9	22.7	8.1	10.9	42.2	70.0	12.7	6.6	40.4
RIPK3	RIP3	ENSG00000129465	"Receptor interacting serine/threonine kinase 3"	Q9Y572	14	24336021-24340045	"Enzymes, Predicted intracellular proteins"	"Apoptosis, Necrosis"	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 25.8"	"Cell type enhanced"	"Detected in many"	7	"Enterocytes: 20.6;Exocrine glandular cells: 30.8;Paneth cells: 17.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"CAPAN-2: 7.6;HDLM-2: 4.3;OE19: 11.3;SK-BR-3: 12.5"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in many"									NA	NA						"unprognostic (1.85e-2)"	"unprognostic (1.66e-1)"	"unprognostic (5.16e-3)"	"unprognostic (1.12e-2)"	"unprognostic (1.95e-1)"	"unprognostic (1.29e-1)"	"unprognostic (1.19e-1)"	"unprognostic (2.32e-1)"	"unprognostic (3.25e-1)"	"unprognostic (2.02e-1)"	"unprognostic (3.31e-2)"	"unprognostic (1.11e-1)"	"unprognostic (5.26e-3)"	"unprognostic (9.58e-2)"	"unprognostic (5.58e-2)"	"unprognostic (1.08e-1)"	"unprognostic (2.93e-2)"	7.6	1.3	1.8	9.7	2.4	4.3	6.0	0.9	1.6	4.5	13.6	1.8	1.4	10.6	3.7	3.8	9.2	3.2	12.7	2.6	2.7	0.6	3.8	1.3	6.4	7.2	3.9	0.8	1.7	8.4	0.5	0.9	3.7	2.3	3.7	11.8	3.6	7.5	1.7	2.1	5.9	25.8	2.1	3.8	15.1	9.2	1.6	3.6	7.2	8.7	6.1	13.3	4.6	5.6	3.5	5.2	6.3	8.8	3.9	9.1	4.3	0.0	0.0	0.0	0.0	2.9	3.2	0.0	0.7	3.9	0.0	0.0	0.1	7.6	0.1	2.0	0.3	0.0	1.9	0.0	0.1	0.0	4.3	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	1.3	1.3	0.0	0.1	0.0	0.0	0.0	0.5	0.0	11.3	0.0	0.0	0.0	1.3	1.4	0.0	0.0	0.0	0.0	12.5	0.0	0.0	2.2	3.3	1.8	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	1.7	0.0	2.6	5.1	6.3	6.3	7.7	6.4	3.5	5.4	6.2	5.2	3.5	2.9	4.0	2.6	3.9	8.8	2.6	9.1	4.3	1.8	2.4	0.9	1.6	2.7	0.6	3.9	0.8	2.3	3.6	3.0	10.8	1.9	1.6	1.3	0.0	0.4	2.5	1.4	1.2	3.5	0.0	0.3	3.3	6.3	0.1	2.9	20.6	0.0	30.8	0.2	1.8	0.6	11.6	0.0	11.0	0.0	5.8	0.0	10.0	0.0	0.0	6.3	3.3	10.8	9.2	0.0	15.3	17.5	0.0	0.0	0.0	0.0	1.9	0.0	0.1	1.3	0.2	8.7	6.5	2.3
RIPK4	"ANKK2, ANKRD3, DIK, PKK, RIP4"	ENSG00000183421	"Receptor interacting serine/threonine kinase 4"	P57078	21	41739369-41767106	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		"Kinase, Receptor, Serine/threonine-protein kinase, Transferase"	"Disease mutation, Ectodermal dysplasia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 42.1"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Group enriched"	"Detected in some"	9	"naive CD4 T-cell: 1.5;neutrophil: 2.2"	"Group enriched"	"Detected in many"	17	"granulocytes: 2.2;T-cells: 1.5"	"Cell line enhanced"	"Detected in many"		"CAPAN-2: 15.9;GAMG: 20.8;HaCaT: 23.5;hTCEpi: 15.8;RPTEC TERT1: 14.2;RT4: 15.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA030942	Enhanced					NA	NA					"HPA030942: AB_2732462"	"unprognostic (8.93e-2)"	"unprognostic (2.67e-1)"	"unprognostic (6.32e-3)"	"unprognostic (7.87e-2)"	"unprognostic (1.24e-1)"	"unprognostic (5.61e-2)"	"unprognostic (1.30e-1)"	"unprognostic (2.88e-2)"	"unprognostic (1.02e-1)"	"prognostic unfavorable (6.22e-5)"	"prognostic unfavorable (3.48e-4)"	"unprognostic (9.98e-2)"	"prognostic favorable (6.52e-4)"	"unprognostic (2.69e-1)"	"unprognostic (2.95e-3)"	"unprognostic (2.28e-1)"	"unprognostic (2.78e-2)"	1.0	0.2	0.2	0.8	0.2	0.1	3.3	0.2	0.2	6.7	9.4	0.3	12.0	6.8	1.7	6.5	42.1	4.2	17.1	1.1	0.4	0.2	10.8	17.3	5.4	0.4	0.2	0.1	1.8	14.4	4.7	6.8	2.8	1.1	10.6	1.3	4.8	10.2	14.8	0.2	11.7	11.6	2.0	0.3	0.2	11.2	2.7	0.0	8.1	13.6	12.3	26.6	5.2	11.0	0.0	0.0	2.2	0.1	0.0	1.5	0.2	6.8	4.4	0.0	0.0	0.0	0.0	6.9	0.0	0.0	0.1	0.1	11.4	15.9	0.0	6.7	1.4	20.8	23.5	0.3	9.5	0.0	0.0	4.7	0.0	3.3	4.2	0.0	0.0	0.0	0.0	15.8	0.1	2.1	0.0	0.0	7.1	0.0	0.0	0.0	5.0	0.9	0.0	0.4	4.5	13.1	0.0	0.0	1.1	14.2	15.1	2.3	0.1	7.7	7.8	7.1	0.7	4.8	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	2.1	0.0	5.9	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	1.5	0.1	2.2	0.0	0.0	0.0	0.0	0.2	0.2	0.2	0.2	0.2	0.4	0.2	0.2	0.1	1.1	0.0	26.8	10.8	0.0	26.1	14.1	0.0	1.0	12.7	17.4	14.8	3.5	0.0	7.0	8.3	10.8	0.4	0.0	17.3	0.0	9.0	4.7	0.7	20.1	2.3	16.1	0.9	0.0	21.8	0.0	1.6	1.1	0.0	0.6	6.8	0.0	13.4	0.0	14.2	8.7	0.0	10.0	0.9	0.0	0.3	1.1	0.6	13.2	2.1	0.0	9.8	19.5
RLIM	"MGC15161, NY-REN-43, RNF12"	ENSG00000131263	"Ring finger protein, LIM domain interacting"	Q9NVW2	X	74585217-74614617	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Transcription, Transcription regulation, Ubl conjugation pathway"	Transferase	"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA018895	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA018895: AB_1856323"	"unprognostic (1.17e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.72e-1)"	"unprognostic (1.31e-3)"	"unprognostic (1.25e-1)"	"unprognostic (1.03e-1)"	"unprognostic (8.98e-3)"	"unprognostic (1.36e-1)"	"unprognostic (1.03e-1)"	"unprognostic (2.06e-1)"	"unprognostic (1.12e-1)"	"unprognostic (4.91e-2)"	"unprognostic (2.25e-1)"	"unprognostic (3.82e-2)"	"unprognostic (1.24e-1)"	"prognostic unfavorable (6.04e-4)"	"unprognostic (1.20e-1)"	11.8	14.3	17.5	10.6	25.6	37.4	12.4	12.6	20.5	12.2	7.4	8.3	5.6	6.4	10.6	8.0	10.2	9.5	10.7	10.5	17.1	16.6	11.6	9.7	13.8	9.2	12.4	13.7	12.4	9.7	19.5	18.5	10.5	28.6	11.9	7.6	5.2	8.9	8.7	11.2	10.2	7.1	10.1	13.9	9.8	8.4	6.9	12.4	9.7	13.0	6.2	10.1	10.5	9.3	3.5	4.8	16.3	7.4	5.2	4.6	3.0	13.7	14.0	13.6	11.3	13.7	14.5	13.4	13.2	15.4	11.9	14.7	10.9	14.4	7.4	15.5	16.6	16.1	11.9	27.3	15.9	18.2	6.7	14.4	13.0	24.7	6.6	12.2	19.5	23.2	14.0	10.0	16.9	29.1	10.2	13.8	12.4	11.2	13.5	15.6	10.5	14.5	11.1	20.9	8.5	13.5	13.9	28.8	12.5	11.0	16.5	10.0	11.7	24.9	12.1	15.4	13.0	6.8	15.4	18.3	14.4	14.0	14.7	11.5	7.2	13.8	11.9	15.7	19.9	14.0	16.3	5.9	5.6	3.2	7.4	3.3	3.0	4.1	4.0	4.8	3.5	4.5	4.1	11.4	5.2	5.4	2.6	4.6	3.0	17.5	25.6	12.6	20.5	17.1	16.6	12.4	13.7	28.6	12.4	14.9	17.1	2.9	24.0	31.8	12.3	26.3	15.3	24.1	20.5	24.4	13.7	14.1	10.0	12.7	5.5	27.4	7.8	0.0	9.2	17.5	26.4	21.1	36.9	11.9	16.0	20.6	22.2	20.3	20.2	3.3	9.2	23.6	16.9	3.6	9.8	13.7	11.6	8.6	17.7	9.6	13.8	6.5	17.6	7.2	17.2	33.9	22.0	17.0	10.2	31.0
RNASE1	"RAC1, RNS1"	ENSG00000129538	"Ribonuclease A family member 1, pancreatic"	P07998	14	20801228-20803278	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"		"Endonuclease, Hydrolase, Lyase, Nuclease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	8	"pancreas: 809.6"	"Cell type enhanced"	"Detected in many"	10	"Alveolar cells type 1: 863.6;Alveolar cells type 2: 748.9;Hofbauer cells: 1257.5;Ito cells: 532.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"classical monocyte: 8.0;myeloid DC: 16.1"	"Group enriched"	"Detected in many"	9	"dendritic cells: 16.1;monocytes: 8.0"	"Cell line enhanced"	"Detected in some"		"HUVEC TERT2: 74.4;OE19: 16.9;RT4: 29.1;TIME: 38.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA001140	Enhanced		Approved	Nucleoplasm,Vesicles	"Secreted to digestive system"	NA	NA		1500000000	Vesicles	Nucleoplasm	"HPA001140: AB_1079816"	"unprognostic (2.32e-2)"	"unprognostic (3.16e-2)"	"unprognostic (9.51e-3)"	"unprognostic (7.77e-2)"	"unprognostic (6.93e-2)"	"unprognostic (1.28e-1)"	"unprognostic (3.42e-3)"	"unprognostic (6.59e-3)"	"unprognostic (4.69e-2)"	"unprognostic (7.92e-2)"	"unprognostic (6.32e-2)"	"unprognostic (3.56e-2)"	"unprognostic (5.14e-3)"	"unprognostic (1.11e-2)"	"unprognostic (1.47e-1)"	"unprognostic (2.43e-2)"	"unprognostic (1.67e-1)"	79.2	48.4	28.7	12.0	38.5	1.6	59.7	4.0	32.2	21.3	33.7	57.8	63.6	16.8	13.6	49.1	19.3	24.3	37.5	70.3	41.2	21.6	33.8	8.6	94.3	23.5	39.0	16.0	19.2	809.6	6.7	4.1	79.0	25.1	23.0	39.8	106.4	15.9	35.6	31.7	10.8	20.6	26.6	52.3	34.5	87.9	86.5	27.1	7.8	11.2	14.3	7.2	29.0	10.9	0.0	16.1	1.3	8.0	0.0	0.0	2.0	0.0	0.3	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.4	0.0	0.5	0.1	0.0	0.3	0.0	0.0	0.0	1.1	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	74.4	0.0	7.2	0.1	0.0	0.0	0.0	0.5	0.3	16.9	0.0	0.0	0.0	0.3	0.0	29.1	0.3	0.3	0.0	0.2	0.0	0.5	0.0	0.0	38.7	0.0	0.7	0.5	0.0	0.1	0.0	0.0	1.0	0.0	1.0	1.3	8.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	16.1	0.0	0.0	0.0	0.1	0.0	0.0	3.7	0.0	2.0	28.7	38.5	4.0	32.2	41.2	21.6	39.0	16.0	25.1	27.1	863.6	748.9	16.1	0.9	31.6	0.0	58.9	40.8	58.9	295.7	15.7	0.0	12.0	0.0	8.2	17.6	308.3	107.7	0.0	270.1	10.2	30.9	1.4	23.3	4.9	1257.5	1.6	46.9	532.2	311.7	43.1	29.7	100.6	38.8	4.6	398.3	0.8	308.4	78.7	10.3	0.3	1.8	97.0	15.6	7.0	5.3	24.6	21.6	7.5	165.1	1.7
RNASE2	"EDN, RAF3, RNS2"	ENSG00000169385	"Ribonuclease A family member 2"	P10153	14	20955452-20956436	"Enzymes, Plasma proteins, Predicted secreted proteins"	Chemotaxis	"Endonuclease, Hydrolase, Lyase, Nuclease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	10	"blood: 137.2;bone marrow: 236.7"	"Cell type enriched"	"Detected in some"	11	"Kupffer cells: 219.4"	"Cancer enriched"	"Detected in many"	7	"glioma: 14.1"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"basophil: 37.8;eosinophil: 137.2"	"Lineage enriched"	"Detected in many"	7	"granulocytes: 137.2"	"Group enriched"	"Detected in some"	318	"HL-60: 54.9;NB-4: 54.8;THP-1: 147.0;U-937: 133.3"									HPA044983	Enhanced				"Secreted to blood"	NA	NA		300000000			"HPA044983: AB_10963689"	"unprognostic (6.66e-2)"	"unprognostic (3.00e-1)"	"unprognostic (6.85e-2)"	"unprognostic (7.68e-2)"	"unprognostic (2.73e-2)"	"unprognostic (9.26e-2)"	"unprognostic (4.94e-3)"	"unprognostic (6.77e-2)"	"unprognostic (9.54e-2)"	"unprognostic (3.24e-2)"	"unprognostic (3.25e-2)"	"unprognostic (3.45e-1)"	"prognostic unfavorable (3.28e-13)"	"unprognostic (2.27e-2)"	"unprognostic (7.14e-3)"	"unprognostic (5.33e-2)"	"unprognostic (1.50e-1)"	2.7	3.2	4.8	2.0	9.3	236.7	0.5	0.9	3.7	0.9	0.6	1.4	0.1	0.5	0.7	0.5	0.5	3.2	0.9	3.7	3.9	1.8	1.2	1.3	6.6	7.2	4.7	0.1	0.5	2.5	0.5	0.6	0.8	4.9	0.5	0.6	0.1	0.7	0.5	0.9	0.9	0.6	2.1	10.5	19.4	0.9	0.6	3.7	0.1	0.5	0.1	0.6	1.4	0.3	0.0	20.0	137.2	11.5	0.0	0.0	3.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	54.9	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	54.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	147.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	133.3	0.0	37.8	11.5	137.2	0.0	2.0	0.0	0.0	0.0	0.0	20.0	0.0	0.0	0.0	1.0	0.0	0.2	0.2	0.0	3.3	4.8	9.3	0.9	3.7	3.9	1.8	4.7	0.1	4.9	3.7	3.0	0.3	0.8	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.1	1.7	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.9	13.1	0.0	0.0	1.8	219.4	1.1	0.3	20.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	19.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0
RNASEH1		ENSG00000171865	"Ribonuclease H1"	O60930	2	3544793-3558616	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		"Endonuclease, Hydrolase, Nuclease"	"Disease mutation, Primary mitochondrial disease, Progressive external ophthalmoplegia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA034817, HPA043037"	Uncertain		Approved	Nucleoplasm,Cytosol	"Intracellular and membrane"	NA	NA			Nucleoplasm	Cytosol	"HPA034817: , HPA043037: AB_2678280"	"unprognostic (1.64e-1)"	"unprognostic (1.38e-1)"	"unprognostic (8.81e-3)"	"unprognostic (4.32e-3)"	"unprognostic (1.79e-1)"	"unprognostic (1.18e-1)"	"prognostic unfavorable (7.83e-6)"	"unprognostic (9.43e-2)"	"unprognostic (8.46e-3)"	"unprognostic (6.38e-2)"	"unprognostic (2.29e-3)"	"unprognostic (2.67e-1)"	"unprognostic (4.06e-2)"	"unprognostic (2.34e-2)"	"unprognostic (2.11e-1)"	"unprognostic (3.06e-2)"	"unprognostic (2.23e-3)"	16.6	12.8	10.1	14.5	15.4	14.7	16.1	11.0	13.1	9.7	12.1	11.4	10.8	11.8	13.3	14.0	14.1	10.0	11.0	18.5	13.1	10.3	10.9	17.0	11.2	18.3	12.9	11.4	10.1	15.1	10.5	10.8	11.5	12.3	11.2	12.6	9.5	11.2	16.0	35.3	11.3	11.3	17.7	11.9	12.4	11.8	13.8	12.5	10.9	10.1	10.3	14.5	12.8	11.8	16.6	15.9	7.4	12.8	17.2	14.6	10.8	8.8	20.6	7.1	12.1	7.5	7.8	15.9	14.5	12.6	12.4	10.0	15.7	10.7	17.0	15.7	13.0	17.8	9.7	11.9	11.8	9.9	12.7	7.8	14.7	12.2	26.3	14.2	19.1	13.9	6.9	9.9	13.4	15.8	5.4	10.9	27.2	20.0	17.0	12.7	17.5	11.3	10.7	13.8	17.7	15.4	13.8	11.7	17.8	7.5	15.6	12.0	15.7	12.3	8.6	12.1	6.9	7.3	7.3	11.2	16.4	11.2	13.0	20.1	25.2	34.1	28.4	15.3	14.4	21.4	2.8	11.5	7.4	14.5	12.8	14.6	16.6	12.7	13.6	14.2	13.8	12.9	12.5	3.2	17.2	11.1	15.9	11.2	10.8	10.1	15.4	11.0	13.1	13.1	10.3	12.9	11.4	12.3	12.5	20.8	5.8	33.5	22.9	6.6	24.6	21.5	10.2	13.4	6.8	3.5	19.6	27.2	31.5	32.0	2.8	17.3	13.6	0.0	42.6	35.7	17.7	24.8	27.6	15.3	27.4	33.4	14.5	14.1	16.4	2.3	12.7	15.4	10.1	37.9	11.2	16.4	36.8	7.0	24.8	20.1	17.0	19.4	19.0	18.4	29.0	10.7	30.6	16.0	14.7	29.8
RNASEH2A	"AGS4, RNASEHI, RNHIA, RNHL"	ENSG00000104889	"Ribonuclease H2 subunit A"	O75792	19	12806556-12815201	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		"Endonuclease, Hydrolase, Nuclease"	"Aicardi-Goutieres syndrome, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 44.8"	"Cell type enhanced"	"Detected in many"	8	"Extravillous trophoblasts: 97.8;Spermatocytes: 51.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042692			Enhanced	Nucleoplasm,Cytosol		No	No			Nucleoplasm	Cytosol	"HPA042692: AB_10793981"	"unprognostic (6.74e-2)"	"prognostic favorable (1.18e-4)"	"prognostic favorable (6.18e-4)"	"unprognostic (2.24e-1)"	"unprognostic (2.62e-1)"	"unprognostic (5.13e-2)"	"prognostic unfavorable (8.72e-5)"	"unprognostic (8.48e-2)"	"unprognostic (9.33e-2)"	"prognostic favorable (1.22e-4)"	"unprognostic (3.80e-3)"	"unprognostic (8.71e-2)"	"prognostic unfavorable (6.29e-6)"	"unprognostic (3.40e-3)"	"unprognostic (4.35e-2)"	"unprognostic (5.35e-2)"	"unprognostic (8.60e-2)"	6.5	5.5	6.4	11.4	10.6	21.9	6.6	11.0	7.5	6.8	6.6	9.2	1.6	8.6	6.8	4.4	14.1	6.0	5.7	5.1	6.7	4.8	8.7	5.9	5.5	9.2	10.6	5.8	7.3	7.0	6.2	4.1	11.8	6.1	5.3	5.7	5.5	8.8	4.3	7.1	13.4	7.1	4.4	7.8	12.0	7.4	14.1	8.4	44.8	8.6	13.4	17.4	6.0	8.0	11.3	7.8	7.1	6.8	12.9	8.6	5.0	14.9	11.3	6.8	6.8	1.0	1.9	8.4	7.0	2.9	10.5	12.1	8.9	5.7	16.0	10.5	1.6	5.9	8.9	5.6	6.9	5.8	8.7	15.1	7.7	12.0	6.8	0.8	7.0	7.1	1.0	1.7	8.8	3.2	2.0	4.0	13.1	10.6	4.8	5.0	25.7	12.9	7.0	6.8	5.6	19.7	13.9	9.9	11.5	2.6	5.9	14.2	8.3	7.5	2.8	3.2	3.1	7.4	4.4	3.8	12.5	6.3	17.7	11.5	11.6	12.8	12.7	7.4	11.3	10.0	7.1	6.8	6.4	8.6	6.6	7.0	9.8	7.0	6.1	4.2	11.3	6.6	6.5	6.8	12.9	5.9	7.8	5.5	5.0	6.4	10.6	11.0	7.5	6.7	4.8	10.6	5.8	6.1	8.4	0.0	1.6	10.4	15.3	12.5	15.9	2.4	10.2	4.0	1.2	0.0	3.9	40.3	0.0	3.9	12.7	4.9	4.6	0.0	5.4	97.8	9.3	6.6	3.5	3.4	41.5	7.9	8.1	10.4	10.3	15.1	7.8	11.9	11.8	6.4	7.7	10.1	1.9	7.0	4.6	0.8	11.2	6.5	11.3	51.9	45.0	11.5	19.0	12.5	19.0	7.3
RNASEL	"PRCA1, RNS4"	ENSG00000135828	"Ribonuclease L"	Q05823	1	182573634-182589256	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Antiviral defense"	"Endonuclease, Hydrolase, Nuclease, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Sertoli cells: 19.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA002633, CAB010906"	Approved		Supported	Cytosol		NA	NA			Cytosol		"CAB010906: AB_477444, HPA002633: AB_1856314"	"unprognostic (3.46e-2)"	"unprognostic (9.10e-2)"	"unprognostic (7.74e-2)"	"unprognostic (1.13e-1)"	"unprognostic (9.29e-2)"	"unprognostic (1.57e-1)"	"unprognostic (6.14e-2)"	"unprognostic (1.42e-1)"	"unprognostic (3.89e-2)"	"unprognostic (1.93e-2)"	"unprognostic (1.01e-1)"	"unprognostic (2.02e-1)"	"unprognostic (5.43e-2)"	"unprognostic (1.99e-1)"	"unprognostic (1.44e-1)"	"unprognostic (2.59e-1)"	"unprognostic (1.81e-1)"	8.1	10.8	7.4	9.5	10.9	3.7	8.3	5.7	7.7	12.5	9.3	6.7	8.5	8.0	12.4	11.9	10.0	8.8	8.0	5.8	7.0	5.3	9.9	3.9	8.4	10.1	7.7	3.3	14.0	5.3	13.5	18.0	8.5	10.1	10.5	10.8	13.3	10.5	10.3	4.1	6.3	12.2	9.6	7.4	10.5	8.8	3.5	6.7	13.3	13.3	2.8	11.0	13.9	11.0	5.0	7.2	26.9	13.5	5.0	9.2	4.9	2.3	3.3	1.4	0.5	7.7	13.4	2.6	4.5	5.7	4.7	4.3	1.9	5.2	5.1	8.0	5.1	2.1	4.3	3.4	4.7	1.8	4.1	2.8	6.0	1.2	0.2	3.9	11.1	11.9	9.5	10.8	2.5	0.7	3.0	2.0	7.6	2.1	4.0	4.0	3.4	3.2	4.6	1.1	7.6	0.9	4.8	1.1	2.6	4.9	3.1	0.7	0.2	4.1	5.0	3.9	3.8	5.1	12.4	2.6	2.4	1.9	2.6	2.5	3.5	1.2	0.6	3.8	6.8	3.5	16.8	7.2	24.6	4.9	7.6	6.4	5.0	5.8	5.2	6.0	3.8	9.2	6.7	26.9	5.0	13.5	7.2	4.6	4.9	7.4	10.9	5.7	7.7	7.0	5.3	7.7	3.3	10.1	6.7	6.0	3.4	2.4	2.7	0.9	1.9	1.2	2.5	8.1	5.7	3.5	3.9	3.4	6.6	5.6	0.0	3.6	6.3	0.0	1.6	2.6	3.7	2.7	5.7	1.5	5.5	1.6	2.4	3.1	10.0	0.0	2.6	4.6	0.0	1.0	7.1	9.1	2.6	3.5	6.0	6.1	6.3	19.4	2.1	0.1	0.9	0.9	2.2	6.9	3.0	4.2
RNF103	"hkf-1, KF1, ZFP103"	ENSG00000239305	"Ring finger protein 103"	O00237	2	86603393-86623866	"Enzymes, Predicted membrane proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"eosinophil: 9.9"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA057922	Approved					NA	NA					"HPA057922: AB_2683555"	"unprognostic (4.41e-1)"	"unprognostic (1.56e-1)"	"unprognostic (6.04e-2)"	"unprognostic (3.26e-1)"	"unprognostic (3.20e-2)"	"unprognostic (1.79e-1)"	"unprognostic (7.42e-2)"	"unprognostic (8.37e-2)"	"unprognostic (4.06e-1)"	"unprognostic (1.13e-2)"	"unprognostic (6.21e-2)"	"unprognostic (1.44e-1)"	"unprognostic (3.54e-3)"	"unprognostic (1.50e-1)"	"unprognostic (1.77e-1)"	"unprognostic (3.67e-2)"	"prognostic favorable (6.77e-5)"	13.2	13.5	18.0	9.8	20.6	9.8	18.5	38.3	24.6	15.8	28.1	16.9	9.6	15.6	18.8	39.7	11.7	12.7	23.3	29.5	16.7	15.9	13.1	43.8	8.6	8.5	17.8	10.6	13.2	20.2	23.8	12.2	16.2	14.7	20.5	14.2	14.5	13.8	16.1	17.7	10.4	27.2	17.9	21.8	8.1	18.7	13.7	16.5	11.9	9.0	8.8	8.3	13.4	11.5	1.4	1.6	9.9	0.9	3.0	3.4	0.9	5.6	7.7	3.9	6.0	18.0	11.7	6.4	8.1	12.5	4.2	5.7	4.4	9.7	9.4	9.9	12.2	15.3	6.9	5.2	6.4	6.4	7.8	7.1	5.3	3.5	9.8	17.1	1.8	8.0	17.0	13.5	6.2	7.8	15.1	12.6	4.5	1.9	5.7	11.5	6.9	4.0	4.7	1.8	11.2	5.5	2.5	16.9	5.5	15.4	8.9	6.2	6.4	9.6	21.5	8.0	5.2	8.2	4.4	14.2	8.2	3.9	8.2	4.8	19.9	6.6	6.3	6.5	3.0	3.9	6.5	0.7	9.9	1.1	0.9	1.5	1.4	1.6	2.4	1.6	1.4	1.9	1.3	1.5	3.0	0.6	1.0	3.4	0.9	18.0	20.6	38.3	24.6	16.7	15.9	17.8	10.6	14.7	16.5	8.9	12.6	8.5	27.7	42.8	14.8	30.8	22.9	17.4	15.9	19.2	3.9	10.6	1.7	14.0	14.5	16.6	43.9	23.3	24.9	6.3	29.6	44.0	18.4	58.4	8.3	17.5	30.5	23.4	11.8	7.0	23.6	10.6	10.1	2.8	35.6	17.5	25.0	38.6	21.5	12.8	8.8	6.5	25.8	21.5	13.0	38.6	34.2	6.4	20.1	37.4
RNF111	"ARK, Arkadia, DKFZP761D081, FLJ38008"	ENSG00000157450	"Ring finger protein 111"	Q6ZNA4	15	58865175-59097419	"Enzymes, Predicted intracellular proteins"	"DNA damage, DNA repair, Ubl conjugation pathway"	"Developmental protein, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038576, HPA038577"	Enhanced		Supported	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA038576: AB_10964492, HPA038577: AB_10960052"	"unprognostic (7.30e-2)"	"unprognostic (2.60e-2)"	"unprognostic (2.39e-1)"	"unprognostic (3.37e-1)"	"unprognostic (7.94e-2)"	"unprognostic (2.09e-1)"	"unprognostic (2.19e-1)"	"unprognostic (3.21e-1)"	"unprognostic (5.10e-2)"	"unprognostic (6.12e-3)"	"unprognostic (3.10e-2)"	"unprognostic (1.42e-1)"	"unprognostic (2.05e-3)"	"unprognostic (2.05e-1)"	"unprognostic (6.61e-2)"	"unprognostic (1.20e-1)"	"unprognostic (9.74e-2)"	12.8	11.2	15.3	15.6	19.3	21.2	12.7	24.1	21.9	15.1	9.8	18.8	10.9	11.4	16.4	9.8	16.2	12.6	13.0	11.0	13.0	13.0	12.9	14.8	13.3	13.9	15.7	15.5	16.8	14.8	20.8	19.2	16.7	17.8	12.7	10.3	12.9	14.9	12.5	15.0	14.1	10.9	11.7	14.2	14.3	12.0	15.7	16.9	14.9	16.4	6.5	17.8	15.8	14.8	7.9	5.2	26.7	9.9	3.3	6.1	2.0	9.6	22.5	14.3	12.3	12.5	14.1	12.3	12.7	14.9	12.7	16.4	9.9	6.5	11.9	14.4	17.7	10.9	19.0	3.9	9.5	15.9	12.3	8.0	14.7	9.2	7.6	13.6	8.6	16.6	11.0	10.3	13.7	15.2	11.6	14.1	11.1	13.6	12.0	15.6	4.7	11.3	5.5	11.8	3.0	8.8	11.4	20.5	9.7	9.7	17.3	11.8	17.2	11.4	11.3	11.0	17.5	8.9	10.6	16.2	20.4	17.0	10.6	12.1	8.7	11.8	14.2	12.4	13.9	15.3	6.4	9.9	9.3	4.8	7.0	4.8	7.4	4.9	4.3	5.2	7.9	5.5	4.2	26.7	3.3	7.6	4.9	6.1	2.0	15.3	19.3	24.1	21.9	13.0	13.0	15.7	15.5	17.8	16.9	3.0	11.8	14.0	10.9	17.9	11.2	16.9	7.6	14.7	9.1	12.2	7.9	7.3	3.3	10.3	18.4	13.4	9.2	0.0	6.0	8.1	9.5	12.3	15.1	9.8	11.7	9.5	15.5	19.0	17.7	7.0	7.2	16.6	11.8	16.2	9.4	9.5	10.9	11.4	13.8	8.4	12.3	25.8	9.2	11.9	7.8	17.3	26.8	11.7	7.9	20.4
RNF112	"BFP, ZNF179"	ENSG00000128482	"Ring finger protein 112"	Q9ULX5	17	19411125-19417276	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Neurogenesis, Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in many"	5	"brain: 47.5"	"Cell type enhanced"	"Detected in some"	12	"Bipolar cells: 3.2;Fibroblasts: 3.0;Muller glia cells: 7.7;Peritubular cells: 3.5;Sertoli cells: 6.5"	"Cancer enriched"	"Detected in some"	8	"glioma: 6.9"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC TERT1: 4.2;fHDF/TERT166: 4.8;SCLC-21H: 4.8;SH-SY5Y: 8.4;U-87 MG: 27.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA015970	Enhanced		Approved	"Nuclear speckles"		NA	NA			"Nuclear speckles"		"HPA015970: AB_1859103"	"unprognostic (1.16e-1)"	"unprognostic (3.74e-1)"	"unprognostic (8.43e-5)"	"unprognostic (3.65e-2)"	"unprognostic (2.96e-2)"	"unprognostic (6.02e-2)"	"unprognostic (1.27e-1)"	"unprognostic (2.88e-1)"	"unprognostic (4.26e-1)"	"unprognostic (5.02e-2)"	"unprognostic (3.17e-1)"	"unprognostic (2.96e-1)"	"unprognostic (1.31e-9)"	"unprognostic (1.32e-1)"	"unprognostic (1.07e-1)"	"unprognostic (1.59e-1)"	"unprognostic (4.24e-1)"	2.5	8.1	11.3	2.3	15.9	0.6	1.8	47.5	29.1	1.2	3.6	1.4	0.0	2.9	2.0	6.9	1.1	1.5	4.4	2.3	12.4	8.2	1.2	0.7	1.7	1.4	3.9	14.1	1.3	0.8	0.5	1.9	1.1	3.1	10.2	4.4	1.6	1.3	3.5	2.1	1.9	3.6	3.5	2.9	1.7	2.1	2.0	3.7	0.0	0.9	0.0	0.8	2.8	1.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	1.2	4.2	0.1	0.2	0.9	0.0	0.0	0.2	0.0	0.0	0.0	4.8	0.0	0.2	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	3.4	0.0	0.0	1.7	0.2	0.1	0.2	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.0	0.3	0.1	0.1	0.2	0.0	0.0	4.8	8.4	0.1	0.0	0.0	1.1	0.0	0.1	0.0	0.0	0.3	0.4	0.0	0.1	0.0	0.0	27.5	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.3	15.9	47.5	15.9	12.4	8.2	3.9	14.1	3.1	3.7	0.0	0.0	0.0	0.0	0.9	3.2	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.3	0.0	0.0	0.0	3.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	7.7	0.0	0.3	3.5	0.0	0.4	6.5	1.5	1.1	0.7	0.9	0.2	0.0	0.1	0.1
RNF114	"PSORS12, ZNF313"	ENSG00000124226	"Ring finger protein 114"	Q9Y508	20	49936336-49953892	"Enzymes, Predicted intracellular proteins"	"Differentiation, Spermatogenesis, Ubl conjugation pathway"	"Developmental protein, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in all"	5	"Early spermatids: 1239.3;Late spermatids: 628.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"SK-BR-3: 110.4"	"Low region specificity"	"Detected in all"							HPA021184	Enhanced		Supported	"Plasma membrane,Cytosol"		NA	NA			"Plasma membrane, Cytosol"		"HPA021184: AB_1859185"	"unprognostic (8.38e-2)"	"unprognostic (3.56e-2)"	"unprognostic (5.62e-2)"	"prognostic unfavorable (8.10e-6)"	"unprognostic (1.56e-1)"	"unprognostic (2.96e-1)"	"prognostic unfavorable (3.11e-4)"	"unprognostic (2.50e-2)"	"unprognostic (1.03e-2)"	"unprognostic (2.12e-1)"	"unprognostic (3.99e-1)"	"unprognostic (2.70e-2)"	"unprognostic (2.54e-3)"	"unprognostic (1.33e-1)"	"unprognostic (1.76e-1)"	"prognostic favorable (3.01e-4)"	"unprognostic (1.36e-2)"	23.2	21.3	24.4	18.3	25.7	31.2	20.6	26.7	23.1	24.0	29.7	32.6	21.1	29.5	20.3	23.4	20.2	23.6	20.1	21.9	23.0	25.3	30.3	31.6	24.4	24.0	28.3	19.4	28.4	36.8	16.1	21.6	40.6	23.7	24.5	21.3	27.1	27.8	24.1	43.8	15.2	33.9	17.6	29.3	36.3	24.2	101.9	24.1	28.3	37.9	20.0	24.1	22.6	25.0	28.5	32.5	43.4	44.6	23.7	29.4	34.9	15.9	15.7	8.1	8.5	16.7	11.5	23.8	14.3	16.2	29.6	12.6	46.6	13.1	7.7	28.6	7.5	18.1	12.8	12.0	14.4	10.3	14.0	8.8	9.8	10.5	32.7	14.7	17.8	11.8	10.0	13.3	11.3	7.8	10.1	7.0	13.4	18.4	9.1	8.6	53.8	14.9	18.5	8.3	12.5	22.6	16.3	8.5	14.0	15.6	13.0	12.4	8.9	17.5	110.4	22.1	6.9	29.4	16.6	9.2	26.8	12.5	14.0	16.4	18.7	19.5	14.7	15.2	11.6	14.8	38.5	42.5	35.7	22.0	39.2	24.6	28.2	24.6	22.4	32.5	28.5	29.4	23.7	43.4	23.7	44.6	26.7	28.8	34.9	24.4	25.7	26.7	23.1	23.0	25.3	28.3	19.4	23.7	24.1	44.7	50.1	53.6	105.2	95.2	25.2	37.5	28.1	32.1	28.4	66.3	11.8	79.1	61.3	83.5	1239.3	54.7	64.9	23.3	88.7	65.1	64.6	89.9	43.9	57.8	95.3	38.1	58.0	44.8	69.1	628.0	65.3	62.5	67.4	101.0	68.6	36.1	81.0	69.1	56.3	87.7	19.7	38.8	75.9	206.1	156.2	76.2	104.4	48.0	73.6	96.0
RNF115	"CL469780, ZNF364"	ENSG00000265491	"Ring finger protein 115"	Q9Y4L5	1	145738868-145824077	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA019130	Approved		Approved	Nucleoli,Mitochondria		NA	NA			"Nucleoli, Mitochondria"		"HPA019130: AB_1859220"	"unprognostic (3.44e-2)"	"unprognostic (2.47e-3)"	"unprognostic (2.24e-1)"	"unprognostic (1.09e-1)"	"unprognostic (5.48e-2)"	"unprognostic (1.90e-1)"	"prognostic unfavorable (2.95e-4)"	"unprognostic (2.29e-2)"	"unprognostic (1.46e-2)"	"unprognostic (1.35e-1)"	"unprognostic (2.64e-2)"	"unprognostic (7.29e-2)"	"unprognostic (1.44e-2)"	"unprognostic (3.23e-1)"	"unprognostic (4.77e-2)"	"unprognostic (2.46e-2)"	"unprognostic (1.08e-1)"	7.2	5.2	6.8	4.8	6.8	6.4	7.7	16.2	7.0	6.3	3.4	4.6	5.7	3.5	8.9	5.0	5.8	4.3	4.8	23.5	5.8		5.6	5.1	3.9	5.6	4.7	6.2	4.7	4.5	5.8	5.9	3.5	5.2	6.5	3.8	7.3	3.6	5.6	27.6	3.8	3.1	10.9	4.5	4.2	3.8	3.4	4.5	6.0	5.0	5.4	4.5	4.1	6.3	2.7	2.4	9.0	2.2	3.2	3.2	1.4	11.3	4.7	5.8	4.3	10.7	14.0	4.7	8.6	16.0	6.4	7.8	5.1	4.1	8.0	9.8	12.2	6.3	8.0	6.4	5.9	6.9	8.0	4.2	6.4	6.1	4.7	6.7	9.9	14.8	8.1	5.2	6.4	7.8	7.3	8.1	6.3	6.3	13.1	11.5	8.6	7.2	6.3	7.3	7.2	10.0	7.0	5.8	6.6	12.4	3.8	5.9	8.1	7.0	8.6	6.4	7.5	9.5	9.5	10.0	9.3	7.3	5.6	9.1	11.0	10.4	8.4	4.7	6.7	5.9	9.0	2.2	3.2	3.2	1.5	2.7	2.7	2.2	3.2	1.8	2.4	2.3	3.1	1.7	3.2	1.6	2.4	2.0	1.4											14.9	29.8	29.4	28.9	18.3	96.0	134.9	25.5	24.1	26.1	17.4	108.0	23.1	28.2	34.8	52.4	66.1	14.0	23.3	69.3	24.5	48.2	51.0	31.1	28.7	32.3	77.9	26.0	66.3	32.6	18.4	36.5	29.9	37.1	88.4	19.7	66.7	49.7	20.9	76.0	37.2	104.3	58.2	49.2	78.7	54.1	15.7	16.6	66.0	23.8	32.8
RNF123	"FLJ12565, KPC1"	ENSG00000164068	"Ring finger protein 123"	Q5XPI4	3	49689499-49721529	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 81.2"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA065983, HPA071879"	Supported		Approved	Cytosol		NA	NA			Cytosol		"HPA065983: AB_2685592, HPA071879: AB_2686468"	"unprognostic (2.68e-1)"	"unprognostic (3.34e-1)"	"unprognostic (2.67e-1)"	"unprognostic (1.04e-1)"	"unprognostic (2.21e-1)"	"unprognostic (9.51e-2)"	"unprognostic (2.04e-1)"	"unprognostic (3.75e-1)"	"unprognostic (4.08e-1)"	"unprognostic (1.07e-1)"	"unprognostic (7.51e-2)"	"unprognostic (5.03e-3)"	"prognostic favorable (1.33e-8)"	"unprognostic (5.69e-2)"	"unprognostic (1.74e-1)"	"unprognostic (7.22e-2)"	"unprognostic (3.83e-1)"	5.3	8.0	7.7	8.0	10.4	17.5	5.0	13.8	13.6	5.2	6.8	6.2	7.8	12.7	6.4	8.0	7.5	6.4	7.0	12.9	8.5	6.8	8.4	21.8	5.7	6.1	7.3	6.6	5.1	7.7	8.9	8.4	7.3	6.6	7.3	4.8	7.6	6.9	6.7	81.2	7.7	12.5	6.2	6.7	7.6	6.9	8.8	7.8	8.3	6.2	12.0	9.1	6.6	4.8	11.3	12.7	11.8	10.9	7.7	11.4	5.3	6.7	9.6	11.4	11.8	17.4	10.8	12.3	8.8	11.7	11.3	12.6	10.2	11.7	16.5	8.1	12.6	10.0	8.5	8.6	13.3	7.9	10.9	11.8	13.4	18.9	22.3	17.4	13.0	14.6	13.6	13.1	10.6	12.3	11.2	11.6	16.8	14.1	14.3	9.5	10.1	13.7	21.1	6.3	8.5	15.5	6.5	7.0	17.0	15.4	11.5	7.8	15.7	12.2	10.8	13.4	6.7	11.1	23.4	12.0	9.9	12.1	8.9	10.9	19.5	19.1	6.6	14.1	16.5	14.9	11.8	10.9	7.9	11.4	9.5	6.8	9.8	7.2	6.8	8.6	11.3	8.7	8.2	6.3	7.7	9.7	12.7	5.5	5.3	7.7	10.4	13.8	13.6	8.5	6.8	7.3	6.6	6.6	7.8	8.9	4.0	4.4	2.4	2.1	8.6	1.0	20.4	1.4	4.5	3.5	3.9	5.6	5.0	4.9	10.6	3.6	13.1	0.0	4.8	3.6	4.9	4.4	6.9	23.8	4.8	6.4	6.4	9.8	9.9	12.6	6.9	3.2	3.3	4.6	5.9	3.5	6.0	7.0	5.3	8.5	8.2	0.0	4.9	8.7	9.1	2.6	7.1	2.9	6.3	3.7
RNF125	FLJ20456	ENSG00000101695	"Ring finger protein 125"	Q96EQ8	18	32018372-32073213	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Adaptive immunity, Immunity, Ubl conjugation pathway"	Transferase	"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	9	"Early spermatids: 67.5;T-cells: 66.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enriched"	"Detected in some"	4	"HMC-1: 32.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041514	Uncertain		Supported	"Nucleoli,Golgi apparatus"		NA	NA			"Golgi apparatus"	Nucleoli	"HPA041514: AB_10795596"	"unprognostic (2.13e-2)"	"unprognostic (2.05e-2)"	"unprognostic (2.88e-1)"	"unprognostic (3.93e-1)"	"unprognostic (5.03e-1)"	"unprognostic (4.50e-2)"	"unprognostic (2.30e-3)"	"unprognostic (6.15e-2)"	"unprognostic (4.21e-2)"	"unprognostic (3.24e-1)"	"unprognostic (1.68e-1)"	"unprognostic (4.35e-2)"	"prognostic unfavorable (4.06e-4)"	"unprognostic (2.99e-1)"	"unprognostic (4.12e-1)"	"unprognostic (1.82e-1)"	"unprognostic (7.07e-3)"	21.9	2.3	4.1	9.1	5.7	18.2	20.4	1.2	6.6	5.0	8.9	12.2	3.3	12.3	7.2	5.5	3.9	4.3	6.0	5.4	6.1	4.1	2.1	14.1	10.3	13.5	7.7	3.1	2.4	4.2	2.5	1.3	4.4	7.0	3.1	7.8	1.6	5.0	1.9	4.4	6.0	26.0	4.1	12.0	7.4	4.2	3.3	8.3	14.8	3.2	2.9	7.2	4.5	6.2	2.1	3.4	9.0	3.8	11.7	12.5	5.1	0.7	0.1	0.1	0.2	0.3	0.5	0.6	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.8	0.0	0.2	0.5	0.9	0.8	0.1	4.0	1.6	0.2	0.2	0.2	0.1	5.2	32.5	1.0	1.5	0.0	1.8	0.2	0.3	1.6	0.1	1.2	0.0	1.2	1.3	4.9	2.6	5.3	0.9	5.5	0.4	0.1	0.3	0.3	0.5	0.2	0.1	0.1	8.0	1.1	0.8	2.5	0.1	0.1	0.5	0.1	0.0	3.8	0.1	0.1	0.4	7.0	4.2	9.0	3.8	3.3	12.5	2.0	8.2	2.0	10.1	10.5	3.4	2.1	8.2	10.6	1.5	11.7	1.9	3.4	10.0	5.1	4.1	5.7	1.2	6.6	6.1	4.1	7.7	3.1	7.0	8.3	3.0	8.0	9.9	2.9	8.8	0.4	1.4	2.5	2.7	5.7	12.2	0.0	0.3	1.7	0.8	67.5	23.2	25.5	0.0	1.6	0.1	1.9	2.4	17.4	15.5	8.9	0.0	1.2	6.7	14.8	11.5	2.6	13.9	1.7	1.0	8.2	1.2	1.3	0.0	0.0	1.1	0.6	0.0	1.9	0.5	0.7	5.9	0.7	66.0	13.6	2.1
RNF126	FLJ20552	ENSG00000070423	"Ring finger protein 126"	Q9BV68	19	647526-663277	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA043050	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA043050: AB_10794768"	"unprognostic (2.24e-1)"	"unprognostic (1.64e-1)"	"unprognostic (1.97e-1)"	"unprognostic (2.48e-3)"	"unprognostic (1.90e-1)"	"unprognostic (2.32e-1)"	"unprognostic (1.09e-3)"	"unprognostic (3.57e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.70e-1)"	"unprognostic (1.88e-2)"	"unprognostic (2.68e-2)"	"unprognostic (9.96e-3)"	"unprognostic (7.04e-3)"	"unprognostic (3.39e-2)"	"unprognostic (2.05e-1)"	"unprognostic (4.67e-2)"	14.2	14.2	13.4	17.0	13.7	18.7	14.5	12.2	24.7	9.8	16.0	14.8	7.4	24.3	10.4	9.2	19.8	9.5	13.1	14.2	13.1	10.2	11.6	27.9	10.4	19.9	11.4	11.6	12.1	22.4	5.9	10.0	14.1	12.3	10.0	6.3	10.1	13.2	9.3	50.3	21.9	20.3	9.9	10.0	18.6	21.0	33.6	9.3	16.1	8.6	19.5	18.6	13.1	11.2	15.9	13.6	7.5	13.8	17.1	17.3	9.2	25.9	8.6	7.3	10.3	1.7	2.4	12.5	13.6	5.2	7.9	7.5	17.4	9.1	21.5	8.9	5.7	3.1	17.4	4.4	10.2	2.2	14.2	31.8	10.9	9.0	14.4	6.6	21.6	16.1	4.1	8.1	6.5	5.1	3.2	7.2	17.7	21.9	21.7	4.1	20.9	22.1	10.1	19.5	5.5	17.0	16.1	6.3	33.8	6.0	14.5	17.4	13.6	10.3	13.6	13.9	2.6	8.7	17.0	9.4	14.4	10.4	21.1	23.3	38.3	19.0	25.2	18.3	12.7	14.8	0.6	9.8	7.5	17.3	11.5	14.2	15.9	15.7	16.7	12.4	15.6	12.2	11.4	2.2	17.1	13.8	13.6	16.8	9.2	13.4	13.7	12.2	24.7	13.1	10.2	11.4	11.6	12.3	9.3	11.9	6.1	54.8	41.2	122.5	31.3	24.2	15.3	12.0	10.3	8.7	15.7	58.6	46.4	55.4	113.7	26.1	51.9	0.0	66.1	118.3	35.3	49.3	14.9	20.2	38.3	30.2	20.8	20.3	27.6	18.2	19.8	38.3	40.5	56.9	34.2	27.0	95.1	54.9	18.4	25.6	22.0	58.2	45.0	118.2	66.8	126.6	73.7	55.3	49.7	76.9
RNF128	"FLJ23516, GRAIL"	ENSG00000133135	"Ring finger protein 128, E3 ubiquitin protein ligase"	Q8TEB7	X	106693794-106796993	"Enzymes, Predicted membrane proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 54.6;liver: 48.4;thyroid gland: 38.4"	"Cell type enhanced"	"Detected in many"	7	"Alveolar cells type 1: 62.5;Cholangiocytes: 61.1;Enterocytes: 52.7;Hepatocytes: 73.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 16.5;CAPAN-2: 13.6;Hep G2: 11.6;OE19: 36.6;RPTEC TERT1: 12.0;RT4: 34.2;WM-115: 20.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA019675	Uncertain					NA	NA					"HPA019675: AB_2670225"	"unprognostic (1.78e-1)"	"unprognostic (1.44e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.88e-3)"	"unprognostic (1.92e-4)"	"unprognostic (2.14e-3)"	"unprognostic (2.37e-2)"	"unprognostic (1.02e-1)"	"unprognostic (2.06e-1)"	"unprognostic (2.43e-2)"	"unprognostic (1.55e-2)"	"unprognostic (1.75e-2)"	"prognostic unfavorable (1.07e-7)"	"unprognostic (1.11e-2)"	"unprognostic (7.61e-2)"	"unprognostic (6.30e-2)"	"unprognostic (5.30e-3)"	1.4	20.6	2.4	2.2	7.2	0.0	3.0	0.7	4.2	0.5	24.4	0.9	0.4	24.2	0.2	2.2	4.0	0.3	27.2	0.6	2.8	5.1	24.4	48.4	6.7	0.0	2.4	2.1	0.7	14.5	0.0	11.0	10.5	4.0	3.4	7.8	0.0	25.4	0.8	3.0	3.6	54.6	0.9	1.1	0.2	17.9	0.3	1.0	1.1	38.4	2.3	2.7	10.2	3.0	0.0	0.0	0.0	0.0	0.0	0.9	0.1	4.1	0.0	0.0	0.0	1.4	0.7	16.5	0.0	0.1	0.0	0.0	7.2	13.6	0.0	0.0	0.2	0.1	5.1	0.0	0.0	0.0	0.0	8.0	0.0	0.0	11.6	0.0	0.0	0.0	0.0	5.7	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.9	36.6	0.1	0.0	0.0	0.0	12.0	34.2	0.0	0.0	0.0	0.9	0.8	0.1	0.9	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	6.0	0.0	20.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	2.4	7.2	0.7	4.2	2.8	5.1	2.4	2.1	4.0	1.0	62.5	15.8	0.0	5.7	6.1	0.0	0.5	61.1	9.4	20.5	31.4	0.0	18.2	0.0	9.8	0.0	0.1	52.7	0.0	13.5	2.1	0.4	1.8	0.0	73.1	1.6	0.0	23.8	0.6	3.8	0.0	0.0	0.2	3.3	0.0	36.5	0.0	21.8	22.4	0.0	21.1	0.0	0.0	0.2	0.0	2.2	4.5	13.8	0.0	23.4	7.4
RNF13	RZF	ENSG00000082996	"Ring finger protein 13"	O43567	3	149812708-149962139	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Ubl conjugation pathway"	Transferase	"Disease mutation, Epilepsy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"neutrophil: 72.4"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA064784	Approved		Supported	Nucleoplasm,Vesicles,Cytosol		NA	NA			"Nucleoplasm, Vesicles"	Cytosol	"HPA064784: AB_2685350"	"unprognostic (1.27e-1)"	"unprognostic (2.32e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.93e-2)"	"unprognostic (1.80e-1)"	"unprognostic (9.64e-2)"	"unprognostic (8.49e-2)"	"unprognostic (4.36e-3)"	"unprognostic (1.72e-1)"	"unprognostic (1.25e-1)"	"unprognostic (6.94e-3)"	"unprognostic (1.13e-1)"	"prognostic favorable (2.00e-8)"	"unprognostic (2.95e-1)"	"unprognostic (4.11e-2)"	"unprognostic (2.17e-1)"	"unprognostic (1.79e-1)"	24.0	21.3	30.6	19.0	39.4	9.8	28.5	19.9	30.4	19.0	17.7	39.9	16.2	14.3	16.8	33.7	16.8	15.9	20.4	16.4	40.5	29.7	35.8	39.2	31.7	19.6	60.9	26.8	18.1	19.6	23.5	14.9	32.4	40.7	25.5	20.3	19.5	36.1	20.9	18.0	18.4	16.3	20.4	102.2	25.5	17.0	12.5	51.2	13.3	32.1	18.8	15.9	21.4	16.5	8.8	15.7	72.4	31.5	7.8	8.5	14.6	19.7	12.3	8.3	9.5	32.8	20.1	13.9	10.9	28.2	10.6	15.8	10.8	28.4	8.2	16.0	13.4	19.5	18.8	11.1	14.0	14.9	10.0	8.1	9.9	5.7	10.5	21.8	10.6	14.1	21.2	26.6	8.9	24.2	12.8	11.7	7.9	3.1	16.7	9.4	11.1	7.6	7.0	5.5	19.1	9.6	5.5	8.9	34.8	20.5	9.2	4.4	12.7	9.0	13.6	35.2	6.8	25.9	11.2	12.2	14.4	5.8	15.2	7.0	28.4	18.7	16.9	12.1	9.9	7.7	12.9	20.3	16.6	6.8	25.2	8.5	8.8	7.6	7.6	15.7	8.3	7.3	7.5	72.4	7.8	31.5	11.2	8.3	14.6	30.6	39.4	19.9	29.2	40.5	29.7	60.9	26.8	40.7	51.2	101.3	59.5	39.3	61.2	65.4	43.7	25.6	38.2	34.8	61.4	45.4	27.5	86.4	36.5	54.3	2.2	62.6	27.6	0.0	62.0	65.2	68.3	63.5	58.9	46.6	172.6	20.6	19.4	77.3	168.9	4.7	70.5	155.4	97.8	42.3	26.4	85.9	48.5	29.6	82.7	59.8	32.2	90.5	50.9	19.7	29.6	63.2	43.8	51.0	24.3	45.5
RNF130	"G1RZFP, GOLIATH, GP"	ENSG00000113269	"Ring finger protein 130"	Q86XS8	5	179911651-180072118	"Enzymes, Predicted membrane proteins"	"Apoptosis, Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"Hofbauer cells: 270.4;Kupffer cells: 303.4;Macrophages: 212.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	8	"basophil: 17.0;classical monocyte: 38.1;eosinophil: 24.6;intermediate monocyte: 27.5;myeloid DC: 31.1;neutrophil: 68.1;non-classical monocyte: 23.8;plasmacytoid DC: 22.9"	"Group enriched"	"Detected in all"	11	"dendritic cells: 31.1;granulocytes: 68.1;monocytes: 38.1"	"Cell line enhanced"	"Detected in many"		"HMC-1: 41.5"	"Low region specificity"	"Detected in all"							HPA014499	Approved					NA	NA					"HPA014499: AB_1856328"	"unprognostic (2.01e-1)"	"prognostic favorable (6.32e-4)"	"unprognostic (2.43e-1)"	"unprognostic (1.37e-1)"	"unprognostic (2.24e-1)"	"unprognostic (1.62e-2)"	"unprognostic (2.83e-1)"	"unprognostic (2.02e-3)"	"unprognostic (2.93e-2)"	"unprognostic (1.78e-1)"	"unprognostic (4.00e-2)"	"unprognostic (2.81e-1)"	"unprognostic (1.14e-1)"	"unprognostic (8.41e-2)"	"unprognostic (4.17e-2)"	"unprognostic (4.32e-1)"	"unprognostic (1.38e-2)"	36.3	16.3	23.5	16.3	32.5	29.5	24.0	19.0	25.3	26.0	16.7	56.0	19.0	10.6	18.5	12.0	10.6	19.5	21.9	17.0	27.8	21.1	20.7	64.4	25.5	19.1	50.2	20.3	21.7	28.6	11.0	16.7	19.8	30.3	16.3	16.1	15.8	30.6	28.3	17.3	7.9	12.1	22.2	58.2	20.4	20.5	7.3	38.8	2.5	14.3	6.3	10.3	20.7	13.3	1.2	31.1	68.1	38.1	4.0	2.0	20.3	8.0	5.9	29.0	21.2	28.3	15.4	5.5	6.3	7.9	6.9	7.5	1.9	6.9	0.0	19.5	11.0	12.3	0.8	20.1	12.8	7.6	0.1	17.9	15.9	3.2	4.1	7.2	3.8	41.5	14.5	6.8	0.5	3.9	17.4	11.2	16.4	3.2	0.1	6.9	12.2	7.2	12.3	7.9	1.5	9.0	16.2	6.7	0.0	8.7	1.4	17.6	7.9	11.7	6.4	24.3	12.3	9.2	9.1	8.7	11.7	4.7	8.2	6.7	0.0	6.2	1.6	1.5	30.5	9.1	17.0	38.1	24.6	2.0	27.5	1.9	1.2	0.9	1.0	31.1	1.2	1.0	1.2	68.1	4.0	23.8	22.9	0.1	20.3	23.5	32.5	19.0	25.3	27.8	21.1	50.2	20.3	30.3	38.8	17.9	25.0	20.3	17.8	12.6	26.9	27.4	73.9	65.6	22.7	40.1	49.1	10.0	19.9	43.4	9.6	42.9	21.0	0.0	67.5	13.5	39.8	43.3	79.8	129.2	270.4	6.4	15.6	43.0	303.4	14.4	33.9	212.8	30.4	45.1	37.0	18.1	46.5	35.1	45.3	34.2	17.7	45.3	40.1	8.6	27.9	11.3	7.3	17.3	61.0	17.1
RNF133		ENSG00000188050	"Ring finger protein 133"	Q8WVZ7	7	122697712-122699156	"Enzymes, Predicted membrane proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	59	"testis: 28.3"	"Group enriched"	"Detected in some"	104	"Early spermatids: 461.8;Late spermatids: 540.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"Karpas-707: 4.1;MCF7: 1.5;NTERA-2: 1.2;PC-3: 1.1;U-266/70: 1.1"	"Not detected"	"Not detected"													NA	NA						"unprognostic (2.82e-1)"	"unprognostic (2.52e-2)"	"unprognostic (1.77e-1)"	"unprognostic (3.04e-2)"	"unprognostic (2.45e-3)"	"unprognostic (1.67e-1)"	"unprognostic (8.87e-3)"	"unprognostic (3.56e-2)"	"unprognostic (3.72e-1)"	"unprognostic (3.29e-3)"	"unprognostic (1.26e-1)"	"unprognostic (1.02e-2)"	"unprognostic (7.76e-2)"	"unprognostic (1.10e-1)"	"unprognostic (2.39e-1)"	"unprognostic (2.37e-2)"	"unprognostic (7.61e-2)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.4	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	28.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.5	0.6	0.3	0.0	0.6	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.2	0.9	0.0	0.0	0.0	0.0	0.1	0.2	0.1	0.0	0.0	0.0	4.1	0.0	1.5	0.0	0.0	1.2	0.5	1.1	0.0	0.0	0.8	0.0	0.4	0.6	0.0	0.0	0.5	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.2	1.1	0.0	0.0	0.4	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	461.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	540.3	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	4.8	1.5	0.0	0.0	0.0	0.0	0.0
RNF135	MGC13061	ENSG00000181481	"Ring finger protein 135"	Q8IUD6	17	30968785-30999911	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Immunity, Innate immunity, Ubl conjugation pathway"	Transferase	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Kupffer cells: 64.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"hTCEpi: 30.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021576, HPA052404"	Approved		Approved	Vesicles		NA	NA			Vesicles		"HPA021576: AB_1856331, HPA052404: AB_2681817"	"unprognostic (1.13e-1)"	"unprognostic (1.87e-2)"	"unprognostic (6.24e-2)"	"unprognostic (2.33e-2)"	"unprognostic (2.68e-2)"	"unprognostic (3.51e-3)"	"unprognostic (1.57e-1)"	"unprognostic (1.24e-1)"	"unprognostic (4.60e-2)"	"unprognostic (4.16e-1)"	"unprognostic (1.35e-2)"	"unprognostic (2.06e-1)"	"prognostic unfavorable (7.51e-5)"	"unprognostic (6.44e-2)"	"unprognostic (1.54e-1)"	"unprognostic (2.42e-1)"	"unprognostic (4.47e-1)"	18.2	11.6	6.5	15.9	7.1	7.1	28.8	6.4	6.1	16.3	22.2	7.2	16.5	9.7	15.7	16.8	18.4	11.8	14.4	7.4	7.1	4.8	19.5	6.0	19.0	28.0	6.8	2.5	15.1	11.7	15.0	5.9	19.2	6.3	18.1	13.2	13.6	13.3	14.8	7.5	21.4	16.7	13.9	6.1	22.7	10.0	8.8	4.8	6.0	25.0	12.7	18.8	13.0	19.1	11.8	18.4	21.7	25.1	5.4	5.3	9.7	5.9	12.4	0.7	12.3	17.0	13.5	10.5	4.7	7.1	4.6	4.1	0.0	4.5	4.8	7.0	9.0	8.2	7.6	6.1	5.8	3.7	4.6	2.6	2.3	3.7	0.0	11.9	6.0	5.2	13.4	30.6	4.9	15.9	7.8	7.3	0.0	0.0	16.4	7.4	7.9	0.0	6.1	5.0	11.5	6.7	12.6	0.0	17.6	6.4	8.5	4.6	0.2	6.8	2.9	6.8	8.3	18.8	9.3	6.4	0.0	1.6	7.5	5.3	0.2	0.5	3.4	8.2	10.4	6.3	9.1	24.0	12.1	5.3	21.8	2.9	11.8	2.8	2.7	18.4	11.2	1.5	2.7	21.7	5.4	25.1	6.6	3.8	9.7	6.5	7.1	6.4	6.1	7.1	4.8	6.8	2.5	6.3	4.8	3.0	5.1	6.5	11.6	8.2	0.0	3.2	7.6	4.0	2.3	10.4	0.0	38.0	24.9	8.1	0.3	10.8	20.4	0.0	16.3	30.0	10.8	9.4	1.1	2.4	45.6	0.0	4.7	28.8	64.6	0.6	15.5	22.7	15.1	36.1	11.5	3.2	9.9	11.5	14.5	34.9	0.6	25.8	12.0	0.4	0.9	12.8	36.5	8.6	15.2	9.8
RNF138	"NARF, STRIN"	ENSG00000134758	"Ring finger protein 138"	Q8WVD3	18	32091855-32131561	"Enzymes, Predicted intracellular proteins"	"DNA damage, DNA repair, Ubl conjugation pathway, Wnt signaling pathway"	"DNA-binding, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	4	"blood: 43.8;bone marrow: 40.4;lymphoid tissue: 28.3;testis: 73.4"	"Group enriched"	"Detected in many"	16	"Early spermatids: 845.1;Late spermatids: 2984.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041101			Approved	Mitochondria		NA	NA			Mitochondria		"HPA041101: AB_10805837"	"unprognostic (2.37e-2)"	"unprognostic (4.63e-3)"	"unprognostic (2.03e-3)"	"unprognostic (1.01e-1)"	"unprognostic (2.34e-1)"	"unprognostic (2.93e-2)"	"unprognostic (1.47e-2)"	"unprognostic (9.64e-2)"	"unprognostic (1.29e-2)"	"unprognostic (1.90e-2)"	"unprognostic (6.90e-2)"	"unprognostic (1.27e-2)"	"unprognostic (6.15e-2)"	"unprognostic (9.52e-3)"	"unprognostic (2.77e-1)"	"unprognostic (9.58e-2)"	"unprognostic (1.90e-1)"	8.2	5.0	6.5	11.0	7.4	40.4	7.7	9.9	7.1	6.5	11.0	9.0	5.8	8.0	7.5	6.3	7.4	9.7	7.1	5.0	6.8	6.4	5.9	10.1	7.6	17.9	10.6	6.3	9.0	7.8	5.6	8.7	7.2	6.7	6.5	10.0	4.5	6.9	4.9	5.1	5.6	11.2	5.6	9.1	14.3	6.6	73.4	8.1	28.3	7.0	5.7	9.9	6.1	6.8	14.4	24.3	25.7	24.9	16.4	43.8	24.2	9.1	5.4	22.4	11.1	2.9	6.1	12.7	9.3	5.3	11.7	13.6	6.4	6.4	22.0	11.7	6.1	7.6	9.5	11.7	10.5	16.0	12.2	19.6	17.3	7.0	7.8	11.5	47.6	15.4	5.9	10.6	12.9	18.4	6.8	11.9	19.7	23.8	9.0	7.5	8.7	32.1	21.3	25.0	15.8	7.5	33.2	14.1	12.6	10.7	6.8	25.4	12.7	12.5	7.2	9.7	10.7	4.7	20.1	9.1	14.1	10.3	3.4	10.4	15.0	19.9	38.1	7.7	26.6	13.8	8.0	24.9	24.0	10.5	18.6	13.4	14.0	22.9	14.8	24.3	14.4	43.8	27.9	25.7	16.4	15.3	10.5	16.7	24.2	6.5	7.4	9.9	7.1	6.8	6.4	10.6	6.3	6.7	8.1	14.9	22.4	13.8	29.1	61.6	6.1	6.7	25.5	16.0	18.2	15.7	0.0	25.9	14.9	15.3	845.1	21.2	16.7	0.0	16.0	16.6	21.4	26.1	22.0	14.7	21.1	7.9	28.7	20.3	27.6	2984.7	27.3	30.7	25.3	10.8	21.0	8.0	10.5	20.1	20.8	10.7	4.8	32.3	25.9	118.9	102.4	45.7	7.4	27.7	27.0	31.8
RNF139	"HRCA1, RCA1, TRC8"	ENSG00000170881	"Ring finger protein 139"	Q8WU17	8	124474738-124487914	"Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins"	"Ubl conjugation pathway"	"Receptor, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	12	"Early spermatids: 763.4;Late spermatids: 690.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA001202	Approved					NA	NA					"HPA001202: AB_1079824"	"unprognostic (3.28e-3)"	"unprognostic (2.92e-2)"	"unprognostic (5.16e-2)"	"unprognostic (5.43e-2)"	"unprognostic (1.03e-1)"	"unprognostic (8.32e-3)"	"unprognostic (2.71e-2)"	"unprognostic (2.00e-1)"	"unprognostic (1.69e-1)"	"unprognostic (1.51e-1)"	"prognostic unfavorable (3.54e-4)"	"unprognostic (9.85e-2)"	"unprognostic (1.53e-2)"	"unprognostic (1.62e-1)"	"unprognostic (2.75e-1)"	"unprognostic (7.75e-2)"	"unprognostic (1.45e-1)"	15.1	17.3	10.4	9.5	12.2	54.5	13.4	12.0	17.1	14.2	10.9	14.0	9.4	6.2	15.3	10.0	12.2	14.2	11.0	11.4	10.4	10.8	11.4	17.7	11.3	14.2	12.4	11.5	17.1	10.3	7.6	10.6	18.4	9.9	12.8	10.4	10.2	10.3	10.5	15.2	12.6	11.3	14.2	12.2	11.8	11.2	60.3	13.3	16.8	11.2	9.6	10.4	14.8	10.7	9.2	9.4	11.8	11.7	8.6	13.9	8.0	13.2	8.9	10.7	10.5	23.6	18.8	8.8	11.9	22.7	10.0	13.0	5.7	11.1	13.7	14.0	15.4	7.2	9.8	9.1	14.6	15.0	19.0	11.5	20.4	5.9	11.8	18.0	9.6	11.8	16.1	21.2	10.6	28.8	13.7	13.4	12.7	14.3	21.1	11.8	35.9	16.2	6.9	7.5	26.6	12.6	6.5	7.9	13.7	18.8	17.0	4.5	11.7	15.5	39.0	16.8	8.4	18.7	10.5	10.5	6.7	15.5	11.3	13.3	17.1	18.2	12.4	10.5	16.3	6.7	3.3	7.4	11.8	11.6	4.7	13.9	9.2	10.8	13.2	9.4	8.5	10.8	11.3	10.8	8.6	11.7	5.1	13.2	8.0	10.4	12.2	12.0	17.1	10.4	10.8	12.4	11.5	9.9	13.3	3.0	6.7	27.4	55.8	58.7	13.6	14.1	33.1	5.3	5.7	21.0	5.9	34.4	10.0	17.2	763.4	21.8	13.6	0.0	15.7	43.0	28.5	26.2	20.7	28.2	22.9	15.9	20.8	16.0	27.6	690.0	27.3	26.6	33.7	19.0	17.2	19.8	18.3	7.0	25.5	12.9	22.3	19.4	53.6	37.9	24.2	61.6	63.2	26.2	16.8	48.5
RNF14	"ARA54, HFB30, TRIAD2"	ENSG00000013561	"Ring finger protein 14"	Q9UBS8	5	141958328-141990291	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation, Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	7	"Early spermatids: 162.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008716, HPA064746"	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA008716: AB_1856337, HPA064746: "	"unprognostic (7.45e-3)"	"unprognostic (1.38e-1)"	"unprognostic (8.56e-2)"	"unprognostic (1.20e-1)"	"unprognostic (3.47e-2)"	"unprognostic (7.24e-3)"	"unprognostic (2.35e-1)"	"unprognostic (4.05e-2)"	"unprognostic (5.22e-2)"	"unprognostic (7.42e-2)"	"unprognostic (7.92e-2)"	"unprognostic (1.46e-1)"	"prognostic favorable (1.71e-4)"	"unprognostic (6.89e-3)"	"unprognostic (2.82e-1)"	"prognostic unfavorable (2.21e-4)"	"unprognostic (1.06e-2)"	21.2	29.5	23.7	11.2	33.9	7.8	22.0	22.5	40.2	18.4	18.7	26.2	16.0	15.3	21.0	21.5	15.6	14.3	15.4	32.9	23.6	24.7	31.3	31.3	13.8	13.3	28.9	17.3	15.9	17.1	26.3	28.8	23.6	47.7	21.6	19.8	20.9	18.1	20.1	27.7	11.9	20.9	20.5	26.3	13.8	15.7	33.7	15.0	16.2	26.3	13.3	14.9	16.7	14.0	12.3	17.1	32.6	18.8	16.8	17.0	12.2	12.7	21.4	15.0	29.5	27.1	28.4	10.1	26.3	14.7	18.5	20.5	17.7	14.9	22.6	30.8	26.9	27.9	7.0	19.1	25.8	16.6	17.0	16.5	14.4	11.2	8.0	29.8	15.7	12.9	21.3	22.8	24.6	30.9	16.1	22.9	15.8	17.4	31.6	37.8	15.2	15.2	5.0	6.3	15.6	24.4	10.1	16.7	24.5	25.4	22.2	16.6	13.5	23.0	42.2	44.6	17.6	29.3	12.3	23.6	24.6	7.9	11.6	24.9	19.9	23.2	20.7	21.1	19.3	30.3	32.6	13.4	13.0	17.0	15.8	16.5	12.3	15.0	16.9	16.2	10.6	11.5	16.7	3.3	16.8	18.8	17.1	16.7	12.2	23.7	33.9	22.5	40.2	23.6	24.7	28.9	17.3	47.7	15.0	8.9	22.9	9.0	14.0	9.5	20.9	36.8	7.6	13.4	13.6	21.0	15.7	24.8	58.0	23.0	162.7	16.9	20.2	23.3	21.8	21.4	16.2	17.2	21.9	29.6	21.4	22.3	14.5	17.8	25.5	22.0	17.8	19.3	30.4	10.8	14.1	20.6	22.7	11.5	31.5	34.8	14.6	38.8	25.8	42.6	27.1	9.3	50.6	17.5	13.3	12.7
RNF144A	"hUIP4, KIAA0161, RNF144, UBCE7IP4"	ENSG00000151692	"Ring finger protein 144A"	P50876	2	6917392-7068286	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 45.5"	"Cell type enhanced"	"Detected in many"	9	"Cone photoreceptor cells: 70.7;Rod photoreceptor cells: 42.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"eosinophil: 8.7"	"Group enriched"	"Detected in many"	7	"granulocytes: 8.7;T-cells: 4.1"	"Cell line enhanced"	"Detected in many"		"HEL: 15.2;HMC-1: 51.6;SH-SY5Y: 15.7;SK-MEL-30: 15.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA049939	Approved		Supported	Vesicles		NA	NA			Vesicles		"HPA049939: AB_2680960"	"unprognostic (1.78e-1)"	"unprognostic (2.53e-3)"	"unprognostic (8.37e-2)"	"prognostic unfavorable (6.00e-4)"	"unprognostic (6.57e-2)"	"prognostic favorable (6.96e-4)"	"unprognostic (7.04e-6)"	"unprognostic (1.20e-1)"	"unprognostic (2.03e-2)"	"unprognostic (5.64e-1)"	"unprognostic (9.11e-2)"	"unprognostic (1.92e-1)"	"unprognostic (1.03e-1)"	"prognostic unfavorable (7.32e-5)"	"unprognostic (1.30e-2)"	"unprognostic (3.01e-1)"	"unprognostic (1.82e-3)"	12.9	28.8	13.3	4.2	21.2	12.1	11.1	45.5	20.7	17.3	5.2	28.7	9.0	3.0	26.0	8.3	4.7	8.4	7.5	8.0	15.6	11.6	7.5	1.8	5.7	7.9	26.5	12.2	20.0	29.7	21.5	12.5	6.2	13.2	8.7	5.7	5.9	4.0	7.4	8.7	5.7	4.1	12.2	21.8	21.1	2.8	5.0	27.1	3.4	3.2	1.2	5.8	5.8	6.5	0.1	0.2	8.7	0.1	0.8	4.1	0.6	0.3	2.2	12.0	2.4	2.7	5.6	9.2	0.0	0.0	0.4	1.1	0.0	0.2	1.1	1.3	0.1	3.5	0.2	3.9	0.0	0.0	0.6	1.0	15.2	0.1	4.5	0.1	0.3	51.6	8.9	0.0	0.8	0.0	0.0	0.0	3.9	6.5	0.2	0.0	1.9	7.8	0.6	4.4	0.3	5.4	6.1	8.7	1.0	0.4	3.9	3.9	15.7	0.2	1.6	15.4	1.6	0.7	1.0	0.0	1.6	4.1	4.2	1.7	4.1	1.3	0.0	6.0	3.4	5.6	1.5	0.1	8.7	2.1	0.0	3.0	0.1	2.1	1.5	0.2	0.1	4.1	2.8	0.4	0.8	0.0	0.0	0.8	0.6	13.3	21.2	45.5	20.3	15.6	11.6	26.5	12.2	13.2	27.1	3.0	3.4	0.5	0.7	2.2	3.6	10.6	2.5	2.7	3.4	0.0	70.7	1.7	1.7	2.7	5.7	7.0	4.2	23.3	5.0	2.7	5.3	3.5	9.2	0.8	3.8	9.5	24.5	28.3	1.0	10.4	4.0	1.0	23.6	1.0	2.5	7.2	4.5	9.1	9.9	0.0	42.2	0.0	3.8	1.6	6.0	1.4	0.9	6.4	2.9	0.2
RNF144B	"bA528A10.3, IBRDC2, P53RFP"	ENSG00000137393	"Ring finger protein 144B"	Q7Z419	6	18387350-18468874	"Enzymes, Predicted membrane proteins"	"Apoptosis, Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	10	"Basal keratinocytes: 563.5;Suprabasal keratinocytes: 1312.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"non-classical monocyte: 28.8"	"Group enriched"	"Detected in many"	9	"dendritic cells: 7.9;granulocytes: 15.6;monocytes: 28.8"	"Cell line enhanced"	"Detected in many"		"Daudi: 55.9;EFO-21: 15.4;hTCEpi: 17.8;HUVEC TERT2: 16.5;TIME: 16.5;U-698: 47.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB046013, HPA054127, HPA072469"	Uncertain		Approved	Nucleoli,Mitochondria		NA	NA			Nucleoli	Mitochondria	"CAB046013: AB_11126028, HPA054127: AB_2682391, HPA072469: "	"unprognostic (2.24e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.56e-1)"	"unprognostic (4.07e-2)"	"unprognostic (2.55e-1)"	"unprognostic (4.48e-3)"	"unprognostic (5.89e-2)"	"unprognostic (1.18e-2)"	"unprognostic (6.55e-2)"	"unprognostic (2.87e-3)"	"unprognostic (2.44e-2)"	"unprognostic (2.60e-1)"	"unprognostic (1.34e-1)"	"unprognostic (2.39e-1)"	"unprognostic (3.91e-2)"	"unprognostic (1.53e-1)"	"unprognostic (1.21e-1)"	16.3	2.0	4.6	11.1	6.8	15.7	21.1	5.1	7.5	8.0	4.2	2.8	4.6	1.5	6.8	7.5	9.4	9.0	6.8	8.7	5.3	4.3	13.8	11.4	39.0	11.1	8.3	2.3	4.2	3.7	3.0	2.3	11.1	8.8	12.8	2.3	8.3	16.9	6.2	36.8	19.2	3.7	4.9	9.2	37.1	4.3	3.3	6.9	5.8	32.9	11.4	12.2	7.3	6.6	2.0	7.9	15.6	28.8	0.2	0.7	2.6	1.3	0.2	0.1	0.0	0.0	0.6	2.9	1.5	1.7	3.3	3.6	0.0	0.1	55.9	15.4	0.6	0.2	4.8	0.0	4.7	4.7	0.2	0.4	0.0	0.0	1.2	0.0	0.0	0.0	0.8	17.8	1.3	4.0	1.5	16.5	1.2	0.0	0.0	0.8	0.5	0.4	0.0	0.5	0.1	0.3	0.2	0.5	3.3	10.0	3.1	0.5	0.0	0.3	7.1	5.3	0.4	8.4	0.1	16.5	2.6	0.5	0.2	0.3	0.0	0.0	47.0	0.3	0.1	0.2	0.1	9.1	5.1	0.2	16.4	0.7	2.0	0.3	0.3	5.6	1.6	0.7	0.4	15.6	0.2	28.8	7.9	0.2	2.6	4.6	6.8	5.1	7.5	5.3	4.3	8.3	2.3	8.8	6.9	41.7	12.9	4.2	36.0	563.5	0.9	10.4	10.2	21.4	36.4	36.6	2.0	9.7	16.6	8.2	1.6	32.1	1.0	0.0	7.7	2.9	12.4	85.1	3.5	17.4	13.8	0.0	1.2	28.8	98.2	1.6	1.1	68.0	57.3	44.1	1.3	16.0	6.0	2.9	2.8	16.3	1.0	0.0	10.1	1.7	2.6	1312.2	1.3	3.2	2.4	20.3
RNF145	FLJ31951	ENSG00000145860	"Ring finger protein 145"	Q96MT1	5	159157409-159210053	"Enzymes, Predicted membrane proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA036562	Uncertain		Approved	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Nucleoplasm, Plasma membrane, Cytosol"		"HPA036562: AB_10696657"	"unprognostic (1.57e-1)"	"unprognostic (9.02e-3)"	"unprognostic (4.11e-2)"	"unprognostic (3.88e-2)"	"unprognostic (3.24e-2)"	"unprognostic (2.93e-2)"	"prognostic unfavorable (1.64e-6)"	"unprognostic (1.35e-1)"	"unprognostic (1.02e-2)"	"unprognostic (1.54e-1)"	"unprognostic (3.53e-1)"	"unprognostic (1.67e-1)"	"unprognostic (8.92e-3)"	"unprognostic (1.49e-1)"	"unprognostic (1.00e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.39e-1)"	13.3	20.1	23.9	15.6	23.0	7.1	24.1	30.2	27.3	11.3	11.7	5.7	5.3	4.7	12.6	13.6	26.7	11.4	20.8	16.8	22.0	8.4	8.2	6.1	30.7	36.3	17.5	9.7	14.1	6.0	26.9	29.0	21.9	18.5	11.8	12.6	10.2	17.8	14.8	5.5	14.9	11.0	13.8	12.4	12.7	11.2	7.9	18.0	12.4	14.3	8.0	19.6	19.3	15.7	8.9	2.7	14.4	2.6	2.1	6.2	1.3	20.3	20.1	31.0	37.2	32.8	14.6	6.0	16.3	28.5	15.1	24.6	6.9	16.9	7.0	29.4	14.3	28.8	26.7	24.4	21.5	26.7	28.8	8.7	14.7	22.9	5.7	14.1	9.7	14.1	9.0	38.9	14.1	20.7	21.2	14.8	17.1	14.6	27.1	14.2	0.5	11.0	3.0	13.4	6.4	10.3	14.7	13.5	14.0	20.2	7.0	11.3	20.9	16.5	17.7	26.8	22.1	12.4	8.9	15.8	17.0	15.6	13.6	28.9	6.0	8.3	6.5	19.8	12.1	36.3	2.8	2.6	14.4	3.2	2.5	3.7	8.9	4.7	3.8	1.9	4.4	6.2	4.3	9.7	2.1	2.2	2.7	5.7	1.3	23.9	23.0	30.2	27.3	22.0	8.4	17.5	9.7	18.5	18.0	104.2	213.5	76.8	93.4	109.1	103.7	10.0	79.0	48.2	106.9	34.9	55.0	2.7	16.6	63.7	22.1	50.7	48.5	46.7	99.7	20.5	58.0	100.6	68.1	16.3	39.0	108.1	52.0	127.7	90.9	29.9	42.8	54.8	62.4	223.6	41.8	63.1	90.1	51.8	48.8	8.4	48.6	45.3	49.5	14.9	33.0	86.9	9.2	73.0	57.2	150.2
RNF146	"dactylidin, dJ351K20.1, DKFZp434O1427"	ENSG00000118518	"Ring finger protein 146"	Q9NTX7	6	127266610-127288567	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Ubl conjugation pathway, Wnt signaling pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027158, HPA027209"	Approved		Supported	"Nucleoplasm,Plasma membrane,Cytosol"		No	No			"Plasma membrane, Cytosol"	Nucleoplasm	"HPA027158: AB_10600772, HPA027209: AB_10602312"	"unprognostic (8.22e-2)"	"unprognostic (1.20e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.32e-1)"	"unprognostic (1.38e-2)"	"unprognostic (1.17e-2)"	"unprognostic (1.37e-1)"	"unprognostic (5.47e-3)"	"unprognostic (1.87e-1)"	"unprognostic (6.74e-2)"	"prognostic favorable (5.26e-5)"	"unprognostic (2.65e-2)"	"prognostic favorable (7.32e-4)"	"unprognostic (4.04e-2)"	"unprognostic (1.29e-1)"	"unprognostic (6.13e-2)"	"unprognostic (2.15e-2)"	27.3	20.9	28.5	16.6	29.1	5.1	23.9	63.7	34.5	22.7	18.6	29.2	10.5	11.8	32.0	35.2	14.2	17.9	21.3	25.2	26.3	21.7	20.9	16.8	21.0	17.3	30.0	27.7	28.5	12.6	26.5	27.4	27.8	31.3	18.6	17.6	17.5	16.7	20.3	55.9	16.0	15.2	26.1	28.7	24.6	15.5	16.3	27.7	9.2	26.7	15.5	17.6	19.2	18.7	11.7	14.2	22.8	22.8	11.5	10.3	9.1	5.5	7.0	26.7	23.5	24.8	24.9	9.7	18.9	30.3	10.1	14.6	9.1	8.4	10.0	13.4	15.4	15.9	7.1	7.9	8.9	14.8	11.5	6.9	12.7	8.4	12.7	24.6	7.5	9.1	21.7	18.7	11.4	22.8	23.4	17.7	10.0	13.7	9.9	22.3	10.6	7.4	13.6	9.7	3.4	7.3	9.4	6.9	5.0	14.4	6.1	16.0	16.2	7.4	10.5	11.6	16.5	7.1	26.1	20.8	17.9	5.9	18.5	13.3	14.3	8.8	6.6	13.7	13.2	16.8	16.8	18.9	16.1	9.3	20.0	9.7	11.1	8.0	10.3	14.2	11.7	7.3	10.2	22.8	11.5	22.8	7.1	8.6	9.1	28.5	29.1	63.7	34.5	26.3	21.7	30.0	27.7	31.3	27.7	32.8	24.8	20.8	11.4	15.8	34.0	33.0	38.2	20.1	7.9	8.7	3.9	25.1	34.9	24.3	40.1	34.9	12.8	0.0	14.1	22.7	38.1	21.4	21.9	25.2	22.8	28.6	19.7	28.3	67.8	33.7	64.5	25.0	43.9	24.4	11.5	36.1	15.1	13.9	62.6	42.1	18.1	32.3	33.5	44.7	12.2	17.6	32.2	28.7	10.9	14.1
RNF149	FLJ90504	ENSG00000163162	"Ring finger protein 149"	Q8NC42	2	101271219-101308701	"Enzymes, Predicted membrane proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 123.7"	"Cell type enhanced"	"Detected in many"	5	"Kupffer cells: 255.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in all"	6	"neutrophil: 123.7"	"Lineage enriched"	"Detected in all"	6	"granulocytes: 123.7"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA011424	Approved		Approved	"Vesicles,Plasma membrane"		NA	NA			"Vesicles, Plasma membrane"		"HPA011424: AB_1079825"	"unprognostic (2.56e-2)"	"unprognostic (4.70e-2)"	"unprognostic (1.96e-1)"	"unprognostic (3.49e-2)"	"unprognostic (3.17e-2)"	"unprognostic (5.17e-3)"	"unprognostic (4.16e-2)"	"unprognostic (4.77e-3)"	"unprognostic (5.61e-2)"	"unprognostic (1.43e-2)"	"unprognostic (5.69e-3)"	"unprognostic (1.51e-1)"	"prognostic unfavorable (2.04e-8)"	"unprognostic (1.39e-1)"	"unprognostic (6.16e-2)"	"unprognostic (2.70e-1)"	"prognostic favorable (2.91e-4)"	20.3	13.4	7.9	29.0	10.9	32.9	13.5	7.9	10.8	12.5	16.6	10.8	11.4	12.3	11.3	12.8	28.9	14.3	14.5	12.1	9.5	9.4	15.1	19.6	24.5	47.4	13.7	6.2	14.3	21.1	14.3	10.6	19.4	11.2	11.1	12.0	12.8	15.8	8.1	8.8	20.2	16.8	9.6	13.9	65.0	13.8	15.2	9.7	17.0	12.7	13.1	24.4	14.9	17.2	2.1	9.3	123.7	21.3	2.3	9.0	9.9	9.7	5.8	4.4	5.5	16.5	16.6	25.7	12.1	15.9	16.4	18.5	14.5	25.8	2.9	14.7	11.9	21.7	19.9	6.2	12.3	15.3	8.4	8.5	6.0	5.1	24.5	22.1	6.5	9.8	15.1	20.3	19.4	12.9	12.6	29.8	6.4	5.3	9.1	16.4	8.3	8.7	6.5	3.0	13.2	10.5	5.7	7.3	11.2	19.3	23.9	5.8	4.3	7.3	18.1	17.5	5.0	4.9	8.8	19.7	8.3	4.7	12.4	2.6	18.4	10.8	0.1	2.7	9.1	6.1	5.8	13.0	14.8	8.2	20.4	7.4	2.1	7.3	8.1	4.8	1.5	5.1	5.3	123.7	2.3	21.3	9.3	9.0	9.9	7.9	10.9	7.9	10.8	9.5	9.4	13.7	6.2	11.2	9.7	44.7	56.9	34.7	63.4	68.3	20.3	10.6	48.4	24.1	23.9	52.4	53.0	48.5	1.7	48.9	61.2	33.8	33.9	0.0	36.5	60.6	44.7	62.7	37.1	38.9	76.7	7.9	8.2	28.8	255.2	27.7	28.4	171.2	38.8	16.2	35.9	11.9	49.2	36.6	18.4	25.1	19.7	58.2	44.3	31.2	36.2	80.0	107.1	69.8	31.9	137.0
RNF152	FLJ39176	ENSG00000176641	"Ring finger protein 152"	Q8N8N0	18	61808063-61894247	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Apoptosis, Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in all"		"kidney: 53.7"	"Cell type enhanced"	"Detected in many"	7	"Hepatocytes: 71.0;Proximal tubular cells: 104.4;Sertoli cells: 64.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"HaCaT: 16.3;HBEC3-KT: 8.7;SH-SY5Y: 10.1;TIME: 10.1;U-138 MG: 16.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA						"unprognostic (3.30e-2)"	"unprognostic (1.97e-2)"	"unprognostic (1.64e-1)"	"unprognostic (8.55e-3)"	"unprognostic (2.05e-1)"	"unprognostic (2.09e-1)"	"unprognostic (2.96e-3)"	"unprognostic (3.62e-1)"	"unprognostic (1.51e-2)"	"unprognostic (8.13e-2)"	"unprognostic (5.14e-2)"	"unprognostic (6.73e-2)"	"prognostic favorable (1.13e-8)"	"prognostic unfavorable (2.85e-5)"	"unprognostic (3.26e-2)"	"unprognostic (2.82e-2)"	"unprognostic (4.83e-2)"	8.3	3.9	2.4	2.3	6.8	1.5	8.8	19.1	3.8	8.5	7.4	4.0	6.2	2.2	8.6	10.4	4.5	3.9	8.0	6.5	2.5	3.1	53.7	28.3	7.8	1.2	4.1	1.4	3.8	3.1	4.7	2.6	6.6	7.7	4.7	6.7	3.4	11.8	6.8	4.6	9.6	9.8	4.6	4.2	1.3	5.7	3.9	4.5	0.0	5.1	4.9	2.0	5.0	11.6	0.5	0.4	1.7	0.4	0.6	0.4	0.2	0.0	0.0	3.5	0.8	3.4	0.5	0.0	2.3	7.1	0.5	0.4	0.0	0.1	0.1	0.7	3.6	0.1	16.3	4.4	8.7	1.0	0.0	0.4	0.0	0.0	0.0	1.8	0.0	0.1	0.5	6.0	2.8	1.7	1.6	6.5	0.0	0.0	0.0	1.0	0.7	0.6	0.0	0.2	0.5	0.0	0.2	2.3	0.0	0.3	2.6	3.0	10.1	0.0	6.4	1.1	3.2	3.9	0.0	10.1	16.5	1.7	0.0	0.3	0.0	0.0	0.0	0.5	0.0	5.5	1.7	0.3	0.4	0.2	0.3	0.3	0.3	0.3	0.3	0.2	0.5	0.4	0.4	1.5	0.6	0.4	0.4	0.3	0.2	2.4	6.8	19.1	3.8	2.5	3.1	4.1	1.4	7.7	4.5	0.0	0.0	0.0	21.4	37.5	13.4	2.5	12.7	0.0	2.3	19.2	0.0	0.4	39.7	2.0	0.2	16.3	37.1	0.0	2.4	0.1	8.3	7.3	0.0	71.0	0.1	20.6	15.5	5.5	2.2	0.0	8.1	2.2	27.0	0.0	4.9	3.7	1.1	31.6	17.3	104.4	3.6	64.7	48.4	0.1	0.1	28.4	0.2	0.0	11.8	18.8
RNF157	KIAA1917	ENSG00000141576	"Ring finger protein 157"	Q96PX1	17	76142453-76240373	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 36.5;skeletal muscle: 52.2;testis: 24.7"	"Cell type enhanced"	"Detected in many"	11	"Bipolar cells: 118.6;Cone photoreceptor cells: 178.7;Horizontal cells: 170.0;Rod photoreceptor cells: 66.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"granulocytes: 2.5;T-cells: 8.5"	"Cell line enhanced"	"Detected in many"		"HDLM-2: 42.3;U-266/70: 22.4;U-266/84: 18.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021854, HPA021991, HPA023922"	Uncertain		Approved	"Golgi apparatus,Vesicles"		NA	NA			"Golgi apparatus"	Vesicles	"HPA021854: AB_10600307, HPA021991: AB_10601112, HPA023922: AB_10602202"	"unprognostic (4.21e-1)"	"unprognostic (4.62e-2)"	"unprognostic (1.55e-2)"	"unprognostic (2.63e-3)"	"unprognostic (4.93e-2)"	"unprognostic (5.06e-2)"	"unprognostic (2.07e-3)"	"unprognostic (4.21e-1)"	"unprognostic (1.07e-1)"	"unprognostic (2.35e-2)"	"unprognostic (1.04e-3)"	"unprognostic (4.02e-1)"	"unprognostic (8.26e-2)"	"unprognostic (8.69e-3)"	"unprognostic (2.28e-1)"	"unprognostic (2.75e-2)"	"unprognostic (1.38e-1)"	10.5	3.5	21.0	3.4	19.4	2.3	2.5	10.7	36.5	1.5	7.6	8.0	0.4	8.2	1.9	3.6	1.5	2.4	1.8	3.6	26.4	15.5	5.1	1.4	1.4	4.5	19.7	12.0	1.4	3.6	8.8	2.7	2.1	25.3	1.8	6.6	6.8	1.9	2.0	52.2	1.5	7.3	2.2	11.3	3.0	2.4	24.7	5.9	0.0	3.8	1.5	2.8	1.5	0.5	0.7	0.4	2.5	0.3	1.1	8.5	1.4	0.1	3.4	12.7	4.6	4.0	2.0	5.9	0.1	3.9	0.8	0.4	1.4	1.4	0.0	1.8	0.3	3.1	0.1	11.2	0.0	0.7	42.3	3.8	0.0	1.2	1.9	0.6	0.5	4.8	1.1	0.0	1.5	0.0	0.7	0.1	2.1	6.6	0.1	1.6	3.4	1.8	0.3	2.1	2.3	9.0	0.0	0.1	0.0	1.5	1.3	2.2	10.5	2.3	0.0	5.0	3.0	0.3	2.1	0.0	0.8	1.1	6.2	3.9	22.4	18.0	0.0	0.3	0.0	6.4	2.5	0.3	0.4	2.3	0.2	4.9	0.3	5.1	4.0	0.2	0.7	8.5	5.5	1.7	1.1	0.3	0.4	2.1	1.4	21.0	19.4	10.7	36.5	26.4	15.5	19.7	12.0	25.3	5.9	3.0	3.5	1.5	0.7	1.8	118.6	8.4	15.3	0.0	2.3	1.8	178.7	0.6	0.0	1.5	22.3	4.4	12.7	0.0	1.0	0.4	1.5	0.8	0.0	4.3	0.3	170.0	2.4	0.6	0.6	21.5	10.6	2.3	1.7	0.0	3.4	34.2	0.1	2.5	13.1	8.2	66.3	0.0	1.0	21.9	22.5	1.9	0.2	12.7	11.0	1.0
RNF165	"ARKL2, RNF111L2"	ENSG00000141622	"Ring finger protein 165"	Q6ZSG1	18	46326809-46463140	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"brain: 28.6"	"Group enriched"	"Detected in many"	8	"Bipolar cells: 36.3;Cone photoreceptor cells: 94.2;Horizontal cells: 76.3;Rod photoreceptor cells: 51.7"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	4	"MAIT T-cell: 1.1;NK-cell: 3.9;plasmacytoid DC: 1.5"	"Group enriched"	"Detected in many"	4	"dendritic cells: 1.5;NK-cells: 3.9;T-cells: 1.1"	"Cell line enhanced"	"Detected in some"		"AF22: 12.7;HaCaT: 7.0;HeLa: 6.9;RPMI-8226: 6.7;SCLC-21H: 13.2;SH-SY5Y: 15.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA041615, HPA047798"	Uncertain		Approved	"Nucleoplasm,Plasma membrane"		NA	NA			"Nucleoplasm, Plasma membrane"		"HPA041615: AB_2677582, HPA047798: AB_2680158"	"unprognostic (6.46e-3)"	"unprognostic (7.25e-2)"	"unprognostic (4.55e-2)"	"unprognostic (1.24e-5)"	"unprognostic (3.43e-1)"	"unprognostic (4.57e-2)"	"unprognostic (5.18e-2)"	"unprognostic (1.69e-1)"	"unprognostic (1.04e-3)"	"unprognostic (1.95e-1)"	"unprognostic (1.23e-1)"	"unprognostic (2.07e-1)"	"unprognostic (1.87e-5)"	"unprognostic (3.53e-3)"	"unprognostic (1.90e-1)"	"unprognostic (1.29e-1)"	"unprognostic (1.64e-1)"	1.9	1.7	9.9	1.0	9.5	0.9	2.1	28.6	13.8	1.0	0.8	1.7	1.7	0.4	1.0	8.4	2.7	3.0	1.0	2.5	6.1	4.4	2.3	8.3	1.0	0.9	2.2	7.2	0.5	1.0	13.1	4.8	0.8	2.0	3.6	0.6	2.7	1.4	3.9	3.6	3.5	1.0	0.7	1.7	5.3	0.7	1.3	1.0	1.7	8.8	1.2	1.3	1.2	1.0	0.0	1.5	0.5	0.0	3.9	1.1	0.0	1.5	0.1	12.7	0.1	0.0	0.0	4.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.2	7.0	0.5	1.0	0.0	0.0	1.0	0.1	6.9	0.0	0.0	2.9	0.0	0.0	0.8	0.0	0.0	0.3	0.0	2.2	0.0	0.2	0.0	0.0	2.3	1.0	1.7	0.3	1.2	2.4	0.5	6.7	0.8	2.1	13.2	15.0	2.3	0.0	0.0	0.9	0.3	0.6	0.0	0.0	0.9	0.0	0.4	0.0	0.0	0.0	0.0	4.1	0.4	0.0	0.0	0.5	0.0	0.0	1.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	3.9	0.0	1.5	0.0	0.0	9.9	9.5	28.6	13.8	6.1	4.4	2.2	7.2	2.0	1.0	3.0	1.7	0.0	8.3	2.4	36.3	7.9	0.0	0.0	3.4	0.0	94.2	0.1	3.3	0.0	2.7	1.9	0.0	0.0	0.0	0.2	1.5	1.7	0.0	5.7	0.1	76.3	0.0	0.6	0.8	3.1	2.3	0.0	1.7	0.0	0.0	3.7	0.1	0.0	3.9	0.0	51.7	0.0	0.8	0.5	0.5	1.8	0.2	2.9	0.0	1.6
RNF167	DKFZP566H073	ENSG00000108523	"Ring finger protein 167"	Q9H6Y7	17	4940008-4945222	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA049810	Approved		Approved	"Vesicles,Mitotic spindle,Centriolar satellite,Cytosol"		NA	NA			"Vesicles, Cytosol"	"Mitotic spindle, Centriolar satellite"	"HPA049810: AB_2680894"	"unprognostic (1.13e-1)"	"unprognostic (5.12e-2)"	"unprognostic (2.29e-3)"	"unprognostic (1.63e-2)"	"unprognostic (3.43e-2)"	"unprognostic (7.32e-2)"	"unprognostic (2.18e-1)"	"unprognostic (6.77e-2)"	"unprognostic (7.46e-2)"	"unprognostic (2.07e-2)"	"prognostic favorable (2.03e-6)"	"unprognostic (2.16e-1)"	"prognostic favorable (4.47e-4)"	"unprognostic (7.62e-2)"	"unprognostic (1.93e-1)"	"unprognostic (3.26e-1)"	"unprognostic (1.12e-1)"	30.5	45.9	45.8	32.1	47.0	40.7	38.3	37.9	67.9	44.3	43.5	54.6	49.2	42.7	43.1	55.8	51.6	44.0	47.4	40.1	43.1	39.9	44.1	84.1	35.6	38.7	43.7	43.6	42.6	52.4	52.8	40.7	49.0	41.2	43.6	46.7	38.5	49.1	51.7	56.5	51.6	51.1	42.4	46.4	47.1	42.7	42.0	33.1	53.9	55.1	47.3	47.6	48.1	40.7	25.6	18.2	54.4	26.7	27.6	53.0	37.9	24.2	35.2	15.3	18.8	37.8	18.9	22.9	15.0	21.0	31.7	25.1	24.5	11.2	17.9	29.2	24.8	15.8	37.3	26.6	29.2	23.7	17.3	42.8	30.6	44.4	24.1	28.6	14.4	64.6	22.1	46.1	33.0	31.4	19.9	20.4	26.7	11.9	61.3	25.3	17.3	22.7	17.9	18.3	25.7	22.6	15.7	15.3	22.3	36.5	20.4	12.1	15.0	13.8	23.7	20.0	22.4	22.6	14.7	12.5	19.0	12.6	17.0	28.5	20.4	20.6	5.9	26.1	20.8	19.8	22.4	21.4	54.4	53.0	22.6	41.1	25.6	40.6	52.7	18.2	24.0	28.5	42.3	52.1	27.6	26.7	18.0	37.7	37.9	45.8	47.0	37.9	67.9	43.1	39.9	43.7	43.6	41.2	33.1	0.0	3.8	37.8	33.1	60.9	40.7	13.4	66.2	2.7	2.3	47.1	19.6	101.9	48.0	68.5	41.4	35.8	73.2	46.7	58.4	102.1	39.8	31.4	13.9	83.9	52.2	17.5	30.5	38.1	36.1	68.6	45.1	42.0	37.1	57.7	40.4	45.0	52.7	40.3	50.5	53.1	25.5	38.8	27.8	111.1	83.5	72.8	104.7	90.0	54.4	39.3
RNF168	FLJ35794	ENSG00000163961	"Ring finger protein 168"	Q8IYW5	3	196468783-196503768	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"DNA damage, DNA repair, Ubl conjugation pathway"	"Chromatin regulator, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	10	"Early spermatids: 199.9;Late spermatids: 360.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA046109			Enhanced	"Nucleoplasm,Nuclear bodies"		NA	NA			"Nucleoplasm, Nuclear bodies"		"HPA046109: AB_2679540"	"unprognostic (6.15e-3)"	"prognostic favorable (8.21e-4)"	"unprognostic (3.11e-1)"	"unprognostic (1.11e-2)"	"unprognostic (4.22e-1)"	"unprognostic (5.04e-2)"	"prognostic unfavorable (2.29e-4)"	"unprognostic (6.81e-3)"	"unprognostic (5.30e-2)"	"unprognostic (1.63e-1)"	"prognostic unfavorable (8.31e-4)"	"unprognostic (4.83e-3)"	"unprognostic (2.80e-3)"	"unprognostic (5.98e-2)"	"unprognostic (1.45e-1)"	"unprognostic (1.95e-2)"	"unprognostic (6.65e-2)"	20.8	9.3	8.9	10.7	11.1	31.6	18.7	21.1	13.0	13.6	11.2	10.7	12.3	11.1	13.9	8.5	14.3	10.1	10.9	12.0	10.2	10.2	7.5	18.8	14.3	12.0	13.8	11.0	14.6	9.2	12.0	8.1	9.9	15.3	10.1	10.8	9.1	11.0	13.6	20.8	20.1	10.1	12.9	10.5	11.7	10.7	18.4	13.4	17.6	9.6	13.9	15.2	14.7	17.1	6.2	5.8	21.8	10.0	7.7	11.6	5.7	12.5	5.0	9.0	11.8	8.4	6.1	12.9	7.7	4.9	5.2	8.2	9.8	6.2	13.3	17.8	6.4	7.3	12.8	12.6	9.2	8.0	6.3	6.2	25.2	12.7	12.1	4.4	7.7	6.3	6.1	3.5	8.1	7.2	3.7	7.5	11.0	7.5	14.0	5.2	21.2	25.5	4.6	10.7	6.8	6.5	11.5	10.5	10.8	4.4	17.4	7.5	7.6	8.7	10.7	6.6	7.0	16.2	6.9	7.4	9.0	7.1	9.5	10.1	12.0	11.2	20.2	8.8	9.4	7.1	21.8	6.6	7.5	11.6	7.1	10.4	5.7	9.8	8.3	5.8	6.2	8.7	9.1	7.3	7.7	10.0	5.5	6.2	5.7	8.9	11.1	21.1	13.0	10.2	10.2	13.8	11.0	15.3	13.4	14.9	29.1	17.1	44.2	89.0	35.1	19.7	12.7	18.7	19.4	14.0	56.9	11.4	14.9	11.9	199.9	29.2	13.6	0.0	7.9	20.7	33.6	23.5	49.6	25.8	15.9	14.3	13.8	17.2	29.0	360.7	18.7	39.0	25.3	37.9	16.0	13.4	8.6	14.4	19.4	8.4	39.6	12.9	35.0	11.1	67.5	110.7	8.9	46.0	18.6	50.5
RNF169	KIAA1991	ENSG00000166439	"Ring finger protein 169"	Q8NCN4	11	74748868-74842413	"Enzymes, Predicted intracellular proteins"	"DNA damage, Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038505, HPA046138, HPA047952"	Uncertain		Enhanced	"Nucleoplasm,Nucleoli,Nucleoli rim,Nuclear bodies,Cytosol"		NA	NA			"Nucleoplasm, Nuclear bodies"	"Nucleoli, Nucleoli rim, Cytosol"	"HPA038505: , HPA046138: AB_2679553, HPA047952: "	"unprognostic (1.71e-1)"	"unprognostic (4.18e-2)"	"unprognostic (4.34e-2)"	"unprognostic (3.72e-2)"	"unprognostic (3.86e-2)"	"unprognostic (3.25e-2)"	"unprognostic (1.74e-1)"	"unprognostic (1.35e-1)"	"unprognostic (2.68e-1)"	"unprognostic (6.47e-2)"	"prognostic unfavorable (8.04e-4)"	"unprognostic (2.76e-1)"	"unprognostic (1.46e-1)"	"unprognostic (3.23e-1)"	"unprognostic (2.34e-1)"	"unprognostic (9.55e-3)"	"unprognostic (1.21e-1)"	12.3	7.0	12.0	11.6	14.0	23.1	12.0	22.6	15.6	13.1	11.2	12.2	6.3	7.4	14.2	8.2	20.6	10.7	10.8	9.2	12.6	5.9	8.9	9.3	16.9	11.3	15.4	9.1	14.6	10.7	17.5	10.4	8.6	13.9	10.5	10.0	8.4	12.4	8.8	15.0	14.1	10.3	14.2	10.1	12.6	10.3	7.2	14.9	12.6	11.5	7.4	12.5	13.1	15.8	0.6	0.8	5.0	1.9	1.2	1.6	0.6	8.3	6.4	7.8	7.6	5.0	6.8	3.1	6.5	6.2	7.3	6.4	10.7	6.3	14.9	6.7	7.8	5.0	8.1	10.4	7.8	9.6	7.4	6.7	10.3	11.8	4.2	5.8	5.4	8.6	6.2	6.2	8.3	19.0	8.2	11.8	10.2	9.1	12.0	7.3	7.0	9.3	9.8	3.0	10.6	4.2	8.7	18.5	8.1	4.7	8.7	3.5	6.3	8.8	6.7	14.2	6.5	8.4	7.0	7.8	12.2	10.3	7.6	5.8	8.7	4.5	17.7	2.4	6.0	7.0	2.8	1.9	1.5	1.6	1.1	1.2	0.3	1.5	0.9	0.8	0.6	1.1	0.9	5.0	1.2	1.0	0.8	1.2	0.6	12.0	14.0	22.6	15.6	12.6	5.9	15.4	9.1	13.9	14.9	8.9	10.7	13.0	26.3	17.6	51.9	2.8	2.5	5.3	7.9	3.5	49.1	5.0	5.0	8.8	2.2	11.7	6.7	0.0	9.5	5.0	9.3	37.6	6.9	11.0	7.6	35.0	11.5	8.6	10.7	2.2	6.9	9.2	10.1	1.8	7.8	33.2	9.1	5.8	9.9	9.1	32.5	25.8	15.1	10.4	10.9	16.3	6.8	16.6	9.7	39.6
RNF170	"ADSA, DKFZP564A022, SNAX1"	ENSG00000120925	"Ring finger protein 170"	Q96K19	8	42849637-42897290	"Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins"	"Ubl conjugation pathway"	Transferase	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Cone photoreceptor cells: 84.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"HPA050931, HPA054621"	Uncertain					NA	NA					"HPA050931: AB_2681279, HPA054621: AB_2682545"	"unprognostic (3.06e-2)"	"unprognostic (4.20e-1)"	"unprognostic (9.54e-2)"	"unprognostic (6.37e-2)"	"unprognostic (4.59e-2)"	"unprognostic (2.84e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.32e-1)"	"unprognostic (3.23e-2)"	"unprognostic (1.17e-1)"	"unprognostic (2.59e-1)"	"unprognostic (3.03e-2)"	"unprognostic (1.61e-3)"	"unprognostic (4.13e-3)"	"unprognostic (2.00e-1)"	"unprognostic (1.49e-1)"	"unprognostic (2.13e-1)"	8.9	13.6	14.3	8.7	17.0	2.2	13.0	15.3	18.8	8.6	10.9	17.5	15.0	10.2	9.8	15.6	14.5	9.7	9.5	8.1	13.7	14.3	17.0	19.4	9.3	8.4	15.7	18.2	13.4	10.8	15.5	16.6	19.0	19.7	11.5	11.7	12.5	12.0	11.5	10.5	14.9	11.3	7.9	21.8	8.8	10.6	7.8	14.2	5.5	29.4	8.0	9.6	10.4	10.6	8.5	11.1	2.6	7.2	5.6	8.0	5.9	6.9	11.3	11.6	5.8	19.0	19.6	7.0	8.4	11.6	7.9	8.6	5.4	22.8	8.4	10.2	7.9	14.3	6.0	6.1	8.3	6.8	5.8	6.5	9.8	5.0	5.7	10.6	1.2	7.1	17.0	13.0	6.0	12.5	10.3	8.5	9.5	8.8	10.1	12.6	2.1	10.3	5.7	5.5	14.9	4.0	5.4	15.5	4.8	12.8	6.8	3.1	9.1	7.9	5.6	14.0	11.9	14.7	5.7	12.2	8.6	3.8	11.4	2.6	16.3	15.5	9.5	11.7	4.1	8.6	1.7	7.2	2.6	4.0	7.1	5.6	8.5	6.3	6.9	10.7	5.1	7.7	5.5	0.7	5.6	6.5	11.1	8.0	5.9	14.3	17.0	15.3	18.8	13.7	14.3	15.7	18.2	19.7	14.2	44.7	18.6	13.8	11.8	6.8	43.6	9.2	17.8	34.8	29.6	22.7	84.4	38.5	14.9	18.4	0.7	13.4	20.6	0.0	24.4	15.7	15.4	9.9	9.2	19.6	20.2	20.6	12.6	19.6	14.6	1.8	14.1	11.0	8.5	19.0	16.3	30.7	24.2	23.2	19.4	20.3	68.8	12.9	10.3	13.1	19.4	10.0	26.1	14.9	17.5	12.2
RNF180		ENSG00000164197	"Ring finger protein 180"	Q86T96	5	64165844-64372869	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"parathyroid gland: 54.0"	"Cell type enhanced"	"Detected in many"	5	"Leydig cells: 31.9;Muller glia cells: 32.9;Sertoli cells: 38.8"	"Cancer enhanced"	"Detected in many"		"glioma: 7.6"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enriched"	"Detected in some"	5	"RPMI-8226: 25.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA006897	Approved		Approved	Cytosol		NA	NA			Cytosol		"HPA006897: AB_1856348"	"unprognostic (7.46e-2)"	"unprognostic (3.90e-3)"	"unprognostic (3.19e-2)"	"unprognostic (8.62e-2)"	"unprognostic (2.45e-1)"	"unprognostic (2.72e-1)"	"unprognostic (5.57e-2)"	"unprognostic (2.38e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.69e-1)"	"unprognostic (3.37e-3)"	"unprognostic (3.68e-2)"	"prognostic favorable (6.81e-5)"	"unprognostic (2.01e-2)"	"unprognostic (3.35e-2)"	"unprognostic (1.81e-2)"	"unprognostic (9.81e-3)"	8.1	8.1	9.9	3.1	12.8	1.6	6.3	6.0	13.0	10.1	7.1	5.5	20.1	3.4	12.7	11.8	6.9	8.1	7.3	10.4	7.4	10.6	12.4	7.2	6.1	3.4	9.4	9.3	12.0	6.6	54.0	16.1	2.0	10.7	11.5	3.0	11.3	7.3	16.4	4.4	6.6	3.2	15.0	11.0	5.1	5.0	8.1	7.1	0.0	20.6	2.5	2.4	10.9	7.9	2.4	1.0	4.2	1.8	2.0	4.2	0.3	0.0	0.1	1.3	0.0	0.0	0.0	0.3	1.1	0.5	1.1	0.6	0.0	0.1	0.0	0.1	0.8	0.6	0.2	0.0	0.5	0.2	0.0	0.1	0.3	0.0	0.0	0.4	0.0	0.2	0.1	2.7	0.0	0.1	5.0	0.0	0.0	0.0	0.0	2.2	0.5	0.0	0.0	0.5	0.0	1.3	0.1	3.3	25.4	1.9	0.3	0.3	0.1	0.0	0.3	0.0	1.7	1.3	0.1	0.1	0.0	3.2	0.1	2.9	0.0	0.0	0.0	0.5	0.0	3.6	3.0	1.8	4.2	1.9	0.6	2.5	1.4	3.0	3.2	0.6	2.4	4.2	3.9	2.6	2.0	0.8	1.0	1.8	0.3	9.9	12.8	6.0	11.7	7.4	10.6	9.4	9.3	10.7	7.1	14.9	10.5	0.0	6.5	4.0	16.5	9.6	12.7	2.7	7.9	15.7	13.7	0.0	6.6	4.5	3.7	5.6	0.0	0.0	2.3	0.1	2.5	5.0	0.0	5.4	0.1	11.1	1.2	12.3	1.2	5.5	31.9	0.2	5.0	0.0	1.6	32.9	2.8	0.6	23.7	14.3	17.3	38.8	17.9	15.4	9.7	6.5	0.0	0.0	0.1	3.8
RNF181	HSPC238	ENSG00000168894	"Ring finger protein 181"	Q9P0P0	2	85595725-85597613	"Enzymes, Predicted intracellular proteins"		Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA046112, HPA062121"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA046112: AB_2679542, HPA062121: AB_2684687"	"unprognostic (3.79e-1)"	"unprognostic (8.31e-2)"	"unprognostic (5.08e-2)"	"unprognostic (2.05e-1)"	"unprognostic (3.24e-1)"	"unprognostic (1.67e-2)"	"unprognostic (3.12e-1)"	"unprognostic (2.22e-2)"	"unprognostic (3.22e-2)"	"unprognostic (5.85e-2)"	"unprognostic (1.11e-1)"	"unprognostic (4.96e-2)"	"prognostic unfavorable (1.06e-6)"	"unprognostic (3.24e-1)"	"unprognostic (2.04e-1)"	"prognostic favorable (4.59e-5)"	"unprognostic (1.49e-2)"	32.9	41.5	42.2	26.4	36.2	32.8	40.4	19.0	38.7	34.4	40.5	33.0	36.0	34.5	28.1	44.5	40.2	33.3	34.8	52.4	34.5	32.9	57.8	85.1	36.0	33.1	41.2	29.3	31.6	85.1	21.8	20.2	50.7	36.0	34.2	35.4	32.1	42.1	45.7	47.0	30.4	46.5	33.2	42.2	37.2	35.7	36.3	31.3	31.0	43.7	39.2	42.6	43.8	29.4	53.2	80.2	78.6	94.7	39.3	54.4	83.3	32.7	33.2	25.9	28.1	26.4	32.8	41.8	27.7	54.6	59.1	56.3	50.6	34.8	31.2	54.5	41.1	56.1	30.7	22.3	44.3	63.6	35.6	27.5	23.7	17.2	60.8	46.5	26.2	32.5	34.2	59.0	39.4	65.9	45.5	49.1	29.4	27.8	32.5	79.8	52.5	24.7	61.1	18.0	43.3	50.2	26.5	54.4	44.4	55.2	30.5	15.5	20.4	23.4	34.1	45.5	32.5	33.8	34.9	42.4	29.0	20.7	58.0	39.5	45.4	37.8	39.1	45.4	39.7	25.5	40.4	94.7	71.6	40.7	69.3	37.7	53.2	42.6	39.1	71.0	44.3	36.7	36.8	78.6	39.3	51.8	80.2	54.4	83.3	42.2	36.2	19.0	38.7	34.5	32.9	41.2	29.3	36.0	31.3	137.0	86.2	115.3	81.4	103.8	25.0	99.1	145.2	88.3	91.0	143.1	2.0	196.4	353.1	216.8	308.0	104.6	151.4	70.0	252.2	207.3	131.6	104.1	100.4	194.3	230.7	17.5	67.4	87.8	155.3	193.3	81.7	162.9	161.9	198.4	101.4	48.2	256.8	175.4	73.6	513.2	19.4	58.2	121.5	89.5	30.4	103.6	185.0	97.2	90.7	92.8
RNF182	MGC33993	ENSG00000180537	"Ring finger protein 182"	Q8N6D2	6	13924446-13980302	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"bone marrow: 12.9;brain: 17.6"	"Group enriched"	"Detected in some"	4	"Bipolar cells: 16.5;Horizontal cells: 14.3;Muller glia cells: 15.3;Sertoli cells: 6.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HeLa: 37.0;RPTEC TERT1: 29.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA012309	Approved		Approved	"Nucleoplasm,Golgi apparatus,Vesicles"		NA	NA			"Nucleoplasm, Golgi apparatus"	Vesicles	"HPA012309: AB_1856349"	"unprognostic (1.29e-1)"	"unprognostic (1.06e-2)"	"unprognostic (2.74e-1)"	"prognostic unfavorable (4.66e-5)"	"unprognostic (6.16e-2)"	"unprognostic (2.08e-1)"	"unprognostic (9.01e-2)"	"unprognostic (6.12e-2)"	"unprognostic (1.71e-2)"	"unprognostic (4.21e-1)"	"unprognostic (6.04e-2)"	"unprognostic (1.42e-1)"	"unprognostic (1.05e-1)"	"unprognostic (9.33e-5)"	"unprognostic (6.66e-3)"	"unprognostic (1.33e-3)"	"unprognostic (1.26e-1)"	1.2	0.7	7.6	0.6	6.2	12.9	1.2	16.6	17.6	1.2	0.7	7.5	2.0	0.8	1.6	2.5	1.0	2.7	0.9	1.0	11.0	7.3	2.6	0.5	5.7	0.8	6.8	8.5	1.1	3.6	0.5	2.0	2.9	14.3	0.9	0.6	2.2	1.9	4.7	0.9	0.8	1.1	1.0	5.1	0.5	0.6	7.0	2.9	0.0	3.0	0.0	0.4	1.5	0.5	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	2.8	5.3	0.0	1.8	2.3	0.3	2.7	3.7	7.5	7.3	0.1	0.0	0.0	0.0	2.9	8.2	0.0	6.2	0.0	13.8	0.0	2.0	0.1	37.0	0.0	0.0	0.0	0.0	1.2	0.0	11.6	0.1	8.7	0.1	1.5	0.2	0.0	5.2	0.0	0.0	0.9	3.0	0.0	10.3	1.5	1.3	0.4	29.7	0.0	6.4	6.1	0.2	0.0	10.4	2.0	0.0	1.0	2.8	9.2	2.0	0.1	6.1	0.0	0.0	0.0	6.2	0.0	13.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.6	6.2	16.6	12.1	11.0	7.3	6.8	8.5	14.3	2.9	0.0	0.0	0.0	0.0	0.2	16.5	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	1.0	0.0	0.0	0.0	0.0	0.1	0.2	0.2	0.0	0.0	0.1	14.3	0.0	0.0	0.0	1.0	0.3	0.0	0.0	0.0	0.0	15.3	0.1	0.0	0.0	0.5	1.2	6.5	0.8	3.0	1.9	0.0	0.2	0.0	0.0	0.0
RNF183	MGC4734	ENSG00000165188	"Ring finger protein 183"	Q96D59	9	113297093-113303376	"Enzymes, Predicted membrane proteins"	"Apoptosis, Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"epididymis: 19.0;kidney: 9.5"	"Cell type enhanced"	"Detected in some"	16	"Cholangiocytes: 7.6;Collecting duct cells: 5.2;Intestinal endocrine cells: 8.1;Proximal tubular cells: 18.3"	"Cancer enhanced"	"Detected in many"		"endometrial cancer: 7.8"					"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	8	"SCLC-21H: 20.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA057675	Uncertain					NA	NA					"HPA057675: AB_2683499"	"unprognostic (1.23e-2)"	"unprognostic (3.17e-1)"	"unprognostic (1.11e-1)"	"prognostic favorable (7.95e-6)"	"unprognostic (2.56e-1)"	"unprognostic (1.75e-2)"	"unprognostic (1.54e-3)"	"unprognostic (1.27e-2)"	"unprognostic (1.03e-1)"	"unprognostic (7.65e-2)"	"unprognostic (3.27e-1)"	"unprognostic (1.98e-1)"	"prognostic favorable (3.51e-4)"	"unprognostic (5.50e-2)"	"unprognostic (8.84e-2)"	"unprognostic (9.61e-2)"	"unprognostic (2.53e-3)"	0.0	0.0	0.0	0.2	0.0	0.0	0.9	0.0	0.0	1.9	0.2			0.2	1.2	19.0	5.1	1.2	6.2	0.0	0.0	0.0	9.5	0.0	0.0	0.0	0.0		0.1	0.1	0.0	1.9	0.0		0.8	0.3		6.9	0.2	0.0	0.1	0.1	0.0	0.0	0.0	3.7	4.3			0.1		0.0	0.2	0.2	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	2.5	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	20.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.4	0.0	0.6	0.3	7.6	0.0	0.0	5.2	0.0	0.0	1.7	0.3	0.1	0.0	0.3	0.0	0.8	0.0	0.0	0.5	0.0	0.0	0.0	0.0	8.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	1.3	0.2	2.1	0.0	0.4	18.3	2.7	0.0	0.1	3.4	1.1	0.0	0.0	0.0	1.5	0.8
RNF185	FLJ38628	ENSG00000138942	"Ring finger protein 185"	Q96GF1	22	31160183-31207019	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Autophagy, Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"									NA	NA						"unprognostic (1.50e-1)"	"unprognostic (1.04e-1)"	"unprognostic (7.11e-2)"	"unprognostic (2.33e-1)"	"unprognostic (3.65e-3)"	"unprognostic (4.76e-3)"	"unprognostic (2.60e-3)"	"unprognostic (1.12e-2)"	"unprognostic (3.97e-1)"	"unprognostic (2.56e-1)"	"unprognostic (2.61e-1)"	"unprognostic (9.41e-2)"	"prognostic favorable (4.82e-5)"	"unprognostic (3.04e-1)"	"unprognostic (1.63e-1)"	"unprognostic (2.86e-1)"	"unprognostic (1.10e-1)"	18.3	16.1	15.2	11.6	20.3	6.8	18.4	16.7	23.4	19.4	17.0	24.3	14.4	15.6	21.8	20.2	20.5	18.3	13.6	15.6	14.7	15.6	27.6	39.7	14.4	11.1	15.9	14.6	21.2	23.5	32.5	24.3	19.8	20.9	30.5	17.3	24.1	27.0	23.5	18.0	22.9	24.4	22.8	16.4	14.4	18.0	11.8	15.1	12.6	39.9	14.4	18.0	19.4	18.5	10.3	12.6	21.5	15.1	15.4	14.0	13.0	9.6	5.7	11.1	12.5	22.5	15.1	10.6	11.5	22.3	15.8	21.5	6.3	4.6	9.2	6.5	20.3	14.0	6.1	10.5	11.9	16.4	9.1	11.4	4.0	5.5	7.7	31.6	9.6	6.2	16.1	42.9	11.1	25.8	14.5	13.2	9.8	4.6	11.0	18.9	6.8	8.3	5.5	4.9	20.0	6.3	8.6	11.0	10.7	11.4	8.4	4.9	9.9	8.4	11.2	16.8	11.9	7.7	6.4	9.2	11.3	8.1	13.0	5.6	15.4	12.5	11.7	14.8	6.2	9.0	15.0	14.6	8.0	12.4	15.1	14.0	10.3	12.7	13.8	12.6	9.0	12.9	11.8	21.5	15.4	12.2	4.7	13.6	13.0	15.2	20.3	16.7	23.4	14.7	15.6	15.9	14.6	20.9	15.1	20.8	9.3	8.3	9.7	8.0	10.1	5.1	12.7	12.0	10.3	17.4	7.9	10.4	18.3	13.4	16.1	8.7	13.4	0.0	12.9	17.5	8.9	12.2	5.7	24.3	12.1	7.9	16.1	27.0	8.1	14.3	6.9	8.8	8.5	11.8	12.0	10.9	13.9	12.7	14.9	18.7	6.7	6.5	8.2	7.0	9.1	9.4	31.1	6.9	7.7	7.4
RNF187	"RACO-1, RACO1"	ENSG00000168159	"Ring finger protein 187"	Q5TA31	1	228487061-228495766	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"eosinophil: 8.7"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"Karpas-707: 42.3;U-266/70: 76.8"	"Low region specificity"	"Detected in all"							HPA030098	Approved		Supported	Nucleoplasm,Cytosol		Yes	No			"Nucleoplasm, Cytosol"		"HPA030098: AB_10602923"	"unprognostic (4.84e-2)"	"unprognostic (1.97e-1)"	"prognostic unfavorable (2.83e-4)"	"unprognostic (4.90e-3)"	"unprognostic (1.13e-1)"	"unprognostic (2.93e-2)"	"unprognostic (3.46e-2)"	"unprognostic (2.53e-1)"	"unprognostic (1.36e-1)"	"unprognostic (5.66e-3)"	"unprognostic (1.37e-1)"	"unprognostic (1.55e-1)"	"unprognostic (2.92e-3)"	"unprognostic (1.59e-1)"	"unprognostic (9.76e-2)"	"unprognostic (1.76e-1)"	"unprognostic (2.32e-2)"	15.7	30.3	25.6	12.5	28.1	12.3	10.3	33.2	54.7	11.4	10.7	15.5	12.5	14.7	12.9	12.2	18.0	14.2	14.5	17.7	25.2	24.9	16.2	20.4	11.5	9.8	20.2	29.3	20.2	19.4	22.3	16.4	8.8	22.7	15.0	6.6	12.3	30.3	12.6	55.5	15.5	13.2	8.6	16.3	19.0	14.2	9.5	11.4	11.1	27.9	19.4	11.2	10.0	13.1	2.0	1.7	8.7	2.1	1.0	2.3	0.6	9.4	7.1	5.0	10.5	5.5	3.6	9.7	7.9	4.9	5.0	3.8	3.6	6.6	21.6	16.6	9.0	4.1	7.6	6.3	6.7	1.9	9.8	8.1	6.5	5.3	4.7	15.0	7.4	12.8	6.3	12.1	3.8	5.2	6.1	4.4	16.5	10.4	42.3	3.6	5.3	11.8	6.6	11.2	6.7	7.3	10.1	4.6	20.3	3.6	6.0	11.1	11.2	8.1	16.8	21.4	1.7	11.8	17.8	10.1	6.2	6.4	6.7	7.5	76.8	23.0	11.8	16.7	7.8	10.4	0.0	1.1	8.7	1.3	2.1	1.5	1.2	1.5	2.3	1.4	2.0	1.4	1.2	0.3	1.0	1.4	1.7	1.3	0.6	25.6	28.1	33.2	47.3	25.2	24.9	20.2	29.3	22.7	11.4	23.8	13.3	36.1	41.5	32.2	84.0	56.1	38.2	8.1	18.2	38.4	17.7	14.3	96.2	13.8	0.5	22.6	33.3	0.0	20.8	20.1	31.6	30.3	44.9	56.2	24.8	52.4	38.4	29.4	29.7	2.5	22.7	23.8	37.1	6.4	26.7	103.2	20.8	20.4	24.4	99.3	37.8	19.4	38.1	4.4	22.0	48.3	14.8	41.5	27.6	24.7
RNF19A	"DKFZp566B1346, dorfin, RNF19"	ENSG00000034677	"Ring finger protein 19A, RBR E3 ubiquitin protein ligase"	Q9NV58	8	100257060-100336218	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	4	"Late spermatids: 203.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"Karpas-707: 60.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB011455, HPA023652"	Approved					NA	NA					"CAB011455: AB_2180446, HPA023652: AB_1847836"	"unprognostic (2.55e-1)"	"unprognostic (1.13e-1)"	"unprognostic (1.84e-1)"	"unprognostic (7.09e-2)"	"unprognostic (3.36e-1)"	"unprognostic (2.12e-2)"	"unprognostic (7.96e-2)"	"unprognostic (8.92e-2)"	"unprognostic (1.13e-1)"	"unprognostic (5.97e-2)"	"unprognostic (5.20e-2)"	"unprognostic (2.99e-1)"	"prognostic unfavorable (7.99e-5)"	"unprognostic (8.44e-2)"	"unprognostic (8.19e-2)"	"unprognostic (2.02e-1)"	"prognostic favorable (3.28e-5)"	28.2	13.8	30.2	21.8	20.8	34.9	26.7	16.3	29.5	40.6	22.8	26.4	11.4	17.0	29.4	19.0	17.6	24.7	30.8	20.1	28.7	16.1	23.0	33.9	28.4	35.2	19.7	25.2	24.8	20.3	14.5	15.7	18.6	23.6	20.7	19.2	11.5	19.8	14.2	23.0	26.6	38.5	32.7	30.1	22.7	21.5	35.4	27.7	25.1	17.0	14.7	29.5	33.9	23.7	13.5	11.4	17.6	10.5	4.8	14.4	4.5	8.6	5.6	4.9	5.6	9.3	8.1	6.4	7.8	7.4	7.4	6.8	3.0	5.8	5.1	14.3	7.9	3.4	6.1	3.8	5.7	10.1	21.5	3.1	8.6	25.8	4.3	7.8	1.7	5.5	8.0	8.8	5.9	11.2	9.0	11.3	5.7	4.7	60.1	7.2	4.3	7.8	2.8	1.7	5.8	5.2	3.2	3.4	10.0	20.2	13.6	3.9	8.4	8.1	4.9	7.5	10.7	4.3	6.7	11.2	8.6	6.8	6.3	4.7	29.2	18.7	3.5	5.6	5.7	5.1	17.6	7.5	6.5	14.4	5.6	9.0	13.5	11.8	10.8	4.6	12.7	6.1	8.8	16.6	4.8	10.5	11.4	12.0	4.5	30.2	20.8	16.3	29.5	28.7	16.1	19.7	25.2	23.6	27.7	47.6	39.3	23.5	84.9	35.6	27.9	35.0	84.1	108.4	101.2	41.8	56.9	8.1	6.6	52.3	151.8	52.5	38.7	46.7	35.2	12.6	44.8	62.3	40.6	34.1	19.7	55.6	20.0	30.7	27.9	203.2	54.1	30.2	20.3	9.0	22.2	41.1	43.0	24.6	64.7	42.5	45.0	19.4	28.3	63.0	44.7	52.8	6.9	48.4	18.2	101.9
RNF19B	"FLJ90005, IBRDC3"	ENSG00000116514	"Ring finger protein 19B"	Q6ZMZ0	1	32936445-32964685	"Enzymes, Predicted membrane proteins"	"Adaptive immunity, Immunity, Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 54.7"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"neutrophil: 16.1"	"Lineage enriched"	"Detected in many"	8	"granulocytes: 16.1"	"Cell line enhanced"	"Detected in all"		"Daudi: 39.3;Karpas-707: 47.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA049587, HPA063640"	Approved		Approved	Cytosol		NA	NA			Cytosol		"HPA049587: AB_2680826, HPA063640: "	"unprognostic (2.83e-2)"	"unprognostic (1.77e-2)"	"unprognostic (1.86e-2)"	"unprognostic (2.01e-1)"	"unprognostic (1.78e-2)"	"prognostic favorable (3.39e-4)"	"prognostic unfavorable (5.41e-6)"	"unprognostic (8.78e-2)"	"unprognostic (5.02e-1)"	"unprognostic (1.69e-1)"	"unprognostic (9.85e-2)"	"unprognostic (1.38e-1)"	"prognostic favorable (4.39e-5)"	"unprognostic (2.58e-2)"	"unprognostic (4.93e-2)"	"unprognostic (3.30e-1)"	"unprognostic (1.23e-2)"	8.6	11.3	8.0	13.1	10.5	36.4	12.0	14.1	14.1	9.9	13.2	10.1	4.8	14.1	10.8	6.9	23.3	7.9	10.1	8.5	6.0	7.2	12.0	6.5	13.8	12.9	9.6	9.3	7.1	7.0	6.4	5.7	9.4	10.2	7.4	15.3	9.0	10.8	5.7	10.2	13.6	15.5	10.6	8.0	9.0	7.4	54.7	8.3	6.8	8.2	11.1	16.7	11.3	12.8	1.3	1.3	16.1	2.0	0.8	1.6	0.7	6.7	5.2	4.5	4.1	2.7	3.9	30.0	3.1	3.8	5.7	6.1	6.1	20.3	39.3	5.5	4.1	7.0	9.7	5.5	7.5	5.2	14.4	3.6	3.4	4.1	6.1	8.8	5.2	7.2	3.1	14.0	12.5	15.4	6.6	11.9	3.9	4.2	47.3	5.5	2.2	3.4	6.4	7.2	7.7	5.9	4.6	6.4	4.0	4.4	9.8	7.1	3.6	10.0	3.4	22.4	11.5	2.9	7.6	13.0	3.1	4.3	7.8	5.4	11.3	5.7	13.9	4.5	5.3	4.6	5.3	2.0	3.5	1.6	1.8	1.2	1.2	1.4	0.8	1.3	1.3	0.4	0.6	16.1	0.8	1.5	0.6	1.5	0.7	8.0	10.5	14.1	14.1	6.0	7.2	9.6	9.3	10.2	8.3	11.9	4.1	1.9	20.3	41.0	4.4	12.0	15.3	6.7	2.3	7.0	2.0	11.0	1.7	9.3	30.1	8.7	34.3	0.0	9.9	5.4	7.1	22.8	4.6	3.4	12.6	3.2	10.9	3.7	20.2	18.4	2.0	28.7	5.0	43.3	16.5	2.0	19.2	17.5	3.5	7.1	7.4	0.0	5.4	29.3	12.6	28.4	6.2	3.2	10.5	35.3
RNF2	"BAP-1, BAP1, DING, HIPI3, RING1B, RING2"	ENSG00000121481	"Ring finger protein 2"	Q99496	1	185045364-185102608	"Enzymes, Predicted intracellular proteins"	"Transcription, Transcription regulation, Ubl conjugation pathway"	"Repressor, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Spermatogonia: 78.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA026803	Uncertain		Enhanced	"Nucleoplasm,Nuclear bodies"		NA	NA			Nucleoplasm	"Nuclear bodies"	"HPA026803: AB_10602086"	"unprognostic (1.23e-1)"	"unprognostic (3.71e-2)"	"unprognostic (1.70e-1)"	"unprognostic (1.35e-3)"	"unprognostic (1.70e-2)"	"unprognostic (1.19e-1)"	"prognostic unfavorable (1.08e-5)"	"unprognostic (5.85e-2)"	"unprognostic (3.56e-3)"	"unprognostic (1.62e-2)"	"unprognostic (2.01e-2)"	"unprognostic (5.51e-2)"	"prognostic unfavorable (1.94e-7)"	"unprognostic (2.08e-1)"	"unprognostic (5.51e-2)"	"unprognostic (9.89e-3)"	"unprognostic (2.52e-1)"	17.8	15.0	14.3	13.9	12.4	15.3	29.7	15.6	23.6	16.6	12.0	7.8	20.7	10.4	16.2	12.6	15.2	11.5	13.1	12.0	16.0	13.1	13.7	11.1	16.7	20.7	9.4	10.4	19.9	15.0	12.3	26.5	28.4	11.4	13.2	13.5	10.1	17.3	20.6	13.1	12.5	9.8	14.8	11.2	16.2	12.2	27.8	9.4	17.2	15.1	11.5	16.1	17.6	16.9	14.7	19.9	20.6	22.1	17.4	19.4	12.0	13.8	7.6	28.2	11.2	8.0	13.7	26.8	9.8	12.4	15.5	12.5	12.1	23.1	4.1	12.3	12.0	10.5	4.9	19.3	14.2	18.9	12.1	10.1	22.3	4.7	10.6	11.8	22.8	12.6	12.9	8.7	12.7	16.3	12.6	15.6	14.4	17.6	9.9	11.2	8.6	19.7	6.7	37.8	11.7	4.2	22.6	17.5	3.9	11.7	9.8	8.3	14.3	6.8	4.1	19.9	32.0	8.7	12.2	11.0	11.2	14.5	10.6	12.4	16.4	10.6	15.4	7.0	10.8	12.5	19.3	17.0	20.6	13.5	21.1	19.4	14.6	12.5	12.6	19.9	14.7	12.8	12.6	7.9	17.4	22.1	10.0	13.2	12.0	14.3	12.4	15.6	23.6	16.0	13.1	9.4	10.4	11.4	9.4	3.0	5.4	10.8	18.7	20.6	9.2	5.9	7.6	5.3	3.4	8.7	3.9	22.5	19.9	10.5	4.8	17.9	4.0	0.0	11.1	42.7	21.1	12.7	12.7	7.3	17.9	6.4	28.4	21.5	20.3	5.2	8.9	21.4	20.3	28.9	10.4	8.5	10.4	11.5	11.0	10.6	5.9	0.0	12.1	29.9	78.0	17.8	23.8	15.0	11.5	33.6
RNF20	"BRE1, BRE1A, FLJ11189, FLJ20382, hBRE1, KAIA2779"	ENSG00000155827	"Ring finger protein 20"	Q5VTR2	9	101533851-101563344	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	"Chromatin regulator, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB012478, HPA051773"	Supported		Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"CAB012478: , HPA051773: AB_2681604"	"unprognostic (7.02e-2)"	"unprognostic (2.21e-1)"	"unprognostic (9.04e-2)"	"unprognostic (2.03e-1)"	"unprognostic (3.12e-2)"	"unprognostic (1.68e-1)"	"unprognostic (1.41e-2)"	"unprognostic (2.90e-1)"	"unprognostic (2.01e-1)"	"unprognostic (5.47e-2)"	"unprognostic (7.27e-3)"	"unprognostic (1.60e-1)"	"prognostic favorable (1.64e-6)"	"unprognostic (2.72e-1)"	"unprognostic (1.76e-1)"	"unprognostic (2.32e-1)"	"unprognostic (9.54e-3)"	16.4	17.1	24.6	17.0	24.9	12.1	17.7	24.4	26.3	18.6	16.4	27.7	15.9	10.1	18.3	18.7	20.4	19.1	13.2	24.1	22.3	22.1	20.5	14.4	14.9	15.5	25.2	20.7	21.1	19.5	31.5	23.1	15.1	30.0	21.6	16.1	16.8	16.2	17.7	32.0	16.3	12.5	23.6	28.8	17.0	13.9	28.2	25.8	21.2	22.0	15.3	18.6	21.1	19.0	13.0	12.5	21.0	23.5	13.8	18.6	10.4	9.7	24.8	14.3	15.7	17.7	14.0	12.2	17.0	13.7	17.1	15.0	15.0	10.4	21.6	9.2	13.1	14.3	24.8	16.6	14.5	17.6	22.5	7.7	11.5	22.7	15.0	13.0	19.8	13.9	13.7	15.6	15.1	19.6	12.9	10.0	8.0	10.9	12.8	18.5	12.7	15.4	5.3	31.6	22.0	12.6	14.9	49.6	10.7	7.0	9.4	15.3	19.3	24.1	12.9	14.0	15.0	11.6	9.4	14.1	15.9	16.0	11.3	14.3	13.9	42.7	11.8	14.0	7.5	19.2	21.0	12.7	19.1	18.6	17.5	14.0	13.0	15.4	13.9	12.5	11.2	16.2	14.9	13.9	13.8	23.5	7.9	11.9	10.4	24.6	24.9	24.4	26.3	22.3	22.1	25.2	20.7	30.0	25.8	23.8	24.5	7.5	8.1	5.7	29.1	42.4	10.2	33.5	26.1	21.0	5.9	13.6	5.0	14.3	26.2	11.3	12.2	0.0	12.1	9.6	11.5	7.2	20.9	16.8	14.4	41.3	23.6	7.4	23.8	15.2	16.7	20.0	10.1	27.9	10.7	27.6	10.2	15.3	22.3	9.1	23.0	32.3	14.4	24.7	15.8	5.1	6.4	16.0	12.0	5.4
RNF213	"C17orf27, KIAA1554, KIAA1618, MYMY2, NET57"	ENSG00000173821	"Ring finger protein 213"	Q63HN8	17	80260866-80398786	"Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Angiogenesis, Ubl conjugation pathway"	"Hydrolase, Transferase"	"Cancer-related genes, Disease mutation, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HDLM-2: 36.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003347, HPA026790"	Approved		Supported	Cytosol		NA	NA			Cytosol		"HPA003347: AB_1079204, HPA026790: AB_10602296"	"unprognostic (8.98e-2)"	"unprognostic (1.60e-1)"	"unprognostic (8.97e-3)"	"prognostic unfavorable (4.65e-5)"	"unprognostic (7.39e-2)"	"unprognostic (3.99e-2)"	"unprognostic (2.23e-2)"	"unprognostic (1.52e-1)"	"unprognostic (4.57e-2)"	"unprognostic (3.85e-1)"	"unprognostic (1.96e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.52e-3)"	"unprognostic (8.92e-2)"	"unprognostic (1.13e-2)"	"unprognostic (1.40e-1)"	"unprognostic (4.56e-2)"	17.0	15.1	7.4	16.9	10.3	22.4	10.2	4.7	7.5	11.0	12.2	15.6	14.9	8.5	16.6	13.0	13.2	9.7	12.1	8.5	7.8	7.8	17.1	11.6	15.4	17.9	10.9	5.6	11.5	9.0	41.1	11.4	15.1	10.0	11.2	8.0	12.3	11.7	12.5	9.0	8.7	14.8	13.6	14.3	17.0	10.6	5.9	8.7	24.5	15.9	7.5	18.2	13.6	15.4	7.2	13.9	37.9	9.6	11.4	12.1	1.8	16.2	28.9	2.9	2.0	10.6	16.2	2.2	4.1	9.0	18.6	15.9	3.1	7.5	1.0	3.5	8.6	19.9	9.5	3.9	5.3	6.3	36.8	1.8	2.5	11.7	5.4	4.5	2.7	2.6	8.9	3.6	10.4	4.5	5.8	14.3	11.8	4.7	6.1	6.9	3.9	10.6	1.1	2.1	3.0	6.7	7.3	6.7	1.2	5.2	14.1	2.8	3.9	10.0	21.2	7.6	6.8	4.8	3.4	18.5	10.4	8.3	6.1	4.2	2.7	2.5	2.9	7.8	3.2	3.7	6.9	9.6	4.2	12.1	8.0	8.1	6.2	8.6	9.7	2.3	7.2	6.9	8.5	37.9	11.4	6.9	13.9	6.4	1.8	7.4	10.3	4.7	7.5	7.8	7.8	10.9	5.6	10.0	8.7	83.4	56.5	111.7	32.9	31.8	18.0	28.5	79.0	38.8	38.7	96.0	47.1	18.7	11.6	100.5	1.1	68.4	78.6	23.3	139.5	24.8	43.3	49.8	44.1	45.9	84.7	22.3	44.2	79.2	104.8	2.0	56.4	97.6	28.7	162.3	61.5	23.6	181.0	73.7	48.4	56.6	71.2	64.7	34.9	1.4	4.4	30.1	18.2	168.3	34.5	65.7
RNF216	"TRIAD3, UBCE7IP1, ZIN"	ENSG00000011275	"Ring finger protein 216"	Q9NWF9	7	5620047-5781739	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Apoptosis, Host-virus interaction, Ubl conjugation pathway"	Transferase	"Disease mutation, Hypogonadotropic hypogonadism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Early spermatids: 118.7;Late spermatids: 171.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA018955, HPA021123"	Supported		Supported	Nucleoplasm,Cytosol		NA	NA			Cytosol	Nucleoplasm	"HPA018955: AB_1858500, HPA021123: AB_1858501"	"unprognostic (3.31e-2)"	"unprognostic (4.24e-2)"	"unprognostic (1.28e-2)"	"unprognostic (1.58e-2)"	"unprognostic (1.81e-2)"	"unprognostic (1.56e-1)"	"prognostic unfavorable (2.26e-4)"	"unprognostic (2.35e-1)"	"unprognostic (2.40e-1)"	"unprognostic (1.40e-2)"	"prognostic favorable (6.24e-5)"	"unprognostic (2.88e-2)"	"unprognostic (9.01e-2)"	"unprognostic (3.49e-1)"	"unprognostic (1.73e-2)"	"unprognostic (1.06e-2)"	"unprognostic (3.69e-3)"	16.9	14.9	22.0	18.8	24.8	22.2	18.4	33.5	27.8	17.8	26.9	22.0	13.4	11.5	26.9	13.3	18.7	19.6	14.2	29.1	20.5	17.4	12.7	11.8	14.9	23.8	23.8	14.8	25.6	21.3	23.2	24.9	14.6	20.4	17.7	11.8	18.9	16.2	21.5	22.5	15.1	20.1	25.0	18.7	23.3	18.3	34.3	26.3	18.5	19.8	9.6	24.1	17.7	30.7	8.8	6.7	24.5	8.4	10.0	9.7	6.5	14.3	15.4	12.7	21.6	15.2	13.1	8.7	15.3	16.1	15.9	14.8	11.1	8.2	12.5	7.9	17.1	27.6	10.3	13.1	10.8	13.0	7.8	11.4	9.7	9.3	11.2	18.1	15.8	16.6	13.5	13.8	12.2	14.9	13.2	12.6	12.2	19.3	8.8	17.6	22.0	5.9	25.2	17.4	8.1	12.9	15.1	17.9	7.0	9.5	12.1	9.7	15.4	9.7	24.3	8.7	14.9	9.6	16.2	13.6	16.1	29.1	16.4	13.8	7.2	5.3	10.2	12.1	14.7	25.6	1.3	7.7	24.5	9.0	8.4	9.0	7.3	7.9	6.7	6.7	8.8	9.7	9.1	13.1	10.0	7.7	5.4	7.0	6.5	22.0	24.8	33.5	27.8	20.5	17.4	23.8	14.8	20.4	26.3	6.0	19.2	11.0	16.6	14.7	36.2	25.7	5.1	13.4	14.8	12.2	49.1	11.9	21.6	15.1	118.7	24.8	10.2	0.0	12.0	11.1	20.5	16.4	18.5	13.4	19.2	27.0	5.8	23.9	19.0	171.4	34.5	23.8	11.8	33.3	12.5	35.8	13.1	3.5	28.3	10.6	49.0	25.8	22.7	96.9	99.0	14.2	12.7	23.0	10.8	13.1
RNF217	"C6orf172, dJ84N20.1, IBRDC1, MGC26996"	ENSG00000146373	"Ring finger protein 217"	Q8TC41	6	124962545-125092633	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	4	"parathyroid gland: 63.3"	"Cell type enhanced"	"Detected in many"	7	"Early spermatids: 92.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"classical monocyte: 1.9;myeloid DC: 1.2"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA029598	Uncertain					NA	NA					"HPA029598: AB_10602297"	"unprognostic (2.96e-2)"	"unprognostic (2.34e-3)"	"unprognostic (8.07e-2)"	"unprognostic (8.62e-2)"	"unprognostic (1.94e-1)"	"unprognostic (2.06e-2)"	"unprognostic (1.06e-1)"	"unprognostic (7.22e-3)"	"unprognostic (4.94e-2)"	"unprognostic (6.69e-2)"	"unprognostic (2.47e-1)"	"unprognostic (2.61e-1)"	"prognostic unfavorable (4.60e-5)"	"unprognostic (8.29e-4)"	"unprognostic (2.16e-1)"	"unprognostic (7.52e-2)"	"prognostic unfavorable (1.92e-4)"	9.6	3.5	3.3	4.2	4.7	10.5	14.6	3.8	3.5	8.0	7.7	5.7	6.4	2.3	5.9	5.6	6.2	7.5	12.1	6.5	3.8	1.7	2.5	6.3	7.3	3.7	4.3	2.9	11.5	3.8	63.3	4.0	12.0	3.4	6.4	2.3	6.0	6.0	6.9	10.1	10.9	3.1	13.0	2.3	2.6	4.5	7.4	5.7	0.1	7.4	3.6	1.6	8.7	13.6	0.0	1.2	0.6	1.9	0.3	0.2	0.3	4.1	4.3	1.5	0.5	5.4	2.1	8.6	5.7	7.7	3.9	5.1	0.0	3.9	0.0	8.0	5.4	8.9	6.0	0.9	5.1	5.5	0.0	4.8	2.3	6.4	1.3	5.2	0.0	0.2	5.9	4.8	2.9	8.6	4.6	4.4	0.0	11.6	0.0	6.8	0.0	0.0	0.0	1.3	0.0	1.1	0.1	6.0	0.0	4.0	1.9	0.7	0.0	2.5	0.6	2.2	4.4	4.2	0.7	6.9	3.2	10.4	0.0	12.2	0.0	0.0	0.0	2.4	0.0	3.8	0.6	1.9	0.0	0.0	0.8	0.0	0.0	0.0	0.0	1.2	0.0	0.2	0.0	0.0	0.3	0.3	0.0	0.0	0.3	3.3	4.7	3.8	3.5	3.8	1.7	4.3	2.9	3.4	5.7	20.8	16.0	0.0	12.7	42.7	6.2	12.5	2.5	5.3	10.3	5.2	15.7	15.2	0.0	6.8	92.0	15.0	1.7	0.0	8.3	23.6	21.6	10.4	1.1	24.6	8.5	20.6	2.9	14.1	12.9	49.9	23.9	13.3	18.6	2.8	3.0	4.0	10.7	0.0	19.8	1.9	5.0	6.5	12.3	1.4	2.6	41.0	15.0	0.5	2.7	9.7
RNF220	"C1orf164, FLJ10597"	ENSG00000187147	"Ring finger protein 220"	Q5VTB9	1	44405194-44651724	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 57.4"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"U-937: 37.2"	"Low region specificity"	"Detected in all"							"HPA027577, HPA027578"	Uncertain		Approved	Nucleoplasm	"Intracellular and membrane"	NA	NA			Nucleoplasm		"HPA027577: AB_2672339, HPA027578: AB_10601482"	"unprognostic (3.12e-2)"	"unprognostic (1.24e-1)"	"unprognostic (3.49e-2)"	"unprognostic (2.56e-1)"	"unprognostic (2.94e-2)"	"unprognostic (6.96e-3)"	"prognostic unfavorable (2.35e-6)"	"unprognostic (1.55e-1)"	"unprognostic (8.47e-2)"	"unprognostic (2.13e-1)"	"unprognostic (2.14e-3)"	"unprognostic (2.96e-2)"	"prognostic unfavorable (5.12e-4)"	"unprognostic (1.51e-2)"	"unprognostic (1.98e-1)"	"unprognostic (1.37e-3)"	"unprognostic (6.46e-2)"	9.8	7.4	20.9	9.6	38.5	12.7	6.7	12.6	40.1	5.4	9.2	40.7	2.7	10.7	8.0	8.8	6.0	9.3	4.5	9.2	33.4	20.9	7.4	5.1	7.4	7.6	49.8	19.8	9.5	8.1	7.0	5.7	8.7	25.8	7.7	5.9	4.2	9.3	7.1	28.4	8.7	8.8	8.0	57.4	7.9	7.6	7.0	49.6	5.0	7.3	4.6	8.0	7.9	5.6	3.6	6.6	2.8	2.3	1.9	4.3	1.4	6.1	2.9	12.6	4.2	4.9	4.5	9.4	7.2	6.7	5.6	8.3	5.0	6.1	11.9	6.4	5.8	8.0	4.0	14.0	5.9	7.6	14.7	12.5	16.3	9.1	8.4	7.9	11.5	8.4	4.9	13.6	6.2	10.0	4.6	3.2	6.3	12.0	5.9	3.5	4.2	11.3	8.7	13.7	6.7	6.6	9.6	7.4	8.5	3.6	3.8	5.7	7.0	6.1	4.3	8.7	4.6	3.2	20.4	4.9	6.0	6.4	5.6	13.3	13.5	12.9	8.5	4.9	37.2	3.5	2.4	2.3	2.8	3.2	1.8	2.4	2.4	1.0	4.3	3.4	3.6	1.9	1.7	1.5	1.9	1.3	6.6	3.2	1.4	20.9	38.5	12.6	30.8	33.4	20.9	49.8	19.8	25.8	49.6	8.9	12.0	15.9	12.3	13.5	23.6	19.4	25.5	4.0	9.1	22.7	23.6	15.6	14.9	16.5	7.9	16.1	22.2	46.7	24.8	20.6	12.8	18.6	10.4	25.9	22.1	22.3	17.3	15.4	25.1	11.8	17.8	12.8	11.8	15.4	22.6	13.2	19.6	20.1	13.1	27.9	17.0	6.5	9.9	27.4	27.9	15.3	8.5	20.0	25.2	12.7
RNF25	"AO7, FLJ13906"	ENSG00000163481	"Ring finger protein 25"	Q96BH1	2	218663864-218672411	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036420, HPA036421"	Uncertain		Approved	"Nucleoplasm,Actin filaments,Cytosol"		NA	NA			Cytosol	"Nucleoplasm, Actin filaments"	"HPA036420: AB_2675114, HPA036421: AB_10669604"	"unprognostic (3.22e-2)"	"unprognostic (7.85e-3)"	"unprognostic (1.34e-2)"	"unprognostic (2.29e-2)"	"unprognostic (1.33e-1)"	"unprognostic (1.31e-1)"	"prognostic unfavorable (6.58e-4)"	"unprognostic (3.58e-2)"	"unprognostic (2.67e-2)"	"unprognostic (3.46e-1)"	"unprognostic (2.04e-3)"	"unprognostic (8.82e-2)"	"unprognostic (1.26e-3)"	"unprognostic (2.50e-1)"	"unprognostic (1.37e-1)"	"unprognostic (2.44e-1)"	"unprognostic (6.69e-2)"	13.4	12.7	13.9	11.1	16.1	6.2	13.7	13.4	27.6	17.3	13.3	17.1	9.8	4.3	16.6	16.2	12.2	16.8	11.8	17.2	13.1	16.5	13.7	15.6	11.9	12.1	12.1	11.6	17.8	13.0	19.3	14.8	17.7	15.4	14.7	9.0	15.3	13.6	17.9	16.9	15.7	10.3	16.0	10.0	12.9	11.8	18.4	9.1	15.3	16.8	12.7	16.8	14.0	11.8	13.3	8.2	23.3	11.2	14.8	15.0	13.9	5.9	7.6	6.9	8.0	10.6	6.5	7.5	6.8	17.1	23.4	21.8	12.7	4.0	4.0	5.4	14.3	12.9	5.4	8.0	13.3	10.2	4.3	10.9	5.4	5.6	12.0	13.0	4.8	5.9	14.3	12.4	21.2	14.3	6.5	12.7	15.4	9.1	6.2	15.0	17.0	5.4	5.9	11.0	4.9	8.7	7.6	4.4	5.8	14.3	6.4	7.0	7.9	5.2	5.9	10.1	5.0	7.0	8.8	7.3	13.3	6.3	5.2	9.6	5.4	4.2	6.7	11.2	6.0	8.0	23.3	10.6	14.9	13.9	10.3	12.6	11.9	13.7	13.6	8.2	13.3	15.0	11.7	8.9	14.8	11.2	7.4	11.5	13.9	13.9	16.1	13.4	27.6	13.1	16.5	12.1	11.6	15.4	9.1	0.0	0.3	4.7	4.6	5.6	7.4	3.1	5.1	5.3	2.3	1.8	7.9	11.1	13.3	10.5	10.3	5.9	6.4	0.0	11.4	8.1	7.2	3.0	6.9	6.4	11.3	4.8	1.2	9.2	5.9	3.4	6.6	4.6	8.5	10.0	4.9	7.0	10.2	8.6	12.0	11.5	4.5	25.8	6.1	14.4	11.9	5.9	8.4	10.1	4.8	3.9
RNF26	MGC2642	ENSG00000173456	"Ring finger protein 26"	Q9BY78	11	119334527-119337313	"Enzymes, Predicted membrane proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Extravillous trophoblasts: 54.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"							"Low region specificity"	"Detected in all"			HPA027620	Uncertain		Approved	Nucleoplasm,Vesicles,Cytosol		NA	Yes			Nucleoplasm	"Vesicles, Cytosol"	"HPA027620: AB_1856356"	"unprognostic (9.23e-3)"	"unprognostic (3.54e-2)"	"unprognostic (1.36e-1)"	"unprognostic (8.68e-3)"	"unprognostic (3.40e-1)"	"unprognostic (1.07e-2)"	"prognostic unfavorable (3.19e-4)"	"unprognostic (2.14e-2)"	"unprognostic (3.26e-1)"	"unprognostic (1.69e-1)"	"unprognostic (7.24e-3)"	"unprognostic (6.22e-2)"	"prognostic favorable (3.45e-6)"	"unprognostic (9.61e-2)"	"unprognostic (3.50e-2)"	"unprognostic (4.41e-2)"	"prognostic unfavorable (7.73e-4)"	19.0	21.5	13.6	15.4	21.6	25.6	16.9	18.4	38.9	19.8	22.0	17.6	14.5	20.3	31.2	15.6	26.0	24.4	19.8	15.1	17.1	13.8	22.3	28.7	17.3	17.5	15.0	16.6	25.6	18.5	31.4	14.3	27.5	27.2	19.2	18.2	20.2	20.0	28.5	17.6	19.8	21.4	27.0	14.3	19.8	24.3	27.6	13.0	26.7	20.6	14.0	21.1	25.8	18.1	13.8	14.2	7.1	15.5	9.8	16.7	16.2	15.7	17.5	16.4	19.3	16.2	12.8	17.4	17.2	18.6	20.1	15.9	29.5	33.2	14.0	23.8	20.4	30.5	28.8	23.2	25.9	12.6	16.6	12.8	36.8	8.2	24.3	12.4	15.4	15.3	13.3	13.3	25.0	22.6	13.2	15.2	21.7	17.8	22.0	13.8	34.5	14.1	16.0	16.4	18.3	22.4	14.7	16.8	11.1	12.3	11.5	11.7	11.3	13.9	17.6	4.6	16.5	39.9	12.9	10.0	24.3	16.2	12.7	15.6	5.3	8.6	0.1	8.1	26.1	18.9	7.1	15.5	3.9	16.7	14.5	11.0	9.0	12.7	14.5	14.2	13.8	14.5	12.4	1.1	9.8	14.1	8.1	6.6	16.2	13.6	21.6	18.4	38.9	17.1	13.8	15.0	16.6	27.2	13.0	3.0	6.5	9.0	12.0	6.2	9.1	0.5	28.1	2.7	7.9	10.4	2.0	31.3	5.0	17.7	3.4	7.5	10.0	0.0	15.0	54.3	13.5	11.2	7.0	19.8	18.0	4.8	13.2	8.6	9.9	4.9	13.0	8.8	1.7	12.6	10.2	9.7	11.8	10.2	16.6	10.3	7.6	6.5	10.3	12.2	8.3	7.4	20.4	9.6	14.5	8.6
RNF31	"FLJ10111, FLJ23501, HOIP, Paul, ZIBRA"	ENSG00000092098	"Ring finger protein 31"	Q96EP0	14	24146683-24160661	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in some"	4	"Alveolar cells type 2: 5.8;Club cells: 5.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"CAB009063, HPA048745"	Approved		Approved	Cytosol		NA	NA			Cytosol		"CAB009063: AB_2127706, HPA048745: AB_2680509"	"unprognostic (3.58e-2)"	"unprognostic (5.22e-2)"	"unprognostic (2.51e-2)"	"unprognostic (9.05e-2)"	"unprognostic (2.52e-1)"	"unprognostic (6.24e-2)"	"unprognostic (9.09e-3)"	"unprognostic (1.55e-2)"	"unprognostic (3.11e-3)"	"unprognostic (1.96e-2)"	"unprognostic (1.33e-1)"	"unprognostic (2.46e-1)"	"unprognostic (6.21e-3)"	"unprognostic (1.15e-1)"	"unprognostic (2.59e-1)"	"unprognostic (1.41e-2)"	"unprognostic (1.99e-1)"	14.4	18.5	11.7	21.5	17.4	20.0	15.1	20.0	26.4	17.7	17.3	18.4	19.9	13.4	22.4	22.3	15.4	17.4	17.2	14.5	10.7	9.8	17.2	14.8	15.3	19.3	11.0	18.0	20.6	23.6	20.0	19.2	18.7	13.4	16.4	14.1	16.9	19.6	23.1	39.5	29.1	16.1	19.7	9.1	27.3	16.5	21.8	11.0	33.6	17.4	13.1	24.9	16.3	13.5	2.4	4.6	3.8	3.7	2.5	4.8	1.3	4.5	10.6	9.9	12.2	6.7	7.0	20.1	7.9	11.7	15.6	12.5	9.6	11.5	9.0	5.0	11.3	9.2	7.8	5.6	11.3	9.3	9.4	4.2	8.4	10.8	21.0	11.1	14.1	15.0	12.8	9.7	7.1	11.1	9.7	9.9	7.5	4.9	11.9	6.9	14.1	13.3	8.3	5.3	7.9	11.6	8.9	7.3	5.7	7.9	18.8	8.8	11.0	7.3	19.3	9.6	9.0	6.8	10.4	9.7	11.0	8.4	8.0	7.4	16.0	14.1	8.8	4.1	5.6	10.2	0.0	2.1	1.5	1.9	3.7	4.8	2.4	1.9	2.1	1.8	1.1	2.3	1.3	3.8	2.5	2.1	4.6	3.0	1.3	11.7	17.4	20.0	26.4	10.7	9.8	11.0	18.0	13.4	11.0	0.0	5.8	0.5	0.2	0.6	0.7	0.2	0.0	1.4	5.7	0.0	0.0	0.4	0.0	0.3	0.0	0.3	0.3	0.0	0.0	0.3	0.4	0.2	0.0	0.6	0.3	0.0	0.0	0.6	0.8	0.0	0.3	0.3	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.1	0.7	0.0	0.1	0.7	0.4	0.6	0.5	0.8	0.0	0.3
RNF34	"FLJ21786, RIF, RIFF"	ENSG00000170633	"Ring finger protein 34"	Q969K3	12	121400041-121430623	"Enzymes, Predicted intracellular proteins"	"Apoptosis, Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA074151			Supported	"Nucleoplasm,Nuclear bodies"		NA	NA			Nucleoplasm	"Nuclear bodies"	"HPA074151: AB_2686668"	"unprognostic (3.54e-1)"	"unprognostic (4.83e-2)"	"unprognostic (1.90e-1)"	"unprognostic (6.10e-2)"	"unprognostic (9.92e-2)"	"unprognostic (2.55e-2)"	"prognostic unfavorable (6.72e-8)"	"unprognostic (3.39e-1)"	"unprognostic (9.99e-2)"	"unprognostic (1.60e-2)"	"unprognostic (5.87e-3)"	"unprognostic (2.80e-2)"	"prognostic unfavorable (4.63e-4)"	"unprognostic (1.09e-1)"	"unprognostic (3.55e-1)"	"unprognostic (5.55e-3)"	"prognostic favorable (3.02e-4)"	11.9	10.6	18.2	19.6	23.4	10.4	12.3	25.2	26.9	11.2	17.3	21.5	10.0	17.0	15.0	12.7	14.4	11.7	15.5	16.0	17.6	17.7	10.8	11.1	11.6	27.2	19.3	19.4	14.0	12.2	11.1	17.1	10.2	19.3	10.2	14.2	12.7	12.4	12.9	45.7	13.8	16.0	15.0	21.3	19.4	16.3	20.8	17.2	21.7	12.7	9.1	22.5	16.4	11.5	31.8	16.9	36.5	20.3	29.9	42.8	25.8	18.5	22.5	14.7	15.4	11.7	10.8	18.5	19.8	17.8	19.8	15.2	27.9	7.1	26.8	15.3	21.3	10.5	13.4	22.2	12.4	17.7	38.9	13.0	30.9	15.6	25.6	14.0	26.7	21.8	9.5	16.9	17.2	15.0	11.4	20.7	16.1	23.3	12.5	19.4	14.7	23.4	39.1	18.9	11.0	20.5	22.4	19.4	15.7	13.7	22.3	21.8	14.2	24.9	9.3	15.1	14.2	16.1	20.3	16.6	17.1	12.4	14.8	15.6	22.4	36.9	29.1	12.2	18.8	17.1	26.9	17.9	36.5	32.4	19.9	33.0	31.8	37.8	34.1	16.9	25.5	32.8	32.6	27.4	29.9	20.3	14.3	42.8	25.8	18.2	23.4	25.2	26.9	17.6	17.7	19.3	19.4	19.3	17.2	14.9	15.2	25.2	16.8	15.5	12.1	18.7	20.4	17.4	12.5	8.7	3.9	20.4	31.5	27.7	10.1	13.5	18.6	23.3	23.8	32.6	15.4	11.7	17.3	9.0	18.1	12.7	39.2	14.1	14.2	7.0	15.8	11.3	16.9	39.7	16.1	17.1	23.7	16.9	17.0	15.3	18.7	19.4	14.6	73.2	30.9	14.1	20.3	41.5	19.5	21.9
RNF38		ENSG00000137075	"Ring finger protein 38"	Q9H0F5	9	36336396-36487548	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	20	"Early spermatids: 442.1;Late spermatids: 1049.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA015853	Approved		Supported	Nucleoplasm		NA	NA			Nucleoplasm		"HPA015853: AB_1856365"	"unprognostic (2.26e-1)"	"unprognostic (2.49e-1)"	"unprognostic (1.53e-1)"	"unprognostic (8.16e-2)"	"unprognostic (6.49e-2)"	"unprognostic (3.65e-3)"	"unprognostic (3.30e-3)"	"unprognostic (1.64e-2)"	"unprognostic (1.58e-1)"	"unprognostic (9.69e-2)"	"unprognostic (2.29e-1)"	"unprognostic (4.15e-2)"	"prognostic favorable (2.90e-6)"	"unprognostic (3.88e-2)"	"unprognostic (5.94e-2)"	"unprognostic (1.46e-1)"	"unprognostic (5.39e-2)"	11.9	8.0	13.1	7.7	14.5	20.3	11.1	18.8	17.0	13.6	14.1	12.2	8.1	6.4	16.3	12.9	10.1	11.7	9.6	9.5	10.0	11.1	12.3	6.8	11.7	14.5	9.2	12.3	24.4	12.8	12.2	5.7	21.2	14.0	15.3	10.1	14.4	10.3	12.8	9.6	8.9	10.2	16.9	8.5	11.4	8.7	46.3	10.0	13.1	14.4	4.3	11.1	16.5	13.5	6.2	4.1	12.2	4.3	8.4	8.7	4.2	9.0	5.2	20.0	11.8	9.2	8.5	19.6	5.7	7.1	7.0	9.2	8.7	5.0	13.7	6.0	10.9	9.2	3.6	12.7	6.6	10.8	12.1	5.4	16.5	7.3	8.5	7.1	12.1	15.1	8.7	7.2	8.8	8.6	11.6	17.7	13.6	3.4	13.2	11.3	3.1	12.4	6.4	13.3	6.0	3.7	11.4	9.0	7.5	11.9	10.5	8.3	9.0	6.4	6.5	6.4	24.4	6.2	12.4	17.4	6.7	10.2	3.9	6.7	8.7	18.1	9.7	6.1	10.2	8.5	12.2	4.3	7.2	7.2	4.1	6.0	5.8	6.5	7.6	4.1	6.2	7.0	7.0	8.0	8.4	4.1	3.3	8.7	4.2	13.1	14.5	18.8	17.0	10.0	11.1	9.2	12.3	14.0	10.0	11.9	13.2	7.3	9.1	15.3	13.4	14.1	12.7	2.7	11.4	7.0	17.7	11.6	8.3	9.5	442.1	22.6	12.5	0.0	10.2	9.9	11.0	16.6	5.8	15.7	9.9	25.4	16.1	22.7	20.0	1049.3	30.5	14.5	18.6	6.4	14.6	14.1	11.6	2.9	37.4	13.4	22.6	12.9	15.8	31.6	18.9	13.0	12.5	17.3	10.5	14.0
RNF4	"RES4-26, SLX5, SNURF"	ENSG00000063978	"Ring finger protein 4"	P78317	4	2462220-2625320	"Enzymes, Predicted intracellular proteins"	"Transcription, Transcription regulation, Ubl conjugation pathway"	"Activator, DNA-binding, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA022047, HPA049356"	Approved		Supported	"Nucleoplasm,Nuclear bodies,Microtubule ends"		NA	NA			"Nucleoplasm, Nuclear bodies"	"Microtubule ends"	"HPA022047: , HPA049356: AB_2680726"	"unprognostic (8.38e-3)"	"unprognostic (1.69e-1)"	"unprognostic (1.29e-2)"	"unprognostic (1.33e-1)"	"unprognostic (1.45e-1)"	"unprognostic (9.31e-3)"	"unprognostic (9.03e-3)"	"prognostic unfavorable (6.38e-4)"	"unprognostic (1.34e-1)"	"unprognostic (6.79e-2)"	"unprognostic (2.58e-1)"	"unprognostic (5.64e-2)"	"unprognostic (1.93e-2)"	"unprognostic (6.40e-2)"	"unprognostic (4.70e-2)"	"unprognostic (8.67e-2)"	"unprognostic (1.54e-1)"	28.6	29.1	25.4	32.2	39.4	36.4	28.6	35.9	50.3	28.2	25.1	34.8	28.4	27.0	32.2	28.0	30.3	27.8	27.1	24.6	22.7	22.8	32.3	25.6	27.4	41.9	23.5	23.4	32.1	31.0	31.2	30.0	29.4	36.7	28.5	26.7	29.2	36.1	28.5	26.0	28.5	29.3	31.8	23.1	41.9	28.9	36.8	23.7	50.4	29.3	19.1	51.5	27.7	26.3	36.9	35.3	41.8	39.9	39.7	43.7	45.8	20.1	19.1	20.0	13.9	17.5	18.2	22.4	24.6	27.7	26.2	23.8	21.6	19.0	25.5	14.7	24.8	34.7	13.2	21.2	19.3	25.0	12.0	12.8	30.9	19.7	20.7	26.2	21.7	27.1	21.1	23.4	24.3	20.3	18.4	24.2	21.7	16.3	35.3	26.7	13.8	34.7	30.3	30.8	16.9	24.0	25.4	19.1	13.2	17.8	25.7	18.6	17.6	17.3	13.4	17.2	22.5	21.3	16.4	20.1	22.9	11.2	21.5	37.7	45.7	60.8	28.3	22.3	23.7	23.7	14.6	29.6	41.8	43.7	39.3	43.7	36.9	37.5	43.0	35.3	27.2	36.2	36.3	32.9	39.7	39.9	23.6	39.9	45.8	25.4	39.4	35.9	50.3	22.7	22.8	23.5	23.4	36.7	23.7	20.8	20.3	25.1	14.7	24.5	12.4	15.7	17.8	13.4	21.6	21.0	15.7	18.0	18.3	19.5	11.0	20.2	14.8	0.0	20.4	27.8	17.2	19.5	13.9	17.8	17.4	12.7	11.6	15.4	34.2	17.3	15.8	20.0	6.8	27.9	14.2	9.2	25.2	14.0	19.4	17.7	16.5	25.8	21.7	26.7	47.3	28.1	18.2	33.1	15.6	29.1
RNF40	"BRE1B, KIAA0661, RBP95, STARING"	ENSG00000103549	"Ring finger protein 40"	O75150	16	30761745-30776307	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	"Chromatin regulator, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Distal tubular cells: 74.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041330, HPA054227"	Approved		Supported	Nucleoplasm		NA	NA			Nucleoplasm		"HPA041330: AB_10793872, HPA054227: AB_2682422"	"unprognostic (1.61e-1)"	"unprognostic (1.74e-2)"	"unprognostic (3.06e-1)"	"unprognostic (4.87e-2)"	"unprognostic (1.21e-1)"	"unprognostic (4.01e-1)"	"unprognostic (5.97e-3)"	"unprognostic (1.56e-1)"	"unprognostic (1.50e-1)"	"unprognostic (1.89e-1)"	"unprognostic (2.16e-2)"	"unprognostic (1.91e-2)"	"prognostic favorable (8.11e-8)"	"unprognostic (9.96e-2)"	"unprognostic (1.36e-1)"	"unprognostic (6.55e-3)"	"unprognostic (6.60e-3)"	21.0	25.2	26.4	21.3	26.5	40.8	20.9	36.8	28.2	25.8	21.0	22.0	18.0	20.1	28.4	17.0	25.6	24.4	21.3	22.8	22.2	17.1	20.0	21.2	20.2	21.9	20.9	18.9	30.5	24.4	44.0	21.6	25.3	19.6	21.4	15.1	20.0	27.3	21.1	20.0	25.5	20.3	18.3	18.6	20.0	19.6	43.1	22.8	23.5	26.8	15.4	20.6	22.5	21.4	7.6	12.0	15.0	14.9	9.9	13.3	12.9	20.3	31.9	19.4	18.4	14.8	15.5	21.2	20.8	16.1	24.1	18.8	25.8	19.0	16.2	30.6	17.8	16.5	22.1	35.3	18.5	18.9	23.2	41.4	15.9	35.0	26.7	19.8	27.4	18.6	14.4	15.5	30.2	17.1	16.1	20.2	14.4	34.8	15.5	14.6	34.0	26.1	25.8	20.2	16.3	19.3	51.9	21.4	31.2	10.6	18.1	32.4	23.8	16.3	20.9	15.1	10.7	32.0	31.2	21.8	27.1	13.8	19.1	23.7	23.2	28.5	32.2	22.5	24.4	27.6	6.2	11.5	14.7	12.9	13.4	13.3	7.6	7.2	9.9	12.0	6.5	5.4	8.3	15.0	9.9	14.9	6.2	6.2	12.9	26.4	26.5	36.8	28.2	22.2	17.1	20.9	18.9	19.6	22.8	11.9	26.4	10.4	10.9	12.4	14.5	2.0	30.6	9.4	11.4	21.0	3.9	13.3	74.6	12.9	18.8	10.9	22.6	0.0	11.6	13.8	11.8	14.0	4.6	18.7	18.7	4.8	13.4	9.8	24.6	16.8	16.7	13.0	16.9	9.0	20.9	16.6	13.6	14.0	16.6	19.9	13.3	12.9	11.2	19.7	9.4	17.2	19.0	13.6	23.6	10.0
RNF41	"NRDP1, SBBI03"	ENSG00000181852	"Ring finger protein 41"	Q9H4P4	12	56202175-56221933	"Enzymes, Predicted intracellular proteins"	"Apoptosis, Autophagy, Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA016812	Approved		Approved	"Nucleoplasm,Nuclear bodies,Midbody ring"		NA	NA			"Nucleoplasm, Nuclear bodies"	"Midbody ring"	"HPA016812: AB_1856370"	"unprognostic (1.14e-2)"	"unprognostic (6.30e-2)"	"unprognostic (4.04e-2)"	"unprognostic (6.86e-2)"	"unprognostic (9.59e-2)"	"unprognostic (8.22e-2)"	"prognostic unfavorable (6.49e-4)"	"unprognostic (6.93e-2)"	"unprognostic (4.18e-2)"	"unprognostic (1.67e-1)"	"unprognostic (5.80e-2)"	"unprognostic (5.90e-2)"	"prognostic favorable (2.52e-5)"	"unprognostic (1.64e-1)"	"unprognostic (1.65e-1)"	"unprognostic (1.45e-1)"	"unprognostic (1.43e-1)"	22.2	17.6	18.6	11.8	30.2	12.0	14.3	30.9	47.1	16.2	15.0	16.9	12.3	8.5	16.4	9.7	16.5	17.7	18.0	22.6	17.3	22.4	14.1	10.5	16.5	14.8	15.3	18.2	17.0	16.0	17.9	16.7	14.6	25.3	25.2	13.6	14.6	10.5	15.6	21.2	10.1	10.8	20.3	11.8	13.5	12.2	10.1	12.1	11.3	20.5	10.1	17.0	16.2	11.5	24.6	13.1	41.1	11.5	13.4	12.5	12.3	7.5	11.6	12.6	20.0	26.5	19.3	9.4	25.3	25.1	22.8	18.6	14.2	9.9	14.6	13.5	21.4	7.6	8.7	17.0	12.2	16.6	15.3	9.3	19.6	8.3	8.1	55.6	21.4	21.4	24.6	28.7	19.0	33.6	30.1	22.1	12.4	13.9	15.0	12.6	12.2	12.2	9.6	15.2	7.6	13.6	13.3	9.1	8.8	12.1	11.1	23.1	14.0	22.1	12.7	20.0	13.2	17.8	25.2	13.3	11.5	12.3	14.8	9.8	10.8	12.4	13.3	13.7	12.9	13.7	21.0	11.5	41.1	12.5	11.4	11.2	22.7	10.6	10.9	13.1	24.6	11.0	11.2	15.8	13.4	11.2	10.2	12.1	12.3	18.6	30.2	30.9	47.1	17.3	22.4	15.3	18.2	25.3	12.1	41.7	26.4	27.0	18.8	10.6	26.2	20.1	25.5	24.1	25.0	15.7	21.6	13.2	14.9	14.3	78.7	16.4	9.3	23.3	18.6	14.4	14.9	30.9	24.4	14.9	17.6	27.0	19.5	22.1	29.2	38.0	21.3	21.9	6.8	21.6	13.2	23.9	17.8	16.1	24.4	15.8	16.9	25.8	21.4	9.9	12.2	14.4	14.1	15.0	13.6	16.9
RNF43	"DKFZp781H0392, FLJ20315, URCC"	ENSG00000108375	"Ring finger protein 43"	Q68DV7	17	58352500-58417595	"Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins"	"Ubl conjugation pathway, Wnt signaling pathway"	"Developmental protein, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	7	"Enterocytes: 33.4;Mucus-secreting cells: 39.0;Undifferentiated cells: 47.8"	"Cancer enhanced"	"Detected in many"		"colorectal cancer: 41.7"	"Region enriched"	"Detected in many"	7	"cerebellum: 30.6"	"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"CACO-2: 13.4;Hep G2: 26.2;OE19: 29.2"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			HPA008079	Uncertain					NA	NA					"HPA008079: AB_1856371"	"unprognostic (2.53e-1)"	"unprognostic (1.09e-1)"	"unprognostic (7.46e-2)"	"unprognostic (2.56e-1)"	"unprognostic (1.10e-1)"	"unprognostic (4.33e-2)"	"unprognostic (1.39e-1)"	"unprognostic (3.62e-1)"	"unprognostic (2.93e-1)"	"unprognostic (1.05e-1)"	"unprognostic (5.69e-2)"	"unprognostic (3.79e-1)"	"prognostic favorable (6.04e-9)"	"unprognostic (3.61e-3)"	"unprognostic (2.56e-1)"	"unprognostic (3.58e-1)"	"unprognostic (1.04e-2)"	0.4	9.4	2.2	6.2	3.5	1.9	4.5	30.6	4.3	3.4	26.4	0.9	21.3	18.5	1.7	9.1	10.0	3.9	8.1	3.3	1.9	1.3	8.0	7.0	6.1	2.7	0.8	1.1	1.6	13.2	3.0	13.3	8.7	4.1	8.0	16.3	3.8	13.7	19.0	0.5	8.9	29.0	0.9	0.8	0.9	4.9	3.1	0.7	3.0	1.8	5.7	6.6	4.0	4.4	0.9	1.1	1.7	1.8	5.6	3.6	1.2	0.6	9.3	1.7	0.0	0.0	0.0	5.2	0.0	0.0	0.0	0.0	13.4	4.5	3.8	4.8	0.0	1.1	2.6	0.3	3.6	0.0	7.9	6.5	3.0	0.4	26.2	0.0	3.7	2.7	0.0	7.4	0.0	1.1	0.5	0.0	1.2	0.2	3.3	0.0	0.1	2.0	3.5	0.2	29.2	0.6	6.2	0.0	2.0	3.3	5.1	1.0	0.3	0.8	0.4	0.3	3.2	1.1	1.0	0.0	0.1	1.1	0.0	0.0	3.4	1.6	2.9	0.3	0.4	2.2	1.7	0.2	1.6	3.1	0.8	3.2	0.9	2.5	3.6	0.4	0.9	2.3	3.0	0.8	5.6	1.8	1.1	1.2	1.2	2.2	3.5	30.6	4.3	1.9	1.3	0.8	1.1	4.1	0.7	3.0	6.2	0.5	15.7	8.5	2.4	3.5	10.2	4.0	3.4	17.4	2.0	19.4	13.3	5.6	1.2	0.7	33.4	0.0	2.4	2.2	0.6	8.7	0.0	8.7	2.3	4.8	14.9	0.6	0.6	1.3	0.3	0.7	13.5	2.8	39.0	11.7	4.5	24.6	0.4	2.2	2.8	0.0	0.4	1.1	0.5	5.4	4.9	3.9	47.8	5.4
RNF5	"G16, NG2, RING5, RMA1"	ENSG00000204308	"Ring finger protein 5"	Q99942	6	32178354-32180793	"Enzymes, Predicted membrane proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Proximal tubular cells: 293.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB034107, HPA065032"	Uncertain		Supported	"Endoplasmic reticulum"		NA	NA			"Endoplasmic reticulum"		"CAB034107: AB_2238618, HPA065032: AB_2685408"	"unprognostic (1.94e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.49e-1)"	"unprognostic (4.45e-3)"	"unprognostic (1.35e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.36e-1)"	"unprognostic (1.37e-2)"	"unprognostic (4.07e-1)"	"prognostic favorable (2.44e-4)"	"unprognostic (1.95e-1)"	"unprognostic (8.93e-3)"	"unprognostic (2.91e-3)"	"unprognostic (8.84e-2)"	"unprognostic (9.17e-2)"	"unprognostic (2.72e-1)"	"unprognostic (2.99e-2)"	9.8	20.6	19.3	9.0	20.6	10.3	14.0	13.6	16.8	11.3	25.7	17.4	14.7	18.1	12.3	14.6	15.9	16.9	13.9	19.2	16.9	12.0	32.7	38.1	14.7	11.6	16.3	14.2	19.0	19.3	7.2	5.8	23.4	12.3	13.1	19.1	12.2	25.3	15.3	24.5	13.4	36.7	13.7	19.7	10.2	14.2	9.6	9.6	10.8	18.0	14.2	12.5	13.2	9.9	6.7	26.9	7.2	6.4	7.5	7.0	6.5	5.3	6.9	4.7	18.1	5.2	3.6	3.7	2.1	2.7	4.7	5.4	9.2	4.5	6.9	7.8	5.2	6.7	4.4	8.8	4.9	5.0	4.3	11.9	5.5	7.8	19.0	6.1	0.0	11.3	3.5	6.6	7.9	6.0	8.6	9.5	12.4	14.1	7.5	6.8	7.5	6.7	15.9	0.0	7.5	2.9	4.6	5.3	9.7	13.3	3.4	4.9	10.2	4.2	4.5	4.7	4.4	9.4	19.4	4.2	5.2	5.1	0.0	8.2	4.1	6.2	8.2	3.6	12.3	3.0	5.1	4.6	7.2	7.0	6.4	6.1	6.7	5.7	6.2	6.6	6.0	6.4	6.3	2.4	7.5	4.5	26.9	5.7	6.5	19.3	20.6	13.6	16.8	16.9	12.0	16.3	14.2	12.3	9.6	17.9	31.3	63.3	54.1	85.1	21.8	54.9	81.5	48.2	43.3	87.2	0.0	66.6	240.4	91.9	15.7	46.6	171.7	70.0	79.3	85.9	60.9	53.6	54.4	112.5	61.3	31.8	70.3	41.7	42.8	15.3	55.0	53.8	81.0	88.4	77.1	59.7	70.4	152.6	68.2	293.3	20.3	64.7	69.2	57.6	36.2	73.8	70.4	52.4	93.3	42.3
RNF6	DKFZp686P0776	ENSG00000127870	"Ring finger protein 6"	Q9Y252	13	26132115-26222493	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Late spermatids: 129.7;Spermatocytes: 94.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039343, HPA040048"	Approved		Supported	"Nuclear membrane"		NA	NA			"Nuclear membrane"		"HPA039343: AB_2676456, HPA040048: AB_10672969"	"unprognostic (3.22e-1)"	"prognostic unfavorable (3.07e-4)"	"unprognostic (1.45e-1)"	"unprognostic (1.63e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.68e-2)"	"unprognostic (1.97e-1)"	"unprognostic (4.07e-2)"	"unprognostic (7.63e-2)"	"unprognostic (6.13e-2)"	"unprognostic (1.39e-1)"	"unprognostic (4.21e-2)"	"unprognostic (2.70e-2)"	"unprognostic (8.35e-3)"	"unprognostic (1.84e-1)"	"unprognostic (7.70e-2)"	"unprognostic (8.47e-2)"	16.4	19.8	22.3	15.9	27.5	25.1	24.2	26.6	28.9	13.1	16.4	8.1	20.3	15.5	13.0	13.0	20.9	13.4	12.5	17.9	20.4	17.3	16.9	17.5	14.5	18.4	15.8	22.6	10.9	14.2	17.9	26.3	23.3	16.8	15.2	17.2	8.1	16.1	13.5	24.8	15.5	21.0	14.3	16.7	16.6	15.1	28.7	14.5	23.6	16.1	14.4	20.7	14.1	19.5	13.5	12.5	24.6	15.0	13.3	13.2	9.2	12.8	11.3	4.3	6.3	15.0	11.8	9.6	22.1	18.0	14.3	10.2	14.1	16.6	23.0	11.1	21.0	12.8	17.3	12.0	17.9	23.9	22.1	7.5	25.1	9.5	12.1	23.4	26.2	26.5	11.1	34.9	16.1	34.4	14.0	14.3	10.1	9.7	0.0	22.1	11.5	14.6	15.3	3.5	23.1	7.9	11.7	16.7	9.1	17.6	17.0	7.8	4.8	11.8	21.7	20.9	10.5	8.3	25.8	18.7	12.4	7.5	16.5	15.7	5.9	5.5	13.8	11.3	15.0	16.1	24.6	10.1	23.7	11.9	13.1	12.8	13.5	13.0	13.2	12.5	9.4	13.2	11.2	7.1	13.3	15.0	6.5	13.1	9.2	22.3	27.5	26.6	28.9	20.4	17.3	15.8	22.6	16.8	14.5	20.8	16.6	13.3	10.0	27.1	20.3	12.6	5.1	29.4	19.4	7.0	23.6	18.0	28.2	13.6	81.3	20.2	17.0	0.0	13.5	17.4	11.7	18.2	25.5	10.2	15.6	28.6	10.9	11.6	23.5	129.7	13.6	19.6	13.5	10.0	13.4	21.8	19.3	14.7	10.6	16.1	37.7	25.8	16.0	94.2	31.6	25.5	35.2	20.3	10.9	20.3
RNF8	KIAA0646	ENSG00000112130	"Ring finger protein 8"	O76064	6	37353972-37394738	"Enzymes, Predicted intracellular proteins"	"Cell cycle, Cell division, DNA damage, DNA repair, Host-virus interaction, Mitosis, Ubl conjugation pathway"	"Chromatin regulator, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"U-698: 40.7"					"Low region specificity"	"Detected in all"			"HPA050731, HPA064925"	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA050731: AB_2681222, HPA064925: AB_2685385"	"unprognostic (1.80e-2)"	"unprognostic (2.23e-1)"	"unprognostic (1.39e-2)"	"unprognostic (8.20e-2)"	"unprognostic (5.17e-2)"	"unprognostic (3.99e-2)"	"prognostic unfavorable (3.33e-5)"	"unprognostic (2.36e-2)"	"prognostic unfavorable (1.91e-4)"	"unprognostic (2.26e-3)"	"unprognostic (3.38e-1)"	"prognostic unfavorable (4.99e-5)"	"unprognostic (7.95e-3)"	"unprognostic (1.78e-1)"	"unprognostic (3.41e-2)"	"unprognostic (3.66e-3)"	"unprognostic (1.09e-1)"	8.0	11.7	13.1	8.2	17.8	8.9	11.5	25.7	18.7	9.2	9.5	10.6	6.8	6.9	13.5	5.7	18.3	12.0	8.8	17.6	13.4	14.8	11.8	7.5	10.8	8.3	12.0	16.0	13.2	6.5	11.9	16.4	10.2	13.7	8.6	8.2	8.0	10.2	11.9	15.2	9.9	8.4	10.7	9.6	7.7	7.6	19.8	13.8	6.6	8.0	9.4	13.3	12.9	15.2	8.8	8.3	2.6	8.1	7.6	10.8	5.5	6.6	4.0	9.7	11.5	7.8	11.3	2.8	6.9	8.6	13.2	14.5	6.0	3.7	8.3	4.2	6.7	11.4	6.3	13.5	8.8	13.8	8.7	13.1	14.2	7.0	8.9	4.5	7.6	10.5	5.6	8.5	7.8	9.1	8.1	12.6	9.8	9.6	2.9	7.5	4.4	9.1	9.4	6.7	3.4	5.3	7.2	8.9	5.7	6.7	4.7	19.1	6.4	5.2	5.9	9.5	6.6	5.3	7.4	5.7	8.7	7.7	8.2	10.2	8.6	11.3	40.7	4.2	10.8	10.0	1.0	4.6	2.6	10.8	6.0	10.0	8.8	8.1	10.2	8.3	6.0	7.1	9.4	0.6	7.6	8.1	3.6	9.3	5.5	13.1	17.8	25.7	18.7	13.4	14.8	12.0	16.0	13.7	13.8	17.9	23.4	13.0	21.7	16.3	26.0	28.3	10.2	28.1	15.9	24.4	37.3	20.9	13.3	20.8	35.2	15.8	8.6	0.0	16.6	21.6	23.9	20.0	27.7	14.7	15.4	47.7	21.4	22.1	14.2	20.2	24.7	13.8	10.1	20.8	16.1	21.5	23.6	15.6	29.0	16.8	29.6	12.9	16.4	43.0	33.1	19.3	4.9	15.8	16.2	17.0
RNFT1	PTD016	ENSG00000189050	"Ring finger protein, transmembrane 1"	Q5M7Z0	17	59952240-59964761	"Enzymes, Predicted membrane proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 45.5"	"Cell type enhanced"	"Detected in many"	12	"Early spermatids: 175.4;Spermatocytes: 283.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"							HPA013739			Approved	Nucleoli		NA	NA			Nucleoli		"HPA013739: AB_1856382"	"unprognostic (1.61e-1)"	"unprognostic (2.83e-1)"	"prognostic favorable (6.57e-4)"	"unprognostic (3.04e-2)"	"unprognostic (6.90e-2)"	"unprognostic (2.16e-1)"	"unprognostic (1.08e-2)"	"prognostic favorable (7.48e-4)"	"unprognostic (5.42e-2)"	"unprognostic (3.45e-1)"	"unprognostic (8.26e-3)"	"unprognostic (9.44e-3)"	"unprognostic (1.19e-3)"	"unprognostic (1.44e-2)"	"unprognostic (2.05e-1)"	"prognostic favorable (2.57e-4)"	"unprognostic (2.60e-1)"	7.9	6.2	2.8	5.3	4.3	3.8	4.2	5.1	3.7	3.1	4.0	2.4	3.7	5.3	2.7	8.1	4.6	3.2	3.1	4.1	3.1	2.2	4.7	12.0	5.0	4.4	2.9	3.1	3.5	7.5	4.7	6.1	4.4	3.4	4.5	4.8	4.2	5.1	3.0	6.7	2.7	7.6	3.0	3.4	4.1	3.9	45.5	3.0	5.9	6.1	4.3	6.0	5.1	3.7	9.5	10.1	20.2	17.1	8.9	7.7	7.9	4.8	2.2	2.3	3.1	7.6	5.7	4.5	6.2	3.3	4.9	6.0	6.9	1.9	7.2	10.4	5.2	11.1	5.6	7.3	4.7	8.5	6.8	7.9	6.1	5.8	6.2	5.7	9.4	9.4	6.3	2.5	4.6	2.0	2.5	4.9	1.7	17.4	4.5	4.1	6.3	3.8	4.5	0.9	6.6	5.1	5.2	17.5	4.2	3.9	3.5	1.4	2.7	8.9	2.2	12.4	3.2	10.3	17.9	3.5	9.5	8.4	5.5	5.3	6.5	18.1	4.3	6.6	5.3	4.7	17.3	11.8	20.2	5.6	13.9	7.7	9.5	5.2	6.3	10.1	6.1	6.8	6.1	5.7	8.9	17.1	6.7	6.5	7.9	2.8	4.3	5.1	3.7	3.1	2.2	2.9	3.1	3.4	3.0	0.0	6.1	15.9	13.3	10.1	7.7	5.6	2.5	16.0	6.8	8.7	19.6	29.6	5.0	12.0	175.4	7.8	14.4	0.0	12.5	30.4	15.3	14.5	18.5	27.2	40.4	17.5	4.1	11.6	25.1	60.1	8.3	27.8	16.9	36.9	7.6	4.5	12.5	19.3	11.0	8.6	6.8	19.4	8.6	283.8	42.4	8.4	24.1	16.0	10.1	7.2
RNGTT	"hCAP, HCE, HCE1"	ENSG00000111880	"RNA guanylyltransferase and 5'-phosphatase"	O60942	6	88610272-88963721	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction, mRNA capping, mRNA processing"	"Hydrolase, Multifunctional enzyme, Nucleotidyltransferase, Protein phosphatase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Rod photoreceptor cells: 43.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003750	Approved		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA003750: AB_1856383"	"unprognostic (5.19e-3)"	"unprognostic (1.00e-1)"	"unprognostic (2.82e-2)"	"unprognostic (3.45e-3)"	"unprognostic (4.82e-2)"	"unprognostic (1.10e-1)"	"prognostic unfavorable (1.37e-4)"	"unprognostic (4.48e-3)"	"unprognostic (1.28e-1)"	"unprognostic (4.05e-3)"	"unprognostic (3.76e-2)"	"unprognostic (1.55e-1)"	"unprognostic (2.23e-3)"	"unprognostic (9.83e-2)"	"unprognostic (6.55e-2)"	"unprognostic (1.67e-1)"	"unprognostic (8.08e-3)"	9.1	12.1	10.2	19.6	12.2	14.2	9.9	18.5	13.1	10.0	8.1	8.7	7.0	7.4	11.1	7.2	12.5	8.7	7.2	9.6	10.5	16.0	9.4	11.8	9.4	26.3	9.8	6.4	10.4	6.6	12.1	23.1	11.6	11.1	9.8	9.8	9.4	8.4	11.6	10.5	9.0	10.7	10.7	10.7	14.3	7.5	15.0	10.4	28.0	10.0	7.8	28.2	10.9	13.8	18.6	4.4	5.7	4.6	8.0	8.4	4.3	5.7	8.8	13.7	17.5	8.1	8.5	8.2	13.2	8.6	10.7	13.6	10.0	4.4	14.9	10.8	9.4	14.2	7.2	16.0	10.6	19.7	20.2	12.5	19.3	7.9	8.0	6.6	20.7	11.0	5.4	9.3	11.1	10.8	9.2	9.4	8.2	19.1	12.0	15.8	7.6	9.1	14.8	8.2	9.5	7.7	18.0	21.2	8.4	9.6	8.9	8.1	11.6	10.9	6.6	7.2	13.6	7.1	20.8	7.5	8.7	8.0	9.8	17.7	10.9	19.0	8.4	12.8	15.5	15.8	3.5	3.0	5.7	6.4	4.6	6.4	18.6	7.2	7.9	4.4	16.8	8.2	8.4	2.5	8.0	3.9	3.1	6.7	4.3	10.2	12.2	18.5	13.1	10.5	16.0	9.8	6.4	11.1	10.4	0.0	18.1	34.7	7.8	7.3	19.8	9.2	2.5	13.4	18.2	12.2	37.3	8.7	0.0	5.7	4.9	4.7	5.9	0.0	4.3	8.0	7.1	6.8	8.1	8.6	6.7	14.3	8.7	6.2	7.5	3.6	5.5	9.8	3.3	6.4	5.7	8.7	5.6	3.5	7.4	5.8	43.3	6.5	7.5	19.9	21.7	7.5	9.8	13.8	6.3	5.8
RNLS	"C10orf59, FLJ11218, renalase"	ENSG00000184719	"Renalase, FAD dependent amine oxidase"	Q5VYX0	10	88273864-88584530	"Enzymes, Predicted secreted proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Proximal tubular cells: 32.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"A-431: 13.2;fHDF/TERT166: 12.9;HSkMC: 15.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"								"Secreted to blood"	NA	NA	10500000000					"unprognostic (3.27e-2)"	"unprognostic (9.16e-2)"	"unprognostic (1.27e-1)"	"unprognostic (2.58e-1)"	"unprognostic (1.46e-3)"	"unprognostic (1.99e-1)"	"unprognostic (2.01e-1)"	"unprognostic (2.29e-1)"	"unprognostic (1.32e-1)"	"unprognostic (1.59e-1)"	"unprognostic (3.98e-1)"	"unprognostic (1.14e-1)"	"unprognostic (1.75e-2)"	"unprognostic (7.74e-3)"	"unprognostic (1.37e-2)"	"unprognostic (9.80e-2)"	"unprognostic (1.71e-1)"	7.1	20.6	3.9	4.9	6.6	2.1	10.2	16.7	10.5	8.9	8.2	5.4	7.5	6.3	8.4	9.4	7.7	6.4	7.2	13.4	3.9	6.4	25.1	13.6	4.0	10.4	4.9	5.7	8.9	10.5	10.9	17.3	2.5	7.5	8.5	9.1	15.1	8.2	5.3	10.0	5.1	7.0	5.6	5.3	7.1	8.7	5.8	3.9	2.1	10.9	6.8	5.0	6.0	6.4	5.3	6.1	2.6	7.0	4.7	5.0	3.4	13.2	6.1	0.3	0.1	2.1	3.0	0.0	3.6	0.4	3.0	2.5	0.8	5.4	0.0	7.4	12.9	0.0	1.9	0.0	0.9	3.0	2.8	0.1	2.2	4.0	0.1	9.7	0.0	0.3	15.5	1.5	8.3	0.0	0.2	4.5	0.1	1.0	7.2	0.1	5.6	0.0	3.8	0.0	0.0	0.0	1.7	0.0	0.0	0.0	1.2	3.4	0.0	0.2	3.1	9.9	4.1	1.8	8.0	1.0	2.2	3.5	5.6	2.9	5.0	5.9	0.1	0.1	7.5	0.0	0.0	4.0	2.6	5.0	7.0	3.6	5.3	3.8	3.5	6.1	4.5	3.9	3.1	0.2	4.7	4.6	5.6	1.7	3.4	3.9	6.6	16.7	10.5	3.9	6.4	4.9	5.7	7.5	3.9	3.0	1.0	2.2	5.9	2.9	6.0	15.9	7.6	1.4	2.3	1.8	2.0	1.5	19.9	5.0	5.1	1.1	6.3	0.0	8.4	0.4	2.7	6.2	1.1	9.6	5.7	4.8	5.2	2.5	4.5	3.6	1.4	2.8	3.3	4.6	5.7	6.3	4.6	8.7	6.0	32.7	5.2	0.0	4.1	2.3	6.1	4.8	1.4	2.2	6.6	5.7
RNMT	RG7MT1	ENSG00000101654	"RNA guanine-7 methyltransferase"	O43148	18	13726660-13764558	"Enzymes, Predicted intracellular proteins"	"mRNA capping, mRNA processing"	"Methyltransferase, RNA-binding, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039409	Approved		Supported	"Nucleoplasm,Nucleoli fibrillar center"		NA	NA			Nucleoplasm	"Nucleoli fibrillar center"	"HPA039409: AB_10795289"	"unprognostic (3.02e-1)"	"unprognostic (1.07e-2)"	"unprognostic (3.48e-1)"	"unprognostic (1.71e-3)"	"unprognostic (3.57e-1)"	"unprognostic (3.04e-1)"	"unprognostic (6.17e-3)"	"unprognostic (1.43e-1)"	"unprognostic (3.76e-2)"	"unprognostic (1.42e-3)"	"unprognostic (9.45e-2)"	"unprognostic (9.15e-2)"	"unprognostic (1.00e-1)"	"unprognostic (1.25e-1)"	"unprognostic (1.56e-1)"	"unprognostic (2.77e-2)"	"unprognostic (1.78e-1)"	18.9	10.1	13.3	12.7	20.4	40.1	16.6	19.7	27.3	14.0	11.5	10.3	12.1	9.1	15.4	13.1	12.6	12.2	9.9	21.2	14.9	18.2	12.9	12.0	12.4	14.6	14.5	21.8	19.6	13.3	16.6	21.2	16.1	28.5	14.7	11.6	10.8	12.8	12.2	29.1	14.3	11.3	15.1	16.1	12.3	11.4	17.1	12.6	12.2	19.2	15.8	15.8	26.5	11.4	20.1	20.8	21.6	13.1	9.4	15.7	4.1	11.5	6.8	13.3	10.0	9.9	12.6	9.3	9.5	11.8	9.9	13.5	8.1	5.6	12.9	11.7	9.7	15.4	4.7	15.7	13.6	16.7	7.1	8.4	9.7	7.0	7.6	10.9	25.3	8.3	9.6	14.8	10.4	29.4	13.0	7.6	14.8	14.5	13.0	11.2	7.2	16.1	9.1	10.1	23.4	5.3	10.5	14.1	17.5	9.1	9.1	10.3	15.5	10.7	7.9	18.2	14.2	6.8	10.6	7.8	19.9	28.0	16.1	10.1	26.2	28.5	26.8	14.6	9.7	9.9	21.6	13.1	8.5	12.5	10.3	10.1	16.2	11.9	10.3	8.1	20.1	15.7	12.2	7.1	9.4	11.4	20.8	12.8	4.1	13.3	20.4	19.7	27.3	14.9	18.2	14.5	21.8	28.5	12.6	68.5	25.1	34.8	48.8	62.5	108.1	45.4	17.8	33.5	27.3	43.6	115.8	54.2	58.0	42.6	22.7	38.6	37.3	0.0	41.9	49.2	49.0	53.0	34.6	31.8	35.7	100.1	71.9	33.2	58.5	8.0	67.3	52.8	47.2	39.7	36.5	38.3	46.4	37.6	57.3	53.0	142.0	38.8	52.5	78.5	106.7	59.7	105.7	61.8	39.2	36.6
RNPEP	APB	ENSG00000176393	"Arginyl aminopeptidase"	Q9H4A4	1	201982372-202006147	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"		"Aminopeptidase, Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Enterocytes: 152.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"dendritic cells: 12.1;granulocytes: 12.3;monocytes: 17.0"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036074, HPA036075, HPA061487"	Approved		Approved	"Golgi apparatus"	"Secreted - unknown location"	NA	NA		6600000	"Golgi apparatus"		"HPA036074: AB_2674926, HPA036075: AB_10672999, HPA061487: AB_2684537"	"unprognostic (8.57e-2)"	"unprognostic (3.43e-2)"	"unprognostic (2.81e-1)"	"unprognostic (5.45e-2)"	"unprognostic (2.68e-1)"	"unprognostic (1.74e-2)"	"unprognostic (1.95e-2)"	"unprognostic (2.87e-2)"	"unprognostic (1.93e-3)"	"unprognostic (1.80e-1)"	"unprognostic (1.07e-1)"	"unprognostic (1.28e-1)"	"unprognostic (3.50e-3)"	"unprognostic (1.91e-1)"	"unprognostic (6.00e-2)"	"unprognostic (1.97e-2)"	"unprognostic (1.68e-1)"	18.5	22.0	6.4	14.9	8.2	9.5	16.7	9.2	11.0	17.8	34.2	13.5	21.2	31.1	17.4	18.7	33.2	19.2	21.8	11.5	6.1	4.6	22.5	18.3	21.5	14.1	7.0	5.4	18.0	19.5	11.6	10.4	26.3	9.0	18.4	26.8	16.4	25.1	13.6	10.0	18.3	66.6	12.8	8.1	22.7	15.7	21.2	6.0	13.9	28.4	19.1	24.7	17.6	17.5	2.3	12.1	12.3	17.0	1.6	3.1	2.2	19.1	20.9	12.5	18.7	20.4	19.2	31.4	14.8	28.8	18.6	21.0	15.0	24.6	4.2	19.1	26.1	11.5	34.9	15.9	29.0	13.0	11.4	20.5	10.5	10.0	14.0	17.4	26.7	37.1	17.5	30.0	16.6	19.1	23.1	33.4	10.4	23.8	6.2	18.8	17.5	3.6	11.4	17.6	30.6	10.4	14.0	17.6	29.6	38.6	17.5	14.4	12.2	36.7	45.8	14.8	25.3	34.8	15.2	23.8	8.7	11.8	8.5	18.0	13.9	11.2	3.8	8.7	22.7	17.4	10.8	9.2	12.3	1.9	15.7	2.6	1.6	2.0	2.2	12.1	2.3	1.8	2.1	6.7	1.6	17.0	4.5	3.1	2.2	6.4	8.2	9.2	11.0	6.1	4.6	7.0	5.4	9.0	6.0	8.9	19.2	23.6	35.3	25.5	11.5	9.0	43.3	13.4	15.9	24.4	9.8	99.1	16.6	59.5	4.4	20.4	152.6	0.0	44.9	74.5	19.0	29.0	15.0	46.6	92.1	11.1	43.1	27.0	67.5	3.8	23.6	48.7	23.6	85.6	66.6	10.8	41.4	81.6	21.5	50.1	7.7	25.8	18.6	15.7	8.2	18.9	73.2	17.5	73.0	31.8
RNPEPL1		ENSG00000142327	"Arginyl aminopeptidase like 1"	Q9HAU8	2	240565804-240581372	"Enzymes, Predicted intracellular proteins"		"Aminopeptidase, Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Enterocytes: 92.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036772, HPA036773"	Uncertain		Supported	"Nucleoplasm,Nuclear bodies"		NA	NA			Nucleoplasm	"Nuclear bodies"	"HPA036772: AB_10670848, HPA036773: "	"unprognostic (3.92e-2)"	"unprognostic (7.28e-2)"	"unprognostic (1.20e-2)"	"unprognostic (2.39e-1)"	"unprognostic (5.24e-3)"	"prognostic favorable (7.43e-4)"	"prognostic unfavorable (5.06e-4)"	"unprognostic (3.72e-3)"	"unprognostic (9.10e-2)"	"unprognostic (1.66e-3)"	"unprognostic (3.10e-1)"	"unprognostic (1.71e-1)"	"unprognostic (1.98e-2)"	"unprognostic (5.33e-2)"	"unprognostic (1.57e-1)"	"unprognostic (5.31e-2)"	"unprognostic (9.86e-2)"	17.2	13.7	10.1	13.7	8.8	17.2	48.4	7.2	10.5	11.0	21.0	9.5	11.8	18.6	8.0	8.9	22.1	8.0	22.3	28.3	9.2	6.0	18.2	26.7	32.2	54.1	12.9	8.2	7.1	40.0	7.7	4.3	10.1	8.1	14.9	9.1	7.0	21.5	13.5	26.5	22.5	31.0	11.4	9.7	25.7	20.0	5.9	7.6	23.1	8.8	16.7	12.1	14.4	18.8	7.0	7.6	22.4	9.1	7.6	12.4	5.4	6.9	11.7	2.6	6.9	9.6	10.0	8.9	4.5	11.2	5.0	6.3	3.2	20.6	2.0	2.3	11.3	7.1	7.6	2.9	8.4	0.5	12.2	4.0	4.6	3.8	18.9	24.1	3.0	8.4	11.8	13.6	2.6	5.2	8.1	17.3	8.0	3.4	13.6	3.4	9.8	3.7	11.3	3.4	13.6	4.7	7.9	3.9	16.9	20.5	9.6	2.4	5.2	3.0	10.4	20.3	3.1	7.3	13.8	11.8	5.5	5.7	7.6	5.1	12.9	1.9	2.3	11.3	8.4	8.2	5.8	9.1	22.4	12.4	7.8	10.6	7.0	9.6	11.1	6.4	6.8	5.4	8.1	16.0	7.6	7.6	7.6	11.1	5.4	10.1	8.8	7.2	10.5	9.2	6.0	12.9	8.2	8.1	7.6	20.8	28.4	28.0	12.0	6.9	6.3	30.7	15.3	2.7	10.3	12.2	0.0	6.1	14.9	22.4	2.6	17.8	92.4	0.0	42.5	5.7	9.9	19.0	33.5	37.6	38.2	3.2	25.3	28.3	58.8	3.7	8.1	30.5	21.9	22.6	46.2	12.2	47.4	37.7	12.7	26.5	6.2	12.9	16.5	0.9	8.3	8.2	4.2	40.6	33.1	19.2
ROCK1	p160ROCK	ENSG00000067900	"Rho associated coiled-coil containing protein kinase 1"	Q13464	18	20946906-21111851	"Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"	Apoptosis	"Kinase, Serine/threonine-protein kinase, Transferase"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Early spermatids: 335.7;Late spermatids: 390.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004562, HPA007567, HPA045639"	Approved					NA	NA		240000			"CAB004562: AB_628223, HPA007567: AB_1856393, HPA045639: AB_2679401"	"unprognostic (7.86e-2)"	"unprognostic (2.86e-2)"	"unprognostic (1.22e-1)"	"unprognostic (6.63e-2)"	"unprognostic (9.90e-2)"	"unprognostic (1.17e-1)"	"unprognostic (6.74e-2)"	"unprognostic (1.00e-1)"	"unprognostic (1.63e-1)"	"unprognostic (8.89e-3)"	"prognostic unfavorable (9.93e-4)"	"unprognostic (3.85e-2)"	"unprognostic (8.93e-3)"	"unprognostic (3.04e-2)"	"unprognostic (5.47e-2)"	"unprognostic (3.19e-1)"	"unprognostic (1.28e-1)"	19.3	9.7	9.7	16.3	9.7	40.0	15.1	18.3	11.0	13.9	12.6	7.1	14.4	10.1	16.0	14.9	13.3	14.4	11.7	11.9	10.3	5.6	10.5	9.2	17.0	20.5	10.1	6.0	13.7	9.5	11.2	12.2	11.5	10.3	14.2	9.4	9.5	9.4	9.8	7.9	8.5	11.6	27.7	10.7	17.3	12.0	6.6	12.4	24.8	10.9	9.6	11.2	17.9	21.0	5.4	5.3	17.9	5.0	2.6	5.1	2.0	6.4	4.0	4.0	3.9	7.6	8.2	6.6	9.0	4.4	4.0	4.4	6.7	2.8	8.0	6.5	10.6	2.2	5.3	3.6	5.2	8.2	11.3	4.2	6.4	7.4	2.9	3.9	17.6	10.0	5.9	4.8	6.0	4.9	3.3	6.1	3.2	3.6	8.3	4.7	4.1	8.3	3.8	3.4	4.3	6.8	11.8	4.7	3.1	3.9	6.0	4.7	3.7	7.2	4.9	3.6	3.8	4.8	6.7	10.1	8.2	6.8	7.3	7.3	11.4	5.1	9.2	6.1	7.6	5.0	2.8	5.0	6.3	5.1	3.1	4.1	3.7	3.8	3.9	4.0	5.4	3.7	3.6	17.9	2.6	3.6	5.3	3.2	2.0	9.7	9.7	18.3	11.0	10.3	5.6	10.1	6.0	10.3	12.4	89.3	78.4	61.5	52.6	41.1	96.1	123.9	25.5	57.6	86.4	31.4	123.7	47.6	13.3	52.8	335.7	72.9	30.7	0.0	33.3	52.8	65.1	50.5	69.5	41.2	54.5	57.2	95.0	46.1	128.2	390.9	90.3	132.9	62.4	85.6	37.7	47.5	51.9	60.4	130.4	14.9	135.4	168.1	157.5	68.9	76.9	32.0	35.9	96.4	35.1	57.6
ROCK2		ENSG00000134318	"Rho associated coiled-coil containing protein kinase 2"	O75116	2	11179761-11348330	"Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"	"Biological rhythms"	"Kinase, Serine/threonine-protein kinase, Transferase"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007459, CAB008666, HPA044109"	Approved		Supported	Cytosol		NA	NA		3700000	Cytosol		"CAB008666: AB_1622617, HPA007459: AB_1079828, HPA044109: AB_2678813"	"unprognostic (4.55e-2)"	"unprognostic (1.05e-2)"	"unprognostic (4.18e-3)"	"unprognostic (4.87e-2)"	"unprognostic (1.49e-1)"	"unprognostic (2.71e-1)"	"unprognostic (1.39e-2)"	"unprognostic (2.72e-1)"	"unprognostic (3.62e-2)"	"unprognostic (6.66e-2)"	"unprognostic (3.83e-2)"	"unprognostic (1.48e-1)"	"prognostic unfavorable (1.57e-5)"	"unprognostic (1.51e-1)"	"unprognostic (1.99e-1)"	"unprognostic (2.52e-2)"	"unprognostic (3.47e-2)"	26.9	7.8	14.6	9.5	21.9	4.4	21.4	26.1	26.4	16.6	16.5	5.6	8.6	12.3	22.4	11.0	12.4	13.2	11.9	12.3	13.4	7.6	11.4	12.3	16.7	6.8	7.2	16.7	15.1	8.6	12.9	14.8	18.4	10.3	14.4	20.3	5.6	10.3	14.4	28.0	8.7	13.8	42.9	7.1	12.6	10.7	5.8	9.6	5.9	10.5	5.1	6.2	22.1	20.8	2.5	3.0	3.6	2.2	3.5	3.3	0.9	6.6	16.2	13.4	13.1	24.3	17.1	8.6	15.8	14.8	10.3	10.9	15.3	14.6	8.4	9.4	24.9	12.5	7.4	9.7	9.1	16.3	11.9	5.8	16.7	27.9	30.5	8.7	9.3	4.8	13.3	5.8	12.7	9.1	8.4	16.4	4.6	14.5	3.4	15.3	5.6	6.8	4.8	7.4	14.1	10.0	8.2	29.5	2.7	5.6	18.9	6.3	6.8	31.0	10.8	10.8	10.6	4.4	5.2	22.3	21.3	15.4	8.4	13.8	2.7	3.3	7.5	9.2	11.0	29.6	3.6	1.8	1.7	2.7	2.2	3.3	1.6	2.2	1.8	1.3	2.5	1.9	2.1	3.0	3.5	1.7	3.0	1.8	0.9	14.6	21.9	26.1	26.4	13.4	7.6	7.2	16.7	10.3	9.6	107.2	64.4	9.3	35.3	35.4	33.2	94.7	35.7	41.5	86.4	21.0	55.0	22.5	1.7	25.4	6.5	88.7	62.6	0.0	34.0	15.9	43.2	45.6	26.7	37.6	16.5	76.3	20.4	58.9	19.8	3.5	40.6	24.0	21.9	8.2	82.3	34.2	30.5	38.6	73.9	13.6	42.5	129.4	101.5	21.4	17.7	24.3	26.3	11.4	40.0	38.2
ROR1	NTRKR1	ENSG00000185483	"Receptor tyrosine kinase like orphan receptor 1"	Q01973	1	63774022-64181498	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Wnt signaling pathway"	"Kinase, Receptor, Transferase"	"Deafness, Disease mutation, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"parathyroid gland: 31.2"	"Cell type enhanced"	"Detected in many"	10	"Alveolar cells type 1: 47.6;Intestinal endocrine cells: 20.6;Leydig cells: 25.6"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in many"	4	"cerebellum: 13.0"	"Group enriched"	"Detected in some"	5	"NK-cell: 3.3;plasmacytoid DC: 1.1"	"Group enriched"	"Detected in many"	5	"dendritic cells: 1.1;NK-cells: 3.3"	"Cell line enhanced"	"Detected in many"		"ASC diff: 19.8;ASC TERT1: 24.8;CACO-2: 16.9;HHSteC: 18.8;HSkMC: 20.3;NTERA-2: 20.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA057016			Approved	Microtubules	"Intracellular and membrane"	NA	NA		2800000	Microtubules		"HPA057016: "	"unprognostic (5.15e-2)"	"unprognostic (1.19e-2)"	"unprognostic (3.65e-2)"	"unprognostic (1.03e-2)"	"unprognostic (6.24e-2)"	"unprognostic (1.61e-1)"	"unprognostic (7.11e-3)"	"unprognostic (1.41e-1)"	"unprognostic (4.06e-1)"	"unprognostic (3.84e-1)"	"unprognostic (3.20e-2)"	"unprognostic (2.02e-2)"	"unprognostic (3.64e-3)"	"unprognostic (1.48e-2)"	"unprognostic (1.52e-1)"	"unprognostic (5.87e-2)"	"unprognostic (5.15e-2)"	5.5	1.7	1.3	3.5	2.7	0.4	3.4	13.0	2.8	16.7	8.8	2.2	4.4	2.0	14.2	5.0	4.9	5.5	10.7	10.6	1.3	1.1	3.6	0.8	9.7	1.1	1.0	2.4	8.3	9.8	31.2	3.6	2.9	3.0	10.9	3.9	7.9	2.8	6.3	2.1	4.5	4.1	17.8	1.1	3.1	9.2	2.7	0.9	1.8	1.5	4.6	2.1	10.2	8.8	0.4	1.1	0.1	0.1	3.3	0.1	0.0	7.1	5.6	2.8	0.4	19.8	24.8	1.9	1.4	3.9	0.8	2.0	16.9	2.3	0.1	3.2	3.3	1.4	1.5	0.0	1.3	0.5	0.0	1.8	0.0	0.7	0.2	18.8	0.0	0.0	20.3	5.2	10.4	12.2	4.0	0.3	0.2	0.0	0.1	5.2	0.1	0.1	0.0	20.6	5.2	2.8	0.1	0.1	4.4	4.1	0.1	1.6	6.6	0.4	0.1	2.9	10.0	0.0	0.0	3.9	1.6	2.9	11.0	2.9	0.0	0.0	0.0	0.2	0.0	0.4	0.0	0.1	0.1	0.1	0.1	0.0	0.4	0.0	0.0	0.2	0.2	0.0	0.0	0.1	3.3	0.1	1.1	0.0	0.0	1.3	2.7	13.0	2.8	1.3	1.1	1.0	2.4	3.0	0.9	47.6	8.0	0.0	1.8	3.4	1.7	8.5	2.5	1.4	2.3	1.8	0.0	0.2	0.0	5.3	7.8	1.3	0.0	0.0	13.4	0.7	7.6	1.5	0.0	0.0	5.8	0.0	20.6	1.3	0.0	4.7	25.6	0.0	3.3	0.0	2.3	4.9	10.7	0.0	13.8	2.8	0.0	6.5	12.0	0.7	1.2	4.0	0.2	0.0	2.6	0.9
ROR2	"BDB, BDB1, NTRKR2"	ENSG00000169071	"Receptor tyrosine kinase like orphan receptor 2"	Q01974	9	91563091-91950162	"Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins"	"Wnt signaling pathway"	"Developmental protein, Kinase, Receptor, Transferase, Tyrosine-protein kinase"	"Disease mutation, Dwarfism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	4	"Basal glandular cells: 9.7;Fibroblasts: 9.1"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in some"	6	"pons and medulla: 6.6"	"Cell type enriched"	"Detected in single"	6	"MAIT T-cell: 3.9"	"Lineage enriched"	"Detected in single"	6	"T-cells: 3.9"	"Cell line enhanced"	"Detected in many"		"AF22: 12.3;HHSteC: 32.4;HSkMC: 26.9;U-266/70: 18.7;U-266/84: 12.5"	"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	9	"cerebellum: 13.5"	HPA021868	Uncertain					NA	NA					"HPA021868: AB_1856406"	"unprognostic (9.38e-3)"	"unprognostic (4.69e-1)"	"unprognostic (2.26e-1)"	"unprognostic (8.48e-3)"	"unprognostic (1.23e-1)"	"unprognostic (2.38e-1)"	"unprognostic (2.06e-1)"	"unprognostic (1.31e-1)"	"unprognostic (8.03e-2)"	"unprognostic (2.03e-1)"	"unprognostic (5.76e-2)"	"unprognostic (2.66e-1)"	"prognostic unfavorable (9.86e-7)"	"unprognostic (2.16e-3)"	"unprognostic (9.13e-2)"	"prognostic unfavorable (4.28e-8)"	"unprognostic (1.25e-2)"	4.4	4.3	0.7	5.3	1.1	0.0	3.6	0.2	0.8	23.4	20.7	2.9	11.1	1.9	29.1	9.1	8.0	8.1	18.7	8.5	1.0	0.9	2.0	0.5	4.2	0.7	0.3	0.0	19.1	3.1	20.3	1.3	7.1	6.6	20.3	2.1	11.0	1.2	13.1	1.1	2.9	6.2	30.0	0.3	4.7	10.5	5.2	0.3	2.6	7.9	1.9	3.3	23.7	18.1	0.6	0.0	0.0	0.0	0.0	3.9	0.0	0.0	0.1	12.3	0.0	2.7	0.2	3.5	0.2	3.2	2.1	3.9	0.0	0.0	0.0	0.0	0.6	1.9	0.1	2.5	0.0	0.9	0.0	2.0	0.0	9.4	0.0	32.4	0.0	0.0	26.9	0.0	2.8	0.0	0.0	0.0	0.1	6.8	0.0	0.0	0.2	0.0	1.7	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	3.6	0.2	0.0	0.0	2.7	7.3	0.1	0.0	0.0	2.4	1.0	0.0	18.7	12.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.9	0.0	0.0	0.6	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	1.1	0.2	0.8	1.0	0.9	0.3	0.0	6.6	0.3	0.0	0.0	0.0	9.7	2.7	1.9	5.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	1.5	3.5	1.1	0.0	0.0	1.3	0.1	9.1	8.3	1.1	0.0	0.7	0.0	2.9	0.6	0.0	6.0	5.5	0.0	5.0	2.8	2.8	6.8	0.8	0.0	8.5	0.0	0.2	6.5	3.9	1.0	6.8	1.9	0.3	0.0	0.8	4.4
ROS1	"c-ros-1, MCF3, ROS"	ENSG00000047936	"ROS proto-oncogene 1, receptor tyrosine kinase"	P08922	6	117288300-117425855	"Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"		"Kinase, Receptor, Transferase, Tyrosine-protein kinase"	"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"epididymis: 38.6;lung: 20.2"	"Group enriched"	"Detected in some"	5	"Alveolar cells type 1: 14.9;Alveolar cells type 2: 56.7"	"Cancer enriched"	"Detected in some"	13	"lung cancer: 6.9"	"Group enriched"	"Detected in some"	10	"cerebral cortex: 7.4;olfactory region: 2.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"GAMG: 16.3;HSkMC: 8.7;hTCEpi: 18.1;LHCN-M2: 12.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA049098, HPA072424"	Uncertain		Approved	Vesicles		NA	NA			Vesicles		"HPA049098: AB_2680628, HPA072424: AB_2686519"	"unprognostic (8.18e-2)"	"unprognostic (4.64e-3)"	"unprognostic (1.60e-1)"	"unprognostic (2.37e-2)"	"unprognostic (7.57e-2)"	"unprognostic (2.05e-2)"	"unprognostic (1.57e-1)"	"unprognostic (1.79e-1)"	"unprognostic (2.79e-2)"	"unprognostic (1.00e-2)"	"unprognostic (2.42e-1)"	"unprognostic (5.20e-2)"	"unprognostic (1.56e-12)"	"unprognostic (1.09e-2)"	"unprognostic (2.81e-1)"	"unprognostic (1.91e-1)"	"unprognostic (2.12e-1)"	0.3	0.2	0.2	0.0	0.4	0.0	0.2	0.2	7.4	0.2	0.4	0.0	7.9	0.0	0.2	38.6	0.2	0.2	0.0	0.2	0.2	0.2	0.4	0.2	20.2	0.0	0.2	2.5	0.2	0.2	0.0	0.3	0.7	0.0	0.2	0.3	0.0	0.2	2.3	0.2	0.7	0.3	0.0	0.2	0.2	0.3	0.7	0.0	0.0	0.2	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	16.3	0.2	0.0	0.0	0.1	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	8.7	18.1	0.2	1.6	0.0	0.0	0.0	0.0	0.0	12.5	0.0	0.0	0.1	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	1.6	0.0	2.2	1.4	0.1	1.7	0.0	0.0	0.0	1.6	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.4	0.2	7.4	0.2	0.2	0.2	2.5	0.0	0.0	14.9	56.7	0.0	0.0	0.0	0.0	0.6	0.0	0.0	6.8	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0
RPAP2	"C1orf82, FLJ13150, Rtr1"	ENSG00000122484	"RNA polymerase II associated protein 2"	Q8IXW5	1	92298965-92402056	"Enzymes, Predicted membrane proteins"	"Transcription, Transcription regulation"	"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	4	"Cone photoreceptor cells: 104.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA046443	Approved		Supported	Nucleoli,Cytosol		No	No			"Nucleoli, Cytosol"		"HPA046443: AB_2679669"	"unprognostic (1.29e-1)"	"unprognostic (2.52e-1)"	"unprognostic (3.71e-2)"	"unprognostic (4.12e-2)"	"unprognostic (4.96e-3)"	"unprognostic (5.73e-2)"	"unprognostic (1.23e-3)"	"unprognostic (3.29e-2)"	"unprognostic (8.01e-3)"	"unprognostic (4.09e-2)"	"unprognostic (2.59e-1)"	"unprognostic (6.09e-2)"	"unprognostic (7.02e-4)"	"unprognostic (1.18e-2)"	"unprognostic (1.69e-1)"	"unprognostic (3.62e-3)"	"unprognostic (4.10e-2)"	6.8	7.0	7.8	7.3	10.5	12.0	7.6	27.2	11.6	8.4	6.3	7.1	7.2	6.6	11.1	11.5	5.6	6.3	5.5	5.9	8.1	8.6	8.1	10.6	5.2	8.2	7.7	6.7	8.2	8.6	9.4	16.1	6.7	11.7	7.6	5.8	6.4	7.2	7.1	10.5	10.7	6.3	7.4	9.9	7.6	6.4	6.7	8.7	12.8	9.4	6.5	6.3	6.6	7.6	4.4	3.5	4.9	2.4	4.0	4.8	1.2	6.3	3.9	6.8	6.3	5.6	7.2	5.8	5.0	3.5	3.3	2.7	2.8	2.9	9.5	8.7	3.7	4.5	4.4	5.6	3.2	5.1	6.5	4.0	5.8	7.0	3.7	3.3	10.0	5.8	3.7	4.0	4.2	4.1	4.9	3.5	5.9	5.9	6.4	5.0	3.3	8.4	6.3	5.3	3.6	4.4	6.3	9.0	4.1	4.3	5.7	6.4	4.7	8.1	7.5	4.0	5.3	3.9	7.7	6.1	5.0	6.4	5.7	7.1	6.2	7.1	5.0	3.5	6.3	3.4	4.8	2.4	1.9	4.1	1.7	4.8	3.4	3.2	3.5	1.8	4.4	3.5	3.8	4.9	4.0	1.9	3.5	2.8	1.2	7.8	10.5	27.2	11.6	8.1	8.6	7.7	6.7	11.7	8.7	59.6	66.2	8.2	15.1	8.1	55.5	21.2	5.1	75.0	68.2	7.0	104.1	17.6	10.0	16.4	39.3	17.1	7.7	23.3	11.9	12.3	13.6	12.8	59.1	7.4	8.5	33.4	12.1	8.0	10.8	4.7	17.5	8.8	1.7	15.4	11.9	39.3	12.8	10.7	20.1	13.0	87.8	25.8	12.0	18.9	18.8	8.5	19.8	24.2	11.1	9.8
RPE		ENSG00000197713	Ribulose-5-phosphate-3-epimerase	Q96AT9	2	210002565-210022259	"Enzymes, Predicted intracellular proteins"	"Carbohydrate metabolism"	Isomerase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA036498, HPA036499"	Approved		Approved	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			Cytosol	"Nucleoplasm, Plasma membrane"	"HPA036498: AB_2675157, HPA036499: AB_10670109"	"unprognostic (5.07e-2)"	"unprognostic (8.15e-2)"	"unprognostic (3.06e-1)"	"unprognostic (2.34e-3)"	"unprognostic (2.00e-1)"	"unprognostic (2.53e-2)"	"prognostic unfavorable (1.42e-6)"	"unprognostic (1.59e-3)"	"unprognostic (1.69e-2)"	"unprognostic (1.28e-1)"	"prognostic unfavorable (7.00e-6)"	"unprognostic (2.33e-2)"	"unprognostic (2.55e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.95e-1)"	"unprognostic (2.89e-1)"	"unprognostic (5.84e-2)"	19.4	26.9	20.6	16.7	28.0	14.6	22.6	26.4	27.7	18.7	19.7	23.3	20.7	17.4	27.8	21.5	24.0	17.6	17.3	17.2	21.1	21.0	26.7	23.3	19.4	21.6	21.7	21.7	22.9	14.1	14.8	41.9	24.4	18.6	20.5	26.6	18.9	18.3	27.9	12.3	17.2	16.0	27.1	25.8	15.6	19.8	11.9	19.7	23.5	25.2	14.5	23.2	24.1	20.2	8.6	28.9	8.0	20.5	30.5	10.7	11.3	20.6	26.8	17.4	17.5	28.3	27.4	29.9	27.2	21.8	25.9	34.8	38.5	31.7	13.9	17.9	21.0	35.1	20.3	25.6	29.0	39.6	16.7	18.1	25.8	39.3	35.9	38.6	27.3	19.9	19.2	28.9	29.7	38.7	23.6	33.7	13.9	25.9	19.4	21.2	32.9	14.8	23.8	25.5	41.7	19.6	18.7	20.8	19.9	29.9	30.9	20.9	12.0	23.0	22.5	18.2	32.8	19.4	31.4	27.6	34.8	23.2	16.9	25.1	11.7	14.8	29.9	25.2	27.0	22.5	6.9	17.3	8.0	10.2	20.5	8.9	8.6	8.0	9.6	28.9	8.4	10.7	9.6	1.7	30.5	13.7	10.6	10.7	11.3	20.6	28.0	26.4	27.7	21.1	21.0	21.7	21.7	18.6	19.7	6.0	6.9	14.7	13.5	14.7	12.5	5.3	7.6	13.4	19.4	17.4	19.6	32.4	26.6	20.5	8.8	11.9	12.3	23.3	15.1	36.8	15.5	12.1	5.8	15.5	33.1	9.5	9.8	17.2	17.6	9.3	10.3	20.4	13.5	16.2	14.2	8.2	17.4	14.0	13.8	37.0	12.9	6.5	14.1	16.4	16.1	17.8	21.4	11.4	18.9	12.0
RPE65	"BCO3, LCA2, rd12, RP20"	ENSG00000116745	"RPE65, retinoid isomerohydrolase"	Q16518	1	68428822-68449959	"Disease related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins"	"Sensory transduction, Vision"	"Hydrolase, Isomerase"	"Disease mutation, FDA approved drug targets, Leber congenital amaurosis, Retinitis pigmentosa"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	25	"retina: 268.3"	"Group enriched"	"Detected in some"	12	"Cone photoreceptor cells: 9.8;Rod photoreceptor cells: 17.3"	"Group enriched"	"Detected in some"	10	"glioma: 5.8;head and neck cancer: 1.5"	"Group enriched"	"Detected in many"	5	"hypothalamus: 6.0;midbrain: 8.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A-431: 6.2;PC-3: 10.6;U-2 OS: 2.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"									NA	NA						"unprognostic (1.59e-1)"	"unprognostic (1.88e-1)"	"unprognostic (3.15e-1)"		"prognostic favorable (9.75e-4)"	"unprognostic (4.55e-2)"		"unprognostic (5.91e-2)"	"unprognostic (6.59e-4)"	"unprognostic (2.98e-2)"	"unprognostic (1.57e-1)"	"unprognostic (8.24e-2)"	"unprognostic (3.21e-4)"	"unprognostic (2.11e-1)"	"unprognostic (2.05e-1)"	"unprognostic (3.48e-2)"	"unprognostic (8.40e-3)"	0.0	0.0	0.9	0.1	0.7	0.0	1.0	0.1	3.8	0.2	0.1	1.3	1.4	0.4	1.4	0.7	0.8	0.6	0.2	0.0	1.5	6.0	0.0	0.0	0.0	0.1	8.8	0.1	0.1	0.0	0.0	0.0	0.0	1.2	4.2	0.2	268.3	0.2	10.5	0.0	0.0	0.1	0.5	1.4	0.2	0.6	0.2	0.6	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.7	0.1	0.6	1.5	6.0	8.8	0.1	1.2	0.6	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	9.8	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.1	0.0	0.0	0.0	17.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0
RPEL1		ENSG00000235376	"Ribulose-5-phosphate-3-epimerase like 1"	Q2QD12	10	103245887-103248016	"Enzymes, Predicted intracellular proteins"	"Carbohydrate metabolism"	Isomerase		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"blood: 1.4;brain: 1.2;pituitary gland: 1.2"	"Cell type enhanced"	"Detected in some"	16	"Bipolar cells: 2.9;Cone photoreceptor cells: 7.9;Rod photoreceptor cells: 2.6"	"Not detected"	"Not detected"							"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"HeLa: 1.1;NB-4: 1.1"									"HPA036498, HPA036499"	Approved		Approved	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			Cytosol	"Nucleoplasm, Plasma membrane"	"HPA036498: AB_2675157, HPA036499: AB_10670109"	"unprognostic (7.52e-2)"	"unprognostic (1.69e-1)"	"unprognostic (4.78e-2)"	"unprognostic (1.54e-1)"	"unprognostic (1.45e-1)"	"unprognostic (1.83e-1)"		"unprognostic (6.01e-2)"	"unprognostic (1.15e-1)"	"unprognostic (8.91e-2)"	"unprognostic (6.59e-2)"	"unprognostic (4.34e-1)"	"unprognostic (1.14e-1)"	"unprognostic (5.69e-2)"	"unprognostic (1.62e-1)"	"unprognostic (6.72e-2)"	"unprognostic (5.06e-2)"	0.0	0.1	0.1	1.0	0.3	0.1	0.1	1.2	0.2	0.0	0.0			0.3	0.4	0.4	0.1	0.0	0.0	0.1	0.1	0.3	0.3	0.0	0.0	0.4	0.1		0.0	0.8	0.0	1.2	0.2		0.1	0.0		0.0	0.0	0.4	0.0	0.4	0.0	0.2	0.1	0.0	0.2			0.1		0.1	0.0	0.0	0.4	1.0	0.3	0.7	1.4	0.6	0.2	0.5	0.5	0.1	0.0	0.0	0.0	0.2	0.3	0.2	0.0	0.2	0.4	0.7	0.1	0.4	0.0	0.1	0.2	0.0	0.0	0.0	0.6	0.0	0.3	1.1	0.3	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.2	0.0	0.0	0.2	1.1	0.7	0.2	0.0	0.0	0.1	0.3	0.5	0.2	0.3	0.1	0.3	0.4	0.2	0.1	0.1	0.4	0.0	0.1	0.9	0.1	0.2	0.3	0.1	0.3	0.7	0.4	0.1	0.3	0.7	0.2	0.5	0.7	0.5	0.4	0.4	0.3	1.0	0.4	0.5	0.6	0.0	1.4	0.4	0.3	0.4	0.2											0.0	0.0	0.0	0.1	0.1	2.9	1.5	0.0	0.0	1.2	0.0	7.9	0.3	0.0	0.5	0.0	0.0	0.0	0.0	0.2	0.4	0.2	0.0	0.0	0.0	0.5	0.0	1.7	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.6	0.0	0.2	0.0	0.0	0.0	2.6	0.0	0.9	0.0	0.2	0.3	0.3	0.0	0.7	0.0
RPIA		ENSG00000153574	"Ribose 5-phosphate isomerase A"	P49247	2	88691644-88750935	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		Isomerase	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	7	"Cytotrophoblasts: 210.0;Syncytiotrophoblasts: 188.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042620, HPA057954"	Approved		Approved	"Nucleoplasm,Vesicles,Plasma membrane"		NA	NA		4100000	"Nucleoplasm, Vesicles, Plasma membrane"		"HPA042620: AB_10793980, HPA057954: AB_2683563"	"unprognostic (3.35e-2)"	"unprognostic (1.35e-2)"	"unprognostic (6.96e-2)"	"unprognostic (9.24e-2)"	"unprognostic (4.31e-1)"	"unprognostic (8.24e-2)"	"prognostic unfavorable (1.46e-5)"	"unprognostic (2.73e-3)"	"unprognostic (1.82e-3)"	"unprognostic (8.70e-2)"	"unprognostic (8.82e-2)"	"unprognostic (2.79e-1)"	"prognostic unfavorable (8.53e-6)"	"unprognostic (3.47e-2)"	"unprognostic (2.53e-1)"	"unprognostic (1.01e-2)"	"unprognostic (8.79e-3)"	12.9	8.8	6.6	15.6	7.0	43.0	12.1	11.1	6.4	8.1	12.7	6.1	11.0	12.4	11.1	7.3	18.3	8.5	14.0	10.9	5.0	4.9	6.8	6.2	9.0	16.2	7.2	3.8	11.7	26.5	3.6	11.4	26.1	6.5	8.8	13.4	6.0	12.6	8.5	17.6	9.2	12.7	7.7	5.1	15.4	10.4	8.9	7.6	30.7	9.6	10.5	19.3	8.1	11.8	18.5	14.1	21.4	12.5	13.3	22.4	11.6	8.5	5.0	10.2	8.1	7.2	7.4	22.4	4.8	4.5	7.9	5.4	17.8	11.4	43.7	10.4	5.5	10.9	5.2	12.7	4.0	12.5	20.7	16.5	17.5	3.2	17.6	7.3	32.0	12.9	6.8	3.4	7.0	11.0	3.9	11.1	23.4	18.7	7.6	7.4	13.4	35.1	28.1	9.2	28.4	8.3	18.4	12.1	10.7	6.5	13.8	7.3	8.3	5.7	7.4	11.0	5.8	4.0	13.2	6.3	4.7	12.4	15.4	13.6	5.9	4.8	43.8	4.8	29.1	6.7	5.5	9.7	21.4	11.1	9.8	14.2	18.5	15.5	16.4	14.1	15.4	22.4	18.4	2.3	13.3	12.5	6.8	12.6	11.6	6.6	7.0	11.1	6.4	5.0	4.9	7.2	3.8	6.5	7.6	11.9	10.4	45.3	15.3	33.2	8.7	11.4	15.3	2.7	3.4	19.2	2.0	210.0	8.3	13.5	6.8	26.6	15.2	70.0	30.1	69.7	29.7	21.6	21.8	5.9	38.8	12.7	18.4	17.8	15.5	2.6	18.4	22.5	38.8	25.2	24.7	4.3	21.4	28.1	17.7	12.9	5.1	19.4	18.0	25.3	32.5	35.8	188.7	37.3	56.2	35.5
RPP14	P14	ENSG00000163684	"Ribonuclease P/MRP subunit p14"	O95059	3	58306247-58324695	"Enzymes, Predicted intracellular proteins"	"tRNA processing"	"Hydrolase, RNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 53.5"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA036194	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"HPA036194: AB_10672082"	"unprognostic (6.05e-2)"	"unprognostic (2.02e-2)"	"unprognostic (1.50e-3)"	"unprognostic (1.36e-1)"	"unprognostic (4.08e-3)"	"unprognostic (2.51e-1)"	"unprognostic (1.30e-1)"	"unprognostic (2.05e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.09e-1)"	"unprognostic (2.95e-3)"	"unprognostic (3.76e-2)"	"prognostic favorable (3.07e-10)"	"unprognostic (5.19e-3)"	"unprognostic (2.36e-1)"	"prognostic unfavorable (2.96e-4)"	"unprognostic (5.78e-2)"	7.1	8.5	8.3	5.7	12.9	5.3	7.1	15.8	10.7	6.6	8.6	5.9	6.6	10.2	8.2	7.8	8.5	7.4	6.2	11.8	7.2	6.8	11.2	15.0	5.6	7.6	6.5	9.9	8.4	11.9	10.8	9.4	6.0	7.2	7.4	8.2	9.0	8.5	7.0	53.5	7.4	9.1	11.7	5.5	7.7	7.7	9.1	5.9	6.3	8.1	18.5	8.5	7.2	7.0	4.6	6.6	4.7	9.8	9.8	6.4	3.5	10.1	8.1	9.4	7.5	7.9	8.5	10.4	8.6	9.3	12.4	14.0	12.3	6.7	12.2	2.0	11.5	10.8	6.2	14.1	12.8	12.1	8.5	7.4	11.6	9.7	6.7	7.7	19.9	9.7	9.3	12.4	14.7	14.1	6.2	9.7	15.0	9.9	8.7	12.0	5.5	13.5	7.0	12.3	8.4	15.4	5.5	7.4	11.8	9.0	14.6	5.9	10.5	8.1	9.7	11.6	6.8	9.3	9.6	8.8	9.4	10.5	9.9	16.3	13.0	22.3	17.6	10.7	14.0	6.6	3.0	5.7	4.7	4.2	4.9	5.6	4.1	5.5	5.8	6.6	4.6	6.4	6.2	2.6	9.8	9.8	6.2	3.0	3.5	8.3	12.9	15.8	10.7	7.2	6.8	6.5	9.9	7.2	5.9	8.9	11.0	7.0	7.1	27.7	24.7	26.6	5.1	8.1	5.7	3.5	23.6	7.2	10.0	5.3	0.7	7.2	11.7	0.0	5.3	5.2	8.4	6.9	3.5	17.9	5.4	17.5	9.2	12.3	11.4	0.9	11.5	9.5	21.9	8.2	12.5	12.9	6.2	3.5	9.2	10.1	28.1	0.0	20.5	8.6	13.5	37.6	8.6	7.0	13.4	6.2
RPP21	"C6orf135, Em:AB014085.3, FLJ22638"	ENSG00000241370	"Ribonuclease P/MRP subunit p21"	Q9H633	6	30345131-30346884	"Enzymes, Predicted intracellular proteins"	"tRNA processing"	"Hydrolase, RNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"AN3-CA: 20.6;EFO-21: 22.1;HEK 293: 24.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA						"unprognostic (2.73e-1)"	"unprognostic (1.09e-3)"	"unprognostic (2.83e-1)"	"unprognostic (4.65e-2)"	"unprognostic (1.78e-1)"	"unprognostic (6.46e-2)"	"unprognostic (2.18e-2)"	"unprognostic (8.37e-2)"	"unprognostic (2.86e-1)"	"unprognostic (1.65e-2)"	"unprognostic (2.65e-2)"	"unprognostic (2.76e-2)"	"prognostic unfavorable (1.04e-5)"	"unprognostic (9.54e-2)"	"unprognostic (1.01e-2)"	"unprognostic (4.13e-2)"	"prognostic favorable (6.78e-5)"	21.9	30.8	16.5	12.4	20.3	10.0	16.7	14.6	21.4	19.4	20.5	10.7	11.0	13.5	20.1	11.4	38.6	26.2	12.6	16.2	13.1	14.6	15.9	16.7	8.3	13.2	13.6	11.7	22.1	27.7	4.1	11.2	10.7	12.5	19.1	3.3	10.2	11.3	16.1	32.5	45.9	15.4	27.4	12.3	11.8	22.8	9.8	10.9	12.3	19.1	8.9	15.6	19.2	16.6	20.1	11.5	11.1	13.1	6.7	17.7	9.6	17.5	0.0	0.0	20.6	8.0	5.7	9.7	4.5	4.0	6.2	6.4	0.3	0.0	13.0	22.1	2.2	7.1	0.1	0.0	9.4	1.5	6.1	24.1	9.6	0.0	2.3	15.3	0.0	0.0	1.6	1.3	0.2	1.1	3.0	0.0	18.2	3.0	5.5	2.5	0.9	0.0	0.7	15.3	0.0	0.0	5.5	0.0	0.6	8.5	8.5	20.0	2.3	0.0	4.4	11.3	1.5	0.0	0.6	0.3	0.0	0.0	14.7	0.1	4.9	12.4	5.7	0.0	1.2	0.0	11.1	13.1	8.4	6.6	11.5	9.1	20.1	11.7	6.9	11.5	16.8	14.1	8.0	4.0	6.7	12.5	4.6	17.7	9.6	16.5	20.3	14.6	21.4	13.1	14.6	13.6	11.7	12.5	10.9	6.0	13.6	16.4	9.6	31.7	3.5	1.1	12.7	16.0	38.7	24.4	0.0	12.9	6.6	30.5	3.0	6.7	27.4	46.7	52.0	15.8	10.5	6.7	12.7	14.3	9.2	1.6	40.9	11.1	14.6	1.4	12.7	14.9	23.6	15.4	27.1	2.3	36.4	37.7	9.9	17.7	3.0	6.5	19.4	17.7	23.2	35.4	9.5	22.4	32.6	9.6
RPP25	FLJ20374	ENSG00000178718	"Ribonuclease P and MRP subunit p25"	Q9BUL9	15	74954416-74957464	"Enzymes, Predicted intracellular proteins"	"rRNA processing, tRNA processing"	"Hydrolase, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	6	"Bipolar cells: 79.4;Hofbauer cells: 60.4;Rod photoreceptor cells: 56.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"plasmacytoid DC: 16.7"	"Group enriched"	"Detected in many"	4	"dendritic cells: 16.7;monocytes: 6.4"	"Cell line enhanced"	"Detected in many"		"HHSteC: 18.6;SCLC-21H: 17.1;SK-MEL-30: 25.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA046900	Approved		Supported	"Nucleoplasm,Centriolar satellite"		NA	NA			Nucleoplasm	"Centriolar satellite"	"HPA046900: AB_10962049"	"unprognostic (9.36e-2)"	"unprognostic (7.17e-3)"	"unprognostic (5.54e-2)"	"unprognostic (2.27e-1)"	"prognostic unfavorable (2.24e-5)"	"unprognostic (7.18e-2)"	"unprognostic (5.73e-3)"	"unprognostic (5.50e-3)"	"unprognostic (7.78e-2)"	"unprognostic (1.44e-1)"	"unprognostic (3.58e-2)"	"unprognostic (1.70e-1)"	"unprognostic (4.71e-3)"	"unprognostic (5.50e-3)"	"unprognostic (5.58e-2)"	"unprognostic (1.10e-1)"	"unprognostic (2.53e-1)"	3.9	7.3	3.0	1.9	4.6	0.0	2.2	3.2	14.0	3.4	6.7	3.7	1.2	6.0	1.7	1.3	3.3	1.8	3.7	2.5	2.5	6.8	2.6	1.9	5.1	2.7	8.0	5.1	12.0	4.9	9.0	2.8	6.1	10.6	2.1	4.1	3.2	2.4	1.3	1.9	2.1	4.6	2.0	7.9	6.2	5.6	1.9	1.8	3.1	4.9	2.6	2.5	4.1	2.4	2.3	16.7	0.3	6.4	0.3	2.7	1.4	8.9	6.8	1.7	0.0	0.6	0.4	2.9	1.7	2.0	0.5	0.4	9.2	8.2	0.0	7.9	1.7	0.5	2.7	5.3	0.3	0.1	3.3	0.2	0.0	7.9	0.2	18.6	0.0	5.3	2.4	0.2	3.4	0.0	0.3	7.9	2.3	6.0	0.0	1.7	3.4	1.4	2.4	8.2	15.7	2.7	0.0	0.0	6.0	1.6	0.1	17.1	12.8	12.8	11.3	25.6	0.9	2.2	7.1	1.8	0.0	0.7	1.6	0.0	0.1	0.0	0.0	0.9	13.9	10.0	0.0	3.3	0.0	1.5	6.4	0.9	2.3	1.1	1.3	3.3	1.9	2.7	2.1	0.3	0.3	4.8	16.7	0.4	1.4	3.0	4.6	3.2	14.0	2.5	6.8	8.0	5.1	10.6	1.8	3.0	0.6	4.5	6.4	9.7	79.4	1.5	10.2	0.0	1.2	8.7	3.9	1.7	11.6	11.4	0.3	5.8	17.2	0.0	16.7	3.9	18.6	13.1	0.0	1.0	60.4	20.6	9.8	36.8	12.1	0.9	36.5	7.9	13.5	22.6	9.4	7.8	15.6	15.8	28.3	12.8	56.0	12.9	10.3	0.5	7.0	10.0	1.9	2.5	18.4	8.7
RPP30	TSG15	ENSG00000148688	"Ribonuclease P/MRP subunit p30"	P78346	10	90871716-90908553	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"rRNA processing, tRNA processing"	"Hydrolase, RNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA037578	Approved		Approved	"Nucleoplasm,Nucleoli,Microtubule ends,Cytosol"		NA	NA			"Nucleoplasm, Nucleoli"	"Microtubule ends, Cytosol"	"HPA037578: AB_10696939"	"unprognostic (1.55e-1)"	"unprognostic (1.77e-3)"	"unprognostic (2.35e-1)"	"unprognostic (4.08e-1)"	"unprognostic (5.64e-2)"	"unprognostic (3.05e-2)"	"unprognostic (3.80e-3)"	"unprognostic (1.27e-1)"	"unprognostic (2.73e-1)"	"unprognostic (1.03e-1)"	"unprognostic (2.27e-2)"	"unprognostic (2.65e-1)"	"prognostic unfavorable (1.01e-6)"	"unprognostic (1.98e-1)"	"unprognostic (9.84e-3)"	"unprognostic (3.43e-2)"	"unprognostic (2.10e-2)"	24.2	19.0	20.9	16.8	20.3	27.2	22.3	26.0	24.0	18.9	19.0	16.2	16.3	11.5	25.2	18.6	23.8	19.2	16.0	26.6	19.8	16.8	20.6	18.4	17.1	23.2	18.5	20.4	23.9	17.7	37.7	23.6	23.6	19.3	18.8	19.3	18.7	19.2	16.5	35.9	23.5	16.4	20.6	19.2	21.3	19.2	32.0	21.6	31.2	18.1	24.0	26.3	21.7	18.9	19.4	22.2	16.2	19.5	14.2	20.3	16.2	28.6	19.1	20.0	24.1	13.0	14.1	7.1	20.5	18.5	34.4	36.1	32.2	23.1	16.9	15.7	13.0	22.4	20.1	26.6	18.2	35.5	27.1	18.3	11.4	12.2	25.4	12.4	23.0	14.4	11.5	11.9	25.9	29.4	14.5	19.4	15.6	22.6	15.5	22.7	17.7	26.6	31.3	12.4	16.3	21.7	14.9	17.1	17.8	12.9	13.6	10.9	10.9	12.0	8.7	24.1	19.2	23.5	14.6	11.0	17.2	17.2	9.7	42.3	10.5	26.8	36.3	21.5	12.5	13.1	4.3	19.5	16.2	17.1	18.7	18.6	19.4	19.6	18.7	22.2	16.7	17.0	18.5	2.2	14.2	15.3	20.7	20.3	16.2	20.9	20.3	26.0	24.0	19.8	16.8	18.5	20.4	19.3	21.6	29.8	20.0	24.7	27.9	30.6	18.6	39.9	22.9	17.4	20.5	14.0	17.7	50.9	26.6	34.6	73.2	18.4	8.7	0.0	30.3	55.9	20.4	16.0	23.1	12.4	49.9	15.9	19.0	20.3	22.6	37.3	26.7	27.6	21.9	32.5	17.8	20.3	27.7	14.0	27.6	27.1	20.1	38.8	28.1	53.2	47.3	29.6	28.3	27.3	17.5	21.8
RPP38		ENSG00000152464	"Ribonuclease P/MRP subunit p38"	P78345	10	15097180-15139818	"Enzymes, Predicted intracellular proteins, Ribosomal proteins"	"rRNA processing, tRNA processing"	"Hydrolase, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	14	"Early spermatids: 439.8;Late spermatids: 144.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA045128, HPA050398"	Approved		Supported	Nucleoli		NA	NA			Nucleoli		"HPA045128: AB_2797230, HPA050398: AB_2732560"	"unprognostic (1.75e-1)"	"unprognostic (3.91e-2)"	"unprognostic (3.76e-2)"	"unprognostic (1.51e-1)"	"unprognostic (9.93e-2)"	"unprognostic (1.17e-1)"	"prognostic unfavorable (1.46e-4)"	"unprognostic (1.41e-2)"	"unprognostic (4.86e-1)"	"unprognostic (1.57e-3)"	"unprognostic (3.42e-1)"	"unprognostic (7.21e-2)"	"prognostic unfavorable (6.25e-4)"	"unprognostic (6.13e-2)"	"unprognostic (1.95e-1)"	"unprognostic (5.11e-2)"	"prognostic favorable (2.89e-6)"	13.1	12.2	12.4	10.7	13.6	9.7	18.3	22.4	12.4	13.6	16.7	12.0	15.8	14.4	15.7	16.1	15.2	18.2	10.3	10.0	11.6	10.2	17.4	21.6	12.5	16.3	15.0	10.0	14.4	16.8	11.3	16.0	17.4	12.7	18.4	15.7	11.7	17.1	14.9	20.9	14.8	17.9	14.3	11.5	16.7	13.5	38.6	12.7	18.8	19.8	13.9	18.5	13.4	13.6	31.0	25.7	23.4	24.5	18.6	31.4	20.2	21.0	15.9	8.8	11.2	11.9	12.2	15.4	10.2	7.7	16.0	16.5	16.0	22.2	17.7	11.0	9.6	13.3	19.7	17.5	17.7	14.8	13.4	15.9	18.2	9.7	14.1	25.5	10.2	15.3	14.5	24.5	13.1	11.6	12.5	12.8	18.0	20.9	12.6	12.2	17.3	18.3	11.2	10.1	26.3	7.8	15.0	8.8	21.9	20.5	8.3	8.3	10.5	14.1	24.5	28.2	14.9	21.9	16.5	11.0	7.5	12.9	15.7	13.4	17.6	18.7	24.0	14.6	12.5	7.0	8.5	24.5	23.4	25.6	23.7	25.1	28.8	26.2	31.4	25.3	31.0	30.6	27.8	8.3	18.6	18.6	25.7	22.0	20.2	12.4	13.6	22.4	12.4	11.6	10.2	15.0	10.0	12.7	12.7	14.9	15.8	18.2	26.3	27.9	13.0	6.5	7.6	107.1	38.7	8.7	5.9	26.5	23.2	28.9	439.8	16.8	18.2	0.0	29.4	37.0	16.2	26.9	12.7	24.6	21.7	7.9	12.7	14.7	16.5	144.4	21.9	21.4	8.5	14.4	19.9	14.9	25.8	21.0	18.7	25.9	29.8	12.9	11.3	28.6	38.0	31.6	26.9	20.8	20.5	39.4
RPP40	"bA428J1.3, RNASEP1"	ENSG00000124787	"Ribonuclease P/MRP subunit p40"	O75818	6	4994732-5004063	"Enzymes, Predicted intracellular proteins"	"rRNA processing, tRNA processing"	"Hydrolase, RNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Spermatogonia: 26.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035685, HPA035686"	Uncertain		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA035685: AB_2674734, HPA035686: AB_10670153"	"unprognostic (2.93e-2)"	"unprognostic (3.22e-2)"	"unprognostic (1.94e-1)"	"prognostic unfavorable (6.10e-6)"	"unprognostic (8.00e-2)"	"unprognostic (4.78e-2)"	"prognostic unfavorable (5.41e-4)"	"unprognostic (1.20e-1)"	"unprognostic (1.72e-2)"	"unprognostic (6.44e-2)"	"unprognostic (8.17e-2)"	"unprognostic (9.57e-2)"	"prognostic unfavorable (7.54e-8)"	"unprognostic (1.54e-1)"	"unprognostic (5.10e-1)"	"unprognostic (4.08e-2)"	"unprognostic (2.19e-1)"	6.9	16.8	10.8	7.2	10.7	6.7	11.1	3.5	11.9	6.0	5.5	4.2	6.3	4.6	6.1	6.6	11.9	5.5	4.7	5.5	10.0	8.8	5.6	10.8	3.9	10.1	9.9	5.8	6.2	7.8	5.2	8.6	5.6	9.1	5.3	5.3	1.5	4.0	6.7	7.7	9.8	3.6	7.5	5.3	6.8	4.3	10.5	8.0	6.1	5.6	13.0	8.3	9.1	6.9	7.8	12.3	0.0	11.1	7.9	8.4	5.0	6.4	10.8	3.4	9.7	6.4	8.1	10.9	6.4	3.2	12.3	9.8	14.7	5.0	14.0	28.3	6.6	16.9	6.9	7.0	9.9	11.2	5.3	14.2	8.8	7.0	19.9	7.5	11.3	5.0	6.3	8.5	12.2	12.2	2.7	12.0	12.9	13.9	2.8	8.9	18.4	5.7	19.5	5.7	7.7	17.6	12.2	6.5	25.6	6.2	7.0	12.3	3.6	6.0	5.8	6.4	9.5	10.5	9.4	5.7	16.2	10.9	10.9	14.5	5.0	21.1	11.0	3.0	19.0	8.3	0.0	6.9	0.0	3.4	11.1	5.0	7.8	5.9	4.1	12.3	6.5	8.1	7.2	0.0	7.9	3.5	5.9	8.4	5.0	10.8	10.7	3.5	11.9	10.0	8.8	9.9	5.8	9.1	8.0	0.0	0.6	4.5	7.0	11.0	0.2	3.6	0.0	5.3	4.5	1.8	0.0	11.1	10.0	8.1	5.5	7.0	0.4	0.0	8.1	10.7	6.0	3.1	0.0	5.8	9.9	0.0	2.9	6.7	2.1	2.1	5.2	3.4	8.5	1.8	3.1	1.3	3.9	2.3	4.6	11.7	0.2	0.0	7.2	11.4	26.8	12.9	8.0	1.9	6.8	7.0
RPS3	"FLJ26283, FLJ27450, MGC87870, S3"	ENSG00000149273	"Ribosomal protein S3"	P23396	11	75399486-75422280	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins, Ribosomal proteins"	"Apoptosis, Cell cycle, Cell division, DNA damage, DNA repair, Mitosis, Transcription, Transcription regulation, Translation regulation"	"DNA-binding, Lyase, Ribonucleoprotein, Ribosomal protein, RNA-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA063339	Uncertain		Supported	"Endoplasmic reticulum,Cytosol"		NA	NA		430000	"Endoplasmic reticulum, Cytosol"		"HPA063339: AB_2684990"	"unprognostic (3.62e-2)"	"unprognostic (6.94e-3)"	"unprognostic (2.64e-1)"	"unprognostic (1.44e-2)"	"unprognostic (5.55e-2)"	"unprognostic (1.08e-2)"	"unprognostic (1.22e-2)"	"unprognostic (1.35e-1)"	"unprognostic (2.69e-1)"	"unprognostic (5.75e-2)"	"unprognostic (3.27e-3)"	"unprognostic (1.96e-1)"	"prognostic unfavorable (6.92e-6)"	"unprognostic (3.22e-1)"	"unprognostic (2.94e-1)"	"unprognostic (1.89e-2)"	"unprognostic (2.19e-1)"	72.2	52.7	36.6	108.4	41.2	122.2	136.6	32.1	33.8	105.1	102.0	32.5	65.2	65.8	102.4	84.7	136.5	92.2	107.7	58.5	29.7	26.5	52.9	78.1	71.0	218.6	47.6	30.6	224.7	288.7	13.8	51.3	75.9	35.0	105.7	65.7	47.6	151.0	61.8	86.9	117.6	78.0	110.6	42.1	121.4	75.4	54.1	36.5	126.5	119.4	134.7	130.1	110.3	118.9	104.5	69.7	22.6	44.5	64.6	144.2	213.9	84.0	52.1	74.1	81.7	93.8	167.4	95.9	80.6	103.9	107.1	69.8	150.4	100.7	294.1	98.8	72.4	59.0	121.9	95.7	150.0	98.7	77.8	74.8	120.4	52.0	66.4	140.0	194.4	79.0	196.4	205.0	73.1	203.4	126.2	140.4	131.7	120.0	83.7	96.1	92.3	116.6	93.5	93.1	295.8	61.9	110.8	260.2	214.2	105.1	70.4	63.9	90.6	59.4	141.4	82.0	75.2	144.2	149.0	112.4	51.8	86.3	70.5	72.8	76.9	94.8	325.8	31.1	109.1	52.3	22.6	44.5	14.7	94.2	31.6	129.1	104.5	123.0	99.4	69.7	95.6	144.2	111.8	11.2	64.6	30.1	60.8	78.2	213.9	36.6	41.2	32.1	33.8	29.7	26.5	47.6	30.6	35.0	36.5	866.5	1237.3	4967.7	6162.8	5594.2	395.4	375.5	1814.0	683.9	1733.4	689.2	125.7	5421.9	1850.2	2098.6	348.9	3202.9	1729.9	1308.2	4686.8	7893.8	2767.0	3521.3	1562.3	1179.0	3205.3	125.5	1988.8	2139.1	2727.1	762.5	3476.8	3124.5	2689.2	3452.7	3995.8	368.1	3769.5	2872.2	1695.0	1677.7	343.0	1099.5	3088.9	437.8	578.7	6855.6	4907.0	4548.4	5852.6	6063.3
RPS6KA1	"HU-1, p90Rsk, RSK, RSK1"	ENSG00000117676	"Ribosomal protein S6 kinase A1"	Q15418	1	26529761-26575030	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Stress response"	"Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"intestine: 45.2"	"Cell type enhanced"	"Detected in many"	6	"Enterocytes: 85.8;monocytes: 68.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HMC-1: 29.9;U-937: 32.2"	"Region enriched"	"Detected in all"	5	"cerebellum: 60.4"	"Low region specificity"	"Detected in all"			"CAB003852, HPA007981"	Enhanced		Supported	Nucleoplasm,Cytosol		NA	NA			Cytosol	Nucleoplasm	"CAB003852: AB_289590, HPA007981: AB_1079850"	"unprognostic (1.04e-3)"	"unprognostic (1.23e-1)"	"unprognostic (1.61e-3)"	"prognostic favorable (7.20e-7)"	"unprognostic (7.35e-2)"	"unprognostic (3.69e-1)"	"unprognostic (6.93e-3)"	"unprognostic (1.12e-2)"	"unprognostic (1.09e-1)"	"unprognostic (7.51e-3)"	"unprognostic (2.37e-2)"	"unprognostic (9.64e-2)"	"prognostic favorable (1.84e-4)"	"prognostic favorable (4.58e-4)"	"unprognostic (4.77e-2)"	"unprognostic (7.61e-2)"	"prognostic favorable (8.33e-4)"	11.0	8.2	6.3	24.2	9.7	15.8	5.0	14.4	6.3	4.9	23.2	11.1	4.4	24.5	2.1	3.6	8.9	6.0	8.0	3.4	5.3	5.1	13.6	5.4	26.1	32.7	10.3	3.5	2.1	10.1	10.0	7.4	3.3	8.6	8.6	15.8	3.6	19.0	5.5	1.1	9.0	45.2	2.8	7.9	27.0	9.7	2.7	9.0	15.9	13.9	4.9	17.3	6.2	4.5	5.0	22.0	40.1	18.0	7.9	8.3	17.1	9.9	3.5	2.8	3.7	0.1	0.0	3.8	0.8	1.6	4.2	4.1	4.0	8.2	18.5	4.6	0.5	5.1	11.7	6.4	22.9	3.0	15.3	4.1	20.3	8.6	7.1	1.3	23.9	29.9	0.7	8.4	3.9	7.0	1.9	1.8	7.4	3.4	6.7	0.2	5.5	0.8	23.6	7.3	19.3	11.1	12.8	3.6	8.1	12.1	2.7	4.1	1.6	7.0	6.6	3.2	3.1	4.2	20.6	1.2	0.2	5.4	0.7	3.3	4.2	4.9	10.1	2.5	32.2	4.1	9.6	18.0	40.1	8.3	16.4	6.9	4.9	6.1	7.3	22.0	5.0	3.9	5.5	34.5	7.9	17.3	8.6	6.0	17.1	6.3	9.7	14.4	6.3	5.3	5.1	10.3	3.5	8.6	9.0	14.9	23.5	13.7	7.4	16.6	1.3	1.2	10.2	10.7	5.7	8.7	3.9	1.2	6.6	15.5	1.8	4.2	85.8	0.0	16.3	14.5	1.9	13.9	32.2	3.8	43.9	0.0	15.6	12.3	57.1	0.5	0.0	36.8	1.7	68.5	34.3	0.4	21.8	41.9	0.0	13.6	1.7	6.5	2.1	1.1	2.7	10.2	3.4	41.5	32.9	6.8
RPS6KA2	"HU-2, RSK, RSK3"	ENSG00000071242	"Ribosomal protein S6 kinase A2"	Q15349	6	166409364-166906451	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"	"Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	5	"Horizontal cells: 271.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	4	"eosinophil: 17.5"	"Lineage enriched"	"Detected in many"	4	"granulocytes: 17.5"	"Cell line enhanced"	"Detected in many"		"ASC diff: 48.4;ASC TERT1: 35.5;HHSteC: 35.9;HSkMC: 31.9;hTERT-HME1: 38.6;hTERT-RPE1: 70.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB026243, HPA045061, HPA054237, CAB069428"	Approved		Supported	Nucleoplasm		NA	NA			Nucleoplasm		"CAB026243: , CAB069428: AB_1622639, HPA045061: AB_2679203, HPA054237: AB_2682425"	"unprognostic (8.71e-2)"	"unprognostic (3.14e-3)"	"unprognostic (7.29e-2)"	"unprognostic (1.72e-1)"	"unprognostic (3.80e-1)"	"unprognostic (2.45e-1)"	"unprognostic (6.44e-3)"	"unprognostic (8.63e-2)"	"unprognostic (1.40e-1)"	"prognostic unfavorable (8.63e-5)"	"unprognostic (8.68e-2)"	"unprognostic (4.11e-2)"	"prognostic favorable (2.86e-5)"	"unprognostic (3.12e-3)"	"unprognostic (1.51e-1)"	"unprognostic (1.56e-2)"	"unprognostic (2.01e-1)"	15.4	6.5	26.8	5.3	35.5	6.9	12.7	12.1	21.5	13.5	7.1	20.3	11.5	4.3	18.3	5.2	14.0	11.9	12.5	40.9	25.0	18.3	9.9	3.3	24.6	10.6	22.4	18.4	20.9	30.2	32.6	18.0	12.1	22.7	10.6	7.4	11.1	9.0	10.5	14.4	7.5	7.2	15.8	37.2	16.5	10.4	5.1	25.7	0.8	24.8	3.5	4.9	15.5	10.2	0.4	3.9	17.5	1.6	3.3	0.6	0.2	1.9	0.0	3.9	5.7	48.4	35.5	0.0	4.1	8.1	2.3	3.2	0.0	1.2	0.2	1.3	14.6	1.8	1.7	2.0	9.0	2.1	0.8	0.5	0.0	8.5	0.1	35.9	0.1	1.6	31.9	6.5	12.5	38.6	70.4	12.6	4.1	0.0	0.0	9.5	0.4	0.1	0.4	1.0	1.9	2.3	0.6	2.0	5.7	2.4	2.1	2.1	15.2	1.4	3.9	5.3	1.0	0.1	3.0	4.6	8.3	0.8	22.8	1.2	1.1	1.7	0.5	5.5	0.2	7.8	0.1	0.5	17.5	0.5	0.7	0.2	0.3	0.5	0.2	0.7	0.4	0.6	0.3	0.4	3.3	1.6	3.9	0.4	0.2	26.8	35.5	12.1	21.5	25.0	18.3	22.4	18.4	22.7	25.7	20.8	34.5	0.0	4.1	4.1	34.9	54.9	22.9	2.7	13.6	34.9	7.9	0.1	10.0	12.8	12.0	47.2	0.5	0.0	20.9	0.2	8.0	9.4	2.3	11.6	7.2	271.7	5.2	38.6	5.0	48.4	4.9	4.7	18.6	3.6	5.5	8.3	22.7	1.4	4.2	4.4	15.4	12.9	6.9	3.2	1.1	3.0	0.2	1.3	1.2	5.8
RPS6KA3	"CLS, HU-3, MRX19, RSK, RSK2"	ENSG00000177189	"Ribosomal protein S6 kinase A3"	P51812	X	20149911-20267519	"Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Cell cycle, Stress response"	"Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes, Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Hep G2: 69.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003221, CAB003853, CAB013520"	Approved		Supported	Nucleoplasm,Nucleoli,Cytosol		No	No			Nucleoplasm	"Nucleoli, Cytosol"	"CAB003853: AB_562343, CAB013520: AB_2533378, HPA003221: AB_1853553"	"unprognostic (1.87e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.80e-2)"	"unprognostic (4.26e-2)"	"unprognostic (3.53e-1)"	"unprognostic (1.11e-1)"	"unprognostic (1.15e-2)"	"unprognostic (1.61e-3)"	"unprognostic (1.02e-1)"	"unprognostic (1.57e-1)"	"unprognostic (5.04e-1)"	"unprognostic (1.07e-1)"	"unprognostic (1.04e-1)"	"unprognostic (4.49e-3)"	"unprognostic (3.91e-1)"	"unprognostic (1.09e-1)"	"unprognostic (2.22e-1)"	19.7	12.5	9.9	23.0	12.5	8.2	16.5	15.2	12.1	11.4	23.2	4.4	22.1	13.7	12.4	10.1	13.6	12.7	15.7	21.3	9.7	8.8	14.1	25.8	21.6	34.0	9.9	10.0	12.7	14.0	36.6	9.8	11.0	10.2	14.5	18.8	7.7	14.3	11.3	45.2	11.7	23.7	16.1	11.7	25.8	11.8	4.8	9.7	29.4	13.5	15.0	18.2	20.3	19.0	4.2	8.6	12.5	6.9	8.3	11.3	2.7	12.9	22.7	8.6	4.4	8.4	14.8	2.6	11.2	17.1	8.4	11.6	25.7	16.7	8.5	3.9	11.8	12.3	9.2	9.8	9.5	15.7	7.1	7.8	10.0	14.3	69.0	8.6	19.5	10.4	9.4	7.6	13.2	16.7	7.4	30.4	9.0	6.6	24.4	8.8	6.1	12.6	6.0	6.2	16.9	13.7	6.7	18.2	9.8	7.3	10.9	4.0	3.9	15.1	4.6	16.4	11.2	0.0	5.8	16.9	9.2	6.4	29.1	6.3	19.5	11.9	9.5	17.4	9.7	21.7	12.5	4.7	9.5	6.3	6.9	11.3	2.9	7.3	6.9	7.0	4.2	5.0	6.0	7.5	8.3	6.9	8.6	3.5	2.7	9.9	12.5	15.2	12.1	9.7	8.8	9.9	10.0	10.2	9.7	41.7	68.2	18.2	31.8	48.3	33.6	19.4	38.2	21.4	51.2	15.7	21.6	3.3	3.3	23.3	0.1	48.1	43.4	0.0	26.0	5.7	28.8	47.0	42.8	61.1	20.6	12.7	24.0	29.4	46.1	1.1	12.0	60.4	35.4	20.8	53.4	26.6	30.0	46.0	19.8	23.7	8.7	19.4	35.0	3.3	7.7	48.6	3.0	56.7	46.1	54.2
RPS6KA4	"MSK2, RSK-B"	ENSG00000162302	"Ribosomal protein S6 kinase A4"	O75676	11	64359148-64372215	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Inflammatory response, Stress response"	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Cytotrophoblasts: 60.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	4	"plasmacytoid DC: 12.6"	"Lineage enriched"	"Detected in many"	4	"dendritic cells: 12.6"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB008649, HPA023225"	Approved		Supported	Nucleoplasm,Cytosol		No	No			Nucleoplasm	Cytosol	"CAB008649: AB_1619460, HPA023225: AB_1854144"	"unprognostic (2.30e-1)"	"unprognostic (7.05e-2)"	"unprognostic (2.03e-1)"	"unprognostic (4.07e-2)"	"unprognostic (2.40e-1)"	"unprognostic (7.47e-2)"	"prognostic unfavorable (8.17e-4)"	"prognostic unfavorable (9.27e-4)"	"unprognostic (2.45e-1)"	"unprognostic (9.03e-2)"	"unprognostic (1.41e-2)"	"unprognostic (3.06e-3)"	"unprognostic (1.98e-2)"	"unprognostic (3.93e-3)"	"unprognostic (5.25e-2)"	"unprognostic (1.09e-1)"	"unprognostic (2.85e-1)"	14.9	9.1	13.3	15.7	17.1	13.2	7.6	37.6	22.7	7.7	12.4	13.1	5.8	14.0	11.0	6.9	18.5	8.1	10.5	7.8	10.9	10.1	8.7	9.6	10.9	15.0	16.7	9.9	6.5	9.2	5.7	4.7	16.6	9.8	8.3	8.4	10.0	10.9	8.9	16.3	17.3	15.4	9.8	11.5	22.2	18.3	3.3	13.5	7.6	6.7	16.7	16.4	9.7	8.8	0.5	12.6	1.4	3.0	0.3	1.0	2.1	28.1	15.8	2.3	5.7	5.1	4.8	32.6	15.0	7.9	11.8	5.8	15.6	14.8	2.9	17.5	8.6	15.0	26.1	2.7	12.2	5.8	8.9	5.3	6.6	13.5	7.9	5.1	6.7	12.4	4.7	11.5	10.0	8.2	4.2	7.1	5.4	2.7	4.1	5.9	25.8	6.0	10.5	2.5	10.9	33.3	11.8	9.4	9.4	8.1	13.0	3.4	2.7	15.5	9.5	13.0	3.4	11.1	8.3	14.1	16.1	20.2	29.0	13.3	4.9	3.8	2.9	10.6	7.7	8.1	1.1	3.0	1.4	0.9	2.4	1.0	0.5	0.7	0.7	2.7	0.4	0.4	0.4	0.2	0.3	1.4	12.6	0.6	2.1	13.3	17.1	37.6	22.7	10.9	10.1	16.7	9.9	9.8	13.5	3.0	4.0	5.7	4.6	10.8	6.3	11.8	5.1	0.0	1.2	3.5	3.9	60.8	5.0	13.7	0.2	7.4	17.0	0.0	21.8	31.5	9.1	7.1	19.5	6.4	26.9	7.9	8.1	11.6	29.2	0.7	10.3	15.3	8.5	12.6	11.6	3.1	40.7	10.7	6.3	7.3	2.0	0.0	9.2	0.7	7.2	9.4	39.0	8.7	13.9	8.5
RPS6KA5	"MSK1, RLPK"	ENSG00000100784	"Ribosomal protein S6 kinase A5"	O75582	14	90847862-91060636	"Enzymes, Predicted intracellular proteins"	"Inflammatory response, Stress response"	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"granulocytes: 86.9;Syncytiotrophoblasts: 93.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HMC-1: 30.1;SK-BR-3: 15.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001274, HPA001780, CAB025458"	Approved		Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"CAB025458: , HPA001274: AB_1079417, HPA001780: AB_2666432"	"unprognostic (3.05e-2)"	"unprognostic (2.19e-3)"	"unprognostic (4.27e-4)"	"unprognostic (1.98e-3)"	"unprognostic (4.79e-2)"	"unprognostic (4.20e-4)"	"unprognostic (3.70e-2)"	"unprognostic (5.80e-4)"	"unprognostic (6.70e-2)"	"unprognostic (8.39e-2)"	"unprognostic (1.84e-1)"	"unprognostic (1.97e-1)"	"unprognostic (1.38e-4)"	"unprognostic (5.73e-3)"	"unprognostic (1.07e-1)"	"unprognostic (2.42e-1)"	"unprognostic (1.75e-1)"	4.9	2.4	8.3	13.0	21.6	5.8	16.3	32.9	12.2	7.0	11.0	12.0	4.2	9.3	11.8	2.6	11.9	8.9	6.7	6.1	9.0	7.9	4.5	4.1	6.1	7.3	12.8	9.7	10.2	4.9	12.0	6.9	14.9	11.0	8.0	11.7	2.8	8.7	9.9	14.3	6.6	9.8	19.4	17.1	7.4	9.8	5.2	13.7	4.8	8.6	7.8	7.7	11.6	7.3	5.8	2.5	20.0	3.2	8.4	7.1	2.2	1.2	1.7	2.0	1.3	0.0	0.4	8.7	0.7	1.1	2.3	3.4	0.9	2.3	5.9	2.5	2.2	1.6	3.8	1.7	1.7	4.8	0.9	3.1	5.9	1.7	0.2	0.0	5.8	30.1	0.5	3.6	1.4	1.1	0.5	2.5	4.1	0.6	6.7	2.3	2.5	1.8	2.9	0.6	3.7	2.7	3.2	9.6	3.0	2.5	2.2	10.1	3.2	2.5	15.1	8.5	1.8	2.9	1.9	0.5	0.7	1.3	0.6	2.9	2.9	2.8	5.1	1.4	4.3	9.5	10.5	2.7	7.8	3.6	2.1	5.9	4.4	4.8	3.5	2.5	5.8	5.6	3.0	20.0	8.4	3.2	1.0	7.1	2.2	8.3	21.6	32.9	12.2	9.0	7.9	12.8	9.7	11.0	13.7	17.9	27.4	40.7	37.9	35.8	29.4	14.1	12.7	37.5	29.6	7.0	15.7	31.0	0.0	8.9	5.5	19.6	27.6	0.0	4.6	4.7	13.2	25.2	86.9	6.8	6.4	25.4	15.6	14.1	16.1	2.1	13.0	16.9	18.6	2.8	17.9	12.9	3.0	11.5	11.0	2.8	29.2	12.9	27.6	13.1	23.7	40.5	93.5	39.5	18.8	42.3
RPS6KA6	RSK4	ENSG00000072133	"Ribosomal protein S6 kinase A6"	Q9UK32	X	84058346-84187907	"Enzymes, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"ductus deferens: 20.7"	"Cell type enhanced"	"Detected in many"	6	"Bipolar cells: 19.9;Collecting duct cells: 17.4;Cone photoreceptor cells: 23.6;Intestinal endocrine cells: 24.0;Rod photoreceptor cells: 18.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"NTERA-2: 11.0;PC-3: 11.9;RH-30: 14.6;SH-SY5Y: 11.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA002852, HPA003904"	Uncertain		Supported	Nucleoplasm,Nucleoli,Mitochondria		NA	NA			"Nucleoplasm, Mitochondria"	Nucleoli	"HPA002852: AB_1079854, HPA003904: AB_1079853"	"unprognostic (1.17e-1)"	"unprognostic (1.02e-2)"	"unprognostic (3.44e-1)"	"unprognostic (4.93e-4)"	"unprognostic (1.71e-1)"	"unprognostic (3.04e-3)"	"unprognostic (2.09e-2)"	"unprognostic (2.50e-1)"	"unprognostic (2.86e-1)"	"unprognostic (4.88e-2)"	"unprognostic (3.38e-3)"	"unprognostic (2.88e-1)"	"unprognostic (2.12e-9)"	"unprognostic (4.44e-3)"	"unprognostic (1.30e-2)"	"unprognostic (2.34e-2)"	"unprognostic (8.49e-3)"	0.7	2.9	5.9	1.0	12.2	0.0	2.3	4.7	5.1	3.1	4.5	1.1	20.7	1.7	2.7	4.0	1.5	4.0	1.9	1.2	5.1	2.9	9.2	0.9	0.8	0.2	1.5	3.3	4.9	3.4	13.5	9.1	0.5	4.4	4.3	3.7	1.5	3.0	15.0	1.4	2.3	2.0	1.7	1.0	0.6	2.4	2.6	2.7	0.8	14.5	0.9	0.6	3.3	2.3	1.2	0.8	2.4	0.5	0.7	2.8	0.1	0.0	3.7	3.6	0.0	3.4	3.4	0.0	7.7	4.1	3.4	2.9	2.8	3.0	0.0	0.0	4.1	0.0	0.1	9.1	6.1	8.1	0.0	4.6	0.0	0.1	0.0	3.1	0.0	0.0	1.9	0.0	0.0	3.8	3.8	0.8	0.0	0.0	0.2	2.7	0.0	1.3	0.1	11.0	0.0	11.9	0.0	14.6	0.0	0.6	8.5	0.0	11.7	0.0	4.2	0.0	5.2	2.0	0.0	0.0	0.1	4.4	0.0	0.0	0.5	0.0	0.0	1.0	0.0	0.0	2.4	0.4	0.5	0.5	0.3	0.4	1.2	0.4	0.7	0.8	0.6	0.4	0.4	1.1	0.7	0.5	0.4	2.8	0.1	5.9	12.2	4.7	5.1	5.1	2.9	1.5	3.3	4.4	2.7	8.9	2.4	2.0	4.4	0.2	19.9	2.0	12.7	6.7	3.4	17.4	23.6	2.1	1.7	0.4	0.4	0.6	3.4	0.0	1.1	0.6	0.3	7.4	0.0	1.5	0.2	1.6	24.0	1.3	0.0	0.0	4.0	0.0	0.0	0.0	5.0	2.8	1.3	2.9	5.6	3.3	18.2	0.0	0.6	3.7	6.3	0.4	1.9	0.0	5.3	4.2
RPS6KB1	"p70(S6K)-alpha, PS6K, S6K1, STK14A"	ENSG00000108443	"Ribosomal protein S6 kinase B1"	P23443	17	59893046-59950564	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Apoptosis, Cell cycle, Translation regulation"	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enriched"	"Detected in all"	5	"MCF7: 76.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB003838, CAB018346, HPA039442"	Approved		Supported	Nucleoplasm		NA	NA			Nucleoplasm		"CAB003838: AB_562325, CAB018346: AB_632156, HPA039442: AB_2676510"	"unprognostic (2.25e-1)"	"unprognostic (4.52e-2)"	"unprognostic (1.91e-3)"	"unprognostic (1.35e-2)"	"unprognostic (9.81e-2)"	"unprognostic (1.13e-1)"	"unprognostic (3.72e-3)"	"unprognostic (1.70e-1)"	"unprognostic (5.86e-2)"	"unprognostic (1.66e-1)"	"unprognostic (3.67e-1)"	"unprognostic (1.76e-2)"	"prognostic unfavorable (5.09e-7)"	"unprognostic (3.45e-1)"	"unprognostic (2.09e-1)"	"unprognostic (3.98e-2)"	"unprognostic (1.52e-3)"	18.4	18.3	16.6	23.2	19.5	20.5	18.4	25.7	24.2	18.1	18.2	13.1	18.4	13.1	19.6	16.5	25.4	14.5	14.9	14.2	15.7	12.6	13.5	20.0	14.8	17.3	20.3	17.5	21.6	22.3	24.5	18.9	20.3	17.6	16.7	15.0	10.1	17.3	21.5	50.3	15.8	14.1	19.3	19.8	17.6	17.5	10.7	20.0	17.8	16.8	18.4	22.0	18.5	20.8	8.9	12.8	25.9	11.1	9.4	13.5	8.3	10.9	10.6	9.1	8.6	6.3	9.2	6.9	10.1	9.4	8.9	10.0	8.7	5.5	13.2	12.6	8.4	10.7	5.7	12.0	9.1	14.4	7.3	13.4	9.0	6.9	9.9	9.3	13.9	9.1	9.4	7.0	10.3	7.6	7.4	11.6	8.5	11.9	8.5	6.6	76.1	16.5	5.9	6.1	9.6	8.2	9.8	15.4	12.3	7.4	8.1	6.6	8.0	8.5	5.0	5.4	11.0	9.8	7.7	10.0	8.7	14.5	7.0	13.4	15.4	13.0	14.9	6.6	8.6	6.9	25.9	10.1	9.0	11.4	10.2	13.5	8.9	10.5	13.0	12.8	8.6	12.3	12.9	10.0	9.4	11.1	8.0	9.5	8.3	16.6	19.5	25.7	24.2	15.7	12.6	20.3	17.5	17.6	20.0	20.8	32.2	20.1	17.7	29.3	16.3	13.7	17.8	25.4	38.7	3.5	17.7	20.8	3.3	10.9	2.6	18.8	10.1	0.0	14.1	15.1	21.8	21.4	22.0	12.4	10.6	17.5	12.7	11.1	14.8	2.1	14.7	18.0	10.1	16.2	16.1	11.9	13.7	10.5	17.0	7.2	18.5	25.8	22.8	11.1	13.1	28.0	25.5	20.3	13.4	24.3
RPS6KB2	"KLS, P70-BETA, p70S6Kb, STK14B"	ENSG00000175634	"Ribosomal protein S6 kinase B2"	Q9UBS0	11	67428460-67435408	"Enzymes, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA010010, CAB019404"	Approved		Supported	Cytosol		NA	NA			Cytosol		"CAB019404: AB_331355, HPA010010: AB_1856469"	"unprognostic (1.38e-1)"	"unprognostic (2.36e-3)"	"unprognostic (8.50e-2)"	"unprognostic (2.56e-2)"	"unprognostic (1.84e-1)"	"unprognostic (1.41e-1)"	"unprognostic (9.01e-3)"	"unprognostic (5.10e-2)"	"unprognostic (1.22e-1)"	"unprognostic (9.49e-3)"	"unprognostic (7.66e-2)"	"unprognostic (2.79e-2)"	"prognostic unfavorable (2.03e-7)"	"unprognostic (1.28e-2)"	"unprognostic (1.55e-1)"	"unprognostic (2.12e-1)"	"unprognostic (2.66e-1)"	8.7	14.1	8.5	12.8	9.2	18.0	11.2	12.9	11.5	13.1	13.0	12.5	12.3	19.8	10.2	10.1	36.1	11.0	10.7	10.7	8.8	4.2	11.3	27.8	10.7	12.0	11.4	8.7	9.5	18.7	9.6	11.7	13.8	8.7	17.2	9.9	11.7	18.1	15.8	25.0	41.4	17.7	8.8	7.6	18.6	17.1	7.5	8.8	21.8	11.4	28.6	21.8	10.1	15.6	15.7	27.1	16.4	28.3	17.8	20.7	20.2	21.3	16.2	8.9	15.0	4.1	8.0	11.7	10.3	13.0	19.4	13.5	25.3	14.4	7.9	18.0	10.1	12.1	16.0	10.0	15.8	7.8	13.6	26.6	12.7	20.7	20.6	14.0	16.1	15.7	10.1	16.6	10.2	10.5	4.9	14.4	21.0	20.4	21.2	9.7	32.8	24.7	25.3	9.5	31.4	20.9	18.3	12.3	37.5	9.0	12.3	13.4	14.4	10.7	29.7	22.1	5.4	34.9	13.4	6.0	10.1	10.8	24.5	11.5	19.0	15.6	12.7	16.6	10.1	12.7	9.7	22.6	16.4	15.7	25.2	15.9	15.7	14.9	15.3	27.1	14.3	10.9	11.9	15.1	17.8	28.3	18.7	20.7	20.2	8.5	9.2	12.9	11.5	8.8	4.2	11.4	8.7	8.7	8.8	8.9	18.6	37.3	23.0	44.3	24.7	1.1	40.8	4.0	9.1	7.0	9.8	63.1	36.5	40.3	10.4	15.8	75.3	23.3	56.9	74.1	22.2	38.7	27.6	48.6	53.5	31.8	44.4	16.0	37.6	22.0	18.7	27.9	18.6	55.1	53.9	19.0	40.6	63.3	16.3	27.7	26.0	19.4	22.7	13.1	13.8	55.7	86.6	44.9	49.3	30.7
RPS6KC1	humS6PKh1	ENSG00000136643	"Ribosomal protein S6 kinase C1"	Q96S38	1	213051233-213274773	"Enzymes, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Late spermatids: 33.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA026531, HPA031565"	Approved		Supported	Endosomes,Lysosomes		NA	NA			"Endosomes, Lysosomes"		"HPA026531: AB_10601497, HPA031565: AB_2673935"	"unprognostic (3.90e-2)"	"unprognostic (5.90e-2)"	"unprognostic (3.22e-1)"	"unprognostic (4.88e-2)"	"unprognostic (2.42e-1)"	"unprognostic (9.81e-2)"	"unprognostic (1.32e-2)"	"unprognostic (1.64e-1)"	"unprognostic (4.10e-2)"	"unprognostic (3.34e-1)"	"unprognostic (4.18e-1)"	"unprognostic (5.11e-2)"	"prognostic unfavorable (2.70e-4)"	"unprognostic (8.10e-2)"	"unprognostic (5.48e-2)"	"unprognostic (2.98e-2)"	"unprognostic (4.44e-2)"	12.0	14.1	15.6	10.0	19.4	6.4	17.1	13.5	19.4	14.1	13.1	12.6	8.8	9.2	15.9	8.4	10.3	11.8	11.6	9.4	17.3	15.6	9.8	10.8	13.6	7.5	17.8	16.8	14.4	13.5	19.9	16.7	12.3	15.3	17.6	10.1	7.3	8.9	17.7	14.1	6.7	8.7	18.5	22.3	11.0	12.5	26.5	13.2	6.8	10.4	6.1	7.8	14.6	16.0	2.5	8.7	13.7	6.8	4.0	3.3	2.2	7.3	6.4	10.5	11.3	10.5	15.6	9.2	9.7	14.3	15.1	17.4	5.2	8.2	4.7	6.6	14.6	9.9	6.1	12.7	7.9	11.5	9.8	4.7	12.6	7.5	7.1	9.7	7.9	15.0	10.2	6.9	13.2	7.2	12.7	12.5	4.6	16.2	7.3	15.4	4.0	3.3	2.6	15.2	6.6	7.2	3.9	9.9	4.5	6.9	7.4	6.1	15.9	10.5	8.3	13.9	18.7	11.9	3.3	11.6	10.3	9.5	11.8	6.3	4.3	8.2	3.6	4.4	3.1	10.5	13.7	4.6	3.3	2.8	6.8	2.3	2.5	2.3	2.4	8.7	1.9	1.5	3.3	0.5	4.0	6.3	1.0	1.6	2.2	15.6	19.4	13.5	19.0	17.3	15.6	17.8	16.8	15.3	13.2	8.9	4.3	1.4	2.2	2.6	17.1	8.9	7.6	4.0	4.5	0.0	13.7	2.6	0.0	4.4	25.9	6.5	4.0	0.0	6.8	3.3	6.9	4.5	7.0	8.1	6.1	19.1	3.5	10.4	8.6	33.0	10.3	9.8	6.8	6.4	3.2	6.6	5.4	2.8	7.1	4.6	18.9	12.9	5.1	13.4	17.2	3.9	3.2	5.1	3.7	2.6
RPS6KL1	MGC11287	ENSG00000198208	"Ribosomal protein S6 kinase like 1"	Q9Y6S9	14	74903954-74923396	"Enzymes, Predicted intracellular proteins"		"Kinase, Ribonucleoprotein, Ribosomal protein, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 29.1"	"Cell type enhanced"	"Detected in many"	10	"Bipolar cells: 67.9;Cone photoreceptor cells: 78.5;Horizontal cells: 38.1;Rod photoreceptor cells: 72.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	4	"memory B-cell: 2.0;naive CD4 T-cell: 1.9;naive CD8 T-cell: 2.0;plasmacytoid DC: 5.4"	"Group enriched"	"Detected in many"	26	"B-cells: 2.0;dendritic cells: 5.4;T-cells: 2.0"	"Cell line enhanced"	"Detected in many"		"HMC-1: 13.0;SCLC-21H: 24.9;SK-BR-3: 14.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027451, HPA027794"	Approved		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA027451: AB_10599304, HPA027794: AB_10602098"	"unprognostic (2.71e-2)"	"unprognostic (9.33e-3)"	"unprognostic (3.36e-1)"	"unprognostic (1.13e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.63e-2)"	"unprognostic (1.44e-2)"	"unprognostic (7.49e-4)"	"unprognostic (2.06e-1)"	"unprognostic (1.54e-1)"	"unprognostic (4.09e-3)"	"unprognostic (2.91e-1)"	"unprognostic (1.11e-1)"	"unprognostic (1.33e-2)"	"unprognostic (1.14e-1)"	"unprognostic (7.03e-2)"	"unprognostic (7.52e-2)"	4.2	7.5	14.7	2.3	13.6	4.2	5.7	18.2	29.1	2.1	4.8	9.0	2.2	3.8	5.1	8.8	5.3	2.5	3.7	10.2	14.3	13.7	2.3	2.1	2.5	2.5	11.1	15.3	1.5	6.7	4.0	10.6	1.4	8.4	2.8	5.6	5.9	3.2	5.4	12.7	1.2	2.8	6.9	8.8	1.7	2.0	11.4	6.8	0.0	3.8	1.2	2.5	1.9	0.8	2.0	5.4	0.1	0.0	0.0	2.0	0.1	2.3	0.3	1.0	3.8	0.1	0.0	4.5	0.4	0.2	1.8	0.5	5.6	1.6	0.0	3.5	0.7	0.5	0.3	1.8	0.3	2.4	0.0	0.8	1.9	0.8	4.2	4.7	2.2	13.0	0.3	3.2	2.0	0.0	0.0	5.9	0.0	2.7	0.7	0.1	7.6	0.0	0.8	0.8	0.7	3.7	1.8	0.0	7.2	1.8	0.0	24.9	3.0	0.3	14.4	2.4	2.0	1.4	1.5	4.0	0.1	0.2	3.1	0.0	10.1	5.3	5.3	1.4	0.2	0.0	0.0	0.0	0.0	0.6	0.0	0.2	2.0	0.4	0.1	0.0	0.4	1.9	2.0	0.1	0.0	0.0	5.4	0.0	0.1	14.7	13.6	18.2	18.2	14.3	13.7	11.1	15.3	8.4	6.8	0.0	0.0	0.0	1.8	0.7	67.9	5.1	0.0	5.3	0.0	3.5	78.5	1.4	1.7	1.2	6.5	2.6	2.0	0.0	5.3	1.1	1.0	1.6	0.0	2.1	3.0	38.1	6.4	1.3	0.0	5.6	2.0	1.2	3.3	0.0	1.5	4.0	3.1	1.5	2.5	0.8	72.2	6.5	2.7	22.3	15.8	1.1	1.1	1.3	2.5	1.3
RRM1		ENSG00000167325	"Ribonucleotide reductase catalytic subunit M1"	P23921	11	4094707-4138876	"Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"	"DNA replication"	"Allosteric enzyme, Oxidoreductase"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 78.6"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB022093, HPA057265, HPA064297"	Enhanced		Supported	Cytosol		NA	Yes		13000	Cytosol		"CAB022093: , HPA057265: AB_2683386, HPA064297: AB_2685236"	"unprognostic (4.47e-2)"	"unprognostic (1.73e-2)"	"unprognostic (1.99e-3)"	"unprognostic (3.65e-1)"	"unprognostic (2.83e-1)"	"unprognostic (2.19e-1)"	"prognostic unfavorable (1.53e-4)"	"unprognostic (1.31e-2)"	"unprognostic (3.43e-2)"	"unprognostic (6.90e-2)"	"unprognostic (1.06e-3)"	"unprognostic (4.21e-2)"	"unprognostic (6.88e-3)"	"unprognostic (9.20e-3)"	"unprognostic (6.16e-2)"	"unprognostic (8.41e-2)"	"unprognostic (9.93e-3)"	13.9	25.3	8.0	15.2	12.2	18.5	14.4	18.0	12.6	15.7	15.9	11.1	11.5	11.9	13.0	9.8	25.4	10.7	8.7	11.9	7.9	9.0	9.2	13.1	11.0	20.2	9.0	10.3	13.6	10.7	24.2	11.2	22.7	18.4	14.0	18.9	12.0	15.4	10.7	28.3	26.8	12.5	17.5	10.7	12.4	13.8	10.5	9.1	78.6	9.8	28.0	27.1	17.5	18.5	5.6	4.3	3.3	8.3	5.7	24.3	6.0	46.1	25.1	41.1	23.9	6.3	12.6	16.0	42.5	21.1	48.4	50.0	22.5	35.1	50.0	10.3	21.2	21.0	37.1	38.1	30.6	57.3	24.5	40.4	25.4	37.6	17.5	2.5	43.4	18.6	5.9	8.3	26.5	19.1	10.6	23.2	30.2	33.1	23.6	40.3	20.9	51.1	9.4	26.0	32.1	25.5	41.4	32.1	17.8	13.3	13.1	35.2	19.3	37.4	22.6	6.8	17.3	22.3	15.2	13.2	45.5	23.8	45.1	31.2	15.5	21.4	54.6	25.3	29.1	28.2	3.3	2.5	2.6	7.7	6.5	13.3	5.6	14.2	10.7	4.3	3.5	11.3	9.2	0.0	5.7	8.3	2.7	24.3	6.0	8.0	12.2	18.0	12.6	7.9	9.0	9.0	10.3	18.4	9.1	17.9	11.8	16.4	16.8	29.8	14.7	30.7	17.8	17.4	21.6	17.4	5.9	33.4	6.6	22.3	59.0	10.8	9.7	70.0	19.4	48.6	21.4	12.0	6.9	14.8	24.3	17.5	17.3	11.6	8.6	43.8	12.0	10.6	10.1	9.0	17.5	21.8	14.0	11.8	15.6	6.3	20.0	12.9	21.5	60.8	31.3	25.3	33.2	15.8	24.7	13.6
RRM2		ENSG00000171848	"Ribonucleotide reductase regulatory subunit M2"	P31350	2	10120698-10131419	"Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"DNA replication"	Oxidoreductase	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"lymphoid tissue: 120.9"	"Cell type enhanced"	"Detected in many"	19	"Erythroid cells: 93.5;Extravillous trophoblasts: 192.1;Spermatogonia: 44.5"	"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in many"		"T-reg: 10.4"	"Lineage enriched"	"Detected in many"	6	"T-cells: 10.4"	"Low cell line specificity"	"Detected in many"											HPA056994	Enhanced		Supported	Cytosol		Yes	Yes			Cytosol		"HPA056994: AB_2683304"	"unprognostic (2.10e-2)"	"unprognostic (1.62e-1)"	"unprognostic (6.40e-3)"	"unprognostic (4.42e-3)"	"unprognostic (5.70e-2)"	"unprognostic (1.69e-1)"	"prognostic unfavorable (1.39e-5)"	"unprognostic (1.04e-3)"	"unprognostic (6.67e-3)"	"unprognostic (4.53e-2)"	"prognostic unfavorable (1.62e-4)"	"unprognostic (5.11e-3)"	"prognostic unfavorable (0.00e+0)"	"unprognostic (3.05e-2)"	"unprognostic (2.24e-1)"	"unprognostic (1.38e-1)"	"unprognostic (2.09e-2)"	4.7	2.2	0.4	32.6	0.4	29.0	4.2	0.4	0.9	3.5	9.3	0.4	0.4	5.2	2.1	1.7	21.6	0.7	5.0	3.3	0.4	0.5	2.0	3.9	5.7	16.4	0.6	0.1	0.9	2.9	0.0	0.7	5.4	0.3	1.0	10.6	0.1	2.9	0.0	0.5	2.8	11.3	3.2	0.8	19.8	5.4	8.0	0.0	120.9	0.8	22.3	33.1	3.8	5.2	1.4	0.3	0.6	0.2	1.8	10.4	2.6	29.5	17.9	25.4	17.4	2.2	4.1	25.1	48.3	24.0	34.5	37.6	29.9	14.1	27.1	6.7	15.1	35.0	14.5	41.0	24.9	42.3	60.8	15.8	52.3	17.2	26.3	0.1	38.7	25.1	1.5	0.5	42.2	3.6	5.7	27.9	21.0	21.9	80.5	42.9	22.3	42.7	20.8	20.5	30.4	21.0	32.2	55.4	18.6	17.0	22.5	25.1	20.7	39.7	28.2	4.9	11.0	15.2	6.9	9.7	26.5	38.5	19.8	67.7	52.3	41.0	55.4	18.8	32.9	38.0	0.3	0.1	0.1	3.7	0.0	0.0	1.4	2.6	2.9	0.2	0.4	0.2	1.2	0.6	1.8	0.2	0.3	10.4	2.6	0.4	0.4	0.4	0.9	0.4	0.5	0.6	0.1	0.3	0.0	3.0	1.0	2.2	1.0	9.3	0.0	1.2	2.5	5.3	1.2	0.0	0.0	5.4	1.7	0.5	3.0	0.3	2.6	93.5	0.0	192.1	3.6	1.1	5.7	1.7	40.1	0.0	0.0	5.5	5.9	5.7	0.3	3.5	0.0	0.0	7.9	0.0	0.5	0.0	0.4	1.6	0.0	0.0	0.3	5.2	44.5	1.4	40.7	7.2	13.0	2.0
RRM2B	p53R2	ENSG00000048392	"Ribonucleotide reductase regulatory TP53 inducible subunit M2B"	Q7LG56	8	102204502-102239118	"Disease related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"DNA damage, DNA repair, DNA replication"	Oxidoreductase	"Disease mutation, FDA approved drug targets, Neuropathy, Primary mitochondrial disease, Progressive external ophthalmoplegia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB006854, HPA028812"	Approved		Enhanced	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"CAB006854: , HPA028812: AB_10602246"	"unprognostic (7.76e-3)"	"unprognostic (4.14e-2)"	"unprognostic (9.41e-3)"	"unprognostic (3.41e-1)"	"unprognostic (1.13e-2)"	"unprognostic (1.28e-1)"	"unprognostic (5.51e-2)"	"unprognostic (1.35e-2)"	"unprognostic (1.66e-1)"	"unprognostic (9.40e-2)"	"unprognostic (1.74e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.70e-2)"	"unprognostic (4.32e-1)"	"unprognostic (1.47e-1)"	"unprognostic (2.52e-1)"	"unprognostic (7.17e-2)"	11.8	18.6	11.7	11.5	11.4	4.3	9.3	8.5	13.5	9.5	10.1	9.8	9.5	10.2	8.2	10.8	8.0	9.7	8.2	11.3	17.5	12.8	17.5	15.1	15.8	12.6	14.9	10.6	9.7	9.5	34.7	24.8	11.6	23.1	11.2	11.1	7.7	9.7	10.9	34.6	7.4	7.6	8.2	26.1	10.6	7.1	6.6	9.4	6.3	37.1	8.1	13.1	10.7	7.0	7.4	6.2	18.3	8.4	3.0	3.3	2.8	5.6	10.0	11.9	7.0	16.8	16.2	9.4	13.0	15.8	7.0	8.2	3.5	4.5	35.8	12.3	14.3	7.1	2.1	5.7	13.2	9.9	5.8	6.2	9.0	4.2	7.5	13.6	2.7	19.2	20.5	24.9	7.7	11.8	16.7	19.6	6.2	6.6	5.5	22.4	5.5	4.7	5.2	6.6	6.1	7.4	3.0	4.8	7.2	16.3	6.4	3.0	5.9	6.8	3.6	7.7	31.0	9.7	6.2	14.9	10.9	21.1	7.5	3.5	5.8	5.3	32.6	16.0	4.2	11.5	10.0	5.1	5.3	2.2	4.5	3.3	5.6	2.0	2.8	6.2	7.4	2.3	2.5	18.3	3.0	8.4	1.8	1.4	2.8	11.7	11.4	8.5	13.5	17.5	12.8	14.9	10.6	23.1	9.4	53.6	24.0	7.2	8.1	17.2	13.1	17.9	20.4	38.8	25.0	38.4	13.7	11.2	21.6	6.2	1.6	16.4	6.4	0.0	7.0	4.9	10.4	10.8	10.5	20.3	11.1	9.5	28.3	18.4	21.8	1.1	13.3	17.8	16.9	7.2	10.3	23.6	5.5	7.0	13.8	18.1	14.7	6.5	10.8	8.2	10.0	16.2	4.0	12.8	11.7	5.4
RTCA	"RPC, RTC1, RTCD1"	ENSG00000137996	"RNA 3'-terminal phosphate cyclase"	O00442	1	100266207-100292769	"Enzymes, Predicted intracellular proteins"		Ligase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027982, HPA027990, HPA028151, HPA028331"	Uncertain		Enhanced	Nucleoplasm		NA	NA		8700	Nucleoplasm		"HPA027982: AB_10601769, HPA027990: AB_2672452, HPA028151: AB_10602099, HPA028331: "	"unprognostic (4.79e-2)"	"unprognostic (1.17e-2)"	"unprognostic (3.97e-2)"	"unprognostic (3.82e-2)"	"unprognostic (6.76e-2)"	"unprognostic (4.12e-2)"	"prognostic unfavorable (2.76e-5)"	"unprognostic (9.55e-3)"	"unprognostic (3.64e-2)"	"unprognostic (1.12e-2)"	"unprognostic (2.46e-1)"	"unprognostic (8.09e-3)"	"unprognostic (3.74e-3)"	"unprognostic (2.10e-2)"	"unprognostic (1.44e-1)"	"unprognostic (3.59e-1)"	"unprognostic (2.94e-2)"	20.9	25.0	19.4	17.8	24.9	25.5	20.0	22.6	31.7	14.7	22.9	20.3	19.9	31.7	14.2	26.0	27.0	13.4	19.9	25.5	20.0	21.0	31.7	23.0	16.1	21.8	21.5	20.7	13.3	27.7	21.1	17.2	21.2	33.1	20.9	22.2	14.1	18.5	17.4	35.4	14.6	37.8	15.4	20.5	24.2	21.8	12.2	12.4	25.0	18.3	20.2	20.8	18.7	17.5	9.6	8.0	8.2	19.6	11.0	20.1	7.7	22.0	11.4	11.3	15.2	14.3	23.3	30.9	26.2	12.8	17.1	14.8	18.6	11.1	22.6	19.9	16.6	21.1	11.2	13.8	12.4	20.7	22.6	11.5	14.9	13.0	23.4	22.1	27.1	23.6	18.9	19.6	22.3	29.9	17.0	21.2	16.5	25.6	34.5	25.8	7.3	13.9	21.1	17.3	15.7	22.1	10.0	20.2	9.9	21.0	18.1	9.1	11.4	16.9	24.5	35.8	18.5	5.3	34.8	18.4	16.2	11.3	25.2	31.4	20.0	20.1	18.1	34.0	23.6	9.6	8.2	9.1	7.5	10.8	11.3	13.8	9.6	10.0	12.8	8.0	7.1	9.3	10.5	4.4	11.0	19.6	7.6	20.1	7.7	19.4	24.9	22.6	31.7	20.0	21.0	21.5	20.7	33.1	12.4	6.0	14.4	26.1	13.0	12.0	22.2	49.6	7.6	13.4	10.3	17.4	11.8	48.9	21.6	37.0	11.5	17.5	35.4	0.0	30.2	65.3	13.9	14.2	12.7	15.3	69.5	20.6	18.5	22.7	41.9	6.4	17.8	28.9	15.1	50.5	26.6	20.6	46.7	37.1	12.0	49.6	26.8	6.5	12.3	27.2	14.7	12.8	38.8	32.0	29.7	15.7
RTCB	"C22orf28, FAAP, HSPC117"	ENSG00000100220	"RNA 2',3'-cyclic phosphate and 5'-OH ligase"	Q9Y3I0	22	32387582-32412255	"Enzymes, Predicted intracellular proteins"	"tRNA processing"	Ligase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000535, HPA001103"	Supported		Supported	Nucleoplasm,Vesicles,Cytosol		NA	NA		43000	Nucleoplasm	"Vesicles, Cytosol"	"HPA000535: AB_2666021, HPA001103: AB_1078351"	"unprognostic (1.84e-1)"	"unprognostic (6.48e-2)"	"unprognostic (1.07e-2)"	"unprognostic (2.71e-3)"	"unprognostic (7.21e-3)"	"unprognostic (1.43e-2)"	"unprognostic (1.75e-3)"	"unprognostic (1.49e-1)"	"unprognostic (3.01e-1)"	"unprognostic (1.52e-1)"	"unprognostic (2.40e-2)"	"unprognostic (5.07e-2)"	"prognostic favorable (4.25e-5)"	"unprognostic (6.91e-2)"	"unprognostic (5.35e-2)"	"unprognostic (2.05e-1)"	"unprognostic (1.55e-1)"	26.4	30.1	20.1	20.4	29.7	15.1	29.2	22.9	34.5	25.7	35.6	35.2	32.7	51.6	29.7	25.8	30.8	26.9	22.9	26.4	19.6	24.6	42.4	55.1	23.1	22.7	29.1	26.2	29.0	29.4	38.4	29.9	33.7	36.7	27.0	42.3	27.1	29.9	28.6	40.9	46.6	61.7	31.8	24.4	29.3	29.7	30.8	25.5	32.0	32.7	30.1	46.6	26.5	24.2	44.6	51.5	29.0	47.7	37.0	40.5	44.0	32.2	29.0	36.4	27.3	31.9	23.8	29.0	28.3	34.1	45.3	43.1	37.6	13.2	8.0	19.0	33.0	27.9	22.0	41.6	41.1	58.7	40.4	41.8	22.8	24.6	34.1	22.0	53.3	20.9	23.4	27.3	44.8	43.6	25.0	40.7	22.6	27.0	22.8	33.0	26.9	22.6	18.5	20.8	37.5	26.6	35.2	39.3	41.2	31.1	28.1	37.6	20.8	30.7	19.9	35.9	40.0	21.8	20.7	30.6	25.0	36.9	21.7	27.1	15.9	12.7	28.9	25.9	24.2	32.6	29.0	43.5	27.4	31.7	47.7	35.5	44.6	33.3	33.0	51.5	43.6	39.9	34.6	4.3	37.0	35.5	28.9	40.5	44.0	20.1	29.7	22.9	34.5	19.6	24.6	29.1	26.2	36.7	25.5	29.8	30.2	40.2	48.9	53.8	50.9	32.3	48.4	37.5	22.7	33.2	19.6	98.9	56.3	89.0	3.8	37.9	93.2	0.0	84.1	74.7	40.4	51.2	42.6	54.7	75.2	49.3	44.9	35.0	41.7	7.0	32.5	40.0	28.7	107.4	50.3	61.1	82.4	59.7	44.9	108.7	48.0	25.8	37.2	57.2	58.8	66.5	81.8	30.9	51.3	61.4
RTEL1	"bK3184A7.3, C20orf41, DKFZP434C013, KIAA1088, NHL, RTEL"	ENSG00000258366	"Regulator of telomere elongation helicase 1"	Q9NZ71	20	63657810-63696253	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"DNA damage, DNA repair"	"DNA-binding, Helicase, Hydrolase"	"Disease mutation, Dyskeratosis congenita"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"											"HPA020622, HPA067329, HPA078328"			Approved	"Nuclear speckles,Nuclear bodies"		NA	NA			"Nuclear speckles, Nuclear bodies"		"HPA020622: AB_2732425, HPA067329: AB_2685823, HPA078328: AB_2732380"	"unprognostic (3.63e-2)"	"unprognostic (8.08e-3)"	"unprognostic (4.80e-2)"	"unprognostic (1.12e-1)"	"unprognostic (4.27e-1)"	"unprognostic (9.30e-3)"	"unprognostic (2.59e-1)"	"unprognostic (3.64e-2)"	"unprognostic (3.30e-2)"	"unprognostic (9.05e-2)"	"unprognostic (4.09e-2)"	"unprognostic (9.50e-2)"	"unprognostic (8.77e-3)"	"unprognostic (1.17e-1)"	"unprognostic (2.55e-1)"	"unprognostic (2.80e-2)"	"unprognostic (8.84e-2)"	8.4	14.3	9.4	11.5	12.4	14.2	7.9	25.6	11.8	9.1	11.1	11.2	10.9	9.8	15.4	7.4	7.0	9.5	9.3	6.2	8.0	6.9	7.1	7.2	8.9	7.8	7.5	12.1	10.6	17.8	7.2	18.2	9.8	8.2	10.2	4.8	10.2	12.9	10.2	10.2	8.2	10.1	8.8	4.4	11.6	10.4	17.6	8.9	9.1	11.9	4.9	9.5	9.3	9.0	1.7	3.6	0.0	3.3	0.4	3.0	2.4	5.3	7.3	5.2	10.1	1.1	1.2	9.7	11.0	2.9	17.2	4.5	14.5	4.5	7.1	5.7	3.3	6.5	9.9	3.6	7.2	4.1	3.5	7.3	8.8	12.6	13.8	3.8	8.6	16.1	1.5	4.0	4.2	5.3	3.3	5.8	12.7	10.8	6.8	3.8	5.7	13.3	11.1	5.1	4.5	15.3	10.7	4.9	7.3	2.8	6.5	10.4	6.3	6.1	18.0	1.4	2.5	4.7	9.7	7.7	19.5	6.4	6.7	8.4	6.3	2.6	4.5	4.7	6.1	6.7	0.0	2.7	0.0	3.0	3.3	1.6	0.9	1.7	2.0	3.6	1.7	2.9	1.1	0.0	0.4	2.6	3.2	1.4	2.4	9.4	12.4	25.6	11.8	8.0	6.9	7.5	12.1	8.2	8.9	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.3	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0
RUVBL1	"ECP54, INO80H, NMP238, Pontin52, RVB1, TIH1, TIP49, TIP49a"	ENSG00000175792	"RuvB like AAA ATPase 1"	Q9Y265	3	128064778-128153914	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, DNA damage, DNA recombination, DNA repair, Growth regulation, Mitosis, Transcription, Transcription regulation"	"Activator, Chromatin regulator, Helicase, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	8	"Ciliated cells: 208.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019947, HPA019948"	Enhanced		Supported	Nucleoplasm,Cytosol		NA	NA		47000	"Nucleoplasm, Cytosol"		"HPA019947: AB_1856516, HPA019948: AB_1856514"	"unprognostic (7.40e-2)"	"unprognostic (2.17e-1)"	"unprognostic (1.28e-1)"	"unprognostic (4.73e-2)"	"unprognostic (3.55e-1)"	"unprognostic (2.66e-2)"	"prognostic unfavorable (1.21e-8)"	"unprognostic (2.43e-2)"	"unprognostic (3.31e-2)"	"unprognostic (1.39e-1)"	"unprognostic (2.25e-2)"	"unprognostic (7.39e-2)"	"unprognostic (2.98e-2)"	"unprognostic (1.73e-1)"	"unprognostic (1.51e-1)"	"unprognostic (1.61e-1)"	"unprognostic (9.27e-2)"	17.6	15.1	10.7	15.8	14.2	11.9	13.9	7.9	14.0	12.5	11.6	12.9	14.3	8.4	19.2	11.4	19.2	37.3	11.3	18.6	11.4	13.6	20.9	13.7	12.9	18.7	10.0	9.8	15.4	13.6	26.5	14.2	19.9	13.0	12.0	14.1	11.5	10.2	12.0	12.9	11.8	10.2	16.1	8.8	21.9	10.9	44.7	10.3	33.4	15.2	18.1	23.9	12.6	15.0	10.6	8.7	1.5	7.9	10.9	20.2	7.2	26.9	24.5	15.1	24.5	11.8	11.5	19.7	13.2	11.4	25.5	17.6	25.6	16.1	38.3	13.2	12.6	19.7	21.5	40.1	28.1	29.8	15.6	19.7	31.8	14.2	17.1	12.2	29.7	10.2	11.7	14.8	21.4	27.6	9.7	17.1	14.6	26.0	9.0	14.5	38.4	31.8	22.5	37.9	30.5	21.0	26.2	18.3	26.6	15.3	10.2	25.3	22.7	14.6	12.1	20.2	14.6	22.0	22.0	11.0	11.6	14.2	17.4	20.0	9.2	14.6	37.6	14.3	18.3	14.5	0.8	4.8	1.5	11.3	7.9	14.6	10.6	13.6	14.0	7.7	10.2	11.5	12.8	0.2	10.9	7.4	8.7	20.2	7.2	10.7	14.2	7.9	14.0	11.4	13.6	10.0	9.8	13.0	10.3	20.8	11.7	25.1	16.5	17.7	16.3	18.7	22.9	208.8	31.8	21.0	2.0	45.7	39.7	29.2	14.5	21.2	2.9	0.0	26.3	53.6	20.6	11.7	25.4	13.2	26.2	22.3	16.3	11.1	5.6	19.6	14.1	10.5	10.1	12.6	12.4	26.0	22.8	14.0	17.3	41.5	16.2	12.9	13.3	96.8	64.3	14.8	20.1	24.9	23.0	11.9
RUVBL2	"ECP51, INO80J, Reptin52, RVB2, TIH2, TIP48, TIP49b"	ENSG00000183207	"RuvB like AAA ATPase 2"	Q9Y230	19	48993448-49015995	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"DNA damage, DNA recombination, DNA repair, Growth regulation, Transcription, Transcription regulation"	"Activator, Chromatin regulator, Helicase, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 59.0"	"Group enriched"	"Detected in all"	4	"Ciliated cells: 184.7;Early spermatids: 493.7;Late spermatids: 663.3;Spermatocytes: 292.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB012432, HPA042880, HPA067966"	Enhanced		Supported	Nucleoplasm,Centrosome,Cytosol		NA	NA			"Nucleoplasm, Cytosol"	Centrosome	"CAB012432: , HPA042880: AB_2678210, HPA067966: AB_2685933"	"unprognostic (1.71e-1)"	"unprognostic (9.06e-3)"	"unprognostic (3.51e-1)"	"unprognostic (3.93e-2)"	"unprognostic (1.19e-1)"	"unprognostic (2.47e-2)"	"prognostic unfavorable (9.28e-4)"	"unprognostic (7.06e-3)"	"unprognostic (6.25e-2)"	"unprognostic (3.28e-1)"	"unprognostic (8.13e-2)"	"unprognostic (7.58e-2)"	"unprognostic (2.81e-2)"	"unprognostic (2.21e-2)"	"unprognostic (7.61e-3)"	"unprognostic (1.61e-1)"	"unprognostic (2.58e-1)"	6.9	5.3	6.7	7.5	7.1	13.4	4.8	8.2	10.4	4.8	9.9	7.6	6.3	11.2	8.3	5.5	16.1	5.5	7.2	9.1	6.9	6.0	7.6	10.3	5.5	8.2	7.7	8.1	6.5	8.7	1.6	6.4	5.5	6.7	6.0	3.2	6.5	10.0	6.6	27.8	7.7	10.0	3.7	7.1	6.9	10.7	59.0	5.8	14.6	8.8	9.4	8.1	6.4	12.9	12.6	16.4	5.6	14.3	11.0	12.5	15.2	28.9	29.8	3.5	20.0	1.5	2.7	9.4	15.7	6.8	18.0	11.8	15.4	12.6	27.2	12.1	3.1	5.1	15.4	2.2	10.3	2.1	16.5	12.2	17.7	9.0	7.8	5.0	34.8	12.4	3.1	2.1	4.0	2.1	3.3	6.6	23.0	30.7	11.6	1.6	5.9	30.7	4.1	10.8	6.0	4.4	25.5	16.1	17.5	3.2	11.2	14.3	20.6	15.8	13.2	5.6	1.1	11.6	13.4	9.7	11.4	16.8	7.5	38.7	23.5	26.8	28.1	8.4	17.1	16.3	5.6	14.3	4.2	11.1	11.1	11.2	10.9	11.1	9.1	16.4	12.6	12.2	8.0	1.0	11.0	10.8	12.5	12.5	15.2	6.7	7.1	8.2	10.4	6.9	6.0	7.7	8.1	6.7	5.8	11.9	20.2	23.7	40.9	24.6	15.0	38.6	28.1	184.7	36.4	31.4	31.4	91.2	39.7	59.0	493.7	24.1	23.6	23.3	61.9	63.4	32.5	34.0	12.7	31.1	44.6	17.5	16.8	27.6	18.3	663.3	33.4	26.7	25.3	43.3	33.6	23.6	48.7	31.6	40.3	61.6	24.1	19.4	37.1	292.2	46.3	24.1	96.9	25.3	49.4	33.5
SARDH	"DMGDHL1, SDH"	ENSG00000123453	"Sarcosine dehydrogenase"	Q9UL12	9	133663560-133739955	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		Oxidoreductase	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"epididymis: 25.3;liver: 52.8;pancreas: 39.4"	"Cell type enriched"	"Detected in some"	6	"Hepatocytes: 94.3"	"Cancer enriched"	"Detected in many"	8	"liver cancer: 18.7"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"memory CD4 T-cell: 4.1;naive CD4 T-cell: 8.4;T-reg: 9.7"	"Lineage enriched"	"Detected in single"	15	"T-cells: 9.7"	"Cell line enhanced"	"Detected in many"		"AN3-CA: 11.1;Hep G2: 18.7;JURKAT: 8.3;MOLT-4: 13.5;RH-30: 11.6;RPMI-8226: 23.4;SH-SY5Y: 9.3"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"HPA057267, HPA058086"	Approved		Approved	Mitochondria		NA	NA		190000	Mitochondria		"HPA057267: AB_2683388, HPA058086: AB_2683601"	"unprognostic (3.64e-2)"	"unprognostic (4.87e-2)"	"unprognostic (2.31e-2)"	"unprognostic (1.38e-1)"	"prognostic unfavorable (4.62e-4)"	"unprognostic (5.83e-2)"	"unprognostic (1.42e-3)"	"unprognostic (2.21e-1)"	"unprognostic (1.58e-1)"	"unprognostic (1.43e-1)"	"unprognostic (2.23e-1)"	"unprognostic (1.74e-1)"	"unprognostic (7.74e-3)"	"unprognostic (2.78e-1)"	"unprognostic (3.48e-1)"	"unprognostic (9.73e-2)"	"unprognostic (1.30e-2)"	0.5	1.1	1.7	1.0	1.8	0.3	0.4	0.8	1.9	0.9	0.5	1.1	2.9	0.8	1.4	25.3	0.3	0.9	1.2	1.1	1.1	1.4	5.8	52.8	1.3	1.7	1.2	2.1	3.4	39.4	2.0	1.9	0.3	1.2	1.4	0.1	3.7	8.2	0.9	0.3	0.2	0.6	0.6	0.6	0.7	1.2	1.1	0.8	2.2	0.8	0.2	1.2	0.6	0.6	0.4	0.3	0.6	0.1	0.1	9.7	1.6	0.0	0.1	0.9	11.1	0.0	0.3	1.5	0.1	0.4	0.5	0.7	0.2	0.1	0.0	1.5	0.2	1.4	0.0	0.0	0.2	0.4	0.0	0.2	1.5	0.0	18.7	1.2	0.0	0.2	2.6	0.0	1.3	0.0	0.3	0.1	8.3	0.0	0.2	7.0	1.9	13.5	1.4	1.7	1.0	0.1	0.9	11.6	23.4	0.0	0.1	1.0	9.3	0.0	0.3	2.3	0.5	1.5	0.1	0.0	2.1	2.0	0.2	0.0	0.1	0.0	0.8	1.3	0.8	0.0	0.1	0.1	0.1	0.4	0.0	1.0	0.0	4.1	1.0	0.0	0.4	8.4	1.5	0.6	0.1	0.0	0.3	9.7	1.6	1.7	1.8	0.8	1.9	1.1	1.4	1.2	2.1	1.2	0.8	0.0	3.4	0.0	0.3	0.2	0.0	0.6	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.9	0.1	1.0	0.2	1.1	94.3	0.1	0.0	1.2	2.5	2.4	0.2	4.4	0.2	0.0	0.0	0.0	2.1	0.2	0.0	2.8	14.7	0.2	0.0	1.0	0.1	0.9	0.1	0.0	2.9	0.0	0.1
SARS	SERS	ENSG00000031698	"Seryl-tRNA synthetase"	P49591	1	109213918-109238169	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Protein biosynthesis, Transcription, Transcription regulation"	"Aminoacyl-tRNA synthetase, DNA-binding, Ligase"	"Disease mutation, Epilepsy, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA016939, HPA064668"	Uncertain		Enhanced	Cytosol		NA	NA		100000	Cytosol		"HPA016939: AB_1856585, HPA064668: AB_2685316"	"unprognostic (4.92e-2)"	"unprognostic (2.61e-1)"	"unprognostic (5.87e-2)"	"unprognostic (6.78e-2)"	"prognostic favorable (9.47e-4)"	"prognostic unfavorable (5.75e-4)"	"prognostic unfavorable (6.13e-5)"	"unprognostic (3.02e-1)"	"unprognostic (1.77e-1)"	"unprognostic (2.68e-2)"	"unprognostic (3.23e-1)"	"unprognostic (2.06e-1)"	"unprognostic (1.69e-1)"	"unprognostic (1.71e-1)"	"unprognostic (1.56e-1)"	"unprognostic (3.85e-2)"	"unprognostic (3.45e-3)"	35.8	42.6	46.1	28.2	45.9	16.3	38.3	42.6	60.6	40.1	37.6	31.2	30.9	33.5	39.4	36.0	42.0	39.6	28.7	43.9	55.9	47.3	37.6	58.6	44.5	28.8	46.4	56.0	44.4	68.7	55.3	40.1	44.9	64.1	34.3	41.0	22.0	54.2	42.3	72.3	46.1	31.1	42.9	41.0	29.4	46.0	20.9	35.0	25.3	75.0	32.9	38.7	41.8	60.4	54.3	45.9	48.6	48.3	41.0	66.1	88.9	33.3	13.1	25.2	37.9	37.9	34.4	43.4	35.1	36.4	30.5	38.1	25.3	10.3	36.0	18.2	49.4	17.0	18.3	39.2	49.6	35.5	25.4	23.9	13.9	16.2	18.3	76.2	17.5	15.7	42.3	86.8	35.9	78.3	26.0	36.3	45.5	31.8	45.1	29.6	31.9	19.4	8.9	10.5	20.0	31.0	16.1	32.2	16.1	23.2	17.7	35.0	18.6	16.8	27.1	95.1	20.0	15.3	20.9	28.6	18.2	22.9	25.8	24.5	34.4	13.9	29.5	57.4	19.3	61.8	35.6	44.5	48.6	56.0	48.2	58.4	54.3	59.3	55.4	45.9	52.5	61.8	57.7	21.3	41.0	48.3	29.6	66.1	88.9	46.1	45.9	42.6	60.6	55.9	47.3	46.4	56.0	64.1	35.0	47.6	92.0	61.1	90.9	109.9	51.2	87.9	81.5	66.9	81.9	68.0	21.6	157.2	112.7	120.1	15.1	64.7	75.8	70.0	195.0	122.6	80.4	56.7	96.0	112.9	78.0	55.6	66.7	63.8	59.4	21.0	73.1	68.8	60.8	110.0	61.3	56.1	142.9	49.1	65.4	85.4	34.4	129.4	118.7	46.1	22.4	95.2	157.6	64.0	84.6	77.6
SARS2	"FLJ20450, mtSerRS, SARS, SARSM, SerRSmt, SERS, SYS"	ENSG00000104835	"Seryl-tRNA synthetase 2, mitochondrial"	Q9NP81	19	38915266-38930896	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Protein biosynthesis"	"Aminoacyl-tRNA synthetase, Ligase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Cytotrophoblasts: 34.4;Late spermatids: 42.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"											"HPA052730, HPA056957"	Approved		Uncertain	Nucleoplasm,Vesicles,Mitochondria		NA	NA			"Nucleoplasm, Mitochondria"	Vesicles	"HPA052730: AB_2681929, HPA056957: AB_2683286"	"unprognostic (3.20e-3)"	"unprognostic (1.17e-1)"	"unprognostic (1.38e-1)"	"unprognostic (3.53e-3)"	"unprognostic (1.08e-1)"	"unprognostic (1.88e-3)"	"unprognostic (4.38e-3)"	"unprognostic (1.22e-1)"	"unprognostic (2.57e-2)"	"unprognostic (8.62e-3)"	"unprognostic (8.36e-2)"	"unprognostic (1.67e-1)"	"unprognostic (5.62e-3)"	"unprognostic (2.50e-2)"	"unprognostic (1.82e-1)"	"unprognostic (9.24e-2)"	"unprognostic (2.69e-2)"	5.8	16.5	9.9	7.2	12.8	11.1	7.4	10.7	20.4	8.0	9.2	11.3	11.4	12.3	9.0	9.4	12.9	11.5	8.2	12.3	8.3	8.6	13.4	20.6	6.3	11.0	10.9	7.8	9.5	14.4	11.2	11.4	10.7	15.0	11.0	8.5	11.8	13.6	9.9	15.5	15.6	9.9	8.1	7.2	11.3	11.1	8.8	11.5	11.4	13.8	9.5	12.6	11.0	8.3	6.3	12.7	0.4	7.2	6.5	8.0	4.3	5.7	17.4	7.0	4.1	2.9	6.0	9.6	4.0	5.5	9.5	7.5	14.2	7.1	6.5	5.8	5.7	3.8	5.4	7.3	11.4	2.4	5.5	9.4	12.9	7.5	12.2	6.9	11.0	12.9	9.1	6.2	6.2	4.3	4.7	6.7	10.5	11.1	6.4	4.8	12.2	8.3	10.0	7.1	9.0	3.5	12.0	6.3	7.1	10.1	13.9	12.0	7.6	5.4	14.5	3.6	2.7	7.4	7.4	4.3	5.9	6.8	4.6	3.9	4.7	2.7	5.1	3.8	7.7	4.9	0.0	4.1	0.4	8.0	7.2	6.4	6.3	5.9	8.0	12.7	5.7	4.3	4.9	0.3	6.5	6.4	5.0	6.6	4.3	9.9	12.8	10.7	20.4	8.3	8.6	10.9	7.8	15.0	11.5	6.0	6.4	9.5	3.4	3.8	7.2	8.1	10.2	4.0	4.5	5.2	7.9	34.4	13.3	13.2	10.2	3.2	5.1	0.0	11.2	19.0	5.1	2.3	5.7	8.1	11.2	4.8	10.9	6.2	6.2	42.6	4.4	3.5	3.3	6.4	7.1	2.9	7.8	3.5	4.6	5.6	13.4	0.0	2.1	1.5	7.2	3.6	24.4	6.9	16.6	2.6
SAT1	"SAT, SSAT"	ENSG00000130066	"Spermidine/spermine N1-acetyltransferase 1"	P21673	X	23783173-23786226	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	6	"monocytes: 7874.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"neutrophil: 206.1"	"Group enriched"	"Detected in all"	9	"granulocytes: 206.1;monocytes: 136.4"	"Cell line enhanced"	"Detected in all"		"HBEC3-KT: 71.7;hTERT-HME1: 110.3;RPTEC TERT1: 91.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB047343, HPA055312, CAB069914"	Supported					NA	NA					"CAB047343: , CAB069914: AB_830224, HPA055312: AB_2682781"	"unprognostic (4.19e-2)"	"unprognostic (3.92e-2)"	"unprognostic (6.41e-2)"	"prognostic favorable (2.87e-4)"	"unprognostic (8.58e-2)"	"unprognostic (7.90e-3)"	"unprognostic (8.52e-3)"	"unprognostic (2.22e-2)"	"unprognostic (2.81e-1)"	"unprognostic (1.18e-1)"	"unprognostic (8.38e-3)"	"unprognostic (2.23e-1)"	"unprognostic (7.58e-2)"	"unprognostic (5.13e-2)"	"unprognostic (1.61e-1)"	"unprognostic (9.97e-3)"	"unprognostic (1.65e-1)"	93.5	40.5	34.2	73.0	60.5	177.2	57.2	14.2	38.9	49.2	56.5	24.6	143.2	82.2	43.9	51.9	56.9	36.8	80.6	81.5	53.7	27.7	79.2	116.1	163.6	67.3	31.9	22.2	26.5	32.3	19.3	74.4	185.7	100.2	51.0	49.9	39.3	110.6	173.3	14.4	25.4	65.5	23.5	100.8	108.6	64.5	25.6	27.1	23.0	102.7	41.1	60.6	52.4	29.6	7.3	19.0	206.1	136.4	1.8	13.2	34.6	7.8	15.9	4.0	6.3	34.7	14.2	11.1	11.6	19.5	2.9	6.7	7.5	23.4	13.1	21.3	2.7	23.0	12.0	2.1	71.7	10.5	4.3	9.7	6.3	6.9	63.8	44.6	6.1	6.1	29.3	54.8	22.4	110.3	26.4	23.8	2.1	2.6	11.6	8.3	7.5	4.4	27.8	2.7	58.2	7.4	3.8	2.6	15.7	91.8	16.2	1.1	1.2	11.8	27.0	22.9	31.0	4.1	1.3	8.9	23.6	1.1	14.1	5.7	4.9	1.1	2.9	14.0	3.6	4.4	25.8	42.0	26.9	4.1	110.5	2.6	7.3	4.9	3.3	19.0	4.7	2.9	3.3	206.1	1.8	136.4	9.4	13.2	34.6	34.2	60.5	14.2	38.9	53.7	27.7	31.9	22.2	100.2	27.1	681.9	1577.9	669.2	3441.7	2163.0	54.6	354.3	471.3	1632.8	1773.2	786.9	110.0	750.1	1008.0	3727.8	14.4	551.6	1333.1	116.8	2669.2	833.7	892.9	4814.5	834.3	777.3	2012.7	68.3	506.3	417.4	3440.6	24.5	153.1	4222.2	3720.0	7874.9	746.4	527.6	2965.8	1220.5	86.7	1310.6	93.3	148.8	597.4	8.8	12.4	1283.5	2409.3	467.7	552.1	4788.0
SAT2	SSAT2	ENSG00000141504	"Spermidine/spermine N1-acetyltransferase family member 2"	Q96F10	17	7626234-7627876	"Enzymes, Predicted intracellular proteins"		"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 73.2"	"Cell type enhanced"	"Detected in many"	8	"Proximal tubular cells: 851.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA022136, HPA057096"	Enhanced					NA	NA					"HPA022136: AB_1856592, HPA057096: AB_2683334"	"unprognostic (2.61e-2)"	"unprognostic (1.27e-2)"	"unprognostic (3.23e-2)"	"prognostic favorable (8.76e-6)"	"unprognostic (2.18e-2)"	"unprognostic (2.32e-1)"	"unprognostic (7.20e-2)"	"prognostic favorable (6.71e-4)"	"unprognostic (4.14e-2)"	"unprognostic (2.75e-1)"	"prognostic favorable (6.05e-5)"	"unprognostic (1.83e-1)"	"unprognostic (6.66e-3)"	"unprognostic (2.49e-1)"	"unprognostic (1.86e-1)"	"unprognostic (1.50e-1)"	"unprognostic (3.12e-2)"	11.3	43.9	14.8	6.3	16.7	6.4	11.0	11.3	17.4	12.5	33.4	9.2	10.8	51.5	11.7	14.9	8.9	10.2	11.3	14.5	13.4	9.8	49.6	73.2	9.1	8.9	18.3	17.1	19.9	20.0	11.3	13.7	5.5	15.2	11.5	9.2	13.9	16.2	13.6	12.0	7.9	47.9	10.1	10.5	12.5	13.3	11.7	16.8	2.7	18.5	11.9	7.3	9.9	13.3	8.6	18.4	5.5	25.6	6.6	11.8	12.9	7.5	11.7	10.2	19.4	15.2	18.8	1.3	5.4	18.6	11.7	15.2	3.8	3.9	1.5	3.1	5.1	13.9	6.8	6.4	5.1	7.5	2.2	19.5	1.7	6.3	19.4	19.8	0.0	5.5	24.5	12.5	6.9	4.8	14.9	17.2	1.6	1.0	2.4	12.4	0.6	0.1	1.6	4.1	4.4	8.0	3.0	5.1	1.8	17.6	8.7	1.1	10.2	5.2	10.3	9.7	9.0	6.5	1.7	8.4	5.6	4.1	0.1	7.8	5.0	4.3	0.2	20.1	2.3	8.6	4.6	25.6	5.5	8.9	17.1	10.5	8.6	7.7	9.1	18.4	8.3	11.8	8.4	1.6	6.6	8.8	8.3	11.2	12.9	14.8	16.7	11.3	17.4	13.4	9.8	18.3	17.1	15.2	16.8	41.7	99.3	62.4	77.5	73.4	114.0	50.8	193.6	53.5	58.0	76.8	64.8	62.2	358.1	104.4	10.1	65.2	92.1	0.0	57.1	27.9	82.7	93.0	60.1	279.6	138.9	122.3	127.3	98.8	132.8	13.8	168.2	127.9	89.4	60.5	87.9	109.7	92.6	97.9	112.1	851.6	143.3	71.1	82.1	26.5	3.6	49.1	66.2	70.8	92.5	80.2
SBK1	Sbk	ENSG00000188322	"SH3 domain binding kinase 1"	Q52WX2	16	28292519-28323849	"Enzymes, Predicted membrane proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	7	"brain: 31.1;lymphoid tissue: 22.1;skeletal muscle: 39.6"	"Cell type enriched"	"Detected in many"	8	"Cone photoreceptor cells: 76.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	8	"gdT-cell: 4.3;MAIT T-cell: 1.4;memory CD4 T-cell: 1.2;memory CD8 T-cell: 2.4;naive CD4 T-cell: 1.4;naive CD8 T-cell: 3.0;NK-cell: 1.4;T-reg: 1.4"	"Group enriched"	"Detected in many"	10	"NK-cells: 1.4;T-cells: 4.3"	"Cell line enhanced"	"Detected in some"		"AF22: 15.3;AN3-CA: 11.0;NTERA-2: 15.8;REH: 16.7;SCLC-21H: 24.3;SH-SY5Y: 22.9"	"Region enriched"	"Detected in all"	5	"cerebellum: 306.7"											NA	NA						"unprognostic (5.15e-2)"	"prognostic favorable (6.88e-4)"	"unprognostic (2.08e-1)"	"unprognostic (6.22e-2)"	"unprognostic (1.81e-1)"	"unprognostic (1.71e-2)"	"unprognostic (5.71e-3)"	"unprognostic (3.66e-3)"	"unprognostic (1.17e-1)"	"unprognostic (1.62e-2)"	"unprognostic (2.87e-2)"	"unprognostic (6.38e-2)"	"unprognostic (1.19e-3)"	"unprognostic (3.99e-2)"	"unprognostic (3.50e-2)"	"unprognostic (7.91e-2)"	"unprognostic (5.03e-3)"	0.9	2.0	8.0	1.8	7.3	2.0	1.7	31.1	17.5	1.7	1.2	1.5	0.0	1.1	1.9	1.3	1.5	1.6	1.0	1.8	9.9	5.6	1.6	0.9	1.8	2.7	6.0	4.0	1.1	2.7	4.2	4.1	0.8	8.3	2.6	1.2	1.4	3.8	1.0	39.6	1.4	1.1	0.9	3.1	2.8	1.6	2.3	3.1	22.1	2.6	0.0	1.7	1.2	0.3	0.2	0.2	0.2	0.1	1.4	4.3	0.4	0.1	0.2	15.3	11.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.1	0.7	0.3	0.1	0.0	0.3	0.3	4.6	0.1	0.0	1.5	0.5	0.0	0.1	0.4	0.0	0.1	0.3	0.0	0.1	0.0	0.0	0.1	0.1	5.8	0.0	1.0	0.0	1.8	7.0	0.1	15.8	1.0	0.1	16.7	0.8	0.1	0.1	0.9	24.3	22.9	0.4	1.4	0.2	1.9	1.7	0.0	0.4	0.0	2.4	0.2	0.1	0.2	0.0	0.2	0.1	0.2	0.9	0.2	0.1	0.1	4.3	0.0	1.4	0.0	1.2	2.4	0.0	0.2	1.4	3.0	0.1	1.4	0.1	0.2	1.4	0.4	8.0	7.3	31.1	17.5	9.9	5.6	6.0	4.0	8.3	3.1	3.0	0.3	0.0	0.8	0.6	9.4	3.1	2.5	2.7	3.4	0.0	76.6	0.0	1.7	6.1	1.0	0.0	0.0	0.0	4.8	0.0	0.4	1.5	0.0	0.2	0.1	0.0	5.8	0.0	0.0	3.1	0.6	0.0	0.0	0.0	0.3	4.2	4.7	0.0	0.0	0.5	2.7	0.0	0.3	1.4	2.3	0.1	0.1	2.5	0.8	0.3
SBK2	SGK069	ENSG00000187550	"SH3 domain binding kinase family member 2"	P0C263	19	55529733-55537089	"Enzymes, Predicted membrane proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	27	"heart muscle: 45.7;tongue: 20.8"	"Group enriched"	"Detected in some"	6	"Early spermatids: 1.3;Late spermatids: 1.8"	"Cancer enhanced"	"Detected in some"		"ovarian cancer: 1.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A549: 4.4;Hep G2: 3.2;MCF7: 4.5;NTERA-2: 8.9;RH-30: 8.3;U-2 OS: 4.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA030631	Enhanced					NA	NA					"HPA030631: AB_10602088"	"unprognostic (1.33e-1)"			"unprognostic (1.85e-3)"	"unprognostic (4.57e-1)"	"unprognostic (3.49e-1)"				"unprognostic (5.43e-3)"	"unprognostic (4.18e-3)"		"unprognostic (2.08e-1)"	"unprognostic (6.58e-2)"	"unprognostic (1.05e-1)"			0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.3	0.0	0.1	45.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.6	0.0	1.2	0.0	0.0	0.0	0.0	0.3	0.0	0.8	0.0	0.0	0.7	20.8	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.4	0.0	0.1	0.0	0.0	0.0	0.7	0.0	0.4	1.0	0.4	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	3.2	0.0	0.0	0.0	0.3	0.0	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.3	4.5	0.0	0.0	8.9	0.0	0.0	0.0	8.3	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	4.9	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
SBK3	SgK110	ENSG00000231274	"SH3 domain binding kinase family member 3"	P0C264	19	55540656-55545543	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	12	"heart muscle: 24.2"	"Cell type enriched"	"Detected in single"	25	"Cardiomyocytes: 2.5"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A549: 9.4;CACO-2: 3.3;CAPAN-2: 5.6;NTERA-2: 2.5;RH-30: 4.1"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			HPA078322			Approved	Mitochondria		NA	NA			Mitochondria		"HPA078322: AB_2732379"	"unprognostic (2.15e-1)"	"unprognostic (1.99e-3)"	"unprognostic (2.71e-1)"	"unprognostic (1.39e-3)"	"unprognostic (7.52e-2)"	"unprognostic (2.83e-1)"	"unprognostic (5.47e-5)"	"unprognostic (4.64e-3)"		"unprognostic (7.24e-2)"	"unprognostic (1.65e-1)"	"unprognostic (3.38e-1)"	"unprognostic (3.08e-3)"	"unprognostic (1.21e-2)"	"unprognostic (4.92e-2)"	"unprognostic (2.41e-1)"	"unprognostic (1.79e-1)"	2.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0			0.2	0.0	0.0	1.7	0.0	0.1	24.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0		0.0	0.2	0.0	0.0	0.0		0.0	0.0		0.1	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.2	0.0			0.1		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.4	0.8	0.0	0.1	0.0	0.2	0.2	0.0	0.1	0.3	3.3	5.6	0.0	0.2	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	1.8	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	1.0	0.0	0.0	2.5	0.1	0.6	0.2	4.1	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.1	0.1	0.0	0.0	0.0	0.2	1.3	0.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
SC5D	SC5DL	ENSG00000109929	Sterol-C5-desaturase	O75845	11	121292453-121308694	"Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins"	"Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis, Steroid metabolism, Sterol biosynthesis, Sterol metabolism"	Oxidoreductase	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 143.5"	"Cell type enhanced"	"Detected in many"	7	"Hepatocytes: 117.3;Ito cells: 163.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA066283, HPA070248"	Enhanced		Approved	"Nucleoplasm,Endoplasmic reticulum,Plasma membrane,Cytosol"		No	No			"Nucleoplasm, Endoplasmic reticulum"	"Plasma membrane, Cytosol"	"HPA066283: AB_2685648, HPA070248: AB_2686240"	"unprognostic (4.78e-2)"	"unprognostic (7.29e-2)"	"unprognostic (2.26e-2)"	"unprognostic (2.36e-1)"	"unprognostic (3.98e-2)"	"prognostic unfavorable (3.30e-4)"	"unprognostic (2.79e-2)"	"unprognostic (7.96e-2)"	"prognostic unfavorable (3.98e-4)"	"unprognostic (4.03e-2)"	"unprognostic (3.18e-2)"	"unprognostic (1.01e-1)"	"prognostic favorable (1.07e-7)"	"unprognostic (4.29e-2)"	"unprognostic (2.51e-1)"	"unprognostic (2.29e-1)"	"unprognostic (1.98e-1)"	10.9	15.3	16.9	5.5	18.4	2.7	23.3	10.4	26.9	9.4	9.4	17.8	24.5	17.4	6.8	30.1	19.5	7.2	7.4	9.4	18.7	19.6	19.7	143.5	10.1	5.5	20.8	17.8	7.8	8.9	17.5	14.7	6.3	40.8	40.3	8.6	8.2	9.5	24.0	3.9	7.7	13.4	7.6	43.4	4.1	8.8	9.7	16.0	3.7	10.4	8.2	8.1	14.0	14.6	6.0	9.8	7.5	6.3	6.8	10.0	3.8	6.8	3.4	51.8	11.0	20.1	17.5	7.3	7.7	14.5	5.2	9.2	21.6	25.5	6.5	24.4	8.4	41.5	25.7	16.1	19.5	5.1	3.2	22.0	9.6	22.6	17.2	16.4	6.0	3.3	14.3	16.0	16.4	16.9	4.4	7.8	6.4	6.2	9.4	24.0	7.1	2.4	7.9	16.1	19.8	11.0	3.4	13.0	5.5	36.5	30.8	13.7	7.7	17.7	4.0	10.1	36.2	16.2	10.4	14.9	5.0	8.1	8.8	3.6	1.8	2.9	8.7	1.9	13.4	8.6	7.5	4.8	1.2	5.0	6.3	8.5	6.0	6.8	6.0	8.5	6.0	10.0	9.5	0.4	6.8	4.5	9.8	6.9	3.8	16.9	18.4	10.4	26.9	18.7	19.6	20.8	17.8	40.8	16.0	17.9	26.4	26.2	53.7	8.7	21.9	17.8	15.3	14.7	18.2	19.2	29.5	13.8	5.0	17.3	2.2	8.4	23.5	0.0	25.4	14.2	17.3	59.7	17.3	117.3	17.9	22.3	13.8	163.9	25.6	1.0	17.8	15.1	18.6	22.6	12.7	40.5	14.5	11.4	15.9	14.6	29.6	12.9	16.7	6.0	13.0	13.6	15.6	21.7	11.9	45.5
SCD	"FADS5, SCDOS"	ENSG00000099194	"Stearoyl-CoA desaturase"	O00767	10	100347124-100364834	"Enzymes, Predicted membrane proteins"	"Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism"	Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"adipose tissue: 245.0;brain: 130.0;breast: 94.0;heart muscle: 109.2;liver: 130.8"	"Cell type enhanced"	"Detected in many"	11	"Alveolar cells type 2: 300.1;Hepatocytes: 153.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"ASC diff: 204.0;CAPAN-2: 141.3"					"Low region specificity"	"Detected in all"			"HPA012107, HPA063921"	Approved		Enhanced	"Endoplasmic reticulum"		No	Yes			"Endoplasmic reticulum"		"HPA012107: AB_1856610, HPA063921: AB_2685154"	"unprognostic (2.10e-1)"	"unprognostic (2.62e-3)"	"unprognostic (7.86e-2)"	"unprognostic (5.19e-2)"	"unprognostic (1.24e-1)"	"unprognostic (6.16e-2)"	"unprognostic (1.13e-1)"	"unprognostic (3.88e-2)"	"unprognostic (6.53e-2)"	"unprognostic (2.72e-1)"	"unprognostic (1.47e-1)"	"unprognostic (1.69e-1)"	"prognostic unfavorable (7.56e-5)"	"unprognostic (7.18e-2)"	"unprognostic (3.27e-1)"	"unprognostic (4.73e-2)"	"prognostic unfavorable (7.79e-5)"	245.0	21.3	59.8	11.4	32.7	5.5	94.0	12.7	83.9	5.3	10.8	63.6	0.1	21.4	3.7	7.0	13.4	1.7	18.3	109.2	61.5	43.4	5.0	130.8	32.2	23.1	65.1	23.6	12.7	6.1	7.7	1.5	5.3	34.5	24.4	10.1	4.5	24.9	3.7	2.4	3.4	6.1	4.6	130.0	4.2	5.9	12.2	35.4	1.4	2.0	6.9	5.4	3.7	5.0	2.0	5.3	0.2	3.3	2.9	5.1	2.1	31.0	28.6	61.1	41.9	204.0	117.7	12.5	3.3	73.7	8.0	42.8	24.6	141.3	13.1	2.6	7.8	36.6	55.6	33.6	119.4	7.0	4.4	13.9	7.3	18.2	49.2	39.4	10.2	8.0	64.0	36.2	31.1	54.8	21.6	15.2	29.1	20.4	40.1	3.2	48.6	11.6	12.2	21.2	9.1	8.2	5.4	22.6	41.1	34.9	34.9	3.8	14.7	6.6	31.2	64.1	18.5	35.0	22.0	6.0	0.8	9.5	0.7	6.8	11.2	6.0	20.2	14.6	32.0	5.1	0.0	1.5	0.0	3.0	3.3	5.1	1.3	1.2	1.6	5.3	2.0	1.0	2.9	0.2	2.9	0.0	3.0	0.0	2.1	59.8	32.7	12.7	27.9	61.5	43.4	65.1	23.6	34.5	35.4	50.6	300.1	34.7	3.9	3.3	4.0	2.9	35.7	9.4	23.9	0.0	5.9	2.0	0.0	12.5	52.9	9.3	13.7	0.0	59.1	53.1	9.3	26.0	5.8	153.5	29.3	25.4	24.8	41.7	97.6	68.6	3.4	8.2	55.6	17.2	15.7	11.8	21.6	2.9	1.4	3.8	4.7	0.0	4.4	0.9	1.1	1.9	14.5	5.2	16.8	3.5
SCD5	"ACOD4, FADS4, FLJ21032, HSCD5, SCD4"	ENSG00000145284	"Stearoyl-CoA desaturase 5"	Q86SK9	4	82629539-82798857	"Enzymes, Predicted membrane proteins"	"Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism"	Oxidoreductase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"adrenal gland: 69.1;brain: 137.3;epididymis: 44.5;ovary: 42.7"	"Cell type enhanced"	"Detected in many"	7	"Early spermatids: 92.6;Horizontal cells: 95.3;Muller glia cells: 134.1"	"Group enriched"	"Detected in all"	6	"glioma: 152.4;thyroid cancer: 38.5"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"BJ: 27.5;RPTEC TERT1: 36.3"					"Low region specificity"	"Detected in all"			HPA042380	Uncertain					NA	NA					"HPA042380: AB_10794797"	"unprognostic (3.23e-2)"	"unprognostic (3.84e-2)"	"unprognostic (2.86e-1)"	"unprognostic (6.98e-2)"	"unprognostic (1.58e-1)"	"unprognostic (2.95e-1)"	"unprognostic (2.83e-1)"	"unprognostic (3.82e-2)"	"unprognostic (6.82e-2)"	"unprognostic (3.22e-1)"	"unprognostic (1.04e-1)"	"unprognostic (2.37e-2)"	"prognostic favorable (2.32e-5)"	"unprognostic (1.28e-1)"	"unprognostic (1.26e-1)"	"unprognostic (3.88e-3)"	"unprognostic (2.92e-2)"	3.0	69.1	61.2	2.7	48.6	2.5	3.0	33.5	137.3	5.9	3.0	50.4	1.8	3.0	6.7	44.5	3.7	9.3	5.1	3.5	49.6	43.4	15.4	2.3	7.5	2.3	58.2	36.3	42.7	18.1	2.2	6.9	4.4	42.0	6.9	3.0	6.3	5.6	12.4	1.7	4.8	3.7	6.2	57.1	3.0	4.3	14.8	43.4	1.2	16.4	0.0	3.0	3.8	2.0	0.9	1.3	3.0	1.2	2.0	7.2	1.8	4.5	2.9	14.7	7.5	8.1	5.3	0.3	27.5	13.6	12.0	9.3	0.3	0.7	8.9	9.6	5.7	3.3	8.0	4.3	3.0	15.2	1.7	1.9	0.4	3.5	0.4	1.2	3.9	2.9	4.1	12.4	2.4	2.1	12.5	19.3	10.4	0.6	1.1	6.3	1.8	16.2	0.9	1.2	0.1	2.0	13.9	8.7	7.0	36.3	4.5	8.3	4.7	4.6	0.4	2.6	1.6	0.6	2.0	23.6	13.0	7.6	4.9	7.4	2.5	1.0	0.9	6.3	4.1	3.7	3.0	1.2	0.4	7.2	0.5	4.6	0.5	1.7	4.3	0.5	0.9	1.5	5.1	2.0	2.0	0.9	1.3	0.4	1.8	61.2	48.6	33.5	41.2	49.6	43.4	58.2	36.3	42.0	43.4	41.7	3.8	0.5	14.0	9.5	79.3	2.0	12.7	12.0	31.8	26.2	23.6	0.7	11.6	71.1	92.6	7.1	0.0	0.0	42.3	0.1	14.4	9.5	0.0	0.0	1.0	95.3	7.5	6.7	1.2	73.6	50.9	1.8	3.3	1.8	0.0	134.1	11.2	0.0	54.8	20.8	12.4	6.5	11.3	3.3	1.4	6.4	0.1	3.9	0.8	8.6
SCLY	SCL	ENSG00000132330	"Selenocysteine lyase"	Q96I15	2	238060889-238099413	"Enzymes, Predicted intracellular proteins"		"Lyase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	12	"Early spermatids: 82.6;Late spermatids: 106.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA020190, HPA055760"	Uncertain		Enhanced	"Golgi apparatus"		NA	NA		110000	"Golgi apparatus"		"HPA020190: , HPA055760: AB_2682910"	"unprognostic (7.39e-3)"	"unprognostic (1.43e-1)"	"unprognostic (3.29e-2)"	"unprognostic (8.65e-5)"	"unprognostic (8.96e-2)"	"unprognostic (9.85e-3)"	"unprognostic (1.14e-3)"	"unprognostic (4.24e-2)"	"unprognostic (1.59e-2)"	"unprognostic (8.38e-2)"	"unprognostic (3.98e-3)"	"unprognostic (1.03e-2)"	"unprognostic (1.02e-3)"	"unprognostic (3.73e-1)"	"unprognostic (4.37e-2)"	"unprognostic (2.50e-3)"	"unprognostic (1.98e-1)"	4.1	3.8	6.0	6.3	7.4	5.3	3.6	10.2	7.4	4.3	6.3	11.1	5.7	9.8	8.4	8.3	4.5	4.6	5.4	6.5	7.3	6.8	9.9	24.1	4.0	6.5	9.6	4.7	6.3	22.7	5.2	5.1	2.6	6.6	5.0	4.3	6.4	4.5	5.6	5.1	2.8	9.6	5.1	9.4	5.6	3.9	15.3	6.1	8.9	8.1	6.3	5.3	4.6	4.0	5.0	5.7	6.9	5.6	4.2	8.1	4.3	5.7	9.7	6.2	16.6	5.0	3.4	12.6	5.8	2.9	6.2	7.6	6.4	4.7	9.6	1.7	3.3	19.9	8.4	24.3	12.4	5.9	10.9	21.8	11.1	13.0	22.0	9.4	9.2	9.6	3.8	6.1	11.6	13.3	2.6	11.5	13.3	19.3	2.7	6.3	8.6	9.1	16.9	20.1	8.0	8.1	10.7	12.0	9.5	5.9	2.0	7.1	15.1	6.4	10.3	10.4	4.8	3.2	13.6	4.9	9.4	6.1	12.4	12.4	6.8	6.2	4.8	5.8	18.7	7.4	2.0	5.3	6.9	4.7	4.3	3.7	5.0	5.7	8.1	5.7	3.5	4.3	4.2	0.9	4.2	5.6	1.2	5.3	4.3	6.0	7.4	10.2	7.4	7.3	6.8	9.6	4.7	6.6	6.1	0.0	0.0	3.7	1.9	1.4	5.3	2.4	0.0	1.4	0.0	0.0	7.9	1.1	3.3	4.4	82.6	2.7	2.1	0.0	3.2	1.4	1.9	1.0	0.0	2.4	3.4	6.4	2.4	1.3	0.0	106.4	2.8	2.0	1.7	2.8	2.6	2.3	2.7	5.8	0.0	1.7	6.1	0.0	1.7	6.0	4.8	1.4	0.6	2.2	2.8	1.4
SCP2		ENSG00000116171	"Sterol carrier protein 2"	P22307	1	52927229-53051703	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Lipid transport, Transport"	"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 168.3"	"Cell type enhanced"	"Detected in all"	6	"Hepatocytes: 1150.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA027101, HPA027135, HPA027317"	Supported		Supported	Nucleoplasm,Peroxisomes		NA	NA		370000	Peroxisomes	Nucleoplasm	"HPA027101: AB_1856634, HPA027135: AB_1856633, HPA027317: AB_10610422"	"unprognostic (7.51e-2)"	"unprognostic (5.23e-2)"	"prognostic favorable (7.05e-5)"	"unprognostic (9.68e-2)"	"unprognostic (1.53e-2)"	"unprognostic (5.53e-2)"	"unprognostic (1.87e-3)"	"unprognostic (1.22e-2)"	"unprognostic (1.62e-2)"	"unprognostic (1.59e-1)"	"unprognostic (4.53e-2)"	"unprognostic (6.16e-2)"	"prognostic favorable (7.85e-8)"	"unprognostic (1.49e-2)"	"unprognostic (1.09e-1)"	"unprognostic (8.64e-2)"	"unprognostic (1.13e-2)"	29.1	26.2	21.8	19.9	21.2	14.0	30.3	12.0	19.7	24.4	51.9	15.9	28.1	49.2	19.0	28.8	32.2	18.1	32.1	29.3	20.0	20.0	54.2	168.3	21.8	14.0	25.6	17.8	22.8	24.6	16.7	24.1	17.1	21.9	25.5	40.5	18.9	21.8	23.3	22.0	18.8	80.1	20.6	27.1	20.9	33.9	16.7	19.4	23.0	28.2	28.6	17.6	22.3	20.5	36.4	57.1	67.8	50.7	40.8	49.2	61.2	25.6	14.1	19.0	34.8	62.4	53.4	20.6	30.6	45.9	20.1	29.2	12.6	27.8	24.4	33.1	44.8	23.5	18.0	13.0	28.6	30.8	35.5	18.9	26.2	20.3	25.9	41.6	37.7	44.2	43.3	39.0	23.8	11.9	44.1	56.9	28.9	23.3	12.7	40.6	14.8	42.0	32.8	20.8	65.1	27.7	22.0	33.5	33.3	55.8	43.6	15.7	19.0	26.7	54.2	25.6	44.1	27.7	43.2	44.0	27.4	14.2	47.7	24.4	21.3	27.0	28.5	35.5	37.5	25.3	55.4	48.7	67.8	49.2	50.7	39.9	36.4	39.2	48.6	57.1	29.8	33.2	47.1	7.5	40.8	46.8	37.1	47.1	61.2	21.8	21.2	12.0	19.7	20.0	20.0	25.6	17.8	21.9	19.4	125.0	163.3	99.5	107.7	133.6	35.0	136.8	201.2	147.2	103.5	176.2	29.5	158.8	401.3	140.3	42.8	125.8	592.0	70.0	143.6	134.4	129.4	170.2	138.2	1150.9	181.7	39.7	225.9	115.4	211.6	39.0	170.6	166.5	182.2	152.3	388.8	98.9	131.8	498.1	161.5	617.2	27.0	77.6	119.7	10.6	19.8	149.3	112.0	172.0	297.8	155.6
SCPEP1	RISC	ENSG00000121064	"Serine carboxypeptidase 1"	Q9HB40	17	56978105-57006768	"Enzymes, Predicted intracellular proteins, Predicted secreted proteins"		"Carboxypeptidase, Hydrolase, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"parathyroid gland: 113.9"	"Cell type enhanced"	"Detected in many"	5	"Ciliated cells: 200.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"eosinophil: 60.8"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"ASC diff: 80.9;U-266/70: 53.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039102, HPA057200"	Enhanced		Approved	"Golgi apparatus"	"Secreted to blood"	NA	NA			"Golgi apparatus"		"HPA039102: AB_10673605, HPA057200: AB_2683365"	"unprognostic (5.83e-3)"	"unprognostic (7.43e-3)"	"unprognostic (4.47e-2)"	"unprognostic (2.96e-1)"	"unprognostic (9.26e-2)"	"unprognostic (1.43e-2)"	"prognostic unfavorable (1.96e-5)"	"unprognostic (1.00e-3)"	"unprognostic (1.68e-1)"	"unprognostic (1.70e-1)"	"unprognostic (3.56e-3)"	"unprognostic (1.40e-1)"	"unprognostic (3.25e-1)"	"unprognostic (7.28e-2)"	"unprognostic (8.89e-2)"	"unprognostic (8.33e-2)"	"unprognostic (1.68e-1)"	29.5	54.1	14.7	12.6	10.2	17.8	25.8	8.8	14.8	21.5	17.6	12.8	50.1	8.8	17.5	24.1	25.9	14.6	20.7	25.0	10.2	11.8	24.8	8.7	25.6	24.5	12.2	14.3	19.9	9.4	113.9	13.6	7.6	14.2	24.6	9.5	13.4	31.5	37.6	6.4	17.8	15.9	23.2	13.9	22.3	20.8	7.7	10.8	2.4	62.7	14.1	25.3	24.7	20.8	14.1	23.4	60.8	44.8	4.6	3.0	20.3	9.7	6.0	9.3	8.6	80.9	18.1	5.2	4.7	23.7	8.3	16.6	2.8	6.2	13.2	27.6	11.2	14.4	9.5	4.4	21.2	8.8	17.7	7.7	3.9	6.0	1.6	18.5	8.1	40.3	21.9	9.1	10.7	8.3	7.7	13.8	5.0	1.1	47.3	11.9	4.2	3.6	20.2	4.2	3.0	8.7	5.1	11.4	8.5	1.8	30.2	2.9	7.2	11.9	9.0	7.0	11.2	4.0	20.7	7.4	25.2	6.7	14.8	5.3	53.4	39.1	7.2	17.6	5.8	6.9	0.3	44.8	60.8	3.0	27.1	1.9	12.9	2.1	1.9	23.4	14.1	2.9	2.9	7.3	4.6	25.3	4.5	2.5	20.3	14.7	10.2	8.8	14.8	10.2	11.8	12.2	14.3	14.2	10.8	41.7	48.6	36.6	158.5	21.1	14.6	27.4	12.7	200.8	135.4	90.7	15.7	8.4	16.6	13.6	0.9	22.1	2.6	23.3	6.1	13.6	64.4	62.4	8.1	19.2	144.9	9.5	23.4	64.4	136.9	1.1	59.5	105.4	23.6	80.2	3.1	27.2	6.2	1.5	64.0	24.5	16.3	51.8	42.2	3.2	7.9	17.3	9.3	20.8	3.5	121.2
SCRN1	KIAA0193	ENSG00000136193	"Secernin 1"	Q12765	7	29920103-29990289	"Enzymes, Predicted intracellular proteins"	Exocytosis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 62.8"	"Cell type enhanced"	"Detected in many"	5	"Horizontal cells: 65.2;Muller glia cells: 76.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"WM-115: 69.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA024517	Enhanced		Approved	Cytosol		No	No		110000	Cytosol		"HPA024517: AB_2184811"	"prognostic unfavorable (8.32e-4)"	"prognostic unfavorable (8.46e-4)"	"unprognostic (1.45e-1)"	"prognostic unfavorable (4.00e-5)"	"unprognostic (1.87e-2)"	"unprognostic (2.43e-1)"	"unprognostic (1.13e-3)"	"unprognostic (1.10e-1)"	"unprognostic (2.29e-1)"	"prognostic unfavorable (7.27e-4)"	"unprognostic (1.09e-2)"	"unprognostic (1.02e-1)"	"prognostic favorable (1.15e-5)"	"unprognostic (2.57e-2)"	"unprognostic (2.10e-1)"	"unprognostic (2.23e-1)"	"prognostic unfavorable (2.60e-4)"	6.8	14.8	32.0	6.3	31.5	3.6	7.6	62.8	55.4	12.4	8.1	23.2	4.5	3.4	13.3	8.8	10.0	13.9	8.5	9.8	26.6	30.7	12.8	1.5	8.3	6.7	42.7	26.6	17.5	18.5	42.9	12.1	8.0	26.3	15.0	5.6	7.8	8.4	20.2	1.0	5.7	5.0	17.7	42.9	5.2	7.1	11.4	23.3	8.2	7.1	1.5	10.6	9.4	5.8	10.4	7.8	6.9	16.7	4.8	8.1	2.2	21.8	15.8	25.8	10.4	18.3	28.2	0.1	20.4	27.4	22.2	24.0	18.2	17.4	2.7	18.2	26.1	49.4	9.9	29.3	8.7	32.5	0.1	6.1	9.0	10.6	11.7	23.4	0.0	0.1	23.5	12.6	20.1	10.8	30.3	20.4	5.9	0.1	7.1	31.2	12.3	3.1	0.0	23.5	0.0	17.0	0.0	27.5	0.2	15.5	10.8	9.4	22.4	21.1	13.7	23.6	33.9	18.5	1.4	22.5	28.9	24.9	0.3	25.8	2.3	35.4	0.2	13.6	0.1	69.6	2.2	2.3	6.9	0.6	10.2	8.1	10.4	0.1	0.8	7.7	5.0	0.6	1.0	0.4	4.8	16.7	7.8	0.0	2.2	32.0	31.5	62.8	43.1	26.6	30.7	42.7	26.6	26.3	23.3	26.8	13.1	8.2	9.7	2.7	63.5	12.6	20.4	21.4	22.7	31.4	43.2	0.3	13.3	18.8	49.3	5.8	0.0	0.0	21.5	1.6	7.7	14.1	8.1	0.5	4.8	65.2	11.6	2.5	10.0	48.7	12.7	10.6	6.8	4.6	0.9	76.1	21.8	17.3	19.8	1.8	39.0	6.5	8.5	2.3	12.3	1.5	0.8	4.3	1.0	17.0
SCRN2		ENSG00000141295	"Secernin 2"	Q96FV2	17	47837692-47841333	"Enzymes, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	5	"Proximal tubular cells: 296.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA022934, HPA023434"	Enhanced		Supported	"Nucleoplasm,Golgi apparatus"		NA	NA		350000	Nucleoplasm	"Golgi apparatus"	"HPA022934: AB_1856638, HPA023434: AB_1856639"	"unprognostic (2.35e-2)"	"unprognostic (1.42e-2)"	"unprognostic (2.86e-1)"	"unprognostic (6.14e-2)"	"unprognostic (2.46e-2)"	"unprognostic (1.73e-1)"	"prognostic favorable (3.86e-4)"	"unprognostic (4.63e-2)"	"unprognostic (3.25e-2)"	"unprognostic (5.77e-2)"	"unprognostic (1.28e-3)"	"unprognostic (8.72e-2)"	"unprognostic (3.43e-2)"	"unprognostic (5.28e-3)"	"unprognostic (1.64e-1)"	"unprognostic (1.20e-1)"	"prognostic favorable (5.83e-4)"	43.4	10.3	8.3	14.2	14.1	6.7	20.8	17.7	13.1	10.6	17.3	11.2	23.6	25.1	11.4	18.1	8.9	15.4	13.3	17.9	8.6	8.9	29.3	17.4	8.3	8.7	8.1	9.6	11.8	25.3	11.4	14.5	7.8	10.5	13.6	6.1	14.8	20.1	19.2	20.0	10.9	20.1	9.7	7.3	15.0	9.8	4.0	10.9	8.5	18.1	9.0	11.0	10.7	10.0	16.9	19.2	25.9	13.4	16.5	22.1	10.8	12.0	19.2	5.3	5.1	15.7	12.2	16.3	6.1	12.5	9.4	9.6	14.4	14.4	6.7	12.3	3.2	5.0	6.6	1.7	10.7	3.2	15.9	13.2	6.8	14.1	12.4	5.6	3.2	5.4	11.7	8.1	5.7	4.5	14.0	10.5	16.2	2.3	7.6	12.8	10.9	10.7	5.6	2.7	5.2	7.6	14.3	4.0	26.9	7.4	5.5	4.1	17.2	3.4	7.3	8.0	3.8	16.6	6.4	4.8	8.6	9.2	2.4	2.8	31.5	4.1	3.1	23.3	5.7	1.9	12.3	12.8	25.9	16.9	13.4	16.3	16.9	14.0	16.4	16.3	15.6	22.1	12.2	3.2	16.5	6.5	19.2	13.9	10.8	8.3	14.1	17.7	13.1	8.6	8.9	8.1	9.6	10.5	10.9	35.7	25.1	11.2	25.9	14.0	11.3	19.8	12.7	26.8	14.8	15.7	9.8	38.7	63.0	22.9	2.8	20.3	52.0	0.0	53.1	8.3	23.5	18.8	16.1	25.3	19.4	19.1	21.5	23.9	8.1	2.1	30.8	12.7	40.5	11.8	30.3	26.6	27.6	34.5	15.6	296.5	15.6	6.5	17.0	5.2	14.9	10.0	28.3	26.1	34.7	16.9
SCRN3	FLJ23142	ENSG00000144306	"Secernin 3"	Q0VDG4	2	174395730-174429575	"Enzymes, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA034689, HPA034690"	Approved		Approved	Vesicles,Cytosol		NA	NA		9300	"Vesicles, Cytosol"		"HPA034689: AB_2674282, HPA034690: AB_10670574"	"unprognostic (5.39e-3)"	"unprognostic (4.58e-2)"	"unprognostic (2.06e-2)"	"unprognostic (3.58e-1)"	"unprognostic (1.91e-1)"	"unprognostic (1.89e-1)"	"unprognostic (9.89e-2)"	"unprognostic (1.57e-1)"	"unprognostic (5.14e-2)"	"unprognostic (5.85e-2)"	"unprognostic (8.81e-2)"	"unprognostic (1.30e-1)"	"unprognostic (6.62e-3)"	"unprognostic (1.75e-1)"	"unprognostic (1.31e-1)"	"unprognostic (5.57e-2)"	"unprognostic (1.57e-1)"	12.4	15.9	19.2	7.6	18.4	3.7	11.4	13.2	27.0	8.4	10.4	16.7	12.5	15.4	10.3	10.1	14.2	9.1	9.4	21.2	20.2	20.0	17.4	18.0	10.1	10.5	23.5	21.1	11.7	12.1	26.6	20.6	10.9	25.9	13.4	11.3	8.7	10.6	12.3	30.3	11.5	11.5	11.8	27.9	9.3	10.2	8.4	20.2	10.4	17.3	6.2	9.5	11.2	9.1	9.9	6.9	18.5	4.6	5.5	7.5	2.2	9.1	5.6	14.6	13.5	11.3	12.8	8.2	14.1	10.9	10.9	13.0	5.5	6.7	1.7	9.3	13.9	8.3	9.1	11.2	12.1	14.1	19.8	10.1	17.0	12.3	4.3	17.1	12.9	9.0	14.4	15.2	20.1	14.8	12.2	12.5	9.5	11.2	6.6	14.8	10.2	10.7	12.6	7.1	20.1	23.9	5.3	15.3	10.0	12.2	9.4	9.5	26.7	9.7	9.6	17.7	16.6	12.9	12.5	9.2	12.7	6.6	14.9	11.8	17.6	18.2	0.2	13.8	6.4	12.7	4.8	4.6	1.9	4.6	2.7	3.3	7.0	4.7	4.3	4.3	9.9	7.5	5.9	18.5	5.5	3.6	6.9	4.8	2.2	19.2	18.4	13.2	27.0	20.2	20.0	23.5	21.1	25.9	20.2	8.9	10.4	3.7	9.8	3.2	12.8	20.6	7.6	13.4	7.9	8.7	9.8	9.3	11.6	7.8	2.2	4.9	6.3	0.0	8.6	5.9	6.3	5.6	8.1	8.3	7.8	17.5	5.8	10.4	6.9	2.3	4.4	4.9	3.3	3.6	6.5	22.0	9.9	3.5	6.3	9.8	14.7	0.0	6.2	18.1	5.2	4.3	5.7	2.5	6.4	10.1
SCYL1	"GKLP, HT019, MGC78454, NKTL, NTKL, P105, TAPK, TEIF, TRAP"	ENSG00000142186	"SCY1 like pseudokinase 1"	Q96KG9	11	65525077-65538704	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"ER-Golgi transport, Transcription, Transcription regulation, Transport"	"Activator, DNA-binding"	"Mental retardation, Neurodegeneration, Spinocerebellar ataxia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Syncytiotrophoblasts: 115.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA015015	Uncertain		Supported	Cytosol		NA	NA			Cytosol		"HPA015015: AB_1856643"	"unprognostic (5.56e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.03e-1)"	"unprognostic (3.99e-1)"	"unprognostic (1.23e-2)"	"unprognostic (7.87e-2)"	"unprognostic (1.23e-2)"	"unprognostic (5.06e-2)"	"unprognostic (1.14e-1)"	"unprognostic (7.23e-2)"	"unprognostic (4.41e-1)"	"unprognostic (4.29e-1)"	"unprognostic (7.86e-3)"	"unprognostic (6.49e-3)"	"unprognostic (4.27e-1)"	"unprognostic (8.29e-2)"	"unprognostic (2.29e-3)"	24.1	35.5	24.1	20.2	24.4	22.8	49.4	24.6	47.3	25.0	21.6	19.0	27.8	22.5	26.9	30.0	24.1	26.7	21.4	35.8	25.1	21.1	24.1	61.4	22.4	22.9	21.7	23.9	34.1	40.7	27.0	24.3	30.7	19.6	24.7	14.3	24.9	34.0	30.3	51.2	23.6	19.8	23.0	17.1	24.7	24.4	31.4	20.6	18.0	27.3	20.2	20.2	24.9	24.1	10.7	15.5	27.9	13.7	11.1	14.7	12.1	19.9	17.2	13.9	19.2	25.5	22.3	19.0	24.8	33.8	29.7	23.3	24.8	12.1	14.4	25.2	32.2	25.3	18.3	14.6	18.7	10.4	16.9	18.7	16.9	18.9	28.4	36.3	11.1	24.5	30.8	18.5	25.5	19.0	21.0	19.4	14.9	17.6	20.4	18.4	43.5	14.8	25.6	13.3	13.5	24.1	15.1	10.8	26.4	18.3	17.9	12.9	13.6	15.3	33.9	27.0	8.9	33.6	14.1	19.1	23.6	15.9	38.2	14.6	28.3	19.7	15.0	27.4	9.3	16.5	1.9	13.7	17.6	14.7	13.2	11.8	10.0	13.8	14.6	15.5	10.7	11.2	10.5	27.9	11.1	8.5	11.3	9.5	12.1	24.1	24.4	24.6	47.3	25.1	21.1	21.7	23.9	19.6	20.6	17.9	11.8	17.1	26.0	19.5	23.4	5.6	15.3	10.7	13.6	19.2	11.8	53.7	31.5	31.7	20.6	21.5	42.3	0.0	37.5	60.7	33.0	37.9	25.3	33.7	33.9	15.9	29.3	23.4	18.4	17.2	42.3	21.4	28.7	44.1	26.8	20.3	31.3	24.6	42.8	30.5	17.4	12.9	34.2	22.4	22.6	20.3	115.9	19.1	29.9	27.8
SCYL2	"CVAK104, KIAA1360"	ENSG00000136021	"SCY1 like pseudokinase 2"	Q6P3W7	12	100267140-100341724	"Enzymes, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA021050	Approved					NA	NA					"HPA021050: AB_1846175"	"unprognostic (7.01e-3)"	"unprognostic (3.04e-2)"	"unprognostic (4.34e-3)"	"unprognostic (4.01e-2)"	"unprognostic (3.87e-2)"	"unprognostic (1.07e-1)"	"unprognostic (1.27e-2)"	"unprognostic (8.19e-2)"	"unprognostic (5.32e-2)"	"unprognostic (1.31e-1)"	"unprognostic (1.34e-2)"	"unprognostic (1.93e-2)"	"unprognostic (4.44e-1)"	"unprognostic (2.72e-1)"	"unprognostic (3.46e-1)"	"unprognostic (1.60e-1)"	"unprognostic (2.18e-1)"	22.7	20.3	19.6	17.5	16.8	19.8	18.3	21.0	20.2	16.9	23.5	13.9	19.5	20.9	18.9	23.7	26.2	16.2	17.3	20.2	13.7	15.2	26.1	35.1	21.2	15.9	12.6	15.7	19.0	19.4	28.1	30.3	31.3	16.2	19.8	28.6	13.3	22.0	17.8	24.6	17.9	23.2	18.5	14.8	19.0	20.8	17.4	11.5	31.7	17.4	16.1	20.3	28.0	21.4	4.4	8.1	13.3	8.1	10.8	7.5	4.7	18.0	13.9	22.6	18.7	14.5	15.4	21.7	18.6	20.2	17.0	14.4	13.3	9.3	11.3	8.9	22.1	11.7	15.5	17.6	13.1	20.4	17.6	12.0	36.2	9.6	9.6	12.9	16.8	35.6	11.4	20.8	19.1	22.2	20.3	21.2	12.6	19.0	9.6	18.1	13.7	14.0	14.7	14.6	10.2	16.0	11.1	16.7	10.9	15.6	28.8	14.4	13.2	21.5	21.8	17.3	24.9	31.8	13.4	21.0	14.8	8.6	13.9	11.9	11.4	15.2	13.9	7.4	12.0	16.9	13.3	6.1	11.7	5.3	8.1	6.8	4.4	5.7	5.0	8.1	3.4	6.3	6.5	8.6	10.8	6.5	2.6	7.5	4.7	19.6	16.8	21.0	20.2	13.7	15.2	12.6	15.7	16.2	11.5	14.9	29.9	10.4	18.0	31.9	17.5	26.5	10.2	13.4	29.6	19.2	25.5	25.0	5.0	14.4	4.8	18.2	24.5	23.3	18.6	17.8	16.2	30.4	27.6	33.4	21.9	14.3	20.8	14.1	31.4	3.1	12.4	26.2	15.1	19.0	29.0	10.4	18.6	31.7	14.5	21.0	16.7	0.0	16.1	21.8	10.3	30.4	49.7	14.1	31.2	40.6
SCYL3	"PACE-1, PACE1"	ENSG00000000457	"SCY1 like pseudokinase 3"	Q8IZE3	1	169849631-169894267	"Enzymes, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA005624	Approved		Uncertain	"Nuclear bodies,Microtubules"		NA	NA			Microtubules	"Nuclear bodies"	"HPA005624: AB_1854916"	"unprognostic (2.35e-1)"	"unprognostic (1.25e-1)"	"unprognostic (7.53e-2)"	"unprognostic (8.36e-2)"	"unprognostic (7.13e-2)"	"unprognostic (2.72e-3)"	"unprognostic (1.31e-1)"	"unprognostic (2.12e-2)"	"unprognostic (2.85e-2)"	"unprognostic (7.17e-2)"	"unprognostic (8.80e-2)"	"unprognostic (9.88e-2)"	"unprognostic (1.20e-3)"	"unprognostic (3.54e-1)"	"unprognostic (1.75e-1)"	"unprognostic (4.60e-2)"	"prognostic favorable (8.85e-4)"	10.8	11.4	8.5	15.4	10.6	5.0	15.8	10.5	11.9	12.1	14.6	11.0	14.6	10.7	12.6	14.0	14.4	10.6	11.0	7.8	7.3	6.5	12.1	18.0	11.8	13.7	9.3	7.8	13.0	12.8	22.7	14.4	15.8	9.5	13.2	13.9	12.3	15.5	13.8	14.6	14.1	14.9	13.0	7.3	12.6	11.3	9.1	8.9	17.2	13.3	9.5	16.0	16.0	12.7	8.3	13.6	12.3	4.3	11.8	10.5	5.9	3.4	4.5	7.0	4.8	9.0	6.5	8.0	5.4	7.1	6.3	6.0	4.1	6.7	7.1	4.0	5.6	3.5	8.1	4.1	4.8	5.7	13.1	3.8	4.9	5.0	2.6	6.4	7.1	6.4	6.3	4.8	4.4	6.1	6.0	6.0	8.0	7.8	9.5	6.0	2.7	5.7	5.5	5.6	23.5	2.2	5.3	3.8	8.5	6.7	6.3	5.2	7.6	4.3	14.3	8.5	10.3	8.0	6.6	4.4	4.6	3.0	5.4	4.3	12.8	11.3	8.5	3.4	5.4	5.0	12.3	3.7	9.7	8.0	3.9	10.5	8.3	10.4	8.7	6.0	7.3	9.2	7.5	8.2	11.8	4.3	13.6	9.5	5.9	8.5	10.6	10.5	11.9	7.3	6.5	9.3	7.8	9.5	8.9	6.0	11.8	5.2	1.7	2.2	9.6	3.4	22.9	2.7	9.1	1.8	9.8	14.5	8.3	5.3	2.9	5.8	10.8	0.0	8.0	4.3	4.3	3.7	5.7	8.6	5.5	9.5	8.7	7.4	10.8	1.5	4.0	5.3	1.7	7.2	12.7	8.9	5.8	10.5	5.3	4.9	17.6	6.5	4.1	7.2	6.4	1.6	9.7	10.2	9.9	2.3
SDHA	"FP, SDH2, SDHF"	ENSG00000073578	"Succinate dehydrogenase complex flavoprotein subunit A"	P31040	5	218241-256700	"Cancer-related genes, Citric acid cycle related proteins, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"	"Electron transport, Transport, Tricarboxylic acid cycle"	Oxidoreductase	"Cancer-related genes, Cardiomyopathy, Disease mutation, FDA approved drug targets, Leigh syndrome, Primary mitochondrial disease, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 100.1;skeletal muscle: 114.0"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB034929, HPA041981, HPA064582"	Enhanced		Supported	Nucleoli,Mitochondria		No	No		780000	Mitochondria	Nucleoli	"CAB034929: AB_2183443, HPA041981: AB_2677779, HPA064582: AB_2685293"	"prognostic unfavorable (6.00e-4)"	"unprognostic (1.93e-1)"	"unprognostic (5.97e-2)"	"unprognostic (1.36e-1)"	"unprognostic (1.89e-1)"	"unprognostic (1.62e-1)"	"unprognostic (2.80e-1)"	"unprognostic (3.14e-2)"	"unprognostic (2.88e-1)"	"unprognostic (1.67e-2)"	"unprognostic (1.97e-1)"	"unprognostic (1.24e-1)"	"prognostic favorable (9.53e-8)"	"unprognostic (1.11e-2)"	"unprognostic (2.62e-1)"	"unprognostic (3.57e-1)"	"unprognostic (1.79e-1)"	17.6	31.4	15.3	11.5	20.3	10.6	12.8	18.8	29.0	10.2	29.4	17.3	10.0	44.3	11.3	12.1	15.3	12.6	14.8	100.1	15.8	14.5	36.5	55.4	10.7	11.7	19.6	19.3	14.5	14.7	23.2	9.5	9.2	29.7	10.7	24.6	14.5	17.3	12.0	114.0	11.5	39.9	16.5	13.2	13.9	21.2	14.6	14.8	15.7	12.5	39.6	12.5	13.2	11.1	28.3	31.9	29.1	29.2	27.1	48.9	32.4	18.7	30.4	12.5	20.4	21.6	16.2	34.0	14.5	18.4	25.0	25.5	32.9	25.6	23.2	45.8	16.5	18.9	24.3	22.1	29.6	14.8	49.4	20.2	11.8	84.1	42.8	13.4	14.7	15.4	16.1	19.0	18.6	9.9	19.9	27.0	16.6	19.0	19.3	11.7	28.7	19.4	39.7	4.3	20.5	38.6	25.1	18.2	45.0	53.1	24.9	13.8	7.9	68.2	44.1	17.9	8.1	26.7	18.6	19.5	18.5	18.2	11.0	11.9	20.6	8.8	17.1	17.9	21.2	11.7	17.8	24.4	29.1	36.4	29.2	32.1	28.3	34.8	35.1	31.9	24.5	34.5	31.7	5.9	27.1	24.1	20.5	48.9	32.4	15.3	20.3	18.8	29.0	15.8	14.5	19.6	19.3	29.7	14.8	32.8	63.8	52.9	58.0	54.4	45.7	238.2	76.5	58.9	40.9	71.5	96.2	94.1	121.0	78.8	32.8	37.6	207.8	0.0	39.4	87.2	53.2	29.4	42.7	135.6	60.4	95.3	45.6	43.0	39.1	20.2	63.3	43.9	86.0	78.5	75.8	40.3	44.9	92.8	52.3	129.8	77.8	77.6	45.0	66.5	55.1	31.5	129.4	59.9	128.8	78.3
SDHB	"SDH, SDH1"	ENSG00000117118	"Succinate dehydrogenase complex iron sulfur subunit B"	P21912	1	17018722-17054170	"Cancer-related genes, Citric acid cycle related proteins, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Electron transport, Transport, Tricarboxylic acid cycle"	Oxidoreductase	"Cancer-related genes, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	4	"Cardiomyocytes: 395.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002868, CAB009822, CAB068233, CAB068234, CAB068235"	Enhanced		Supported	"Nucleoplasm,Plasma membrane,Mitochondria"	"Intracellular and membrane"	NA	NA			Mitochondria	"Nucleoplasm, Plasma membrane"	"CAB009822: AB_2183458, CAB068233: AB_2665638, CAB068234: AB_2665639, CAB068235: AB_2665640, HPA002868: AB_1079889"	"unprognostic (1.06e-1)"	"unprognostic (2.86e-2)"	"unprognostic (2.19e-2)"	"unprognostic (2.93e-2)"	"unprognostic (1.88e-1)"	"unprognostic (2.79e-3)"	"unprognostic (1.58e-1)"	"unprognostic (3.02e-1)"	"unprognostic (1.19e-1)"	"unprognostic (8.45e-2)"	"unprognostic (5.51e-2)"	"unprognostic (3.93e-2)"	"prognostic favorable (2.93e-7)"	"unprognostic (1.46e-1)"	"unprognostic (2.75e-1)"	"unprognostic (7.82e-2)"	"unprognostic (3.82e-2)"	17.8	25.6	19.8	16.6	21.7	17.0	26.4	18.0	29.1	13.9	30.8	12.3	15.1	34.0	14.2	15.7	19.8	13.6	15.1	86.9	18.2	16.4	51.0	75.1	16.8	24.6	20.1	18.9	10.5	30.7	20.0	11.3	15.6	16.7	13.0	31.5	11.7	15.9	19.5	96.2	13.2	31.4	21.3	16.5	17.2	21.7	18.7	15.7	14.2	15.5	52.2	18.0	15.4	17.1	22.2	45.9	48.5	48.7	18.9	26.7	25.0	26.0	25.8	14.7	18.8	28.7	28.5	16.8	22.8	29.3	52.3	47.2	36.3	31.3	35.7	28.5	30.7	33.8	30.7	58.7	45.4	59.0	20.9	48.1	32.1	26.9	27.8	35.1	50.2	23.9	29.3	30.0	45.2	76.6	27.8	36.9	31.4	26.8	41.4	36.3	21.5	33.3	28.7	12.2	41.9	51.9	24.0	28.4	44.2	48.1	14.8	27.8	15.2	30.9	38.7	64.9	16.3	22.7	28.4	18.3	20.1	22.7	36.9	30.0	17.3	21.3	36.5	30.8	76.6	22.2	16.6	38.4	37.4	18.3	48.7	18.3	22.2	21.2	19.5	45.9	18.3	19.3	19.5	48.5	18.9	42.2	21.5	26.7	25.0	19.8	21.7	18.0	29.1	18.2	16.4	20.1	18.9	16.7	15.7	59.6	39.6	77.3	79.1	46.2	28.1	395.8	109.5	78.9	40.9	45.4	13.7	93.2	300.1	104.4	146.0	54.0	212.4	116.8	130.5	121.6	58.6	70.1	65.7	198.8	162.9	35.0	46.7	41.7	81.2	13.8	53.5	90.6	60.8	125.4	89.5	52.1	97.2	192.9	63.6	355.3	35.5	38.8	60.4	85.9	68.4	47.7	101.8	52.3	135.8	97.0
SDR16C5	"EPHD-2, RDH-E2, RDHE2"	ENSG00000170786	"Short chain dehydrogenase/reductase family 16C member 5"	Q8N3Y7	8	56300010-56320776	"Enzymes, Predicted membrane proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 27.5;lung: 34.0;skin 1: 35.9;tongue: 25.8"	"Cell type enhanced"	"Detected in many"	13	"Alveolar cells type 1: 44.7;Alveolar cells type 2: 125.1;Basal keratinocytes: 45.3;Ciliated cells: 48.2;Pancreatic endocrine cells: 58.7;Suprabasal keratinocytes: 63.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	36	"memory B-cell: 9.1;naive B-cell: 2.5"	"Lineage enriched"	"Detected in single"	56	"B-cells: 9.1"	"Group enriched"	"Detected in some"	4	"CAPAN-2: 18.0;HaCaT: 9.0;hTCEpi: 14.9;OE19: 21.3;T-47d: 6.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA025224	Enhanced					NA	NA					"HPA025224: AB_1856163"	"unprognostic (1.66e-1)"	"unprognostic (8.88e-2)"	"unprognostic (9.46e-2)"	"unprognostic (4.18e-4)"	"unprognostic (8.83e-3)"	"prognostic favorable (7.88e-4)"		"unprognostic (1.66e-1)"	"unprognostic (2.51e-1)"	"unprognostic (2.42e-1)"	"unprognostic (1.78e-3)"	"unprognostic (2.39e-1)"	"unprognostic (2.48e-5)"	"unprognostic (2.55e-1)"	"unprognostic (8.17e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.71e-1)"	0.3	0.2	2.0	2.0	1.9	0.0	7.4	0.9	6.2	8.1	5.9	0.2	0.0	1.7	0.2	0.0	27.5	0.2	1.5	0.2	0.6	1.2	0.2	0.2	34.0	0.3	1.4	2.9	0.2	0.3	0.0	0.5	0.0	10.6	0.3	3.0	0.2	9.2	0.0	0.3	35.9	16.9	0.2	0.4	0.2	12.9	0.5	0.2	0.0	0.2	25.8	21.1	1.0	11.5	9.1	0.0	0.0	0.0	0.0	0.1	0.1	3.3	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	18.0	0.0	0.0	0.0	0.0	9.0	0.0	0.8	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	14.9	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	21.3	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	6.9	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.1	0.0	0.1	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	2.0	1.9	0.9	6.2	0.6	1.2	1.4	2.9	10.6	0.2	44.7	125.1	0.0	5.5	45.3	0.2	0.1	10.2	48.2	36.4	0.0	0.0	0.0	0.0	0.1	0.0	0.1	4.1	0.0	1.2	0.0	1.5	5.5	3.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.8	3.3	1.0	7.1	9.9	58.7	3.2	0.0	0.0	1.4	0.0	0.3	0.2	4.1	63.1	0.0	0.0	4.5	19.5
SDS	SDH	ENSG00000135094	"Serine dehydratase"	P20132	12	113392445-113426301	"Enzymes, Plasma proteins, Predicted intracellular proteins"	Gluconeogenesis	Lyase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	21	"liver: 276.9"	"Group enriched"	"Detected in many"	4	"Hepatocytes: 317.5;Hofbauer cells: 211.0;monocytes: 169.5"	"Cancer enriched"	"Detected in all"	31	"liver cancer: 165.3"	"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in some"	10	"myeloid DC: 12.8"	"Lineage enriched"	"Detected in single"	15	"dendritic cells: 12.8"	"Cell line enhanced"	"Detected in some"		"HMC-1: 5.5;SK-BR-3: 3.4"	"Low region specificity"	"Detected in single"							HPA039230	Uncertain		Approved	Mitochondria,Cytosol		NA	NA			Cytosol	Mitochondria	"HPA039230: AB_10674281"	"unprognostic (1.31e-1)"	"prognostic favorable (5.24e-4)"	"unprognostic (6.37e-3)"	"unprognostic (6.94e-2)"	"unprognostic (9.19e-3)"	"unprognostic (2.65e-2)"	"unprognostic (2.35e-2)"	"unprognostic (8.85e-2)"	"unprognostic (1.79e-1)"	"unprognostic (2.55e-1)"	"unprognostic (4.89e-2)"	"unprognostic (3.20e-1)"	"unprognostic (4.08e-3)"	"unprognostic (2.12e-1)"	"unprognostic (2.07e-2)"	"unprognostic (4.35e-1)"	"unprognostic (2.99e-2)"	0.9	0.9	2.2	1.4	5.9	0.5	0.4	0.6	2.1	0.5	0.9	0.8	0.0	0.7	0.4	0.2	0.2	0.2	1.4	0.2	1.7	2.5	0.2	276.9	0.6	0.6	4.2	0.7	0.3	0.4	0.1	0.0	1.0	2.8	0.3	0.8	1.3	0.3	0.2	0.2	0.2	0.7	0.3	1.3	0.5	0.9	0.3	0.8	0.1	0.3	0.0	0.3	0.8	0.0	0.0	12.8	0.6	0.8	0.2	0.0	0.3	0.0	0.4	0.2	1.3	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.4	0.2	0.4	2.3	0.0	0.3	0.4	0.0	0.0	0.0	0.5	0.5	1.3	0.6	0.6	0.1	0.8	5.5	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.9	0.6	0.0	1.4	0.1	0.4	0.8	0.0	0.9	0.0	0.8	0.1	0.2	0.6	0.1	0.1	1.6	3.4	0.7	0.1	1.2	1.7	0.6	0.0	0.9	1.1	0.3	0.7	0.4	0.2	1.1	0.8	0.3	0.1	0.8	0.0	0.0	0.7	0.0	0.0	0.0	0.0	12.8	0.0	0.0	0.0	0.6	0.2	0.1	1.3	0.0	0.3	2.2	5.9	0.6	1.6	1.7	2.5	4.2	0.7	2.8	0.8	0.0	1.1	21.2	0.2	2.2	0.0	0.4	7.6	0.0	0.0	0.0	0.0	0.7	0.0	2.1	0.0	0.3	0.0	23.3	0.3	0.7	0.8	0.2	0.0	317.5	211.0	0.0	0.0	10.4	27.7	0.0	0.0	55.6	1.7	169.5	0.0	0.3	0.3	0.0	0.0	0.0	0.2	0.0	2.1	0.0	0.0	2.8	2.1	3.3	0.0	0.0
SDSL	"cSDH, SDS-RS1"	ENSG00000139410	"Serine dehydratase like"	Q96GA7	12	113422237-113438276	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"		Lyase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 53.2"	"Cell type enhanced"	"Detected in many"	9	"Hepatocytes: 118.4;Hofbauer cells: 93.1;monocytes: 174.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	8	"classical monocyte: 6.5;intermediate monocyte: 7.1;myeloid DC: 13.2;plasmacytoid DC: 12.8"	"Group enriched"	"Detected in many"	8	"dendritic cells: 13.2;monocytes: 7.1"	"Cell line enhanced"	"Detected in many"		"HMC-1: 22.6;MCF7: 38.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA005740	Approved		Approved	Cytosol		NA	NA			Cytosol		"HPA005740: AB_10601486"	"unprognostic (1.34e-1)"	"unprognostic (8.33e-2)"	"unprognostic (3.62e-2)"	"unprognostic (3.54e-2)"	"unprognostic (2.24e-2)"	"unprognostic (6.17e-3)"	"unprognostic (1.57e-1)"	"unprognostic (6.46e-2)"	"unprognostic (8.22e-2)"	"unprognostic (2.00e-2)"	"prognostic favorable (8.58e-4)"	"unprognostic (2.93e-1)"	"prognostic favorable (3.09e-5)"	"unprognostic (2.22e-2)"	"unprognostic (1.43e-1)"	"unprognostic (2.54e-1)"	"unprognostic (7.33e-2)"	3.1	15.3	4.2	3.8	5.1	1.4	2.8	1.5	7.1	2.6	7.1	5.5	6.2	10.0	2.5	9.7	1.3	4.6	5.2	7.2	3.6	6.1	15.5	53.2	2.8	2.8	9.5	4.2	4.6	15.3	5.0	7.6	3.1	7.8	4.2	5.0	4.6	4.9	4.5	2.1	0.7	7.8	2.9	8.8	3.0	5.2	7.0	2.6	1.5	20.3	1.3	1.6	4.0	1.5	1.1	13.2	0.3	7.1	1.3	0.2	1.7	3.6	14.2	2.0	6.0	0.4	0.9	1.4	2.1	0.5	2.2	1.9	6.1	3.8	0.2	10.7	3.4	6.2	3.7	0.9	4.8	0.8	8.6	3.6	9.1	3.4	2.6	12.0	1.1	22.6	1.9	6.8	5.5	8.2	2.6	3.3	0.0	7.1	2.8	2.7	38.7	0.0	4.5	2.1	3.9	6.1	0.0	3.0	6.8	5.9	4.4	0.6	0.2	8.8	10.0	8.5	1.9	12.3	10.4	3.0	2.7	5.3	12.1	1.8	0.6	0.5	0.1	11.6	3.7	3.3	0.1	6.5	0.0	0.0	7.1	0.0	1.1	0.0	0.0	13.2	0.1	0.0	0.0	0.3	1.3	0.9	12.8	0.2	1.7	4.2	5.1	1.5	7.1	3.6	6.1	9.5	4.2	7.8	2.6	0.0	6.1	8.6	2.1	0.8	0.2	15.7	25.5	0.0	0.0	27.9	2.0	11.4	66.3	30.4	0.4	2.9	43.5	23.3	17.7	2.6	3.8	6.0	43.8	118.4	93.1	3.2	30.5	4.9	12.3	1.1	2.6	14.9	3.3	174.9	28.9	19.5	17.4	40.3	5.3	76.8	1.5	0.0	5.7	0.0	0.2	0.5	6.1	4.3	25.5	4.3
SEC11A	"SEC11L1, sid2895, SPC18, SPCS4A"	ENSG00000140612	"SEC11 homolog A, signal peptidase complex subunit"	P67812	15	84669538-84716716	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"		"Hydrolase, Protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA047533			Approved	"Nuclear membrane,Golgi apparatus"		NA	NA		7400000	"Nuclear membrane"	"Golgi apparatus"	"HPA047533: AB_2680078"	"unprognostic (8.81e-3)"	"unprognostic (1.97e-1)"	"unprognostic (3.19e-2)"	"prognostic favorable (1.94e-5)"	"unprognostic (3.39e-2)"	"prognostic unfavorable (5.99e-5)"	"unprognostic (1.51e-1)"	"unprognostic (1.95e-1)"	"unprognostic (2.79e-1)"	"unprognostic (1.42e-2)"	"unprognostic (6.17e-2)"	"unprognostic (6.24e-2)"	"unprognostic (1.09e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.80e-1)"	"prognostic favorable (2.95e-4)"	"unprognostic (7.89e-2)"	65.5	43.6	18.7	23.3	17.3	36.4	42.6	11.2	15.5	44.4	38.5	23.0	38.8	20.7	41.8	57.9	40.3	27.3	33.2	30.8	18.7	18.4	56.5	68.2	44.7	41.1	24.7	12.6	55.7	70.9	21.2	41.7	46.0	18.4	44.4	28.0	28.5	43.5	36.2	51.9	23.3	33.3	39.7	31.5	38.4	29.5	28.2	19.7	33.2	74.6	39.3	32.1	49.8	37.8	29.1	44.3	32.6	48.4	34.3	45.9	46.3	23.7	51.3	37.9	58.6	48.1	60.0	29.1	38.0	44.3	31.2	37.4	54.9	59.0	11.8	25.0	46.7	36.9	51.9	52.5	31.9	34.0	29.0	38.8	34.5	58.5	51.6	41.7	25.9	39.1	41.3	40.1	21.5	34.9	50.9	44.1	15.5	34.2	31.8	42.1	55.7	10.6	56.4	40.3	36.1	22.1	13.3	49.0	38.5	70.2	66.7	18.6	41.8	31.6	35.4	85.5	59.4	34.5	60.3	30.0	31.7	23.8	27.0	46.2	31.2	59.2	16.7	34.4	45.7	24.7	20.7	43.8	24.1	28.4	47.3	28.5	29.1	35.4	30.4	43.8	26.6	30.2	30.9	32.6	34.3	48.4	44.3	45.9	46.3	18.7	17.3	11.2	15.5	18.7	18.4	24.7	12.6	18.4	19.7	83.4	82.6	129.4	146.5	95.1	26.0	57.2	214.0	68.3	101.2	122.1	21.6	264.5	202.2	211.7	36.2	236.3	103.8	23.3	215.7	493.0	216.8	157.8	217.7	143.3	324.9	19.1	151.1	167.6	353.0	67.9	277.3	291.4	150.1	267.9	172.8	64.3	169.6	103.7	156.3	255.0	33.2	168.1	121.7	176.8	142.9	104.8	255.7	159.2	214.9	195.4
SEC11C	"SEC11L3, SPC21, SPCS4C"	ENSG00000166562	"SEC11 homolog C, signal peptidase complex subunit"	Q9BY50	18	59139477-59158836	"Enzymes, Predicted membrane proteins"		"Hydrolase, Protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"salivary gland: 132.6"	"Cell type enhanced"	"Detected in all"	5	"Glandular cells: 405.9;Muller glia cells: 440.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 59.5;Karpas-707: 64.1;RPMI-8226: 129.8;U-266/70: 65.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA026816, HPA047533"	Approved		Approved	"Nuclear membrane,Golgi apparatus"		NA	NA			"Nuclear membrane"	"Golgi apparatus"	"HPA026816: AB_10602089, HPA047533: AB_2680078"	"unprognostic (1.47e-2)"	"unprognostic (2.20e-2)"	"unprognostic (1.26e-1)"	"unprognostic (2.44e-2)"	"unprognostic (3.13e-3)"	"unprognostic (4.48e-3)"	"unprognostic (2.95e-1)"	"unprognostic (2.32e-2)"	"unprognostic (1.15e-1)"	"unprognostic (4.33e-2)"	"unprognostic (1.80e-2)"	"unprognostic (1.72e-1)"	"unprognostic (6.25e-2)"	"unprognostic (3.83e-2)"	"unprognostic (4.63e-2)"	"unprognostic (2.58e-1)"	"unprognostic (1.15e-1)"	5.9	18.4	30.1	18.6	29.7	11.3	16.0	14.9	25.2	12.2	18.7	24.4	27.8	27.5	9.1	58.0	10.7	9.2	11.1	7.2	27.7	33.9	19.0	66.8	13.0	22.0	41.8	21.3	7.0	96.8	14.6	46.6	8.1	27.1	48.8	16.4	10.0	132.6	34.1	4.3	7.9	21.1	6.6	51.3	23.6	28.4	6.4	25.3	7.3	35.9	8.6	23.4	18.9	5.9	33.6	50.0	10.6	17.6	17.3	34.4	32.6	8.8	10.7	5.8	9.0	3.6	0.6	7.4	8.0	6.9	9.9	6.0	7.5	4.8	20.3	12.7	4.8	7.3	9.5	9.1	6.0	5.7	59.5	12.5	6.5	7.4	22.9	10.8	21.5	9.9	2.0	14.4	6.1	16.6	2.1	3.2	8.7	7.5	64.1	3.5	10.4	8.8	8.6	5.9	14.7	6.6	8.0	5.7	129.8	6.4	7.4	27.1	10.8	4.8	19.5	27.1	3.3	8.8	15.8	2.6	12.0	5.0	4.2	9.6	65.4	48.1	19.9	12.0	14.6	14.7	10.6	13.1	9.4	25.9	15.5	33.1	33.6	27.3	25.2	13.5	17.4	14.3	19.5	2.0	17.3	17.6	50.0	34.4	32.6	30.1	29.7	14.9	25.2	27.7	33.9	41.8	21.3	27.1	25.3	26.8	96.0	46.9	40.1	29.0	63.6	51.8	132.5	95.0	89.9	57.6	47.1	59.9	74.6	117.2	35.1	52.2	73.8	23.3	229.6	80.5	24.9	405.9	46.2	201.1	102.0	47.7	325.7	35.6	28.2	14.8	11.5	58.2	243.0	32.5	93.2	440.4	146.8	74.8	21.5	86.0	65.5	6.5	40.9	97.2	84.1	39.6	125.2	74.3	75.9	57.4
SELENBP1	"hSBP, hSP56, LPSB"	ENSG00000143416	"Selenium binding protein 1"	Q13228	1	151364302-151372733	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Protein transport, Transport"	Oxidoreductase	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"intestine: 112.3"	"Cell type enhanced"	"Detected in many"	6	"Alveolar cells type 2: 401.2;Enterocytes: 467.1;Hepatocytes: 434.3;Paneth cells: 327.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	4	"myeloid DC: 4.8"	"Lineage enriched"	"Detected in many"	4	"dendritic cells: 4.8"	"Cell line enhanced"	"Detected in many"		"ASC diff: 38.5;HEL: 28.5;HSkMC: 19.8;OE19: 23.2;SK-BR-3: 68.7"					"Low region specificity"	"Detected in all"			"HPA005741, CAB008366, HPA011731"	Enhanced		Supported	Nucleoli		NA	NA		57000000	Nucleoli		"CAB008366: AB_592677, HPA005741: AB_1856662, HPA011731: AB_1856663"	"unprognostic (1.51e-1)"	"unprognostic (7.01e-2)"	"unprognostic (8.52e-3)"	"unprognostic (6.25e-3)"	"unprognostic (6.28e-2)"	"prognostic favorable (6.63e-4)"	"unprognostic (1.08e-2)"	"unprognostic (1.21e-2)"	"unprognostic (3.78e-3)"	"unprognostic (2.86e-1)"	"unprognostic (1.46e-1)"	"unprognostic (2.60e-1)"	"unprognostic (2.67e-2)"	"unprognostic (6.98e-2)"	"unprognostic (1.95e-1)"	"unprognostic (1.86e-2)"	"unprognostic (6.86e-3)"	27.9	5.1	17.2	28.9	16.4	17.6	18.4	6.5	11.9	15.1	105.1	10.4	15.8	17.2	13.5	23.1	11.0	32.4	28.8	11.7	18.5	5.1	20.8	56.3	64.9	5.6	10.9	14.9	13.2	7.2	1.4	4.1	5.6	11.3	19.1	112.3	27.9	14.5	15.4	15.9	6.4	29.1	22.9	6.5	13.0	29.1	4.1	13.0	0.0	52.9	18.3	6.0	15.8	8.1	0.0	4.8	0.0	1.1	0.0	0.0	5.5	0.0	4.3	8.0	0.4	38.5	15.4	2.0	1.6	0.8	0.8	1.6	4.3	1.3	0.0	7.4	2.6	0.0	0.0	0.0	0.1	0.6	0.0	3.7	28.5	14.4	6.9	8.1	0.0	0.0	19.8	0.2	1.3	0.0	0.1	4.8	0.0	2.8	0.0	2.0	3.2	0.0	0.0	6.4	23.2	8.1	0.0	0.4	0.1	1.8	0.0	0.1	0.1	0.0	68.7	0.0	6.8	11.8	0.4	0.4	0.0	0.2	4.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.1	0.0	0.0	0.7	0.0	0.0	0.0	0.0	4.8	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	5.5	17.2	16.4	6.5	11.9	18.5	5.1	10.9	14.9	11.3	13.0	273.9	401.2	14.3	27.8	9.6	0.2	107.6	81.5	93.7	100.1	5.2	0.0	2.2	97.8	10.9	0.6	13.2	467.1	280.4	7.9	1.9	45.2	28.8	26.5	434.3	11.9	0.0	149.0	21.5	23.4	2.0	61.5	8.5	32.1	0.0	88.1	35.2	8.1	327.6	76.0	115.0	1.0	51.8	66.0	0.0	0.2	8.7	3.3	6.9	282.5	68.5
SELENOI	"EPT1, KIAA1724, SELI, SEPI"	ENSG00000138018	"Selenoprotein I"	Q9C0D9	2	26308547-26395891	"Enzymes, Predicted membrane proteins"	"Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"	9	"Alveolar cells type 1: 11.9;Collecting duct cells: 21.0;Ductal cells: 9.5;Pancreatic endocrine cells: 11.6;Syncytiotrophoblasts: 13.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA064125	Approved					NA	NA					"HPA064125: "	"unprognostic (6.29e-2)"	"unprognostic (7.46e-2)"	"unprognostic (1.38e-3)"	"unprognostic (3.05e-3)"	"unprognostic (1.50e-1)"	"unprognostic (1.39e-2)"	"unprognostic (7.44e-3)"	"unprognostic (5.00e-3)"	"unprognostic (7.79e-2)"	"unprognostic (2.55e-2)"	"unprognostic (6.65e-2)"	"unprognostic (9.40e-2)"	"unprognostic (1.52e-2)"	"unprognostic (2.95e-1)"	"unprognostic (1.76e-1)"	"unprognostic (9.87e-3)"	"unprognostic (1.42e-2)"	5.5	8.8	10.3	7.0	20.6	13.3	10.8	21.4	22.5	7.1	10.7	14.1	5.0	15.3	5.8	7.6	15.7	5.0	5.6	6.1	14.7	11.3	10.6	28.6	6.7	6.9	9.7	9.4	5.9	11.3	27.2	11.7	8.5	14.9	8.5	11.5	9.2	9.5	6.2	10.1	22.5	22.1	5.2	15.6	6.3	9.1	5.8	11.0	8.0	9.4	9.4	9.1	7.1	9.9	5.4	3.0	0.6	2.5	2.1	5.0	1.0	19.5	12.1	10.0	10.0	6.3	5.1	15.3	9.6	4.4	4.9	5.0	25.4	12.6	22.8	11.7	4.5	10.4	16.1	15.5	8.5	7.1	6.3	7.3	14.4	8.7	14.9	6.0	19.1	4.7	4.0	7.6	10.7	10.7	2.9	4.4	8.3	16.3	8.0	6.4	8.5	11.3	9.6	12.9	10.0	8.3	10.4	23.7	11.6	9.4	15.2	22.0	9.4	8.1	17.3	7.7	8.7	8.3	5.7	7.1	8.3	10.8	10.9	14.7	10.9	26.9	31.2	8.5	11.9	7.4	0.1	1.7	0.0	2.2	2.5	2.3	5.4	2.3	2.9	1.7	2.6	3.0	5.0	0.6	2.1	2.1	3.0	4.1	1.0	10.3	20.6	21.4	22.4	14.7	11.3	9.7	9.4	14.9	11.0	11.9	8.3	0.0	0.0	0.0	0.0	0.0	0.0	4.0	5.7	21.0	0.0	5.1	0.0	9.5	0.0	0.0	0.0	0.0	8.9	4.9	0.0	0.0	1.1	0.0	5.9	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	1.0	0.0	0.0	11.6	0.0	0.0	5.3	0.0	0.0	0.0	0.0	0.0	0.0	13.8	0.0	0.0	0.0
SELENOT	SELT	ENSG00000198843	"Selenoprotein T"	P62341	3	150602875-150630445	"Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	9	"Cytotrophoblasts: 180.2;Extravillous trophoblasts: 191.0;Hofbauer cells: 214.0;monocytes: 215.6;Syncytiotrophoblasts: 409.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA039780	Approved					NA	NA					"HPA039780: AB_10805594"	"unprognostic (1.13e-1)"	"unprognostic (4.03e-2)"	"unprognostic (2.78e-1)"	"unprognostic (1.92e-1)"	"unprognostic (3.31e-1)"	"unprognostic (1.34e-2)"	"unprognostic (2.65e-3)"	"unprognostic (1.49e-1)"	"unprognostic (8.96e-2)"	"unprognostic (5.79e-3)"	"unprognostic (6.30e-3)"	"unprognostic (1.99e-1)"	"unprognostic (3.08e-3)"	"unprognostic (4.91e-2)"	"unprognostic (4.08e-2)"	"unprognostic (1.58e-1)"	"unprognostic (3.41e-2)"	29.7	52.6	39.9	32.1	44.1	54.5	31.0	33.9	48.2	29.9	29.7	37.7	26.7	29.7	29.2	41.8	30.3	31.2	23.5	32.7	41.6	47.4	47.0	52.5	31.1	44.5	41.3	28.2	27.7	34.2	30.6	46.6	50.8	48.0	31.8	36.7	30.2	31.5	33.0	30.5	20.0	38.5	33.4	50.0	49.8	28.5	23.6	31.9	32.3	45.7	23.0	43.2	34.3	23.1	32.1	34.0	54.5	43.2	26.5	42.3	71.0	48.7	20.3	13.1	11.7	20.2	19.9	24.8	38.9	28.8	27.0	18.5	32.1	28.8	27.7	39.8	28.8	23.9	16.9	20.4	24.4	41.6	23.1	17.0	28.8	12.4	15.0	22.2	16.9	21.9	17.1	19.6	24.1	21.0	20.1	29.1	12.5	6.6	81.8	39.3	30.0	22.4	9.8	14.0	29.4	21.8	16.1	16.5	46.1	23.3	29.3	14.0	8.6	23.3	14.7	15.4	17.1	28.0	20.3	27.3	14.7	9.2	26.4	35.7	57.3	29.4	38.3	20.0	30.8	12.5	41.9	43.2	36.4	38.5	35.0	42.3	32.1	32.0	35.2	34.0	26.7	25.3	32.0	54.5	26.5	37.7	24.1	33.5	71.0	39.9	44.1	33.9	48.2	41.6	47.4	41.3	28.2	48.0	31.9	56.6	58.2	0.0	0.0	0.0	0.0	0.0	0.0	60.2	53.4	102.9	0.0	180.2	82.9	154.9	0.0	0.0	0.0	0.0	118.0	191.0	0.0	0.0	41.8	0.0	214.0	0.0	0.0	0.0	0.0	0.0	0.0	45.9	0.0	215.6	0.0	0.0	158.1	0.0	0.0	154.8	0.0	0.0	0.0	0.0	0.0	0.0	409.2	0.0	0.0	0.0
SENP1		ENSG00000079387	"SUMO1/sentrin specific peptidase 1"	Q9P0U3	12	48042898-48106308	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 60.2"	"Cell type enhanced"	"Detected in many"	10	"Spermatocytes: 64.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA011765, HPA046491"			Supported	"Nucleoplasm,Focal adhesion sites"		NA	NA			Nucleoplasm	"Focal adhesion sites"	"HPA011765: AB_1079907, HPA046491: AB_2679672"	"unprognostic (2.66e-2)"	"unprognostic (6.51e-2)"	"unprognostic (3.14e-1)"	"unprognostic (5.69e-2)"	"unprognostic (2.83e-1)"	"unprognostic (1.09e-1)"	"prognostic unfavorable (7.72e-5)"	"unprognostic (6.48e-2)"	"unprognostic (2.44e-3)"	"unprognostic (8.20e-3)"	"unprognostic (2.57e-1)"	"unprognostic (2.23e-1)"	"prognostic unfavorable (8.37e-4)"	"unprognostic (7.61e-2)"	"unprognostic (3.02e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.28e-1)"	5.7	3.3	3.0	9.0	4.0	8.4	5.2	5.3	3.2	5.5	4.9	3.8	3.5	3.4	6.2	4.3	5.7	5.2	3.8	3.6	2.7	3.3	3.8	3.9	4.3	7.3	3.0	2.3	6.2	4.4	6.1	11.4	8.1	3.0	4.4	4.7	5.1	20.0	4.7	6.8	6.6	4.5	5.8	4.3	6.4	4.5	60.2	3.6	15.0	5.2	4.8	8.3	5.7	6.3	5.3	3.8	7.1	2.6	3.8	5.5	2.3	7.1	9.2	11.5	8.6	3.4	5.1	8.5	7.7	8.6	13.2	10.8	11.3	11.6	19.4	6.7	7.0	5.2	7.0	14.2	6.8	13.5	17.6	6.4	17.0	8.9	5.4	5.7	15.8	11.5	4.1	5.6	11.9	10.6	5.9	6.9	13.2	14.9	9.3	6.8	5.7	19.7	5.0	10.5	4.9	7.0	18.7	12.1	9.5	3.6	8.8	12.1	8.3	11.1	6.8	4.5	6.8	10.7	7.6	6.3	11.2	10.1	6.5	8.1	9.6	15.5	19.0	6.9	36.8	5.1	2.0	1.8	7.1	4.3	2.6	5.5	2.4	4.2	3.9	3.3	5.3	3.6	4.1	3.8	3.8	2.0	3.8	5.0	2.3	3.0	4.0	5.3	3.2	2.7	3.3	3.0	2.3	3.0	3.6	8.9	6.2	5.6	4.2	3.3	8.2	2.1	7.6	5.3	10.3	3.5	3.9	3.1	3.3	3.0	10.2	6.3	2.5	0.0	5.6	2.8	3.7	3.6	5.8	6.6	3.8	14.3	3.4	7.4	10.0	3.3	5.8	4.8	1.7	5.4	3.7	4.8	4.5	2.0	6.3	3.4	8.3	0.0	3.1	64.4	24.9	5.4	2.3	4.4	3.6	3.0
SENP2	"AXAM2, DKFZp762A2316, KIAA1331, SMT3IP2"	ENSG00000163904	"SUMO1/sentrin/SMT3 specific peptidase 2"	Q9HC62	3	185582496-185633551	"Enzymes, Plasma proteins, Predicted intracellular proteins, Transporters"	"mRNA transport, Protein transport, Translocation, Transport, Ubl conjugation pathway, Wnt signaling pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	9	"Early spermatids: 190.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029247, HPA029248"	Approved		Supported	Cytosol		NA	NA			Cytosol		"HPA029247: AB_10599305, HPA029248: AB_10601855"	"unprognostic (4.57e-2)"	"unprognostic (1.84e-2)"	"unprognostic (6.80e-2)"	"prognostic unfavorable (7.98e-5)"	"unprognostic (7.85e-2)"	"unprognostic (2.90e-2)"	"unprognostic (4.41e-3)"	"unprognostic (1.45e-1)"	"unprognostic (1.59e-1)"	"unprognostic (1.46e-1)"	"unprognostic (1.85e-1)"	"unprognostic (8.41e-3)"	"unprognostic (5.12e-2)"	"unprognostic (6.92e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.92e-1)"	"unprognostic (1.56e-1)"	10.3	10.1	16.0	7.6	19.8	13.8	11.6	18.8	20.2	8.7	8.8	13.8	7.8	9.2	9.5	15.4	9.3	9.7	7.0	10.9	15.2	15.1	11.3	14.2	9.5	8.6	14.6	12.0	16.0	9.1	15.6	16.7	13.4	13.9	9.7	9.6	9.1	11.0	10.3	24.6	13.9	8.5	9.2	12.9	9.2	9.4	34.9	17.1	11.0	11.2	7.3	8.9	8.5	9.3	4.2	4.4	7.8	3.2	5.1	3.8	1.9	15.3	3.1	7.6	8.7	13.7	9.3	9.9	7.2	8.1	9.0	9.6	11.6	4.9	8.3	13.6	6.4	15.6	8.2	15.9	5.8	13.4	6.1	7.5	5.6	6.4	6.9	7.3	8.2	3.7	5.8	8.8	5.1	6.3	6.6	6.2	8.0	6.6	11.8	7.7	7.6	6.9	9.2	28.1	7.8	5.3	8.2	10.4	13.8	5.0	5.1	7.9	8.9	6.0	13.3	11.1	16.1	18.2	11.1	3.9	6.0	6.5	10.9	11.2	13.7	16.3	15.2	9.8	8.8	8.1	7.2	3.0	5.4	3.7	2.8	3.8	3.0	3.1	3.0	2.2	4.2	3.7	3.6	7.8	5.1	3.2	4.4	2.7	1.9	16.0	19.8	18.8	20.2	15.2	15.1	14.6	12.0	13.9	17.1	26.8	21.4	9.0	19.8	9.6	23.0	20.5	10.2	32.1	35.2	8.7	29.5	21.4	5.0	11.3	190.6	11.3	16.0	0.0	13.3	16.4	13.4	15.3	10.4	15.8	11.1	11.1	5.2	16.5	9.1	24.4	21.0	9.5	16.9	8.2	13.7	15.6	13.8	3.5	16.6	14.7	34.4	19.4	13.4	83.9	30.9	10.9	33.2	16.7	14.4	18.2
SENP3	"DKFZP586K0919, DKFZp762A152, SMT3IP1, SSP3, Ulp1"	ENSG00000161956	"SUMO1/sentrin/SMT3 specific peptidase 3"	Q9H4L4	17	7561875-7571969	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Cone photoreceptor cells: 21.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"											HPA060290	Supported		Supported	Nucleoplasm,Nucleoli		Yes	No			"Nucleoplasm, Nucleoli"		"HPA060290: AB_2684244"	"unprognostic (5.68e-2)"	"unprognostic (2.39e-1)"	"unprognostic (1.65e-1)"	"unprognostic (1.01e-1)"	"unprognostic (3.34e-1)"	"unprognostic (3.48e-1)"	"unprognostic (1.30e-3)"	"unprognostic (2.82e-1)"	"unprognostic (7.37e-2)"	"unprognostic (3.72e-2)"	"prognostic favorable (6.22e-5)"	"unprognostic (2.71e-2)"	"unprognostic (1.96e-1)"	"unprognostic (1.42e-1)"	"unprognostic (1.37e-1)"	"unprognostic (8.21e-2)"	"unprognostic (2.56e-2)"	16.3	16.0	22.3	20.9	23.4	16.6	18.0	29.2	38.4	15.9	22.5	18.4	16.8	16.2	18.6	22.7	18.6	19.9	17.0	26.1	21.0	19.2	17.5	15.1	18.7	18.8	20.0	23.3	19.6	17.8	29.5	17.3	23.6	17.2	16.0	20.5	17.3	18.6	21.9	22.0	20.8	17.6	23.1	15.3	18.9	17.2	28.8	16.4	18.9	19.0	14.2	23.4	16.8	32.8	0.8	0.7	1.1	0.7	1.1	1.7	0.3	26.5	32.2	19.1	29.6	21.7	15.9	20.0	19.5	20.0	34.0	32.0	19.2	11.6	31.8	19.4	25.6	23.5	25.6	41.1	30.5	28.6	22.4	37.5	16.5	27.3	19.7	29.3	15.1	21.0	20.3	31.2	38.8	38.1	19.6	27.3	36.3	21.1	9.0	26.2	17.8	36.8	11.5	23.7	24.8	19.6	33.7	17.9	18.3	22.7	15.6	19.1	24.7	19.5	18.9	20.7	25.5	15.9	9.9	14.3	19.6	17.0	18.6	41.8	13.2	13.7	20.2	19.7	16.1	28.9	0.1	0.7	0.2	0.4	0.4	0.1	0.4	0.2	1.3	0.1	0.8	1.7	0.5	1.1	1.1	0.1	0.7	0.3	0.3	22.3	23.4	29.2	38.4	21.0	19.2	20.0	23.3	17.2	16.4	3.0	4.8	2.7	5.7	7.6	5.8	5.9	7.6	1.4	4.5	1.8	21.6	2.6	0.0	1.9	1.1	4.5	2.3	0.0	2.1	1.9	3.9	4.1	1.1	2.6	1.3	6.4	6.3	9.8	6.9	0.4	3.7	4.1	3.3	1.8	2.5	5.0	1.9	0.0	2.1	0.7	8.0	0.0	3.6	2.8	3.5	10.2	3.4	4.9	3.4	5.6
SENP5	MGC27076	ENSG00000119231	"SUMO1/sentrin specific peptidase 5"	Q96HI0	3	196867856-196934714	"Enzymes, Predicted intracellular proteins"	"Cell cycle, Cell division, Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA006575			Approved	Nucleoplasm,Nucleoli,Centrosome,Cytosol		NA	NA			"Nucleoplasm, Nucleoli"	"Centrosome, Cytosol"	"HPA006575: "	"unprognostic (4.07e-2)"	"unprognostic (4.91e-3)"	"unprognostic (7.63e-2)"	"prognostic unfavorable (4.04e-4)"	"unprognostic (4.13e-1)"	"unprognostic (1.08e-1)"	"prognostic unfavorable (4.15e-4)"	"unprognostic (2.95e-1)"	"unprognostic (2.20e-1)"	"unprognostic (2.88e-1)"	"unprognostic (2.89e-1)"	"unprognostic (9.57e-3)"	"prognostic unfavorable (2.14e-5)"	"unprognostic (2.02e-1)"	"unprognostic (1.62e-1)"	"unprognostic (1.62e-2)"	"unprognostic (6.71e-2)"	13.8	13.5	20.0	15.3	20.0	25.7	16.1	28.3	23.8	15.0	15.1	16.1	14.5	11.3	14.6	16.2	16.3	12.9	14.4	15.9	18.9	21.7	13.6	19.5	15.2	15.9	19.4	18.4	17.5	15.7	19.8	21.5	17.8	23.5	15.1	14.0	12.0	13.2	15.9	17.8	16.4	13.0	16.8	18.2	17.1	14.0	36.6	16.4	19.3	14.1	9.2	21.1	14.9	20.1	8.9	7.8	15.8	8.7	7.6	8.9	4.2	13.3	6.1	9.8	8.8	8.3	9.9	7.8	8.5	9.1	9.3	15.0	10.6	5.3	12.5	23.8	9.3	15.9	9.2	10.1	4.5	15.1	6.7	6.6	16.9	9.1	7.4	9.6	14.0	8.0	8.5	12.3	9.5	10.1	6.7	9.0	11.2	11.2	19.4	10.8	11.5	13.1	8.2	7.6	7.3	12.0	8.5	7.9	8.5	4.5	7.6	6.1	8.1	9.5	10.8	10.5	10.3	18.1	10.7	10.1	9.1	9.3	12.4	17.4	20.8	36.3	27.0	12.2	11.3	10.3	15.8	7.6	7.1	8.9	8.1	8.1	8.9	8.6	8.8	5.0	8.5	8.0	8.6	14.9	7.6	8.7	7.8	6.9	4.2	20.0	20.0	28.3	23.8	18.9	21.7	19.4	18.4	23.5	16.4	20.8	13.0	17.1	20.7	54.0	26.0	12.5	10.2	9.4	14.8	8.7	15.7	15.8	10.0	14.8	27.7	20.4	12.4	0.0	12.2	12.8	21.0	19.3	25.5	16.6	12.0	27.0	20.7	13.5	16.1	36.8	15.0	18.8	13.5	14.4	13.2	15.4	20.6	17.5	15.6	14.7	27.7	25.8	24.0	36.7	40.5	54.3	19.1	26.7	10.1	28.1
SENP6	"KIAA0797, SUSP1"	ENSG00000112701	"SUMO1/sentrin specific peptidase 6"	Q9GZR1	6	75601509-75718278	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA024376	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA024376: AB_1856678"	"unprognostic (9.86e-2)"	"unprognostic (1.20e-2)"	"unprognostic (4.84e-2)"	"unprognostic (1.87e-2)"	"unprognostic (6.38e-3)"	"unprognostic (7.33e-2)"	"unprognostic (1.13e-2)"	"unprognostic (2.97e-1)"	"unprognostic (3.93e-2)"	"unprognostic (5.32e-3)"	"unprognostic (7.81e-2)"	"unprognostic (9.24e-2)"	"prognostic unfavorable (6.09e-4)"	"unprognostic (1.78e-1)"	"unprognostic (1.74e-1)"	"prognostic unfavorable (2.83e-5)"	"unprognostic (1.72e-1)"	25.9	20.0	24.3	21.8	24.5	27.1	25.9	35.0	24.3	32.5	27.7	23.5	24.9	16.8	37.7	21.2	21.0	27.4	21.5	20.0	22.8	19.8	24.1	22.5	22.5	21.1	29.6	20.3	38.7	21.8	40.1	44.2	26.8	27.0	27.7	21.8	23.0	20.4	25.7	27.8	22.0	24.1	43.0	27.2	24.7	21.3	26.1	28.6	28.5	34.8	15.8	23.9	27.1	34.0	9.9	10.9	19.4	13.1	9.8	11.2	5.5	10.9	11.5	26.2	18.7	20.4	27.2	19.5	19.8	22.1	16.8	21.0	15.8	10.6	18.6	18.8	22.8	19.8	14.1	24.6	13.2	26.0	27.4	21.3	28.2	13.9	14.7	28.4	24.5	20.8	21.0	22.1	15.7	35.1	20.4	27.7	15.6	34.1	20.7	20.5	13.4	9.7	13.2	15.9	14.8	9.8	18.3	13.8	27.2	17.9	16.4	22.9	23.7	16.9	15.0	17.2	22.0	13.5	23.4	23.1	15.0	16.4	7.7	20.4	23.8	23.6	14.9	7.5	23.4	15.8	5.2	7.4	19.4	7.7	7.9	11.2	9.3	7.8	10.2	8.7	9.9	11.2	9.9	14.7	9.8	13.1	10.9	6.5	5.5	24.3	24.5	35.0	24.3	22.8	19.8	29.6	20.3	27.0	28.6	62.5	112.5	47.7	47.5	41.3	58.8	66.9	35.7	56.2	105.8	27.9	86.4	28.4	14.9	28.8	30.6	40.8	33.0	0.0	28.8	23.6	46.3	54.5	61.4	29.8	25.4	57.2	26.5	36.8	38.9	28.6	65.6	37.8	33.7	39.7	33.3	61.0	28.0	24.6	59.4	24.5	62.7	25.8	62.7	116.1	58.3	42.3	34.4	34.8	39.8	53.1
SENP7		ENSG00000138468	"SUMO1/sentrin specific peptidase 7"	Q9BQF6	3	101324205-101513241	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027259, HPA071998"	Approved		Supported	"Nucleoplasm,Nuclear bodies,Centrosome,Cytosol"		NA	NA			Nucleoplasm	"Nuclear bodies, Centrosome, Cytosol"	"HPA027259: AB_1856679, HPA071998: "	"unprognostic (1.50e-1)"	"unprognostic (6.12e-2)"	"unprognostic (2.78e-2)"	"unprognostic (7.31e-2)"	"unprognostic (2.44e-2)"	"prognostic favorable (4.23e-4)"	"unprognostic (1.38e-3)"	"unprognostic (9.25e-3)"	"unprognostic (8.80e-2)"	"unprognostic (2.24e-1)"	"unprognostic (7.77e-3)"	"unprognostic (1.94e-1)"	"unprognostic (9.85e-2)"	"unprognostic (8.08e-3)"	"unprognostic (3.27e-1)"	"unprognostic (9.03e-2)"	"unprognostic (2.23e-2)"	17.0	9.0	11.0	19.1	14.5	19.5	16.5	35.5	19.5	21.7	13.1	11.8	8.2	6.4	24.3	15.2	11.9	18.6	12.8	10.0	13.2	9.1	10.5	7.7	11.5	19.0	12.9	10.8	27.9	15.9	22.4	24.4	17.0	18.7	15.1	10.0	9.2	10.2	11.1	11.1	18.6	13.8	16.0	17.3	14.1	13.6	7.9	16.8	32.1	16.0	9.4	15.4	17.2	14.0	6.8	3.2	24.5	4.1	6.2	7.6	3.8	7.0	4.8	23.6	13.0	4.5	6.9	4.3	4.1	3.0	6.8	8.5	3.1	6.6	5.4	6.4	3.9	6.3	7.1	7.3	3.7	13.8	10.1	2.2	9.8	3.7	4.2	3.7	5.7	9.7	5.3	6.8	3.4	7.8	6.2	9.8	10.7	8.1	14.0	6.4	4.6	10.4	6.6	4.8	3.7	5.1	11.6	6.3	4.9	8.2	4.1	9.1	7.0	3.8	3.9	5.1	12.7	6.3	7.6	8.0	9.5	5.9	3.2	4.0	9.9	5.9	12.8	3.3	7.6	7.7	24.5	4.1	3.8	4.2	3.6	5.2	4.2	5.6	4.2	3.2	6.8	7.6	5.1	12.6	6.2	3.8	2.8	4.5	3.8	11.0	14.5	35.5	19.5	13.2	9.1	12.9	10.8	18.7	16.8	14.9	26.4	9.5	7.3	8.0	47.4	19.3	5.1	38.8	25.0	15.7	19.6	5.0	5.0	6.0	2.1	22.9	5.6	0.0	4.5	2.2	13.9	6.7	34.8	9.6	6.7	49.3	12.6	42.4	22.1	2.5	17.0	11.6	10.1	1.8	6.3	20.1	6.1	2.9	18.4	6.7	33.6	45.3	9.9	20.4	17.1	8.7	2.1	22.4	4.9	3.9
SENP8	"DEN1, HsT17512, NEDP1, PRSC2"	ENSG00000166192	"SUMO/sentrin peptidase family member, NEDD8 specific"	Q96LD8	15	72114258-72143688	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 26.5"	"Group enriched"	"Detected in many"	11	"Early spermatids: 71.2;Late spermatids: 177.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA036273	Approved		Approved	Nucleoplasm,Vesicles		NA	NA			"Nucleoplasm, Vesicles"		"HPA036273: AB_10669985"	"unprognostic (1.83e-2)"	"unprognostic (1.78e-1)"	"unprognostic (9.85e-4)"	"unprognostic (5.43e-2)"	"unprognostic (1.49e-1)"	"unprognostic (6.09e-3)"	"unprognostic (3.06e-2)"	"unprognostic (4.35e-2)"	"unprognostic (1.06e-1)"	"unprognostic (2.04e-1)"	"unprognostic (3.11e-2)"	"unprognostic (1.19e-1)"	"unprognostic (8.46e-12)"	"unprognostic (1.24e-1)"	"unprognostic (1.12e-1)"	"unprognostic (1.85e-2)"	"unprognostic (1.54e-2)"	2.5	4.8	6.4	3.4	8.1	5.0	4.4	5.7	8.0	4.0	4.0	3.9	6.4	3.8	3.9	6.7	4.8	5.1	4.2	7.7	7.3	6.9	9.3	5.0	3.3	3.1	6.2	7.7	5.3	6.2	3.9	12.7	3.7	8.0	5.9	4.3	4.2	5.6	6.6	11.0	3.5	3.3	4.2	5.0	3.1	4.3	26.5	4.3	2.2	12.0	4.5	2.7	4.9	3.0	3.0	5.7	2.1	5.6	7.1	3.7	2.1	1.9	3.3	6.4	5.0	7.7	9.3	3.6	5.0	3.2	3.1	2.8	2.7	4.6	1.9	7.5	3.2	5.4	4.6	9.8	7.8	4.5	2.1	5.3	3.1	4.6	2.2	5.4	3.6	1.7	4.5	7.9	1.9	8.5	4.0	2.8	5.9	4.6	3.7	7.2	4.9	3.7	4.8	5.1	4.5	3.3	2.4	5.4	4.1	8.0	3.4	7.8	2.6	5.3	4.4	5.3	8.0	6.8	2.8	2.9	6.2	2.3	10.2	2.6	3.0	3.6	2.3	2.9	5.0	4.4	2.1	1.9	1.4	1.6	3.9	2.3	3.0	2.8	2.5	5.7	1.4	3.1	3.7	0.7	7.1	5.6	1.7	2.1	2.1	6.4	8.1	5.7	8.0	7.3	6.9	6.2	7.7	8.0	4.3	6.0	4.0	0.0	2.0	0.2	4.0	5.2	2.5	8.1	5.7	1.8	3.9	6.1	11.6	2.8	71.2	0.9	1.6	0.0	1.6	3.1	2.1	1.4	0.0	1.0	1.9	1.6	1.2	1.8	1.5	177.0	1.7	2.1	0.0	4.6	1.3	7.2	1.4	1.9	1.1	5.7	3.2	0.0	0.5	10.4	11.4	0.4	6.5	0.5	2.1	0.9
SEPHS1	"SPS, SPS1"	ENSG00000086475	"Selenophosphate synthetase 1"	P49903	10	13317424-13348298	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA037645, HPA062118"	Enhanced		Uncertain	Nucleoplasm		NA	NA			Nucleoplasm		"HPA037645: AB_10671631, HPA062118: AB_2732676"	"unprognostic (8.18e-3)"	"unprognostic (1.79e-1)"	"unprognostic (1.06e-3)"	"unprognostic (2.07e-1)"	"unprognostic (3.50e-2)"	"unprognostic (2.99e-2)"	"prognostic unfavorable (2.16e-7)"	"unprognostic (2.66e-2)"	"unprognostic (1.43e-1)"	"unprognostic (2.61e-2)"	"prognostic favorable (3.12e-4)"	"unprognostic (1.09e-1)"	"unprognostic (1.38e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.85e-1)"	"unprognostic (1.66e-1)"	"unprognostic (5.11e-2)"	15.1	21.9	19.8	11.4	18.0	11.5	33.2	17.3	16.2	14.4	16.0	14.6	10.4	11.9	17.5	20.2	15.4	19.1	15.1	16.1	18.3	15.4	30.5	39.1	20.0	24.3	16.3	11.2	19.8	37.3	23.2	16.6	14.2	17.3	14.4	17.6	15.1	20.6	14.0	20.5	11.8	13.0	17.7	16.6	17.9	15.1	13.7	16.1	44.7	29.8	22.2	17.2	14.1	17.0	8.1	13.2	8.7	19.6	12.7	10.9	6.6	27.5	20.1	41.2	39.7	13.7	10.5	19.4	12.3	9.5	26.3	22.4	22.8	26.0	26.9	15.3	14.3	12.7	17.7	43.6	20.3	27.6	40.4	18.0	14.7	15.0	28.8	14.2	19.8	9.4	9.1	14.6	15.3	9.0	12.3	21.2	57.1	19.3	22.0	18.6	36.5	48.9	8.4	68.1	26.1	9.1	38.2	20.1	16.0	14.2	11.2	14.6	27.2	37.7	16.7	16.8	37.5	21.1	21.1	14.1	11.7	22.3	15.2	25.6	16.2	29.9	49.8	9.4	14.8	9.3	8.7	9.7	7.1	7.1	14.5	8.6	8.1	7.3	8.0	11.6	6.3	9.4	8.7	1.5	12.7	19.6	13.2	10.9	6.6	19.8	18.0	17.3	16.2	18.3	15.4	16.3	11.2	17.3	16.1	11.9	12.5	6.0	14.0	15.2	15.5	10.8	17.8	10.7	15.9	21.0	0.0	28.1	28.2	26.2	8.6	19.0	12.4	23.3	26.1	37.4	15.8	15.2	15.1	27.1	18.2	20.6	16.0	16.5	7.5	11.1	13.8	14.2	15.1	7.2	10.4	22.9	27.4	14.0	17.3	32.7	11.3	6.5	20.6	18.2	15.4	14.8	21.4	11.4	14.6	12.1
SEPHS2	"SPS2, SPS2b"	ENSG00000179918	"Selenophosphate synthetase 2"	Q99611	16	30443631-30446181	"Enzymes, Predicted intracellular proteins"		"Kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"intestine: 52.8;liver: 111.2"	"Cell type enhanced"	"Detected in many"	11	"Distal tubular cells: 326.6;Proximal tubular cells: 285.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HMC-1: 96.4"	"Low region specificity"	"Detected in all"							HPA047931	Approved		Approved	Nucleoplasm		No	No			Nucleoplasm		"HPA047931: AB_2680216"	"unprognostic (5.33e-2)"	"unprognostic (2.02e-1)"	"unprognostic (1.92e-2)"	"unprognostic (9.85e-2)"	"unprognostic (2.67e-2)"	"unprognostic (6.29e-2)"	"unprognostic (5.67e-2)"	"unprognostic (7.69e-3)"	"unprognostic (2.38e-1)"	"unprognostic (9.86e-2)"	"unprognostic (9.66e-3)"	"unprognostic (1.49e-1)"	"prognostic favorable (4.35e-8)"	"unprognostic (2.24e-2)"	"unprognostic (1.35e-1)"	"unprognostic (3.25e-2)"	"unprognostic (3.62e-2)"	9.0	9.0	4.9	6.9	6.4	4.0	6.7	6.3	8.4	5.3	25.6	5.2	5.5	26.6	7.6	6.1	6.0	6.1	12.6	5.3	5.2	5.1	32.8	111.2	5.8	7.6	5.5	3.8	5.2	10.0	7.3	6.4	7.5	7.7	6.6	13.1	6.2	10.6	4.7	11.1	5.5	52.8	4.9	4.4	10.5	12.1	3.0	4.6	14.1	11.9	6.4	9.5	8.1	4.4	14.6	15.3	20.5	13.7	23.2	18.9	8.9	14.8	13.4	4.8	16.5	14.7	9.4	12.5	10.3	12.7	10.1	12.6	8.3	11.4	21.3	15.9	10.9	9.2	8.3	8.8	9.4	10.3	13.6	27.2	21.3	7.3	39.0	18.6	11.8	96.4	11.9	20.1	9.5	17.7	6.4	9.2	15.8	17.2	13.9	8.9	21.9	17.7	24.4	11.8	11.2	10.2	17.3	8.3	16.3	12.5	13.4	10.1	8.7	8.8	25.8	33.4	10.0	22.6	39.5	7.7	10.6	7.5	10.2	6.2	12.0	19.2	11.1	9.2	22.1	11.8	6.1	12.9	20.5	11.2	11.2	17.1	12.4	15.9	16.1	15.3	14.6	18.9	12.9	12.9	23.2	13.7	10.9	15.1	8.9	4.9	6.4	6.3	8.4	5.2	5.1	5.5	3.8	7.7	4.6	41.7	32.3	26.8	1.1	33.3	0.8	46.2	0.0	21.4	21.6	61.1	0.0	1.1	326.6	80.1	0.0	17.5	13.1	0.0	72.7	0.9	24.9	1.7	30.1	6.7	1.2	0.0	34.0	0.6	2.4	0.0	0.0	34.5	42.2	64.1	1.1	0.2	55.5	3.5	0.0	285.3	0.8	0.0	54.6	0.7	0.7	37.3	1.0	20.8	1.4	0.6
SEPSECS	"SLA, SLA/LP"	ENSG00000109618	"Sep (O-phosphoserine) tRNA:Sec (selenocysteine) tRNA synthase"	Q9HD40	4	25120014-25160442	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Protein biosynthesis"	"RNA-binding, Transferase, tRNA-binding"	"Disease mutation, Epilepsy, Mental retardation, Neurodegeneration"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 34.2"	"Cell type enhanced"	"Detected in many"	5	"Hepatocytes: 35.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA070409			Approved	Vesicles		NA	NA			Vesicles		"HPA070409: AB_2686265"	"unprognostic (1.83e-1)"	"unprognostic (4.09e-2)"	"unprognostic (6.37e-3)"	"unprognostic (5.86e-2)"	"unprognostic (9.63e-2)"	"unprognostic (4.61e-3)"	"unprognostic (1.82e-3)"	"unprognostic (6.33e-2)"	"unprognostic (1.24e-1)"	"unprognostic (3.34e-1)"	"unprognostic (2.52e-1)"	"unprognostic (3.56e-2)"	"unprognostic (4.45e-3)"	"unprognostic (4.64e-2)"	"unprognostic (1.65e-1)"	"unprognostic (1.16e-2)"	"unprognostic (2.13e-3)"	7.0	6.1	3.8	8.5	6.4	11.8	7.4	5.4	6.0	5.3	13.5	7.8	8.9	11.8	6.7	9.6	5.3	6.5	8.9	5.6	4.8	3.6	10.5	34.2	9.4	9.7	7.2	4.9	8.5	11.3	7.3	5.1	4.4	5.4	4.7	7.8	5.2	6.2	9.2	5.5	10.9	15.3	3.7	7.0	7.5	7.4	8.9	6.8	12.3	7.7	4.8	8.0	6.8	5.5	5.7	5.9	3.2	4.0	3.4	5.5	2.2	2.9	1.6	6.2	3.3	5.7	7.9	5.4	3.0	4.1	3.4	3.4	1.3	7.2	5.4	3.0	3.4	3.8	3.6	4.8	3.6	3.8	2.7	1.6	6.6	5.6	2.6	6.4	5.8	8.7	7.4	5.7	2.5	5.6	5.2	3.6	12.2	10.4	5.5	2.7	1.7	9.3	16.3	2.9	2.4	6.1	4.8	7.4	4.8	4.7	3.1	4.7	4.4	2.7	2.2	5.2	4.6	4.2	5.6	3.7	5.2	2.7	1.6	2.9	8.6	9.6	6.0	3.2	9.6	3.1	2.4	4.0	2.2	3.6	3.4	3.5	3.4	4.5	4.9	3.4	5.7	4.6	5.5	3.2	3.4	2.4	5.9	2.6	2.2	3.8	6.4	5.4	6.0	4.8	3.6	7.2	4.9	5.4	6.8	0.0	7.4	4.1	1.5	2.2	2.6	3.9	25.5	9.4	3.4	15.7	0.0	4.7	6.6	4.2	17.7	6.3	8.5	0.0	4.1	3.2	4.0	2.3	3.5	35.0	5.4	4.8	5.8	6.7	6.9	13.0	3.1	5.8	3.3	6.4	6.4	3.1	4.6	7.0	6.0	17.4	2.2	0.0	1.8	13.4	18.5	2.9	4.9	4.9	7.3	1.1
SESN1	"PA26, SEST1"	ENSG00000080546	"Sestrin 1"	Q9Y6P5	6	108986437-109094819	"Enzymes, Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Early spermatids: 108.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Group enriched"	"Detected in all"	6	"B-cells: 21.0;NK-cells: 21.8;T-cells: 30.6"	"Cell line enhanced"	"Detected in all"		"BEWO: 36.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA073659			Supported	"Nucleoplasm,Nucleoli fibrillar center"		NA	NA			"Nucleoli fibrillar center"	Nucleoplasm	"HPA073659: AB_2686622"	"unprognostic (2.22e-1)"	"unprognostic (5.97e-2)"	"unprognostic (1.02e-1)"	"unprognostic (3.52e-2)"	"unprognostic (1.17e-1)"	"prognostic favorable (6.47e-5)"	"unprognostic (2.68e-1)"	"unprognostic (6.91e-2)"	"unprognostic (1.01e-1)"	"unprognostic (8.33e-2)"	"unprognostic (1.83e-3)"	"prognostic favorable (2.07e-4)"	"unprognostic (3.54e-2)"	"unprognostic (1.65e-1)"	"unprognostic (1.08e-1)"	"unprognostic (5.72e-2)"	"unprognostic (7.95e-2)"	23.5	14.2	14.5	11.0	23.7	22.7	39.3	21.2	18.9	13.2	16.9	10.2	17.3	10.3	17.1	14.4	11.9	15.2	10.0	32.4	13.0	11.3	8.8	14.1	17.5	54.1	12.2	14.6	33.0	16.1	18.1	25.6	26.8	13.0	15.2	12.8	9.5	10.0	17.2	69.2	19.7	18.6	17.9	13.7	19.3	14.9	20.8	13.6	9.6	18.2	15.4	16.4	16.1	15.3	21.0	2.1	3.9	3.0	21.8	30.6	7.8	1.5	2.5	11.6	5.4	14.8	19.0	36.5	6.1	7.0	2.1	4.1	4.7	1.6	12.8	5.2	4.5	1.6	1.8	3.1	12.2	2.6	1.1	15.5	5.6	3.2	17.7	9.1	2.2	5.8	20.4	19.5	3.8	6.2	9.3	11.0	3.7	4.1	9.2	10.4	3.0	4.8	7.0	4.7	2.4	1.6	3.9	3.3	5.8	4.6	7.7	2.8	5.8	3.3	2.1	2.4	19.6	2.0	14.6	6.7	1.6	3.2	1.5	1.9	9.3	5.3	5.2	3.6	5.6	3.5	3.9	1.0	1.2	14.2	2.3	30.6	4.4	13.3	11.1	1.0	21.0	16.6	8.8	3.9	21.8	3.0	2.1	5.6	7.8	14.5	23.7	21.2	18.9	13.0	11.3	12.2	14.6	13.0	13.6	59.6	15.3	22.2	3.5	5.8	21.5	24.9	17.8	34.8	22.7	14.0	43.2	39.6	8.3	3.4	108.0	6.3	7.9	0.0	4.7	11.8	13.0	7.1	3.5	11.6	35.8	25.4	14.9	11.1	30.9	78.2	31.9	10.8	15.1	9.0	9.7	36.4	2.9	8.6	33.2	5.8	42.4	25.8	13.3	13.2	15.7	7.3	37.3	34.6	11.5	2.3
SESN2	"DKFZp761M0212, HI95, SES2, SEST2"	ENSG00000130766	"Sestrin 2"	P58004	1	28259527-28282491	"Enzymes, Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Syncytiotrophoblasts: 56.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"hTCEpi: 23.1;SK-MEL-30: 27.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA018191	Uncertain		Approved	Cytosol		NA	NA			Cytosol		"HPA018191: AB_1856750"	"unprognostic (7.05e-2)"	"unprognostic (4.95e-3)"	"unprognostic (1.43e-1)"	"unprognostic (1.37e-1)"	"unprognostic (1.37e-1)"	"unprognostic (1.71e-1)"	"prognostic unfavorable (4.78e-4)"	"unprognostic (8.97e-2)"	"unprognostic (2.50e-3)"	"unprognostic (1.41e-1)"	"unprognostic (1.80e-2)"	"unprognostic (2.39e-2)"	"unprognostic (1.71e-1)"	"unprognostic (2.52e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.84e-1)"	"unprognostic (1.60e-1)"	9.2	7.7	7.0	6.8	6.7	32.0	7.6	6.1	11.1	6.1	9.6	3.5	4.6	14.3	7.2	4.0	15.2	6.2	7.6	4.3	4.5	6.1	12.5	18.4	7.7	4.1	8.4	4.5	22.4	10.4	7.5	5.4	9.3	7.6	5.2	8.3	6.9	14.5	4.6	5.8	4.9	12.6	6.2	10.9	5.8	7.2	9.2	4.3	4.8	7.0	4.2	9.7	7.3	14.9	1.9	2.8	6.2	2.7	3.9	9.6	2.5	2.6	1.4	3.5	5.8	5.7	4.5	19.2	5.1	4.7	3.1	3.7	2.0	1.9	3.0	2.1	2.3	3.5	2.6	4.1	3.6	2.2	2.7	3.8	1.2	2.0	3.4	18.8	4.5	6.8	14.3	23.1	8.4	20.1	1.4	3.4	7.1	7.1	14.5	2.9	1.5	1.6	1.2	2.8	1.2	2.9	2.5	0.9	6.6	2.1	4.5	1.2	1.3	1.4	1.2	27.9	4.0	3.2	6.4	1.9	1.6	4.9	3.6	3.1	18.8	4.7	4.7	3.7	4.6	3.5	0.0	2.3	1.9	9.6	1.9	4.7	1.9	3.4	4.6	2.4	1.4	2.1	4.3	6.2	3.9	2.7	2.8	3.9	2.5	7.0	6.7	6.1	11.1	4.5	6.1	8.4	4.5	7.6	4.3	0.0	5.3	7.3	16.1	15.0	12.1	6.1	7.6	1.4	1.2	7.0	7.9	25.1	3.3	20.3	2.0	5.8	23.8	0.0	14.6	17.0	10.4	12.6	4.6	18.8	11.7	0.0	12.6	8.0	3.3	2.7	2.3	10.9	6.8	7.2	10.7	5.8	23.7	11.5	3.2	20.7	7.4	0.0	21.9	4.7	3.3	10.9	56.0	12.8	11.5	19.1
SETD1A	"KIAA0339, KMT2F, Set1"	ENSG00000099381	"SET domain containing 1A"	O15047	16	30957294-30984664	"Enzymes, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Activator, Chromatin regulator, Methyltransferase, RNA-binding, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"HPA020646, HPA058376"	Enhanced		Supported	"Nuclear speckles"		NA	NA			"Nuclear speckles"		"HPA020646: AB_1856752, HPA058376: AB_2683695"	"unprognostic (8.62e-2)"	"unprognostic (1.93e-2)"	"unprognostic (3.96e-2)"	"unprognostic (1.53e-1)"	"unprognostic (1.85e-1)"	"unprognostic (1.40e-2)"	"prognostic unfavorable (8.47e-4)"	"unprognostic (5.01e-2)"	"unprognostic (1.54e-1)"	"unprognostic (3.18e-1)"	"unprognostic (5.77e-2)"	"unprognostic (1.72e-1)"	"unprognostic (1.55e-1)"	"unprognostic (1.27e-1)"	"unprognostic (2.12e-1)"	"unprognostic (1.70e-2)"	"unprognostic (1.94e-1)"	11.0	10.5	10.0	12.4	10.2	25.6	10.3	23.0	14.5	11.1	12.1	14.1	7.6	10.2	15.3	6.7	9.4	11.2	9.7	7.6	8.8	6.7	9.3	10.5	9.0	12.6	9.3	9.8	15.3	14.8	15.6	12.9	11.3	9.5	10.9	5.7	13.5	12.7	10.5	15.2	12.3	11.4	11.7	8.0	14.5	10.3	22.3	10.0	15.5	12.7	5.4	14.1	10.6	9.9	2.0	2.6	2.5	1.4	1.3	1.6	0.9	6.5	12.6	8.7	10.1	5.0	3.5	9.4	7.4	5.5	6.3	5.4	10.7	6.7	17.5	8.2	6.8	6.6	8.6	7.7	7.5	5.2	9.3	30.4	8.1	21.8	12.0	4.8	13.8	13.9	6.0	5.9	8.9	5.7	5.1	4.8	10.3	16.3	9.9	3.4	13.7	16.3	14.0	12.4	4.7	8.4	24.8	8.6	11.0	4.0	7.2	9.4	9.6	9.9	8.2	5.5	5.0	8.5	11.2	6.6	9.6	9.3	6.1	7.7	15.1	18.2	17.1	7.7	12.0	7.2	0.0	0.8	2.5	1.2	1.4	1.6	0.2	1.0	0.8	0.6	2.0	0.7	1.5	0.5	1.3	0.4	2.6	0.4	0.9	10.0	10.2	23.0	14.5	8.8	6.7	9.3	9.8	9.5	10.0	3.0	8.6	7.6	4.7	14.0	7.7	3.2	10.2	2.7	3.4	7.0	5.9	4.0	0.0	3.5	2.6	9.8	4.6	0.0	3.6	3.1	6.1	4.3	3.5	7.7	5.7	12.7	9.9	9.2	3.5	2.2	9.2	3.2	8.5	2.8	6.9	5.6	4.5	6.2	11.0	2.2	5.3	6.5	5.3	12.9	19.8	11.3	2.4	7.5	5.7	3.9
SETD1B	"KIAA1076, KMT2G, Set1B"	ENSG00000139718	"SET domain containing 1B"	Q9UPS6	12	121804180-121832584	"Enzymes, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Activator, Chromatin regulator, Methyltransferase, RNA-binding, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021667, HPA059412"	Approved		Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"HPA021667: AB_1856753, HPA059412: AB_2684006"	"unprognostic (1.69e-1)"	"unprognostic (2.38e-2)"	"unprognostic (6.32e-2)"	"unprognostic (3.51e-1)"	"unprognostic (2.06e-1)"	"unprognostic (2.75e-2)"	"unprognostic (5.32e-2)"	"unprognostic (1.35e-1)"	"unprognostic (1.28e-2)"	"unprognostic (5.65e-2)"	"unprognostic (1.59e-2)"	"unprognostic (1.75e-1)"	"unprognostic (7.33e-2)"	"unprognostic (1.55e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.39e-1)"	"unprognostic (2.13e-2)"	13.8	9.6	9.3	16.8	9.4	22.7	18.1	22.0	11.1	19.6	25.0	7.4	16.0	13.0	27.2	14.8	15.8	21.1	18.2	10.0	8.9	4.6	10.1	10.9	10.9	11.9	5.4	7.4	17.4	14.3	12.1	11.9	12.2	7.1	16.5	6.8	14.4	15.9	31.1	12.9	11.8	15.3	14.7	5.4	14.4	17.8	9.1	7.3	31.1	14.7	8.9	14.7	22.8	14.4	1.3	2.1	3.9	2.0	1.0	2.1	0.8	6.0	12.1	6.4	10.5	6.0	4.1	9.7	5.7	4.7	4.6	2.6	6.8	3.7	4.5	5.3	6.4	2.7	9.5	7.4	4.6	2.6	7.9	9.0	13.9	15.0	5.8	5.1	12.6	11.9	5.0	5.4	6.2	4.9	5.2	4.8	9.0	14.2	3.2	3.1	14.3	18.0	16.7	8.9	2.9	7.4	14.1	4.2	6.4	4.1	12.7	7.9	6.0	13.0	8.7	4.7	4.8	10.8	10.9	8.0	6.5	8.1	9.2	6.3	6.3	3.2	2.7	5.4	7.9	7.4	3.9	0.9	2.0	1.9	2.0	1.3	1.2	1.3	1.8	0.7	1.3	2.1	1.3	3.8	1.0	0.8	2.1	1.3	0.8	9.3	9.4	22.0	11.1	8.9	4.6	5.4	7.4	7.1	7.3	3.0	5.3	2.4	3.2	10.4	12.0	8.3	7.6	0.0	6.8	5.2	7.9	6.5	0.0	4.5	7.5	9.3	5.5	0.0	6.2	5.9	7.4	6.7	3.5	11.9	5.7	11.1	7.0	12.9	21.6	14.4	10.6	5.6	1.7	1.0	7.3	5.3	5.7	9.5	9.6	3.0	8.4	6.5	7.2	12.5	1.0	11.3	11.0	8.5	6.7	6.5
SETD2	"FLJ23184, HIF-1, HYPB, KIAA1732, KMT3A"	ENSG00000181555	"SET domain containing 2"	Q9BYW2	3	47016429-47163967	"Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Antiviral defense, Differentiation, DNA damage, DNA repair, Host-virus interaction, Immunity, Innate immunity, Transcription, Transcription regulation"	"Activator, Chromatin regulator, Developmental protein, Methyltransferase, Transferase"	"Autism spectrum disorder, Cancer-related genes, Disease mutation, Mental retardation, Tumor suppressor"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042451	Approved		Approved	"Nuclear speckles,Cytosol"		NA	NA			"Nuclear speckles"	Cytosol	"HPA042451: AB_10806239"	"unprognostic (2.78e-1)"	"unprognostic (1.01e-1)"	"unprognostic (6.08e-2)"	"unprognostic (1.01e-1)"	"unprognostic (3.37e-2)"	"unprognostic (1.37e-2)"	"unprognostic (1.40e-2)"	"unprognostic (1.01e-2)"	"prognostic unfavorable (8.19e-4)"	"unprognostic (6.19e-2)"	"unprognostic (2.45e-1)"	"unprognostic (7.84e-2)"	"prognostic favorable (7.99e-6)"	"unprognostic (1.03e-1)"	"unprognostic (1.91e-1)"	"unprognostic (8.79e-2)"	"unprognostic (5.43e-2)"	13.2	10.5	12.2	15.2	15.4	20.0	11.7	22.4	16.4	13.4	14.0	9.1	12.9	9.5	15.8	7.5	10.8	11.4	8.7	8.8	10.6	6.8	11.4	10.3	10.4	11.8	11.7	9.5	16.0	13.4	21.4	16.3	10.7	11.3	12.4	10.9	7.7	12.7	14.8	27.6	12.5	11.5	11.9	9.8	13.8	10.4	12.8	12.8	23.2	15.8	5.5	12.8	16.1	15.5	4.8	2.6	6.0	2.3	7.1	3.9	1.0	11.6	9.2	15.4	7.9	9.3	10.7	6.5	10.7	10.4	12.6	11.5	9.7	7.6	25.7	6.7	14.8	12.3	7.1	16.7	10.2	17.1	14.7	6.6	26.4	15.3	7.5	7.0	19.7	15.3	9.2	9.9	12.4	15.4	10.2	11.6	13.3	16.9	9.7	10.3	6.1	14.5	2.6	11.7	5.6	7.7	9.6	15.0	13.3	6.4	15.3	6.7	10.6	18.1	7.1	6.7	11.5	7.5	14.7	14.8	13.9	10.4	11.8	17.1	12.5	13.9	26.0	8.0	11.3	8.1	2.4	2.2	5.2	3.9	2.3	2.4	3.7	2.4	3.0	2.5	4.8	3.5	3.0	6.0	7.1	1.9	2.6	1.0	1.0	12.2	15.4	22.4	16.4	10.6	6.8	11.7	9.5	11.3	12.8	44.7	53.3	20.6	20.5	29.7	33.4	58.5	22.9	66.9	80.8	10.4	39.3	16.3	10.0	17.4	24.0	29.3	26.5	0.0	19.3	10.1	20.8	25.9	55.6	26.7	14.3	25.4	21.2	23.4	27.2	20.8	28.1	21.6	16.9	20.8	27.8	21.7	20.0	17.5	31.1	9.3	37.0	12.9	21.7	78.1	18.9	31.1	15.4	27.7	24.8	34.2
SETD3	"C14orf154, FLJ23027"	ENSG00000183576	"SET domain containing 3"	Q86TU7	14	99397746-99480889	"Enzymes, Predicted intracellular proteins"		"Actin-binding, Methyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Early spermatids: 146.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003591, HPA003639"	Approved		Approved	Mitochondria		NA	NA			Mitochondria		"HPA003591: AB_1079930, HPA003639: AB_1079931"	"unprognostic (6.82e-2)"	"unprognostic (2.66e-2)"	"unprognostic (8.07e-2)"	"unprognostic (2.16e-2)"	"unprognostic (2.42e-1)"	"prognostic unfavorable (6.46e-4)"	"unprognostic (1.04e-2)"	"unprognostic (3.24e-2)"	"unprognostic (3.29e-1)"	"unprognostic (2.73e-2)"	"unprognostic (2.01e-1)"	"unprognostic (4.42e-1)"	"prognostic favorable (1.89e-15)"	"unprognostic (6.81e-2)"	"unprognostic (3.21e-1)"	"unprognostic (2.20e-1)"	"unprognostic (2.62e-3)"	17.1	12.5	24.7	13.3	26.8	9.2	16.6	14.6	23.8	14.3	22.7	18.7	26.9	16.2	14.2	39.6	16.9	21.7	13.4	34.1	24.1	17.9	43.4	21.0	16.7	11.9	23.7	13.9	11.7	16.9	17.4	14.5	19.4	18.4	16.9	17.6	16.2	24.9	20.2	68.7	14.1	16.5	26.0	25.3	13.7	15.4	39.1	15.3	11.5	25.6	20.3	10.9	24.0	21.4	9.2	18.6	19.9	17.4	16.0	18.2	11.3	13.8	15.9	12.0	11.4	14.0	15.8	42.8	17.5	13.4	18.4	18.9	15.3	23.5	13.6	14.4	19.7	14.5	18.0	14.7	19.7	29.4	13.3	7.8	12.3	10.3	14.0	17.5	18.5	18.6	11.0	26.0	16.3	23.9	13.9	22.8	20.5	9.7	20.6	20.3	25.9	19.2	20.1	7.1	34.6	18.1	11.7	24.6	11.2	26.4	17.1	21.5	10.0	15.7	16.4	13.4	22.8	22.2	16.2	20.1	8.3	11.5	55.9	13.3	14.7	16.7	14.7	15.7	18.5	12.6	6.4	15.0	19.9	15.5	17.4	18.2	9.2	13.4	14.5	18.6	7.6	11.2	13.9	9.4	16.0	14.8	11.7	9.7	11.3	24.7	26.8	14.6	23.8	24.1	17.9	23.7	13.9	18.4	15.3	23.8	35.6	13.7	15.9	21.6	24.5	76.3	25.5	34.8	29.6	24.4	25.5	52.8	28.2	21.0	146.2	23.8	28.2	0.0	24.3	35.0	18.6	20.9	31.3	24.9	31.6	17.5	20.8	15.4	28.0	98.0	17.5	26.8	10.1	16.2	24.4	39.5	20.0	21.0	19.8	84.0	33.4	6.5	22.0	89.9	86.5	28.2	25.1	20.3	27.1	17.3
SETD7	"KIAA1717, KMT7, SET7, SET7/9, Set9"	ENSG00000145391	"SET domain containing lysine methyltransferase 7"	Q8WTS6	4	139495941-139606699	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Activator, Chromatin regulator, Methyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Hepatocytes: 64.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA058111	Enhanced		Enhanced	"Nucleoli,Nucleoli rim,Mitotic chromosome"		Yes	No			"Nucleoli, Nucleoli rim"	"Mitotic chromosome"	"HPA058111: AB_2683607"	"prognostic unfavorable (8.28e-4)"	"unprognostic (7.07e-2)"	"unprognostic (4.04e-1)"	"unprognostic (2.07e-1)"	"unprognostic (2.92e-1)"	"unprognostic (4.82e-2)"	"unprognostic (1.48e-2)"	"unprognostic (2.04e-1)"	"unprognostic (1.71e-2)"	"unprognostic (9.10e-2)"	"unprognostic (6.44e-2)"	"unprognostic (7.75e-2)"	"unprognostic (1.37e-1)"	"unprognostic (6.16e-3)"	"unprognostic (1.17e-1)"	"unprognostic (6.92e-2)"	"unprognostic (6.56e-3)"	26.1	13.2	12.0	9.6	12.3	5.7	26.3	10.2	16.2	27.9	17.7	17.9	11.0	4.8	23.8	12.0	18.3	13.8	16.9	25.2	13.0	10.0	7.2	30.7	12.1	6.9	18.0	10.1	13.3	13.8	26.8	9.3	12.0	15.4	22.8	10.2	12.4	13.7	13.9	56.4	14.2	9.9	33.3	19.0	11.8	17.7	10.6	16.5	2.9	10.3	15.2	9.9	24.2	30.1	2.3	6.8	1.8	5.6	0.5	5.6	1.6	9.0	11.7	4.5	2.6	26.5	22.9	9.9	21.5	22.4	11.0	9.3	6.9	12.4	21.1	8.5	36.2	7.6	4.6	14.9	17.0	17.9	10.4	10.5	2.9	15.3	0.2	13.1	10.1	4.5	19.8	19.9	17.5	18.7	14.0	13.9	9.0	1.7	32.9	14.0	15.1	6.6	1.5	2.2	13.3	7.7	6.2	15.5	12.1	10.7	8.3	17.4	5.8	14.3	21.3	5.1	4.5	8.4	9.2	22.5	19.5	13.9	23.2	17.8	28.4	27.2	13.4	22.5	10.2	9.3	1.0	5.6	0.5	0.6	3.2	4.1	1.8	1.8	1.8	6.8	2.3	0.8	0.5	1.8	0.5	4.8	3.5	5.6	1.6	12.0	12.3	10.2	16.2	13.0	10.0	18.0	10.1	15.4	16.5	6.0	13.1	3.4	10.9	15.2	6.6	35.4	17.8	4.0	6.8	8.7	11.8	21.9	0.0	20.5	0.9	24.7	1.8	23.3	18.1	14.4	19.2	35.1	2.3	64.4	18.3	7.9	1.2	36.8	29.7	3.5	21.3	18.3	10.1	7.2	11.2	13.3	21.5	0.0	26.5	3.9	12.6	19.4	21.0	3.2	1.9	19.3	38.6	5.0	9.9	14.2
SETDB1	"ESET, KG1T, KIAA0067, KMT1E, TDRD21"	ENSG00000143379	"SET domain bifurcated 1"	Q15047	1	150926263-150964744	"Cancer-related genes, Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Transcription, Transcription regulation"	"Chromatin regulator, Methyltransferase, Repressor, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enriched"	"Detected in all"	5	"U-698: 90.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA018142, HPA058484"	Uncertain		Supported	Nucleoplasm,Vesicles		Yes	No			Nucleoplasm	Vesicles	"HPA018142: AB_1856757, HPA058484: AB_2683731"	"unprognostic (1.07e-1)"	"unprognostic (4.08e-1)"	"unprognostic (8.02e-2)"	"unprognostic (2.24e-3)"	"unprognostic (1.65e-2)"	"unprognostic (9.57e-2)"	"prognostic unfavorable (8.88e-4)"	"unprognostic (6.03e-2)"	"unprognostic (9.94e-3)"	"unprognostic (7.13e-2)"	"unprognostic (1.21e-1)"	"unprognostic (6.65e-2)"	"prognostic unfavorable (4.25e-4)"	"unprognostic (1.59e-1)"	"unprognostic (3.93e-2)"	"unprognostic (3.14e-2)"	"unprognostic (1.14e-1)"	16.9	15.4	9.5	21.2	15.9	16.9	17.7	21.6	18.2	18.6	15.4	25.2	18.6	13.0	22.8	18.9	15.6	16.8	14.0	10.9	9.6	8.5	13.3	12.7	15.6	20.7	15.3	13.2	23.9	17.6	21.0	15.4	18.4	13.7	14.9	16.8	20.6	16.1	18.5	20.0	18.0	17.1	17.9	13.7	21.9	15.0	33.5	14.2	24.5	18.6	12.0	20.7	18.6	16.3	11.2	12.8	6.9	14.9	7.6	9.1	5.3	5.9	6.9	10.0	6.6	4.8	6.4	16.7	4.9	5.7	7.1	6.1	4.6	8.2	11.6	6.8	5.4	2.8	7.4	9.3	5.3	5.6	5.6	11.5	6.6	7.1	5.3	6.8	11.6	6.3	8.4	5.9	5.8	9.5	7.2	8.3	7.5	11.0	9.5	5.0	11.4	8.0	6.8	13.7	8.3	5.5	9.3	6.5	8.6	5.4	6.8	7.3	13.3	7.5	8.8	5.9	12.6	9.5	15.7	5.6	4.1	4.3	4.5	6.8	9.9	10.6	90.6	4.3	4.1	4.0	6.8	10.7	6.9	8.3	14.9	8.7	8.7	7.4	9.1	12.8	11.2	8.3	8.3	6.5	7.6	10.6	8.6	4.7	5.3	9.5	15.9	21.6	18.2	9.6	8.5	15.3	13.2	13.7	14.2	6.0	12.3	5.3	7.2	4.8	10.9	4.1	5.1	9.4	6.8	7.0	17.7	11.4	3.3	6.6	23.5	6.9	6.2	0.0	5.0	7.2	4.9	6.2	7.0	6.2	8.8	6.4	3.5	10.4	14.2	21.8	9.5	10.4	1.7	7.2	10.3	6.3	7.3	10.7	9.2	5.4	10.1	6.5	5.9	22.4	14.5	4.4	8.4	7.0	9.3	6.4
SETDB2	"C13orf4, CLLD8, CLLL8, KMT1F"	ENSG00000136169	"SET domain bifurcated 2"	Q96T68	13	49444374-49495003	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"	"Chromatin regulator, Developmental protein, Methyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"Daudi: 25.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB012190, HPA071677"	Approved		Approved	Nucleoplasm		No	No			Nucleoplasm		"CAB012190: AB_2186195, HPA071677: AB_2686430"	"unprognostic (1.77e-1)"	"unprognostic (1.11e-2)"	"unprognostic (1.58e-1)"	"unprognostic (3.61e-2)"	"unprognostic (4.20e-1)"	"unprognostic (3.70e-3)"	"unprognostic (3.74e-2)"	"unprognostic (3.44e-3)"	"unprognostic (7.29e-2)"	"unprognostic (7.08e-2)"	"unprognostic (1.09e-3)"	"unprognostic (7.95e-2)"	"prognostic favorable (1.92e-7)"	"unprognostic (2.83e-2)"	"unprognostic (1.64e-1)"	"unprognostic (1.95e-1)"	"unprognostic (1.85e-1)"	10.2	14.5	9.8	20.5	10.8	9.5	14.1	14.4	12.3	13.0	12.4	8.3	13.6	7.8	13.1	11.6	9.8	9.9	9.7	12.7	8.2	6.9	12.4	11.0	16.3	19.0	7.2	11.1	21.0	15.0	10.8	15.8	7.8	9.5	13.6	11.9	13.5	11.7	10.9	5.5	9.6	11.4	11.3	8.4	19.0	10.7	18.1	8.7	17.3	14.6	3.7	16.6	11.9	10.3	8.4	7.4	4.7	5.4	7.8	10.2	4.5	2.0	1.4	4.3	4.4	6.1	6.9	2.2	5.9	7.4	5.3	5.0	8.7	5.0	25.7	1.2	3.8	4.0	4.2	4.5	4.0	5.2	5.8	3.9	8.9	3.9	5.2	8.6	13.5	5.1	5.3	7.4	4.0	13.4	5.8	4.5	8.3	3.9	3.6	4.8	1.8	5.1	10.1	2.2	5.5	3.4	10.0	5.4	5.4	4.9	1.9	2.2	2.6	2.6	3.7	12.6	3.9	3.1	11.8	2.7	5.1	1.8	6.8	2.4	4.3	6.0	13.6	1.6	11.0	2.3	4.1	4.1	4.7	6.9	5.4	5.8	8.4	7.1	7.1	7.4	8.1	10.2	7.6	1.4	7.8	4.3	5.2	9.4	4.5	9.8	10.8	14.4	12.3	8.2	6.9	7.2	11.1	9.5	8.7	26.8	14.1	32.7	5.3	6.2	12.6	22.4	10.2	13.4	10.3	5.2	25.5	4.8	8.3	3.3	14.7	8.2	6.9	0.0	3.8	2.9	5.1	3.0	5.8	5.9	15.9	12.7	11.1	5.5	19.0	11.1	9.2	17.4	13.5	10.0	6.2	10.8	3.1	2.9	7.8	3.4	29.6	0.0	5.2	18.2	11.8	5.3	2.4	19.1	8.5	2.0
SETMAR	metnase	ENSG00000170364	"SET domain and mariner transposase fusion gene"	Q53H47	3	4303304-4317567	"Enzymes, Predicted intracellular proteins"	"DNA damage, DNA repair"	"Chromatin regulator, DNA-binding, Endonuclease, Hydrolase, Methyltransferase, Multifunctional enzyme, Nuclease, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"											HPA057999			Supported	Nucleoli		NA	NA			Nucleoli		"HPA057999: AB_2683574"	"unprognostic (1.59e-1)"	"unprognostic (1.22e-2)"	"unprognostic (5.24e-3)"	"unprognostic (4.89e-2)"	"unprognostic (7.73e-2)"	"unprognostic (4.73e-2)"	"prognostic unfavorable (2.85e-4)"	"unprognostic (1.58e-2)"	"unprognostic (1.54e-2)"	"unprognostic (3.29e-1)"	"unprognostic (1.19e-3)"	"unprognostic (1.19e-1)"	"prognostic favorable (6.61e-6)"	"unprognostic (5.42e-1)"	"unprognostic (3.06e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.26e-3)"	14.1	6.2	7.3	7.2	9.2	3.7	14.2	6.9	8.5	12.5	6.5	6.2	5.2	4.3	19.4	7.6	7.2	12.5	8.2	6.3	6.6	4.3	10.1	5.3	5.1	6.5	9.1	8.7	19.4	9.8	5.7	7.4	5.6	6.5	13.9	6.9	5.7	11.9	10.0	7.7	7.3	5.7	16.8	7.2	5.0	6.0	7.3	10.8	13.1	11.5	8.3	4.4	11.3	13.3	3.8	1.6	1.9	3.3	0.5	5.3	1.5	3.0	2.7	8.2	1.7	19.7	6.5	8.3	3.3	1.0	3.3	3.1	2.8	2.3	8.0	3.5	1.8	6.0	2.6	7.2	5.0	3.6	5.4	6.2	10.0	4.9	4.5	2.3	4.7	4.2	7.7	3.9	2.4	0.8	3.0	4.8	9.1	6.6	3.0	5.1	4.1	7.0	3.0	8.0	1.9	4.7	8.3	8.1	3.3	3.1	4.2	6.5	9.6	4.0	5.0	4.3	5.4	4.8	2.7	3.1	4.9	6.9	4.1	4.3	4.0	9.5	19.8	1.8	5.4	4.1	1.9	1.1	1.3	2.3	3.3	2.0	2.9	2.7	2.9	1.0	3.8	4.5	5.3	0.2	0.5	1.9	1.6	1.7	1.5	7.3	9.2	6.9	8.5	6.6	4.3	9.1	8.7	6.5	10.8	0.0	5.3	2.7	7.6	2.2	5.2	5.9	5.1	9.4	13.6	0.0	0.0	20.4	11.6	10.1	0.6	6.8	2.3	0.0	11.6	12.2	7.4	3.2	1.1	2.5	5.2	0.0	3.5	3.7	1.0	0.9	8.9	1.8	0.0	4.6	2.6	4.1	6.6	5.1	12.4	4.3	2.8	6.5	5.7	4.6	5.1	0.5	13.6	1.3	5.6	3.1
SGK1	SGK	ENSG00000118515	"Serum/glucocorticoid regulated kinase 1"	O00141	6	134169246-134318112	"Cancer-related genes, Enzymes, Predicted intracellular proteins"	"Apoptosis, Stress response"	"Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"parathyroid gland: 141.3"	"Cell type enhanced"	"Detected in many"	5	"Ito cells: 455.4;Syncytiotrophoblasts: 484.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"classical monocyte: 11.7;eosinophil: 45.9;neutrophil: 26.2"	"Group enriched"	"Detected in many"	7	"granulocytes: 45.9;monocytes: 11.7"	"Cell line enhanced"	"Detected in many"		"HHSteC: 51.2;RPTEC TERT1: 78.5;SK-MEL-30: 50.9;TIME: 61.1;U-266/84: 56.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB022085, CAB025148, HPA051251"	Approved		Enhanced	"Nuclear speckles"		NA	NA			"Nuclear speckles"		"CAB022085: , CAB025148: , HPA051251: AB_2681407"	"unprognostic (2.05e-2)"	"prognostic favorable (5.26e-4)"	"unprognostic (1.12e-1)"	"unprognostic (5.09e-3)"	"unprognostic (2.76e-1)"	"unprognostic (4.20e-2)"	"unprognostic (4.53e-2)"	"unprognostic (5.62e-2)"	"unprognostic (4.03e-1)"	"unprognostic (7.94e-2)"	"unprognostic (1.78e-1)"	"unprognostic (2.55e-1)"	"unprognostic (5.82e-3)"	"unprognostic (9.10e-2)"	"unprognostic (3.81e-2)"	"unprognostic (1.79e-1)"	"unprognostic (6.59e-2)"	45.6	35.5	16.8	12.8	43.2	15.8	22.9	10.6	25.0	18.4	62.3	51.7	10.8	14.2	14.9	11.2	30.0	16.1	47.8	12.5	22.9	9.6	37.5	51.1	31.2	8.4	48.8	16.6	47.2	47.8	141.3	4.7	19.2	28.3	18.3	11.3	45.8	26.2	18.4	12.4	25.8	131.8	13.6	40.3	7.6	31.1	12.2	50.1	6.2	22.3	24.8	20.4	26.1	31.7	0.6	4.0	45.9	11.7	0.9	0.7	3.1	0.6	1.1	0.7	0.0	8.8	2.2	1.0	12.6	26.3	16.5	13.5	1.9	1.7	2.1	1.9	13.0	8.1	0.4	1.1	2.0	12.2	0.0	0.5	0.1	31.4	1.4	51.2	0.1	1.1	13.2	12.6	16.2	21.0	6.6	27.6	0.3	4.0	32.0	5.9	0.1	0.1	0.4	0.8	3.2	1.3	0.4	1.5	0.2	78.5	0.2	0.3	3.1	39.6	0.1	50.9	7.6	0.1	0.3	61.1	4.8	2.1	29.5	2.7	6.0	56.0	6.5	4.5	1.9	6.5	0.6	11.7	45.9	0.2	6.8	0.5	0.6	0.4	0.2	4.0	0.4	0.5	0.6	26.2	0.9	3.7	0.2	0.7	3.1	16.8	43.2	10.6	25.0	22.9	9.6	48.8	16.6	28.3	50.1	35.7	233.2	40.3	98.2	162.8	10.8	19.4	96.8	24.1	99.0	64.6	33.4	39.9	18.3	60.3	7.2	107.9	230.9	0.0	151.5	27.8	58.7	45.7	257.3	17.5	283.4	0.0	10.2	455.4	148.5	5.6	14.1	322.4	254.8	6.4	46.9	4.3	52.7	129.6	14.9	92.1	28.6	12.9	39.1	48.4	7.5	101.6	484.9	9.6	6.4	68.4
SGK2		ENSG00000101049	"SGK2, serine/threonine kinase 2"	Q9HBY8	20	43558968-43588237	"Enzymes, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 33.1;kidney: 39.1;liver: 32.9"	"Cell type enhanced"	"Detected in many"	15	"Distal tubular cells: 64.6;Enterocytes: 26.9;Hepatocytes: 26.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A549: 10.3;CAPAN-2: 8.0;Hep G2: 10.4;OE19: 34.0;RPTEC TERT1: 14.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA008859, HPA011387"	Uncertain		Supported	Nucleoplasm		NA	NA			Nucleoplasm		"HPA008859: AB_2668159, HPA011387: AB_1856744"	"unprognostic (1.82e-1)"	"unprognostic (1.84e-1)"	"unprognostic (4.53e-2)"	"unprognostic (2.86e-1)"	"unprognostic (6.27e-2)"	"unprognostic (2.98e-4)"	"unprognostic (2.05e-2)"	"unprognostic (1.35e-1)"	"unprognostic (4.30e-2)"	"unprognostic (2.60e-1)"	"unprognostic (1.05e-1)"	"unprognostic (5.72e-4)"	"unprognostic (4.15e-2)"	"unprognostic (1.38e-1)"	"unprognostic (2.56e-1)"	"unprognostic (3.11e-2)"	"prognostic favorable (5.65e-4)"	11.4	0.7	2.8	4.3	9.9	0.2	3.1	1.0	10.2	1.4	21.3	33.1	0.9	17.8	1.0	19.7	0.7	1.6	7.9	0.7	4.3	2.5	39.1	32.9	0.6	0.5	6.9	5.1	3.2	14.1	0.5	1.7	0.5	13.7	1.4	23.4	0.0	0.9	1.8	0.4	3.2	20.7	1.0	14.2	0.7	11.9	1.0	6.0	0.0	1.0	0.2	0.2	3.1	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.3	0.2	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.5	8.0	0.0	4.1	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.0	10.4	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.4	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.1	0.1	34.0	0.0	0.0	0.0	0.0	14.7	1.7	0.1	0.4	0.0	0.7	0.1	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	9.9	1.0	10.2	4.3	2.5	6.9	5.1	13.7	6.0	0.0	0.0	0.0	0.1	0.1	0.8	2.2	12.7	0.0	0.0	10.4	0.0	3.4	64.6	3.9	0.1	0.1	26.9	0.0	5.4	1.0	0.2	0.1	0.0	26.9	0.6	6.4	1.7	1.3	1.0	0.0	0.0	0.0	0.0	0.0	3.4	0.1	2.6	8.4	0.4	15.7	0.8	0.0	0.0	0.0	0.2	0.1	14.3	0.0	5.9	0.1
SGK3	"SGK2, SGKL"	ENSG00000104205	"Serum/glucocorticoid regulated kinase family member 3"	Q96BR1	8	66667596-66862022	"Enzymes, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"monocytes: 45.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006699, HPA027146"	Supported		Supported	Nucleoplasm,Vesicles		NA	NA			Vesicles	Nucleoplasm	"HPA006699: , HPA027146: AB_1856745"	"prognostic favorable (5.52e-6)"	"prognostic favorable (8.28e-4)"	"unprognostic (8.52e-3)"	"unprognostic (1.10e-2)"	"unprognostic (3.75e-1)"	"unprognostic (1.37e-2)"	"unprognostic (2.32e-1)"	"unprognostic (1.69e-3)"	"unprognostic (9.51e-2)"	"unprognostic (8.86e-3)"	"prognostic favorable (9.65e-4)"	"unprognostic (1.94e-2)"	"unprognostic (8.95e-2)"	"unprognostic (4.55e-3)"	"unprognostic (1.77e-1)"	"unprognostic (1.01e-1)"	"unprognostic (5.29e-3)"	6.5	5.9	13.9	8.7	20.9	7.7	23.9	9.8	14.8	12.0	10.0	24.0	8.7	8.6	8.0	10.3	7.6	7.8	7.8	5.4	16.1	10.2	14.9	13.6	9.9	8.5	28.8	9.3	9.8	15.6	29.2	14.8	5.9	14.6	7.8	10.7	17.2	7.0	7.7	6.1	12.4	10.8	6.0	32.8	8.2	7.2	8.9	21.9	8.3	17.3	4.3	6.8	6.1	8.0	5.8	13.8	21.4	15.7	6.9	13.3	8.0	11.6	3.0	0.5	1.9	3.5	7.0	6.5	7.4	7.1	4.1	4.3	5.3	7.8	8.8	1.8	8.1	11.0	3.8	6.1	4.3	5.1	4.9	10.3	7.9	2.2	5.2	3.5	7.1	9.4	3.3	3.9	1.9	6.8	3.8	6.5	7.0	1.5	4.2	7.7	1.8	5.6	4.4	1.7	6.7	4.1	9.8	4.4	5.9	5.4	2.6	2.5	2.0	3.3	5.0	11.2	5.2	23.5	14.2	7.7	3.9	3.4	3.3	2.8	5.2	10.1	10.1	4.5	12.0	4.0	21.4	15.7	6.2	8.1	9.3	13.3	3.7	8.4	8.5	13.8	5.8	9.0	6.9	2.5	6.9	4.4	7.7	5.3	8.0	13.9	20.9	9.8	14.8	16.1	10.2	28.8	9.3	14.6	21.9	6.0	22.6	7.8	5.6	11.7	1.7	5.6	7.6	16.0	11.4	10.4	17.7	7.0	13.3	5.8	0.6	9.8	10.5	0.0	15.8	1.2	4.5	8.9	14.0	18.3	21.3	0.0	15.5	17.2	34.8	1.1	3.7	32.9	8.5	45.1	7.0	3.5	12.1	9.7	7.4	30.7	1.6	0.0	3.1	4.1	11.3	13.8	4.0	15.8	8.2	4.7
SGMS2	"MGC26963, SMS2"	ENSG00000164023	"Sphingomyelin synthase 2"	Q8NHU3	4	107824563-107915047	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Lipid metabolism, Sphingolipid metabolism"	"Kinase, Transferase"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Basal glandular cells: 144.6;Ciliated cells: 116.4;Club cells: 131.9;Urothelial cells: 179.5"	"Low cancer specificity"	"Detected in all"			"Region enriched"	"Detected in all"	6	"pons and medulla: 17.0"	"Group enriched"	"Detected in some"	8	"classical monocyte: 5.7;eosinophil: 3.9;intermediate monocyte: 2.4;myeloid DC: 6.6;non-classical monocyte: 2.0"	"Group enriched"	"Detected in many"	32	"dendritic cells: 6.6;granulocytes: 3.9;monocytes: 5.7"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			HPA015076	Supported					NA	NA					"HPA015076: AB_1857298"	"unprognostic (7.44e-2)"	"unprognostic (2.32e-2)"	"unprognostic (2.36e-2)"	"unprognostic (1.87e-2)"	"unprognostic (7.88e-3)"	"unprognostic (9.53e-2)"	"unprognostic (5.01e-2)"	"unprognostic (1.32e-1)"	"unprognostic (4.15e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.82e-3)"	"unprognostic (3.26e-1)"	"prognostic favorable (1.37e-4)"	"unprognostic (6.18e-2)"	"unprognostic (5.63e-2)"	"unprognostic (8.71e-2)"	"unprognostic (5.22e-3)"	7.5	3.3	1.9	8.6	2.9	2.1	8.0	1.7	1.9	8.3	22.2	3.4	5.6	11.4	12.5	9.7	14.9	7.5	24.9	7.8	2.5	2.6	13.2	12.6	20.7	6.4	2.7	1.4	5.4	8.4	4.6	48.5	30.7	17.0	8.0	6.4	11.8	14.2	3.2	5.0	4.5	38.1	18.5	4.6	1.5	9.8	8.6	1.0	0.2	22.0	12.2	5.3	10.7	11.2	0.1	6.6	3.9	5.7	0.0	0.1	1.4	10.0	3.8	0.6	2.9	6.7	15.6	0.2	12.4	9.4	5.9	6.2	1.7	21.0	0.7	4.9	19.7	5.1	3.8	7.2	10.9	10.6	2.8	2.8	0.4	8.5	0.6	7.7	6.8	0.0	5.4	7.7	11.5	14.0	12.4	13.0	0.1	0.1	0.2	9.3	3.4	0.2	0.0	0.3	5.9	4.3	0.2	5.0	1.4	15.7	4.9	1.0	0.0	9.5	13.6	1.6	1.6	7.3	0.1	22.1	7.1	11.2	10.1	5.7	0.7	0.2	0.4	9.5	1.6	2.9	0.0	5.7	3.9	0.0	2.4	0.0	0.1	0.0	0.0	6.6	0.1	0.1	0.0	0.5	0.0	2.0	0.0	0.0	1.4	1.9	2.9	1.7	1.9	2.5	2.6	2.7	1.4	17.0	1.0	80.4	97.5	2.7	144.6	49.7	0.4	17.1	28.1	116.4	131.9	15.7	0.0	0.8	3.3	16.4	47.7	9.0	30.7	0.0	16.7	0.6	20.1	102.6	9.3	20.2	5.9	1.6	8.5	4.9	31.9	5.9	2.3	23.7	8.5	1.0	19.0	0.0	26.8	38.6	0.4	9.1	0.0	0.0	30.9	0.5	2.8	63.7	11.6	1.3	9.3	179.5
SGPL1	SPL	ENSG00000166224	"Sphingosine-1-phosphate lyase 1"	O95470	10	70815961-70881173	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Apoptosis, Lipid metabolism, Sphingolipid metabolism"	Lyase	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"RT4: 45.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021125, HPA023086"	Enhanced		Supported	"Endoplasmic reticulum"		NA	NA			"Endoplasmic reticulum"		"HPA021125: AB_1856803, HPA023086: AB_1856804"	"unprognostic (1.14e-1)"	"unprognostic (1.77e-1)"	"unprognostic (1.15e-1)"	"unprognostic (3.07e-2)"	"unprognostic (2.13e-1)"	"unprognostic (2.34e-1)"	"unprognostic (7.60e-2)"	"unprognostic (2.98e-2)"	"unprognostic (2.88e-1)"	"unprognostic (1.06e-1)"	"unprognostic (1.70e-2)"	"unprognostic (2.12e-1)"	"unprognostic (9.52e-2)"	"unprognostic (3.42e-1)"	"unprognostic (2.14e-1)"	"unprognostic (9.21e-2)"	"unprognostic (4.68e-3)"	9.6	11.2	12.0	20.2	11.4	4.9	24.4	10.8	10.6	16.2	17.1	16.0	21.9	13.3	15.5	16.8	26.7	13.5	13.4	8.3	11.3	9.8	18.2	27.1	10.4	20.1	11.9	9.5	10.0	34.6	15.4	10.2	11.3	10.4	16.1	15.6	7.6	15.0	19.5	7.6	28.6	32.5	12.1	15.7	22.9	10.3	15.3	11.0	14.7	17.6	12.8	18.0	21.4	26.8	5.6	9.7	8.9	24.8	10.9	11.5	6.6	10.7	14.4	13.9	15.9	3.8	5.0	9.2	6.3	6.8	6.9	9.0	15.6	23.9	9.7	7.5	6.4	6.7	18.2	11.9	12.8	9.9	15.5	6.4	1.0	7.3	18.6	14.5	4.2	8.8	9.4	21.7	9.3	24.5	14.7	4.3	9.2	2.8	8.5	9.8	11.9	5.1	2.8	6.3	14.3	8.0	6.6	10.6	3.6	11.1	45.7	9.5	11.6	12.7	19.5	11.6	11.4	10.1	3.0	8.3	6.3	16.5	4.8	12.1	3.5	4.8	4.5	6.2	7.8	4.4	0.6	11.5	7.9	11.5	20.3	10.4	4.7	7.5	9.4	9.7	5.6	5.7	9.0	8.9	10.9	24.8	5.4	6.8	6.6	12.0	11.4	10.8	10.4	11.3	9.8	11.9	9.5	10.4	11.0	14.9	5.4	9.9	14.9	10.9	6.5	5.6	30.6	14.7	14.8	43.6	19.6	6.6	3.3	32.5	2.3	6.4	38.8	0.0	33.2	10.9	12.4	23.9	14.9	39.5	25.3	14.3	24.1	6.2	30.2	4.5	10.6	15.9	6.8	16.2	20.8	9.3	41.0	17.3	19.1	11.5	8.2	6.5	11.4	19.9	31.5	19.8	5.3	11.4	16.2	20.4
SGSH	"HSS, MPS3A, SFMD"	ENSG00000181523	"N-sulfoglucosamine sulfohydrolase"	P51688	17	80206716-80220923	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		Hydrolase	"Disease mutation, Mucopolysaccharidosis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HHSteC: 28.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023436, HPA023451"	Enhanced				"Intracellular and membrane"	NA	NA					"HPA023436: AB_1856806, HPA023451: AB_1856807"	"unprognostic (4.33e-2)"	"unprognostic (4.03e-2)"	"unprognostic (1.06e-2)"	"unprognostic (4.01e-2)"	"unprognostic (4.26e-3)"	"unprognostic (1.39e-3)"	"prognostic unfavorable (7.71e-4)"	"prognostic favorable (2.72e-4)"	"unprognostic (6.08e-2)"	"unprognostic (3.65e-1)"	"prognostic favorable (3.10e-4)"	"unprognostic (2.05e-1)"	"prognostic unfavorable (2.66e-4)"	"unprognostic (1.42e-2)"	"prognostic unfavorable (5.37e-4)"	"unprognostic (7.50e-2)"	"unprognostic (3.68e-2)"	14.4	37.1	7.8	11.6	7.5	2.3	13.5	5.5	7.3	12.0	11.2	9.3	16.5	8.5	13.8	14.8	11.2	13.2	14.2	8.5	7.9	9.3	16.3	9.9	15.1	19.9	5.5	6.7	11.3	19.5	16.5	13.8	19.2	7.7	17.2	5.8	18.1	18.8	19.5	6.1	14.9	12.3	11.2	6.8	23.3	13.2	8.1	6.7	3.6	16.6	11.4	16.1	14.5	8.9	3.9	16.0	1.8	16.1	6.4	14.4	9.5	1.2	3.7	3.2	6.7	9.4	8.5	4.7	8.4	16.5	11.6	10.6	3.2	4.3	0.0	13.6	7.2	4.6	4.1	2.0	3.5	2.1	4.0	5.1	0.0	9.4	9.4	28.3	0.0	2.9	16.1	4.3	3.3	4.5	1.7	22.8	2.2	3.5	9.4	6.2	6.5	0.1	0.1	2.0	2.8	6.6	0.5	1.8	9.8	7.2	6.5	0.9	6.7	9.3	17.4	4.5	2.5	15.7	0.2	15.6	13.5	3.9	5.1	2.9	15.7	1.8	1.7	6.2	0.0	6.6	0.0	16.1	0.0	10.9	6.8	14.4	3.1	9.2	10.8	16.0	3.9	7.5	6.3	1.8	6.4	6.0	1.1	10.9	9.5	7.8	7.5	5.5	7.3	7.9	9.3	5.5	6.7	7.7	6.7	3.0	9.6	2.4	3.7	4.5	3.1	1.4	7.6	2.7	7.9	7.0	7.9	15.1	0.0	7.2	0.2	7.7	8.5	0.0	13.8	7.3	9.3	5.1	0.0	3.9	15.7	0.0	2.9	10.4	13.2	0.0	10.6	7.9	1.7	5.4	9.9	5.2	7.6	3.5	13.4	4.1	4.0	12.9	4.2	0.2	0.7	4.8	22.5	5.4	6.7	2.4
SH3RF1	"KIAA1494, POSH, RNF142, SH3MD2"	ENSG00000154447	"SH3 domain containing ring finger 1"	Q7Z6J0	4	169094256-169271105	"Enzymes, Predicted intracellular proteins"	"Host-virus interaction, Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	4	"intermediate monocyte: 5.9;myeloid DC: 3.4;non-classical monocyte: 8.5"	"Group enriched"	"Detected in many"	13	"dendritic cells: 3.4;monocytes: 8.5"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA074783	Approved		Supported	"Vesicles,Intermediate filaments"		No	No			Vesicles	"Intermediate filaments"	"HPA074783: AB_2732268"	"unprognostic (4.14e-1)"	"unprognostic (4.67e-2)"	"unprognostic (1.23e-1)"	"unprognostic (7.83e-2)"	"unprognostic (1.02e-1)"	"unprognostic (1.30e-2)"	"unprognostic (1.29e-1)"	"unprognostic (2.65e-1)"	"unprognostic (8.44e-2)"	"unprognostic (9.58e-2)"	"unprognostic (4.77e-3)"	"unprognostic (7.88e-2)"	"prognostic favorable (5.51e-8)"	"unprognostic (4.43e-2)"	"unprognostic (1.63e-1)"	"unprognostic (5.99e-2)"	"unprognostic (1.77e-1)"	15.2	4.8	13.8	7.2	11.8	3.7	11.1	2.5	12.7	7.5	17.2	15.9	10.8	15.7	6.8	7.2	7.1	6.9	19.7	7.8	17.8	9.3	14.6	9.6	11.3	3.7	13.0	10.9	11.9	12.0	5.2	7.8	8.6	10.3	17.2	16.0	10.7	20.9	10.7	16.2	6.8	17.2	8.8	11.7	4.5	27.6	7.0	11.3	0.9	23.1	7.6	5.5	9.4	6.3	0.4	3.4	0.0	8.5	0.3	0.0	0.7	7.3	6.1	5.6	16.1	6.0	7.6	7.2	20.5	9.9	15.2	7.1	6.1	8.9	0.0	1.0	21.2	4.1	4.9	4.5	8.0	16.9	0.0	2.6	4.3	14.0	3.2	13.7	1.5	0.1	4.5	4.4	13.0	10.4	19.4	9.4	1.6	0.0	0.0	14.1	3.0	1.5	1.4	2.8	9.5	5.3	2.2	1.8	0.3	7.0	5.8	4.2	5.1	5.1	8.0	2.0	2.5	2.6	0.6	8.4	7.2	5.6	12.0	7.2	0.5	0.0	0.0	8.2	1.5	8.6	0.0	1.4	0.0	0.0	5.9	0.0	0.4	0.0	0.0	3.4	0.1	0.0	0.0	0.0	0.3	8.5	0.2	0.0	0.7	13.8	11.8	2.5	12.7	17.8	9.3	13.0	10.9	10.3	11.3	59.6	33.6	6.2	32.4	30.5	2.1	5.2	45.9	34.8	45.5	26.2	0.0	9.8	10.0	35.2	4.4	11.2	52.9	0.0	55.1	19.0	14.9	71.6	10.3	7.6	6.5	0.0	30.1	8.6	6.5	3.1	11.2	7.5	3.3	1.8	26.8	11.3	54.5	27.9	11.3	13.3	0.9	64.7	42.1	2.3	7.5	11.0	11.0	0.0	28.8	55.9
SH3RF2	"FLJ23654, Hepp1, POSHER, PPP1R39, RNF158"	ENSG00000156463	"SH3 domain containing ring finger 2"	Q8TEC5	5	145936579-146081791	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	"Protein phosphatase inhibitor, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"gallbladder: 40.8"	"Cell type enriched"	"Detected in many"	5	"Late spermatids: 7204.3"	"Low cancer specificity"	"Detected in many"			"Group enriched"	"Detected in many"	6	"basal ganglia: 11.5;cerebral cortex: 2.9"	"Low cell type specificity"	"Detected in some"			"Group enriched"	"Detected in many"	4	"dendritic cells: 1.4;T-cells: 1.6"	"Cell line enhanced"	"Detected in many"		"CACO-2: 34.6;GAMG: 15.3;hTERT-RPE1: 17.2"	"Region enriched"	"Detected in single"	14	"basal ganglia: 23.9"	"Region enhanced"	"Detected in some"		"basal ganglia: 14.5"	"HPA035903, HPA058119"	Uncertain		Enhanced	Nucleoplasm		NA	Yes			Nucleoplasm		"HPA035903: AB_10696515, HPA058119: AB_2683611"	"unprognostic (8.90e-3)"	"unprognostic (2.00e-3)"	"unprognostic (5.11e-3)"	"unprognostic (1.66e-2)"	"unprognostic (1.45e-3)"	"unprognostic (1.47e-2)"	"unprognostic (9.96e-3)"	"unprognostic (8.22e-2)"	"unprognostic (3.92e-1)"	"unprognostic (7.37e-3)"	"unprognostic (2.44e-3)"	"unprognostic (1.66e-1)"	"unprognostic (2.98e-2)"	"unprognostic (5.21e-2)"	"unprognostic (1.46e-1)"	"unprognostic (2.64e-2)"	"unprognostic (4.13e-3)"	2.6	0.6	1.2	6.2	11.5	0.0	2.9	0.2	2.9	6.4	19.1	0.4	0.4	9.2	2.9	2.2	22.2	3.6	40.8	23.5	0.8	0.3	0.8	4.6	1.9	0.0	0.3	1.1	1.0	14.3	0.0	3.3	0.3	0.1	2.2	8.5	0.9	16.9	1.0	21.7	33.1	21.4	1.2	0.5	0.2	11.9	6.4	0.6	0.6	3.8	19.6	16.1	0.9	10.0	0.0	1.4	0.3	0.1	0.0	1.6	0.3	10.2	2.8	0.1	0.6	0.0	0.0	0.0	0.1	0.8	2.1	0.8	34.6	9.5	0.0	5.4	0.4	15.3	9.5	0.0	11.2	2.0	0.1	0.1	0.0	4.1	4.6	0.6	0.0	0.0	0.1	6.0	3.2	7.6	17.2	0.1	0.2	0.0	0.0	0.9	0.0	0.0	0.0	0.8	8.5	0.7	0.0	0.1	0.0	4.4	1.0	0.0	0.0	0.6	0.2	0.2	0.5	3.3	0.0	4.9	0.4	8.9	0.7	3.3	0.0	0.0	0.0	5.5	0.0	0.0	0.3	0.0	0.0	1.2	0.0	0.0	0.0	1.6	0.7	1.4	0.0	0.0	1.5	0.2	0.0	0.1	0.0	0.8	0.3	1.2	11.5	0.2	2.9	0.8	0.3	0.3	1.1	0.1	0.6	14.9	2.9	0.0	4.5	48.9	0.6	414.9	2.5	2.7	2.3	1.8	0.0	0.0	0.0	6.5	1412.5	1.5	27.7	0.0	7.6	0.0	0.5	1.3	1.1	8.3	0.2	0.0	1.2	0.6	0.0	7204.3	23.9	0.0	8.5	1.0	12.2	1.9	13.6	17.5	32.5	0.6	0.0	12.9	1.4	32.0	16.2	43.7	0.0	0.0	27.1	6.4
SHMT1	"CSHMT, MGC15229, MGC24556, SHMT"	ENSG00000176974	"Serine hydroxymethyltransferase 1"	P34896	17	18327860-18363563	"Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"	"One-carbon metabolism"	Transferase	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"kidney: 57.8;liver: 108.3"	"Cell type enhanced"	"Detected in many"	14	"Hepatocytes: 213.8;Proximal tubular cells: 332.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in many"							"HPA023314, HPA078682"	Enhanced		Supported	Nucleoplasm,Cytosol		NA	NA		240000	Cytosol	Nucleoplasm	"HPA023314: AB_1856830, HPA078682: "	"unprognostic (4.76e-2)"	"unprognostic (1.98e-2)"	"unprognostic (5.46e-2)"	"unprognostic (3.76e-1)"	"unprognostic (2.45e-1)"	"unprognostic (8.44e-3)"	"prognostic favorable (2.52e-4)"	"unprognostic (7.55e-3)"	"unprognostic (4.50e-1)"	"unprognostic (2.42e-1)"	"unprognostic (2.14e-1)"	"unprognostic (1.70e-1)"	"prognostic favorable (8.54e-6)"	"unprognostic (1.70e-2)"	"unprognostic (2.66e-1)"	"unprognostic (2.57e-3)"	"unprognostic (4.04e-2)"	10.9	3.2	2.2	4.9	4.1	2.1	10.4	6.5	3.0	4.6	15.2	5.3	7.3	12.3	2.8	7.4	16.3	3.9	4.0	2.0	2.6	1.8	57.8	108.3	4.3	3.8	3.5	1.9	4.1	3.5	30.1	1.6	2.8	3.6	3.4	3.5	7.2	9.8	8.0	5.7	6.2	15.1	2.3	2.9	8.6	3.9	6.3	3.8	11.1	10.9	10.8	8.7	4.3	6.3	8.6	6.7	6.2	10.6	13.0	18.7	7.9	22.6	23.0	7.3	11.4	18.6	11.6	27.0	4.8	5.9	16.1	17.8	22.8	10.1	17.6	14.3	4.1	11.7	22.4	15.2	19.3	9.2	10.5	22.2	7.9	18.0	17.2	4.7	5.2	8.6	9.7	7.6	12.5	5.6	6.5	11.0	22.7	6.6	4.0	5.7	16.7	26.1	7.3	9.1	34.5	7.5	21.4	28.9	14.9	25.6	15.4	10.0	5.3	32.6	6.2	8.2	38.7	25.4	7.5	2.6	3.1	9.3	28.4	15.1	8.2	7.8	7.1	6.1	12.4	7.4	6.0	8.2	6.2	10.1	10.6	17.1	8.6	12.3	12.8	6.7	6.9	12.3	13.0	0.1	13.0	7.5	3.1	18.7	7.9	2.2	4.1	6.5	3.0	2.6	1.8	3.5	1.9	3.6	3.8	11.9	26.5	19.1	16.8	9.2	2.8	2.2	25.5	2.7	9.1	34.9	3.9	17.7	69.6	11.6	4.9	4.3	8.4	0.0	7.0	62.1	4.8	6.6	8.1	213.8	31.1	0.0	1.2	10.4	27.9	4.1	5.5	5.0	11.8	5.4	10.3	31.2	5.1	7.0	2.8	332.8	3.9	19.4	3.8	15.6	21.8	9.3	7.1	10.0	29.5	4.8
SHMT2	SHMT	ENSG00000182199	"Serine hydroxymethyltransferase 2"	P34897	12	57229327-57234935	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"One-carbon metabolism"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 103.1"	"Cell type enhanced"	"Detected in many"	6	"Hepatocytes: 158.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"RH-30: 212.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA020543, HPA020549"	Enhanced		Supported	Microtubules,Mitochondria		NA	NA		160000	Mitochondria	Microtubules	"HPA020543: AB_1856833, HPA020549: AB_1856834"	"prognostic unfavorable (8.37e-5)"	"unprognostic (1.24e-1)"	"unprognostic (1.90e-1)"	"unprognostic (2.65e-2)"	"unprognostic (1.65e-1)"	"unprognostic (4.97e-2)"	"unprognostic (1.58e-2)"	"unprognostic (9.83e-2)"	"unprognostic (1.11e-2)"	"unprognostic (2.67e-2)"	"unprognostic (4.00e-2)"	"unprognostic (3.19e-2)"	"prognostic unfavorable (4.84e-8)"	"unprognostic (3.05e-1)"	"unprognostic (2.30e-1)"	"unprognostic (2.72e-1)"	"unprognostic (4.74e-2)"	13.0	13.5	5.9	15.0	7.1	12.6	9.5	9.6	9.5	10.5	11.5	6.1	5.0	13.4	10.2	8.5	22.1	8.6	10.3	11.0	6.5	5.4	15.5	103.1	11.8	18.7	8.7	4.6	17.9	38.9	4.5	8.1	16.8	6.5	10.3	9.4	7.1	44.6	5.7	16.5	13.7	11.5	9.9	7.6	23.5	13.4	5.4	6.3	26.1	13.2	19.0	25.6	11.2	13.8	33.6	14.5	6.5	11.7	9.7	48.7	12.3	25.1	11.7	11.8	31.2	9.3	14.3	23.4	13.6	22.2	18.3	16.8	16.7	12.2	46.6	22.6	16.8	7.6	16.1	21.3	22.2	9.9	26.0	19.0	19.2	7.2	11.8	68.7	31.7	17.0	18.3	32.2	14.7	49.2	16.6	18.1	24.8	20.0	44.3	13.8	16.5	25.2	17.4	10.1	10.1	19.0	17.0	212.4	43.1	9.1	11.6	25.3	12.1	7.1	16.8	49.3	4.5	22.8	39.0	11.4	7.4	15.1	9.6	18.5	59.5	32.5	39.5	16.0	29.6	13.3	6.5	9.8	5.9	6.9	11.7	8.0	33.6	12.1	7.4	14.5	32.4	5.3	5.4	0.5	9.7	7.5	4.8	48.7	12.3	5.9	7.1	9.6	9.5	6.5	5.4	8.7	4.6	6.5	6.3	8.9	13.1	58.9	19.1	30.8	6.2	7.5	20.4	9.4	12.5	3.5	0.0	53.0	11.6	41.7	0.4	13.5	11.0	46.7	41.3	42.8	21.6	14.9	28.8	158.5	43.3	7.9	9.2	20.3	38.1	0.2	16.7	22.7	37.1	27.1	21.6	42.4	40.1	21.0	15.2	48.7	4.9	6.5	22.6	2.1	7.2	28.4	31.2	26.2	37.7	17.6
SHPK	"CARKL, SHK"	ENSG00000197417	Sedoheptulokinase	Q9UHJ6	17	3608262-3636322	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		"Kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Cone photoreceptor cells: 15.7;Rod photoreceptor cells: 15.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA024361, HPA064939"	Enhanced		Approved	"Nucleoplasm,Nuclear speckles"		NA	NA		150000	"Nucleoplasm, Nuclear speckles"		"HPA024361: AB_1846030, HPA064939: AB_2685388"	"unprognostic (1.75e-2)"	"unprognostic (1.51e-2)"	"unprognostic (3.53e-2)"	"unprognostic (1.23e-2)"	"unprognostic (3.57e-3)"	"unprognostic (1.54e-2)"	"unprognostic (1.95e-2)"	"unprognostic (3.01e-2)"	"unprognostic (1.56e-1)"	"unprognostic (3.64e-2)"	"unprognostic (1.08e-2)"	"unprognostic (1.42e-1)"	"unprognostic (3.82e-2)"	"unprognostic (6.75e-2)"	"unprognostic (1.55e-1)"	"unprognostic (1.05e-1)"	"unprognostic (1.12e-1)"	8.9	12.9	7.6	6.2	10.6	5.9	8.9	17.3	12.3	8.8	14.1	14.9	8.8	18.5	10.7	6.1	11.6	7.6	5.3	5.9	7.0	5.5	14.3	26.7	6.3	5.3	12.0	4.5	10.2	13.7	11.8	6.2	8.6	9.8	7.4	8.6	12.3	8.9	9.4	7.5	12.1	22.8	5.1	6.7	6.1	9.7	5.2	13.0	7.7	7.7	4.0	7.6	7.5	9.6	5.2	7.1	5.1	4.8	6.4	7.5	5.4	5.3	10.9	11.6	7.4	4.8	4.9	6.4	3.6	3.2	7.0	4.2	18.7	5.0	6.3	8.0	6.9	6.6	10.4	15.4	11.6	5.1	10.1	15.0	6.9	9.3	13.4	5.8	5.9	9.8	8.2	5.6	7.8	5.3	6.0	13.2	5.0	9.1	8.1	6.8	9.5	7.6	4.6	5.8	12.3	7.3	10.5	6.1	10.1	10.0	6.9	3.3	8.9	13.1	12.1	3.6	7.4	10.8	3.5	9.4	10.8	5.1	10.3	8.7	2.7	3.5	4.2	11.7	5.4	5.4	3.3	4.7	5.1	4.6	4.8	4.7	5.2	4.2	3.7	6.5	4.0	7.5	4.7	0.9	6.4	4.1	7.1	3.6	5.4	7.6	10.6	17.3	12.3	7.0	5.5	12.0	4.5	9.8	13.0	0.0	2.7	1.5	0.8	0.0	5.4	0.8	7.6	1.4	1.2	5.2	15.7	8.1	1.7	2.9	0.4	2.2	10.5	0.0	4.1	8.6	0.9	1.9	0.0	14.8	6.9	14.3	3.4	1.8	1.3	0.0	3.7	2.5	0.0	3.6	5.9	3.1	4.3	5.8	2.5	6.5	15.6	0.0	0.8	0.6	1.2	0.4	4.7	1.0	5.5	1.7
SHPRH	"bA545I5.2, FLJ90837, KIAA2023"	ENSG00000146414	"SNF2 histone linker PHD RING helicase"	Q149N8	6	145864245-145964423	"Enzymes, Predicted intracellular proteins"	"DNA damage, DNA repair, Ubl conjugation pathway"	"Helicase, Hydrolase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"Cone photoreceptor cells: 198.3;Rod photoreceptor cells: 175.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA034854, HPA044852"	Approved		Approved	"Nucleoplasm,Nuclear membrane,Cytosol"		NA	NA			"Nucleoplasm, Nuclear membrane, Cytosol"		"HPA034854: AB_10964488, HPA044852: "	"unprognostic (3.10e-2)"	"unprognostic (4.46e-2)"	"unprognostic (5.61e-3)"	"unprognostic (1.53e-2)"	"unprognostic (7.40e-3)"	"unprognostic (2.20e-2)"	"unprognostic (2.63e-1)"	"unprognostic (1.83e-1)"	"unprognostic (1.36e-1)"	"unprognostic (8.66e-3)"	"unprognostic (5.03e-1)"	"unprognostic (7.90e-2)"	"unprognostic (6.01e-3)"	"unprognostic (3.29e-2)"	"unprognostic (2.70e-1)"	"unprognostic (1.13e-1)"	"unprognostic (3.01e-1)"	10.9	7.3	8.3	11.0	10.0	5.5	10.4	38.0	11.5	10.6	8.0	4.5	10.8	6.0	14.1	9.2	8.5	9.8	6.7	7.2	7.2	4.2	8.4	6.5	7.1	9.0	7.6	5.9	18.8	8.7	11.4	19.7	6.6	8.5	8.3	7.4	7.3	10.2	13.7	11.4	13.9	8.2	11.0	10.3	8.8	8.5	10.7	8.7	8.4	12.5	7.2	8.0	10.7	11.5	6.7	4.8	4.4	2.4	3.4	4.3	1.2	3.0	2.3	11.7	6.8	5.4	5.8	5.6	3.6	2.9	4.5	5.8	5.3	2.1	10.6	4.5	2.7	3.5	5.2	7.1	5.1	5.9	4.7	8.1	10.7	5.3	4.4	4.0	22.4	6.7	4.0	5.9	4.2	6.2	4.4	4.8	7.6	14.8	6.0	3.8	2.7	14.4	8.3	7.8	5.0	4.1	10.4	18.1	3.6	6.1	3.0	9.6	6.7	6.4	5.9	4.0	8.4	3.1	10.8	5.3	2.9	5.4	5.6	4.2	4.9	7.0	12.7	3.0	9.6	4.4	1.6	2.3	4.4	4.3	2.4	3.7	3.9	3.6	2.9	2.7	6.7	4.1	3.3	0.1	3.4	2.4	4.8	3.3	1.2	8.3	10.0	38.0	11.5	7.2	4.2	7.6	5.9	8.5	8.7	26.8	18.9	20.8	15.3	18.8	113.2	15.9	17.8	12.0	23.9	21.0	198.3	12.7	6.6	15.4	8.3	19.7	10.0	0.0	11.1	5.8	14.4	13.4	12.7	14.8	10.2	89.0	18.5	14.1	21.8	5.1	46.9	15.5	13.5	15.4	14.3	57.4	13.0	10.5	32.2	4.5	175.4	71.1	21.7	76.9	67.5	17.2	5.5	20.3	15.0	9.6
SI		ENSG00000090402	Sucrase-isomaltase	P14410	3	164978898-165078495	"Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted membrane proteins"		"Glycosidase, Hydrolase, Multifunctional enzyme"	"Disease mutation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	123	"intestine: 181.4"	"Group enriched"	"Detected in some"	7	"Enterocytes: 48.7;Mucus-secreting cells: 79.9;Paneth cells: 46.3;Undifferentiated cells: 29.8"	"Cancer enhanced"	"Detected in some"		"stomach cancer: 6.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 2.9;CACO-2: 4.1;HeLa: 3.2;NB-4: 3.4;RPMI-8226: 4.9;SH-SY5Y: 3.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA011897	Enhanced					NA	NA					"HPA011897: AB_1856840"			"unprognostic (2.71e-2)"								"unprognostic (1.62e-2)"	"unprognostic (2.68e-1)"		"unprognostic (2.05e-1)"	"unprognostic (4.41e-2)"			0.1	0.1	0.1	1.4	0.1	0.0	0.1	0.1	0.1	0.1	93.3	0.0	0.0	94.1	0.1	0.0	0.1	0.1	0.2	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.1	5.4	0.0	0.1	0.0	0.1	0.1	181.4	0.0	0.1	0.1	0.1	0.7	0.0	0.0	0.1	0.1	0.0	0.1	0.1	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.9	0.0	0.0	0.0	0.0	4.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.4	0.0	0.0	0.0	0.0	0.0	4.9	0.0	0.0	0.6	3.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.0	0.0	48.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.2	0.0	0.0	3.8	0.0	0.0	0.0	0.0	79.9	0.0	0.0	46.3	0.0	0.0	0.0	0.0	0.0	0.7	0.2	0.0	0.0	0.0	29.8	0.0
SIAE	"CSE-C, LSE, MGC87009, YSG2"	ENSG00000110013	"Sialic acid acetylesterase"	Q9HAT2	11	124633113-124695707	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		"Hydrolase, Serine esterase"	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Cardiomyocytes: 56.7;Enterocytes: 65.0;Paneth cells: 57.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"ASC diff: 31.6;ASC TERT1: 32.9;HSkMC: 35.2;OE19: 32.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038052, HPA038053"	Approved				"Intracellular and membrane"	NA	NA		1800000			"HPA038052: AB_10671518, HPA038053: AB_10673039"	"unprognostic (9.97e-2)"	"unprognostic (1.28e-2)"	"unprognostic (2.48e-3)"	"prognostic favorable (4.66e-5)"	"unprognostic (3.30e-2)"	"unprognostic (5.20e-2)"	"unprognostic (4.90e-2)"	"unprognostic (4.32e-2)"	"unprognostic (1.18e-1)"	"unprognostic (2.26e-1)"	"unprognostic (2.45e-1)"	"unprognostic (9.19e-2)"	"prognostic favorable (4.42e-11)"	"unprognostic (7.24e-2)"	"unprognostic (3.22e-1)"	"unprognostic (4.49e-2)"	"unprognostic (1.92e-2)"	9.0	12.3	9.0	6.7	13.4	1.9	8.2	8.2	16.8	7.0	46.7	15.7	7.3	16.8	5.9	17.8	10.2	9.9	8.4	23.0	10.3	17.6	42.5	28.3	10.7	2.8	18.2	8.1	5.1	11.2	32.4	13.1	7.8	31.4	10.7	51.7	9.9	15.9	8.3	17.3	6.7	25.5	5.4	19.9	7.9	9.3	5.6	8.1	1.9	46.1	11.1	7.0	9.8	4.7	2.7	4.1	8.6	5.8	1.2	4.3	3.2	3.0	4.7	2.8	12.1	31.6	32.9	7.4	5.8	8.2	1.5	0.9	3.6	21.0	1.9	8.5	7.2	3.3	5.9	4.4	6.4	1.5	8.7	1.3	2.9	1.5	3.8	14.9	0.5	2.7	35.2	8.7	3.9	6.0	20.6	10.5	3.8	2.4	13.1	5.0	5.5	0.2	1.3	1.8	32.8	9.8	1.1	0.1	3.2	18.0	4.3	1.0	1.8	15.8	6.5	2.7	8.8	12.7	2.8	11.6	8.4	1.6	9.3	1.4	3.5	2.6	0.4	3.0	1.6	3.4	8.6	5.6	0.3	1.9	4.2	2.2	2.4	3.1	2.0	4.1	2.7	4.3	3.4	1.2	1.2	5.8	2.5	2.2	3.2	9.0	13.4	8.2	16.8	10.3	17.6	18.2	8.1	31.4	8.1	17.9	47.6	2.2	5.0	2.9	6.2	56.7	17.8	12.0	9.1	34.9	0.0	6.7	8.3	9.3	7.8	5.8	65.0	0.0	3.4	7.5	3.3	9.8	1.1	26.0	4.0	4.8	13.9	10.4	3.2	9.8	2.8	2.8	3.3	4.6	27.5	2.3	6.8	57.5	1.1	21.4	1.6	0.0	6.6	12.8	9.1	4.5	5.6	1.0	46.6	6.5
SIAH1	hSIAH1	ENSG00000196470	"Siah E3 ubiquitin protein ligase 1"	Q8IUQ4	16	48356364-48448402	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Apoptosis, Cell cycle, Differentiation, Spermatogenesis, Ubl conjugation pathway"	"Developmental protein, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"placenta: 102.6"	"Group enriched"	"Detected in many"	5	"Cytotrophoblasts: 161.7;Syncytiotrophoblasts: 624.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			CAB018724	Enhanced		Uncertain	Nucleoplasm,Mitochondria		NA	NA			Mitochondria	Nucleoplasm	"CAB018724: AB_2188865"	"unprognostic (7.08e-2)"	"unprognostic (1.16e-1)"	"unprognostic (4.88e-2)"	"unprognostic (1.07e-1)"	"unprognostic (2.92e-3)"	"unprognostic (1.25e-2)"	"unprognostic (7.93e-3)"	"unprognostic (1.12e-2)"	"unprognostic (9.22e-3)"	"unprognostic (3.26e-1)"	"unprognostic (8.02e-2)"	"unprognostic (7.84e-3)"	"unprognostic (7.67e-3)"	"unprognostic (4.38e-2)"	"unprognostic (4.00e-1)"	"unprognostic (9.55e-2)"	"unprognostic (1.26e-2)"	20.6	11.4	11.9	11.0	13.5	19.2	25.5	15.5	16.6	14.6	13.1	15.0	6.5	12.8	16.8	13.4	12.7	12.9	12.9	11.4	12.6	11.6	12.1	17.5	13.9	10.0	12.8	11.6	16.7	11.4	13.1	9.1	102.6	14.1	14.2	12.2	32.1	13.2	12.1	17.0	16.6	16.0	18.6	12.7	11.3	12.5	17.9	13.0	17.5	14.5	9.3	11.5	15.9	14.8	12.6	8.3	21.9	5.2	5.3	6.1	3.5	8.6	7.8	16.9	15.1	14.6	12.8	17.3	8.1	11.0	12.1	5.9	5.9	11.3	11.2	9.0	10.2	8.4	10.1	11.6	11.8	14.9	4.5	9.4	6.0	6.1	15.4	20.4	5.9	9.3	15.3	21.3	7.0	16.4	13.5	10.1	10.5	9.7	10.7	9.8	5.9	15.9	12.1	20.6	9.6	12.1	18.6	25.4	11.8	11.2	10.9	19.3	17.1	24.0	12.0	20.7	15.2	7.6	13.7	10.7	12.9	11.7	7.0	8.6	14.0	5.8	20.6	9.6	7.4	11.6	6.9	5.2	21.9	2.7	2.2	3.0	12.6	3.0	4.2	8.3	12.1	6.1	4.5	2.9	5.3	1.3	7.9	1.6	3.5	11.9	13.5	15.5	16.6	12.6	11.6	12.8	11.6	14.1	13.0	11.9	11.9	16.4	51.3	76.1	18.3	12.0	10.2	9.4	10.3	15.7	7.9	161.7	26.6	21.4	60.8	27.0	18.8	0.0	19.9	25.3	52.6	43.7	4.6	19.5	29.5	33.4	21.7	28.8	18.3	53.9	21.0	23.2	47.2	38.7	18.3	30.7	19.2	14.4	18.4	21.1	16.5	19.4	37.1	68.6	47.5	66.1	624.0	13.4	16.7	38.7
SIAH2		ENSG00000181788	"Siah E3 ubiquitin protein ligase 2"	O43255	3	150741127-150763477	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Apoptosis, Biological rhythms, Cell cycle, Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	9	"Syncytiotrophoblasts: 325.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA061293, CAB069930"	Approved		Approved	Nucleoplasm,Vesicles		NA	NA			Nucleoplasm	Vesicles	"CAB069930: AB_1217916, HPA061293: AB_2684470"	"prognostic favorable (1.17e-4)"	"unprognostic (1.04e-3)"	"unprognostic (3.83e-2)"	"unprognostic (9.15e-2)"	"unprognostic (1.69e-1)"	"unprognostic (6.91e-2)"	"unprognostic (1.86e-2)"	"unprognostic (5.68e-3)"	"unprognostic (6.26e-2)"	"unprognostic (1.95e-2)"	"prognostic unfavorable (8.21e-5)"	"unprognostic (1.34e-1)"	"unprognostic (1.38e-1)"	"unprognostic (2.38e-2)"	"unprognostic (5.56e-1)"	"unprognostic (1.66e-1)"	"unprognostic (4.69e-2)"	9.6	48.0	7.6	11.8	10.3	22.7	23.5	10.9	17.2	30.0	10.5	8.4	20.3	7.9	23.5	13.9	28.8	14.9	11.0	10.7	7.2	7.3	8.4	35.5	11.8	19.1	9.9	7.5	19.0	14.6	6.4	8.1	31.4	7.9	18.8	9.2	8.3	11.2	21.7	8.3	19.3	9.5	17.4	9.4	16.9	12.0	8.7	8.6	23.6	11.4	10.6	25.1	22.7	25.6	3.0	3.1	10.0	2.7	1.6	3.6	1.1	16.9	4.2	3.3	6.6	11.3	8.5	13.3	7.1	8.2	8.6	10.4	8.6	7.6	9.4	10.4	7.3	7.2	10.5	8.8	6.3	8.1	7.9	6.3	18.5	5.1	28.4	16.2	10.2	5.5	7.7	14.7	5.1	11.7	6.8	6.6	18.6	4.6	37.4	5.3	20.3	18.6	5.2	10.7	15.8	8.4	13.7	7.1	33.9	5.4	5.9	12.7	6.0	5.3	5.0	12.5	7.8	33.4	15.4	4.6	5.9	5.3	12.8	9.5	44.5	16.9	13.2	5.6	14.7	3.0	9.5	2.7	10.0	2.1	1.5	3.2	2.5	3.6	3.2	2.4	3.0	1.9	1.9	5.9	1.6	1.5	3.1	2.0	1.1	7.6	10.3	10.9	17.2	7.2	7.3	9.9	7.5	7.9	8.6	6.0	3.7	47.8	71.4	130.4	40.0	14.9	15.3	17.4	7.9	21.0	35.3	144.9	11.6	5.6	2.0	9.2	26.2	46.7	5.7	18.3	47.9	44.4	10.3	47.4	28.4	33.4	36.8	16.5	64.5	1.5	40.9	27.9	42.2	16.2	31.8	33.5	8.9	10.5	29.0	13.0	2.2	12.9	39.1	0.5	6.6	124.5	325.6	52.4	29.9	65.9
SIK1	"msk, SNF1LK"	ENSG00000142178	"Salt inducible kinase 1"	P57059	21	43414483-43427189	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Biological rhythms, Cell cycle, Differentiation"	"Developmental protein, Kinase, Serine/threonine-protein kinase, Transferase"	"Disease mutation, Epilepsy, Tumor suppressor"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in all"		"skin 1: 34.5"	"Cell type enhanced"	"Detected in many"	17	"Alveolar cells type 2: 112.3;Basal keratinocytes: 268.2;Melanocytes: 91.1;Suprabasal keratinocytes: 369.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"memory B-cell: 2.0;plasmacytoid DC: 1.6"	"Group enriched"	"Detected in many"	10	"B-cells: 2.0;dendritic cells: 1.6"	"Cell line enhanced"	"Detected in many"		"HBEC3-KT: 16.9;HeLa: 28.1;hTCEpi: 21.8;LHCN-M2: 21.9;U-266/84: 15.9"									"CAB023801, HPA038211, HPA078064"	Approved		Approved	Nucleoplasm,Vesicles		NA	NA			Nucleoplasm	Vesicles	"CAB023801: , HPA038211: AB_2675894, HPA078064: "	"unprognostic (4.06e-2)"	"unprognostic (9.38e-2)"	"unprognostic (3.31e-3)"	"unprognostic (3.00e-1)"	"unprognostic (5.02e-2)"	"unprognostic (7.97e-3)"	"unprognostic (1.51e-1)"	"unprognostic (7.30e-3)"	"unprognostic (2.35e-3)"	"unprognostic (4.97e-2)"	"unprognostic (1.89e-2)"	"unprognostic (1.30e-1)"	"unprognostic (3.89e-1)"	"unprognostic (9.94e-3)"	"unprognostic (3.88e-2)"	"unprognostic (2.89e-1)"	"unprognostic (1.82e-1)"	8.8	2.3	3.0	3.6	3.0	5.9	7.5	3.0	3.0	13.5	3.0	3.0	3.0	0.0	3.0	3.0	12.9	5.5	10.7	7.1	3.0	0.8	3.0	12.3	5.4	3.0	3.0	3.0	13.7	7.3	3.5	5.7	8.2	3.0	3.9	0.1	3.0	4.6	9.8	5.0	34.5	3.0	3.3	3.0	4.0	5.3	3.0	3.0	3.0	3.9	3.0	3.0	10.5	6.1	2.0	1.6	0.0	0.1	0.0	0.1	0.1	0.5	1.7	2.0	0.0	0.1	0.8	0.8	0.9	0.3	1.7	1.3	2.4	0.0	2.5	0.7	0.2	9.5	11.2	1.6	16.9	1.0	0.1	0.5	0.7	28.1	0.9	2.3	0.7	0.1	1.0	21.8	0.4	5.2	9.9	0.3	0.0	0.1	0.5	21.9	0.1	0.4	1.7	0.8	0.0	1.5	0.0	0.3	2.5	1.9	6.3	0.0	0.0	11.0	1.9	0.4	0.3	1.1	0.3	3.7	0.4	2.0	0.1	0.0	4.3	15.9	0.5	4.7	2.1	0.4	0.0	0.1	0.0	0.1	0.0	0.1	2.0	0.0	0.1	0.5	0.9	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.1	3.0	3.0	3.0	3.0	3.0	0.8	3.0	3.0	3.0	3.0	26.8	112.3	2.4	0.6	268.2	0.2	9.3	7.6	9.4	17.0	12.2	0.0	0.5	0.0	2.8	0.0	2.2	14.2	0.0	1.8	1.0	5.2	0.4	18.5	7.8	1.7	0.0	26.6	1.8	3.7	0.0	0.0	4.0	91.1	2.8	15.1	0.5	5.0	23.0	0.0	0.0	0.1	0.0	10.8	0.0	0.5	369.5	2.1	1.3	18.6	1.0
SIK2	"DKFZp434K1115, KIAA0781, LOH11CR1I, QIK, SNF1LK2"	ENSG00000170145	"Salt inducible kinase 2"	Q9H0K1	11	111602391-111730853	"Enzymes, Predicted membrane proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Cone photoreceptor cells: 62.8;Rod photoreceptor cells: 60.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"ASC diff: 34.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA016026, HPA071049"	Approved		Approved	"Nucleoplasm,Nuclear speckles,Vesicles,Intermediate filaments,Cytosol"		NA	NA			"Nucleoplasm, Vesicles"	"Nuclear speckles, Intermediate filaments, Cytosol"	"HPA016026: AB_1857321, HPA071049: "	"unprognostic (2.35e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.08e-1)"	"unprognostic (1.10e-2)"	"unprognostic (1.59e-2)"	"unprognostic (4.81e-2)"	"prognostic favorable (4.93e-4)"	"unprognostic (6.41e-2)"	"unprognostic (1.87e-1)"	"unprognostic (1.40e-2)"	"unprognostic (3.72e-3)"	"unprognostic (9.27e-2)"	"prognostic favorable (1.17e-9)"	"unprognostic (1.23e-1)"	"unprognostic (2.79e-1)"	"unprognostic (2.82e-3)"	"unprognostic (2.13e-2)"	32.8	10.7	10.1	6.6	17.2	4.0	22.5	10.6	17.3	10.0	9.9	15.1	5.2	7.7	9.5	7.0	7.9	9.7	12.7	14.5	10.5	10.3	14.6	24.4	13.6	5.4	9.7	9.9	16.4	37.8	22.0	28.6	7.5	11.9	8.4	8.3	14.9	15.4	8.6	35.1	8.7	7.7	8.7	9.6	5.8	19.6	4.2	13.0	4.4	11.1	7.9	5.8	8.6	10.0	2.2	2.7	2.8	3.6	2.2	3.5	2.1	5.9	4.0	7.0	7.5	34.8	10.3	4.1	5.2	7.5	4.0	4.6	13.4	6.4	4.7	7.3	6.1	4.7	8.4	5.4	3.9	5.2	3.5	2.3	5.1	3.5	6.6	7.5	4.9	3.3	10.0	5.8	5.8	7.6	8.0	4.7	4.7	4.7	6.9	6.2	2.8	5.1	4.5	2.4	5.0	3.9	6.9	7.4	5.6	8.9	5.4	3.3	7.7	7.7	3.1	3.1	6.6	7.7	4.0	6.5	8.8	5.3	5.6	7.1	2.0	1.5	9.9	2.8	7.0	5.9	1.1	3.3	2.8	3.5	3.6	1.9	2.0	2.5	2.5	2.7	2.2	1.4	2.0	1.4	2.2	2.9	1.5	2.4	2.1	10.1	17.2	10.6	16.4	10.5	10.3	9.7	9.9	11.9	13.0	17.9	32.3	9.1	6.7	13.1	14.4	16.6	22.9	13.4	11.4	15.7	62.8	3.5	5.0	7.1	12.4	18.0	9.5	46.7	6.7	4.1	14.4	5.8	9.2	34.2	4.8	30.2	17.3	9.8	12.4	9.7	10.6	8.6	18.6	2.8	10.2	13.3	9.2	8.6	13.8	20.7	60.3	0.0	13.7	3.2	5.9	10.5	4.3	7.4	9.9	6.5
SLC27A2	"ACSVL1, FACVL1, FATP2, hFACVL1, HsT17226, VLACS, VLCS"	ENSG00000140284	"Solute carrier family 27 member 2"	O14975	15	50182196-50236395	"Enzymes, Predicted membrane proteins, Transporters"	"Fatty acid metabolism, Lipid metabolism"	Ligase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"liver: 168.1"	"Cell type enhanced"	"Detected in many"	15	"Cytotrophoblasts: 236.8;Hepatocytes: 188.9;Proximal tubular cells: 112.0"	"Cancer enhanced"	"Detected in many"		"liver cancer: 49.2"	"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in some"	27	"basophil: 27.3"	"Lineage enriched"	"Detected in many"	27	"granulocytes: 27.3"	"Cell line enhanced"	"Detected in many"		"A549: 17.9;HaCaT: 32.2;HL-60: 23.1;OE19: 36.0"	"Low region specificity"	"Detected in many"			"Region enriched"	"Detected in single"	6	"hippocampal formation: 2.5"	HPA026089	Enhanced					NA	NA					"HPA026089: AB_1857060"	"unprognostic (3.03e-2)"	"unprognostic (1.13e-1)"	"unprognostic (1.51e-1)"	"unprognostic (2.10e-2)"	"unprognostic (3.06e-1)"	"unprognostic (1.10e-1)"	"unprognostic (4.06e-3)"	"unprognostic (3.33e-1)"	"unprognostic (1.89e-1)"	"unprognostic (6.38e-3)"	"unprognostic (4.83e-2)"	"unprognostic (1.82e-1)"	"prognostic favorable (7.48e-6)"	"unprognostic (5.01e-3)"	"unprognostic (4.08e-1)"	"unprognostic (1.22e-2)"	"prognostic favorable (6.40e-4)"	1.1	8.1	0.7	4.1	0.8	1.2	3.4	1.5	1.0	0.5	4.2	0.4	1.3	2.5	0.2	17.5	1.2	2.6	1.3	0.2	1.1	1.1	39.4	168.1	1.7	0.8	0.3	1.0	0.7	6.3	2.0	10.4	7.4	3.0	1.2	4.0	3.2	0.6	0.3	0.2	0.6	5.3	0.1	0.3	0.4	0.4	0.7	0.1	0.1	1.0	0.2	1.3	1.4	0.8	0.1	0.0	27.3	0.0	1.0	0.5	0.2	0.0	17.9	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.3	0.5	9.3	2.5	0.0	0.2	0.4	0.2	32.2	8.2	0.2	0.8	12.6	10.1	13.2	16.6	8.3	0.1	23.1	9.5	0.0	0.7	0.0	0.0	0.0	0.0	6.1	4.0	0.0	0.0	2.9	0.6	15.6	0.6	36.0	0.6	0.0	0.0	0.6	1.7	16.3	14.9	0.9	3.1	0.4	0.0	0.4	1.7	8.1	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	7.5	0.0	27.3	0.0	0.4	0.4	0.0	0.4	0.1	0.4	0.4	0.0	0.1	0.1	0.1	0.2	1.0	0.0	0.0	0.5	0.2	0.7	0.8	1.5	1.0	1.1	1.1	0.3	1.0	3.0	0.1	0.0	0.6	0.9	0.8	0.9	0.7	0.3	0.0	54.9	6.8	8.7	0.0	236.8	10.0	0.3	0.4	0.1	20.6	0.0	1.7	2.6	0.0	1.8	5.8	188.9	14.3	1.6	4.1	3.7	2.5	0.0	0.3	0.1	0.0	0.0	18.6	0.5	1.6	28.1	0.0	112.0	1.5	0.0	0.1	1.8	2.5	0.3	45.9	4.3	21.1	4.4
SLC27A5	"ACSB, ACSVL6, FACVL3, FATP5, FLJ22987, VLACSR, VLCS-H2, VLCSH2"	ENSG00000083807	"Solute carrier family 27 member 5"	Q9Y2P5	19	58479512-58512413	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Fatty acid metabolism, Lipid metabolism"	"Ligase, Oxidoreductase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	8	"liver: 157.6"	"Group enriched"	"Detected in many"	6	"Early spermatids: 114.0;Hepatocytes: 338.0;Late spermatids: 303.5"	"Cancer enriched"	"Detected in all"	26	"liver cancer: 49.8"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"HPA007292, CAB056160, CAB068239"	Enhanced					NA	NA					"CAB056160: AB_2665590, CAB068239: AB_2665592, HPA007292: AB_1857064"	"unprognostic (5.97e-2)"	"unprognostic (9.12e-2)"	"unprognostic (9.95e-2)"	"unprognostic (6.36e-3)"	"unprognostic (2.52e-1)"	"unprognostic (7.46e-2)"	"prognostic favorable (1.57e-4)"	"unprognostic (1.04e-1)"	"unprognostic (1.85e-2)"	"unprognostic (2.46e-1)"	"unprognostic (1.78e-2)"	"unprognostic (8.56e-2)"	"unprognostic (1.66e-4)"	"unprognostic (2.27e-1)"	"unprognostic (3.33e-2)"	"unprognostic (7.80e-2)"	"unprognostic (2.16e-1)"	1.3	2.0	5.4	1.4	5.3	1.1	2.0	1.9	3.9	1.7	1.0	1.7	1.2	1.0	1.1	1.1	1.4	2.6	1.1	1.3	3.7	3.8	1.9	157.6	0.9	1.4	4.3	2.5	1.4	2.6	1.1	1.3	0.8	3.4	1.4	0.8	1.3	2.7	2.1	1.4	1.1	0.9	1.5	2.7	1.1	1.1	2.3	3.0	1.4	1.8	0.6	1.4	1.1	1.6	13.3	10.8	2.2	3.0	9.6	18.7	8.9	16.0	22.0	3.9	4.1	3.7	3.9	2.4	0.9	2.1	3.1	4.3	1.7	3.5	20.9	2.7	1.1	0.6	3.4	4.5	14.1	1.3	9.7	14.9	14.0	22.9	18.3	5.6	7.3	5.0	4.5	2.4	0.4	8.5	5.3	1.5	15.9	12.9	0.0	3.7	13.1	18.1	15.5	2.4	13.5	12.9	9.1	0.1	28.4	10.1	7.6	5.4	7.3	0.0	21.7	4.7	1.1	6.4	6.4	1.2	0.0	2.8	0.0	1.8	13.8	15.4	8.5	4.5	13.7	0.8	0.0	2.4	2.2	8.7	3.0	18.7	13.3	11.2	11.4	6.5	8.9	13.9	14.3	0.3	9.6	2.1	10.8	13.3	8.9	5.4	5.3	1.9	3.9	3.7	3.8	4.3	2.5	3.4	3.0	0.0	8.2	11.5	13.1	8.0	11.5	5.6	22.9	9.4	5.7	5.2	0.0	6.4	33.2	10.3	114.0	11.9	1.3	0.0	13.3	2.3	7.6	17.0	4.7	338.0	9.1	9.5	9.7	15.4	11.3	303.5	10.0	8.9	15.1	1.8	3.5	6.1	7.4	0.0	8.9	39.7	7.6	6.5	15.5	8.8	13.2	12.3	2.9	10.2	4.7	12.1
SLK	"KIAA0204, se20-9, STK2"	ENSG00000065613	"STE20 like kinase"	Q9H2G2	10	103967201-104029233	"Enzymes, Plasma proteins, Predicted intracellular proteins"	Apoptosis	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	4	"Urothelial cells: 181.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA015757	Approved		Approved	"Plasma membrane,Cytosol"		NA	NA		17000	"Plasma membrane, Cytosol"		"HPA015757: AB_1857236"	"unprognostic (1.89e-1)"	"unprognostic (1.80e-1)"	"unprognostic (1.38e-1)"	"unprognostic (8.28e-2)"	"unprognostic (1.01e-1)"	"unprognostic (3.64e-1)"	"unprognostic (8.67e-2)"	"unprognostic (6.85e-2)"	"unprognostic (1.01e-1)"	"unprognostic (2.31e-1)"	"prognostic unfavorable (2.77e-5)"	"unprognostic (1.95e-1)"	"prognostic favorable (3.95e-5)"	"unprognostic (8.48e-2)"	"unprognostic (3.95e-1)"	"unprognostic (3.09e-2)"	"unprognostic (1.07e-1)"	15.2	11.2	13.7	11.0	36.7	14.6	16.1	16.7	13.1	16.6	19.0	9.9	10.9	9.1	17.0	12.1	40.2	12.1	13.6	17.2	10.6	7.1	14.9	12.2	17.1	10.1	11.2	13.4	17.2	12.5	22.6	13.1	17.4	12.8	19.3	13.6	11.4	19.8	12.7	19.3	16.6	15.5	29.8	13.0	12.1	15.7	10.2	12.8	12.0	15.8	21.6	12.5	24.9	23.6	1.4	2.2	6.5	1.4	1.3	3.6	0.7	21.6	12.7	15.1	10.8	16.4	22.9	6.4	13.5	18.0	10.1	9.5	8.0	23.3	11.5	8.5	13.9	8.6	23.6	8.0	17.1	14.8	9.2	11.0	11.7	10.4	6.7	12.3	13.9	10.1	11.7	22.5	13.6	39.9	14.1	18.1	7.5	14.6	8.0	13.2	7.5	9.7	7.7	3.7	14.0	8.1	9.5	18.6	6.0	13.2	25.0	3.5	6.2	11.7	11.4	11.2	8.0	5.9	10.1	27.3	7.4	7.8	13.6	15.8	9.7	11.8	7.3	11.0	18.8	4.7	1.2	1.4	3.3	3.6	1.2	3.6	1.1	2.2	2.2	1.2	1.4	1.5	2.5	6.5	1.3	1.0	2.2	1.4	0.7	13.7	36.7	16.7	13.1	10.6	7.1	11.2	13.4	12.8	12.8	166.7	108.1	23.8	57.3	50.6	27.3	89.7	28.1	66.9	138.8	41.8	23.6	27.8	3.3	28.4	6.3	53.4	45.3	23.3	46.5	11.5	39.3	60.5	32.5	21.7	17.3	23.8	17.7	41.7	24.0	11.0	43.1	31.1	8.5	37.9	31.8	23.4	61.5	54.9	59.4	11.3	24.1	6.5	34.9	42.3	39.1	59.8	43.8	21.8	29.4	181.1
SMARCAD1	"DKFZP762K2015, ETL1, KIAA1122"	ENSG00000163104	"SWI/SNF-related, matrix-associated actin-dependent regulator of chromatin, subfamily a, containing DEAD/H box 1"	Q9H4L7	4	94207611-94291292	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"DNA damage, DNA repair"	"Chromatin regulator, DNA-binding, Helicase, Hydrolase"	"Ectodermal dysplasia, Palmoplantar keratoderma"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA016737	Approved		Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"HPA016737: AB_1857271"	"unprognostic (5.01e-2)"	"unprognostic (5.83e-2)"	"unprognostic (2.59e-3)"	"unprognostic (1.23e-1)"	"unprognostic (8.41e-3)"	"unprognostic (9.08e-3)"	"prognostic unfavorable (3.22e-5)"	"unprognostic (2.45e-1)"	"unprognostic (3.49e-3)"	"unprognostic (3.55e-1)"	"unprognostic (2.57e-2)"	"unprognostic (7.72e-2)"	"unprognostic (2.99e-2)"	"unprognostic (1.43e-1)"	"unprognostic (1.95e-1)"	"unprognostic (1.55e-1)"	"unprognostic (3.20e-3)"	12.8	15.4	15.4	22.2	14.6	8.6	20.1	26.7	25.1	15.4	13.6	9.4	14.4	12.6	19.6	17.5	17.2	16.5	13.9	12.9	13.6	14.7	16.6	14.9	21.6	22.8	17.6	11.1	20.8	15.0	17.2	33.0	18.3	14.9	15.4	16.5	10.2	14.9	20.9	11.8	26.5	13.9	15.6	17.9	17.6	13.9	15.3	16.2	42.0	20.2	11.4	17.8	16.0	15.9	5.5	4.3	3.5	3.0	7.5	6.2	2.7	7.4	9.7	30.1	19.7	8.7	14.3	15.6	13.3	12.5	11.1	10.7	8.7	12.2	19.2	9.2	11.4	10.1	6.5	21.2	11.2	16.1	14.7	9.6	13.8	10.5	13.3	12.6	20.1	14.8	14.6	9.3	13.8	17.8	13.8	17.3	16.8	22.8	8.0	16.8	5.9	34.2	10.7	20.9	9.4	4.8	19.9	17.2	9.8	13.0	9.1	17.7	26.2	10.2	17.2	14.6	19.3	8.8	13.6	16.3	14.5	15.5	8.9	10.1	11.3	16.9	23.0	13.6	10.8	17.9	3.5	2.5	0.3	4.6	3.0	4.8	5.5	5.1	4.9	4.3	4.2	5.5	6.2	0.0	7.5	2.9	3.7	4.1	2.7	15.4	14.6	26.7	25.1	13.6	14.7	17.6	11.1	14.9	16.2	11.9	9.9	6.0	5.4	10.4	19.7	12.3	5.1	37.5	34.2	8.7	15.7	11.2	1.7	10.8	1.7	14.3	5.0	0.0	8.7	9.4	10.1	5.8	22.1	11.0	9.3	17.5	8.6	11.1	14.0	1.8	13.3	12.3	3.3	7.2	12.6	9.4	12.3	8.2	17.3	12.7	18.1	6.5	7.2	26.5	34.0	8.4	8.0	16.2	10.9	3.8
SMG1	"ATX, KIAA0421, LIP"	ENSG00000157106	"SMG1, nonsense mediated mRNA decay associated PI3K related kinase"	Q96Q15	16	18804853-18926454	"Enzymes, Predicted intracellular proteins"	"DNA damage, DNA repair, Nonsense-mediated mRNA decay"	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006870, HPA031623, HPA073972"	Approved		Supported	Nucleoplasm		NA	NA			Nucleoplasm		"HPA006870: AB_1079725, HPA031623: AB_2673962, HPA073972: AB_2686648"	"unprognostic (6.34e-2)"	"unprognostic (5.88e-2)"	"unprognostic (5.98e-2)"	"unprognostic (2.66e-1)"	"unprognostic (2.44e-2)"	"unprognostic (1.35e-2)"	"unprognostic (1.03e-1)"	"unprognostic (2.28e-1)"	"unprognostic (1.22e-1)"	"unprognostic (2.42e-1)"	"unprognostic (8.32e-3)"	"unprognostic (7.28e-2)"	"unprognostic (1.05e-1)"	"unprognostic (2.61e-2)"	"unprognostic (1.15e-1)"	"unprognostic (3.17e-2)"	"unprognostic (2.45e-2)"	4.7	3.0	2.1	4.5	3.5	11.7	6.2	13.2	3.0	4.4	4.5			3.1	5.4	5.1	5.5	4.0	3.0	4.5	2.3	2.2	4.6	5.4	4.1	6.2	2.3		6.3	4.5	7.2	3.9	3.1		4.2	5.0		4.7	3.3	21.1	14.4	5.0	3.9	3.4	4.5	4.3	4.0			6.0		5.8	5.2	4.9	7.1	4.6	19.1	5.6	2.3	6.1	1.0	23.5	15.8	14.9	10.5	17.1	18.1	11.1	11.0	10.9	12.0	13.5	13.9	8.7	32.5	15.9	15.3	12.7	13.4	17.1	9.6	19.2	20.9	10.7	14.8	13.9	17.7	13.9	19.9	11.7	10.6	16.3	24.9	30.0	11.9	16.8	17.7	22.7	18.1	13.2	12.6	13.7	11.9	15.9	8.6	9.1	15.9	20.1	11.1	10.4	18.5	13.5	10.4	17.1	11.6	12.1	12.8	9.3	12.7	21.2	18.1	12.1	11.1	16.3	9.3	12.0	21.4	12.0	15.5	10.8	19.1	2.5	3.4	6.1	2.8	2.9	3.7	4.0	4.3	2.5	7.1	5.4	4.7	7.6	2.3	5.6	4.6	3.7	1.0											71.5	85.2	53.9	67.9	171.7	51.1	42.5	20.4	48.2	92.1	26.2	70.7	16.8	3.3	19.5	15.5	65.3	48.7	23.3	20.4	15.0	55.9	71.2	38.1	39.9	21.0	39.7	37.7	36.8	38.1	15.4	27.6	61.1	37.1	36.1	38.6	20.1	26.6	57.5	24.8	12.2	43.3	45.3	56.7	45.2	29.8	178.7	25.1	60.7	35.2	83.0
SMOX	"C20orf16, dJ779E11.1, FLJ20746, MGC1010, PAO, PAOh1, SMO"	ENSG00000088826	"Spermine oxidase"	Q9NWM0	20	4120980-4187747	"Enzymes, FDA approved drug targets, Predicted intracellular proteins"		Oxidoreductase	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	9	"Ductal cells: 48.0;Pancreatic endocrine cells: 84.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"myeloid DC: 2.1;neutrophil: 3.5"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"A549: 35.5;Karpas-707: 60.7;RPTEC TERT1: 28.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA047117, HPA060198"	Approved		Supported	"Nucleoplasm,Nuclear membrane,Vesicles,Cytosol"		NA	NA			Nucleoplasm	"Nuclear membrane, Vesicles, Cytosol"	"HPA047117: AB_2679940, HPA060198: AB_2684220"	"unprognostic (1.24e-2)"	"unprognostic (6.55e-2)"	"unprognostic (7.24e-3)"	"unprognostic (2.77e-1)"	"unprognostic (1.40e-1)"	"unprognostic (2.32e-1)"	"prognostic unfavorable (3.33e-6)"	"prognostic unfavorable (1.36e-4)"	"unprognostic (4.92e-2)"	"unprognostic (3.37e-1)"	"unprognostic (7.18e-2)"	"unprognostic (7.58e-2)"	"prognostic unfavorable (1.06e-4)"	"unprognostic (4.08e-2)"	"unprognostic (2.64e-3)"	"unprognostic (1.26e-2)"	"unprognostic (3.07e-1)"	3.5	3.1	26.0	4.1	22.7	24.2	3.4	10.1	29.0	9.6	6.7	23.5	17.6	9.5	10.2	6.9	6.1	4.7	14.0	2.9	28.8	16.2	3.8	4.4	2.1	4.0	25.1	16.5	9.2	28.9	8.7	6.0	5.7	20.7	8.1	1.4	6.5	10.6	10.2	2.5	7.8	7.1	3.9	25.9	2.9	7.4	3.9	24.1	0.3	3.9	3.4	2.6	5.3	5.2	0.1	2.1	3.5	0.9	0.2	0.2	15.3	3.2	35.5	2.5	1.8	1.7	2.6	4.5	4.6	8.9	3.4	2.3	14.6	8.9	0.0	1.5	4.2	5.5	6.5	2.0	2.2	1.4	0.0	1.1	6.2	1.1	14.8	10.9	1.2	2.5	9.8	4.0	7.1	3.0	4.1	6.0	5.0	1.3	60.7	2.0	1.0	2.3	3.5	3.1	3.1	4.9	2.0	3.1	8.4	28.0	2.4	0.5	2.1	8.6	1.0	15.9	1.3	0.1	1.5	7.1	3.9	3.7	0.7	3.6	2.8	0.4	0.0	3.2	1.5	3.0	0.0	0.9	0.1	0.0	0.4	0.0	0.1	0.2	0.2	2.1	0.0	0.0	0.0	3.5	0.2	0.1	1.0	0.0	15.3	26.0	22.7	10.1	17.6	28.8	16.2	25.1	16.5	20.7	24.1	0.0	0.3	1.5	9.5	11.2	0.5	1.4	12.7	1.4	4.5	10.4	0.0	0.3	0.0	48.0	3.1	5.6	2.1	23.3	26.4	0.6	9.5	12.1	5.7	2.0	16.2	0.0	5.8	14.1	3.4	5.6	13.6	10.4	8.5	36.9	2.1	28.2	84.5	0.8	12.7	1.4	1.3	0.0	8.1	4.2	4.9	9.3	0.2	0.0	2.9	8.8
SMPD1	ASM	ENSG00000166311	"Sphingomyelin phosphodiesterase 1"	P17405	11	6390431-6394998	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins"		"Glycosidase, Hydrolase"	"Disease mutation, Neurodegeneration, Niemann-Pick disease"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"Late spermatids: 155.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"ASC diff: 41.6;fHDF/TERT166: 41.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"								"Secreted to blood"	NA	NA		2000000				"unprognostic (8.76e-2)"	"unprognostic (2.66e-1)"	"unprognostic (6.99e-2)"	"unprognostic (2.28e-3)"	"prognostic unfavorable (7.72e-5)"	"unprognostic (9.46e-2)"	"unprognostic (1.46e-1)"	"unprognostic (4.90e-2)"	"unprognostic (8.06e-2)"	"unprognostic (1.72e-1)"	"prognostic favorable (7.47e-4)"	"unprognostic (4.35e-2)"	"prognostic favorable (4.57e-6)"	"unprognostic (4.27e-2)"	"unprognostic (2.00e-1)"	"unprognostic (1.12e-2)"	"unprognostic (1.71e-1)"	14.7	21.4	12.4	10.9	18.7	5.4	10.7	17.2	32.4	14.5	17.4	30.6	15.7	14.3	12.2	15.0	11.6	7.9	18.5	26.8	14.5	13.2	47.1	77.5	17.1	10.7	17.4	15.9	12.9	19.9	35.4	23.8	23.1	21.6	17.6	12.9	23.3	21.5	18.5	20.9	19.7	15.8	14.9	17.8	11.7	13.3	7.4	14.1	18.8	20.2	10.3	11.8	12.5	11.4	3.2	1.8	3.4	2.7	6.8	11.4	3.1	4.6	3.7	2.8	7.6	41.6	21.7	5.0	17.6	27.3	8.0	9.7	6.4	3.3	1.2	8.2	41.0	17.4	1.9	2.4	3.6	3.8	5.9	2.8	1.4	6.0	1.7	18.6	1.0	11.0	28.6	6.9	7.4	5.0	29.6	17.6	0.5	2.5	8.8	17.1	4.7	0.0	1.8	1.1	6.5	6.6	0.3	1.6	1.9	6.9	1.7	4.9	2.8	7.9	5.5	10.8	3.8	2.1	1.9	15.2	29.9	3.2	17.3	4.1	11.3	12.0	0.9	27.7	3.0	13.3	1.8	2.7	3.4	6.9	2.1	5.6	1.6	5.9	5.5	1.4	3.2	11.3	11.4	2.7	6.8	0.6	1.8	4.8	3.1	12.4	18.7	17.2	32.4	14.5	13.2	17.4	15.9	21.6	14.1	23.8	15.6	18.0	17.3	7.0	11.9	31.1	22.9	2.7	9.1	24.4	23.6	33.4	10.0	42.6	42.2	13.5	58.4	0.0	33.0	11.7	31.4	37.7	10.4	72.3	30.5	19.1	22.8	27.6	12.7	155.2	10.6	8.6	52.3	4.6	17.5	16.4	24.7	17.5	12.7	60.8	4.9	0.0	24.5	1.2	1.8	6.9	28.7	20.3	10.9	12.0
SMPD2	"ISC1, nSMase"	ENSG00000135587	"Sphingomyelin phosphodiesterase 2"	O60906	6	109440763-109443919	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Lipid metabolism, Sphingolipid metabolism"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	14	"Early spermatids: 151.6;Late spermatids: 248.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA018110, HPA018125"	Uncertain		Approved	"Vesicles,Plasma membrane,Cell Junctions"		NA	NA			"Vesicles, Plasma membrane"	"Cell Junctions"	"HPA018110: AB_1857292, HPA018125: AB_1857293"	"unprognostic (1.61e-1)"	"unprognostic (8.01e-2)"	"unprognostic (1.97e-1)"	"unprognostic (8.79e-3)"	"unprognostic (3.88e-2)"	"unprognostic (2.38e-1)"	"prognostic unfavorable (1.17e-4)"	"unprognostic (7.08e-2)"	"unprognostic (7.59e-2)"	"unprognostic (1.41e-1)"	"prognostic favorable (1.00e-3)"	"unprognostic (3.60e-2)"	"unprognostic (2.14e-3)"	"unprognostic (7.94e-2)"	"unprognostic (2.25e-1)"	"unprognostic (1.45e-2)"	"prognostic favorable (1.70e-4)"	6.0	6.8	4.2	20.2	4.9	8.5	8.5	5.4	6.4	9.0	12.6	9.8	16.4	10.5	6.1	16.0	17.2	17.4	12.6	5.1	4.9	3.7	10.2	7.8	8.4	9.4	4.7	4.2	6.7	15.5	17.9	8.8	19.5	4.8	10.1	10.2	8.4	16.6	11.9	3.3	16.9	15.4	7.8	4.3	10.1	11.1	35.1	4.7	18.3	10.5	13.5	23.0	6.3	10.1	18.3	13.4	9.3	7.8	6.2	8.0	5.3	8.9	10.4	5.5	8.6	9.7	5.3	18.3	3.0	11.2	7.6	7.2	9.8	7.3	4.9	6.4	6.4	16.0	11.5	5.5	13.2	4.6	6.2	14.2	5.7	10.7	6.0	8.1	6.2	6.7	5.6	15.3	6.7	13.3	8.5	6.9	8.7	11.0	8.7	3.7	12.9	10.0	13.5	1.5	11.9	5.0	7.1	2.6	5.3	13.7	15.3	7.2	6.0	5.7	17.9	13.5	4.6	5.7	12.0	4.4	3.4	4.9	2.7	11.2	5.9	1.5	3.1	6.6	6.0	6.0	5.7	7.8	9.3	6.6	7.5	7.3	12.8	7.4	8.0	10.2	18.3	5.6	5.7	2.3	6.2	6.6	13.4	7.2	5.3	4.2	4.9	5.4	6.4	4.9	3.7	4.7	4.2	4.8	4.7	11.9	7.4	4.2	8.5	8.8	1.3	2.0	12.7	58.9	7.9	12.2	3.9	8.2	1.7	14.7	151.6	3.8	27.2	0.0	17.1	16.1	6.0	12.7	0.0	3.2	8.5	0.0	8.1	4.3	6.6	248.2	8.6	10.8	8.5	11.8	21.2	2.3	13.7	24.6	8.5	7.9	5.2	12.9	2.8	36.6	10.6	16.3	14.2	4.9	13.8	13.7
SMPD3	NSMASE2	ENSG00000103056	"Sphingomyelin phosphodiesterase 3"	Q9NY59	16	68358325-68448688	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Cell cycle, Lipid metabolism, Sphingolipid metabolism"	"Developmental protein, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 44.5;intestine: 46.4;lymphoid tissue: 73.0"	"Cell type enriched"	"Detected in many"	6	"Horizontal cells: 284.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	7	"plasmacytoid DC: 44.5"	"Lineage enriched"	"Detected in many"	7	"dendritic cells: 44.5"	"Cell line enhanced"	"Detected in some"		"HMC-1: 9.6;MOLT-4: 13.6;RPMI-8226: 11.3;SCLC-21H: 13.1"	"Region enhanced"	"Detected in many"		"basal ganglia: 103.1"	"Low region specificity"	"Detected in all"			"CAB033885, HPA065535, HPA069383"	Approved		Supported	"Endoplasmic reticulum"		NA	NA			"Endoplasmic reticulum"		"CAB033885: AB_1126788, HPA065535: , HPA069383: "	"unprognostic (1.21e-1)"	"prognostic favorable (7.72e-4)"	"unprognostic (5.61e-3)"	"prognostic favorable (3.86e-4)"	"unprognostic (2.46e-1)"	"unprognostic (5.85e-4)"	"unprognostic (7.87e-2)"	"unprognostic (8.12e-3)"	"unprognostic (2.77e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.75e-1)"	"unprognostic (1.81e-1)"	"unprognostic (1.04e-3)"	"unprognostic (5.02e-3)"	"unprognostic (2.49e-1)"	"unprognostic (1.19e-1)"	"unprognostic (1.93e-3)"	3.5	2.3	6.0	3.1	18.3	1.8	1.6	9.4	15.4	1.0	9.6	2.5	0.0	46.4	1.7	0.7	1.8	2.7	17.2	1.2	8.7	3.6	0.9	3.8	2.1	3.5	2.5	5.0	2.7	1.9	0.7	10.7	0.8	3.9	2.2	5.8	4.3	2.2	0.9	1.8	8.1	42.7	1.2	1.4	3.0	18.6	4.2	4.4	73.0	1.3	1.3	4.3	1.6	1.2	0.6	44.5	6.1	0.0	0.0	0.7	0.3	0.3	0.7	0.3	0.1	0.0	0.0	5.3	0.4	0.0	0.4	0.1	2.9	0.9	0.4	0.5	0.2	0.2	1.1	0.0	0.0	0.1	0.3	0.7	0.1	2.1	0.3	0.0	0.0	9.6	0.0	0.0	0.0	0.2	0.5	0.0	0.9	0.8	0.3	0.3	0.2	13.6	2.6	0.6	4.6	0.1	0.6	0.2	11.3	0.0	0.1	13.1	2.6	0.4	1.5	0.6	0.3	1.0	0.9	0.0	0.4	0.8	1.4	0.1	2.2	1.1	0.2	0.2	0.9	0.2	1.0	0.0	6.1	0.7	0.0	0.1	0.6	0.0	0.2	0.0	0.2	0.2	0.1	0.0	0.0	0.0	44.5	0.5	0.3	6.0	18.3	9.4	15.4	8.7	3.6	2.5	5.0	3.9	4.4	3.0	0.6	0.0	1.4	0.1	39.5	2.5	5.1	16.0	1.2	0.0	0.0	0.0	0.0	0.9	6.0	0.0	51.1	0.0	0.8	0.2	0.3	3.7	0.0	5.0	0.2	284.4	24.8	0.0	0.6	13.0	14.1	0.0	0.0	0.0	25.6	0.8	1.2	43.0	43.2	0.0	3.3	0.0	0.0	5.4	0.3	0.9	0.0	5.0	18.7	4.7
SMPD4	"FLJ20297, FLJ20756, KIAA1418, NET13, nSMase-3, NSMASE3"	ENSG00000136699	"Sphingomyelin phosphodiesterase 4"	Q9NXE4	2	130151392-130182750	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"		Hydrolase	"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA046279, HPA049426"	Approved		Approved	"Nuclear membrane,Cytosol"		NA	NA			"Nuclear membrane"	Cytosol	"HPA046279: AB_2679611, HPA049426: AB_2680762"	"unprognostic (5.02e-2)"	"unprognostic (9.61e-3)"	"unprognostic (6.31e-2)"	"prognostic unfavorable (7.47e-5)"	"unprognostic (1.69e-1)"	"unprognostic (8.80e-2)"	"prognostic unfavorable (8.37e-6)"	"unprognostic (3.27e-2)"	"unprognostic (1.72e-1)"	"unprognostic (7.47e-2)"	"unprognostic (1.49e-2)"	"prognostic unfavorable (1.73e-4)"	"prognostic unfavorable (8.16e-8)"	"unprognostic (1.74e-1)"	"unprognostic (2.28e-1)"	"unprognostic (1.47e-3)"	"unprognostic (2.09e-1)"	13.2	16.1	12.4	17.1	20.7	39.1	14.8	22.1	25.1	19.9	15.8	31.4	15.3	15.5	22.5	14.1	19.3	19.5	12.7	13.4	13.2	16.0	14.3	18.5	14.7	20.5	21.3	12.2	22.2	22.2	24.1	31.2	24.3	19.5	16.3	16.7	17.7	17.1	15.2	17.0	17.5	15.2	18.3	16.0	16.4	14.5	23.6	21.6	27.9	22.8	19.6	27.1	16.9	16.6	10.5	9.8	14.5	11.4	11.7	15.2	9.7	32.0	15.8	20.0	14.8	10.3	7.6	26.1	17.1	12.7	25.2	21.1	45.8	16.5	20.9	15.2	17.1	14.4	18.2	25.5	22.6	17.5	27.7	24.7	23.5	17.0	36.3	8.8	26.2	15.0	8.8	15.2	28.3	11.3	9.3	14.5	20.9	29.2	17.0	14.1	17.3	27.4	13.2	30.7	13.7	21.1	29.1	15.2	22.7	10.7	15.2	27.8	15.6	16.8	20.6	7.5	11.6	14.0	11.5	11.2	21.6	21.0	14.1	20.0	14.8	16.6	28.1	19.5	15.0	15.3	1.8	9.3	14.5	13.9	11.4	15.2	9.5	10.4	12.4	9.8	10.5	10.2	11.4	4.5	11.7	8.0	6.4	9.4	9.7	12.4	20.7	22.1	25.1	13.2	16.0	21.3	12.2	19.5	21.6	3.0	9.9	10.2	9.1	13.4	20.0	3.2	5.1	6.7	6.8	7.0	11.8	19.8	8.3	8.1	17.4	7.4	7.1	0.0	10.5	21.1	10.3	8.6	5.8	13.5	12.1	14.3	12.6	9.8	9.4	32.6	13.6	6.5	15.1	5.4	12.5	7.8	11.0	9.1	17.3	5.6	15.1	0.0	8.0	24.0	22.0	18.1	13.0	12.8	12.1	7.9
SMS	"MRSR, SPMSY, SpS, SRS"	ENSG00000102172	"Spermine synthase"	P52788	X	21940573-21994835	"Disease related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins"	"Polyamine biosynthesis"	Transferase	"FDA approved drug targets, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Cytotrophoblasts: 588.3;Distal tubular cells: 515.6;Syncytiotrophoblasts: 727.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA029849, HPA029852"	Approved		Approved	"Nuclear bodies,Cytosol"		No	No		26000	"Nuclear bodies"	Cytosol	"HPA029849: AB_10602072, HPA029852: AB_10611521"	"unprognostic (2.51e-2)"	"unprognostic (2.91e-1)"	"unprognostic (1.89e-2)"	"unprognostic (1.39e-1)"	"unprognostic (1.43e-1)"	"prognostic unfavorable (7.49e-4)"	"prognostic unfavorable (7.79e-8)"	"unprognostic (1.02e-2)"	"unprognostic (2.72e-1)"	"unprognostic (3.18e-3)"	"unprognostic (3.95e-3)"	"unprognostic (2.45e-1)"	"prognostic unfavorable (7.85e-5)"	"unprognostic (2.70e-1)"	"unprognostic (1.22e-1)"	"unprognostic (1.67e-1)"	"unprognostic (8.50e-2)"	21.7	48.1	29.7	18.7	25.0	18.6	28.4	36.6	35.4	20.8	23.1	8.1	26.0	23.5	20.8	31.3	19.2	13.3	20.9	26.3	22.3	25.0	55.1	19.5	17.6	18.5	25.6	28.5	42.4	16.7	13.6	19.2	63.6	24.2	61.3	24.4	15.7	20.7	20.6	18.0	9.7	25.1	36.8	17.4	18.9	18.8	18.4	11.0	19.6	27.6	11.7	20.8	28.2	16.5	13.2	19.4	37.0	25.7	11.7	20.3	12.3	83.0	21.3	36.2	13.8	9.6	16.3	11.2	22.8	13.6	35.0	33.6	26.3	27.2	30.2	7.9	23.2	96.8	18.3	35.5	41.6	69.4	13.9	16.6	15.6	25.6	18.7	17.7	30.2	13.7	10.7	12.7	36.0	67.7	25.5	33.5	12.2	33.2	4.2	47.8	17.7	22.2	30.2	61.5	18.8	31.6	22.2	24.9	22.9	46.7	11.8	17.3	14.0	18.2	23.4	60.0	96.2	21.1	12.6	29.6	25.4	25.6	52.7	37.0	3.2	6.5	17.9	49.6	13.4	35.2	2.9	21.4	37.0	7.6	22.1	9.4	13.2	12.0	13.2	19.4	8.3	7.9	9.3	21.1	11.7	25.7	4.0	20.3	12.3	29.7	25.0	36.6	35.4	22.3	25.0	25.6	28.5	24.2	11.0	23.8	21.6	43.8	142.7	58.5	33.8	30.5	48.4	48.2	55.7	104.7	11.8	588.3	515.6	219.3	1.6	38.1	67.1	0.0	132.3	261.4	79.8	237.6	39.3	44.0	322.1	20.6	56.6	52.8	131.4	3.6	88.3	123.6	87.7	344.5	84.4	32.3	142.0	65.4	97.2	354.3	33.3	64.7	46.4	5.9	214.2	44.3	727.3	67.0	102.6	134.1
SMURF1	KIAA1625	ENSG00000198742	"SMAD specific E3 ubiquitin protein ligase 1"	Q9HCE7	7	99027438-99144100	"Enzymes, Predicted intracellular proteins"	"Differentiation, Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Urothelial cells: 65.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019671, HPA055245"	Approved		Approved	Nucleoplasm,Vesicles		NA	NA			Vesicles	Nucleoplasm	"HPA019671: , HPA055245: AB_2682757"	"unprognostic (2.21e-1)"	"unprognostic (6.15e-2)"	"unprognostic (8.88e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.96e-2)"	"unprognostic (1.42e-1)"	"unprognostic (1.29e-1)"	"unprognostic (1.73e-1)"	"unprognostic (2.00e-1)"	"unprognostic (2.15e-2)"	"unprognostic (3.92e-3)"	"unprognostic (2.58e-1)"	"unprognostic (1.46e-1)"	"unprognostic (7.83e-2)"	"unprognostic (1.68e-1)"	"unprognostic (3.81e-1)"	"unprognostic (4.62e-2)"	15.0	11.1	8.7	10.5	15.0	23.8	12.4	12.1	16.5	11.8	10.9	20.9	6.9	9.5	11.6	5.7	19.3	10.2	12.5	7.9	9.3	8.4	10.3	10.1	16.0	8.1	15.4	9.4	19.6	22.5	9.0	15.1	15.4	14.9	11.7	10.6	14.3	13.4	9.6	10.7	17.3	10.3	9.8	10.6	9.1	19.5	26.0	11.8	6.6	7.8	6.6	12.7	11.5	13.3	1.2	1.2	2.4	1.9	1.0	2.1	0.6	13.7	7.9	6.4	4.5	5.1	5.4	9.6	7.7	7.4	6.3	5.9	3.9	11.4	4.3	8.4	7.2	13.9	7.5	3.5	10.0	6.5	3.2	3.0	2.3	4.6	3.8	4.8	2.6	5.7	4.8	6.9	9.9	11.5	9.6	5.9	4.2	6.9	7.6	5.8	11.2	4.5	5.4	7.5	7.6	8.5	4.3	6.0	2.6	6.9	11.4	2.8	6.4	7.4	9.8	6.8	11.8	3.1	5.0	8.7	10.0	10.3	17.8	15.4	6.8	4.6	4.5	5.0	5.2	15.4	2.0	1.4	2.3	1.3	1.5	1.6	0.9	2.1	1.3	1.1	1.2	1.2	1.0	2.4	1.0	1.9	1.2	2.0	0.6	8.7	15.0	12.1	16.5	9.3	8.4	15.4	9.4	14.9	11.8	17.9	28.0	5.2	20.4	23.0	25.8	3.9	20.4	20.1	20.5	12.2	7.9	6.1	1.7	13.9	3.7	10.8	7.8	0.0	13.9	8.0	10.1	31.9	2.3	6.7	5.7	25.4	10.9	7.4	3.1	5.3	5.8	8.5	8.5	4.6	8.7	3.7	25.0	10.5	13.1	4.4	6.9	6.5	15.5	41.5	1.0	19.3	17.6	2.5	7.8	65.2
SMURF2		ENSG00000108854	"SMAD specific E3 ubiquitin protein ligase 2"	Q9HAU4	17	64542295-64662068	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"BJ: 55.2;HBF TERT88: 42.4;LHCN-M2: 42.4;TIME: 48.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA071508	Enhanced		Supported	"Nuclear speckles"		NA	NA			"Nuclear speckles"		"HPA071508: AB_2686406"	"unprognostic (1.21e-1)"	"unprognostic (2.07e-2)"	"unprognostic (1.59e-2)"	"unprognostic (3.24e-1)"	"unprognostic (6.19e-2)"	"unprognostic (7.33e-2)"	"unprognostic (2.67e-2)"	"unprognostic (1.50e-1)"	"unprognostic (7.94e-2)"	"unprognostic (1.09e-2)"	"unprognostic (5.46e-3)"	"unprognostic (2.54e-1)"	"unprognostic (5.55e-2)"	"unprognostic (1.98e-2)"	"unprognostic (7.82e-2)"	"unprognostic (2.20e-2)"	"unprognostic (1.41e-1)"	12.3	9.2	10.5	9.0	15.0	11.5	10.2	16.7	10.0	9.2	9.1	11.5	8.1	9.3	7.9	6.9	7.6	7.8	10.5	8.2	12.6	4.6	9.4	5.7	19.0	8.6	9.5	4.8	8.5	9.0	8.2	10.7	15.3	10.1	10.6	8.2	9.6	9.9	7.6	7.5	11.0	13.7	8.9	6.6	9.9	9.8	21.6	10.6	8.9	11.4	4.1	9.6	9.4	11.7	3.0	3.0	4.8	2.2	7.3	3.5	1.7	15.9	4.4	3.8	2.8	2.6	10.2	1.8	55.2	25.1	21.6	18.8	2.4	12.2	2.1	3.5	9.4	8.5	3.5	3.6	9.5	42.4	1.1	2.4	2.2	2.7	2.9	2.4	2.9	1.4	2.7	3.7	29.9	11.5	13.1	24.9	2.7	3.3	2.1	42.4	3.5	6.8	1.3	2.2	2.5	5.8	1.6	9.2	1.4	5.9	2.8	3.6	3.2	3.4	1.7	2.5	7.3	2.9	2.4	48.9	24.5	13.3	9.4	36.6	2.4	2.9	3.8	6.0	1.7	7.4	2.8	2.2	4.8	3.3	2.0	2.8	2.0	2.4	3.5	3.0	3.0	2.3	2.6	4.4	7.3	1.0	2.6	1.1	1.7	10.5	15.0	16.7	10.0	12.6	4.6	9.5	4.8	10.1	10.6	29.8	21.3	9.5	27.8	38.9	26.4	9.1	7.6	13.4	19.4	8.7	41.2	10.4	8.3	13.5	18.7	24.0	18.8	0.0	8.4	2.7	21.3	22.7	12.7	4.5	12.6	25.4	17.1	43.6	16.7	7.8	11.5	14.0	20.3	4.6	10.3	20.6	18.4	17.3	11.3	7.4	46.8	0.0	20.3	31.2	24.5	34.8	6.1	20.8	11.5	21.8
SMYD1	"BOP, KMT3D, ZMYND22"	ENSG00000115593	"SET and MYND domain containing 1"	Q8NB12	2	88067780-88113387	"Enzymes, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"DNA-binding, Methyltransferase, Repressor, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	10	"heart muscle: 45.9;skeletal muscle: 103.7;tongue: 36.4"	"Cell type enriched"	"Detected in single"	1107	"Cardiomyocytes: 207.9"	"Cancer enhanced"	"Detected in some"		"stomach cancer: 1.6"	"Region enriched"	"Detected in single"	4	"cerebral cortex: 1.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	5	"HSkMC: 5.6"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			HPA062282	Enhanced					NA	NA					"HPA062282: AB_2684736"	"unprognostic (1.93e-2)"		"unprognostic (2.49e-1)"		"unprognostic (4.09e-2)"	"unprognostic (8.51e-3)"			"unprognostic (2.74e-1)"		"unprognostic (3.91e-1)"			"unprognostic (8.81e-3)"	"unprognostic (1.40e-1)"			2.7	0.0	0.1	0.1	0.3	0.0	1.2	0.0	1.4	0.0	4.6	0.0	0.0	0.4	0.0	3.4	2.5	0.0	0.2	45.9	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	1.8	0.0	0.0	0.0	0.9	0.4	0.0	1.5	0.0	103.7	0.0	4.4	6.3	0.1	0.0	2.6	0.1	0.0	0.0	0.2	36.4	2.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	1.4	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	207.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
SMYD2	"HSKM-B, KMT3C, ZMYND14"	ENSG00000143499	"SET and MYND domain containing 2"	Q9NRG4	1	214281102-214337131	"Enzymes, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Chromatin regulator, Methyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 75.7"	"Cell type enhanced"	"Detected in many"	6	"Cardiomyocytes: 109.6;Cytotrophoblasts: 142.7;Early spermatids: 113.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA029023	Uncertain		Approved	"Intermediate filaments,Mitochondria,Cytosol"		NA	NA			Cytosol	"Intermediate filaments, Mitochondria"	"HPA029023: AB_10601605"	"unprognostic (8.53e-2)"	"prognostic unfavorable (1.53e-5)"	"unprognostic (5.98e-2)"	"unprognostic (1.00e-2)"	"unprognostic (8.55e-2)"	"unprognostic (2.53e-2)"	"unprognostic (2.24e-2)"	"unprognostic (1.72e-2)"	"unprognostic (1.90e-3)"	"unprognostic (1.65e-1)"	"unprognostic (9.44e-2)"	"unprognostic (2.77e-1)"	"prognostic favorable (8.68e-4)"	"unprognostic (2.65e-1)"	"unprognostic (4.92e-2)"	"unprognostic (8.10e-2)"	"unprognostic (6.37e-2)"	5.9	5.7	8.8	5.6	7.3	2.7	10.0	5.0	23.9	4.9	4.7	2.1	3.1	4.8	3.8	6.7	7.3	10.4	4.5	75.7	7.0	8.4	7.7	9.7	8.1	8.0	5.3	10.0	4.7	7.8	2.9	7.5	10.6	6.9	4.6	5.8	3.1	6.2	3.0	29.5	4.3	4.7	3.8	4.7	6.2	6.2	8.9	2.2	8.0	7.8	5.1	5.6	5.2	4.0	9.3	5.5	8.1	5.9	17.6	14.5	7.3	24.5	7.1	9.7	6.8	10.0	17.5	41.3	13.9	11.5	17.6	20.0	28.0	21.0	12.7	14.3	15.7	9.6	11.6	9.2	25.8	17.1	10.6	10.7	4.1	12.0	22.3	9.0	17.8	2.9	18.7	14.6	12.2	9.7	12.2	12.7	12.2	12.9	3.2	15.7	12.8	12.4	11.2	8.7	14.4	9.7	7.7	23.5	10.8	17.4	18.0	9.6	22.4	10.8	38.9	28.6	23.3	30.3	11.9	14.6	13.7	20.2	7.5	21.5	13.1	4.9	14.6	17.8	14.2	15.6	6.7	5.9	8.1	9.5	3.2	11.2	9.3	14.5	12.7	5.5	4.8	12.7	11.6	0.6	17.6	1.2	3.8	14.5	7.3	8.8	7.3	5.0	23.9	7.0	8.4	5.3	10.0	6.9	2.2	17.9	11.9	11.2	14.0	18.3	3.8	109.6	22.9	48.2	12.5	3.5	0.0	142.7	26.6	32.4	113.6	10.8	12.7	0.0	17.4	93.2	12.2	8.9	3.5	15.5	33.9	14.3	4.1	22.1	17.4	93.5	10.9	9.9	15.1	10.8	15.2	15.2	22.5	10.5	3.5	27.8	4.6	12.9	15.7	15.2	43.7	15.7	71.9	12.8	20.8	7.6
SMYD3	"KMT3E, ZMYND1, ZNFN3A1"	ENSG00000185420	"SET and MYND domain containing 3"	Q9H7B4	1	245749342-246507312	"Cancer-related genes, Enzymes, Predicted intracellular proteins"		"Chromatin regulator, Methyltransferase, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"granulocytes: 108.5;Late spermatids: 74.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HMC-1: 95.1;K-562: 35.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB012229, HPA045821, HPA054352"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"CAB012229: , HPA045821: AB_2679461, HPA054352: AB_2682458"	"unprognostic (7.00e-3)"	"unprognostic (7.45e-2)"	"unprognostic (1.52e-1)"	"unprognostic (6.18e-3)"	"unprognostic (3.32e-2)"	"unprognostic (5.08e-3)"	"unprognostic (3.25e-3)"	"unprognostic (1.72e-3)"	"unprognostic (4.53e-2)"	"unprognostic (1.57e-1)"	"unprognostic (1.71e-1)"	"unprognostic (2.10e-1)"	"unprognostic (3.78e-5)"	"unprognostic (9.03e-3)"	"unprognostic (2.14e-1)"	"unprognostic (1.08e-2)"	"unprognostic (1.58e-1)"	6.0	12.0	9.9	9.7	16.2	7.6	10.6	25.9	14.7	8.9	6.5	6.4	3.7	4.5	8.7	21.8	6.1	10.0	7.7	5.8	10.3	12.0	8.9	5.5	9.2	6.3	12.0	10.2	8.0	7.2	6.7	11.9	4.6	15.3	6.8	8.3	9.5	5.3	5.9	9.5	6.7	5.2	7.6	6.8	5.3	6.1	10.5	8.1	7.5	18.8	3.6	9.3	8.3	6.6	11.3	5.9	8.3	3.4	19.4	12.9	8.7	4.7	2.9	4.2	3.6	4.8	6.6	4.2	6.7	5.0	7.9	17.8	3.7	5.5	7.7	5.4	6.2	4.9	3.1	3.8	7.5	26.5	4.0	3.9	4.5	4.3	4.5	9.0	4.6	95.1	17.7	1.8	10.4	6.7	6.0	5.4	5.5	35.9	2.7	7.7	1.6	8.7	8.8	3.7	6.6	4.7	8.1	5.1	11.2	5.7	6.9	10.0	4.8	3.1	0.4	6.1	4.7	3.9	7.8	4.1	3.8	2.6	2.7	7.9	13.6	3.7	4.0	7.3	6.3	4.4	8.1	3.4	8.3	10.5	3.0	10.8	11.3	11.1	12.8	5.9	11.1	12.3	12.9	2.4	19.4	3.3	3.8	11.8	8.7	9.9	16.2	25.9	14.7	10.3	12.0	12.0	10.2	15.3	8.1	6.0	27.8	5.3	13.2	10.9	5.8	7.7	2.5	44.2	13.6	12.2	21.6	7.8	13.3	20.6	46.2	11.7	4.2	0.0	28.1	33.5	15.4	5.4	108.5	4.2	10.3	9.5	24.1	9.2	3.8	74.1	10.3	6.0	11.8	1.8	8.3	9.1	16.5	2.9	16.3	14.6	13.9	0.0	15.1	17.3	24.7	10.0	6.1	13.6	9.2	6.4
SNRK	"FLJ20224, HSNFRK, KIAA0096"	ENSG00000163788	"SNF related kinase"	Q9NRH2	3	43286512-43424764	"Enzymes, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Ito cells: 86.5;Sertoli cells: 122.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HUVEC TERT2: 51.9;TIME: 30.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042163	Uncertain		Approved	"Nucleoplasm,Vesicles,Plasma membrane,Cell Junctions"		NA	NA			"Vesicles, Plasma membrane, Cell Junctions"	Nucleoplasm	"HPA042163: AB_10794645"	"prognostic favorable (9.28e-4)"	"unprognostic (8.46e-2)"	"unprognostic (2.79e-3)"	"unprognostic (6.41e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.16e-3)"	"unprognostic (2.00e-2)"	"unprognostic (1.08e-1)"	"unprognostic (2.63e-3)"	"unprognostic (4.25e-1)"	"unprognostic (2.32e-1)"	"unprognostic (4.68e-2)"	"prognostic favorable (9.41e-5)"	"unprognostic (9.21e-3)"	"unprognostic (2.04e-1)"	"unprognostic (7.06e-3)"	"unprognostic (7.38e-2)"	31.5	8.8	9.8	13.1	14.4	41.0	22.6	34.5	21.1	17.6	14.4	7.9	5.9	12.8	20.9	10.5	16.2	11.5	16.4	13.9	11.0	11.0	16.8	20.3	24.7	19.8	11.4	10.6	15.1	18.0	18.4	16.2	26.2	22.5	12.1	9.9	14.7	10.7	9.4	12.5	24.5	17.0	18.7	9.8	25.4	11.2	13.9	7.2	48.4	24.8	13.5	14.4	15.8	19.3	3.2	3.0	20.9	5.5	8.1	10.7	6.5	3.3	2.0	3.8	3.6	11.3	4.0	3.6	3.6	6.1	3.9	3.8	2.8	4.8	5.3	2.8	4.5	2.6	2.1	4.4	7.7	4.1	6.0	3.6	6.0	3.8	3.2	5.9	6.7	6.7	4.5	5.3	4.4	7.5	4.0	51.9	6.1	2.6	6.1	3.5	1.7	6.8	5.9	4.2	1.8	9.3	4.7	2.8	5.5	10.1	5.7	2.7	5.6	3.1	3.3	4.3	3.4	2.3	8.6	30.2	3.4	3.5	3.9	4.1	9.9	7.1	4.5	2.4	8.1	4.9	4.8	2.8	5.4	7.6	5.5	10.7	2.8	6.7	7.6	3.0	3.2	10.1	10.1	20.9	8.1	5.0	0.9	7.1	6.5	9.8	14.4	34.5	21.1	11.0	11.0	11.4	10.6	22.5	7.2	29.8	30.3	12.9	9.7	46.9	49.8	14.5	22.9	16.0	18.2	15.7	15.7	6.3	10.0	9.2	40.0	52.3	28.4	0.0	7.8	2.7	11.8	9.9	13.9	21.3	11.3	28.6	10.4	86.5	27.6	4.9	11.5	16.6	21.9	4.6	8.9	15.6	8.4	8.2	11.0	10.4	17.2	122.9	26.4	10.7	15.7	44.8	6.9	41.7	8.5	15.4
SNRNP200	"ASCC3L1, BRR2, HELIC2, KIAA0788, RP33, U5-200KD"	ENSG00000144028	"Small nuclear ribonucleoprotein U5 subunit 200"	O75643	2	96274336-96305515	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	"Helicase, Hydrolase"	"Disease mutation, Retinitis pigmentosa"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA029321	Approved		Supported	Nucleoplasm		NA	NA		6600	Nucleoplasm		"HPA029321: AB_10604096"	"unprognostic (2.63e-2)"	"unprognostic (1.45e-1)"	"unprognostic (1.44e-1)"	"prognostic unfavorable (3.89e-4)"	"unprognostic (1.50e-1)"	"unprognostic (1.09e-1)"	"unprognostic (2.48e-3)"	"unprognostic (1.01e-1)"	"unprognostic (1.75e-1)"	"unprognostic (1.74e-1)"	"unprognostic (3.10e-1)"	"unprognostic (6.46e-2)"	"unprognostic (2.61e-2)"	"unprognostic (1.82e-1)"	"unprognostic (2.69e-1)"	"unprognostic (1.50e-1)"	"unprognostic (1.03e-1)"	26.6	25.2	18.4	28.4	21.9	32.0	26.1	37.2	25.8	24.4	23.6	23.7	20.6	18.4	34.7	22.6	23.4	26.5	22.0	22.0	19.7	12.3	19.0	25.8	22.7	25.1	16.6	18.9	39.3	22.7	49.4	25.2	33.7	18.9	21.3	22.0	25.5	28.3	23.0	39.7	25.3	27.6	28.3	15.8	25.2	23.4	34.3	19.5	57.3	25.3	21.3	31.2	33.7	24.0	8.5	7.7	15.3	7.5	9.1	12.6	6.0	23.1	26.3	35.4	26.5	16.5	14.6	33.3	16.0	19.6	29.4	28.1	47.9	17.0	40.4	25.4	20.5	44.7	18.4	64.9	21.8	30.4	21.8	34.3	51.6	41.9	25.9	10.7	39.5	22.7	15.1	13.6	33.4	28.4	15.5	23.8	23.9	45.1	27.2	16.9	20.2	37.0	11.8	46.0	19.1	25.5	43.8	34.3	25.3	11.4	34.3	39.3	37.4	26.0	22.3	16.6	42.5	21.3	24.7	20.6	24.5	29.7	24.8	23.1	25.3	29.8	50.3	16.6	26.4	26.1	15.3	5.6	7.5	10.1	7.0	12.2	7.8	7.8	12.6	7.3	8.5	7.6	9.3	6.2	9.1	7.5	7.7	8.5	6.0	18.4	21.9	37.2	25.8	19.7	12.3	16.6	18.9	18.9	19.5	41.7	51.7	49.6	23.8	26.3	74.3	30.5	71.4	40.2	45.5	48.8	98.2	36.0	5.0	36.2	22.5	41.7	37.6	23.3	40.2	31.2	30.8	30.4	24.3	42.9	30.8	82.6	44.9	33.2	27.5	10.6	53.2	32.3	16.9	37.9	40.6	92.0	36.3	35.1	51.9	14.6	128.6	64.7	38.7	86.5	54.9	28.9	37.3	66.0	41.3	27.3
SOAT1	"ACAT, SOAT, STAT"	ENSG00000057252	"Sterol O-acyltransferase 1"	P35610	1	179293714-179358680	"Enzymes, FDA approved drug targets, Predicted membrane proteins"	"Cholesterol metabolism, Lipid metabolism, Steroid metabolism, Sterol metabolism"	"Acyltransferase, Transferase"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adrenal gland: 87.4"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009533, HPA047171"	Enhanced		Enhanced	"Endoplasmic reticulum"		NA	NA			"Endoplasmic reticulum"		"CAB009533: AB_633499, HPA047171: AB_2679967"	"unprognostic (3.29e-2)"	"unprognostic (7.60e-2)"	"unprognostic (1.11e-1)"	"unprognostic (3.21e-2)"	"unprognostic (2.83e-1)"	"unprognostic (1.81e-3)"	"unprognostic (7.81e-3)"	"unprognostic (3.29e-1)"	"unprognostic (9.00e-2)"	"unprognostic (9.84e-2)"	"unprognostic (1.06e-1)"	"unprognostic (5.45e-3)"	"unprognostic (7.02e-3)"	"unprognostic (4.67e-3)"	"unprognostic (9.64e-2)"	"unprognostic (4.67e-2)"	"unprognostic (1.82e-1)"	23.9	87.4	4.1	8.3	5.7	7.0	9.6	2.9	4.0	6.8	7.2	5.6	7.8	5.5	8.2	6.0	3.4	8.3	9.8	5.7	5.5	4.1	12.1	8.8	18.6	13.0	6.2	2.3	10.8	15.5	8.1	14.6	11.6	4.9	13.1	6.9	9.6	51.1	8.9	4.1	5.8	7.0	7.5	10.5	13.6	8.1	6.8	4.9	4.0	6.2	2.9	7.2	9.4	8.7	6.6	24.3	19.8	26.8	18.5	16.0	14.8	20.4	9.6	7.9	11.7	30.9	16.9	42.5	9.9	17.5	22.0	25.7	9.8	23.4	11.6	15.7	18.0	26.8	7.5	25.1	5.9	23.8	13.2	5.2	5.4	8.1	10.2	12.7	9.2	2.1	13.3	3.8	25.7	22.1	9.3	9.4	14.3	11.6	6.0	34.2	4.3	9.8	3.0	3.8	3.3	3.2	12.2	10.3	6.8	19.4	12.8	2.4	6.2	15.3	6.5	5.7	9.8	6.8	6.3	8.9	26.2	12.6	28.6	21.8	8.5	31.0	9.9	10.4	5.0	48.5	19.6	26.8	0.7	14.0	17.0	13.5	6.6	13.1	13.1	24.3	5.5	12.7	12.6	19.8	18.5	11.1	4.4	16.0	14.8	4.1	5.7	2.9	4.0	5.5	4.1	6.2	2.3	4.9	4.9	20.8	33.1	10.4	8.5	8.9	7.2	5.6	22.9	48.2	14.8	19.2	13.7	14.8	1.7	33.4	19.5	13.0	7.9	0.0	21.9	46.9	18.6	33.8	13.9	21.9	69.5	6.4	57.5	21.5	66.9	10.8	30.2	63.1	21.9	44.1	27.7	6.8	20.1	10.5	24.4	12.8	13.0	25.8	13.0	5.6	8.2	4.5	7.3	27.9	16.8	6.5
SOAT2	ACAT2	ENSG00000167780	"Sterol O-acyltransferase 2"	O75908	12	53103518-53124538	"Enzymes, Predicted membrane proteins"	"Cholesterol metabolism, Lipid metabolism, Steroid metabolism, Sterol metabolism"	"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	14	"intestine: 60.8"	"Cell type enhanced"	"Detected in single"	15	"Club cells: 1.2"	"Group enriched"	"Detected in some"	8	"liver cancer: 5.2;testis cancer: 5.5"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"MAIT T-cell: 3.7;memory CD4 T-cell: 1.5;memory CD8 T-cell: 2.7;naive CD8 T-cell: 1.5"	"Lineage enriched"	"Detected in single"	7	"T-cells: 3.7"	"Group enriched"	"Detected in some"	5	"CACO-2: 9.8;Hep G2: 21.4;U-266/70: 7.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"									NA	NA						"unprognostic (2.53e-1)"	"unprognostic (2.72e-3)"	"unprognostic (1.15e-1)"	"unprognostic (1.40e-1)"	"unprognostic (1.30e-4)"	"unprognostic (3.88e-3)"	"unprognostic (9.26e-2)"	"unprognostic (4.20e-2)"	"unprognostic (1.32e-1)"	"unprognostic (3.29e-1)"	"unprognostic (1.06e-2)"	"unprognostic (2.53e-1)"	"unprognostic (1.83e-2)"	"unprognostic (9.05e-2)"	"unprognostic (2.37e-1)"	"unprognostic (7.58e-3)"	"unprognostic (3.28e-1)"	0.5	0.0	0.2	0.2	0.2	0.2	0.6	0.2	0.2	0.9	16.4	0.2	0.2	12.3	0.7	0.3	0.2	0.9	0.4	0.2	0.2	0.0	0.6	4.2	0.2	0.6	0.2	0.2	0.4	0.2	0.0	0.3	0.2	0.2	0.6	0.0	0.2	0.4	0.2	0.2	0.4	60.8	0.2	0.3	2.2	0.3	0.2	0.2	0.2	0.4	0.2	0.3	0.3	1.1	0.0	0.0	0.0	0.3	0.5	3.7	0.2	0.2	0.1	0.0	0.0	0.0	0.2	0.0	0.3	0.0	0.4	0.4	9.8	0.1	0.0	0.0	0.4	0.0	0.8	0.0	0.0	0.7	0.0	0.0	0.9	0.0	21.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.9	0.0	0.0	0.0	0.3	2.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	7.1	1.6	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.3	3.7	0.0	1.5	2.7	0.0	0.0	0.4	1.5	0.0	0.5	0.0	0.0	0.0	0.2	0.2	0.2	0.2	0.2	0.2	0.0	0.2	0.2	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.3	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0
SOD1	"ALS, ALS1, IPOA"	ENSG00000142168	"Superoxide dismutase 1"	P00441	21	31659622-31668931	"Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		"Antioxidant, Oxidoreductase"	"Amyotrophic lateral sclerosis, Cancer-related genes, Disease mutation, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 282.6"	"Cell type enhanced"	"Detected in all"	5	"Hepatocytes: 2529.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001401, CAB008670"	Enhanced		Supported	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA	44900000	91000000	"Nucleoplasm, Plasma membrane, Cytosol"		"CAB008670: AB_1623312, HPA001401: AB_1080132"	"unprognostic (1.73e-1)"	"unprognostic (1.18e-2)"	"unprognostic (4.43e-1)"	"unprognostic (6.19e-2)"	"unprognostic (1.39e-1)"	"unprognostic (9.59e-3)"	"unprognostic (8.34e-2)"	"unprognostic (2.30e-1)"	"unprognostic (3.47e-1)"	"unprognostic (5.28e-2)"	"unprognostic (9.33e-2)"	"unprognostic (1.96e-1)"	"unprognostic (1.03e-2)"	"unprognostic (1.66e-1)"	"unprognostic (1.74e-2)"	"unprognostic (1.57e-1)"	"unprognostic (3.26e-2)"	39.2	86.5	71.1	29.1	74.3	24.6	108.6	35.6	74.9	26.8	37.7	19.1	35.4	62.5	24.6	42.2	25.8	36.0	46.8	96.5	77.8	73.1	84.0	282.6	23.0	26.8	80.2	67.0	53.9	27.2	27.1	30.4	29.7	96.1	35.1	32.6	19.3	19.7	39.3	83.9	20.5	45.5	45.2	88.2	19.2	25.8	22.2	43.8	12.3	30.1	34.7	25.6	25.4	124.0	57.6	32.3	24.9	57.2	29.6	95.6	55.6	56.2	49.2	34.5	34.5	46.2	32.3	28.7	47.5	28.3	32.3	24.4	63.7	35.8	67.3	50.0	43.7	58.6	20.4	49.5	34.9	26.6	49.7	61.4	108.7	64.6	91.1	30.6	47.9	40.7	33.4	26.6	45.2	25.2	36.8	36.2	51.6	74.9	86.2	38.9	91.3	51.4	48.4	51.9	89.1	52.5	44.3	69.6	104.7	63.1	34.6	37.8	31.7	87.9	46.5	45.6	32.5	53.5	42.4	42.4	25.1	55.7	33.9	34.9	65.8	142.4	79.8	51.3	70.0	33.3	22.1	21.9	24.9	45.0	30.2	51.6	57.6	73.1	56.9	28.6	40.9	76.2	59.3	5.1	29.6	57.2	32.3	95.6	55.6	71.1	74.3	35.6	74.9	77.8	73.1	80.2	67.0	96.1	43.8	273.9	132.0	321.6	545.9	436.4	220.9	652.4	591.1	509.9	249.1	371.6	45.2	624.2	1382.7	369.6	242.1	264.2	846.2	327.1	713.9	544.4	341.5	540.9	215.8	2529.1	314.9	267.0	277.0	292.2	203.5	693.0	483.3	265.6	398.1	397.7	279.9	378.3	307.6	522.5	496.4	1894.8	157.7	433.4	418.2	79.3	538.3	305.8	607.1	266.4	526.4	451.3
SOD2		ENSG00000285441	"Superoxide dismutase 2"	P04179	6	159679119-159762529	"Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		Oxidoreductase	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"blood: 3.2;bone marrow: 4.9;seminal vesicle: 3.5"	"Cell type enhanced"	"Detected in many"	8	"Glandular cells: 2400.7"									"Cell type enhanced"	"Detected in single"		"memory B-cell: 3.2"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"BJ hTERT+: 2.0"															NA	NA		140000000																					0.0	0.0	0.0	0.2	0.4	4.9	0.3	0.0	1.7	0.0	0.1	1.6	0.0	0.0	0.0	1.3	0.0	0.1	0.0	0.0	0.0		0.3	1.0	0.6	0.0	0.0	0.0	0.6	0.0	0.2	0.0	0.0	1.6	0.5	0.2	1.0	0.1	3.5	0.1	0.0	0.0	0.0	0.0	0.0	0.1	1.2	0.7	0.0	0.0	0.0	0.2	0.0	0.0	3.2	0.4	0.9	0.4	0.2	0.8	0.2	0.0	0.3	0.4	0.4	1.4	1.3	0.5	0.1	2.0	0.8	1.4	0.5	0.2	0.1	0.4	0.4	0.7	0.3	1.0	1.8	0.5	0.2	0.0	0.2	0.4	0.7	0.6	0.1	0.1	1.0	1.4	1.6	0.0	0.0	0.1	1.0	0.2	0.6	0.4	0.0	0.7	0.1	0.1	0.1	0.0	0.5	0.3	0.4	0.4	0.0	0.7	0.6	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.3	0.3	0.0	0.6	0.6	0.2	0.2	0.2	0.1	0.6	0.4	0.4	0.7	0.2	0.1	3.2	0.6	0.4	0.4	0.9	0.8	0.4	0.9	0.2	0.4	0.2	0.5	0.2											187.6	839.5	86.8	908.7	608.2	42.9	372.0	290.4	132.5	254.8	225.1	43.2	0.0	72.9	1002.5	235.6	199.1	118.6	0.0	1172.3	0.0	582.9	2400.7	104.5	344.0	0.0	30.2	76.4	57.7	302.5	83.4	53.8	537.1	494.3	311.0	86.3	39.8	850.4	109.4	61.2	221.1	55.3	38.8	714.8	49.3	44.9	596.0	0.0	49.4	100.0	611.0
SOD3	EC-SOD	ENSG00000109610	"Superoxide dismutase 3"	P08294	4	24789912-24800842	"Enzymes, Plasma proteins, Predicted secreted proteins"		"Antioxidant, Heparin-binding, Oxidoreductase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	7	"Leydig cells: 392.7;Peritubular cells: 343.7;Smooth muscle cells: 404.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC diff: 19.9;BJ: 11.0;PC-3: 16.0;RPTEC TERT1: 67.3;T-47d: 10.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042110	Supported				"Secreted to blood"	NA	NA	50400000	830000000			"HPA042110: AB_2677850"	"unprognostic (7.67e-2)"	"unprognostic (1.33e-1)"	"unprognostic (1.01e-1)"	"unprognostic (8.80e-2)"	"unprognostic (3.32e-2)"	"unprognostic (9.66e-2)"	"unprognostic (1.73e-1)"	"unprognostic (4.98e-2)"	"unprognostic (3.68e-1)"	"unprognostic (2.39e-1)"	"unprognostic (3.26e-2)"	"unprognostic (1.50e-1)"	"unprognostic (2.80e-2)"	"unprognostic (8.80e-2)"	"unprognostic (3.68e-2)"	"unprognostic (1.42e-1)"	"unprognostic (4.45e-2)"	90.0	9.9	3.7	13.8	5.0	0.8	31.9	1.6	8.3	46.4	24.7	14.7	8.0	10.4	34.4	21.1	52.1	39.5	55.1	61.9	6.4	1.9	40.4	3.9	40.1	6.7	3.4	6.2	36.1	41.0	1.6	4.6	30.4	24.3	40.0	8.1	45.0	13.7	15.5	16.1	19.9	13.7	53.6	5.4	8.4	25.4	25.9	2.1	4.4	68.0	25.2	17.7	61.1	52.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	19.9	5.2	0.6	11.0	4.8	0.6	0.4	0.1	0.0	0.0	3.5	2.3	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	5.0	0.0	4.6	0.0	5.3	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.3	2.3	0.0	16.0	0.0	0.0	0.1	67.3	0.2	0.0	0.0	0.0	0.3	0.0	0.6	10.0	0.0	0.0	2.6	0.3	0.4	0.1	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.7	5.0	1.6	8.3	6.4	1.9	3.4	6.2	24.3	2.1	11.9	17.8	0.8	63.7	80.6	0.3	15.1	79.0	0.0	13.6	85.5	0.0	93.1	13.3	64.9	10.0	6.8	5.1	0.0	1.5	13.0	180.5	65.7	0.0	0.0	14.9	0.0	33.3	15.4	0.0	24.2	392.7	4.3	75.9	0.0	50.3	19.4	5.0	86.3	343.7	114.0	1.0	194.1	404.7	27.7	3.7	61.5	158.9	2.2	57.8	8.9
SORD		ENSG00000140263	"Sorbitol dehydrogenase"	Q00796	15	45023104-45077185	"Enzymes, Plasma proteins, Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"cervix, uterine: 66.3;liver: 98.4;thyroid gland: 116.3"	"Cell type enhanced"	"Detected in many"	17	"Hepatocytes: 654.8;Proximal tubular cells: 226.9"	"Cancer enhanced"	"Detected in all"		"prostate cancer: 72.5"	"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	7	"eosinophil: 36.4"	"Lineage enriched"	"Detected in many"	13	"granulocytes: 36.4"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040260, HPA040621"	Enhanced		Approved	Cytosol		NA	NA		430000	Cytosol		"HPA040260: AB_10794872, HPA040621: AB_10795384"	"unprognostic (8.18e-2)"	"unprognostic (7.58e-2)"	"unprognostic (8.19e-2)"	"unprognostic (1.51e-1)"	"unprognostic (5.69e-3)"	"unprognostic (3.90e-2)"	"prognostic favorable (6.14e-5)"	"unprognostic (3.33e-3)"	"unprognostic (1.67e-1)"	"unprognostic (4.95e-2)"	"unprognostic (7.04e-3)"	"unprognostic (1.40e-1)"	"unprognostic (4.26e-2)"	"unprognostic (1.23e-2)"	"unprognostic (8.53e-2)"	"unprognostic (2.31e-2)"	"unprognostic (1.56e-1)"	1.4	10.2	3.0	1.5	3.2	1.0	7.1	3.1	3.8	66.3	5.5	6.2	39.2	2.6	2.6	3.2	6.7	3.5	3.9	3.4	3.0	3.0	20.9	98.4	1.6	2.2	4.2	2.3	1.6	7.3	1.2	1.8	0.5	5.0	48.5	3.8	2.3	7.6	46.7	1.4	8.0	8.7	2.0	5.0	2.4	5.6	2.5	3.9	3.1	116.3	3.8	3.5	4.2	4.4	1.6	2.4	36.4	2.7	0.4	1.0	1.3	15.6	13.8	3.5	11.3	3.0	5.3	3.7	4.3	3.0	9.9	8.4	11.5	8.6	2.0	9.8	5.3	10.7	23.6	18.1	16.4	7.9	34.0	11.2	15.7	18.1	25.3	2.3	27.3	26.4	6.8	12.5	5.7	9.1	4.8	9.3	24.2	17.6	5.6	9.3	6.3	16.5	14.8	13.5	26.5	14.7	0.0	22.8	7.6	7.2	15.3	24.8	13.0	8.9	14.0	6.6	3.9	20.2	11.2	8.3	7.9	7.0	17.6	10.4	1.0	6.9	2.0	12.8	24.1	20.6	5.0	2.7	36.4	0.6	2.5	1.0	1.2	0.6	0.8	2.4	1.6	0.5	0.6	1.4	0.4	2.5	1.3	0.6	1.3	3.0	3.2	3.1	3.8	3.0	3.0	4.2	2.3	5.0	3.9	0.0	1.9	16.8	20.6	6.9	9.5	2.8	38.2	28.1	28.4	31.4	0.0	1.0	24.9	52.5	26.1	3.8	9.1	0.0	118.4	3.9	5.8	134.4	8.1	654.8	14.4	3.2	81.4	20.9	21.2	17.1	3.4	8.2	15.1	8.2	29.3	6.8	90.9	13.3	5.6	226.9	3.6	0.0	9.2	6.5	2.5	17.8	0.8	6.4	32.6	87.8
SPACA5	"dJ54B20.3, LYC5, LYZL5, PNPK6288, SLLP2, UNQ6288"	ENSG00000171489	"Sperm acrosome associated 5"	Q96QH8	X	48004336-48009729	"Enzymes, Predicted secreted proteins"		"Glycosidase, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	8	"testis: 15.1"	"Cell type enriched"	"Detected in single"	29	"Early spermatids: 2.9"	"Not detected"	"Not detected"							"Cell type enhanced"	"Detected in some"		"T-reg: 1.9"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"CACO-2: 1.3;JURKAT: 1.3;NB-4: 3.9;U-266/70: 1.2;U-266/84: 2.1"									"HPA044747, HPA047149"	Supported				"Secreted in male reproductive system"	NA	NA					"HPA044747: AB_2679071, HPA047149: AB_2679955"																		0.0	0.0	0.3	0.0	0.3	0.1	0.0	0.2	0.4	0.0	0.0			0.0	0.2	0.8	0.0	0.3	0.0	0.0	0.2	0.2	0.1	0.0	0.0	0.5	0.4		0.3	1.4	0.0	0.0	0.0		0.2	0.0		0.0	0.0	0.0	0.8	0.1	0.0	0.2	0.0	0.0	15.1			1.3		0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	1.9	0.3	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.9	0.0	0.1	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	1.3	0.0	0.0	0.0	0.0	0.3	3.9	0.9	0.0	0.0	0.4	0.0	1.1	0.0	0.0	0.5	0.0	0.0	0.4	0.0	0.5	1.1	0.0	0.0	0.4	0.0	0.7	0.0	1.2	2.1	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	1.0	0.0	0.1	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.8	1.9	0.3											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
SPACA5B	LYZL5B	ENSG00000171478	"Sperm acrosome associated 5B"	Q96QH8	X	48130657-48132613	"Enzymes, Predicted secreted proteins"		"Glycosidase, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	10	"testis: 18.3"	"Cell type enriched"	"Detected in single"	12	"Early spermatids: 1.2"	"Not detected"	"Not detected"							"Cell type enriched"	"Detected in single"	19	"T-reg: 1.9"	"Lineage enriched"	"Detected in single"	19	"T-cells: 1.9"	"Not detected"	"Not detected"											"HPA044747, HPA047149"	Supported				"Secreted in male reproductive system"	NA	NA					"HPA044747: AB_2679071, HPA047149: AB_2679955"																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	18.3			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
SPAM1	"HYAL5, PH-20, SPAG15"	ENSG00000106304	"Sperm adhesion molecule 1"	P38567	7	123925237-123971414	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion"	"Glycosidase, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	38	"testis: 19.6"	"Group enriched"	"Detected in some"	58	"Early spermatids: 169.9;Late spermatids: 83.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 1.0;SuSa: 1.5"					"Not detected"	"Not detected"			HPA017984	Enhanced					NA	NA					"HPA017984: AB_1857413"															"unprognostic (2.44e-1)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.3	0.0	0.0	0.0	0.0	19.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.2	0.2	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.1	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	169.9	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	83.5	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.9	1.1	0.0	2.2	0.0	0.0	0.0
SPAST	"ADPSP, FSP2, KIAA1083, SPG4"	ENSG00000021574	Spastin	Q9UBP0	2	32063547-32157637	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Cell cycle, Cell division, Differentiation, Neurogenesis"	"Allosteric enzyme, Developmental protein, Isomerase"	"Disease mutation, Hereditary spastic paraplegia, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA017311	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA017311: AB_1857415"	"unprognostic (1.89e-1)"	"unprognostic (1.59e-2)"	"unprognostic (5.33e-2)"	"unprognostic (3.90e-2)"	"unprognostic (3.75e-2)"	"unprognostic (4.00e-2)"	"prognostic unfavorable (1.62e-4)"	"unprognostic (3.26e-2)"	"unprognostic (2.35e-2)"	"unprognostic (7.39e-2)"	"unprognostic (5.98e-2)"	"unprognostic (3.52e-1)"	"prognostic unfavorable (4.15e-4)"	"unprognostic (5.71e-2)"	"unprognostic (3.04e-1)"	"unprognostic (1.53e-2)"	"unprognostic (1.13e-1)"	12.7	9.6	18.4	14.8	16.4	13.4	9.8	21.1	21.9	14.7	12.7	15.1	12.5	11.5	12.3	8.7	11.1	10.4	10.2	6.2	20.2	18.5	9.4	14.6	9.7	18.9	20.6	10.0	15.1	10.9	11.8	12.3	11.5	17.5	10.3	12.0	6.8	9.3	13.7	15.4	11.5	17.6	11.6	27.0	15.5	9.7	14.4	14.6	21.5	13.4	6.2	13.8	11.3	10.1	5.0	7.1	9.5	9.0	6.6	7.6	4.3	10.8	7.8	12.9	12.6	8.1	9.6	11.6	6.0	8.9	6.3	5.7	10.6	9.5	19.0	5.6	8.3	9.3	7.7	12.7	6.1	7.8	12.7	7.6	20.8	4.2	12.9	7.4	14.5	14.7	5.3	8.1	8.1	7.7	7.7	13.9	6.2	17.0	6.4	6.9	4.6	23.3	12.2	13.4	12.1	4.6	12.4	18.1	12.3	8.6	6.8	18.3	19.7	10.2	8.7	10.0	11.0	5.6	10.0	12.1	7.0	10.8	6.2	7.0	9.7	18.0	15.4	7.6	12.6	8.4	3.4	6.3	6.7	3.6	9.0	5.2	5.0	5.8	5.6	7.1	3.9	5.9	6.0	9.5	6.6	6.3	3.2	7.6	4.3	18.4	16.4	21.1	15.8	20.2	18.5	20.6	10.0	17.5	14.6	8.9	4.1	4.2	5.3	8.5	14.5	7.5	7.6	13.4	6.8	5.2	21.6	7.6	0.0	5.6	2.5	8.7	9.7	0.0	7.0	6.2	5.0	7.3	9.3	10.9	8.8	9.5	10.4	6.2	14.6	6.4	8.1	16.6	1.7	8.2	10.1	8.0	8.4	8.4	9.6	6.5	14.3	0.0	8.1	15.4	22.2	11.4	6.8	7.5	8.4	5.5
SPEG	"APEG1, BPEG, KIAA1297, MGC12676, SPEGalpha, SPEGbeta"	ENSG00000072195	"SPEG complex locus"	Q15772	2	219434846-219498287	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	Differentiation	"Kinase, Serine/threonine-protein kinase, Transferase"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skeletal muscle: 88.7"	"Cell type enhanced"	"Detected in many"	9	"Cardiomyocytes: 55.0;Late spermatids: 30.8;Sertoli cells: 45.3;Smooth muscle cells: 36.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"hTERT-RPE1: 27.9;U-87 MG: 14.6"	"Low region specificity"	"Detected in all"							HPA018904	Enhanced		Approved	Vesicles		NA	NA			Vesicles		"HPA018904: AB_1844924"	"unprognostic (3.70e-1)"	"unprognostic (1.23e-2)"	"unprognostic (5.05e-3)"	"unprognostic (2.45e-4)"	"unprognostic (2.04e-2)"	"unprognostic (4.65e-3)"	"unprognostic (2.41e-2)"	"unprognostic (1.12e-1)"	"unprognostic (8.92e-3)"	"unprognostic (2.29e-2)"	"unprognostic (8.66e-4)"	"unprognostic (1.06e-1)"	"unprognostic (3.47e-9)"	"unprognostic (1.14e-1)"	"unprognostic (7.01e-2)"	"unprognostic (5.95e-4)"	"unprognostic (1.28e-3)"	7.7	7.1	10.1	9.1	7.7	1.2	4.2	10.4	9.8	19.2	45.1	4.1	10.5	5.7	31.6	14.1	13.5	19.0	17.4	17.8	8.7	5.3	2.0	1.4	3.0	1.7	4.0	8.0	7.0	2.9	4.7	10.5	4.8	5.5	16.7	4.5	6.7	7.8	23.0	88.7	2.2	9.2	45.2	9.1	1.9	16.1	3.0	3.9	0.0	2.0	16.8	1.6	22.5	12.6	0.0	0.3	0.0	0.0	0.0	0.5	0.7	3.6	0.3	1.8	3.1	0.9	2.9	1.2	7.7	5.2	5.2	3.9	2.8	1.3	0.0	2.8	5.6	2.9	4.5	1.5	1.8	2.0	0.4	1.2	0.4	3.3	0.1	1.3	0.0	0.6	8.2	2.7	4.7	1.1	27.9	0.0	2.0	2.7	0.0	3.7	1.0	0.0	11.0	3.9	0.1	1.4	1.8	4.2	0.6	5.0	0.0	2.1	9.6	0.5	0.0	0.1	9.2	0.3	0.1	0.1	13.0	13.2	1.5	12.1	0.4	0.0	0.1	14.6	0.1	0.8	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.3	0.0	0.7	10.1	7.7	10.4	9.8	8.7	5.3	4.0	8.0	5.5	3.9	0.0	2.1	0.0	5.6	2.9	1.1	55.0	5.1	0.0	0.0	1.8	2.0	0.8	0.0	1.2	17.7	1.4	5.9	0.0	1.0	0.7	8.5	2.7	0.0	2.4	1.0	4.8	6.4	3.7	6.6	30.8	9.8	1.7	3.3	1.8	3.3	6.5	0.3	2.9	17.7	2.3	0.8	45.3	36.2	1.1	2.6	1.3	1.1	0.0	2.4	3.5
SPG7	"CAR, CMAR, SPG5C"	ENSG00000197912	"SPG7, paraplegin matrix AAA peptidase subunit"	Q9UQ90	16	89490719-89557768	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"		"Hydrolase, Metalloprotease, Protease"	"Disease mutation, Hereditary spastic paraplegia, Neurodegeneration, Osteogenesis imperfecta"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA						"unprognostic (1.42e-1)"	"unprognostic (1.72e-1)"	"unprognostic (4.12e-2)"	"prognostic favorable (2.22e-4)"	"unprognostic (4.10e-1)"	"unprognostic (1.11e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.50e-1)"	"unprognostic (1.54e-1)"	"unprognostic (2.33e-1)"	"prognostic favorable (4.91e-4)"	"unprognostic (3.56e-2)"	"unprognostic (7.01e-2)"	"unprognostic (1.44e-2)"	"unprognostic (2.58e-1)"	"unprognostic (1.71e-1)"	"prognostic favorable (4.25e-4)"	14.6	23.6	15.6	11.7	19.9	14.5	17.5	25.2	33.2	14.2	14.9	19.1	19.5	18.0	18.3	16.1	14.2	13.9	15.9	34.3	15.6	15.6	22.3	24.5	14.1	16.2	13.9	23.7	21.6	22.1	17.9	21.0	10.2	19.3	15.9	14.0	16.5	17.4	18.1	75.6	27.9	17.7	17.8	16.9	17.8	16.5	24.1	12.9	13.3	28.4	18.4	16.1	16.6	13.4	6.6	5.0	7.9	4.9	7.2	6.4	2.0	5.5	15.2	7.9	14.1	15.1	9.3	6.2	14.9	10.4	8.7	5.2	12.0	11.6	8.7	16.0	9.2	8.4	14.9	10.7	11.1	9.5	5.0	13.4	4.2	7.6	21.8	6.6	3.5	5.7	5.2	7.7	5.4	6.3	12.5	12.1	10.3	9.5	3.7	8.2	10.9	7.6	12.8	14.0	13.1	11.0	14.1	13.9	5.3	8.4	8.5	8.5	5.6	21.8	3.8	4.5	9.0	12.4	9.1	18.9	6.9	9.6	4.8	6.9	6.2	9.8	7.6	8.9	10.1	8.2	7.9	4.9	7.4	5.6	4.7	5.4	3.3	3.5	2.8	5.0	6.6	6.4	4.3	7.2	7.2	3.3	4.9	3.6	2.0	15.6	19.9	25.2	33.2	15.6	15.6	13.9	23.7	19.3	12.9	44.7	49.6	31.3	24.6	14.2	52.0	39.7	25.5	26.8	43.3	33.2	90.3	32.7	16.6	35.1	57.2	38.6	49.1	23.3	22.6	24.1	28.8	23.0	19.8	33.4	28.0	38.1	35.7	52.2	37.1	16.2	39.7	32.7	20.3	39.7	41.2	36.4	31.8	45.6	31.5	18.3	70.5	6.5	29.3	44.2	37.0	15.7	21.6	38.3	44.4	23.8
SPHK1	SPHK	ENSG00000176170	"Sphingosine kinase 1"	Q9NYA1	17	76376584-76387860	"Enzymes, Predicted intracellular proteins"		"Calmodulin-binding, Kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	9	"Ductal cells: 89.4;monocytes: 99.2;Muller glia cells: 144.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"plasmacytoid DC: 8.0"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"Hep G2: 34.4;hTEC/SVTERT24-B: 30.0;TIME: 30.0;U-138 MG: 30.2;U-251 MG: 38.5"	"Low region specificity"	"Detected in many"			"Region enriched"	"Detected in single"	5	"olfactory region: 11.7"	"HPA022829, HPA028761"	Uncertain		Supported	"Plasma membrane,Cytosol"		NA	NA			"Plasma membrane, Cytosol"		"HPA022829: AB_1857438, HPA028761: AB_10600814"	"unprognostic (1.04e-1)"	"unprognostic (6.30e-2)"	"unprognostic (1.09e-2)"	"unprognostic (8.66e-2)"	"unprognostic (2.25e-2)"	"unprognostic (1.82e-1)"	"unprognostic (1.68e-2)"	"unprognostic (9.32e-3)"	"unprognostic (3.13e-1)"	"unprognostic (7.43e-2)"	"unprognostic (8.99e-3)"	"unprognostic (2.18e-1)"	"prognostic unfavorable (5.14e-6)"	"unprognostic (1.39e-1)"	"unprognostic (4.82e-2)"	"unprognostic (8.29e-2)"	"unprognostic (1.10e-3)"	9.3	2.2	4.7	10.5	3.5	15.0	20.4	0.4	3.2	5.5	5.0	4.0	0.4	1.9	6.3	8.3	13.8	5.3	12.7	10.5	5.3	2.1	4.1	2.4	12.9	10.1	4.4	1.5	5.5	15.1	3.1	2.7	7.4	4.7	4.3	1.1	11.0	11.5	1.7	6.8	8.7	6.3	5.2	4.0	2.7	3.8	3.7	6.3	3.0	9.4	16.2	12.1	5.6	7.0	0.2	8.0	2.4	3.4	0.1	1.4	1.3	9.8	1.0	4.3	0.2	2.2	2.0	4.4	22.8	15.1	19.2	11.6	5.3	1.0	0.4	2.1	16.8	8.2	2.1	3.2	29.2	4.7	0.4	1.7	0.1	7.3	34.4	4.8	0.3	0.8	3.9	0.6	30.0	11.8	8.2	18.5	1.0	4.6	0.0	3.7	12.6	0.9	0.1	0.2	2.2	8.3	0.6	1.1	0.7	1.0	0.1	0.5	1.0	2.3	0.2	19.7	2.7	0.8	1.4	30.0	30.2	5.8	23.1	38.5	0.4	0.1	0.4	22.9	1.7	4.5	2.4	3.4	0.0	1.4	1.7	0.4	0.0	0.2	0.4	1.0	0.2	0.0	0.3	0.4	0.1	0.3	8.0	0.0	1.3	4.7	3.5	0.4	3.2	5.3	2.1	4.4	1.5	4.7	6.3	0.0	0.0	0.5	42.7	11.2	1.3	3.9	33.1	0.0	3.4	1.8	0.0	0.6	0.0	89.4	0.2	35.0	0.7	0.0	10.7	14.8	17.3	28.4	6.9	0.0	31.0	31.8	0.0	4.3	5.7	0.9	3.4	17.1	11.8	99.2	1.1	144.5	62.5	0.3	18.7	1.1	1.8	0.0	39.2	0.0	7.7	9.4	1.1	5.7	0.2	22.4
SPHK2		ENSG00000063176	"Sphingosine kinase 2"	Q9NRA0	19	48619291-48630717	"Enzymes, Predicted intracellular proteins"		"Kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"Bipolar cells: 66.9;Cone photoreceptor cells: 72.6;Rod photoreceptor cells: 83.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"NB-4: 33.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA049062			Supported	Nucleoplasm		NA	NA			Nucleoplasm		"HPA049062: "	"unprognostic (5.33e-2)"	"unprognostic (4.11e-2)"	"unprognostic (9.61e-2)"	"prognostic unfavorable (5.19e-4)"	"unprognostic (2.10e-1)"	"unprognostic (7.19e-3)"	"unprognostic (3.04e-1)"	"unprognostic (4.45e-3)"	"unprognostic (7.28e-2)"	"unprognostic (2.80e-1)"	"prognostic favorable (9.30e-4)"	"unprognostic (1.25e-1)"	"prognostic favorable (2.59e-5)"	"unprognostic (1.18e-2)"	"unprognostic (9.97e-2)"	"unprognostic (4.21e-2)"	"unprognostic (7.06e-2)"	9.3	8.9	12.6	9.9	13.0	5.2	5.1	13.6	22.0	7.2	12.9	13.4	4.9	33.2	7.4	4.2	4.9	7.3	7.8	4.7	22.5	14.8	19.3	15.2	6.1	8.7	26.3	14.9	9.1	7.2	15.0	9.5	4.1	22.3	8.7	6.2	7.2	7.5	8.0	6.1	4.3	22.2	4.9	14.1	8.4	11.3	17.2	13.7	4.0	9.1	3.1	5.3	6.2	12.4	10.4	7.4	12.5	9.4	7.2	7.0	4.2	4.1	11.9	4.4	8.1	4.9	2.0	8.4	4.5	3.8	5.2	6.3	20.3	5.4	7.7	3.1	2.9	3.1	3.1	4.1	3.6	0.7	8.7	9.8	8.5	5.2	7.0	7.7	5.4	9.4	3.7	2.0	3.6	2.5	2.5	2.9	10.5	5.5	6.9	2.6	4.3	12.8	33.8	5.9	3.1	5.8	11.8	3.6	5.0	2.4	2.8	16.1	12.7	4.3	6.8	4.3	2.6	3.7	3.7	4.5	7.5	4.2	5.8	8.9	13.3	15.3	8.5	4.3	6.3	6.7	12.5	8.3	3.6	6.0	9.4	5.9	6.5	4.8	5.8	7.4	10.4	6.6	7.0	3.3	7.2	7.4	6.6	4.6	4.2	12.6	13.0	13.6	22.0	22.5	14.8	26.3	14.9	22.3	13.7	6.0	7.7	5.4	4.8	3.0	66.9	1.0	7.6	2.7	4.5	10.4	72.6	5.9	1.7	5.3	8.2	6.4	28.6	0.0	4.4	5.3	5.2	5.4	4.6	17.3	7.6	42.9	15.5	4.9	10.7	9.0	15.3	6.3	3.3	7.2	9.2	22.9	6.0	11.5	12.0	13.5	83.3	6.5	5.4	18.7	6.4	2.5	3.8	16.6	12.8	3.6
SPO11	"CT35, SPATA43, TOPVIA"	ENSG00000054796	"SPO11, initiator of meiotic double stranded breaks"	Q9Y5K1	20	57329759-57343994	"Enzymes, Plasma proteins, Predicted intracellular proteins"	Meiosis	"DNA-binding, Hydrolase, Isomerase"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in single"	142	"testis: 14.2"	"Cell type enriched"	"Detected in some"	5	"Spermatocytes: 58.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	19	"Daudi: 1.7;SiHa: 1.3;U-698: 2.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"									NA	NA																							0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	58.6	11.7	0.0	0.0	0.0	0.0	0.0
SPPL2A	"IMP3, PSL2"	ENSG00000138600	"Signal peptide peptidase like 2A"	Q8TCT8	15	50702266-50765808	"Enzymes, Plasma proteins, Predicted membrane proteins, Transporters"		"Hydrolase, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036062, HPA067304"	Enhanced		Supported	Vesicles		NA	NA			Vesicles		"HPA036062: AB_10611670, HPA067304: AB_2685820"	"unprognostic (1.66e-1)"	"unprognostic (1.03e-1)"	"unprognostic (2.70e-1)"	"unprognostic (5.82e-3)"	"unprognostic (3.71e-1)"	"unprognostic (1.70e-1)"	"unprognostic (2.15e-1)"	"unprognostic (1.88e-1)"	"unprognostic (2.22e-2)"	"unprognostic (6.36e-2)"	"unprognostic (2.04e-2)"	"unprognostic (4.00e-2)"	"unprognostic (3.11e-2)"	"unprognostic (2.26e-2)"	"unprognostic (1.44e-2)"	"unprognostic (6.96e-2)"	"unprognostic (3.66e-1)"	20.5	23.5	6.9	18.0	8.6	15.0	23.3	6.2	8.1	16.4	29.3	10.8	15.3	24.9	14.5	17.9	18.7	13.0	14.9	37.6	7.8	5.3	23.3	44.8	19.2	23.9	8.3	6.1	13.2	32.7	61.0	11.8	32.2	14.4	14.7	26.9	14.9	21.7	15.5	63.1	15.8	39.2	20.5	8.5	21.2	18.3	10.2	7.4	21.6	15.6	17.4	17.7	19.7	13.9	9.8	19.4	24.0	27.3	11.9	15.4	22.4	15.4	26.9	10.5	13.8	41.4	24.7	16.5	24.9	41.8	22.9	32.7	31.1	17.9	9.6	18.6	48.7	34.4	23.3	12.6	15.1	25.6	19.6	7.7	18.2	18.4	16.0	34.2	11.3	29.8	21.4	27.8	18.9	30.6	17.0	22.5	10.5	13.7	37.8	30.2	35.6	5.3	4.3	4.5	24.8	6.1	6.5	16.2	21.1	31.4	36.0	8.4	9.5	15.0	29.0	16.8	22.0	20.6	22.4	27.4	37.0	14.9	23.7	29.3	15.4	26.3	10.6	16.7	19.0	25.3	21.2	26.9	24.0	15.4	24.6	9.7	9.8	12.6	13.9	19.4	9.3	7.2	11.5	19.4	11.9	27.3	17.1	15.4	22.4	6.9	8.6	6.2	8.1	7.8	5.3	8.3	6.1	14.4	7.4	44.7	34.7	37.5	70.0	38.2	14.8	64.5	58.6	29.4	37.5	64.6	19.6	118.1	19.9	75.9	11.3	46.7	152.1	0.0	145.2	68.6	45.2	72.3	45.0	111.7	79.3	7.9	36.9	43.0	60.6	5.6	41.4	67.0	30.4	170.5	66.7	31.2	103.1	123.8	34.3	42.8	17.0	25.8	39.1	30.5	14.8	33.9	171.1	48.4	59.7	82.4
SPPL2B	"IMP4, KIAA1532, PSL1"	ENSG00000005206	"Signal peptide peptidase like 2B"	Q8TCT7	19	2328615-2354806	"Enzymes, Predicted membrane proteins"		"Hydrolase, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Late spermatids: 82.4"	"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB005592, HPA039292"	Approved		Approved	"Nucleoplasm,Plasma membrane,Centrosome"		NA	NA			"Nucleoplasm, Plasma membrane"	Centrosome	"CAB005592: AB_325074, HPA039292: AB_2676429"	"unprognostic (4.16e-2)"	"unprognostic (2.97e-2)"	"unprognostic (2.48e-2)"	"prognostic favorable (5.00e-5)"	"unprognostic (2.34e-1)"	"unprognostic (1.54e-3)"	"unprognostic (1.74e-1)"	"unprognostic (7.93e-3)"	"unprognostic (3.00e-1)"	"unprognostic (1.72e-1)"	"prognostic favorable (1.33e-4)"	"unprognostic (3.29e-3)"	"prognostic unfavorable (6.45e-4)"	"unprognostic (2.26e-2)"	"unprognostic (2.45e-1)"	"unprognostic (3.02e-1)"	"unprognostic (3.40e-2)"	5.4	4.6	5.0	11.7	5.4	11.7	4.0	6.9	6.9	3.4	9.0	7.9	9.6	19.3	4.7	10.0	3.2	5.2	9.8	3.3	5.6		4.2	3.9	3.5	10.3	7.1	4.7	3.4	13.8	6.3	11.0	6.8	7.1	4.7	3.9	6.0	10.5	8.7	7.5	8.7	16.2	5.0	7.0	8.1	13.8	20.1	6.4	9.3	3.0	3.7	5.7	2.3	2.0	14.4	17.4	9.3	7.7	6.2	8.2	5.9	8.3	13.4	5.8	10.2	4.8	4.9	14.8	11.0	3.2	4.0	4.3	9.4	9.6	8.0	10.4	5.1	3.8	11.3	1.9	3.8	1.2	9.3	8.4	5.3	21.0	12.5	9.0	9.3	7.0	7.1	4.3	3.8	2.7	6.3	5.6	16.8	8.6	20.5	2.4	9.3	10.1	11.9	10.8	7.5	5.5	16.9	3.0	22.1	4.4	21.1	10.3	9.8	11.0	6.7	8.4	3.9	11.2	15.7	12.5	7.4	5.3	18.6	8.6	27.1	9.7	8.4	9.2	10.9	12.8	9.3	7.7	7.0	6.6	7.5	4.8	9.0	6.0	6.5	9.4	14.4	7.8	8.2	3.4	6.2	5.1	17.4	5.9	5.9											3.0	15.0	22.0	6.2	0.0	23.4	5.1	28.1	20.1	9.1	24.4	45.2	44.0	1.7	13.7	36.9	9.0	59.3	0.0	10.0	18.3	4.6	7.2	6.9	10.6	10.4	30.2	39.1	14.7	9.5	82.4	13.8	5.3	0.0	5.4	51.1	13.7	10.1	30.8	14.9	6.2	39.6	0.0	8.1	41.9	12.4	0.0	35.8	4.5	38.9	4.3
SPPL2C	IMP5	ENSG00000185294	"Signal peptide peptidase like 2C"	Q8IUH8	17	45844835-45847072	"Enzymes, Predicted membrane proteins"		"Hydrolase, Protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	31	"testis: 45.0"	"Group enriched"	"Detected in some"	132	"Early spermatids: 211.9;Late spermatids: 461.7"	"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	9	"cerebellum: 1.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"									NA	NA						"unprognostic (6.70e-4)"				"unprognostic (1.34e-1)"													0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	45.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	211.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	461.7	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	1.4	1.0	0.0	0.0	0.0	0.0	0.0
SPPL3	"DKFZP586C1324, IMP2, MGC126674, MGC126676, MGC90402, PSL4"	ENSG00000157837	"Signal peptide peptidase like 3"	Q8TCT6	12	120762510-120904371	"Enzymes, Predicted membrane proteins"		"Hydrolase, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004194, HPA059958"	Uncertain		Supported	"Vesicles,Plasma membrane"		NA	NA			"Vesicles, Plasma membrane"		"HPA004194: AB_2667171, HPA059958: AB_2684179"	"unprognostic (3.29e-1)"	"unprognostic (2.29e-2)"	"unprognostic (3.39e-2)"	"unprognostic (1.63e-1)"	"unprognostic (2.06e-1)"	"unprognostic (7.96e-3)"	"prognostic unfavorable (1.29e-5)"	"unprognostic (3.17e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.28e-1)"	"unprognostic (2.48e-1)"	"unprognostic (2.44e-1)"	"unprognostic (2.66e-1)"	"unprognostic (9.34e-2)"	"unprognostic (9.92e-2)"	"unprognostic (7.54e-2)"	"unprognostic (9.40e-2)"	17.8	15.3	18.9	12.8	23.1	13.9	19.4	21.8	31.4	25.2	20.4	25.6	18.4	14.0	23.1	13.3	39.5	23.3	18.2	13.9	17.4	18.3	18.3	14.9	20.8	21.5	19.2	20.6	25.9	19.6	42.4	14.3	21.9	16.5	16.9	21.7	19.1	19.2	22.7	13.8	48.3	18.5	23.5	17.1	19.0	14.2	34.7	20.8	25.2	24.7	22.2	20.6	19.8	29.3	4.1	6.3	7.3	2.9	2.8	4.4	1.5	12.4	12.5	18.9	11.8	25.0	16.9	13.3	9.6	28.6	20.7	16.7	12.9	12.8	11.5	0.1	16.7	18.4	15.3	19.2	20.7	21.5	9.1	11.8	9.8	7.4	9.8	26.5	11.3	12.8	17.0	33.2	17.7	16.7	24.6	20.3	17.8	10.8	5.8	17.8	11.0	15.1	9.1	12.6	11.7	8.8	9.0	15.9	8.2	16.2	35.5	13.0	14.0	18.3	8.4	14.4	21.1	25.5	7.9	15.1	9.6	13.2	5.9	7.1	13.5	24.2	11.2	14.3	9.4	15.9	7.3	2.9	2.6	3.2	2.8	4.4	3.2	4.0	4.0	4.9	4.1	3.9	4.3	5.5	2.8	2.4	6.3	3.1	1.5	18.9	23.1	21.8	31.4	17.4	18.3	19.2	20.6	16.5	20.8	17.9	17.3	21.4	28.0	48.9	33.5	17.7	17.8	8.1	13.6	38.4	25.5	32.4	1.7	16.9	6.4	28.1	32.5	0.0	21.2	21.9	34.3	27.4	4.6	27.7	32.0	35.0	26.0	32.5	31.3	6.2	26.4	27.5	25.3	13.6	36.3	27.5	19.2	31.7	32.9	18.7	22.1	12.9	21.7	48.8	40.1	74.0	54.0	16.0	33.6	30.8
SPR	SDR38C1	ENSG00000116096	"Sepiapterin reductase"	P35270	2	72887360-72892158	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		Oxidoreductase	"Disease mutation, Dystonia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"pancreas: 61.7"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	7	"classical monocyte: 9.3;intermediate monocyte: 2.6;myeloid DC: 9.9"	"Group enriched"	"Detected in many"	13	"dendritic cells: 9.9;monocytes: 9.3"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"							HPA039505	Uncertain		Supported	Nucleoplasm,Cytosol		NA	NA		52000	"Nucleoplasm, Cytosol"		"HPA039505: AB_10795466"	"unprognostic (4.09e-1)"	"unprognostic (1.22e-1)"	"unprognostic (7.72e-3)"	"unprognostic (1.97e-1)"	"unprognostic (2.46e-2)"	"unprognostic (1.06e-2)"	"unprognostic (1.36e-1)"	"unprognostic (1.47e-1)"	"unprognostic (1.12e-1)"	"unprognostic (9.79e-2)"	"unprognostic (1.62e-1)"	"unprognostic (1.37e-1)"	"unprognostic (1.80e-1)"	"unprognostic (7.50e-3)"	"unprognostic (2.87e-1)"	"unprognostic (1.43e-3)"	"unprognostic (1.95e-1)"	13.3	22.6	6.3	6.1	8.2	0.0	36.2	2.0	6.4	6.0	17.1	3.1	8.9	11.4	5.7	19.1	13.4	13.2	11.4	16.1	6.4	6.0	20.3	43.5	7.2	5.3	7.9	5.0	8.7	61.7	16.7	5.5	3.9	7.9	17.3	16.2	4.5	20.9	8.8	16.0	3.3	15.1	9.5	4.9	4.7	15.4	4.9	7.2	1.0	31.7	6.2	3.6	9.5	41.4	0.0	9.9	0.7	9.3	0.0	0.4	2.5	13.5	38.0	0.2	5.9	15.6	5.7	9.5	6.4	9.3	4.8	4.5	24.2	14.1	9.9	7.7	7.5	24.1	12.9	17.0	10.2	4.0	2.8	13.2	14.9	9.4	24.8	5.8	2.3	4.1	5.0	11.4	5.2	5.9	9.8	12.5	7.4	15.3	2.0	6.2	28.5	0.9	8.8	3.2	40.2	36.4	0.0	24.7	5.8	25.2	21.2	2.4	4.4	11.7	26.5	8.7	5.2	11.9	2.8	15.3	5.2	12.8	9.1	11.2	2.2	4.8	0.6	7.5	5.0	9.1	0.0	9.3	0.7	0.4	2.6	0.4	0.0	0.2	0.1	9.9	0.0	0.2	0.4	0.0	0.0	1.0	0.9	0.0	2.5	6.3	8.2	2.0	6.4	6.4	6.0	7.9	5.0	7.9	7.2	11.9	5.3	1.9	19.7	7.4	0.6	40.5	40.8	6.7	7.9	40.1	0.0	14.2	18.3	46.9	0.2	17.6	68.6	0.0	71.1	9.3	12.5	27.5	4.6	52.9	35.3	1.6	10.9	11.6	4.7	0.9	8.6	9.4	13.5	34.3	31.7	8.6	48.5	51.8	5.3	75.1	0.5	6.5	12.5	0.3	6.6	5.6	3.7	1.7	50.4	13.2
SPTLC1	"hLCB1, HSAN1, HSN1, LCB1, SPTI"	ENSG00000090054	"Serine palmitoyltransferase long chain base subunit 1"	O15269	9	92000087-92115384	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted membrane proteins"	"Lipid metabolism, Sphingolipid metabolism"	"Acyltransferase, Transferase"	"Disease mutation, Neurodegeneration, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Early spermatids: 76.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA010860, CAB018747, HPA063907"	Supported		Supported	"Endoplasmic reticulum"		NA	NA			"Endoplasmic reticulum"		"CAB018747: AB_2195864, HPA010860: AB_1080086, HPA063907: AB_2685148"	"unprognostic (1.22e-1)"	"unprognostic (1.75e-2)"	"unprognostic (1.47e-1)"	"unprognostic (3.51e-2)"	"unprognostic (1.54e-1)"	"unprognostic (1.23e-2)"	"unprognostic (3.03e-2)"	"unprognostic (4.22e-3)"	"unprognostic (1.27e-1)"	"unprognostic (4.06e-1)"	"unprognostic (3.55e-3)"	"unprognostic (8.37e-2)"	"prognostic favorable (1.36e-6)"	"unprognostic (1.13e-1)"	"unprognostic (2.41e-2)"	"unprognostic (4.28e-1)"	"unprognostic (1.49e-1)"	16.4	17.7	13.3	11.4	17.1	9.9	16.8	19.9	17.6	20.3	17.2	20.9	18.1	14.0	17.3	15.1	30.5	19.2	15.5	11.4	13.9	15.3	19.0	13.5	14.8	10.6	18.0	12.2	35.3	15.8	23.6	23.1	28.3	20.5	14.5	18.8	12.0	18.5	13.3	9.4	20.1	17.8	15.1	20.8	10.7	16.0	19.8	14.1	9.7	26.2	16.0	16.5	17.4	20.9	9.3	21.0	21.1	22.1	10.2	15.2	16.0	18.4	16.8	11.6	9.7	28.4	22.2	20.1	19.4	24.9	16.8	18.3	10.5	38.7	10.2	12.4	24.6	20.4	48.5	12.5	16.5	19.6	11.8	7.3	9.4	9.5	10.2	21.4	15.5	12.7	19.9	20.0	17.4	18.9	16.0	15.3	11.0	21.9	12.7	19.1	19.9	9.7	3.8	15.6	20.9	12.2	10.8	14.1	7.8	16.7	11.3	9.4	8.8	26.2	20.1	11.8	14.5	10.3	9.2	19.4	16.4	12.7	18.8	13.5	9.2	12.6	5.7	19.6	7.7	19.6	14.6	22.1	11.9	11.5	21.6	11.0	8.9	11.6	11.6	21.0	9.3	14.2	10.7	21.1	10.2	19.2	10.8	15.2	16.0	13.3	17.1	19.9	17.6	13.9	15.3	18.0	12.2	20.5	14.1	35.7	41.3	10.3	9.6	9.4	8.1	3.7	2.5	40.2	35.2	34.9	13.7	10.9	8.3	46.0	76.8	8.7	7.7	0.0	49.5	11.1	12.2	7.8	23.2	4.4	9.7	6.4	2.4	6.7	6.5	22.6	5.8	22.2	11.8	28.9	6.2	11.3	47.8	4.0	5.6	22.6	7.9	12.9	10.3	33.1	25.8	8.0	18.2	11.4	6.0	13.2
SPTLC2	"hLCB2a, KIAA0526, LCB2, LCB2A"	ENSG00000100596	"Serine palmitoyltransferase long chain base subunit 2"	O15270	14	77505997-77616773	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted membrane proteins"	"Lipid metabolism, Sphingolipid metabolism"	"Acyltransferase, Transferase"	"Disease mutation, Neurodegeneration, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA027552			Approved	Mitochondria		Yes	No			Mitochondria		"HPA027552: AB_10601717"	"unprognostic (3.16e-1)"	"unprognostic (2.82e-2)"	"unprognostic (1.24e-1)"	"unprognostic (4.41e-2)"	"unprognostic (2.12e-1)"	"unprognostic (1.42e-1)"	"prognostic unfavorable (3.62e-4)"	"unprognostic (1.46e-2)"	"unprognostic (3.09e-1)"	"unprognostic (4.05e-1)"	"unprognostic (1.98e-2)"	"unprognostic (2.51e-1)"	"prognostic favorable (6.69e-8)"	"unprognostic (1.29e-2)"	"unprognostic (2.35e-1)"	"unprognostic (4.94e-2)"	"unprognostic (1.32e-1)"	30.0	12.8	15.4	11.4	27.0	27.3	25.6	6.9	18.5	15.3	17.0	32.4	8.5	13.4	10.2	7.6	22.8	13.7	11.1	7.8	20.8	14.1	17.1	7.2	12.2	17.5	33.1	13.3	10.2	7.6	12.8	9.8	18.8	21.2	8.2	18.8	6.0	16.6	9.6	5.5	11.3	15.8	11.0	47.6	23.5	18.8	4.7	34.9	10.0	10.3	8.8	12.0	13.2	17.1	4.8	18.2	15.1	18.2	10.0	4.2	6.9	12.1	8.0	6.1	6.7	6.3	8.0	10.5	18.1	13.4	12.5	13.1	10.1	27.1	12.1	4.6	18.3	6.4	15.0	16.3	10.1	19.0	5.3	4.8	34.4	6.2	6.0	5.4	3.5	11.4	5.2	5.0	8.1	9.1	7.1	17.5	8.4	6.7	5.9	7.1	10.5	9.1	11.9	4.0	19.2	7.2	9.9	6.3	4.1	14.4	27.3	5.9	7.5	6.5	21.8	6.8	11.3	26.8	6.4	11.0	11.5	8.2	4.2	4.1	3.3	5.5	8.2	7.6	12.4	6.5	8.8	18.2	15.1	3.8	13.8	3.5	4.1	3.2	4.2	18.2	4.8	2.2	3.6	11.2	10.0	16.7	6.5	3.3	6.9	15.4	27.0	6.9	18.5	20.8	14.1	33.1	13.3	21.2	34.9	26.8	23.5	25.0	21.1	28.7	13.3	7.3	10.2	24.1	27.3	45.4	33.4	10.3	1.7	21.2	1.4	32.3	28.5	46.7	14.2	10.9	16.6	24.2	49.7	6.6	21.7	4.8	12.7	57.1	63.4	1.5	13.6	29.2	18.6	15.4	36.9	10.3	24.7	28.1	14.9	9.1	18.8	32.3	8.6	6.7	16.0	25.5	5.5	22.7	27.5	47.7
SPTLC3	"C20orf38, FLJ11112, hLCB2b, LCB2B, SPTLC2L"	ENSG00000172296	"Serine palmitoyltransferase long chain base subunit 3"	Q9NUV7	20	13008979-13169103	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Lipid metabolism, Sphingolipid metabolism"	"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"placenta: 154.0"	"Cell type enhanced"	"Detected in many"	7	"Cytotrophoblasts: 22.9;Syncytiotrophoblasts: 38.6"	"Low cancer specificity"	"Detected in all"			"Region enriched"	"Detected in all"	4	"pons and medulla: 10.5"	"Group enriched"	"Detected in some"	5	"MAIT T-cell: 3.0;NK-cell: 4.1"	"Group enriched"	"Detected in many"	13	"NK-cells: 4.1;T-cells: 3.0"	"Cell line enhanced"	"Detected in many"		"Karpas-707: 16.4;RPTEC TERT1: 21.8;U-2197: 15.2;U-87 MG: 28.8"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"HPA044247, HPA048079"	Enhanced		Approved	Microtubules		NA	NA			Microtubules		"HPA044247: AB_2678872, HPA048079: AB_2680252"	"unprognostic (6.81e-2)"	"unprognostic (7.76e-2)"	"unprognostic (4.46e-2)"	"unprognostic (1.25e-3)"	"unprognostic (5.43e-2)"	"unprognostic (2.12e-1)"	"unprognostic (5.70e-2)"	"unprognostic (7.99e-2)"	"unprognostic (9.51e-2)"	"unprognostic (2.21e-1)"	"prognostic unfavorable (6.02e-4)"	"unprognostic (5.08e-2)"	"prognostic favorable (4.51e-7)"	"unprognostic (2.80e-2)"	"unprognostic (1.01e-1)"	"unprognostic (1.17e-1)"	"unprognostic (3.18e-1)"	3.2	4.5	1.3	1.6	2.2	0.0	4.3	1.7	1.7	4.3	5.0	2.2	4.4	8.3	4.8	9.6	5.6	3.4	5.8	4.8	2.0	1.5	15.6	11.9	5.7	0.7	2.5	2.2	4.3	3.8	10.2	4.2	154.0	10.5	4.5	3.8	3.8	7.8	5.8	1.0	25.1	9.0	3.0	6.9	1.9	2.2	4.2	1.4	5.7	24.3	3.6	1.9	4.8	6.0	0.0	0.2	0.1	0.0	4.1	3.0	0.2	0.7	1.1	0.9	0.0	7.1	10.3	5.5	0.0	1.5	1.0	4.1	8.9	4.5	0.0	0.5	0.2	9.0	12.2	0.0	3.4	1.4	0.0	0.0	0.0	2.8	12.6	0.6	0.0	0.1	5.8	10.7	4.0	1.4	3.8	0.7	2.1	0.0	16.4	11.5	0.2	0.0	0.0	0.0	1.0	1.4	1.1	2.0	7.2	21.8	8.7	0.0	0.1	0.1	1.1	0.0	1.6	9.1	0.2	1.6	4.6	1.5	15.2	1.0	0.1	0.0	0.0	28.8	0.0	0.0	0.1	0.0	0.0	0.5	0.0	3.0	0.0	0.4	0.1	0.0	0.0	0.7	0.1	0.1	4.1	0.0	0.2	0.0	0.2	1.3	2.2	1.7	1.7	2.0	1.5	2.5	2.2	10.5	1.4	6.0	18.2	0.0	4.8	2.2	0.0	15.1	5.1	4.0	6.8	8.7	0.0	22.9	6.6	2.2	15.0	2.2	4.9	0.0	3.8	10.5	7.2	3.4	1.1	18.7	2.5	0.0	0.0	0.6	2.5	8.5	3.4	0.9	0.0	0.0	4.7	13.6	2.5	8.0	2.5	11.9	0.0	0.0	0.3	0.9	0.1	1.9	38.6	1.3	6.1	1.8
SQLE		ENSG00000104549	"Squalene epoxidase"	Q14534	8	124998497-125022283	"Enzymes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins"		Oxidoreductase	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA018038, HPA020762"	Enhanced		Uncertain	Vesicles,Cytosol		NA	NA			"Vesicles, Cytosol"		"HPA018038: AB_2669753, HPA020762: AB_2670512"	"unprognostic (1.37e-2)"	"unprognostic (6.26e-3)"	"unprognostic (5.12e-2)"	"unprognostic (9.51e-3)"	"unprognostic (4.63e-1)"	"prognostic unfavorable (7.42e-4)"	"unprognostic (4.76e-3)"	"prognostic unfavorable (4.67e-4)"	"unprognostic (3.45e-2)"	"unprognostic (7.21e-2)"	"prognostic unfavorable (2.73e-4)"	"unprognostic (7.51e-2)"	"prognostic unfavorable (5.70e-4)"	"unprognostic (9.71e-2)"	"unprognostic (4.62e-2)"	"unprognostic (1.19e-3)"	"unprognostic (7.74e-3)"	4.6	15.7	11.1	9.9	13.9	10.4	12.1	8.9	19.9	15.1	11.5	28.8	4.4	15.8	8.9	5.1	40.3	10.0	6.3	4.2	15.4	14.5	7.8	38.1	16.0	8.6	10.8	9.7	17.5	6.3	16.5	9.5	24.7	28.5	13.8	10.1	9.3	10.4	4.7	1.3	23.8	8.7	6.6	36.0	5.6	11.5	29.3	18.7	9.8	5.7	24.2	15.0	5.3	21.6	15.1	12.4	1.2	9.7	9.5	9.0	6.1	25.8	10.0	60.2	17.3	18.7	31.8	6.1	6.8	21.0	9.3	17.1	13.6	37.9	17.8	9.9	8.4	37.4	19.8	25.1	37.7	10.8	14.7	53.0	50.9	6.8	34.7	27.6	5.9	15.0	21.7	40.4	27.7	22.9	6.0	10.1	12.6	29.0	34.7	7.5	42.7	20.6	7.5	24.9	17.8	6.9	9.1	11.0	24.3	65.6	29.8	18.8	9.5	14.0	45.0	14.0	20.2	12.0	15.6	9.9	3.8	13.6	4.5	6.0	6.3	12.8	24.4	6.4	18.2	6.6	1.2	5.1	0.5	9.0	8.5	4.4	13.6	5.4	8.3	12.4	15.1	7.5	7.8	0.1	9.5	9.7	8.8	5.6	6.1	11.1	13.9	8.9	16.4	15.4	14.5	10.8	9.7	28.5	18.7	56.6	84.1	38.7	41.4	20.4	26.3	6.1	28.1	108.4	52.4	50.6	47.1	81.6	6.6	50.5	18.8	11.2	44.6	46.7	73.0	111.6	54.5	79.8	41.4	15.7	48.5	139.8	30.4	12.3	13.0	9.6	22.2	16.0	20.3	154.1	29.4	23.5	64.9	21.0	10.3	2.9	47.5	25.8	29.0	131.6	152.1	77.9	181.6	17.5	20.4	100.4
SRC	"ASV, c-src, SRC1"	ENSG00000197122	"SRC proto-oncogene, non-receptor tyrosine kinase"	P12931	20	37344685-37406050	"Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Transporters"	"Cell adhesion, Cell cycle, Host-virus interaction, Immunity"	"Kinase, Transferase, Tyrosine-protein kinase"	"Cancer-related genes, Disease mutation, FDA approved drug targets, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"intermediate monocyte: 5.3;non-classical monocyte: 4.4"	"Group enriched"	"Detected in many"	6	"dendritic cells: 3.0;monocytes: 5.3"	"Cell line enhanced"	"Detected in many"		"A549: 35.9;HBEC3-KT: 33.4;RT4: 34.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004023, HPA030875"	Approved		Supported	"Nucleoplasm,Plasma membrane,Cell Junctions,Cytosol"		NA	NA		20000000	"Plasma membrane, Cell Junctions"	"Nucleoplasm, Cytosol"	"CAB004023: AB_2106059, HPA030875: AB_2673640"	"unprognostic (5.58e-2)"	"unprognostic (9.83e-2)"	"unprognostic (3.56e-1)"	"unprognostic (4.54e-3)"	"unprognostic (1.52e-1)"	"unprognostic (1.54e-2)"	"prognostic unfavorable (4.90e-5)"	"unprognostic (3.89e-2)"	"unprognostic (7.04e-2)"	"unprognostic (8.13e-2)"	"unprognostic (1.54e-2)"	"prognostic unfavorable (1.63e-4)"	"prognostic unfavorable (1.22e-4)"	"unprognostic (2.33e-2)"	"unprognostic (4.72e-2)"	"unprognostic (3.65e-2)"	"prognostic favorable (5.22e-5)"	6.9	17.5	12.8	11.1	12.0	5.4	9.9	6.4	16.0	16.0	16.4	3.5	15.1	29.5	20.3	9.7	16.2	14.2	42.1	5.8	11.3	6.6	13.4	2.9	10.4	7.0	3.3	9.9	15.8	19.1	6.6	11.3	6.3	5.1	19.9	13.1	13.1	7.5	22.5	3.4	7.7	28.1	27.2	3.6	12.2	29.8	27.3	4.8	4.0	6.6	10.5	10.4	26.4	20.0	0.3	3.0	0.1	5.3	0.6	0.1	1.6	7.7	35.9	8.3	7.4	3.1	5.0	17.2	7.2	6.2	8.8	5.6	13.5	7.0	0.2	4.5	13.0	10.0	14.2	4.9	33.4	3.4	0.0	4.5	2.0	1.3	20.9	7.5	0.1	3.1	5.3	11.4	5.7	7.7	9.8	8.0	4.6	0.2	0.0	1.4	5.3	1.9	0.2	3.9	21.5	32.6	8.4	2.2	0.2	3.7	34.4	7.7	27.9	8.1	11.4	8.9	6.6	10.2	2.8	11.6	10.5	7.1	3.8	6.4	0.1	0.2	0.1	7.4	0.0	7.8	0.0	2.6	0.0	0.0	5.3	0.0	0.3	0.0	0.1	1.1	0.3	0.0	0.0	0.1	0.6	4.4	3.0	0.1	1.6	12.8	12.0	6.4	16.0	11.3	6.6	3.3	9.9	5.1	4.8	3.0	1.7	4.4	10.8	7.2	5.4	1.6	15.3	1.4	0.0	12.2	2.0	1.6	1.7	9.7	1.3	1.4	30.0	0.0	16.2	7.0	8.2	11.2	0.0	0.9	5.8	3.2	16.1	1.3	6.9	1.5	10.0	12.1	1.7	7.2	25.9	4.1	29.0	18.1	16.3	9.5	4.7	12.9	6.4	0.2	0.7	8.0	1.9	0.0	14.9	27.7
SRD5A1		ENSG00000145545	"Steroid 5 alpha-reductase 1"	P18405	5	6633343-6674386	"Cancer-related genes, Enzymes, FDA approved drug targets, Predicted membrane proteins"	"Differentiation, Sexual differentiation"	Oxidoreductase	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 42.4"	"Cell type enhanced"	"Detected in many"	9	"Hepatocytes: 75.4;monocytes: 55.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"							HPA051402	Approved					NA	NA					"HPA051402: AB_2681470"	"unprognostic (1.40e-2)"	"unprognostic (1.33e-2)"	"unprognostic (2.30e-3)"	"prognostic unfavorable (8.73e-6)"	"unprognostic (9.38e-3)"	"unprognostic (8.90e-2)"	"unprognostic (3.78e-2)"	"unprognostic (5.90e-2)"	"unprognostic (3.83e-1)"	"unprognostic (1.42e-1)"	"unprognostic (7.70e-3)"	"unprognostic (1.54e-1)"	"unprognostic (1.56e-3)"	"unprognostic (3.01e-1)"	"unprognostic (2.24e-1)"	"unprognostic (1.59e-1)"	"unprognostic (5.47e-2)"	2.4	3.3	7.7	2.9	8.2	3.2	14.8	9.2	11.8	5.6	5.2	5.3	0.7	5.7	3.1	4.6	24.2	2.9	4.0	1.9	9.3	7.5	6.4	42.4	3.0	3.5	6.2	5.5	4.1	4.3	3.0	1.9	2.1	13.4	2.6	3.6	2.4	5.0	2.1	2.2	17.5	10.4	2.6	3.1	2.9	3.9	2.7	2.9	3.3	2.4	15.3	12.1	2.6	10.1	1.9	3.7	7.0	3.3	1.3	1.3	1.3	5.6	5.5	7.4	6.3	7.1	7.0	3.4	5.4	4.2	5.4	3.4	5.5	5.0	6.8	9.0	7.9	8.8	9.1	6.0	3.6	5.8	4.2	2.6	2.1	13.9	3.4	3.3	3.0	1.8	5.1	10.4	3.8	3.0	4.0	2.6	2.7	3.6	6.3	6.9	6.6	1.4	3.5	4.7	3.7	4.4	4.7	5.7	2.0	7.2	5.2	14.0	6.3	16.6	7.4	5.1	7.7	3.0	0.9	5.5	8.2	4.1	13.3	6.8	3.4	4.5	2.4	6.8	3.6	7.4	7.0	3.3	1.4	1.0	2.4	0.7	1.7	1.0	1.3	3.7	1.9	0.9	1.0	2.0	1.3	2.6	1.8	1.1	1.3	7.7	8.2	9.2	11.8	9.3	7.5	6.2	5.5	13.4	2.9	3.0	2.4	8.2	5.5	16.5	4.4	2.4	5.1	8.1	2.3	5.2	3.9	0.7	6.6	9.1	7.8	3.1	7.8	0.0	4.1	6.1	3.7	6.5	1.1	75.4	12.0	6.4	2.4	4.3	19.6	1.9	3.1	7.9	6.8	55.1	5.6	3.5	6.5	8.7	7.4	19.5	3.7	0.0	4.2	2.7	2.6	26.6	0.7	4.4	11.7	9.6
SRD5A2		ENSG00000277893	"Steroid 5 alpha-reductase 2"	P31213	2	31522480-31581067	"Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Predicted membrane proteins"	"Differentiation, Sexual differentiation"	Oxidoreductase	"Cancer-related genes, Disease mutation, FDA approved drug targets, Pseudohermaphroditism"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"epididymis: 17.9;liver: 30.9;prostate: 28.4"	"Cell type enhanced"	"Detected in some"	23	"Ciliated cells: 13.4;Early spermatids: 70.2;Hepatocytes: 14.7;Late spermatids: 41.4"	"Group enriched"	"Detected in some"	6	"endometrial cancer: 1.1;liver cancer: 4.2;prostate cancer: 3.2"					"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	7	"BJ hTERT+: 2.9;RT4: 5.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"									NA	NA						"unprognostic (6.75e-3)"	"unprognostic (2.00e-2)"	"unprognostic (1.66e-1)"	"unprognostic (1.08e-3)"	"unprognostic (5.92e-3)"	"unprognostic (3.37e-2)"	"unprognostic (2.79e-3)"	"unprognostic (6.56e-2)"	"unprognostic (9.10e-2)"	"unprognostic (1.39e-2)"	"unprognostic (3.06e-2)"	"unprognostic (9.79e-3)"	"unprognostic (6.61e-6)"	"unprognostic (4.37e-2)"	"unprognostic (2.04e-1)"	"unprognostic (3.85e-1)"	"unprognostic (3.48e-3)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.2	0.0	0.0	10.1	0.0	0.2	17.9	0.0	10.4	0.0	0.0	0.0		0.0	30.9	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	28.4	0.0	0.0	0.0	11.2	0.0	0.0	0.0	0.5	0.1	0.0	0.0	0.4	0.0	0.3	0.0	0.0	0.1	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.6	2.9	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.1	0.0	0.3	5.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.1	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0											0.0	0.0	0.0	3.1	0.0	0.0	0.4	2.5	13.4	1.2	0.0	0.0	0.0	0.0	0.0	70.2	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	14.7	0.0	0.0	0.0	0.0	0.0	41.4	0.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.1	0.2	0.0	0.0	0.0	1.1	0.6	0.0	0.0	0.0	0.0	4.7
SRD5A3	"FLJ13352, SRD5A2L, SRD5A2L1"	ENSG00000128039	"Steroid 5 alpha-reductase 3"	Q9H8P0	4	55346109-55373096	"Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins"		Oxidoreductase	"Cataract, Congenital disorder of glycosylation, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Exocrine glandular cells: 92.9;Extravillous trophoblasts: 88.2;Pancreatic endocrine cells: 133.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"SK-BR-3: 42.6"	"Low region specificity"	"Detected in all"							HPA027006	Uncertain		Approved	"Plasma membrane,Cytosol"		NA	NA			"Plasma membrane, Cytosol"		"HPA027006: AB_1857469"	"unprognostic (1.12e-2)"	"unprognostic (1.01e-1)"	"unprognostic (4.02e-2)"	"prognostic favorable (9.39e-4)"	"unprognostic (1.50e-2)"	"unprognostic (4.81e-2)"	"prognostic unfavorable (1.80e-6)"	"unprognostic (9.31e-2)"	"unprognostic (5.28e-2)"	"unprognostic (1.81e-2)"	"unprognostic (3.29e-3)"	"unprognostic (1.18e-1)"	"prognostic unfavorable (4.85e-10)"	"unprognostic (4.16e-2)"	"unprognostic (1.42e-1)"	"unprognostic (1.43e-2)"	"unprognostic (9.52e-2)"	13.8	12.2	11.5	5.9	13.4	6.6	17.8	7.3	18.3	22.9	11.3	20.3	3.5	6.9	13.8	9.6	24.4	5.9	22.6	10.5	13.2	10.7	12.3	15.0	12.4	10.1	15.5	12.0	3.5	26.8	14.0	7.0	8.8	13.6	8.9	10.9	6.8	16.3	6.6	5.8	15.6	8.3	6.2	22.1	6.9	13.8	4.0	15.3	10.0	7.6	9.9	12.1	12.1	12.1	5.9	28.4	10.3	25.2	3.6	9.2	10.3	4.8	3.2	5.8	5.5	19.5	12.5	2.9	5.3	6.2	2.2	3.6	3.2	10.1	11.5	6.0	8.3	6.2	3.8	4.1	4.9	2.8	3.3	7.3	6.3	3.6	8.6	5.2	11.6	3.5	11.4	9.1	3.8	3.5	4.8	9.0	21.5	10.7	25.8	12.6	6.3	17.0	5.1	7.3	27.6	4.3	5.5	1.8	6.5	7.4	5.2	9.0	5.0	5.6	42.6	3.8	6.0	5.2	10.2	4.4	14.2	2.6	1.0	4.0	13.8	7.6	4.2	18.0	16.0	13.8	10.3	16.5	4.9	7.9	25.1	9.2	5.9	6.0	7.4	14.1	5.2	5.3	7.1	0.8	3.6	25.2	28.4	5.8	10.3	11.5	13.4	7.3	18.3	13.2	10.7	15.5	12.0	13.6	15.3	8.9	15.7	3.0	9.5	12.0	4.6	4.6	45.9	12.0	12.5	5.2	3.9	22.7	3.3	67.0	2.0	14.3	8.4	0.0	92.9	88.2	17.0	22.1	13.9	17.1	62.0	9.5	11.5	17.8	20.9	0.0	1.7	27.9	23.6	24.4	19.3	18.6	133.4	5.8	5.3	12.2	3.8	12.9	9.5	2.1	18.8	26.0	6.3	4.9	20.9	49.7
SRM	"SPS1, SRML1"	ENSG00000116649	"Spermidine synthase"	P19623	1	11054584-11060024	"Enzymes, Predicted intracellular proteins"	"Polyamine biosynthesis, Spermidine biosynthesis"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"pancreas: 107.4"	"Cell type enhanced"	"Detected in many"	4	"Extravillous trophoblasts: 175.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA015746	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA015746: AB_1857472"	"unprognostic (4.97e-2)"	"unprognostic (1.55e-1)"	"unprognostic (1.80e-1)"	"unprognostic (2.52e-2)"	"unprognostic (1.75e-1)"	"unprognostic (1.97e-1)"	"prognostic unfavorable (2.25e-5)"	"unprognostic (2.11e-2)"	"unprognostic (2.44e-1)"	"unprognostic (3.58e-2)"	"unprognostic (3.01e-1)"	"unprognostic (3.45e-1)"	"prognostic unfavorable (3.80e-8)"	"unprognostic (1.74e-2)"	"unprognostic (8.98e-3)"	"unprognostic (1.36e-1)"	"unprognostic (2.98e-2)"	26.7	17.7	20.3	29.0	35.4	15.2	16.9	10.2	30.8	14.3	13.3	14.0	11.5	10.8	18.8	9.8	17.7	15.8	14.2	24.9	19.6	16.9	13.9	45.3	14.0	31.0	15.3	15.0	22.8	107.4	8.0	14.5	14.8	15.6	13.1	11.7	15.0	36.0	17.6	43.6	18.2	9.8	22.9	11.7	21.1	14.5	14.4	14.1	17.9	11.9	21.2	20.8	20.2	19.8	10.7	10.2	0.3	6.0	5.0	10.3	2.0	24.9	36.4	12.1	40.4	24.2	26.2	19.0	38.8	19.9	55.5	29.8	44.8	15.1	48.3	22.9	33.6	17.4	19.6	38.6	31.2	18.5	23.7	58.4	30.4	40.3	50.4	35.6	51.0	27.9	26.2	22.6	53.7	47.2	13.0	23.4	31.6	49.4	40.9	27.0	54.8	43.5	44.5	26.4	23.0	70.5	32.7	12.5	78.8	19.7	9.9	23.3	22.3	20.1	43.3	30.3	9.8	15.1	25.9	19.4	36.3	28.6	62.8	43.5	33.0	33.3	72.3	25.2	68.6	41.7	0.0	5.4	0.3	7.0	6.0	10.3	10.7	7.1	9.1	6.4	9.3	8.4	9.7	0.2	5.0	3.1	10.2	7.5	2.0	20.3	35.4	10.2	30.8	19.6	16.9	15.3	15.0	15.6	14.1	0.0	2.9	57.4	63.7	84.3	27.7	26.4	30.6	2.7	1.2	27.9	19.6	62.5	64.6	20.3	3.4	46.6	5.1	23.3	36.6	175.3	66.1	60.8	27.5	47.6	85.0	28.6	26.4	35.6	21.8	10.5	66.4	35.3	64.1	8.2	27.0	28.1	26.0	7.0	49.8	69.0	12.3	0.0	49.9	12.8	74.2	98.9	30.1	23.5	26.6	92.1
SRMS	"C20orf148, dJ697K14.1, PTK70, SRM"	ENSG00000125508	"Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites"	Q9H3Y6	20	63540810-63547504	"Enzymes, Predicted intracellular proteins"		"Kinase, Transferase, Tyrosine-protein kinase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"epididymis: 10.2"	"Not detected"	"Not detected"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Cell type enhanced"	"Detected in single"		"naive B-cell: 1.1"	"Lineage enriched"	"Detected in single"	8	"B-cells: 1.1"	"Cell line enhanced"	"Detected in some"		"CAPAN-2: 5.5;MCF7: 4.7;OE19: 7.0;RT4: 9.7"	"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			"CAB044668, CAB044669, HPA073987"	Uncertain		Approved	"Intermediate filaments,Actin filaments,Cytosol"		No	NA			"Intermediate filaments"	"Actin filaments, Cytosol"	"CAB044668: AB_10609403, CAB044669: AB_10608235, HPA073987: AB_2686650"	"unprognostic (2.26e-2)"	"unprognostic (1.26e-2)"	"unprognostic (2.52e-3)"	"unprognostic (8.32e-2)"	"unprognostic (2.62e-1)"	"unprognostic (5.47e-3)"	"unprognostic (1.65e-1)"	"unprognostic (2.28e-1)"	"unprognostic (9.63e-2)"	"unprognostic (6.48e-3)"	"unprognostic (7.28e-3)"	"unprognostic (1.46e-1)"	"unprognostic (1.73e-3)"	"unprognostic (2.58e-3)"	"unprognostic (4.75e-2)"	"unprognostic (4.97e-2)"	"unprognostic (2.54e-3)"	0.3	0.0	0.3	0.5	0.3	0.0	1.1	1.1	0.3	0.3	1.8	0.3	0.3	0.4	0.3	10.2	0.4	0.0	0.3	0.3	0.3	0.0	0.9	0.3	0.3	0.3	0.3	0.3	0.3	2.7	0.0	0.3	0.3	0.3	2.2	0.0	0.3	2.5	0.3	0.3	1.7	0.8	0.3	0.3	2.5	4.2	0.9	0.3	0.3	0.3	0.3	0.8	1.5	0.3	1.1	0.0	0.0	0.0	0.0	0.1	0.3	0.2	0.0	0.0	0.3	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.1	5.5	0.2	2.2	0.0	0.0	2.5	0.0	0.0	0.0	0.5	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	4.7	0.0	0.2	0.0	7.0	0.8	0.0	0.2	0.0	0.0	9.7	0.8	0.9	0.3	2.0	0.4	0.0	2.5	0.0	0.0	0.0	0.3	0.2	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	1.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.3	1.1	0.3	0.3	0.0	0.3	0.3	0.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
SRPK1	SFRSK1	ENSG00000096063	"SRSF protein kinase 1"	Q96SB4	6	35832966-35921342	"Enzymes, Predicted intracellular proteins"	"Chromosome partition, Differentiation, Host-virus interaction, mRNA processing, mRNA splicing"	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	8	"Early spermatids: 311.7;Late spermatids: 401.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA016431, HPA056486"	Approved		Supported	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Nucleoplasm, Cytosol"	"Plasma membrane"	"HPA016431: AB_1857478, HPA056486: AB_2683148"	"unprognostic (4.65e-3)"	"unprognostic (6.82e-3)"	"unprognostic (2.54e-3)"	"unprognostic (1.01e-3)"	"unprognostic (7.74e-2)"	"unprognostic (3.31e-2)"	"prognostic unfavorable (7.90e-6)"	"unprognostic (1.23e-2)"	"unprognostic (2.54e-3)"	"unprognostic (2.36e-2)"	"prognostic unfavorable (6.53e-5)"	"unprognostic (7.28e-2)"	"unprognostic (2.21e-3)"	"unprognostic (9.24e-2)"	"unprognostic (4.43e-1)"	"unprognostic (1.01e-1)"	"unprognostic (7.55e-3)"	13.5	7.1	8.1	15.4	11.7	32.1	11.7	22.5	17.8	12.8	23.8	7.8	10.8	20.3	15.2	7.9	24.9	8.9	10.8	8.7	8.9	7.8	17.8	18.9	14.9	14.6	8.0	8.3	9.5	26.0	11.7	17.7	27.9	9.6	10.5	28.7	12.4	17.6	9.4	19.9	26.2	25.7	11.3	7.9	19.0	13.9	32.7	7.6	21.0	8.5	17.0	19.8	15.2	15.7	4.3	2.8	24.6	3.4	5.0	6.7	2.9	29.9	11.4	16.8	25.0	9.4	12.3	21.2	18.4	17.8	17.2	18.3	32.0	10.1	40.0	15.6	11.3	20.0	15.4	32.8	21.9	31.0	27.3	23.6	21.0	13.4	27.7	8.3	31.1	10.4	7.9	12.0	19.8	26.0	13.7	21.6	22.9	44.5	17.0	14.4	10.6	32.0	24.2	13.7	18.3	12.5	22.5	20.1	24.7	17.3	50.4	35.8	13.1	18.9	18.0	12.7	17.8	10.1	20.7	15.6	16.2	12.7	11.0	23.1	10.0	22.1	37.6	6.4	36.1	14.4	24.5	2.1	13.7	4.3	2.5	6.1	4.3	5.7	5.7	2.8	3.3	4.8	5.2	24.6	5.0	3.4	1.6	6.7	2.9	8.1	11.7	22.5	17.8	8.9	7.8	8.0	8.3	9.6	7.6	8.9	26.3	24.4	65.1	37.5	33.6	21.8	12.7	32.1	38.7	21.0	35.3	43.2	24.9	50.7	311.7	24.1	38.6	23.3	58.8	43.3	21.3	68.6	7.0	40.0	19.1	9.5	44.4	11.1	17.1	401.7	20.4	16.9	15.1	36.1	44.8	13.4	78.7	42.1	23.3	44.4	84.4	6.5	23.1	154.9	90.6	36.5	33.2	34.8	87.4	132.9
SRPK2	SFRSK2	ENSG00000135250	"SRSF protein kinase 2"	P78362	7	105110704-105399308	"Enzymes, Predicted intracellular proteins"	"Differentiation, mRNA processing, mRNA splicing"	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 69.3"	"Group enriched"	"Detected in many"	6	"Early spermatids: 1076.1;Late spermatids: 1865.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"neutrophil: 58.2"	"Lineage enriched"	"Detected in all"	5	"granulocytes: 58.2"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA015522, HPA020876"	Enhanced		Supported	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"HPA015522: AB_1857479, HPA020876: AB_1857480"	"unprognostic (9.75e-2)"	"unprognostic (1.68e-2)"	"unprognostic (1.12e-1)"	"unprognostic (4.64e-2)"	"unprognostic (3.54e-1)"	"unprognostic (1.30e-1)"	"unprognostic (5.14e-2)"	"unprognostic (1.54e-1)"	"unprognostic (2.28e-2)"	"unprognostic (1.92e-1)"	"unprognostic (2.19e-1)"	"unprognostic (2.31e-1)"	"unprognostic (5.38e-2)"	"unprognostic (7.95e-2)"	"unprognostic (4.72e-2)"	"unprognostic (2.87e-2)"	"unprognostic (3.44e-1)"	9.9	12.1	24.8	10.1	27.6	7.1	13.3	28.4	47.1	12.7	9.4	21.0	7.8	8.2	13.2	11.9	11.9	10.9	11.6	10.4	26.4	28.6	10.3	10.1	9.2	11.5	27.2	30.2	13.0	10.5	11.9	15.3	12.0	27.3	14.0	10.9	7.9	10.1	11.1	7.9	16.9	8.2	13.3	23.1	12.0	11.3	69.3	32.3	22.1	11.3	4.7	14.0	13.6	9.7	12.2	7.3	58.2	8.1	10.0	11.9	6.0	13.3	8.9	14.2	28.1	15.2	17.2	7.9	13.1	15.3	13.1	15.3	6.9	11.4	8.5	16.7	16.9	14.7	8.0	14.3	13.8	16.8	14.7	12.7	12.0	8.4	6.0	17.6	11.4	18.0	11.9	25.7	11.1	20.9	12.7	22.5	20.3	11.8	34.8	14.5	25.2	42.2	8.7	11.7	7.6	9.7	13.7	15.6	18.4	18.9	20.7	20.8	14.4	14.8	22.3	13.8	19.6	8.3	8.0	14.7	24.2	17.6	23.0	12.2	38.2	37.6	20.9	9.5	11.8	18.0	11.2	8.1	26.0	11.9	5.5	7.1	12.2	9.0	8.9	7.3	11.6	8.5	9.7	58.2	10.0	6.2	6.4	10.1	6.0	24.8	27.6	28.4	38.7	26.4	28.6	27.2	30.2	27.3	32.3	26.8	28.5	33.3	51.2	189.1	70.3	20.1	33.1	48.2	27.3	22.7	47.1	40.1	23.2	44.1	1076.1	52.5	12.9	0.0	40.5	30.6	44.1	65.7	40.4	25.1	41.0	117.6	27.6	43.0	45.7	1865.0	71.1	31.8	55.6	40.5	32.1	65.3	32.7	21.0	90.2	21.7	65.2	45.3	45.3	237.2	50.3	90.3	53.9	56.8	23.6	46.7
SRPK3	"MSSK1, STK23"	ENSG00000184343	"SRSF protein kinase 3"	Q9UPE1	X	153776412-153785732	"Enzymes, Predicted intracellular proteins"	"Differentiation, Myogenesis"	"Developmental protein, Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"skeletal muscle: 73.4"	"Group enriched"	"Detected in some"	6	"Cardiomyocytes: 23.8;Cone photoreceptor cells: 7.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in single"		"plasmacytoid DC: 2.6"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"RH-30: 31.4;U-266/70: 13.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"									NA	NA						"unprognostic (1.79e-3)"	"unprognostic (6.21e-2)"	"unprognostic (1.79e-2)"	"unprognostic (7.24e-2)"	"unprognostic (1.44e-1)"	"unprognostic (2.51e-1)"	"unprognostic (1.97e-1)"	"unprognostic (4.47e-4)"	"unprognostic (2.83e-1)"	"unprognostic (1.71e-1)"	"unprognostic (4.10e-4)"	"unprognostic (8.70e-2)"	"unprognostic (5.38e-7)"	"unprognostic (1.97e-2)"	"unprognostic (1.97e-1)"	"unprognostic (3.83e-2)"	"unprognostic (1.07e-4)"	1.6	1.8	1.3	0.9	1.8	0.8	0.3	7.7	1.5	0.9	4.5	1.1	0.2	1.3	2.5	3.3	2.6	0.7	1.7	16.7	2.0	1.8	0.2	0.2	0.4	0.8	2.0	0.7	0.7	0.7	1.0	5.8	0.3	1.1	2.8	0.8	0.9	2.9	0.5	73.4	2.3	1.3	4.0	2.0	0.8	1.3	0.5	0.9	0.3	0.6	18.3	1.6	2.0	0.8	0.4	2.6	0.9	0.3	0.1	0.6	0.3	3.2	4.4	0.8	2.2	0.0	0.1	1.0	0.4	0.0	0.2	0.0	3.7	0.6	3.3	0.4	0.4	0.3	0.9	0.0	0.1	0.0	2.8	3.1	1.7	2.7	0.6	0.0	0.8	5.1	2.8	0.0	0.0	0.0	0.2	0.0	4.7	2.2	3.9	0.9	7.0	0.6	4.8	0.8	0.2	1.2	1.5	31.4	0.9	0.0	1.5	5.3	2.5	0.0	2.3	1.0	0.3	2.9	3.8	0.1	1.2	2.8	2.3	0.4	13.0	2.1	2.2	0.6	6.2	1.6	0.8	0.3	0.2	0.5	0.1	0.6	0.2	0.1	0.1	0.0	0.4	0.1	0.1	0.9	0.1	0.0	2.6	0.0	0.3	1.3	1.8	7.7	1.5	2.0	1.8	2.0	0.7	1.1	0.9	0.0	0.0	0.0	1.0	0.6	2.2	23.8	0.0	0.0	0.0	0.0	7.9	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.8	0.0	0.0	0.0	1.6	1.2	0.0	0.0	0.0	0.3	0.0	0.0	0.0	2.4	0.7	0.0	0.0	2.8	0.0	0.2	0.0	2.7	0.0	0.1	0.4	0.0	0.0	0.2	0.3
SRR	"ILV1, ISO1"	ENSG00000167720	"Serine racemase"	Q9GZT4	17	2303383-2325260	"Enzymes, Predicted intracellular proteins"		"Allosteric enzyme, Isomerase, Lyase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007529, CAB015343"	Approved		Approved	Vesicles		NA	NA			Vesicles		"CAB015343: AB_2195009, HPA007529: AB_2667853"	"unprognostic (2.96e-1)"	"unprognostic (7.86e-2)"	"unprognostic (6.01e-2)"	"prognostic favorable (6.20e-5)"	"unprognostic (3.05e-1)"	"unprognostic (1.57e-2)"	"unprognostic (4.32e-2)"	"unprognostic (9.97e-2)"	"unprognostic (9.09e-2)"	"unprognostic (4.85e-2)"	"prognostic favorable (8.16e-4)"	"unprognostic (5.17e-2)"	"prognostic favorable (2.45e-6)"	"unprognostic (6.14e-2)"	"unprognostic (1.99e-1)"	"unprognostic (1.89e-1)"	"unprognostic (5.84e-2)"	11.6	12.6	17.1	7.7	14.7	13.9	16.7	12.2	24.9	8.4	10.4	13.9	11.4	7.9	10.9	11.3	12.9	10.0	9.6	12.6	15.2	13.0	10.3	9.0	10.9	7.0	12.6	15.6	9.8	14.8	11.0	9.7	6.5	12.4	9.6	8.8	10.6	11.9	9.3	16.9	13.4	7.5	15.0	13.2	7.3	9.2	13.8	9.0	13.4	13.8	6.1	6.0	12.1	7.3	9.7	15.5	5.2	12.6	13.9	13.5	8.7	7.3	13.5	24.4	9.1	13.3	14.1	11.9	15.7	9.8	10.4	10.8	12.4	9.3	13.9	2.1	16.2	7.7	15.6	6.7	5.8	13.3	16.1	13.1	7.2	9.9	4.7	13.4	2.0	4.0	11.9	5.9	23.2	11.2	12.1	15.2	14.8	7.4	10.2	23.1	4.3	14.2	2.7	5.1	7.0	10.1	23.5	27.7	6.4	12.0	3.4	4.8	12.3	13.6	1.7	7.1	8.3	10.7	5.0	11.9	11.2	7.9	12.7	9.3	9.0	12.2	2.5	20.0	6.7	15.2	2.4	8.2	5.2	9.5	8.7	9.9	9.7	12.3	10.1	15.5	8.9	10.4	13.5	1.0	13.9	12.6	10.4	8.9	8.7	17.1	14.7	12.2	24.9	15.2	13.0	12.6	15.6	12.4	9.0	3.0	3.0	1.4	3.9	2.6	7.6	3.6	0.0	5.3	3.4	1.8	0.0	4.2	11.6	8.3	1.1	3.2	2.2	0.0	6.0	3.1	4.6	2.4	0.0	2.6	8.0	15.9	1.7	8.0	3.2	1.0	3.7	3.6	5.0	13.6	2.8	10.8	5.8	0.0	4.9	4.9	5.3	0.0	3.8	14.0	4.7	2.0	2.9	2.5	3.1	2.0
SRXN1	"C20orf139, dJ850E9.2, Npn3, SRX1, YKL086W"	ENSG00000271303	"Sulfiredoxin 1"	Q9BYN0	20	646615-653370	"Enzymes, Predicted intracellular proteins"		"Antioxidant, Oxidoreductase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"	11	"Ductal cells: 4.2;Enterocytes: 2.6;Exocrine glandular cells: 5.7;monocytes: 2.8;Pancreatic endocrine cells: 6.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	4	"neutrophil: 12.8"	"Lineage enriched"	"Detected in many"	4	"granulocytes: 12.8"	"Cell line enhanced"	"Detected in many"		"GAMG: 59.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA						"unprognostic (7.31e-3)"	"unprognostic (6.08e-3)"	"unprognostic (2.50e-1)"	"unprognostic (5.49e-2)"	"unprognostic (1.70e-2)"	"unprognostic (1.18e-3)"	"prognostic unfavorable (6.22e-5)"	"unprognostic (1.37e-3)"	"unprognostic (1.69e-1)"	"unprognostic (1.58e-2)"	"unprognostic (5.26e-2)"	"unprognostic (2.48e-1)"	"unprognostic (7.71e-2)"	"unprognostic (1.79e-2)"	"unprognostic (7.57e-2)"	"unprognostic (1.57e-2)"	"unprognostic (1.52e-3)"	13.4	34.3	12.2	8.0	14.3	15.7	22.1	12.3	18.6	10.2	11.3	5.2	8.4	14.3	10.4	12.8	34.8	12.8	13.0	33.0	11.4	13.5	17.4	35.6	16.2	11.7	14.4	14.3	14.3	11.9	15.4	13.6	12.3	16.7	13.2	12.6	12.0	14.1	15.8	25.4	6.3	10.6	15.5	9.0	9.0	16.9	6.3	8.8	1.5	22.2	40.3	11.6	17.3	22.6	0.5	1.1	12.8	2.2	0.5	2.8	0.4	26.6	45.4	3.0	5.8	13.0	14.5	6.8	19.2	15.0	13.7	8.1	15.6	14.6	4.8	12.3	30.5	59.6	13.5	11.6	30.4	13.3	5.1	6.5	18.5	10.2	47.2	17.6	8.1	11.6	9.3	28.5	18.4	18.1	11.2	14.8	6.7	16.8	19.2	15.0	7.9	0.0	4.6	5.8	40.6	17.1	0.0	3.9	9.9	9.6	9.5	3.8	7.2	14.8	32.2	22.3	8.3	11.3	4.7	14.5	19.0	13.2	17.2	26.8	5.4	13.5	3.9	12.1	4.0	15.1	2.2	2.2	3.0	2.3	1.9	1.6	0.5	1.2	2.8	1.1	0.0	0.0	0.7	12.8	0.5	1.9	0.1	1.1	0.4	12.2	14.3	12.3	18.6	11.4	13.5	14.4	14.3	16.7	8.8	0.0	0.0	0.0	0.0	0.1	0.7	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	4.2	0.0	0.0	2.6	0.0	5.7	0.2	0.0	0.1	0.0	0.4	0.8	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	2.8	1.4	0.2	6.4	0.0	0.4	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0
SSH1	KIAA1298	ENSG00000084112	"Slingshot protein phosphatase 1"	Q8WYL5	12	108778192-108857590	"Enzymes, Predicted intracellular proteins"		"Actin-binding, Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"WM-115: 34.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA019845	Uncertain		Uncertain	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Plasma membrane"	"Nucleoplasm, Cytosol"	"HPA019845: AB_1857497"	"unprognostic (1.18e-3)"	"unprognostic (3.00e-1)"	"unprognostic (2.49e-1)"	"unprognostic (2.70e-2)"	"unprognostic (9.40e-2)"	"unprognostic (7.45e-2)"	"prognostic unfavorable (5.80e-5)"	"unprognostic (3.28e-2)"	"unprognostic (3.69e-2)"	"unprognostic (1.72e-3)"	"unprognostic (7.12e-2)"	"unprognostic (3.42e-1)"	"unprognostic (1.71e-2)"	"unprognostic (1.41e-1)"	"unprognostic (8.66e-2)"	"unprognostic (9.55e-2)"	"unprognostic (6.22e-2)"	7.3	7.8	8.5	7.4	8.1	10.6	9.3	20.3	8.8	7.4	8.5	6.8	13.1	4.4	9.8	7.9	7.6	8.2	8.3	10.1	8.0	6.9	5.8	7.4	10.1	8.7	7.7	5.2	7.9	8.0	9.7	6.8	7.8	8.4	6.5	6.5	15.0	5.9	8.0	21.4	7.1	6.5	10.4	8.1	8.6	7.1	5.2	6.6	2.0	7.0	7.9	6.6	10.0	13.3	1.8	2.0	5.7	4.0	2.1	2.9	1.2	5.1	6.8	4.5	3.5	8.5	7.3	4.0	6.6	14.2	6.1	5.4	3.4	2.5	2.4	4.7	15.5	10.4	5.1	2.7	11.2	5.0	5.0	2.6	5.7	3.1	2.1	4.6	2.9	15.2	10.0	3.8	5.5	12.3	15.1	5.6	3.0	1.3	2.0	15.9	2.9	3.3	4.2	3.1	2.0	5.5	2.4	5.3	3.2	2.4	9.2	3.3	4.5	5.8	1.6	12.8	6.5	2.1	2.6	4.4	10.9	4.7	6.5	3.8	3.9	3.5	3.0	5.7	2.4	34.4	4.2	2.4	4.8	2.9	4.0	2.7	1.6	1.5	2.5	1.6	1.8	1.4	1.6	5.7	2.1	3.2	2.0	1.7	1.2	8.5	8.1	20.3	8.8	8.0	6.9	7.7	5.2	8.4	6.6	8.9	17.3	4.7	15.4	8.4	10.6	21.2	12.7	8.1	14.8	14.0	15.7	4.7	5.0	7.7	1.6	37.5	3.5	0.0	7.0	3.7	10.3	7.2	19.7	13.4	11.2	11.1	5.2	25.8	24.7	2.6	6.1	17.8	11.8	43.3	6.6	8.8	10.1	0.0	12.0	4.9	20.7	6.5	17.6	1.1	6.6	7.9	1.9	15.4	5.7	12.2
SSH2	KIAA1725	ENSG00000141298	"Slingshot protein phosphatase 2"	Q76I76	17	29625938-29930276	"Enzymes, Predicted intracellular proteins"		"Actin-binding, Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 59.6"	"Cell type enhanced"	"Detected in many"	4	"Kupffer cells: 119.4;Late spermatids: 117.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"eosinophil: 37.8"	"Lineage enriched"	"Detected in all"	5	"granulocytes: 37.8"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB017189, HPA057099"	Uncertain					NA	NA					"CAB017189: , HPA057099: AB_2683336"	"unprognostic (1.45e-1)"	"unprognostic (1.57e-1)"	"unprognostic (3.56e-2)"	"unprognostic (1.27e-2)"	"unprognostic (1.44e-1)"	"unprognostic (1.53e-1)"	"unprognostic (3.00e-3)"	"unprognostic (7.05e-2)"	"unprognostic (1.14e-1)"	"unprognostic (6.80e-2)"	"unprognostic (9.80e-3)"	"unprognostic (7.52e-2)"	"unprognostic (1.48e-2)"	"unprognostic (8.28e-2)"	"unprognostic (7.70e-2)"	"unprognostic (2.74e-1)"	"unprognostic (1.86e-1)"	12.3	7.7	15.8	19.0	16.0	43.1	7.9	23.9	18.0	6.8	10.6	17.5	8.8	7.4	6.1	8.5	9.4	6.5	7.9	12.0	12.9	8.4	10.8	9.8	15.1	20.9	13.6	12.4	3.7	11.8	6.4	6.5	8.8	10.6	5.1	10.0	7.9	8.6	11.6	59.6	10.5	14.5	6.9	12.6	21.3	10.3	26.1	15.2	22.7	10.7	9.5	19.9	7.8	6.5	7.9	4.0	37.8	4.5	1.4	5.9	1.8	12.0	9.8	6.3	5.4	17.4	11.9	3.7	6.0	6.8	9.9	10.5	5.3	4.5	10.0	9.6	7.1	6.6	14.0	7.7	8.7	11.5	3.5	13.7	6.9	10.0	7.7	8.2	7.4	15.0	14.0	5.8	10.5	7.0	4.9	22.6	17.8	4.9	7.8	6.9	3.4	34.8	7.5	4.7	4.6	5.1	16.7	15.9	17.5	17.1	9.4	10.6	11.8	8.7	9.7	17.3	8.9	6.4	7.8	12.4	6.7	13.8	11.8	7.2	11.9	7.8	25.0	8.0	5.9	6.2	11.0	3.8	37.8	3.5	4.5	2.9	7.5	4.4	3.5	4.0	7.9	4.1	3.0	9.6	1.4	3.8	2.6	5.9	1.8	15.8	16.0	23.9	18.0	12.9	8.4	13.6	12.4	10.6	15.2	8.9	36.3	54.0	11.9	35.1	12.4	22.6	10.2	12.0	13.6	15.7	25.5	18.7	21.6	14.9	77.6	21.9	36.6	0.0	30.8	18.1	14.6	14.0	11.6	24.1	20.1	19.1	34.0	22.1	119.4	117.3	11.2	43.4	33.7	19.0	31.7	6.8	31.7	27.4	7.8	39.3	20.1	6.5	14.4	41.9	16.4	31.7	15.2	40.3	22.3	20.4
SSH3	"FLJ10928, FLJ20515"	ENSG00000172830	"Slingshot protein phosphatase 3"	Q8TE77	11	67303448-67312607	"Enzymes, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"basophil: 10.8;eosinophil: 10.5"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 10.8"	"Cell line enhanced"	"Detected in many"		"HaCaT: 23.8;RT4: 36.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA019949, HPA019957"	Approved		Approved	"Nuclear speckles,Plasma membrane,Actin filaments,Cytosol"		NA	NA			"Nuclear speckles, Cytosol"	"Plasma membrane, Actin filaments"	"HPA019949: AB_1857498, HPA019957: AB_1857499"	"unprognostic (4.38e-2)"	"unprognostic (1.37e-1)"	"unprognostic (3.50e-3)"	"unprognostic (3.73e-2)"	"unprognostic (2.61e-3)"	"unprognostic (9.30e-2)"	"unprognostic (2.99e-1)"	"unprognostic (1.84e-1)"	"unprognostic (1.63e-1)"	"unprognostic (2.45e-2)"	"prognostic unfavorable (2.89e-4)"	"unprognostic (1.50e-1)"	"unprognostic (2.06e-2)"	"unprognostic (1.47e-1)"	"unprognostic (3.20e-1)"	"unprognostic (4.94e-3)"	"unprognostic (6.78e-3)"	8.6	5.5	5.6	6.8	9.7	8.1	13.5	17.8	9.4	14.6	15.9	15.4	19.5	12.4	10.1	10.6	27.0	15.2	20.5	7.7	6.0	6.1	10.3	7.5	9.0	3.5	13.6	5.4	17.1	12.0	11.3	7.4	20.0	8.5	19.8	9.2	11.9	19.1	30.5	5.2	18.2	13.6	13.1	9.3	6.9	13.9	4.2	9.7	0.8	12.8	14.0	13.2	33.3	18.6	0.3	1.6	10.8	2.3	1.5	2.2	1.0	6.2	6.7	0.1	0.2	4.8	4.9	7.4	4.1	5.4	2.1	2.0	7.3	16.5	0.3	12.6	3.7	4.5	23.8	2.2	17.2	1.2	1.3	2.5	1.6	10.9	2.9	3.3	0.3	6.1	4.3	15.9	3.1	3.3	5.0	2.4	0.1	0.0	0.6	2.5	21.0	0.2	3.0	1.5	17.0	5.4	7.7	0.2	1.1	7.0	36.0	1.4	2.2	9.5	14.1	4.4	2.6	19.8	5.2	3.9	1.7	3.7	4.8	1.1	0.7	0.3	0.2	4.9	2.7	1.6	10.8	1.4	10.5	2.2	2.3	1.7	0.3	2.1	1.8	1.6	0.2	0.8	0.9	4.5	1.5	1.1	1.1	1.8	1.0	5.6	9.7	17.8	9.4	6.0	6.1	13.6	5.4	8.5	9.7	3.0	5.4	0.0	20.7	6.3	1.1	3.4	15.3	8.1	10.3	15.7	0.0	12.6	3.3	16.4	0.0	3.9	17.2	0.0	19.0	20.2	6.2	13.1	3.5	4.3	6.8	1.6	3.5	4.3	8.6	0.0	12.0	2.9	8.5	12.6	14.7	4.6	16.4	17.5	11.3	6.3	0.4	0.0	8.3	0.3	0.0	9.2	13.2	4.3	18.5	22.9
SSU72	HSPC182	ENSG00000160075	"SSU72 homolog, RNA polymerase II CTD phosphatase"	Q9NP77	1	1541673-1574869	"Enzymes, Predicted intracellular proteins"	"mRNA processing"	"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Late spermatids: 520.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA069290, HPA070604"	Supported		Approved	Nucleoplasm,Cytosol		No	No			"Nucleoplasm, Cytosol"		"HPA069290: AB_2686108, HPA070604: AB_2686285"	"unprognostic (3.33e-2)"	"unprognostic (2.79e-2)"	"unprognostic (6.37e-2)"	"unprognostic (2.27e-2)"	"unprognostic (2.41e-1)"	"unprognostic (9.84e-2)"	"unprognostic (2.40e-3)"	"unprognostic (2.43e-2)"	"unprognostic (3.23e-1)"	"unprognostic (3.23e-1)"	"unprognostic (6.75e-2)"	"unprognostic (1.36e-1)"	"unprognostic (6.56e-3)"	"unprognostic (1.19e-1)"	"unprognostic (8.51e-2)"	"unprognostic (3.77e-1)"	"unprognostic (1.06e-1)"	44.1	32.5	48.0	33.6	51.5	29.3	73.9	42.3	51.5	37.2	40.1	25.4	39.3	41.3	32.6	51.8	45.7	46.2	35.3	44.4	40.7	42.5	38.0	50.9	37.5	49.0	39.4	39.0	38.0	61.8	33.9	39.9	35.8	36.9	33.9	35.9	34.1	54.2	35.8	107.1	36.9	40.8	35.4	35.0	41.7	38.5	28.0	28.4	37.0	50.9	45.3	36.3	30.8	42.2	35.5	30.1	62.0	28.8	20.7	46.5	28.1	41.4	26.6	19.2	29.6	33.1	32.0	19.7	36.1	28.2	31.5	32.9	24.9	48.2	42.2	19.8	28.4	30.8	32.4	31.0	29.7	30.8	35.1	36.6	26.5	23.3	39.3	37.5	33.5	23.2	28.5	25.1	33.7	32.2	26.5	29.4	25.7	45.8	32.7	24.9	36.9	38.3	53.8	33.6	40.9	40.4	30.5	31.0	59.0	34.5	12.8	35.6	24.4	24.4	62.7	106.5	34.0	32.7	29.2	22.4	30.4	19.3	34.2	30.9	39.9	47.9	52.7	31.8	53.4	14.7	37.1	28.3	53.6	25.9	28.8	31.9	35.5	34.4	30.7	30.1	33.1	42.2	34.1	62.0	20.7	25.4	19.0	46.5	28.1	48.0	51.5	42.3	51.5	40.7	42.5	39.4	39.0	36.9	28.4	26.8	71.4	136.9	121.9	165.4	98.0	80.5	117.2	36.1	37.5	96.0	19.6	178.0	247.1	62.6	202.0	95.1	177.2	0.0	92.6	189.0	93.0	151.4	60.0	123.8	125.1	106.5	136.4	90.9	152.3	520.2	97.0	118.3	158.6	91.0	137.9	96.8	78.9	168.6	80.6	258.7	57.5	58.2	97.3	81.2	147.4	192.6	205.2	116.7	134.0	129.8
ST14	"HAI, MT-SP1, PRSS14, SNC19, TMPRSS14"	ENSG00000149418	"Suppression of tumorigenicity 14"	Q9Y5Y6	11	130159562-130210376	"Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted membrane proteins"		"Hydrolase, Protease, Serine protease"	"Cancer-related genes, Disease mutation, Hypotrichosis, Ichthyosis"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 94.1"	"Cell type enhanced"	"Detected in many"	7	"Enterocytes: 295.9;Mucus-secreting cells: 176.7;Paneth cells: 178.5;Urothelial cells: 230.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in many"	4	"plasmacytoid DC: 18.2"	"Lineage enriched"	"Detected in many"	5	"dendritic cells: 18.2"	"Cell line enhanced"	"Detected in some"		"CACO-2: 36.0;CAPAN-2: 72.5;HaCaT: 50.8;OE19: 38.5;RPMI-8226: 47.5;SK-BR-3: 33.6;T-47d: 50.8;U-698: 34.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			HPA047014			Approved	Nucleoplasm,Vesicles		NA	NA		220000	"Nucleoplasm, Vesicles"		"HPA047014: AB_2679902"	"unprognostic (1.17e-1)"	"unprognostic (1.15e-1)"	"unprognostic (9.62e-2)"	"unprognostic (1.32e-1)"	"unprognostic (2.17e-2)"	"unprognostic (7.94e-2)"	"unprognostic (1.20e-1)"	"unprognostic (3.97e-2)"	"unprognostic (5.29e-1)"	"unprognostic (3.21e-1)"	"unprognostic (1.03e-3)"	"unprognostic (2.25e-1)"	"prognostic favorable (5.03e-11)"	"unprognostic (1.92e-2)"	"unprognostic (2.71e-1)"	"unprognostic (1.28e-2)"	"unprognostic (5.60e-2)"	10.1	1.8	0.7	21.9	1.8	0.5	5.5	0.8	1.4	8.9	48.6	0.5	23.8	33.8	2.8	16.9	38.9	9.7	32.4	1.1	0.5	0.5	30.5	3.2	9.5	7.5	1.8	0.6	3.6	34.3	8.4	9.5	12.7	1.5	12.1	15.4	0.7	25.1	15.8	0.7	17.8	94.1	1.2	1.8	4.0	16.7	2.1	1.5	5.2	24.0	20.1	28.4	8.3	14.9	3.8	18.2	2.3	2.7	0.0	0.1	0.8	26.4	0.0	0.0	0.1	0.0	0.0	14.4	0.0	0.0	0.0	0.0	36.0	72.5	26.1	2.7	0.0	0.0	50.8	0.0	16.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	3.4	0.1	0.0	8.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	20.4	0.0	0.1	0.2	38.5	0.1	0.0	0.0	47.5	4.7	21.7	2.9	0.0	0.2	33.6	0.0	0.2	50.8	5.1	0.0	0.0	0.4	0.1	0.1	0.0	0.0	34.6	0.0	8.0	0.0	0.0	2.7	2.3	0.0	1.5	0.1	3.8	0.0	0.0	4.5	2.3	0.0	0.0	0.3	0.0	0.2	18.2	0.0	0.8	0.7	1.8	0.8	1.4	0.5	0.5	1.8	0.6	1.5	1.5	29.8	25.8	9.3	31.0	36.4	0.0	0.8	38.2	17.4	20.5	59.3	0.0	40.3	3.3	108.8	27.9	0.4	295.9	0.0	80.1	11.6	2.6	89.5	11.5	1.9	60.1	0.0	118.5	0.0	25.4	11.5	1.7	19.0	6.8	8.2	176.7	0.0	114.4	178.5	0.7	10.5	0.0	6.5	1.4	0.2	0.1	38.3	33.2	1.3	155.8	230.3
ST3GAL1	"SIAT4A, SIATFL, ST3GalA.1, ST3O"	ENSG00000008513	"ST3 beta-galactoside alpha-2,3-sialyltransferase 1"	Q11201	8	133454848-133571940	"Enzymes, Predicted intracellular proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Hepatocytes: 143.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"PC-3: 47.7;RT4: 36.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA040466	Approved				"Intracellular and membrane"	NA	NA		290000			"HPA040466: AB_10805712"	"unprognostic (1.36e-2)"	"unprognostic (1.11e-2)"	"unprognostic (6.66e-2)"	"unprognostic (1.83e-3)"	"unprognostic (5.53e-3)"	"unprognostic (4.43e-2)"	"unprognostic (4.79e-2)"	"unprognostic (2.66e-1)"	"unprognostic (1.97e-1)"	"unprognostic (1.04e-1)"	"unprognostic (3.55e-3)"	"unprognostic (1.10e-1)"	"unprognostic (1.83e-3)"	"unprognostic (1.67e-2)"	"unprognostic (3.29e-2)"	"unprognostic (8.64e-3)"	"unprognostic (2.95e-2)"	14.4	14.4	5.1	11.8	3.6	10.2	7.8	3.7	6.5	9.8	5.4	4.1	18.1	1.8	8.5	11.8	9.0	9.0	17.0	35.4	4.2	3.4	23.1	44.5	11.9	12.4	4.7	2.5	10.3	8.2	4.4	7.6	49.8	6.4	7.1	2.9	11.2	18.2	15.1	20.9	4.0	6.5	12.3	3.9	17.3	9.4	5.0	1.4	6.3	40.2	7.9	16.8	14.0	14.3	22.7	7.0	21.3	9.8	21.9	19.9	9.5	4.7	2.5	1.0	2.9	10.3	5.4	5.3	5.4	13.1	2.1	1.6	4.4	5.3	1.1	3.7	9.9	1.0	1.4	3.4	4.0	1.9	13.3	0.6	9.9	7.6	8.8	7.9	2.0	7.9	6.3	2.0	7.5	4.2	9.7	9.2	2.6	0.1	15.3	1.5	5.0	2.8	2.7	0.7	25.6	47.7	3.3	1.3	8.1	0.9	36.7	0.2	0.8	2.4	8.2	2.5	5.8	1.5	2.7	8.9	6.5	10.3	5.6	2.3	18.9	13.6	1.2	14.7	6.9	6.6	20.5	4.7	21.3	14.4	4.5	13.3	12.8	14.6	16.4	2.9	22.7	19.9	18.5	8.6	21.9	9.8	7.0	8.9	9.5	5.1	3.6	3.7	6.5	4.2	3.4	4.7	2.5	6.4	1.4	6.0	58.6	36.0	6.4	5.0	7.4	59.9	12.7	8.1	21.6	1.8	2.0	8.2	5.0	34.3	2.8	41.9	0.0	23.3	21.6	34.2	37.0	10.6	8.1	143.6	32.3	57.2	0.0	33.7	44.5	0.9	33.9	42.2	13.5	78.5	0.4	10.1	25.8	0.0	67.5	39.3	21.7	12.9	32.2	0.2	1.9	3.0	22.1	43.7	0.0	37.3
ST3GAL2	"SIAT4B, ST3GalA.2, ST3GALII"	ENSG00000157350	"ST3 beta-galactoside alpha-2,3-sialyltransferase 2"	Q16842	16	70375978-70439237	"Enzymes, Predicted membrane proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Erythroid cells: 46.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HMC-1: 28.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA017270	Approved		Approved	Vesicles	"Intracellular and membrane"	NA	NA			Vesicles		"HPA017270: AB_1857523"	"unprognostic (2.76e-2)"	"unprognostic (6.33e-2)"	"unprognostic (3.41e-1)"	"unprognostic (1.35e-1)"	"unprognostic (4.99e-1)"	"unprognostic (1.01e-1)"	"prognostic unfavorable (2.79e-4)"	"unprognostic (1.14e-2)"	"unprognostic (2.21e-1)"	"unprognostic (1.91e-2)"	"prognostic favorable (2.33e-4)"	"unprognostic (9.54e-2)"	"prognostic unfavorable (3.34e-6)"	"unprognostic (7.42e-2)"	"unprognostic (8.83e-3)"	"unprognostic (4.64e-2)"	"unprognostic (5.20e-2)"	12.6	9.1	9.3	17.2	11.9	14.3	8.9	24.1	10.6	11.3	8.8	5.1	9.3	9.2	13.9	5.6	5.8	9.0	6.8	9.2	10.4	6.0	8.8	12.9	9.3	14.9	5.1	4.7	13.6	4.2	8.8	7.2	8.8	6.8	7.5	4.7	9.9	4.9	9.0	33.3	6.0	10.5	12.0	4.0	17.7	5.4	9.6	5.9	16.0	6.6	4.9	12.6	9.1	12.0	3.2	14.3	11.2	2.2	2.8	4.2	1.1	1.4	8.5	7.4	9.8	4.0	5.4	1.7	6.0	6.4	6.7	3.3	5.1	3.3	4.1	10.8	6.5	6.0	1.0	2.9	2.5	3.2	9.7	4.7	17.5	3.5	7.6	4.9	6.4	28.9	4.1	1.4	6.8	1.2	8.2	9.2	7.1	23.9	4.0	3.7	0.7	6.7	17.5	10.0	2.8	4.6	12.9	2.8	5.5	4.5	1.1	3.3	9.7	15.1	0.3	6.6	8.0	1.6	7.1	9.8	8.5	10.2	3.6	4.4	8.4	3.3	8.4	9.3	5.4	11.9	2.7	2.0	5.7	2.0	2.2	1.9	1.7	2.4	2.2	1.0	3.2	4.2	3.3	11.2	2.8	1.3	14.3	2.7	1.1	9.3	11.9	24.1	10.6	10.4	6.0	5.1	4.7	6.8	5.9	8.9	6.9	13.0	3.6	3.0	15.1	5.6	10.2	1.4	2.3	8.7	13.7	3.7	0.0	5.4	14.0	13.1	5.1	46.7	3.8	1.6	10.6	2.2	17.3	11.5	11.6	17.5	12.7	14.7	10.0	25.8	10.9	14.4	1.7	23.4	4.0	5.1	2.4	0.0	7.8	5.0	10.2	6.5	7.1	5.4	8.1	2.0	1.5	8.6	5.2	1.8
ST3GAL3	"MRT12, SIAT6"	ENSG00000126091	"ST3 beta-galactoside alpha-2,3-sialyltransferase 3"	Q11203	1	43705824-43931165	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"		"Glycosyltransferase, Transferase"	"Disease mutation, Epilepsy, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in all"		"skeletal muscle: 71.5"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA051102	Uncertain				"Intracellular and membrane"	NA	NA					"HPA051102: AB_2681344"	"unprognostic (8.42e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.41e-2)"	"unprognostic (5.18e-2)"	"unprognostic (1.22e-1)"	"unprognostic (3.20e-1)"	"unprognostic (9.72e-2)"	"unprognostic (7.01e-2)"	"unprognostic (4.39e-2)"	"unprognostic (2.33e-2)"	"unprognostic (1.38e-3)"	"unprognostic (7.00e-2)"	"unprognostic (3.68e-3)"	"unprognostic (1.67e-2)"	"unprognostic (1.30e-1)"	"unprognostic (4.35e-1)"	"unprognostic (6.60e-2)"	11.6	9.0	13.0	8.9	16.5	9.9	12.8	15.5	20.4	9.0	10.3	9.0	8.0	3.2	10.8	10.7	8.7	8.3	7.2	16.9	12.8	13.9	6.7	9.1	7.2	7.6	12.0	10.4	13.3	7.5	6.9	10.9	6.7	11.6	8.8	5.1	9.0	8.0	13.9	71.5	7.4	3.8	15.9	7.7	6.0	5.9	14.5	10.3	3.2	8.1	17.8	4.8	8.1	7.0	7.1	7.0	5.8	4.2	4.7	7.6	6.1	2.4	1.9	14.2	6.7	11.2	14.2	1.8	9.3	19.4	8.7	8.4	1.6	4.0	4.5	4.8	11.9	4.8	2.3	1.2	6.1	10.5	5.3	3.2	8.6	6.0	4.6	9.4	3.9	4.3	7.5	4.6	6.4	14.0	16.7	6.8	11.2	5.1	8.4	16.1	1.6	4.0	7.4	5.6	0.6	5.0	6.7	1.9	3.0	7.0	1.6	5.8	8.5	3.7	1.4	8.1	6.0	2.1	18.8	6.5	5.2	2.4	8.5	9.4	6.7	3.8	4.2	7.7	9.4	9.6	2.9	4.2	2.5	6.8	2.5	6.1	4.5	4.4	5.1	3.0	7.1	7.6	5.7	5.8	4.7	3.7	7.0	5.2	6.1	13.0	16.5	15.5	20.4	12.8	13.9	12.0	10.4	11.6	10.3	6.0	20.0	0.9	2.8	3.0	8.5	22.8	2.5	6.7	3.4	3.5	0.0	2.1	5.0	2.6	16.4	7.4	0.2	0.0	2.1	1.2	7.4	2.0	23.1	9.0	2.6	17.5	2.4	4.3	2.4	10.2	3.4	4.6	3.3	3.6	1.2	3.9	2.3	0.0	11.0	5.6	16.1	19.4	7.2	5.2	3.8	1.1	0.8	3.5	1.6	7.9
ST3GAL4	"CGS23, FLJ11867, NANTA3, SAT3, SIAT4, SIAT4C, STZ"	ENSG00000110080	"ST3 beta-galactoside alpha-2,3-sialyltransferase 4"	Q11206	11	126355640-126440344	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"placenta: 74.2"	"Cell type enriched"	"Detected in many"	9	"Syncytiotrophoblasts: 804.9"	"Cancer enhanced"	"Detected in all"		"melanoma: 57.2"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"basophil: 31.3;neutrophil: 22.8;plasmacytoid DC: 29.6"	"Group enriched"	"Detected in many"	11	"dendritic cells: 29.6;granulocytes: 31.3"	"Cell line enhanced"	"Detected in many"		"SK-MEL-30: 45.3;WM-115: 102.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA049827	Approved				"Intracellular and membrane"	NA	NA					"HPA049827: AB_2680900"	"unprognostic (8.89e-2)"	"unprognostic (1.10e-2)"	"unprognostic (4.92e-2)"	"unprognostic (6.93e-2)"	"unprognostic (8.33e-2)"	"unprognostic (3.80e-2)"	"unprognostic (2.71e-3)"	"unprognostic (1.90e-3)"	"unprognostic (2.62e-1)"	"unprognostic (1.80e-2)"	"unprognostic (1.57e-1)"	"unprognostic (1.45e-1)"	"unprognostic (3.16e-3)"	"unprognostic (2.79e-2)"	"unprognostic (1.28e-1)"	"unprognostic (8.36e-3)"	"unprognostic (8.78e-3)"	7.8	38.0	6.2	6.5	12.2	7.8	12.9	4.0	13.6	8.3	27.0	26.4	5.1	2.0	6.0	42.1	25.5	6.0	11.4	26.5	8.6	6.2	16.7	11.5	12.4	9.0	18.7	9.0	39.3	5.1	0.8	5.6	74.2	13.8	12.1	31.5	35.7	14.4	8.0	1.9	5.6	3.8	11.0	23.0	17.0	4.8	18.8	12.4	2.2	6.1	4.3	10.1	21.1	13.2	0.1	29.6	31.3	2.6	1.2	1.7	1.8	4.9	4.1	3.2	2.7	9.5	7.9	8.0	5.7	11.1	5.2	3.6	2.4	8.5	1.4	4.3	9.0	17.7	7.7	6.7	3.7	4.1	5.3	1.9	12.6	10.2	2.7	6.2	15.0	25.8	6.3	6.0	7.8	12.4	9.6	6.9	5.5	7.8	3.8	6.4	20.2	4.7	15.4	2.0	31.9	26.8	4.9	9.9	0.6	1.2	14.2	6.1	3.9	6.3	38.2	45.3	2.2	13.3	10.0	2.5	12.5	2.8	8.8	10.7	0.3	0.8	0.7	5.7	23.0	102.8	31.3	1.6	0.2	1.7	2.6	1.6	0.1	0.6	1.1	6.6	0.0	0.1	0.8	22.8	1.2	1.2	29.6	0.0	1.8	6.2	12.2	4.0	13.6	8.6	6.2	18.7	9.0	13.8	12.4	8.9	1.1	3.7	5.3	9.4	4.2	26.6	7.6	1.4	4.5	29.6	9.8	90.3	41.4	4.3	1.1	9.8	34.8	0.0	5.6	59.0	44.0	13.8	41.5	8.9	16.2	4.8	5.1	36.8	4.1	3.8	70.5	7.2	74.2	10.8	43.5	5.0	7.3	93.0	88.1	3.4	8.3	12.9	23.6	1.4	3.8	5.8	804.9	12.2	8.8	13.1
ST3GAL5	"SIAT9, SIATGM3S, ST3GalV"	ENSG00000115525	"ST3 beta-galactoside alpha-2,3-sialyltransferase 5"	Q9UNP4	2	85837120-85905199	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"		"Glycosyltransferase, Transferase"	"Epilepsy, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adrenal gland: 40.1"	"Cell type enhanced"	"Detected in many"	5	"Alveolar cells type 1: 80.4;Alveolar cells type 2: 105.8"	"Cancer enhanced"	"Detected in all"		"thyroid cancer: 41.7"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"AN3-CA: 26.2;RT4: 22.2;SK-MEL-30: 18.4;U-266/84: 19.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA034708, HPA040425, HPA068928"	Uncertain		Approved	Vesicles		NA	NA			Vesicles		"HPA034708: AB_10601594, HPA040425: AB_2676978, HPA068928: AB_2686060"	"unprognostic (7.90e-2)"	"unprognostic (1.61e-2)"	"unprognostic (3.84e-2)"	"unprognostic (2.93e-2)"	"unprognostic (1.27e-1)"	"unprognostic (1.75e-1)"	"unprognostic (1.12e-2)"	"unprognostic (5.81e-3)"	"unprognostic (1.38e-1)"	"unprognostic (6.45e-2)"	"unprognostic (5.03e-3)"	"unprognostic (3.43e-2)"	"prognostic unfavorable (2.25e-7)"	"unprognostic (2.22e-1)"	"unprognostic (5.74e-2)"	"prognostic favorable (4.99e-4)"	"prognostic favorable (4.48e-4)"	8.0	40.1	15.3	7.2	18.5	4.1	4.2	9.9	34.9	3.3	3.8	18.8	0.0	2.7	8.0	2.9	2.9	4.9	11.8	2.1	14.8	12.0	2.4	7.0	18.0	11.5	14.0	13.4	7.2	2.9	1.5	7.4	24.1	18.1	4.8	5.0	18.7	4.8	2.2	9.5	5.0	3.4	6.2	18.0	11.1	4.1	9.0	13.4	5.5	36.7	0.4	6.9	30.9	7.8	2.5	1.1	1.3	6.1	1.4	1.8	0.5	0.1	12.8	1.2	26.2	10.9	5.9	3.9	2.8	8.6	2.7	2.4	0.2	9.3	0.3	0.1	4.8	1.2	0.5	1.7	3.0	3.4	0.1	1.5	0.2	0.5	0.4	8.7	0.1	3.8	3.3	0.4	1.0	0.4	4.9	6.5	3.5	0.3	14.5	8.8	0.8	0.8	1.4	0.1	4.4	0.0	1.6	8.3	5.1	1.4	22.2	1.8	1.8	0.1	0.0	18.4	2.7	0.1	0.5	2.1	0.0	1.3	0.0	0.2	14.6	19.3	0.2	2.1	2.6	13.2	0.9	1.8	0.1	1.4	6.1	1.8	2.5	0.8	0.9	1.1	1.5	0.7	0.8	1.3	1.4	5.1	0.4	0.3	0.5	15.3	18.5	9.9	21.9	14.8	12.0	14.0	13.4	18.1	13.4	80.4	105.8	40.9	24.7	4.9	49.5	1.6	30.6	14.7	50.0	3.5	55.0	0.3	3.3	8.1	9.5	5.2	0.0	0.0	14.5	0.5	10.3	8.0	33.5	15.5	30.3	68.3	6.4	33.2	46.9	8.7	7.5	25.6	30.4	12.6	0.0	52.2	6.7	0.0	1.8	2.9	41.0	0.0	5.0	6.9	20.0	3.3	0.2	19.7	0.0	5.1
ST6GAL1	SIAT1	ENSG00000073849	"ST6 beta-galactoside alpha-2,6-sialyltransferase 1"	P15907	3	186930485-187078553	"Enzymes, Predicted intracellular proteins, Predicted secreted proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 161.4"	"Cell type enhanced"	"Detected in many"	14	"Collecting duct cells: 225.1;Hepatocytes: 512.9;Ito cells: 264.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Daudi: 32.6;U-266/70: 104.1;U-266/84: 133.1;U-698: 48.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB015018, CAB016122"	Supported				"Secreted to blood"	NA	NA	15000000	580000			"CAB015018: AB_629203, CAB016122: AB_627178"	"unprognostic (5.85e-3)"	"unprognostic (4.19e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.62e-1)"	"unprognostic (2.64e-1)"	"unprognostic (2.44e-2)"	"unprognostic (1.38e-3)"	"unprognostic (3.43e-2)"	"unprognostic (3.17e-1)"	"unprognostic (2.20e-1)"	"unprognostic (3.99e-1)"	"unprognostic (1.43e-1)"	"unprognostic (1.91e-2)"	"unprognostic (7.30e-3)"	"unprognostic (1.25e-1)"	"unprognostic (1.16e-1)"	"unprognostic (1.93e-2)"	10.6	6.5	11.8	16.7	15.4	4.0	10.5	2.8	11.8	19.1	11.4	22.7	4.2	4.3	8.6	4.3	4.4	8.6	5.7	10.6	10.7	7.6	19.1	161.4	10.9	27.6	18.2	7.6	4.5	4.1	20.5	5.7	5.5	13.7	19.5	14.2	5.4	17.7	4.6	5.7	4.5	12.6	5.8	22.3	27.0	8.5	2.4	15.1	19.4	19.4	4.0	41.6	13.2	14.3	33.6	4.6	6.9	8.9	8.5	29.3	16.9	0.7	0.7	3.1	2.3	0.2	0.0	4.8	0.2	0.4	0.1	0.3	0.2	0.2	32.6	2.7	0.0	1.2	1.4	19.2	2.0	0.2	1.6	0.8	1.3	0.1	15.9	0.1	3.0	10.3	0.2	4.1	0.0	1.8	2.8	11.3	3.3	6.6	3.1	1.0	1.4	2.2	2.1	6.9	1.6	1.0	5.3	0.0	1.0	1.4	0.0	5.0	0.5	0.2	3.7	8.5	4.7	5.4	2.2	4.3	0.0	0.4	0.0	0.3	104.1	133.1	48.5	0.1	6.1	11.3	6.9	2.7	1.1	16.5	5.2	15.0	32.7	18.2	13.8	4.6	33.6	29.3	20.2	1.3	8.5	8.9	4.2	14.2	16.9	11.8	15.4	2.8	11.8	10.7	7.6	18.2	7.6	13.7	15.1	41.7	20.6	118.9	14.7	3.5	0.0	22.2	86.6	24.1	44.3	225.1	0.0	0.3	0.0	14.5	0.3	29.9	4.1	23.3	0.8	3.1	1.9	58.6	10.4	512.9	16.4	0.0	90.6	264.6	52.6	0.7	0.3	13.4	6.8	5.4	3.3	0.0	6.7	5.8	0.7	0.5	1.1	0.0	5.1	0.0	0.2	1.4	0.6	20.0	28.1	28.2
ST6GAL2	"KIAA1877, SIAT2, St6gal2, St6GalII"	ENSG00000144057	"ST6 beta-galactoside alpha-2,6-sialyltransferase 2"	Q96JF0	2	106801600-106887108	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 16.7;thyroid gland: 34.0"	"Cell type enhanced"	"Detected in some"	14	"Bipolar cells: 7.7;Ito cells: 2.5;Mucus-secreting cells: 2.3"	"Cancer enriched"	"Detected in many"	7	"thyroid cancer: 16.0"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"A549: 5.7;hTERT-RPE1: 7.2;NTERA-2: 4.9;PC-3: 6.4;RPMI-8226: 10.2;SCLC-21H: 6.8;U-138 MG: 8.3;U-266/70: 10.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA014459	Uncertain		Approved	"Nucleoplasm,Nucleoli fibrillar center"		NA	NA			"Nucleoli fibrillar center"	Nucleoplasm	"HPA014459: AB_1857528"	"unprognostic (2.08e-1)"	"unprognostic (5.80e-2)"	"unprognostic (1.55e-1)"	"unprognostic (4.63e-2)"	"unprognostic (6.44e-3)"	"unprognostic (1.62e-1)"	"unprognostic (2.35e-2)"	"unprognostic (1.10e-2)"	"unprognostic (1.29e-4)"	"unprognostic (4.56e-3)"	"unprognostic (7.04e-2)"	"unprognostic (1.84e-2)"	"unprognostic (7.01e-4)"	"unprognostic (4.70e-4)"	"unprognostic (4.06e-2)"	"unprognostic (2.83e-1)"	"unprognostic (2.07e-2)"	1.2	0.7	14.1	0.7	5.6	1.5	1.3	2.3	16.7	2.1	1.5	4.1	1.7	0.7	3.7	1.9	2.7	1.2	12.7	1.9	5.4	4.0	1.1	3.4	1.2	0.9	3.8	7.1	0.9	0.5	0.5	0.3	2.3	4.2	1.6	3.3	0.0	1.6	1.6	0.7	1.3	0.7	2.8	1.9	0.6	0.9	7.9	1.5	0.0	34.0	1.6	0.8	1.5	1.4	0.7	0.6	1.8	0.5	1.0	0.7	0.5	0.0	5.7	3.1	0.1	0.0	0.0	0.1	0.3	0.0	1.3	0.4	0.1	0.0	0.6	0.1	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.2	0.0	0.3	0.0	0.1	0.0	0.0	1.1	0.0	7.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	4.9	0.0	6.4	0.0	0.0	10.2	0.2	0.0	6.8	4.4	0.0	0.1	0.0	0.3	0.0	0.1	0.0	8.3	0.1	0.2	0.0	10.9	0.2	0.1	0.0	0.0	0.0	1.4	0.5	0.4	0.6	0.3	0.5	0.4	0.4	0.5	0.2	0.7	0.5	0.7	1.8	1.0	0.3	0.6	0.5	0.5	14.1	5.6	2.3	14.8	5.4	4.0	3.8	7.1	4.2	1.5	0.0	0.0	0.0	0.1	0.8	7.7	1.2	0.0	0.0	1.2	1.8	0.0	0.0	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.0	1.2	0.3	0.0	0.0	0.2	0.0	1.2	2.5	0.0	0.0	0.3	0.0	0.0	0.0	2.3	0.8	0.0	0.0	0.7	0.6	0.5	0.0	1.4	0.0	1.3	0.0	0.2	0.0	1.2	0.0
ST6GALNAC1	"SIAT7A, ST6GalNAcI"	ENSG00000070526	"ST6 N-acetylgalactosaminide alpha-2,6-sialyltransferase 1"	Q9NSC7	17	76624761-76643838	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 69.4"	"Cell type enriched"	"Detected in many"	6	"Mucus-secreting cells: 708.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	5	"memory CD4 T-cell: 11.2;naive CD4 T-cell: 4.2"	"Lineage enriched"	"Detected in single"	25	"T-cells: 11.2"	"Group enriched"	"Detected in some"	4	"K-562: 23.7;OE19: 44.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA014767, HPA014975"	Enhanced		Approved	"Nucleoplasm,Golgi apparatus"		NA	NA		1200000	"Golgi apparatus"	Nucleoplasm	"HPA014767: , HPA014975: AB_1857529"	"unprognostic (4.59e-2)"	"unprognostic (8.60e-3)"	"unprognostic (5.32e-3)"	"unprognostic (1.86e-3)"	"unprognostic (6.31e-3)"	"prognostic favorable (2.54e-5)"	"unprognostic (1.39e-2)"	"unprognostic (1.63e-2)"	"unprognostic (2.45e-1)"	"unprognostic (2.58e-2)"	"unprognostic (8.64e-3)"	"unprognostic (2.81e-1)"	"unprognostic (1.67e-1)"	"unprognostic (2.75e-1)"	"unprognostic (1.18e-1)"	"unprognostic (5.87e-3)"	"unprognostic (5.58e-2)"	1.4	0.3	1.2	13.9	2.6	0.7	1.3	0.8	3.2	20.4	50.9	3.1	0.3	19.8	6.3	1.8	19.6	1.5	26.6	4.1	1.6	1.3	0.4	1.1	5.7	1.1	1.8	1.2	2.0	1.1	0.1	0.4	1.7	3.7	2.6	69.4	0.1	20.8	1.4	0.9	0.6	49.0	1.9	1.5	6.0	23.9	4.0	0.6	0.0	0.5	4.5	21.6	1.9	2.6	0.0	0.0	0.4	0.0	0.0	11.2	1.1	0.0	1.1	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	1.4	0.0	4.4	0.0	0.0	4.9	0.0	1.3	0.0	0.0	0.0	7.9	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	23.7	0.0	0.0	0.0	0.1	0.0	0.0	44.4	0.1	0.0	0.0	0.1	0.0	0.3	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	11.2	0.2	0.0	0.0	4.2	0.0	0.4	0.0	0.0	0.0	1.4	1.1	1.2	2.6	0.8	3.2	1.6	1.3	1.8	1.2	3.7	0.6	14.9	6.9	0.0	5.2	0.1	0.0	1.5	30.6	112.4	76.2	0.0	0.0	0.1	0.0	1.6	0.2	14.2	50.8	0.0	16.6	0.1	0.6	3.2	0.0	0.0	0.2	0.0	31.7	4.3	0.0	0.5	1.4	0.3	0.0	0.0	708.1	0.0	27.0	66.2	0.0	0.0	1.1	0.0	0.1	0.3	0.0	0.1	0.1	0.0	108.2	20.7
ST6GALNAC4	"SIAT3C, SIAT7D, ST6GALNACIV"	ENSG00000136840	"ST6 N-acetylgalactosaminide alpha-2,6-sialyltransferase 4"	Q9H4F1	9	127907886-127917038	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 58.8;pancreas: 61.0"	"Cell type enhanced"	"Detected in many"	6	"Intestinal endocrine cells: 65.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	9	"plasmacytoid DC: 58.8"	"Lineage enriched"	"Detected in many"	9	"dendritic cells: 58.8"	"Cell line enhanced"	"Detected in many"		"HDLM-2: 35.5;RPMI-8226: 50.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA009042			Approved	"Nucleoplasm,Golgi apparatus"		NA	NA			"Golgi apparatus"	Nucleoplasm	"HPA009042: AB_1079963"	"unprognostic (2.05e-3)"	"unprognostic (2.32e-1)"	"unprognostic (2.22e-1)"	"unprognostic (1.53e-2)"	"unprognostic (3.18e-1)"	"unprognostic (2.32e-1)"	"prognostic unfavorable (8.63e-7)"	"unprognostic (1.62e-2)"	"unprognostic (4.26e-1)"	"prognostic unfavorable (5.12e-4)"	"unprognostic (1.04e-1)"	"unprognostic (3.04e-1)"	"prognostic unfavorable (8.39e-4)"	"unprognostic (1.30e-3)"	"unprognostic (2.72e-1)"	"unprognostic (2.64e-2)"	"unprognostic (2.03e-2)"	8.0	7.8	5.6	7.9	5.6	26.2	12.1	9.8	8.5	9.2	9.3	4.8	28.9	11.7	8.7	9.6	6.9	8.7	12.2	18.4	5.2	3.4	9.4	5.0	13.5	9.7	4.2	4.7	14.9	61.0	2.4	9.4	4.3	4.8	6.1	5.4	4.8	9.3	30.0	12.6	4.0	9.7	6.1	3.9	18.2	7.2	4.3	4.7	4.7	6.3	5.9	12.5	8.9	8.3	6.7	58.8	0.8	3.2	4.3	3.4	2.4	3.2	5.5	1.4	7.0	9.9	7.6	1.0	5.6	6.2	5.7	3.3	3.1	5.9	20.5	8.5	7.0	8.1	7.9	2.9	5.9	0.9	35.5	2.4	6.5	17.6	11.6	12.1	0.5	6.8	9.2	6.3	5.1	4.6	4.6	15.2	3.9	4.6	13.7	2.7	1.5	1.2	0.7	1.6	10.5	13.6	6.2	3.7	50.3	5.8	0.1	12.0	2.7	8.1	17.6	1.0	0.5	3.6	4.2	10.8	4.7	5.4	14.6	8.7	22.4	11.5	6.4	9.4	2.9	0.6	0.8	2.1	0.0	2.9	1.9	3.3	6.7	1.8	3.4	2.8	4.9	2.3	3.1	0.2	4.3	3.2	58.8	3.3	2.4	5.6	5.6	9.8	8.5	5.2	3.4	4.2	4.7	4.8	4.7	8.9	24.5	43.4	11.9	1.9	2.4	10.3	10.2	5.3	4.5	1.8	0.0	0.9	1.7	14.0	0.1	10.8	19.6	23.3	12.5	14.4	11.9	2.0	8.1	1.5	22.1	0.0	65.1	4.9	11.4	0.0	16.1	8.5	6.8	12.6	13.1	14.1	11.9	6.5	40.3	17.3	1.7	12.9	8.9	0.2	1.3	2.8	3.8	10.2	16.4	10.0
ST8SIA1	"SIAT8, SIAT8A"	ENSG00000111728	"ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 1"	Q92185	12	22063773-22437041	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Lipid metabolism, Sphingolipid metabolism"	"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 20.2"	"Cell type enhanced"	"Detected in many"	10	"Cone photoreceptor cells: 43.2;granulocytes: 32.4;Muller glia cells: 41.7"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Group enriched"	"Detected in many"	5	"granulocytes: 1.2;T-cells: 3.0"	"Cell line enhanced"	"Detected in some"		"AF22: 9.1;ASC TERT1: 6.0;hTERT-RPE1: 4.2;RPTEC TERT1: 4.6;SK-MEL-30: 8.3;WM-115: 9.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA026775	Approved					NA	NA					"HPA026775: AB_1857534"	"unprognostic (1.98e-1)"	"unprognostic (5.76e-3)"	"unprognostic (1.79e-1)"	"unprognostic (9.58e-2)"	"unprognostic (2.89e-1)"	"unprognostic (6.44e-3)"	"unprognostic (1.76e-2)"	"unprognostic (1.07e-2)"	"unprognostic (3.07e-1)"	"unprognostic (1.99e-1)"	"unprognostic (6.37e-3)"	"unprognostic (2.80e-2)"	"unprognostic (1.07e-8)"	"unprognostic (1.10e-1)"	"unprognostic (1.95e-1)"	"unprognostic (5.28e-2)"	"unprognostic (3.16e-2)"	1.7	7.6	7.0	5.3	6.2	2.3	5.9	20.2	13.0	3.5	5.4	2.3	2.3	0.4	4.5	1.4	3.0	2.3	2.4	4.4	7.6	8.5	1.1	0.6	3.8	8.6	7.6	6.5	2.6	1.2	7.2	0.6	0.4	9.4	6.6	3.5	1.5	3.2	4.4	1.0	4.3	2.1	6.3	10.9	2.7	2.1	1.0	4.8	0.2	1.4	0.5	9.2	6.7	3.1	0.3	0.2	1.2	0.2	0.3	3.0	0.6	0.1	0.5	9.1	0.0	1.4	6.0	0.9	0.0	0.0	0.1	0.4	0.3	0.1	1.1	0.0	0.0	0.2	0.4	0.0	0.2	0.6	0.0	0.0	1.1	0.1	0.1	0.0	0.3	0.1	0.5	0.9	0.1	0.9	4.2	0.2	0.1	0.0	0.6	0.2	0.0	1.2	0.3	2.3	3.5	0.0	0.0	0.2	0.2	4.6	0.0	0.1	0.2	0.0	0.1	8.3	0.3	0.7	0.1	0.0	0.7	0.9	0.1	1.4	0.7	0.5	0.7	1.4	0.1	9.0	1.2	0.2	0.2	0.4	0.1	0.9	0.1	2.9	2.3	0.1	0.3	0.4	1.0	0.9	0.3	0.2	0.2	3.0	0.6	7.0	6.2	20.2	13.0	7.6	8.5	7.6	6.5	9.4	4.8	0.0	2.6	0.0	0.4	3.9	7.5	3.1	0.0	8.1	2.3	0.0	43.2	3.0	1.7	0.0	5.3	0.7	0.0	0.0	0.0	10.1	3.0	3.7	32.4	0.0	0.7	4.8	0.0	0.0	0.0	3.0	0.3	0.0	11.8	0.0	0.0	41.7	0.0	0.0	0.0	0.2	2.8	0.0	1.2	3.9	5.5	2.0	3.1	4.3	0.0	0.1
STAMBP	AMSH	ENSG00000124356	"STAM binding protein"	O95630	2	73828916-73873659	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Ubl conjugation pathway"	"Hydrolase, Metalloprotease, Protease"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enriched"	"Detected in all"	12	"LHCN-M2: 162.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035800, HPA035801"	Uncertain		Supported	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA		11000	Nucleoplasm	"Plasma membrane, Cytosol"	"HPA035800: AB_10670591, HPA035801: AB_2732470"	"unprognostic (1.86e-2)"	"unprognostic (1.14e-1)"	"unprognostic (2.16e-1)"	"prognostic unfavorable (4.70e-5)"	"unprognostic (6.13e-2)"	"unprognostic (2.08e-3)"	"unprognostic (3.73e-2)"	"unprognostic (1.71e-1)"	"unprognostic (6.58e-2)"	"unprognostic (2.96e-2)"	"prognostic unfavorable (5.79e-4)"	"unprognostic (1.01e-1)"	"unprognostic (2.29e-1)"	"unprognostic (7.72e-2)"	"unprognostic (2.63e-1)"	"unprognostic (1.43e-1)"	"unprognostic (2.89e-1)"	12.9	12.8	22.1	13.9	23.0	10.5	17.8	20.1	21.8	18.1	18.4	35.0	13.6	17.8	23.1	15.4	22.7	16.5	14.7	19.0	23.3	21.2	19.6	16.9	13.4	15.3	33.0	14.3	16.3	15.1	20.9	17.8	20.6	26.3	20.2	20.7	14.6	18.3	15.7	30.1	14.4	25.2	19.0	54.7	13.8	15.6	13.3	22.3	18.4	20.1	15.9	19.0	16.8	16.4	17.6	16.9	27.8	17.8	16.7	20.7	12.3	5.4	6.3	5.0	4.6	4.7	5.7	5.8	3.3	4.6	6.2	6.0	10.5	5.2	4.6	5.3	2.8	8.3	4.3	5.3	11.8	7.1	8.0	6.0	6.1	4.4	8.2	6.5	5.0	7.4	4.5	8.5	7.3	10.6	7.9	3.6	6.3	6.6	7.0	162.7	6.6	7.7	4.5	8.0	7.8	3.4	5.4	13.2	6.5	6.6	6.2	9.2	6.8	4.1	5.0	7.1	5.6	4.7	3.0	3.1	5.6	6.7	3.3	5.9	6.6	6.4	3.5	6.9	5.4	6.5	22.6	16.2	27.8	14.4	17.8	15.4	17.6	16.7	14.0	16.9	16.2	17.5	13.2	24.1	16.7	15.7	16.4	20.7	12.3	22.1	23.0	20.1	21.2	23.3	21.2	33.0	14.3	26.3	22.3	17.9	15.3	14.1	25.1	14.4	19.9	35.5	35.7	25.4	27.3	24.4	11.8	35.2	41.4	32.4	59.2	21.7	40.9	46.7	31.9	28.3	22.6	34.8	51.9	34.7	29.0	25.4	9.9	20.3	24.7	104.7	30.2	29.2	6.8	36.9	31.9	21.5	36.9	38.6	32.5	47.1	19.2	38.8	20.6	32.3	49.5	18.9	37.2	19.5	31.2	23.0
STAMBPL1	"ALMalpha, AMSH-FP, AMSH-LP, bA399O19.2, FLJ31524, KIAA1373"	ENSG00000138134	"STAM binding protein like 1"	Q96FJ0	10	88879734-88975153	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	"Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 18.6"	"Cell type enhanced"	"Detected in many"	8	"Early spermatids: 37.8;Spermatocytes: 27.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA040202	Uncertain		Approved	"Plasma membrane"		NA	NA			"Plasma membrane"		"HPA040202: AB_10805708"	"unprognostic (2.73e-1)"	"unprognostic (1.95e-1)"	"unprognostic (7.56e-2)"	"unprognostic (4.25e-2)"	"unprognostic (6.46e-2)"	"unprognostic (6.27e-2)"	"unprognostic (1.68e-2)"	"unprognostic (1.05e-2)"	"unprognostic (4.67e-2)"	"unprognostic (8.20e-2)"	"unprognostic (2.78e-1)"	"unprognostic (6.57e-2)"	"prognostic unfavorable (1.08e-5)"	"unprognostic (4.41e-2)"	"unprognostic (4.06e-2)"	"unprognostic (1.50e-1)"	"unprognostic (4.40e-3)"	3.9	15.9	3.7	6.8	5.1	2.8	2.1	12.4	8.9	2.0	5.8	3.4	1.5	4.5	2.7	1.5	2.7	1.2	2.9	4.8	3.3	3.4	1.5	1.7	2.9	11.3	2.6	14.8	8.5	1.8	2.2	6.6	1.5	4.1	1.9	8.0	1.5	1.5	1.5	1.5	3.4	6.1	1.8	3.1	6.0	3.1	18.6	3.2	1.5	1.5	1.5	9.5	3.9	2.7	10.5	15.2	4.3	0.6	13.1	14.7	4.5	6.8	8.1	0.5	0.3	8.1	15.6	0.0	14.4	14.2	9.3	8.3	0.3	13.1	8.4	1.0	7.8	6.2	3.4	2.0	2.9	9.4	7.4	5.1	2.1	5.8	0.4	5.5	9.2	3.0	5.5	0.7	15.5	4.9	10.6	0.2	10.1	0.0	3.8	24.9	1.4	15.3	10.9	3.0	6.5	6.3	1.5	6.1	1.8	3.5	2.6	4.7	5.6	1.8	0.6	16.4	2.0	1.0	1.9	2.1	8.3	6.0	9.9	9.0	8.9	8.4	7.8	9.1	9.4	7.8	4.3	0.6	4.2	6.3	0.6	8.2	10.5	9.2	7.9	0.9	7.0	9.9	5.9	0.9	13.1	0.3	15.2	14.7	4.5	3.7	5.1	12.4	8.9	3.3	3.4	2.6	14.8	4.1	3.2	0.0	5.0	9.3	4.1	8.5	3.7	5.0	0.0	8.1	0.0	5.2	0.0	0.1	0.0	0.8	37.8	2.2	7.4	0.0	1.6	0.1	5.1	1.5	4.7	1.9	3.0	6.4	8.7	1.8	1.0	13.9	6.6	3.5	0.0	1.0	8.1	10.6	1.2	0.0	1.4	0.5	0.2	0.0	6.7	27.6	2.4	9.9	0.1	14.9	13.3	1.6
STK10	"LOK, PRO2729"	ENSG00000072786	"Serine/threonine kinase 10"	O94804	5	172042073-172188386	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Cell cycle"	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 40.9"	"Cell type enhanced"	"Detected in many"	7	"Kupffer cells: 78.5;T-cells: 70.5"	"Low cancer specificity"	"Detected in all"			"Region enriched"	"Detected in all"	5	"cerebellum: 27.5"	"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"WM-115: 52.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA015083, CAB020840"	Enhanced		Approved	"Nucleoplasm,Plasma membrane"		NA	NA		24000	"Nucleoplasm, Plasma membrane"		"CAB020840: , HPA015083: AB_2669151"	"unprognostic (1.17e-1)"	"unprognostic (5.43e-2)"	"prognostic favorable (2.76e-4)"	"unprognostic (2.88e-1)"	"unprognostic (6.96e-3)"	"unprognostic (1.02e-1)"	"unprognostic (5.25e-3)"	"unprognostic (3.07e-2)"	"unprognostic (1.07e-1)"	"unprognostic (1.03e-1)"	"unprognostic (2.65e-1)"	"unprognostic (3.43e-1)"	"prognostic unfavorable (1.63e-4)"	"unprognostic (1.09e-1)"	"unprognostic (1.01e-2)"	"unprognostic (3.10e-1)"	"unprognostic (1.84e-1)"	15.0	4.7	2.6	25.8	4.4	38.3	13.5	27.5	3.0	3.6	5.0	4.8	3.4	4.7	4.4	4.4	3.6	4.2	11.0	9.0	2.4	2.5	5.3	4.5	15.4	40.9	5.4	1.9	3.5	4.1	2.5	3.7	16.2	4.5	4.3	4.0	5.6	7.8	2.5	3.1	9.0	12.2	5.7	4.6	33.0	6.2	13.1	3.5	20.6	4.6	3.1	23.7	9.5	11.3	5.0	10.3	22.3	30.8	7.4	18.0	15.6	7.8	7.3	4.5	6.8	5.3	6.6	11.6	10.2	8.5	7.4	6.9	3.8	10.4	9.5	5.4	12.6	15.7	9.2	2.0	12.5	4.8	12.3	3.4	11.4	3.0	2.1	7.6	11.5	13.5	6.5	2.7	10.1	8.4	2.7	6.4	3.7	1.0	13.3	5.2	12.6	8.2	25.8	1.8	3.9	5.8	13.6	3.6	6.2	3.0	9.9	3.1	3.8	5.9	8.3	28.0	5.9	2.9	24.4	8.9	8.3	4.2	5.8	5.5	11.2	16.5	6.0	10.9	17.7	52.3	7.1	10.8	10.0	18.0	21.4	13.3	5.0	9.4	12.8	10.3	4.4	5.6	9.6	22.3	7.4	30.8	3.2	12.2	15.6	2.6	4.4	27.5	3.0	2.4	2.5	5.4	1.9	4.5	3.5	3.0	12.8	25.0	7.9	6.0	3.8	3.6	2.5	5.3	5.7	1.8	5.9	2.8	1.7	4.4	1.7	17.8	8.4	0.0	5.3	25.1	7.4	6.7	26.7	2.1	30.8	44.5	11.5	20.3	78.5	2.7	2.6	39.2	8.5	9.0	15.0	3.1	7.9	7.0	1.4	1.5	2.2	12.9	8.2	5.7	6.8	3.6	4.2	70.5	4.7	9.5
STK11	"LKB1, PJS"	ENSG00000118046	"Serine/threonine kinase 11"	Q15831	19	1177558-1228435	"Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Apoptosis, Autophagy, Cell cycle, Differentiation, DNA damage, Spermatogenesis"	"Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes, Disease mutation, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	11	"Early spermatids: 124.0;Late spermatids: 234.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"neutrophil: 11.7"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB016231, HPA017254, CAB022105, HPA067481"	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"CAB016231: AB_627890, CAB022105: , HPA017254: AB_1852924, HPA067481: AB_2685847"	"unprognostic (8.60e-2)"	"unprognostic (1.68e-1)"	"unprognostic (5.00e-2)"	"prognostic favorable (3.69e-5)"	"unprognostic (2.04e-2)"	"prognostic favorable (1.96e-4)"	"unprognostic (9.11e-3)"	"unprognostic (3.19e-1)"	"unprognostic (9.08e-2)"	"unprognostic (1.26e-1)"	"unprognostic (1.95e-3)"	"unprognostic (7.70e-3)"	"unprognostic (3.54e-2)"	"unprognostic (3.16e-2)"	"unprognostic (1.60e-1)"	"unprognostic (3.31e-1)"	"unprognostic (3.12e-3)"	13.4	13.7	13.5	11.8	12.4	19.3	16.7	17.8	16.0	12.2	16.1	8.3	19.8	18.1	10.8	8.7	15.1	10.0	11.8	15.3	12.6	9.8	10.7	22.1	9.4	12.5	9.7	10.4	11.0	16.8	10.7	11.6	12.2	9.9	12.2	5.3	11.9	16.0	12.2	49.2	16.8	18.0	7.7	7.6	16.9	15.5	59.8	7.5	11.8	12.4	14.5	19.0	11.4	9.8	2.7	1.9	11.7	6.3	1.9	1.8	0.5	21.2	10.3	7.8	14.8	7.4	6.7	16.5	10.4	10.9	9.8	10.4	8.4	14.9	13.9	11.5	10.8	4.4	13.8	7.7	16.0	3.0	26.0	18.8	14.2	0.6	10.5	16.0	14.3	23.9	12.2	11.7	7.5	11.2	8.9	9.8	11.1	26.6	19.2	5.5	15.9	13.7	14.5	15.0	7.3	12.7	21.8	8.4	15.6	8.8	15.6	18.1	13.1	0.0	7.7	11.2	4.7	12.1	23.5	13.2	10.1	11.5	19.8	16.5	37.8	15.9	10.4	10.1	19.1	10.4	2.0	4.2	4.5	0.6	6.0	0.4	2.7	1.0	1.8	1.9	1.0	1.0	0.9	11.7	1.9	6.3	1.0	0.7	0.5	13.5	12.4	17.8	16.0	12.6	9.8	9.7	10.4	9.9	7.5	6.0	13.6	11.1	6.4	14.8	23.6	11.8	17.8	2.7	6.8	22.7	17.7	6.7	6.6	8.1	124.0	14.7	29.5	0.0	11.9	4.5	10.4	14.2	2.3	25.2	12.9	17.5	14.5	16.0	22.2	234.7	22.7	10.4	15.1	17.2	29.2	19.3	13.0	25.9	19.4	8.6	19.8	12.9	20.8	49.9	19.4	13.6	7.3	8.6	33.0	10.9
STK16	"MPSK, PKL12"	ENSG00000115661	"Serine/threonine kinase 16"	O75716	2	219245455-219250337	"Enzymes, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA029450	Approved		Supported	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			Cytosol	"Nucleoplasm, Plasma membrane"	"HPA029450: AB_10603118"	"unprognostic (1.99e-1)"	"unprognostic (2.08e-1)"	"unprognostic (5.84e-2)"	"prognostic favorable (6.09e-4)"	"unprognostic (6.21e-2)"	"unprognostic (5.55e-2)"	"unprognostic (4.98e-3)"	"unprognostic (4.25e-1)"	"unprognostic (1.48e-1)"	"unprognostic (4.22e-2)"	"unprognostic (1.73e-2)"	"unprognostic (3.17e-1)"	"unprognostic (4.39e-3)"	"unprognostic (1.76e-1)"	"unprognostic (2.00e-1)"	"unprognostic (2.68e-1)"	"unprognostic (1.34e-1)"	10.2	19.0	15.7	12.8	20.3	13.3	14.6	8.8	21.0	11.5	16.2	15.2	20.5	17.2	11.4	22.1	16.0	18.3	15.5	13.0	14.5	11.9	19.5	30.1	11.4	24.6	14.2	13.2	13.2	24.5	16.5	15.1	14.0	13.3	14.3	13.7	12.8	19.0	16.3	9.9	12.2	14.2	11.5	12.3	15.9	16.8	18.9	12.7	27.2	19.8	12.8	17.0	12.9	10.3	7.9	7.8	5.8	7.6	14.5	11.2	9.7	7.4	9.8	8.6	7.3	21.5	21.0	9.9	9.6	13.3	8.2	8.2	11.4	16.6	4.3	13.5	16.0	13.1	7.7	10.0	16.0	4.4	10.5	11.5	9.7	8.9	9.8	19.5	9.2	11.4	22.4	25.7	11.3	29.9	16.2	9.9	10.1	12.1	11.8	14.0	13.7	10.0	20.1	8.0	13.5	6.0	9.5	9.7	12.6	17.1	8.6	6.9	8.8	3.4	13.7	19.7	6.5	14.3	19.5	7.6	11.2	7.9	9.1	9.2	14.6	6.2	10.3	12.4	9.8	9.8	2.0	7.6	5.8	6.0	4.2	6.8	7.8	7.5	11.2	7.8	7.9	7.8	10.0	5.2	14.5	3.6	6.7	8.4	9.7	15.7	20.3	8.8	21.0	14.5	11.9	14.2	13.2	13.3	12.7	6.0	6.4	22.9	15.0	8.8	7.4	7.8	28.1	5.3	5.7	7.0	15.7	20.2	58.0	33.5	69.7	11.7	27.6	0.0	51.6	21.3	17.4	15.1	8.1	39.4	25.1	12.7	24.8	11.6	19.1	56.4	14.1	15.7	20.3	43.3	36.3	18.3	30.3	42.9	12.7	72.1	18.4	0.0	12.2	38.1	6.9	9.8	10.8	30.5	35.9	14.0
STK17A	DRAK1	ENSG00000164543	"Serine/threonine kinase 17a"	Q9UEE5	7	43582758-43626786	"Enzymes, Plasma proteins, Predicted membrane proteins"	Apoptosis	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 43.3"	"Cell type enhanced"	"Detected in many"	10	"Basal glandular cells: 549.3;Urothelial cells: 279.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"											"HPA018138, HPA037979"	Uncertain		Supported	"Nuclear speckles,Plasma membrane"		Yes	No			"Nuclear speckles"	"Plasma membrane"	"HPA018138: AB_2669784, HPA037979: AB_10795247"	"unprognostic (1.81e-3)"	"unprognostic (1.08e-2)"	"unprognostic (2.67e-1)"	"unprognostic (5.41e-2)"	"unprognostic (5.11e-2)"	"unprognostic (3.35e-2)"	"unprognostic (1.03e-2)"	"unprognostic (9.15e-3)"	"unprognostic (2.07e-1)"	"unprognostic (6.34e-2)"	"unprognostic (1.36e-2)"	"unprognostic (6.61e-2)"	"unprognostic (2.99e-3)"	"unprognostic (3.76e-2)"	"unprognostic (3.08e-1)"	"unprognostic (1.97e-3)"	"unprognostic (3.66e-1)"	7.1	10.1	6.1	43.3	8.2	20.2	8.4	7.9	7.2	4.8	9.3	3.7	2.0	6.1	5.3	4.2	10.1	4.7	8.6	17.7	5.7	5.6	6.7	8.1	15.2	36.6	6.6	2.6	7.3	14.3	1.5	6.3	37.2	5.7	6.2	5.3	3.6	8.6	3.4	10.7	4.8	12.3	5.8	5.3	27.8	11.0	9.0	2.8	30.1	7.3	6.8	37.7	10.3	8.1	10.8	1.4	11.5	0.9	12.7	11.4	2.9	4.4	5.5	5.0	3.4	6.3	8.3	2.1	15.9	17.3	8.7	8.9	4.8	3.2	7.1	25.1	13.3	17.8	9.1	3.8	21.2	12.2	17.5	4.3	6.3	4.1	5.9	4.7	10.8	4.2	6.8	25.0	11.5	10.6	34.5	16.3	7.7	7.4	24.4	10.0	2.0	17.6	5.0	7.7	2.6	18.1	6.1	3.2	14.0	15.2	3.3	2.7	6.1	7.2	3.3	4.6	10.7	3.8	5.5	16.3	19.0	7.2	11.2	17.8	14.8	7.3	10.2	19.3	9.6	30.2	0.7	0.4	11.5	5.8	0.2	5.8	10.8	6.1	9.7	0.3	10.1	11.4	10.2	6.4	12.7	0.9	1.4	3.2	2.9	6.1	8.2	7.9	5.9	5.7	5.6	6.6	2.6	5.7	2.8	113.2	27.8	121.1	549.3	161.6	3.0	25.4	5.1	52.2	81.9	19.2	9.8	44.4	28.2	110.3	36.3	19.4	29.1	0.0	82.8	19.7	31.9	134.1	39.1	7.7	15.8	0.0	6.9	16.5	16.2	8.8	5.5	19.9	33.7	55.1	27.8	8.1	75.9	56.1	2.5	9.7	25.2	6.5	55.6	45.1	29.6	118.9	55.8	186.8	10.0	279.4
STK17B	DRAK2	ENSG00000081320	"Serine/threonine kinase 17b"	O94768	2	196133566-196176503	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	Apoptosis	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 62.0;bone marrow: 103.4;lymphoid tissue: 72.2"	"Cell type enhanced"	"Detected in many"	5	"B-cells: 158.6;granulocytes: 189.5;Kupffer cells: 142.8;Macrophages: 145.8;T-cells: 178.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Daudi: 36.3;HMC-1: 36.8;Karpas-707: 34.1;U-698: 39.5"	"Region enriched"	"Detected in many"	6	"cerebellum: 71.1"	"Low region specificity"	"Detected in all"			HPA034858	Enhanced		Uncertain	"Plasma membrane,Cytosol"		NA	Yes			"Plasma membrane, Cytosol"		"HPA034858: AB_10670981"	"unprognostic (2.14e-1)"	"unprognostic (2.45e-3)"	"unprognostic (3.68e-2)"	"unprognostic (3.61e-2)"	"unprognostic (3.63e-2)"	"unprognostic (7.43e-3)"	"unprognostic (1.75e-1)"	"unprognostic (7.63e-2)"	"unprognostic (9.15e-2)"	"unprognostic (1.14e-1)"	"unprognostic (9.90e-2)"	"unprognostic (1.52e-1)"	"prognostic unfavorable (5.72e-8)"	"unprognostic (1.88e-1)"	"unprognostic (1.19e-2)"	"unprognostic (2.64e-2)"	"unprognostic (5.80e-2)"	21.0	4.1	3.2	42.8	3.8	103.4	10.1	3.2	3.3	8.2	18.8	1.1	3.8	8.5	3.4	3.9	8.9	6.3	8.6	5.7	3.3	2.2	7.2	2.9	26.2	53.7	2.3	1.8	3.1	5.0	0.7	3.8	6.5	1.7	6.8	5.7	3.5	16.7	6.1	3.4	10.9	31.8	5.3	2.7	59.3	6.0	4.6	1.4	72.2	7.5	7.0	56.2	11.3	6.0	16.9	13.6	62.0	27.0	10.3	28.4	19.0	3.2	2.2	3.4	1.2	15.0	5.7	3.8	7.7	11.6	8.5	8.9	6.8	1.1	36.3	7.1	4.4	2.2	2.2	1.4	3.3	10.4	6.4	3.8	3.4	2.9	0.6	4.5	13.7	36.8	7.2	3.3	10.5	5.5	12.1	3.5	8.6	2.6	34.1	21.1	1.7	17.8	31.0	1.9	5.9	5.2	2.9	20.7	11.0	5.0	7.6	1.3	1.3	1.9	1.9	1.6	5.5	1.3	7.2	4.2	8.3	4.1	5.9	4.3	14.0	22.6	39.5	6.2	4.7	3.6	35.9	19.7	40.2	12.0	20.7	15.3	13.3	21.5	14.5	13.6	16.9	28.4	23.1	62.0	10.3	27.0	9.7	18.5	19.0	3.2	3.8	3.2	3.3	3.3	2.2	2.3	1.8	1.7	1.4	83.4	80.3	158.6	22.9	53.1	0.3	2.2	10.2	34.8	52.4	10.4	0.0	5.9	3.3	5.2	4.6	11.6	59.1	46.7	2.5	20.9	21.2	28.7	189.5	2.4	23.5	0.0	2.9	7.4	142.8	2.0	5.2	145.8	55.6	40.5	11.0	0.9	7.9	38.6	4.2	1.4	0.2	6.5	20.5	28.6	24.9	55.5	4.2	178.5	10.5	39.9
STK19	"D6S60, G11, RP1"	ENSG00000204344	"Serine/threonine kinase 19"	P49842	6	31971091-31982821	"Cancer-related genes, Enzymes, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Proximal tubular cells: 132.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 4.9;HEL: 3.6;HL-60: 3.8;REH: 4.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031510, HPA031511, HPA068559"	Uncertain		Supported	"Nuclear speckles"		NA	NA			"Nuclear speckles"		"HPA031510: AB_10603119, HPA031511: AB_2673915, HPA068559: AB_2686004"	"unprognostic (1.65e-1)"	"unprognostic (2.30e-1)"	"unprognostic (3.31e-1)"	"unprognostic (1.86e-1)"	"unprognostic (2.63e-1)"	"unprognostic (1.67e-1)"	"unprognostic (1.15e-2)"	"unprognostic (4.26e-2)"	"prognostic unfavorable (1.18e-4)"	"unprognostic (3.95e-2)"	"unprognostic (2.76e-3)"	"unprognostic (2.25e-2)"	"unprognostic (1.08e-2)"	"unprognostic (1.02e-1)"	"unprognostic (1.60e-1)"	"unprognostic (2.40e-1)"	"unprognostic (4.10e-1)"	6.4	8.2	3.8	4.3	6.5	2.9	4.0	9.9	6.3	5.7	6.6	5.5	4.2	2.2	6.0	5.5	5.3	3.5	5.3	3.6	5.0	3.5	3.9	6.6	4.1	2.5	4.3	7.5	5.7	12.4	4.7	4.6	6.3	4.0	6.2	2.7	5.6	2.9	6.7	6.1	6.8	2.6	5.9	3.7	7.0	6.3	7.9	4.2	2.6	4.7	4.1	3.8	4.4	4.2	2.1	2.7	0.4	3.8	0.9	1.1	0.5	0.0	0.3	0.0	1.1	3.0	1.7	0.0	2.4	0.3	0.5	1.1	0.0	2.0	1.5	0.6	1.2	0.0	2.1	0.0	0.6	0.9	4.9	0.9	3.6	1.0	0.2	1.5	3.8	0.0	1.6	0.1	0.9	0.3	1.0	0.0	0.0	0.0	0.7	0.2	0.0	0.0	0.0	0.6	0.1	0.0	4.5	2.5	1.2	0.0	0.0	1.0	0.9	0.3	0.6	0.2	0.0	1.7	0.0	0.0	0.0	1.1	1.1	0.0	0.1	2.3	0.1	1.9	0.6	0.1	0.0	3.8	0.1	0.6	1.4	0.7	2.1	0.9	0.1	2.7	1.0	1.1	0.5	0.4	0.9	1.4	1.5	0.1	0.5	3.8	6.5	9.9	6.3	5.0	3.5	4.3	7.5	4.0	4.2	8.9	19.2	8.6	14.6	11.6	11.5	7.5	10.2	33.5	22.7	21.0	19.6	30.1	33.2	22.2	63.7	15.8	13.1	0.0	24.4	16.5	21.1	11.5	9.2	19.6	16.6	9.5	18.6	13.5	11.9	51.4	18.7	8.9	16.9	8.2	15.4	23.5	20.7	14.4	17.3	132.6	19.7	32.3	16.9	29.9	17.8	15.8	41.5	21.8	11.2	9.8
STK24	"MST-3, MST3, MST3B, STE20, STK3"	ENSG00000102572	"Serine/threonine kinase 24"	Q9Y6E0	13	98445185-98577940	"Enzymes, Predicted intracellular proteins"	Apoptosis	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA026435, HPA026502"	Enhanced		Supported	Nucleoli,Cytosol		No	No		2800000	"Nucleoli, Cytosol"		"HPA026435: AB_1854151, HPA026502: AB_1854152"	"unprognostic (3.49e-2)"	"unprognostic (2.39e-2)"	"unprognostic (1.78e-1)"	"unprognostic (3.44e-2)"	"unprognostic (2.86e-1)"	"unprognostic (3.25e-2)"	"unprognostic (9.67e-3)"	"prognostic unfavorable (6.23e-6)"	"unprognostic (5.45e-2)"	"unprognostic (1.13e-1)"	"prognostic unfavorable (5.81e-4)"	"unprognostic (9.62e-2)"	"prognostic favorable (6.91e-5)"	"unprognostic (3.10e-2)"	"unprognostic (4.49e-2)"	"unprognostic (3.88e-2)"	"unprognostic (1.12e-2)"	28.6	14.2	15.0	29.7	16.9	19.1	34.8	12.2	21.0	36.3	37.4	12.1	23.0	31.9	24.6	26.5	68.4	20.4	41.3	30.0	14.7	12.8	30.5	14.2	23.9	31.2	10.6	10.1	20.0	20.6	12.4	13.9	38.4	14.7	28.3	28.8	36.8	30.8	21.6	18.8	60.6	67.9	34.8	9.2	31.7	30.2	22.1	7.6	38.2	28.2	41.6	48.5	39.2	45.4	8.1	11.2	11.4	13.4	1.5	13.7	6.7	36.0	11.3	20.0	18.5	30.8	18.5	28.5	16.9	23.8	23.7	23.2	33.0	49.1	25.7	8.6	21.1	14.9	32.7	18.5	37.3	22.7	64.1	9.5	27.5	14.4	18.9	43.6	27.6	19.5	11.9	59.6	18.6	54.9	25.1	20.4	20.3	9.9	17.8	15.5	15.7	20.6	11.4	17.9	49.1	8.5	26.1	12.3	13.9	22.9	32.6	11.7	16.8	10.7	17.3	22.8	31.9	20.8	26.9	27.4	15.1	11.0	12.3	19.4	17.4	9.1	9.6	23.5	16.7	24.8	5.8	13.4	6.1	6.1	10.6	7.2	6.6	11.4	8.7	11.2	8.1	7.8	6.1	11.4	1.5	12.7	7.5	13.7	6.7	15.0	16.9	12.2	21.0	14.7	12.8	10.6	10.1	14.7	7.6	11.9	24.3	29.0	62.3	63.0	20.3	2.8	68.8	34.8	44.3	64.6	53.0	35.6	21.6	29.9	2.5	26.3	110.9	0.0	47.8	36.3	36.7	53.4	18.4	22.9	24.7	9.5	40.9	27.0	68.7	3.4	24.7	40.1	54.0	16.2	70.9	22.1	67.8	59.4	28.7	31.9	11.4	38.8	29.0	1.8	3.6	71.8	16.7	21.8	51.8	117.9
STK25	"SOK1, YSK1"	ENSG00000115694	"Serine/threonine kinase 25"	O00506	2	241492674-241509730	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	5	"skeletal muscle: 164.2"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA047147	Uncertain					NA	NA					"HPA047147: AB_10966137"	"unprognostic (1.75e-1)"	"unprognostic (8.29e-2)"	"prognostic unfavorable (6.03e-4)"	"unprognostic (3.42e-2)"	"unprognostic (2.71e-1)"	"unprognostic (1.24e-1)"	"prognostic unfavorable (3.91e-8)"	"unprognostic (6.16e-2)"	"unprognostic (7.15e-3)"	"unprognostic (1.11e-1)"	"unprognostic (2.58e-3)"	"unprognostic (1.55e-1)"	"unprognostic (2.47e-2)"	"unprognostic (2.00e-1)"	"unprognostic (1.37e-1)"	"unprognostic (3.19e-1)"	"unprognostic (4.58e-1)"	17.8	13.6	22.3	14.2	26.0	16.3	12.9	22.3	35.3	16.4	17.1	17.0	13.0	14.6	17.7	15.9	19.3	15.4	16.7	19.0	19.4	20.0	17.3	13.5	13.4	13.5	16.3	20.4	17.5	19.2	18.9	17.1	15.6	16.4	15.1	12.9	13.5	14.2	17.6	164.2	15.3	14.2	17.3	12.6	15.8	16.1	16.8	14.4	15.2	20.0	24.6	12.6	14.6	16.6	15.0	13.6	13.7	16.4	21.5	19.9	10.6	18.7	11.9	23.9	29.6	29.4	20.6	36.7	31.3	21.1	23.9	27.4	13.3	16.6	7.1	8.8	41.7	21.7	16.0	33.6	34.1	29.1	26.7	35.3	20.0	25.3	34.3	26.7	12.1	15.5	29.5	24.5	23.1	18.6	29.4	53.9	26.4	30.8	6.4	43.7	19.7	18.0	18.9	33.3	17.5	17.2	30.3	30.4	10.7	21.0	15.9	40.2	18.4	15.2	11.5	19.6	28.3	9.2	21.6	62.8	18.1	22.1	20.7	22.2	13.2	2.9	12.1	17.5	10.0	20.5	13.7	14.8	11.5	16.9	13.4	15.5	14.5	15.5	17.5	13.6	15.0	12.0	11.6	5.5	21.5	16.4	10.7	19.9	10.6	22.3	26.0	22.3	35.3	19.4	20.0	16.3	20.4	16.4	14.4	20.8	36.6	14.1	25.2	22.7	49.3	31.3	33.1	16.0	19.4	24.4	25.5	71.0	23.2	38.2	10.6	44.7	31.6	46.7	29.7	65.7	31.3	25.3	25.3	21.2	39.2	30.2	34.0	44.8	29.8	9.6	30.2	21.3	18.6	65.9	34.9	46.4	36.1	52.6	37.4	37.8	36.1	45.3	29.9	72.8	32.6	26.6	43.8	25.4	41.9	24.5
STK26	"MASK, MST4"	ENSG00000134602	"Serine/threonine kinase 26"	Q9P289	X	132023265-132075943	"Enzymes, Predicted intracellular proteins"	Apoptosis	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Cytotrophoblasts: 44.8;Syncytiotrophoblasts: 49.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"U-937: 41.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA059921	Approved		Uncertain	"Nucleoplasm,Golgi apparatus,Centrosome,Cytosol"		Yes	No			Nucleoplasm	"Golgi apparatus, Centrosome, Cytosol"	"HPA059921: AB_2684163"	"unprognostic (6.53e-2)"	"unprognostic (7.83e-2)"	"unprognostic (1.77e-1)"	"unprognostic (1.02e-3)"	"unprognostic (4.42e-1)"	"unprognostic (1.03e-2)"	"prognostic unfavorable (6.82e-4)"	"unprognostic (1.18e-1)"	"unprognostic (1.93e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.42e-3)"	"unprognostic (2.49e-1)"	"prognostic unfavorable (6.87e-5)"	"unprognostic (4.76e-2)"	"unprognostic (1.83e-1)"	"unprognostic (1.77e-1)"	"unprognostic (2.88e-1)"	5.4	1.4	1.1	13.5	5.1	25.9	3.3	3.8	1.1	18.0	6.4	0.3	34.8	3.7	42.3	29.6	11.7	6.0	5.2	1.9	1.2	2.3	3.5	3.2	6.7	12.8	1.2	0.3	4.7	4.0	10.2	5.8	50.7	1.2	11.5	4.8	2.2	6.3	22.4	1.2	5.1	6.1	19.1	1.5	8.5	4.7	5.2	0.8	44.7	2.3	6.8	10.2	18.0	6.6	8.4	6.2	26.4	11.6	22.0	13.3	10.2	9.1	3.2	0.4	0.0	1.5	1.4	21.0	0.3	1.1	0.1	0.1	8.4	8.3	12.5	5.7	2.0	6.5	10.4	23.4	14.7	0.0	10.8	19.1	18.0	7.9	7.9	1.4	37.6	1.5	2.0	8.8	0.0	9.9	4.4	4.1	17.2	8.0	11.8	3.5	8.1	38.7	35.0	18.8	6.2	1.2	28.0	11.6	16.1	9.5	14.8	7.8	8.6	5.5	5.0	0.2	17.0	6.4	9.9	0.1	3.8	4.0	11.4	13.5	9.1	14.2	13.9	3.4	41.0	1.9	26.4	5.1	16.6	13.3	6.7	13.0	8.4	9.1	11.3	6.2	7.3	11.8	12.2	10.0	22.0	11.6	2.3	4.0	10.2	1.1	5.1	3.8	1.1	1.2	2.3	1.2	0.3	1.2	0.8	20.8	14.1	8.6	27.8	0.0	0.0	1.1	5.1	12.0	14.8	10.4	0.0	44.8	3.3	4.4	0.4	0.4	0.9	0.0	6.3	28.5	4.9	17.5	10.5	3.0	10.7	0.0	1.2	0.6	10.1	0.0	3.1	7.2	0.0	9.0	6.4	0.0	8.6	3.5	2.1	1.2	0.0	6.5	2.9	1.1	2.3	0.0	49.4	17.5	6.3	15.3
STK3	"KRS1, MST2"	ENSG00000104375	"Serine/threonine kinase 3"	Q13188	8	98401403-98942827	"Enzymes, Plasma proteins, Predicted intracellular proteins"	Apoptosis	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Early spermatids: 118.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in all"	5	"dendritic cells: 8.3;granulocytes: 9.0;monocytes: 8.7"	"Cell line enhanced"	"Detected in many"		"A-431: 37.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007120, CAB025316"	Uncertain		Approved	"Intermediate filaments,Rods & Rings"		NA	NA			"Intermediate filaments, Rods & Rings"		"CAB025316: , HPA007120: AB_10601664"	"unprognostic (7.88e-3)"	"unprognostic (1.96e-1)"	"unprognostic (6.57e-2)"	"prognostic unfavorable (1.53e-4)"	"unprognostic (2.95e-1)"	"unprognostic (1.12e-3)"	"unprognostic (9.68e-3)"	"prognostic unfavorable (4.25e-4)"	"unprognostic (6.71e-2)"	"unprognostic (9.83e-2)"	"prognostic unfavorable (9.21e-5)"	"unprognostic (9.16e-2)"	"unprognostic (1.03e-1)"	"unprognostic (2.27e-1)"	"unprognostic (1.29e-1)"	"unprognostic (5.86e-2)"	"unprognostic (9.72e-2)"	16.5	16.6	6.5	8.1	12.4	2.5	20.5	2.6	10.6	17.2	13.1	10.5	14.2	4.6	22.2	13.1	9.0	16.0	12.6	10.0	7.4	4.1	14.7	12.0	16.2	10.8	12.8	3.6	22.8	10.7	15.1	18.9	53.1	9.9	15.0	6.0	8.2	10.8	16.4	11.6	10.0	10.8	23.5	12.9	8.2	9.5	10.1	11.4	3.4	10.6	7.9	5.9	16.4	24.3	1.9	8.3	9.0	8.7	1.8	1.8	2.9	37.3	7.0	7.5	9.8	24.2	12.1	7.5	13.0	11.7	12.2	10.6	5.2	15.9	0.0	11.4	12.9	6.4	15.1	5.2	11.2	19.7	9.0	6.6	10.0	3.5	3.5	8.3	3.3	8.7	8.0	19.4	6.2	17.0	8.0	5.2	5.9	4.2	5.4	8.8	4.7	8.3	4.0	2.2	25.8	2.7	7.4	6.4	3.2	13.8	4.7	1.9	4.3	8.3	9.6	8.0	10.0	7.9	5.4	3.9	8.2	5.2	12.4	7.2	4.3	6.5	2.7	7.4	4.2	13.0	2.1	8.6	4.5	1.3	8.7	1.4	1.9	0.8	1.8	8.3	1.3	1.1	0.7	9.0	1.8	5.4	3.4	0.1	2.9	6.5	12.4	2.6	10.6	7.4	4.1	12.8	3.6	9.9	11.4	35.7	32.0	4.7	38.6	38.8	6.0	15.1	22.9	33.5	42.1	27.9	13.7	36.5	19.9	17.3	118.9	30.2	17.6	0.0	16.5	49.2	41.3	37.6	16.2	18.4	16.1	9.5	8.7	22.1	14.6	63.7	84.3	20.2	23.6	7.2	7.6	15.1	19.7	9.5	69.6	20.3	14.2	38.8	39.6	17.0	11.9	35.4	54.1	8.2	9.3	31.1
STK31	"SgK396, TDRD8"	ENSG00000196335	"Serine/threonine kinase 31"	Q9BXU1	7	23710167-23832513	"Enzymes, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	63	"testis: 56.0"	"Cell type enriched"	"Detected in some"	5	"Spermatocytes: 163.1"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	8	"CACO-2: 20.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA023194	Enhanced					NA	NA					"HPA023194: AB_1857590"	"unprognostic (4.25e-2)"	"unprognostic (1.04e-1)"	"unprognostic (3.98e-2)"	"unprognostic (5.41e-2)"	"unprognostic (1.62e-1)"	"unprognostic (1.50e-2)"	"unprognostic (1.09e-2)"	"unprognostic (1.26e-1)"	"unprognostic (1.34e-1)"	"unprognostic (1.73e-1)"	"unprognostic (2.42e-3)"	"unprognostic (2.92e-1)"	"unprognostic (1.29e-6)"	"unprognostic (7.83e-2)"	"unprognostic (9.21e-3)"	"unprognostic (1.46e-1)"	"unprognostic (3.65e-1)"	0.1	0.0	0.1	0.1	0.7	0.0	0.1	0.8	0.1	0.1	0.1	0.1	0.1	0.2	0.1	0.2	0.1	0.0	0.1	0.1	0.2	0.0	0.1	0.1	0.2	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.2	0.1	0.1	56.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.5	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	20.1	2.5	0.0	2.5	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.7	0.8	0.1	0.2	0.0	0.1	0.1	0.1	0.1	3.0	1.4	0.0	0.2	0.1	1.7	0.4	2.5	6.7	4.5	0.0	0.0	0.5	0.0	0.2	16.5	0.0	0.3	0.0	0.6	0.1	0.0	0.3	0.0	0.8	0.2	0.0	1.2	0.0	0.0	12.3	3.1	0.0	0.0	0.0	0.2	1.3	0.4	0.8	2.8	0.0	1.2	0.0	0.0	163.1	32.6	0.1	0.5	0.0	0.4	0.4
STK32A	"MGC22688, YANK1"	ENSG00000169302	"Serine/threonine kinase 32A"	Q8WU08	5	147234963-147387852	"Enzymes, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"adrenal gland: 19.7;brain: 21.1;retina: 31.9"	"Cell type enhanced"	"Detected in some"	14	"Early spermatids: 5.0;Melanocytes: 15.1;Muller glia cells: 4.6"	"Cancer enhanced"	"Detected in many"		"melanoma: 11.9"	"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	5	"neutrophil: 1.2"	"Lineage enriched"	"Detected in single"	10	"granulocytes: 1.2"	"Group enriched"	"Detected in some"	5	"RT4: 9.8;SK-MEL-30: 34.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA040236			Approved	Centrosome		NA	NA			Centrosome		"HPA040236: AB_10795416"	"unprognostic (1.90e-1)"	"unprognostic (4.71e-4)"	"unprognostic (5.32e-2)"	"unprognostic (3.49e-2)"	"unprognostic (7.62e-2)"	"unprognostic (6.82e-2)"	"unprognostic (2.66e-2)"	"unprognostic (2.96e-3)"	"unprognostic (4.85e-2)"	"unprognostic (2.36e-2)"	"unprognostic (3.87e-1)"	"unprognostic (8.38e-2)"	"unprognostic (2.50e-3)"	"unprognostic (5.53e-5)"	"unprognostic (2.48e-1)"	"unprognostic (3.20e-2)"	"unprognostic (3.67e-3)"	2.1	19.7	4.8	1.3	7.1	0.4	2.3	21.1	7.7	1.2	1.8	6.2	0.6	1.2	1.6	5.6	1.0	1.3	4.3	1.6	4.9	12.6	6.3	0.6	2.1	0.5	12.1	2.2	5.1	4.2	0.4	8.5	0.7	20.7	2.1	1.1	31.9	1.2	1.8	0.6	2.9	1.1	1.4	12.4	0.8	1.4	2.1	6.9	0.0	15.7	0.5	0.5	4.1	2.1	0.1	0.0	1.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.3	0.0	0.9	0.0	0.0	0.0	0.1	0.0	0.0	2.7	0.0	0.0	0.4	0.0	0.0	0.1	0.1	0.0	0.1	0.1	0.0	0.0	0.0	4.2	0.0	0.0	0.0	0.0	0.3	0.0	0.8	0.0	0.0	0.1	3.8	9.8	0.9	0.4	0.0	0.1	34.7	0.1	0.0	0.0	0.1	0.0	0.6	0.4	0.4	1.1	0.2	0.0	1.1	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	4.8	7.1	21.1	2.3	4.9	12.6	12.1	2.2	20.7	6.9	0.0	1.6	0.0	0.2	1.3	1.2	0.4	0.0	0.0	1.2	1.8	0.0	0.0	1.7	1.2	5.0	0.0	0.0	0.0	2.4	0.0	1.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	4.4	0.9	0.0	15.1	0.0	0.0	4.6	4.1	0.0	3.9	3.0	0.9	0.0	0.3	0.0	0.0	0.3	0.1	0.0	0.0	0.6
STK32B	"HSA250839, STK32, STKG6, YANK2"	ENSG00000152953	"Serine/threonine kinase 32B"	Q9NY57	4	5051442-5500998	"Enzymes, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 23.6;lymphoid tissue: 33.6"	"Cell type enhanced"	"Detected in some"	25	"Distal tubular cells: 14.9;Early spermatids: 83.1;Late spermatids: 31.4;Proximal tubular cells: 13.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	4	"naive B-cell: 1.3;plasmacytoid DC: 3.5"	"Group enriched"	"Detected in many"	4	"B-cells: 1.3;dendritic cells: 3.5"	"Cell line enhanced"	"Detected in some"		"GAMG: 11.9;HUVEC TERT2: 11.7;REH: 10.3;U-2197: 18.7;WM-115: 47.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA015820			Approved	"Nucleoplasm,Nuclear bodies,Cytosol"		NA	NA			"Nucleoplasm, Nuclear bodies"	Cytosol	"HPA015820: AB_1858913"	"unprognostic (4.48e-2)"	"unprognostic (1.02e-1)"	"unprognostic (6.08e-2)"	"unprognostic (1.35e-1)"	"unprognostic (8.12e-3)"	"unprognostic (9.96e-2)"	"unprognostic (1.64e-4)"	"unprognostic (1.27e-1)"	"unprognostic (1.27e-1)"	"unprognostic (1.70e-1)"	"unprognostic (2.54e-1)"	"unprognostic (8.82e-2)"	"prognostic favorable (1.63e-8)"	"unprognostic (8.10e-3)"	"unprognostic (5.04e-2)"	"unprognostic (3.62e-2)"	"unprognostic (1.67e-3)"	5.2	0.8	6.0	2.1	4.8	2.3	7.3	1.0	5.8	6.0	2.1	5.2	1.6	1.2	5.7	1.6	2.3	2.5	4.7	0.9	4.5	7.6	23.6	0.5	1.3	2.8	5.3	2.2	1.2	4.9	0.8	0.8	5.1	4.2	2.3	2.2	3.0	2.9	1.9	2.1	3.6	1.6	7.0	3.9	0.6	9.5	7.1	2.9	33.6	2.8	2.1	1.9	4.2	6.1	1.3	3.5	0.0	0.5	0.0	0.0	0.0	0.0	5.8	0.3	0.0	0.2	0.4	0.0	4.0	0.5	2.7	0.1	0.0	0.0	0.0	0.9	8.2	11.9	0.0	0.6	0.0	1.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.1	0.1	11.7	0.6	0.0	0.0	1.4	0.0	0.0	0.8	1.7	0.0	0.0	10.3	0.0	0.0	2.6	0.0	0.1	0.0	0.0	0.0	3.5	0.3	0.0	0.0	3.0	0.0	1.2	18.7	0.0	0.4	0.0	0.0	0.0	0.0	47.7	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	1.3	0.0	0.0	0.0	0.0	0.0	3.5	0.0	0.0	6.0	4.8	1.0	5.8	4.5	7.6	5.3	2.2	4.2	2.9	0.0	0.6	0.0	0.1	2.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	14.9	0.8	83.1	1.6	0.0	0.0	0.0	0.1	3.8	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	31.4	1.4	0.9	5.0	0.0	0.0	0.0	0.3	0.0	1.1	13.3	0.0	0.0	0.3	0.9	3.0	0.9	0.0	0.0	0.0	0.0
STK32C	"MGC23665, PKE, YANK3"	ENSG00000165752	"Serine/threonine kinase 32C"	Q86UX6	10	132207492-132331847	"Enzymes, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	4	"Early spermatids: 222.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA017894	Uncertain					NA	NA					"HPA017894: AB_1857591"	"unprognostic (2.11e-1)"	"unprognostic (8.40e-2)"	"unprognostic (4.80e-3)"	"prognostic unfavorable (1.09e-4)"	"unprognostic (1.65e-2)"	"unprognostic (5.52e-2)"	"prognostic unfavorable (1.68e-6)"	"unprognostic (2.03e-1)"	"unprognostic (7.79e-2)"	"unprognostic (2.14e-1)"	"unprognostic (1.18e-2)"	"unprognostic (1.13e-1)"	"prognostic unfavorable (5.31e-6)"	"unprognostic (8.65e-2)"	"unprognostic (3.20e-1)"	"unprognostic (5.05e-2)"	"unprognostic (1.36e-1)"	6.8	8.2	23.5	6.4	23.5	6.1	7.1	8.3	31.6	4.1	4.9	6.3	6.0	5.0	4.6	15.5	3.4	9.4	7.8	7.0	17.9	12.8	6.3	4.2	7.3	8.5	9.2	16.1	5.8	7.0	6.2	6.7	4.8	7.7	4.6	4.7	3.2	5.6	5.5	11.3	7.1	4.7	4.9	7.7	10.7	4.8	26.1	8.1	8.7	4.9	3.0	6.1	4.6	3.6	5.5	14.5	25.0	11.2	3.2	4.9	3.6	32.1	21.1	6.5	16.3	9.1	11.6	1.3	6.8	5.3	8.6	11.1	4.7	22.5	7.1	5.1	7.8	10.9	7.4	9.4	2.7	8.4	4.2	15.1	4.1	21.6	22.3	11.5	3.7	15.5	8.7	10.3	7.8	8.9	11.0	7.5	12.1	7.2	5.0	9.2	9.7	4.7	14.2	4.2	5.9	15.4	5.7	4.1	2.2	11.2	5.6	17.0	13.3	4.8	4.5	9.5	4.0	5.2	9.0	5.0	7.1	7.1	8.9	5.3	9.3	1.7	17.7	15.5	3.6	3.4	25.0	10.7	9.2	3.5	11.2	4.5	3.6	2.9	4.0	14.5	5.5	3.6	2.9	1.4	3.2	9.5	8.3	4.9	3.6	23.5	23.5	8.3	31.6	17.9	12.8	9.2	16.1	7.7	8.1	0.0	11.1	5.2	5.5	4.6	8.8	2.9	2.5	14.7	5.7	12.2	11.8	2.8	16.6	5.0	222.3	8.3	2.6	0.0	7.5	2.0	7.3	7.5	15.1	4.9	13.1	35.0	18.4	11.1	20.5	53.0	8.3	18.4	11.8	6.4	5.5	7.3	6.0	4.0	6.3	9.7	14.6	6.5	5.3	31.4	17.2	4.4	1.3	9.2	7.9	6.2
STK33		ENSG00000130413	"Serine/threonine kinase 33"	Q9BYT3	11	8391868-8594289	"Enzymes, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"testis: 34.4"	"Cell type enhanced"	"Detected in many"	12	"Ciliated cells: 245.0;Late spermatids: 113.1;Rod photoreceptor cells: 83.4;Spermatocytes: 126.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	4	"memory B-cell: 7.1;naive B-cell: 4.4"	"Lineage enriched"	"Detected in many"	5	"B-cells: 7.1"	"Cell line enhanced"	"Detected in many"		"Daudi: 14.0;hTERT-RPE1: 14.2;Karpas-707: 13.1;SCLC-21H: 14.7;U-251 MG: 14.8"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA015742, HPA056855"	Uncertain		Approved	Nucleoplasm,Nucleoli,Cytosol		NA	NA			Nucleoplasm	"Nucleoli, Cytosol"	"HPA015742: AB_1857592, HPA056855: AB_2683257"	"unprognostic (2.57e-2)"	"unprognostic (2.80e-1)"	"unprognostic (2.23e-3)"	"unprognostic (2.76e-3)"	"unprognostic (3.57e-1)"	"unprognostic (1.40e-1)"	"unprognostic (7.28e-2)"	"unprognostic (3.85e-4)"	"unprognostic (1.23e-1)"	"unprognostic (8.06e-2)"	"unprognostic (1.33e-3)"	"unprognostic (9.46e-2)"	"prognostic favorable (4.89e-6)"	"unprognostic (2.39e-2)"	"unprognostic (1.37e-1)"	"unprognostic (3.49e-2)"	"unprognostic (2.90e-2)"	0.9	6.1	4.7	1.6	7.5	1.1	0.6	6.1	4.4	5.4	5.3	6.8	7.7	2.6	9.6	15.3	2.3	30.7	4.5	11.4	6.6	6.1	7.7	0.4	5.3	2.3	4.9	2.7	10.3	4.6	20.4	29.9	0.3	17.7	5.3	1.3	14.8	1.6	8.9	2.6	0.3	2.5	7.0	6.7	1.2	4.4	34.4	4.6	4.5	14.6	1.5	1.8	3.7	1.4	7.1	0.7	0.0	0.0	0.2	1.4	0.3	0.0	2.0	9.7	0.0	0.0	0.0	0.0	1.7	1.9	4.2	3.9	1.1	0.0	14.0	7.3	0.3	5.5	0.0	4.3	1.3	3.7	0.0	11.9	0.0	2.6	3.3	1.6	7.8	0.0	0.4	0.0	0.1	0.0	14.2	0.3	6.9	0.0	13.1	0.1	0.0	0.2	0.0	6.9	0.0	0.0	5.2	1.3	8.8	3.8	0.0	14.7	3.9	0.0	0.0	0.1	2.7	0.0	0.8	0.0	0.0	6.6	0.1	14.8	3.1	12.4	0.2	4.2	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	7.1	0.0	1.4	0.0	4.4	0.0	1.1	0.0	0.2	0.0	0.7	0.2	0.3	4.7	7.5	6.1	4.4	6.6	6.1	4.9	2.7	17.7	4.6	17.9	12.6	5.4	1.1	0.0	19.2	34.4	10.2	245.0	47.8	19.2	66.8	0.1	3.3	7.5	72.9	1.3	0.0	0.0	4.4	2.7	0.3	0.2	1.1	0.0	0.2	1.6	8.7	0.0	0.0	113.1	4.0	0.4	0.0	0.0	1.3	30.6	4.5	0.0	15.9	11.9	83.4	0.0	0.2	126.9	25.1	0.0	0.0	0.0	2.9	0.0
STK35	"bA550O8.2, CLIK1"	ENSG00000125834	"Serine/threonine kinase 35"	Q8TDR2	20	2101611-2177038	"Enzymes, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"retina: 27.8;testis: 37.6"	"Cell type enhanced"	"Detected in many"	18	"Early spermatids: 169.1;Horizontal cells: 278.1;Late spermatids: 665.5;Muller glia cells: 155.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA026452, HPA051673"	Uncertain		Supported	"Nucleoplasm,Nuclear bodies"		NA	NA			"Nucleoplasm, Nuclear bodies"		"HPA026452: AB_2671861, HPA051673: AB_2681569"	"unprognostic (2.25e-2)"	"unprognostic (2.97e-1)"	"unprognostic (2.87e-2)"	"unprognostic (1.30e-2)"	"unprognostic (3.25e-1)"	"unprognostic (2.28e-1)"	"prognostic unfavorable (9.46e-6)"	"unprognostic (6.53e-2)"	"unprognostic (1.82e-1)"	"unprognostic (3.05e-2)"	"unprognostic (1.37e-1)"	"unprognostic (2.07e-1)"	"unprognostic (4.39e-2)"	"unprognostic (1.74e-1)"	"unprognostic (4.67e-1)"	"unprognostic (1.40e-1)"	"unprognostic (4.99e-2)"	5.3	6.0	10.3	3.6	14.3	4.3	5.1	6.1	13.7	3.7	4.3	3.1	2.5	4.2	4.5	3.5	8.0	5.1	4.3	5.2	5.9	4.8	4.4	5.7	4.2	3.3	4.4	7.6	3.9	5.9	5.3	6.5	3.5	4.0	3.8	5.2	27.8	6.1	4.0	3.5	6.3	4.6	4.9	4.5	4.1	4.1	37.6	4.4	1.7	5.4	6.1	4.5	4.1	3.7	1.8	2.0	3.2	1.4	0.8	2.7	1.2	15.1	12.9	10.0	17.2	4.6	6.4	12.2	6.2	7.7	8.3	8.6	16.9	11.8	10.4	5.1	7.7	13.0	22.9	11.8	14.3	9.5	4.1	5.6	9.9	4.5	18.3	5.9	8.9	4.6	5.5	12.6	13.3	11.5	7.7	7.9	10.1	9.5	8.6	5.4	6.7	11.1	12.6	18.6	12.1	8.7	9.7	9.0	6.6	7.5	15.2	16.7	8.1	11.1	19.9	9.9	12.2	9.8	8.9	6.6	14.3	9.8	7.1	9.8	7.6	9.8	7.3	7.6	9.7	6.2	0.0	1.2	0.7	1.9	1.0	2.5	1.7	2.7	1.3	2.0	1.8	2.6	2.2	3.2	0.8	1.4	1.7	1.3	1.2	10.3	14.3	6.1	13.7	5.9	4.8	4.4	7.6	4.0	4.4	11.9	9.8	1.9	4.0	10.3	110.1	11.0	0.0	0.0	6.8	3.5	141.4	6.0	1.7	5.5	169.1	7.7	8.1	0.0	5.9	9.9	6.4	5.1	9.2	7.8	5.0	278.1	5.8	4.3	6.0	665.5	6.4	3.9	6.8	1.8	7.6	155.8	8.1	11.5	5.6	3.1	88.5	0.0	4.6	14.9	11.5	10.3	4.8	6.4	9.9	5.1
STK36	"FU, KIAA1278"	ENSG00000163482	"Serine/threonine kinase 36"	Q9NRP7	2	218672026-218702716	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Cilium biogenesis/degradation"	"Developmental protein, Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 63.2"	"Cell type enhanced"	"Detected in many"	8	"Ciliated cells: 20.1;Cone photoreceptor cells: 35.3;Spermatocytes: 26.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027409, HPA027453, HPA030058"	Approved		Supported	Cytosol		NA	NA			Cytosol		"HPA027409: AB_10600223, HPA027453: AB_10601893, HPA030058: AB_10601225"	"unprognostic (8.11e-2)"	"unprognostic (3.77e-1)"	"unprognostic (3.59e-2)"	"unprognostic (1.27e-1)"	"unprognostic (1.50e-1)"	"unprognostic (2.52e-2)"	"prognostic unfavorable (5.20e-4)"	"unprognostic (1.55e-1)"	"unprognostic (5.83e-3)"	"unprognostic (9.04e-2)"	"unprognostic (1.38e-2)"	"unprognostic (1.13e-2)"	"unprognostic (3.52e-3)"	"unprognostic (1.46e-1)"	"unprognostic (2.60e-2)"	"unprognostic (1.77e-1)"	"unprognostic (1.99e-3)"	4.8	10.0	7.5	4.7	11.4	2.0	6.4	7.9	11.1	9.1	7.4	7.0	11.9	4.1	14.4	13.3	5.0	13.9	9.8	3.3	6.3	3.5	10.1	4.4	6.9	3.9	2.3	6.6	13.6	9.7	12.3	23.2	3.9	7.6	9.5	6.3	9.3	7.3	8.3	3.3	4.6	5.8	7.8	5.5	4.9	7.9	63.2	4.2	3.5	11.4	3.7	5.0	9.3	7.1	1.8	1.6	3.2	1.9	2.2	1.6	1.7	2.5	5.8	12.8	10.9	14.0	10.9	7.9	7.0	5.6	8.9	8.4	7.6	4.2	3.4	9.8	7.3	6.0	5.2	8.8	7.3	7.9	1.4	7.3	3.3	17.6	10.5	6.8	4.6	5.6	11.7	5.5	8.7	6.2	23.8	6.7	4.5	7.6	4.3	7.4	5.9	2.7	5.8	7.7	3.2	3.7	5.1	5.5	3.4	10.9	12.9	10.4	8.9	5.4	8.9	3.6	13.9	9.0	3.8	6.3	12.4	4.6	4.7	4.7	5.5	4.2	1.8	7.7	2.2	5.1	0.0	1.9	3.2	1.5	1.2	0.9	1.8	1.1	1.3	1.6	0.6	1.1	1.6	0.2	2.2	1.4	1.3	1.0	1.7	7.5	11.4	7.9	11.1	6.3	3.5	2.3	6.6	7.6	4.2	8.9	4.6	1.7	1.0	1.0	7.7	2.8	5.1	20.1	1.2	3.5	35.3	1.4	0.0	2.9	11.3	2.1	2.0	0.0	2.2	1.3	1.8	1.3	1.1	4.9	2.3	1.6	2.4	4.3	2.8	4.1	5.5	1.2	0.0	1.0	4.4	5.6	1.9	3.7	4.6	3.3	9.8	6.5	2.1	26.8	8.2	0.9	0.7	1.5	3.8	0.4
STK38	NDR	ENSG00000112079	"Serine/threonine kinase 38"	Q15208	6	36493892-36547470	"Enzymes, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004673, HPA038623, HPA051324"	Uncertain		Approved	Cytosol		NA	NA			Cytosol		"CAB004673: AB_425892, HPA038623: AB_10967059, HPA051324: AB_2681442"	"unprognostic (3.58e-3)"	"unprognostic (1.80e-2)"	"unprognostic (3.07e-2)"	"unprognostic (6.76e-3)"	"unprognostic (8.25e-2)"	"unprognostic (1.47e-2)"	"unprognostic (2.88e-3)"	"unprognostic (2.08e-1)"	"prognostic unfavorable (9.44e-5)"	"unprognostic (3.78e-2)"	"unprognostic (2.18e-1)"	"unprognostic (3.21e-2)"	"unprognostic (1.98e-2)"	"unprognostic (3.80e-1)"	"unprognostic (2.59e-1)"	"unprognostic (1.69e-1)"	"unprognostic (3.13e-3)"	19.1	8.4	12.4	39.8	10.0	19.4	32.8	18.8	12.7	16.0	26.3	7.8	14.9	17.0	18.8	16.4	28.1	14.6	18.3	15.3	12.1	7.0	15.0	17.3	21.7	45.9	11.9	6.4	12.3	9.5	7.8	11.0	15.4	9.0	17.0	27.1	11.3	24.8	18.7	14.9	21.8	29.1	28.1	13.1	25.1	16.4	24.4	11.0	34.3	10.6	13.4	28.5	22.4	19.8	10.6	13.1	33.2	30.5	25.8	27.6	22.4	17.8	13.2	14.0	15.1	28.3	21.6	12.2	20.0	16.2	20.8	21.0	10.1	12.3	24.1	15.5	29.7	17.3	19.2	11.6	8.3	24.6	9.8	9.9	17.2	17.2	9.1	14.0	6.5	9.5	14.2	21.9	16.1	10.4	24.0	13.0	12.3	14.0	14.1	29.6	10.7	10.5	17.0	5.8	21.3	11.8	40.8	17.0	6.4	19.7	22.5	16.4	7.8	24.3	11.2	14.0	16.4	12.0	17.2	12.5	16.9	15.0	13.5	12.9	11.8	21.0	17.0	3.8	25.4	16.3	33.2	19.8	15.0	27.6	22.6	21.5	10.6	22.9	24.1	13.1	8.1	20.5	22.3	27.1	25.8	30.5	6.6	21.4	22.4	12.4	10.0	18.8	12.7	12.1	7.0	11.9	6.4	9.0	11.0	17.9	16.5	10.8	8.5	11.9	2.5	15.1	22.9	37.5	50.0	7.0	0.0	11.8	1.7	16.1	5.8	12.4	32.4	0.0	11.2	15.4	19.9	11.5	12.7	13.6	11.7	4.8	13.8	11.1	28.5	4.1	25.0	31.7	16.9	9.0	22.9	6.1	19.6	25.9	28.3	13.6	8.5	12.9	13.7	23.6	9.6	18.4	12.8	23.6	22.1	22.5
STK38L	"KIAA0965, NDR2"	ENSG00000211455	"Serine/threonine kinase 38 like"	Q9Y2H1	12	27243968-27325959	"Enzymes, Predicted intracellular proteins"		"Actin-binding, Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Group enriched"	"Detected in all"	5	"dendritic cells: 19.3;granulocytes: 32.2;monocytes: 13.0"	"Cell line enhanced"	"Detected in all"		"HDLM-2: 57.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038623, HPA051324"	Approved		Approved	Cytosol		NA	NA			Cytosol		"HPA038623: AB_10967059, HPA051324: AB_2681442"	"unprognostic (2.14e-2)"	"unprognostic (1.01e-1)"	"unprognostic (9.94e-2)"	"unprognostic (2.43e-2)"	"unprognostic (2.02e-1)"	"unprognostic (1.76e-1)"	"unprognostic (3.33e-2)"	"unprognostic (4.68e-2)"	"unprognostic (5.56e-2)"	"unprognostic (1.56e-1)"	"prognostic unfavorable (5.82e-4)"	"unprognostic (1.16e-1)"	"unprognostic (3.41e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.95e-1)"	"unprognostic (5.05e-2)"	"unprognostic (1.05e-2)"	21.2	8.4	11.0	14.6	10.9	10.9	27.2	9.6	14.6	13.0	26.3	5.7	9.7	8.4	23.9	18.2	16.8	14.8	18.2	30.2	10.9	7.8	8.9	8.5	10.8	7.8	11.1	11.8	9.6	8.9	30.2	15.2	10.6	11.9	15.3	15.0	6.8	14.0	10.9	9.1	10.8	14.6	52.3	17.0	7.6	15.6	7.5	10.1	10.0	8.8	10.5	9.8	21.9	22.7	4.5	19.3	32.2	13.0	4.0	4.0	5.3	4.2	5.8	15.1	6.7	6.9	4.7	11.2	2.7	4.0	1.7	2.5	7.3	3.2	9.9	6.5	2.4	5.2	7.9	6.8	4.7	2.7	57.8	5.6	6.1	7.0	3.6	5.8	15.0	7.1	5.7	4.9	6.4	8.2	11.2	13.9	12.8	7.4	7.8	3.5	3.0	9.8	16.3	17.9	11.2	8.8	3.7	17.6	7.6	2.5	8.1	2.4	8.1	12.2	7.5	4.7	15.4	3.7	5.1	5.4	6.0	5.3	8.6	7.4	2.8	2.8	10.4	3.0	7.0	2.4	6.0	13.0	22.9	4.0	11.1	2.8	4.5	3.1	3.9	19.3	3.4	3.8	3.1	32.2	4.0	8.1	8.2	4.0	5.3	11.0	10.9	9.6	14.6	10.9	7.8	11.1	11.8	11.9	10.1	17.9	14.4	9.8	27.4	31.5	11.3	44.5	10.2	9.4	20.5	8.7	2.0	10.0	8.3	41.2	13.6	21.5	19.7	0.0	35.8	7.9	16.0	21.3	16.3	13.0	27.6	9.5	18.5	18.4	33.1	2.3	6.1	48.1	20.3	45.1	27.7	7.5	51.1	31.7	11.3	10.5	6.4	19.4	50.7	6.5	12.1	28.0	23.2	12.5	20.5	39.1
STK39	"DCHT, SPAK"	ENSG00000198648	"Serine/threonine kinase 39"	Q9UEW8	2	167954020-168248141	"Enzymes, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"testis: 35.5"	"Cell type enhanced"	"Detected in many"	5	"Glandular cells: 65.7;Urothelial cells: 55.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB046022, HPA061803, HPA062802"	Enhanced		Supported	Nucleoplasm,Vesicles,Cytosol		NA	NA			Nucleoplasm	"Vesicles, Cytosol"	"CAB046022: AB_2196960, HPA061803: AB_2684616, HPA062802: AB_2684870"	"prognostic favorable (3.96e-4)"	"unprognostic (2.97e-2)"	"unprognostic (4.40e-2)"	"unprognostic (4.22e-2)"	"unprognostic (4.36e-1)"	"unprognostic (6.14e-2)"	"prognostic unfavorable (5.67e-5)"	"unprognostic (3.04e-2)"	"unprognostic (8.86e-2)"	"unprognostic (9.43e-2)"	"unprognostic (3.20e-2)"	"unprognostic (1.38e-1)"	"unprognostic (2.06e-1)"	"unprognostic (9.45e-2)"	"unprognostic (8.61e-3)"	"unprognostic (1.14e-1)"	"unprognostic (6.20e-3)"	6.2	2.1	8.4	4.6	11.0	1.3	3.5	9.3	14.1	4.3	9.1	8.3	1.7	10.5	2.3	4.7	14.1	1.9	5.9	7.6	9.8	7.4	2.9	0.8	2.4	7.3	12.3	9.7	3.2	9.9	5.0	8.2	1.2	14.2	9.9	11.7	7.1	22.8	3.8	2.2	3.4	6.1	4.3	19.0	2.5	11.2	35.5	5.5	7.2	2.2	1.8	8.0	5.6	5.3	0.7	1.0	0.0	0.7	1.9	3.4	0.5	6.7	4.1	15.5	4.9	9.5	14.1	1.5	17.0	12.5	11.4	10.6	0.0	22.0	18.7	4.7	11.0	9.9	17.7	9.9	12.4	14.3	5.9	6.1	7.7	4.5	13.8	17.8	10.4	0.8	9.7	17.7	13.5	14.1	13.8	7.7	14.7	0.1	0.0	23.9	3.9	18.1	3.7	10.7	14.0	8.6	25.8	6.1	1.5	8.6	16.8	22.9	9.7	5.9	0.9	6.9	7.7	3.1	7.6	7.3	13.8	4.3	9.7	11.1	0.0	0.0	15.0	10.5	9.3	9.3	0.0	0.7	0.0	2.5	0.4	1.3	0.7	1.9	3.4	1.0	0.7	0.4	2.0	0.0	1.9	0.3	0.3	3.3	0.5	8.4	11.0	9.3	14.1	9.8	7.4	12.3	9.7	14.2	5.5	3.0	12.3	0.8	21.2	3.4	13.8	25.8	22.9	6.7	7.9	5.2	15.7	0.1	18.3	9.7	21.3	3.5	23.2	0.0	19.9	0.0	7.3	65.7	0.0	0.0	3.5	19.1	21.9	3.1	5.1	13.5	9.5	5.2	16.9	1.0	13.9	26.9	26.4	17.3	10.6	3.8	25.3	6.5	7.2	19.9	7.7	3.9	0.2	15.2	20.4	55.5
STK4	"KRS2, MST1, YSK3"	ENSG00000101109	"Serine/threonine kinase 4"	Q13043	20	44966474-45079959	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, RAS pathway related proteins"	Apoptosis	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	10	"monocytes: 469.7;T-cells: 231.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004038, HPA015270"	Approved		Supported	"Nucleoplasm,Nuclear bodies,Cytosol"		NA	NA			"Nuclear bodies"	"Nucleoplasm, Cytosol"	"CAB004038: AB_2144632, HPA015270: AB_1854150"	"unprognostic (2.77e-1)"	"unprognostic (1.10e-1)"	"unprognostic (8.83e-2)"	"unprognostic (8.49e-3)"	"unprognostic (2.95e-2)"	"unprognostic (1.24e-1)"	"prognostic unfavorable (8.04e-4)"	"unprognostic (1.70e-1)"	"unprognostic (2.51e-1)"	"unprognostic (1.05e-1)"	"unprognostic (1.96e-1)"	"unprognostic (2.70e-2)"	"prognostic unfavorable (1.84e-5)"	"unprognostic (1.28e-1)"	"unprognostic (5.70e-2)"	"unprognostic (3.96e-1)"	"unprognostic (1.18e-2)"	9.5	8.8	10.4	24.5	11.5	39.5	8.1	7.5	13.4	7.8	8.6	10.3	5.4	8.1	9.3	6.5	8.9	7.3	9.4	6.1	9.3	8.8	6.3	7.4	18.8	30.6	10.5	9.1	8.3	6.4	5.9	9.3	8.2	7.7	7.5	10.6	7.4	9.3	8.7	4.2	11.4	16.1	8.2	12.0	29.1	9.6	7.4	9.6	32.3	8.0	4.9	36.6	11.5	8.7	10.8	6.9	40.6	13.3	10.3	14.5	7.9	11.8	8.0	10.3	7.3	6.3	7.9	7.1	10.5	16.0	17.7	16.1	22.7	6.5	28.9	9.1	7.4	14.9	12.6	10.8	14.0	22.8	12.9	5.7	21.1	11.7	16.0	11.1	27.1	30.0	6.4	11.6	16.6	18.2	8.9	6.5	19.6	9.7	16.7	8.9	9.3	20.2	18.3	6.2	7.7	5.5	13.1	11.3	13.4	6.5	8.1	4.9	6.0	15.5	9.0	11.8	8.2	8.2	17.1	8.3	13.4	13.0	15.4	12.0	21.8	17.1	32.3	13.1	13.0	9.8	24.4	7.6	20.5	14.5	7.7	14.4	10.3	13.8	13.3	6.9	10.8	14.3	11.9	40.6	10.3	13.3	3.9	13.3	7.9	10.4	11.5	7.5	13.4	9.3	8.8	10.5	9.1	7.7	9.6	14.9	24.0	181.6	40.4	49.5	24.2	7.0	15.3	16.0	18.2	40.1	49.1	20.3	8.3	14.1	4.8	32.3	20.5	0.0	15.3	21.4	24.3	25.1	129.5	19.1	53.0	41.3	24.6	22.7	103.3	3.6	21.0	108.8	126.5	469.7	17.4	20.3	16.0	25.9	15.9	10.9	64.0	12.9	30.2	36.4	43.8	46.3	16.2	231.2	17.4	36.3
STK40	"MGC4796, SgK495"	ENSG00000196182	"Serine/threonine kinase 40"	Q8N2I9	1	36339624-36385896	"Enzymes, Predicted membrane proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"Late spermatids: 181.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"neutrophil: 19.2"	"Group enriched"	"Detected in all"	5	"granulocytes: 19.2;monocytes: 8.5"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA008026	Uncertain		Supported	Nucleoplasm,Cytosol		NA	NA			Cytosol	Nucleoplasm	"HPA008026: AB_1857603"	"unprognostic (3.32e-1)"	"unprognostic (3.00e-1)"	"unprognostic (6.47e-2)"	"unprognostic (4.55e-1)"	"unprognostic (1.38e-1)"	"unprognostic (4.43e-2)"	"unprognostic (2.69e-3)"	"unprognostic (6.09e-2)"	"unprognostic (2.09e-1)"	"unprognostic (5.96e-2)"	"prognostic favorable (5.59e-4)"	"unprognostic (1.19e-1)"	"unprognostic (2.75e-2)"	"unprognostic (7.06e-2)"	"unprognostic (2.64e-1)"	"unprognostic (1.07e-2)"	"unprognostic (2.51e-2)"	22.9	7.2	9.8	15.3	9.4	9.2	26.5	8.9	11.1	10.2	19.1	7.4	16.7	9.4	11.8	12.2	22.3	11.3	18.2	25.6	10.0	7.1	14.3	23.5	16.6	15.4	13.1	7.4	22.2	34.4	9.2	14.7	19.2	12.1	15.7	9.1	9.0	25.1	17.7	53.9	17.2	10.8	26.0	10.3	17.2	17.0	32.0	8.9	9.2	14.6	20.7	16.6	19.5	26.6	2.4	2.7	19.2	8.5	1.6	2.9	2.4	7.1	3.1	15.7	16.3	11.1	6.5	8.8	7.2	9.8	8.8	9.5	17.2	10.3	30.2	5.9	6.7	9.3	7.2	14.3	3.1	6.5	13.1	11.2	19.7	2.9	21.9	11.1	11.5	26.3	5.8	11.9	6.7	3.5	4.7	5.5	23.4	24.2	11.0	5.4	11.2	11.9	15.2	10.1	12.9	4.3	13.7	10.7	20.0	5.5	8.0	19.3	9.8	5.5	8.7	24.1	10.4	5.9	13.6	9.1	5.5	11.6	16.2	15.9	11.5	6.4	25.5	28.9	10.1	18.1	1.0	3.0	4.9	2.6	6.7	2.9	2.3	1.7	1.7	2.7	2.4	1.0	1.5	19.2	1.6	8.5	2.6	1.0	2.4	9.8	9.4	8.9	11.1	10.0	7.1	13.1	7.4	12.1	8.9	11.9	18.3	19.8	48.5	54.5	12.0	21.1	2.5	6.7	7.9	10.4	3.9	4.7	14.9	14.5	92.4	11.0	27.7	0.0	27.1	8.3	15.3	55.1	12.7	19.5	21.4	9.5	22.4	12.9	20.3	181.6	21.3	21.3	28.7	14.4	12.9	4.5	23.4	14.4	31.5	10.5	9.5	25.8	30.9	12.6	8.7	65.9	47.8	14.6	10.8	43.7
STKLD1	"C9orf96, MGC43306, SGK071"	ENSG00000198870	"Serine/threonine kinase like domain containing 1"	Q8NE28	9	133376367-133406096	"Enzymes, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	7	"testis: 16.2"	"Cell type enhanced"	"Detected in many"	16	"Early spermatids: 27.3;Late spermatids: 39.6;Spermatocytes: 15.1"	"Low cancer specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in some"			"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			HPA029902	Uncertain					NA	NA					"HPA029902: AB_10603554"	"unprognostic (6.65e-2)"	"unprognostic (9.43e-3)"	"unprognostic (7.54e-4)"	"unprognostic (8.15e-2)"	"unprognostic (9.51e-2)"	"unprognostic (1.39e-2)"	"unprognostic (1.99e-2)"	"unprognostic (1.41e-3)"	"unprognostic (6.05e-2)"	"unprognostic (2.94e-4)"	"unprognostic (1.92e-4)"	"unprognostic (1.19e-1)"	"unprognostic (7.93e-2)"	"unprognostic (4.69e-2)"	"unprognostic (3.65e-1)"	"unprognostic (5.86e-2)"	"unprognostic (4.52e-2)"	0.4	0.4	0.4	0.2	1.4	0.5	0.4	0.7	2.2	0.4	0.3	2.2	1.3	0.5	0.9	2.1	0.3	0.6	0.5	0.3	0.8	0.3	0.3	0.4	0.3	0.8	0.5	1.3	0.8	0.4	0.1	0.3	0.5	1.5	0.5	0.1	0.8	0.6	0.4	0.6	0.8	0.5	0.3	0.5	0.4	0.4	16.2	0.7	0.0	0.3	0.0	0.3	0.3	0.3	0.6	0.4	0.0	0.2	0.2	0.6	0.0	0.0	0.6	0.4	0.7	0.5	0.5	1.1	0.2	0.0	0.1	0.2	0.9	0.3	0.3	0.2	0.0	0.6	0.6	0.1	0.0	0.0	0.4	0.8	0.7	0.9	0.5	0.3	0.5	0.4	0.4	0.1	0.0	0.1	0.4	0.0	1.5	0.8	1.0	0.0	0.2	0.6	0.8	0.3	0.6	1.0	0.3	0.3	0.8	0.1	0.1	1.0	1.0	0.3	0.9	2.2	0.3	1.3	0.3	0.6	1.0	0.6	0.9	0.1	2.2	2.2	0.6	0.4	0.4	0.3	0.0	0.2	0.0	0.3	0.0	0.2	0.2	0.4	0.2	0.1	0.6	0.6	0.2	0.0	0.2	0.1	0.4	0.0	0.0	0.4	1.4	0.7	2.2	0.8	0.3	0.5	1.3	1.5	0.7	0.0	0.0	0.0	1.1	0.0	3.3	1.2	2.5	0.0	1.2	0.0	2.0	3.6	8.3	0.4	27.3	0.5	0.0	0.0	1.0	0.6	0.3	0.7	0.0	1.0	0.8	1.6	0.0	0.0	0.3	39.6	2.0	0.0	0.0	0.0	0.3	1.2	0.3	0.0	1.8	1.7	2.3	0.0	0.2	15.1	3.4	0.0	2.7	0.0	0.7	0.6
STRADA	"LYK5, NY-BR-96, Stlk, STRAD"	ENSG00000266173	"STE20-related kinase adaptor alpha"	Q7RTN6	17	63682336-63741986	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Cell cycle"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	13	"monocytes: 29.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA031637	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"HPA031637: AB_10601718"	"unprognostic (1.59e-1)"	"unprognostic (2.19e-1)"	"unprognostic (5.59e-3)"	"unprognostic (5.52e-2)"	"unprognostic (8.91e-2)"	"unprognostic (7.56e-5)"	"unprognostic (6.79e-4)"	"unprognostic (3.68e-2)"	"unprognostic (1.70e-1)"	"unprognostic (2.28e-1)"	"prognostic favorable (5.34e-5)"	"unprognostic (7.29e-2)"	"prognostic unfavorable (6.08e-7)"	"unprognostic (1.40e-1)"	"unprognostic (1.44e-1)"	"unprognostic (1.25e-1)"	"prognostic favorable (6.43e-4)"	13.3	17.7	19.4	14.6	23.7	17.5	13.0	25.0	28.4	15.2	13.2	27.1	8.7	9.5	16.1	20.6	14.3	20.9	14.5	15.1	18.9	20.2	14.7	13.0	13.9	19.6	20.9	21.7	18.5	12.5	21.9	17.5	14.4	26.0	13.8	13.1	22.2	12.6	16.7	10.3	20.1	12.0	19.1	19.4	20.7	12.6	55.4	21.4	16.2	13.3	8.9	21.3	12.9	12.8	11.2	16.2	18.6	10.0	15.6	11.7	7.5	7.2	21.7	18.9	19.0	18.6	13.9	7.4	13.8	12.7	19.9	17.8	5.7	8.4	11.0	8.6	11.7	9.9	6.0	12.5	13.3	19.8	12.2	12.1	21.8	15.2	13.4	13.2	20.6	15.7	14.5	11.5	22.6	13.1	13.3	22.0	17.3	13.9	11.8	18.8	13.4	24.2	14.1	9.4	6.2	12.4	15.8	30.1	13.5	17.8	14.3	20.7	23.2	9.4	15.5	15.1	20.4	11.4	15.0	17.6	19.0	13.5	15.3	11.4	11.8	12.6	13.9	14.2	12.5	14.9	18.6	9.5	8.6	10.5	7.1	9.7	11.2	9.7	11.7	16.2	9.0	9.6	8.5	11.4	15.6	10.0	13.7	7.2	7.5	19.4	23.7	25.0	28.4	18.9	20.2	20.9	21.7	26.0	21.4	8.9	8.2	2.2	0.1	0.0	1.5	0.5	0.0	2.7	4.5	8.7	0.0	1.5	0.0	6.0	1.1	0.6	1.6	0.0	2.5	0.7	0.7	0.3	2.3	0.0	1.3	1.6	0.0	0.6	0.3	1.6	0.6	4.6	0.0	29.7	1.6	1.0	3.9	2.5	1.4	0.6	3.7	0.0	1.4	2.7	0.5	0.4	2.1	1.0	1.9	0.1
STRADB	"ALS2CR2, CALS-21, ILPIP, ILPIPA, PAPK"	ENSG00000082146	"STE20-related kinase adaptor beta"	Q9C0K7	2	201387858-201480846	"Enzymes, Predicted intracellular proteins"	"Cell cycle"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	8	"Erythroid cells: 186.9;Proximal tubular cells: 173.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"LHCN-M2: 60.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA026549, HPA028520"	Approved		Uncertain	Aggresome,Cytosol		NA	NA			Cytosol	Aggresome	"HPA026549: AB_1844779, HPA028520: AB_10604100"	"unprognostic (6.34e-2)"	"unprognostic (2.48e-1)"	"unprognostic (2.63e-1)"	"unprognostic (3.56e-3)"	"unprognostic (4.04e-2)"	"unprognostic (7.64e-2)"	"unprognostic (1.35e-1)"	"unprognostic (1.58e-1)"	"unprognostic (2.63e-3)"	"unprognostic (2.65e-2)"	"unprognostic (6.21e-2)"	"unprognostic (2.74e-2)"	"prognostic unfavorable (1.35e-4)"	"unprognostic (1.08e-1)"	"unprognostic (7.83e-2)"	"prognostic favorable (4.45e-4)"	"unprognostic (4.93e-2)"	13.8	28.6	13.8	7.9	11.7	32.7	9.2	8.8	13.5	6.4	13.7	16.9	4.9	18.8	10.3	9.5	8.9	5.7	7.9	15.2	15.3	11.5	35.2	50.5	7.2	10.1	15.8	11.0	7.8	9.1	3.9	14.1	11.6	12.7	7.1	15.9	10.1	7.1	7.7	48.3	4.4	21.3	7.4	21.0	7.3	4.7	7.8	9.4	8.3	9.7	7.8	7.7	6.2	6.2	24.1	10.4	9.7	8.6	16.3	10.4	9.6	3.9	6.8	11.9	15.2	19.4	24.6	8.4	8.0	14.0	11.2	17.0	9.0	3.8	0.0	5.3	12.7	13.8	4.0	11.5	7.6	20.3	4.6	9.4	4.8	3.2	19.9	14.7	5.6	5.4	20.8	6.9	14.3	12.8	20.9	8.4	9.2	10.2	1.7	60.3	2.1	5.1	9.8	16.0	3.7	7.0	7.0	4.6	2.9	9.5	3.2	2.0	9.8	5.5	4.2	23.6	22.7	2.2	10.8	8.1	6.9	5.3	8.7	6.1	6.7	11.8	1.8	11.6	2.5	6.4	3.4	8.0	9.7	6.0	8.6	5.4	16.7	8.0	8.6	10.4	24.1	10.4	10.3	1.6	16.3	7.5	4.6	9.5	9.6	13.8	11.7	8.8	13.5	15.3	11.5	15.8	11.0	12.7	9.4	8.9	3.4	20.8	6.4	1.9	10.4	29.0	15.3	5.3	3.4	14.0	78.5	41.3	33.2	9.4	3.0	4.9	62.6	186.9	13.6	22.9	10.8	10.0	5.7	77.9	16.8	11.1	16.3	3.1	17.8	5.8	10.0	8.3	15.1	17.2	23.2	13.5	11.0	26.2	3.5	173.8	17.1	6.5	4.1	27.0	44.7	1.3	23.3	9.6	22.7	7.7
STS	"ARSC, ARSC1"	ENSG00000101846	"Steroid sulfatase"	P08842	X	7219456-7354810	"Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins"	"Lipid metabolism, Pregnancy, Steroid metabolism"	Hydrolase	"Disease mutation, Ichthyosis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	25	"placenta: 258.8"	"Cell type enhanced"	"Detected in many"	13	"Cytotrophoblasts: 34.3;Syncytiotrophoblasts: 78.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"intermediate monocyte: 4.7"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"ASC diff: 20.3;RPMI-8226: 25.9;U-266/70: 43.0;U-698: 18.0"									HPA002904	Enhanced					NA	NA					"HPA002904: AB_1080116"	"unprognostic (1.09e-1)"	"unprognostic (3.90e-2)"	"unprognostic (1.44e-2)"	"unprognostic (2.75e-1)"	"unprognostic (6.72e-2)"	"unprognostic (1.94e-2)"	"unprognostic (2.62e-1)"	"unprognostic (1.84e-1)"	"unprognostic (8.23e-2)"	"unprognostic (4.67e-2)"	"prognostic unfavorable (3.47e-4)"	"unprognostic (4.05e-2)"	"unprognostic (2.78e-2)"	"unprognostic (2.77e-1)"	"unprognostic (2.56e-1)"	"unprognostic (1.92e-2)"	"unprognostic (1.34e-1)"	10.3	2.2	3.0	2.2	3.9	0.0	4.1	2.3	9.0	3.4	3.5	2.3	2.2	0.8	2.4	2.2	2.2	2.6	4.1	3.6	3.9	4.0	2.5	4.7	5.0	2.2	3.8	2.4	2.4	2.2	1.6	2.2	258.8	2.4	2.9	3.0	2.3	2.2	3.3	4.0	2.3	2.4	3.8	2.4	2.2	6.7	2.2	2.3	2.2	2.4	2.2	2.2	4.9	2.7	0.9	1.9	1.9	4.7	1.0	0.7	1.0	4.1	1.3	2.8	0.9	20.3	10.5	15.0	8.4	3.0	2.3	2.1	7.4	3.9	7.7	1.6	6.1	1.8	1.0	1.6	1.4	2.3	0.6	3.2	0.4	4.7	2.1	1.1	1.1	4.4	3.4	0.2	1.4	0.8	1.5	3.4	0.6	0.4	8.1	6.0	0.9	0.6	1.0	1.0	0.0	1.9	1.1	1.6	25.9	5.7	6.0	2.0	1.7	1.7	3.0	0.9	4.8	1.3	0.4	6.0	9.1	0.5	11.6	1.3	43.0	0.0	18.0	2.1	0.9	2.4	0.0	3.2	0.6	0.5	4.7	0.2	0.6	0.2	0.3	1.9	0.9	0.1	0.5	1.9	1.0	2.5	0.3	0.7	1.0	3.0	3.9	2.3	9.0	3.9	4.0	3.8	2.4	2.4	2.3	11.9	2.1	1.5	1.7	0.8	3.1	5.0	2.5	0.0	1.2	1.8	0.0	34.3	0.0	6.9	0.1	4.3	4.1	0.0	17.1	18.7	4.1	7.6	6.9	7.4	6.6	1.6	3.5	2.5	5.9	0.0	2.6	2.7	1.7	2.8	2.3	3.1	8.7	7.4	6.3	1.4	0.8	0.0	4.7	0.0	1.4	0.9	78.6	0.0	2.2	7.4
STT3A	"ITM1, MGC9042, STT3-A, TMC"	ENSG00000134910	"STT3A, catalytic subunit of the oligosaccharyltransferase complex"	P46977	11	125591712-125625215	"Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins"		"Glycosyltransferase, Transferase"	"Cancer-related genes, Congenital disorder of glycosylation, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"parathyroid gland: 202.3"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA030735	Approved		Uncertain	Nucleoplasm,Vesicles,Cytosol		NA	NA			"Nucleoplasm, Cytosol"	Vesicles	"HPA030735: AB_10603342"	"unprognostic (8.25e-3)"	"unprognostic (5.45e-2)"	"unprognostic (3.02e-2)"	"prognostic favorable (1.32e-4)"	"unprognostic (5.10e-2)"	"unprognostic (1.72e-2)"	"prognostic unfavorable (3.57e-4)"	"unprognostic (8.40e-2)"	"unprognostic (4.80e-2)"	"unprognostic (1.16e-2)"	"unprognostic (8.96e-3)"	"unprognostic (1.31e-1)"	"prognostic unfavorable (4.96e-4)"	"unprognostic (2.60e-2)"	"unprognostic (6.38e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.82e-2)"	20.6	20.5	8.3	13.1	11.7	8.3	16.9	10.7	13.9	27.8	19.3	17.7	39.6	12.0	30.5	41.4	19.6	20.8	15.1	19.5	8.3	9.1	26.2	67.1	18.7	14.9	9.3	7.7	30.1	59.0	202.3	27.5	35.9	11.6	22.2	17.4	20.8	50.7	41.4	9.5	12.9	19.8	17.1	12.3	21.8	17.7	17.1	6.7	19.2	38.6	13.6	20.8	19.5	18.0	15.0	53.2	27.0	15.5	17.2	27.5	13.4	21.0	19.2	24.5	33.6	46.2	35.8	26.3	38.5	46.0	31.3	39.2	58.2	56.9	27.4	46.7	56.6	44.4	38.9	33.9	33.7	41.7	21.3	18.0	64.5	13.2	40.2	51.1	38.6	30.3	27.6	24.5	43.4	84.8	36.9	34.9	12.3	27.1	41.1	39.5	15.5	15.5	12.3	15.7	42.1	20.9	18.4	20.9	41.2	34.2	32.7	15.2	13.2	27.2	44.5	13.7	30.0	52.2	27.8	31.2	45.2	16.3	19.0	30.2	12.9	15.1	21.1	17.4	39.1	35.8	27.0	15.5	11.6	19.7	14.8	27.5	15.0	19.1	18.2	21.6	11.6	13.8	16.0	5.4	17.2	13.0	53.2	14.1	13.4	8.3	11.7	10.7	13.9	8.3	9.1	9.3	7.7	11.6	6.7	26.8	23.5	18.2	11.3	14.3	10.2	18.6	12.7	14.7	14.8	15.7	19.6	40.7	1.7	26.7	7.6	11.9	13.5	23.3	23.5	56.2	25.7	16.7	16.2	32.7	27.0	1.6	15.0	33.2	22.3	2.6	19.8	13.2	23.6	8.2	32.3	15.2	29.5	14.0	17.7	11.9	13.8	19.4	10.3	29.9	10.9	12.9	38.1	13.3	22.9	12.9
STT3B	"FLJ90106, SIMP, STT3-B"	ENSG00000163527	"STT3B, catalytic subunit of the oligosaccharyltransferase complex"	Q8TCJ2	3	31532638-31637622	"Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins"		"Glycosyltransferase, Transferase"	"Congenital disorder of glycosylation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036448, HPA036646"	Approved		Supported	"Endoplasmic reticulum"		NA	NA		9300	"Endoplasmic reticulum"		"HPA036448: AB_2675129, HPA036646: AB_10673472"	"unprognostic (2.17e-2)"	"unprognostic (2.23e-1)"	"prognostic favorable (7.91e-5)"	"unprognostic (1.60e-1)"	"unprognostic (3.11e-1)"	"unprognostic (2.74e-2)"	"unprognostic (2.02e-2)"	"unprognostic (1.44e-1)"	"unprognostic (1.04e-1)"	"unprognostic (2.60e-1)"	"unprognostic (3.26e-3)"	"unprognostic (3.68e-2)"	"unprognostic (3.86e-2)"	"unprognostic (9.18e-2)"	"unprognostic (1.42e-1)"	"unprognostic (6.71e-3)"	"unprognostic (1.02e-1)"	23.0	30.3	16.0	27.5	16.7	21.7	27.4	15.4	19.4	28.4	25.0	16.9	37.0	18.6	28.4	37.9	28.8	22.4	29.0	27.5	15.1	15.6	28.2	64.1	30.1	36.9	16.5	15.5	62.3	39.4	36.2	20.3	85.9	16.5	26.3	25.1	22.3	25.2	26.3	31.2	19.2	29.2	23.2	19.7	29.4	22.9	36.7	13.6	60.2	44.3	23.4	30.3	27.5	27.7	3.6	7.7	8.4	5.3	8.4	8.5	3.0	16.6	28.0	25.8	27.0	32.5	32.8	56.4	31.3	27.5	23.4	27.2	25.5	36.2	29.0	15.4	28.3	19.3	14.1	23.8	27.1	30.8	81.6	15.7	24.8	28.5	27.1	25.1	53.5	29.7	25.1	29.1	33.3	42.2	36.2	23.6	37.2	13.3	46.5	31.8	9.4	52.3	33.1	20.8	27.9	15.8	54.7	14.0	42.0	27.2	24.1	11.0	13.4	31.0	46.1	18.1	23.0	20.7	28.6	45.9	31.7	20.3	31.3	27.5	29.3	35.1	24.3	28.7	36.8	26.0	2.3	4.6	8.4	4.7	5.3	7.5	3.4	8.5	6.5	4.0	3.6	8.2	6.5	1.7	8.4	3.7	7.7	4.1	3.0	16.0	16.7	15.4	19.4	15.1	15.6	16.5	15.5	16.5	13.6	80.4	51.9	42.7	51.5	60.6	48.3	64.1	56.0	40.2	88.7	41.8	64.8	58.7	11.6	32.8	125.1	35.0	40.6	0.0	38.9	84.1	47.2	61.2	31.1	58.2	50.2	42.9	43.4	38.6	46.8	186.1	33.6	58.1	49.0	9.0	50.8	36.3	38.5	49.1	30.8	26.4	33.6	25.8	38.9	61.2	52.7	54.1	79.8	62.1	51.2	55.9
STUB1	"CHIP, HSPABP2, NY-CO-7, SDCCAG7, UBOX1"	ENSG00000103266	"STIP1 homology and U-box containing protein 1"	Q9UNE7	16	680224-682870	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"DNA damage, DNA repair, Ubl conjugation pathway"	Transferase	"Disease mutation, Neurodegeneration, Spinocerebellar ataxia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB037202, CAB037209, HPA041222, HPA043531"	Enhanced		Supported	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"CAB037202: AB_1840759, CAB037209: AB_1840757, HPA041222: AB_2677368, HPA043531: AB_2678533"	"unprognostic (5.70e-2)"	"unprognostic (2.53e-1)"	"unprognostic (1.90e-1)"	"unprognostic (3.89e-1)"	"unprognostic (9.00e-2)"	"unprognostic (3.06e-1)"	"unprognostic (4.09e-3)"	"unprognostic (2.21e-1)"	"unprognostic (2.23e-1)"	"unprognostic (8.31e-2)"	"unprognostic (5.78e-2)"	"unprognostic (6.77e-2)"	"prognostic favorable (6.49e-9)"	"unprognostic (9.67e-2)"	"unprognostic (3.57e-1)"	"unprognostic (1.55e-1)"	"unprognostic (1.30e-1)"	29.4	43.7	52.2	20.1	43.2	19.3	40.5	39.1	53.3	25.1	24.8	18.1	27.6	24.1	19.7	34.9	35.2	31.1	25.5	45.2	43.2	38.6	24.0	25.9	23.6	28.1	42.0	42.5	29.4	43.4	39.8	27.2	12.1	35.0	23.4	17.7	18.6	37.7	29.7	92.5	33.7	20.9	24.5	34.5	19.7	22.8	13.8	25.4	13.1	29.1	30.2	19.4	22.3	35.9	18.0	21.0	19.4	14.5	10.3	16.9	6.9	18.0	24.5	16.6	28.0	37.9	34.7	9.5	24.6	29.0	29.3	26.1	30.4	23.1	18.3	17.5	41.3	18.9	15.4	20.4	37.1	12.2	20.1	67.6	11.4	35.3	25.4	54.6	19.1	22.7	41.3	39.8	34.3	21.7	23.1	29.6	17.9	18.3	30.6	45.3	71.5	20.7	18.8	18.5	29.0	26.8	32.1	10.9	45.0	39.1	18.0	28.9	23.5	19.8	43.5	30.9	11.0	27.7	36.7	23.4	26.9	23.6	22.2	29.6	30.3	31.3	29.5	21.2	17.3	30.3	11.9	14.5	19.4	16.9	11.9	15.4	18.0	14.6	14.7	11.7	17.3	13.6	12.9	14.0	10.3	12.4	21.0	12.2	6.9	52.2	43.2	39.1	53.3	43.2	38.6	42.0	42.5	35.0	25.4	35.7	24.7	77.5	88.5	102.0	92.7	1.1	101.9	28.1	22.7	123.9	49.1	67.7	242.1	127.5	6.6	66.9	130.5	23.3	147.7	75.3	72.2	130.8	20.7	112.4	99.1	79.4	72.9	61.4	56.4	11.8	100.9	74.8	111.3	200.2	92.2	123.1	150.1	93.1	105.4	269.6	58.7	71.1	101.9	23.5	69.3	105.3	84.2	61.0	87.3	99.9
STYK1	"DKFZp761P1010, NOK, SuRTK106"	ENSG00000060140	"Serine/threonine/tyrosine kinase 1"	Q6J9G0	12	10618939-10674318	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"		"Kinase, Transferase, Tyrosine-protein kinase"	Proto-oncogene	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 15.8;stomach 1: 16.0"	"Cell type enhanced"	"Detected in some"	8	"Ciliated cells: 8.1;Enterocytes: 12.5;Mucus-secreting cells: 8.3;Paneth cells: 9.5;Undifferentiated cells: 6.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in some"	7	"NK-cell: 12.5"	"Lineage enriched"	"Detected in many"	7	"NK-cells: 12.5"	"Cell line enhanced"	"Detected in many"		"CAPAN-2: 18.5;HDLM-2: 10.9;HMC-1: 12.1;HUVEC TERT2: 16.6;TIME: 15.4"	"Region enhanced"	"Detected in single"		"basal ganglia: 2.3"	"Not detected"	"Not detected"			"HPA040468, HPA048569"	Enhanced		Approved	"Nucleoplasm,Plasma membrane"		NA	NA			"Plasma membrane"	Nucleoplasm	"HPA040468: AB_2676998, HPA048569: AB_2680446"	"unprognostic (2.30e-1)"	"unprognostic (2.22e-1)"	"unprognostic (1.21e-1)"	"unprognostic (1.75e-1)"	"unprognostic (3.11e-2)"	"unprognostic (3.35e-2)"	"unprognostic (6.85e-2)"	"unprognostic (5.08e-3)"	"unprognostic (3.37e-1)"	"unprognostic (3.50e-1)"	"unprognostic (2.21e-3)"	"unprognostic (1.02e-1)"	"unprognostic (1.70e-14)"	"unprognostic (5.18e-3)"	"unprognostic (1.22e-1)"	"unprognostic (2.33e-1)"	"unprognostic (1.45e-2)"	0.6	0.3	2.6	2.3	10.6	1.0	3.8	0.1	13.4	2.2	14.4	0.7	0.5	2.1	0.5	1.1	8.9	1.9	6.2	0.1	1.8	1.6	0.5	0.3	1.2	2.4	1.8	4.2	0.4	0.3	0.0	8.4	3.4	2.1	10.6	15.8	0.0	7.8	2.6	0.2	2.6	10.3	0.6	0.6	1.0	16.0	0.3	0.7	0.0	0.4	0.6	2.8	4.3	3.6	0.0	0.0	0.4	0.0	12.5	1.9	0.2	3.0	0.1	0.0	0.4	0.0	0.0	0.9	4.9	0.5	2.3	2.2	1.6	18.5	0.2	3.1	1.2	2.9	0.8	1.0	5.1	4.9	10.9	0.3	0.7	1.3	0.1	0.0	1.4	12.1	0.2	0.3	3.4	0.2	0.4	16.6	0.1	0.2	0.2	5.3	1.7	0.1	0.8	2.7	7.5	1.3	0.0	1.4	0.2	1.6	9.5	0.6	0.0	2.8	2.9	0.0	4.5	2.3	0.3	15.4	0.6	2.6	0.3	0.6	0.0	0.6	0.1	2.1	0.1	3.6	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	1.3	0.4	12.5	0.0	0.0	0.0	0.2	2.6	10.6	0.1	13.4	1.8	1.6	1.8	4.2	2.1	0.7	0.0	2.1	0.0	0.6	0.2	0.4	0.4	2.5	8.1	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.1	12.5	0.0	0.2	0.5	0.0	5.9	1.1	0.0	0.0	0.0	4.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.3	0.0	3.6	9.5	0.0	0.0	0.3	0.0	0.1	0.0	0.9	0.9	0.2	0.7	6.8	4.8
SUCLA2		ENSG00000136143	"Succinate-CoA ligase ADP-forming beta subunit"	Q9P2R7	13	47745736-48037968	"Citric acid cycle related proteins, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Tricarboxylic acid cycle"	Ligase	"Disease mutation, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 89.0"	"Cell type enhanced"	"Detected in many"	6	"Early spermatids: 204.8;Late spermatids: 235.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039435, HPA039536, HPA061528"	Enhanced	Supported	Enhanced	Mitochondria		NA	NA		6600	Mitochondria		"HPA039435: AB_10673144, HPA039536: AB_2676561, HPA061528: AB_2684553"	"unprognostic (5.66e-3)"	"unprognostic (1.72e-2)"	"unprognostic (1.14e-1)"	"unprognostic (8.76e-2)"	"unprognostic (1.60e-1)"	"unprognostic (3.45e-2)"	"unprognostic (2.48e-1)"	"unprognostic (1.71e-1)"	"unprognostic (4.70e-2)"	"unprognostic (1.41e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.38e-1)"	"prognostic favorable (7.59e-14)"	"unprognostic (3.53e-1)"	"unprognostic (2.19e-1)"	"unprognostic (2.29e-1)"	"prognostic unfavorable (1.22e-4)"	21.6	18.5	19.2	8.6	22.1	5.2	17.5	29.7	32.4	15.3	15.7	11.7	15.6	24.5	12.7	12.1	14.6	11.3	9.4	42.1	20.0	21.6	34.0	12.9	7.9	11.4	22.6	19.1	14.4	10.8	19.8	14.9	12.2	28.7	16.2	16.5	8.9	13.9	14.8	89.0	10.0	22.7	14.7	18.3	9.7	12.3	8.0	15.4	15.6	16.9	25.6	10.2	11.0	12.6	17.1	29.5	12.4	25.0	23.4	25.2	17.2	15.7	18.3	23.3	13.9	26.7	20.1	14.0	24.2	27.1	25.2	17.1	32.5	18.0	22.2	18.5	23.6	15.1	22.0	30.7	23.0	31.9	21.2	26.3	24.9	17.4	21.0	18.6	25.1	14.6	19.0	27.1	17.1	20.3	21.0	18.5	25.7	16.8	8.0	25.0	10.9	25.9	28.8	24.1	54.9	23.4	22.1	21.3	17.2	36.4	15.3	12.9	15.4	20.1	18.7	14.2	26.8	16.5	22.4	14.1	14.0	9.0	19.9	16.7	8.4	13.0	25.8	8.7	18.4	20.5	5.7	24.5	12.4	17.6	25.0	21.2	17.1	19.7	21.6	29.5	16.3	25.2	24.9	4.5	23.4	20.0	24.3	21.6	17.2	19.2	22.1	29.7	32.4	20.0	21.6	22.6	19.1	28.7	15.4	23.8	12.6	14.3	29.8	28.7	43.5	135.6	17.8	20.1	17.0	29.6	11.8	41.8	139.3	28.6	204.8	21.5	31.6	0.0	15.6	35.7	34.0	31.8	33.4	11.5	26.3	42.9	18.5	18.4	16.2	235.9	34.2	23.7	40.5	27.9	17.8	38.6	17.5	36.8	43.5	98.7	33.0	38.8	40.8	31.2	27.2	27.7	43.6	13.1	28.8	31.9
SUCLG1		ENSG00000163541	"Succinate-CoA ligase alpha subunit"	P53597	2	84423523-84460045	"Citric acid cycle related proteins, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Tricarboxylic acid cycle"	Ligase	"Disease mutation, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"kidney: 125.6"	"Cell type enhanced"	"Detected in all"	10	"Distal tubular cells: 792.5;Proximal tubular cells: 1327.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036683, HPA036684"	Enhanced		Approved	"Plasma membrane,Mitochondria,Cytosol"	"Intracellular and membrane"	NA	NA		330000	Mitochondria	"Plasma membrane, Cytosol"	"HPA036683: AB_10671708, HPA036684: AB_2675248"	"unprognostic (6.84e-3)"	"unprognostic (7.16e-3)"	"unprognostic (2.58e-3)"	"prognostic unfavorable (5.23e-4)"	"unprognostic (1.02e-1)"	"unprognostic (2.11e-1)"	"unprognostic (3.63e-2)"	"unprognostic (3.49e-2)"	"unprognostic (1.02e-1)"	"unprognostic (2.00e-1)"	"unprognostic (2.36e-2)"	"unprognostic (9.24e-2)"	"prognostic favorable (2.21e-8)"	"unprognostic (4.94e-2)"	"unprognostic (2.08e-1)"	"unprognostic (2.81e-2)"	"unprognostic (1.23e-1)"	26.1	23.3	18.0	15.0	18.9	10.6	23.8	18.9	19.5	14.1	50.1	17.7	23.2	53.9	13.9	19.6	25.0	13.5	14.0	57.7	17.4	17.3	125.6	44.1	12.8	13.3	19.2	17.0	12.7	33.9	36.2	16.3	13.8	17.3	17.1	39.4	16.9	39.3	24.9	57.6	15.6	71.6	26.5	17.1	12.1	21.9	13.3	16.0	16.9	28.8	42.8	15.2	24.3	16.3	26.6	43.5	31.6	40.3	35.2	39.1	46.8	20.8	23.0	18.2	22.1	34.2	23.1	31.5	23.8	20.4	30.7	22.5	52.6	17.3	28.8	16.5	28.5	24.7	30.5	37.4	28.1	36.5	27.7	34.0	25.0	19.8	29.9	29.0	25.4	20.4	27.4	23.0	25.9	35.3	18.8	27.3	23.6	25.3	23.7	27.9	31.9	36.0	23.2	9.5	78.5	41.2	22.9	42.2	31.5	41.2	25.4	22.1	12.3	19.0	39.5	37.9	17.8	24.1	20.0	22.1	24.1	23.4	29.5	29.2	20.8	29.5	24.8	28.2	35.3	21.2	31.6	34.4	28.7	31.4	40.3	34.6	26.6	29.2	35.1	43.5	20.2	32.4	34.2	18.5	35.2	40.0	23.7	39.1	46.8	18.0	18.9	18.9	19.5	17.4	17.3	19.2	17.0	17.3	16.0	59.6	67.8	89.4	89.8	31.5	32.1	379.6	132.5	91.0	108.1	134.3	21.6	202.1	792.5	102.4	24.5	56.3	282.3	23.3	99.5	100.2	83.9	68.7	90.0	177.6	116.1	42.9	102.0	59.5	64.6	28.6	50.6	82.9	113.1	78.5	140.8	56.0	65.8	217.5	69.6	1327.5	31.0	51.8	72.6	79.7	46.4	36.1	157.6	70.5	304.8	88.9
SUCLG2		ENSG00000172340	"Succinate-CoA ligase GDP-forming beta subunit"	Q96I99	3	67360460-67654614	"Citric acid cycle related proteins, Enzymes, Plasma proteins, Predicted intracellular proteins"	"Tricarboxylic acid cycle"	Ligase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 90.9"	"Cell type enhanced"	"Detected in all"	4	"Hepatocytes: 290.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA046705, HPA051998"	Enhanced		Approved	"Plasma membrane,Mitochondria"		NA	NA		290000	Mitochondria	"Plasma membrane"	"HPA046705: AB_2679762, HPA051998: AB_2681687"	"unprognostic (1.69e-1)"	"unprognostic (2.31e-1)"	"prognostic favorable (1.08e-4)"	"unprognostic (2.12e-1)"	"unprognostic (3.10e-1)"	"unprognostic (5.32e-2)"	"unprognostic (1.87e-2)"	"unprognostic (1.69e-1)"	"unprognostic (3.88e-1)"	"unprognostic (3.26e-2)"	"unprognostic (4.61e-3)"	"unprognostic (5.59e-2)"	"prognostic favorable (2.79e-10)"	"unprognostic (3.08e-2)"	"unprognostic (2.79e-1)"	"unprognostic (1.07e-1)"	"unprognostic (1.38e-1)"	17.0	19.3	8.8	26.5	10.0	3.4	12.4	2.4	7.2	15.3	38.9	9.5	16.4	31.4	11.5	18.3	18.6	9.9	27.9	23.6	6.6	6.2	38.3	90.9	14.6	21.1	9.8	6.5	16.5	20.9	5.9	8.5	8.5	7.6	14.0	34.5	9.6	21.0	17.3	57.0	9.3	42.4	23.5	8.6	24.7	25.4	6.5	8.1	9.6	16.4	27.0	16.7	19.9	13.2	19.2	10.2	5.8	18.2	27.1	31.1	18.9	12.8	11.2	11.1	13.5	18.7	32.4	13.5	15.4	22.5	18.1	20.3	12.3	28.7	16.4	5.0	21.6	11.9	6.6	8.6	21.2	23.5	6.9	5.9	14.8	10.1	19.2	24.1	19.5	10.4	24.2	18.5	14.2	32.6	22.5	19.2	12.6	11.3	15.0	39.4	9.0	7.3	6.2	10.4	58.8	6.9	5.1	17.2	24.5	30.7	19.9	2.2	7.5	24.4	28.2	20.3	7.8	21.7	12.5	16.7	18.0	11.9	19.7	18.2	10.3	15.0	11.5	26.5	15.3	21.1	5.8	15.3	5.2	13.8	18.2	16.7	19.2	20.0	17.4	10.2	16.7	31.1	23.7	0.7	27.1	14.8	4.0	18.5	18.9	8.8	10.0	2.4	7.2	6.6	6.2	9.8	6.5	7.6	8.1	32.8	40.3	57.4	34.0	33.0	2.6	146.2	84.1	61.6	42.1	76.8	7.9	46.8	207.2	71.1	2.4	35.8	224.3	46.7	70.7	37.8	47.4	43.6	29.0	290.2	50.0	4.8	55.9	44.8	60.1	4.1	38.3	46.7	40.5	32.5	187.4	22.3	55.1	140.3	44.6	211.1	3.8	32.3	67.3	1.4	6.8	43.2	31.8	55.8	241.0	45.3
SUGCT	"C7orf10, DERP13, FLJ11808, ORF19"	ENSG00000175600	"Succinyl-CoA:glutarate-CoA transferase"	Q9HAC7	7	40134977-40860763	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		Transferase	"Disease mutation, Glutaricaciduria"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 42.1;liver: 27.6"	"Cell type enhanced"	"Detected in many"	14	"Early spermatids: 24.1;Proximal tubular cells: 61.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"naive CD4 T-cell: 4.6"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HBEC3-KT: 28.0;LHCN-M2: 16.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA026698, HPA026704, HPA026705"	Enhanced					NA	NA					"HPA026698: AB_10600191, HPA026704: AB_10600230, HPA026705: AB_10601003"	"unprognostic (4.66e-3)"	"unprognostic (3.45e-2)"	"unprognostic (2.06e-2)"	"unprognostic (3.32e-3)"	"unprognostic (5.26e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.14e-3)"	"unprognostic (1.75e-2)"	"unprognostic (2.61e-1)"	"unprognostic (1.80e-1)"	"unprognostic (5.27e-3)"	"unprognostic (7.65e-2)"	"prognostic favorable (3.93e-7)"	"unprognostic (2.62e-2)"	"unprognostic (3.38e-1)"	"unprognostic (3.41e-3)"	"prognostic unfavorable (2.53e-4)"	2.7	13.5	3.2	5.1	4.6	0.7	4.0	1.1	3.1	4.4	5.0	1.1	0.7	1.4	9.6	2.9	3.2	2.7	4.5	6.9	4.3	2.4	42.1	27.6	1.2	3.9	2.8	2.4	5.7	3.8	3.8	3.5	1.2	4.8	3.4	2.9	5.4	2.4	4.3	11.3	1.6	5.6	13.9	5.0	1.3	1.8	4.1	4.1	0.0	2.4	6.3	1.5	2.9	3.5	1.4	0.2	1.1	0.2	0.0	4.6	0.7	0.5	0.0	3.1	2.3	3.3	7.7	1.2	1.6	2.9	2.2	2.5	1.3	0.6	2.1	0.8	2.2	2.3	0.1	1.0	28.0	3.5	0.0	1.4	1.8	0.2	4.5	4.2	0.2	0.2	9.8	6.4	2.4	1.4	4.5	0.6	0.9	2.4	0.3	16.9	0.0	0.1	0.3	5.3	0.0	2.4	1.9	0.3	0.0	4.8	0.0	0.2	1.8	2.5	1.1	3.5	5.5	0.1	0.4	2.3	9.6	2.7	0.1	0.6	0.2	0.0	0.1	1.8	0.8	2.2	0.0	0.1	0.3	0.7	0.0	1.2	1.4	2.0	1.0	0.1	1.2	4.6	2.7	1.1	0.0	0.2	0.2	0.0	0.7	3.2	4.6	1.1	3.1	4.3	2.4	2.8	2.4	4.8	4.1	3.0	0.3	2.2	1.8	1.8	0.8	4.3	0.0	0.0	5.7	1.8	7.9	1.4	14.9	1.5	24.1	0.6	7.9	0.0	0.7	2.1	2.0	0.7	0.0	15.3	0.3	0.0	3.5	0.0	1.5	12.2	5.8	0.4	3.3	0.0	1.3	5.2	0.6	3.2	2.8	61.7	4.3	6.5	5.6	2.1	2.5	0.5	0.7	0.0	5.2	0.6
SULT1A1	"P-PST, STP, STP1"	ENSG00000196502	"Sulfotransferase family 1A member 1"	P50225	16	28605196-28623625	"Enzymes, Predicted intracellular proteins"	"Catecholamine metabolism, Lipid metabolism, Steroid metabolism"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 98.1"	"Cell type enhanced"	"Detected in many"	11	"Enterocytes: 529.7;Hepatocytes: 206.6;Paneth cells: 294.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	7	"classical monocyte: 50.6;intermediate monocyte: 39.2;myeloid DC: 22.9;neutrophil: 47.7;non-classical monocyte: 22.3"	"Group enriched"	"Detected in many"	26	"dendritic cells: 22.9;granulocytes: 47.7;monocytes: 50.6"	"Group enriched"	"Detected in many"	4	"EFO-21: 42.4;Hep G2: 83.9"									"HPA049500, HPA051051"	Supported					NA	NA		3700000			"HPA049500: AB_2680796, HPA051051: AB_2681327"	"unprognostic (2.57e-2)"	"unprognostic (2.80e-2)"	"unprognostic (8.40e-2)"	"unprognostic (1.30e-1)"	"unprognostic (5.60e-3)"	"unprognostic (7.63e-2)"	"unprognostic (4.17e-2)"	"prognostic favorable (7.02e-4)"	"unprognostic (1.30e-1)"	"unprognostic (2.40e-1)"	"unprognostic (6.71e-2)"	"unprognostic (2.07e-1)"	"unprognostic (3.70e-3)"	"unprognostic (1.49e-1)"	"unprognostic (4.10e-2)"	"unprognostic (7.39e-2)"	"unprognostic (1.89e-2)"	10.2	36.1	12.0	7.2	15.4	9.3	5.7	15.8	19.8	4.6	21.4	4.5	15.5	54.2	3.7	14.4	3.1	6.6	5.4	9.7	14.7	10.4	11.0	98.1	26.7	8.4	9.2	14.9	3.5	9.6	6.7	10.0	5.6	10.3	3.7	17.5	12.2	11.5	22.5	4.9	1.4	41.1	5.2	6.3	23.2	7.2	5.1	4.6	4.0	13.4	2.6	3.7	6.3	2.2	0.3	22.9	47.7	50.6	0.9	1.5	19.3	1.6	0.6	0.8	2.8	0.0	0.0	5.7	0.0	0.0	0.0	0.0	0.3	10.5	0.2	42.4	0.0	0.4	0.6	0.8	2.9	0.1	0.3	7.5	2.8	3.2	83.9	5.0	0.0	3.2	0.2	0.2	0.1	0.0	0.1	0.8	3.2	1.1	1.4	0.8	9.9	0.2	2.2	0.7	0.4	0.0	3.1	0.3	5.5	0.7	0.9	2.6	0.2	0.7	13.8	0.3	3.9	8.2	8.1	5.5	0.2	2.1	0.2	0.1	3.3	1.9	0.4	0.7	15.5	0.0	4.9	50.6	0.9	0.6	39.2	0.7	0.3	0.6	0.5	22.9	0.1	0.9	0.6	47.7	0.9	22.3	1.7	1.5	19.3	12.0	15.4	15.8	19.8	14.7	10.4	9.2	14.9	10.3	4.6	178.6	77.7	8.2	7.0	1.0	16.8	12.3	43.3	46.8	22.7	15.7	9.8	2.0	109.5	9.9	94.0	8.0	529.7	0.0	18.0	1.1	16.2	2.7	47.5	206.6	32.1	7.9	19.1	43.0	192.8	26.4	47.5	39.4	1.7	16.2	39.6	65.5	6.2	294.5	32.5	16.8	3.5	19.4	9.9	20.2	4.5	0.3	1.6	7.5	70.4	5.8
SULT1A2	"HAST4, STP2"	ENSG00000197165	"Sulfotransferase family 1A member 2"	P50226	16	28591943-28597109	"Enzymes, Predicted intracellular proteins"	"Catecholamine metabolism, Lipid metabolism, Steroid metabolism"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 37.5;liver: 26.2;seminal vesicle: 24.2"	"Cell type enriched"	"Detected in many"	5	"Enterocytes: 311.3"	"Cancer enhanced"	"Detected in many"		"liver cancer: 6.8"	"Low region specificity"	"Detected in some"			"Group enriched"	"Detected in many"	7	"classical monocyte: 10.2;intermediate monocyte: 7.0;myeloid DC: 3.5;neutrophil: 12.6;non-classical monocyte: 3.6"	"Group enriched"	"Detected in many"	16	"dendritic cells: 3.5;granulocytes: 12.6;monocytes: 10.2"	"Cell line enhanced"	"Detected in many"		"BEWO: 6.9;EFO-21: 8.8;Hep G2: 32.6"									"HPA049500, HPA051051"	Supported					NA	NA					"HPA049500: AB_2680796, HPA051051: AB_2681327"	"unprognostic (4.15e-2)"	"unprognostic (9.88e-2)"	"unprognostic (1.53e-1)"	"unprognostic (6.13e-2)"	"unprognostic (5.35e-2)"	"unprognostic (1.43e-1)"	"unprognostic (1.05e-1)"	"unprognostic (2.41e-2)"	"unprognostic (1.05e-1)"	"unprognostic (2.49e-4)"	"unprognostic (5.83e-2)"	"unprognostic (2.81e-1)"	"unprognostic (1.02e-1)"	"unprognostic (2.74e-1)"	"unprognostic (2.98e-1)"	"unprognostic (1.44e-1)"	"unprognostic (8.52e-3)"	1.0	1.9	0.6	2.5	1.0	0.5	1.2	1.6	0.7	0.3	9.8	0.6	5.9	25.7	0.5	1.1	0.9	0.6	1.6	2.1	0.8	0.5	2.3	26.2	11.9	0.3	0.6	0.6	0.9	1.4	1.0	1.2	2.7	0.7	0.3	6.8	4.6	0.9	24.2	0.2	0.2	37.5	0.2	0.6	2.7	0.7	0.3	0.2	0.5	4.5	0.5	0.2	1.9	1.1	0.2	3.5	12.6	10.2	0.4	0.5	3.9	1.3	0.7	0.6	0.5	0.1	0.3	6.9	0.7	0.0	0.1	0.0	1.3	3.0	0.2	8.8	0.2	0.1	1.2	0.3	0.5	0.2	0.4	0.4	1.3	1.7	32.6	0.5	1.1	1.3	0.2	0.6	0.5	0.1	0.4	0.2	0.6	0.7	1.5	0.1	1.6	0.2	2.1	1.0	0.3	0.3	1.3	0.2	0.6	0.1	1.3	0.4	0.9	0.2	4.6	0.0	1.1	3.2	0.6	0.4	1.7	1.0	1.3	0.5	2.4	1.3	0.3	0.4	0.5	0.5	1.1	10.2	0.1	0.3	7.0	0.5	0.1	0.2	0.2	3.5	0.2	0.3	0.3	12.6	0.4	3.6	0.8	0.4	3.9	0.6	1.0	1.6	0.7	0.8	0.5	0.6	0.6	0.7	0.2	26.8	10.8	0.5	0.5	0.2	0.2	2.0	0.0	2.7	9.1	3.5	0.0	0.1	13.3	5.9	0.1	0.8	311.3	0.0	4.1	0.2	2.6	0.2	11.5	43.6	1.3	0.0	2.9	10.4	7.9	0.8	1.4	0.2	0.0	0.0	6.8	3.7	5.0	59.6	1.4	5.6	0.5	0.0	0.4	0.7	0.1	0.1	0.2	0.0	9.8	0.9
SULT1A3	"STM, TL-PST"	ENSG00000261052	"Sulfotransferase family 1A member 3"	P0DMM9	16	30199228-30204310	"Enzymes, Predicted intracellular proteins"	"Catecholamine metabolism, Lipid metabolism, Steroid metabolism"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 27.8;intestine: 31.0"	"Cell type enhanced"	"Detected in many"	6	"Paneth cells: 24.9;Undifferentiated cells: 21.1"	"Not detected"	"Not detected"							"Group enriched"	"Detected in many"	10	"classical monocyte: 27.8;intermediate monocyte: 24.0;myeloid DC: 16.2;non-classical monocyte: 11.1"	"Group enriched"	"Detected in many"	11	"dendritic cells: 16.2;monocytes: 27.8"	"Cell line enhanced"	"Detected in all"		"CAPAN-2: 40.0;Hep G2: 54.8"									"HPA049500, HPA051051"	Supported					NA	NA		3200000			"HPA049500: AB_2680796, HPA051051: AB_2681327"	"unprognostic (2.61e-1)"	"unprognostic (1.72e-3)"	"unprognostic (1.98e-3)"	"unprognostic (4.98e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.18e-1)"	"unprognostic (7.27e-2)"	"unprognostic (2.09e-2)"	"unprognostic (2.99e-2)"	"unprognostic (2.31e-2)"	"unprognostic (2.12e-1)"	"unprognostic (1.04e-1)"	"unprognostic (9.18e-8)"	"unprognostic (2.34e-2)"	"unprognostic (2.51e-1)"	"unprognostic (1.66e-1)"	"unprognostic (9.48e-5)"	1.4	3.8	5.6	4.3	4.9	7.5	2.5	14.0	6.3	2.1	6.7			31.0	2.5	4.5	4.0	3.7	2.0	1.7	5.6	5.2	6.6	10.1	3.8	3.2	4.3		2.9	4.3	8.1	8.0	3.0		5.8	6.1		5.3	5.2	1.5	5.6	17.9	4.0	3.4	5.7	2.7	2.1			6.4		5.8	3.6	2.4	1.5	16.2	1.4	27.8	0.4	2.0	11.2	4.9	10.3	10.3	7.1	9.4	5.4	13.7	5.5	4.6	5.5	6.2	4.3	40.0	5.0	29.0	5.2	3.7	12.9	10.6	4.3	5.4	4.6	7.6	4.0	14.1	54.8	3.8	3.3	9.4	7.6	7.0	6.0	2.1	12.3	6.3	7.0	1.2	31.6	3.7	15.2	2.6	20.9	6.0	10.7	6.0	11.2	4.1	9.1	7.1	4.4	4.0	5.3	1.5	16.2	2.4	3.3	6.1	7.4	2.4	10.9	5.3	8.0	3.2	9.4	8.7	3.1	3.9	5.8	6.4	1.4	27.8	0.1	2.0	24.0	0.3	1.5	0.3	0.6	16.2	0.3	0.3	0.3	0.4	0.4	11.1	0.2	0.3	11.2											11.9	8.1	5.2	1.9	1.8	5.0	1.5	5.1	2.7	11.4	0.0	7.9	4.6	0.0	2.5	1.0	4.5	15.0	0.0	3.6	2.1	2.0	2.8	1.1	2.4	1.3	1.6	1.2	3.1	3.5	0.4	0.9	2.8	1.7	3.6	10.7	2.6	4.3	24.9	1.8	0.3	5.7	0.0	2.0	0.6	0.2	2.4	2.5	3.2	21.1	1.6
SULT1A4		ENSG00000213648	"Sulfotransferase family 1A member 4"	P0DMN0	16	29459889-29464976	"Enzymes, Predicted intracellular proteins"	"Catecholamine metabolism, Lipid metabolism, Steroid metabolism"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in many"	5	"blood: 16.7;intestine: 38.8"	"Group enriched"	"Detected in some"	5	"Alveolar cells type 1: 6.0;Club cells: 6.8"	"Not detected"	"Not detected"							"Group enriched"	"Detected in some"	13	"classical monocyte: 11.3;intermediate monocyte: 16.7;myeloid DC: 11.3;non-classical monocyte: 5.0"	"Group enriched"	"Detected in many"	16	"dendritic cells: 11.3;monocytes: 16.7"	"Cell line enhanced"	"Detected in many"		"CAPAN-2: 31.5;EFO-21: 26.2;HEL: 21.4;Hep G2: 69.1;Karpas-707: 41.2"									"HPA049500, HPA051051"	Supported					NA	NA					"HPA049500: AB_2680796, HPA051051: AB_2681327"										"unprognostic (4.14e-2)"				"unprognostic (1.04e-1)"				2.7	0.7	3.3	2.0	1.6	0.9	2.0	4.3	2.6	3.0	8.1			38.8	1.2	0.0	0.3	1.7	1.6	1.7	2.8	1.6	2.8	1.7	3.4	2.9	1.5		0.9	0.6	0.0	1.8	2.4		2.2	7.6		1.8	0.0	0.7	5.2	25.9	2.7	1.1	3.3	3.2	1.1			3.4		2.1	0.1	1.0	0.6	11.3	0.8	16.7	0.2	0.6	2.4	4.1	4.1	1.3	0.1	0.1	1.4	1.8	0.4	0.7	0.1	0.1	2.4	31.5	0.2	26.2	0.2	0.6	4.5	1.7	0.4	0.1	1.5	2.3	21.4	2.8	69.1	0.6	0.7	3.0	0.0	0.0	2.0	0.0	0.3	4.9	0.0	4.3	41.2	0.1	2.0	0.4	3.2	0.9	12.0	0.8	1.7	0.6	1.1	3.0	2.9	0.9	2.3	0.0	6.3	0.0	0.5	1.3	0.0	8.6	0.8	0.4	1.3	0.7	1.8	14.0	0.4	2.0	3.7	0.2	0.2	11.3	0.0	0.6	16.7	0.1	0.6	0.3	0.1	11.3	0.5	0.3	0.1	0.8	0.2	5.0	0.2	0.3	2.4											6.0	1.3	0.0	0.0	0.2	0.0	0.0	0.0	1.4	6.8	0.0	0.0	0.2	0.0	0.2	0.0	0.1	1.3	0.0	0.8	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.9	0.0
SULT1C3		ENSG00000196228	"Sulfotransferase family 1C member 3"	Q6IMI6	2	108247195-108265351	"Enzymes, Predicted intracellular proteins"		Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in some"	43	"breast: 91.1"	"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in some"		"breast cancer: 2.4"					"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"OE19: 3.7;U-87 MG: 1.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"									NA	NA								"unprognostic (1.14e-3)"								"unprognostic (1.78e-1)"	"unprognostic (4.13e-1)"		"unprognostic (6.64e-2)"				0.0	0.0	0.0	0.0	0.0	0.0	91.1	0.0	0.0	0.1	0.0			0.6	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.2	0.0		0.0	0.0	0.0	0.3	2.1	0.0	0.0	0.0	0.2	0.1			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	3.7	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
SULT1E1	"EST, STE"	ENSG00000109193	"Sulfotransferase family 1E member 1"	P49888	4	69841212-69860152	"Cancer-related genes, Enzymes, Predicted intracellular proteins"		Transferase	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 37.8;liver: 26.2;vagina: 15.8"	"Cell type enriched"	"Detected in some"	4	"Hepatocytes: 47.0"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in single"	8	"pons and medulla: 3.3"	"Cell type enhanced"	"Detected in single"		"neutrophil: 1.7"	"Low lineage specificity"	"Detected in single"			"Group enriched"	"Detected in some"	16	"HHSteC: 38.0;HSkMC: 17.2;hTCEpi: 14.3;HUVEC TERT2: 10.4"									"HPA028213, HPA028728, CAB047344"	Enhanced		Uncertain	"Nuclear membrane,Cytosol"		NA	NA			"Nuclear membrane, Cytosol"		"CAB047344: , HPA028213: AB_10599848, HPA028728: AB_10601894"	"unprognostic (5.60e-2)"	"prognostic favorable (4.06e-4)"	"unprognostic (2.48e-1)"	"unprognostic (1.07e-3)"	"unprognostic (2.42e-1)"	"unprognostic (1.95e-1)"	"unprognostic (1.70e-1)"	"unprognostic (1.72e-1)"	"unprognostic (1.41e-1)"	"unprognostic (2.89e-1)"	"unprognostic (3.22e-3)"	"unprognostic (8.62e-2)"	"unprognostic (6.48e-5)"	"unprognostic (2.48e-1)"	"unprognostic (4.11e-2)"		"unprognostic (5.55e-2)"	0.1	9.8	0.1	0.1	0.3	0.1	1.1	0.1	0.4	13.1	8.9	0.5	0.1	19.8	0.4	3.7	0.4	0.1	1.2	0.1	0.1	0.0	1.5	26.2	2.0	0.1	0.3	0.3	0.2	0.1	0.0	0.4	0.1	3.3	1.0	0.1	0.3	4.7	0.3	0.1	10.9	37.8	0.5	0.3	0.1	1.3	0.4	0.1	0.6	0.2	0.1	1.0	0.4	15.8	0.6	0.2	1.7	0.3	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	38.0	0.0	0.0	17.2	14.3	0.0	0.4	0.0	10.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.3	0.0	0.1	0.1	0.1	0.3	0.2	0.2	0.1	0.6	0.2	0.1	1.7	0.3	0.3	0.2	0.0	0.0	0.1	0.3	0.1	0.4	0.1	0.0	0.3	0.3	3.3	0.1	0.0	0.0	0.0	1.0	10.5	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.1	0.0	0.0	0.0	0.0	0.7	0.0	1.2	0.2	0.1	0.0	0.0	47.0	0.2	0.0	0.0	1.8	1.0	0.0	0.3	0.0	1.7	0.0	0.2	0.0	0.5	3.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	3.0	1.3	0.0	0.0	0.1
SULT2A1	"DHEA-ST, STD"	ENSG00000105398	"Sulfotransferase family 2A member 1"	Q06520	19	47870466-47886397	"Enzymes, Predicted intracellular proteins"	"Bile acid catabolism, Lipid degradation, Lipid metabolism, Steroid metabolism"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"liver: 211.7"	"Cell type enriched"	"Detected in some"	24	"Hepatocytes: 1127.7"	"Cancer enriched"	"Detected in some"	52	"liver cancer: 244.3"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in many"		"basophil: 5.3"	"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in some"	34	"Hep G2: 26.6;RT4: 18.1"					"Low region specificity"	"Detected in all"			"CAB018755, HPA041487, HPA063633"	Enhanced		Supported	Cytosol		NA	NA		210000	Cytosol		"CAB018755: AB_650242, HPA041487: AB_2677507, HPA063633: AB_2685066"			"unprognostic (2.14e-1)"				"unprognostic (6.79e-3)"							"unprognostic (6.82e-2)"	"unprognostic (1.36e-1)"		"unprognostic (1.31e-2)"	0.1	46.9	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	11.4	1.1	1.1	8.2	0.1	0.2	0.1	0.0	0.1	0.1	0.1	0.0	0.1	211.7	0.1	0.1	0.1	0.1	0.1	0.1	1.1	0.1	0.1	0.2	0.6	0.0	0.1	0.1	3.9	0.1	0.0	42.7	0.1	0.1	0.1	2.8	0.7	0.1	0.1	0.2	0.1	0.1	0.6	0.2	1.3	1.0	5.3	0.8	2.3	1.3	0.4	0.0	0.0	0.1	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.2	26.6	0.0	0.6	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.2	0.0	0.0	0.0	0.2	0.1	0.0	0.1	0.0	0.3	0.2	0.0	18.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.2	0.0	0.1	0.1	0.1	0.0	0.1	0.0	5.3	0.8	0.7	0.9	0.4	0.6	0.7	1.0	0.6	0.3	1.3	1.3	1.0	3.1	2.3	0.4	1.0	0.6	0.4	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.2	0.1	0.0	0.0	7.0	0.5	0.1	0.6	0.6	10.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	46.7	0.0	0.0	0.1	0.3	0.0	1127.7	0.0	0.0	0.0	38.6	31.7	0.0	2.8	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.4	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.5	0.8	0.0	0.3
SULT2B1	HSST2	ENSG00000088002	"Sulfotransferase family 2B member 1"	O00204	19	48552075-48599425	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Lipid metabolism, Steroid metabolism"	Transferase	"Disease mutation, Ichthyosis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 91.8;lymphoid tissue: 78.6;tongue: 79.6"	"Cell type enhanced"	"Detected in many"	13	"Glandular cells: 53.7;Suprabasal keratinocytes: 120.1;Urothelial cells: 113.8"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in some"	4	"CAPAN-2: 27.6;MCF7: 16.9;OE19: 44.8;T-47d: 13.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"HPA041724, HPA043539, HPA076510"	Enhanced		Supported	Vesicles		NA	NA			Vesicles		"HPA041724: AB_2677638, HPA043539: AB_2678540, HPA076510: "	"unprognostic (6.55e-2)"	"unprognostic (1.47e-1)"	"unprognostic (5.28e-3)"	"unprognostic (8.74e-2)"	"unprognostic (5.00e-2)"	"unprognostic (5.97e-2)"	"unprognostic (4.43e-2)"	"unprognostic (3.29e-3)"	"unprognostic (1.62e-1)"	"unprognostic (1.11e-2)"	"unprognostic (2.54e-2)"	"unprognostic (4.42e-2)"	"unprognostic (5.01e-6)"	"unprognostic (7.96e-3)"	"unprognostic (1.32e-1)"	"unprognostic (8.04e-2)"	"unprognostic (2.77e-2)"	0.1	0.1	0.1	0.3	0.1	0.0	4.0	0.1	0.2	28.7	0.8	0.0	9.2	2.9	2.2	5.2	91.8	0.3	2.3	0.0	0.1	0.1	2.5	0.1	6.5	0.0	0.2	0.0	0.1	0.2	0.8	0.1	11.4	0.0	6.9	0.0	0.0	12.4	6.9	0.2	45.7	13.4	0.0	0.1	0.0	0.7	0.2	0.0	0.5	1.1	79.6	78.6	0.6	32.0	0.7	1.5	2.5	1.0	1.1	3.1	0.9	4.5	5.8	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.3	27.6	0.0	0.0	0.0	0.2	1.4	0.0	0.1	0.0	0.1	0.1	0.0	0.2	0.2	0.0	0.0	2.5	0.0	0.8	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	16.9	0.0	0.2	0.0	44.8	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	2.3	0.1	0.0	13.8	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	2.5	0.8	0.4	2.1	0.9	3.1	0.4	1.8	1.4	0.7	0.7	0.6	1.2	1.4	1.1	1.0	1.5	1.1	0.9	0.1	0.1	0.1	0.2	0.1	0.1	0.2	0.0	0.0	0.0	17.9	0.3	0.0	28.4	21.4	0.0	0.6	2.5	4.0	13.6	8.7	0.0	2.8	0.0	11.1	0.0	0.3	8.6	0.0	1.0	2.7	2.0	53.7	0.0	0.0	0.6	0.0	4.6	0.0	0.0	0.2	0.3	0.2	11.8	0.0	7.1	1.2	10.8	7.0	0.0	0.8	0.6	0.0	2.8	0.2	7.5	120.1	1.6	0.0	2.6	113.8
SULT6B1		ENSG00000138068	"Sulfotransferase family 6B member 1"	Q6IMI4	2	37167820-37196598	"Enzymes, Predicted intracellular proteins"		Transferase		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"blood: 2.4;fallopian tube: 2.0;testis: 7.1"	"Cell type enhanced"	"Detected in single"	25	"Late spermatids: 1.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"basophil: 2.4"	"Lineage enriched"	"Detected in single"	7	"granulocytes: 2.4"	"Cell line enriched"	"Detected in some"	6	"WM-115: 7.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"									NA	NA										"unprognostic (1.86e-1)"										"unprognostic (8.98e-2)"			0.1	0.1	0.1	0.1	0.3	0.9	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	2.0	0.1	0.1	0.3	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.2	0.1	0.1	0.0	0.1	0.1	0.3	0.1	0.0	7.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	2.4	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.3	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	7.2	2.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.3	0.0	0.6	0.0	0.0	0.0	0.1	0.0	0.1	0.3	0.1	0.1	0.3	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0
SUOX		ENSG00000139531	"Sulfite oxidase"	P51687	12	55997180-56006641	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		Oxidoreductase	"Disease mutation, Epilepsy, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Hepatocytes: 41.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"T-47d: 35.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038208, HPA038209"	Approved					NA	NA		26000			"HPA038208: AB_2675892, HPA038209: AB_10672738"	"unprognostic (1.72e-1)"	"unprognostic (7.40e-2)"	"unprognostic (2.04e-1)"	"unprognostic (1.25e-2)"	"unprognostic (1.86e-1)"	"unprognostic (9.72e-3)"	"unprognostic (1.71e-3)"	"unprognostic (2.86e-3)"	"unprognostic (3.27e-2)"	"unprognostic (9.74e-2)"	"prognostic favorable (6.28e-4)"	"unprognostic (6.95e-2)"	"prognostic favorable (4.77e-7)"	"unprognostic (1.65e-1)"	"unprognostic (1.89e-1)"	"unprognostic (2.85e-2)"	"prognostic favorable (8.32e-5)"	12.2	25.4	11.9	6.4	13.3	7.5	11.9	9.7	21.3	12.4	11.8	18.8	15.4	12.8	14.5	22.2	14.1	16.0	13.6	18.9	10.5	9.8	26.8	43.4	10.5	7.0	14.2	15.8	16.1	13.5	45.6	11.9	7.6	15.2	17.5	11.7	17.5	17.4	25.0	25.9	7.0	10.4	12.9	11.6	9.6	13.4	5.5	14.4	3.2	15.1	13.4	11.4	16.5	9.6	1.6	10.0	17.6	11.8	9.2	4.6	7.1	4.7	14.0	8.9	14.4	15.1	6.5	20.5	5.6	6.2	8.0	5.6	13.6	10.4	0.5	9.7	6.7	5.4	6.3	7.0	7.0	4.5	21.1	4.7	7.2	8.4	16.3	5.8	0.1	13.6	10.3	3.0	6.7	4.9	12.0	18.8	0.7	12.9	9.9	8.3	11.5	0.2	4.8	4.0	7.3	10.2	6.4	3.7	10.0	8.9	9.4	4.5	5.9	9.9	21.6	8.0	9.1	35.0	8.8	9.6	4.1	5.3	5.1	3.8	11.3	9.7	0.6	7.1	4.3	6.1	5.9	8.1	17.6	0.1	11.8	0.0	1.6	0.7	0.0	10.0	0.2	0.5	0.2	3.2	9.2	9.4	0.2	4.6	7.1	11.9	13.3	9.7	21.3	10.5	9.8	14.2	15.8	15.2	14.4	8.9	10.4	1.4	3.2	1.1	4.6	19.7	12.7	5.3	13.6	14.0	5.9	25.0	14.9	4.4	0.5	5.2	6.7	0.0	5.5	16.5	5.1	3.2	4.6	41.5	9.0	9.5	5.8	6.7	4.9	0.7	4.0	5.3	1.7	11.8	7.3	7.7	4.3	7.0	8.5	25.1	8.0	6.5	3.1	2.1	0.9	1.9	25.7	2.2	6.8	1.7
SUPT16H	"CDC68, FACT, FACTP140, FLJ10857, FLJ14010, SPT16/CDC68"	ENSG00000092201	"SPT16 homolog, facilitates chromatin remodeling subunit"	Q9Y5B9	14	21351472-21384266	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"DNA damage, DNA repair, DNA replication, Host-virus interaction, Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB022551, HPA049787"	Enhanced		Supported	"Nucleoplasm,Nucleoli fibrillar center"		NA	NA			Nucleoplasm	"Nucleoli fibrillar center"	"CAB022551: , HPA049787: AB_2680881"	"unprognostic (1.65e-1)"	"unprognostic (2.22e-1)"	"unprognostic (3.52e-2)"	"unprognostic (7.12e-2)"	"unprognostic (7.32e-2)"	"unprognostic (1.22e-2)"	"unprognostic (1.38e-3)"	"unprognostic (1.86e-1)"	"unprognostic (7.65e-2)"	"unprognostic (4.91e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.26e-1)"	"unprognostic (6.48e-3)"	"unprognostic (1.02e-1)"	"unprognostic (7.58e-3)"	"unprognostic (9.05e-2)"	"unprognostic (5.87e-3)"	21.6	18.3	16.3	21.6	26.2	21.5	21.3	39.1	27.9	22.8	21.3	14.4	20.7	13.5	31.5	18.5	20.9	23.7	14.5	15.9	17.9	16.2	17.7	14.1	17.1	28.0	18.8	22.8	29.0	15.7	40.3	24.0	18.9	28.6	18.8	21.5	11.3	19.3	20.5	21.4	22.1	19.9	27.4	18.9	22.6	19.1	24.9	19.0	32.7	20.3	17.0	29.5	24.6	20.7	23.3	17.1	21.1	20.4	23.2	26.8	16.7	30.4	28.8	39.9	29.2	18.1	18.1	28.4	27.6	22.0	33.7	31.8	27.8	27.5	64.7	10.6	20.0	21.7	32.6	50.5	24.9	51.1	20.6	21.5	39.2	26.3	39.0	18.5	55.4	29.2	15.9	15.3	28.1	31.8	16.3	22.8	36.9	32.2	27.9	27.8	19.7	51.7	16.9	44.6	28.0	28.6	56.0	45.6	35.0	13.5	33.7	40.0	34.1	44.6	26.8	16.7	26.9	14.8	26.3	19.2	29.6	24.7	18.3	29.8	27.8	46.5	65.2	10.9	32.7	22.4	21.1	13.1	19.6	22.8	17.3	26.8	23.3	21.8	25.3	17.1	21.3	25.0	25.1	11.0	23.2	20.4	16.1	20.3	16.7	16.3	26.2	39.1	27.9	17.9	16.2	18.8	22.8	28.6	19.0	59.6	49.3	32.0	29.5	31.6	44.4	58.8	33.1	42.8	59.1	50.6	45.2	48.1	21.6	50.6	100.7	39.8	13.9	23.3	52.8	51.4	33.7	25.7	81.0	29.7	36.5	52.4	22.4	28.3	36.2	67.9	55.3	36.3	16.9	116.4	31.1	49.8	52.6	10.5	56.3	25.0	40.5	19.4	44.2	130.3	136.3	36.3	38.1	45.9	38.2	26.4
SUPV3L1	SUV3	ENSG00000156502	"Suv3 like RNA helicase"	Q8IYB8	10	69180232-69209099	"Enzymes, Predicted intracellular proteins"		"Helicase, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038380, HPA038405"	Supported		Supported	Mitochondria		NA	NA			Mitochondria		"HPA038380: AB_2675983, HPA038405: AB_10675797"	"unprognostic (4.70e-2)"	"unprognostic (1.85e-2)"	"unprognostic (2.25e-1)"	"unprognostic (1.19e-2)"	"unprognostic (3.74e-2)"	"unprognostic (3.32e-2)"	"unprognostic (1.44e-2)"	"unprognostic (1.78e-1)"	"unprognostic (1.57e-1)"	"unprognostic (9.47e-3)"	"unprognostic (1.70e-1)"	"unprognostic (1.06e-1)"	"unprognostic (5.48e-3)"	"unprognostic (5.03e-2)"	"unprognostic (1.61e-1)"	"unprognostic (5.27e-2)"	"unprognostic (1.33e-1)"	12.8	17.0	11.1	12.6	17.3	26.1	17.7	21.9	19.9	10.8	14.4	12.6	7.8	11.2	13.5	12.4	13.2	11.9	12.6	19.2	12.0	11.3	16.4	22.2	9.6	15.2	9.9	13.1	15.8	18.2	15.4	14.7	10.9	16.1	11.4	16.7	12.4	11.8	13.9	31.1	15.6	12.5	13.9	9.9	15.5	13.0	26.6	9.9	12.7	14.1	13.4	14.8	12.4	11.6	10.1	7.3	5.6	7.7	7.4	13.7	6.2	11.5	8.1	7.3	22.3	8.2	7.0	9.6	7.2	11.2	14.6	13.8	20.8	9.8	20.8	5.9	7.2	10.4	13.3	17.4	11.2	14.1	8.7	13.7	9.1	6.4	10.9	20.7	21.6	6.9	8.8	14.2	13.4	30.8	10.0	8.4	13.3	23.7	10.9	8.0	7.5	13.1	13.4	8.7	11.0	44.4	12.1	10.3	9.1	6.6	5.6	10.4	7.9	9.9	20.8	18.9	8.4	6.4	9.5	5.2	5.8	10.5	8.8	13.9	8.6	10.0	19.5	9.6	22.9	3.6	5.6	5.2	4.3	12.3	7.7	13.7	10.1	8.9	10.5	7.3	8.3	9.9	10.6	0.9	7.4	5.2	4.0	8.7	6.2	11.1	17.3	21.9	19.9	12.0	11.3	9.9	13.1	16.1	9.9	6.0	9.0	10.0	9.6	21.2	21.5	19.6	10.2	14.7	13.6	7.0	3.9	15.0	10.0	10.0	8.2	8.5	7.8	0.0	7.4	9.9	9.7	6.9	7.0	10.9	8.7	11.1	8.6	6.7	3.1	3.4	6.4	5.6	5.0	5.4	8.6	10.8	8.0	9.0	8.5	12.2	11.3	6.5	13.4	28.6	24.5	19.4	18.8	15.8	11.8	9.5
SUV39H1	"KMT1A, SUV39H"	ENSG00000101945	"Suppressor of variegation 3-9 homolog 1"	O43463	X	48695554-48709012	"Enzymes, Predicted intracellular proteins"	"Biological rhythms, Cell cycle, Differentiation, Host-virus interaction, rRNA processing, Transcription, Transcription regulation"	"Chromatin regulator, Methyltransferase, Repressor, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	10	"Extravillous trophoblasts: 24.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA						"unprognostic (4.92e-2)"	"prognostic favorable (8.93e-5)"	"unprognostic (9.51e-2)"	"unprognostic (4.18e-2)"	"unprognostic (1.75e-1)"	"unprognostic (1.66e-2)"	"unprognostic (1.36e-2)"	"unprognostic (1.94e-1)"	"unprognostic (1.03e-1)"	"unprognostic (3.59e-2)"	"unprognostic (1.13e-1)"	"unprognostic (2.43e-1)"	"prognostic unfavorable (1.91e-7)"	"unprognostic (2.29e-3)"	"unprognostic (6.47e-3)"	"unprognostic (2.01e-1)"	"unprognostic (5.67e-2)"	5.7	3.3	6.5	6.4	7.6	18.0	4.9	8.7	12.5	7.0	5.1	9.3	6.0	5.1	5.7	20.7	7.3	5.3	3.4	6.0	6.0	8.3	5.0	9.2	4.6	10.8	8.8	6.9	6.5	4.4	3.6	4.7	9.3	6.7	4.5	5.4	8.3	6.5	5.4	6.9	7.0	6.0	4.7	6.2	9.5	5.2	6.7	5.9	21.2	3.9	6.4	10.7	4.8	3.5	5.8	2.8	7.1	6.4	10.7	11.7	6.8	14.8	18.2	7.2	7.6	1.8	2.2	14.7	7.2	5.5	14.1	11.5	11.1	10.0	16.5	4.4	5.2	14.3	10.5	17.8	10.2	8.5	12.5	18.2	6.5	16.9	9.0	1.1	15.9	3.6	2.0	2.0	12.4	6.4	2.3	10.0	10.8	16.3	11.6	7.6	17.2	13.6	16.6	8.5	7.3	17.7	10.0	13.3	17.4	4.6	8.3	9.5	6.2	9.8	9.5	5.2	8.4	14.1	13.3	5.3	8.7	15.0	12.0	12.1	8.0	12.0	13.9	6.5	22.9	9.5	4.5	3.0	7.1	9.8	4.4	7.2	5.3	6.5	10.3	2.4	5.8	8.1	7.7	2.1	10.7	6.4	2.8	11.7	6.8	6.5	7.6	8.7	12.5	6.0	8.3	8.8	6.9	6.7	5.9	6.0	0.0	7.7	0.8	1.5	4.9	2.2	0.0	4.0	1.2	1.8	0.0	4.4	3.3	1.8	0.1	0.9	1.6	0.0	2.5	24.4	1.4	0.4	1.1	5.6	4.5	0.0	2.9	1.8	1.9	0.0	1.1	2.5	5.0	3.6	1.5	0.6	1.8	1.7	1.4	1.4	3.5	0.0	1.2	1.5	0.8	1.0	5.1	4.5	1.6	0.3
SUV39H2	"FLJ23414, KMT1B"	ENSG00000152455	"Suppressor of variegation 3-9 homolog 2"	Q9H5I1	10	14878820-14904315	"Enzymes, Predicted intracellular proteins"	"Biological rhythms, Cell cycle, Differentiation, Transcription, Transcription regulation"	"Chromatin regulator, Methyltransferase, Repressor, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 41.8"	"Cell type enhanced"	"Detected in many"	22	"Early spermatids: 302.5;Late spermatids: 78.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA045901, HPA057554"	Enhanced		Approved	Mitochondria		NA	NA			Mitochondria		"HPA045901: AB_10960702, HPA057554: AB_2683466"	"prognostic unfavorable (5.55e-4)"	"unprognostic (1.45e-1)"	"unprognostic (2.98e-2)"	"unprognostic (8.78e-3)"	"unprognostic (6.80e-2)"	"unprognostic (1.23e-3)"	"prognostic unfavorable (2.01e-6)"	"unprognostic (1.06e-1)"	"unprognostic (9.15e-2)"	"unprognostic (3.59e-3)"	"unprognostic (2.42e-1)"	"unprognostic (4.13e-3)"	"prognostic unfavorable (5.71e-5)"	"unprognostic (2.71e-2)"	"unprognostic (1.40e-1)"	"unprognostic (5.55e-2)"	"unprognostic (1.39e-1)"	3.0	2.9	4.7	3.4	7.4	4.9	5.2	20.0	8.6	3.1	3.8	1.6	2.1	3.2	3.8	2.3	4.0	3.0	3.2	2.4	5.4	2.8	3.5	3.8	2.7	3.6	3.3	4.4	4.2	2.4	2.4	6.3	5.1	3.3	3.9	4.7	1.6	2.4	3.6	2.4	3.3	2.9	3.7	3.0	3.4	2.7	41.8	4.4	10.3	2.8	4.9	4.0	3.3	2.8	0.8	3.1	0.5	1.8	5.6	4.0	0.8	13.7	13.1	22.0	12.5	4.1	5.0	8.6	7.5	4.6	14.0	19.9	19.6	7.9	11.1	6.8	4.5	12.3	9.7	16.3	9.1	17.3	11.3	10.8	16.7	9.3	12.1	2.4	7.5	8.0	2.4	3.2	14.2	4.4	3.1	9.6	18.9	21.5	7.5	10.3	13.5	14.8	2.1	13.6	12.6	3.5	18.4	14.5	8.9	5.9	6.6	7.3	8.1	11.7	7.3	6.3	13.5	12.9	6.5	5.6	10.1	16.3	12.3	11.9	4.3	16.1	25.5	6.2	8.2	6.5	0.5	0.4	0.3	2.8	1.8	4.0	0.8	2.4	3.5	2.2	0.6	3.8	3.6	0.3	5.6	0.5	3.1	3.7	0.8	4.7	7.4	20.0	8.6	5.4	2.8	3.3	4.4	3.3	4.4	0.0	1.0	0.0	7.0	7.3	7.4	2.4	0.0	4.0	7.9	1.8	9.8	11.4	5.0	3.5	302.5	5.2	0.9	0.0	1.8	20.4	5.5	6.6	2.3	2.9	4.3	11.1	3.4	1.8	1.8	78.4	4.4	2.4	1.7	1.0	2.8	2.4	2.2	1.1	2.5	5.0	9.8	6.5	6.6	37.0	52.7	7.8	7.4	1.8	3.9	10.9
SYK		ENSG00000165025	"Spleen associated tyrosine kinase"	P43405	9	90801787-90898549	"Cancer-related genes, Enzymes, Predicted intracellular proteins"	"Adaptive immunity, Angiogenesis, Host-virus interaction, Immunity, Innate immunity"	"Kinase, Transferase, Tyrosine-protein kinase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 38.5"	"Cell type enhanced"	"Detected in many"	6	"B-cells: 53.8;Hofbauer cells: 63.0;Kupffer cells: 79.3;Macrophages: 66.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	15	"classical monocyte: 21.4;eosinophil: 23.3;intermediate monocyte: 19.0;memory B-cell: 23.1;myeloid DC: 24.9;naive B-cell: 17.5;neutrophil: 32.8;NK-cell: 8.7;non-classical monocyte: 16.4;plasmacytoid DC: 18.5"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"Daudi: 39.4;HEL: 22.7;HL-60: 31.3;HMC-1: 20.9;REH: 26.2;THP-1: 24.1;U-698: 18.6;U-937: 22.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA001384, CAB007773"	Enhanced		Approved	"Vesicles,Plasma membrane,Cytosol"		No	NA		1000000	"Plasma membrane, Cytosol"	Vesicles	"CAB007773: AB_562232, HPA001384: AB_1080144"	"unprognostic (1.01e-1)"	"unprognostic (5.45e-2)"	"unprognostic (2.10e-1)"	"unprognostic (2.69e-2)"	"unprognostic (2.31e-1)"	"unprognostic (7.92e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.34e-1)"	"unprognostic (6.41e-2)"	"unprognostic (1.78e-2)"	"unprognostic (7.20e-2)"	"unprognostic (9.93e-2)"	"unprognostic (2.55e-3)"	"unprognostic (8.77e-2)"	"unprognostic (5.36e-3)"	"unprognostic (3.41e-2)"	"unprognostic (1.06e-2)"	7.2	3.3	6.0	38.1	9.6	18.2	6.7	1.1	4.5	3.7	10.3	6.7	1.5	12.3	2.3	6.7	16.2	6.9	6.6	5.5	7.2	3.2	8.6	2.5	13.7	36.4	9.1	2.5	2.1	8.9	25.9	3.1	5.0	6.1	4.1	8.3	2.8	8.9	1.8	1.4	8.3	22.2	3.5	11.3	38.5	7.4	5.5	7.9	30.5	18.1	7.8	32.2	8.6	7.5	23.1	24.9	32.8	21.4	8.7	0.1	10.2	7.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.6	39.4	1.1	0.0	1.3	6.1	0.8	3.2	0.0	0.0	5.4	22.7	0.0	0.0	0.0	31.3	20.9	0.0	4.5	0.0	0.4	0.0	0.0	4.9	0.6	3.2	0.0	4.8	0.0	13.7	0.2	14.8	0.0	26.2	0.0	10.8	0.8	5.9	2.1	1.8	0.0	2.8	0.0	0.1	2.5	24.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	18.6	0.0	22.1	0.0	1.4	21.4	23.3	0.1	19.0	0.1	23.1	0.0	0.0	24.9	17.5	0.0	0.0	32.8	8.7	16.4	18.5	0.0	10.2	6.0	9.6	1.1	4.5	7.2	3.2	9.1	2.5	6.1	7.9	11.9	22.7	53.8	3.7	3.1	0.9	1.6	12.7	12.0	17.0	14.0	0.0	1.2	13.3	12.6	5.5	1.1	18.4	0.0	10.9	1.3	1.1	1.8	40.6	0.9	63.0	0.0	9.9	4.9	79.3	4.7	0.6	66.0	11.8	24.4	23.8	0.0	15.3	28.1	0.0	0.3	0.1	6.5	1.0	0.7	0.7	5.0	1.1	5.3	24.7	6.5
SYNJ1	"INPP5G, PARK20"	ENSG00000159082	"Synaptojanin 1"	O43426	21	32628759-32728048	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	Endocytosis	"Hydrolase, RNA-binding"	"Disease mutation, Epilepsy, Neurodegeneration, Parkinson disease, Parkinsonism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 39.0"	"Cell type enhanced"	"Detected in many"	5	"Cone photoreceptor cells: 43.2;Rod photoreceptor cells: 40.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA011916	Enhanced		Approved	Nucleoplasm,Centrosome,Cytosol		NA	NA			"Nucleoplasm, Cytosol"	Centrosome	"HPA011916: AB_1857692"	"unprognostic (6.84e-2)"	"unprognostic (8.64e-2)"	"unprognostic (5.76e-2)"	"unprognostic (6.44e-2)"	"unprognostic (1.27e-1)"	"prognostic favorable (4.43e-4)"	"unprognostic (1.45e-1)"	"unprognostic (3.73e-3)"	"unprognostic (1.63e-1)"	"unprognostic (6.22e-3)"	"unprognostic (1.84e-2)"	"prognostic unfavorable (2.58e-4)"	"unprognostic (1.28e-1)"	"unprognostic (6.36e-2)"	"unprognostic (5.97e-2)"	"unprognostic (1.79e-1)"	"unprognostic (2.92e-1)"	5.5	6.8	13.6	5.0	25.9	20.6	4.2	19.5	39.0	4.8	4.8	6.5	0.8	3.9	4.6	5.3	3.9	4.0	5.2	5.2	18.3	18.2	7.4	5.5	6.5	5.7	16.6	18.4	4.6	4.5	10.6	10.9	9.3	33.5	3.6	5.5	7.0	3.8	4.0	4.4	5.0	4.6	5.0	7.3	6.0	4.2	9.0	5.7	3.2	6.8	1.5	4.8	4.7	3.3	0.4	3.1	11.5	6.0	0.5	3.0	1.1	5.6	2.8	5.2	5.7	9.1	7.3	10.6	11.7	6.7	7.2	6.0	6.4	2.6	2.1	3.9	7.0	9.6	5.3	9.3	6.8	8.6	6.7	8.9	14.1	9.2	3.5	4.9	5.8	12.5	4.1	5.1	12.4	6.3	5.9	11.2	7.5	10.5	12.1	9.2	5.7	5.4	4.8	3.7	6.2	6.5	5.9	11.3	7.4	7.6	4.1	5.9	4.6	14.4	9.2	5.6	7.4	7.9	7.5	12.3	11.1	5.5	8.9	6.4	6.3	7.3	4.4	8.4	11.0	8.8	3.7	3.4	7.9	1.6	6.0	2.7	0.2	2.4	2.6	3.1	0.4	2.9	2.8	11.5	0.5	5.3	1.6	3.0	1.1	13.6	25.9	19.5	28.7	18.3	18.2	16.6	18.4	33.5	5.7	6.0	4.8	2.9	2.0	4.2	21.5	7.3	5.1	4.0	2.3	1.8	43.2	13.3	5.0	1.6	14.8	7.9	4.9	0.0	1.2	7.9	3.7	2.2	3.5	3.6	8.6	9.5	2.9	8.6	19.0	8.6	2.6	7.5	1.7	1.0	2.7	19.5	2.1	3.5	4.2	5.0	40.7	6.5	3.4	16.4	10.9	2.9	31.8	6.9	4.0	4.1
SYNJ2	INPP5H	ENSG00000078269	"Synaptojanin 2"	O15056	6	157981887-158099176	"Enzymes, Predicted intracellular proteins"		"Hydrolase, RNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	4	"brain: 62.0"	"Cell type enhanced"	"Detected in many"	8	"Pancreatic endocrine cells: 88.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"GAMG: 46.3;TIME: 37.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA031575	Approved		Approved	Microtubules,Cytosol		NA	NA			Microtubules	Cytosol	"HPA031575: AB_10604101"	"prognostic unfavorable (2.63e-4)"	"unprognostic (1.94e-2)"	"unprognostic (7.61e-2)"	"unprognostic (1.25e-2)"	"unprognostic (1.48e-2)"	"unprognostic (7.68e-2)"	"unprognostic (1.24e-1)"	"unprognostic (7.06e-2)"	"unprognostic (2.91e-1)"	"unprognostic (7.29e-3)"	"unprognostic (1.26e-1)"	"unprognostic (1.36e-1)"	"prognostic unfavorable (4.02e-6)"	"unprognostic (1.66e-2)"	"unprognostic (3.75e-2)"	"unprognostic (1.75e-1)"	"unprognostic (9.45e-2)"	2.8	3.9	12.2	4.9	25.1	15.3	6.7	3.0	18.7	3.9	8.7	50.5	3.7	5.8	5.2	9.4	6.0	4.6	8.0	8.5	17.8	10.9	3.2	4.0	2.8	4.4	46.8	8.8	2.9	6.6	1.1	2.9	2.6	33.0	5.3	8.9	1.4	13.5	5.1	4.3	3.1	5.6	6.6	62.0	3.3	7.0	6.5	24.4	3.0	4.4	1.4	5.3	5.9	3.0	3.2	1.1	9.3	1.3	2.4	3.8	0.8	5.4	19.2	1.6	2.5	1.2	4.0	8.5	10.1	20.5	12.1	14.3	9.8	4.6	0.1	6.9	19.4	46.3	5.2	3.4	6.3	14.1	7.6	3.2	10.6	10.0	10.3	2.3	3.7	11.6	2.0	3.4	18.4	4.3	16.4	21.0	5.6	8.1	2.4	5.5	2.5	4.6	4.1	1.8	17.1	10.7	2.0	6.6	4.9	4.0	6.3	12.2	0.7	7.8	4.9	1.9	6.3	3.8	2.3	37.1	9.2	9.4	21.2	12.2	1.0	2.6	0.2	17.2	5.9	6.3	4.5	1.3	1.1	1.9	0.6	3.8	1.9	2.6	1.7	1.1	3.2	2.2	1.7	9.3	2.4	0.8	1.1	2.1	0.8	12.2	25.1	3.0	18.7	17.8	10.9	46.8	8.8	33.0	24.4	3.0	3.5	2.7	16.6	19.3	0.0	10.4	10.2	10.7	6.8	17.4	0.0	5.3	3.3	36.4	22.7	10.5	15.3	0.0	30.7	4.2	14.6	30.3	4.7	4.5	1.9	0.0	16.7	7.4	3.4	37.2	1.1	4.6	10.1	10.8	14.5	1.5	88.4	3.5	6.0	1.4	0.4	0.0	6.6	0.7	1.1	15.1	13.3	5.3	14.5	32.4
SYVN1	"DER3, HRD1"	ENSG00000162298	"Synoviolin 1"	Q86TM6	11	65121780-65134533	"Enzymes, Predicted membrane proteins"	"Stress response, Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	4	"Hepatocytes: 60.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"U-698: 56.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA005480, HPA024300, CAB037030"	Enhanced		Supported	"Nucleoplasm,Endoplasmic reticulum,Plasma membrane"		NA	NA			Nucleoplasm	"Endoplasmic reticulum, Plasma membrane"	"CAB037030: AB_1840939, HPA005480: AB_1079084, HPA024300: AB_1851073"	"unprognostic (1.12e-1)"	"unprognostic (3.10e-1)"	"unprognostic (1.22e-1)"	"unprognostic (2.17e-2)"	"unprognostic (2.85e-2)"	"prognostic favorable (6.88e-4)"	"unprognostic (7.67e-2)"	"unprognostic (2.50e-2)"	"unprognostic (2.64e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.59e-1)"	"unprognostic (1.12e-1)"	"unprognostic (1.77e-2)"	"unprognostic (1.56e-2)"	"unprognostic (4.89e-1)"	"unprognostic (3.85e-2)"	"unprognostic (1.16e-1)"	13.8	20.8	11.0	33.0	15.3	13.8	14.9	13.3	19.3	15.1	14.2	21.0	20.2	13.2	16.0	21.1	14.4	16.1	15.3	12.9	11.3	10.0	16.4	78.0	14.2	28.9	18.2	8.7	17.1	68.1	24.4	21.0	20.9	14.4	15.0	15.4	13.3	48.9	22.6	16.7	14.4	19.6	13.6	12.8	27.1	18.3	14.4	14.9	10.3	23.5	8.0	42.2	13.3	12.6	17.5	13.0	11.6	5.4	2.2	5.5	3.8	8.6	11.1	6.7	9.0	17.1	9.8	6.7	9.0	9.3	11.5	8.2	6.0	15.2	49.0	12.3	11.5	15.2	13.5	7.3	9.1	9.5	7.6	5.5	7.7	12.9	13.4	20.8	11.5	14.0	12.4	16.5	10.1	23.0	10.3	7.4	5.2	9.6	25.1	6.7	12.9	5.0	8.3	7.2	9.1	7.7	8.5	5.7	19.7	7.2	8.6	4.4	9.0	8.3	20.7	14.5	6.2	15.4	7.6	7.1	8.0	5.3	14.3	6.0	50.2	34.7	56.6	10.8	5.9	8.9	11.6	5.4	9.3	5.5	3.3	5.0	15.4	3.9	5.1	3.1	17.5	2.9	3.0	5.2	2.2	3.2	13.0	3.6	3.8	11.0	15.3	13.3	19.3	11.3	10.0	18.2	8.7	14.4	14.9	14.9	21.3	22.2	6.0	15.7	10.2	3.4	33.1	9.4	20.5	10.4	31.4	11.5	1.7	10.5	4.3	8.3	15.8	23.3	16.3	12.6	12.1	13.4	1.1	60.4	13.6	12.7	8.1	14.1	14.8	3.5	19.0	11.6	11.8	6.4	25.0	10.8	17.1	12.4	12.4	7.2	17.1	12.9	7.5	21.0	10.9	14.1	35.8	10.2	14.5	11.6
TAF1	"BA2R, CCG1, CCGS, DYT3, DYT3/TAF1, KAT4, NSCL2, TAF2A, TAFII250"	ENSG00000147133	"TATA-box binding protein associated factor 1"	P21675	X	71366239-71532374	"Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Transcription factors"	"Cell cycle, Host-virus interaction, Transcription, Transcription regulation"	"Acyltransferase, DNA-binding, Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes, Disease mutation, Dystonia, Mental retardation, Parkinsonism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Cone photoreceptor cells: 76.6;Erythroid cells: 70.0;Rod photoreceptor cells: 71.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA001075, CAB016283"	Supported		Supported	Nucleoplasm		NA	NA			Nucleoplasm		"CAB016283: AB_671202, HPA001075: AB_1080179"	"unprognostic (2.95e-2)"	"unprognostic (1.77e-1)"	"unprognostic (6.45e-3)"	"unprognostic (1.91e-2)"	"unprognostic (1.88e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.44e-1)"	"prognostic favorable (6.54e-4)"	"unprognostic (2.68e-2)"	"unprognostic (3.43e-2)"	"unprognostic (2.03e-1)"	"unprognostic (5.59e-2)"	"prognostic unfavorable (6.03e-4)"	"unprognostic (1.14e-2)"	"unprognostic (1.41e-1)"	"unprognostic (1.82e-2)"	"unprognostic (2.56e-2)"	20.1	16.2	15.0	17.1	19.8	16.3	17.7	20.7	18.0	20.7	15.5	23.8	17.1	10.0	25.4	17.1	14.4	19.1	16.1	12.9	15.4	12.0	11.9	12.9	13.8	17.8	18.5	16.5	23.9	17.5	25.5	19.3	15.4	17.3	16.9	15.4	20.8	14.5	16.1	19.6	16.8	17.1	18.3	17.2	21.3	15.8	12.2	21.3	19.4	20.1	12.0	18.7	18.4	15.8	5.0	4.7	5.2	4.8	4.2	4.9	1.8	11.4	10.0	11.4	7.7	9.1	15.9	7.1	8.6	8.0	9.0	7.5	7.5	6.9	10.7	7.3	9.5	8.0	10.9	15.9	6.8	11.6	7.1	13.9	12.8	13.1	7.3	6.6	24.2	12.3	9.2	6.9	9.7	18.4	8.1	9.4	8.3	17.3	26.0	9.1	8.1	13.4	10.7	13.1	12.8	13.1	12.3	23.2	13.1	6.1	14.9	6.1	9.4	23.9	8.4	10.5	9.4	6.1	12.9	11.8	10.7	9.0	8.6	5.9	11.2	10.3	13.8	5.9	19.5	7.9	4.4	4.1	1.1	4.4	2.8	3.8	3.0	4.6	4.5	4.7	5.0	4.4	4.9	5.2	4.2	4.8	3.5	3.1	1.8	15.0	19.8	20.7	18.0	15.4	12.0	18.5	16.5	17.3	21.3	29.8	25.3	10.9	8.1	10.5	33.8	14.8	5.1	13.4	34.2	3.5	76.6	6.7	1.7	5.1	2.0	23.9	8.4	70.0	6.0	4.9	10.4	8.4	22.0	12.1	7.7	15.9	10.9	19.0	15.4	1.8	20.4	17.0	5.0	6.4	15.4	18.7	6.4	14.0	20.8	3.6	71.6	0.0	14.2	6.0	8.9	15.2	4.8	13.8	14.6	7.6
TALDO1		ENSG00000177156	"Transaldolase 1"	P37837	11	747329-765024	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Pentose shunt"	Transferase	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 204.6"	"Cell type enhanced"	"Detected in all"	6	"monocytes: 1009.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"eosinophil: 148.6;neutrophil: 204.6"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA048089			Approved	Nucleoplasm,Cytosol		NA	NA		39000000	Nucleoplasm	Cytosol	"HPA048089: AB_2680260"	"unprognostic (5.29e-2)"	"unprognostic (1.78e-2)"	"unprognostic (3.47e-1)"	"unprognostic (9.65e-3)"	"unprognostic (2.97e-2)"	"unprognostic (4.15e-2)"	"prognostic unfavorable (2.29e-4)"	"unprognostic (9.78e-2)"	"unprognostic (4.27e-2)"	"unprognostic (1.74e-1)"	"unprognostic (7.97e-3)"	"unprognostic (2.94e-1)"	"unprognostic (1.59e-1)"	"unprognostic (9.99e-2)"	"unprognostic (1.20e-1)"	"unprognostic (2.37e-1)"	"unprognostic (1.16e-3)"	39.0	24.2	26.6	34.8	31.3	117.4	44.2	20.6	38.3	27.7	28.5	51.2	18.8	34.2	20.4	20.7	90.0	23.2	33.2	37.5	29.2	23.6	45.8	48.4	37.9	60.0	46.5	26.6	23.4	31.9	14.6	15.8	34.3	30.7	28.3	23.7	15.5	38.3	19.5	31.2	38.4	29.4	40.4	47.5	45.6	35.8	14.8	33.0	34.1	42.2	82.4	43.1	51.4	37.5	8.5	36.1	204.6	60.8	5.9	10.4	45.3	42.2	53.5	15.5	29.3	32.1	18.7	45.7	32.1	41.4	31.8	26.3	22.7	92.2	23.6	43.7	42.1	24.6	45.7	24.5	34.7	16.6	30.8	49.7	40.8	20.7	79.4	34.3	65.2	60.9	15.3	28.0	21.4	17.4	23.0	43.7	29.8	52.9	39.5	29.5	40.4	37.9	77.3	24.3	62.0	43.4	31.6	18.2	84.5	57.8	24.6	38.3	13.4	30.0	62.0	31.1	14.4	29.4	49.6	58.0	14.6	13.7	11.5	30.1	16.7	16.2	28.0	32.4	57.0	58.9	64.7	60.8	148.6	5.6	23.2	6.1	8.5	7.5	6.8	36.1	6.8	6.1	5.7	204.6	5.9	23.2	14.8	10.4	45.3	26.6	31.3	20.6	38.3	29.2	23.6	46.5	26.6	30.7	33.0	131.0	100.4	88.6	136.2	65.4	45.6	40.9	122.3	141.8	86.4	143.1	13.7	355.3	212.2	199.7	61.7	74.4	141.1	280.4	236.4	383.3	78.6	213.8	155.0	128.2	368.8	47.7	97.4	79.8	301.9	17.2	109.0	235.0	133.3	1009.1	137.9	126.1	238.1	181.4	97.9	218.5	43.3	71.1	73.5	122.7	154.7	72.6	440.3	79.1	199.9	251.7
TAMM41	"C3orf31, DKFZp434E0519, MGC16471"	ENSG00000144559	"TAM41 mitochondrial translocator assembly and maintenance homolog"	Q96BW9	3	11790442-11846919	"Enzymes, Predicted intracellular proteins"	"Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism"	"Nucleotidyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036834, HPA044861"	Uncertain		Approved	Cytosol		NA	NA			Cytosol		"HPA036834: AB_10672270, HPA044861: AB_2679116"	"unprognostic (2.40e-2)"	"unprognostic (4.41e-2)"	"prognostic favorable (1.23e-4)"	"unprognostic (4.45e-2)"	"unprognostic (1.44e-2)"	"unprognostic (5.60e-2)"	"unprognostic (2.03e-5)"	"unprognostic (1.57e-1)"	"unprognostic (2.35e-1)"	"unprognostic (3.95e-1)"	"unprognostic (1.60e-1)"	"unprognostic (7.33e-3)"	"unprognostic (3.78e-2)"	"unprognostic (2.04e-1)"	"unprognostic (1.63e-1)"	"unprognostic (7.34e-2)"	"unprognostic (3.59e-3)"	13.9	12.9	21.8	15.9	27.5	9.1	15.7	25.6	19.8	12.5	12.2	14.2	12.5	11.5	17.7	23.7	15.2	12.4	10.0	13.8	13.9	11.5	12.4	12.0	18.7	25.0	11.3	15.3	21.7	12.9	12.5	15.4	9.9	11.4	10.7	12.0	11.2	11.7	14.2	15.2	17.3	10.4	15.0	13.7	12.3	10.1	14.1	14.8	12.7	10.8	8.4	17.4	13.8	13.8	8.7	8.9	7.7	7.1	7.1	11.3	5.0	4.2	7.9	9.7	6.7	10.5	13.3	17.9	6.5	4.7	10.0	10.0	9.5	7.0	16.2	9.6	6.8	4.4	5.2	16.2	9.8	13.0	6.0	15.3	9.6	7.6	11.0	12.3	17.6	5.1	7.6	14.6	9.4	10.6	6.6	15.4	12.9	14.1	5.0	12.8	12.2	9.9	13.2	7.7	6.6	16.9	9.9	5.5	14.2	15.3	10.4	4.5	3.9	5.7	7.4	10.8	11.4	9.6	8.0	4.0	5.2	6.0	15.6	9.2	3.9	9.5	8.3	6.3	15.0	4.8	2.2	5.3	7.7	7.2	3.6	9.2	8.7	11.3	7.0	8.9	8.0	10.4	10.6	0.2	7.1	7.1	6.6	8.7	5.0	21.8	27.5	25.6	19.8	13.9	11.5	11.3	15.3	11.4	14.8	6.0	6.5	7.3	7.8	3.8	10.6	8.1	0.0	10.7	5.7	3.5	11.8	10.3	8.3	9.7	1.6	5.8	2.8	0.0	8.0	9.1	4.6	5.4	2.3	5.7	8.1	9.5	2.9	4.9	6.5	1.1	7.2	7.2	3.3	4.6	7.3	10.8	6.6	3.5	6.0	7.9	14.0	0.0	6.2	8.4	11.9	3.6	5.8	9.5	7.6	4.6
TAOK1	"FLJ14314, KIAA1361, MAP3K16, MARKK, PSK2, TAO1"	ENSG00000160551	"TAO kinase 1"	Q7L7X3	17	29390464-29551904	"Enzymes, Predicted intracellular proteins"	"Apoptosis, DNA damage, DNA repair"	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA007669	Approved		Uncertain	Vesicles		NA	NA		13000	Vesicles		"HPA007669: AB_1080201"	"unprognostic (1.46e-1)"	"unprognostic (7.15e-3)"	"unprognostic (2.70e-2)"	"unprognostic (1.52e-1)"	"unprognostic (1.81e-2)"	"unprognostic (4.85e-2)"	"unprognostic (1.28e-2)"	"unprognostic (4.31e-2)"	"unprognostic (1.15e-1)"	"unprognostic (6.91e-2)"	"unprognostic (1.61e-1)"	"unprognostic (1.36e-1)"	"unprognostic (2.85e-2)"	"unprognostic (5.53e-3)"	"unprognostic (3.57e-1)"	"unprognostic (1.66e-1)"	"unprognostic (2.62e-1)"	17.2	11.5	19.1	11.9	25.0	12.7	13.3	20.1	24.4	15.8	11.9	22.2	7.9	7.1	14.9	10.8	12.7	11.0	11.6	15.3	18.7	15.5	13.6	10.6	13.2	11.1	30.0	17.6	13.5	9.3	31.7	13.7	14.3	21.8	12.0	10.7	10.9	11.1	13.3	15.0	13.8	9.8	17.7	21.0	13.0	10.8	14.3	23.5	11.7	17.7	6.0	11.2	14.5	17.1	2.4	4.8	5.5	2.1	1.4	3.0	0.9	13.7	24.5	19.3	8.2	14.4	18.3	8.1	13.0	13.9	11.9	12.6	13.2	4.8	8.5	12.7	21.1	12.8	10.8	17.6	9.0	21.6	17.8	13.0	13.6	14.1	7.0	10.5	15.0	12.6	12.0	11.6	17.6	18.1	12.6	16.3	8.7	13.9	7.8	15.6	9.2	11.8	5.6	8.2	7.6	6.3	10.9	27.2	5.9	11.3	19.9	10.7	13.1	22.3	20.9	13.4	20.4	15.1	13.9	23.6	18.3	14.9	16.0	18.2	7.2	15.4	9.9	13.4	9.4	16.5	1.7	1.9	1.5	2.0	2.1	1.6	1.6	2.0	2.4	1.7	2.4	3.0	2.2	5.5	1.4	1.9	4.8	1.2	0.9	19.1	25.0	20.1	22.7	18.7	15.5	30.0	17.6	21.8	23.5	44.7	47.4	18.4	23.0	39.5	53.4	78.7	30.6	24.1	38.7	43.6	92.3	15.2	13.3	23.9	10.7	41.3	21.4	0.0	20.9	13.5	47.9	34.5	27.7	23.6	25.9	49.3	36.1	51.5	65.2	12.5	36.8	44.8	38.8	23.4	20.1	35.6	30.2	21.2	50.9	15.9	48.3	25.8	36.8	55.4	33.6	40.1	31.5	19.8	18.0	38.2
TAOK2	"KIAA0881, MAP3K17, PSK, PSK1, TAO1, TAO2"	ENSG00000149930	"TAO kinase 2"	Q9UL54	16	29973641-29992261	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Ito cells: 44.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA010650	Approved		Supported	Nucleoplasm,Nucleoli,Cytosol		NA	NA			"Nucleoplasm, Cytosol"	Nucleoli	"HPA010650: AB_1080204"	"unprognostic (7.30e-2)"	"unprognostic (1.78e-1)"	"prognostic unfavorable (2.51e-4)"	"prognostic favorable (3.87e-5)"	"unprognostic (8.46e-2)"	"unprognostic (2.14e-3)"	"unprognostic (6.08e-2)"	"unprognostic (1.12e-3)"	"unprognostic (1.01e-2)"	"unprognostic (1.60e-1)"	"prognostic favorable (4.78e-4)"	"unprognostic (3.85e-3)"	"prognostic favorable (3.66e-4)"	"unprognostic (7.42e-3)"	"unprognostic (3.17e-1)"	"unprognostic (7.47e-2)"	"unprognostic (1.37e-1)"	27.8	24.1	26.2	15.1	26.7	12.3	17.7	29.2	30.6	13.5	13.6	21.5	11.8	18.5	16.8	13.0	12.4	14.1	15.1	17.6	25.0	18.2	13.9	10.4	23.0	14.4	22.1	22.7	15.8	16.3	26.2	18.7	22.5	20.7	13.6	9.6	15.0	17.1	15.9	22.8	20.0	19.3	14.8	14.9	26.3	16.0	21.2	20.2	14.0	15.9	9.8	11.5	12.8	18.0	2.6	3.3	4.8	2.8	2.0	3.2	2.0	11.2	21.5	11.8	18.6	13.9	9.3	18.1	20.7	11.1	14.0	13.1	17.2	15.1	12.2	17.6	14.9	9.4	17.6	10.7	10.4	7.6	18.9	22.7	13.1	21.7	17.2	10.1	12.9	25.3	10.9	9.1	14.9	6.0	9.8	23.4	11.7	11.8	12.4	13.3	20.8	15.0	18.3	11.4	8.4	14.5	27.7	17.1	11.3	8.8	10.6	13.9	11.2	11.8	15.8	6.2	7.9	19.8	14.6	32.6	24.2	11.2	17.1	11.9	18.1	11.6	11.5	14.8	14.8	17.6	1.3	2.8	1.5	2.9	2.7	3.1	2.0	2.9	2.6	1.8	2.6	1.6	1.4	4.8	2.0	1.4	3.3	3.2	2.0	26.2	26.7	29.2	30.6	25.0	18.2	22.1	22.7	20.7	20.2	8.9	11.5	2.2	4.2	9.5	13.3	8.1	5.1	4.0	7.9	8.7	37.3	6.7	1.7	7.6	3.1	27.6	23.3	0.0	10.2	4.8	9.3	5.8	3.5	9.7	8.4	9.5	12.6	44.2	12.4	2.1	11.5	5.5	6.8	4.6	14.9	8.7	12.7	14.2	12.0	6.4	19.2	6.5	7.6	21.1	17.2	8.4	10.1	9.2	13.3	5.7
TAOK3	"DPK, JIK, MAP3K18"	ENSG00000135090	"TAO kinase 3"	Q9H2K8	12	118149801-118372945	"Enzymes, Predicted intracellular proteins"	"DNA damage, DNA repair"	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	5	"Rod photoreceptor cells: 324.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HMC-1: 42.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA017160	Approved		Uncertain	Mitochondria		NA	NA			Mitochondria		"HPA017160: AB_1851994"	"unprognostic (3.21e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.65e-1)"	"unprognostic (3.74e-2)"	"unprognostic (5.18e-2)"	"unprognostic (2.09e-1)"	"unprognostic (4.80e-1)"	"unprognostic (5.86e-2)"	"unprognostic (1.00e-1)"	"unprognostic (7.38e-2)"	"unprognostic (2.76e-2)"	"unprognostic (8.23e-2)"	"unprognostic (1.08e-2)"	"unprognostic (2.08e-2)"	"unprognostic (4.14e-3)"	"unprognostic (2.56e-1)"	"unprognostic (1.44e-1)"	14.6	16.2	31.9	24.1	31.0	30.8	14.6	44.3	33.5	11.6	21.2	17.2	10.3	23.1	15.2	11.4	16.0	9.8	16.9	15.1	27.8	31.7	14.0	15.3	19.4	26.3	25.7	20.8	17.5	10.9	20.2	23.6	11.9	20.7	25.6	21.3	12.0	13.6	14.6	18.5	17.0	31.6	15.3	23.7	24.2	20.9	8.9	28.6	28.3	18.1	9.9	26.9	18.5	18.3	20.9	22.4	38.2	37.8	36.4	27.8	17.1	8.3	5.8	4.3	3.8	10.7	13.1	4.9	8.8	10.0	5.1	6.7	2.9	13.0	25.6	2.9	11.7	7.4	7.6	3.7	7.8	8.0	9.2	3.2	30.2	2.9	3.8	12.5	30.9	42.6	8.8	9.4	16.1	23.7	10.8	16.3	15.3	17.5	3.0	9.3	5.9	16.3	20.3	1.7	3.9	3.1	9.5	5.9	2.7	4.8	14.5	0.8	4.3	8.1	3.7	11.2	2.0	7.6	23.2	25.3	8.8	1.5	8.2	7.5	2.9	2.8	20.3	12.5	21.4	11.8	38.2	17.0	37.6	27.8	23.3	26.2	20.9	21.2	24.1	22.4	19.3	18.8	24.5	37.7	36.4	37.8	20.9	19.3	17.1	31.9	31.0	44.3	33.5	27.8	31.7	25.7	20.8	20.7	28.6	32.8	78.2	81.8	42.2	31.3	72.1	47.4	63.7	6.7	30.7	43.6	200.3	29.7	59.7	35.4	11.4	29.2	94.6	23.3	52.0	83.1	34.9	47.7	159.8	52.0	71.7	38.1	24.1	26.4	84.7	8.2	35.9	117.0	33.7	141.5	60.6	40.4	64.9	98.2	44.9	27.2	324.3	45.3	40.5	20.5	22.8	27.5	36.6	86.3	58.2	47.4
TARS		ENSG00000113407	"Threonyl-tRNA synthetase"	P26639	5	33440696-33469539	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Protein biosynthesis"	"Aminoacyl-tRNA synthetase, Ligase, RNA-binding, tRNA-binding"	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA037425	Approved		Approved	"Actin filaments,Cytosol"		NA	NA		170000	Cytosol	"Actin filaments"	"HPA037425: AB_10672279"	"prognostic unfavorable (6.14e-5)"	"unprognostic (5.13e-2)"	"unprognostic (9.04e-2)"	"prognostic unfavorable (5.17e-4)"	"unprognostic (9.10e-2)"	"unprognostic (1.07e-3)"	"prognostic unfavorable (9.88e-7)"	"unprognostic (1.43e-1)"	"unprognostic (1.61e-1)"	"unprognostic (2.65e-3)"	"unprognostic (5.97e-3)"	"unprognostic (1.56e-2)"	"prognostic unfavorable (9.63e-4)"	"unprognostic (1.37e-1)"	"unprognostic (5.15e-2)"	"unprognostic (1.18e-1)"	"unprognostic (7.25e-2)"	17.4	25.6	10.2	16.0	13.1	19.2	17.7	14.4	17.2	12.7	22.1	12.3	18.7	11.6	18.3	19.7	31.0	12.2	11.9	19.1	10.3	10.9	19.2	57.0	17.2	12.7	17.5	7.8	21.3	27.6	21.3	27.0	18.5	16.8	13.9	24.7	10.8	42.1	15.8	25.1	11.7	21.7	21.2	19.5	18.3	21.2	9.6	15.4	17.6	22.8	27.3	21.2	21.8	21.9	13.1	16.0	14.2	12.6	24.0	15.0	9.7	29.7	24.9	20.9	29.5	13.8	26.2	30.4	33.5	28.4	25.3	28.7	30.4	18.6	11.8	12.2	27.6	41.7	21.3	44.5	33.1	52.3	17.5	16.2	17.2	64.0	17.3	43.0	27.6	18.4	25.0	53.2	34.9	45.2	15.8	27.1	29.6	33.7	31.9	32.4	16.5	21.5	9.5	22.2	27.1	18.5	18.3	37.1	17.4	28.8	23.8	12.3	13.9	31.0	22.7	22.1	19.3	11.9	24.7	14.3	19.9	29.7	15.7	23.5	18.8	37.0	18.5	22.2	36.4	21.6	14.2	11.6	10.5	15.0	12.6	14.1	13.1	12.7	15.0	16.0	11.5	11.6	14.7	1.5	24.0	10.1	8.8	12.1	9.7	10.2	13.1	14.4	17.2	10.3	10.9	17.5	7.8	16.8	15.4	23.8	23.7	38.9	37.6	25.4	23.3	57.6	35.7	26.8	39.8	17.4	17.7	32.0	41.4	75.9	12.6	24.1	36.2	93.5	83.0	34.9	31.7	29.7	61.2	66.0	28.4	42.9	39.5	25.8	26.4	6.0	17.8	26.3	10.1	83.8	30.4	67.9	95.7	33.7	22.6	30.4	36.0	12.9	31.5	24.1	22.1	17.2	43.6	22.4	28.9	37.7
TARS2	"FLJ12528, TARSL1"	ENSG00000143374	"Threonyl-tRNA synthetase 2, mitochondrial"	Q9BW92	1	150487364-150507609	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Protein biosynthesis"	"Aminoacyl-tRNA synthetase, Ligase"	"Disease mutation, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA028626	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"HPA028626: AB_10601719"	"unprognostic (2.48e-1)"	"unprognostic (7.75e-2)"	"unprognostic (6.68e-2)"	"unprognostic (3.75e-3)"	"unprognostic (2.03e-1)"	"unprognostic (1.62e-1)"	"unprognostic (4.93e-2)"	"unprognostic (2.14e-1)"	"unprognostic (9.35e-2)"	"unprognostic (4.26e-2)"	"unprognostic (2.25e-1)"	"unprognostic (3.76e-2)"	"unprognostic (9.23e-2)"	"unprognostic (9.29e-3)"	"unprognostic (4.19e-2)"	"unprognostic (1.14e-2)"	"unprognostic (5.55e-2)"	10.7	21.1	16.5	10.5	17.8	9.2	11.3	17.5	21.4	10.2	10.9	14.8	12.9	9.4	10.5	14.7	15.7	13.0	11.8	20.9	18.1	12.3	15.6	26.8	9.1	14.0	15.0	19.7	13.3	11.5	20.4	12.2	9.4	16.5	9.8	12.5	13.3	11.3	10.9	36.0	13.3	10.5	10.9	13.8	15.1	12.4	10.7	16.6	10.6	12.3	12.2	15.7	12.5	10.8	21.5	17.4	20.4	18.6	21.5	20.9	12.2	17.2	14.4	9.7	14.7	11.0	10.1	18.5	8.4	9.2	16.7	16.8	11.7	16.1	25.0	18.6	6.3	11.5	18.0	23.6	19.5	12.8	15.0	20.5	11.8	13.7	11.8	10.9	16.3	18.1	8.9	16.4	12.6	17.2	10.9	10.7	14.0	20.5	17.6	11.6	20.8	13.7	13.3	12.0	23.9	21.5	14.2	12.4	30.9	11.3	8.1	13.8	16.2	12.7	28.2	19.8	14.4	22.7	25.5	6.3	9.7	10.4	8.0	14.1	17.0	20.0	18.8	14.5	19.0	9.4	15.1	11.0	20.4	15.7	18.3	15.6	21.5	15.4	15.5	17.4	18.6	15.1	15.8	1.7	21.5	18.6	11.7	20.9	12.2	16.5	17.8	17.5	21.4	18.1	12.3	15.0	19.7	16.5	16.6	3.0	13.8	7.2	4.6	3.0	15.8	19.0	12.7	10.7	12.5	7.0	19.6	21.6	10.0	9.9	0.9	6.3	6.6	0.0	8.6	11.4	6.0	3.8	21.9	15.3	11.8	14.3	4.1	7.4	6.5	2.1	7.8	8.0	3.3	16.2	8.9	8.4	9.9	0.0	6.7	6.3	15.4	6.5	7.2	15.4	11.1	3.4	11.8	7.0	10.8	4.1
TARSL2	FLJ25005	ENSG00000185418	"Threonyl-tRNA synthetase like 2"	A2RTX5	15	101653598-101724604	"Enzymes, Predicted intracellular proteins"	"Protein biosynthesis"	"Aminoacyl-tRNA synthetase, Ligase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 47.7"	"Cell type enhanced"	"Detected in many"	5	"Rod photoreceptor cells: 78.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in all"	4	"B-cells: 9.7;NK-cells: 9.0;T-cells: 6.1"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA066697	Enhanced		Approved	Cytosol		NA	NA			Cytosol		"HPA066697: AB_2685705"	"unprognostic (9.33e-3)"	"unprognostic (2.13e-2)"	"unprognostic (1.88e-1)"	"unprognostic (2.54e-1)"	"unprognostic (8.44e-2)"	"unprognostic (1.92e-1)"	"unprognostic (8.45e-2)"	"unprognostic (3.40e-2)"	"unprognostic (3.24e-2)"	"unprognostic (7.77e-2)"	"unprognostic (2.26e-3)"	"unprognostic (9.76e-3)"	"unprognostic (4.00e-2)"	"unprognostic (2.23e-1)"	"unprognostic (7.52e-2)"	"unprognostic (6.48e-3)"	"unprognostic (2.79e-2)"	7.4	6.9	15.1	6.4	20.2	4.8	7.5	15.8	16.2	7.2	7.1	20.2	5.5	6.2	6.5	6.0	6.3	6.5	5.9	21.0	16.9	13.8	8.3	5.9	6.2	6.5	20.0	11.2	11.0	9.8	12.9	10.5	3.7	15.7	9.2	6.2	4.0	7.1	9.7	47.7	4.9	6.5	6.9	19.9	6.2	8.5	5.4	18.9	3.9	9.6	8.0	7.1	7.0	7.8	9.7	2.0	1.6	1.7	9.0	6.1	1.0	2.1	4.0	6.9	3.7	7.4	5.8	3.5	7.4	4.9	5.8	3.6	5.9	1.9	2.8	2.9	8.9	4.7	6.3	12.1	4.3	5.4	3.2	19.5	6.9	2.6	4.6	3.4	3.1	1.4	4.1	4.0	2.7	3.4	6.9	4.1	6.1	6.7	6.1	5.7	3.5	1.7	6.1	8.4	10.6	2.8	3.5	10.5	7.2	4.8	2.1	11.0	6.8	10.0	3.9	4.0	13.3	2.5	6.3	5.5	2.8	6.6	5.6	2.4	8.5	9.5	3.5	7.3	5.6	5.1	0.9	1.1	1.6	3.4	1.7	3.4	4.8	6.1	5.2	0.8	9.7	5.9	3.2	0.3	9.0	0.7	2.0	1.0	1.0	15.1	20.2	15.8	16.2	16.9	13.8	20.0	11.2	15.7	18.9	0.0	5.6	26.9	18.3	16.1	51.2	37.0	5.1	12.0	11.4	5.2	41.2	2.7	16.6	7.6	13.2	12.5	18.0	0.0	10.8	4.0	18.6	13.9	24.3	14.7	4.6	30.2	23.6	8.0	8.9	5.7	21.9	8.6	10.1	9.0	13.5	34.6	17.6	9.3	17.7	17.7	78.2	19.4	16.7	27.4	21.3	10.3	3.5	31.7	12.6	7.1
TAT		ENSG00000198650	"Tyrosine aminotransferase"	P17735	16	71565660-71577130	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Phenylalanine catabolism, Tyrosine catabolism"	"Aminotransferase, Transferase"	"Disease mutation, Mental retardation, Palmoplantar keratoderma"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	44	"liver: 387.0"	"Cell type enriched"	"Detected in some"	42	"Hepatocytes: 3069.2"	"Cancer enriched"	"Detected in some"	10	"liver cancer: 152.8"	"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in some"	5	"Daudi: 2.4;Hep G2: 7.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"									NA	NA						"unprognostic (3.66e-3)"	"unprognostic (1.29e-1)"	"unprognostic (8.17e-2)"	"unprognostic (2.21e-1)"	"unprognostic (1.67e-1)"	"unprognostic (1.01e-2)"	"prognostic favorable (6.51e-4)"	"unprognostic (1.69e-1)"	"unprognostic (9.32e-2)"	"unprognostic (2.27e-1)"	"unprognostic (3.73e-3)"	"unprognostic (1.88e-1)"	"unprognostic (1.27e-4)"	"unprognostic (1.19e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.09e-1)"	"unprognostic (1.05e-2)"	0.0	0.0	0.0	0.0	0.0	0.0	8.8	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	387.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.1	0.0	0.1	0.0	0.0	1.9	2.6	1.5	0.4	0.2	0.5	0.2	0.1	0.2	0.2	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.4	0.5	0.2	7.3	0.0	0.9	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.2	0.0	0.0	0.9	0.0	0.2	0.4	0.0	0.1	0.0	0.7	0.9	0.0	0.1	0.3	0.1	0.6	0.0	0.2	0.0	0.1	0.0	0.0	0.1	0.4	0.0	0.0	0.5	0.2	0.5	0.0	0.3	0.2	1.5	0.4	0.2	0.3	0.1	0.4	1.2	0.5	0.4	0.2	1.9	0.5	0.5	1.5	0.2	0.1	2.6	0.1	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	14.0	0.0	0.0	0.2	0.3	73.9	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.9	0.0	1.0	23.3	0.6	0.0	0.0	0.0	0.0	3069.2	0.0	0.0	0.0	53.4	61.8	0.6	0.6	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.9	0.0	0.0	0.9	1.5	0.0	0.0	0.0	0.0	0.0
TBCK	"HSPC302, MGC16169"	ENSG00000145348	"TBC1 domain containing kinase"	Q8TEA7	4	106041599-106321495	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"			"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+ SV40 Large T+: 25.3;BJ hTERT+ SV40 Large T+ RasG12V: 44.5;HBF TERT88: 30.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039951, HPA051611"	Uncertain		Approved	"Nucleoplasm,Nucleoli fibrillar center"		NA	NA			"Nucleoplasm, Nucleoli fibrillar center"		"HPA039951: AB_10795300, HPA051611: AB_2681550"	"unprognostic (1.65e-1)"	"unprognostic (2.60e-2)"	"unprognostic (8.47e-2)"	"unprognostic (1.12e-1)"	"unprognostic (8.06e-2)"	"unprognostic (1.13e-3)"	"unprognostic (1.55e-1)"	"unprognostic (3.81e-1)"	"unprognostic (8.68e-2)"	"unprognostic (1.85e-1)"	"unprognostic (3.67e-2)"	"unprognostic (1.80e-1)"	"prognostic favorable (3.20e-4)"	"unprognostic (8.17e-3)"	"unprognostic (1.69e-1)"	"unprognostic (1.12e-1)"	"unprognostic (2.29e-1)"	12.8	19.0	14.2	7.6	15.2	3.4	10.0	16.3	15.2	13.5	8.3	10.0	11.0	4.4	10.9	14.9	10.6	13.0	13.2	9.3	12.1	11.1	17.8	10.5	9.6	6.9	15.0	8.5	17.5	8.2	12.6	24.2	13.7	12.1	11.9	9.1	9.0	9.1	14.6	4.2	8.5	7.2	13.3	10.3	8.5	8.1	12.0	13.8	18.5	13.9	4.6	8.9	14.5	10.7	10.7	6.3	11.9	6.8	5.9	8.4	4.2	0.9	2.5	5.2	1.9	19.6	12.3	0.9	3.9	6.3	25.3	44.5	4.5	3.9	1.7	5.9	13.2	3.7	2.3	3.5	4.8	30.4	2.4	1.0	5.4	2.1	4.7	5.1	2.2	3.2	11.4	4.0	2.3	4.0	11.1	6.6	3.2	4.2	2.1	7.7	3.4	2.8	2.1	1.2	6.6	1.8	2.1	3.2	3.6	6.6	4.5	2.8	2.2	3.4	2.4	3.4	7.3	3.4	4.9	3.7	4.5	2.2	1.0	1.9	1.0	2.8	3.7	6.2	3.3	2.3	11.9	6.4	6.3	6.2	6.8	7.2	6.2	6.8	8.4	6.3	10.7	7.4	6.7	0.5	5.9	4.6	6.1	6.7	4.2	14.2	15.2	16.3	15.2	12.1	11.1	15.0	8.5	12.1	13.8	17.9	28.0	8.9	5.8	2.1	19.0	6.7	5.1	14.7	20.5	14.0	19.6	9.6	3.3	3.8	35.4	8.2	3.8	0.0	0.8	5.5	7.0	4.2	10.5	4.4	5.8	11.1	5.2	9.8	4.7	28.9	10.3	4.3	5.0	2.8	6.4	10.1	2.1	5.8	12.0	6.9	15.8	0.0	3.8	10.4	8.2	2.0	6.2	6.9	5.5	4.2
TBK1	NAK	ENSG00000183735	"TANK binding kinase 1"	Q9UHD2	12	64451880-64502108	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, RAS pathway related proteins"	"Antiviral defense, Host-virus interaction, Immunity, Innate immunity"	"Kinase, Serine/threonine-protein kinase, Transferase"	"Amyotrophic lateral sclerosis, Disease mutation, Glaucoma, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA045797, HPA060211"	Uncertain		Enhanced	Nucleoplasm,Vesicles		NA	NA			Nucleoplasm	Vesicles	"HPA045797: AB_2679457, HPA060211: AB_2684222"	"unprognostic (4.73e-2)"	"unprognostic (8.46e-2)"	"unprognostic (6.07e-3)"	"unprognostic (1.90e-1)"	"unprognostic (1.94e-1)"	"unprognostic (1.28e-1)"	"prognostic unfavorable (3.30e-4)"	"unprognostic (1.26e-1)"	"prognostic unfavorable (3.48e-4)"	"unprognostic (1.69e-1)"	"unprognostic (2.54e-2)"	"unprognostic (1.24e-2)"	"prognostic unfavorable (4.20e-6)"	"unprognostic (4.35e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.26e-2)"	"unprognostic (9.56e-3)"	19.1	23.3	13.7	16.8	17.1	32.3	19.1	17.8	20.5	14.9	18.3	10.0	14.1	18.0	17.0	15.1	15.3	13.8	15.6	11.7	14.7	15.6	15.4	20.8	17.8	18.3	20.2	13.6	15.6	11.1	13.1	27.2	40.6	21.1	16.3	12.9	10.1	15.0	18.3	24.8	12.1	21.4	17.2	18.8	24.6	14.5	27.9	16.9	3.4	13.3	12.6	16.7	18.4	19.6	9.7	8.2	22.5	11.9	16.3	11.8	5.9	13.4	15.4	8.8	12.8	15.8	16.0	19.4	14.7	21.5	13.9	13.2	8.7	8.2	18.8	12.8	15.9	20.1	12.7	11.3	12.4	16.4	17.3	10.8	20.2	11.2	12.0	17.3	20.6	25.2	12.0	11.3	13.9	13.4	24.1	18.5	7.2	15.4	27.4	17.9	16.4	0.6	16.1	17.6	12.3	9.0	9.6	9.8	18.1	15.1	24.4	7.4	10.7	19.4	20.0	14.3	15.3	20.4	15.0	17.1	12.5	12.1	10.0	14.4	17.4	30.2	18.3	15.8	11.4	16.1	22.5	7.3	16.6	11.0	11.9	11.8	9.7	8.0	11.0	8.2	7.6	2.8	7.1	15.1	16.3	10.6	1.9	9.5	5.9	13.7	17.1	17.8	20.5	14.7	15.6	20.2	13.6	21.1	16.9	17.9	15.6	14.7	23.9	9.7	18.4	10.0	7.6	18.7	19.4	21.0	9.8	24.9	10.0	17.0	24.8	24.1	10.7	0.0	20.6	24.3	13.6	35.1	41.6	14.3	18.1	17.5	16.6	16.5	19.0	20.1	17.8	26.2	13.5	27.9	8.0	13.0	14.3	10.2	19.4	11.6	15.8	25.8	17.8	49.9	12.9	13.0	77.5	25.8	9.3	32.4
TBXAS1	"CYP5, CYP5A1, THAS, TS, TXAS, TXS"	ENSG00000059377	"Thromboxane A synthase 1"	P24557	7	139777051-140020325	"Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism, Prostaglandin biosynthesis, Prostaglandin metabolism"	"Isomerase, Monooxygenase, Oxidoreductase"	"Disease mutation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 67.1;lymphoid tissue: 51.7"	"Group enriched"	"Detected in many"	5	"granulocytes: 69.3;Hofbauer cells: 78.3;Kupffer cells: 159.9;Macrophages: 116.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	13	"basophil: 38.1;classical monocyte: 44.5;eosinophil: 45.2;intermediate monocyte: 67.1;myeloid DC: 18.7;neutrophil: 38.8;non-classical monocyte: 56.4"	"Group enriched"	"Detected in all"	20	"dendritic cells: 18.7;granulocytes: 45.2;monocytes: 67.1"	"Cell line enhanced"	"Detected in some"		"NB-4: 35.3;PC-3: 11.4;RPTEC TERT1: 10.1;U-937: 28.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"HPA031257, HPA031258, HPA031259"	Enhanced					NA	NA		32000000			"HPA031257: AB_2673812, HPA031258: AB_2673813, HPA031259: AB_2673814"	"unprognostic (4.46e-2)"	"unprognostic (3.07e-1)"	"unprognostic (8.80e-2)"	"unprognostic (1.12e-1)"	"unprognostic (2.72e-1)"	"unprognostic (9.41e-2)"	"unprognostic (5.10e-2)"	"unprognostic (3.12e-1)"	"unprognostic (2.38e-1)"	"unprognostic (3.07e-2)"	"unprognostic (1.11e-1)"	"unprognostic (3.03e-2)"	"prognostic unfavorable (1.14e-4)"	"unprognostic (1.52e-1)"	"unprognostic (5.00e-3)"	"unprognostic (8.53e-2)"	"unprognostic (5.34e-2)"	13.5	7.7	6.6	17.6	8.9	13.8	5.4	1.5	5.6	3.7	6.3	13.9	0.8	6.5	3.2	4.1	3.4	5.0	13.9	3.7	7.6	5.7	6.1	8.1	20.3	43.9	12.6	2.0	2.5	3.1	1.4	3.5	9.0	9.0	5.2	8.6	4.4	8.2	2.6	1.6	1.9	9.3	7.9	19.3	51.7	7.1	2.0	12.7	7.5	2.4	2.2	6.1	9.3	2.5	1.3	18.7	45.2	67.1	1.5	2.2	25.1	0.1	3.0	0.1	0.0	0.6	1.9	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	5.9	0.0	0.1	0.0	0.0	0.0	0.0	4.6	0.4	8.3	0.0	0.0	0.8	2.8	7.4	1.0	0.0	0.0	0.4	0.5	1.1	0.0	0.2	1.0	0.3	0.0	1.0	35.3	0.1	8.3	11.4	1.3	0.0	0.5	10.1	0.0	0.1	0.5	0.1	0.0	0.3	0.0	0.0	6.7	0.9	0.3	0.1	0.7	0.5	2.4	0.4	0.1	0.2	28.7	0.9	38.1	44.5	45.2	1.1	67.1	1.7	1.3	2.2	0.6	18.7	0.5	0.3	0.2	38.8	1.5	56.4	3.3	2.0	25.1	6.6	8.9	1.5	5.6	7.6	5.7	12.6	2.0	9.0	12.7	3.0	16.2	6.0	0.9	0.3	1.0	0.8	7.6	1.4	2.3	1.8	5.9	0.4	8.3	4.3	0.4	2.9	0.1	0.0	8.4	0.6	0.8	7.4	69.3	4.0	78.3	3.2	1.7	18.4	159.9	0.4	0.3	116.3	3.3	16.2	2.0	3.2	3.9	7.0	0.0	4.6	3.8	19.4	0.9	0.4	0.4	0.5	0.5	14.9	2.7	1.0
TDG		ENSG00000139372	"Thymine DNA glycosylase"	Q13569	12	103965804-103988874	"Enzymes, Predicted intracellular proteins"	"DNA damage, DNA repair, Transcription, Transcription regulation"	"Activator, Chromatin regulator, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA052263	Supported		Supported	"Nucleoplasm,Plasma membrane"		NA	NA			Nucleoplasm	"Plasma membrane"	"HPA052263: AB_2681777"	"unprognostic (3.15e-1)"	"unprognostic (1.36e-1)"	"unprognostic (9.89e-3)"	"unprognostic (6.93e-2)"	"unprognostic (3.66e-2)"	"unprognostic (1.13e-1)"	"prognostic unfavorable (6.27e-5)"	"unprognostic (1.56e-2)"	"prognostic unfavorable (6.90e-5)"	"unprognostic (5.37e-2)"	"unprognostic (1.82e-1)"	"unprognostic (8.48e-2)"	"prognostic unfavorable (1.90e-10)"	"unprognostic (3.68e-1)"	"unprognostic (2.90e-1)"	"unprognostic (1.11e-1)"	"unprognostic (1.16e-1)"	12.3	16.6	7.0	17.9	11.1	15.9	12.8	10.7	13.4	17.7	14.7	10.0	11.3	11.0	15.8	17.8	23.8	12.4	12.8	12.0	7.7	6.9	13.4	17.4	13.7	19.7	8.7	7.9	14.4	13.2	11.0	21.0	27.9	10.8	13.0	16.8	10.9	13.2	11.3	11.1	16.3	18.7	17.8	8.8	19.8	13.1	5.8	8.1	33.4	12.4	15.3	19.6	13.3	14.7	18.9	41.4	18.8	24.3	14.2	13.6	7.2	13.3	6.8	21.5	12.5	5.3	4.8	21.7	10.1	4.2	14.2	8.0	11.6	6.1	31.6	6.2	8.4	2.3	9.0	25.6	11.9	11.2	12.9	20.7	24.8	10.3	5.2	5.0	30.7	18.8	5.6	15.9	10.5	8.5	8.7	13.9	18.7	27.7	5.3	6.8	14.0	34.3	17.3	26.0	9.9	10.9	35.4	11.1	11.2	15.5	19.8	28.3	19.6	12.3	14.5	9.0	13.2	23.2	16.6	8.4	4.4	7.3	4.7	12.0	11.6	15.3	27.1	4.9	16.6	8.5	18.5	24.3	18.8	13.6	16.3	10.3	17.7	13.0	11.2	14.9	18.9	13.5	12.1	16.0	14.2	15.9	41.4	12.6	7.2	7.0	11.1	10.7	13.4	7.7	6.9	8.7	7.9	10.8	8.1	35.7	18.4	41.0	33.6	70.2	45.5	23.0	35.7	40.2	40.9	31.4	25.5	58.2	31.5	66.4	3.9	43.9	26.9	23.3	46.9	70.7	38.1	38.3	38.3	30.1	39.3	33.4	78.4	36.2	38.6	2.1	25.3	39.1	15.1	39.7	39.8	23.0	64.5	34.5	28.3	18.0	37.1	45.3	30.7	9.9	25.0	89.8	131.0	39.9	38.9	48.0
TDO2	"TDO, TPH2"	ENSG00000151790	"Tryptophan 2,3-dioxygenase"	P48775	4	155854738-155920406	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Tryptophan catabolism"	"Dioxygenase, Oxidoreductase"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	32	"liver: 187.9"	"Cell type enriched"	"Detected in some"	8	"Hepatocytes: 1048.1"	"Cancer enriched"	"Detected in many"	18	"liver cancer: 35.7"	"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"EFO-21: 8.6;HDLM-2: 16.7;U-87 MG: 9.8"	"Group enriched"	"Detected in some"	9	"cerebellum: 7.0;hippocampal formation: 5.9"	"Not detected"	"Not detected"			HPA039611	Uncertain		Uncertain	"Plasma membrane,Cytosol"		NA	NA			"Plasma membrane, Cytosol"		"HPA039611: "	"unprognostic (1.10e-1)"	"unprognostic (3.00e-3)"	"unprognostic (3.84e-2)"	"unprognostic (1.95e-1)"	"unprognostic (7.06e-2)"	"unprognostic (3.50e-1)"	"unprognostic (1.18e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.00e-1)"	"unprognostic (2.13e-2)"	"unprognostic (1.42e-1)"	"unprognostic (1.01e-1)"	"unprognostic (4.68e-8)"	"unprognostic (7.99e-2)"	"unprognostic (9.29e-3)"	"unprognostic (1.28e-1)"	"unprognostic (1.95e-2)"	0.2	0.5	0.2	2.5	0.5	0.0	0.1	0.1	2.0	0.1	0.2	0.0	0.1	0.6	0.1	0.2	0.2	0.1	0.3	0.1	1.5	0.2	0.2	187.9	0.8	2.9	0.2	0.7	0.1	0.1	0.0	5.8	0.1	0.1	0.1	0.2	0.0	0.1	0.0	0.1	0.1	1.1	0.4	0.2	1.5	0.3	0.1	0.0	0.0	0.1	0.0	0.4	1.2	0.1	0.0	0.0	0.2	0.1	0.0	0.2	0.0	0.0	1.8	0.0	0.0	0.1	0.0	0.0	0.0	1.5	0.0	0.0	0.1	0.0	0.0	8.6	0.0	0.2	0.0	0.1	0.0	0.0	16.7	0.0	0.1	0.0	0.0	0.3	0.2	0.0	0.9	0.0	0.0	0.0	0.8	0.0	0.0	0.1	2.9	0.3	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.1	1.3	0.0	0.3	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.0	1.1	0.4	0.4	0.0	2.7	0.0	0.0	9.8	0.1	0.0	0.0	0.1	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.5	0.1	2.0	1.5	0.2	0.2	0.7	0.1	0.0	0.0	0.0	7.0	0.0	0.0	0.0	0.4	132.5	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.4	0.0	0.0	23.3	0.0	0.0	0.1	0.3	0.0	1048.1	0.9	0.0	0.0	25.2	23.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.5	0.8	0.2	0.2	0.0	0.2	0.0	0.0	0.0
TDRD12	"ECAT8, FLJ13072"	ENSG00000173809	"Tudor domain containing 12"	Q587J7	19	32719753-32829580	"Enzymes, Predicted intracellular proteins"	"Differentiation, Meiosis, RNA-mediated gene silencing, Spermatogenesis"	"Developmental protein, Helicase, Hydrolase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	4	"testis: 36.1"	"Cell type enhanced"	"Detected in some"	18	"Early spermatids: 18.5;Spermatocytes: 43.5;Spermatogonia: 44.9"	"Cancer enriched"	"Detected in many"	9	"testis cancer: 10.4"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"naive CD8 T-cell: 1.8"	"Lineage enriched"	"Detected in single"	4	"T-cells: 1.8"	"Group enriched"	"Detected in some"	30	"HDLM-2: 12.8;NTERA-2: 42.6"	"Low region specificity"	"Detected in many"													NA	NA						"unprognostic (5.43e-2)"	"unprognostic (3.97e-1)"	"unprognostic (1.14e-1)"	"unprognostic (1.87e-7)"	"unprognostic (5.44e-2)"	"unprognostic (1.78e-1)"	"unprognostic (6.79e-2)"	"unprognostic (1.20e-1)"	"unprognostic (2.07e-1)"	"unprognostic (1.40e-1)"	"unprognostic (9.69e-2)"	"unprognostic (1.90e-1)"	"unprognostic (1.43e-4)"	"unprognostic (2.09e-1)"	"unprognostic (4.75e-2)"	"unprognostic (3.08e-2)"	"unprognostic (2.69e-2)"	0.2	0.7	0.2	0.1	0.4	0.0	0.4	0.2	0.5	0.9	0.3	0.2	0.6	0.0	1.1	8.5	0.2	1.1	0.3	0.3	0.1	0.2	0.9	0.1	0.2	0.8	0.3	0.1	1.8	0.1	0.0	0.2	0.2	0.6	0.2	0.0	0.3	0.2	0.6	0.1	1.7	1.2	0.1	0.1	0.9	0.2	36.1	0.1	0.6	0.9	0.1	0.6	0.5	0.3	0.0	0.4	0.0	0.0	0.0	1.8	0.0	0.0	0.5	0.1	0.6	0.0	0.0	0.9	0.1	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	12.8	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	42.6	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.1	0.0	0.0	0.0	0.2	0.1	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.4	0.0	0.0	0.2	0.4	0.2	0.5	0.1	0.2	0.3	0.1	0.6	0.1	0.0	0.0	0.0	0.3	0.0	0.2	0.6	0.0	0.0	0.0	1.8	0.0	0.3	0.0	0.0	18.5	0.0	0.0	0.0	0.0	1.0	0.2	0.2	0.0	0.0	0.1	0.0	0.0	0.6	0.0	9.0	2.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	1.4	0.2	0.3	0.0	0.1	43.5	44.9	0.1	0.2	0.0	0.2	0.0
TDRD9	"C14orf75, DKFZp434N0820, FLJ36164, NET54"	ENSG00000156414	"Tudor domain containing 9"	Q8NDG6	14	103928462-104052667	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Differentiation, Meiosis, RNA-mediated gene silencing, Spermatogenesis"	"Developmental protein, Helicase, Hydrolase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	7	"parathyroid gland: 19.9;testis: 48.0"	"Group enriched"	"Detected in many"	5	"Spermatocytes: 69.1;Spermatogonia: 37.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in single"	5	"classical monocyte: 4.6"	"Lineage enriched"	"Detected in single"	5	"monocytes: 4.6"	"Cell line enhanced"	"Detected in some"		"HDLM-2: 11.1;HeLa: 9.7;HMC-1: 45.2;RPTEC TERT1: 12.3;SK-MEL-30: 6.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"									NA	NA						"unprognostic (3.71e-1)"	"unprognostic (3.02e-1)"	"unprognostic (1.59e-1)"	"unprognostic (1.89e-1)"	"unprognostic (1.91e-1)"	"unprognostic (1.55e-1)"	"unprognostic (2.74e-1)"	"unprognostic (3.74e-1)"	"unprognostic (1.55e-1)"	"unprognostic (1.61e-1)"	"unprognostic (2.13e-4)"	"unprognostic (1.60e-2)"	"unprognostic (4.57e-3)"	"unprognostic (8.97e-2)"	"unprognostic (3.34e-1)"	"prognostic unfavorable (5.52e-4)"	"unprognostic (2.41e-2)"	0.4	0.4	0.7	0.4	1.5	1.2	0.5	1.5	1.5	0.3	0.3	0.8	0.6	0.1	0.3	0.3	0.2	0.7	2.1	0.6	0.8	0.7	1.8	0.5	1.0	0.3	0.8	1.3	0.3	0.7	19.9	0.9	0.4	3.4	0.3	0.1	1.8	0.9	1.0	0.1	0.1	0.3	0.4	1.6	2.8	0.6	48.0	0.5	0.2	4.2	0.0	0.8	0.4	0.2	0.0	0.8	0.0	4.6	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.1	0.0	0.0	9.7	0.0	0.0	0.0	45.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.3	0.0	4.1	0.0	0.0	0.3	6.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.7	1.5	1.5	1.5	0.8	0.7	0.8	1.3	3.4	0.5	6.0	1.3	0.0	0.0	0.0	3.1	9.7	0.0	0.0	1.2	0.0	3.9	0.0	1.7	0.6	11.1	0.7	0.0	0.0	0.0	0.0	0.6	0.6	0.0	0.0	1.8	6.4	0.0	0.0	2.4	6.0	0.9	0.2	0.0	0.0	0.0	0.5	0.5	0.0	2.1	1.9	1.7	6.5	0.5	69.1	37.7	0.0	0.0	0.0	0.0	0.0
TEC	PSCTK4	ENSG00000135605	"Tec protein tyrosine kinase"	P42680	4	48135783-48269864	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Adaptive immunity, Immunity"	"Kinase, Transferase, Tyrosine-protein kinase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	8	"Cholangiocytes: 12.7;granulocytes: 18.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	4	"basophil: 13.3;eosinophil: 11.0"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 13.3"	"Cell line enhanced"	"Detected in many"		"HEL: 10.6;HMC-1: 16.7;U-266/70: 16.7;U-266/84: 11.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA005733, HPA024657"	Approved		Supported	"Plasma membrane"		NA	NA			"Plasma membrane"		"HPA005733: AB_1857878, HPA024657: AB_2671637"	"unprognostic (7.19e-2)"	"unprognostic (1.44e-1)"	"unprognostic (1.41e-2)"	"unprognostic (4.07e-3)"	"unprognostic (4.21e-2)"	"unprognostic (8.57e-2)"	"unprognostic (3.14e-1)"	"unprognostic (1.67e-1)"	"unprognostic (8.36e-2)"	"prognostic favorable (7.12e-4)"	"unprognostic (7.46e-3)"	"unprognostic (7.83e-2)"	"unprognostic (1.01e-4)"	"unprognostic (4.24e-2)"	"unprognostic (2.16e-1)"	"unprognostic (7.39e-2)"	"unprognostic (4.96e-3)"	3.9	4.5	0.8	7.2	1.1	9.8	5.1	0.6	2.0	3.4	4.8	0.5	8.4	2.8	3.0	21.6	9.5	3.6	2.1	3.3	0.9	0.9	4.0	5.7	6.4	7.0	1.5	0.3	2.9	2.9	2.6	6.4	2.0	3.2	2.0	2.5	3.0	6.8	4.7	2.1	8.1	6.5	3.0	1.2	6.7	2.2	5.5	0.6	4.4	4.4	5.8	11.1	3.2	6.5	0.9	1.3	13.3	0.6	2.9	0.4	0.3	2.3	0.6	0.0	0.0	0.0	0.0	0.1	0.4	1.8	1.1	2.3	0.0	1.8	1.5	1.7	0.0	0.0	0.5	0.9	0.0	1.5	0.1	0.7	10.6	0.8	0.1	0.0	1.7	16.7	0.0	0.2	1.4	0.0	1.1	0.0	0.5	5.8	0.4	3.3	0.8	1.0	3.8	0.3	1.1	0.7	2.4	2.2	0.0	2.8	0.7	0.0	0.2	0.5	0.3	0.4	0.9	0.6	3.4	0.0	0.0	0.0	2.3	0.0	16.7	11.9	2.1	0.0	2.4	0.1	13.3	0.5	11.0	0.1	0.6	0.3	0.9	0.1	0.4	1.3	0.6	0.4	0.4	0.4	2.9	0.1	0.1	0.0	0.3	0.8	1.1	0.6	2.0	0.9	0.9	1.5	0.3	3.2	0.6	6.0	5.0	0.8	1.5	2.3	0.5	1.6	12.7	0.0	4.5	0.0	0.0	1.3	0.0	1.3	3.9	0.6	2.2	0.0	0.9	0.1	0.9	1.1	18.5	3.2	4.0	0.0	2.9	0.0	4.5	1.7	0.0	2.8	1.7	0.0	1.4	5.0	0.9	0.0	0.4	1.8	2.4	6.5	0.7	0.7	1.1	2.6	0.7	2.5	2.0	1.3
TECR	"GPSN2, MRT14, SC2, TER"	ENSG00000099797	"Trans-2,3-enoyl-CoA reductase"	Q9NZ01	19	14517085-14565980	"Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins"	"Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism, Sphingolipid metabolism"	Oxidoreductase	"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	5	"Late spermatids: 750.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029780, HPA056488"	Supported		Supported	"Endoplasmic reticulum"		NA	NA			"Endoplasmic reticulum"		"HPA029780: AB_10603348, HPA056488: AB_2683149"	"unprognostic (9.73e-2)"	"unprognostic (3.69e-3)"	"unprognostic (1.55e-1)"	"unprognostic (8.08e-3)"	"unprognostic (1.20e-1)"	"unprognostic (3.96e-2)"	"unprognostic (3.68e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.36e-1)"	"unprognostic (9.16e-2)"	"unprognostic (1.29e-1)"	"unprognostic (5.05e-2)"	"unprognostic (3.65e-3)"	"unprognostic (2.53e-3)"	"unprognostic (2.34e-1)"	"unprognostic (2.07e-2)"	"prognostic unfavorable (2.60e-4)"	32.8	43.2	45.0	15.0	43.7	23.0	26.2	51.7	70.8	34.9	26.1	64.5	40.1	37.8	16.5	38.2	89.6	32.4	19.0	22.3	42.9	38.3	29.0	45.9	20.7	17.8	45.6	34.7	25.0	37.0	95.0	20.9	68.5	50.4	23.9	21.7	34.5	69.8	42.0	121.4	89.5	34.8	13.8	53.3	20.0	24.5	59.6	40.2	29.8	33.5	40.7	49.5	18.3	43.8	21.7	30.2	10.7	22.8	34.3	60.6	32.7	36.5	27.3	26.1	29.4	38.1	17.4	27.6	10.7	30.3	34.5	42.9	36.3	42.3	19.6	22.5	22.4	26.7	57.1	27.5	43.5	13.9	32.2	23.6	33.4	40.9	39.9	23.0	23.6	25.5	25.8	34.8	30.3	16.6	17.2	16.2	29.3	21.4	67.8	17.6	46.0	27.8	41.2	27.3	94.0	29.6	25.9	17.0	87.0	46.8	19.7	32.6	20.0	17.9	48.2	22.9	13.6	25.9	46.9	9.4	27.7	11.9	24.0	36.0	20.8	19.9	20.3	28.4	35.6	27.6	9.2	16.0	10.7	32.0	22.8	34.7	21.7	42.0	36.6	27.3	21.0	49.2	38.8	7.2	34.3	17.1	30.2	60.6	32.7	45.0	43.7	51.7	70.8	42.9	38.3	45.6	34.7	50.4	40.2	68.5	70.5	64.7	187.4	150.7	86.7	43.3	104.4	85.6	61.4	157.1	115.8	406.1	48.0	132.1	327.6	56.2	226.7	46.7	199.9	418.2	76.1	121.3	34.7	135.7	163.0	106.5	96.0	70.6	99.0	750.0	67.3	92.0	155.3	61.3	121.5	562.9	101.5	115.2	56.6	150.3	157.6	64.7	100.0	163.9	115.2	209.5	406.6	101.5	176.8	172.7
TEK	"CD202b, TIE-2, TIE2, VMCM, VMCM1"	ENSG00000120156	"TEK receptor tyrosine kinase"	Q02763	9	27109141-27230175	"Cancer-related genes, CD markers, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted membrane proteins, Predicted secreted proteins, RAS pathway related proteins"	Angiogenesis	"Kinase, Receptor, Transferase, Tyrosine-protein kinase"	"Cancer-related genes, Disease mutation, FDA approved drug targets, Glaucoma"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in some"	8	"Endothelial cells: 58.3;Ito cells: 110.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"neutrophil: 2.2"	"Lineage enhanced"	"Detected in single"		"granulocytes: 2.2"	"Group enriched"	"Detected in some"	4	"HUVEC TERT2: 36.5;NTERA-2: 18.2;TIME: 39.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB010359, HPA073265"	Approved		Supported	"Plasma membrane,Centriolar satellite"	"Secreted to blood"	NA	NA	7750000	8300000	"Plasma membrane"	"Centriolar satellite"	"CAB010359: AB_2203226, HPA073265: AB_2686592"	"unprognostic (2.24e-1)"	"unprognostic (1.74e-1)"	"unprognostic (5.55e-2)"	"unprognostic (1.83e-2)"	"unprognostic (1.68e-1)"	"unprognostic (1.26e-3)"	"prognostic favorable (2.31e-5)"	"unprognostic (7.48e-2)"	"unprognostic (1.72e-2)"	"unprognostic (1.41e-1)"	"unprognostic (5.58e-2)"	"unprognostic (2.72e-1)"	"prognostic favorable (7.81e-4)"	"unprognostic (7.50e-3)"	"unprognostic (6.87e-3)"	"unprognostic (1.83e-1)"	"unprognostic (5.24e-3)"	28.6	7.8	8.1	4.6	5.9	0.4	17.9	3.4	5.4	10.8	4.7	4.6	3.4	3.2	14.5	5.3	6.7	5.9	9.1	13.0	7.1	6.1	25.4	8.7	27.8	2.9	6.9	3.4	6.1	4.5	3.5	4.0	36.3	6.9	5.4	4.7	12.4	3.4	5.5	7.8	3.0	5.3	10.6	5.3	23.4	4.0	3.7	3.5	0.3	9.7	8.4	2.4	6.4	12.4	0.0	0.1	2.2	0.6	0.0	0.0	0.0	0.1	0.0	1.4	0.0	0.2	2.3	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	1.0	0.0	0.7	0.0	0.0	0.7	0.0	0.9	0.3	0.0	36.5	0.0	0.0	0.0	0.3	0.0	0.0	0.0	18.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	7.8	0.0	0.0	39.6	0.0	0.2	3.6	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	8.1	5.9	3.4	5.4	7.1	6.1	6.9	3.4	6.9	3.5	3.0	2.2	0.0	0.0	1.3	0.0	7.8	0.0	0.0	1.2	1.8	0.0	0.4	0.0	0.0	0.6	58.3	0.0	0.0	0.0	1.5	2.4	0.2	0.0	0.8	0.2	0.0	0.0	110.5	10.4	0.4	0.6	0.9	0.0	0.0	0.0	0.0	0.7	0.0	0.4	0.0	0.2	0.0	0.4	0.0	0.2	1.1	1.1	0.0	0.0	0.0
TERT	"EST2, hEST2, TCS1, TP2, TRT"	ENSG00000164362	"Telomerase reverse transcriptase"	O14746	5	1253147-1295069	"Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins"		"DNA-binding, Nucleotidyltransferase, Ribonucleoprotein, RNA-directed DNA polymerase, Transferase"	"Cancer-related genes, Disease mutation, Dyskeratosis congenita"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"bone marrow: 3.4;lymphoid tissue: 12.0;testis: 5.0"	"Cell type enhanced"	"Detected in some"	24	"Cardiomyocytes: 1.2;Spermatogonia: 1.9"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC TERT1: 62.6;fHDF/TERT166: 59.4;HBEC3-KT: 120.8;hTEC/SVTERT24-B: 76.3;LHCN-M2: 34.4;TIME: 98.2"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"HPA054641, HPA065897"	Supported		Supported	"Nucleoplasm,Nuclear speckles,Cytosol"		NA	NA			Nucleoplasm	"Nuclear speckles, Cytosol"	"HPA054641: AB_2682554, HPA065897: AB_2685576"	"unprognostic (1.21e-2)"	"unprognostic (2.88e-2)"	"unprognostic (1.24e-3)"	"unprognostic (1.53e-1)"	"unprognostic (1.43e-3)"	"unprognostic (6.42e-3)"	"unprognostic (1.85e-2)"	"unprognostic (2.21e-1)"	"unprognostic (6.91e-2)"	"unprognostic (1.89e-1)"	"unprognostic (3.59e-1)"	"unprognostic (9.16e-4)"	"unprognostic (8.84e-11)"	"unprognostic (1.92e-1)"	"unprognostic (2.15e-1)"		"unprognostic (3.35e-1)"	0.0	0.0	0.0	7.1	0.9	3.4	0.0	0.0	0.2	0.1	1.1	0.0	0.0	1.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.0	2.4	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.9	0.0	0.0	1.0	0.4	5.0	0.0	12.0	0.0	0.0	2.8	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	31.3	62.6	0.5	0.0	23.8	4.3	8.0	0.1	0.1	0.7	0.0	59.4	0.0	0.0	0.2	120.8	5.1	0.0	0.3	0.0	0.0	0.1	0.0	0.3	0.3	0.0	3.1	76.3	0.8	0.1	0.2	0.5	0.6	0.1	34.4	0.0	0.2	1.7	0.4	0.0	0.2	0.9	0.0	0.8	3.5	0.2	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.2	98.2	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.2	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.9	0.0	0.0	0.0	0.2	0.0
TESK1		ENSG00000107140	"Testis-specific kinase 1"	Q15569	9	35605305-35610041	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase, Tyrosine-protein kinase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA						"unprognostic (5.17e-2)"	"unprognostic (2.82e-1)"	"unprognostic (4.96e-3)"	"unprognostic (5.18e-2)"	"unprognostic (2.04e-2)"	"unprognostic (8.76e-2)"	"prognostic unfavorable (9.68e-4)"	"unprognostic (1.82e-2)"	"unprognostic (1.24e-1)"	"unprognostic (2.66e-3)"	"unprognostic (1.22e-2)"	"unprognostic (2.56e-1)"	"unprognostic (5.57e-2)"	"unprognostic (1.74e-2)"	"unprognostic (2.34e-1)"	"unprognostic (1.43e-2)"	"unprognostic (1.25e-3)"	30.9	19.4	13.5	10.8	20.5	5.6	25.4	13.4	26.4	14.3	15.2	15.0	9.7	13.7	15.3	13.4	11.0	12.0	13.0	12.8	13.7	13.1	10.5	10.0	11.5	10.7	14.1	10.3	17.0	16.0	13.1	15.7	12.3	12.6	15.1	8.8	14.2	14.6	21.0	47.2	13.7	12.7	16.9	7.3	11.0	12.9	28.4	12.9	9.2	13.0	12.3	9.0	16.6	20.9	1.0	2.3	0.3	1.8	2.1	4.9	1.5	9.5	8.9	6.1	10.2	24.6	10.3	7.0	10.9	9.8	10.2	6.5	5.2	2.7	17.4	6.2	10.9	27.1	3.3	3.9	7.9	1.9	11.2	5.2	2.5	8.5	4.5	14.4	2.1	8.4	10.0	12.5	7.9	10.9	10.9	7.1	8.6	2.9	6.3	10.1	10.5	4.8	10.6	3.8	8.8	10.5	7.5	3.7	4.1	7.5	4.4	5.0	6.1	6.2	7.6	4.6	4.4	9.0	3.2	6.2	22.6	9.7	16.2	6.5	3.8	5.4	6.5	16.4	2.5	5.1	0.0	1.8	0.3	3.4	0.4	3.0	0.8	1.4	4.9	2.1	1.0	1.5	1.6	0.0	2.1	0.8	2.3	0.3	1.5	13.5	20.5	13.4	26.4	13.7	13.1	14.1	10.3	12.6	12.9	6.0	7.7	5.9	5.6	12.8	10.4	1.9	5.1	4.0	3.4	7.0	7.9	3.2	1.7	5.6	33.3	8.7	14.2	0.0	9.0	7.2	8.9	13.5	1.1	9.3	13.1	12.7	9.1	4.9	4.1	27.1	11.2	8.4	13.5	2.8	12.4	11.3	8.3	8.2	13.4	6.1	12.2	6.5	7.8	13.0	5.9	12.2	2.7	6.9	6.1	6.8
TESK2		ENSG00000070759	"Testis-specific kinase 2"	Q96S53	1	45343883-45491166	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase, Tyrosine-protein kinase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Spermatocytes: 26.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BEWO: 13.1;RT4: 12.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027257, HPA063869"	Uncertain		Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"HPA027257: AB_10602477, HPA063869: AB_2685137"	"unprognostic (2.95e-1)"	"prognostic favorable (2.22e-4)"	"unprognostic (3.90e-2)"	"unprognostic (5.04e-3)"	"unprognostic (6.03e-2)"	"unprognostic (1.87e-3)"	"unprognostic (3.22e-2)"	"unprognostic (1.43e-2)"	"unprognostic (5.15e-2)"	"unprognostic (2.96e-1)"	"unprognostic (2.28e-1)"	"unprognostic (2.86e-1)"	"unprognostic (4.36e-2)"	"unprognostic (2.49e-2)"	"unprognostic (1.13e-1)"	"unprognostic (4.37e-2)"	"unprognostic (2.01e-1)"	5.5	3.3	6.1	5.9	17.4	12.6	9.6	7.8	12.6	7.7	8.4	25.7	4.0	11.9	4.7	5.7	9.1	4.1	3.9	5.8	9.6	5.1	3.5	9.7	5.5	6.0	19.2	4.7	14.4	4.6	6.7	4.1	8.3	13.2	22.1	10.1	7.6	11.2	5.7	10.1	17.1	14.8	4.4	18.7	6.3	5.6	11.7	14.8	4.2	5.1	3.2	7.2	8.2	9.7	7.5	2.0	15.9	5.9	1.1	3.7	2.6	1.6	0.0	0.8	0.0	3.2	1.7	13.1	0.6	4.3	1.9	3.2	3.6	1.5	5.3	0.6	1.6	4.9	2.0	3.4	2.7	1.5	3.7	4.3	3.6	1.8	2.7	1.7	1.2	9.9	1.8	2.9	2.1	3.0	2.9	1.5	7.1	0.6	10.9	1.3	0.6	3.0	2.4	3.4	1.5	1.5	4.4	0.1	1.4	1.7	12.8	0.3	1.4	3.4	6.4	12.2	8.1	10.0	1.5	0.0	0.2	2.0	1.6	1.1	7.2	4.2	1.0	1.0	0.0	0.8	9.4	3.8	10.6	2.4	2.8	1.7	7.5	2.2	1.6	2.0	5.7	3.7	2.1	15.9	1.1	5.9	1.1	1.5	2.6	6.1	17.4	7.8	12.6	9.6	5.1	19.2	4.7	13.2	14.8	0.0	3.2	2.4	6.5	6.9	2.3	1.1	5.1	1.4	3.4	0.0	13.7	6.5	0.0	1.0	18.1	2.9	12.4	0.0	2.3	2.5	2.2	12.9	6.9	5.5	5.9	0.0	4.1	1.3	4.6	5.2	2.6	4.5	3.3	2.8	5.3	1.1	1.0	7.4	1.8	0.6	2.8	6.5	4.7	26.8	5.7	7.4	12.4	4.4	4.9	7.3
TET1	"bA119F7.1, CXXC6, KIAA1676, LCX"	ENSG00000138336	"Tet methylcytosine dioxygenase 1"	Q8NFU7	10	68560656-68694482	"Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, Chromatin regulator, Dioxygenase, DNA-binding, Oxidoreductase, Repressor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	10	"Extravillous trophoblasts: 59.1;Horizontal cells: 33.4;Leydig cells: 23.9"	"Cancer enriched"	"Detected in some"	15	"testis cancer: 10.4"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"BEWO: 15.3;HAP1: 17.4;K-562: 9.7;NTERA-2: 10.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019032, HPA057273"			Supported	"Nucleoplasm,Nuclear membrane"		NA	NA			Nucleoplasm	"Nuclear membrane"	"HPA019032: AB_1847363, HPA057273: AB_2683391"	"unprognostic (1.60e-1)"	"unprognostic (8.30e-2)"	"unprognostic (9.85e-2)"	"unprognostic (1.67e-2)"	"unprognostic (1.27e-1)"	"unprognostic (8.15e-2)"	"unprognostic (3.60e-3)"	"unprognostic (1.12e-1)"	"unprognostic (2.00e-1)"	"unprognostic (7.90e-3)"	"unprognostic (1.83e-1)"	"unprognostic (1.71e-1)"	"unprognostic (1.18e-3)"	"unprognostic (2.88e-4)"	"unprognostic (4.02e-2)"	"unprognostic (2.54e-1)"	"unprognostic (9.52e-3)"	4.4	1.6	3.3	4.3	2.6	1.6	3.1	4.4	4.3	5.1	2.4	5.8	3.2	1.2	6.0	3.4	2.4	2.9	3.5	2.4	3.5	2.3	1.8	1.5	1.6	1.7	2.5	2.6	6.1	1.6	7.4	2.2	5.8	2.9	3.2	2.0	8.1	15.9	4.8	4.0	2.2	1.8	6.5	3.6	1.7	2.2	1.4	5.9	1.2	3.2	3.2	1.8	5.1	5.4	1.3	1.1	1.0	0.0	0.9	2.3	0.2	0.6	0.7	6.9	7.8	0.7	0.6	15.3	0.4	0.8	0.6	1.1	4.6	0.2	0.0	0.2	0.7	0.1	0.0	17.4	0.0	0.7	0.2	2.8	1.8	0.0	4.1	1.0	1.6	0.9	0.9	0.1	0.4	0.0	1.4	0.1	2.9	9.7	1.2	0.6	0.5	2.7	1.2	10.2	0.0	0.9	2.7	2.2	0.2	0.3	0.7	1.9	3.1	0.3	0.4	1.4	7.2	0.9	1.2	0.2	0.6	1.4	0.0	0.5	0.5	0.5	2.7	0.1	0.0	0.1	0.0	0.0	1.0	1.5	0.0	2.0	1.3	0.8	1.3	0.2	0.5	1.4	1.1	0.0	0.9	0.0	1.1	2.3	0.2	3.3	2.6	4.4	2.6	3.5	2.3	2.5	2.6	2.9	5.9	3.0	3.8	0.0	1.9	1.0	2.2	4.5	2.5	1.4	4.5	0.0	9.8	16.6	0.0	1.4	0.4	3.3	0.0	0.0	0.3	59.1	11.8	2.1	0.0	2.1	3.3	33.4	13.2	7.4	0.0	0.6	23.9	0.1	1.7	0.0	0.0	17.3	0.9	0.0	19.4	0.8	10.8	6.5	3.8	0.5	0.7	1.0	23.3	1.7	0.4	0.3
TET2	"FLJ20032, KIAA1546"	ENSG00000168769	"Tet methylcytosine dioxygenase 2"	Q6N021	4	105145875-105279816	"Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Cell cycle"	"Chromatin regulator, Dioxygenase, DNA-binding, Oxidoreductase"	"Cancer-related genes, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"neutrophil: 29.0"	"Lineage enriched"	"Detected in all"	4	"granulocytes: 29.0"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA043135	Supported		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA043135: AB_10794177"	"unprognostic (6.83e-2)"	"unprognostic (3.52e-2)"	"unprognostic (1.69e-2)"	"unprognostic (9.42e-2)"	"unprognostic (4.15e-2)"	"unprognostic (5.88e-2)"	"unprognostic (6.12e-2)"	"unprognostic (1.19e-3)"	"unprognostic (1.15e-2)"	"unprognostic (1.57e-2)"	"unprognostic (5.77e-2)"	"unprognostic (7.29e-2)"	"unprognostic (2.70e-3)"	"unprognostic (6.10e-2)"	"unprognostic (1.89e-1)"	"unprognostic (9.15e-2)"	"unprognostic (7.84e-2)"	9.9	6.1	8.7	11.9	11.4	26.3	8.0	4.1	10.0	9.6	7.4	10.1	5.8	8.2	10.1	7.4	16.2	9.2	6.6	6.8	9.0	4.2	6.7	5.5	9.9	9.8	13.7	5.7	8.5	7.0	7.4	29.0	12.4	9.1	6.5	8.0	4.7	13.5	8.2	9.8	16.0	10.2	7.8	15.5	12.9	6.8	3.2	14.6	9.3	7.2	6.9	8.7	9.8	12.3	2.8	5.1	29.0	7.0	2.6	2.1	1.4	4.8	3.1	10.6	10.8	1.9	4.3	4.3	3.5	4.7	5.0	4.9	3.1	6.5	0.5	4.0	4.3	2.4	4.6	10.2	6.1	5.7	6.2	2.7	6.8	6.0	1.1	5.4	15.4	11.3	3.7	8.3	4.8	6.2	8.1	6.6	3.7	7.2	12.7	4.3	3.6	2.5	4.2	2.3	6.4	1.9	7.9	5.3	1.0	4.6	10.2	7.6	6.2	3.8	9.9	0.6	6.0	4.5	11.1	8.5	7.6	6.9	2.2	5.9	8.5	6.1	6.4	4.6	3.8	7.4	10.8	7.0	7.2	2.1	5.5	0.8	2.6	1.2	1.2	5.1	2.8	1.0	1.6	29.0	2.6	6.4	4.5	1.5	1.4	8.7	11.4	4.1	10.0	9.0	4.2	13.7	5.7	9.1	14.6	23.8	26.1	5.6	9.4	12.8	21.1	21.6	7.6	21.4	20.5	8.7	15.7	16.9	6.6	5.6	0.2	12.9	15.8	0.0	6.6	4.8	7.5	10.8	26.6	6.6	13.0	33.4	22.3	9.2	49.2	0.4	7.5	43.4	5.0	11.8	15.9	5.6	6.6	17.3	6.7	2.4	23.8	12.9	8.2	0.2	0.6	31.5	28.6	17.5	12.7	22.5
TET3	"hCG_40738, MGC22014"	ENSG00000187605	"Tet methylcytosine dioxygenase 3"	O43151	2	73986404-74108176	"Enzymes, Predicted intracellular proteins"		"Chromatin regulator, Developmental protein, Dioxygenase, DNA-binding, Oxidoreductase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 26.0"	"Cell type enhanced"	"Detected in many"	7	"Basal keratinocytes: 44.0;Suprabasal keratinocytes: 59.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA050845	Uncertain		Approved	Nucleoplasm,Vesicles,Cytosol		NA	NA			Nucleoplasm	"Vesicles, Cytosol"	"HPA050845: AB_2681256"	"unprognostic (1.07e-2)"	"unprognostic (1.21e-2)"	"unprognostic (3.08e-1)"	"unprognostic (1.12e-2)"	"unprognostic (4.44e-2)"	"unprognostic (2.75e-2)"	"unprognostic (1.72e-3)"	"unprognostic (1.46e-1)"	"unprognostic (1.01e-1)"	"unprognostic (9.83e-2)"	"unprognostic (7.74e-2)"	"unprognostic (2.03e-1)"	"prognostic unfavorable (3.58e-5)"	"unprognostic (2.05e-1)"	"unprognostic (5.30e-1)"	"unprognostic (1.55e-2)"	"unprognostic (1.10e-1)"	2.9	2.3	7.2	6.1	10.8	20.9	3.9	26.0	17.1	3.2	5.1	20.6	0.5	6.7	2.9	1.9	10.2	3.0	3.3	1.6	7.1	3.3	2.6	5.1	5.6	4.3	12.0	9.5	2.9	3.6	3.5	4.2	5.7	12.4	3.6	5.5	5.9	5.9	1.8	1.8	18.9	7.2	2.7	5.3	5.5	5.3	2.1	11.7	0.6	3.4	1.7	5.1	4.0	5.0	1.1	1.4	2.5	2.2	0.4	0.9	0.9	6.2	5.5	10.5	6.4	0.9	1.0	19.4	1.3	1.7	2.5	2.0	11.8	5.8	10.5	2.6	1.7	1.1	6.7	9.3	3.7	2.6	4.5	3.7	13.4	4.6	4.0	3.9	14.0	8.3	1.5	9.8	3.1	7.3	3.1	3.8	7.4	9.1	3.5	1.4	10.3	6.9	9.2	5.9	5.4	1.9	10.5	6.6	3.6	2.8	11.7	13.2	11.3	2.8	7.5	3.6	4.4	4.8	11.4	4.8	2.7	11.4	1.3	4.7	3.1	1.3	9.1	1.8	9.8	3.5	0.5	2.0	1.0	0.4	2.2	0.9	1.1	0.5	0.5	1.4	0.9	0.7	0.6	2.5	0.4	0.7	1.4	0.0	0.9	7.2	10.8	26.0	17.1	7.1	3.3	12.0	9.5	12.4	11.7	6.0	7.0	0.0	3.0	44.0	14.5	2.8	5.1	10.7	9.1	1.8	19.6	5.5	0.0	3.0	2.9	5.6	9.5	23.3	3.8	27.5	6.6	4.8	2.3	4.4	8.9	9.5	5.8	3.7	27.8	0.6	0.6	13.8	10.1	9.0	8.4	1.5	5.1	10.5	2.8	1.2	5.8	0.0	5.3	0.5	3.1	59.6	2.1	4.3	6.4	4.8
TEX14	CT113	ENSG00000121101	"Testis expressed 14, intercellular bridge forming factor"	Q8IWB6	17	58556678-58692055	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Transporters"	"Cell cycle, Cell division, Mitosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	35	"testis: 52.7"	"Cell type enhanced"	"Detected in many"	15	"Early spermatids: 13.5;Spermatocytes: 29.0;Spermatogonia: 15.8"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HDLM-2: 9.1;Karpas-707: 11.9;MCF7: 4.8"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA030620, HPA077020"	Enhanced		Approved	"Vesicles,Plasma membrane,Cytosol"		NA	NA			"Plasma membrane, Cytosol"	Vesicles	"HPA030620: AB_10601598, HPA077020: AB_2732327"	"unprognostic (1.21e-2)"	"unprognostic (2.12e-1)"	"unprognostic (2.06e-1)"	"unprognostic (9.49e-2)"	"unprognostic (2.48e-1)"	"unprognostic (1.23e-2)"	"unprognostic (1.10e-1)"	"unprognostic (6.17e-2)"	"unprognostic (2.07e-2)"	"unprognostic (1.61e-3)"	"unprognostic (2.67e-2)"	"unprognostic (8.10e-2)"	"unprognostic (1.76e-9)"	"unprognostic (1.77e-1)"	"unprognostic (2.54e-1)"	"unprognostic (5.00e-3)"	"unprognostic (5.88e-2)"	0.1	0.1	0.2	0.1	0.3	1.5	0.1	0.9	0.2	0.1	0.1	0.1	0.1	0.0	0.1	0.2	0.1	0.2	0.1	0.1	0.3	0.2	0.1	0.1	0.2	0.1	0.2	0.1	0.3	0.1	0.0	0.1	0.1	0.4	0.2	0.0	0.1	0.1	0.1	0.3	0.1	0.2	0.1	0.5	0.2	0.0	52.7	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.2	0.0	0.8	0.2	0.1	0.0	0.2	2.6	0.0	0.0	0.3	0.0	0.0	0.1	0.3	0.0	0.0	0.7	0.2	0.0	0.2	0.0	0.4	0.0	0.2	9.1	1.4	0.3	0.0	0.0	0.0	0.2	0.1	0.0	0.0	1.2	0.0	0.1	0.0	0.5	0.1	11.9	0.0	4.8	0.4	0.1	0.6	0.1	0.1	0.5	0.4	1.8	0.0	0.1	1.4	0.2	0.0	0.1	0.6	0.4	0.4	0.1	0.0	0.1	0.3	0.0	0.0	2.1	0.5	1.1	0.1	0.1	0.1	0.0	0.2	0.0	0.2	0.0	0.5	0.0	0.8	0.4	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.3	0.9	0.2	0.3	0.2	0.2	0.1	0.4	0.1	0.0	0.0	0.0	1.2	0.8	0.4	1.4	5.1	0.0	2.3	1.8	0.0	0.9	0.0	0.0	13.5	0.2	0.0	0.0	0.0	0.7	0.6	0.6	1.1	0.4	3.1	0.0	0.0	1.8	1.2	3.6	0.3	2.4	3.3	0.0	0.0	0.5	0.1	0.0	0.4	0.0	1.1	0.0	0.9	29.0	15.8	0.1	0.9	0.0	0.0	0.3
TFR2	"HFE3, TFRC2"	ENSG00000106327	"Transferrin receptor 2"	Q9UP52	7	100620416-100642779	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters"		Receptor	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	20	"liver: 112.6"	"Cell type enriched"	"Detected in many"	4	"Hepatocytes: 379.7"	"Cancer enriched"	"Detected in many"	70	"liver cancer: 136.2"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	46	"basophil: 5.5;eosinophil: 3.9"	"Lineage enriched"	"Detected in single"	54	"granulocytes: 5.5"	"Group enriched"	"Detected in some"	11	"HEL: 28.5;HMC-1: 39.6;K-562: 26.3"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"CAB016255, HPA017171, HPA073125"	Enhanced		Approved	"Golgi apparatus"		NA	NA			"Golgi apparatus"		"CAB016255: AB_628395, HPA017171: , HPA073125: "	"unprognostic (4.18e-2)"	"unprognostic (1.97e-2)"	"unprognostic (2.74e-1)"	"unprognostic (1.04e-1)"	"unprognostic (1.26e-2)"	"unprognostic (4.13e-2)"	"prognostic favorable (2.48e-4)"	"unprognostic (2.29e-2)"	"unprognostic (4.49e-2)"	"unprognostic (9.26e-2)"	"unprognostic (1.93e-1)"	"unprognostic (2.90e-1)"	"unprognostic (1.18e-9)"	"unprognostic (6.51e-2)"	"unprognostic (1.68e-1)"	"unprognostic (3.28e-1)"	"unprognostic (8.18e-2)"	0.1	0.0	0.1	0.1	0.1	5.3	0.1	0.8	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.0	0.3	0.3	0.1	0.0	0.1	112.6	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.2	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.2	1.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	5.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	28.5	0.0	2.9	0.0	0.6	39.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	26.3	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.5	0.0	3.9	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.8	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.0	7.8	0.9	0.2	5.3	0.9	12.7	0.0	1.2	0.0	7.9	0.1	0.0	0.4	4.0	0.0	0.0	93.5	0.2	1.1	0.4	0.5	0.0	379.7	0.3	20.6	0.0	7.4	6.9	5.7	0.0	0.5	0.0	0.0	0.2	0.3	0.1	0.0	0.0	0.0	1.8	0.0	0.7	0.7	2.0	0.5	0.1	2.5	0.5	0.6
TFRC	"CD71, p90, TFR1"	ENSG00000072274	"Transferrin receptor"	P02786	3	196027183-196082189	"Cancer-related genes, CD markers, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins, Transporters"	"Endocytosis, Host-virus interaction"	"Host cell receptor for virus entry, Receptor, Transducer"	"Cancer-related genes, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"placenta: 110.0"	"Cell type enhanced"	"Detected in many"	10	"Erythroid cells: 560.6;Syncytiotrophoblasts: 420.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB000153, HPA028598"	Enhanced		Supported	Endosomes,Lysosomes	"Secreted to blood"	NA	NA	1310000000	14000000	"Endosomes, Lysosomes"		"CAB000153: AB_2533029, HPA028598: AB_10601599"	"unprognostic (2.95e-2)"	"prognostic unfavorable (3.67e-4)"	"unprognostic (2.55e-1)"	"unprognostic (1.48e-2)"	"unprognostic (6.75e-2)"	"unprognostic (7.88e-3)"	"prognostic unfavorable (1.15e-4)"	"unprognostic (6.92e-2)"	"unprognostic (3.30e-3)"	"unprognostic (4.35e-2)"	"unprognostic (1.34e-2)"	"unprognostic (1.14e-2)"	"unprognostic (3.63e-3)"	"unprognostic (3.65e-2)"	"unprognostic (1.19e-2)"	"prognostic unfavorable (2.96e-4)"	"unprognostic (2.62e-2)"	24.3	11.9	11.9	20.6	11.3	73.8	7.6	9.6	17.8	11.8	25.0	9.5	3.8	11.9	12.1	7.5	18.5	11.7	11.4	18.7	9.5	8.3	15.3	13.6	28.1	8.1	7.4	9.5	50.0	7.8	18.0	6.9	110.0	26.5	7.2	19.4	8.5	8.3	5.0	25.6	9.9	37.4	10.9	13.2	7.9	10.0	8.3	6.1	14.3	7.0	10.5	12.9	11.2	8.0	5.7	7.5	2.2	12.4	1.8	6.5	2.1	22.2	20.2	9.3	18.9	20.6	12.0	58.3	31.8	24.2	22.4	37.2	49.3	20.5	22.8	60.4	11.8	49.0	34.3	31.9	10.5	27.5	109.0	10.8	86.4	17.3	22.9	16.3	70.8	17.5	13.5	10.4	19.3	17.4	6.4	7.4	12.6	36.0	21.9	17.5	20.6	23.2	15.0	28.4	29.3	41.5	12.3	13.8	27.3	20.1	56.3	21.3	8.8	30.7	80.8	7.2	16.1	78.4	14.8	9.5	26.7	21.7	23.3	47.6	6.2	48.1	35.6	31.2	19.2	16.1	0.0	1.6	2.2	2.5	7.9	1.7	5.7	2.7	1.7	3.7	3.2	2.5	1.9	0.3	1.8	12.4	7.5	6.5	2.1	11.9	11.3	9.6	17.8	9.5	8.3	7.4	9.5	26.5	6.1	41.7	27.2	29.6	33.6	53.5	48.1	81.5	45.9	28.1	26.1	19.2	139.4	104.0	0.0	43.1	2.6	17.8	72.1	560.6	36.6	18.5	33.8	15.8	22.0	94.1	70.3	12.7	53.9	6.7	33.3	3.9	10.6	89.7	16.9	72.1	50.0	17.3	38.9	52.6	8.1	9.1	42.4	25.8	34.8	22.3	19.3	31.2	420.4	21.8	70.2	22.9
TGDS	"SDR2E1, TDPGD"	ENSG00000088451	"TDP-glucose 4,6-dehydratase"	O95455	13	94574051-94596257	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		Lyase	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"U-698: 42.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039927, HPA040857"	Approved		Approved	Nucleoplasm,Nucleoli,Cytosol		Yes	No			Nucleoplasm	"Nucleoli, Cytosol"	"HPA039927: AB_10795238, HPA040857: AB_10794867"	"unprognostic (4.07e-2)"	"unprognostic (3.56e-1)"	"unprognostic (2.66e-2)"	"unprognostic (2.76e-1)"	"unprognostic (1.27e-1)"	"unprognostic (2.25e-2)"	"unprognostic (1.60e-1)"	"unprognostic (2.87e-1)"	"unprognostic (9.99e-2)"	"unprognostic (1.96e-1)"	"unprognostic (9.17e-2)"	"prognostic unfavorable (2.48e-4)"	"unprognostic (5.51e-2)"	"unprognostic (1.13e-2)"	"unprognostic (2.26e-1)"	"unprognostic (1.71e-2)"	"unprognostic (1.09e-1)"	11.1	12.2	7.9	11.4	11.8	5.8	13.4	8.0	7.8	11.9	9.0	9.0	13.4	11.1	13.7	13.2	10.3	10.5	8.7	7.7	7.0	7.0	11.8	31.9	7.8	12.5	11.8	6.8	13.9	14.1	6.2	24.3	10.8	10.1	10.5	10.6	15.4	12.5	12.7	7.6	7.9	11.1	10.3	12.6	11.9	9.8	7.2	12.6	27.1	15.8	8.9	12.5	10.9	9.2	9.9	8.0	10.5	7.0	10.4	17.4	6.7	7.4	3.1	5.2	4.7	7.7	6.2	6.5	6.8	6.5	6.4	6.2	8.5	7.3	11.4	6.9	4.7	4.2	4.7	9.2	5.3	6.6	9.0	3.6	9.2	3.6	7.9	9.8	31.4	6.3	7.2	4.2	3.6	10.3	5.1	5.9	8.4	9.0	4.0	5.8	4.5	8.6	16.2	6.9	12.0	4.0	7.3	5.3	6.7	8.1	3.3	7.4	4.1	5.1	10.8	19.0	9.1	4.8	17.1	5.5	2.6	6.8	3.9	5.6	9.1	4.9	42.1	7.0	11.7	7.0	10.5	5.3	9.6	9.6	6.2	14.5	9.9	11.3	10.5	8.0	7.3	17.4	12.4	1.5	10.4	7.0	7.1	12.5	6.7	7.9	11.8	8.0	7.8	7.0	7.0	11.8	6.8	10.1	12.6	11.9	5.0	15.6	9.5	2.2	4.5	4.7	0.0	10.7	10.3	7.0	2.0	12.9	8.3	9.8	1.1	6.3	5.5	0.0	8.0	15.4	12.0	9.9	10.5	19.8	10.0	1.6	5.2	9.2	7.6	0.4	13.3	9.6	8.5	12.6	8.1	6.3	8.2	7.0	7.8	13.3	4.0	25.8	6.4	12.0	10.4	3.1	8.7	8.7	8.0	8.7
TGFBR1	"ACVRLK4, ALK-5, ALK5, ESS1, MSSE, TBR-i, TBRI"	ENSG00000106799	"Transforming growth factor beta receptor 1"	P36897	9	99104038-99154192	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Apoptosis, Differentiation, Growth regulation"	"Kinase, Receptor, Serine/threonine-protein kinase, Transferase"	"Aortic aneurysm, Craniosynostosis, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Early spermatids: 114.1;Late spermatids: 74.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"RH-30: 68.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002441, CAB031481, HPA056473"	Uncertain		Supported	"Plasma membrane"	"Intracellular and membrane"	NA	NA			"Plasma membrane"		"CAB002441: AB_564029, CAB031481: AB_2202455, HPA056473: AB_2683144"	"unprognostic (2.58e-3)"	"unprognostic (1.20e-2)"	"unprognostic (3.64e-3)"	"unprognostic (2.80e-1)"	"unprognostic (8.63e-2)"	"unprognostic (3.36e-2)"	"unprognostic (1.97e-2)"	"unprognostic (1.32e-3)"	"unprognostic (1.97e-1)"	"unprognostic (1.45e-1)"	"unprognostic (8.21e-3)"	"unprognostic (1.82e-1)"	"unprognostic (1.18e-1)"	"unprognostic (1.01e-3)"	"unprognostic (3.40e-2)"	"unprognostic (3.19e-2)"	"unprognostic (1.14e-2)"	11.1	6.9	10.3	11.5	14.6	20.0	15.4	12.6	11.3	14.4	20.0	11.0	5.5	7.4	18.8	8.0	13.2	10.9	14.9	9.7	7.8	7.5	16.0	9.8	19.2	18.9	15.8	4.3	13.3	8.8	6.5	13.5	50.9	14.1	12.3	9.2	10.4	10.2	12.2	8.4	6.6	11.0	28.6	17.9	13.9	25.5	11.4	12.4	10.8	7.7	8.1	11.5	13.0	10.2	1.6	2.0	13.1	2.4	4.0	8.3	1.9	3.4	5.2	31.4	9.7	7.3	5.4	4.7	11.7	12.9	11.0	12.3	5.2	2.5	7.6	3.6	9.1	8.7	8.1	10.6	9.1	14.8	19.9	3.3	11.4	5.7	4.6	12.1	7.0	27.9	11.2	9.8	17.1	8.1	6.9	1.9	2.9	15.8	3.2	15.0	5.3	1.0	8.0	6.7	3.2	3.1	2.8	68.5	3.2	2.7	0.8	8.5	9.9	9.1	40.7	12.2	13.5	7.5	9.6	3.6	8.2	7.1	35.0	7.1	3.3	3.3	5.2	17.2	12.1	7.0	13.1	2.4	9.1	8.3	1.6	7.2	1.6	3.6	6.1	2.0	1.3	3.5	6.7	4.9	4.0	1.9	1.4	2.2	1.9	10.3	14.6	12.6	11.3	7.8	7.5	15.8	4.3	14.1	12.4	6.0	9.1	9.3	6.5	20.9	7.2	6.3	5.1	1.4	10.3	57.6	0.0	17.0	0.0	14.1	114.1	14.5	3.3	23.3	27.1	5.9	46.2	13.4	29.9	11.5	43.1	0.0	9.2	8.0	20.9	74.1	8.9	36.3	33.7	19.0	6.6	2.9	25.9	3.5	12.7	12.2	1.6	32.3	22.2	8.0	10.5	14.2	16.2	11.5	7.2	8.4
TGFBR2	"MFS2, TBR-ii, TBRII"	ENSG00000163513	"Transforming growth factor beta receptor 2"	P37173	3	30606502-30694142	"Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted membrane proteins"	"Apoptosis, Differentiation, Growth regulation"	"Kinase, Receptor, Serine/threonine-protein kinase, Transferase"	"Aortic aneurysm, Cancer-related genes, Craniosynostosis, Disease mutation, Hereditary nonpolyposis colorectal cancer"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	14	"Endothelial cells: 188.8;Ito cells: 564.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"ASC diff: 54.5;ASC TERT1: 82.2;HSkMC: 70.9;LHCN-M2: 67.2;TIME: 61.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB073537			Supported	"Plasma membrane"		NA	NA		560000	"Plasma membrane"		"CAB073537: "	"unprognostic (1.74e-1)"	"unprognostic (1.84e-2)"	"unprognostic (3.70e-1)"	"unprognostic (3.02e-2)"	"unprognostic (1.92e-1)"	"unprognostic (2.26e-1)"	"unprognostic (1.96e-1)"	"unprognostic (1.62e-1)"	"unprognostic (1.40e-1)"	"unprognostic (2.24e-2)"	"unprognostic (7.36e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.65e-2)"	"unprognostic (4.72e-2)"	"unprognostic (1.81e-2)"	"unprognostic (8.81e-2)"	"unprognostic (8.02e-2)"	91.8	24.6	6.7	24.6	10.3	7.3	88.3	3.6	7.3	36.5	42.6	9.8	18.6	13.2	42.6	23.3	36.2	28.4	42.6	73.5	6.9	5.2	32.6	21.9	52.6	75.7	12.6	3.7	22.2	26.0	17.4	10.3	24.2	9.9	35.2	17.5	27.9	22.5	19.5	34.9	17.0	31.3	37.2	12.0	68.7	26.8	15.4	8.2	19.3	40.9	16.8	26.9	48.0	82.0	5.3	6.8	20.0	6.6	1.4	19.7	3.9	2.5	14.7	0.9	0.0	54.5	82.2	2.5	12.8	18.0	4.4	4.4	3.3	13.6	0.3	46.2	17.1	5.2	5.1	0.6	18.7	7.3	1.0	1.3	1.4	1.7	16.5	23.3	2.3	12.1	70.9	16.6	19.0	18.4	20.2	47.6	1.7	0.3	0.0	67.2	0.2	2.3	1.7	0.4	12.8	5.9	2.1	5.9	0.3	23.6	6.0	0.0	0.9	3.8	1.0	3.6	1.2	0.0	2.5	61.6	21.7	5.4	9.8	4.8	0.5	0.0	2.0	13.0	2.5	8.7	6.9	2.9	20.0	3.5	3.0	3.2	4.0	5.4	4.2	2.6	5.3	19.7	9.1	12.6	1.4	6.6	6.8	1.2	3.9	6.7	10.3	3.6	7.3	6.9	5.2	12.6	3.7	9.9	8.2	134.0	83.8	41.5	14.2	33.2	1.9	64.1	48.4	12.0	53.4	26.2	0.0	5.3	3.3	11.4	2.0	188.8	9.7	0.0	13.8	4.3	48.1	7.3	28.9	45.3	27.1	0.0	8.1	564.1	139.2	2.0	30.5	46.1	28.7	1.8	11.9	0.2	25.3	10.8	44.6	5.6	0.9	32.3	36.0	0.3	1.1	26.7	3.1	39.4	13.0	9.0
TGM1	"ICR2, LI, LI1, TGASE, TGK"	ENSG00000092295	"Transglutaminase 1"	P22735	14	24249114-24264432	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	Keratinization	"Acyltransferase, Transferase"	"Disease mutation, Ichthyosis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"esophagus: 106.0;lymphoid tissue: 70.0;tongue: 86.8"	"Cell type enhanced"	"Detected in some"	17	"Alveolar cells type 1: 11.9;Club cells: 6.8;Distal tubular cells: 24.9"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 78.3"	"Region enriched"	"Detected in single"	11	"cerebellum: 3.0"	"Cell type enhanced"	"Detected in single"		"memory CD4 T-cell: 1.1"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"BEWO: 13.1;HaCaT: 18.0;HeLa: 11.8;MCF7: 12.9;SK-BR-3: 16.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"CAB015159, HPA040171"	Enhanced		Approved	"Vesicles,Plasma membrane"		NA	NA		430000	"Vesicles, Plasma membrane"		"CAB015159: AB_2202870, HPA040171: AB_2676869"	"unprognostic (2.95e-2)"	"unprognostic (8.79e-2)"	"unprognostic (2.92e-2)"	"unprognostic (1.89e-2)"	"unprognostic (2.36e-1)"	"unprognostic (1.10e-1)"	"unprognostic (4.04e-2)"	"unprognostic (1.12e-2)"	"unprognostic (2.39e-1)"	"unprognostic (3.01e-2)"	"unprognostic (6.72e-2)"	"unprognostic (2.15e-1)"	"unprognostic (1.94e-7)"	"unprognostic (7.11e-2)"	"unprognostic (7.38e-2)"	"unprognostic (2.22e-3)"	"unprognostic (1.86e-2)"	2.9	0.2	0.2	0.4	0.2	0.2	0.7	3.0	0.3	10.1	1.0	0.2	0.2	0.3	0.5	2.0	106.0	1.3	0.2	0.6	0.2	0.0	0.6	0.3	0.9	0.4	0.2	0.2	0.7	1.3	0.2	0.2	0.9	0.2	0.5	0.3	0.4	12.8	1.4	0.7	9.3	0.3	0.2	0.2	0.4	0.2	0.4	0.2	0.5	0.4	86.8	70.0	0.4	17.2	0.4	0.5	0.0	0.5	0.0	1.1	0.2	0.8	1.5	0.8	0.7	0.0	0.6	13.1	0.3	0.2	0.7	1.3	0.9	1.3	0.8	1.7	1.0	0.2	18.0	2.1	1.5	0.5	1.4	2.5	1.0	11.8	4.1	0.6	0.6	1.1	1.1	7.1	0.4	1.5	0.4	0.5	2.5	0.7	0.8	0.5	12.9	0.5	1.4	0.2	0.8	1.6	0.8	0.1	0.8	0.5	1.5	0.9	1.2	0.2	16.0	0.0	1.1	1.1	0.8	0.6	0.8	3.8	1.5	0.6	1.1	1.2	0.2	0.3	1.5	0.9	0.0	0.5	0.0	0.5	0.0	0.0	0.0	1.1	0.0	0.0	0.4	0.5	0.0	0.0	0.0	0.2	0.5	0.0	0.2	0.2	0.2	3.0	0.2	0.2	0.0	0.2	0.2	0.2	0.2	11.9	1.4	0.0	4.2	0.2	0.8	0.8	0.0	0.0	6.8	0.0	0.0	1.1	24.9	1.9	0.1	0.0	0.0	0.0	0.8	0.6	0.6	3.1	4.6	0.0	0.3	0.0	0.0	0.0	0.8	0.0	0.6	0.0	0.0	0.0	0.0	0.3	1.5	0.0	0.4	0.1	0.6	0.0	0.3	0.0	0.8	1.6	1.0	0.0	0.0	4.6
TGM2	TGC	ENSG00000198959	"Transglutaminase 2"	P21980	20	38127387-38166578	"Enzymes, Predicted intracellular proteins"		"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 187.6;placenta: 212.7"	"Cell type enhanced"	"Detected in many"	7	"Cytotrophoblasts: 276.1;Ito cells: 326.6;Pancreatic endocrine cells: 240.4;Syncytiotrophoblasts: 312.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	9	"intermediate monocyte: 2.5;memory B-cell: 1.9;myeloid DC: 2.4"	"Group enriched"	"Detected in many"	23	"B-cells: 1.9;dendritic cells: 2.4;monocytes: 2.5"	"Group enriched"	"Detected in many"	4	"CAPAN-2: 155.5;EFO-21: 52.3;hTERT-RPE1: 102.6;HUVEC TERT2: 70.7;TIME: 92.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"CAB002598, HPA021019, HPA029518"	Enhanced		Approved	"Plasma membrane,Cytosol"		Yes	No		1700000	Cytosol	"Plasma membrane"	"CAB002598: , HPA021019: AB_1858247, HPA029518: AB_10603133"	"unprognostic (7.80e-2)"	"unprognostic (1.51e-1)"	"unprognostic (5.22e-2)"	"unprognostic (1.40e-2)"	"unprognostic (1.56e-2)"	"unprognostic (5.61e-3)"	"unprognostic (2.81e-1)"	"unprognostic (3.32e-3)"	"unprognostic (3.29e-2)"	"unprognostic (9.78e-3)"	"prognostic unfavorable (2.97e-4)"	"unprognostic (6.99e-2)"	"prognostic unfavorable (1.67e-7)"	"unprognostic (1.60e-2)"	"unprognostic (1.93e-2)"	"unprognostic (6.70e-2)"	"unprognostic (6.40e-2)"	33.3	9.5	6.0	18.3	8.1	1.0	7.7	4.3	7.5	94.3	12.6	4.0	4.7	8.4	54.6	21.7	15.8	58.7	62.8	77.1	7.5	3.4	25.3	187.6	61.2	16.4	6.9	3.0	18.7	5.0	5.2	25.6	212.7	8.5	33.6	6.3	57.4	1.9	17.1	19.3	0.7	12.8	43.9	5.7	20.4	13.6	7.4	6.4	0.8	17.0	3.4	3.1	38.2	21.6	1.9	2.4	0.0	2.5	0.0	0.0	0.2	6.3	4.7	0.0	0.1	4.9	0.5	2.4	9.6	4.6	0.0	0.1	7.8	155.5	0.0	52.3	0.1	11.1	0.1	0.0	22.5	0.3	0.0	0.0	1.0	0.2	3.4	20.3	0.0	0.0	0.5	0.0	4.1	0.0	102.6	70.7	0.0	2.1	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	6.9	0.0	0.0	0.1	22.6	0.0	0.8	3.3	0.2	0.0	92.1	0.1	5.9	0.7	4.5	0.0	0.0	0.0	6.3	0.0	1.8	0.0	0.2	0.0	0.0	2.5	0.0	1.9	0.0	0.0	2.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	6.0	8.1	4.3	7.5	7.5	3.4	6.9	3.0	8.5	6.4	8.9	28.9	15.2	9.8	0.5	0.0	156.9	48.4	16.0	27.3	14.0	2.0	276.1	3.3	184.1	2.3	166.8	4.2	93.5	124.7	21.8	45.8	45.4	2.3	137.1	49.2	0.0	0.0	326.6	22.9	3.5	1.1	11.4	0.0	10.8	0.0	0.4	240.4	0.0	5.6	19.0	0.5	0.0	65.7	0.5	4.9	0.0	312.9	1.3	0.4	12.3
TGM3	TGE	ENSG00000125780	"Transglutaminase 3"	Q08188	20	2296001-2341078	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	Keratinization	"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	8	"esophagus: 195.0;lymphoid tissue: 152.6;tongue: 206.5"	"Cell type enriched"	"Detected in some"	6	"Intestinal endocrine cells: 44.4"	"Cancer enriched"	"Detected in many"	9	"head and neck cancer: 81.6"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	205	"neutrophil: 20.4"	"Lineage enriched"	"Detected in single"	205	"granulocytes: 20.4"	"Cell line enriched"	"Detected in some"	6	"EFO-21: 11.9"	"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			HPA004728	Enhanced					NA	NA		14000000			"HPA004728: AB_1080360"	"unprognostic (7.14e-2)"	"unprognostic (8.93e-2)"	"unprognostic (2.18e-2)"	"unprognostic (3.23e-3)"	"unprognostic (4.27e-2)"	"unprognostic (4.20e-2)"	"unprognostic (8.62e-2)"	"unprognostic (4.21e-2)"	"unprognostic (1.50e-1)"	"unprognostic (8.00e-2)"	"unprognostic (4.88e-3)"	"unprognostic (1.35e-1)"	"unprognostic (7.78e-8)"	"unprognostic (1.56e-1)"	"unprognostic (1.61e-1)"	"unprognostic (1.45e-2)"	"unprognostic (9.67e-2)"	0.0	0.0	0.1	0.0	0.0	0.2	0.6	0.0	0.0	4.9	0.1	0.0	0.0	0.0	0.1	0.1	195.0	0.5	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.0	24.5	0.0	0.1	7.7	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	206.5	152.6	0.0	2.8	0.0	0.0	20.4	0.0	0.0	0.0	0.0	0.0	1.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	11.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.2	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.2	0.0	0.1	0.1	0.6	0.5	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	20.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	1.4	0.0	0.3	0.0	4.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.0	0.0	0.0	0.0	44.4	0.0	0.0	2.5	0.0	0.0	0.0	0.0	2.7	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.4	7.2	0.0	0.0	0.0	0.0
TGM4	TGP	ENSG00000163810	"Transglutaminase 4"	P49221	3	44874608-44914990	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins"		"Acyltransferase, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	4	"prostate: 107.8"	"Cell type enriched"	"Detected in some"	37	"Glandular cells: 201.3"	"Cancer enriched"	"Detected in single"	312	"prostate cancer: 75.4"	"Region enriched"	"Detected in single"	254	"cerebral cortex: 25.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 9.7;hTERT-HME1: 2.6;NB-4: 5.2;RPMI-8226: 3.7;SH-SY5Y: 2.9"	"Not detected"	"Not detected"							"CAB033571, HPA073290"	Enhanced					NA	NA					"CAB033571: AB_2287329, HPA073290: "	"unprognostic (4.40e-2)"	"unprognostic (4.68e-2)"	"unprognostic (1.92e-1)"	"unprognostic (2.17e-3)"	"unprognostic (2.84e-1)"	"unprognostic (2.19e-2)"	"unprognostic (1.37e-1)"	"unprognostic (1.92e-1)"	"unprognostic (2.41e-2)"	"unprognostic (1.65e-1)"	"unprognostic (8.56e-3)"	"unprognostic (5.08e-2)"	"unprognostic (1.44e-8)"	"unprognostic (1.10e-1)"	"unprognostic (1.98e-2)"	"unprognostic (3.68e-1)"	"unprognostic (6.41e-2)"	0.0	0.2	0.0	0.0	0.0	0.1	0.1	0.0	25.4	0.0	0.0	0.0	0.4	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	107.8	0.0	0.0	2.3	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.2	0.0	0.6	0.2	0.0	0.3	0.0	0.0	0.0	0.0	0.0	9.7	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.5	0.1	2.6	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	5.2	0.0	0.0	0.2	0.0	0.0	3.7	0.0	0.0	0.0	2.9	0.0	0.0	0.0	0.1	0.0	1.5	0.5	0.0	0.7	0.7	0.1	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.3	0.2	0.0	0.2	0.6	0.0	0.3	0.0	0.0	0.0	0.0	0.0	25.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	3.5	0.5	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	4.8	0.0	0.0	0.0	0.0	0.2	0.2	201.3	0.0	0.0	0.1	0.0	0.0	0.6	0.0	5.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.3	0.4	0.8	0.0	0.0	2.6
TGM5	TGX	ENSG00000104055	"Transglutaminase 5"	O43548	15	43232595-43266857	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		"Acyltransferase, Transferase"	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"esophagus: 9.7;lymphoid tissue: 10.4;skin 1: 24.3;tongue: 13.1"	"Cell type enhanced"	"Detected in some"	21	"Early spermatids: 3.1;Late spermatids: 2.6;Suprabasal keratinocytes: 5.8;Urothelial cells: 12.6"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	7	"HEL: 20.2"	"Region enriched"	"Detected in single"	11	"cerebellum: 2.9"	"Not detected"	"Not detected"									NA	NA						"unprognostic (3.17e-2)"	"unprognostic (1.03e-2)"		"unprognostic (5.92e-2)"	"unprognostic (2.65e-1)"	"unprognostic (2.24e-2)"		"unprognostic (1.94e-2)"	"unprognostic (1.78e-1)"	"unprognostic (7.68e-2)"	"unprognostic (2.25e-2)"	"unprognostic (1.77e-1)"	"unprognostic (1.44e-15)"	"unprognostic (1.94e-1)"	"unprognostic (3.14e-1)"	"unprognostic (7.22e-3)"	"unprognostic (5.71e-2)"	0.3	0.0	0.1	0.1	0.1	0.2	2.1	0.1	0.1	2.6	0.1	0.1	0.1	0.0	0.7	0.1	9.7	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.8	0.1	0.6	0.0	0.1	2.8	3.4	0.1	24.3	0.1	0.7	0.1	0.1	0.0	0.1	0.1	0.1	0.1	13.1	10.4	0.8	4.7	0.0	0.0	0.9	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	20.2	0.0	0.4	0.0	0.7	2.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.1	0.0	2.7	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.5	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.0	2.3	0.8	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	3.1	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	5.8	1.6	0.0	0.0	12.6
TGM6	"dJ734P14.3, SCA35, TGM3L, TGY"	ENSG00000166948	"Transglutaminase 6"	O95932	20	2380908-2432753	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		"Acyltransferase, Transferase"	"Disease mutation, Neurodegeneration, Spinocerebellar ataxia"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in some"	34	"lymphoid tissue: 5.7;skin 1: 3.3;tongue: 4.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	12	"SCLC-21H: 3.6"	"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	22	"cerebellum: 1.8"	HPA059196	Uncertain					NA	NA					"HPA059196: AB_2683943"						"unprognostic (1.18e-1)"						"unprognostic (2.84e-2)"						0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	4.2	5.7	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
TGM7	TGMZ	ENSG00000159495	"Transglutaminase 7"	Q96PF1	15	43276280-43302255	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins"		"Acyltransferase, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"lymphoid tissue: 5.9;testis: 2.9"	"Cell type enriched"	"Detected in some"	5	"Early spermatids: 60.4"	"Cancer enriched"	"Detected in single"	13	"endometrial cancer: 2.1"					"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	78	"EFO-21: 9.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"									NA	NA							"unprognostic (2.45e-2)"		"unprognostic (2.04e-1)"		"unprognostic (2.82e-2)"				"unprognostic (1.71e-2)"		"unprognostic (1.07e-1)"			"unprognostic (2.01e-1)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0			0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.3	0.0		0.2	0.1	1.5	0.0	0.0	0.0	0.0	0.0	0.0	2.9			0.0		5.9	0.0	1.6	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	60.4	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.3	0.3	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.7	0.0	0.0	0.0	0.0	2.8
TH	DYT5b	ENSG00000180176	"Tyrosine hydroxylase"	P07101	11	2163929-2171877	"Disease related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins"	"Catecholamine biosynthesis, Neurotransmitter biosynthesis"	"Monooxygenase, Oxidoreductase"	"Disease mutation, Dystonia, FDA approved drug targets, Parkinson disease, Parkinsonism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	31	"adrenal gland: 83.5;brain: 41.4"	"Cell type enhanced"	"Detected in some"	21	"Collecting duct cells: 1.8;Extravillous trophoblasts: 7.9;Leydig cells: 3.1;Syncytiotrophoblasts: 1.8"	"Cancer enhanced"	"Detected in some"		"urothelial cancer: 4.0"	"Group enriched"	"Detected in many"	6	"hypothalamus: 15.5;midbrain: 41.4;pons and medulla: 41.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	32	"PC-3: 35.9;SK-BR-3: 12.8"	"Region enhanced"	"Detected in many"		"olfactory region: 220.1"	"Region enriched"	"Detected in many"	19	"midbrain: 692.0"	"CAB002522, HPA013768, HPA014010, HPA061003, CAB072340"	Enhanced	Supported	Approved	Cytosol		NA	NA			Cytosol		"CAB002522: AB_564047, CAB072340: , HPA013768: , HPA014010: , HPA061003: AB_2630374"	"unprognostic (1.31e-1)"	"unprognostic (1.30e-1)"	"unprognostic (9.08e-2)"	"unprognostic (1.75e-4)"	"unprognostic (8.82e-3)"	"unprognostic (5.88e-2)"	"unprognostic (1.93e-1)"	"unprognostic (1.74e-3)"	"unprognostic (3.83e-2)"	"unprognostic (4.39e-4)"	"unprognostic (4.97e-1)"	"unprognostic (3.61e-2)"	"unprognostic (1.92e-1)"	"unprognostic (1.60e-1)"	"unprognostic (2.43e-1)"	"unprognostic (2.70e-2)"	"unprognostic (2.18e-2)"	1.3	83.5	0.0	0.3	5.4	0.2	0.2	0.0	0.7	1.8	0.2	6.2	0.0	0.2	0.3	0.3	0.2	0.3	0.4	0.2	0.3	15.5	0.2	0.2	0.2	0.2	41.4	0.0	0.3	0.3	0.2	0.2	0.9	41.2	0.6	0.2	0.3	0.2	2.0	0.2	0.5	0.4	0.2	0.0	0.3	0.2	0.3	1.5	0.0	0.2	0.0	0.2	0.9	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.3	35.9	0.0	0.0	0.0	0.1	0.0	0.7	0.1	0.0	12.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.4	0.0	0.7	0.3	15.5	41.4	0.0	41.2	1.5	0.0	0.0	0.0	0.1	0.1	0.0	0.8	0.0	0.0	0.0	1.8	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	7.9	0.4	0.0	0.0	0.0	0.4	0.0	0.0	1.3	0.0	0.0	3.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.5	0.0	1.8	0.0	0.0	0.1
THEM4	CTMP	ENSG00000159445	"Thioesterase superfamily member 4"	Q5T1C6	1	151873584-151909808	"Enzymes, Predicted intracellular proteins"	"Apoptosis, Fatty acid metabolism, Lipid metabolism"	Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Cone photoreceptor cells: 98.2;Rod photoreceptor cells: 70.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"SK-MEL-30: 30.5"	"Low region specificity"	"Detected in all"							HPA028161	Approved					NA	NA					"HPA028161: AB_10603454"	"unprognostic (2.88e-2)"	"unprognostic (1.93e-1)"	"unprognostic (1.50e-1)"	"unprognostic (1.04e-2)"	"unprognostic (1.29e-1)"	"unprognostic (7.89e-2)"	"prognostic unfavorable (1.38e-4)"	"unprognostic (3.15e-3)"	"unprognostic (2.23e-2)"	"unprognostic (1.07e-1)"	"prognostic favorable (2.51e-4)"	"unprognostic (1.17e-1)"	"unprognostic (4.19e-2)"	"unprognostic (3.02e-2)"	"unprognostic (9.25e-2)"	"unprognostic (1.91e-1)"	"unprognostic (5.93e-3)"	8.3	15.3	8.4	9.8	11.7	4.9	12.2	19.8	13.2	6.6	8.0	11.3	22.4	8.5	10.3	18.0	6.1	8.5	7.2	9.8	8.7	11.9	19.9	13.4	8.9	15.7	10.8	6.4	9.2	15.9	10.9	21.0	6.3	11.1	8.0	11.6	14.9	9.2	23.1	18.3	6.7	8.1	7.9	10.0	9.2	9.6	10.2	11.8	3.1	11.3	6.4	13.6	11.3	8.3	3.0	5.0	1.8	1.6	6.2	18.6	2.8	3.7	4.3	1.0	3.5	3.7	3.0	3.4	3.1	3.8	4.3	3.5	4.8	3.3	10.2	5.0	4.6	2.0	4.0	2.9	10.0	4.3	10.6	2.0	13.8	6.0	5.5	3.5	15.9	4.5	5.9	4.4	4.5	4.5	3.5	7.2	0.1	17.3	7.8	6.2	6.4	0.0	4.2	18.0	4.5	7.6	0.0	0.8	2.6	5.1	3.7	4.6	8.3	2.2	4.0	30.5	3.7	10.4	6.6	6.2	0.4	3.8	2.9	1.3	12.7	16.4	6.5	6.5	8.7	20.3	1.5	0.6	1.8	6.1	1.6	9.1	3.0	12.7	6.0	2.0	1.5	12.3	8.7	0.4	6.2	0.5	5.0	18.6	2.8	8.4	11.7	19.8	13.2	8.7	11.9	10.8	6.4	11.1	11.8	6.0	13.7	16.1	7.2	4.9	35.0	16.1	12.7	5.3	12.5	14.0	98.2	25.2	34.9	15.2	30.2	12.0	7.0	0.0	16.8	13.9	14.6	5.0	23.1	15.3	11.4	12.7	17.4	21.5	3.1	23.7	15.5	10.4	20.3	9.0	7.0	23.7	12.7	11.4	15.2	21.4	70.5	12.9	10.8	26.5	20.0	3.9	8.6	24.5	12.8	3.5
THEM5	FLJ37964	ENSG00000196407	"Thioesterase superfamily member 5"	Q8N1Q8	1	151847263-151853697	"Enzymes, Predicted intracellular proteins"	"Fatty acid metabolism, Lipid metabolism"	Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	7	"skin 1: 59.8;tongue: 24.7"	"Cell type enriched"	"Detected in some"	18	"Suprabasal keratinocytes: 30.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"Cell type enhanced"	"Detected in some"		"MAIT T-cell: 4.2"	"Lineage enriched"	"Detected in single"	7	"T-cells: 4.2"	"Cell line enriched"	"Detected in some"	6	"HDLM-2: 39.1"	"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	15	"basal ganglia: 20.0"							NA	NA						"unprognostic (2.28e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.07e-1)"	"unprognostic (3.41e-2)"	"unprognostic (2.58e-3)"	"unprognostic (9.55e-3)"	"unprognostic (1.27e-1)"	"unprognostic (1.93e-1)"	"unprognostic (1.83e-1)"	"unprognostic (7.86e-3)"	"unprognostic (3.07e-3)"	"unprognostic (9.37e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.97e-2)"	"unprognostic (2.49e-1)"	"unprognostic (5.34e-2)"	"unprognostic (1.62e-2)"	0.1	0.6	0.3	0.5	0.2	0.0	1.8	0.2	1.6	3.6	0.1	0.2	0.1	0.3	0.8	0.1	4.4	0.1	1.0	1.1	0.3	0.2	0.3	0.2	0.3	1.9	0.2	0.8	0.1	0.3	0.0	0.2	5.8	0.1	0.1	0.0	0.1	1.5	0.1	0.2	59.8	0.1	0.1	0.3	0.1	0.5	0.3	0.1	0.4	0.1	24.7	1.7	0.6	1.1	0.0	0.5	0.5	0.2	0.0	4.2	5.6	4.4	0.0	0.0	0.1	0.0	0.0	0.8	0.2	0.0	0.0	0.0	0.0	0.4	0.0	0.1	0.0	0.0	1.6	0.0	0.0	0.0	39.1	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	1.6	0.0	1.2	0.1	0.0	4.7	0.7	0.3	0.0	0.2	0.5	0.0	0.0	0.3	0.1	6.0	1.4	0.8	1.0	1.0	1.4	0.0	0.0	0.0	1.0	0.1	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	1.8	0.2	4.2	0.0	1.6	1.0	0.0	0.0	0.0	0.6	0.5	0.0	0.0	0.5	1.9	5.6	0.3	0.2	0.2	1.3	0.3	0.2	0.2	0.8	0.1	0.1	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	30.4	0.9	0.0	0.0	0.0
THG1L	"FLJ11601, FLJ20546, hTHG1, ICF45, IHG-1"	ENSG00000113272	"TRNA-histidine guanylyltransferase 1 like"	Q9NWX6	5	157731197-157741448	"Enzymes, Predicted intracellular proteins"	"tRNA processing"	"Nucleotidyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035877, HPA035878"	Approved					NA	NA					"HPA035877: AB_10669979, HPA035878: AB_10672993"	"unprognostic (4.30e-3)"	"unprognostic (2.64e-1)"	"unprognostic (3.99e-3)"	"unprognostic (2.86e-2)"	"unprognostic (1.74e-1)"	"unprognostic (4.37e-2)"	"unprognostic (5.74e-3)"	"unprognostic (4.08e-2)"	"unprognostic (1.72e-1)"	"unprognostic (7.16e-2)"	"unprognostic (1.34e-1)"	"unprognostic (4.05e-1)"	"prognostic unfavorable (3.93e-6)"	"unprognostic (1.48e-1)"	"unprognostic (1.47e-1)"	"unprognostic (3.09e-1)"	"unprognostic (1.69e-1)"	7.9	9.7	4.1	7.9	4.1	7.6	8.0	5.2	6.6	12.7	12.0	6.7	9.6	8.2	15.2	9.4	13.5	9.9	11.6	6.2	4.3	4.9	7.3	10.6	7.5	7.7	4.8	3.6	13.5	12.5	5.4	10.0	7.4	4.7	15.8	11.9	6.8	6.9	9.8	7.6	8.1	9.7	15.8	4.7	12.3	10.5	7.9	4.4	11.2	21.9	9.3	9.8	17.5	8.9	7.7	7.8	5.9	10.2	7.1	8.5	4.5	6.3	11.1	5.5	10.2	5.1	15.1	4.2	5.0	9.3	10.2	13.9	15.3	6.5	15.9	4.3	4.4	6.3	6.8	6.6	9.5	11.5	6.5	9.2	5.7	7.6	6.5	5.8	11.9	6.0	13.7	11.6	9.0	12.5	9.9	3.7	2.5	9.9	5.1	6.1	8.8	1.4	8.0	5.2	2.8	11.1	2.3	10.4	9.0	6.4	8.1	6.9	9.7	4.0	6.1	8.1	4.2	10.3	6.9	4.2	8.3	5.5	6.8	13.3	4.5	5.0	10.3	3.6	11.5	5.2	5.9	9.6	0.1	4.2	9.8	5.0	7.7	5.8	4.5	7.8	6.7	8.5	7.1	0.9	7.1	10.2	5.9	5.3	4.5	4.1	4.1	5.2	6.6	4.3	4.9	4.8	3.6	4.7	4.4	3.0	7.5	15.9	24.4	18.3	2.8	4.8	12.7	4.0	7.9	3.5	3.9	14.6	8.3	13.8	15.1	10.8	7.7	0.0	22.7	10.0	16.2	13.1	2.3	7.4	16.9	0.0	6.9	3.7	14.9	6.0	13.3	14.9	5.0	16.2	13.5	1.7	12.9	26.0	14.5	8.0	5.3	6.5	13.7	16.4	7.8	13.4	11.6	12.9	25.8	24.6
THOP1		ENSG00000172009	"Thimet oligopeptidase 1"	P52888	19	2785460-2815807	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	8	"Enterocytes: 167.6;Paneth cells: 149.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB025497, HPA035262"	Uncertain		Supported	Cytosol		NA	NA		1400000	Cytosol		"CAB025497: , HPA035262: AB_2674541"	"unprognostic (1.52e-2)"	"unprognostic (1.73e-3)"	"unprognostic (7.94e-2)"	"prognostic favorable (2.35e-4)"	"unprognostic (1.82e-1)"	"unprognostic (2.16e-2)"	"unprognostic (9.35e-2)"	"unprognostic (1.19e-1)"	"unprognostic (4.05e-2)"	"unprognostic (1.43e-1)"	"unprognostic (1.20e-3)"	"unprognostic (3.00e-2)"	"unprognostic (1.39e-1)"	"prognostic favorable (5.90e-4)"	"unprognostic (1.27e-1)"	"unprognostic (2.64e-1)"	"unprognostic (5.37e-2)"	8.2	9.4	19.1	12.3	19.8	18.4	6.2	21.7	26.1	5.2	11.8	14.1	5.8	24.6	7.5	8.4	11.0	8.4	6.7	11.6	18.5	15.4	7.1	30.4	6.2	11.9	14.1	15.2	11.1	7.8	7.0	12.7	22.3	13.1	18.1	8.2	11.9	13.7	6.8	29.1	11.9	20.0	7.1	10.7	9.8	7.8	27.3	10.9	17.0	7.5	11.5	11.3	5.8	6.8	7.5	9.8	8.0	7.5	3.9	9.5	3.2	29.4	21.9	8.6	18.3	4.4	4.3	30.5	18.4	6.8	18.3	14.8	25.7	9.4	26.6	9.0	7.1	12.8	24.0	12.7	15.1	7.7	0.1	26.6	9.4	24.1	30.4	4.7	18.1	14.7	4.8	5.4	15.2	6.8	5.2	10.4	18.0	21.8	13.0	7.7	22.8	20.1	34.0	25.2	8.8	30.2	16.7	11.4	25.1	7.6	17.1	23.3	18.5	16.1	14.5	8.9	4.6	14.0	17.6	11.7	14.1	12.1	30.0	31.1	22.8	19.1	17.9	15.7	30.4	16.7	8.0	3.5	1.6	5.5	3.9	4.5	5.6	4.0	7.4	4.9	7.5	5.1	4.3	1.7	3.9	7.5	9.8	9.5	3.2	19.1	19.8	21.7	26.1	18.5	15.4	14.1	15.2	13.1	10.9	3.0	11.7	12.3	8.7	6.1	20.3	7.3	10.2	5.3	7.9	10.4	33.4	20.9	8.3	17.0	11.4	5.7	167.6	0.0	12.9	46.8	8.4	12.6	5.7	79.1	19.9	6.4	39.2	6.2	9.5	18.4	10.6	7.0	3.3	11.8	46.9	12.9	15.9	149.7	5.6	9.1	29.7	12.9	9.2	47.9	19.4	5.1	28.3	6.5	38.5	6.4
THTPA	THTPASE	ENSG00000259431	"Thiamine triphosphatase"	Q9BU02	14	23555988-23560271	"Enzymes, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Distal tubular cells: 46.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA028876	Approved		Uncertain	Nucleoplasm,Nucleoli		NA	NA			Nucleoplasm	Nucleoli	"HPA028876: AB_10600731"	"unprognostic (3.50e-3)"	"unprognostic (1.51e-1)"	"unprognostic (1.20e-1)"	"unprognostic (7.11e-2)"	"unprognostic (2.25e-1)"	"unprognostic (2.12e-1)"	"unprognostic (4.13e-1)"	"unprognostic (1.58e-3)"	"unprognostic (1.98e-1)"	"unprognostic (1.57e-1)"	"unprognostic (4.47e-2)"	"unprognostic (1.50e-1)"	"prognostic favorable (1.70e-9)"	"unprognostic (3.47e-2)"	"unprognostic (2.32e-1)"	"unprognostic (3.62e-2)"	"unprognostic (5.40e-2)"	14.9	19.5	27.7	12.2	23.3	7.6	12.9	16.4	24.3	12.3	14.0	20.7	15.9	15.7	13.3	18.4	10.1	17.7	16.8	16.3	23.3	17.4	16.3	12.1	10.7	10.7	21.9	13.3	15.4	12.7	25.0	12.4	7.6	16.1	18.8	12.3	17.1	18.0	23.5	21.9	7.4	11.7	13.7	19.5	11.3	11.6	18.8	14.3	14.1	15.9	12.3	11.2	9.9	7.9	14.3	17.0	11.1	14.4	6.9	11.6	8.7	2.7	17.1	8.4	9.1	19.3	10.9	4.6	8.0	7.1	7.9	7.9	3.5	11.3	5.2	7.0	9.6	9.0	8.5	8.8	10.0	5.9	10.9	9.6	7.0	12.1	9.3	9.8	6.4	6.4	14.8	7.4	12.1	8.9	16.7	9.5	8.4	5.3	11.4	11.5	8.2	10.1	2.6	3.0	14.6	14.6	6.9	5.7	9.4	13.9	5.4	16.2	7.7	7.9	16.2	4.6	5.2	10.8	3.1	7.4	5.2	5.5	10.7	4.7	13.5	8.2	2.9	5.4	2.9	8.0	11.1	14.4	7.3	9.6	10.6	9.5	9.6	6.9	7.5	13.2	14.3	11.6	9.9	1.5	6.9	13.4	17.0	5.4	8.7	27.7	23.3	16.4	24.3	23.3	17.4	21.9	13.3	16.1	14.3	6.0	6.9	15.9	5.8	0.0	27.6	0.0	10.2	5.3	6.8	7.0	7.9	9.0	46.4	13.0	16.7	2.9	8.4	0.0	10.7	4.4	7.2	8.5	23.1	7.6	15.9	7.9	5.8	8.0	10.0	16.8	10.6	8.2	0.0	11.8	6.4	18.8	8.1	8.6	7.1	24.6	9.4	12.9	0.1	19.6	8.7	0.0	5.6	6.4	8.5	5.4
TIE1	"JTK14, TIE"	ENSG00000066056	"Tyrosine kinase with immunoglobulin like and EGF like domains 1"	P35590	1	43300993-43323108	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	Angiogenesis	"Kinase, Receptor, Transferase, Tyrosine-protein kinase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"Endothelial cells: 81.7;Ito cells: 106.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	22	"basophil: 3.4;NK-cell: 5.4"	"Group enriched"	"Detected in many"	22	"granulocytes: 3.4;NK-cells: 5.4"	"Group enriched"	"Detected in some"	5	"EFO-21: 28.5;HUVEC TERT2: 63.1;TIME: 54.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"								"Intracellular and membrane"	NA	NA		75000000				"unprognostic (1.88e-1)"	"unprognostic (1.26e-1)"	"unprognostic (7.60e-3)"	"unprognostic (1.01e-1)"	"unprognostic (3.91e-2)"	"unprognostic (1.53e-3)"	"unprognostic (1.19e-2)"	"unprognostic (7.83e-2)"	"unprognostic (2.02e-1)"	"unprognostic (9.34e-2)"	"unprognostic (1.91e-2)"	"unprognostic (2.25e-1)"	"unprognostic (1.17e-3)"	"unprognostic (2.16e-2)"	"unprognostic (1.89e-1)"	"unprognostic (1.29e-2)"	"unprognostic (2.35e-2)"	39.4	5.4	3.9	6.6	6.0	1.0	43.6	2.5	6.0	10.8	8.4	4.5	4.2	4.5	18.6	10.9	7.8	10.2	11.1	15.1	4.9	4.2	9.4	10.8	22.0	13.1	6.4	3.1	7.0	3.0	2.7	5.1	39.9	5.5	8.6	3.0	6.9	6.0	6.9	17.8	4.2	5.8	12.1	5.3	14.8	5.1	5.1	3.8	1.1	13.9	10.2	3.1	9.0	14.7	0.0	0.2	3.4	0.0	5.4	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	28.5	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	10.7	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.4	63.1	0.0	0.0	0.0	0.0	0.0	0.0	5.2	0.3	0.0	0.0	2.0	4.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	54.8	0.3	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.0	3.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	5.4	0.0	0.1	0.0	0.0	3.9	6.0	2.5	6.0	4.9	4.2	6.4	3.1	5.5	3.8	0.0	6.2	0.0	0.6	1.9	0.3	3.4	0.0	6.7	3.4	0.0	0.0	0.1	0.0	0.0	1.5	81.7	0.0	0.0	0.2	0.1	1.4	0.6	19.7	0.9	0.4	0.0	0.0	106.2	8.6	1.5	2.0	1.6	1.7	0.0	0.0	0.2	0.0	0.0	0.7	0.8	0.7	0.0	0.9	0.7	0.1	1.3	0.2	6.9	0.0	0.6
TIGAR	C12orf5	ENSG00000078237	"TP53 induced glycolysis regulatory phosphatase"	Q9NQ88	12	4307763-4354593	"Enzymes, Predicted intracellular proteins"	"Apoptosis, Autophagy"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Hofbauer cells: 53.0;monocytes: 43.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BEWO: 36.9;SuSa: 36.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB034010, HPA040354, HPA044111"	Approved		Supported	Cytosol		NA	NA			Cytosol		"CAB034010: AB_1128227, HPA040354: AB_2676935, HPA044111: AB_2678814"	"unprognostic (1.76e-1)"	"unprognostic (6.33e-2)"	"unprognostic (4.08e-1)"	"unprognostic (2.60e-1)"	"unprognostic (1.32e-1)"	"unprognostic (2.35e-1)"	"prognostic unfavorable (3.18e-4)"	"unprognostic (5.41e-2)"	"unprognostic (2.11e-1)"	"unprognostic (9.37e-2)"	"unprognostic (1.85e-1)"	"unprognostic (5.21e-2)"	"unprognostic (2.03e-2)"	"unprognostic (2.02e-3)"	"unprognostic (2.44e-1)"	"unprognostic (3.31e-1)"	"unprognostic (1.05e-1)"	14.3	14.3	8.3	12.3	10.8	10.5	7.1	3.7	17.8	6.3	10.4	10.1	6.4	6.7	7.5	7.3	10.3	5.7	8.5	9.8	9.5	7.9	7.7	11.0	10.4	12.3	13.5	7.9	6.0	5.2	9.0	14.4	14.6	12.2	7.5	13.5	8.4	8.2	9.5	13.6	6.2	8.7	12.5	12.3	14.9	8.5	8.4	8.3	8.9	6.0	6.6	12.6	13.9	8.9	3.7	14.0	4.7	15.5	3.2	5.7	3.6	5.3	8.6	7.0	8.1	6.6	6.4	36.9	9.3	7.9	7.1	9.7	10.4	5.5	6.0	1.3	6.4	7.6	6.8	7.4	15.9	8.9	7.7	5.4	0.1	5.7	8.5	14.0	3.3	1.2	11.6	19.2	8.3	15.0	4.4	14.4	4.4	0.6	4.5	14.3	7.9	2.9	1.7	15.0	6.3	2.6	4.2	11.4	2.2	6.9	10.9	0.2	4.2	8.8	4.4	11.5	36.2	1.4	2.9	12.4	9.6	12.4	7.5	5.2	3.8	3.8	10.3	6.7	2.3	7.6	0.5	8.2	0.7	3.6	14.4	3.4	3.7	2.8	3.9	14.0	2.9	1.9	3.2	4.7	3.2	15.5	5.5	5.7	3.6	8.3	10.8	3.7	17.8	9.5	7.9	13.5	7.9	12.2	8.3	0.0	1.7	11.5	7.6	0.0	3.3	9.7	2.5	0.0	0.0	5.2	17.7	23.6	13.3	13.4	23.6	8.7	1.6	0.0	12.0	23.6	8.6	7.1	0.0	5.1	53.0	1.6	7.0	5.5	19.7	22.4	3.4	12.3	0.0	43.3	1.8	11.0	13.1	3.5	4.2	7.3	3.1	6.5	6.6	17.0	23.4	0.0	28.7	4.4	2.0	10.8
TINAG		ENSG00000137251	"Tubulointerstitial nephritis antigen"	Q9UJW2	6	54307859-54390152	"Enzymes, Predicted intracellular proteins, Predicted secreted proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	11	"intestine: 27.2;kidney: 53.0"	"Group enriched"	"Detected in some"	6	"Enterocytes: 52.3;Proximal tubular cells: 176.4"	"Cancer enhanced"	"Detected in some"		"renal cancer: 15.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	34	"RPTEC TERT1: 46.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"HPA035427, HPA073753"	Approved				"Secreted to extracellular matrix"	NA	NA		26000			"HPA035427: AB_10601822, HPA073753: "			"unprognostic (7.62e-3)"			"unprognostic (1.12e-2)"	"prognostic unfavorable (2.05e-5)"	"unprognostic (7.27e-2)"			"unprognostic (5.99e-3)"		"prognostic favorable (8.75e-5)"	"unprognostic (7.10e-2)"				0.0	0.0	0.1	3.6	0.0	0.0	0.0	0.0	0.2	0.0	9.5	0.0	0.0	5.1	0.0	0.0	0.0	0.0	1.7	0.1	0.0	0.1	53.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	6.2	0.0	0.0	0.0	0.2	0.0	27.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	46.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.1	0.2	0.0	0.4	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.4	0.0	0.0	0.0	7.0	0.0	0.0	19.9	0.0	0.7	0.0	52.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.4	0.0	1.3	10.5	0.0	176.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.3	0.0
TINAGL1	"ARG1, LCN7, LIECG3, P3ECSL, TINAGRP"	ENSG00000142910	"Tubulointerstitial nephritis antigen like 1"	Q9GZM7	1	31576485-31587686	"Enzymes, Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"placenta: 128.4"	"Cell type enhanced"	"Detected in many"	15	"Cytotrophoblasts: 1103.3;Syncytiotrophoblasts: 1627.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"basophil: 4.8"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"BEWO: 58.8;CAPAN-2: 32.1;EFO-21: 74.1;HaCaT: 32.2;HBEC3-KT: 37.9;HUVEC TERT2: 31.4;TIME: 67.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			HPA048695	Approved				"Secreted to extracellular matrix"	NA	NA		170000			"HPA048695: AB_2680497"	"unprognostic (1.27e-1)"	"unprognostic (2.94e-2)"	"unprognostic (7.53e-2)"	"unprognostic (1.80e-3)"	"unprognostic (2.74e-1)"	"unprognostic (1.72e-3)"	"unprognostic (8.29e-3)"	"unprognostic (6.02e-3)"	"unprognostic (4.18e-1)"	"unprognostic (6.96e-2)"	"unprognostic (7.02e-3)"	"unprognostic (1.22e-1)"	"prognostic favorable (3.65e-6)"	"unprognostic (7.42e-2)"	"unprognostic (6.64e-2)"	"prognostic favorable (9.64e-4)"	"unprognostic (3.43e-2)"	43.0	8.4	2.2	11.6	3.4	0.8	60.0	0.8	4.4	30.2	22.0	2.9	14.2	12.0	25.7	23.4	23.7	17.0	36.1	52.6	3.4	2.3	53.3	14.7	24.4	12.8	3.9	3.3	15.5	7.4	3.2	5.6	128.4	5.0	19.4	7.9	12.0	24.2	20.0	19.6	7.6	15.9	22.5	2.7	34.3	16.3	10.3	2.1	0.8	30.7	11.0	6.4	39.8	20.0	1.1	0.6	4.8	0.5	1.5	0.8	0.0	16.7	0.0	0.0	0.1	0.1	0.0	58.8	2.6	0.3	0.1	0.0	7.9	32.1	0.0	74.1	2.3	1.2	32.2	0.0	37.9	0.0	0.1	0.0	0.0	1.4	2.0	0.8	0.0	0.1	0.0	6.9	0.0	1.4	0.0	31.4	0.0	0.4	0.0	0.0	0.0	0.1	0.1	0.1	9.1	1.0	0.0	0.0	0.0	10.2	12.9	0.0	0.1	6.8	22.7	0.7	3.6	1.3	0.0	67.1	0.0	17.0	0.1	0.5	0.0	0.1	0.2	0.0	0.0	0.6	4.8	0.5	0.5	0.8	0.3	0.5	0.4	0.6	0.5	0.1	1.1	0.8	0.8	2.7	1.5	0.5	0.6	0.5	0.0	2.2	3.4	0.8	4.4	3.4	2.3	3.9	3.3	5.0	2.1	8.9	7.2	5.3	91.5	9.7	0.0	41.9	38.2	1.4	7.9	125.6	0.0	1103.3	1.7	361.6	1.2	133.2	75.1	0.0	83.6	184.7	19.9	41.9	14.9	1.1	78.0	0.0	10.9	249.8	10.8	0.4	6.9	5.7	21.9	3.6	27.7	0.3	206.9	37.7	3.9	67.7	0.4	420.4	356.4	0.2	0.9	5.6	1627.5	6.4	49.2	157.0
TIPARP	"DDF1, DKFZP434J214, DKFZp686N0351, PARP-1, PARP-7, PARP7, pART14, RM1"	ENSG00000163659	"TCDD inducible poly(ADP-ribose) polymerase"	Q7Z3E1	3	156673235-156706770	"Enzymes, Predicted intracellular proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Basal keratinocytes: 174.1;Early spermatids: 204.3;Urothelial cells: 186.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"basophil: 24.1"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HBEC3-KT: 50.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA036796			Approved	Microtubules		NA	NA			Microtubules		"HPA036796: AB_10672268"	"prognostic favorable (2.00e-5)"	"unprognostic (3.50e-1)"	"unprognostic (7.62e-2)"	"unprognostic (5.21e-2)"	"unprognostic (2.62e-1)"	"unprognostic (4.56e-2)"	"unprognostic (9.50e-2)"	"unprognostic (3.57e-2)"	"unprognostic (2.23e-1)"	"unprognostic (1.43e-1)"	"unprognostic (4.27e-3)"	"unprognostic (2.01e-1)"	"unprognostic (4.69e-2)"	"unprognostic (7.26e-2)"	"unprognostic (1.73e-1)"	"unprognostic (6.16e-3)"	"unprognostic (4.90e-3)"	31.6	29.8	10.9	11.1	24.7	31.8	19.9	7.1	16.3	16.2	12.7	14.2	18.8	6.8	18.3	20.7	27.2	27.8	18.8	26.5	16.0	9.4	14.2	21.3	20.2	15.2	16.2	6.2	37.0	14.5	73.8	11.4	6.1	30.9	13.6	7.5	10.0	8.2	36.0	17.4	26.2	22.1	21.6	37.4	8.4	11.3	23.1	12.5	8.4	10.8	19.1	13.8	18.7	16.7	3.7	3.3	24.1	5.4	7.0	6.0	2.2	12.5	8.8	3.0	2.5	11.1	8.2	2.4	21.0	17.0	10.7	14.9	5.0	26.2	3.7	6.8	23.8	14.3	13.1	7.6	50.4	15.9	7.9	5.6	6.3	9.2	3.4	4.7	2.1	11.7	6.6	31.6	10.9	26.3	29.0	9.7	2.8	4.9	15.1	37.1	2.4	1.8	2.8	3.4	15.8	7.4	3.1	6.8	12.9	11.3	6.0	9.2	2.3	16.5	5.1	3.5	7.2	7.9	3.7	21.0	4.6	1.5	8.7	7.5	16.9	3.0	3.3	7.9	3.3	15.5	24.1	3.5	4.7	4.2	2.2	6.0	1.9	4.2	5.6	2.3	3.7	2.6	3.5	10.7	7.0	5.4	3.3	4.7	2.2	10.9	24.7	7.1	16.3	16.0	9.4	16.2	6.2	30.9	12.5	80.4	77.0	6.1	84.9	174.1	4.4	21.3	30.6	46.8	81.9	7.0	37.3	3.3	18.3	29.3	204.3	26.0	33.2	0.0	20.7	6.8	35.1	72.6	116.2	17.0	17.1	20.6	52.3	13.5	16.1	11.0	18.1	36.2	35.4	20.8	21.8	7.8	28.1	28.1	18.0	8.2	9.4	12.9	57.7	61.8	20.2	106.1	6.3	34.5	12.3	186.7
TK1		ENSG00000167900	"Thymidine kinase 1"	P04183	17	78174075-78187233	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins"	"DNA synthesis"	"Kinase, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 32.8;lymphoid tissue: 41.8;tongue: 33.0"	"Cell type enhanced"	"Detected in many"	14	"Extravillous trophoblasts: 178.8;Hofbauer cells: 55.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"T-reg: 21.2"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			CAB004683	Enhanced					NA	Yes					"CAB004683: AB_437067"	"unprognostic (7.09e-2)"	"unprognostic (1.17e-3)"	"unprognostic (1.82e-1)"	"unprognostic (2.14e-3)"	"unprognostic (3.22e-1)"	"unprognostic (1.94e-1)"	"prognostic unfavorable (6.87e-4)"	"prognostic unfavorable (3.03e-5)"	"unprognostic (4.05e-2)"	"unprognostic (3.18e-3)"	"unprognostic (6.64e-3)"	"unprognostic (2.76e-2)"	"prognostic unfavorable (6.50e-11)"	"unprognostic (5.55e-3)"	"unprognostic (1.92e-1)"	"unprognostic (1.42e-1)"	"unprognostic (4.94e-2)"	5.3	2.0	2.1	21.4	4.5	32.8	4.8	1.1	1.9	3.7	11.4	2.2	1.9	8.5	2.4	4.8	18.9	2.2	7.0	4.3	1.6	0.7	7.9	6.2	9.3	15.7	3.1	1.6	2.1	3.6	0.1	1.3	8.6	2.1	2.3	7.9	0.5	4.6	2.0	2.0	6.2	8.5	4.4	1.7	9.0	9.4	3.6	1.6	41.8	1.3	33.0	20.5	3.1	5.8	4.0	2.1	1.1	1.2	6.2	21.2	3.5	65.8	54.7	10.9	13.8	1.0	4.3	7.1	32.7	17.2	48.7	67.6	48.3	27.8	21.4	11.5	19.6	20.3	30.0	9.9	29.2	25.2	7.4	36.5	37.8	19.6	31.6	0.3	16.0	24.4	2.1	1.0	25.4	3.5	3.4	19.8	7.5	23.2	47.5	18.6	49.1	8.0	9.0	5.6	38.5	38.1	21.7	44.2	47.8	12.9	21.4	4.9	14.5	25.1	68.9	9.2	10.0	46.5	21.5	9.1	47.9	47.0	34.1	42.0	20.0	10.4	27.5	23.5	10.8	21.5	0.0	0.7	0.0	1.1	1.2	0.5	4.0	5.3	2.7	2.1	1.2	0.3	1.4	1.1	6.2	1.0	0.7	21.2	3.5	2.1	4.5	1.1	1.9	1.6	0.7	3.1	1.6	2.1	1.6	0.0	2.4	8.2	6.8	25.2	0.0	0.6	2.5	4.0	7.9	12.2	0.0	46.0	6.6	6.3	2.6	3.2	3.9	46.7	9.8	178.8	7.2	3.3	0.0	8.6	55.5	0.0	5.2	9.8	10.8	4.2	0.6	11.3	3.3	8.2	12.4	0.0	11.2	8.6	0.7	14.7	0.0	0.0	2.2	1.1	18.4	9.8	42.7	7.2	25.1	12.3
TK2	SCA31	ENSG00000166548	"Thymidine kinase 2, mitochondrial"	O00142	16	66508003-66552544	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"DNA synthesis"	"Kinase, Transferase"	"Disease mutation, Primary mitochondrial disease, Progressive external ophthalmoplegia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041162	Uncertain					NA	NA					"HPA041162: AB_10961178"	"unprognostic (1.12e-1)"	"unprognostic (2.11e-1)"	"unprognostic (1.12e-1)"	"unprognostic (6.27e-3)"	"unprognostic (3.94e-1)"	"unprognostic (2.93e-1)"	"unprognostic (1.10e-1)"	"unprognostic (4.83e-2)"	"unprognostic (3.35e-2)"	"unprognostic (3.45e-1)"	"unprognostic (3.59e-2)"	"unprognostic (2.85e-1)"	"prognostic favorable (2.18e-6)"	"unprognostic (3.05e-2)"	"unprognostic (1.74e-1)"	"unprognostic (2.71e-1)"	"unprognostic (7.05e-2)"	34.0	25.4	18.5	9.0	18.9	6.2	25.5	13.1	22.4	19.8	10.9	17.2	18.5	9.5	15.2	29.0	11.0	17.4	18.3	15.2	19.2	15.5	20.9	27.8	16.5	11.5	18.2	18.5	23.7	21.6	50.2	18.0	12.9	27.9	14.9	11.5	13.7	18.1	18.8	20.8	10.0	10.5	17.0	28.2	17.4	12.0	29.4	15.5	6.5	23.4	9.0	8.7	15.5	18.6	1.4	12.6	10.3	15.6	4.4	4.3	3.3	4.7	9.3	5.0	5.2	27.7	22.8	0.3	8.1	9.8	6.5	7.6	2.7	10.4	0.1	9.0	25.2	8.2	4.1	2.5	6.7	4.2	3.1	2.3	0.8	5.9	5.2	19.8	1.3	3.5	16.9	6.4	7.5	10.4	26.7	9.7	6.2	2.7	10.9	15.3	1.6	2.5	6.2	2.5	2.1	5.5	2.7	9.0	10.7	20.0	3.9	1.9	3.2	24.4	2.4	10.5	2.6	3.7	6.7	10.2	12.6	6.5	10.1	2.9	12.3	5.2	5.5	15.1	2.4	7.4	4.7	15.6	10.3	4.3	13.3	3.3	0.9	2.9	3.0	12.6	1.4	1.4	2.3	8.2	4.4	9.8	5.2	2.8	3.3	18.5	18.9	13.1	22.4	19.2	15.5	18.2	18.5	27.9	15.5	20.8	9.4	2.2	4.9	5.0	17.1	5.5	22.9	9.4	6.8	21.0	21.6	7.1	8.3	12.3	17.6	10.9	7.9	0.0	19.4	4.5	8.5	4.3	25.3	42.3	19.3	20.6	9.2	29.4	48.2	27.3	21.6	17.8	10.1	6.4	5.1	17.5	22.8	3.5	18.0	31.5	20.3	0.0	4.7	49.3	10.3	3.3	2.4	6.5	6.8	3.3
TKFC	"DAK, DKFZP586B1621, NET45"	ENSG00000149476	"Triokinase and FMN cyclase"	Q3LXA3	11	61333210-61353295	"Enzymes, Predicted intracellular proteins"		"Kinase, Lyase, Multifunctional enzyme, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"intestine: 90.2;liver: 42.8"	"Cell type enhanced"	"Detected in many"	7	"Hepatocytes: 92.7;Proximal tubular cells: 63.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"Hep G2: 40.5;RPMI-8226: 42.7;T-47d: 42.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039486, HPA048186"	Enhanced		Approved	Nucleoplasm,Cytosol		NA	NA		4800000	Cytosol	Nucleoplasm	"HPA039486: AB_10795402, HPA048186: AB_2680305"	"unprognostic (4.00e-1)"	"unprognostic (3.13e-1)"	"unprognostic (7.42e-2)"	"prognostic favorable (1.32e-5)"	"unprognostic (1.07e-1)"	"unprognostic (1.19e-1)"	"unprognostic (3.02e-2)"	"unprognostic (2.81e-3)"	"unprognostic (1.49e-1)"	"unprognostic (2.47e-1)"	"unprognostic (1.51e-1)"	"unprognostic (2.15e-1)"	"prognostic favorable (8.38e-5)"	"unprognostic (2.07e-2)"	"unprognostic (8.96e-2)"	"unprognostic (3.30e-1)"	"unprognostic (4.02e-1)"	3.1	34.7	3.6	6.1	5.3	5.3	4.6	3.7	7.3	3.4	43.4	7.6	8.0	69.5	4.6	7.8	6.2	5.9	8.8	2.8	3.1	2.6	17.4	42.8	3.5	5.2	3.3	5.3	4.5	9.8	3.0	5.5	3.9	4.4	5.0	2.3	7.3	7.2	7.1	4.6	6.1	90.2	2.6	3.1	5.4	5.7	17.1	3.4	5.5	6.4	6.3	6.7	5.4	3.9	9.7	18.4	5.4	11.4	5.3	10.9	7.8	6.1	15.6	2.7	9.5	3.4	3.7	7.7	3.6	3.9	3.4	2.2	7.1	14.8	7.6	12.6	2.6	3.5	8.6	5.1	6.7	1.1	13.1	6.8	4.7	8.2	40.5	5.9	3.9	7.9	5.9	4.6	3.2	11.2	2.9	3.3	5.3	8.2	14.8	2.4	27.9	3.5	3.6	7.5	5.8	10.7	6.2	4.3	42.7	5.4	10.9	10.6	9.5	6.6	11.6	6.0	1.9	42.8	2.8	4.0	6.7	7.0	5.3	2.1	27.4	22.6	6.9	6.9	3.7	6.1	2.3	11.4	5.4	6.7	6.8	8.6	9.7	7.8	6.5	18.4	9.7	5.6	5.9	0.9	5.3	5.3	9.0	10.9	7.8	3.6	5.3	3.7	7.3	3.1	2.6	3.3	5.3	4.4	3.4	0.0	12.6	6.7	10.8	0.0	12.9	3.4	12.7	20.1	12.5	14.0	13.7	25.7	24.9	15.5	7.9	4.5	5.4	0.0	12.8	4.4	3.0	11.6	7.0	92.7	14.9	7.9	12.9	6.2	18.3	9.3	14.1	5.9	0.0	27.9	13.9	8.7	12.3	18.1	21.2	63.4	16.0	6.5	2.4	39.2	14.5	0.0	12.7	5.7	18.4	10.6
TKT		ENSG00000163931	Transketolase	P29401	3	53224707-53256052	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		Transferase	"Disease mutation, Dwarfism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 216.3"	"Cell type enhanced"	"Detected in all"	5	"Kupffer cells: 587.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	6	"classical monocyte: 63.0;eosinophil: 41.5;intermediate monocyte: 31.0;myeloid DC: 32.5;neutrophil: 60.1;non-classical monocyte: 35.5"	"Group enriched"	"Detected in all"	8	"dendritic cells: 32.5;granulocytes: 60.1;monocytes: 63.0"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029480, HPA029481"	Enhanced		Enhanced	Nucleoplasm		NA	NA		190000000	Nucleoplasm		"HPA029480: AB_10599307, HPA029481: AB_10601895"	"unprognostic (5.05e-2)"	"unprognostic (3.34e-2)"	"unprognostic (1.02e-2)"	"unprognostic (1.77e-2)"	"unprognostic (2.06e-1)"	"unprognostic (1.02e-2)"	"prognostic unfavorable (7.21e-6)"	"unprognostic (6.78e-2)"	"unprognostic (1.70e-1)"	"unprognostic (4.73e-2)"	"unprognostic (3.06e-3)"	"unprognostic (1.36e-2)"	"unprognostic (2.08e-1)"	"unprognostic (2.99e-1)"	"unprognostic (1.07e-1)"	"unprognostic (3.29e-1)"	"unprognostic (9.90e-3)"	53.6	37.0	21.2	24.1	26.0	216.3	70.1	18.1	24.3	19.0	24.3	21.1	9.9	31.8	16.9	9.5	60.4	21.8	36.5	15.3	19.4	23.0	51.9	27.4	50.1	45.6	33.4	16.0	35.2	69.9	22.5	16.9	29.8	28.7	25.2	19.6	17.5	21.0	21.6	5.2	16.8	22.5	34.5	28.2	45.6	24.5	10.8	23.3	44.8	67.7	37.9	25.1	58.2	57.3	6.8	32.5	60.1	63.0	4.7	5.7	37.6	31.4	159.3	22.8	25.3	50.9	62.2	46.6	21.3	37.0	37.0	35.4	44.0	81.1	39.6	10.3	31.1	71.5	45.6	39.5	80.3	11.0	13.2	21.9	26.4	111.4	66.0	62.3	32.2	17.8	45.0	46.2	44.2	22.8	101.2	46.5	33.7	18.7	17.3	15.0	38.5	33.6	36.1	77.4	61.4	38.5	20.3	10.4	73.6	57.8	53.5	14.8	11.0	39.7	63.6	38.3	72.9	19.8	44.6	34.8	11.4	17.7	33.7	40.7	10.0	18.7	23.7	25.0	32.7	21.2	7.0	63.0	41.5	3.0	31.0	3.8	6.8	4.4	3.4	32.5	3.5	4.6	3.4	60.1	4.7	35.5	5.5	5.7	37.6	21.2	26.0	18.1	24.3	19.4	23.0	33.4	16.0	28.7	23.3	125.0	107.1	122.7	318.5	70.5	32.5	12.0	68.8	60.2	69.4	59.3	27.5	317.9	68.0	167.6	5.0	48.1	125.0	23.3	233.6	204.0	47.6	102.3	61.2	73.1	233.2	35.0	50.5	56.4	587.5	2.7	145.6	247.7	72.6	160.5	113.7	78.1	222.7	69.1	100.4	170.5	36.1	51.8	72.1	14.1	21.1	58.6	345.9	84.1	213.7	357.0
TKTL1	"TKR, TKT2"	ENSG00000007350	"Transketolase like 1"	P51854	X	154295671-154330350	"Enzymes, Predicted intracellular proteins"		Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	50	"blood: 28.6;testis: 103.6"	"Cell type enriched"	"Detected in some"	14	"Spermatogonia: 515.6"	"Cancer enriched"	"Detected in many"	8	"testis cancer: 44.2"	"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	6	"eosinophil: 28.6;gdT-cell: 12.0"	"Group enriched"	"Detected in many"	6	"granulocytes: 28.6;T-cells: 12.0"	"Cell line enriched"	"Detected in single"	157	"THP-1: 102.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA000505, HPA029155, CAB032191"	Enhanced		Enhanced	Cytosol		NA	NA			Cytosol		"CAB032191: , HPA000505: AB_1858022, HPA029155: AB_10603134"	"unprognostic (2.69e-1)"	"unprognostic (1.92e-1)"	"unprognostic (1.98e-1)"	"unprognostic (5.80e-3)"	"unprognostic (2.43e-1)"	"unprognostic (1.83e-1)"	"unprognostic (1.36e-2)"	"unprognostic (1.00e-1)"	"unprognostic (2.10e-2)"	"unprognostic (1.61e-1)"	"unprognostic (1.98e-1)"	"unprognostic (2.01e-1)"	"unprognostic (1.63e-1)"	"unprognostic (1.34e-2)"	"unprognostic (3.90e-2)"	"unprognostic (5.04e-2)"	"unprognostic (2.38e-1)"	0.1	0.0	0.0	0.1	0.1	0.3	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.2	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.2	0.0	103.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	28.6	0.1	3.3	12.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	102.8	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.5	0.0	0.0	0.0	0.8	0.0	28.6	12.0	0.1	1.8	0.0	1.4	1.1	0.0	0.0	3.1	2.7	0.4	3.3	0.1	0.1	1.5	2.7	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.2	17.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	32.7	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.2	23.8	0.0	0.0	0.0	16.9	3.7	1.3	0.0	0.0	0.0	5.3	0.0	0.0	1.8	0.0	1.1	25.8	1.4	35.6	515.6	0.1	0.0	0.5	0.0	0.0
TKTL2	"DKFZP434L1717, FLJ32975"	ENSG00000151005	"Transketolase like 2"	Q9H0I9	4	163471093-163473746	"Enzymes, Predicted intracellular proteins"		Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	109	"testis: 66.8"	"Group enriched"	"Detected in some"	19	"Early spermatids: 47.2;Late spermatids: 27.7;Spermatocytes: 100.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"									NA	NA						"unprognostic (2.19e-1)"	"unprognostic (1.55e-1)"			"unprognostic (8.62e-2)"			"unprognostic (2.05e-2)"		"unprognostic (2.90e-1)"	"unprognostic (2.21e-1)"		"unprognostic (7.72e-2)"	"unprognostic (1.15e-1)"	"unprognostic (1.15e-2)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	66.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.5	0.0	0.4	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.3	0.3	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.5	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.5	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	47.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	27.7	3.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	100.1	1.6	0.0	0.0	0.0	0.0	0.0
TLK1	"KIAA0137, PKU-BETA"	ENSG00000198586	"Tousled like kinase 1"	Q9UKI8	2	170990823-171231314	"Enzymes, Predicted intracellular proteins"	"Cell cycle, DNA damage"	"Chromatin regulator, Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA016043	Approved		Supported	Nucleoplasm		NA	NA			Nucleoplasm		"HPA016043: AB_1858027"	"unprognostic (2.13e-2)"	"unprognostic (3.87e-1)"	"unprognostic (7.36e-2)"	"unprognostic (6.00e-3)"	"unprognostic (2.00e-1)"	"unprognostic (6.78e-2)"	"unprognostic (2.47e-2)"	"unprognostic (7.60e-2)"	"unprognostic (1.61e-1)"	"unprognostic (5.26e-2)"	"unprognostic (2.57e-1)"	"unprognostic (1.11e-1)"	"unprognostic (6.13e-2)"	"unprognostic (2.08e-1)"	"unprognostic (1.55e-1)"	"unprognostic (2.63e-1)"	"unprognostic (1.53e-1)"	13.8	20.1	22.0	32.9	21.0	14.4	26.2	18.3	23.2	19.6	20.2	8.4	22.3	13.7	16.1	16.1	14.1	14.4	16.2	12.7	20.6	19.3	19.5	21.4	22.1	33.7	21.7	20.8	21.5	19.8	37.8	21.0	36.0	18.3	18.0	18.2	10.8	16.4	30.3	18.6	15.4	18.9	20.5	18.7	26.0	19.9	24.2	12.2	28.0	25.7	11.1	21.7	21.9	19.1	10.5	5.3	11.3	5.5	9.5	12.3	6.6	8.6	8.5	12.3	9.6	8.8	8.8	13.6	12.1	17.6	12.2	10.2	11.7	14.2	18.0	9.9	18.1	13.2	7.4	15.6	13.5	13.4	21.4	7.8	20.8	10.6	15.1	9.5	26.3	10.5	9.6	13.8	24.2	16.0	13.0	13.3	11.6	21.3	15.4	7.3	10.8	22.1	8.4	11.3	8.4	4.8	16.7	14.9	18.6	10.0	16.7	14.0	10.9	13.1	9.3	8.9	8.7	7.6	9.2	18.1	10.9	13.4	7.1	9.4	12.9	21.7	32.7	13.5	10.9	10.9	11.3	3.9	6.5	6.6	3.0	9.1	10.5	10.7	7.2	3.5	10.5	12.3	8.1	5.0	9.5	5.5	5.3	10.0	6.6	22.0	21.0	18.3	23.2	20.6	19.3	21.7	20.8	18.3	12.2	47.6	23.8	55.6	30.2	36.7	31.7	26.5	28.1	33.5	29.6	48.8	56.9	70.8	74.6	24.8	57.8	27.4	38.0	23.3	28.2	44.9	25.5	42.8	26.5	30.0	23.9	42.9	23.0	12.3	25.7	21.5	40.0	26.9	35.4	15.4	31.6	25.5	28.4	34.8	42.1	38.3	72.6	0.0	28.8	29.9	22.6	34.3	146.2	48.0	28.0	31.4
TLK2	"MGC44450, PKU-ALPHA"	ENSG00000146872	"Tousled like kinase 2"	Q86UE8	17	62458658-62615481	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, DNA damage"	"Chromatin regulator, Kinase, Serine/threonine-protein kinase, Transferase"	"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 47.9"	"Cell type enhanced"	"Detected in all"	5	"Late spermatids: 128.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA						"unprognostic (2.50e-2)"	"unprognostic (2.12e-1)"	"unprognostic (7.06e-2)"	"unprognostic (1.48e-2)"	"unprognostic (9.53e-3)"	"unprognostic (6.57e-2)"	"prognostic unfavorable (9.40e-4)"	"unprognostic (4.53e-2)"	"unprognostic (5.28e-2)"	"unprognostic (2.32e-1)"	"unprognostic (2.82e-2)"	"unprognostic (4.78e-2)"	"unprognostic (5.32e-2)"	"unprognostic (9.79e-2)"	"unprognostic (4.32e-2)"	"unprognostic (4.88e-1)"	"unprognostic (7.30e-2)"	7.4	6.4	8.3	7.3	7.2	12.0	12.5	7.8	14.0	5.8	7.8	4.0	3.1	7.4	9.0	3.1	9.0	6.2	9.9	17.8	7.7	7.4	5.7	5.0	6.9	8.7	7.7	7.3	8.5	8.9	5.6	6.9	9.0	10.4	6.6	5.3	7.5	8.6	8.7	11.7	8.7	10.1	6.5	8.6	8.9	6.7	47.9	5.7	4.1	11.7	3.1	10.0	8.5	7.2	4.6	3.6	8.6	2.8	6.6	4.9	1.5	15.8	14.6	25.2	26.6	8.2	10.7	14.7	17.5	13.6	20.7	19.0	15.1	14.2	31.0	9.0	11.4	18.3	10.8	17.7	7.5	19.8	16.4	14.1	21.1	13.7	15.2	14.7	22.2	13.4	9.2	10.2	13.9	16.9	12.7	10.2	17.7	20.8	14.1	11.1	34.5	31.6	7.9	16.0	9.3	12.2	21.7	33.2	9.8	9.8	15.9	27.2	36.7	14.9	10.2	22.4	22.1	17.3	20.0	13.8	29.1	27.7	13.1	19.7	16.4	20.4	28.4	12.0	11.4	15.2	3.7	2.8	8.6	2.5	2.2	2.6	4.5	4.4	3.1	2.5	4.6	3.5	4.6	5.5	6.6	2.4	3.6	4.9	1.5	8.3	7.2	7.8	14.0	7.7	7.4	7.7	7.3	10.4	5.7	29.8	22.4	16.6	13.3	20.1	58.1	26.4	12.7	38.8	12.5	14.0	78.5	9.5	10.0	8.7	90.3	13.1	14.6	23.3	8.6	9.8	15.0	18.6	19.7	8.3	10.8	27.0	17.2	11.1	14.2	128.6	19.5	18.0	16.9	10.0	14.2	23.8	12.6	23.0	16.6	6.3	82.2	6.5	16.0	73.9	28.9	19.2	12.7	14.1	15.1	20.0
TLL1		ENSG00000038295	"Tolloid like 1"	O43897	4	165873258-166103895	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins"	Differentiation	"Developmental protein, Hydrolase, Metalloprotease, Protease"	"Atrial septal defect, Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 40.6"	"Cell type enhanced"	"Detected in many"	11	"Bipolar cells: 15.1;Endothelial cells: 11.3;Horizontal cells: 7.9"	"Low cancer specificity"	"Detected in some"			"Region enriched"	"Detected in many"	5	"cerebellum: 40.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"HeLa: 8.7;Karpas-707: 13.6;PC-3: 4.9"	"Low region specificity"	"Detected in many"			"Region enriched"	"Detected in all"	10	"cerebellum: 132.6"	HPA060767			Approved	Vesicles	"Secreted to extracellular matrix"	NA	NA			Vesicles		"HPA060767: AB_2684357"	"unprognostic (2.17e-1)"	"unprognostic (6.45e-4)"	"unprognostic (8.60e-2)"	"unprognostic (2.65e-5)"	"unprognostic (9.85e-2)"	"unprognostic (2.51e-4)"	"unprognostic (3.37e-2)"	"unprognostic (3.61e-2)"	"unprognostic (1.56e-1)"	"unprognostic (5.07e-4)"	"unprognostic (2.86e-2)"	"unprognostic (2.34e-1)"	"unprognostic (2.23e-2)"	"unprognostic (2.13e-3)"	"unprognostic (7.76e-2)"	"unprognostic (6.91e-3)"	"unprognostic (1.21e-5)"	10.1	1.3	1.2	2.6	2.8	0.0	7.9	40.6	2.9	5.0	5.4	0.2	4.2	1.4	3.0	2.7	2.5	2.4	5.4	2.4	2.2	1.7	3.3	0.5	3.1	3.0	1.1	0.6	1.6	4.6	1.1	2.2	13.8	8.5	3.1	2.2	3.3	1.9	1.9	1.6	2.7	4.4	3.3	0.9	0.4	1.7	1.5	0.1	0.0	3.2	1.4	1.6	3.6	7.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	2.0	0.5	1.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	2.2	0.0	0.1	0.0	8.7	0.0	0.0	0.0	0.0	0.6	1.5	0.0	1.8	0.0	1.4	0.0	0.0	13.6	0.0	0.0	0.0	0.2	1.2	0.0	4.9	0.0	0.0	0.0	0.2	0.0	1.1	0.0	0.7	0.2	0.0	0.0	0.0	0.0	0.0	0.1	1.5	0.0	0.3	0.2	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	2.8	40.6	2.9	2.2	1.7	1.1	0.6	8.5	0.1	0.0	1.1	0.0	0.2	1.5	15.1	4.1	0.0	1.4	1.2	0.0	0.0	3.9	0.0	1.5	0.0	11.3	0.0	0.0	1.9	0.9	1.6	0.8	0.0	0.0	0.2	7.9	0.0	1.8	0.0	0.0	2.8	0.0	1.7	0.0	0.0	0.0	0.1	0.0	4.2	0.8	0.5	0.0	0.3	0.1	0.0	1.5	1.6	0.0	0.0	0.1
TLL2		ENSG00000095587	"Tolloid like 2"	Q9Y6L7	10	96364606-96513918	"Enzymes, Predicted secreted proteins"	Differentiation	"Developmental protein, Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 7.4"	"Cell type enhanced"	"Detected in some"	8	"Cardiomyocytes: 4.8;Early spermatids: 5.2;Late spermatids: 3.4;Syncytiotrophoblasts: 2.9"	"Low cancer specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	11	"RPTEC TERT1: 21.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"								"Secreted - unknown location"	NA	NA						"unprognostic (1.28e-2)"	"unprognostic (7.54e-4)"	"unprognostic (1.50e-1)"	"unprognostic (3.31e-3)"	"unprognostic (2.67e-1)"	"unprognostic (2.14e-3)"	"unprognostic (1.31e-2)"	"unprognostic (3.52e-4)"	"unprognostic (7.08e-2)"	"unprognostic (2.50e-1)"	"unprognostic (6.71e-2)"	"unprognostic (3.37e-2)"	"unprognostic (4.98e-4)"	"unprognostic (2.90e-1)"	"unprognostic (8.41e-2)"	"unprognostic (1.95e-4)"	"unprognostic (2.30e-1)"	0.7	1.1	3.2	1.4	4.9	1.6	0.7	0.7	5.8	0.8	1.1	5.7	2.5	1.7	1.2	1.1	0.9	0.7	2.6	7.4	3.3	3.8	0.7	0.6	0.5	1.8	3.4	2.1	1.4	1.5	0.4	2.8	1.1	4.6	1.1	1.1	0.0	3.9	2.7	4.1	1.0	2.1	0.9	6.1	0.9	2.1	1.1	5.7	0.0	1.5	4.0	0.7	0.8	0.5	0.9	0.3	0.6	0.2	0.3	0.2	0.0	0.2	0.1	0.4	0.2	0.1	0.0	0.1	0.2	0.0	0.1	0.1	0.0	0.1	0.3	1.1	0.1	0.2	0.1	0.2	0.1	0.0	2.0	0.4	0.0	0.2	0.0	0.0	0.0	0.1	0.2	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.1	0.1	0.0	1.3	0.7	0.1	0.1	0.4	0.0	21.7	0.1	0.8	0.1	0.1	0.0	0.1	0.7	0.0	0.0	0.0	0.1	0.4	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.2	0.0	0.2	0.9	0.2	0.1	0.0	0.9	0.2	0.2	0.6	0.3	0.2	0.3	0.1	0.0	3.2	4.9	0.7	4.0	3.3	3.8	3.4	2.1	4.6	5.7	0.0	0.6	0.0	0.4	0.1	0.0	4.8	2.5	0.0	1.2	0.0	0.0	2.2	0.0	0.3	5.2	0.5	0.0	0.0	0.5	0.0	0.6	0.9	0.0	0.0	0.3	0.0	0.0	0.0	0.3	3.4	0.3	1.0	0.0	0.0	1.3	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.5	0.1	2.0	0.4	2.9	0.0	0.0	0.4
TM7SF2	"ANG1, DHCR14A, NET47"	ENSG00000149809	"Transmembrane 7 superfamily member 2"	O76062	11	65111845-65116384	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Cholesterol biosynthesis, Cholesterol metabolism, Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis, Steroid metabolism, Sterol biosynthesis, Sterol metabolism"	Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adrenal gland: 78.1"	"Cell type enhanced"	"Detected in many"	7	"Muller glia cells: 176.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"plasmacytoid DC: 22.6"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"MCF7: 22.1;RPTEC TERT1: 25.4;T-47d: 49.4"					"Low region specificity"	"Detected in all"			"HPA030691, HPA072704"	Enhanced		Supported	"Endoplasmic reticulum,Vesicles"		NA	NA			"Endoplasmic reticulum"	Vesicles	"HPA030691: AB_10602480, HPA072704: AB_2686551"	"unprognostic (1.62e-1)"	"unprognostic (5.23e-2)"	"unprognostic (1.70e-2)"	"unprognostic (1.78e-1)"	"unprognostic (5.74e-2)"	"unprognostic (1.10e-1)"	"unprognostic (5.98e-2)"	"unprognostic (6.06e-2)"	"unprognostic (5.72e-2)"	"unprognostic (1.74e-2)"	"unprognostic (7.06e-2)"	"unprognostic (1.69e-1)"	"prognostic favorable (8.49e-8)"	"unprognostic (8.77e-2)"	"unprognostic (1.90e-1)"	"unprognostic (1.35e-1)"	"unprognostic (3.44e-2)"	27.7	78.1	6.9	2.2	12.5	2.0	10.0	5.6	21.7	4.7	3.1	22.4	5.1	4.8	1.5	11.0	11.5	6.4	8.5	28.2	7.4	6.6	8.3	38.6	5.1	1.7	10.3	9.6	13.5	22.6	11.8	6.2	2.2	13.2	19.8	2.3	5.4	28.5	3.3	3.3	17.9	2.8	1.3	7.3	1.9	8.8	5.3	8.8	1.9	7.4	13.6	10.4	2.6	6.1	7.4	22.6	1.8	1.0	7.3	7.6	3.0	2.6	3.6	8.5	12.2	3.4	0.2	5.4	0.6	1.3	1.0	1.1	8.8	12.4	5.4	9.6	0.4	0.3	4.3	3.7	6.0	0.7	5.2	1.9	3.3	1.0	17.7	6.9	1.3	3.7	1.5	1.8	4.9	0.6	4.0	0.9	10.3	1.9	4.2	0.3	22.1	2.3	5.8	4.6	5.6	4.1	7.2	0.4	12.7	25.4	3.9	9.6	10.8	0.4	9.3	2.1	5.6	49.4	3.6	0.6	0.1	1.3	1.2	0.8	9.6	6.0	3.1	0.8	2.1	0.3	0.5	1.0	1.8	5.5	0.8	4.3	7.1	3.5	4.5	0.9	7.4	7.6	5.5	0.7	7.3	0.5	22.6	3.1	3.0	6.9	12.5	5.6	21.7	7.4	6.6	10.3	9.6	13.2	8.8	8.9	36.6	11.1	5.3	1.6	15.6	89.9	50.9	6.7	5.7	41.8	9.8	64.7	14.9	20.7	26.9	4.5	21.7	0.0	24.2	1.7	3.3	37.3	6.9	79.7	12.7	23.8	57.1	4.3	6.3	49.4	9.2	3.5	11.8	13.6	16.5	176.3	28.8	11.5	2.1	62.4	21.2	12.9	2.3	10.9	9.4	6.0	68.7	8.5	12.4	8.4
TMEM129	D4S2561E	ENSG00000168936	"Transmembrane protein 129"	A0AVI4	4	1715952-1721358	"Enzymes, Predicted membrane proteins"	"Ubl conjugation pathway, Unfolded protein response"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA						"unprognostic (6.07e-2)"	"unprognostic (1.54e-1)"	"unprognostic (2.12e-1)"	"unprognostic (2.85e-1)"	"unprognostic (4.04e-2)"	"unprognostic (1.22e-3)"	"unprognostic (7.35e-3)"	"unprognostic (4.82e-2)"	"unprognostic (2.27e-1)"	"unprognostic (2.94e-2)"	"unprognostic (2.51e-3)"	"unprognostic (2.81e-1)"	"prognostic favorable (9.64e-8)"	"unprognostic (1.47e-1)"	"unprognostic (6.49e-2)"	"unprognostic (3.08e-1)"	"unprognostic (2.36e-3)"	18.2	19.8	17.6	11.3	21.7	6.0	11.0	19.3	25.6	16.4	17.9	22.1	21.5	23.7	16.1	14.6	18.7	18.0	16.5	29.0	18.3	16.2	22.4	26.3	14.5	12.8	20.1	14.0	17.3	32.6	25.9	24.9	15.8	16.9	17.5	9.6	20.4	34.0	22.8	20.9	15.7	17.6	12.7	14.9	14.6	16.0	15.0	20.0	11.5	32.4	11.0	12.3	14.6	10.5	2.1	7.7	0.7	3.3	2.0	3.6	2.1	9.1	10.5	8.9	13.2	16.4	9.6	10.3	7.4	12.0	7.7	8.3	7.8	22.7	12.0	8.9	7.9	13.8	9.2	4.6	9.4	1.3	8.2	13.5	6.5	7.6	9.9	13.4	9.2	11.9	15.9	20.3	4.2	3.9	18.0	11.9	11.4	7.4	8.9	7.3	7.1	12.6	15.0	13.8	10.0	13.1	8.2	4.7	14.7	19.2	10.2	20.7	12.7	6.3	11.3	9.7	3.3	23.1	4.3	8.1	9.0	6.9	7.9	7.1	22.4	6.7	5.7	10.4	12.7	9.6	0.3	3.3	0.1	3.6	2.2	3.1	1.6	3.2	2.6	3.4	2.1	2.2	1.5	0.7	2.0	2.4	7.7	1.5	2.1	17.6	21.7	19.3	25.6	18.3	16.2	20.1	14.0	16.9	20.0	20.8	9.4	8.0	14.9	4.5	24.9	10.6	12.7	5.3	2.3	22.7	5.9	17.6	21.6	18.2	0.9	9.2	19.8	0.0	17.0	6.2	14.6	13.1	10.3	17.1	15.5	23.8	12.6	16.5	9.4	2.1	28.1	8.5	10.1	4.6	25.1	37.3	12.1	10.5	33.9	16.1	18.7	12.9	17.6	3.7	5.8	8.3	4.6	11.4	26.7	9.1
TMEM2		ENSG00000135048	"Transmembrane protein 2"	Q9UHN6	9	71683366-71816690	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	Angiogenesis	"Developmental protein, Glycosidase, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"placenta: 67.6"	"Cell type enhanced"	"Detected in many"	5	"Ito cells: 115.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"AF22: 36.6;BEWO: 34.0;OE19: 36.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044889	Approved		Supported	"Vesicles,Plasma membrane"		NA	NA		130000	"Plasma membrane"	Vesicles	"HPA044889: AB_10962641"	"unprognostic (2.06e-1)"	"unprognostic (1.12e-1)"	"unprognostic (3.85e-2)"	"unprognostic (1.01e-2)"	"unprognostic (6.15e-3)"	"unprognostic (1.21e-2)"	"unprognostic (2.93e-2)"	"unprognostic (3.53e-1)"	"unprognostic (3.29e-2)"	"unprognostic (1.92e-1)"	"unprognostic (1.57e-2)"	"unprognostic (2.33e-1)"	"prognostic unfavorable (1.31e-4)"	"unprognostic (1.13e-2)"	"unprognostic (2.33e-1)"	"unprognostic (7.59e-2)"	"unprognostic (1.16e-1)"	23.3	3.9	6.0	10.5	4.4	12.4	13.6	8.9	6.0	3.0	18.6	1.9	10.1	12.2	4.5	5.2	4.4	4.9	19.2	9.5	8.6	3.6	9.3	24.9	35.7	14.0	4.0	4.1	3.1	9.2	24.0	9.5	67.6	4.3	5.5	13.1	7.9	9.5	10.2	5.5	6.4	20.0	5.5	5.1	15.6	14.5	3.7	2.4	6.4	8.0	4.6	8.8	11.4	6.8	6.3	0.9	5.5	2.1	0.5	4.1	1.4	5.8	28.0	36.6	1.7	3.8	6.9	34.0	19.7	12.6	13.7	10.1	7.8	8.0	0.1	5.9	5.0	3.0	8.7	11.8	2.7	18.6	0.7	3.6	10.0	5.9	20.8	5.9	0.0	2.7	7.1	3.0	10.6	2.4	3.6	18.0	0.8	1.4	3.0	7.4	4.9	1.1	0.1	7.6	36.1	2.7	0.9	10.9	0.7	8.6	18.9	1.8	0.2	5.1	3.6	5.3	11.8	2.5	0.3	7.8	9.3	10.5	5.1	9.8	0.6	8.4	0.3	1.8	0.9	11.7	0.2	2.1	5.5	2.7	1.9	0.8	0.7	2.9	2.6	0.9	6.3	4.1	2.0	4.5	0.5	1.8	0.2	3.9	1.4	6.0	4.4	8.9	6.0	8.6	3.6	4.0	4.1	4.3	2.4	32.8	30.4	9.4	38.3	26.8	5.5	0.0	33.1	4.0	17.0	0.0	9.8	36.3	0.0	0.0	10.6	37.9	75.4	0.0	0.0	12.0	19.0	42.5	4.6	27.6	35.9	0.0	9.7	115.4	56.5	2.9	2.8	14.9	16.9	0.0	32.3	73.6	0.0	26.4	1.1	0.0	35.2	6.5	20.8	1.0	0.6	19.2	75.1	62.3	28.3	40.3
TMEM86B	MGC30208	ENSG00000180089	"Transmembrane protein 86B"	Q8N661	19	55226639-55229264	"Enzymes, Predicted membrane proteins"		Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in all"		"liver: 15.1"	"Cell type enhanced"	"Detected in many"	10	"Cholangiocytes: 30.6;Hepatocytes: 28.9"	"Cancer enriched"	"Detected in all"	5	"liver cancer: 10.0"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			HPA057689	Uncertain		Uncertain	Midbody,Centrosome		Yes	No			Centrosome	Midbody	"HPA057689: AB_2683504"	"unprognostic (2.36e-1)"	"unprognostic (1.10e-1)"	"unprognostic (2.76e-5)"	"unprognostic (1.87e-1)"	"unprognostic (1.29e-1)"	"unprognostic (6.55e-2)"	"prognostic favorable (3.13e-4)"	"unprognostic (1.10e-2)"	"unprognostic (2.00e-1)"	"unprognostic (2.10e-1)"	"prognostic favorable (9.97e-6)"	"unprognostic (1.96e-2)"	"unprognostic (6.63e-8)"	"unprognostic (2.28e-1)"	"unprognostic (1.07e-1)"	"unprognostic (3.70e-1)"	"unprognostic (3.19e-3)"	2.5	2.4	2.8	3.1	4.0	7.8	1.4	4.7	4.2	1.4	7.5	1.4	1.4	5.6	1.5	1.4	1.4	1.8	7.7	2.9	2.2	1.6	2.0	15.1	2.7	5.2	1.4	1.4	1.4	1.4	1.7	2.8	5.2	1.7	1.5	0.4	1.4	1.4	1.4	2.2	3.0	7.7	1.4	1.4	4.3	3.6	2.8	1.4	1.4	2.3	1.4	3.0	1.4	1.4	0.7	1.0	0.6	0.7	0.0	1.6	0.4	4.1	3.9	2.4	3.9	0.4	0.6	3.6	1.5	0.7	1.3	1.8	6.3	2.2	4.8	1.2	1.1	1.3	1.7	0.9	1.0	0.6	0.9	11.2	8.8	2.5	5.9	1.2	4.0	3.7	0.8	1.7	2.1	1.3	1.8	0.5	9.2	6.0	3.5	0.8	2.4	6.4	10.0	0.9	1.9	2.4	6.0	2.8	12.6	1.1	5.1	2.1	3.9	1.8	0.8	4.9	1.3	2.2	8.4	2.8	5.7	3.2	2.5	3.8	2.9	3.4	10.2	4.7	11.1	2.1	0.0	0.7	0.6	1.6	0.1	0.6	0.0	0.5	0.1	0.1	0.7	0.6	1.4	0.1	0.0	0.1	1.0	0.0	0.4	2.8	4.0	4.7	4.2	2.2	1.6	1.4	1.4	1.7	1.4	6.0	2.4	0.8	0.4	3.0	7.6	0.5	30.6	0.0	1.2	0.0	2.0	0.4	0.0	0.9	2.0	1.7	5.2	0.0	0.2	0.3	1.1	1.1	0.0	28.9	0.9	9.5	10.3	0.0	6.2	3.6	0.9	1.7	3.3	1.8	1.9	1.1	0.8	0.0	0.4	0.8	3.6	0.0	0.5	1.6	1.1	1.9	0.2	4.6	1.9	1.7
TMEM8A	"M83, PGAP6, TMEM6, TMEM8"	ENSG00000129925	"Transmembrane protein 8A"	Q9HCN3	16	370773-387113	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins, Transporters"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	5	"Enterocytes: 67.7;Syncytiotrophoblasts: 83.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"neutrophil: 24.3"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA051281, HPA064673"	Approved		Supported	"Nucleoplasm,Cytokinetic bridge"		Yes	No			Nucleoplasm	"Cytokinetic bridge"	"HPA051281: AB_2681418, HPA064673: AB_2685317"	"unprognostic (5.84e-2)"	"unprognostic (6.13e-2)"	"unprognostic (3.85e-2)"	"unprognostic (3.21e-2)"	"unprognostic (5.77e-2)"	"unprognostic (3.19e-2)"	"unprognostic (1.13e-3)"	"unprognostic (1.56e-2)"	"unprognostic (8.89e-2)"	"unprognostic (7.73e-2)"	"unprognostic (3.43e-1)"	"unprognostic (1.38e-2)"	"prognostic favorable (1.29e-5)"	"unprognostic (4.20e-3)"	"unprognostic (3.19e-2)"	"unprognostic (4.93e-2)"	"unprognostic (2.48e-1)"	8.4	9.3	6.9	9.5	7.8	15.2	13.5	7.7	7.9	6.8	16.6	7.3	24.1	17.7	7.3	29.6	11.8	6.5	15.2	10.0	5.6	4.3	28.7	33.5	13.0	10.7	7.1	3.2	8.3	44.2	11.5	10.7	45.5	6.7	11.4	6.0	8.8	22.5	8.8	12.8	3.7	25.0	5.0	4.7	13.2	17.5	26.3	6.0	12.6	12.3	5.2	14.6	9.3	8.8	2.0	2.9	24.3	5.5	0.9	7.6	3.3	4.4	11.8	6.8	12.5	9.3	8.4	13.6	12.9	13.5	6.6	9.5	46.4	21.1	4.8	17.5	12.4	10.1	6.4	3.0	14.2	1.8	13.6	11.3	7.9	8.0	26.4	21.6	5.9	15.0	9.7	4.3	10.1	2.9	6.7	15.2	5.4	12.6	7.4	8.2	27.8	8.3	11.7	10.8	7.2	4.7	18.1	7.8	10.9	10.7	11.5	8.1	9.3	7.2	7.3	37.9	3.7	13.1	11.9	22.1	18.8	20.3	13.0	6.8	14.9	7.4	9.5	9.5	6.3	11.9	4.6	5.0	6.3	7.4	5.5	5.9	1.8	5.8	5.8	2.5	2.0	7.6	5.5	24.3	0.9	3.8	2.9	4.3	3.3	6.9	7.8	7.7	7.9	5.6	4.3	7.1	3.2	6.7	6.0	14.9	12.5	10.7	3.2	2.6	5.7	12.5	10.2	1.4	1.2	22.7	9.8	46.7	5.0	27.5	15.5	8.7	67.7	23.3	36.8	5.9	6.6	11.5	1.1	25.5	24.7	17.5	26.6	14.7	14.5	58.4	2.6	10.1	6.8	8.2	26.1	8.2	42.6	38.6	1.8	9.9	7.8	12.9	6.1	1.1	2.5	2.8	83.8	7.5	18.9	6.8
TMLHE	"BBOX2, FLJ10727, TMLH, XAP130"	ENSG00000185973	"Trimethyllysine hydroxylase, epsilon"	Q9NVH6	X	155490115-155669944	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Carnitine biosynthesis"	"Dioxygenase, Oxidoreductase"	"Autism, Autism spectrum disorder, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA034589, HPA040331"	Approved		Supported	Mitochondria		NA	NA			Mitochondria		"HPA034589: AB_10670571, HPA040331: AB_2676929"	"unprognostic (1.98e-1)"	"unprognostic (9.15e-2)"	"unprognostic (3.04e-1)"	"unprognostic (5.41e-2)"	"unprognostic (6.66e-3)"	"unprognostic (1.10e-3)"	"unprognostic (6.50e-2)"	"unprognostic (1.00e-1)"	"unprognostic (3.27e-1)"	"unprognostic (4.08e-2)"	"unprognostic (1.20e-3)"	"unprognostic (6.97e-2)"	"prognostic favorable (3.68e-6)"	"unprognostic (1.69e-1)"	"unprognostic (5.74e-2)"	"unprognostic (2.73e-1)"	"unprognostic (7.75e-2)"	10.1	15.0	8.5	6.7	10.5	6.7	10.4	17.1	13.5	11.3	10.5	10.0	9.1	10.7	10.9	10.1	9.5	9.5	7.4	22.3	10.3	7.5	15.8	16.9	6.9	14.6	12.5	7.4	12.4	10.7	18.4	17.5	7.6	11.5	7.7	11.6	10.6	16.2	9.6	28.1	7.8	10.0	13.8	13.7	9.2	9.8	3.1	11.2	12.2	10.5	5.3	8.7	10.2	9.1	9.1	10.3	14.7	15.7	4.3	5.6	4.5	15.2	7.5	6.2	18.1	7.7	11.9	0.0	6.2	9.1	7.8	20.4	5.3	8.6	0.0	25.0	10.8	18.0	8.3	13.2	6.0	8.9	6.2	9.0	6.8	12.2	6.2	10.8	6.4	4.9	12.6	12.7	8.7	13.2	11.7	12.3	9.8	9.5	5.6	12.9	5.7	7.7	7.2	1.9	13.2	0.1	7.7	9.9	5.8	9.4	5.2	5.9	8.9	5.8	0.3	6.7	7.0	6.7	7.3	10.3	6.6	6.3	13.0	7.6	7.0	7.5	5.8	8.0	10.0	6.0	1.9	10.1	11.3	3.9	11.4	2.9	6.2	4.3	3.3	10.3	9.1	5.6	4.9	14.7	4.3	15.7	4.7	4.2	4.5	8.5	10.5	17.1	13.5	10.3	7.5	12.5	7.4	11.5	11.2	0.0	2.9	10.0	9.7	4.6	3.6	6.5	7.6	9.4	4.5	8.7	0.0	7.2	19.9	8.9	0.0	5.6	8.6	0.0	6.6	5.8	7.5	2.7	9.3	11.3	10.9	0.0	5.8	5.5	14.6	0.0	7.8	11.4	11.8	10.8	6.9	7.2	8.0	7.0	5.3	11.3	5.2	0.0	8.2	0.4	1.7	3.6	5.6	6.9	7.6	8.7
TMPRSS11A	ECRG1	ENSG00000187054	"Transmembrane serine protease 11A"	Q6ZMR5	4	67909385-67964140	"Enzymes, Predicted membrane proteins"	"Cell cycle"	"Hydrolase, Protease, Serine protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"cervix, uterine: 19.5;esophagus: 48.4;lymphoid tissue: 18.7;tongue: 47.6"	"Group enriched"	"Detected in some"	6	"Early spermatids: 4.6;Urothelial cells: 6.2"	"Group enriched"	"Detected in some"	9	"cervical cancer: 14.4;head and neck cancer: 11.6;lung cancer: 4.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"Daudi: 1.1;OE19: 2.5"	"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			HPA078316	Enhanced					NA	NA					"HPA078316: "	"unprognostic (1.63e-1)"	"unprognostic (4.60e-2)"				"unprognostic (1.76e-2)"		"unprognostic (6.98e-2)"	"unprognostic (1.98e-1)"	"unprognostic (2.66e-1)"		"unprognostic (4.58e-1)"	"unprognostic (1.32e-1)"	"unprognostic (4.36e-2)"	"unprognostic (1.05e-1)"	"unprognostic (3.50e-1)"	"unprognostic (2.33e-2)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	19.5	0.0	0.0	0.0	0.0	0.0	0.0	48.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	3.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	47.6	18.7	0.3	8.9	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.1	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.1	0.0	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.3	0.0	0.0	0.2	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.6	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.2
TMPRSS11B		ENSG00000185873	"Transmembrane serine protease 11B"	Q86T26	4	68226653-68245720	"Enzymes, Predicted membrane proteins"		"Hydrolase, Protease, Serine protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"esophagus: 138.8;lymphoid tissue: 57.0;tongue: 44.0"	"Group enriched"	"Detected in some"	35	"Early spermatids: 8.5;Late spermatids: 11.5"	"Group enriched"	"Detected in some"	12	"cervical cancer: 2.6;head and neck cancer: 2.6;stomach cancer: 1.4"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"neutrophil: 2.4"	"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in some"			"Not detected"	"Not detected"			"Not detected"	"Not detected"									NA	NA							"unprognostic (4.24e-2)"				"prognostic favorable (6.91e-4)"				"unprognostic (2.92e-1)"				"unprognostic (3.96e-1)"				0.1	0.1	0.0	0.1	0.0	0.2	0.1	0.0	0.1	11.2	0.1	0.0	0.0	0.1	0.5	0.1	138.8	0.1	0.1	0.1	0.0	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.1	0.1	0.0	13.4	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.2	0.0	0.0	0.1	44.0	57.0	0.1	23.2	0.7	0.6	2.4	0.5	0.4	0.7	0.0	0.3	1.4	0.8	0.1	0.1	0.0	0.3	0.3	0.1	0.0	0.3	0.9	0.4	1.4	0.2	0.4	0.4	1.1	0.2	0.1	0.0	0.1	1.6	0.8	1.9	2.1	0.1	1.1	1.4	0.5	0.2	0.0	0.1	0.2	0.0	0.5	0.7	2.0	0.1	0.7	0.5	1.3	0.1	0.3	1.0	0.6	0.6	0.5	0.2	1.5	0.9	0.3	0.1	0.2	0.1	0.6	0.4	0.2	1.3	1.0	0.3	0.5	0.1	0.3	0.9	0.8	0.3	1.0	0.1	0.3	0.4	0.2	0.4	0.1	0.3	0.3	0.3	0.4	0.0	0.7	0.3	0.7	2.4	0.4	0.5	0.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.5	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1
TMPRSS11D		ENSG00000153802	"Transmembrane serine protease 11D"	O60235	4	67820876-67884032	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"		"Hydrolase, Protease, Serine protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"cervix, uterine: 18.1;esophagus: 41.2;lymphoid tissue: 20.3;tongue: 67.6;vagina: 23.1"	"Cell type enriched"	"Detected in single"	32	"Urothelial cells: 8.6"	"Group enriched"	"Detected in many"	5	"cervical cancer: 36.0;head and neck cancer: 30.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"RH-30: 1.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA077704	Enhanced				"Intracellular and membrane"	NA	NA					"HPA077704: "	"unprognostic (1.19e-1)"	"unprognostic (6.83e-2)"		"unprognostic (8.82e-2)"	"unprognostic (2.10e-2)"	"unprognostic (1.21e-2)"		"unprognostic (1.12e-1)"	"unprognostic (3.22e-1)"	"unprognostic (2.88e-1)"	"unprognostic (1.32e-1)"	"unprognostic (4.79e-1)"	"unprognostic (4.38e-3)"	"unprognostic (1.96e-1)"	"unprognostic (6.91e-2)"	"unprognostic (4.48e-2)"	"unprognostic (2.19e-3)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	18.1	0.0	0.0	0.0	0.0	0.6	0.0	41.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.6	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.0	67.6	20.3	0.4	23.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.6
TMPRSS11E	"DESC1, TMPRSS11E2"	ENSG00000087128	"Transmembrane serine protease 11E"	Q9UL52	4	68447449-68497604	"Enzymes, Predicted membrane proteins"		"Hydrolase, Protease, Serine protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 103.8;lymphoid tissue: 39.1;tongue: 40.5;vagina: 36.6"	"Group enriched"	"Detected in some"	6	"Basal glandular cells: 12.6;Urothelial cells: 38.8"	"Group enriched"	"Detected in many"	6	"cervical cancer: 22.0;head and neck cancer: 25.3;lung cancer: 11.5;urothelial cancer: 7.6"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"memory B-cell: 1.8"	"Lineage enhanced"	"Detected in single"		"B-cells: 1.8"	"Group enriched"	"Detected in some"	6	"HaCaT: 5.0;HBEC3-KT: 1.9;OE19: 5.2;SuSa: 1.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA051062	Enhanced				"Intracellular and membrane"	NA	NA					"HPA051062: AB_2681329"	"unprognostic (2.53e-1)"	"unprognostic (3.10e-1)"	"unprognostic (1.84e-1)"	"unprognostic (9.14e-2)"		"unprognostic (5.03e-2)"		"prognostic unfavorable (6.73e-4)"	"unprognostic (2.22e-1)"		"unprognostic (9.70e-3)"	"unprognostic (2.16e-1)"	"unprognostic (3.74e-2)"	"unprognostic (4.03e-2)"	"unprognostic (8.39e-2)"	"unprognostic (1.27e-1)"	"unprognostic (3.08e-3)"	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	28.9	0.0	0.0	1.2	0.0	1.1	10.5	103.8	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.2	0.0	1.4	0.0	0.0	13.6	0.5	0.0	1.6	0.0	1.2	0.0	0.0	0.0	0.2	0.0	0.1	0.0	40.5	39.1	2.6	36.6	1.8	0.0	0.0	0.0	0.0	0.5	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	5.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	5.2	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.4	0.0	1.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.5	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.6	0.3	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	4.4	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.9	0.0	0.0	38.8
TMPRSS11F	FLJ16046	ENSG00000198092	"Transmembrane serine protease 11F"	Q6ZWK6	4	68053198-68129880	"Enzymes, Predicted membrane proteins"		"Hydrolase, Protease, Serine protease"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"esophagus: 18.3;lymphoid tissue: 11.4;skin 1: 10.9;tongue: 13.1"	"Cell type enhanced"	"Detected in single"	19	"Cytotrophoblasts: 1.1"	"Group enriched"	"Detected in some"	7	"cervical cancer: 1.6;head and neck cancer: 2.1;lung cancer: 0.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	8	"HEL: 2.5;K-562: 5.5;Karpas-707: 1.6;U-266/70: 1.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA026911	Uncertain					NA	NA					"HPA026911: AB_2205589"		"unprognostic (9.46e-2)"			"unprognostic (5.30e-1)"	"unprognostic (7.16e-2)"		"unprognostic (8.79e-3)"	"unprognostic (1.09e-1)"			"unprognostic (2.40e-1)"			"unprognostic (1.22e-1)"	"unprognostic (5.08e-2)"		0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	5.4	0.0	0.0	0.0	0.0	0.2	0.0	18.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	3.8	0.0	0.1	0.0	0.0	1.4	0.0	0.0	10.9	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.2	0.0	13.1	11.4	0.0	5.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.5	1.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.4	0.0	0.2	0.0	0.0	0.3
TMPRSS12	"CT151, MGC57341"	ENSG00000186452	"Transmembrane serine protease 12"	Q86WS5	12	50842920-50887884	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"		"Hydrolase, Protease, Serine protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	32	"testis: 52.7"	"Group enriched"	"Detected in some"	9	"Early spermatids: 21.7;Spermatocytes: 50.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"neutrophil: 1.6"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"BEWO: 2.9;Karpas-707: 1.1;NTERA-2: 1.4;SK-BR-3: 1.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"									NA	NA						"unprognostic (1.04e-1)"	"unprognostic (9.09e-2)"		"unprognostic (3.03e-2)"		"unprognostic (7.25e-3)"		"unprognostic (1.70e-1)"		"unprognostic (1.39e-1)"	"unprognostic (3.88e-1)"	"unprognostic (2.98e-2)"	"unprognostic (2.60e-1)"	"unprognostic (1.88e-1)"	"unprognostic (1.29e-1)"	"unprognostic (5.65e-3)"	"unprognostic (1.03e-2)"	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	52.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.3	1.6	0.1	0.4	0.3	0.0	0.0	0.8	0.0	0.5	0.0	0.0	2.9	0.1	0.0	0.0	0.0	0.1	0.4	0.0	0.1	0.0	0.1	0.2	0.0	0.0	0.1	0.0	0.1	0.1	0.3	0.2	0.0	0.2	0.2	0.0	0.0	0.3	0.0	0.3	0.0	0.1	0.1	1.1	0.0	0.0	0.3	0.4	1.4	0.0	0.5	0.2	0.0	0.2	0.0	0.3	0.3	0.1	0.6	1.1	0.0	0.2	0.1	0.2	0.3	0.3	0.1	0.0	0.0	0.5	0.1	0.1	0.3	0.2	0.2	1.3	0.1	0.5	0.2	0.0	0.1	0.1	0.2	0.1	0.0	0.4	0.3	0.3	1.6	0.4	0.1	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.0	0.1	0.0	0.0	0.0	1.8	0.0	0.7	0.0	0.0	21.7	0.0	0.0	0.0	0.0	0.7	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	4.1	3.7	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.7	0.2	0.0	0.0	0.0	50.5	1.5	0.3	0.6	0.0	0.0	0.1
TMPRSS13	"MSPL, TMPRSS11"	ENSG00000137747	"Transmembrane serine protease 13"	Q9BYE2	11	117900643-117929459	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"		"Hydrolase, Protease, Serine protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"placenta: 22.1;salivary gland: 16.6;skin 1: 26.0"	"Cell type enhanced"	"Detected in many"	9	"Cholangiocytes: 7.6;Cytotrophoblasts: 12.9;Extravillous trophoblasts: 12.2;Syncytiotrophoblasts: 16.2"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"A-431: 7.5;BEWO: 17.9;MCF7: 15.1;SK-BR-3: 25.9;T-47d: 26.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"									NA	NA						"unprognostic (1.08e-3)"	"unprognostic (5.18e-2)"	"unprognostic (6.59e-2)"	"unprognostic (1.06e-3)"	"unprognostic (1.04e-1)"	"unprognostic (1.01e-1)"	"unprognostic (3.64e-1)"	"unprognostic (5.61e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.49e-1)"	"unprognostic (1.92e-2)"	"unprognostic (2.03e-1)"	"unprognostic (3.16e-6)"	"unprognostic (2.05e-1)"	"unprognostic (7.75e-2)"	"unprognostic (1.08e-1)"	"unprognostic (3.44e-1)"	0.2	0.3	0.2	0.6	0.2	0.3	6.2	0.2	0.2	5.8	0.2	0.2	0.2	0.2	0.9	0.7	14.8	0.1	0.2	0.2	0.4	0.0	0.7	0.2	4.0	0.7	0.2	0.2	0.3	5.7	0.0	0.5	22.1	0.2	0.9	0.2	0.6	16.6	0.2	0.2	26.0	0.5	0.2	0.2	1.0	0.1	0.3	0.2	0.4	9.5	13.7	10.6	0.3	5.6	1.0	2.6	1.0	0.7	1.9	1.2	0.8	7.5	0.0	0.0	0.0	0.0	0.0	17.9	0.0	0.0	0.0	0.0	5.7	0.1	0.4	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.5	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.3	0.4	0.0	15.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.8	0.0	2.1	0.2	0.0	0.0	25.9	0.3	0.9	26.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	1.0	0.6	0.0	0.9	0.7	0.0	1.0	0.1	1.2	1.8	0.5	0.4	0.1	0.0	1.9	0.5	2.6	0.7	0.8	0.2	0.2	0.2	0.2	0.4	0.0	0.2	0.2	0.2	0.2	0.0	2.9	0.0	3.7	1.4	0.0	1.4	7.6	0.0	2.3	0.0	0.0	12.9	0.0	6.2	0.3	0.0	0.4	0.0	1.0	12.2	0.5	5.3	0.0	0.0	2.5	0.0	0.0	0.0	1.2	0.6	0.0	0.7	0.0	0.0	0.3	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	6.9	16.2	0.0	0.4	6.9
TMPRSS15	"ENTK, MGC133046, PRSS7"	ENSG00000154646	"Transmembrane serine protease 15"	P98073	21	18269116-18485879	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		"Hydrolase, Protease, Serine protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	67	"intestine: 154.6"	"Cell type enriched"	"Detected in single"	11	"Early spermatids: 4.2"	"Group enriched"	"Detected in some"	12	"liver cancer: 0.7;pancreatic cancer: 1.5;stomach cancer: 1.5"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"naive B-cell: 2.3"	"Low lineage specificity"	"Detected in single"			"Group enriched"	"Detected in some"	20	"U-138 MG: 20.3;U-87 MG: 56.6"	"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	5	"olfactory region: 9.3"	"HPA015611, HPA034857, HPA072934"	Enhanced		Approved	"Nucleoli,Plasma membrane"		NA	NA			"Plasma membrane"	Nucleoli	"HPA015611: AB_1855791, HPA034857: , HPA072934: AB_2732214"					"unprognostic (9.26e-2)"	"unprognostic (4.14e-1)"		"unprognostic (3.52e-1)"	"unprognostic (8.33e-2)"	"unprognostic (1.19e-1)"	"unprognostic (7.20e-2)"	"unprognostic (4.70e-2)"		"unprognostic (6.35e-2)"	"unprognostic (5.92e-2)"			0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.0	0.0	0.0	80.5	0.0	0.0	154.6	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	42.4	0.0	0.1	0.1	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	2.3	0.0	0.5	0.1	0.6	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	1.6	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	20.3	0.0	0.1	0.0	0.3	0.0	0.1	56.6	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.3	0.1	0.5	0.6	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0
TMPRSS2	PRSS10	ENSG00000184012	"Transmembrane serine protease 2"	O15393	21	41464551-41531116	"Cancer-related genes, Enzymes, Predicted intracellular proteins, Predicted membrane proteins"		"Hydrolase, Protease, Serine protease"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 75.6;pancreas: 64.5;prostate: 68.2"	"Cell type enhanced"	"Detected in many"	10	"Enterocytes: 190.3;Glandular cells: 290.4;Paneth cells: 127.7;Urothelial cells: 115.9"	"Cancer enriched"	"Detected in many"	7	"prostate cancer: 250.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"CACO-2: 14.1;MCF7: 6.1;OE19: 20.6;RT4: 33.9;SK-BR-3: 6.9"	"Not detected"	"Not detected"							"HPA034493, HPA035787"	Enhanced		Approved	"Nucleoplasm,Plasma membrane"	"Intracellular and membrane"	NA	NA			"Plasma membrane"	Nucleoplasm	"HPA034493: , HPA035787: AB_2674782"	"unprognostic (4.80e-3)"	"unprognostic (3.49e-1)"	"unprognostic (2.16e-1)"	"prognostic favorable (2.56e-4)"	"unprognostic (1.72e-1)"	"unprognostic (1.05e-2)"	"unprognostic (4.28e-2)"	"unprognostic (1.51e-3)"	"unprognostic (9.43e-2)"	"unprognostic (9.02e-3)"	"unprognostic (6.24e-2)"	"unprognostic (6.43e-2)"	"prognostic favorable (7.86e-6)"	"unprognostic (2.00e-2)"	"unprognostic (1.68e-1)"	"unprognostic (1.41e-1)"	"unprognostic (2.15e-2)"	0.2	0.1	0.2	15.5	0.4	0.0	6.1	0.2	0.5	1.3	38.7	0.4	24.4	17.5	0.5	0.9	10.7	2.2	17.3	0.2	0.3	0.1	19.4	18.4	20.7	0.2	0.2	0.2	0.7	64.5	0.0	1.3	1.0	0.4	68.2	18.5	0.3	52.3	35.7	0.2	2.1	75.6	0.9	0.2	0.3	36.7	0.8	0.3	0.5	19.9	3.9	10.2	5.9	4.3	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	14.1	1.9	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.1	0.1	0.5	1.2	20.6	0.0	0.0	0.0	1.3	0.5	33.9	0.0	0.4	0.0	6.9	0.1	0.2	5.2	0.0	0.0	0.0	0.3	0.3	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.2	0.4	0.2	0.5	0.3	0.1	0.2	0.2	0.4	0.3	47.6	88.6	0.0	31.0	0.2	0.0	0.6	25.5	14.7	38.7	45.4	0.0	0.5	19.9	30.0	19.4	0.0	190.3	0.0	52.6	0.1	0.6	290.4	6.9	28.7	0.1	0.0	17.3	0.0	0.8	3.5	0.0	1.5	10.1	1.0	79.6	0.0	53.4	127.7	0.0	3.7	0.0	0.0	1.0	0.2	0.0	0.1	0.2	0.0	73.2	115.9
TMPRSS3	"DFNB10, DFNB8"	ENSG00000160183	"Transmembrane serine protease 3"	P57727	21	42371837-42396846	"Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins"		"Hydrolase, Protease, Serine protease"	"Cancer-related genes, Deafness, Disease mutation, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"fallopian tube: 24.7"	"Cell type enhanced"	"Detected in many"	9	"Alveolar cells type 1: 11.9;Cholangiocytes: 28.1;Ciliated cells: 17.4;Ductal cells: 14.4;Exocrine glandular cells: 12.6;Muller glia cells: 23.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"MAIT T-cell: 6.3"	"Lineage enriched"	"Detected in single"	7	"T-cells: 6.3"	"Group enriched"	"Detected in some"	5	"HEL: 18.8;U-266/84: 75.2"	"Region enriched"	"Detected in single"	7	"cerebellum: 0.9"	"Not detected"	"Not detected"									NA	NA						"unprognostic (8.47e-3)"	"unprognostic (2.83e-1)"	"prognostic unfavorable (3.64e-4)"	"unprognostic (2.85e-1)"	"unprognostic (2.45e-3)"	"unprognostic (3.97e-2)"	"unprognostic (1.43e-1)"	"unprognostic (8.17e-2)"	"unprognostic (9.62e-2)"	"unprognostic (4.81e-2)"	"unprognostic (2.65e-1)"	"unprognostic (1.42e-1)"	"prognostic unfavorable (8.24e-4)"	"unprognostic (2.66e-2)"	"unprognostic (2.73e-1)"	"unprognostic (8.00e-2)"	"unprognostic (1.33e-1)"	1.8	0.7	8.6	0.3	7.7	0.3	9.4	0.3	7.1	6.8	0.4	0.0	0.0	1.7	0.9	0.4	0.4	24.7	8.6	0.2	1.8	1.6	3.5	3.5	3.7	0.6	3.7	2.0	2.8	7.4	0.2	5.8	5.7	3.3	0.8	0.4	2.4	12.3	0.6	0.3	0.6	1.3	0.2	0.2	0.6	15.9	0.2	0.8	0.0	9.8	0.2	0.6	1.9	0.0	0.0	0.1	0.7	0.8	0.0	6.3	1.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.6	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	9.2	0.0	18.8	7.9	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.0	4.1	0.0	0.4	1.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.8	0.4	0.0	0.0	9.8	0.4	0.0	0.0	0.9	0.1	0.0	0.0	0.5	0.0	0.0	0.2	75.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.2	6.3	0.0	3.5	3.6	0.1	0.0	0.7	1.8	0.7	0.0	0.8	0.0	1.6	1.0	8.6	7.7	0.3	7.1	1.8	1.6	3.7	2.0	3.3	0.8	11.9	3.0	0.0	1.9	0.2	0.1	0.6	28.1	17.4	3.4	7.0	0.0	0.0	5.0	14.4	1.3	0.0	1.3	0.0	12.6	0.1	0.1	1.9	0.0	0.0	0.1	0.0	0.0	0.6	0.0	0.4	0.3	0.1	0.0	0.0	0.7	23.8	7.9	0.6	0.0	0.0	0.5	0.0	0.2	0.0	0.0	0.1	0.0	1.3	0.4	3.9
TMPRSS4	"MT-SP2, TMPRSS3"	ENSG00000137648	"Transmembrane serine protease 4"	Q9NRS4	11	118077012-118121890	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"		"Hydrolase, Protease, Serine protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 60.9;gallbladder: 45.4;lymphoid tissue: 41.0;urinary bladder: 43.9"	"Cell type enhanced"	"Detected in many"	18	"Enterocytes: 108.9;Paneth cells: 61.7;Undifferentiated cells: 54.6;Urothelial cells: 226.3"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	5	"basophil: 4.5"	"Lineage enriched"	"Detected in single"	6	"granulocytes: 4.5"	"Group enriched"	"Detected in some"	5	"CAPAN-2: 37.9;HaCaT: 16.2;OE19: 64.5;RPTEC TERT1: 26.6;RT4: 33.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA006238	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA006238: AB_1080316"	"unprognostic (1.48e-1)"	"unprognostic (3.27e-2)"	"unprognostic (1.19e-2)"	"unprognostic (1.23e-1)"	"unprognostic (5.23e-2)"	"unprognostic (5.50e-2)"	"unprognostic (8.17e-3)"	"unprognostic (1.95e-2)"	"unprognostic (2.41e-1)"	"unprognostic (9.62e-2)"	"prognostic unfavorable (3.14e-4)"	"unprognostic (2.87e-3)"	"unprognostic (2.80e-1)"	"unprognostic (4.58e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.10e-2)"	"unprognostic (9.96e-3)"	0.3	0.3	0.2	14.2	0.3	0.0	0.3	0.3	0.2	11.4	23.5	0.1	0.0	16.1	3.1	2.8	60.9	0.6	45.4	0.3	0.3	0.3	17.7	0.3	3.2	0.0	0.2	0.0	0.3	0.4	0.0	0.3	0.8	0.1	9.9	26.2	0.2	4.0	0.0	0.3	2.4	27.4	4.2	0.2	0.3	13.7	0.7	0.0	0.6	0.3	13.7	41.0	43.9	22.3	0.5	0.1	4.5	0.7	0.2	0.1	0.0	7.5	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	1.7	37.9	0.0	1.4	0.0	0.0	16.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.3	0.0	1.1	0.0	64.5	0.0	0.0	0.0	0.0	26.6	33.2	0.0	0.0	0.0	2.9	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.5	0.1	0.3	0.1	0.1	0.1	0.2	0.1	0.1	0.0	0.5	0.1	0.1	0.9	0.2	0.7	0.1	0.1	0.0	0.2	0.3	0.3	0.2	0.3	0.3	0.2	0.0	0.1	0.0	0.0	1.7	0.0	21.5	1.0	0.0	0.6	0.0	17.4	36.4	10.4	0.0	0.1	0.0	0.1	2.6	0.0	108.9	0.0	6.6	1.6	0.2	6.8	5.7	0.0	0.2	0.0	4.1	0.0	0.0	1.3	0.0	1.0	0.0	0.0	49.1	0.0	30.7	61.7	0.0	1.4	0.0	0.0	0.7	0.0	0.1	5.5	0.2	0.0	54.6	226.3
TMPRSS5	"MGC141886, MGC148044"	ENSG00000166682	"Transmembrane serine protease 5"	Q9H3S3	11	113687546-113706373	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"		"Hydrolase, Protease, Serine protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"brain: 24.0;salivary gland: 15.0;skeletal muscle: 6.0"	"Cell type enhanced"	"Detected in some"	14	"Collecting duct cells: 1.8;Cone photoreceptor cells: 2.0;Horizontal cells: 4.8;Muller glia cells: 3.4"	"Cancer enhanced"	"Detected in some"		"glioma: 5.3"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 4.3;CAPAN-2: 7.1;WM-115: 5.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA010992			Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA010992: AB_1858152"	"unprognostic (1.53e-2)"	"unprognostic (3.81e-2)"	"unprognostic (2.97e-1)"	"unprognostic (1.05e-1)"	"unprognostic (1.93e-1)"	"unprognostic (8.73e-2)"	"unprognostic (2.99e-3)"	"unprognostic (3.08e-1)"	"unprognostic (5.19e-3)"	"unprognostic (8.49e-2)"	"unprognostic (8.13e-2)"	"unprognostic (3.38e-2)"	"unprognostic (1.96e-3)"	"unprognostic (1.18e-1)"	"unprognostic (1.75e-1)"	"unprognostic (1.80e-1)"	"unprognostic (4.04e-3)"	2.1	1.7	10.8	1.0	24.0	3.2	2.2	2.1	14.8	1.2	1.0	21.6	0.0	1.0	1.2	0.9	1.8	1.1	2.2	1.2	11.5	5.7	0.9	0.9	0.9	1.1	11.6	12.7	1.4	1.2	0.6	1.5	1.2	16.5	1.2	1.3	0.9	15.0	1.4	6.0	2.7	0.7	1.2	16.9	1.1	2.4	2.3	8.8	0.0	1.1	0.4	1.3	0.9	0.4	0.5	0.0	0.0	0.0	0.0	0.1	0.0	0.5	0.8	4.3	2.5	0.5	0.4	0.6	1.2	0.5	0.6	0.9	2.5	7.1	0.3	3.2	0.5	0.8	0.8	0.3	0.4	0.3	0.4	1.3	1.0	0.6	0.0	0.3	1.0	0.8	0.6	0.6	0.5	1.2	0.5	0.8	1.7	0.8	0.5	0.9	0.0	0.8	1.2	0.5	4.3	0.2	0.9	0.5	0.0	0.7	0.4	0.6	1.0	0.5	0.1	3.5	0.6	0.5	0.5	0.5	0.9	1.7	0.6	0.7	0.5	0.2	0.1	0.4	0.9	5.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.8	24.0	2.1	12.3	11.5	5.7	11.6	12.7	16.5	8.8	0.0	0.0	0.0	0.2	0.2	0.5	0.4	0.0	0.0	0.0	1.8	2.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.8	0.0	0.2	0.1	0.0	0.0	0.1	4.8	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	3.4	0.5	0.0	0.0	0.0	1.3	0.0	0.0	0.5	0.5	0.0	0.0	0.0	0.0	0.1
TMPRSS6	FLJ30744	ENSG00000187045	"Transmembrane serine protease 6"	Q8IU80	22	37065436-37109563	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"		"Hydrolase, Protease, Serine protease"	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	11	"liver: 59.3"	"Group enriched"	"Detected in some"	14	"Early spermatids: 60.9;Hepatocytes: 67.0;Late spermatids: 87.3"	"Group enriched"	"Detected in many"	14	"liver cancer: 51.3;thyroid cancer: 14.1"	"Region enriched"	"Detected in single"	10	"basal ganglia: 1.8"	"Cell type enhanced"	"Detected in single"		"memory CD8 T-cell: 1.3"	"Low lineage specificity"	"Detected in single"			"Group enriched"	"Detected in some"	4	"Hep G2: 7.7;SCLC-21H: 13.2"	"Low region specificity"	"Detected in single"			"Region enriched"	"Detected in single"	5	"basal ganglia: 2.2"							NA	NA						"unprognostic (3.93e-1)"	"unprognostic (3.28e-1)"	"unprognostic (8.62e-2)"	"unprognostic (6.29e-5)"	"unprognostic (7.95e-2)"	"unprognostic (1.62e-1)"	"prognostic favorable (8.16e-6)"	"unprognostic (2.44e-1)"	"unprognostic (3.07e-1)"	"unprognostic (2.41e-1)"	"unprognostic (1.16e-2)"	"unprognostic (3.58e-2)"	"unprognostic (1.15e-7)"	"unprognostic (2.38e-1)"	"unprognostic (9.15e-2)"	"unprognostic (2.39e-2)"	"unprognostic (3.86e-5)"	0.1	0.0	0.1	0.1	1.8	0.0	0.8	0.1	0.1	0.1	0.3	0.1	0.1	1.1	0.1	0.4	0.1	0.2	0.4	0.1	0.1	0.0	0.1	59.3	1.9	0.1	0.1	0.1	0.5	0.9	0.0	5.3	0.6	0.1	0.2	0.2	0.1	0.1	0.1	0.1	1.1	0.6	0.1	0.1	0.1	2.3	2.6	0.1	0.2	0.1	0.1	0.1	0.1	0.1	0.7	0.1	0.0	0.1	0.0	1.3	0.0	0.2	0.8	0.2	0.4	0.0	0.0	0.6	0.2	0.0	0.0	0.0	0.4	0.0	0.1	0.3	0.0	0.1	0.0	0.0	0.0	0.0	1.9	2.3	0.3	0.1	7.7	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.2	0.0	1.0	0.1	0.6	0.0	1.3	0.0	0.0	0.3	0.2	0.1	0.5	0.2	0.3	0.0	0.0	13.2	0.4	0.2	1.0	0.0	0.2	0.1	0.0	0.6	0.5	1.6	0.1	0.0	1.6	0.4	0.1	0.4	0.1	0.0	0.0	0.1	0.0	0.4	0.0	0.8	0.5	0.2	1.3	0.1	0.7	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.8	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.5	0.0	0.4	5.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	60.9	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	67.0	0.1	0.0	5.1	2.5	2.9	87.3	0.3	0.0	0.0	0.0	1.0	0.0	0.3	1.5	0.4	0.0	0.0	0.0	0.0	0.2	0.7	0.1	0.2	0.0	0.6	0.0
TMPRSS7		ENSG00000176040	"Transmembrane serine protease 7"	Q7RTY8	3	112034843-112081269	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"		"Hydrolase, Protease, Serine protease"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"blood: 2.2;testis: 5.2"	"Cell type enhanced"	"Detected in some"	17	"Basal glandular cells: 3.4;Ciliated cells: 10.7;Early spermatids: 3.3;Urothelial cells: 2.6"	"Not detected"	"Not detected"							"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"HaCaT: 1.4;hTCEpi: 2.8;RT4: 1.3;U-266/70: 1.8"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA040630	Uncertain					NA	NA					"HPA040630: AB_10796124"	"unprognostic (4.02e-2)"	"unprognostic (9.87e-2)"	"unprognostic (9.05e-2)"	"unprognostic (2.16e-2)"	"unprognostic (2.24e-1)"	"unprognostic (4.64e-3)"		"unprognostic (6.63e-2)"		"unprognostic (2.16e-1)"	"unprognostic (2.29e-2)"	"unprognostic (4.64e-1)"	"unprognostic (1.68e-1)"	"unprognostic (1.94e-1)"	"unprognostic (7.23e-2)"	"unprognostic (2.96e-1)"	"unprognostic (2.06e-2)"	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.3	0.2	0.0	0.1			0.4	0.0	0.0	0.0	1.5	0.1	0.0	0.1	0.1	0.0	0.0	0.2	0.0	0.0		0.0	0.7	0.0	0.8	0.0		0.0	0.2		0.1	0.1	0.0	0.5	0.8	0.0	0.0	0.0	1.0	5.2			0.3		0.0	0.2	0.0	0.8	0.5	2.2	0.3	0.5	0.7	0.1	0.3	0.0	0.7	0.2	0.4	0.1	0.9	0.6	0.7	0.2	0.5	0.6	0.2	0.0	0.0	0.0	0.8	1.4	0.0	0.9	0.6	0.0	0.0	0.5	0.3	0.0	0.0	0.0	0.0	0.0	2.8	0.1	0.8	0.4	0.0	0.0	0.0	0.0	0.2	0.0	0.4	0.1	0.1	0.9	0.4	0.0	0.8	0.0	0.5	1.3	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.3	0.0	0.0	1.8	0.0	0.2	0.0	0.0	0.0	2.2	0.3	0.7	0.2	0.2	0.1	0.6	0.3	0.2	0.0	0.8	0.7	0.2	1.7	0.5	0.2	0.5	0.2	0.1											0.0	0.0	0.0	3.4	0.5	0.0	0.3	0.0	10.7	2.3	0.0	0.0	0.3	0.0	0.2	3.3	0.0	1.4	0.0	0.2	0.1	0.2	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	1.5	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.6	0.7	0.0	0.1	2.6
TMPRSS9		ENSG00000178297	"Transmembrane serine protease 9"	Q7Z410	19	2389771-2426239	"Enzymes, Predicted membrane proteins"		"Hydrolase, Protease, Serine protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"liver: 6.3;lymphoid tissue: 4.6;testis: 5.9"	"Cell type enhanced"	"Detected in some"	19	"Early spermatids: 19.9;Erythroid cells: 23.3;Late spermatids: 37.0;Spermatocytes: 8.6"	"Low cancer specificity"	"Detected in some"							"Cell type enhanced"	"Detected in single"		"eosinophil: 2.4"	"Lineage enhanced"	"Detected in single"		"granulocytes: 2.4"	"Cell line enhanced"	"Detected in some"		"Karpas-707: 6.3;SK-BR-3: 3.2;U-266/70: 5.5"	"Region enhanced"	"Detected in single"		"basal ganglia: 0.5"	"Low region specificity"	"Detected in all"			HPA051483	Uncertain					NA	NA					"HPA051483: AB_2681501"	"unprognostic (1.63e-1)"	"unprognostic (1.94e-2)"	"unprognostic (5.62e-3)"	"unprognostic (1.86e-1)"	"unprognostic (1.54e-2)"	"unprognostic (1.87e-3)"	"unprognostic (3.30e-1)"	"unprognostic (6.44e-2)"	"unprognostic (7.29e-2)"	"unprognostic (2.07e-1)"	"unprognostic (6.30e-2)"	"unprognostic (9.20e-3)"	"unprognostic (2.28e-3)"	"unprognostic (8.67e-2)"	"unprognostic (1.96e-1)"	"unprognostic (3.07e-3)"	"unprognostic (6.73e-2)"	0.1	1.1	0.9	0.4	0.2	2.0	1.3	0.0	0.2	0.0	0.4			0.3	0.4	0.0	0.0	0.1	0.3	0.0	0.1	0.1	0.0	6.3	0.0	0.1	0.0		0.2	1.2	0.0	0.2	0.1		0.1	0.0		0.5	0.0	1.5	1.8	0.4	0.0	0.0	4.6	0.1	5.9			0.0		0.0	0.0	0.0	0.0	0.9	2.4	0.0	0.0	0.0	0.1	1.7	0.3	0.2	0.6	0.0	0.0	0.5	0.9	0.0	0.0	0.0	0.6	0.6	0.4	0.6	0.0	0.2	1.3	0.0	0.0	0.0	0.0	0.8	0.2	2.2	2.3	0.0	2.4	0.3	0.0	0.0	0.0	0.0	0.2	0.0	0.6	1.0	6.3	0.0	1.2	0.2	0.4	0.5	0.1	0.8	1.1	0.0	0.9	0.0	0.3	0.1	0.2	0.2	3.2	0.1	0.3	0.4	1.6	0.4	1.1	0.8	1.1	0.7	5.5	1.3	1.5	0.2	0.9	0.2	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.1											0.0	0.0	0.0	0.0	0.0	0.6	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	19.9	0.0	0.0	23.3	0.0	0.1	0.3	0.0	0.0	2.4	0.2	0.0	0.0	1.3	0.0	37.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.6	2.7	0.0	0.5	0.0	0.0	0.0
TMX3	"FLJ20793, KIAA1830, PDIA13, TXNDC10"	ENSG00000166479	"Thioredoxin related transmembrane protein 3"	Q96JJ7	18	68673688-68715298	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"		Isomerase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA014157	Uncertain				"Intracellular and membrane"	NA	NA					"HPA014157: AB_1858469"	"unprognostic (2.11e-1)"	"unprognostic (5.15e-2)"	"unprognostic (2.14e-2)"	"unprognostic (9.47e-2)"	"unprognostic (6.82e-2)"	"unprognostic (7.20e-2)"	"unprognostic (4.96e-3)"	"unprognostic (1.54e-1)"	"unprognostic (3.21e-3)"	"unprognostic (5.20e-2)"	"unprognostic (9.83e-3)"	"unprognostic (2.73e-1)"	"prognostic unfavorable (2.87e-4)"	"unprognostic (2.69e-2)"	"unprognostic (1.53e-2)"	"unprognostic (1.38e-2)"	"unprognostic (1.21e-1)"	22.8	16.8	14.7	22.8	31.3	12.2	20.5	28.0	34.2	16.4	15.4	14.0	16.0	17.8	22.1	21.7	16.9	18.3	16.8	20.2	17.1	18.2	19.2	19.9	23.3	25.6	14.2	18.7	16.0	16.3	20.4	19.3	19.6	26.8	18.7	16.9	18.2	14.6	16.3	14.1	16.5	21.1	21.1	16.7	26.3	15.2	11.1	11.1	29.6	19.2	13.4	22.1	19.9	14.8	4.9	9.6	3.4	6.9	7.6	8.7	4.1	3.4	5.5	10.7	8.3	22.1	23.7	7.9	27.2	29.1	19.8	22.2	2.6	10.2	9.8	5.4	39.5	8.4	13.0	7.0	13.6	30.5	9.3	6.3	9.0	8.7	4.5	23.5	19.0	14.9	18.8	8.8	21.4	19.4	20.3	25.1	8.6	5.7	13.7	23.5	2.1	10.2	6.0	4.5	2.8	9.0	9.5	21.2	11.9	16.8	7.5	10.3	8.0	13.2	8.6	10.0	11.1	5.6	16.3	24.0	35.5	9.7	7.9	19.8	9.2	9.2	9.2	21.5	15.8	25.9	2.6	4.3	3.4	6.1	6.9	8.7	4.9	6.3	5.6	6.9	3.6	7.1	6.9	1.1	7.6	4.7	9.6	6.4	4.1	14.7	31.3	28.0	34.2	17.1	18.2	14.2	18.7	26.8	11.1	26.8	23.8	18.0	14.7	18.0	26.7	19.3	15.3	33.5	17.0	15.7	17.7	12.5	1.7	13.7	2.1	24.0	10.8	0.0	8.8	17.9	26.7	15.3	19.7	22.1	16.4	25.4	17.2	30.1	22.9	2.3	22.5	24.0	23.6	7.2	13.0	24.1	13.2	11.9	15.6	5.7	31.8	38.8	20.6	18.2	26.0	21.2	10.4	19.3	7.6	14.0
TNFAIP3	"A20, OTUD7C"	ENSG00000118503	"TNF alpha induced protein 3"	P21580	6	137867188-137883312	"Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Apoptosis, Inflammatory response, Ubl conjugation pathway"	"DNA-binding, Hydrolase, Multifunctional enzyme, Protease, Thiol protease, Transferase"	"Cancer-related genes, Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 112.4"	"Cell type enhanced"	"Detected in many"	10	"Basal keratinocytes: 688.4;Suprabasal keratinocytes: 651.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"GAMG: 31.8;Karpas-707: 48.1;REH: 41.8;U-266/84: 35.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA002116	Approved		Approved	Centrosome,Cytosol		NA	NA			"Centrosome, Cytosol"		"HPA002116: AB_1858162"	"unprognostic (5.50e-3)"	"unprognostic (9.98e-3)"	"unprognostic (3.06e-2)"	"unprognostic (1.01e-2)"	"unprognostic (4.01e-2)"	"unprognostic (9.47e-2)"	"unprognostic (5.01e-3)"	"unprognostic (4.40e-2)"	"unprognostic (2.92e-2)"	"unprognostic (2.58e-1)"	"unprognostic (1.72e-1)"	"unprognostic (2.06e-1)"	"prognostic unfavorable (6.05e-4)"	"unprognostic (6.06e-2)"	"unprognostic (3.55e-3)"	"unprognostic (1.27e-1)"	"unprognostic (6.29e-2)"	27.4	6.0	1.5	58.6	1.8	112.4	17.2	0.4	1.5	7.7	15.7	3.2	2.6	5.1	9.7	7.3	12.7	12.1	17.0	11.7	2.1	1.3	6.8	8.1	45.1	38.8	2.1	2.6	37.5	7.2	2.1	3.7	14.5	4.6	13.8	6.3	7.2	8.2	3.5	10.7	20.5	17.2	8.2	3.8	25.9	8.0	9.3	2.1	38.6	5.7	9.2	31.4	23.3	9.5	7.1	18.6	10.0	9.7	7.5	20.5	9.0	8.9	1.4	0.5	0.8	3.0	5.1	2.1	5.1	19.9	1.4	1.8	9.9	2.9	2.0	13.1	5.8	31.8	6.8	0.3	14.7	2.6	14.5	0.5	2.0	5.1	5.8	3.3	2.7	3.6	4.6	2.1	16.8	16.0	1.7	0.8	5.3	4.0	48.1	2.4	0.5	14.7	11.5	0.3	0.6	0.4	41.8	10.4	1.4	4.3	4.3	0.2	0.0	1.0	1.5	4.3	2.1	1.0	3.3	4.0	14.4	1.7	12.9	2.9	15.5	35.9	4.1	5.2	3.4	1.7	5.6	9.7	5.5	14.8	7.1	20.5	6.2	15.1	13.3	10.3	7.1	10.0	7.4	10.0	7.5	3.7	18.6	14.7	9.0	1.5	1.8	0.4	1.5	2.1	1.3	2.1	2.6	4.6	2.1	35.7	83.1	25.1	141.6	688.4	1.0	4.2	30.6	41.5	26.1	0.0	27.5	5.5	1.7	50.3	2.3	27.0	39.0	0.0	23.4	88.6	55.5	117.9	248.4	10.2	45.4	0.0	11.3	45.4	74.2	2.4	6.4	241.1	123.2	82.0	12.5	1.7	27.9	8.2	5.6	2.2	13.3	6.5	87.3	0.9	2.3	651.8	19.3	101.2	8.5	60.3
TNIK	KIAA0551	ENSG00000154310	"TRAF2 and NCK interacting kinase"	Q9UKE5	3	171061339-171460408	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Neurogenesis, Wnt signaling pathway"	"Kinase, Serine/threonine-protein kinase, Transferase"	"Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 30.9"	"Cell type enhanced"	"Detected in many"	7	"granulocytes: 79.9;Muller glia cells: 79.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	23	"basophil: 4.4;eosinophil: 10.5;gdT-cell: 4.2;MAIT T-cell: 5.2;memory CD4 T-cell: 5.0;memory CD8 T-cell: 3.7;naive CD4 T-cell: 6.7;naive CD8 T-cell: 3.8;NK-cell: 2.7;T-reg: 5.3"	"Group enriched"	"Detected in many"	29	"granulocytes: 10.5;NK-cells: 2.7;T-cells: 6.7"	"Cell line enhanced"	"Detected in many"		"AF22: 19.9;HEL: 27.0;HMC-1: 30.8;WM-115: 23.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA012128, HPA012297"	Approved		Supported	Nucleoplasm,Cytosol		NA	NA		9100	Nucleoplasm	Cytosol	"HPA012128: AB_1858226, HPA012297: AB_1858225"	"unprognostic (2.29e-1)"	"unprognostic (1.12e-2)"	"unprognostic (1.32e-1)"	"unprognostic (5.90e-2)"	"unprognostic (5.25e-2)"	"unprognostic (9.23e-2)"	"unprognostic (4.91e-2)"	"unprognostic (2.41e-3)"	"unprognostic (1.91e-1)"	"unprognostic (7.81e-2)"	"unprognostic (5.91e-2)"	"unprognostic (1.96e-2)"	"unprognostic (3.34e-3)"	"unprognostic (2.41e-1)"	"unprognostic (1.64e-1)"	"unprognostic (2.13e-2)"	"unprognostic (3.97e-2)"	2.2	5.4	29.0	7.4	30.9	4.9	3.6	21.1	26.1	1.9	10.9	12.2	4.1	25.8	4.3	2.1	5.6	4.3	7.1	11.2	30.9	14.8	5.6	4.6	11.3	7.9	11.4	18.3	2.6	5.2	0.7	9.0	3.1	13.6	5.6	9.5	3.5	2.9	7.3	23.2	1.6	25.6	6.0	14.5	5.8	9.2	10.7	21.1	3.7	7.1	2.2	6.9	6.4	2.6	0.2	0.0	10.5	0.1	2.7	6.7	1.1	0.3	0.5	19.9	2.1	0.3	0.0	4.7	4.1	1.2	3.3	2.2	17.8	7.4	0.0	1.5	3.8	3.0	6.1	2.8	1.1	3.6	0.1	4.4	27.0	1.5	0.0	9.5	5.3	30.8	2.9	3.0	1.9	0.4	7.7	19.8	4.5	9.7	0.0	0.5	0.4	1.7	6.8	8.2	14.2	7.7	0.0	5.1	7.1	6.4	0.0	0.9	1.0	2.5	0.2	4.4	2.2	9.0	1.3	0.2	0.0	3.5	9.0	3.0	0.0	0.0	0.0	0.9	6.0	23.0	4.4	0.1	10.5	4.2	0.0	5.2	0.0	5.0	3.7	0.0	0.2	6.7	3.8	0.1	2.7	0.1	0.0	5.3	1.1	29.0	30.9	21.1	22.2	30.9	14.8	11.4	18.3	13.6	21.1	6.0	37.9	0.5	1.4	2.3	9.3	25.7	25.5	2.7	12.5	8.7	13.7	4.7	5.0	9.2	29.5	1.6	26.2	0.0	6.8	1.8	4.4	0.6	79.9	6.8	2.5	0.0	12.7	1.3	5.6	33.0	2.3	3.3	1.7	0.0	9.4	79.4	4.8	16.5	6.0	14.9	27.7	0.0	7.6	2.8	1.0	1.4	2.1	31.2	15.3	2.4
TNK1		ENSG00000174292	"Tyrosine kinase non receptor 1"	Q13470	17	7380534-7389774	"Enzymes, Predicted intracellular proteins"		"Kinase, Transferase, Tyrosine-protein kinase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	5	"Enterocytes: 10.4"	"Low cancer specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"basal ganglia: 6.4;cerebellum: 11.4;cerebral cortex: 4.0;pons and medulla: 4.3"	"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	6	"B-cells: 1.6;T-cells: 3.8"	"Cell line enhanced"	"Detected in many"		"HaCaT: 10.5;HBEC3-KT: 7.0;hTCEpi: 7.9;T-47d: 8.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"HPA012065, HPA056452"	Uncertain		Approved	"Cell Junctions"		NA	NA			"Cell Junctions"		"HPA012065: AB_1858165, HPA056452: "	"unprognostic (4.90e-2)"	"unprognostic (1.93e-1)"	"unprognostic (2.95e-1)"	"prognostic favorable (4.28e-4)"	"unprognostic (2.84e-1)"	"unprognostic (1.60e-1)"	"unprognostic (1.41e-2)"	"unprognostic (3.65e-1)"	"unprognostic (2.20e-1)"	"unprognostic (2.52e-2)"	"unprognostic (2.43e-1)"	"unprognostic (3.10e-1)"	"prognostic favorable (6.40e-4)"	"unprognostic (1.77e-3)"	"unprognostic (1.61e-1)"	"unprognostic (1.38e-1)"	"prognostic favorable (1.52e-4)"	3.4	0.6	1.1	2.2	6.4	0.4	7.9	11.4	4.0	5.4	11.7	0.4	7.7	7.1	5.1	5.3	7.2	3.5	6.3	2.0	1.0	0.4	4.6	6.9	3.2	2.7	1.5	0.8	4.4	6.8	5.4	2.7	2.5	4.3	8.9	4.5	7.7	10.5	4.8	1.8	8.3	11.3	5.1	0.7	2.4	9.6	2.2	0.6	0.6	11.6	5.7	5.2	4.5	4.4	1.6	0.1	0.4	0.0	0.0	3.8	0.6	6.4	1.0	0.2	0.4	0.0	0.0	4.4	0.2	0.0	0.4	0.4	3.3	3.0	0.0	2.6	0.3	0.1	10.5	0.0	7.0	0.1	0.7	1.5	0.0	3.7	1.9	0.4	0.0	0.3	0.1	7.9	0.0	1.2	0.2	0.0	2.8	0.8	0.0	0.0	4.9	0.6	0.0	0.9	5.6	0.9	0.2	0.2	0.7	4.9	3.0	0.2	0.5	3.6	5.3	1.0	0.3	8.7	0.1	1.7	0.2	0.8	0.2	0.0	0.5	1.0	0.1	0.1	0.4	0.5	0.0	0.0	0.0	1.0	0.0	1.9	1.6	1.8	1.2	0.1	1.5	3.3	3.8	0.4	0.0	0.0	0.0	0.8	0.6	1.1	6.4	11.4	4.0	1.0	0.4	1.5	0.8	4.3	0.6	6.0	4.3	0.5	2.1	2.3	1.2	0.8	2.5	0.0	2.3	1.8	0.0	0.2	0.0	4.4	1.1	0.7	10.4	0.0	5.9	0.4	1.0	4.0	0.0	2.5	0.1	0.0	2.9	1.3	0.0	0.6	1.1	0.1	0.0	0.0	6.3	0.2	6.4	6.5	0.4	1.4	2.4	0.0	0.9	0.6	0.9	2.0	0.6	1.0	6.4	1.8
TNK2	"ACK, ACK1, p21cdc42Hs"	ENSG00000061938	"Tyrosine kinase non receptor 2"	Q07912	3	195863364-195911945	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins"	Endocytosis	"Kinase, Serine/threonine-protein kinase, Transferase, Tyrosine-protein kinase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	10	"Cone photoreceptor cells: 47.1;Horizontal cells: 93.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041954	Approved		Approved	Cytosol		NA	NA			Cytosol		"HPA041954: AB_10794164"	"unprognostic (1.97e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.15e-3)"	"prognostic unfavorable (8.96e-4)"	"unprognostic (1.34e-1)"	"unprognostic (8.92e-2)"	"unprognostic (1.45e-1)"	"unprognostic (1.30e-1)"	"unprognostic (8.89e-3)"	"unprognostic (1.13e-1)"	"unprognostic (8.92e-3)"	"unprognostic (4.49e-2)"	"prognostic unfavorable (1.30e-4)"	"unprognostic (6.82e-2)"	"unprognostic (9.76e-2)"	"unprognostic (1.44e-1)"	"prognostic favorable (1.00e-4)"	9.2	7.6	36.3	16.2	27.6	38.9	8.5	20.7	43.7	6.0	6.3	17.6	3.8	6.6	8.0	6.6	13.0	10.7	6.5	10.6	28.4	21.8	4.1	7.2	9.3	18.1	21.6	31.8	8.6	7.8	5.1	19.3	8.4	20.0	10.8	3.9	5.3	16.8	8.2	30.5	37.1	6.9	7.6	10.3	17.0	12.1	7.7	21.8	3.4	4.6	9.8	12.8	7.7	12.3	6.1	3.1	6.3	3.2	0.9	1.9	1.2	31.9	3.1	5.2	5.5	7.2	4.6	31.1	6.2	5.9	3.7	3.4	4.9	24.7	9.3	21.6	8.4	6.3	11.4	4.5	7.6	1.1	21.9	5.7	8.4	10.4	3.5	3.2	4.3	4.2	3.4	12.2	5.1	6.1	10.6	4.7	3.5	3.4	12.9	3.4	23.5	1.8	15.7	4.9	8.5	11.5	5.4	6.2	9.4	3.3	15.5	6.3	6.4	4.0	16.2	7.9	5.2	26.5	5.4	7.6	8.6	5.0	4.4	17.1	28.2	3.0	5.8	7.7	14.0	6.3	2.0	2.4	0.9	1.9	3.2	1.1	2.7	1.8	1.0	1.1	6.1	1.4	1.3	6.3	0.9	2.8	3.1	0.2	1.2	36.3	27.6	20.7	33.3	28.4	21.8	21.6	31.8	20.0	21.8	6.0	4.8	11.8	6.8	6.2	26.5	12.8	5.1	5.3	11.4	0.0	47.1	10.6	1.7	3.5	0.8	7.5	6.9	0.0	4.5	2.6	5.3	7.2	1.1	13.5	7.2	93.8	5.8	9.8	20.5	0.8	6.1	11.4	5.0	9.0	1.4	6.6	19.1	3.5	6.0	1.4	20.9	0.0	5.5	3.9	10.0	9.3	3.5	8.9	3.3	16.3
TNKS	"PARP-5a, PARP5A, pART5, TIN1, TINF1, TNKS1"	ENSG00000173273	Tankyrase	O95271	8	9555914-9782346	"Enzymes, Predicted intracellular proteins, Transporters"	"Cell cycle, Cell division, Mitosis, mRNA transport, Protein transport, Translocation, Transport, Wnt signaling pathway"	"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"Early spermatids: 118.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA025690	Approved		Approved	"Nucleoplasm,Nuclear membrane,Nuclear bodies"		NA	NA			Nucleoplasm	"Nuclear membrane, Nuclear bodies"	"HPA025690: AB_10602249"	"unprognostic (2.07e-1)"	"unprognostic (1.72e-2)"	"unprognostic (5.45e-3)"	"unprognostic (8.22e-2)"	"unprognostic (2.42e-1)"	"unprognostic (1.27e-2)"	"unprognostic (4.75e-2)"	"unprognostic (1.13e-1)"	"unprognostic (9.06e-2)"	"unprognostic (8.01e-2)"	"unprognostic (6.21e-2)"	"unprognostic (9.10e-2)"	"unprognostic (4.14e-2)"	"unprognostic (1.12e-1)"	"unprognostic (5.43e-1)"	"unprognostic (7.76e-2)"	"unprognostic (5.36e-2)"	9.1	13.4	17.8	8.7	19.6	14.6	14.0	26.5	22.3	18.1	8.9	17.0	12.5	8.5	14.9	25.3	7.7	11.9	8.9	9.5	18.6	17.9	9.0	9.1	10.3	12.9	28.7	17.2	19.2	10.2	23.9	20.0	11.0	20.1	11.5	10.0	10.9	9.4	11.7	22.1	15.6	9.8	11.0	21.0	8.7	10.1	26.3	21.8	15.6	13.7	4.4	11.7	10.8	13.6	6.8	3.6	7.4	2.8	2.9	4.8	1.2	6.1	8.1	20.8	12.5	13.2	17.7	7.7	9.5	10.8	7.7	8.8	4.8	4.9	13.2	3.9	9.3	10.4	6.5	11.8	8.9	11.2	3.4	6.1	9.2	7.4	10.8	11.9	4.7	5.7	12.5	10.8	8.0	15.8	12.6	10.4	10.3	8.6	14.1	14.2	4.0	11.9	7.2	13.6	6.7	4.7	9.6	12.9	3.8	9.3	12.5	21.2	15.6	7.4	7.1	13.4	13.2	4.7	7.1	13.9	12.7	7.8	8.6	7.0	4.9	7.9	9.4	13.7	6.7	12.2	4.8	2.3	1.8	4.4	2.2	2.4	4.2	3.5	4.2	2.8	6.8	4.2	4.8	7.4	2.9	2.8	3.6	1.7	1.2	17.8	19.6	26.5	22.3	18.6	17.9	28.7	17.2	20.1	21.8	14.9	9.4	11.0	11.2	10.2	32.0	14.3	17.8	26.8	9.1	8.7	13.7	9.0	1.7	9.8	118.1	10.9	9.0	0.0	7.4	7.7	14.9	11.9	9.3	15.8	6.2	39.7	13.3	20.9	9.4	58.4	15.5	7.3	11.8	1.8	13.5	18.4	11.2	13.1	17.0	6.0	36.2	0.0	9.9	30.7	13.5	13.6	10.3	11.5	11.7	10.2
TNKS2	"PARP-5b, PARP-5c, PARP5B, PARP5C, pART6, TANK2, TNKL"	ENSG00000107854	"Tankyrase 2"	Q9H2K2	10	91798312-91865276	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Wnt signaling pathway"	"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA036606			Approved	Microtubules		NA	NA			Microtubules		"HPA036606: AB_10673470"	"unprognostic (1.12e-1)"	"unprognostic (2.66e-1)"	"unprognostic (4.16e-1)"	"unprognostic (1.61e-2)"	"unprognostic (3.07e-2)"	"unprognostic (1.51e-2)"	"unprognostic (2.14e-1)"	"unprognostic (1.41e-1)"	"unprognostic (2.93e-1)"	"unprognostic (2.59e-2)"	"unprognostic (1.50e-1)"	"unprognostic (2.26e-2)"	"unprognostic (1.00e-1)"	"unprognostic (2.35e-1)"	"unprognostic (1.69e-1)"	"unprognostic (7.97e-2)"	"unprognostic (2.53e-1)"	17.6	16.3	16.7	23.0	18.6	26.9	18.4	27.9	20.0	18.8	13.9	18.3	18.3	11.9	18.9	18.8	24.7	16.7	17.2	12.2	16.6	14.9	14.6	16.8	17.0	22.9	20.3	14.9	26.0	19.3	20.8	26.7	47.5	16.1	16.7	14.3	16.1	21.4	16.0	39.7	23.9	16.5	18.9	18.0	22.8	15.8	9.5	17.9	42.9	24.5	21.0	23.8	18.6	18.9	3.6	5.2	3.8	2.5	3.3	3.5	1.4	14.2	12.1	25.0	21.2	17.7	16.2	27.9	15.3	28.0	18.7	23.0	10.7	11.6	13.4	7.4	19.9	12.6	15.4	15.6	11.8	26.6	13.5	15.1	11.1	11.6	11.9	17.2	21.3	16.6	16.4	15.7	18.9	33.8	28.3	17.5	12.1	8.1	14.9	19.4	7.6	18.3	14.6	12.5	6.5	8.1	17.2	15.6	10.1	12.8	15.4	6.5	11.8	15.4	6.8	19.0	21.0	16.5	14.9	18.9	10.1	8.6	13.3	14.5	18.8	15.4	17.5	13.4	16.1	9.0	1.0	2.5	3.8	3.5	2.3	3.0	3.5	3.3	3.2	3.4	3.6	2.8	2.4	2.5	3.3	2.2	5.2	1.7	1.4	16.7	18.6	27.9	20.0	16.6	14.9	20.3	14.9	16.1	17.9	38.7	18.2	20.6	28.6	66.2	37.6	18.2	10.2	37.5	27.3	41.8	45.2	36.2	6.6	14.8	4.0	33.7	12.9	0.0	21.2	46.2	23.5	36.2	2.3	30.5	23.0	39.7	31.8	35.6	54.0	5.9	28.7	29.3	32.1	17.2	20.1	33.3	24.0	11.5	33.2	14.5	30.9	45.3	29.7	16.3	19.4	95.4	84.4	29.7	13.4	52.2
TNNI3K	CARK	ENSG00000116783	"TNNI3 interacting kinase"	Q59H18	1	74235401-74544428	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"	"Cardiomyopathy, Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	7	"heart muscle: 44.6"	"Group enriched"	"Detected in some"	4	"Cardiomyocytes: 23.4;Early spermatids: 20.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"intermediate monocyte: 2.3;plasmacytoid DC: 1.9"	"Group enriched"	"Detected in many"	5	"dendritic cells: 1.9;monocytes: 2.3;T-cells: 1.0"	"Cell line enhanced"	"Detected in some"		"CAPAN-2: 3.8;HSkMC: 2.6;OE19: 2.8;RPTEC TERT1: 2.6"															NA	NA						"unprognostic (1.04e-2)"	"unprognostic (1.34e-2)"	"unprognostic (3.83e-1)"	"unprognostic (2.20e-1)"	"unprognostic (3.46e-1)"	"unprognostic (3.40e-2)"	"unprognostic (3.05e-1)"	"unprognostic (2.48e-3)"	"unprognostic (2.00e-1)"	"unprognostic (9.66e-2)"	"unprognostic (5.04e-2)"	"unprognostic (1.80e-1)"	"unprognostic (3.59e-3)"	"unprognostic (4.88e-3)"	"unprognostic (1.20e-1)"	"unprognostic (8.80e-2)"	"unprognostic (8.77e-2)"	0.7	0.6	1.1	0.5	1.5	0.0	1.0	6.0	1.7	0.5	0.5	0.5	0.5	0.2	0.5	1.7	0.5	0.7	0.5	44.6	1.1	1.3	2.2	0.5	0.5	0.5	0.6	0.5	0.7	0.5	0.3	0.6	0.5	0.9	0.5	0.3	0.5	0.5	1.2	0.5	0.9	0.5	0.6	0.5	0.5	0.1	1.8	0.5	0.5	0.6	0.5	0.5	0.5	0.5	0.3	1.9	0.0	2.3	0.0	1.0	0.1	0.0	0.6	0.7	0.0	0.5	1.5	0.0	0.0	1.3	0.3	1.0	0.0	3.8	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.7	0.5	2.6	1.5	0.2	0.0	0.0	0.5	0.3	0.0	0.8	1.1	0.0	0.2	0.2	1.1	2.8	0.0	0.2	0.0	0.0	2.6	0.0	0.3	0.9	0.0	0.0	0.0	0.1	0.0	0.8	1.3	0.0	0.1	0.1	0.4	0.2	0.0	0.0	0.0	0.5	0.3	0.0	0.2	0.0	0.1	2.3	0.0	0.1	0.3	1.0	0.1	0.3	0.2	0.4	0.0	0.0	0.2	1.9	0.0	0.1	1.1	1.5	6.0	1.7	1.1	1.3	0.6	0.5	0.9	0.5	0.0	0.0	0.0	0.1	0.8	1.2	23.4	0.0	0.0	0.0	1.8	0.0	0.0	1.7	0.1	20.4	0.0	0.0	0.0	0.0	0.1	0.2	0.1	0.0	0.0	0.1	1.6	0.0	0.0	0.0	5.4	0.9	0.0	0.0	0.0	0.0	0.8	0.1	0.0	0.7	3.3	0.2	0.0	1.7	0.4	1.1	0.3	0.1	0.0	0.0	0.1
TOP1		ENSG00000198900	"DNA topoisomerase I"	P11387	20	41028818-41124487	"Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins"	"Biological rhythms, Host-virus interaction"	"DNA-binding, Isomerase, Topoisomerase"	"Cancer-related genes, FDA approved drug targets, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	6	"Syncytiotrophoblasts: 670.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009058, HPA019039"	Supported		Supported	"Nucleoplasm,Nucleoli fibrillar center"		No	Yes			"Nucleoplasm, Nucleoli fibrillar center"		"CAB009058: AB_2303554, HPA019039: AB_1858187"	"unprognostic (1.46e-1)"	"unprognostic (8.65e-2)"	"unprognostic (1.33e-2)"	"unprognostic (1.92e-3)"	"unprognostic (5.05e-2)"	"unprognostic (1.49e-3)"	"prognostic unfavorable (6.42e-4)"	"unprognostic (5.86e-2)"	"unprognostic (1.51e-1)"	"unprognostic (4.60e-2)"	"unprognostic (3.74e-3)"	"unprognostic (6.51e-2)"	"unprognostic (8.65e-2)"	"unprognostic (4.70e-2)"	"unprognostic (5.14e-1)"	"unprognostic (3.64e-1)"	"unprognostic (1.29e-1)"	26.6	31.0	24.6	46.3	25.3	55.3	37.4	39.6	31.1	21.3	30.0	11.1	26.7	29.7	22.9	22.5	36.0	20.5	29.2	21.0	23.0	18.3	31.8	32.7	37.9	38.6	21.9	20.9	25.5	22.5	22.2	39.9	43.9	25.2	23.3	27.2	13.6	25.3	34.3	26.2	24.6	48.4	23.1	27.4	36.9	26.7	14.2	24.2	54.2	31.5	25.1	40.6	25.2	41.7	9.0	17.2	18.4	11.1	5.8	8.2	4.6	22.0	15.4	28.9	23.7	11.7	14.0	28.7	20.0	17.6	23.2	21.2	40.5	27.8	62.9	21.4	10.3	24.8	21.5	34.7	31.9	34.1	13.6	17.7	80.2	12.4	28.7	30.6	34.5	27.6	15.8	17.0	22.6	37.2	20.8	24.2	23.0	34.7	21.9	26.2	49.0	48.8	21.9	23.3	22.1	28.8	41.7	27.2	33.4	24.8	20.5	24.1	16.7	31.3	19.4	20.3	21.8	21.6	30.9	23.7	18.8	16.0	17.4	21.4	13.9	15.6	73.3	25.3	19.4	17.8	9.1	9.2	14.3	6.5	9.2	8.2	9.0	7.2	6.8	8.6	8.7	7.7	6.9	18.4	5.8	11.1	17.2	7.9	4.6	24.6	25.3	39.6	31.1	23.0	18.3	21.9	20.9	25.2	24.2	110.2	181.3	71.6	274.4	218.4	93.3	38.9	84.1	73.6	228.6	94.2	56.9	139.0	63.0	78.8	6.3	78.8	108.1	210.2	57.1	149.4	129.3	136.7	76.2	114.3	86.4	68.3	88.0	63.8	84.7	6.5	55.3	93.8	69.2	72.1	73.8	94.4	93.7	112.2	65.4	91.4	80.4	84.1	77.1	95.2	57.3	187.2	670.2	61.2	78.0	206.2
TOP1MT		ENSG00000184428	"DNA topoisomerase I mitochondrial"	Q969P6	8	143304384-143359979	"Enzymes, FDA approved drug targets, Predicted intracellular proteins"		"DNA-binding, Isomerase, Topoisomerase"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in all"		"MOLT-4: 58.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001915, HPA021542"	Approved		Supported	Mitochondria		NA	NA			Mitochondria		"HPA001915: AB_1080331, HPA021542: AB_1858186"	"unprognostic (5.02e-3)"	"unprognostic (3.79e-2)"	"unprognostic (6.57e-2)"	"unprognostic (6.92e-3)"	"unprognostic (2.32e-2)"	"unprognostic (1.04e-2)"	"unprognostic (3.05e-3)"	"unprognostic (1.44e-1)"	"unprognostic (1.44e-1)"	"unprognostic (1.13e-1)"	"unprognostic (1.50e-2)"	"unprognostic (4.42e-2)"	"prognostic unfavorable (1.52e-7)"	"unprognostic (3.66e-2)"	"unprognostic (3.62e-2)"	"unprognostic (8.55e-3)"	"unprognostic (5.66e-3)"	11.7	13.5	8.1	13.7	9.8	33.0	22.1	2.2	10.3	14.7	10.7	4.5	3.9	6.0	10.0	7.4	14.9	11.3	11.0	5.9	8.8	5.6	9.6	22.5	8.5	11.4	6.9	8.1	27.0	15.9	5.9	8.6	5.9	7.3	14.7	8.0	5.9	11.0	10.8	5.7	15.4	8.3	8.8	6.8	11.4	9.3	18.1	6.4	25.1	19.2	9.6	11.4	14.0	30.9	16.7	18.8	11.7	5.5	0.2	14.3	4.7	7.6	11.8	4.9	18.6	7.1	8.0	8.8	3.5	4.6	6.5	6.7	14.8	11.1	22.5	13.5	4.9	4.6	8.2	10.5	6.6	5.6	8.8	16.1	19.8	6.6	14.9	8.0	13.2	21.6	8.1	7.0	5.4	7.9	5.6	7.8	6.5	23.7	8.8	5.7	32.1	58.6	26.4	8.6	16.7	20.2	7.4	6.5	33.7	4.8	12.4	8.9	10.8	10.2	9.1	18.4	6.4	6.0	22.0	5.1	4.5	18.4	5.1	9.1	4.8	5.0	11.5	7.6	19.8	5.4	11.7	5.5	0.2	3.5	3.2	3.6	16.7	6.4	4.8	18.8	8.0	14.3	10.4	0.4	0.2	0.6	16.4	1.7	4.7	8.1	9.8	2.2	10.3	8.8	5.6	6.9	8.1	7.3	6.4	6.0	7.5	9.0	28.1	21.1	1.4	2.0	7.6	4.0	13.6	8.7	0.0	10.3	6.6	9.5	19.8	7.3	2.7	23.3	7.8	19.8	11.7	15.2	6.9	7.8	10.8	3.2	4.7	6.7	5.9	6.7	8.1	10.1	20.3	4.6	8.7	1.4	9.6	8.6	4.2	12.3	0.1	6.5	13.4	31.6	39.0	20.8	8.5	6.4	19.3	18.6
TOP2A	TOP2	ENSG00000131747	"DNA topoisomerase II alpha"	P11388	17	40388516-40417950	"Cancer-related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"	"Biological rhythms"	"DNA-binding, Isomerase, Topoisomerase"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"lymphoid tissue: 146.3;testis: 36.8"	"Group enriched"	"Detected in many"	4	"Erythroid cells: 280.4;Spermatocytes: 527.8;Spermatogonia: 241.9"	"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"T-reg: 5.7"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"CAB002448, HPA006458, HPA026773"	Enhanced	Approved	Supported	Nucleoplasm,Nucleoli		Yes	Yes			Nucleoplasm	Nucleoli	"CAB002448: AB_564035, HPA006458: AB_1858189, HPA026773: AB_1858190"	"unprognostic (2.09e-1)"	"unprognostic (1.24e-1)"	"unprognostic (2.28e-3)"	"unprognostic (9.42e-3)"	"unprognostic (1.80e-1)"	"unprognostic (1.52e-1)"	"prognostic unfavorable (5.92e-6)"	"prognostic unfavorable (4.99e-4)"	"unprognostic (6.21e-3)"	"unprognostic (2.09e-1)"	"prognostic unfavorable (3.83e-5)"	"unprognostic (5.03e-2)"	"prognostic unfavorable (0.00e+0)"	"unprognostic (7.46e-2)"	"unprognostic (1.07e-1)"	"unprognostic (2.18e-1)"	"unprognostic (2.29e-1)"	2.7	2.0	0.4	20.0	0.5	14.6	4.1	0.4	0.5	3.0	6.9	0.5	0.5	7.0	2.0	3.4	18.2	0.7	2.4	2.3	0.6	0.5	1.4	1.9	5.5	15.4	0.6	0.4	1.2	1.1	0.0	0.4	10.7	0.6	1.2	8.0	0.6	3.2	0.3	0.6	5.9	9.2	2.6	1.8	7.3	4.5	36.8	0.3	146.3	0.9	11.8	16.7	3.2	5.7	1.3	0.3	0.3	0.3	3.2	5.7	1.1	34.3	45.6	58.1	26.6	2.9	5.9	12.9	47.1	25.4	43.4	38.5	21.4	26.3	55.4	24.0	15.9	26.0	54.7	44.6	18.8	58.3	29.5	29.8	36.6	29.2	35.6	0.2	51.2	39.0	1.3	1.5	30.5	31.1	9.4	22.8	36.1	39.5	38.0	46.8	11.9	59.3	34.4	24.1	24.9	18.2	50.4	90.2	23.0	10.4	22.0	34.3	24.7	38.0	47.5	15.0	35.3	39.8	23.6	14.9	28.6	40.4	33.0	45.2	21.8	24.6	48.3	16.1	35.3	47.7	0.3	0.0	0.0	0.6	0.0	0.0	1.3	0.9	0.9	0.3	0.4	0.2	0.1	0.3	3.2	0.3	0.0	5.7	1.1	0.4	0.5	0.4	0.5	0.6	0.5	0.6	0.4	0.6	0.3	0.0	1.3	28.7	1.4	10.4	0.0	1.1	2.5	0.0	6.8	0.0	0.0	8.4	0.0	0.9	12.5	0.7	2.1	280.4	0.0	81.4	9.7	1.2	0.0	3.9	64.5	0.0	0.0	27.6	30.0	15.2	4.4	13.1	1.7	2.8	5.9	0.0	0.2	3.6	1.8	0.0	0.0	71.1	1.4	527.8	241.9	5.4	7.4	7.7	24.2	2.6
TOP2B		ENSG00000077097	"DNA topoisomerase II beta"	Q02880	3	25597905-25664907	"Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"		"DNA-binding, Isomerase, Topoisomerase"	"Autism spectrum disorder, Disease mutation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"REH: 106.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004601, HPA024120, HPA050441"	Supported		Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"CAB004601: AB_628384, HPA024120: AB_1858191, HPA050441: AB_2681127"	"unprognostic (2.90e-2)"	"unprognostic (5.17e-2)"	"unprognostic (7.21e-3)"	"unprognostic (2.42e-1)"	"unprognostic (1.60e-1)"	"unprognostic (1.43e-2)"	"prognostic unfavorable (1.86e-7)"	"unprognostic (7.86e-2)"	"unprognostic (1.89e-1)"	"unprognostic (2.84e-1)"	"unprognostic (7.14e-2)"	"unprognostic (1.08e-1)"	"prognostic favorable (2.43e-4)"	"unprognostic (1.01e-1)"	"unprognostic (1.59e-1)"	"unprognostic (1.49e-1)"	"unprognostic (7.93e-2)"	19.3	18.8	23.4	23.1	29.7	26.5	21.1	48.4	33.5	24.1	22.4	21.1	18.9	17.1	29.6	25.6	21.1	20.6	20.7	22.7	22.0	19.9	20.3	18.4	17.7	28.2	21.0	28.5	26.8	17.2	43.0	21.6	22.3	26.4	24.7	20.8	17.6	21.3	22.3	31.3	20.9	19.3	24.4	23.4	24.6	20.1	11.3	22.7	60.2	28.3	20.7	27.3	34.8	21.5	5.5	5.6	5.3	4.6	7.8	7.2	2.2	10.7	11.1	24.6	30.1	8.2	10.4	9.8	10.4	13.4	9.7	10.6	5.7	8.5	33.3	7.3	15.0	6.0	9.1	20.3	11.6	16.3	15.9	10.9	50.4	13.8	9.5	5.8	39.4	27.0	7.4	5.8	10.8	9.5	9.8	15.7	22.8	16.9	16.4	12.4	11.9	25.5	9.7	18.6	7.2	8.5	106.6	13.8	15.4	8.7	37.9	12.4	21.5	15.5	11.1	9.5	14.8	11.5	35.3	15.0	13.5	10.5	10.7	11.1	25.4	14.4	35.3	8.8	29.5	8.9	4.2	2.9	5.3	6.3	3.3	6.9	4.3	6.1	6.4	4.3	5.5	7.2	6.4	2.0	7.8	4.6	5.6	4.4	2.2	23.4	29.7	48.4	33.5	22.0	19.9	21.0	28.5	26.4	22.7	59.6	57.9	25.1	36.1	34.8	53.5	109.0	43.3	34.8	40.9	24.4	53.0	41.2	11.6	29.3	2.9	32.2	17.7	23.3	28.8	20.8	35.0	47.5	31.4	33.5	23.1	57.2	57.0	21.5	40.9	4.8	36.2	38.8	21.9	21.6	32.6	46.4	32.0	17.5	31.5	21.9	89.3	32.3	36.7	66.2	27.0	33.0	39.0	45.0	37.9	57.7
TOP3A	"TOP3, ZGRF7"	ENSG00000177302	"DNA topoisomerase III alpha"	Q13472	17	18271428-18315007	"Cancer-related genes, Enzymes, Predicted intracellular proteins"		"DNA-binding, Isomerase, Topoisomerase"	"Cancer-related genes, Disease mutation, Dwarfism, Primary mitochondrial disease, Progressive external ophthalmoplegia"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Cone photoreceptor cells: 37.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB002449	Approved					NA	NA					"CAB002449: AB_564037"	"unprognostic (5.49e-2)"	"unprognostic (9.04e-2)"	"unprognostic (8.99e-2)"	"unprognostic (7.24e-3)"	"unprognostic (4.01e-2)"	"unprognostic (1.95e-2)"	"unprognostic (2.33e-3)"	"unprognostic (6.54e-2)"	"unprognostic (2.34e-1)"	"unprognostic (2.74e-1)"	"prognostic favorable (1.39e-4)"	"prognostic unfavorable (4.59e-4)"	"unprognostic (5.58e-2)"	"unprognostic (8.80e-2)"	"unprognostic (3.53e-2)"	"unprognostic (5.05e-2)"	"unprognostic (6.05e-2)"	12.5	11.6	10.9	12.5	14.0	23.8	12.0	21.4	17.9	11.0	11.2	13.8	9.1	10.3	13.3	10.4	12.1	11.8	9.5	8.4	9.3	10.5	9.3	15.6	10.8	15.5	9.4	9.0	11.4	16.1	15.0	15.1	10.7	11.1	11.0	13.1	12.8	11.6	9.0	13.0	19.1	10.8	14.1	9.0	16.6	10.5	17.9	11.8	25.9	10.3	7.4	16.2	11.6	10.7	2.1	2.7	10.4	5.9	4.1	4.0	3.3	7.6	12.8	10.5	12.8	5.4	5.4	9.6	8.1	5.8	14.3	14.0	23.4	3.4	13.2	5.3	7.3	6.6	10.7	15.8	6.8	15.1	9.8	12.6	12.1	13.3	8.0	5.3	6.0	10.7	3.5	4.4	15.1	8.8	3.3	6.6	11.2	10.4	5.4	8.3	7.9	13.4	7.6	8.1	19.2	7.1	15.3	25.0	12.5	4.2	7.9	7.5	14.1	12.4	7.8	8.0	29.6	15.5	6.3	6.2	10.2	8.1	19.4	13.9	6.0	10.7	9.3	6.3	8.3	9.7	1.4	5.9	6.5	4.0	5.8	2.6	1.7	3.0	3.1	2.6	2.1	2.6	2.7	10.4	4.1	2.9	2.7	2.2	3.3	10.9	14.0	21.4	17.9	9.3	10.5	9.4	9.0	11.1	11.8	6.0	4.5	10.0	4.0	1.8	19.7	2.8	7.6	8.1	10.3	10.4	37.3	5.4	3.3	3.5	7.2	4.7	3.4	0.0	3.2	5.9	4.3	4.8	4.7	6.4	4.6	20.6	0.0	7.4	10.0	6.2	7.5	6.8	1.7	4.6	3.4	6.0	3.3	3.5	6.0	1.2	20.6	12.9	4.9	15.9	17.9	3.0	3.7	8.5	4.1	4.1
TOP3B		ENSG00000100038	"DNA topoisomerase III beta"	O95985	22	21957025-21982816	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"DNA-binding, Isomerase, Topoisomerase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"K-562: 49.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA072114			Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA072114: "	"unprognostic (1.03e-1)"	"unprognostic (2.05e-2)"	"unprognostic (1.44e-1)"	"unprognostic (1.68e-2)"	"unprognostic (3.37e-1)"	"unprognostic (5.04e-2)"	"unprognostic (2.27e-1)"	"unprognostic (3.93e-1)"	"unprognostic (2.15e-2)"	"unprognostic (2.89e-2)"	"unprognostic (1.95e-1)"	"unprognostic (1.29e-2)"	"unprognostic (1.96e-2)"	"unprognostic (1.69e-2)"	"unprognostic (1.21e-1)"	"unprognostic (3.53e-2)"	"unprognostic (1.11e-4)"	10.4	11.7	12.1	16.1	17.4	20.8	10.9	17.2	17.1	12.5	11.0	16.9	14.9	15.4	16.1	11.0	14.2	11.0	11.2	10.1	12.7	5.5	13.4	15.3	12.7	17.0	18.7	6.5	20.2	12.1	13.5	21.0	12.1	16.2	15.6	14.9	14.1	13.3	13.3	13.4	17.5	16.1	14.5	17.4	23.6	11.8	11.1	16.9	13.1	14.2	5.7	18.9	10.5	14.3	9.0	8.8	2.7	6.8	6.1	9.3	5.2	9.7	9.3	19.1	7.6	7.1	5.9	11.9	6.5	8.1	15.0	13.3	10.1	4.2	13.4	4.9	6.7	6.3	17.9	8.6	11.5	12.1	6.8	20.6	10.5	12.0	10.4	9.6	14.3	6.9	2.9	17.6	12.4	6.0	8.7	12.5	7.8	49.2	7.3	7.0	9.9	8.9	11.1	7.8	7.1	8.9	14.1	12.7	2.1	7.4	13.0	12.5	9.1	7.9	7.1	6.0	8.0	5.5	9.2	9.0	6.2	13.0	5.8	7.9	10.8	8.8	12.7	4.8	8.7	6.4	2.5	6.7	2.7	9.3	6.8	6.5	7.5	5.8	6.5	7.4	9.0	5.9	5.7	2.3	6.1	3.8	8.8	6.7	5.2	12.1	17.4	17.2	17.1	12.7	5.5	18.7	6.5	16.2	16.9	0.0	1.6	4.7	2.3	1.5	4.5	0.0	12.7	5.3	1.2	3.5	9.8	4.1	1.7	4.1	0.9	2.5	4.1	0.0	3.7	3.0	2.8	3.6	1.1	4.4	3.5	1.6	4.6	7.4	3.7	1.1	9.8	2.7	5.0	2.8	3.9	2.4	5.2	3.5	7.1	2.2	5.3	6.5	1.4	5.4	4.7	1.4	3.3	5.7	5.6	2.5
TOPORS	"LUN, RP31, TP53BPL"	ENSG00000197579	"TOP1 binding arginine/serine rich protein"	Q9NS56	9	32540544-32552553	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"DNA damage, Ubl conjugation pathway"	Transferase	"Retinitis pigmentosa"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Early spermatids: 148.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"neutrophil: 33.4"	"Lineage enriched"	"Detected in all"	5	"granulocytes: 33.4"	"Cell line enhanced"	"Detected in all"		"HEL: 45.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA060640, HPA065661"	Supported		Supported	Nucleoplasm		NA	NA			Nucleoplasm		"HPA060640: AB_2684334, HPA065661: AB_2685527"	"unprognostic (1.75e-1)"	"unprognostic (1.73e-1)"	"unprognostic (1.20e-2)"	"unprognostic (1.14e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.45e-1)"	"unprognostic (1.37e-2)"	"unprognostic (9.94e-2)"	"prognostic favorable (7.07e-4)"	"unprognostic (2.70e-1)"	"unprognostic (3.61e-1)"	"prognostic favorable (6.64e-6)"	"unprognostic (1.22e-1)"	"unprognostic (5.95e-2)"	"unprognostic (3.13e-1)"	"unprognostic (2.92e-1)"	16.0	12.5	12.7	8.5	16.0	22.9	13.7	18.6	15.1	14.0	12.2	9.6	9.5	8.8	12.9	11.4	13.1	10.5	11.7	9.3	15.9	9.6	14.6	17.4	10.6	10.0	20.1	5.2	17.5	13.2	19.6	19.5	17.9	14.8	13.1	10.3	9.2	11.0	10.8	10.9	10.2	16.8	12.3	17.8	12.4	10.7	18.9	15.0	15.5	15.6	9.8	10.5	16.3	16.0	5.2	4.9	33.4	5.9	7.1	7.4	3.4	8.2	7.6	10.5	9.2	12.9	11.7	6.7	10.5	9.9	8.7	10.2	4.7	4.2	13.4	6.1	10.5	7.7	5.5	12.4	11.9	12.3	11.1	6.8	45.2	13.3	5.9	8.0	12.8	12.5	9.4	13.4	12.6	8.9	10.9	10.6	10.2	7.8	7.0	14.2	4.4	11.4	23.6	14.0	6.1	7.8	11.8	9.4	6.0	11.7	8.7	5.2	8.4	10.5	5.7	6.8	12.4	5.8	7.3	11.1	9.6	9.8	5.0	7.7	4.9	7.8	14.5	8.9	7.4	4.3	14.6	4.9	10.0	5.0	4.6	5.4	4.6	5.4	5.8	4.9	5.2	7.4	7.2	33.4	7.1	5.9	4.0	6.3	3.4	12.7	16.0	18.6	15.1	15.9	9.6	20.1	5.2	14.8	15.0	50.6	20.6	26.5	37.9	41.9	48.4	16.8	28.1	18.7	38.7	24.4	35.3	25.9	16.6	21.0	148.7	37.9	22.0	0.0	16.2	14.5	27.8	32.6	40.5	20.2	15.7	52.4	44.0	22.1	16.6	13.0	30.8	27.2	18.6	27.9	18.4	48.5	18.7	22.9	30.8	19.1	38.4	19.4	37.1	51.9	49.7	41.7	42.4	34.1	19.0	41.6
TP53RK	"BUD32, C20orf64, dJ101A2.2, Nori-2p, prpk"	ENSG00000172315	"TP53 regulating kinase"	Q96S44	20	46684365-46689779	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"tRNA processing"	"Hydrolase, Kinase, Serine/threonine-protein kinase, Transferase"	"Disease mutation, Epilepsy, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"Early spermatids: 176.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HMC-1: 70.6"					"Low region specificity"	"Detected in all"			"CAB004688, HPA015837"	Approved					NA	NA					"CAB004688: AB_426116, HPA015837: AB_1855776"	"unprognostic (9.45e-2)"	"unprognostic (3.73e-1)"	"unprognostic (9.76e-2)"	"prognostic unfavorable (6.70e-5)"	"unprognostic (4.41e-2)"	"unprognostic (2.63e-1)"	"prognostic unfavorable (6.27e-5)"	"unprognostic (9.16e-3)"	"unprognostic (6.11e-2)"	"unprognostic (2.10e-1)"	"unprognostic (2.36e-1)"	"unprognostic (5.72e-2)"	"unprognostic (1.25e-2)"	"unprognostic (3.37e-2)"	"unprognostic (1.75e-1)"	"unprognostic (1.59e-1)"	"unprognostic (1.74e-2)"	11.2	14.5	12.7	12.6	15.3	9.6	16.8	8.1	20.3	14.1	11.7	13.7	5.3	8.8	14.8	8.9	16.9	12.2	12.6	9.9	12.1	11.3	12.7	13.6	10.6	18.2	13.1	12.8	15.3	10.1	11.8	15.7	14.9	12.1	15.5	11.4	12.6	13.8	12.2	12.4	16.8	11.2	12.7	10.6	13.2	13.3	26.4	11.8	21.9	16.6	13.1	21.1	14.3	12.7	14.7	19.1	21.7	12.4	16.2	18.5	12.2	4.0	2.8	5.9	5.2	6.3	5.2	5.4	5.7	5.3	7.5	5.5	7.9	2.6	9.7	8.6	4.7	6.8	6.3	7.5	6.5	6.6	2.4	3.8	9.8	2.8	7.0	8.3	6.3	70.6	6.9	8.0	5.2	5.2	3.5	4.9	4.1	6.6	4.3	6.4	6.0	9.5	10.5	4.8	5.8	9.4	5.6	5.3	5.7	5.0	4.4	7.1	3.7	6.9	13.9	27.6	3.2	5.0	7.0	5.0	8.8	5.1	5.7	6.3	4.7	5.8	7.7	5.1	4.8	4.1	21.7	12.4	20.6	13.7	11.5	15.8	14.7	14.8	15.6	12.6	14.2	16.4	14.0	2.0	16.2	10.2	19.1	18.5	12.2	12.7	15.3	8.1	20.3	12.1	11.3	13.1	12.8	12.1	11.8	8.9	12.5	16.4	45.5	45.1	8.7	5.7	12.7	5.3	10.3	8.7	11.8	36.5	23.2	24.6	176.8	13.1	10.9	0.0	20.7	62.1	26.2	45.0	23.0	12.1	23.0	14.3	12.6	12.3	13.1	26.3	20.4	12.4	35.4	20.8	14.8	8.0	29.4	3.5	15.2	25.4	9.8	6.5	23.7	35.2	15.3	54.1	74.1	17.5	12.3	49.2
TPH1	"TPH, TPRH"	ENSG00000129167	"Tryptophan hydroxylase 1"	P17752	11	18017564-18042426	"Enzymes, FDA approved drug targets, Predicted intracellular proteins"	"Serotonin biosynthesis"	"Monooxygenase, Oxidoreductase"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"brain: 4.2;intestine: 16.2;pituitary gland: 5.4;stomach 1: 13.3"	"Cell type enriched"	"Detected in many"	164	"Intestinal endocrine cells: 1412.4"	"Low cancer specificity"	"Detected in some"			"Region enriched"	"Detected in single"	6	"cerebral cortex: 4.2"	"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HL-60: 4.5"	"Low region specificity"	"Detected in some"							"CAB010767, HPA022483"	Approved		Uncertain	Cytosol		NA	NA			Cytosol		"CAB010767: AB_261587, HPA022483: AB_1858378"	"unprognostic (2.14e-4)"	"unprognostic (9.97e-2)"	"unprognostic (6.92e-2)"	"unprognostic (6.78e-2)"	"unprognostic (1.55e-1)"	"unprognostic (6.26e-5)"	"unprognostic (1.73e-1)"	"unprognostic (5.33e-2)"	"unprognostic (1.60e-1)"	"unprognostic (2.12e-2)"	"unprognostic (1.19e-4)"	"unprognostic (6.72e-2)"	"unprognostic (5.40e-8)"	"unprognostic (3.76e-2)"	"unprognostic (7.42e-2)"	"unprognostic (3.10e-1)"	"unprognostic (2.46e-5)"	0.7	0.0	0.7	0.7	0.7	0.6	0.9	0.7	4.2	0.7	7.1	0.7	0.7	8.2	0.7	0.7	0.7	1.5	0.7	0.7	0.7	0.3	0.7	0.7	0.7	0.7	0.7	0.7	1.0	0.7	0.0	5.4	0.7	0.7	1.3	16.2	0.7	0.7	0.7	0.7	1.0	9.1	0.7	0.7	1.0	13.3	0.9	0.7	0.7	0.7	0.7	0.7	0.7	0.7	1.4	0.8	1.5	0.5	0.9	1.6	0.2	0.4	0.1	1.7	1.5	0.1	0.0	0.6	0.6	0.5	0.2	1.1	1.8	0.3	1.4	0.3	0.0	0.1	0.6	0.4	1.5	0.7	1.3	3.1	2.2	0.8	3.5	0.0	4.5	1.2	0.0	1.8	0.2	0.6	0.3	0.7	2.7	0.9	0.8	0.1	0.5	1.0	0.7	0.5	0.1	0.3	1.7	0.3	0.0	0.0	1.0	1.3	0.9	0.2	0.4	0.9	0.2	0.3	2.9	0.2	0.4	1.3	0.5	1.7	0.2	0.3	1.1	0.2	1.0	1.4	1.5	0.4	0.4	1.6	0.2	0.8	0.5	0.5	0.4	0.1	1.4	0.6	0.6	1.5	0.9	0.5	0.8	0.6	0.2	0.7	0.7	0.7	4.2	0.7	0.3	0.7	0.7	0.7	0.7	0.0	0.0	0.0	0.4	0.3	4.7	0.4	0.0	1.4	0.0	5.2	2.0	0.2	0.0	0.2	0.7	0.3	1.0	0.0	0.5	0.0	0.7	2.0	0.0	0.0	0.2	1.6	1412.4	0.0	0.0	0.4	0.9	0.9	0.0	0.0	2.8	1.5	0.4	8.6	1.1	0.2	6.0	6.5	1.0	2.7	3.4	1.3	0.0	0.5	1.7	0.0
TPH2	"FLJ37295, NTPH"	ENSG00000139287	"Tryptophan hydroxylase 2"	Q8IWU9	12	71938846-72186618	"Disease related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins"	"Serotonin biosynthesis"	"Monooxygenase, Oxidoreductase"	"Disease mutation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	14	"brain: 46.2"	"Group enriched"	"Detected in some"	4	"Early spermatids: 5.6;Late spermatids: 4.5"	"Not detected"	"Not detected"			"Region enriched"	"Detected in many"	15	"pons and medulla: 46.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	8	"EFO-21: 2.9;NTERA-2: 3.1;SCLC-21H: 1.5;SuSa: 1.0"	"Group enriched"	"Detected in some"	32	"midbrain: 127.6;pons and medulla: 36.3"	"Group enriched"	"Detected in some"	10	"midbrain: 95.6;pons and medulla: 91.5"	CAB078198	Enhanced					NA	NA					"CAB078198: AB_2665804"	"unprognostic (1.19e-1)"	"unprognostic (6.01e-1)"		"unprognostic (3.46e-2)"	"unprognostic (2.31e-1)"				"unprognostic (5.91e-2)"	"unprognostic (2.02e-1)"	"unprognostic (5.01e-2)"			"unprognostic (7.32e-2)"	"unprognostic (1.34e-1)"			0.1	0.2	0.4	0.3	0.5	0.1	0.1	0.3	4.4	0.1	0.2	0.0	0.0	0.1	0.1	0.1	0.1	0.2	0.2	0.2	3.0	1.5	0.1	0.3	0.1	0.1	0.9	0.0	0.1	1.7	0.1	3.2	0.1	46.2	0.1	0.1	0.0	0.1	0.3	0.1	0.1	0.1	0.2	0.3	0.1	0.1	1.0	0.0	0.0	0.2	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.9	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	3.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.5	0.0	0.0	0.2	0.0	1.0	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.4	0.5	0.3	1.4	3.0	1.5	0.9	0.0	46.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	1.2	0.0	0.0	0.0	0.0	0.1
TPI1		ENSG00000111669	"Triosephosphate isomerase 1"	P60174	12	6867119-6870948	"Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Gluconeogenesis, Glycolysis"	"Isomerase, Lyase"	"Cancer-related genes, Disease mutation, Hereditary hemolytic anemia"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 234.8;skeletal muscle: 211.0"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA050924, HPA053568"	Uncertain		Approved	Nucleoplasm,Vesicles		NA	NA		270000000	Nucleoplasm	Vesicles	"HPA050924: AB_2681276, HPA053568: AB_2682193"	"unprognostic (2.85e-1)"	"unprognostic (5.58e-3)"	"unprognostic (1.65e-1)"	"unprognostic (1.62e-2)"	"unprognostic (6.94e-2)"	"unprognostic (2.31e-2)"	"prognostic unfavorable (1.04e-5)"	"unprognostic (4.14e-3)"	"unprognostic (7.49e-2)"	"unprognostic (2.13e-2)"	"unprognostic (2.11e-2)"	"unprognostic (1.63e-1)"	"prognostic unfavorable (6.54e-4)"	"unprognostic (7.04e-2)"	"unprognostic (1.82e-1)"	"unprognostic (1.53e-1)"	"unprognostic (1.11e-2)"	20.2	41.2	41.2	24.3	46.9	27.4	83.4	93.2	196.1	27.1	39.1	12.8	18.6	40.1	17.2	22.6	51.0	22.1	33.3	94.9	36.7	33.1	43.1	40.8	48.8	140.2	34.0	34.6	19.9	87.0	32.1	16.8	27.1	70.7	19.0	43.5	21.1	26.0	28.7	211.0	25.8	37.8	29.4	20.8	20.1	21.6	15.7	19.4	14.2	20.2	38.4	38.0	23.0	28.0	55.4	170.3	145.5	148.2	81.2	67.1	234.8	115.0	103.1	54.7	84.5	53.6	56.6	96.6	83.3	92.0	157.5	191.0	106.5	63.3	67.6	16.8	82.2	81.5	57.3	130.0	139.2	174.7	89.1	96.8	87.5	75.6	70.2	39.9	99.6	71.9	61.4	58.1	121.4	104.7	221.1	95.7	34.4	45.2	26.0	120.8	84.7	52.3	84.2	134.8	98.1	65.8	30.7	90.0	69.3	98.6	82.2	38.9	64.8	72.7	75.6	40.3	119.8	17.3	74.9	59.1	84.5	72.3	54.6	122.1	50.8	20.8	100.9	169.5	62.0	60.6	87.7	146.1	145.5	56.1	148.2	57.0	55.4	56.5	54.5	170.3	44.3	39.9	49.3	61.1	81.2	127.8	30.7	67.1	234.8	41.2	46.9	93.2	196.1	36.7	33.1	34.0	34.6	70.7	19.4	125.0	186.6	268.1	429.8	608.3	247.2	505.0	410.2	145.9	159.3	369.9	104.1	935.0	1278.3	1116.4	147.7	369.6	973.7	70.0	686.0	1611.5	538.5	310.9	357.6	425.4	827.4	281.3	408.6	284.8	382.5	523.4	258.3	552.8	639.4	1545.5	419.4	603.3	953.1	852.2	247.5	1236.2	208.3	194.1	473.8	15.1	66.8	538.4	1279.9	363.9	717.3	571.4
TPK1	"HTPK1, PP20"	ENSG00000196511	"Thiamin pyrophosphokinase 1"	Q9H3S4	7	144451941-144836395	"Disease related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins"		"Kinase, Transferase"	"Disease mutation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	8	"Early spermatids: 70.4;Late spermatids: 75.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"AN3-CA: 27.3;CACO-2: 6.5;EFO-21: 8.3;TIME: 6.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021545, HPA021849"	Approved		Approved	Vesicles		NA	NA		78000	Vesicles		"HPA021545: AB_1858209, HPA021849: AB_1858210"	"unprognostic (4.05e-2)"	"unprognostic (3.28e-2)"	"unprognostic (2.38e-2)"	"unprognostic (3.32e-2)"	"unprognostic (2.42e-1)"	"unprognostic (1.63e-1)"	"unprognostic (7.62e-2)"	"unprognostic (6.08e-2)"	"unprognostic (2.37e-1)"	"unprognostic (1.68e-1)"	"unprognostic (3.76e-2)"	"unprognostic (6.06e-2)"	"unprognostic (1.45e-3)"	"unprognostic (3.15e-1)"	"unprognostic (2.87e-1)"	"unprognostic (1.59e-1)"	"unprognostic (9.22e-3)"	12.2	7.4	5.1	9.6	4.7	3.6	7.6	4.0	7.2	4.3	8.4	4.2	2.4	18.2	5.1	5.0	3.3	3.9	5.4	6.4	5.6	6.6	6.0	6.2	8.8	23.3	4.9	3.1	4.4	3.3	3.6	4.6	7.0	4.4	3.7	8.5	8.9	7.1	4.1	3.0	2.9	13.9	5.1	6.0	15.1	4.0	5.9	2.0	5.1	4.9	4.1	14.2	5.5	3.3	5.4	9.6	3.4	7.4	4.0	5.5	3.8	0.2	0.2	0.3	27.3	0.2	0.2	2.2	0.1	0.1	0.0	0.0	6.5	1.1	0.4	8.3	0.4	0.5	0.0	0.5	0.3	0.2	1.6	0.4	0.1	0.1	0.1	0.7	2.0	0.6	0.5	0.5	0.3	0.4	0.7	5.2	1.0	0.5	1.2	0.1	0.8	0.6	3.0	0.7	0.8	2.3	0.2	0.6	0.9	4.2	2.4	0.2	0.0	0.4	0.0	0.5	0.5	0.3	3.9	6.2	0.3	0.7	0.5	0.3	0.6	1.5	0.6	0.9	5.2	0.2	0.3	7.3	0.2	3.9	5.3	4.0	5.0	4.4	3.5	9.6	5.4	5.2	4.2	3.4	4.0	7.4	2.3	5.5	3.8	5.1	4.7	4.0	7.2	5.6	6.6	4.9	3.1	4.4	2.0	8.9	3.2	15.9	2.3	2.1	3.2	4.5	10.2	2.7	0.0	3.5	7.9	35.1	16.6	4.2	70.4	7.7	15.5	0.0	5.7	11.9	5.3	2.4	7.0	3.9	14.8	1.6	1.2	6.7	13.9	75.1	4.6	16.2	8.5	7.2	4.3	2.4	6.9	7.4	1.1	6.9	4.5	0.0	3.4	7.9	11.8	1.5	26.8	6.4	6.3	3.6
TPMT		ENSG00000137364	"Thiopurine S-methyltransferase"	P51580	6	18128311-18155074	"Enzymes, FDA approved drug targets, Predicted intracellular proteins"		"Methyltransferase, Transferase"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"thyroid gland: 48.2"	"Cell type enhanced"	"Detected in many"	8	"Proximal tubular cells: 230.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019851, HPA062364"	Enhanced					NA	NA					"HPA019851: AB_1858213, HPA062364: "	"unprognostic (6.24e-2)"	"unprognostic (3.16e-2)"	"unprognostic (5.46e-3)"	"prognostic unfavorable (8.45e-5)"	"unprognostic (4.98e-2)"	"unprognostic (2.25e-1)"	"unprognostic (8.16e-2)"	"unprognostic (4.36e-3)"	"unprognostic (9.62e-2)"	"prognostic favorable (1.41e-4)"	"unprognostic (4.49e-2)"	"unprognostic (3.40e-2)"	"prognostic favorable (1.10e-4)"	"unprognostic (7.56e-2)"	"unprognostic (1.31e-1)"	"unprognostic (1.07e-1)"	"unprognostic (8.39e-3)"	5.3	13.2	11.5	6.6	10.2	4.9	5.6	13.1	14.3	4.6	18.2	4.1	6.2	18.4	6.5	10.1	8.9	4.1	7.6	6.5	9.0	8.0	40.2	36.2	6.5	6.2	9.3	7.5	3.8	9.4	12.9	11.6	3.3	8.5	6.2	19.4	6.9	12.9	7.2	7.0	5.7	29.4	6.2	7.2	9.4	6.6	4.1	7.5	5.4	48.2	6.3	5.3	6.4	5.6	1.6	16.9	3.7	23.8	5.4	8.3	8.3	11.9	3.6	4.1	10.0	6.7	13.1	10.0	13.9	15.5	11.9	18.6	8.4	3.0	1.5	10.4	18.3	9.2	6.0	5.7	10.0	19.9	7.9	8.2	9.9	6.2	12.3	7.4	4.5	8.9	7.5	10.8	13.3	8.5	7.8	16.5	6.8	19.5	2.9	8.6	5.5	4.6	6.2	6.7	16.6	10.5	5.8	10.0	6.7	13.8	12.3	6.6	5.1	9.1	16.2	17.8	10.6	11.7	4.5	7.0	27.4	5.3	14.3	19.7	4.1	18.5	3.9	9.8	6.2	27.4	3.4	12.0	3.7	6.5	23.8	8.3	1.5	5.3	6.2	16.9	1.6	4.8	6.5	1.2	5.4	19.6	3.7	8.2	8.3	11.5	10.2	13.1	14.3	9.0	8.0	9.3	7.5	8.5	7.5	14.9	13.3	18.0	32.1	37.9	15.1	15.4	22.9	4.0	6.8	33.2	21.6	17.3	97.8	34.1	1.2	11.7	80.0	0.0	32.7	21.7	11.7	34.2	23.0	79.7	40.7	6.4	23.1	12.3	34.5	1.5	3.7	56.7	23.6	19.8	31.8	22.9	51.4	78.6	9.6	230.3	16.8	0.0	14.7	0.4	8.1	30.2	14.6	23.5	36.6	71.2
TPO	TPX	ENSG00000115705	"Thyroid peroxidase"	P07202	2	1374223-1543711	"Disease related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Hydrogen peroxide, Thyroid hormones biosynthesis"	"Oxidoreductase, Peroxidase"	"Congenital hypothyroidism, Disease mutation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	58	"thyroid gland: 411.3"	"Group enriched"	"Detected in some"	5	"Cardiomyocytes: 2.2;Early spermatids: 3.0;Endothelial cells: 1.1;Late spermatids: 3.8;Peritubular cells: 3.5"	"Cancer enriched"	"Detected in some"	364	"thyroid cancer: 188.3"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	13	"memory CD4 T-cell: 5.1;T-reg: 3.0"	"Lineage enriched"	"Detected in single"	21	"T-cells: 5.1"	"Group enriched"	"Detected in some"	5	"Karpas-707: 14.3;RPMI-8226: 6.0"	"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			"HPA007987, CAB009587"	Enhanced				"Intracellular and membrane"	NA	NA					"CAB009587: , HPA007987: AB_1080270"	"unprognostic (1.55e-1)"	"unprognostic (1.04e-1)"	"unprognostic (2.88e-1)"	"unprognostic (1.77e-2)"	"unprognostic (3.56e-2)"	"unprognostic (9.11e-2)"	"unprognostic (2.24e-2)"	"unprognostic (1.85e-1)"	"unprognostic (1.32e-1)"	"unprognostic (1.19e-4)"	"unprognostic (2.61e-2)"	"unprognostic (3.29e-1)"	"unprognostic (5.44e-4)"	"unprognostic (1.21e-1)"	"unprognostic (3.73e-2)"	"unprognostic (4.98e-3)"	"unprognostic (7.10e-3)"	1.1	0.0	0.1	0.1	0.1	0.0	0.9	0.1	0.1	0.1	0.3	0.1	0.1	0.0	0.1	0.1	0.1	0.0	0.4	1.0	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	1.2	0.1	0.5	0.0	0.2	0.1	0.1	7.1	0.2	0.1	0.1	0.1	411.3	0.1	0.1	0.1	0.1	0.1	0.0	0.2	0.0	0.0	5.1	0.9	0.1	0.1	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	14.3	0.0	1.4	0.0	0.0	0.1	0.0	0.2	0.0	0.0	6.0	0.0	0.0	0.0	0.1	0.0	2.1	0.0	0.1	1.1	0.0	0.1	0.1	0.0	0.1	0.0	0.1	0.3	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	5.1	0.3	0.0	0.1	0.0	0.3	0.2	0.0	0.0	0.0	3.0	0.9	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.8	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0
TPP1	"CLN2, SCAR7"	ENSG00000166340	"Tripeptidyl peptidase 1"	O14773	11	6612763-6619485	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		"Hydrolase, Protease, Serine protease"	"Disease mutation, Epilepsy, Neurodegeneration, Neuronal ceroid lipofuscinosis, Spinocerebellar ataxia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"Hofbauer cells: 223.6;Kupffer cells: 312.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037709, HPA044868"	Enhanced				"Intracellular and membrane"	NA	NA		13000000			"HPA037709: AB_10672913, HPA044868: AB_2679122"	"unprognostic (8.27e-3)"	"unprognostic (5.85e-2)"	"unprognostic (7.12e-3)"	"unprognostic (3.34e-3)"	"unprognostic (1.56e-2)"	"prognostic unfavorable (4.31e-4)"	"prognostic unfavorable (1.11e-4)"	"unprognostic (6.32e-2)"	"unprognostic (3.01e-1)"	"unprognostic (2.39e-2)"	"unprognostic (1.31e-1)"	"unprognostic (6.54e-2)"	"unprognostic (6.23e-2)"	"prognostic unfavorable (4.46e-4)"	"unprognostic (3.87e-2)"	"unprognostic (2.59e-1)"	"unprognostic (1.12e-2)"	37.4	64.6	32.2	28.8	36.2	43.0	23.1	15.1	33.3	24.0	26.8	41.7	13.2	28.0	32.0	22.3	20.3	18.0	26.9	25.6	24.5	25.1	36.0	45.1	35.9	42.3	31.0	29.3	22.0	14.8	35.1	30.0	56.4	25.4	19.4	28.2	43.4	18.4	29.1	15.4	15.5	31.4	42.4	32.8	69.0	19.8	17.9	24.7	21.7	24.0	9.1	26.9	25.6	29.4	9.4	43.5	12.8	38.9	7.0	15.3	26.2	4.8	9.8	4.9	9.3	57.7	31.9	3.8	9.5	45.1	7.4	12.9	4.0	20.7	6.9	6.3	24.0	45.7	14.5	9.7	13.3	11.2	6.9	5.6	5.6	5.1	10.9	43.6	8.1	34.2	47.8	21.7	8.6	19.2	49.8	31.5	6.5	10.7	21.0	21.6	6.0	2.5	10.0	3.5	11.4	11.8	6.3	4.1	13.6	13.1	7.6	0.6	3.8	10.2	7.6	17.8	16.9	5.0	15.5	36.0	21.4	6.1	19.2	3.4	17.8	17.4	2.4	27.1	19.0	11.2	12.8	37.7	8.9	10.7	38.9	8.7	9.4	8.5	11.0	43.5	8.5	5.8	7.6	6.9	7.0	26.4	24.2	15.3	26.2	32.2	36.2	15.1	33.3	24.5	25.1	31.0	29.3	25.4	24.7	23.8	31.2	61.7	25.6	21.1	22.8	35.0	58.6	10.7	23.9	15.7	11.8	31.4	5.0	32.3	10.2	39.0	51.3	23.3	11.7	36.7	29.8	25.6	62.2	63.8	223.6	14.3	16.0	90.9	312.0	7.8	25.0	115.7	86.0	64.1	29.1	42.4	18.5	39.0	24.8	46.1	22.8	6.5	22.7	0.5	1.1	17.6	73.6	44.8	28.0	23.0
TPP2	TPPII	ENSG00000134900	"Tripeptidyl peptidase 2"	P29144	13	102597003-102679958	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Aminopeptidase, Hydrolase, Protease, Serine protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in all"	9	"Early spermatids: 628.9;Late spermatids: 647.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021069, HPA049630"	Approved		Supported	"Nuclear bodies,Cytosol"		NA	NA		410000	"Nuclear bodies, Cytosol"		"HPA021069: AB_1858344, HPA049630: AB_2680836"	"unprognostic (4.75e-2)"	"unprognostic (4.78e-2)"	"unprognostic (9.97e-2)"	"unprognostic (1.08e-1)"	"unprognostic (2.01e-2)"	"unprognostic (4.43e-2)"	"unprognostic (2.45e-2)"	"unprognostic (8.33e-3)"	"unprognostic (5.02e-2)"	"unprognostic (1.51e-1)"	"unprognostic (3.12e-1)"	"unprognostic (2.75e-3)"	"unprognostic (6.26e-2)"	"unprognostic (3.12e-1)"	"unprognostic (7.53e-2)"	"unprognostic (3.95e-2)"	"unprognostic (3.43e-3)"	19.9	12.4	10.8	21.4	14.5	24.7	18.1	23.1	18.4	16.8	14.7	12.2	50.3	13.1	20.0	21.8	14.4	16.7	13.5	17.0	11.7	9.7	12.9	22.8	18.4	32.8	11.7	13.8	21.6	16.3	15.7	15.7	19.2	15.3	13.9	21.0	12.9	15.6	34.5	35.7	14.1	17.4	19.2	13.4	20.7	15.4	34.5	14.0	23.8	21.9	16.0	19.7	17.0	16.0	6.0	5.8	9.2	6.9	10.9	12.1	4.7	16.2	6.5	18.9	16.1	12.8	17.7	13.5	16.6	12.2	10.7	13.4	13.8	21.9	17.9	5.7	13.4	12.1	16.0	14.6	11.7	19.4	12.4	13.0	34.0	17.1	11.0	10.8	38.4	20.7	13.7	5.3	12.0	16.1	11.5	15.3	17.5	20.2	20.0	15.1	5.1	17.6	28.8	15.3	21.0	9.1	19.6	14.3	16.1	13.9	13.4	17.6	14.4	10.4	17.4	7.4	15.4	10.0	43.1	12.2	10.2	7.4	6.5	13.8	19.7	23.8	15.6	17.0	27.7	13.1	9.2	6.0	4.0	9.1	6.9	10.7	6.0	10.3	10.1	5.8	5.5	12.1	11.5	1.3	10.9	5.7	4.6	10.9	4.7	10.8	14.5	23.1	18.4	11.7	9.7	11.7	13.8	15.3	14.0	35.7	35.3	24.4	13.2	13.7	25.9	36.2	7.6	50.9	23.9	14.0	68.7	24.1	8.3	16.1	628.9	16.1	9.5	23.3	7.5	23.0	16.0	13.4	37.0	19.2	27.1	7.9	19.0	25.2	21.0	647.3	29.7	22.2	16.9	16.2	16.9	12.9	12.1	15.3	17.7	11.2	44.7	25.8	17.5	51.0	29.6	11.7	27.7	27.7	18.3	16.5
TPSAB1	"TPS1, TPS2, TPSB1"	ENSG00000172236	"Tryptase alpha/beta 1"	Q15661	16	1240696-1242554	"Enzymes, Predicted intracellular proteins, Predicted secreted proteins"		"Hydrolase, Protease, Serine protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Low tissue specificity"	"Detected in many"			"Cell type enriched"	"Detected in many"	24	"granulocytes: 5492.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in single"	308	"basophil: 30.8"	"Lineage enriched"	"Detected in single"	308	"granulocytes: 30.8"	"Cell line enriched"	"Detected in some"	173	"HMC-1: 301.2"									"CAB016369, CAB022175, HPA049153, HPA049554"	Supported				"Secreted to blood"	NA	NA					"CAB016369: AB_628406, CAB022175: , HPA049153: AB_2680656, HPA049554: AB_2680815"	"unprognostic (2.06e-2)"	"unprognostic (5.14e-2)"	"unprognostic (2.02e-3)"	"unprognostic (1.64e-2)"	"unprognostic (9.31e-3)"	"prognostic favorable (9.62e-6)"	"unprognostic (1.02e-1)"	"unprognostic (4.08e-2)"	"unprognostic (1.80e-1)"	"unprognostic (1.43e-1)"	"unprognostic (2.24e-1)"	"unprognostic (2.83e-2)"	"unprognostic (4.13e-2)"	"unprognostic (2.23e-1)"	"unprognostic (2.81e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.36e-2)"	22.4	0.2	1.6	5.8	1.6	0.0	10.6	1.6	1.6	13.9	17.1	1.6	1.6	17.7	18.7	10.4	15.2	6.1	33.1	4.7	1.6	0.0	4.4	2.8	29.2	16.8	1.6	1.6	2.9	4.5	0.0	1.6	1.9	1.6	24.1	10.0	5.1	14.6	6.3	3.6	29.9	31.0	15.0	1.6	1.6	24.5	5.1	1.6	3.1	3.7	3.8	6.9	21.6	16.0	0.0	0.0	30.8	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.1	301.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	1.6	0.1	30.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	1.6	1.6	1.6	1.6	1.6	0.0	1.6	1.6	1.6	1.6	23.8	231.9	0.0	1.4	16.6	0.0	0.2	0.0	9.4	14.8	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.5	0.0	0.0	0.1	17.1	2.5	5492.7	0.0	5.5	0.0	0.0	0.0	0.3	0.0	0.0	9.0	18.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.2	0.0	0.1	8.7	0.2	1.0	0.0	5.6
TPSB2		ENSG00000197253	"Tryptase beta 2 (gene/pseudogene)"	P20231	16	1227272-1230184	"Enzymes, Predicted secreted proteins"		"Hydrolase, Protease, Serine protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"gallbladder: 16.2"	"Cell type enriched"	"Detected in some"	18	"granulocytes: 8345.3"	"Low cancer specificity"	"Detected in many"							"Cell type enriched"	"Detected in single"	84	"basophil: 8.4"	"Lineage enriched"	"Detected in single"	84	"granulocytes: 8.4"	"Cell line enriched"	"Detected in some"	8	"HMC-1: 83.3"									"HPA049153, HPA049554"	Supported				"Secreted to blood"	NA	NA		7500000			"HPA049153: AB_2680656, HPA049554: AB_2680815"	"unprognostic (9.05e-2)"	"unprognostic (8.46e-3)"	"unprognostic (2.42e-3)"	"unprognostic (2.27e-2)"	"unprognostic (4.97e-3)"	"unprognostic (1.02e-3)"	"unprognostic (1.11e-1)"	"unprognostic (8.55e-2)"	"unprognostic (2.48e-1)"	"unprognostic (2.24e-1)"	"unprognostic (1.95e-1)"	"unprognostic (8.30e-3)"	"unprognostic (1.91e-2)"	"unprognostic (5.76e-2)"	"unprognostic (2.41e-2)"	"unprognostic (4.65e-2)"	"unprognostic (3.17e-2)"	1.8	0.0	0.9	1.9	0.9	0.0	4.1	0.9	0.9	8.8	5.3	0.9	0.9	4.9	2.9	0.9	7.7	0.1	16.2	0.9	0.9		0.9	0.9	12.3	2.4	0.9	0.9	0.9	1.3	0.0	0.9	0.9	0.9	2.7	2.3	0.9	6.2	1.2	0.9	3.4	9.7	4.4	0.9	0.9	13.6	0.9	0.9	0.9	0.9	0.9	0.9	4.2	0.9	0.0	0.0	8.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	10.7	0.0	0.0	0.0	0.1	83.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	1.2	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	8.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1											35.7	468.0	0.0	1.9	0.0	0.0	1.3	0.0	6.7	30.7	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.0	3.9	8345.3	0.0	4.1	0.0	0.0	0.0	0.0	0.6	0.0	0.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.1	0.0	0.0	4.6
TPSD1		ENSG00000095917	"Tryptase delta 1"	Q9BZJ3	16	1256059-1258998	"Enzymes, Predicted intracellular proteins"		"Hydrolase, Protease, Serine protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enriched"	"Detected in some"	17	"granulocytes: 189.2"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	65	"basophil: 6.4"	"Lineage enriched"	"Detected in single"	65	"granulocytes: 6.4"	"Group enriched"	"Detected in some"	48	"HEL: 18.7;HMC-1: 28.6"									"CAB002215, CAB032871, HPA040182, HPA049554"	Supported				"Intracellular and membrane"	NA	NA					"CAB002215: AB_563870, CAB032871: AB_2206475, HPA040182: AB_2676875, HPA049554: AB_2680815"	"unprognostic (5.99e-2)"	"unprognostic (3.00e-1)"	"unprognostic (1.38e-1)"	"unprognostic (1.04e-2)"	"unprognostic (8.97e-3)"	"unprognostic (1.15e-4)"	"unprognostic (1.70e-1)"	"unprognostic (5.45e-2)"	"unprognostic (9.00e-2)"	"unprognostic (2.88e-1)"	"unprognostic (4.30e-1)"	"unprognostic (2.94e-2)"	"unprognostic (2.50e-3)"	"unprognostic (3.74e-2)"	"unprognostic (4.14e-1)"	"unprognostic (3.89e-1)"	"unprognostic (7.46e-3)"	6.6	0.1	0.6	3.8	0.6	0.8	3.7	0.6	0.8	3.2	5.6	0.6	0.6	2.7	7.5	3.3	7.6	2.3	13.0	2.0	0.6	0.0	1.3	2.3	17.0	13.7	0.6	0.6	0.6	0.9	0.1	0.6	0.9	0.6	4.3	0.4	3.1	3.6	0.7	1.6	7.8	9.3	4.7	0.6	0.6	15.7	3.5	0.6	1.6	1.1	2.8	2.6	8.9	6.6	0.0	0.0	6.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	18.7	0.0	0.0	0.0	0.1	28.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.6	0.6	0.8	0.6	0.0	0.6	0.6	0.6	0.6	3.0	11.4	0.0	0.0	0.3	0.0	0.4	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	189.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
TPSG1	"PRSS31, TMT"	ENSG00000116176	"Tryptase gamma 1"	Q9NRR2	16	1221651-1225257	"Enzymes, Predicted membrane proteins"		"Hydrolase, Protease, Serine protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"intestine: 16.0"	"Cell type enriched"	"Detected in some"	6	"Mucus-secreting cells: 264.6"	"Cancer enhanced"	"Detected in many"		"colorectal cancer: 5.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	9	"HMC-1: 22.8;MCF7: 7.4"	"Not detected"	"Not detected"							HPA060458	Enhanced					NA	NA					"HPA060458: AB_2684283"	"unprognostic (1.86e-1)"	"unprognostic (3.46e-1)"	"unprognostic (5.21e-3)"	"unprognostic (1.27e-1)"	"unprognostic (5.58e-2)"	"unprognostic (1.18e-2)"	"unprognostic (3.45e-2)"	"unprognostic (4.60e-2)"	"unprognostic (9.97e-2)"	"unprognostic (1.34e-1)"	"unprognostic (8.92e-2)"	"unprognostic (6.39e-2)"	"prognostic unfavorable (1.76e-8)"	"unprognostic (2.19e-1)"	"unprognostic (1.70e-1)"	"unprognostic (8.65e-4)"	"unprognostic (5.70e-2)"	1.3	0.6	0.4	4.5	0.4	0.0	3.1	0.4	0.4	0.6	14.4	0.4	0.4	14.0	1.2	0.4	0.7	0.5	1.0	0.4	0.4	0.0	0.4	0.4	0.6	0.4	0.4	0.4	2.0	0.4	0.0	3.2	0.4	0.4	1.1	8.8	0.4	0.4	0.4	0.4	1.1	16.0	1.2	0.4	0.4	1.0	1.3	0.4	0.4	0.4	1.1	0.4	1.4	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	1.0	0.0	0.9	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	1.2	0.0	0.0	0.0	0.0	22.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.4	0.0	0.0	0.7	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.6	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.4	0.4	0.4	0.4	0.0	0.4	0.4	0.4	0.4	0.0	1.1	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.3	0.0	0.0	0.0	0.0	0.0	41.5	0.0	0.0	0.0	3.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	264.6	0.0	0.0	4.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	3.6	0.0
TPST1	TANGO13A	ENSG00000169902	"Tyrosylprotein sulfotransferase 1"	O60507	7	66205199-66420543	"Enzymes, Predicted intracellular proteins"		Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Fibroblasts: 72.5;Spermatocytes: 81.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"basophil: 21.3;neutrophil: 17.3"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA047415, HPA061837"	Approved		Supported	"Golgi apparatus"	"Intracellular and membrane"	NA	NA			"Golgi apparatus"		"HPA047415: AB_10964056, HPA061837: AB_2732672"	"unprognostic (7.46e-2)"	"unprognostic (1.45e-1)"	"unprognostic (8.62e-2)"	"unprognostic (3.43e-2)"	"unprognostic (3.52e-2)"	"unprognostic (1.78e-3)"	"unprognostic (5.71e-2)"	"unprognostic (8.21e-2)"	"unprognostic (3.59e-1)"	"unprognostic (9.25e-3)"	"unprognostic (4.12e-2)"	"unprognostic (4.98e-1)"	"prognostic unfavorable (8.16e-6)"	"prognostic unfavorable (8.78e-4)"	"unprognostic (2.48e-1)"	"unprognostic (1.74e-2)"	"prognostic unfavorable (3.73e-5)"	15.4	12.8	16.7	9.8	28.2	5.6	11.2	12.2	19.2	34.0	7.7	8.8	3.4	3.4	20.2	13.8	10.8	10.9	34.2	6.6	26.1	22.2	13.4	38.9	9.0	5.9	15.3	12.2	11.5	7.1	8.1	19.6	23.2	28.1	15.5	7.9	9.7	5.4	15.8	2.9	6.2	5.9	35.7	27.5	9.0	10.0	19.6	11.4	0.3	10.7	3.2	5.2	27.2	19.9	6.3	0.1	21.3	1.1	3.9	2.0	0.8	4.3	2.6	6.8	8.6	20.7	16.6	2.1	8.2	19.0	10.2	14.4	8.3	2.5	0.5	6.6	16.8	16.2	3.4	6.3	9.3	13.5	1.2	3.6	0.9	6.4	6.3	24.5	0.7	0.7	23.5	7.4	19.4	8.6	11.3	12.3	1.1	0.4	3.9	15.5	2.3	0.0	1.1	6.1	0.1	3.5	3.0	5.5	4.4	10.5	4.6	3.9	16.8	10.4	0.8	22.1	14.1	3.3	1.7	23.4	13.0	8.3	9.3	14.9	3.5	4.8	1.7	11.5	2.6	18.3	21.3	1.1	10.7	0.4	0.0	0.3	2.4	0.2	0.3	0.1	6.3	1.1	2.0	17.3	3.9	0.0	0.0	0.0	0.8	16.7	28.2	12.2	19.2	26.1	22.2	15.3	12.2	28.1	11.4	0.0	6.2	6.2	7.4	9.6	9.4	1.2	2.5	18.7	5.7	29.6	2.0	1.7	8.3	19.8	7.2	17.9	0.0	0.0	42.8	3.7	72.5	4.4	4.6	28.0	14.3	6.4	7.5	12.9	5.1	9.1	44.5	5.6	13.5	27.1	0.7	4.9	20.9	0.0	35.0	3.1	3.7	6.5	26.4	81.4	24.5	6.6	3.2	0.0	0.4	7.0
TPST2	TANGO13B	ENSG00000128294	"Tyrosylprotein sulfotransferase 2"	O60704	22	26521983-26596717	"Enzymes, Predicted intracellular proteins"		Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	4	"blood: 71.0;pancreas: 192.5"	"Cell type enhanced"	"Detected in many"	5	"Cytotrophoblasts: 157.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HMC-1: 57.1"	"Low region specificity"	"Detected in all"							HPA021054	Enhanced				"Intracellular and membrane"	NA	NA		33000			"HPA021054: AB_1858221"	"unprognostic (2.24e-1)"	"unprognostic (1.70e-1)"	"unprognostic (1.74e-2)"	"prognostic favorable (8.08e-5)"	"unprognostic (8.88e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.19e-2)"	"unprognostic (9.70e-2)"	"unprognostic (3.18e-2)"	"unprognostic (3.38e-1)"	"unprognostic (2.70e-1)"	"unprognostic (5.54e-2)"	"prognostic unfavorable (2.34e-6)"	"unprognostic (9.68e-2)"	"unprognostic (9.21e-3)"	"unprognostic (5.62e-2)"	"unprognostic (2.01e-1)"	5.8	8.4	4.7	3.7	3.6	5.2	9.0	2.1	6.9	4.6	2.9	3.0	7.4	3.5	4.7	31.8	4.5	4.1	3.2	5.2	5.2	3.2	5.7	20.0	10.7	4.8	3.7	3.6	2.4	192.5	1.1	2.9	11.0	3.2	3.8	2.3	4.0	2.8	7.9	8.6	4.0	3.1	3.2	2.8	8.9	3.0	4.8	3.1	3.0	12.2	2.2	5.2	4.5	6.7	4.3	20.0	71.0	15.1	57.2	46.4	35.2	4.3	3.2	4.2	2.1	8.9	6.9	5.8	9.8	17.6	8.0	7.3	2.1	2.2	7.4	2.6	17.5	4.2	6.8	3.1	6.7	4.6	3.0	5.9	17.8	2.0	4.4	3.7	2.0	57.1	7.4	10.8	8.0	2.7	8.1	14.7	3.4	17.8	23.2	6.1	4.9	8.2	13.9	5.5	3.4	3.2	7.7	5.6	20.5	2.4	4.9	3.1	2.2	4.5	4.0	5.4	6.4	1.8	8.5	11.6	9.9	22.4	8.0	9.4	7.5	10.4	7.1	7.5	8.0	8.9	71.0	13.4	18.6	46.4	14.5	13.0	4.1	10.9	34.5	8.4	4.3	5.4	31.4	28.4	57.2	15.1	20.0	12.2	35.2	4.7	3.6	2.1	6.9	5.2	3.2	3.7	3.6	3.2	3.1	14.9	13.0	19.3	70.7	33.9	7.0	10.6	38.2	13.4	4.5	21.0	5.9	157.8	23.2	11.5	8.4	57.7	7.8	0.0	56.2	41.8	11.9	27.5	49.9	68.4	105.1	6.4	0.0	93.9	52.0	2.6	4.9	37.1	27.0	10.8	9.2	2.0	65.3	10.5	3.9	7.6	4.3	6.5	17.3	2.9	16.6	31.5	119.6	57.3	12.3	71.9
TPTE	"CT44, PTEN2"	ENSG00000274391	"Transmembrane phosphatase with tensin homology"	P56180	21	10521553-10606140	"Enzymes, Plasma proteins, Predicted membrane proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	69	"testis: 78.6"	"Group enriched"	"Detected in some"	14	"Spermatocytes: 282.4;Spermatogonia: 73.0"	"Cancer enriched"	"Detected in single"	7	"testis cancer: 0.8"					"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 7.4;K-562: 8.6;Karpas-707: 7.0;MCF7: 5.1;PC-3: 5.2;RPMI-8226: 9.5;SuSa: 8.9;U-2 OS: 4.6;U-266/70: 8.5"									"HPA049690, HPA068342"	Enhanced		Approved	"Endoplasmic reticulum,Cytosol"		NA	NA			Cytosol	"Endoplasmic reticulum"	"HPA049690: AB_2680850, HPA068342: AB_2685976"															"unprognostic (3.63e-2)"			0.1	0.0	0.0	0.7	0.2	0.0	1.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.2	0.1	0.1	0.0	0.2	0.1	0.0		0.1	0.8	0.4	0.6	0.0	0.0	0.0	0.1	0.0	0.0	1.1	0.0	0.1	0.0	0.2	0.7	0.3	0.0	0.0	0.2	0.4	0.0	0.9	0.0	78.6	0.0	0.4	0.1	0.4	0.8	0.2	0.0	0.0	0.1	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.6	7.0	0.0	5.1	0.0	0.0	1.2	0.0	5.2	0.0	0.0	9.5	0.0	0.0	0.0	0.8	0.0	0.0	0.0	8.9	0.0	0.0	0.0	2.0	4.6	2.4	0.0	8.5	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	9.7	0.0	0.0	0.0	0.0	0.8	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	9.6	4.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.2	0.0	12.9	0.0	282.4	73.0	0.0	0.9	0.0	0.0	0.0
TPTE2	TPIP	ENSG00000132958	"Transmembrane phosphoinositide 3-phosphatase and tensin homolog 2"	Q6XPS3	13	19422877-19536762	"Enzymes, Plasma proteins, Predicted membrane proteins"		Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in some"	12	"testis: 12.3"	"Cell type enhanced"	"Detected in some"	23	"Collecting duct cells: 1.8;Early spermatids: 3.5;Spermatocytes: 9.3;Spermatogonia: 2.5"	"Cancer enriched"	"Detected in single"	6	"testis cancer: 0.8"					"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"HDLM-2: 10.1;Karpas-707: 2.9"									HPA068342			Approved	"Endoplasmic reticulum,Cytosol"		NA	NA			Cytosol	"Endoplasmic reticulum"	"HPA068342: AB_2685976"	"unprognostic (2.50e-1)"	"unprognostic (2.10e-1)"	"unprognostic (1.76e-1)"	"unprognostic (2.70e-1)"	"unprognostic (1.25e-2)"	"unprognostic (5.33e-3)"		"unprognostic (1.90e-1)"	"unprognostic (1.24e-1)"	"unprognostic (5.40e-2)"	"unprognostic (3.67e-2)"	"unprognostic (2.81e-1)"	"unprognostic (1.05e-12)"	"unprognostic (1.04e-1)"	"unprognostic (1.47e-1)"	"unprognostic (2.44e-1)"	"unprognostic (5.00e-3)"	0.0	0.1	0.4	0.2	1.0	0.0	0.1	0.7	0.8	0.0	0.1			0.4	0.0	0.3	0.0	0.0	0.0	0.0	0.3	0.7	0.0	0.0	0.0	0.3	0.4		0.0	0.0	0.0	0.1	0.1		0.0	0.1		0.2	0.2	0.0	0.0	0.1	0.0	0.2	0.2	0.2	12.3			0.0		0.6	0.0	0.0	0.5	0.4	0.0	0.1	0.5	0.7	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	10.1	0.0	0.1	0.0	0.0	0.6	0.0	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.6	0.1	2.9	0.0	0.3	0.3	0.1	0.0	0.0	0.1	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.2	0.0	1.4	0.0	0.0	0.1	0.0	0.0	1.3	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.4	0.5	0.0	0.0	0.0	0.5	0.1	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	3.5	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	1.3	0.3	0.0	0.3	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.2	0.0	0.3	9.3	2.5	0.1	0.1	0.0	0.0	0.0
TRAF2	"RNF117, TRAP3"	ENSG00000127191	"TNF receptor associated factor 2"	Q12933	9	136881912-136926607	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins"	"Apoptosis, Ubl conjugation pathway"	Transferase	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"monocytes: 55.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004603, HPA009972, HPA010634"	Uncertain		Enhanced	Cytosol		NA	NA			Cytosol		"CAB004603: AB_628389, HPA009972: AB_1080350, HPA010634: AB_1080347"	"unprognostic (7.77e-2)"	"unprognostic (4.54e-3)"	"prognostic unfavorable (9.32e-4)"	"unprognostic (1.15e-1)"	"unprognostic (1.11e-2)"	"unprognostic (1.45e-1)"	"prognostic unfavorable (3.06e-4)"	"unprognostic (4.91e-2)"	"unprognostic (7.23e-2)"	"unprognostic (4.28e-2)"	"unprognostic (7.39e-2)"	"unprognostic (2.82e-2)"	"prognostic unfavorable (2.09e-4)"	"unprognostic (1.80e-3)"	"unprognostic (5.52e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.53e-2)"	7.3	6.6	8.7	20.3	10.4	15.9	8.6	16.0	10.0	7.3	8.7	7.4	7.3	11.1	12.3	6.9	12.3	9.0	8.3	8.3	7.5	6.5	8.5	12.3	11.5	19.7	11.2	8.3	6.8	13.9	5.9	8.8	12.1	8.1	10.2	6.2	7.5	13.0	10.1	6.4	13.0	10.4	10.6	8.2	13.8	10.7	13.7	6.4	16.4	14.7	5.2	15.9	8.4	37.5	12.6	11.5	6.7	8.3	10.1	17.4	6.2	10.6	32.9	8.9	7.9	2.5	4.0	17.5	8.8	4.9	12.9	8.8	20.3	19.4	13.3	11.5	5.5	17.5	28.2	12.2	14.4	5.3	20.2	9.9	10.0	29.8	12.6	3.7	9.9	10.4	3.0	4.4	10.5	6.0	4.9	6.1	12.4	16.9	15.2	5.7	15.5	15.9	14.2	14.5	24.5	14.8	15.1	13.7	18.1	7.9	8.4	14.6	6.8	11.0	25.9	10.0	10.4	18.6	11.6	6.8	16.9	10.9	11.0	14.8	6.4	10.3	13.3	6.0	8.1	12.4	1.3	3.7	6.7	10.4	4.2	14.6	12.6	11.1	13.0	4.9	10.0	9.1	10.9	3.3	10.1	8.3	11.5	17.4	6.2	8.7	10.4	16.0	10.0	7.5	6.5	11.2	8.3	8.1	6.4	0.0	8.3	13.4	12.1	10.5	6.8	6.3	12.7	0.0	3.4	5.2	0.0	16.7	3.3	18.9	2.5	8.2	15.4	0.0	11.0	25.5	7.4	11.2	10.3	4.0	11.7	17.5	10.9	4.3	2.4	2.7	3.1	7.3	13.5	55.1	9.2	4.2	16.3	5.8	7.4	5.0	10.0	19.4	12.7	9.2	22.0	11.2	14.9	13.8	12.4	9.1
TRAF3	"CAP-1, CD40bp, CRAF1, LAP1, RNF118"	ENSG00000131323	"TNF receptor associated factor 3"	Q13114	14	102777476-102911500	"Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Apoptosis, Immunity, Ubl conjugation pathway"	Transferase	"Cancer-related genes, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA002933	Uncertain					NA	NA					"HPA002933: AB_1080352"	"unprognostic (4.06e-2)"	"unprognostic (1.75e-2)"	"unprognostic (2.08e-2)"	"unprognostic (4.49e-3)"	"unprognostic (5.25e-2)"	"unprognostic (4.17e-2)"	"prognostic unfavorable (1.02e-5)"	"unprognostic (1.31e-1)"	"unprognostic (7.24e-2)"	"unprognostic (1.16e-1)"	"prognostic favorable (2.42e-5)"	"unprognostic (1.29e-1)"	"unprognostic (2.29e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.71e-1)"	"unprognostic (3.13e-2)"	"unprognostic (2.12e-1)"	7.6	5.3	13.6	23.3	9.1	18.8	7.7	12.5	16.0	4.2	8.9	8.8	5.8	8.4	7.5	3.9	7.5	8.9	7.1	7.3	16.6	12.7	6.7	7.0	8.1	26.0	11.5	8.0	4.8	5.1	10.0	10.3	6.8	8.5	6.1	8.0	7.9	5.7	8.0	5.5	7.9	11.8	7.8	9.8	14.2	7.1	12.2	6.6	10.5	7.5	4.1	25.4	11.1	9.3	12.0	6.7	4.3	5.7	2.4	5.1	4.9	12.0	13.7	7.6	4.8	4.4	6.3	11.6	9.4	10.4	10.2	8.6	6.6	18.0	9.6	11.8	10.1	13.6	7.4	10.9	10.4	10.5	23.9	7.1	9.0	6.0	5.0	7.2	10.2	26.9	6.4	7.9	7.0	10.2	5.9	7.3	13.8	9.1	28.7	6.5	12.3	21.8	6.0	4.1	5.3	10.4	12.0	10.6	4.9	9.1	14.8	20.4	7.3	10.3	7.2	6.7	3.5	6.8	11.6	15.6	9.7	7.4	25.2	13.4	20.8	23.7	17.5	10.5	5.3	11.4	2.6	5.7	1.7	3.7	4.6	3.0	12.0	5.1	3.3	4.1	11.5	3.7	2.6	4.3	2.4	2.8	6.7	4.4	4.9	13.6	9.1	12.5	16.0	16.6	12.7	11.5	8.0	8.5	6.6	6.0	9.9	20.3	15.5	10.9	29.2	7.3	10.2	14.7	10.3	0.0	5.9	4.3	3.3	15.5	7.2	5.2	15.8	0.0	15.5	9.5	10.8	17.4	8.1	4.9	12.3	14.3	16.7	1.3	5.7	6.1	1.7	12.4	16.9	17.2	14.2	4.9	16.8	6.2	6.0	6.9	10.4	0.0	12.8	14.0	31.3	11.0	2.9	11.4	10.5	22.0
TRAF6	RNF85	ENSG00000175104	"TNF receptor associated factor 6"	Q9Y4K3	11	36487027-36510272	"Enzymes, Predicted intracellular proteins"	"DNA damage, Immunity, Osteogenesis, Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004605, HPA019805, HPA020599"	Approved		Uncertain	Nucleoli,Mitochondria		NA	NA			Mitochondria	Nucleoli	"CAB004605: AB_628391, HPA019805: AB_1858231, HPA020599: AB_1858232"	"unprognostic (2.48e-2)"	"unprognostic (1.38e-1)"	"unprognostic (2.83e-1)"	"unprognostic (8.73e-2)"	"unprognostic (1.71e-1)"	"unprognostic (1.55e-1)"	"unprognostic (2.43e-1)"	"unprognostic (2.10e-1)"	"unprognostic (1.40e-1)"	"unprognostic (1.21e-1)"	"unprognostic (1.16e-2)"	"unprognostic (9.22e-2)"	"prognostic favorable (1.36e-4)"	"unprognostic (2.82e-2)"	"unprognostic (1.20e-1)"	"unprognostic (3.92e-2)"	"unprognostic (1.07e-1)"	13.0	11.0	12.9	8.5	17.0	31.8	11.9	18.1	15.0	10.6	10.7	13.6	8.2	9.5	12.9	9.8	12.4	11.5	9.4	13.9	9.8	7.1	11.2	12.3	15.2	9.2	14.8	10.6	14.6	11.3	11.0	11.9	10.3	12.7	9.6	10.5	10.5	11.0	9.3	13.9	12.7	12.5	12.1	10.1	13.0	10.3	15.0	12.8	18.5	15.6	6.7	10.8	11.3	13.0	10.6	7.7	27.7	11.4	9.6	13.1	8.5	5.2	6.6	12.9	7.2	12.2	8.9	5.6	7.9	8.6	7.4	9.6	5.8	3.5	6.9	4.9	8.4	8.5	9.9	10.2	8.0	12.2	11.3	11.9	6.6	5.2	5.2	7.8	7.3	8.2	8.2	11.3	3.9	12.1	7.2	10.3	9.3	9.9	7.6	9.2	6.4	11.7	4.0	7.0	6.0	6.1	7.8	17.5	3.9	8.9	10.9	2.1	11.3	7.9	7.7	5.6	9.0	8.9	7.2	8.1	10.5	9.3	9.6	9.6	8.8	7.4	7.5	5.9	5.3	7.8	27.7	8.0	20.9	11.9	11.4	11.7	10.6	10.3	11.6	7.7	8.1	10.0	13.1	11.1	9.6	8.2	4.5	8.0	8.5	12.9	17.0	18.1	15.0	9.8	7.1	14.8	10.6	12.7	12.8	8.9	6.1	5.0	10.6	11.3	2.6	6.9	10.2	1.4	1.2	3.5	5.9	5.6	5.0	7.6	3.2	9.2	7.2	0.0	6.4	5.2	6.0	9.7	18.5	5.6	6.2	7.9	4.1	20.3	8.1	2.7	2.3	6.6	6.8	11.8	5.5	3.9	5.9	5.7	3.9	4.3	2.6	12.9	10.5	9.1	8.3	10.9	5.4	8.5	3.2	10.6
TRAF7	"DKFZp586I021, MGC7807, RFWD1, RNF119"	ENSG00000131653	"TNF receptor associated factor 7"	Q6Q0C0	16	2155698-2178129	"Cancer-related genes, Enzymes, Predicted intracellular proteins"	"Apoptosis, Transcription, Transcription regulation, Ubl conjugation pathway"	Transferase	"Cancer-related genes, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041229	Approved		Supported	"Vesicles,Plasma membrane"		NA	NA			Vesicles	"Plasma membrane"	"HPA041229: AB_10794194"	"unprognostic (1.94e-1)"	"unprognostic (5.97e-2)"	"unprognostic (1.13e-1)"	"unprognostic (4.23e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.65e-2)"	"unprognostic (2.77e-3)"	"unprognostic (7.08e-2)"	"unprognostic (3.52e-2)"	"unprognostic (1.52e-2)"	"unprognostic (1.08e-1)"	"unprognostic (9.23e-2)"	"unprognostic (6.07e-2)"	"unprognostic (2.99e-2)"	"unprognostic (2.43e-1)"	"unprognostic (8.48e-2)"	16.0	18.2	18.3	22.3	20.6	28.5	39.1	28.7	25.6	22.1	29.4	9.1	21.1	37.3	20.4	18.3	32.9	21.9	36.9	21.0	18.3	14.8	21.3	47.3	18.3	40.9	13.4	14.7	19.3	41.6	17.7	20.3	19.5	12.8	16.2	16.9	13.0	24.4	23.1	25.5	32.2	37.8	28.8	14.1	21.4	25.1	13.2	10.6	26.1	20.3	30.9	21.9	21.9	28.9	6.7	12.3	7.7	13.9	3.0	7.1	5.2	20.7	26.6	15.2	27.2	15.8	29.8	17.9	16.0	20.2	18.9	17.1	32.3	26.8	13.3	19.0	20.4	12.1	24.4	14.2	28.4	7.2	21.0	18.2	19.0	35.4	24.7	20.9	20.2	27.6	29.5	23.8	18.2	23.9	15.6	36.5	26.4	20.3	18.0	18.0	47.5	20.7	23.5	29.9	28.7	13.0	38.7	25.3	26.7	15.2	11.2	30.7	25.5	13.4	25.8	17.5	8.3	29.3	24.9	27.5	23.0	32.4	21.4	17.4	26.1	19.3	17.6	13.1	13.1	17.8	3.7	10.0	7.7	5.4	13.9	5.0	6.7	5.3	5.7	12.3	4.9	3.8	4.5	6.9	3.0	9.4	6.0	7.1	5.2	18.3	20.6	28.7	25.6	18.3	14.8	13.4	14.7	12.8	10.6	0.0	8.6	11.9	15.5	25.5	14.6	3.4	17.8	4.0	4.5	14.0	5.9	20.5	14.9	35.4	3.8	23.9	60.0	0.0	51.6	30.1	20.0	27.8	9.2	26.1	37.6	35.0	32.6	23.4	38.3	9.1	23.0	18.8	10.1	35.1	35.9	10.5	45.1	40.3	20.8	18.9	8.9	6.5	16.0	4.8	21.5	28.4	22.3	12.9	33.8	29.6
TRAIP	"RNF206, TRIP"	ENSG00000183763	"TRAF interacting protein"	Q9BWF2	3	49828599-49856574	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase	"Disease mutation, Dwarfism, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 25.0"	"Cell type enhanced"	"Detected in many"	7	"Spermatocytes: 11.8;Spermatogonia: 9.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA036261, HPA036262"	Enhanced		Supported	"Plasma membrane,Cytosol"		NA	NA			"Plasma membrane, Cytosol"		"HPA036261: AB_10673348, HPA036262: AB_2675029"	"unprognostic (5.30e-3)"	"unprognostic (9.41e-2)"	"unprognostic (1.48e-1)"	"unprognostic (6.50e-3)"	"unprognostic (1.88e-1)"	"unprognostic (7.68e-3)"	"prognostic unfavorable (8.77e-5)"	"unprognostic (4.61e-2)"	"unprognostic (1.52e-2)"	"unprognostic (8.61e-2)"	"unprognostic (1.24e-2)"	"unprognostic (7.97e-2)"	"unprognostic (9.01e-5)"	"unprognostic (5.84e-2)"	"unprognostic (4.24e-1)"	"unprognostic (1.78e-1)"	"unprognostic (1.24e-1)"	4.8	1.6	3.4	6.0	10.7	9.5	3.0	7.4	3.0	3.5	3.7	2.0	3.2	2.3	3.8	2.4	4.5	3.0	2.9	1.5	2.7	2.7	1.6	1.2	1.3	8.1	2.0	2.8	3.4	1.6	1.6	2.0	2.5	3.0	2.9	4.8	2.7	3.1	1.7	2.8	6.7	3.4	3.4	5.1	3.7	1.9	25.0	3.4	11.5	2.2	3.1	6.8	1.9	3.0	5.1	1.6	0.6	3.0	2.7	4.9	1.6	6.4	7.9	11.3	11.4	1.0	1.6	9.4	7.8	3.8	16.6	15.9	9.6	7.5	16.0	5.6	4.5	11.6	8.6	11.9	9.0	12.4	9.2	7.9	12.0	9.6	8.5	0.4	9.8	10.1	1.1	1.3	13.3	7.1	2.0	4.3	14.3	8.6	11.6	7.3	9.4	16.2	12.5	9.1	7.7	13.1	9.0	7.7	9.3	3.0	9.1	5.5	9.4	8.7	7.3	5.5	8.5	6.6	13.9	3.3	10.6	12.7	14.6	15.3	8.5	20.3	17.1	5.3	13.3	9.5	0.0	1.5	0.6	2.3	0.8	2.0	5.1	1.3	4.9	1.3	3.8	1.7	2.6	0.3	2.7	3.0	1.6	0.8	1.6	3.4	10.7	7.4	3.0	2.7	2.7	2.0	2.8	3.0	3.4	3.0	1.1	2.2	0.6	1.0	3.1	2.0	0.0	0.0	0.0	3.5	0.0	2.1	0.0	1.3	3.3	0.7	0.5	0.0	0.8	6.7	1.4	0.5	0.0	0.8	3.0	0.0	0.0	0.6	0.3	4.0	2.3	0.5	1.7	2.8	1.3	1.9	0.9	0.0	1.1	0.3	3.6	0.0	1.0	11.8	9.5	0.3	0.8	2.9	2.3	0.1
TRDMT1	"DNMT2, RNMT1"	ENSG00000107614	"TRNA aspartic acid methyltransferase 1"	O14717	10	17142254-17202054	"Enzymes, Predicted intracellular proteins"	"tRNA processing"	"Methyltransferase, RNA-binding, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Erythroid cells: 23.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009468, HPA036945, HPA036946"	Approved					NA	NA					"CAB009468: AB_2208432, HPA036945: AB_2675398, HPA036946: AB_2675399"	"unprognostic (4.55e-1)"	"unprognostic (3.22e-2)"	"unprognostic (4.49e-6)"	"unprognostic (7.07e-2)"	"unprognostic (3.87e-3)"	"unprognostic (1.33e-1)"	"unprognostic (3.27e-4)"	"unprognostic (3.28e-3)"	"unprognostic (1.09e-1)"	"unprognostic (1.65e-1)"	"unprognostic (1.55e-1)"	"unprognostic (2.65e-2)"	"unprognostic (3.50e-2)"	"unprognostic (1.44e-1)"	"unprognostic (1.60e-1)"	"unprognostic (1.40e-1)"	"unprognostic (2.64e-2)"	6.1	4.4	4.4	8.5	7.7	4.0	6.3	14.0	6.2	5.3	3.8	4.2	4.7	4.1	7.5	14.4	3.9	6.8	5.1	5.0	4.9	4.5	6.7	2.7	5.3	5.3	4.3	2.9	9.6	5.0	12.8	12.6	5.1	6.2	5.0	3.6	8.0	5.6	3.8	4.3	4.4	5.0	5.4	5.1	5.9	4.2	4.2	6.1	19.9	11.5	3.3	5.7	4.0	5.2	6.1	10.5	5.2	4.4	3.5	8.0	3.6	5.0	2.5	10.0	2.5	3.8	2.2	0.0	4.4	3.2	4.6	5.5	4.2	4.2	3.5	0.6	4.9	8.8	2.6	6.7	4.2	5.4	7.3	4.3	5.2	3.8	2.5	3.3	3.4	3.9	3.0	2.6	3.1	2.2	4.3	6.1	9.5	6.4	3.9	7.7	1.6	16.9	0.8	6.2	1.4	2.8	3.7	7.8	2.2	2.5	2.8	2.6	3.3	0.0	1.9	3.3	5.0	4.8	3.1	3.5	3.4	7.2	6.3	5.1	5.0	4.7	8.8	4.3	4.8	3.3	5.2	4.4	2.4	3.9	2.5	7.2	5.4	6.6	4.9	5.5	6.1	8.0	5.8	2.8	3.5	1.4	10.5	2.2	3.6	4.4	7.7	14.0	6.2	4.9	4.5	4.3	2.9	6.2	6.1	6.0	3.7	0.9	1.6	3.0	12.4	3.6	2.5	6.7	7.9	3.5	3.9	1.9	5.0	3.6	5.0	5.0	1.7	23.3	4.2	2.0	4.0	1.3	12.7	0.5	4.5	15.9	0.0	3.1	4.8	4.7	6.1	4.2	0.0	1.8	1.2	16.5	2.2	1.4	6.0	3.7	18.5	0.0	2.9	12.6	3.6	2.8	1.5	5.0	2.9	0.7
TREH	"MGC129621, TRE, TREA"	ENSG00000118094	Trehalase	O43280	11	118657316-118679690	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		"Glycosidase, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	8	"intestine: 51.8"	"Cell type enriched"	"Detected in some"	6	"Late spermatids: 233.7"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 5.4;Hep G2: 2.1;RPMI-8226: 1.9;SiHa: 1.8;SK-MEL-30: 1.5;U-2 OS: 2.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"HPA039913, HPA042045"	Enhanced				"Intracellular and membrane"	NA	NA		12000000			"HPA039913: AB_10674988, HPA042045: AB_2677817"	"unprognostic (1.29e-1)"	"unprognostic (1.58e-1)"	"unprognostic (1.01e-2)"	"unprognostic (5.22e-4)"	"unprognostic (2.52e-1)"	"unprognostic (9.83e-2)"	"prognostic favorable (3.76e-4)"	"unprognostic (1.17e-1)"	"unprognostic (1.34e-1)"	"unprognostic (2.42e-1)"	"unprognostic (1.04e-1)"	"unprognostic (1.63e-2)"	"prognostic favorable (2.33e-6)"	"unprognostic (2.09e-2)"	"unprognostic (6.30e-2)"	"unprognostic (1.22e-1)"	"unprognostic (1.15e-1)"	0.1	0.1	0.1	0.2	0.1	0.0	0.1	0.2	0.1	0.1	24.1	0.0	0.0	28.9	0.1	3.3	0.6	0.1	3.7	0.1	0.1	0.1	6.1	2.6	0.1	0.0	0.1	0.0	0.1	0.5	0.0	0.1	0.0	0.1	0.2	0.4	0.0	0.2	0.0	0.1	0.1	51.8	0.0	0.1	0.1	0.6	0.3	0.0	0.0	0.1	0.0	0.3	0.1	0.1	0.0	0.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.1	0.3	5.4	0.0	0.0	0.0	0.0	0.8	0.7	0.0	0.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	2.1	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.1	0.0	0.0	0.0	0.1	1.9	0.0	0.0	0.2	0.9	1.8	0.3	1.5	0.1	0.7	0.0	0.8	0.1	2.5	0.4	0.2	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.1	0.1	0.1	0.2	0.1	0.1	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	6.6	0.1	37.2	0.0	2.9	0.0	2.3	0.0	0.0	0.2	0.0	0.0	0.1	0.0	2.9	0.0	0.0	233.7	2.0	0.0	0.0	0.0	0.9	0.0	0.6	5.8	1.8	16.5	0.0	0.0	0.1	1.8	0.8	0.0	0.0	0.0	1.2	0.0
TREX1	"AGS1, DRN3"	ENSG00000213689	"Three prime repair exonuclease 1"	Q9NSU2	3	48465811-48467645	"Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins"		"Exonuclease, Hydrolase, Nuclease"	"Aicardi-Goutieres syndrome, Disease mutation, Neurodegeneration, Systemic lupus erythematosus"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"	20	"Basal keratinocytes: 8.0;Cardiomyocytes: 5.0;Melanocytes: 23.6;Smooth muscle cells: 7.6;Suprabasal keratinocytes: 12.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+ SV40 Large T+ RasG12V: 30.9"					"Low region specificity"	"Detected in all"			"HPA035437, HPA046721"	Supported		Supported	Cytosol		NA	NA			Cytosol		"HPA035437: AB_10672092, HPA046721: AB_2732531"																		14.2	14.3	16.7	14.6	10.6	20.7	17.2	13.0	16.9	13.4	11.0	12.8	17.5	10.3	8.1	14.9	16.6	14.5	12.3	9.8	14.4	14.2	11.6	12.7	12.5	26.2	14.6	17.4	7.3	13.0	6.8	31.2	11.6	11.2	15.4	9.3	10.8	32.2	19.3	10.8	22.9	10.9	8.2	12.6	25.5	12.4	4.6	10.1	18.5	7.4	18.3	21.7	13.3	10.6	24.9	35.5	23.3	41.8	8.6	13.1	20.1	8.0	7.4	6.2	4.4	7.7	7.9	0.0	2.6	13.1	22.0	30.9	0.1	9.6	9.5	5.4	11.1	20.8	9.4	0.4	11.8	3.1	8.0	0.7	5.5	26.5	0.4	9.7	5.0	3.9	6.9	1.1	11.1	4.4	4.5	9.3	6.6	0.0	14.6	9.3	0.1	7.0	3.6	0.0	4.7	4.6	5.8	1.6	18.5	5.8	1.6	0.0	3.7	9.6	13.0	6.3	0.4	0.4	8.4	9.8	4.1	3.9	8.7	6.1	11.8	6.8	4.0	9.1	10.7	3.3	2.1	41.8	3.0	9.8	32.5	5.6	24.6	13.1	9.4	35.5	24.9	12.4	10.3	23.3	8.6	24.3	28.0	11.6	20.1	16.7	10.6	13.0	16.9	14.4	14.2	14.6	17.4	11.2	10.1	0.0	0.3	0.0	0.0	8.0	0.0	5.0	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	23.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.6	0.0	0.0	12.2	0.0	0.0	0.0	0.0
TREX2		ENSG00000183479	"Three prime repair exonuclease 2"	Q9BQ50	X	153444720-153470587	"Enzymes, Predicted intracellular proteins"	"DNA damage, DNA repair"	"Exonuclease, Hydrolase, Nuclease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skin 1: 39.6"	"Cell type enhanced"	"Detected in single"	21	"Suprabasal keratinocytes: 1.0"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	10	"basophil: 3.9;eosinophil: 5.7"	"Lineage enriched"	"Detected in single"	12	"granulocytes: 5.7"	"Cell line enhanced"	"Detected in many"		"HEK 293: 7.6;U-698: 10.3;U-937: 9.6"	"Not detected"	"Not detected"							HPA054060	Uncertain					NA	NA					"HPA054060: AB_2682362"	"unprognostic (2.32e-2)"	"unprognostic (2.05e-3)"	"unprognostic (1.13e-3)"	"unprognostic (7.18e-4)"	"unprognostic (6.05e-2)"	"unprognostic (1.81e-2)"	"unprognostic (8.40e-2)"	"unprognostic (2.19e-1)"	"unprognostic (2.09e-1)"	"unprognostic (1.61e-1)"	"unprognostic (1.70e-1)"	"unprognostic (1.57e-1)"	"unprognostic (1.42e-1)"	"unprognostic (1.52e-1)"	"unprognostic (9.34e-2)"	"unprognostic (2.15e-1)"	"unprognostic (1.23e-2)"	3.2	1.5	2.1	3.4	3.0	1.9	2.1	1.1	3.6	4.3	2.6	1.9	15.5	1.4	2.5	2.2	4.5	2.6	2.2	3.5	1.6	1.2	2.8	4.6	2.4	3.1	2.4	2.4	2.1	2.2	1.5	1.7	2.6	2.7	2.5	1.4	1.4	4.5	7.4	2.0	39.6	2.3	1.9	1.2	4.3	1.7	2.1	1.9	5.8	3.3	6.2	4.7	2.2	5.2	0.4	0.3	5.7	0.1	0.2	0.4	0.2	2.8	3.6	0.3	1.3	0.5	0.7	0.3	0.9	0.8	0.7	2.0	1.0	0.7	0.3	1.9	0.8	0.2	3.1	1.2	2.0	0.0	3.2	7.6	0.3	0.7	0.4	0.3	0.8	2.0	0.8	1.9	0.9	0.7	0.4	0.3	0.6	0.4	3.5	0.2	3.3	2.0	2.3	1.2	0.6	2.4	4.9	1.0	2.3	0.3	1.0	0.8	0.4	0.3	0.3	1.1	0.1	0.6	0.9	0.0	1.3	2.4	2.8	1.1	4.0	2.7	10.3	0.3	9.6	1.5	3.9	0.0	5.7	0.3	0.0	0.2	0.4	0.1	0.3	0.3	0.3	0.4	0.1	0.0	0.2	0.1	0.0	0.1	0.2	2.1	3.0	1.1	3.6	1.6	1.2	2.4	2.4	2.7	1.9	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.0	0.6	0.0	0.0	0.0
TRHDE	"PAP-II, PGPEP2, TRH-DE"	ENSG00000072657	"Thyrotropin releasing hormone degrading enzyme"	Q9UKU6	12	72087266-72670757	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"		"Aminopeptidase, Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 30.3;pancreas: 19.4"	"Group enriched"	"Detected in some"	4	"Early spermatids: 30.7;Late spermatids: 47.8;Leydig cells: 27.3;Peritubular cells: 12.7"	"Cancer enhanced"	"Detected in some"		"renal cancer: 1.9"	"Region enhanced"	"Detected in many"		"cerebellum: 30.3"	"Cell type enhanced"	"Detected in single"		"basophil: 1.0"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"BJ: 20.8;BJ hTERT+: 20.2;EFO-21: 10.9;HBF TERT88: 7.4;hTERT-RPE1: 7.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA		6200000				"unprognostic (3.56e-2)"	"unprognostic (4.06e-3)"	"unprognostic (6.01e-2)"	"unprognostic (1.44e-6)"	"unprognostic (1.77e-1)"	"unprognostic (6.37e-2)"	"unprognostic (7.79e-2)"	"unprognostic (6.96e-2)"	"unprognostic (3.99e-2)"	"unprognostic (1.48e-1)"	"unprognostic (5.14e-4)"	"unprognostic (2.40e-1)"	"prognostic favorable (1.53e-7)"	"unprognostic (2.55e-2)"	"unprognostic (2.48e-1)"	"unprognostic (8.91e-3)"	"unprognostic (2.94e-2)"	6.2	2.2	2.9	1.0	4.7	1.0	7.6	30.3	12.3	10.2	2.4	0.1	2.5	4.8	2.7	1.7	0.9	2.5	2.5	2.2	7.3	2.8	9.9	1.5	3.0	0.6	1.2	5.5	6.5	19.4	0.4	1.6	0.7	1.5	5.5	1.5	1.0	2.4	5.8	0.7	0.8	4.2	1.2	0.9	4.8	1.1	1.7	0.5	0.0	0.5	0.4	1.0	2.8	7.6	0.2	0.0	1.0	0.3	0.3	0.0	0.0	2.4	0.0	0.4	0.0	1.1	0.0	6.7	20.8	20.2	2.0	1.4	0.0	0.0	0.0	10.9	3.0	2.1	0.2	3.8	0.0	7.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	1.6	7.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	6.0	0.0	0.0	0.0	6.9	4.6	2.0	0.0	0.0	0.0	0.0	0.4	0.0	4.0	0.0	0.0	2.2	0.0	0.3	0.0	0.0	0.0	0.0	0.4	0.0	1.0	0.1	0.2	0.0	0.3	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.8	0.3	0.0	0.0	0.0	0.0	2.9	4.7	30.3	12.3	7.3	2.8	1.2	5.5	1.5	0.5	0.0	0.3	0.0	0.0	0.0	0.2	0.8	0.0	1.4	0.0	1.8	0.0	0.0	3.3	0.0	30.7	0.0	6.9	0.0	2.2	0.3	0.5	0.2	0.0	1.3	0.2	0.0	0.0	0.0	0.0	47.8	27.3	0.3	0.0	0.0	1.5	0.3	2.1	2.9	12.7	7.4	0.6	0.0	0.4	0.1	0.7	0.0	0.1	0.0	0.7	0.1
TRIB1	"C8FW, GIG2, TRB1"	ENSG00000173334	"Tribbles pseudokinase 1"	Q96RU8	8	125430321-125438405	"Enzymes, Predicted intracellular proteins"		"Protein kinase inhibitor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 84.2;thyroid gland: 90.7"	"Cell type enhanced"	"Detected in many"	6	"Alveolar cells type 2: 192.3;Basal glandular cells: 267.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	5	"eosinophil: 10.8;neutrophil: 5.8;non-classical monocyte: 3.7;T-reg: 3.1"	"Group enriched"	"Detected in many"	11	"granulocytes: 10.8;monocytes: 3.7;T-cells: 3.1"	"Cell line enhanced"	"Detected in many"		"HEL: 55.1;U-266/70: 33.8;U-266/84: 33.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA063982			Approved	"Plasma membrane,Cytosol"		NA	NA			"Plasma membrane, Cytosol"		"HPA063982: AB_2685165"	"unprognostic (1.90e-3)"	"unprognostic (1.45e-1)"	"unprognostic (8.80e-3)"	"unprognostic (1.34e-2)"	"unprognostic (3.56e-1)"	"unprognostic (2.32e-1)"	"unprognostic (2.00e-1)"	"unprognostic (4.57e-2)"	"unprognostic (4.12e-2)"	"unprognostic (1.62e-2)"	"unprognostic (6.81e-3)"	"unprognostic (9.36e-2)"	"unprognostic (2.97e-3)"	"unprognostic (1.94e-1)"	"unprognostic (1.04e-2)"	"unprognostic (5.55e-2)"	"unprognostic (2.08e-2)"	26.7	6.5	5.9	17.6	6.5	84.2	13.3	4.3	6.1	10.4	12.4	4.4	6.6	4.9	6.2	6.7	10.9	10.9	21.0	11.1	4.3	4.0	16.6	63.5	28.9	14.6	4.2	3.9	6.4	23.6	20.9	7.2	15.5	4.5	12.1	13.3	15.0	14.5	9.1	22.3	10.4	16.9	11.3	3.1	15.9	18.5	5.6	3.1	9.2	90.7	17.6	12.1	12.4	9.0	0.2	0.5	10.8	3.7	0.0	3.1	0.1	4.1	4.7	0.6	1.3	1.3	2.7	7.5	2.7	3.8	2.0	0.6	6.3	5.5	7.5	2.5	1.9	12.1	3.1	2.0	2.6	1.7	3.3	9.9	55.1	2.1	12.3	3.5	27.5	5.0	2.6	4.0	8.2	18.8	9.8	5.8	0.1	4.8	24.0	0.2	4.4	2.5	4.3	4.6	9.9	9.2	5.2	0.9	8.2	16.2	15.8	4.0	1.5	6.6	7.2	26.2	4.3	1.9	1.3	3.0	2.2	2.8	2.1	3.3	33.8	33.7	10.5	3.9	0.2	5.1	0.0	0.9	10.8	0.0	1.2	0.0	0.2	0.1	0.0	0.5	0.0	0.0	0.0	5.8	0.0	3.7	0.3	3.1	0.1	5.9	6.5	4.3	6.1	4.3	4.0	4.2	3.9	4.5	3.1	125.0	192.3	11.2	267.7	89.0	20.4	14.4	17.8	33.5	64.8	15.7	0.0	9.2	10.0	31.3	0.4	32.9	172.0	0.0	21.2	17.2	32.4	153.9	29.9	128.8	29.9	20.6	107.4	8.6	53.9	1.4	0.3	47.3	54.0	40.5	87.2	21.4	42.4	51.5	0.4	21.6	3.4	0.0	14.4	0.0	1.3	56.1	25.6	4.5	56.6	79.9
TRIB2	"GS3955, TRB2"	ENSG00000071575	"Tribbles pseudokinase 2"	Q92519	2	12716889-12742734	"Enzymes, Predicted membrane proteins"		"Protein kinase inhibitor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Exocrine glandular cells: 89.7;Muller glia cells: 115.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"T-reg: 24.8"	"Group enriched"	"Detected in many"	9	"B-cells: 7.1;NK-cells: 9.5;T-cells: 24.8"	"Cell line enhanced"	"Detected in many"		"AN3-CA: 41.0;HEL: 40.3;K-562: 54.8;SK-MEL-30: 40.0;WM-115: 54.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA001305	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"HPA001305: AB_1080371"	"unprognostic (1.84e-1)"	"unprognostic (2.49e-2)"	"unprognostic (4.31e-3)"	"unprognostic (1.86e-3)"	"unprognostic (6.68e-3)"	"unprognostic (3.93e-2)"	"unprognostic (4.10e-1)"	"unprognostic (1.53e-1)"	"unprognostic (2.80e-2)"	"unprognostic (3.32e-2)"	"unprognostic (2.52e-3)"	"unprognostic (1.67e-2)"	"unprognostic (1.08e-3)"	"unprognostic (1.30e-1)"	"unprognostic (8.71e-2)"	"unprognostic (9.59e-2)"	"unprognostic (2.13e-2)"	19.6	30.9	13.2	17.7	13.3	7.0	23.2	23.2	23.0	10.8	12.3	10.5	6.7	8.7	23.0	22.6	8.1	11.6	14.5	18.2	15.0	10.8	24.8	10.6	18.9	33.0	13.4	16.2	52.3	14.4	6.6	11.3	23.0	15.5	16.3	6.9	35.7	9.9	13.6	6.9	8.2	11.9	17.6	10.4	38.9	19.5	13.9	10.1	37.3	12.1	6.2	33.4	21.9	23.2	7.1	0.6	1.5	0.1	9.5	24.8	4.5	0.0	0.0	31.3	41.0	11.3	10.4	0.0	1.7	1.6	1.1	1.8	0.2	3.4	3.5	1.2	3.7	0.2	0.5	2.3	3.5	0.9	3.9	6.4	40.3	0.1	0.6	14.0	2.2	15.4	9.6	3.6	4.5	1.2	11.1	4.9	5.3	54.8	0.0	1.7	0.3	5.1	9.6	14.8	1.5	4.0	0.0	10.4	1.4	7.1	5.1	26.9	12.8	0.2	1.6	40.0	9.8	0.0	0.2	3.0	14.9	7.5	0.1	3.8	0.0	0.0	5.0	8.0	7.9	54.9	0.8	0.1	1.5	7.3	0.0	8.8	5.3	14.4	7.7	0.6	7.1	8.5	5.2	0.3	9.5	0.1	0.0	24.8	4.5	13.2	13.3	23.2	23.0	15.0	10.8	13.4	16.2	15.5	10.1	3.0	8.8	8.0	10.2	5.5	46.7	13.3	20.4	6.7	11.4	15.7	29.5	1.9	6.6	13.3	3.9	36.4	0.0	0.0	89.7	0.1	7.1	10.3	33.5	5.4	4.4	19.1	0.0	63.3	5.3	10.7	71.7	2.5	28.7	1.8	0.0	115.1	49.1	0.0	70.0	0.7	66.1	51.8	22.5	0.9	2.7	4.6	0.7	20.8	0.0	11.1
TRIB3	"C20orf97, dJ1103G7.3, TRB3"	ENSG00000101255	"Tribbles pseudokinase 3"	Q96RU7	20	362835-397559	"Enzymes, Predicted intracellular proteins"	"Apoptosis, Stress response, Transcription, Transcription regulation"	"Protein kinase inhibitor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 39.0;salivary gland: 47.5"	"Cell type enhanced"	"Detected in many"	8	"Ductal cells: 49.9;Hepatocytes: 25.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HHSteC: 88.9;hTCEpi: 55.1;hTERT-HME1: 64.0;SK-MEL-30: 80.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA015272, HPA055442"	Approved		Supported	Nucleoplasm		NA	NA			Nucleoplasm		"HPA015272: AB_1858269, HPA055442: AB_2682818"	"unprognostic (5.40e-2)"	"unprognostic (1.89e-1)"	"unprognostic (1.57e-1)"	"unprognostic (2.25e-3)"	"unprognostic (1.92e-1)"	"prognostic unfavorable (1.70e-4)"	"prognostic unfavorable (6.75e-5)"	"unprognostic (1.52e-3)"	"unprognostic (1.76e-1)"	"unprognostic (1.24e-1)"	"unprognostic (7.95e-2)"	"unprognostic (1.79e-1)"	"prognostic unfavorable (2.07e-13)"	"unprognostic (7.62e-2)"	"unprognostic (2.79e-2)"	"unprognostic (2.31e-1)"	"unprognostic (4.05e-3)"	4.8	8.7	1.6	2.8	1.5	9.7	6.0	3.8	4.2	2.5	1.8	1.2	3.6	1.0	2.1	3.1	9.8	1.1	2.7	3.0	1.4	2.0	3.3	39.0	8.2	7.3	1.0	2.4	4.4	13.8	2.0	10.5	6.2	1.6	3.9	1.6	3.7	47.5	5.3	1.5	6.5	2.5	1.3	0.7	7.9	4.4	2.7	0.6	6.7	27.2	4.1	7.0	2.7	5.3	15.5	4.7	3.3	4.4	6.6	11.4	5.1	11.1	5.7	0.7	1.6	1.9	2.5	4.8	3.3	8.9	3.2	6.6	11.7	5.6	4.8	3.3	3.0	14.3	9.0	3.1	14.9	2.9	1.8	2.2	3.7	1.2	19.1	88.9	9.4	1.8	10.3	55.1	6.0	64.0	2.2	6.1	12.2	12.9	21.7	0.3	10.4	0.5	11.4	1.7	16.5	18.5	2.1	0.9	10.4	3.7	4.5	2.1	3.3	0.7	27.1	80.8	1.0	7.8	25.0	3.5	1.7	3.0	0.0	5.1	7.6	9.8	8.6	1.5	8.3	6.1	2.5	4.4	1.0	10.0	3.4	7.1	15.5	9.3	11.4	4.7	10.2	10.7	7.6	3.3	6.6	1.7	2.1	6.4	5.1	1.6	1.5	3.8	4.2	1.4	2.0	1.0	2.4	1.6	0.6	3.0	1.0	7.6	7.2	6.1	3.8	1.2	10.2	2.7	1.2	1.8	3.9	13.1	0.0	49.9	0.0	5.8	0.0	23.3	19.2	4.3	1.5	10.5	4.7	25.3	5.6	0.0	1.2	8.0	2.1	0.0	1.7	4.0	6.8	1.8	6.5	0.5	23.3	2.3	1.4	0.0	6.7	6.5	4.1	1.9	2.2	4.6	5.9	5.0	0.6	4.8
TRIM11	"BIA1, RNF92"	ENSG00000154370	"Tripartite motif containing 11"	Q96F44	1	228393673-228406840	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Antiviral defense, Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	8	"Early spermatids: 105.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028541, HPA043879"	Approved		Enhanced	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"HPA028541: AB_10600833, HPA043879: AB_2678711"	"unprognostic (1.73e-1)"	"unprognostic (9.73e-3)"	"unprognostic (5.48e-3)"	"unprognostic (7.73e-2)"	"unprognostic (3.27e-1)"	"unprognostic (2.33e-1)"	"prognostic unfavorable (7.42e-5)"	"unprognostic (1.08e-1)"	"unprognostic (9.74e-2)"	"unprognostic (2.04e-1)"	"unprognostic (1.40e-1)"	"unprognostic (3.15e-1)"	"prognostic unfavorable (1.62e-4)"	"unprognostic (3.40e-2)"	"unprognostic (4.89e-2)"	"unprognostic (2.04e-1)"	"unprognostic (1.22e-2)"	8.8	9.2	8.9	13.8	16.5	33.2	23.8	45.2	11.5	8.7	11.2	6.4	15.1	10.1	8.7	10.6	13.3	9.4	13.9	6.9	9.2	8.5	7.7	7.1	27.5	18.6	9.0	8.0	9.0	11.9	8.5	7.2	9.4	7.1	10.5	9.7	6.0	14.4	18.2	5.0	12.5	11.8	8.6	6.0	16.5	12.6	9.5	7.8	20.0	9.0	9.7	13.1	9.5	24.3	6.4	6.9	10.0	11.4	9.4	11.8	5.4	13.9	13.2	7.1	9.7	5.4	4.4	33.6	9.1	6.1	10.6	8.5	16.1	12.2	10.5	10.2	6.1	7.0	22.7	8.6	8.8	4.5	11.6	20.6	8.7	12.2	8.6	14.6	10.9	13.2	6.0	14.0	11.0	5.5	5.4	5.2	17.2	19.7	13.5	5.4	9.0	13.2	17.2	18.1	11.8	11.7	13.0	6.4	12.6	6.9	17.1	11.9	21.8	7.6	21.6	12.0	3.0	15.3	18.3	5.8	6.8	9.5	15.7	18.8	13.9	9.2	9.2	8.4	8.8	10.6	6.1	6.9	8.3	9.6	8.2	10.2	5.8	10.7	11.8	6.9	6.4	6.3	8.4	10.0	9.4	11.4	5.5	9.8	5.4	8.9	16.5	45.2	11.5	9.2	8.5	9.0	8.0	7.1	7.8	3.0	7.2	3.9	12.3	14.1	12.6	2.8	7.6	4.0	7.9	1.8	2.0	13.8	14.9	13.0	105.9	8.3	22.7	0.0	9.7	12.0	7.0	15.1	5.7	4.9	10.0	4.8	13.8	6.7	10.0	12.4	8.9	9.7	5.0	25.2	16.1	8.1	14.3	17.3	7.1	6.3	1.7	6.5	9.7	5.5	11.8	16.9	47.9	24.9	13.4	22.9
TRIM13	"DLEU5, Leu5, RFP2, RNF77"	ENSG00000204977	"Tripartite motif containing 13"	O60858	13	49995888-50020481	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Immunity, Innate immunity, Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enriched"	"Detected in all"	8	"Early spermatids: 422.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA000367	Enhanced					NA	NA					"HPA000367: AB_1856196"	"unprognostic (1.14e-1)"	"unprognostic (8.22e-2)"	"unprognostic (6.14e-2)"	"unprognostic (2.23e-3)"	"unprognostic (4.75e-3)"	"unprognostic (5.01e-2)"	"unprognostic (4.60e-2)"	"unprognostic (2.83e-2)"	"unprognostic (2.59e-2)"	"unprognostic (2.38e-2)"	"unprognostic (2.44e-1)"	"unprognostic (5.07e-1)"	"unprognostic (7.28e-3)"	"unprognostic (4.66e-2)"	"unprognostic (9.01e-2)"	"unprognostic (2.37e-2)"	"unprognostic (1.55e-2)"	13.2	9.8	9.9	11.9	11.4	37.5	19.6	18.5	13.5	13.1	11.7	12.3	15.2	8.6	13.9	10.7	18.8	12.2	8.7	12.4	10.1	9.2	16.6	9.9	14.7	12.4	12.2	8.0	13.8	14.0	10.8	14.4	10.0	11.5	14.5	14.0	9.6	16.2	15.6	16.3	18.2	13.0	10.4	10.8	15.3	10.6	49.0	12.1	25.1	17.3	13.9	15.5	13.0	12.9	28.4	20.6	21.6	13.0	15.4	17.2	8.4	5.1	6.1	21.1	16.3	11.9	18.6	9.6	8.5	12.4	6.9	4.9	8.4	11.9	19.3	2.7	9.2	6.3	8.1	9.2	11.2	8.6	7.3	8.2	19.1	4.6	9.2	13.3	18.2	11.2	13.6	16.6	6.3	10.6	17.5	15.3	16.5	10.1	6.1	13.6	4.7	15.1	28.6	19.1	12.0	4.5	18.5	0.9	5.7	14.8	8.5	8.5	13.9	7.8	8.1	11.9	15.6	9.1	23.1	14.2	7.2	6.7	5.8	4.8	4.4	3.7	14.1	3.2	8.4	9.7	12.1	10.8	16.1	12.2	9.3	15.3	28.2	16.5	15.9	13.5	28.4	14.6	13.6	21.6	15.4	13.0	20.6	17.2	8.4	9.9	11.4	18.5	13.5	10.1	9.2	12.2	8.0	11.5	12.1	23.8	23.2	36.1	36.2	24.5	23.5	16.2	17.8	36.1	21.6	26.2	19.6	29.2	16.6	21.0	422.5	29.4	20.1	23.3	17.5	13.3	23.7	28.6	38.1	13.7	16.3	11.1	43.1	22.1	17.3	42.4	23.9	27.2	16.9	23.4	24.2	13.2	17.6	31.1	28.0	24.9	52.1	19.4	29.7	55.2	19.6	29.2	26.9	36.3	22.4	26.3
TRIM17	"RBCC, RNF16, terf"	ENSG00000162931	"Tripartite motif containing 17"	Q9Y577	1	228407940-228416861	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 25.8;testis: 18.3"	"Group enriched"	"Detected in some"	56	"Early spermatids: 233.3;Late spermatids: 64.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"BEWO: 7.8;HEL: 3.5;NTERA-2: 3.3;SH-SY5Y: 4.1;T-47d: 9.6"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			HPA054908	Uncertain		Approved	Vesicles		NA	NA			Vesicles		"HPA054908: AB_2682638"	"prognostic favorable (1.86e-4)"	"unprognostic (2.12e-1)"	"unprognostic (3.06e-2)"	"unprognostic (5.45e-2)"	"unprognostic (1.25e-1)"	"unprognostic (7.74e-3)"	"unprognostic (7.42e-3)"	"unprognostic (2.02e-1)"	"unprognostic (1.17e-2)"	"unprognostic (8.91e-2)"	"unprognostic (2.23e-1)"	"unprognostic (2.04e-1)"	"unprognostic (5.96e-4)"	"unprognostic (3.88e-1)"	"unprognostic (4.88e-2)"	"unprognostic (6.33e-2)"	"unprognostic (3.64e-1)"	1.3	0.8	14.4	1.5	19.1	1.1	1.9	25.8	11.8	1.5	0.9	0.6	1.7	1.4	3.6	1.7	1.3	3.9	1.7	1.5	8.9	3.4	1.2	0.6	1.7	2.0	0.7	9.2	2.2	1.1	0.8	1.0	1.3	2.7	2.0	0.8	1.9	5.9	3.8	0.8	3.5	1.6	1.1	0.9	5.3	1.4	18.3	4.7	0.0	2.9	0.1	1.2	2.5	1.3	1.7	0.6	0.7	0.3	0.0	1.0	0.1	0.3	0.7	0.5	0.4	0.0	0.0	7.8	0.5	0.0	0.0	0.1	1.7	0.9	0.1	1.9	0.0	0.2	1.7	0.0	0.0	0.1	0.3	0.8	3.5	1.0	0.2	1.6	0.1	0.3	0.2	0.2	0.1	0.0	0.1	0.0	0.5	0.2	0.5	0.1	0.1	0.3	0.0	3.3	0.1	0.2	0.1	0.1	0.0	0.0	0.8	0.5	4.1	0.0	0.4	0.0	0.8	9.6	0.2	0.0	0.4	1.7	0.3	0.1	0.1	0.0	0.2	0.2	0.1	0.3	0.0	0.3	0.7	0.9	0.1	1.0	0.6	0.2	1.0	0.0	1.7	1.0	0.8	0.2	0.0	0.2	0.6	0.0	0.1	14.4	19.1	25.8	11.8	8.9	3.4	0.7	9.2	2.7	4.7	0.0	0.3	0.0	1.1	0.2	1.1	0.6	0.0	2.7	2.3	1.8	0.0	0.0	0.0	0.7	233.3	0.0	0.0	0.0	0.0	0.0	0.2	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	64.0	1.1	0.0	0.0	0.0	0.0	0.5	0.9	0.0	0.4	0.0	0.0	0.0	0.0	1.2	1.6	0.3	0.7	0.5	0.0	0.6
TRIM2	"CMT2R, KIAA0517, RNF86"	ENSG00000109654	"Tripartite motif containing 2"	Q9C040	4	153152342-153339320	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase	"Charcot-Marie-Tooth disease, Disease mutation, Neurodegeneration, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 67.0"	"Cell type enhanced"	"Detected in many"	4	"Horizontal cells: 104.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"memory CD4 T-cell: 5.4"	"Group enriched"	"Detected in many"	4	"B-cells: 1.9;T-cells: 5.4"	"Cell line enhanced"	"Detected in many"		"AF22: 28.6;NTERA-2: 23.5;RPTEC TERT1: 26.7;SK-MEL-30: 25.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035853, HPA035854"	Enhanced		Approved	Centrosome		NA	NA			Centrosome		"HPA035853: AB_10669533, HPA035854: AB_10669659"	"unprognostic (8.94e-2)"	"unprognostic (7.89e-2)"	"unprognostic (6.21e-3)"	"unprognostic (7.51e-3)"	"unprognostic (2.07e-2)"	"unprognostic (2.32e-1)"	"unprognostic (1.16e-2)"	"unprognostic (2.30e-3)"	"unprognostic (5.30e-2)"	"unprognostic (6.77e-2)"	"unprognostic (1.93e-2)"	"unprognostic (1.42e-2)"	"prognostic favorable (6.58e-14)"	"unprognostic (5.89e-2)"	"unprognostic (1.17e-2)"	"unprognostic (4.19e-2)"	"unprognostic (4.13e-2)"	4.2	9.9	28.4	4.4	35.7	0.6	12.2	28.9	56.9	19.6	17.8	67.0	5.9	13.5	9.7	15.1	8.5	12.9	10.3	6.2	38.9	25.3	22.1	6.4	5.9	2.3	39.4	34.6	10.9	8.2	1.0	10.9	2.5	45.3	11.5	19.2	4.6	30.1	11.8	1.8	3.8	14.4	6.6	44.2	8.8	23.5	1.9	44.7	0.0	38.9	0.6	4.3	7.6	5.5	1.9	0.8	0.3	0.6	0.3	5.4	0.7	4.8	0.2	28.6	12.5	10.8	12.4	0.5	6.4	8.7	1.8	2.7	2.8	0.3	0.2	4.1	11.1	5.5	4.3	13.3	2.4	1.9	0.1	5.0	0.2	2.9	0.6	12.6	0.2	0.1	8.0	1.4	3.6	2.3	7.0	1.7	0.3	0.2	0.1	2.2	0.4	1.4	0.0	23.5	14.3	5.7	0.8	5.2	0.0	26.7	6.3	9.2	18.1	3.0	11.6	25.6	4.3	1.2	0.2	2.4	8.0	2.3	6.2	3.0	0.1	0.0	0.1	11.9	0.1	9.8	0.3	0.6	0.1	0.1	0.0	0.0	1.6	5.4	0.1	0.8	1.9	1.6	1.0	0.2	0.3	0.0	0.1	2.6	0.7	28.4	35.7	28.9	41.1	38.9	25.3	39.4	34.6	45.3	44.7	6.0	22.3	3.2	14.9	6.3	65.3	26.2	12.7	81.7	61.4	55.8	27.5	1.4	86.2	8.4	2.7	14.0	51.1	0.0	23.1	0.4	18.1	22.3	1.1	10.9	1.1	104.9	59.8	18.4	1.5	2.1	27.3	2.6	60.8	4.6	59.2	78.7	19.0	31.6	30.8	12.2	20.8	25.8	9.9	0.4	0.9	3.4	0.6	1.0	74.3	26.7
TRIM21	"RNF81, Ro/SSA, RO52, SSA1"	ENSG00000132109	"Tripartite motif containing 21"	P19474	11	4384897-4393696	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Ubl conjugation pathway"	"DNA-binding, Ribonucleoprotein, RNA-binding, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 72.4"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"CAB004566, HPA005673"	Enhanced		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"CAB004566: AB_628286, HPA005673: AB_1080090"	"prognostic favorable (4.83e-5)"	"unprognostic (4.55e-2)"	"unprognostic (3.64e-2)"	"unprognostic (3.01e-2)"	"unprognostic (1.50e-1)"	"unprognostic (1.43e-1)"	"prognostic unfavorable (1.87e-4)"	"unprognostic (1.20e-1)"	"unprognostic (5.04e-2)"	"unprognostic (1.27e-1)"	"unprognostic (2.49e-2)"	"unprognostic (3.31e-1)"	"unprognostic (1.82e-2)"	"unprognostic (6.27e-2)"	"unprognostic (4.69e-2)"	"prognostic favorable (2.26e-6)"	"unprognostic (9.12e-3)"	18.2	12.1	4.9	13.7	6.5	15.0	9.8	2.5	6.4	15.0	11.7	6.4	6.0	12.5	11.6	10.3	14.6	10.4	10.8	8.5	5.0	5.3	12.9	14.9	14.6	21.4	6.8	4.0	17.4	10.7	4.3	9.9	19.9	8.6	18.0	12.0	8.5	11.9	8.6	4.5	6.9	21.8	12.0	4.7	28.3	13.5	6.0	4.7	21.5	19.1	6.8	17.0	11.6	13.5	10.9	22.0	72.4	27.5	14.5	19.5	28.6	5.7	6.8	3.4	3.2	7.1	10.7	4.8	7.4	14.0	29.4	32.6	3.1	16.8	8.8	3.4	10.9	30.4	8.3	6.0	11.3	9.1	14.8	6.7	13.6	3.9	2.8	15.8	16.0	13.6	10.4	6.8	5.9	4.1	10.7	17.9	7.7	4.2	9.7	9.7	5.1	8.4	11.8	2.9	6.6	3.5	5.9	4.5	4.9	11.6	5.4	0.0	1.5	6.1	6.8	8.2	5.8	2.3	11.0	16.1	7.2	5.6	3.7	2.7	5.1	4.0	5.6	6.5	12.7	5.1	18.8	26.9	60.1	19.3	27.5	16.8	10.5	16.6	17.1	22.0	10.9	14.9	15.7	72.4	14.5	24.4	7.4	19.5	28.6	4.9	6.5	2.5	6.4	5.0	5.3	6.8	4.0	8.6	4.7	8.9	4.6	4.7	4.4	1.8	0.5	2.5	5.1	10.7	11.4	5.2	0.0	5.5	6.6	10.3	0.0	6.2	6.7	0.0	7.4	7.2	2.8	3.4	11.6	7.6	8.6	1.6	2.4	9.8	11.0	0.4	4.0	7.2	1.7	10.0	6.9	1.4	9.9	5.8	6.7	3.1	0.0	12.9	4.2	0.3	0.4	1.5	7.6	8.3	4.8	2.8
TRIM22	"GPSTAF50, RNF94, STAF50"	ENSG00000132274	"Tripartite motif containing 22"	Q8IYM9	11	5689689-5737089	"Enzymes, Predicted intracellular proteins"	"Antiviral defense, Host-virus interaction, Transcription, Transcription regulation, Ubl conjugation pathway"	"Repressor, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"B-cells: 76.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"ASC TERT1: 37.6;BJ hTERT+ SV40 Large T+ RasG12V: 48.4;HSkMC: 42.4;TIME: 33.7"									"HPA003307, HPA003575"	Approved		Supported	"Nucleoplasm,Nuclear bodies"		NA	NA			"Nucleoplasm, Nuclear bodies"		"HPA003307: AB_1080381, HPA003575: AB_1080378"	"unprognostic (1.47e-2)"	"unprognostic (5.27e-3)"	"unprognostic (4.00e-2)"	"unprognostic (4.21e-3)"	"unprognostic (2.21e-1)"	"unprognostic (1.21e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.23e-1)"	"unprognostic (1.19e-1)"	"unprognostic (1.86e-3)"	"unprognostic (2.93e-2)"	"unprognostic (2.10e-1)"	"unprognostic (1.98e-2)"	"unprognostic (1.30e-1)"	"unprognostic (2.50e-2)"	"unprognostic (1.15e-1)"	"unprognostic (9.16e-2)"	34.3	6.9	8.8	32.8	13.3	22.2	17.3	3.2	10.3	14.4	12.2	10.6	15.1	6.5	20.0	18.9	17.6	17.2	20.2	12.4	10.3	6.6	13.9	19.3	29.8	62.2	15.5	6.5	21.9	5.6	2.1	8.1	9.4	13.3	20.4	13.7	15.0	17.2	14.6	7.1	7.8	28.7	13.5	22.9	65.4	11.2	6.3	12.0	35.6	15.5	13.4	40.6	19.8	13.5	49.0	55.2	33.0	50.3	18.0	58.1	47.3	0.8	0.2	3.4	0.6	18.7	37.6	1.1	11.0	19.3	21.0	48.4	0.3	2.2	23.2	3.4	15.6	4.9	2.3	7.7	11.5	2.1	0.5	0.0	1.3	1.3	0.4	24.5	3.5	2.2	42.4	10.9	4.2	1.9	26.0	25.8	0.2	0.5	1.2	22.8	0.4	12.1	3.7	9.9	0.1	1.2	15.0	0.8	0.5	11.0	3.6	0.4	0.8	1.0	1.0	0.5	13.6	1.2	3.9	33.7	13.0	7.1	0.6	0.6	1.3	1.1	2.6	16.3	6.5	1.7	27.4	35.7	23.8	35.8	43.5	47.0	46.5	39.0	37.8	42.8	49.0	35.2	33.7	33.0	18.0	50.3	55.2	58.1	47.3	8.8	13.3	3.2	10.3	10.3	6.6	15.5	6.5	13.3	12.0	62.5	55.5	76.7	13.5	11.2	0.6	5.6	7.6	41.5	44.3	27.9	0.0	1.0	5.0	10.5	0.1	36.1	2.0	0.0	7.2	3.3	14.7	9.9	16.3	4.9	18.1	1.6	4.1	26.4	62.2	0.2	33.4	49.6	5.0	13.6	7.8	8.0	3.9	5.8	28.3	2.6	0.9	12.9	14.5	0.5	0.2	7.5	1.9	55.8	3.8	16.3
TRIM23	"ARD1, ARFD1, RNF46"	ENSG00000113595	"Tripartite motif containing 23"	P36406	5	65589680-65625975	"Cancer-related genes, Enzymes, Predicted intracellular proteins"	"Host-virus interaction, Immunity, Innate immunity, Ubl conjugation pathway"	Transferase	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Horizontal cells: 42.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039605	Approved					NA	NA					"HPA039605: AB_10673146"	"unprognostic (4.06e-1)"	"unprognostic (1.07e-1)"	"unprognostic (5.11e-2)"	"unprognostic (3.63e-1)"	"unprognostic (7.96e-2)"	"unprognostic (1.59e-1)"	"unprognostic (1.02e-1)"	"unprognostic (5.00e-3)"	"unprognostic (6.51e-2)"	"unprognostic (1.89e-2)"	"unprognostic (1.73e-2)"	"unprognostic (3.19e-1)"	"unprognostic (3.19e-2)"	"unprognostic (1.06e-2)"	"unprognostic (2.62e-1)"	"unprognostic (6.55e-3)"	"unprognostic (2.70e-1)"	8.6	12.7	15.0	6.6	17.9	7.6	9.4	25.8	34.3	11.5	7.8	9.5	7.3	4.5	10.6	7.0	9.0	8.6	6.3	12.3	16.3	15.2	10.2	11.8	6.6	7.7	14.4	18.8	16.2	6.5	11.1	11.6	7.9	22.1	12.9	5.3	4.1	5.7	9.4	14.8	6.6	5.2	9.3	14.2	8.2	5.6	10.9	14.0	7.5	12.4	4.4	7.6	7.5	7.6	6.0	3.8	14.5	4.5	5.6	9.9	4.5	6.3	8.7	9.3	14.0	14.6	14.7	7.0	12.2	11.6	10.5	12.9	8.0	6.1	4.9	14.7	8.6	10.7	5.1	9.1	7.1	16.2	5.1	9.7	3.9	11.9	5.0	13.6	2.4	5.5	11.4	6.1	11.6	10.6	10.1	5.0	5.9	4.5	7.1	12.3	6.0	5.0	2.7	5.1	1.1	3.6	4.7	17.0	7.0	5.4	6.6	5.6	7.7	11.6	3.5	9.6	8.3	7.6	3.3	8.5	8.1	8.8	10.2	9.0	8.7	8.0	6.0	9.6	4.7	8.1	14.5	4.0	9.5	5.6	3.0	6.9	4.7	6.1	4.9	3.6	6.0	9.9	7.5	10.1	5.6	4.5	3.8	6.9	4.5	15.0	17.9	25.8	31.1	16.3	15.2	14.4	18.8	22.1	14.0	17.9	5.6	2.9	2.1	6.2	26.4	18.6	12.7	13.4	9.1	5.2	15.7	2.9	5.0	3.4	2.7	7.3	3.3	23.3	2.6	2.1	7.4	7.8	3.5	11.9	3.4	42.9	6.3	11.6	7.8	2.1	19.2	3.3	10.1	1.0	5.5	29.3	5.4	4.8	15.9	7.8	23.8	32.3	6.6	23.7	13.4	5.5	5.8	9.6	3.9	2.5
TRIM24	"hTIF1, RNF82, TIF1, Tif1a"	ENSG00000122779	"Tripartite motif containing 24"	O15164	7	138460334-138589993	"Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Transcription, Transcription regulation, Ubl conjugation pathway"	"DNA-binding, Repressor, Transferase"	"Cancer-related genes, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"AF22: 43.3;HMC-1: 58.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043495, HPA061717"	Approved		Enhanced	Nucleoplasm	"Intracellular and membrane"	NA	NA			Nucleoplasm		"HPA043495: AB_10962915, HPA061717: AB_2684592"	"unprognostic (2.40e-1)"	"unprognostic (9.52e-3)"	"unprognostic (2.23e-1)"	"unprognostic (3.96e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.15e-1)"	"prognostic unfavorable (9.94e-4)"	"prognostic favorable (6.57e-4)"	"unprognostic (4.01e-2)"	"unprognostic (8.93e-2)"	"unprognostic (2.53e-1)"	"unprognostic (2.02e-1)"	"unprognostic (4.62e-2)"	"unprognostic (1.62e-1)"	"unprognostic (2.25e-2)"	"unprognostic (5.54e-2)"	"unprognostic (6.34e-2)"	10.3	31.4	10.4	11.2	10.6	8.8	8.8	8.5	10.7	9.4	9.2	14.6	5.7	9.4	9.0	8.5	11.3	7.0	10.3	9.7	8.4	8.5	9.6	21.5	10.7	8.5	10.5	8.0	29.9	11.6	20.7	7.3	13.5	8.4	13.6	9.1	7.5	10.1	7.1	16.0	9.8	14.1	9.4	8.0	8.5	10.8	24.1	11.3	34.8	8.8	9.2	8.9	11.3	11.2	1.3	1.9	3.7	2.5	2.2	2.7	0.8	4.2	5.2	43.3	12.5	2.9	2.7	3.3	3.9	4.2	3.1	3.0	8.2	3.9	8.1	3.9	3.8	6.4	2.3	21.0	3.3	4.6	6.2	5.2	17.9	3.9	25.2	3.9	13.9	58.5	2.4	3.5	2.6	4.1	2.2	7.3	4.5	20.2	5.0	3.7	8.2	23.7	12.6	16.5	22.1	4.7	18.8	5.1	6.8	6.9	12.6	9.0	20.5	7.3	6.6	2.1	15.7	4.5	9.2	3.1	3.6	3.0	6.3	5.4	4.6	5.0	13.8	6.0	9.2	5.2	1.1	2.3	3.6	2.2	2.5	0.4	0.9	1.9	1.2	1.9	1.3	1.8	2.0	3.7	2.2	1.1	1.4	2.7	0.8	10.4	10.6	8.5	9.7	8.4	8.5	10.5	8.0	8.4	11.3	47.6	42.2	4.5	11.6	12.4	13.3	38.8	15.3	17.4	20.5	7.0	15.7	25.9	5.0	6.3	45.5	13.2	8.0	0.0	10.6	11.7	11.8	10.1	38.3	28.4	9.2	38.1	9.7	14.1	11.2	28.3	13.0	12.4	13.5	4.6	8.2	28.0	10.1	9.3	15.2	7.7	20.8	12.9	9.9	43.1	8.5	10.3	18.5	10.2	15.5	12.2
TRIM25	"EFP, RNF147, ZNF147"	ENSG00000121060	"Tripartite motif containing 25"	Q14258	17	56887909-56914038	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins"	"Antiviral defense, Host-virus interaction, Immunity, Innate immunity, Ubl conjugation pathway"	"Ligase, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	7	"neutrophil: 20.0"	"Lineage enriched"	"Detected in many"	8	"granulocytes: 20.0"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA005909	Approved		Approved	"Nucleoplasm,Nuclear bodies,Cytosol"		NA	NA		35000	"Nucleoplasm, Cytosol"	"Nuclear bodies"	"HPA005909: AB_1078722"	"unprognostic (8.73e-3)"	"unprognostic (1.57e-2)"	"unprognostic (2.06e-2)"	"unprognostic (6.06e-2)"	"unprognostic (2.69e-1)"	"unprognostic (3.78e-2)"	"prognostic unfavorable (9.37e-4)"	"unprognostic (1.53e-1)"	"unprognostic (4.23e-1)"	"unprognostic (1.15e-1)"	"prognostic favorable (3.36e-4)"	"unprognostic (3.23e-1)"	"unprognostic (3.11e-2)"	"prognostic favorable (9.35e-4)"	"unprognostic (5.21e-2)"	"unprognostic (5.13e-2)"	"unprognostic (7.39e-2)"	20.0	19.7	7.5	23.6	8.9	32.6	19.3	11.6	7.8	15.3	22.5	5.0	8.0	15.3	13.4	12.6	17.7	15.3	18.4	8.3	5.8	6.3	10.1	27.0	20.8	15.9	6.7	5.5	13.3	15.3	13.6	11.5	55.0	7.4	12.2	14.3	12.5	14.5	11.5	11.7	23.1	20.7	10.1	5.2	35.8	14.1	12.8	6.5	26.2	11.8	15.1	18.5	10.6	35.9	1.7	2.4	20.0	2.3	0.8	1.5	0.7	28.5	14.2	3.5	11.8	26.5	22.4	0.0	11.3	22.9	27.1	23.3	13.8	15.7	27.9	23.5	10.8	29.6	17.0	17.0	15.2	15.2	23.8	13.5	18.0	11.0	15.3	22.7	21.5	13.0	10.0	25.6	14.1	30.0	12.9	17.9	19.2	4.4	17.1	13.7	19.1	24.0	15.5	2.2	23.7	27.6	17.2	11.7	17.6	15.8	22.6	6.8	6.4	8.9	14.3	26.2	2.3	19.4	17.5	11.9	12.7	9.1	19.5	11.7	9.7	18.5	4.6	12.3	14.8	4.9	3.0	2.3	0.9	0.9	1.9	1.1	1.7	0.8	0.8	2.4	1.4	0.6	0.8	20.0	0.8	1.4	1.7	1.5	0.7	7.5	8.9	11.6	7.8	5.8	6.3	6.7	5.5	7.4	6.5	32.8	17.5	11.5	7.3	16.5	8.7	7.0	12.7	20.1	20.5	8.7	27.5	4.1	0.0	16.7	2.1	22.4	32.6	0.0	18.7	8.3	7.8	14.6	3.5	28.7	12.5	3.2	17.9	28.3	31.6	1.2	8.9	23.3	13.5	5.4	26.1	5.2	26.1	26.4	8.9	6.3	19.2	6.5	6.4	0.3	0.0	26.7	13.3	8.6	21.8	16.6
TRIM26	"RNF95, ZNF173"	ENSG00000234127	"Tripartite motif containing 26"	Q12899	6	30184455-30213427	"Enzymes, Predicted intracellular proteins"	"Immunity, Innate immunity"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Daudi: 23.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA044975, HPA050456"	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"HPA044975: AB_2679162, HPA050456: AB_2681133"	"unprognostic (1.93e-1)"	"unprognostic (5.41e-2)"	"unprognostic (8.53e-2)"	"unprognostic (1.96e-3)"	"unprognostic (1.52e-1)"	"unprognostic (5.50e-2)"	"unprognostic (2.02e-1)"	"unprognostic (1.40e-2)"	"unprognostic (2.85e-1)"	"unprognostic (3.08e-2)"	"unprognostic (1.97e-1)"	"unprognostic (7.00e-3)"	"unprognostic (1.37e-2)"	"unprognostic (1.63e-3)"	"unprognostic (5.21e-2)"	"unprognostic (8.82e-2)"	"prognostic favorable (3.25e-5)"	11.9	12.6	10.6	20.0	12.2	13.8	13.2	17.6	14.9	10.7	16.1	15.9	14.5	18.5	12.9	18.4	21.5	21.1	18.6	8.4	10.8	11.3	19.5	19.2	12.2	21.3	13.1	8.1	10.9	15.3	16.3	11.5	10.8	12.3	13.4	9.8	17.7	18.4	20.6	9.9	21.5	21.9	14.2	13.1	17.6	15.2	10.9	14.0	13.7	15.8	10.7	21.7	14.7	24.6	3.6	3.8	1.7	4.2	2.1	4.1	3.6	10.2	2.2	0.0	14.5	4.8	2.9	4.8	2.8	3.3	7.3	7.2	0.0	0.4	23.0	8.3	7.1	10.1	11.7	0.0	10.0	2.3	0.0	6.7	3.6	1.6	8.3	4.5	4.5	2.9	3.0	3.5	7.3	4.6	0.0	4.5	11.0	1.6	0.0	0.0	0.0	7.5	11.1	0.0	0.0	3.9	9.9	6.9	3.4	6.0	9.6	0.4	6.2	10.6	4.6	2.9	2.5	3.6	1.5	7.6	5.6	3.9	0.0	0.1	9.2	16.4	12.1	0.0	13.0	9.0	1.7	3.1	0.5	3.9	4.2	3.2	3.2	2.9	3.8	3.8	3.6	1.8	2.7	1.7	2.1	2.6	1.9	4.1	3.6	10.6	12.2	17.6	14.9	10.8	11.3	13.1	8.1	12.3	14.0	26.8	17.1	17.1	21.1	26.8	20.4	11.8	22.9	28.1	13.6	12.2	15.7	16.4	10.0	13.3	0.3	16.1	16.5	0.0	13.7	10.8	12.8	21.2	4.7	45.0	12.2	12.7	21.5	8.6	13.2	1.3	6.9	20.9	16.9	17.2	13.7	11.2	10.2	14.2	11.3	13.0	18.9	6.5	12.5	2.4	12.6	29.6	14.8	22.4	13.3	19.5
TRIM27	"RFP, RNF76"	ENSG00000204713	"Tripartite motif containing 27"	P14373	6	28903002-28923989	"Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Transcription, Transcription regulation, Transport, Ubl conjugation pathway"	"DNA-binding, Repressor, Transferase"	"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA048684, HPA053408"	Approved		Approved	Nucleoplasm,Nucleoli		NA	NA			Nucleoli	Nucleoplasm	"HPA048684: AB_2680493, HPA053408: AB_2682139"	"unprognostic (1.57e-1)"	"unprognostic (1.48e-2)"	"unprognostic (2.36e-1)"	"unprognostic (1.14e-2)"	"unprognostic (1.70e-2)"	"unprognostic (2.56e-1)"	"unprognostic (2.00e-3)"	"unprognostic (1.17e-2)"	"unprognostic (1.01e-2)"	"unprognostic (1.12e-3)"	"unprognostic (4.76e-3)"	"unprognostic (1.16e-2)"	"prognostic unfavorable (3.50e-6)"	"unprognostic (1.27e-1)"	"unprognostic (1.41e-1)"	"unprognostic (1.47e-1)"	"prognostic favorable (2.71e-4)"	11.5	10.6	8.8	25.5	9.7	7.9	9.3	10.1	12.2	11.2	10.2	8.7	20.2	23.8	12.1	13.2	7.8	12.1	11.4	8.1	8.2	9.6	10.1	22.5	10.4	17.4	12.6	8.3	14.7	31.0	7.4	13.9	13.7	10.6	13.7	4.6	7.7	17.0	25.2	12.2	9.7	19.4	9.2	8.4	18.6	18.5	9.2	9.2	16.7	12.5	7.9	12.1	9.9	11.8	12.5	12.5	13.8	13.9	11.2	15.9	13.8	3.3	2.3	1.0	6.1	0.8	1.7	0.7	4.6	1.1	1.4	1.7	1.7	1.4	7.7	8.0	1.3	3.0	7.4	1.1	2.7	0.1	3.0	13.1	11.0	0.5	2.3	1.3	4.6	1.7	1.3	1.7	1.2	0.5	0.1	1.2	8.0	10.6	3.3	0.4	1.3	6.4	2.4	0.0	2.1	7.4	9.1	7.0	14.3	1.1	1.1	3.3	13.1	5.6	3.4	7.4	0.3	3.3	3.6	4.0	3.5	7.1	6.3	2.7	12.2	14.6	12.2	1.8	11.7	5.2	12.6	13.8	8.8	12.7	13.9	15.9	12.5	12.6	14.4	12.5	10.5	11.8	12.1	13.8	11.2	12.1	9.8	10.4	13.8	8.8	9.7	10.1	12.2	8.2	9.6	12.6	8.3	10.6	9.2	14.9	21.9	30.9	26.1	25.2	11.0	14.9	30.6	24.1	19.4	27.9	15.7	41.3	18.3	35.7	9.4	29.1	15.7	23.3	37.7	49.1	24.4	31.4	20.8	36.5	36.4	7.9	26.5	25.2	23.8	4.4	22.2	24.5	8.5	25.2	24.4	9.8	42.8	19.5	17.3	24.1	13.1	19.4	21.1	5.1	11.2	17.1	38.1	26.2	24.4	24.0
TRIM28	"KAP1, PPP1R157, RNF96, TF1B, TIF1B"	ENSG00000130726	"Tripartite motif containing 28"	Q13263	19	58544091-58550722	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction, Transcription, Transcription regulation, Ubl conjugation pathway"	"Chromatin regulator, Repressor, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HEK 293: 221.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB010066, HPA064033"	Supported		Enhanced	Nucleoplasm	"Intracellular and membrane"	NA	NA		140000	Nucleoplasm		"CAB010066: AB_2209905, HPA064033: AB_2685179"	"unprognostic (2.76e-1)"	"unprognostic (1.40e-1)"	"unprognostic (1.16e-1)"	"unprognostic (1.19e-1)"	"unprognostic (1.34e-1)"	"unprognostic (2.99e-1)"	"prognostic unfavorable (1.85e-6)"	"unprognostic (1.20e-2)"	"unprognostic (2.10e-2)"	"unprognostic (2.66e-1)"	"unprognostic (4.92e-3)"	"unprognostic (9.28e-2)"	"unprognostic (2.47e-2)"	"unprognostic (4.67e-2)"	"unprognostic (7.34e-2)"	"unprognostic (4.22e-1)"	"unprognostic (3.28e-2)"	24.2	26.4	17.9	40.1	20.6	52.2	30.6	34.5	26.3	46.7	36.5	26.2	26.2	26.8	43.3	30.0	34.1	34.5	38.5	28.4	18.5	16.4	27.3	42.3	29.5	38.1	29.2	22.7	69.3	47.0	30.7	25.7	45.6	22.8	37.6	18.5	21.5	31.8	32.4	56.5	41.2	27.5	38.4	17.9	34.9	32.9	48.1	23.1	119.9	50.6	33.5	33.5	34.0	46.4	13.7	14.6	5.0	7.6	16.0	16.9	6.3	36.5	78.7	42.3	31.2	18.5	14.2	47.2	24.0	21.8	23.5	18.0	54.8	30.8	40.2	15.9	20.7	43.6	25.1	47.8	34.6	15.4	20.6	221.1	69.2	35.7	43.6	19.7	43.9	44.5	19.2	19.3	30.0	23.5	19.8	21.9	47.6	33.6	22.7	21.6	54.1	61.3	54.1	29.6	37.7	50.7	58.2	25.6	43.2	21.0	60.7	42.4	33.2	25.1	32.7	13.4	13.1	22.4	42.7	20.2	55.3	21.9	12.0	43.0	29.3	47.7	45.0	25.0	32.8	35.0	1.3	7.1	5.0	8.9	7.6	11.6	11.5	12.8	12.3	9.0	13.7	16.9	15.1	3.8	16.0	4.9	14.6	8.2	6.3	17.9	20.6	34.5	26.3	18.5	16.4	29.2	22.7	22.8	23.1	11.9	15.2	37.3	46.8	57.1	60.0	8.4	40.8	8.1	17.0	31.4	25.5	50.7	19.9	38.6	75.8	40.5	45.0	0.0	47.9	51.6	41.1	44.2	21.8	31.0	40.2	52.4	62.0	26.4	32.9	81.1	60.9	36.2	27.0	29.7	61.8	50.0	49.3	45.6	38.9	32.1	31.8	58.2	46.4	124.7	74.6	53.1	46.9	30.5	58.1	39.7
TRIM31	"C6orf13, HCG1, HCGI, RNF"	ENSG00000204616	"Tripartite motif containing 31"	Q9BZY9	6	30102897-30113106	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"intestine: 16.3;lymphoid tissue: 7.4;urinary bladder: 12.2"	"Group enriched"	"Detected in many"	4	"Enterocytes: 222.6;Urothelial cells: 174.9"	"Group enriched"	"Detected in many"	5	"cervical cancer: 6.7;colorectal cancer: 25.8;pancreatic cancer: 11.4;stomach cancer: 19.8;urothelial cancer: 12.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	490	"RT4: 81.4"									HPA074175	Enhanced					NA	NA					"HPA074175: "	"unprognostic (1.37e-1)"	"unprognostic (7.78e-3)"	"unprognostic (1.83e-1)"	"unprognostic (7.05e-3)"	"unprognostic (1.75e-1)"	"unprognostic (9.37e-2)"	"unprognostic (6.13e-2)"	"unprognostic (1.32e-1)"	"unprognostic (2.05e-1)"	"unprognostic (1.11e-2)"	"unprognostic (1.97e-2)"	"unprognostic (1.92e-1)"	"unprognostic (1.43e-3)"	"unprognostic (5.84e-3)"	"unprognostic (6.20e-2)"	"unprognostic (1.60e-1)"	"unprognostic (2.50e-3)"	0.1	0.0	0.1	7.4	0.1	0.0	0.1	0.1	0.1	0.2	16.3	0.1	0.1	1.2	0.1	0.1	0.1	0.1	3.3	0.1	0.1	0.0	0.1	1.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	2.1	0.4	0.1	0.1	0.1	0.1	0.1	13.7	0.7	0.1	0.1	4.8	2.0	0.1	0.1	0.1	0.1	0.1	12.2	5.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	81.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.6	0.5	2.2	0.1	0.0	5.0	7.6	4.0	1.2	0.0	0.0	0.0	0.0	0.9	0.1	0.0	222.6	0.0	1.5	0.0	0.0	1.1	4.6	0.0	0.1	0.0	5.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	36.6	0.0	4.5	45.6	0.0	0.5	0.0	0.0	0.4	2.3	0.1	0.0	0.0	0.0	6.9	174.9
TRIM32	"BBS11, HT2A, LGMD2H, TATIP"	ENSG00000119401	"Tripartite motif containing 32"	Q13049	9	116687302-116701300	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase	"Bardet-Biedl syndrome, Ciliopathy, Disease mutation, Limb-girdle muscular dystrophy, Mental retardation, Obesity"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA050060	Approved		Approved	"Intermediate filaments"		No	No			"Intermediate filaments"		"HPA050060: AB_2681000"	"unprognostic (2.47e-2)"	"unprognostic (7.06e-3)"	"unprognostic (5.50e-2)"	"unprognostic (3.63e-1)"	"unprognostic (5.08e-2)"	"prognostic unfavorable (4.53e-4)"	"prognostic unfavorable (4.72e-4)"	"unprognostic (2.41e-3)"	"unprognostic (2.92e-1)"	"unprognostic (5.01e-2)"	"unprognostic (1.79e-2)"	"unprognostic (5.63e-2)"	"unprognostic (6.03e-2)"	"unprognostic (7.06e-2)"	"unprognostic (2.73e-1)"	"unprognostic (6.64e-3)"	"unprognostic (9.77e-2)"	9.5	9.1	6.6	5.8	11.5	0.8	8.0	23.2	17.1	12.8	7.9	7.2	6.2	6.7	17.0	8.0	8.8	15.9	8.2	8.9	5.7	7.3	6.2	5.0	6.3	8.4	5.7	9.8	12.6	12.5	12.2	7.7	7.0	9.1	10.3	7.4	10.4	10.9	9.2	23.9	6.6	8.9	12.9	5.3	6.9	6.8	6.5	2.2	9.4	8.4	6.2	8.3	11.1	8.8	6.1	3.5	0.2	2.6	5.6	16.0	4.7	6.5	15.0	8.9	9.8	18.1	13.0	6.7	12.2	13.4	13.9	11.7	10.0	7.2	6.8	5.4	18.7	10.4	14.0	10.8	13.7	12.7	5.9	5.2	3.6	9.7	6.1	9.4	2.4	12.0	11.2	12.4	13.1	7.8	15.4	9.0	7.6	5.0	5.8	16.3	8.4	6.4	0.0	8.1	15.8	9.1	7.6	24.0	4.4	5.7	15.3	8.9	4.5	9.6	6.7	6.9	9.4	18.5	2.4	11.1	13.0	10.4	9.5	9.1	9.5	2.5	10.6	10.8	1.6	12.7	0.0	1.3	0.0	9.3	2.6	7.2	6.1	8.2	7.4	1.8	4.4	8.3	8.4	0.2	5.6	2.1	3.5	16.0	4.7	6.6	11.5	23.2	17.1	5.7	7.3	5.7	9.8	9.1	2.2	6.0	1.1	3.0	5.1	3.8	11.5	6.1	7.6	6.7	5.7	8.7	0.0	6.0	1.7	7.8	2.8	2.4	2.4	0.0	7.0	3.6	6.5	2.8	2.3	3.9	5.8	1.6	4.1	2.5	2.7	1.3	4.9	1.4	1.7	1.0	5.2	4.1	4.9	3.5	11.3	2.2	4.5	0.0	3.6	9.8	11.1	3.1	6.2	4.6	4.9	3.4
TRIM33	"FLJ11429, KIAA1113, PTC7, RFG7, TF1G, TIF1G, TIF1GAMMA, TIFGAMMA"	ENSG00000197323	"Tripartite motif containing 33"	Q9UPN9	1	114392777-114511160	"Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Transcription, Transcription regulation, Ubl conjugation pathway"	"DNA-binding, Repressor, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	4	"Early spermatids: 155.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"MCF7: 49.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA004345	Supported		Approved	Nucleoplasm,Vesicles		NA	NA			Vesicles	Nucleoplasm	"HPA004345: AB_1858287"	"unprognostic (8.90e-2)"	"unprognostic (5.86e-2)"	"prognostic favorable (6.20e-4)"	"unprognostic (1.09e-2)"	"unprognostic (8.42e-3)"	"prognostic favorable (8.93e-4)"	"unprognostic (1.34e-2)"	"unprognostic (1.83e-1)"	"unprognostic (6.75e-2)"	"unprognostic (4.58e-2)"	"unprognostic (2.14e-1)"	"unprognostic (1.08e-1)"	"unprognostic (2.27e-2)"	"unprognostic (4.84e-2)"	"unprognostic (1.99e-1)"	"unprognostic (1.40e-1)"	"unprognostic (1.68e-1)"	15.2	12.8	16.9	18.4	19.9	27.1	17.1	38.3	21.8	16.9	14.3	11.0	21.9	10.9	19.8	38.3	16.4	15.0	15.6	10.8	18.1	12.5	17.3	15.0	14.3	15.2	12.1	18.0	19.8	15.7	21.8	22.4	27.2	15.2	16.5	13.0	10.7	16.4	19.1	14.3	19.5	14.8	20.2	12.9	14.9	14.1	29.0	16.3	20.5	17.9	9.8	16.6	17.9	28.7	3.4	4.0	12.2	2.8	4.7	4.4	1.0	13.1	7.1	13.4	10.0	5.7	6.0	22.9	6.7	7.2	9.4	10.0	8.0	5.6	14.1	7.0	7.8	6.1	7.6	12.2	7.8	13.0	10.6	7.2	13.6	9.4	9.3	6.3	17.1	11.3	5.7	5.8	11.1	11.4	7.2	7.8	12.0	16.9	10.0	8.9	49.4	17.2	7.3	18.1	5.0	7.2	14.9	20.5	4.6	6.7	20.7	9.3	9.8	12.7	15.4	12.1	9.0	7.0	9.4	8.8	6.5	10.6	15.1	9.4	7.0	6.5	14.7	9.2	10.0	18.5	12.2	1.6	7.4	3.5	1.8	3.1	3.4	3.7	3.7	2.0	2.2	2.9	4.4	4.8	4.7	2.8	4.0	2.0	1.0	16.9	19.9	38.3	21.8	18.1	12.5	12.1	18.0	15.2	16.3	17.9	29.5	19.1	25.9	46.9	71.6	22.0	25.5	10.7	25.0	52.4	92.3	49.7	1.7	18.3	155.1	31.1	23.6	23.3	20.5	27.8	32.1	38.2	36.9	40.5	26.3	25.4	50.1	37.4	44.7	78.9	45.5	39.2	18.6	17.2	31.4	33.5	25.3	32.6	34.6	12.6	58.2	32.3	23.7	54.0	29.6	48.4	73.3	35.5	28.9	48.8
TRIM36	"HAPRIN, RBCC728, RNF98"	ENSG00000152503	"Tripartite motif containing 36"	Q9NQ86	5	115124762-115180546	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"testis: 88.8"	"Group enriched"	"Detected in many"	39	"Early spermatids: 1875.0;Late spermatids: 3810.8"	"Cancer enhanced"	"Detected in many"		"prostate cancer: 9.0"	"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"myeloid DC: 7.5;non-classical monocyte: 7.7"	"Group enriched"	"Detected in many"	43	"dendritic cells: 7.5;granulocytes: 4.2;monocytes: 7.7"	"Cell line enhanced"	"Detected in many"		"RH-30: 17.8;SCLC-21H: 19.9;SH-SY5Y: 14.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA061321			Approved	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"HPA061321: AB_2684479"	"unprognostic (6.36e-2)"	"unprognostic (2.99e-1)"	"unprognostic (4.54e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.55e-1)"	"unprognostic (2.31e-2)"	"unprognostic (5.33e-6)"	"unprognostic (2.19e-1)"	"unprognostic (1.17e-1)"	"unprognostic (1.94e-1)"	"unprognostic (1.84e-1)"	"unprognostic (1.90e-1)"	"unprognostic (2.82e-13)"	"unprognostic (4.95e-2)"	"unprognostic (1.38e-1)"	"unprognostic (2.19e-1)"	"unprognostic (6.80e-3)"	1.0	1.4	6.8	1.4	7.6	0.8	3.2	0.6	11.7	1.4	4.8	7.7	0.0	8.2	1.1	1.0	0.8	1.9	1.0	0.7	10.1	7.2	0.9	0.9	1.6	0.8	7.1	8.6	3.5	1.5	0.7	8.2	1.3	18.3	5.7	4.8	5.1	1.0	1.0	0.7	1.0	7.9	1.1	8.7	0.9	2.0	88.8	4.7	0.0	0.8	0.0	0.9	0.8	1.0	0.1	7.5	4.2	7.7	0.0	0.0	0.8	2.4	0.7	1.2	6.2	0.1	0.1	1.5	0.5	2.1	1.1	1.3	0.9	1.2	0.0	1.0	0.1	8.8	0.6	5.8	1.1	0.8	0.4	1.9	4.3	2.5	1.2	0.2	4.2	3.6	0.1	1.1	0.5	1.5	1.4	0.0	8.2	0.1	5.9	1.7	3.3	1.1	3.8	4.9	0.4	2.8	0.9	17.8	1.4	0.6	0.0	19.9	14.5	3.8	0.4	2.3	0.6	4.3	5.4	0.5	1.7	1.3	1.3	1.9	0.9	0.5	0.0	1.9	2.4	0.8	0.0	1.7	4.2	0.0	1.6	0.0	0.0	0.0	0.0	7.5	0.1	0.0	0.0	0.3	0.0	7.7	1.6	0.0	0.8	6.8	7.6	0.6	11.7	10.1	7.2	7.1	8.6	18.3	4.7	0.0	4.3	0.0	0.8	2.1	4.8	2.0	0.0	6.7	0.0	1.8	53.0	0.0	0.0	0.4	1875.0	0.7	21.6	0.0	1.6	0.4	0.6	8.8	1.1	0.0	2.5	4.8	3.4	0.6	1.6	3810.8	13.8	6.3	8.5	5.4	11.8	5.7	1.4	9.1	12.0	0.0	73.6	6.5	2.8	33.1	23.0	1.1	0.2	0.0	7.0	0.1
TRIM37	"KIAA0898, MUL, POB1, TEF3"	ENSG00000108395	"Tripartite motif containing 37"	O94972	17	58982638-59106921	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Transcription, Ubl conjugation pathway"	"Repressor, Transferase"	"Dwarfism, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 46.1"	"Cell type enhanced"	"Detected in many"	6	"Early spermatids: 95.8;Spermatocytes: 106.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"basophil: 20.0"	"Low lineage specificity"	"Detected in all"			"Cell line enriched"	"Detected in all"	4	"MCF7: 77.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA021911	Uncertain					NA	NA					"HPA021911: AB_10964487"	"unprognostic (4.07e-2)"	"unprognostic (1.71e-1)"	"unprognostic (2.99e-3)"	"unprognostic (1.23e-1)"	"unprognostic (2.11e-1)"	"unprognostic (1.06e-1)"	"prognostic unfavorable (4.99e-6)"	"unprognostic (7.83e-2)"	"unprognostic (1.44e-1)"	"unprognostic (2.21e-1)"	"unprognostic (1.10e-3)"	"unprognostic (4.79e-2)"	"unprognostic (2.18e-1)"	"unprognostic (1.56e-1)"	"unprognostic (2.46e-1)"	"unprognostic (4.27e-2)"	"unprognostic (3.04e-2)"	6.7	10.3	17.4	7.1	24.4	5.1	7.1	33.4	33.9	7.2	5.9	7.9	4.9	5.2	7.4	9.2	7.1	8.2	7.5	9.1	19.0	19.5	6.5	6.5	7.4	6.8	17.7	18.1	5.5	6.5	6.1	8.9	7.7	32.4	8.1	6.2	5.8	4.4	8.1	7.9	6.1	4.6	8.9	8.7	6.4	5.3	46.1	7.4	6.8	11.1	2.1	6.7	6.8	4.4	3.8	3.4	20.0	3.1	2.9	6.5	2.5	7.0	10.3	7.0	9.3	7.0	6.4	11.4	7.7	11.9	8.4	13.8	6.2	4.8	6.6	11.7	8.0	14.4	6.1	10.2	5.7	13.4	13.0	9.9	10.1	9.7	8.6	12.3	5.2	5.4	5.1	5.5	10.5	13.6	8.6	10.7	6.0	7.9	9.7	8.3	77.0	10.5	3.1	10.4	9.9	6.8	4.7	18.6	4.6	8.0	9.0	17.2	10.2	8.0	3.4	7.5	9.1	9.9	2.5	8.3	13.2	15.8	12.0	8.7	9.8	14.4	5.9	9.0	5.6	6.2	20.0	3.1	3.6	6.3	2.4	5.9	3.2	4.1	4.1	3.4	3.8	3.7	4.7	4.5	2.9	2.3	2.6	6.5	2.5	17.4	24.4	33.4	33.9	19.0	19.5	17.7	18.1	32.4	7.4	8.9	8.3	11.0	5.0	7.0	19.5	20.7	2.5	36.1	21.6	8.7	31.4	13.1	3.3	8.7	95.8	9.0	4.9	0.0	4.9	8.9	8.5	11.1	10.4	15.6	7.5	42.9	11.5	12.3	11.6	61.0	9.2	8.4	11.8	1.8	6.0	18.4	8.5	9.3	16.6	8.1	36.0	12.9	10.1	106.4	36.2	5.5	14.9	5.0	7.6	5.9
TRIM38	"RNF15, RORET"	ENSG00000112343	"Tripartite motif containing 38"	O00635	6	25962802-25991226	"Enzymes, Predicted intracellular proteins"	"Immunity, Innate immunity, Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"B-cells: 100.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA031685	Approved		Approved	"Plasma membrane,Cell Junctions,Centrosome"		NA	NA			Centrosome	"Plasma membrane, Cell Junctions"	"HPA031685: AB_10603218"	"unprognostic (6.62e-2)"	"unprognostic (1.65e-3)"	"unprognostic (3.34e-1)"	"unprognostic (2.72e-2)"	"unprognostic (1.25e-1)"	"unprognostic (6.51e-2)"	"unprognostic (7.79e-2)"	"unprognostic (3.27e-2)"	"unprognostic (2.78e-2)"	"prognostic favorable (8.95e-5)"	"unprognostic (2.81e-2)"	"unprognostic (6.28e-2)"	"unprognostic (2.73e-1)"	"unprognostic (3.36e-1)"	"unprognostic (4.49e-2)"	"prognostic favorable (8.20e-5)"	"prognostic favorable (4.94e-9)"	13.3	8.4	2.5	15.7	2.3	12.0	7.9	1.1	3.4	17.2	12.1	3.1	20.5	6.7	26.2	22.3	15.7	8.9	9.2	5.8	2.8	2.3	26.1	8.8	14.0	14.4	3.7	1.8	11.5	4.3	1.0	4.3	10.3	3.5	15.5	7.8	9.2	9.8	16.5	9.0	5.3	14.6	13.1	4.5	17.6	6.6	5.3	2.9	16.6	13.7	9.5	20.1	18.0	15.4	16.5	10.1	12.1	12.9	6.7	7.9	6.3	3.5	2.0	0.3	4.3	10.4	13.9	3.6	4.5	9.0	8.8	14.6	1.6	3.8	7.9	7.4	5.5	8.5	5.6	2.7	4.4	5.2	8.0	1.8	3.6	3.3	1.4	13.8	4.2	7.4	13.9	3.3	5.4	1.9	7.3	7.6	3.9	2.3	4.4	10.4	1.7	4.0	4.8	1.4	0.0	2.7	6.2	4.3	8.2	10.4	7.1	0.1	0.1	3.4	7.1	12.0	0.5	1.0	5.5	7.7	1.6	2.7	2.7	3.0	5.1	3.7	8.9	4.3	5.2	9.7	10.1	10.6	4.7	7.6	12.9	7.4	14.3	6.5	6.8	10.1	16.5	6.2	6.7	12.1	6.7	11.4	9.5	7.9	6.3	2.5	2.3	1.1	3.4	2.8	2.3	3.7	1.8	3.5	2.9	23.8	43.9	100.5	47.4	13.3	0.6	3.5	22.9	17.4	29.6	43.6	0.0	19.8	14.9	19.1	0.9	42.0	39.9	0.0	13.0	17.5	17.0	35.9	34.6	14.8	28.8	0.0	17.4	27.0	84.3	2.2	18.4	61.3	10.1	49.5	29.9	0.3	17.8	40.3	17.7	62.8	0.7	6.5	18.9	0.2	0.2	8.2	17.7	36.2	23.3	78.5
TRIM39	RNF23	ENSG00000204599	"Tripartite motif containing 39"	Q9HCM9	6	30326479-30343729	"Enzymes, Predicted intracellular proteins"	"Apoptosis, Cell cycle, Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"											"HPA051120, HPA059496"	Uncertain		Supported	Cytosol		NA	NA			Cytosol		"HPA051120: AB_2681348, HPA059496: AB_2684040"	"unprognostic (2.90e-1)"	"unprognostic (1.61e-2)"	"unprognostic (2.79e-2)"	"unprognostic (2.86e-2)"	"unprognostic (6.38e-2)"	"unprognostic (4.55e-2)"	"unprognostic (1.46e-2)"	"unprognostic (1.15e-2)"	"unprognostic (3.47e-1)"	"unprognostic (9.44e-2)"	"prognostic favorable (2.50e-4)"	"unprognostic (1.30e-2)"	"unprognostic (4.69e-2)"	"unprognostic (6.35e-3)"	"unprognostic (1.46e-1)"	"unprognostic (1.06e-1)"	"unprognostic (2.39e-3)"	8.6	7.6	5.2	14.3	6.4	11.8	7.4	8.6	7.6	10.2	11.2	7.3	9.7	7.1	10.0	15.2	11.9	8.5	13.6	6.1	5.4	5.5	7.6	9.6	11.1	6.7	7.7	6.3	10.3	9.1	8.9	11.4	11.6	7.1	7.9	7.1	11.4	8.2	15.5	9.9	6.5	10.9	8.8	6.0	13.1	8.0	14.1	7.2	7.8	8.9	8.3	10.1	9.1	12.3	3.4	1.6	8.4	2.5	4.4	5.2	2.1	4.4	0.2	3.9	6.9	1.8	1.8	4.0	2.1	2.5	3.1	2.8	5.3	0.6	5.7	4.1	3.9	1.9	1.5	4.4	3.1	3.2	4.4	4.9	4.5	0.7	1.9	4.0	6.7	5.1	2.1	2.6	3.9	4.3	4.7	1.9	4.9	6.7	4.6	4.0	4.0	1.4	1.4	5.2	1.9	3.3	3.1	0.8	4.3	3.3	4.3	8.4	4.1	1.6	3.3	4.0	3.9	4.5	1.8	1.7	3.4	2.7	4.1	6.9	8.4	10.1	5.9	2.0	2.4	5.2	1.4	1.7	6.8	5.2	2.5	4.6	3.4	3.7	3.8	1.6	3.3	4.4	4.1	8.4	4.4	2.4	1.2	2.9	2.1	5.2	6.4	8.6	7.6	5.4	5.5	7.7	6.3	7.1	7.2	3.0	7.4	11.5	5.5	3.3	4.9	5.2	2.5	5.3	3.4	1.8	5.9	4.0	6.6	4.2	2.7	3.6	5.8	0.0	5.3	4.8	4.4	3.2	5.7	3.9	2.9	3.2	5.2	6.7	7.2	6.6	2.6	4.4	3.3	3.6	4.4	6.5	5.1	8.6	4.2	3.3	7.7	0.0	5.0	20.2	8.1	3.6	8.4	13.8	3.7	4.7
TRIM4	RNF87	ENSG00000146833	"Tripartite motif containing 4"	Q9C037	7	99876958-99919600	"Enzymes, Predicted intracellular proteins"	"Immunity, Innate immunity, Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"							"Low region specificity"	"Detected in all"			"HPA019356, HPA029461"	Approved		Supported	"Plasma membrane,Cytosol"		NA	NA			Cytosol	"Plasma membrane"	"HPA019356: AB_1856376, HPA029461: AB_10600834"	"unprognostic (1.88e-1)"	"unprognostic (2.97e-2)"	"unprognostic (3.37e-1)"	"unprognostic (3.46e-2)"	"unprognostic (1.80e-2)"	"unprognostic (7.06e-2)"	"unprognostic (1.22e-1)"	"unprognostic (5.42e-2)"	"unprognostic (3.85e-2)"	"unprognostic (2.67e-3)"	"unprognostic (2.48e-2)"	"unprognostic (1.60e-1)"	"prognostic favorable (7.36e-6)"	"unprognostic (1.00e-1)"	"unprognostic (2.38e-1)"	"unprognostic (7.46e-2)"	"unprognostic (5.65e-2)"	19.1	22.6	13.5	22.1	15.9	6.7	22.1	20.1	15.5	19.5	17.3	12.4	22.5	13.9	21.9	18.8	16.4	19.0	19.8	11.1	13.3	9.3	16.6	17.9	21.1	22.4	15.3	8.8	35.0	23.2	18.9	27.4	16.1	12.2	21.9	15.7	18.4	19.4	33.8	9.4	20.7	18.3	18.1	11.9	18.2	17.4	16.2	14.5	18.4	20.5	11.9	18.8	20.0	28.9	18.6	17.0	20.0	19.2	13.9	30.3	17.4	9.7	11.7	7.0	5.8	18.4	17.3	3.1	16.4	20.0	13.7	16.0	6.2	9.6	14.2	0.1	13.9	12.1	11.6	9.2	10.1	14.0	14.4	0.7	11.6	6.2	9.7	26.0	16.7	16.6	18.4	21.5	10.6	27.0	18.7	11.9	7.2	16.9	22.0	11.4	12.1	12.3	15.0	5.3	14.7	10.1	7.0	10.0	16.2	15.2	12.6	8.2	5.8	12.5	19.2	19.5	10.7	8.8	9.6	14.5	15.2	13.6	29.1	15.7	18.5	20.2	11.5	10.0	18.8	20.1	20.0	19.2	15.3	20.6	19.2	23.8	18.6	21.6	23.5	17.0	18.6	30.3	22.2	8.2	13.9	16.6	12.7	21.5	17.4	13.5	15.9	20.1	15.5	13.3	9.3	15.3	8.8	12.2	14.5	23.8	15.3	18.2	24.1	22.2	20.2	4.8	12.7	16.0	10.3	21.0	17.7	13.3	8.3	12.8	5.2	16.1	9.7	23.3	11.3	5.9	15.1	19.8	27.6	17.5	12.8	6.4	8.6	17.8	20.0	8.4	28.7	15.4	21.9	18.0	10.3	34.3	12.7	11.8	25.8	13.4	20.0	0.0	23.1	19.3	8.2	20.1	13.6	18.7	12.1	22.0
TRIM41	"MGC1127, RINCK"	ENSG00000146063	"Tripartite motif containing 41"	Q8WV44	5	181222499-181235809	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 43.7"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HDLM-2: 39.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA024204	Approved		Supported	"Nucleoli,Nuclear bodies"		NA	NA			"Nucleoli, Nuclear bodies"		"HPA024204: AB_1858299"	"unprognostic (1.13e-1)"	"unprognostic (7.05e-2)"	"unprognostic (1.23e-2)"	"unprognostic (7.93e-2)"	"unprognostic (1.61e-1)"	"unprognostic (1.07e-1)"	"unprognostic (9.56e-2)"	"unprognostic (7.24e-2)"	"unprognostic (8.66e-2)"	"unprognostic (6.87e-2)"	"unprognostic (2.21e-3)"	"unprognostic (2.07e-1)"	"unprognostic (5.17e-3)"	"unprognostic (2.45e-3)"	"unprognostic (1.34e-1)"	"prognostic unfavorable (4.22e-4)"	"unprognostic (2.68e-2)"	10.0	8.3	25.5	9.4	24.3	9.3	5.4	7.3	17.0	6.9	6.5	19.8	8.8	11.2	6.1	8.3	7.3	8.4	7.0	9.8	26.9	20.4	10.7	7.6	6.9	6.0	37.3	12.5	5.9	12.3	18.8	7.6	7.3	17.0	7.0	4.0	7.8	8.3	8.4	30.0	9.0	9.0	5.3	43.7	7.5	9.5	19.1	18.3	10.6	11.3	7.2	7.2	5.8	5.2	2.2	2.4	3.9	2.3	1.9	4.3	1.4	4.6	12.3	4.6	7.6	5.4	5.4	10.8	6.9	3.7	5.1	4.8	10.3	7.1	7.9	11.3	4.7	9.5	8.9	4.7	16.5	2.8	39.0	15.1	9.0	12.1	5.8	5.2	6.6	6.2	4.7	8.5	6.3	2.3	4.9	2.9	12.3	11.2	9.9	2.8	16.8	9.9	7.4	4.3	3.5	5.9	9.4	7.0	10.3	2.9	7.5	7.1	6.7	6.3	7.5	9.6	2.1	15.0	7.5	6.0	7.0	4.7	4.1	5.2	21.7	13.7	11.2	7.3	7.8	5.8	0.9	1.4	2.2	2.4	1.1	3.6	1.9	2.5	4.3	1.6	2.2	2.6	3.1	3.9	1.9	2.3	2.4	3.2	1.4	25.5	24.3	7.3	17.0	26.9	20.4	37.3	12.5	17.0	18.3	3.0	14.3	11.3	9.2	7.1	18.9	11.3	7.6	20.1	10.3	10.4	17.7	12.2	10.0	7.4	5.5	9.2	10.7	0.0	10.6	7.8	6.2	7.5	2.3	19.5	7.7	27.0	12.2	11.6	12.3	2.6	4.9	6.7	8.5	8.2	12.0	14.5	8.9	10.1	11.0	6.7	27.6	0.0	7.5	32.2	19.0	9.8	10.9	12.7	10.6	5.8
TRIM5	"RNF88, TRIM5alpha"	ENSG00000132256	"Tripartite motif containing 5"	Q9C035	11	5663557-5938619	"Enzymes, Predicted intracellular proteins"	"Antiviral defense, Autophagy, Host-virus interaction, Immunity, Innate immunity, Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"							"Low region specificity"	"Detected in many"			"CAB013497, HPA023420, HPA023422"	Approved		Supported	Cytosol		NA	NA			Cytosol		"CAB013497: , HPA023420: AB_1856378, HPA023422: AB_1856379"	"unprognostic (2.60e-1)"	"unprognostic (9.62e-2)"	"unprognostic (2.04e-2)"	"unprognostic (1.41e-2)"	"unprognostic (6.88e-2)"	"unprognostic (4.74e-3)"	"unprognostic (5.48e-3)"	"unprognostic (5.82e-2)"	"unprognostic (1.49e-1)"	"unprognostic (6.76e-3)"	"unprognostic (8.54e-3)"	"unprognostic (1.64e-1)"	"unprognostic (2.20e-2)"	"unprognostic (1.90e-1)"	"unprognostic (1.09e-1)"	"unprognostic (1.07e-2)"	"unprognostic (6.12e-2)"	12.5	15.0	3.7	11.6	6.7	3.0	10.7	2.4	5.1	14.2	8.5	4.8	20.1	8.4	16.1	19.9	12.0	11.9	9.9	7.8	5.6	2.9	15.1	16.2	15.2	9.2	6.5	2.9	15.3	24.8	6.1	9.2	12.2	8.8	11.8	8.3	11.8	22.0	12.4	3.0	6.5	13.2	12.0	9.0	19.8	9.5	7.7	6.5	24.9	20.5	7.9	13.3	14.8	12.3	3.9	11.7	13.8	9.8	5.9	5.4	4.6	4.7	7.3	12.5	8.7	13.9	12.8	3.7	10.1	18.8	20.6	27.9	7.4	9.4	3.0	7.9	9.9	16.6	7.8	10.1	14.7	9.3	6.5	2.8	9.1	5.0	5.9	12.3	6.7	9.8	9.7	13.2	6.8	18.1	12.8	31.7	6.6	9.5	6.2	17.3	2.2	5.5	3.1	5.7	7.0	5.1	8.6	2.7	0.8	14.3	9.0	0.3	0.7	7.1	10.3	4.4	12.7	5.3	3.9	23.9	9.7	12.9	1.8	2.4	5.5	3.9	1.2	9.0	4.5	10.0	10.2	9.8	12.9	5.4	9.8	5.3	3.9	4.1	4.3	11.7	3.9	3.4	4.9	13.8	5.9	9.2	9.7	3.3	4.6	3.7	6.7	2.4	5.1	5.6	2.9	6.5	2.9	8.8	6.5	6.0	9.4	12.9	8.1	4.6	0.1	4.8	2.5	2.7	13.6	10.4	0.0	6.5	5.0	10.5	3.2	11.6	5.9	0.0	7.7	8.4	8.9	11.0	0.0	11.1	5.7	0.0	1.2	13.5	11.5	2.3	7.2	7.7	3.3	1.8	8.6	5.7	9.0	3.5	7.1	5.7	0.0	19.4	6.8	5.8	3.6	4.6	6.5	5.7	5.6	8.2
TRIM50	"FLJ32804, TRIM50A"	ENSG00000146755	"Tripartite motif containing 50"	Q86XT4	7	73312539-73328082	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in some"	4	"pancreas: 17.2;stomach 1: 22.8"	"Cell type enhanced"	"Detected in some"	14	"Distal tubular cells: 1.7;Early spermatids: 1.9;Spermatocytes: 4.4;Spermatogonia: 4.5"	"Group enriched"	"Detected in some"	8	"liver cancer: 2.9;renal cancer: 6.0"					"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	33	"Hep G2: 12.3"									"HPA019862, HPA047843"	Uncertain		Approved	Cytosol		NA	NA			Cytosol		"HPA019862: AB_1858305, HPA047843: AB_2680176"	"unprognostic (1.93e-1)"	"unprognostic (3.93e-1)"	"unprognostic (1.07e-2)"	"unprognostic (5.96e-2)"	"unprognostic (3.87e-1)"	"unprognostic (2.66e-2)"	"unprognostic (1.49e-1)"	"unprognostic (3.04e-3)"	"unprognostic (2.63e-2)"	"unprognostic (2.00e-1)"	"unprognostic (2.13e-1)"	"unprognostic (1.33e-1)"	"prognostic favorable (9.36e-7)"	"unprognostic (3.91e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.20e-1)"	"unprognostic (2.25e-1)"	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0			1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0		0.0	17.2	0.2	0.0	0.3		0.0	0.0		0.0	0.0	1.8	0.0	1.0	0.0	0.0	0.1	22.8	4.4			0.0		0.0	0.0	0.0	0.9	0.3	0.0	0.8	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	12.3	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.3	0.9	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.4	1.9	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.2	0.3	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	4.4	4.5	0.0	0.1	0.0	0.0	0.0
TRIM56	RNF109	ENSG00000169871	"Tripartite motif containing 56"	Q9BRZ2	7	101085439-101097967	"Enzymes, Predicted intracellular proteins"	"Antiviral defense, Immunity, Innate immunity, Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA024358	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"HPA024358: AB_1858308"	"unprognostic (6.47e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.99e-2)"	"unprognostic (1.62e-1)"	"unprognostic (9.44e-3)"	"unprognostic (8.30e-2)"	"prognostic unfavorable (3.87e-4)"	"unprognostic (2.63e-1)"	"unprognostic (4.11e-1)"	"unprognostic (3.90e-1)"	"unprognostic (1.91e-1)"	"unprognostic (1.43e-1)"	"unprognostic (2.35e-2)"	"unprognostic (2.47e-3)"	"unprognostic (8.13e-2)"	"unprognostic (1.49e-1)"	"prognostic favorable (2.13e-4)"	14.3	12.0	6.2	15.7	9.3	4.7	24.5	3.2	11.1	14.9	15.0	6.8	22.3	9.7	14.3	13.1	12.9	12.8	13.7	8.7	7.5	5.2	10.8	10.4	23.7	11.7	15.8	5.2	17.3	10.8	10.7	15.2	14.0	8.8	12.5	8.3	7.5	12.2	22.1	8.7	13.2	12.8	15.2	8.5	17.2	10.3	5.6	12.0	9.7	14.0	9.1	12.0	13.6	22.0	3.3	2.1	7.4	2.4	7.7	3.6	1.0	9.9	12.5	5.4	6.9	12.5	13.0	6.5	8.3	7.4	13.5	12.6	5.9	14.5	11.8	9.0	6.9	18.8	11.5	2.2	7.6	9.1	11.8	3.5	7.4	15.7	4.4	11.2	13.1	16.9	8.2	11.1	8.8	14.4	13.2	7.1	7.6	12.9	15.0	9.3	13.6	11.0	14.6	5.4	5.3	10.4	10.2	8.8	7.7	7.1	10.4	0.3	0.2	9.2	25.8	7.0	7.2	5.9	8.6	13.4	19.0	16.9	14.2	8.9	7.4	7.4	9.3	9.4	10.7	14.8	2.5	2.4	2.1	3.6	1.5	2.6	2.0	2.7	2.3	0.8	3.3	2.6	3.4	7.4	7.7	2.1	2.1	1.1	1.0	6.2	9.3	3.2	11.1	7.5	5.2	15.8	5.2	8.8	12.0	68.5	72.4	41.5	67.9	4.6	3.2	19.1	89.2	77.6	52.4	48.8	2.0	33.7	3.3	51.6	1.8	75.8	45.5	23.3	41.2	22.2	26.5	58.9	14.0	41.9	17.0	9.5	28.1	86.5	38.1	0.8	122.6	36.3	1.7	21.6	43.9	23.6	46.8	49.1	88.8	6.7	2.8	64.7	27.4	4.7	6.6	2.9	24.9	62.3	41.9	50.8
TRIM58	BIA2	ENSG00000162722	"Tripartite motif containing 58"	Q8NG06	1	247857199-247878205	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 24.8;placenta: 22.4;thyroid gland: 15.2"	"Cell type enriched"	"Detected in many"	16	"Erythroid cells: 186.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"HAP1: 8.0;HEL: 21.4;K-562: 11.8;PC-3: 20.7;U-2 OS: 16.8;WM-115: 21.8"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			HPA023637	Uncertain					NA	NA		310000			"HPA023637: AB_1858309"	"unprognostic (3.85e-1)"	"unprognostic (5.24e-3)"	"unprognostic (7.00e-2)"	"unprognostic (6.52e-4)"	"unprognostic (1.46e-1)"	"unprognostic (3.47e-2)"	"unprognostic (1.10e-1)"	"unprognostic (4.14e-5)"	"unprognostic (3.59e-1)"	"unprognostic (2.07e-1)"	"unprognostic (1.27e-1)"	"unprognostic (5.00e-2)"	"unprognostic (3.31e-1)"	"unprognostic (1.08e-2)"	"unprognostic (3.34e-1)"	"unprognostic (1.00e-2)"	"unprognostic (2.57e-2)"	0.7	0.8	1.3	1.0	4.4	24.8	0.7	0.3	3.7	0.6	1.3	0.2	0.0	0.3	0.5	0.4	0.5	1.4	0.5	0.8	1.5	3.2	0.5	0.6	3.4	0.4	2.4	1.2	1.1	0.4	0.3	0.7	22.4	6.9	1.7	1.0	1.1	0.5	0.4	0.5	1.2	0.6	0.8	1.3	5.8	0.7	4.9	0.1	0.0	15.2	0.0	0.4	1.9	0.7	3.1	0.6	3.7	0.7	1.7	0.3	1.9	0.0	0.0	0.0	0.0	0.3	1.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.2	1.0	8.0	0.0	0.0	0.0	0.8	21.4	0.0	0.0	0.0	2.8	1.6	0.0	0.0	0.1	0.0	0.0	0.0	0.8	11.8	0.1	0.0	0.0	0.0	0.1	1.4	0.0	20.7	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.8	0.1	2.1	0.0	0.0	16.8	0.0	0.0	3.6	0.0	0.0	0.0	6.1	21.8	2.8	0.7	1.8	0.3	0.5	0.2	3.1	0.2	0.2	0.6	1.0	0.3	0.2	3.7	1.7	0.6	0.6	0.2	1.9	1.3	4.4	0.3	3.7	1.5	3.2	2.4	1.2	6.9	0.1	3.0	4.0	1.7	0.6	0.9	2.3	0.4	0.0	6.7	10.3	1.8	11.8	2.4	0.0	0.1	3.1	0.8	0.0	186.9	0.0	3.3	1.5	2.9	8.1	0.0	2.0	0.0	1.2	1.8	2.6	0.5	0.9	1.6	1.7	0.0	0.4	1.5	0.2	0.0	0.7	0.0	3.5	0.0	0.8	2.8	10.9	0.6	4.1	1.3	0.8	0.9
TRIM6	RNF89	ENSG00000121236	"Tripartite motif containing 6"	Q9C030	11	5596109-5612958	"Enzymes, Predicted intracellular proteins"	"Host-virus interaction, Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"kidney: 42.7"	"Cell type enhanced"	"Detected in many"	19	"Cytotrophoblasts: 11.1;Extravillous trophoblasts: 12.7;Proximal tubular cells: 42.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"neutrophil: 3.9"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"NTERA-2: 14.4;SuSa: 25.2;U-2 OS: 14.2"	"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			HPA060514	Uncertain					NA	NA					"HPA060514: AB_2684300"	"unprognostic (9.00e-2)"	"unprognostic (2.10e-3)"	"unprognostic (9.16e-3)"	"unprognostic (1.82e-1)"	"unprognostic (3.25e-3)"	"unprognostic (3.25e-3)"	"unprognostic (2.35e-2)"	"unprognostic (3.26e-3)"	"unprognostic (8.59e-2)"	"unprognostic (3.40e-2)"	"unprognostic (8.61e-2)"	"unprognostic (3.90e-1)"	"unprognostic (5.68e-2)"	"unprognostic (4.65e-4)"	"unprognostic (4.77e-1)"	"unprognostic (3.33e-2)"	"unprognostic (4.36e-1)"	3.7	5.8	0.6	1.5	1.3	1.3	3.0	0.2	1.4	4.2	2.6	1.4	3.2	0.1	4.2	4.3	6.0	3.1	1.8	2.6	0.8	0.7	42.7	1.1	2.2	0.2	0.7	0.6	3.9	1.8	1.9	1.9	10.9	2.1	3.9	1.2	6.6	14.7	3.9	1.3	1.1	2.2	4.7	1.4	2.8	1.6	15.5	1.0	1.6	3.8	1.1	3.2	4.9	3.7	0.3	2.2	3.9	0.7	1.0	0.3	0.4	0.4	10.4	0.7	0.0	1.2	2.0	12.2	2.8	2.1	2.8	2.7	0.3	2.3	0.0	1.6	2.8	7.8	1.8	4.7	4.3	4.0	0.3	3.2	1.2	1.0	0.0	0.4	4.1	5.7	3.4	4.1	3.9	2.8	4.2	2.4	0.0	4.9	0.1	1.2	0.1	0.0	0.5	14.4	1.6	3.6	4.8	0.0	0.1	0.6	4.2	0.0	0.1	0.0	5.4	0.5	25.2	2.0	0.7	12.2	2.7	14.2	0.0	2.9	0.1	0.1	0.0	2.4	0.0	2.2	0.7	0.7	1.4	0.3	0.0	0.1	0.3	0.1	0.0	2.2	0.2	0.1	0.1	3.9	1.0	0.0	0.9	0.1	0.4	0.6	1.3	0.2	1.4	0.8	0.7	0.7	0.6	2.1	1.0	0.0	4.5	0.0	0.4	0.5	0.0	0.4	0.0	1.4	0.0	1.8	0.0	11.1	3.3	0.9	1.0	0.6	0.0	0.0	0.2	12.7	1.9	0.4	0.0	0.6	2.8	0.0	0.0	0.0	2.9	0.0	0.9	1.1	1.7	3.6	0.1	0.0	0.5	0.0	1.8	42.8	0.0	0.0	0.4	7.7	2.1	0.4	4.8	0.0	0.1	0.2
TRIM62	"DEAR1, FLJ10759"	ENSG00000116525	"Tripartite motif containing 62"	Q9BVG3	1	33145402-33182059	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Horizontal cells: 9.5;Sertoli cells: 6.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"AF22: 20.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA050061			Approved	"Vesicles,Focal adhesion sites"		NA	NA			"Vesicles, Focal adhesion sites"		"HPA050061: AB_2681001"	"unprognostic (1.57e-1)"	"unprognostic (4.39e-2)"	"unprognostic (2.39e-2)"	"unprognostic (2.62e-2)"	"unprognostic (1.14e-2)"	"unprognostic (5.80e-2)"	"unprognostic (5.10e-5)"	"unprognostic (2.05e-2)"	"unprognostic (1.14e-1)"	"unprognostic (4.32e-2)"	"unprognostic (3.55e-3)"	"unprognostic (3.66e-1)"	"prognostic unfavorable (7.08e-5)"	"unprognostic (2.14e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.05e-1)"	"unprognostic (2.05e-3)"	4.8	11.8	10.1	6.4	19.2	9.3	6.2	19.0	13.9	5.6	4.9	31.8	1.6	5.6	4.9	6.9	6.9	5.1	4.9	5.3	12.3	10.5	5.3	2.7	5.6	9.6	28.1	9.1	6.7	4.8	7.5	9.2	19.6	15.4	8.7	5.4	5.0	10.8	7.5	6.7	20.5	5.8	6.9	12.8	8.3	6.5	4.0	23.7	8.7	6.3	5.1	10.4	9.8	7.3	3.0	1.8	6.0	3.5	1.7	8.5	2.1	2.9	2.3	20.7	3.4	5.2	2.3	6.3	2.9	8.7	5.4	4.8	2.4	3.0	4.7	3.2	2.6	2.6	6.0	4.1	3.8	5.2	4.5	3.2	5.4	2.5	1.9	5.0	1.7	13.5	4.5	3.5	7.2	1.8	8.9	5.4	4.3	0.8	3.1	5.5	7.8	5.3	1.7	4.9	3.7	2.9	6.7	10.8	2.2	3.5	7.7	5.0	3.1	3.2	12.2	13.8	12.1	3.4	1.2	5.2	2.3	3.2	6.6	2.2	5.8	2.5	2.3	4.2	3.2	2.8	2.2	2.0	6.0	2.7	3.5	4.6	2.2	4.1	3.7	1.8	3.0	2.8	2.7	4.4	1.7	2.2	0.8	8.5	2.1	10.1	19.2	19.0	13.9	12.3	10.5	28.1	9.1	15.4	23.7	3.0	2.1	0.9	0.7	2.4	2.4	0.6	0.0	0.0	0.0	1.8	0.0	0.8	0.0	1.4	0.5	1.0	1.1	0.0	1.7	1.6	1.3	2.2	1.1	0.6	1.0	9.5	1.7	1.3	1.2	0.0	2.3	1.2	0.0	1.0	2.0	1.4	2.1	0.0	4.6	0.6	0.8	6.5	2.0	1.1	0.4	4.1	1.1	1.9	0.9	1.7
TRIM63	"IRF, MURF-1, RNF28, SMRZ"	ENSG00000158022	"Tripartite motif containing 63"	Q969Q1	1	26051304-26068436	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	"Muscle protein, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	7	"skeletal muscle: 271.4"	"Cell type enriched"	"Detected in some"	11	"Cardiomyocytes: 236.2"	"Cancer enriched"	"Detected in some"	10	"melanoma: 31.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	38	"ASC diff: 10.7;SK-MEL-30: 34.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"									NA	NA						"unprognostic (1.10e-1)"	"unprognostic (4.80e-4)"	"unprognostic (1.45e-2)"	"unprognostic (7.52e-3)"	"unprognostic (1.44e-1)"	"unprognostic (2.05e-2)"	"unprognostic (3.42e-1)"	"unprognostic (1.12e-1)"	"unprognostic (2.71e-1)"	"unprognostic (1.06e-1)"	"unprognostic (3.17e-1)"	"unprognostic (1.01e-1)"	"unprognostic (2.16e-2)"	"unprognostic (5.90e-2)"	"unprognostic (1.33e-2)"	"unprognostic (2.32e-1)"	"unprognostic (5.58e-2)"	3.4	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	1.0	1.2	1.7	0.0	0.6	38.2	0.0	0.0	0.3	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.9	0.1	0.5	0.0	3.6	1.0	0.0	271.4	0.6	0.1	0.9	0.1	0.0	0.1	0.1	0.0	0.0	1.7	12.7	0.8	1.2	0.3	0.0	0.9	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	10.7	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.6	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	34.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.1	0.0	0.1	0.8	0.0	236.2	10.2	0.0	0.0	1.8	0.0	0.4	1.7	0.7	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	9.3	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.8	0.0	0.0	0.0	0.2	0.0	0.0	21.6	0.0	0.0	0.0	0.0	0.0	0.1	1.4	0.0	0.0	0.0
TRIM68	"FLJ10369, RNF137, SS-56"	ENSG00000167333	"Tripartite motif containing 68"	Q6AZZ1	11	4598672-4608259	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA023455	Uncertain		Supported	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"HPA023455: AB_1858319"	"unprognostic (4.77e-2)"	"unprognostic (5.15e-2)"	"unprognostic (1.18e-1)"	"unprognostic (4.10e-2)"	"unprognostic (4.13e-2)"	"unprognostic (8.63e-2)"	"unprognostic (2.01e-2)"	"unprognostic (1.28e-1)"	"unprognostic (2.01e-1)"	"unprognostic (6.70e-2)"	"unprognostic (2.75e-2)"	"unprognostic (7.78e-2)"	"prognostic favorable (4.14e-6)"	"unprognostic (4.23e-2)"	"unprognostic (2.98e-1)"	"unprognostic (1.61e-1)"	"unprognostic (1.37e-1)"	7.7	11.3	11.1	8.0	11.1	3.1	10.6	15.2	12.8	16.3	10.9	12.6	18.2	10.3	10.6	12.2	8.0	12.6	10.3	9.4	9.6	7.9	14.9	12.7	11.7	7.6	13.1	10.5	17.3	9.9	12.6	10.5	9.8	10.0	16.8	10.1	9.9	12.0	17.5	8.7	7.6	9.8	9.8	11.9	10.7	12.4	13.2	9.5	10.0	17.8	6.7	8.9	11.7	8.4	9.1	5.9	8.9	5.2	5.5	12.8	7.6	8.4	9.5	3.9	6.4	6.4	10.5	0.0	9.3	6.9	8.5	7.8	1.2	8.8	5.8	5.7	4.7	8.1	10.0	3.9	6.5	7.3	14.4	7.6	7.1	2.4	0.0	7.4	11.3	10.0	8.1	9.6	5.0	7.6	8.9	10.7	5.4	6.5	3.0	7.6	2.0	9.3	3.1	4.6	5.9	7.9	7.5	5.6	0.2	5.5	3.8	2.1	3.8	0.0	9.5	5.9	8.1	4.1	5.7	8.6	11.4	7.9	11.5	4.1	11.9	12.9	8.4	7.9	5.0	10.7	6.4	2.7	8.9	9.0	5.1	10.1	9.1	9.9	10.0	5.9	7.9	12.8	10.1	0.3	5.5	5.2	4.0	8.7	7.6	11.1	11.1	15.2	12.8	9.6	7.9	13.1	10.5	10.0	9.5	0.0	2.2	0.9	1.1	0.7	3.7	4.3	0.0	0.0	6.8	5.2	2.0	4.9	5.0	2.5	0.4	2.2	2.3	0.0	2.9	2.1	1.6	1.8	3.5	4.5	2.0	0.0	6.4	3.1	2.2	0.0	1.7	1.5	0.0	2.8	5.9	3.7	2.4	0.0	1.8	1.7	2.7	6.5	2.1	2.6	4.3	0.9	3.7	1.3	4.3	0.5
TRIM69	"RNF36, Trif, TRIMLESS"	ENSG00000185880	"Tripartite motif containing 69"	Q86WT6	15	44728988-44767829	"Enzymes, Predicted intracellular proteins"	"Apoptosis, Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	5	"testis: 68.6"	"Cell type enhanced"	"Detected in many"	9	"Early spermatids: 172.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	4	"T-reg: 8.2"	"Lineage enriched"	"Detected in many"	7	"T-cells: 8.2"	"Cell line enhanced"	"Detected in some"		"Karpas-707: 4.1;U-266/70: 13.8;U-266/84: 3.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA028894	Enhanced					NA	NA					"HPA028894: AB_10603136"	"unprognostic (4.82e-3)"	"unprognostic (1.23e-2)"	"unprognostic (4.10e-1)"	"unprognostic (2.01e-1)"	"unprognostic (1.75e-2)"	"unprognostic (4.20e-1)"	"unprognostic (9.27e-2)"	"unprognostic (4.95e-2)"	"unprognostic (6.49e-2)"	"unprognostic (3.53e-3)"	"unprognostic (1.38e-1)"	"unprognostic (3.72e-2)"	"prognostic favorable (2.26e-5)"	"unprognostic (4.79e-2)"	"unprognostic (1.82e-1)"	"unprognostic (1.91e-2)"	"unprognostic (1.49e-2)"	4.6	3.9	9.0	4.0	10.8	3.0	3.9	7.2	9.1	3.5	4.4	5.1	1.7	3.6	3.4	3.7	4.7	3.4	4.1	11.0	7.9	7.9	4.7	3.8	3.8	4.9	7.5	5.4	3.8	2.8	3.4	4.9	3.1	5.3	5.9	4.2	3.7	3.7	3.2	14.0	4.1	4.0	5.3	5.7	6.7	3.9	68.6	4.7	3.9	5.3	5.2	5.5	4.1	8.1	1.2	0.0	0.1	0.3	0.0	8.2	0.3	0.2	0.0	0.4	0.7	0.5	1.2	0.0	0.1	0.5	0.9	2.5	0.0	0.3	0.2	0.2	0.0	0.2	0.0	0.3	0.0	0.6	2.6	0.0	0.3	0.1	0.0	0.9	0.0	0.2	1.5	0.9	0.2	0.2	2.1	0.2	1.0	0.0	4.1	0.4	0.0	0.0	0.1	0.1	0.6	0.0	0.3	0.0	0.0	0.4	0.0	0.2	0.3	0.0	0.0	0.0	0.4	0.1	0.0	0.1	0.0	0.0	0.8	0.3	13.8	3.4	2.1	0.4	0.4	0.1	0.0	0.0	0.0	0.6	0.2	1.2	1.2	1.9	1.8	0.0	0.0	0.3	1.2	0.1	0.0	0.3	0.0	8.2	0.3	9.0	10.8	7.2	9.1	7.9	7.9	7.5	5.4	5.3	4.7	6.0	6.1	20.6	18.3	18.9	9.8	54.6	10.2	9.4	14.8	8.7	3.9	4.6	34.9	28.3	172.6	14.8	12.1	0.0	14.0	3.5	9.3	13.2	13.9	4.7	32.0	22.3	4.1	11.1	18.8	66.2	8.6	18.5	11.8	73.9	6.5	11.7	18.3	14.4	11.0	17.2	2.6	6.5	21.7	6.7	1.5	36.0	1.3	22.0	5.3	41.5
TRIM7	"GNIP, RNF90"	ENSG00000146054	"Tripartite motif containing 7"	Q9C029	5	181193924-181205293	"Cancer-related genes, Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skeletal muscle: 81.8;tongue: 34.0"	"Cell type enhanced"	"Detected in many"	8	"Basal keratinocytes: 15.9;Cardiomyocytes: 22.9;Sertoli cells: 12.9;Suprabasal keratinocytes: 24.8"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in some"	16	"cerebellum: 21.7"	"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"monocytes: 4.9;T-cells: 2.2"	"Cell line enhanced"	"Detected in many"		"HaCaT: 11.4;HDLM-2: 24.1;PC-3: 13.3;TIME: 11.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA039213	Approved		Approved	Nucleoplasm,Vesicles,Cytosol		NA	NA			Vesicles	"Nucleoplasm, Cytosol"	"HPA039213: AB_10795173"	"unprognostic (6.58e-2)"	"unprognostic (1.17e-1)"	"unprognostic (5.20e-2)"	"unprognostic (1.10e-2)"	"unprognostic (6.85e-2)"	"unprognostic (1.80e-2)"	"unprognostic (3.89e-4)"	"unprognostic (3.45e-2)"	"unprognostic (3.72e-1)"	"unprognostic (1.64e-1)"	"unprognostic (3.48e-2)"	"unprognostic (1.97e-1)"	"unprognostic (7.16e-3)"	"unprognostic (1.26e-1)"	"unprognostic (3.90e-2)"	"unprognostic (6.17e-2)"	"unprognostic (1.15e-2)"	1.3	0.9	0.1	0.9	0.5	0.5	3.4	21.7	1.3	2.5	0.8	0.3	1.1	0.5	1.0	6.4	13.0	0.6	1.7	2.2	0.1	0.8	2.2	0.5	0.9	0.6	0.2	0.2	0.6	4.2	1.6	1.9	0.5	0.5	2.0	0.6	0.6	5.9	1.1	81.8	9.5	0.6	0.9	0.3	0.8	1.4	0.9	0.2	0.1	3.3	34.0	13.5	1.6	2.9	0.7	0.8	0.1	4.9	0.5	2.2	1.1	6.1	3.0	0.0	0.3	0.5	0.5	0.2	1.4	0.0	0.5	1.2	0.3	8.1	0.4	4.3	1.7	2.6	11.4	3.3	9.3	0.1	24.1	1.3	0.5	7.9	0.1	1.6	0.0	1.4	0.1	7.2	0.2	4.6	1.8	2.6	1.1	0.3	1.3	0.2	0.8	0.3	0.2	0.0	9.7	13.3	0.3	4.2	0.9	3.3	0.0	0.3	0.7	2.9	0.2	4.1	0.1	0.7	0.2	11.0	0.1	2.4	0.4	4.3	1.9	0.2	0.7	0.3	0.4	1.0	0.0	4.9	0.1	1.4	1.9	2.2	0.4	1.2	1.4	0.8	0.7	2.2	1.8	0.1	0.5	1.4	0.6	2.2	1.1	0.1	0.5	21.7	1.3	0.1	0.8	0.2	0.2	0.5	0.2	0.0	1.4	0.0	3.9	15.9	5.7	22.9	0.0	0.0	0.0	3.5	0.0	0.0	5.0	0.4	0.6	1.4	2.4	0.0	2.0	0.4	0.8	1.8	0.0	0.2	1.1	0.0	0.0	1.8	9.4	0.0	0.9	1.6	1.7	0.0	3.1	0.5	3.2	8.5	1.4	1.1	2.7	12.9	9.0	0.9	0.4	24.8	0.0	0.0	2.2	2.4
TRIM71	"LIN-41, LIN41"	ENSG00000206557	"Tripartite motif containing 71"	Q2Q1W2	3	32818018-32897826	"Enzymes, Predicted intracellular proteins"	"RNA-mediated gene silencing, Ubl conjugation pathway"	"Developmental protein, RNA-binding, Transferase"	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"lung: 6.5;testis: 11.1"	"Cell type enhanced"	"Detected in some"	12	"Alveolar cells type 1: 8.9;Extravillous trophoblasts: 13.2;Spermatogonia: 12.6"	"Cancer enriched"	"Detected in some"	28	"testis cancer: 28.6"	"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 11.9;BEWO: 36.1;Hep G2: 23.3;NTERA-2: 31.9;SuSa: 30.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"HPA038141, HPA038142"	Uncertain		Approved	"Plasma membrane,Actin filaments,Focal adhesion sites"		NA	NA			"Plasma membrane, Actin filaments, Focal adhesion sites"		"HPA038141: AB_2675857, HPA038142: AB_10697240"	"unprognostic (2.93e-2)"	"unprognostic (4.29e-3)"	"unprognostic (1.70e-1)"	"unprognostic (1.02e-2)"	"unprognostic (2.58e-2)"	"unprognostic (3.27e-2)"	"unprognostic (2.09e-2)"	"unprognostic (1.25e-1)"	"unprognostic (3.16e-2)"	"unprognostic (3.04e-1)"	"unprognostic (1.11e-2)"	"unprognostic (3.11e-1)"	"unprognostic (4.36e-6)"	"unprognostic (3.92e-2)"	"unprognostic (9.27e-2)"	"unprognostic (8.17e-2)"	"unprognostic (4.65e-2)"	0.1	0.0	0.7	0.1	1.9	0.5	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.0	0.0	2.7	0.7	2.2	0.0	6.5	0.0	0.2	0.0	0.1	0.0	0.0	0.5	1.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.0	0.0	0.1	0.1	11.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.5	0.3	0.0	0.1	0.0	0.0	0.0	11.9	0.0	0.0	0.0	36.1	0.0	0.0	0.0	0.0	8.5	0.0	0.0	0.0	0.0	0.0	0.0	3.1	0.0	0.0	0.0	0.0	0.6	0.0	23.3	0.0	0.6	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.1	0.0	0.0	0.2	2.5	31.9	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	30.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	1.1	0.0	0.2	0.3	0.0	0.1	0.0	0.0	0.1	0.1	0.1	0.3	0.0	0.1	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.7	1.9	0.0	0.5	2.7	0.7	0.2	0.0	1.9	0.0	8.9	2.6	0.0	0.0	0.0	0.4	2.8	0.0	1.4	3.4	0.0	0.0	3.1	0.0	0.0	1.0	0.0	0.0	0.0	0.0	13.2	0.3	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.4	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	2.9	0.4	0.0	0.0	0.3	12.6	0.0	3.3	0.0	0.0	0.0
TRIM8	"GERP, RNF27"	ENSG00000171206	"Tripartite motif containing 8"	Q9BZR9	10	102642310-102660680	"Enzymes, Predicted intracellular proteins"	"Immunity, Innate immunity, Ubl conjugation pathway"	Transferase	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023560, HPA023561"	Approved		Supported	Nucleoplasm,Vesicles,Cytosol		NA	NA			Nucleoplasm	"Vesicles, Cytosol"	"HPA023560: AB_10600414, HPA023561: AB_10601861"	"unprognostic (4.32e-2)"	"unprognostic (6.90e-2)"	"unprognostic (3.02e-3)"	"unprognostic (1.45e-1)"	"unprognostic (1.78e-1)"	"unprognostic (5.03e-1)"	"unprognostic (3.82e-2)"	"unprognostic (1.03e-1)"	"unprognostic (2.15e-3)"	"unprognostic (4.62e-2)"	"unprognostic (5.41e-2)"	"unprognostic (1.52e-1)"	"unprognostic (9.55e-2)"	"unprognostic (1.48e-1)"	"unprognostic (3.12e-2)"	"unprognostic (8.34e-2)"	"unprognostic (1.36e-2)"	31.7	18.4	26.1	23.9	25.2	17.0	18.0	26.1	31.6	31.8	19.5	22.9	15.4	15.8	18.0	14.3	17.8	21.6	19.8	25.0	23.2	18.0	27.2	21.9	23.0	25.4	20.1	20.0	19.3	35.9	24.7	14.7	17.5	16.3	17.4	8.1	19.4	28.5	18.5	34.8	14.6	23.7	13.6	15.7	22.5	21.2	11.7	21.9	48.3	26.6	14.5	30.3	21.4	15.9	9.0	11.9	17.8	5.3	5.5	7.2	3.9	26.9	6.3	6.3	10.2	6.9	14.1	5.8	9.7	19.7	10.5	8.5	11.4	32.6	8.7	26.0	21.5	4.6	9.9	4.2	13.0	8.7	8.8	8.2	21.9	5.3	26.0	17.6	4.9	8.8	16.1	7.2	23.1	13.7	35.0	14.0	4.5	4.1	13.1	8.2	17.5	9.3	16.4	3.4	9.8	12.9	4.6	14.1	4.3	12.5	19.0	3.8	7.4	5.3	6.6	12.8	7.4	18.8	9.8	25.9	14.2	6.3	7.9	21.7	11.9	7.8	5.0	21.6	12.3	3.6	10.7	4.8	2.6	6.8	4.4	6.7	9.0	7.2	5.3	4.1	7.0	6.4	5.5	17.8	5.5	5.3	11.9	6.9	3.9	26.1	25.2	26.1	31.6	23.2	18.0	20.1	20.0	16.3	21.9	53.6	64.6	14.3	12.5	27.9	37.2	34.1	33.1	37.5	36.4	83.7	7.9	10.3	34.9	50.3	0.9	21.5	18.8	0.0	39.1	2.9	23.8	18.6	8.1	24.1	21.7	27.0	20.7	26.4	31.7	0.4	28.7	27.1	16.9	46.9	30.1	22.7	48.9	17.5	32.2	40.0	14.3	12.9	24.3	2.3	5.3	19.9	9.2	17.5	20.4	18.7
TRIM9	"RNF91, SPRING"	ENSG00000100505	"Tripartite motif containing 9"	Q9C026	14	50975262-51096061	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	9	"brain: 61.5"	"Group enriched"	"Detected in some"	6	"Bipolar cells: 45.6;Cone photoreceptor cells: 31.4;Muller glia cells: 49.8;Rod photoreceptor cells: 26.4"	"Cancer enriched"	"Detected in some"	8	"glioma: 25.4"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AN3-CA: 19.7;HAP1: 14.0;HDLM-2: 21.5;SCLC-21H: 20.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA						"unprognostic (1.22e-1)"	"unprognostic (6.37e-2)"	"unprognostic (1.17e-1)"	"unprognostic (1.10e-3)"	"unprognostic (6.67e-2)"	"unprognostic (1.13e-2)"	"unprognostic (2.24e-3)"	"unprognostic (7.66e-2)"	"unprognostic (1.88e-1)"	"unprognostic (3.06e-2)"	"unprognostic (2.38e-3)"	"unprognostic (1.06e-1)"	"unprognostic (1.20e-1)"	"unprognostic (1.55e-1)"	"unprognostic (9.00e-2)"	"unprognostic (7.57e-6)"	"unprognostic (1.85e-3)"	1.9	3.9	21.5	2.7	20.9	2.2	2.7	49.1	61.5	2.1	2.5	10.3	0.0	1.5	4.8	3.0	1.7	1.5	6.5	1.7	17.4	11.4	1.9	3.6	1.5	1.5	10.8	21.7	2.3	1.9	1.5	5.7	1.6	13.0	2.0	2.4	1.8	3.9	5.2	1.5	1.6	1.7	5.2	7.1	1.6	1.7	2.0	11.5	0.0	1.5	0.0	1.5	2.0	0.9	0.0	0.1	0.8	0.0	0.0	0.4	0.4	0.0	2.2	3.5	19.7	0.0	0.0	1.3	0.0	0.0	0.3	0.5	1.5	0.2	0.2	0.1	0.3	3.4	0.0	14.0	0.0	0.6	21.5	2.8	1.0	0.0	0.0	0.0	0.7	0.7	0.6	0.0	0.3	0.0	0.0	0.0	1.8	0.0	0.1	0.5	0.0	4.2	0.5	1.1	0.0	3.0	2.5	5.1	0.1	0.0	0.0	20.3	1.6	0.3	0.0	4.3	0.2	0.3	0.5	0.0	1.3	0.6	0.0	0.9	0.4	0.0	0.2	6.0	0.5	7.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.8	0.0	0.0	0.0	0.0	0.4	21.5	20.9	49.1	28.6	17.4	11.4	10.8	21.7	13.0	11.5	0.0	0.0	0.0	0.1	0.5	45.6	1.4	2.5	0.0	0.0	0.0	31.4	0.1	1.7	0.2	0.1	0.0	0.0	0.0	0.0	1.9	0.5	0.2	0.0	0.0	0.2	1.6	1.2	0.6	0.3	0.0	2.0	0.0	6.8	0.0	0.0	49.8	0.1	0.0	3.9	0.2	26.4	0.0	0.5	0.2	0.7	0.0	0.2	0.0	0.0	0.0
TRIML1	"FLJ36180, RNF209"	ENSG00000184108	"Tripartite motif family like 1"	Q8N9V2	4	188139419-188147743	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	"Developmental protein, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	21	"testis: 14.1"	"Cell type enriched"	"Detected in some"	4	"Early spermatids: 94.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	5	"BEWO: 5.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"									NA	NA											"unprognostic (6.99e-2)"									"unprognostic (5.21e-1)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	5.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	94.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	23.2	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.9	0.2	0.0	0.9	0.0	0.0	0.0
TRIML2	"FLJ25801, SPRYD6"	ENSG00000179046	"Tripartite motif family like 2"	Q8N7C3	4	188091273-188109603	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"placenta: 9.8;testis: 6.2"	"Cell type enhanced"	"Detected in some"	17	"Cytotrophoblasts: 13.9;Early spermatids: 18.8;Extravillous trophoblasts: 5.5;Syncytiotrophoblasts: 7.4"	"Cancer enriched"	"Detected in some"	33	"testis cancer: 24.4"	"Region enhanced"	"Detected in single"		"basal ganglia: 1.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	4	"SuSa: 58.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA043838	Uncertain		Approved	"Plasma membrane,Cytosol"		NA	NA			"Plasma membrane, Cytosol"		"HPA043838: AB_10963835"	"unprognostic (3.32e-1)"	"unprognostic (1.99e-1)"		"unprognostic (1.30e-1)"	"unprognostic (9.82e-2)"	"unprognostic (1.21e-5)"		"unprognostic (3.06e-2)"	"unprognostic (1.65e-3)"		"unprognostic (2.65e-1)"		"unprognostic (0.00e+0)"	"unprognostic (2.26e-2)"	"unprognostic (1.20e-1)"		"unprognostic (1.28e-3)"	0.1	0.1	0.2	0.1	1.4	0.0	0.1	0.1	0.4	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.2	0.1	0.1	0.1	0.1	0.1	0.0	0.1	9.8	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	6.2	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	12.6	0.0	0.0	0.0	0.0	7.0	0.1	0.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	2.9	0.3	2.4	0.0	0.0	0.8	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	8.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	58.2	0.0	0.0	0.0	0.0	2.9	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	1.4	0.1	0.4	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.3	0.0	0.0	0.0	0.0	0.0	13.9	0.0	0.0	18.8	0.0	0.0	0.0	0.0	5.5	0.3	0.1	0.0	0.0	1.2	0.0	0.0	0.0	0.0	3.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	2.5	0.0	7.4	0.0	0.0	0.3
TRIO	ARHGEF23	ENSG00000038382	"Trio Rho guanine nucleotide exchange factor"	O75962	5	14143702-14532128	"Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		"Guanine-nucleotide releasing factor, Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes, Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Leydig cells: 72.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"U-87 MG: 63.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008157, HPA064664"	Supported		Approved	Vesicles,Cytosol		No	No			Cytosol	Vesicles	"HPA008157: AB_1858327, HPA064664: AB_2685315"	"unprognostic (6.65e-2)"	"unprognostic (4.21e-3)"	"unprognostic (1.65e-1)"	"prognostic unfavorable (1.90e-4)"	"unprognostic (9.39e-2)"	"unprognostic (4.13e-1)"	"unprognostic (2.18e-3)"	"unprognostic (2.55e-1)"	"unprognostic (7.52e-2)"	"unprognostic (1.63e-1)"	"unprognostic (2.02e-1)"	"unprognostic (1.82e-1)"	"prognostic unfavorable (3.11e-5)"	"unprognostic (1.78e-2)"	"unprognostic (1.96e-1)"	"unprognostic (4.58e-3)"	"unprognostic (2.23e-1)"	29.7	13.7	27.6	15.8	18.9	5.8	30.3	32.6	29.7	13.7	18.5	11.3	9.2	8.3	23.1	19.3	10.4	12.2	25.2	15.1	18.9	15.0	11.7	12.6	15.8	10.9	11.0	17.7	28.9	11.5	17.2	19.6	13.7	12.3	16.3	16.5	23.3	10.5	14.0	19.8	16.0	15.6	22.7	11.6	24.2	13.7	11.3	11.5	7.4	10.0	11.9	12.3	15.6	16.9	3.8	2.7	0.3	1.9	4.3	0.6	0.4	12.3	4.4	10.7	5.1	23.0	30.2	12.3	11.5	13.7	9.2	10.6	2.8	4.9	2.8	8.6	15.5	22.5	3.8	1.8	5.4	19.1	7.9	2.5	1.5	12.0	3.5	11.9	3.8	4.3	14.1	5.7	32.5	10.4	8.7	8.1	1.9	0.3	1.9	22.3	2.3	0.0	2.6	2.7	1.3	4.0	2.8	6.5	9.5	9.0	5.6	4.9	19.7	9.7	2.5	5.1	14.1	1.5	0.6	18.8	17.8	11.3	12.9	13.5	0.0	0.6	3.6	63.2	2.5	4.2	0.3	1.5	0.0	0.1	1.9	0.3	2.0	0.0	0.0	1.4	3.8	0.0	0.0	0.0	4.3	1.4	2.7	0.6	0.4	27.6	18.9	32.6	29.7	18.9	15.0	11.0	17.7	12.3	11.5	17.9	23.4	9.0	13.2	14.5	29.9	15.7	10.2	16.0	22.7	10.4	13.7	7.6	0.0	18.3	1.9	24.8	13.6	0.0	12.1	17.8	12.4	32.5	17.3	15.3	13.2	27.0	17.3	11.1	12.3	2.4	72.8	16.8	5.0	6.4	21.7	7.1	29.1	16.1	40.3	2.9	3.0	6.5	11.5	2.8	6.4	12.0	6.9	4.6	17.1	20.1
TRIP12	KIAA0045	ENSG00000153827	"Thyroid hormone receptor interactor 12"	Q14669	2	229763838-229923239	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"DNA damage, DNA repair, Ubl conjugation pathway"	Transferase	"Autism spectrum disorder, Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036835, HPA045893"	Enhanced		Approved	"Nuclear speckles"		NA	NA			"Nuclear speckles"		"HPA036835: AB_2675340, HPA045893: AB_2679486"	"unprognostic (1.22e-1)"	"unprognostic (4.87e-2)"	"unprognostic (2.61e-1)"	"unprognostic (3.33e-2)"	"unprognostic (6.81e-2)"	"unprognostic (1.88e-1)"	"prognostic unfavorable (3.60e-4)"	"unprognostic (3.37e-3)"	"unprognostic (3.49e-3)"	"unprognostic (4.87e-2)"	"unprognostic (5.21e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.22e-1)"	"unprognostic (1.62e-1)"	"unprognostic (6.83e-2)"	"unprognostic (8.80e-2)"	"unprognostic (2.01e-2)"	29.6	28.1	23.6	25.4	26.9	26.9	23.1	20.5	26.2	24.0	23.1	26.2	24.3	14.3	25.3	26.3	30.6	19.9	20.7	35.9	19.0	19.3	26.2	24.9	26.2	26.5	23.1	20.5	24.3	18.8	32.4	33.1	27.2	24.8	25.8	21.3	22.3	25.5	22.0	62.7	23.6	22.0	26.2	23.3	32.5	23.4	77.1	24.0	42.2	28.0	21.5	31.5	26.5	27.4	7.0	9.1	25.8	12.0	9.1	12.7	6.1	24.1	27.3	25.1	21.0	23.9	29.1	23.3	37.4	25.3	27.1	30.2	21.9	19.4	9.4	27.4	33.3	34.8	18.9	36.5	26.6	39.7	38.7	13.3	65.8	22.9	19.3	20.7	49.4	43.0	25.2	20.5	45.0	28.9	21.1	35.3	23.8	48.6	10.2	30.9	18.4	27.6	17.1	19.6	12.3	12.5	25.1	49.5	8.3	20.1	41.6	25.5	18.2	0.5	12.5	25.7	22.8	12.7	30.3	49.0	35.2	25.0	22.8	28.8	17.7	20.2	30.9	26.8	19.5	29.4	18.8	9.9	15.7	9.5	11.3	9.7	7.0	8.8	9.2	9.1	6.8	7.3	7.0	25.8	9.1	12.0	9.0	12.7	6.1	23.6	26.9	20.5	26.2	19.0	19.3	23.1	20.5	24.8	24.0	83.4	49.3	17.2	24.2	27.5	29.6	80.3	38.2	65.6	51.2	29.6	49.1	23.6	13.3	31.9	89.6	47.2	37.6	0.0	38.7	20.9	28.2	43.4	37.1	48.3	30.9	39.7	17.9	58.3	81.5	79.5	32.2	36.5	25.3	26.2	30.2	28.2	45.3	32.3	42.8	26.2	32.5	19.4	30.1	113.9	53.0	31.7	35.5	27.7	25.5	54.5
TRIT1	"FLJ20061, IPT"	ENSG00000043514	"TRNA isopentenyltransferase 1"	Q9H3H1	1	39841022-39883511	"Enzymes, Predicted intracellular proteins"	"tRNA processing"	Transferase	"Disease mutation, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA024174, HPA027330"	Approved		Supported	Mitochondria		NA	NA			Mitochondria		"HPA024174: AB_1858346, HPA027330: "	"unprognostic (4.61e-2)"	"unprognostic (1.77e-1)"	"unprognostic (8.38e-3)"	"prognostic unfavorable (8.80e-4)"	"unprognostic (4.00e-2)"	"unprognostic (8.55e-2)"	"prognostic unfavorable (5.34e-6)"	"unprognostic (2.90e-1)"	"unprognostic (2.21e-3)"	"unprognostic (3.18e-2)"	"unprognostic (3.54e-1)"	"unprognostic (6.68e-3)"	"prognostic unfavorable (7.08e-8)"	"unprognostic (6.03e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.22e-1)"	"unprognostic (6.90e-2)"	9.5	10.3	12.9	10.4	19.1	8.0	19.8	25.8	18.4	15.1	13.4	15.9	22.7	11.4	19.3	21.3	19.8	18.4	9.1	15.9	12.5	12.0	14.6	13.2	11.9	14.8	13.9	10.4	16.7	27.7	14.1	26.7	17.6	14.4	21.4	15.8	13.5	15.1	23.9	10.1	22.9	11.7	18.0	9.8	14.0	12.9	17.3	17.9	15.4	19.2	9.4	14.7	17.2	17.5	3.9	13.4	0.9	6.6	2.4	5.2	2.8	14.7	6.8	14.8	15.1	7.4	11.2	22.4	9.8	13.2	15.8	17.8	13.1	19.5	8.6	13.0	8.4	9.5	15.1	21.3	16.9	22.2	10.4	10.8	18.3	15.8	8.1	17.1	17.7	10.0	9.4	15.3	19.8	19.6	16.2	12.7	18.9	24.7	10.3	9.9	7.2	13.5	19.1	19.9	11.2	6.2	14.4	18.6	19.6	15.0	19.0	16.8	11.2	14.1	9.6	10.8	16.4	10.7	30.4	9.1	10.6	13.0	18.2	16.2	14.0	11.0	17.3	13.4	18.1	9.1	0.0	6.6	0.9	2.7	4.9	5.2	3.9	2.6	2.9	13.4	3.2	3.4	3.5	0.1	2.4	5.8	11.6	2.7	2.8	12.9	19.1	25.8	18.4	12.5	12.0	13.9	10.4	14.4	17.9	20.8	5.6	4.4	14.1	13.2	3.1	8.9	7.6	20.1	10.3	7.0	2.0	27.7	6.6	9.5	3.6	5.1	3.2	0.0	8.1	30.0	8.3	6.6	2.3	5.8	7.2	14.3	9.8	8.6	6.2	2.0	8.9	6.8	5.0	7.2	8.2	5.2	9.2	7.0	10.6	7.0	7.3	0.0	5.2	18.6	16.7	14.9	13.8	3.5	8.9	9.0
TRMT1	"FLJ20244, TRM1"	ENSG00000104907	"TRNA methyltransferase 1"	Q9NXH9	19	13104902-13117567	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"tRNA processing"	"Methyltransferase, RNA-binding, Transferase, tRNA-binding"	"Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Kupffer cells: 88.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041130, HPA041380"	Approved		Approved	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Plasma membrane, Cytosol"	Nucleoplasm	"HPA041130: AB_10803995, HPA041380: AB_10793873"	"unprognostic (2.10e-2)"	"unprognostic (2.40e-3)"	"unprognostic (2.23e-2)"	"unprognostic (1.01e-1)"	"unprognostic (1.12e-2)"	"unprognostic (5.54e-2)"	"unprognostic (1.08e-3)"	"unprognostic (2.19e-2)"	"unprognostic (1.59e-1)"	"unprognostic (7.62e-2)"	"unprognostic (1.91e-2)"	"unprognostic (8.74e-3)"	"prognostic unfavorable (9.87e-7)"	"unprognostic (1.19e-3)"	"unprognostic (3.47e-2)"	"unprognostic (2.22e-1)"	"unprognostic (2.49e-2)"	15.5	15.0	19.1	19.8	23.5	23.1	16.6	19.5	22.6	15.0	16.3	17.3	15.5	14.9	19.2	19.0	17.6	19.6	19.4	13.2	15.7	13.4	14.4	17.3	13.5	26.8	22.1	14.7	29.1	23.8	16.3	14.4	14.4	21.9	18.1	14.5	10.9	14.9	15.6	21.4	22.1	16.1	16.5	12.4	25.0	16.3	16.8	20.1	12.2	15.6	12.1	19.6	17.3	18.8	11.2	14.9	3.1	15.7	4.3	10.2	8.5	15.4	10.4	11.3	19.2	11.5	14.8	16.2	17.4	8.7	19.2	16.7	11.1	12.7	19.4	22.8	9.3	10.0	14.3	18.9	15.3	8.9	12.6	26.4	15.4	26.8	18.7	20.9	30.8	18.2	20.9	20.6	19.9	18.8	12.3	14.1	14.5	33.3	6.2	11.9	17.1	12.5	33.3	26.8	9.8	24.5	21.1	14.6	26.7	11.9	15.7	26.9	12.2	10.8	22.6	18.1	8.6	8.8	17.3	15.6	27.7	10.8	16.7	30.4	10.8	20.8	17.9	12.9	32.7	14.4	1.2	15.7	0.5	8.1	11.9	7.7	10.4	8.6	7.7	14.9	11.2	10.2	7.7	3.1	4.3	7.5	8.8	5.6	8.5	19.1	23.5	19.5	22.6	15.7	13.4	22.1	14.7	21.9	20.1	11.9	16.2	35.0	22.3	21.3	8.0	6.4	12.7	10.7	4.5	12.2	2.0	19.4	5.0	14.1	16.4	17.5	6.3	0.0	12.8	18.8	13.9	10.4	28.9	8.6	41.5	7.9	6.9	7.4	88.1	36.5	13.0	39.6	16.9	23.4	9.6	5.8	12.2	5.8	12.0	11.2	11.1	12.9	16.5	21.7	18.3	18.1	12.9	18.7	17.4	18.4
TRMT10A	"MGC27034, RG9MTD2, TRM10"	ENSG00000145331	"TRNA methyltransferase 10A"	Q8TBZ6	4	99546709-99564032	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		"Methyltransferase, Transferase"	"Diabetes mellitus, Disease mutation, Dwarfism, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Spermatocytes: 76.6;Spermatogonia: 51.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA047601, HPA058241"	Uncertain		Supported	"Nucleoplasm,Nucleoli,Actin filaments,Cytosol"		NA	NA			"Nucleoplasm, Nucleoli, Actin filaments"	Cytosol	"HPA047601: AB_2680099, HPA058241: AB_2683651"	"unprognostic (5.24e-2)"	"unprognostic (1.69e-1)"	"unprognostic (1.34e-1)"	"unprognostic (1.96e-3)"	"unprognostic (2.10e-1)"	"unprognostic (5.65e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.02e-1)"	"unprognostic (1.59e-2)"	"unprognostic (3.65e-2)"	"unprognostic (1.57e-1)"	"unprognostic (3.51e-1)"	"unprognostic (7.49e-3)"	"unprognostic (3.32e-2)"	"unprognostic (2.78e-2)"	"prognostic unfavorable (2.14e-4)"	"unprognostic (1.68e-2)"	7.0	8.9	6.5	7.5	8.9	3.3	13.1	6.1	8.7	4.6	6.0	9.3	7.5	7.3	5.5	7.2	9.2	10.1	6.1	5.0	7.9	6.7	9.1	16.8	4.9	7.4	9.2	6.1	6.6	12.4	6.7	12.2	10.0	9.7	7.4	6.9	2.5	7.3	4.7	9.3	6.5	10.4	5.1	10.5	7.0	7.6	16.7	10.1	10.7	10.8	5.1	8.0	7.2	10.8	8.8	10.0	9.2	7.6	5.8	7.1	4.0	6.7	4.8	9.3	4.8	5.5	7.8	6.7	8.2	3.2	5.8	4.3	3.9	8.4	9.3	3.2	4.8	5.2	3.9	10.8	5.2	8.9	11.8	4.8	6.4	4.1	6.4	5.3	16.2	6.9	4.9	13.4	5.8	12.7	3.4	5.8	8.5	14.7	8.4	4.9	7.8	13.6	3.3	5.5	12.1	4.6	7.9	8.9	5.9	7.8	5.5	5.8	5.1	4.5	24.9	8.2	8.1	8.1	7.0	4.2	5.9	6.1	4.8	9.3	5.8	9.8	8.5	4.5	9.5	4.1	4.0	7.6	3.7	3.8	7.1	3.1	6.3	6.5	6.4	10.0	8.8	6.7	6.2	9.2	5.8	6.2	5.6	7.1	4.0	6.5	8.9	6.1	8.7	7.9	6.7	9.2	6.1	9.7	10.1	3.0	9.3	6.0	5.1	7.2	4.6	5.9	12.7	20.1	4.5	10.4	3.9	14.6	36.5	11.9	34.0	6.7	10.7	0.0	16.6	14.7	5.4	5.0	8.1	24.2	7.1	4.8	6.9	9.2	7.9	11.7	6.1	4.7	5.0	5.4	9.8	7.8	14.8	11.0	7.1	17.0	5.9	12.9	7.1	76.6	51.2	8.3	14.6	4.8	9.6	5.9
TRMT10B	"bA3J10.9, FLJ31455, RG9MTD3"	ENSG00000165275	"TRNA methyltransferase 10B"	Q6PF06	9	37753803-37778972	"Enzymes, Predicted intracellular proteins"		"Methyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA021800	Uncertain		Approved	"Nucleoplasm,Plasma membrane"		NA	NA			Nucleoplasm	"Plasma membrane"	"HPA021800: AB_1856214"	"unprognostic (1.00e-2)"	"unprognostic (1.78e-1)"	"unprognostic (3.35e-2)"	"unprognostic (3.89e-2)"	"unprognostic (2.42e-2)"	"unprognostic (7.68e-2)"	"unprognostic (7.78e-2)"	"prognostic favorable (3.91e-4)"	"unprognostic (5.49e-3)"	"unprognostic (1.71e-2)"	"prognostic favorable (5.34e-4)"	"unprognostic (1.40e-1)"	"unprognostic (6.62e-2)"	"unprognostic (1.76e-2)"	"unprognostic (1.68e-1)"	"unprognostic (9.58e-2)"	"unprognostic (2.33e-3)"	7.4	10.3	9.9	10.9	10.3	10.1	9.8	13.7	12.3	10.6	11.8	12.7	12.8	8.3	17.3	9.5	10.4	9.6	10.6	7.0	9.9	9.2	8.2	8.0	8.6	13.1	16.4	9.8	15.4	10.5	9.0	13.8	7.4	10.0	14.8	7.1	12.1	10.3	12.1	7.8	20.4	9.7	11.8	12.7	12.1	10.8	5.0	10.4	10.0	12.4	5.6	13.6	14.8	10.1	9.2	4.6	6.6	5.3	4.6	7.6	2.7	5.3	6.3	8.2	7.3	5.0	4.1	3.8	5.3	3.8	5.4	4.7	3.8	4.7	10.0	3.9	4.0	3.2	6.2	3.9	6.4	4.9	4.3	6.9	8.7	15.6	3.9	9.2	8.9	6.3	4.7	6.6	4.7	9.1	6.5	5.5	12.1	7.0	4.4	4.1	3.8	9.1	7.0	7.3	5.6	7.8	9.3	2.9	5.2	5.2	4.9	11.2	10.8	4.3	5.4	4.7	5.4	5.9	6.5	5.4	4.2	6.1	6.7	4.6	5.0	6.8	7.9	2.5	7.1	8.5	6.6	5.3	2.8	6.7	4.6	7.6	6.6	6.0	6.3	2.5	9.2	7.3	6.7	5.4	4.6	3.2	4.6	3.9	2.7	9.9	10.3	13.7	12.3	9.9	9.2	16.4	9.8	10.0	10.4	3.0	6.2	23.8	10.8	6.5	15.5	7.4	10.2	8.1	9.1	3.5	5.9	13.3	10.0	9.6	1.6	12.0	7.8	23.3	11.0	7.0	7.4	11.1	13.9	6.6	7.2	15.9	13.3	9.2	11.4	0.2	13.6	12.3	10.1	7.2	12.9	12.8	8.8	7.0	22.3	6.7	12.8	25.8	8.6	4.4	3.2	6.6	10.2	19.2	9.0	7.8
TRMT10C	"FLJ20432, MRPP1, RG9MTD1"	ENSG00000174173	"TRNA methyltransferase 10C, mitochondrial RNase P subunit"	Q7L0Y3	3	101561862-101566446	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"tRNA processing"	"Methyltransferase, Transferase"	"Disease mutation, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA036671	Approved		Supported	Nucleoplasm,Mitochondria		NA	NA			Mitochondria	Nucleoplasm	"HPA036671: AB_10602085"	"unprognostic (7.42e-2)"	"unprognostic (2.68e-1)"	"unprognostic (9.08e-3)"	"unprognostic (4.47e-3)"	"unprognostic (5.01e-2)"	"unprognostic (5.55e-2)"	"prognostic unfavorable (6.56e-5)"	"unprognostic (1.67e-2)"	"unprognostic (8.48e-2)"	"unprognostic (5.42e-2)"	"unprognostic (4.70e-2)"	"unprognostic (3.28e-2)"	"prognostic favorable (3.32e-5)"	"unprognostic (2.77e-2)"	"unprognostic (1.37e-1)"	"unprognostic (1.04e-1)"	"unprognostic (1.05e-2)"	18.0	21.2	13.1	13.6	14.1	14.4	19.7	16.4	19.1	16.1	15.3	5.5	12.9	11.6	14.6	13.1	20.9	15.0	10.7	20.4	13.0	13.4	26.6	34.6	10.0	19.3	12.5	16.7	18.8	12.1	9.9	19.9	18.2	18.5	16.2	14.2	5.5	14.5	13.0	35.2	15.2	16.5	15.3	14.3	19.6	15.6	14.7	10.6	23.0	16.6	30.5	18.5	15.6	11.3	21.6	15.4	27.4	14.8	12.2	23.1	11.8	21.0	10.3	13.7	13.8	12.6	10.8	12.8	12.6	12.3	16.4	18.4	15.6	14.3	43.8	16.4	7.8	13.3	21.3	26.4	19.2	22.7	15.6	13.0	29.4	8.2	11.3	9.7	25.8	12.5	12.6	20.0	14.3	13.4	8.8	15.9	16.8	24.9	9.8	17.6	14.4	20.6	18.9	25.5	27.4	22.4	15.4	11.2	19.5	21.0	17.9	34.2	19.5	9.8	20.9	27.6	12.6	27.6	28.4	10.5	9.0	17.0	5.9	13.2	11.4	20.8	42.0	15.2	18.6	13.4	27.4	11.2	7.3	13.6	14.4	18.8	21.6	16.8	15.8	13.5	20.4	23.1	21.1	4.9	12.2	14.8	15.4	15.0	11.8	13.1	14.1	16.4	19.1	13.0	13.4	12.5	16.7	18.5	10.6	20.8	20.0	45.2	114.9	83.8	27.3	45.1	15.3	44.2	47.8	27.9	13.7	57.1	44.7	44.7	22.0	33.0	12.7	0.0	29.3	34.7	35.1	33.3	46.1	46.1	28.0	20.6	34.3	28.8	19.4	6.3	34.5	28.4	13.5	36.9	26.7	27.5	31.9	14.0	35.3	55.3	29.1	32.3	41.5	61.4	51.3	91.8	54.8	41.7	40.3	115.3
TRMT12	"FLJ20772, Trm12, TYW2"	ENSG00000183665	"TRNA methyltransferase 12 homolog"	Q53H54	8	124450820-124462150	"Enzymes, Predicted intracellular proteins"	"tRNA processing"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"MCF7: 37.2"	"Low region specificity"	"Detected in all"							HPA023939	Approved		Approved	Nucleoplasm,Mitochondria		No	No			Nucleoplasm	Mitochondria	"HPA023939: AB_1848793"	"unprognostic (2.54e-2)"	"unprognostic (2.20e-1)"	"unprognostic (7.81e-2)"	"unprognostic (1.02e-2)"	"unprognostic (8.75e-2)"	"prognostic unfavorable (2.99e-5)"	"prognostic unfavorable (5.10e-4)"	"unprognostic (6.89e-2)"	"unprognostic (1.99e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.51e-1)"	"unprognostic (6.56e-2)"	"unprognostic (4.72e-3)"	"unprognostic (3.39e-2)"	"unprognostic (2.40e-1)"	"prognostic unfavorable (9.25e-4)"	"unprognostic (1.04e-2)"	10.8	11.6	16.7	8.4	20.9	4.1	15.0	13.8	18.3	11.8	9.5	8.0	6.8	7.5	11.9	10.7	9.6	13.2	8.6	9.9	19.4	9.9	12.9	9.8	9.8	11.8	13.6	14.3	8.8	10.1	14.7	17.7	8.9	14.7	12.0	11.2	7.8	12.0	11.0	18.0	9.9	9.6	14.3	12.9	11.0	10.6	11.7	13.4	9.1	14.9	12.0	10.7	10.2	8.5	5.8	5.0	6.3	6.1	5.1	7.6	4.4	7.4	6.5	5.4	4.2	10.3	5.3	1.3	4.7	5.6	7.0	6.0	4.0	5.2	7.6	6.6	4.8	4.5	5.2	7.7	7.8	8.3	7.5	5.9	7.3	6.2	1.3	8.1	0.0	6.0	6.6	10.4	6.8	8.7	2.0	5.8	8.0	10.2	5.3	4.3	37.2	8.6	3.1	0.0	17.4	6.1	2.7	3.6	5.0	6.4	8.1	9.2	7.4	7.0	26.2	9.8	4.8	7.4	3.1	4.6	4.9	12.8	3.6	5.3	5.5	7.7	2.9	4.4	2.6	3.9	0.5	6.1	6.3	4.5	4.9	5.6	4.0	6.1	4.6	5.0	5.8	7.6	7.4	2.4	5.1	5.5	1.5	3.7	4.4	16.7	20.9	13.8	18.3	19.4	9.9	13.6	14.3	14.7	13.4	8.9	6.9	5.9	5.4	4.6	5.6	2.7	7.6	8.1	1.2	3.5	15.7	5.8	5.0	4.9	11.1	5.2	3.6	0.0	5.4	4.5	3.3	3.4	9.2	5.1	4.5	7.9	2.9	3.7	3.2	14.2	3.7	3.3	5.0	2.8	4.2	3.9	3.6	3.5	5.6	6.6	8.3	0.0	5.5	10.7	3.8	3.8	4.1	4.3	3.7	4.3
TRMT13	"CCDC76, FLJ10287, FLJ11219"	ENSG00000122435	"TRNA methyltransferase 13 homolog"	Q9NUP7	1	100133150-100150497	"Enzymes, Predicted intracellular proteins"	"tRNA processing"	"Methyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA028494	Approved		Approved	"Nucleoplasm,Nuclear bodies,Plasma membrane,Cytosol"		NA	NA			"Nucleoplasm, Plasma membrane"	"Nuclear bodies, Cytosol"	"HPA028494: AB_10601254"	"unprognostic (1.12e-1)"	"unprognostic (3.33e-1)"	"unprognostic (5.76e-2)"	"unprognostic (2.37e-1)"	"unprognostic (9.17e-3)"	"unprognostic (4.97e-2)"	"prognostic unfavorable (5.81e-5)"	"unprognostic (1.16e-3)"	"unprognostic (3.28e-2)"	"unprognostic (8.08e-2)"	"unprognostic (3.22e-1)"	"unprognostic (1.02e-3)"	"prognostic unfavorable (6.89e-6)"	"unprognostic (3.12e-2)"	"unprognostic (7.71e-2)"	"unprognostic (1.99e-2)"	"unprognostic (1.70e-3)"	13.0	12.2	13.9	21.7	24.1	5.9	18.3	26.5	22.5	17.4	13.1	18.2	24.2	13.6	17.4	15.4	13.7	13.9	9.6	12.0	14.4	9.0	12.1	13.0	9.6	20.9	23.1	12.8	21.4	18.1	23.8	26.8	13.2	15.6	14.9	14.4	10.8	14.3	17.4	16.9	17.9	14.2	14.3	19.4	16.5	12.6	11.1	25.8	17.8	16.5	12.0	17.6	13.9	15.8	15.1	9.6	2.2	4.5	5.4	13.6	3.9	10.7	6.3	10.6	7.4	5.7	11.3	11.7	11.4	4.5	8.7	7.3	7.5	4.5	17.8	14.2	9.0	5.8	9.8	19.5	8.8	15.1	17.9	15.5	10.6	13.9	7.2	10.4	18.3	10.0	7.8	10.1	16.4	21.7	5.5	7.9	13.3	22.2	11.5	8.7	4.1	14.9	9.7	14.8	10.4	12.7	16.0	16.1	9.7	7.1	8.6	6.9	11.6	10.5	10.1	13.4	10.9	5.9	16.3	8.2	11.6	7.8	9.7	15.1	14.8	11.9	21.1	13.1	14.7	4.4	0.1	4.5	2.2	8.5	4.4	10.4	14.8	9.0	8.3	5.2	15.1	13.6	11.1	1.9	5.4	3.5	9.6	6.2	3.9	13.9	24.1	26.5	22.5	14.4	9.0	23.1	12.8	15.6	25.8	23.8	13.4	31.3	12.1	8.7	36.7	10.0	17.8	25.4	28.4	14.0	27.5	11.7	11.6	9.2	7.7	11.7	9.1	0.0	5.2	8.8	10.8	10.7	20.8	9.9	6.7	27.0	19.5	17.2	6.1	4.3	23.0	9.9	10.1	8.2	8.1	19.7	7.8	12.5	17.3	8.4	45.1	19.4	12.2	36.3	22.8	10.5	6.1	19.7	13.2	8.4
TRMT2B	"CXorf34, FLJ12687"	ENSG00000188917	"TRNA methyltransferase 2 homolog B"	Q96GJ1	X	101009346-101052116	"Enzymes, Predicted intracellular proteins"	"tRNA processing"	"Methyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003745, HPA035120, HPA040814"	Uncertain		Approved	"Nucleoplasm,Nuclear bodies"		NA	NA			Nucleoplasm	"Nuclear bodies"	"HPA003745: AB_2667047, HPA035120: AB_10601702, HPA040814: "	"prognostic unfavorable (1.58e-5)"	"unprognostic (6.72e-3)"	"unprognostic (3.28e-1)"	"unprognostic (1.54e-2)"	"unprognostic (4.44e-1)"	"unprognostic (8.74e-2)"	"unprognostic (3.52e-2)"	"unprognostic (8.16e-3)"	"unprognostic (5.77e-2)"	"unprognostic (2.01e-1)"	"unprognostic (8.80e-2)"	"unprognostic (2.78e-2)"	"prognostic favorable (2.30e-7)"	"unprognostic (4.58e-2)"	"unprognostic (4.82e-1)"	"unprognostic (5.03e-2)"	"unprognostic (1.60e-2)"	7.6	10.4	6.9	8.9	10.3	9.1	8.5	7.0	14.2	9.6	11.4	6.9	10.7	8.1	8.1	8.6	12.9	7.4	7.3	13.0	10.7	6.6	12.3	9.5	9.4	12.6	9.5	6.6	11.3	10.4	18.5	17.6	5.9	10.7	10.1	12.6	13.4	15.3	10.4	17.6	9.5	13.5	7.9	8.4	16.6	11.4	4.0	7.9	18.2	12.8	5.3	17.7	9.9	9.5	16.5	8.1	14.8	8.2	14.4	19.2	11.5	15.3	13.3	2.7	6.3	6.3	3.3	8.4	8.0	10.7	8.9	13.4	14.3	12.3	13.6	15.9	7.3	18.2	9.6	12.2	11.1	11.3	11.7	7.7	8.6	11.0	6.7	5.6	15.3	14.1	4.2	6.6	12.9	6.0	6.3	17.2	14.8	8.8	13.0	8.2	15.5	19.0	8.1	3.7	18.9	9.9	15.6	13.1	13.0	6.6	9.1	4.0	5.2	13.6	9.9	7.9	7.8	6.5	7.4	10.1	11.4	6.9	10.5	7.1	8.3	12.5	12.7	8.8	17.6	8.7	9.6	8.2	14.8	13.8	6.5	14.6	14.9	16.1	13.3	7.4	16.5	19.2	16.1	4.8	14.4	7.0	8.1	13.0	11.5	6.9	10.3	7.0	14.2	10.7	6.6	9.5	6.6	10.7	7.9	6.0	7.5	4.4	5.2	2.1	0.4	9.0	2.5	5.3	3.4	14.0	2.0	5.0	6.6	3.6	0.0	3.7	4.2	0.0	3.1	2.6	1.6	4.2	12.7	3.0	3.0	1.6	6.4	2.5	3.5	0.0	3.1	2.8	1.7	2.8	5.2	4.5	3.9	6.0	3.5	5.6	1.8	0.0	1.4	0.2	3.6	1.4	4.2	8.7	5.6	4.7
TRMT44	"C4orf23, FLJ35725, METTL19, TRM44"	ENSG00000155275	"TRNA methyltransferase 44 homolog"	Q8IYL2	4	8436140-8493531	"Enzymes, Predicted intracellular proteins"	"tRNA processing"	"Methyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Cone photoreceptor cells: 23.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA045461	Uncertain		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA045461: AB_10961276"	"unprognostic (1.50e-1)"	"unprognostic (1.65e-3)"	"unprognostic (3.47e-1)"	"unprognostic (1.01e-2)"	"unprognostic (2.06e-1)"	"unprognostic (1.34e-2)"	"unprognostic (1.75e-1)"	"unprognostic (1.78e-2)"	"unprognostic (3.46e-1)"	"unprognostic (8.13e-2)"	"unprognostic (3.44e-3)"	"unprognostic (2.69e-3)"	"unprognostic (1.49e-1)"	"unprognostic (1.16e-2)"	"unprognostic (1.28e-1)"	"unprognostic (6.76e-2)"	"unprognostic (8.34e-3)"	11.5	7.6	13.3	7.3	17.5	13.1	15.4	20.3	16.2	10.1	9.2	14.1	10.1	7.1	16.3	10.7	13.6	12.3	8.6	9.8	12.1	6.3	7.1	8.9	8.8	9.8	12.2	14.7	17.1	9.7	11.3	10.9	10.2	8.7	10.8	7.2	9.4	12.4	8.7	11.5	17.2	7.6	9.7	6.7	8.1	11.3	15.8	13.8	7.8	9.9	9.0	10.7	10.8	11.4	2.1	2.1	0.4	2.1	0.8	3.0	0.5	5.6	6.0	7.4	8.8	8.0	7.8	16.2	6.8	4.8	8.9	8.0	7.3	8.1	7.7	3.3	2.7	7.2	4.3	10.8	6.6	7.9	3.9	5.3	7.2	9.3	5.7	6.9	12.4	6.0	4.7	9.1	6.8	7.5	7.6	9.5	5.3	11.0	8.4	5.6	3.7	10.3	9.1	8.5	7.2	9.0	7.7	8.0	4.9	7.7	6.9	8.1	5.6	4.4	4.0	5.9	8.8	3.6	4.8	5.6	5.5	3.0	5.1	10.4	9.8	6.1	7.1	6.1	11.7	5.3	0.4	1.2	0.1	2.3	1.2	1.6	0.8	2.1	2.5	2.1	2.1	3.0	0.9	0.2	0.8	2.1	1.7	0.2	0.5	13.3	17.5	20.3	16.2	12.1	6.3	12.2	14.7	8.7	13.8	8.9	5.3	2.2	3.7	6.1	7.8	2.6	12.7	5.3	2.3	7.0	23.6	8.6	5.0	4.2	3.0	3.9	2.3	0.0	3.9	5.3	5.1	3.9	4.7	2.9	4.0	3.2	1.7	3.1	4.6	1.4	5.5	2.9	1.7	4.6	2.3	3.2	3.6	2.5	3.5	2.2	10.9	0.0	1.8	6.2	6.1	5.1	13.6	3.2	2.8	7.0
TRMT5	"KIAA1393, TRM5"	ENSG00000126814	"TRNA methyltransferase 5"	Q32P41	14	60971451-60981358	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"tRNA processing"	"Methyltransferase, Transferase"	"Disease mutation, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	5	"Early spermatids: 162.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA000943	Supported		Approved	Nucleoplasm,Nucleoli		NA	NA			"Nucleoplasm, Nucleoli"		"HPA000943: AB_1080388"	"unprognostic (1.58e-2)"	"unprognostic (3.62e-2)"	"unprognostic (6.63e-3)"	"unprognostic (1.11e-2)"	"unprognostic (7.70e-3)"	"unprognostic (2.26e-2)"	"unprognostic (7.82e-3)"	"unprognostic (4.50e-2)"	"unprognostic (3.95e-1)"	"unprognostic (1.78e-1)"	"unprognostic (1.47e-1)"	"unprognostic (2.84e-2)"	"unprognostic (1.60e-3)"	"unprognostic (1.82e-1)"	"unprognostic (1.97e-2)"	"unprognostic (2.10e-2)"	"unprognostic (1.40e-1)"	15.8	10.1	7.9	13.8	12.1	5.4	12.9	9.3	11.8	10.9	8.6	5.7	11.9	7.5	12.0	10.9	11.1	10.0	6.7	6.8	7.7	7.1	12.5	13.9	6.6	7.3	6.7	8.3	17.1	11.1	15.9	13.1	10.8	9.0	10.6	8.1	4.8	11.5	9.9	14.8	9.7	7.4	9.2	6.3	8.6	8.1	24.9	5.9	12.4	10.4	12.1	7.2	13.3	9.0	7.2	7.4	0.9	7.5	2.0	6.0	3.7	28.9	7.4	10.9	15.2	9.7	14.5	11.9	10.9	8.4	11.7	9.4	5.4	17.4	14.9	12.2	7.9	8.8	13.4	13.7	15.8	15.4	14.7	6.9	10.9	5.0	6.0	15.8	19.3	6.1	11.4	15.3	10.6	15.8	10.4	10.2	13.0	14.2	5.4	17.1	10.9	9.9	9.7	10.0	11.3	12.3	3.2	25.3	12.6	9.9	9.9	13.4	13.3	12.1	12.2	9.7	9.9	20.4	11.6	9.6	13.6	16.5	9.6	10.4	3.3	6.1	7.0	9.5	4.2	12.6	0.1	4.6	0.9	3.5	7.5	5.0	7.2	5.2	5.2	4.2	4.9	5.6	5.1	0.4	2.0	7.5	7.4	6.0	3.7	7.9	12.1	9.3	11.8	7.7	7.1	6.7	8.3	9.0	5.9	6.0	7.5	8.3	16.7	5.7	5.0	7.1	0.0	18.7	25.0	10.4	3.9	11.0	1.7	7.1	162.4	8.6	2.9	0.0	6.5	11.6	7.7	5.7	5.8	5.9	9.5	3.2	5.2	11.6	6.1	35.3	10.3	8.2	6.8	4.6	7.3	10.4	7.2	3.5	7.1	8.8	4.5	12.9	6.2	10.9	10.9	3.8	16.0	4.6	7.1	10.7
TRMT61A	"C14orf172, FLJ40452, GCD14, Gcd14p, hTRM61"	ENSG00000166166	"TRNA methyltransferase 61A"	Q96FX7	14	103529184-103537073	"Enzymes, Predicted intracellular proteins"	"tRNA processing"	"Methyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Cardiomyocytes: 45.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA024269			Approved	Mitochondria		NA	NA			Mitochondria		"HPA024269: "	"unprognostic (5.12e-2)"	"unprognostic (2.73e-2)"	"unprognostic (1.36e-1)"	"unprognostic (5.59e-3)"	"unprognostic (1.49e-1)"	"unprognostic (3.70e-2)"	"prognostic unfavorable (1.60e-4)"	"unprognostic (1.94e-1)"	"unprognostic (3.29e-1)"	"unprognostic (2.20e-1)"	"unprognostic (3.70e-2)"	"unprognostic (9.86e-3)"	"unprognostic (2.88e-3)"	"unprognostic (4.16e-1)"	"unprognostic (2.79e-1)"	"unprognostic (1.42e-1)"	"unprognostic (1.28e-1)"	12.4	10.6	9.0	10.4	16.4	9.1	8.2	10.3	16.7	9.7	16.7	16.0	9.2	10.5	14.9	8.9	10.6	14.3	10.9	6.2	10.7	8.1	9.1	9.6	7.5	8.0	11.7	8.7	10.5	20.7	6.7	5.9	6.7	10.5	13.1	4.6	9.0	14.4	18.3	9.7	15.5	8.6	19.9	9.1	7.9	9.7	10.9	11.3	6.0	11.9	7.5	7.5	11.9	8.5	3.8	4.1	0.3	12.2	3.0	3.7	2.6	5.5	13.9	2.1	4.4	2.2	2.4	8.9	6.2	2.8	7.8	4.3	18.9	9.6	9.0	7.8	3.2	4.5	14.4	4.6	4.7	2.2	6.1	8.6	6.9	5.2	10.0	4.0	8.9	5.4	2.6	6.1	6.8	2.8	1.8	1.3	6.6	10.2	4.4	2.6	16.1	10.8	6.8	7.5	11.7	28.3	13.5	6.8	7.8	3.1	8.3	11.4	7.1	7.1	6.7	8.3	0.9	12.5	5.2	2.6	7.1	7.6	18.6	12.6	6.0	3.8	11.4	7.6	7.1	13.4	0.0	2.6	0.3	3.4	6.5	2.5	3.4	2.7	3.7	4.1	3.8	3.2	3.1	0.1	3.0	12.2	2.8	2.0	2.6	9.0	16.4	10.3	16.7	10.7	8.1	11.7	8.7	10.5	11.3	0.0	8.9	7.7	12.9	23.2	11.5	45.6	5.1	2.7	2.3	7.0	3.9	11.1	14.9	15.6	3.6	11.3	7.4	0.0	10.4	11.8	12.7	10.0	2.3	7.8	10.9	28.6	10.3	4.3	7.3	11.9	10.3	6.1	10.1	16.2	7.8	7.5	15.5	8.6	17.3	12.7	10.7	0.0	19.1	6.6	10.8	26.2	10.1	7.5	13.3	9.6
TRMT61B	FLJ20628	ENSG00000171103	"TRNA methyltransferase 61B"	Q9BVS5	2	28849821-28870301	"Enzymes, Predicted intracellular proteins"	"tRNA processing"	"Methyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"HPA026747, HPA026751"	Enhanced		Uncertain	Cytosol		NA	NA			Cytosol		"HPA026747: AB_1848782, HPA026751: AB_1848784"	"unprognostic (1.01e-2)"	"unprognostic (1.32e-2)"	"unprognostic (1.63e-3)"	"unprognostic (2.05e-2)"	"unprognostic (3.32e-2)"	"unprognostic (4.14e-2)"	"prognostic unfavorable (3.61e-4)"	"unprognostic (2.36e-2)"	"unprognostic (2.55e-2)"	"unprognostic (2.77e-1)"	"unprognostic (2.52e-2)"	"unprognostic (2.52e-2)"	"prognostic favorable (9.61e-5)"	"unprognostic (2.19e-1)"	"unprognostic (1.43e-1)"	"unprognostic (5.38e-2)"	"unprognostic (2.34e-1)"	11.6	19.5	20.4	12.8	22.5	10.9	18.5	33.7	21.0	13.8	11.7	17.4	10.9	19.2	15.6	20.4	12.6	11.8	10.1	16.3	17.2	18.4	19.8	16.9	9.0	13.8	17.0	15.6	13.7	10.0	21.1	25.4	12.2	17.8	15.2	13.2	14.2	12.6	11.8	17.9	11.9	18.6	14.4	14.7	13.2	12.4	14.6	18.7	12.6	12.8	10.4	14.5	14.8	10.8	11.9	6.8	2.7	7.0	13.9	12.4	6.3	17.9	10.8	11.0	19.4	15.0	12.9	13.3	10.7	13.3	13.7	12.8	12.3	9.7	19.0	9.9	9.3	16.4	14.1	15.3	13.0	14.2	14.2	10.3	5.8	8.9	16.1	17.1	12.2	6.6	13.1	14.5	10.8	14.8	10.1	13.0	12.5	11.7	7.3	11.2	7.1	10.8	18.6	20.3	21.4	17.4	8.1	17.7	16.4	11.9	11.7	18.6	19.8	11.5	18.2	17.5	9.6	9.3	4.3	10.2	9.2	15.4	9.0	13.4	9.1	14.9	29.5	12.1	18.4	12.2	0.0	6.6	2.7	9.8	7.0	12.1	11.9	11.1	10.5	6.4	11.6	12.4	8.9	0.9	13.9	5.7	6.8	11.6	6.3	20.4	22.5	33.7	21.0	17.2	18.4	17.0	15.6	17.8	18.7	14.9	5.4	12.0	9.6	16.1	9.9	2.0	10.2	12.0	9.1	8.7	5.9	17.9	13.3	12.4	6.3	6.8	7.1	0.0	8.9	13.0	9.9	6.1	9.2	8.3	8.0	6.4	4.6	1.3	6.9	2.7	8.1	7.1	6.8	10.0	9.5	9.1	9.0	9.9	9.9	23.8	20.7	6.5	9.5	21.8	9.6	13.8	7.3	7.9	13.3	6.5
TRMU	"FLJ10140, MTO2, TRMT"	ENSG00000100416	"TRNA 5-methylaminomethyl-2-thiouridylate methyltransferase"	O75648	22	46330875-46357340	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"tRNA processing"	"RNA-binding, Transferase, tRNA-binding"	"Deafness, Disease mutation, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000824, HPA035273, HPA043300"	Uncertain		Supported	Mitochondria		NA	NA			Mitochondria		"HPA000824: AB_2732393, HPA035273: AB_10602901, HPA043300: AB_2678415"	"unprognostic (2.96e-1)"	"unprognostic (1.09e-2)"	"unprognostic (8.07e-2)"	"unprognostic (4.27e-2)"	"unprognostic (2.64e-1)"	"unprognostic (3.52e-3)"	"prognostic unfavorable (3.04e-5)"	"unprognostic (4.72e-2)"	"unprognostic (7.14e-2)"	"unprognostic (7.89e-2)"	"prognostic favorable (6.86e-4)"	"unprognostic (4.74e-3)"	"prognostic unfavorable (5.63e-6)"	"unprognostic (7.26e-2)"	"unprognostic (1.73e-1)"	"unprognostic (3.56e-1)"	"unprognostic (7.44e-3)"	8.5	16.1	11.5	9.9	16.0	6.4	7.5	17.8	16.0	9.7	8.7	11.5	10.2	10.9	12.1	18.0	10.9	6.2	7.3	16.8	11.3	11.9	20.5	18.8	7.1	10.2	15.7	11.8	8.0	22.7	20.0	13.6	9.7	11.2	8.7	10.2	9.0	12.5	15.5	17.8	9.8	7.6	9.4	11.4	8.7	9.2	8.3	13.9	6.5	9.6	8.3	9.8	7.1	9.1	6.2	7.6	3.9	9.6	7.5	11.3	6.3	10.8	10.0	4.3	9.7	8.1	5.7	10.8	11.3	8.0	16.1	12.6	14.1	2.8	7.1	8.1	10.1	7.0	9.7	18.2	10.1	13.8	4.6	24.5	8.5	15.3	16.6	6.9	16.2	5.8	5.4	11.4	16.7	5.3	6.7	10.3	3.7	11.7	1.7	9.8	11.4	6.3	13.2	16.1	6.6	17.6	7.4	9.2	13.2	8.0	7.6	10.2	12.3	10.0	11.8	19.0	5.6	6.7	6.7	7.5	7.2	12.9	10.2	12.6	4.2	4.5	7.6	10.2	11.8	14.5	0.0	6.8	3.9	11.1	9.4	9.4	5.7	9.4	10.0	7.6	6.2	8.6	8.0	1.4	7.5	9.6	6.0	11.3	6.3	11.5	16.0	17.8	16.0	11.3	11.9	15.7	11.8	11.2	13.9	8.9	6.7	12.6	9.5	5.6	25.1	12.4	5.1	9.4	5.7	10.4	15.7	20.8	23.2	18.2	0.8	11.9	11.4	23.3	16.7	17.5	10.3	9.9	9.2	16.6	13.8	12.7	12.0	15.4	11.8	1.7	14.1	8.3	8.5	17.2	9.8	11.0	16.7	10.5	15.9	22.8	26.2	6.5	11.7	18.2	13.2	8.4	12.8	10.1	15.3	8.2
TRNT1	"CCA1, CGI-47, MtCCA"	ENSG00000072756	"TRNA nucleotidyl transferase 1"	Q96Q11	3	3126916-3150879	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"tRNA processing"	"Nucleotidyltransferase, RNA-binding, Transferase"	"Disease mutation, Retinitis pigmentosa"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA036938	Uncertain		Supported	Mitochondria		Yes	No			Mitochondria		"HPA036938: AB_10670566"	"unprognostic (6.39e-3)"	"unprognostic (1.58e-1)"	"unprognostic (2.38e-3)"	"unprognostic (4.69e-2)"	"unprognostic (4.92e-2)"	"unprognostic (2.41e-1)"	"unprognostic (1.39e-2)"	"unprognostic (2.68e-1)"	"unprognostic (6.22e-2)"	"unprognostic (5.65e-2)"	"unprognostic (4.62e-2)"	"unprognostic (1.41e-2)"	"unprognostic (1.24e-2)"	"unprognostic (6.50e-2)"	"unprognostic (1.09e-1)"	"unprognostic (3.78e-1)"	"unprognostic (1.02e-1)"	15.2	16.9	17.5	17.8	20.7	8.7	18.2	14.5	22.7	12.9	13.2	13.2	17.4	11.1	18.4	14.7	15.9	12.2	15.6	13.9	17.1	16.0	21.1	16.1	13.7	19.0	17.5	15.6	14.6	13.9	14.3	31.0	19.0	21.3	23.9	16.4	10.1	13.2	13.1	14.8	15.3	12.5	15.3	19.3	20.5	15.5	13.5	15.1	22.1	20.9	10.6	19.8	17.8	13.0	15.1	10.5	29.0	12.0	15.1	16.6	7.4	12.0	17.4	13.5	7.7	16.1	13.8	14.4	13.8	11.5	13.8	14.3	16.1	14.8	22.0	9.2	13.3	22.0	8.7	17.8	12.4	17.6	16.3	8.6	20.4	18.6	16.1	21.5	21.6	16.6	12.9	17.6	14.2	4.8	11.6	13.6	17.0	15.9	9.2	23.7	22.5	13.9	19.5	10.6	18.0	12.7	13.3	18.2	21.4	18.4	18.0	7.7	11.1	20.0	14.5	11.5	19.0	13.4	12.3	11.1	15.6	13.6	16.1	17.7	9.5	18.9	27.7	11.7	19.4	17.4	29.0	8.8	22.5	12.1	11.8	11.9	15.1	15.0	12.7	10.5	9.5	16.6	14.3	11.7	15.1	12.0	9.6	11.1	7.4	17.5	20.7	14.5	22.7	17.1	16.0	17.5	15.6	21.3	15.1	14.9	8.3	13.9	18.6	13.2	12.9	12.1	2.5	10.7	13.6	17.4	13.7	21.8	38.1	16.1	1.5	22.5	9.6	0.0	8.7	14.3	13.9	19.8	22.0	7.8	11.6	9.5	8.1	10.4	12.9	1.9	10.0	11.3	6.8	18.0	9.7	15.8	10.1	8.6	8.1	25.6	16.8	0.0	17.7	20.0	16.9	11.4	23.7	13.8	11.5	18.2
TRPM6	"CHAK2, FLJ22628, HOMG, HSH"	ENSG00000119121	"Transient receptor potential cation channel subfamily M member 6"	Q9BX84	9	74722495-74888094	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Calcium transport, Ion transport, Transport"	"Calcium channel, Ion channel, Kinase, Serine/threonine-protein kinase, Transferase"	"Disease mutation, Primary hypomagnesemia"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 16.1;intestine: 19.5"	"Group enriched"	"Detected in many"	4	"Enterocytes: 28.8;Paneth cells: 10.5"	"Cancer enhanced"	"Detected in some"		"testis cancer: 1.8"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	6	"basophil: 16.1;neutrophil: 6.6"	"Lineage enriched"	"Detected in single"	30	"granulocytes: 16.1"	"Cell line enhanced"	"Detected in some"		"BEWO: 7.7;HeLa: 4.5;Karpas-707: 2.6;RT4: 7.4;U-266/70: 2.8"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"									NA	NA						"unprognostic (3.95e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.76e-1)"	"unprognostic (1.65e-1)"	"unprognostic (7.80e-2)"	"unprognostic (9.20e-2)"	"unprognostic (1.59e-2)"	"unprognostic (1.72e-1)"	"unprognostic (2.82e-1)"	"unprognostic (1.84e-1)"	"unprognostic (5.72e-4)"	"unprognostic (1.58e-1)"	"unprognostic (1.71e-2)"	"unprognostic (8.10e-2)"	"unprognostic (7.54e-2)"	"unprognostic (1.89e-2)"	"unprognostic (2.11e-2)"	2.9	0.0	1.3	0.5	1.2	2.5	1.1	1.3	1.2	0.8	13.3	0.2	1.0	7.2	0.4	0.2	0.6	0.4	1.0	0.5	1.9	1.2	3.1	0.2	1.5	0.2	2.6	0.0	0.4	0.2	3.8	4.9	0.2	1.6	1.7	17.5	0.4	1.1	0.0	1.6	0.8	19.5	0.7	5.0	3.9	0.2	1.7	0.5	1.6	0.3	1.1	2.1	0.5	0.6	0.3	0.3	16.1	0.1	0.5	0.1	0.0	0.1	1.7	0.2	0.2	0.0	0.0	7.7	0.1	0.0	0.0	0.1	2.1	0.2	0.6	0.0	0.1	0.3	0.3	0.5	0.5	0.0	0.1	0.2	0.2	4.5	0.3	0.1	0.1	0.2	0.3	0.2	0.0	0.0	0.1	0.2	0.3	0.0	2.6	0.1	0.9	0.0	0.1	0.6	0.1	0.2	0.0	0.0	0.3	0.0	7.4	0.3	0.0	0.0	0.1	0.1	0.4	0.3	0.0	0.0	0.2	1.1	0.2	0.0	2.8	0.0	0.2	0.1	0.1	0.3	16.1	0.1	1.9	0.1	0.1	0.0	0.1	0.1	0.1	0.0	0.3	0.1	0.1	6.6	0.5	0.1	0.3	0.0	0.0	1.3	1.2	1.3	1.2	1.9	1.2	2.6	0.0	1.6	0.5	0.0	1.7	0.0	1.7	0.1	0.2	0.6	0.0	1.4	2.3	3.5	0.0	0.2	0.0	0.0	2.5	0.7	28.8	0.0	0.0	0.1	0.3	1.1	0.0	0.0	0.0	0.0	3.5	4.9	0.3	0.4	0.0	0.2	0.0	0.0	3.3	0.1	0.0	10.5	0.4	0.0	2.3	0.0	0.3	1.5	2.3	0.9	0.1	0.0	2.6	0.9
TRPM7	"CHAK1, LTRPC7, TRP-PLIK"	ENSG00000092439	"Transient receptor potential cation channel subfamily M member 7"	Q96QT4	15	50552473-50686815	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Calcium transport, Ion transport, Necrosis, Transport"	"Calcium channel, Ion channel, Kinase, Serine/threonine-protein kinase, Transferase"	"Amyotrophic lateral sclerosis, Neurodegeneration, Parkinsonism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"parathyroid gland: 91.8"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"U-2197: 50.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035522, HPA052173"	Enhanced		Approved	"Vesicles,Plasma membrane,Cytosol"		NA	NA			"Plasma membrane"	"Vesicles, Cytosol"	"HPA035522: , HPA052173: AB_2681749"	"unprognostic (3.14e-2)"	"unprognostic (1.86e-1)"	"unprognostic (1.58e-1)"	"unprognostic (1.42e-2)"	"unprognostic (1.89e-1)"	"unprognostic (1.60e-2)"	"unprognostic (1.85e-2)"	"unprognostic (2.59e-2)"	"unprognostic (5.46e-3)"	"unprognostic (2.64e-1)"	"unprognostic (2.91e-1)"	"unprognostic (1.59e-2)"	"unprognostic (3.20e-2)"	"unprognostic (2.08e-1)"	"unprognostic (7.59e-2)"	"unprognostic (9.45e-2)"	"unprognostic (1.97e-1)"	13.3	10.8	6.6	14.7	9.0	12.8	12.1	19.5	9.3	11.8	11.7	8.1	9.7	9.9	16.5	10.7	9.4	11.0	8.2	19.1	5.5	4.9	16.0	20.0	10.8	10.6	12.4	5.2	16.6	11.6	91.8	14.6	14.3	10.2	9.7	10.3	28.6	11.5	13.5	10.8	11.7	12.8	12.8	9.8	11.1	10.3	6.9	10.0	14.5	12.6	6.9	12.6	12.9	12.3	7.0	4.7	4.4	3.4	5.7	7.6	2.0	8.5	8.5	7.1	7.9	20.6	15.5	8.7	10.8	15.0	6.9	9.1	11.7	4.7	18.6	5.3	12.4	17.8	14.4	9.5	7.9	9.9	10.3	5.7	14.8	13.1	6.1	18.8	15.3	11.5	14.4	9.4	7.8	14.7	10.1	5.5	11.8	16.7	14.3	12.5	13.4	9.8	7.5	5.4	11.8	5.3	10.8	9.9	9.1	9.6	20.2	5.9	7.5	7.4	11.9	14.5	13.1	7.4	16.7	8.4	11.0	5.2	50.9	12.4	9.7	21.5	17.9	11.9	31.3	10.2	3.8	3.4	3.9	6.6	3.2	7.6	5.6	4.8	4.4	3.7	7.0	4.4	5.2	4.4	5.7	3.2	4.7	4.8	2.0	6.6	9.0	19.5	9.3	5.5	4.9	12.4	5.2	10.2	10.0	17.9	25.3	18.2	14.9	28.0	22.9	21.4	28.1	24.1	7.9	12.2	11.8	18.5	3.3	9.7	25.2	18.5	16.9	23.3	11.1	8.0	17.0	21.2	16.3	35.0	12.7	20.6	17.7	15.4	18.6	17.9	24.5	17.0	18.6	14.4	17.3	9.1	12.8	12.9	19.1	9.6	21.5	12.9	13.7	13.6	19.4	21.1	13.6	17.5	16.3	9.0
TRPT1	MGC11134	ENSG00000149743	"TRNA phosphotransferase 1"	Q86TN4	11	64223799-64226254	"Enzymes, Predicted intracellular proteins"	"tRNA processing"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Early spermatids: 121.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038705, HPA038706"	Uncertain		Approved	Mitochondria		NA	NA			Mitochondria		"HPA038705: AB_2676161, HPA038706: AB_10671863"	"unprognostic (2.50e-2)"	"unprognostic (1.72e-1)"	"unprognostic (1.33e-1)"	"unprognostic (3.59e-2)"	"unprognostic (7.20e-2)"	"unprognostic (1.53e-1)"	"unprognostic (5.84e-2)"	"unprognostic (8.56e-2)"	"unprognostic (1.18e-1)"	"unprognostic (3.26e-3)"	"unprognostic (1.12e-1)"	"unprognostic (7.71e-2)"	"unprognostic (7.38e-2)"	"unprognostic (2.49e-1)"	"unprognostic (3.28e-1)"	"unprognostic (1.99e-1)"	"unprognostic (4.58e-3)"	8.1	12.2	10.8	11.1	12.6	4.4	9.1	6.4	12.1	8.8	15.1	10.9	37.4	12.5	7.8	15.3	13.3	10.4	13.5	34.4	10.9	10.3	16.9	13.7	7.0	8.3	13.6	8.5	8.7	23.3	9.1	11.6	8.5	10.8	11.3	10.8	9.9	22.3	33.5	58.8	10.8	13.1	7.0	10.1	10.3	12.2	18.9	10.3	17.2	13.3	23.9	13.2	11.9	7.7	22.9	31.7	14.5	16.2	12.4	13.2	6.5	10.7	10.7	11.9	19.1	14.8	10.9	14.8	7.3	14.1	12.9	10.9	7.0	16.4	10.9	29.3	11.9	10.0	15.1	5.2	15.7	4.5	10.5	6.4	5.5	10.8	12.1	21.4	6.9	9.8	8.1	9.3	14.3	12.7	24.3	9.0	21.8	9.6	12.2	10.7	25.5	12.8	14.8	7.6	14.6	11.9	17.0	8.9	30.8	33.2	12.9	10.6	15.3	5.8	14.4	21.1	8.5	16.6	11.2	10.5	8.9	6.8	17.3	7.1	24.4	6.0	6.9	21.3	3.6	14.2	6.0	9.4	14.5	10.9	16.2	8.4	20.8	10.5	11.2	13.0	22.9	11.9	13.2	8.3	12.4	13.9	31.7	13.2	6.5	10.8	12.6	6.4	12.1	10.9	10.3	13.6	8.5	10.8	10.3	8.9	17.2	12.7	16.5	11.7	9.7	39.2	35.7	49.5	14.8	26.2	0.0	38.4	81.2	35.4	121.1	14.3	67.0	23.3	51.2	36.0	16.3	24.7	23.2	22.7	21.9	9.5	25.8	19.6	13.4	59.9	18.4	14.8	35.4	36.1	72.6	18.7	41.3	45.6	15.9	57.2	10.3	6.5	28.3	51.6	13.5	16.2	30.1	17.8	33.0	17.7
TSEN2	"MGC2776, SEN2, SEN2L"	ENSG00000154743	"TRNA splicing endonuclease subunit 2"	Q8NCE0	3	12484432-12539623	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"mRNA processing, tRNA processing"	Lyase	"Neurodegeneration, Pontocerebellar hypoplasia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Cone photoreceptor cells: 41.2;Rod photoreceptor cells: 33.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027120, HPA027125, HPA027268"	Approved		Supported	Nucleoplasm,Centrosome,Cytosol		NA	NA			Nucleoplasm	"Centrosome, Cytosol"	"HPA027120: AB_10600197, HPA027125: AB_10601896, HPA027268: AB_10601347"	"unprognostic (5.58e-2)"	"unprognostic (4.49e-1)"	"unprognostic (1.49e-1)"	"unprognostic (3.71e-2)"	"unprognostic (9.59e-2)"	"unprognostic (1.13e-1)"	"prognostic unfavorable (1.13e-5)"	"unprognostic (1.42e-1)"	"unprognostic (5.66e-2)"	"unprognostic (1.28e-1)"	"unprognostic (2.71e-1)"	"unprognostic (6.15e-2)"	"unprognostic (1.41e-2)"	"unprognostic (6.99e-2)"	"unprognostic (4.90e-2)"	"unprognostic (6.06e-2)"	"prognostic favorable (3.49e-4)"	8.8	10.6	9.7	8.8	19.1	6.7	10.9	16.5	14.0	10.4	9.8	12.7	8.4	5.8	14.0	9.9	7.9	12.8	10.3	14.3	10.5	12.3	9.8	7.3	7.3	10.9	11.5	7.6	18.0	11.9	14.3	15.3	4.9	10.2	10.5	10.9	13.5	7.2	13.1	16.7	15.3	6.1	12.3	12.3	6.1	8.5	11.3	9.1	9.9	12.5	9.6	8.1	8.6	8.3	8.5	7.1	2.6	4.2	5.0	13.7	5.6	7.8	13.7	7.4	9.6	12.5	13.3	17.0	7.4	6.6	8.0	5.8	7.7	8.4	9.4	5.2	6.0	9.5	7.3	12.3	12.7	9.1	7.4	15.2	10.3	18.3	7.9	9.6	16.2	4.0	11.5	14.8	14.5	17.8	5.9	6.4	13.8	15.3	5.2	9.2	14.8	12.4	7.4	10.4	22.2	16.5	9.4	5.1	18.9	11.9	8.1	4.8	8.4	6.9	6.2	5.8	5.3	11.2	11.3	5.7	5.1	5.0	6.9	11.5	4.9	12.5	11.8	6.8	16.4	6.3	2.4	4.2	0.3	6.4	4.2	10.9	8.5	9.8	7.4	5.9	8.3	13.7	11.7	2.6	5.0	3.6	7.1	3.5	5.6	9.7	19.1	16.5	14.0	10.5	12.3	11.5	7.6	10.2	9.1	3.0	3.5	10.9	9.7	2.6	27.2	6.2	15.3	9.4	2.3	10.4	41.2	7.4	1.7	4.9	1.3	5.6	2.6	0.0	3.7	3.2	3.8	5.0	4.7	5.5	4.1	9.5	4.1	3.1	4.0	2.1	8.3	3.2	3.3	1.0	4.7	8.7	3.5	3.5	9.6	5.0	33.9	6.5	5.1	10.3	19.3	4.3	1.6	5.7	8.2	8.0
TSEN34	"LENG5, SEN34, SEN34L"	ENSG00000170892	"TRNA splicing endonuclease subunit 34"	Q9BSV6	19	54189938-54194536	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"mRNA processing, tRNA processing"	Lyase	"Disease mutation, Neurodegeneration, Pontocerebellar hypoplasia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"neutrophil: 24.8"	"Group enriched"	"Detected in many"	6	"granulocytes: 24.8;monocytes: 8.1"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041111, HPA048208"	Approved		Supported	Nucleoplasm		NA	NA			Nucleoplasm		"HPA041111: AB_10794263, HPA048208: AB_2680313"	"unprognostic (3.24e-2)"	"unprognostic (2.95e-2)"	"unprognostic (1.59e-1)"	"unprognostic (3.88e-2)"	"unprognostic (3.48e-2)"	"unprognostic (4.82e-2)"	"prognostic unfavorable (1.44e-7)"	"unprognostic (2.38e-1)"	"unprognostic (7.35e-2)"	"unprognostic (1.51e-1)"	"unprognostic (5.04e-3)"	"unprognostic (8.98e-2)"	"unprognostic (4.55e-3)"	"unprognostic (2.02e-3)"	"unprognostic (1.81e-1)"	"unprognostic (2.81e-1)"	"unprognostic (1.12e-1)"	12.3	28.0	10.4	10.8	10.2	8.2	15.4	4.0	12.8	19.8	19.5	9.4	19.2	3.0	17.3	23.4	20.2	25.3	18.1	20.0	8.8	9.8	15.4	20.0	13.4	18.2	8.7	8.9	31.8	27.3	19.2	14.3	22.0	8.7	23.2	12.3	15.7	17.8	29.5	15.7	14.7	9.8	18.6	7.8	18.0	13.0	27.3	7.7	12.9	28.5	19.6	14.9	19.8	15.5	1.4	2.6	24.8	8.1	0.8	2.4	1.5	29.2	4.3	11.9	17.0	7.1	14.4	13.0	3.6	7.4	8.8	8.3	2.2	4.2	2.2	1.0	5.7	15.3	20.6	16.2	21.5	6.5	7.6	24.6	2.6	0.8	2.4	6.7	0.8	3.6	23.2	9.9	6.0	7.1	7.4	18.1	0.0	5.9	1.4	18.8	3.6	1.5	0.0	2.7	18.6	3.2	7.3	8.1	1.0	25.5	2.5	0.6	6.9	0.8	21.8	8.0	7.7	17.3	2.1	1.2	0.0	12.3	12.8	22.4	8.3	8.0	2.1	21.3	1.3	13.5	4.1	8.1	17.8	0.9	3.3	1.8	1.0	1.3	2.4	2.3	1.4	2.3	0.9	24.8	0.8	5.2	2.6	0.7	1.5	10.4	10.2	4.0	12.8	8.8	9.8	8.7	8.9	8.7	7.7	11.9	20.1	13.7	83.2	65.4	36.0	10.5	50.9	33.5	6.8	41.8	27.5	85.1	81.2	59.2	19.5	32.8	50.1	0.0	52.3	87.0	54.1	67.1	26.5	33.9	49.4	15.9	73.7	33.7	31.5	13.0	62.7	44.3	43.9	23.4	79.0	62.4	50.8	51.8	62.6	85.1	41.1	58.2	56.2	46.1	66.6	61.4	92.8	29.7	61.7	51.5
TSSK1B	"FKSG81, SPOGA4, STK22D, TSSK1"	ENSG00000212122	"Testis specific serine kinase 1B"	Q9BXA7	5	113432554-113435031	"Enzymes, Predicted membrane proteins"	"Differentiation, Spermatogenesis"	"Developmental protein, Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	50	"testis: 59.9"	"Group enriched"	"Detected in some"	101	"Early spermatids: 408.3;Late spermatids: 766.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"CAPAN-2: 1.3;EFO-21: 2.1;RT4: 1.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA027827	Enhanced					NA	NA					"HPA027827: AB_10603138"																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	59.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.0	0.4	0.0	0.0	0.2	0.6	0.1	0.2	0.0	1.0	0.0	0.0	0.0	0.2	0.0	1.3	0.2	2.1	0.0	0.4	0.4	0.2	0.4	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.1	0.0	0.6	0.7	0.1	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.5	0.6	0.1	0.0	0.1	0.1	0.3	0.0	0.4	0.0	0.5	0.2	0.2	0.3	0.1	0.0	0.4	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	408.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	766.1	4.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.2	0.0	0.0	0.0	0.0	5.8	3.2	0.0	0.0	0.0	0.0	0.0
TSSK2	"FLJ38613, SPOGA2, STK22B"	ENSG00000206203	"Testis specific serine kinase 2"	Q96PF2	22	19130808-19132623	"Enzymes, Predicted membrane proteins"	"Differentiation, Spermatogenesis"	"Developmental protein, Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	57	"testis: 95.7"	"Group enriched"	"Detected in some"	70	"Early spermatids: 1437.9;Late spermatids: 2322.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"NK-cell: 1.6"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"HaCaT: 1.6;HL-60: 1.8;SCLC-21H: 3.5;THP-1: 3.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"									NA	NA																							0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.0	95.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.3	1.0	0.0	1.6	0.8	0.0	0.0	0.9	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	1.8	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.7	0.0	1.2	0.0	0.0	0.8	0.0	0.6	0.0	0.0	3.5	0.0	0.0	0.0	0.0	0.0	0.7	3.3	0.8	1.4	0.5	0.0	0.2	0.1	0.9	0.3	0.0	0.3	1.2	0.0	0.0	1.0	0.4	0.0	0.0	0.5	0.1	0.8	0.3	0.7	0.2	0.5	0.2	1.6	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1437.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2322.2	17.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.7	0.0	0.0	6.5	0.0	26.9	11.5	0.0	0.0	0.0	0.0	0.0
TSSK3	"SPOGA3, STK22C"	ENSG00000162526	"Testis specific serine kinase 3"	Q96PN8	1	32351521-32364312	"Enzymes, Predicted intracellular proteins"	"Differentiation, Spermatogenesis"	"Developmental protein, Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	8	"testis: 68.1"	"Group enriched"	"Detected in some"	52	"Early spermatids: 242.3;Late spermatids: 839.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Cell type enhanced"	"Detected in some"		"naive CD4 T-cell: 2.3"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"HeLa: 9.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA037516			Approved	"Nucleoplasm,Nucleoli,Nuclear bodies"		NA	NA			"Nucleoplasm, Nucleoli"	"Nuclear bodies"	"HPA037516: AB_2675517"	"unprognostic (5.71e-2)"	"unprognostic (1.42e-1)"	"unprognostic (2.32e-1)"	"unprognostic (1.37e-1)"	"unprognostic (7.69e-2)"	"unprognostic (2.02e-4)"	"unprognostic (2.06e-1)"	"unprognostic (1.98e-3)"	"unprognostic (2.05e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.46e-2)"	"unprognostic (9.20e-2)"	"unprognostic (1.02e-3)"	"unprognostic (1.11e-2)"	"unprognostic (1.51e-1)"	"unprognostic (1.88e-1)"	"unprognostic (2.68e-3)"	1.1	2.0	0.8	1.7	0.8	8.2	1.1	3.9	0.8	1.3	0.9	0.8	1.4	2.5	1.8	2.9	0.8	1.3	1.0	0.9	0.8	0.0	0.9	1.3	1.4	2.4	0.8	0.8	2.0	1.2	0.0	0.8	0.8	1.0	1.0	0.0	0.8	1.4	0.8	1.7	3.4	2.9	0.8	0.8	3.4	1.2	68.1	0.8	0.8	1.3	0.8	0.8	0.9	1.1	0.6	0.1	0.1	0.7	0.3	2.3	0.1	2.3	2.3	6.0	3.5	0.0	1.2	5.4	0.7	1.1	0.0	0.0	0.5	1.2	1.2	0.9	0.0	1.0	3.7	0.0	0.0	0.0	3.5	7.2	2.7	9.8	3.7	4.4	1.1	3.4	0.1	0.9	0.0	1.3	6.3	0.0	4.6	3.1	5.8	0.0	0.6	1.4	1.5	1.5	0.4	1.2	1.9	1.7	4.4	0.0	1.9	1.8	3.8	0.8	2.8	4.1	4.4	1.9	2.7	2.9	2.1	3.4	3.0	2.4	8.5	2.8	1.8	3.7	3.9	0.5	0.0	0.1	0.0	1.1	0.7	0.0	0.0	0.2	0.0	0.1	0.6	2.3	0.9	0.1	0.3	0.5	0.0	0.0	0.1	0.8	0.8	3.9	0.8	0.8	0.0	0.8	0.8	1.0	0.8	0.0	0.3	0.0	0.4	0.1	0.1	0.3	0.0	1.4	0.0	0.0	0.0	0.2	0.0	0.2	242.3	0.0	0.0	0.0	0.6	0.0	0.3	0.1	0.0	0.0	0.1	0.0	0.0	0.6	0.0	839.4	8.6	0.0	0.0	0.0	0.3	0.9	0.2	0.0	8.9	0.6	1.4	6.5	0.0	10.3	3.8	0.0	0.2	0.0	0.2	0.2
TSSK4	"C14orf20, STK22E"	ENSG00000139908	"Testis specific serine kinase 4"	Q6SA08	14	24205697-24208362	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Differentiation, Spermatogenesis"	"Developmental protein, Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	10	"testis: 46.1"	"Cell type enriched"	"Detected in some"	15	"Early spermatids: 178.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA060660, HPA077103"	Approved		Approved	"Cell Junctions"		NA	NA			"Cell Junctions"		"HPA060660: AB_2684339, HPA077103: AB_2732332"	"unprognostic (1.95e-1)"	"unprognostic (4.30e-2)"	"unprognostic (1.52e-1)"	"unprognostic (5.69e-2)"	"unprognostic (2.36e-1)"	"unprognostic (3.38e-5)"	"unprognostic (1.06e-1)"	"unprognostic (6.25e-3)"	"unprognostic (1.64e-1)"	"unprognostic (3.39e-1)"	"unprognostic (7.03e-3)"	"unprognostic (1.27e-3)"	"unprognostic (3.42e-1)"	"unprognostic (4.30e-2)"	"unprognostic (6.28e-2)"	"unprognostic (8.98e-2)"	"unprognostic (7.26e-2)"	0.6	0.9	0.6	1.7	0.6	3.1	0.6	1.5	1.8	0.6	0.6	0.6	0.6	1.5	0.8	0.9	1.4	0.8	1.7	0.6	0.6	0.4	0.6	0.6	0.8	2.8	0.6	0.6	0.8	0.9	0.0	0.6	0.6	0.6	0.6	0.0	0.6	1.4	0.6	1.0	4.7	1.6	0.6	0.6	1.5	0.6	46.1	0.6	0.6	1.4	0.6	0.6	1.0	0.6	2.1	1.7	2.0	1.0	1.8	2.0	0.7	1.0	4.1	4.0	1.5	0.1	0.0	4.3	1.6	0.1	0.0	0.0	2.1	3.7	3.1	0.9	0.1	0.8	3.8	0.0	0.1	0.0	1.6	3.1	3.5	4.8	3.0	0.0	1.5	3.8	0.0	0.0	0.0	0.6	3.6	0.1	3.7	1.3	2.0	0.0	3.8	3.6	1.7	0.7	0.9	3.2	3.0	1.6	2.7	0.0	5.3	2.2	2.1	2.7	2.5	0.8	1.8	1.6	1.8	1.4	2.9	1.8	3.8	1.3	4.3	4.8	4.8	1.0	2.8	0.9	0.0	1.0	2.0	2.0	1.0	0.7	2.0	1.6	1.6	0.6	2.1	1.6	1.7	2.0	1.8	0.9	1.7	0.7	0.7	0.6	0.6	1.5	0.6	0.6	0.4	0.6	0.6	0.6	0.6	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	178.8	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	11.8	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	1.2	0.7	0.0	0.1	0.0	0.0	0.0
TSSK6	"CT72, FLJ24002, SSTK"	ENSG00000178093	"Testis specific serine kinase 6"	Q9BXA6	19	19512418-19515685	"Enzymes, Predicted intracellular proteins"	"Differentiation, Spermatogenesis"	"Developmental protein, Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	13	"testis: 50.8"	"Cell type enriched"	"Detected in some"	5	"Late spermatids: 5597.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"BEWO: 8.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"									NA	NA						"unprognostic (2.12e-1)"	"unprognostic (7.89e-2)"	"unprognostic (7.26e-2)"	"unprognostic (6.64e-2)"	"unprognostic (3.39e-1)"	"unprognostic (7.20e-5)"	"unprognostic (3.38e-1)"	"unprognostic (5.51e-3)"	"unprognostic (5.17e-2)"	"unprognostic (1.46e-1)"	"unprognostic (3.98e-4)"	"unprognostic (2.28e-2)"	"unprognostic (5.34e-3)"	"unprognostic (2.74e-3)"	"unprognostic (2.78e-2)"	"unprognostic (1.52e-3)"	"unprognostic (9.89e-2)"	0.9	1.2	1.0	1.2	1.5	1.3	1.0	0.9	1.9	0.9	1.1	2.2	1.6	2.1	0.9	3.7	1.1	1.1	1.0	0.7	1.2	0.8	1.8	2.2	0.7	1.2	2.5	1.0	0.9	3.3	1.1	1.0	0.6	1.3	1.4	0.6	0.9	1.3	1.0	1.0	2.7	1.9	1.2	1.9	2.1	1.7	50.8	1.7	3.1	2.0	0.1	1.7	1.1	1.0	3.1	1.0	2.2	0.7	0.4	3.8	0.8	1.6	2.7	0.1	1.1	0.4	1.0	8.0	1.1	0.5	0.6	0.3	4.2	1.3	1.4	2.0	0.0	0.5	1.4	0.5	1.1	0.2	1.0	1.9	0.7	1.7	0.9	1.2	0.9	3.2	0.6	1.0	0.6	1.9	0.6	0.3	5.4	1.9	0.8	0.0	0.5	3.4	2.0	3.7	0.8	4.4	2.7	0.7	1.2	0.1	0.5	0.6	2.9	1.6	0.4	1.4	0.4	2.6	0.7	0.3	2.0	0.6	3.9	1.7	3.5	1.4	0.8	2.2	1.2	1.9	0.0	0.6	2.2	0.8	0.2	1.1	3.1	1.7	2.0	0.3	1.9	3.8	2.1	1.1	0.4	0.7	1.0	1.0	0.8	1.0	1.5	0.9	1.9	1.2	0.8	2.5	1.0	1.3	1.7	0.0	0.0	0.0	0.2	0.3	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	1053.4	0.0	0.0	0.0	0.2	0.1	0.0	0.2	0.0	0.0	0.1	0.0	0.0	1.3	0.6	5597.9	44.3	0.0	1.7	0.0	0.0	0.0	0.1	0.0	53.7	0.1	0.0	19.4	0.6	51.3	21.7	0.1	0.1	0.0	0.0	0.0
TST	RDS	ENSG00000128311	"Thiosulfate sulfurtransferase"	Q16762	22	37010859-37020183	"Enzymes, Predicted intracellular proteins"		"RNA-binding, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 102.1"	"Cell type enhanced"	"Detected in many"	8	"Cholangiocytes: 203.8;Enterocytes: 300.1;Hepatocytes: 350.5;Paneth cells: 284.5;Proximal tubular cells: 229.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"myeloid DC: 16.0"	"Group enriched"	"Detected in all"	6	"dendritic cells: 16.0;granulocytes: 14.3;monocytes: 11.5"	"Cell line enhanced"	"Detected in many"		"OE19: 73.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003044, HPA003643, CAB009546"	Enhanced		Supported	Mitochondria		NA	NA		2800000	Mitochondria		"CAB009546: AB_2211220, HPA003044: AB_1858417, HPA003643: AB_1080411"	"unprognostic (3.09e-2)"	"unprognostic (2.70e-1)"	"unprognostic (2.07e-1)"	"unprognostic (1.21e-2)"	"unprognostic (2.36e-2)"	"unprognostic (1.11e-1)"	"unprognostic (2.49e-2)"	"unprognostic (2.38e-2)"	"unprognostic (2.32e-1)"	"unprognostic (7.96e-3)"	"unprognostic (4.38e-2)"	"unprognostic (1.78e-1)"	"prognostic favorable (7.59e-6)"	"unprognostic (6.08e-3)"	"unprognostic (3.46e-1)"	"unprognostic (1.16e-1)"	"prognostic favorable (1.04e-4)"	8.5	29.7	6.0	13.5	7.6	5.7	6.1	5.0	10.5	9.5	38.4	12.9	10.9	37.4	5.9	4.0	16.6	6.8	38.4	14.1	5.1	4.9	19.7	102.1	6.2	3.2	8.2	7.0	7.2	23.9	1.8	2.3	5.0	5.9	8.1	21.6	6.2	13.6	6.9	8.3	5.4	39.5	3.8	4.7	3.5	22.8	3.3	6.7	1.8	8.5	12.8	10.5	7.2	9.2	1.6	16.0	14.3	11.5	2.2	1.2	5.2	11.1	24.9	3.1	10.6	7.7	3.0	5.9	6.2	5.3	3.6	5.4	7.2	7.3	3.0	5.2	4.9	3.5	9.6	2.3	6.2	0.8	8.7	13.9	3.1	4.7	14.0	19.2	4.3	7.4	5.9	7.0	2.7	2.3	5.1	8.8	1.6	3.6	5.2	1.7	25.6	0.1	13.9	5.4	73.6	10.9	10.0	3.4	5.2	10.2	10.5	1.8	4.8	6.5	11.8	8.4	3.2	12.2	10.9	6.6	4.1	7.7	6.8	1.9	3.9	3.9	0.9	1.5	12.4	2.4	5.3	11.5	4.9	0.6	3.0	1.1	1.6	0.5	0.4	16.0	0.8	0.3	0.2	14.3	2.2	0.8	1.1	1.2	5.2	6.0	7.6	5.0	10.5	5.1	4.9	8.2	7.0	5.9	6.7	26.8	66.9	14.5	10.5	1.1	0.8	32.5	203.8	21.4	19.4	19.2	0.0	9.5	39.7	35.3	1.4	5.0	300.1	0.0	38.8	6.0	15.5	9.3	13.9	350.5	13.2	1.6	33.0	36.2	24.7	2.7	12.0	8.3	1.7	17.2	154.8	25.4	33.8	284.5	7.4	229.1	0.6	0.0	3.6	0.7	0.1	2.0	9.5	10.9	155.4	15.2
TSTA3	"FX, P35B, SDR4E1"	ENSG00000104522	"Tissue specific transplantation antigen P35B"	Q13630	8	143612618-143618048	"Enzymes, Predicted intracellular proteins"		"Isomerase, Multifunctional enzyme, Oxidoreductase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA023361	Approved		Approved	Nucleoplasm,Cytosol		Yes	No		600000	Cytosol	Nucleoplasm	"HPA023361: AB_1858420"	"unprognostic (1.37e-2)"	"unprognostic (5.35e-2)"	"unprognostic (8.62e-3)"	"unprognostic (3.55e-2)"	"unprognostic (2.90e-1)"	"unprognostic (5.82e-2)"	"unprognostic (2.48e-2)"	"unprognostic (1.98e-1)"	"unprognostic (8.62e-2)"	"prognostic favorable (2.41e-4)"	"unprognostic (6.62e-3)"	"unprognostic (6.89e-2)"	"prognostic unfavorable (1.59e-4)"	"unprognostic (4.23e-2)"	"unprognostic (2.78e-2)"	"unprognostic (1.87e-2)"	"unprognostic (3.27e-2)"	9.4	12.0	7.0	9.5	10.1	16.3	10.2	6.1	13.8	8.6	18.7	8.4	16.6	24.8	8.4	9.9	28.0	7.7	23.7	15.7	8.1	7.8	11.7	40.0	8.9	16.5	6.8	8.1	9.7	60.1	6.4	14.2	21.9	12.2	13.9	14.9	9.5	35.4	14.2	16.8	28.4	20.2	6.9	4.7	11.3	35.5	24.6	5.6	14.7	13.0	17.8	24.8	9.8	10.4	18.7	25.6	17.7	21.0	28.1	26.9	20.5	16.4	12.0	6.0	18.0	5.1	4.9	11.2	13.6	13.4	9.7	7.3	14.6	17.5	7.2	13.4	9.6	4.0	11.8	9.1	18.5	4.4	18.6	13.2	10.6	21.2	16.9	10.4	7.1	12.2	6.1	9.6	6.5	23.3	7.9	15.7	12.9	11.8	10.5	7.3	49.8	9.2	10.8	8.2	47.2	16.4	10.6	4.6	22.1	19.6	16.5	12.4	9.7	9.3	18.4	13.7	4.5	23.4	10.4	13.1	6.4	25.6	7.6	13.1	7.9	5.6	5.3	9.9	16.3	9.6	10.5	15.9	17.7	21.0	21.0	21.2	16.1	22.7	22.6	18.0	18.7	16.9	18.7	16.3	28.1	16.3	25.6	26.9	20.5	7.0	10.1	6.1	13.8	8.1	7.8	6.8	8.1	12.2	5.6	14.9	27.3	38.0	42.2	74.1	12.6	12.5	61.1	18.7	12.5	8.7	5.9	73.8	46.4	110.8	79.5	30.8	86.0	46.7	170.3	125.9	25.3	69.4	25.3	62.7	61.4	12.7	59.5	26.4	25.1	197.6	38.0	25.2	28.7	33.3	168.9	16.3	123.1	69.1	32.2	68.8	9.3	12.9	27.2	56.2	48.1	108.3	73.3	42.9	88.1	73.3
TTBK1	KIAA1855	ENSG00000146216	"Tau tubulin kinase 1"	Q5TCY1	6	43243680-43288259	"Enzymes, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 28.9"	"Cell type enhanced"	"Detected in some"	17	"Bipolar cells: 6.7;Horizontal cells: 4.8;Proximal tubular cells: 1.9"	"Cancer enhanced"	"Detected in some"		"glioma: 3.0"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	9	"SCLC-21H: 21.3;SH-SY5Y: 8.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031735, HPA031736"	Enhanced		Supported	Nucleoplasm,Cytosol		NA	NA			Cytosol	Nucleoplasm	"HPA031735: AB_2674019, HPA031736: AB_10670294"	"unprognostic (1.68e-1)"	"unprognostic (7.88e-3)"	"unprognostic (7.01e-2)"	"unprognostic (1.62e-3)"	"unprognostic (2.18e-1)"	"unprognostic (2.24e-4)"	"unprognostic (2.46e-3)"	"unprognostic (3.01e-2)"	"unprognostic (3.09e-1)"	"unprognostic (1.85e-1)"	"unprognostic (3.01e-2)"	"unprognostic (2.12e-4)"	"unprognostic (7.42e-2)"	"unprognostic (3.68e-1)"	"unprognostic (1.32e-1)"	"unprognostic (2.64e-3)"	"unprognostic (3.04e-4)"	1.1	3.9	12.4	1.3	12.9	0.9	1.0	14.9	28.9	1.0	1.4	8.2	0.0	4.6	1.0	1.0	1.0	1.1	1.4	1.3	10.3	7.5	1.7	3.5	1.1	1.2	7.1	12.5	1.0	1.4	1.6	7.7	1.0	9.0	1.3	1.3	0.7	1.0	1.2	1.0	1.0	6.8	1.1	6.2	1.2	1.3	2.3	8.3	0.0	1.0	0.0	1.3	1.1	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	1.1	0.0	0.3	0.0	0.0	0.7	0.0	0.2	0.1	0.7	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.3	0.6	0.0	0.1	0.0	0.0	0.0	0.0	21.3	8.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.5	1.6	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	12.4	12.9	14.9	21.7	10.3	7.5	7.1	12.5	9.0	8.3	0.0	0.0	0.0	0.0	0.0	6.7	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.0	0.0	0.2	0.0	0.0	0.0	0.0	1.1	0.1	4.8	0.0	0.6	0.0	0.2	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	1.9	0.5	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.2	0.0
TTBK2	"KIAA0847, SCA11"	ENSG00000128881	"Tau tubulin kinase 2"	Q6IQ55	15	42738734-42920809	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Cilium biogenesis/degradation"	"Kinase, Serine/threonine-protein kinase, Transferase"	"Neurodegeneration, Spinocerebellar ataxia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 41.8"	"Cell type enhanced"	"Detected in many"	7	"Early spermatids: 69.2;Late spermatids: 113.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA018113, HPA049866"	Approved		Uncertain	"Intermediate filaments"		NA	NA			"Intermediate filaments"		"HPA018113: AB_1858421, HPA049866: AB_2680923"	"unprognostic (2.15e-1)"	"unprognostic (1.67e-1)"	"unprognostic (1.08e-1)"	"unprognostic (6.30e-2)"	"unprognostic (7.73e-2)"	"unprognostic (4.26e-1)"	"unprognostic (6.64e-2)"	"unprognostic (5.11e-2)"	"unprognostic (1.32e-1)"	"unprognostic (2.43e-2)"	"unprognostic (2.78e-2)"	"unprognostic (8.62e-2)"	"unprognostic (3.46e-2)"	"unprognostic (7.29e-2)"	"unprognostic (3.63e-2)"	"unprognostic (2.18e-1)"	"unprognostic (1.38e-1)"	6.7	7.3	8.7	5.1	14.0	8.0	6.0	17.8	22.0	7.0	7.2	10.9	3.8	3.3	8.5	6.2	4.2	7.8	6.2	10.7	9.4	11.5	6.1	4.3	6.1	5.5	11.1	14.8	11.5	3.3	9.0	13.9	8.8	24.7	8.2	5.6	7.6	4.8	6.5	11.6	6.3	4.6	8.4	10.9	7.1	4.9	41.8	10.8	3.6	6.7	1.9	5.4	6.8	8.7	2.5	1.4	1.3	3.0	2.1	3.1	0.7	6.2	3.4	9.3	4.9	6.4	6.6	1.9	5.1	7.3	4.4	6.6	4.6	1.5	4.0	6.5	4.9	8.9	4.2	8.1	6.0	6.8	13.0	5.7	5.0	7.7	1.9	5.0	7.1	8.6	5.2	6.2	4.0	21.0	9.6	5.5	5.4	7.5	6.5	4.2	0.8	4.7	5.0	2.6	1.5	3.8	7.9	8.8	2.0	5.6	3.8	6.9	7.8	12.5	0.9	2.6	6.7	3.2	8.8	6.7	5.7	5.7	7.1	7.1	7.6	10.1	6.0	4.2	5.5	3.6	0.4	3.0	1.2	1.7	1.4	3.1	1.5	1.6	1.3	0.8	2.5	2.1	1.5	1.3	2.1	1.5	1.4	0.5	0.7	8.7	14.0	17.8	22.0	9.4	11.5	11.1	14.8	24.7	10.8	6.0	10.2	7.4	11.8	9.5	31.0	14.2	15.3	33.5	9.1	8.7	35.3	3.5	0.0	4.9	69.2	12.8	3.6	23.3	3.7	2.6	13.1	11.0	18.5	6.8	6.4	42.9	13.7	12.9	13.9	113.0	15.5	15.4	11.8	9.0	4.9	15.0	6.5	2.9	19.1	4.5	38.8	12.9	18.9	39.4	7.1	8.2	2.6	8.7	5.2	5.5
TTC3	"DCRR1, RNF105, TPRD, TPRDI, TPRDII, TPRDIII"	ENSG00000182670	"Tetratricopeptide repeat domain 3"	P53804	21	37073226-37203112	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA016810, HPA023964, HPA036304"	Uncertain		Approved	Nucleoplasm,Nucleoli,Cytosol		No	No			"Nucleoplasm, Nucleoli"	Cytosol	"HPA016810: AB_1858434, HPA023964: AB_1858435, HPA036304: AB_2675049"	"unprognostic (3.90e-2)"	"unprognostic (1.65e-1)"	"unprognostic (1.19e-1)"	"unprognostic (1.22e-1)"	"unprognostic (1.53e-1)"	"unprognostic (1.37e-2)"	"unprognostic (8.52e-2)"	"unprognostic (9.29e-2)"	"unprognostic (8.71e-2)"	"unprognostic (1.61e-1)"	"unprognostic (2.05e-2)"	"unprognostic (1.99e-1)"	"unprognostic (9.10e-2)"	"unprognostic (1.02e-1)"	"unprognostic (1.60e-1)"	"unprognostic (1.39e-1)"	"unprognostic (6.74e-2)"	22.9	22.1	34.0	18.7	36.5	12.0	23.4	39.2	40.0	34.9	20.6	15.9	26.7	13.0	21.6	33.3	15.3	19.5	19.0	21.5	29.1	16.5	21.4	17.0	15.4	14.3	17.7	27.5	34.5	25.8	27.4	50.4	15.2	34.7	28.9	19.9	16.1	24.5	25.4	21.6	16.1	16.8	21.6	21.7	13.6	21.3	19.5	19.9	19.7	35.4	11.1	15.1	23.3	18.9	10.6	12.8	4.8	5.7	9.1	18.6	3.8	21.7	7.8	36.3	6.8	35.0	51.1	12.6	24.0	29.9	10.8	14.7	10.2	11.0	18.8	8.4	40.2	10.1	7.2	10.9	14.8	15.3	19.9	7.8	38.0	11.6	13.4	12.8	21.2	12.3	26.4	9.1	11.0	9.8	21.8	16.0	16.7	22.8	22.1	20.3	16.8	20.6	5.5	10.3	14.5	13.2	27.6	17.4	9.9	12.6	16.9	27.7	21.1	29.8	17.1	15.4	8.7	19.4	8.3	20.9	15.5	6.2	19.0	9.0	22.2	15.9	18.8	25.6	21.2	11.7	2.9	4.4	4.8	9.1	4.8	13.6	9.5	10.6	12.3	7.9	10.6	18.6	11.3	0.7	9.1	5.7	12.8	7.2	3.8	34.0	36.5	39.2	40.0	29.1	16.5	17.7	27.5	34.7	19.9	116.1	118.5	109.7	81.2	58.5	344.6	127.3	56.0	75.0	101.2	71.5	214.0	39.6	140.9	74.9	160.4	67.6	60.1	0.0	65.5	79.7	132.8	164.9	62.4	80.5	56.3	311.4	182.6	102.5	80.0	149.3	194.5	74.4	200.8	61.3	133.8	187.6	72.0	84.2	245.4	81.7	228.9	51.8	103.8	264.1	280.4	54.8	44.1	76.7	118.3	90.4
TTK	"CT96, MPH1, MPS1, MPS1L1"	ENSG00000112742	"TTK protein kinase"	P33981	6	80003887-80042527	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase, Tyrosine-protein kinase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 58.3;testis: 31.7"	"Cell type enhanced"	"Detected in many"	15	"Early spermatids: 19.9;Erythroid cells: 23.3;Spermatocytes: 63.4;Spermatogonia: 28.5"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in many"		"T-reg: 4.0"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"CAB010166, CAB013229"	Enhanced		Approved	Nucleoli,Cytosol		NA	Yes			"Nucleoli, Cytosol"		"CAB010166: AB_632567, CAB013229: AB_2533230"	"unprognostic (4.27e-2)"	"unprognostic (8.71e-2)"	"unprognostic (1.04e-2)"	"prognostic unfavorable (1.44e-5)"	"unprognostic (7.97e-2)"	"unprognostic (4.78e-2)"	"prognostic unfavorable (3.84e-10)"	"unprognostic (1.56e-3)"	"unprognostic (7.95e-2)"	"unprognostic (2.02e-3)"	"prognostic unfavorable (2.54e-4)"	"unprognostic (1.54e-1)"	"unprognostic (0.00e+0)"	"unprognostic (3.51e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.46e-1)"	"unprognostic (1.66e-1)"	1.1	1.4	0.3	3.2	0.4	13.9	1.0	0.3	0.4	1.0	2.7	0.2	0.2	2.2	0.5	1.0	6.5	0.3	0.4	1.5	0.4	0.3	0.9	0.6	1.2	4.6	0.4	0.2	0.4	0.5	0.0	0.3	3.0	0.6	0.6	3.6	0.3	1.2	0.6	0.3	2.0	2.8	0.7	0.8	2.1	1.8	31.7	0.2	58.3	0.5	2.6	5.4	0.8	1.8	1.7	0.0	1.1	0.0	1.1	4.0	0.8	13.3	8.0	24.0	19.6	1.1	3.5	13.6	15.5	9.5	22.7	27.8	10.9	10.2	19.8	12.1	6.6	23.8	17.3	21.1	9.5	31.6	18.0	17.0	18.3	10.6	8.9	0.0	21.5	11.9	0.4	1.0	15.8	10.1	3.3	12.8	27.9	19.9	20.4	19.2	9.9	12.2	15.5	14.1	12.0	9.7	11.0	43.8	8.2	5.7	8.6	16.5	9.7	9.1	9.9	5.6	13.5	9.3	16.3	5.3	10.2	10.2	6.6	24.7	4.6	15.5	11.0	3.6	20.0	8.7	0.0	0.0	1.1	0.6	0.0	0.6	0.9	1.0	1.6	0.0	1.7	0.3	0.5	0.3	1.1	0.0	0.0	4.0	0.8	0.3	0.4	0.3	0.4	0.4	0.3	0.4	0.2	0.6	0.2	3.0	0.6	0.0	0.5	1.1	0.0	0.7	0.0	4.0	3.4	0.0	2.0	4.1	3.3	0.4	19.9	0.1	0.2	23.3	0.2	13.1	0.8	0.2	1.1	0.0	5.2	0.0	1.7	0.0	2.4	12.8	0.9	1.2	0.0	9.0	1.0	0.3	0.4	0.0	0.7	0.0	1.2	6.5	0.2	63.4	28.5	0.3	3.1	0.0	1.2	0.7
TTL	MGC46235	ENSG00000114999	"Tubulin tyrosine ligase"	Q8NG68	2	112482154-112541739	"Enzymes, Predicted intracellular proteins"		Ligase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Erythroid cells: 46.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA066819			Approved	Nucleoplasm,Vesicles		NA	NA			Vesicles	Nucleoplasm	"HPA066819: AB_2685728"	"unprognostic (1.05e-2)"	"unprognostic (3.90e-3)"	"unprognostic (2.25e-1)"	"unprognostic (3.95e-3)"	"unprognostic (9.75e-2)"	"unprognostic (1.81e-2)"	"prognostic unfavorable (5.65e-4)"	"unprognostic (2.95e-1)"	"unprognostic (3.65e-1)"	"unprognostic (2.10e-1)"	"unprognostic (5.48e-2)"	"unprognostic (7.19e-2)"	"unprognostic (6.12e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.45e-1)"	"unprognostic (2.01e-1)"	"unprognostic (4.55e-2)"	4.4	4.0	9.9	4.2	11.9	7.1	11.3	5.0	12.5	3.3	4.1	9.2	2.5	3.1	4.6	4.2	5.2	3.2	4.9	10.3	9.4	6.5	3.9	3.3	5.9	4.4	8.1	5.3	3.2	3.8	4.1	2.4	5.3	5.9	3.2	3.9	2.6	3.0	3.7	13.1	6.0	3.2	5.8	5.4	4.0	3.2	3.0	6.5	5.1	4.2	5.2	3.8	4.8	2.9	1.8	1.2	2.7	1.3	1.0	1.3	0.5	3.7	2.9	3.7	8.2	4.4	6.3	1.4	6.4	5.3	6.9	5.9	3.5	1.4	3.5	3.6	5.5	4.5	2.6	6.4	3.3	8.3	2.4	3.6	2.9	4.1	4.4	2.0	4.1	1.5	2.8	2.3	10.0	5.3	3.1	5.8	2.4	4.8	2.8	5.4	1.9	3.6	2.3	3.2	1.1	5.8	3.9	4.1	1.9	2.1	2.9	7.8	5.4	5.0	1.7	8.9	2.5	1.7	2.4	5.8	8.2	6.0	6.4	4.8	1.6	3.1	2.9	9.0	3.1	3.5	2.7	1.3	1.0	1.3	0.8	1.1	0.8	1.0	1.0	0.4	1.8	0.9	1.1	2.4	1.0	1.1	1.2	0.8	0.5	9.9	11.9	5.0	12.5	9.4	6.5	8.1	5.3	5.9	6.5	11.9	8.3	3.7	4.2	18.0	16.4	32.0	5.1	2.7	7.9	12.2	11.8	2.6	0.0	6.0	6.1	13.0	5.0	46.7	8.3	2.1	9.4	5.0	0.0	9.4	10.2	7.9	10.9	20.9	24.8	3.6	2.8	15.5	6.8	10.8	5.5	9.1	8.6	5.8	5.3	4.9	21.2	6.5	9.0	1.9	4.3	15.7	1.0	6.1	5.2	3.7
TTN	"CMD1G, CMH9, CMPD4, FLJ32040, LGMD2J, MYLK5, TMD"	ENSG00000155657	Titin	Q8WZ42	2	178525989-178830802	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"		"Calmodulin-binding, Kinase, Serine/threonine-protein kinase, Transferase"	"Cardiomyopathy, Disease mutation, Limb-girdle muscular dystrophy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"heart muscle: 136.5;skeletal muscle: 713.8;tongue: 227.0"	"Cell type enriched"	"Detected in many"	134	"Cardiomyocytes: 19161.7"	"Cancer enhanced"	"Detected in single"		"head and neck cancer: 1.3"	"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"RH-30: 4.9"	"Not detected"	"Not detected"							"HPA007042, CAB022682, HPA030048"	Enhanced					NA	NA		25000000			"CAB022682: , HPA007042: AB_1080292, HPA030048: AB_2732451"	"unprognostic (1.00e-2)"	"unprognostic (3.92e-1)"	"unprognostic (1.77e-1)"	"unprognostic (7.11e-2)"	"unprognostic (3.71e-2)"	"unprognostic (1.49e-2)"	"unprognostic (6.62e-2)"	"unprognostic (1.84e-1)"	"unprognostic (2.49e-2)"	"unprognostic (1.86e-1)"	"unprognostic (2.79e-1)"	"unprognostic (2.65e-1)"	"unprognostic (3.49e-4)"	"unprognostic (1.99e-1)"	"unprognostic (1.15e-1)"	"unprognostic (1.09e-1)"	"unprognostic (1.34e-2)"	23.7	0.3	0.2	0.3	0.3	0.9	0.3	0.2	0.4	0.2	0.2	0.0	0.0	0.2	0.2	21.3	8.3	0.2	0.3	136.5	0.2	0.2	0.2	0.2	0.4	0.4	0.2	0.0	0.3	0.4	0.2	0.3	0.3	0.0	0.7	0.2	0.0	11.6	0.2	713.8	0.3	0.2	0.2	0.3	0.3	0.2	0.4	0.0	0.0	5.6	227.0	15.8	0.3	0.2	7.0	0.3	1.9	0.3	5.0	7.3	0.1	0.7	0.3	1.9	1.0	0.0	0.0	3.4	0.6	0.0	0.0	0.0	1.8	0.3	2.4	0.6	0.0	1.8	1.8	0.0	0.0	0.0	2.4	2.0	3.7	2.7	1.1	0.0	0.3	0.8	2.4	0.0	0.0	0.0	1.7	1.4	1.8	2.2	1.2	0.4	0.4	1.6	2.5	0.4	0.2	1.8	1.3	4.9	1.3	0.0	0.6	1.1	1.7	0.4	1.3	0.0	1.7	0.8	2.4	1.6	0.0	0.0	0.9	0.4	3.6	0.4	3.5	0.1	1.1	0.9	1.9	0.3	0.7	0.5	0.2	0.2	6.9	1.2	0.9	0.2	7.0	2.7	3.5	1.3	5.0	0.2	0.3	7.3	0.1	0.2	0.3	0.2	0.2	0.2	0.2	0.2	0.0	0.0	0.0	14.9	142.6	2.2	0.2	0.8	28.9	19161.7	17.8	5.3	11.4	0.0	19.6	0.4	1.7	7.7	35.3	0.7	0.0	0.0	23.6	0.2	0.5	0.1	9.3	0.5	0.2	15.9	4.1	2.5	0.0	4.3	1.1	0.4	0.0	0.0	0.0	10.3	0.9	0.0	4.2	0.0	26.3	0.0	1.4	5.7	0.2	0.1	0.3	4.9	0.0	0.0
TUT1	"FLJ21850, FLJ22267, FLJ22347, PAPD2, RBM21, TUTase"	ENSG00000149016	"Terminal uridylyl transferase 1, U6 snRNA-specific"	Q9H6E5	11	62575045-62592177	"Enzymes, Predicted intracellular proteins"	"mRNA processing"	"Nucleotidyltransferase, RNA-binding, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA069055, HPA071838"			Supported	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA069055: AB_2686075, HPA071838: AB_2686456"	"unprognostic (3.81e-2)"	"unprognostic (3.54e-2)"	"prognostic unfavorable (9.51e-4)"	"unprognostic (2.43e-1)"	"unprognostic (1.01e-1)"	"unprognostic (7.59e-2)"	"unprognostic (1.83e-1)"	"unprognostic (2.59e-2)"	"unprognostic (1.83e-1)"	"unprognostic (5.79e-3)"	"unprognostic (1.59e-2)"	"unprognostic (2.71e-1)"	"unprognostic (7.20e-3)"	"unprognostic (1.03e-2)"	"unprognostic (4.41e-1)"	"unprognostic (1.35e-1)"	"unprognostic (3.97e-3)"	10.9	12.1	10.7	9.9	13.6	7.8	12.9	13.5	13.3	10.5	8.7	15.9	13.0	12.9	11.5	10.8	10.0	16.9	13.7	10.7	13.6	8.3	12.2	22.7	9.6	18.1	15.5	9.5	14.5	26.2	15.5	16.2	12.3	13.0	13.9	6.2	11.9	16.4	11.9	20.5	13.9	11.7	10.2	11.4	14.6	12.5	18.6	13.2	17.1	14.0	8.8	13.6	11.5	9.8	13.1	9.4	6.6	7.3	9.8	16.0	7.2	7.3	9.2	6.4	8.9	7.8	4.5	8.3	7.9	4.8	6.7	5.8	8.2	14.4	11.7	18.2	3.8	8.4	13.8	11.7	9.2	3.4	9.0	6.2	12.0	9.4	7.8	8.7	8.5	5.5	6.3	9.9	8.3	12.8	6.3	6.4	15.2	18.0	12.1	5.6	16.0	12.0	18.1	7.3	4.8	11.3	13.5	10.2	28.4	6.2	4.2	10.6	14.9	6.0	11.4	9.8	5.6	15.9	8.3	5.7	7.6	6.8	8.8	6.0	21.1	18.5	14.4	8.9	6.7	6.2	5.9	5.9	6.6	10.5	7.3	14.6	9.8	9.9	8.4	7.8	13.1	16.0	12.5	3.6	9.8	5.3	9.4	8.9	7.2	10.7	13.6	13.5	13.3	13.6	8.3	15.5	9.5	13.0	13.2	0.0	7.9	8.1	4.8	2.4	7.4	3.2	10.2	9.4	2.3	10.4	5.9	10.6	5.0	7.3	25.9	13.4	5.6	0.0	6.4	6.5	3.8	6.1	2.3	16.2	5.0	1.6	6.9	12.3	4.0	12.8	6.6	3.1	10.1	2.8	6.0	9.3	5.4	3.5	3.2	4.9	8.7	0.0	1.4	9.2	14.8	1.9	11.7	6.9	6.0	2.8
TWNK	"C10orf2, FLJ21832, IOSCA, PEO, PEO1, TWINKLE, TWINL"	ENSG00000107815	"Twinkle mtDNA helicase"	Q96RR1	10	100987367-100994401	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"DNA replication"	"Helicase, Hydrolase"	"Deafness, Disease mutation, Neurodegeneration, Neuropathy, Primary mitochondrial disease, Progressive external ophthalmoplegia"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"	8	"Club cells: 5.7;Cytotrophoblasts: 3.6;Distal tubular cells: 3.3;Ductal cells: 3.9;Pancreatic endocrine cells: 3.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA002532	Uncertain					NA	NA					"HPA002532: AB_1078311"	"unprognostic (8.10e-2)"	"unprognostic (9.65e-2)"	"unprognostic (1.16e-1)"	"unprognostic (2.19e-2)"	"unprognostic (2.81e-2)"	"unprognostic (1.19e-1)"	"unprognostic (7.82e-3)"	"unprognostic (7.99e-2)"	"unprognostic (1.22e-1)"	"unprognostic (7.95e-2)"	"unprognostic (7.52e-2)"	"unprognostic (1.96e-2)"	"unprognostic (9.46e-2)"	"unprognostic (9.82e-3)"	"unprognostic (1.64e-1)"	"unprognostic (1.36e-1)"	"unprognostic (1.45e-1)"	8.5	12.1	8.4	11.1	9.9	4.2	12.6	8.7	10.4	6.1	7.3	6.0	2.6	5.4	9.1	9.0	10.1	11.4	6.6	8.4	8.7	5.1	8.4	10.8	4.4	9.6	10.6	7.4	9.8	14.7	9.5	11.1	6.4	9.4	7.7	8.3	3.9	6.8	5.9	32.5	9.6	6.8	7.4	12.2	10.4	7.0	15.0	10.9	12.6	8.9	9.8	13.1	6.6	14.1	5.4	2.4	1.1	1.5	4.7	7.8	2.5	6.5	13.8	5.5	17.5	5.1	3.5	6.6	4.8	6.5	7.8	7.8	22.8	5.8	23.7	9.4	2.9	4.7	11.0	23.1	12.0	9.9	11.0	13.6	17.9	8.1	17.5	8.5	22.9	7.4	6.8	13.8	11.3	35.8	7.2	4.7	11.7	19.2	6.6	5.4	8.9	15.5	8.4	15.9	12.4	11.6	15.2	12.2	14.5	5.1	6.7	9.0	17.3	5.2	7.1	17.3	6.5	9.3	7.8	5.4	3.9	7.9	4.8	14.1	12.4	12.8	20.3	4.7	21.0	4.3	1.1	1.1	0.1	2.6	0.9	7.8	5.4	3.8	5.0	2.1	4.0	4.1	4.5	0.0	4.7	1.5	2.4	1.0	2.5	8.4	9.9	8.7	10.4	8.7	5.1	10.6	7.4	9.4	10.9	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.7	1.8	0.0	3.6	3.3	3.9	0.0	0.0	0.0	0.0	2.5	2.8	0.0	0.0	1.1	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	1.8	0.0	0.0	3.4	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0
TXK	"BTKL, PSCTK5, PTK4, RLK, TKL"	ENSG00000074966	"TXK tyrosine kinase"	P42681	4	48066393-48134256	"Enzymes, Predicted intracellular proteins"	"Adaptive immunity, Immunity, Transcription, Transcription regulation"	"DNA-binding, Kinase, Transferase, Tyrosine-protein kinase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 43.5;lymphoid tissue: 49.1;placenta: 28.4"	"Cell type enriched"	"Detected in some"	9	"T-cells: 43.1"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in many"		"NK-cell: 43.5"	"Group enriched"	"Detected in many"	26	"NK-cells: 43.5;T-cells: 17.5"	"Cell line enhanced"	"Detected in some"		"CAPAN-2: 4.8;HMC-1: 11.3;U-266/70: 5.5;U-266/84: 6.8;WM-115: 25.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA062482			Approved	Vesicles		NA	NA			Vesicles		"HPA062482: AB_2684778"	"unprognostic (1.04e-2)"	"unprognostic (2.21e-2)"	"unprognostic (4.13e-2)"	"unprognostic (9.24e-3)"	"unprognostic (1.09e-2)"	"unprognostic (2.58e-4)"	"unprognostic (1.32e-1)"	"unprognostic (1.94e-1)"	"unprognostic (1.50e-1)"	"unprognostic (6.39e-3)"	"unprognostic (8.13e-2)"	"unprognostic (4.06e-1)"	"unprognostic (1.33e-1)"	"unprognostic (1.37e-1)"	"unprognostic (1.61e-1)"	"unprognostic (2.59e-1)"	"unprognostic (2.04e-2)"	1.8	1.5	0.3	15.3	0.4	3.9	1.5	0.2	0.6	0.8	2.1	0.3	0.2	1.3	1.3	11.6	2.4	2.6	1.7	0.7	0.2	0.4	2.1	2.8	4.0	49.1	0.5	0.5	0.5	1.0	0.4	1.3	28.4	0.6	0.9	1.0	1.0	6.1	0.2	0.5	1.7	7.9	0.4	0.4	17.8	1.0	1.7	0.2	14.0	1.9	0.2	19.3	2.4	1.4	0.0	0.1	1.1	0.0	43.5	17.5	10.6	2.3	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.4	0.0	4.8	0.0	1.4	0.0	0.2	0.2	0.0	0.0	0.4	0.2	0.1	2.4	0.0	0.0	0.0	0.3	11.3	0.0	0.0	0.1	0.0	0.8	0.1	0.4	0.2	0.0	0.7	0.0	0.0	2.1	0.0	0.6	0.8	0.3	0.0	0.0	1.4	1.3	0.0	0.2	0.0	0.0	1.1	0.1	0.0	0.2	0.4	0.0	0.0	0.3	0.1	5.5	6.8	0.4	0.0	0.4	25.4	1.1	0.0	0.3	13.2	0.0	17.4	0.0	6.8	6.4	0.0	0.0	17.5	11.9	0.8	43.5	0.0	0.1	5.1	10.6	0.3	0.4	0.2	0.6	0.2	0.4	0.5	0.5	0.6	0.2	0.0	2.6	0.8	0.5	0.3	0.0	0.2	2.5	0.0	0.0	0.0	3.9	0.2	1.7	1.3	4.3	0.1	0.0	0.0	0.0	0.1	0.5	0.4	1.1	1.0	1.2	0.0	0.0	4.3	5.1	1.3	0.3	0.5	1.7	0.0	0.0	2.3	0.2	0.0	0.0	0.6	0.4	0.0	0.0	0.4	0.2	1.0	0.5	43.1	0.2	0.6
TXNDC12	"AGR1, ERP18, ERP19, hAG-1, PDIA16, TLP19"	ENSG00000117862	"Thioredoxin domain containing 12"	O95881	1	52020131-52056171	"Enzymes, Plasma proteins, Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"								"Intracellular and membrane"	NA	NA		95000				"unprognostic (6.54e-2)"	"unprognostic (5.46e-2)"	"prognostic favorable (4.44e-4)"	"unprognostic (2.33e-3)"	"unprognostic (2.19e-1)"	"prognostic unfavorable (2.61e-4)"	"prognostic unfavorable (1.28e-5)"	"unprognostic (1.25e-1)"	"unprognostic (3.28e-2)"	"unprognostic (1.17e-1)"	"unprognostic (6.14e-2)"	"unprognostic (2.42e-1)"	"prognostic unfavorable (1.40e-12)"	"unprognostic (2.13e-1)"	"unprognostic (5.83e-2)"	"unprognostic (1.73e-2)"	"unprognostic (1.17e-1)"	30.5	24.6	20.4	19.8	20.1	19.5	22.7	19.2	20.4	23.1	25.6	15.3	20.9	20.4	18.6	28.5	18.9	25.1	20.2	21.6	18.2	22.1	30.7	60.3	24.5	20.6	23.5	12.5	28.0	51.9	14.0	29.4	32.4	18.5	19.7	29.1	15.4	30.3	22.0	15.5	17.2	35.0	17.7	21.0	35.1	24.3	16.7	18.3	31.8	38.6	18.3	26.6	20.8	21.6	24.2	28.6	62.8	36.4	22.3	33.3	36.7	18.1	16.7	18.9	26.9	31.3	16.7	15.0	28.0	27.6	25.4	29.4	18.6	15.0	14.1	18.4	22.0	28.4	24.4	26.2	21.3	34.1	18.5	23.8	18.0	15.4	29.8	37.7	33.2	36.2	24.3	29.1	26.3	42.4	19.6	25.4	19.3	16.0	10.8	20.9	16.6	18.5	43.3	41.7	26.3	16.3	18.9	27.9	38.8	33.7	15.7	15.0	19.6	27.6	24.4	26.5	38.3	13.7	43.7	16.2	18.3	20.2	20.9	31.5	22.0	33.1	15.9	26.6	31.2	20.7	46.7	36.4	54.6	23.2	33.2	29.0	24.2	28.5	24.8	26.9	20.9	27.4	26.3	62.8	22.3	34.4	28.6	33.3	36.7	20.4	20.1	19.2	20.4	18.2	22.1	23.5	12.5	18.5	18.3	8.9	10.5	52.4	53.7	39.2	18.1	12.7	45.9	25.4	9.1	41.8	13.7	96.2	14.9	64.8	5.6	58.2	36.0	0.0	78.0	136.0	41.8	60.0	33.4	29.0	107.7	20.6	46.6	43.6	52.6	4.5	51.8	56.6	49.0	71.3	56.4	36.1	65.7	59.6	29.0	25.4	12.5	32.3	36.0	49.4	9.6	39.6	99.1	50.0	68.5	55.2
TXNRD1	"GRIM-12, Trxr1, TXNR"	ENSG00000198431	"Thioredoxin reductase 1"	Q16881	12	104215779-104350305	"Cancer-related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"	"Electron transport, Transport"	Oxidoreductase	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	8	"Basal glandular cells: 272.3;Urothelial cells: 489.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"fHDF/TERT166: 144.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001395, CAB004607, CAB015834, HPA043871"	Approved		Supported	Nucleoplasm		NA	NA		5900000	Nucleoplasm		"CAB004607: AB_628405, CAB015834: , HPA001395: AB_1858377, HPA043871: AB_2678709"	"unprognostic (2.52e-2)"	"unprognostic (1.16e-1)"	"unprognostic (5.48e-2)"	"unprognostic (1.01e-1)"	"unprognostic (3.15e-1)"	"unprognostic (1.94e-2)"	"prognostic unfavorable (1.12e-5)"	"unprognostic (5.55e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.08e-1)"	"unprognostic (6.42e-2)"	"unprognostic (2.21e-1)"	"prognostic unfavorable (1.20e-5)"	"unprognostic (2.13e-1)"	"unprognostic (1.27e-1)"	"unprognostic (1.18e-2)"	"unprognostic (8.80e-2)"	19.1	79.2	14.1	15.6	16.9	22.6	18.5	11.1	13.7	13.0	21.8	9.7	19.7	23.5	23.5	14.7	16.7	19.0	23.2	32.4	11.0	11.7	25.3	19.6	29.3	18.1	12.0	10.9	16.4	7.9	10.5	16.2	30.8	16.4	25.3	19.1	18.1	10.6	26.5	30.0	5.7	17.0	99.6	10.9	14.9	24.2	14.8	8.9	15.6	16.5	16.9	13.2	73.2	72.0	8.1	14.2	37.6	16.2	8.3	10.2	8.7	22.2	103.7	12.1	11.3	58.1	32.6	42.0	41.4	26.2	18.7	19.4	10.9	33.2	16.7	19.3	144.9	70.2	7.8	23.8	15.9	22.2	8.1	10.3	14.1	81.4	46.1	93.3	21.9	15.4	18.5	16.4	41.4	13.2	57.6	64.1	23.0	19.3	7.9	28.0	10.7	22.4	10.0	11.6	44.8	106.9	22.3	8.4	14.5	21.8	12.3	18.8	11.4	33.5	53.0	33.0	23.9	12.5	13.0	85.6	9.2	19.1	20.6	33.9	8.7	17.0	25.1	19.3	12.2	54.4	33.0	10.6	24.7	9.1	14.0	10.2	8.1	8.4	9.0	14.2	5.2	7.6	6.6	37.6	8.3	16.2	9.2	7.1	8.7	14.1	16.9	11.1	11.2	11.0	11.7	12.0	10.9	16.4	8.9	59.6	55.0	27.6	272.3	92.4	28.0	55.7	38.2	104.4	96.7	15.7	21.6	22.9	34.9	73.1	34.3	40.9	44.4	23.3	68.7	28.0	34.6	217.3	50.9	45.7	36.8	27.0	19.7	50.3	37.2	13.4	63.0	64.0	18.6	55.9	17.9	23.3	183.4	20.3	27.6	28.5	19.7	0.0	58.8	11.6	28.8	63.7	42.9	23.5	24.1	489.6
TXNRD2	"TR, TR3, TRXR2"	ENSG00000184470	"Thioredoxin reductase 2"	Q9NNW7	22	19875517-19941992	"Enzymes, Plasma proteins, Predicted intracellular proteins"		Oxidoreductase	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"U-2 OS: 49.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002007, HPA003323"	Supported		Approved	Vesicles,Mitochondria,Cytosol		NA	NA		410000	"Vesicles, Mitochondria, Cytosol"		"CAB002007: , HPA003323: AB_1080396"	"unprognostic (3.17e-2)"	"unprognostic (8.72e-2)"	"unprognostic (4.30e-1)"	"unprognostic (9.71e-3)"	"unprognostic (7.25e-2)"	"unprognostic (6.35e-2)"	"unprognostic (3.21e-1)"	"unprognostic (1.12e-1)"	"unprognostic (2.78e-1)"	"unprognostic (2.83e-1)"	"unprognostic (4.94e-3)"	"unprognostic (2.49e-1)"	"prognostic favorable (1.10e-7)"	"unprognostic (2.47e-1)"	"unprognostic (5.99e-2)"	"unprognostic (1.69e-1)"	"unprognostic (1.10e-1)"	9.8	30.2	8.5	8.3	10.1	11.6	7.4	19.0	15.0	8.3	10.3	9.0	7.6	9.2	11.9	12.3	8.8	8.4	13.0	22.6	8.3	7.5	13.9	40.9	10.8	8.4	7.8	9.7	11.9	13.0	9.9	9.9	14.0	7.1	17.9	4.5	10.0	15.2	8.8	16.5	6.0	10.2	5.4	5.6	11.2	14.6	10.5	6.8	4.9	12.6	9.2	10.5	7.5	7.9	4.8	9.1	5.8	12.1	4.8	4.9	4.9	6.4	13.3	1.2	5.2	2.4	3.4	3.0	6.2	7.3	11.2	8.3	12.4	6.7	3.6	15.1	6.5	11.6	11.4	6.2	8.5	4.3	6.8	15.3	6.0	10.6	7.3	4.6	6.7	2.9	3.3	6.5	5.7	4.9	4.6	31.8	0.7	33.2	6.1	8.7	15.6	2.3	10.0	6.1	15.9	9.5	3.4	29.6	3.3	6.8	7.0	6.6	5.8	10.7	13.9	7.1	2.1	11.4	9.1	17.7	8.2	49.4	6.8	13.0	6.1	4.4	2.2	7.9	5.1	10.3	3.2	12.1	5.8	4.3	9.2	3.3	4.8	3.8	3.9	9.1	3.6	4.9	4.0	1.3	4.8	8.7	3.4	2.4	4.9	8.5	10.1	19.0	15.0	8.3	7.5	7.8	9.7	7.1	6.8	14.9	27.1	5.2	19.2	3.8	20.0	13.6	17.8	13.4	10.3	19.2	9.8	51.6	49.7	18.7	21.0	11.3	13.5	0.0	27.8	19.6	12.5	19.5	1.1	47.4	23.3	9.5	1.2	10.4	20.5	14.1	14.4	12.1	5.0	25.2	12.1	19.0	19.9	14.0	8.5	44.0	9.5	6.5	9.1	8.6	12.8	4.5	35.1	11.7	14.7	12.7
TXNRD3	"TGR, TR2, TRXR3"	ENSG00000197763	"Thioredoxin reductase 3"	Q86VQ6	3	126607052-126655155	"Enzymes, Predicted intracellular proteins"	"Differentiation, Electron transport, Spermatogenesis, Transport"	"Developmental protein, Oxidoreductase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"testis: 27.8"	"Cell type enhanced"	"Detected in many"	13	"Spermatocytes: 54.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"naive CD4 T-cell: 4.0"	"Lineage enriched"	"Detected in single"	4	"T-cells: 4.0"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB020802, HPA036109"	Uncertain		Enhanced	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"CAB020802: , HPA036109: AB_2674945"	"unprognostic (1.41e-1)"	"unprognostic (1.55e-2)"	"unprognostic (3.92e-1)"	"prognostic unfavorable (3.35e-4)"	"unprognostic (3.90e-1)"	"unprognostic (2.96e-1)"	"unprognostic (3.01e-1)"	"unprognostic (3.39e-2)"	"unprognostic (1.07e-1)"	"unprognostic (1.03e-1)"	"prognostic unfavorable (2.86e-4)"	"unprognostic (3.14e-1)"	"prognostic favorable (2.72e-4)"	"unprognostic (5.94e-2)"	"unprognostic (1.74e-1)"	"unprognostic (1.03e-2)"	"unprognostic (2.51e-1)"	5.4	5.9	4.9	2.4	4.7	0.9	7.2	5.5	5.7	7.3	4.2	4.6	5.5	1.6	8.3	7.1	6.4	4.7	5.2	4.9	4.0	2.9	6.7	10.0	7.0	5.2	4.6	3.5	8.8	7.1	12.3	8.5	3.3	7.0	5.2	3.6	6.4	5.7	5.1	7.3	4.8	2.6	8.1	5.1	3.3	4.9	27.8	5.8	5.0	7.4	3.6	2.1	6.6	5.3	0.3	0.7	0.5	0.9	0.9	4.0	0.3	14.0	3.6	4.6	7.2	8.5	13.0	2.3	6.2	5.6	5.1	7.2	6.4	7.9	0.0	7.9	8.5	3.1	5.6	5.7	6.4	6.5	0.0	4.2	1.6	3.3	4.9	7.4	5.7	0.5	11.9	5.6	1.7	11.8	7.0	3.7	4.6	3.4	0.0	8.2	10.1	1.2	3.1	6.5	3.8	2.7	0.4	4.0	2.3	5.4	7.0	8.0	4.9	17.8	5.2	9.0	3.7	7.2	2.2	6.1	6.3	1.5	8.5	2.9	3.7	1.6	0.0	3.4	2.0	5.3	0.0	0.9	0.5	0.5	0.8	0.1	0.0	0.2	0.6	0.7	0.3	4.0	1.3	0.0	0.9	0.2	0.0	0.0	0.3	4.9	4.7	5.5	5.7	4.0	2.9	4.6	3.5	7.0	5.8	3.0	7.4	0.0	4.8	0.9	1.9	3.6	5.1	2.7	3.4	3.5	2.0	7.5	3.3	4.3	15.1	1.5	0.0	0.0	3.4	4.6	3.7	2.1	5.7	7.3	2.6	0.0	4.1	1.3	0.3	2.9	4.4	0.3	0.0	0.0	2.3	2.3	3.9	0.0	8.1	2.8	0.5	0.0	2.7	54.7	15.3	0.5	6.1	0.0	1.5	2.5
TYK2	JTK1	ENSG00000105397	"Tyrosine kinase 2"	P29597	19	10350529-10380676	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		"Kinase, Transferase, Tyrosine-protein kinase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Distal tubular cells: 44.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"NB-4: 63.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA005157	Uncertain		Approved	Cytosol		NA	NA			Cytosol		"HPA005157: AB_1858480"	"unprognostic (1.60e-2)"	"unprognostic (6.12e-3)"	"unprognostic (3.67e-2)"	"prognostic favorable (9.62e-4)"	"unprognostic (7.61e-2)"	"prognostic favorable (1.05e-5)"	"unprognostic (1.20e-2)"	"unprognostic (6.16e-3)"	"unprognostic (4.93e-2)"	"unprognostic (1.90e-2)"	"prognostic favorable (1.02e-4)"	"unprognostic (1.24e-2)"	"prognostic unfavorable (4.43e-4)"	"unprognostic (2.10e-3)"	"unprognostic (1.78e-1)"	"unprognostic (4.19e-1)"	"prognostic favorable (4.16e-4)"	16.8	19.0	22.9	36.0	22.6	49.4	17.5	24.4	23.9	17.8	19.4	26.7	13.9	20.0	19.3	20.2	15.0	16.8	21.8	17.0	18.3	14.0	24.0	34.4	27.5	31.5	24.7	17.4	20.0	21.3	19.0	24.8	13.9	19.1	21.1	18.6	21.6	24.4	15.4	15.6	24.4	23.8	16.7	17.9	47.9	18.5	6.4	22.8	33.9	20.9	13.5	34.7	16.7	15.1	5.8	15.8	22.9	13.4	5.3	9.1	7.3	8.6	12.7	7.6	11.9	10.1	14.3	7.3	11.9	12.2	15.1	16.7	9.7	5.8	13.2	14.1	13.3	10.4	8.8	9.2	14.0	8.0	23.3	14.2	24.4	25.3	23.9	15.9	10.2	28.2	13.8	9.9	17.2	10.2	9.5	14.6	17.5	10.2	37.0	13.3	27.3	15.0	63.2	2.4	8.6	22.2	15.0	6.5	13.5	12.3	28.0	7.2	8.8	11.6	12.3	8.5	6.2	6.8	17.4	12.4	20.4	7.3	23.5	14.0	30.5	23.7	12.1	10.2	21.4	11.4	6.6	13.4	17.0	9.1	10.2	5.9	5.6	5.5	8.1	15.8	5.8	3.8	5.1	22.9	5.3	9.7	9.0	6.8	7.3	22.9	22.6	24.4	23.9	18.3	14.0	24.7	17.4	19.1	22.8	11.9	19.9	6.7	4.8	6.0	8.4	23.6	12.7	5.3	10.3	8.7	3.9	6.0	44.7	6.5	1.4	7.5	10.2	0.0	9.5	6.9	9.4	5.5	18.5	20.2	13.0	0.0	4.6	14.1	30.7	6.4	6.9	18.0	15.1	15.4	8.3	7.4	9.1	11.5	9.2	19.5	9.7	0.0	8.6	1.4	4.3	6.4	5.6	19.2	9.0	4.9
TYMP	"ECGF1, MNGIE"	ENSG00000025708	"Thymidine phosphorylase"	P19971	22	50525752-50530056	"Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"	"Angiogenesis, Chemotaxis, Differentiation"	"Developmental protein, Glycosyltransferase, Growth factor, Transferase"	"Cancer-related genes, Disease mutation, FDA approved drug targets, Neuropathy, Primary mitochondrial disease, Progressive external ophthalmoplegia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 57.8"	"Cell type enriched"	"Detected in many"	5	"monocytes: 2738.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	6	"classical monocyte: 23.0;eosinophil: 18.2;intermediate monocyte: 22.4;myeloid DC: 12.2;neutrophil: 6.7;non-classical monocyte: 15.9"	"Group enriched"	"Detected in many"	18	"dendritic cells: 12.2;granulocytes: 18.2;monocytes: 23.0"	"Cell line enhanced"	"Detected in many"		"CAPAN-2: 16.2;HHSteC: 40.2;Karpas-707: 38.8;U-266/70: 18.6"	"Low region specificity"	"Detected in some"							"HPA000530, HPA001072, CAB002518"	Enhanced		Approved	"Nuclear bodies,Golgi apparatus,Cytosol"		NA	NA		16000000	"Nuclear bodies, Golgi apparatus"	Cytosol	"CAB002518: AB_563953, HPA000530: AB_2666017, HPA001072: AB_1080274"	"unprognostic (7.02e-3)"	"unprognostic (1.00e-1)"	"unprognostic (3.61e-1)"	"prognostic favorable (4.34e-5)"	"unprognostic (7.60e-2)"	"unprognostic (1.16e-2)"	"unprognostic (2.40e-1)"	"unprognostic (7.17e-2)"	"unprognostic (4.64e-2)"	"unprognostic (1.33e-1)"	"unprognostic (3.31e-2)"	"unprognostic (2.17e-1)"	"prognostic unfavorable (3.50e-8)"	"unprognostic (1.32e-1)"	"unprognostic (4.02e-2)"	"unprognostic (1.52e-2)"	"unprognostic (4.60e-2)"	25.2	7.9	2.8	41.6	8.4	12.1	19.0	1.5	4.4	10.7	10.7	3.8	2.3	10.4	4.4	15.7	22.0	13.7	9.6	15.0	7.0	2.6	18.6	38.1	28.8	57.8	6.5	0.4	7.5	5.8	1.7	3.9	11.5	9.1	7.9	4.9	5.4	16.5	3.8	10.0	8.8	13.9	7.3	15.2	43.9	12.4	3.0	5.0	13.3	12.5	25.5	28.8	12.4	9.4	0.9	12.2	18.2	23.0	0.8	0.9	2.6	6.7	0.8	0.0	0.1	1.0	1.3	0.6	1.2	0.1	2.4	5.4	0.0	16.2	0.5	0.8	2.7	0.8	5.9	0.2	0.3	0.0	2.8	1.4	0.3	1.1	0.4	40.2	0.1	7.7	2.5	2.4	3.2	0.0	0.1	0.0	0.0	0.2	38.8	0.2	0.1	0.0	1.0	0.0	0.9	2.1	0.2	0.0	7.8	0.0	0.0	0.0	1.4	6.2	8.5	0.6	0.0	0.7	4.9	1.5	0.0	0.6	0.1	0.2	18.6	3.8	0.4	0.2	0.1	0.2	2.5	23.0	18.2	0.3	22.4	0.2	0.8	0.3	0.2	12.2	0.9	0.2	0.1	6.7	0.8	15.9	1.1	0.9	2.6	2.8	8.4	1.5	4.4	7.0	2.6	6.5	0.4	9.1	5.0	11.9	35.6	80.8	45.0	52.0	2.9	2.0	40.8	21.4	19.4	31.4	3.9	11.5	24.9	326.6	1.8	45.0	161.9	0.0	563.3	281.5	67.3	63.5	54.1	80.8	472.8	0.0	16.1	38.1	417.7	8.6	4.6	429.6	108.0	2738.6	29.6	2.0	289.0	94.7	1.8	76.1	5.4	25.8	44.2	1.4	8.3	49.4	28.0	34.5	27.7	63.3
TYMS	"HsT422, TMS, TS, Tsase"	ENSG00000176890	"Thymidylate synthetase"	P04818	18	657604-673578	"Cancer-related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"	"Nucleotide biosynthesis"	"Methyltransferase, Transferase"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 34.9;lymphoid tissue: 75.5"	"Cell type enhanced"	"Detected in many"	12	"Extravillous trophoblasts: 109.0;Spermatocytes: 197.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"T-reg: 13.8"	"Group enriched"	"Detected in many"	6	"NK-cells: 6.8;T-cells: 13.8"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"Group enriched"	"Detected in some"	5	"cerebellum: 6.7;olfactory region: 8.8"	"CAB002784, HPA074922"	Enhanced					NA	Yes					"CAB002784: , HPA074922: "	"unprognostic (7.58e-2)"	"unprognostic (2.06e-3)"	"unprognostic (9.31e-2)"	"unprognostic (2.34e-2)"	"unprognostic (7.35e-2)"	"unprognostic (1.05e-1)"	"prognostic unfavorable (5.10e-6)"	"unprognostic (1.62e-3)"	"unprognostic (1.68e-2)"	"unprognostic (9.82e-2)"	"unprognostic (1.07e-3)"	"unprognostic (3.28e-2)"	"unprognostic (1.23e-2)"	"unprognostic (6.34e-2)"	"unprognostic (1.66e-1)"	"unprognostic (5.65e-3)"	"unprognostic (2.47e-1)"	3.0	2.6	4.6	15.5	5.8	34.9	2.8	1.2	6.3	3.4	10.1	10.2	1.5	4.8	2.5	3.6	12.3	2.4	4.6	2.0	5.8	2.9	4.8	5.1	4.2	15.4	3.4	4.5	2.0	3.1	1.1	1.3	14.3	3.4	3.0	12.9	1.1	3.4	0.8	0.7	3.6	6.9	5.5	4.6	8.9	4.2	21.5	5.3	75.5	1.7	10.9	19.3	4.8	4.3	1.2	1.8	1.0	0.1	6.8	13.8	2.5	13.9	21.5	44.9	21.7	5.0	8.4	22.8	32.9	19.7	35.6	42.7	18.1	11.2	21.7	12.9	17.7	20.2	6.3	31.3	12.4	30.8	20.4	34.8	36.8	20.2	31.1	1.1	75.6	40.4	7.4	2.9	22.4	7.0	6.8	29.7	46.2	29.5	34.9	44.8	16.0	91.0	41.9	16.2	17.0	16.1	60.2	40.4	26.1	13.3	12.4	15.3	24.9	27.8	12.9	8.3	29.1	8.8	34.5	11.7	41.2	81.4	37.7	64.2	43.3	53.3	49.6	10.9	32.7	47.0	0.0	0.0	1.0	1.1	0.1	0.0	1.2	2.9	2.2	1.8	0.0	0.0	0.7	0.6	6.8	0.1	0.3	13.8	2.5	4.6	5.8	1.2	6.3	5.8	2.9	3.4	4.5	3.4	5.3	0.0	2.9	3.0	11.2	12.8	0.4	2.1	5.1	0.0	7.9	0.0	0.0	36.1	1.7	2.4	18.3	1.5	8.4	23.3	0.7	109.0	7.2	4.0	6.9	1.7	57.9	0.0	1.2	6.2	15.9	22.3	5.8	9.2	10.1	6.4	13.0	42.9	1.4	3.5	3.5	19.4	1.9	12.9	4.1	197.1	30.9	6.4	22.5	7.5	39.0	3.5
TYR	"OCA1, OCA1A, OCAIA"	ENSG00000077498	Tyrosinase	P14679	11	89177452-89295759	"Disease related genes, Enzymes, FDA approved drug targets, Predicted membrane proteins"	"Melanin biosynthesis"	"Monooxygenase, Oxidoreductase, Tumor antigen"	"Albinism, Deafness, Disease mutation, FDA approved drug targets, Waardenburg syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	70	"retina: 82.0;skin 1: 25.2"	"Cell type enriched"	"Detected in some"	8	"Melanocytes: 175.5"	"Cancer enriched"	"Detected in single"	1755	"melanoma: 351.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	864	"SK-MEL-30: 86.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"CAB000079, HPA043241, HPA050889, HPA064583"	Enhanced		Enhanced	Vesicles		NA	NA			Vesicles		"CAB000079: AB_564045, HPA043241: AB_2678383, HPA050889: AB_2681264, HPA064583: "	"unprognostic (1.16e-1)"								"unprognostic (1.01e-1)"		"unprognostic (1.85e-3)"		"unprognostic (9.75e-3)"					0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	82.0	0.7	0.0	0.0	25.2	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	86.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	7.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	23.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.6	0.3	0.0	175.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	1.8	0.0	0.0	0.0	0.0
TYRO3	"Brt, Dtk, Etk-2, Rek, RSE, Sky, Tif"	ENSG00000092445	"TYRO3 protein tyrosine kinase"	Q06418	15	41557675-41583586	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion, Host-virus interaction"	"Host cell receptor for virus entry, Kinase, Receptor, Transferase, Tyrosine-protein kinase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 39.2;ovary: 48.2"	"Cell type enhanced"	"Detected in many"	9	"Leydig cells: 41.1;Peritubular cells: 44.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"neutrophil: 5.0"	"Lineage enriched"	"Detected in many"	4	"granulocytes: 5.0"	"Cell line enhanced"	"Detected in many"		"BEWO: 33.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA071245	Approved					NA	NA		6400000			"HPA071245: AB_2686371"	"unprognostic (1.26e-1)"	"unprognostic (6.34e-2)"	"unprognostic (1.47e-1)"	"unprognostic (2.68e-1)"	"unprognostic (3.29e-1)"	"unprognostic (6.77e-2)"	"unprognostic (1.56e-3)"	"unprognostic (5.41e-2)"	"unprognostic (3.72e-1)"	"unprognostic (3.21e-1)"	"unprognostic (2.69e-1)"	"unprognostic (1.37e-1)"	"unprognostic (1.92e-10)"	"unprognostic (7.59e-2)"	"unprognostic (5.22e-1)"	"unprognostic (4.04e-3)"	"unprognostic (1.84e-2)"	18.3	4.1	18.7	2.1	16.6	1.5	7.7	27.3	39.2	2.3	1.8	25.6	1.2	2.3	5.0	4.2	12.7	11.7	3.1	2.5	15.1	7.8	6.4	1.6	3.2	1.9	19.6	18.2	48.2	9.5	1.3	0.8	5.9	14.0	3.3	1.7	1.7	2.4	6.7	1.4	13.0	2.9	4.8	23.1	5.4	3.6	17.9	16.6	0.0	1.8	2.2	4.1	2.9	2.8	1.2	1.0	5.0	0.9	1.0	0.8	0.2	4.8	3.2	10.1	11.0	9.5	6.4	33.9	7.0	4.5	7.0	6.5	17.8	1.6	0.1	9.0	5.6	9.8	11.4	11.2	1.7	3.2	2.7	7.5	1.4	10.1	8.5	6.6	2.4	0.2	2.0	3.6	5.3	1.8	2.8	5.1	4.7	8.8	2.1	3.8	4.6	1.1	0.4	23.2	7.5	3.2	14.9	9.1	1.8	0.6	9.3	12.1	3.4	6.5	10.5	7.8	15.3	8.6	2.8	4.0	13.9	6.1	10.2	10.5	0.8	1.6	1.4	8.4	16.0	8.3	2.6	0.9	0.8	0.6	0.5	0.6	0.7	0.6	0.8	0.3	1.2	0.7	0.7	5.0	1.0	0.5	1.0	0.5	0.2	18.7	16.6	27.3	32.7	15.1	7.8	19.6	18.2	14.0	16.6	3.0	1.4	0.9	6.2	6.1	1.2	3.7	2.5	0.0	0.0	3.5	5.9	2.4	0.0	3.4	2.7	4.9	0.9	0.0	3.1	8.9	5.6	4.8	0.0	0.2	1.0	0.0	1.7	12.3	0.6	4.0	41.1	1.1	8.5	0.0	0.1	6.5	3.7	0.0	44.2	1.5	3.9	0.0	2.8	2.4	5.4	9.5	15.8	0.0	1.6	4.7
TYSND1	"MGC34695, NET41"	ENSG00000156521	"Trypsin domain containing 1"	Q2T9J0	10	70137981-70146676	"Enzymes, Predicted intracellular proteins"		"Hydrolase, Protease, Serine protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 40.7"	"Cell type enhanced"	"Detected in many"	11	"Early spermatids: 90.7;Late spermatids: 154.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HaCaT: 18.0;PC-3: 27.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA030304	Approved		Uncertain	Nucleoplasm,Centrosome,Cytosol		NA	NA			"Nucleoplasm, Centrosome"	Cytosol	"HPA030304: AB_10670560"	"unprognostic (4.75e-3)"	"unprognostic (4.30e-2)"	"unprognostic (2.44e-2)"	"unprognostic (7.69e-2)"	"unprognostic (1.84e-1)"	"unprognostic (4.53e-2)"	"unprognostic (2.02e-2)"	"unprognostic (1.55e-1)"	"unprognostic (1.33e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.59e-2)"	"unprognostic (2.80e-1)"	"unprognostic (1.37e-1)"	"unprognostic (9.26e-3)"	"unprognostic (1.91e-1)"	"unprognostic (1.30e-1)"	"unprognostic (1.69e-2)"	15.2	8.2	4.7	7.0	6.8	3.0	8.0	6.7	7.3	6.0	6.7	5.9	6.9	10.1	5.3	8.4	13.9	5.4	5.2	3.5	3.7	2.8	7.4	7.4	3.5	7.2	3.7	3.6	5.6	9.0	3.3	4.5	4.7	3.5	6.9	2.7	6.9	8.0	5.7	5.3	12.5	8.5	4.8	4.7	9.0	8.2	40.7	3.4	6.2	8.5	6.6	10.1	6.5	7.6	6.1	1.4	1.2	1.6	2.9	6.3	2.3	9.5	6.9	0.5	4.1	0.8	0.6	2.5	1.2	0.9	1.4	1.3	4.3	6.1	8.6	4.0	0.3	0.3	18.0	0.7	2.7	0.3	5.4	6.2	0.5	1.9	2.1	1.7	0.7	0.0	1.3	5.2	1.2	2.2	0.8	1.0	3.1	0.0	2.6	0.6	4.2	3.2	3.5	2.2	2.3	27.7	5.7	1.6	3.8	0.6	1.6	5.0	2.6	4.2	9.4	3.6	0.2	6.1	0.7	1.7	1.6	1.1	3.0	5.4	9.8	5.9	4.2	1.9	3.6	1.2	0.0	1.3	1.2	6.3	1.6	4.1	5.1	3.7	4.9	1.4	6.1	5.3	4.4	0.4	2.9	1.1	1.0	4.0	2.3	4.7	6.8	6.7	7.3	3.7	2.8	3.7	3.6	3.5	3.4	8.9	4.0	13.7	13.8	12.7	6.8	4.3	25.5	1.4	5.7	10.4	0.0	30.0	14.9	6.8	90.7	6.7	14.8	0.0	8.3	6.8	6.3	10.9	13.8	14.3	10.7	0.0	13.7	6.7	9.5	154.7	8.6	8.0	11.8	2.8	10.6	6.2	5.1	10.5	7.4	12.4	4.5	6.5	4.7	41.1	11.1	16.2	14.0	11.8	20.3	5.2
TYW1	"FLJ10900, MGC23001, MGC60291, RSAFD1, TYW1A, YPL207W"	ENSG00000198874	"TRNA-yW synthesizing protein 1 homolog"	Q9NV66	7	66995173-67239519	"Enzymes, Predicted membrane proteins"	"tRNA processing"	Lyase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA013568, HPA014118, HPA015535, HPA043136, HPA047029, HPA047052, HPA052097"	Approved		Approved	"Nucleoplasm,Nucleoli,Nucleoli rim"		NA	NA			"Nucleoplasm, Nucleoli, Nucleoli rim"		"HPA013568: AB_2668852, HPA014118: AB_2668941, HPA015535: AB_1856487, HPA043136: AB_2678333, HPA047029: AB_2679909, HPA047052: AB_2679918, HPA052097: AB_2681723"	"unprognostic (1.53e-1)"	"unprognostic (5.49e-3)"	"unprognostic (1.62e-1)"	"unprognostic (3.05e-2)"	"unprognostic (1.84e-2)"	"unprognostic (2.20e-1)"	"unprognostic (1.83e-2)"	"unprognostic (1.79e-1)"	"unprognostic (1.47e-1)"	"prognostic unfavorable (1.73e-4)"	"unprognostic (4.86e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.85e-2)"	"unprognostic (4.70e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.36e-2)"	"unprognostic (1.79e-2)"	15.4	19.1	10.2	12.3	15.4	11.9	15.1	14.9	15.3	18.8	12.9	21.2	18.2	14.1	22.7	15.3	12.0	15.5	10.8	12.9	10.8	9.8	15.2	17.7	11.1	15.5	14.1	10.8	19.4	23.9	22.9	28.0	13.2	14.5	14.9	16.5	17.8	15.3	14.7	26.2	14.4	12.8	14.0	13.9	15.1	12.6	13.7	13.4	19.7	19.0	13.6	23.3	15.3	15.2	9.6	8.3	3.6	9.1	11.2	11.8	5.3	10.6	13.6	8.3	17.2	12.5	8.7	9.7	11.4	8.7	9.0	8.5	15.5	13.9	18.5	17.5	10.5	12.7	12.6	17.2	14.0	13.1	14.5	13.2	8.0	11.3	10.5	12.4	18.4	10.6	8.9	14.2	12.2	18.8	7.1	8.2	13.5	21.0	11.2	10.3	10.5	11.6	15.5	14.6	18.0	12.2	13.2	11.6	23.3	12.2	10.8	12.8	12.7	13.7	26.6	11.4	16.6	18.1	13.1	9.6	10.4	7.4	8.2	15.5	11.3	15.9	22.3	8.5	17.4	14.3	2.0	7.0	3.6	8.6	7.8	11.7	8.5	9.4	9.8	8.3	9.6	11.5	11.8	2.0	11.2	9.1	6.6	6.8	5.3	10.2	15.4	14.9	15.3	10.8	9.8	14.1	10.8	14.5	13.4	6.0	15.4	4.5	4.9	9.3	9.0	8.1	10.2	9.4	4.5	10.4	3.9	16.5	0.0	6.6	5.5	6.7	4.7	0.0	6.0	10.7	7.7	4.9	33.5	12.5	6.9	3.2	4.6	6.7	4.3	3.1	7.8	8.9	8.5	10.0	12.1	7.7	6.1	3.5	7.8	2.1	11.7	19.4	7.1	17.0	22.7	14.8	12.7	8.5	9.7	2.8
TYW3	"C1orf171, FLJ40918"	ENSG00000162623	"TRNA-yW synthesizing protein 3 homolog"	Q6IPR3	1	74733152-74766678	"Enzymes, Predicted intracellular proteins"	"tRNA processing"	"Methyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA029641	Approved		Approved	"Plasma membrane,Cytosol"		No	No			Cytosol	"Plasma membrane"	"HPA029641: AB_2272535"	"unprognostic (6.89e-3)"	"unprognostic (1.06e-1)"	"unprognostic (1.08e-1)"	"unprognostic (1.09e-1)"	"unprognostic (1.42e-1)"	"unprognostic (7.24e-2)"	"prognostic unfavorable (1.49e-7)"	"unprognostic (3.79e-1)"	"unprognostic (2.23e-1)"	"unprognostic (2.96e-1)"	"unprognostic (4.08e-2)"	"unprognostic (1.59e-1)"	"unprognostic (1.70e-1)"	"unprognostic (1.13e-1)"	"unprognostic (2.05e-1)"	"unprognostic (8.90e-2)"	"unprognostic (2.98e-3)"	16.5	19.7	13.7	13.5	17.7	11.9	18.3	15.0	19.9	20.4	17.7	7.5	13.7	9.5	21.0	15.2	20.6	16.4	10.0	21.1	11.1	12.9	20.4	17.0	11.3	14.3	16.2	17.2	30.0	14.4	22.2	34.3	13.5	17.0	20.7	12.3	8.6	13.8	15.7	12.3	10.5	10.9	24.7	15.6	16.0	14.8	12.3	18.1	12.3	23.5	14.3	16.9	23.5	33.3	9.7	9.0	6.0	8.0	13.6	13.9	5.2	8.6	7.3	12.6	8.9	14.3	15.7	19.1	14.9	13.7	14.3	12.6	15.4	7.4	22.7	13.7	12.8	21.0	7.1	14.4	17.2	17.9	14.1	12.4	17.8	22.3	29.8	9.4	35.6	11.6	11.9	17.4	18.2	17.6	11.5	12.7	15.8	30.8	17.5	18.3	7.3	17.3	11.9	33.5	13.0	17.0	16.4	26.3	10.2	12.2	11.3	9.8	8.3	7.1	19.4	22.9	14.3	10.6	13.1	8.2	6.3	17.3	17.1	17.8	10.1	18.3	15.9	14.2	12.9	18.2	6.0	6.0	1.6	10.3	8.0	9.9	9.7	9.1	9.3	9.0	8.8	13.2	13.9	0.5	13.6	5.9	8.7	8.4	5.2	13.7	17.7	15.0	19.9	11.1	12.9	16.2	17.2	17.0	18.1	14.9	22.9	32.0	34.6	22.8	31.3	26.5	17.8	24.1	36.4	15.7	3.9	37.5	66.3	29.4	14.9	24.8	8.0	0.0	51.1	41.5	28.2	34.8	20.7	29.2	29.0	47.7	13.3	17.8	27.2	18.5	40.3	22.8	20.3	29.7	17.0	18.0	31.2	7.0	57.7	43.8	19.9	12.9	38.0	31.8	45.3	19.8	18.7	27.7	24.9	23.3
TYW5	"C2orf60, FLJ37953"	ENSG00000162971	"TRNA-yW synthesizing protein 5"	A2RUC4	2	199929975-199955736	"Enzymes, Predicted intracellular proteins"	"tRNA processing"	"Dioxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	11	"Cone photoreceptor cells: 115.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028294, HPA045803"	Uncertain		Approved	"Nuclear bodies"		NA	NA			"Nuclear bodies"		"HPA028294: AB_2672549, HPA045803: AB_10964878"	"unprognostic (3.44e-3)"	"unprognostic (3.74e-1)"	"unprognostic (2.11e-1)"	"unprognostic (3.03e-2)"	"unprognostic (9.22e-3)"	"unprognostic (4.95e-2)"	"unprognostic (1.47e-3)"	"unprognostic (9.72e-2)"	"unprognostic (6.55e-3)"	"unprognostic (6.30e-3)"	"unprognostic (9.54e-2)"	"unprognostic (6.98e-3)"	"unprognostic (2.87e-3)"	"unprognostic (8.67e-2)"	"unprognostic (4.46e-1)"	"unprognostic (2.08e-1)"	"unprognostic (5.42e-3)"	4.5	7.5	5.7	7.4	9.3	6.7	4.4	7.8	8.4	4.2	5.1	4.0	5.2	5.8	4.4	6.4	6.1	5.8	3.8	5.5	7.3	5.0	5.5	8.8	3.5	5.4	7.0	3.5	5.5	6.3	6.2	7.5	5.2	5.7	4.6	4.5	4.5	4.4	4.6	4.2	6.7	6.1	4.5	7.4	5.5	4.8	4.2	6.8	4.2	5.4	2.9	5.3	5.9	4.2	2.4	1.4	2.2	2.4	0.1	3.4	0.7	2.4	4.0	2.9	1.8	2.2	1.4	5.9	5.2	2.3	3.9	3.2	4.0	3.0	1.4	3.8	2.4	4.3	2.7	7.4	2.4	4.9	4.7	3.0	3.2	5.7	4.8	5.7	4.7	3.0	3.0	4.9	2.7	4.0	4.0	3.5	2.0	4.4	3.2	2.3	3.0	3.5	4.2	4.7	2.4	7.5	2.2	3.6	2.0	4.7	3.4	3.1	1.5	3.0	5.2	6.1	7.2	3.0	4.2	3.6	2.9	2.7	2.9	3.7	2.6	4.6	2.5	2.6	3.9	3.6	2.1	1.7	2.2	1.4	1.3	1.6	2.4	1.9	2.6	1.4	1.4	2.0	3.4	1.3	0.1	2.4	0.4	2.1	0.7	5.7	9.3	7.8	8.4	7.3	5.0	7.0	3.5	5.7	6.8	6.0	19.9	3.9	12.5	7.3	19.7	4.6	5.1	6.7	7.9	12.2	115.8	8.8	3.3	7.0	1.9	7.1	5.8	0.0	5.5	7.9	8.9	14.1	5.8	7.3	5.4	7.9	2.4	9.2	6.9	0.8	5.8	8.2	6.8	10.8	6.7	34.0	8.4	5.8	5.3	8.6	31.5	6.5	9.2	7.9	12.8	5.3	7.0	6.7	10.0	16.1
UAP1	"AgX, AGX1, SPAG2"	ENSG00000117143	"UDP-N-acetylglucosamine pyrophosphorylase 1"	Q16222	1	162561506-162599842	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Nucleotidyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"hTERT-HME1: 107.8;U-251 MG: 70.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA014659	Approved		Supported	"Nucleoplasm,Plasma membrane,Cytosol"		No	Yes		19000	"Nucleoplasm, Plasma membrane, Cytosol"		"HPA014659: AB_1857409"	"unprognostic (2.32e-2)"	"unprognostic (2.45e-1)"	"unprognostic (2.07e-2)"	"unprognostic (1.28e-2)"	"unprognostic (2.71e-2)"	"unprognostic (1.46e-2)"	"unprognostic (1.37e-2)"	"unprognostic (1.47e-1)"	"unprognostic (2.09e-1)"	"unprognostic (1.30e-1)"	"unprognostic (1.29e-3)"	"unprognostic (4.96e-2)"	"prognostic unfavorable (5.12e-5)"	"unprognostic (1.59e-1)"	"unprognostic (2.04e-1)"	"unprognostic (3.51e-1)"	"unprognostic (3.45e-2)"	38.4	18.5	7.0	17.4	9.8	17.2	24.8	9.0	13.4	16.1	26.9	5.7	45.7	17.2	10.9	19.4	23.6	15.7	18.3	22.5	7.7	7.8	11.0	67.1	16.0	7.4	6.6	8.9	20.4	31.4	5.1	16.0	21.5	9.1	13.9	26.9	7.8	43.9	62.5	19.4	12.4	33.4	28.8	7.1	8.1	23.0	37.7	3.7	5.6	12.4	13.5	15.3	24.4	16.7	8.3	5.6	8.1	1.6	6.2	16.1	4.8	30.5	2.2	6.1	4.9	29.8	23.9	4.2	44.9	16.6	34.7	28.3	5.8	14.4	1.2	10.1	34.4	12.5	5.3	6.9	13.1	57.2	4.8	10.3	5.4	7.0	11.4	14.0	9.2	3.7	11.0	6.2	38.0	107.8	15.9	21.2	9.6	30.5	12.6	46.4	5.6	5.3	5.9	4.5	31.4	10.0	4.8	11.9	14.9	5.4	3.6	6.6	6.8	19.6	12.2	10.4	7.5	6.0	10.5	36.0	17.5	16.1	44.0	70.2	21.2	7.4	10.1	10.0	4.3	11.0	1.0	1.6	8.1	13.0	1.6	16.1	8.3	7.9	13.3	3.4	6.5	7.6	9.5	1.6	6.2	0.8	5.6	3.9	4.8	7.0	9.8	9.0	13.4	7.7	7.8	6.6	8.9	9.1	3.7	6.0	30.4	17.9	120.0	119.7	10.0	26.6	17.8	53.5	38.7	15.7	7.9	22.4	61.3	24.8	36.3	23.3	84.7	0.0	56.9	52.1	141.3	91.8	33.4	88.9	14.0	6.4	52.6	21.5	7.0	11.8	46.9	15.2	81.0	27.9	124.5	14.0	55.8	69.1	38.9	20.2	12.3	19.4	160.3	182.9	121.8	71.5	81.7	20.1	59.9	111.6
UBA1	"A1S9T, CFAP124, GXP1, POC20, UBE1, UBE1X"	ENSG00000130985	"Ubiquitin like modifier activating enzyme 1"	P22314	X	47190861-47215128	"Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Ubl conjugation pathway"	Ligase	"Cancer-related genes, Disease mutation, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000289, HPA001506, CAB019435, CAB073410"	Approved		Supported	Nucleoplasm		NA	NA		16000000	Nucleoplasm		"CAB019435: AB_2211440, CAB073410: , HPA000289: AB_1080443, HPA001506: AB_2756305"	"unprognostic (7.18e-3)"	"unprognostic (1.52e-1)"	"unprognostic (7.54e-2)"	"unprognostic (2.40e-1)"	"unprognostic (9.29e-2)"	"unprognostic (1.02e-1)"	"prognostic unfavorable (6.10e-5)"	"unprognostic (7.22e-2)"	"unprognostic (2.42e-3)"	"unprognostic (3.43e-2)"	"unprognostic (8.50e-3)"	"unprognostic (2.17e-3)"	"unprognostic (1.85e-3)"	"unprognostic (1.13e-1)"	"unprognostic (5.38e-2)"	"prognostic favorable (1.78e-4)"	"unprognostic (1.21e-2)"	45.6	63.0	56.0	47.2	50.6	42.0	38.3	58.1	75.7	48.0	39.3	55.9	44.9	36.3	52.9	34.1	59.4	56.0	39.9	48.7	49.5	39.9	51.1	60.0	42.0	48.2	47.7	62.3	57.6	34.9	78.8	55.5	39.1	47.6	40.2	35.5	41.0	47.5	45.7	77.7	56.1	37.9	59.4	35.5	53.4	38.7	36.0	48.6	52.7	65.0	43.9	54.0	39.2	52.7	28.9	30.6	32.6	36.0	25.6	29.0	24.1	46.0	47.9	54.8	83.2	37.5	34.2	24.2	30.7	32.7	44.2	36.0	38.0	35.2	34.4	20.4	61.4	65.4	44.6	68.7	65.3	32.4	28.5	69.8	21.5	53.1	30.5	26.4	36.2	46.5	32.1	34.2	64.2	50.1	31.6	57.8	41.4	23.3	30.9	43.8	58.4	34.1	32.0	58.4	27.9	74.9	39.8	38.3	58.5	35.3	49.7	35.5	26.7	91.4	44.5	20.4	61.4	61.8	22.6	42.2	33.2	38.5	47.7	28.6	21.2	22.0	49.1	34.1	25.9	39.6	17.4	27.0	27.4	29.0	36.0	25.4	28.9	24.0	25.9	30.6	22.0	19.1	23.4	32.6	25.6	32.8	20.8	28.2	24.1	56.0	50.6	58.1	75.7	49.5	39.9	47.7	62.3	47.6	48.6	47.6	32.5	35.6	30.6	29.9	25.4	44.0	71.4	29.4	29.6	78.5	15.7	42.1	29.9	67.7	29.3	28.1	83.5	23.3	78.8	52.0	36.1	52.8	17.4	40.8	53.6	11.1	55.2	46.1	45.1	41.8	39.1	34.8	18.6	66.7	64.2	20.0	108.7	57.9	61.9	49.5	24.4	38.8	40.3	8.8	19.6	36.8	59.5	26.6	52.5	48.1
UBA6	"FLJ10808, UBE1L2"	ENSG00000033178	"Ubiquitin like modifier activating enzyme 6"	A0AVT1	4	67612652-67701179	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	Ligase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Urothelial cells: 126.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA037001	Approved		Enhanced	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"HPA037001: AB_10672787"	"unprognostic (2.52e-1)"	"unprognostic (4.89e-2)"	"unprognostic (3.97e-3)"	"unprognostic (2.81e-1)"	"unprognostic (3.67e-2)"	"unprognostic (4.92e-2)"	"unprognostic (3.55e-3)"	"unprognostic (6.06e-3)"	"unprognostic (1.09e-1)"	"unprognostic (1.10e-2)"	"unprognostic (3.38e-2)"	"unprognostic (5.30e-2)"	"prognostic unfavorable (7.01e-5)"	"unprognostic (2.35e-1)"	"unprognostic (1.83e-1)"	"unprognostic (4.33e-2)"	"unprognostic (4.05e-3)"	16.8	12.6	14.1	14.1	16.6	22.7	13.0	18.0	16.0	17.0	10.5	14.6	7.0	12.2	16.7	10.0	20.5	9.9	12.4	9.5	12.0	12.0	10.2	16.4	14.5	17.3	18.7	11.2	14.3	10.9	17.4	44.8	18.5	17.7	12.7	13.2	7.5	13.7	10.4	10.1	12.6	15.3	13.4	20.7	16.9	13.9	14.6	18.6	27.1	12.3	13.3	19.9	15.7	19.5	5.6	5.1	9.3	4.0	9.7	5.8	1.9	15.1	8.5	14.1	11.0	7.0	8.2	9.5	31.4	12.3	14.4	16.9	8.9	20.5	19.2	11.2	12.9	14.7	9.0	14.5	15.6	21.8	22.1	4.0	12.3	15.0	8.3	6.0	21.6	9.5	5.9	5.0	18.6	11.3	9.9	12.7	9.9	29.2	11.4	17.0	5.7	22.4	4.9	8.3	10.8	10.3	13.3	28.9	7.1	11.8	17.2	6.9	8.7	17.7	12.6	5.9	12.3	8.4	5.8	18.3	13.4	15.1	10.8	13.7	8.2	6.4	19.4	23.8	6.0	12.8	9.3	3.0	4.6	4.4	3.9	4.8	5.6	5.1	5.8	3.7	5.2	3.9	4.5	2.2	9.7	4.0	5.1	4.2	1.9	14.1	16.6	18.0	16.0	12.0	12.0	18.7	11.2	17.7	18.6	23.8	20.8	33.8	52.9	62.3	46.2	14.4	12.7	25.4	20.5	15.7	51.1	22.4	3.3	21.4	1.4	34.4	21.2	0.0	14.8	12.9	28.2	64.5	30.1	17.3	20.5	31.8	31.0	17.8	27.9	4.0	19.8	35.3	23.6	33.3	24.7	19.8	36.7	21.0	18.7	10.2	42.3	19.4	23.0	37.9	35.1	40.4	49.2	29.9	19.6	126.8
UBASH3B	"KIAA1959, STS-1, TULA-2, TULA2"	ENSG00000154127	"Ubiquitin associated and SH3 domain containing B"	Q8TF42	11	122655675-122814473	"Enzymes, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 32.5;lymphoid tissue: 27.7"	"Cell type enhanced"	"Detected in many"	7	"Cytotrophoblasts: 29.2;Extravillous trophoblasts: 45.7;Hofbauer cells: 34.3;Kupffer cells: 31.7;Syncytiotrophoblasts: 39.8"	"Low cancer specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"cerebellum: 32.5;pons and medulla: 21.2"	"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HEL: 42.6;HMC-1: 32.5;hTEC/SVTERT24-B: 26.5;REH: 25.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038605, HPA038607"	Approved		Approved	"Plasma membrane"		NA	NA		2200000	"Plasma membrane"		"HPA038605: AB_10669648, HPA038607: AB_2676112"	"unprognostic (4.94e-2)"	"unprognostic (6.03e-3)"	"unprognostic (1.34e-1)"	"unprognostic (2.98e-1)"	"unprognostic (2.02e-1)"	"unprognostic (1.49e-1)"	"unprognostic (9.09e-2)"	"unprognostic (4.67e-3)"	"unprognostic (1.21e-1)"	"unprognostic (1.95e-1)"	"unprognostic (1.46e-3)"	"unprognostic (6.20e-2)"	"unprognostic (9.02e-3)"	"unprognostic (1.54e-1)"	"unprognostic (3.22e-2)"	"unprognostic (2.72e-3)"	"unprognostic (1.53e-1)"	4.3	1.3	2.8	5.5	4.0	7.2	1.5	32.5	4.9	4.0	1.5	0.7	0.0	1.7	1.3	0.3	1.8	1.1	2.4	1.3	3.4	3.5	1.5	1.7	5.5	10.9	5.1	1.9	0.8	1.2	0.6	0.9	16.8	21.2	1.3	1.8	0.9	1.3	0.9	1.8	4.1	2.4	2.3	2.1	27.7	1.7	2.1	0.2	23.9	2.9	1.7	3.8	3.4	1.3	1.0	1.7	9.8	11.0	6.5	4.9	1.8	4.5	11.1	2.0	2.7	0.9	1.6	10.6	16.2	9.0	6.6	5.1	4.4	2.4	1.8	1.3	8.6	6.3	2.2	0.0	5.8	10.5	0.0	0.3	42.6	0.3	3.7	2.5	5.1	32.5	1.4	0.3	26.5	9.8	7.2	4.4	1.9	0.0	0.0	6.4	0.1	6.3	3.3	0.9	4.6	2.6	25.4	1.2	0.2	10.4	3.8	4.6	0.1	4.3	0.3	3.6	4.4	0.0	1.4	11.4	8.6	4.6	5.0	6.7	0.4	0.0	5.4	4.5	7.3	15.5	0.0	1.3	9.8	2.0	6.5	2.2	0.3	2.6	1.8	1.7	1.0	3.0	1.6	2.8	6.5	11.0	0.2	4.9	1.8	2.8	4.0	32.5	4.9	3.4	3.5	5.1	1.9	21.2	0.2	0.0	6.6	0.0	3.5	6.4	0.6	1.2	0.0	0.0	1.2	3.5	0.0	29.2	0.0	9.2	1.9	4.2	0.4	0.0	8.3	45.7	4.2	2.9	12.7	0.0	34.3	11.1	0.0	4.9	31.7	2.8	0.0	19.6	1.7	0.0	0.0	0.5	16.9	0.0	0.4	0.0	1.1	0.0	4.2	0.0	0.5	5.3	39.8	7.2	0.3	2.7
UBE2A	"HHR6A, RAD6A, UBC2"	ENSG00000077721	"Ubiquitin conjugating enzyme E2 A"	P49459	X	119574467-119591083	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"DNA damage, DNA repair, Ubl conjugation pathway"	"Chromatin regulator, Transferase"	"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	6	"Syncytiotrophoblasts: 425.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003875, HPA051765, HPA065898"			Supported	"Nucleoplasm,Vesicles,Plasma membrane,Cytosol"		NA	NA			"Nucleoplasm, Plasma membrane"	"Vesicles, Cytosol"	"HPA003875: AB_2667061, HPA051765: AB_2681597, HPA065898: AB_2685577"	"unprognostic (2.27e-3)"	"prognostic favorable (2.16e-4)"	"unprognostic (1.12e-1)"	"unprognostic (9.09e-2)"	"unprognostic (1.63e-1)"	"prognostic unfavorable (9.07e-4)"	"unprognostic (1.66e-3)"	"unprognostic (1.96e-2)"	"unprognostic (6.54e-2)"	"unprognostic (2.96e-2)"	"unprognostic (3.49e-2)"	"unprognostic (1.33e-1)"	"prognostic unfavorable (2.20e-6)"	"unprognostic (9.54e-2)"	"unprognostic (3.06e-2)"	"unprognostic (1.21e-1)"	"unprognostic (7.92e-2)"	24.8	20.6	26.7	23.1	24.6	16.8	32.5	20.2	24.2	23.7	32.8	23.9	20.2	21.7	23.8	26.7	37.2	20.3	21.2	42.2	23.6	22.1	32.2	26.6	22.8	26.3	26.8	19.7	18.7	17.2	24.3	18.2	112.4	24.7	20.4	30.2	20.0	21.0	22.6	46.8	23.6	29.2	27.9	29.1	25.1	20.4	17.0	19.5	36.3	23.2	32.8	31.5	26.7	24.0	21.0	29.0	34.1	36.3	12.8	21.2	17.4	31.1	26.3	16.6	14.0	29.0	35.8	15.5	32.4	28.9	38.5	36.6	13.6	21.5	24.7	32.9	35.6	64.7	22.5	23.6	17.1	37.2	34.2	14.0	10.9	21.0	12.1	26.6	27.2	18.8	24.4	24.5	37.0	16.1	27.2	26.7	22.1	13.4	22.1	43.6	33.0	42.0	25.8	27.6	32.9	29.8	21.5	17.6	23.0	31.1	20.5	12.7	13.1	43.0	19.8	23.5	21.6	17.3	23.9	26.0	24.8	11.1	48.9	36.5	21.4	34.8	24.3	26.4	34.6	19.3	16.5	22.7	34.1	18.1	35.4	14.3	21.0	15.7	15.8	29.0	18.8	10.0	14.3	30.1	12.8	36.3	23.0	21.2	17.4	26.7	24.6	20.2	24.2	23.6	22.1	26.8	19.7	24.7	19.5	95.3	39.2	51.3	71.2	110.8	14.0	62.9	48.4	83.0	53.4	38.4	29.5	150.4	86.2	88.0	32.0	62.8	76.2	46.7	89.2	129.6	86.9	77.3	55.4	31.6	116.0	7.9	43.7	44.2	59.6	10.6	34.2	89.3	79.2	168.7	43.9	37.6	102.2	80.7	38.2	92.2	34.3	45.3	103.2	39.1	30.0	111.8	425.3	58.0	43.9	88.5
UBE2B	"HHR6B, RAD6B, UBC2"	ENSG00000119048	"Ubiquitin conjugating enzyme E2 B"	P63146	5	134371179-134391992	"Enzymes, Predicted intracellular proteins"	"DNA damage, DNA repair, Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 106.5"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"neutrophil: 83.3"	"Lineage enriched"	"Detected in all"	6	"granulocytes: 83.3"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003875, HPA051765, HPA065898"			Supported	"Nucleoplasm,Vesicles,Plasma membrane,Cytosol"		NA	NA			"Nucleoplasm, Plasma membrane"	"Vesicles, Cytosol"	"HPA003875: AB_2667061, HPA051765: AB_2681597, HPA065898: AB_2685577"	"unprognostic (1.98e-1)"	"unprognostic (1.35e-1)"	"unprognostic (7.39e-2)"	"unprognostic (6.66e-2)"	"unprognostic (1.44e-1)"	"unprognostic (1.48e-2)"	"unprognostic (2.56e-1)"	"unprognostic (1.27e-1)"	"unprognostic (1.91e-1)"	"unprognostic (2.44e-1)"	"unprognostic (2.49e-1)"	"unprognostic (8.39e-2)"	"unprognostic (1.64e-3)"	"unprognostic (6.30e-3)"	"unprognostic (3.42e-2)"	"unprognostic (2.04e-1)"	"unprognostic (5.52e-2)"	17.7	27.7	20.4	17.0	16.6	25.9	22.8	16.2	28.3	13.8	18.0	7.9	11.6	14.4	19.4	17.0	25.6	13.6	18.3	59.2	20.3	16.4	17.8	19.8	21.8	18.7	13.8	18.7	16.7	26.4	7.8	16.2	27.8	17.6	15.4	15.1	10.2	16.1	18.5	106.5	15.9	16.2	21.6	15.1	16.6	14.1	21.7	12.7	13.2	18.2	34.0	16.3	19.2	22.8	9.6	8.8	83.3	14.1	9.6	14.6	10.5	35.5	9.3	19.6	18.6	17.1	18.5	31.6	26.7	14.1	17.2	20.5	28.3	23.9	19.4	32.3	17.0	47.0	14.2	14.8	19.7	18.8	30.7	16.0	10.6	25.9	30.3	20.0	12.6	21.9	15.9	27.0	15.6	13.2	23.2	14.7	16.2	19.5	35.3	15.5	20.7	20.0	33.4	8.4	10.6	8.9	20.2	21.6	27.0	15.4	27.5	26.5	20.6	21.0	9.9	46.4	22.2	21.3	34.8	29.1	20.0	14.0	26.9	29.2	29.5	40.3	27.4	22.6	23.9	19.9	34.7	11.5	31.2	9.4	12.5	8.6	9.6	12.0	9.5	7.9	9.6	14.6	12.3	83.3	9.6	14.1	8.8	14.1	10.5	20.4	16.6	16.2	28.3	20.3	16.4	13.8	18.7	17.6	12.7	68.5	53.6	80.6	311.1	324.0	73.3	287.9	109.5	50.9	37.5	71.5	76.6	127.7	145.9	138.0	194.0	119.9	104.0	210.2	148.2	103.0	162.4	304.2	116.3	90.1	106.8	82.6	126.4	82.3	121.3	244.2	143.5	139.6	215.9	189.4	109.5	124.2	180.7	129.8	106.4	130.7	89.5	148.8	178.2	201.6	171.6	323.2	605.1	89.5	82.7	405.3
UBE2C	UBCH10	ENSG00000175063	"Ubiquitin conjugating enzyme E2 C"	O00762	20	45812576-45816957	"Cancer-related genes, Enzymes, Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis, Ubl conjugation pathway"	Transferase	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"lymphoid tissue: 130.8"	"Group enriched"	"Detected in many"	5	"Erythroid cells: 397.1;Extravillous trophoblasts: 368.9"	"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in many"		"T-reg: 10.0"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in single"			"CAB011464, HPA034569, CAB035990, HPA054975"	Approved		Supported	"Plasma membrane,Cytosol"		Yes	Yes			"Plasma membrane, Cytosol"		"CAB011464: AB_442965, CAB035990: , HPA034569: AB_2674226, HPA054975: AB_2682658"	"unprognostic (1.45e-2)"	"unprognostic (2.19e-1)"	"unprognostic (1.06e-1)"	"unprognostic (2.11e-3)"	"unprognostic (2.54e-1)"	"unprognostic (1.35e-1)"	"prognostic unfavorable (6.24e-6)"	"unprognostic (2.27e-3)"	"unprognostic (2.59e-2)"	"unprognostic (1.04e-1)"	"prognostic unfavorable (6.91e-4)"	"unprognostic (3.76e-2)"	"prognostic unfavorable (0.00e+0)"	"unprognostic (3.09e-1)"	"unprognostic (3.61e-1)"	"unprognostic (4.65e-2)"	"unprognostic (2.68e-1)"	3.1	2.3	0.4	24.0	0.9	25.1	4.3	0.4	0.7	3.8	9.5	0.4	0.8	7.8	2.0	2.6	25.6	0.6	3.2	2.8	0.5	0.4	2.1	2.1	4.6	15.6	0.6	0.5	1.2	1.3	0.0	0.6	12.6	0.9	1.3	11.7	0.7	3.7	0.6	1.0	8.3	10.0	3.5	1.2	11.6	7.0	15.3	0.5	130.8	0.8	17.6	26.3	2.8	7.8	1.2	0.9	2.7	0.6	2.4	10.0	4.2	39.3	28.9	52.2	25.0	1.4	3.2	30.0	31.3	15.9	51.6	37.1	94.9	45.6	41.8	30.7	14.9	64.3	38.9	0.2	33.5	52.7	17.8	27.5	12.9	22.2	24.9	0.4	18.4	32.3	1.0	3.6	34.9	34.2	7.8	25.1	26.7	0.2	35.6	42.4	64.9	30.3	5.2	31.3	44.8	69.3	32.2	47.3	0.2	17.4	13.7	30.1	25.1	49.3	36.1	19.8	27.4	36.5	27.1	9.1	46.3	40.5	31.4	60.5	11.3	0.3	46.5	28.1	13.1	43.8	0.0	0.1	0.0	0.2	0.0	0.0	1.2	1.2	2.3	0.9	0.2	0.2	0.1	2.7	2.4	0.6	0.5	10.0	4.2	0.4	0.9	0.4	0.7	0.5	0.4	0.6	0.5	0.9	0.5	0.0	5.9	29.5	3.6	15.3	0.0	0.0	2.5	0.0	7.9	0.0	0.0	15.5	0.0	0.8	5.8	0.2	5.5	397.1	0.4	368.9	5.1	2.7	5.7	3.9	75.1	0.0	1.2	22.7	19.9	5.4	0.9	9.3	0.0	1.8	12.8	0.0	1.0	6.2	0.0	0.0	0.0	0.0	1.9	6.1	18.0	10.2	26.1	10.1	15.1	8.2
UBE2D1	"E2(17)KB1, SFT, UBC4/5, UBCH5, UbcH5A"	ENSG00000072401	"Ubiquitin conjugating enzyme E2 D1"	P51668	10	58334975-58370753	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 74.9"	"Cell type enhanced"	"Detected in many"	4	"Basal keratinocytes: 172.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"neutrophil: 41.0"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003920	Approved		Approved	"Plasma membrane,Cytosol"		NA	NA			"Plasma membrane, Cytosol"		"HPA003920: AB_1858519"	"unprognostic (1.12e-1)"	"unprognostic (2.08e-1)"	"unprognostic (4.23e-3)"	"unprognostic (1.76e-1)"	"unprognostic (1.52e-2)"	"unprognostic (1.21e-2)"	"prognostic unfavorable (5.58e-4)"	"unprognostic (2.20e-2)"	"unprognostic (1.03e-1)"	"unprognostic (2.24e-2)"	"unprognostic (4.37e-3)"	"unprognostic (2.17e-1)"	"prognostic unfavorable (8.04e-6)"	"unprognostic (9.71e-3)"	"unprognostic (4.14e-1)"	"unprognostic (1.95e-1)"	"unprognostic (5.66e-2)"	8.2	10.6	8.1	10.0	7.9	17.1	7.5	7.7	9.0	6.3	7.3	5.5	4.8	4.7	8.5	5.5	8.2	5.5	6.4	25.6	7.6	7.2	5.5	5.4	7.0	13.7	8.1	6.7	5.9	4.8	5.3	7.4	6.8	7.4	6.5	7.9	3.5	6.4	5.0	74.9	4.6	5.8	8.8	8.4	11.0	5.6	3.2	8.4	5.5	6.0	25.1	7.1	9.5	10.0	3.7	7.2	41.0	13.7	2.8	3.5	7.1	10.7	5.8	10.9	14.0	22.4	18.1	7.1	7.1	12.1	8.1	12.0	11.8	9.3	0.0	11.2	10.6	6.0	9.8	21.1	10.3	11.5	11.1	12.4	2.8	2.1	6.7	14.7	8.5	6.9	20.9	11.6	8.5	15.8	11.0	16.2	7.5	5.5	4.5	11.0	3.4	9.1	9.5	13.4	6.5	9.2	7.7	9.9	5.9	12.2	6.3	8.3	11.1	13.9	23.5	11.3	17.5	8.6	5.7	13.1	3.1	10.9	10.6	7.8	11.6	9.0	9.5	9.9	17.7	3.5	2.8	13.7	6.2	2.4	9.5	2.8	3.3	2.9	3.0	7.2	3.7	3.0	2.3	41.0	2.8	7.9	3.0	3.5	7.1	8.1	7.9	7.7	9.0	7.6	7.2	8.1	6.7	7.4	8.4	11.9	9.1	36.6	70.2	172.6	16.8	82.7	20.4	12.0	15.9	26.2	17.7	26.7	64.6	55.7	3.4	26.3	20.4	0.0	37.1	42.2	48.3	73.3	23.0	12.3	68.9	15.9	39.9	20.3	88.9	2.2	30.8	81.6	50.6	49.5	35.6	15.8	57.2	16.4	30.4	41.3	13.7	6.5	58.7	28.6	16.0	166.2	124.6	28.7	24.7	105.6
UBE2D2	"UBC4, UbcH5B"	ENSG00000131508	"Ubiquitin conjugating enzyme E2 D2"	P62837	5	139526431-139628433	"Enzymes, Plasma proteins, Predicted intracellular proteins, Transporters"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003920	Approved		Approved	"Plasma membrane,Cytosol"		NA	NA			"Plasma membrane, Cytosol"		"HPA003920: AB_1858519"	"unprognostic (1.14e-1)"	"unprognostic (2.75e-3)"	"prognostic favorable (5.09e-5)"	"prognostic favorable (5.90e-4)"	"unprognostic (2.33e-1)"	"unprognostic (8.19e-3)"	"prognostic unfavorable (9.63e-7)"	"unprognostic (7.41e-3)"	"unprognostic (2.17e-1)"	"unprognostic (1.21e-1)"	"unprognostic (9.33e-2)"	"unprognostic (1.41e-3)"	"prognostic unfavorable (2.09e-5)"	"unprognostic (8.00e-2)"	"unprognostic (1.01e-1)"	"unprognostic (4.20e-1)"	"unprognostic (1.07e-1)"	35.6	25.0	41.2	31.5	39.9	44.2	35.9	31.9	49.6	43.9	50.4	35.5	31.5	22.2	35.5	52.2	44.8	47.6	27.1	34.8	39.5	40.5	37.2	39.5	34.8	55.6	40.5	36.1	35.3	41.7	23.8	35.3	33.6	35.9	30.8	46.4	30.7	30.5	37.9	80.6	33.2	37.4	39.3	41.9	41.3	29.1	68.0	29.3	71.0	34.4	31.2	64.5	42.2	36.1	34.3	39.3	40.8	23.0	22.5	41.7	19.5	34.1	22.8	40.0	27.9	27.0	34.7	25.6	36.1	33.8	42.6	49.9	58.6	32.5	48.8	47.6	37.2	52.7	21.7	39.2	60.9	57.1	31.5	22.9	27.7	25.2	33.7	52.9	27.0	24.7	27.2	31.5	42.3	63.3	36.9	45.4	32.3	24.0	41.8	39.5	34.3	41.6	38.5	22.0	12.0	24.8	31.8	41.6	35.3	44.8	40.4	36.5	24.1	31.5	40.6	57.4	89.9	25.4	24.0	29.7	32.6	18.1	27.0	44.1	30.1	48.9	68.5	23.3	44.6	25.9	14.8	20.9	40.8	22.6	18.8	24.7	34.1	32.7	31.7	23.4	34.3	41.7	35.2	34.5	22.5	23.0	39.3	40.0	19.5	41.2	39.9	31.9	49.6	39.5	40.5	40.5	36.1	35.9	29.3	29.8	71.1	173.0	150.9	152.6	68.0	80.9	79.0	36.1	43.3	64.6	76.6	160.4	182.4	173.6	500.3	117.4	113.7	70.0	156.3	191.8	125.8	164.5	136.2	71.0	157.1	89.0	118.5	93.9	121.3	409.1	96.7	157.7	145.1	191.2	112.3	128.4	182.8	103.7	88.1	147.6	99.0	116.4	156.8	337.7	125.2	178.2	208.7	191.8	148.1	221.1
UBE2D3	UbcH5C	ENSG00000109332	"Ubiquitin conjugating enzyme E2 D3"	P61077	4	102794383-102868896	"Enzymes, Predicted intracellular proteins"	"Apoptosis, DNA damage, DNA repair, Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA003920	Uncertain		Approved	"Plasma membrane,Cytosol"		NA	NA			"Plasma membrane, Cytosol"		"HPA003920: AB_1858519"	"unprognostic (7.43e-2)"	"unprognostic (3.19e-1)"	"unprognostic (1.27e-2)"	"unprognostic (5.78e-2)"	"unprognostic (6.44e-2)"	"unprognostic (4.96e-2)"	"unprognostic (1.17e-1)"	"unprognostic (8.44e-3)"	"unprognostic (1.14e-1)"	"unprognostic (1.95e-1)"	"unprognostic (5.75e-2)"	"unprognostic (3.31e-2)"	"prognostic favorable (4.51e-4)"	"unprognostic (5.08e-2)"	"unprognostic (2.79e-1)"	"unprognostic (4.54e-2)"	"unprognostic (1.34e-2)"	67.2	70.6	39.1	52.7	44.6	132.7	70.4	36.9	50.9	45.5	51.8	37.5	38.4	49.3	46.3	39.1	63.2	45.7	47.5	72.5	37.3	39.5	63.0	91.9	67.5	68.1	43.4	36.9	60.6	53.4	42.8	49.1	66.5	45.2	49.6	48.5	38.4	46.7	43.3	91.1	53.2	58.9	48.4	44.4	68.2	49.5	40.0	42.2	88.8	66.3	55.4	61.4	74.6	81.4	24.7	31.2	118.0	36.2	29.7	33.2	50.9	53.5	30.7	51.2	41.3	54.7	79.0	44.0	54.5	72.7	48.7	46.0	46.0	76.5	57.4	35.7	55.3	63.2	30.7	54.6	73.2	67.1	53.2	27.5	52.2	31.6	37.5	57.4	73.4	45.0	59.9	46.4	53.7	75.3	63.0	63.1	47.3	65.6	58.7	64.8	43.2	107.7	41.8	37.1	61.3	30.7	56.8	50.3	41.4	49.1	51.2	51.8	43.6	33.5	86.1	61.5	63.1	35.7	43.4	57.9	51.0	43.6	33.3	49.5	52.0	67.0	87.8	54.3	40.9	54.7	71.1	35.9	54.6	25.1	36.1	33.2	24.7	31.8	29.6	31.2	20.1	32.6	29.7	118.0	29.7	36.2	21.5	32.6	50.9	39.1	44.6	36.9	50.9	37.3	39.5	43.4	36.9	45.2	42.2	154.9	181.2	227.9	605.7	749.7	127.0	210.7	150.3	190.1	129.7	132.6	117.8	279.1	464.2	286.3	668.3	228.0	265.9	93.5	333.2	474.9	260.0	477.5	219.4	203.4	354.6	116.0	231.0	159.0	357.1	423.2	152.5	359.3	339.1	356.1	198.5	111.8	351.4	245.4	140.0	328.0	157.1	103.5	376.3	128.5	151.0	711.0	533.9	297.5	192.3	680.6
UBE2D4	HBUCE1	ENSG00000078967	"Ubiquitin conjugating enzyme E2 D4 (putative)"	Q9Y2X8	7	43926438-43956136	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 48.6"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"SH-SY5Y: 25.3"					"Low region specificity"	"Detected in all"			HPA003920	Approved		Approved	"Plasma membrane,Cytosol"		NA	NA			"Plasma membrane, Cytosol"		"HPA003920: AB_1858519"	"unprognostic (9.95e-3)"	"unprognostic (6.76e-2)"	"unprognostic (6.87e-2)"	"unprognostic (8.94e-2)"	"unprognostic (8.24e-2)"	"unprognostic (5.24e-2)"	"unprognostic (2.42e-1)"	"unprognostic (3.58e-3)"	"unprognostic (4.74e-2)"	"unprognostic (5.04e-2)"	"prognostic favorable (4.86e-4)"	"prognostic favorable (5.77e-4)"	"prognostic favorable (6.51e-4)"	"unprognostic (1.11e-1)"	"unprognostic (8.74e-3)"	"unprognostic (1.89e-1)"	"unprognostic (1.34e-1)"	10.1	13.1	14.7	5.0	13.3	4.5	9.1	13.8	17.4	8.8	7.6	11.4	7.9	5.3	7.5	11.2	8.0	9.0	7.2	23.8	14.2	10.0	12.7	15.3	8.4	5.3	12.1	9.4	7.9	17.4	8.7	6.9	5.9	11.9	8.7	6.2	8.1	10.6	9.1	48.6	9.4	5.3	10.3	12.8	7.3	6.5	5.1	6.1	2.7	9.6	16.1	5.7	7.7	6.5	10.7	11.8	12.9	20.5	7.7	14.0	6.7	3.8	3.2	2.0	9.1	9.4	3.8	1.5	1.9	4.7	2.4	3.2	1.7	4.6	3.7	5.3	5.0	6.8	4.4	2.5	2.1	3.7	8.3	4.2	4.0	5.0	4.4	3.5	8.7	8.2	2.9	4.4	2.7	4.2	3.5	3.0	4.6	4.4	7.8	3.3	2.5	5.1	5.0	4.4	4.7	4.2	3.2	2.8	5.8	5.1	4.7	7.4	25.3	4.0	8.1	3.0	3.8	4.0	2.6	2.6	1.6	5.1	3.4	5.5	11.2	8.4	1.8	4.8	11.4	8.9	6.3	11.7	12.9	9.3	18.4	9.5	10.3	11.6	10.5	11.8	10.7	14.0	11.5	1.1	7.7	20.5	10.2	9.4	6.7	14.7	13.3	13.8	17.4	14.2	10.0	12.1	9.4	11.9	6.1	0.0	6.2	8.8	8.1	5.6	8.3	21.8	5.1	2.7	6.8	15.7	2.0	9.7	46.4	15.9	5.0	11.9	8.4	0.0	24.7	17.3	10.8	9.8	4.6	22.2	24.7	11.1	18.0	9.2	7.3	8.0	11.2	12.9	15.1	24.4	7.1	9.1	14.6	5.8	20.5	38.0	10.4	6.5	12.0	15.1	8.3	9.8	6.4	6.9	7.9	9.3
UBE2E1	UbcH6	ENSG00000170142	"Ubiquitin conjugating enzyme E2 E1"	P51965	3	23805903-23891316	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA030445, CAB073413"	Approved		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"CAB073413: , HPA030445: AB_10669599"	"unprognostic (7.50e-2)"	"unprognostic (2.78e-2)"	"unprognostic (7.91e-3)"	"unprognostic (7.13e-2)"	"unprognostic (6.74e-3)"	"unprognostic (1.74e-1)"	"prognostic unfavorable (9.97e-7)"	"unprognostic (3.69e-2)"	"unprognostic (3.53e-2)"	"unprognostic (1.34e-2)"	"unprognostic (5.36e-3)"	"unprognostic (2.70e-2)"	"unprognostic (2.40e-2)"	"unprognostic (1.94e-1)"	"unprognostic (2.94e-1)"	"unprognostic (2.75e-1)"	"unprognostic (1.93e-1)"	32.0	28.1	50.8	34.7	44.4	56.1	52.6	38.7	43.4	41.9	40.6	32.4	27.5	23.9	35.3	35.6	57.9	29.5	29.9	58.5	47.3	43.2	33.6	34.0	34.9	44.9	52.0	36.9	36.5	32.0	41.6	22.5	44.5	38.1	38.5	37.8	23.2	30.3	36.4	52.2	33.3	25.8	44.1	55.6	36.3	29.9	24.3	43.3	33.8	41.4	38.0	47.3	52.2	46.3	6.7	7.6	6.8	9.1	7.0	7.2	4.1	33.9	21.4	33.7	16.8	20.6	30.1	29.5	25.7	40.0	28.9	38.8	16.1	37.6	30.1	21.8	24.8	24.6	11.0	39.8	31.8	37.9	36.3	44.5	41.5	16.1	19.6	29.7	40.9	22.1	28.4	30.0	36.8	49.5	34.0	45.9	21.1	29.0	33.5	23.1	17.5	28.7	44.5	49.5	18.7	54.9	32.0	14.8	86.5	45.0	24.3	9.8	35.1	23.0	21.4	37.0	35.2	24.0	54.1	29.8	21.2	26.3	15.7	19.1	28.0	16.5	59.5	22.9	39.3	16.4	2.4	8.4	6.8	4.5	9.1	6.5	6.5	5.4	3.8	7.3	6.7	7.2	4.3	3.3	7.0	5.8	7.6	3.9	4.1	50.8	44.4	38.7	43.4	47.3	43.2	52.0	36.9	38.1	43.3	41.7	28.2	30.6	52.3	64.2	26.4	54.9	28.1	46.8	28.4	17.4	3.9	83.0	48.0	80.0	20.6	53.7	35.4	0.0	68.5	82.1	57.3	58.6	40.3	19.1	88.2	19.1	44.5	42.4	63.6	39.3	37.7	75.5	92.8	111.0	36.1	49.9	62.2	59.6	45.6	32.6	20.9	51.8	80.2	36.3	62.2	78.9	60.3	35.4	44.6	59.6
UBE2E2	"FLJ25157, UbcH8"	ENSG00000182247	"Ubiquitin conjugating enzyme E2 E2"	Q96LR5	3	23203020-23591793	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"classical monocyte: 15.2;intermediate monocyte: 17.8;memory B-cell: 12.3;myeloid DC: 20.9;naive B-cell: 14.8;non-classical monocyte: 18.3;plasmacytoid DC: 27.1"	"Group enriched"	"Detected in many"	6	"B-cells: 14.8;dendritic cells: 27.1;monocytes: 18.3"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003303, HPA028872, HPA030445, CAB073417"	Approved		Approved	Nucleoplasm		No	No			Nucleoplasm		"CAB073417: , HPA003303: AB_1858521, HPA028872: AB_10966277, HPA030445: AB_10669599"	"unprognostic (2.20e-1)"	"unprognostic (2.30e-1)"	"unprognostic (1.52e-2)"	"unprognostic (3.68e-3)"	"unprognostic (3.74e-2)"	"unprognostic (1.70e-1)"	"unprognostic (9.19e-3)"	"unprognostic (3.11e-3)"	"unprognostic (1.32e-1)"	"unprognostic (1.20e-1)"	"unprognostic (4.20e-1)"	"unprognostic (4.59e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.44e-2)"	"unprognostic (2.68e-2)"	"unprognostic (3.11e-2)"	"unprognostic (6.11e-3)"	22.7	11.4	19.2	12.0	23.3	7.6	15.9	18.8	32.7	22.4	14.5	20.8	7.5	5.9	17.7	31.9	19.7	12.0	18.5	23.4	21.3	21.8	19.1	15.8	16.7	17.7	14.1	19.7	19.0	9.8	15.5	14.4	9.0	20.9	18.2	6.4	8.4	11.2	17.0	32.0	14.8	7.2	22.4	17.6	15.9	11.1	17.8	13.3	14.8	16.8	11.1	14.5	17.0	16.2	14.8	27.1	0.4	18.3	0.8	3.6	5.2	17.1	6.2	16.3	0.3	14.5	16.2	14.8	10.8	18.5	10.2	14.4	1.7	14.1	14.9	7.5	9.5	14.1	1.7	11.8	16.9	13.2	0.1	11.9	0.0	7.3	2.0	10.4	0.0	12.0	12.8	17.8	14.7	24.8	10.5	9.8	11.8	0.8	15.9	9.2	2.7	7.8	3.3	11.6	9.8	9.0	16.4	6.3	17.1	10.0	0.4	4.2	8.7	11.9	7.0	0.2	12.3	15.0	9.9	8.5	10.1	14.3	6.7	12.2	15.3	5.0	22.0	9.5	6.7	2.8	0.0	15.2	0.0	0.2	17.8	0.3	12.3	0.5	0.2	20.9	14.8	3.6	1.3	0.4	0.8	18.3	27.1	0.2	5.2	19.2	23.3	18.8	32.7	21.3	21.8	14.1	19.7	20.9	13.3	20.8	9.8	36.3	10.5	22.8	22.7	32.7	20.4	5.3	4.5	29.6	15.7	28.0	58.0	12.3	17.6	20.4	0.0	0.0	25.6	33.5	29.3	47.2	0.0	38.4	44.7	30.2	1.7	14.7	43.5	12.0	36.5	55.4	74.2	35.1	0.7	10.9	13.5	0.3	49.8	98.2	2.9	32.3	50.9	33.5	99.2	36.9	32.3	2.5	0.5	5.1
UBE2E3	UbcH9	ENSG00000170035	"Ubiquitin conjugating enzyme E2 E3"	Q969T4	2	180967248-181076585	"Enzymes, Predicted intracellular proteins"	"Growth regulation, Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"AF22: 115.4"	"Low region specificity"	"Detected in all"							"HPA003303, HPA030445"	Approved					NA	NA					"HPA003303: AB_1858521, HPA030445: AB_10669599"	"unprognostic (8.85e-2)"	"unprognostic (1.77e-1)"	"unprognostic (1.51e-1)"	"unprognostic (2.96e-2)"	"unprognostic (2.23e-1)"	"prognostic unfavorable (8.08e-5)"	"prognostic unfavorable (9.11e-4)"	"unprognostic (1.00e-3)"	"unprognostic (4.99e-2)"	"unprognostic (8.46e-2)"	"prognostic unfavorable (1.78e-5)"	"unprognostic (8.75e-2)"	"unprognostic (3.86e-1)"	"unprognostic (2.50e-1)"	"unprognostic (1.28e-1)"	"unprognostic (2.18e-1)"	"unprognostic (4.40e-1)"	29.1	23.9	35.6	21.1	33.0	20.1	49.7	37.4	62.9	30.4	25.2	18.6	19.8	23.0	26.6	29.2	23.1	29.7	35.9	37.8	43.9	32.5	36.0	29.6	28.5	37.6	31.5	31.9	27.7	29.9	42.9	21.6	23.9	30.5	20.9	27.8	24.6	26.3	22.7	76.8	28.1	26.2	24.1	41.3	20.4	28.3	28.1	21.5	30.9	37.4	27.8	23.0	31.8	23.0	7.7	29.7	25.6	16.9	8.5	12.0	9.6	17.6	8.1	115.4	4.0	34.3	44.3	18.4	23.7	30.0	20.0	25.0	8.7	21.5	8.7	20.8	32.3	16.8	7.6	69.6	24.3	36.0	21.2	21.0	30.1	10.9	24.1	16.5	13.9	14.4	17.4	22.7	17.5	16.9	20.4	26.3	18.3	15.3	16.3	49.0	9.7	25.3	13.1	22.0	12.1	38.2	24.8	11.8	20.7	34.0	15.6	20.1	22.5	10.3	11.0	9.7	33.0	5.9	20.7	24.2	39.0	25.7	22.8	27.5	14.3	9.1	24.5	38.4	5.5	21.6	13.0	14.0	25.6	9.3	12.3	11.1	7.7	7.3	12.0	9.2	4.9	7.8	8.5	13.2	8.5	16.9	29.7	2.8	9.6	35.6	33.0	37.4	62.9	43.9	32.5	31.5	31.9	30.5	21.5	8.9	21.6	43.9	66.6	91.4	128.2	30.3	89.2	34.8	33.0	52.4	27.5	34.3	193.9	78.5	28.7	62.5	41.0	70.0	89.6	68.0	102.0	68.5	23.1	44.5	72.1	71.5	57.4	65.7	57.3	50.1	58.1	56.9	123.2	35.1	42.3	53.3	82.5	28.1	33.9	136.3	56.9	25.8	51.2	91.9	204.0	107.0	30.1	59.0	46.5	88.8
UBE2F	NCE2	ENSG00000184182	"Ubiquitin conjugating enzyme E2 F (putative)"	Q969M7	2	237966827-238042782	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	6	"Extravillous trophoblasts: 231.1;monocytes: 312.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA037444	Approved		Approved	Cytosol		NA	NA			Cytosol		"HPA037444: AB_10672491"	"unprognostic (1.73e-1)"	"unprognostic (1.65e-1)"	"unprognostic (3.80e-2)"	"unprognostic (6.92e-3)"	"unprognostic (3.39e-1)"	"unprognostic (1.56e-1)"	"prognostic unfavorable (2.72e-4)"	"unprognostic (3.43e-3)"	"unprognostic (6.64e-2)"	"unprognostic (3.87e-1)"	"unprognostic (1.69e-2)"	"unprognostic (2.04e-1)"	"prognostic unfavorable (1.59e-7)"	"unprognostic (2.04e-2)"	"unprognostic (6.39e-2)"	"unprognostic (3.60e-2)"	"unprognostic (2.51e-1)"	14.5	18.4	21.3	13.6	17.6	19.9	17.2	12.2	19.8	16.7	15.8	17.7	12.3	13.6	14.7	32.2	25.0	11.0	16.3	34.6	20.2	21.6	14.6	24.1	12.9	26.4	23.4	10.1	10.4	62.8	16.3	13.2	22.2	24.2	14.9	19.6	11.4	15.3	18.2	32.1	10.3	17.9	20.2	20.2	14.6	15.1	13.9	16.8	15.8	32.9	17.4	17.7	18.7	16.4	10.9	23.1	35.6	30.0	39.9	29.1	24.6	13.5	7.7	17.8	18.2	23.2	28.3	25.2	12.7	18.3	14.4	14.8	8.4	8.7	7.0	4.6	28.5	31.4	11.5	20.1	27.7	22.6	10.6	7.8	9.6	9.8	27.4	29.2	4.0	22.7	16.2	45.8	19.0	29.0	13.4	25.5	33.0	29.3	4.5	26.0	20.3	10.9	17.7	19.6	19.5	11.8	13.3	11.8	12.4	21.7	5.7	11.9	17.8	14.9	11.3	23.6	31.2	10.2	16.8	15.8	15.9	14.0	18.0	13.6	5.6	4.3	13.7	18.8	12.2	11.7	35.6	21.0	25.2	29.1	27.6	11.5	10.9	19.9	17.6	18.6	10.1	18.6	18.8	15.6	39.9	30.0	23.1	20.5	24.6	21.3	17.6	12.2	19.8	20.2	21.6	23.4	10.1	24.2	16.8	6.0	20.2	41.4	18.8	28.8	21.7	44.5	28.1	24.1	5.7	26.2	7.9	72.4	48.0	42.5	17.3	25.5	37.0	70.0	68.9	231.1	37.6	41.8	20.8	40.0	129.2	25.4	40.1	23.9	54.8	47.2	23.9	61.5	33.7	312.0	46.7	15.8	69.1	29.2	29.0	52.2	19.3	38.8	35.6	90.0	52.7	35.3	54.9	47.3	30.7	31.1
UBE2G1	"UBC7, UBE2G"	ENSG00000132388	"Ubiquitin conjugating enzyme E2 G1"	P62253	17	4269259-4366628	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 95.6"	"Cell type enhanced"	"Detected in many"	6	"Basal keratinocytes: 254.1;Suprabasal keratinocytes: 209.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA045681, HPA050551"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"HPA045681: AB_2679417, HPA050551: AB_2681171"	"unprognostic (1.57e-3)"	"unprognostic (1.94e-1)"	"unprognostic (2.34e-2)"	"unprognostic (1.80e-2)"	"unprognostic (5.16e-2)"	"unprognostic (5.84e-2)"	"unprognostic (1.87e-1)"	"unprognostic (2.64e-2)"	"unprognostic (5.13e-2)"	"unprognostic (1.86e-1)"	"unprognostic (2.80e-1)"	"unprognostic (1.67e-2)"	"unprognostic (9.99e-2)"	"unprognostic (2.16e-1)"	"unprognostic (4.58e-2)"	"unprognostic (3.97e-2)"	"unprognostic (6.50e-2)"	10.8	11.1	12.6	17.8	13.5	14.3	11.2	11.6	15.3	13.0	19.4	17.8	8.9	11.9	13.3	8.5	27.4	9.2	9.7	26.9	13.5	11.2	14.6	17.7	8.9	18.7	15.2	9.7	9.1	17.1	12.0	6.0	11.4	14.5	14.0	13.3	8.8	11.9	12.0	95.6	14.1	16.6	14.6	19.4	15.0	11.9	11.8	13.6	21.3	12.5	20.7	23.3	17.7	16.5	23.7	13.1	24.4	11.5	20.5	20.6	13.1	21.2	23.1	21.6	15.8	17.7	18.7	30.8	20.8	16.7	19.8	17.5	15.9	10.9	33.4	21.8	20.4	16.2	23.1	26.8	19.3	32.0	17.5	21.8	12.5	12.3	18.1	17.4	18.1	23.7	15.9	28.9	18.8	27.4	14.0	26.5	22.5	21.8	36.2	16.3	9.5	23.0	16.6	23.8	15.8	12.0	29.9	11.4	30.5	23.1	14.0	9.3	17.4	19.6	17.1	16.1	33.3	16.7	11.9	19.8	19.9	15.2	23.3	23.2	14.1	16.5	47.2	15.3	17.0	15.3	8.1	10.3	24.4	15.4	10.8	20.6	23.7	20.1	20.1	13.1	15.5	20.2	20.5	18.6	20.5	11.5	9.6	18.3	13.1	12.6	13.5	11.6	15.3	13.5	11.2	15.2	9.7	14.5	13.6	20.8	11.8	63.6	34.1	254.1	16.5	62.6	30.6	13.4	13.6	24.4	5.9	36.7	69.6	27.6	105.5	28.7	35.4	0.0	23.2	45.9	34.4	47.3	20.7	52.9	41.3	14.3	36.9	32.5	36.1	173.0	18.1	34.1	64.1	33.3	32.7	23.0	32.9	27.5	19.8	61.3	13.9	6.5	47.9	63.9	47.7	209.5	55.8	43.3	26.8	53.3
UBE2G2	UBC7	ENSG00000184787	"Ubiquitin conjugating enzyme E2 G2"	P60604	21	44768580-44802019	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003332	Approved					NA	NA					"HPA003332: AB_1858525"	"unprognostic (7.58e-2)"	"unprognostic (5.41e-2)"	"unprognostic (1.58e-2)"	"unprognostic (4.45e-2)"	"unprognostic (6.30e-2)"	"unprognostic (4.67e-2)"	"unprognostic (5.99e-2)"	"unprognostic (3.79e-3)"	"unprognostic (6.93e-3)"	"unprognostic (7.02e-2)"	"unprognostic (1.40e-2)"	"unprognostic (6.98e-3)"	"prognostic unfavorable (7.02e-5)"	"unprognostic (1.79e-1)"	"unprognostic (1.69e-1)"	"unprognostic (2.75e-2)"	"unprognostic (3.55e-2)"	30.9	20.7	18.9	22.8	20.9	25.8	21.1	21.0	21.6	18.9	22.7	20.5	19.8	14.9	22.2	18.4	19.3	20.5	18.0	37.1	18.3	17.1	26.2	27.3	19.7	19.7	19.0	17.0	18.1	30.2	22.1	26.0	17.0	18.9	18.3	16.5	18.6	15.4	28.3	50.8	15.6	16.9	28.5	17.8	23.8	20.2	14.0	18.8	18.4	20.6	18.7	21.6	20.9	18.9	11.9	17.5	5.9	13.0	14.0	17.3	12.1	15.8	3.3	10.9	14.1	15.0	6.5	10.0	11.2	8.7	9.8	10.7	12.6	2.1	20.5	10.8	11.1	12.8	6.4	16.0	13.5	8.9	19.2	16.5	33.4	2.3	10.1	11.9	24.6	5.7	10.6	16.0	13.1	12.8	4.3	15.4	23.2	31.0	14.3	13.5	7.1	27.2	2.9	28.4	11.0	14.2	22.3	10.1	18.4	12.8	8.5	12.7	22.7	15.8	5.1	16.1	10.5	5.0	21.4	10.9	9.5	6.8	8.8	18.1	22.5	44.3	20.3	9.5	29.1	11.2	2.3	11.6	5.9	16.0	11.8	17.3	11.8	14.7	16.2	12.5	11.9	15.7	16.6	3.6	14.0	13.0	17.5	14.6	12.1	18.9	20.9	21.0	19.3	18.3	17.1	19.0	17.0	18.9	18.8	53.6	111.1	38.9	31.3	42.4	53.2	62.9	33.1	54.9	61.4	50.6	62.8	35.1	21.6	28.3	52.3	44.9	23.7	0.0	34.6	19.9	31.7	31.1	41.7	58.7	31.0	30.2	28.8	38.1	32.5	135.1	38.3	37.1	27.0	32.5	25.2	36.8	34.2	17.3	47.4	29.6	96.5	25.8	32.3	26.1	49.0	48.9	30.0	30.5	38.7	35.8
UBE2H	"GID3, UBC8, UBCH"	ENSG00000186591	"Ubiquitin conjugating enzyme E2 H"	P62256	7	129830732-129952949	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003302	Approved		Approved	Mitochondria		NA	NA			Mitochondria		"HPA003302: AB_1858526"	"unprognostic (1.15e-1)"	"unprognostic (5.85e-2)"	"unprognostic (5.67e-3)"	"unprognostic (2.76e-1)"	"unprognostic (2.25e-1)"	"unprognostic (3.08e-2)"	"unprognostic (1.13e-1)"	"unprognostic (1.37e-1)"	"unprognostic (9.43e-2)"	"unprognostic (6.19e-2)"	"prognostic unfavorable (2.33e-5)"	"unprognostic (1.13e-1)"	"unprognostic (3.73e-2)"	"unprognostic (2.37e-1)"	"unprognostic (1.12e-1)"	"unprognostic (3.58e-1)"	"unprognostic (1.23e-1)"	29.0	49.9	31.1	16.6	31.0	22.5	24.5	36.1	30.2	31.1	27.3	33.2	26.6	15.2	35.5	25.3	32.1	29.4	26.6	61.0	26.4	25.4	27.6	28.1	26.3	17.5	28.1	23.4	27.6	52.3	41.8	29.5	37.9	33.3	24.1	16.8	22.9	28.5	28.8	46.3	21.3	16.5	31.5	26.2	19.1	22.7	24.7	29.5	24.7	37.7	23.6	29.5	25.5	34.3	6.1	3.7	7.8	2.2	1.3	6.5	1.9	22.1	12.0	14.3	14.5	35.4	30.5	24.7	20.5	26.5	12.6	14.1	6.4	23.8	9.2	25.7	20.2	32.6	16.9	12.2	21.8	16.5	11.3	6.5	3.2	17.7	7.7	27.9	6.3	10.1	41.0	29.0	17.0	27.3	28.0	24.5	9.8	7.5	26.7	19.4	7.9	8.4	6.9	22.4	15.1	14.3	6.6	7.3	19.6	26.3	29.1	5.4	16.5	18.8	42.1	11.0	44.9	4.4	6.2	24.8	13.7	6.9	19.3	20.4	24.4	17.5	15.2	27.3	7.6	13.3	3.5	2.2	5.1	4.7	1.7	6.4	3.8	4.7	4.2	2.0	6.1	6.0	6.4	7.8	1.3	2.1	3.7	6.5	1.9	31.1	31.0	36.1	30.2	26.4	25.4	28.1	23.4	33.3	29.5	38.7	38.0	39.2	140.7	129.5	52.7	101.3	53.5	54.9	53.4	68.0	56.9	93.6	34.9	51.9	67.1	55.4	27.8	116.8	62.1	57.4	57.8	206.4	14.9	63.8	35.3	41.3	56.6	44.8	35.5	35.6	40.9	28.3	45.5	12.6	27.9	82.0	95.7	31.7	73.9	39.7	32.0	12.9	55.1	22.7	17.7	134.4	167.6	24.9	23.0	232.4
UBE2J1	"CGI-76, HSPC153, NCUBE1, UBC6"	ENSG00000198833	"Ubiquitin conjugating enzyme E2 J1"	Q9Y385	6	89326625-89352848	"Enzymes, Predicted membrane proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	7	"Early spermatids: 501.0;Late spermatids: 1092.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Daudi: 63.8;Karpas-707: 55.2;U-266/70: 62.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003509, CAB073419"	Enhanced					NA	NA					"CAB073419: , HPA003509: AB_1858531"	"unprognostic (1.82e-1)"	"unprognostic (3.20e-2)"	"unprognostic (1.55e-3)"	"prognostic favorable (2.87e-4)"	"unprognostic (3.41e-1)"	"unprognostic (7.93e-3)"	"prognostic unfavorable (6.90e-5)"	"unprognostic (1.19e-1)"	"unprognostic (9.36e-2)"	"prognostic favorable (7.43e-4)"	"unprognostic (1.74e-1)"	"unprognostic (9.33e-2)"	"prognostic unfavorable (1.11e-4)"	"unprognostic (5.11e-2)"	"unprognostic (2.83e-1)"	"unprognostic (3.87e-2)"	"unprognostic (9.38e-2)"	18.7	17.3	14.6	47.1	15.4	52.7	28.2	19.1	13.6	18.8	25.9	11.3	24.4	28.0	19.5	18.4	19.2	18.0	19.9	17.1	14.4	14.7	18.7	33.5	20.4	52.0	17.0	9.5	17.2	46.1	11.5	13.6	27.5	13.0	22.9	26.3	10.7	42.1	33.2	12.5	11.3	36.3	17.9	18.9	45.8	24.4	17.7	14.4	42.5	17.6	16.4	47.7	21.7	21.4	20.7	23.7	15.9	17.8	6.4	6.4	6.1	8.3	2.9	8.1	10.3	8.5	11.1	0.0	13.3	11.8	8.2	9.1	4.7	5.2	63.8	7.4	13.7	6.9	3.4	5.3	7.7	13.5	8.9	8.2	11.6	3.8	7.7	22.6	14.5	7.6	8.4	7.7	6.9	11.8	11.1	18.4	7.6	9.3	55.2	9.6	5.1	6.0	11.2	2.8	5.9	4.2	23.9	10.5	30.5	10.3	5.9	4.1	8.3	5.6	12.4	12.3	12.3	4.9	32.3	12.3	4.6	4.4	8.1	10.2	62.1	30.8	17.5	9.1	10.5	7.6	10.3	6.6	12.3	3.4	11.1	4.0	20.7	4.6	4.2	6.5	13.4	4.3	3.9	15.9	6.4	17.8	23.7	6.4	6.1	14.6	15.4	19.1	13.6	14.4	14.7	17.0	9.5	13.0	14.4	14.9	33.4	95.3	52.5	22.0	31.9	8.1	30.6	22.7	18.2	19.2	27.5	69.3	43.1	55.4	501.0	59.9	55.1	0.0	88.1	72.0	50.7	96.3	24.3	37.6	70.2	22.3	74.2	98.8	102.2	1092.2	50.6	55.8	69.2	46.9	54.1	14.7	86.7	70.2	44.9	36.1	13.7	32.3	55.6	20.7	19.6	30.4	108.2	36.2	57.4	100.2
UBE2J2	"NCUBE2, Ubc6p"	ENSG00000160087	"Ubiquitin conjugating enzyme E2 J2"	Q8N2K1	1	1253909-1273885	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Ubl conjugation pathway, Unfolded protein response"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"Late spermatids: 350.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA						"unprognostic (9.39e-2)"	"unprognostic (1.17e-1)"	"unprognostic (2.25e-1)"	"unprognostic (3.04e-2)"	"unprognostic (1.88e-2)"	"unprognostic (4.46e-2)"	"unprognostic (1.67e-3)"	"unprognostic (1.60e-1)"	"unprognostic (1.60e-2)"	"unprognostic (9.57e-2)"	"unprognostic (1.28e-3)"	"unprognostic (1.32e-1)"	"prognostic unfavorable (2.00e-4)"	"unprognostic (2.09e-2)"	"unprognostic (6.19e-2)"	"unprognostic (1.87e-1)"	"unprognostic (3.46e-2)"	24.4	22.2	17.5	21.6	17.1	19.4	33.0	23.8	24.9	17.8	22.0	17.9	19.9	22.0	22.9	21.4	25.2	21.8	20.7	21.2	17.5	17.1	21.6	27.3	17.4	27.4	15.9	15.4	19.4	36.3	14.4	22.8	22.6	15.9	16.9	16.2	18.7	24.2	20.2	29.8	23.2	23.6	19.3	13.1	25.2	22.2	68.3	12.8	26.1	22.8	21.7	23.8	18.3	19.3	24.5	22.3	39.6	23.0	22.0	25.3	17.7	25.7	10.7	15.3	14.6	12.4	12.8	11.9	19.9	15.8	27.2	19.9	19.0	18.8	13.9	21.3	18.4	15.0	18.8	15.5	19.8	21.7	23.5	27.8	20.9	21.0	17.1	24.1	19.1	20.1	12.0	11.1	21.3	15.9	14.9	19.1	19.0	28.8	13.8	15.7	12.8	27.7	21.5	16.5	17.0	26.9	25.8	14.2	22.9	14.1	8.7	56.4	27.9	13.7	29.6	31.4	14.5	15.2	21.8	15.6	16.5	15.8	19.1	20.3	30.4	29.5	38.8	21.2	30.4	13.0	38.2	23.0	39.6	22.0	22.2	20.1	24.5	23.4	22.8	22.3	21.7	21.2	20.9	32.6	22.0	21.3	20.8	25.3	17.7	17.5	17.1	23.8	24.9	17.5	17.1	15.9	15.4	15.9	12.8	8.9	15.9	25.3	40.7	37.9	27.4	16.7	33.1	6.7	21.6	27.9	7.9	59.9	48.0	58.6	187.2	33.6	39.3	0.0	81.4	63.5	40.5	45.1	16.1	24.1	46.5	22.3	16.8	23.9	23.0	350.9	34.8	33.1	38.8	45.1	36.5	29.9	79.3	31.6	35.3	57.4	25.4	32.3	40.3	121.4	83.7	38.1	73.0	44.7	38.2	51.2
UBE2K	"HIP2, HYPG, UBC1"	ENSG00000078140	"Ubiquitin conjugating enzyme E2 K"	P61086	4	39698044-39782792	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028869, CAB033212, CAB033515"	Supported		Approved	"Plasma membrane,Cytosol"		NA	NA		150000	Cytosol	"Plasma membrane"	"CAB033212: AB_2272506, CAB033515: AB_2304024, HPA028869: AB_10602487"	"unprognostic (1.14e-2)"	"unprognostic (6.02e-2)"	"unprognostic (2.42e-3)"	"unprognostic (3.06e-1)"	"unprognostic (6.81e-2)"	"unprognostic (2.05e-1)"	"unprognostic (5.05e-3)"	"unprognostic (1.44e-2)"	"unprognostic (2.71e-3)"	"unprognostic (1.01e-1)"	"prognostic unfavorable (8.60e-4)"	"unprognostic (1.08e-1)"	"unprognostic (3.67e-1)"	"unprognostic (4.83e-2)"	"unprognostic (6.88e-2)"	"unprognostic (1.22e-1)"	"unprognostic (4.10e-3)"	27.2	21.8	27.0	21.2	27.6	17.3	21.6	38.6	40.7	17.0	33.2	11.8	14.1	29.1	19.9	18.5	29.9	14.9	18.5	28.1	27.7	26.8	26.6	44.5	17.1	17.9	24.1	26.4	16.9	15.8	18.9	26.9	29.8	25.2	19.7	24.0	13.4	18.4	17.3	31.8	22.0	24.6	18.8	19.2	16.9	29.3	16.0	15.9	21.3	23.6	19.7	18.8	22.8	20.4	17.6	23.7	20.6	19.9	10.9	14.1	8.9	24.2	24.9	13.4	12.7	8.4	7.9	22.8	33.4	7.1	9.0	9.4	37.6	25.0	30.3	29.4	9.4	22.1	10.2	25.8	14.6	14.4	20.3	18.5	39.2	25.2	32.5	10.6	42.1	22.2	7.4	16.5	12.6	13.6	9.4	11.7	13.3	39.8	10.9	9.2	23.5	29.3	23.4	17.8	14.0	19.0	17.3	40.3	11.3	12.5	33.8	27.9	12.3	25.0	9.5	14.9	15.5	12.2	14.1	32.0	14.0	29.7	16.6	30.7	15.4	45.0	33.3	7.3	27.0	16.4	13.9	16.6	20.6	13.5	14.3	12.7	17.6	14.1	12.6	16.6	12.5	10.7	12.0	13.3	10.9	19.9	23.7	13.7	8.9	27.0	27.6	38.6	37.7	27.7	26.8	24.1	26.4	25.2	15.9	53.6	50.8	35.6	49.5	109.2	60.1	57.3	45.9	71.0	67.1	47.1	27.5	74.8	56.3	76.3	97.5	58.3	92.6	70.0	77.7	144.5	61.6	76.6	33.5	101.0	71.4	98.5	57.3	61.4	71.5	150.7	60.4	73.4	54.0	103.6	63.5	70.2	109.4	73.0	53.0	81.7	38.2	38.8	67.9	71.4	46.9	120.6	123.3	48.4	65.5	98.3
UBE2L3	UBCH7	ENSG00000185651	"Ubiquitin conjugating enzyme E2 L3"	P68036	22	21549447-21624034	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation, Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"K-562: 110.3"									"HPA045609, HPA062415"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA		8800000	"Nucleoplasm, Cytosol"		"HPA045609: AB_10961322, HPA062415: AB_2684756"	"unprognostic (4.90e-2)"	"unprognostic (3.05e-1)"	"unprognostic (1.92e-2)"	"unprognostic (1.07e-2)"	"unprognostic (2.74e-2)"	"unprognostic (9.99e-3)"	"prognostic unfavorable (1.29e-4)"	"unprognostic (3.28e-2)"	"unprognostic (3.65e-2)"	"prognostic favorable (3.82e-6)"	"unprognostic (3.53e-2)"	"unprognostic (4.55e-2)"	"unprognostic (3.18e-2)"	"unprognostic (4.66e-2)"	"unprognostic (5.09e-2)"	"unprognostic (2.77e-1)"	"unprognostic (3.15e-3)"	27.8	34.9	34.8	23.5	29.6	31.3	24.9	25.5	36.9	25.9	27.7	38.4	22.8	26.4	25.6	29.2	38.0	26.9	23.0	33.0	30.7	30.8	27.4	36.0	23.5	32.5	34.3	33.1	24.3	23.9	24.3	21.7	30.1	36.9	27.5	31.7	29.3	30.6	26.7	43.5	23.9	34.4	33.1	36.2	28.5	25.1	35.7	22.6	25.3	25.0	32.4	33.9	28.4	22.2	34.7	49.9	46.1	45.8	34.6	46.9	54.9	24.9	14.4	21.1	16.5	23.1	20.7	12.2	21.1	24.1	27.1	25.8	16.4	12.1	23.6	10.6	27.9	20.5	21.4	28.1	22.9	27.1	23.5	30.4	27.3	14.1	19.5	15.4	39.0	19.7	18.2	20.0	19.7	14.3	19.6	30.4	14.7	110.3	12.7	29.3	18.4	20.2	28.2	15.5	28.0	15.2	16.6	31.8	6.4	25.4	20.1	19.0	14.1	16.8	21.2	19.4	20.3	13.2	21.6	21.8	19.3	24.8	16.2	21.4	12.4	20.0	21.6	26.1	18.1	18.2	30.8	40.4	46.1	41.4	45.8	38.8	34.7	39.6	44.2	49.9	31.2	34.5	41.6	34.2	34.6	37.6	48.4	46.9	54.9	34.8	29.6	25.5	36.9	30.7	30.8	34.3	33.1	36.9	22.6	101.3	71.0	116.9	138.6	111.5	51.2	50.6	107.0	125.8	95.5	68.0	15.7	283.0	167.5	270.4	53.8	105.0	174.1	140.2	335.7	335.1	102.8	131.4	126.9	137.0	262.0	65.2	120.8	104.3	125.9	41.0	80.8	163.0	119.8	326.4	95.3	76.6	339.4	136.8	97.6	204.5	41.2	103.5	83.5	134.5	117.6	113.3	311.1	142.4	115.8	190.0
UBE2L5	UBE2L5P	ENSG00000236444	"Ubiquitin conjugating enzyme E2 L5"		13	30422488-30428616	"Enzymes, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"			"Tissue enriched"	"Detected in some"	9	"testis: 31.5"	"Cell type enriched"	"Detected in single"	4	"Ciliated cells: 1.4"	"Low cancer specificity"	"Detected in single"							"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"							"Low region specificity"	"Detected in single"			"HPA045609, HPA062415"	Approved		Uncertain	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"HPA045609: AB_10961322, HPA062415: AB_2684756"	"unprognostic (2.09e-1)"	"unprognostic (1.18e-2)"	"unprognostic (8.01e-3)"	"unprognostic (6.41e-4)"	"unprognostic (1.78e-1)"	"unprognostic (7.13e-2)"	"unprognostic (2.20e-1)"	"unprognostic (1.65e-1)"	"unprognostic (1.19e-1)"	"unprognostic (6.49e-3)"	"unprognostic (1.78e-1)"	"unprognostic (8.00e-2)"	"unprognostic (3.50e-2)"	"unprognostic (9.37e-2)"	"unprognostic (2.60e-1)"	"unprognostic (2.44e-2)"	"unprognostic (8.75e-2)"	0.2	0.0	0.0	0.0	0.7	0.1	0.0	0.3	0.3	0.0	0.1	0.4	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.7	0.7		0.3	0.2	0.2	0.1	0.2	0.5	0.3	0.0	0.0	0.0	0.1	0.5	0.1	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.1	0.0	0.0	0.0	31.5	0.1	0.0	0.0	0.0	0.0	0.1	0.0	3.2	1.9	2.7	3.6	1.9	2.0	2.8	0.7	0.3	1.3	1.6	0.6	0.7	0.7	1.2	0.6	0.4	0.2	0.0	3.1	1.4	0.6	1.3	1.3	0.6	0.8	0.4	1.1	2.5	0.6	0.4	0.8	0.2	0.2	0.7	1.5	0.2	0.3	0.6	0.2	1.4	0.9	0.9	0.8	1.3	0.3	0.0	1.6	2.6	1.4	0.2	0.2	0.4	0.6	0.4	0.9	1.5	1.2	0.3	0.4	0.1	1.8	0.9	0.6	2.4	0.0	0.7	0.5	0.7	1.1	1.5	0.3	1.6	1.0	0.9	0.4	1.8	1.1	1.9	1.4	3.6	1.2	3.2	1.5	1.6	1.5	1.7	1.4	2.0	2.7	1.9	1.6	1.9	2.0	2.8											0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
UBE2L6	UBCH8	ENSG00000156587	"Ubiquitin conjugating enzyme E2 L6"	O14933	11	57551656-57568284	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	5	"Hofbauer cells: 148.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003328, CAB073407"	Enhanced		Approved	Cytosol		NA	NA		34000	Cytosol		"CAB073407: , HPA003328: AB_1858539"	"prognostic favorable (6.75e-4)"	"unprognostic (2.10e-2)"	"unprognostic (1.09e-2)"	"unprognostic (2.93e-2)"	"unprognostic (1.72e-1)"	"unprognostic (1.18e-1)"	"unprognostic (3.13e-2)"	"unprognostic (4.74e-2)"	"unprognostic (1.36e-2)"	"unprognostic (1.37e-3)"	"prognostic unfavorable (4.88e-4)"	"unprognostic (3.07e-2)"	"unprognostic (1.02e-2)"	"unprognostic (1.28e-1)"	"unprognostic (4.17e-2)"	"unprognostic (1.88e-2)"	"unprognostic (6.42e-2)"	31.1	31.0	32.0	34.1	28.6	30.4	40.4	18.2	25.6	23.3	19.1	17.0	17.1	19.0	21.9	30.0	19.9	28.6	27.4	18.4	23.5	27.4	28.3	55.1	50.5	45.0	28.9	20.4	27.1	21.8	17.9	18.5	21.7	25.8	26.0	18.8	18.7	42.8	22.2	10.1	15.9	23.5	28.3	23.6	47.9	21.4	7.7	23.6	44.0	33.6	15.1	34.4	33.0	49.0	49.2	53.6	113.6	83.4	61.2	66.4	112.6	8.7	4.4	15.0	4.7	31.7	39.5	1.6	5.1	30.5	45.2	58.9	1.6	22.8	28.1	18.1	15.5	39.1	7.0	6.4	16.8	9.6	25.5	0.2	27.6	0.0	6.3	58.7	6.3	9.2	42.2	3.9	21.2	5.8	16.8	14.2	29.7	1.2	19.5	8.1	11.1	42.6	15.3	3.9	0.0	5.6	37.7	9.1	19.2	12.1	9.8	0.3	7.8	10.2	0.8	22.4	2.7	11.2	3.2	5.2	9.4	3.3	7.1	1.6	26.6	26.8	0.5	26.4	16.0	2.0	56.7	71.6	62.5	51.2	83.4	56.4	49.2	53.4	53.4	53.6	39.7	46.5	48.8	113.6	61.2	68.3	34.0	66.4	112.6	32.0	28.6	18.2	25.6	23.5	27.4	28.9	20.4	25.8	23.6	26.8	17.4	54.4	23.2	20.7	10.2	5.2	28.1	24.1	27.3	12.2	3.9	3.0	54.7	68.9	3.6	46.7	22.7	23.3	57.3	31.0	37.7	34.1	53.1	27.3	148.0	12.7	23.0	41.1	54.9	9.6	44.5	69.1	8.5	44.1	29.8	31.5	45.0	31.7	31.5	19.8	3.9	25.8	41.2	1.9	6.0	24.2	2.9	74.7	21.7	24.6
UBE2N	"MGC8489, UBC13, UbcH-ben"	ENSG00000177889	"Ubiquitin conjugating enzyme E2 N"	P61088	12	93405673-93442262	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins"	"DNA damage, DNA repair, Ubl conjugation pathway"	Transferase	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in all"	15	"Early spermatids: 2177.0;Late spermatids: 6552.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											HPA044976	Enhanced		Supported	"Nucleoplasm,Nucleoli fibrillar center"		NA	NA		4600000	Nucleoplasm	"Nucleoli fibrillar center"	"HPA044976: AB_2679163"	"unprognostic (1.74e-2)"	"unprognostic (5.53e-1)"	"unprognostic (1.26e-2)"	"unprognostic (2.30e-1)"	"unprognostic (1.07e-1)"	"unprognostic (8.09e-2)"	"prognostic unfavorable (2.41e-4)"	"unprognostic (8.49e-3)"	"unprognostic (2.72e-1)"	"unprognostic (4.28e-3)"	"unprognostic (1.07e-1)"	"unprognostic (9.28e-2)"	"unprognostic (1.03e-1)"	"unprognostic (3.31e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.48e-1)"	"unprognostic (1.30e-3)"	24.7	25.0	29.0	28.7	39.1	29.0	21.2	29.2	44.3	18.4	26.6	15.6	15.1	20.7	23.2	20.0	30.4	19.7	17.0	27.7	31.0	33.7	25.4	22.3	19.3	36.1	27.6	34.5	17.4	17.6	13.9	18.2	24.2	34.9	23.4	22.6	13.7	18.0	18.5	35.7	19.1	20.4	21.3	24.6	21.5	19.3	83.7	17.4	32.2	15.5	16.8	35.1	22.7	18.8	53.8	35.5	29.9	39.2	29.5	57.3	51.9	36.5	26.5	44.7	28.6	17.3	17.2	31.2	51.1	27.3	41.1	34.5	47.1	15.9	74.4	11.6	29.9	27.2	29.1	49.3	37.5	39.2	61.9	25.6	50.0	14.6	41.5	22.2	59.7	33.4	18.0	15.5	24.5	30.6	29.2	31.6	29.2	55.6	11.6	42.6	30.0	59.0	55.6	58.2	32.3	37.1	45.9	36.3	36.4	34.2	55.3	43.8	39.9	27.0	31.8	25.0	25.2	41.6	36.8	32.6	27.9	23.3	25.0	36.8	20.0	54.3	63.2	10.9	31.9	33.9	29.9	27.1	28.9	31.7	35.4	36.9	53.8	40.2	39.2	35.5	38.6	36.0	34.4	8.2	29.5	39.2	26.7	57.3	51.9	29.0	39.1	29.2	44.3	31.0	33.7	27.6	34.5	34.9	17.4	35.7	44.5	137.9	175.3	286.2	65.4	70.5	33.1	62.9	66.0	85.5	25.5	212.3	162.5	138.2	2177.0	83.9	61.7	70.0	87.1	187.9	124.3	118.3	92.3	44.8	144.3	82.6	71.7	46.1	58.9	6552.8	86.9	108.4	140.0	201.0	50.2	87.6	106.5	77.7	80.9	127.4	40.9	45.3	165.8	246.5	216.4	281.9	238.1	122.0	65.5	190.8
UBE2O	E2-230K	ENSG00000175931	"Ubiquitin conjugating enzyme E2 O"	Q9C0C9	17	76389451-76453206	"Enzymes, Predicted intracellular proteins"	"Transport, Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Bipolar cells: 42.3;Horizontal cells: 42.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA023605	Uncertain		Supported	"Nucleoplasm,Nuclear bodies"		No	No		1600000	Nucleoplasm	"Nuclear bodies"	"HPA023605: AB_2671257"	"unprognostic (8.75e-2)"	"unprognostic (2.04e-1)"	"unprognostic (7.44e-2)"	"unprognostic (8.68e-2)"	"unprognostic (1.17e-1)"	"unprognostic (3.22e-2)"	"prognostic unfavorable (6.84e-8)"	"unprognostic (3.54e-1)"	"unprognostic (2.68e-1)"	"unprognostic (7.61e-2)"	"unprognostic (1.32e-3)"	"unprognostic (1.18e-2)"	"prognostic unfavorable (4.34e-9)"	"unprognostic (7.22e-2)"	"unprognostic (9.64e-2)"	"unprognostic (9.12e-2)"	"unprognostic (2.07e-1)"	8.5	8.5	13.8	10.2	22.6	19.2	7.3	25.2	38.1	9.4	7.2	12.2	7.4	9.9	9.9	8.2	11.7	10.8	7.1	15.4	12.7	15.2	6.5	7.6	6.6	12.8	11.7	14.6	13.9	14.4	16.4	14.3	9.8	30.6	9.4	6.0	10.5	13.4	10.4	23.0	15.2	8.2	8.0	8.0	10.8	10.8	18.1	12.2	10.9	15.8	6.9	9.2	8.6	9.1	4.9	4.1	2.7	1.7	1.5	4.0	1.9	13.1	15.1	15.5	19.0	9.7	6.2	13.4	6.2	6.7	10.1	9.9	13.1	6.7	18.7	4.4	7.7	15.9	13.4	18.0	10.7	7.2	5.3	22.2	18.9	9.9	21.9	8.0	11.4	11.5	6.3	8.7	9.6	8.3	8.8	13.6	10.4	15.7	16.7	5.1	10.8	22.5	13.2	14.3	7.9	20.3	22.3	20.0	20.6	4.5	11.3	23.0	20.7	9.0	23.6	12.4	14.8	13.5	8.2	8.0	11.9	11.2	10.0	10.2	13.8	4.5	15.8	13.0	9.6	7.7	0.0	1.7	2.7	4.0	0.8	2.2	2.6	2.6	2.0	1.0	4.9	2.1	3.0	0.4	1.5	1.0	4.1	2.3	1.9	13.8	22.6	25.2	38.1	12.7	15.2	11.7	14.6	30.6	12.2	3.0	7.7	17.1	5.1	7.7	42.3	23.4	7.6	4.0	6.8	7.0	39.3	5.0	0.0	5.2	1.1	7.5	4.7	0.0	8.0	6.4	7.7	7.2	6.9	5.0	7.0	42.9	22.4	8.6	7.9	1.1	8.9	3.9	5.0	9.0	8.7	8.2	6.5	7.0	7.4	3.1	23.7	6.5	10.0	16.6	18.4	10.8	4.3	6.4	7.9	4.8
UBE2Q1	"NICE-5, PRO3094, UBE2Q"	ENSG00000160714	"Ubiquitin conjugating enzyme E2 Q1"	Q7Z7E8	1	154548577-154559028	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA063368	Approved		Approved	Nucleoplasm,Centrosome		No	No			Nucleoplasm	Centrosome	"HPA063368: AB_2684996"	"unprognostic (3.88e-1)"	"unprognostic (2.13e-1)"	"unprognostic (4.44e-3)"	"unprognostic (3.64e-3)"	"unprognostic (5.32e-3)"	"unprognostic (6.10e-3)"	"prognostic unfavorable (8.74e-4)"	"unprognostic (2.92e-1)"	"unprognostic (2.07e-1)"	"unprognostic (9.92e-3)"	"unprognostic (3.79e-2)"	"unprognostic (1.46e-1)"	"prognostic unfavorable (4.84e-7)"	"unprognostic (2.20e-1)"	"unprognostic (4.46e-1)"	"prognostic favorable (1.86e-5)"	"unprognostic (1.04e-2)"	17.3	18.7	26.5	16.2	29.4	24.2	19.4	26.4	29.0	20.0	21.2	18.7	8.2	16.2	18.3	25.4	20.9	21.8	18.2	17.6	24.5	25.8	25.7	27.4	23.0	26.3	22.8	21.0	21.7	27.2	21.4	29.3	24.5	27.2	21.4	25.7	18.5	19.0	19.8	19.1	21.6	21.4	21.9	19.1	26.0	20.5	30.0	22.0	25.1	21.0	14.0	29.9	19.3	18.5	3.2	5.1	8.1	3.1	4.7	6.2	1.6	17.2	14.9	21.1	16.1	21.7	22.4	18.3	17.1	26.0	22.0	17.8	16.7	18.4	21.2	24.6	23.8	18.4	15.0	24.8	19.8	19.0	21.3	15.7	16.8	13.3	16.1	27.4	27.3	27.1	21.5	26.3	17.8	20.7	24.0	28.2	19.7	14.1	26.3	28.1	26.7	16.6	20.1	28.8	41.3	25.4	19.2	14.7	22.3	24.2	18.3	21.5	30.1	17.3	32.6	27.9	37.7	19.9	41.7	19.6	14.3	15.9	16.9	18.2	32.2	23.8	28.1	16.0	19.4	21.5	8.1	2.8	5.6	4.8	3.1	4.3	3.0	4.5	5.9	2.5	3.2	5.0	5.7	4.4	4.7	2.6	5.1	6.2	1.6	26.5	29.4	26.4	29.0	24.5	25.8	22.8	21.0	27.2	22.0	29.8	21.6	22.7	16.5	14.3	38.7	26.9	25.5	34.8	20.5	15.7	3.9	15.3	10.0	13.0	2.7	27.8	23.7	0.0	18.0	14.1	15.8	22.6	10.4	34.2	23.2	57.2	32.3	32.5	41.4	4.3	16.4	19.3	13.5	15.4	30.4	45.6	21.9	11.5	18.0	15.1	19.3	12.9	13.2	30.7	24.4	16.7	16.4	20.8	20.4	22.9
UBE2Q2	DKFZp762C143	ENSG00000140367	"Ubiquitin conjugating enzyme E2 Q2"	Q8WVN8	15	75843285-75901078	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	5	"Rod photoreceptor cells: 151.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"																	NA	NA						"unprognostic (1.28e-1)"	"unprognostic (1.66e-2)"	"unprognostic (2.45e-2)"	"unprognostic (4.28e-2)"	"unprognostic (8.82e-2)"	"unprognostic (1.13e-1)"	"unprognostic (1.07e-3)"	"unprognostic (1.32e-1)"	"unprognostic (6.38e-2)"	"prognostic favorable (5.73e-4)"	"unprognostic (1.67e-1)"	"unprognostic (1.87e-1)"	"unprognostic (1.47e-3)"	"unprognostic (1.01e-3)"	"unprognostic (1.92e-1)"	"unprognostic (1.69e-2)"	"unprognostic (5.92e-2)"	17.8	19.8	15.6	18.8	10.9	22.2	41.1	11.6	14.4	20.0	25.2	12.4	12.9	6.0	17.6	15.5	24.7	11.8	22.7	25.1	15.0	16.0	16.5	6.3	21.0	25.9	19.8	10.3	17.2	13.8	7.7	12.6	34.8	12.0	22.3	13.5	13.0	20.1	15.0	26.4	11.0	11.1	42.9	23.1	15.1	14.7	13.5	11.6	27.6	21.4	22.3	11.2	40.2	35.7	6.1	4.2	18.0	6.9	10.6	9.6	4.8	9.6	14.8	13.8	9.8	19.3	25.5	20.7	21.4	24.2	14.2	16.2	7.7	13.3	9.6	15.9	30.7	12.7	7.9	24.7	14.1	17.5	9.8	10.0	12.0	9.0	10.4	21.3	12.5	7.0	17.7	16.4	10.0	14.8	21.2	19.6	17.4	4.5	14.5	30.1	7.4	10.2	11.6	9.7	1.5	10.7	12.2	21.6	3.8	22.6	15.4	12.0	9.4	18.4	17.3	23.3	20.6	11.1	17.2	25.9	17.7	16.2	11.8	7.5	15.8	27.7	7.6	7.1	19.3	10.7	18.0	4.7	15.5	7.2	5.3	9.0	6.1	9.6	7.6	4.2	4.8	7.7	6.4	0.7	10.6	6.9	1.5	6.1	4.8	15.6	10.9	11.6	14.4	15.0	16.0	19.8	10.3	12.0	11.6	3.0	9.2	13.9	24.8	44.8	18.2	27.1	17.8	2.7	17.0	22.7	127.6	47.1	19.9	22.6	48.2	37.3	1.6	23.3	14.7	102.2	32.0	46.6	19.7	3.8	22.3	6.4	17.9	28.3	25.4	26.7	22.5	34.8	35.4	26.2	21.3	14.6	20.4	10.5	27.3	24.5	151.5	25.8	46.7	48.6	74.1	40.7	92.0	27.7	17.9	30.6
UBE2QL1	FLJ25076	ENSG00000215218	"Ubiquitin conjugating enzyme E2 Q family like 1"	A1L167	5	6448623-6494909	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in many"	4	"brain: 28.1;heart muscle: 11.3;retina: 8.2;seminal vesicle: 8.6;skeletal muscle: 21.3"	"Group enriched"	"Detected in some"	4	"Bipolar cells: 23.6;Cardiomyocytes: 25.0;Horizontal cells: 42.9;Rod photoreceptor cells: 49.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in single"		"eosinophil: 1.2"	"Lineage enhanced"	"Detected in single"		"granulocytes: 1.2"	"Cell line enhanced"	"Detected in some"		"Karpas-707: 18.2;PC-3: 15.2;SCLC-21H: 14.2;U-266/70: 34.1;U-266/84: 30.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA057414			Supported	"Nucleoplasm,Plasma membrane"		NA	NA			Nucleoplasm	"Plasma membrane"	"HPA057414: "	"unprognostic (1.45e-2)"	"unprognostic (1.58e-2)"	"unprognostic (1.79e-2)"	"unprognostic (2.10e-1)"	"unprognostic (1.08e-2)"	"unprognostic (7.43e-2)"	"unprognostic (1.15e-2)"	"unprognostic (1.36e-1)"	"unprognostic (3.10e-1)"	"unprognostic (7.16e-2)"	"unprognostic (2.15e-3)"	"unprognostic (8.41e-2)"	"prognostic favorable (6.81e-8)"	"unprognostic (3.18e-3)"	"unprognostic (2.81e-1)"	"unprognostic (1.27e-2)"	"unprognostic (1.41e-2)"	0.6	2.3	8.6	0.8	4.2	0.3	0.9	20.7	28.1	1.0	1.8	1.0	0.5	0.7	1.4	1.8	1.0	0.5	0.8	11.3	12.6	8.2	2.6	1.1	0.4	0.7	5.2	4.6	3.6	0.8	0.3	1.3	0.3	8.7	3.1	0.8	8.2	1.0	8.6	21.3	2.4	1.0	1.3	1.4	0.4	2.2	0.9	0.0	0.0	1.9	2.0	0.5	0.5	0.9	0.5	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	18.2	0.0	3.1	0.0	0.0	0.2	0.0	15.2	0.1	0.0	6.7	0.0	0.0	14.2	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	34.1	30.2	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.6	4.2	20.7	19.4	12.6	8.2	5.2	4.6	8.7	0.0	0.0	0.0	0.0	0.6	1.1	23.6	25.0	0.0	0.0	0.0	0.0	5.9	0.0	5.0	0.0	0.0	0.5	0.0	0.0	0.2	0.0	0.5	0.7	0.0	0.8	0.1	42.9	5.2	0.0	0.3	0.0	3.7	0.0	0.0	0.0	0.0	8.4	0.2	0.0	6.3	0.0	49.0	0.0	1.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0
UBE2R2	"CDC34B, FLJ20419, MGC10481, UBC3B"	ENSG00000107341	"Ubiquitin conjugating enzyme E2 R2"	Q712K3	9	33817567-33920404	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	5	"Early spermatids: 295.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"neutrophil: 21.9"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA061000, HPA074334"			Approved	Nucleoplasm,Nucleoli,Cytosol		NA	NA			"Nucleoplasm, Nucleoli"	Cytosol	"HPA061000: AB_2684408, HPA074334: "	"unprognostic (1.51e-1)"	"unprognostic (1.50e-1)"	"unprognostic (7.08e-2)"	"unprognostic (1.53e-1)"	"unprognostic (6.55e-2)"	"unprognostic (5.15e-2)"	"prognostic unfavorable (4.37e-4)"	"unprognostic (1.82e-3)"	"unprognostic (4.61e-3)"	"unprognostic (3.05e-3)"	"unprognostic (2.22e-2)"	"unprognostic (4.19e-1)"	"unprognostic (2.01e-2)"	"unprognostic (4.18e-2)"	"unprognostic (1.22e-1)"	"unprognostic (5.72e-2)"	"unprognostic (1.43e-1)"	26.1	19.7	29.4	19.7	26.8	13.9	39.3	23.7	32.3	25.6	24.1	27.9	16.3	28.0	26.1	18.4	25.3	22.3	21.8	29.2	25.5	20.3	22.1	34.5	23.0	27.1	30.5	23.2	29.8	44.5	15.7	13.9	24.6	21.6	21.0	21.4	19.3	18.7	20.8	56.1	28.1	25.7	28.5	24.2	21.6	20.8	34.5	29.6	36.7	19.5	22.5	25.7	35.8	30.5	3.3	4.2	21.9	11.6	5.0	2.1	2.4	16.5	18.1	35.0	15.2	19.3	31.5	10.8	14.7	20.5	17.3	17.3	14.5	12.4	14.1	6.0	20.5	12.6	7.4	18.3	16.8	19.0	23.2	9.7	12.2	20.0	18.4	27.5	14.4	13.3	26.7	25.0	14.1	26.8	27.7	29.0	17.0	11.4	15.2	17.1	9.6	27.1	38.0	19.9	14.2	15.1	25.3	10.6	7.3	18.3	12.5	16.4	19.7	17.2	15.4	11.0	23.2	13.5	17.6	21.7	16.7	15.2	11.5	13.6	9.7	9.1	19.8	15.9	8.4	35.9	12.4	7.5	4.1	2.0	7.5	1.3	3.1	1.9	1.6	4.2	3.3	1.9	1.7	21.9	5.0	11.6	2.6	2.1	2.4	29.4	26.8	23.7	32.3	25.5	20.3	30.5	23.2	21.6	29.6	20.8	30.7	29.5	39.6	93.8	61.0	106.8	56.0	22.7	25.0	21.0	13.7	52.6	13.3	43.8	295.7	77.1	60.6	23.3	59.7	65.2	54.0	68.4	12.7	72.1	68.5	57.2	69.2	77.3	105.2	195.4	62.2	81.9	33.7	49.5	57.3	87.1	69.4	38.6	71.5	49.6	30.1	58.2	41.9	90.2	66.2	105.3	69.2	30.5	49.0	79.7
UBE2S	E2-EPF	ENSG00000108106	"Ubiquitin conjugating enzyme E2 S"	Q16763	19	55399745-55407777	"Enzymes, Predicted intracellular proteins"	"Cell cycle, Cell division, Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 68.0;lymphoid tissue: 60.2;testis: 69.4"	"Cell type enhanced"	"Detected in many"	4	"Extravillous trophoblasts: 226.9;Spermatocytes: 216.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB015228, HPA057150"	Approved		Approved	"Nucleoplasm,Plasma membrane"		NA	Yes			"Plasma membrane"	Nucleoplasm	"CAB015228: , HPA057150: AB_2683351"	"unprognostic (2.79e-1)"	"unprognostic (2.42e-1)"	"unprognostic (2.57e-1)"	"prognostic unfavorable (2.05e-4)"	"unprognostic (9.54e-2)"	"unprognostic (1.41e-1)"	"prognostic unfavorable (8.00e-6)"	"unprognostic (1.42e-3)"	"unprognostic (2.32e-1)"	"unprognostic (2.31e-1)"	"unprognostic (8.08e-2)"	"unprognostic (4.52e-2)"	"prognostic unfavorable (8.16e-8)"	"unprognostic (1.05e-1)"	"unprognostic (9.51e-2)"	"unprognostic (1.58e-1)"	"unprognostic (1.75e-1)"	10.2	9.2	18.0	19.5	15.9	68.0	4.7	11.4	21.6	6.1	12.0	9.1	4.5	8.4	7.1	7.2	17.1	6.0	9.7	18.0	18.7	18.1	5.9	5.6	6.3	22.9	13.7	14.4	6.4	6.0	3.7	12.9	9.8	12.9	7.0	7.1	6.2	4.9	5.3	7.3	6.2	7.3	10.7	15.3	11.0	10.6	69.4	8.2	60.2	5.9	14.3	21.1	10.0	7.1	4.5	3.1	6.0	1.9	0.6	2.6	0.3	60.3	32.7	28.8	22.9	1.8	2.6	5.1	49.2	14.9	30.4	27.7	22.1	21.6	58.8	20.4	12.3	36.6	17.8	28.8	12.8	13.5	46.0	95.7	35.1	18.8	7.1	5.5	42.0	34.2	2.9	3.6	22.3	21.6	6.6	11.9	32.1	34.9	41.2	19.0	16.0	56.8	21.8	72.2	16.9	55.5	50.1	22.2	21.1	8.1	12.9	73.1	39.6	62.7	15.6	27.9	9.1	11.1	22.8	18.2	18.3	52.1	15.6	116.9	33.2	79.7	69.0	19.2	29.7	66.3	1.1	1.9	2.9	1.8	1.5	1.2	4.5	2.6	2.6	1.5	1.6	2.5	1.5	6.0	0.6	0.9	3.1	1.0	0.3	18.0	15.9	11.4	21.6	18.7	18.1	13.7	14.4	12.9	8.2	0.0	4.3	37.3	136.4	144.5	56.5	2.4	7.6	0.0	0.0	19.2	51.1	34.3	13.3	44.4	86.7	31.2	25.8	70.0	26.4	226.9	94.9	63.2	18.4	9.6	55.5	30.2	88.9	22.7	24.7	27.7	16.1	39.9	70.9	55.1	28.4	76.7	57.6	28.1	11.7	14.8	59.0	12.9	96.6	216.2	140.8	101.4	50.0	44.7	30.4	121.0
UBE2T	"FANCT, HSPC150"	ENSG00000077152	"Ubiquitin conjugating enzyme E2 T"	Q9NPD8	1	202331657-202341980	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"DNA damage, DNA repair, Ubl conjugation pathway"	Transferase	"Disease mutation, Fanconi anemia"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 46.8"	"Cell type enhanced"	"Detected in many"	12	"Erythroid cells: 186.9;Extravillous trophoblasts: 82.9;Spermatocytes: 115.5;Spermatogonia: 96.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA002831			Approved	Nucleoplasm,Nucleoli		NA	Yes			Nucleoli	Nucleoplasm	"HPA002831: AB_1080445"	"unprognostic (2.38e-3)"	"unprognostic (6.37e-2)"	"unprognostic (5.27e-2)"	"unprognostic (5.19e-2)"	"unprognostic (2.81e-1)"	"unprognostic (6.13e-3)"	"prognostic unfavorable (4.79e-6)"	"unprognostic (1.71e-2)"	"unprognostic (2.32e-2)"	"prognostic favorable (6.90e-6)"	"unprognostic (6.28e-3)"	"unprognostic (2.85e-2)"	"prognostic unfavorable (2.22e-16)"	"unprognostic (5.37e-3)"	"unprognostic (1.58e-1)"	"unprognostic (1.20e-1)"	"unprognostic (4.86e-2)"	1.9	4.2	9.6	8.5	12.2	20.8	3.9	4.4	13.5	3.5	11.2	0.7	17.2	7.5	4.3	4.1	10.3	2.9	3.0	8.8	8.8	11.2	4.5	2.8	3.1	15.2	8.7	8.2	1.3	0.9	2.4	3.1	8.7	8.2	2.2	13.9	1.9	2.8	7.0	13.1	4.5	6.9	8.1	3.4	6.7	4.0	16.0	1.8	46.8	2.6	12.8	15.3	6.3	4.5	9.0	3.6	1.7	8.6	1.1	11.1	2.9	30.4	29.1	43.3	20.4	4.0	7.4	24.8	33.3	18.6	38.1	26.9	20.7	37.4	35.5	13.2	12.1	28.4	24.9	40.0	19.5	34.4	32.2	22.9	21.7	15.8	23.6	1.8	25.9	26.4	2.6	4.7	29.9	12.5	9.1	22.1	40.1	27.3	29.3	29.8	28.3	46.4	33.1	16.8	31.7	14.8	36.0	46.1	30.8	14.6	14.6	34.1	34.8	23.3	28.7	11.1	13.5	30.2	16.4	10.8	17.2	27.5	30.0	39.5	14.9	29.1	45.2	17.0	27.0	35.6	0.0	0.8	1.7	3.7	2.4	2.8	9.0	5.0	3.9	1.7	6.3	7.3	8.0	0.0	1.1	8.6	3.6	11.1	2.9	9.6	12.2	4.4	13.5	8.8	11.2	8.7	8.2	8.2	1.8	0.0	2.1	10.4	11.0	12.7	5.2	12.2	0.0	6.7	7.9	5.2	0.0	33.9	5.0	11.2	13.0	1.9	2.7	186.9	6.6	82.9	4.8	2.2	8.1	1.7	23.5	9.5	1.2	4.3	1.8	6.6	2.8	5.2	3.3	3.6	9.0	1.3	7.8	0.0	3.9	7.9	0.9	6.5	1.9	115.5	96.9	9.5	18.8	9.5	19.6	4.1
UBE2U	MGC35130	ENSG00000177414	"Ubiquitin conjugating enzyme E2 U (putative)"	Q5VVX9	1	64203627-64267368	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in some"	20	"testis: 31.8"	"Group enriched"	"Detected in some"	12	"Early spermatids: 118.4;Late spermatids: 169.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"EFO-21: 2.4;U-266/84: 1.3"					"Region enhanced"	"Detected in many"		"midbrain: 19.5"							NA	NA									"unprognostic (9.44e-4)"				"unprognostic (5.52e-2)"		"unprognostic (1.81e-1)"	"unprognostic (2.37e-1)"		"unprognostic (4.01e-2)"	"unprognostic (3.63e-1)"	"unprognostic (7.69e-2)"			0.0	0.0	0.1	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.5	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.4	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	31.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.7	118.4	0.0	0.0	0.0	0.2	2.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	169.4	1.7	0.0	0.0	1.0	0.0	0.0	1.1	0.0	0.7	0.0	0.0	0.0	0.0	11.9	1.8	0.0	0.2	0.0	0.0	0.0
UBE2W	"FLJ11011, UBC-16"	ENSG00000104343	"Ubiquitin conjugating enzyme E2 W"	Q96B02	8	73780097-73878910	"Enzymes, Predicted intracellular proteins"	"DNA damage, DNA repair, Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA045161, HPA073181"	Uncertain		Approved	Nucleoli		NA	NA			Nucleoli		"HPA045161: AB_10960706, HPA073181: AB_2686578"	"unprognostic (5.36e-2)"	"unprognostic (1.87e-1)"	"unprognostic (7.52e-2)"	"unprognostic (1.32e-3)"	"unprognostic (3.17e-1)"	"unprognostic (9.74e-2)"	"unprognostic (3.09e-2)"	"unprognostic (6.93e-3)"	"unprognostic (1.83e-1)"	"unprognostic (3.47e-1)"	"unprognostic (1.33e-1)"	"unprognostic (2.34e-1)"	"unprognostic (5.01e-2)"	"unprognostic (4.38e-2)"	"unprognostic (9.31e-2)"	"unprognostic (1.62e-1)"	"unprognostic (1.18e-1)"	15.2	14.2	13.5	13.3	21.8	17.5	13.4	18.9	24.4	12.0	9.8	11.3	11.0	7.9	13.4	10.5	16.6	9.4	15.2	14.8	19.0	12.3	21.9	23.4	13.6	11.6	11.6	13.0	11.8	12.7	18.4	20.9	13.6	18.4	12.0	11.5	9.5	12.2	10.6	16.4	10.6	8.5	12.8	12.6	13.6	10.0	16.4	12.3	14.7	17.1	4.8	12.9	16.8	12.8	5.0	8.1	23.0	9.4	4.7	4.3	4.8	8.6	5.7	7.0	7.5	12.2	12.5	6.1	9.5	10.5	9.2	9.6	4.7	9.7	4.0	7.9	9.9	14.0	8.8	10.2	9.7	15.3	6.5	6.2	8.1	5.9	7.2	8.2	4.5	11.6	9.8	10.9	10.7	19.2	8.3	11.1	4.5	4.0	8.6	13.9	6.9	9.7	4.8	5.3	12.3	11.2	2.9	7.1	3.4	17.0	9.5	5.2	5.7	7.6	24.7	11.4	7.9	11.5	8.0	9.9	11.1	8.4	8.4	6.9	7.3	7.5	3.0	9.7	7.1	9.5	12.9	9.4	11.5	3.5	8.8	4.3	5.0	3.6	2.6	6.3	4.3	3.2	3.8	23.0	4.7	9.4	8.1	4.0	4.8	13.5	21.8	18.9	24.4	19.0	12.3	11.6	13.0	18.4	12.3	14.9	12.3	22.7	24.3	49.1	33.4	20.4	20.4	9.4	11.4	50.6	15.7	15.8	43.1	21.3	107.9	29.2	13.4	116.8	15.1	16.5	23.4	29.3	20.7	25.1	35.4	39.7	22.3	20.3	43.6	45.7	19.0	46.1	40.5	76.7	12.2	23.6	17.3	14.0	17.7	41.3	27.1	19.4	60.9	31.4	29.8	56.3	46.1	34.9	12.5	36.9
UBE2Z	"FLJ13855, USE1"	ENSG00000159202	"Ubiquitin conjugating enzyme E2 Z"	Q9H832	17	48908369-48929056	"Enzymes, Predicted intracellular proteins"	"Apoptosis, Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA007922	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"HPA007922: AB_1858551"	"unprognostic (6.85e-2)"	"unprognostic (5.72e-3)"	"prognostic favorable (4.62e-4)"	"unprognostic (9.11e-2)"	"unprognostic (3.71e-3)"	"unprognostic (1.76e-1)"	"prognostic unfavorable (5.57e-4)"	"unprognostic (2.32e-2)"	"unprognostic (5.26e-2)"	"unprognostic (8.66e-2)"	"unprognostic (9.17e-3)"	"unprognostic (3.48e-2)"	"prognostic unfavorable (1.05e-4)"	"unprognostic (2.63e-2)"	"unprognostic (2.11e-2)"	"unprognostic (1.91e-2)"	"unprognostic (1.52e-1)"	27.1	40.6	29.2	27.7	37.0	22.2	28.8	34.4	50.2	33.7	28.9	59.9	45.1	26.6	36.2	49.5	37.2	36.0	28.0	28.7	30.5	29.2	32.1	25.6	29.2	30.9	46.6	28.0	32.5	29.5	36.6	28.0	35.0	39.7	32.9	32.5	28.4	33.3	43.2	24.1	35.9	30.5	39.1	32.7	36.6	29.4	22.4	43.4	29.4	39.8	22.2	44.2	28.8	32.2	12.8	10.1	11.0	14.5	7.4	13.1	8.6	24.9	30.9	11.6	11.0	29.6	28.8	15.9	27.3	33.5	32.8	31.6	38.5	21.6	20.3	39.2	33.5	41.2	16.2	14.6	25.5	41.9	67.1	15.8	18.4	20.5	23.9	34.2	13.0	19.8	24.5	28.3	26.7	34.6	35.1	24.0	9.7	13.4	26.5	35.1	39.8	14.0	12.9	10.8	30.5	27.1	11.3	29.6	11.5	25.6	24.6	12.0	18.2	18.5	10.0	18.6	27.4	27.6	10.3	28.1	49.0	23.7	16.0	22.2	20.2	19.2	12.0	24.0	9.6	21.2	6.5	11.0	8.1	13.1	14.5	10.7	9.4	11.4	13.0	8.0	12.8	11.1	12.0	11.0	7.4	13.0	10.1	11.5	8.6	29.2	37.0	34.4	50.2	30.5	29.2	46.6	28.0	39.7	43.4	23.8	16.3	32.1	40.1	46.9	52.1	29.9	30.6	18.7	10.3	34.9	39.3	29.1	18.3	38.9	1.4	40.2	31.5	0.0	46.7	25.9	26.8	61.1	5.8	22.9	22.6	41.3	46.7	39.9	23.9	2.9	25.9	27.7	28.7	52.3	35.4	30.6	59.6	28.1	27.3	20.7	33.6	32.3	35.3	21.4	22.7	49.8	35.8	22.3	24.7	60.4
UBE3A	"ANCR, AS, E6-AP, EPVE6AP, FLJ26981, HPVE6A"	ENSG00000114062	"Ubiquitin protein ligase E3A"	Q05086	15	25333728-25439056	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Biological rhythms, Host-virus interaction, Ubl conjugation pathway"	Transferase	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009723, HPA039410, HPA040380"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"CAB009723: AB_639982, HPA039410: AB_10671997, HPA040380: AB_2676952"	"unprognostic (7.95e-2)"	"unprognostic (2.61e-2)"	"unprognostic (1.58e-1)"	"unprognostic (2.99e-1)"	"unprognostic (1.13e-1)"	"unprognostic (3.55e-2)"	"unprognostic (1.44e-1)"	"unprognostic (3.05e-1)"	"unprognostic (5.07e-2)"	"unprognostic (1.69e-1)"	"unprognostic (3.40e-2)"	"unprognostic (4.83e-2)"	"unprognostic (6.31e-2)"	"unprognostic (3.08e-2)"	"unprognostic (1.42e-1)"	"unprognostic (1.15e-1)"	"unprognostic (8.17e-2)"	19.3	19.4	20.3	23.1	25.0	17.8	20.2	30.0	25.1	21.7	19.9	14.3	19.8	14.1	21.0	22.1	19.8	18.5	17.2	24.0	22.2	20.8	20.2	24.6	19.7	23.1	19.1	19.5	23.0	17.2	26.1	24.6	20.1	20.9	20.6	17.9	13.3	19.3	21.5	70.2	18.4	18.8	21.2	19.9	18.8	16.9	26.4	16.4	36.4	25.0	26.6	19.5	19.9	26.6	15.6	11.9	11.6	14.8	21.1	16.0	5.7	19.6	11.1	28.1	16.7	16.4	19.5	13.8	30.3	19.0	21.5	19.6	25.7	9.8	35.4	23.0	22.6	21.2	18.2	35.5	21.4	26.3	18.2	11.9	29.3	18.8	15.2	24.7	35.3	21.7	23.1	20.1	20.3	26.0	22.4	16.9	31.1	29.5	25.3	33.7	10.7	29.3	10.3	18.2	21.5	16.2	30.0	42.0	15.6	19.5	31.0	28.9	21.8	24.6	26.7	34.9	19.0	21.8	20.0	21.6	37.7	31.2	18.1	22.1	28.9	34.1	47.7	21.6	19.3	19.6	8.6	8.7	11.6	13.3	7.6	15.2	12.0	14.0	15.9	11.9	15.6	16.0	14.2	2.0	21.1	14.8	11.1	10.1	5.7	20.3	25.0	30.0	25.1	22.2	20.8	19.1	19.5	20.9	16.4	89.3	73.3	52.7	60.3	63.2	78.1	154.5	43.3	71.0	67.1	36.6	53.0	43.4	16.6	42.2	101.1	45.8	39.4	0.0	43.1	41.8	44.5	85.9	62.2	52.0	41.5	76.3	65.9	47.3	56.6	43.8	52.6	44.6	50.6	37.9	48.7	54.8	47.5	42.1	60.8	44.0	56.4	77.6	54.5	143.0	88.7	79.3	61.9	44.9	47.9	87.8
UBE3B		ENSG00000151148	"Ubiquitin protein ligase E3B"	Q7Z3V4	12	109477402-109536705	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase	"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041012	Approved		Approved	"Nuclear speckles,Mitochondria"		NA	NA			"Nuclear speckles"	Mitochondria	"HPA041012: AB_10964435"	"unprognostic (1.53e-2)"	"unprognostic (1.01e-1)"	"unprognostic (7.12e-2)"	"unprognostic (7.37e-2)"	"unprognostic (7.43e-2)"	"unprognostic (1.29e-1)"	"unprognostic (4.92e-2)"	"unprognostic (7.19e-2)"	"unprognostic (2.93e-1)"	"unprognostic (4.46e-3)"	"unprognostic (9.39e-2)"	"unprognostic (1.23e-1)"	"prognostic favorable (2.49e-5)"	"unprognostic (3.35e-1)"	"unprognostic (3.35e-2)"	"unprognostic (2.87e-1)"	"unprognostic (1.26e-1)"	14.5	19.3	17.2	12.9	21.2	9.2	15.3	19.7	27.8	14.4	17.3	23.3	14.0	14.6	17.4	16.2	20.1	19.3	13.9	28.6	14.6	11.6	19.8	16.4	15.5	13.1	18.6	13.9	18.4	20.3	25.5	15.1	16.8	15.8	17.5	21.2	20.7	15.7	17.4	34.0	21.6	16.3	18.6	15.2	17.0	17.3	24.5	18.3	18.2	21.1	17.6	15.9	19.5	19.6	15.9	14.5	22.4	16.7	14.3	18.2	11.4	10.4	16.5	13.0	9.4	22.2	17.9	11.4	13.8	15.8	16.8	11.3	17.3	10.7	6.5	10.3	22.6	14.3	13.5	13.1	17.7	16.2	14.3	9.3	12.4	10.8	15.6	14.2	10.1	10.4	20.3	16.5	16.2	19.5	25.4	18.1	15.5	13.6	6.2	19.1	16.3	6.9	14.8	13.3	11.7	19.9	11.5	12.2	12.7	14.4	18.8	12.1	22.4	16.1	21.9	10.7	15.9	22.4	10.8	16.5	20.8	6.0	10.6	9.8	13.9	11.5	11.5	20.7	8.5	17.2	22.4	15.3	14.3	15.9	16.7	15.7	15.9	15.3	11.2	14.5	12.9	12.9	17.1	19.5	14.3	13.6	13.5	18.2	11.4	17.2	21.2	19.7	27.8	14.6	11.6	18.6	13.9	15.8	18.3	11.9	10.8	6.7	10.0	4.5	20.4	32.1	10.2	14.7	14.8	15.7	31.4	15.7	10.0	16.0	11.8	13.5	15.1	23.3	13.2	9.3	8.4	15.1	9.2	16.0	11.1	20.6	8.6	12.9	17.1	24.6	11.5	11.0	10.1	14.4	15.8	16.7	18.8	10.5	9.2	17.7	25.0	6.5	8.5	9.6	12.7	6.4	19.8	10.9	13.8	12.2
UBE3C	"KIAA0010, KIAA10"	ENSG00000009335	"Ubiquitin protein ligase E3C"	Q15386	7	157138913-157269372	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039915	Approved		Approved	"Nucleoplasm,Plasma membrane,Mitochondria"		NA	NA			"Nucleoplasm, Mitochondria"	"Plasma membrane"	"HPA039915: AB_10795264"	"unprognostic (2.83e-2)"	"unprognostic (9.27e-3)"	"unprognostic (2.41e-1)"	"unprognostic (2.29e-1)"	"unprognostic (1.19e-2)"	"unprognostic (3.14e-2)"	"unprognostic (1.36e-1)"	"unprognostic (7.02e-2)"	"unprognostic (2.34e-2)"	"unprognostic (1.58e-1)"	"unprognostic (3.01e-3)"	"unprognostic (8.64e-2)"	"prognostic favorable (9.18e-6)"	"unprognostic (9.74e-2)"	"unprognostic (1.86e-1)"	"unprognostic (1.87e-1)"	"unprognostic (3.60e-2)"	24.7	21.0	14.0	17.9	23.1	12.4	19.8	25.5	29.9	21.3	23.4	17.2	15.3	17.4	28.8	16.8	26.8	18.8	24.8	31.8	14.4	13.8	21.2	30.5	16.7	16.7	14.5	15.1	20.7	22.1	29.6	20.3	21.3	22.3	19.0	21.0	20.2	31.7	21.5	51.2	21.2	23.9	25.7	16.1	20.5	21.8	35.9	11.1	20.3	15.6	24.5	24.4	23.1	19.1	2.5	4.0	2.1	4.6	3.7	6.6	2.9	22.8	18.2	11.7	23.3	21.0	22.1	12.9	25.3	21.9	21.4	21.7	16.3	19.1	12.4	22.5	27.9	27.9	14.5	18.1	23.3	25.4	22.5	16.6	12.6	12.7	11.7	20.9	18.8	18.5	19.5	21.6	23.7	19.7	16.3	24.9	10.4	18.3	13.8	30.2	20.0	18.4	11.9	18.5	20.5	21.9	10.6	13.1	25.4	22.1	25.2	18.7	19.3	24.9	21.5	18.5	13.6	11.1	13.2	22.3	27.0	5.8	66.1	31.3	13.9	13.9	12.5	31.0	28.1	30.8	0.5	3.5	2.1	4.8	4.6	6.6	2.5	5.2	5.2	4.0	2.5	4.9	5.9	1.3	3.7	4.5	3.6	5.2	2.9	14.0	23.1	25.5	29.9	14.4	13.8	14.5	15.1	22.3	11.1	20.8	19.5	9.7	13.9	24.5	31.4	31.5	28.1	16.0	9.1	24.4	62.8	12.2	8.3	17.0	8.4	19.9	22.1	0.0	15.2	14.4	14.7	19.9	9.2	39.2	13.9	30.2	23.5	24.5	21.2	8.5	14.4	15.0	5.0	12.6	20.6	10.9	22.5	10.5	24.1	16.5	42.8	0.0	17.6	20.4	27.4	29.1	12.6	13.8	22.4	27.3
UBE3D	"C6orf157, DKFZp434A1520, H10BH, UBE2CBP, YJR141W"	ENSG00000118420	"Ubiquitin protein ligase E3D"	Q7Z6J8	6	82892398-83065841	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Ciliated cells: 40.2;Cone photoreceptor cells: 33.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA027231	Uncertain		Approved	"Rods & Rings"		NA	NA			"Rods & Rings"		"HPA027231: AB_2256689"	"unprognostic (1.91e-1)"	"unprognostic (3.60e-2)"	"unprognostic (5.05e-2)"	"unprognostic (6.17e-3)"	"unprognostic (2.91e-3)"	"unprognostic (5.03e-2)"	"unprognostic (2.39e-5)"	"unprognostic (6.93e-2)"	"unprognostic (2.08e-1)"	"unprognostic (2.70e-2)"	"unprognostic (3.48e-3)"	"unprognostic (1.14e-1)"	"unprognostic (1.47e-1)"	"unprognostic (4.26e-1)"	"unprognostic (1.78e-1)"	"unprognostic (1.58e-2)"	"unprognostic (3.18e-1)"	4.6	9.0	6.3	6.2	9.5	3.0	8.7	13.1	10.6	6.7	5.5	6.0	4.9	7.5	6.9	5.0	6.7	14.0	5.1	5.4	6.1	9.1	7.9	4.9	4.1	7.6	7.4	7.2	8.0	10.1	8.9	11.0	4.2	5.9	4.1	6.8	6.4	6.5	5.6	8.8	4.1	4.2	8.7	5.8	8.2	6.3	3.7	7.7	4.5	10.0	5.2	7.8	8.6	6.0	6.6	3.1	0.3	2.7	1.3	8.2	3.2	2.7	3.8	3.8	3.5	3.1	5.0	3.0	3.0	3.7	3.8	6.5	5.5	1.5	12.6	4.6	1.8	6.6	2.9	7.3	3.6	6.0	5.3	16.6	7.3	2.1	6.0	4.2	6.2	3.6	3.9	5.1	4.1	5.0	2.8	4.9	6.9	10.4	5.8	3.2	3.1	3.8	7.9	4.7	10.0	6.2	5.8	8.6	5.0	7.2	3.7	6.8	4.2	1.7	4.3	2.6	5.3	2.7	4.5	1.5	1.7	4.5	3.6	7.2	6.4	12.8	4.3	2.8	11.5	3.4	0.0	1.0	0.3	4.7	2.7	6.1	6.6	5.2	3.7	3.1	4.4	5.6	8.2	0.0	1.3	1.2	2.3	5.2	3.2	6.3	9.5	13.1	10.6	6.1	9.1	7.4	7.2	5.9	7.7	6.0	5.4	9.3	4.8	5.6	11.1	2.4	2.5	40.2	4.5	7.0	33.4	5.9	1.7	4.6	1.5	5.2	2.0	0.0	4.0	4.1	6.2	2.7	1.1	2.4	4.4	6.4	7.5	4.3	3.2	0.8	6.4	3.6	6.8	0.0	5.2	5.1	3.7	6.2	3.9	4.2	15.7	6.5	3.6	5.9	15.9	5.9	2.5	4.4	6.6	3.4
UBE4A	"E4, KIAA0126, UBOX2, UFD2"	ENSG00000110344	"Ubiquitination factor E4A"	Q14139	11	118359585-118399211	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA055035, HPA064010"	Approved		Supported	"Nuclear speckles"		NA	NA			"Nuclear speckles"		"HPA055035: AB_2682679, HPA064010: AB_2685174"	"unprognostic (1.32e-2)"	"unprognostic (8.15e-2)"	"unprognostic (5.23e-3)"	"unprognostic (3.34e-1)"	"unprognostic (2.80e-2)"	"unprognostic (1.97e-1)"	"unprognostic (7.67e-3)"	"unprognostic (3.31e-1)"	"unprognostic (1.30e-1)"	"unprognostic (4.67e-2)"	"unprognostic (6.01e-2)"	"unprognostic (5.83e-2)"	"unprognostic (7.73e-3)"	"unprognostic (4.74e-2)"	"unprognostic (5.94e-2)"	"unprognostic (2.72e-1)"	"unprognostic (8.86e-2)"	19.3	18.5	17.7	20.5	30.1	16.6	19.7	49.4	36.6	19.0	18.5	33.0	16.1	20.3	23.2	21.2	21.2	19.8	17.0	20.3	17.7	18.8	20.3	29.5	18.4	22.2	25.7	25.7	24.2	26.7	31.1	24.2	18.6	35.5	21.5	23.1	21.2	20.3	17.2	32.5	25.6	23.7	19.9	25.5	24.0	25.5	21.8	27.5	22.1	22.1	15.1	22.6	21.6	20.4	5.7	11.0	14.6	13.2	7.1	9.0	5.2	9.3	9.1	11.7	11.6	20.3	18.8	11.6	13.9	14.5	10.3	12.6	25.1	23.0	19.7	26.8	17.4	13.9	20.7	16.4	13.1	17.2	11.1	7.6	32.3	8.1	12.8	17.5	18.2	24.8	18.9	9.5	21.1	20.7	13.8	17.1	17.4	18.3	18.6	14.8	17.6	15.5	18.2	10.8	18.9	11.7	9.9	16.9	20.1	11.3	21.9	10.6	11.1	20.0	17.4	6.1	13.3	23.2	8.3	17.6	15.3	10.1	13.0	11.5	5.5	6.7	18.8	8.5	21.1	15.7	14.6	10.9	10.5	9.0	12.0	6.9	5.7	6.9	6.4	11.0	4.3	7.4	6.6	11.0	7.1	13.2	6.5	7.7	5.2	17.7	30.1	49.4	36.6	17.7	18.8	25.7	25.7	35.5	27.5	11.9	26.4	13.7	19.3	23.8	18.0	14.9	15.3	37.5	22.7	14.0	17.7	16.7	5.0	16.7	12.4	18.0	17.7	23.3	24.6	14.8	17.7	22.8	10.4	40.3	19.1	15.9	17.9	20.3	28.8	11.0	15.8	24.1	23.6	16.2	19.6	21.4	21.8	17.5	20.1	10.2	16.0	19.4	18.4	31.7	19.8	34.4	20.7	21.8	19.8	23.0
UBE4B	"E4, KIAA0684, UBOX3, UFD2"	ENSG00000130939	"Ubiquitination factor E4B"	O95155	1	10032832-10181239	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA019219	Approved					NA	NA					"HPA019219: AB_1858554"	"unprognostic (5.32e-2)"	"unprognostic (1.56e-1)"	"unprognostic (3.74e-2)"	"unprognostic (5.46e-2)"	"unprognostic (7.19e-2)"	"unprognostic (4.39e-2)"	"prognostic unfavorable (3.69e-5)"	"unprognostic (2.53e-1)"	"unprognostic (9.72e-2)"	"unprognostic (1.12e-1)"	"unprognostic (4.26e-1)"	"unprognostic (3.10e-1)"	"unprognostic (1.86e-3)"	"unprognostic (2.99e-1)"	"unprognostic (3.99e-1)"	"unprognostic (1.35e-1)"	"unprognostic (1.76e-3)"	11.8	18.6	16.4	11.5	20.2	16.5	12.7	27.1	24.2	17.5	19.3	26.5	12.6	15.1	16.7	12.8	20.4	14.1	11.3	22.5	18.9	17.3	13.0	13.9	10.5	11.3	18.5	15.0	22.8	20.4	24.3	15.3	18.3	23.6	14.5	12.8	18.2	12.0	12.7	43.5	24.3	14.5	16.6	16.3	13.0	15.1	8.6	21.4	15.7	19.7	11.2	13.6	16.8	12.0	6.0	6.7	9.4	7.9	2.9	9.8	5.3	21.7	13.9	17.1	18.9	22.8	30.1	13.5	14.3	18.1	14.0	14.5	15.0	25.4	18.7	17.4	25.4	11.1	16.1	21.5	16.5	16.7	19.1	12.0	20.2	24.3	17.6	17.3	21.0	14.4	24.7	15.0	18.9	16.1	26.6	20.7	13.7	34.5	24.9	13.0	11.3	13.5	10.3	22.9	14.1	11.6	13.3	17.0	20.1	14.2	9.9	21.0	16.1	22.5	16.1	29.7	19.1	12.3	15.5	17.8	12.6	19.5	15.5	11.7	11.4	15.4	21.7	18.5	24.4	15.9	4.2	7.9	3.6	5.3	6.0	8.8	6.0	8.8	8.5	6.7	5.6	8.0	6.5	9.4	2.9	4.4	3.2	9.8	5.3	16.4	20.2	27.1	24.2	18.9	17.3	18.5	15.0	23.6	21.4	20.8	20.0	17.1	11.5	15.7	13.3	33.5	15.3	13.4	11.4	8.7	23.6	28.0	8.3	10.9	2.4	13.5	13.1	23.3	12.7	11.4	17.5	19.5	5.8	15.3	14.9	15.9	15.6	16.5	22.1	3.1	10.3	14.2	5.0	9.0	16.9	11.3	18.3	13.9	8.1	8.6	34.6	19.4	11.2	6.6	12.4	19.6	17.2	13.1	17.9	12.2
UBLCP1	"CPUB1, MGC10067"	ENSG00000164332	"Ubiquitin like domain containing CTD phosphatase 1"	Q8WVY7	5	159263081-159286040	"Enzymes, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039615	Approved		Supported	"Nucleoplasm,Nucleoli,Nucleoli rim"		NA	NA			"Nucleoplasm, Nucleoli, Nucleoli rim"		"HPA039615: AB_10674425"	"unprognostic (1.25e-1)"	"unprognostic (3.10e-1)"	"unprognostic (6.04e-3)"	"unprognostic (3.45e-2)"	"unprognostic (7.08e-2)"	"unprognostic (6.82e-2)"	"prognostic unfavorable (4.46e-5)"	"unprognostic (4.01e-1)"	"unprognostic (2.14e-2)"	"unprognostic (1.98e-1)"	"unprognostic (1.91e-2)"	"unprognostic (5.43e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.87e-1)"	"unprognostic (1.18e-1)"	"unprognostic (6.39e-2)"	"unprognostic (2.51e-2)"	17.1	16.0	16.7	18.4	19.7	16.7	16.3	20.2	33.0	18.5	12.5	12.2	11.4	9.8	22.5	13.1	22.2	14.7	14.5	13.1	20.9	19.1	17.5	14.4	17.8	24.1	19.7	22.7	16.8	12.6	18.0	23.9	19.6	36.7	14.7	14.7	10.9	15.4	17.6	15.3	14.2	13.8	19.5	20.4	22.2	13.3	24.2	15.4	26.8	14.4	16.1	30.1	18.8	16.8	11.9	10.8	21.9	13.9	25.5	19.2	8.2	14.6	10.7	22.2	24.1	23.1	21.4	13.1	16.0	24.5	16.5	22.0	8.7	10.2	13.1	17.7	20.0	23.7	11.2	13.7	30.8	28.8	26.2	13.5	10.1	9.4	7.9	29.2	22.8	15.9	18.9	28.9	14.9	29.9	13.2	15.6	13.9	13.8	17.8	22.9	4.7	12.3	6.9	15.4	7.3	6.5	15.7	21.8	15.3	16.3	11.3	11.8	15.7	16.2	10.8	37.7	14.0	11.4	15.2	16.7	17.0	14.2	8.8	20.2	14.3	14.3	20.0	18.0	15.8	25.1	21.9	6.5	16.1	16.6	13.5	18.6	11.9	15.8	17.3	8.5	10.9	18.5	19.2	19.4	25.5	13.9	10.8	16.9	8.2	16.7	19.7	20.2	33.0	20.9	19.1	19.7	22.7	36.7	15.4	11.9	38.2	22.7	8.2	14.2	9.9	12.2	10.2	34.8	30.7	14.0	3.9	27.7	29.9	18.9	3.4	20.0	9.5	46.7	21.7	14.9	21.7	11.4	43.9	14.0	33.1	19.1	10.3	30.7	42.1	2.2	19.0	27.8	16.9	25.2	14.0	17.9	18.8	8.6	23.3	23.8	13.4	19.4	14.4	70.2	48.5	18.1	14.9	21.7	13.9	7.9
UBOX5	"KIAA0860, RNF37, Ubce7ip5, UIP5"	ENSG00000185019	"U-box domain containing 5"	O94941	20	3107573-3160196	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA028871	Approved		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA028871: AB_10603140"	"unprognostic (4.11e-2)"	"unprognostic (2.01e-2)"	"unprognostic (1.77e-1)"	"unprognostic (1.04e-1)"	"unprognostic (2.18e-1)"	"prognostic favorable (4.52e-5)"	"unprognostic (2.58e-2)"	"unprognostic (1.02e-1)"	"unprognostic (3.11e-2)"	"unprognostic (1.61e-1)"	"prognostic favorable (1.80e-5)"	"unprognostic (4.02e-2)"	"unprognostic (9.71e-3)"	"unprognostic (3.33e-1)"	"unprognostic (5.58e-2)"	"unprognostic (1.07e-2)"	"unprognostic (1.61e-2)"	10.1	9.9	9.6	10.0	13.0	17.7	15.4	14.9	16.3	11.6	12.7	12.3	9.0	8.6	14.1	8.8	11.2	13.9	8.8	10.8	10.0	9.1	13.7	12.2	10.1	19.6	10.0	10.2	15.2	17.8	12.8	11.6	11.1	11.9	11.8	8.8	9.5	13.2	13.6	34.1	16.3	10.7	12.2	7.9	10.4	10.8	15.1	9.3	14.9	10.4	11.1	11.5	12.8	9.7	8.7	7.0	11.4	7.0	7.5	8.4	5.5	6.3	6.5	5.2	3.3	6.8	3.8	2.7	5.4	4.9	6.5	6.5	6.1	5.5	4.8	2.1	4.5	7.5	8.8	3.4	8.1	4.0	1.4	2.9	8.3	2.0	5.7	5.5	3.5	3.3	4.9	6.1	5.2	6.7	5.3	4.2	4.0	6.8	4.7	3.8	4.2	7.1	5.2	4.0	6.7	3.9	4.8	6.5	3.4	4.1	6.6	6.4	6.2	3.4	20.0	4.2	4.2	8.5	2.6	4.7	4.4	2.8	4.8	4.3	6.4	9.3	4.3	2.4	3.6	3.1	11.1	7.0	11.4	7.1	7.0	7.3	8.7	8.0	5.8	7.0	6.8	8.4	8.1	11.4	7.5	5.9	5.6	7.6	5.5	9.6	13.0	14.9	16.3	10.0	9.1	10.0	10.2	11.9	9.3	11.9	5.9	4.4	3.4	1.6	6.8	1.0	2.5	1.4	2.3	0.0	5.9	6.2	0.0	3.2	1.1	2.2	4.0	0.0	3.7	3.3	3.3	4.1	2.3	3.8	4.3	6.4	9.8	6.2	4.8	1.2	6.4	2.9	3.3	5.4	5.1	3.9	3.6	3.5	3.5	4.4	4.7	6.5	2.0	8.6	4.2	2.0	8.5	2.9	5.0	5.6
UBR1		ENSG00000159459	"Ubiquitin protein ligase E3 component n-recognin 1"	Q8IWV7	15	42942897-43106113	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Ubl conjugation pathway"	Transferase	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038838, HPA038839"	Approved		Approved	Nucleoplasm,Vesicles,Cytosol		NA	NA			Vesicles	"Nucleoplasm, Cytosol"	"HPA038838: AB_10673120, HPA038839: "	"unprognostic (1.07e-2)"	"unprognostic (5.02e-2)"	"unprognostic (9.77e-2)"	"unprognostic (1.55e-2)"	"unprognostic (1.89e-2)"	"unprognostic (1.29e-1)"	"unprognostic (2.67e-1)"	"unprognostic (1.49e-1)"	"unprognostic (4.79e-1)"	"unprognostic (2.97e-2)"	"unprognostic (1.93e-2)"	"unprognostic (1.79e-1)"	"unprognostic (1.27e-3)"	"unprognostic (5.78e-2)"	"unprognostic (1.52e-1)"	"unprognostic (2.00e-1)"	"unprognostic (1.89e-1)"	16.7	13.2	13.7	18.3	16.7	28.4	18.8	21.8	18.1	18.2	16.2	14.8	10.5	11.3	21.0	12.9	10.8	15.9	14.2	19.7	10.0	15.4	14.4	10.6	16.6	14.9	11.8	10.5	16.3	16.4	26.3	25.6	16.2	18.9	15.3	12.9	12.5	11.8	16.8	23.6	11.0	14.4	18.2	12.1	14.7	13.8	13.7	14.7	23.2	18.8	9.7	14.3	17.3	19.7	4.6	5.0	5.5	4.2	6.2	7.2	1.8	5.0	7.3	8.4	6.9	13.4	10.4	8.0	12.4	13.6	10.9	14.1	9.3	3.9	5.9	7.3	12.6	13.7	8.8	12.2	10.8	13.0	12.1	5.9	23.3	14.7	4.5	9.3	16.4	11.2	11.2	6.1	13.4	10.9	10.7	12.3	12.0	13.3	9.0	13.5	2.8	8.8	4.9	4.8	13.4	7.6	11.7	11.6	5.1	11.0	11.9	8.6	7.6	16.2	8.6	5.7	10.2	8.3	8.6	16.8	13.5	8.3	12.0	12.5	10.6	18.0	17.1	9.2	10.4	12.1	4.4	3.0	5.2	5.7	4.2	6.5	4.1	5.9	6.9	2.9	4.6	5.9	7.2	5.5	6.2	3.4	5.0	4.1	1.8	13.7	16.7	21.8	18.1	10.0	15.4	11.8	10.5	18.9	14.7	44.7	27.8	14.6	10.3	9.4	26.8	24.5	17.8	17.4	25.0	8.7	25.5	10.4	0.0	8.8	11.6	17.9	10.8	0.0	12.5	6.2	15.0	9.4	27.7	8.5	7.3	30.2	13.8	14.7	16.2	13.2	15.0	10.5	8.5	10.0	10.0	15.6	8.9	9.1	19.4	6.7	39.2	12.9	19.1	25.3	14.9	6.4	30.9	20.8	10.0	7.4
UBR2	"bA49A4.1, C6orf133, dJ392M17.3, KIAA0349"	ENSG00000024048	"Ubiquitin protein ligase E3 component n-recognin 2"	Q8IWV8	6	42564062-42693504	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	4	"Erythroid cells: 93.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"neutrophil: 25.2"	"Lineage enriched"	"Detected in all"	4	"granulocytes: 25.2"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027869, HPA027880"	Approved		Approved	"Nucleoplasm,Plasma membrane"		NA	NA			Nucleoplasm	"Plasma membrane"	"HPA027869: AB_10600416, HPA027880: AB_10601217"	"unprognostic (3.26e-1)"	"unprognostic (1.29e-1)"	"unprognostic (8.33e-2)"	"unprognostic (2.95e-2)"	"unprognostic (1.08e-2)"	"unprognostic (4.23e-2)"	"unprognostic (1.32e-1)"	"unprognostic (7.24e-2)"	"unprognostic (5.05e-2)"	"prognostic favorable (1.65e-4)"	"unprognostic (1.12e-1)"	"unprognostic (7.53e-2)"	"unprognostic (1.30e-2)"	"unprognostic (3.88e-1)"	"unprognostic (1.81e-1)"	"unprognostic (5.78e-2)"	"unprognostic (7.77e-3)"	19.8	18.8	14.4	21.8	16.7	22.1	18.6	26.6	20.4	17.2	19.3	17.8	17.8	20.1	29.5	16.8	16.2	15.6	16.2	16.8	13.8	13.2	17.8	24.0	19.3	18.0	16.7	12.9	20.8	24.6	28.0	26.3	16.3	17.2	16.5	20.1	15.8	18.3	15.6	33.5	18.0	24.6	19.9	15.9	21.3	18.2	9.2	17.2	26.1	20.1	14.9	17.7	18.9	29.8	3.6	3.5	25.2	5.7	3.9	4.4	1.9	14.4	7.3	8.5	13.3	17.5	16.9	11.5	11.1	12.0	9.9	10.3	10.5	6.0	9.9	8.9	12.0	11.5	14.6	12.2	9.5	12.6	13.3	8.6	15.7	10.8	13.6	14.2	15.1	10.8	11.9	10.4	9.8	10.8	12.2	11.1	14.4	18.3	12.6	9.4	11.6	11.8	13.4	7.7	28.5	7.1	10.6	12.7	14.8	11.3	12.6	10.1	8.0	11.2	10.8	10.9	13.5	10.6	14.7	16.0	9.0	7.1	11.0	8.0	11.7	10.3	15.3	4.7	11.4	5.4	10.4	4.6	9.2	4.4	4.8	3.7	3.4	2.9	3.4	3.5	3.6	3.0	3.3	25.2	3.9	5.7	2.6	3.3	1.9	14.4	16.7	26.6	20.4	13.8	13.2	16.7	12.9	17.2	17.2	14.9	21.1	12.8	17.4	14.7	41.6	32.9	22.9	25.4	22.7	19.2	56.9	14.8	14.9	14.7	4.6	21.1	31.4	93.5	13.2	11.0	18.8	19.9	19.7	28.1	12.0	60.4	12.1	18.4	28.9	3.9	23.6	24.6	18.6	17.2	19.6	23.5	14.1	22.9	22.6	9.6	50.0	38.8	23.4	9.2	8.1	14.2	14.4	32.0	18.0	18.7
UBR3	"DKFZp434P117, FLJ37422, KIAA2024, ZNF650"	ENSG00000144357	"Ubiquitin protein ligase E3 component n-recognin 3 (putative)"	Q6ZT12	2	169827458-170084131	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 76.3"	"Cell type enhanced"	"Detected in all"	4	"Cardiomyocytes: 97.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA035390	Approved		Approved	Nucleoplasm,Nucleoli		NA	NA			"Nucleoplasm, Nucleoli"		"HPA035390: AB_10670699"	"unprognostic (1.35e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.59e-2)"	"unprognostic (1.27e-1)"	"unprognostic (2.07e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.00e-1)"	"unprognostic (3.91e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.24e-1)"	"unprognostic (1.76e-1)"	"unprognostic (1.26e-1)"	"unprognostic (3.19e-2)"	"unprognostic (5.56e-2)"	"unprognostic (2.01e-1)"	"unprognostic (3.38e-1)"	"unprognostic (2.18e-1)"	11.9	15.5	10.9	6.1	18.3	5.4	9.6	15.5	18.9	9.9	10.0	9.8	9.1	6.7	11.5	7.1	10.7	8.1	7.8	23.1	10.3	7.2	12.9	16.9	9.2	5.6	11.9	14.0	8.9	9.8	20.9	14.9	7.2	14.7	11.2	7.3	8.0	11.1	9.2	76.3	11.5	8.4	9.6	10.2	6.9	9.2	7.9	11.4	6.3	14.9	10.9	6.0	12.8	8.7	2.0	2.8	1.9	2.1	2.4	4.3	1.2	8.9	7.6	8.1	10.7	16.2	12.9	6.8	16.2	9.4	9.4	7.6	11.7	5.7	10.2	14.1	12.6	7.6	11.9	9.7	8.2	11.7	10.5	8.3	37.1	8.1	12.3	8.1	12.2	12.0	7.7	7.7	12.3	8.2	7.5	9.2	5.1	19.3	11.1	16.0	8.4	7.9	6.0	6.3	9.1	6.4	7.6	13.3	10.8	6.8	12.7	16.0	8.7	11.4	10.5	6.5	6.8	6.9	6.9	11.7	14.2	5.7	11.1	10.2	9.0	7.0	9.4	11.7	7.2	7.8	0.0	2.1	1.7	3.2	1.8	4.2	2.0	1.9	2.7	2.8	1.2	3.3	4.3	1.9	2.4	1.6	2.4	3.1	1.2	10.9	18.3	15.5	18.6	10.3	7.2	11.9	14.0	14.7	11.4	41.7	21.1	7.5	11.4	23.0	40.4	97.6	15.3	9.4	19.4	12.2	76.6	14.8	3.3	8.0	6.6	23.7	13.4	23.3	9.5	6.8	18.3	22.3	16.1	32.7	8.9	60.4	16.0	31.9	21.5	7.4	23.9	16.8	15.1	4.6	12.5	63.3	9.4	14.0	18.0	10.2	53.7	25.8	26.4	13.0	7.6	25.3	19.2	13.1	9.9	12.3
UBR4	"KIAA0462, KIAA1307, RBAF600, ZUBR1"	ENSG00000127481	"Ubiquitin protein ligase E3 component n-recognin 4"	Q5T4S7	1	19074506-19210276	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Host-virus interaction, Ubl conjugation pathway"	"Calmodulin-binding, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	5	"Basal keratinocytes: 240.8;Suprabasal keratinocytes: 220.9;Urothelial cells: 215.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA013394, HPA021046"	Approved		Supported	Nucleoplasm,Centrosome,Cytosol		NA	NA			Nucleoplasm	"Centrosome, Cytosol"	"HPA013394: , HPA021046: AB_1858578"	"unprognostic (1.37e-1)"	"unprognostic (2.57e-2)"	"unprognostic (2.82e-2)"	"unprognostic (2.02e-1)"	"unprognostic (8.78e-2)"	"unprognostic (9.77e-2)"	"unprognostic (1.14e-3)"	"unprognostic (3.09e-1)"	"unprognostic (1.96e-1)"	"unprognostic (9.14e-3)"	"unprognostic (7.48e-2)"	"unprognostic (2.53e-1)"	"unprognostic (7.68e-3)"	"unprognostic (4.30e-1)"	"unprognostic (1.19e-1)"	"unprognostic (5.58e-2)"	"unprognostic (1.52e-1)"	24.4	25.4	22.4	29.0	25.4	58.3	23.7	28.5	32.5	22.4	28.5	26.3	31.5	18.2	34.0	32.5	22.7	20.3	27.3	20.5	23.3	15.9	25.5	29.7	31.2	20.3	21.0	20.9	35.5	21.0	40.9	31.4	28.4	25.0	30.7	20.5	30.6	24.7	27.1	55.9	69.0	25.5	39.3	20.2	26.5	30.2	41.1	21.6	37.7	26.1	17.3	25.9	43.4	29.0	4.6	9.1	18.3	18.5	2.7	3.4	4.6	22.2	22.5	20.4	15.0	38.1	19.7	17.6	17.3	18.4	18.9	17.3	35.9	19.2	13.4	16.3	22.9	16.6	15.3	15.9	17.3	17.7	11.1	14.1	30.7	21.7	23.3	26.9	18.8	20.4	17.6	22.2	38.5	37.2	18.5	20.7	23.9	21.0	12.5	17.9	15.9	8.9	22.9	16.5	45.7	12.7	12.4	15.9	11.2	17.1	13.1	14.4	14.3	20.5	11.8	14.8	19.5	8.2	14.8	32.0	22.2	13.9	26.2	19.4	14.9	9.0	15.6	15.2	29.1	18.8	18.3	18.5	2.9	3.4	3.8	2.9	4.6	3.0	1.9	9.1	2.9	2.7	2.5	9.8	2.7	1.3	4.3	2.1	4.6	22.4	25.4	28.5	32.5	23.3	15.9	21.0	20.9	25.0	21.6	32.8	42.3	16.3	79.1	240.8	54.0	15.6	40.8	30.8	26.1	29.6	143.3	19.2	11.6	31.4	14.7	21.1	36.4	23.3	35.5	14.1	29.1	39.1	18.5	77.9	54.8	74.7	16.8	28.8	47.4	19.9	28.4	42.8	47.2	36.1	30.4	30.7	51.2	14.0	33.6	88.2	48.0	19.4	26.8	37.4	17.9	220.9	28.4	21.0	19.5	215.5
UBR5	"DD5, EDD, EDD1, HYD, KIAA0896"	ENSG00000104517	"Ubiquitin protein ligase E3 component n-recognin 5"	O95071	8	102253012-102412841	"Cancer-related genes, Enzymes, Predicted intracellular proteins"	"DNA damage, DNA repair, Host-virus interaction, Ubl conjugation pathway"	Transferase	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA053688			Supported	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA053688: AB_2682230"	"unprognostic (3.79e-3)"	"unprognostic (7.44e-3)"	"unprognostic (1.25e-1)"	"unprognostic (2.10e-2)"	"unprognostic (2.44e-2)"	"unprognostic (1.41e-1)"	"prognostic unfavorable (1.26e-4)"	"unprognostic (2.50e-1)"	"unprognostic (1.75e-2)"	"unprognostic (7.54e-3)"	"unprognostic (8.29e-3)"	"unprognostic (3.84e-2)"	"unprognostic (6.64e-2)"	"unprognostic (3.16e-1)"	"unprognostic (1.94e-1)"	"unprognostic (1.69e-2)"	"unprognostic (2.45e-1)"	27.0	16.7	27.1	29.5	31.7	30.3	29.2	40.8	32.8	24.9	25.0	19.1	21.1	14.4	26.8	24.0	23.8	22.0	17.6	22.7	25.5	15.3	17.9	17.0	24.2	29.6	21.9	20.6	29.7	22.2	32.4	25.5	25.0	23.6	20.2	17.1	19.7	22.9	21.8	39.9	29.7	22.4	29.3	17.5	21.9	21.1	39.7	28.3	37.9	20.3	15.9	27.0	27.5	28.6	5.0	4.0	6.3	5.5	2.4	7.1	2.1	23.6	10.6	20.5	10.4	20.2	20.6	18.9	17.9	15.8	14.0	12.3	10.6	15.9	47.1	15.5	16.7	9.2	14.4	17.5	15.5	19.7	20.4	8.6	39.3	14.5	19.0	18.0	12.2	21.7	23.6	15.5	14.4	25.2	16.0	16.8	13.5	18.9	26.8	13.7	21.4	31.0	14.6	15.4	22.9	12.0	18.1	12.1	22.3	12.8	23.2	15.1	12.6	12.5	12.1	12.4	18.6	19.6	13.0	16.8	15.0	17.5	13.4	12.4	14.4	13.8	48.5	14.8	19.1	12.1	3.1	3.4	5.0	5.6	3.4	5.6	5.0	6.0	5.9	4.0	3.9	4.8	7.1	6.3	2.4	5.5	3.6	7.1	2.1	27.1	31.7	40.8	32.8	25.5	15.3	21.9	20.6	23.6	28.3	23.8	27.7	29.8	38.5	46.4	48.4	35.8	5.1	40.2	63.7	29.6	64.8	19.1	8.3	15.1	25.0	38.3	17.3	0.0	13.1	14.9	48.2	37.7	28.9	15.8	15.4	54.0	32.0	23.4	29.4	20.2	36.8	28.9	42.2	27.1	17.9	31.5	16.2	17.3	34.3	6.7	44.0	12.9	38.7	64.7	30.4	53.3	58.2	30.5	17.7	46.9
UBR7	C14orf130	ENSG00000012963	"Ubiquitin protein ligase E3 component n-recognin 7 (putative)"	Q8N806	14	93207056-93229215	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in all"	7	"Early spermatids: 246.4;Late spermatids: 271.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA000861	Approved		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA000861: AB_1078321"	"unprognostic (9.60e-2)"	"unprognostic (5.12e-3)"	"unprognostic (1.11e-1)"	"unprognostic (9.20e-2)"	"unprognostic (3.30e-1)"	"unprognostic (2.12e-1)"	"prognostic unfavorable (8.12e-5)"	"unprognostic (1.14e-1)"	"unprognostic (9.83e-2)"	"unprognostic (1.04e-2)"	"unprognostic (4.30e-2)"	"unprognostic (5.94e-2)"	"prognostic favorable (9.76e-5)"	"unprognostic (3.61e-2)"	"unprognostic (2.91e-1)"	"unprognostic (2.86e-1)"	"unprognostic (1.78e-1)"	14.1	12.3	16.4	12.5	22.9	17.0	17.5	20.0	25.8	17.1	15.7	17.7	11.3	11.1	14.9	13.4	14.8	13.7	11.9	19.0	14.2	12.8	15.3	13.2	11.9	18.0	14.0	17.1	17.0	20.4	28.2	11.5	11.4	13.3	13.9	17.1	13.6	13.7	14.9	19.9	15.2	12.7	14.1	16.9	13.8	14.1	21.1	14.3	31.9	15.4	12.9	23.3	13.4	13.3	18.1	10.7	15.8	9.5	11.5	16.5	8.2	6.5	8.7	13.5	11.2	6.3	6.8	4.8	13.8	9.8	15.4	11.7	6.3	7.4	15.5	11.6	7.0	6.7	7.9	14.4	7.7	15.8	12.0	7.8	11.2	9.4	6.0	2.9	16.4	12.6	4.1	5.4	8.5	5.4	5.7	8.6	14.9	10.4	15.6	14.7	19.1	26.6	9.0	6.2	17.2	15.9	20.5	24.1	8.5	5.2	10.7	16.9	12.1	9.9	8.3	4.1	8.3	15.0	11.3	6.5	11.3	6.1	9.7	14.2	18.1	27.7	16.0	9.9	12.7	9.6	15.8	7.3	11.8	12.7	9.1	13.3	18.1	11.4	11.7	7.8	14.8	10.0	10.6	11.5	11.5	9.5	10.7	16.5	8.2	16.4	22.9	20.0	25.8	14.2	12.8	14.0	17.1	13.3	14.3	14.9	5.4	14.3	6.6	17.6	5.8	15.3	10.2	2.7	10.3	10.4	9.8	7.8	10.0	8.8	246.4	8.2	9.2	23.3	11.2	13.2	10.2	4.3	4.7	10.4	11.8	3.2	5.2	14.1	10.1	271.2	8.6	8.5	13.5	7.2	7.6	12.6	8.2	5.8	11.7	7.0	13.4	6.5	10.7	34.9	27.7	11.8	5.5	10.7	10.7	3.3
UCHL1	"PARK5, PGP9.5, Uch-L1"	ENSG00000154277	"Ubiquitin C-terminal hydrolase L1"	P09936	4	41256413-41268455	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"	"Disease mutation, Hereditary spastic paraplegia, Neurodegeneration, Parkinson disease, Parkinsonism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"brain: 225.8"	"Cell type enhanced"	"Detected in many"	14	"Collecting duct cells: 109.9;Distal tubular cells: 218.8;Horizontal cells: 138.2;Spermatogonia: 90.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"memory B-cell: 3.6"	"Lineage enriched"	"Detected in single"	37	"B-cells: 3.6"	"Cell line enhanced"	"Detected in many"		"EFO-21: 99.0;SCLC-21H: 98.8;U-251 MG: 90.4;U-266/84: 87.2;U-87 MG: 96.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002580, HPA005993, CAB079024"	Enhanced	Supported	Supported	Nucleoplasm,Cytosol		NA	NA		440000	Cytosol	Nucleoplasm	"CAB002580: AB_563981, CAB079024: , HPA005993: AB_1858560"	"unprognostic (1.54e-1)"	"unprognostic (1.96e-1)"	"unprognostic (1.12e-1)"	"prognostic unfavorable (4.08e-5)"	"unprognostic (2.34e-1)"	"unprognostic (1.98e-1)"	"unprognostic (6.28e-3)"	"unprognostic (1.09e-2)"	"unprognostic (4.31e-2)"	"unprognostic (8.77e-3)"	"unprognostic (3.56e-3)"	"unprognostic (3.70e-2)"	"unprognostic (1.82e-3)"	"unprognostic (1.24e-2)"	"unprognostic (7.12e-3)"	"unprognostic (2.10e-2)"	"prognostic unfavorable (1.93e-4)"	8.2	40.2	52.4	8.9	65.1	2.0	3.1	17.5	225.8	4.5	6.3	11.5	0.0	5.5	6.0	1.8	2.7	5.7	6.5	5.4	53.4	97.4	14.0	2.0	2.7	6.5	62.0	57.1	15.4	6.3	1.8	30.5	2.7	100.6	5.3	4.7	6.0	3.0	4.4	7.5	2.7	8.6	5.2	38.6	2.3	2.8	8.0	8.3	0.0	3.9	0.0	4.5	5.6	2.8	3.6	0.0	0.0	0.0	0.0	0.0	0.6	0.2	56.1	11.6	0.0	1.5	1.9	0.0	58.7	30.3	20.8	21.0	11.3	0.0	0.0	99.0	29.9	31.4	0.1	21.4	0.0	8.5	0.1	8.7	0.0	0.3	0.0	44.9	0.0	0.0	10.8	0.2	16.7	0.0	34.7	0.1	0.0	0.0	0.2	11.0	0.0	0.0	0.9	33.6	0.0	63.4	0.0	24.8	0.0	31.4	0.0	98.8	62.0	0.3	0.2	0.2	13.9	0.0	0.5	0.3	1.3	0.4	0.0	90.4	46.4	87.2	0.2	96.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	3.6	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	52.4	65.1	17.5	92.6	53.4	97.4	62.0	57.1	100.6	8.3	0.0	1.9	0.8	0.8	1.4	19.7	2.5	0.0	12.0	5.7	109.9	7.9	2.5	218.8	3.6	2.0	2.1	0.0	0.0	0.7	0.8	15.8	2.8	2.3	0.4	4.7	138.2	4.1	11.1	0.3	4.4	34.2	1.7	3.3	1.0	0.0	22.6	4.0	0.0	16.3	7.9	39.1	0.0	7.3	6.6	90.2	1.4	1.3	0.0	0.0	0.6
UCHL3		ENSG00000118939	"Ubiquitin C-terminal hydrolase L3"	P15374	13	75549480-75606020	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"HPA019678, CAB037139, CAB037208"	Approved		Supported	Nucleoplasm,Cytosol		No	No		490000	"Nucleoplasm, Cytosol"		"CAB037139: AB_1841234, CAB037208: AB_1841235, HPA019678: AB_1858583"	"unprognostic (4.16e-1)"	"unprognostic (3.84e-2)"	"unprognostic (8.83e-3)"	"unprognostic (1.14e-1)"	"unprognostic (5.15e-2)"	"unprognostic (6.46e-3)"	"prognostic unfavorable (6.41e-4)"	"unprognostic (1.19e-1)"	"unprognostic (5.59e-2)"	"unprognostic (9.71e-2)"	"unprognostic (1.24e-1)"	"unprognostic (7.09e-2)"	"unprognostic (4.47e-2)"	"unprognostic (3.97e-1)"	"unprognostic (2.76e-2)"	"unprognostic (8.84e-2)"	"unprognostic (3.26e-2)"	13.7	39.1	23.6	11.9	37.6	17.4	21.4	17.5	18.7	10.6	21.2	11.4	12.8	12.8	9.0	40.5	37.7	8.1	12.4	15.5	20.6	12.6	20.7	36.8	10.3	12.2	18.2	13.5	7.7	20.8	9.5	28.9	26.3	14.7	12.4	25.0	6.1	24.0	14.9	31.7	28.8	15.0	16.9	13.3	15.3	14.5	24.6	18.6	18.9	28.1	29.8	20.2	16.0	16.2	17.4	46.0	15.8	43.5	20.5	23.4	17.3	51.7	8.7	7.6	5.2	14.2	17.0	21.9	19.6	19.5	25.6	28.7	48.0	25.2	26.8	14.2	20.6	19.5	28.6	17.7	47.7	38.9	14.3	15.5	16.9	14.4	30.6	20.5	40.3	12.7	15.0	33.1	20.0	32.2	10.8	24.9	21.8	18.5	7.7	38.4	18.6	16.4	26.4	11.3	60.9	26.2	13.1	12.2	17.6	30.1	21.1	22.9	6.7	11.2	21.8	9.0	17.1	12.5	11.5	19.2	11.2	13.3	11.9	26.2	10.8	12.0	31.2	22.6	43.7	8.0	15.6	24.1	15.8	10.9	43.5	14.2	17.4	19.9	15.5	33.6	16.0	19.8	18.3	5.4	20.5	36.2	46.0	23.4	17.3	23.6	37.6	17.5	18.7	20.6	12.6	18.2	13.5	14.7	18.6	8.9	22.6	16.0	62.8	67.9	8.8	22.6	35.7	28.1	42.1	43.6	2.0	84.6	77.9	139.8	157.4	22.0	32.0	0.0	124.1	137.9	25.4	82.5	23.1	42.0	76.8	15.9	23.1	17.2	26.4	26.7	15.5	32.1	25.3	20.8	45.7	8.6	125.1	31.7	11.0	96.2	8.8	19.4	18.6	110.6	30.9	69.3	141.3	20.3	55.3	79.8
UCHL5	"CGI-70, INO80R, UCH37"	ENSG00000116750	"Ubiquitin C-terminal hydrolase L5"	Q9Y5K5	1	193012250-193060080	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"DNA damage, DNA recombination, DNA repair, Transcription, Transcription regulation, Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA005908, HPA006069"	Approved		Supported	Nucleoplasm,Nucleoli,Cytosol		NA	NA			"Nucleoplasm, Cytosol"	Nucleoli	"HPA005908: AB_1858585, HPA006069: "	"unprognostic (3.66e-2)"	"unprognostic (3.84e-3)"	"unprognostic (5.17e-2)"	"unprognostic (5.98e-2)"	"unprognostic (1.20e-2)"	"unprognostic (1.20e-1)"	"unprognostic (3.50e-2)"	"unprognostic (7.41e-2)"	"unprognostic (1.96e-2)"	"unprognostic (1.04e-3)"	"unprognostic (3.44e-3)"	"unprognostic (6.92e-2)"	"unprognostic (6.41e-3)"	"unprognostic (1.51e-1)"	"unprognostic (7.15e-2)"	"prognostic unfavorable (7.10e-5)"	"unprognostic (4.33e-2)"	15.7	18.3	20.1	16.1	26.2	16.0	18.2	30.1	34.8	10.9	17.7	11.5	12.6	19.0	12.5	14.7	26.1	10.7	11.9	22.0	21.6	20.6	21.6	28.3	12.4	19.9	21.3	29.4	13.4	24.8	15.6	16.2	17.8	33.3	17.8	18.8	10.3	19.3	12.9	29.1	16.7	18.0	13.9	20.1	17.3	14.0	9.9	17.5	20.0	15.1	19.1	23.0	14.8	14.8	22.5	20.8	23.8	21.1	35.6	30.9	20.9	33.6	18.7	16.2	16.6	9.5	9.6	19.3	19.8	10.1	19.0	16.5	17.7	22.9	26.4	19.2	11.0	11.5	20.9	21.6	25.6	25.2	27.2	15.5	31.3	24.2	23.4	15.2	49.1	17.6	8.9	11.4	27.3	24.2	8.7	18.7	26.6	68.6	21.6	16.1	27.2	36.1	18.2	15.0	23.1	11.8	21.0	18.2	51.4	17.7	19.8	16.5	20.3	17.8	25.8	27.6	17.9	21.0	24.8	12.2	17.8	5.4	18.0	31.5	16.8	26.0	29.8	10.7	30.6	30.3	23.8	16.5	19.0	28.3	19.5	30.9	22.5	25.9	26.9	19.4	18.0	28.2	30.5	10.0	35.6	21.1	20.8	24.8	20.9	20.1	26.2	30.1	34.8	21.6	20.6	21.3	29.4	33.3	17.5	8.9	24.6	13.7	12.3	21.6	18.3	68.2	15.3	26.8	29.6	26.2	41.2	31.3	38.1	21.6	1.8	20.4	19.5	0.0	24.6	27.1	16.4	17.3	53.3	22.2	24.8	23.8	10.4	18.4	20.3	3.4	13.8	24.5	16.9	19.8	18.3	25.7	20.3	7.0	16.3	30.8	41.8	19.4	17.0	14.0	16.8	26.2	21.1	27.7	20.6	10.5
UCK1	"FLJ12255, URK1"	ENSG00000130717	"Uridine-cytidine kinase 1"	Q9HA47	9	131523801-131531268	"Enzymes, Predicted intracellular proteins"		"Kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA050969, HPA070526"	Approved		Approved	Nucleoplasm,Nucleoli		NA	NA			Nucleoplasm	Nucleoli	"HPA050969: AB_2681294, HPA070526: "	"unprognostic (2.20e-1)"	"prognostic favorable (3.19e-4)"	"unprognostic (1.16e-2)"	"unprognostic (1.74e-3)"	"unprognostic (7.29e-2)"	"unprognostic (1.43e-1)"	"unprognostic (8.71e-2)"	"unprognostic (1.78e-1)"	"unprognostic (2.44e-1)"	"unprognostic (1.18e-1)"	"unprognostic (1.36e-3)"	"unprognostic (1.54e-1)"	"prognostic favorable (2.21e-7)"	"unprognostic (5.11e-2)"	"unprognostic (3.29e-2)"	"unprognostic (1.74e-1)"	"unprognostic (1.07e-1)"	13.2	15.9	21.7	13.7	22.5	13.7	15.6	29.9	23.2	15.0	15.6	17.3	20.8	11.4	12.2	19.3	14.5	17.6	16.5	21.0	19.6	18.4	18.3	26.7	12.7	12.9	20.4	19.1	21.3	24.0	17.6	14.4	16.4	14.8	14.9	9.2	17.6	24.1	18.3	30.0	12.0	12.2	14.8	19.9	12.1	13.4	15.7	15.6	12.5	18.5	10.8	11.5	13.6	9.4	7.9	6.6	9.4	7.8	6.8	13.5	6.1	7.0	15.7	18.2	23.3	12.9	9.2	15.5	11.5	17.0	20.0	15.2	15.6	6.5	7.7	7.0	13.8	15.6	13.8	16.9	14.7	8.6	14.1	15.7	7.2	23.6	9.8	18.5	11.8	10.7	10.3	13.9	16.1	11.7	12.1	12.2	19.2	9.0	5.9	14.6	28.2	16.0	6.0	21.5	13.9	15.7	15.4	28.1	12.9	12.8	6.7	24.6	15.5	16.6	12.7	17.9	8.7	24.8	7.0	8.9	22.2	11.3	13.7	11.2	12.2	15.6	9.8	11.0	8.3	15.4	2.3	6.2	9.4	8.5	7.8	11.3	7.9	10.1	7.6	5.7	7.9	13.5	6.8	4.1	6.8	2.7	6.6	12.3	6.1	21.7	22.5	29.9	23.2	19.6	18.4	20.4	19.1	14.8	15.6	14.9	5.3	14.9	10.3	12.7	17.5	12.9	7.6	0.0	3.4	14.0	7.9	26.0	24.9	19.6	15.1	13.4	17.0	0.0	22.9	12.0	15.5	11.2	2.3	19.4	22.3	25.4	11.6	11.1	11.1	20.2	16.4	8.2	15.1	27.1	11.8	17.7	15.6	11.6	18.7	23.7	10.2	19.4	18.9	29.3	29.4	10.9	21.5	9.6	11.8	7.1
UCK2	UMPK	ENSG00000143179	"Uridine-cytidine kinase 2"	Q9BZX2	1	165827531-165911618	"Enzymes, Predicted intracellular proteins"		"Kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"placenta: 65.8"	"Cell type enhanced"	"Detected in many"	8	"Early spermatids: 94.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA057128			Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA057128: AB_2683346"	"unprognostic (5.37e-2)"	"unprognostic (1.75e-2)"	"unprognostic (2.51e-1)"	"unprognostic (1.20e-2)"	"unprognostic (4.54e-2)"	"unprognostic (6.83e-3)"	"prognostic unfavorable (9.22e-8)"	"prognostic unfavorable (4.98e-4)"	"prognostic unfavorable (6.70e-4)"	"unprognostic (3.04e-2)"	"unprognostic (1.49e-1)"	"unprognostic (1.13e-2)"	"prognostic unfavorable (5.12e-13)"	"unprognostic (2.49e-3)"	"unprognostic (1.14e-1)"	"unprognostic (2.01e-3)"	"unprognostic (1.83e-1)"	12.5	7.1	6.5	11.1	8.6	11.6	17.5	16.9	9.6	9.3	18.4	8.9	11.0	15.3	10.1	15.3	20.5	8.8	9.0	9.6	6.4	6.6	6.6	14.6	11.1	10.3	10.5	6.6	7.5	17.6	7.9	9.4	65.8	11.2	8.1	19.9	5.0	16.1	9.9	20.9	15.0	24.8	10.0	8.2	7.7	13.2	7.2	7.9	13.1	6.4	12.4	12.3	9.0	11.1	3.4	14.7	0.8	5.6	3.4	3.9	2.0	25.2	26.3	14.2	12.7	7.3	12.2	23.1	27.9	20.6	29.8	34.0	24.9	27.8	12.5	19.9	17.3	12.1	20.8	26.6	32.8	26.7	22.9	22.4	14.5	22.6	25.6	18.2	28.3	11.1	11.5	16.9	56.2	35.0	7.2	19.6	24.1	38.3	18.0	26.7	18.3	25.1	18.2	38.9	35.2	25.5	11.5	15.6	42.5	13.8	16.5	21.4	25.3	19.9	39.4	19.3	28.3	24.3	27.0	20.4	16.7	23.3	18.9	29.5	24.2	36.0	46.3	14.4	18.8	12.7	0.8	5.6	0.1	1.8	3.7	3.9	3.4	1.7	2.4	14.7	3.4	0.0	1.4	0.2	3.4	3.2	14.0	2.2	2.0	6.5	8.6	16.9	9.6	6.4	6.6	10.5	6.6	11.2	7.9	0.0	1.4	3.0	24.7	20.4	4.3	4.1	12.7	1.4	4.5	8.7	0.0	1.2	6.6	15.0	94.9	15.3	22.2	0.0	19.1	46.9	11.0	10.1	0.0	4.9	11.9	0.0	6.4	4.9	3.5	31.3	6.1	7.1	10.1	17.2	13.7	4.0	38.8	14.4	3.2	5.8	4.2	0.0	9.0	5.2	11.5	26.0	22.1	4.8	18.3	20.9
UCKL1	"FLJ20517, URKL1"	ENSG00000198276	"Uridine-cytidine kinase 1 like 1"	Q9NWZ5	20	63939829-63956415	"Enzymes, Predicted intracellular proteins"	"Host-virus interaction"	"Kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"Cone photoreceptor cells: 78.5;Rod photoreceptor cells: 130.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA004722, HPA004769"	Approved		Approved	"Endoplasmic reticulum"		NA	NA			"Endoplasmic reticulum"		"HPA004722: AB_1080455, HPA004769: AB_1080453"	"unprognostic (1.03e-1)"	"unprognostic (2.77e-2)"	"unprognostic (2.64e-1)"	"unprognostic (8.34e-2)"	"unprognostic (7.29e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.99e-2)"	"unprognostic (1.87e-1)"	"unprognostic (2.45e-1)"	"unprognostic (1.29e-1)"	"prognostic favorable (4.42e-4)"	"unprognostic (5.87e-2)"	"unprognostic (3.18e-2)"	"unprognostic (9.11e-2)"	"unprognostic (2.81e-1)"	"unprognostic (3.01e-1)"	"unprognostic (5.26e-3)"	17.4	18.1	16.5	16.0	18.3	21.1	19.8	50.4	20.7	18.5	21.9	21.6	17.3	32.0	18.0	17.7	19.7	17.9	12.0	21.0	17.1	9.4	21.3	20.6	15.6	18.3	20.3	11.5	31.7	22.6	14.1	22.1	17.5	15.7	19.4	9.1	31.0	28.9	24.4	52.3	27.9	29.8	18.1	11.8	26.7	20.1	11.5	19.7	16.7	24.1	33.1	20.1	16.2	21.2	22.2	8.9	6.3	14.0	5.3	14.8	7.9	11.5	12.3	10.6	14.1	7.8	6.7	17.1	9.3	6.4	19.3	9.7	29.3	9.0	11.7	15.7	6.0	13.2	19.0	8.2	12.8	3.8	4.9	13.8	8.9	24.6	42.8	8.6	15.1	17.0	9.3	11.5	7.7	6.4	7.7	8.9	11.6	12.5	12.5	6.0	14.9	17.7	26.4	7.8	9.2	28.8	18.1	8.0	20.1	7.9	16.8	25.2	14.7	13.4	13.2	14.2	5.5	13.8	13.7	9.8	20.5	7.7	13.3	12.0	13.1	7.0	5.4	10.5	10.8	7.7	4.2	7.7	6.3	13.2	12.9	14.8	22.2	12.8	11.2	8.9	12.7	7.5	9.0	1.2	5.3	14.0	5.1	13.5	7.9	16.5	18.3	50.4	20.7	17.1	9.4	20.3	11.5	15.7	19.7	23.8	8.8	20.2	17.9	16.8	27.5	18.2	22.9	8.1	11.4	8.7	78.5	27.3	19.9	17.0	1.9	16.5	26.3	0.0	9.6	20.5	15.0	11.6	12.7	10.5	16.0	19.1	20.6	10.4	9.1	2.2	16.4	13.4	10.1	22.6	20.8	17.1	16.9	23.0	19.4	12.3	130.6	25.8	18.7	10.7	14.0	16.7	27.9	9.6	21.7	17.1
UFSP1	UFSP	ENSG00000176125	"UFM1 specific peptidase 1 (inactive)"	Q6NVU6	7	100888723-100889718	"Enzymes, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Distal tubular cells: 6.6;Proximal tubular cells: 5.3;Sertoli cells: 6.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"											HPA027099	Uncertain					NA	NA					"HPA027099: AB_2214069"	"unprognostic (8.56e-2)"	"unprognostic (2.62e-2)"	"unprognostic (2.23e-1)"	"unprognostic (1.94e-1)"	"unprognostic (7.21e-3)"	"unprognostic (1.18e-1)"	"unprognostic (2.62e-1)"	"unprognostic (1.51e-2)"	"unprognostic (2.14e-1)"	"unprognostic (2.11e-1)"	"unprognostic (3.55e-3)"	"unprognostic (5.71e-2)"	"unprognostic (4.40e-2)"	"unprognostic (1.77e-1)"	"unprognostic (2.48e-1)"	"unprognostic (2.46e-1)"	"unprognostic (3.09e-2)"	7.4	6.3	2.8	3.9	5.4	2.6	4.0	3.1	4.1	3.1	4.5	6.1	2.8	4.3	5.6	6.1	4.1	4.6	2.5	3.6	4.8	4.6	5.3	6.5	2.8	5.9	8.9	4.1	5.8	8.6	3.4	6.8	5.7	3.9	4.8	2.8	3.0	6.4	5.0	10.6	3.4	5.8	4.0	3.5	4.3	5.1	2.0	7.8	6.5	4.2	2.8	5.0	4.8	4.7	5.9	7.2	2.4	3.9	4.4	6.4	3.1	3.7	4.7	1.1	4.9	4.9	2.9	3.1	2.8	0.9	1.2	0.8	1.9	2.6	0.8	2.2	2.3	1.8	7.1	1.5	1.7	0.7	3.2	10.7	3.1	3.9	2.2	4.8	1.3	1.5	3.2	2.2	1.6	6.1	1.3	0.3	1.9	4.6	2.3	1.8	9.1	3.0	7.5	3.7	3.8	6.6	1.5	1.5	7.0	2.1	1.5	3.5	5.6	5.6	7.3	3.1	1.4	1.8	1.1	1.2	3.3	3.2	3.5	2.2	2.3	2.7	0.2	1.1	2.4	3.6	0.0	3.9	2.4	5.4	3.4	6.1	1.8	4.7	2.9	4.8	5.9	5.3	6.4	0.8	4.4	3.3	7.2	2.0	3.1	2.8	5.4	3.1	4.1	4.8	4.6	8.9	4.1	3.9	7.8	0.0	0.0	0.0	1.9	0.6	0.2	0.6	0.0	0.0	0.0	1.8	0.0	2.0	6.6	2.0	0.3	0.6	1.7	0.0	1.8	1.1	1.2	1.1	0.0	2.9	1.6	0.0	2.9	1.8	1.2	0.0	1.7	0.3	0.0	0.0	1.4	2.0	1.8	1.7	1.8	5.3	0.5	6.5	1.2	0.2	0.2	0.9	1.4	0.0	2.0	1.8
UFSP2	"C4orf20, FLJ11200"	ENSG00000109775	"UFM1 specific peptidase 2"	Q9NUQ7	4	185399540-185425985	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"	"Disease mutation, Dwarfism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	4	"Early spermatids: 125.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039985, HPA043298"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"HPA039985: AB_10794206, HPA043298: AB_10795037"	"unprognostic (8.87e-2)"	"unprognostic (1.85e-2)"	"unprognostic (1.52e-1)"	"unprognostic (1.97e-1)"	"unprognostic (1.17e-1)"	"unprognostic (1.29e-1)"	"unprognostic (3.63e-2)"	"unprognostic (3.19e-2)"	"unprognostic (3.69e-1)"	"unprognostic (1.50e-1)"	"unprognostic (2.04e-2)"	"unprognostic (2.56e-1)"	"prognostic favorable (1.07e-8)"	"unprognostic (1.92e-1)"	"unprognostic (8.12e-2)"	"unprognostic (9.36e-3)"	"unprognostic (6.70e-3)"	15.8	20.3	12.5	10.3	14.9	4.1	18.7	11.3	20.3	17.3	17.4	16.3	17.0	11.0	19.4	17.4	20.1	17.3	13.5	24.2	11.4	11.7	28.1	19.2	13.2	11.6	14.6	11.3	30.5	20.1	18.3	22.8	12.3	17.0	18.4	12.6	13.7	14.4	20.3	40.8	16.6	13.6	16.9	20.2	14.2	17.3	23.7	14.6	15.8	23.5	19.2	12.2	20.8	13.3	15.6	13.0	5.5	7.9	13.9	17.9	8.2	12.2	7.5	21.1	15.2	19.1	19.8	11.7	12.7	12.9	15.2	14.4	12.5	15.7	12.3	5.9	15.3	11.4	9.7	16.4	20.6	15.8	13.2	9.5	6.5	7.3	11.3	21.1	9.9	8.1	11.6	16.1	13.3	13.7	19.6	24.3	16.0	16.5	24.9	19.6	7.4	13.2	7.4	5.4	8.9	10.8	13.0	8.3	14.8	14.6	7.1	12.6	11.8	7.9	12.9	15.4	13.1	9.9	7.0	14.1	6.3	11.2	4.4	9.8	22.7	8.7	5.9	20.5	6.2	16.1	5.5	7.9	5.4	16.3	6.8	17.1	15.6	16.5	17.6	9.8	11.0	17.8	17.9	0.4	13.9	6.6	13.0	14.0	8.2	12.5	14.9	11.3	20.3	11.4	11.7	14.6	11.3	17.0	14.6	6.0	19.2	16.7	28.0	19.6	46.6	23.8	10.2	28.1	29.6	19.2	62.8	22.2	94.5	25.2	125.0	22.7	9.1	23.3	28.8	24.6	26.8	16.4	27.8	14.9	23.8	17.5	18.6	14.1	16.7	32.5	32.8	19.1	33.7	14.4	16.8	50.3	19.5	19.3	39.6	62.7	79.4	64.7	30.1	53.7	53.4	16.6	35.0	21.5	15.3	15.4
UGCG	GCS	ENSG00000148154	"UDP-glucose ceramide glucosyltransferase"	Q16739	9	111896766-111935369	"Enzymes, FDA approved drug targets, Predicted membrane proteins, Transporters"	"Lipid biosynthesis, Lipid metabolism, Sphingolipid metabolism"	"Glycosyltransferase, Transferase"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	9	"Urothelial cells: 446.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	19	"plasmacytoid DC: 39.7"	"Lineage enriched"	"Detected in many"	19	"dendritic cells: 39.7"	"Cell line enhanced"	"Detected in all"		"LHCN-M2: 50.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA024124	Approved					NA	NA					"HPA024124: AB_1858595"	"unprognostic (1.22e-2)"	"prognostic favorable (6.62e-4)"	"unprognostic (5.39e-2)"	"prognostic favorable (4.44e-5)"	"unprognostic (1.53e-2)"	"unprognostic (9.70e-2)"	"unprognostic (3.20e-2)"	"unprognostic (2.04e-1)"	"unprognostic (3.40e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.95e-2)"	"unprognostic (3.22e-1)"	"unprognostic (9.84e-3)"	"unprognostic (2.24e-2)"	"unprognostic (4.92e-2)"	"unprognostic (1.99e-1)"	"unprognostic (3.77e-2)"	33.7	37.7	5.9	21.4	7.8	55.2	20.5	9.5	11.2	14.6	19.6	5.0	3.3	13.3	10.6	8.6	34.0	11.1	24.5	17.5	8.6	9.0	23.8	18.4	28.1	35.4	7.1	5.8	15.9	11.4	3.5	11.9	15.3	6.8	12.4	10.5	11.9	10.8	5.4	14.0	21.7	25.5	12.4	12.9	33.1	26.1	11.7	6.2	17.9	8.5	16.9	27.7	34.2	25.9	2.0	39.7	0.4	0.3	0.5	1.2	0.5	23.1	2.4	4.0	2.7	8.8	10.6	2.1	14.5	15.3	17.0	23.1	4.9	17.8	5.5	11.5	9.6	37.3	11.9	4.7	6.3	18.3	2.2	2.7	2.2	3.7	2.4	6.3	2.4	3.6	10.5	4.9	16.2	23.4	39.5	5.2	2.7	12.1	10.7	50.2	3.9	2.6	2.7	4.6	7.8	2.6	3.0	28.9	1.7	39.1	8.8	1.9	3.1	6.4	5.4	15.9	25.1	29.2	2.5	24.4	7.8	4.0	21.9	10.3	2.0	7.3	2.5	9.7	1.5	10.6	0.0	0.1	0.0	0.4	0.2	0.7	1.6	0.8	0.6	0.6	2.0	0.7	0.7	0.4	0.5	0.3	39.7	1.2	0.5	5.9	7.8	9.5	11.2	8.6	9.0	7.1	5.8	6.8	6.2	38.7	48.5	29.9	123.9	67.2	26.0	9.2	30.6	115.1	113.7	27.9	58.9	5.7	14.9	98.3	14.5	72.6	52.6	0.0	43.7	10.2	46.0	156.5	10.4	15.5	19.6	17.5	17.7	92.7	30.2	3.6	45.5	30.8	55.6	69.5	41.5	7.8	67.4	21.0	36.0	56.0	14.2	12.9	60.8	1.6	1.5	106.9	2.9	26.6	12.8	446.9
UGDH		ENSG00000109814	"UDP-glucose 6-dehydrogenase"	O60701	4	39498755-39528311	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Carbohydrate metabolism"	"Allosteric enzyme, Oxidoreductase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"liver: 125.8"	"Cell type enhanced"	"Detected in many"	6	"Exocrine glandular cells: 293.1;Hepatocytes: 215.1;Pancreatic endocrine cells: 205.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"A549: 85.7;Hep G2: 99.2;U-2197: 61.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB034444, HPA036656, HPA036657"	Enhanced		Supported	Nucleoplasm		Yes	No		42000	Nucleoplasm		"CAB034444: AB_2019602, HPA036656: AB_10671706, HPA036657: AB_10672360"	"unprognostic (1.22e-2)"	"unprognostic (1.62e-1)"	"unprognostic (2.73e-2)"	"unprognostic (3.96e-2)"	"unprognostic (5.54e-2)"	"unprognostic (1.63e-1)"	"unprognostic (8.78e-3)"	"unprognostic (6.07e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.41e-1)"	"unprognostic (9.81e-3)"	"unprognostic (6.86e-2)"	"prognostic unfavorable (5.51e-10)"	"unprognostic (2.48e-1)"	"unprognostic (2.04e-1)"	"unprognostic (1.66e-1)"	"unprognostic (4.97e-2)"	25.9	11.3	4.4	24.7	3.2	0.2	12.7	4.0	3.1	13.0	29.3	3.8	10.2	13.7	11.5	9.7	22.9	9.9	12.9	10.1	3.6	3.5	28.2	125.8	13.5	4.7	4.0	2.2	20.6	24.9	5.1	4.7	26.8	5.3	13.2	23.3	7.5	8.2	7.3	7.5	5.5	24.2	17.7	3.7	3.3	14.1	5.0	3.8	1.7	16.7	12.7	7.1	30.2	24.1	12.0	12.3	17.1	12.0	21.8	22.4	10.2	4.9	85.7	9.4	12.3	30.9	34.4	7.9	16.3	19.4	16.1	14.8	12.0	18.5	3.1	10.2	22.6	14.8	5.1	9.8	4.6	16.9	4.0	1.7	3.5	11.1	99.2	12.2	4.3	3.5	11.5	2.5	27.6	8.7	13.0	10.3	2.5	4.6	2.6	11.1	14.6	4.2	4.7	7.6	32.4	6.3	7.2	14.6	3.1	8.9	19.7	4.8	7.1	10.0	5.9	6.8	7.2	3.3	3.6	12.0	16.6	7.7	61.6	7.8	6.0	4.3	3.1	14.0	3.6	8.6	17.1	12.0	10.9	14.3	10.6	22.4	10.9	11.4	14.8	10.7	12.0	9.8	12.0	2.3	21.8	6.1	12.3	7.3	10.2	4.4	3.2	4.0	3.0	3.6	3.5	4.0	2.2	5.3	3.8	23.8	22.2	19.5	56.0	103.1	7.7	7.3	22.9	72.3	30.7	19.2	13.7	18.5	59.7	44.3	0.9	20.2	111.9	0.0	293.1	59.3	101.2	100.0	35.7	215.1	16.1	9.5	108.6	23.4	18.5	0.9	30.8	17.2	28.7	26.2	69.3	5.2	205.5	85.2	27.3	54.9	8.6	32.3	92.4	2.4	4.0	35.0	24.3	11.5	88.0	69.0
UGP2	"UGP1, UGPP1"	ENSG00000169764	"UDP-glucose pyrophosphorylase 2"	Q16851	2	63840940-63891562	"Enzymes, Predicted intracellular proteins"		"Nucleotidyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 185.5"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	5	"basophil: 93.6;T-reg: 29.9"	"Group enriched"	"Detected in all"	5	"granulocytes: 93.6;T-cells: 29.9"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA034696, HPA034697, HPA064836"	Enhanced		Approved	Nucleoplasm,Centrosome,Mitochondria		NA	NA		12000000	"Centrosome, Mitochondria"	Nucleoplasm	"HPA034696: AB_10670171, HPA034697: AB_2674287, HPA064836: AB_2685365"	"unprognostic (1.00e-2)"	"unprognostic (6.93e-2)"	"unprognostic (5.12e-2)"	"unprognostic (1.06e-1)"	"unprognostic (2.65e-2)"	"unprognostic (1.91e-1)"	"prognostic favorable (2.50e-5)"	"unprognostic (2.20e-1)"	"unprognostic (3.01e-1)"	"unprognostic (1.84e-1)"	"unprognostic (1.57e-2)"	"unprognostic (8.31e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.25e-2)"	"unprognostic (3.93e-2)"	"unprognostic (3.81e-1)"	"unprognostic (8.44e-2)"	58.2	14.7	23.3	13.6	22.5	7.8	25.2	12.4	30.4	13.3	38.2	6.7	7.4	12.3	15.5	12.5	19.8	12.7	12.2	46.3	18.8	13.2	33.0	185.5	12.7	15.2	17.3	18.3	12.0	13.4	17.1	22.9	31.0	19.3	11.0	33.1	5.7	18.5	12.9	104.1	11.0	17.2	16.8	8.6	9.9	13.0	8.1	10.5	31.0	17.4	75.5	12.7	19.7	19.5	6.4	5.9	93.6	7.8	12.7	29.9	11.0	27.5	14.5	13.9	9.3	47.4	61.5	58.3	35.6	29.1	19.2	22.9	37.1	23.4	28.9	10.7	38.2	17.5	12.1	16.8	22.3	31.2	19.3	7.1	18.3	10.3	25.3	22.7	16.1	16.1	40.3	40.9	18.0	18.6	25.9	26.6	9.8	9.1	11.7	80.1	10.8	21.8	15.2	33.3	45.0	10.2	17.9	27.6	16.6	34.0	16.0	7.3	6.0	28.4	36.6	13.5	44.1	10.4	11.5	36.3	20.1	31.7	29.9	18.7	21.0	9.4	36.6	24.1	25.3	61.3	93.6	7.0	9.7	9.9	7.8	10.3	6.4	11.4	10.3	5.9	6.2	12.6	11.2	9.0	12.7	7.6	5.5	29.9	11.0	23.3	22.5	12.4	30.4	18.8	13.2	17.3	18.3	19.3	10.5	26.8	52.5	51.7	74.0	67.3	48.5	238.8	89.2	73.6	69.4	45.4	60.9	359.1	205.6	116.3	61.0	61.3	412.6	0.0	90.6	369.3	148.4	77.6	65.8	448.9	107.3	82.6	42.9	66.3	100.6	64.7	73.4	90.8	91.1	173.1	112.3	37.4	81.0	167.8	72.9	209.2	49.4	71.1	124.3	71.2	57.5	50.6	395.3	112.8	144.5	90.3
UGT1A1	"GNT1, UGT1, UGT1A"	ENSG00000241635	"UDP glucuronosyltransferase family 1 member A1"	P22309	2	233760248-233773299	"Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted membrane proteins"		"Glycosyltransferase, Transferase"	"Cancer-related genes, Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	16	"intestine: 48.6;liver: 120.3"	"Cell type enriched"	"Detected in some"	12	"Hepatocytes: 83.9"	"Cancer enriched"	"Detected in some"	19	"liver cancer: 16.4"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"neutrophil: 4.7"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"HaCaT: 8.1;OE19: 35.4;RT4: 19.3"	"Not detected"	"Not detected"													NA	NA								"unprognostic (7.28e-2)"			"unprognostic (2.49e-2)"	"unprognostic (3.60e-1)"	"unprognostic (5.69e-2)"			"unprognostic (4.17e-3)"	"unprognostic (6.31e-3)"	"unprognostic (1.94e-5)"	"unprognostic (2.78e-3)"			"unprognostic (2.99e-4)"	0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.2	0.2	35.6	0.1	0.1	48.6	0.1	0.1	4.3	0.0	0.3	0.1	0.1	0.0	4.5	120.3	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.3	0.4	0.1	0.7	0.1	0.1	0.9	48.2	0.5	0.1	0.1	1.3	0.2	0.1	0.1	0.2	0.1	0.1	5.2	0.8	1.0	0.4	4.7	0.4	1.1	0.5	0.2	0.2	0.6	0.1	0.1	0.0	0.1	0.4	0.0	0.0	0.0	0.0	3.1	0.2	0.1	1.4	0.0	0.0	8.1	0.0	0.1	0.0	0.1	0.1	0.0	0.3	0.8	0.0	0.3	0.1	0.1	0.3	0.0	0.0	0.0	0.0	0.1	0.1	0.3	0.0	0.4	0.0	0.2	0.3	35.4	3.6	0.0	0.1	0.3	0.0	19.3	0.1	0.2	1.4	0.2	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.2	0.0	0.1	0.1	0.1	0.4	0.2	0.1	2.1	0.4	0.4	0.4	0.3	0.3	0.4	0.4	0.3	0.1	1.0	0.4	0.5	4.7	1.1	0.4	0.4	0.3	0.2	0.1	0.1	0.1	0.2	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	2.7	6.8	1.8	0.0	0.0	0.0	0.2	2.8	0.0	3.5	0.0	0.0	0.0	0.0	0.9	0.0	83.9	0.0	0.0	0.0	1.3	3.3	0.8	0.0	0.0	0.0	0.0	0.6	0.0	0.5	1.4	0.0	1.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.6	6.2
UGT1A10	UGT1J	ENSG00000242515	"UDP glucuronosyltransferase family 1 member A10"	Q9HAW8	2	233636454-233773305	"Cancer-related genes, Enzymes, Predicted intracellular proteins, Predicted membrane proteins"		"Glycosyltransferase, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"esophagus: 9.4;gallbladder: 8.4;intestine: 31.1;stomach 1: 12.4"	"Cell type enhanced"	"Detected in some"	22	"Club cells: 1.2;Enterocytes: 2.1"	"Cancer enhanced"	"Detected in many"		"urothelial cancer: 9.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	142	"RT4: 109.0"														"Intracellular and membrane"	NA	NA								"unprognostic (9.33e-2)"			"unprognostic (7.64e-2)"	"unprognostic (2.45e-3)"	"unprognostic (1.73e-1)"			"prognostic unfavorable (4.55e-4)"		"unprognostic (1.49e-10)"	"unprognostic (2.90e-1)"	"unprognostic (1.50e-1)"		"unprognostic (3.59e-3)"	0.3	0.0	0.3	2.6	0.3	0.0	0.3	0.3	0.3	0.3	19.2	0.3	0.3	31.1	0.3	0.3	9.4	0.1	8.4	0.3	0.3	0.0	0.3	1.4	0.6	0.3	0.3	0.3	0.3	0.3	0.0	0.3	0.3	0.3	0.3	14.3	0.3	0.9	0.3	0.3	0.3	20.2	0.5	0.3	0.3	12.4	1.0	0.3	0.3	0.3	0.3	1.4	0.9	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	109.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.3	0.3	0.3	0.0	0.3	0.3	0.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1
UGT1A3	UGT1C	ENSG00000243135	"UDP glucuronosyltransferase family 1 member A3"	P35503	2	233729108-233773299	"Cancer-related genes, Enzymes, Predicted membrane proteins"		"Glycosyltransferase, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	15	"liver: 40.6"	"Not detected"	"Not detected"			"Cancer enriched"	"Detected in single"	6	"liver cancer: 2.1"					"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	7	"HaCaT: 16.7"															NA	NA												"unprognostic (5.15e-2)"	"unprognostic (9.93e-2)"			"unprognostic (2.97e-1)"	"unprognostic (4.59e-2)"	"unprognostic (1.04e-4)"	"unprognostic (8.22e-2)"			"unprognostic (2.08e-3)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0			1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	40.6	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0			0.0		0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	16.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	2.4	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
UGT1A4	"HUG-BR2, UGT1D"	ENSG00000244474	"UDP glucuronosyltransferase family 1 member A4"	P22310	2	233718778-233773299	"Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins"		"Glycosyltransferase, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	51	"liver: 99.4"	"Group enriched"	"Detected in some"	8	"Club cells: 4.5;Hepatocytes: 10.5"	"Cancer enriched"	"Detected in single"	487	"liver cancer: 24.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HaCaT: 1.6;HL-60: 1.4;RH-30: 2.2"															NA	NA												"unprognostic (9.89e-3)"						"unprognostic (6.77e-5)"	"unprognostic (2.59e-1)"			"unprognostic (3.50e-3)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	99.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.6	0.2	0.0	0.0	0.0	2.2	0.0	0.0	0.7	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.5	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.5	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
UGT1A5	UGT1E	ENSG00000240224	"UDP glucuronosyltransferase family 1 member A5"	P35504	2	233712992-233773299	"Enzymes, Predicted membrane proteins"		"Glycosyltransferase, Transferase"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"gallbladder: 3.7;intestine: 13.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"RPMI-8226: 1.7;RT4: 1.6"															NA	NA												"unprognostic (2.18e-3)"							"unprognostic (1.36e-1)"				0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.9	0.0	0.0	11.2	0.0	0.0	0.2	0.0	3.7	0.0	0.0	0.0	0.2	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.3	9.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	1.6	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
UGT1A6	"GNT1, HLUGP, UGT1F"	ENSG00000167165	"UDP glucuronosyltransferase family 1 member A6"	P19224	2	233691607-233773300	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"kidney: 111.7;liver: 50.1;urinary bladder: 32.7"	"Group enriched"	"Detected in some"	5	"Early spermatids: 37.7;Late spermatids: 19.3"	"Cancer enhanced"	"Detected in many"		"renal cancer: 7.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"HaCaT: 40.4;OE19: 160.5"									"CAB009819, HPA054065"	Enhanced					NA	NA					"CAB009819: AB_2241481, HPA054065: AB_2682367"		"unprognostic (9.09e-2)"	"unprognostic (6.07e-2)"	"unprognostic (5.43e-2)"		"unprognostic (6.03e-2)"	"prognostic unfavorable (2.89e-6)"	"unprognostic (2.79e-1)"	"unprognostic (6.18e-2)"		"unprognostic (2.09e-3)"	"unprognostic (9.97e-2)"	"unprognostic (2.16e-2)"	"unprognostic (3.52e-1)"	"unprognostic (7.50e-2)"		"unprognostic (2.01e-2)"	0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.8	0.5	0.2	0.5	2.0	0.3	0.9	13.0	0.0	1.1	0.1	0.1	0.0	111.7	50.1	1.9	0.1	0.1	0.1	0.1	0.1	0.0	0.5	0.3	0.1	3.3	0.4	0.1	1.3	1.2	0.1	3.8	1.2	2.3	0.1	0.1	8.1	0.2	0.1	0.5	0.2	5.6	8.7	32.7	2.9	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.3	0.2	0.0	11.3	0.0	0.1	40.4	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	4.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	160.5	0.0	0.0	0.0	0.0	0.4	20.4	0.0	0.0	0.9	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.0	1.5	0.8	0.0	0.3	0.0	0.0	4.5	1.8	0.0	0.0	0.0	0.0	37.7	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.0	5.6	0.0	0.0	0.0	0.6	0.0	19.3	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.4	0.0	0.0	0.0	0.7	0.0	1.0	0.0	0.0	0.0	2.1
UGT1A7	UGT1G	ENSG00000244122	"UDP glucuronosyltransferase family 1 member A7"	Q9HAW7	2	233681938-233773299	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	12	"esophagus: 54.4;lymphoid tissue: 40.2;tongue: 23.6"	"Cell type enriched"	"Detected in some"	5	"Urothelial cells: 8.4"	"Group enriched"	"Detected in some"	10	"cervical cancer: 1.2;head and neck cancer: 2.3;lung cancer: 3.0"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"basophil: 1.6"	"Low lineage specificity"	"Detected in single"			"Cell line enriched"	"Detected in some"	14	"SiHa: 50.6"															NA	NA							"unprognostic (6.27e-2)"	"unprognostic (1.02e-1)"			"unprognostic (7.76e-2)"	"unprognostic (1.03e-2)"	"unprognostic (1.09e-1)"			"unprognostic (7.92e-2)"		"unprognostic (1.71e-7)"	"unprognostic (2.14e-1)"			"unprognostic (4.57e-2)"	0.1	0.7	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.7	0.1	0.0	0.0	0.1	0.0	0.0	54.4	0.0	0.0	0.0	0.0	0.0	0.3	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	3.2	0.0	0.0	2.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	23.6	40.2	0.2	2.8	0.2	0.1	1.6	0.2	0.6	0.1	0.0	0.0	0.8	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	50.6	3.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.1	0.1	0.0	0.2	0.1	0.1	0.0	0.2	0.1	0.0	0.2	0.6	0.2	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.2	8.4
UGT1A8	UGT1H	ENSG00000242366	"UDP glucuronosyltransferase family 1 member A8"	Q9HAW9	2	233617645-233773310	"Enzymes, Predicted membrane proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"intestine: 13.0;urinary bladder: 15.7"	"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in some"		"urothelial cancer: 2.4"					"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	58	"RT4: 52.5"															NA	NA								"unprognostic (1.27e-2)"			"unprognostic (1.35e-1)"	"unprognostic (1.42e-3)"				"unprognostic (1.23e-1)"	"unprognostic (4.78e-1)"	"unprognostic (9.71e-12)"	"unprognostic (9.26e-2)"			"unprognostic (1.96e-1)"	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	13.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	5.2	0.0	0.0		4.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	7.3	0.0	0.0	0.0	0.0	0.0	3.3	5.5	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	3.0	15.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	52.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.1	0.1
UGT1A9	"HLUGP4, LUGP4, UGT1AI"	ENSG00000241119	"UDP glucuronosyltransferase family 1 member A9"	O60656	2	233671853-233773300	"Cancer-related genes, Enzymes, Predicted membrane proteins"		"Glycosyltransferase, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	4	"kidney: 169.8"	"Cell type enhanced"	"Detected in some"	29	"Club cells: 1.2;Hepatocytes: 5.9;Proximal tubular cells: 3.3"	"Group enriched"	"Detected in some"	157	"liver cancer: 16.1;renal cancer: 16.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	20	"A549: 4.9;RT4: 4.0"															NA	NA												"unprognostic (2.46e-2)"				"unprognostic (3.56e-1)"		"prognostic unfavorable (5.04e-5)"	"unprognostic (4.26e-2)"			"unprognostic (1.60e-1)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	169.8	39.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
UGT2A1		ENSG00000173610	"UDP glucuronosyltransferase family 2 member A1 complex locus"	Q9Y4X1	4	69588417-69653249	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Olfaction, Sensory transduction"	"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"kidney: 10.6;liver: 14.5;pituitary gland: 21.2"	"Cell type enriched"	"Detected in some"	6	"Proximal tubular cells: 32.3"	"Cancer enhanced"	"Detected in some"		"liver cancer: 0.7"	"Region enriched"	"Detected in single"	17	"pons and medulla: 1.7"	"Cell type enhanced"	"Detected in some"		"neutrophil: 2.0"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"ASC diff: 3.2;HUVEC TERT2: 1.9;U-266/70: 3.6"									"HPA017261, HPA045108"	Uncertain					NA	NA					"HPA017261: AB_10963582, HPA045108: AB_2679218"							"unprognostic (3.93e-3)"	"unprognostic (5.62e-1)"					"unprognostic (1.28e-4)"	"unprognostic (1.74e-1)"	"unprognostic (2.76e-2)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.6	14.5	2.4	0.0	0.0	0.0	0.0	0.0	0.0	21.2	0.0	1.7	0.0	0.0	1.5	0.0	0.2	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.5	2.0	0.5	0.9	0.4	0.0	0.0	0.0	0.1	0.0	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	1.9	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.4	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.9	0.0	0.0	0.0	0.1	0.0	0.1	0.0	3.6	0.0	0.0	0.0	0.0	0.2	1.7	0.5	0.4	0.2	0.2	0.1	0.1	0.4	0.2	0.1	0.3	0.2	0.1	2.0	0.9	0.2	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.0	3.5	0.0	0.0	5.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	32.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
UGT2A2		ENSG00000271271	"UDP glucuronosyltransferase family 2 member A2"	Q9Y4X1	4	69589309-69639642	"Enzymes, Predicted membrane proteins"	"Olfaction, Sensory transduction"	"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	14	"cervix, uterine: 1.6;kidney: 2.6;liver: 5.4;pituitary gland: 3.8;skin 1: 1.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"U-266/70: 2.6"	"Not detected"	"Not detected"							HPA045108	Uncertain					NA	NA					"HPA045108: AB_2679218"																		0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.6	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	5.4	0.0	0.0	0.0		0.0	0.0	0.0	3.8	0.0		0.0	0.0		0.0	0.0	0.0	1.8	0.0	0.1	0.0	0.0	0.0	0.2			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
UGT2A3	FLJ21934	ENSG00000135220	"UDP glucuronosyltransferase family 2 member A3"	Q6UWM9	4	68928463-68951791	"Enzymes, Predicted membrane proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	7	"intestine: 150.5;kidney: 43.2"	"Cell type enhanced"	"Detected in some"	11	"Cholangiocytes: 94.3;Enterocytes: 115.5;Hepatocytes: 49.3;Paneth cells: 52.6;Proximal tubular cells: 125.8;Undifferentiated cells: 72.7"	"Cancer enriched"	"Detected in many"	5	"renal cancer: 46.9"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	10	"eosinophil: 5.3"	"Lineage enriched"	"Detected in single"	53	"granulocytes: 5.3"	"Cell line enriched"	"Detected in some"	9	"Hep G2: 21.0"									HPA045108	Supported					NA	NA					"HPA045108: AB_2679218"			"prognostic favorable (3.31e-4)"				"unprognostic (3.97e-3)"				"unprognostic (8.87e-3)"		"prognostic favorable (6.07e-7)"	"unprognostic (2.10e-2)"				0.1	0.1	0.1	4.3	0.1	0.0	0.7	0.1	0.1	0.1	63.8	0.1	0.1	31.9	0.1	1.7	0.1	0.1	14.6	0.3	0.1	0.1	43.2	9.6	0.1	0.1	0.1	0.1	0.1	12.0	0.0	0.1	0.1	0.1	0.1	8.6	0.1	0.1	0.1	0.1	0.1	150.5	0.1	0.1	0.1	0.3	0.2	0.1	0.1	0.1	0.2	0.1	0.1	0.1	0.0	0.0	5.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	2.1	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	21.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.3	0.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	5.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.8	0.0	0.0	0.0	0.1	94.3	0.0	0.0	3.5	0.0	0.0	10.0	21.3	0.0	0.0	115.5	0.0	2.3	0.0	0.0	0.0	0.0	49.3	0.0	0.0	11.7	0.0	1.8	0.0	0.0	0.0	0.0	0.0	28.2	0.0	6.0	52.6	0.0	125.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	72.7	0.0
UGT2B10		ENSG00000109181	"UDP glucuronosyltransferase family 2 member B10"	P36537	4	68815993-68831196	"Enzymes, Predicted membrane proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	277	"liver: 120.4"	"Cell type enriched"	"Detected in some"	15	"Hepatocytes: 221.7"	"Cancer enriched"	"Detected in single"	296	"liver cancer: 93.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	39	"Hep G2: 16.1"									HPA045108	Uncertain					NA	NA					"HPA045108: AB_2679218"			"unprognostic (3.50e-3)"				"unprognostic (1.92e-3)"						"unprognostic (4.17e-1)"					0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	120.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	16.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	12.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	221.7	0.0	0.0	0.0	1.3	4.7	1.7	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0
UGT2B11		ENSG00000213759	"UDP glucuronosyltransferase family 2 member B11"	O75310	4	69199951-69214731	"Enzymes, Predicted membrane proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"		"Tissue enriched"	"Detected in some"	10	"breast: 77.4"	"Cell type enriched"	"Detected in some"	7	"Cholangiocytes: 12.7"	"Group enriched"	"Detected in some"	17	"breast cancer: 17.4;liver cancer: 13.1"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	62	"basophil: 6.8;eosinophil: 5.6"	"Lineage enriched"	"Detected in single"	68	"granulocytes: 6.8"	"Cell line enhanced"	"Detected in some"		"Hep G2: 1.5;HL-60: 3.1;NB-4: 2.5;RPTEC TERT1: 3.7;U-2197: 1.5"									HPA045108	Uncertain					NA	NA					"HPA045108: AB_2679218"	"unprognostic (1.12e-1)"						"unprognostic (1.18e-3)"			"unprognostic (1.49e-1)"	"unprognostic (6.53e-2)"	"unprognostic (2.26e-2)"	"unprognostic (1.65e-1)"	"unprognostic (7.84e-3)"	"unprognostic (5.47e-1)"	"unprognostic (1.32e-1)"	"unprognostic (1.51e-3)"	0.1	0.0	0.1	0.1	0.1	0.0	77.4	0.1	0.1	0.1	0.6	0.1	0.1	0.0	0.1	0.1	0.1	0.0	3.3	0.1	0.1	0.0	1.2	7.3	0.1	0.1	0.1	0.1	0.1	0.5	0.0	0.1	0.1	0.1	0.1	0.0	0.1	7.0	0.1	0.1	1.2	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.9	0.1	0.1	0.1	0.1	0.0	0.0	6.8	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.5	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	3.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.5	0.0	0.0	0.1	0.0	3.7	0.2	0.0	0.0	0.1	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.1	0.6	0.0	0.0	6.8	0.0	5.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
UGT2B15	UGT2B8	ENSG00000196620	"UDP glucuronosyltransferase family 2 member B15"	P54855	4	68646630-68670628	"Enzymes, Predicted membrane proteins"	"Lipid metabolism, Steroid metabolism"	"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	8	"gallbladder: 22.4;intestine: 50.7;liver: 65.4"	"Group enriched"	"Detected in some"	6	"Cholangiocytes: 168.2;Hepatocytes: 134.4"	"Cancer enriched"	"Detected in many"	10	"liver cancer: 120.2"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"naive B-cell: 2.7"	"Lineage enhanced"	"Detected in single"		"B-cells: 2.7"	"Cell line enhanced"	"Detected in some"		"A549: 3.2;HL-60: 2.2;RH-30: 1.2;RPMI-8226: 1.1"									HPA045108	Approved					NA	NA					"HPA045108: AB_2679218"	"unprognostic (1.40e-1)"	"unprognostic (2.25e-1)"	"unprognostic (2.22e-2)"	"unprognostic (3.86e-1)"		"unprognostic (1.94e-1)"	"prognostic favorable (9.82e-4)"	"unprognostic (6.73e-2)"			"unprognostic (3.49e-2)"	"unprognostic (7.84e-2)"	"unprognostic (5.81e-3)"	"unprognostic (2.39e-2)"	"unprognostic (5.38e-2)"		"prognostic favorable (4.50e-4)"	0.1	0.0	0.1	0.6	0.1	0.0	0.1	0.1	0.1	0.1	48.0	0.1	0.1	5.4	0.1	0.1	0.2	0.0	22.4	0.1	0.1	0.0	0.1	65.4	0.1	0.1	0.1	0.1	0.1	5.3	0.0	0.1	0.1	0.1	0.2	1.6	0.1	0.1	0.1	0.1	0.0	50.7	0.1	0.1	0.1	5.7	0.1	0.1	0.1	0.1	0.1	0.1	0.3	0.1	2.7	0.0	0.9	0.0	0.0	0.0	0.0	0.0	3.2	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.4	0.0	0.1	0.3	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	2.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.0	0.0	0.0	0.0	0.2	0.8	0.0	0.0	1.2	1.1	0.0	0.2	0.1	0.6	0.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.8	0.2	0.4	0.1	0.5	0.0	0.6	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.7	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	168.2	0.0	0.0	0.0	0.0	0.0	0.0	14.9	1.9	0.0	0.0	0.0	3.0	0.0	0.0	0.0	0.0	134.4	0.0	0.0	0.0	1.8	2.5	0.0	0.0	0.0	0.0	1.0	0.0	0.0	23.8	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.5	0.0	0.0	0.0	0.1	0.5
UGT2B17		ENSG00000197888	"UDP glucuronosyltransferase family 2 member B17"	O75795	4	68537184-68568527	"Enzymes, Predicted membrane proteins"	"Lipid metabolism, Steroid metabolism"	"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"intestine: 68.1;liver: 21.6"	"Cell type enhanced"	"Detected in some"	11	"Alveolar cells type 2: 2.2;Cholangiocytes: 2.5;Ciliated cells: 1.4;Club cells: 1.2;Hepatocytes: 1.3;Intestinal endocrine cells: 1.7;Melanocytes: 3.3"	"Group enriched"	"Detected in many"	7	"colorectal cancer: 16.3;liver cancer: 10.1"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	38	"memory B-cell: 3.3;naive B-cell: 11.9"	"Lineage enriched"	"Detected in single"	59	"B-cells: 11.9"	"Group enriched"	"Detected in some"	7	"BEWO: 3.1;NB-4: 3.6;RPMI-8226: 5.2;SH-SY5Y: 2.3;U-2197: 2.1"									HPA045108	Supported					NA	NA					"HPA045108: AB_2679218"	"unprognostic (1.66e-1)"	"unprognostic (2.97e-2)"	"unprognostic (2.96e-2)"	"unprognostic (2.41e-1)"	"unprognostic (1.88e-1)"	"unprognostic (1.19e-2)"	"unprognostic (2.36e-1)"	"unprognostic (8.44e-3)"		"unprognostic (9.67e-2)"	"unprognostic (4.80e-3)"	"unprognostic (8.52e-2)"	"unprognostic (2.45e-1)"	"unprognostic (6.44e-2)"	"unprognostic (1.75e-1)"		"unprognostic (1.76e-1)"	0.4	0.1	0.4	4.7	0.4	0.0	0.4	0.4	0.4	0.4	55.6	0.4	0.4	54.1	0.4	0.4	0.4	0.1	0.4	0.4	0.4	0.1	0.4	21.6	0.4	0.4	0.4	0.4	0.4	0.4	0.0	0.4	0.4	0.4	0.4	20.7	0.4	0.4	0.4	0.4	0.1	68.1	1.1	0.4	0.4	0.1	0.4	0.4	0.4	0.4	0.4	0.4	0.4	0.4	11.9	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	3.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	3.6	0.0	0.2	0.0	0.0	0.0	5.2	0.2	0.0	0.3	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.4	0.1	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.2	3.3	0.0	0.0	0.0	11.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.4	0.4	0.4	0.4	0.1	0.4	0.4	0.4	0.4	0.0	2.2	0.0	0.0	0.0	0.0	0.0	2.5	1.4	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.3	0.0	0.0	1.7	0.6	0.0	0.0	0.0	0.0	3.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.1
UGT2B28		ENSG00000135226	"UDP glucuronosyltransferase family 2 member B28"	Q9BY64	4	69280499-69295050	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in some"	11	"breast: 71.7;salivary gland: 25.6"	"Cell type enriched"	"Detected in single"	178	"Cholangiocytes: 17.8"	"Cancer enriched"	"Detected in single"	8	"breast cancer: 1.9"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	12	"basophil: 2.5;eosinophil: 4.0"	"Lineage enriched"	"Detected in single"	14	"granulocytes: 4.0"	"Group enriched"	"Detected in some"	10	"Daudi: 7.1;NB-4: 6.5"									HPA045108	Uncertain				"Intracellular and membrane"	NA	NA					"HPA045108: AB_2679218"	"unprognostic (1.81e-1)"						"unprognostic (1.40e-1)"	"unprognostic (7.20e-3)"				"unprognostic (1.51e-2)"	"unprognostic (4.37e-5)"				"unprognostic (9.79e-4)"	0.0	0.0	0.0	0.0	0.0	0.0	71.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	4.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	25.6	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.2	0.1	0.0	0.2	4.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	6.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.0	4.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	17.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
UGT2B4	UGT2B11	ENSG00000156096	"UDP glucuronosyltransferase family 2 member B4"	P06133	4	69480165-69526014	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	105	"liver: 175.1"	"Cell type enriched"	"Detected in some"	12	"Hepatocytes: 831.9"	"Cancer enriched"	"Detected in some"	96	"liver cancer: 351.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	9	"RH-30: 10.4"									"CAB033260, HPA045108"	Enhanced				"Intracellular and membrane"	NA	NA					"CAB033260: AB_2241496, HPA045108: AB_2679218"	"unprognostic (7.46e-2)"						"unprognostic (1.50e-1)"	"unprognostic (9.37e-2)"			"unprognostic (1.51e-1)"	"unprognostic (2.47e-2)"	"unprognostic (1.47e-1)"	"unprognostic (9.43e-3)"	"unprognostic (3.52e-1)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.6	0.0	0.0	0.1	175.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.7	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	10.4	0.1	0.3	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.1	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.3	0.0	0.0	0.0	34.2	15.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	70.0	0.0	0.0	0.0	0.0	0.0	831.9	0.1	0.0	0.0	14.7	12.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
UGT2B7	UGT2B9	ENSG00000171234	"UDP glucuronosyltransferase family 2 member B7"	P16662	4	69051363-69112987	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Lipid metabolism, Steroid metabolism"	"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"kidney: 125.4;liver: 156.0"	"Group enriched"	"Detected in many"	6	"Hepatocytes: 539.4;Proximal tubular cells: 775.7"	"Group enriched"	"Detected in many"	7	"liver cancer: 116.4;renal cancer: 101.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"EFO-21: 21.0;RPTEC TERT1: 83.6"									HPA045108	Uncertain					NA	NA					"HPA045108: AB_2679218"	"unprognostic (1.04e-1)"	"unprognostic (1.65e-1)"	"prognostic favorable (7.65e-5)"	"unprognostic (1.11e-2)"		"unprognostic (2.10e-1)"	"unprognostic (2.30e-2)"	"unprognostic (5.41e-3)"	"unprognostic (1.68e-1)"	"unprognostic (1.74e-2)"	"unprognostic (1.17e-3)"	"unprognostic (1.98e-1)"	"prognostic favorable (3.79e-4)"	"unprognostic (1.08e-2)"	"unprognostic (2.55e-1)"	"unprognostic (6.23e-3)"	"prognostic favorable (5.38e-4)"	0.1	0.1	0.1	0.2	0.1	0.0	0.4	0.1	0.1	3.1	7.9	0.1	2.5	6.4	0.6	4.7	0.1	4.7	1.5	0.1	0.1	0.1	125.4	156.0	0.2	0.1	0.1	0.1	0.6	14.7	0.0	0.1	0.2	0.1	0.3	0.4	0.2	1.0	2.7	0.3	0.2	27.7	0.1	0.1	0.2	0.1	0.6	0.1	0.2	0.1	0.1	0.3	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	21.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	10.7	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.1	0.0	83.6	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	11.5	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	3.9	0.6	0.1	0.0	0.0	58.6	0.0	0.0	118.7	0.0	0.0	82.9	5.6	0.2	0.0	6.7	0.0	9.1	0.0	0.0	0.4	0.0	539.4	0.1	0.0	3.4	6.2	10.7	0.0	1.7	0.0	3.3	0.0	20.1	0.0	11.8	11.9	0.0	775.7	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	5.2	2.0
UGT3A1	FLJ34658	ENSG00000145626	"UDP glycosyltransferase family 3 member A1"	Q6NUS8	5	35951010-36001028	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	8	"kidney: 44.0;liver: 47.7"	"Group enriched"	"Detected in some"	5	"Collecting duct cells: 47.1;Early spermatids: 91.4;Hepatocytes: 63.1;Proximal tubular cells: 58.6"	"Group enriched"	"Detected in some"	15	"liver cancer: 6.7;renal cancer: 4.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	42	"RH-30: 25.3"									"HPA047697, HPA056290"	Uncertain		Approved	Vesicles,Cytosol		NA	NA			"Vesicles, Cytosol"		"HPA047697: AB_2680122, HPA056290: AB_2683088"				"unprognostic (2.41e-3)"			"unprognostic (4.47e-1)"			"unprognostic (4.04e-1)"	"unprognostic (4.62e-1)"	"unprognostic (1.42e-2)"	"unprognostic (6.05e-2)"	"unprognostic (9.14e-2)"	"unprognostic (1.76e-1)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	3.5	0.0	0.0	5.1	0.0	0.6	0.1	0.0	0.0	0.0	0.0	0.0	44.0	47.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.1	0.0	0.1	0.1	0.0	3.2	0.1	6.1	0.0	0.0	0.0	0.0	5.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.1	0.2	0.1	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	25.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.1	0.0	0.4	0.2	0.2	0.0	0.4	0.2	0.6	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.2	0.4	0.0	0.0	0.0	47.1	0.0	0.0	3.3	0.0	91.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	63.1	0.1	0.0	0.0	2.5	2.2	12.5	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	58.6	0.3	6.5	0.0	1.0	0.8	0.0	0.0	0.0	0.0	0.0
UGT3A2		ENSG00000168671	"UDP glycosyltransferase family 3 member A2"	Q3SY77	5	36035017-36071358	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"lymphoid tissue: 37.0;skin 1: 14.4;testis: 13.2"	"Group enriched"	"Detected in some"	5	"Collecting duct cells: 3.5;Early spermatids: 3.6;Late spermatids: 5.7;Proximal tubular cells: 3.3"	"Cancer enriched"	"Detected in some"	5	"testis cancer: 4.4"	"Region enhanced"	"Detected in single"		"pons and medulla: 2.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HDLM-2: 5.2;MOLT-4: 9.3;REH: 21.8;SuSa: 9.8;T-47d: 5.7;THP-1: 12.8"									HPA059475	Uncertain		Approved	"Nucleoplasm,Golgi apparatus,Cytosol"		Yes	NA			Nucleoplasm	"Golgi apparatus, Cytosol"	"HPA059475: AB_2684031"	"unprognostic (1.83e-4)"	"unprognostic (9.94e-2)"	"unprognostic (8.87e-2)"	"unprognostic (4.82e-4)"	"unprognostic (3.18e-1)"	"unprognostic (3.52e-2)"	"unprognostic (1.56e-1)"	"unprognostic (6.08e-2)"	"unprognostic (2.04e-1)"	"unprognostic (8.13e-2)"	"unprognostic (7.49e-2)"	"unprognostic (4.17e-2)"	"unprognostic (1.36e-3)"	"unprognostic (6.65e-2)"	"unprognostic (7.52e-2)"	"unprognostic (7.38e-2)"	"unprognostic (4.52e-3)"	0.1	1.1	0.1	0.0	0.2	6.4	1.6	0.1	0.6	0.1	0.1	0.5	0.4	0.0	0.1	0.8	0.1	0.1	0.2	0.2	0.1	0.6	5.6	0.8	0.1	0.0	0.5	0.0	0.2	0.0	0.0	1.7	0.2	2.0	0.6	0.0	2.9	0.1	0.0	0.1	14.4	0.1	0.0	0.3	1.4	0.1	13.2	0.0	37.0	0.1	0.2	0.1	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.5	0.3	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.5	1.1	0.0	0.0	0.0	0.0	0.2	0.3	0.0	1.0	0.0	0.4	5.2	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	4.2	0.0	0.0	0.0	0.0	9.3	0.0	3.9	0.0	0.0	21.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.8	5.7	12.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.2	0.1	0.6	0.1	0.6	0.5	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	3.5	0.0	0.1	0.0	0.0	3.6	0.0	0.0	0.0	0.0	0.5	0.2	0.1	0.0	0.5	0.1	0.0	0.0	0.0	0.0	5.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.3	0.0	0.0	0.0	0.0	0.8	0.0	0.2	0.0	0.0	0.0
UGT8	CGT	ENSG00000174607	"UDP glycosyltransferase 8"	Q16880	4	114598455-114678224	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Lipid metabolism, Sphingolipid metabolism"	"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"brain: 96.6"	"Cell type enhanced"	"Detected in many"	8	"Collecting duct cells: 24.4;Intestinal endocrine cells: 46.4;Mucus-secreting cells: 25.7;Spermatogonia: 36.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	10	"memory B-cell: 7.3;naive B-cell: 10.6"	"Lineage enriched"	"Detected in single"	12	"B-cells: 10.6"	"Cell line enhanced"	"Detected in many"		"CAPAN-2: 21.5;OE19: 41.1;RPTEC TERT1: 21.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA014405, HPA065785"	Enhanced		Approved	Mitochondria		No	No			Mitochondria		"HPA014405: AB_1858606, HPA065785: AB_2685559"	"unprognostic (7.38e-3)"	"unprognostic (2.07e-1)"	"unprognostic (1.25e-2)"	"unprognostic (2.38e-1)"	"unprognostic (1.63e-1)"	"unprognostic (1.63e-2)"	"unprognostic (1.16e-2)"	"unprognostic (2.38e-1)"	"unprognostic (7.78e-2)"	"unprognostic (1.56e-3)"	"unprognostic (4.49e-2)"	"unprognostic (2.76e-1)"	"prognostic favorable (8.55e-5)"	"unprognostic (2.80e-1)"	"unprognostic (1.78e-2)"	"unprognostic (7.53e-2)"	"unprognostic (1.49e-1)"	0.9	0.8	13.2	2.8	30.0	1.0	3.1	2.7	44.8	4.9	15.5	66.6	0.0	18.4	2.7	0.6	1.2	3.0	7.1	0.9	24.2	12.4	20.1	0.8	1.0	3.2	53.9	15.9	0.8	4.8	0.3	0.9	0.5	38.3	0.9	17.3	0.0	4.5	0.8	0.8	1.8	16.1	1.5	96.6	1.3	10.0	3.3	42.6	0.0	8.5	0.0	3.4	0.8	1.0	10.6	0.0	0.9	0.0	0.0	0.6	0.3	0.2	0.1	1.7	0.3	0.1	0.0	0.3	0.1	0.0	0.0	1.2	5.8	21.5	6.4	0.5	0.1	5.1	9.1	0.0	0.0	0.0	0.1	4.5	0.1	9.6	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	1.9	0.0	0.1	5.4	1.3	0.0	0.1	0.1	0.7	2.5	41.1	3.2	0.6	10.3	0.1	21.3	0.2	12.1	1.8	0.0	1.9	0.3	0.4	0.3	2.1	0.4	0.5	7.3	0.3	6.8	2.1	0.3	0.2	10.6	0.3	6.6	0.2	0.0	0.9	0.0	0.0	0.6	7.3	0.1	0.0	0.0	10.6	0.3	0.1	0.1	0.0	0.0	0.0	0.0	0.3	13.2	30.0	2.7	24.4	24.2	12.4	53.9	15.9	38.3	42.6	6.0	1.0	8.1	1.2	0.0	0.0	0.4	7.6	2.7	6.8	24.4	0.0	0.0	8.3	1.8	5.5	0.1	20.6	0.0	11.4	0.0	0.2	0.5	0.0	0.0	0.0	0.0	46.4	0.0	0.0	1.7	1.1	0.7	1.7	0.0	25.7	0.0	9.1	17.5	0.0	1.3	0.0	0.0	0.2	10.6	36.2	0.1	0.0	0.0	21.1	0.9
UHMK1	"KIS, Kist"	ENSG00000152332	"U2AF homology motif kinase 1"	Q8TAS1	1	162497251-162529629	"Enzymes, Predicted intracellular proteins"		"Kinase, RNA-binding, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA071190			Approved	"Nucleoplasm,Golgi apparatus,Midbody"		Yes	No			"Nucleoplasm, Golgi apparatus"	Midbody	"HPA071190: AB_2686358"	"unprognostic (6.69e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.05e-1)"	"unprognostic (1.46e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.33e-1)"	"unprognostic (2.08e-2)"	"unprognostic (8.16e-2)"	"unprognostic (9.63e-2)"	"unprognostic (1.82e-1)"	"unprognostic (7.81e-3)"	"unprognostic (9.10e-2)"	"unprognostic (3.11e-1)"	"unprognostic (3.44e-2)"	"unprognostic (9.08e-2)"	"unprognostic (8.77e-2)"	"unprognostic (4.66e-2)"	21.6	22.0	23.5	18.9	26.2	30.1	23.5	10.8	30.5	14.3	16.3	17.2	30.8	16.3	11.5	12.9	16.0	12.9	12.1	11.4	27.0	31.8	27.9	32.4	16.9	24.3	30.6	20.3	12.1	11.8	25.0	12.5	16.5	33.4	14.7	17.4	14.1	15.9	22.9	30.6	11.5	21.8	9.6	20.5	21.3	16.8	10.4	14.1	23.0	17.1	11.7	24.1	16.1	12.8	5.7	4.3	4.5	9.2	5.9	8.5	4.0	21.1	9.9	5.2	12.7	14.9	11.8	11.7	28.0	15.3	23.0	16.6	6.4	13.3	17.3	24.5	20.9	11.2	12.3	9.9	15.5	37.1	23.7	7.2	17.1	12.3	5.8	11.5	24.9	20.0	12.1	16.4	22.6	21.7	16.1	13.2	12.0	14.9	24.1	39.4	8.9	13.2	6.6	6.9	15.9	13.4	8.5	23.3	14.4	15.3	21.9	9.5	8.8	24.7	23.0	18.0	7.5	19.9	28.0	20.5	26.3	14.9	18.1	39.0	25.0	34.7	20.5	21.9	12.2	23.8	4.5	3.3	3.7	8.2	8.6	8.5	5.4	6.2	6.8	3.6	5.7	6.3	7.1	2.0	5.9	9.2	4.3	4.9	4.0	23.5	26.2	10.8	30.5	27.0	31.8	30.6	20.3	33.4	14.1	17.9	32.1	50.1	25.7	26.2	21.7	29.4	56.0	41.5	50.0	50.6	11.8	22.6	48.0	23.2	35.7	30.8	40.7	0.0	20.2	32.6	19.3	44.8	45.0	71.0	27.6	22.3	32.1	35.0	64.6	34.6	19.8	51.7	27.0	44.1	35.0	13.6	28.8	34.8	18.4	49.4	21.6	0.0	27.3	23.4	22.0	21.5	18.8	52.2	31.1	52.1
UHRF1	"FLJ21925, ICBP90, Np95, RNF106, TDRD22"	ENSG00000276043	"Ubiquitin like with PHD and ring finger domains 1"	Q96T88	19	4903080-4962154	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Cell cycle, DNA damage, DNA repair, Transcription, Transcription regulation, Ubl conjugation pathway"	"Chromatin regulator, DNA-binding, Repressor, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"lymphoid tissue: 75.6"	"Cell type enhanced"	"Detected in many"	5	"Extravillous trophoblasts: 5.8;Hofbauer cells: 7.5;Spermatogonia: 6.9"	"Low cancer specificity"	"Detected in all"							"Cell type enhanced"	"Detected in many"		"plasmacytoid DC: 8.2"	"Group enriched"	"Detected in many"	4	"dendritic cells: 8.2;T-cells: 4.2"	"Cell line enhanced"	"Detected in many"		"MOLT-4: 63.9;REH: 145.0"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"HPA049408, HPA055446"	Enhanced		Supported	Nucleoplasm		No	Yes			Nucleoplasm		"HPA049408: AB_2756317, HPA055446: AB_2732597"	"unprognostic (3.83e-2)"	"unprognostic (6.83e-3)"	"unprognostic (5.13e-2)"	"unprognostic (1.69e-1)"	"unprognostic (1.40e-1)"	"unprognostic (7.21e-2)"	"prognostic unfavorable (1.63e-4)"	"unprognostic (4.30e-2)"	"prognostic unfavorable (6.81e-4)"	"unprognostic (2.82e-1)"	"prognostic unfavorable (4.52e-5)"	"unprognostic (2.33e-3)"	"unprognostic (0.00e+0)"	"unprognostic (3.75e-3)"	"unprognostic (2.45e-1)"	"unprognostic (2.01e-1)"	"unprognostic (2.02e-1)"	0.7	0.0	0.7	8.2	3.7	16.5	0.7	0.3	4.2	0.3	1.5	1.6	0.0	2.1	0.3	0.2	2.0	0.0	1.0	0.9	1.2		0.1	0.1	0.3	10.0	4.3	0.7	0.3	0.6	0.0	0.0	1.0	1.4	0.0	1.4	0.0	0.0	0.0	0.3	1.9	2.2	0.8	0.7	2.2	1.9	3.1	4.0	75.6	0.0	4.0	6.6	1.1	0.0	0.4	8.2	1.5	0.4	0.9	4.2	0.9	15.9	11.6	17.5	12.4	0.5	2.0	2.8	13.0	6.2	13.6	13.2	13.8	8.1	9.1	3.2	5.7	4.9	8.0	12.0	7.0	9.6	14.7	13.7	7.8	10.8	14.7	0.2	19.3	11.9	1.0	0.5	7.3	1.9	2.1	4.0	14.4	11.2	10.5	8.1	12.5	63.9	11.8	7.8	5.8	12.5	145.0	39.1	6.6	3.7	11.7	13.0	10.3	10.2	5.6	1.8	2.9	10.1	18.4	5.0	14.4	11.7	18.6	15.7	4.5	4.6	26.8	8.3	18.8	18.3	0.6	0.4	0.2	1.1	0.1	0.1	0.3	1.5	1.9	2.2	0.4	0.4	1.5	1.5	0.9	0.3	8.2	4.2	0.9											0.0	0.0	1.5	0.6	0.0	2.6	1.6	2.5	1.4	1.2	0.0	0.0	1.7	0.0	1.7	2.5	0.0	0.9	0.0	0.3	5.8	0.5	0.5	0.0	0.6	7.5	3.2	0.0	0.0	2.1	0.9	0.6	0.7	0.0	2.8	1.5	0.5	2.6	1.9	0.4	0.0	0.8	0.0	1.5	4.2	6.9	0.0	1.1	0.0	4.7	0.7
UHRF2	"MGC33463, NIRF, RNF107, TDRD23, URF2"	ENSG00000147854	"Ubiquitin like with PHD and ring finger domains 2"	Q96PU4	9	6413151-6507054	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Cell cycle, Ubl conjugation pathway"	"DNA-binding, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA026633, HPA026697"			Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"HPA026633: AB_2732431, HPA026697: AB_2732432"	"unprognostic (1.08e-1)"	"unprognostic (1.13e-1)"	"unprognostic (1.52e-1)"	"unprognostic (1.68e-1)"	"unprognostic (1.12e-1)"	"unprognostic (8.40e-2)"	"unprognostic (4.35e-3)"	"unprognostic (4.12e-2)"	"unprognostic (1.53e-1)"	"unprognostic (4.17e-2)"	"unprognostic (1.73e-1)"	"unprognostic (5.69e-3)"	"unprognostic (2.14e-2)"	"unprognostic (6.21e-2)"	"unprognostic (8.77e-2)"	"unprognostic (7.42e-2)"	"unprognostic (1.50e-1)"	14.1	12.9	10.6	25.4	12.2	49.1	19.0	24.8	11.8	18.6	15.6	12.7	17.6	7.9	17.5	15.1	13.3	12.0	11.9	11.3	10.2	10.6	10.1	9.8	13.5	19.3	12.3	10.5	18.9	14.5	12.7	12.7	14.6	11.4	19.3	12.0	10.7	13.0	16.4	15.7	11.0	12.0	17.1	12.2	14.1	11.6	10.6	14.8	40.3	15.2	10.2	19.8	18.7	18.2	5.1	2.5	7.5	1.4	1.2	3.6	1.2	6.7	7.7	11.1	4.7	9.1	13.2	8.1	15.6	9.6	9.8	17.2	4.9	4.9	10.3	3.4	7.7	9.1	4.4	10.2	9.1	15.0	18.7	4.7	18.0	15.0	7.8	7.5	8.4	6.1	5.9	5.9	7.6	18.8	18.8	38.2	10.6	1.7	10.1	23.1	2.3	14.1	32.7	4.3	9.9	5.7	16.0	5.1	3.6	7.3	4.6	10.0	3.9	6.7	4.5	9.7	14.1	5.6	16.9	32.2	10.5	3.8	4.3	13.0	2.7	8.0	12.1	5.1	7.4	4.1	7.5	1.1	4.3	2.3	0.9	1.7	3.5	3.6	1.8	0.7	5.1	2.3	3.0	1.3	1.2	1.4	2.5	3.5	1.2	10.6	12.2	24.8	11.8	10.2	10.6	12.3	10.5	11.4	14.8	6.0	11.8	25.0	9.7	19.2	22.6	42.0	5.1	5.3	9.1	12.2	29.5	10.8	1.7	5.1	16.0	20.4	8.1	23.3	3.4	8.5	12.4	13.9	17.3	11.3	9.2	27.0	6.8	15.4	11.7	5.9	17.8	11.0	20.3	6.4	12.4	6.7	6.0	12.9	13.8	5.1	34.9	12.9	13.7	37.2	17.2	16.7	4.9	13.8	11.3	7.1
ULK1	"ATG1, ATG1A"	ENSG00000177169	"Unc-51 like autophagy activating kinase 1"	O75385	12	131894651-131923167	"Enzymes, Plasma proteins, Predicted intracellular proteins"	Autophagy	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"Horizontal cells: 50.9;Rod photoreceptor cells: 87.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"neutrophil: 6.9;plasmacytoid DC: 6.4"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA063990			Approved	Cytosol		NA	NA			Cytosol		"HPA063990: AB_2685167"	"unprognostic (1.53e-1)"	"unprognostic (5.19e-2)"	"unprognostic (2.52e-3)"	"unprognostic (2.21e-3)"	"unprognostic (8.01e-3)"	"unprognostic (5.48e-2)"	"unprognostic (2.74e-2)"	"unprognostic (5.04e-3)"	"unprognostic (3.94e-3)"	"unprognostic (2.03e-2)"	"unprognostic (9.09e-3)"	"unprognostic (8.19e-2)"	"unprognostic (6.25e-2)"	"unprognostic (2.38e-1)"	"unprognostic (2.75e-1)"	"unprognostic (1.82e-2)"	"unprognostic (3.16e-1)"	10.9	18.6	14.6	9.2	49.6	33.2	8.9	24.0	24.4	14.4	11.8	6.9	13.3	11.7	16.5	10.7	9.8	10.6	16.2	17.4	11.5	8.3	9.0	15.8	9.0	8.3	7.9	12.0	18.2	59.6	13.8	23.8	17.2	11.6	13.4	4.0	13.9	18.1	13.4	33.4	24.3	11.5	10.2	5.4	16.5	11.4	11.4	11.4	13.8	10.7	9.6	6.5	12.1	10.9	0.6	6.4	6.9	1.7	0.2	0.8	0.6	5.2	16.9	7.8	9.7	3.5	2.9	10.7	8.3	6.0	3.6	2.9	3.6	5.4	1.4	8.8	5.8	7.2	5.2	1.7	3.3	1.0	5.6	10.2	3.5	13.8	4.9	6.6	2.5	7.8	5.3	9.1	3.9	1.6	9.9	4.4	10.8	4.6	4.2	2.3	11.9	15.6	14.7	8.6	2.4	16.2	11.8	2.8	6.9	2.1	6.5	19.9	11.0	8.9	9.2	4.6	8.3	13.9	17.1	8.3	8.5	5.1	14.8	3.8	18.6	6.7	1.9	14.4	4.4	9.8	0.2	1.7	2.3	0.8	0.7	0.2	0.1	0.7	0.7	0.3	0.6	0.5	0.5	6.9	0.2	0.7	6.4	0.5	0.6	14.6	49.6	24.0	24.4	11.5	8.3	7.9	12.0	11.6	11.4	14.9	16.7	11.8	5.7	12.8	23.0	18.0	17.8	4.0	11.4	7.0	37.3	4.0	1.7	8.0	0.7	12.0	5.2	0.0	10.9	2.6	9.3	12.0	3.5	23.1	4.8	50.9	18.4	6.2	11.9	1.9	11.5	5.4	5.0	3.6	15.4	12.6	18.3	7.0	14.9	2.4	87.3	12.9	10.3	3.9	5.9	16.9	14.4	8.3	8.3	6.9
ULK2	"ATG1B, KIAA0623, Unc51.2"	ENSG00000083290	"Unc-51 like autophagy activating kinase 2"	Q8IYT8	17	19770829-19867936	"Enzymes, Predicted intracellular proteins"	"Autophagy, Neurogenesis"	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Late spermatids: 51.2;Spermatocytes: 38.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"intermediate monocyte: 6.9;non-classical monocyte: 5.8"	"Lineage enriched"	"Detected in many"	4	"monocytes: 6.9"	"Cell line enhanced"	"Detected in many"		"SuSa: 29.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB037021	Approved					NA	NA					"CAB037021: AB_1841237"	"unprognostic (1.47e-1)"	"unprognostic (1.88e-1)"	"unprognostic (2.56e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.23e-1)"	"unprognostic (1.31e-1)"	"unprognostic (6.53e-2)"	"unprognostic (1.07e-1)"	"unprognostic (5.83e-2)"	"unprognostic (1.39e-2)"	"unprognostic (5.11e-3)"	"unprognostic (1.39e-1)"	"unprognostic (1.16e-1)"	"unprognostic (3.44e-1)"	"unprognostic (2.69e-1)"	"unprognostic (3.23e-1)"	"unprognostic (1.38e-2)"	10.3	7.1	15.5	4.4	19.1	2.8	7.6	15.5	21.8	9.3	7.2	28.3	6.7	3.1	9.5	8.4	6.8	11.5	7.7	8.3	15.0	10.9	7.0	3.7	8.8	4.6	15.8	12.0	12.4	7.5	14.2	4.2	8.5	15.9	9.0	4.8	8.5	5.3	11.0	13.5	7.8	3.6	9.9	28.3	7.1	5.5	33.0	14.6	2.0	7.0	1.4	3.8	7.7	6.3	0.1	1.4	0.5	6.9	0.4	1.6	0.6	7.5	7.8	11.2	1.5	6.6	12.4	0.0	6.3	7.8	6.6	6.2	0.1	1.6	0.0	3.3	8.1	7.5	3.6	0.0	1.3	6.3	6.2	8.1	0.2	3.3	0.0	8.6	0.0	3.8	8.0	9.8	3.3	2.8	5.8	4.6	0.0	0.0	0.0	5.5	2.1	0.0	0.3	1.6	0.1	2.0	0.4	0.0	0.0	4.8	3.3	2.8	11.7	9.9	1.3	3.5	29.0	7.7	2.9	7.3	0.0	1.0	2.4	3.8	0.0	0.0	0.0	1.0	0.0	2.3	0.0	1.5	0.3	0.6	6.9	0.2	0.1	1.0	1.0	1.4	0.1	1.6	1.0	0.5	0.4	5.8	0.1	0.2	0.6	15.5	19.1	15.5	21.8	15.0	10.9	15.8	12.0	15.9	14.6	17.9	10.2	0.0	4.2	6.5	15.9	9.5	7.6	8.1	7.9	7.0	7.9	6.4	3.3	3.0	27.9	2.9	0.7	0.0	2.9	2.6	9.0	6.0	0.0	1.7	7.1	14.3	2.4	3.7	16.1	51.2	13.0	5.1	8.5	4.6	3.2	5.6	2.3	3.2	11.7	4.5	10.6	12.9	11.3	38.8	20.5	8.4	2.4	3.8	2.1	3.4
ULK3	"DKFZP434C131, FLJ90566"	ENSG00000140474	"Unc-51 like kinase 3"	Q6PHR2	15	74836116-74843346	"Enzymes, Predicted intracellular proteins"	Autophagy	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Bipolar cells: 75.1;Horizontal cells: 84.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA040474	Approved					NA	NA					"HPA040474: AB_2677003"	"unprognostic (3.67e-2)"	"unprognostic (8.90e-3)"	"unprognostic (2.65e-3)"	"unprognostic (1.59e-2)"	"unprognostic (1.70e-1)"	"unprognostic (2.07e-3)"	"unprognostic (1.19e-1)"	"unprognostic (1.58e-2)"	"unprognostic (1.47e-2)"	"unprognostic (4.18e-2)"	"prognostic favorable (7.47e-4)"	"unprognostic (1.97e-2)"	"unprognostic (2.70e-2)"	"unprognostic (1.30e-2)"	"unprognostic (1.63e-1)"	"unprognostic (1.16e-1)"	"unprognostic (4.97e-3)"	7.0	11.7	11.8	8.4	15.4	2.9	7.4	21.3	20.4	7.9	13.8	9.0	9.0	7.9	5.3	9.5	33.9	6.7	9.6	14.1	11.8	8.9	13.4	9.3	6.4	7.9	11.2	15.3	4.9	14.7	12.1	12.3	5.7	21.1	8.2	14.4	10.4	10.4	7.4	19.1	24.6	20.3	7.2	5.8	9.9	11.1	6.0	7.6	4.2	6.1	10.9	13.7	8.6	10.6	3.8	4.2	3.8	7.8	5.8	12.6	4.9	3.9	10.7	5.6	9.7	6.4	4.2	3.7	3.1	4.5	6.5	7.1	4.2	8.9	8.5	6.0	3.5	7.5	4.0	15.6	4.3	2.7	16.2	15.4	25.2	13.6	5.1	9.3	6.0	16.2	5.5	8.6	5.7	5.4	2.4	9.8	11.8	6.9	9.2	5.3	5.8	4.4	6.2	6.2	9.3	5.5	13.0	6.8	16.1	4.2	5.0	10.4	13.2	6.1	5.8	19.3	5.9	8.4	15.1	5.5	8.7	5.6	8.6	6.7	12.8	11.6	6.2	4.9	17.7	7.5	3.8	3.6	1.4	12.6	7.8	10.1	3.8	7.4	10.3	4.0	3.5	8.1	5.5	0.9	5.8	6.2	4.2	9.7	4.9	11.8	15.4	21.3	20.4	11.8	8.9	11.2	15.3	21.1	7.6	8.9	11.7	3.7	6.8	9.0	75.1	15.1	7.6	2.7	2.3	12.2	15.7	7.1	16.6	9.2	0.8	8.4	42.8	0.0	10.2	2.5	7.3	8.4	20.7	11.0	13.7	84.2	10.9	13.5	6.3	1.5	12.0	6.5	5.0	19.0	17.8	18.4	10.1	16.4	11.0	13.3	54.3	0.0	7.6	9.4	19.8	19.1	4.8	17.0	20.4	7.2
ULK4	"FAM7C1, FLJ20574, REC01035"	ENSG00000168038	"Unc-51 like kinase 4"	Q96C45	3	41246599-41962430	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	6	"Early spermatids: 279.5;Late spermatids: 329.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA017930	Uncertain		Approved	Nucleoplasm,Mitochondria,Cytosol		NA	NA			"Nucleoplasm, Mitochondria, Cytosol"		"HPA017930: AB_1858615"	"unprognostic (3.16e-2)"	"unprognostic (2.98e-3)"	"unprognostic (9.72e-3)"	"unprognostic (3.46e-2)"	"unprognostic (2.58e-1)"	"unprognostic (8.68e-2)"	"unprognostic (1.87e-1)"	"unprognostic (3.50e-2)"	"unprognostic (1.80e-1)"	"unprognostic (1.41e-1)"	"unprognostic (3.75e-3)"	"unprognostic (3.43e-1)"	"unprognostic (1.91e-2)"	"unprognostic (5.46e-2)"	"unprognostic (1.61e-1)"	"unprognostic (2.53e-1)"	"unprognostic (6.12e-2)"	4.3	4.8	5.1	4.7	8.3	10.3	4.2	4.3	5.4	11.9	2.8	5.9	6.0	2.1	10.7	10.9	2.8	12.3	3.1	13.1	5.2	3.0	5.4	3.4	5.5	4.2	3.1	4.2	4.5	3.6	13.5	19.7	9.0	5.8	4.4	2.8	6.7	4.2	4.5	1.4	3.5	3.3	5.1	5.7	4.4	3.4	27.5	3.4	6.3	7.1	1.7	8.4	4.0	6.0	6.4	5.1	10.7	6.3	2.6	10.3	5.2	7.3	1.7	2.7	3.0	1.1	1.7	4.6	2.5	2.6	3.1	2.6	0.9	2.2	8.6	1.4	5.8	3.0	3.7	3.2	1.9	2.8	1.1	0.9	1.6	5.4	2.9	3.9	5.6	1.7	1.6	2.2	15.0	3.1	3.9	2.1	5.9	1.9	7.2	2.2	5.9	7.0	4.5	3.3	1.8	3.1	1.6	8.5	3.7	6.5	7.1	1.4	9.9	2.6	1.2	2.1	1.8	3.0	1.8	6.2	2.0	2.2	13.2	2.1	4.3	8.0	3.6	11.0	5.9	2.4	5.7	5.8	5.8	8.0	6.3	6.5	5.6	8.6	7.2	5.1	6.4	6.5	9.2	10.7	2.6	3.2	4.6	10.3	5.2	5.1	8.3	4.3	5.4	5.2	3.0	3.1	4.2	5.8	3.4	8.9	5.8	1.9	2.8	1.8	5.4	12.8	5.1	53.5	4.5	3.5	51.1	2.8	0.0	2.3	279.5	4.4	1.1	0.0	2.1	3.9	3.3	1.2	1.1	5.9	6.5	11.1	1.7	1.8	4.1	329.6	6.1	5.6	0.0	6.4	1.1	11.2	2.8	0.0	3.9	5.0	25.1	6.5	3.3	29.9	8.7	3.1	3.5	4.4	1.7	0.8
UMPS		ENSG00000114491	"Uridine monophosphate synthetase"	P11172	3	124730366-124749273	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Pyrimidine biosynthesis"	"Decarboxylase, Glycosyltransferase, Lyase, Multifunctional enzyme, Transferase"	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Syncytiotrophoblasts: 91.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036178, HPA036179"	Uncertain		Approved	Cytosol		NA	NA			Cytosol		"HPA036178: AB_10673002, HPA036179: AB_10673615"	"unprognostic (6.41e-2)"	"unprognostic (6.70e-2)"	"unprognostic (1.79e-2)"	"unprognostic (1.13e-3)"	"unprognostic (2.70e-1)"	"unprognostic (1.72e-1)"	"unprognostic (1.15e-3)"	"unprognostic (5.51e-2)"	"unprognostic (4.85e-3)"	"unprognostic (1.43e-1)"	"unprognostic (5.36e-2)"	"prognostic unfavorable (9.20e-4)"	"unprognostic (2.18e-2)"	"unprognostic (1.58e-2)"	"unprognostic (1.91e-1)"	"unprognostic (4.61e-2)"	"unprognostic (1.31e-1)"	8.4	12.2	4.9	6.8	6.8	4.8	8.0	9.3	7.6	5.9	9.1	8.5	5.2	8.4	6.8	6.7	13.2	8.2	6.6	3.6	4.0	3.9	9.6	20.7	5.2	10.1	7.3	3.6	8.9	19.0	9.5	9.3	11.6	4.7	6.4	7.1	6.4	8.9	4.0	10.9	9.5	8.5	5.5	5.9	9.8	8.3	6.8	6.2	10.6	7.4	12.0	9.3	7.8	6.4	16.6	13.1	4.6	9.8	10.2	13.0	7.9	1.4	4.4	5.0	2.1	3.0	3.5	5.3	7.5	2.3	3.2	2.7	3.8	2.0	3.8	8.3	2.9	6.6	8.4	7.1	2.5	5.0	4.4	4.1	7.8	2.8	2.6	2.6	8.2	5.9	3.9	2.3	2.0	3.9	1.9	1.4	7.7	3.5	1.8	2.3	3.4	10.0	1.6	11.1	3.9	2.8	6.6	6.0	3.2	2.5	2.5	4.0	2.6	11.3	4.0	4.2	3.8	4.0	3.0	14.4	2.5	5.0	6.9	3.0	7.5	10.2	10.5	2.8	3.4	2.5	4.5	9.0	4.6	12.5	9.8	12.1	13.7	8.9	11.3	13.1	16.6	13.0	10.4	0.6	10.2	8.0	9.7	10.3	7.9	4.9	6.8	9.3	5.7	4.0	3.9	7.3	3.6	4.7	6.2	6.0	7.8	5.2	15.9	14.1	8.0	5.7	12.7	22.7	10.3	8.7	3.9	56.7	24.9	23.5	3.1	13.4	10.4	0.0	26.6	27.5	9.3	9.3	11.5	28.8	19.3	4.8	9.2	8.0	5.4	3.9	12.7	9.6	3.3	21.6	9.4	10.1	19.5	7.0	13.1	19.5	7.7	12.9	9.9	19.7	30.7	16.7	91.3	12.8	15.8	15.5
UNG	"DGU, HIGM4, UDG, UNG1, UNG2"	ENSG00000076248	"Uracil DNA glycosylase"	P13051	12	109097574-109110992	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"DNA damage, DNA repair, Host-virus interaction"	Hydrolase	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Spermatogonia: 64.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			CAB011605	Uncertain		Approved	Cytosol		NA	Yes			Cytosol		"CAB011605: AB_778737"	"unprognostic (4.38e-2)"	"unprognostic (3.82e-3)"	"unprognostic (1.03e-2)"	"unprognostic (1.33e-2)"	"unprognostic (4.64e-1)"	"unprognostic (4.10e-2)"	"prognostic unfavorable (6.40e-4)"	"unprognostic (5.68e-3)"	"prognostic unfavorable (3.06e-4)"	"unprognostic (4.66e-2)"	"unprognostic (8.78e-3)"	"unprognostic (1.91e-1)"	"unprognostic (1.35e-3)"	"unprognostic (2.57e-2)"	"unprognostic (4.50e-1)"	"unprognostic (1.40e-2)"	"unprognostic (6.89e-2)"	16.3	44.1	17.0	19.4	17.0	10.0	22.8	10.5	14.4	13.5	20.3	10.2	21.4	12.6	11.8	10.8	22.5	11.8	11.0	15.4	13.5	13.1	20.4	23.3	7.1	12.1	19.6	12.2	12.3	12.7	17.3	8.9	18.6	12.0	12.9	22.1	10.7	16.6	19.7	29.1	22.5	13.5	11.0	19.7	13.2	12.3	35.6	9.8	35.1	25.1	19.8	19.0	11.5	14.4	9.8	3.9	5.8	3.0	8.7	19.5	7.9	20.1	20.7	20.0	18.1	33.3	9.6	19.1	11.9	8.2	18.9	14.5	16.4	13.9	26.5	18.0	10.7	9.9	12.8	22.0	12.4	18.4	22.4	40.9	25.9	12.0	27.7	5.0	38.4	16.0	8.6	11.4	9.0	5.0	15.1	13.6	31.9	20.9	8.9	12.7	25.2	35.3	45.4	35.5	32.9	32.0	32.6	30.1	22.6	11.8	25.5	28.5	15.8	21.5	18.5	10.4	27.2	34.5	18.0	7.0	16.4	14.7	10.8	16.5	17.3	37.2	50.3	12.5	25.9	20.0	5.8	1.5	2.7	13.4	3.0	19.5	9.8	15.9	15.5	3.9	9.2	10.3	11.5	0.0	8.7	3.0	2.8	14.0	7.9	17.0	17.0	10.5	14.4	13.5	13.1	19.6	12.2	12.0	9.8	0.0	4.5	6.7	10.0	16.0	2.6	10.6	7.6	2.7	2.3	40.1	3.9	41.8	16.6	11.9	3.2	11.6	7.3	0.0	5.5	24.6	10.3	5.9	7.0	20.3	15.7	4.8	8.1	14.7	2.9	3.4	13.0	4.5	13.5	5.4	18.2	11.8	5.9	7.0	13.8	14.6	3.0	6.5	9.0	18.6	64.3	18.2	17.0	17.8	34.2	7.6
UPB1	BUP1	ENSG00000100024	"Beta-ureidopropionase 1"	Q9UBR1	22	24494107-24528390	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		Hydrolase	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	6	"liver: 85.7"	"Group enriched"	"Detected in many"	7	"Hepatocytes: 119.4;monocytes: 36.9;Proximal tubular cells: 58.6"	"Cancer enriched"	"Detected in some"	8	"liver cancer: 25.4"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	27	"basophil: 11.4;neutrophil: 3.0"	"Lineage enriched"	"Detected in single"	43	"granulocytes: 11.4"	"Group enriched"	"Detected in some"	5	"CACO-2: 11.2;NB-4: 4.6;THP-1: 6.1;U-937: 6.9"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"HPA000728, HPA076321"	Enhanced					NA	NA		790000			"HPA000728: AB_1080471, HPA076321: "	"unprognostic (7.27e-2)"	"unprognostic (4.57e-3)"	"unprognostic (2.27e-1)"	"unprognostic (7.62e-2)"	"unprognostic (1.97e-1)"	"unprognostic (1.09e-4)"	"prognostic favorable (2.30e-7)"	"unprognostic (8.41e-2)"	"unprognostic (1.06e-1)"	"unprognostic (2.93e-1)"	"unprognostic (4.89e-6)"	"unprognostic (3.82e-2)"	"unprognostic (1.93e-2)"	"unprognostic (1.81e-1)"	"unprognostic (2.56e-1)"	"unprognostic (1.99e-1)"	"unprognostic (4.63e-3)"	0.1	0.0	0.1	0.1	0.2	1.0	0.1	0.1	0.1	0.1	1.1	0.1	0.1	0.6	0.1	0.5	0.1	0.0	0.1	0.5	0.1	0.0	13.5	85.7	0.2	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.4	0.1	0.1	0.2	0.2	1.5	0.1	0.1	0.2	0.0	0.8	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	11.4	0.1	0.2	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.7	0.0	0.2	0.0	0.0	11.2	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	1.2	0.0	0.3	1.2	0.5	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.3	0.0	0.0	0.0	4.6	0.0	0.2	0.0	0.1	0.4	0.3	0.1	0.0	0.2	1.1	1.3	0.4	0.0	0.0	0.0	6.1	0.5	0.1	0.1	0.0	0.0	1.2	0.1	1.3	1.4	6.9	0.0	11.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.1	3.0	0.2	0.0	0.0	0.0	0.0	0.1	0.2	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	1.3	0.0	1.2	0.6	3.0	1.8	0.0	0.0	0.0	1.8	9.8	0.1	10.0	0.1	0.8	2.3	0.0	0.0	0.3	0.1	1.0	1.0	0.0	119.4	0.1	0.0	2.4	4.9	3.7	0.9	0.3	0.0	0.0	36.9	0.0	0.3	0.0	0.0	0.0	58.6	2.0	0.0	2.1	3.4	6.4	1.0	0.2	0.0	0.0	0.7
UPP1	"UDRPASE, UP, UPASE, UPP"	ENSG00000183696	"Uridine phosphorylase 1"	Q16831	7	48088628-48108733	"Enzymes, Predicted intracellular proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Extravillous trophoblasts: 206.2;Macrophages: 205.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"GAMG: 26.4;hTERT-HME1: 103.9;SK-MEL-30: 24.1;WM-115: 23.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA054040, HPA055394"	Enhanced		Enhanced	Nucleoplasm		No	No			Nucleoplasm		"HPA054040: AB_2682352, HPA055394: AB_2682805"	"unprognostic (1.16e-1)"	"prognostic unfavorable (1.02e-4)"	"unprognostic (5.96e-2)"	"unprognostic (1.01e-1)"	"unprognostic (3.21e-3)"	"unprognostic (6.36e-2)"	"unprognostic (1.78e-3)"	"prognostic unfavorable (1.97e-4)"	"unprognostic (3.81e-2)"	"unprognostic (1.91e-1)"	"unprognostic (1.53e-1)"	"unprognostic (2.59e-1)"	"unprognostic (1.52e-3)"	"unprognostic (2.95e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.30e-1)"	"unprognostic (1.39e-1)"	16.7	8.4	2.8	12.6	4.2	17.6	7.1	5.7	3.8	10.3	8.0	1.7	2.1	7.5	2.8	4.2	37.7	3.3	8.5	7.0	2.3	3.3	12.4	9.1	18.3	17.4	5.8	1.4	2.9	5.8	2.4	5.0	28.9	5.5	3.0	7.6	2.9	7.5	2.1	5.1	2.0	9.7	5.2	3.9	13.9	2.5	1.8	4.8	1.2	6.2	34.0	19.4	7.9	19.6	0.6	8.2	15.7	22.0	5.7	19.7	16.0	6.5	7.9	0.8	1.6	2.7	1.2	8.1	3.2	4.5	4.1	5.1	3.3	3.2	0.0	1.2	2.6	26.4	4.6	1.5	13.1	2.7	1.3	1.4	0.2	1.9	1.3	2.4	0.2	0.5	1.6	6.4	1.9	103.9	1.9	2.7	0.2	0.4	3.9	2.2	0.7	0.0	1.1	3.1	1.1	6.9	0.0	1.7	1.7	9.5	3.4	0.7	0.7	3.3	0.9	24.1	8.9	0.8	0.2	3.8	9.7	8.3	2.6	8.2	7.5	10.0	1.1	9.8	1.0	23.6	15.7	22.0	15.1	19.7	16.7	12.5	0.2	12.6	13.5	8.2	0.6	13.0	12.0	9.1	5.7	15.9	0.7	11.2	16.0	2.8	4.2	5.7	3.8	2.3	3.3	5.8	1.4	5.5	4.8	17.9	64.1	14.6	17.3	41.6	27.8	10.4	22.9	8.1	13.6	10.4	31.4	6.0	59.7	36.9	0.6	58.5	53.1	0.0	35.8	206.2	39.5	10.1	24.4	15.1	111.9	15.9	12.5	78.5	137.0	1.5	4.9	205.8	82.7	43.3	11.6	13.5	73.7	52.6	2.1	15.4	28.8	6.5	33.0	0.0	3.0	26.1	65.8	46.7	13.3	29.6
UPP2	"UDRPASE2, UP2, UPASE2"	ENSG00000007001	"Uridine phosphorylase 2"	O95045	2	157876702-158136154	"Enzymes, Predicted intracellular proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in many"	5	"kidney: 40.1;liver: 22.1"	"Group enriched"	"Detected in some"	4	"Distal tubular cells: 11.6;Proximal tubular cells: 23.3"	"Cancer enriched"	"Detected in some"	6	"liver cancer: 3.6"	"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in single"		"basophil: 1.0"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"CAPAN-2: 1.8;GAMG: 2.0;hTERT-RPE1: 1.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA035225, HPA035226"			Approved	Nucleoplasm,Vesicles,Mitochondria		NA	NA			Nucleoplasm	"Vesicles, Mitochondria"	"HPA035225: AB_10604002, HPA035226: AB_10696503"	"unprognostic (1.87e-1)"	"unprognostic (2.33e-1)"	"unprognostic (4.22e-3)"	"unprognostic (1.36e-3)"	"unprognostic (2.29e-1)"	"unprognostic (1.55e-1)"	"unprognostic (3.53e-2)"	"unprognostic (5.51e-2)"	"unprognostic (5.11e-2)"	"unprognostic (1.23e-2)"	"unprognostic (4.65e-3)"	"unprognostic (2.34e-1)"	"unprognostic (2.23e-2)"	"unprognostic (4.89e-2)"	"unprognostic (2.78e-2)"	"unprognostic (1.78e-2)"	"unprognostic (1.16e-2)"	1.2	0.4	1.8	0.3	4.1	0.3	1.6	6.9	2.0	0.4	0.3	1.5	0.7	0.3	1.2	2.4	1.0	0.4	2.5	0.8	2.9	1.2	40.1	22.1	0.3	0.4	1.2	0.9	0.6	0.4	0.3	3.9	0.4	1.3	2.3	0.3	1.1	1.7	0.7	0.3	0.6	0.4	0.3	2.3	0.3	0.3	0.4	1.0	0.0	0.5	0.0	0.7	0.4	0.2	0.8	0.0	1.0	0.1	0.0	0.2	0.0	0.3	0.2	0.6	0.6	0.0	0.0	0.3	0.5	0.0	0.0	0.0	0.0	1.8	0.2	0.1	0.0	2.0	0.0	0.0	0.0	0.0	0.8	0.1	0.1	0.2	0.1	0.0	0.0	0.2	0.0	0.5	0.0	0.0	1.9	0.0	0.7	0.8	0.9	0.0	0.0	0.0	0.1	1.1	0.6	1.2	1.4	0.3	0.0	0.3	0.6	0.6	0.4	0.4	0.5	0.0	0.4	0.8	0.1	0.0	0.2	0.2	0.0	0.0	1.2	0.1	0.4	0.3	1.2	0.4	1.0	0.0	0.1	0.1	0.1	0.1	0.1	0.2	0.2	0.0	0.8	0.1	0.2	0.2	0.0	0.0	0.0	0.1	0.0	1.8	4.1	6.9	2.0	2.9	1.2	1.2	0.9	1.3	1.0	0.0	0.0	0.0	0.0	0.0	1.0	0.1	0.0	0.0	0.0	1.8	0.0	0.0	11.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.3	0.0	0.0	0.0	0.6	0.8	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	23.3	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1
UQCRC1	"D3S3191, QCR1, UQCR1"	ENSG00000010256	"Ubiquinol-cytochrome c reductase core protein 1"	P31930	3	48599002-48610976	"Enzymes, Predicted intracellular proteins"	"Electron transport, Respiratory chain, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 172.7"	"Cell type enhanced"	"Detected in all"	4	"Cardiomyocytes: 576.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"PC-3: 65.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002815, HPA003525, CAB033782"	Enhanced		Supported	Mitochondria		NA	NA		1300000	Mitochondria		"CAB033782: AB_2213631, HPA002815: AB_1080486, HPA003525: AB_1080484"	"unprognostic (1.29e-1)"	"unprognostic (3.15e-3)"	"unprognostic (6.91e-3)"	"unprognostic (1.06e-1)"	"unprognostic (1.66e-1)"	"unprognostic (9.91e-2)"	"unprognostic (8.53e-2)"	"unprognostic (1.99e-1)"	"unprognostic (3.11e-2)"	"unprognostic (9.14e-2)"	"unprognostic (3.37e-1)"	"unprognostic (7.20e-2)"	"prognostic favorable (2.35e-10)"	"unprognostic (5.37e-2)"	"unprognostic (2.35e-1)"	"unprognostic (1.02e-1)"	"unprognostic (6.72e-2)"	18.1	13.7	11.1	9.8	12.5	9.4	11.8	12.5	20.5	11.0	33.7	6.9	10.4	20.0	9.1	9.7	15.8	12.4	10.8	66.7	10.8	11.2	23.0	30.5	7.7	9.3	13.3	13.5	6.3	14.4	20.4	7.8	11.5	13.3	12.5	12.3	7.8	19.5	21.9	172.7	14.0	20.9	12.0	8.7	8.4	23.0	18.4	7.4	9.4	9.1	39.9	9.8	10.3	9.1	23.3	52.7	28.1	57.8	15.1	22.0	74.3	10.1	16.5	6.0	3.6	8.8	8.1	27.1	18.8	15.2	15.6	14.2	25.6	3.0	26.3	11.9	8.4	18.3	9.8	7.5	21.8	2.9	15.6	35.9	27.0	14.3	27.7	17.5	16.9	11.7	11.1	24.8	10.6	17.5	7.4	15.5	17.4	14.5	1.8	9.4	17.7	12.2	19.3	15.0	15.0	65.5	8.3	16.0	21.5	16.1	11.1	6.4	11.4	25.4	3.1	15.0	1.7	6.5	2.7	15.5	4.3	16.5	13.6	19.3	16.0	14.1	15.2	9.6	19.5	13.9	17.6	57.8	28.1	18.9	56.9	17.9	23.3	18.9	19.0	52.7	18.6	17.1	16.4	14.1	15.1	48.5	21.0	22.0	74.3	11.1	12.5	12.5	20.5	10.8	11.2	13.3	13.5	13.3	7.4	53.6	50.3	63.6	133.4	104.5	38.0	576.9	142.7	78.9	46.6	115.1	27.5	292.1	310.0	150.4	116.4	44.8	496.0	46.7	145.4	266.4	68.1	72.4	80.8	173.2	214.8	38.1	138.8	44.2	110.4	218.8	54.1	87.6	113.1	113.6	228.6	55.4	138.8	252.6	66.4	309.3	39.8	58.2	92.9	102.7	76.4	92.1	281.6	56.5	307.7	117.4
UQCRC2	"QCR2, UQCR2"	ENSG00000140740	"Ubiquinol-cytochrome c reductase core protein 2"	P22695	16	21952660-21983660	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Electron transport, Respiratory chain, Transport"		"Disease mutation, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007998, HPA019146"	Enhanced		Enhanced	Mitochondria		NA	NA		4000000	Mitochondria		"HPA007998: AB_1858648, HPA019146: AB_1858649"	"unprognostic (1.33e-1)"	"unprognostic (1.32e-1)"	"unprognostic (1.49e-3)"	"unprognostic (3.35e-1)"	"unprognostic (1.26e-2)"	"unprognostic (6.91e-2)"	"unprognostic (2.71e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.72e-1)"	"unprognostic (8.87e-2)"	"unprognostic (1.67e-2)"	"unprognostic (2.43e-2)"	"prognostic favorable (6.58e-9)"	"unprognostic (2.33e-1)"	"unprognostic (9.78e-3)"	"unprognostic (4.67e-3)"	"unprognostic (7.36e-2)"	22.7	26.8	20.6	17.1	32.7	20.5	21.3	29.2	33.7	17.7	38.4	17.4	19.5	45.0	20.8	18.6	28.7	20.0	19.1	94.9	19.8	19.3	35.1	35.8	15.9	23.6	20.9	28.5	21.9	20.8	36.6	20.2	17.8	29.6	17.7	40.5	18.5	22.1	20.2	103.9	22.2	42.0	30.4	16.5	16.5	29.3	10.3	19.2	25.2	21.4	70.0	22.9	27.9	20.0	20.0	30.6	14.3	29.3	18.7	25.7	27.4	19.3	21.2	13.1	8.7	14.7	20.6	18.6	18.8	15.3	17.2	17.5	34.3	19.1	38.3	16.9	16.1	12.8	35.3	21.3	18.8	19.9	17.5	19.7	21.7	18.7	48.4	15.5	27.5	54.9	24.0	23.6	13.4	18.5	17.6	22.5	21.3	23.4	20.1	18.6	25.6	28.6	17.9	14.4	24.5	16.4	33.5	30.5	41.9	25.8	22.8	18.2	13.3	26.6	33.6	20.2	16.6	38.4	29.3	19.9	12.2	11.5	11.9	16.7	14.5	10.5	34.0	20.0	29.3	13.9	14.3	24.7	12.8	16.9	29.3	21.9	20.0	20.5	18.6	30.6	15.8	22.8	20.8	9.1	18.7	27.6	13.2	25.7	27.4	20.6	32.7	29.2	33.7	19.8	19.3	20.9	28.5	29.6	19.2	59.6	42.0	98.3	164.9	80.5	95.9	481.5	84.1	72.3	54.6	68.0	82.5	196.5	386.3	104.6	67.7	84.2	282.6	23.3	96.2	128.0	82.0	92.1	91.1	104.1	172.2	65.2	109.2	63.3	130.3	64.8	63.3	104.5	124.9	144.3	181.4	81.7	88.0	175.6	91.2	254.0	122.1	77.6	118.3	52.3	51.5	77.2	232.7	106.2	298.0	149.1
UQCRFS1	"RIP1, RIS1, RISP, UQCR5"	ENSG00000169021	"Ubiquinol-cytochrome c reductase, Rieske iron-sulfur polypeptide 1"	P47985	19	29205321-29213541	"Enzymes, Predicted intracellular proteins"	"Electron transport, Respiratory chain, Transport"	Translocase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 112.3"	"Cell type enhanced"	"Detected in all"	6	"Cardiomyocytes: 1206.2;Distal tubular cells: 877.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA041863, HPA050339"	Enhanced		Approved	Mitochondria		NA	NA			Mitochondria		"HPA041863: AB_10794638, HPA050339: AB_2681095"	"unprognostic (4.00e-2)"	"unprognostic (2.23e-3)"	"prognostic favorable (3.29e-4)"	"unprognostic (7.91e-3)"	"unprognostic (3.93e-2)"	"unprognostic (8.68e-2)"	"unprognostic (1.84e-1)"	"unprognostic (7.53e-2)"	"unprognostic (3.53e-2)"	"prognostic unfavorable (3.84e-4)"	"unprognostic (1.73e-2)"	"unprognostic (1.66e-1)"	"prognostic favorable (3.92e-9)"	"unprognostic (6.11e-2)"	"unprognostic (2.96e-1)"	"unprognostic (1.45e-1)"	"unprognostic (1.92e-2)"	15.2	27.1	20.1	10.8	18.3	25.4	28.2	18.3	33.4	11.9	27.3	9.1	9.8	24.3	10.5	14.3	16.9	11.9	14.2	95.3	19.4	14.8	34.9	33.8	12.0	21.2	18.3	13.1	9.1	26.4	15.9	10.6	10.8	17.6	11.8	30.3	11.5	17.0	13.9	112.3	12.9	27.0	19.6	11.5	11.3	18.8	16.6	6.5	17.7	12.9	55.0	14.5	13.7	10.0	18.5	35.6	14.9	29.9	15.0	22.1	45.1	21.8	37.0	13.8	12.4	22.6	17.3	15.3	17.1	17.9	23.7	26.3	22.4	13.6	19.9	18.1	19.3	19.4	23.3	30.1	20.4	28.7	13.5	30.1	28.2	14.6	20.3	19.2	26.8	24.8	20.8	22.1	16.2	24.7	14.0	18.9	24.9	20.0	12.5	25.4	20.2	18.7	20.1	14.4	46.7	14.4	17.1	18.4	15.1	29.5	26.4	16.8	8.2	15.6	30.9	19.6	16.1	14.4	22.4	11.9	16.1	24.5	11.0	17.7	6.0	11.3	18.4	14.2	23.3	11.4	14.9	29.9	14.0	17.9	29.3	17.8	18.5	19.2	18.3	35.6	15.7	20.4	19.4	9.1	15.0	24.3	19.7	22.1	45.1	20.1	18.3	18.3	33.4	19.4	14.8	18.3	13.1	17.6	6.5	50.6	43.5	83.4	229.0	131.1	67.3	1206.2	170.7	48.2	45.5	108.2	15.7	255.3	877.0	208.2	176.6	94.4	303.4	70.0	204.7	204.0	122.3	162.8	88.9	250.4	234.4	49.3	153.7	93.9	135.6	102.8	85.4	113.1	156.9	178.5	238.4	96.8	186.1	196.4	76.7	532.4	58.7	97.0	163.6	296.9	77.1	140.0	319.3	108.3	325.0	307.9
URAD	PRHOXNB	ENSG00000183463	"Ureidoimidazoline (2-oxo-4-hydroxy-4-carboxy-5-) decarboxylase"	A6NGE7	13	27977714-27988654	"Enzymes, Predicted intracellular proteins"	"Purine metabolism"	"Decarboxylase, Lyase"		"Evidence at transcript level"	"Evidence at transcript level"				"Group enriched"	"Detected in some"	5	"breast: 8.8;intestine: 16.7"	"Group enriched"	"Detected in some"	5	"Enterocytes: 112.1;Mucus-secreting cells: 56.3;Paneth cells: 57.5"	"Cancer enriched"	"Detected in some"	15	"colorectal cancer: 7.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	13	"BEWO: 6.9;CACO-2: 6.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA038972	Uncertain					NA	NA					"HPA038972: AB_10671869"			"unprognostic (2.00e-1)"											"unprognostic (1.05e-1)"	"unprognostic (5.21e-2)"			2.8	0.0	0.1	1.5	0.1	0.0	8.8	0.6	0.1	0.1	16.7	0.1	0.1	8.2	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.9	0.1	0.1	0.1	0.1	0.0	16.0	0.2	0.1	0.1	0.0	0.2	0.1	0.6	0.1	0.1	0.1	0.1	0.1	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.9	0.0	0.0	0.0	0.0	6.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.6	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	3.3	0.0	0.3	0.0	112.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	10.2	0.0	0.0	0.0	0.0	0.0	0.0	1.8	56.3	0.0	0.0	57.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	16.4	0.0
UROC1	"FLJ31300, HMFN0320"	ENSG00000159650	"Urocanate hydratase 1"	Q96N76	3	126481281-126517773	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Histidine metabolism"	Lyase	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	32	"liver: 50.7"	"Cell type enriched"	"Detected in some"	17	"Hepatocytes: 31.8"	"Cancer enriched"	"Detected in single"	100	"liver cancer: 12.1"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"neutrophil: 1.5"	"Lineage enhanced"	"Detected in single"		"granulocytes: 1.5"	"Cell line enriched"	"Detected in some"	8	"NB-4: 9.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA069863	Enhanced					NA	NA		510000			"HPA069863: AB_2732143"	"unprognostic (1.28e-1)"	"unprognostic (2.74e-2)"	"unprognostic (1.08e-1)"	"unprognostic (7.43e-2)"	"unprognostic (6.43e-2)"	"unprognostic (1.43e-1)"	"unprognostic (2.23e-3)"	"unprognostic (2.95e-1)"	"unprognostic (2.57e-2)"	"unprognostic (7.71e-2)"	"unprognostic (9.97e-2)"	"unprognostic (3.04e-1)"	"unprognostic (3.65e-5)"	"unprognostic (3.97e-2)"	"unprognostic (2.66e-1)"		"unprognostic (5.52e-2)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	50.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	9.5	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	31.8	0.3	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
UROD		ENSG00000126088	"Uroporphyrinogen decarboxylase"	P06132	1	45012147-45015575	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Heme biosynthesis, Porphyrin biosynthesis"	"Decarboxylase, Lyase"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	11	"Erythroid cells: 607.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"K-562: 81.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027468, HPA028668, HPA030350"	Uncertain		Supported	Nucleoplasm,Cytosol		NA	NA		5200000	"Nucleoplasm, Cytosol"		"HPA027468: AB_1858654, HPA028668: AB_10603458, HPA030350: AB_2673440"	"unprognostic (5.90e-2)"	"unprognostic (2.94e-2)"	"unprognostic (2.49e-1)"	"unprognostic (9.61e-2)"	"unprognostic (7.94e-2)"	"unprognostic (1.96e-1)"	"prognostic unfavorable (2.48e-4)"	"unprognostic (2.31e-2)"	"unprognostic (4.76e-2)"	"unprognostic (6.75e-2)"	"unprognostic (7.72e-3)"	"unprognostic (3.92e-1)"	"unprognostic (1.24e-1)"	"unprognostic (4.68e-2)"	"unprognostic (1.41e-1)"	"unprognostic (8.73e-2)"	"unprognostic (8.12e-2)"	20.7	50.2	23.1	12.2	26.2	67.5	20.7	14.2	28.6	17.7	24.2	16.5	25.9	11.2	27.8	22.6	17.8	20.8	17.4	34.0	21.1	20.3	29.6	58.1	14.3	14.8	21.6	22.9	27.4	18.4	35.9	17.6	25.8	16.2	19.2	12.3	24.3	45.6	19.2	28.8	12.1	13.2	22.9	18.9	16.6	15.0	16.3	11.5	17.2	26.3	23.6	16.0	15.0	13.0	25.7	48.6	20.6	36.3	26.0	27.4	35.6	12.7	8.4	13.4	17.7	23.3	21.9	6.5	15.6	40.4	33.0	25.4	12.1	6.8	9.1	16.6	23.7	23.3	6.6	25.6	30.5	23.0	8.1	26.9	47.0	19.4	39.9	27.1	14.3	8.7	22.7	19.4	31.4	25.5	24.4	42.3	17.6	81.5	10.0	31.4	10.7	9.7	12.4	20.9	10.2	29.7	14.7	20.0	13.1	28.7	10.9	14.4	11.3	17.1	12.9	26.4	15.9	10.1	15.0	27.3	18.8	14.7	6.5	25.2	10.4	11.1	7.6	29.4	21.7	9.4	17.6	36.3	20.6	19.7	25.8	20.0	25.7	23.8	19.2	48.6	23.7	22.3	20.3	6.6	26.0	15.5	32.4	27.4	35.6	23.1	26.2	14.2	28.6	21.1	20.3	21.6	22.9	16.2	11.5	41.7	38.9	45.2	26.1	20.4	23.6	60.9	40.8	22.7	18.2	26.2	15.7	83.3	76.3	62.1	7.2	47.7	22.7	607.3	55.7	45.2	63.6	19.5	50.8	86.0	88.6	12.7	17.2	30.7	34.3	12.5	73.6	37.9	45.5	163.3	18.4	80.8	47.4	21.8	52.6	99.3	21.8	38.8	41.5	35.1	38.5	21.7	41.6	21.8	17.4	22.2
UROS		ENSG00000188690	"Uroporphyrinogen III synthase"	P10746	10	125784980-125823248	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Heme biosynthesis, Porphyrin biosynthesis"	Lyase	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	5	"Erythroid cells: 186.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044038	Approved		Approved	Nucleoplasm,Cytosol		NA	NA		15000	Nucleoplasm	Cytosol	"HPA044038: AB_10966692"	"unprognostic (8.86e-2)"	"unprognostic (7.64e-2)"	"unprognostic (2.77e-1)"	"unprognostic (7.19e-2)"	"unprognostic (1.90e-1)"	"unprognostic (2.41e-1)"	"unprognostic (1.08e-1)"	"unprognostic (5.82e-2)"	"unprognostic (1.27e-1)"	"unprognostic (4.35e-3)"	"unprognostic (4.23e-3)"	"unprognostic (2.00e-2)"	"prognostic unfavorable (6.27e-4)"	"unprognostic (1.58e-1)"	"unprognostic (1.50e-1)"	"unprognostic (1.68e-1)"	"unprognostic (3.93e-1)"	13.8	16.1	48.6	9.0	46.6	33.2	13.9	12.8	35.3	8.9	11.4	15.7	12.8	13.2	9.3	41.2	10.5	11.3	11.5	31.4	36.9	20.4	22.6	25.5	10.0	16.8	22.7	23.4	14.5	14.1	14.4	12.0	7.9	20.0	12.9	12.4	14.0	18.1	14.0	45.6	9.8	12.0	13.0	12.5	11.7	12.5	13.8	13.8	10.8	16.4	14.4	12.7	9.4	6.3	17.3	27.1	2.4	15.6	24.7	21.3	17.8	17.7	19.3	14.1	31.2	18.8	19.1	19.0	23.0	39.8	16.2	16.2	8.3	21.6	24.8	10.7	28.5	11.3	10.2	8.1	16.3	15.2	30.6	15.5	52.7	10.9	13.7	26.6	22.2	12.4	23.9	9.4	11.3	30.3	22.5	14.8	18.4	9.1	23.6	27.0	21.2	19.4	25.0	15.3	13.3	20.1	13.8	15.5	14.7	21.2	11.0	11.0	19.0	23.0	17.8	31.2	15.0	15.8	21.2	14.7	21.5	8.0	16.5	19.5	21.8	15.8	16.9	29.9	9.0	10.1	2.4	15.6	2.2	16.1	15.4	18.5	15.7	16.0	20.4	27.1	17.3	21.3	16.3	1.2	24.7	14.6	12.9	14.2	17.8	48.6	46.6	12.8	35.3	36.9	20.4	22.7	23.4	20.0	13.8	17.9	20.2	41.0	10.4	8.2	45.4	60.5	33.1	20.1	17.0	34.9	43.2	49.6	86.2	49.2	45.5	19.3	27.7	186.9	52.4	38.4	25.6	22.0	11.5	53.9	68.9	44.5	13.9	27.6	41.0	95.8	33.1	23.1	59.1	66.7	19.6	51.6	42.5	10.5	38.2	117.1	33.3	6.5	28.2	41.5	71.3	11.2	16.7	38.9	37.7	19.7
USP1		ENSG00000162607	"Ubiquitin specific peptidase 1"	O94782	1	62436297-62451804	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"DNA damage, DNA repair, Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 70.6"	"Cell type enhanced"	"Detected in many"	6	"Spermatocytes: 281.4;Spermatogonia: 214.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028387, HPA028440"	Approved		Supported	Nucleoplasm		NA	NA			Nucleoplasm		"HPA028387: AB_2672578, HPA028440: AB_10603000"	"unprognostic (1.22e-1)"	"unprognostic (5.36e-2)"	"unprognostic (1.78e-3)"	"unprognostic (4.05e-3)"	"unprognostic (2.57e-1)"	"unprognostic (1.72e-2)"	"prognostic unfavorable (5.81e-5)"	"unprognostic (6.72e-2)"	"unprognostic (1.11e-2)"	"unprognostic (5.32e-2)"	"unprognostic (3.33e-3)"	"unprognostic (3.99e-2)"	"unprognostic (2.76e-2)"	"unprognostic (9.61e-3)"	"unprognostic (5.70e-2)"	"unprognostic (1.96e-1)"	"unprognostic (1.71e-1)"	11.6	9.0	11.3	17.2	10.7	29.3	15.9	20.6	14.2	19.2	13.3	7.8	8.0	10.8	15.1	12.0	15.6	13.8	8.9	9.0	11.5	9.6	11.8	9.3	11.7	19.2	14.2	9.6	26.7	12.7	14.8	18.4	13.6	10.9	14.8	13.9	7.6	12.7	13.5	11.7	12.3	13.3	15.8	15.5	18.1	11.6	31.6	11.8	70.6	15.0	13.3	20.1	16.5	16.5	14.7	11.8	23.4	12.4	15.5	16.3	9.2	22.3	6.6	27.8	15.0	6.2	7.5	15.4	21.5	14.7	26.8	29.3	11.1	10.9	40.4	15.6	12.0	24.0	13.0	22.7	14.8	37.5	20.2	16.4	33.2	22.9	11.6	6.8	35.5	16.8	4.0	9.7	24.2	18.3	7.3	12.6	27.5	24.0	35.3	18.8	10.0	36.3	13.7	24.4	13.4	13.7	34.5	47.1	25.0	10.0	16.7	28.7	16.1	24.3	19.9	23.5	19.4	11.4	21.7	8.7	20.7	22.5	30.2	30.1	14.0	19.5	46.4	14.0	28.4	18.5	17.4	9.5	23.4	12.6	9.6	16.3	14.7	15.0	12.7	11.4	10.7	14.3	11.9	16.9	15.5	12.4	11.8	13.6	9.2	11.3	10.7	20.6	14.2	11.5	9.6	14.2	9.6	10.9	11.8	44.7	25.6	45.4	30.6	55.3	44.0	29.7	20.4	56.2	43.3	15.7	21.6	30.6	16.6	26.4	117.0	37.9	12.9	0.0	29.7	56.2	38.1	45.1	26.6	15.8	26.9	33.4	8.1	23.4	28.2	52.6	46.3	31.1	25.3	53.3	29.2	47.5	22.4	7.0	38.5	13.5	78.0	51.8	47.7	281.4	214.8	56.2	27.6	46.5	30.4	28.8
USP10	"KIAA0190, UBPO"	ENSG00000103194	"Ubiquitin specific peptidase 10"	Q14694	16	84699978-84779922	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Autophagy, DNA damage, DNA repair, Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 105.5"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in all"	6	"neutrophil: 105.5"	"Lineage enriched"	"Detected in all"	6	"granulocytes: 105.5"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006731, HPA006749"	Enhanced		Supported	Nucleoplasm,Cytosol		NA	NA			Cytosol	Nucleoplasm	"HPA006731: AB_1080495, HPA006749: AB_1080492"	"unprognostic (4.14e-2)"	"unprognostic (2.28e-1)"	"unprognostic (2.36e-2)"	"unprognostic (4.85e-2)"	"unprognostic (6.93e-2)"	"unprognostic (1.77e-3)"	"unprognostic (1.03e-3)"	"unprognostic (2.91e-3)"	"unprognostic (1.75e-1)"	"unprognostic (3.84e-2)"	"unprognostic (2.56e-2)"	"unprognostic (1.82e-3)"	"prognostic favorable (1.00e-4)"	"unprognostic (5.91e-2)"	"unprognostic (4.57e-2)"	"unprognostic (8.57e-2)"	"unprognostic (1.38e-1)"	13.9	18.8	16.0	24.2	19.0	13.4	14.4	24.4	20.4	15.9	18.1	15.6	8.4	16.1	20.2	10.4	19.7	18.2	12.0	16.4	19.3	15.1	16.4	20.7	13.7	18.8	19.7	17.4	18.5	17.1	35.8	15.0	23.5	16.2	15.0	15.6	17.9	15.3	17.8	47.0	17.0	17.5	20.2	16.3	16.0	15.0	15.5	16.2	20.4	17.6	15.7	20.9	19.7	15.8	7.2	10.4	105.5	8.6	7.7	17.3	10.0	13.9	19.3	18.8	23.3	6.9	11.8	25.4	13.8	14.6	23.4	12.9	27.2	12.2	24.2	16.0	14.4	11.7	16.0	26.1	21.9	31.2	9.8	13.7	13.9	9.1	18.0	9.2	20.6	8.4	7.4	17.0	24.4	28.3	13.9	17.9	16.2	37.9	5.3	16.2	29.2	21.3	10.0	22.6	15.6	13.1	27.8	10.3	11.5	14.7	11.4	17.6	10.4	33.0	10.7	9.3	17.2	24.7	13.2	13.1	16.3	13.0	8.2	13.1	8.9	12.3	61.4	10.5	13.3	16.6	2.5	8.6	1.6	5.7	7.0	6.8	7.2	17.3	6.3	10.4	6.7	9.9	6.0	105.5	7.7	6.3	3.5	6.1	10.0	16.0	19.0	24.4	20.4	19.3	15.1	19.7	17.4	16.2	16.2	50.6	41.3	27.5	36.9	45.7	24.1	56.0	25.5	124.5	62.6	26.2	27.5	85.2	26.6	26.4	61.2	28.2	27.5	23.3	21.5	65.0	33.0	35.8	53.5	33.4	27.3	19.1	27.7	27.0	34.9	79.4	21.9	31.0	23.6	27.9	26.5	20.1	22.1	17.5	21.2	35.6	48.5	25.8	38.2	32.5	29.0	43.3	50.9	25.4	33.2	36.5
USP11	UHX1	ENSG00000102226	"Ubiquitin specific peptidase 11"	P51784	X	47232690-47248328	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction, Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 74.0"	"Cell type enhanced"	"Detected in all"	6	"Bipolar cells: 178.6;Horizontal cells: 131.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003103, HPA037536"	Enhanced	Supported	Supported	Nucleoplasm,Cytosol	"Intracellular and membrane"	NA	NA			Nucleoplasm	Cytosol	"HPA003103: AB_10671088, HPA037536: AB_10672904"	"unprognostic (1.60e-1)"	"unprognostic (2.77e-3)"	"unprognostic (5.84e-2)"	"prognostic unfavorable (2.95e-4)"	"unprognostic (3.08e-2)"	"unprognostic (2.02e-1)"	"unprognostic (6.11e-3)"	"unprognostic (9.21e-2)"	"unprognostic (3.18e-2)"	"unprognostic (3.52e-1)"	"unprognostic (3.29e-3)"	"unprognostic (3.74e-2)"	"prognostic favorable (4.13e-5)"	"unprognostic (3.14e-2)"	"unprognostic (9.23e-2)"	"unprognostic (9.51e-2)"	"unprognostic (7.11e-2)"	11.5	17.3	32.9	11.5	55.0	4.9	9.4	35.7	74.0	17.5	9.1	19.9	5.8	6.0	22.6	12.7	9.7	26.6	12.8	20.6	27.0	44.0	13.6	6.7	12.5	13.8	23.1	47.4	38.2	13.8	28.4	32.3	12.6	27.8	15.7	7.6	17.9	9.3	21.3	13.7	7.8	7.3	19.1	17.0	13.5	9.1	19.2	14.6	19.0	27.2	4.3	14.3	11.0	9.8	21.0	20.6	22.8	8.7	19.8	31.7	16.4	14.4	22.8	39.3	26.7	14.9	10.0	10.9	11.1	17.5	22.1	24.7	21.7	11.9	9.6	8.8	20.0	23.6	17.3	31.8	7.8	19.7	14.8	24.1	11.2	18.1	19.2	17.3	12.6	23.4	14.3	3.3	23.3	10.0	12.4	8.8	22.5	8.3	1.3	17.2	22.0	24.3	13.4	29.2	7.9	20.3	27.4	38.5	8.0	10.8	20.0	22.3	38.1	20.3	4.1	12.0	26.2	8.6	7.2	9.2	18.6	19.7	26.2	12.6	17.8	11.2	16.7	11.6	15.7	16.6	22.8	3.5	7.4	22.6	7.4	19.9	20.1	10.2	22.1	4.6	21.0	15.4	31.7	2.2	19.8	8.7	20.6	12.7	16.4	32.9	55.0	35.7	74.0	27.0	44.0	23.1	47.4	27.8	14.6	20.8	15.3	34.1	35.1	12.0	178.6	20.7	12.7	41.5	29.6	31.4	53.0	16.9	43.1	13.8	20.4	19.6	7.8	23.3	9.0	11.2	33.9	14.4	45.0	6.6	12.0	131.9	34.0	23.4	8.8	28.3	27.3	12.9	27.0	26.2	7.9	89.6	11.0	7.0	39.6	12.5	53.1	25.8	33.0	11.7	38.3	5.6	13.6	30.6	8.0	25.7
USP12	USP12L1	ENSG00000152484	"Ubiquitin specific peptidase 12"	O75317	13	27066142-27171896	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007288, HPA059492"	Uncertain		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA007288: AB_1080531, HPA059492: "	"unprognostic (6.72e-3)"	"unprognostic (2.63e-3)"	"unprognostic (1.04e-1)"	"unprognostic (2.34e-2)"	"unprognostic (1.22e-1)"	"unprognostic (5.85e-2)"	"unprognostic (1.79e-1)"	"unprognostic (3.39e-1)"	"unprognostic (8.38e-2)"	"unprognostic (8.77e-2)"	"unprognostic (2.20e-1)"	"unprognostic (3.06e-2)"	"unprognostic (1.22e-2)"	"unprognostic (1.40e-1)"	"unprognostic (2.91e-1)"	"unprognostic (6.77e-2)"	"unprognostic (1.73e-1)"	15.7	10.4	18.3	23.3	17.8	46.0	15.6	16.6	18.3	12.1	30.6	16.1	8.8	13.0	15.3	11.6	23.5	9.5	14.5	11.3	19.3	15.9	18.3	27.9	19.9	19.6	20.5	7.5	12.0	13.4	10.7	16.2	14.8	12.4	17.5	19.1	10.1	8.9	9.5	9.8	17.3	33.0	43.8	18.5	16.5	14.7	11.0	13.1	8.4	12.0	6.6	18.5	42.8	24.2	4.6	3.0	5.3	2.1	2.3	3.6	1.2	12.1	7.6	14.6	7.6	9.8	12.6	5.2	17.1	12.1	9.5	7.1	13.8	19.1	17.3	8.6	13.5	23.1	7.5	9.5	9.9	20.4	27.9	8.2	26.7	9.9	9.7	12.4	15.4	18.8	7.8	14.6	10.7	12.4	12.1	21.9	12.0	8.9	8.4	19.7	7.1	9.4	20.6	10.5	15.6	13.5	10.8	18.7	4.1	18.8	8.6	16.2	9.8	14.7	12.4	13.8	19.1	5.8	15.0	25.8	10.0	9.6	21.3	15.5	6.5	7.2	12.3	16.8	9.2	11.1	0.0	1.2	5.3	1.5	1.3	2.5	3.2	2.4	2.0	1.6	4.6	1.6	1.7	1.2	2.3	2.1	3.0	3.6	1.2	18.3	17.8	16.6	15.5	19.3	15.9	20.5	7.5	12.4	13.1	26.8	25.1	15.1	22.9	81.5	21.6	22.6	10.2	16.0	10.3	22.7	37.3	12.2	24.9	11.8	16.7	31.9	32.8	46.7	14.0	5.6	31.0	29.2	12.7	22.2	12.6	27.0	20.1	17.2	15.8	8.2	7.2	23.3	37.1	44.1	23.6	10.9	19.7	25.8	6.0	15.7	29.9	32.3	45.3	2.5	8.9	69.1	9.2	13.8	20.4	30.3
USP13	IsoT-3	ENSG00000058056	"Ubiquitin specific peptidase 13"	Q92995	3	179652755-179789401	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Autophagy, Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 34.8;skeletal muscle: 90.3"	"Cell type enriched"	"Detected in many"	6	"Cardiomyocytes: 182.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	5	"MAIT T-cell: 15.4"	"Lineage enriched"	"Detected in many"	8	"T-cells: 15.4"	"Cell line enhanced"	"Detected in many"		"HDLM-2: 36.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA004827	Enhanced		Approved	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"HPA004827: AB_1080497"	"unprognostic (1.00e-2)"	"unprognostic (2.09e-1)"	"unprognostic (5.82e-2)"	"unprognostic (7.14e-2)"	"unprognostic (9.94e-2)"	"unprognostic (3.96e-2)"	"prognostic unfavorable (2.40e-5)"	"unprognostic (1.76e-1)"	"unprognostic (4.55e-2)"	"unprognostic (7.79e-2)"	"unprognostic (1.69e-3)"	"unprognostic (2.22e-2)"	"prognostic unfavorable (3.46e-6)"	"unprognostic (4.93e-2)"	"unprognostic (9.79e-2)"	"unprognostic (3.38e-2)"	"prognostic unfavorable (3.06e-4)"	6.4	7.5	2.0	2.3	2.8	0.8	3.5	2.9	4.1	2.7	2.1	4.6	1.5	0.7	3.2	3.8	2.6	2.5	2.5	34.8	2.0	2.3	2.3	3.4	6.0	2.5	2.1	2.1	7.2	3.0	3.3	9.8	1.9	3.0	3.0	1.8	3.1	3.3	2.1	90.3	1.8	1.7	3.7	2.5	1.6	1.6	5.6	1.3	1.7	5.5	17.1	3.2	2.6	1.9	2.0	1.9	0.0	0.4	0.0	15.4	0.7	12.5	5.4	10.2	7.8	4.6	6.4	4.9	7.4	8.5	10.9	9.2	7.9	4.4	15.5	8.3	8.9	12.3	0.9	11.4	4.5	13.0	36.6	4.9	4.1	8.1	7.4	3.3	11.4	0.0	6.9	1.6	8.5	10.8	5.3	8.7	6.1	2.0	20.0	9.0	8.2	6.9	2.1	7.9	1.1	4.9	11.9	10.1	12.7	7.4	3.5	5.8	7.5	7.1	9.5	4.3	3.0	16.4	8.2	9.4	13.2	10.5	11.3	28.4	9.7	8.1	31.7	6.1	7.7	12.2	0.0	0.2	0.0	1.3	0.4	15.4	2.0	1.3	2.9	1.5	0.6	1.0	1.0	0.0	0.0	0.4	1.9	0.6	0.7	2.0	2.8	2.9	4.1	2.0	2.3	2.1	2.1	3.0	1.3	8.9	31.0	4.3	1.7	2.3	12.7	182.3	5.1	2.7	9.1	1.8	5.9	8.7	13.3	1.0	2.1	9.7	0.3	0.0	3.7	1.6	7.1	3.4	2.3	6.8	3.7	15.9	9.2	27.6	3.1	2.0	8.6	4.7	13.5	0.0	1.6	6.3	1.6	5.8	8.9	2.7	9.7	12.9	5.3	5.1	2.1	1.4	4.2	3.2	3.8	1.6
USP14	TGT	ENSG00000101557	"Ubiquitin specific peptidase 14"	P54578	18	158383-214629	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Immunity, Innate immunity, Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA001308	Approved		Supported	"Plasma membrane,Cytosol"		NA	NA		1400000	"Plasma membrane, Cytosol"		"HPA001308: AB_1080499"	"unprognostic (2.21e-1)"	"unprognostic (4.05e-2)"	"unprognostic (1.90e-1)"	"unprognostic (2.59e-3)"	"unprognostic (6.04e-2)"	"prognostic unfavorable (7.81e-5)"	"prognostic unfavorable (4.30e-5)"	"unprognostic (5.14e-2)"	"unprognostic (5.00e-2)"	"prognostic favorable (7.91e-4)"	"unprognostic (1.64e-2)"	"unprognostic (2.39e-1)"	"unprognostic (1.51e-3)"	"unprognostic (2.58e-1)"	"unprognostic (1.55e-1)"	"unprognostic (2.20e-2)"	"unprognostic (3.76e-2)"	24.8	24.2	25.9	20.7	32.1	19.4	21.7	21.7	28.4	16.5	17.1	17.9	19.1	13.4	19.4	24.3	25.3	14.7	14.4	23.3	22.1	27.6	23.2	24.4	15.8	21.9	22.6	28.8	16.2	16.2	22.3	18.0	25.1	29.2	29.9	19.4	14.5	16.7	20.5	53.3	15.7	12.9	23.9	22.1	15.4	15.6	17.2	16.5	19.5	20.1	25.4	28.6	17.8	17.8	13.1	15.2	7.7	15.2	23.0	21.2	11.0	27.1	22.3	19.0	19.3	18.8	18.8	34.0	35.7	19.5	36.3	34.0	29.0	14.5	40.3	27.3	29.2	34.9	15.3	37.4	27.2	41.4	11.4	18.5	22.7	15.0	22.7	18.9	55.7	21.8	15.0	21.1	37.1	21.3	16.8	27.9	19.9	31.2	29.9	35.8	22.0	31.1	15.2	18.5	16.3	26.2	25.9	24.9	29.3	26.8	23.6	22.2	18.6	37.0	17.9	15.2	21.6	17.5	15.1	31.5	42.7	32.3	39.2	50.5	19.8	35.9	40.0	24.6	23.3	26.5	5.0	10.7	7.7	17.8	15.2	21.2	13.1	17.7	18.4	15.2	10.1	17.5	16.9	0.8	23.0	11.4	11.1	16.7	11.0	25.9	32.1	21.7	27.1	22.1	27.6	22.6	28.8	29.2	16.5	20.8	33.1	28.2	36.7	52.1	52.7	40.0	22.9	42.8	51.2	41.8	29.5	80.1	38.1	58.5	41.3	39.3	15.4	23.3	46.8	58.4	42.1	56.1	33.5	39.4	45.0	109.7	21.2	28.3	30.4	14.7	29.4	39.1	33.7	54.1	19.4	35.6	58.1	19.5	43.2	43.1	50.1	0.0	45.7	26.2	61.2	45.8	113.4	38.8	27.3	39.1
USP15	"KIAA0529, UNPH4"	ENSG00000135655	"Ubiquitin specific peptidase 15"	Q9Y4E8	12	62260338-62417431	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction, Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 88.9"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"neutrophil: 68.5"	"Lineage enriched"	"Detected in all"	5	"granulocytes: 68.5"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006237, HPA006428, HPA071014"	Approved		Supported	"Plasma membrane,Cytosol"		NA	NA		280000	Cytosol	"Plasma membrane"	"HPA006237: AB_1080502, HPA006428: AB_2667588, HPA071014: AB_2686333"	"unprognostic (8.18e-2)"	"unprognostic (3.22e-1)"	"unprognostic (9.63e-2)"	"unprognostic (2.09e-1)"	"unprognostic (1.10e-1)"	"unprognostic (2.75e-1)"	"prognostic unfavorable (8.04e-4)"	"unprognostic (6.59e-2)"	"unprognostic (7.70e-3)"	"unprognostic (2.19e-1)"	"unprognostic (2.47e-1)"	"unprognostic (4.51e-2)"	"prognostic unfavorable (1.58e-5)"	"unprognostic (9.28e-2)"	"unprognostic (5.81e-3)"	"unprognostic (1.11e-2)"	"unprognostic (1.26e-1)"	23.1	16.8	11.5	22.5	11.9	88.9	17.8	21.1	15.7	14.5	14.5	5.2	11.9	11.4	12.7	12.4	16.1	14.1	11.2	15.2	9.6	6.2	13.8	20.4	23.8	26.2	11.6	9.4	22.5	15.8	18.9	22.5	31.0	14.9	12.4	13.8	7.6	16.2	10.7	28.5	23.0	19.7	16.3	16.2	35.6	14.3	20.0	11.0	33.1	14.1	15.4	18.9	18.4	17.9	5.7	6.0	68.5	14.2	3.3	12.1	4.8	9.4	8.9	8.9	7.8	14.1	16.5	16.0	15.4	13.7	13.6	12.2	8.9	9.5	10.1	8.8	13.2	5.8	10.4	11.9	13.4	16.0	11.2	7.3	13.9	7.6	6.8	13.6	22.0	33.8	12.0	14.0	16.1	14.3	12.8	16.2	10.3	45.0	19.6	12.6	10.5	13.1	11.1	13.0	8.6	13.2	8.4	9.4	16.3	12.7	10.9	11.3	5.4	17.8	11.3	8.7	9.7	15.0	13.2	19.3	10.6	10.6	16.5	9.5	9.3	10.4	11.6	12.2	17.9	12.0	27.2	14.2	13.8	3.4	7.3	3.5	5.7	4.6	3.2	4.9	4.7	5.9	3.5	68.5	3.3	5.8	6.0	12.1	4.8	11.5	11.9	21.1	15.7	9.6	6.2	11.6	9.4	14.9	11.0	35.7	31.3	91.0	32.3	52.2	54.5	62.7	17.8	42.8	59.1	22.7	104.1	25.1	10.0	31.3	139.8	44.6	32.3	93.5	36.2	36.1	49.5	31.6	85.6	42.0	41.1	39.7	40.4	22.1	108.1	130.5	57.2	94.6	50.6	36.1	22.9	24.4	41.2	45.6	27.6	19.4	146.4	38.8	56.5	62.9	41.8	67.2	55.0	65.0	23.3	54.9
USP16	Ubp-M	ENSG00000156256	"Ubiquitin specific peptidase 16"	Q9Y5T5	21	29024629-29054488	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis, Transcription, Transcription regulation, Ubl conjugation pathway"	"Activator, Chromatin regulator, Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	5	"Early spermatids: 399.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA021140	Supported		Approved	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"HPA021140: AB_1858668"	"unprognostic (6.06e-2)"	"unprognostic (3.14e-1)"	"unprognostic (1.10e-2)"	"unprognostic (1.47e-1)"	"unprognostic (5.92e-2)"	"unprognostic (5.79e-3)"	"unprognostic (1.92e-1)"	"unprognostic (8.99e-2)"	"unprognostic (5.78e-2)"	"unprognostic (7.40e-2)"	"unprognostic (8.73e-2)"	"unprognostic (8.65e-2)"	"unprognostic (6.68e-2)"	"unprognostic (2.84e-1)"	"unprognostic (1.55e-1)"	"unprognostic (2.84e-2)"	"unprognostic (1.54e-1)"	25.4	21.7	24.4	27.4	24.2	20.4	22.8	32.4	23.1	24.2	24.3	13.5	23.6	20.4	22.6	28.2	27.1	19.4	17.0	23.8	23.8	22.6	28.4	34.0	16.8	20.7	25.8	19.5	27.3	23.6	31.6	41.6	45.9	25.3	26.0	22.3	13.3	20.6	28.8	35.8	16.1	33.2	26.2	28.6	29.1	20.8	20.1	25.3	37.6	28.4	25.6	25.5	30.8	17.1	30.9	23.5	21.2	20.5	19.9	26.2	10.1	22.0	8.8	14.1	12.6	10.0	16.5	13.3	21.6	14.4	15.0	14.3	11.0	14.4	22.5	6.5	20.7	22.9	10.1	17.4	15.7	19.6	21.6	18.5	30.1	10.7	12.2	14.9	29.5	16.7	14.1	16.6	19.5	18.1	11.1	14.3	12.9	24.7	39.9	17.3	10.1	18.1	10.8	15.0	18.0	11.5	12.2	34.8	25.8	12.3	16.0	15.3	16.3	14.0	22.4	18.9	10.0	15.4	20.2	14.4	17.6	21.8	16.1	22.1	34.1	46.8	23.7	18.3	21.4	17.4	21.2	16.2	20.9	25.4	16.1	19.8	26.4	23.9	22.8	14.9	30.9	26.2	24.8	15.5	19.9	20.5	23.5	24.5	10.1	24.4	24.2	32.4	23.1	23.8	22.6	25.8	19.5	25.3	25.3	80.4	84.0	98.9	106.9	50.8	161.8	74.6	53.5	112.4	87.6	50.6	84.4	70.3	112.7	61.8	399.0	40.7	72.4	23.3	103.3	66.4	62.2	82.7	136.5	77.6	53.4	68.3	79.3	46.1	54.6	89.6	81.1	59.7	59.1	95.6	64.7	103.3	77.6	75.8	81.7	60.8	186.0	58.2	71.0	80.0	64.3	56.2	135.5	69.2	70.2	111.6
USP17L1	USP17L1P	ENSG00000230549	"Ubiquitin specific peptidase 17-like family member 1"	Q7RTZ2	8	7332387-7333979	"Enzymes, Predicted intracellular proteins"	"Apoptosis, Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"No human protein/transcript evidence"		"Tissue enhanced"	"Detected in single"		"brain: 2.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"GAMG: 1.0;JURKAT: 1.4"									HPA045642	Uncertain					NA	NA					"HPA045642: AB_2679403"																		0.0	0.0		0.0		0.0	0.0		2.1	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.0			0.6	0.0	0.0		0.0		0.0	0.0		0.0	0.0	0.0	0.4	0.0	0.0		0.0	0.0	0.4			0.0		0.0	0.0		0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.2	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
USP17L10		ENSG00000231396	"Ubiquitin specific peptidase 17-like family member 10"	C9JJH3	4	9210657-9212608	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"No human protein/transcript evidence"	"No human protein/transcript evidence"	"No human protein/transcript evidence"	"No human protein/transcript evidence"		"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA045642	Uncertain					NA	NA					"HPA045642: AB_2679403"																		0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
USP17L11		ENSG00000233136	"Ubiquitin specific peptidase 17-like family member 11"	C9JVI0	4	9215405-9217356	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"No human protein/transcript evidence"		"Tissue enhanced"	"Detected in some"		"blood: 1.0;fallopian tube: 1.2;thyroid gland: 1.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Cell type enriched"	"Detected in single"	11	"plasmacytoid DC: 1.0"	"Lineage enriched"	"Detected in single"	11	"dendritic cells: 1.0"	"Cell line enhanced"	"Detected in some"		"CAPAN-2: 2.5;JURKAT: 1.4;NTERA-2: 1.6"									HPA045642	Uncertain					NA	NA					"HPA045642: AB_2679403"																		0.0	0.0	0.0	0.0	0.3	0.0	0.3	0.0	0.6	0.0	0.0			0.0	0.1	0.0	0.0	1.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0		0.1	0.0	0.0	0.1	0.0		0.0	0.0		0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0			1.3		0.0	0.2	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	1.4	0.0	0.0	0.0	0.5	0.0	0.0	1.6	0.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
USP17L12		ENSG00000227551	"Ubiquitin specific peptidase 17-like family member 12"	C9JPN9	4	9220152-9221744	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"No human protein/transcript evidence"	"No human protein/transcript evidence"	"No human protein/transcript evidence"	"No human protein/transcript evidence"		"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA045642	Uncertain					NA	NA					"HPA045642: AB_2679403"																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0		0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
USP17L13		ENSG00000232399	"Ubiquitin specific peptidase 17-like family member 13"	C9JLJ4	4	9224896-9226847	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"No human protein/transcript evidence"	"No human protein/transcript evidence"	"No human protein/transcript evidence"	"No human protein/transcript evidence"		"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"NTERA-2: 1.2"									HPA045642	Uncertain					NA	NA					"HPA045642: AB_2679403"																		0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.2	0.0			0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.3		0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2			0.4		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
USP17L15		ENSG00000223569	"Ubiquitin specific peptidase 17-like family member 15"	C9J2P7	4	9234385-9236334	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"No human protein/transcript evidence"		"Tissue enhanced"	"Detected in some"		"brain: 1.0;epididymis: 1.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"U-87 MG: 1.2"									HPA045642	Uncertain					NA	NA					"HPA045642: AB_2679403"																		0.0	0.0	0.3	0.0	0.7	0.0	0.0	0.0	1.0	0.1	0.0			0.0	0.2	1.0	0.0	0.3	0.0	0.1	0.3	0.4	0.0	0.4	0.2	0.0	0.2		0.0	0.0	0.4	0.4	0.0		0.0	0.0		0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.1	0.0			0.1		0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.4	0.0	0.0	0.0	0.6	0.0	0.8	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.9	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.4	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
USP17L17		ENSG00000249104	"Ubiquitin specific peptidase 17-like family member 17"	D6RBQ6	4	9243879-9245830	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"No human protein/transcript evidence"		"Tissue enhanced"	"Detected in single"		"thyroid gland: 1.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HDLM-2: 1.2;NTERA-2: 1.4"									HPA045642	Uncertain					NA	NA					"HPA045642: AB_2679403"																		0.0	0.0	0.0	0.0	0.2	0.0	0.3	0.0	0.1	0.4	0.0			0.0	0.4	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.2		0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1			1.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
USP17L18		ENSG00000250844	"Ubiquitin specific peptidase 17-like family member 18"	D6R9N7	4	9248630-9250581	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"No human protein/transcript evidence"	"No human protein/transcript evidence"	"No human protein/transcript evidence"	"No human protein/transcript evidence"		"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"OE19: 1.2"									HPA045642	Uncertain					NA	NA					"HPA045642: AB_2679403"																		0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.2	0.3	0.0			0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.5	0.0	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
USP17L19		ENSG00000248920	"Ubiquitin specific peptidase 17-like family member 19"	D6RCP7	4	9253378-9255329	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"No human protein/transcript evidence"	"No human protein/transcript evidence"	"No human protein/transcript evidence"	"No human protein/transcript evidence"		"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA045642	Uncertain					NA	NA					"HPA045642: AB_2679403"																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
USP17L2	DUB3	ENSG00000223443	"Ubiquitin specific peptidase 17-like family member 2"	Q6R6M4	8	12137168-12139077	"Enzymes, Predicted intracellular proteins"	"Apoptosis, Cell cycle, Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Low tissue specificity"	"Detected in some"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"HEK 293: 1.3"									HPA045642	Uncertain					NA	NA					"HPA045642: AB_2679403"															"unprognostic (2.01e-1)"			0.1	0.4	0.1	0.1	0.5	0.0	0.2	0.8	0.3	0.1	0.1	0.1	0.1	0.0	0.3	0.3	0.1	0.3	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.3	0.1	0.1	1.0	1.1	0.0	0.3	0.1	0.1	0.4	0.0	0.1	0.1	0.1	0.1	0.6	0.1	0.1	0.1	0.2	0.0	0.5	0.1	0.1	0.2	0.1	0.1	0.3	0.2	0.1	0.0	0.0	0.0	0.0	0.5	0.0	0.1	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.6	0.0	0.5	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.5	0.8	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
USP17L20		ENSG00000250745	"Ubiquitin specific peptidase 17-like family member 20"	D6RJB6	4	9258124-9260075	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"No human protein/transcript evidence"	"No human protein/transcript evidence"	"No human protein/transcript evidence"	"No human protein/transcript evidence"		"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"GAMG: 1.1;hTERT-HME1: 1.1"									HPA045642	Uncertain					NA	NA					"HPA045642: AB_2679403"																		0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.2	0.2	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.3	0.0	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1			0.0		0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.5	0.1	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.8	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
USP17L21		ENSG00000249811	"Ubiquitin specific peptidase 17-like family member 21"	D6R901	4	9262872-9264823	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"No human protein/transcript evidence"	"No human protein/transcript evidence"	"No human protein/transcript evidence"	"No human protein/transcript evidence"		"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA045642	Uncertain					NA	NA					"HPA045642: AB_2679403"																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0			0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0		0.2	0.0	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0		0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
USP17L22		ENSG00000248933	"Ubiquitin specific peptidase 17-like family member 22"	D6RA61	4	9267619-9269570	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"No human protein/transcript evidence"	"No human protein/transcript evidence"	"No human protein/transcript evidence"	"No human protein/transcript evidence"		"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"BEWO: 1.0"									HPA045642	Uncertain					NA	NA					"HPA045642: AB_2679403"																		0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.2	0.2	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0		0.1	0.0	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.4			0.5		0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
USP17L23		ENSG00000250913	"Ubiquitin specific peptidase 17-like family member 23"	D6RBM5	4	9272364-9272914	"Enzymes, Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enhanced"	"Detected in single"		"gallbladder: 1.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	12	"HMC-1: 1.4"															NA	NA																							0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0			0.0		0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.4											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
USP17L24		ENSG00000232264	"Ubiquitin specific peptidase 17-like family member 24"	Q0WX57	4	9325165-9327116	"Enzymes, Predicted intracellular proteins"	"Apoptosis, Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Evidence at protein level"		"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA045642	Uncertain					NA	NA					"HPA045642: AB_2679403"																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.2	0.0	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
USP17L25		ENSG00000230430	"Ubiquitin specific peptidase 17-like family member 25"	Q0WX57	4	9329911-9331862	"Enzymes, Predicted intracellular proteins"	"Apoptosis, Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Evidence at protein level"		"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA045642	Uncertain					NA	NA					"HPA045642: AB_2679403"																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.2	0.0	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
USP17L26		ENSG00000229579	"Ubiquitin specific peptidase 17-like family member 26"	Q0WX57	4	9334658-9336609	"Enzymes, Predicted intracellular proteins"	"Apoptosis, Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Evidence at protein level"		"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA045642	Uncertain					NA	NA					"HPA045642: AB_2679403"																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.2	0.0	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
USP17L27		ENSG00000235780	"Ubiquitin specific peptidase 17-like family member 27"	Q0WX57	4	9344148-9345740	"Enzymes, Predicted intracellular proteins"	"Apoptosis, Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Evidence at protein level"		"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA045642	Uncertain					NA	NA					"HPA045642: AB_2679403"																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
USP17L28		ENSG00000231051	"Ubiquitin specific peptidase 17-like family member 28"	Q0WX57	4	9348893-9350485	"Enzymes, Predicted intracellular proteins"	"Apoptosis, Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Evidence at protein level"		"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA045642	Uncertain					NA	NA					"HPA045642: AB_2679403"																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
USP17L29		ENSG00000231637	"Ubiquitin specific peptidase 17-like family member 29"	Q0WX57	4	9353638-9355230	"Enzymes, Predicted intracellular proteins"	"Apoptosis, Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Evidence at protein level"		"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA045642	Uncertain					NA	NA					"HPA045642: AB_2679403"																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
USP17L3	"USP17B, USP17F"	ENSG00000225327	"Ubiquitin specific peptidase 17-like family member 3"	A6NCW0	8	7976393-7977985	"Enzymes, Predicted intracellular proteins"	"Apoptosis, Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"No human protein/transcript evidence"	"No human protein/transcript evidence"	"No human protein/transcript evidence"	"No human protein/transcript evidence"		"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA045642	Uncertain					NA	NA					"HPA045642: AB_2679403"																		0.0	0.0		0.0		0.0	0.0		0.0	0.0	0.0			0.0	0.1	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.0			0.0	0.0	0.0		0.0		0.0	0.0		0.0	0.0	0.0	0.2	0.0	0.0		0.0	0.0	0.0			0.1		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
USP17L30		ENSG00000228856	"Ubiquitin specific peptidase 17-like family member 30"	Q0WX57	4	9363129-9364721	"Enzymes, Predicted intracellular proteins"	"Apoptosis, Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Evidence at protein level"		"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA045642	Uncertain					NA	NA					"HPA045642: AB_2679403"																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
USP17L4		ENSG00000236125	"Ubiquitin specific peptidase 17-like family member 4"	A6NCW7	8	7337115-7338707	"Enzymes, Predicted intracellular proteins"				"No human protein/transcript evidence"	"No human protein/transcript evidence"	"No human protein/transcript evidence"	"No human protein/transcript evidence"		"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA045642	Uncertain					NA	NA					"HPA045642: AB_2679403"																		0.0	0.0		0.0		0.0	0.0		0.0	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.0			0.0	0.0	0.0		0.0		0.5	0.0		0.0	0.0	0.0	0.6	0.0	0.0		0.0	0.0	0.1			0.1		0.0	0.0		0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
USP17L5		ENSG00000227140	"Ubiquitin specific peptidase 17-like family member 5"	A8MUK1	4	9339403-9340995	"Enzymes, Predicted intracellular proteins"	"Apoptosis, Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"No human protein/transcript evidence"	"No human protein/transcript evidence"	"No human protein/transcript evidence"	"No human protein/transcript evidence"		"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA045642	Uncertain					NA	NA					"HPA045642: AB_2679403"																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
USP17L7		ENSG00000226430	"Ubiquitin specific peptidase 17-like family member 7"	P0C7H9	8	12132417-12134438	"Enzymes, Predicted intracellular proteins"				"No human protein/transcript evidence"	"No human protein/transcript evidence"	"No human protein/transcript evidence"	"No human protein/transcript evidence"		"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"HEK 293: 1.1"									HPA045642	Uncertain					NA	NA					"HPA045642: AB_2679403"															"unprognostic (5.31e-2)"			0.1	0.0		0.0		0.0	0.0		0.9	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.0			0.0	0.8	0.0		0.0		0.0	0.0		0.0	0.0	0.0	0.3	0.0	0.0		0.0	0.0	0.0			0.1		0.0	0.1		0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.1	1.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.5	0.1	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
USP17L8		ENSG00000237038	"Ubiquitin specific peptidase 17-like family member 8"	P0C7I0	8	7971661-7973253	"Enzymes, Predicted intracellular proteins"				"No human protein/transcript evidence"	"No human protein/transcript evidence"	"No human protein/transcript evidence"	"No human protein/transcript evidence"		"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA045642	Uncertain					NA	NA					"HPA045642: AB_2679403"																		0.0	0.0		0.0		0.0	0.0		0.3	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.3			0.0	0.0	0.0	0.0			0.0	0.0	0.0		0.0		0.0	0.0		0.0	0.0	0.0	0.6	0.0	0.0		0.0	0.0	0.0			0.0		0.0	0.0		0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
USP18		ENSG00000184979	"Ubiquitin specific peptidase 18"	Q9UMW8	22	18149899-18177397	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	9	"Distal tubular cells: 39.7;Extravillous trophoblasts: 27.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+ SV40 Large T+: 48.9;BJ hTERT+ SV40 Large T+ RasG12V: 53.2"									HPA044768	Uncertain		Supported	Vesicles,Cytosol		NA	NA			Cytosol	Vesicles	"HPA044768: AB_10963697"	"unprognostic (2.06e-1)"	"unprognostic (3.55e-2)"	"unprognostic (1.57e-2)"	"unprognostic (5.04e-3)"	"unprognostic (1.40e-2)"	"unprognostic (5.42e-2)"	"unprognostic (3.29e-2)"	"unprognostic (5.11e-3)"	"unprognostic (1.81e-1)"	"unprognostic (1.79e-3)"	"unprognostic (9.77e-2)"	"unprognostic (1.47e-1)"	"unprognostic (4.29e-3)"	"unprognostic (2.58e-1)"	"unprognostic (2.77e-2)"	"unprognostic (2.28e-2)"	"unprognostic (8.38e-2)"	20.4	6.4	4.8	13.0	4.8	6.3	15.4	1.9	5.5	5.3	6.3	5.6	3.2	5.2	6.1	9.5	6.0	6.5	7.1	5.4	4.4	4.6	8.8	20.9	14.0	15.9	4.3	4.8	4.9	4.2	3.8	7.8	7.6	4.7	4.8	3.9	5.7	11.7	2.3	9.7	4.2	15.5	4.5	4.1	10.6	6.4	10.6	4.0	22.4	10.6	2.9	7.7	4.3	6.9	4.1	2.9	6.6	8.8	11.0	11.0	4.8	3.7	3.8	1.1	4.9	5.0	3.7	5.0	1.9	4.6	48.9	53.2	0.6	5.3	0.0	3.0	1.0	15.6	1.3	5.7	1.7	1.6	16.7	7.9	7.3	0.5	6.9	0.6	1.7	7.0	1.6	0.6	3.4	0.0	0.2	10.8	5.5	0.3	0.4	0.4	6.4	8.5	4.3	3.4	4.0	2.9	3.4	7.6	0.0	0.9	3.2	4.1	3.2	2.3	4.0	18.2	4.6	2.7	1.7	17.7	0.3	1.0	1.1	1.9	0.9	11.4	0.0	4.4	4.4	2.8	2.7	3.2	6.6	7.8	8.8	10.0	4.1	6.7	10.1	1.6	2.7	7.9	8.8	0.5	11.0	6.6	2.9	11.0	4.8	4.8	4.8	1.9	4.0	4.4	4.6	4.3	4.8	4.7	4.0	8.9	3.7	0.5	3.7	1.4	0.2	0.4	5.1	8.1	6.8	0.0	0.0	4.5	39.7	5.1	1.2	6.0	4.3	0.0	9.9	27.4	3.1	3.8	0.0	4.3	7.7	0.0	2.9	9.2	4.5	1.4	3.4	1.8	3.3	0.0	2.2	3.9	9.2	2.9	6.7	5.7	0.2	6.5	1.2	6.2	0.4	0.9	1.3	1.5	2.8	2.5
USP19	"KIAA0891, ZMYND9"	ENSG00000172046	"Ubiquitin specific peptidase 19"	O94966	3	49108046-49120938	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA						"unprognostic (3.23e-2)"	"unprognostic (2.12e-1)"	"unprognostic (5.91e-2)"	"unprognostic (1.37e-1)"	"unprognostic (1.92e-2)"	"unprognostic (3.90e-3)"	"unprognostic (2.99e-2)"	"unprognostic (3.00e-3)"	"unprognostic (2.69e-1)"	"unprognostic (3.65e-2)"	"unprognostic (2.31e-2)"	"unprognostic (1.26e-1)"	"prognostic favorable (7.05e-9)"	"unprognostic (2.99e-1)"	"unprognostic (2.11e-1)"	"unprognostic (1.72e-3)"	"unprognostic (7.54e-2)"	13.9	19.5	10.3	14.6	12.2	16.2	14.9	19.4	37.1	17.0	16.3	12.5	19.6	14.6	18.7	17.9	14.3	17.2	19.9	17.9	10.3	9.4	14.8	16.5	14.7	13.8	11.9	9.5	17.2	15.2	22.4	13.2	17.6	11.4	14.2	10.9	14.9	24.7	26.0	57.3	18.4	16.1	13.9	8.5	17.5	15.1	14.9	11.7	23.0	17.7	15.2	12.6	17.4	14.1	5.1	6.7	12.3	5.7	4.3	8.4	5.3	8.3	12.0	14.4	20.3	17.7	12.2	18.4	9.4	12.6	17.6	13.3	12.0	12.8	18.0	9.6	11.8	17.5	11.1	18.2	13.6	7.3	14.1	14.0	17.5	24.1	11.0	18.4	19.8	18.5	17.3	10.6	16.6	12.1	12.3	11.5	16.1	13.7	13.6	8.8	10.8	18.7	20.5	27.3	12.5	17.6	9.1	10.7	20.8	10.9	15.9	7.9	22.7	13.9	18.2	16.3	12.5	12.3	26.4	9.1	11.7	14.3	17.3	14.2	34.4	33.3	15.9	15.1	15.7	14.5	12.3	4.9	7.5	7.2	5.3	6.8	4.6	5.8	8.4	6.7	5.1	5.7	6.2	8.8	4.3	5.7	3.0	4.1	5.3	10.3	12.2	19.4	37.1	10.3	9.4	11.9	9.5	11.4	11.7	11.9	9.7	2.9	4.0	5.6	11.4	9.6	2.5	10.7	10.3	7.0	17.7	8.5	5.0	6.6	2.7	7.1	13.1	0.0	6.7	4.4	5.8	4.6	2.3	12.1	7.8	12.7	8.7	7.4	6.1	4.1	12.0	8.4	3.3	1.8	11.3	7.7	9.8	11.8	11.7	6.3	11.2	12.9	5.2	10.5	10.0	4.6	11.3	6.4	10.9	2.6
USP2	UBP41	ENSG00000036672	"Ubiquitin specific peptidase 2"	O75604	11	119355215-119381726	"Enzymes, Predicted intracellular proteins"	"Biological rhythms, Cell cycle, Myogenesis, Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skeletal muscle: 79.9"	"Group enriched"	"Detected in many"	5	"Early spermatids: 399.1;Late spermatids: 802.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"naive CD4 T-cell: 1.3"	"Lineage enriched"	"Detected in single"	13	"T-cells: 1.3"	"Cell line enriched"	"Detected in many"	4	"U-266/70: 35.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006777, HPA007222"	Approved		Supported	"Plasma membrane,Cytosol"		NA	NA			Cytosol	"Plasma membrane"	"HPA006777: AB_1080507, HPA007222: AB_1080505"	"unprognostic (6.83e-2)"	"unprognostic (2.02e-2)"	"unprognostic (5.54e-2)"	"unprognostic (1.37e-2)"	"unprognostic (1.25e-1)"	"unprognostic (7.46e-3)"	"unprognostic (1.00e-1)"	"unprognostic (5.27e-2)"	"unprognostic (1.24e-1)"	"unprognostic (5.24e-3)"	"unprognostic (8.02e-3)"	"unprognostic (7.33e-2)"	"prognostic favorable (3.09e-11)"	"unprognostic (1.58e-1)"	"unprognostic (1.20e-1)"	"unprognostic (1.96e-2)"	"unprognostic (2.66e-2)"	3.1	4.8	6.9	1.4	12.2	1.5	1.6	12.6	16.1	2.5	5.9	10.0	0.0	7.9	2.6	6.4	5.9	7.0	2.2	26.8	5.7	3.1	29.7	10.6	2.2	0.7	5.7	6.2	2.9	10.1	18.4	7.6	1.3	6.7	2.3	3.9	19.1	3.2	2.4	79.9	4.6	11.7	4.2	3.8	0.8	2.7	36.1	8.8	0.0	2.2	25.2	1.0	1.9	2.0	0.0	0.0	0.0	0.0	0.0	1.3	0.3	3.5	0.3	0.5	2.0	0.1	0.1	0.8	0.4	0.2	0.0	0.4	3.6	0.5	6.1	1.1	0.6	0.9	0.6	4.8	1.8	0.1	4.2	0.6	1.7	2.6	7.5	1.7	0.0	1.7	0.6	0.3	0.4	1.2	0.8	0.3	4.6	8.4	0.5	1.0	2.4	0.0	0.4	0.9	1.2	0.8	0.0	1.3	0.9	2.8	0.2	7.4	2.2	2.1	1.6	0.4	1.1	5.4	3.7	0.0	0.0	0.9	0.5	0.6	35.2	7.7	0.1	0.0	1.1	0.8	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.7	0.0	0.0	1.3	0.7	0.0	0.0	0.0	0.0	0.3	0.3	6.9	12.2	12.6	16.1	5.7	3.1	5.7	6.2	6.7	8.8	3.0	2.4	0.0	4.5	2.2	73.3	74.6	5.1	42.8	9.1	5.2	90.3	0.3	96.2	2.6	399.1	2.2	31.5	0.0	1.4	0.5	4.6	1.0	0.0	19.8	13.2	9.5	0.0	1.3	1.5	802.9	6.1	1.3	0.0	0.0	1.6	37.9	1.5	10.5	6.7	24.9	128.7	19.4	18.6	19.9	14.9	3.4	1.1	1.5	2.2	2.0
USP20	KIAA1003	ENSG00000136878	"Ubiquitin specific peptidase 20"	Q9Y2K6	9	129834698-129881838	"Enzymes, Predicted intracellular proteins"	"Endocytosis, Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"JURKAT: 42.3;K-562: 25.9;MOLT-4: 23.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006287, HPA007008"	Uncertain	Supported	Approved	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Nucleoplasm, Plasma membrane, Cytosol"		"HPA006287: AB_1080510, HPA007008: "	"unprognostic (2.64e-2)"	"prognostic favorable (8.01e-4)"	"prognostic unfavorable (2.48e-4)"	"prognostic favorable (4.01e-4)"	"unprognostic (4.69e-1)"	"unprognostic (1.89e-2)"	"unprognostic (2.25e-1)"	"unprognostic (2.55e-3)"	"unprognostic (1.24e-1)"	"unprognostic (7.89e-2)"	"prognostic favorable (1.54e-7)"	"unprognostic (2.09e-1)"	"prognostic favorable (5.65e-5)"	"unprognostic (1.76e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.19e-2)"	"unprognostic (1.24e-2)"	7.8	13.2	10.5	15.2	14.6	24.4	8.5	23.0	19.6	13.2	12.1	12.7	10.2	9.7	13.3	6.2	9.3	11.6	12.5	8.8	10.5	13.7	8.0	7.3	9.1	19.6	9.6	16.1	16.8	12.9	11.5	19.0	8.0	11.9	14.9	6.1	10.8	13.7	17.2	10.2	14.0	11.8	20.0	8.8	14.6	10.2	14.0	8.8	51.5	19.3	4.2	15.3	15.6	10.0	3.8	2.4	4.8	1.7	9.0	10.7	5.4	2.5	2.5	4.4	6.0	5.8	5.0	6.3	4.1	3.5	3.2	2.2	2.1	2.8	3.5	3.6	4.0	3.6	6.5	2.6	3.0	1.3	19.0	3.5	6.5	6.8	1.4	4.1	6.1	4.8	4.4	4.4	4.2	3.1	5.6	3.4	42.3	25.9	4.4	1.9	6.8	23.8	14.5	3.5	5.4	6.0	4.0	5.0	5.9	2.5	2.8	1.0	4.9	4.8	6.2	3.9	2.7	6.4	8.5	5.0	3.5	1.6	4.7	2.7	4.3	6.3	2.4	7.0	8.0	3.3	1.0	1.7	4.8	8.6	1.4	9.3	3.7	8.8	8.3	2.4	3.8	10.4	8.9	2.8	9.0	1.3	2.1	10.7	5.4	10.5	14.6	23.0	19.6	10.5	13.7	9.6	16.1	11.9	8.8	8.9	8.6	3.2	2.3	2.5	7.9	5.9	2.5	4.0	2.3	1.8	3.9	5.1	3.3	2.2	1.1	2.4	4.0	0.0	3.4	2.1	3.8	3.0	1.1	5.6	3.0	9.5	8.1	7.4	2.1	2.8	5.8	3.1	3.3	3.6	4.6	5.8	2.3	3.7	4.6	2.2	5.9	0.0	6.2	12.2	4.4	1.8	5.1	11.3	5.1	1.4
USP21	"USP16, USP23"	ENSG00000143258	"Ubiquitin specific peptidase 21"	Q9UK80	1	161159450-161165723	"Enzymes, Predicted intracellular proteins"	"Transcription, Transcription regulation, Ubl conjugation pathway"	"Activator, Chromatin regulator, Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA028397	Uncertain	Approved	Supported	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			Cytosol	"Nucleoplasm, Plasma membrane"	"HPA028397: AB_10603227"	"unprognostic (9.17e-2)"	"unprognostic (1.44e-1)"	"unprognostic (3.95e-2)"	"prognostic unfavorable (7.05e-4)"	"unprognostic (1.22e-2)"	"unprognostic (1.26e-2)"	"prognostic unfavorable (1.68e-4)"	"unprognostic (5.35e-2)"	"unprognostic (6.73e-2)"	"unprognostic (2.76e-2)"	"unprognostic (3.87e-3)"	"unprognostic (1.31e-2)"	"prognostic unfavorable (9.50e-6)"	"unprognostic (2.45e-1)"	"unprognostic (3.28e-1)"	"unprognostic (2.13e-2)"	"prognostic favorable (3.35e-5)"	11.8	16.4	22.1	12.8	21.2	15.3	19.1	23.6	24.8	18.1	16.1	25.5	14.0	15.5	19.7	14.6	18.3	33.3	14.1	13.7	20.9	12.1	15.4	10.6	14.0	16.7	26.4	14.1	28.3	19.0	24.4	17.2	15.2	20.5	18.1	13.1	17.1	19.0	25.3	19.4	23.5	15.4	15.1	17.0	18.7	16.0	17.0	22.9	16.0	24.5	9.6	15.6	17.9	19.2	14.1	12.0	18.3	11.1	13.4	17.2	10.7	7.4	12.9	16.9	16.3	13.5	11.3	10.4	5.5	9.0	15.2	11.9	11.8	14.7	9.8	9.5	6.8	9.5	12.9	10.9	10.7	8.4	18.6	18.4	11.6	18.6	9.2	9.8	10.3	8.7	9.5	14.4	10.4	15.1	17.2	10.7	21.7	17.2	13.6	9.7	13.7	18.2	16.2	15.8	14.6	16.4	17.3	5.6	16.4	8.9	8.9	15.4	19.9	10.3	10.9	8.3	13.2	23.9	16.7	6.3	10.9	9.8	7.6	9.4	27.6	21.3	14.5	10.0	8.9	9.8	13.0	11.1	18.3	14.9	7.1	17.2	12.8	13.8	15.4	12.0	14.1	16.0	14.6	9.6	13.4	7.7	12.0	13.3	10.7	22.1	21.2	23.6	24.8	20.9	12.1	26.4	14.1	20.5	22.9	0.0	3.0	1.7	1.5	1.3	3.9	2.2	10.2	10.7	3.4	1.8	5.9	3.6	1.7	1.4	0.6	2.8	2.0	0.0	2.0	2.1	2.4	2.0	2.3	1.7	1.9	0.0	5.2	6.2	7.6	0.4	4.6	1.7	1.7	0.0	4.1	3.0	1.7	2.9	3.9	1.8	4.4	6.5	1.9	3.6	2.7	1.3	2.6	2.5	3.7	1.4
USP22	"KIAA1063, USP3L"	ENSG00000124422	"Ubiquitin specific peptidase 22"	Q9UPT9	17	20999593-21043760	"Enzymes, Predicted intracellular proteins"	"Cell cycle, Transcription, Transcription regulation, Ubl conjugation pathway"	"Activator, Chromatin regulator, Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044980	Supported		Approved	"Nuclear speckles"		NA	NA			"Nuclear speckles"		"HPA044980: AB_10794503"	"unprognostic (7.24e-2)"	"unprognostic (5.38e-2)"	"unprognostic (7.67e-2)"	"unprognostic (6.19e-2)"	"unprognostic (4.72e-1)"	"unprognostic (1.11e-2)"	"prognostic unfavorable (9.66e-4)"	"unprognostic (2.17e-2)"	"unprognostic (7.81e-2)"	"unprognostic (6.37e-2)"	"unprognostic (1.07e-3)"	"unprognostic (5.68e-2)"	"prognostic favorable (1.53e-7)"	"unprognostic (8.95e-2)"	"unprognostic (1.93e-1)"	"unprognostic (2.91e-1)"	"unprognostic (1.79e-2)"	22.5	33.0	40.7	21.5	49.5	25.9	24.6	66.1	66.4	26.8	23.6	31.9	25.1	18.9	36.7	29.3	21.9	33.9	23.0	44.1	38.7	47.6	27.7	22.9	26.1	25.1	31.0	40.7	45.6	24.5	47.4	32.2	22.4	35.1	27.5	20.5	28.7	20.0	29.5	47.6	22.1	21.1	31.2	24.8	23.7	22.7	20.2	23.7	41.2	32.8	24.8	27.3	25.1	23.2	13.7	12.1	13.4	13.3	8.9	15.5	6.9	19.6	35.6	34.6	29.7	20.2	21.0	16.5	22.6	17.4	20.4	17.4	41.0	8.9	26.9	21.8	34.7	13.8	21.1	33.5	27.0	30.6	12.8	23.2	22.3	23.7	19.9	24.0	24.5	19.5	23.1	16.2	23.1	24.3	23.3	25.4	17.7	25.3	9.8	28.8	20.2	34.3	11.7	17.8	23.3	11.7	38.0	54.8	18.3	18.8	28.9	16.7	34.4	29.2	12.1	23.7	99.0	20.3	14.5	32.2	20.9	27.8	21.4	30.5	10.5	14.1	89.5	21.2	13.1	32.2	6.8	13.3	12.6	11.0	9.8	11.1	10.9	11.7	10.9	12.1	13.7	15.5	14.6	13.4	8.9	12.2	10.2	7.8	6.9	40.7	49.5	66.1	66.4	38.7	47.6	31.0	40.7	35.1	23.7	38.7	45.6	40.4	39.5	29.3	90.6	20.9	58.6	29.4	35.2	57.6	88.4	42.1	19.9	47.1	31.0	40.9	35.1	0.0	50.6	33.9	44.7	49.2	29.0	55.2	34.1	111.2	84.7	78.0	53.0	39.2	47.2	23.7	33.7	24.4	42.7	58.7	59.0	38.6	67.5	45.1	54.5	12.9	38.8	14.2	16.6	25.5	55.0	23.0	46.6	38.9
USP24	KIAA1057	ENSG00000162402	"Ubiquitin specific peptidase 24"	Q9UPU5	1	55066359-55215113	"Enzymes, Predicted intracellular proteins"	"Host-virus interaction, Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 46.0"	"Cell type enhanced"	"Detected in many"	6	"Cone photoreceptor cells: 68.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA026723, HPA028428, HPA067124"	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA026723: AB_10599851, HPA028428: AB_10600991, HPA067124: AB_2685785"	"unprognostic (2.28e-1)"	"unprognostic (9.81e-3)"	"unprognostic (4.70e-3)"	"unprognostic (4.86e-3)"	"unprognostic (9.31e-3)"	"unprognostic (4.84e-3)"	"prognostic unfavorable (1.34e-7)"	"unprognostic (2.04e-1)"	"unprognostic (6.93e-2)"	"unprognostic (2.98e-1)"	"unprognostic (5.08e-2)"	"unprognostic (1.86e-1)"	"unprognostic (8.12e-2)"	"unprognostic (1.79e-1)"	"unprognostic (6.42e-2)"	"unprognostic (4.12e-2)"	"unprognostic (1.64e-1)"	12.3	7.6	7.5	12.1	8.8	30.1	10.6	20.1	8.5	7.8	10.2	6.8	10.6	5.0	10.1	7.0	7.7	6.9	7.0	14.7	7.9	6.4	10.4	9.3	7.6	12.7	8.0	5.6	10.9	7.3	15.5	16.9	5.8	6.9	7.6	8.5	5.1	9.7	10.7	46.0	8.9	8.7	7.3	6.2	10.9	7.8	4.9	8.7	16.4	7.4	11.5	12.7	9.7	13.7	6.0	10.5	5.9	2.2	3.8	4.5	1.1	17.7	9.8	12.3	6.6	16.0	14.1	14.2	7.9	9.9	11.4	11.9	13.9	6.3	14.3	8.7	14.6	23.4	14.4	16.3	13.3	17.9	14.9	9.8	28.6	21.4	16.3	9.5	19.7	22.2	12.3	11.8	17.2	19.6	11.0	10.3	14.6	26.3	6.0	15.1	4.2	11.8	10.5	18.0	8.6	11.9	12.3	15.7	6.2	19.8	12.0	10.8	7.6	13.4	9.6	11.7	19.5	6.7	9.8	13.9	10.4	10.1	12.5	12.5	7.6	5.6	18.8	9.9	16.4	9.3	5.9	2.0	2.5	4.5	1.8	2.8	4.8	3.5	3.5	1.8	6.0	3.2	4.2	2.3	3.8	2.2	10.5	1.9	1.1	7.5	8.8	20.1	8.5	7.9	6.4	8.0	5.6	6.9	8.7	14.9	18.3	14.2	7.0	13.3	12.9	28.1	10.2	8.1	15.9	12.2	68.7	3.6	0.0	8.8	0.4	13.1	6.8	0.0	8.7	6.5	9.6	9.6	12.7	10.9	8.4	36.5	16.6	10.4	17.5	1.3	10.9	12.2	10.1	12.6	16.4	7.1	9.9	11.5	7.4	4.5	16.7	6.5	10.5	8.6	5.8	15.1	1.3	17.1	14.9	8.6
USP25	USP21	ENSG00000155313	"Ubiquitin specific peptidase 25"	Q9UHP3	21	15730025-15880069	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"Early spermatids: 124.6;Late spermatids: 145.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA018297, HPA024142"	Approved		Supported	Cytosol		NA	NA			Cytosol		"HPA018297: AB_1858672, HPA024142: AB_1858673"	"unprognostic (6.35e-2)"	"unprognostic (1.50e-1)"	"unprognostic (6.90e-2)"	"unprognostic (6.29e-2)"	"unprognostic (1.39e-1)"	"unprognostic (2.88e-2)"	"unprognostic (3.91e-2)"	"unprognostic (1.65e-1)"	"unprognostic (1.44e-2)"	"unprognostic (1.38e-1)"	"unprognostic (2.33e-2)"	"unprognostic (1.40e-1)"	"unprognostic (8.24e-3)"	"unprognostic (2.34e-3)"	"unprognostic (4.50e-2)"	"unprognostic (1.61e-1)"	"unprognostic (2.32e-2)"	14.9	8.5	11.0	14.2	15.5	12.4	28.7	11.3	11.1	17.5	11.8	6.6	17.8	6.5	20.7	14.5	12.6	10.6	10.1	17.8	9.9	5.8	12.9	10.4	22.1	14.8	7.6	7.1	14.5	8.2	8.1	8.4	17.7	7.7	12.9	8.6	7.8	11.4	13.6	56.3	8.3	12.3	19.2	7.3	11.6	9.0	26.1	7.5	16.5	10.5	14.6	9.6	13.8	18.1	3.1	2.8	5.8	2.9	2.3	7.2	1.6	13.2	10.0	9.5	1.4	17.6	26.3	11.2	9.5	9.5	7.1	9.0	8.8	7.6	14.3	14.1	15.0	10.8	7.1	7.3	12.6	9.9	14.2	8.4	11.7	10.6	6.7	29.2	15.4	5.4	17.0	15.4	11.4	33.2	18.7	24.9	13.1	15.0	27.1	12.8	5.5	17.6	2.9	11.7	5.3	8.9	13.5	8.8	10.8	19.3	3.6	2.1	5.7	13.6	11.5	8.8	12.1	6.1	9.1	23.6	11.1	7.2	11.6	5.3	7.9	4.8	11.4	7.2	6.9	8.1	0.0	2.9	3.6	4.0	2.8	4.4	3.1	3.4	7.2	2.5	2.2	3.2	4.8	5.8	2.3	2.5	2.8	4.4	1.6	11.0	15.5	11.3	11.1	9.9	5.8	7.6	7.1	7.7	7.5	53.6	22.7	11.5	16.1	15.1	5.7	52.1	10.2	25.4	31.8	21.0	3.9	27.3	5.0	7.8	124.6	19.1	12.8	0.0	11.4	6.8	16.0	19.0	5.8	17.3	11.9	4.8	9.2	17.2	23.7	145.9	17.5	18.8	15.1	6.4	11.9	4.2	10.4	7.0	12.0	12.2	6.0	19.4	15.5	9.8	5.3	16.8	27.7	17.5	10.2	20.5
USP26		ENSG00000134588	"Ubiquitin specific peptidase 26"	Q9BXU7	X	133024631-133097109	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in single"	7	"testis: 3.8"	"Cell type enriched"	"Detected in single"	14	"Spermatogonia: 3.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in some"							"Not detected"	"Not detected"			"HPA000424, HPA027310"	Approved		Supported	Nucleoplasm		NA	NA			Nucleoplasm		"HPA000424: , HPA027310: "	"unprognostic (7.92e-4)"		"unprognostic (3.59e-2)"											"unprognostic (1.99e-2)"	"unprognostic (2.08e-1)"			0.1	0.1	0.1	0.1	0.1	0.3	0.5	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.2	0.4	0.1	0.1	0.2	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.2	0.1	0.1	0.2	0.2	0.4	0.1	0.1	0.1	0.1	0.1	3.8	0.1	0.1	0.1	0.1	0.3	0.1	0.1	0.2	0.1	0.5	0.1	0.2	0.3	0.0	0.0	0.5	0.4	0.5	0.4	0.1	0.1	0.2	0.2	0.7	0.1	0.2	0.1	0.7	0.1	0.1	0.0	0.1	0.7	0.1	0.2	0.3	1.0	0.3	1.0	0.3	0.1	0.1	0.0	1.5	0.6	0.4	0.1	0.3	0.1	0.4	0.4	0.4	0.2	0.2	0.1	0.8	0.4	0.2	0.3	0.4	0.1	0.0	0.9	0.5	0.5	0.2	0.1	0.1	0.2	1.0	0.1	0.7	0.3	0.9	0.1	0.3	0.4	0.9	0.3	0.1	0.2	0.4	0.3	0.2	0.1	0.2	0.1	0.1	0.0	0.0	0.1	0.0	0.1	0.2	0.0	0.0	0.5	0.2	0.0	0.0	0.3	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	3.7	0.0	0.0	0.0	0.0	0.0
USP27X	USP27	ENSG00000273820	"Ubiquitin specific peptidase 27, X-linked"	A6NNY8	X	49879948-49882565	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"	"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	8	"Alveolar cells type 1: 17.9;Ciliated cells: 24.1;Cytotrophoblasts: 34.3;Syncytiotrophoblasts: 21.9"	"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"SuSa: 17.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA077264			Approved	Nucleoplasm,Vesicles		NA	NA			Vesicles	Nucleoplasm	"HPA077264: AB_2686831"	"unprognostic (4.12e-2)"	"unprognostic (9.58e-3)"	"unprognostic (2.29e-1)"	"unprognostic (4.66e-2)"	"unprognostic (1.98e-1)"	"unprognostic (1.74e-1)"	"prognostic unfavorable (6.14e-4)"	"unprognostic (3.10e-3)"	"unprognostic (3.91e-2)"	"unprognostic (1.31e-2)"	"prognostic favorable (9.31e-4)"	"unprognostic (5.37e-2)"	"unprognostic (7.45e-3)"	"unprognostic (1.19e-1)"	"unprognostic (1.12e-1)"	"unprognostic (2.01e-2)"	"unprognostic (2.58e-1)"	1.8	3.3	1.8	5.9	2.9	0.3	7.7	1.7	7.4	3.9	5.9	4.8	2.2	1.1	12.7	4.1	3.1	4.7	3.8	3.9	2.2		3.5	3.5	6.1	1.9	1.3	3.2	8.8	3.2	4.1	0.8	15.5	2.8	4.1	1.7	4.1	5.2	3.9	7.5	2.6	4.7	3.9	1.3	2.0	1.9	3.8	1.9	2.8	3.2	3.6	2.2	3.7	3.1	1.7	1.0	0.7	0.7	0.3	1.3	0.4	1.8	4.7	5.5	6.3	5.2	4.3	4.6	2.1	3.4	2.4	2.0	8.5	2.1	1.2	2.0	5.4	7.9	3.0	7.8	5.2	3.5	2.4	3.7	2.0	1.4	7.7	3.5	0.6	4.3	6.0	3.6	3.4	3.4	5.9	3.3	5.5	3.9	2.0	3.8	4.5	2.9	1.7	6.0	3.5	3.3	3.1	4.8	0.4	3.9	1.8	1.4	4.1	4.0	3.8	4.9	17.9	4.4	1.4	2.5	2.8	5.4	4.8	0.8	1.9	0.5	0.8	3.2	1.7	3.0	0.7	0.4	0.1	0.6	0.4	0.8	0.6	0.5	0.3	1.0	1.7	0.8	0.6	0.7	0.3	0.7	0.4	1.3	0.4											17.9	13.3	0.0	4.1	2.6	9.7	2.3	0.0	24.1	13.6	0.0	0.0	34.3	5.0	1.1	0.0	3.1	0.7	0.0	0.6	2.0	1.8	2.5	2.3	1.7	3.4	4.8	4.1	3.1	0.3	0.0	2.0	1.1	0.0	1.0	1.2	10.2	1.2	0.0	3.2	2.6	2.0	6.5	1.7	0.0	1.4	1.9	21.9	1.3	1.7	1.7
USP28	KIAA1515	ENSG00000048028	"Ubiquitin specific peptidase 28"	Q96RU2	11	113797874-113875570	"Enzymes, Predicted intracellular proteins"	"DNA damage, DNA repair, Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 40.1;skeletal muscle: 50.2"	"Cell type enriched"	"Detected in many"	5	"Cardiomyocytes: 130.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"SuSa: 42.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006778, HPA006779"	Enhanced		Supported	"Nucleoplasm,Nuclear bodies"		NA	NA			Nucleoplasm	"Nuclear bodies"	"HPA006778: AB_1080520, HPA006779: AB_1080517"	"unprognostic (2.54e-1)"	"unprognostic (2.72e-1)"	"unprognostic (2.99e-2)"	"unprognostic (3.72e-2)"	"unprognostic (5.51e-2)"	"unprognostic (2.30e-1)"	"unprognostic (9.73e-3)"	"unprognostic (3.00e-1)"	"unprognostic (2.04e-3)"	"unprognostic (1.82e-3)"	"unprognostic (3.17e-2)"	"unprognostic (1.19e-1)"	"unprognostic (5.11e-2)"	"unprognostic (2.06e-2)"	"unprognostic (9.03e-2)"	"unprognostic (1.35e-3)"	"unprognostic (5.03e-2)"	3.9	3.4	4.8	8.6	5.7	2.4	5.7	26.4	8.6	11.6	5.1	4.9	14.0	4.7	6.0	6.0	5.7	5.0	4.0	40.1	5.0	4.8	5.1	5.6	5.1	7.2	6.8	4.5	7.5	4.1	10.6	9.7	3.9	4.8	8.9	6.0	5.7	5.7	12.2	50.2	3.5	5.1	11.6	6.4	6.9	4.4	5.5	3.8	3.6	5.1	10.1	7.7	7.1	4.6	10.3	4.1	2.1	3.7	17.9	16.2	6.0	8.6	9.7	13.1	17.3	10.8	10.7	9.3	6.4	8.8	8.6	14.8	14.4	12.5	11.5	14.6	8.6	19.9	17.0	18.5	12.0	12.0	12.8	8.4	6.1	6.8	7.7	6.6	7.8	6.1	6.4	9.1	10.0	11.9	12.6	15.5	5.7	10.5	7.5	9.0	4.4	5.9	12.8	15.7	16.0	7.0	14.7	18.3	13.9	9.5	8.5	5.7	6.2	15.2	5.2	4.9	42.9	12.6	2.7	8.2	9.6	14.4	8.7	6.5	5.1	7.3	9.7	0.9	15.3	6.2	0.1	3.2	2.1	16.2	2.4	8.4	10.3	4.1	11.4	4.1	8.4	2.7	9.4	0.9	17.9	3.7	1.2	5.6	6.0	4.8	5.7	26.4	8.6	5.0	4.8	6.8	4.5	4.8	3.8	8.9	9.1	10.0	6.9	1.4	16.1	130.6	5.1	14.7	10.3	5.2	17.7	3.5	5.0	5.7	1.4	4.3	5.1	0.0	3.4	3.7	4.7	6.2	1.1	6.7	3.9	4.8	4.7	6.2	4.1	1.4	6.4	6.5	1.7	5.4	10.3	10.1	4.4	3.5	13.1	6.3	20.2	6.5	5.2	10.8	10.0	1.8	0.9	24.5	9.2	4.9
USP29		ENSG00000131864	"Ubiquitin specific peptidase 29"	Q9HBJ7	19	57119138-57131926	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Group enriched"	"Detected in some"	5	"blood: 4.1;bone marrow: 2.7;pancreas: 2.1;skin 1: 2.3;testis: 8.4"	"Group enriched"	"Detected in some"	9	"Collecting duct cells: 1.8;Early spermatids: 1.7;Spermatocytes: 4.8;Spermatogonia: 1.5"	"Not detected"	"Not detected"							"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"BEWO: 3.3;HEK 293: 3.2"					"Not detected"	"Not detected"			HPA076515	Enhanced					NA	NA					"HPA076515: "															"unprognostic (1.32e-1)"			0.1	0.1	0.2	0.0	0.2	2.7	0.1	0.1	0.4	0.1	0.1			0.0	0.1	0.0	0.1	0.1	0.0	0.6	0.3	0.2	0.1	0.1	0.1	0.3	0.1		0.2	2.1	0.0	0.1	0.0		0.1	0.0		0.7	0.0	0.2	2.3	0.1	0.0	0.1	0.1	0.4	8.4			0.4		0.0	0.7	0.1	1.1	1.9	4.1	1.1	1.2	0.8	0.6	0.1	0.7	0.8	0.3	0.0	0.0	3.3	0.0	0.0	0.1	0.1	1.7	0.0	0.9	0.0	0.0	0.0	2.0	0.0	0.0	0.0	1.0	3.2	0.8	0.0	0.0	1.1	0.0	2.0	0.9	1.0	1.4	0.0	0.0	0.0	1.0	0.3	0.9	0.0	0.7	0.0	1.2	0.0	0.5	1.0	0.9	0.0	1.0	0.0	2.1	2.1	0.7	0.6	0.4	0.3	1.2	0.8	1.3	1.5	1.3	0.5	0.0	0.0	1.6	0.5	1.5	0.5	0.8	0.0	3.1	1.1	1.1	0.8	0.7	0.6	0.5	0.7	0.3	0.3	1.1	0.7	0.7	4.1	1.2	0.4	1.9	0.5	0.6											0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.8	1.5	0.0	0.0	0.0	0.0	0.1
USP3		ENSG00000140455	"Ubiquitin specific peptidase 3"	Q9Y6I4	15	63504511-63594640	"Enzymes, Predicted intracellular proteins"	"Cell cycle, DNA damage, Ubl conjugation pathway"	"Chromatin regulator, Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Region enriched"	"Detected in all"	4	"cerebellum: 33.4"	"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA053275, HPA060513, HPA077975"			Supported	"Nucleoplasm,Midbody ring"	"Intracellular and membrane"	No	No			Nucleoplasm	"Midbody ring"	"HPA053275: AB_2682096, HPA060513: AB_2684299, HPA077975: AB_2732365"	"unprognostic (4.63e-3)"	"unprognostic (2.71e-1)"	"unprognostic (7.88e-2)"	"unprognostic (3.33e-2)"	"unprognostic (2.16e-2)"	"unprognostic (6.03e-2)"	"unprognostic (6.26e-2)"	"unprognostic (4.52e-2)"	"unprognostic (1.62e-2)"	"unprognostic (2.36e-1)"	"unprognostic (3.54e-2)"	"unprognostic (4.87e-2)"	"unprognostic (1.17e-1)"	"unprognostic (8.61e-2)"	"unprognostic (2.78e-1)"	"unprognostic (6.21e-2)"	"prognostic favorable (1.38e-4)"	16.0	9.0	5.9	20.4	6.5	38.6	21.3	33.4	6.6	12.7	19.1	6.0	16.8	16.2	18.1	13.3	13.6	10.4	14.2	7.6	6.6	4.4	12.9	10.8	17.5	28.2	8.1	3.9	19.5	27.1	7.1	8.2	10.2	7.9	12.4	11.5	8.2	18.5	14.8	12.4	15.9	19.0	16.1	8.0	23.6	14.7	10.3	7.8	22.7	12.5	11.4	22.5	21.3	17.9	11.4	20.6	52.6	28.1	7.2	12.9	13.4	9.2	30.2	15.6	9.8	7.7	12.6	13.8	7.9	9.9	7.7	9.5	11.8	17.3	9.4	12.6	7.9	5.1	11.7	14.6	12.3	7.5	15.3	7.9	10.6	10.8	12.7	6.6	6.3	12.8	9.0	16.3	9.3	16.2	7.8	16.7	16.9	14.1	12.0	4.9	14.3	13.1	10.2	19.7	18.9	13.1	19.2	9.4	16.6	9.2	31.7	13.7	10.6	4.9	16.2	9.7	8.9	9.7	12.3	15.8	8.9	18.6	5.2	10.5	10.8	19.9	20.8	8.6	17.5	7.4	28.8	28.1	3.5	8.4	22.6	9.3	10.3	11.9	8.6	20.6	11.4	12.9	9.3	52.6	7.2	18.7	4.1	9.1	13.4	5.9	6.5	33.4	6.6	6.6	4.4	8.1	3.9	7.9	7.8	35.7	60.4	35.8	31.2	46.8	31.1	9.1	20.4	36.1	43.3	15.7	11.8	17.3	34.9	36.4	19.7	20.3	33.9	0.0	32.3	46.8	16.4	35.8	25.5	20.8	22.8	12.7	42.1	11.1	75.5	53.6	14.7	64.4	40.5	27.1	32.5	24.6	35.0	31.7	17.3	19.9	17.8	12.9	25.2	10.2	41.8	51.6	28.5	37.4	34.7	33.1
USP30	"FLJ40511, MGC10702"	ENSG00000135093	"Ubiquitin specific peptidase 30"	Q70CQ3	12	109023089-109088026	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Late spermatids: 37.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA016952	Approved					NA	NA					"HPA016952: AB_1858680"	"unprognostic (2.34e-1)"	"unprognostic (1.57e-2)"	"unprognostic (7.04e-2)"	"unprognostic (9.91e-2)"	"unprognostic (2.48e-1)"	"unprognostic (5.89e-2)"	"unprognostic (1.91e-1)"	"unprognostic (3.60e-3)"	"unprognostic (1.98e-1)"	"unprognostic (4.96e-2)"	"unprognostic (5.07e-2)"	"unprognostic (1.07e-1)"	"prognostic favorable (5.23e-6)"	"unprognostic (2.49e-1)"	"unprognostic (1.23e-1)"	"unprognostic (1.12e-1)"	"unprognostic (1.02e-3)"	11.7	18.9	12.7	9.0	17.6	12.2	10.4	11.9	21.0	10.3	13.2	29.2	13.6	14.9	12.4	8.5	9.2	11.1	8.4	9.0	10.3	10.6	12.4	21.7	8.9	10.4	16.6	7.8	17.5	12.4	14.7	13.0	6.7	16.0	9.4	11.3	16.4	10.1	12.4	16.4	13.6	14.1	8.6	14.3	9.8	8.5	21.3	16.3	8.7	11.1	5.3	7.1	10.8	8.1	14.2	12.2	12.7	11.0	18.3	17.4	6.0	4.6	3.6	9.5	8.2	6.7	7.7	5.3	5.2	6.8	6.1	5.4	4.2	3.6	11.7	4.4	5.1	5.6	5.2	8.3	5.4	7.0	13.5	10.4	3.8	3.2	6.0	7.2	7.4	4.2	9.2	6.6	5.4	5.3	15.8	7.0	12.1	5.6	5.7	5.1	5.4	11.7	4.2	3.0	5.6	10.1	12.7	6.8	7.0	4.9	5.6	8.7	7.7	7.0	5.3	5.5	7.3	13.1	5.8	5.0	5.6	3.1	5.4	3.4	14.3	11.9	17.5	6.0	4.5	6.2	9.5	7.1	12.7	15.4	11.0	17.4	14.2	12.9	14.3	4.6	14.2	13.7	12.6	4.2	18.3	8.8	12.2	11.2	6.0	12.7	17.6	11.9	21.0	10.3	10.6	16.6	7.8	16.0	16.3	0.0	2.9	0.8	2.3	1.8	7.7	6.4	10.2	4.0	5.7	5.2	7.9	4.9	0.0	3.9	22.7	2.9	9.7	0.0	4.9	3.5	3.3	2.0	0.0	13.9	4.9	6.4	6.4	1.8	4.6	37.3	3.4	1.4	1.7	1.0	10.2	6.5	4.6	3.5	3.5	5.1	14.1	12.9	2.1	16.9	5.3	2.9	6.1	1.9	10.4	2.6
USP31	KIAA1203	ENSG00000103404	"Ubiquitin specific peptidase 31"	Q70CQ4	16	23061406-23149270	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Basal glandular cells: 55.8;Basal keratinocytes: 59.3;Spermatogonia: 60.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA006937	Uncertain		Approved	Cytosol		NA	NA			Cytosol		"HPA006937: AB_1080523"	"unprognostic (6.45e-2)"	"unprognostic (2.42e-1)"	"unprognostic (1.08e-1)"	"unprognostic (4.43e-3)"	"unprognostic (1.24e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.23e-1)"	"unprognostic (1.29e-1)"	"unprognostic (1.03e-1)"	"unprognostic (2.52e-1)"	"unprognostic (6.15e-2)"	"unprognostic (2.01e-1)"	"prognostic unfavorable (4.41e-5)"	"unprognostic (5.59e-2)"	"unprognostic (3.75e-1)"	"unprognostic (3.07e-1)"	"unprognostic (1.98e-3)"	6.3	5.3	11.2	4.0	16.6	7.1	8.7	12.7	16.5	10.9	4.9	19.7	2.6	3.7	15.3	7.7	9.3	6.5	4.1	11.0	9.0	6.3	6.2	7.7	7.3	3.6	24.6	8.1	3.7	6.3	20.6	10.4	7.4	17.4	9.6	4.9	2.8	6.0	8.5	10.9	15.9	3.4	14.2	14.8	2.8	3.5	20.7	19.3	1.7	4.2	2.4	4.9	13.4	9.5	0.5	0.8	0.6	1.3	0.1	2.1	0.2	9.5	10.1	2.9	4.0	5.3	4.2	2.7	3.3	3.0	4.3	5.2	6.4	5.8	3.2	3.6	4.2	7.0	12.6	7.2	13.1	7.1	2.3	2.9	1.3	5.8	13.4	6.7	3.3	3.6	3.5	11.3	8.0	18.5	1.6	7.6	3.2	3.9	10.0	5.8	6.5	1.6	2.8	5.8	3.2	3.1	7.9	8.2	6.4	6.4	14.3	7.8	5.1	5.2	10.3	2.9	3.4	4.1	7.4	4.5	8.8	6.5	4.4	9.0	3.3	5.4	3.4	6.3	4.5	3.5	0.1	0.7	0.6	0.8	0.3	2.1	0.1	0.7	1.5	0.8	0.5	0.8	0.8	0.1	0.1	1.3	0.2	1.3	0.2	11.2	16.6	12.7	16.5	9.0	6.3	24.6	8.1	17.4	19.3	6.0	3.0	6.1	55.8	59.3	12.6	9.2	10.2	8.1	7.9	5.2	2.0	11.1	0.0	6.1	3.6	14.6	1.4	0.0	7.2	6.2	5.4	14.2	1.1	25.0	4.2	0.0	4.6	7.4	3.1	8.9	7.2	2.9	6.8	1.0	3.5	4.8	7.6	0.0	4.2	9.1	7.4	19.4	7.1	23.8	60.3	23.2	6.3	1.3	5.2	19.5
USP32	"NY-REN-60, USP10"	ENSG00000170832	"Ubiquitin specific peptidase 32"	Q8NFA0	17	60179094-60422470	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 58.4"	"Cell type enhanced"	"Detected in all"	11	"Cone photoreceptor cells: 227.8;Rod photoreceptor cells: 128.6;Spermatocytes: 100.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"plasmacytoid DC: 28.4"	"Group enriched"	"Detected in many"	10	"dendritic cells: 28.4;granulocytes: 13.5"	"Cell line enhanced"	"Detected in all"		"MCF7: 61.6"									HPA044365	Approved		Approved	"Golgi apparatus,Cytosol"		NA	NA			"Golgi apparatus"	Cytosol	"HPA044365: AB_2678914"	"unprognostic (4.10e-2)"	"unprognostic (3.38e-2)"	"unprognostic (3.57e-2)"	"prognostic unfavorable (1.50e-4)"	"unprognostic (2.15e-1)"	"unprognostic (4.33e-2)"	"unprognostic (1.90e-3)"	"unprognostic (2.33e-2)"	"unprognostic (2.24e-1)"	"unprognostic (3.93e-1)"	"unprognostic (6.49e-2)"	"unprognostic (2.78e-1)"	"unprognostic (2.82e-1)"	"unprognostic (1.97e-1)"	"unprognostic (7.23e-2)"	"unprognostic (8.35e-2)"	"unprognostic (4.16e-2)"	9.5	13.9	17.3	10.8	19.5	20.6	10.9	14.6	20.3	8.0	8.5	18.9	7.9	7.2	8.2	5.4	13.1	7.4	9.1	11.1	14.7	12.2	15.5	19.7	12.5	8.6	18.8	14.3	7.4	8.5	17.3	11.4	9.8	19.2	8.7	8.9	11.6	8.2	9.0	23.0	12.2	7.2	9.8	16.5	12.1	8.1	58.4	18.1	7.3	15.6	7.9	8.5	8.8	8.5	1.4	28.4	13.5	2.1	0.6	1.1	0.9	11.1	12.7	6.8	10.8	17.2	16.2	6.4	9.1	13.8	12.0	15.4	6.6	7.3	6.9	7.7	16.8	19.3	5.9	11.5	12.6	21.2	5.2	5.1	13.8	10.1	7.2	17.1	10.9	12.6	15.1	9.3	16.1	14.9	12.4	13.1	8.3	13.9	5.7	14.8	61.6	11.0	7.7	7.9	10.7	6.1	5.3	17.9	4.1	12.6	8.1	4.8	7.2	7.6	2.2	11.7	12.3	9.4	15.2	11.0	18.2	19.0	11.4	8.5	5.9	11.2	6.5	9.1	8.6	11.8	4.3	2.1	7.2	1.0	1.8	0.7	1.4	0.7	0.8	4.1	1.1	0.5	1.0	13.5	0.6	2.0	28.4	1.1	0.9	17.3	19.5	14.6	20.3	14.7	12.2	18.8	14.3	19.2	18.1	6.0	13.1	7.7	11.6	23.9	16.9	7.6	5.1	6.7	13.6	5.2	227.8	4.3	3.3	9.0	69.1	8.4	6.8	23.3	6.3	5.3	10.4	9.3	11.5	10.6	16.5	12.7	7.9	9.2	33.2	25.6	12.0	27.7	5.0	14.4	4.2	10.3	8.4	9.1	5.3	3.7	128.6	25.8	9.5	100.3	9.1	19.2	4.1	12.9	4.4	7.1
USP33	"KIAA1097, VDU1"	ENSG00000077254	"Ubiquitin specific peptidase 33"	Q8TEY7	1	77695987-77759852	"Enzymes, Predicted intracellular proteins"	"Endocytosis, Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA005719	Uncertain		Supported	"Nucleoplasm,Golgi apparatus"		NA	NA			"Nucleoplasm, Golgi apparatus"		"HPA005719: AB_10601708"	"unprognostic (2.31e-3)"	"unprognostic (2.73e-2)"	"unprognostic (1.04e-2)"	"unprognostic (2.36e-1)"	"unprognostic (9.19e-3)"	"unprognostic (1.88e-3)"	"unprognostic (1.22e-2)"	"unprognostic (6.06e-2)"	"unprognostic (2.48e-1)"	"unprognostic (2.25e-1)"	"unprognostic (2.67e-1)"	"unprognostic (3.59e-1)"	"unprognostic (5.36e-3)"	"unprognostic (4.89e-2)"	"unprognostic (5.76e-2)"	"unprognostic (2.19e-1)"	"unprognostic (2.02e-2)"	30.8	27.1	28.1	18.8	32.1	24.6	28.6	55.3	37.5	21.6	20.4	20.6	18.5	20.2	23.3	23.0	17.8	19.2	21.7	17.0	30.7	30.6	26.0	20.3	21.0	20.7	26.0	25.4	25.3	17.0	28.8	23.4	34.6	38.7	24.6	21.0	21.4	19.5	19.8	16.3	19.4	23.8	19.8	21.4	22.3	19.5	19.9	21.6	27.8	25.1	12.9	20.3	21.0	20.0	15.7	12.2	33.2	18.4	12.3	17.8	10.6	16.1	7.4	25.6	17.7	36.9	32.3	22.0	17.7	16.9	21.6	24.3	9.8	14.0	12.1	16.8	17.2	35.5	12.8	18.6	12.1	26.6	11.1	14.5	42.7	18.1	8.5	23.0	14.5	10.8	23.7	9.5	20.9	15.4	20.9	19.2	11.1	16.6	10.6	16.2	6.2	13.1	14.5	24.7	12.6	14.7	12.6	27.0	8.5	20.4	16.6	21.5	16.6	12.4	16.5	24.7	22.8	9.2	15.8	16.1	20.0	14.2	20.1	16.7	8.7	11.0	11.8	15.1	17.2	10.1	33.2	15.4	20.0	15.1	15.0	15.3	13.4	14.7	15.2	11.5	15.7	17.8	15.6	20.9	12.3	18.4	12.2	13.2	10.6	28.1	32.1	55.3	37.5	30.7	30.6	26.0	25.4	38.7	21.6	41.7	36.3	21.6	16.5	15.2	50.9	31.5	20.4	36.1	25.0	33.2	55.0	21.0	8.3	16.9	2.8	26.4	26.8	0.0	13.4	15.9	21.2	23.9	22.0	18.1	16.5	58.8	34.1	28.8	33.6	3.6	33.1	22.3	21.9	19.8	26.0	34.5	15.7	28.6	30.1	19.2	40.3	19.4	17.5	36.1	26.3	14.3	10.0	27.5	22.9	20.0
USP34	"KIAA0570, KIAA0729"	ENSG00000115464	"Ubiquitin specific peptidase 34"	Q70CQ2	2	61187463-61470769	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway, Wnt signaling pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Cone photoreceptor cells: 235.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA025815, HPA070764"	Uncertain		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA025815: AB_1858681, HPA070764: AB_2686308"	"unprognostic (4.04e-2)"	"unprognostic (8.21e-3)"	"unprognostic (5.08e-2)"	"unprognostic (3.14e-2)"	"unprognostic (4.13e-2)"	"unprognostic (1.43e-2)"	"unprognostic (1.04e-1)"	"unprognostic (2.66e-1)"	"unprognostic (1.47e-1)"	"unprognostic (2.90e-2)"	"unprognostic (8.91e-2)"	"unprognostic (4.62e-2)"	"unprognostic (9.58e-2)"	"unprognostic (1.66e-1)"	"unprognostic (2.53e-1)"	"unprognostic (6.34e-2)"	"unprognostic (7.01e-2)"	17.2	19.6	31.8	37.2	25.6	24.8	28.3	77.1	35.5	22.5	22.7	14.4	31.1	11.4	22.2	44.5	18.6	17.5	20.0	16.9	30.5	24.0	20.5	21.5	29.7	34.2	22.0	21.2	24.7	17.2	33.5	40.3	13.4	22.0	22.7	21.5	21.2	16.9	45.2	27.0	31.6	21.0	22.7	20.8	24.8	19.3	26.4	25.3	21.7	23.2	13.9	33.5	19.1	16.7	6.0	5.8	3.4	4.6	5.2	7.5	2.3	16.8	12.1	15.7	16.3	29.9	20.1	13.2	10.4	14.7	9.3	8.9	16.9	6.5	40.0	11.1	22.4	9.9	9.3	12.4	13.7	17.4	14.3	9.8	24.2	11.7	27.2	25.2	17.9	15.4	21.9	17.8	17.0	25.4	22.8	19.6	11.4	16.5	13.0	20.7	15.8	11.8	26.1	10.6	17.2	9.6	12.7	19.2	10.7	27.5	20.7	13.0	13.9	16.4	12.2	17.9	21.0	6.4	13.0	17.5	14.8	19.7	8.7	13.6	15.1	7.4	42.0	13.9	16.7	12.6	3.4	2.0	2.8	7.5	2.2	6.7	5.1	5.1	5.5	1.8	6.0	5.8	7.5	3.4	5.2	4.6	5.8	4.5	2.3	31.8	25.6	77.1	35.5	30.5	24.0	22.0	21.2	22.0	25.3	59.6	60.6	35.3	50.1	54.3	132.9	41.8	56.0	33.5	59.1	31.4	235.6	26.6	8.3	35.4	108.3	51.2	38.6	0.0	29.1	19.8	45.2	63.1	31.2	36.3	19.7	101.7	46.7	23.4	40.3	105.2	52.6	41.4	38.8	30.7	32.2	62.5	38.7	38.4	62.9	18.3	185.3	25.8	46.7	97.9	106.7	53.6	44.6	40.8	31.2	57.6
USP35	KIAA1372	ENSG00000118369	"Ubiquitin specific peptidase 35"	Q9P2H5	11	78188812-78214711	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"parathyroid gland: 32.4"	"Group enriched"	"Detected in many"	4	"Early spermatids: 20.7;Late spermatids: 31.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	5	"eosinophil: 3.4"	"Lineage enriched"	"Detected in single"	5	"granulocytes: 3.4"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA055213, HPA058592"	Uncertain		Approved	"Nucleoplasm,Nucleoli fibrillar center"		NA	NA			"Nucleoli fibrillar center"	Nucleoplasm	"HPA055213: AB_2682740, HPA058592: AB_2683766"	"unprognostic (6.69e-2)"	"unprognostic (1.17e-2)"	"unprognostic (1.69e-1)"	"unprognostic (6.87e-3)"	"unprognostic (3.38e-2)"	"unprognostic (1.08e-2)"	"unprognostic (2.00e-1)"	"unprognostic (1.46e-1)"	"unprognostic (3.57e-2)"	"unprognostic (3.84e-3)"	"unprognostic (1.03e-2)"	"unprognostic (3.11e-2)"	"unprognostic (1.29e-3)"	"unprognostic (2.93e-1)"	"unprognostic (1.31e-1)"	"unprognostic (4.38e-2)"	"unprognostic (1.49e-2)"	4.9	17.1	5.1	5.4	9.3	3.8	5.2	10.4	15.0	6.4	5.8	8.0	6.3	5.5	6.8	5.4	5.6	5.4	5.6	8.7	6.1	6.7	5.0	13.8	5.6	4.8	6.7	8.8	6.6	6.4	32.4	12.0	7.1	15.0	5.0	3.4	7.7	4.0	5.6	5.6	3.2	5.3	7.8	4.5	4.6	3.9	5.3	4.0	1.9	7.7	2.9	4.1	5.2	6.6	0.0	0.1	3.4	0.6	0.1	0.3	0.2	2.1	3.3	5.7	6.0	9.7	9.0	3.9	4.9	5.8	5.8	4.1	8.3	4.6	1.7	5.1	9.2	6.2	5.7	3.8	7.6	3.4	12.2	2.0	2.8	8.6	4.8	7.6	1.8	8.3	7.6	5.1	12.1	3.5	11.5	7.1	6.2	3.9	4.2	4.5	1.9	4.6	7.2	1.7	6.0	5.3	2.8	5.3	2.0	4.6	3.9	2.8	5.4	3.8	5.0	1.8	8.5	4.2	1.5	8.6	10.7	6.1	12.6	2.6	5.7	1.8	2.6	3.2	1.9	6.2	0.0	0.2	3.4	0.1	0.6	0.0	0.0	0.2	0.2	0.1	0.0	0.3	0.0	0.2	0.1	0.1	0.1	0.1	0.2	5.1	9.3	10.4	15.0	6.1	6.7	6.7	8.8	15.0	4.0	0.0	2.6	0.0	0.1	0.7	0.7	1.8	0.0	0.0	0.0	0.0	5.9	0.6	0.0	0.8	20.7	1.5	0.8	0.0	1.7	1.3	2.0	0.2	0.0	3.0	1.3	0.0	0.0	2.5	0.8	31.6	1.4	0.9	1.7	3.6	0.6	0.5	1.8	0.0	2.8	0.8	0.5	6.5	0.9	0.9	1.6	0.9	0.2	3.9	0.7	0.1
USP36	"FLJ12851, KIAA1453"	ENSG00000055483	"Ubiquitin specific peptidase 36"	Q9P275	17	78787381-78841441	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA012082, HPA012395, HPA052860"	Uncertain	Supported	Enhanced	"Nucleoli,Nucleoli rim,Nuclear speckles"		NA	NA			"Nucleoli, Nucleoli rim"	"Nuclear speckles"	"HPA012082: AB_1858682, HPA012395: , HPA052860: AB_2681974"	"unprognostic (1.94e-2)"	"unprognostic (2.80e-2)"	"unprognostic (1.07e-1)"	"prognostic unfavorable (5.18e-5)"	"unprognostic (9.35e-2)"	"unprognostic (1.98e-1)"	"unprognostic (2.50e-3)"	"unprognostic (1.35e-1)"	"unprognostic (2.04e-1)"	"unprognostic (1.33e-1)"	"unprognostic (1.68e-2)"	"unprognostic (2.78e-2)"	"unprognostic (1.31e-2)"	"unprognostic (1.45e-1)"	"unprognostic (1.81e-1)"	"unprognostic (4.03e-3)"	"unprognostic (1.78e-1)"	26.3	23.4	12.9	21.3	16.0	36.5	28.1	28.3	17.4	17.2	16.4	25.4	19.2	12.3	25.1	22.2	14.6	18.0	21.9	17.4	10.4	11.2	15.9	16.4	20.0	17.2	17.5	16.0	41.3	33.6	19.6	30.0	23.4	14.6	21.0	15.1	20.4	21.8	45.5	19.5	29.3	15.1	25.2	14.5	18.2	17.3	20.8	13.7	12.8	19.3	11.2	22.2	24.6	18.1	6.7	12.4	8.9	5.3	5.6	8.8	2.5	16.0	19.4	5.7	10.6	12.3	13.7	11.0	13.2	13.4	12.7	8.6	18.8	8.1	20.5	6.7	11.7	13.8	11.8	13.4	9.8	22.8	4.9	20.3	18.7	28.3	19.6	12.7	20.5	10.3	11.9	16.3	18.1	40.6	9.8	11.0	9.3	14.9	21.7	10.4	12.3	18.6	20.8	8.8	12.0	15.6	14.4	12.6	13.8	8.0	17.0	16.9	10.3	9.5	44.3	24.0	13.0	11.4	13.1	9.3	30.1	14.0	17.5	23.3	16.1	6.3	25.3	11.8	16.0	9.4	8.9	3.9	3.1	7.6	5.3	8.8	6.4	7.2	6.4	2.3	6.7	8.0	7.7	5.7	5.6	3.3	12.4	4.8	2.5	12.9	16.0	28.3	17.4	10.4	11.2	17.5	16.0	14.6	13.7	11.9	41.5	16.3	21.0	45.9	31.4	13.5	15.3	12.0	26.1	14.0	31.4	6.9	5.0	8.7	12.1	20.4	6.8	0.0	8.3	8.9	25.9	22.8	19.7	12.4	34.2	25.4	17.7	12.3	20.6	6.1	10.9	34.8	28.7	10.8	13.6	17.3	10.7	8.6	11.7	4.1	32.5	6.5	22.7	14.2	10.6	37.9	10.8	30.5	14.0	20.4
USP37	KIAA1594	ENSG00000135913	"Ubiquitin specific peptidase 37"	Q86T82	2	218450251-218568361	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis, Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	8	"Early spermatids: 117.3;Late spermatids: 116.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA045160	Approved		Approved	Nucleoplasm,Nucleoli		NA	NA			"Nucleoplasm, Nucleoli"		"HPA045160: AB_10795620"	"unprognostic (7.00e-2)"	"unprognostic (2.29e-1)"	"unprognostic (8.83e-2)"	"unprognostic (9.19e-4)"	"unprognostic (1.83e-1)"	"prognostic favorable (2.85e-4)"	"unprognostic (2.18e-2)"	"unprognostic (1.14e-1)"	"unprognostic (9.66e-3)"	"unprognostic (1.17e-1)"	"unprognostic (3.78e-3)"	"unprognostic (1.11e-1)"	"unprognostic (3.82e-2)"	"unprognostic (3.26e-1)"	"unprognostic (2.87e-1)"	"unprognostic (6.69e-2)"	"unprognostic (6.41e-3)"	10.4	8.4	9.2	9.7	10.5	19.2	9.0	16.2	10.0	8.3	6.6	10.4	8.0	5.8	9.6	15.8	8.2	7.8	7.0	6.9	7.4	5.5	6.1	7.4	8.1	10.5	8.7	7.8	15.3	6.9	10.7	17.1	8.5	8.7	7.3	7.0	7.4	9.7	9.6	11.1	9.9	7.2	8.1	10.2	7.0	6.6	22.2	10.5	13.4	9.8	5.4	9.4	10.5	9.1	7.4	6.1	7.4	4.8	5.9	9.0	2.5	7.4	5.4	11.5	8.8	3.0	3.7	9.8	5.7	4.1	9.9	11.2	10.2	5.9	6.8	6.2	4.4	7.6	7.1	12.5	6.3	10.9	9.2	6.6	18.3	11.0	6.7	3.4	11.9	9.2	2.0	3.8	10.4	7.5	3.6	4.2	11.9	13.2	13.1	6.2	5.5	15.3	8.2	9.8	4.8	4.7	12.4	17.2	6.2	3.4	8.8	12.6	6.8	9.1	4.5	5.7	11.5	5.2	8.4	5.4	11.2	9.8	6.2	7.4	8.9	7.9	13.9	6.0	8.8	7.6	6.5	4.2	7.4	7.0	4.8	7.3	5.4	5.8	5.9	4.4	7.4	9.0	5.7	3.5	5.9	4.4	6.1	7.3	2.5	9.2	10.5	16.2	10.0	7.4	5.5	8.7	7.8	8.7	10.5	0.0	8.3	11.5	5.5	17.3	16.4	3.3	2.5	10.7	10.3	7.0	25.5	6.1	0.0	4.6	117.3	9.0	5.1	0.0	2.0	5.4	9.3	10.2	4.7	10.2	6.5	14.3	9.9	11.6	8.1	116.2	9.2	13.7	20.3	5.4	8.1	9.9	4.6	6.8	9.2	3.6	21.1	6.5	10.3	40.0	12.8	18.1	6.1	17.9	7.0	5.8
USP38	"HP43.8KD, KIAA1891"	ENSG00000170185	"Ubiquitin specific peptidase 38"	Q8NB14	4	143184917-143223830	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 45.3"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"U-266/84: 35.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036990, HPA047948"	Uncertain		Approved	Nucleoplasm,Centrosome,Cytosol		NA	NA			Nucleoplasm	"Centrosome, Cytosol"	"HPA036990: AB_2675419, HPA047948: AB_2680220"	"unprognostic (5.01e-2)"	"unprognostic (2.45e-1)"	"unprognostic (2.04e-3)"	"unprognostic (2.99e-2)"	"unprognostic (1.87e-1)"	"unprognostic (2.61e-2)"	"unprognostic (1.67e-1)"	"unprognostic (7.49e-2)"	"unprognostic (3.66e-2)"	"unprognostic (3.97e-2)"	"unprognostic (8.03e-2)"	"unprognostic (7.72e-3)"	"prognostic favorable (1.20e-4)"	"unprognostic (3.15e-1)"	"unprognostic (1.26e-1)"	"unprognostic (1.29e-1)"	"unprognostic (1.02e-1)"	7.7	7.8	6.6	6.6	6.5	19.1	8.3	7.4	7.8	7.9	12.1	8.6	8.8	8.8	8.3	7.1	8.6	7.1	7.6	12.5	6.6	5.3	9.3	15.2	12.7	11.1	10.3	5.1	6.3	8.8	10.0	6.2	11.4	5.9	6.6	6.6	7.1	7.2	7.0	45.3	8.9	13.2	6.5	10.8	10.6	7.4	7.5	8.2	22.6	8.6	10.2	8.4	7.8	8.8	6.3	8.1	12.5	5.7	12.3	9.9	5.0	4.8	4.5	4.0	6.9	5.3	5.3	3.0	7.7	7.5	7.2	6.1	13.1	7.2	6.0	5.5	6.5	4.6	3.8	9.5	7.7	5.9	14.6	6.1	5.5	5.4	2.8	7.3	11.1	5.5	6.4	7.1	7.3	5.9	5.1	7.1	6.9	11.9	18.9	4.7	7.7	14.5	2.1	3.6	9.8	8.9	9.5	6.0	5.7	4.6	5.6	8.2	7.4	6.0	10.5	6.7	3.1	6.4	4.2	8.4	6.6	5.4	5.7	8.0	21.1	35.7	10.9	6.7	8.5	5.5	12.5	5.4	11.7	7.5	5.7	9.6	6.3	6.6	6.5	8.1	5.7	6.7	5.7	5.4	12.3	5.7	3.5	9.9	5.0	6.6	6.5	7.4	7.7	6.6	5.3	10.3	5.1	5.9	8.2	20.8	13.7	10.5	16.5	47.6	7.5	15.1	7.6	13.4	14.8	0.0	11.8	10.9	1.7	7.5	27.8	12.0	18.4	0.0	6.6	5.8	9.7	16.1	3.5	32.7	9.2	7.9	29.4	17.8	14.5	15.4	6.4	12.2	11.8	1.8	19.9	13.6	8.5	11.5	8.9	14.2	8.2	12.9	15.1	9.5	5.1	51.7	22.3	13.4	14.5	38.1
USP39	"CGI-21, SAD1, SNRNP65"	ENSG00000168883	"Ubiquitin specific peptidase 39"	Q53GS9	2	85602856-85649282	"Enzymes, Predicted intracellular proteins"	"Cell cycle, Cell division, mRNA processing, mRNA splicing"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA034823, HPA077350"	Supported	Supported	Supported	Nucleoplasm		NA	NA			Nucleoplasm		"HPA034823: AB_10602488, HPA077350: "	"unprognostic (1.10e-2)"	"unprognostic (3.31e-3)"	"unprognostic (1.83e-1)"	"prognostic unfavorable (5.52e-4)"	"unprognostic (8.46e-3)"	"unprognostic (3.67e-2)"	"prognostic unfavorable (2.84e-6)"	"unprognostic (1.10e-2)"	"unprognostic (1.69e-1)"	"unprognostic (1.89e-1)"	"unprognostic (5.17e-3)"	"unprognostic (3.14e-2)"	"prognostic unfavorable (4.05e-7)"	"unprognostic (3.95e-3)"	"unprognostic (2.25e-1)"	"unprognostic (2.52e-2)"	"unprognostic (2.52e-1)"	19.0	15.1	14.5	23.5	16.8	30.4	18.3	14.9	20.8	20.2	24.1	18.7	11.8	14.7	22.1	24.1	20.7	16.8	20.6	25.5	13.7	13.7	17.8	20.8	18.5	20.8	15.2	14.5	19.2	15.0	17.7	13.7	28.0	15.8	21.6	20.5	18.0	17.2	20.0	44.2	20.2	17.8	19.0	15.0	21.0	18.1	17.2	13.0	56.5	24.7	23.9	27.0	23.0	26.0	25.3	28.8	29.8	29.7	26.4	37.3	28.2	22.1	22.5	23.1	25.3	16.8	13.2	25.9	18.7	17.7	27.9	24.9	36.0	16.0	26.2	17.7	17.5	20.6	16.0	44.2	20.2	35.4	26.3	28.0	32.5	13.6	31.7	16.6	39.5	22.3	9.3	16.2	21.4	19.3	13.1	22.2	27.7	39.8	15.5	20.4	25.7	38.8	29.7	30.5	27.0	21.0	35.9	49.5	19.9	14.9	17.3	21.3	17.2	11.7	19.2	16.1	19.7	12.9	19.3	14.2	17.3	21.6	20.5	30.9	13.7	25.3	28.1	14.7	41.7	20.6	28.0	25.5	29.8	30.3	29.7	35.2	24.3	31.8	31.2	28.8	25.3	31.4	28.5	16.4	26.4	26.9	22.5	37.3	28.2	14.5	16.8	14.9	20.8	13.7	13.7	15.2	14.5	15.8	13.0	17.9	18.5	11.5	13.7	18.2	7.6	16.2	7.6	17.4	18.2	12.2	7.9	50.4	18.3	16.6	21.7	16.1	10.2	0.0	16.4	24.7	19.3	13.0	16.2	12.5	22.0	4.8	11.6	17.2	10.4	9.4	17.8	16.8	18.6	23.4	14.3	14.0	15.5	8.6	17.7	12.4	10.3	0.0	16.7	17.4	16.8	14.2	29.9	20.3	14.6	13.4
USP4	"UNP, Unph"	ENSG00000114316	"Ubiquitin specific peptidase 4"	Q13107	3	49277831-49340712	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"	Proto-oncogene	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Early spermatids: 100.2;Late spermatids: 90.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA018499	Approved		Approved	"Plasma membrane,Cytosol"		NA	NA			"Plasma membrane, Cytosol"		"HPA018499: AB_1858689"	"unprognostic (2.34e-3)"	"unprognostic (1.52e-1)"	"unprognostic (2.22e-3)"	"unprognostic (6.12e-2)"	"unprognostic (3.51e-1)"	"unprognostic (4.33e-2)"	"unprognostic (9.42e-2)"	"prognostic favorable (4.46e-5)"	"unprognostic (3.54e-1)"	"unprognostic (9.07e-3)"	"unprognostic (2.78e-2)"	"unprognostic (1.70e-3)"	"prognostic favorable (4.29e-5)"	"unprognostic (7.30e-2)"	"unprognostic (1.00e-1)"	"unprognostic (1.18e-2)"	"unprognostic (1.65e-2)"	22.1	18.4	21.4	22.4	29.3	41.4	23.1	30.3	32.5	20.7	20.1	26.8	16.9	16.1	23.6	20.9	23.5	19.3	17.5	22.8	22.2	18.0	20.2	18.5	25.7	25.5	20.2	17.5	23.6	17.1	23.6	19.7	22.1	24.3	20.9	21.9	23.6	19.1	21.3	25.7	27.6	19.4	25.9	20.4	30.6	17.7	25.0	19.7	36.8	21.2	14.1	42.4	22.1	22.0	17.0	24.1	59.4	27.3	21.5	18.6	22.2	6.4	7.4	10.2	13.6	19.0	20.4	6.9	17.5	15.6	22.7	20.5	7.8	16.2	12.4	7.0	25.5	13.1	8.7	13.6	24.8	21.2	19.1	4.0	27.5	14.7	8.7	27.9	14.5	15.9	20.9	10.9	24.9	20.5	16.5	26.2	14.1	9.6	19.7	21.0	10.9	17.1	24.6	8.7	8.0	12.9	7.1	6.4	10.8	17.8	13.3	8.5	11.4	12.7	9.0	6.5	10.7	6.2	23.3	23.2	15.3	8.3	19.1	10.2	15.8	7.6	18.1	13.7	23.0	17.5	18.0	27.3	30.0	16.9	22.1	18.6	17.0	17.6	16.9	24.1	14.1	17.1	15.0	59.4	21.5	24.4	9.6	18.6	22.2	21.4	29.3	30.3	32.5	22.2	18.0	20.2	17.5	24.3	19.7	38.7	21.4	18.1	15.0	16.7	16.6	15.3	15.3	33.5	25.0	19.2	19.6	18.9	18.3	14.2	100.2	17.9	11.6	0.0	11.9	12.1	12.3	13.1	32.4	12.1	21.7	11.1	10.3	16.0	38.8	90.2	14.4	25.3	15.1	30.7	11.4	12.0	14.6	5.8	18.0	10.5	21.5	12.9	14.7	18.5	13.6	16.2	20.3	24.9	11.9	11.8
USP40	FLJ10785	ENSG00000085982	"Ubiquitin specific peptidase 40"	Q9NVE5	2	233475520-233566782	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA005821	Uncertain		Approved	"Vesicles,Focal adhesion sites"		NA	NA			Vesicles	"Focal adhesion sites"	"HPA005821: AB_1080526"	"unprognostic (2.19e-1)"	"unprognostic (1.04e-1)"	"unprognostic (1.13e-1)"	"unprognostic (1.33e-1)"	"unprognostic (3.70e-1)"	"unprognostic (2.15e-1)"	"unprognostic (5.30e-2)"	"unprognostic (2.25e-1)"	"unprognostic (1.80e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.96e-1)"	"unprognostic (1.26e-1)"	"unprognostic (2.22e-1)"	"unprognostic (1.45e-1)"	"unprognostic (4.09e-2)"	"unprognostic (1.90e-2)"	"unprognostic (2.53e-2)"	12.5	20.5	11.0	8.2	17.7	3.5	16.1	8.2	13.5	12.4	12.1	26.1	22.5	11.6	16.2	28.1	13.9	13.4	13.2	10.8	11.3	8.5	16.9	15.7	13.9	7.6	22.1	10.1	19.6	17.2	22.8	24.3	16.3	16.5	16.1	11.2	16.4	13.9	19.7	13.6	21.7	15.2	17.1	20.1	11.4	16.3	23.3	18.9	9.8	21.2	9.4	12.0	18.0	11.8	1.9	5.0	0.4	2.8	1.4	2.2	1.4	9.5	11.1	10.2	6.9	15.0	14.1	9.0	9.4	7.3	8.8	9.6	7.9	11.4	0.2	2.8	15.1	22.6	17.0	7.8	16.7	12.6	0.0	5.1	7.5	9.2	13.3	13.1	3.1	5.1	13.4	12.1	12.9	18.2	15.4	10.1	4.6	12.1	1.8	12.3	7.7	3.4	4.7	4.5	9.9	9.0	0.0	21.2	4.4	10.4	15.4	5.6	6.1	7.5	7.8	9.7	8.0	8.8	7.1	9.9	12.2	7.6	5.1	11.4	3.4	2.6	0.4	15.9	5.7	10.6	0.0	2.7	0.0	1.3	2.8	0.6	1.3	1.5	1.3	4.0	1.9	1.9	2.2	0.4	1.4	2.3	5.0	2.0	1.4	11.0	17.7	8.2	13.5	11.3	8.5	22.1	10.1	16.5	18.9	29.8	31.5	3.7	9.6	6.5	18.6	8.9	10.2	24.1	23.9	15.7	23.6	17.1	6.6	7.9	6.7	7.1	10.9	0.0	10.6	8.8	7.4	11.3	9.2	20.9	7.0	22.3	14.5	12.3	10.4	7.8	6.4	6.7	3.3	5.4	9.1	13.0	9.7	8.6	7.8	11.6	20.8	12.9	8.2	31.2	14.9	9.3	13.2	4.4	11.2	7.1
USP41		ENSG00000161133	"Ubiquitin specific peptidase 41"	Q3LFD5	22	20350578-20390758	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Low tissue specificity"	"Detected in some"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Low cell type specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"NTERA-2: 1.6;RH-30: 4.2;RT4: 1.7;SCLC-21H: 4.9;SK-BR-3: 1.8;U-937: 1.5"															NA	NA						"unprognostic (4.01e-6)"	"unprognostic (1.26e-1)"	"unprognostic (1.44e-1)"	"unprognostic (4.63e-3)"	"unprognostic (7.44e-2)"	"unprognostic (1.75e-1)"		"unprognostic (5.28e-2)"	"unprognostic (4.34e-2)"	"unprognostic (3.66e-2)"	"unprognostic (9.91e-5)"	"unprognostic (3.43e-2)"	"unprognostic (3.51e-2)"	"unprognostic (2.54e-2)"	"unprognostic (4.98e-2)"	"unprognostic (1.40e-1)"	"unprognostic (4.63e-1)"	0.7	0.3	0.4	0.0	0.6	1.0	0.6	0.0	1.8	0.3	0.3			1.6	0.2	0.0	0.2	0.2	0.0	0.1	0.4	0.4	0.1	0.9	1.3	0.1	0.2		0.1	0.2	0.0	0.4	0.1		0.4	0.2		0.5	0.0	0.7	0.1	0.3	0.0	0.3	0.3	2.0	0.3			0.4		0.3	0.3	0.1	0.4	1.2	0.3	0.4	0.4	0.5	0.1	0.0	0.0	0.3	0.7	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.9	0.9	0.0	1.6	0.0	0.4	0.0	4.2	0.0	0.0	1.7	4.9	0.2	0.0	1.8	0.0	0.1	0.2	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.1	0.8	1.2	1.5	0.3	0.0	0.0	0.3	0.2	0.2	0.4	0.4	0.1	0.5	0.1	0.2	0.0	0.2	0.0	0.4	0.4	1.2	0.4	0.1											0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
USP42	FLJ12697	ENSG00000106346	"Ubiquitin specific peptidase 42"	Q9H9J4	7	6104884-6161564	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Differentiation, Spermatogenesis, Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Early spermatids: 70.7;Spermatocytes: 67.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA064800			Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA064800: AB_2685355"	"unprognostic (1.48e-2)"	"unprognostic (1.47e-1)"	"unprognostic (2.59e-1)"	"unprognostic (1.69e-1)"	"unprognostic (1.30e-2)"	"unprognostic (1.53e-1)"	"unprognostic (1.19e-2)"	"unprognostic (3.32e-1)"	"unprognostic (1.05e-1)"	"unprognostic (2.82e-1)"	"unprognostic (6.21e-3)"	"unprognostic (2.47e-2)"	"unprognostic (3.17e-3)"	"unprognostic (3.14e-2)"	"unprognostic (3.06e-2)"	"unprognostic (2.19e-2)"	"unprognostic (2.66e-1)"	6.7	5.6	5.7	5.7	9.5	19.8	7.2	14.1	10.6	8.5	7.4	10.4	5.5	8.1	14.1	7.0	6.9	8.1	6.5	5.4	5.8	6.0	7.4	7.1	7.3	6.5	6.7	4.9	10.6	11.7	10.5	10.9	8.2	6.2	7.4	6.5	8.9	6.6	6.3	7.4	9.2	9.2	8.7	9.9	7.8	6.7	25.2	8.1	14.3	7.7	6.2	8.3	7.6	6.9	1.9	2.2	3.3	2.4	1.9	4.3	0.8	8.4	6.3	11.4	11.1	6.6	5.0	7.8	4.6	5.9	5.4	5.4	4.4	4.5	10.1	3.0	5.7	8.0	7.9	9.5	5.0	5.9	2.4	7.4	4.6	5.4	4.5	5.6	10.8	5.3	5.9	6.0	5.8	7.5	5.0	6.6	8.5	17.8	6.8	3.6	7.5	6.5	12.1	12.9	4.4	4.8	12.4	8.9	6.9	5.1	4.5	8.8	15.5	5.8	12.2	3.6	10.9	5.6	5.6	5.5	4.9	18.1	6.1	5.4	6.1	5.1	8.8	4.1	6.6	9.5	2.3	1.1	3.3	2.1	2.4	3.0	1.9	2.6	1.3	1.1	1.1	1.7	4.3	1.4	1.9	1.2	2.2	1.8	0.8	5.7	9.5	14.1	10.6	5.8	6.0	6.7	4.9	6.2	8.1	11.9	6.5	11.5	16.3	35.9	18.1	6.9	0.0	10.7	6.8	1.8	21.6	7.3	0.0	9.4	70.7	12.2	12.5	0.0	8.9	6.5	8.5	16.7	9.2	7.8	7.2	20.6	10.3	14.7	7.0	32.5	13.3	11.5	10.1	6.4	14.6	11.3	10.2	7.0	12.0	4.2	17.9	12.9	11.3	67.4	32.6	36.3	22.4	12.1	11.3	13.5
USP43	FLJ30626	ENSG00000154914	"Ubiquitin specific peptidase 43"	Q70EL4	17	9644698-9729691	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"placenta: 61.6"	"Cell type enhanced"	"Detected in many"	11	"Syncytiotrophoblasts: 61.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in single"		"NK-cell: 1.1"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"BEWO: 12.4;SK-BR-3: 8.6;T-47d: 10.4"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"HPA023389, HPA027762"	Uncertain					NA	NA					"HPA023389: AB_1858691, HPA027762: AB_10603001"	"unprognostic (1.39e-1)"	"unprognostic (1.75e-2)"	"unprognostic (1.07e-1)"	"unprognostic (2.30e-3)"	"unprognostic (1.08e-1)"	"unprognostic (5.24e-2)"	"unprognostic (2.04e-1)"	"unprognostic (6.40e-3)"	"unprognostic (2.26e-1)"	"unprognostic (3.05e-3)"	"unprognostic (2.41e-2)"	"unprognostic (7.49e-2)"	"unprognostic (5.95e-2)"	"prognostic favorable (5.39e-4)"	"unprognostic (3.24e-1)"	"unprognostic (2.06e-1)"	"unprognostic (3.28e-1)"	0.2	0.2	4.2	1.2	3.4	0.9	3.0	0.7	6.0	4.9	10.0	0.6	15.7	6.2	2.9	1.7	6.7	6.3	5.1	0.2	4.1	3.8	3.7	8.7	3.4	0.2	1.7	3.1	1.0	7.7	1.7	3.7	61.6	0.7	10.8	5.0	0.3	11.3	12.4	0.2	2.4	12.5	0.3	1.0	0.2	2.6	2.9	0.2	0.4	1.7	4.2	2.7	1.3	2.1	0.0	0.5	0.0	0.0	1.1	0.1	0.1	5.7	1.5	0.0	0.6	0.0	0.0	12.4	0.1	0.2	0.7	1.7	2.8	4.7	0.0	1.9	0.2	2.7	7.0	0.6	5.5	0.7	3.6	1.9	0.3	3.0	1.0	0.1	0.5	0.0	0.0	7.2	0.3	3.0	0.3	0.0	0.8	0.0	0.0	0.0	2.7	0.9	4.7	0.7	4.9	0.3	3.7	0.0	0.8	4.4	3.1	0.8	0.0	2.5	8.6	1.0	4.1	10.4	1.4	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.8	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.1	4.2	3.4	0.7	6.0	4.1	3.8	1.7	3.1	0.7	0.2	3.0	1.9	0.0	7.2	4.1	0.0	0.5	7.6	21.4	7.9	10.4	5.9	16.6	1.7	3.9	1.1	0.0	9.0	0.0	4.0	19.6	0.6	9.5	0.0	12.4	2.4	0.0	2.4	0.0	1.6	0.8	0.0	0.0	5.0	0.0	7.8	8.1	8.5	2.9	0.0	1.3	1.3	0.0	0.3	1.1	0.2	2.9	61.2	0.0	9.0	10.0
USP44	FLJ14528	ENSG00000136014	"Ubiquitin specific peptidase 44"	Q9H0E7	12	95516560-95551490	"Enzymes, Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis, Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"testis: 26.8"	"Cell type enriched"	"Detected in many"	4	"Early spermatids: 343.6"	"Cancer enhanced"	"Detected in some"		"testis cancer: 3.0"	"Region enriched"	"Detected in many"	5	"cerebellum: 10.9"	"Cell type enhanced"	"Detected in many"		"naive CD4 T-cell: 8.6"	"Group enriched"	"Detected in many"	39	"B-cells: 5.6;T-cells: 8.6"	"Cell line enhanced"	"Detected in some"		"HEL: 10.0;JURKAT: 22.6;NTERA-2: 54.2"					"Low region specificity"	"Detected in some"			HPA026543			Approved	"Nucleoli fibrillar center,Microtubules"		NA	NA			"Nucleoli fibrillar center, Microtubules"		"HPA026543: AB_1858692"	"unprognostic (2.12e-2)"	"unprognostic (1.14e-1)"	"unprognostic (4.68e-2)"	"unprognostic (1.01e-3)"	"unprognostic (1.83e-4)"	"unprognostic (7.18e-4)"	"unprognostic (5.55e-2)"	"unprognostic (1.85e-2)"	"unprognostic (2.16e-1)"	"unprognostic (3.73e-2)"	"unprognostic (6.88e-2)"	"unprognostic (2.97e-2)"	"unprognostic (8.12e-2)"	"unprognostic (1.41e-2)"	"unprognostic (1.08e-1)"	"unprognostic (7.41e-2)"	"unprognostic (7.07e-2)"	1.3	1.0	0.7	1.2	1.3	0.5	1.4	10.9	2.1	1.7	1.7	1.7	1.4	0.5	3.0	1.0	0.9	1.6	1.1	1.0	0.7	0.6	1.9	0.2	4.7	1.9	1.3	1.2	1.6	3.6	4.8	4.0	0.3	1.8	1.7	0.6	2.3	1.8	2.6	0.4	0.6	1.3	1.2	0.6	1.9	1.0	26.8	1.2	0.8	1.7	0.0	1.6	1.1	2.3	5.6	0.1	0.1	0.0	0.1	8.6	1.3	0.0	0.1	4.5	0.0	0.0	0.0	0.1	0.4	1.3	0.5	0.2	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.7	0.0	2.2	10.0	0.0	0.0	2.3	4.0	0.2	0.0	0.0	0.3	0.0	0.2	0.2	22.6	1.5	0.0	0.0	0.0	5.1	0.0	54.2	0.0	0.0	0.0	0.0	0.0	0.9	0.3	3.5	2.3	0.0	0.0	0.0	5.4	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.7	0.0	0.3	0.1	0.0	0.0	0.0	1.5	0.0	3.4	5.6	2.3	2.0	0.0	4.4	8.6	5.5	0.1	0.1	0.0	0.1	0.3	1.3	0.7	1.3	10.9	2.1	0.7	0.6	1.3	1.2	1.8	1.2	11.9	19.9	0.0	2.9	0.9	6.2	1.2	0.0	0.0	6.8	7.0	5.9	2.1	0.0	3.9	343.6	2.3	0.0	0.0	2.7	0.3	1.0	2.7	0.0	0.0	0.1	0.0	0.0	1.3	0.3	78.5	5.2	0.4	3.3	1.0	0.0	3.4	1.3	0.0	3.2	1.1	8.6	6.5	3.1	10.0	5.2	0.6	0.9	1.7	0.0	1.6
USP45	MGC14793	ENSG00000123552	"Ubiquitin specific peptidase 45"	Q70EL2	6	99432379-99521728	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"	"Disease mutation, Leber congenital amaurosis"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029602, HPA029604"	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"HPA029602: AB_10600418, HPA029604: AB_10602283"	"unprognostic (7.81e-3)"	"unprognostic (3.10e-3)"	"unprognostic (1.63e-2)"	"unprognostic (6.62e-2)"	"unprognostic (1.02e-2)"	"unprognostic (1.92e-1)"	"unprognostic (2.15e-2)"	"unprognostic (1.01e-1)"	"unprognostic (2.77e-2)"	"unprognostic (8.65e-2)"	"unprognostic (2.95e-3)"	"unprognostic (1.10e-1)"	"unprognostic (3.43e-3)"	"unprognostic (1.13e-1)"	"unprognostic (3.53e-1)"	"unprognostic (1.43e-1)"	"unprognostic (6.91e-2)"	9.8	9.1	8.5	10.2	12.2	7.2	9.0	28.4	11.6	9.0	9.7	8.6	8.9	13.7	15.7	9.6	10.0	8.1	11.9	11.5	7.7	8.5	12.2	9.0	7.1	12.7	9.8	8.0	10.7	9.6	10.2	21.7	9.6	15.0	9.9	13.1	7.9	9.8	8.4	14.6	11.8	12.4	10.8	10.6	9.9	8.9	5.7	9.4	7.1	10.7	10.4	9.5	8.8	15.0	8.6	5.1	3.7	2.5	2.6	6.2	1.4	4.2	3.0	6.0	8.5	11.2	10.6	6.4	7.4	8.3	7.7	11.1	6.3	4.8	11.3	5.5	7.4	9.1	5.8	9.2	7.3	10.7	8.9	8.8	11.0	6.0	4.9	8.6	10.2	6.3	11.3	5.9	6.9	11.9	8.2	11.4	10.3	26.5	11.3	7.3	3.9	3.2	9.8	9.7	6.6	6.5	4.8	4.5	6.3	10.8	5.0	8.5	7.0	5.3	6.9	5.4	7.9	3.7	5.0	11.5	4.2	5.4	6.2	11.2	4.8	4.4	20.7	7.3	9.7	7.5	3.7	2.0	0.6	4.9	1.3	6.2	7.4	4.2	5.6	3.5	8.6	3.0	2.9	0.5	2.6	2.5	5.1	3.5	1.4	8.5	12.2	28.4	11.6	7.7	8.5	9.8	8.0	15.0	9.4	3.0	4.3	4.4	6.8	2.1	7.9	7.1	7.6	12.0	3.4	3.5	17.7	5.3	5.0	3.9	10.8	5.3	5.8	0.0	2.3	5.9	3.8	5.6	2.3	3.8	3.5	9.5	2.4	8.0	4.1	5.9	12.0	3.9	3.3	13.6	2.3	5.6	4.3	2.9	8.1	13.4	7.6	0.0	6.2	1.8	5.5	2.5	6.2	5.1	6.0	6.5
USP46	FLJ12552	ENSG00000109189	"Ubiquitin specific peptidase 46"	P62068	4	52590972-52659335	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Behavior, Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	9	"Bipolar cells: 123.5;Early spermatids: 151.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"							"HPA007288, CAB076369, CAB076370"	Uncertain		Approved	"Nucleoli,Nucleoli rim"		NA	NA			"Nucleoli, Nucleoli rim"		"CAB076369: AB_2665642, CAB076370: AB_2665643, HPA007288: AB_1080531"	"unprognostic (1.15e-2)"	"unprognostic (1.64e-1)"	"unprognostic (1.19e-1)"	"unprognostic (1.61e-2)"	"unprognostic (1.31e-1)"	"unprognostic (1.41e-1)"	"unprognostic (1.53e-3)"	"unprognostic (1.59e-1)"	"unprognostic (2.45e-2)"	"unprognostic (1.80e-2)"	"unprognostic (2.89e-1)"	"unprognostic (1.95e-1)"	"unprognostic (1.05e-1)"	"unprognostic (1.45e-1)"	"unprognostic (3.95e-2)"	"unprognostic (2.02e-2)"	"unprognostic (1.28e-1)"	4.7	9.5	26.0	3.5	20.9	2.8	7.0	23.7	29.4	8.9	4.2	12.8	5.2	4.8	7.2	6.2	12.4	7.8	5.8	28.9	21.9	19.0	10.8	3.1	4.4	3.7	19.1	13.9	12.3	5.6	12.2	5.3	10.6	12.7	7.7	4.6	5.3	8.0	7.8	13.7	8.0	4.5	5.5	18.9	3.5	6.3	12.2	15.0	1.0	10.0	4.3	5.8	7.3	5.7	1.4	4.4	2.0	1.4	1.2	3.9	1.0	5.4	3.8	12.5	9.2	13.6	17.1	13.8	8.9	7.2	6.6	5.6	7.7	4.2	3.6	10.5	8.8	9.3	3.2	21.7	10.3	12.1	3.1	7.6	5.6	3.7	8.6	13.6	7.3	6.5	14.5	9.7	6.8	6.4	12.9	9.8	5.1	5.5	5.1	13.9	4.9	3.1	3.9	9.2	6.0	4.7	8.0	9.1	0.7	14.2	10.0	7.5	9.0	4.3	14.9	8.5	12.5	5.4	5.5	9.0	6.5	14.2	7.6	13.3	5.2	2.4	2.9	10.0	4.5	8.0	2.0	1.4	0.3	2.3	1.2	1.7	1.4	3.9	2.0	2.8	1.2	0.9	0.8	0.3	1.2	0.9	4.4	1.2	1.0	26.0	20.9	23.7	24.3	21.9	19.0	19.1	13.9	12.7	15.0	6.0	4.5	1.9	9.8	4.7	123.5	42.3	12.7	24.1	11.4	14.0	3.9	10.5	18.3	10.3	151.7	8.4	3.8	0.0	10.5	10.9	10.3	17.3	0.0	5.7	5.0	33.4	4.1	7.4	7.6	24.3	26.7	4.4	8.5	14.4	5.6	21.3	9.7	7.6	33.9	12.6	7.9	6.5	8.3	3.0	11.5	7.2	6.4	4.4	6.0	15.9
USP47		ENSG00000170242	"Ubiquitin specific peptidase 47"	Q96K76	11	11841423-11959323	"Enzymes, Predicted intracellular proteins"	"DNA damage, DNA repair, Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029286, HPA029289"	Supported		Approved	"Vesicles,Intermediate filaments"		NA	NA			"Intermediate filaments"	Vesicles	"HPA029286: AB_10599852, HPA029289: AB_10601675"	"unprognostic (2.02e-1)"	"unprognostic (2.72e-1)"	"unprognostic (3.05e-1)"	"unprognostic (1.84e-1)"	"unprognostic (2.99e-2)"	"unprognostic (2.65e-2)"	"unprognostic (2.27e-2)"	"unprognostic (7.39e-2)"	"unprognostic (1.54e-2)"	"unprognostic (7.05e-2)"	"unprognostic (2.83e-2)"	"unprognostic (2.35e-1)"	"unprognostic (1.51e-1)"	"unprognostic (9.96e-3)"	"unprognostic (1.90e-1)"	"unprognostic (1.49e-1)"	"unprognostic (2.85e-1)"	16.6	17.0	17.9	18.5	20.9	20.3	16.9	25.7	19.0	16.4	18.1	16.2	21.3	11.6	18.0	15.0	18.7	13.7	13.5	25.5	18.1	13.4	14.6	25.1	16.6	13.4	21.9	12.9	16.9	19.6	38.8	31.8	23.7	19.3	18.0	14.2	10.2	15.1	19.2	58.1	18.4	15.1	21.3	19.5	13.3	18.1	16.8	23.9	27.9	16.8	12.4	15.2	21.3	19.4	9.7	10.1	14.0	13.2	22.8	19.3	9.7	21.4	13.1	23.5	11.1	17.0	18.8	10.8	24.7	18.7	16.3	18.5	12.9	19.1	24.3	11.8	22.9	19.4	14.7	18.1	12.4	25.2	23.6	15.3	14.6	24.2	9.0	15.1	18.9	20.5	17.4	17.1	10.7	23.8	18.6	18.1	17.2	29.1	21.0	19.9	8.5	17.0	8.4	6.3	21.3	10.6	17.6	24.8	7.5	17.6	24.9	8.2	16.7	22.1	15.4	13.7	15.1	12.3	13.9	20.0	23.1	14.1	19.6	15.0	6.6	15.2	23.0	15.9	11.7	16.6	13.3	7.7	14.0	15.2	9.5	19.3	9.7	13.8	14.7	10.1	8.6	17.9	15.3	3.6	22.8	13.2	6.1	9.9	9.7	17.9	20.9	25.7	19.0	18.1	13.4	21.9	12.9	19.3	23.9	65.5	50.8	26.5	58.2	63.1	66.5	188.1	30.6	62.9	67.1	22.7	45.2	55.8	21.6	33.6	26.3	35.8	25.1	23.3	33.7	29.2	48.3	58.2	51.0	50.0	24.2	60.4	56.9	30.1	18.5	22.9	40.9	32.0	23.6	27.9	30.5	80.7	36.7	31.6	47.0	17.9	50.6	51.8	47.2	72.0	59.0	76.9	105.2	47.3	32.2	47.7
USP48	"FLJ11328, FLJ20103, FLJ23054, FLJ23277, MGC14879, USP31"	ENSG00000090686	"Ubiquitin specific peptidase 48"	Q86UV5	1	21678298-21783606	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030045, HPA030046"	Approved		Supported	Nucleoplasm,Mitochondria,Cytosol		NA	NA			Nucleoplasm	"Mitochondria, Cytosol"	"HPA030045: AB_10670833, HPA030046: AB_10603325"	"unprognostic (1.35e-1)"	"unprognostic (3.72e-1)"	"unprognostic (5.46e-3)"	"unprognostic (2.21e-1)"	"unprognostic (1.23e-1)"	"unprognostic (7.00e-3)"	"prognostic unfavorable (6.09e-8)"	"unprognostic (1.04e-2)"	"unprognostic (3.01e-3)"	"unprognostic (9.30e-2)"	"unprognostic (7.54e-2)"	"unprognostic (4.45e-2)"	"unprognostic (4.16e-3)"	"unprognostic (2.03e-1)"	"unprognostic (1.06e-1)"	"unprognostic (5.70e-2)"	"unprognostic (2.80e-2)"	20.1	38.8	18.6	28.9	30.9	30.9	22.1	48.2	27.5	19.9	18.4	25.6	15.4	17.6	21.3	17.6	19.0	17.4	20.5	17.8	16.9	15.8	15.5	18.3	18.3	26.2	26.6	22.5	27.0	19.8	24.6	35.4	23.1	26.8	21.6	22.0	22.1	24.5	16.3	17.0	23.9	22.2	22.2	19.7	29.1	26.2	15.8	23.6	25.8	23.9	14.0	29.0	19.8	21.0	13.7	10.5	33.7	9.6	5.6	11.2	5.6	14.9	7.1	16.8	12.1	14.6	18.0	16.6	18.8	12.8	12.7	16.8	6.5	15.3	16.8	12.7	17.0	9.9	13.8	20.6	15.2	19.3	16.3	14.1	35.9	26.5	11.8	13.0	18.0	19.2	14.6	13.1	12.8	14.3	17.4	37.2	12.8	28.2	47.5	15.5	7.4	14.9	23.4	10.5	15.3	12.8	21.0	16.9	19.6	14.5	12.6	20.5	12.8	17.7	16.3	42.5	23.5	8.3	21.8	26.4	13.7	11.2	16.7	10.9	38.2	27.1	16.7	13.2	22.3	20.0	33.7	9.6	16.7	6.4	4.6	7.6	13.7	9.5	9.5	10.5	12.8	11.2	7.0	8.9	5.6	5.0	7.7	10.1	5.6	18.6	30.9	48.2	27.5	16.9	15.8	26.6	22.5	26.8	23.6	50.6	38.5	34.3	22.6	19.7	74.8	58.2	22.9	32.1	20.5	19.2	58.9	51.8	21.6	25.0	51.8	24.5	18.7	70.0	17.5	50.1	30.9	20.6	47.5	21.2	26.0	47.7	20.8	28.3	22.2	33.0	32.2	24.7	55.6	47.7	26.9	29.1	20.0	17.5	48.4	16.5	69.2	32.3	25.0	42.9	48.2	22.5	27.2	35.5	30.2	17.1
USP49	MGC20741	ENSG00000164663	"Ubiquitin specific peptidase 49"	Q70CQ1	6	41789896-41895361	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing, Ubl conjugation pathway"	"Chromatin regulator, Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	8	"Bipolar cells: 21.6;Cone photoreceptor cells: 41.2;Erythroid cells: 23.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"basophil: 8.5"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 8.5"	"Cell line enhanced"	"Detected in many"		"REH: 23.7;U-698: 33.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030254, HPA030255"	Uncertain					NA	NA					"HPA030254: AB_10600198, HPA030255: AB_10601218"	"unprognostic (1.71e-1)"	"unprognostic (4.86e-3)"	"unprognostic (1.93e-1)"	"unprognostic (2.57e-4)"	"unprognostic (4.46e-2)"	"unprognostic (2.84e-4)"	"unprognostic (7.17e-3)"	"unprognostic (5.06e-2)"	"unprognostic (1.19e-2)"	"unprognostic (3.22e-1)"	"unprognostic (5.59e-3)"	"unprognostic (8.28e-2)"	"unprognostic (1.26e-5)"	"unprognostic (5.39e-2)"	"unprognostic (4.58e-2)"	"unprognostic (4.37e-3)"	"unprognostic (3.24e-3)"	2.4	2.4	7.6	3.5	6.0	7.3	2.7	12.7	9.3	2.3	1.9	2.0	4.3	2.2	4.0	2.3	1.8	2.2	2.1	3.5	7.6	4.2	1.6	1.7	2.4	3.7	3.0	5.8	4.0	3.2	2.6	4.8	1.8	4.2	2.4	2.1	3.7	2.7	2.4	3.8	4.1	2.2	3.2	3.2	3.5	2.2	7.4	3.2	7.3	7.7	0.6	3.4	2.8	2.0	1.2	0.7	8.5	1.8	0.8	0.9	0.4	3.0	0.9	12.5	6.1	1.5	1.7	5.1	1.2	1.1	1.8	2.3	3.9	0.7	12.5	1.3	1.5	2.6	1.3	7.7	1.2	2.8	3.1	5.7	4.5	4.7	1.3	1.1	3.5	2.7	1.7	0.9	2.6	1.7	1.7	1.1	13.0	9.3	3.5	1.4	1.8	13.3	5.3	3.4	3.2	1.2	23.7	6.0	2.7	0.7	2.1	8.4	3.4	1.6	0.6	0.7	3.1	1.9	3.2	3.2	4.3	4.3	1.4	1.6	6.5	5.6	33.7	0.5	3.6	0.8	8.5	1.3	1.4	0.8	1.5	0.4	1.2	0.4	0.8	0.5	0.9	0.9	0.7	2.4	0.8	1.8	0.7	0.4	0.4	7.6	6.0	12.7	9.3	7.6	4.2	3.0	5.8	4.2	3.2	0.0	11.9	1.5	2.8	4.4	21.6	3.4	5.1	1.4	6.8	5.2	41.2	2.3	1.7	1.5	6.4	2.4	1.6	23.3	1.7	1.3	3.6	3.3	1.1	1.5	1.8	14.3	0.0	1.3	4.1	6.3	3.4	3.6	3.3	1.0	1.4	3.1	1.8	1.7	5.6	1.0	11.9	6.5	2.5	8.9	15.8	5.5	4.8	2.2	1.7	3.9
USP5	IsoT	ENSG00000111667	"Ubiquitin specific peptidase 5"	P45974	12	6852128-6866632	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA006756	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA		820000	"Nucleoplasm, Cytosol"		"HPA006756: AB_1080534"	"unprognostic (2.19e-1)"	"unprognostic (5.83e-2)"	"unprognostic (2.48e-1)"	"unprognostic (2.57e-1)"	"unprognostic (7.60e-2)"	"unprognostic (2.21e-2)"	"unprognostic (4.02e-2)"	"unprognostic (3.93e-2)"	"unprognostic (2.57e-1)"	"unprognostic (4.71e-2)"	"unprognostic (8.90e-3)"	"unprognostic (4.69e-2)"	"unprognostic (1.17e-2)"	"unprognostic (2.65e-2)"	"unprognostic (3.56e-1)"	"unprognostic (3.23e-1)"	"unprognostic (2.02e-3)"	18.6	28.7	23.1	17.8	32.6	13.6	12.9	24.6	50.9	15.9	21.5	26.8	13.8	17.6	22.3	12.8	27.7	19.1	14.7	22.4	23.9	28.6	14.9	24.8	14.4	18.6	23.6	33.2	14.4	13.2	29.7	19.6	21.7	36.8	19.5	16.1	11.6	14.1	22.7	41.2	33.5	18.1	25.3	23.6	14.1	15.9	30.9	18.7	22.8	19.2	20.4	19.9	21.3	16.0	10.8	18.6	5.3	16.6	10.8	17.1	16.6	25.6	40.1	27.0	30.5	18.4	17.0	34.5	27.9	21.4	33.4	24.4	37.9	25.5	31.0	14.7	29.0	26.5	22.7	29.6	27.7	21.4	58.2	25.1	28.4	32.3	20.6	14.3	25.6	30.0	17.1	16.1	28.9	20.0	22.4	28.5	12.5	24.4	12.5	27.5	28.1	38.5	12.8	52.6	26.2	17.0	30.3	35.2	21.5	19.1	25.0	14.9	30.1	19.0	29.0	12.1	35.1	11.6	21.1	27.6	28.3	34.3	21.5	34.7	15.0	34.6	47.3	31.5	16.4	27.5	2.3	12.3	5.3	17.1	16.6	16.1	10.8	15.2	14.4	18.6	10.0	14.6	14.8	0.9	10.8	14.7	13.6	12.9	16.6	23.1	32.6	24.6	50.9	23.9	28.6	23.6	33.2	36.8	18.7	8.9	12.5	13.0	9.5	10.3	18.1	8.1	17.8	4.0	5.7	21.0	56.9	38.0	10.0	25.9	8.7	7.9	17.7	0.0	17.8	24.3	16.4	7.4	14.9	19.7	24.7	38.1	16.0	9.2	12.1	15.5	21.3	9.6	15.1	47.7	14.7	13.8	16.9	17.8	31.8	14.7	14.5	32.3	9.7	24.5	23.8	13.6	44.2	14.1	22.7	5.6
USP50		ENSG00000170236	"Ubiquitin specific peptidase 50"	Q70EL3	15	50500562-50546708	"Enzymes, Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in some"	15	"testis: 20.2"	"Group enriched"	"Detected in some"	87	"Early spermatids: 76.1;Late spermatids: 42.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"plasmacytoid DC: 1.3"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"GAMG: 1.2;HaCaT: 1.2;HEL: 1.1;OE19: 1.3;RH-30: 1.0;SK-BR-3: 1.6;SK-MEL-30: 2.8;U-698: 1.0"	"Region enriched"	"Detected in single"	9	"hippocampal formation: 0.4"	"Not detected"	"Not detected"			HPA039470	Uncertain					NA	NA					"HPA039470: AB_10672964"	"unprognostic (7.05e-3)"	"unprognostic (2.38e-1)"		"unprognostic (2.01e-2)"	"unprognostic (4.04e-3)"	"unprognostic (3.37e-1)"	"unprognostic (2.53e-2)"	"unprognostic (3.95e-2)"	"unprognostic (1.73e-2)"	"unprognostic (1.51e-1)"	"unprognostic (1.42e-1)"	"unprognostic (1.85e-1)"	"unprognostic (3.81e-2)"	"unprognostic (4.65e-2)"	"unprognostic (2.47e-1)"	"unprognostic (7.49e-4)"	"unprognostic (3.03e-1)"	0.1	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	20.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.8	0.0	0.3	0.0	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	1.2	0.2	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	1.0	0.0	0.0	0.3	0.0	0.0	0.2	1.6	2.8	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.5	0.6	1.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	76.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	42.7	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.2	0.0	0.1	0.0	0.0	0.0
USP51		ENSG00000247746	"Ubiquitin specific peptidase 51"	Q70EK9	X	55484616-55489202	"Enzymes, Predicted intracellular proteins"	"DNA damage, DNA repair, Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	8	"epididymis: 34.1"	"Cell type enhanced"	"Detected in many"	7	"Bipolar cells: 24.4;Ciliated cells: 17.4;Muller glia cells: 29.9"	"Low cancer specificity"	"Detected in many"							"Cell type enhanced"	"Detected in some"		"eosinophil: 2.4;naive CD4 T-cell: 2.4"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"SuSa: 10.2"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			HPA001942	Uncertain		Approved	"Nucleoli fibrillar center,Cytosol"		NA	NA			Cytosol	"Nucleoli fibrillar center"	"HPA001942: AB_1080536"	"unprognostic (1.19e-2)"	"unprognostic (4.65e-2)"	"unprognostic (3.67e-2)"	"unprognostic (1.02e-3)"	"unprognostic (8.08e-2)"	"unprognostic (3.26e-1)"	"unprognostic (3.17e-3)"	"unprognostic (2.07e-3)"	"unprognostic (5.69e-2)"	"prognostic favorable (5.70e-4)"	"unprognostic (1.01e-3)"	"unprognostic (1.27e-1)"	"prognostic favorable (2.63e-5)"	"unprognostic (2.81e-3)"	"unprognostic (5.92e-2)"	"unprognostic (5.85e-2)"	"unprognostic (1.63e-1)"	0.6	2.7	2.0	0.3	2.9	0.1	0.9	2.3	1.8	1.4	0.6			0.0	1.8	34.1	0.2	3.4	0.3	1.0	1.8	3.7	2.2	0.5	0.7	0.4	1.6		4.1	0.8	3.6	1.8	1.3		1.3	0.3		0.3	1.5	0.0	0.5	0.5	1.1	1.4	0.9	0.3	1.3			3.2		0.5	0.7	0.5	0.9	0.0	2.4	0.0	0.6	2.4	0.1	0.0	0.8	5.4	1.6	2.7	1.4	0.0	0.9	0.4	1.0	1.3	1.7	0.7	0.0	6.4	1.2	1.1	0.3	1.4	0.6	1.6	1.7	0.1	1.4	0.3	0.0	1.1	3.3	0.3	5.5	0.1	0.6	0.0	0.4	0.3	4.1	4.1	4.1	0.9	3.5	3.2	1.7	6.7	0.0	0.3	4.6	1.0	2.1	1.3	0.2	0.0	1.1	1.5	0.2	5.0	10.2	1.3	1.7	0.2	2.1	2.9	0.5	0.1	6.5	2.6	1.3	1.4	1.8	1.4	0.0	0.0	2.4	0.3	0.0	0.0	0.6	0.6	0.0	0.0	0.9	2.4	0.2	0.0	0.6	0.0	0.0	0.0	0.1											3.0	5.6	0.0	1.7	0.8	24.4	5.0	0.0	17.4	3.4	3.5	5.9	3.4	8.3	1.0	0.3	5.8	0.0	0.0	0.0	2.1	4.3	1.1	1.1	0.8	6.1	6.4	3.5	4.9	3.9	0.8	3.7	2.5	5.0	0.0	0.3	29.9	0.3	0.0	7.8	12.2	15.2	0.0	3.9	3.6	6.7	0.4	2.3	1.7	0.2	0.4
USP53	KIAA1350	ENSG00000145390	"Ubiquitin specific peptidase 53"	Q70EK8	4	119212587-119295517	"Enzymes, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 84.0;SK-MEL-30: 26.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035844, HPA035845"	Uncertain		Approved	"Plasma membrane,Cytosol"		NA	NA			"Plasma membrane, Cytosol"		"HPA035844: AB_10669532, HPA035845: AB_2674817"	"unprognostic (9.33e-2)"	"unprognostic (1.49e-2)"	"prognostic favorable (3.15e-6)"	"unprognostic (4.37e-3)"	"unprognostic (4.82e-2)"	"unprognostic (5.03e-2)"	"unprognostic (1.55e-1)"	"unprognostic (9.54e-2)"	"unprognostic (1.77e-1)"	"unprognostic (9.81e-3)"	"unprognostic (1.28e-1)"	"prognostic unfavorable (7.54e-6)"	"prognostic favorable (3.58e-8)"	"unprognostic (9.02e-2)"	"unprognostic (1.72e-1)"	"unprognostic (1.58e-1)"	"unprognostic (3.70e-2)"	26.7	11.9	4.6	11.2	7.9	0.7	20.7	10.9	6.2	16.5	15.0	2.9	27.4	4.5	11.6	16.1	17.9	24.7	8.2	18.6	6.4	5.3	20.2	6.6	26.1	8.7	8.8	4.0	11.4	19.3	6.2	33.9	10.4	13.4	10.7	13.1	17.2	17.7	25.8	33.7	11.3	11.2	9.0	15.5	14.1	13.6	10.2	4.9	4.8	10.7	15.6	8.0	20.5	27.0	1.9	0.8	3.1	0.0	2.2	5.1	0.9	2.8	1.7	0.6	0.0	16.1	16.2	3.5	18.0	84.0	1.6	2.1	1.8	2.6	11.5	0.6	5.3	3.1	1.4	1.4	1.3	4.2	1.5	1.1	0.7	1.3	0.6	12.6	0.9	0.1	5.4	3.9	5.7	8.2	3.1	7.6	0.7	1.7	0.4	2.1	0.6	0.7	1.3	1.7	1.7	0.9	0.2	2.9	2.2	4.2	1.8	0.9	0.7	1.0	7.1	26.0	3.6	1.8	0.6	8.2	0.5	1.8	6.8	1.6	0.8	1.2	1.9	8.2	0.4	2.0	3.1	0.0	0.2	1.3	0.0	1.4	1.7	2.6	2.0	0.4	1.9	5.1	2.7	0.6	2.2	0.0	0.8	2.2	0.9	4.6	7.9	10.9	6.2	6.4	5.3	8.8	4.0	13.4	4.9	32.8	45.2	11.8	55.8	55.0	22.5	82.3	28.1	24.1	35.2	113.4	27.5	41.0	38.1	22.7	3.3	36.0	117.1	0.0	53.9	14.3	44.2	81.1	67.2	21.7	7.6	23.8	33.3	24.5	17.1	2.6	17.5	32.4	13.5	78.5	63.2	26.1	75.8	58.3	10.3	14.2	29.1	6.5	33.5	14.1	3.0	36.9	41.6	17.0	43.2	107.0
USP54	"bA137L10.3, bA137L10.4, C10orf29, FLJ37318"	ENSG00000166348	"Ubiquitin specific peptidase 54"	Q70EL1	10	73497538-73625953	"Enzymes, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 49.5"	"Cell type enhanced"	"Detected in many"	7	"Alveolar cells type 1: 44.7;Glandular cells: 59.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"PC-3: 24.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA047663, HPA063665"	Approved		Approved	Mitochondria		NA	NA			Mitochondria		"HPA047663: AB_2680116, HPA063665: "	"unprognostic (2.46e-2)"	"unprognostic (1.67e-1)"	"unprognostic (3.17e-2)"	"unprognostic (1.89e-2)"	"unprognostic (2.48e-2)"	"unprognostic (4.89e-3)"	"unprognostic (6.63e-4)"	"prognostic favorable (7.00e-4)"	"unprognostic (6.24e-2)"	"unprognostic (4.35e-2)"	"unprognostic (8.91e-3)"	"unprognostic (3.49e-1)"	"unprognostic (1.95e-3)"	"unprognostic (8.18e-2)"	"unprognostic (6.88e-2)"	"unprognostic (1.65e-2)"	"unprognostic (1.31e-1)"	2.9	1.7	12.3	2.5	33.8	0.5	7.7	7.9	21.3	7.9	7.8	43.8	1.8	2.5	4.2	4.5	10.2	7.7	3.1	4.0	14.1	6.8	2.7	1.6	9.0	0.6	49.5	14.2	4.0	6.3	7.1	3.4	1.2	28.6	5.8	11.1	3.4	8.8	3.6	12.0	6.1	2.9	4.0	25.4	1.5	11.3	4.7	42.8	0.4	24.3	1.2	3.6	5.6	4.0	2.4	2.2	1.3	2.4	1.5	3.2	2.3	6.3	6.6	10.2	9.6	2.7	3.2	3.2	3.4	6.7	5.7	6.6	5.5	10.5	4.8	4.0	3.5	4.4	8.8	6.5	2.4	7.6	2.3	6.1	3.0	4.8	3.7	2.2	3.3	1.2	2.5	2.3	6.6	6.6	11.6	2.6	3.5	4.7	0.7	3.9	3.2	3.2	2.1	4.7	17.8	24.0	4.8	9.1	1.8	4.1	6.2	3.3	3.2	6.5	8.0	7.7	6.3	10.4	3.0	3.5	2.2	6.7	4.3	4.3	1.7	3.1	3.4	5.4	3.1	2.0	0.8	2.3	1.3	1.6	1.9	3.1	2.4	2.7	2.5	1.9	1.0	3.2	1.9	0.1	1.5	2.4	2.2	3.0	2.3	12.3	33.8	7.9	21.3	14.1	6.8	49.5	14.2	28.6	42.8	44.7	23.5	0.0	4.6	2.4	7.1	5.6	5.1	17.4	15.9	12.2	15.7	0.6	0.0	4.1	1.6	4.5	11.4	0.0	7.1	0.8	2.9	59.6	3.5	1.7	1.2	4.8	9.9	3.1	0.6	1.7	3.1	1.4	8.5	1.0	20.7	13.0	8.8	7.0	10.3	1.1	11.1	6.5	3.8	8.0	6.6	3.4	1.1	1.3	10.5	10.5
USP6	"HRP1, Tre-2, TRE17, Tre2, TRESMCR"	ENSG00000129204	"Ubiquitin specific peptidase 6"	P35125	17	5116438-5175034	"Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Ubl conjugation pathway"	"Calmodulin-binding, Hydrolase, Protease, Thiol protease"	"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in some"	9	"skeletal muscle: 18.2;testis: 29.0"	"Cell type enhanced"	"Detected in many"	5	"Early spermatids: 19.3;Erythroid cells: 23.3;Spermatocytes: 19.2"	"Cancer enriched"	"Detected in single"	14	"testis cancer: 2.8"	"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"							HPA046969			Uncertain	Vesicles		NA	NA			Vesicles		"HPA046969: "	"unprognostic (3.89e-2)"	"unprognostic (3.79e-3)"	"unprognostic (2.50e-1)"	"unprognostic (1.85e-1)"	"unprognostic (9.32e-2)"	"unprognostic (3.50e-3)"	"unprognostic (1.29e-1)"	"unprognostic (1.67e-2)"	"unprognostic (3.45e-2)"	"unprognostic (2.46e-2)"	"unprognostic (7.91e-4)"	"unprognostic (6.28e-3)"	"unprognostic (3.24e-4)"	"unprognostic (3.75e-2)"	"unprognostic (3.13e-1)"	"unprognostic (2.71e-1)"	"unprognostic (7.09e-4)"	0.3	0.3	0.3	0.3	0.6	0.2	0.4	0.5	0.5	0.3	0.5	0.3	1.2	0.0	0.6	0.6	0.3	0.5	0.4	0.3	0.3	0.1	0.3	0.3	0.3	0.3	0.3	0.3	2.6	0.3	0.0	0.4	0.4	0.3	0.4	0.1	0.3	0.3	0.3	18.2	0.6	0.7	0.9	0.3	0.3	0.0	29.0	0.3	0.3	0.4	0.3	0.3	0.3	0.3	0.9	1.2	1.9	1.0	0.2	0.4	0.1	2.2	0.9	2.2	1.6	0.4	0.2	2.3	1.9	0.1	0.6	0.4	0.8	1.0	2.2	1.6	1.2	1.9	1.0	0.7	0.8	0.5	1.5	1.3	1.7	1.3	0.9	1.2	0.5	2.8	1.1	0.5	0.1	0.2	2.5	0.3	1.8	0.5	0.3	0.5	2.5	1.8	0.7	1.5	0.7	0.1	1.4	1.9	0.2	0.5	0.7	0.9	2.1	1.0	0.1	3.3	3.7	2.1	2.2	1.2	0.9	3.2	2.0	1.4	2.0	1.6	1.5	0.0	0.1	2.6	0.1	0.4	0.9	0.4	0.3	0.2	0.6	0.3	0.3	0.3	0.9	0.3	0.4	1.9	0.2	1.0	1.2	0.1	0.1	0.3	0.6	0.5	0.3	0.3	0.1	0.3	0.3	0.3	0.3	6.0	9.6	0.5	0.9	9.6	7.9	1.6	7.6	5.3	5.7	3.5	11.8	0.5	3.3	0.0	19.3	2.9	0.0	23.3	0.0	0.8	1.5	2.4	0.0	2.6	2.3	1.6	0.0	4.9	4.9	9.4	1.7	5.7	3.3	0.0	0.0	4.7	0.1	0.0	2.5	2.8	9.8	6.5	0.6	19.2	5.5	9.2	0.6	0.7	0.0	0.9
USP7	HAUSP	ENSG00000187555	"Ubiquitin specific peptidase 7"	Q93009	16	8892094-8964514	"Enzymes, Predicted intracellular proteins"	"Biological rhythms, DNA damage, DNA repair, Host-virus interaction, Ubl conjugation pathway"	"Developmental protein, Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	6	"Early spermatids: 217.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB008108, HPA015641, CAB079904"	Approved		Supported	"Nucleoplasm,Nuclear bodies"		NA	NA			Nucleoplasm	"Nuclear bodies"	"CAB008108: AB_2233500, CAB079904: AB_2552261, HPA015641: AB_1858700"	"unprognostic (6.73e-2)"	"unprognostic (1.59e-1)"	"unprognostic (3.36e-3)"	"unprognostic (1.94e-2)"	"unprognostic (9.64e-2)"	"unprognostic (8.09e-2)"	"unprognostic (4.69e-2)"	"unprognostic (4.56e-2)"	"unprognostic (4.81e-1)"	"unprognostic (2.49e-1)"	"unprognostic (2.35e-1)"	"unprognostic (9.93e-2)"	"prognostic favorable (8.56e-5)"	"unprognostic (1.35e-1)"	"unprognostic (1.07e-1)"	"unprognostic (7.31e-2)"	"unprognostic (2.69e-1)"	17.8	16.8	23.9	25.8	22.9	37.6	21.3	28.7	24.5	21.2	26.3	16.2	18.4	17.7	23.5	16.4	24.4	20.3	18.7	23.7	22.8	20.8	16.5	21.3	21.0	30.5	19.6	22.6	22.5	24.0	44.4	19.7	19.3	16.2	18.5	27.4	16.0	18.4	20.3	42.2	25.2	21.5	22.7	15.3	22.9	22.6	43.3	16.5	68.8	19.5	22.3	35.1	23.9	31.7	7.5	9.8	5.5	7.8	3.9	8.7	1.8	12.4	23.3	20.6	15.4	11.7	15.0	14.2	17.2	14.8	16.1	13.7	20.8	15.3	30.1	11.0	19.9	9.2	15.6	31.5	20.6	27.0	19.7	12.5	25.0	15.7	42.9	16.9	27.5	16.2	12.9	13.1	17.5	20.7	12.4	22.8	45.5	24.1	33.4	16.4	23.8	40.3	5.3	14.4	15.8	13.5	35.9	23.1	27.5	11.3	24.5	19.5	12.0	19.3	18.2	9.5	22.0	18.1	12.3	19.5	17.5	17.9	26.8	12.9	16.2	39.6	46.0	16.3	16.0	14.0	5.5	3.3	3.8	7.1	3.2	8.7	5.9	6.6	8.2	3.3	7.5	8.0	6.8	5.2	3.9	7.8	9.8	7.0	1.8	23.9	22.9	28.7	24.5	22.8	20.8	19.6	22.6	16.2	16.5	32.8	46.2	23.4	19.2	41.3	47.4	61.8	20.4	46.8	46.6	27.9	23.6	18.4	5.0	21.1	217.0	25.9	29.6	46.7	28.3	12.6	24.0	27.0	25.5	34.2	17.5	41.3	40.6	25.2	28.0	84.4	23.6	28.5	18.6	16.2	46.7	25.0	27.8	28.8	32.5	11.8	41.6	6.5	29.2	29.9	31.9	43.7	17.6	26.6	47.0	32.7
USP8	"HumORF8, KIAA0055, SPG59, UBPY"	ENSG00000138592	"Ubiquitin specific peptidase 8"	P40818	15	50424380-50514419	"Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Cell cycle, Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"	"Cancer-related genes, Cushing syndrome, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA050215	Approved		Supported	"Golgi apparatus,Cytosol"		NA	NA			"Golgi apparatus"	Cytosol	"HPA050215: AB_2681054"	"unprognostic (5.81e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.46e-1)"	"unprognostic (9.58e-2)"	"unprognostic (2.35e-2)"	"unprognostic (2.91e-1)"	"unprognostic (1.42e-1)"	"unprognostic (3.96e-1)"	"unprognostic (1.68e-2)"	"unprognostic (5.08e-2)"	"unprognostic (2.94e-1)"	"unprognostic (3.99e-2)"	"prognostic favorable (1.29e-5)"	"unprognostic (4.89e-2)"	"unprognostic (1.13e-1)"	"unprognostic (3.79e-1)"	"unprognostic (1.58e-1)"	19.4	21.9	21.0	20.6	20.6	21.6	18.1	27.3	21.6	21.4	23.9	13.8	19.5	20.2	22.1	17.4	22.3	17.4	15.5	17.4	19.7	18.2	28.2	26.4	17.0	25.4	21.8	15.2	21.9	16.7	42.6	43.2	29.1	29.7	16.7	18.9	10.7	19.9	17.9	24.3	17.8	32.1	19.2	29.3	30.3	17.7	27.5	26.1	28.9	24.1	12.7	20.9	22.3	18.4	16.7	10.6	38.1	15.1	9.5	11.9	6.9	11.2	16.2	9.1	16.0	16.6	18.7	12.6	16.2	19.2	15.8	18.7	10.8	7.5	11.9	12.5	18.5	17.8	21.8	12.4	12.1	18.7	10.4	8.2	21.9	15.1	11.0	17.1	14.7	14.9	14.4	14.6	13.9	23.6	14.7	15.3	8.5	12.5	14.5	14.8	23.1	9.4	5.8	10.4	12.9	7.5	8.5	16.9	17.8	15.0	26.5	11.6	10.6	17.0	25.5	21.2	20.1	14.0	18.0	17.3	16.4	9.2	50.5	21.3	11.3	23.4	13.1	13.1	29.7	15.8	38.1	13.3	22.4	11.1	12.4	10.7	16.5	11.4	11.1	10.6	16.7	11.9	10.7	22.7	9.5	15.1	9.9	8.5	6.9	21.0	20.6	27.3	21.6	19.7	18.2	21.8	15.2	29.7	26.1	89.3	104.5	61.4	35.4	25.6	51.6	61.8	48.4	147.2	88.7	45.4	64.8	49.9	21.6	44.4	53.0	44.9	70.6	23.3	44.6	38.3	35.3	38.8	83.3	45.5	40.2	31.8	51.2	53.4	59.1	12.4	49.8	49.2	38.8	52.3	54.2	53.3	45.7	54.3	58.0	40.7	75.6	45.3	42.6	86.1	47.1	36.3	88.0	47.9	55.0	52.6
USP9X	"DFFRX, FAF, MRX99"	ENSG00000124486	"Ubiquitin specific peptidase 9, X-linked"	Q93008	X	41085635-41236579	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Biological rhythms, Cell cycle, Cell division, Chromosome partition, Mitosis, Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"	"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB011618, HPA047417, CAB070164"	Approved		Uncertain	Vesicles		NA	NA			Vesicles		"CAB011618: AB_470860, CAB070164: AB_10011071, HPA047417: "	"unprognostic (5.42e-3)"	"unprognostic (6.42e-2)"	"unprognostic (3.19e-3)"	"unprognostic (2.94e-2)"	"unprognostic (5.99e-2)"	"unprognostic (4.76e-1)"	"unprognostic (1.82e-2)"	"unprognostic (4.07e-1)"	"unprognostic (1.90e-1)"	"unprognostic (1.72e-1)"	"unprognostic (7.07e-2)"	"unprognostic (1.09e-1)"	"unprognostic (5.82e-2)"	"unprognostic (1.59e-1)"	"unprognostic (4.19e-2)"	"unprognostic (2.78e-1)"	"unprognostic (1.33e-1)"	18.0	21.8	17.7	14.0	15.9	15.5	16.8	16.6	16.7	18.4	20.6	11.4	25.4	13.2	19.6	19.0	17.3	17.0	17.1	20.9	14.2	14.2	18.5	34.2	16.7	23.1	15.2	15.4	15.7	16.5	45.8	17.0	41.1	12.9	13.4	14.4	13.9	14.2	25.2	42.8	14.8	22.0	17.3	14.0	16.7	16.9	16.9	14.0	21.1	20.3	17.6	16.5	20.3	19.9	6.4	5.5	13.0	5.0	4.9	7.8	3.1	18.2	21.6	19.2	19.6	16.1	16.9	4.4	10.5	14.1	12.0	13.9	9.9	8.5	12.3	5.9	23.9	35.9	12.4	32.9	19.1	20.1	15.4	23.6	14.2	20.9	8.9	13.6	12.3	10.4	14.6	8.6	28.7	27.2	17.2	18.5	8.3	17.2	10.0	18.5	13.3	8.8	4.9	20.3	6.5	11.9	9.7	26.2	7.9	11.4	15.1	10.9	10.2	44.2	12.2	12.0	36.0	11.8	6.9	19.7	18.3	14.2	17.3	11.3	9.2	10.7	15.7	13.1	5.5	9.1	3.3	4.7	6.0	5.6	4.2	7.8	6.4	6.6	6.2	5.5	4.7	6.7	6.0	13.0	4.9	5.0	4.2	5.6	3.1	17.7	15.9	16.6	16.7	14.2	14.2	15.2	15.4	12.9	14.0	38.7	32.0	23.8	26.8	42.8	35.0	73.6	43.3	30.8	36.4	26.2	35.3	31.0	6.6	26.8	13.0	39.8	39.2	70.0	22.8	21.8	35.1	30.2	24.4	55.5	29.3	35.0	25.8	52.8	43.4	13.1	30.8	38.0	32.1	33.3	42.5	32.0	27.0	35.7	46.3	20.3	29.3	32.3	39.6	31.4	69.2	48.3	39.0	26.1	36.7	34.3
USP9Y	DFFRY	ENSG00000114374	"Ubiquitin specific peptidase 9, Y-linked"	O00507	Y	12701231-12860839	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	7	"Cone photoreceptor cells: 60.9"	"Cancer enhanced"	"Detected in many"		"prostate cancer: 5.7"					"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"B-cells: 2.4;dendritic cells: 2.0;T-cells: 2.7"	"Cell line enhanced"	"Detected in many"		"RPTEC TERT1: 16.2;RT4: 8.7"	"Not detected"	"Not detected"							HPA057687			Uncertain	Vesicles		NA	NA			Vesicles		"HPA057687: "			"unprognostic (2.63e-1)"		"unprognostic (8.97e-2)"	"unprognostic (1.10e-5)"	"unprognostic (8.46e-3)"	"unprognostic (4.93e-2)"	"unprognostic (2.53e-2)"	"unprognostic (2.77e-1)"	"unprognostic (3.17e-2)"	"unprognostic (1.71e-1)"	"unprognostic (4.05e-2)"	"unprognostic (1.41e-4)"	"unprognostic (2.28e-1)"	"unprognostic (1.19e-2)"	"unprognostic (1.42e-1)"	1.2	2.2	1.4	0.9	3.1	1.7	1.1	9.6	4.0	0.0	1.6			1.4	0.0	8.6	4.4	0.0	3.8	2.4	1.8	3.4	2.9	2.2	2.2	1.4	2.1		0.0	2.7	0.0	4.8	1.7		9.3	4.8		2.3	7.6	2.8	2.0	1.8	0.0	1.5	2.2	1.5	2.9			2.8		4.5	3.2	0.0	2.4	2.0	0.1	0.2	0.5	2.7	0.2	0.0	2.3	0.0	0.0	0.0	0.0	2.5	7.2	7.2	3.6	3.9	0.0	0.0	4.1	0.0	6.0	0.0	0.0	0.0	0.0	3.3	2.3	0.0	2.6	0.0	7.1	4.0	0.0	0.0	6.0	5.3	0.0	0.0	0.0	0.0	0.8	0.0	0.0	6.5	0.0	4.0	0.0	1.5	0.0	0.0	0.0	2.0	0.9	16.2	8.7	2.8	0.0	0.0	0.0	2.1	5.4	0.0	0.0	5.5	4.4	0.0	0.0	3.2	0.0	3.8	7.1	0.1	0.0	0.0	0.0	0.1	0.0	1.9	0.2	2.7	1.2	2.2	1.5	0.3	2.4	2.2	1.3	0.1	0.5	0.0	2.0	1.6	0.2											23.8	19.7	0.8	7.4	10.4	22.1	24.6	2.5	21.4	15.9	19.2	60.9	4.3	1.7	4.1	0.4	5.8	0.0	0.0	0.0	1.1	9.3	11.2	2.3	0.2	2.5	25.4	0.0	5.5	6.9	0.0	11.5	7.3	3.3	2.8	0.3	8.1	3.7	0.0	14.5	5.4	24.9	0.0	7.6	3.2	1.7	10.2	2.9	10.0	0.0	9.9
USPL1	"bA121O19.1, C13orf22, D13S106E"	ENSG00000132952	"Ubiquitin specific peptidase like 1"	Q5W0Q7	13	30617693-30660770	"Enzymes, Predicted intracellular proteins"		"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	11	"Early spermatids: 131.8;Late spermatids: 230.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039342, HPA040172"	Uncertain					NA	NA					"HPA039342: AB_10795105, HPA040172: AB_10796447"	"unprognostic (5.74e-2)"	"unprognostic (6.26e-2)"	"unprognostic (8.16e-2)"	"unprognostic (4.29e-2)"	"unprognostic (4.96e-2)"	"unprognostic (3.65e-1)"	"unprognostic (1.00e-2)"	"unprognostic (1.65e-1)"	"unprognostic (1.20e-1)"	"unprognostic (6.79e-2)"	"unprognostic (2.21e-2)"	"unprognostic (1.27e-2)"	"unprognostic (3.18e-1)"	"unprognostic (2.68e-1)"	"unprognostic (1.49e-1)"	"unprognostic (3.78e-1)"	"unprognostic (5.32e-3)"	12.6	10.0	13.0	16.2	14.9	29.7	13.2	22.1	14.6	11.5	10.3	9.6	8.7	8.8	14.2	10.5	10.1	11.4	9.0	7.5	12.9	7.8	9.4	15.3	12.2	16.7	20.8	10.4	16.2	13.1	6.6	15.2	11.7	13.7	13.4	9.9	7.4	9.8	10.1	10.0	13.6	14.3	9.9	18.0	19.7	10.4	23.1	18.9	12.5	12.3	5.8	16.1	14.1	42.6	11.3	6.9	7.5	7.7	8.4	10.6	5.9	4.2	6.3	14.9	8.9	7.5	9.4	6.2	10.0	8.0	9.8	7.9	8.7	11.4	9.5	5.1	8.4	12.8	8.9	15.6	5.9	14.6	8.0	6.4	11.9	9.5	7.6	6.8	11.4	9.6	6.9	10.7	7.2	10.0	14.3	14.2	10.7	11.9	6.4	10.7	3.6	15.7	23.0	12.6	14.1	4.2	15.0	11.0	8.7	7.9	2.8	12.7	11.9	5.4	6.2	8.7	11.9	7.0	14.2	8.9	6.8	6.7	8.9	7.4	6.6	5.6	14.0	4.0	8.0	13.2	6.1	7.7	7.5	7.7	5.8	10.6	11.0	7.5	7.8	6.9	11.3	10.2	9.2	3.8	8.4	4.6	5.2	7.8	5.9	13.0	14.9	22.1	14.6	12.9	7.8	20.8	10.4	13.7	18.9	14.9	9.8	13.2	6.2	3.9	10.1	15.9	10.2	8.1	9.1	7.0	15.7	3.7	3.3	4.5	131.8	8.3	5.2	0.0	3.9	4.7	9.1	7.3	1.1	4.9	6.2	14.3	13.7	11.1	7.5	230.0	6.4	12.4	3.3	2.8	8.3	8.1	4.6	3.5	4.9	3.1	11.9	6.5	10.3	15.9	8.1	3.3	2.6	10.0	6.4	4.1
UXS1	"FLJ23591, SDR6E1, UGD"	ENSG00000115652	"UDP-glucuronate decarboxylase 1"	Q8NBZ7	2	106093303-106194339	"Enzymes, Predicted intracellular proteins"		"Decarboxylase, Lyase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"RPTEC TERT1: 83.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA008825	Uncertain				"Intracellular and membrane"	NA	NA		10000			"HPA008825: AB_1858708"	"unprognostic (4.08e-1)"	"unprognostic (1.52e-1)"	"unprognostic (1.99e-1)"	"unprognostic (3.63e-2)"	"unprognostic (3.92e-2)"	"prognostic unfavorable (5.45e-4)"	"prognostic unfavorable (1.38e-4)"	"unprognostic (3.20e-3)"	"unprognostic (2.07e-1)"	"prognostic favorable (7.94e-4)"	"unprognostic (3.95e-2)"	"unprognostic (1.40e-2)"	"unprognostic (8.46e-2)"	"unprognostic (3.96e-2)"	"unprognostic (6.18e-2)"	"unprognostic (1.86e-2)"	"unprognostic (5.32e-2)"	12.3	11.7	15.2	17.3	19.9	20.7	20.1	23.0	20.5	14.1	13.3	11.9	27.6	9.5	16.1	22.3	15.6	19.2	16.2	20.0	17.0	18.2	40.2	16.1	28.8	20.7	15.1	11.6	16.3	17.0	18.6	13.4	37.9	19.6	16.2	15.6	14.7	11.6	17.6	18.0	11.5	9.9	13.8	22.9	19.7	17.9	19.4	10.6	15.0	26.2	14.1	19.1	21.6	15.3	11.6	7.5	11.2	9.8	11.9	34.1	15.1	16.5	12.5	13.2	10.0	23.6	17.6	28.6	18.3	17.2	13.0	16.2	24.5	28.3	3.0	22.8	18.9	29.2	8.4	5.7	15.0	14.2	15.9	10.0	9.1	5.6	27.5	9.3	7.4	10.1	11.4	16.6	13.2	8.9	15.1	13.6	5.8	5.3	7.3	26.8	11.8	8.2	15.9	15.5	16.0	16.8	15.3	10.0	8.5	83.9	15.6	4.4	4.9	13.1	11.8	10.8	18.6	4.4	23.6	12.2	14.6	15.3	11.8	11.3	9.0	12.4	4.1	14.5	16.6	26.7	3.9	9.8	11.2	8.8	8.0	9.5	4.9	19.6	14.3	7.5	11.6	25.4	17.6	2.0	11.9	5.3	5.4	34.1	15.1	15.2	19.9	23.0	20.5	17.0	18.2	15.1	11.6	19.6	10.6	83.4	72.6	12.3	22.3	14.9	9.1	15.3	22.9	29.4	61.4	82.0	3.9	59.1	43.1	42.5	42.6	18.9	11.0	23.3	21.9	60.0	31.9	15.7	28.9	12.9	29.5	7.9	6.3	8.6	19.8	11.4	14.1	25.4	13.5	80.2	14.3	10.0	25.7	10.5	12.0	16.7	6.8	19.4	20.8	11.9	59.8	11.5	20.6	30.5	19.9	15.5
VARS	VARS2	ENSG00000204394	"Valyl-tRNA synthetase"	P26640	6	31777518-31795953	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Protein biosynthesis"	"Aminoacyl-tRNA synthetase, Ligase"	"Disease mutation, Epilepsy, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in all"	5	"Early spermatids: 205.7;Late spermatids: 188.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"RPMI-8226: 25.2;U-266/84: 25.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA046710	Approved		Enhanced	Cytosol		NA	NA		23000	Cytosol		"HPA046710: AB_2679765"	"unprognostic (1.86e-2)"	"prognostic unfavorable (7.25e-4)"	"unprognostic (2.19e-1)"	"unprognostic (2.07e-1)"	"unprognostic (2.49e-2)"	"unprognostic (3.43e-2)"	"prognostic unfavorable (1.86e-4)"	"prognostic unfavorable (6.90e-4)"	"unprognostic (3.20e-1)"	"unprognostic (2.76e-1)"	"unprognostic (4.72e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.09e-2)"	"unprognostic (1.98e-1)"	"unprognostic (1.69e-1)"	"unprognostic (3.85e-2)"	"unprognostic (2.59e-1)"	11.7	11.4	8.9	12.0	9.5	9.1	18.3	7.6	14.0	8.1	11.3	7.3	5.0	12.8	13.5	6.7	14.2	10.2	8.1	9.5	6.4	6.8	9.5	22.7	11.5	24.2	8.3	9.7	9.6	19.2	15.6	15.0	8.5	8.6	7.7	9.4	6.1	9.1	5.9	30.6	14.3	10.3	13.2	8.7	14.4	15.2	40.6	7.5	10.9	8.2	13.2	11.8	9.7	8.5	1.6	1.5	0.6	1.2	2.4	1.0	0.9	2.2	2.0	3.2	6.4	3.6	2.8	8.7	8.8	2.7	6.6	4.0	2.6	1.4	7.7	10.9	5.5	5.0	2.4	10.2	6.7	4.0	5.6	14.4	3.8	5.1	6.1	4.7	15.3	12.6	4.2	2.4	2.6	6.1	1.9	3.3	3.5	10.6	10.5	4.2	3.5	6.9	0.7	6.1	3.2	4.3	9.0	1.7	25.2	5.1	2.9	3.9	1.5	0.7	8.6	3.7	2.2	5.2	6.1	1.1	4.6	4.2	6.1	14.5	15.0	25.9	6.3	3.3	3.1	5.1	0.0	0.6	0.6	1.0	1.2	1.0	1.6	0.6	0.4	1.1	1.1	0.8	0.8	0.0	2.4	1.0	1.5	0.6	0.9	8.9	9.5	7.6	14.0	6.4	6.8	8.3	9.7	8.6	7.5	6.0	8.2	11.1	8.3	7.3	7.0	7.8	7.6	8.1	9.1	15.7	5.9	19.8	8.3	30.5	205.7	9.2	18.8	23.3	36.1	40.7	10.4	7.3	9.2	21.9	26.7	1.6	22.5	6.2	9.2	188.8	19.2	12.0	6.8	10.0	12.5	7.2	28.7	5.8	12.7	11.4	12.4	19.4	8.1	24.4	29.8	11.3	13.8	6.9	19.2	7.0
VARS2	"DKFZP434L1435, G7a, KIAA1885, VARS2L, VARSL"	ENSG00000137411	"Valyl-tRNA synthetase 2, mitochondrial"	Q5ST30	6	30908242-30926459	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Protein biosynthesis"	"Aminoacyl-tRNA synthetase, Ligase"	"Disease mutation, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"AN3-CA: 14.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA062449, HPA070267"	Approved		Approved	Mitochondria		NA	NA			Mitochondria		"HPA062449: AB_2684766, HPA070267: AB_2686245"	"unprognostic (1.74e-1)"	"unprognostic (8.24e-2)"	"unprognostic (1.96e-3)"	"unprognostic (2.50e-1)"	"unprognostic (5.80e-2)"	"unprognostic (3.05e-2)"	"unprognostic (2.43e-2)"	"unprognostic (1.66e-2)"	"unprognostic (3.14e-1)"	"unprognostic (8.98e-2)"	"unprognostic (4.23e-2)"	"unprognostic (2.60e-2)"	"unprognostic (2.15e-3)"	"unprognostic (1.04e-2)"	"unprognostic (7.23e-2)"	"unprognostic (1.19e-2)"	"unprognostic (2.43e-2)"	7.2	7.8	6.3	12.5	8.6	6.9	6.8	21.4	11.4	4.2	6.5	8.9	6.2	6.2	8.8	6.2	20.6	6.3	7.4	4.9	7.4	6.4	12.0	13.5	7.3	12.9	5.6	9.3	8.8	12.5	8.5	9.7	5.1	7.9	6.0	8.1	4.6	8.2	10.5	9.4	11.0	7.4	4.4	6.3	7.8	8.6	8.3	3.4	13.4	8.2	4.6	10.0	4.8	6.1	1.8	1.3	0.1	0.9	0.2	1.8	0.5	8.6	6.9	3.7	14.8	3.1	2.3	0.1	1.2	0.8	1.2	1.1	6.0	4.9	6.5	5.1	0.9	3.4	0.0	10.4	0.0	1.9	3.4	8.9	7.8	5.8	0.6	2.7	1.6	0.0	1.8	2.6	3.7	0.8	0.4	0.9	11.0	0.0	7.4	3.0	0.0	2.5	0.0	0.9	0.0	0.9	6.1	0.0	6.3	4.9	0.0	4.5	0.1	0.0	3.3	3.7	3.2	10.1	4.1	1.6	9.2	0.6	0.5	0.1	6.8	10.5	13.5	0.0	0.3	6.1	0.0	0.2	0.0	1.1	0.9	1.8	1.8	1.0	1.6	1.0	0.7	0.6	0.3	0.1	0.2	0.6	1.3	1.2	0.5	6.3	8.6	21.4	11.4	7.4	6.4	5.6	9.3	7.9	3.4	6.0	15.1	9.3	4.8	3.5	6.2	11.0	10.2	6.7	4.5	8.7	0.0	7.5	1.7	5.3	1.2	3.8	10.5	0.0	6.1	9.2	3.5	2.0	12.7	19.2	8.2	7.9	12.6	8.6	7.5	0.5	3.7	4.9	1.7	8.2	7.2	2.9	6.7	5.9	3.9	10.7	5.7	0.0	3.4	9.1	8.1	3.6	2.9	7.5	8.6	3.3
VCP	"CDC48, IBMPFD, p97, TERA"	ENSG00000165280	"Valosin containing protein"	P55072	9	35056064-35073249	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters"	"Autophagy, DNA damage, DNA repair, Transport, Ubl conjugation pathway"	Hydrolase	"Amyotrophic lateral sclerosis, Charcot-Marie-Tooth disease, Disease mutation, Neurodegeneration, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	4	"Syncytiotrophoblasts: 452.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB005593, HPA012728, HPA012814"	Supported		Enhanced	Nucleoplasm,Cytosol		No	No		110000000	"Nucleoplasm, Cytosol"		"CAB005593: AB_2214638, HPA012728: AB_1858730, HPA012814: AB_1858729"	"unprognostic (1.10e-1)"	"unprognostic (2.66e-1)"	"unprognostic (8.15e-2)"	"prognostic favorable (7.30e-4)"	"unprognostic (5.78e-2)"	"unprognostic (1.87e-1)"	"unprognostic (2.52e-3)"	"unprognostic (1.13e-2)"	"unprognostic (3.82e-2)"	"unprognostic (1.81e-2)"	"unprognostic (2.19e-2)"	"unprognostic (3.24e-1)"	"prognostic favorable (9.63e-7)"	"unprognostic (1.83e-2)"	"unprognostic (1.16e-1)"	"unprognostic (3.93e-1)"	"unprognostic (9.11e-2)"	33.7	43.6	19.6	30.3	21.8	30.8	31.4	19.4	31.0	32.2	25.7	22.7	32.9	22.2	30.5	34.0	40.0	24.7	33.8	69.6	20.0	23.4	30.1	63.4	27.6	42.7	23.1	21.1	25.0	34.9	44.5	29.0	46.3	26.3	33.4	26.5	21.2	30.7	34.1	80.4	29.2	26.3	29.2	23.0	37.8	28.9	25.6	18.2	43.3	32.1	42.2	35.7	31.5	26.5	25.9	29.4	43.4	30.6	23.0	32.1	34.4	36.0	41.2	28.4	15.3	34.3	24.2	21.7	33.6	38.1	50.3	37.2	27.5	14.9	28.6	29.5	41.7	44.2	17.4	42.3	40.1	43.6	30.7	24.5	19.9	39.0	37.6	26.7	22.3	26.6	27.6	27.0	43.6	19.5	21.1	54.4	13.1	20.6	20.8	40.2	25.4	21.8	53.7	37.0	18.7	39.4	19.4	22.1	17.7	39.3	25.8	15.5	19.5	20.3	23.0	10.2	36.9	18.5	15.9	44.5	20.2	26.1	17.9	29.5	10.6	22.4	24.5	33.1	16.1	25.8	43.4	24.5	31.9	24.7	27.2	23.8	25.9	23.6	24.8	29.4	21.1	17.7	18.5	28.4	23.0	30.6	18.9	32.1	34.4	19.6	21.8	19.4	31.0	20.0	23.4	23.1	21.1	26.3	18.2	74.5	72.0	80.5	100.9	68.5	80.1	178.9	43.3	71.0	68.2	52.4	111.9	240.5	63.0	177.8	24.1	121.1	90.3	23.3	162.4	147.5	81.6	98.2	61.1	102.4	116.5	69.9	80.8	122.8	57.9	36.5	77.6	66.7	72.6	234.4	63.9	87.7	195.1	56.3	81.7	89.3	82.6	135.8	82.4	127.7	117.9	79.3	452.1	76.6	57.1	105.3
VCPIP1	"DUBA3, FLJ23132, KIAA1850, VCIP135"	ENSG00000175073	"Valosin containing protein interacting protein 1"	Q96JH7	8	66628487-66667217	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA023932	Uncertain		Approved	"Plasma membrane,Centrosome"		NA	NA			"Plasma membrane"	Centrosome	"HPA023932: AB_2671373"	"unprognostic (1.12e-1)"	"unprognostic (1.31e-2)"	"unprognostic (9.13e-2)"	"unprognostic (1.10e-2)"	"unprognostic (4.01e-2)"	"unprognostic (5.56e-2)"	"unprognostic (5.23e-2)"	"unprognostic (7.21e-2)"	"unprognostic (2.80e-1)"	"unprognostic (3.96e-1)"	"unprognostic (5.23e-3)"	"unprognostic (7.28e-2)"	"unprognostic (6.12e-3)"	"unprognostic (2.03e-2)"	"unprognostic (1.83e-1)"	"unprognostic (2.13e-2)"	"unprognostic (8.58e-3)"	9.5	8.7	15.7	12.6	14.5	30.9	8.9	14.4	15.1	7.5	8.4	7.0	3.8	7.0	7.8	8.7	8.1	6.9	7.0	6.7	10.2	9.2	8.3	12.3	10.5	13.6	10.3	13.7	7.8	9.0	14.0	5.9	8.0	12.3	7.0	7.8	6.0	9.0	7.1	14.8	7.3	10.0	6.3	9.6	14.7	8.0	10.8	11.7	11.6	8.0	2.8	13.3	7.9	7.0	2.6	3.4	11.3	8.8	2.8	4.3	1.7	9.0	8.2	4.2	5.6	13.0	9.2	4.1	7.3	7.4	5.6	6.5	4.8	8.5	12.2	2.1	9.7	6.9	8.0	6.8	6.1	8.0	9.0	4.9	13.5	8.1	6.0	7.8	4.5	14.6	9.9	9.0	6.1	11.1	6.9	6.0	6.7	9.1	11.8	8.2	4.4	9.7	7.8	8.0	7.6	5.7	6.3	6.6	6.1	8.1	7.1	2.5	4.8	5.6	8.6	6.3	5.6	8.8	7.5	12.0	7.4	5.5	6.5	4.8	10.5	5.1	13.1	7.3	6.5	5.5	9.2	3.2	6.7	4.3	5.2	3.6	2.0	2.7	3.1	3.4	2.6	2.2	2.9	11.3	2.8	8.8	1.3	3.3	1.7	15.7	14.5	14.4	15.1	10.2	9.2	10.3	13.7	12.3	11.7	17.9	14.6	9.0	8.1	15.0	11.1	16.5	12.7	12.0	11.4	7.0	21.6	8.8	3.3	9.7	4.3	9.9	14.0	23.3	11.7	4.8	12.3	11.3	18.5	20.2	12.4	11.1	5.8	15.4	47.5	4.5	7.5	18.0	10.1	10.8	15.0	11.8	10.8	15.3	14.9	9.9	10.8	6.5	10.8	26.8	14.7	18.1	8.2	26.6	13.3	14.2
VKORC1	VKCFD2	ENSG00000167397	"Vitamin K epoxide reductase complex subunit 1"	Q9BQB6	16	31090842-31095980	"Disease related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins"		Oxidoreductase	"Disease mutation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 173.3"	"Cell type enhanced"	"Detected in all"	8	"Hepatocytes: 682.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"ASC diff: 98.9"					"Low region specificity"	"Detected in all"			HPA042720	Approved		Supported	"Endoplasmic reticulum"	"Intracellular and membrane"	NA	NA			"Endoplasmic reticulum"		"HPA042720: AB_10961864"	"unprognostic (5.99e-2)"	"unprognostic (2.98e-1)"	"unprognostic (7.11e-3)"	"unprognostic (7.68e-3)"	"unprognostic (5.49e-2)"	"unprognostic (3.23e-3)"	"unprognostic (3.02e-2)"	"unprognostic (2.32e-2)"	"unprognostic (2.42e-1)"	"unprognostic (2.66e-1)"	"unprognostic (1.04e-1)"	"unprognostic (1.19e-1)"	"prognostic unfavorable (2.09e-10)"	"unprognostic (1.11e-2)"	"unprognostic (6.65e-2)"	"unprognostic (3.12e-2)"	"unprognostic (9.66e-2)"	21.3	23.0	9.3	11.5	11.0	12.9	28.1	9.4	14.5	24.3	19.3	17.1	16.5	12.6	24.0	27.4	18.5	17.8	22.6	20.1	9.8	10.2	29.9	173.3	16.4	17.5	13.7	9.1	25.5	55.5	14.0	25.0	22.5	13.3	22.3	12.6	20.8	34.8	21.4	11.4	15.9	26.8	27.7	12.5	15.4	17.5	18.2	10.6	15.8	25.6	13.8	14.6	28.4	18.7	32.3	49.9	59.6	40.6	24.7	43.7	33.6	10.5	27.1	8.9	25.5	98.9	58.9	9.9	39.1	34.0	19.3	32.8	11.2	12.1	8.3	21.2	48.9	13.6	9.8	12.3	15.3	22.0	11.7	29.9	7.5	37.5	53.9	15.6	14.6	11.3	34.0	8.2	26.6	22.9	52.3	20.8	11.8	9.8	19.8	37.6	38.2	10.7	30.0	16.1	14.6	26.1	19.4	23.7	41.2	19.0	9.2	18.2	22.1	17.1	12.5	19.0	15.0	20.6	17.8	18.1	25.9	9.3	23.7	14.7	12.0	11.1	7.3	67.4	25.3	13.3	21.5	40.6	59.6	40.3	28.1	39.7	29.9	40.5	40.7	39.6	32.3	36.4	35.4	34.2	24.7	28.3	49.9	43.7	33.6	9.3	11.0	9.4	14.5	9.8	10.2	13.7	9.1	13.3	10.6	53.6	38.2	37.9	58.4	75.2	11.2	20.0	119.8	32.1	40.9	102.9	7.9	64.0	53.0	183.3	4.8	87.9	36.0	46.7	112.2	211.1	138.5	58.9	55.3	682.4	166.1	9.5	64.4	119.7	79.0	8.3	146.4	85.1	109.6	129.8	41.2	64.7	107.2	24.6	161.9	160.1	16.9	58.2	95.7	23.7	24.7	97.9	33.1	47.3	51.3	46.5
VKORC1L1		ENSG00000196715	"Vitamin K epoxide reductase complex subunit 1 like 1"	Q8N0U8	7	65873267-65959563	"Enzymes, FDA approved drug targets, Predicted membrane proteins"		Oxidoreductase	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Alveolar cells type 1: 68.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											HPA053954	Approved		Supported	"Endoplasmic reticulum"		NA	NA			"Endoplasmic reticulum"		"HPA053954: AB_2682319"	"unprognostic (3.01e-1)"	"unprognostic (1.76e-3)"	"unprognostic (4.64e-2)"	"unprognostic (4.65e-2)"	"unprognostic (3.00e-3)"	"unprognostic (7.15e-3)"	"unprognostic (1.30e-3)"	"unprognostic (8.84e-3)"	"unprognostic (5.12e-2)"	"unprognostic (5.59e-2)"	"unprognostic (9.23e-3)"	"unprognostic (1.07e-1)"	"unprognostic (1.59e-2)"	"unprognostic (1.17e-1)"	"unprognostic (7.03e-3)"	"unprognostic (4.30e-1)"	"unprognostic (5.06e-2)"	38.2	9.2	10.5	8.3	16.7	3.0	23.7	9.0	19.7	10.4	11.1	14.2	9.2	8.6	10.1	8.8	10.0	8.8	8.0	9.3	10.3	11.4	8.2	17.8	14.3	6.2	12.0	12.1	14.4	11.7	28.5	8.0	9.7	14.1	9.9	10.0	8.0	9.0	10.5	14.9	11.4	9.7	9.3	13.2	5.7	9.9	9.4	7.6	9.1	11.1	4.5	6.6	9.7	9.3	2.8	7.5	5.6	4.2	6.5	3.4	1.8	22.4	14.5	11.7	14.7	37.4	14.9	21.3	24.4	15.8	14.6	14.8	14.0	22.2	19.6	19.8	17.5	22.2	15.5	16.7	9.9	24.5	12.2	16.5	13.3	13.3	11.9	18.3	18.4	10.3	11.9	12.8	14.8	20.7	11.4	14.5	11.2	28.0	15.0	17.4	8.8	15.1	21.5	28.1	21.3	10.9	16.6	17.1	24.4	14.1	9.0	14.1	20.2	18.9	34.3	10.7	17.4	17.2	14.3	16.4	23.7	16.2	14.8	24.7	13.6	22.1	22.5	14.5	21.0	20.6	3.8	2.7	5.6	2.9	2.5	2.4	2.8	3.4	3.2	2.8	2.5	2.3	2.3	3.1	6.5	4.2	7.5	3.1	1.8	10.5	16.7	9.0	19.7	10.3	11.4	12.0	12.1	14.1	7.6	68.5	29.5	0.8	14.6	22.0	20.5	21.3	30.6	8.1	26.1	15.7	11.8	10.0	5.0	15.9	28.9	15.9	16.9	23.3	21.7	18.4	16.7	23.4	4.7	44.5	14.4	28.6	13.3	8.6	7.0	5.5	16.4	9.0	6.8	4.6	23.5	8.5	24.2	2.9	17.3	10.2	17.4	6.5	13.4	17.9	6.6	28.0	7.3	5.2	18.7	16.9
VNN1	Tiff66	ENSG00000112299	"Vanin 1"	O95497	6	132681590-132714049	"Enzymes, Plasma proteins, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"intestine: 131.9;liver: 112.2"	"Group enriched"	"Detected in many"	5	"Cholangiocytes: 71.4;Ductal cells: 179.6;Hepatocytes: 68.4;Pancreatic endocrine cells: 77.2"	"Cancer enhanced"	"Detected in many"		"liver cancer: 41.5"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in many"		"classical monocyte: 13.4"	"Group enriched"	"Detected in many"	71	"dendritic cells: 4.9;granulocytes: 8.0;monocytes: 13.4"	"Cell line enhanced"	"Detected in some"		"A-431: 4.1;CAPAN-2: 4.3;EFO-21: 15.1;HBEC3-KT: 4.0;LHCN-M2: 4.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA064145	Uncertain				"Intracellular and membrane"	NA	NA		1100000000			"HPA064145: AB_2685197"	"unprognostic (9.53e-2)"	"unprognostic (5.01e-2)"	"unprognostic (9.95e-2)"	"unprognostic (1.35e-3)"	"unprognostic (6.11e-2)"	"unprognostic (1.16e-2)"	"unprognostic (2.20e-1)"	"unprognostic (4.20e-2)"	"unprognostic (2.06e-2)"	"unprognostic (3.64e-2)"	"unprognostic (2.11e-2)"	"unprognostic (4.62e-1)"	"prognostic unfavorable (2.52e-4)"	"unprognostic (2.26e-2)"	"unprognostic (4.42e-2)"	"unprognostic (2.16e-1)"	"unprognostic (2.34e-1)"	1.8	0.4	0.3	0.6	0.3	2.4	0.7	0.2	0.3	0.4	128.6	0.1	0.0	40.6	2.5	0.2	0.6	1.7	27.0	1.1	0.3	0.3	6.5	112.2	7.9	2.4	0.4	0.1	0.4	0.9	0.0	0.3	1.0	0.5	0.4	0.3	0.2	1.5	0.1	0.4	0.5	131.9	0.0	0.5	5.6	0.8	0.5	0.1	0.2	0.4	0.0	0.4	0.4	0.9	0.1	4.9	8.0	13.4	0.0	0.0	3.6	4.1	0.0	0.5	0.1	0.1	1.3	0.9	0.3	0.3	0.0	0.0	0.1	4.3	0.2	15.1	0.0	0.8	0.1	0.0	4.0	1.1	0.1	0.0	0.2	0.2	2.3	2.3	0.3	0.1	0.4	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.2	4.3	0.2	0.0	0.6	0.1	0.1	0.2	0.1	0.2	1.8	0.9	0.3	0.2	0.6	0.1	0.0	0.0	0.0	0.0	0.0	2.7	1.0	0.1	0.5	0.2	0.4	0.0	0.1	0.5	0.1	0.6	2.3	13.4	0.0	0.0	7.4	0.0	0.0	0.0	0.0	4.9	0.1	0.0	0.0	8.0	0.0	10.2	0.2	0.0	3.6	0.3	0.3	0.2	0.3	0.3	0.3	0.4	0.1	0.5	0.1	0.0	4.8	0.0	0.0	1.1	0.0	0.3	71.4	1.4	1.2	1.8	0.0	0.0	0.0	179.6	0.0	0.0	13.2	0.0	17.0	0.1	0.2	3.1	0.0	68.4	13.9	0.0	0.0	0.6	13.9	0.0	0.0	10.6	0.0	5.4	4.3	0.0	77.2	0.9	0.0	18.4	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.6	9.9
VNN2	"FOAP-4, GPI-80"	ENSG00000112303	"Vanin 2"	O95498	6	132743870-132763459	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"		Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"blood: 85.2;lung: 36.4;lymphoid tissue: 43.6"	"Cell type enhanced"	"Detected in many"	11	"Ciliated cells: 17.4;Ductal cells: 36.1;Kupffer cells: 27.8;Macrophages: 17.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in many"	8	"neutrophil: 85.2"	"Lineage enriched"	"Detected in all"	8	"granulocytes: 85.2"	"Cell line enriched"	"Detected in some"	8	"Daudi: 35.7"					"Not detected"	"Not detected"									NA	NA		270000				"unprognostic (2.13e-1)"	"unprognostic (1.15e-1)"	"unprognostic (9.60e-3)"	"unprognostic (5.71e-2)"	"unprognostic (2.14e-1)"	"unprognostic (5.61e-3)"	"unprognostic (1.98e-3)"	"unprognostic (4.38e-1)"	"unprognostic (3.07e-1)"	"unprognostic (3.46e-1)"	"unprognostic (2.84e-1)"	"unprognostic (8.30e-2)"	"prognostic unfavorable (2.72e-7)"	"unprognostic (1.62e-1)"	"unprognostic (8.17e-2)"	"unprognostic (2.01e-1)"	"unprognostic (5.45e-2)"	10.1	1.4	1.1	9.5	1.1	10.8	1.4	1.4	1.4	1.8	1.9	0.8	0.0	0.7	0.9	3.1	2.1	4.3	10.2	10.5	1.1	1.1	2.8	5.6	36.4	39.8	3.8	0.3	2.1	2.4	0.0	1.2	8.6	1.5	2.4	0.9	1.8	1.3	0.2	1.0	0.7	3.6	2.4	2.2	43.6	2.8	3.6	0.6	3.4	1.4	0.7	17.7	7.3	10.9	6.4	2.2	85.2	10.9	5.8	6.7	5.7	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	35.7	0.7	0.0	0.6	0.0	0.0	0.0	0.0	4.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.6	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.6	0.9	0.0	0.0	1.5	10.9	0.0	4.2	2.4	1.7	6.4	1.4	4.9	2.2	5.5	4.5	6.7	85.2	5.8	1.5	0.4	0.9	5.7	1.1	1.1	1.4	1.4	1.1	1.1	3.8	0.3	1.5	0.6	0.0	10.7	0.0	0.0	0.0	0.0	1.2	2.5	17.4	3.4	0.0	0.0	0.6	0.0	36.1	0.0	0.0	0.0	0.0	0.3	0.1	0.5	5.6	4.7	0.0	11.3	0.0	0.0	4.3	27.8	0.0	0.0	17.1	0.0	1.8	0.0	0.0	4.0	0.0	0.0	0.3	0.0	6.5	0.5	0.0	0.0	0.0	1.1	6.1	0.0	8.4
VNN3	HSA238982	ENSG00000093134	"Vanin 3"	Q9NY84	6	132722787-132734765	"Enzymes, Predicted intracellular proteins, Predicted secreted proteins"		Hydrolase		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Group enriched"	"Detected in many"	4	"blood: 39.5;bone marrow: 29.8;liver: 29.4"	"Group enriched"	"Detected in some"	5	"Ciliated cells: 69.6;Club cells: 19.4"	"Cancer enhanced"	"Detected in some"		"liver cancer: 3.9"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in some"	6	"neutrophil: 39.5"	"Lineage enriched"	"Detected in single"	40	"granulocytes: 39.5"	"Cell line enhanced"	"Detected in some"		"Daudi: 2.5;EFO-21: 3.7;GAMG: 1.6;hTCEpi: 2.3"														"Secreted to blood"	NA	NA	150000000					"unprognostic (3.20e-2)"	"unprognostic (2.70e-1)"	"unprognostic (7.92e-3)"	"unprognostic (1.71e-2)"	"unprognostic (3.05e-3)"	"unprognostic (1.06e-3)"	"unprognostic (1.19e-1)"	"unprognostic (1.01e-1)"	"unprognostic (2.42e-2)"	"unprognostic (7.68e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.63e-1)"	"unprognostic (5.84e-8)"	"unprognostic (1.25e-2)"	"unprognostic (1.52e-1)"	"unprognostic (9.32e-2)"	"unprognostic (1.56e-1)"	1.1	0.1	0.4	3.3	0.4	29.8	0.2	0.2	0.6	2.4	1.2	0.2	0.2	0.0	0.2	0.8	0.9	2.4	1.3	1.0	0.4	0.0	0.3	29.4	6.1	1.2	0.4	0.2	1.2	0.2	0.0	0.2	5.8	0.3	0.5	0.0	0.4	1.1	0.2	0.2	0.1	0.2	0.2	0.2	7.6	0.4	0.3	0.2	0.2	0.3	2.4	0.7	0.6	0.3	0.0	0.0	39.5	0.9	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.1	2.5	3.7	0.0	1.6	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.4	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.4	0.0	0.0	6.3	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	39.5	0.0	0.0	0.0	0.0	0.1	0.4	0.4	0.2	0.6	0.4	0.0	0.4	0.2	0.3	0.2	0.0	3.2	0.0	0.0	0.0	0.0	0.3	0.0	69.6	19.4	0.0	0.0	0.0	0.0	2.4	0.2	0.0	0.0	0.0	0.2	0.0	0.0	1.0	0.0	9.7	0.1	0.0	0.0	0.6	9.4	0.0	0.0	1.1	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.8
VPS4A	"FLJ22197, SKD1, SKD1A, SKD2, VPS4, VPS4-1"	ENSG00000132612	"Vacuolar protein sorting 4 homolog A"	Q9UN37	16	69311356-69326939	"Enzymes, Predicted intracellular proteins"	"Cell cycle, Cell division, Protein transport, Transport"	Hydrolase	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"CAB018751, CAB034411, HPA060092"	Approved		Supported	Midbody		NA	NA			Midbody		"CAB018751: AB_2215497, CAB034411: AB_2304400, HPA060092: AB_2684203"	"unprognostic (2.60e-2)"	"unprognostic (2.32e-2)"	"unprognostic (1.26e-1)"	"unprognostic (9.26e-2)"	"unprognostic (4.03e-1)"	"unprognostic (1.20e-1)"	"unprognostic (2.55e-2)"	"unprognostic (2.70e-2)"	"unprognostic (4.63e-2)"	"unprognostic (8.61e-2)"	"unprognostic (3.91e-3)"	"unprognostic (2.19e-1)"	"prognostic favorable (1.76e-4)"	"unprognostic (5.44e-2)"	"unprognostic (1.46e-1)"	"unprognostic (2.61e-1)"	"unprognostic (6.79e-2)"	20.2	19.6	24.8	14.4	26.5	13.0	24.2	28.7	35.6	12.9	17.8	19.3	14.5	22.0	16.6	14.5	26.3	16.0	16.1	34.3	24.4	22.8	23.2	13.7	15.8	17.5	25.4	29.3	21.0	31.4	29.7	9.6	16.6	33.6	17.5	13.2	15.6	30.4	15.5	81.6	24.3	20.5	18.4	34.3	15.0	18.9	15.5	17.4	8.9	27.5	21.1	13.0	15.6	21.2	11.1	11.6	15.7	13.1	9.3	18.1	14.4	11.0	19.0	13.2	17.3	11.9	10.6	11.5	15.1	13.7	20.1	13.5	17.9	10.5	18.8	15.1	15.0	9.9	16.7	13.0	15.2	12.2	7.8	16.9	11.8	11.4	14.4	18.5	14.7	11.0	12.2	20.0	17.4	15.9	12.3	14.9	15.2	19.5	5.7	14.8	24.8	19.0	11.1	14.9	11.2	13.4	25.7	10.6	22.0	10.1	9.1	22.0	14.0	32.3	10.1	11.5	9.2	17.6	11.1	17.7	18.6	11.7	16.9	11.7	20.5	16.2	34.1	17.1	10.0	20.4	10.0	11.6	15.7	14.6	10.2	13.3	11.1	12.3	18.1	11.6	10.1	14.3	13.0	9.5	9.3	13.1	6.8	13.8	14.4	24.8	26.5	28.7	35.6	24.4	22.8	25.4	29.3	33.6	17.4	23.8	21.3	28.2	30.2	27.2	53.3	26.2	20.4	5.3	11.4	22.7	21.6	49.8	63.0	45.4	7.2	30.7	47.9	0.0	71.8	54.7	29.7	38.7	28.8	20.2	39.8	69.9	30.1	27.0	23.4	7.7	27.3	27.5	42.2	45.9	31.5	52.2	53.2	38.7	28.7	46.3	36.1	51.8	37.6	27.3	33.4	27.4	58.6	36.7	35.7	36.3
VPS4B	"SKD1, SKD1B, VPS4-2"	ENSG00000119541	"Vacuolar protein sorting 4 homolog B"	O75351	18	63389190-63422483	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Protein transport, Transport"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040393, CAB046445, HPA057649"	Approved		Approved	"Vesicles,Intermediate filaments"		No	No		34000	Vesicles	"Intermediate filaments"	"CAB046445: AB_10603252, HPA040393: , HPA057649: AB_2683489"	"unprognostic (8.54e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.85e-3)"	"unprognostic (5.59e-2)"	"unprognostic (1.71e-1)"	"unprognostic (9.47e-2)"	"unprognostic (1.75e-1)"	"unprognostic (1.79e-1)"	"unprognostic (4.54e-2)"	"unprognostic (9.10e-2)"	"unprognostic (1.94e-3)"	"unprognostic (1.67e-1)"	"prognostic favorable (1.23e-4)"	"unprognostic (4.59e-1)"	"unprognostic (1.40e-1)"	"unprognostic (4.08e-1)"	"unprognostic (1.21e-1)"	16.8	13.0	14.3	14.3	17.2	28.0	17.2	15.4	19.1	19.8	24.0	21.8	15.5	20.0	16.7	12.1	55.0	13.1	15.1	9.9	13.7	16.0	15.6	20.5	14.3	21.6	17.0	14.7	11.9	14.0	17.5	17.4	27.4	23.4	14.3	22.2	9.3	21.8	15.0	9.9	22.1	28.7	15.2	20.2	17.3	18.7	9.0	14.6	27.8	17.0	17.6	31.8	18.6	24.7	20.7	13.6	56.4	20.6	19.1	18.9	15.4	18.7	6.9	7.7	8.4	12.0	17.0	13.5	16.5	15.6	12.6	13.8	5.1	13.4	18.1	10.8	12.0	10.7	40.8	9.2	18.0	16.8	13.1	7.5	9.0	9.7	7.9	17.2	31.1	19.8	15.4	28.1	11.1	19.8	12.8	11.7	10.5	4.5	17.0	17.9	6.5	19.4	9.8	8.0	7.6	10.9	16.3	16.4	17.4	15.9	22.0	13.2	11.7	12.4	12.2	18.4	10.3	11.7	17.0	18.0	19.5	9.5	7.3	10.8	57.1	27.4	23.3	11.2	14.7	14.5	39.4	16.8	36.0	16.5	16.6	15.4	18.9	17.4	17.0	13.6	20.7	15.8	16.6	56.4	19.1	20.6	13.6	18.9	15.4	14.3	17.2	15.4	19.1	13.7	16.0	17.0	14.7	23.4	14.6	107.2	43.6	46.5	38.8	61.1	39.4	35.8	45.9	89.7	64.8	31.4	21.6	56.4	38.1	41.7	73.2	41.4	81.3	23.3	36.8	46.3	33.4	30.3	55.7	52.3	40.7	41.3	43.7	33.7	56.7	9.1	45.5	48.9	30.4	30.7	72.2	37.9	63.8	86.0	34.3	37.8	28.4	58.2	32.9	26.0	26.6	72.9	117.4	69.2	60.0	67.1
VRK1		ENSG00000100749	"Vaccinia related kinase 1"	Q99986	14	96797304-96931722	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Cell cycle, Cell division, Mitosis"	"Kinase, Serine/threonine-protein kinase, Transferase"	Neurodegeneration	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 39.0"	"Cell type enhanced"	"Detected in many"	8	"Erythroid cells: 93.5;Spermatocytes: 141.1;Spermatogonia: 122.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000660, HPA017929"	Enhanced		Supported	Nucleoplasm,Cytosol		Yes	No			Nucleoplasm	Cytosol	"HPA000660: AB_1080579, HPA017929: AB_1858770"	"unprognostic (1.03e-1)"	"unprognostic (1.17e-2)"	"unprognostic (1.84e-2)"	"unprognostic (2.24e-3)"	"unprognostic (5.42e-2)"	"unprognostic (1.19e-2)"	"prognostic unfavorable (4.15e-4)"	"unprognostic (4.20e-2)"	"unprognostic (2.11e-2)"	"unprognostic (5.47e-2)"	"unprognostic (5.14e-2)"	"unprognostic (1.60e-1)"	"unprognostic (2.53e-2)"	"unprognostic (6.70e-2)"	"unprognostic (4.56e-2)"	"unprognostic (3.36e-2)"	"unprognostic (1.58e-1)"	6.0	4.4	7.1	9.8	17.1	39.0	8.7	8.6	10.2	6.1	7.8	4.4	4.1	5.2	5.9	5.7	9.4	6.9	3.3	6.0	7.4	6.5	6.2	4.3	4.5	18.3	6.9	6.1	5.9	3.7	3.8	5.1	7.1	6.7	5.3	9.1	4.1	4.8	4.1	4.3	6.4	6.9	5.4	6.1	15.7	6.7	33.3	6.9	33.0	4.9	6.1	18.4	5.9	5.7	20.8	13.5	20.1	9.5	28.5	22.3	12.5	15.8	9.1	22.7	10.1	2.7	5.0	14.1	12.0	9.3	19.2	19.2	10.9	15.8	40.4	8.1	7.1	11.8	17.6	21.2	15.7	26.5	23.0	11.3	25.1	6.0	11.1	3.0	48.4	15.8	2.7	2.8	14.5	10.6	3.9	13.3	31.0	21.4	25.6	16.5	18.1	38.4	20.8	14.5	12.1	17.5	36.0	39.7	13.7	8.8	16.4	16.0	9.1	10.6	10.8	8.1	11.9	12.4	19.2	7.1	8.8	7.8	15.1	12.0	13.4	15.8	39.1	13.7	21.2	10.4	20.1	7.6	14.5	15.1	9.3	18.4	20.3	17.6	18.5	9.9	20.8	19.1	19.3	4.5	28.5	9.5	13.5	22.3	12.5	7.1	17.1	8.6	10.2	7.4	6.5	6.9	6.1	6.7	6.9	3.0	2.9	30.5	11.8	14.9	12.3	10.6	15.3	42.8	13.6	14.0	7.9	19.7	10.0	9.8	13.3	11.3	2.4	93.5	16.8	39.6	10.4	5.3	27.7	2.4	16.3	9.5	2.9	6.2	9.7	10.8	5.2	11.5	11.8	12.6	8.0	5.2	7.6	0.0	9.2	8.4	6.6	19.4	11.3	141.1	122.1	12.2	12.6	26.7	11.2	8.4
VRK2		ENSG00000028116	"Vaccinia related kinase 2"	Q86Y07	2	57907651-58159920	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Host-virus interaction"	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB046459, HPA047503"	Approved		Supported	"Endoplasmic reticulum"		NA	NA			"Endoplasmic reticulum"		"CAB046459: AB_1858773, HPA047503: AB_2680071"	"unprognostic (1.87e-1)"	"unprognostic (5.84e-2)"	"unprognostic (4.65e-2)"	"unprognostic (1.33e-3)"	"unprognostic (1.27e-1)"	"unprognostic (1.60e-2)"	"prognostic unfavorable (6.32e-6)"	"unprognostic (3.90e-2)"	"unprognostic (4.76e-2)"	"unprognostic (2.96e-2)"	"prognostic unfavorable (4.65e-4)"	"unprognostic (1.36e-1)"	"prognostic unfavorable (4.66e-5)"	"unprognostic (3.48e-1)"	"unprognostic (1.62e-1)"	"unprognostic (2.99e-1)"	"unprognostic (3.56e-1)"	18.7	17.7	10.9	21.9	28.3	14.9	16.1	2.4	15.1	15.6	13.5	27.3	16.3	9.9	18.4	16.7	26.8	13.2	10.9	21.6	14.4	8.9	12.4	15.2	15.6	19.5	29.2	13.5	14.2	20.0	16.1	18.7	16.1	18.7	15.7	15.6	9.3	20.5	17.6	21.5	12.8	12.9	20.1	19.0	20.1	13.5	12.5	31.2	13.6	17.4	16.7	23.0	18.1	19.4	19.7	17.0	21.6	21.3	11.3	12.2	9.2	14.2	9.5	1.1	6.3	7.1	13.1	19.7	13.2	13.2	9.1	9.3	19.4	15.1	17.4	17.4	11.6	15.0	10.9	13.8	14.4	13.7	31.2	9.3	19.6	7.7	13.8	11.3	16.6	11.7	7.2	17.2	14.6	21.1	10.9	26.2	2.4	19.2	11.2	15.2	8.2	0.1	12.7	12.0	22.6	4.8	19.0	4.8	11.8	15.1	11.7	3.8	0.1	20.9	12.5	10.5	10.9	8.8	10.2	14.6	0.2	30.3	8.2	0.2	16.5	13.0	9.3	7.4	20.6	15.0	13.7	16.8	21.6	10.1	21.3	12.2	19.7	9.8	11.8	16.6	19.0	7.4	9.5	6.0	11.3	20.6	17.0	11.5	9.2	10.9	28.3	2.4	15.1	14.4	8.9	29.2	13.5	18.7	31.2	20.8	9.1	14.1	11.3	8.8	1.0	17.1	10.2	30.8	15.9	17.4	0.0	19.7	13.3	22.0	16.8	15.0	2.9	46.7	22.8	18.5	8.5	8.1	16.3	6.8	17.1	0.0	6.3	4.9	17.7	6.5	5.5	21.4	10.1	49.5	4.3	4.6	21.8	7.8	5.6	7.1	3.6	6.5	13.7	8.3	12.6	7.3	16.2	12.7	7.1	12.2
VRK3		ENSG00000105053	"Vaccinia related kinase 3"	Q8IV63	19	49976467-50025946	"Enzymes, Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 77.2"	"Group enriched"	"Detected in all"	6	"Early spermatids: 469.4;Late spermatids: 1260.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA056489	Approved		Supported	Nucleoplasm,Vesicles		NA	NA			"Nucleoplasm, Vesicles"		"HPA056489: AB_2683150"	"unprognostic (2.09e-1)"	"unprognostic (3.14e-2)"	"unprognostic (1.26e-1)"	"unprognostic (4.94e-3)"	"unprognostic (1.23e-1)"	"unprognostic (2.22e-3)"	"unprognostic (9.78e-2)"	"unprognostic (3.47e-1)"	"unprognostic (8.79e-2)"	"unprognostic (2.48e-1)"	"unprognostic (1.31e-2)"	"unprognostic (1.43e-1)"	"prognostic favorable (1.83e-4)"	"unprognostic (9.38e-2)"	"unprognostic (2.15e-1)"	"unprognostic (1.06e-1)"	"prognostic favorable (5.66e-4)"	9.7	11.9	9.2	9.4	12.7	10.7	8.3	12.0	14.1	8.9	13.4	11.9	9.3	13.4	15.7	10.8	8.4	18.0	12.2	7.4	9.3	11.1	16.7	16.2	8.5	13.4	10.4	9.9	11.2	11.5	7.1	11.8	10.7	9.8	9.4	11.7	14.2	14.3	8.5	11.8	7.7	17.3	7.5	11.0	12.8	10.9	77.2	9.1	24.7	14.1	6.0	12.9	9.9	8.0	24.5	19.7	47.3	20.9	33.5	30.1	18.1	16.0	16.7	12.3	13.2	16.3	15.1	12.8	11.6	13.9	17.3	19.1	8.9	18.0	19.4	8.3	11.2	12.1	12.0	11.4	9.9	14.0	16.9	23.4	15.1	10.1	15.4	12.3	18.8	26.6	13.5	14.9	10.0	10.6	15.5	14.2	21.3	18.3	29.0	12.4	6.8	25.4	12.7	6.6	28.6	14.4	20.5	12.9	24.8	14.7	17.0	13.8	6.7	11.4	14.0	12.6	11.4	12.9	20.1	10.7	17.7	10.3	7.1	9.0	18.8	23.9	10.2	14.2	11.7	12.1	37.0	17.8	32.4	23.8	18.8	19.1	24.5	21.7	22.7	19.7	21.9	22.1	20.4	47.3	33.5	20.9	18.8	30.1	18.1	9.2	12.7	12.0	14.1	9.3	11.1	10.4	9.9	9.8	9.1	6.0	29.4	27.3	13.1	6.0	34.9	7.1	20.4	56.2	26.1	14.0	135.5	38.6	26.6	25.3	469.4	15.8	62.6	23.3	28.7	31.8	13.8	24.2	17.4	37.6	29.7	30.2	21.4	25.2	25.0	1260.7	20.4	23.9	13.5	47.7	27.2	28.4	29.0	71.9	24.4	60.6	112.4	12.9	10.5	91.2	49.8	9.5	47.9	33.7	27.6	26.7
WARS	"IFI53, IFP53"	ENSG00000140105	"Tryptophanyl-tRNA synthetase"	P23381	14	100333788-100376805	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Angiogenesis, Protein biosynthesis"	"Aminoacyl-tRNA synthetase, Ligase"	"Disease mutation, Neurodegeneration, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 142.8;thyroid gland: 157.0"	"Cell type enhanced"	"Detected in many"	4	"Early spermatids: 112.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"intermediate monocyte: 131.2;non-classical monocyte: 142.8"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HHSteC: 118.8;SK-MEL-30: 143.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA005573, HPA018944"	Enhanced		Enhanced	Cytosol		No	No		53000000	Cytosol		"HPA005573: AB_2667366, HPA018944: AB_2669986"	"unprognostic (5.36e-2)"	"unprognostic (5.98e-2)"	"unprognostic (3.99e-2)"	"unprognostic (1.54e-1)"	"unprognostic (2.30e-1)"	"unprognostic (9.25e-2)"	"prognostic unfavorable (7.88e-4)"	"unprognostic (5.14e-2)"	"unprognostic (4.26e-2)"	"prognostic favorable (1.94e-4)"	"unprognostic (4.84e-2)"	"unprognostic (3.21e-1)"	"unprognostic (3.53e-3)"	"unprognostic (1.37e-1)"	"unprognostic (9.45e-2)"	"unprognostic (1.62e-1)"	"unprognostic (5.92e-3)"	42.5	23.3	14.5	53.9	20.1	17.0	20.6	10.7	25.4	11.1	19.1	13.3	7.1	12.7	16.5	20.5	17.8	14.5	13.7	32.0	17.8	18.7	24.6	17.9	68.5	35.3	16.9	14.8	12.1	15.6	9.4	23.5	89.6	28.2	16.4	21.0	23.5	15.7	11.7	22.3	9.3	19.8	21.0	15.7	51.6	19.8	23.7	9.4	20.9	157.0	19.2	22.7	24.0	13.8	5.6	27.7	51.8	142.8	3.3	3.4	46.4	11.1	10.6	7.0	40.7	10.1	14.4	11.2	14.4	27.9	31.0	39.2	6.9	10.0	12.1	13.5	34.3	7.6	19.0	20.2	16.4	20.0	19.2	5.8	7.8	8.1	8.5	118.8	22.2	12.8	16.3	23.6	18.0	37.5	9.4	27.8	8.2	24.4	32.1	13.2	21.3	7.6	10.4	7.0	11.4	19.3	6.4	11.0	7.7	15.1	9.8	18.7	10.9	8.6	7.5	143.4	9.4	19.1	28.2	18.4	3.3	7.5	33.9	7.5	62.6	31.8	22.5	37.4	17.3	30.2	6.1	39.5	51.8	3.4	131.2	3.1	5.6	2.8	3.1	27.7	4.1	2.0	2.4	14.1	3.3	142.8	4.2	3.3	46.4	14.5	20.1	10.7	25.4	17.8	18.7	16.9	14.8	28.2	9.4	23.8	39.7	41.6	6.7	12.9	9.0	12.1	7.6	30.8	29.6	21.0	19.6	14.6	13.3	29.0	112.5	76.4	8.5	0.0	56.4	9.8	20.5	12.1	29.0	14.9	40.6	7.9	14.3	87.8	44.2	82.6	10.6	72.8	8.5	71.3	14.1	9.3	34.3	7.2	12.7	15.3	15.8	19.4	21.7	69.3	20.9	10.7	13.8	10.2	10.1	11.4
WARS2	TrpRS	ENSG00000116874	"Tryptophanyl tRNA synthetase 2, mitochondrial"	Q9UGM6	1	119031216-119140671	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Protein biosynthesis"	"Aminoacyl-tRNA synthetase, Ligase"	"Disease mutation, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Early spermatids: 52.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028007, HPA069692"	Enhanced		Supported	Mitochondria		NA	NA			Mitochondria		"HPA028007: , HPA069692: AB_2686172"	"unprognostic (1.00e-1)"	"unprognostic (2.25e-1)"	"unprognostic (2.03e-1)"	"unprognostic (5.64e-2)"	"unprognostic (3.42e-1)"	"unprognostic (7.05e-2)"	"unprognostic (7.73e-3)"	"unprognostic (3.72e-1)"	"unprognostic (2.14e-2)"	"unprognostic (1.17e-2)"	"unprognostic (3.96e-2)"	"unprognostic (6.76e-3)"	"prognostic favorable (1.45e-4)"	"unprognostic (4.83e-2)"	"unprognostic (1.83e-1)"	"unprognostic (9.88e-3)"	"unprognostic (4.71e-2)"	17.3	16.7	6.8	11.7	8.3	2.8	14.6	7.5	8.7	12.9	11.2	7.7	7.6	12.3	13.5	10.4	13.4	14.9	8.8	12.1	6.2	6.1	15.3	14.9	9.2	12.4	6.4	6.1	14.7	17.8	15.1	12.3	14.9	8.3	14.1	12.7	11.3	10.5	10.4	12.2	10.0	13.1	9.0	5.4	9.9	11.2	6.9	6.1	11.6	12.8	13.2	14.2	14.3	10.4	7.2	9.0	0.5	6.9	5.3	7.4	4.9	10.3	4.5	6.1	6.4	7.8	17.6	6.6	5.8	8.3	6.1	7.3	11.3	4.7	15.2	9.5	9.3	3.7	7.0	10.9	9.9	9.4	8.2	14.2	7.2	12.1	10.8	15.9	11.6	4.1	13.4	7.7	8.9	16.3	8.1	9.1	6.7	11.2	11.1	11.3	12.0	6.9	6.7	8.2	7.8	9.3	5.1	20.2	7.7	16.7	14.5	9.0	5.5	9.1	12.7	13.1	11.2	5.6	9.1	6.9	6.7	8.0	12.5	11.0	5.4	3.6	6.7	8.2	9.8	12.3	0.0	6.9	0.5	5.1	4.9	7.4	6.6	5.4	6.7	9.0	7.2	6.5	6.2	0.3	5.3	3.0	4.5	6.0	4.9	6.8	8.3	7.5	8.7	6.2	6.1	6.4	6.1	8.3	6.1	8.9	10.5	8.8	16.5	8.5	6.3	9.2	7.6	16.0	10.3	10.4	5.9	14.1	14.9	9.0	52.2	6.8	5.2	0.0	10.3	13.0	10.8	11.7	8.1	7.3	8.4	6.4	6.4	1.8	7.3	24.7	9.2	6.3	10.1	15.4	9.5	4.9	9.1	3.5	7.8	12.6	7.7	6.5	9.5	3.5	5.9	9.4	16.7	6.4	14.6	11.3
WDYHV1	"C8orf32, FLJ10204"	ENSG00000156795	"WDYHV motif containing 1"	Q96HA8	8	123416725-123467230	"Enzymes, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"SK-BR-3: 39.8"	"Low region specificity"	"Detected in all"							"HPA024823, HPA053680"	Approved		Supported	Nucleoplasm,Vesicles		NA	NA			Nucleoplasm	Vesicles	"HPA024823: AB_1845773, HPA053680: AB_2682228"	"unprognostic (9.97e-2)"	"unprognostic (4.82e-2)"	"unprognostic (3.48e-1)"	"prognostic unfavorable (4.93e-5)"	"unprognostic (1.69e-1)"	"unprognostic (5.00e-2)"	"prognostic unfavorable (3.47e-4)"	"unprognostic (1.93e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.90e-1)"	"unprognostic (1.19e-1)"	"unprognostic (5.79e-2)"	"unprognostic (2.81e-2)"	"unprognostic (1.26e-1)"	"unprognostic (5.39e-2)"	"unprognostic (7.46e-2)"	"unprognostic (2.37e-1)"	10.5	15.5	13.2	7.9	13.6	6.3	17.2	14.3	16.8	14.5	9.9	13.9	10.7	5.8	11.2	12.0	10.2	9.8	8.8	24.8	12.8	19.8	13.6	9.1	8.6	11.4	17.0	10.8	20.4	21.3	9.0	12.8	8.2	16.2	13.5	9.5	9.7	8.3	12.5	19.2	9.8	5.4	13.0	17.0	7.9	10.0	17.5	15.6	5.3	14.4	9.1	11.3	10.1	9.1	5.9	7.2	8.7	7.5	13.1	9.2	5.5	9.1	10.8	12.7	6.7	5.5	12.6	5.7	7.6	6.7	7.2	9.2	6.4	6.1	7.3	6.9	5.3	10.2	5.3	8.1	8.8	9.7	17.2	7.1	7.9	5.2	8.7	7.7	3.0	3.4	8.5	5.4	9.6	11.8	9.3	7.2	13.8	5.9	10.1	10.6	28.5	8.8	6.2	5.1	21.2	7.4	5.1	8.0	5.8	9.6	8.1	6.5	14.1	7.8	39.8	12.1	14.3	6.6	3.3	3.9	9.6	15.1	7.1	9.2	7.6	15.4	9.0	7.8	4.6	6.0	8.7	6.3	2.5	7.8	7.5	8.4	5.2	8.4	7.3	7.2	5.9	6.5	7.4	1.8	13.1	4.0	4.6	9.2	5.5	13.2	13.6	14.3	16.8	12.8	19.8	17.0	10.8	16.2	15.6	3.0	6.7	12.0	8.7	6.6	5.4	16.2	7.6	1.4	5.7	14.0	2.0	10.4	33.2	10.5	7.6	8.2	3.3	0.0	13.2	18.4	7.7	13.3	8.1	4.2	12.0	4.8	0.0	10.4	9.5	11.5	8.1	7.2	10.1	9.0	6.2	6.0	10.4	9.1	11.0	11.2	7.2	12.9	11.3	20.6	28.7	7.9	8.4	4.3	8.8	8.7
WEE1	WEE1A	ENSG00000166483	"WEE1 G2 checkpoint kinase"	P30291	11	9573681-9593457	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"	"Kinase, Transferase, Tyrosine-protein kinase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Basal glandular cells: 165.0;Suprabasal keratinocytes: 167.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"CAB004619, HPA068845"	Approved		Approved	Nucleoli		No	No			Nucleoli		"CAB004619: AB_628447, HPA068845: AB_2686048"	"unprognostic (6.04e-2)"	"unprognostic (1.90e-3)"	"unprognostic (1.09e-2)"	"unprognostic (9.29e-2)"	"unprognostic (1.26e-1)"	"unprognostic (1.39e-2)"	"unprognostic (3.79e-3)"	"unprognostic (2.48e-2)"	"unprognostic (1.22e-1)"	"unprognostic (1.79e-2)"	"unprognostic (3.21e-3)"	"unprognostic (3.73e-1)"	"prognostic unfavorable (5.19e-4)"	"unprognostic (1.07e-1)"	"unprognostic (3.06e-1)"	"unprognostic (2.08e-1)"	"unprognostic (3.80e-1)"	6.9	3.5	2.0	26.1	2.1	6.6	27.4	5.3	1.6	12.8	18.0	2.5	15.4	3.7	21.9	14.3	22.1	12.4	20.2	23.0	2.0	2.2	6.8	19.3	10.2	10.9	1.8	1.2	11.1	4.4	4.9	6.1	42.7	4.7	17.0	4.7	5.9	12.8	17.8	12.0	33.3	10.4	22.9	2.4	8.0	12.5	28.3	2.0	35.9	12.0	26.8	26.4	19.8	14.7	8.5	0.1	6.4	0.0	2.1	7.8	0.6	14.4	5.6	21.5	11.9	18.9	9.5	42.6	17.9	13.8	10.0	10.0	10.2	17.8	33.9	6.7	7.8	9.4	17.5	14.7	6.9	12.8	12.1	12.0	13.3	9.0	6.8	2.0	20.1	13.3	3.1	7.5	4.7	16.6	10.4	6.2	13.2	21.6	23.6	17.4	3.4	20.5	10.9	32.4	10.0	6.4	19.8	16.9	7.3	7.9	30.5	8.1	10.6	12.1	14.3	8.7	26.8	9.0	9.6	7.1	18.1	12.6	7.3	14.2	5.5	16.5	44.8	7.7	11.1	12.6	0.0	0.0	6.4	2.0	0.0	0.2	8.5	2.0	3.3	0.1	3.6	0.1	1.6	0.1	2.1	0.0	0.1	7.8	0.6	2.0	2.1	5.3	1.6	2.0	2.2	1.8	1.2	4.7	2.0	47.6	26.9	13.5	165.0	156.6	1.8	53.3	66.2	49.5	56.9	40.1	0.0	78.4	11.6	22.0	18.2	13.0	34.2	23.3	11.8	154.6	38.6	75.9	6.9	86.3	14.7	1.6	58.5	9.2	1.6	29.5	10.9	8.4	16.9	2.8	32.0	9.3	20.6	25.7	10.3	6.7	4.4	6.5	22.1	42.6	52.9	167.1	114.8	13.1	37.4	55.3
WEE2	FLJ16107	ENSG00000214102	"WEE1 homolog 2"	P0C1S8	7	141708353-141731271	"Enzymes, Predicted intracellular proteins"	Meiosis	"Kinase, Transferase, Tyrosine-protein kinase"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"	21	"Distal tubular cells: 1.7;Proximal tubular cells: 1.7"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	5	"CACO-2: 8.2"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"HPA027418, HPA054280"	Uncertain		Enhanced	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA027418: AB_10603144, HPA054280: "	"unprognostic (6.35e-2)"	"unprognostic (1.47e-1)"	"unprognostic (1.89e-1)"	"unprognostic (3.18e-1)"	"unprognostic (2.33e-1)"	"unprognostic (4.00e-2)"	"unprognostic (2.90e-1)"	"unprognostic (1.97e-2)"	"unprognostic (3.23e-2)"	"unprognostic (3.02e-2)"	"unprognostic (2.61e-1)"	"unprognostic (1.76e-2)"	"unprognostic (1.73e-1)"	"unprognostic (3.25e-2)"	"unprognostic (2.66e-1)"	"unprognostic (6.07e-2)"	"unprognostic (2.88e-3)"	0.6	0.1	0.5	0.3	1.0	0.0	0.4	0.8	0.6	0.6	0.1			0.0	0.7	0.0	1.3	0.7	1.6	1.3	0.5	0.6	1.3	0.1	0.3	1.6	0.6		1.2	1.1	0.0	1.0	0.0		0.3	0.0		0.9	0.0	0.7	2.8	0.4	0.0	0.8	0.4	0.8	1.3			2.0		0.0	0.5	0.3	0.2	0.0	0.0	0.0	0.5	0.6	0.0	0.0	0.0	1.4	0.9	0.0	0.0	0.5	0.0	0.0	0.0	0.0	8.2	0.4	0.3	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.7	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.5	0.0	1.4	0.1	0.1	0.0	0.3	1.0	0.3	0.1	0.3	0.2	0.1	0.1	0.1	0.0	0.3	0.5	1.6	1.2	0.0	0.0	0.2	0.1	0.0	0.9	0.0	0.0	0.2	0.1	1.7	1.1	0.5	0.0	0.4	0.7	0.0	0.0	0.0	0.4	0.0	0.1	0.2	0.4	0.6	0.0	0.1	0.1	0.6	0.0	0.5	0.0	0.0	0.2	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
WNK1	"HSAN2, HSN2, PPP1R167, PRKWNK1"	ENSG00000060237	"WNK lysine deficient protein kinase 1"	Q9H4A3	12	752593-911452	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		"Kinase, Protein kinase inhibitor, Serine/threonine-protein kinase, Transferase"	"Neurodegeneration, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA046541, HPA059157"	Enhanced		Supported	Cytosol		NA	NA			Cytosol		"HPA046541: AB_2679690, HPA059157: AB_2683935"	"unprognostic (1.40e-1)"	"unprognostic (1.54e-2)"	"unprognostic (4.82e-2)"	"unprognostic (1.75e-1)"	"unprognostic (1.27e-1)"	"unprognostic (7.68e-2)"	"unprognostic (1.05e-3)"	"unprognostic (1.57e-1)"	"unprognostic (1.24e-1)"	"prognostic unfavorable (9.67e-4)"	"unprognostic (1.84e-1)"	"unprognostic (2.49e-1)"	"unprognostic (4.38e-1)"	"unprognostic (1.40e-1)"	"unprognostic (1.32e-1)"	"unprognostic (5.17e-2)"	"unprognostic (1.30e-2)"	30.0	12.4	49.3	19.1	47.5	28.9	45.4	22.5	36.7	21.2	12.6	42.6	10.6	8.5	15.9	19.4	45.5	16.9	16.5	38.5	53.7	36.4	45.6	18.0	33.0	34.3	62.3	27.1	18.5	11.3	29.1	12.7	20.3	41.4	17.1	14.3	12.0	15.4	20.3	43.4	31.3	10.3	22.3	82.8	16.9	15.7	23.8	38.8	23.9	16.7	17.4	24.5	18.9	26.5	3.7	2.6	10.9	7.1	2.1	5.2	1.9	14.1	26.8	35.4	3.3	25.6	24.6	13.5	14.1	17.0	15.3	14.3	15.0	16.1	20.0	5.0	30.2	18.6	10.7	23.9	16.3	21.6	34.5	14.3	44.5	35.6	13.0	18.8	24.0	19.4	19.0	24.8	25.3	45.4	17.0	20.7	18.8	20.3	48.2	23.1	13.0	43.2	4.0	28.9	12.0	6.4	20.6	39.3	5.3	22.0	30.6	10.3	12.1	32.9	21.4	9.5	49.5	23.5	24.7	22.8	19.0	22.0	26.6	20.7	7.4	12.2	30.2	18.1	12.7	15.4	0.9	2.7	2.6	3.8	4.0	5.2	3.0	4.3	3.6	2.6	3.7	2.3	4.1	10.9	2.1	7.1	1.7	4.9	1.9	49.3	47.5	22.5	36.7	53.7	36.4	62.3	27.1	41.4	38.8	95.3	107.5	34.5	38.1	100.2	81.8	197.8	58.6	61.6	53.4	85.5	141.4	27.8	72.9	26.9	18.6	99.1	21.1	210.2	21.1	25.9	54.1	46.4	50.8	62.5	49.6	79.4	56.4	45.4	101.9	17.5	57.2	66.8	35.4	48.7	24.6	57.2	32.3	29.8	52.3	16.5	92.4	12.9	41.9	139.7	38.1	118.8	23.8	69.2	21.9	46.1
WNK2	"KIAA1760, NY-CO-43, PRKWNK2, SDCCAG43"	ENSG00000165238	"WNK lysine deficient protein kinase 2"	Q9Y3S1	9	93184916-93320572	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 21.9;pancreas: 18.3;salivary gland: 19.5;skeletal muscle: 23.7"	"Cell type enhanced"	"Detected in many"	9	"Cone photoreceptor cells: 151.2;Rod photoreceptor cells: 101.2"	"Low cancer specificity"	"Detected in many"							"Cell type enriched"	"Detected in single"	5	"neutrophil: 1.9"	"Lineage enriched"	"Detected in single"	5	"granulocytes: 1.9"	"Cell line enhanced"	"Detected in many"		"Daudi: 11.5;Hep G2: 18.8;SCLC-21H: 23.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA015555, HPA016519, CAB017813"	Enhanced		Approved	Cytosol		NA	NA			Cytosol		"CAB017813: , HPA015555: AB_2669218, HPA016519: AB_2669380"	"unprognostic (5.02e-2)"	"unprognostic (1.32e-2)"	"unprognostic (2.61e-1)"	"unprognostic (1.95e-1)"	"unprognostic (2.28e-1)"	"unprognostic (1.01e-1)"	"unprognostic (2.04e-1)"	"unprognostic (1.79e-3)"	"unprognostic (1.94e-1)"	"unprognostic (2.81e-2)"	"unprognostic (1.31e-3)"	"unprognostic (2.23e-1)"	"unprognostic (4.48e-3)"	"unprognostic (6.51e-2)"	"unprognostic (1.44e-1)"	"unprognostic (4.38e-4)"	"unprognostic (1.62e-1)"	0.0	0.7	3.9	0.9	3.8	0.0	1.2	9.5	7.2	0.7	7.5			7.4	1.3	1.5	2.1	6.6	0.1	21.9	4.0	4.2	0.0	0.0	0.0	0.0	2.6		0.0	18.3	0.8	7.5	0.9		4.9	4.8		19.5	5.5	23.7	3.0	6.2	1.6	1.1	0.5	3.0	1.5			0.0		0.0	1.0	0.1	0.0	0.0	1.9	0.0	0.0	0.3	0.0	4.4	4.0	2.9	8.2	0.0	0.0	5.6	0.0	0.0	0.0	0.0	1.6	0.1	11.5	1.5	0.0	0.8	0.2	6.5	0.0	0.0	0.0	7.5	0.0	3.5	18.8	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	1.4	7.3	0.0	0.0	6.0	0.1	0.1	7.3	4.4	0.2	0.0	0.0	9.3	0.0	0.7	23.9	9.4	1.5	6.5	0.6	0.8	0.8	1.3	0.1	0.0	3.1	0.1	0.0	0.0	0.0	5.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.3	0.0											0.0	0.0	0.8	8.1	1.1	57.3	56.7	30.6	5.3	9.1	0.0	151.2	11.9	0.0	11.7	0.9	0.5	34.4	0.0	8.0	5.6	1.1	12.9	0.0	0.0	2.9	1.6	31.2	0.6	1.0	1.9	0.9	0.0	1.7	1.0	57.9	60.6	3.3	42.1	5.6	0.7	101.2	12.9	4.4	0.4	6.6	4.8	13.0	0.0	51.8	6.4
WNK3	PRKWNK3	ENSG00000196632	"WNK lysine deficient protein kinase 3"	Q9BYP7	X	54192823-54358642	"Enzymes, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"epididymis: 31.6;testis: 26.7"	"Cell type enhanced"	"Detected in many"	15	"Cardiomyocytes: 178.0;Spermatogonia: 48.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"naive CD4 T-cell: 1.9"	"Group enriched"	"Detected in many"	10	"B-cells: 1.1;T-cells: 1.9"	"Cell line enhanced"	"Detected in some"		"AF22: 5.9;AN3-CA: 4.5;HAP1: 6.8;NTERA-2: 11.9;SiHa: 5.8;SuSa: 5.3;U-2 OS: 5.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA077678	Approved		Approved	Vesicles		NA	NA			Vesicles		"HPA077678: AB_2686850"	"unprognostic (1.86e-1)"	"unprognostic (1.68e-3)"	"unprognostic (2.44e-1)"	"unprognostic (7.87e-5)"	"unprognostic (4.82e-3)"	"unprognostic (1.85e-3)"	"unprognostic (1.85e-2)"	"unprognostic (3.32e-2)"	"unprognostic (3.38e-1)"	"unprognostic (3.03e-2)"	"unprognostic (5.78e-4)"	"unprognostic (2.22e-1)"	"unprognostic (2.64e-2)"	"unprognostic (5.61e-2)"	"unprognostic (9.99e-2)"	"unprognostic (7.63e-2)"	"unprognostic (8.74e-2)"	0.9	5.0	3.9	0.9	4.3	0.8	1.7	3.0	3.6	1.5	0.7	1.7	13.9	1.0	1.3	31.6	1.1	1.8	1.1	1.5	3.9	3.4	2.8	8.7	0.9	1.0	2.3	3.0	5.7	0.9	2.2	14.0	1.2	3.9	2.2	0.7	1.3	1.2	4.8	0.7	0.9	0.7	1.5	3.3	1.0	1.2	26.7	3.5	0.0	1.7	0.0	0.8	1.3	1.9	1.1	0.0	0.1	0.0	0.1	1.9	0.1	0.0	0.0	5.9	4.5	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	2.5	0.0	6.8	0.1	0.2	0.0	1.2	0.0	0.0	0.1	0.2	0.0	0.2	0.4	0.0	0.2	0.0	1.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	11.9	0.0	0.0	2.8	0.8	0.0	1.2	0.2	1.9	1.8	5.8	0.0	0.7	5.3	0.5	0.0	0.3	0.0	5.2	0.0	1.2	0.0	4.0	0.0	1.6	0.0	2.6	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.6	0.0	0.0	1.1	1.9	0.4	0.1	0.1	0.0	0.0	0.0	0.1	3.9	4.3	3.0	3.6	3.9	3.4	2.3	3.0	3.9	3.5	0.0	2.9	0.8	4.6	3.3	24.5	178.0	2.5	0.0	5.7	7.0	13.7	0.2	5.0	1.4	4.2	3.1	0.0	0.0	0.0	0.3	3.1	4.8	5.8	41.5	0.1	33.4	0.0	17.8	0.6	14.6	14.7	0.5	0.0	0.0	0.0	20.7	0.3	0.0	41.1	3.1	40.9	6.5	3.3	30.2	48.2	1.0	0.1	0.0	0.0	1.1
WNK4	PRKWNK4	ENSG00000126562	"WNK lysine deficient protein kinase 4"	Q96J92	17	42780678-42796936	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 28.1;ovary: 14.6"	"Group enriched"	"Detected in some"	7	"Distal tubular cells: 135.9;Mucus-secreting cells: 39.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Cell type enhanced"	"Detected in single"		"memory CD4 T-cell: 1.0"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"fHDF/TERT166: 19.9;K-562: 22.2;TIME: 21.4;WM-115: 14.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA016500	Approved					NA	NA					"HPA016500: AB_10962984"	"unprognostic (6.34e-3)"	"unprognostic (1.35e-1)"	"unprognostic (2.15e-1)"	"unprognostic (5.58e-2)"	"unprognostic (1.78e-2)"	"unprognostic (1.96e-1)"	"unprognostic (2.48e-1)"	"unprognostic (1.69e-1)"	"unprognostic (5.84e-2)"	"unprognostic (3.94e-1)"	"unprognostic (2.08e-3)"	"unprognostic (4.33e-3)"	"unprognostic (7.70e-3)"	"unprognostic (1.62e-1)"	"unprognostic (6.11e-2)"	"unprognostic (1.43e-1)"	"unprognostic (7.99e-2)"	1.1	0.0	0.8	5.8	0.2	0.0	2.6	0.6	0.3	0.7	12.9	0.4	0.4	2.1	0.2	2.8	8.7	0.5	1.0	0.2	2.6	0.0	28.1	0.2	0.4	0.1	0.1	0.3	14.6	1.0	0.0	2.4	0.0	1.7	11.1	11.7	12.2	1.4	1.2	0.0	0.5	3.3	0.4	0.8	0.1	2.6	0.4	0.2	0.0	0.0	0.2	2.0	0.3	0.4	0.4	0.0	0.0	0.3	0.0	1.0	0.0	1.2	0.6	0.2	0.0	0.2	0.1	2.9	7.4	2.9	2.8	0.9	0.4	0.5	0.2	4.4	19.9	0.7	0.0	0.1	0.2	4.8	0.4	1.0	0.0	0.0	2.9	4.7	0.0	0.4	2.5	0.4	4.0	1.2	1.4	0.2	0.2	22.2	0.7	0.0	0.6	0.0	0.5	0.2	1.2	5.1	0.3	0.7	0.0	0.0	0.3	0.0	0.1	0.0	0.1	1.0	2.7	1.4	1.6	21.4	0.2	1.9	0.2	0.1	3.6	3.1	0.7	0.0	1.2	14.5	0.0	0.3	0.0	0.0	0.0	0.7	0.4	1.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.2	0.6	0.3	2.6	0.0	0.1	0.3	1.7	0.2	0.0	1.1	0.0	0.1	0.0	0.2	0.7	2.5	5.3	1.2	7.0	0.0	0.0	135.9	0.0	0.0	0.0	1.1	0.0	0.2	0.1	0.0	6.5	4.6	0.0	0.0	0.0	12.6	1.3	0.0	0.0	0.0	0.0	0.0	0.0	39.6	0.0	0.1	2.9	0.4	0.5	0.3	0.0	0.3	0.7	0.8	0.4	0.0	0.0	13.3	0.1
WRN	"RECQ3, RECQL2"	ENSG00000165392	"Werner syndrome RecQ like helicase"	Q14191	8	31033801-31173769	"Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"DNA damage, DNA repair"	"DNA-binding, Exonuclease, Helicase, Hydrolase, Multifunctional enzyme, Nuclease"	"Cancer-related genes, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA028661	Approved		Supported	"Nuclear speckles"		NA	NA			"Nuclear speckles"		"HPA028661: AB_10602255"	"unprognostic (8.73e-2)"	"unprognostic (9.33e-2)"	"unprognostic (1.51e-3)"	"unprognostic (3.85e-2)"	"unprognostic (1.41e-1)"	"unprognostic (1.85e-2)"	"unprognostic (2.21e-3)"	"unprognostic (1.25e-1)"	"unprognostic (1.07e-1)"	"unprognostic (1.16e-2)"	"unprognostic (1.27e-2)"	"unprognostic (6.63e-2)"	"unprognostic (1.53e-2)"	"unprognostic (6.51e-2)"	"unprognostic (2.49e-1)"	"unprognostic (1.00e-2)"	"unprognostic (2.66e-1)"	10.1	9.2	5.6	8.5	6.6	15.6	11.1	10.7	7.3	14.2	8.0	7.7	7.7	5.5	24.4	8.8	7.6	9.7	6.9	7.0	5.9	4.0	5.1	7.7	7.2	6.7	8.2	5.3	12.0	9.9	7.8	28.1	8.5	7.0	8.6	7.8	8.3	10.8	7.8	7.7	10.2	7.0	12.1	14.9	8.9	8.3	10.4	7.3	11.8	7.9	6.3	9.3	10.8	8.7	3.9	2.7	1.3	1.9	2.9	6.2	1.6	6.5	6.4	13.3	8.4	8.0	12.8	8.4	7.4	7.3	9.1	9.5	4.1	4.0	15.4	6.8	7.5	6.9	3.4	8.2	5.3	13.6	4.3	7.0	15.7	6.1	3.4	10.0	9.3	5.8	9.3	5.9	8.6	10.4	4.5	8.7	10.8	24.8	9.7	8.3	4.2	19.3	4.5	11.4	7.1	4.6	11.1	10.1	6.2	3.8	7.2	2.9	7.7	9.0	5.1	7.0	7.8	3.5	4.6	13.9	9.9	6.1	5.0	6.2	2.6	2.8	19.3	7.3	7.3	6.8	1.2	1.9	1.3	3.3	1.9	6.2	3.9	3.8	3.3	2.7	3.5	2.5	3.2	0.5	2.9	0.8	2.0	2.8	1.6	5.6	6.6	10.7	7.3	5.9	4.0	8.2	5.3	7.0	7.3	8.9	8.8	10.8	8.0	11.9	14.2	6.5	12.7	9.4	11.4	15.7	21.6	5.9	1.7	5.1	37.8	8.5	3.2	23.3	8.4	4.7	10.8	8.1	2.3	8.9	4.5	14.3	2.4	6.2	5.1	8.1	17.5	4.9	10.1	5.4	12.1	21.9	7.1	2.9	13.4	2.1	22.1	6.5	9.5	8.7	18.6	8.9	4.7	5.1	7.6	9.8
WRNIP1	"bA420G6.2, FLJ22526, WHIP"	ENSG00000124535	"Werner helicase interacting protein 1"	Q96S55	6	2765414-2786952	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"DNA damage, DNA repair, DNA replication, Immunity, Innate immunity"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA031752, HPA031753"	Enhanced		Approved	Nucleoplasm		No	No			Nucleoplasm		"HPA031752: AB_10603004, HPA031753: AB_2674028"	"unprognostic (5.52e-2)"	"unprognostic (5.95e-2)"	"unprognostic (6.83e-3)"	"unprognostic (8.35e-3)"	"unprognostic (7.66e-2)"	"unprognostic (7.10e-2)"	"unprognostic (5.63e-3)"	"unprognostic (3.40e-2)"	"unprognostic (1.39e-2)"	"unprognostic (1.73e-2)"	"unprognostic (1.81e-1)"	"unprognostic (6.29e-2)"	"unprognostic (2.28e-1)"	"unprognostic (2.37e-1)"	"unprognostic (2.61e-2)"	"unprognostic (1.85e-1)"	"unprognostic (2.29e-1)"	15.4	23.1	29.9	19.8	32.1	31.2	22.4	42.5	33.5	22.2	21.9	23.3	25.7	17.7	19.8	29.7	32.8	28.0	24.7	28.8	30.9	30.1	23.3	25.8	21.2	23.4	27.4	26.2	23.2	37.4	39.2	31.2	32.3	21.3	22.5	22.6	23.9	34.6	22.0	29.0	27.8	19.6	18.5	20.2	20.7	19.3	24.6	24.2	34.1	31.6	36.0	25.3	18.8	29.2	3.4	4.2	9.1	2.8	3.7	6.5	2.3	31.5	15.9	16.2	26.5	17.2	14.9	21.6	14.5	20.4	26.8	26.7	25.1	14.8	28.4	39.7	18.7	29.1	24.6	26.5	29.2	26.2	28.3	29.1	29.7	18.1	39.2	19.6	18.6	20.6	15.1	23.9	24.6	26.8	18.7	33.9	27.0	22.6	10.3	19.5	30.9	27.5	33.8	13.9	21.8	19.8	22.0	23.7	28.8	28.4	19.5	49.0	14.0	17.2	17.5	33.8	26.7	22.5	21.0	18.4	20.1	15.2	17.4	35.1	13.3	23.1	22.1	7.9	20.3	27.2	9.1	2.6	3.4	6.5	2.8	2.1	3.4	4.7	4.8	2.1	2.4	5.5	5.2	1.1	3.7	1.4	4.2	6.5	2.3	29.9	32.1	42.5	33.5	30.9	30.1	27.4	26.2	21.3	24.2	17.9	10.5	3.7	10.8	28.8	23.9	17.3	35.7	21.4	7.9	10.4	7.9	26.5	3.3	12.6	42.1	18.0	18.7	0.0	11.8	20.2	14.8	14.5	9.2	21.9	11.1	7.9	38.2	30.1	13.8	11.0	20.8	12.7	20.3	7.2	24.1	18.0	15.9	11.5	20.8	11.3	16.5	6.5	11.8	21.4	24.7	28.1	21.3	4.5	23.0	13.2
WWP1	"AIP5, DKFZP434D2111"	ENSG00000123124	"WW domain containing E3 ubiquitin protein ligase 1"	Q9H0M0	8	86342738-86478420	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Host-virus interaction, Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA023180	Approved		Approved	"Golgi apparatus,Plasma membrane,Cytosol"		NA	NA			Cytosol	"Golgi apparatus, Plasma membrane"	"HPA023180: AB_10602587"	"unprognostic (3.89e-1)"	"unprognostic (6.63e-2)"	"unprognostic (3.81e-2)"	"unprognostic (7.91e-2)"	"unprognostic (3.70e-1)"	"unprognostic (1.02e-1)"	"unprognostic (1.93e-1)"	"unprognostic (4.24e-2)"	"unprognostic (1.83e-1)"	"unprognostic (9.43e-3)"	"unprognostic (3.09e-3)"	"unprognostic (1.48e-1)"	"prognostic favorable (5.45e-5)"	"unprognostic (2.35e-1)"	"unprognostic (4.63e-1)"	"unprognostic (3.19e-3)"	"unprognostic (1.01e-1)"	15.4	9.1	9.7	15.6	14.1	5.2	20.9	8.5	9.5	11.5	16.9	7.5	21.1	8.7	11.9	19.3	11.7	7.2	22.0	40.7	8.7	8.5	16.9	37.2	10.2	15.9	10.0	7.8	10.1	11.3	40.7	7.3	15.6	12.7	17.8	11.3	8.9	11.8	9.4	58.0	13.8	13.0	18.4	9.9	19.1	11.4	10.4	9.5	11.1	11.2	18.0	12.5	14.5	12.3	3.7	2.6	6.5	2.8	2.9	10.4	2.3	22.6	10.6	7.4	5.2	9.3	9.2	6.8	8.3	8.8	6.6	7.9	7.5	14.0	9.7	5.6	14.1	9.2	19.5	10.3	13.3	11.4	12.1	8.3	11.2	9.4	17.5	6.8	4.4	5.8	8.3	16.9	7.2	13.4	10.2	29.1	11.5	5.9	11.5	11.1	11.3	10.6	3.4	4.5	31.7	12.0	7.0	8.9	8.6	14.8	17.3	2.2	5.2	8.2	41.6	8.8	16.8	12.4	4.2	33.4	9.9	11.7	10.4	4.2	13.6	8.3	10.0	12.2	0.8	7.5	6.5	2.8	4.8	7.2	2.4	6.0	3.7	8.7	7.1	1.9	3.6	10.4	6.3	1.7	2.9	2.8	2.6	8.0	2.3	9.7	14.1	8.5	9.5	8.7	8.5	10.0	7.8	12.7	9.5	23.8	19.9	7.5	24.5	31.8	24.5	71.8	45.9	10.7	17.0	27.9	55.0	21.8	36.5	16.7	18.9	25.5	14.8	0.0	32.4	2.7	17.3	35.8	3.5	77.6	43.8	38.1	22.8	64.4	64.9	9.4	30.0	17.5	28.7	10.8	25.5	21.3	37.0	14.0	34.3	38.8	48.9	6.5	13.0	10.9	14.7	34.5	19.2	20.3	18.3	32.8
WWP2	AIP2	ENSG00000198373	"WW domain containing E3 ubiquitin protein ligase 2"	O00308	16	69762306-69941741	"Enzymes, Predicted intracellular proteins"	"Host-virus interaction, Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA						"unprognostic (1.63e-1)"	"unprognostic (3.72e-2)"	"unprognostic (1.93e-1)"	"unprognostic (1.09e-3)"	"unprognostic (2.86e-1)"	"unprognostic (1.73e-1)"	"unprognostic (1.14e-2)"	"unprognostic (5.22e-2)"	"unprognostic (1.14e-1)"	"unprognostic (7.50e-2)"	"unprognostic (2.08e-2)"	"unprognostic (9.81e-2)"	"prognostic favorable (5.87e-11)"	"unprognostic (4.26e-2)"	"unprognostic (4.10e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.62e-1)"	21.8	27.0	18.0	21.5	24.4	31.0	19.1	19.1	29.0	18.9	22.8	29.7	19.6	23.9	31.9	17.2	21.3	23.9	19.3	12.2	18.0	17.4	26.9	14.9	22.7	20.6	20.0	15.9	22.5	27.3	34.1	15.9	24.1	21.7	17.7	20.7	28.1	29.0	19.4	17.6	24.4	25.3	15.3	19.7	26.2	24.1	17.0	18.4	25.2	19.7	14.6	37.7	16.5	17.3	7.1	8.2	28.0	15.5	4.6	9.5	8.1	12.6	12.8	8.4	8.7	7.1	5.9	12.8	8.5	9.9	14.7	15.5	11.9	9.8	14.8	9.3	14.9	8.1	15.2	11.0	12.9	11.2	6.9	9.5	8.2	7.8	20.4	13.3	14.4	12.2	8.7	9.6	20.1	14.1	8.3	13.5	12.8	12.4	8.4	9.4	22.4	7.9	16.2	11.7	10.6	5.7	17.8	7.0	25.1	14.3	12.4	10.4	11.4	36.4	10.5	7.8	5.7	16.4	17.9	13.4	11.5	16.9	16.1	10.2	19.4	12.9	22.3	12.4	12.3	20.3	18.2	10.0	15.6	9.5	12.9	7.3	6.4	7.1	7.6	8.2	7.1	7.5	5.1	28.0	4.6	15.5	4.0	6.3	8.1	18.0	24.4	19.1	29.0	18.0	17.4	20.0	15.9	21.7	18.4	8.9	32.3	13.8	7.1	6.5	8.7	8.0	20.4	26.8	14.8	14.0	9.8	8.0	1.7	10.3	20.1	10.8	24.8	23.3	17.3	7.2	6.1	7.5	20.8	12.1	11.3	9.5	16.1	14.7	24.8	21.3	9.5	15.1	10.1	13.6	14.2	11.0	14.2	19.0	8.1	8.4	6.0	12.9	22.8	5.6	6.1	5.3	16.7	12.5	14.3	8.6
XDH	"XO, XOR"	ENSG00000158125	"Xanthine dehydrogenase"	P47989	2	31334321-31414715	"Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"		Oxidoreductase	"Disease mutation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 78.6;liver: 32.5"	"Group enriched"	"Detected in many"	5	"Enterocytes: 95.3;Hepatocytes: 35.8"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"BJ: 6.2;HBEC3-KT: 15.3;hTERT-HME1: 24.5;U-251 MG: 6.7"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"HPA062641, HPA069323"	Supported		Uncertain	Nucleoplasm,Nucleoli	"Intracellular and membrane"	No	No			Nucleoplasm	Nucleoli	"HPA062641: AB_2684816, HPA069323: AB_2686121"	"unprognostic (8.58e-2)"	"unprognostic (4.07e-2)"	"unprognostic (1.34e-2)"	"unprognostic (1.79e-1)"	"unprognostic (2.08e-2)"	"unprognostic (7.06e-2)"	"unprognostic (4.38e-3)"	"unprognostic (7.48e-3)"	"unprognostic (3.55e-1)"	"unprognostic (3.60e-2)"	"unprognostic (3.95e-3)"	"unprognostic (3.51e-2)"	"unprognostic (1.24e-6)"	"unprognostic (2.25e-1)"	"unprognostic (5.25e-2)"	"unprognostic (2.54e-1)"	"prognostic favorable (8.73e-6)"	0.2	0.2	0.2	2.4	0.2	0.0	17.8	0.2	0.2	2.6	17.9	0.1	0.0	20.1	0.3	6.3	9.3	0.2	1.8	0.2	0.1	0.2	0.4	32.5	0.2	0.0	0.2	0.0	0.2	0.4	0.0	1.5	3.7	0.1	1.2	4.2	0.1	20.9	0.0	0.7	1.0	78.6	0.1	0.2	0.2	1.3	0.2	0.0	0.2	0.3	2.4	6.1	1.8	1.1	0.7	0.3	1.0	0.6	0.7	0.5	0.0	1.5	0.3	0.0	0.0	0.0	0.1	0.1	6.2	3.6	0.7	1.1	0.2	1.7	0.0	1.2	0.2	0.6	3.2	0.0	15.3	0.8	0.7	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	1.4	0.9	24.5	0.3	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.1	0.3	0.9	0.1	0.0	1.1	3.3	4.5	3.9	0.0	0.0	0.0	0.2	0.0	1.3	0.0	0.0	0.0	3.0	1.9	0.1	6.7	2.0	0.1	0.0	0.2	0.0	0.0	0.5	0.6	0.2	0.2	0.2	0.4	0.1	0.3	0.3	0.0	0.7	0.2	0.5	1.0	0.7	0.2	0.3	0.2	0.0	0.2	0.2	0.2	0.2	0.1	0.2	0.2	0.0	0.1	0.0	0.0	3.7	0.0	2.6	0.5	0.3	0.3	2.5	0.0	2.3	0.0	0.0	0.1	0.0	2.4	0.2	0.0	95.3	0.0	7.2	0.5	0.0	0.5	0.0	35.8	0.0	0.0	11.3	1.8	1.6	0.0	0.0	0.0	0.0	0.0	5.2	0.1	8.8	7.0	0.0	0.0	0.5	0.0	0.2	0.0	0.1	0.1	0.3	0.0	12.8	14.2
XIAP	"API3, BIRC4, hILP"	ENSG00000101966	"X-linked inhibitor of apoptosis"	P98170	X	123859724-123913979	"Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"	"Apoptosis, Ubl conjugation pathway, Wnt signaling pathway"	"Protease inhibitor, Thiol protease inhibitor, Transferase"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"											"CAB009203, HPA042428"	Approved		Supported	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Nucleoplasm, Cytosol"	"Plasma membrane"	"CAB009203: AB_2257167, HPA042428: AB_2677993"	"prognostic unfavorable (9.21e-4)"	"unprognostic (8.43e-2)"	"unprognostic (1.50e-2)"	"unprognostic (2.14e-1)"	"unprognostic (1.40e-1)"	"unprognostic (9.41e-2)"	"unprognostic (1.95e-2)"	"unprognostic (8.51e-2)"	"unprognostic (9.17e-2)"	"unprognostic (3.90e-2)"	"unprognostic (7.50e-2)"	"unprognostic (4.41e-2)"	"unprognostic (3.15e-3)"	"unprognostic (8.21e-3)"	"unprognostic (2.26e-1)"	"unprognostic (4.99e-2)"	"unprognostic (4.65e-2)"	17.4	14.4	20.0	18.1	20.2	12.0	15.9	21.3	18.9	17.2	19.4	14.5	22.9	16.1	17.4	17.0	18.9	12.6	14.7	15.7	18.9	22.1	19.8	19.4	16.5	15.5	18.8	14.6	13.9	19.7	36.6	26.1	18.2	15.9	15.6	16.8	16.9	14.6	22.9	21.5	14.2	23.4	17.0	19.0	15.8	16.2	7.0	12.3	13.9	24.3	11.4	14.0	15.4	20.5	5.7	4.3	11.1	3.9	3.3	5.5	1.9	11.7	10.0	7.9	6.8	9.4	12.1	10.3	12.8	9.5	7.0	6.0	4.5	13.8	11.0	19.0	10.9	13.3	4.4	11.7	8.0	12.9	11.4	6.4	7.4	8.4	6.8	11.9	13.4	15.4	8.3	12.5	11.6	15.0	8.1	9.6	8.3	11.7	12.7	13.5	12.2	7.5	6.5	6.5	11.7	7.9	8.0	9.2	11.6	10.5	17.1	5.4	7.9	17.5	10.1	10.3	7.3	6.2	6.6	11.9	0.4	4.8	21.0	14.2	10.7	10.7	12.2	14.4	9.6	8.8	11.1	2.6	3.5	5.0	2.3	4.7	4.6	3.8	5.5	1.4	5.7	4.4	3.0	8.2	3.3	3.9	4.3	2.5	1.9	20.0	20.2	21.3	18.9	18.9	22.1	18.8	14.6	15.9	12.3	74.5	82.4	26.9	28.9	23.7	71.7	36.7	56.0	46.8	63.7	50.6	90.3	15.7	23.2	32.6	2.2	45.7	74.1	0.0	46.9	25.4	27.8	42.3	57.9	73.4	26.6	71.5	45.5	66.3	41.2	1.5	39.4	43.8	8.5	27.9	52.4	42.8	52.8	48.9	48.4	48.2	129.5	64.7	27.8	10.4	19.9	31.0	31.8	33.1	39.8	58.3
XPNPEP1	"XPNPEP, XPNPEPL, XPNPEPL1"	ENSG00000108039	"X-prolyl aminopeptidase 1"	Q9NQW7	10	109864766-109923553	"Enzymes, Predicted intracellular proteins"		"Aminopeptidase, Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB025196, HPA030419, HPA030420, HPA030422"	Supported		Enhanced	Cytosol		NA	NA		760000	Cytosol		"CAB025196: , HPA030419: AB_10598917, HPA030420: AB_10611523, HPA030422: AB_10601783"	"unprognostic (3.17e-2)"	"unprognostic (2.36e-2)"	"unprognostic (1.11e-1)"	"unprognostic (2.31e-2)"	"unprognostic (2.46e-1)"	"unprognostic (2.01e-3)"	"prognostic unfavorable (2.12e-5)"	"unprognostic (8.03e-2)"	"unprognostic (2.10e-2)"	"unprognostic (1.88e-1)"	"unprognostic (4.89e-2)"	"unprognostic (7.61e-2)"	"unprognostic (2.43e-2)"	"unprognostic (1.34e-2)"	"unprognostic (1.74e-1)"	"unprognostic (2.40e-1)"	"unprognostic (5.18e-2)"	16.6	14.7	13.4	16.1	18.9	12.8	13.6	14.8	22.2	15.7	20.6	19.5	14.1	33.2	17.5	16.1	17.8	15.8	20.3	17.8	13.7	11.4	18.3	21.0	14.8	14.9	13.8	14.0	17.8	46.0	14.9	15.9	19.0	17.2	16.0	26.9	15.6	19.6	11.3	18.5	20.4	38.6	18.6	11.9	18.0	16.8	15.1	12.0	9.9	15.7	15.2	24.2	14.1	13.8	5.5	24.0	10.0	21.0	14.7	10.6	13.4	25.5	11.2	18.0	24.5	29.4	27.6	13.8	14.2	29.1	21.4	23.2	21.8	22.0	36.5	12.3	21.9	10.9	13.6	14.2	17.6	21.0	10.8	13.7	24.3	7.3	9.0	20.5	18.9	20.3	27.2	10.9	23.5	20.9	32.9	35.1	23.7	7.9	11.7	27.1	8.6	13.5	11.8	7.0	19.4	12.2	15.1	36.3	6.5	27.2	8.0	5.5	20.9	12.4	7.9	23.8	20.5	9.6	17.7	18.0	8.7	11.4	13.8	12.5	19.9	9.7	31.2	20.6	26.5	6.9	10.0	13.7	5.6	10.6	21.0	7.3	5.5	7.0	9.5	24.0	4.8	5.0	6.6	1.1	14.7	17.5	18.8	7.5	13.4	13.4	18.9	14.8	22.2	13.7	11.4	13.8	14.0	17.2	12.0	6.0	15.6	11.9	11.4	7.9	19.1	15.7	20.4	12.0	10.3	3.5	5.9	33.7	14.9	29.4	4.5	12.1	36.7	0.0	63.7	24.7	19.7	19.6	10.5	9.6	27.2	25.4	16.1	16.5	16.1	4.1	17.0	17.4	8.5	39.7	34.2	24.9	47.2	35.3	28.0	18.8	18.4	12.9	8.8	8.4	37.1	7.5	21.1	20.8	34.1	19.3
XPNPEP2		ENSG00000122121	"X-prolyl aminopeptidase 2"	O43895	X	129738974-129769538	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		"Aminopeptidase, Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	9	"intestine: 145.6;kidney: 49.7"	"Cell type enhanced"	"Detected in some"	23	"Enterocytes: 21.3;Hepatocytes: 11.6;Proximal tubular cells: 49.7"	"Group enriched"	"Detected in many"	6	"colorectal cancer: 5.3;liver cancer: 18.3;stomach cancer: 3.9"	"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	4	"gdT-cell: 7.3;intermediate monocyte: 2.1;MAIT T-cell: 2.2;memory CD4 T-cell: 2.4;memory CD8 T-cell: 4.8;naive CD8 T-cell: 3.6;non-classical monocyte: 4.4;T-reg: 2.2"	"Group enriched"	"Detected in many"	7	"monocytes: 4.4;T-cells: 7.3"	"Cell line enhanced"	"Detected in some"		"ASC diff: 6.3;ASC TERT1: 33.4;HSkMC: 16.9"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"HPA000339, CAB025136, CAB025269, HPA064568"	Enhanced		Approved	"Plasma membrane,Cytosol"	"Intracellular and membrane"	NA	NA		8900000	"Plasma membrane, Cytosol"		"CAB025136: , CAB025269: , HPA000339: AB_1858894, HPA064568: "	"unprognostic (7.95e-2)"	"unprognostic (5.73e-2)"	"unprognostic (2.56e-1)"	"unprognostic (6.21e-3)"	"unprognostic (3.54e-2)"	"unprognostic (1.54e-1)"	"unprognostic (4.04e-1)"	"unprognostic (3.26e-1)"	"unprognostic (3.01e-1)"	"unprognostic (2.41e-2)"	"unprognostic (3.07e-1)"	"unprognostic (9.28e-3)"	"unprognostic (2.77e-2)"	"unprognostic (6.53e-2)"	"unprognostic (3.18e-2)"	"unprognostic (1.39e-2)"	"unprognostic (3.26e-3)"	4.7	0.5	0.0	1.1	0.1	0.0	3.2	0.0	0.1	1.7	57.4	0.1	0.8	37.0	1.2	1.7	4.2	3.4	1.3	2.6	0.0	0.0	49.7	8.0	1.0	1.2	0.0	0.0	3.5	0.9	0.0	0.0	0.6	0.1	3.6	2.0	0.7	0.7	0.3	1.6	2.1	145.6	2.5	0.1	0.2	1.7	1.2	0.0	0.1	0.9	1.4	0.3	4.0	10.7	0.4	0.8	0.2	4.4	0.0	7.3	1.3	0.0	0.0	0.5	0.0	6.3	33.4	0.4	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.8	0.0	0.0	16.9	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.4	0.0	0.6	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	7.3	2.1	2.2	0.0	2.4	4.8	0.3	0.4	0.7	3.6	0.2	0.0	4.4	0.8	2.2	1.3	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.5	0.0	1.6	0.0	0.4	0.0	0.0	0.0	1.8	0.0	0.1	5.0	0.0	0.0	0.0	21.3	0.0	0.0	0.0	4.4	0.0	0.0	11.6	0.7	0.0	1.2	0.6	0.3	0.0	0.0	0.0	1.7	0.0	0.9	0.0	0.0	5.8	0.0	49.7	0.0	0.0	0.2	0.0	0.0	0.9	1.0	0.0	0.2	0.0
XPNPEP3	"APP3, ICP55, NPHPL1"	ENSG00000196236	"X-prolyl aminopeptidase 3"	Q9NQH7	22	40857077-40932815	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		"Aminopeptidase, Hydrolase, Metalloprotease, Protease"	"Disease mutation, Nephronophthisis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"Early spermatids: 196.2;Late spermatids: 233.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"							HPA000527	Approved		Supported	Mitochondria,Cytosol		NA	NA			Mitochondria	Cytosol	"HPA000527: AB_1079266"	"prognostic unfavorable (8.19e-4)"	"unprognostic (6.77e-2)"	"unprognostic (3.22e-3)"	"unprognostic (5.03e-3)"	"unprognostic (6.18e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.65e-1)"	"unprognostic (1.13e-1)"	"unprognostic (1.64e-1)"	"unprognostic (2.53e-1)"	"unprognostic (1.73e-2)"	"unprognostic (1.51e-1)"	"unprognostic (6.69e-2)"	"unprognostic (8.00e-3)"	"unprognostic (2.49e-1)"	"prognostic unfavorable (6.10e-4)"	"unprognostic (1.24e-1)"	8.2	13.6	7.5	5.8	9.2	4.7	9.7	5.2	7.8	7.3	6.1	10.8	11.6	32.3	10.7	12.3	7.2	9.4	10.5	11.2	7.6	7.1	9.8	19.0	6.6	10.6	7.9	6.1	10.7	10.5	8.0	15.0	6.1	10.7	7.3	6.2	9.3	8.5	13.6	12.0	11.5	20.9	7.1	9.3	7.7	6.8	18.9	8.2	11.5	9.1	7.3	8.8	12.6	8.2	5.9	6.0	6.4	10.0	1.2	4.4	4.0	3.3	4.7	3.2	7.1	9.0	6.0	2.2	4.1	3.1	2.3	2.3	3.9	2.1	6.5	2.3	7.9	9.7	7.6	6.0	3.2	3.4	3.9	12.4	4.2	9.3	7.3	4.1	7.4	0.7	5.3	5.0	7.2	4.3	3.5	4.0	4.6	3.5	5.9	4.9	5.0	3.5	3.9	1.9	6.0	9.6	4.9	4.3	3.7	6.5	4.4	2.8	2.5	4.1	6.1	3.8	3.5	7.1	3.4	4.0	4.7	4.1	4.3	2.4	5.6	4.2	7.9	7.2	9.6	3.2	4.0	4.4	4.4	3.4	3.9	1.8	5.9	2.1	2.2	3.1	3.7	4.4	3.3	6.4	1.2	10.0	6.0	3.0	4.0	7.5	9.2	5.2	7.8	7.6	7.1	7.9	6.1	10.7	8.2	6.0	21.2	6.5	6.9	11.7	14.9	17.6	20.4	29.4	13.6	8.7	17.7	17.8	13.3	11.7	196.2	11.7	4.2	0.0	14.7	16.0	11.3	6.7	13.9	32.1	12.4	15.9	13.3	11.1	13.5	233.7	18.4	13.0	16.9	2.8	9.5	12.1	10.8	9.7	14.5	18.6	19.3	32.3	13.2	50.5	32.5	14.3	16.7	5.0	10.6	6.2
XXYLT1	"C3orf21, FLJ35155"	ENSG00000173950	"Xyloside xylosyltransferase 1"	Q8NBI6	3	195068279-195271167	"Enzymes, Predicted intracellular proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"plasmacytoid DC: 12.7"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA		34000				"unprognostic (1.39e-2)"	"unprognostic (2.31e-2)"	"unprognostic (3.42e-2)"	"unprognostic (2.32e-3)"	"unprognostic (9.57e-2)"	"unprognostic (2.34e-1)"	"unprognostic (6.29e-3)"	"unprognostic (5.67e-2)"	"unprognostic (5.50e-2)"	"unprognostic (6.57e-2)"	"unprognostic (3.13e-2)"	"unprognostic (4.13e-1)"	"prognostic unfavorable (1.70e-4)"	"unprognostic (1.07e-1)"	"unprognostic (2.23e-2)"	"unprognostic (8.20e-2)"	"unprognostic (1.07e-2)"	10.1	7.0	7.4	10.3	8.8	8.1	10.2	8.1	13.6	11.1	8.5	11.0	3.6	7.0	14.5	8.0	16.7	9.6	9.5	8.3	6.7	9.5	7.0	5.2	10.3	10.7	8.5	8.7	11.3	4.6	9.9	8.7	16.3	10.7	7.9	7.8	9.8	7.8	9.5	3.4	13.4	6.7	13.8	7.5	9.1	6.8	6.6	6.1	8.1	7.0	10.0	10.8	9.7	11.7	2.3	12.7	2.1	4.8	2.1	1.9	1.4	7.6	6.6	19.9	32.4	11.4	9.9	7.1	12.3	8.5	12.2	10.6	6.9	5.4	9.1	13.2	9.6	9.4	9.2	8.3	7.2	6.4	5.1	13.2	9.1	5.4	7.4	5.3	11.4	14.8	7.1	9.6	4.3	4.8	6.7	25.5	6.1	11.1	2.7	4.1	19.2	7.6	14.6	15.3	7.3	11.7	13.0	8.1	9.9	8.9	2.6	18.4	17.0	7.6	6.0	7.6	11.1	18.2	6.4	16.8	7.1	1.8	6.8	12.4	2.3	6.9	22.4	4.6	14.7	7.5	1.1	4.8	2.1	1.9	3.4	1.6	1.7	1.7	1.9	3.3	2.3	1.7	1.7	1.4	2.1	2.9	12.7	0.9	1.4	7.4	8.8	8.1	13.6	6.7	9.5	8.5	8.7	10.7	6.1	3.0	4.1	4.5	4.0	3.8	7.1	2.8	5.1	5.3	5.7	7.0	3.9	9.0	3.3	9.1	0.2	6.8	1.3	0.0	4.6	12.7	11.5	3.9	2.3	0.8	7.2	0.0	8.1	13.5	8.9	1.6	6.1	4.0	0.0	4.6	2.0	5.1	6.6	0.0	9.9	3.1	2.6	6.5	5.1	0.4	6.1	6.1	4.0	2.2	4.3	4.4
XYLB	"FLJ10343, FLJ12539"	ENSG00000093217	Xylulokinase	O75191	3	38346760-38421348	"Enzymes, Predicted intracellular proteins"	"Carbohydrate metabolism, Xylose metabolism"	"Kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 34.0"	"Group enriched"	"Detected in many"	5	"Hepatocytes: 42.9;Proximal tubular cells: 19.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"dendritic cells: 6.4;monocytes: 3.6;T-cells: 3.9"	"Cell line enhanced"	"Detected in many"		"Hep G2: 21.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA037863, HPA038415"	Uncertain		Approved	"Nuclear speckles"		NA	NA			"Nuclear speckles"		"HPA037863: AB_10672729, HPA038415: AB_10672592"	"unprognostic (2.48e-1)"	"unprognostic (9.72e-2)"	"unprognostic (3.42e-2)"	"unprognostic (6.25e-2)"	"unprognostic (7.52e-2)"	"unprognostic (5.19e-2)"	"unprognostic (5.82e-2)"	"unprognostic (1.26e-3)"	"unprognostic (6.55e-2)"	"unprognostic (2.22e-1)"	"unprognostic (6.91e-3)"	"unprognostic (4.63e-2)"	"prognostic favorable (8.57e-4)"	"unprognostic (3.26e-1)"	"unprognostic (2.06e-1)"	"unprognostic (5.78e-2)"	"unprognostic (3.37e-2)"	2.3	3.2	2.7	1.9	3.4	2.5	3.0	10.3	4.7	2.7	5.9	2.3	1.6	5.8	3.7	3.6	3.1	1.9	2.5	1.5	1.8	1.8	11.3	34.0	1.8	1.3	1.9	3.3	2.8	6.1	1.2	3.1	1.4	4.1	2.1	5.1	3.0	7.1	1.8	1.3	1.9	9.8	3.6	2.0	1.6	3.7	2.1	1.6	2.3	1.5	1.8	1.3	2.7	2.9	0.4	6.4	1.1	3.6	0.9	3.9	1.1	3.0	5.8	2.1	4.7	2.9	3.3	5.2	4.3	1.6	3.9	3.8	7.8	3.3	2.7	1.1	5.5	5.0	2.1	6.3	2.6	4.3	3.8	4.9	5.3	4.5	21.3	1.8	7.6	5.8	2.1	4.4	5.3	2.1	1.2	3.5	7.2	14.6	5.3	3.7	1.6	6.5	1.0	3.1	6.4	7.0	3.2	4.2	3.9	0.4	4.8	2.6	2.5	2.5	11.6	9.4	1.9	5.6	4.4	1.4	7.4	5.8	11.2	1.9	2.8	4.6	7.4	4.0	6.3	5.4	0.5	2.2	0.7	1.5	3.6	1.0	0.3	1.2	0.8	6.4	0.4	1.5	1.5	1.1	0.9	2.9	1.3	3.9	1.1	2.7	3.4	10.3	4.7	1.8	1.8	1.9	3.3	4.1	1.6	0.0	2.2	0.0	1.6	0.8	3.1	0.8	0.0	1.4	2.3	0.0	0.0	3.2	1.7	0.9	0.2	1.0	4.9	0.0	2.6	3.0	1.3	0.9	0.0	42.9	3.4	0.0	0.0	1.8	1.2	0.0	1.4	2.3	0.0	1.0	4.7	0.4	1.3	6.6	1.8	19.9	5.0	0.0	0.9	0.3	2.7	0.6	1.1	0.5	4.5	1.8
XYLT1	"PXYLT1, XT-I"	ENSG00000103489	"Xylosyltransferase 1"	Q86Y38	16	17101769-17470881	"Disease related genes, Enzymes, Potential drug targets, Predicted secreted proteins"		"Glycosyltransferase, Transferase"	"Disease mutation, Dwarfism"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 21.6"	"Group enriched"	"Detected in many"	4	"Cone photoreceptor cells: 92.3;Peritubular cells: 47.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"ASC diff: 19.2;ASC TERT1: 11.9;U-2197: 19.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA007478, HPA007966"	Approved		Approved	"Endoplasmic reticulum,Plasma membrane"	"Secreted to blood"	NA	NA		30000	"Plasma membrane"	"Endoplasmic reticulum"	"HPA007478: AB_1080616, HPA007966: AB_1080618"	"unprognostic (1.82e-1)"	"unprognostic (7.17e-2)"	"unprognostic (1.63e-1)"	"unprognostic (1.38e-2)"	"unprognostic (2.83e-1)"	"unprognostic (9.12e-2)"	"unprognostic (8.13e-2)"	"unprognostic (9.40e-2)"	"unprognostic (2.41e-3)"	"unprognostic (2.82e-2)"	"unprognostic (2.11e-1)"	"unprognostic (1.01e-1)"	"unprognostic (8.66e-3)"	"unprognostic (2.49e-1)"	"unprognostic (1.76e-1)"	"unprognostic (2.95e-1)"	"unprognostic (6.05e-2)"	5.7	5.9	6.3	21.6	3.1	5.9	7.0	3.8	6.7	8.0	7.4	1.4	0.9	3.9	7.4	3.0	4.9	3.2	4.4	3.8	6.3	4.2	1.9	0.9	2.9	7.5	4.3	2.2	5.5	2.6	0.2	1.8	5.4	2.6	4.4	4.9	3.4	2.6	4.3	1.3	4.1	4.7	5.1	3.9	6.3	3.2	3.0	2.1	4.6	2.7	6.7	6.6	4.7	4.2	1.2	0.8	1.2	3.6	0.9	0.7	0.5	0.0	0.1	2.7	0.0	19.2	11.9	3.3	8.5	4.3	1.0	0.4	0.2	0.2	2.1	0.0	10.3	0.3	0.2	0.0	1.7	1.5	4.1	0.2	2.6	0.0	0.0	0.2	3.7	3.5	4.4	0.2	5.5	0.8	1.6	0.0	0.2	0.3	8.0	1.0	0.3	0.0	4.0	2.9	1.4	0.0	1.2	0.0	0.4	0.0	3.9	0.7	5.2	0.6	2.6	0.5	2.1	0.7	2.3	0.0	9.0	1.0	19.7	0.0	9.0	0.5	3.9	10.0	4.2	7.6	0.6	0.6	1.2	0.6	2.5	0.7	1.2	0.5	0.3	0.8	1.2	0.5	0.4	0.3	0.9	3.6	0.2	0.7	0.5	6.3	3.1	3.8	5.3	6.3	4.2	4.3	2.2	2.6	2.1	3.0	4.5	7.5	1.5	7.0	13.3	2.7	0.0	0.0	1.2	0.0	92.3	9.8	0.0	1.2	0.4	2.2	5.1	0.0	1.4	16.8	16.2	3.4	2.3	0.0	3.3	0.0	12.1	2.5	8.5	0.4	11.8	8.0	3.3	2.8	3.8	1.3	2.6	7.0	47.0	0.2	4.1	6.5	5.7	0.2	2.5	16.2	11.0	4.4	6.5	4.2
XYLT2	"PXYLT2, XT-II"	ENSG00000015532	"Xylosyltransferase 2"	Q9H1B5	17	50346092-50363138	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins"		"Glycosyltransferase, Transferase"	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"stomach 1: 53.4"	"Group enriched"	"Detected in many"	7	"Early spermatids: 305.8;Late spermatids: 85.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"								"Secreted to blood"	NA	NA		990000				"unprognostic (1.52e-1)"	"unprognostic (2.84e-1)"	"unprognostic (1.65e-1)"	"unprognostic (8.07e-2)"	"unprognostic (1.90e-3)"	"unprognostic (1.90e-1)"	"unprognostic (7.29e-3)"	"unprognostic (2.52e-2)"	"unprognostic (1.92e-1)"	"unprognostic (2.30e-1)"	"unprognostic (1.54e-2)"	"unprognostic (2.81e-1)"	"unprognostic (7.63e-2)"	"unprognostic (5.15e-2)"	"unprognostic (7.38e-2)"	"unprognostic (1.52e-2)"	"unprognostic (2.68e-2)"	6.9	8.5	5.8	11.3	10.6	4.1	7.4	10.3	10.9	10.7	9.2	5.4	15.8	10.0	9.6	12.2	8.5	10.4	14.9	9.4	5.3	4.8	9.2	6.1	6.1	10.2	4.7	8.8	11.8	13.5	9.1	5.8	9.0	5.4	12.1	3.9	13.1	12.7	11.7	7.9	15.6	6.9	17.0	3.8	8.4	53.4	5.8	3.7	10.2	9.5	6.7	10.4	11.7	9.0	5.3	4.9	6.6	4.0	7.8	7.8	4.3	9.9	12.7	3.5	2.9	4.9	4.8	9.1	9.3	8.6	8.4	9.5	13.5	7.5	5.2	23.7	8.3	7.4	7.7	1.1	13.1	1.7	25.7	9.1	11.7	3.9	5.8	6.7	3.6	6.3	6.5	8.1	6.7	3.1	8.4	7.1	4.6	2.0	4.3	5.5	13.0	6.7	5.0	3.1	6.6	9.0	3.4	10.2	4.3	4.7	5.2	1.9	4.4	6.2	5.9	9.8	4.1	28.2	3.5	8.4	19.2	9.8	10.4	8.3	23.9	10.9	1.8	20.3	5.9	5.2	6.6	4.0	3.2	5.9	2.8	6.3	2.9	5.9	7.8	4.9	5.3	6.0	5.3	4.7	7.8	2.5	3.4	5.2	4.3	5.8	10.6	10.3	10.9	5.3	4.8	4.7	8.8	5.4	3.7	8.9	6.7	4.2	4.0	5.0	8.2	6.4	15.3	0.0	2.3	1.8	27.5	6.0	0.0	6.2	305.8	7.4	4.2	0.0	5.5	4.7	9.1	1.4	1.1	7.2	3.4	6.4	10.4	8.6	4.1	85.8	11.5	3.8	6.8	1.8	9.9	5.7	5.8	0.0	16.3	2.1	5.6	25.8	7.2	1.4	4.5	2.8	1.3	3.1	11.8	0.6
YARS	"tyrRS, YRS, YTS"	ENSG00000134684	"Tyrosyl-tRNA synthetase"	P54577	1	32775237-32818153	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Protein biosynthesis"	"Aminoacyl-tRNA synthetase, Ligase, RNA-binding, tRNA-binding"	"Charcot-Marie-Tooth disease, Disease mutation, Neurodegeneration, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA017936, HPA018950, HPA018954"	Enhanced		Enhanced	Cytosol		No	No		230000	Cytosol		"HPA017936: AB_1858916, HPA018950: AB_1858919, HPA018954: AB_1858915"	"unprognostic (4.05e-2)"	"unprognostic (2.52e-1)"	"unprognostic (4.21e-1)"	"unprognostic (4.78e-2)"	"unprognostic (9.54e-2)"	"unprognostic (3.38e-3)"	"prognostic unfavorable (6.97e-11)"	"unprognostic (5.05e-2)"	"unprognostic (6.29e-2)"	"unprognostic (1.93e-1)"	"unprognostic (1.81e-3)"	"unprognostic (4.96e-2)"	"prognostic unfavorable (1.02e-11)"	"unprognostic (3.57e-3)"	"unprognostic (1.02e-1)"	"unprognostic (4.94e-2)"	"prognostic unfavorable (6.57e-4)"	16.6	36.3	22.8	22.8	40.6	17.4	13.9	26.6	43.1	14.6	17.5	16.3	22.4	17.1	14.2	15.5	24.1	14.4	11.2	15.5	24.9	28.3	14.1	29.6	21.3	23.2	24.9	27.4	21.2	54.8	19.3	13.9	17.5	26.7	12.7	21.9	11.2	23.5	25.7	27.3	16.5	14.9	22.7	22.7	14.6	25.9	20.9	26.0	15.2	30.0	16.8	29.6	17.0	28.0	9.9	17.8	20.9	13.4	36.5	24.3	17.1	28.8	15.1	15.9	38.3	19.8	22.8	17.0	29.8	24.7	24.5	31.3	17.9	19.9	52.5	11.8	30.9	20.0	17.0	48.4	35.1	38.8	22.1	19.2	48.1	22.9	16.8	65.2	37.9	29.1	22.6	43.7	38.7	98.6	17.7	24.8	42.5	52.9	55.6	21.0	14.9	42.5	20.8	29.0	29.5	20.9	37.2	15.2	44.1	17.6	14.5	30.7	18.9	16.2	19.1	55.0	19.0	19.1	41.3	20.1	14.9	26.6	30.2	24.6	44.9	47.9	49.1	37.3	52.9	40.9	20.9	12.7	6.6	24.3	13.4	23.9	9.9	14.5	22.3	17.8	8.1	10.8	16.5	3.0	36.5	12.4	10.2	15.6	17.1	22.8	40.6	26.6	43.1	24.9	28.3	24.9	27.4	26.7	26.0	20.8	45.6	14.5	22.1	22.2	19.3	14.9	5.1	34.8	34.2	8.7	25.5	36.7	3.3	30.4	14.4	19.0	12.8	0.0	71.3	38.8	20.0	22.9	12.8	23.3	35.7	30.2	16.7	7.4	22.2	12.4	11.8	21.1	13.5	35.1	12.7	10.8	50.1	3.5	10.6	9.8	19.8	12.9	24.5	26.7	19.4	21.3	31.5	33.0	17.5	30.1
YARS2	"CGI-04, FLJ13995, mt-TyrRS"	ENSG00000139131	"Tyrosyl-tRNA synthetase 2"	Q9Y2Z4	12	32727490-32755902	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Protein biosynthesis"	"Aminoacyl-tRNA synthetase, Ligase"	"Disease mutation, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038721, HPA057610, HPA074097"	Uncertain		Supported	"Nuclear bodies,Mitochondria"		NA	NA			Mitochondria	"Nuclear bodies"	"HPA038721: AB_10674837, HPA057610: AB_2683483, HPA074097: AB_2686660"	"unprognostic (1.55e-1)"	"unprognostic (1.41e-2)"	"unprognostic (2.30e-3)"	"unprognostic (1.02e-2)"	"unprognostic (2.12e-1)"	"unprognostic (5.99e-3)"	"prognostic unfavorable (3.19e-5)"	"unprognostic (1.41e-2)"	"unprognostic (4.98e-2)"	"unprognostic (1.40e-2)"	"unprognostic (1.15e-2)"	"unprognostic (8.39e-2)"	"unprognostic (7.45e-2)"	"unprognostic (1.99e-1)"	"unprognostic (4.71e-1)"	"unprognostic (4.07e-1)"	"unprognostic (2.09e-1)"	12.6	15.8	11.0	12.6	15.3	13.9	13.8	11.6	14.9	13.1	11.8	11.5	18.4	9.8	13.3	12.9	17.5	11.3	9.1	12.1	11.9	9.7	12.4	16.3	9.2	15.5	10.8	11.7	13.3	21.0	11.0	16.6	15.9	13.5	12.9	13.7	11.3	17.4	10.0	15.9	12.0	10.8	11.1	12.6	13.3	12.3	12.5	12.6	17.5	12.3	16.0	16.4	13.3	11.8	11.8	9.5	9.4	9.9	12.9	12.7	5.2	9.4	11.4	6.7	7.9	7.3	8.6	21.0	7.2	7.4	9.0	8.8	28.5	12.1	17.1	11.9	7.3	13.0	12.3	13.2	19.1	10.2	7.4	20.7	11.3	8.6	15.8	10.6	12.0	6.6	8.0	12.2	8.5	15.5	11.6	14.2	9.1	15.9	7.9	9.4	7.7	8.9	14.5	36.6	6.3	14.0	10.1	14.2	10.1	11.4	13.6	10.3	5.0	11.1	9.7	7.1	27.1	18.1	10.9	9.5	8.5	9.0	13.8	12.2	4.7	5.0	17.8	7.9	9.0	7.0	9.4	7.0	4.1	10.1	8.9	10.6	8.8	10.7	10.4	9.5	11.8	11.2	12.7	1.4	12.9	9.9	9.3	9.3	5.2	11.0	15.3	11.6	14.9	11.9	9.7	10.8	11.7	13.5	12.6	6.0	4.1	13.7	17.3	9.0	16.5	6.9	2.5	5.3	7.9	10.4	19.6	29.4	6.6	17.0	4.4	5.7	5.2	23.3	14.2	29.0	10.7	7.9	6.9	4.5	17.9	14.3	6.9	5.5	7.0	2.8	9.8	5.5	5.0	19.0	6.6	11.6	12.2	10.4	8.1	9.3	18.8	12.9	6.2	4.9	14.7	7.3	15.0	12.1	11.5	11.4
YES1	"c-yes, HsT441, Yes"	ENSG00000176105	"YES proto-oncogene 1, Src family tyrosine kinase"	P07947	18	721588-812546	"Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"		"Kinase, Transferase, Tyrosine-protein kinase"	"FDA approved drug targets, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	6	"basophil: 14.7"	"Lineage enriched"	"Detected in many"	6	"granulocytes: 14.7"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004370, HPA026480"	Approved		Supported	"Plasma membrane,Cytosol"		NA	NA		4300000	"Plasma membrane, Cytosol"		"CAB004370: AB_627370, HPA026480: AB_1858921"	"unprognostic (3.28e-1)"	"unprognostic (1.62e-2)"	"unprognostic (5.87e-2)"	"unprognostic (2.47e-2)"	"unprognostic (6.24e-2)"	"unprognostic (4.24e-2)"	"unprognostic (6.01e-2)"	"unprognostic (1.03e-2)"	"unprognostic (1.95e-2)"	"unprognostic (1.85e-3)"	"prognostic unfavorable (2.46e-4)"	"unprognostic (2.14e-1)"	"unprognostic (8.12e-2)"	"unprognostic (4.65e-2)"	"unprognostic (1.81e-1)"	"unprognostic (4.79e-2)"	"unprognostic (4.11e-1)"	26.2	13.1	17.0	9.4	15.6	2.6	47.2	6.7	12.8	15.8	23.8	8.9	13.7	18.2	13.1	17.4	22.0	10.7	14.9	17.9	14.8	12.4	22.6	43.2	23.6	13.7	15.8	6.6	13.2	21.4	16.7	10.7	31.3	16.8	12.2	17.3	6.5	23.7	21.0	10.6	12.3	24.8	18.8	16.8	34.5	15.5	13.6	12.0	8.1	16.8	15.6	7.1	21.9	17.5	0.1	0.1	14.7	0.0	1.0	2.5	0.6	14.4	7.2	22.8	17.8	13.7	17.0	26.8	9.6	19.7	11.4	15.7	17.1	10.7	0.0	10.3	16.3	14.6	8.5	21.3	17.1	22.4	0.0	7.2	4.3	7.1	11.9	11.1	3.3	7.7	13.0	18.4	17.2	19.2	14.2	38.4	2.4	18.7	6.4	16.2	9.9	2.0	4.3	14.4	8.8	9.2	2.5	17.9	1.2	16.6	17.2	4.6	5.4	19.9	15.1	12.6	15.7	10.4	6.9	33.0	28.1	31.2	21.2	25.9	5.6	2.7	0.8	10.6	4.7	16.6	14.7	0.0	0.9	2.5	0.0	1.6	0.1	0.5	1.4	0.0	0.0	1.2	1.9	0.0	1.0	0.0	0.1	0.1	0.6	17.0	15.6	6.7	12.8	14.8	12.4	15.8	6.6	16.8	12.0	23.8	30.8	1.5	33.5	53.3	6.2	16.5	20.4	26.8	34.2	27.9	5.9	28.2	3.3	25.6	20.2	77.6	27.4	0.0	34.0	20.3	31.2	52.1	12.8	33.4	4.3	3.2	21.9	41.1	5.6	7.9	17.0	5.3	23.6	1.0	35.7	16.3	40.3	21.0	12.0	38.5	8.0	19.4	20.6	12.8	11.7	43.4	38.1	15.2	31.0	58.7
YME1L1		ENSG00000136758	"YME1 like 1 ATPase"	Q96TA2	10	27110112-27155266	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"		"Hydrolase, Metalloprotease, Protease"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA066953	Approved		Supported	"Nuclear bodies,Mitochondria"		NA	NA			Mitochondria	"Nuclear bodies"	"HPA066953: AB_2685753"	"unprognostic (2.28e-3)"	"unprognostic (3.00e-2)"	"unprognostic (1.34e-1)"	"unprognostic (7.19e-2)"	"unprognostic (8.12e-2)"	"unprognostic (2.47e-1)"	"prognostic unfavorable (8.25e-6)"	"unprognostic (7.08e-2)"	"unprognostic (2.91e-1)"	"unprognostic (9.24e-2)"	"unprognostic (9.43e-3)"	"unprognostic (1.64e-1)"	"unprognostic (1.21e-1)"	"unprognostic (1.03e-1)"	"unprognostic (5.53e-2)"	"unprognostic (1.44e-2)"	"unprognostic (7.09e-2)"	27.8	37.3	22.7	25.0	26.2	41.4	39.2	27.8	27.5	27.6	24.3	15.7	29.8	22.3	29.9	35.9	34.5	25.3	24.4	34.1	23.4	21.5	26.8	45.4	26.9	38.7	19.3	25.5	32.5	33.8	27.8	28.6	33.4	22.0	25.9	26.3	23.3	28.1	31.3	79.0	26.8	25.3	34.6	20.2	26.5	24.7	24.7	20.9	41.7	30.9	32.0	28.9	36.4	28.9	55.6	79.2	73.9	53.0	45.5	56.0	45.9	40.9	30.8	36.8	18.2	36.2	38.9	30.1	40.5	23.7	41.5	47.7	41.5	50.4	43.6	26.9	44.6	29.8	39.6	44.2	35.7	45.9	39.6	26.5	41.5	27.4	29.1	39.7	28.3	34.1	31.9	42.3	36.2	36.7	36.7	43.4	39.9	48.1	44.5	45.8	27.7	52.3	16.4	29.2	34.2	14.4	45.3	59.1	40.4	33.9	19.5	28.4	36.4	40.4	31.4	40.5	31.8	30.1	35.5	42.5	25.2	35.2	42.2	36.2	22.4	32.8	55.8	35.8	52.6	19.2	53.0	53.0	55.2	55.3	44.8	56.0	51.4	53.8	51.2	42.6	55.6	49.7	51.9	73.9	45.5	47.3	79.2	52.6	45.9	22.7	26.2	27.8	27.5	23.4	21.5	19.3	25.5	22.0	20.9	62.5	66.8	93.1	70.6	62.3	52.1	93.2	25.5	80.3	70.5	27.9	78.5	53.8	13.3	45.6	37.7	61.8	166.4	0.0	41.6	60.0	62.5	67.3	107.5	64.8	64.5	47.7	48.2	55.3	92.4	21.3	53.5	112.2	54.0	43.3	68.3	59.1	53.7	84.2	40.7	38.2	67.9	71.1	75.6	83.7	30.3	56.8	79.3	84.7	70.3	58.6
YOD1	"DKFZp451J1719, DUBA8, OTUD2"	ENSG00000180667	"YOD1 deubiquitinase"	Q5VVQ6	1	207043849-207052980	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway, Unfolded protein response"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 44.7"	"Cell type enhanced"	"Detected in many"	6	"Late spermatids: 69.8;Urothelial cells: 62.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HEL: 40.3;K-562: 28.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028400, HPA028439"	Uncertain		Supported	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA		40000	"Nucleoplasm, Plasma membrane, Cytosol"		"HPA028400: AB_10599854, HPA028439: AB_10600994"	"unprognostic (3.69e-2)"	"unprognostic (8.72e-2)"	"unprognostic (1.17e-1)"	"unprognostic (2.39e-1)"	"unprognostic (2.03e-2)"	"unprognostic (3.28e-2)"	"unprognostic (9.87e-3)"	"unprognostic (9.38e-2)"	"unprognostic (2.31e-3)"	"unprognostic (8.96e-2)"	"unprognostic (1.47e-3)"	"unprognostic (1.03e-2)"	"unprognostic (6.07e-2)"	"unprognostic (6.86e-2)"	"unprognostic (2.83e-1)"	"unprognostic (1.79e-2)"	"unprognostic (3.62e-1)"	4.5	4.6	4.0	4.0	5.3	44.7	6.6	4.8	7.5	6.1	3.9	7.6	2.6	4.1	4.0	3.1	24.5	3.7	3.5	5.0	4.0	2.2	4.5	5.2	9.4	4.2	7.1	4.4	3.5	3.6	2.5	5.1	6.3	5.1	3.4	4.0	3.4	9.7	3.0	6.5	14.9	4.8	2.7	8.5	5.2	8.4	5.6	6.9	14.3	5.8	10.0	8.2	5.8	12.3	0.5	1.3	3.9	1.5	1.2	1.8	0.9	5.4	2.9	4.6	2.7	1.6	2.1	9.0	3.6	2.8	2.7	2.8	5.5	5.6	2.8	1.5	2.2	1.3	6.0	0.0	4.4	3.1	2.3	4.9	40.3	11.9	2.6	1.5	5.2	14.2	1.5	3.4	2.2	8.6	3.2	2.4	5.9	28.0	0.0	2.3	0.0	4.6	2.9	4.4	2.2	6.5	2.3	0.2	2.1	2.7	6.1	2.4	5.3	5.9	6.9	7.7	4.2	2.4	3.7	1.1	2.4	6.2	1.9	4.7	4.6	0.2	4.2	2.8	0.0	1.6	3.9	1.2	2.0	1.1	1.5	1.5	0.4	1.7	0.9	1.3	0.5	1.4	1.8	2.9	1.2	1.0	0.7	0.8	0.9	4.0	5.3	4.8	7.5	4.0	2.2	7.1	4.4	5.1	6.9	38.7	9.8	0.8	21.4	28.0	7.8	5.3	5.1	13.4	5.7	1.8	3.9	2.3	1.7	3.8	28.6	3.5	9.8	46.7	9.3	2.7	5.7	29.8	8.1	5.4	2.4	11.1	8.5	3.7	8.5	69.8	1.4	6.4	13.5	1.8	3.5	4.2	15.5	4.9	2.1	5.4	16.2	6.5	3.1	8.8	4.1	35.1	1.5	7.5	5.4	62.9
YTHDC2	"DKFZp564A186, FLJ10053, FLJ2194"	ENSG00000047188	"YTH domain containing 2"	Q9H6S0	5	113513683-113595285	"Enzymes, Predicted intracellular proteins"	"Differentiation, Meiosis, Oogenesis, Spermatogenesis"	"Helicase, Hydrolase, RNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Rod photoreceptor cells: 92.8;Spermatocytes: 97.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037364, HPA072678"	Approved		Approved	"Nucleoplasm,Nuclear bodies,Cytoplasmic bodies"		NA	NA			Nucleoplasm	"Nuclear bodies, Cytoplasmic bodies"	"HPA037364: AB_10672788, HPA072678: AB_2686548"	"unprognostic (2.09e-1)"	"unprognostic (2.10e-1)"	"prognostic favorable (1.82e-5)"	"unprognostic (4.33e-3)"	"unprognostic (1.45e-1)"	"unprognostic (6.48e-3)"	"unprognostic (1.96e-1)"	"unprognostic (7.82e-3)"	"unprognostic (3.55e-2)"	"unprognostic (8.56e-3)"	"unprognostic (4.61e-2)"	"unprognostic (2.03e-1)"	"unprognostic (4.15e-2)"	"unprognostic (3.05e-1)"	"unprognostic (9.96e-2)"	"unprognostic (1.08e-2)"	"unprognostic (2.56e-2)"	15.2	16.3	12.4	18.5	16.8	12.8	15.3	25.2	26.1	16.5	12.7	11.7	9.0	13.6	17.7	14.6	16.1	14.2	12.2	13.0	10.4	10.5	14.3	18.3	12.4	18.7	12.8	10.2	19.9	14.7	35.5	26.2	10.3	18.6	12.8	15.3	14.9	15.5	13.3	18.5	16.5	16.5	13.2	13.7	19.3	13.4	20.5	13.3	19.7	16.2	15.4	18.4	14.7	14.8	9.5	5.5	4.2	4.9	5.7	5.7	1.7	11.1	10.1	13.1	22.2	7.3	9.7	14.4	8.7	9.6	11.1	17.4	7.0	6.3	20.4	6.2	7.2	14.3	10.9	15.8	19.4	14.6	8.8	14.3	11.1	18.1	9.5	10.8	8.8	9.8	7.9	7.5	7.0	12.8	10.5	15.4	9.3	10.8	9.4	9.8	3.7	12.2	6.3	6.1	3.3	6.7	5.2	11.4	15.8	9.3	14.8	10.5	8.8	11.6	8.5	8.9	8.6	12.0	8.0	13.4	17.1	6.0	8.8	11.7	9.7	12.1	12.8	9.8	10.1	7.2	0.0	4.3	4.2	4.5	2.8	5.3	9.5	5.3	4.8	3.6	8.1	5.7	4.7	1.8	5.7	4.9	5.5	3.7	1.7	12.4	16.8	25.2	26.1	10.4	10.5	12.8	10.2	18.6	13.3	26.8	29.1	18.2	17.4	11.7	58.8	17.3	12.7	28.1	30.7	12.2	78.5	11.1	0.0	15.3	22.0	18.5	11.2	23.3	16.5	8.1	14.7	12.8	11.6	19.7	14.4	49.3	6.9	20.9	27.6	37.6	18.4	18.8	11.8	17.2	13.0	25.3	13.7	7.0	13.8	15.2	92.8	25.8	19.4	97.9	24.0	12.5	15.1	21.2	13.6	15.2
ZADH2	MGC45594	ENSG00000180011	"Zinc binding alcohol dehydrogenase domain containing 2"	Q8N4Q0	18	75195108-75209348	"Enzymes, Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021468, HPA053646"	Uncertain		Approved	"Nucleoplasm,Golgi apparatus,Vesicles"		NA	NA			Vesicles	"Nucleoplasm, Golgi apparatus"	"HPA021468: AB_1858932, HPA053646: AB_2682216"	"unprognostic (3.22e-2)"	"unprognostic (1.03e-2)"	"unprognostic (7.14e-2)"	"unprognostic (1.13e-1)"	"unprognostic (4.79e-1)"	"unprognostic (5.11e-3)"	"unprognostic (1.15e-1)"	"unprognostic (1.49e-1)"	"unprognostic (3.62e-3)"	"unprognostic (1.42e-1)"	"unprognostic (3.05e-2)"	"unprognostic (1.48e-1)"	"prognostic favorable (1.02e-6)"	"unprognostic (3.41e-1)"	"unprognostic (1.87e-1)"	"prognostic unfavorable (1.94e-4)"	"unprognostic (2.23e-1)"	14.1	12.1	15.6	12.5	22.5	12.7	28.1	19.1	24.1	15.5	18.9	10.8	13.6	13.7	12.8	19.0	18.1	13.5	15.7	24.4	17.4	11.3	18.0	23.4	13.3	12.7	12.9	18.4	19.6	19.5	22.4	20.5	26.2	19.3	13.8	21.4	13.5	16.3	14.1	34.5	15.8	24.0	16.9	12.1	15.0	15.5	7.1	11.2	11.2	20.7	15.5	14.5	17.4	15.5	2.7	3.3	12.1	5.2	2.5	4.8	2.3	9.4	6.3	6.7	13.8	10.5	13.6	7.4	17.2	20.0	6.8	8.5	3.8	13.5	6.6	2.8	17.0	8.0	12.9	8.3	14.5	4.8	41.3	12.2	14.9	13.9	7.5	7.5	25.1	15.2	15.0	14.6	5.4	12.5	12.6	13.9	15.8	8.0	24.5	12.9	11.1	6.3	12.4	1.7	9.2	14.4	13.5	10.8	21.9	13.2	16.1	12.5	10.3	9.5	9.8	10.9	5.0	9.8	12.5	12.3	13.4	10.2	4.2	5.4	4.0	17.4	4.5	8.8	21.8	10.7	1.9	5.0	12.1	4.8	4.2	3.8	2.7	4.1	4.5	3.3	2.5	2.3	3.5	2.7	2.5	5.2	2.5	4.4	2.3	15.6	22.5	19.1	24.1	17.4	11.3	12.9	18.4	19.3	11.2	32.8	14.1	10.4	16.0	8.7	56.1	45.6	17.8	5.3	10.3	26.2	5.9	8.2	16.6	10.1	0.4	23.3	27.4	0.0	18.6	5.9	16.9	16.0	6.9	20.7	14.3	23.8	22.5	19.6	18.6	1.1	33.9	14.8	11.8	14.4	25.7	20.9	12.7	21.0	59.4	14.6	39.1	19.4	9.8	0.3	6.3	9.7	5.6	10.0	27.0	18.3
ZAP70	"SRK, STD, ZAP-70"	ENSG00000115085	"Zeta chain of T cell receptor associated protein kinase 70"	P43403	2	97713560-97739862	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, RAS pathway related proteins"	"Adaptive immunity, Immunity"	"Kinase, Transferase, Tyrosine-protein kinase"	"Disease mutation, SCID"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"blood: 37.4;lymphoid tissue: 107.1"	"Cell type enriched"	"Detected in many"	4	"T-cells: 96.4"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	41	"gdT-cell: 37.4;MAIT T-cell: 25.4;memory CD4 T-cell: 19.6;memory CD8 T-cell: 29.2;naive CD4 T-cell: 14.3;naive CD8 T-cell: 21.9;NK-cell: 26.4;T-reg: 19.9"	"Group enriched"	"Detected in many"	53	"NK-cells: 26.4;T-cells: 37.4"	"Group enriched"	"Detected in some"	11	"JURKAT: 39.8;MOLT-4: 57.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"CAB002625, HPA003134"	Enhanced					NA	NA					"CAB002625: , HPA003134: AB_1080629"	"unprognostic (4.11e-3)"	"prognostic favorable (6.89e-5)"	"unprognostic (3.82e-3)"	"prognostic favorable (9.66e-8)"	"unprognostic (5.78e-2)"	"prognostic favorable (3.93e-6)"	"unprognostic (2.30e-3)"	"unprognostic (1.09e-3)"	"unprognostic (3.30e-1)"	"unprognostic (1.37e-2)"	"unprognostic (9.23e-3)"	"unprognostic (2.70e-1)"	"prognostic unfavorable (3.02e-8)"	"unprognostic (1.29e-1)"	"unprognostic (1.65e-1)"	"unprognostic (6.40e-2)"	"unprognostic (5.83e-3)"	2.2	0.5	0.3	18.1	0.6	11.2	1.5	0.7	0.6	1.2	3.7	0.7	0.3	2.9	1.2	1.1	1.7	1.5	2.8	0.9	0.4	0.8	2.2	2.3	5.8	28.1	0.8	0.6	0.9	1.3	0.0	0.7	0.9	0.6	2.1	0.6	1.0	5.5	1.0	0.7	1.0	12.3	0.7	0.7	24.8	3.2	1.4	0.6	107.1	2.5	1.1	20.8	3.0	1.7	0.4	0.2	0.5	0.2	26.4	37.4	14.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	39.8	0.0	0.2	0.0	0.0	57.4	0.1	0.0	0.0	0.0	2.2	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.4	0.0	0.0	0.0	0.0	0.0	0.1	37.4	0.1	25.4	0.0	19.6	29.2	0.0	0.4	14.3	21.9	0.5	26.4	0.2	0.2	19.9	14.3	0.3	0.6	0.7	0.6	0.4	0.8	0.8	0.6	0.6	0.6	8.9	22.3	1.4	0.0	1.3	0.0	3.6	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.8	0.0	0.0	0.0	0.0	0.0	1.4	0.1	2.3	0.6	1.7	0.0	0.0	3.1	0.8	0.7	0.0	1.1	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.4	1.4	1.7	1.3	0.0	96.4	0.0	0.1
ZCCHC11	"KIAA0191, PAPD3, TUT4"	ENSG00000134744	"Zinc finger CCHC-type containing 11"	Q5TAX3	1	52408282-52553487	"Enzymes, Predicted intracellular proteins"	"RNA-mediated gene silencing"	"Nucleotidyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Cone photoreceptor cells: 229.7;Horizontal cells: 198.6;Rod photoreceptor cells: 193.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027412, HPA027973"	Supported		Supported	Nucleoli,Cytosol		NA	NA			Cytosol	Nucleoli	"HPA027412: AB_1852281, HPA027973: AB_10603242"	"unprognostic (2.74e-2)"	"unprognostic (1.67e-2)"	"unprognostic (1.19e-2)"	"unprognostic (3.48e-2)"	"unprognostic (1.36e-2)"	"unprognostic (1.85e-3)"	"prognostic unfavorable (9.00e-4)"	"unprognostic (2.64e-1)"	"unprognostic (5.05e-2)"	"unprognostic (3.84e-1)"	"unprognostic (6.57e-3)"	"unprognostic (3.11e-2)"	"unprognostic (5.35e-3)"	"unprognostic (2.26e-1)"	"unprognostic (1.67e-1)"	"unprognostic (7.08e-2)"	"unprognostic (2.33e-1)"	13.8	19.1	18.4	25.6	19.0	20.5	18.7	50.9	21.3	22.4	13.3	11.8	16.1	7.7	22.1	22.0	11.5	16.8	14.0	13.5	17.8	16.5	14.2	17.7	13.3	27.4	15.4	14.6	28.3	17.6	34.4	56.0	18.8	16.3	16.1	10.5	12.1	12.6	20.6	44.6	28.1	17.1	20.3	26.6	20.9	12.3	24.9	21.1	31.9	23.9	14.6	25.1	18.3	17.0	23.2	26.0	26.7	4.3	10.3	15.0	2.2	10.3	9.8	24.2	16.3	9.5	12.2	16.8	9.2	13.5	13.4	15.6	10.1	5.4	22.1	10.9	12.8	21.8	8.6	18.1	9.8	17.2	18.0	16.5	23.3	12.7	21.0	15.8	25.2	13.3	14.4	21.7	14.4	17.9	17.1	9.3	15.5	18.9	11.1	11.2	0.1	25.1	18.0	17.5	5.3	12.5	22.3	24.6	17.3	14.5	8.6	13.0	12.9	14.2	6.1	13.8	28.7	8.4	13.2	7.8	10.5	14.2	9.6	11.2	24.3	31.9	31.8	6.9	13.8	7.6	26.7	4.3	13.8	11.8	1.7	8.8	19.1	12.4	9.5	2.1	23.2	15.0	9.9	16.2	10.3	1.4	26.0	9.3	2.2	18.4	19.0	50.9	21.3	17.8	16.5	15.4	14.6	16.3	21.1	56.6	47.0	71.8	47.7	40.9	133.4	0.0	45.9	66.9	56.9	0.0	229.7	39.6	0.0	0.0	48.0	31.6	5.9	0.0	0.0	15.9	34.0	45.0	55.6	29.2	14.9	198.6	35.3	38.1	14.9	22.9	59.2	16.4	16.9	0.0	15.8	50.0	0.0	12.2	57.3	0.0	193.4	19.4	28.8	108.0	77.6	44.5	30.9	55.4	16.1	36.0
ZCCHC6	"FLJ13409, KIAA1711, PAPD6, TUT7"	ENSG00000083223	"Zinc finger CCHC-type containing 6"	Q5VYS8	9	86287733-86354454	"Enzymes, Predicted intracellular proteins"		"Nucleotidyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"neutrophil: 42.1"	"Group enriched"	"Detected in all"	5	"granulocytes: 42.1;monocytes: 15.7"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA020615, HPA020620"	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			Cytosol	Nucleoplasm	"HPA020615: AB_1858983, HPA020620: AB_1858984"	"unprognostic (1.10e-1)"	"unprognostic (1.36e-1)"	"unprognostic (1.64e-1)"	"unprognostic (1.26e-2)"	"unprognostic (3.66e-1)"	"unprognostic (1.39e-1)"	"unprognostic (4.11e-2)"	"unprognostic (2.49e-2)"	"unprognostic (4.43e-2)"	"unprognostic (6.51e-2)"	"unprognostic (1.91e-2)"	"unprognostic (3.07e-1)"	"unprognostic (5.79e-3)"	"unprognostic (1.59e-2)"	"unprognostic (1.13e-1)"	"unprognostic (4.14e-2)"	"unprognostic (1.40e-1)"	11.2	9.3	7.7	22.6	11.2	17.0	17.3	9.7	13.7	10.8	13.5	5.6	12.8	9.4	8.6	8.1	23.1	8.3	10.3	10.1	9.4	5.2	7.4	33.1	16.3	19.5	9.8	5.1	9.0	12.9	9.2	18.6	33.3	9.0	19.3	10.8	4.5	14.0	13.6	12.5	30.9	15.6	9.7	13.6	22.2	11.7	10.3	10.7	23.3	8.7	15.2	16.9	13.7	14.3	4.4	4.3	42.1	15.7	4.5	5.7	2.9	9.9	10.8	6.4	9.3	16.5	25.1	7.9	13.6	13.3	6.0	7.0	4.9	8.9	14.2	12.4	9.0	6.2	17.6	7.6	7.7	9.0	16.6	4.1	10.2	11.5	9.1	14.0	11.6	14.9	16.6	16.1	9.6	11.4	9.5	10.1	7.9	9.6	15.4	16.8	10.7	9.7	7.0	5.2	17.2	7.3	4.9	11.2	6.5	10.7	19.6	4.7	3.7	8.3	11.0	4.7	8.2	4.1	5.3	15.5	5.8	7.0	10.2	9.3	17.8	13.9	10.6	13.8	7.0	7.6	11.5	7.1	7.1	5.7	9.1	4.9	4.4	3.2	4.1	4.3	4.4	3.7	4.0	42.1	4.5	15.7	2.0	3.0	2.9	7.7	11.2	9.7	13.7	9.4	5.2	9.8	5.1	9.0	10.7	59.6	30.7	5.3	28.7	28.0	13.1	0.0	12.7	26.8	37.5	0.0	17.7	18.4	0.0	0.0	77.5	14.4	23.4	0.0	0.0	14.3	9.9	42.1	45.1	45.3	20.1	17.5	16.0	17.2	62.4	17.6	15.8	40.3	30.4	0.0	18.3	11.4	0.0	20.7	12.4	0.0	14.9	12.9	10.3	19.8	7.8	35.4	77.3	27.7	17.7	54.5
ZDHHC1	"C16orf1, HSU90653, ZNF377"	ENSG00000159714	"Zinc finger DHHC-type containing 1"	Q8WTX9	16	67394419-67416833	"Enzymes, Predicted membrane proteins"		"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	8	"Early spermatids: 24.6;Late spermatids: 44.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	10	"classical monocyte: 2.6;intermediate monocyte: 3.6;myeloid DC: 2.4;non-classical monocyte: 3.5"	"Group enriched"	"Detected in many"	10	"dendritic cells: 2.4;monocytes: 3.6"	"Cell line enhanced"	"Detected in many"		"ASC diff: 13.6;ASC TERT1: 15.1;U-138 MG: 13.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042531, HPA048659"	Uncertain		Approved	Cytosol		NA	NA			Cytosol		"HPA042531: AB_2678041, HPA048659: AB_2680483"	"unprognostic (8.96e-2)"	"unprognostic (1.43e-2)"	"unprognostic (1.05e-3)"	"prognostic favorable (1.25e-6)"	"unprognostic (1.68e-2)"	"unprognostic (9.33e-2)"	"unprognostic (6.03e-2)"	"unprognostic (1.82e-2)"	"unprognostic (1.93e-1)"	"unprognostic (2.67e-1)"	"prognostic favorable (5.99e-4)"	"unprognostic (2.17e-1)"	"prognostic favorable (1.55e-6)"	"unprognostic (2.10e-1)"	"unprognostic (1.59e-1)"	"unprognostic (1.46e-1)"	"unprognostic (5.63e-3)"	9.6	6.3	4.3	3.9	6.6	0.5	10.2	5.3	10.5	16.9	7.4	5.5	7.9	3.8	13.5	16.4	6.3	22.6	14.0	6.2	4.5	3.7	11.2	3.8	7.8	4.9	5.3	3.5	17.1	16.2	11.5	14.0	15.1	6.5	11.6	3.2	11.2	14.7	12.1	8.0	10.8	3.9	9.3	3.3	10.1	6.2	25.7	2.6	0.6	31.3	9.3	4.9	6.9	9.7	0.0	2.4	0.3	3.6	0.0	0.0	0.8	5.1	6.2	1.5	8.2	13.6	15.1	0.0	2.9	11.1	2.9	3.5	0.0	3.2	0.0	1.3	5.2	3.0	3.3	0.5	0.5	0.6	1.6	4.7	0.4	0.1	0.4	6.9	0.3	4.3	7.2	6.4	3.2	0.9	6.9	3.8	0.0	0.0	0.0	2.0	0.5	0.0	0.0	3.0	2.0	0.1	0.0	0.1	0.0	4.2	3.1	2.2	7.5	0.5	0.2	6.7	0.6	2.1	1.2	5.0	13.1	2.1	6.3	3.5	1.5	0.3	0.0	8.0	0.1	5.4	0.0	2.6	0.0	0.0	3.6	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.3	0.0	3.5	0.0	0.0	0.8	4.3	6.6	5.3	10.5	4.5	3.7	5.3	3.5	6.5	2.6	0.0	0.0	0.0	5.5	6.4	2.4	0.8	15.3	1.4	1.2	7.0	3.9	1.4	8.3	2.9	24.6	4.5	2.1	0.0	3.4	0.1	6.6	6.0	0.0	1.6	2.0	3.2	8.6	7.4	15.2	44.2	13.6	1.3	5.0	0.0	12.5	8.3	2.2	3.5	10.3	5.1	0.3	0.0	6.4	8.7	5.1	6.1	4.8	0.0	6.2	4.4
ZDHHC11	"FLJ13153, ZNF399"	ENSG00000188818	"Zinc finger DHHC-type containing 11"	Q9H8X9	5	795606-850986	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"		"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 15.2"	"Cell type enhanced"	"Detected in many"	13	"Alveolar cells type 1: 17.9;Ciliated cells: 42.8;Club cells: 23.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"T-47d: 11.5"									"HPA057886, HPA069008"	Uncertain		Approved	Mitochondria		NA	NA			Mitochondria		"HPA057886: AB_2683548, HPA069008: AB_2686068"	"unprognostic (2.67e-1)"	"unprognostic (9.76e-3)"	"unprognostic (4.47e-5)"	"unprognostic (5.43e-2)"	"unprognostic (7.46e-2)"	"unprognostic (4.68e-2)"	"unprognostic (3.71e-2)"	"unprognostic (1.49e-2)"	"unprognostic (1.01e-2)"	"unprognostic (2.32e-1)"	"unprognostic (2.28e-2)"	"unprognostic (2.65e-1)"	"unprognostic (5.23e-5)"	"unprognostic (4.80e-2)"	"unprognostic (3.98e-1)"	"unprognostic (1.86e-2)"	"unprognostic (3.51e-2)"	1.8	1.4	3.4	1.0	4.2	0.7	2.7	11.0	3.8	1.6	1.5	6.3	1.0	9.5	1.7	2.9	3.2	10.3	1.2	6.4	4.2	3.8	2.0	2.6	7.5	1.0	15.2	1.9	1.5	1.9	1.8	7.8	1.2	10.9	2.7	1.2	1.0	1.4	3.4	2.1	2.7	1.7	1.0	5.0	2.4	5.9	6.3	6.1	1.0	1.1	2.3	1.8	1.0	1.0	0.0	0.0	0.7	0.0	0.0	0.4	0.0	0.3	7.4	4.1	0.8	1.3	0.3	5.5	0.3	0.1	0.2	0.1	1.0	0.3	3.0	0.8	0.1	0.9	6.9	2.2	0.0	0.1	9.0	4.8	0.3	2.6	3.7	0.3	4.3	0.3	0.4	0.3	0.9	1.0	0.3	0.0	1.2	0.7	1.7	0.2	3.3	0.4	2.6	7.3	0.0	2.9	4.5	2.8	4.1	0.2	1.5	4.1	0.7	0.2	0.1	3.1	8.4	11.5	0.7	0.4	0.2	6.9	3.9	0.1	5.5	7.7	0.9	0.3	8.9	0.2	0.0	0.0	0.7	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.4	4.2	11.0	3.8	4.2	3.8	15.2	1.9	10.9	6.1	17.9	9.6	0.0	0.3	1.6	2.0	6.7	0.0	42.8	23.9	0.0	0.0	0.2	0.0	0.4	6.6	0.8	1.7	0.0	0.0	0.1	1.7	0.4	3.5	1.7	0.3	6.4	1.7	1.3	0.0	6.8	0.6	0.0	0.0	0.0	2.0	0.3	0.2	1.1	0.0	0.8	1.7	6.5	1.0	9.3	3.8	1.4	0.2	0.0	1.1	0.3
ZDHHC11B		ENSG00000206077	"Zinc finger DHHC-type containing 11B"	P0C7U3	5	710360-766952	"Enzymes, Predicted membrane proteins"		"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"No human protein/transcript evidence"	"No human protein/transcript evidence"		"Tissue enhanced"	"Detected in many"		"brain: 11.7"	"Cell type enhanced"	"Detected in many"	12	"Alveolar cells type 1: 17.9;Alveolar cells type 2: 16.5;Ciliated cells: 36.1"	"Low cancer specificity"	"Detected in many"							"Cell type enhanced"	"Detected in single"		"T-reg: 1.5"	"Lineage enriched"	"Detected in single"	15	"T-cells: 1.5"	"Cell line enhanced"	"Detected in some"		"HAP1: 5.1;RPMI-8226: 4.5;SCLC-21H: 6.6;THP-1: 7.2"									"HPA057886, HPA069008"	Uncertain		Approved	Mitochondria		NA	NA			Mitochondria		"HPA057886: AB_2683548, HPA069008: AB_2686068"	"unprognostic (2.81e-1)"	"unprognostic (8.38e-3)"	"unprognostic (3.79e-2)"	"unprognostic (5.11e-3)"	"unprognostic (7.18e-2)"	"unprognostic (4.02e-3)"	"unprognostic (1.19e-1)"	"prognostic favorable (3.98e-4)"	"unprognostic (4.39e-3)"	"unprognostic (1.29e-1)"	"unprognostic (1.45e-4)"	"unprognostic (6.94e-2)"	"unprognostic (1.43e-2)"	"unprognostic (9.21e-2)"	"unprognostic (1.73e-1)"	"unprognostic (5.13e-2)"	"unprognostic (2.31e-1)"	0.3	1.8	2.9	0.0	3.7	0.0	0.6	11.7	5.3	0.0	1.1			3.8	0.5	0.4	2.8	3.4	0.5	3.8	3.9	2.9	0.4	0.6	5.3	0.0	2.8		0.8	2.4	1.5	3.7	0.1		0.6	1.9		1.0	0.4	3.3	4.8	5.9	0.0	2.5	3.3	3.8	0.8			0.7		0.2	1.0	0.1	0.0	0.0	0.0	0.0	0.0	1.5	0.1	0.0	1.9	0.8	2.4	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.6	0.2	1.0	0.3	0.0	0.8	2.4	5.1	0.2	0.0	3.1	2.3	0.1	1.9	0.9	0.0	1.6	0.2	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.7	0.0	0.0	0.3	0.1	0.3	0.0	0.0	4.5	0.1	1.5	6.6	1.9	0.1	0.0	0.6	0.6	0.1	7.2	0.1	0.0	2.6	0.0	0.0	2.5	0.8	0.3	0.1	0.2	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.1											17.9	16.5	0.0	1.0	2.4	6.1	7.3	2.5	36.1	10.3	3.5	0.0	0.0	0.0	0.6	1.1	1.1	2.4	0.0	0.7	0.0	1.1	0.4	1.1	1.6	1.3	9.5	2.9	0.6	0.0	0.0	0.9	0.0	0.0	0.0	2.3	0.5	0.1	0.6	0.0	0.3	0.2	6.5	2.1	1.0	0.8	2.8	0.0	0.0	1.7	0.8
ZDHHC12	"FLJ14524, ZNF400"	ENSG00000160446	"Zinc finger DHHC-type containing 12"	Q96GR4	9	128720869-128724127	"Enzymes, Predicted membrane proteins"		"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 77.4"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"MCF7: 54.8"	"Low region specificity"	"Detected in all"							HPA059339	Uncertain		Approved	"Nucleoplasm,Intermediate filaments"		No	No			Nucleoplasm	"Intermediate filaments"	"HPA059339: AB_2683985"	"unprognostic (2.05e-1)"	"unprognostic (5.81e-2)"	"unprognostic (2.54e-1)"	"unprognostic (1.53e-3)"	"unprognostic (5.34e-3)"	"unprognostic (3.11e-2)"	"unprognostic (1.50e-3)"	"unprognostic (6.56e-3)"	"unprognostic (1.02e-1)"	"unprognostic (6.42e-2)"	"unprognostic (9.97e-2)"	"unprognostic (9.41e-2)"	"unprognostic (1.09e-2)"	"unprognostic (8.82e-3)"	"unprognostic (2.18e-1)"	"unprognostic (1.95e-2)"	"unprognostic (3.23e-1)"	7.3	10.9	3.9	15.3	4.5	21.8	11.2	2.5	6.5	7.5	21.2	6.8	19.3	16.2	5.9	8.3	27.2	6.9	21.5	9.2	3.5	3.1	20.6	23.6	14.2	28.0	3.8	3.8	5.0	40.5	4.3	5.0	24.7	4.8	11.1	8.4	7.7	26.3	13.3	7.5	16.8	33.0	5.4	5.8	14.9	18.7	9.2	2.7	23.6	10.3	16.4	24.4	10.1	11.7	22.2	50.6	77.4	28.7	17.4	26.1	18.8	14.2	39.0	1.6	8.4	5.1	3.5	16.4	9.2	8.2	10.1	6.8	31.9	16.5	9.9	8.6	6.9	17.6	37.7	3.5	18.2	1.0	18.2	9.4	5.2	29.7	14.0	10.4	8.7	24.2	5.6	12.6	8.2	3.1	4.8	7.4	18.8	5.2	25.3	1.9	54.8	11.9	17.5	7.2	31.7	32.3	5.4	5.9	28.5	7.7	13.4	11.6	8.4	12.5	17.3	4.9	2.7	26.7	9.3	7.4	0.0	10.5	7.1	12.3	16.4	28.9	4.4	16.8	10.1	11.1	39.2	26.5	77.4	23.5	24.7	20.3	20.3	21.8	22.5	21.0	22.2	22.7	20.6	56.8	17.4	28.7	50.6	26.1	18.8	3.9	4.5	2.5	6.5	3.5	3.1	3.8	3.8	4.8	2.7	14.9	8.1	54.1	42.0	14.3	0.9	9.6	79.0	4.0	11.4	43.6	0.0	147.4	11.6	94.7	58.6	14.7	157.1	70.0	176.4	191.0	11.1	49.6	18.4	48.9	121.4	0.0	49.2	28.3	52.9	22.4	8.9	39.8	40.5	159.7	93.7	14.5	109.4	171.9	6.7	32.7	1.7	6.5	9.5	23.1	17.5	24.6	112.1	48.4	94.2	52.6
ZDHHC13	"FLJ10852, FLJ10941, HIP14L"	ENSG00000177054	"Zinc finger DHHC-type containing 13"	Q8IUH4	11	19117099-19176422	"Enzymes, Predicted membrane proteins, Transporters"		"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Early spermatids: 73.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HUVEC TERT2: 54.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA016759, HPA018791"	Uncertain		Supported	"Golgi apparatus,Vesicles"		NA	NA			Vesicles	"Golgi apparatus"	"HPA016759: AB_1858993, HPA018791: AB_1858992"	"unprognostic (1.43e-2)"	"unprognostic (4.00e-3)"	"unprognostic (1.08e-1)"	"unprognostic (1.11e-3)"	"unprognostic (2.95e-2)"	"unprognostic (1.34e-2)"	"unprognostic (1.55e-2)"	"unprognostic (1.57e-1)"	"unprognostic (3.57e-3)"	"unprognostic (3.03e-2)"	"unprognostic (1.63e-1)"	"unprognostic (2.16e-1)"	"unprognostic (6.95e-3)"	"unprognostic (1.15e-1)"	"unprognostic (7.93e-2)"	"unprognostic (2.17e-1)"	"unprognostic (2.76e-2)"	4.7	5.2	6.3	9.3	8.0	6.8	7.3	13.2	9.7	8.8	13.2	5.8	7.1	8.7	6.4	5.6	36.4	10.5	6.9	7.7	6.2	7.1	10.8	2.3	4.7	6.9	5.4	5.2	5.8	14.0	10.9	20.1	9.4	9.4	7.1	14.7	6.4	11.2	5.9	2.1	14.9	12.3	4.9	4.7	6.3	14.4	11.2	4.8	15.0	7.7	18.2	27.5	15.3	14.5	6.3	4.3	23.4	5.8	4.3	7.5	3.5	15.9	7.6	7.3	6.2	2.6	3.0	7.0	7.7	7.1	8.6	10.0	4.6	3.8	8.2	5.3	6.4	19.4	24.4	10.4	5.0	9.5	10.1	9.1	4.3	4.8	3.7	6.0	5.8	7.4	3.4	6.0	3.6	5.1	8.1	54.4	11.5	4.1	4.1	8.8	5.2	7.4	4.7	6.0	15.1	7.0	8.2	10.1	1.9	8.9	10.6	12.7	9.3	9.2	11.2	4.1	7.3	5.3	6.7	15.6	7.7	5.4	11.7	6.1	3.5	10.8	7.5	9.2	6.0	13.4	7.4	3.5	23.4	6.8	5.8	6.1	6.3	5.3	7.5	4.3	4.2	5.1	6.5	4.4	4.3	4.6	4.2	6.8	3.5	6.3	8.0	13.2	9.7	6.2	7.1	5.4	5.2	9.4	4.8	8.9	12.5	4.9	19.3	21.5	10.4	32.9	10.2	33.5	21.6	15.7	9.8	7.5	5.0	17.2	73.0	9.3	13.5	0.0	17.0	15.7	10.6	33.7	11.5	0.8	5.5	15.9	15.0	9.2	5.9	36.4	7.2	7.4	3.3	29.7	21.1	61.2	17.7	14.0	2.1	2.2	8.5	0.0	5.6	38.7	22.6	31.7	5.3	8.7	18.7	44.2
ZDHHC14	"FLJ20984, NEW1CP"	ENSG00000175048	"Zinc finger DHHC-type containing 14"	Q8IZN3	6	157381133-157678146	"Enzymes, Predicted membrane proteins"		"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	5	"Horizontal cells: 116.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"plasmacytoid DC: 4.2"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 33.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA063754	Approved		Approved	Nucleoli,Mitochondria		NA	NA			Nucleoli	Mitochondria	"HPA063754: AB_2685113"	"unprognostic (1.66e-2)"	"unprognostic (1.27e-2)"	"unprognostic (1.58e-2)"	"unprognostic (3.98e-2)"	"unprognostic (1.59e-1)"	"unprognostic (6.78e-3)"	"unprognostic (1.84e-1)"	"unprognostic (6.02e-2)"	"unprognostic (2.87e-2)"	"unprognostic (1.63e-1)"	"prognostic favorable (6.93e-4)"	"unprognostic (3.94e-2)"	"unprognostic (5.01e-3)"	"unprognostic (1.89e-1)"	"unprognostic (7.95e-2)"	"unprognostic (4.43e-1)"	"unprognostic (2.63e-1)"	6.4	3.9	9.0	4.4	10.8	4.8	3.6	15.6	16.2	7.4	5.3	22.1	2.9	6.2	22.6	2.6	4.2	4.8	5.3	11.1	10.6	8.8	6.9	8.7	6.4	4.8	15.8	7.1	3.3	5.7	12.7	3.7	5.1	15.3	7.9	4.0	9.1	4.6	3.8	4.7	3.3	8.6	13.7	22.0	6.4	8.1	6.3	11.8	0.7	3.8	1.5	5.7	5.3	5.0	1.5	4.2	0.0	0.1	0.4	0.9	0.4	1.7	1.8	0.6	2.6	1.4	1.1	5.9	2.7	2.5	1.9	1.7	2.2	1.3	4.3	0.9	2.2	3.7	0.9	1.5	1.5	1.8	33.4	2.1	8.4	0.7	1.0	1.9	1.1	1.9	0.7	1.6	2.0	0.8	1.7	2.9	1.9	6.7	3.2	1.1	1.1	0.7	2.8	1.1	3.4	2.2	0.1	0.3	2.5	4.0	0.7	4.3	1.3	3.2	2.1	2.3	1.2	0.3	1.3	4.0	2.9	2.1	5.7	3.5	0.7	0.8	0.6	1.0	3.0	3.2	0.0	0.1	0.0	0.5	0.0	0.9	1.5	0.4	0.4	0.0	0.8	0.0	0.3	0.0	0.4	0.0	4.2	0.0	0.4	9.0	10.8	15.6	16.2	10.6	8.8	15.8	7.1	15.3	11.8	3.0	0.0	2.7	2.3	11.4	14.5	14.4	15.3	0.0	1.2	7.0	5.9	8.9	10.0	5.2	7.8	10.5	6.6	0.0	2.8	1.8	7.9	14.3	0.0	21.2	9.2	116.0	2.4	24.5	12.1	4.0	7.5	3.6	10.1	1.8	12.2	4.8	2.5	9.9	9.6	3.3	5.7	0.0	7.2	2.4	4.1	7.3	17.6	5.0	9.7	2.4
ZDHHC15	"DHHC15, FLJ31812, MRX91"	ENSG00000102383	"Zinc finger DHHC-type containing 15"	Q96MV8	X	75368427-75523502	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted membrane proteins"		"Acyltransferase, Transferase"	"Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	5	"Alveolar cells type 1: 6.0;Cardiomyocytes: 6.9;Sertoli cells: 6.5"	"Cancer enhanced"	"Detected in some"		"glioma: 2.9"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"HEL: 5.7;K-562: 3.6;LHCN-M2: 4.0;MOLT-4: 4.2;NTERA-2: 3.7;RH-30: 5.8;RPTEC TERT1: 3.2;SH-SY5Y: 4.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003618	Uncertain		Approved	"Nuclear speckles,Cytosol"		NA	NA			"Nuclear speckles"	Cytosol	"HPA003618: AB_2217686"	"unprognostic (8.28e-2)"	"unprognostic (1.73e-1)"	"unprognostic (8.05e-2)"	"unprognostic (1.62e-5)"	"unprognostic (1.64e-2)"	"unprognostic (1.00e-1)"	"unprognostic (4.00e-4)"	"unprognostic (1.96e-2)"	"unprognostic (3.19e-1)"	"unprognostic (8.70e-2)"	"unprognostic (3.77e-3)"	"unprognostic (1.40e-1)"	"unprognostic (4.78e-13)"	"unprognostic (2.60e-3)"	"unprognostic (1.17e-2)"	"unprognostic (1.09e-1)"	"unprognostic (9.67e-4)"	3.0	5.4	4.9	1.5	6.8	1.1	5.3	6.2	9.9	5.8	3.4	3.9	2.4	1.3	6.5	3.7	3.2	4.5	3.3	5.4	5.9	8.7	5.3	1.2	4.1	1.6	4.8	5.3	8.5	4.7	5.0	8.7	0.7	7.0	4.0	2.3	5.4	12.7	6.9	1.6	2.8	1.8	5.2	6.4	2.9	2.1	2.6	3.1	2.0	6.6	2.1	1.5	2.6	3.1	0.3	0.4	0.7	0.2	0.5	1.6	0.3	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	2.9	0.0	0.0	0.0	0.0	5.7	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	2.6	3.6	0.1	4.0	0.0	4.2	0.1	3.7	0.0	0.0	0.0	5.8	0.0	3.2	0.0	1.6	4.8	0.0	0.0	0.0	2.0	0.0	0.1	0.0	0.5	1.0	0.0	0.7	2.9	0.1	0.0	0.0	0.0	0.0	0.5	0.2	0.1	0.1	0.0	0.1	0.3	0.6	0.0	0.0	0.2	1.6	1.1	0.7	0.5	0.1	0.4	0.0	0.3	4.9	6.8	6.2	9.6	5.9	8.7	4.8	5.3	7.0	3.1	6.0	1.9	0.0	1.4	3.5	3.7	6.9	2.5	0.0	2.3	5.2	3.9	0.0	0.0	0.7	0.0	2.1	0.0	0.0	0.6	0.0	0.9	1.0	1.1	0.0	0.1	0.0	1.7	1.8	0.0	0.0	0.9	0.0	0.0	0.0	0.0	2.3	0.3	0.0	3.5	1.0	2.1	6.5	1.4	0.1	0.4	3.1	0.0	0.0	0.0	0.3
ZDHHC16	APH2	ENSG00000171307	"Zinc finger DHHC-type containing 16"	Q969W1	10	97446131-97457370	"Enzymes, Predicted membrane proteins"	"Apoptosis, DNA damage"	"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA039893, HPA040214"	Uncertain		Supported	"Nucleoplasm,Nuclear membrane,Cytosol"		NA	NA			Nucleoplasm	"Nuclear membrane, Cytosol"	"HPA039893: AB_10794757, HPA040214: AB_2676886"	"unprognostic (4.44e-2)"	"unprognostic (3.14e-2)"	"unprognostic (3.34e-1)"	"unprognostic (1.20e-2)"	"unprognostic (8.75e-2)"	"unprognostic (8.35e-3)"	"unprognostic (1.27e-2)"	"unprognostic (3.62e-2)"	"unprognostic (5.49e-2)"	"unprognostic (1.57e-1)"	"unprognostic (2.31e-1)"	"unprognostic (6.34e-2)"	"unprognostic (1.93e-3)"	"unprognostic (1.34e-1)"	"unprognostic (1.07e-1)"	"unprognostic (1.28e-2)"	"unprognostic (2.48e-1)"	12.0	13.7	15.9	10.8	17.3	6.4	17.9	17.6	24.6	17.1	17.9	15.6	18.1	15.1	15.5	21.2	17.6	11.5	14.4	18.1	13.2	11.0	23.3	37.4	20.8	11.1	10.9	13.0	15.1	22.5	21.8	15.4	30.7	10.5	16.0	18.9	18.1	28.5	14.1	20.7	14.0	15.7	17.6	8.5	13.2	19.4	16.4	10.8	14.7	19.6	15.4	16.1	15.1	20.0	9.3	14.2	9.4	10.4	13.0	12.0	5.8	21.7	25.5	17.0	21.0	27.3	18.7	17.8	23.9	31.9	27.6	26.5	19.8	19.5	19.2	27.6	34.9	24.2	25.6	21.4	33.8	24.7	19.0	24.8	12.2	17.9	18.8	21.9	14.4	17.9	20.9	22.4	32.3	23.3	30.0	28.3	17.8	9.7	14.6	35.0	20.7	21.8	19.8	13.9	19.8	22.2	15.0	17.3	17.6	23.4	10.1	8.3	11.8	14.6	15.1	12.9	17.7	19.9	14.2	17.3	17.4	16.2	11.2	27.9	14.0	22.6	11.8	20.1	22.5	9.1	0.3	9.8	9.4	7.0	10.4	8.0	8.2	12.0	11.1	14.2	9.3	9.9	9.8	0.5	13.0	10.4	10.9	9.4	5.8	15.9	17.3	17.6	24.6	13.2	11.0	10.9	13.0	10.5	10.8	17.9	17.2	14.5	15.7	4.6	15.1	9.7	15.3	6.7	27.3	12.2	3.9	35.3	21.6	31.3	20.3	9.2	12.9	0.0	28.4	55.1	10.0	16.3	6.9	15.8	21.8	12.7	6.9	8.0	7.3	5.7	8.1	7.5	3.3	24.4	16.7	10.4	30.7	10.5	3.5	17.8	10.6	6.5	4.9	16.1	12.7	3.8	31.7	7.5	17.9	14.1
ZDHHC17	"HIP14, HYPH, KIAA0946"	ENSG00000186908	"Zinc finger DHHC-type containing 17"	Q8IUH5	12	76763588-76853696	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins, Transporters"		"Acyltransferase, Transferase"	"Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"plasmacytoid DC: 16.3"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA016807, HPA058674"	Approved		Supported	"Golgi apparatus,Vesicles"		NA	NA			"Golgi apparatus, Vesicles"		"HPA016807: AB_1858999, HPA058674: AB_2732626"	"unprognostic (1.06e-1)"	"unprognostic (2.26e-2)"	"unprognostic (2.63e-2)"	"unprognostic (3.04e-1)"	"unprognostic (6.12e-2)"	"unprognostic (2.83e-2)"	"unprognostic (2.35e-3)"	"unprognostic (3.09e-1)"	"unprognostic (8.38e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.56e-3)"	"unprognostic (5.42e-2)"	"prognostic unfavorable (7.11e-5)"	"unprognostic (1.77e-2)"	"unprognostic (2.69e-1)"	"unprognostic (2.98e-1)"	"unprognostic (1.71e-2)"	7.9	7.8	10.0	5.8	14.0	11.3	8.8	18.1	18.1	8.0	5.9	9.2	3.8	3.6	12.0	6.8	6.4	7.0	5.5	6.4	8.7	6.5	9.1	13.1	5.4	7.1	11.3	10.7	11.5	5.2	9.5	10.3	8.7	13.2	7.9	5.4	5.9	5.7	7.3	5.4	5.9	6.4	8.0	10.0	7.1	6.1	6.4	11.6	7.5	6.2	4.1	5.7	5.6	6.3	3.8	16.3	5.8	2.2	1.7	3.6	1.4	5.2	6.4	20.1	10.2	12.1	12.8	9.8	10.6	8.8	7.1	6.2	5.0	3.8	7.3	6.4	10.3	7.0	4.9	7.9	6.6	11.0	6.0	8.4	10.5	7.9	7.7	8.2	10.5	9.4	12.0	6.9	6.6	9.9	23.8	8.1	10.0	11.3	3.4	9.2	4.9	7.5	14.1	14.9	2.3	7.4	10.2	7.1	7.8	8.1	8.0	7.9	13.6	11.6	4.3	6.8	18.1	9.5	10.6	11.1	9.7	7.3	5.9	6.0	5.4	5.3	7.9	3.6	5.0	10.0	5.7	2.1	5.2	3.6	2.2	2.9	2.6	2.9	2.7	2.6	3.8	3.1	2.6	5.8	1.7	2.1	16.3	1.2	1.4	10.0	14.0	18.1	13.8	8.7	6.5	11.3	10.7	13.2	11.6	29.8	16.5	7.3	9.8	6.4	45.0	18.5	10.2	18.7	19.4	12.2	37.3	14.4	0.0	7.7	7.3	19.6	4.1	23.3	4.0	8.2	15.1	9.9	40.4	9.8	7.6	27.0	18.4	18.4	13.2	10.6	18.7	14.9	5.0	7.2	5.9	26.4	6.4	5.5	19.8	4.4	32.3	0.0	16.0	17.4	22.1	4.8	4.7	10.9	5.2	4.5
ZDHHC18	DKFZp667O2416	ENSG00000204160	"Zinc finger DHHC-type containing 18"	Q9NUE0	1	26826710-26857602	"Enzymes, Predicted membrane proteins"		"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 86.2"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	5	"neutrophil: 27.0"	"Lineage enriched"	"Detected in many"	20	"granulocytes: 27.0"	"Cell line enhanced"	"Detected in all"		"HDLM-2: 54.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA040234	Approved		Approved	Microtubules		NA	NA			Microtubules		"HPA040234: AB_10805709"	"unprognostic (2.68e-1)"	"unprognostic (1.21e-2)"	"unprognostic (2.35e-1)"	"unprognostic (1.47e-1)"	"prognostic unfavorable (5.15e-4)"	"unprognostic (1.01e-1)"	"prognostic unfavorable (7.42e-7)"	"unprognostic (1.53e-1)"	"unprognostic (2.90e-2)"	"unprognostic (2.38e-2)"	"unprognostic (2.13e-2)"	"unprognostic (2.91e-1)"	"prognostic unfavorable (1.36e-10)"	"unprognostic (3.85e-2)"	"unprognostic (2.70e-1)"	"unprognostic (1.00e-1)"	"unprognostic (1.93e-1)"	20.5	8.2	13.3	22.7	18.9	86.2	39.0	21.4	18.4	10.2	13.0	11.9	7.5	11.7	12.4	6.4	19.3	9.9	13.5	9.8	13.5	20.0	7.8	14.5	16.2	23.5	16.3	12.8	9.6	10.8	7.1	10.5	20.3	15.2	10.7	13.9	11.2	14.1	9.8	8.7	16.3	12.2	16.6	10.4	27.1	10.8	7.0	9.5	11.7	14.6	10.1	23.3	16.5	24.7	0.2	0.4	27.0	0.6	0.5	1.3	0.2	18.5	8.3	13.5	9.3	11.3	7.9	13.3	11.2	13.3	19.7	14.7	7.6	11.9	8.6	7.2	14.8	10.3	13.1	14.3	6.7	17.0	54.3	12.2	8.3	6.1	10.5	9.7	7.3	7.3	6.8	9.1	18.1	12.0	7.1	11.0	13.3	8.6	17.9	7.8	9.0	13.9	5.9	12.9	11.6	8.0	11.6	11.6	9.1	8.3	4.7	6.3	7.6	7.5	5.7	8.1	10.8	5.1	7.3	9.3	13.7	10.5	22.3	12.8	21.3	15.3	7.4	7.7	13.4	9.3	0.0	0.2	5.1	0.9	0.6	0.7	0.2	0.6	0.6	0.4	0.1	0.4	0.4	27.0	0.5	0.4	0.2	1.3	0.2	13.3	18.9	21.4	18.4	13.5	20.0	16.3	12.8	15.2	9.5	8.9	9.3	9.8	7.5	22.8	39.0	4.8	12.7	0.0	6.8	1.8	25.5	8.9	0.0	3.2	2.9	8.0	12.3	23.3	2.5	6.3	7.1	12.5	1.1	10.4	6.6	17.5	2.9	6.7	6.9	1.4	5.8	8.9	10.1	36.9	4.3	4.8	6.7	9.5	3.5	2.2	33.0	0.0	5.5	2.2	11.1	31.7	5.1	8.7	5.2	13.2
ZDHHC19	MGC33345	ENSG00000163958	"Zinc finger DHHC-type containing 19"	Q8WVZ1	3	196197449-196211437	"Enzymes, Predicted membrane proteins"		"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	10	"testis: 53.4"	"Group enriched"	"Detected in some"	15	"Early spermatids: 298.7;Late spermatids: 632.3"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	21	"eosinophil: 2.4;memory B-cell: 3.9;naive B-cell: 5.2;neutrophil: 3.4"	"Group enriched"	"Detected in many"	24	"B-cells: 5.2;granulocytes: 3.4"	"Cell line enhanced"	"Detected in some"		"HMC-1: 1.7;K-562: 1.2;NTERA-2: 1.1;SH-SY5Y: 1.9;THP-1: 2.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"									NA	NA						"unprognostic (1.15e-1)"	"unprognostic (7.50e-4)"	"unprognostic (2.87e-3)"	"unprognostic (6.72e-3)"	"unprognostic (3.79e-1)"	"unprognostic (1.59e-1)"	"unprognostic (2.05e-2)"	"unprognostic (1.25e-1)"	"unprognostic (3.66e-3)"	"unprognostic (4.63e-2)"	"unprognostic (6.52e-2)"	"unprognostic (2.86e-2)"	"unprognostic (3.46e-7)"	"unprognostic (8.05e-4)"	"unprognostic (4.71e-1)"	"unprognostic (7.08e-3)"	"unprognostic (4.28e-2)"	0.0	0.6	0.0	0.4	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.0	0.0	53.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.2	0.1	3.4	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.2	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.2	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	3.9	0.0	0.0	0.0	5.2	0.0	0.0	3.4	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.2	0.3	0.0	1.4	0.0	0.0	0.0	0.3	0.0	0.0	298.7	0.7	0.0	0.0	0.0	0.4	0.3	0.1	0.0	3.4	1.3	0.0	0.0	0.0	1.5	632.3	15.3	1.4	0.0	0.0	0.0	0.2	0.0	0.0	30.1	0.4	0.0	0.0	0.0	4.9	3.0	0.0	2.1	0.0	0.0	0.0
ZDHHC2	"DHHC2, ZNF372"	ENSG00000104219	"Zinc finger DHHC-type containing 2"	Q9UIJ5	8	17156029-17224799	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"		"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Cone photoreceptor cells: 72.6;Rod photoreceptor cells: 80.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023331, HPA023334"	Uncertain		Approved	"Plasma membrane"		NA	NA			"Plasma membrane"		"HPA023331: AB_2671165, HPA023334: "	"unprognostic (8.92e-2)"	"unprognostic (4.23e-1)"	"unprognostic (1.80e-2)"	"unprognostic (2.53e-1)"	"unprognostic (6.89e-2)"	"unprognostic (2.25e-1)"	"unprognostic (6.12e-2)"	"unprognostic (1.78e-2)"	"unprognostic (1.04e-1)"	"unprognostic (2.37e-2)"	"unprognostic (2.16e-1)"	"unprognostic (1.58e-1)"	"prognostic favorable (3.24e-4)"	"unprognostic (5.00e-2)"	"unprognostic (3.87e-1)"	"unprognostic (2.87e-2)"	"unprognostic (5.10e-2)"	10.1	22.5	14.8	9.4	14.5	24.4	14.8	22.8	12.2	12.9	13.4	17.5	17.4	9.3	7.0	10.5	5.3	12.8	6.4	10.1	13.0	14.0	24.2	7.5	12.7	10.3	13.6	10.9	13.0	27.0	19.2	20.2	6.1	14.7	12.0	10.3	21.2	15.9	13.7	15.9	3.4	9.1	8.8	25.9	11.2	14.1	14.2	14.5	13.8	32.3	10.4	10.2	17.3	8.7	5.3	4.6	4.9	2.7	4.4	7.0	1.5	0.9	5.2	10.2	2.1	9.0	16.1	6.0	17.6	21.4	10.0	11.9	1.6	14.7	10.6	6.9	15.3	25.2	0.6	13.7	8.7	18.6	6.9	6.9	9.6	7.6	2.1	9.0	10.1	1.1	6.7	1.4	12.5	11.4	23.1	16.4	12.7	1.1	28.6	12.0	0.2	7.4	6.1	6.5	7.8	8.1	7.4	10.2	3.9	18.1	11.3	5.5	3.6	7.5	0.0	1.6	15.9	0.4	4.6	13.5	5.1	15.6	11.2	17.5	5.7	21.3	12.5	14.1	9.3	2.3	2.6	2.6	4.9	4.1	2.7	7.0	5.3	5.1	4.9	2.2	4.6	4.7	5.0	1.8	4.4	1.6	4.6	2.6	1.5	14.8	14.5	22.8	12.2	13.0	14.0	13.6	10.9	14.7	14.5	41.7	20.1	11.5	11.9	2.7	37.3	11.3	10.2	6.7	14.8	48.8	72.6	0.5	18.3	19.5	6.7	9.0	6.3	0.0	29.1	0.9	7.4	32.3	8.1	7.3	11.7	11.1	18.9	5.5	21.8	8.2	4.6	15.5	21.9	4.6	15.0	23.4	34.3	10.5	2.8	19.8	80.1	12.9	7.6	5.5	2.5	2.4	0.3	13.4	13.7	23.7
ZDHHC20	"DHHC20, FLJ25952"	ENSG00000180776	"Zinc finger DHHC-type containing 20"	Q5W0Z9	13	21372573-21459370	"Enzymes, Predicted membrane proteins"		"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 47.4"	"Cell type enhanced"	"Detected in many"	4	"Early spermatids: 77.2;Kupffer cells: 86.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA014483, HPA014702"	Approved		Supported	"Vesicles,Plasma membrane"		NA	NA			"Vesicles, Plasma membrane"		"HPA014483: AB_1859000, HPA014702: AB_1859001"	"unprognostic (1.31e-1)"	"unprognostic (2.16e-3)"	"unprognostic (7.31e-3)"	"unprognostic (8.89e-2)"	"unprognostic (3.37e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.06e-3)"	"unprognostic (3.77e-1)"	"unprognostic (1.24e-2)"	"unprognostic (1.26e-2)"	"prognostic unfavorable (6.55e-4)"	"unprognostic (1.10e-1)"	"prognostic unfavorable (1.01e-4)"	"unprognostic (3.76e-2)"	"unprognostic (7.65e-2)"	"unprognostic (6.15e-2)"	"unprognostic (1.13e-2)"	7.5	7.0	8.3	9.4	33.6	14.9	11.3	6.4	15.3	10.3	10.9	21.0	7.6	10.8	9.3	5.6	18.4	7.1	10.0	5.4	12.7	11.8	3.8	7.6	10.6	12.3	47.4	4.9	6.5	6.1	4.0	5.3	10.8	26.1	9.2	9.6	3.1	10.4	9.9	5.5	12.2	15.4	8.9	45.0	8.6	23.1	22.0	35.8	10.4	10.0	5.1	10.9	16.2	9.6	4.6	7.8	8.8	15.2	10.1	10.2	11.1	13.2	7.7	11.2	7.1	10.5	11.1	27.5	14.6	14.7	9.8	8.7	13.9	40.9	14.2	7.9	17.8	10.3	21.7	12.9	11.2	18.5	15.4	8.2	24.9	4.8	7.7	5.9	16.8	10.8	10.0	7.9	9.6	6.8	12.4	15.1	18.4	6.9	6.0	14.4	11.2	23.5	6.4	9.1	35.2	7.6	18.9	20.2	4.9	11.6	24.9	10.7	4.9	19.1	12.0	7.8	12.0	11.0	8.6	26.2	10.3	9.9	17.3	10.8	6.2	7.6	14.7	7.4	9.7	29.1	8.8	15.2	3.4	10.2	14.2	9.4	4.6	8.8	8.7	7.8	3.7	8.3	8.5	2.7	10.1	12.0	3.9	9.3	11.1	8.3	33.6	6.4	15.3	12.7	11.8	47.4	4.9	26.1	35.8	47.6	26.9	15.8	6.9	0.9	8.3	6.4	17.8	20.1	36.4	10.4	7.9	18.2	0.0	8.6	77.2	15.0	29.0	0.0	10.5	16.6	10.3	19.1	13.9	17.4	19.9	17.5	23.1	19.6	86.8	67.8	14.4	35.8	1.7	7.2	29.0	4.4	18.7	23.0	10.3	6.2	9.6	19.4	6.9	9.7	12.3	1.4	37.3	20.8	23.4	16.9
ZDHHC21	"DHHC21, DNZ1, HSPC097"	ENSG00000175893	"Zinc finger DHHC-type containing 21"	Q8IVQ6	9	14611071-14693471	"Enzymes, Predicted membrane proteins"		"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Muller glia cells: 75.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HEL: 23.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA065254	Approved		Approved	"Golgi apparatus,Cytosol"		NA	NA			"Golgi apparatus, Cytosol"		"HPA065254: AB_2685446"	"unprognostic (2.95e-2)"	"unprognostic (1.45e-1)"	"unprognostic (2.06e-2)"	"unprognostic (2.01e-1)"	"unprognostic (4.19e-2)"	"unprognostic (2.58e-2)"	"unprognostic (2.81e-2)"	"unprognostic (1.13e-2)"	"unprognostic (2.18e-2)"	"unprognostic (8.37e-2)"	"unprognostic (9.79e-3)"	"unprognostic (3.97e-2)"	"prognostic favorable (1.29e-4)"	"unprognostic (1.21e-1)"	"unprognostic (1.14e-1)"	"unprognostic (8.87e-2)"	"prognostic favorable (9.28e-6)"	6.5	10.8	15.9	7.9	16.8	4.2	11.6	29.0	22.6	7.8	8.5	9.3	3.8	12.2	9.8	11.7	14.4	7.5	6.7	9.0	13.8	10.4	9.4	4.8	9.2	11.1	9.4	16.5	10.0	8.4	11.5	22.2	7.8	14.8	10.0	9.9	6.6	8.3	7.4	7.7	15.7	12.6	7.7	9.9	9.5	7.9	7.3	9.7	4.7	11.3	9.9	10.7	7.7	11.3	5.2	1.4	0.5	0.8	2.8	1.7	0.6	5.4	2.8	5.6	3.6	0.9	1.0	4.3	7.0	2.2	2.5	2.9	1.4	2.6	5.4	1.7	4.9	3.1	3.6	3.8	2.3	3.6	10.8	2.9	23.0	6.1	2.7	3.0	4.0	7.7	1.9	5.3	2.9	1.9	4.6	14.6	2.2	1.9	0.6	4.4	3.0	0.9	3.9	3.9	2.3	5.3	0.0	2.6	2.7	7.7	6.1	3.4	9.1	3.2	4.0	2.1	4.4	5.0	6.6	10.3	1.8	2.7	1.8	6.4	2.3	4.2	0.0	3.8	0.2	1.8	0.5	0.4	0.1	1.2	0.8	1.3	5.2	1.2	1.1	0.2	3.5	0.8	1.2	0.0	2.8	0.6	1.4	1.7	0.6	15.9	16.8	29.0	22.6	13.8	10.4	9.4	16.5	14.8	9.7	20.8	17.9	23.9	7.6	8.5	42.8	16.2	20.4	10.7	22.7	41.8	41.2	7.1	5.0	13.7	4.0	14.8	33.7	0.0	15.6	5.4	9.4	16.4	10.4	6.8	9.6	35.0	15.0	30.7	15.1	4.5	17.8	11.7	1.7	12.6	13.4	75.7	25.7	10.5	29.4	7.9	50.3	6.5	11.3	14.6	16.1	17.6	6.4	10.2	10.2	13.2
ZDHHC22	C14orf59	ENSG00000177108	"Zinc finger DHHC-type containing 22"	Q8N966	14	77131270-77142734	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"		"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in many"	17	"brain: 52.3"	"Cell type enhanced"	"Detected in some"	25	"Bipolar cells: 9.9;Cone photoreceptor cells: 3.9;Late spermatids: 3.3"	"Cancer enriched"	"Detected in single"	40	"glioma: 7.7"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"AF22: 5.3;NTERA-2: 5.6;RH-30: 9.4;SCLC-21H: 10.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA049471, HPA072213"			Enhanced	"Plasma membrane"		NA	NA			"Plasma membrane"		"HPA049471: AB_2732553, HPA072213: AB_2686496"	"unprognostic (1.02e-1)"	"unprognostic (3.42e-1)"		"unprognostic (1.22e-4)"	"unprognostic (1.66e-1)"	"unprognostic (8.86e-2)"		"unprognostic (2.68e-1)"	"unprognostic (3.41e-1)"	"unprognostic (1.87e-1)"	"unprognostic (6.94e-4)"	"unprognostic (3.05e-1)"	"unprognostic (6.30e-2)"	"unprognostic (1.16e-1)"	"unprognostic (4.02e-1)"	"unprognostic (1.95e-1)"	"unprognostic (4.79e-1)"	1.1	1.5	11.2	1.1	12.6	1.1	1.1	8.4	52.3	1.1	1.2	6.7	0.0	1.1	1.1	1.4	1.3	1.2	1.1	1.2	14.5	18.4	1.1	1.1	1.1	1.1	10.7	19.5	1.1	1.1	1.1	3.1	1.1	9.2	1.1	1.3	0.5	1.1	1.1	1.3	1.1	1.1	1.2	3.6	1.1	1.3	1.4	5.1	0.0	1.3	0.0	1.1	1.4	0.0	0.0	0.0	0.1	0.0	0.2	0.1	0.0	0.0	0.0	5.3	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.4	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.6	0.0	0.0	5.6	0.0	0.7	0.0	9.4	0.0	0.0	0.0	10.4	1.9	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	11.2	12.6	8.4	29.5	14.5	18.4	10.7	19.5	9.2	5.1	0.0	0.0	0.0	0.0	0.0	9.9	0.3	0.0	0.0	0.0	0.0	3.9	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0
ZDHHC23	MGC42530	ENSG00000184307	"Zinc finger DHHC-type containing 23"	Q8IYP9	3	113947901-113965401	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"		"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"testis: 25.8"	"Cell type enhanced"	"Detected in many"	6	"Early spermatids: 20.4;Late spermatids: 26.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"memory B-cell: 2.7;naive B-cell: 1.7"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA016808	Uncertain		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA016808: AB_1859002"	"unprognostic (2.10e-3)"	"unprognostic (2.86e-1)"	"unprognostic (4.48e-3)"	"prognostic unfavorable (2.85e-4)"	"unprognostic (1.49e-1)"	"unprognostic (3.98e-3)"	"unprognostic (1.37e-2)"	"unprognostic (2.48e-1)"	"unprognostic (3.19e-1)"	"unprognostic (6.63e-2)"	"unprognostic (1.86e-1)"	"unprognostic (2.78e-2)"	"prognostic favorable (1.48e-7)"	"unprognostic (2.58e-2)"	"unprognostic (1.83e-1)"	"prognostic unfavorable (5.90e-4)"	"unprognostic (3.29e-3)"	1.0	0.8	6.3	2.1	5.9	0.4	1.9	2.7	10.4	1.4	7.7	0.9	2.2	6.0	1.5	1.6	1.7	2.1	1.8	1.3	8.9	1.9	4.7	3.2	2.4	2.7	0.9	4.7	1.1	4.4	8.2	3.5	0.4	1.4	1.8	9.9	1.2	4.9	1.4	1.2	2.9	5.4	0.7	0.9	1.9	5.0	25.8	0.6	0.8	5.5	0.9	2.8	1.7	1.5	2.7	1.1	0.5	0.0	0.0	0.5	0.1	13.1	3.3	0.4	7.8	1.2	0.2	11.5	5.2	1.6	1.0	1.6	5.4	8.9	6.1	4.6	3.0	8.6	8.7	10.0	1.4	1.7	3.6	4.6	5.6	4.8	3.3	0.4	6.2	5.2	0.2	1.7	0.2	0.6	1.2	0.8	6.5	0.0	3.6	0.1	7.6	5.1	0.4	2.4	13.6	3.7	0.9	4.5	5.0	5.6	6.5	13.7	3.5	4.0	13.5	2.6	3.2	8.1	2.1	0.2	3.8	7.6	0.8	2.3	4.0	5.2	9.8	3.2	4.1	1.6	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.5	0.1	0.0	1.7	0.1	0.0	0.5	0.0	0.0	1.1	0.1	0.1	6.3	5.9	2.7	10.4	8.9	1.9	0.9	4.7	1.4	0.6	0.0	1.0	5.9	1.6	2.7	1.8	1.2	10.2	5.3	2.3	15.7	7.9	0.6	0.0	2.1	20.4	1.4	15.7	0.0	1.6	1.2	0.6	3.5	0.0	5.4	0.4	0.0	13.3	1.8	0.3	26.8	1.1	1.2	3.3	1.0	12.2	3.8	0.7	9.5	0.0	3.4	0.7	0.0	0.3	11.6	1.9	2.4	0.2	0.0	11.4	1.7
ZDHHC24		ENSG00000174165	"Zinc finger DHHC-type containing 24"	Q6UX98	11	66520637-66546238	"Enzymes, Predicted membrane proteins"		"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA016619	Approved		Approved	Vesicles,Cytosol		NA	NA			"Vesicles, Cytosol"		"HPA016619: AB_2288672"	"unprognostic (2.77e-1)"	"unprognostic (2.51e-1)"	"unprognostic (2.52e-1)"	"unprognostic (1.55e-3)"	"prognostic unfavorable (3.28e-4)"	"unprognostic (8.76e-2)"	"unprognostic (7.74e-3)"	"unprognostic (7.11e-2)"	"unprognostic (6.20e-2)"	"unprognostic (1.41e-1)"	"unprognostic (3.73e-2)"	"unprognostic (1.48e-1)"	"unprognostic (8.10e-2)"	"unprognostic (6.99e-3)"	"unprognostic (3.10e-1)"	"unprognostic (4.88e-1)"	"unprognostic (1.35e-1)"	11.7	17.4	10.5	10.3	12.8	14.1	12.3	5.7	15.5	7.7	8.3	13.8	10.8	9.1	9.4	17.0	12.2	9.0	11.3	9.9	10.7	11.8	17.3	13.4	11.1	20.4	12.8	10.3	6.5	19.4	22.6	9.6	13.7	9.3	11.4	7.7	10.0	12.4	13.1	7.9	13.2	9.4	7.1	10.0	16.0	12.4	9.9	10.5	11.7	17.7	7.9	13.4	10.0	7.8	5.8	17.2	2.4	5.5	6.6	7.2	4.6	4.7	7.6	2.5	6.5	6.2	5.1	6.3	4.0	3.4	3.2	2.2	6.6	7.7	1.4	10.9	3.4	8.5	11.6	1.9	3.5	2.3	6.8	4.8	2.9	3.7	4.1	5.8	3.0	7.2	6.1	6.3	2.7	3.8	3.8	5.3	11.0	4.2	4.2	4.0	10.3	5.7	8.3	5.0	12.0	6.5	7.3	5.3	8.9	3.9	3.8	3.5	5.5	6.4	6.7	11.0	2.9	9.3	2.4	8.3	7.4	2.3	8.6	2.9	6.3	2.0	2.0	6.5	1.4	8.0	2.4	5.5	1.0	6.2	4.8	5.7	5.4	5.0	7.2	6.3	5.8	3.0	5.4	2.4	6.6	4.4	17.2	5.1	4.6	10.5	12.8	5.7	15.5	10.7	11.8	12.8	10.3	9.3	10.5	11.9	8.8	14.9	12.3	7.1	8.8	3.8	12.7	5.3	2.3	22.7	9.8	28.2	8.3	42.7	10.7	17.0	37.0	0.0	42.7	30.1	14.0	21.3	9.2	14.3	58.2	22.3	13.8	20.3	38.9	10.2	6.9	18.7	16.9	38.7	17.0	17.5	34.3	31.6	9.2	24.8	10.3	19.4	12.2	31.9	2.7	7.0	20.1	28.7	19.6	19.7
ZDHHC3	"DHHC3, GODZ, ZNF373"	ENSG00000163812	"Zinc finger DHHC-type containing 3"	Q9NYG2	3	44915257-44976185	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"		"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in all"	8	"Early spermatids: 493.4;Late spermatids: 1185.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB012465, HPA016616"	Approved		Approved	"Golgi apparatus"		NA	NA			"Golgi apparatus"		"CAB012465: , HPA016616: AB_1859004"	"unprognostic (2.80e-1)"	"unprognostic (6.07e-2)"	"prognostic favorable (3.43e-4)"	"unprognostic (3.10e-2)"	"unprognostic (2.47e-2)"	"unprognostic (3.38e-1)"	"prognostic unfavorable (1.37e-4)"	"unprognostic (4.20e-2)"	"unprognostic (1.04e-1)"	"unprognostic (6.37e-2)"	"unprognostic (1.22e-3)"	"unprognostic (1.24e-1)"	"prognostic favorable (1.81e-8)"	"unprognostic (2.64e-1)"	"unprognostic (1.49e-1)"	"unprognostic (5.33e-2)"	"unprognostic (4.26e-2)"	23.1	25.8	11.7	17.5	14.0	29.5	39.8	12.5	20.8	17.2	27.9	13.7	17.8	18.4	19.2	17.9	29.1	13.0	22.7	34.6	11.2	9.1	21.7	19.0	20.2	16.1	12.1	7.7	16.5	15.0	16.9	8.8	19.5	19.4	16.1	28.9	14.7	17.4	22.5	20.0	43.0	33.2	15.4	13.6	15.4	20.9	48.0	10.1	14.1	20.4	22.1	20.6	21.4	20.7	5.4	11.4	17.1	10.0	6.0	7.1	5.2	12.0	9.7	8.8	12.1	37.5	19.0	9.8	10.6	13.3	13.6	12.3	11.6	15.9	11.0	5.8	18.8	8.2	15.5	13.5	18.8	14.5	10.8	5.7	9.7	13.4	8.5	8.5	25.1	7.9	16.3	23.3	13.0	12.9	10.7	14.3	11.0	14.2	9.8	12.5	7.8	7.6	18.3	11.7	27.2	19.4	5.7	7.4	8.3	13.5	37.8	2.7	10.6	12.8	13.2	5.8	13.9	10.0	17.4	15.2	11.8	10.9	13.8	13.9	6.7	12.5	10.8	10.8	38.5	8.8	17.1	10.0	13.8	6.5	5.5	6.1	4.7	4.7	7.1	11.4	5.4	4.9	6.3	11.4	6.0	7.2	6.7	6.9	5.2	11.7	14.0	12.5	20.8	11.2	9.1	12.1	7.7	19.4	10.1	38.7	75.1	15.7	29.8	42.7	9.4	24.0	25.5	16.0	18.2	50.6	5.9	40.9	61.3	37.0	493.4	30.7	99.2	23.3	69.9	48.5	26.6	52.0	18.5	25.9	43.7	14.3	34.4	38.1	31.1	1185.8	48.1	27.2	23.6	30.7	65.3	25.6	78.0	59.6	42.1	23.7	8.6	19.4	23.7	52.6	40.9	52.7	85.0	20.8	60.2	82.9
ZDHHC4	"FLJ10479, ZNF374"	ENSG00000136247	"Zinc finger DHHC-type containing 4"	Q9NPG8	7	6577434-6589374	"Enzymes, Predicted membrane proteins"		"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA032124	Approved					NA	NA					"HPA032124: AB_10610699"	"unprognostic (1.07e-1)"	"prognostic unfavorable (9.35e-4)"	"unprognostic (6.82e-2)"	"unprognostic (8.36e-2)"	"unprognostic (3.66e-1)"	"prognostic unfavorable (3.95e-6)"	"unprognostic (9.80e-2)"	"unprognostic (1.40e-1)"	"unprognostic (2.37e-1)"	"unprognostic (4.60e-2)"	"unprognostic (1.52e-1)"	"unprognostic (1.43e-1)"	"prognostic favorable (1.18e-7)"	"unprognostic (8.75e-2)"	"unprognostic (9.41e-2)"	"unprognostic (1.42e-1)"	"prognostic unfavorable (8.94e-4)"	17.7	24.3	20.7	13.5	22.0	11.4	23.6	8.2	29.9	20.7	24.9	22.5	18.2	14.0	21.6	26.9	16.1	25.5	18.8	21.9	17.3	19.7	25.7	34.5	17.0	19.7	19.8	17.7	22.7	46.5	27.2	18.7	14.1	20.4	20.0	16.3	28.0	29.8	22.4	34.9	9.5	16.3	22.7	17.1	13.6	23.5	27.0	12.3	18.1	30.5	17.4	16.5	23.3	13.7	17.6	50.6	20.9	14.9	11.9	15.4	12.6	21.7	13.9	5.2	31.0	28.5	21.5	23.7	12.3	3.1	15.1	18.8	17.3	31.3	12.9	19.6	22.7	32.4	20.0	18.2	12.2	15.7	7.7	10.6	14.3	16.6	18.5	25.3	17.0	15.7	22.5	18.0	11.8	0.0	19.2	13.4	25.7	29.3	19.3	20.9	22.8	9.1	16.7	27.1	20.1	12.1	12.6	26.4	19.2	12.0	17.3	12.5	32.0	16.3	6.0	21.4	28.7	20.7	22.4	9.0	17.8	25.9	17.0	17.8	28.6	22.8	29.9	10.7	21.4	24.9	20.9	11.7	18.0	11.5	14.9	12.5	17.6	11.6	12.7	13.2	16.1	15.4	14.7	1.3	11.9	10.8	50.6	10.3	12.6	20.7	22.0	8.2	29.9	17.3	19.7	19.8	17.7	20.4	12.3	35.7	15.3	25.1	40.1	10.1	30.0	3.6	56.0	26.8	31.8	33.2	9.8	58.4	72.9	53.9	2.0	10.8	10.2	0.0	58.4	56.0	26.7	32.7	10.3	38.4	48.4	20.6	31.2	20.9	26.0	2.2	16.7	18.1	20.3	38.7	19.1	45.6	49.0	17.5	30.8	58.5	19.8	12.9	30.9	76.1	50.3	8.2	40.8	22.4	29.3	26.5
ZDHHC5	"DHHC5, KIAA1748, ZNF375"	ENSG00000156599	"Zinc finger DHHC-type containing 5"	Q9C0B5	11	57667747-57701187	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"		"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA014670	Approved		Approved	"Nucleoplasm,Plasma membrane"		NA	NA			"Plasma membrane"	Nucleoplasm	"HPA014670: AB_2257442"	"unprognostic (1.34e-1)"	"unprognostic (3.47e-2)"	"unprognostic (2.51e-1)"	"unprognostic (2.29e-1)"	"unprognostic (5.32e-2)"	"unprognostic (1.70e-2)"	"unprognostic (9.82e-3)"	"unprognostic (1.74e-3)"	"unprognostic (4.36e-2)"	"unprognostic (9.78e-2)"	"prognostic unfavorable (6.74e-5)"	"unprognostic (1.76e-1)"	"unprognostic (4.72e-3)"	"unprognostic (2.16e-1)"	"unprognostic (6.80e-2)"	"unprognostic (2.06e-2)"	"unprognostic (1.74e-3)"	19.6	18.2	6.9	14.2	16.1	13.0	17.3	12.4	19.2	20.0	18.7	14.1	20.9	14.6	19.8	15.9	45.8	16.0	19.1	18.2	8.2	8.1	27.8	24.8	18.7	18.0	8.5	8.2	16.2	21.3	31.4	13.9	31.4	12.8	15.5	18.2	19.1	29.3	18.4	31.3	33.2	25.9	15.2	8.7	21.5	16.3	35.7	7.8	26.4	25.5	23.9	39.1	23.3	26.0	9.4	13.4	15.5	11.3	6.9	13.1	9.0	28.4	31.6	12.4	12.6	27.5	21.2	23.4	26.8	32.1	22.4	16.8	19.1	35.1	19.2	34.8	31.6	19.3	40.3	19.3	31.7	20.0	23.6	8.7	16.3	14.5	17.0	30.8	30.5	27.7	29.8	28.7	33.1	33.7	18.6	25.2	16.2	21.4	24.3	28.3	17.1	17.1	8.5	15.0	21.1	19.0	17.1	25.1	23.7	25.6	42.2	9.0	11.5	24.9	28.2	26.1	17.5	30.2	17.5	29.5	29.1	15.1	30.5	18.6	17.7	21.9	16.5	21.6	15.8	25.2	15.5	8.1	9.8	11.1	10.1	13.1	9.0	10.9	9.4	8.0	9.4	11.0	11.1	10.2	6.9	11.3	13.4	9.8	9.0	6.9	16.1	12.4	19.2	8.2	8.1	8.5	8.2	12.8	7.8	14.9	10.9	5.3	10.2	14.3	17.5	18.1	12.7	14.7	20.5	12.2	35.3	8.5	3.3	13.1	15.8	11.7	31.9	0.0	15.7	8.4	8.5	14.0	19.6	13.2	11.0	12.7	11.1	13.5	16.1	6.8	10.9	12.0	1.7	9.0	16.2	9.6	19.0	19.3	7.1	10.2	45.0	0.0	9.2	6.5	6.6	17.3	15.6	8.7	15.8	15.9
ZDHHC6	"FLJ21952, ZNF376"	ENSG00000023041	"Zinc finger DHHC-type containing 6"	Q9H6R6	10	112424428-112446917	"Enzymes, Predicted membrane proteins"		"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA014357	Approved					NA	NA					"HPA014357: AB_2304658"	"unprognostic (1.21e-1)"	"unprognostic (1.00e-1)"	"unprognostic (6.31e-2)"	"unprognostic (2.51e-2)"	"unprognostic (1.80e-1)"	"unprognostic (2.07e-1)"	"unprognostic (3.29e-2)"	"unprognostic (6.24e-2)"	"unprognostic (5.21e-1)"	"unprognostic (3.54e-2)"	"unprognostic (1.56e-1)"	"unprognostic (7.14e-3)"	"unprognostic (3.00e-2)"	"unprognostic (9.30e-2)"	"unprognostic (8.87e-2)"	"unprognostic (7.64e-2)"	"unprognostic (1.22e-2)"	17.6	17.7	14.4	21.6	17.2	13.9	17.7	17.5	19.1	16.6	21.3	15.4	25.6	32.2	21.6	25.7	21.1	16.5	17.1	15.1	15.4	13.2	41.7	21.3	17.6	20.3	20.1	15.2	24.5	19.0	15.6	17.6	19.3	19.8	18.6	22.6	18.2	21.4	23.5	13.8	14.8	43.8	16.7	15.5	22.3	18.8	10.7	15.0	20.2	20.5	12.9	21.6	16.7	17.9	16.8	16.4	20.2	17.2	15.5	23.0	15.0	20.6	16.2	16.9	20.9	16.4	12.5	12.0	20.3	19.3	16.1	19.3	15.3	37.1	11.5	9.3	12.3	18.1	24.7	14.0	12.9	18.8	26.8	17.2	11.8	18.6	18.9	10.6	27.0	20.9	9.4	8.7	17.6	20.8	24.9	20.1	17.3	12.8	19.2	17.3	17.3	15.0	30.3	9.9	23.1	13.3	12.6	21.4	10.7	19.0	11.5	6.3	8.8	10.5	16.7	19.1	13.8	9.3	19.9	14.3	18.5	11.7	12.3	19.1	10.8	12.4	15.2	16.4	47.9	12.0	9.3	17.2	20.2	15.5	15.8	20.1	16.8	17.9	19.5	16.4	13.3	15.2	17.1	11.4	15.5	12.4	13.6	23.0	15.0	14.4	17.2	17.5	19.1	15.4	13.2	20.1	15.2	19.8	15.0	20.8	19.0	24.4	27.9	18.0	10.0	11.3	38.2	12.0	28.4	33.2	7.9	29.6	51.4	30.8	61.9	18.0	37.6	0.0	26.1	38.6	18.6	25.9	23.1	19.0	30.0	14.3	10.9	19.0	19.4	13.2	15.0	28.1	11.8	15.4	20.6	16.6	24.8	21.0	18.4	33.5	12.4	6.5	16.0	8.6	12.0	19.4	30.6	33.0	20.7	40.4
ZDHHC7	"DHHC7, FLJ10792, FLJ20279, SERZ-B, SERZ1, ZNF370"	ENSG00000153786	"Zinc finger DHHC-type containing 7"	Q9NXF8	16	84974181-85011535	"Enzymes, Predicted membrane proteins"		"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019215, HPA059054, HPA059642"	Uncertain		Supported	"Golgi apparatus"		NA	NA			"Golgi apparatus"		"HPA019215: AB_2670102, HPA059054: AB_2683892, HPA059642: AB_2684093"	"unprognostic (9.77e-2)"	"unprognostic (2.12e-1)"	"unprognostic (6.70e-2)"	"unprognostic (1.09e-1)"	"unprognostic (2.31e-1)"	"unprognostic (8.76e-2)"	"prognostic unfavorable (4.20e-4)"	"unprognostic (1.41e-2)"	"unprognostic (5.78e-2)"	"unprognostic (2.21e-2)"	"unprognostic (7.79e-3)"	"unprognostic (8.04e-2)"	"prognostic favorable (1.12e-5)"	"unprognostic (1.67e-1)"	"unprognostic (1.36e-2)"	"unprognostic (2.45e-1)"	"unprognostic (5.42e-2)"	23.4	20.9	17.7	25.4	14.7	40.3	45.8	17.8	20.0	23.7	26.8	15.5	15.6	19.7	27.7	18.6	20.4	19.2	29.1	24.9	13.0	11.6	23.4	21.3	31.3	36.3	15.5	14.5	21.8	30.0	31.1	15.2	25.1	14.8	24.1	24.3	18.1	18.7	18.4	36.5	23.1	25.5	31.1	14.9	27.1	32.3	18.6	13.9	16.1	19.9	25.8	18.8	27.7	28.9	2.0	6.9	8.5	10.6	1.5	3.0	3.5	20.4	18.0	9.5	11.4	42.3	32.0	13.1	18.9	36.7	29.8	14.8	18.9	24.0	9.4	11.1	30.5	9.8	21.6	12.2	25.0	37.7	5.4	9.8	7.3	7.7	21.4	17.7	12.7	7.1	26.4	28.7	24.3	14.0	19.0	15.3	8.9	21.8	3.2	18.8	24.4	8.7	12.2	14.7	17.2	13.1	10.8	8.7	5.1	29.3	26.9	8.1	10.3	24.4	13.7	11.8	15.1	25.9	7.8	22.2	18.0	13.7	16.9	11.0	11.3	15.6	21.2	17.1	9.5	14.2	6.7	10.6	8.5	2.5	8.8	3.0	1.6	2.4	2.0	6.9	2.0	1.8	2.6	7.1	1.5	7.2	4.7	0.6	3.5	17.7	14.7	17.8	20.0	13.0	11.6	15.5	14.5	14.8	13.9	29.8	25.1	8.2	20.6	11.7	8.2	18.5	15.3	20.1	9.1	15.7	5.9	15.1	1.7	12.1	6.5	8.9	21.7	0.0	13.5	21.1	17.0	18.9	3.5	9.4	25.9	14.3	12.1	12.9	49.0	7.1	16.1	22.8	15.1	16.2	31.0	5.6	22.2	28.1	19.8	7.4	5.7	12.9	13.0	8.4	11.4	11.2	13.5	13.8	29.1	28.5
ZDHHC8	"KIAA1292, ZNF378"	ENSG00000099904	"Zinc finger DHHC-type containing 8"	Q9ULC8	22	20129456-20148007	"Enzymes, Predicted membrane proteins"		"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003422	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			Cytosol	Nucleoplasm	"HPA003422: AB_1080640"	"unprognostic (1.00e-2)"	"prognostic unfavorable (9.68e-4)"	"unprognostic (3.36e-1)"	"unprognostic (1.36e-1)"	"unprognostic (2.49e-1)"	"unprognostic (8.02e-2)"	"unprognostic (5.14e-2)"	"unprognostic (1.03e-2)"	"unprognostic (2.43e-1)"	"unprognostic (1.43e-3)"	"unprognostic (9.34e-3)"	"unprognostic (3.20e-1)"	"prognostic unfavorable (4.04e-4)"	"unprognostic (1.11e-1)"	"unprognostic (1.02e-1)"	"unprognostic (9.88e-2)"	"unprognostic (9.57e-2)"	20.7	19.2	25.7	16.9	23.0	9.2	23.4	24.4	35.3	14.3	9.9	14.0	17.3	11.6	16.0	10.9	13.9	13.6	14.4	16.0	18.7	10.6	15.2	16.5	14.6	15.4	17.7	17.6	18.0	23.9	17.4	21.0	16.4	19.0	13.4	7.0	17.5	20.4	16.6	20.5	22.2	11.2	13.0	10.4	19.8	15.9	8.4	18.6	8.9	18.5	7.9	11.1	12.9	14.5	2.0	4.1	4.0	1.5	1.3	2.5	0.5	11.5	7.4	11.8	15.5	17.3	10.4	10.6	21.8	14.9	14.8	13.3	3.8	6.0	0.0	9.0	18.1	8.0	15.9	6.2	16.7	7.3	16.6	23.7	5.6	19.4	8.8	14.3	0.0	7.9	18.1	11.3	11.4	9.6	9.1	16.5	8.3	38.6	9.1	13.1	5.6	6.8	15.1	6.0	5.1	11.7	14.6	10.3	4.1	6.4	14.1	19.0	9.6	8.8	4.3	10.4	5.6	0.3	7.9	18.9	33.7	24.7	18.9	9.7	13.2	4.3	4.4	9.9	7.3	9.9	4.0	1.2	0.3	2.5	1.5	1.3	0.8	0.7	1.2	0.4	2.0	1.3	1.8	0.0	1.3	0.8	4.1	2.0	0.5	25.7	23.0	24.4	35.3	18.7	10.6	17.7	17.6	19.0	18.6	3.0	1.9	2.7	3.4	8.0	11.5	6.8	5.1	0.0	3.4	10.4	13.7	3.1	1.7	4.5	0.5	9.0	2.4	0.0	3.8	6.1	8.0	4.0	5.7	7.8	4.2	12.7	4.1	11.6	4.9	1.3	10.0	5.0	5.0	2.8	5.5	8.3	6.2	4.3	13.8	1.9	11.0	6.5	5.5	0.3	2.3	8.5	2.9	2.5	4.8	2.7
ZDHHC9	"CGI-89, CXorf11, ZDHHC10, ZNF379, ZNF380"	ENSG00000188706	"Zinc finger DHHC-type containing 9"	Q9Y397	X	129803288-129843909	"Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins, Transporters"		"Acyltransferase, Transferase"	"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 78.3"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA031814	Uncertain		Supported	"Endoplasmic reticulum,Golgi apparatus,Cytosol"		NA	NA			"Endoplasmic reticulum, Golgi apparatus"	Cytosol	"HPA031814: AB_10610700"	"prognostic unfavorable (9.77e-5)"	"prognostic unfavorable (4.64e-5)"	"unprognostic (2.83e-2)"	"unprognostic (7.53e-3)"	"unprognostic (2.68e-1)"	"prognostic unfavorable (2.45e-4)"	"unprognostic (4.01e-3)"	"unprognostic (1.02e-1)"	"unprognostic (4.04e-1)"	"unprognostic (3.49e-2)"	"unprognostic (9.70e-3)"	"unprognostic (4.76e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.05e-2)"	"unprognostic (1.31e-1)"	"unprognostic (1.17e-2)"	"unprognostic (4.11e-2)"	18.2	7.3	16.7	6.7	24.7	3.2	14.2	7.8	33.9	14.1	14.7	78.3	5.1	21.1	8.4	8.4	9.8	7.9	10.4	7.4	24.1	15.2	25.4	27.0	15.6	3.0	24.9	13.9	8.0	17.4	19.6	7.1	11.5	28.4	13.4	17.3	3.8	13.2	8.3	7.4	19.7	22.2	10.4	32.7	2.4	12.8	2.8	25.3	1.2	9.6	5.7	4.3	10.8	9.4	4.6	7.8	2.6	6.8	3.4	7.6	3.3	15.0	7.9	11.4	23.0	39.4	31.1	9.3	14.9	17.1	7.2	9.0	12.5	19.7	0.5	25.5	15.9	18.6	10.2	12.8	15.0	10.4	0.8	8.0	3.0	8.3	16.4	15.6	2.0	5.4	33.7	24.4	11.7	17.4	12.6	13.5	5.0	3.2	6.1	11.5	13.1	2.8	3.7	6.1	33.8	13.7	2.7	7.3	8.8	10.4	8.4	9.0	7.6	4.2	22.1	6.9	14.0	9.4	3.3	10.9	7.3	2.5	17.1	12.0	5.7	4.0	1.8	13.1	8.3	3.6	0.0	3.3	2.6	4.8	2.9	6.1	4.6	5.8	4.7	3.7	2.7	7.6	4.3	0.0	3.4	6.8	7.8	2.5	3.3	16.7	24.7	7.8	33.9	24.1	15.2	24.9	13.9	28.4	25.3	20.8	28.7	3.0	9.8	16.6	9.1	3.5	28.1	5.3	17.0	43.6	2.0	5.0	3.3	16.9	1.1	10.3	26.8	0.0	17.0	17.3	20.5	23.0	2.3	41.5	4.4	1.6	17.3	6.7	2.1	1.3	11.2	4.6	10.1	0.0	24.9	1.2	26.6	10.5	7.1	24.6	2.4	0.0	13.7	6.1	6.0	16.8	8.6	2.5	25.5	13.6
ZFP91	"PZF, ZNF757"	ENSG00000186660	"ZFP91 zinc finger protein"	Q96JP5	11	58579111-58621042	"Enzymes, Predicted intracellular proteins, Transcription factors"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	5	"Early spermatids: 181.7;Late spermatids: 146.8;Spermatocytes: 142.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA024037, CAB025417, HPA065325"	Approved		Supported	Nucleoplasm,Nucleoli		NA	NA			"Nucleoplasm, Nucleoli"		"CAB025417: , HPA024037: AB_1859051, HPA065325: AB_2685468"	"unprognostic (6.10e-2)"	"unprognostic (5.01e-2)"	"unprognostic (3.33e-3)"	"unprognostic (9.19e-2)"	"unprognostic (1.24e-1)"	"unprognostic (2.33e-1)"	"unprognostic (2.33e-2)"	"unprognostic (3.37e-2)"	"unprognostic (1.06e-1)"	"unprognostic (2.36e-2)"	"prognostic unfavorable (3.74e-6)"	"unprognostic (3.16e-1)"	"unprognostic (1.75e-3)"	"unprognostic (3.12e-2)"	"unprognostic (2.61e-1)"	"unprognostic (2.23e-1)"	"unprognostic (2.00e-3)"	17.1	14.7	20.1	13.6	25.6	32.0	14.9	24.4	21.7	15.3	18.1	23.2	15.8	16.2	16.3	11.8	16.3	13.6	13.8	26.5	20.3	15.4	16.3	19.4	15.0	14.4	20.8	18.1	14.9	14.3	26.7	17.0	14.2	19.7	13.1	21.9	11.2	14.5	15.5	33.8	17.5	19.6	16.9	21.6	15.0	13.9	71.0	19.4	15.7	16.8	14.6	15.9	17.8	21.4	4.6	7.0	5.4	5.0	3.7	5.4	2.8	24.8	14.3	16.8	17.0	16.1	19.5	9.2	20.6	38.7	23.8	20.4	7.8	26.3	29.8	20.4	25.9	23.8	22.2	17.0	21.8	31.4	15.8	9.6	19.6	14.5	8.4	18.3	24.7	32.4	17.0	21.5	33.5	39.3	19.8	23.6	20.2	19.4	28.3	30.6	8.3	21.3	13.7	8.8	14.4	13.9	16.6	28.4	19.7	17.5	24.0	18.0	14.4	26.2	24.1	33.5	9.5	26.9	18.6	26.4	30.2	20.8	45.3	22.8	16.4	12.1	24.7	26.6	13.9	30.7	3.9	5.0	3.5	5.4	4.5	3.0	4.5	3.3	3.3	4.9	4.6	3.6	4.6	5.4	3.7	4.2	7.0	2.6	2.8	20.1	25.6	24.4	21.7	20.3	15.4	20.8	18.1	19.7	19.4	23.8	34.8	33.2	21.5	53.3	28.8	39.5	48.4	25.4	21.6	17.4	15.7	10.3	11.6	19.8	181.7	27.0	27.7	46.7	27.1	10.5	32.9	25.9	48.6	41.4	14.5	33.4	24.2	25.8	36.8	146.8	28.4	27.0	21.9	20.8	30.4	19.8	24.5	11.5	25.5	19.1	19.0	19.4	20.6	142.7	40.2	58.2	11.6	21.8	37.2	34.3
ZMPSTE24	"FACE-1, HGPS, PRO1, STE24, Ste24p"	ENSG00000084073	"Zinc metallopeptidase STE24"	O75844	1	40258107-40294184	"Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins, Transporters"		"Hydrolase, Metalloprotease, Protease"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA006988	Approved					NA	NA		13000			"HPA006988: AB_1080659"	"unprognostic (6.32e-2)"	"unprognostic (1.63e-2)"	"unprognostic (3.75e-3)"	"unprognostic (4.63e-2)"	"unprognostic (4.16e-3)"	"unprognostic (1.37e-1)"	"prognostic unfavorable (5.73e-6)"	"unprognostic (1.86e-1)"	"unprognostic (1.17e-1)"	"unprognostic (1.84e-3)"	"unprognostic (4.78e-2)"	"unprognostic (7.96e-2)"	"unprognostic (5.06e-2)"	"unprognostic (3.65e-2)"	"unprognostic (2.65e-1)"	"prognostic unfavorable (6.34e-4)"	"unprognostic (2.71e-2)"	21.6	24.2	17.6	15.4	19.6	6.5	18.6	10.7	21.3	20.9	20.6	14.9	27.0	17.9	29.7	19.7	21.4	19.9	20.7	20.8	17.1	16.9	34.2	48.7	16.2	23.1	21.9	17.0	16.0	20.4	39.8	17.0	23.0	23.5	21.7	23.3	15.6	18.9	19.0	19.1	14.7	20.9	25.2	19.2	17.7	19.0	10.7	17.9	20.9	20.6	14.7	18.4	19.1	16.7	15.1	25.8	15.1	23.9	24.2	22.5	20.3	20.9	14.0	10.9	8.1	29.0	23.3	21.2	22.0	18.4	24.9	22.8	15.3	36.4	18.1	15.3	26.9	9.7	21.8	22.3	20.3	28.7	17.0	14.3	17.4	15.0	14.0	16.6	28.1	21.9	16.8	20.8	21.2	9.2	14.0	17.4	9.0	18.5	18.2	23.5	9.8	17.0	8.4	21.0	13.9	14.6	14.8	19.4	22.4	22.0	20.3	11.4	13.5	20.3	45.3	27.3	17.6	16.7	77.7	17.3	22.5	16.5	20.9	26.7	11.2	30.0	15.8	24.7	19.8	23.8	15.1	20.0	13.6	17.9	23.9	21.5	15.1	19.1	18.9	25.8	11.6	17.0	22.5	11.8	24.2	22.7	16.9	22.3	20.3	17.6	19.6	10.7	21.3	17.1	16.9	21.9	17.0	23.5	17.9	35.7	23.7	17.1	19.8	28.4	5.7	18.7	50.9	49.5	28.4	69.8	0.0	33.1	26.6	47.9	2.1	31.5	34.1	0.0	31.7	32.0	28.1	33.2	20.7	56.7	30.7	9.5	26.5	20.3	28.9	0.5	26.4	29.6	23.6	31.5	26.3	29.0	37.5	25.9	30.8	33.7	6.3	0.0	21.5	7.0	5.5	23.7	32.6	17.5	28.0	19.9
ZNRF1	"DKFZp434E229, FLJ14846, nin283"	ENSG00000186187	"Zinc and ring finger 1"	Q8ND25	16	74999030-75110994	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 80.1"	"Cell type enhanced"	"Detected in many"	4	"Cone photoreceptor cells: 49.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"basophil: 4.5;T-reg: 5.2"	"Group enriched"	"Detected in many"	4	"granulocytes: 4.5;monocytes: 1.4;T-cells: 5.2"	"Cell line enhanced"	"Detected in many"		"HMC-1: 54.8;MOLT-4: 39.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA027470	Approved					NA	NA					"HPA027470: AB_10603108"	"unprognostic (2.78e-2)"	"prognostic favorable (9.90e-4)"	"unprognostic (4.45e-3)"	"unprognostic (1.51e-1)"	"unprognostic (4.34e-2)"	"unprognostic (1.18e-2)"	"unprognostic (2.51e-1)"	"unprognostic (2.07e-1)"	"unprognostic (1.12e-2)"	"unprognostic (5.38e-2)"	"unprognostic (3.69e-1)"	"unprognostic (2.28e-1)"	"unprognostic (1.46e-1)"	"unprognostic (4.89e-2)"	"unprognostic (2.87e-1)"	"unprognostic (2.10e-2)"	"unprognostic (1.44e-2)"	10.0	9.5	13.4	8.1	13.7	5.2	16.6	6.3	16.5	13.2	12.5	8.1	6.7	8.3	10.7	9.1	28.2	10.0	11.3	9.1	11.6	14.6	5.6	12.8	12.8	8.7	9.1	9.4	10.1	6.1	12.2	6.2	9.7	7.8	9.1	10.8	7.2	7.5	7.5	58.6	14.5	11.2	10.1	8.8	2.8	11.8	21.6	4.9	80.1	21.4	16.9	13.3	14.0	15.5	0.2	0.8	4.5	1.4	0.0	5.2	0.3	3.2	4.7	8.1	8.4	8.7	6.8	28.1	3.9	5.5	5.4	5.3	7.6	10.0	0.8	3.0	8.5	5.2	7.7	3.9	5.4	4.3	7.8	2.2	16.8	1.5	13.8	6.9	8.0	54.8	6.1	4.5	5.6	4.6	9.6	8.8	20.7	8.0	2.6	4.1	30.8	39.2	29.6	11.3	9.3	5.1	17.4	3.0	5.1	7.6	9.1	10.9	11.7	6.2	8.3	2.2	7.0	21.9	7.7	6.0	3.7	6.5	6.6	2.3	15.6	15.8	9.3	4.9	9.0	3.8	4.5	1.4	0.9	0.2	1.1	1.3	0.2	1.5	0.2	0.8	0.0	0.0	0.2	1.2	0.0	1.1	0.0	5.2	0.3	13.4	13.7	6.3	16.5	11.6	14.6	9.1	9.4	7.8	4.9	8.9	11.8	0.8	13.7	14.2	10.6	15.7	15.3	14.7	12.5	3.5	49.1	5.5	0.0	6.8	17.8	23.3	12.9	0.0	10.9	9.4	10.4	10.2	35.8	11.6	8.3	3.2	19.0	9.2	5.9	10.1	6.4	4.0	13.5	7.2	14.4	11.9	14.8	11.5	3.9	5.1	5.5	0.0	7.6	11.3	16.1	17.1	3.8	6.4	9.8	25.7
ZNRF2	RNF202	ENSG00000180233	"Zinc and ring finger 2"	Q8NHG8	7	30284307-30367692	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"plasmacytoid DC: 5.8"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA072244	Approved		Uncertain	"Nucleoplasm,Nucleoli fibrillar center,Vesicles"		NA	NA			"Nucleoplasm, Vesicles"	"Nucleoli fibrillar center"	"HPA072244: AB_2732197"	"unprognostic (9.44e-2)"	"unprognostic (2.38e-2)"	"unprognostic (8.64e-2)"	"prognostic unfavorable (7.68e-4)"	"unprognostic (4.46e-2)"	"unprognostic (1.24e-1)"	"unprognostic (3.06e-1)"	"unprognostic (6.10e-2)"	"unprognostic (1.26e-1)"	"unprognostic (1.67e-1)"	"unprognostic (1.71e-1)"	"unprognostic (5.93e-2)"	"prognostic favorable (2.29e-4)"	"unprognostic (1.51e-1)"	"unprognostic (2.71e-1)"	"prognostic favorable (8.71e-4)"	"unprognostic (8.67e-2)"	7.8	8.0	10.0	9.3	10.6	9.7	16.2	12.8	10.0	5.8	16.1	10.5	7.6	11.3	7.7	9.7	14.2	5.2	8.7	8.4	9.6	6.1	19.3	24.0	7.9	12.0	10.0	7.4	5.8	14.0	8.0	9.9	9.6	11.0	7.0	14.3	5.8	10.5	13.7	17.5	11.5	12.7	8.3	10.5	9.2	12.4	20.6	9.1	7.9	13.3	9.8	10.9	9.4	11.8	1.3	5.8	1.4	1.1	0.7	2.4	0.5	6.7	2.5	2.0	1.8	2.3	1.6	10.7	2.6	2.7	2.9	3.9	1.2	11.3	7.1	6.8	2.1	7.5	6.6	6.7	4.4	3.1	6.9	6.1	4.4	5.2	3.3	1.2	3.4	8.4	2.5	7.5	2.0	4.9	3.0	2.4	5.5	5.4	14.2	3.1	2.6	6.9	9.0	4.7	6.7	3.1	6.0	4.4	12.1	8.7	14.6	7.0	6.6	5.2	22.0	4.3	12.4	5.9	13.8	2.7	2.8	4.8	2.7	5.4	24.3	20.8	9.3	3.1	7.4	4.1	0.5	0.9	1.1	1.0	0.9	1.5	1.3	1.2	1.4	0.8	0.8	0.7	1.1	1.4	0.7	1.1	5.8	2.4	0.5	10.0	10.6	12.8	10.0	9.6	6.1	10.0	7.4	11.0	9.1	8.9	6.7	5.2	5.8	14.2	11.0	3.2	17.8	2.7	4.5	15.7	39.3	7.5	6.6	4.9	4.3	4.5	42.5	0.0	8.9	8.0	4.4	5.5	3.5	33.4	9.4	1.6	30.1	9.2	18.9	7.6	2.6	11.2	11.8	9.0	14.5	4.3	6.7	14.4	2.1	26.0	5.7	6.5	7.2	20.9	7.9	16.6	9.6	8.7	19.6	10.8
ZNRF3	"BK747E2.3, FLJ22057, KIAA1133, RNF203"	ENSG00000183579	"Zinc and ring finger 3"	Q9ULT6	22	28883592-29057487	"Enzymes, Predicted membrane proteins"	"Ubl conjugation pathway, Wnt signaling pathway"	"Developmental protein, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"Hep G2: 29.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036702, HPA036703"	Uncertain		Uncertain	"Golgi apparatus"		NA	NA			"Golgi apparatus"		"HPA036702: , HPA036703: AB_10672227"	"unprognostic (1.07e-1)"	"unprognostic (2.13e-3)"	"unprognostic (7.48e-3)"	"unprognostic (5.72e-2)"	"unprognostic (6.81e-2)"	"unprognostic (1.36e-1)"	"unprognostic (2.22e-2)"	"unprognostic (1.75e-2)"	"unprognostic (1.37e-1)"	"unprognostic (3.68e-2)"	"unprognostic (5.18e-2)"	"unprognostic (3.94e-1)"	"unprognostic (9.55e-5)"	"unprognostic (6.49e-2)"	"unprognostic (1.02e-1)"	"unprognostic (3.70e-2)"	"unprognostic (2.55e-2)"	4.6	11.8	16.8	2.5	14.7	1.0	4.5	12.2	18.1	7.8	5.7	7.7	21.8	5.1	8.3	22.2	5.9	8.1	3.8	4.3	22.0	5.0	13.6	7.5	8.7	1.2	6.1	17.7	10.0	5.4	16.3	4.2	8.0	8.1	12.0	5.9	4.9	12.1	13.4	5.6	7.6	4.7	7.8	8.9	2.2	6.4	6.7	10.5	0.0	6.9	1.9	1.5	5.7	4.9	0.2	0.4	1.5	1.0	2.0	0.5	0.1	3.7	8.9	8.3	2.3	1.5	1.8	15.8	2.3	1.1	1.8	1.7	13.4	2.1	0.0	3.6	1.2	3.3	6.4	5.7	3.5	2.2	4.9	5.8	1.5	1.6	29.2	1.4	4.3	1.5	1.8	3.3	2.9	2.9	1.5	1.6	2.7	3.1	2.1	2.5	3.5	0.1	2.2	3.0	4.7	3.6	4.4	5.4	3.4	7.7	5.5	13.8	5.1	4.0	4.0	2.3	2.7	2.7	2.0	1.5	6.9	6.0	5.4	3.7	2.8	3.9	5.2	3.0	2.5	3.6	1.0	0.2	1.3	0.2	1.0	0.4	0.1	0.2	0.1	0.4	0.2	0.1	0.5	1.5	2.0	0.2	0.3	0.1	0.1	16.8	14.7	12.2	18.1	22.0	5.0	6.1	17.7	8.1	10.5	11.9	17.6	0.0	4.4	11.2	3.7	6.2	5.1	6.7	6.8	12.2	0.0	23.0	1.7	4.7	12.1	5.2	1.3	23.3	2.1	1.5	4.7	6.0	0.0	16.1	2.9	1.6	8.1	1.8	1.0	11.0	10.0	0.2	0.0	0.0	8.3	6.6	4.0	0.0	12.0	9.8	4.1	0.0	4.4	3.4	2.9	6.6	6.4	0.7	14.1	2.0
ZNRF4	"RNF204, spzn, Ssrzf1"	ENSG00000105428	"Zinc and ring finger 4"	Q8WWF5	19	5455431-5456856	"Enzymes, Predicted membrane proteins"		Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	243	"testis: 90.2"	"Group enriched"	"Detected in some"	94	"Early spermatids: 525.4;Late spermatids: 405.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"									NA	NA																							0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	90.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	525.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	405.2	4.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.2	0.0	0.0	0.0	0.0	4.7	3.1	0.0	0.0	0.0	0.0	0.0
ZRANB1	TRABID	ENSG00000019995	"Zinc finger RANBP2-type containing 1"	Q9UGI0	10	124942123-124988189	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway, Wnt signaling pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029239, HPA029240, HPA029241"	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA029239: AB_10599419, HPA029240: AB_10601450, HPA029241: AB_10602205"	"unprognostic (2.06e-1)"	"unprognostic (5.16e-2)"	"unprognostic (6.96e-2)"	"unprognostic (1.67e-1)"	"unprognostic (1.40e-1)"	"unprognostic (9.53e-3)"	"unprognostic (4.16e-2)"	"unprognostic (1.89e-1)"	"unprognostic (1.71e-1)"	"unprognostic (1.46e-1)"	"unprognostic (4.20e-1)"	"unprognostic (1.46e-1)"	"unprognostic (1.22e-2)"	"unprognostic (1.60e-1)"	"unprognostic (2.76e-1)"	"unprognostic (1.26e-1)"	"unprognostic (1.47e-2)"	5.1	9.3	4.9	1.9	4.7	7.9	5.3	11.9	6.0	6.3	5.2			1.4	5.9	5.2	4.1	4.4	3.6	7.3	4.6	4.0	4.2	10.4	4.2	2.5	4.4		8.6	3.1	7.1	3.9	3.9		4.6	3.3		3.4	5.8	18.0	5.2	3.0	6.3	3.8	2.8	3.6	7.7			3.8		3.9	4.2	4.8	3.4	1.4	4.6	1.1	3.8	4.4	0.8	7.7	4.4	9.5	6.9	14.8	12.5	4.0	7.6	20.8	14.5	16.9	6.6	6.1	8.1	5.7	9.6	4.7	5.6	12.0	5.6	19.6	8.6	5.9	4.6	5.1	7.1	31.6	6.9	3.5	13.8	16.5	10.6	22.8	20.3	9.1	7.5	0.6	6.7	7.8	6.1	8.1	6.0	3.4	4.2	4.8	7.0	6.7	3.6	6.4	5.6	4.8	8.1	6.4	5.0	8.4	9.3	5.5	5.9	6.7	6.2	6.4	5.1	9.4	7.2	6.2	9.4	7.0	4.9	3.0	2.1	1.1	3.0	2.2	0.4	1.9	2.4	2.6	2.2	0.9	3.4	4.4	3.3	4.6	3.8	0.5	1.4	2.2	0.8											17.9	25.9	5.7	19.6	21.9	32.7	21.0	15.3	21.4	19.4	17.4	47.1	10.6	0.0	11.6	60.8	18.8	11.6	0.0	10.0	8.1	20.6	26.5	25.4	38.0	10.6	35.0	25.7	15.4	16.8	27.1	22.2	19.1	15.1	8.2	15.7	23.9	15.7	8.2	21.5	8.7	24.5	12.9	24.7	23.3	19.0	24.3	23.0	17.5	10.5	20.0
ZSWIM2	"MEX, MGC33890, ZZZ2"	ENSG00000163012	"Zinc finger SWIM-type containing 2"	Q8NEG5	2	186827835-186849208	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Apoptosis, Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in some"	12	"testis: 17.4"	"Group enriched"	"Detected in some"	5	"Early spermatids: 41.7;Late spermatids: 15.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HSkMC: 1.1;U-138 MG: 2.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"									NA	NA										"unprognostic (2.00e-1)"													0.0	0.1	0.1	0.0	0.3	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	17.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.7	0.0	0.3	0.2	0.5	0.4	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.2	0.4	0.3	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.9	0.1	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.5	0.1	0.4	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	41.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	15.4	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.2	0.6	0.0	0.2	0.0	0.0	0.0
